PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	El Kharbili, M; Agaesse, G; Barbollat-Boutrand, L; Pommier, RM; de la Fouchardiere, A; Larue, L; Caramel, J; Puisieux, A; Berthier-Vergnes, O; Masse, I				El Kharbili, Manale; Agaesse, Gweltaz; Barbollat-Boutrand, Laetitia; Pommier, Roxane M.; de la Fouchardiere, Arnaud; Larue, Lionel; Caramel, Julie; Puisieux, Alain; Berthier-Vergnes, Odile; Masse, Ingrid			Tspan8-beta-catenin positive feedback loop promotes melanoma invasion	ONCOGENE			English	Article							BETA-CATENIN EXPRESSION; TETRASPANIN CO-029; CELL MOTILITY; METASTASIS; TUMORS; OVEREXPRESSION; ASSOCIATION; PROGRESSION; CADHERIN; PATHWAY	Due to its high proclivity to metastasize, and despite the recent development of targeted and immune therapy strategies, melanoma is still the deadliest form of skin cancer. Therefore, understanding the molecular mechanisms underlying melanoma invasion remains crucial. We previously characterized Tspan8 for its ability to prompt melanoma cell detachment from their microenvironment and trigger melanoma cell invasiveness, but the signaling events by which Tspan8 regulates the invasion process still remain unknown. Here, we demonstrated that beta-catenin stabilization is a molecular signal subsequent to the onset of Tspan8 expression, and that, in turn, beta-catenin triggers the direct transcriptional activation of Tspan8 expression, leading to melanoma invasion. Moreover, we showed that beta-catenin activation systematically correlates with a high expression of Tspan8 protein in melanoma lesions from transgenic Nras; bcat* mice, as well as in deep penetrating naevi, a type of human pre-melanoma neoplasm characterized by a combined activation of beta-catenin and MAP kinase signaling. Overall, our data suggest that beta-catenin and Tspan8 are part of a positive feedback loop, which sustains a high Tspan8 expression level, conferring to melanoma cells the invasive properties required for tumor progression and dissemination.	[El Kharbili, Manale; Agaesse, Gweltaz; Barbollat-Boutrand, Laetitia; Berthier-Vergnes, Odile; Masse, Ingrid] Univ Lyon, F-69003 Lyon, France; [El Kharbili, Manale; Agaesse, Gweltaz; Barbollat-Boutrand, Laetitia; Berthier-Vergnes, Odile; Masse, Ingrid] Univ Lyon 1, F-69003 Lyon, France; [El Kharbili, Manale; Agaesse, Gweltaz; Barbollat-Boutrand, Laetitia; Berthier-Vergnes, Odile; Masse, Ingrid] CNRS, UMR5534, Ctr Genet & Physiol Mol & Cellulaires, F-69622 Villeurbanne, France; [Pommier, Roxane M.; de la Fouchardiere, Arnaud; Caramel, Julie; Puisieux, Alain] Univ Lyon 1, Univ Lyon, Ctr Rech Cancerol Lyon, CNRS,UMR5286,Inserm,U1052, F-69000 Lyon, France; [de la Fouchardiere, Arnaud] Ctr Leon Berard, Dept Biopathol, Lyon, France; [Larue, Lionel] PSL Res Univ, Normal & Pathol Dev Melanocytes, Inst Curie, INSERM,U1021, Orsay, France; [Larue, Lionel] Univ Paris Saclay, Univ Paris Sud, CNRS, UMR 3347, Orsay, France; [Larue, Lionel] Equipe Labellisee Ligue Canc, Orsay, France; [El Kharbili, Manale] Univ Colorado, Dept Dermatol, Anschutz Med Campus,12800 E 19th Ave,P18-8132, Aurora, CO 80045 USA; [Barbollat-Boutrand, Laetitia; Masse, Ingrid] Univ Lyon 1, Univ Lyon, Ctr Rech Cancerol Lyon, CNRS,UMR5286,Inserm,U1052, F-69000 Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; University of Colorado System; University of Colorado Anschutz Medical Campus; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard	Masse, I (corresponding author), Univ Lyon, F-69003 Lyon, France.; Masse, I (corresponding author), Univ Lyon 1, F-69003 Lyon, France.; Masse, I (corresponding author), CNRS, UMR5534, Ctr Genet & Physiol Mol & Cellulaires, F-69622 Villeurbanne, France.; Masse, I (corresponding author), Univ Lyon 1, Univ Lyon, Ctr Rech Cancerol Lyon, CNRS,UMR5286,Inserm,U1052, F-69000 Lyon, France.	ingrid.masse@univ-lyon1.fr		Caramel, Julie/0000-0002-8883-918X; POMMIER, Roxane/0000-0002-5351-7367; MASSE, Ingrid/0000-0003-3193-970X; PUISIEUX, Alain/0000-0002-9938-3798	French Society for Dermatological Research (SRD); La Ligue Contre le Cancer (Comite Ardeche); association "Vaincre le Melanome"	French Society for Dermatological Research (SRD); La Ligue Contre le Cancer (Comite Ardeche); association "Vaincre le Melanome"	This work was supported by a grant from the French Society for Dermatological Research (SRD), a grant from La Ligue Contre le Cancer (Comite Ardeche) and a grant from the association "Vaincre le Melanome".	Abe M, 2008, CANCER LETT, V266, P163, DOI 10.1016/j.canlet.2008.02.058; Agaesse G, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.11; Agaesse G, 2017, ONCOGENE, V36, P446, DOI 10.1038/onc.2016.219; Ailane N, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00364; Aktary Z, 2016, PIGM CELL MELANOMA R, V29, P524, DOI 10.1111/pcmr.12501; Arozarena I, 2011, ONCOGENE, V30, P4531, DOI 10.1038/onc.2011.162; Bachmann IM, 2005, CLIN CANCER RES, V11, P8606, DOI 10.1158/1078-0432.CCR-05-0011; Berthier-Vergnes O, 2011, BRIT J CANCER, V104, P155, DOI 10.1038/sj.bjc.6605994; Bhansali M, 2016, MOL ENDOCRINOL, V30, P13, DOI 10.1210/me.2015-1075; Cavard C, 2006, ONCOGENE, V25, P599, DOI 10.1038/sj.onc.1208860; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Claas C, 1998, J CELL BIOL, V141, P267, DOI 10.1083/jcb.141.1.267; Conde-Perez A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9093; Damsky WE, 2011, CANCER CELL, V20, P741, DOI 10.1016/j.ccr.2011.10.030; Delmas V, 2003, GENESIS, V36, P73, DOI 10.1002/gene.10197; Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107; Eichhoff OM, 2011, PIGM CELL MELANOMA R, V24, P631, DOI 10.1111/j.1755-148X.2011.00871.x; El Kharbili M, 2017, ONCOTARGET, V8, P17140, DOI 10.18632/oncotarget.15084; Gallagher SJ, 2013, ONCOGENE, V32, P2230, DOI 10.1038/onc.2012.229; Gesierich S, 2005, CLIN CANCER RES, V11, P2840, DOI 10.1158/1078-0432.CCR-04-1935; Gesierich S, 2006, CANCER RES, V66, P7083, DOI 10.1158/0008-5472.CAN-06-0391; Greco C, 2010, CANCER RES, V70, P7674, DOI 10.1158/0008-5472.CAN-09-4482; Grossmann AH, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003398; Guo Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053523; Hemler ME, 2014, NAT REV CANCER, V14, P49, DOI 10.1038/nrc3640; Herlevsen M, 2003, J CELL SCI, V116, P4373, DOI 10.1242/jcs.00760; Kageshita T, 2001, BRIT J DERMATOL, V145, P210, DOI 10.1046/j.1365-2133.2001.04336.x; Kanetaka K, 2003, J GASTROEN HEPATOL, V18, P1309, DOI 10.1046/j.1440-1746.2003.03182.x; Kanetaka K, 2001, J HEPATOL, V35, P637, DOI 10.1016/S0168-8278(01)00183-0; Larue L, 2006, FRONT BIOSCI-LANDMRK, V11, P733, DOI 10.2741/1831; Le Naour F, 2006, MOL CELL PROTEOMICS, V5, P845, DOI 10.1074/mcp.M500330-MCP200; Li L, 2018, INT J ONCOL, V52, P473, DOI 10.3892/ijo.2017.4231; Luke JJ, 2017, NAT REV CLIN ONCOL, V14, P463, DOI 10.1038/nrclinonc.2017.43; Maelandsmo GM, 2003, CLIN CANCER RES, V9, P3383; Maisonial-Besset A, 2017, ONCOTARGET, V8, P22034, DOI 10.18632/oncotarget.15787; Masse I, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.62; Murakami T, 2001, BIOCHEM BIOPH RES CO, V288, P8, DOI 10.1006/bbrc.2001.5719; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Pan SJ, 2015, INT J MOL SCI, V16, P5363, DOI 10.3390/ijms16035363; Pan SJ, 2015, BIOCHEM BIOPH RES CO, V458, P476, DOI 10.1016/j.bbrc.2015.01.128; Park CS, 2016, ONCOGENE, V35, P4540, DOI 10.1038/onc.2015.520; Rodia MT, 2016, ONCOTARGET, V7, P30295, DOI 10.18632/oncotarget.8108; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Seubert B, 2015, INT J CANCER, V136, P2304, DOI 10.1002/ijc.29296; Shain AH, 2016, NEW ENGL J MED, V374, P995, DOI 10.1056/NEJMc1515834; Sinnberg T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023429; SZALA S, 1990, P NATL ACAD SCI USA, V87, P3542, DOI 10.1073/pnas.87.9.3542; Yeh I, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00758-3; Yue SJ, 2015, ONCOTARGET, V6, P2366, DOI 10.18632/oncotarget.2958; Zhou Z, 2008, CLIN EXP METASTAS, V25, P537, DOI 10.1007/s10585-008-9168-0; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	51	16	16	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 16	2019	38	20					3781	3793		10.1038/s41388-019-0691-z	http://dx.doi.org/10.1038/s41388-019-0691-z			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HY3OI	30679790				2022-12-26	WOS:000468035600002
J	Stancill, JS; Broniowska, KA; Oleson, BJ; Naatz, A; Corbett, JA				Stancill, Jennifer S.; Broniowska, Katarzyna A.; Oleson, Bryndon J.; Naatz, Aaron; Corbett, John A.			Pancreatic beta-cells detoxify H2O2 through the peroxiredoxin/thioredoxin antioxidant system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hydrogen peroxide; beta-cell; oxidative stress; thioredoxin reductase; reactive oxygen species (ROS); diabetes; metabolic dysfunction; oxidative phosphorylation; ROS detoxification	OXIDATIVE STRESS; DNA-DAMAGE; GLUTATHIONE-PEROXIDASE; SUPEROXIDE-DISMUTASE; INSULIN-SECRETION; RINM5F CELLS; NITRIC-OXIDE; GLUCOSE; EXPRESSION; TOXICITY	Oxidative stress is thought to promote pancreatic beta-cell dysfunction and contribute to both type 1 and type 2 diabetes. Reactive oxygen species (ROS), such as superoxide and hydrogen peroxide, are mediators of oxidative stress that arise largely from electron leakage during oxidative phosphorylation. Reports that beta-cells express low levels of antioxidant enzymes, including catalase and GSH peroxidases, have supported a model in which beta-cells are ill-equipped to detoxify ROS. This hypothesis seems at odds with the essential role of beta-cells in the control of metabolic homeostasis and organismal survival through exquisite coupling of oxidative phosphorylation, a prominent ROS-producing pathway, to insulin secretion. Using glucose oxidase to deliver H2O2 continuously over time and Amplex Red to measure extracellular H2O2 concentration, we found here that beta-cells can remove micromolar levels of this oxidant. This detoxification pathway utilizes the peroxiredoxin/thioredoxin antioxidant system, as selective chemical inhibition or siRNA-mediated depletion of thioredoxin reductase sensitized beta-cells to continuously generated H2O2. In contrast, when delivered as a bolus, H2O2 induced the DNA damage response, depleted cellular energy stores, and decreased beta-cell viability independently of thioredoxin reductase inhibition. These findings show that beta-cells have the capacity to detoxify micromolar levels of H2O2 through a thioredoxin reductase-dependent mechanism and are not as sensitive to oxidative damage as previously thought.	[Stancill, Jennifer S.; Broniowska, Katarzyna A.; Oleson, Bryndon J.; Naatz, Aaron; Corbett, John A.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Corbett, JA (corresponding author), Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA.	jcorbett@mcw.edu		Stancill, Jennifer/0000-0002-1612-4695	NIDDK, National Institutes of Health [DK-052194]; Division of Intramural Research, NIAID, National Institutes of Health [AI-044458]; NHLBI, National Institutes of Health [T32 HL134643]; American Heart Association Fellowship [14PRE20380585]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL134643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052194] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Division of Intramural Research, NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health Grant DK-052194; Division of Intramural Research, NIAID, National Institutes of Health Grant AI-044458; and a gift from the Forest County Potawatomi Foundation (to J. A. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the NHLBI, National Institutes of Health Grant T32 HL134643.; Supported by American Heart Association Fellowship 13POST16940076.; Supported by American Heart Association Fellowship 14PRE20380585.	Ackermann AM, 2007, J MOL ENDOCRINOL, V38, P193, DOI 10.1677/JME-06-0053; Alfar EA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03873-9; Bast A, 2002, DIABETOLOGIA, V45, P867, DOI 10.1007/s00125-002-0846-1; Benhamou PY, 1998, DIABETOLOGIA, V41, P1093, DOI 10.1007/s001250051035; Broniowska KA, 2015, J BIOL CHEM, V290, P7952, DOI 10.1074/jbc.M114.627869; Broniowska KA, 2013, BIOCHEMISTRY-US, V52, P4364, DOI 10.1021/bi400342t; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; GHISELLI A, 1992, FREE RADICAL BIO MED, V13, P621, DOI 10.1016/0891-5849(92)90036-G; GOPAUL NK, 1995, FEBS LETT, V368, P225, DOI 10.1016/0014-5793(95)00649-T; GRANKVIST K, 1981, BIOCHEM J, V199, P393, DOI 10.1042/bj1990393; Harmon JS, 2009, ENDOCRINOLOGY, V150, P4855, DOI 10.1210/en.2009-0708; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hotta M, 1998, J EXP MED, V188, P1445, DOI 10.1084/jem.188.8.1445; Ihara Y, 1999, DIABETES, V48, P927, DOI 10.2337/diabetes.48.4.927; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Kalyanaraman B, 2017, ARCH BIOCHEM BIOPHYS, V617, P38, DOI 10.1016/j.abb.2016.08.021; Kelly Colleen B, 2003, Methods Mol Med, V83, P3; Khan P, 2014, APPL BIOCHEM BIOTECH, V173, P333, DOI 10.1007/s12010-014-0850-1; KUBISCH HM, 1994, P NATL ACAD SCI USA, V91, P9956, DOI 10.1073/pnas.91.21.9956; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343; Lenzen S, 2017, BBA-GEN SUBJECTS, V1861, P1929, DOI 10.1016/j.bbagen.2017.05.013; Long LH, 2009, BIOCHEM BIOPH RES CO, V388, P700, DOI 10.1016/j.bbrc.2009.08.069; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; Marinho HS, 2013, METHOD ENZYMOL, V526, P159, DOI 10.1016/B978-0-12-405883-5.00010-7; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Meares GP, 2013, AM J PHYSIOL-ENDOC M, V304, pE614, DOI 10.1152/ajpendo.00424.2012; Mehmeti I, 2014, J BIOL CHEM, V289, P26904, DOI 10.1074/jbc.M114.568329; Munro D, 2017, J EXP BIOL, V220, P1170, DOI 10.1242/jeb.132142; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; NOUROOZZADEH J, 1995, DIABETES, V44, P1054, DOI 10.2337/diabetes.44.9.1054; Olahova M, 2015, AGING CELL, V14, P558, DOI 10.1111/acel.12321; Oleson BJ, 2016, MOL CELL BIOL, V36, P2067, DOI 10.1128/MCB.00262-16; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Paula FMM, 2013, MOL CELL ENDOCRINOL, V374, P56, DOI 10.1016/j.mce.2013.04.009; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Rehman A, 1999, FEBS LETT, V448, P120, DOI 10.1016/S0014-5793(99)00339-7; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Sakuraba H, 2002, DIABETOLOGIA, V45, P85, DOI 10.1007/s125-002-8248-z; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; Shin CS, 2001, DIABETES CARE, V24, P733, DOI 10.2337/diacare.24.4.733; Sobotta MC, 2015, NAT CHEM BIOL, V11, P64, DOI 10.1038/nchembio.1695; STOCCHI V, 1987, ANAL BIOCHEM, V167, P181, DOI 10.1016/0003-2697(87)90150-3; Stocker S, 2018, NAT CHEM BIOL, V14, P148, DOI 10.1038/nchembio.2536; Tanaka Y, 1999, P NATL ACAD SCI USA, V96, P10857, DOI 10.1073/pnas.96.19.10857; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P12363, DOI 10.1073/pnas.192445199; Tiedge M, 1998, DIABETES, V47, P1578, DOI 10.2337/diabetes.47.10.1578; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Wolf G, 2010, J ENDOCRINOL, V207, P163, DOI 10.1677/JOE-09-0455; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Xu B, 1999, FREE RADICAL BIO MED, V27, P830, DOI 10.1016/S0891-5849(99)00130-6; Zhao F, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-22	57	39	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4843	4853		10.1074/jbc.RA118.006219	http://dx.doi.org/10.1074/jbc.RA118.006219			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30659092	hybrid, Green Published			2022-12-26	WOS:000463985600010
J	Gonzalez-Magana, A; de Opakua, AI; Romano-Moreno, M; Murciano-Calles, J; Merino, N; Luque, I; Rojas, AL; Onesti, S; Blanco, FJ; De Biasio, A				Gonzalez-Magana, Amaia; Ibanez de Opakua, Alain; Romano-Moreno, Miguel; Murciano-Calles, Javier; Merino, Nekane; Luque, Irene; Rojas, Adriana L.; Onesti, Silvia; Blanco, Francisco J.; De Biasio, Alfredo			The p12 subunit of human polymerase uses an atypical PIP box for molecular recognition of proliferating cell nuclear antigen (PCNA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA replication; DNA polymerase; proliferating cell nuclear antigen (PCNA); protein-protein interaction; processivity; protein structure; PCNA interacting sequence; PIP-box	DNA-POLYMERASE; UBIQUITIN LIGASE; DELTA; REPLICATION; PROTEIN; DAMAGE; DEGRADATION; PREDICTION; COMPLEX; MOTIFS	Human DNA polymerase is essential for DNA replication and acts in conjunction with the processivity factor proliferating cell nuclear antigen (PCNA). In addition to its catalytic subunit (p125), pol comprises three regulatory subunits (p50, p68, and p12). PCNA interacts with all of these subunits, but only the interaction with p68 has been structurally characterized. Here, we report solution NMR-, isothermal calorimetry-, and X-ray crystallography-based analyses of the p12-PCNA interaction, which takes part in the modulation of the rate and fidelity of DNA synthesis by pol . We show that p12 binds with micromolar affinity to the classical PIP-binding pocket of PCNA via a highly atypical PIP box located at the p12 N terminus. Unlike the canonical PIP box of p68, the PIP box of p12 lacks the conserved glutamine; binds through a 2-fork plug made of an isoleucine and a tyrosine residue at +3 and +8 positions, respectively; and is stabilized by an aspartate at +6 position, which creates a network of intramolecular hydrogen bonds. These findings add to growing evidence that PCNA can bind a diverse range of protein sequences that may be broadly grouped as PIP-like motifs as has been previously suggested.	[Gonzalez-Magana, Amaia; Ibanez de Opakua, Alain; Romano-Moreno, Miguel; Merino, Nekane; Rojas, Adriana L.; Blanco, Francisco J.] CIC bioGUNE, Parque Tecnol Bizkaia Edificio 800, Derio 48160, Spain; [Murciano-Calles, Javier; Luque, Irene] Univ Granada, Dept Phys Chem, E-18071 Granada, Spain; [Murciano-Calles, Javier; Luque, Irene] Univ Granada, Inst Biotechnol, E-18071 Granada, Spain; [Onesti, Silvia; De Biasio, Alfredo] Elettra Sincrotrone Trieste SCpA, Struct Biol Lab, I-34149 Trieste, Italy; [Blanco, Francisco J.] Ikerbasque, Basque Fdn Sci, Bilbao 48013, Spain; [De Biasio, Alfredo] Univ Leicester, Leicester Inst Struct & Chem Biol, Lancaster Rd, Leicester LE1 7HB, Leics, England; [De Biasio, Alfredo] Univ Leicester, Dept Mol & Cell Biol, Lancaster Rd, Leicester LE1 7HB, Leics, England; [Ibanez de Opakua, Alain] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Gottingen, Germany	CIC bioGUNE; University of Granada; University of Granada; Elettra Sincrotrone Trieste; Basque Foundation for Science; University of Leicester; University of Leicester; Max Planck Society	Blanco, FJ (corresponding author), CIC bioGUNE, Parque Tecnol Bizkaia Edificio 800, Derio 48160, Spain.; De Biasio, A (corresponding author), Univ Leicester, Leicester Inst Struct & Chem Biol, Lancaster Rd, Leicester LE1 7HB, Leics, England.; De Biasio, A (corresponding author), Univ Leicester, Dept Mol & Cell Biol, Lancaster Rd, Leicester LE1 7HB, Leics, England.	fblanco@cicbiogune.es; adb43@leicester.ac.uk	Blanco, Francisco J/D-4401-2009; Luque, Irene/K-4758-2012; Ibáñez de Opakua, Alain/H-5081-2018; Murciano-Calles, Javier/J-8897-2012; Rojas, Adriana L./G-2403-2011	Blanco, Francisco J/0000-0003-2545-4319; Luque, Irene/0000-0003-2757-4779; Ibáñez de Opakua, Alain/0000-0003-1700-9354; Murciano-Calles, Javier/0000-0002-8667-1651; Gonzalez Magana, Amaia/0000-0002-6007-8390; Rojas, Adriana L./0000-0002-7358-3505; Onesti, Silvia/0000-0002-0612-7948; De Biasio, Alfredo/0000-0003-2139-2958	Italian Association for Cancer Research (iCARE fellowship from AIRC); Italian Association for Cancer Research (European Commission); Italian Association for Cancer Research (AIRC Grant) [IG14718]; MINECO/FEDER, UE [CTQ2017-83810-R]; MINECO Fellowship [BES-2015-075847]; Basque Government Predoctoral Fellowship [PRE_2016_2_0249]	Italian Association for Cancer Research (iCARE fellowship from AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Association for Cancer Research (European Commission); Italian Association for Cancer Research (AIRC Grant)(Fondazione AIRC per la ricerca sul cancro); MINECO/FEDER, UE(Spanish Government); MINECO Fellowship(Spanish Government); Basque Government Predoctoral Fellowship	This work was supported by the Italian Association for Cancer Research (iCARE fellowship from AIRC and the European Commission to A. D. B. and AIRC Grant IG14718 to S. O.), by Grant CTQ2017-83810-R (MINECO/FEDER, UE; to F. J. B.), by MINECO Fellowship BES-2015-075847 (to A. G.-M.), and by Basque Government Predoctoral Fellowship PRE_2016_2_0249 (to M. R.-M.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Anthis NJ, 2013, PROTEIN SCI, V22, P851, DOI 10.1002/pro.2253; Armstrong AA, 2012, NATURE, V483, P59, DOI 10.1038/nature10883; Baranovskiy AG, 2008, CELL CYCLE, V7, P3026, DOI 10.4161/cc.7.19.6720; Boehm EM, 2016, BIOESSAYS, V38, P1117, DOI 10.1002/bies.201600116; Bruning JB, 2004, STRUCTURE, V12, P2209, DOI 10.1016/j.str.2004.09.018; Bubeck D, 2011, NUCLEIC ACIDS RES, V39, P3652, DOI 10.1093/nar/gkq980; Choe KN, 2017, MOL CELL, V65, P380, DOI 10.1016/j.molcel.2016.12.020; De Biasio A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7439; De Biasio A, 2013, ADV PROTEIN CHEM STR, V91, P1, DOI 10.1016/B978-0-12-411637-5.00001-9; De Biasio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048390; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Hara K, 2018, ACTA CRYSTALLOGR F, V74, P214, DOI 10.1107/S2053230X18003242; Havens CG, 2012, J BIOL CHEM, V287, P11410, DOI 10.1074/jbc.M111.337683; Havens CG, 2009, MOL CELL, V35, P93, DOI 10.1016/j.molcel.2009.05.012; Hedglin M, 2016, ELIFE, V5, DOI 10.7554/eLife.19788; Hishiki A, 2009, J BIOL CHEM, V284, P10552, DOI 10.1074/jbc.M809745200; Hoffmann S, 2016, J CELL BIOL, V212, P63, DOI 10.1083/jcb.201506071; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kanagaraj R, 2006, NUCLEIC ACIDS RES, V34, P5217, DOI 10.1093/nar/gkl677; Kaufmann T, 2017, NUCLEIC ACIDS RES, V45, P9741, DOI 10.1093/nar/gkx604; Kontopidis G, 2005, P NATL ACAD SCI USA, V102, P1871, DOI 10.1073/pnas.0406540102; Lee MYWT, 2017, GENES-BASEL, V8, DOI 10.3390/genes8070190; LEE MYWT, 1984, BIOCHEMISTRY-US, V23, P1906, DOI 10.1021/bi00304a003; Li H, 2006, J BIOL CHEM, V281, P14748, DOI 10.1074/jbc.M600322200; Meng X, 2010, BIOCHEMISTRY-US, V49, P3545, DOI 10.1021/bi100042b; Meng X, 2009, NUCLEIC ACIDS RES, V37, P647, DOI 10.1093/nar/gkn1000; Michishita M, 2011, GENES CELLS, V16, P12, DOI 10.1111/j.1365-2443.2010.01464.x; Mo JY, 2000, BIOCHEMISTRY-US, V39, P7245, DOI 10.1021/bi0000871; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nishida H, 2009, P NATL ACAD SCI USA, V106, P20693, DOI 10.1073/pnas.0907780106; Olaisen C, 2018, FEBS OPEN BIO, V8, P1135, DOI 10.1002/2211-5463.12442; Palacios A, 2008, J BIOL CHEM, V283, P15956, DOI 10.1074/jbc.M710020200; PRELICH G, 1987, NATURE, V326, P471, DOI 10.1038/326471a0; Rahmeh AA, 2012, BIOCHEMISTRY-US, V51, P416, DOI 10.1021/bi201638e; Sebesta M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15847; Tahirov Tahir H, 2012, Subcell Biochem, V62, P217, DOI 10.1007/978-94-007-4572-8_12; TAN CK, 1986, J BIOL CHEM, V261, P2310; Urban V, 2016, J CELL BIOL, V214, P401, DOI 10.1083/jcb.201507099; Wang Y, 2016, BIOCHEM BIOPH RES CO, V474, P264, DOI 10.1016/j.bbrc.2016.04.053; Wang YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027092; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xie B, 2002, BIOCHEMISTRY-US, V41, P13133, DOI 10.1021/bi0262707; Xu H, 2001, BIOCHEMISTRY-US, V40, P4512, DOI 10.1021/bi010103+; Zhang P, 1999, J BIOL CHEM, V274, P26647, DOI 10.1074/jbc.274.38.26647; ZHANG SJ, 1995, J BIOL CHEM, V270, P7988, DOI 10.1074/jbc.270.14.7988; Zhang SF, 2007, J BIOL CHEM, V282, P15330, DOI 10.1074/jbc.M610356200; Zhang SF, 2013, J BIOL CHEM, V288, P29550, DOI 10.1074/jbc.M113.490466; Zhou YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039156	54	10	10	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					3947	3956		10.1074/jbc.RA118.006391	http://dx.doi.org/10.1074/jbc.RA118.006391			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30655288	Green Published, hybrid			2022-12-26	WOS:000461854400012
J	Sanchez-Lozada, LG; Andres-Hernando, A; Garcia-Arroyo, FE; Cicerchi, C; Li, NX; Kuwabara, M; Roncal-Jimenez, CA; Johnson, RJ; Lanaspa, MA				Sanchez-Lozada, Laura G.; Andres-Hernando, Ana; Garcia-Arroyo, Fernando E.; Cicerchi, Christina; Li, Nanxing; Kuwabara, Masanari; Roncal-Jimenez, Carlos A.; Johnson, Richard J.; Lanaspa, Miguel A.			Uric acid activates aldose reductase and the polyol pathway for endogenous fructose and fat production causing development of fatty liver in rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fructose; uric acid; metabolic syndrome; liver metabolism; fatty acid; aldose reductase; polyol pathway; sorbitol	TRANSCRIPTIONAL ACTIVATOR; CELL-PROLIFERATION; METABOLIC SYNDROME; HYPERTONIC STRESS; DIETARY FRUCTOSE; OXIDATIVE STRESS; EXPRESSION; DISEASE; CONSUMPTION; CHILDREN	Dietary, fructose-containing sugars have been strongly associated with the development of nonalcoholic fatty liver disease (NAFLD). Recent studies suggest that fructose also can be produced via the polyol pathway in the liver, where it may induce hepatic fat accumulation. Moreover, fructose metabolism yields uric acid, which is highly associated with NAFLD. Here, using biochemical assays, reporter gene expression, and confocal fluorescence microscopy, we investigated whether uric acid regulates aldose reductase, a key enzyme in the polyol pathway. We evaluated whether soluble uric acid regulates aldose reductase expression both in cultured hepatocytes (HepG2 cells) and in the liver of hyperuricemic rats and whether this stimulation is associated with endogenous fructose production and fat accumulation. Uric acid dose-dependently stimulated aldose reductase expression in the HepG2 cells, and this stimulation was associated with endogenous fructose production and triglyceride accumulation. This stimulatory mechanism was mediated by uric acid-induced oxidative stress and stimulation of the transcription factor nuclear factor of activated T cells 5 (NFAT5). Uric acid also amplified the effects of elevated glucose levels to stimulate hepatocyte triglyceride accumulation. Hyperuricemic rats exhibited elevated hepatic aldose reductase expression, endogenous fructose accumulation, and fat buildup that was significantly reduced by co-administration of the xanthine oxidase inhibitor allopurinol. These results suggest that uric acid generated during fructose metabolism may act as a positive feedback mechanism that stimulates endogenous fructose production by stimulating aldose reductase in the polyol pathway. Our findings suggest an amplifying mechanism whereby soft drinks rich in glucose and fructose can induce NAFLD.	[Sanchez-Lozada, Laura G.; Garcia-Arroyo, Fernando E.] Inst Nacl Cardiol Ignacio Chavez, Lab Renal Physiopathol, Mexico City 14080, DF, Mexico; [Andres-Hernando, Ana; Cicerchi, Christina; Li, Nanxing; Kuwabara, Masanari; Roncal-Jimenez, Carlos A.; Johnson, Richard J.; Lanaspa, Miguel A.] Univ Colorado, Sch Med, Div Renal Dis & Hypertens, Aurora, CO 80045 USA	National Institute of Cardiology - Mexico; University of Colorado System; University of Colorado Anschutz Medical Campus	Lanaspa, MA (corresponding author), Univ Colorado, Sch Med, Div Renal Dis & Hypertens, Aurora, CO 80045 USA.	miguel.lanaspagarcia@ucdenver.edu	Lanaspa, Miguel/AAO-4971-2020; Sanchez-Lozada, Laura/AAS-2104-2021; Kuwabara, Masanari/O-9844-2017	Kuwabara, Masanari/0000-0002-6601-4347; Andres-Hernando, Ana/0000-0002-0676-0188; Lanaspa, Miguel/0000-0002-1163-1831; Garcia, Fernando/0000-0003-1545-9765; Sanchez-Lozada, Laura-Gabriela/0000-0003-0348-9617	National Institutes of Health [NIDDK 1R01DK109408-01A1, NIDDK R01 DK108859-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK095930, R01DK108859, R01DK109408, P30DK048520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants NIDDK 1R01DK109408-01A1 and NIDDK R01 DK108859-01. Some of the authors are members of Colorado Research Partners LLC, a start-up company developing inhibitors of fructose metabolism (M. A. L., A. A.-H., C. A. R.-J., R. J. J., and L. G. S.-L.). Dr. Johnson also has equity with a start-up company (XORT Therapeutics) developing novel xanthine oxidase inhibitors. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdelmalek MF, 2012, HEPATOLOGY, V56, P952, DOI 10.1002/hep.25741; Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535; Abid A, 2009, J HEPATOL, V51, P918, DOI 10.1016/j.jhep.2009.05.033; Ackerman Z, 2005, HYPERTENSION, V45, P1012, DOI 10.1161/01.HYP.0000164570.20420.67; Al-attar R, 2017, PEERJ, V5, DOI 10.7717/peerj.2797; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Andres-Hernando A, 2008, J BIOL CHEM, V283, P25082, DOI 10.1074/jbc.M802381200; Brown KE, 2005, HISTOL HISTOPATHOL, V20, P429, DOI 10.14670/HH-20.429; Choi YJ, 2014, LAB INVEST, V94, P1114, DOI 10.1038/labinvest.2014.98; Collison KS, 2009, OBESITY, V17, P2003, DOI 10.1038/oby.2009.58; Ferreira VSG, 2010, ARQ BRAS ENDOCRINOL, V54, P362, DOI 10.1590/S0004-27302010000400004; Garcia-Arroyo FE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202901; Gersch C, 2009, NUCLEOS NUCLEOT NUCL, V28, P118, DOI 10.1080/15257770902736400; Hodgkinson AD, 2001, KIDNEY INT, V60, P211, DOI 10.1046/j.1523-1755.2001.00788.x; Huang ZY, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-016-0158-6; Imaram W, 2010, FREE RADICAL BIO MED, V49, P275, DOI 10.1016/j.freeradbiomed.2010.04.010; Ishimoto T, 2012, P NATL ACAD SCI USA, V109, P4320, DOI 10.1073/pnas.1119908109; Jensen T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30267-2; Jensen T, 2018, J HEPATOL, V68, P1063, DOI 10.1016/j.jhep.2018.01.019; Jin R, 2012, J CLIN ENDOCR METAB, V97, pE1088, DOI 10.1210/jc.2012-1370; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Kang DH, 2002, J AM SOC NEPHROL, V13, P2888, DOI 10.1097/01.ASN.0000034910.58454.FD; Kang DH, 2005, AM J NEPHROL, V25, P425, DOI 10.1159/000087713; Kim NH, 2014, EUR J IMMUNOL, V44, P2721, DOI 10.1002/eji.201343669; Kuwabara M, 2018, INT J CARDIOL, V261, P183, DOI 10.1016/j.ijcard.2018.03.045; Lanaspa MA, 2008, P NATL ACAD SCI USA, V105, P15797, DOI 10.1073/pnas.0805761105; Lanaspa MA, 2018, P NATL ACAD SCI USA, V115, P3138, DOI 10.1073/pnas.1713837115; Lanaspa MA, 2014, J AM SOC NEPHROL, V25, P2526, DOI 10.1681/ASN.2013080901; Lanaspa MA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3434; Lanaspa MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048801; Lanaspa MA, 2012, J BIOL CHEM, V287, P40732, DOI 10.1074/jbc.M112.399899; Lanaspa MA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047948, 10.1371/journal.pone.0048801]; Lanaspa MA, 2010, J BIOL CHEM, V285, P31694, DOI 10.1074/jbc.M109.093690; Lee JW, 2010, GUT LIVER, V4, P378, DOI 10.5009/gnl.2010.4.3.378; Li YM, 2009, J HEPATOL, V50, P1029, DOI 10.1016/j.jhep.2008.11.021; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; LIN LR, 1993, INVEST OPHTH VIS SCI, V34, P2352; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; Maersk M, 2012, AM J CLIN NUTR, V95, P283, DOI 10.3945/ajcn.111.022533; Mohandas R, 2014, EXP CELL RES, V326, P136, DOI 10.1016/j.yexcr.2014.05.025; Mosca A, 2017, J HEPATOL, V66, P1031, DOI 10.1016/j.jhep.2016.12.025; Na KY, 2003, J AM SOC NEPHROL, V14, P283, DOI 10.1097/01.ASN.0000045050.19544.B2; Nakatsu Y, 2015, AM J PHYSIOL-GASTR L, V309, pG42, DOI 10.1152/ajpgi.00443.2014; Nomura K, 2012, J NUTR BIOCHEM, V23, P203, DOI 10.1016/j.jnutbio.2011.09.006; O'Connor T, 1999, BIOCHEM J, V343, P487, DOI 10.1042/0264-6021:3430487; Ouyang X, 2008, J HEPATOL, V48, P993, DOI 10.1016/j.jhep.2008.02.011; Paschos P, 2018, CURR VASC PHARMACOL, V16, P269, DOI 10.2174/1570161115666170621082237; Petta S, 2011, ALIMENT PHARM THER, V34, P757, DOI 10.1111/j.1365-2036.2011.04788.x; Qiu LX, 2012, EXP DIABETES RES, DOI 10.1155/2012/789730; Rittner HL, 1999, J CLIN INVEST, V103, P1007, DOI 10.1172/JCI4711; Ruepp B, 1996, P NATL ACAD SCI USA, V93, P8624, DOI 10.1073/pnas.93.16.8624; Sanchez-Lozada LG, 2008, AM J PHYSIOL-RENAL, V295, pF1134, DOI 10.1152/ajprenal.00104.2008; Sanchez-Lozada LG, 2012, NEPHRON EXP NEPHROL, V121, pE71, DOI 10.1159/000345509; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Schwarz JM, 2017, GASTROENTEROLOGY, V153, P743, DOI 10.1053/j.gastro.2017.05.043; Shah VO, 1997, J CLIN ENDOCR METAB, V82, P2294, DOI 10.1210/jc.82.7.2294; Sirota JC, 2013, METABOLISM, V62, P392, DOI 10.1016/j.metabol.2012.08.013; Sylvia S., 2016, 9 EUR GASTR C OCT 24; Vos MB, 2012, J PEDIATR GASTR NUTR, V54, P90, DOI 10.1097/MPG.0b013e318229da1a; Woo SK, 2002, PFLUG ARCH EUR J PHY, V444, P579, DOI 10.1007/s00424-002-0849-2; Xu CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011578; Yu MA, 2010, J HYPERTENS, V28, P1234, DOI 10.1097/HJH.0b013e328337da1d; Zhou XM, 2005, AM J PHYSIOL-RENAL, V289, pF377, DOI 10.1152/ajprenal.00463.2004	63	49	54	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4272	4281		10.1074/jbc.RA118.006158	http://dx.doi.org/10.1074/jbc.RA118.006158			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30651350	Green Published, hybrid			2022-12-26	WOS:000461854400036
J	Layton, C; Shelamoff, V; Cameron, MJ; Tatsumi, M; Wright, JT; Johnson, CR				Layton, Cayne; Shelamoff, Victor; Cameron, Matthew J.; Tatsumi, Masayuki; Wright, Jeffrey T.; Johnson, Craig R.			Resilience and stability of kelp forests: The importance of patch dynamics and environment-engineer feedbacks	PLOS ONE			English	Article							HABITAT-FORMING KELP; ECKLONIA-RADIATA; PHYSICAL DISTURBANCE; MACROCYSTIS-PYRIFERA; POPULATION BIOLOGY; LIGHT PENETRATION; SEDIMENT MOVEMENT; SUBTIDAL HABITAT; CANOPY; RECRUITMENT	Habitat forming 'ecosystem engineers' such as kelp species create complex habitats that support biodiverse and productive communities. Studies of the resilience and stability of ecosystem engineers have typically focussed on the role of external factors such as disturbance. However, their population dynamics are also likely to be influenced by internal processes, such that the environmental modifications caused by engineer species feedback to affect their own demography (e.g. recruitment, survivorship). In numerous regions globally, kelp forests are declining and experiencing reductions in patch size and kelp density. To explore how resilience and stability of kelp habitats is influenced by this habitat degradation, we created an array of patch reefs of various sizes and supporting adult Ecklonia radiata kelp transplanted at different densities. This enabled testing of how sub-canopy abiotic conditions change with reductions in patch size and adult kelp density, and how this influenced demographic processes of microscopic and macroscopic juvenile kelp. We found that ecosystem engineering by adult E. radiata modified the environment to reduce sub-canopy water flow, sedimentation, and irradiance. However, the capacity of adult kelp canopy to engineer abiotic change was dependent on patch size, and to a lesser extent, kelp density. Reductions in patch size and kelp density also impaired the recruitment, growth and survivorship of microscopic and macroscopic juvenile E. radiata, and even after the provisioning of established juveniles, demographic processes were impaired in the absence of sufficient adult kelp. These results are consistent with the hypothesis that ecosystem engineering by adult E. radiata facilitates development of juvenile conspecifics. Habitat degradation seems to impair the ability of E. radiata to engineer abiotic change, causing breakdown of positive intraspecific feedback and collapse of demographic functions, and overall, leading to reductions in ecosystem stability and resilience well before local extirpation.	[Layton, Cayne; Shelamoff, Victor; Cameron, Matthew J.; Tatsumi, Masayuki; Wright, Jeffrey T.; Johnson, Craig R.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia	University of Tasmania	Layton, C (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	cayne.layton@utas.edu.au	Layton, Cayne/J-8443-2013; Wright, Jeffrey/J-7536-2014	Layton, Cayne/0000-0002-3390-6437; Wright, Jeffrey/0000-0002-1085-4582	Australian Research Council [DP130101113]; Holsworth Wildlife Research Endowment; Australian Government Postgraduate Award	Australian Research Council(Australian Research Council); Holsworth Wildlife Research Endowment; Australian Government Postgraduate Award(Australian Government)	This study was funded by an Australian Research Council Discovery Grant (DP130101113; www.arc.gov.au) awarded to JTW and CRJ, and a Holsworth Wildlife Research Endowment (www.ecolsoc.org.au/awards-and-prizes/holsworth-wildlife-research-endowment) awarded to CL. CL was also supported by an Australian Government Postgraduate Award (www.education.gov.au) administered through the University of Tasmania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2003, OCEANOGR MAR BIOL, V41, P161; Altamirano M, 2004, AQUAT BOT, V79, P125, DOI 10.1016/j.aquabot.2004.01.011; Bennett S, 2016, MAR FRESHWATER RES, V67, P47, DOI 10.1071/MF15232; Bennett S, 2015, ECOL LETT, V18, P677, DOI 10.1111/ele.12446; Bennett S, 2014, J ECOL, V102, P1462, DOI 10.1111/1365-2745.12302; Bulleri F, 2009, J ECOL, V97, P1121, DOI 10.1111/j.1365-2745.2009.01567.x; CHAPMAN ARO, 1984, J EXP MAR BIOL ECOL, V78, P99, DOI 10.1016/0022-0981(84)90072-8; Cie DK, 2008, J PHYCOL, V44, P495, DOI 10.1111/j.1529-8817.2008.00464.x; Coleman MA, 2009, MAR FRESHWATER RES, V60, P802, DOI 10.1071/MF08268; Connell SD, 2014, MAR ECOL PROG SER, V495, P299, DOI 10.3354/meps10513; Connell SD, 2005, MAR ECOL PROG SER, V289, P53, DOI 10.3354/meps289053; Connell SD, 2003, MAR BIOL, V142, P1065, DOI 10.1007/s00227-003-1021-z; Connell SD, 2008, J BIOGEOGR, V35, P1608, DOI 10.1111/j.1365-2699.2008.01903.x; Connell SD, 2008, MAR ECOL PROG SER, V360, P63, DOI 10.3354/meps07526; Crain CM, 2006, BIOSCIENCE, V56, P211; Crotty SM, 2015, ECOLOGY, V96, P2575, DOI 10.1890/15-0240.1; Cuddington K, 2009, AM NAT, V173, P488, DOI 10.1086/597216; DAYTON PK, 1984, ECOL MONOGR, V54, P253, DOI 10.2307/1942498; DAYTON PK, 1992, ECOL MONOGR, V62, P421, DOI 10.2307/2937118; Dayton PK, 1999, ECOL MONOGR, V69, P219, DOI 10.1890/0012-9615(1999)069[0219:TASSOK]2.0.CO;2; Denny M, 1998, LIMNOL OCEANOGR, V43, P955, DOI 10.4319/lo.1998.43.5.0955; DEVINNY JS, 1978, MAR BIOL, V48, P343, DOI 10.1007/BF00391638; ECKMAN JE, 1989, J EXP MAR BIOL ECOL, V129, P173, DOI 10.1016/0022-0981(89)90055-5; Fairhead VA, 2004, MAR BIOL, V145, P41, DOI 10.1007/s00227-004-1308-8; Filbee-Dexter K, 2018, BIOSCIENCE, V68, P64, DOI 10.1093/biosci/bix147; FLETCHER WJ, 1983, J EXP MAR BIOL ECOL, V71, P205, DOI 10.1016/0022-0981(83)90115-6; Flukes EB, 2014, MAR ECOL PROG SER, V514, P57, DOI 10.3354/meps10964; Flukes EB, 2012, MAR ECOL PROG SER, V464, P179, DOI 10.3354/meps09881; FONSECA MS, 1986, MAR ECOL PROG SER, V29, P15, DOI 10.3354/meps029015; Fung T, 2011, ECOLOGY, V92, P967, DOI 10.1890/10-0378.1; Graham MH, 2003, ECOLOGY, V84, P1250, DOI 10.1890/0012-9658(2003)084[1250:CPOTSA]2.0.CO;2; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; Hurd CL, 2000, J PHYCOL, V36, P453, DOI 10.1046/j.1529-8817.2000.99139.x; Irving AD, 2002, MAR ECOL PROG SER, V245, P83, DOI 10.3354/meps245083; Irving AD, 2006, MAR ECOL PROG SER, V324, P127, DOI 10.3354/meps324127; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Jones CG, 2010, OIKOS, V119, P1862, DOI 10.1111/j.1600-0706.2010.18782.x; JONES GP, 1990, AUST J ECOL, V15, P505, DOI 10.1111/j.1442-9993.1990.tb01474.x; Jurg B, 1996, AQUAT SCI, V58, P283, DOI 10.1007/BF00877472; KENDRICK GA, 1991, J EXP MAR BIOL ECOL, V147, P47, DOI 10.1016/0022-0981(91)90036-V; KENNELLY SJ, 1987, J EXP MAR BIOL ECOL, V112, P49, DOI 10.1016/S0022-0981(87)80014-X; KENNELLY SJ, 1993, J EXP MAR BIOL ECOL, V168, P35, DOI 10.1016/0022-0981(93)90115-5; KENNELLY SJ, 1987, MAR ECOL PROG SER, V40, P145, DOI 10.3354/meps040145; KENNELLY SJ, 1989, MAR ECOL PROG SER, V50, P215, DOI 10.3354/meps050215; Kinlan BP, 2003, J PHYCOL, V39, P47, DOI 10.1046/j.1529-8817.2003.02087.x; KIRKMAN H, 1981, J EXP MAR BIOL ECOL, V55, P243, DOI 10.1016/0022-0981(81)90115-5; Kitching JA, 1941, BIOL BULL-US, V80, P324, DOI 10.2307/1537719; KOMAR PD, 1973, J SEDIMENT PETROL, V43, P1101; Konar B, 2003, ECOLOGY, V84, P174, DOI 10.1890/0012-9658(2003)084[0174:TSOBRB]2.0.CO;2; Krumhansl KA, 2016, P NATL ACAD SCI USA, V113, P13785, DOI 10.1073/pnas.1606102113; LARKUM AWD, 1986, J EXP MAR BIOL ECOL, V96, P177, DOI 10.1016/0022-0981(86)90241-8; Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; LUNING K, 1979, HELGOLAND WISS MEER, V32, P403, DOI 10.1007/BF02277985; Mabin CJT, 2013, MAR ECOL PROG SER, V483, P117, DOI 10.3354/meps10261; Mohring MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065310; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Porter ET, 2000, LIMNOL OCEANOGR, V45, P145, DOI 10.4319/lo.2000.45.1.0145; REED DC, 1988, ECOL MONOGR, V58, P321, DOI 10.2307/1942543; REED DC, 1990, ECOLOGY, V71, P776, DOI 10.2307/1940329; Romero GQ, 2015, BIOL REV, V90, P877, DOI 10.1111/brv.12138; Schiel DR, 2006, ANNU REV ECOL EVOL S, V37, P343, DOI 10.1146/annurev.ecolsys.37.091305.110251; Schiel DR, 2015, BIOL ECOLOGY GIANT K; Serrao EA, 1996, P NATL ACAD SCI USA, V93, P5286, DOI 10.1073/pnas.93.11.5286; Smale DA, 2011, MAR BIOL, V158, P1757, DOI 10.1007/s00227-011-1689-4; SOUSA WP, 1984, ECOLOGY, V65, P1918, DOI 10.2307/1937789; Steneck RS, 2014, MARINE COMMUNITY ECOLOGY AND CONSERVATION, P315; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Strain EMA, 2014, GLOBAL CHANGE BIOL, V20, P3300, DOI 10.1111/gcb.12619; Tatsumi M, 2016, MAR ECOL PROG SER, V552, P131, DOI 10.3354/meps11743; Teagle H, 2017, J EXP MAR BIOL ECOL, V492, P81, DOI 10.1016/j.jembe.2017.01.017; THOMPSON TL, 1994, LIMNOL OCEANOGR, V39, P1768, DOI 10.4319/lo.1994.39.7.1768; Toohey B, 2004, MAR BIOL, V144, P1019, DOI 10.1007/s00227-003-1267-5; Toohey BD, 2007, OIKOS, V116, P1618, DOI 10.1111/j.2007.0030-1299.15689.x; Toohey BD, 2007, J EXP MAR BIOL ECOL, V349, P170, DOI 10.1016/j.jembe.2007.05.008; Valentine JP, 2005, BOT MAR, V48, P106, DOI 10.1515/BOT.2005.025; van der Zee EM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2326; Vega JMA, 2005, REV CHIL HIST NAT, V78, P33; VELIMIROV B, 1979, BOT MAR, V22, P169, DOI 10.1515/botm.1979.22.3.169; Verges A, 2016, P NATL ACAD SCI USA, V113, P13791, DOI 10.1073/pnas.1610725113; Watanabe H, 2016, SCI REP-UK, V6, DOI 10.1038/srep18677; Wernberg T, 2005, AQUAT ECOL, V39, P419, DOI 10.1007/s10452-005-9009-z; Wernberg T, 2018, OCEANOGRAPHY MARINE, V57; Wernberg T, 2016, SCIENCE, V353, P169, DOI 10.1126/science.aad8745; WOOD WF, 1987, MAR BIOL, V96, P143, DOI 10.1007/BF00394848; Wright JP, 2004, OIKOS, V105, P336, DOI 10.1111/j.0030-1299.2004.12654.x	88	46	46	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210220	10.1371/journal.pone.0210220	http://dx.doi.org/10.1371/journal.pone.0210220			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682047	Green Published, gold, Green Accepted			2022-12-26	WOS:000457037500028
J	Varkey, R; Du, Q; Karnell, JL; Xiao, XD; Casey, KA; Woods, R; Rosenthai, K; Wilson, S; Dall'Acqua, WF; Wu, H; Herbst, R; Ettinger, R; Damschroder, M				Varkey, Reena; Du, Qun; Karnell, Jodi L.; Xiao, Xiaodong; Casey, Kerry A.; Woods, Rob; Rosenthai, Kim; Wilson, Susan; Dall'Acqua, William F.; Wu, Herren; Herbst, Ronald; Ettinger, Rachel; Damschroder, Melissa			Discovery and characterization of potent IL-21 neutralizing antibodies via a novel alternating antigen immunization and humanization strategy	PLOS ONE			English	Article							COMMON GAMMA-CHAIN; MONOCLONAL-ANTIBODIES; VARIABLE REGION; MOUSE MODEL; RECEPTOR; INTERLEUKIN-21; GENERATION; GLYCOSYLATION; CARBOHYDRATE; PROTEINS	Interleukin-21 (IL-21), a member of the common cytokine receptor gamma chain (gamma(c)) family, is secreted by CD4(+)T cells and natural killer T cells and induces effector function through interactions with the IL-21 receptor (IL-21R)/gamma(c) complex expressed on both immune and non-immune cells. Numerous studies suggest that IL-21 plays a significant role in autoimmune disorders. Therapeutic intervention to disrupt the IL-21/IL-21R/gamma(c) interaction and inhibit subsequent downstream signal transduction could offer a treatment paradigm for these diseases. Potent neutralizing antibodies reported in the literature were generated after extensive immunizations with human IL-21 alone and in combination with various adjuvants. To circumvent the laborious method of antibody generation while targeting a conserved functional epitope, we designed a novel alternating-antigen immunization strategy utilizing both human and cynomolgus monkey (cyno) IL-21. Despite the high degree of homology between human and cyno IL-21, our alternating-immunization strategy elicited higher antibody titers and more potent neutralizing hybridomas in mice than did the immunization with human IL-21 antigen alone. The lead hybridoma clone was humanized by grafting the murine complementarity-determining regions onto human germline framework templates, using a unique rational design. The final humanized and engineered antibody, MEDI7169, encodes only one murine residue at the variable heavy/light-chain interface, retains the sub-picomolar affinity for IL-21, specifically inhibits IL-21/IL-21R-mediated signaling events and is currently under clinical development as a potential therapeutic agent for autoimmune diseases. This study provides experimental evidence of the immune system's potential to recognize and respond to shared epitopes of antigens from distinct species, and presents a generally applicable, novel method for the rapid generation of exceptional therapeutic antibodies using the hybridoma platform.	[Varkey, Reena; Du, Qun; Xiao, Xiaodong; Woods, Rob; Rosenthai, Kim; Wilson, Susan; Dall'Acqua, William F.; Wu, Herren; Damschroder, Melissa] MedImmune LLC, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA; [Karnell, Jodi L.; Casey, Kerry A.; Herbst, Ronald; Ettinger, Rachel] MedImmune LLC, Dept Resp Inflammat & Autoimmun, Gaithersburg, MD USA; [Karnell, Jodi L.; Ettinger, Rachel] Viela Bio, Gaithersburg, MD USA; [Xiao, Xiaodong] Jecho Labs, Frederick, MD USA; [Woods, Rob] Novavax, Gaithersburg, MD USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune	Damschroder, M (corresponding author), MedImmune LLC, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA.	DamschroderM@medimmune.com	Casey, Kerry A/B-5274-2011; Casey, Kerry A/N-1456-2019	Casey, Kerry A/0000-0001-7194-8585; 	MedImmune, the global R&D biologics arm of AstraZeneca	MedImmune, the global R&D biologics arm of AstraZeneca	This work was funded by MedImmune, the global R&D biologics arm of AstraZeneca.	Abdiche YN, 2009, ANAL BIOCHEM, V386, P172, DOI 10.1016/j.ab.2008.11.038; ABEL CA, 1968, BIOCHEMISTRY-US, V7, P1271, DOI 10.1021/bi00844a004; Adair JR, 1999, US patent, Patent No. [5,859,205, 5859205]; Ahmadzadeh Vahideh, 2014, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V33, P67, DOI 10.1089/mab.2013.0080; Almagro JC, 2008, FRONT BIOSCI-LANDMRK, V13, P1619, DOI 10.2741/2786; Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; Bazan J, 2012, HUM VACC IMMUNOTHER, V8, P1817, DOI 10.4161/hv.21703; Brewer JM, 1999, J IMMUNOL, V163, P6448; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; Coloma MJ, 1999, J IMMUNOL, V162, P2162; Costanzo A, 2010, J DERMATOL SCI, V60, P61, DOI 10.1016/j.jdermsci.2010.08.016; Dall'Acqua WF, 2005, METHODS, V36, P43, DOI 10.1016/j.ymeth.2005.01.005; Damschroder MM, 2007, MOL IMMUNOL, V44, P3049, DOI 10.1016/j.molimm.2006.12.019; Dolff S, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3474; Dong S, 2017, ANAL BIOCHEM, V531, P60, DOI 10.1016/j.ab.2017.05.016; Escolano A, 2016, CELL, V166, P1445, DOI 10.1016/j.cell.2016.07.030; Ettinger CK, US, Patent No. [10, 022, 443, B2, 10022443]; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Ettinger R, 2008, IMMUNOL REV, V223, P60, DOI 10.1111/j.1600-065X.2008.00631.x; FOOTE J, 1992, J MOL BIOL, V224, P487, DOI 10.1016/0022-2836(92)91010-M; Frenzel A, 2016, MABS-AUSTIN, V8, P1177, DOI 10.1080/19420862.2016.1212149; Habib T, 2002, BIOCHEMISTRY-US, V41, P8725, DOI 10.1021/bi0202023; Hamming OJ, 2012, J BIOL CHEM, V287, P9454, DOI 10.1074/jbc.M111.311084; Herber D, 2007, J IMMUNOL, V178, P3822, DOI 10.4049/jimmunol.178.6.3822; Higel F, 2016, EUR J PHARM BIOPHARM, V100, P94, DOI 10.1016/j.ejpb.2016.01.005; Igawa T, 2011, MABS-AUSTIN, V3, P243, DOI 10.4161/mabs.3.3.15234; Kabat EA, 1991, SEQUENCES PROTEINS I; Kang KY, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3504; KHAZAELI MB, 1994, J IMMUNOTHER, V15, P42, DOI 10.1097/00002371-199401000-00006; Kohler G, 2005, J IMMUNOL, V174, P2453; Kool M, 2012, J MED MICROBIOL, V61, P927, DOI 10.1099/jmm.0.038943-0; Kuchen S, 2007, J IMMUNOL, V179, P5886, DOI 10.4049/jimmunol.179.9.5886; Li QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068145; Li Y, 2014, NEUROL SCI, V35, P29, DOI 10.1007/s10072-013-1460-3; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; Liu LM, 2015, J PHARM SCI-US, V104, P1866, DOI 10.1002/jps.24444; Liu R, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4100; Lo Benny K C, 2004, Methods Mol Biol, V248, P135; Maurer MF, 2012, MABS-AUSTIN, V4, P69, DOI 10.4161/mabs.4.1.18713; McGuire HM, 2011, IMMUNITY, V34, P602, DOI 10.1016/j.immuni.2011.01.021; Michels DA, 2012, ANAL CHEM, V84, P5380, DOI 10.1021/ac3008847; Nakou M, 2013, CLIN EXP RHEUMATOL, V31, P172; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Reichert JM, 2016, THERAPEUTIC MONOCLON; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0; Rolling C, 1996, FEBS LETT, V393, P53, DOI 10.1016/0014-5793(96)00835-6; Rossant CJ, 2015, J BIOMOL SCREEN, V20, P508, DOI 10.1177/1087057114557464; Spolski R, 2008, CURR OPIN IMMUNOL, V20, P295, DOI 10.1016/j.coi.2008.02.004; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Terrier B, 2012, ARTHRITIS RHEUM-US, V64, P2001, DOI 10.1002/art.34327; Vugmeyster Y, 2010, MABS-AUSTIN, V2, P335, DOI 10.4161/mabs.2.3.11850; WRIGHT A, 1991, EMBO J, V10, P2717, DOI 10.1002/j.1460-2075.1991.tb07819.x; Wu PW., 2008, RAT RABBIT CYNOMOLGU; Yagami H, 2013, PHARM PAT ANAL, V2, P249, DOI [10.4155/PPA.13.2, 10.4155/ppa.13.2]; Young DA, 2007, ARTHRITIS RHEUM, V56, P1152, DOI 10.1002/art.22452; Zhang JL, 2003, BIOCHEM BIOPH RES CO, V300, P291, DOI 10.1016/S0006-291X(02)02836-X; Zhu M, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-65	58	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211236	10.1371/journal.pone.0211236	http://dx.doi.org/10.1371/journal.pone.0211236			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682117	Green Published, gold, Green Submitted			2022-12-26	WOS:000457037500131
J	Drysch, M; Wallner, C; Schmidt, SV; Reinkemeier, F; Wagner, JM; Lehnhardt, M; Behr, B				Dryschi, Marius; Wallner, Christoph; Schmidt, Sonja Verena; Reinkemeier, Felix; Wagner, Johannes Maximilian; Lehnhardt, Marcus; Behr, Bjoern			An optimized low-pressure tourniquet murine hind limb ischemia reperfusion model: Inducing acute ischemia reperfusion injury in C57BL/6 wild type mice	PLOS ONE			English	Article							P38 MAPK; SKELETAL-MUSCLE; MOUSE MODEL; ACTIVATION; CELLS; ISCHEMIA/REPERFUSION; PERFUSION; MARKER; KINASE	Acute ischemia reperfusion injury in skeletal muscle remains an important issue in several fields of regenerative medicine. Thus, a valid model is essential to gain deeper insights into pathophysiological relations and evaluate possible treatment options. While the vascular anatomy of mice regularly prevents sufficient vessel occlusion by invasive methods, there is a multitude of existing models to induce ischemia reperfusion injury without surgical procedures. Since there is no consensus on which model to prefer, this study aims to develop and evaluate a novel, optimized low-pressure tourniquet model. C57BL/6 mice underwent an ischemic procedure by either tourniquet or invasive artery clamping. A sham group served as control. With exception of the sham group, mice underwent 2 hours of ischemia followed by 4 hours of reperfusion. Groups were compared using microcirculatory and spectroscopic measurements, distinctions in tissue edema, histological and immunohistochemical analyses. Both procedures led to a significant decrease in tissue blood flow (-97% vs. -86%) and oxygenation (-87% vs. -75%) with a superiority of the low-pressure tourniquet. Tissue edema in the tourniquet cohort was significantly increased (+59%), while the increase in the clamping cohort was non-significant (+7%). Haematoxylin Eosin staining showed significantly more impaired muscle fibers in the tourniquet group (+77 p.p. vs. +11 p.p.) and increased neutrophil infiltration/ROI (+51 vs. +8). Immunofluorescence demonstrated an equal increase of p38 in both groups (7-fold vs. 8-fold), while the increase in apoptotic markers (Caspase-3, 3-Nitrotyrosine, 4-Hydroxynonenal) was significantly higher in the tourniquet group. The low-pressure tourniquet has been proven to produce reproducible and thus reliable ischemia reperfusion injury. In addition, significantly less force was needed than previously stated. It is therefore an important instrument for studying the pathophysiology of ischemia reperfusion injury and for the development of prophylactic as well as therapeutic interventions.	[Dryschi, Marius; Wallner, Christoph; Schmidt, Sonja Verena; Reinkemeier, Felix; Wagner, Johannes Maximilian; Lehnhardt, Marcus; Behr, Bjoern] Ruhr Univ Bochum, BG Univ Hosp Bergmannsheil, Dept Plast Surg, Burkle Camp Pl 1, Bochum, Germany	Ruhr University Bochum	Wallner, C (corresponding author), Ruhr Univ Bochum, BG Univ Hosp Bergmannsheil, Dept Plast Surg, Burkle Camp Pl 1, Bochum, Germany.	christoph.wallner@bergmannsheil.de	Behr, Björn/AAS-1877-2021; Drysch, Marius/AAY-2816-2020	, Marius/0000-0001-8447-2694				Ashraf MI, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-6; Bonheur JA, 2004, J SURG RES, V116, P55, DOI 10.1016/S0022-4804(03)00232-4; Brentnall M, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-32; Claytor RB, 2007, J RECONSTR MICROSURG, V23, P93, DOI 10.1055/s-2007-970189; Collard CD, 2001, ANESTHESIOLOGY, V94, P1133, DOI 10.1097/00000542-200106000-00030; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Crawford RS, 2007, AM J PHYSIOL-HEART C, V292, pH830, DOI 10.1152/ajpheart.00581.2006; Darwish RS, 2007, J TRAUMA, V63, P439, DOI 10.1097/TA.0b013e318069178a; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Gomez-Rodriguez V, 2015, FASEB J, V29, P960, DOI 10.1096/fj.14-259689; Griffin G, 2014, REV SCI TECH OIE, V33, P265, DOI 10.20506/rst.33.1.2283; Hammers DW, 2011, EXP GERONTOL, V46, P265, DOI 10.1016/j.exger.2010.11.002; Heemskerk AM, 2006, MAGN RESON MED, V56, P272, DOI 10.1002/mrm.20953; Hellingman AA, 2010, EUR J VASC ENDOVASC, V40, P796, DOI 10.1016/j.ejvs.2010.07.009; Herce-Pagliai C, 1998, NITRIC OXIDE-BIOL CH, V2, P324, DOI 10.1006/niox.1998.0192; Ikebe K, 2001, J SURG RES, V99, P1, DOI 10.1006/jsre.2001.6134; Kim SH, 2019, MINERVA ANESTESIOL, V85, P279, DOI 10.23736/S0375-9393.18.13015-X; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Koca K, 2011, J TRAUMA, V70, P717, DOI 10.1097/TA.0b013e3181f30fb0; Kochi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084047; Koul Ashok Raj, 2013, Indian J Plast Surg, V46, P247, DOI 10.4103/0970-0358.118600; Kumphune S, 2015, PHARM BIOL, V53, P1831, DOI 10.3109/13880209.2015.1014569; Liu W, 2000, J CELL SCI, V113, P635; Marais E, 2001, J MOL CELL CARDIOL, V33, P769, DOI 10.1006/jmcc.2001.1347; Mars M, 2014, J S AFR VET ASSOC, V85, DOI 10.4102/jsava.v85i1.1125; Martins L, 2014, METHODS MOL BIOL, V1213, P147, DOI 10.1007/978-1-4939-1453-1_13; McFalls EO, 2004, AM J PHYSIOL-HEART C, V287, pH1328, DOI 10.1152/ajpheart.01188.2003; Muyskens JB, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12671; Niiyama Hiroshi, 2009, J Vis Exp, DOI 10.3791/1035; Padgett ME, 2016, JOVE-J VIS EXP, DOI 10.3791/54166; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Rasmussen LE, 2018, KNEE, V25, P306, DOI 10.1016/j.knee.2018.01.002; Soenmez TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066498; Steenbergen C, 2002, BASIC RES CARDIOL, V97, P276, DOI 10.1007/s00395-002-0364-9; Syslova K, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/562860; Thomas D, 2016, TISSUE ENG PART C-ME, V22, P370, DOI [10.1089/ten.tec.2015.0441, 10.1089/ten.TEC.2015.0441]; Tomita S, 1999, CIRCULATION, V100, P247, DOI 10.1161/01.cir.100.suppl_2.ii-247; Vignaud A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/724914; Yassin MMI, 2002, WORLD J SURG, V26, P115, DOI 10.1007/s00268-001-0169-2; Zarkovic N., MOL ASPECTS MED, V24, P281	40	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210961	10.1371/journal.pone.0210961	http://dx.doi.org/10.1371/journal.pone.0210961			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677066	gold, Green Submitted, Green Published			2022-12-26	WOS:000456700400037
J	Meybosch, S; De Monie, A; Anne, C; Bruyndonckx, L; Jurgens, A; De Winter, BY; Trouet, D; Ledeganck, KJ				Meybosch, Sarang; De Monie, Amandine; Anne, Charlotte; Bruyndonckx, Luc; Juergens, Angelika; De Winter, Benedicte Y.; Trouet, Dominique; Ledeganck, Kristien J.			Epidermal growth factor and its influencing variables in healthy children and adults	PLOS ONE			English	Article							EGF; EXCRETION; URINE; RAT; EXPRESSION; RECOVERY; ROLES; TRPM6; AGE	Background & objective Epidermal growth factor (EGF) stimulates cell proliferation and differentiation after binding to its receptor. Next to its role in magnesium homeostasis, EGF disturbances have been described in oncology, diabetes and autism spectrum disorders. The aim of this study was to determine EGF serum and urine values for both healthy children and adults. Next, we investigated the relation between several variables and urinary and serum EGF concentrations. Methods Both healthy adults (n = 50) and children (n = 78) were included. Serum and urinary EGF concentrations were measured with ELISA technology. Results Serum EGF was inversely correlated with age (r = -0.873; p<0.001) and positively correlated with serum magnesium (r = 0.597; p<0.001). The urinary EGF was also inversely correlated with age (r = -0.855; p<0.001). In adults and children older than 13 years of age, the urinary EGF significantly differed between sexes (p = 0.001). Urinary EGF was positively correlated with serum magnesium (r = 0.583; p<0.001) and creatinine clearance (r = 0.524; p<0.001) and negatively correlated with the fractional excretion of magnesium (r = 0.248; p = 0.014). In a multivariate model, age and serum magnesium remained independently related to serum EGF while age, serum EGF and serum magnesium remained independently related to urinary EGF. Conclusions This study provides valuable insights in urinary and serum EGF patterns in healthy subjects. By systematically correcting EGF for body surface, significant correlations with age, gender and magnesium were observed.	[Meybosch, Sarang; De Monie, Amandine; Anne, Charlotte; Bruyndonckx, Luc; Juergens, Angelika; De Winter, Benedicte Y.; Trouet, Dominique; Ledeganck, Kristien J.] Univ Antwerp, Lab Expt Med & Pediat, Antwerp, Belgium; [Bruyndonckx, Luc; Trouet, Dominique] Antwerp Univ Hosp, Dept Pediat Nephrol, Antwerp, Belgium	University of Antwerp; University of Antwerp	Ledeganck, KJ (corresponding author), Univ Antwerp, Lab Expt Med & Pediat, Antwerp, Belgium.	kristien.ledeganck@uantwerpen.be	Ledeganck, Kristien/AAY-1428-2020; trouet, dominique/AAW-8587-2021; De Winter, Benedicte Y/G-2616-2011; Bruyndonckx, Luc/F-4777-2013	Ledeganck, Kristien/0000-0003-4377-7648; De Winter, Benedicte Y/0000-0003-0327-6304; Bruyndonckx, Luc/0000-0002-2315-9925				Chou JS, 1997, ANN CLIN LAB SCI, V27, P116; COHEN S, 1975, P NATL ACAD SCI USA, V72, P1317, DOI 10.1073/pnas.72.4.1317; Ellison DH, 2008, NEPHROL DIAL TRANSPL, V23, P1497, DOI 10.1093/ndt/gfm952; Grandaliano G, 2000, KIDNEY INT, V58, P182, DOI 10.1046/j.1523-1755.2000.00153.x; Groenestege WMT, 2007, J CLIN INVEST, V117, P2260, DOI 10.1172/JCI31680; Hassan M, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.116.003592; HUMES HD, 1989, J CLIN INVEST, V84, P1757, DOI 10.1172/JCI114359; JOH T, 1986, CLIN CHIM ACTA, V158, P81, DOI 10.1016/0009-8981(86)90118-X; Ju WJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7071; KATORI R, 1979, TOHOKU J EXP MED, V128, P377, DOI 10.1620/tjem.128.377; Ledeganck KJ, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060677; Ledeganck KJ, 2014, NEPHROL DIAL TRANSPL, V29, P1097, DOI 10.1093/ndt/gft498; Ledeganck KJ, 2011, AM J PHYSIOL-RENAL, V301, pF486, DOI 10.1152/ajprenal.00116.2011; LEVRAN A, 1990, CLIN CHIM ACTA, V192, P201, DOI 10.1016/0009-8981(90)90222-E; Li ZZ, 2012, PEDIATR NEPHROL, V27, P2251, DOI 10.1007/s00467-012-2243-4; MATTILA AL, 1986, LIFE SCI, V39, P1879, DOI 10.1016/0024-3205(86)90298-5; MATTILA AL, 1985, J CLIN ENDOCR METAB, V61, P997, DOI 10.1210/jcem-61-5-997; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; NIELSEN S, 1989, AM J PHYSIOL, V256, pE55, DOI 10.1152/ajpendo.1989.256.1.E55; NORMAN J, 1990, CLIN SCI, V78, P445, DOI 10.1042/cs0780445; OLSEN PS, 1984, REGUL PEPTIDES, V10, P37, DOI 10.1016/0167-0115(84)90051-X; Onore Charity, 2012, Autism Res Treat, V2012, P205362, DOI 10.1155/2012/205362; Saika T, 2000, UROL RES, V28, P230; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Thebault S, 2009, J AM SOC NEPHROL, V20, P78, DOI 10.1681/ASN.2008030327; Tsau YK, 1996, PEDIATR RES, V39, P20, DOI 10.1203/00006450-199601000-00003; Wong RWC, 2004, CYTOKINE GROWTH F R, V15, P147, DOI 10.1016/j.cytogfr.2004.01.004; Xian CJ, 1999, MOL NEUROBIOL, V20, P157, DOI 10.1007/BF02742440; Xian CJ, 2004, FRONT BIOSCI-LANDMRK, V9, P85, DOI 10.2741/1210; Zeng F, 2014, SEMIN CELL DEV BIOL, V28, P2, DOI 10.1016/j.semcdb.2014.01.011	31	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211212	10.1371/journal.pone.0211212	http://dx.doi.org/10.1371/journal.pone.0211212			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677083	Green Submitted, Green Published, gold			2022-12-26	WOS:000456700400062
J	Neves, HHR; Vargas, G; Brito, LF; Schenkel, FS; Albuquerque, LG; Carvalheiro, R				Neves, Haroldo H. R.; Vargas, Giovana; Brito, Luiz F.; Schenkel, Flavio S.; Albuquerque, Lucia G.; Carvalheiro, Roberto			Genetic and genomic analyses of testicular hypoplasia in Nellore cattle	PLOS ONE			English	Article							SPERM MOTILITY; PROTEIN; PHOSPHORYLATION; ASSOCIATION; NETWORKS; DATABASE; PATHWAY; GROWTH; KEGG; TOOL	Reproductive performance is a key indicator of the long-term sustainability of any livestock production system. Testicular hypoplasia (TH) is a morphological and functional reproductive disorder that affects bulls around the world and consequently causes major economic losses due to reduced fertility rates. Despite the improvements in management practices to enhance performance of affected animals, the use of hypoplastic animals for reproduction might contribute to expand the prevalence of this disorder. The aim of this study was to identify genomic regions that are associated with TH in Nellore cattle by performing a genome-wide association study (GWAS) and functional analyses. Phenotypic and pedigree data from 47,563 animals and genotypes (500,689 Single Nucleotide Polymorphism, SNPs) from 265 sires were used in this study. TH was evaluated as a binary trait measured at 18 months of age. The estimated breeding values (EBVs) were calculated by fitting a single-trait threshold animal model using a Bayesian approach. The SNP effects were estimated using the Bayes C method and de-regressed EBVs for TH as the response variable (pseudo-phenotype). The top-15 ranking windows (5-adjacent SNPs) that explained the highest proportion of variance were identified for further functional and biological network analyses. The posterior mean (95% highest posterior density) of the heritability for TH was 0.16 (0.08; 0.23). The most important genomic windows were located on BTA1, BTA3, BTA4, BTA5, BTA9, BTA22, BTA23, and BTA25. These windows explained together 22.69% of the total additive genetic variance for TH. Strong candidate genes associated with metabolism and synthesis of steroids, cell survival, spermatogenesis process and sperm motility were identified, which might play an important role in the expression of TH. Our findings contribute to a better biological understanding of TH and future characterization of causal variants might enable improved genomic prediction of this trait in beef cattle.	[Neves, Haroldo H. R.; Carvalheiro, Roberto] GenSys Associated Consultants, Porto Alegre, RS, Brazil; [Vargas, Giovana; Albuquerque, Lucia G.] Sao Paulo State Univ UNESP, Sch Agr & Vet Sci, Dept Anim Sci, Jaboticabal, SP, Brazil; [Brito, Luiz F.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Schenkel, Flavio S.] Univ Guelph, Dept Anim Biosci, CGIL, Guelph, ON, Canada; [Albuquerque, Lucia G.; Carvalheiro, Roberto] Cnpq, Natl Council Sci & Technol Dev, Brasilia, DF, Brazil	Universidade Estadual Paulista; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Guelph	Vargas, G (corresponding author), Sao Paulo State Univ UNESP, Sch Agr & Vet Sci, Dept Anim Sci, Jaboticabal, SP, Brazil.	gi.vargas@hotmail.com	Schenkel, Flavio/ABG-1842-2021; Albuquerque, Lucia/A-7402-2013; Carvalheiro, Roberto/AAG-2222-2020	Albuquerque, Lucia/0000-0002-2030-7590; Carvalheiro, Roberto/0000-0002-4506-0555; Schenkel, Flavio/0000-0001-8700-0633; Neves, Haroldo/0000-0002-8317-9434	Sao Paulo Research Foundation (FAPESP) [2017/10630-2]; CNPq [308636/2014-7]; GenSys Associated Consultants	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); GenSys Associated Consultants	This work was supported by Grant #2017/10630-2 Sao Paulo Research Foundation (FAPESP); grant #308636/2014-7 (CNPq). GenSys Associated Consultants provided support in the form of salaries for authors HHRN and RC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Aparicio IM, 2007, REPRODUCTION, V134, P435, DOI 10.1530/REP-06-0388; Bicudo S., 2007, BIOL GICO, V69, P43; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; CALO LL, 1973, J ANIM SCI, V37, P676, DOI 10.2527/jas1973.373676x; Carreau Serge, 2003, Reprod Biol Endocrinol, V1, P35, DOI 10.1186/1477-7827-1-35; COULTER GH, 1976, J DAIRY SCI, V59, P730, DOI 10.3168/jds.S0022-0302(76)84265-8; Eacker SM, 2008, MOL ENDOCRINOL, V22, P623, DOI 10.1210/me.2006-0534; Finlin BS, 2001, J BIOL CHEM, V276, P42259, DOI 10.1074/jbc.M105888200; Franceschini A, 2016, BIOINFORMATICS, V32, P1085, DOI 10.1093/bioinformatics/btv696; Galloway DB, 1979, FATORES QUE AFETAM F, P209; Garrick DJ, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-55; Geweke J, 1992, BAYESIAN STAT, V4, P169; Gianola D, 1993, GENET SEL EVOL, V15, P201; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Hiendleder S, 2003, J HERED, V94, P496, DOI 10.1093/jhered/esg090; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; KAY GW, 1992, J REPROD FERTIL, V96, P537; Legarra A., 2014, GS3 USER MANUAL; Li Y, 2009, J ANDROL, V30, P325, DOI 10.2164/jandrol.108.005934; Luu W, 2014, J LIPID RES, V55, P410, DOI 10.1194/jlr.M043257; McClure MC, 2010, ANIM GENET, V41, P597, DOI 10.1111/j.1365-2052.2010.02063.x; McEntee K., 1990, SCROTUM SPERMATIC CO, P279; Miller WL., 1995, ENDOCRINOL METAB, P555; Nascimento EF, 2003, PATOLOGIA REPROD ANI, P133; Pelz L, 2017, J BIOL CHEM, V292, P21490, DOI 10.1074/jbc.RA117.000113; Perumal P, 2014, Int Sch Res Notices, V2014, P249537, DOI 10.1155/2014/249537; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2018, R LANG ENV STAT COMP; Roso V.M., 2006, P WORLD CONG GEN APP, V8, P13; Sanderson JT, 2006, TOXICOL SCI, V94, P3, DOI 10.1093/toxsci/kfl051; Sargolzaei M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-478; Schulke JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011717; Sever N, 2004, J BIOL CHEM, V279, P43136, DOI 10.1074/jbc.M406406200; Sorensen DA., 2002, STAT BIOL HEALTH; Steffen D, 1997, VET CLIN N AM-FOOD A, V13, P243, DOI 10.1016/S0749-0720(15)30338-8; Suzu S, 2002, BIOCHEM BIOPH RES CO, V296, P1215, DOI 10.1016/S0006-291X(02)02025-9; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; van den Berg I, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-19; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Venhoranta H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075659; Vijayaraghavan S, 2000, BIOL REPROD, V62, P1647, DOI 10.1095/biolreprod62.6.1647; Zhang ZG, 2016, MOL BIOL CELL, V27, P3705, DOI 10.1091/mbc.E16-05-0318; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	48	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211159	10.1371/journal.pone.0211159	http://dx.doi.org/10.1371/journal.pone.0211159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677076	Green Submitted, Green Published, gold			2022-12-26	WOS:000456700400055
J	Upton, EC; Maciunas, LJ; Loll, PJ				Upton, Elizabeth C.; Maciunas, Lina J.; Loll, Patrick J.			Vancomycin does not affect the enzymatic activities of purified VanS(A)	PLOS ONE			English	Article							2-COMPONENT REGULATORY SYSTEM; GLYCOPEPTIDE RESISTANCE GENES; ENTEROCOCCUS-FAECIUM BM4147; MEMBRANE-PROTEINS; HISTIDINE KINASE; IN-VIVO; SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI; INDUCTION; BINDING	VanS is a membrane-bound sensor histidine kinase responsible for sensing vancomycin and activating transcription of vancomycin-resistance genes. In the presence of vancomycin, VanS phosphorylates the transcription factor VanR, converting it to its transcriptionally active form. In the absence of vancomycin, VanS dephosphorylates VanR, thereby maintaining it in a transcriptionally inactive state. To date, the mechanistic details of how vancomycin modulates VanS activity have remained elusive. We have therefore studied these details in an in vitro system, using the full-length VanS and VanR proteins responsible for type-A vancomycin resistance in enterococci. Both detergent-and amphipol-solubilized VanS(A) display all the enzymatic activities expected for a sensor histidine kinase, with amphipol reconstitution providing a marked boost in overall activity relative to detergent solubilization. A putative constitutively activated VanS(A) mutant (T168K) was constructed and purified, and was found to exhibit the expected reduction in phosphatase activity, providing confidence that detergent-solubilized VanS(A) behaves in a physiologically relevant manner. In both detergent and amphipol solutions, VanS(A)'s enzymatic activities were found to be insensitive to vancomycin, even at levels many times higher than the antibiotic's minimum inhibitory concentration. This result argues against direct activation of VanS(A) via formation of a binary antibiotic-kinase complex, suggesting instead that either additional factors are required to form a functional signaling complex, or that activation does not require direct interaction with the antibiotic.	[Upton, Elizabeth C.; Maciunas, Lina J.; Loll, Patrick J.] Drexel Univ, Dept Biochem & Mol Biol, Coll Med, Philadelphia, PA 19104 USA	Drexel University	Loll, PJ (corresponding author), Drexel Univ, Dept Biochem & Mol Biol, Coll Med, Philadelphia, PA 19104 USA.	pjl28@drexel.edu		Loll, Patrick/0000-0001-5416-4500	National Institutes of Health [R01 GM079508, F31 AI136385]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI136385] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by National Institutes of Health R01 GM079508; F31 AI136385 (LJM) Departmental Funding, Dept. of Biochemistry & Molecular Biology, Drexel University College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN NE, 1995, FEMS MICROBIOL LETT, V132, P107, DOI 10.1016/0378-1097(95)00296-H; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Arthur M, 1997, J BACTERIOL, V179, P97, DOI 10.1128/jb.179.1.97-106.1997; ARTHUR M, 1992, J BACTERIOL, V174, P2582, DOI 10.1128/jb.174.8.2582-2591.1992; ARTHUR M, 1993, ANTIMICROB AGENTS CH, V37, P1563, DOI 10.1128/AAC.37.8.1563; Arthur M, 1999, MICROBIOL-UK, V145, P1849, DOI 10.1099/13500872-145-8-1849; Baptista M, 1996, ANTIMICROB AGENTS CH, V40, P2291, DOI 10.1128/AAC.40.10.2291; Baptista M, 1997, MOL MICROBIOL, V25, P93, DOI 10.1046/j.1365-2958.1997.4401812.x; Baptista M, 1999, MOL MICROBIOL, V32, P17, DOI 10.1046/j.1365-2958.1999.01308.x; Barbieri CM, 2008, ANAL BIOCHEM, V376, P73, DOI 10.1016/j.ab.2008.02.004; Bauer J, 2013, MOL PLANT, V6, P959, DOI 10.1093/mp/sss126; Bhattacharya M, 2010, BIOCHIMIE, V92, P263, DOI 10.1016/j.biochi.2009.11.009; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P142, DOI 10.1016/j.mib.2010.01.015; BUGG TDH, 1991, BIOCHEMISTRY-US, V30, P10408, DOI 10.1021/bi00107a007; Carlson HK, 2010, ANAL BIOCHEM, V397, P139, DOI 10.1016/j.ab.2009.10.009; Cheung J, 2010, CURR OPIN MICROBIOL, V13, P116, DOI 10.1016/j.mib.2010.01.016; Depardieu F, 2009, ANTIMICROB AGENTS CH, V53, P1952, DOI 10.1128/AAC.01348-08; Eriks LR, 2003, ANAL BIOCHEM, V323, P234, DOI 10.1016/j.ab.2003.09.002; Gao R, 2018, METHOD ENZYMOL, V607, P301, DOI 10.1016/bs.mie.2018.04.004; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; GrissomArnold J, 1997, MICROB DRUG RESIST, V3, P53, DOI 10.1089/mdr.1997.3.53; Haldimann A, 1997, J BACTERIOL, V179, P5903, DOI 10.1128/jb.179.18.5903-5913.1997; HANDWERGER S, 1990, FEMS MICROBIOL LETT, V70, P167, DOI 10.1016/S0378-1097(05)80033-3; Hornschemeyer P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149187; HOLMAN TR, 1994, BIOCHEMISTRY-US, V33, P4625, DOI 10.1021/bi00181a024; Hughes CS, 2017, DATA BRIEF, V14, P41, DOI 10.1016/j.dib.2017.07.012; Hughes CS, 2017, BBA-GEN SUBJECTS, V1861, P1951, DOI 10.1016/j.bbagen.2017.05.011; Hussain R, 2016, BIOCHEM SOC T, V44, P810, DOI 10.1042/BST20160023; Jacob-Dubuisson F, 2018, NAT REV MICROBIOL, V16, P585, DOI 10.1038/s41579-018-0055-7; King ST, 2007, METHOD ENZYMOL, V422, P352, DOI 10.1016/S0076-6879(06)22017-2; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Koteva K, 2010, NAT CHEM BIOL, V6, P327, DOI 10.1038/nchembio.350; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kwun MJ, 2013, ANTIMICROB AGENTS CH, V57, P4470, DOI 10.1128/AAC.00523-13; Loll PJ, 2014, ACTA CRYSTALLOGR F, V70, P1576, DOI 10.1107/S2053230X14025035; Mattison K, 2002, J BIOL CHEM, V277, P11143, DOI 10.1074/jbc.M111128200; McComas CC, 2003, J AM CHEM SOC, V125, P9314, DOI 10.1021/ja035901x; Molday LL, 2014, METHODS MOL BIOL, V1177, P1, DOI 10.1007/978-1-4939-1034-2_1; O'Driscoll T, 2015, INFECT DRUG RESIST, V8, P217, DOI 10.2147/IDR.S54125; Ortet P, 2015, NUCLEIC ACIDS RES, V43, pD536, DOI 10.1093/nar/gku968; Phillips-Jones Mary K, 2018, Biophys Rev, V10, P347, DOI 10.1007/s12551-018-0404-9; Phillips-Jones MK, 2017, SCI REP-UK, V7, DOI 10.1038/srep46180; Pocanschi CL, 2006, BIOCHEMISTRY-US, V45, P13954, DOI 10.1021/bi0616706; Reyes K, 2016, INFECT DIS CLIN N AM, V30, P953, DOI 10.1016/j.idc.2016.07.009; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Silva JC, 1998, P NATL ACAD SCI USA, V95, P11951, DOI 10.1073/pnas.95.20.11951; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Srivastava SK, 2014, J BACTERIOL, V196, P2876, DOI 10.1128/JB.01530-14; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tribet C, 1996, P NATL ACAD SCI USA, V93, P15047, DOI 10.1073/pnas.93.26.15047; Huynh TN, 2011, MOL MICROBIOL, V82, P275, DOI 10.1111/j.1365-2958.2011.07829.x; Ulijasz AT, 1996, J BACTERIOL, V178, P6305, DOI 10.1128/jb.178.21.6305-6309.1996; Ulrich LE, 2010, NUCLEIC ACIDS RES, V38, pD401, DOI 10.1093/nar/gkp940; Vergis JM, 2010, ANAL BIOCHEM, V407, P1, DOI 10.1016/j.ab.2010.07.019; Walsh CT, 1996, CHEM BIOL, V3, P21, DOI 10.1016/S1074-5521(96)90079-4; Weeks SD, 2007, PROTEIN EXPRES PURIF, V53, P40, DOI 10.1016/j.pep.2006.12.006; Willett JW, 2013, MBIO, V4, DOI 10.1128/mBio.00420-13; Willett JW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003084; WRIGHT GD, 1993, BIOCHEMISTRY-US, V32, P5057, DOI 10.1021/bi00070a013; Yoshida T, 2002, MOL MICROBIOL, V46, P1283, DOI 10.1046/j.1365-2958.2002.03240.x; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zoonens M., 2014, MEMBRANE PROTEINS PR, P173; Zschiedrich CP, 2016, J MOL BIOL, V428, P3752, DOI 10.1016/j.jmb.2016.08.003	63	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210627	10.1371/journal.pone.0210627	http://dx.doi.org/10.1371/journal.pone.0210627			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677074	Green Submitted, Green Published, gold			2022-12-26	WOS:000456700400020
J	Espunyes, J; Bartolome, J; Garel, M; Galvez-Ceron, A; Aguilar, XF; Colom-Cadena, A; Calleja, JA; Gasso, D; Jarque, L; Lavin, S; Marco, I; Serrano, E				Espunyes, Johan; Bartolome, Jordi; Garel, Mathieu; Galvez-Ceron, Arturo; Fernandez Aguilar, Xavier; Colom-Cadena, Andreu; Antonio Calleja, Juan; Gasso, Diana; Jarque, Laia; Lavin, Santiago; Marco, Ignasi; Serrano, Emmanuel			Seasonal diet composition of Pyrenean chamois is mainly shaped by primary production waves	PLOS ONE			English	Article							DEER CERVUS-ELAPHUS; RUPICAPRA-PYRENAICA; FECAL ANALYSIS; RED DEER; CHEMICAL-COMPOSITION; AUTUMN NUTRITION; SUMMER DIET; LAND-USE; ALPINE; VEGETATION	In alpine habitats, the seasonally marked climatic conditions generate seasonal and spatial differences in forage availability for herbivores. Vegetation availability and quality during the growing season are known to drive life history traits of mountain ungulates. However, little effort has been made to understand the association between plant phenology and changes in the foraging strategies of these mountain dwellers. Furthermore, this link can be affected by the seasonal presence of livestock in the same meadows. The objective of this work was to study the seasonal changes in diet composition of Pyrenean chamois (Rupicapra p. pyrenaica) and its relationship to primary production trends in a Mediterranean alpine environment. Moreover, diet composition in two populations with contrasting livestock pressure was compared in order to study the effect of sheep flocks on the feeding behaviour of chamois. From 2009 to 2012, monthly diet composition was estimated by cuticle microhistological analysis of chamois faeces collected in the eastern Pyrenees. The primary production cycle was assessed by remote sensing, using the Normalized Difference Vegetation Index. Additionally, the diet of sheep sharing seasonally the subalpine and alpine meadows with chamois was analysed. Diet selection of chamois and sheep and their overlap was also assessed. Our results show an intra-annual variation in the diet composition of Pyrenean chamois and demonstrate a strong relationship between plant consumption dynamics and phenology in alpine areas. In addition, Calluna vulgaris, Cytisusspp. and Festucaspp., as well as forbs in the summer, are found to be key forage species for Pyrenean chamois. Furthermore, this study couldn't detect differences between both chamois populations despite the presence of sheep flocks in only one area. However, the detection of a shift in the diet of chamois in both areas after the arrival of high densities of multi-specific livestock suggest a general livestock effect. In conclusion, Pyrenean chamois are well adapted to the variations in the seasonal availability of plants in alpine habitats but could be disturbed by the seasonal presence of livestock. Due to the key plants in their diet, we suggest that population management programmes should focus on the preservation of mixed grasslands composed of patches of shrubs and herbs. The effects of climate change and shrub expansion should be studied as they may potentially affect chamois population dynamics through changes in habitat composition and temporal shifts in forage availability.	[Espunyes, Johan; Galvez-Ceron, Arturo; Fernandez Aguilar, Xavier; Colom-Cadena, Andreu; Gasso, Diana; Jarque, Laia; Lavin, Santiago; Marco, Ignasi; Serrano, Emmanuel] Univ Autonoma Barcelona, Wildlife Ecol & Hlth Grp WE&H, Barcelona, Spain; [Espunyes, Johan; Galvez-Ceron, Arturo; Fernandez Aguilar, Xavier; Colom-Cadena, Andreu; Gasso, Diana; Jarque, Laia; Lavin, Santiago; Marco, Ignasi; Serrano, Emmanuel] Univ Autonoma Barcelona, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge SEFaS, Fac Vet, Barcelona, Spain; [Bartolome, Jordi; Jarque, Laia] Univ Autonoma Barcelona, Dept Ciencia Anim & Aliments, Ruminant Res Grp, Fac Vet, Barcelona, Spain; [Garel, Mathieu] Unite Ongules Sauvages, Off Natl Chasse & Faune Sauvage, Gieres, France; [Galvez-Ceron, Arturo] Univ Narino, Fac Ciencias Pecuarias, Pasto, Colombia; [Fernandez Aguilar, Xavier] Univ Calgary, Fac Vet Med, Dept Ecosyst & Publ Hlth, Calgary, AB, Canada; [Antonio Calleja, Juan] Univ Autonoma Barcelona, Dept Biol Anim Biol Vegetal & Ecol, Bot, Bellaterra, Spain; [Antonio Calleja, Juan] CREAF, Cerdanyola Del Valles, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; University of Calgary; Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF)	Espunyes, J; Serrano, E (corresponding author), Univ Autonoma Barcelona, Wildlife Ecol & Hlth Grp WE&H, Barcelona, Spain.; Espunyes, J; Serrano, E (corresponding author), Univ Autonoma Barcelona, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge SEFaS, Fac Vet, Barcelona, Spain.	johan.espunyes@gmail.com; emmanuel.serrano@uab.cat	Fernandez Aguilar, Xavier/P-9919-2017; Espunyes, Johan/AAV-9517-2020; Marco, Ignasi/E-8633-2015; Alarcón, Juan Antonio Calleja/T-2297-2019; SERRANO-FERRON, Emmanuel/J-4489-2013; /P-4243-2017; Lavín, Santiago/L-5975-2014; Bartolomé, Jordi/AAB-4362-2020	Fernandez Aguilar, Xavier/0000-0002-4939-6048; Espunyes, Johan/0000-0002-8692-1593; Marco, Ignasi/0000-0001-7479-3419; Alarcón, Juan Antonio Calleja/0000-0002-6586-0939; SERRANO-FERRON, Emmanuel/0000-0002-9799-9804; /0000-0003-4553-8528; Lavín, Santiago/0000-0001-5655-588X; Bartolomé, Jordi/0000-0002-3784-5248	Government of Andorra [ATC015]; Spanish Ministerio de Economia y Competitividad (MINECO) through a Ramon y Cajal [RYC2016-21120]	Government of Andorra; Spanish Ministerio de Economia y Competitividad (MINECO) through a Ramon y Cajal	JE acknowledges a predoctoral grant from the Government of Andorra, ATC015 - AND-2015/2016, 2016/2017 and 2017/2018. ES was funded by the Spanish Ministerio de Economia y Competitividad (MINECO) through a Ramon y Cajal agreement (RYC2016-21120). The same RYC-2016-21120 project has partially covered the publication fees of this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldezabal A, 2002, ECOSISTEMAS, V11; ALIPAYO D, 1992, J RANGE MANAGE, V45, P148, DOI 10.2307/4002773; Ammar H, 2004, ANIM FEED SCI TECH, V115, P327, DOI 10.1016/j.anifeedsci.2004.03.003; Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; Anderson MB, 2018, J ENVIRON POL PLAN, V20, P198, DOI 10.1080/1523908X.2017.1348286; Andreoli E, 2016, WILDLIFE BIOL, V22, P78, DOI 10.2981/wlb.00153; ANTHONY RG, 1974, J WILDLIFE MANAGE, V38, P535, DOI 10.2307/3800886; Arft AM, 1999, ECOL MONOGR, V69, P491, DOI 10.1890/0012-9615(1999)069[0491:ROTPTE]2.0.CO;2; ARMSTRONG DG, 1953, J AGR SCI, V43, P223, DOI 10.1017/S0021859600045019; BARTOLOME J, 1995, J RANGE MANAGE, V48, P267, DOI 10.2307/4002432; Bartolome J, 1998, ACTAS DE LA XXXVIII, P367; Bartolome J, 2011, RANGELAND ECOL MANAG, V64, P319, DOI 10.2111/REM-D-09-00160.1; Berducou C., 1986, P390; Bergman EJ, 2014, J WILDLIFE MANAGE, V78, P448, DOI 10.1002/jwmg.683; Bertolino S, 2009, J ZOOL, V277, P63, DOI 10.1111/j.1469-7998.2008.00512.x; Bocci A, 2010, J ZOOL, V280, P379, DOI 10.1111/j.1469-7998.2009.00672.x; Bovolenta S, 2008, ANIM FEED SCI TECH, V146, P178, DOI 10.1016/j.anifeedsci.2008.06.003; BRAND MR, 1978, AM MIDL NAT, V100, P228, DOI 10.2307/2424794; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Celaya R, 2011, ANIMAL, V5, P1467, DOI 10.1017/S1751731111000449; Chapuis JL, 2001, J RANGE MANAGE, V54, P239, DOI 10.2307/4003240; Chirichella R., 2014, BEHAV MANAGEMENT EUR, P110; Chirichella R, 2013, MAMM BIOL, V78, P344, DOI 10.1016/j.mambio.2013.04.005; Christensen JH, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1217; Christianson D, 2009, ECOL APPL, V19, P1323, DOI 10.1890/08-0987.1; Cook JG, 2004, WILDLIFE MONOGR, P1; Corlatti L, 2013, J ZOOL, V291, P111, DOI 10.1111/jzo.12049; Corlatti L, 2011, MAMMAL REV, V41, P163, DOI 10.1111/j.1365-2907.2011.00187.x; Crampe JP, 2007, CAN J ZOOL, V85, P16, DOI 10.1139/Z06-185; CROKER BARBARA H., 1959, NEW ZEALAND JOUR AGRIC RES, V2, P72; DAGET P, 1971, ANN AGRON, V22, P5; DEBOER WF, 1990, OECOLOGIA, V82, P264, DOI 10.1007/BF00323544; Didan K., 2015, MOD13A2 MODIS TERRA, DOI [DOI 10.5067/MODIS/MOD13A2.006, 10.5067/MODIS/MOD13Q1.006, DOI 10.5067/MODIS/MOD13Q1.006]; Ernakovich JG, 2014, GLOBAL CHANGE BIOL, V20, P3256, DOI 10.1111/gcb.12568; Evju M, 2006, ECOSCIENCE, V13, P459, DOI 10.2980/1195-6860(2006)13[459:SHSATA]2.0.CO;2; Fankhauser R, 2008, EUR J WILDLIFE RES, V54, P88, DOI 10.1007/s10344-007-0115-1; FERRARI C, 1988, Z SAUGETIERKD, V53, P170; Ferretti F, 2015, BEHAV ECOL, V26, P550, DOI 10.1093/beheco/aru226; Fewster RM, 2000, ECOLOGY, V81, P1970, DOI 10.2307/177286; Forkel M, 2015, GLOBAL CHANGE BIOL, V21, P3414, DOI 10.1111/gcb.12950; Forkel M, 2013, REMOTE SENS-BASEL, V5, P2113, DOI 10.3390/rs5052113; Galvez-Ceron A, 2013, EUR J WILDLIFE RES, V59, P115, DOI 10.1007/s10344-012-0672-9; Garcia-Gonzalez R., 1984, ACTA BIOL MONTANA, V4, P333; Garcia-gonzalez R, 1984, DOC ECOL PYRENEENNE, V3-4, P307; Garcia-Gonzalez R, 1986, 26 REUN CIENT SEEP, P119; GarciaGonzalez R, 1996, FOREST ECOL MANAG, V88, P15, DOI 10.1016/S0378-1127(96)03805-4; GILL RB, 1983, J WILDLIFE MANAGE, V47, P902, DOI 10.2307/3808149; Hamel S, 2009, J APPL ECOL, V46, P582, DOI 10.1111/j.1365-2664.2009.01643.x; HAVSTAD KM, 1978, J RANGE MANAGE, V31, P469, DOI 10.2307/3897210; Hibert F, 2011, EUR J WILDLIFE RES, V57, P495, DOI 10.1007/s10344-010-0458-x; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; Hofmann RR, 1984, FEEDING HABITS MOUFL, P341; Homolka M, 2001, FOLIA ZOOL, V50, P89; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; JALAL MAF, 1982, PHYTOCHEMISTRY, V21, P1397, DOI 10.1016/0031-9422(82)80150-7; JOHNSON MK, 1981, J RANGE MANAGE, V34, P232, DOI 10.2307/3898049; Jonas T, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000680; Jonsson KI, 1997, OIKOS, V78, P57, DOI 10.2307/3545800; K?rner C., 2011, ALPINE PLANT LIFE FU; La Morgia V, 2009, ECOL RES, V24, P1043, DOI 10.1007/s11284-008-0581-2; Loison A., 2003, Ecological Studies, V167, P351; Lovari S, 2014, ANIM CONSERV, V17, P359, DOI 10.1111/acv.12103; Mack G, 2013, ENVIRON SCI POLICY, V32, P48, DOI 10.1016/j.envsci.2013.01.019; Manly BFJ, 1993, RESOURCE SELECTION B; Marinas A, 2003, ANIM SCI, V76, P461, DOI 10.1017/S1357729800058689; Marinas A, 2006, PIRINEOS, V161, P85, DOI DOI 10.3989/pirineos.2006.v161.4; Mason THE, 2017, BEHAV ECOL, V28, P908, DOI 10.1093/beheco/arx057; Mason THE, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0069-6; MCINNIS ML, 1983, J RANGE MANAGE, V36, P302, DOI 10.2307/3898474; Montalvo AE, 2017, WILDLIFE BIOL, DOI 10.2981/wlb.00320; Montserrat P., 1990, ECOSYSTEMS WORLD, V17, P37; Morano S, 2013, J MAMMAL, V94, P162, DOI 10.1644/12-MAMM-A-074.1; MOSS R, 1969, J ANIM ECOL, V38, P103, DOI 10.2307/2741; Mottet A, 2006, AGR ECOSYST ENVIRON, V114, P296, DOI 10.1016/j.agee.2005.11.017; Nagy L, 2009, THE BIOLOGY OF ALPIN; Neuner G, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00654; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; PerezBarberia FJ, 1997, ACTA THERIOL, V42, P37, DOI 10.4098/AT.arch.97-5; Pettorelli N, 2013, THE NORMALIZED DIFFE; Pettorelli N, 2007, ECOLOGY, V88, P381, DOI 10.1890/06-0875; Poyatos R, 2003, MT RES DEV, V23, P362, DOI 10.1659/0276-4741(2003)023[0362:LUALCC]2.0.CO;2; Prevosto B, 2006, ACTA OECOL, V30, P258, DOI 10.1016/j.actao.2006.05.001; Prevosto B, 2011, FOLIA GEOBOT, V46, P303, DOI 10.1007/s12224-010-9096-z; R Core Team, 2018, R A LANGUAGE AND ENV; Raye G, 2011, ECOL RES, V26, P265, DOI 10.1007/s11284-010-0780-5; Rebollo S., 1993, Pirineos, V141-142, P47; Redjadj C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084756; Rieger G, 2008, J AGR FOOD CHEM, V56, P9080, DOI 10.1021/jf801104e; ROMINGER EM, 1988, J WILDLIFE MANAGE, V52, P47, DOI 10.2307/3801056; Ruttimann S, 2008, EUR J WILDLIFE RES, V54, P110, DOI 10.1007/s10344-007-0118-y; Rughetti M, 2011, ACTA THERIOL, V56, P329, DOI 10.1007/s13364-011-0040-2; Schoenecker KA, 2016, WILD EQUIDS ECOLOGY; Scornavacca D, 2016, ETHOLOGY, V122, P807, DOI 10.1111/eth.12530; SMITH EP, 1982, ECOLOGY, V63, P1248, DOI 10.2307/1938851; STAINES BW, 1982, J APPL ECOL, V19, P65, DOI 10.2307/2402991; STEWART DRM, 1967, J APPL ECOL, V4, P83, DOI 10.2307/2401411; Suter W, 2004, WILDLIFE BIOL, V10, P43, DOI 10.2981/wlb.2004.008; Takahashi H, 2001, ECOL RES, V16, P257, DOI 10.1046/j.1440-1703.2001.00391.x; Thuiller W, 2018, DIVERS DISTRIB, V24, P352, DOI 10.1111/ddi.12684; Tolera A, 1997, ANIM FEED SCI TECH, V67, P181, DOI 10.1016/S0377-8401(96)01119-4; Tollefson TN, 2010, J WILDLIFE MANAGE, V74, P974, DOI 10.2193/2008-529; Treanor JJ, 2015, ECOL EVOL, V5, P3783, DOI 10.1002/ece3.1633; Vigo J, 2008, LALTA MUNTANYA CATAL; Vigop J, 1984, FLORA DELS PAISOSCAT, V1; Villamuelas M, 2016, ECOL INDIC, V61, P658, DOI 10.1016/j.ecolind.2015.10.017; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Yockney IJ, 2000, NEW ZEAL J ECOL, V24, P31	108	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210819	10.1371/journal.pone.0210819	http://dx.doi.org/10.1371/journal.pone.0210819			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673757	Green Submitted, Green Published, gold			2022-12-26	WOS:000456442800054
J	Chung, CM; Hung, CC; Lee, CH; Lee, CP; Lee, KW; Chen, MK; Yeh, KT; Ko, YC				Chung, Chia-Min; Hung, Chung-Chieh; Lee, Chien-Hung; Lee, Chi-Pin; Lee, Ka-Wo; Chen, Mu-Kuan; Yeh, Kun-Tu; Ko, Ying-Chin			Variants in FAT1 and COL9A1 genes in male population with or without substance use to assess the risk factors for oral malignancy	PLOS ONE			English	Article							ALCOHOL-CONSUMPTION; SUBMUCOUS FIBROSIS; CANCER; SUSCEPTIBILITY; ASSOCIATION; BIOMARKERS; LESIONS; HEAD; MUTATIONS	A number of genetic variants were suggested to be associated with oral malignancy, few variants can be replicated. The aim of this study was to identify significant variants that enhanced personal risk prediction for oral malignancy. A total of 360 patients diagnosed with oral squamous cell carcinoma, 486 controls and 17 newly diagnosed patients with OPMD including leukoplakia or oral submucous fibrosis were recruited. Fifteen tagSNPs which were derived from somatic mutations were genotyped and examined in associations with the occurrence of oral malignancy. Environmental variables along with the SNPs data were used to developed risk predictive models for oral malignancy occurrence. The step-wise model analysis was conducted to fit the best model in an economically efficient way. Two tagSNPs, rs28647489 in FAT1 gene and rs550675 in COL9A1 gene, were significantly associated with the risk of oral malignancy. The sensitivity and specificity were 85.7% and 85.5%, respectively (area under the receiver operating characteristic curve (AUC) was 0.91) for predicting oral squamous cell carcinoma occurrence with the combined genetic variants, betel-quid, alcohol and age. The AUC for OPMD was only 0.69. The predictive probability of squamous cell carcinoma occurrence for genetic risk score without substance use increased from 10% up to 43%; with substance use increased from 73% up to 92%. Genetic variants with or without substance use may enhance risk prediction for oral malignancy occurrence in male population. The prediction model may be useful as a clinical index for oral malignancy occurrence and its risk assessments.	[Chung, Chia-Min; Lee, Chi-Pin; Ko, Ying-Chin] China Med Univ Hosp, Environm Om Dis Res Ctr, Taichung, Taiwan; [Chung, Chia-Min; Hung, Chung-Chieh] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Hung, Chung-Chieh] China Med Univ Hosp, Dept Psychiat, Taichung, Taiwan; [Lee, Chien-Hung] Kaohsiung Med Univ, Dept Publ Hlth, Coll Hlth Sci, Kaohsiung, Taiwan; [Lee, Ka-Wo] Kaohsiung Med Univ Hosp, Dept Otolaryngol, Kaohsiung, Taiwan; [Chen, Mu-Kuan] Changhua Christian Hosp, Oral Canc Ctr, Changhua, Taiwan; [Yeh, Kun-Tu] Changhua Christian Hosp, Dept Pathol, Changhua, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Changhua Christian Hospital; Changhua Christian Hospital	Ko, YC (corresponding author), China Med Univ Hosp, Environm Om Dis Res Ctr, Taichung, Taiwan.	ycko0406@gmail.com	Lee, Chien-Hung/D-4437-2009	Lee, Chien-Hung/0000-0002-0988-264X	Ministry of Science and Technology [MOST106-2314-B-039-016-MY3]; China Medical University Hospital [DMR-107-090]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); China Medical University Hospital	This work is supported by Ministry of Science and Technology, MOST106-2314-B-039-016-MY3, and China Medical University Hospital, DMR-107-090. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatnagar R, 2012, ORAL ONCOL, V48, P831, DOI 10.1016/j.oraloncology.2012.03.007; BRYANT PJ, 1988, DEV BIOL, V129, P541, DOI 10.1016/0012-1606(88)90399-5; Chang PY, 2017, J AGR FOOD CHEM, V65, P10197, DOI 10.1021/acs.jafc.7b03999; Chang YS, 2016, APPL IMMUNOHISTO M M, V24, P97, DOI 10.1097/PAI.0000000000000158; Chen F, 2017, ONCOTARGET, V8, P55525, DOI 10.18632/oncotarget.14821; Chuang SL, 2017, CANCER-AM CANCER SOC, V123, P1597, DOI 10.1002/cncr.30517; Chung CM, 2017, CANCER PREV RES, V10, P355, DOI 10.1158/1940-6207.CAPR-16-0259; Normando AGC, 2017, SUPPORT CARE CANCER, V25, P2969, DOI 10.1007/s00520-017-3783-8; Dionne KR, 2015, INT J CANCER, V136, P503, DOI 10.1002/ijc.28754; Er TK, 2015, ORAL DIS, V21, P872, DOI 10.1111/odi.12357; Guha N, 2014, INT J CANCER, V135, P1433, DOI 10.1002/ijc.28643; Johansson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036888; KO YC, 1995, J ORAL PATHOL MED, V24, P450, DOI 10.1111/j.1600-0714.1995.tb01132.x; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lee CH, 2003, BRIT J CANCER, V88, P366, DOI 10.1038/sj.bjc.6600727; Lee CH, 2018, JAMA PSYCHIAT, V75, P261, DOI 10.1001/jamapsychiatry.2017.4307; Lee CH, 2014, ADDICTION, V109, P1194, DOI 10.1111/add.12530; Li N, 2011, MED HYPOTHESES, V77, P834, DOI 10.1016/j.mehy.2011.07.049; Lian IB, 2013, ORAL ONCOL, V49, P427, DOI 10.1016/j.oraloncology.2012.12.004; Liao G, 2014, ORAL DIS, V20, P644, DOI 10.1111/odi.12184; Lingen MW, 2011, ORAL DIS, V17, P7, DOI 10.1111/j.1601-0825.2011.01789.x; Liu Y, 2017, ONCOTARGET, V8, P46057, DOI 10.18632/oncotarget.17550; Liu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126760; Liu YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep24014; Luo L, 2011, GENOME RES, V21, P1099, DOI 10.1101/gr.115998.110; Maitra A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3873; Morris LGT, 2013, NAT GENET, V45, P253, DOI 10.1038/ng.2538; Napier SS, 2008, J ORAL PATHOL MED, V37, P1, DOI 10.1111/j.1600-0714.2007.00579.x; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Piotrowski A, 2006, GENE CHROMOSOME CANC, V45, P656, DOI 10.1002/gcc.20331; Radoi L, 2013, COMMUNITY DENT ORAL, V41, DOI 10.1111/j.1600-0528.2012.00710.x; Rao SK, 2016, COMMUNITY DENT ORAL, V44, P76, DOI 10.1111/cdoe.12192; RYAN DAJ, 1992, BIOMETRICS, V48, P155, DOI 10.2307/2532746; Sharan RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042759; Tanoue T, 2005, J CELL SCI, V118, P2347, DOI 10.1242/jcs.02398; Tanuma JI, 2010, ONCOL REP, V23, P739, DOI 10.3892/or_00000692; Vairaktaris E, 2009, ORAL ONCOL, V45, P247, DOI 10.1016/j.oraloncology.2008.05.003; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Yan LJ, 2017, EUR ARCH OTO-RHINO-L, V274, P1945, DOI 10.1007/s00405-016-4427-1; Zeng XT, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-469	40	4	4	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210901	10.1371/journal.pone.0210901	http://dx.doi.org/10.1371/journal.pone.0210901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657779	Green Published, gold, Green Submitted			2022-12-26	WOS:000456017000021
J	Showalter, LE; Oechsle, C; Ghimirey, N; Steele, C; Czerniecki, BJ; Koski, GK				Showalter, Loral E.; Oechsle, Crystal; Ghimirey, Nirmala; Steele, Chase; Czerniecki, Brian J.; Koski, Gary K.			Th1 cytokines sensitize HER-expressing breast cancer cells to lapatinib	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; TYROSINE KINASE INHIBITORS; CRYSTAL-STRUCTURE; EXTRACELLULAR REGION; SUPPRESSIVE FUNCTION; SIGNAL-TRANSDUCTION; DENDRITIC CELLS; OPEN-LABEL; RECEPTOR; RESISTANCE	The HER family of receptor tyrosine kinases has been linked to deregulation of growth and proliferation for multiple types of cancer. Members have therefore become thefocus of many drug and immune-based therapy innovations. The targeted anti-cancer agent, lapatinib, is a small molecule inhibitor that directly interferes with EGFR (HER-1) and HER-2 signaling, and indirectly reduces HER-3 signaling, thus suppressing important downstream events. A recently-developed dendritic cell-based vaccine against early breast cancer (ductal carcinoma in situ; DCIS) that generates strong Th1-dominated immunity against HER-2 has induced pathologic complete response in about one-third of immunized individuals. In vitro studies suggested cytokines secreted by Th1 cells could be major contributors to the vaccine effects including induction of apoptosis and suppression of HER expression. With a view toward improving complete response rates, we investigated whether the principle Th1 cytokines (IFN-gamma and TNF-alpha) could act in concert with lapatinib to suppress activity of breast cancer lines in vitro. Lapatinib-sensitive SKBR3, MDA-MB-468 and BT474 cells were incubated with Th1 cytokines, lapatinib, or both. It was found that combined treatment maximized metabolic suppression(Alamar Blue assay), as well as cell death (Trypan Blue) and apoptosis(Annexin V/Propidium Iodide and TMRE staining). Combined drug plus cytokine treatment also maximized suppression of both total and phosphorylated forms of HER-2 and HER-3. Interestingly, when lapatinib resistant lines MDA-MB-453 and JIMT-1 were tested, it was found that the presence of Th1 cytokines appeared to enhance sensitivity for lapatinib-induced metabolic suppression and induction of apoptotic cell death, nearly abrogating drug resistance. These studies provide pre-clinical data suggesting the possibility that targeted drug therapy may be combined with vaccination to enhance anti-cancer effects, and furthermore that robust immunity in the form of secreted Th1 cytokines may have the capacity to mitigate resistance to targeted drugs.	[Showalter, Loral E.; Oechsle, Crystal; Ghimirey, Nirmala; Steele, Chase; Koski, Gary K.] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA; [Czerniecki, Brian J.] H Lee Moffitt Canc Ctr & Res Inst, Dept Breast Oncol, Tampa, FL USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; H Lee Moffitt Cancer Center & Research Institute	Koski, GK (corresponding author), Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA.	dendritic_cell@hotmail.com			US Department of Defense [W81XH-16-110385]; Pennies in Action Foundation; Werner and Gertrude Henle Charitable Trust	US Department of Defense(United States Department of Defense); Pennies in Action Foundation; Werner and Gertrude Henle Charitable Trust	This work was supported by a grant from the US Department of Defense (http://cdmrp.army.mil/; Grant number W81XH-16-110385: BJC, GKK) and by support from Pennies in Action Foundation (GKK) and the Werner and Gertrude Henle Charitable Trust (GKK and LS).	Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; Azim H, 2009, CANCER TREAT REV, V35, P633, DOI 10.1016/j.ctrv.2009.06.007; Baselga J, 2012, LANCET, V379, P633, DOI 10.1016/S0140-6736(11)61847-3; Braumuller H, 2013, NATURE, V494, P361, DOI 10.1038/nature11824; Burris HA, 2005, J CLIN ONCOL, V23, P5305, DOI 10.1200/JCO.2005.16.584; Canonici A, 2013, ONCOTARGET, V4, P1592, DOI 10.18632/oncotarget.1148; CARRAWAY KL, 1994, CELL, V78, P5, DOI 10.1016/0092-8674(94)90564-9; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Crown JP, 2008, BREAST CANCER RES TR, V112, P317, DOI 10.1007/s10549-007-9860-9; Czerniecki BJ, 1997, J IMMUNOL, V159, P3823; Czerniecki BJ, 2007, CANCER RES, V67, P1842, DOI 10.1158/0008-5472.CAN-06-4038; D'Amato V, 2015, CANCER TREAT REV, V41, P877, DOI 10.1016/j.ctrv.2015.08.001; de Azambuja E, 2014, LANCET ONCOL, V15, P1137, DOI 10.1016/S1470-2045(14)70320-1; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Ercan D, 2015, CLIN CANCER RES, V21, P3913, DOI 10.1158/1078-0432.CCR-14-2789; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Guan ZZ, 2013, J CLIN ONCOL, V31, P1947, DOI 10.1200/JCO.2011.40.5241; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Koski GK, 2012, J IMMUNOTHER, V35, P54, DOI 10.1097/CJI.0b013e318235f512; Liu L, 2009, CANCER RES, V69, P6871, DOI 10.1158/0008-5472.CAN-08-4490; Liu S, 2016, ONCOTARGET, V7, P11310, DOI 10.18632/oncotarget.7023; Lowenfeld L, 2017, CLIN CANCER RES, V23, P2961, DOI 10.1158/1078-0432.CCR-16-1924; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; Namjoshi P., 2016, ONCOTARGET; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Rexer Brent N., 2012, Critical Reviews in Oncogenesis, V17, P1; Rusnak DW, 2001, CANCER RES, V61, P7196; Saleem A, 2015, EJNMMI RES, V5, DOI 10.1186/s13550-015-0103-5; Segovia-Mendoza M, 2015, AM J CANCER RES, V5, P2531; Sendur MAN, 2013, CURR MED RES OPIN, V29, P1015, DOI 10.1185/03007995.2013.807232; Sharma A, 2012, CANCER-AM CANCER SOC, V118, P4354, DOI 10.1002/cncr.26734; Siwak DR, 2010, J ONCOL, V2010, P1, DOI DOI 10.1155/2010/568938; Sullivan RJ, 2013, EUR J CANCER, V49, P1297, DOI 10.1016/j.ejca.2012.11.019; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Wang SH, 2016, J BIOL CHEM, V291, P21085, DOI 10.1074/jbc.M116.717892; Wetterskog D, 2014, ONCOGENE, V33, P966, DOI 10.1038/onc.2013.41; Zaiss DMW, 2013, IMMUNITY, V38, P275, DOI 10.1016/j.immuni.2012.09.023	44	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210209	10.1371/journal.pone.0210209	http://dx.doi.org/10.1371/journal.pone.0210209			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657766	Green Published, Green Submitted, gold			2022-12-26	WOS:000456017000007
J	Ingram, LA; Butler, AA; Gandevia, SC; Walsh, LD				Ingram, Lewis A.; Butler, Annie A.; Gandevia, Simon C.; Walsh, Lee D.			Proprioceptive measurements of perceived hand position using pointing and verbal localisation tasks	PLOS ONE			English	Article							IMPLICIT BODY REPRESENTATIONS; ANESTHESIA; DISTORTIONS; MOVEMENTS; POSTURE; BIASES; MODEL	Previous studies revealed that healthy individuals consistently misjudge the size and shape of their hidden hand during a localisation task. Specifically, they overestimate the width of their hand and underestimate the length of their fingers. This would also imply that the same individuals misjudge the actual location of at least some parts of their hand during the task. Therefore, the primary aim of the current study was to determine whether healthy individuals could accurately locate the actual position of their hand when hidden from view, and whether accuracy depends on the type of localisation task used, the orientation of the hidden hand, and whether the left or right hand is tested. Sixteen healthy right-handed participants performed a hand localisation task that involved both pointing to and verbally indicating the perceived position of landmarks on their hidden hand. Hand position was consistently misjudged as closer to the wrist (proximal bias) and, to a lesser extent, away from the thumb (ulnar bias). The magnitude of these biases depended on the localisation task (pointing vs. verbal), the orientation of the hand (straight vs. rotated), and the hand tested (left vs. right). Furthermore, the proximal location bias increased in size as the duration of the experiment increased, while the magnitude of ulnar bias remained stable through the experiment. Finally, the resultant maps of perceived hand location appear to replicate the previously reported overestimation of hand width and underestimation of finger length. Once again, the magnitude of these distortions is dependent on the task, orientation, and hand tested. These findings underscore the need to control and standardise each component of the hand localisation task in future studies.	[Ingram, Lewis A.; Butler, Annie A.; Gandevia, Simon C.] Neurosci Res Australia, Sydney, NSW, Australia; [Ingram, Lewis A.; Butler, Annie A.; Gandevia, Simon C.] Univ New South Wales, Sydney, NSW, Australia; [Walsh, Lee D.] Platypus Tech Consultants Pty Ltd, Canberra, ACT, Australia	Neuroscience Research Australia; University of New South Wales Sydney	Gandevia, SC (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.; Gandevia, SC (corresponding author), Univ New South Wales, Sydney, NSW, Australia.	s.gandevia@neura.edu.au	Walsh, Lee/D-6184-2011; Butler, Annie/O-5645-2014; Gandevia, Simon/D-5009-2011	Walsh, Lee/0000-0002-1405-1031; Ingram, Lewis/0000-0003-2741-1574; Butler, Annie/0000-0002-3678-1297; Gandevia, Simon/0000-0002-1345-3821	National Health and Medical Research Council (NHMRC) [1055084]; NHMRC; Platypus Technical Consultants	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Platypus Technical Consultants	This study was supported by the Motor Impairment Program grant from the National Health and Medical Research Council (NHMRC), #1055084. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr Lee Walsh is currently the director of Platypus Technical Consultants Pty Ltd (Australia). The company had no role in any aspect of the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders provided some support in the form of salaries for authors (from NHMRC for SG, AB; from Platypus Technical Consultants for LW), but did not have role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'Author contributions' section.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bellan V, 2015, EXP BRAIN RES, V233, P1689, DOI 10.1007/s00221-015-4242-8; BURGESS PR, 1982, ANNU REV NEUROSCI, V5, P171, DOI 10.1146/annurev.ne.05.030182.001131; CRASKE B, 1984, J EXP PSYCHOL HUMAN, V10, P307, DOI 10.1037/0096-1523.10.2.307; CRASKE B, 1975, PERCEPT MOTOR SKILL, V40, P755, DOI 10.2466/pms.1975.40.3.755; CROWE A, 1987, PERCEPT MOTOR SKILL, V64, P831, DOI 10.2466/pms.1987.64.3.831; Desmurget M, 2000, EXP BRAIN RES, V134, P363, DOI 10.1007/s002210000473; Ferre ER, 2013, NEUROPSYCHOLOGIA, V51, P1445, DOI 10.1016/j.neuropsychologia.2013.04.006; FISK JD, 1985, EXP BRAIN RES, V60, P159; Fuentes CT, 2013, ACTA PSYCHOL, V144, P344, DOI 10.1016/j.actpsy.2013.06.012; Gandevia SC, 1999, J PHYSIOL-LONDON, V514, P609, DOI 10.1111/j.1469-7793.1999.609ae.x; Gandevia SC, 2006, J PHYSIOL-LONDON, V571, P703, DOI 10.1113/jphysiol.2005.103093; GHILARDI MF, 1995, J NEUROPHYSIOL, V73, P2535, DOI 10.1152/jn.1995.73.6.2535; Gurfinkel VS, 1991, BRAIN, V34, P102; Haggard P, 2000, PERCEPT PSYCHOPHYS, V62, P363, DOI 10.3758/BF03205556; Hillier S, 2015, NEUROREHAB NEURAL RE, V29, P933, DOI 10.1177/1545968315573055; Hoang PD, 2016, MULT SCLER J EXP TRA, V2, P1; Hodges P., 2013, SPINAL CONTROL REHAB; Hoseini N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135757; Inui N, 2011, J PHYSIOL-LONDON, V589, P5775, DOI 10.1113/jphysiol.2011.219949; Jones SAH, 2010, EXP BRAIN RES, V204, P373, DOI 10.1007/s00221-009-2079-8; Jull G.A., 2008, WHIPLASH HEADACHE NE; Kaya D, 2018, PROPRIOCEPTION ORTHO; Longo MR, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00656; Longo MR, 2015, CONSCIOUS COGN, V36, P96, DOI 10.1016/j.concog.2015.06.009; Longo MR, 2015, ACTA PSYCHOL, V160, P77, DOI 10.1016/j.actpsy.2015.07.002; Longo MR, 2014, EXP BRAIN RES, V232, P1241, DOI 10.1007/s00221-014-3840-1; Longo MR, 2012, ACTA PSYCHOL, V141, P164, DOI 10.1016/j.actpsy.2012.07.015; Longo MR, 2012, PSYCHOL SCI, V23, P740, DOI 10.1177/0956797612441219; Longo MR, 2012, J EXP PSYCHOL HUMAN, V38, P9, DOI 10.1037/a0025428; Longo MR, 2010, P NATL ACAD SCI USA, V107, P11727, DOI 10.1073/pnas.1003483107; Longo MR, 2010, NEUROPSYCHOLOGIA, V48, P655, DOI 10.1016/j.neuropsychologia.2009.08.022; Lopez C, 2012, NEUROPSYCHOLOGIA, V50, P1830, DOI 10.1016/j.neuropsychologia.2012.04.008; Margolis AN, 2015, EXP BRAIN RES, V233, P351, DOI 10.1007/s00221-014-4118-3; Mattioni S, 2014, ACTA PSYCHOL, V153, P60, DOI 10.1016/j.actpsy.2014.09.009; Medina J, 2017, J EXP PSYCHOL HUMAN, V43, P1430, DOI 10.1037/xhp0000397; Medina J, 2010, NEUROPSYCHOLOGIA, V48, P645, DOI 10.1016/j.neuropsychologia.2009.08.017; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paillard J, NEUROPSYCHOLOGY SPAT; Proske U, 2018, COMPR PHYSIOL, V8, P1157, DOI 10.1002/cphy.c170036; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Rincon-Gonzalez L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025214; Sherrington C.S., 1906, INTEGRATIVE ACTION N, Vfirst, DOI 10.1037/13798-000; Twisk JW, 2013, APPL LONGITUDINAL DA; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; Tyson SF, 2008, NEUROREHAB NEURAL RE, V22, P166, DOI 10.1177/1545968307305523; Vaugoyeau M, 2011, HUM MOVEMENT SCI, V30, P405, DOI 10.1016/j.humov.2010.10.006; Walsh LD, 2015, EXP BRAIN RES, V233, P1761, DOI 10.1007/s00221-015-4249-1; Walsh LD, 2010, J PHYSIOL-LONDON, V588, P1269, DOI 10.1113/jphysiol.2009.183038; WANN JP, 1992, EXP BRAIN RES, V91, P162; Wilson ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011851	51	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210911	10.1371/journal.pone.0210911	http://dx.doi.org/10.1371/journal.pone.0210911			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653568	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000456015500088
J	Leynaud-Kieffer, LMC; Curran, SC; Kim, I; Magnuson, JK; Gladden, JM; Baker, SE; Simmons, BA				Leynaud-Kieffer, Laure M. C.; Curran, Samuel C.; Kim, Irene; Magnuson, Jon K.; Gladden, John M.; Baker, Scott E.; Simmons, Blake A.			A new approach to Cas9-based genome editing in Aspergillus niger that is precise, efficient and selectable	PLOS ONE			English	Article							FILAMENTOUS FUNGI; HOMOLOGOUS RECOMBINATION; GENE; TRANSFORMATION; ENDONUCLEASE; EXPRESSION; SELECTION; ENZYMES	Aspergillus niger and other filamentous fungi are widely used in industry, but efficient genetic engineering of these hosts remains nascent. For example, while molecular genetic tools have been developed, including CRISPR/Cas9, facile genome engineering of A. niger remains challenging. To address these challenges, we have developed a simple Cas9-based gene targeting method that provides selectable, iterative, and ultimately marker-free generation of genomic deletions and insertions. This method leverages locus-specific "popout" recombination to suppress off-target integrations. We demonstrated the effectiveness of this method by targeting the phenotypic marker albA and validated it by targeting the glaA and mstC loci. After two selection steps, we observed 100% gene editing efficiency across all three loci. This method greatly reduces the effort required to engineer the A. niger genome and overcomes low Cas9 transformations efficiency by eliminating the need for extensive screening. This method represents a significant addition to the A. niger genome engineering toolbox and could be adapted for use in other organisms. It is expected that this method will impact several areas of industrial biotechnology, such as the development of new strains for the secretion of heterologous enzymes and the discovery and optimization of metabolic pathways.	[Leynaud-Kieffer, Laure M. C.] Swiss Fed Inst Technol Lausanne, Lausanne, Vaud, Switzerland; [Leynaud-Kieffer, Laure M. C.; Curran, Samuel C.; Magnuson, Jon K.; Gladden, John M.; Baker, Scott E.; Simmons, Blake A.] Joint Bioenergy Inst, Emeryville, CA 94608 USA; [Leynaud-Kieffer, Laure M. C.; Curran, Samuel C.; Simmons, Blake A.] Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA; [Curran, Samuel C.] Univ Calif Berkeley, Comparat Biochem Grad Grp, Berkeley, CA 94720 USA; [Kim, Irene] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Magnuson, Jon K.] Pacific Northwest Natl Lab, Chem & Biol Proc Dev Grp, Richland, WA USA; [Gladden, John M.] Sandia Natl Labs, Dept Biomass Sci & Convers Technol, Livermore, CA USA; [Baker, Scott E.] Pacific Northwest Natl Lab, Environm Mol Sci Div, Biosyst Design & Simulat Grp, Richland, WA USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Simmons, BA (corresponding author), Joint Bioenergy Inst, Emeryville, CA 94608 USA.; Simmons, BA (corresponding author), Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA.	basimmons@lbl.gov	Baker, Scott E./ABB-1635-2020; Simmons, Blake/N-6022-2016	Baker, Scott E./0000-0001-5085-3106; Simmons, Blake/0000-0002-1332-1810; Leynaud Kieffer, Laure/0000-0002-2074-9903	DOE Joint BioEnergy Institute; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; U.S. Department of Energy (DOE) Office of Energy Efficiency and Renewable Energy (EERE), Bioenergy Technologies Office; U.S. Department of Energy (DOE) Office of Energy Efficiency and Renewable Energy (EERE), Vehicle Technologies Office	DOE Joint BioEnergy Institute; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); U.S. Department of Energy (DOE) Office of Energy Efficiency and Renewable Energy (EERE), Bioenergy Technologies Office(United States Department of Energy (DOE)); U.S. Department of Energy (DOE) Office of Energy Efficiency and Renewable Energy (EERE), Vehicle Technologies Office(United States Department of Energy (DOE))	This work was supported by the DOE Joint BioEnergy Institute (http://www.jbei.org) and by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy. The United States Government retains and the publisher, by accepting the article for publication, acknowledges that the United States Government retains a nonexclusive, paid-up, irrevocable, worldwide license to publish or reproduce the published form of this manuscript, or allow others to do so, for United States Government purposes. This research was also conducted as part of the Co-Optimization of Fuels & Engines (Co-Optima) project sponsored by the U.S. Department of Energy (DOE) Office of Energy Efficiency and Renewable Energy (EERE), Bioenergy Technologies and Vehicle Technologies Offices. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrio JL, 2014, BIOMOLECULES, V4, P117, DOI 10.3390/biom4010117; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Chiang YM, 2011, FUNGAL GENET BIOL, V48, P430, DOI 10.1016/j.fgb.2010.12.001; dEnfert C, 1996, CURR GENET, V30, P76, DOI 10.1007/s002940050103; Deng HX, 2017, GENE, V627, P212, DOI 10.1016/j.gene.2017.06.019; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93; GEMS D, 1991, GENE, V98, P61, DOI 10.1016/0378-1119(91)90104-J; Gladden JM, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-15; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Haq I, 2012, BIOTECHNOL LETT, V34, P1703, DOI 10.1007/s10529-012-0953-0; Horlbeck M. A., 2016, ELIFE, P5; Imran M, 2010, PAKISTAN J BOT; Jensen KT, 2017, FEBS LETT, V591, P1892, DOI 10.1002/1873-3468.12707; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Krappmann Sven, 2007, Fungal Biology Reviews, V21, P25, DOI 10.1016/j.fbr.2007.02.004; Li DD, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0785-7; Ling SOS, 2013, SCI WORLD J, DOI 10.1155/2013/634317; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Martinez AT, 2005, INT MICROBIOL, V8, P195; Meyer V, 2008, BIOTECHNOL ADV, V26, P177, DOI 10.1016/j.biotechadv.2007.12.001; Meyer V, 2007, J BIOTECHNOL, V128, P770, DOI 10.1016/j.jbiotec.2006.12.021; Nodvig CS, 2018, FUNGAL GENET BIOL, V115, P78, DOI 10.1016/j.fgb.2018.01.004; Nodvig CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133085; Olempska-Beer ZS, 2006, REGUL TOXICOL PHARM, V45, P144, DOI 10.1016/j.yrtph.2006.05.001; Patyshakuliyeva A, 2016, BIOTECHNOL LETT, V38, P969, DOI 10.1007/s10529-016-2060-0; Punt PJ, 2002, TRENDS BIOTECHNOL, V20, P200, DOI 10.1016/S0167-7799(02)01933-9; Reilly MC, 2018, APPL MICROBIOL BIOT, V102, P1797, DOI 10.1007/s00253-017-8717-3; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Ruiz-Diez B, 2002, J APPL MICROBIOL, V92, P189, DOI 10.1046/j.1365-2672.2002.01516.x; Schmidt FR, 2004, APPL MICROBIOL BIOT, V65, P363, DOI 10.1007/s00253-004-1656-9; Schuster M, 2016, FUNGAL GENET BIOL, V89, P3, DOI 10.1016/j.fgb.2015.09.001; Shi TQ, 2017, APPL MICROBIOL BIOT, V101, P7435, DOI 10.1007/s00253-017-8497-9; Song L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202868; SUGAWARA N, 1992, MOL CELL BIOL, V12, P563, DOI 10.1128/MCB.12.2.563; Ward OP, 2012, BIOTECHNOL ADV, V30, P1119, DOI 10.1016/j.biotechadv.2011.09.012; Zhang JX, 2011, CURR MICROBIOL, V62, P1342, DOI 10.1007/s00284-010-9853-5; Zheng YR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17658-7; Zhu XG, 2004, SCI CHINA SER C, V47, P139, DOI 10.1360/03yc0097; Zischewski J, 2017, BIOTECHNOL ADV, V35, P95, DOI 10.1016/j.biotechadv.2016.12.003	43	30	33	9	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210243	10.1371/journal.pone.0210243	http://dx.doi.org/10.1371/journal.pone.0210243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653574	Green Submitted, gold, Green Published			2022-12-26	WOS:000456015500029
J	Barker, SE; Bricknell, IR; Covello, J; Purcell, S; Fast, MD; Wolters, W; Bouchard, DA				Barker, Sarah E.; Bricknell, Ian R.; Covello, Julia; Purcell, Sarah; Fast, Mark D.; Wolters, William; Bouchard, Deborah A.			Sea lice, Lepeophtheirus salmonis (Kroyer 1837), infected Atlantic salmon (Salmo salar L.) are more susceptible to infectious salmon anemia virus	PLOS ONE			English	Article							ORTHOMYXO-LIKE VIRUS; SINGLE-STEP METHOD; IMMUNE-RESPONSES; NEW-BRUNSWICK; RISK-FACTORS; LOUSE; INTERFERON; RNA; CALIGIDAE; COPEPODA	The role of parasitic sea lice (Siphonostomatoida; Caligidae), especially Lepeophtheirus salmonis, in the epidemiology of Infectious Salmon Anemia Virus (ISAv) has long been suspected. The epidemiological studies conducted during the 1998 major Infectious Salmon Anaemia (ISA) outbreak in Scotland demonstrated a strong correlation between sea lice presence and ISAv positive sites or subsequent clinical outbreaks of ISA. The question posed from this observation was "do sea lice infestations on Atlantic salmon make them more susceptible to viral infections?" This study investigated the role that sea lice infestations have on the severity of ISAv infections and disease mortality in experimental populations of farmed Atlantic salmon (Salmo salar). A series of experiments was carried out that investigated the potential of sea lice to modify the outcome of an ISAv infection. Experimental populations of Atlantic salmon were established that had: no lice and no ISAv, a single infection with either ISAv or lice and a co-infection with lice then ISAV. The results were quite clear, the process of infestation by the parasite prior to ISAv exposure significantly increased the mortality and death rates of Atlantic salmon, when compared to uninfected controls and ISAv infected groups only. This was consistent over two source strains of Atlantic salmon (Pennobscot and Saint John River), but the severity and timing was altered. Immunological responses were also consistent in that pro-inflammatory genes were induced in lice only and co-infected fish, whereas the anti-viral response, Mx, MH class I beta, Galectin 9 and TRIM 16, 25 genes were down-regulated by lice infection prior to and shortly after co-infection with ISAv. It is concluded that the sea lice settlement on Atlantic salmon and the parasite's subsequent manipulation of the host's immune system, which increases parasite settlement success, also increased susceptibility to ISAv.	[Barker, Sarah E.; Bricknell, Ian R.; Bouchard, Deborah A.] Univ Maine, Aquaculture Res Inst, Hitchner Hall, Orono, ME 04469 USA; [Bricknell, Ian R.] Univ Maine, Sch Marine Sci, Hitchner Hall, Orono, ME USA; [Covello, Julia; Purcell, Sarah; Fast, Mark D.] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Pathol & Microbiol, Hoplite Lab, Charlottetown, PE, Canada; [Wolters, William] ARS, USDA, Natl Cold Water Marine Aquaculture Ctr, Franklin, ME USA; [Barker, Sarah E.] Benchmark Anim Hlth Ltd, Edinburgh Technopole, Penicuik, Midlothian, Scotland	University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University of Prince Edward Island; United States Department of Agriculture (USDA)	Bouchard, DA (corresponding author), Univ Maine, Aquaculture Res Inst, Hitchner Hall, Orono, ME 04469 USA.	deborah.bouchard@maine.edu		Bouchard, Deborah/0000-0001-9552-4576	Northeastern Regional Aquaculture Center [2010-38580-21074]; Maine Agricultural and Forest Experiment Station (US), NIFA MAFES [ME21501]	Northeastern Regional Aquaculture Center; Maine Agricultural and Forest Experiment Station (US), NIFA MAFES	The authors would like to thank the Northeastern Regional Aquaculture Center for award #2010-38580-21074, https://www.ncrac.org, and the Maine Agricultural and Forest Experiment Station (US), https://umaine.edu/mafes/, NIFA MAFES for award #ME21501, for their support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolofia J, 2017, MAR RESOUR ECON, V32, P329, DOI 10.1086/691981; Barker DE, 2009, PARASITOL RES, V105, P1173, DOI 10.1007/s00436-009-1523-9; Bierne H, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a010272; Bierne H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039080; Bjorn PA, 2011, AQUACULTURE ENV INTE, V1; Blake S, 1999, DIS AQUAT ORGAN, V36, P238; Bouchard D, 1999, DIS AQUAT ORGAN, V36, P238; Braden LM, 2015, DEV COMP IMMUNOL, V48, P178, DOI 10.1016/j.dci.2014.09.015; Braden LM, 2012, COMP BIOCHEM PHYS D, V7, P100, DOI 10.1016/j.cbd.2011.12.002; Braden LM, 2016, 11 INT SEA LIC C 201; BRON JE, 1991, J ZOOL, V224, P201, DOI 10.1111/j.1469-7998.1991.tb04799.x; Brown ABJ, 2017, 42 ANN E FISH HLTH W; Butler R.G., 2001, THESIS; Chang CJ, 2014, VACCINE, V32, P4695, DOI 10.1016/j.vaccine.2014.05.059; CHOMCZYNSKI P, 1995, ANAL BIOCHEM, V225, P163, DOI 10.1006/abio.1995.1126; CHOMCZYNSKI P, 1995, BIOTECHNIQUES, V19, P942; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Collet B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137767; Costello MJ, 2006, TRENDS PARASITOL, V22, P475, DOI 10.1016/j.pt.2006.08.006; D'Cruz AA, 2013, BIOCHEM J, V456, P231, DOI 10.1042/BJ20121425; EVENSEN O, 1991, RES VET SCI, V51, P215, DOI 10.1016/0034-5288(91)90017-I; Falk K, 1997, J VIROL, V71, P9016, DOI 10.1128/JVI.71.12.9016-9023.1997; Fast MD, 2007, PARASITE IMMUNOL, V29, P179, DOI 10.1111/j.1365-3024.2007.00932.x; Fast MD, 2014, DEV COMP IMMUNOL, V43, P300, DOI 10.1016/j.dci.2013.08.019; Fast MD, 2004, EXP PARASITOL, V107, P5, DOI 10.1016/j.exppara.2004.04.001; Hammell KL, 2005, J FISH DIS, V28, P651, DOI 10.1111/j.1365-2761.2005.00668.x; Hammell KL, 2005, J FISH DIS, V28, P639, DOI 10.1111/j.1365-2761.2005.00667.x; Hammell KL, 2005, RISK FACTORS ASS MOR; Hastings T, 1999, BULL EUR ASSN FISH P, V19, P286; Holler O, 2009, REV SCI TECH OIE, V28, P219, DOI 10.20506/rst.28.1.1867; Holm H, 2015, FISH SHELLFISH IMMUN, V42, P384, DOI 10.1016/j.fsi.2014.10.038; Jackson D, 2012, AQUACULTURE, V364, P118, DOI 10.1016/j.aquaculture.2012.08.003; Jakob E, 2011, DIS AQUAT ORGAN, V97, P155, DOI 10.3354/dao02414; Johansen LH, 2011, AQUACULTURE, V315, P167, DOI 10.1016/j.aquaculture.2011.02.014; Jones SRM, 2006, J PARASITOL, V92, P473, DOI 10.1645/GE-685R1.1; Jorgensen SM, 2007, FISH SHELLFISH IMMUN, V23, P576, DOI 10.1016/j.fsi.2007.01.005; Kibenge FSB, 2001, DIS AQUAT ORGAN, V45, P9, DOI 10.3354/dao045009; Kileng O, 2008, FISH SHELLFISH IMMUN, V24, P514, DOI 10.1016/j.fsi.2007.10.005; Kileng O, 2007, FISH SHELLFISH IMMUN, V23, P378, DOI 10.1016/j.fsi.2006.11.011; Krasnov A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-130; Krossoy B, 1999, J VIROL, V73, P2136; Kvello AR, 2007, CELLS; Lafferty KD, 2015, ANNU REV MAR SCI, V7, P471, DOI 10.1146/annurev-marine-010814-015646; LeBlanc F, 2012, MOL IMMUNOL, V51, P197, DOI 10.1016/j.molimm.2012.03.021; LeBlanc F, 2010, FISH SHELLFISH IMMUN, V29, P217, DOI 10.1016/j.fsi.2010.03.007; Lewis DL, 2014, FISH SHELLFISH IMMUN, V38, P175, DOI 10.1016/j.fsi.2014.03.014; McClure CA, 2005, PREV VET MED, V72, P263, DOI 10.1016/j.prevetmed.2005.07.010; McClure CA, 2005, DIS AQUAT ORGAN, V63, P119, DOI 10.3354/dao063119; Mishra A, 2017, INT REV IMMUNOL, V36, P89, DOI 10.1080/08830185.2017.1291640; Mjaaland S, 1997, J VIROL, V71, P7681, DOI 10.1128/JVI.71.10.7681-7686.1997; Molloy SD, 2013, J FISH DIS, V36, P35, DOI 10.1111/j.1365-2761.2012.01412.x; Mordue AJ, 2009, J FISH DIS, V32, P3, DOI 10.1111/j.1365-2761.2008.01004.x; Murray AG, 2010, DIS AQUAT ORGAN, V91, P189, DOI 10.3354/dao02262; NESE L, 1993, DIS AQUAT ORGAN, V16, P79, DOI 10.3354/dao016079; Nylund A., 1991, Bulletin of the European Association of Fish Pathologists, V11, P213; Oelckers K, 2015, LAT AM J AQUAT RES, V43, P380, DOI 10.3856/vol43-issue2-fulltext-15; Pert CC, 2014, AQUACULT ENV INTERAC, V5, P49, DOI 10.3354/aei00094; Pino-Marambio J, 2007, AQUACULTURE, V271, P70, DOI 10.1016/j.aquaculture.2007.05.025; Purcell SL, 2013, J FISH DIS, V36, P229, DOI 10.1111/jfd.12024; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rimstad E, 2002, APMIS, V110, P273, DOI 10.1034/j.1600-0463.2002.100401.x; Rodger HD, 2016, BIRKHAUSER ADV INFEC, P1, DOI 10.1007/978-3-0348-0980-1_1; Schiotz BL, 2008, VIRUS RES, V136, P65, DOI 10.1016/j.virusres.2008.04.019; Shi WK, 2018, ACTA TROP, V177, P97, DOI 10.1016/j.actatropica.2017.09.027; Skugor S, 2008, BMC GENOMICS, V9, P18, DOI [10.1186/1471-2164-9-18, DOI 10.1186/1471-2164-9-18]; Skugor S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1921-7; Snow M, NEW DIAGNOSTIC TECHN, P133; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Torrissen O, 2013, J FISH DIS, V36, P171, DOI 10.1111/jfd.12061; Valdes-Donoso P, 2013, J FISH DIS, V36, P353, DOI 10.1111/jfd.12070; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	72	32	32	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209178	10.1371/journal.pone.0209178	http://dx.doi.org/10.1371/journal.pone.0209178			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650077	Green Submitted, gold, Green Published			2022-12-26	WOS:000455813300009
J	Cavazos-Rehg, PA; Krauss, MJ; Costello, SJ; Kaiser, N; Cahn, ES; Fitzsimmons-Craft, EE; Wilfley, DE				Cavazos-Rehg, Patricia A.; Krauss, Melissa J.; Costello, Shaina J.; Kaiser, Nina; Cahn, Elizabeth S.; Fitzsimmons-Craft, Ellen E.; Wilfley, Denise E.			"I just want to be skinny.": A content analysis of tweets expressing eating disorder symptoms	PLOS ONE			English	Article							EXAMINATION-QUESTIONNAIRE; NUMBER-THINSPIRATION; FITSPIRATION; PREVALENCE; COMMUNITY	There is increasing concern about online communities that promote eating disorder (ED) behaviors through messages and/or images that encourage a "thin ideal" (i.e., promotion of thinness as attractive) and harmful weight loss/weight control practices. The purpose of this paper is to assess the content of body image and ED-related content on Twitter and provide a deeper understanding of EDs that may be used for future studies and online-based interventions. Tweets containing ED or body image-related keywords were collected from January 1-January 31, 2015 (N = 28,642). A random sample (n = 3000) was assessed for expressions of behaviors that align with subscales of the Eating Disorder Examination (EDE) 16.0. Demographic characteristics were inferred using a social media analytics company. The comprehensive research that we conducted indicated that 2,584 of the 3,000 tweets were ED-related; 65% expressed a preoccupation with body shape, 13% displayed issues related to food/eating/calories, and 4% expressed placing a high level of importance on body weight. Most tweets were sent by girls (90%) who were <= 19 years old (77%). Our findings stress a need to better understand if and how ED-related content on social media can be used for targeting prevention and intervention messages towards those who are inneed and could potentially benefit from these efforts.	[Cavazos-Rehg, Patricia A.; Krauss, Melissa J.; Costello, Shaina J.; Kaiser, Nina; Cahn, Elizabeth S.; Fitzsimmons-Craft, Ellen E.; Wilfley, Denise E.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA	Washington University (WUSTL)	Cavazos-Rehg, PA (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	pcavazos@wustl.edu		Cavazos-Rehg, Patricia/0000-0003-3352-1198	National Institutes of Health [R01DA032843, R01DA039455]; Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) [UL1 TR000448]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, UL1TR002345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA039455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health [grant numbers R01DA032843 (PCR), R01DA039455 (PCR)] and the Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) [grant number UL1 TR000448]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 2015, MEDIA IS BRAINWASHIN; [Anonymous], 2012, CBS NEW YORK    0717; Arseniev-Koehler A, 2016, J ADOLESCENT HEALTH, V58, P659, DOI 10.1016/j.jadohealth.2016.02.012; Beevolve, 2012, EXH STUD TWITT US WO; Berg KC, 2012, INT J EAT DISORDER, V45, P428, DOI 10.1002/eat.20931; Brown A., 2015, TEX REV ENT SPORTS L, V16, P87; Carrotte ER, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.6368; Cavazos-Rehg PA, 2016, COMPUT HUM BEHAV, V54, P351, DOI 10.1016/j.chb.2015.08.023; COOPER PJ, 1993, INT J EAT DISORDER, V13, P385, DOI 10.1002/1098-108X(199305)13:4<385::AID-EAT2260130406>3.0.CO;2-W; Cornelius T, 2016, EAT DISORD, V24, P138, DOI 10.1080/10640266.2014.1000102; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; FAIRBURN CG, 1986, INT J EAT DISORDER, V5, P403, DOI 10.1002/1098-108X(198603)5:3<403::AID-EAT2260050302>3.0.CO;2-Z; Fairburn CG, 2008, COGNITIVE BEHAV THER; Fiesler C, 2017, CSCW'17: PROCEEDINGS OF THE 2017 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING, P567, DOI 10.1145/2998181.2998223; Ghaznavi J, 2015, BODY IMAGE, V14, P54, DOI 10.1016/j.bodyim.2015.03.006; Holland G, 2017, INT J EAT DISORDER, V50, P76, DOI 10.1002/eat.22559; Krippendorff K, 2004, HUM COMMUN RES, V30, P411, DOI 10.1111/j.1468-2958.2004.tb00738.x; Krippendorff K., 2007, COMPUTING KRIPPENDOR; Livingstone S., 2010, RISKS SAFETY INTERNE; Mishra R, 2012, CAMB Q HEALTHC ETHIC, V21, P396, DOI 10.1017/S0963180112000138; Mislove A, 2011, P 5 INT C WEBL SOC M, P554; Mond JM, 2004, BEHAV RES THER, V42, P551, DOI 10.1016/S0005-7967(03)00161-X; Pater JA, 2016, ACM CONFERENCE ON COMPUTER-SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING (CSCW 2016), P1185, DOI 10.1145/2818048.2820030; Peterson CB, 2007, INT J EAT DISORDER, V40, P386, DOI 10.1002/eat.20373; Qian Jie, 2013, Shanghai Arch Psychiatry, V25, P212, DOI 10.3969/j.issn.1002-0829.2013.04.003; Smink FRE, 2012, CURR PSYCHIAT REP, V14, P406, DOI 10.1007/s11920-012-0282-y; Sowles SJ, 2018, BODY IMAGE, V24, P137, DOI 10.1016/j.bodyim.2018.01.001; Swanson SA, 2011, ARCH GEN PSYCHIAT, V68, P714, DOI 10.1001/archgenpsychiatry.2011.22; Talbot CV, 2017, J EAT DISORD, V5, DOI 10.1186/s40337-017-0170-2; Tiggemann M, 2018, BODY IMAGE, V25, P133, DOI 10.1016/j.bodyim.2018.03.002; Tiggemann M, 2018, J HEALTH PSYCHOL, V23, P1003, DOI 10.1177/1359105316639436	32	26	26	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0207506	10.1371/journal.pone.0207506	http://dx.doi.org/10.1371/journal.pone.0207506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650072	Green Submitted, Green Published, gold			2022-12-26	WOS:000455813300004
J	Cespedes, V; Valdecasas, AG; Green, AJ; Sanchez, MI				Cespedes, Vanessa; Valdecasas, Antonio G.; Green, Andy J.; Sanchez, Marta I.			Water boatman survival and fecundity are related to ectoparasitism and salinity stress	PLOS ONE			English	Article							NATIONAL-PARK SW; TEMPORARY PONDS; CLIMATE-CHANGE; PARASITISM; CORIXIDAE; HEMIPTERA; DONANA; LARVAE; MITES; DISEASES	Salinity is increasing in aquatic ecosystems in the Mediterranean region due to global change, and this is likely to have an important impact on host-parasite interactions. Here we studied the relationships between infection by ectoparasitic water mites and salinity variation, on survival and fecundity of water boatmen Corixidae in the laboratory. Larvae of Sigara lateralis parasitised by larval mites (Hydrachna skorikowi) had lower survivorship, and failed to moult to the adult stage. In adult corixids (S. lateralis and Corixa affinis) fitness was reduced at high salinities and in individuals infected by H. skorikowi, both in terms of survival and fecundity. We also found evidence for parasitism-salinity interactions. Our results suggest that ongoing increases in salinity in Mediterranean ponds due to climate change and water abstraction for agriculture or urban use have a strong impact on water bugs, and that their interactions with ectoparasites may modify salinity effects.	[Cespedes, Vanessa; Green, Andy J.; Sanchez, Marta I.] CSIC, Dept Ecol Humedales, Estn Biol Donana, Seville, Spain; [Valdecasas, Antonio G.] CSIC, Museo Nacl Ciencias Nat, Dept Biodiversidad & Biol Evolut, Madrid, Spain; [Sanchez, Marta I.] Univ Cadiz, Inst Univ Invest Marina INMAR, Campus Excelencia Int Global Mar CEI MAR, Puerto Real, Cadiz, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Universidad de Cadiz	Cespedes, V (corresponding author), CSIC, Dept Ecol Humedales, Estn Biol Donana, Seville, Spain.	vanessa.cespedes@ebd.csic.es	Sánchez, Marta I/E-9723-2010; Céspedes, Vanessa/AAF-6316-2019; Valdecasas, Antonio G/H-6696-2015; Green, Andy J/A-5189-2008	Sánchez, Marta I/0000-0002-8349-5410; Céspedes, Vanessa/0000-0002-9399-8791; Valdecasas, Antonio G/0000-0002-5665-4906; Green, Andy J/0000-0002-1268-4951	Consejeria de Innovacion, Ciencia y empresa, Junta de Andalucia [P10-RNM-6262]; MICINN [EEBB-I-17-12675, SVP-2013-067595]; Ministerio de Economia, Industria y Competitividad, Gobierno de Espana [RYC-2011-09382]	Consejeria de Innovacion, Ciencia y empresa, Junta de Andalucia(Junta de Andalucia); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Ministerio de Economia, Industria y Competitividad, Gobierno de Espana(Spanish Government)	This work was funded by project P10-RNM-6262 (Consejeria de Innovacion, Ciencia y empresa, Junta de Andalucia). The first author (VC) was supported by a predoctoral Severo Ochoa grant SVP-2013-067595 from the MICINN and mobility grant EEBB-I-17-12675 from the MICINN. Funding was also provided by Ministerio de Economia, Industria y Competitividad, Gobierno de Espana (grant RYC-2011-09382) to MIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRO A, 1982, J INVERTEBR PATHOL, V39, P373, DOI 10.1016/0022-2011(82)90062-3; APPLEGATE RL, 1977, AM MIDL NAT, V97, P198, DOI 10.2307/2424695; Aykut M, 2018, ZOOKEYS, P89, DOI 10.3897/zookeys.738.21021; Blanar CA, 2009, AQUAT TOXICOL, V93, P18, DOI 10.1016/j.aquatox.2009.03.002; BOTTGER K, 1976, FRESHWATER BIOL, V6, P497, DOI 10.1111/j.1365-2427.1976.tb01641.x; Bradley T. J., 2008, Aquatic insects: challenges to populations, P20, DOI 10.1079/9781845933968.0020; CAMPBELL BC, 1979, CAN ENTOMOL, V111, P1005, DOI 10.4039/Ent1111005-9; Carbonell JA, 2016, HYDROBIOLOGIA, V768, P273, DOI 10.1007/s10750-015-2556-y; Carbonell JA, 2012, FRESHWATER BIOL, V57, P2580, DOI 10.1111/fwb.12029; Carbonell JA, 2017, FUNCT ECOL, V31, P1957, DOI 10.1111/1365-2435.12884; Cespedes V, 2019, HYDROBIOLOGIA, V827, P309, DOI [10.1007/s10750-018-3782-x, 10.100]; Cespedes V, 2017, PEERJ, V5, DOI 10.7717/peerj.3554; Coccia C, 2016, AQUAT SCI, V78, P779, DOI 10.1007/s00027-016-0469-0; Coors A, 2008, J APPL ECOL, V45, P1820, DOI 10.1111/j.1365-2664.2008.01566.x; Crisp D. T., 1959, Irish Naturalists' Journal, V13, P88; DAVIDS C, 1973, Netherlands Journal of Zoology, V23, P363; Davids C., 2006, GREEN INFRASTRUCTURE, P241, DOI [10.1007/978- 3-662- 55958-1_7, 10.1007/978-3-662-55958-1_7]; Davids C, 1975, VERHANDLUNGEN INT VE, V19, P3079; Di Sabatino A, 2000, FRESHWATER BIOL, V44, P47, DOI 10.1046/j.1365-2427.2000.00591.x; Diaz-Paniagua C, 2015, LIMNETICA, V34, P407; Fairn ER, 2008, ECOSCIENCE, V15, P327, DOI 10.2980/15-3-3134; Florencio M, 2009, HYDROBIOLOGIA, V634, P167, DOI 10.1007/s10750-009-9897-3; Frisch D, 2006, HYDROBIOLOGIA, V556, P327, DOI 10.1007/s10750-005-1305-z; Gledhill T., 1985, Freshwater Biological Association Annual Report, V53, P45; Green AJ, 2017, FRONT ECOL ENVIRON, V15, P99, DOI 10.1002/fee.1459; Hall MD, 2013, OECOLOGIA, V171, P789, DOI 10.1007/s00442-012-2452-3; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Heine-Fuster I, 2010, J PLANKTON RES, V32, P1405, DOI 10.1093/plankt/fbq055; Jeppesen E, 2015, HYDROBIOLOGIA, V750, P201, DOI 10.1007/s10750-014-2169-x; Kefford BJ, 2004, HYDROBIOLOGIA, V517, P179, DOI 10.1023/B:HYDR.0000027346.06304.bc; Kelly DW, 2010, J APPL ECOL, V47, P498, DOI 10.1111/j.1365-2664.2010.01791.x; KELTS LJ, 1979, HYDROBIOLOGIA, V64, P37, DOI 10.1007/BF00015451; Kortegaard Leo, 1974, Wildfowl, V25, P134; LANCIANI CA, 1975, ECOLOGY, V56, P689, DOI 10.2307/1935503; LANCIANI CA, 1982, PARASITOLOGY, V85, P1, DOI 10.1017/S0031182000054081; LANCIANI CA, 1969, T AM MICROSC SOC, V88, P356, DOI 10.2307/3224702; LOPEZ T, 1991, ARCH HYDROBIOL, V120, P357; Lorenzo-Carballa MO, 2011, EXP APPL ACAROL, V54, P225, DOI 10.1007/s10493-011-9437-5; Marcogliese DJ, 2008, REV SCI TECH OIE, V27, P467, DOI 10.20506/rst.27.2.1820; Marcogliese DJ, 2011, TRENDS PARASITOL, V27, P123, DOI 10.1016/j.pt.2010.11.002; Marcogliese DJ, 2001, CAN J ZOOL, V79, P1331, DOI 10.1139/cjz-79-8-1331; Muhling BA, 2018, ESTUAR COAST, V41, P349, DOI 10.1007/s12237-017-0280-8; MURILLO J, 1986, Miscellania Zoologica (Barcelona), V10, P135; Nielsen GJ, 1976, ACAROLOGIA; Oren A, 1999, MICROBIOL MOL BIOL R, V63, P334, DOI 10.1128/MMBR.63.2.334-348.1999; OVERSTREET RM, 1993, ADV FISH SC, P111; POULIN R, 1992, PARASITOL TODAY, V8, P58, DOI 10.1016/0169-4758(92)90090-O; Proctor HC, 2015, THORP COVICHS FRESHW, P599, DOI DOI 10.1016/B978-0-12-385026-3.00025-5; Proctor HC, 2015, ECOLOGY AND GENERAL BIOLOGY, VOL I: THORP AND COVICH'S FRESHWATER INVERTEBRATES, 4TH EDITION, P599, DOI 10.1016/B978-0-12-385026-3.00025-5; Randolt K, 2008, ARCH INSECT BIOCHEM, V69, P155, DOI 10.1002/arch.20269; Rose JB, 2001, ENVIRON HEALTH PERSP, V109, P211, DOI 10.2307/3435011; Sanchez MI, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005459; Sanchez MI, 2015, J INSECT CONSERV, V19, P433, DOI 10.1007/s10841-015-9764-7; Scudder G.G.E., 1976, P263; SERRANO L, 1995, ARCH HYDROBIOL, V133, P497; Serrano L., 2006, LIMNETICA, V25, P11, DOI DOI 10.1016/S1001-6058(15)60453-X; Simonis JL, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00019.1; SMITH BP, 1988, ANNU REV ENTOMOL, V33, P487, DOI 10.1146/annurev.en.33.010188.002415; Smith BP, 1977, THESIS; Smith IM, 2010, AQUAT ECOL-SAN DIEGO, P485, DOI 10.1016/B978-0-12-374855-3.00015-7; Sternberg ED, 2014, TRENDS PARASITOL, V30, P115, DOI 10.1016/j.pt.2013.12.010; Stevens M., 1999, ECOLOGY EVOLUTION AC, P381, DOI DOI 10.1007/978-94-017-1343-6_; Studer A, 2012, J EXP MAR BIOL ECOL, V412, P110, DOI 10.1016/j.jembe.2011.11.008; Sures B., 2008, ENV PARASITOLOGY INT, P434; Sures B, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2001-3; TONES PI, 1975, CAN J ZOOL, V53, P1207, DOI 10.1139/z75-144; Van de Meutter F, 2010, FUND APPL LIMNOL, V177, P283, DOI 10.1127/1863-9135/2010/0177-0283; WURTSBAUGH WA, 1992, OECOLOGIA, V89, P168, DOI 10.1007/BF00317215; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	69	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209828	10.1371/journal.pone.0209828	http://dx.doi.org/10.1371/journal.pone.0209828			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650162	Green Published, gold, Green Submitted			2022-12-26	WOS:000455813300029
J	Ferreira, SM; le Roex, N; Greaver, C				Ferreira, Sam M.; le Roex, Nikki; Greaver, Cathy			Species-specific drought impacts on black and white rhinoceroses	PLOS ONE			English	Article							LARGE HERBIVORES; NATIONAL-PARK; MEGA-GRAZER; POPULATION; DENSITY; VULNERABILITY; VARIABILITY; PERFORMANCE; COEXISTENCE; RESILIENCE	Unrelenting poaching to feed the illegal trafficking of rhinoceros (rhino) horn remains the principle threat to the persistence of south-central black and southern white rhino that live in the Kruger National Park (Kruger), South Africa. Other global environmental change drivers, such as unpredictable climatic conditions, impose additional uncertainties on the management and persistence of these species. The drought experienced in Kruger over the 2015/2016 rainy season may have affected rhino population growth and thus added an additional population pressure to the poaching pressure already occurring. Under drought conditions, reduced grass biomass predicts increased natural deaths and a subsequent decrease in birth rate for the grazing white rhino. Such variance in natural death and birth rates for the browsing black rhino are not expected under these conditions. We evaluated these predictions using rhino population survey data from 2013 to 2017. Comparisons of natural deaths and birth rates between pre-(2013/2014 and 2014/15), during(2015/2016) and post-drought (2016/2017) periods in Kruger showed increased natural mortality and decreased births for white rhino, but no significant changes for black rhino, supporting our predictions. As a result, despite reduced poaching rates, the total mortality rate of white rhino remains significantly higher than the birth rate. Decreased poaching, decreased natural deaths and no apparent drought effects in black rhino resulted in a lower total mortality rate than the estimated birth rate in 2017. Active biological management and traditional anti-poaching initiatives together therefore represent the most likely way to buffer the impacts of decreased population growth through climate change and wildlife crime on the persistence of rhinos.	[Ferreira, Sam M.; le Roex, Nikki; Greaver, Cathy] South African Natl Pk, Sci Serv, Skukuza, South Africa; [le Roex, Nikki] Univ Cape Town, Dept Biol Sci, Inst Commun & Wildlife Africa iCWild, Cape Town, South Africa	University of Cape Town	Ferreira, SM (corresponding author), South African Natl Pk, Sci Serv, Skukuza, South Africa.	sam.ferreira@sanparks.org			SANParks Park Development Fund; SANParks	SANParks Park Development Fund; SANParks	SANParks Park Development Fund provide internal budget for rhino surveys.; SANParks provided financial and logistical support. We thank Cathy Dreyer, Adolf Manganyi, Marius Renke, Marius Snyders and Pauli Viljoen for the census observations. Chenay Simms assisted with GIS requirements. We are also grateful to the pilot John Bassi for his assistance.	Aryal A, 2017, CONSERV BIOL, V31, P1494, DOI 10.1111/cobi.12894; Aryal A, 2016, ECOL EVOL, V6, P4065, DOI 10.1002/ece3.2196; Bucini G., 2010, ECOSYSTEM FUNCTION S, P219, DOI DOI 10.1201/B10275; Clauss M, 2006, J ANIM PHYSIOL AN N, V90, P325, DOI 10.1111/j.1439-0396.2006.00606.x; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Courchamp F, 2000, OIKOS, V91, P311, DOI 10.1034/j.1600-0706.2000.910212.x; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Dudley JP, 2001, AFR J ECOL, V39, P187, DOI 10.1046/j.0141-6707.2000.00297.x; Emslie R.H., 2016, 16 COP17; Emslie RH, 1995, FINE TUNING RHINO MA; Ferreira SM, 2018, AFR J WILDL RES, V48, DOI 10.3957/056.048.013001; Ferreira SM, 2011, S AFR J WILDL RES, V41, P192, DOI 10.3957/056.041.0206; Fishman G. S., 1995, MONTE CARLO CONCEPTS; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gertenbach W. P. D., 1980, Koedoe, V23, P35; Greaver C, 2014, AUSTRAL ECOL, V39, P437, DOI 10.1111/aec.12101; Guisoni N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115187; Higgins SI, 2000, J ECOL, V88, P213, DOI 10.1046/j.1365-2745.2000.00435.x; HILLMANSMITH AKK, 1986, J ZOOL, V210, P355; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Huso MMP, 2011, ENVIRONMETRICS, V22, P318, DOI 10.1002/env.1052; Hyndman RJ, 1996, AM STAT, V50, P361, DOI 10.2307/2684934; Janssen MA, 2006, GLOBAL ENVIRON CHANG, V16, P240, DOI 10.1016/j.gloenvcha.2006.04.001; JOLLY G M, 1969, East African Agricultural and Forestry Journal, V34, P46; Knight M., 2013, GOV GAZ S AFR, V36096, P5; Knight M.H., 2015, BIODIVERSITY MANAGEM; Knight MH, 1995, AFR J ECOL, V33, P377, DOI 10.1111/j.1365-2028.1995.tb01047.x; Kruger JM, 2008, WILDLIFE RES, V35, P371, DOI 10.1071/WR07084; Linklater WL, 2008, J WILDLIFE MANAGE, V72, P1059, DOI 10.2193/2007-398; Maron M, 2015, DIVERS DISTRIB, V21, P731, DOI 10.1111/ddi.12339; MCKEE TB, 1993, P 8 C APPL CLIM AN C; Plotz R.D., 2014, THESIS; Rosser AM, 2002, CONSERV BIOL, V16, P584, DOI 10.1046/j.1523-1739.2002.01635.x; Sankaran M, 2004, ECOL LETT, V7, P480, DOI 10.1111/j.1461-0248.2004.00596.x; Shrader AM, 2006, FUNCT ECOL, V20, P376, DOI 10.1111/j.1365-2435.2006.01107.x; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; Smalman N., 2016, DEVASTATING EFFECTS; Smit IPJ, 2013, PACHYDERM, P91; Trimble MJ, 2009, J ZOOL, V279, P18, DOI 10.1111/j.1469-7998.2009.00560.x; Vetter S, 2009, S AFR J SCI, V105, P29, DOI 10.1590/s0038-23532009000100017; Waldram MS, 2008, ECOSYSTEMS, V11, P101, DOI 10.1007/s10021-007-9109-9; WALKER BH, 1987, J APPL ECOL, V24, P381, DOI 10.2307/2403882; Wilson Clevo, 2003, Human Dimensions of Wildlife, V8, P49, DOI 10.1080/10871200390180145; Wittemyer G, 2007, ECOGRAPHY, V30, P42, DOI 10.1111/j.2006.0906-7590.04900.x; Wittemyer G, 2014, P NATL ACAD SCI USA, V111, P13117, DOI 10.1073/pnas.1403984111	45	20	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209678	10.1371/journal.pone.0209678	http://dx.doi.org/10.1371/journal.pone.0209678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650097	Green Published, Green Submitted, gold			2022-12-26	WOS:000455813300023
J	Wen, HJ; Wang, SL; Chen, PC; Guo, YL				Wen, Hui-Ju; Wang, Shu-Li; Chen, Pau-Chung; Guo, Yue Leon			Prenatal perfluorooctanoic acid exposure and glutathione s-transferase T1/M1 genotypes and their association with atopic dermatitis at 2 years of age	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; PERFLUORINATED CHEMICALS; AIRWAY INFLAMMATION; ALLERGIC DISEASES; LUNG-FUNCTION; ASTHMA; PERFLUOROALKYL; POLYMORPHISMS; PREVALENCE; CHILDREN	Background Perfluoroalkyl substance (PFAS) exposure was found associated with atopic diseases. Atopic dermatitis (AD) is a childhood skin disorder. However, the effect of interaction between PFASs and glutathione S-transferase (GST) T1/M1 genotype on AD remains unclear. Objective To investigate the association between gene-environmental interaction and childhood AD using a birth cohort study. Methods From 2001 to 2005, 1,264 mother-newborn pairs were recruited from eight Taiwanese maternity hospitals. PFAS levels and Genotypes were analysed from cord blood. Information on children's health status including AD occurrence was obtained via phone interviews at 6 months and 2 years. Cord plasma concentrations of nine PFASs were measured via ultra-high performance liquid chromatography/tandem mass spectrometry. GSTT1/M1 was genotyped (null/present) via polymerase chain reaction. Environment-gene interaction effects on AD were assessed using multiple logistic regression analysis. Results Overall, 839 mother-newborn pairs completed all measurements. The prevalence of ever having physician-diagnosed AD by 2 years of age was 5.4%. Among PFASs, perfluorooctanoic acid (PFOA) was positively associated with AD adjusted for potential confounders. After grouping PFOA levels into three groups: undetected, below and above the median in those with detected, children in above the median group who had the GSTT1-null, or GSTM1-null genotype exhibited a higher odds ratio for AD (OR [95%CI] = 3.45 [1.26-9.99] and 2.92 [1.12-7.91], respectively) as compared to the undetected group. Conclusions Our data demonstrated that in-utero PFOA exposure with GSTT1/M1 null genotype were associated with AD. Minimizing early-life PFAS exposure may help against AD development, especially in genetically susceptible individuals.	[Wen, Hui-Ju; Wang, Shu-Li; Guo, Yue Leon] Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Miaoli, Taiwan; [Wang, Shu-Li] Natl Def Med Ctr, Dept Publ Hlth, Taipei, Taiwan; [Chen, Pau-Chung; Guo, Yue Leon] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei, Taiwan; [Chen, Pau-Chung; Guo, Yue Leon] NTU, Dept Environm & Occupat Med, Coll Med, Taipei, Taiwan; [Chen, Pau-Chung; Guo, Yue Leon] NTU Hosp, Taipei, Taiwan; [Chen, Pau-Chung] Natl Taiwan Univ, Dept Publ Hlth, Coll Publ Hlth, Taipei, Taiwan	National Health Research Institutes - Taiwan; National Defense Medical Center; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Guo, YL (corresponding author), Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Miaoli, Taiwan.; Guo, YL (corresponding author), Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei, Taiwan.; Guo, YL (corresponding author), NTU, Dept Environm & Occupat Med, Coll Med, Taipei, Taiwan.; Guo, YL (corresponding author), NTU Hosp, Taipei, Taiwan.	leonguo@ntu.edu.tw	Chen, Pau-Chung/H-5686-2011; Guo, Yue-Liang Leon/ABF-2314-2020	Chen, Pau-Chung/0000-0002-6242-5974; GUO, Yue Leon/0000-0002-8530-4809; Wang, Shu-Li/0000-0002-0686-4729; Wen, Hui-Ju/0000-0003-1268-3120	Ministry of Science and Technology, Taiwan [NSC101-2621-M-002-002-, MOST106-3114-B-400-002-, MOST 107-2321-B-400-010-]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was funded by the Ministry of Science and Technology, Taiwan, grant numbers NSC101-2621-M-002-002-, MOST106-3114-B-400-002-, and MOST 107-2321-B-400-010-. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson-Mahoney P, 2008, NEW SOLUT, V18, P129, DOI 10.2190/NS.18.2.d; Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748; Buck Robert C., 2011, Integrated Environmental Assessment and Management, V7, P513, DOI 10.1002/ieam.258; Carlsten C, 2016, THORAX, V71, P35, DOI 10.1136/thoraxjnl-2015-207399; Chang HY, 2016, J ALLERGY CLIN IMMUN, V138, P468, DOI 10.1016/j.jaci.2016.01.020; Chen BY, 2016, ENVIRON RES, V149, P145, DOI 10.1016/j.envres.2016.05.007; Chen Q, 2018, ENVIRON HEALTH-GLOB, V17, DOI 10.1186/s12940-018-0352-7; Cho HR, 2011, INT J IMMUNOGENET, V38, P145, DOI 10.1111/j.1744-313X.2010.00987.x; Chung J, 2015, NUTRIENTS, V7, P9440, DOI 10.3390/nu7115473; DeWitt J, 2009, CRIT REV TOXICOL, V39, P76, DOI [10.1080/10408440802209804, 10.1080/10408440802209804 ]; Dong GH, 2013, ENVIRON HEALTH PERSP, V121, P507, DOI 10.1289/ehp.1205351; Dong GH, 2011, ARCH TOXICOL, V85, P1235, DOI 10.1007/s00204-011-0661-x; Fairley KJ, 2007, TOXICOL SCI, V97, P375, DOI 10.1093/toxsci/kfm053; Fernandez-Sanjuan M, 2013, ENVIRON SCI POLLUT R, V20, P2661, DOI 10.1007/s11356-012-1158-8; Fromme H, 2009, INT J HYG ENVIR HEAL, V212, P239, DOI 10.1016/j.ijheh.2008.04.007; Huang CC, 2018, PEDIAT ALLERG IMM-UK, V29, P159, DOI 10.1111/pai.12835; Humblet O, 2014, ENV HLTH PERSPECT, V122; Jang HJ, 2016, ASIA PAC ALLERGY, V6, P213, DOI 10.5415/apallergy.2016.6.4.213; Kay AB, 2000, BRIT MED BULL, V56, P843, DOI 10.1258/0007142001903481; KAY J, 1994, J AM ACAD DERMATOL, V30, P35, DOI 10.1016/S0190-9622(94)70004-4; Laughter D, 2000, J AM ACAD DERMATOL, V43, P649, DOI 10.1067/mjd.2000.107773; Lee YL, 2005, CHEST, V128, P1156, DOI 10.1378/chest.128.3.1156; Lee YL, 2005, PEDIAT ALLERG IMM-UK, V16, P157, DOI 10.1111/j.1399-3038.2005.00211.x; Lien GW, 2011, J CHROMATOGR B, V879, P641, DOI 10.1016/j.jchromb.2011.01.037; Lin CY, 2011, ENVIRON SCI TECHNOL, V45, P10691, DOI 10.1021/es201964x; Liu CS, 2007, AQUAT TOXICOL, V82, P135, DOI 10.1016/j.aquatox.2007.02.006; Lovett-Racke AE, 2004, J IMMUNOL, V172, P5790, DOI 10.4049/jimmunol.172.9.5790; Okada E, 2014, ENVIRON INT, V65, P127, DOI 10.1016/j.envint.2014.01.007; Patelarou E, 2011, NUTR REV, V69, P627, DOI 10.1111/j.1753-4887.2011.00445.x; Qin XD, 2017, ENVIRON RES, V155, P15, DOI 10.1016/j.envres.2017.01.025; Singh TSK, 2012, TOXICOL LETT, V210, P64, DOI 10.1016/j.toxlet.2012.01.014; Somanunt S, 2017, ASIAN PAC J ALLERGY, V35, P137, DOI 10.12932/AP0825; Stein CR, 2016, PEDIATR RES, V79, P348, DOI 10.1038/pr.2015.213; Takacs ML, 2007, TOXICOL SCI, V95, P108, DOI 10.1093/toxsci/kfl135; Wang IJ, 2011, EUR RESPIR J, V37, P1371, DOI 10.1183/09031936.00137210; Wang IJ, 2011, ENVIRON RES, V111, P785, DOI 10.1016/j.envres.2011.04.006; Wang IJ, 2010, ANN ALLERG ASTHMA IM, V105, P124, DOI 10.1016/j.anai.2010.04.017; Wen HJ, 2009, BRIT J DERMATOL, V161, P1166, DOI 10.1111/j.1365-2133.2009.09412.x; Wen HJ, 2011, PEDIAT ALLERG IMM-UK, V22, P695, DOI 10.1111/j.1399-3038.2011.01177.x; Wood LG, 2003, EUR RESPIR J, V21, P177, DOI 10.1183/09031936.03.00017003a	40	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210708	10.1371/journal.pone.0210708	http://dx.doi.org/10.1371/journal.pone.0210708			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650146	Green Published, gold, Green Submitted			2022-12-26	WOS:000455813300071
J	Kaibori, Y; Saito, Y; Nakayama, Y				Kaibori, Yuichiro; Saito, Youhei; Nakayama, Yuji			EphA2 phosphorylation at Ser897 by the Cdk1/MEK/ERK/RSK pathway regulates M-phase progression via maintenance of cortical rigidity	FASEB JOURNAL			English	Article						RhoG; Ephexin4; mitosis; mitotic spindle formation; blebbing	MAP KINASE PATHWAY; CELL-MIGRATION; B-RAF; SPINDLE ORIENTATION; TYROSINE RESIDUES; MECHANISMS; CYCLIN; ACTIVATION; RESISTANCE; INHIBITION	Successful cell division is accomplished by the proper formation of the mitotic spindle. Here, we show that EphA2 knockdown causes mitotic errors, including a delay in M-phase progression, asymmetric spindle positioning, multipolar spindles, and cell blebs. It has been known that EphA2 is phosphorylated at Tyr588, which is triggered by the ligand binding, and at Ser897 downstream of growth factor signaling. Upon mitotic entry, EphA2 is phosphorylated at Ser897, accompanied by a reduction in Tyr588 phosphorylation. This EphA2 phosphorylation at Ser897 is inhibited by MEK/ERK and 90 kDa ribosomal S6 kinase (RSK) inhibitors and is induced by the introduction of active cyclin-dependent kinase 1 (Cdk1) and cyclin B1. EphA2 knockdown-induced M-phase delay and cell blebs are rescued by wild type EphA2 expression but not by Ser897Ala mutant. The Ras homolog gene family member G (RhoG) guanine nucleotide exchange factor Ephexin4 interacts with EphA2 in a Ser897 phosphorylation-dependent manner, and its knockdown delays M-phase progression and causes RhoG delocalization. RhoG knockdown delays M-phase progression, and EphA2 knockdown-induced M-phase delay is partially rescued by the constitutively active RhoG mutant. These results suggest that, in EphA2-expressing cells, EphA2 phosphorylation at Ser897 participates in proper M-phase progression downstream of the Cdk1/MEK/ERK/RSK pathway because of its role in maintaining cortical rigidity via Ephexin4 and RhoG and thereby regulating mitotic spindle formation.	[Kaibori, Yuichiro; Saito, Youhei; Nakayama, Yuji] Kyoto Pharmaceut Univ, Dept Biochem & Mol Biol, Kyoto, Japan	Kyoto Pharmaceutical University	Nakayama, Y (corresponding author), Kyoto Pharmaceut Univ, Dept Biochem & Mol Biol, Yamashina Ku, 5 Misasagi Nakauchi Cho, Kyoto 6078414, Japan.	nakayama@mb.kyoto-phu.ac.jp		Saito, Youhei/0000-0002-8545-6925; Nakayama, Yuji/0000-0001-7882-0066	Japan Society for the Promotion of Science [16K08253, 25460076, 26870701]; Promotion and Mutual Aid Corporation for Private Schools of Japan (Kyoto Pharmaceutical University); Promotion and Mutual Aid Corporation for Private Schools of Japan (Chiba University, Chiba, Japan); Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research; Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities [S1311035, S1511024L]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Promotion and Mutual Aid Corporation for Private Schools of Japan (Kyoto Pharmaceutical University); Promotion and Mutual Aid Corporation for Private Schools of Japan (Chiba University, Chiba, Japan); Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research; Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported, in part, by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (Grants 16K08253, 25460076, and 26870701), grants from the Promotion and Mutual Aid Corporation for Private Schools of Japan (Kyoto Pharmaceutical University and Chiba University, Chiba, Japan), the Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research (to Y.S.), and the Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities [Grant S1311035 (to Y.S.) and S1511024L (to Y.N.)]. The authors declare no conflicts of interest.	Barquilla A, 2016, MOL BIOL CELL, V27, P2757, DOI 10.1091/mbc.E16-01-0048; Bastos RN, 2012, J CELL BIOL, V198, P865, DOI 10.1083/jcb.201204107; Bin Fang W, 2008, J BIOL CHEM, V283, P16017, DOI 10.1074/jbc.M709934200; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Borysov SI, 2008, MOL BIOL CELL, V19, P2907, DOI 10.1091/mbc.E07-07-0679; Borysov SI, 2006, J BIOL CHEM, V281, P22586, DOI 10.1074/jbc.M601432200; Borysova MK, 2008, CELL CYCLE, V7, P2894, DOI 10.4161/cc.7.18.6678; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Bovellan M, 2014, CURR BIOL, V24, P1628, DOI 10.1016/j.cub.2014.05.069; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Carreno S, 2008, J CELL BIOL, V180, P739, DOI 10.1083/jcb.200709161; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Duxbury MS, 2004, BIOCHEM BIOPH RES CO, V320, P1096, DOI 10.1016/j.bbrc.2004.06.054; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Goshima G, 2010, ANNU REV CELL DEV BI, V26, P21, DOI 10.1146/annurev-cellbio-100109-104006; Grill SW, 2005, DEV CELL, V8, P461, DOI 10.1016/j.devcel.2005.03.014; Grimsley CM, 2006, J BIOL CHEM, V281, P5928, DOI 10.1074/jbc.M510647200; Gross SD, 1999, SCIENCE, V286, P1365, DOI 10.1126/science.286.5443.1365; Gucciardo E, 2014, CELL MOL LIFE SCI, V71, P3685, DOI 10.1007/s00018-014-1633-0; Guo H, 2006, CANCER RES, V66, P7050, DOI 10.1158/0008-5472.CAN-06-0004; Hagting A, 1998, EMBO J, V17, P4127, DOI 10.1093/emboj/17.14.4127; Hamaoka Y, 2016, CELL SIGNAL, V28, P937, DOI 10.1016/j.cellsig.2016.04.009; Hiramoto-Yamaki N, 2010, J CELL BIOL, V190, P461, DOI 10.1083/jcb.201005141; IKEBE M, 1985, J BIOL CHEM, V260, P27; Iwamoto E, 2016, J CELL BIOCHEM, V117, P1340, DOI 10.1002/jcb.25424; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Jones LA, 2014, J CELL BIOL, V207, P499, DOI 10.1083/jcb.201408025; Jungas T, 2016, J CELL BIOL, V214, P555, DOI 10.1083/jcb.201602057; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Kawai H, 2013, FEBS OPEN BIO, V3, P78, DOI 10.1016/j.fob.2013.01.002; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Kiyomitsu T, 2013, CELL, V154, P391, DOI 10.1016/j.cell.2013.06.010; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Kwiatkowska A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-65; Ladwein M, 2008, FEBS LETT, V582, P2066, DOI 10.1016/j.febslet.2008.04.033; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Martiny-Baron G, 2010, ANGIOGENESIS, V13, P259, DOI 10.1007/s10456-010-9183-z; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Miao H, 2012, SEMIN CELL DEV BIOL, V23, P16, DOI 10.1016/j.semcdb.2011.10.013; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Miozzo M, 2000, INT J CANCER, V87, P68, DOI 10.1002/1097-0215(20000701)87:1<68::AID-IJC10>3.0.CO;2-V; Nakayama Y, 2009, EXP CELL RES, V315, P2515, DOI 10.1016/j.yexcr.2009.06.007; Nam HJ, 2014, CELL SIGNAL, V26, P208, DOI 10.1016/j.cellsig.2013.11.014; Noblitt LW, 2004, CANCER GENE THER, V11, P757, DOI 10.1038/sj.cgt.7700761; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; SOMLYO AP, 1994, NATURE, V372, P812; Song W, 2017, ONCOGENE, V36, P5620, DOI 10.1038/onc.2017.170; Tanenbaum ME, 2010, DEV CELL, V19, P797, DOI 10.1016/j.devcel.2010.11.011; Tian D, 2015, CURR BIOL, V25, P1135, DOI 10.1016/j.cub.2015.02.072; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Willard FS, 2001, CELL SIGNAL, V13, P653, DOI 10.1016/S0898-6568(01)00185-1; Woo MS, 2004, MOL CELL BIOL, V24, P3025, DOI 10.1128/MCB.24.7.3025-3035.2004; Wykosky J, 2005, MOL CANCER RES, V3, P541, DOI 10.1158/1541-7786.MCR-05-0056; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; ZernickaGoetz M, 1997, DEVELOPMENT, V124, P1133; Zhou Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8679; Zhuang GL, 2010, CANCER RES, V70, P299, DOI 10.1158/0008-5472.CAN-09-1845	75	10	11	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5334	5349		10.1096/fj.201801519RR	http://dx.doi.org/10.1096/fj.201801519RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30668924	Bronze			2022-12-26	WOS:000462888500057
J	Alimov, I; Menon, S; Cochran, N; Maher, R; Wang, Q; Alford, J; Concannon, JB; Yang, ZE; Harrington, E; Llamas, L; Lindeman, A; Hoffman, G; Schuhmann, T; Russ, C; Reece-Hoyes, J; Canham, SM; Cai, XM				Alimov, Irina; Menon, Suchithra; Cochran, Nadire; Maher, Rob; Wang, Qiong; Alford, John; Concannon, John B.; Yang, Zinger; Harrington, Edmund; Llamas, Luis; Lindeman, Alicia; Hoffman, Gregory; Schuhmann, Tim; Russ, Carsten; Reece-Hoyes, John; Canham, Stephen M.; Cai, Xinming			Bile acid analogues are activators of pyrin inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammasome; CRISPR; Cas; microbiome; mucosal immunology; bile acid; pyrin; familial Mediterranean fever; CRISPR screen; microbiota; biotransformation; immune response; gut homeostasis; autoimmune disease	FAMILIAL MEDITERRANEAN FEVER; NLRP3 INFLAMMASOME; DEOXYCHOLIC-ACID; CULTURE-SYSTEM; MICROBIOTA; DISEASE; GENE; EPIMERIZATION; MECHANISM; COLITIS	Bile acids are critical metabolites in the gastrointestinal tract and contribute to maintaining intestinal immune homeostasis through cross-talk with the gut microbiota. The conversion of bile acids by the gut microbiome is now recognized as a factor affecting both host metabolism and immune responses, but its physiological roles remain unclear. We conducted a screen for microbiome metabolites that would function as inflammasome activators and herein report the identification of 12-oxo-lithocholic acid (BAA485), a potential microbiome-derived bile acid metabolite. We demonstrate that the more potent analogue 11-oxo-12S-hydroxylithocholic acid methyl ester (BAA473) can induce secretion of interleukin-18 (IL-18) through activation of the inflammasome in both myeloid and intestinal epithelial cells. Using a genome-wide CRISPR screen with compound induced pyroptosis in THP-1 cells, we identified that inflammasome activation by BAA473 is pyrin-dependent (MEFV). To our knowledge, the bile acid analogues BAA485 and BAA473 are the first small molecule activators of the pyrin inflammasome. We surmise that pyrin inflammasome activation through microbiota-modified bile acid metabolites such as BAA473 and BAA485 plays a role in gut microbiota regulated intestinal immune response. The discovery of these two bioactive compounds may help to further unveil the importance of pyrin in gut homeostasis and autoimmune diseases.	[Alimov, Irina; Menon, Suchithra; Cochran, Nadire; Maher, Rob; Wang, Qiong; Alford, John; Concannon, John B.; Yang, Zinger; Harrington, Edmund; Llamas, Luis; Lindeman, Alicia; Hoffman, Gregory; Schuhmann, Tim; Russ, Carsten; Reece-Hoyes, John; Canham, Stephen M.; Cai, Xinming] Novartis Inst Biomed Res, 181 Massachusetts Ave, Cambridge, MA 02139 USA; [Schuhmann, Tim] Novartis Pharma AG, Novartis Inst Biomed Res, Forum 1 Novartis Campus, CH-4056 Basel, Switzerland	Novartis; Novartis	Canham, SM; Cai, XM (corresponding author), Novartis Inst Biomed Res, 181 Massachusetts Ave, Cambridge, MA 02139 USA.; Cai, XM (corresponding author), Sanofi US, 270 Albany St, Cambridge, MA 02139 USA.	steve.canham@novartis.com; xinming.cai@sanofi.com		Reece-Hoyes, John/0000-0001-5251-5813; Canham, Stephen/0000-0003-4750-8066; Yang Loureiro, Zinger/0000-0001-8543-4841				Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Batu ED, 2016, ARTHRIT CARE RES, V68, P1859, DOI 10.1002/acr.22901; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; DeJesus R, 2016, ELIFE, V5, DOI [10.7554/elife.17290, 10.7554/eLife.17290]; Devlin AS, 2015, NAT CHEM BIOL, V11, P685, DOI [10.1038/NCHEMBIO.1864, 10.1038/nchembio.1864]; EDENHARDER R, 1985, SYST APPL MICROBIOL, V6, P18, DOI 10.1016/S0723-2020(85)80005-9; EDENHARDER R, 1985, APPL ENVIRON MICROB, V49, P964, DOI 10.1128/AEM.49.4.964-968.1985; EDENHARDER R, 1984, SYST APPL MICROBIOL, V5, P287, DOI 10.1016/S0723-2020(84)80031-4; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Fidder H, 2005, AM J GASTROENTEROL, V100, P338, DOI 10.1111/j.1572-0241.2005.40810.x; GALLAGHER TF, 1946, J BIOL CHEM, V162, P539; Gao WQ, 2016, P NATL ACAD SCI USA, V113, pE4857, DOI 10.1073/pnas.1601700113; GROH H, 1993, J BASIC MICROB, V33, P59, DOI 10.1002/jobm.3620330115; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Hamilton JP, 2007, AM J PHYSIOL-GASTR L, V293, pG256, DOI 10.1152/ajpgi.00027.2007; HERSHBERG EB, 1952, J AM CHEM SOC, V74, P2585, DOI 10.1021/ja01130a036; Hoffman GR, 2014, P NATL ACAD SCI USA, V111, P3128, DOI 10.1073/pnas.1316793111; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; KELSEY MI, 1976, J STEROID BIOCHEM, V7, P641, DOI 10.1016/0022-4731(76)90059-5; Khachatryan ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003064; Ktsoyan ZA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00776; Ktsoyan ZA, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00002; Kubosaki A, 2010, MOL IMMUNOL, V47, P2295, DOI 10.1016/j.molimm.2010.05.289; Lei-Leston AC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01168; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Liberzon A, 2014, METHODS MOL BIOL, V1150, P153, DOI 10.1007/978-1-4939-0512-6_9; MACDONALD IA, 1983, J LIPID RES, V24, P675; Marker RE, 1938, J AM CHEM SOC, V60, P1334, DOI 10.1021/ja01273a017; Moon C, 2014, MUCOSAL IMMUNOL, V7, P818, DOI 10.1038/mi.2013.98; Ozen S, 2009, ANN RHEUM DIS, V68, P246, DOI 10.1136/ard.2008.092031; Schmid-Burgk JL, 2016, J BIOL CHEM, V291, P103, DOI 10.1074/jbc.C115.700492; SCHWABE AD, 1974, MEDICINE, V53, P453, DOI 10.1097/00005792-197411000-00005; Sharma D, 2018, GASTROENTEROLOGY, V154, P948, DOI 10.1053/j.gastro.2017.11.276; Van Gijn ME, 2018, J MED GENET, V55, P530, DOI 10.1136/jmedgenet-2017-105216; VanDussen KL, 2015, GUT, V64, P911, DOI 10.1136/gutjnl-2013-306651; Villani AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007154; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; Yao LN, 2018, ELIFE, V7, DOI 10.7554/eLife.37182; Yepiskoposyan L, 2007, EUR J HUM GENET, V15, P911, DOI 10.1038/sj.ejhg.5201869; Zhernakova A, 2008, AM J HUM GENET, V82, P1202, DOI 10.1016/j.ajhg.2008.03.016	42	25	25	2	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3359	3366		10.1074/jbc.RA118.005103	http://dx.doi.org/10.1074/jbc.RA118.005103			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30647128	hybrid, Green Published			2022-12-26	WOS:000461853900004
J	Gonzalez-Garcia, S; Alvarez-Perez, JM; de Miera, LES; Cobos, R; Ibanez, A; Diez-Galan, A; Garzon-Jimeno, E; Coque, JJR				Gonzalez-Garcia, Sandra; Manuel Alvarez-Perez, Jose; Saenz de Miera, Luis E.; Cobos, Rebeca; Ibanez, Ana; Diez-Galan, Alba; Garzon-Jimeno, Enrique; Coque, Juan Jose R.			Developing tools for evaluating inoculation methods of biocontrol Streptomyces sp. strains into grapevine plants	PLOS ONE			English	Article							BLACK FOOT; DISEASE; SOIL; RAPD	The endophytic Streptomyces sp. VV/E1, and rhizosphere Streptomyces sp. VV/R4 strains, isolated from grapevine plants were shown in a previous work to reduce the infection rate of fungal pathogens involved in young grapevine decline. In this study we cloned fragments from randomly amplified polymorphic DNA (RAPD), and developed two stably diagnostic sequence-characterized amplified region (SCAR) markers of 182 and 160 bp for the VV/E1 and VV/R4 strains, respectively. The SCAR markers were not found in another 50 actino-bacterial strains isolated from grapevine plants. Quantitative real-time PCR protocols based on the amplification of these SCAR markers were used for the detection and quantification of both strains in plant material. These strains were applied on young potted plants using two methods: perforation of the rootstock followed by injection of the microorganisms or soaking the root system in a bacterial suspension. Both methods were combined with a booster treatment by direct addition of a bacterial suspension to the soil near the root system. Analysis of uprooted plants showed that those inoculated by injection exhibited the highest rate of colonization. In contrast, direct addition of either strain to the soil did not lead to reliable colonization. This study has developed molecular tools for analyzing different methods for inoculating grapevine plants with selected Streptomyces sp. strains which protect them from fungal infections that enter through their root system. These tools are of great applied interest since they could easily be established in nurseries to produce grafted grapevine plants that are protected against fungal pathogens. Finally, this methodology might also be applied to other vascular plants for their colonization with beneficial biological control agents.	[Gonzalez-Garcia, Sandra; Manuel Alvarez-Perez, Jose; Ibanez, Ana; Garzon-Jimeno, Enrique; Coque, Juan Jose R.] Univ Leon, Inst Invest Vina & Vino, Leon, Spain; [Saenz de Miera, Luis E.] Univ Leon, Dept Biol Mol, Area Genet, Leon, Spain; [Cobos, Rebeca; Diez-Galan, Alba] RGA Bioinvest SL, Leon, Spain	Universidad de Leon; Universidad de Leon	Coque, JJR (corresponding author), Univ Leon, Inst Invest Vina & Vino, Leon, Spain.	jjrubc@unileon.es	Sáenz de Miera, Luis/ABA-4573-2021; de Miera, Luis E Sáenz/D-6864-2018; Alvarez-Perez, Jose Manuel/AAG-7167-2019; Cobos, Rebeca/F-2322-2016; Coque, Juan Jose Rubio/AAV-2049-2021	Sáenz de Miera, Luis/0000-0003-1871-7379; de Miera, Luis E Sáenz/0000-0003-1871-7379; Cobos, Rebeca/0000-0002-6487-1556; Coque, Juan Jose Rubio/0000-0001-8221-7817; Diez-Galan, Alba/0000-0002-2721-0388; Ibanez Sanchez, Ana Maria/0000-0002-8867-0732	Viveros Villanueva Vides S.L. (Larraga, Spain) - Centro para el Desarrollo Tecnologico Industrial-CDTI-(Madrid, Spain) through the GLOBALVITI project (CIEN Program); FPU fellowship from the Ministerio de Educacion, Cultura y Deporte (Madrid, Spain) [FPU15/03475]; Programa Torres Quevedo from the Ministerio de Ciencia, Innovacion y Universidades (Madrid, Spain) [PTQ-14-06849]; University of Leon (Spain)	Viveros Villanueva Vides S.L. (Larraga, Spain) - Centro para el Desarrollo Tecnologico Industrial-CDTI-(Madrid, Spain) through the GLOBALVITI project (CIEN Program); FPU fellowship from the Ministerio de Educacion, Cultura y Deporte (Madrid, Spain); Programa Torres Quevedo from the Ministerio de Ciencia, Innovacion y Universidades (Madrid, Spain); University of Leon (Spain)	This work was supported by Viveros Villanueva Vides S.L. (Larraga, Spain) which was financed by the Centro para el Desarrollo Tecnologico Industrial-CDTI-(Madrid, Spain) through the GLOBALVITI project (CIEN Program) (http://viverosvillanueva.es/, https://www.cdti.es/).SGG was supported by an FPU fellowship (Grant number FPU15/03475) from the Ministerio de Educacion, Cultura y Deporte (Madrid, Spain) (http://www.mecd.gob.es/).RC was supported by the Programa Torres Quevedo (Grant number PTQ-14-06849) from the Ministerio de Ciencia, Innovacion y Universidades (Madrid, Spain), (http://www.ciencia.gob.es/).RGA Bio-Investigacion S.L. is a spin-off of the University of Leon (Spain) that provided support in the form of salaries for authors RC and ADG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Auffret M, 2011, WATER RES, V45, P6753, DOI 10.1016/j.watres.2011.10.020; Bertsch C, 2013, PLANT PATHOL, V62, P243, DOI 10.1111/j.1365-3059.2012.02674.x; Bhagyawant S. S., 2016, J BIOSCI MED, V4, P1, DOI DOI 10.4236/JBM.2016.41001; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carlucci A, 2017, PHYTOPATHOL MEDITERR, V56, P10, DOI 10.14601/Phytopathol_Mediterr-18769; Corte L, 2005, J APPL MICROBIOL, V99, P609, DOI 10.1111/j.1365-2672.2005.02631.x; De Mendiburu F, 2009, THESIS; Di Marco S, 2007, PHYTOPATHOL MEDITERR, V46, P73; Doumbou CL, 2001, PHYTOPROTECTION, V82, P85, DOI 10.7202/706219ar; Forootan Amin, 2017, Biomol Detect Quantif, V12, P1, DOI 10.1016/j.bdq.2017.04.001; Fourie PR, 2004, PLANT DIS, V88, P1241, DOI 10.1094/PDIS.2004.88.11.1241; Gharaibeh R, 2003, J BASIC MICROB, V43, P18, DOI 10.1002/jobm.200390000; Gramaje D, 2011, PLANT DIS, V95, P1040, DOI 10.1094/PDIS-01-11-0025; Halleen F, 2006, PHYTOPATHOL MEDITERR, V45, pS55; Hiltunen LH, 2009, J APPL MICROBIOL, V106, P199, DOI 10.1111/j.1365-2672.2008.03992.x; Hopwood D. A., 1985, GENETIC MANIPULATION; Kinkel LL, 2012, RES MICROBIOL, V163, P490, DOI 10.1016/j.resmic.2012.07.005; Kiran U, 2010, FITOTERAPIA, V81, P969, DOI 10.1016/j.fitote.2010.08.002; Law JWF, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00003; Leisso RS, 2009, CAN J PLANT PATHOL, V31, P38, DOI 10.1080/07060660909507570; Li J, 2012, ANTON LEEUW INT J G, V101, P515, DOI 10.1007/s10482-011-9661-3; Alvarez-Perez JM, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.01564-17; Nomura R, 2006, J MED MICROBIOL, V55, P1135, DOI 10.1099/jmm.0.46609-0; Pertot I, 2016, BIOCONTROL, V61, P257, DOI 10.1007/s10526-016-9723-6; Schlatter DC, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0470-6; Schrey SD, 2008, ANTON LEEUW INT J G, V94, P11, DOI 10.1007/s10482-008-9241-3; Schrey SD, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-164; TAUTZ D, 1983, ANAL BIOCHEM, V132, P14, DOI 10.1016/0003-2697(83)90419-0; Toumatia O, 2016, S AFR J BOT, V105, P234, DOI 10.1016/j.sajb.2016.03.020; Van der Meij A, 2017, FEMS MICROBIOL REV, V41, P392, DOI 10.1093/femsre/fux005; Vurukonda SSKP, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19040952; Yang LQ, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-501	32	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211225	10.1371/journal.pone.0211225	http://dx.doi.org/10.1371/journal.pone.0211225			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677098	Green Published, gold, Green Submitted			2022-12-26	WOS:000456700400063
J	Prado-Gutierrez, P; Martinez-Montes, E; Weinstein, A; Zanartu, M				Prado-Gutierrez, Pavel; Martinez-Montes, Eduardo; Weinstein, Alejandro; Zanartu, Matias			Estimation of auditory steady-state responses based on the averaging of independent EEG epochs	PLOS ONE			English	Article							AMPLITUDE-MODULATED TONES; VENTRAL COCHLEAR NUCLEUS; EVOKED-POTENTIALS; 40 HZ; P2 COMPONENTS; TIME-COURSE; STIMULATION; RAT; ADAPTATION; HEARING	The amplitude of auditory steady-state responses (ASSRs) generated in the brainstem of rats exponentially decreases over the sequential averaging of EEG epochs. This behavior is partially due to the adaptation of the ASSR induced by the continuous and monotonous stimulation. In this study, we analyzed the potential clinical relevance of the ASSR adaptation. ASSR were elicited in eight anesthetized adult rats by 8-kHz tones, modulated in amplitude at 115 Hz. We called independent epochs to those EEG epochs acquired with sufficiently long interstimulus interval, so the ASSR contained in any given epoch is not affected by the previous stimulation. We tested whether the detection of ASSRs is improved when the response is computed by averaging independent EEG epochs, containing only unadapted auditory responses. The improvements in the ASSR detection obtained with standard, weighted and sorted averaging were compared. In the absence of artifacts, when the ASSR was elicited by continuous acoustic stimulation, the computation of the ASSR amplitude relied upon the averaging method. While the adaptive behavior of the ASSR was still evident after the weighting of epochs, the sorted averaging resulted in under-estimations of the ASSR amplitude. In the absence of artifacts, the ASSR amplitudes computed by averaging independent epochs did not depend on the averaging procedure. Averaging independent epochs resulted in higher ASSR amplitudes and halved the number of EEG epochs needed to be acquired to achieve the maximum detection rate of the ASSR. Acquisition protocols based on averaging independent EEG epochs, in combination with appropriate averaging methods for artifact reduction might contribute to develop more accurate hearing assessments based on ASSRs.	[Prado-Gutierrez, Pavel; Weinstein, Alejandro; Zanartu, Matias] Univ Tecn Federico Santa Maria, Adv Ctr Elect & Elect Engn, Valparaiso, Chile; [Martinez-Montes, Eduardo] Cuban Neurosci Ctr, Neuroinformat Dept, Havana, Cuba; [Weinstein, Alejandro] Univ Valparaiso, Biomed Engn Sch, Valparaiso, Chile; [Zanartu, Matias] Univ Tecn Federico Santa Maria, Dept Elect Engn, Valparaiso, Chile	Universidad Tecnica Federico Santa Maria; Universidad de Valparaiso; Universidad Tecnica Federico Santa Maria	Prado-Gutierrez, P (corresponding author), Univ Tecn Federico Santa Maria, Adv Ctr Elect & Elect Engn, Valparaiso, Chile.	pavel.prado@usm.cl	Weinstein, Alejandro/O-1919-2019; Prado, Pavel/O-2711-2019; Zañartu, Matías/N-1338-2019; Martínez-Montes, Eduardo/AAA-9485-2020	Weinstein, Alejandro/0000-0003-1486-7003; Prado, Pavel/0000-0002-1324-6400; Zañartu, Matías/0000-0001-5581-4392; Martínez-Montes, Eduardo/0000-0002-5852-964X	CONICYT [BASAL FB0008, MEC 80170124, FONDECYT 3150442]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P50DC015446] Funding Source: NIH RePORTER	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by CONICYT grants BASAL FB0008, MEC 80170124, and FONDECYT 3150442. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts J, 2010, AUDIOL NEURO-OTOL, V15, P116, DOI 10.1159/000231637; Andrade GN, 2015, EUR J NEUROSCI, V41, P923, DOI 10.1111/ejn.12849; [Anonymous], 2007, CLIN NEUROPHYSIOL; BOURBON WT, 1987, ELECTROEN CLIN NEURO, V66, P160, DOI 10.1016/0013-4694(87)90185-4; Boutros NN, 1997, BIOL PSYCHIAT, V42, P1051, DOI 10.1016/S0006-3223(97)00161-3; Budd TW, 2013, BRAIN RES, V1498, P59, DOI 10.1016/j.brainres.2012.12.033; Choi JM, 2011, EAR HEARING, V32, P593, DOI 10.1097/AUD.0b013e318212085e; COHEN LT, 1991, J ACOUST SOC AM, V90, P2467, DOI 10.1121/1.402050; Custead R, 2015, BRAIN RES, V1622, P81, DOI 10.1016/j.brainres.2015.06.025; DAWSON GD, 1954, ELECTROEN CLIN NEURO, V6, P65, DOI 10.1016/0013-4694(54)90007-3; de Bruin NMWJ, 2001, BIOL PSYCHOL, V55, P195, DOI 10.1016/S0301-0511(00)00084-3; Duque D, 2018, HEARING RES, V370, P294, DOI 10.1016/j.heares.2018.08.011; ELBERLING C, 1985, SCAND AUDIOL, V14, P89, DOI 10.3109/01050398509045928; GALAMBOS R, 1981, P NATL ACAD SCI-BIOL, V78, P2643, DOI 10.1073/pnas.78.4.2643; Glaser EM, 1976, PRINCIPLES NEUROBIOL, DOI [10.1016/j.ijpsycho.2014.09.012, DOI 10.1016/J.IJPSYCHO.2014.09.012]; Griskova-Bulanova I, 2014, ACTA NEUROBIOL EXP, V74, P91; HEFFNER H, 1980, J ACOUST SOC AM, V68, P1584, DOI 10.1121/1.385213; HOKE M, 1984, ELECTROEN CLIN NEURO, V57, P484, DOI 10.1016/0013-4694(84)90078-6; John M Sasha, 2002, J Am Acad Audiol, V13, P246; John MS, 2004, EAR HEARING, V25, P539, DOI 10.1097/01.AUD.0000148050.80749.AC; John MS, 2002, EAR HEARING, V23, P106, DOI 10.1097/00003446-200204000-00004; John MS, 2000, COMPUT METH PROG BIO, V61, P125, DOI 10.1016/S0169-2607(99)00035-8; John MS, 2001, AUDIOL NEURO-OTOL, V6, P12, DOI 10.1159/000046805; John MS, 2001, CLIN NEUROPHYSIOL, V112, P555, DOI 10.1016/S1388-2457(01)00456-4; John MS., 2008, AUDITORY STEADY STAT, P11; KELLY JB, 1977, J COMP PHYSIOL PSYCH, V91, P930, DOI 10.1037/h0077356; KNIGHT RT, 1985, ELECTROEN CLIN NEURO, V61, P430, DOI 10.1016/0013-4694(85)91035-1; Lins OG, 1996, EAR HEARING, V17, P81, DOI 10.1097/00003446-199604000-00001; Loquet G, 2004, AUDIOL NEURO-OTOL, V9, P144, DOI 10.1159/000077266; LUTKENHONER B, 1985, BIOL CYBERN, V52, P409, DOI 10.1007/BF00449599; Luts H, 2004, INT J PEDIATR OTORHI, V68, P915, DOI 10.1016/j.ijporl.2004.02.007; Luts H, 2008, EAR HEARING, V29, P638, DOI 10.1097/AUD.0b013e318174f051; Malmierca MS, 2009, J NEUROSCI, V29, P5483, DOI 10.1523/JNEUROSCI.4153-08.2009; McFadden KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085748; Meyer K, 2007, HEARING RES, V228, P144, DOI 10.1016/j.heares.2007.02.002; Muhler R, 1999, SCAND AUDIOL, V28, P145, DOI 10.1080/010503999424716; OHMAN A, 1972, PHYSIOL BEHAV, V8, P79, DOI 10.1016/0031-9384(72)90132-1; Ozdamar O, 2006, J ACOUST SOC AM, V119, P429, DOI 10.1121/1.2133682; Ozdamar O, 2007, CLIN NEUROPHYSIOL, V118, P1261, DOI 10.1016/j.clinph.2007.02.016; Paiva TO, 2016, CLIN NEUROPHYSIOL, V127, P499, DOI 10.1016/j.clinph.2015.06.016; Pereira DR, 2014, INT J PSYCHOPHYSIOL, V94, P311, DOI 10.1016/j.ijpsycho.2014.09.012; Perez-Abalo MC, 2001, EAR HEARING, V22, P200, DOI 10.1097/00003446-200106000-00004; Picton TW, 2003, INT J AUDIOL, V42, P177, DOI 10.3109/14992020309101316; Picton TW, 2001, CLIN NEUROPHYSIOL, V112, P1698, DOI 10.1016/S1388-2457(01)00608-3; Prado-Gutierrez P, 2015, AUDIOL RES, V5, P21, DOI 10.4081/audiores.2015.113; Prado-Gutierrez P, 2012, INT J AUDIOL, V51, P309, DOI 10.3109/14992027.2011.639812; Presacco A, 2010, CLIN NEUROPHYSIOL, V121, P1540, DOI 10.1016/j.clinph.2010.03.020; Perez-Alcazar M, 2008, EXP NEUROL, V210, P144, DOI 10.1016/j.expneurol.2007.10.017; Rahne I., J NEUROSCI METHODS; Rahne T, 2008, J NEUROSCI METH, V172, P74, DOI 10.1016/j.jneumeth.2008.04.006; Resende LM, 2015, J NEUROENG REHABIL, V12, P1; RITTER W, 1968, ELECTROEN CLIN NEURO, V25, P550, DOI 10.1016/0013-4694(68)90234-4; Rosburg T, 2016, CLIN NEUROPHYSIOL, V127, P397, DOI 10.1016/j.clinph.2015.04.071; Rosburg T, 2010, EXP BRAIN RES, V205, P559, DOI 10.1007/s00221-010-2391-3; Sambeth A, 2004, INT J PSYCHOPHYSIOL, V53, P197, DOI 10.1016/j.ijpsycho.2004.04.004; Santos TS, 2016, HEARING RES, V339, P125, DOI 10.1016/j.heares.2016.05.017; Savio G, 2001, AUDIOL NEURO-OTOL, V6, P279, DOI 10.1159/000046133; SHAW NA, 1988, PROG NEUROBIOL, V31, P19, DOI 10.1016/0301-0082(88)90021-4; Tan XD, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00697; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; Fortuny AT, 2011, ACTA OTORRINOLAR ESP, V62, P173, DOI 10.1016/j.otorri.2010.10.008; Valdes JL, 1997, EAR HEARING, V18, P420, DOI 10.1097/00003446-199710000-00007; Van Eeckhoutte M, 2018, EAR HEARING, V39, P260, DOI 10.1097/AUD.0000000000000483; Van Eeckhoutte M, 2016, HEARING RES, V342, P58, DOI 10.1016/j.heares.2016.09.009; Van Maanen A, 2005, INT J AUDIOL, V44, P613, DOI 10.1080/14992020500258628; Venkataraman Y, 2014, DEV NEUROBIOL, V74, P541, DOI 10.1002/dneu.22148; Vercammen C, 2017, INT J AUDIOL, V56, P464, DOI 10.1080/14992027.2017.1288304; Voicikas A, 2016, NEUROSCI LETT, V629, P215, DOI 10.1016/j.neulet.2016.07.019; Wilding TS, 2012, EAR HEARING, V33, P279, DOI 10.1097/AUD.0b013e318230bba0; Wilson US, 2016, INT J AUDIOL, V55, P239, DOI 10.3109/14992027.2015.1122238; Zacharias N, 2012, PSYCHOPHYSIOLOGY, V49, P909, DOI 10.1111/j.1469-8986.2012.01370.x; Zhang F, 2009, J AM ACAD AUDIOL, V20, P239, DOI 10.3766/jaaa.20.4.4; ZUREK PM, 1992, EAR HEARING, V13, P307, DOI 10.1097/00003446-199210000-00008	73	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0206018	10.1371/journal.pone.0206018	http://dx.doi.org/10.1371/journal.pone.0206018			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677031	gold, Green Submitted, Green Published			2022-12-26	WOS:000456700400003
J	Primo, ME; Thompson, CS; Valentini, BS; Sarli, M; Novoa, MB; Mangold, AJ; de Echaide, ST				Primo, Maria E.; Thompson, Carolina S.; Valentini, Beatriz S.; Sarli, Macarena; Novoa, Maria B.; Mangold, Atilio J.; de Echaide, Susana T.			Development of a novel fusion protein with Anaplasma marginale and A. centrale MSP5 improved performance of Anaplasma antibody detection by cELISA in infected and vaccinated cattle	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; CROSS-REACTIVITY; DIAGNOSIS; ELISA; TICK	Detection of antibodies to Anaplasma spp. using commercial competitive enzyme-linked immunosorbent assay (ccELISA) is based on the recombinant major surface protein 5 fused to maltose binding protein (MBP-MSP5) or glutathione S-transferase (GST-MSP5). To avoid false positive reactions due to the presence of antibodies against E. coli M BP in cattle, previous sera absorption is required. This study evaluated the replacement of MBP-MSP5 or GST-MSP5 antigens by the truncate MSP5 (residues 28-210) of A. marginale (tMSP5m), A. centrale (tMSP5c) and fusion protein MSP5 (tMSP5cm), expressed without N-terminus transmembrane helix in the ccELISA test. Immunoreactivity was evaluated by western blot using monoclonal antibodies against the tMSP5 and by in-house cELISA (hcELISA) with purified tMSP5m, tMSP5c or tMSP5cm using sera from cattle infected with A. marginale (n = 226) or vaccinated with A. centrale (n = 173) and uninfected cattle (n = 216). Results of hcELISA were compared with those of ccELISA. Recombinant protein was expressed highly soluble (> 95%) in E. coli without a molecular chaperone. Specificity of the hcELISA-tMSP5m,-MSP5c or-tMSP5cm was identical to (99.5%) and greater than that in ccELISA (96.3%). Sensitivity of hcELISA-tMSP5m and ccELISA was identical (95.5%), but lower than that of hcELISA-tMSP5cm (96.2%) and-tMSP5c (97.2%). The analysis of vaccinated cattle by hcELISA-tMSP5c showed sensitivity of 99.4%. In summary, the generation of fusion MSP5 A. marginale-A. centrale protein without transmembrane helix was a very effective method to express the recombinant protein highly soluble in the bacterial cytoplasm and contributed to an increased test performance for detecting antibodies in cattle naturally infected with A. marginale or vaccinated with A. centrale.	[Primo, Maria E.; Thompson, Carolina S.; Valentini, Beatriz S.; Sarli, Macarena; Novoa, Maria B.; Mangold, Atilio J.; de Echaide, Susana T.] Inst Nacl Tecnol Agr, Estn Expt Agr Rafaela, Rafaela, Santa Fe, Argentina; [Primo, Maria E.; Sarli, Macarena; Novoa, Maria B.; Mangold, Atilio J.] Consejo Nacl Invest Cient & Tecn, Santa Fe, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Primo, ME (corresponding author), Inst Nacl Tecnol Agr, Estn Expt Agr Rafaela, Rafaela, Santa Fe, Argentina.; Primo, ME (corresponding author), Consejo Nacl Invest Cient & Tecn, Santa Fe, Argentina.	primo.maria@inta.gob.ar		Sarli, Macarena/0000-0001-8592-6635; Novoa, Maria Belen/0000-0001-6726-5239; Primo, Maria Evangelina/0000-0002-6873-8867	ANPCyT [PICT 2013-0369]; TCP INTA EEA Rafaela Asoc . Coop. [426100]	ANPCyT(ANPCyT); TCP INTA EEA Rafaela Asoc . Coop.	This work was supported by ANPCyT (PICT 2013-0369) and TCP INTA EEA Rafaela Asoc. Coop. 426100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala A A, 1990, Rev Elev Med Vet Pays Trop, V43, P155; Al-Adhami B, 2011, J VET DIAGN INVEST, V23, P1181, DOI 10.1177/1040638711425593; Anziani O, 1979, MEMORIA REUNION ANUA; ANZIANI OS, 1987, TROP ANIM HEALTH PRO, V19, P83, DOI 10.1007/BF02297324; Aubry P, 2011, TRANSBOUND EMERG DIS, V58, P1, DOI 10.1111/j.1865-1682.2010.01173.x; Bono F, 2004, ANAPLASMOSIS BOVINA; Chung C, 2014, J VET DIAGN INVEST, V26, P61, DOI 10.1177/1040638713511813; de Echaide ST, 1998, J CLIN MICROBIOL, V36, P777, DOI 10.1128/JCM.36.3.777-782.1998; de Echaide ST, 2005, VET MICROBIOL, V106, P287, DOI 10.1016/j.vetmic.2004.12.026; Diaz AA, 2010, BIOTECHNOL BIOENG, V105, P374, DOI 10.1002/bit.22537; Dreher UM, 2005, CLIN DIAGN LAB IMMUN, V12, P1177, DOI 10.1128/CDLI.12.10.1177-1183.2005; DUZGUN A, 1988, VET PARASITOL, V29, P1, DOI 10.1016/0304-4017(88)90002-7; ERIKS IS, 1993, J CLIN MICROBIOL, V31, P2091, DOI 10.1128/JCM.31.8.2091-2096.1993; Francis Dana M, 2010, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0524s61; GONZALEZ EF, 1978, AM J VET RES, V39, P1538; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Knowles D, 1996, J CLIN MICROBIOL, V34, P2225, DOI 10.1128/JCM.34.9.2225-2230.1996; Kocan KM, 2010, VET PARASITOL, V167, P95, DOI 10.1016/j.vetpar.2009.09.012; Mastropaolo M., 2009, FAVE, V8, P29, DOI 10.14409/favecv.v8i1.1477; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Molad T, 2006, VET MICROBIOL, V113, P55, DOI 10.1016/j.vetmic.2005.10.026; Molloy JB, 1999, AUST VET J, V77, P245, DOI 10.1111/j.1751-0813.1999.tb11712.x; Molloy JB, 2001, INT J PARASITOL, V31, P179, DOI 10.1016/S0020-7519(00)00145-4; MONTENEGROJAMES S, 1990, AM J VET RES, V51, P1518; OIE, 2015, BOV AN; Palacios C, 2014, RES VET SCI, V97, P514, DOI 10.1016/j.rvsc.2014.10.005; POTGIETER FT, 1979, J S AFR VET ASSOC, V50, P367; POTGIETER FT, 1983, ONDERSTEPOORT J VET, V50, P29; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Singh SM, 2005, J BIOSCI BIOENG, V99, P303, DOI 10.1263/jbb.99.303; Strik NI, 2007, CLIN VACCINE IMMUNOL, V14, P262, DOI 10.1128/CVI.00320-06; Theiler A., 1910, REP GOV VET BACTERIO, P7; VISSER ES, 1992, INFECT IMMUN, V60, P5139, DOI 10.1128/IAI.60.12.5139-5144.1992; Yang Z, 2014, KOREAN J PARASITOL, V52, P367, DOI [10.3347/kjp.2014.52.4.367, 10.3347/kjp.2014.52.4.367.]	35	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211149	10.1371/journal.pone.0211149	http://dx.doi.org/10.1371/journal.pone.0211149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673770	Green Submitted, Green Published, gold			2022-12-26	WOS:000456442800077
J	Huynh, TV; Bekrater-Bodmann, R; Frohner, J; Vogt, J; Beckerle, P				The Vu Huynh; Bekrater-Bodmann, Robin; Froehner, Jakob; Vogt, Joachim; Beckerle, Philipp			Robotic hand illusion with tactile feedback: Unravelling the relative contribution of visuotactile and visuomotor input to the representation of body parts in space	PLOS ONE			English	Article							RUBBER HAND; OWNERSHIP; LIMB; EMBODIMENT; AGENCY; BRAIN; TOUCH; EXPERIENCE; ARM	The rubber hand illusion describes a phenomenon in which participants experience a rubber hand as being part of their body by the synchronous application of visuotactile stimulation to the real and the artificial limb. In the recently introduced robotic hand illusion (RobHl), a robotic hand is incorporated into one's body representation due to the integration of synchronous visuomotor information. However, there are no setups so far that combine visuotactile and visuomotor feedback, which is expected to unravel mechanisms that cannot be detected in experimental designs applying this information in isolation. We developed a robotic hand, controlled by a sensor glove and equipped with pressure sensors, and varied systematically and separately the synchrony for motor feedback (MF) and tactile feedback (TF). In Experiment 1, we implemented a ball-grasping task and assessed the perceived proprioceptive drift of one's own hand as a behavioral measure of the spatial calibration of body coordinates as well as explicit embodiment experiences by a questionnaire. Results revealed significant main effects of both MF and TF for proprioceptive drift data, but we only observed main effects for MF on perceived embodiment. Furthermore, for the proprioceptive drift we found that synchronous feedback in one factor compensates for asynchronous feedback in the other. In Experiment 2, including a new sample of naive participants, we further explored this finding by adding unimodal conditions, in which we manipulated the presence or absence of MF and/or TF. These findings replicated the results from Experiment 1 and we further found evidence for a supper-additive multisensory effect on spatial body representation caused by the presence of both factors. Results on conscious body perception were less consistent across both experiments. The findings indicate that sensory and motor input equally contribute to the representation of spatial body coordinates which for their part are subject to multisensory enhancing effects. The results outline the potential of human-in-the-loop approaches and might have important implications for clinical applications such as for the future design of robotic prostheses.	[The Vu Huynh; Vogt, Joachim] Tech Univ Darmstadt, Work & Engn Psychol Res Grp, Darmstadt, Germany; [Bekrater-Bodmann, Robin] Heidelberg Univ, Dept Cognit & Clin Neurosci, Cent Inst Mental Hlth, Med Fac Mannheim, Mannheim, Germany; [Froehner, Jakob] Tech Univ Munich, Dept Elect & Comp Engn, Chair Informat Oriented Control, Munich, Germany; [Beckerle, Philipp] Tech Univ Dortmund, Elast Lightweight Robot Grp, Robot Res Inst, Dept Elect Engn & Informat Technol, Dortmund, Germany; [Beckerle, Philipp] Tech Univ Darmstadt, Inst Mechatron Syst Mech Engn, Darmstadt, Germany	Technical University of Darmstadt; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Technical University of Munich; Dortmund University of Technology; Technical University of Darmstadt	Huynh, TV (corresponding author), Tech Univ Darmstadt, Work & Engn Psychol Res Grp, Darmstadt, Germany.	huynh@psychologie.tu-darmstadt.de	Beckerle, Philipp/H-5731-2015	Beckerle, Philipp/0000-0001-5703-6029				Abrams AMH, 2018, ACMIEEE INT CONF HUM, P289, DOI 10.1145/3173386.3176915; [Anonymous], 2017, JASP VERS 0 8 4; Apps MAJ, 2014, NEUROSCI BIOBEHAV R, V41, P85, DOI 10.1016/j.neubiorev.2013.01.029; Arata J, 2014, IEEE T HAPTICS, V7, P526, DOI 10.1109/TOH.2014.2304722; Beckerle P, WILEY INTERDISCIPLIN; Beckerle P, 2016, 2016 25 IEEE INT S R; Beckerle P, 2017, FRONT NEUROROBOTICS, V11, DOI 10.3389/fnbot.2017.00024; Bekrater-Bodmann R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087013; Bekrater-Bodmann R, 2013, J NEUROSCI, V33, P2729, DOI 10.1523/JNEUROSCI.5547-12.2013; Biddiss E, 2007, AM J PHYS MED REHAB, V86, P977, DOI 10.1097/PHM.0b013e3181587f6c; Blanke O, 2015, NEURON, V88, P145, DOI 10.1016/j.neuron.2015.09.029; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Canzoneri E, 2013, SCI REP-UK, V3, DOI 10.1038/srep02844; Canzoneri E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044306; Caspar EA, 2015, BEHAV RES METHODS, V47, P744, DOI 10.3758/s13428-014-0498-3; Christ O., 2012, Biomedical Engineering-Biomedizinische Technik, V57, DOI 10.1515/bmt-2012-4297; D'Alonzo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050756; De Beir A, 2014, 23 IEEE INT S ROB HU; Dummer T, 2009, PERCEPTION, V38, P271, DOI 10.1068/p5921; Ehrsson HH, 2008, BRAIN, V131, P3443, DOI 10.1093/brain/awn297; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Erro R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20551-6; Filippetti ML, 2017, COGNITION, V159, P1, DOI 10.1016/j.cognition.2016.11.002; Flogel M, 2016, PSYCHOL RES-PSYCH FO, V80, P298, DOI 10.1007/s00426-015-0650-4; Fuchs X, 2016, SCI REP-UK, V6, DOI 10.1038/srep24362; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Hara M, 2016, IEEE T HUM-MACH SYST, V46, P78, DOI 10.1109/THMS.2015.2487499; Holmes Nicholas P, 2004, Cogn Process, V5, P94, DOI 10.1007/s10339-004-0013-3; Holmes NP, 2005, CURR BIOL, V15, pR762, DOI 10.1016/j.cub.2005.08.058; Imaizumi S, 2016, CONSCIOUS COGN, V45, P75, DOI 10.1016/j.concog.2016.08.019; Ismail MAF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159619; Jenkinson PM, 2013, NEUROPSYCHOLOGIA, V51, P1453, DOI 10.1016/j.neuropsychologia.2013.03.029; Jiang N, 2012, IEEE SIGNAL PROC MAG, V29, P147, DOI 10.1109/MSP.2012.2203480; Kalckert A, 2014, CONSCIOUS COGN, V30, P118, DOI 10.1016/j.concog.2014.08.022; Kalckert A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00040; Kalveram K.T., 1998, WIE INDIVIDUUM SEINE; Keetels M., 2012, NEURAL BASEMULTISE; Kern U, 2009, SCHMERZ, V23, P479, DOI 10.1007/s00482-009-0786-5; Kokkinara E, 2014, PERCEPTION, V43, P43, DOI 10.1068/p7545; Kording KP, 2006, TRENDS COGN SCI, V10, P319, DOI 10.1016/j.tics.2006.05.003; Lloyd DM, 2007, BRAIN COGNITION, V64, P104, DOI 10.1016/j.bandc.2006.09.013; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Marasco PD, 2011, BRAIN, V134, P747, DOI 10.1093/brain/awq361; MEREDITH MA, 1983, SCIENCE, V221, P389, DOI 10.1126/science.6867718; Olive I, 2015, HUM BRAIN MAPP, V36, P717, DOI 10.1002/hbm.22659; Padilla-Castaneda MA, 2014, PRESENCE-TELEOP VIRT, V23, P209, DOI 10.1162/PRES_a_00181; Pavani F, 2007, PERCEPTION, V36, P1547, DOI 10.1068/p5853; Pfeiffer C, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00031; Rohde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021659; Romano D, 2015, NEUROPSYCHOLOGIA, V70, P414, DOI 10.1016/j.neuropsychologia.2014.10.033; Rosen B, 2009, SCAND J PLAST RECONS, V43, P260, DOI 10.3109/02844310903113107; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; SANCHEZVIVES MV, 2010, PLOS ONE, V5; Serino A, 2015, SCI REP-UK, V5, DOI 10.1038/srep18603; Shimada S, 2005, NEUROIMAGE, V24, P1225, DOI 10.1016/j.neuroimage.2004.10.039; Shimada S., 2009, PLOS ONE, V4; Synofzik M, 2008, CONSCIOUS COGN, V17, P411, DOI 10.1016/j.concog.2008.03.008; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; Tsakiris M, 2010, EXP BRAIN RES, V204, P343, DOI 10.1007/s00221-009-2039-3; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034	61	8	8	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210058	10.1371/journal.pone.0210058	http://dx.doi.org/10.1371/journal.pone.0210058			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI4TC	30673739	Green Published, Green Submitted, gold			2022-12-26	WOS:000456442800029
J	Amberbir, A; Banda, V; Singano, V; Matengeni, A; Pfaff, C; Ismail, Z; Allain, TJ; Chan, AK; Sodhi, SK; van Oosterhout, JJ				Amberbir, Alemayehu; Banda, Victor; Singano, Victor; Matengeni, Alfred; Pfaff, Colin; Ismail, Zahra; Allain, Theresa J.; Chan, Adrienne K.; Sodhi, Sumeet K.; van Oosterhout, Joep J.			Effect of cardio-metabolic risk factors on all-cause mortality among HIV patients on antiretroviral therapy in Malawi: A prospective cohort study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HYPERTENSION; CARE; PREVALENCE; BURDEN; ART	Background Cardiovascular disease (CVD) risk among people living with HIV is elevated due to persistent inflammation, hypertension and diabetes comorbidity, lifestyle factors and exposure to antiretroviral therapy (ART). Data from Africa on how CVD risk affects morbidity and mortality among ART patients are lacking. We explored the effect of CVD risk factors and the Framingham Risk Score (FRS) on medium-term ART outcomes. Methods A prospective cohort study of standardized ART outcomes (Dead, Alive on ART, stopped ART, Defaulted and Transferred out) was conducted from July 2014-December 2016 among patients on ART at a rural and an urban HIV clinic in Zomba district, Malawi. The primary outcome was Dead. Active defaulter tracing was not done and patients who transferred out and defaulted were excluded from the analysis. At enrolment, hypertension, diabetes and dyslipidemia were diagnosed, lifestyle data collected and the FRS was determined. Cox-regression analysis was used to determine independent risk factors for the outcome Dead. Results Of 933 patients enrolled, median age was 42 years (IQR: 35-50), 72% were female, 24% had hypertension, 4% had diabetes and 15.8% had elevated total cholesterol. The median follow up time was 2.4 years. Twenty (2.1%) patients died, 50 (5.4%) defaulted, 63 (6.8%) transferred out and 800 (85.7%) were alive on ART care (81.7% urban vs. 89.9% rural). In multivariable survival analysis, male gender (aHR = 3.28; 95% CI: 1.33-8.07, p = 0.01) and total/HDL cholesterol ratio (aHR = 5.77, 95% CI: 1.21-27.32; p = 0.03) were significantly associated with mortality. There was no significant association between mortality and hypertension, body mass index, central obesity, diabetes, FRS, physical inactivity, smoking at enrolment, ART regimen and WHO disease stage. Conclusions Medium-term all-cause mortality among ART patients was associated with male gender and elevated total/HDL cholesterol ratio.	[Amberbir, Alemayehu; Banda, Victor; Singano, Victor; Matengeni, Alfred; Pfaff, Colin; Chan, Adrienne K.; Sodhi, Sumeet K.; van Oosterhout, Joep J.] Dignitas Int, Zomba, Malawi; [Ismail, Zahra] Pirimiti Rural Hosp, Pirimiti, Malawi; [Allain, Theresa J.; van Oosterhout, Joep J.] Univ Malawi, Dept Med, Coll Med, Blantyre, Malawi; [Chan, Adrienne K.] Univ Toronto, Div Infect Dis, Dept Med, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Sodhi, Sumeet K.] Univ Hlth Network, Toronto Western Hosp, Dept Family & Community Med, Toronto, ON, Canada	University of Malawi; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Amberbir, A (corresponding author), Dignitas Int, Zomba, Malawi.	a.amberbir@dignitasinternational.org	Amberbir, Alemayehu/HGC-2647-2022					Amberbir A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197728; Benjamin LA, 2016, NEUROLOGY, V86, P324, DOI 10.1212/WNL.0000000000002278; Chihana M, 2012, TROP MED INT HEALTH, V17, pe74, DOI 10.1111/j.1365-3156.2012.02929.x; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Dillon DG, 2013, INT J EPIDEMIOL, V42, P1754, DOI 10.1093/ije/dyt198; Divala OH, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3916-x; Gunda Daniel Wilfred, 2017, J Sex Transm Dis, V2017, P7075601, DOI 10.1155/2017/7075601; Harries AD, 2015, TROP MED INT HEALTH, V20, P961, DOI 10.1111/tmi.12506; Jahn A, 2016, B WORLD HEALTH ORGAN, V94, P772, DOI 10.2471/BLT.15.166074; Jamieson L, 2017, HIV MED MAR, V23; Mageda K, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/843598; Malawi Ministry of Health, 2014, INT HIV PROGR REP OC; Mateen FJ, 2013, J HYPERTENS, V31, P1372, DOI 10.1097/HJH.0b013e328360de1c; Mbanya JC, 2011, LANCET, V377, P536, DOI 10.1016/S0140-6736(10)61891-0; Msyamboza KP, 2012, INT HEALTH, V4, P246, DOI 10.1016/j.inhe.2012.09.005; Muyanja D, 2016, AIDS PATIENT CARE ST, V30, P4, DOI 10.1089/apc.2015.0213; Nou E, 2016, AIDS, V30; Rucker SCM, 2018, AIDS, V32, P253, DOI 10.1097/QAD.0000000000001700; Setegn T, 2015, AIDS RES TREAT, V2015, DOI 10.1155/2015/148769; Seyoum D, 2017, INT J ENV RES PUB HE, V14, P1; World Health Organization, 2003, STEPS Q Q GUID CHRON	23	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210629	10.1371/journal.pone.0210629	http://dx.doi.org/10.1371/journal.pone.0210629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653539	Green Published, gold, Green Submitted			2022-12-26	WOS:000456015500056
J	Fu, Y; Zorman, B; Sumazin, P; Sanna, PP; Repunte-Canonigo, V				Fu, Yu; Zorman, Barry; Sumazin, Pavel; Sanna, Pietro Paolo; Repunte-Canonigo, Vez			Epitranscriptomics: Correlation of N-6-methyladenosine RNA methylation and pathway dysregulation in the hippocampus of HIV transgenic rats	PLOS ONE			English	Article							MESSENGER-RNA; M(6)A RNA; GENE FTO; EXPRESSION; N6-METHYLADENOSINE; INJURY; CELL; ASSOCIATION; ENRICHMENT; METHYLOMES	Internal RNA modifications have been known for decades, however their roles in mRNA regulation have only recently started to be elucidated. Here we investigated the most abundant mRNA modification, N-6-methyladenosine (m(6)A) in transcripts from the hippocampus of HIV transgenic (Tg) rats. The distribution of m(6)A peaks within HIV transcripts in HIV Tg rats largely corresponded to the ones observed for HIV transcripts in cell lines and T cells. Host transcripts were found to be differentially m(6)A methylated in HIV Tg rats. The functional roles of the differentially m(6)A methylated pathways in HIV Tg rats is consistent with a key role of RNA methylation in the regulation of the brain transcriptome in chronic HIV disease. In particular, host transcripts show significant differential m(6)A methylation of genes involved in several pathways related to neural function, suggestive of synaptodendritic injury and neurodegeneration, inflammation and immune response, as well as RNA processing and metabolism, such as splicing. Changes in m(6)A methylation were usually positively correlated with differential expression, while differential m(6)A methylation of pathways involved in RNA processing were more likely to be negatively correlated with gene expression changes. Thus, sets of differentially m(6)A methylated, functionally-related transcripts appear to be involved in coordinated transcriptional responses in the context of chronic HIV. Altogether, our results support that m(6)A methylation represents an additional layer of regulation of HIV and host gene expression in vivo that contributes significantly to the transcriptional effects of chronic HIV.	[Fu, Yu; Sanna, Pietro Paolo; Repunte-Canonigo, Vez] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Fu, Yu; Sanna, Pietro Paolo; Repunte-Canonigo, Vez] Scripps Res Inst, Dept Neurosci, La Jolla, CA 92037 USA; [Zorman, Barry; Sumazin, Pavel] Baylor Coll Med, Dept Pediat, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Fu, Yu] European Bioinformat Inst EMBL EBI, Hinxton, England	Scripps Research Institute; Scripps Research Institute; Baylor College of Medicine; European Molecular Biology Laboratory (EMBL)	Sanna, PP; Repunte-Canonigo, V (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.; Sanna, PP; Repunte-Canonigo, V (corresponding author), Scripps Res Inst, Dept Neurosci, La Jolla, CA 92037 USA.	psanna@scripps.edu; canonigo@scripps.edu	Sumazin, Pavel/AAE-6607-2020	Sumazin, Pavel/0000-0002-1215-4977	National Institutes of Health/National Institute on Drug Abuse [DA041750, DA043268]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA025012, R01AA021667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA041750, R01DA046204, R01DA043268, R01DA046170] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health/National Institute on Drug Abuse grants DA041750 and DA043268, https://www.drugabuse.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon CR, 2015, NATURE, V519, P482, DOI 10.1038/nature14281; Cao GC, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160003; Choudhry Z, 2013, OBESITY, V21, pE738, DOI 10.1002/oby.20444; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; DIMOCK K, 1977, BIOCHEMISTRY-US, V16, P471, DOI 10.1021/bi00622a021; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Ellis R, 2007, NAT REV NEUROSCI, V8, P33, DOI 10.1038/nrn2040; Everall I, 2009, J NEUROVIROL, V15, P360, DOI 10.3109/13550280903131915; Festa L, 2015, J NEUROSCI, V35, P10550, DOI 10.1523/JNEUROSCI.4403-14.2015; FINKEL D, 1983, VIROLOGY, V131, P409, DOI 10.1016/0042-6822(83)90508-1; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015; Hess ME, 2013, NAT NEUROSCI, V16, P1042, DOI 10.1038/nn.3449; Iles MM, 2013, NAT GENET, V45, P428, DOI 10.1038/ng.2571; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Ke SD, 2017, GENE DEV, V31, P990, DOI 10.1101/gad.301036.117; Ke SD, 2015, GENE DEV, V29, P2037, DOI 10.1101/gad.269415.115; Kennedy EM, 2017, J VIROL, V91, DOI 10.1128/JVI.02263-16; Kennedy EM, 2016, CELL HOST MICROBE, V19, P675, DOI 10.1016/j.chom.2016.04.002; Kok YL, 2017, TRENDS MICROBIOL, V25, P932, DOI 10.1016/j.tim.2017.06.002; KRUG RM, 1976, J VIROL, V20, P45, DOI 10.1128/JVI.20.1.45-53.1976; Lashomb AL, 2009, J NEUROVIROL, V15, P14, DOI 10.1080/13550280802232996; LAVI S, 1975, P NATL ACAD SCI USA, V72, P2012, DOI 10.1073/pnas.72.6.2012; LE PT, 1986, J IMMUNOL, V136, P2526; Leng SX, 2015, CURR HIV-AIDS REP, V12, P25, DOI 10.1007/s11904-014-0247-3; Li S, 2014, ANNU REV GENOM HUM G, V15, P127, DOI 10.1146/annurev-genom-090413-025405; Lichinchi G, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.11, 10.1038/nmicrobiol.2016.11]; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Liu N, 2013, RNA, V19, P1848, DOI 10.1261/rna.041178.113; Maor GL, 2015, TRENDS GENET, V31, P274, DOI 10.1016/j.tig.2015.03.002; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; Meyer KD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0874-7; Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; PEREIRAMONTECINOS, 2017, BIOCHIM BIOPHYS ACTA, V1860, P460, DOI DOI 10.1016/J.BBAGRM.2017.02.002; PERRY RP, 1974, CELL, V1, P37, DOI 10.1016/0092-8674(74)90153-6; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; Reid W, 2001, P NATL ACAD SCI USA, V98, P9271, DOI 10.1073/pnas.161290298; Reitz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050354; Repunte-Canonigo V, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-26; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Royal W, 2012, J NEUROIMMUNOL, V247, P16, DOI 10.1016/j.jneuroim.2012.03.015; Sacktor N, 2014, CURR OPIN HIV AIDS, V9, P517, DOI 10.1097/COH.0000000000000102; Sanna PP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175316; Satterlee JS, 2014, J NEUROSCI, V34, P15170, DOI 10.1523/JNEUROSCI.3236-14.2014; Shen F, 2015, J CLIN ENDOCR METAB, V100, pE148, DOI 10.1210/jc.2014-1893; SOMMER S, 1976, NUCLEIC ACIDS RES, V3, P749, DOI 10.1093/nar/3.3.749; STOLTZFUS CM, 1982, J VIROL, V42, P918, DOI 10.1128/JVI.42.3.918-931.1982; STOLTZFUS CM, 1983, J GEN VIROL, V64, P2191, DOI 10.1099/0022-1317-64-10-2191; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tirumuru N, 2016, ELIFE, V5, DOI [10.7554/eLife.15528, 10.7554/eLife.31482]; Tung YCL, 2011, ANN NY ACAD SCI, V1220, P162, DOI 10.1111/j.1749-6632.2010.05903.x; Vigorito M, 2007, J NEUROIMMUNE PHARM, V2, P319, DOI 10.1007/s11481-007-9078-y; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; WEI CM, 1975, NATURE, V257, P251, DOI 10.1038/257251a0; WEI CM, 1977, BIOCHEMISTRY-US, V16, P1672, DOI 10.1021/bi00627a023; Wei WQ, 2017, J CELL BIOCHEM, V118, P2534, DOI 10.1002/jcb.25967; Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012; Xu C, 2014, NAT CHEM BIOL, V10, P927, DOI [10.1038/nchembio.1654, 10.1038/NCHEMBIO.1654]; Yang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep24345; Yue YN, 2015, GENE DEV, V29, P1343, DOI 10.1101/gad.262766.115	63	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0203566	10.1371/journal.pone.0203566	http://dx.doi.org/10.1371/journal.pone.0203566			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653517	gold, Green Published, Green Submitted			2022-12-26	WOS:000456015500005
J	Lichtblau, D; Stoean, C				Lichtblau, Daniel; Stoean, Catalin			Cancer diagnosis through a tandem of classifiers for digitized histopathological slides	PLOS ONE			English	Article							IMAGE-ANALYSIS; CLASSIFICATION; OPTIMIZATION; MODEL	The current research study is concerned with the automated differentiation between histopathological slides from colon tissues with respect to four classes (healthy tissue and cancerous of grades 1, 2 or 3) through an optimized ensemble of predictors. Six distinct classifiers with prediction accuracies ranging from 87% to 95% are considered for the task. The proposed method of combining them takes into account the probabilities of the individual classifiers for each sample to be assigned to any of the four classes, optimizes weights for each technique by differential evolution and attains an accuracy that is significantly better than the individual results. Moreover, a degree of confidence is defined that would allow the pathologists to separate the data into two distinct sets, one that is correctly classified with a high level of confidence and the rest that would need their further attention. The tandem is also validated on other benchmark data sets. The proposed methodology proves to be efficient in improving the classification accuracy of each algorithm taken separately and performs reasonably well on other data sets, even with default weights. In addition, by establishing a degree of confidence the method becomes more viable for use by actual practitioners.	[Lichtblau, Daniel] Wolfram Res, Champaign, IL USA; [Stoean, Catalin] Univ Craiova, Fac Sci, Craiova, Romania	University of Craiova	Stoean, C (corresponding author), Univ Craiova, Fac Sci, Craiova, Romania.	catalin.stoean@inf.ucv.ro	Stoean, Catalin/C-7242-2008	Stoean, Catalin/0000-0001-5917-1857	Romanian Ministry of National Education (MEN) - Research [26/2014, PN-II-PT-PCCA-2013-4-1153]; Executive Agency for Higher Education Research Development and Innovation Funding (UEFISCDI) [26/2014, PN-II-PT-PCCA-2013-4-1153]	Romanian Ministry of National Education (MEN) - Research; Executive Agency for Higher Education Research Development and Innovation Funding (UEFISCDI)(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	Wolfram Research, Inc. provided support in the form of salary to DL but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. CS acknowledges the support of the research grant no. 26/2014, code PN-II-PT-PCCA-2013-4-1153, entitled "Intelligent Medical Information System for the Diagnosis and Monitoring of the Treatment of Patients with Colorectal Neoplasm"; financed by the Romanian Ministry of National Education (MEN) - Research, and the Executive Agency for Higher Education Research Development and Innovation Funding (UEFISCDI). CS received support in the form of salaries and research materials from the UEFISCDI. The grant was led by CS and made possible in collaboration with physicians. The specific roles of these authors are articulated in the 'author contributions' section.	Ahammer H, 2008, PATTERN RECOGN LETT, V29, P2189, DOI 10.1016/j.patrec.2008.08.008; Arik S, 2017, LECT NOTES COMPUT SC, V10636, P903, DOI 10.1007/978-3-319-70090-8_92; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BRUNYE P, 2017, JOURNAL OF BIOMEDICA, V66, P171; CAICEDO JC, 2009, BERLIN, P126; cancer org, 2016, AMERICAN CANCER SOCI; CHAM, 2013, SPRINGER, V2013, P411; CHAM, SPRINGER; COELHO LP, 2010, BERLIN, P23; Das S., 2016, SWARM EVOL COMPUT, V27, P1, DOI [DOI 10.1016/J.SWEV0.2016.01.004, 10.1016/j.swevo.2016.01.004, DOI 10.1016/J.SWEVO.2016.01.004]; DC, HISTOLOGY; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; Doi K, 2007, COMPUT MED IMAG GRAP, V31, P198, DOI 10.1016/j.compmedimag.2007.02.002; Doyle S, 2012, IEEE T BIO-MED ENG, V59, P1205, DOI 10.1109/TBME.2010.2053540; Dubitzky W, 2006, INC; DUBITZKY W, 2006, FUNDAMENTALS OF DATA; DUBITZKY W, 2009, FUNDAMENTALS OF DATA; Elmore JG, 2016, ANN INTERN MED, V164, P649, DOI 10.7326/M15-0964; FREEDMAN DA, 2009, PRESS; Freedman DA, 2009, MEDICAL IMAGE COMPUT; Gorunescu F, 2011, SPRINGER, V12; Gorunescu F, 2011, INTEL SYST REF LIBR, P1, DOI 10.1007/978-3-642-19721-5; Gorunescu F, 2010, INT J GEN SYST, V39, P471, DOI 10.1080/03081079.2010.484282; Guo ZH, 2010, IEEE T IMAGE PROCESS, V19, P1657, DOI 10.1109/TIP.2010.2044957; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; Hamilton NA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-110; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Kearney N, 2006, ELSEVIER HEALTH SCIE; Kolter JZ, 2007, J MACH LEARN RES, V8, P2755; Krizhevsky A., 2012, ADV NEURAL INF PROCE; LICHTBLAU D, 2012, INT J SWARM INTELLIG, V1, P1; Lichtblau D, 2016, INT SYMP SYMB NUMERI, P105, DOI [10.1109/SYNASC.2016.22, 10.1109/SYNASC.2016.028]; Madabhushi A, 2016, MED IMAGE ANAL, V33, P170, DOI 10.1016/j.media.2016.06.037; Mitchell TM, 1997, SCI REPORTS; MITCHELL TM, 1997, INC, P1; Mittal S, 2018, P NATL ACAD SCI USA, V115, pE5651, DOI 10.1073/pnas.1719551115; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; OJANSIVU V, 2008, BERLIN, V8, P236; Onder D, 2013, MICRON, V47, P33, DOI 10.1016/j.micron.2013.01.003; PAJA W, 2015, FEDCSIS, V2015, P281; POSTAVARU S, 2017, SPRINGER, P38; Sertel O, 2009, PATTERN RECOGN, V42, P1093, DOI 10.1016/j.patcog.2008.08.027; Sertel O, 2009, J SIGNAL PROCESS SYS, V55, P169, DOI 10.1007/s11265-008-0201-y; SIRINUKUNWATTAN.K, 2016, CORR, V1603, P275; Sirinukunwattana K, 2016, COLORECTAL CANCER HI; Sirinukunwattana K, 2016, IEEE T MED IMAGING, V35, P1196, DOI 10.1109/TMI.2016.2525803; Sirinukunwattana K, 2015, IEEE T MED IMAGING, V34, P2366, DOI 10.1109/TMI.2015.2433900; Spanhol FA, 2016, IEEE T BIO-MED ENG, V63, P1455, DOI 10.1109/TBME.2015.2496264; STOEAN C, INTELLIGENT INTERACT; Stoean C, 2016, SPRINGER; Stoean C, 2009, EVOLUTION OF COOPERA, P47, DOI 10.1007/978-3-642-01885-5_3; Stoean C, 2017, INT SYMP SYMB NUMERI, P419, DOI 10.1109/SYNASC.2017.00076; Stoean C, 2016, INT SYMP SYMB NUMERI, P449, DOI [10.1109/SYNASC.2016.074, 10.1109/SYNASC.2016.68]; Stoean C, 2010, IEEE T EVOLUT COMPUT, V14, P842, DOI 10.1109/TEVC.2010.2041668; STOEAN R, 2018, NEURAL COMPUTING APP; Stoean R, 2018, MATHEMATICA 11 2, DOI 10.1007/s00521-018-3709-5; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Thon A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185995; Vapnik V., 1998, STAT LEARNING THEORY; Veta M, 2015, MED IMAGE ANAL, V20, P237, DOI 10.1016/j.media.2014.11.010; Wang CW, 2010, APPL INTELL, V33, P357, DOI 10.1007/s10489-009-0172-0; Wang YS, 2018, J BIOMED INFORM, V77, P34, DOI 10.1016/j.jbi.2017.11.011; Xu Y, 2014, MED IMAGE ANAL, V18, P591, DOI 10.1016/j.media.2014.01.010; Zheng YS, 2017, PATTERN RECOGN, V71, P14, DOI 10.1016/j.patcog.2017.05.010	64	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209274	10.1371/journal.pone.0209274	http://dx.doi.org/10.1371/journal.pone.0209274			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650087	Green Submitted, Green Published, gold			2022-12-26	WOS:000455813300011
J	Liu, JJ; Cui, ZZ; Wang, F; Yao, YP; Yu, GT; Liu, JJ; Cao, DC; Niu, SS; You, MH; Sun, Z; Lian, D; Zhao, TY; Kang, YM; Zhao, YF; Xue, HH; Yu, SY				Liu, Juanjuan; Cui, Zhengzhi; Wang, Fang; Yao, Yingpeng; Yu, Guotao; Liu, Jingjing; Cao, Dengchao; Niu, Shuaishuai; You, Menghao; Sun, Zhen; Lian, Di; Zhao, Tianyan; Kang, Youmin; Zhao, Yaofeng; Xue, Hai-Hui; Yu, Shuyang			Lrp5 and Lrp6 are required for maintaining self-renewal and differentiation of hematopoietic stem cells	FASEB JOURNAL			English	Article						Wnt signaling; reconstitution; development; lineage; cell cycle	BETA-CATENIN; BONE MASS; WNT; PROLIFERATION; TRANSCRIPTION; EXPRESSION; IMPAIRS; DEFICIENCY; ACTIVATION; MECHANISMS	Hematopoietic stem cells (HSCs) have the capacity for self-renewal to maintain the HSCs' pool and the ability for multilineage differentiation, which are responsible for sustained production of multiple blood lineages. The regulation of HSC development is controlled precisely by complex signal networks and hematopoietic microenvironment, which has been termed the HSCs' niche. The Wnt signaling pathway is one of a variety of signaling pathways that have been involved in HSC self-renewal and maintenance. Previous studies are indeterminant on the regulation of adult HSCs upon canonical Wnt signaling pathways because of the different experimental systems and models used. In this study, we generated the conditional knockout Wnt coreceptor low-density lipoprotein receptor-related protein 5 (Lrp5) and low-density lipoprotein receptor-related protein 6 (Lrp6) mice in adult hematopoiesis viaVav-Cre Loxp system. Inactivation of Lrp5 and -6 in a hematopoietic system diminished the pool of HSCs, but there were no obvious defects in mature immune cells. Lrp5 and -6 double deficiency HSCs showed intrinsic defects in self-renewal and differentiation due to reduced proliferation and increased quiescence of the cell cycle. Analysis of HSC gene expression suggested that the quiescence regulators were significantly up-regulated, such as Egr1, Cdkn1a, Nr4a1, Gata2, Junb and Btg2, and the positive cell cycle regulators were correspondingly down-regulated, such as Ccna2 and Ranbp1. Taken together, we investigated the roles of Lrp5 and -6 in HSCs by functional and bioinformatic assays, and we demonstrated that Lrp5 and -6 are required for the self-renewal and differentiation of adult HSCs. The canonical Wnt pathway may contribute to maintaining the HSC pool and regulate the differentiation of adult HSCs by controlling cell cycle gene regulatory module.	[Liu, Juanjuan; Cui, Zhengzhi; Wang, Fang; Yao, Yingpeng; Yu, Guotao; Liu, Jingjing; Cao, Dengchao; Niu, Shuaishuai; You, Menghao; Sun, Zhen; Lian, Di; Zhao, Tianyan; Kang, Youmin; Zhao, Yaofeng; Yu, Shuyang] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing, Peoples R China; [Liu, Juanjuan; Cui, Zhengzhi; Wang, Fang; Yao, Yingpeng; Yu, Guotao; Liu, Jingjing; Cao, Dengchao; Niu, Shuaishuai; You, Menghao; Sun, Zhen; Lian, Di; Zhao, Tianyan; Yu, Shuyang] China Agr Univ, Coll Biol Sci, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China; [Xue, Hai-Hui] Univ Iowa, Dept Microbiol & Immunol, Carver Coll Med, Iowa City, IA USA	China Agricultural University; China Agricultural University; University of Iowa	Yu, SY (corresponding author), China Agr Univ, Yuanmingyuan West Rd 2, Beijing 100193, Peoples R China.	ysy@cau.edu.cn	Wang, Fang/GLV-0025-2022; Cao, Dengchao/AIA-7934-2022	Wang, Fang/0000-0002-2604-4429; Cao, Dengchao/0000-0001-9808-991X; Liu, Jingjing/0000-0002-3266-7331; Yao, Yingpeng/0000-0002-5415-2443	National Key R&D Program of China [2017YFA0104401]; National Natural Science Foundation of China [31571522, 31630038, 31422037]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. Bart Williams (Center for Cancer and Cell Biology, Van Andel Research Institute, Grand Rapids MI, USA) for providing Lrp5- and Lrp6-floxed mice. The authors also thank Dr. Jinping Song for her assistance with cell sorting at China Astronaut Research and Training Center, Beijing, China. This work is supported by National Key R&D Program of China (2017YFA0104401 to S.Y.) and the National Natural Science Foundation of China (31571522, 31630038, and 31422037 to S.Y.). The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Battistoni A, 1997, J CELL SCI, V110, P2345; Blank U, 2008, BLOOD, V111, P492, DOI 10.1182/blood-2007-07-075168; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; De Ferrari GV, 2006, ONCOGENE, V25, P7545, DOI 10.1038/sj.onc.1210064; de Iongh RU, 2006, FRONT BIOSCI-LANDMRK, V11, P2442, DOI 10.2741/1982; de Pater E, 2013, J EXP MED, V210, P2843, DOI 10.1084/jem.20130751; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Freire PR, 2018, BLOOD, V131, P1081, DOI 10.1182/blood-2017-07-795757; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Goel S, 2012, J BIOL CHEM, V287, P16454, DOI 10.1074/jbc.M112.362137; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Guarguaglini G, 1997, BIOCHEM J, V325, P277, DOI 10.1042/bj3250277; Herz J, 2009, J LIPID RES, V50, pS287, DOI 10.1194/jlr.R800077-JLR200; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang X, 2007, CELL DEATH DIFFER, V14, P1851, DOI 10.1038/sj.cdd.4402225; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Joeng KS, 2011, DEV BIOL, V359, P222, DOI 10.1016/j.ydbio.2011.08.020; Joiner DM, 2013, TRENDS ENDOCRIN MET, V24, P31, DOI 10.1016/j.tem.2012.10.003; Kalaszczynska I, 2009, CELL, V138, P352, DOI 10.1016/j.cell.2009.04.062; Kanakkanthara A, 2016, SCIENCE, V353, P1549, DOI 10.1126/science.aaf7463; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Kubota T, 2008, J BONE MINER RES, V23, P1661, DOI 10.1359/JBMR.080512; Liu CC, 2014, NEURON, V84, P63, DOI 10.1016/j.neuron.2014.08.048; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luis TC, 2009, BLOOD, V113, P546, DOI 10.1182/blood-2008-06-163774; Ma F, 2016, J CLIN INVEST, V126, P1745, DOI 10.1172/JCI78815; Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Ruiz-Herguido C, 2012, J EXP MED, V209, P1457, DOI 10.1084/jem.20120225; Santaguida M, 2009, CANCER CELL, V15, P341, DOI 10.1016/j.ccr.2009.02.016; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Schumacher CA, 2016, BONE RES, V4, DOI 10.1038/boneres.2015.42; Song KD, 2016, HUM CELL, V29, P53, DOI 10.1007/s13577-016-0134-x; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsang JCH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0739-5; Tzahor E, 2007, DEV CELL, V13, P10, DOI 10.1016/j.devcel.2007.06.006; Williams BO, 2009, J BONE MINER RES, V24, P171, DOI [10.1359/JBMR.081235, 10.1359/jbmr.081235]; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yu SY, 2016, J BIOL CHEM, V291, P11148, DOI 10.1074/jbc.M116.717801; Yu SY, 2011, BLOOD, V117, P2166, DOI 10.1182/blood-2010-09-306563; Zhang LL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154238; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	51	16	16	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5615	5625		10.1096/fj.201802072R	http://dx.doi.org/10.1096/fj.201802072R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30668923	Green Published, Bronze			2022-12-26	WOS:000462888500078
J	Pan, WL; Chopp, M; Fan, BY; Zhang, RL; Wang, XL; Hu, JN; Zhang, XM; Zhang, ZG; Liu, XS				Pan, Wan Long; Chopp, Michael; Fan, Baoyan; Zhang, Ruilan; Wang, Xinli; Hu, Jiani; Zhang, Xiao Ming; Zhang, Zheng Gang; Liu, Xian Shuang			Ablation of the microRNA-17-92 cluster in neural stem cells diminishes adult hippocampal neurogenesis and cognitive function	FASEB JOURNAL			English	Article						cognition; hippocampus; small RNA; neuronal differentiation; adult NSC	SUBVENTRICULAR ZONE; PROGENITOR CELLS; DIFFERENTIATION; PROLIFERATION; MEMORY	Impairment of adult neurogenesis in the hippocampus causes cognitive deficits; however, the underlying molecular mechanisms have not been fully elucidated. microRNAs (miRNAs) regulate neural stem cell (NSC) function. With the use of a transgenic mouse line with conditional ablation of the miR-17-92 cluster in nestin lineage NSCs, we tested the hypothesis that the miR-17-92 cluster regulates adult neurogenesis and cognitive function in vivo. Compared with wild-type mice, ablation of the miR-17-92 cluster significantly reduced the number of proliferating NSCs and neuroblasts and neuronal differentiation in the dentate gyrus (DG) of the hippocampus and significantly impaired hippocampal-dependent learning and memory, as assayed by social recognition memory, novel object recognition, and Morris water-maze tests. Statistical analysis showed a highly significant correlation between newly generated neuroblasts in the DG and cognition deficits in miR-17-92 knockout (KO) mice. Western blot analysis showed that conditional KO of the miR-17-92 cluster significantly increased and reduced a cytoskeleton-associated protein, Enigma homolog 1 (ENH1), and its downstream transcription factor, inhibitor of differentiation 1 (ID1), respectively, as well as increased phosphatase and tensin homolog gene. These proteins are related to neuronal differentiation. Our study demonstrates that the miR-17-92 cluster in NSCs is critical for cognitive and behavioral function and regulates neurogenesis and that the miR-17-92 cluster may target ENH1/ID1 signaling.	[Pan, Wan Long] North Sichuan Med Coll, Affiliated Hosp, Dept Microbiol & Immunol, Nanchong, Peoples R China; [Zhang, Xiao Ming] North Sichuan Med Coll, Affiliated Hosp, Dept Radiol, Sichuan Key Lab Med Imaging, Wenhua Rd 63, Nanchong 637000, Sichuan, Peoples R China; [Pan, Wan Long; Chopp, Michael; Fan, Baoyan; Zhang, Ruilan; Wang, Xinli; Zhang, Zheng Gang; Liu, Xian Shuang] Henry Ford Hosp, Dept Neurol, 2799 West Grand Blvd, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA; [Hu, Jiani] Wayne State Univ, Dept Radiol, Detroit, MI USA	North Sichuan Medical University; North Sichuan Medical University; Henry Ford Health System; Henry Ford Hospital; Oakland University; Wayne State University	Zhang, XM (corresponding author), North Sichuan Med Coll, Affiliated Hosp, Dept Radiol, Sichuan Key Lab Med Imaging, Wenhua Rd 63, Nanchong 637000, Sichuan, Peoples R China.; Liu, XS (corresponding author), Henry Ford Hosp, Dept Neurol, 2799 West Grand Blvd, Detroit, MI 48202 USA.	zhangxm@nsmc.edu.cn; xliu2@hfhs.org	Wang, Xin/GYU-1129-2022; zhang, zheng/HCH-9684-2022; Pan, Wanlong/AAP-2420-2020	Pan, Wanlong/0000-0003-4590-0240	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [RO1 DK102861]; American Heart/Stroke Association [18IPA34170331]; NIH National Institute of Neurological Disorders and Stroke [RO1 NS075156, RO1 NS088656]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088656] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart/Stroke Association; NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grant RO1 DK102861 (to X.S.L.); American Heart/Stroke Association Grant 18IPA34170331 (to X.S.L.); and NIH National Institute of Neurological Disorders and Stroke Grants RO1 NS075156 (to Z.G.Z.) and RO1 NS088656 (to M.C.). The authors declare no conflicts of interest.	Alvarez-Buylla A, 2000, Prog Brain Res, V127, P1; Amiri A, 2012, J NEUROSCI, V32, P5880, DOI 10.1523/JNEUROSCI.5462-11.2012; Bian S, 2013, CELL REP, V3, P1398, DOI 10.1016/j.celrep.2013.03.037; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Christian KM, 2014, ANNU REV NEUROSCI, V37, P243, DOI 10.1146/annurev-neuro-071013-014134; Coolen M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00220; Coras R, 2010, BRAIN, V133, P3359, DOI 10.1093/brain/awq215; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Fineberg SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038562; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Guo L, 2012, GENE, V511, P187, DOI 10.1016/j.gene.2012.09.066; Guo WX, 2012, NAT PROTOC, V7, P2005, DOI 10.1038/nprot.2012.123; Janus C, 2004, LEARN MEMORY, V11, P337, DOI 10.1101/lm.70104; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Kaidanovich-Beilin O, 2011, JOVE-J VIS EXP, DOI 10.3791/2473; Kirschenbaum B, 1999, J NEUROSCI, V19, P2171; Lang MF, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00071; Lasorella A, 2006, P NATL ACAD SCI USA, V103, P4976, DOI 10.1073/pnas.0600168103; Li XK, 2010, NAT REV NEUROSCI, V11, P329, DOI 10.1038/nrn2739; Liu XS, 2017, MOL NEUROBIOL, V54, P227, DOI 10.1007/s12035-015-9655-7; Liu XS, 2013, J BIOL CHEM, V288, P12478, DOI 10.1074/jbc.M112.449025; Liu XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023461; Liu XS, 2009, J BIOL CHEM, V284, P22680, DOI 10.1074/jbc.M109.006551; Marschallinger J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9466; Niola F, 2012, NAT CELL BIOL, V14, P477, DOI 10.1038/ncb2490; Qiu H, 2016, CELL DEATH DIFFER, V23, P1658, DOI 10.1038/cdd.2016.56; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Shi YH, 2010, J NEUROSCI, V30, P14931, DOI 10.1523/JNEUROSCI.4280-10.2010; Wang L, 2007, J BIOL CHEM, V282, P32462, DOI 10.1074/jbc.M706880200; Wang WY, 2012, LEARN MEMORY, V19, P359, DOI 10.1101/lm.026492.112; Xu JA, 2011, NUCLEIC ACIDS RES, V39, P825, DOI 10.1093/nar/gkq832; Zhang RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050822; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576	36	29	29	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5257	5267		10.1096/fj.201801019R	http://dx.doi.org/10.1096/fj.201801019R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30668139	Green Published, Bronze			2022-12-26	WOS:000462888500051
J	Jendroszek, A; Madsen, JB; Chana-Munoz, A; Dupont, DM; Christensen, A; Panitz, F; Fuchtbauer, EM; Lovell, SC; Jensen, JK				Jendroszek, Agnieszka; Madsen, Jeppe B.; Chana-Munoz, Andres; Dupont, Daniel M.; Christensen, Anni; Panitz, Frank; Fuchtbauer, Ernst-Martin; Lovell, Simon C.; Jensen, Jan K.			Biochemical and structural analyses suggest that plasminogen activators coevolved with their cognate protein substrates and inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						serine protease; serpin; substrate specificity; protein evolution; surface plasmon resonance (SPR)	UROKINASE-TYPE; CRYSTAL-STRUCTURE; IMMUNOHISTOCHEMICAL LOCALIZATION; MECHANISM; SPECIFICITY; BINDING; RECEPTOR; TYPE-1	Protein sequences of members of the plasminogen activation system are present throughout the entire vertebrate phylum. This important and well-described proteolytic cascade is governed by numerous protease-substrate and protease-inhibitor interactions whose conservation is crucial to maintaining unchanged protein function throughout evolution. The pressure to preserve protein-protein interactions may lead to either co-conservation or covariation of binding interfaces. Here, we combined covariation analysis and structure-based prediction to analyze the binding interfaces of urokinase (uPA):plasminogen activator inhibitor-1 (PAI-1) and uPA:plasminogen complexes. We detected correlated variation between the S3-pocket-lining residues of uPA and the P3 residue of both PAI-1 and plasminogen. These residues are known to form numerous polar interactions in the human uPA:PAI-1 Michaelis complex. To test the effect of mutations that correlate with each other and have occurred during mammalian diversification on protein-protein interactions, we produced uPA, PAI-1, and plasminogen from human and zebrafish to represent mammalian and nonmammalian orthologs. Using single amino acid point substitutions in these proteins, we found that the binding interfaces of uPA:plasminogen and uPA:PAI-1 may have coevolved to maintain tight interactions. Moreover, we conclude that although the interaction areas between protease-substrate and protease-inhibitor are shared, the two interactions are mechanistically different. Compared with a protease cleaving its natural substrate, the interaction between a protease and its inhibitor is more complex and involves a more fine-tuned mechanism. Understanding the effects of evolution on specific protein interactions may help further pharmacological interventions of the plasminogen activation system and other proteolytic systems.	[Jendroszek, Agnieszka; Madsen, Jeppe B.; Chana-Munoz, Andres; Dupont, Daniel M.; Christensen, Anni; Panitz, Frank; Fuchtbauer, Ernst-Martin; Jensen, Jan K.] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Lovell, Simon C.] Univ Manchester, Sch Biol Sci, Manchester M13 9PL, Lancs, England	Aarhus University; University of Manchester	Jensen, JK (corresponding author), Aarhus Univ, Ny Munkegade 116,Bygning 1521,418, DK-8000 Aarhus, Denmark.	jkj@mbg.au.dk	Dupont, Daniel M./H-7556-2019; Panitz, Frank/A-3281-2017	Panitz, Frank/0000-0002-6909-5162; Dupont, Daniel Miotto/0000-0003-1378-1670	Danish Research Council	Danish Research Council(Det Frie Forskningsrad (DFF))	This work was supported by The Danish Research Council. The authors declare that they have no conflicts of interest with the contents of this article.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDREASEN PA, 1990, MOL CELL ENDOCRINOL, V68, P1, DOI 10.1016/0303-7207(90)90164-4; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Bager R, 2013, J MOL BIOL, V425, P2867, DOI 10.1016/j.jmb.2013.05.007; Bager R, 2012, J BIOL CHEM, V287, P27526, DOI 10.1074/jbc.M112.369207; Blouse GE, 2003, BIOCHEMISTRY-US, V42, P12260, DOI 10.1021/bi034737n; CHIBBER BAK, 1985, BIOCHEMISTRY-US, V24, P3429, DOI 10.1021/bi00335a006; Christensen L, 1996, INT J CANCER, V66, P441; Coombs GS, 1996, J BIOL CHEM, V271, P4461; DING L, 1995, P NATL ACAD SCI USA, V92, P7627, DOI 10.1073/pnas.92.17.7627; Dupont DM, 2009, FRONT BIOSCI-LANDMRK, V14, P1337, DOI 10.2741/3312; ELLIS V, 1987, J BIOL CHEM, V262, P14998; Gong LH, 2015, J BIOL CHEM, V290, P25795, DOI 10.1074/jbc.M115.677567; GRONDAHLHANSEN J, 1987, J INVEST DERMATOL, V88, P28, DOI 10.1111/1523-1747.ep12464827; Harms MJ, 2013, NAT REV GENET, V14, P559, DOI 10.1038/nrg3540; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hong ZB, 2016, J BIOL CHEM, V291, P14340, DOI 10.1074/jbc.M115.707240; Hopf TA, 2014, ELIFE, V3, DOI 10.7554/eLife.03430; Huntington JA, 2011, J THROMB HAEMOST, V9, P26, DOI 10.1111/j.1538-7836.2011.04360.x; Ibarra CA, 2004, J BIOL CHEM, V279, P3643, DOI 10.1074/jbc.M310601200; Im H, 2000, PROTEIN SCI, V9, P934, DOI 10.1110/ps.9.5.934; Jendroszek A, 2017, THROMB HAEMOSTASIS, V117, P1688, DOI 10.1160/TH17-02-0102; Jensen JK, 2002, FEBS LETT, V521, P91, DOI 10.1016/S0014-5793(02)02830-2; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Kaslik G, 1997, BIOCHEMISTRY-US, V36, P5455, DOI 10.1021/bi962931m; Law RHP, 2013, CURR OPIN STRUC BIOL, V23, P836, DOI 10.1016/j.sbi.2013.10.006; Lee C, 2000, P NATL ACAD SCI USA, V97, P7727, DOI 10.1073/pnas.97.14.7727; Li W., 2015, NUCLEIC ACIDS RES, V43, pW58, DOI DOI 10.1093/nar/gkv316; Lin ZH, 2011, J BIOL CHEM, V286, P7027, DOI 10.1074/jbc.M110.204537; Lovell SC, 2010, MOL BIOL EVOL, V27, P2567, DOI 10.1093/molbev/msq144; MADISON EL, 1995, J BIOL CHEM, V270, P7558, DOI 10.1074/jbc.270.13.7558; Medynski D, 2007, PROTEIN EXPRES PURIF, V52, P395, DOI 10.1016/j.pep.2006.10.012; MILES LA, 1983, THROMB RES, V29, P407, DOI 10.1016/0049-3848(83)90244-X; Petersen HH, 2001, EUR J BIOCHEM, V268, P4430, DOI 10.1046/j.1432-1327.2001.02365.x; ROBBINS KC, 1967, J BIOL CHEM, V242, P2333; ROBBINS KC, 1973, J BIOL CHEM, V248, P7242; Simonetti FL, 2013, NUCLEIC ACIDS RES, V41, pW8, DOI 10.1093/nar/gkt427; SPRAGGON G, 1995, STRUCTURE, V3, P681, DOI 10.1016/S0969-2126(01)00203-9; STEIN P, 1991, J MOL BIOL, V221, P615, DOI 10.1016/0022-2836(91)80076-7; Tom R, 2008, COLD SPRING HARB PRO, V2008, P1, DOI DOI 10.1101/PDB.PR0T4977	40	2	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3794	3805		10.1074/jbc.RA118.005419	http://dx.doi.org/10.1074/jbc.RA118.005419			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30651349	hybrid, Green Published			2022-12-26	WOS:000461853900039
J	Takaya, A; Takeda, H; Tashiro, S; Kawashima, H; Yamamoto, T				Takaya, Akiko; Takeda, Hikari; Tashiro, Shogo; Kawashima, Hiroto; Yamamoto, Tomoko			Chaperone-mediated secretion switching from early to middle substrates in the type III secretion system encoded by Salmonella pathogenicity island 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; type III secretion system (T3SS); protein secretion; protein assembly; protein folding; Salmonella enterica; virulence factor; effector protein; protein secretion switching; Salmonella pathogenicity island 2; SsaE; SsaH	NEEDLE PROTEIN YSCF; ESCHERICHIA-COLI; COMPLEX; LENGTH; SPECIFICITY; IDENTIFICATION; VIRULENCE; EXPORT; GENES; TYPHIMURIUM	The bacterial type III secretion system (T3SS) delivers virulence proteins, called effectors, into eukaryotic cells. T3SS comprises a transmembrane secretion apparatus and a complex network of specialized chaperones that target protein substrates to this secretion apparatus. However, the regulation of secretion switching from early (needle and inner rod) to middle (tip/filament and translocators) substrates is incompletely understood. Here, we investigated chaperone-mediated secretion switching from early to middle substrates in the T3SS encoded by Salmonella pathogenicity island 2 (SPI2), essential for systemic infection. Our findings revealed that the protein encoded by ssaH regulates the secretion of an inner rod and early substrate, SsaI. Structural modeling revealed that SsaH is structurally similar to class III chaperones, known to associate with proteins in various pathogenic bacteria. The SPI2 protein SsaE was identified as a class V chaperone homolog and partner of SsaH. A pulldown analysis disclosed that SsaH and SsaE form a heterodimer, which interacted with another early substrate, the needle protein SsaG. Moreover, SsaE also helped stabilize SsaH and a middle substrate, SseB. We also found that SsaE regulates cellular SsaH levels to translocate the early substrates SsaG and SsaI and then promotes the translocation of SseB by stabilizing it. In summary, our results indicate that the class III chaperone SsaH facilitates SsaI secretion, and a heterodimer of SsaH and the type V chaperone SsaE then switches secretion to SsaG. This is the first report of a chaperone system that regulates both early and middle substrates during substrate switching for T3SS assembly.	[Takaya, Akiko; Takeda, Hikari; Tashiro, Shogo; Kawashima, Hiroto] Chiba Univ, Grad Sch Pharmaceut Sci, Lab Microbiol & Immunol, Chiba 2608675, Japan; [Yamamoto, Tomoko] Chiba Univ, Med Mycol Res Ctr, Chiba 2608673, Japan	Chiba University; Chiba University	Takaya, A (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Lab Microbiol & Immunol, Chiba 2608675, Japan.	akiko@faculty.chiba-u.jp	Takaya, Akiko/H-2769-2017	Takaya, Akiko/0000-0003-1726-7150	Japan Society for the Promotion of Science (JSPS) KAKENHI Grants [16K15272, 18K07102]; Institute for Global Prominent Research, Chiba University	Japan Society for the Promotion of Science (JSPS) KAKENHI Grants; Institute for Global Prominent Research, Chiba University	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants 16K15272 and 18K07102 (to A. T.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Institute for Global Prominent Research, Chiba University.	Agrain C, 2005, MOL MICROBIOL, V57, P1415, DOI 10.1111/j.1365-2958.2005.04758.x; Agrain C, 2005, MOL MICROBIOL, V56, P54, DOI 10.1111/j.1365-2958.2005.04534.x; Allison SE, 2014, J BIOL CHEM, V289, P23734, DOI 10.1074/jbc.M114.578476; Bergeron JRC, 2016, J BIOL CHEM, V291, P1676, DOI 10.1074/jbc.M115.684423; Betts HJ, 2008, J BACTERIOL, V190, P1680, DOI 10.1128/JB.01671-07; Beuzon CR, 1999, MOL MICROBIOL, V33, P806, DOI 10.1046/j.1365-2958.1999.01527.x; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Cao SY, 2017, J BIOL CHEM, V292, P5488, DOI 10.1074/jbc.M116.743591; Chatterjee C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019208; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Darboe N, 2006, PROTEIN SCI, V15, P543, DOI 10.1110/ps.051733506; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Day JB, 2000, INFECT IMMUN, V68, P6466, DOI 10.1128/IAI.68.11.6466-6471.2000; Deng WY, 2017, NAT REV MICROBIOL, V15, P323, DOI 10.1038/nrmicro.2017.20; Diepold A, 2011, MOL MICROBIOL, V82, P502, DOI 10.1111/j.1365-2958.2011.07830.x; Diepold A, 2010, EMBO J, V29, P1928, DOI 10.1038/emboj.2010.84; Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Feria JVM, 2015, MBIO, V6, DOI 10.1128/mBio.01459-15; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; GAMER J, 1992, CELL, V69, P833, DOI 10.1016/0092-8674(92)90294-M; GULIG PA, 1987, INFECT IMMUN, V55, P2891, DOI 10.1128/IAI.55.12.2891-2901.1987; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Ho O, 2017, J BIOL CHEM, V292, P3299, DOI 10.1074/jbc.M116.770255; Izore T, 2011, STRUCTURE, V19, P603, DOI 10.1016/j.str.2011.03.015; Jennings E, 2017, CELL HOST MICROBE, V22, P217, DOI 10.1016/j.chom.2017.07.009; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; Klein JR, 2001, INFECT IMMUN, V69, P737, DOI 10.1128/IAI.69.2.737-743.2001; Kuhle V, 2004, CELL MOL LIFE SCI, V61, P2812, DOI 10.1007/s00018-004-4248-z; Lara-Tejero M, 2011, SCIENCE, V331, P1188, DOI 10.1126/science.1201476; Lefebre MD, 2014, P NATL ACAD SCI USA, V111, P817, DOI 10.1073/pnas.1319698111; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; Miki T, 2009, J BACTERIOL, V191, P6843, DOI 10.1128/JB.00863-09; Feria JM, 2012, J BACTERIOL, V194, P6029, DOI 10.1128/JB.01215-12; Nikolaus T, 2001, J BACTERIOL, V183, P6036, DOI 10.1128/JB.183.20.6036-6045.2001; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Phan J, 2005, PROTEIN SCI, V14, P2759, DOI 10.1110/ps.051706105; Portaliou AG, 2016, TRENDS BIOCHEM SCI, V41, P175, DOI 10.1016/j.tibs.2015.09.005; Quinaud M, 2005, J BIOL CHEM, V280, P36293, DOI 10.1074/jbc.M508089200; Quinaud M, 2007, P NATL ACAD SCI USA, V104, P7803, DOI 10.1073/pnas.0610098104; Sal-Man N, 2013, J BACTERIOL, V195, P2481, DOI 10.1128/JB.00118-13; Souza CD, 2018, MICROBIOL-SGM, V164, P338, DOI 10.1099/mic.0.000610; Srikumar S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005262; Sukhan A, 2003, J BACTERIOL, V185, P3480, DOI 10.1128/JB.185.11.3480-3483.2003; Sukhan A, 2001, J BACTERIOL, V183, P1159, DOI 10.1128/JB.183.4.1159-1167.2001; Sun P, 2008, J MOL BIOL, V377, P819, DOI 10.1016/j.jmb.2007.12.067; Tan YW, 2008, PROTEIN SCI, V17, P1748, DOI 10.1110/ps.036798.108; Wagner S, 2010, P NATL ACAD SCI USA, V107, P17745, DOI 10.1073/pnas.1008053107; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wilharm G, 2007, INT J MED MICROBIOL, V297, P27, DOI 10.1016/j.ijmm.2006.10.003; Wood SE, 2008, J BACTERIOL, V190, P4252, DOI 10.1128/JB.00328-08; Yoshida Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094347; Yu XJ, 2010, SCIENCE, V328, P1040, DOI 10.1126/science.1189000	53	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3783	3793		10.1074/jbc.RA118.005072	http://dx.doi.org/10.1074/jbc.RA118.005072			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30651351	Green Published, hybrid			2022-12-26	WOS:000461853900038
J	Shen, K; Valenstein, ML; Gu, X; Sabatini, DM				Shen, Kuang; Valenstein, Max L.; Gu, Xin; Sabatini, David M.			Arg-78 of Nprl2 catalyzes GATOR1-stimulated GTP hydrolysis by the Rag GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mTOR complex (mTORC); GATOR1 (GTPase-activating protein (GAP) activity toward Rags-1); Rag GTPase; GTPase activating protein (GAP); enzyme mechanism; amino acid; arginine finger; Nprl2 (NPR2-like GATOR1 complex subunit); nutrient sensing	BINDING PROTEINS; CELL-GROWTH; RHEB; EPILEPSY; COMPLEX	mTOR complex 1 (mTORC1) is a major regulator of cell growth and proliferation that coordinates nutrient inputs with anabolic and catabolic processes. Amino acid signals are transmitted to mTORC1 through the Rag GTPases, which directly recruit mTORC1 onto the lysosomal surface, its site of activation. The Rag GTPase heterodimer has a unique architecture that consists of two GTPase subunits, RagA or RagB bound to RagC or RagD. Their nucleotide-loading states are strictly controlled by several lysosomal or cytosolic protein complexes that directly detect and transmit the amino acid signals. GATOR1 (GTPase-activating protein (GAP) activity toward Rags-1), a negative regulator of the cytosolic branch of the nutrient-sensing pathway, comprises three subunits, Depdc5 (DEP domain-containing protein 5), Nprl2 (NPR2-like GATOR1 complex subunit), and Nprl3 (NPR3-like GATOR1 complex subunit), and is a GAP for RagA. GATOR1 binds the Rag GTPases via two modes: an inhibitory mode that holds the Rag GTPase heterodimer and has previously been captured by structural determination, and a GAP mode that stimulates GTP hydrolysis by RagA but remains structurally elusive. Here, using site-directed mutagenesis, GTP hydrolysis assays, coimmunoprecipitation experiments, and structural analysis, we probed the GAP mode and found that a critical residue on Nprl2, Arg-78, is the arginine finger that carries out GATOR1's GAP function. Substitutions of this arginine residue rendered mTORC1 signaling insensitive to amino acid starvation and are found frequently in cancers such as glioblastoma. Our results reveal the biochemical bases of mTORC1 inactivation through the GATOR1 complex.	[Shen, Kuang; Valenstein, Max L.; Gu, Xin] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Shen, Kuang; Valenstein, Max L.; Gu, Xin; Sabatini, David M.] MIT, Dept Biol, 455 Main St, Cambridge, MA 02142 USA; [Shen, Kuang; Valenstein, Max L.; Gu, Xin] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Shen, Kuang; Valenstein, Max L.; Gu, Xin] Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Shen, Kuang; Valenstein, Max L.; Gu, Xin] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA; [Sabatini, David M.] Howard Hughes Med Inst, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute	Sabatini, DM (corresponding author), MIT, Dept Biol, 455 Main St, Cambridge, MA 02142 USA.; Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 455 Main St, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu		Valenstein, Max/0000-0001-7616-0148	National Institutes of Health [R01 CA103866, R01 CA129105, R37 AI047389]; Department of Defense [W81XWH-15-1-0230]; Lustgarten Foundation; National Institutes of Health Fellowship [F30 CA228229, T32 GM007753]; Ludwig Center for Molecular Oncology; Life Sciences Research Foundation; NATIONAL CANCER INSTITUTE [R01CA103866, F30CA228229, R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Lustgarten Foundation; National Institutes of Health Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Center for Molecular Oncology; Life Sciences Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 CA103866, R01 CA129105, and R37 AI047389, Department of Defense Grant W81XWH-15-1-0230, and the Lustgarten Foundation (to D. M. S.); National Institutes of Health Fellowship Grants F30 CA228229 and T32 GM007753 (to M. L. V.); a fellowship from the Ludwig Center for Molecular Oncology (to X. G.); and a fellowship from the Life Sciences Research Foundation (to K. S.), where he is a Pfizer Fellow. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Baldassari S, 2019, GENET MED, V21, P398, DOI 10.1038/s41436-018-0060-2; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Baulac S, 2015, ANN NEUROL, V77, P675, DOI 10.1002/ana.24368; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Hirose E, 1998, J CELL SCI, V111, P11; Mossmann D, 2018, NAT REV CANCER, V18, P744, DOI 10.1038/s41568-018-0074-8; Nakashima N, 1996, J CELL SCI, V109, P2311; Panchaud N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004112; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; SCHURMANN A, 1995, J BIOL CHEM, V270, P28982, DOI 10.1074/jbc.270.48.28982; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Shen K, 2018, P NATL ACAD SCI USA, V115, P9545, DOI 10.1073/pnas.1811727115; Shen K, 2018, NATURE, V556, P64, DOI 10.1038/nature26158; Shen K, 2017, MOL CELL, V68, P552, DOI 10.1016/j.molcel.2017.09.026; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Yuskaitis CJ, 2018, NEUROBIOL DIS, V111, P91, DOI 10.1016/j.nbd.2017.12.010; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	23	35	36	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2970	2975		10.1074/jbc.AC119.007382	http://dx.doi.org/10.1074/jbc.AC119.007382			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30651352	hybrid, Green Published			2022-12-26	WOS:000459601600035
J	Endersid, C; Lang, GE; Dreyhaupt, J; Loidl, M; Lang, GK; Werner, JU				Enders, Christian; Lang, Gabriele E.; Dreyhaupt, Jens; Loidl, Max; Lang, Gerhard K.; Werner, Jens U.			Quantity and quality of image artifacts in optical coherence tomography angiography	PLOS ONE			English	Article								Objective To analyze quality and frequency of OCTA artifacts and to evaluate their impact on the interpretability of OCTA images. Design 75 patients with diabetic retinopathy (DR), retinal artery occlusion (RAO), retinal vein occlusion (RVO), or neovascular age-related macular degeneration (nAMD) and healthy controls were enrolled in this cross-sectional study in the outpatient department of a tertiary eye care center. Methods All participants underwent an OCTA examination (spectral domain OCT Cirrus 5000 equipped with the AngioPlex module). OCTA scans were analyzed independently by two experienced ophthalmologists. Frequency of various artifacts for the entire OCTA scan and for different segmentation layers and the grading of OCTA interpretability were investigated. Results The analysis of 75 eyes of 38 women and 37 men between 24 and 94 years were included. Six eyes had no retinal disease, 19 eyes had nAMD, 16 had DR, 19 eyes had RVO, and 15 eyes showed RAO. A macular edema (ME) was present in 40 of the diseased eyes. Projection artifacts occurred in all eyes in any structure below the superficial retinal vessel layer, segmentation and motion artifacts were found in 55% (41/75) and 49% (37/75) of eyes, respectively. Other artifacts occurred less frequently. Segmentation artifacts were significantly more frequent in diseased than in healthy eyes (p< 0.01). Qualitative assessment of OCTA images was graded as excellent in 65% and sufficient in 25% of cases, adding up to 91% images deemed acceptable for examination. Presence of ME was associated with a significantly poorer interpretability (p< 0.01). Conclusion and relevance Various artifacts appear at different frequencies in OCTA images. Nevertheless, a qualitative assessment of the OCTA images is almost always possible. Good knowledge of possible artifacts and critical analysis of the complete OCTA dataset are essential for correct clinical interpretation and determining a precise clinical diagnosis.	[Enders, Christian; Lang, Gabriele E.; Loidl, Max; Lang, Gerhard K.; Werner, Jens U.] Ulm Univ, Dept Ophthalmol, Ulm, Germany; [Dreyhaupt, Jens] Ulm Univ, Inst Epidemiol & Med Biometry, Ulm, Germany	Ulm University; Ulm University	Endersid, C (corresponding author), Ulm Univ, Dept Ophthalmol, Ulm, Germany.	christian.enders@uniklinik-ulm.de		Enders, Christian/0000-0003-3922-3765	Carl Zeiss Meditec AG, Jena, Germany	Carl Zeiss Meditec AG, Jena, Germany	The authors CE, GEL, ML, GKL and JUW received financial support from Carl Zeiss Meditec AG, Jena, Germany. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen L, 2018, GRAEF ARCH CLIN EXP, V256, P2283, DOI 10.1007/s00417-018-4138-y; de Carlo Talisa E, 2015, Int J Retina Vitreous, V1, P5; Falavarjani KG, 2016, RETINA-J RET VIT DIS, V36, pS168, DOI 10.1097/IAE.0000000000001259; Lang GE, 2016, KLIN MONATSBL AUGENH, V233, P613, DOI 10.1055/s-0042-105325; Lang GE, 2017, KLIN MONATSBL AUGENH, V234, P1109, DOI 10.1055/s-0043-112857; Patel RC, 2018, OPHTHALMOL RETINA, V2, P816, DOI 10.1016/j.oret.2017.11.010; Say EAT, 2017, RETINA-J RET VIT DIS, V37, P1660, DOI 10.1097/IAE.0000000000001414; Spaide RF, 2015, RETINA-J RET VIT DIS, V35, P2163, DOI 10.1097/IAE.0000000000000765; Yu SS, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0277-2; Zhang AQ, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.10.100901; Zhang QQ, 2017, OPHTHALMOL RETINA, V1, P124, DOI 10.1016/j.oret.2016.08.005	11	39	40	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210505	10.1371/journal.pone.0210505	http://dx.doi.org/10.1371/journal.pone.0210505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682050	Green Published, gold, Green Submitted			2022-12-26	WOS:000457037500041
J	Rodriguez, P; Ochoa-Ochoa, LM; Munguia, M; Sanchez-Cordero, V; Navarro-Siguenza, AG; Flores-Villela, OA; Nakamura, M				Rodriguez, Pilar; Ochoa-Ochoa, Leticia M.; Munguia, Mariana; Sanchez-Cordero, Victor; Navarro-Siguenza, Adolfo G.; Flores-Villela, Oscar A.; Nakamura, Miguel			Environmental heterogeneity explains coarse-scale beta-diversity of terrestrial vertebrates in Mexico	PLOS ONE			English	Article							GLOBAL PATTERNS; TURNOVER; CLIMATE; DISTRIBUTIONS; COMPONENTS; RICHNESS; RANGE	We explored the hypothesis that high beta-diversity of terrestrial vertebrates of Mexico is associated with a high environmental heterogeneity (HEH) and identify the drivers of beta-diversity at different spatial scales. We used distribution range maps of 2,513 species of amphibians, reptiles, mammals, and birds occurring in Mexico. We estimated beta-diversity for each taxon at four spatial scales (grid cells of 2 degrees, 1 degrees,0.5 degrees and 0.25 degrees) using the multiplicative formula of Whittaker beta(w). For each spatial scale, we derived 10 variables of environmental heterogeneity among cells based on raw data of temperature, precipitation, elevation, vegetation and soil. We applied conditional autoregressive models (CAR) to identify the drivers of beta-diversity for each taxon at each spatial scale. CARs increased in explanatory power from fine-to-coarse spatial scales in amphibians, reptiles and mammals. The heterogeneity in precipitation including both, coefficient of variation (CV) and range of values (ROV), resulted in the most important drivers of beta-diversity of amphibians; the heterogeneity in temperature (CV) and elevation (ROV) were the most important drivers of beta-diversity for reptiles; the heterogeneity in temperature (ROV) resulted in the most important driver in beta-diversity for mammals. For birds, CARs resulted significant at fine scales (grid cells of 0.5 degrees and 0.25 degrees), and the precipitation (ROV and CV), temperature (ROV), and vegetation (H) and soil (H) were heterogeneity variables retained in the model. We found support for the hypothesis of environmental heterogeneity (HEH) for terrestrial vertebrates at coarse scales (grid cell of 2 degrees). Different variables of heterogeneity, mainly abiotic, were significant for each taxon, reflecting physiological differences among terrestrial vertebrate groups. Our study revealed the importance of mountain areas in the geographic patterns of beta-diversity of terrestrial vertebrates in Mexico. At a coarse scale, specific variables of heterogeneity can be used as a proxy of beta-diversity for amphibians and reptiles.	[Rodriguez, Pilar; Munguia, Mariana] Comis Nacl Conocimiento & Uso Biodiversidad, Mexico City, DF, Mexico; [Ochoa-Ochoa, Leticia M.; Navarro-Siguenza, Adolfo G.; Flores-Villela, Oscar A.] Univ Nacl Autonoma Mexico, Fac Ciencias, Museo Zool, Mexico City, DF, Mexico; [Sanchez-Cordero, Victor] Univ Nacl Autonoma Mexico, Inst Biol, Mexico City, DF, Mexico; [Nakamura, Miguel] Asociac Ci, Ctr Invest Matemat, Guanajuato, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; CIMAT - Centro de Investigacion en Matematicas	Ochoa-Ochoa, LM (corresponding author), Univ Nacl Autonoma Mexico, Fac Ciencias, Museo Zool, Mexico City, DF, Mexico.	leticia.ochoa@ciencias.unam.mx	Ochoa-Ochoa, Leticia/C-5849-2015	Ochoa-Ochoa, Leticia/0000-0002-9846-4596	DGAPA-UNAM Posdoctoral fellowship	DGAPA-UNAM Posdoctoral fellowship	DGAPA-UNAM Posdoctoral fellowship to LMO-O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Arita H. T, 1993, CIENCIAS, V7, P13; Arita HT, 1997, BIODIVERS CONSERV, V6, P787, DOI 10.1023/B:BIOC.0000010402.08813.ab; Arita HT, 2002, ECOGRAPHY, V25, P541, DOI 10.1034/j.1600-0587.2002.250504.x; Arita HT, 1997, CONSERV BIOL, V11, P92, DOI 10.1046/j.1523-1739.1997.95274.x; Barton PS, 2013, GLOBAL ECOL BIOGEOGR, V22, P639, DOI 10.1111/geb.12031; Baselga A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032341; Baselga A, 2010, ECOLOGY, V91, P1974, DOI 10.1890/09-0320.1; Bivand R. S., 2013, APPL SPATIAL DATA AN, V10, P1, DOI DOI 10.1007/978-0-387-78171-6; Bivand R, 2013, GEOGR ANAL, V45, P150, DOI 10.1111/gean.12008; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; Calderon-Patron JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082905; Ceballos G., 2002, MAMMALS MEXICO COMPO, P28; Dobrovolski R, 2012, GLOBAL ECOL BIOGEOGR, V21, P191, DOI 10.1111/j.1466-8238.2011.00671.x; Flores-Villela O, 2014, REV MEX BIODIVERS, V85, pS467, DOI 10.7550/rmb.43236; Gaston KJ, 2007, P ROY SOC B-BIOL SCI, V274, P1567, DOI 10.1098/rspb.2007.0236; Gaston KJ, 2007, SCALING BIODIVERSITY, DOI [10.1017/cbo9780511814938.012, DOI 10.1017/CBO9780511814938.012, 10.1017/CBO9780511814938.012]; Harrison S., 1993, BIOTIC INTERACTIONS; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Koleff P., 2008, CAPITAL NATURAL ME X; Leprieur F, 2011, ECOL LETT, V14, P325, DOI 10.1111/j.1461-0248.2011.01589.x; Lira-Noriega A, 2007, DIVERS DISTRIB, V13, P185, DOI 10.1111/j.1472-4642.2006.00304.x; Lopez-Gonzalez C, 2015, ECOGRAPHY, V38, P261, DOI 10.1111/ecog.00813; Martin B, 2015, ACTA OECOL, V68, P1, DOI 10.1016/j.actao.2015.06.006; Mazel F, 2017, GLOBAL ECOL BIOGEOGR, V26, P1211, DOI 10.1111/geb.12632; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; Melo AS, 2009, ECOGRAPHY, V32, P226, DOI 10.1111/j.1600-0587.2008.05502.x; Munguia M, 2008, J BIOGEOGR, V35, P1879, DOI 10.1111/j.1365-2699.2008.01921.x; Myers JA, 2013, ECOL LETT, V16, P151, DOI 10.1111/ele.12021; Navarro S. Adolfo G., 2003, Bulletin of the British Ornithologists' Club, V123A, P207; Ochoa-Ochoa LM, 2014, REV MEX BIODIVERS, V85, P918, DOI 10.7550/rmb.38737; Ochoa-Ochoa LM, 2014, BIOL J LINN SOC, V111, P305, DOI 10.1111/bij.12201; Ochoa-Ochoa LM., 2006, AREAS DIVERSIDAD END; Ortega J, 1998, J MAMMAL, V79, P772, DOI 10.2307/1383088; Parra-Olea G, 2014, REV MEX BIODIVERS, V85, pS460, DOI 10.7550/rmb.32027; Penone C, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1028; R Core Team, 2013, R LANG ENV STAT COMP; SAKIA RM, 1992, J ROY STAT SOC D-STA, V41, P169, DOI 10.2307/2348250; Soininen J, 2007, ECOLOGY, V88, P2830, DOI 10.1890/06-1730.1; Stein A, 2015, BIOL REV, V90, P815, DOI 10.1111/brv.12135; Vitt L.J., 2013, HERPETOLOGY INTRO BI, DOI [10.1016/C2010-0-67152-5, DOI 10.1016/C2010-0-67152-5]; Waller LA, 2004, WILEY SERIES PROBABI, DOI [10.1198/jasa.2005.s15, DOI 10.1198/JASA.2005.S15]; WHITTAKER RH, 1960, ECOL MONOGR, V30, P280, DOI 10.2307/1943563	44	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210890	10.1371/journal.pone.0210890	http://dx.doi.org/10.1371/journal.pone.0210890			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682061	Green Submitted, Green Published, gold			2022-12-26	WOS:000457037500073
J	Aldoghachi, AF; Tor, YS; Redzun, SZ; Bin Lokman, KA; Razaq, NAA; Shahbudin, AF; Badamasi, IM; Cheah, PS; Stanslas, J; Veerakumarasivam, A; Rosli, R; Ibrahim, N; Lye, MS; Ling, KH				Aldoghachi, Asraa Faris; Tor, Yin Sim; Redzun, Siti Zubaidah; Bin Lokman, Khairul Aiman; Razaq, Nurul Asyikin Abdul; Shahbudin, Aishah Farhana; Badamasi, Ibrahim Mohamed; Cheah, Pike-See; Stanslas, Johnson; Veerakumarasivam, Abhi; Rosli, Rozita; Ibrahim, Normala; Lye, Munn Sann; Ling, King-Hwa			Screening of brain-derived neurotrophic factor (BDNF) single nucleotide polymorphisms and plasma BDNF levels among Malaysian major depressive disorder patients	PLOS ONE			English	Article							ACTIVITY-DEPENDENT SECRETION; VAL66MET POLYMORPHISM; FACTOR GENE; HIGH-FAT; SERUM; PLASTICITY; ASSOCIATION; INCREASES; VARIANTS; RELEASE	Background Brain-derived neurotrophic factor (BDNF) is a neurotrophin found in abundance in brain regions such as the hippocampus, cortex, cerebellum and basal forebrain. It has been associated with the risk of susceptibility to major depressive disorder (MDD). This study aimed to determine the association of three BDNF variants (rs6265, rs1048218 and rs1048220) with Malaysian MDD patients. Methods The correlation of these variants to the plasma BDNF level among Malaysian MDD patients was assessed. A total of 300 cases and 300 matched controls recruited from four public hospitals within the Klang Valley of Selangor State, Malaysia and matched for age, sex and ethnicity were screened for BDNF rs6265, rs1048218 and rs1048220 using high resolution melting (HRM). Findings BDNF rs1048218 and BDNF rs1048220 were monomorphic and were excluded from further analysis. The distribution of the alleles and genotypes for BDNF rs6265 was in Hardy-Weinberg equilibrium for the controls (p = 0.13) but was in Hardy Weinberg disequilibrium for the cases (p = 0.011). Findings from this study indicated that having BDNF rs6265 in the Malaysian population increase the odds of developing MDD by 2.05 folds (95% CI = 1.48-3.65). Plasma from 206 cases and 206 controls were randomly selected to measure the BDNF level using enzyme-linked immunosorbent assay (ELISA). A significant decrease in the plasma BDNF level of the cases as compared to controls (p<0.0001) was observed. However, there was no evidence of the effect of the rs6265 genotypes on the BDNF level indicating a possible role of other factors in modulating the BDNF level that warrants further investigation. Conclusion The study indicated that having the BDNF rs6265 allele (A) increase the risk of developing MDD in the Malaysian population suggesting a possible role of BDNF in the etiology of the disorder.	[Aldoghachi, Asraa Faris; Rosli, Rozita; Ling, King-Hwa] Univ Putra Malaysia, Dept Biomed Sci, Serdang, Selangor, Malaysia; [Tor, Yin Sim; Bin Lokman, Khairul Aiman; Shahbudin, Aishah Farhana; Lye, Munn Sann] Univ Putra Malaysia, Dept Community Hlth, Serdang, Selangor, Malaysia; [Redzun, Siti Zubaidah; Razaq, Nurul Asyikin Abdul; Ibrahim, Normala] Univ Putra Malaysia, Dept Psychiat, Serdang, Selangor, Malaysia; [Badamasi, Ibrahim Mohamed; Stanslas, Johnson] Univ Putra Malaysia, Dept Med, Serdang, Selangor, Malaysia; [Cheah, Pike-See] Univ Putra Malaysia, Dept Human Anat, Serdang, Selangor, Malaysia; [Veerakumarasivam, Abhi] Sunway Univ, Dept Biol Sci, Sch Sci & Technol, Subang Jaya, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Sunway University	Ling, KH (corresponding author), Univ Putra Malaysia, Dept Biomed Sci, Serdang, Selangor, Malaysia.	lkh@upm.edu.my	Badamasi, Ibrahim/AAQ-6025-2021; sim, tor yin/M-6258-2017; Ling, King-Hwa/M-2349-2018; Stanslas, Johnson/E-8266-2011; Cheah, Pike-See/F-4978-2014; Veerakumarasivam, Abhi/AAX-3876-2020	Badamasi, Ibrahim/0000-0002-6747-4468; sim, tor yin/0000-0002-4354-1486; Ling, King-Hwa/0000-0002-3968-7263; Stanslas, Johnson/0000-0002-6938-954X; Veerakumarasivam, Abhi/0000-0002-2676-1815; Cheah, Pike See/0000-0003-2181-2502; ibrahim, normala/0000-0003-2868-9834; Shahbudin, Aishah Farhana/0000-0002-8206-212X	Universiti Putra Malaysia internal funding, Geran Putra IPB (Interdisciplinary) [GP-IPB/2013/9415701]	Universiti Putra Malaysia internal funding, Geran Putra IPB (Interdisciplinary)	The study was supported by Universiti Putra Malaysia internal funding, Geran Putra IPB (Interdisciplinary) (GP-IPB/2013/9415701) awarded to KHL and NI. There was no additional external funding received for this study.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Aydemir C, 2006, PROG NEURO-PSYCHOPH, V30, P1256, DOI 10.1016/j.pnpbp.2006.03.025; Banerjee R, 2013, CLIN MED INSIGHTS PA; Bocchio-Chiavetto L, 2010, WORLD J BIOL PSYCHIA, V11, P763, DOI 10.3109/15622971003611319; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309; Cardoso TD, 2014, NEUROCHEM RES, V39, P1571, DOI 10.1007/s11064-014-1349-4; Chagnon YC, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00230; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Chen Zhe-Yu, 2008, Novartis Found Symp, V289, P180; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Choi MJ, 2006, BRAIN RES, V1118, P176, DOI 10.1016/j.brainres.2006.08.012; Cole J, 2011, GENES BRAIN BEHAV, V10, P756, DOI 10.1111/j.1601-183X.2011.00714.x; Colle R, 2017, NEUROPSYCHOBIOLOGY, V75, P39, DOI 10.1159/000478862; Cozza A, 2008, J ALZHEIMERS DIS, V15, P61; Dotta-Panichi RM, 2015, REV BRAS PSIQUIATR, V37, P113, DOI 10.1590/1516-4446-2014-1421; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Faris A, 2018, MALAYSIAN J MED HLTH, V14, P64; Frodl T, 2007, ARCH GEN PSYCHIAT, V64, P410, DOI 10.1001/archpsyc.64.4.410; Goekint M, 2008, MED SCI SPORT EXER, V40, P1990, DOI 10.1249/MSS.0b013e31817eee85; Gottmann K, 2009, EXP BRAIN RES, V199, P203, DOI 10.1007/s00221-009-1994-z; Guilloux JP, 2012, MOL PSYCHIATR, V17, P1130, DOI 10.1038/mp.2011.113; Henderson CE, 1996, CURR OPIN NEUROBIOL, V6, P64, DOI 10.1016/S0959-4388(96)80010-9; Hobara T, 2010, J PSYCHIATR RES, V44, P263, DOI 10.1016/j.jpsychires.2009.08.015; Hong CJ, 2003, NEUROPSYCHOBIOLOGY, V48, P186, DOI 10.1159/000074636; Hou Y, 2010, NEUROPHARMACOLOGY, V58, P911, DOI 10.1016/j.neuropharm.2009.11.002; Huang R, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.044883; Hwang JP, 2006, NEUROBIOL AGING, V27, P1834, DOI 10.1016/j.neurobiolaging.2005.10.013; Iga JI, 2007, AM J MED GENET B, V144B, P1003, DOI 10.1002/ajmg.b.30520; Institute for Public Health (IPH), 2015, NAT HLTH MORB SURV 2, VII, DOI DOI 10.1017/CBO9781107415324.004; Jin P, 2015, J ALLERGY CLIN IMMUN, V135, P1486, DOI 10.1016/j.jaci.2014.12.1870; Karege F, 2002, NEUROSCI LETT, V328, P261, DOI 10.1016/S0304-3940(02)00529-3; Karege F, 2005, BIOL PSYCHIAT, V57, P1068, DOI 10.1016/j.biopsych.2005.01.008; Klein AB, 2011, INT J NEUROPSYCHOPH, V14, P347, DOI 10.1017/S1461145710000738; Koshimizu H, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-27; Lang UE, 2013, CELL PHYSIOL BIOCHEM, V31, P761, DOI 10.1159/000350094; Lee BH, 2007, J AFFECT DISORDERS, V101, P239, DOI 10.1016/j.jad.2006.11.005; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Lopizzo N, 2015, FRONT PSYCHIATRY, V6, DOI [10.3389/fpsyt.2015.0068, 10.3389/fpsyt.2015.00068]; Molteni R, 2004, NEUROSCIENCE, V123, P429, DOI 10.1016/j.neuroscience.2003.09.020; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Oswald P, 2005, EUR NEUROPSYCHOPHARM, V15, P491, DOI 10.1016/j.euroneuro.2005.01.001; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; Piccinni A, 2008, J AFFECT DISORDERS, V105, P279, DOI 10.1016/j.jad.2007.05.005; Polacchini A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17989; Ribeiro L, 2007, NEUROREPORT, V18, P1291, DOI 10.1097/WNR.0b013e328273bcb0; Schumacher J, 2005, BIOL PSYCHIAT, V58, P307, DOI 10.1016/j.biopsych.2005.04.006; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Surtees PG, 2007, J PSYCHIATR RES, V41, P404, DOI 10.1016/j.jpsychires.2006.01.004; Suwa M, 2006, METABOLISM, V55, P852, DOI 10.1016/j.metabol.2006.02.012; Tripp A, 2012, AM J PSYCHIAT, V169, P1194, DOI 10.1176/appi.ajp.2012.12020248; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Watanabe K, 2010, PROG NEURO-PSYCHOPH, V34, P1450, DOI 10.1016/j.pnpbp.2010.07.036; World Health Organization, 2017, DEPRESSION OTHER COM; Yoshida T, 2012, OPEN CLIN CHEM J, V5, P70, DOI [10.1016/j.jpsychires.2009.08.015, DOI 10.1016/J.JPSYCHIRES.2009.08.015]; Zoladz JA, 2008, J PHYSIOL PHARMACOL, V59, P119	57	19	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211241	10.1371/journal.pone.0211241	http://dx.doi.org/10.1371/journal.pone.0211241			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677092	Green Published, Green Submitted, gold			2022-12-26	WOS:000456700400065
J	Kojima, K; Nakamura, T; Ooizumi, Y; Igarashi, K; Tanaka, T; Yokoi, K; Ishii, S; Nishizawa, N; Katoh, H; Kosaka, Y; Sato, T; Watanabe, M; Yamashita, K				Kojima, Keita; Nakamura, Takatoshi; Ooizumi, Yosuke; Igarashi, Kazuharu; Tanaka, Toshimichi; Yokoi, Keigo; Ishii, Satoru; Nishizawa, Nobuyuki; Katoh, Hiroshi; Kosaka, Yoshimasa; Sato, Takeo; Watanabe, Masahiko; Yamashita, Keishi			Clinical significance of cancer specific methylation of the CDO1 gene in small bowel cancer	PLOS ONE			English	Article							ABERRANT DNA METHYLATION; CYSTEINE DIOXYGENASE; UNITED-STATES; ADENOCARCINOMAS; HYPERMETHYLATION; EPIDEMIOLOGY; CARCINOMA; SURVIVAL; MUTATION; RISK	Although small bowel cancer (SBC) is extremely rare, its prognosis is poor, and molecular mechanism of the SBC development remains unclear. The aim of our study is to elucidate whether DNA methylation of the promoter region of the cancer-specific methylation gene, cysteine dioxygenase 1 (CDO1), contributes to the carcinogenic process in SBC. The study group comprised patients with 53 patients with SBC, 107 colorectal cancer (CRC), and other rare tumors of the small intestine such as 4 malignant lymphomas, 2 leiomyosarcomas, and 9 gastrointestinal stromal tumors. We analyzed the extent of methylation in each tissue using quantitative TaqMan methylation-specific PCR for CDO1. Significantly higher CDO1 methylation was observed in cancer tissues compared with non-cancerous mucosa of the small intestine (ROC = 0.96). Among the various clinicopathological factors, positive correlation of CDO1 methylation with tumor diameter was observed (R = 0.31, p = 0.03), and the CDO1 methylation level was a possible prognostic factor for relapse-free survival (p = 0.09). Compared with CRC, SBC had a significantly poorer prognosis (p = 0.007) and displayed a significantly higher CDO1 methylation level (p < 0.0001). Intriguingly, especially in pStage I/II, there were robust prognostic difference between SBC and CRC (p = 0.08 / p < 0.0001), which may reflect CDO1 methylation status (p = 0.02 /p = 0.001). Among small bowel tumors, CDO1 methylation in SBC was higher in order of malignant lymphoma, cancer, and leiomyosarcoma/GIST (p = 0.002) by ANOVA. The CDO1 gene shows extremely cancer-specific hypermethylation, and it can be a prognostic marker in SBC.	[Kojima, Keita; Nakamura, Takatoshi; Ooizumi, Yosuke; Igarashi, Kazuharu; Tanaka, Toshimichi; Yokoi, Keigo; Ishii, Satoru; Nishizawa, Nobuyuki; Katoh, Hiroshi; Kosaka, Yoshimasa; Sato, Takeo; Watanabe, Masahiko; Yamashita, Keishi] Kitasato Univ, Sch Med, Dept Surg, Sagamihara, Kanagawa, Japan; [Yamashita, Keishi] Ctr New Med Frontiers, Div Adv Surg Oncol, Dept Res & Dev, Sagamihara, Kanagawa, Japan	Kitasato University	Yamashita, K (corresponding author), Kitasato Univ, Sch Med, Dept Surg, Sagamihara, Kanagawa, Japan.; Yamashita, K (corresponding author), Ctr New Med Frontiers, Div Adv Surg Oncol, Dept Res & Dev, Sagamihara, Kanagawa, Japan.	keishi23@med.kitasato-u.ac.jp			Parents' Association Grant of Kitasato University, School of Medicine	Parents' Association Grant of Kitasato University, School of Medicine	This work was supported by the Parents' Association Grant of Kitasato University, School of Medicine to KK.	Alvi MA, 2015, ONCOTARGET, V6, P20863, DOI 10.18632/oncotarget.4576; Arai M, 1997, INT J CANCER, V70, P390, DOI 10.1002/(SICI)1097-0215(19970207)70:4<390::AID-IJC3>3.0.CO;2-R; Bilimoria KY, 2009, ANN SURG, V249, P63, DOI 10.1097/SLA.0b013e31818e4641; Blokzijl F, 2016, NATURE, V538, P260, DOI 10.1038/nature19768; Boardman LA, 1998, ANN INTERN MED, V128, P896, DOI 10.7326/0003-4819-128-11-199806010-00004; Brait M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044951; Brucher BLDM, 2006, INT J CANCER, V119, P1298, DOI 10.1002/ijc.21990; DeSesso JM, 2001, FOOD CHEM TOXICOL, V39, P209, DOI 10.1016/S0278-6915(00)00136-8; Diosdado B, 2010, CLIN CANCER RES, V16, P1391, DOI 10.1158/1078-0432.CCR-09-1773; Friedman S, 2006, GASTROENTEROL CLIN N, V35, P621, DOI 10.1016/j.gtc.2006.07.008; FROST DB, 1994, ANN SURG ONCOL, V1, P290, DOI 10.1007/BF02303567; Fu T, 2012, CLIN CANCER RES, V18, P4743, DOI 10.1158/1078-0432.CCR-12-0707; Giardiello FM, 2000, GASTROENTEROLOGY, V119, P1447, DOI 10.1053/gast.2000.20228; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Haselkorn T, 2005, CANCER CAUSE CONTROL, V16, P781, DOI 10.1007/s10552-005-3635-6; Igarashi K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188178; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Joseph CA, 2007, CHEM COMMUN, P3338, DOI 10.1039/b702158e; Kojima K, 2017, Dis Esophagus, V30, P1, DOI 10.1093/dote/dow001; Kojima K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194785; KONISHI F, 1987, DIS COLON RECTUM, V30, P790, DOI 10.1007/BF02554629; Kwon J, 2015, TUMOR BIOL, V36, P7449, DOI 10.1007/s13277-015-3443-x; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; Minatani N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144862; Nishiyama KI, 2002, ONCOL REP, V9, P293; Overman Michael J, 2013, Am Soc Clin Oncol Educ Book, P189, DOI 10.1200/EdBook_AM.2013.33.189; PERZIN KH, 1981, CANCER, V48, P799, DOI 10.1002/1097-0142(19810801)48:3<799::AID-CNCR2820480324>3.0.CO;2-Q; Prabhu A, 2014, CANCER RES, V74, P787, DOI 10.1158/0008-5472.CAN-13-1423; Ren PT, 2012, INTERNAL MED, V51, P877, DOI 10.2169/internalmedicine.51.6999; Schottenfeld D, 2009, ANN EPIDEMIOL, V19, P58, DOI 10.1016/j.annepidem.2008.10.004; Stipanuk MH, 2009, AMINO ACIDS, V37, P55, DOI 10.1007/s00726-008-0202-y; Ushijima T, 2010, CANCER SCI, V101, P300, DOI 10.1111/j.1349-7006.2009.01434.x; Ushiku H, 2017, GASTRIC CANCER, V20, P784, DOI 10.1007/s10120-017-0697-6; Ushiku Hideki, 2017, Dis Esophagus, V30, P1, DOI 10.1111/dote.12496; Warth A, 2011, MODERN PATHOL, V24, P564, DOI 10.1038/modpathol.2010.223; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Yamashita K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113546; Young JI, 2016, DIS COLON RECTUM, V59, P306, DOI 10.1097/DCR.0000000000000562	38	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211108	10.1371/journal.pone.0211108	http://dx.doi.org/10.1371/journal.pone.0211108			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677088	Green Published, gold, Green Submitted			2022-12-26	WOS:000456700400049
J	Yamada, T; Tatsumi, N; Anraku, A; Suzuki, H; Kamejima, S; Uchiyama, T; Ohkido, I; Yokoo, T; Okabe, M				Yamada, Taku; Tatsumi, Norifumi; Anraku, Akane; Suzuki, Hideaki; Kamejima, Sahoko; Uchiyama, Taketo; Ohkido, Ichiro; Yokoo, Takashi; Okabe, Masataka			Gcm2 regulates the maintenance of parathyroid cells in adult mice	PLOS ONE			English	Article							CALCIUM-SENSING RECEPTOR; THYMUS ORGANOGENESIS; GENE-EXPRESSION; HORMONE GENE; HYPERPARATHYROIDISM; DIFFERENTIATION; MISSING-2; MAFB	Glial cells missing homolog 2 (GCM2), a zinc finger-type transcription factor, is essential for the development of parathyroid glands. It is considered to be a master regulator because the glands do not form when Gcm2 is deficient. Remarkably, Gcm2 expression is maintained throughout the fetal stage and after birth. Considering the Gcm2 function in embryonic stages, it is predicted that Gcm2 maintains parathyroid cell differentiation and survival in adults. However, there is a lack of research regarding the function of Gcm2 in adulthood. Therefore, we analyzed Gcm2 function in adult tamoxifen-inducible Gcm2 conditional knockout mice. One month after tamoxifen injection, Gcm2-knockout mice showed no significant difference in serum calcium, phosphate, and PTH levels and in the expressions of calcium-sensing receptor (Casr) and parathyroid hormone (Pth), whereas Ki-67 positive cells were decreased and terminal deoxynucleotidyl transferase (TdT) dUTP Nick-End Labeling (TUNEL) positive cell number did not change, as compared with those of controls. Seven months after tamoxifen injection, Gcm2-knockout mice showed shrinkage of the parathyroid glands and fewer parathyroid cells. A significant decrease was noted in Casr- and Pth-expressing cells and serum PTH and Ca levels, whereas serum phosphate levels increased, as compared with those of controls. All our results concluded that a reduction of Gcm2 expression leads to a reduction of parathyroid cell proliferation, an increase in cell death, and an attenuation of parathyroid function. Therefore, we indicate that Gcm2 plays a prominent role in adult parathyroid cell proliferation and maintenance.	[Yamada, Taku; Kamejima, Sahoko; Uchiyama, Taketo; Ohkido, Ichiro; Yokoo, Takashi] Jikei Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Tokyo, Japan; [Yamada, Taku; Tatsumi, Norifumi; Anraku, Akane; Suzuki, Hideaki; Kamejima, Sahoko; Okabe, Masataka] Jikei Univ, Sch Med, Dept Anat, Tokyo, Japan	Jikei University; Jikei University	Okabe, M (corresponding author), Jikei Univ, Sch Med, Dept Anat, Tokyo, Japan.	maokabe@jikei.ac.jp		Tatsumi, Norifumi/0000-0001-6640-150X; Okabe, Masataka/0000-0002-8618-6859	Kidney Foundation, Japan [JKFB15-34]; Japan Society for the Promotion of Science (JSPS KAKENHI) [JP21370098]; JSPS KAKENHI [JP21370098]	Kidney Foundation, Japan(Kidney Foundation, Japan); Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Taku Yamada received an award from The Kidney Foundation, Japan (JKFB15-34 T.Y.), URL: http://www.jinzouzaidan.or.jp/, and Masataka Okabe received grant JP21370098 M.O. from the Japan Society for the Promotion of Science (JSPS KAKENHI). The sponsors played no role in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; FLP mice were kindly gifted by Prof. Kenji Sakimura and Rie Natsume (Niigata University, Japan). We thank Takumi Kimura, Shizuka Ohki, and Miyoko Takazawa for providing technical support. We thank Prof. Tsutomu Miyake for advice on composition of English. This work was supported by The Kidney Foundation, Japan (JKFB15-34 T.Y.) and JSPS KAKENHI (JP21370098 M.O.).	Canaff L, 2002, J BIOL CHEM, V277, P30337, DOI 10.1074/jbc.M201804200; Canaff L, 2009, HUM MUTAT, V30, P85, DOI 10.1002/humu.20827; Chang WH, 2004, CELL CALCIUM, V35, P183, DOI 10.1016/j.ceca.2003.10.012; Chen H., 2013, OPEN ANATOMY J, V5, P1, DOI [10.2174/1877609401305010001, DOI 10.2174/1877609401305010001]; Chen RA, 2004, AM J PHYSIOL-RENAL, V286, pF1005, DOI 10.1152/ajprenal.00013.2004; Chojnowski JL, 2014, DEVELOPMENT, V141, P3697, DOI 10.1242/dev.110833; D'Agruma L, 2014, J CLIN ENDOCR METAB, V99, pE2794, DOI 10.1210/jc.2014-2857; Gordon J, 2001, MECH DEVELOP, V103, P141, DOI 10.1016/S0925-4773(01)00333-1; Guan B, 2016, AM J HUM GENET, V99, P1034, DOI 10.1016/j.ajhg.2016.08.018; Gunther T, 2000, NATURE, V406, P199, DOI 10.1038/35018111; Han S, 2015, MOL CELL ENDOCRINOL, V411, P113, DOI 10.1016/j.mce.2015.04.018; Hendy GN, 2013, BEST PRACT RES CL EN, V27, P285, DOI 10.1016/j.beem.2013.02.009; Hitoshi S, 2011, NAT NEUROSCI, V14, P957, DOI 10.1038/nn.2875; Kamitani-Kawamoto A, 2011, J BONE MINER RES, V26, P2463, DOI 10.1002/jbmr.458; Kawahara M, 2010, BONE, V47, P534, DOI 10.1016/j.bone.2010.05.031; Kebebew E, 2004, SURGERY, V136, P1261, DOI 10.1016/j.surg.2004.06.056; Kim JS, 1998, P NATL ACAD SCI USA, V95, P12364, DOI 10.1073/pnas.95.21.12364; Liu ZJ, 2007, DEV BIOL, V305, P333, DOI 10.1016/j.ydbio.2007.02.014; Manley NR, 2000, SEMIN IMMUNOL, V12, P421, DOI 10.1006/smim.2000.0263; Manley NR, 2003, CURR OPIN IMMUNOL, V15, P225, DOI 10.1016/S0952-7915(03)00006-2; Mizobuchi M, 2009, J BONE MINER RES, V24, P1173, DOI [10.1359/JBMR.090211, 10.1359/jbmr.090211]; Moore-Scott BA, 2005, DEV BIOL, V278, P323, DOI 10.1016/j.ydbio.2004.10.027; Morito N, 2018, KIDNEY INT, V93, P54, DOI 10.1016/j.kint.2017.06.023; Okabe M, 2004, P NATL ACAD SCI USA, V101, P17716, DOI 10.1073/pnas.0406116101; Ritter CS, 2012, J CLIN ENDOCR METAB, V97, pE1499, DOI 10.1210/jc.2011-3366; Stephen AE, 2004, SURGERY, V136, P1143, DOI 10.1016/j.surg.2004.06.042; Su DM, 2001, DEV BIOL, V236, P316, DOI 10.1006/dbio.2001.0342; Tatsumi N, 2016, SCI REP-UK, V6, DOI 10.1038/srep30580; Yuan ZQ, 2014, TRANSGENIC RES, V23, P631, DOI 10.1007/s11248-014-9799-7	29	16	19	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210662	10.1371/journal.pone.0210662	http://dx.doi.org/10.1371/journal.pone.0210662			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677043	Green Published, Green Submitted, gold			2022-12-26	WOS:000456700400023
J	Olagaray, KE; Brouk, MJ; Mamedova, LK; Sivinski, SE; Liu, H; Robert, F; Dupuis, E; Zachut, M; Bradford, J				Olagaray, K. E.; Brouk, M. J.; Mamedova, L. K.; Sivinski, S. E.; Liu, H.; Robert, F.; Dupuis, E.; Zachut, M.; Bradford, J.			Dietary supplementation of Scutellaria baicalensis extract during early lactation decreases milk somatic cells and increases whole lactation milk yield in dairy cattle	PLOS ONE			English	Article							COWS; PERFORMANCE; INFLAMMATION; INDICATORS; QUERCETIN; BIOAVAILABILITY; BAICALIN; STRESS; GLUCOSE-6-PHOSPHATE; LIPOPOLYSACCHARIDE	Systemic inflammation is common in early lactation dairy cows and is associated with decreased milk production. The Scutellaria baicalensis plant contains flavonoids with anti-inflammatory and anti-oxidative properties, which may counteract the inflammatory state in early lactation dairy cows. The objective of this experiment was to determine whether Scutellaria baicalensis extract (SBE), a source of bioactive flavonoids, would alter the adaptation to lactation. Multiparous Holstein cows (n = 122) were used in a randomized block design to determine the effect of short-term and long-term postpartum administration of SBE on 305-d milk yield, 120-d milk component yield, and early lactation milk markers of inflammation and metabolic function. Treatments were 1) control, 2) short term (5-d) administration of the SBE (SBE5), and 3) long term (60-d) administration of the SBE (SBE60). Treatments were included in a treatment pellet that was identical to a control pellet in ingredient source and composition except for the extract (10 g/d SBE providing 3.3 g/d of the flavonoid baicalin), both provided via an automated milking system beginning on d 1 of lactation. Milk samples were collected on d 1, 3, and once during d 5-12 of lactation, followed by weekly sampling until 120 days in milk (DIM). Milk samples collected in the first 2 wk were used for biomarker analysis (haptoglobin, P-hydroxybutyrate [BHB], and glucose-6-phosphate [G6P]), and all samples were used for composition analysis. Cows were body condition scored every 2 wk prepartum and postpartum. Milk production, programmed pellet allocation, and actual provision of both pelleted feeds were recorded daily. Treatment effects were evaluated by contrasts between control and SBE5 and control and SBE60 for both the treatment (TP; wk 1-9) and carryover periods (CP; wk 10-37). Total pellet offered was greater for SBE60 in both the TP (P < 0.01) and CP (P = 0.02) but was not different for SBE5 during either period (P >= 0.13). No treatment effects were observed for body condition score (BCS), milk haptoglobin, BHB, or G6P. SBE5 did not alter milk yield or milk components. SBE60 increased whole-lactation milk yield by 1,419 kg (13%; P=0.03). SBE60 increased milk lactose and fat yields (P <= 0.04) and tended to increase milk protein yield (P=0.09) during TP, and each increased during CP (P <= 0.04). Somatic cell count decreased by 10% in SBE60 during TP (P=0.02) but not CP (P=0.13). Mastitis incidence tended to differ by treatment, being lesser for both SBE5 and SBE60 vs. control (14 and 15% vs. 33%). SBE supplementation did not impact time to pregnancy or hazard of leaving the herd. In conclusion, despite no detected treatment effects on BCS or milk biomarkers of inflammation and metabolic status, supplementation of postpartum dairy cows with Scutellaria baicalensis extract for 60 d was effective at increasing whole lactation milk yield.	[Olagaray, K. E.; Brouk, M. J.; Mamedova, L. K.; Sivinski, S. E.; Liu, H.; Bradford, J.] Kansas State Univ, Dept Anim Sci & Ind, Manhattan, KS 66506 USA; [Robert, F.; Dupuis, E.] CCPA Grp, Janze, France; [Zachut, M.] Agr Res Org, Volcani Ctr, Rishon Leziyyon, Israel	Kansas State University; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Bradford, J (corresponding author), Kansas State Univ, Dept Anim Sci & Ind, Manhattan, KS 66506 USA.	bbradfor@ksu.edu	Bradford, Barry/B-7870-2010	Bradford, Barry/0000-0002-6775-4961; Mamedova, Laman/0000-0003-3612-0381	CCPA Group (Janze, France)	CCPA Group (Janze, France)	Contribution no. 18-364-J from the Kansas Agricultural Experiment Station. This work was funded in part by CCPA Group (Janze, France). The funder provided support in the form of salaries for authors FR and EDP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Balcells J, 2012, J ANIM SCI, V90, P4975, DOI 10.2527/jas.2011-4955; Ballou MA, 2013, FLOR RUM NUTR S, P50; Bauman DE, 2003, ANNU REV NUTR, V23, P203, DOI 10.1146/annurev.nutr.23.011702.073408; Berger LM, 2012, J DAIRY SCI, V95, P5047, DOI 10.3168/jds.2012-5439; Bertoni G, 2008, J DAIRY SCI, V91, P3300, DOI 10.3168/jds.2008-0995; Besle JM, 2010, J DAIRY SCI, V93, P2846, DOI 10.3168/jds.2009-2939; Bjerre-Harpoth V, 2016, J DAIRY RES, V83, P156, DOI 10.1017/S0022029916000145; Bradford BJ, 2015, J DAIRY SCI, V98, P6631, DOI 10.3168/jds.2015-9683; Carpenter AJ, 2016, J DAIRY SCI, V99, P672, DOI 10.3168/jds.2015-10048; Cermak R, 2003, J NUTR, V133, P2802, DOI 10.1093/jn/133.9.2802; De Nardi R, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0653-4; Dematawewa CMB, 1997, J DAIRY SCI, V80, P754, DOI 10.3168/jds.S0022-0302(97)75995-2; Drackley JK, 1999, J DAIRY SCI, V82, P2259, DOI 10.3168/jds.S0022-0302(99)75474-3; Enjalbert F, 2001, J DAIRY SCI, V84, P583, DOI 10.3168/jds.S0022-0302(01)74511-0; Farney JK, 2013, AM J PHYSIOL-REG I, V305, pR110, DOI 10.1152/ajpregu.00152.2013; Ferruzzi MG, 2006, FOOD CHEM, V99, P484, DOI 10.1016/j.foodchem.2005.08.010; FOX LK, 1985, J DAIRY SCI, V68, P2100, DOI 10.3168/jds.S0022-0302(85)81074-2; Gao J, 2008, J PHARM PHARM SCI, V11, P77; Garavaglia L, 2015, NEW ZEAL VET J, V63, P313, DOI 10.1080/00480169.2015.1047911; Gessner DK, 2017, J ANIM PHYSIOL AN N, V101, P605, DOI 10.1111/jpn.12579; Gessner DK, 2015, J DAIRY SCI, V98, P8856, DOI 10.3168/jds.2015-9478; Gohlke A, 2013, J DAIRY SCI, V96, P2303, DOI 10.3168/jds.2012-6234; HARMON RJ, 1994, J DAIRY SCI, V77, P2103, DOI 10.3168/jds.S0022-0302(94)77153-8; He X, 2015, INT IMMUNOPHARMACOL, V28, P470, DOI DOI 10.1016/J.INTIMP.2015.07.012; Hiss S, 2004, J DAIRY SCI, V87, P3778, DOI 10.3168/jds.S0022-0302(04)73516-X; Hiss S, 2009, J DAIRY SCI, V92, P4439, DOI 10.3168/jds.2008-1632; Huzzey JM, 2015, PREV VET MED, V120, P291, DOI 10.1016/j.prevetmed.2015.04.011; Klein MS, 2010, J DAIRY SCI, V93, P1539, DOI 10.3168/jds.2009-2563; Lai MY, 2003, J PHARM PHARMACOL, V55, P205, DOI 10.1211/002235702522; Larsen T, 2015, ANIMAL, V9, P86, DOI 10.1017/S1751731114002043; Li CR, 2011, BIOPHARM DRUG DISPOS, V32, P427, DOI 10.1002/bdd.771; Li-Weber M, 2009, CANCER TREAT REV, V35, P57, DOI 10.1016/j.ctrv.2008.09.005; Lin M, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-19; Liu LL, 2008, BIOCHEM PHARMACOL, V75, P914, DOI 10.1016/j.bcp.2007.10.009; McCarthy MM, 2016, J DAIRY SCI, V99, P680, DOI 10.3168/jds.2015-9694; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; Robert F, 2014, 5 ANN M EAAP COP, P372; Robert F, 2016, United States patent, Patent No. [US 14/ 910,707, 14910707]; Shabtay A, 2012, ANIM FEED SCI TECH, V175, P24, DOI 10.1016/j.anifeedsci.2012.04.004; Silanikove N, 2014, J DAIRY RES, V81, P358, DOI 10.1017/S0022029914000260; Stoldt AK, 2015, J DAIRY SCI, V98, P4509, DOI 10.3168/jds.2014-9053; Tedesco D, 2004, J DAIRY SCI, V87, P2239, DOI 10.3168/jds.S0022-0302(04)70044-2; Thomas FC, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0533-3; Wakabayashi I, 1999, PHARMACOL TOXICOL, V84, P288, DOI 10.1111/j.1600-0773.1999.tb01496.x; Wang Hong-zhi, 2007, Zhongguo Zhong Yao Za Zhi, V32, P1637; Wang QH, 2013, J ETHNOPHARMACOL, V146, P9, DOI 10.1016/j.jep.2012.12.013; WILDMAN EE, 1982, J DAIRY SCI, V65, P495, DOI 10.3168/jds.S0022-0302(82)82223-6; Winkler A, 2015, ARCH ANIM NUTR, V69, P425, DOI 10.1080/1745039X.2015.1093873; Ylioja CM, 2018, J DAIRY SCI, V101, P6066, DOI 10.3168/jds.2017-13991; Zachut M, 2016, RSC ADV, V6, P65412, DOI 10.1039/c6ra11924g	50	9	15	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210744	10.1371/journal.pone.0210744	http://dx.doi.org/10.1371/journal.pone.0210744			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673736	Green Published, Green Submitted, gold			2022-12-26	WOS:000456442800052
J	Kim, JH; Park, EC				Kim, Jae-Hyun; Park, Eun-Cheol			Can diabetes patients seeking a second hospital get better care? Results from nested case-control study	PLOS ONE			English	Article							DOCTOR-SHOPPING BEHAVIOR; HEALTH-CARE; NATIONAL-HEALTH; COMMUNICATION; ASSOCIATION; COMPLICATIONS; CONTINUITY; OUTCOMES; SYSTEM; USERS	This study investigates the effects of the number of medical institutions visited on risk of death. This study conducted a nested case-control design using the National Health Insurance Service-Senior database from 2002 to 2013. Cases were defined as those with death among outpatients who had first diagnosis of diabetes mellitus (E10-E14) after entry into the base cohort and controls were selected by incidence density sampling and matched to cases based on age, and sex. Our main results were presented by conditional logistic regression for nested case-controls design. Of total 55,558 final study samples, there were 9,313 (16.8%) cases and 46,245 (83.2%) controls. With an increase by one point in the number of hospitals per medical utilization, risk of death significantly increased by 4.1% (odds ratio (OR): 1.041, 95% confidence interval [CI]: 1.039-1.043). In both medical utilization and number of hospitals, those with high medical utilization (OR: 1.065, 95% CI: 1.059-1.070) and number of hospitals (OR: 1.049, 95% CI: 1.041-1.058) for risk of death were significantly higher than those with low medical utilization (OR: 1.040, 95% CI: 1.037-1.043) and number of hospitals (OR: 1.029, 95% CI: 1.027-1.032), respectively. The number of medical institution visited was significantly associated with risk of death. Therefore, diabetics should be warned about the potential of risk of death incurred from excessive access to medical utilizations.	[Kim, Jae-Hyun] Dankook Univ, Dept Hlth Adm, Coll Hlth Sci, Cheonan, South Korea; [Kim, Jae-Hyun] Dankook Univ, Inst Hlth Promot & Policy, Cheonan, South Korea; [Park, Eun-Cheol] Yonsei Univ, Inst Hlth Serv Res, Seoul, South Korea; [Park, Eun-Cheol] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea	Dankook University; Dankook University; Yonsei University; Yonsei University; Yonsei University Health System	Park, EC (corresponding author), Yonsei Univ, Inst Hlth Serv Res, Seoul, South Korea.; Park, EC (corresponding author), Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.	ecpark@yuhs.ac	Park, Eun-Cheol/O-5644-2019	Park, Eun-Cheol/0000-0002-2306-5398				Asai A, 1998, BIOETHICS, V12, P162, DOI 10.1111/1467-8519.00102; Chu HY, 2012, MED CARE, V50, P1002, DOI 10.1097/MLR.0b013e31826c870f; DEMERS M, 1995, CAN MED ASSOC J, V153, P37; Fox CS, 2004, JAMA-J AM MED ASSOC, V292, P2495, DOI 10.1001/jama.292.20.2495; GREENE MG, 1994, SOC SCI MED, V38, P1279, DOI 10.1016/0277-9536(94)90191-0; Hagihara A, 2005, J EVAL CLIN PRACT, V11, P556, DOI 10.1111/j.1365-2753.2005.00581.x; Hariman KW, 2013, FEVER PREDICTOR DOCT, V1; Hsieh CI, 2013, PATIENT PREFER ADHER, V7, P693, DOI 10.2147/PPA.S43631; Hsu MH, 2011, INT J MED INFORM, V80, P181, DOI 10.1016/j.ijmedinf.2010.11.003; Kim DJ, 2011, DIABETES METAB J, V35, P303, DOI 10.4093/dmj.2011.35.4.303; Klienschmidt R, 1995, Aust Fam Physician, V24, P1037; Kwon S, 2009, HEALTH POLICY PLANN, V24, P63, DOI 10.1093/heapol/czn037; Lee HK, 2014, IRAN J PUBLIC HEALTH, V43, P6; Lee J, 2016, BOUND VALUE PROBL, DOI 10.1186/s13661-016-0603-x; Lin CC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-318; Lo A Y, 1994, Int J Qual Health Care, V6, P371; Mercer SW, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-46; National Statistical Office, 2014, ANN REP VIT STAT KOR; ONG LML, 1995, SOC SCI MED, V40, P903, DOI 10.1016/0277-9536(94)00155-M; Resnick HE, 2000, DIABETES CARE, V23, P176, DOI 10.2337/diacare.23.2.176; Retnakaran R, 2006, DIABETES, V55, P1832, DOI 10.2337/db05-1620; Richardson DB, 2004, OCCUP ENVIRON MED, V61, DOI 10.1136/oem.2004.014472; SATO T, 1995, GEN HOSP PSYCHIAT, V17, P115, DOI 10.1016/0163-8343(94)00094-T; Schoen C, 2006, HEALTH AFFAIR, V25, pW457, DOI 10.1377/hlthaff.25.w457; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Van Walraven C, 2006, CLIN CHEM, V52, P2219, DOI 10.1373/clinchem.2006.072934; Wang MJ, 2010, HEALTH POLICY, V94, P61, DOI 10.1016/j.healthpol.2009.08.009; Yang JH, 2015, INT J MED INFORM, V84, P912, DOI 10.1016/j.ijmedinf.2015.08.007	28	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210809	10.1371/journal.pone.0210809	http://dx.doi.org/10.1371/journal.pone.0210809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI2WF	30668580	Green Published, Green Submitted, gold			2022-12-26	WOS:000456306400015
J	Nishio, M; Kubo, T; Togashi, K				Nishio, Mizuho; Kubo, Takeshi; Togashi, Kaori			Estimation of lung cancer risk using homology-based emphysema quantification in patients with lung nodules	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; CT; REGIONS	The purpose of this study was to assess whether homology-based emphysema quantification (HEQ) is significantly associated with lung cancer risk. This retrospective study was approved by our institutional review board. We included 576 patients with lung nodules (317 men and 259 women; age, 66.8 +/- 12.3 years), who were selected from a database previously generated for computer-aided diagnosis. Of these, 283 were diagnosed with lung cancer, whereas the remaining 293 showed benign lung nodules. HEQ was performed and percentage of low-attenuation lung area (LAA%) was calculated on the basis of computed tomography scans. Statistical models were constructed to estimate lung cancer risk using logistic regression; sex, age, smoking history (Brinkman index), LAA%, and HEQ were considered independent variables. The following three models were evaluated: the base model (sex, age, and smoking history); the LAA% model (the base model + LAA%); and the HEQ model (the base model + HEQ). Model performance was assessed using receiver operating characteristic analysis and the associated area under the curve (AUC). Differences in AUCs among the models were evaluated using Delong's test. AUCs of the base, LAA%, and HEQ models were 0.585, 0.593, and 0.622, respectively. HEQ coefficient was statistically significant in the HEQ model (P = 0.00487), but LAA% coefficient was not significant in the LAA% model (P = 0.199). Delong's test revealed significant difference in AUCs between the LAA% and HEQ models (P = 0.0455). In conclusion, after adjusting for age, sex, and smoking history (Brinkman index), HEQ was significantly associated with lung cancer risk.	[Nishio, Mizuho; Kubo, Takeshi; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Kyoto, Japan; [Nishio, Mizuho] Kyoto Univ Hosp, Preempt Med & Lifestyle Related Dis Res Ctr, Kyoto, Kyoto, Japan	Kyoto University; Kyoto University	Nishio, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Kyoto, Japan.; Nishio, M (corresponding author), Kyoto Univ Hosp, Preempt Med & Lifestyle Related Dis Res Ctr, Kyoto, Kyoto, Japan.	nmizuho@kuhp.kyoto-u.ac.jp	Nishio, Mizuho/ACC-0897-2022		Japan Society for the Promotion of Science KAKENHI [JP16K19883]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The present study was supported by Japan Society for the Promotion of Science KAKENHI (Grant Number JP16K19883). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Adamek M, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.04.03; AOYAMA G, 2016, MED IMAGING TECHNOL, V34, P267; Gierada DS, 2011, RADIOLOGY, V261, P950, DOI 10.1148/radiol.11110542; Gietema HA, 2011, ACAD RADIOL, V18, P661, DOI 10.1016/j.acra.2011.01.011; Kawagishi M, 2017, INT J COMPUT ASS RAD, V12, P767, DOI 10.1007/s11548-017-1554-0; Mishima M, 1999, P NATL ACAD SCI USA, V96, P8829, DOI 10.1073/pnas.96.16.8829; MULLER NL, 1988, CHEST, V94, P782, DOI 10.1378/chest.94.4.782; Nakagomi K, 2013, MED IMAGE ANAL, V17, P62, DOI 10.1016/j.media.2012.08.002; Nakane K, 2013, DIAGN PATHOL, V8, P1; Nakane K, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0244-x; Nishio M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178217; Nishio M, 2016, INT J CHRONIC OBSTR, V11, P2125, DOI 10.2147/COPD.S110504; Nishio M, 2014, EUR J RADIOL, V83, P2268, DOI 10.1016/j.ejrad.2014.09.011; Sawano T, 2017, NEUROSCIENCE, V346, P43, DOI 10.1016/j.neuroscience.2016.12.052; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Smith BM, 2012, LUNG CANCER, V77, P58, DOI 10.1016/j.lungcan.2012.02.019; Tammemagi MC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001764; ten Haaf K, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002277; Wille MMW, 2016, EUR RADIOL, V26, P487, DOI 10.1007/s00330-015-3826-9; Wilson DO, 2011, J THORAC ONCOL, V6, P1200, DOI 10.1097/JTO.0b013e318219aa93; Zurawska JH, 2012, CHEST, V141, P1147, DOI 10.1378/chest.11-1863	22	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210720	10.1371/journal.pone.0210720	http://dx.doi.org/10.1371/journal.pone.0210720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668605	Green Submitted, Green Published, gold			2022-12-26	WOS:000456306400011
J	Sandford, AJ; Ha, A; Ngan, DA; Akhabir, L; Saferali, A; Fox, N; Allen, AJH; Warby, SC; van Eeden, SF; Ayas, NT				Sandford, Andrew J.; Ha, Amanda; Ngan, David A.; Akhabir, Loubna; Saferali, Aabida; Fox, Nurit; Allen, A. J. Hirsch; Warby, Simon C.; van Eeden, Stephan F.; Ayas, Najib T.			Adhesion molecule gene variants and plasma protein levels in patients with suspected obstructive sleep apnea	PLOS ONE			English	Article							ABO BLOOD-GROUP; FUTURE MYOCARDIAL-INFARCTION; CORONARY-ARTERY DISEASE; VON-WILLEBRAND-FACTOR; E-SELECTIN; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; SOLUBLE FORMS; RISK; ASSOCIATION	Study objectives Untreated obstructive sleep apnea (OSA) patients have an increased risk of cardiovascular disease (CVD). Adhesion molecules, including soluble E-selectin (sE-selectin), intercellular adhesion molecule-1 (ICAM-1), and vascular adhesion molecule-1 (VCAM-1), are associated with incident CVD. We hypothesized that specific genetic variants will be associated with plasma levels of adhesion molecules in suspected OSA patients. We also hypothesized that there may be an interaction between these variants and OSA. Methods We measured levels of sE-selectin, sICAM-1 and sVCAM-1 in 491 patients with suspected OSA and genotyped them for 20 polymorphisms. Results The most significant association was between the ABO rs579459 polymorphism and sE-selectin levels (P = 7x10(-21)), with the major allele T associated with higher levels. The direction of effect and proportion of the variance in sE-selectin levels accounted for by rs579459 (16%) was consistent with estimates from non-OSA cohorts. In a multivariate regression analysis, addition of rs579459 improved the model performance in predicting sE-selectin levels. Three polymorphisms were nominally associated with sICAM-1 levels but none with sVCAM-1 levels. The combination of severe OSA and two rs579459 T alleles identified a group of patients with high sE-selectin levels; however, the increase in sE-selectin levels associated with severe OSA was greater in patients without two T alleles (P = 0.05 test for interaction). Conclusions These genetic polymorphisms may help to identify patients at greatest risk of incident CVD and may help in developing a more precision-based approach to OSA care.	[Sandford, Andrew J.; Ha, Amanda; Ngan, David A.; Akhabir, Loubna; Saferali, Aabida; van Eeden, Stephan F.] St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC, Canada; [Sandford, Andrew J.; Ha, Amanda; Ngan, David A.; Akhabir, Loubna; Saferali, Aabida; van Eeden, Stephan F.; Ayas, Najib T.] Univ British Columbia, Vancouver, BC, Canada; [Fox, Nurit; Allen, A. J. Hirsch; Ayas, Najib T.] Univ British Columbia, UBC Hosp Sleep Disorders Program, Div Resp Med, Vancouver, BC, Canada; [Warby, Simon C.] Hop Sacre Coeur Montreal, Ctr Rech, Ctr Adv Res Sleep Med, Montreal, PQ, Canada; [Warby, Simon C.] Univ Montreal, Dept Psychiat, Montreal, PQ, Canada; [Ayas, Najib T.] Univ British Columbia, Div Crit Care Med, Vancouver, BC, Canada; [Ayas, Najib T.] St Pauls Hosp, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada	St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of British Columbia; Universite de Montreal; Universite de Montreal; University of British Columbia; St. Paul's Hospital; University of Saskatchewan	Sandford, AJ (corresponding author), St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC, Canada.; Sandford, AJ (corresponding author), Univ British Columbia, Vancouver, BC, Canada.	andrew.sandford@hli.ubc.ca			British Columbia Lung Association; CIHR Team grant; Canadian Sleep and Circadian Network	British Columbia Lung Association; CIHR Team grant(Canadian Institutes of Health Research (CIHR)); Canadian Sleep and Circadian Network	This study was supported by funding from the British Columbia Lung Association, a CIHR Team grant, and the Canadian Sleep and Circadian Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the participants in the Sleep Apnea Clinical Research Registry and the excellent technical assistance of Sunny Fung. This study was supported by funding from the British Columbia Lung Association, a CIHR Team grant, and the Canadian Sleep and Circadian Network.	Al Lawati N, 2009, SLEEP BREATH, V13, P391, DOI 10.1007/s11325-009-0259-1; Al Lawati NM, 2009, PROG CARDIOVASC DIS, V51, P285, DOI 10.1016/j.pcad.2008.08.001; Barbalic M, 2010, HUM MOL GENET, V19, P1863, DOI 10.1093/hmg/ddq061; Blann AD, 1996, BRIT J HAEMATOL, V92, P498, DOI 10.1046/j.1365-2141.1996.d01-1486.x; Bowen DJ, 2003, J THROMB HAEMOST, V1, P33, DOI 10.1046/j.1538-7836.2003.00007.x; Bruzelius M, 2014, THROMB RES, V134, P426, DOI 10.1016/j.thromres.2014.03.054; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Dehghan A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144997; Dentali F, 2012, SEMIN THROMB HEMOST, V38, P535, DOI 10.1055/s-0032-1315758; El-Solh AA, 2002, CHEST, V121, P1541, DOI 10.1378/chest.121.5.1541; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Gallinaro L, 2008, BLOOD, V111, P3540, DOI 10.1182/blood-2007-11-122945; Gaunt TR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-428; GEARING AJH, 1992, ANN NY ACAD SCI, V667, P324, DOI 10.1111/j.1749-6632.1992.tb51633.x; Gozal D, 2008, AM J RESP CRIT CARE, V177, P369, DOI 10.1164/rccm.200608-1190PP; Hwang SJ, 1997, CIRCULATION, V96, P4219; Jurado-Gamez B, 2012, INTERNAL MED, V51, P363, DOI 10.2169/internalmedicine.51.6571; Kunutsor SK, 2017, J ATHEROSCLER THROMB, V24, P804, DOI 10.5551/jat.38836; LEEUWENBERG JFM, 1992, IMMUNOLOGY, V77, P543; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; O'Donnell JS, 2005, BLOOD, V106, P1988, DOI 10.1182/blood-2005-02-0792; Otto VI, 2006, GLYCOBIOLOGY, V16, P1033, DOI 10.1093/glycob/cwl032; Pare G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001374; Pare G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000118; Paterson AD, 2009, ARTERIOSCL THROM VAS, V29, P1958, DOI 10.1161/ATVBAHA.109.192971; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Qi L, 2010, HUM MOL GENET, V19, P1856, DOI 10.1093/hmg/ddq057; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Ridker PM, 1998, LANCET, V351, P88, DOI 10.1016/S0140-6736(97)09032-6; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; RIECKMANN P, 1995, J NEUROIMMUNOL, V60, P9, DOI 10.1016/0165-5728(95)00047-6; Ryan S, 2006, AM J RESP CRIT CARE, V174, P824, DOI 10.1164/rccm.200601-066OC; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sode BF, 2013, CAN MED ASSOC J, V185, pE229, DOI 10.1503/cmaj.121636; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705	38	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210732	10.1371/journal.pone.0210732	http://dx.doi.org/10.1371/journal.pone.0210732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653588	Green Submitted, Green Published, gold			2022-12-26	WOS:000456015500064
J	Arroyo, L; Valent, D; Carreras, R; Pena, R; Sabria, J; Velarde, A; Bassols, A				Arroyo, Laura; Valent, Daniel; Carreras, Ricard; Pena, Raquel; Sabria, Josefa; Velarde, Antonio; Bassols, Anna			Housing and road transport modify the brain neurotransmitter systems of pigs: Do pigs raised in different conditions cope differently with unknown environments?	PLOS ONE			English	Article							C-FOS EXPRESSION; MEAT QUALITY; DOPAMINE TRANSPORTER; STRESS INDICATORS; SOCIAL STRESS; ENRICHMENT; RESPONSES; BEHAVIOR; OUTDOOR; PROTEIN	How housing and transport conditions may affect welfare in porcine production is a leading topic in livestock research. This study investigated whether pigs present a different neurological response to management conditions and to ascertain whether pigs living partially outdoors cope differently with road transport-associated stress. Twenty-four female pigs were divided in two groups: one living indoors (ID, n = 12) and the other housed combining indoor conditions with 4 hours per day of outdoor pasture (OD, n = 12). After one month, one set of animals from each housing condition were driven in a truck to the slaughterhouse in low-stress conditions (5 min drive, no mixing groups, soft management, LS group, n = 12) or high-stress conditions (2 hours drive, mixing groups, harsh management, HS group, n = 12). At the slaughterhouse, blood was collected, and the prefrontal cortex (PFC) and the hippocampus (HC) dissected. OD pigs had lower serum haptoglobin and increased dopaminergic pathway (DA-system) in the PFC, suggesting that living outdoors increases their wellbeing. HS conditions increased serum creatine kinase (CK) and affected several brain pathways: activation of the noradrenergic (NA-system) and DA-system in the PFC and the activation of the DA-system and an increase in c-Fos as well as a decrease in brain-derived neurotrophic factor (BDNF) in the HC. The serotonergic system (5-HT-system) was mildly altered in both areas. There was an interaction between housing and transport in serum NA and the DA-system in the HC, indicating that living conditions affected the response to stress. Multivariate analysis was able to discriminate the four animal groups. In conclusion, this work indicates that housing conditions and road transport markedly modifies the neurophysiology of pigs, and suggests that animals raised partially outdoors respond differently to transport-associated stress than animals raised indoors, indicating that they cope differently with unknown environments.	[Arroyo, Laura; Valent, Daniel; Pena, Raquel; Bassols, Anna] Univ Autonoma Barcelona, Fac Vet, Dept Bioquim & Biol Mol, Cerdanyola De Valles, Spain; [Carreras, Ricard; Velarde, Antonio] IRTA, Anim Welf Subprogram, Veinat Sies S-N, Monells, Spain; [Pena, Raquel] Univ Autonoma Barcelona, Fac Vet, Serv Bioquim Clin Vet, Cerdanyola De Valles, Spain; [Sabria, Josefa] Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Inst Neurociencies, Cerdanyola De Valles, Spain	Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona; Autonomous University of Barcelona	Bassols, A (corresponding author), Univ Autonoma Barcelona, Fac Vet, Dept Bioquim & Biol Mol, Cerdanyola De Valles, Spain.	anna.bassols@uab.cat	Velarde, Antonio/L-4466-2014; Bassols, Anna/K-7961-2014; Sabria, Josefa/A-2439-2010	Velarde, Antonio/0000-0002-2634-3138; Bassols, Anna/0000-0003-4213-2274; Sabria, Josefa/0000-0002-1456-4136; Pena, Raquel/0000-0002-7193-9141; Carreras, Ricard/0000-0003-1610-7630	Spanish Ministerio de Economia y Competitividad [AGL2010-21578-C03-01, AGL2011-30598-C03-02]; Generalitat de Catalunya [2014 SGR4]; FEDER program from European Union	Spanish Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); FEDER program from European Union	This study was supported by AGL2010-21578-C03-01, Spanish Ministerio de Economia y Competitividad, to AV; AGL2011-30598-C03-02 from the Spanish Ministerio de Economia y Competitividad, to AB; 2014 SGR4 from the Generalitat de Catalunya to AB; and part of the funding was financed by the FEDER program from the European Union (https://sede.micinn.gob.es; http://agaur.gencat.cat/en/inici/index.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AD, 2014, NEUROBIOL LEARN MEM, V108, P65, DOI 10.1016/j.nlm.2013.11.007; ADEOLA O, 1993, J ANIM SCI, V71, P968, DOI 10.2527/1993.714968x; Arroyo L, 2016, PHYSIOL BEHAV, V167, P374, DOI 10.1016/j.physbeh.2016.10.005; Aumann TD, 2016, J CHEM NEUROANAT, V73, P21, DOI 10.1016/j.jchemneu.2015.12.009; Bangasser DA, 2007, NAT NEUROSCI, V10, P1401, DOI 10.1038/nn1973; Belujon P, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2516; Belujon P, 2011, ANN NY ACAD SCI, V1216, P114, DOI 10.1111/j.1749-6632.2010.05896.x; Blum K, 2012, J PSYCHOACTIVE DRUGS, V44, P134, DOI 10.1080/02791072.2012.685407; CAROLDI S, 1985, BRIT J PHARMACOL, V84, P357, DOI 10.1111/j.1476-5381.1985.tb12920.x; CHAN RKW, 1993, J NEUROSCI, V13, P5126, DOI 10.1523/JNEUROSCI.13-12-05126.1993; Chaouloff F, 1999, NEUROPSYCHOPHARMACOL, V21, pS28, DOI 10.1016/S0893-133X(99)00008-1; Cowansage Kiriana K, 2010, Curr Mol Pharmacol, V3, P12; Darna M, 2015, BRAIN RES, V1599, P115, DOI 10.1016/j.brainres.2014.12.034; de Jong IC, 2000, PHYSIOL BEHAV, V68, P571, DOI 10.1016/S0031-9384(99)00212-7; De Jong IC, 1998, PHYSIOL BEHAV, V64, P303, DOI 10.1016/S0031-9384(98)00066-3; De Vry J, 2012, HORM BEHAV, V62, P10, DOI 10.1016/j.yhbeh.2012.04.019; Douglas AJ, 2005, STRESS, V8, P5, DOI 10.1080/10253890500044380; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Edwards SA, 2005, LIVEST PROD SCI, V94, P5, DOI 10.1016/j.livprodsci.2004.11.028; Enfalt AC, 1997, MEAT SCI, V45, P1, DOI 10.1016/S0309-1740(96)00101-5; Foury A, 2011, ANIMAL, V5, P1620, DOI 10.1017/S1751731111000784; Gade PB, 2008, ANIMAL, V2, P902, DOI 10.1017/S1751731108002000; Galani R, 2007, NEUROBIOL LEARN MEM, V88, P1, DOI 10.1016/j.nlm.2007.03.009; Garrido P, 2013, J NEURAL TRANSM, V120, P829, DOI 10.1007/s00702-012-0935-3; Girbovan C, 2013, BEHAV BRAIN RES, V253, P178, DOI 10.1016/j.bbr.2013.07.018; Grandin T., 1998, ANIMAL WELFARE MEAT; Herring A, 2010, BRAIN PATHOL, V20, P166, DOI 10.1111/j.1750-3639.2008.00257.x; Honeyman MS, 2005, LIVEST PROD SCI, V94, P15, DOI 10.1016/j.livprodsci.2004.11.029; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; IMAKI T, 1995, ENDOCR J, V42, P121, DOI 10.1507/endocrj.42.121; Jain V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062235; Jarvinen MK, 1998, DEV BRAIN RES, V107, P21, DOI 10.1016/S0165-3806(97)00210-1; Kandel E. R., 2013, PRINCIPLES NEURAL SC; Kang DK, 2000, MOL CELLS, V10, P546, DOI 10.1007/s100590000010; Klont RE, 2001, J ANIM SCI, V79, P2835; Kotloski RJ, 2015, EXP NEUROL, V264, P121, DOI 10.1016/j.expneurol.2014.11.012; Kovacs KJ, 1998, NEUROCHEM INT, V33, P287, DOI 10.1016/S0197-0186(98)00023-0; Lebret B, 2015, ANIMAL, V9, P1404, DOI 10.1017/S1751731115000609; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; Joca SRL, 2007, STRESS, V10, P227, DOI 10.1080/10253890701223130; Marchant JN, 1997, APPL ANIM BEHAV SCI, V55, P67, DOI 10.1016/S0168-1591(97)00022-1; Marco-Ramell A, 2011, Vet J, V190, pe66, DOI 10.1016/j.tvjl.2011.01.003; Martinez M, 2002, STRESS, V5, P3, DOI 10.1080/102538902900012369; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; Millet S, 2005, J SCI FOOD AGR, V85, P709, DOI 10.1002/jsfa.2033; Mora F, 2012, BRAIN RES, V1476, P71, DOI 10.1016/j.brainres.2011.12.049; Nikulina EM, 2014, NEUROSCIENCE, V282, P122, DOI 10.1016/j.neuroscience.2014.05.028; Nilzen V, 2001, MEAT SCI, V58, P267, DOI 10.1016/S0309-1740(00)00164-9; Otten W, 2010, DOMEST ANIM ENDOCRIN, V38, P146, DOI 10.1016/j.domaniend.2009.09.002; Pacak K, 2001, ENDOCR REV, V22, P502, DOI 10.1210/er.22.4.502; Pena Y, 2006, BEHAV BRAIN RES, V174, P181, DOI 10.1016/j.bbr.2006.07.007; Pezze MA, 2004, PROG NEUROBIOL, V74, P301, DOI 10.1016/j.pneurobio.2004.09.004; Piekarzewska AB, 2000, J VET MED A, V47, P257, DOI 10.1046/j.1439-0442.2000.00262.x; Pineiro M, 2007, VET J, V173, P669, DOI 10.1016/j.tvjl.2006.02.006; Poletto R, 2010, J ANIM SCI, V88, P3107, DOI 10.2527/jas.2009-1876; Poletto R, 2011, BRAIN RES, V1381, P11, DOI 10.1016/j.brainres.2010.11.035; Rault JL, 2018, DOMEST ANIM ENDOCRIN, V65, P67, DOI 10.1016/j.domaniend.2018.05.007; Revest JM, 2005, NAT NEUROSCI, V8, P664, DOI 10.1038/nn1441; Robinson CE, 1999, ANAL BIOCHEM, V266, P48, DOI 10.1006/abio.1998.2932; Rocha LM, 2016, J ANIM SCI, V94, P359, DOI 10.2527/jas.2015-9176; Rosochacki SJ, 2003, J ANIM BREED GENET, V120, P192, DOI 10.1046/j.1439-0388.2003.00380.x; Rutledge RB, 2015, J NEUROSCI, V35, P9811, DOI 10.1523/JNEUROSCI.0702-15.2015; Sabria J, 2003, ADDICT BIOL, V8, P287, DOI 10.1080/13556210310001602194; Saco Y, 2003, ANIM WELFARE, V12, P403; Salamano G, 2008, VET J, V177, P110, DOI 10.1016/j.tvjl.2007.03.015; Sarinana J, 2014, P NATL ACAD SCI USA, V111, P8245, DOI 10.1073/pnas.1407395111; Shen CP, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-36; Simpson J, 2011, BEHAV BRAIN RES, V222, P246, DOI 10.1016/j.bbr.2011.04.002; Terlouw C, 2009, LIVEST SCI, V122, P199, DOI 10.1016/j.livsci.2008.08.016; Tovote P, 2015, NAT REV NEUROSCI, V16, P317, DOI 10.1038/nrn3945; Tozawa A, 2016, ASIAN AUSTRAL J ANIM, V29, P428, DOI 10.5713/ajas.15.0190; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Valros A, 2015, PHYSIOL BEHAV, V143, P151, DOI 10.1016/j.physbeh.2015.02.049; van de Weerd HA, 2009, APPL ANIM BEHAV SCI, V116, P1, DOI 10.1016/j.applanim.2008.08.001; Vermetten E, 2002, DEPRESS ANXIETY, V15, P126, DOI 10.1002/da.10016; WARRISS PD, 1983, MEAT SCI, V9, P271, DOI 10.1016/0309-1740(83)90037-2; Zhu J, 2005, J NEUROCHEM, V93, P1434, DOI 10.1111/j.1471-4159.2005.03130.x; Zhu J, 2004, BEHAV BRAIN RES, V148, P107, DOI 10.1016/S0166-4328(03)00190-6	78	4	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210406	10.1371/journal.pone.0210406	http://dx.doi.org/10.1371/journal.pone.0210406			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650149	Green Submitted, Green Published, gold			2022-12-26	WOS:000455813300057
J	Brennan, JR; Hale, JT				Brennan, Jonathan R.; Hale, John T.			Hierarchical structure guides rapid linguistic predictions during naturalistic listening	PLOS ONE			English	Article							ANTERIOR NEGATIVITY LAN; BRAIN POTENTIALS; MORPHOSYNTACTIC AGREEMENT; CONTEXT-FREE; LANGUAGE; INFORMATION; SENSITIVITY; INTEGRATION; FMRI	The grammar, or syntax, of human language is typically understood in terms of abstract hierarchical structures. However, theories of language processing that emphasize sequential information, not hierarchy, successfully model diverse phenomena. Recent work probing brain signals has shown mixed evidence for hierarchical information in some tasks. We ask whether sequential or hierarchical information guides the expectations that a human listener forms about a word's part-of-speech when simply listening to every-day language. We compare the predictions of three computational models against electroencephalography signals recorded from human participants who listen passively to an audiobook story. We find that predictions based on hierarchical structure correlate with the human brain response above-and-beyond predictions based only on sequential information. This establishes a link between hierarchical linguistic structure and neural signals that generalizes across the range of syntactic structures found in every-day language.	[Brennan, Jonathan R.] Univ Michigan, Dept Linguist, Ann Arbor, MI 48109 USA; [Hale, John T.] Cornell Univ, Dept Linguist, Ithaca, NY USA; [Hale, John T.] Univ Georgia, Dept Linguist, Athens, GA 30602 USA	University of Michigan System; University of Michigan; Cornell University; University System of Georgia; University of Georgia	Brennan, JR (corresponding author), Univ Michigan, Dept Linguist, Ann Arbor, MI 48109 USA.	jobrenn@umich.edu		Brennan, Jonathan R/0000-0002-3639-350X	National Science Foundation [1607251, 1607441]; NSF [1607251, 1607441]	National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	This work was supported in part by grants from the National Science Foundation (Grant #1607251 to JRB, Grant #1607441 to JTH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank R. L. Lewis for helpful comments on this manuscript. This work was supported by grants from the NSF (Grant #1607251 to JRB, Grant #1607441 to JTH).	Alday PM, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0311-16.2017; Balota DA, 2007, BEHAV RES METHODS, V39, P445, DOI 10.3758/BF03193014; Bever TG, 1970, COGNITION AND THE DE; Blevins T, 2018, PROCEEDINGS OF THE 56TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 2, P14; Bradley DC, 1983, COMPUTATIONAL DISTIN; Brennan JR, 2017, COGNITIVE SCI, V41, P1515, DOI 10.1111/cogs.12445; Brennan JR, 2016, BRAIN LANG, V157, P81, DOI 10.1016/j.bandl.2016.04.008; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Chomsky N., 1965, ASPECTS OF THE THEOR; Christiansen MH, 2016, BEHAV BRAIN SCI, V39, DOI 10.1017/S0140525X1500031X; Dikker S, 2013, BRAIN LANG, V127, P55, DOI 10.1016/j.bandl.2012.08.004; Dikker S, 2010, PSYCHOL SCI, V21, P629, DOI 10.1177/0956797610367751; Dikker S, 2009, COGNITION, V110, P293, DOI 10.1016/j.cognition.2008.09.008; Ding N, 2017, LANG COGN NEUROSCI, V32, P570, DOI 10.1080/23273798.2016.1215477; Ding N, 2016, NAT NEUROSCI, V19, P158, DOI 10.1038/nn.4186; Dyer Chris, 2016, P 2016 C N AM CHAPT, P199, DOI DOI 10.18653/V1/N16-1024; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Ferreira F, 2002, CURR DIR PSYCHOL SCI, V11, P11, DOI 10.1111/1467-8721.00158; Fine AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077661; Frangoulidis S, 2018, TRENDS CLASS SUPPL V, V61, P1, DOI 10.1515/9783110596182-001; Frank R, 2013, LANG ACQUIS, V20, P181, DOI 10.1080/10489223.2013.796950; Frank SL, 2015, BRAIN LANG, V140, P1, DOI 10.1016/j.bandl.2014.10.006; Frank SL, 2013, TOP COGN SCI, V5, P475, DOI 10.1111/tops.12025; Frank SL, 2012, P ROY SOC B-BIOL SCI, V279, P4522, DOI 10.1098/rspb.2012.1741; Frank SL, 2011, PSYCHOL SCI, V22, P829, DOI 10.1177/0956797611409589; FRIEDERICI AD, 1993, COGNITIVE BRAIN RES, V1, P183, DOI 10.1016/0926-6410(93)90026-2; Gers FA, 2001, IEEE T NEURAL NETWOR, V12, P1333, DOI 10.1109/72.963769; Gulordava K, 2018, PROCEEDINGS OF NAACL; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Hale J, 2001, 2ND MEETING OF THE NORTH AMERICAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P159; Hale J, 2018, PROCEEDINGS OF THE 56TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL), VOL 1, P2727; Hale J, 2016, LANG LINGUIST COMPAS, V10, P397, DOI 10.1111/lnc3.12196; Hale JT, 2014, AUTOMATON THEORIES O; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Henderson JM, 2016, NEUROIMAGE, V132, P293, DOI 10.1016/j.neuroimage.2016.02.050; Jelinek F., 1998, STATISTICAL METHODS; Joshi A.K., 1985, NATURAL LANGUAGE PRO, P206, DOI [10.1017/CBO9780511597855.007, DOI 10.1017/CBO9780511597855]; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Klein D, 2003, 41ST ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P423, DOI 10.3115/1075096.1075150; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lau E, 2006, BRAIN LANG, V98, P74, DOI 10.1016/j.bandl.2006.02.003; Levy R, 2008, COGNITION, V106, P1126, DOI 10.1016/j.cognition.2007.05.006; Linzen Tal, 2016, T ASSOC COMPUT LING, V4, P521, DOI DOI 10.1162/TACL_A_00115; Lopopolo A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177794; Luong MT, 2013, TRANSACTIONS OF THE; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Martin AE, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000663; McDonald SA, 2003, PSYCHOL SCI, V14, P648, DOI 10.1046/j.0956-7976.2003.psci_1480.x; Molinaro N, 2015, CORTEX, V66, P156, DOI 10.1016/j.cortex.2014.06.009; Molinaro N, 2011, CORTEX, V47, P908, DOI 10.1016/j.cortex.2011.02.019; Nelson MJ, 2017, P NATL ACAD SCI USA, V114, pE3669, DOI 10.1073/pnas.1701590114; NEVILLE H, 1991, J COGNITIVE NEUROSCI, V3, P151, DOI 10.1162/jocn.1991.3.2.151; Nicenboim B, 2016, LANG LINGUIST COMPAS, V10, P591, DOI 10.1111/lnc3.12207; Nieuwland MS, 2018, ELIFE, V7, DOI 10.7554/eLife.33468; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; PERRIN F, 1987, ELECTROEN CLIN NEURO, V66, P75, DOI 10.1016/0013-4694(87)90141-6; Phillips C, 2006, LANGUAGE, V82, P795, DOI 10.1353/lan.2006.0217; Roark B., 2012, P ACL 2012 SYSTEM DE, P61; Roark Brian, 2009, P 2009 C EMP METH NA, P324, DOI DOI 10.3115/1699510.1699553; Sanford AJ, 2002, TRENDS COGN SCI, V6, P382, DOI 10.1016/S1364-6613(02)01958-7; Smith NJ, 2015, PSYCHOPHYSIOLOGY, V52, P157, DOI 10.1111/psyp.12317; Steinhauer K, 2012, BRAIN LANG, V120, P135, DOI 10.1016/j.bandl.2011.07.001; STOLCKE A, 1995, COMPUT LINGUIST, V21, P165; Sundermeyer M, 2014, PROCEEDINGS OF INTER; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Tanner D, 2015, CORTEX, V66, P149, DOI 10.1016/j.cortex.2014.04.007; Townsend D.J., 2001, SENTENCE COMPREHENSI; Vehtari A, 2017, STAT COMPUT, V27, P1413, DOI 10.1007/s11222-016-9696-4; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x; Willems RM, 2016, CEREB CORTEX, V26, P2506, DOI 10.1093/cercor/bhv075; WILSON WM, 1973, NATURE, V244, P522, DOI 10.1038/244522a0	74	21	22	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0207741	10.1371/journal.pone.0207741	http://dx.doi.org/10.1371/journal.pone.0207741			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650078	Green Submitted, Green Published, gold			2022-12-26	WOS:000455813300005
J	Dickey, J; Perrot, V				Dickey, James; Perrot, Veronique			Adjunct phage treatment enhances the effectiveness of low antibiotic concentration against Staphylococcus aureus biofilms in vitro	PLOS ONE			English	Article							BACTERIOPHAGE THERAPY; PSEUDOMONAS; RESISTANCE; INFECTIONS	Phage therapy is drawing more interest as antibiotic resistance becomes an ever more serious threat to public health. Bacterial biofilms represent a major obstacle in the fight against bacterial infections as they are inherently refractory to many types of antibiotics. Treating biofilms with phage has shown promise in a handful of experimental and case studies. However, quantification of the effect of phage combined with antibiotics is needed to pave the way for larger clinical trials. Here we explore the effect of using phage in combination with a total of nine antibiotics, applied simultaneously or as a pretreatment before antibiotics are applied to in vitro biofilms of Staphylococcus aureus. Most antibiotics alone were ineffective at low concentration (2xMIC), but the addition of phage to treatment regimens led to substantial improvements in efficacy. At high concentration (10xMIC), antibiotics alone were effective, and in most cases the addition of phage to treatment regimens did not improve efficacy. Using phage with rifampin was also very effective at reducing the outgrowth of resistant strains during the course of treatment.	[Dickey, James; Perrot, Veronique] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Dickey, James] Med Coll Georgia, Augusta, GA 30912 USA	Emory University; University System of Georgia; Augusta University	Perrot, V (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	vperrot@emory.edu			NIH-NIGMS grant [GM091875]; Emory College of Arts and Sciences; Emory University School of Medicine; NIH [S10 RR025679]	NIH-NIGMS grant; Emory College of Arts and Sciences; Emory University School of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by NIH-NIGMS grant GM091875. The Robert P. Apkarian Integrated Electron Microscopy Core is subsidized by the Emory College of Arts and Sciences and the Emory University School of Medicine and is one of the Emory Integrated Core Facilities, and the JEOL JEM-1400 120kV TEM is supported by NIH grant S10 RR025679. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon ST, 2015, PHARMACEUTICALS-BASE, V8, P525, DOI 10.3390/ph8030525; Abedon Stephen T, 2011, Bacteriophage, V1, P66; Alemayehu D, 2012, MBIO, V3, DOI 10.1128/mBio.00029-12; [Anonymous], 2015, RSTUDIO INT DEV ENV; Bhattacharya M, 2015, EXPERT REV ANTI-INFE, V13, P1499, DOI 10.1586/14787210.2015.1100533; Biswas B, 2002, INFECT IMMUN, V70, P204, DOI 10.1128/IAI.70.1.204-210.2002; Bull JJ, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-35; Chan BK, 2016, SCI REP-UK, V6, DOI 10.1038/srep26717; Chaudhry WN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168615; Colvin KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001264; d'Herelle F, 1917, CR HEBD ACAD SCI, V165, P373; D'Herelle F., 1926, NATURE, V118, P183, DOI [10.1038/118183a0, DOI 10.1038/118183A0]; Danis-Wlodarczyk K, 2016, SCI REP-UK, V6, DOI 10.1038/srep28115; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; de Kraker MEA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002184; Debarbieux L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnv225; DESRANLEAU J M, 1948, Can J Public Health, V39, P317; Ferreira FA, 2012, J MICROBIOL METH, V88, P393, DOI 10.1016/j.mimet.2012.01.007; Forrest GN, 2010, CLIN MICROBIOL REV, V23, P14, DOI 10.1128/CMR.00034-09; Galtier M, 2016, ENVIRON MICROBIOL, V18, P2237, DOI 10.1111/1462-2920.13284; Gorski A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01515; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Harper DR, 2014, ANTIBIOTICS-BASEL, V3, P270, DOI 10.3390/antibiotics3030270; Hawkins C, 2010, VET MICROBIOL, V146, P309, DOI 10.1016/j.vetmic.2010.05.014; Henein Alexandra, 2013, Bacteriophage, V3, pe24872; Jennes S, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1709-y; Johnson PJT, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003123; Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952; Khan W, 2010, INT MICROBIOL, V13, P207, DOI 10.2436/20.1501.01.127; Kim S, 2012, APPL ENVIRON MICROB, V78, P6380, DOI 10.1128/AEM.00648-12; KNOUF EG, 1946, JAMA-J AM MED ASSOC, V132, P134, DOI 10.1001/jama.1946.02870380016006; Kumaran D, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00127; Kwan T, 2005, P NATL ACAD SCI USA, V102, P5174, DOI 10.1073/pnas.0501140102; LANG G, 1979, REV CHIR ORTHOP, V65, P33; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; ONeill J., 2016, TACKLING DRUG RESIST; Pirnay JP, 2011, PHARM RES-DORDR, V28, P934, DOI 10.1007/s11095-010-0313-5; Rahman M, 2011, BIOFOULING, V27, P1087, DOI 10.1080/08927014.2011.631169; Roach DR, 2017, CELL HOST MICROBE, V22, P38, DOI 10.1016/j.chom.2017.06.018; Rose T, 2014, INT J BURNS TRAUMA, V4, P66; Schooley RT, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00954-17; Shen Y, 2016, ELIFE, V5; SMITH HW, 1982, J GEN MICROBIOL, V128, P307; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Thandar M, 2016, ANTIMICROB AGENTS CH, V60, P2671, DOI 10.1128/AAC.02972-15; Torres-Barcelo C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106628; Twort FW, 1915, LANCET, V2, P1241, DOI 10.1016/s0140-6736(01)20383-3; Verma V, 2010, BIOFOULING, V26, P729, DOI 10.1080/08927014.2010.511196; Waters EM, 2017, THORAX, V72, P666, DOI 10.1136/thoraxjnl-2016-209265	50	57	59	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209390	10.1371/journal.pone.0209390	http://dx.doi.org/10.1371/journal.pone.0209390			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650088	Green Submitted, gold, Green Published			2022-12-26	WOS:000455813300013
J	Levin, AM; Francis, JH; McFadden, M; Brodie, S; Gobin, YP; Abramson, DH				Levin, Ariana M.; Francis, Jasmine H.; McFadden, Molly; Brodie, Scott; Gobin, Y. Pierre; Abramson, David H.			Association of electroretinography with visual outcomes after ophthalmic artery chemosurgery for retinoblastoma in ICRb D and E eyes	PLOS ONE			English	Article							BILATERAL RETINOBLASTOMA; CHEMOREDUCTION; CHEMOTHERAPY	Importance Predictions of visual outcomes are useful in clinical and family decisions regarding treatment for retinoblastoma. Very little has been published on the association of post-treatment visual acuity with pre-treatment electroretinography (ERG), which can be performed on infants too young to reliably quantify visual acuity. Objective To report associations of pre-treatment ERG with post-treatment visual acuity in eyes with advanced retinoblastoma treated with ophthalmic artery chemosurgery (OAC). Design Retrospective case-control study of eyes treated from 2006 through 2017, with mean followup of 51 months (range 2.3-150 months). Setting Single large academic center. Participants Group D and E eyes treated with OAC at Memorial Sloan Kettering Cancer Center with recorded visual acuity and ERG (30Hz flicker). Main outcome and measure Snellen visual acuity (uncorrected) compared to initial 30Hz flicker ERG. Results This study included 157 Group D and E eyes. Results of the Jonckheere-Terpstra test for trend were statistically significant and indicated that eyes with lower pre-treatment ERG readings tended to have more visual impairment post-treatment. Among eyes with initial ERG 75+ mu V, 11 of 32 eyes (34%) had visual acuity 20/40 or better. Among eyes with ERG 0 mu V, 44 of 46 (96%) had visual acuity of 20/200 or worse. Conclusions and relevance Eyes with advanced intraocular retinoblastoma treated with OAC can achieve excellent visual acuity, but poor ERG at initial visit is associated with poor visual acuity after treatment in the majority of eyes. Expectations regarding visual potential may influence decisions about treatment.	[Levin, Ariana M.; Francis, Jasmine H.; Brodie, Scott; Abramson, David H.] Mem Sloan Kettering Canc Ctr, Ophthalm Oncol Serv, 1275 York Ave, New York, NY 10021 USA; [Levin, Ariana M.; McFadden, Molly] Univ Utah, Moran Eye Ctr, Salt Lake City, UT 84112 USA; [Francis, Jasmine H.; Gobin, Y. Pierre; Abramson, David H.] Weill Cornell Med Ctr, New York, NY USA; [Brodie, Scott] NYU, Sch Med, Dept Ophthalmol, New York, NY USA	Memorial Sloan Kettering Cancer Center; Utah System of Higher Education; University of Utah; Cornell University; New York University	Levin, AM (corresponding author), Mem Sloan Kettering Canc Ctr, Ophthalm Oncol Serv, 1275 York Ave, New York, NY 10021 USA.; Levin, AM (corresponding author), Univ Utah, Moran Eye Ctr, Salt Lake City, UT 84112 USA.	ariana.levin@hsc.utah.edu		Francis, Jasmine/0000-0002-7637-3108; Brodie, Scott/0000-0002-3303-4552	Fund For Ophthalmic Knowledge, Inc.; Achievement Rewards for College Scientists Foundation	Fund For Ophthalmic Knowledge, Inc.; Achievement Rewards for College Scientists Foundation(General Electric)	This work was supported by The Fund For Ophthalmic Knowledge, Inc. (N.Y.) and the Achievement Rewards for College Scientists Foundation.	Berry JL, 2014, BRIT J OPHTHALMOL, V98, P1061, DOI 10.1136/bjophthalmol-2013-304411; Berry JL, 2013, PEDIATR BLOOD CANCER, V60, P688, DOI 10.1002/pbc.24303; Brodie SE, 2012, BRIT J OPHTHALMOL, V96, P877, DOI 10.1136/bjophthalmol-2011-301248; Chen QY, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4406-6; Choi SY, 2010, J KOREAN MED SCI, V25, P546, DOI 10.3346/jkms.2010.25.4.546; Fabian ID, 2017, AM J OPHTHALMOL, V179, P137, DOI 10.1016/j.ajo.2017.05.003; Francis JH, 2018, NEOPLASIA, V20, P757, DOI 10.1016/j.neo.2018.05.007; Francis JH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197081; Jung EH, 2018, J PEDIAT HEMATOL ONC, P763, DOI [10.1016/j.neo.2018.05.007, DOI 10.1016/J.NEO.2018.05.007]; Kim Jae Min, 2010, Korean J Ophthalmol, V24, P347, DOI 10.3341/kjo.2010.24.6.347; Rao R, 2018, BRIT J OPHTHALMOL, V102, P490, DOI 10.1136/bjophthalmol-2017-310641; Schefler AC, 2007, OPHTHALMOLOGY, V114, P162, DOI 10.1016/j.ophtha.2006.06.042; Shields CL, 2009, OPHTHALMOLOGY, V116, P544, DOI 10.1016/j.ophtha.2008.10.014; Tsimpida M, 2013, BRIT J OPHTHALMOL, V97, P1464, DOI 10.1136/bjophthalmol-2013-303694	14	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210647	10.1371/journal.pone.0210647	http://dx.doi.org/10.1371/journal.pone.0210647			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650131	Green Submitted, Green Published, gold			2022-12-26	WOS:000455813300067
J	Chen, XY; Zhu, SY; Zhenin, M; Xu, WY; Bose, SJ; Wong, MPF; Leung, GPH; Senderowitz, H; Chen, JH				Chen, Xinying; Zhu, Siyu; Zhenin, Michael; Xu, Weiyi; Bose, Samuel J.; Wong, Molly Pik-Fan; Leung, George P. H.; Senderowitz, Hanoch; Chen, Jeng-Haur			A defective flexible loop contributes to the processing and gating defects of the predominant cystic fibrosis-causing mutation	FASEB JOURNAL			English	Article						CFTR; Delta F508 mutation; chloride channel; low temperature; corrector C18	TRANSMEMBRANE CONDUCTANCE REGULATOR; NUCLEOTIDE-BINDING DOMAIN; SMALL-MOLECULE CORRECTORS; DELTA-F508 CFTR; THERMODYNAMIC STABILITY; CHANNEL FUNCTION; RESCUE; MUTANT; NBD1; PHOSPHORYLATION	People with the genetic disease cystic fibrosis (CF) often carry a deletion mutation Delta F508 on the gene encoding the CF transmembrane conductance regulator (CFTR) Cl- channel. This mutation greatly reduces the CFTR maturation process and slows the channel opening rate. Here, we investigate whether residues near F508 contribute to these defects in Delta F508-CFTR. Most deletion mutations, but not alanine substitutions, of individual residues from positions 503 to 513 impaired CFTR maturation. Interestingly, only protein processing of Delta Y512-CFTR, like that of Delta F508-CFTR, was greatly improved by low-temperature culture at 27 degrees C or small-molecule corrector C18. The 2 mutant Cl- channels were equally slow to open, suggesting that they may share common structural flaws. Studies on the H3-H4 loop that links residues F508 and Y512 demonstrate that G509A/V510G mutations, moving G509 1 position backward in the loop, markedly enhanced Delta F508-CFTR maturation and opening rate while promoting protein stability and persistence of the H3 helix in Delta F508 nucleotide-binding domain 1. Moreover, V510A/S511A mutations noticeably increased Delta Y512-CFTR maturation at 27 degrees C and its opening rate. Thus, loop abnormalities may contribute to Delta F508- and Delta Y512-CFTR defects. Importantly, correcting defects from G509 displacement in Delta F508-CFTR may offer a new avenue for drug discovery and CF treatments.	[Chen, Xinying; Zhu, Siyu; Xu, Weiyi; Wong, Molly Pik-Fan; Chen, Jeng-Haur] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China; [Leung, George P. H.] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Peoples R China; [Chen, Xinying; Zhu, Siyu; Xu, Weiyi; Wong, Molly Pik-Fan; Chen, Jeng-Haur] Univ Hong Kong, Shenzhen Inst Res & Innovat, Shenzhen, Peoples R China; [Zhenin, Michael; Senderowitz, Hanoch] Bar Ilan Univ, Dept Chem, Ramat Gan, Israel; [Bose, Samuel J.] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Bristol, Avon, England	University of Hong Kong; University of Hong Kong; University of Hong Kong; Bar Ilan University; University of Bristol	Chen, JH (corresponding author), Univ Hong Kong, Sch Biomed Sci, Pokfulam, Fac Med Bldg,21 Sassoon Rd, Hong Kong, Peoples R China.	jeng-haur-chen@hku.hk	Chen, Jeng-Haur/E-1483-2011; Leung, George Pak Heng/B-4529-2009	Chen, Jeng-Haur/0000-0001-6756-6939; Leung, George Pak Heng/0000-0003-3529-9367; Bose, Samuel/0000-0003-2922-3075	Hong Kong Research Grants Council [789713M, 17106315]; National Natural Science Foundation of China [31370765, 81570001]; Cystic Fibrosis Foundation Therapeutics [SENDER13XX0]; Binational Science Foundation [2013391]; University of Hong Kong; Lee Shau Kee Postgraduate Fellowship at the University of Hong Kong; Collaborative Awards in Science and Engineering (CASE) studentship from the Medical Research Council [MR/L015919/1]	Hong Kong Research Grants Council(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); Binational Science Foundation(US-Israel Binational Science Foundation); University of Hong Kong(University of Hong Kong); Lee Shau Kee Postgraduate Fellowship at the University of Hong Kong; Collaborative Awards in Science and Engineering (CASE) studentship from the Medical Research Council	The authors thank Prof. Michael J. Welsh (University of Iowa, Iowa City, IA, USA) for generous gifts of WT human CFTR plasmids, Prof. Robert J. Bridges (Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA) and Cystic Fibrosis Foundation Therapeutics for providing the CFTR correctors, and departmental colleagues for valuable discussions. The authors acknowledge S. M. Chan for great assistance with experiments. This work was supported by grants from the Hong Kong Research Grants Council (789713M and 17106315) and National Natural Science Foundation of China (31370765 and 81570001) to J.-H.C. This work was also supported by grants from the Cystic Fibrosis Foundation Therapeutics (SENDER13XX0) and Binational Science Foundation (2013391) to H.S. In addition, X.C., S.Z., and W.X. were recipients of postgraduate scholarships from the University of Hong Kong. W.X. was also a recipient of Lee Shau Kee Postgraduate Fellowship at the University of Hong Kong. S.J.B. was the recipient of a Collaborative Awards in Science and Engineering (CASE) studentship from the Medical Research Council (Grant MR/L015919/1). The authors declare no conflicts of interest.	Aleksandrov AA, 2012, J MOL BIOL, V419, P41, DOI 10.1016/j.jmb.2012.03.001; Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Amaral MD, 2013, CURR PHARM DESIGN, V19, P3497; [Anonymous], 2016, DISC STUD MOD ENV RE; Atwell S, 2010, PROTEIN ENG DES SEL, V23, P375, DOI 10.1093/protein/gzq004; Awatade NT, 2019, J CYST FIBROS, V18, P182, DOI 10.1016/j.jcf.2018.07.001; Bebok Z, 1998, AM J PHYSIOL-CELL PH, V275, pC599, DOI 10.1152/ajpcell.1998.275.2.C599; Bisignano P, 2010, BIOCHIMIE, V92, P51, DOI 10.1016/j.biochi.2009.09.007; Cai ZW, 2002, J BIOL CHEM, V277, P19546, DOI 10.1074/jbc.M108023200; CARSON MR, 1995, J BIOL CHEM, V270, P1711, DOI 10.1074/jbc.270.4.1711; Chang XB, 1999, MOL CELL, V4, P137, DOI 10.1016/S1097-2765(00)80196-3; Chen JH, 2017, J PHYSIOL-LONDON, V595, P1059, DOI 10.1113/JP273205; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dong Q, 2012, P NATL ACAD SCI USA, V109, P917, DOI 10.1073/pnas.1120065109; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Guimbellot J, 2017, PEDIATR PULM, V52, pS4, DOI 10.1002/ppul.23773; He LH, 2015, J MOL BIOL, V427, P106, DOI 10.1016/j.jmb.2014.07.026; He LH, 2013, FASEB J, V27, P536, DOI 10.1096/fj.12-216119; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; Hoelen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015458; Hwang TC, 1997, AM J PHYSIOL-CELL PH, V273, pC988, DOI 10.1152/ajpcell.1997.273.3.C988; Hwang TC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009498; Jih KY, 2013, P NATL ACAD SCI USA, V110, P4404, DOI 10.1073/pnas.1215982110; Kalid O, 2010, J COMPUT AID MOL DES, V24, P971, DOI 10.1007/s10822-010-9390-0; Kanelis V, 2010, EMBO J, V29, P263, DOI 10.1038/emboj.2009.329; Lazrak A, 2013, FASEB J, V27, P4630, DOI 10.1096/fj.13-227330; Lella M, 2017, BIOCHEMISTRY-US, V56, P2971, DOI 10.1021/acs.biochem.7b00375; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Liu FY, 2017, CELL, V169, P85, DOI 10.1016/j.cell.2017.02.024; Liu J, 2018, BRIT J PHARMACOL, V175, P1017, DOI 10.1111/bph.14141; Liu XH, 2012, BIOCHEMISTRY-US, V51, P5113, DOI 10.1021/bi300018e; Loo TW, 2017, BIOCHEM PHARMACOL, V136, P24, DOI 10.1016/j.bcp.2017.03.020; Loo TW, 2010, BIOCHEMISTRY-US, V49, P6352, DOI 10.1021/bi100807h; Lopes-Pacheco M, 2016, CHEMBIOCHEM, V17, P493, DOI 10.1002/cbic.201500620; Luz S, 2011, MOL CELL BIOL, V31, P4392, DOI 10.1128/MCB.05517-11; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Meng X, 2017, J BIOL CHEM, V292, P3706, DOI 10.1074/jbc.M116.751537; Odolczyk N, 2013, EMBO MOL MED, V5, P1484, DOI 10.1002/emmm.201302699; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Ostedgaard LS, 2007, P NATL ACAD SCI USA, V104, P15370, DOI 10.1073/pnas.0706974104; Ostedgaard LS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001868; Papaleo E, 2016, CHEM REV, V116, P6391, DOI 10.1021/acs.chemrev.5b00623; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pissarra LS, 2008, CHEM BIOL, V15, P62, DOI 10.1016/j.chembiol.2007.11.012; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; Qu BH, 1996, J BIOL CHEM, V271, P7261, DOI 10.1074/jbc.271.13.7261; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rosser MFN, 2008, MOL BIOL CELL, V19, P4570, DOI 10.1091/mbc.E08-04-0357; Roxo-Rosa M, 2006, P NATL ACAD SCI USA, V103, P17891, DOI 10.1073/pnas.0608312103; Serohijos AWR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000008; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; TEEM JL, 1993, CELL, V73, P335, DOI 10.1016/0092-8674(93)90233-G; Teem JL, 1996, RECEPTOR CHANNEL, V4, P63; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; THOMAS PJ, 1992, J BIOL CHEM, V267, P5727; Vauthier V, 2017, BIOCHEM PHARMACOL, V136, P1, DOI 10.1016/j.bcp.2017.02.020; VENGLARIK CJ, 1994, J GEN PHYSIOL, V104, P123, DOI 10.1085/jgp.104.1.123; Wang C, 2010, PROTEIN SCI, V19, P1932, DOI 10.1002/pro.480; Wang F, 2000, J PHYSIOL-LONDON, V524, P637, DOI 10.1111/j.1469-7793.2000.00637.x; Wang W, 2011, J BIOL CHEM, V286, P41937, DOI 10.1074/jbc.M111.296061; Wang YT, 2014, BRIT J PHARMACOL, V171, P4490, DOI 10.1111/bph.12791; Welsh MJ, 2010, NEW ENGL J MED, V363, P2056, DOI 10.1056/NEJMe1010123; Xu Z, 2014, J PHYSIOL-LONDON, V592, P1931, DOI 10.1113/jphysiol.2014.271817; Zhang Z, 2017, CELL, V170, P483, DOI 10.1016/j.cell.2017.06.041; Zhang Z, 2016, CELL, V167, P1586, DOI 10.1016/j.cell.2016.11.014; Zhenin M, 2015, J CHEM INF MODEL, V55, P2349, DOI 10.1021/acs.jcim.5b00312	75	1	1	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5126	5142		10.1096/fj.201801218RR	http://dx.doi.org/10.1096/fj.201801218RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30668920	Green Submitted, Bronze			2022-12-26	WOS:000462888500041
J	Lionikaite, V; Henning, P; Drevinge, C; Shah, FA; Palmquist, A; Wikstrom, P; Windahl, SH; Lerner, UH				Lionikaite, Vikte; Henning, Petra; Drevinge, Christina; Shah, Furqan A.; Palmquist, Anders; Wikstrom, Pernilla; Windahl, Sara H.; Lerner, Ulf H.			Vitamin A decreases the anabolic bone response to mechanical loading by suppressing bone formation	FASEB JOURNAL			English	Article						osteoblasts retinoids; physical activity; Raman spectroscopy	SUBCLINICAL HYPERVITAMINOSIS-A; MINERAL DENSITY; RETINOIC ACID; HETEROTOPIC OSSIFICATION; DIETARY-INTAKE; MASS; METAANALYSIS; EXERCISE; MODEL; RISK	Increased vitamin A consumption is associated with decreased cortical bone mass and increased fracture risk in humans. Rodent studies have demonstrated that hypervitaminosis A increases cortical bone resorption, whereas the importance of the effects on bone formation is less well defined. We used an experimental model of increased bone formation by loading of the tibiae to investigate the effect of vitamin A on bone formation. Control [retinol activity equivalents (RAE) 4.5 mu g/g chow] or vitamin A (RAE 60 mu g/g chow) diets were given to female C57BL/6N mice for 4 wk, after which the tibiae were subjected to axial loading on alternate days for 2 wk, while the diets were continued. Vitamin A inhibited the loading-induced increase in trabecular and cortical bone volume. This was attributed to inhibition of loading-induced increase in osteoblast number and activity, and expression of osteoblastic genes Sp7, Alpl, and Col1a1 in cortical bone. Vitamin A, loading, and combination thereof also resulted in site-specific effects on bone composition measured by Raman spectroscopy. In summary, a clinically relevant dose of vitamin A suppresses the loading-induced gain of bone mass by decreasing bone formation. These observations may have implications for regulation of bone mass caused by physical activity and the risk of osteoporosis in humans.	[Lionikaite, Vikte; Henning, Petra; Drevinge, Christina; Windahl, Sara H.; Lerner, Ulf H.] Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Ctr Bone & Arthrit Res,Inst Med, Gothenburg, Sweden; [Shah, Furqan A.; Palmquist, Anders] Univ Gothenburg, Sahlgrenska Acad, Dept Biomat, Inst Clin Sci, Gothenburg, Sweden; [Wikstrom, Pernilla] Umea Univ, Dept Med Biosci, Pathol, Umea, Sweden; [Windahl, Sara H.] Karolinska Inst, Huddinge, Sweden	University of Gothenburg; University of Gothenburg; Umea University; Karolinska Institutet	Lerner, UH (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Ctr Bone & Arthrit Res, Vita Straket 11, S-41345 Gothenburg, Sweden.	sara.windahl@ki.se; ulf.lerner@gu.se	Shah, Furqan/Y-9485-2019; Palmquist, Anders/D-2171-2014	Shah, Furqan/0000-0002-9876-0467; Palmquist, Anders/0000-0002-6974-2577; Lerner, Ulf/0000-0002-3579-1960; Henning, Petra/0000-0002-9330-6265; Windahl, Sara/0000-0002-6611-6001	Marie Curie Initial Training Network (FP7-People-2013-ITN) [607446]; Swedish Research Council; Swedish government [237551]; Swedish county councils [237551]; IngaBritt and Arne Lundberg Foundation; Royal 80 Year Fund of King Gustav V; Ake Wibergs Foundation	Marie Curie Initial Training Network (FP7-People-2013-ITN); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish government; Swedish county councils; IngaBritt and Arne Lundberg Foundation; Royal 80 Year Fund of King Gustav V; Ake Wibergs Foundation	The authors thank the late Anette Hansevi, Anna Westerlund (Centre for Bone and Arthritis Research at Sahlgrenska Academy, University of Gothenburg), and Maria Norgard (Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden) for excellent technical assistance. This work was funded by the Marie Curie Initial Training Network (FP7-People-2013-ITN, Grant 607446, Euroclast), the Swedish Research Council, the Swedish state under the agreement between the Swedish government and the county councils (the ALF agreement, Grant 237551), the IngaBritt and Arne Lundberg Foundation, the Royal 80 Year Fund of King Gustav V, and the Ake Wibergs Foundation. The authors declare no conflicts of interest.	Bailey RL, 2011, J NUTR, V141, P261, DOI 10.3945/jn.110.133025; Bergstrom I, 2018, BONE, V112, P10, DOI 10.1016/j.bone.2018.04.002; Bergstrom I, 2017, OSTEOPOROSIS INT, V28, P1121, DOI 10.1007/s00198-016-3846-6; Conaway HH, 2013, ENDOCR REV, V34, P766, DOI 10.1210/er.2012-1071; Conaway HH, 2011, J BIOL CHEM, V286, P31425, DOI 10.1074/jbc.M111.247734; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; De Souza RL, 2005, BONE, V37, P810, DOI 10.1016/j.bone.2005.07.022; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Feskanich D, 2002, JAMA-J AM MED ASSOC, V287, P47, DOI 10.1001/jama.287.1.47; Flurkey K, 2007, MOUSE BIOMEDICAL RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1; Fonseca H, 2014, SPORTS MED, V44, P37, DOI 10.1007/s40279-013-0100-7; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; Green AC, 2018, J BONE MINER RES, V33, P2202, DOI 10.1002/jbmr.3558; Green AC, 2016, J STEROID BIOCHEM, V155, P135, DOI 10.1016/j.jsbmb.2015.09.036; Green AC, 2015, J STEROID BIOCHEM, V150, P46, DOI 10.1016/j.jsbmb.2015.03.005; Henning P, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00031; HOUGH S, 1988, ENDOCRINOLOGY, V122, P2933, DOI 10.1210/endo-122-6-2933; Howe TE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000333, 10.1002/14651858.CD000333.pub2]; Huk DJ, 2013, ARTERIOSCL THROM VAS, V33, P285, DOI 10.1161/ATVBAHA.112.300388; Johansson S, 2002, BONE, V31, P685, DOI 10.1016/S8756-3282(02)00910-9; Kelley GA, 2001, AM J PHYS MED REHAB, V80, P65, DOI 10.1097/00002060-200101000-00017; Kneissel M, 2005, BONE, V36, P202, DOI 10.1016/j.bone.2004.11.006; KRASINSKI SD, 1989, AM J CLIN NUTR, V49, P112, DOI 10.1093/ajcn/49.1.112; Lind PM, 2006, CHEM-BIOL INTERACT, V159, P73, DOI 10.1016/j.cbi.2005.10.104; Lind T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176217; Lind T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082388; Lind T, 2011, BONE, V48, P496, DOI 10.1016/j.bone.2010.10.169; Lionikaite V, 2018, J ENDOCRINOL, V239, P389, DOI 10.1530/JOE-18-0316; Maughan RJ, 2007, J SPORT SCI, V25, pS103, DOI 10.1080/02640410701607395; Meakin LB, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00154; Meakin LB, 2014, J BONE MINER RES, V29, P1859, DOI 10.1002/jbmr.2222; Melhus H, 1998, ANN INTERN MED, V129, P770, DOI 10.7326/0003-4819-129-10-199811150-00003; Michaelsson K, 2003, NEW ENGL J MED, V348, P287, DOI 10.1056/NEJMoa021171; Milgrom C, 2000, AM J SPORT MED, V28, P245, DOI 10.1177/03635465000280021701; Milgrom C, 2001, AM J PHYS MED REHAB, V80, P433, DOI 10.1097/00002060-200106000-00009; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Nilsson M, 2017, J BONE MINER RES, V32, P473, DOI 10.1002/jbmr.3006; Office of the Surgeon General (US), 2004, BON HLTH OST REP SUR, P437; Osborne DL, 2005, J HISTOTECHNOL, V28, P73; Pacifici M, 2018, BONE, V109, P267, DOI 10.1016/j.bone.2017.08.010; Promislow JHE, 2002, J BONE MINER RES, V17, P1349, DOI 10.1359/jbmr.2002.17.8.1349; Radimer K, 2004, AM J EPIDEMIOL, V160, P339, DOI 10.1093/aje/kwh207; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Schuster GU, 2008, J IMMUNOL, V180, P1834, DOI 10.4049/jimmunol.180.3.1834; Shimono K, 2011, NAT MED, V17, P454, DOI 10.1038/nm.2334; Sims Natalie A, 2014, Bonekey Rep, V3, P481, DOI 10.1038/bonekey.2013.215; TRECHSEL U, 1987, J CLIN INVEST, V80, P1679, DOI 10.1172/JCI113257; Trumbo P, 2001, J AM DIET ASSOC, V101, P294, DOI 10.1016/S0002-8223(01)00078-5; Wallace BA, 2000, CALCIFIED TISSUE INT, V67, P10, DOI 10.1007/s00223001089; Windahl SH, 2013, P NATL ACAD SCI USA, V110, P2294, DOI 10.1073/pnas.1220811110; Wolff I, 1999, OSTEOPOROSIS INT, V9, P1, DOI 10.1007/s001980050109; Wray AE, 2011, J NUTR, V141, P660, DOI 10.3945/jn.110.132126; Wu AM, 2014, J BONE MINER RES, V29, P2032, DOI 10.1002/jbmr.2237; Yorgan TA, 2016, J BONE MINER METAB, V34, P161, DOI 10.1007/s00774-015-0666-2; 1999, NUTR REV, V57, P192	58	9	9	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5237	5247		10.1096/fj.201802040R	http://dx.doi.org/10.1096/fj.201802040R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30668919	hybrid, Green Published			2022-12-26	WOS:000462888500049
J	Takase, R; Hino, S; Nagaoka, K; Anan, K; Kohrogi, K; Araki, H; Hino, Y; Sakamoto, A; Nicholson, TB; Chen, TP; Nakao, M				Takase, Ryuta; Hino, Shinjiro; Nagaoka, Katsuya; Anan, Kotaro; Kohrogi, Kensaku; Araki, Hirotaka; Hino, Yuko; Sakamoto, Akihisa; Nicholson, Thomas B.; Chen, Taiping; Nakao, Mitsuyoshi			Lysine-specific demethylase-2 is distinctively involved in brown and beige adipogenic differentiation	FASEB JOURNAL			English	Article						LSD2; adipogenesis; gene regulation; oxidative metabolism	ADIPOSE-TISSUE; TRANSCRIPTIONAL CONTROL; EPIGENETIC CONTROL; FAT; OBESITY; ADIPOCYTES; ACTIVATION; REVEALS	Transcriptional and epigenetic regulation is fundamentally involved in initiating and maintaining progression of cellular differentiation. The 2 types of thermogenic adipocytes, brown and beige, are thought to be of different origins but share functionally similar phenotypes. Here, we report that lysine-specific demethylase 2 (LSD2) regulates the expression of genes associated with lineage identity during the differentiation of brown and beige adipogenic progenitors in mice. In HB2 mouse brown preadipocytes, short hairpin RNA-mediated knockdown (KD) of LSD2 impaired formation of lipid droplet-containing adipocytes and down-regulated brown adipogenesis-associated genes. Transcriptomic analysis revealed that myogenesis-associated genes were up-regulated in LSD2-KD cells under adipogenic induction. In addition, loss of LSD2 during later phases of differentiation had no obvious influence on adipogenic traits, suggesting that LSD2 functions during earlier phases of brown adipocyte differentiation. Using adipogenic cells from the brown adipose tissues of LSD2-knockout (KO) mice, we found reduced expression of brown adipogenesis genes, whereas myogenesis genes were not affected. In contrast, when LSD2-KO cells from inguinal white adipose tissues were subjected to beige induction, these cells showed a dramatic rise in myogenic gene expression. Collectively, these results suggest that LSD2 regulates distinct sets of genes during brown and beige adipocyte formation.	[Takase, Ryuta; Hino, Shinjiro; Nagaoka, Katsuya; Anan, Kotaro; Kohrogi, Kensaku; Araki, Hirotaka; Hino, Yuko; Sakamoto, Akihisa; Nakao, Mitsuyoshi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Med Cell Biol, Kumamoto, Japan; [Nicholson, Thomas B.] Novartis Pharmaceut, Novartis Inst BioMed Res, Cambridge, MA USA; [Chen, Taiping] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX USA	Kumamoto University; Novartis; University of Texas System; UTMD Anderson Cancer Center	Hino, S; Nakao, M (corresponding author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Med Cell Biol, Chuo Ku, 2-2-1 Honjo, Kumamoto 8600811, Japan.	s-hino@kumamoto-u.ac.jp; mnakao@gpo.kumamoto-u.ac.jp	Nagaoka, Katsuya/ABU-5640-2022; NAGAOKA, Katsuya/GQZ-0492-2022	Nagaoka, Katsuya/0000-0002-7152-6101; NAGAOKA, Katsuya/0000-0002-7152-6101; Anan, Kotaro/0000-0001-8370-6292	Japan Society for the Promotion of Science (JSPS) [JP15H04707, JP18H02618, JP16K07215, 25430178]; Takeda Science Foundation; The Shinnihon Foundation of Advanced Medical Treatment Research; Ono Medical Research Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant [1R01DK106418-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106418] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); The Shinnihon Foundation of Advanced Medical Treatment Research; Ono Medical Research Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Shingo Usuki and Sayoko Fujimura (both of Kumamoto University) for their technical support in RNA-seq and histological analyses, respectively. This work was supported by the following funding sources: Japan Society for the Promotion of Science (JSPS) KAKENHI [JP15H04707 (to M.N.), JP18H02618 (to M.N.), JP16K07215 (to S.H.), and 25430178 (to S.H.)], Takeda Science Foundation (to M.N. and S.H.), The Shinnihon Foundation of Advanced Medical Treatment Research (to S.H.), Ono Medical Research Foundation (to S.H.), Mochida Memorial Foundation for Medical and Pharmaceutical Research (to S.H.), and U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant 1R01DK106418-01 (to T.C.). The authors declare no conflicts of interest.	Abe Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8052; Allott EH, 2015, ENDOCR-RELAT CANCER, V22, pR365, DOI 10.1530/ERC-15-0400; Aune UL, 2013, JOVE-J VIS EXP, DOI 10.3791/50191; Avgustinova A, 2016, NAT REV MOL CELL BIO, V17, P643, DOI 10.1038/nrm.2016.76; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chen Y, 2016, CELL CHEM BIOL, V23, P1228, DOI 10.1016/j.chembiol.2016.08.010; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Duteil D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5093; Fang R, 2010, MOL CELL, V39, P222, DOI 10.1016/j.molcel.2010.07.008; Hasegawa Y, 2018, CELL METAB, V27, P180, DOI 10.1016/j.cmet.2017.12.005; Hino S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1755; Holmberg J, 2012, NAT REV GENET, V13, P429, DOI 10.1038/nrg3209; Inagaki T, 2016, NAT REV MOL CELL BIO, V17, P480, DOI 10.1038/nrm.2016.62; Irie Y, 1999, BIOCHEM BIOPH RES CO, V255, P221, DOI 10.1006/bbrc.1998.9999; Jiang YW, 2014, CELL REP, V9, P1007, DOI 10.1016/j.celrep.2014.09.049; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Long JZ, 2014, CELL METAB, V19, P810, DOI 10.1016/j.cmet.2014.03.025; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Molchadsky A, 2013, CELL DEATH DIFFER, V20, P774, DOI 10.1038/cdd.2013.9; Nagaoka K, 2015, MOL CELL BIOL, V35, P1068, DOI 10.1128/MCB.01404-14; Niwa H, 2017, EPIGENETICS-US, V12, P340, DOI 10.1080/15592294.2017.1290032; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Pan DN, 2015, DEV CELL, V35, DOI 10.1016/j.devcel.2015.11.002; Pedersen MT, 2010, TRENDS CELL BIOL, V20, P662, DOI 10.1016/j.tcb.2010.08.011; Perino M, 2016, DEV CELL, V38, P610, DOI 10.1016/j.devcel.2016.08.004; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Sanchez-Gurmaches J, 2016, TRENDS CELL BIOL, V26, P313, DOI 10.1016/j.tcb.2016.01.004; Sanchez-Gurmaches J, 2012, CELL METAB, V16, P348, DOI 10.1016/j.cmet.2012.08.003; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Shapira SN, 2017, GENE DEV, V31, P660, DOI 10.1101/gad.294405.116; van Essen D, 2010, MOL CELL, V39, P750, DOI 10.1016/j.molcel.2010.08.010; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Yang Y, 2015, MOL CELL, V58, P47, DOI 10.1016/j.molcel.2015.01.038; Zeng X, 2016, GENE DEV, V30, P1822, DOI 10.1101/gad.285312.116; Zhang Q, 2013, CELL RES, V23, P225, DOI 10.1038/cr.2012.177	39	2	3	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5300	5311		10.1096/fj.201801422RR	http://dx.doi.org/10.1096/fj.201801422RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30681884	Green Published, Bronze			2022-12-26	WOS:000462888500054
J	Shekhar, R; Priyanka, P; Kumar, P; Ghosh, T; Khan, MM; Nagarajan, P; Saxena, S				Shekhar, Ritu; Priyanka, Priyanka; Kumar, Praveen; Ghosh, Tanushree; Khan, Md. Muntaz; Nagarajan, Perumal; Saxena, Sandeep			The microRNAs miR-449a and miR-424 suppress osteosarcoma by targeting cyclin A2 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microRNA (miRNA); cell cycle; cyclin; tumor suppressor gene; osteosarcoma (OS); bone cancer; CCNA2; cyclin A2; non-coding RNA; oncogenesis; posttranscriptional regulation	FUNCTIONAL-CHARACTERIZATION; TUMOR-SUPPRESSOR; DOWN-REGULATION; CELL-LINES; S-PHASE; INVASION; DIFFERENTIATION; IDENTIFICATION; PROLIFERATION; ARREST	MicroRNAs of the miR-16 and miR-34 families have been reported to inhibit cell cycle progression, and their loss has been linked to oncogenic transformation. Utilizing a high-throughput, genome-wide screen for miRNAs and mRNAs that are differentially regulated in osteosarcoma (OS) cell lines, we report that miR-449a and miR-424, belonging to the miR-34 and miR-16 families, respectively, target the major S/G(2) phase cyclin, cyclin A2 (CCNA2), in a bipartite manner. We found that the 3-UTR of CCNA2 is recognized by miR-449a, whereas the CCNA2 coding region is targeted by miR-424. Of note, we observed loss of both miR-449a and miR-424 in OS, resulting in derepression of CCNA2 and appearance of aggressive cancer phenotypes. Ectopic expression of miR-449a and miR-424 significantly decreased cyclin A2 levels and inhibited proliferation rate, migratory potential, and colony-forming ability of OS cells. To further probe the roles of miR-449a and miR-424 in OS, we developed an OS mouse model by intraosseous injection of U2OS cells into the tibia bone of NOD-scid mice, which indicated that miR-449a and miR-424 co-expression suppresses tumor growth. On the basis of this discovery, we analyzed the gene expression of human OS biopsy samples, revealing that miR-449a and miR-424 are both down-regulated, whereas cyclin A2 is significantly up-regulated in these OS samples. In summary, the findings in our study highlight that cyclin A2 repression by miRNAs of the miR-16 and miR-34 families is lost in aggressive OS.	[Shekhar, Ritu; Priyanka, Priyanka; Kumar, Praveen; Ghosh, Tanushree; Khan, Md. Muntaz; Nagarajan, Perumal; Saxena, Sandeep] Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Saxena, S (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	sandeep@nii.res.in	Nagarajan, Perumal/AAJ-8599-2021	Nagarajan, Perumal/0000-0003-4557-4633; Priyanka, Fnu/0000-0001-7933-3809; Ghosh, Tanushree/0000-0002-0988-2367	Government of India [BT/PR22824/BRB/10/1578/2016, EMR/2016/001702]	Government of India	This study was supported in part by Government of India Projects BT/PR22824/BRB/10/1578/2016 and EMR/2016/001702. The authors declare that they have no conflicts of interest with the contents of this article.	Achari C, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-538; Allen-Rhoades W, 2015, CANCER MED-US, V4, P977, DOI 10.1002/cam4.438; Bae YJ, 2012, HUM MOL GENET, V21, P2991, DOI 10.1093/hmg/dds129; Beg MS, 2017, INVEST NEW DRUG, V35, P180, DOI 10.1007/s10637-016-0407-y; Bueno MJ, 2011, BLOOD, V117, P6255, DOI 10.1182/blood-2010-10-315432; Cai CK, 2012, ONCOL REP, V28, P1764, DOI 10.3892/or.2012.1995; Chen J, 2015, TUMOR BIOL, V36, P8221, DOI 10.1007/s13277-015-3568-y; Deng NA, 2018, BIOCHEM BIOPH RES CO, V495, P189, DOI 10.1016/j.bbrc.2017.11.028; Fotedar A, 1996, J BIOL CHEM, V271, P31627, DOI 10.1074/jbc.271.49.31627; Ge L, 2016, ONCOL LETT, V11, P2207, DOI 10.3892/ol.2016.4162; Ghosh T, 2017, J BIOL CHEM, V292, P21264, DOI 10.1074/jbc.M117.808287; Gopinathan L, 2014, CANCER RES, V74, P3870, DOI 10.1158/0008-5472.CAN-13-3440; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hu YL, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180375; Jiang QQ, 2013, ASIAN PAC J CANCER P, V14, P4127, DOI 10.7314/APJCP.2013.14.7.4127; Kobayashi Eisuke, 2012, Sarcoma, V2012, P359739, DOI 10.1155/2012/359739; Kuijjer ML, 2012, GENE CHROMOSOME CANC, V51, P696, DOI 10.1002/gcc.21956; Lauvrak SU, 2013, BRIT J CANCER, V109, P2228, DOI 10.1038/bjc.2013.549; Lewis IJ, 2007, JNCI-J NATL CANCER I, V99, P112, DOI 10.1093/jnci/djk015; Li JQ, 2002, HUM PATHOL, V33, P1006, DOI 10.1053/hupa.2002.125774; Li Q, 2017, INT J BIOL SCI, V13, P1038, DOI 10.7150/ijbs.19476; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long XH, 2013, EXP THER MED, V5, P1048, DOI 10.3892/etm.2013.959; Lulla Rishi R., 2011, Sarcoma, V2011, P732690, DOI 10.1155/2011/732690; Lv T, 2018, CANCER BIOMARK, V23, P315, DOI 10.3233/CBM-170906; Mao JH, 2012, ONCOL LETT, V4, P1125, DOI 10.3892/ol.2012.863; Miller CW, 1996, J CANCER RES CLIN, V122, P559, DOI 10.1007/BF01213553; Mohseny AB, 2011, LAB INVEST, V91, P1195, DOI 10.1038/labinvest.2011.72; Nana-Sinkam SP, 2013, CLIN PHARMACOL THER, V93, P98, DOI 10.1038/clpt.2012.192; Noonan EJ, 2010, ONCOTARGET, V1, P349, DOI 10.18632/oncotarget.167; Otto T, 2017, P NATL ACAD SCI USA, V114, P10660, DOI 10.1073/pnas.1702914114; Patel N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02800-2; Perdigao-Henriques R, 2016, ONCOGENE, V35, P158, DOI 10.1038/onc.2015.69; Picci P, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-6; Ren XS, 2014, CANCER LETT, V344, P195, DOI 10.1016/j.canlet.2013.10.031; RESNITZKY D, 1995, MOL CELL BIOL, V15, P4347; Stahlhut C, 2015, CELL CYCLE, V14, P2171, DOI 10.1080/15384101.2014.1003008; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; van der Deen M, 2013, J BIOL CHEM, V288, P21307, DOI 10.1074/jbc.M112.445890; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Xiao X, 2015, ARCH BIOCHEM BIOPHYS, V566, P49, DOI 10.1016/j.abb.2014.12.007; Xu M, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0972-x; Yang F, 2015, J BIOL CHEM, V290, P6507, DOI 10.1074/jbc.M114.620369; Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009; Yasmeen A, 2003, EXPERT REV MOL DIAGN, V3, P617, DOI 10.1586/14737159.3.5.617; Yin D, 2013, ONCOGENE, V32, P1155, DOI 10.1038/onc.2012.132; Zhao ZZ, 2015, RNA BIOL, V12, P538, DOI 10.1080/15476286.2015.1023495	51	41	41	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4381	4400		10.1074/jbc.RA118.005778	http://dx.doi.org/10.1074/jbc.RA118.005778			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30679313	hybrid, Green Published			2022-12-26	WOS:000462969500009
J	Alotaibi, B; Yassin, Y; Mushi, A; Maashi, F; Thomas, A; Mohamed, G; Hassan, A; Yezli, S				Alotaibi, Badriah; Yassin, Yara; Mushi, Abdulaziz; Maashi, Fuad; Thomas, Abin; Mohamed, Gamal; Hassan, Amir; Yezli, Saber			Tuberculosis knowledge, attitude and practice among healthcare workers during the 2016 Hajj	PLOS ONE			English	Article							INFECTION-CONTROL KNOWLEDGE; PULMONARY TUBERCULOSIS; ADDIS-ABABA; DISTRICT; FACILITIES; PILGRIMS; STIGMA; IRAN	Background Given the inherent characteristics of the Hajj pilgrimage, the event is a risk for tuberculosis (TB) infection. Early diagnosis and appropriate management of TB cases by knowledgeable and skilled healthcare workers (HCWs) are key in improving patients' outcome and preventing transmission during the Hajj mass gathering and globally. Method We conducted a cross-sectional study to assess knowledge, attitude and practice (KAP) of HCWs deployed during the 2016 Hajj regarding TB and its management using an anonymous self-administered questionnaire. Results Data was collected from 540 HCWs from 13 hospitals. HCWs originated from 17 countries and included physicians, nurses and other non-administrative HCWs. Nearly half of HCWs declared having experience dealing with TB patients. In general, HCWs had average knowledge (mean knowledge score of 52%), above average attitude (mean attitude score of 73%) and good practice (mean practice score of 85%) regarding TB, based on our scoring system and cut-off points. Knowledge gaps were identified in relation to the definition of MDR-/XDR-TB and LTBI, smear microscopy results, length of standard TB treatment for drug-sensitive TB, 2nd line anti-TB drugs, BCG vaccination, and appropriate PPE to be used with active PTB patients. Poor attitudes were found in relation to willingness to work in TB clinic/ward and to the management and treatment of TB patients. Poor practices were reported for commencing anti-TB treatment on suspected TB cases before laboratory confirmation and not increasing natural ventilation in TB patients' rooms. Age, gender, nationality, occupation, length of work experience and experience dealing with TB patients were associated with knowledge scores. Age and occupation were associated with attitude scores while length of work experience and occupation were associated with practice scores. There was a weak but statistically significant positive correlation between score for knowledge and attitude (r(s) = 0.11, p = 0.009) and attitude and practice (r(s) = 0.13, p = 0.002). Conclusions While the results of the study are encouraging, important knowledge gaps and some poor attitudes and practices regarding TB were identified among HCWs during Hajj. This calls for multifaceted interventions to improve HCWs KAP regarding TB including tailored, periodic TB education and training aimed at boosting knowledge and improving behaviour.	[Alotaibi, Badriah; Yassin, Yara; Mushi, Abdulaziz; Maashi, Fuad; Yezli, Saber] Minist Hlth, Global Ctr Mass Gatherings Med, Riyadh, Saudi Arabia; [Thomas, Abin] Minist Natl Guard Hlth Affairs, King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Mohamed, Gamal; Hassan, Amir] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England	Ministry of Health - Saudi Arabia; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); Ministry of National Guard - Health Affairs; Liverpool School of Tropical Medicine	Alotaibi, B (corresponding author), Minist Hlth, Global Ctr Mass Gatherings Med, Riyadh, Saudi Arabia.	bmalotaibi@moh.gov.sa		Thomas, Abin/0000-0002-8283-6762; Yassin, Yara/0000-0002-8762-5403; Yezli, Saber/0000-0002-3380-7092				Abd Wahab F, 2016, MALAYS J MED SCI, V23, P25, DOI 10.21315/mjms2016.23.6.3; Al-Orainey IO, 2013, SAUDI MED J, V34, P676; Awofeso N, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-20; Bhebhe LT, 2014, AFR J PRIM HEALTH CA, V6, DOI 10.4102/phcfm.v6i1.597; Buregyeya E, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1740-7; Chang SH, 2014, INT J TUBERC LUNG D, V18, P168, DOI 10.5588/ijtld.13.0181; Dielman M, 2006, IMPROVING HLTH WORKE; Dodor EA, 2008, INT J TUBERC LUNG D, V12, P1048; Dodor EA, 2010, HEALTH POLICY, V98, P195, DOI 10.1016/j.healthpol.2010.06.017; Engelbrecht M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1984-2; Ferreira Júnior Sérgio, 2013, Rev. bras. epidemiol., V16, P100, DOI 10.1590/S1415-790X2013000100010; Ghabrah TM, 2007, SCAND J INFECT DIS, V39, P1018, DOI 10.1080/00365540701466173; Gizaw GD, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0062-3; Hashim D S, 2003, East Mediterr Health J, V9, P718; Hoa NP, 2005, HEALTH POLICY, V72, P1, DOI 10.1016/j.healthpol.2004.02.013; Hoffman SJ, 2016, AM J TROP MED HYG, V94, P959, DOI 10.4269/ajtmh.15-0538; HONG YP, 1995, TUBERCLE LUNG DIS, V76, P431, DOI 10.1016/0962-8479(95)90010-1; Irani AD, 2015, AM J INFECT CONTROL, V43, pE7, DOI 10.1016/j.ajic.2015.01.020; Isara AR, 2015, NIGER J CLIN PRACT, V18, P664, DOI 10.4103/1119-3077.154212; Kanjee Z, 2011, J HOSP INFECT, V79, P333, DOI 10.1016/j.jhin.2011.06.017; Kiefer E, 2009, J INFECT DEV COUNTR, V3, P783, DOI 10.3855/jidc.335; Lai KK, 1996, INFECT CONT HOSP EP, V17, P168; Langendam MW, 2012, EUR RESPIR J, V39, P1012, DOI 10.1183/09031936.00125511; Lateef Fatimah, 2010, J Emerg Trauma Shock, V3, P348, DOI 10.4103/0974-2700.70743; Lertkanokkun S, 2013, JITMM2012 P, V2, P1; Malangu N, 2015, AFR J PRIM HEALTH CA, V7, DOI 10.4102/phcfm.v7i1.774; Minnery M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075698; Naidoo S, 2002, SADJ, V57, P476; Naidoo S, 2011, Educ Health (Abingdon), V24, P514; Noe A, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-016-0344-8; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Schmidt BM, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5518-2; Shrestha A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2828-4; Singla N, 1998, INT J TUBERC LUNG D, V2, P384; Temesgen C, 2014, BMC HEALTH SERV RES, V14, P593; Tenna A, 2013, INFECT CONT HOSP EP, V34, P1289, DOI 10.1086/673979; van der Werf MJ, 2012, EUR RESPIR J, V39, P1248, DOI 10.1183/09031936.00125611; WHO, 2017, GLOB TUB REP 2017; Woith W, 2012, INT J TUBERC LUNG D, V16, P1092, DOI 10.5588/ijtld.10.0779; Woith WM, 2010, INT J TUBERC LUNG D, V14, P1489; World Health Organization, 2008, ADVOCACY COMMUNICATI; World Health Organization, 2014, GLOB TUB REP; Yezli S, 2018, TRAVEL MED INFECT DI, P30281; Yezli S, 2017, AM J TROP MED HYG, V97, P1304, DOI 10.4269/ajtmh.17-0271; Yezli S, 2017, SAUDI MED J, V38, P868, DOI 10.15537/smj.2017.8.20124	45	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210913	10.1371/journal.pone.0210913	http://dx.doi.org/10.1371/journal.pone.0210913			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682065	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000457037500074
J	Ren, XW; Xia, JL				Ren, Xiaowei; Xia, Jielai			An algorithm for computing profile likelihood based pointwise confidence intervals for nonlinear dose-response models	PLOS ONE			English	Article								This study was inspired by the need to estimate pointwise confidence intervals (CIs) for a nonlinear dose-response model from a dose-finding clinical trial. Profile likelihood based CI for a nonlinear dose response model is often recommended. However, it is still not commonly used in dose-finding studies because it cannot generally be calculated explicitly. Most previous research has mainly focused on the performance of the profile likelihood based CI method compared with other common approaches. However, there are still no reports on computing profile likelihood based pointwise CIs for an entire dose-response curve. Based on a previous dose-finding trial with binary-response data, this present study proposed to calculate profile likelihood based pointwise CIs by using the bisection method with proper calculation order for doses in the curve plus crude search when the expected response is close to a boundary. The convergence could be improved by applying appropriate starting values for the optimization procedure with straightforward programming techniques. The algorithm worked well in most cases based on the simulation study and it can be applied more generally to other dose-response models, and other type of data like normally distributed response. It would indeed be great to be able to use profile likelihood approaches more routinely when constructing pointwise CIs for nonlinear dose-response models.	[Ren, Xiaowei; Xia, Jielai] Fourth Mil Med Univ, Dept Hlth Stat, Xian, Shaanxi, Peoples R China; [Ren, Xiaowei] Bayer Healthcare Co Ltd, Stat & Data Insights, Beijing, Peoples R China	Air Force Military Medical University; Bayer AG	Xia, JL (corresponding author), Fourth Mil Med Univ, Dept Hlth Stat, Xian, Shaanxi, Peoples R China.	jielaixia@yahoo.com						Baayen C, 2015, STAT MED, V34, P3546, DOI 10.1002/sim.6566; Belz RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033432; Brain P, 2014, PHARM STAT, V13, P364, DOI 10.1002/pst.1636; Bretz F, 2005, BIOMETRICS, V61, P738, DOI 10.1111/j.1541-0420.2005.00344.x; Bretz F, 2008, BIOMETRICAL J, V50, P480, DOI 10.1002/bimj.200810438; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Cedergreen N, 2005, ENVIRON TOXICOL CHEM, V24, P3166, DOI 10.1897/05-014R.1; Dinse GE, 2011, J AGR BIOL ENVIR ST, V16, P221, DOI 10.1007/s13253-010-0045-3; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Millar RB, 2011, STAT PRACT, P1, DOI 10.1002/9780470094846; Moerbeek M, 2004, RISK ANAL, V24, P31, DOI 10.1111/j.0272-4332.2004.00409.x; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Peddada Shyamal D., 2005, Dose-Response, V3, P342, DOI 10.2203/dose-response.003.03.005; SAS, 2015, SAS STAT 14 1 US GUI; Ting N., 2006, DOSE FINDING DRUG DE; VENZON DJ, 1988, J R STAT SOC C-APPL, V37, P87, DOI 10.2307/2347496; Wicklin R., 2013, SIMULATING DATA SAS	19	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210953	10.1371/journal.pone.0210953	http://dx.doi.org/10.1371/journal.pone.0210953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682081	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500078
J	Roth, N; Biedermann, L; Fournier, N; Butter, M; Vavricka, SR; Navarini, AA; Rogler, G; Scharl, M				Roth, Nina; Biedermann, Luc; Fournier, Nicolas; Butter, Matthias; Vavricka, Stephan R.; Navarini, Alexander A.; Rogler, Gerhard; Scharl, Michael		Swiss IBD Cohort Study Grp	Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study	PLOS ONE			English	Article							EXTRAINTESTINAL MANIFESTATIONS; CROHNS-DISEASE; PYODERMA-GANGRENOSUM; ERYTHEMA-NODOSUM; ULCERATIVE-COLITIS; SMOKING-CESSATION; CLINICAL-COURSE; COMPLICATIONS; DIAGNOSIS	Background/Aims Extraintestinal cutaneous manifestations of IBD represent a severe disease complication and an early and accurate treatment might positively influence the disease course. Using the patient collective of the Swiss IBD Cohort Study (SIBDCS), we analysed epidemiological as well as clinical factors being associated with the onset of pyoderma gangrenosum, erythema nodosum and aphthous ulcers in IBD patients. Methods We included 3266 SIBDCs patients, 1840 with Crohn's disease (CD) and 1426 with ulcerative colitis (UC) or IBD unclassified (IBDU) and analysed the association of cutaneous manifestations with age, age at diagnosis time, type of disease, gender, family history, HLA-allotype, smoking, intestinal disease activity, therapy and other extraintestinal manifestations (EIM). Results 354 CD patients and 136 UC/IBDU patients presented with skin manifestations at any time during their disease course. In both, CD and UC, female gender and younger age at IBD diagnosis were significantly associated with extraintestinal skin manifestations. For CD, we also detected a positive family history as associated factor. As an indicator of more intensive intestinal disease activity, patients with cutaneous manifestations of IBD needed more frequently therapy with antibiotics, steroids, immunomodulators and anti-TNF. Multivariate analysis revealed female gender, younger age at diagnosis and presence of other extraintestinal manifestations as factors being associated with skin EIM in IBD patients and anti-TNF as well as immunomodulatory treatment in CD patients. Conclusion Our results suggest that young females with a positive family history of IBD might be at increased risk for the onset of skin manifestations and require a careful screening for such complications.	[Roth, Nina; Biedermann, Luc; Butter, Matthias; Vavricka, Stephan R.; Rogler, Gerhard; Scharl, Michael] Univ Zurich, Univ Hosp Zurich, Dept Gastroenterol & Hepatol, Zurich, Switzerland; [Roth, Nina] Buergerspital Solothurn, Dept Internal Med, Solothurn, Switzerland; [Fournier, Nicolas] Lausanne Univ Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Navarini, Alexander A.] Univ Hosp Zurich, Dept Dermatol, Zurich, Switzerland; [Rogler, Gerhard; Scharl, Michael] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Scharl, M (corresponding author), Univ Zurich, Univ Hosp Zurich, Dept Gastroenterol & Hepatol, Zurich, Switzerland.; Scharl, M (corresponding author), Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland.	michael.scharl@usz.ch	; Navarini, Alexander/C-5504-2014	Scharl, Michael/0000-0002-6729-1469; Navarini, Alexander/0000-0001-7059-632X	Stiftung Experimentelle Biomedizin; Promedica Foundation; Swiss National Science Foundation [314730_166381, 3347CO-108792]; Promedica & Bruno Bloch Foundation; HSM-2 grant "Immunvermittelte Erkrankungen" from the Kanton of Zurich, Switzerland	Stiftung Experimentelle Biomedizin; Promedica Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Promedica & Bruno Bloch Foundation; HSM-2 grant "Immunvermittelte Erkrankungen" from the Kanton of Zurich, Switzerland	This work was supported by research grants from the Stiftung Experimentelle Biomedizin to MS, the Promedica Foundation to MS, the Swiss National Science Foundation to MS [Grant No. 314730_166381] and to GR for the Swiss IBD Cohort [Grant No. 3347CO-108792], the Promedica & Bruno Bloch Foundation and by the HSM-2 grant "Immunvermittelte Erkrankungen" from the Kanton of Zurich, Switzerland to AN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampuero J, 2014, J GASTROEN HEPATOL, V29, P291, DOI 10.1111/jgh.12352; Ardizzone S, 2008, DIGEST LIVER DIS, V40, pS253, DOI 10.1016/S1590-8658(08)60534-4; Bastida G, 2011, WORLD J GASTROENTERO, V17, P2740, DOI [10.3748/wjg.v17.i22.2740, 10.3748/wjg.v17.i22.2734]; Bernstein CN, 2001, AM J GASTROENTEROL, V96, P1116; BHAGAT S, 1994, GASTROENTEROLOGY, V107, P103, DOI 10.1016/0016-5085(94)90066-3; Chang D, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0113684, 10.1371/journal.pone.0113596]; Ciccacci C, 2013, J CROHNS COLITIS, V7, P44, DOI 10.1016/j.crohns.2012.02.020; Cosnes J, 1999, ALIMENT PHARM THERAP, V13, P1403; Cosnes J, 2001, GASTROENTEROLOGY, V120, P1093, DOI 10.1053/gast.2001.23231; Danese S, 2005, WORLD J GASTROENTERO, V11, P7227, DOI 10.3748/wjg.v11.i46.7227; Das KM, 1999, DIGEST DIS SCI, V44, P1, DOI 10.1023/A:1026629528233; Farhi D, 2008, MEDICINE, V87, P281, DOI 10.1097/MD.0b013e318187cc9c; FARMER RG, 1975, GASTROENTEROLOGY, V68, P627; Gravina AG, 2016, UNITED EUR GASTROENT, V4, P165, DOI 10.1177/2050640615597835; GREENSTEIN AJ, 1976, MEDICINE, V55, P401, DOI 10.1097/00005792-197609000-00004; Greuter T, 2017, CLIN REV ALLERG IMMU, V53, P413, DOI 10.1007/s12016-017-8617-4; Kethu SR, 2006, J CLIN GASTROENTEROL, V40, P467, DOI 10.1097/00004836-200607000-00003; Menachem Y, 2004, ISRAEL MED ASSOC J, V6, P88; Mendoza JL, 2005, MED CLIN-BARCELONA, V125, P297; MONSEN U, 1990, AM J GASTROENTEROL, V85, P711; Nunes T, 2016, AM J GASTROENTEROL, V111, P411, DOI 10.1038/ajg.2015.401; Nunes T, 2013, INFLAMM BOWEL DIS, V19, P23, DOI 10.1002/ibd.22959; Orchard TR, 2002, GASTROENTEROLOGY, V123, P714, DOI 10.1053/gast.2002.35396; Orchard TR, 2000, GASTROENTEROLOGY, V118, P274, DOI 10.1016/S0016-5085(00)70209-5; PERSSON PG, 1990, GUT, V31, P1377, DOI 10.1136/gut.31.12.1377; Pittet V, 2009, INT J EPIDEMIOL, V38, P922, DOI 10.1093/ije/dyn180; RANKIN GB, 1979, GASTROENTEROLOGY, V77, P914; Ricart E, 2004, INFLAMM BOWEL DIS, V10, P207, DOI 10.1097/00054725-200405000-00005; Rothfuss KS, 2006, WORLD J GASTROENTERO, V12, P4819; Roussomoustakaki M, 1997, GASTROENTEROLOGY, V112, P1845, DOI 10.1053/gast.1997.v112.pm9178675; Su CYG, 2002, GASTROENTEROL CLIN N, V31, P307, DOI 10.1016/S0889-8553(01)00019-X; Trikudanathan G, 2012, DRUGS, V72, P2333, DOI 10.2165/11638120-000000000-00000; Vavricka SR, 2015, INFLAMM BOWEL DIS, V21, P1982, DOI 10.1097/MIB.0000000000000392; Vavricka SR, 2015, INFLAMM BOWEL DIS, V21, P1794, DOI 10.1097/MIB.0000000000000429; Vavricka SR, 2011, AM J GASTROENTEROL, V106, P110, DOI 10.1038/ajg.2010.343; Veloso FT, 2011, WORLD J GASTROENTERO, V17, P2702, DOI 10.3748/wjg.v17.i22.2702; Veloso FT, 2004, ALIMENT PHARM THER, V20, P50, DOI 10.1111/j.1365-2036.2004.02055.x; Veloso FT, 1996, J CLIN GASTROENTEROL, V23, P29, DOI 10.1097/00004836-199607000-00009; Yuksel I, 2009, INFLAMM BOWEL DIS, V15, P546, DOI 10.1002/ibd.20807; Zelinkova Z, 2012, J CROHNS COLITIS, V6, P771, DOI 10.1016/j.crohns.2012.01.002	40	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210436	10.1371/journal.pone.0210436	http://dx.doi.org/10.1371/journal.pone.0210436			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682031	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000457037500037
J	Weinberg, EO; Ferran, B; Tsukahara, Y; Hatch, MMS; Han, JY; Murdoch, CE; Matsui, R				Weinberg, Ellen O.; Ferran, Beatriz; Tsukahara, Yuko; Hatch, Michaela M. S.; Han, Jingyan; Murdoch, Colin E.; Matsui, Reiko			IL-33 induction and signaling are controlled by glutaredoxin-1 in mouse macrophages	PLOS ONE			English	Article							NF-KAPPA-B; S-GLUTATHIONYLATION; LUNG INFLAMMATION; CYTOKINE IL-33; INTERLEUKIN-33; RECEPTOR; GENE; EXPRESSION; POLARIZATION; ACTIVATION	Interleukin (IL)-33 is an interleukin-1 like cytokine that enhances Th2 responses and mediates mucosal immunity and allergic inflammation but the mechanism regulating endogenous IL-33 production are still under investigation. In macrophages, lipopolysaccharide (LPS) administration resulted in marked induction of IL-33 mRNA that was blunted in macrophages from glutaredoxin-1 (Glrx) knockout mice and in RAW264.7 macrophages with Glrx knockdown by siRNA. Glutaredoxin-1 is a small cytosolic thioltransferase that controls a reversible protein thiol modification, S-glutationylation (protein-GSH adducts), thereby regulating redox signaling. In this study, we examined the mechanism of Glrx regulation of endogenous IL-33 induction in macrophages. Glrx knockdown resulted in impaired de-glutathionylation of TRAF6, which is required for TRAF6 activation, and inhibited downstream IKK beta and NF-kappa B activation. Inhibitors of NF-kappa B suppressed IL-33 induction and chromatin IP sequencing data analysis confirmed that IL-33 is an NF-kappa B-responsive gene. Since TRAF6-NF-kappa B activation is also essential for IL-33 signaling through its receptor, ST2L, we next tested the involvement of Glrx in exogenous IL-33 responses in RAW264.7 cells. Recombinant IL-33 (rIL-33) administration induced IL-33 mRNA expression in RAW264.7 macrophages, and this was inhibited by Glrx knockdown. Interestingly, rIL-33-induced IL-33 protein was identified as the 20 kDa cleaved form whereas LPS-induced IL-33 protein was identified as full-length IL-33, which may be less active than the cleaved form. In a clinically-relevant mouse model of asthma, intra-tracheal cockroach antigen treatment induced Glrx protein in wild type mouse lungs but Glrx induction was attenuated in IL-33 knockout mouse lungs, suggesting that IL-33 may regulate Glrx induction in vivo in response to allergen challenge. In summary, our data reveal a novel mechanism by which Glrx controls both LPS-and IL-33-mediated NF-kappa B activation leading to IL-33 production, and paracrine IL-33 can induce Glrx to further regulate inflammatory reactions.	[Weinberg, Ellen O.] Boston Univ, Sch Med, Dept Med, Infect Dis Sect, Boston, MA 02118 USA; [Ferran, Beatriz; Tsukahara, Yuko; Hatch, Michaela M. S.; Han, Jingyan; Murdoch, Colin E.; Matsui, Reiko] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Dept Med,Vasc Biol Sect, Boston, MA 02118 USA; [Weinberg, Ellen O.] Tufts Univ, Sch Med, Dept Immunol, Boston, MA 02111 USA; [Hatch, Michaela M. S.] Univ Calif Irvine, Mol Biol & Biochem, Irvine, CA USA; [Murdoch, Colin E.] Univ Dundee, Sch Med, Med Syst, Dundee, Scotland	Boston University; Boston University; Tufts University; University of California System; University of California Irvine; University of Dundee	Matsui, R (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Dept Med,Vasc Biol Sect, Boston, MA 02118 USA.	rmatsui@bu.edu	; Murdoch, Colin/J-9798-2016	Weinberg, Ellen/0000-0002-6937-0371; Murdoch, Colin/0000-0002-0274-819X	NIH [R03 AI 090404, R01 HL133013];  [R03 AG051857]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007224, R01HL133013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS108724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG051857] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by NIH R03 AI 090404 (EOW), NIH R01 HL133013 (RM) and R03 AG051857 (RM).	Aesif SW, 2011, FREE RADICAL BIO MED, V51, P1249, DOI 10.1016/j.freeradbiomed.2011.06.025; Aesif SW, 2011, AM J RESP CELL MOL, V44, P491, DOI 10.1165/rcmb.2009-0136OC; Aizawa H, 2018, RESP RES, V19, P1, DOI [10.1186/s12931-017-0698-3, DOI 10.1186/S12931-017-0698-3, 10.1186/s12931-018-0752-9, DOI 10.1186/S12931-018-0752-9]; Ali S, 2011, J IMMUNOL, V187, P1609, DOI 10.4049/jimmunol.1003080; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Bonilla WV, 2012, SCIENCE, V335, P984, DOI 10.1126/science.1215418; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Carter RW, 2001, EUR J IMMUNOL, V31, P2979, DOI 10.1002/1521-4141(2001010)31:10<2979::AID-IMMU2979>3.0.CO;2-B; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chantzoura E, 2010, BIOCHEM BIOPH RES CO, V403, P335, DOI 10.1016/j.bbrc.2010.11.029; Choi YS, 2009, BLOOD, V114, P3117, DOI 10.1182/blood-2009-02-203372; Cohen ES, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9327; Funakoshi-Tago M, 2008, CELL SIGNAL, V20, P1679, DOI 10.1016/j.cellsig.2008.05.013; Gautier V, 2016, SCI REP, V6, P1, DOI [10.1038/s41598-016-0001-8, DOI 10.1038/S41598-016-0001-8]; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Haspeslagh E, 2017, METHODS MOL BIOL, V1559, P121, DOI 10.1007/978-1-4939-6786-5_10; Hazlett LD, 2010, INVEST OPHTH VIS SCI, V51, P1524, DOI 10.1167/iovs.09-3983; He RG, 2017, MOL IMMUNOL, V90, P42, DOI 10.1016/j.molimm.2017.06.249; Hiraide S, 2018, EUR J PHARMACOL, V818, P235, DOI 10.1016/j.ejphar.2017.10.057; Ho YS, 2007, FREE RADICAL BIO MED, V43, P1299, DOI 10.1016/j.freeradbiomed.2007.07.025; Hoffman SM, 2016, AM J RESP CELL MOL, V55, P377, DOI 10.1165/rcmb.2015-0401OC; Kamijo S, 2013, J IMMUNOL, V190, P4489, DOI 10.4049/jimmunol.1201212; Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020; Kuchler AM, 2008, AM J PATHOL, V173, P1229, DOI 10.2353/ajpath.2008.080014; Kuipers I, 2011, AM J RESP CELL MOL, V45, P931, DOI 10.1165/rcmb.2010-0249OC; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Lefrancais E, 2014, P NATL ACAD SCI USA, V111, P15502, DOI 10.1073/pnas.1410700111; Lefrancais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Murdoch CE, 2014, BIOCHEM SOC T, V42, P1665, DOI 10.1042/BST20140213; Murdoch CE, 2014, J BIOL CHEM, V289, P8633, DOI 10.1074/jbc.M113.517219; Nile CJ, 2010, IMMUNOLOGY, V130, P172, DOI 10.1111/j.1365-2567.2009.03221.x; Oboki K, 2011, ALLERGY ASTHMA IMMUN, V3, P81, DOI 10.4168/aair.2011.3.2.81; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Ohno T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018404; Ohno T, 2009, J IMMUNOL, V183, P7890, DOI 10.4049/jimmunol.0802449; Park JB, 1997, GENE, V197, P189, DOI 10.1016/S0378-1119(97)00262-X; Pineda-Molina E, 2001, BIOCHEMISTRY-US, V40, P14134, DOI 10.1021/bi011459o; Reynaert NL, 2007, AM J RESP CELL MOL, V36, P147, DOI 10.1165/rcmb.2006-0259RC; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shelton MD, 2008, MOL CELLS, V25, P332; Sjoberg LC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03674-0; Sullivan DM, 2000, BIOCHEMISTRY-US, V39, P11121, DOI 10.1021/bi0007674; Talabot-Ayer D, 2009, J BIOL CHEM, V284, P19420, DOI 10.1074/jbc.M901744200; Tashiro H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157571; Tjota MY, 2013, J CLIN INVEST, V123, P2287, DOI 10.1172/JCI63802; Wang J, 2003, P NATL ACAD SCI USA, V100, P5103, DOI 10.1073/pnas.0931345100; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	49	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210827	10.1371/journal.pone.0210827	http://dx.doi.org/10.1371/journal.pone.0210827			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682073	Green Published, gold, Green Submitted			2022-12-26	WOS:000457037500066
J	Yu, JT; Liu, Y; Dong, P; Cheng, RE; Ke, SX; Chen, KQ; Wang, JJ; Shen, ZS; Tang, QY; Zhang, Z				Yu, Jia-Tian; Liu, Ye; Dong, Ping; Cheng, Run-En; Ke, Shao-Xi; Chen, Kai-Qin; Wang, Jing-Jing; Shen, Zhong-Shan; Tang, Qiong-Yao; Zhang, Zhe			Up-regulation of antioxidative proteins TRX1, TXNL1 and TXNRD1 in the cortex of PTZ kindling seizure model mice	PLOS ONE			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; THIOL REDOX STATE; OXIDATIVE STRESS; THIOREDOXIN; EPILEPSY; PENTYLENETETRAZOL; INVOLVEMENT; GLUTATHIONE	Oxidative stress has been considered as one of pathogenesis of brain damage led by epilepsy. Reducing oxidative stress can ameliorate brain damage during seizures. However, expression levels of important antioxidative enzymes such as thioredoxin-1 (TRX1), thioredoxin-like 1 protein (TXNL1) and thioredoxin reductase 1 (TXNRD1) during seizures have not been investigated. In this study, we examined protein and mRNA expression levels of TRX1, TXNL1 and TXNRD1 in different brain regions in PTZ induced seizure model mice. We found that protein expression levels of TRX1, TXNL1 and TXNRD1 are simultaneously up-regulated by 2- or 3-fold in the cortex of both acute and chronic seizure model mice. But there is no unified expression pattern change of these enzymes in the hippocampus, cerebellum and diencephalon in the seizure model mice. Less extent up-regulation of mRNA expression of these enzymes were also observed in the cortex of seizure mice. These data suggest that antioxidative enzymes may provide a protective effect against oxidative stress in the cortex during seizures.	[Liu, Ye; Dong, Ping; Ke, Shao-Xi; Chen, Kai-Qin; Wang, Jing-Jing; Shen, Zhong-Shan; Tang, Qiong-Yao; Zhang, Zhe] Xuzhou Med Univ, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Jiangsu, Peoples R China; [Liu, Ye; Dong, Ping; Ke, Shao-Xi; Chen, Kai-Qin; Wang, Jing-Jing; Shen, Zhong-Shan; Tang, Qiong-Yao; Zhang, Zhe] Xuzhou Med Univ, Jiangsu Prov Key Lab Anesthesia & Analgesia Appli, Xuzhou, Jiangsu, Peoples R China; [Yu, Jia-Tian] Xuzhou Med Univ, Coll Biomed Sci, Dept Anat, Xuzhou, Jiangsu, Peoples R China; [Cheng, Run-En] Xuzhou Med Univ, Sch Clin Med, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University	Tang, QY; Zhang, Z (corresponding author), Xuzhou Med Univ, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Jiangsu, Peoples R China.; Tang, QY; Zhang, Z (corresponding author), Xuzhou Med Univ, Jiangsu Prov Key Lab Anesthesia & Analgesia Appli, Xuzhou, Jiangsu, Peoples R China.	Qiongyaotang@hotmail.com; Zhangzhe70@xzhmu.edu.cn	WANG, JINGYI/GSJ-1241-2022; wang, jing/GVT-8700-2022; wang, jing/GRS-7509-2022; Zhang, Zhe/C-5068-2011	Zhang, Zhe/0000-0001-7295-6894	Natural Science Foundation of China (NSFC) [81471314, 81671090]; Natural Science Foundation of Jiangsu Province [BK20151170]; Xuzhou Science and Technology Program [KC16H0230, 16631635]; NSFC [31671212]; General Project of Natural Science in College and University in Jiangsu Province [14KJB180023]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Xuzhou Science and Technology Program; NSFC(National Natural Science Foundation of China (NSFC)); General Project of Natural Science in College and University in Jiangsu Province	This work was supported by Natural Science Foundation of China (NSFC) grant to Z.Z. (81471314, 81671090), Natural Science Foundation of Jiangsu Province to Z.Z (BK20151170). Xuzhou Science and Technology Program (16631635) to Z.Z. NSFC grant to Q.-Y.T. (31671212), Xuzhou Science and Technology Program to Q.-Y.T (KC16H0230). The General Project of Natural Science in College and University in Jiangsu Province to J.T Yu (14KJB180023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KM, 2009, J BIOL CHEM, V284, P15246, DOI 10.1074/jbc.M900016200; Booze ML, 2016, FREE RADICAL BIO MED, V99, P533, DOI 10.1016/j.freeradbiomed.2016.09.013; Brown JD, 2013, CELL REP, V5, P1425, DOI 10.1016/j.celrep.2013.10.036; Emoto MC, 2017, BIOCHEM BIOPH RES CO, V485, P802, DOI 10.1016/j.bbrc.2017.02.134; Emoto MC, 2015, NEUROSCI LETT, V608, P40, DOI 10.1016/j.neulet.2015.10.008; Ercegovac M, 2010, SEIZURE-EUR J EPILEP, V19, P205, DOI 10.1016/j.seizure.2010.02.002; Gataullina S, 2015, DEV MED CHILD NEUROL, V57, P194, DOI 10.1111/dmcn.12574; Ishii T, 2013, J BIOL CHEM, V288, P7263, DOI 10.1074/jbc.M112.418004; Jimenez A, 2006, FEBS LETT, V580, P960, DOI 10.1016/j.febslet.2006.01.025; Kaas GA, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0221-16.2016; Lin YT, 2010, CELL MOL NEUROBIOL, V30, P947, DOI 10.1007/s10571-010-9524-x; Liu ZH, 2013, NEURAL REGEN RES, V8, P3275, DOI 10.3969/j.issn.1673-5374.2013.35.002; Luttjohann A, 2009, PHYSIOL BEHAV, V98, P579, DOI 10.1016/j.physbeh.2009.09.005; Mendez-Armenta M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/293689; Patenaude A, 2005, CELL MOL LIFE SCI, V62, P1063, DOI 10.1007/s00018-005-4541-5; Patsoukis N, 2005, EPILEPSIA, V46, P1205, DOI 10.1111/j.1528-1167.2005.63704.x; Patsoukis N, 2004, EPILEPSY RES, V62, P65, DOI 10.1016/j.eplepsyres.2004.08.005; Rauca C, 2004, BRAIN RES, V1009, P203, DOI 10.1016/j.brainres.2004.01.082; Ren XY, 2017, ANTIOXID REDOX SIGN, V27, P989, DOI 10.1089/ars.2016.6925; Rowley S, 2013, FREE RADICAL BIO MED, V62, P121, DOI 10.1016/j.freeradbiomed.2013.02.002; Shin EJ, 2008, NEUROCHEM INT, V52, P1134, DOI 10.1016/j.neuint.2007.12.003; Shin EJ, 2015, FREE RADICAL BIO MED, V84, P355, DOI 10.1016/j.freeradbiomed.2015.03.031; Soerensen J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001813; Tang QY, 2016, CELL REP, V14, P129, DOI 10.1016/j.celrep.2015.12.019; Tinkov AA, 2018, CELL MOL LIFE SCI, V75, P1567, DOI 10.1007/s00018-018-2745-8; Ueda Y, 2007, EXP BRAIN RES, V181, P571, DOI 10.1007/s00221-007-0954-8; Yoshida T, 2005, ANN NY ACAD SCI, V1055, P1, DOI 10.1196/annals.1323.002; Zhu XJ, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00377; Zsurka G, 2015, LANCET NEUROL, V14, P956, DOI 10.1016/S1474-4422(15)00148-9	29	9	9	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210670	10.1371/journal.pone.0210670	http://dx.doi.org/10.1371/journal.pone.0210670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677045	Green Submitted, gold, Green Published			2022-12-26	WOS:000456700400024
J	Cantu-Iris, M; Pastor-Palacios, G; Mauricio-Castillo, JA; Banuelos-Hernandez, B; Avalos-Calleros, JA; Juarez-Reyes, A; Rivera-Bustamante, R; Arguello-Astorga, GR				Cantu-Iris, Mariana; Pastor-Palacios, Guillermo; Armando Mauricio-Castillo, Jorge; Banuelos-Hernandez, Bernardo; Aaron Avalos-Calleros, Jesus; Juarez-Reyes, Alejandro; Rivera-Bustamante, Rafael; Arguello-Astorga, Gerardo R.			Analysis of a new begomovirus unveils a composite element conserved in the CP gene promoters of several Geminiviridae genera: Clues to comprehend the complex regulation of late genes	PLOS ONE			English	Article							COAT PROTEIN PROMOTER; CURLY TOP VIRUS; SINGLE-STRANDED-DNA; 1ST REPORT; TOMATO; SEQUENCE; IDENTIFICATION; ACTIVATION; EXPRESSION; AC2	A novel bipartite begomovirus, Blechum interveinal chlorosis virus (BIeICV), was characterized at the genome level. Comparative analyses revealed that BIeICV coat protein (CP) gene promoter is highly divergent from the equivalent region of other begomoviruses (BGVs), with the single exception of Tomato chino La Paz virus (ToChLPV) with which it shares a 23-bp phylogenetic footprint exhibiting dyad symmetry. Systematic examination of the homologous CP promoter segment of 132 New World BGVs revealed the existence of a quasi-palindromic DNA segment displaying a strongly conserved ACTT-(N7)-AAGT core. The spacer sequence between the palindromic motifs is constant in length, but its sequence is highly variable among viral species, presenting a relaxed consensus (TT)GGKCCCY, which is similar to the Conserved Late Element or CLE (GTGGTCCC), a putative TrAP-responsive element. The homologous CP promoter region of Old World BGVs exhibited a distinct organization, with the putative TATA-box overlapping the left half of the ACTT-N7 composite element. Similar CP promoter sequences, dubbed "TATA-associated composite element" or TACE, were found in viruses belonging to different Geminiviridae genera, hence hinting unsuspected evolutionary relationships among those lineages. To get cues about the TACE function, the regulatory function of the CLE was explored in distinct experimental systems. Transgenic tobacco plants harboring a GUS reporter gene driven by a promoter composed by CLE multimers expressed high beta-glucuronidase activity in absence of viral factors, and that expression was increased by begomovirus infection. On the other hand, the TrAP-responsiveness of a truncated CP promoter of Tomato golden mosaic virus (TGMV) was abolished by site-directed mutation of the only CLE present in it, whereas the artificial addition of one CLE to the -125 truncated promoter strongly enhanced the transactivation level in tobacco protoplasts. These results indicate that the CLE is a TrAP-responsive element, hence providing valuable clues to interpret the recurrent association of the CLE with the TACE. On the basis of the aforesaid direct evidences and the insights afforded by the extensive comparative analysis of BIeICV CP promoter, we propose that the TACE might be involved in the TrAP-mediated derepression of CP gene in vascular tissues.	[Cantu-Iris, Mariana; Aaron Avalos-Calleros, Jesus; Juarez-Reyes, Alejandro; Arguello-Astorga, Gerardo R.] Inst Potosino Invest Cient & Tecnol AC, Div Biol Mol, San Luis Potosi, SLP, Mexico; [Pastor-Palacios, Guillermo] CONACYT CIIDZA Inst Potosino Invest Cient & Tecno, San Luis Potosi, SLP, Mexico; [Armando Mauricio-Castillo, Jorge] Univ Autonoma Zacatecas, Unidad Acad Agron, Cieneguillas, Zacatecas, Mexico; [Banuelos-Hernandez, Bernardo] Univ La Salle Bajio, Fac Agron & Vet, Ave Univ 602, Lomas Del Campestre, Leon Guanajuato, Mexico; [Rivera-Bustamante, Rafael] IPN, Ctr Invest & Estudios Avanzados, Dept Ingn Genet Plantas, Irapuato, Gto, Mexico	Instituto Potosino Investigacion Cientifica y Tecnologica; Universidad Autonoma de Zacatecas; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Arguello-Astorga, GR (corresponding author), Inst Potosino Invest Cient & Tecnol AC, Div Biol Mol, San Luis Potosi, SLP, Mexico.	grarguel@ipicyt.edu.mx	Rivera-Bustamante, Rafael F./AAL-8009-2020; Rivera-Bustamante, Rafael Francisco/CBN-8680-2022; Bañuelos-Hernández, Bernardo/P-8851-2019	Rivera-Bustamante, Rafael F./0000-0002-5114-2370; Rivera-Bustamante, Rafael Francisco/0000-0002-5114-2370; Bañuelos-Hernández, Bernardo/0000-0003-4399-0887; JUAREZ REYES, ALEJANDRO/0000-0002-9732-3345; Arguello-Astorga, Gerardo R./0000-0003-1901-7761; Pastor-Palacios, Guillermo/0000-0003-4273-2851	Consejo Nacional de Ciencia y Tecnologia (CONACYT) of Mexico [SEP-CB-2015-257136]; Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico)	Consejo Nacional de Ciencia y Tecnologia (CONACYT) of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was supported by the Consejo Nacional de Ciencia y Tecnologia (CONACYT) of Mexico (URL-https://www.conacyt.gob.mx/). Grant SEP-CB-2015-257136 to GRAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank to Dr. Roberto Ruiz-Medrano, Dr. Jose Trinidad Ascencio-Ibanez and MSc. Nadia Martinez-Marrero, for critical reading of the manuscript and thoughtful comments and suggestions. MCI and AAC were supported by a fellowship from the Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico).	Al Rwahnih M, 2017, PHYTOPATHOLOGY, V107, P240, DOI 10.1094/PHYTO-07-16-0282-R; ARGUELLOASTORGA G, 1994, PLANT MOL BIOL, V26, P553, DOI 10.1007/BF00013742; ArguelloAstorga GR, 1996, PLANT PHYSIOL, V112, P1151, DOI 10.1104/pp.112.3.1151; ARGUELLOASTORGA GR, 1994, VIROLOGY, V203, P90, DOI 10.1006/viro.1994.1458; Babu KSD, 2018, BIOINFORMATION, V14, P294, DOI 10.6026/97320630014294; Borah BK, 2016, VIROLOGY, V495, P101, DOI 10.1016/j.virol.2016.04.033; Briddon RW, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-97; BRIDDON RW, 1990, VIROLOGY, V177, P85, DOI 10.1016/0042-6822(90)90462-Z; Briddon RW, 1996, VIROLOGY, V219, P387, DOI 10.1006/viro.1996.0264; BROUGH CL, 1992, VIROLOGY, V187, P1, DOI 10.1016/0042-6822(92)90289-2; Brown JK, 2015, ARCH VIROL, V160, P1593, DOI 10.1007/s00705-015-2398-y; Cazzonelli CI, 2005, PLANT MOL BIOL, V58, P465, DOI 10.1007/s11103-005-6589-x; Chang WC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-561; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fondong VN, 2013, MOL PLANT PATHOL, V14, P635, DOI 10.1111/mpp.12032; Gonzalez N, 2015, PLANT CELL, V27, P2273, DOI 10.1105/tpc.15.00006; Gregorio-Jorge J, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-275; GUMUCIO DL, 1992, MOL CELL BIOL, V12, P4919, DOI 10.1128/MCB.12.11.4919; HALEY A, 1992, VIROLOGY, V188, P905, DOI 10.1016/0042-6822(92)90551-Y; Hanley-Bowdoin L, 2013, NAT REV MICROBIOL, V11, P777, DOI 10.1038/nrmicro3117; Hartitz MD, 1999, VIROLOGY, V263, P1, DOI 10.1006/viro.1999.9925; Hernandez C, 2010, PLANT DIS, V94, P917, DOI 10.1094/PDIS-94-7-0917B; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Jeske H., TT VIRUSES 2009, P185; Klute KA, 1996, J GEN VIROL, V77, P1369, DOI 10.1099/0022-1317-77-7-1369; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lacatus G, 2008, VIROLOGY, V376, P79, DOI 10.1016/j.virol.2008.03.012; Lacatus G, 2009, VIROLOGY, V392, P196, DOI 10.1016/j.virol.2009.07.004; Lefeuvre P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019193; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Liang PB, 2015, J GEN VIROL, V96, P2411, DOI 10.1099/vir.0.000173; LIU F, 1994, NATURE, V368, P520, DOI 10.1038/368520a0; Liu L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0302-7; Loconsole G, 2012, VIROLOGY, V432, P162, DOI 10.1016/j.virol.2012.06.005; Ma YX, 2015, J GEN VIROL, V96, P2421, DOI 10.1099/vir.0.000175; Macedo MA, 2018, ARCH VIROL, V163, P737, DOI 10.1007/s00705-017-3662-0; Martinez-Hernandez A, 2002, PLANT PHYSIOL, V128, P1223, DOI 10.1104/pp.010678; Mauricio-Castillo JA, 2007, PLANT DIS, V91, P1513, DOI 10.1094/PDIS-91-11-1513B; Melgarejo TA, 2013, J VIROL, V87, P5397, DOI 10.1128/JVI.00234-13; Muhire BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108277; Nawaz-Ul-Rehman MS, 2009, FEBS LETT, V583, P1825, DOI 10.1016/j.febslet.2009.05.045; Rojas MR, 2005, ANNU REV PHYTOPATHOL, V43, P361, DOI 10.1146/annurev.phyto.43.040204.135939; Ruiz-Medrano R, 1999, VIROLOGY, V253, P162, DOI 10.1006/viro.1998.9484; SAUNDERS K, 1995, J GEN VIROL, V76, P2287, DOI 10.1099/0022-1317-76-9-2287; Shimada-Beltran H, 2007, J GEN VIROL, V88, P3145, DOI 10.1099/vir.0.83003-0; Shivaprasad PV, 2005, J VIROL, V79, P8149, DOI 10.1128/JVI.79.13.8149-8163.2005; Soitamo AJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-204; Sung YK, 1996, FEBS LETT, V383, P51, DOI 10.1016/0014-5793(96)00217-7; SUNTER G, 1994, VIROLOGY, V203, P203, DOI 10.1006/viro.1994.1477; Sunter G, 1997, VIROLOGY, V232, P269, DOI 10.1006/viro.1997.8549; Sunter G, 2003, VIROLOGY, V305, P452, DOI 10.1006/viro.2002.1757; SUNTER G, 1992, PLANT CELL, V4, P1321, DOI 10.1105/tpc.4.10.1321; Medina CGV, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02665; Varma A, 2003, ANN APPL BIOL, V142, P145, DOI 10.1111/j.1744-7348.2003.tb00240.x; Varsani A, 2017, ARCH VIROL, V162, P1819, DOI 10.1007/s00705-017-3268-6; Varsani A, 2014, ARCH VIROL, V159, P1873, DOI 10.1007/s00705-014-1982-x; Whitfield AE, 2015, VIROLOGY, V479, P278, DOI 10.1016/j.virol.2015.03.026; Zerbini FM, 2017, J GEN VIROL, V98, P131, DOI 10.1099/jgv.0.000738	60	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210485	10.1371/journal.pone.0210485	http://dx.doi.org/10.1371/journal.pone.0210485			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673741	Green Published, Green Submitted, gold			2022-12-26	WOS:000456442800044
J	Wood, N; McMunn, A; Webb, E; Stafford, M				Wood, Natasha; McMunn, Anne; Webb, Elizabeth; Stafford, Mai			Marriage and physical capability at mid to later life in England and the USA	PLOS ONE			English	Article							MARITAL-STATUS; SOCIAL-RELATIONS; GRIP STRENGTH; DISABILITY ONSET; OLDER EUROPEANS; COHORT PROFILE; UNITED-STATES; HEALTH; MEN; RISK	Background Married people have lower rates of mortality and report better physical and mental health at older ages, compared to their unmarried counterparts. However, there is limited evidence on the association between marriage and physical capability, the ability to carry out the tasks of daily living, which is predictive of future mortality and social care use. We investigate the association between marital status and physical capability at mid to later life in England and the United States. Methods We examine the association between marriage and physical capability at mid to later life in England and the USA using two performance-based measures of physical capability: grip strength and walking speed. Multiple linear regression was carried out on Wave 4 (2008) of the English Longitudinal Study of Ageing (ELSA) and Waves 8 and 9 (2006 and 2008) of the US Health and Retirement Study (HRS). Results In age adjusted models married men and women had better physical capability than their unmarried counterparts. Much of the marriage advantage was explained by the greater wealth of married people. However, remarried men were found to have stronger grip strength and widowed and never married men had a slower walking speed than men in their first marriage, which was not explained by wealth, demographic and socioeconomic characteristics, health behaviours, chronic disease or depressive symptoms. There were no differences in the association between England and the USA. Conclusions Marriage may be an important factor in maintaining physical capability in both England and the USA, particularly because of the greater wealth which married people have accrued by the time they reach older ages. The grip strength advantage for remarried men may be due to unobserved selective factors into remarriage.	[Wood, Natasha] UCL Inst Educ, CLOSER, London, England; [McMunn, Anne; Webb, Elizabeth] UCL, Dept Epidemiol & Publ Hlth, London, England; [Stafford, Mai] Hlth Fdn, London, England	University of London; University College London; UCL Institute of Education; University of London; University College London	Wood, N (corresponding author), UCL Inst Educ, CLOSER, London, England.	natasha.wood.12@ucl.ac.uk		McMunn, Anne/0000-0003-3237-9345	Economic and Social Research Council [ES/J500185/1]; ESRC [ES/R008930/1] Funding Source: UKRI; MRC [MC_UU_12019/5] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Economic and Social Research Council, grant number ES/J500185/1 (https://esrc.ukri.org/) to NW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avendano M, 2009, AM J PUBLIC HEALTH, V99, P540, DOI 10.2105/AJPH.2008.139469; Avlund K, 2004, ARCH GERONTOL GERIAT, V38, P85, DOI 10.1016/j.archger.2003.08.003; Banks J, 2006, JAMA-J AM MED ASSOC, V295, P2037, DOI 10.1001/jama.295.17.2037; Banks J, 2012, J EPIDEMIOL COMMUN H, V66, P259, DOI 10.1136/jech.2010.108415; Blekesaune M, 2005, EUR SOCIOL REV, V21, P259, DOI 10.1093/esr/jci016; Brewer M., 2014, PARTNERSHIP DISSOLUT; Brunner E, 2009, J GERONTOL A-BIOL, V64, P1082, DOI 10.1093/gerona/glp078; Carr D, 2010, J MARRIAGE FAM, V72, P743, DOI 10.1111/j.1741-3737.2010.00728.x; Cawthon PM, 2009, J AM GERIATR SOC, V57, P1411, DOI 10.1111/j.1532-5415.2009.02366.x; Cherlin AJ, 2005, FUTURE CHILD, V15, P33, DOI 10.1353/foc.2005.0015; Clarke P, 2011, J GERONTOL B-PSYCHOL, V66, P457, DOI 10.1093/geronb/gbr054; CLEMENT FJ, 1974, J GERONTOL, V29, P423, DOI 10.1093/geronj/29.4.423; Clouston SAP, 2014, CAN J AGING, V33, P413, DOI 10.1017/S0714980814000282; COOPER R, 2010, BRIT MED J, V341; Cooper R., 2013, LIFE COURSE APPROACH; Cooper R., 2011, PLOS ONE, V6; Cooper R, 2011, AGE AGEING, V40, P14, DOI 10.1093/ageing/afq117; den Ouden MEM, 2011, MATURITAS, V69, P208, DOI 10.1016/j.maturitas.2011.04.008; Fuhrer R, 2002, SOC SCI MED, V54, P811, DOI 10.1016/S0277-9536(01)00111-3; Gjonca E, 2009, J EPIDEMIOL COMMUN H, V63, P928, DOI 10.1136/jech.2008.082776; GOLDMAN N, 1995, SOC SCI MED, V40, P1717, DOI 10.1016/0277-9536(94)00281-W; Guralnik JM, 2009, AGING CLIN EXP RES, V21, P174; GURALNIK JM, 1989, J GERONTOL, V44, pM141, DOI 10.1093/geronj/44.5.M141; Guralnik JM, 2003, AM J PREV MED, V25, P112, DOI 10.1016/S0749-3797(03)00174-0; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hairi FM, 2010, J EPIDEMIOL COMMUN H, V64, P829, DOI 10.1136/jech.2009.088476; Hughes ME, 2009, J HEALTH SOC BEHAV, V50, P344, DOI 10.1177/002214650905000307; Hurst L, 2013, AM J PUBLIC HEALTH, V103, P1641, DOI 10.2105/AJPH.2013.301240; Jarvis S, 1999, POP STUD-J DEMOG, V53, P237, DOI 10.1080/00324720308077; KIERNAN KE, 1988, J BIOSOC SCI, V20, P253, DOI 10.1017/S0021932000006593; Kuh D, 2005, J GERONTOL A-BIOL, V60, P224, DOI 10.1093/gerona/60.2.224; Kuh D, 2007, J GERONTOL A-BIOL, V62, P717, DOI 10.1093/gerona/62.7.717; Lin IF, 2012, GERONTOLOGIST, V52, P153, DOI 10.1093/geront/gnr141; Litwin H, 2013, EUR J AGEING, V10, P159, DOI 10.1007/s10433-013-0269-5; Lund R, 2010, AGE AGEING, V39, P319, DOI 10.1093/ageing/afq020; Manzoli L, 2007, SOC SCI MED, V64, P77, DOI 10.1016/j.socscimed.2006.08.031; Monden CWS, 2013, EUR J POPUL, V29, P103, DOI 10.1007/s10680-012-9269-y; ONS. Office for National Statistic, 2014, MARR DIV STAT 2012; Pienta AM, 2000, J FAM ISSUES, V21, P559, DOI 10.1177/019251300021005003; Ploubidis GB, 2015, AM J PUBLIC HEALTH, pe1; Raley R. Kelly, 2009, RACE SOC PROBL, V1, P132, DOI DOI 10.1007/S12552-009-9013-3; Rapp I, 2012, KOLNER Z SOZIOL SOZ, V64, P783, DOI 10.1007/s11577-012-0184-3; Rastegar A., 2011, RAND HRS DATA DOCUME; Schane RE, 2008, J GEN INTERN MED, V23, P1757, DOI 10.1007/s11606-008-0749-z; Schneider D, 2011, AM J SOCIOL, V117, P627, DOI 10.1086/661594; Sonnega A, 2014, INT J EPIDEMIOL, V43, P576, DOI 10.1093/ije/dyu067; Spruit MA, 2013, J AM MED DIR ASSOC, V14, DOI 10.1016/j.jamda.2013.06.013; Stansfeld, 2006, SOCIAL DETERMINANTS; Steptoe A, 2013, INT J EPIDEMIOL, V42, P1640, DOI 10.1093/ije/dys168; Syddall H, 2009, J AGING HEALTH, V21, P913, DOI 10.1177/0898264309340793; van den Brink CL, 2004, J AM GERIATR SOC, V52, P353, DOI 10.1111/j.1532-5415.2004.52105.x; Vespa J, 2011, DEMOGRAPHY, V48, P983, DOI 10.1007/s13524-011-0043-2; Wahrendorf M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071893; Waite LJ., 2001, CASE MARRIAGE WHY MA; Williams K, 2004, J HEALTH SOC BEHAV, V45, P81, DOI 10.1177/002214650404500106; Wilmoth J, 2002, J MARRIAGE FAM, V64, P254, DOI 10.1111/j.1741-3737.2002.00254.x; Yan XY, 2011, J INT MED RES, V39, P1142, DOI 10.1177/147323001103900402	57	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0209388	10.1371/journal.pone.0209388	http://dx.doi.org/10.1371/journal.pone.0209388			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI4TC	30673714	Green Published, Green Submitted, gold			2022-12-26	WOS:000456442800017
J	Escobar-Flores, JG; Sandoval, S; Valdez, R; Shahriary, E; Torres, J; Alvarez-Cardenas, S; Gallina-Tessaro, P				Gabriel Escobar-Flores, Jonathan; Sandoval, Sarahi; Valdez, Raul; Shahriary, Eahsan; Torres, Jorge; Alvarez-Cardenas, Sergio; Gallina-Tessaro, Patricia			Waterhole detection using a vegetation index in desert bighorn sheep (Ovis canadensis cremnobates) habitat	PLOS ONE			English	Article							BAJA-CALIFORNIA; WILDLIFE; ENVIRONMENTS; POPULATION; CLIMATE; NDVI; NDWI	In arid ecosystems, desert bighorn sheep are dependent on natural waterholes, particularly in summer when forage is scarce and environmental temperatures are high. To detect waterholes in Sierra Santa Isabel, which is the largest area of desert bighorn sheep habitat in the state of Baja California, Mexico, we used the normalized difference vegetation index (NDVI) and normalized difference water index (NDWI) from Sentinel-2 satellite images. Waterhole detection was based on the premise that sites with greater water availability, where NDVI was higher, can be identified by their density of vegetation greenness. For the detected waterholes, we estimated the escape terrain (presence of cliffs or steep, rocky slopes) around each by the vector ruggedness measure to determine their potential use by desert bighorn sheep based on the animals' presence as documented by camera traps. We detected 14 waterholes with the NDVI of which 11 were known by land owners and 3 were unrecorded. Desert bighorn were not detected in waterholes with high values of escape terrain, i.e., flat areas. Waterhole detection by NDVI is a simple method, and with the assistance and knowledge of the inhabitants of the Sierra, it was possible to confirm the presence each waterhole in the field.	[Gabriel Escobar-Flores, Jonathan] Inst Politecn Nacl, Ctr Interdisciplinario Invest Desarrollo Integral, Unidad Durango, Durango, Mexico; [Sandoval, Sarahi] Inst Politecn Nacl, Ctr Interdisciplinario Invest Desarrollo Integral, Unidad Durango, CONACYT, Durango, Mexico; [Valdez, Raul] New Mexico State Univ, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA; [Shahriary, Eahsan] Univ Texas El Paso, Environm Sci & Engn Program, El Paso, TX 79968 USA; [Torres, Jorge] Ctr Invest Cient & Educ Super Ensenada, Dept Comp Sci, Ensenada, Baja California, Mexico; [Alvarez-Cardenas, Sergio; Gallina-Tessaro, Patricia] Ctr Invest Biol Noroeste, La Paz, Baja California, Mexico	Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; New Mexico State University; University of Texas System; University of Texas El Paso; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Telefonica SA	Sandoval, S (corresponding author), Inst Politecn Nacl, Ctr Interdisciplinario Invest Desarrollo Integral, Unidad Durango, CONACYT, Durango, Mexico.	sarahisandovale@gmail.com		Sandoval, Sarahi/0000-0001-7221-5498	Comision Nacional de Ciencia y Tecnologia [205965];  [98109-1916]	Comision Nacional de Ciencia y Tecnologia; 	All the funding or sources of support received during this specific study. JiJi Foundation (grant number 98109-1916) URL: http://jiji.org/. Comision Nacional de Ciencia y Tecnologia (grant number 205965) URL:www.conacyt.gob.mx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraira V., 2001, SEMERGEN, V27, P247, DOI [DOI 10.1016/S1138-3593(01)73955-X, 10.1016/S1138-3593(01)73955-X]; Aguilar C, 2012, ECOL INDIC, V23, P290, DOI 10.1016/j.ecolind.2012.04.008; Alvarez-Cardenas S, 2009, TROP CONSERV SCI, V2, P189, DOI 10.1177/194008290900200206; [Anonymous], [No title captured]; BERGER J, 1991, ANIM BEHAV, V41, P61, DOI 10.1016/S0003-3472(05)80503-2; Bleich VC, 2006, WILDLIFE SOC B, V34, P627, DOI 10.2193/0091-7648(2006)34[627:QOWATW]2.0.CO;2; Borras J, 2017, REV TELEDETEC, P55, DOI 10.4995/raet.2017.7133; Cain JW, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2007-209; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Cutler TL, 1999, WILDLIFE SOC B, V27, P571; DeForge J., 1993, DESERT BIGHORN COUNC, V37, P24; Dowdy S., 2004, STAT RES, V3rd; Du Y, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8040354; Escobar-Flores JG, 2016, THESIS; Escobar-Flores Jonathan G., 2015, Therya, V6, P519, DOI 10.12933/therya-15-284; Gilad O, 2013, APPL GEOGR, V41, P96, DOI 10.1016/j.apgeog.2013.03.012; GIONFRIDDO JP, 1986, J WILDLIFE MANAGE, V50, P331, DOI 10.2307/3801923; Gonzalez-Abraham CE, 2010, B SOC BOT MEX, V87, P69; Hamel S, 2009, J APPL ECOL, V46, P582, DOI 10.1111/j.1365-2664.2009.01643.x; Hatcher L., 2003, STEP BY STEP BASIC S; Hoglander C, 2015, J WILDLIFE MANAGE, V79, P77, DOI 10.1002/jwmg.818; Isaacson S, 2017, REMOTE SENS ENVIRON, V198, P95, DOI 10.1016/j.rse.2017.05.035; Jones H.G., 2010, REMOTE SENSING VEGET; Krausman PR, 1999, MOUNTAIN SHEEP OF NORTH AMERICA, P139; Lee R, 2012, CALIF FISH GAME, V98, P51; Lioubimtseva E, 2004, PROG PHYS GEOG, V28, P502, DOI 10.1191/0309133304pp422oa; Littell RC, 2002, SAS LINEAR MODELS; Martinez GR, 2011, MUESTREO TERRESTRE A; Martinez-Gallardo R, 2008, ADV STUDY MAMMALS ME, VII, P661; McFeeters SK, 1996, INT J REMOTE SENS, V17, P1425, DOI 10.1080/01431169608948714; Miranda E., 2018, P 2018 INT C INFORM, P69, DOI 10.1109/ICIMTech.2018.8528122; Owen HJF, 2015, REMOTE SENS ECOL CON, V1, P61, DOI 10.1002/rse2.5; Parkes David, 2003, Ecological Management & Restoration, V4, pS29, DOI 10.1046/j.1442-8903.4.s.4.x; Perry TW, 2010, SOUTHWEST NAT, V55, P517, DOI 10.1894/SGM-07.1; QGIS Development Team, 2016, QGIS GEOGR INF SYST; Rebman J.P., 2012, BAJA CALIFORNIA PLAN; Reichenheim ME, 2004, STATA J, V4, P421, DOI 10.1177/1536867X0400400404; Rokni K, 2014, REMOTE SENS-BASEL, V6, P4173, DOI 10.3390/rs6054173; Rosenstock SS, 1999, J RANGE MANAGE, V52, P302, DOI 10.2307/4003538; Rouse JW, 1974, P 3 EARTH RES TECHN, P301; Sandoval AV, 2014, ECOLOGIA MANEJO FAUN, P475; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Sisay A., 2016, AM J GEOGRAPHIC INFO, V5, P33, DOI [10.5923/j.ajgis.20160502.01, DOI 10.5923/J.AJGIS.20160502.01]; Villepique J.T., 2015, ADV ECOL, V2015, P1, DOI [10.1155/2015/357080, DOI 10.1155/2015/357080]; Xu HQ, 2006, INT J REMOTE SENS, V27, P3025, DOI 10.1080/01431160600589179	46	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0211202	10.1371/journal.pone.0211202	http://dx.doi.org/10.1371/journal.pone.0211202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668602	gold, Green Published, Green Submitted			2022-12-26	WOS:000456306400034
J	Lee, SR; Cho, AR; Lee, SY; Cho, YH; Park, EJ; Kim, YJ; Lee, JG				Lee, Sae Rom; Cho, A-ra; Lee, Sang Yeoup; Cho, Young Hye; Park, Eun Ju; Kim, Yun Jin; Lee, Jeong Gyu			Secondhand smoke knowledge, sources of information, and associated factors among hospital staff	PLOS ONE			English	Article							EXPOSURE; ATTITUDES; BEHAVIORS	Purpose To evaluate knowledge of secondhand smoke (SHS) risks, sources of information, and associated factors and behaviors among hospital staff. Methods We conducted a cross-sectional survey using a 40-item self-administered questionnaire among 328 employees at a university hospital. The questions on representative diseases related to SHS were used to measure the degree of knowledge of SHS. Multiple regression analysis was used to determine the correlation between SHS knowledge scores and variables. Results Females had better SHS knowledge scores than males, regardless of smoking status (p<0.05). SHS knowledge was positively correlated with cessation education in males, nonsmokers, and the total sample (beta = 3.950, 2.356, and 2.684, respectively, p<0.05). It was correlated with the experience of any SHS exposure-related symptoms in males, non-smokers, and the total sample (beta = 3.950, 2.356, and 2.684, respectively, p<0.05) and discomfort when exposed to SHS in non-smokers and the total sample (beta = 0.670 and 0.821, respectively, p<0.05). Conclusion SHS knowledge is high among females, when hospital staff are educated about SHS risks, and when they have experienced any SHS exposure-related symptoms or felt uncomfortable when exposed to SHS. SHS risk education is an effective tool to increase SHS knowledge in hospital staff.	[Lee, Sae Rom; Cho, A-ra; Lee, Sang Yeoup; Cho, Young Hye; Park, Eun Ju] Pusan Natl Univ, Yangsan Hosp, Family Med Clin, Yangsan, South Korea; [Lee, Sae Rom; Cho, A-ra; Lee, Sang Yeoup; Cho, Young Hye; Park, Eun Ju] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan, South Korea; [Lee, Sang Yeoup] Pusan Natl Univ, Sch Med, Dept Med Educ, Yangsan, South Korea; [Kim, Yun Jin; Lee, Jeong Gyu] Pusan Natl Univ, Sch Med, Dept Family Med, Yangsan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital	Lee, SY (corresponding author), Pusan Natl Univ, Yangsan Hosp, Family Med Clin, Yangsan, South Korea.; Lee, SY (corresponding author), Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan, South Korea.; Lee, SY (corresponding author), Pusan Natl Univ, Sch Med, Dept Med Educ, Yangsan, South Korea.	saylee@pnu.edu	Lee, Sang Yeoup/AAV-2125-2020; Park, Eunju/AAC-5266-2021	Lee, Sang Yeoup/0000-0002-3585-9910				Aronson E., 1969, ADV EXP SOC PSYCHOL, P1, DOI [10.1016/s0065-2601(08)60075-1, DOI 10.1016/S0065-2601(08)60075-1]; Eisner MD, 2001, ENVIRON HEALTH PERSP, V109, P809, DOI 10.2307/3454823; Evans KA, 2012, J PUBLIC HEALTH-UK, V34, P183, DOI 10.1093/pubmed/fdr104; Gharaibeh H, 2011, INT J ENV RES PUB HE, V8, P4207, DOI 10.3390/ijerph8114207; Gilpin E A, 1999, Nicotine Tob Res, V1, P153, DOI 10.1080/14622299050011261; Jones LL, 2011, NICOTINE TOB RES, V13, P479, DOI 10.1093/ntr/ntr030; Ma GX, 2005, ADDICT BEHAV, V30, P725, DOI 10.1016/j.addbeh.2004.08.018; Nakkash R, 2009, TOB CONTROL, V18, P310, DOI 10.1136/tc.2008.029405; Ponsonby AL, 1996, J EPIDEMIOL COMMUN H, V50, P40, DOI 10.1136/jech.50.1.40; Robinson J, 2007, SOC SCI MED, V65, P641, DOI 10.1016/j.socscimed.2007.03.048; Sim HS, 2000, KOREAN J PREV MED, V33, P91; Substance Abuse and Mental Health Services Administration (US) and Office of the Surgeon General (US), 2020, SMOK CESS REP SURG G; Tshitenge S, 2015, S AFR FAM PRACT, V57, P177, DOI 10.1080/20786190.2014.976963; World Health Organization, 2003, FRAM CONV TOB CONTR, DOI DOI 10.1136/TC.12.3.241	14	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210981	10.1371/journal.pone.0210981	http://dx.doi.org/10.1371/journal.pone.0210981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI2WF	30668578	Green Published, gold, Green Submitted			2022-12-26	WOS:000456306400024
J	da Silva, DA; Tsai, SM; Chiorato, AF; Andrade, SCD; Esteves, JAD; Recchia, GH; Carbonell, SAM				da Silva, Daiana Alves; Tsai, Siu Mui; Chiorato, Alisson Fernando; da Silva Andrade, Sonia Cristina; de Fatima Esteves, Jose Antonio; Recchia, Gustavo Henrique; Morais Carbonell, Sergio Augusto			Analysis of the common bean (Phaseolus vulgaris L.) transcriptome regarding efficiency of phosphorus use	PLOS ONE			English	Article							PHOSPHATE STARVATION; ALIGNMENT; PLANT	Common bean is a highly important food in tropical regions, where most production occurs on small farms with limited use of technology and, consequently, greater vulnerability to abiotic stresses such as nutritional stress. Usually phosphorus (P) is the most limiting nutrient for crop growth in these regions. The aim of this study was to characterize the gene expression profiles of the genotypes of common bean IAC Imperador (P-responsive) and DOR 364 (P-unresponsive) under different P concentrations using RNA-seq transcriptome sequencing technology. Plants were grown hydroponically, with application of two P concentrations (4.00 mg L-1 restrictive level and 8.00 mg L-1 control level). Differential expression analyses, annotation, and functional classification were performed comparing genotypes within each P rate administered and comparing each genotype response to the different P levels. Considering differential expression analyses within genotypes, IAC Imperador exhibited 1538 up-regulated genes under P restriction and 1679 up-regulated genes in the control, while DOR 364 exhibited 13 up-regulated genes in the control and only 2 up-regulated genes under P restriction, strongly corroborating P-unresponsiveness of this genotype. Genes related to phosphorus restriction were identified among the differentially expressed genes, including transcription factors such as WRKY, ERF, and MYB families, phosphatase related genes such as pyrophosphatase, acid phosphatase, and purple acid phosphatase, and phosphate transporters. The enrichment test for the P restriction treatment showed 123 enriched gene ontologies (GO) for IAC Imperador, while DOR 364 enriched only 24. Also, the enriched GO correlated with P metabolism, compound metabolic processes containing phosphate, nucleoside phosphate binding, phosphorylation, and also response to stresses. Thus, this study proved to be informative to phosphorus limitation in common bean showing global changes at transcript level.	[da Silva, Daiana Alves; Chiorato, Alisson Fernando; de Fatima Esteves, Jose Antonio; Morais Carbonell, Sergio Augusto] Ctr Graos & Fibras, Inst Agron IAC, Campinas, SP, Brazil; [Tsai, Siu Mui; Recchia, Gustavo Henrique] Ctr Energia Nucl Agr CENA, Av Centenario, Piracicaba, SP, Brazil; [da Silva Andrade, Sonia Cristina] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Rua Matao, Sao Paulo, SP, Brazil	Instituto Agronomico de Campinas (IAC); Universidade de Sao Paulo	da Silva, DA (corresponding author), Ctr Graos & Fibras, Inst Agron IAC, Campinas, SP, Brazil.	daiagrouel2002@hotmail.com	Tsai, Siu Mui/C-2793-2012; Andrade, Sonia/GLS-1234-2022; Andrade, Sonia CS/F-8267-2014; Recchia, Gustavo Henrique/F-6162-2016	Tsai, Siu Mui/0000-0002-3733-6312; Andrade, Sonia/0000-0002-1302-5261; Andrade, Sonia CS/0000-0002-1302-5261; Recchia, Gustavo Henrique/0000-0002-5054-9806	FAPESP -Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	FAPESP -Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Funded by FAPESP -Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1992, MAXIMIZING CROP YIEL; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Da Silva DA, 2014, SCI AGR, V71, P232, DOI 10.1590/S0103-90162014000300008; Dalla Via V, 2015, PLANT PHYSIOL, V169, P1356, DOI 10.1104/pp.15.00508; FAGERIA NK, 2015, PHOSPHORUS NUTR UPLA, V46, P9, DOI DOI 10.1080/00103624.2015.1018526; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; George Timothy S., 2008, V7, P247; Glass K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04191; Hernandez G, 2007, PLANT PHYSIOL, V144, P752, DOI 10.1104/pp.107.096958; Hernandez-Domiguez EE, 2012, PLANT SCI, V187, P39, DOI 10.1016/j.plantsci.2012.01.009; Hiz MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092598; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liang C, 2012, PLOS ONE, V7, P5; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lynch Jonathan P., 2008, V7, P83; Malavolta E., 1989, Avaliacao de estado nutricional das plantas: principios e aplicacoes., ppp; Miklas PN, 2006, EUPHYTICA, V147, P105, DOI 10.1007/s10681-006-4600-5; Moura WM, 1999, GENTICA LINHAGENS C, V34, P2, DOI [10.11.1/002832, DOI 10.1101/002832]; O'Rourke JA, 2013, PLANT PHYSIOL, V161, P705, DOI 10.1104/pp.112.209254; Oono Y, 2013, PLANT MOL BIOL, V83, P523, DOI 10.1007/s11103-013-0106-4; Patel SS, 2014, LEGUME GENOMICS GENE, V5, P1, DOI DOI 10.5376/LGG.2014.05.0007; Poirier Y, 2015, ANN PLANT REV, V48, DOI [10.1002/978118958841.ch5, DOI 10.1002/978118958841.CH5]; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; Ramirez M, 2013, INT J MOL SCI, V14, P8328, DOI 10.3390/ijms14048328; Scheible WR, 2015, ANNU PLANT REV, V48, P25, DOI 10.1002/9781118958841.ch2; SIDDIQI MY, 1981, J PLANT NUTR, V4, P289, DOI 10.1080/01904168109362919; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tryphone G.M, 2012, INT SCHOLARLY RES NE, V2012, P1, DOI DOI 10.5402/2012/309614; Westermann DT, 2011, CAN J PLANT SCI, V91, P1089, DOI [10.4141/cjps10114, 10.4141/CJPS10114]; White Philip J., 2008, V7, P51; Zhang DH, 2014, INTERNATIONAL CONFERENCE ON ADVANCED COMPUTER SCIENCE AND ENGINEERING (ACSE 2014), P1, DOI 10.1109/JSYST.2014.2346625	37	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210428	10.1371/journal.pone.0210428	http://dx.doi.org/10.1371/journal.pone.0210428			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657755	Green Published, Green Submitted, gold			2022-12-26	WOS:000456017000010
J	Jiang, LB; Tian, XX; Peng, DZ; Zhang, LR; Xie, FX; Bi, CR; Wang, R; Wang, JJ; Qi, DB				Jiang, Lingbo; Tian, Xinxin; Peng, Dezhi; Zhang, Liran; Xie, Fengxiang; Bi, Chunrui; Wang, Rui; Wang, Jiajia; Qi, Debo			HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS PREVALENCE; INVASIVE CERVICAL-CANCER; INTRAEPITHELIAL NEOPLASIA; CONSENSUS GUIDELINES; GLOBAL BURDEN; INFECTION; RISK; DNA; PERFORMANCE; MANAGEMENT	Background Data regarding human papillomavirus (HPV) prevalence and genotype distribution are limited in Shandong Province, China. Therefore, we investigated the recent HPV prevalence and genotype distribution among females in Shandong and aimed to provide comprehensive data to guide HPV-based cervical cancer screening and HPV vaccination for this population of Chinese women. Methods HPV testing results of 94,489 females were retrospectively reviewed and extracted from the database of Jinan KingMed Diagnostics, the largest independent pathology laboratory in Shandong Province, China. HPV was detected by a HPV genotyping panel from January 2011 to June 2017. The overall prevalence, age-specific prevalence, and genotype distribution were analyzed. Results A total of 26,839 cases (28.4%) were HPV-positive, with 4.3% positive for low- or undetermined-risk HPV (lr-/urHPV)-only, 18.1% positive for high-risk HPV (hrHPV)-only, and 6.1% positive for mixed lr-/urHPV and hrHPV infections. Single HPV infections accounted for 62.8%, while the rest were multiple HPV infections of two or more genotypes. HPV16 (5.8%), HPV52 (5.1%), HPV58 (3.5%), HPV51 (2.6%), and HPV56 (2.3%) were the five most common hrHPV genotypes; while HPV81 (2.8%), HPV53 (2.8%), and HPV6 (2.3%) were the three most common lr-/urHPV genotypes. HPV18 (1.7%) was only the ninth most common hrHPV genotype. HPV16 but not HPV52 was more common in single infections than in multiple infections. The distribution of both mixed lr-/urHPV and hrHPV as well as overall HPV infections demonstrated a bimodal pattern across age groups, of which the first peak appeared in the younger group and the second peak was found in older women. A similar age-specific distribution was observed in multiple infections of three or more subtypes as well. Moreover, the proportion of mixed lr-/urHPV and hrHPV infection significantly increased, while those of lr-/urHPV-only and hrHPV-only infections declined as the number of co-infections increased during the study period. Conclusion This large daily clinical practice report shows that HPV prevalence and genotype distribution are different in this population, who had limited cervical cancer screening service, compared to those in developed countries. Therefore, different strategies should be developed for HPV-based cervical cancer screening and vaccine-based HPV prevention in Shandong Province.	[Jiang, Lingbo; Tian, Xinxin; Peng, Dezhi; Bi, Chunrui; Wang, Rui; Wang, Jiajia] Jinan KingMed Diagnost, Dept Lab Med, Jinan, Shandong, Peoples R China; [Zhang, Liran; Xie, Fengxiang; Qi, Debo] Jinan KingMed Diagnost, Dept Pathol, Jinan, Shandong, Peoples R China		Qi, DB (corresponding author), Jinan KingMed Diagnost, Dept Pathol, Jinan, Shandong, Peoples R China.	bobo8369@163.com						Arbyn M, 2009, EUR J CANCER, V45, P2671, DOI 10.1016/j.ejca.2009.07.016; Bergstrom R, 1999, BRIT J CANCER, V81, P159, DOI 10.1038/sj.bjc.6690666; Bi QQ, 2015, J MED VIROL, V87, P2114, DOI 10.1002/jmv.24281; BOUVARD V, 2009, LANCET ONCOL, V10, P321, DOI [DOI 10.1016/S1470-2045(09)70096-8, 10.1016/s1470-2045(09)70096-8]; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Castle PE, 2012, VACCINE, V30, pF117, DOI 10.1016/j.vaccine.2012.05.071; Castle PE, 2011, LANCET ONCOL, V12, P880, DOI 10.1016/S1470-2045(11)70188-7; Chan PKS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107573; Crosbie EJ, 2013, LANCET, V382, P889, DOI 10.1016/S0140-6736(13)60022-7; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Di Jiangli, 2015, Asian Pac J Cancer Prev, V16, P7401; Feldman S, 2011, NEW ENGL J MED, V365, P2145, DOI 10.1056/NEJMp1112532; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Franceschi S, 2006, INT J CANCER, V119, P2677, DOI 10.1002/ijc.22241; Gonzalez P, 2010, CANCER EPIDEM BIOMAR, V19, P3044, DOI 10.1158/1055-9965.EPI-10-0645; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; Herrero R, 2009, J INFECT DIS, V199, P919, DOI 10.1086/597308; Huh WK, 2015, GYNECOL ONCOL, V136, P178, DOI [10.1016/j.ygyno.2014.12.022, 10.1097/AOG.0000000000000669]; Jing LP, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-388; Joura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044; Katki HA, 2011, LANCET ONCOL, V12, P663, DOI 10.1016/S1470-2045(11)70145-0; Lee SA, 2003, CANCER LETT, V198, P187, DOI 10.1016/S0304-3835(03)00312-4; Li J, 2013, ASIAN PAC J CANCER P, V14, P4015, DOI 10.7314/APJCP.2013.14.7.4015; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Li YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118391; Massad LS, 2013, J LOW GENIT TRACT DI, V17, pS1, DOI 10.1097/LGT.0b013e318287d329; Maucort-Boulch D, 2008, CANCER EPIDEM BIOMAR, V17, P717, DOI 10.1158/1055-9965.EPI-07-2691; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Schmitt M, 2013, J CLIN MICROBIOL, V51, P1458, DOI 10.1128/JCM.00087-13; Serrano B, 2014, CANCER EPIDEMIOL, V38, P748, DOI 10.1016/j.canep.2014.09.003; Shi JF, 2012, INT J CANCER, V130, P641, DOI 10.1002/ijc.26042; Stanley M, 2006, VACCINE, V24, P16, DOI 10.1016/j.vaccine.2005.09.002; Wang LQ, 2015, J MED VIROL, V87, P516, DOI 10.1002/jmv.24094; Wang R, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0998-5; WHO/ICO Information Centre on HPV and Cervical Cancer, 2007, Vaccine, V25 Suppl 3, pC1; Wingo PA, 2003, CANCER-AM CANCER SOC, V97, P3133, DOI 10.1002/cncr.11380; Wright TC, 2007, AM J OBSTET GYNECOL, V197, P346, DOI 10.1016/j.ajog.2007.07.047; Wu EQ, 2013, CANCER CAUSE CONTROL, V24, P795, DOI 10.1007/s10552-013-0162-8; Yang L, 2015, EUR J GYNAECOL ONCOL, V36, P73; Yuan XY, 2011, ARCH GYNECOL OBSTET, V283, P1385, DOI 10.1007/s00404-010-1584-0; Zeng ZY, 2016, J CANCER, V7, P1037, DOI 10.7150/jca.14971; Zeng ZY, 2016, AM J CLIN PATHOL, V145, P622, DOI [10.1093/ajcp/aqw010, 10.1093/AJCP/AQW010]; Zhang L, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2223-1; Zhang LR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180618; Zhao FH, 2010, LANCET ONCOL, V11, P1160, DOI 10.1016/S1470-2045(10)70256-4; Zhu XX, 2015, J MED VIROL, V87, P2106, DOI 10.1002/jmv.24280	52	32	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210311	10.1371/journal.pone.0210311	http://dx.doi.org/10.1371/journal.pone.0210311			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653566	Green Published, Green Submitted, gold			2022-12-26	WOS:000456015500033
J	Latek, D; Rutkowska, E; Niewieczerzal, S; Cielecka-Piontek, J				Latek, Dorota; Rutkowska, Ewelina; Niewieczerzal, Szymon; Cielecka-Piontek, Judyta			Drug-induced diabetes type 2: In silico study involving class B GPCRs	PLOS ONE			English	Article							STRUCTURE-BASED DISCOVERY; GUI MEMBRANE-BUILDER; GLP-1 RECEPTOR; CARDIOVASCULAR-DISEASE; CLINICAL-TRIALS; GLUCOSE; MELLITUS; RISK; DATABASE; INSULIN	A disturbance of glucose homeostasis leading to type 2 diabetes mellitus (T2DM) is one of the severe side effects that may occur during a prolonged use of many drugs currently available on the market. In this manuscript we describe the most common cases of drug-induced T2DM, discuss available pharmacotherapies and propose new ones. Among various pharmacotherapies of T2DM, incretin therapies have recently focused attention due to the newly determined crystal structure of incretin hormone receptor GLP1R. Incretin hormone receptors: GLP1R and GIPR together with the glucagon receptor GCGR regulate food intake and insulin and glucose secretion. Our study showed that incretin hormone receptors, named also gut hormone receptors as they are expressed in the gastrointestinal tract, could potentially act as unintended targets (off-targets) for orally administrated drugs. Such off-target interactions, depending on their effect on the receptor (stimulation or inhibition), could be beneficial, like in the case of incretin mimetics, or unwanted if they cause, e.g., decreased insulin secretion. In this in silico study we examined which well-known pharmaceuticals could potentially interact with gut hormone receptors in the off-target way. We observed that drugs with the strongest binding affinity for gut hormone receptors were also reported in the medical information resources as the least disturbing the glucose homeostasis among all drugs in their class. We suggested that those strongly binding molecules could potentially stimulate GIPR and GLP1R and/or inhibit GCGR which could lead to increased insulin secretion and decreased hepatic glucose production. Such positive effect on the glucose homeostasis could compensate for other, adverse effects of pharmacotherapy which lead to drug-induced T2DM. In addition, we also described several top hits as potential substitutes of peptidic incretin mimetics which were discovered in the drug repositioning screen using gut hormone receptors structures against the ZINC15 compounds subset.	[Latek, Dorota; Rutkowska, Ewelina; Niewieczerzal, Szymon] Univ Warsaw, Fac Chem, Warsaw, Poland; [Cielecka-Piontek, Judyta] Poznan Univ Med Sci, Dept Pharmacognosy, Fac Pharm, Poznan, Poland	University of Warsaw; Poznan University of Medical Sciences	Latek, D (corresponding author), Univ Warsaw, Fac Chem, Warsaw, Poland.	dlatek@chem.uw.edu.pl		Cielecka-Piontek, Judyta/0000-0003-0891-5419; Latek, Dorota/0000-0002-0429-0637	National Science Centre in Poland [DEC-2012/07/D/NZ1/04244]	National Science Centre in Poland(National Science Centre, Poland)	DL acknowledges National Science Centre in Poland (https://www.ncn.gov.pl) for financing (Grant No. DEC-2012/07/D/NZ1/04244) and Faculty of Chemistry (http://www.chem.uw.edu.pl), Biological and Chemical Research Centre (http://cnbch.uw.edu.pl) of University of Warsaw for providing the infrastructure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2017, P NATL ACAD SCI USA, V114, P1708, DOI 10.1073/pnas.1620645114; Aiman U, 2014, J PHARMACOL PHARMACO, V5, P181, DOI 10.4103/0976-500X.136097; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; [Anonymous], 2015, SCHRODINGER RELEASE; Anyanwagu U, 2016, CLIN PHARMACOL THER, V99, P390, DOI 10.1002/cpt.274; Arumugam S, 2014, EXP MOL PATHOL, V97, P137, DOI 10.1016/j.yexmp.2014.06.007; Bell DSH, 2014, DIABETES OBES METAB, V16, P689, DOI 10.1111/dom.12254; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Blackburn DF, 2006, CAN J CARDIOL, V22, P229, DOI 10.1016/S0828-282X(06)70902-3; Boulin M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162951; Bozkurt O, 2009, AM J HYPERTENS, V22, P545, DOI 10.1038/ajh.2009.38; Brown MJ, 2016, LANCET DIABETES ENDO, V4, P136, DOI 10.1016/S2213-8587(15)00377-0; BRUNO A, 1987, ARCH INTERN MED, V147, P679, DOI 10.1001/archinte.147.4.679; Butler PC, 2013, DIABETES CARE, V36, P2118, DOI 10.2337/dc12-2713; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Carter AA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2610; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chang RL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000938; Chatterjee A, 2014, BIOORGAN MED CHEM, V22, P6409, DOI 10.1016/j.bmc.2014.09.043; Chen LG, 2010, PHARMACOGENET GENOM, V20, P687, DOI 10.1097/FPC.0b013e32833fe789; Cheng FX, 2013, J CHEM INF MODEL, V53, P744, DOI 10.1021/ci4000079; Clore JN, 2009, ENDOCR PRACT, V15, P469, DOI 10.4158/EP08331.RAR; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Cooper-DeHoff RM, 2014, CIRCULATION CARDIOVA; Cordomi A, 2016, CURR OPIN PHARMACOL, V31, P63, DOI 10.1016/j.coph.2016.09.001; Cutler JA, 2006, HYPERTENSION, V48, P198, DOI 10.1161/01.HYP.0000231339.51310.b3; de Graaf C, 2016, PHARMACOL REV, V68, P954, DOI 10.1124/pr.115.011395; Di Dalmazi G, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/525093; Egan AG, 2014, NEW ENGL J MED, V370, P794, DOI 10.1056/NEJMp1314078; Elliott WJ, 2007, LANCET, V369, P201, DOI 10.1016/S0140-6736(07)60108-1; Esteva-Font C, 2015, NAT REV NEPHROL, V11, P113, DOI 10.1038/nrneph.2014.219; Finan B, 2015, NAT MED, V21, P27, DOI 10.1038/nm.3761; Gerthoffer WT, 2013, CURR OPIN PHARMACOL, V13, P324, DOI 10.1016/j.coph.2013.04.002; Gilson MK, 2016, NUCLEIC ACIDS RES, V44, pD1045, DOI 10.1093/nar/gkv1072; Glover M, 2011, CARDIOVASC THER, V29, P68, DOI 10.1111/j.1755-5922.2010.00180.x; Guney E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10331; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hirst JA, 2015, BRIT J CLIN PHARMACO, V79, P733, DOI 10.1111/bcp.12543; Hollenstein K, 2014, TRENDS PHARMACOL SCI, V35, P12, DOI 10.1016/j.tips.2013.11.001; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Hwang JL, 2014, DIABETES-METAB RES, V30, P96, DOI 10.1002/dmrr.2486; Imatoh T, 2017, J CLIN PHARM THER, V42, P215, DOI 10.1111/jcpt.12499; Irwin N, 2009, BEST PRACT RES CL EN, V23, P499, DOI 10.1016/j.beem.2009.03.001; Izzedine Hassane, 2005, Expert Opin Drug Saf, V4, P1097, DOI 10.1517/14740338.4.6.1097; Jazayeri A, 2017, NATURE, V546, P254, DOI 10.1038/nature22800; Jazayeri A, 2016, NATURE, V533, P274, DOI 10.1038/nature17414; Ji YL, 2016, CANCER PREV RES, V9, P379, DOI 10.1158/1940-6207.CAPR-15-0300; Jiao MK, 2015, CURR TOP MED CHEM, V15, P767, DOI 10.2174/1568026615666150302105831; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; Kappe C, 2015, CLIN SCI, V129, P405, DOI 10.1042/CS20140719; Kim D, 2016, BIOCHEM BIOPH RES CO, V469, P399, DOI 10.1016/j.bbrc.2015.11.095; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Kolb P, 2009, P NATL ACAD SCI USA, V106, P6843, DOI 10.1073/pnas.0812657106; Konstantopoulos N, 2012, DIABETES, V61, P2146, DOI 10.2337/db11-0578; Kostis JB, 2005, AM J CARDIOL, V95, P29, DOI 10.1016/j.amjcard.2004.08.059; Kuhn M, 2016, NUCLEIC ACIDS RES, V44, pD1075, DOI 10.1093/nar/gkv1075; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; Latek D, 2017, BMC STRUCT BIOL, V17, DOI 10.1186/s12900-017-0078-8; Latek D, 2016, J CHEM INF MODEL, V56, P630, DOI 10.1021/acs.jcim.5b00451; Latek D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056742; Latek D, 2011, J MOL MODEL, V17, P2353, DOI 10.1007/s00894-011-0986-7; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Li YY, 2012, GENOME MED, V4, DOI 10.1186/gm326; Lim VJY, 2018, PROTEINS, V86, P978, DOI 10.1002/prot.25533; Lohinai Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144797; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; Mandal AK, 2012, J DIABETES RES CLIN, V1, P4; Manglik A, 2016, NATURE, V537, P185, DOI 10.1038/nature19112; Manrique C, 2010, HYPERTENSION, V55, P15, DOI 10.1161/HYPERTENSIONAHA.109.142620; McCreight LJ, 2016, DIABETOLOGIA, V59, P426, DOI 10.1007/s00125-015-3844-9; McLaughlin JT, 2016, CURR OPIN PHARMACOL, V31, P8, DOI 10.1016/j.coph.2016.08.006; Messerli FH, 2011, AM J MED, V124, P896, DOI 10.1016/j.amjmed.2011.05.009; Mills E, 2015, LONDON J PRIM CARE, V7, P103, DOI 10.1080/17571472.2015.1082344; Miszta P, 2018, NUCLEIC ACIDS RES, V46, pW387, DOI 10.1093/nar/gky429; Moran BM, 2016, CURR OPIN PHARMACOL, V31, P57, DOI 10.1016/j.coph.2016.08.009; Myers MG, 2012, NATURE, V491, P357, DOI 10.1038/nature11705; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Okuyama H, 2016, PHARMACOLOGY, V98, P134, DOI 10.1159/000446704; OMOTE M, 1994, ARZNEIMITTELFORSCH, V44-1, P149; Ong KL, 2014, AM HEART J, V167, P421, DOI 10.1016/j.ahj.2013.12.025; Oprea Tudor I, 2011, Drug Discov Today Ther Strateg, V8, P61; Orgaard A, 2017, DIABETOLOGIA, V60, P1731, DOI 10.1007/s00125-017-4315-2; Paoletta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097858; Pasznik P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210705; Pearson MJ, 2016, DIABETES CARE, V39, P1075, DOI 10.2337/dci15-0033; Petrillo MG, 2017, FASEB J S, V31; Preiss D, 2012, EUR J HEART FAIL, V14, P909, DOI 10.1093/eurjhf/hfs067; Qureshi SA, 2004, DIABETES, V53, P3267, DOI 10.2337/diabetes.53.12.3267; Rajeev SP, 2016, CURR OPIN PHARMACOL, V31, P44, DOI 10.1016/j.coph.2016.08.005; Ravindranath PA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004586; Rehman A, 2011, DIABETES SPECTR, V24, P234, DOI DOI 10.2337/DIASPECT.24.4.234; Roglic G., 2016, GLOBAL REPORT DIABET; Rognan D, 2017, PHARMACOL THERAPEUT, V175, P47, DOI 10.1016/j.pharmthera.2017.02.034; Sander GE, 2011, J CLIN HYPERTENS, V13, P296, DOI 10.1111/j.1751-7176.2011.00454.x; Sandhu K, 2017, WORLD J CARDIOL, V9, P1, DOI 10.4330/wjc.v9.i1.1; Shafi T, 2008, HYPERTENSION, V52, P1022, DOI 10.1161/HYPERTENSIONAHA.108.119438; Sica Doemnic A, 2004, J Clin Hypertens (Greenwich), V6, P532, DOI 10.1111/j.1524-6175.2004.03789.x; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Song GJ, 2017, NATURE, V546, P312, DOI 10.1038/nature22378; Sowers JR, 2010, J HYPERTENS, V28, P1761, DOI 10.1097/HJH.0b013e32833af380; Sterling T, 2015, J CHEM INF MODEL, V55, P2324, DOI 10.1021/acs.jcim.5b00559; Suh S, 2017, ENDOCRINOL METAB, V32, P180, DOI 10.3803/EnM.2017.32.2.180; Szklarczyk D, 2016, NUCLEIC ACIDS RES, V44, pD380, DOI 10.1093/nar/gkv1277; Thakker D, 2016, PHARMACOEPIDEM DR S, V25, P1131, DOI 10.1002/pds.4020; Thanawala VJ, 2014, CURR OPIN PHARMACOL, V16, P50, DOI 10.1016/j.coph.2014.03.002; Troke RC, 2014, THER ADV CHRONIC DIS, V5, P4, DOI 10.1177/2040622313506730; Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e; Van den Driessche G, 2017, J CHEMINFORMATICS, V9, DOI 10.1186/s13321-017-0202-6; van der Goes MC, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4686; Vohra S, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0846; Vue MH., 2011, DIABETES SPECTR, V24, P171, DOI DOI 10.2337/DIASPECT.24.3.171; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Warshaviak DT, 2014, J CHEM INF MODEL, V54, P1941, DOI 10.1021/ci500175r; WHEELER MB, 1993, ENDOCRINOLOGY, V133, P57, DOI 10.1210/en.133.1.57; Wootten D, 2016, CELL, V165, P1632, DOI 10.1016/j.cell.2016.05.023; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Yang LL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8859; YOON D, 2016, MEDICINE, V95; Yuan SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047114; ZHANG DQ, 2013, BIOMED RES INT, P36053, DOI DOI 10.1155/2013/; Zhang HN, 2017, NATURE, V546, P259, DOI 10.1038/nature22363; Zhang WW, 2013, CLIN DRUG INVEST, V33, P263, DOI 10.1007/s40261-013-0063-3; Zhang Y, 2002, DIABETES CARE, V25, P500, DOI 10.2337/diacare.25.3.500; Zhang Y, 2017, NATURE, V546, P248, DOI 10.1038/nature22394; Zhou J, 2017, EUR J MED CHEM, V138, P1158, DOI 10.1016/j.ejmech.2017.07.046; Zhu T, 2013, J MED CHEM, V56, P6560, DOI 10.1021/jm301916b	129	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0208892	10.1371/journal.pone.0208892	http://dx.doi.org/10.1371/journal.pone.0208892			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650080	Green Submitted, Green Published, gold			2022-12-26	WOS:000455813300007
J	Nagaraju, M; Kumar, SA; Reddy, PS; Kumar, A; Rao, DM; Kishor, PBK				Nagaraju, M.; Kumar, S. Anil; Reddy, Palakolanu Sudhakar; Kumar, Anuj; Rao, D. Manohar; Kishor, P. B. Kavi			Genome-scale identification, classification, and tissue specific expression analysis of late embryogenesis abundant (LEA) genes under abiotic stress conditions in Sorghum bicolor L.	PLOS ONE			English	Article							WATER-USE EFFICIENCY; PROTEIN GENE; WIDE IDENTIFICATION; DNA-BINDING; FUNCTIONAL-ANALYSIS; CITRUS DEHYDRIN; ABSCISIC-ACID; METAL-BINDING; FAMILY; TOLERANCE	Late embryogenesis abundant (LEA) proteins, the space fillers or molecular shields, are the hydrophilic protective proteins which play an important role during plant development and abiotic stress. The systematic survey and characterization revealed a total of 68 LEA genes, belonging to 8 families in Sorghum bicolor. The LEA-2, a typical hydrophobic family is the most abundant family. All of them are evenly distributed on all 10 chromosomes and chromosomes 1, 2, and 3 appear to be the hot spots. Majority of the S. bicolor LEA (SbLEA) genes are intron less or have fewer introns. A total of 22 paralogous events were observed and majority of them appear to be segmental duplications. Segmental duplication played an important role in SbLEA-2 family expansion. A total of 12 orthologs were observed with Arabidopsis and 13 with Oryza sativa. Majority of them are basic in nature, and targeted by chloroplast subcellular localization. Fifteen miRNAs targeted to 25 SbLEAs appear to participate in development, as well as in abiotic stress tolerance. Promoter analysis revealed the presence of abiotic stress-responsive DRE, MYB, MYC, and GT1, biotic stress-responsive W-Box, hormone-responsive ABA, ERE, and TGA, and development-responsive SKn cis-elements. This reveals that LEA proteins play a vital role during stress tolerance and developmental processes. Using microarray data, 65 SbLEA genes were analyzed in different tissues (roots, pith, rind, internode, shoot, and leaf) which show clear tissue specific expression. qRT-PCR analysis of 23 SbLEA genes revealed their abundant expression in various tissues like roots, stems and leaves. Higher expression was noticed in stems compared to roots and leaves. Majority of the SbLEA family members were up-regulated at least in one tissue under different stress conditions. The SbLEA3-2 is the regulator, which showed abundant expression under diverse stress conditions. Present study provides new insights into the formation of LEAs in S. bicolor and to understand their role in developmental processes under stress conditions, which may be a valuable source for future research.	[Nagaraju, M.; Rao, D. Manohar; Kishor, P. B. Kavi] Osmania Univ, Dept Genet, Hyderabad, India; [Kumar, S. Anil] Vignans Fdn Sci Technol & Res, Dept Biotechnol, Guntur, Andhra Pradesh, India; [Reddy, Palakolanu Sudhakar] Int Crops Res Inst Semi Arid Trop, Hyderabad, India; [Kumar, Anuj] Uttarakhand Council Biotechnol, Adv Ctr Computat & Appl Biotechnol, Silk Pk, Dehra Dun, Uttar Pradesh, India	Osmania University; Vignan's Foundation for Science, Technology & Research (VFSTR); CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT)	Kishor, PBK (corresponding author), Osmania Univ, Dept Genet, Hyderabad, India.	pbkavi@yahoo.com	Kumar, Anuj/AAE-8773-2021; MARKA, NAGARAJU/Y-7001-2019; Kumar, Anuj/J-7067-2019	Kumar, Anuj/0000-0002-5023-7618; Marka, Nagaraju/0000-0002-9170-8543; Kavi Kishor, Polavarapu/0000-0002-9587-7547	UGC, New Delhi; CSIR, New Delhi	UGC, New Delhi(University Grants Commission, India); CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	MN is thankful to the UGC, New Delhi, for providing fellowship. PBK is thankful to the CSIR, New Delhi, for providing CSIR-Emeritus Scientist Fellowship.	Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Almodares A, 2008, AFR J BIOTECHNOL, V7, P4051; Almodares A., 2008, Research Journal of Environmental Sciences, V2, P298; Alsheikh MK, 2003, J BIOL CHEM, V278, P40882, DOI 10.1074/jbc.M307151200; Altunoglu YC, 2017, PHYSIOL MOL BIOL PLA, V23, P5, DOI 10.1007/s12298-016-0405-8; Altunoglu YC, 2016, PLANT GROWTH REGUL, V80, P225, DOI 10.1007/s10725-016-0160-4; Ambros V, 2007, DEVELOPMENT, V134, P1635, DOI 10.1242/dev.002006; Artimo Panu, 2012, Nucleic Acids Res, V40, pW597, DOI 10.1093/nar/gks400; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bies-Etheve N, 2008, PLANT MOL BIOL, V67, P107, DOI 10.1007/s11103-008-9304-x; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Boucher V, 2010, PLANT CELL ENVIRON, V33, P418, DOI 10.1111/j.1365-3040.2009.02093.x; Candat A, 2014, PLANT CELL, V26, P3148, DOI 10.1105/tpc.114.127316; Cao J, 2015, PLANTA, V241, P757, DOI 10.1007/s00425-014-2215-y; Cao J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-465; Charfeddine S, 2015, MOL BIOL REP, V42, P1163, DOI 10.1007/s11033-015-3853-2; Chen WQ, 2002, PLANT CELL, V14, P559, DOI 10.1105/tpc.010410; Chen YZ, 2014, J INTEGR PLANT BIOL, V56, P133, DOI 10.1111/jipb.12127; Cramer GR, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-163; Dai Xinbin, 2011, Nucleic Acids Res, V39, pW155, DOI 10.1093/nar/gkr319; Dalal M, 2009, J BIOTECHNOL, V139, P137, DOI 10.1016/j.jbiotec.2008.09.014; Du DL, 2013, MOL BIOL REP, V40, P1937, DOI 10.1007/s11033-012-2250-3; DURE L, 1981, BIOCHEMISTRY-US, V20, P4162, DOI 10.1021/bi00517a033; DURE L, 1989, PLANT MOL BIOL, V12, P475, DOI 10.1007/BF00036962; DURE L, 1993, PLANT J, V3, P363, DOI 10.1046/j.1365-313X.1993.t01-18-00999.x; Eriksson SK, 2011, DEHYDRINS MOL BIOL S; ESPELUND M, 1992, PLANT J, V2, P241; Filiz E, 2013, PLANT OMICS, V6, P433; Flexas J, 2004, PLANT BIOLOGY, V6, P269, DOI 10.1055/s-2004-820867; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Gai YP, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010363; Gao J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19467; Gao S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19736; Garay-Arroyo A, 2000, J BIOL CHEM, V275, P5668, DOI 10.1074/jbc.275.8.5668; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Grelet J, 2005, PLANT PHYSIOL, V137, P157, DOI 10.1104/pp.104.052480; Grennan AK, 2006, PLANT PHYSIOL, V141, P1164, DOI 10.1104/pp.104.900198; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; Hara M, 2005, J EXP BOT, V56, P2695, DOI 10.1093/jxb/eri262; Hara M, 2009, PLANT CELL ENVIRON, V32, P532, DOI 10.1111/j.1365-3040.2009.01947.x; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hincha DK, 2012, BIOCHEM SOC T, V40, P1000, DOI 10.1042/BST20120109; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Huang Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165953; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1895; Imai R, 1996, GENE, V170, P243, DOI 10.1016/0378-1119(95)00868-3; Jeffares DC, 2008, TRENDS GENET, V24, P375, DOI 10.1016/j.tig.2008.05.006; Kamisugi Y, 2005, PLANT MOL BIOL, V59, P723, DOI 10.1007/s11103-005-0909-z; Katiyar A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00506; Kong H, 2007, PLANT J, V50, P873, DOI 10.1111/j.1365-313X.2007.03097.x; Kovacs D, 2008, PLANT PHYSIOL, V147, P381, DOI 10.1104/pp.108.118208; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kruger C, 2002, J BIOL CHEM, V277, P25062, DOI 10.1074/jbc.M201896200; Lan T, 2013, TREE GENET GENOMES, V9, P253, DOI 10.1007/s11295-012-0551-2; Leprince O, 2010, PLANT SCI, V179, P554, DOI 10.1016/j.plantsci.2010.02.011; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Li CN, 2015, ENVIRON EXP BOT, V114, P80, DOI 10.1016/j.envexpbot.2014.06.014; Li Le, 2011, Scientia Agricultura Sinica, V44, P3945; Li X, 2016, PLANT MOL BIOL REP, V34, P15, DOI 10.1007/s11105-015-0901-y; Liang Y., 2016, SCI REP UK, V6; Lin CH, 2012, PLANT CELL PHYSIOL, V53, P930, DOI 10.1093/pcp/pcs040; Liu GB, 2011, PLANT CELL PHYSIOL, V52, P994, DOI 10.1093/pcp/pcr052; Liu HJ, 2015, MOL PLANT, V8, P871, DOI 10.1016/j.molp.2015.01.016; Liu Y, 2013, PLANT CELL PHYSIOL, V54, P944, DOI 10.1093/pcp/pct047; Magwanga RO, 2018, BMC GENET, V19, DOI 10.1186/s12863-017-0596-1; Maskin L, 2007, BIOCHEM BIOPH RES CO, V352, P831, DOI 10.1016/j.bbrc.2006.11.115; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Nagaraju M, 2018, PLANT GENE, V13, P64, DOI DOI 10.1016/J.PLGENE.2018.01.004; Nekrutenko A, 2003, GENE, V306, P99, DOI 10.1016/S0378-1119(03)00427-X; Nishiuchi T, 2004, J BIOL CHEM, V279, P55355, DOI 10.1074/jbc.M409674200; Olvera-Carrillo Y, 2010, PLANT PHYSIOL, V154, P373, DOI 10.1104/pp.110.158964; Opitz N, 2016, J EXP BOT, V67, P1095, DOI 10.1093/jxb/erv453; Park HC, 2004, PLANT PHYSIOL, V135, P2150, DOI 10.1104/pp.104.041442; Patil A, 2006, FEBS LETT, V580, P2041, DOI 10.1016/j.febslet.2006.03.003; Pedrosa AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145785; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Promkhambut A., 2010, Asian Journal of Plant Sciences, V9, P183; Reddy PS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00529; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Salih H, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0436-8; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shao HB, 2005, COLLOID SURFACE B, V45, P131, DOI 10.1016/j.colsurfb.2005.07.017; Sivamani E, 2000, PLANT SCI, V155, P1, DOI 10.1016/S0168-9452(99)00247-2; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Sonnhammer ELL, 2015, NUCLEIC ACIDS RES, V43, pD234, DOI 10.1093/nar/gku1203; Steduto P, 1997, FIELD CROP RES, V54, P221, DOI 10.1016/S0378-4290(97)00050-6; SUNKAR R, 2008, BMC PLANT BIOL, V8; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tian T, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw099; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang MZ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0290-7; Wang XS, 2007, PLANT SCI, V172, P414, DOI 10.1016/j.plantsci.2006.10.004; Wang Y, 2008, PLANT PHYSIOL, V148, P1201, DOI 10.1104/pp.108.126375; Xie FL, 2015, J EXP BOT, V66, P789, DOI 10.1093/jxb/eru437; Xiong L, 2002, PLANT CELL ENVIRON, V25, P131, DOI 10.1046/j.1365-3040.2002.00782.x; Xu DP, 1996, PLANT PHYSIOL, V110, P249, DOI 10.1104/pp.110.1.249; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yang TB, 2002, J BIOL CHEM, V277, P45049, DOI 10.1074/jbc.M207941200; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yu JN, 2005, J INTEGR PLANT BIOL, V47, P1372, DOI 10.1111/j.1744-7909.2005.00126.x; [张林生 Zhang Lin Sheng], 2003, [植物生理学通讯, Plant Physiology Communications], V39, P61; Zhou M, 2013, PLANT PHYSIOL, V161, P1375, DOI 10.1104/pp.112.208702	113	36	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209980	10.1371/journal.pone.0209980	http://dx.doi.org/10.1371/journal.pone.0209980			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650107	Green Accepted, Green Published, gold			2022-12-26	WOS:000455813300036
J	Seoane, M; Buhs, S; Iglesias, P; Strauss, J; Puller, AC; Muller, J; Gerull, H; Feldhaus, S; Alawi, M; Brandner, JM; Eggert, D; Du, JY; Thomale, J; Wild, PJ; Zimmermann, M; Sternsdorf, T; Schumacher, U; Nollau, P; Fisher, DE; Horstmann, MA				Seoane, Marcos; Buhs, Sophia; Iglesias, Pablo; Strauss, Julia; Puller, Ann-Christin; Mueller, Juergen; Gerull, Helwe; Feldhaus, Susanne; Alawi, Malik; Brandner, Johanna M.; Eggert, Dennis; Du, Jinyan; Thomale, Juergen; Wild, Peter J.; Zimmermann, Martin; Sternsdorf, Thomas; Schumacher, Udo; Nollau, Peter; Fisher, David E.; Horstmann, Martin A.			Lineage-specific control of TFIIH by MITF determines transcriptional homeostasis and DNA repair	ONCOGENE			English	Article							NUCLEOTIDE EXCISION-REPAIR; CELL-CYCLE ARREST; XERODERMA-PIGMENTOSUM; MASTER REGULATOR; MELANOMA; MICROPHTHALMIA; MELANOCYTES; ACTIVATION; MYC; EXPRESSION	The melanocytic lineage, which is prominently exposed to ultraviolet radiation (UVR) and radiation-independent oxidative damage, requires specific DNA-damage response mechanisms to maintain genomic and transcriptional homeostasis. The coordinate lineage-specific regulation of intricately intertwined DNA repair and transcription is incompletely understood. Here we demonstrate that the Microphthalmia-associated transcription factor (MITF) directly controls general transcription and UVR-induced nucleotide excision repair by transactivation of GTF2H1 as a core element of TFIIH. Thus, MITF ensures the rapid resumption of transcription after completion of strand repair and maintains transcriptional output, which is indispensable for survival of the melanocytic lineage including melanoma in vitro and in vivo. Moreover, MITF controls c-MYC implicated in general transcription by transactivation of far upstream binding protein 2 (FUBP2/KSHRP), which induces c-MYC pulse regulation through TFIIH, and experimental depletion of MITF results in consecutive loss of CDK7 in the TFIIH-CAK subcomplex. Targeted for proteasomal degradation, CDK7 is dependent on transactivation by MITF or c-MYC to maintain a steady state. The dependence of TFIIH-CAK on sequence-specific MITF and c-MYC constitutes a previously unrecognized mechanism feeding into super-enhancer-driven or other oncogenic transcriptional circuitries, which supports the concept of a transcription-directed therapeutic intervention in melanoma.	[Seoane, Marcos; Buhs, Sophia; Iglesias, Pablo; Strauss, Julia; Puller, Ann-Christin; Mueller, Juergen; Gerull, Helwe; Sternsdorf, Thomas; Nollau, Peter; Horstmann, Martin A.] Childrens Canc Ctr Hamburg, Res Inst, D-20246 Hamburg, Germany; [Seoane, Marcos; Buhs, Sophia; Iglesias, Pablo; Strauss, Julia; Puller, Ann-Christin; Mueller, Juergen; Gerull, Helwe; Sternsdorf, Thomas; Nollau, Peter; Horstmann, Martin A.] Univ Med Ctr Hamburg, Dept Pediat Hematol & Oncol, D-20246 Hamburg, Germany; [Feldhaus, Susanne; Schumacher, Udo] Univ Med Ctr Hamburg, Inst Anat & Expt Morphol, D-20246 Hamburg, Germany; [Alawi, Malik] Univ Med Ctr Hamburg, Bioinformat Serv Facil, D-20246 Hamburg, Germany; [Alawi, Malik; Eggert, Dennis] Leibniz Inst Expt Virol, Heinrich Pette Inst, D-20251 Hamburg, Germany; [Brandner, Johanna M.] Univ Med Ctr Hamburg, Dept Dermatol, D-20246 Hamburg, Germany; [Eggert, Dennis] Max Planck Inst Struct & Dynam Matter, D-22761 Hamburg, Germany; [Du, Jinyan] Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Thomale, Juergen] Univ Duisburg Essen, Inst Cell Biol, D-45122 Essen, Germany; [Wild, Peter J.] Univ Hosp Zurich, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Zimmermann, Martin] Med Sch Hannover, Dept Pediat Hematol & Oncol, D-30625 Hannover, Germany; [Fisher, David E.] Harvard Med Sch, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Dept Dermatol, Boston, MA 02115 USA; [Du, Jinyan] Merrimack Pharmaceut, Cambridge, MA 02139 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; Max Planck Society; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Duisburg Essen; University of Zurich; University Zurich Hospital; Hannover Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Horstmann, MA (corresponding author), Childrens Canc Ctr Hamburg, Res Inst, D-20246 Hamburg, Germany.; Horstmann, MA (corresponding author), Univ Med Ctr Hamburg, Dept Pediat Hematol & Oncol, D-20246 Hamburg, Germany.	horstman@uke.de	, Malik/AAB-7437-2021; Fisher, David/AAH-2878-2019	, Malik/0000-0002-5993-7709; Iglesias Vazquez, Pablo/0000-0003-2506-5313; Wild, Peter Johannes/0000-0002-1017-3744	Deutsche Forschungsgemeinschaft (DFG) [Ho2176/3-1/2]; Fordergemeinschaft Kinderkrebs-Zentrum Hamburg; Rudiger Colditz Stiftung; NATIONAL CANCER INSTITUTE [R01CA222871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Fordergemeinschaft Kinderkrebs-Zentrum Hamburg; Rudiger Colditz Stiftung; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Deutsche Forschungsgemeinschaft (DFG) grants to M.A.H. (Ho2176/3-1/2), Fordergemeinschaft Kinderkrebs-Zentrum Hamburg and the Rudiger Colditz Stiftung. We gratefully acknowledge help from members of the Grundhoff lab for technical support and members of the microscopy and imaging group, both at the Heinrich-Pette-Institute, Hamburg. We also thank Ewa Wladykowski, Christine Knies, and Tobias Gosau for technical assistance.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Beerens N, 2005, J BIOL CHEM, V280, P4722, DOI 10.1074/jbc.M409147200; Bertolotto C, 2011, NATURE, V480, P94, DOI 10.1038/nature10539; Bushnell DA, 1996, J BIOL CHEM, V271, P20170, DOI 10.1074/jbc.271.33.20170; Carreira S, 2005, NATURE, V433, P764, DOI 10.1038/nature03269; Chen J, 2003, NATURE, V424, P228, DOI 10.1038/nature01746; Chymkowitch P, 2011, EMBO J, V30, P468, DOI 10.1038/emboj.2010.337; Coin F, 2008, MOL CELL, V31, P9, DOI 10.1016/j.molcel.2008.04.024; Compe E, 2012, NAT REV MOL CELL BIO, V13, P343, DOI 10.1038/nrm3350; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; Davis IJ, 2006, CANCER CELL, V9, P473, DOI 10.1016/j.ccr.2006.04.021; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Development Core Team, 2013, R LANG ENV STAT COMP; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; Drapkin R, 1996, P NATL ACAD SCI USA, V93, P6488, DOI 10.1073/pnas.93.13.6488; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Eliades P, 2018, J INVEST DERMATOL, V138, P1582, DOI 10.1016/j.jid.2017.09.056; FISCHER L, 1992, SCIENCE, V257, P1392, DOI 10.1126/science.1529339; Ganuza M, 2012, EMBO J, V31, P2498, DOI 10.1038/emboj.2012.94; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Garrett S, 2001, MOL CELL BIOL, V21, P88, DOI 10.1128/MCB.21.1.88-99.2001; Gervais V, 2004, NAT STRUCT MOL BIOL, V11, P616, DOI 10.1038/nsmb782; Hachiya A, 2001, J INVEST DERMATOL, V116, P578, DOI 10.1046/j.1523-1747.2001.01290.x; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Iben S, 2002, CELL, V109, P297, DOI 10.1016/S0092-8674(02)00729-8; James L, 2002, P NATL ACAD SCI USA, V99, P10429, DOI 10.1073/pnas.162369299; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; King R, 1999, AM J PATHOL, V155, P731, DOI 10.1016/S0002-9440(10)65172-3; Kraemer KH, 2007, NEUROSCIENCE, V145, P1388, DOI 10.1016/j.neuroscience.2006.12.020; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Larochelle S, 2012, NAT STRUCT MOL BIOL, V19, P1108, DOI 10.1038/nsmb.2399; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Liedert B, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl051; Limsirichaikul S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp023; Liu JH, 2006, EMBO J, V25, P2119, DOI 10.1038/sj.emboj.7601101; Loercher AE, 2005, J CELL BIOL, V168, P35, DOI 10.1083/jcb.200410115; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Miller AJ, 2004, CANCER RES, V64, P509, DOI 10.1158/0008-5472.CAN-03-2440; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; Price ER, 1998, J BIOL CHEM, V273, P33042, DOI 10.1074/jbc.273.49.33042; RochetteEgly C, 1997, CELL, V90, P97, DOI 10.1016/S0092-8674(00)80317-7; Singleton KR, 2017, CELL REP, V21, P2796, DOI 10.1016/j.celrep.2017.11.022; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Strub T, 2011, ONCOGENE, V30, P2319, DOI 10.1038/onc.2010.612; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wellbrock C, 2015, PIGM CELL MELANOMA R, V28, P390, DOI 10.1111/pcmr.12370; Xia M, 2017, CELL REP, V20, P1794, DOI 10.1016/j.celrep.2017.07.056; Yokoi M, 2000, J BIOL CHEM, V275, P9870, DOI 10.1074/jbc.275.13.9870; Yokoyama S, 2011, NATURE, V480, P99, DOI 10.1038/nature10630; Zhuang D, 2008, ONCOGENE, V27, P6623, DOI 10.1038/onc.2008.258; 2004, CANC CELL, V6, P565	57	11	11	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 9	2019	38	19					3616	3635		10.1038/s41388-018-0661-x	http://dx.doi.org/10.1038/s41388-018-0661-x			20	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HX4OU	30651597	Green Published, hybrid			2022-12-26	WOS:000467379600005
J	Cho, H; Shen, GQ; Wang, XF; Wang, F; Archacki, S; Li, YB; Yu, G; Chakrabarti, S; Chen, QY; Wang, QK				Cho, Hyosuk; Shen, Gong-Qing; Wang, Xiaofeng; Wang, Fan; Archacki, Stephen; Li, Yabo; Yu, Gang; Chakrabarti, Susmita; Chen, Qiuyun; Wang, Qing Kenneth			Long noncoding RNA ANRIL regulates endothelial cell activities associated with coronary artery disease by up-regulating CLIP1, EZR, and LYVE1 genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						long noncoding RNA (long ncRNA; lncRNA); gene regulation; EZR (ezrin); endothelial cell; cell adhesion; ANRIL (CDKN2B-AS1); CLIP1 (CLIP-170); coronary artery disease; LYVE1 (LYVE-1); transendothelial migration of monocytes (TEM); monocyte adhesion	EXPRESSION; LOCUS; ANGIOGENESIS; ADTRP; ATHEROSCLEROSIS; IDENTIFICATION; PROLIFERATION; INFLAMMATION; PATHWAY; PROTEIN	Coronary artery disease (CAD) is the leading cause of death worldwide. Long noncoding RNAs (lncRNAs) are a class of noncoding transcripts of > 200 nucleotides and are increasingly recognized as playing functional roles in physiology and disease. ANRIL is an lncRNA gene mapped to the chromosome 9p21 genetic locus for CAD identified by the first series of genome-wide association studies (GWAS). However, ANRIL's role in CAD and the underlying molecular mechanism are unknown. Here, we show that the major ANRIL transcript in endothelial cells (ECs) is DQ485454 with a much higher expression level in ECs than in THP-1 monocytes. Of note, DQ485454 expression was down-regulated in CAD coronary arteries compared with non-CAD arteries. DQ485454 overexpression significantly reduced monocyte adhesion to ECs, transendothelial monocyte migration (TEM), and EC migration, which are critical cellular processes involved in CAD initiation, whereas siRNA-mediated ANRIL knockdown (KD) had the opposite effect. Microarray and follow-up quantitative RT-PCR analyses revealed that the ANRIL KD down-regulated expression of AHNAK2, CLIP1, CXCL11, ENC1, EZR, LYVE1, WASL, and TNFSF10 genes and up-regulated TMEM100 and TMEM106B genes. Mechanistic studies disclosed that overexpression of CLIP1, EZR, and LYVE1 reversed the effects of ANRIL KD on monocyte adhesion to ECs, TEM, and EC migration. These findings indicate that ANRIL regulates EC functions directly related to CAD, supporting the hypothesis that ANRIL is involved in CAD pathogenesis at the 9p21 genetic locus and identifying a molecular mechanism underlying lncRNA-mediated regulation of EC function and CAD development.	[Cho, Hyosuk; Wang, Qing Kenneth] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Cho, Hyosuk; Shen, Gong-Qing; Wang, Fan; Archacki, Stephen; Li, Yabo; Yu, Gang; Chakrabarti, Susmita; Chen, Qiuyun; Wang, Qing Kenneth] Cleveland Clin, Lerner Res Inst, Dept Cardiovasc & Metab Sci, Cleveland, OH 44195 USA; [Wang, Xiaofeng] Cleveland Clin, Lerner Res Inst, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA; [Cho, Hyosuk; Shen, Gong-Qing; Wang, Fan; Archacki, Stephen; Li, Yabo; Yu, Gang; Chakrabarti, Susmita; Chen, Qiuyun; Wang, Qing Kenneth] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Dept Mol Med, Cleveland, OH 44195 USA; [Yu, Gang; Wang, Qing Kenneth] Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ, Cardio X Ctr,Coll Life Sci & Technol, Wuhan 430073, Peoples R China; [Yu, Gang; Wang, Qing Kenneth] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan 430073, Peoples R China	Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Chen, QY; Wang, QK (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cardiovasc & Metab Sci, Cleveland, OH 44195 USA.	chenq3@ccf.org; wangq2@ccf.org	Chakrabarti, Susmita/CAH-2331-2022	Chakrabarti, Susmita/0000-0003-1197-2780; WANG, FAN/0000-0001-9806-5037; Cho, Hyosuk/0000-0003-0592-9102; Wang, Qing Kenneth/0000-0002-2235-6572; Wang, Qing/0000-0002-5639-8519	NHLBI, National Institutes of Health [R01 HL121358, R01 HL126729]; American Heart Association Innovative Research Grant [11IRG5570046]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121358, R01HL126729] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Innovative Research Grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NHLBI, National Institutes of Health, Grants R01 HL121358 and R01 HL126729; American Heart Association Innovative Research Grant 11IRG5570046. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Archacki Stephen, 2004, Human Genomics, V1, P355; Bai Y, 2014, STROKE, V45, P383, DOI 10.1161/STROKEAHA.113.003393; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Cheng XA, 2011, DIABETES, V60, P680, DOI 10.2337/db10-0185; D'Angelo R, 2007, MOL BIOL CELL, V18, P4780, DOI 10.1091/mbc.E06-12-1144; Fan C, 2009, J BIOL CHEM, V284, P25653, DOI 10.1074/jbc.M109.041368; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Holdt LM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003588; Holdt LM, 2012, ARTERIOSCL THROM VAS, V32, P196, DOI 10.1161/ATVBAHA.111.232678; Holdt LM, 2010, ARTERIOSCL THROM VAS, V30, P620, DOI 10.1161/ATVBAHA.109.196832; Holdt LM, 2011, ATHEROSCLEROSIS, V214, P264, DOI 10.1016/j.atherosclerosis.2010.06.029; Hu WT, 2018, ATHEROSCLEROSIS, V278, P39, DOI 10.1016/j.atherosclerosis.2018.09.018; Johnson LA, 2017, NAT IMMUNOL, V18, P762, DOI 10.1038/ni.3750; Kong YH, 2016, DIABETOLOGIA, V59, P1579, DOI 10.1007/s00125-016-3967-7; Lessner SM, 2002, AM J PATHOL, V160, P2145, DOI 10.1016/S0002-9440(10)61163-7; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lim JP, 2011, IMMUNOL CELL BIOL, V89, P836, DOI 10.1038/icb.2011.20; Luo CY, 2017, BBA-MOL BASIS DIS, V1863, P2319, DOI 10.1016/j.bbadis.2017.06.015; Luo CY, 2017, BBA-MOL BASIS DIS, V1863, P1640, DOI 10.1016/j.bbadis.2017.03.010; Luo CY, 2016, PHYSIOL GENOMICS, V48, P554, DOI 10.1152/physiolgenomics.00028.2016; Matsuzawa Y, 2014, CORONARY ARTERY DIS, V25, P713, DOI 10.1097/MCA.0000000000000178; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Nishida-Fukuda H, 2016, J BIOL CHEM, V291, P10490, DOI 10.1074/jbc.M115.683201; Rey-Gallardo A, 2018, J CELL SCI, V131, DOI 10.1242/jcs.215541; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Sun XD, 2013, PROTEIN CELL, V4, P266, DOI 10.1007/s13238-013-3007-z; Vestweber D, 2015, NAT REV IMMUNOL, V15, P692, DOI 10.1038/nri3908; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; Xie SB, 2014, ATHEROSCLEROSIS, V233, P403, DOI 10.1016/j.atherosclerosis.2014.01.009; Ye J, 2016, SCI REP-UK, V6, DOI 10.1038/srep34034; Zhang T, 2016, HUM MOL GENET, V25, P5094, DOI 10.1093/hmg/ddw273; Zhao LP, 2016, J HUAZHONG U SCI-MED, V36, P243, DOI 10.1007/s11596-016-1574-y; Zhao YY, 2015, BBA-MOL BASIS DIS, V1852, P2024, DOI 10.1016/j.bbadis.2015.07.016; Zhou X, 2016, RNA BIOL, V13, P98, DOI 10.1080/15476286.2015.1122164	35	33	33	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					3881	3898		10.1074/jbc.RA118.005050	http://dx.doi.org/10.1074/jbc.RA118.005050			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30655286	Green Published, hybrid			2022-12-26	WOS:000461854400007
J	Chen, JQ; Xing, YH; Yao, WJ; Xu, X; Zhang, CL; Zhang, ZH; Liu, Q				Chen, Jianqin; Xing, Yuhui; Yao, Wenjia; Xu, Xue; Zhang, Chenling; Zhang, Zhenhua; Liu, Qing			Phylomitogenomics reconfirm the phylogenetic position of the genus Metaplax inferred from the two grapsid crabs (Decapoda: Brachyura: Grapsoidea)	PLOS ONE			English	Article							MITOCHONDRIAL GENOMES; MOLECULAR PHYLOGENY; CRUSTACEA DECAPODA; ORDER; MORPHOLOGY; EVOLUTION; SELECTION	Two new complete mitogenomes of the grapsids, Metaplax longipes Stimpson, 1858 and Nanosesarma minutum (De Man, 1887) were sequenced using next-generation sequencing (NGS). By analyzing a combination of 75 Brachyura taxa, our phylomitogenomic inferences suggested that Metaplax crab seperated earlier from the sesarmid crabs and closely related to the varunids with respect to Nanosesarma crab. It reconfirmed that the Metaplax should be removed from the Sesarmidae and assinged to the Varunidae. Additional mitogenomic comparisons including gene rearrangement and genomic organization were conducted among the 33 taxa of Grapsoidea and Ocypodoidea, and a shared rearrangement pattern between Metaplax longipes and the varunids were recovered, which also strongly supported the inference for the phylogenetic position of the Metaplax.	[Chen, Jianqin; Zhang, Chenling; Zhang, Zhenhua; Liu, Qing] Jiangsu Second Normal Univ, Sch Life Sci Chem & Chem Engn, Inst Aquat Biol, Jiangsu Key Lab Biofunct Mol, Nanjing, Jiangsu, Peoples R China; [Xing, Yuhui] Nanjing Normal Univ, Zhongbei Coll, Nanjing, Jiangsu, Peoples R China; [Yao, Wenjia; Xu, Xue] Nanjing Normal Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China	Jiangsu Second Normal University; Nanjing Normal University; Nanjing Normal University	Chen, JQ (corresponding author), Jiangsu Second Normal Univ, Sch Life Sci Chem & Chem Engn, Inst Aquat Biol, Jiangsu Key Lab Biofunct Mol, Nanjing, Jiangsu, Peoples R China.	jqchen1102@126.com	zhang, zh/GWV-4677-2022		Natural Science Fund of Colleges and Universities in Jiangsu Province [16KJA180005, 16KJB180006]	Natural Science Fund of Colleges and Universities in Jiangsu Province	This work was supported by the Natural Science Fund of Colleges and Universities in Jiangsu Province (16KJA180005, 16KJB180006). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock A., 1900, J ASIATIC SOC BENGAL, V69, P279, DOI DOI 10.5962/BHL.TITLE.15344; BALSS H, 1957, KLASSEN ORDNUNGEN TI, V5, P1505; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Chen JQ, 2018, GENE, V675, P27, DOI 10.1016/j.gene.2018.06.088; Cuesta JA, 2001, CRUSTACEANA, V74, P895, DOI 10.1163/15685400152682656; Dai A., 1991, P1; DAVIE P. J. F., 2002, ZOOLOGICAL CATALOGUE, V19, P1; Hoang DT, 2018, MOL BIOL EVOL, V35, P518, DOI 10.1093/molbev/msx281; Ding Hongyin, 2010, Transactions of Oceanology and Limnology, V2, P49; GUINOT D, 1978, Bulletin Biologique de la France et de la Belgique, V112, P211; Huang XX, 2017, J ZHEJIANG NORMAL U, V40, P446; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ji YK, 2014, J CRUSTACEAN BIOL, V34, P494, DOI 10.1163/1937240X-00002252; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kitaura J, 2002, J CRUSTACEAN BIOL, V22, P682, DOI 10.1651/0278-0372(2002)022[0682:MPOGAO]2.0.CO;2; Kitaura J, 2010, CRUSTACEANA, V83, P1315, DOI 10.1163/001121610X533548; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Lowe TM, 2016, NUCLEIC ACIDS RES, V44, pW54, DOI 10.1093/nar/gkw413; Miller M.A., 2010, P GAT COMP ENV WORKS; Tan MH, 2018, MOL PHYLOGENET EVOL, V127, P320, DOI 10.1016/j.ympev.2018.05.015; Ng Peter K.L., 2008, Raffles Bulletin of Zoology Supplement, V17, P1; Qian GH, 2011, ZOOL J LINN SOC-LOND, V162, P471, DOI 10.1111/j.1096-3642.2010.00686.x; RAND DM, 1994, TRENDS ECOL EVOL, V9, P125, DOI 10.1016/0169-5347(94)90176-7; Rathbun MJ, 1918, B US NATN MUS, V97, p[1, 1], DOI DOI 10.5479/SI.03629236.97.I; Sakai T., 1976, P1; Schubart CD, 2006, J ZOOL SYST EVOL RES, V44, P193, DOI 10.1111/j.1439-0469.2006.00354.x; Schubart CD, 2000, MOL PHYLOGENET EVOL, V15, P179, DOI 10.1006/mpev.1999.0754; Schubart CD, 2002, J CRUSTACEAN BIOL, V22, P28, DOI 10.1651/0278-0372(2002)022[0028:GANBFF]2.0.CO;2; Shen X, 2015, ACTA OCEANOL SIN, V34, P84, DOI 10.1007/s13131-015-0583-1; Sun HY, 2005, GENE, V349, P207, DOI 10.1016/j.gene.2004.12.036; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan MH, 2017, PEERJ, V5, DOI 10.7717/peerj.2982; Tan MH, 2015, MOL PHYLOGENET EVOL, V85, P180, DOI 10.1016/j.ympev.2015.02.009; Tsang LM, 2014, MOL BIOL EVOL, V31, P1173, DOI 10.1093/molbev/msu068; von Sternberg R., 1998, Journal of Comparative Biology, V3, P115; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xing YH, 2017, ZOOKEYS, P41, DOI 10.3897/zookeys.705.11852	43	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210763	10.1371/journal.pone.0210763	http://dx.doi.org/10.1371/journal.pone.0210763			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682071	gold, Green Published, Green Submitted			2022-12-26	WOS:000457037500061
J	Chura-Chambi, RM; da Silva, CMR; Pereira, LR; Bartolini, P; Ferreira, LCD; Morganti, L				Chura-Chambi, Rosa Maria; Rosa da Silva, Cleide Mara; Pereira, Lennon Ramos; Bartolini, Paolo; de Souza Ferreira, Luis Carlos; Morganti, Ligia			Protein refolding based on high hydrostatic pressure and alkaline pH: Application on a recombinant dengue virus NS1 protein	PLOS ONE			English	Article							HUMAN GROWTH-HORMONE; INCLUSION-BODIES; ESCHERICHIA-COLI; SOLUBILIZATION; OPTIMIZATION; EXPRESSION; ENDOSTATIN; ARGININE	In this study we evaluated the association of high hydrostatic pressure (HHP) and alkaline pH as a minimally denaturing condition for the solubilization of inclusion bodies (IBs) generated by recombinant proteins expressed by Escherichia coli strains. The method was successfully applied to a recombinant form of the dengue virus (DENV) non-structural protein 1 (NS1). The minimal pH for IBs solubilization at 1 bar was 12 while a pH of 10 was sufficient for solubilization at HHP: 2.4 kbar for 90 min and 0.4 kbar for 14 h 30 min. An optimal refolding condition was achieved by compression of IBs at HHP and pH 10.5 in the presence of arginine, oxidized and reduced glutathiones, providing much higher yields (up to 8-fold) than association of HHP and GdnHCl via an established protocol. The refolded NS1, 109 +/- 9.5 mg/L bacterial culture was recovered mainly as monomer and dimer, corresponding up to 90% of the total protein and remaining immunologically active. The proposed conditions represent an alternative for the refolding of immunologically active recombinant proteins expressed as IBs.	[Chura-Chambi, Rosa Maria; Rosa da Silva, Cleide Mara; Bartolini, Paolo; Morganti, Ligia] IPEN CNEN SP, Inst Pesquisas Energet & Nucl, Ctr Biotecnol, Sao Paulo, SP, Brazil; [Pereira, Lennon Ramos; de Souza Ferreira, Luis Carlos] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Sao Paulo, SP, Brazil	Comissao Nacional de Energia Nuclear (CNEN); Instituto de Pesquisas Energeticas e Nucleares (IPEN); Universidade de Sao Paulo	Morganti, L (corresponding author), IPEN CNEN SP, Inst Pesquisas Energet & Nucl, Ctr Biotecnol, Sao Paulo, SP, Brazil.	lmorganti@ipen.br	; Morganti, Ligia/K-4352-2014	Ramos Pereira, Lennon/0000-0002-8070-7772; Morganti, Ligia/0000-0002-7870-1793	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/02574-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [130256/2015-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported from a grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, www.fapesp.br), Process number 2015/02574-0 to LM and a Fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, www.cnpq.br), Process number 130256/2015-3 to CMRdS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allonso D, 2011, J VIROL METHODS, V175, P109, DOI 10.1016/j.jviromet.2011.04.029; Ami D, 2006, BBA-PROTEINS PROTEOM, V1764, P793, DOI 10.1016/j.bbapap.2005.12.005; Amorim JH, 2014, VIRUS RES, V181, P53, DOI 10.1016/j.virusres.2014.01.001; Amorim JH, 2010, J VIROL METHODS, V167, P186, DOI 10.1016/j.jviromet.2010.04.003; Athmaram TN, 2013, VIRUS GENES, V46, P219, DOI 10.1007/s11262-012-0851-5; Chura-Chambi RM, 2013, PROCESS BIOCHEM, V48, P250, DOI 10.1016/j.procbio.2012.12.017; Chura-Chambi RM, 2013, J BIOTECHNOL, V168, P511, DOI 10.1016/j.jbiotec.2013.09.017; Chura-Chambi RM, 2008, ANAL BIOCHEM, V379, P32, DOI 10.1016/j.ab.2008.04.024; Crisman RI, 2009, BIOTECHNOL BIOENG, V102, P483, DOI 10.1002/bit.22082; de Groot NS, 2009, TRENDS BIOCHEM SCI, V34, P408, DOI 10.1016/j.tibs.2009.03.009; Garcia-Fruitos E, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-27; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemke LS, 2015, PROTEIN EXPRES PURIF, V106, P72, DOI 10.1016/j.pep.2014.10.013; Malavasi NV, 2011, PROCESS BIOCHEM, V46, P512, DOI 10.1016/j.procbio.2010.10.002; Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008; Papaneophytou CP, 2014, PROTEIN EXPRES PURIF, V94, P22, DOI 10.1016/j.pep.2013.10.016; Patra AK, 2000, PROTEIN EXPRES PURIF, V18, P182, DOI 10.1006/prep.1999.1179; Qoronfleh MW, 2007, PROTEIN EXPRES PURIF, V55, P209, DOI 10.1016/j.pep.2007.05.014; Rathore AS, 2013, J CHEM TECHNOL BIOT, V88, P1794, DOI 10.1002/jctb.4152; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; Singh SM, 2005, J BIOSCI BIOENG, V99, P303, DOI 10.1263/jbb.99.303; Singh SM, 2008, J CHEM TECHNOL BIOT, V83, P1126, DOI 10.1002/jctb.1945; St John RJ, 1999, P NATL ACAD SCI USA, V96, P13029, DOI 10.1073/pnas.96.23.13029; St John RJ, 2001, J BIOL CHEM, V276, P46856, DOI 10.1074/jbc.M107671200; Tsumoto K, 2004, BIOTECHNOL PROGR, V20, P1301, DOI 10.1021/bp0498793; Vera A, 2007, BIOTECHNOL BIOENG, V96, P1101, DOI 10.1002/bit.21218; Xie Q, 2004, INT J BIOCHEM CELL B, V36, P296, DOI 10.1016/S1357-2725(03)00252-8; Yongsawatdigul J, 2004, J FOOD SCI, V69, pC499, DOI 10.1111/j.1365-2621.2004.tb13642.x	28	12	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211162	10.1371/journal.pone.0211162	http://dx.doi.org/10.1371/journal.pone.0211162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682103	gold, Green Published, Green Submitted			2022-12-26	WOS:000457037500115
J	Fett, D; Trompeter, K; Platen, P				Fett, Daniela; Trompeter, Katharina; Platen, Petra			Prevalence of back pain in a group of elite athletes exposed to repetitive overhead activity	PLOS ONE			English	Article							CROSS-COUNTRY SKIERS; RISK-FACTORS; ADOLESCENT; SYMPTOMS; INJURIES; CHILDREN; PLAYERS; ROWERS; TRUNK	Background The prevalence of back pain in athletes has been investigated in several studies, but there are still under-or uninvestigated sports discipline like sports exposed to repetitive overhead activity. Elite athletes spend much time in training and competition and, because of the nature of their disciplines, subject their bodies to a great deal of mechanical strain, which puts a high level of stress on their musculoskeletal systems. From this it is hypothesized that elite athletes who engage in repetitive overhead motions experience a higher strain on their spine and thus possibly a higher prevalence of back pain compared with an active control group. Objectives To examine the prevalence of back pain and the exact location of pain in a cohort of elite athletes with repetitive overhead activity and in a control group of physically active sport students. Additionally, to examine different characteristics of pain, and to evaluate the influence of confounders on back pain. Methods A standardized and validated online back pain questionnaire was sent by the German Olympic Sports Confederation to German national and international elite athletes, and a control group of physically active but non-elite sports students. Results The final sample comprised 181 elite athletes of the sports disciplines badminton, beach volleyball, handball, tennis and volleyball and 166 physically active controls. In elite athletes, lifetime prevalence of back pain was 85%, 12-month prevalence was 75%, 3-month prevalence was 58% and point prevalence was 38%; for the physically active control group, these prevalences were 81%, 70%, 59% and 43%, respectively. There was no significant group difference in prevalence over all time periods. The lower back was the main location of back pain in elite athletes across all disciplines and in controls; additionally a distinct problem of upper back pain was found among volleyball players. Conclusion Despite the high mechanical load inherent in the sport disciplines included in this study, the elite athletes who engaged in repetitive overhead activities did not suffer more from back pain than the physically active controls. This suggests that other mechanisms may be influencing back pain prevalences in a positive way in these athletes. Furthermore, these disciplines may practice preventive factors for back pain that outweigh their detrimental factors. Therefore, we posit that extensive prevention work is already being implemented in these sports and that there are additional individual protection factors in play. More research is required to explore these suppositions, and should include investigations into which preventive training programs are being used. Nevertheless, in volleyball particularly, a focus on stabilization/preventive training should be applied to the upper back and neck.	[Fett, Daniela; Trompeter, Katharina; Platen, Petra] Ruhr Univ Bochum, Dept Sports Med & Sports Nutr, Bochum, Germany	Ruhr University Bochum	Fett, D (corresponding author), Ruhr Univ Bochum, Dept Sports Med & Sports Nutr, Bochum, Germany.	daniela.fett@rub.de		Platen, Petra/0000-0002-3440-8245	German Federal Institute of Sport Science [ZMVI1-080102A/11-18]	German Federal Institute of Sport Science	The present study was funded by the German Federal Institute of Sport Science (http://www.bisp.de).The research was realized within the project RAN Rucken (ZMVI1-080102A/11-18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alyas F, 2007, BRIT J SPORT MED, V41, P836, DOI 10.1136/bjsm.2007.037747; Bahr R, 2004, SPINE, V29, P449, DOI 10.1097/01.BRS.0000096176.92881.37; Bahr R, 2009, BRIT J SPORT MED, V43, P966, DOI 10.1136/bjsm.2009.066936; Balague F, 1999, EUR SPINE J, V8, P429, DOI 10.1007/s005860050201; Bartolozzi C, 1991, Radiol Med, V82, P757; Bono CM, 2004, J BONE JOINT SURG AM, V86A, P382, DOI 10.2106/00004623-200402000-00027; Brynhildsen J, 1997, ACTA OBSTET GYN SCAN, V76, P873, DOI 10.3109/00016349709024368; Cali A, 2013, SCI SPORTS, V28, pe93, DOI [10.1016/j.scispo.2012.08.003, DOI 10.1016/J.SCISPO.2012.08.003]; Campbell A, 2016, J APPL BIOMECH, V32, P32, DOI 10.1123/jab.2015-0122; Campbell A, 2013, MED SCI SPORT EXER, V45, P1562, DOI 10.1249/MSS.0b013e31828bea5e; Close C, 2016, MIDWIFERY, V37, P1, DOI 10.1016/j.midw.2016.03.013; Correia JP, 2016, J SCI MED SPORT, V19, P311, DOI 10.1016/j.jsams.2015.04.002; Dalichau S, 2002, DEUT Z SPORTMED, V53, P12; Elders LAM, 2003, SPINE, V28, P1340, DOI 10.1097/00007632-200306150-00021; Eriksson K, 1996, SCAND J MED SCI SPOR, V6, P31; Fett D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180130; Fett J, 2017, INT J SPORTS SCI COA, V12, P119, DOI 10.1177/1747954116684393; Foster D, 1989, Br J Sports Med, V23, P150; Haus BM, 2012, CLIN SPORT MED, V31, P423, DOI 10.1016/j.csm.2012.03.011; Hendrick P, 2011, EUR SPINE J, V20, P464, DOI 10.1007/s00586-010-1616-2; Heneweer H, 2011, EUR SPINE J, V20, P826, DOI 10.1007/s00586-010-1680-7; Heneweer H, 2009, PAIN, V143, P21, DOI 10.1016/j.pain.2008.12.033; Hoogendoorn WE, 2000, SPINE, V25, P3087, DOI 10.1097/00007632-200012010-00018; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Jonasson P, 2011, KNEE SURG SPORT TR A, V19, P1540, DOI 10.1007/s00167-011-1539-4; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Legault EP, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0681-4; Ng L, 2014, J SCI MED SPORT, V17, P266, DOI 10.1016/j.jsams.2013.08.003; Maffulli N, 2011, BRIT MED BULL, V97, P47, DOI 10.1093/bmb/ldq026; Maselli F, 2015, J BACK MUSCULOSKELET, V28, P365, DOI 10.3233/BMR-140529; Muller J, 2017, SCAND J MED SCI SPOR, V27, P448, DOI 10.1111/sms.12664; Narita T, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2012-091875; Newlands C, 2015, BRIT J SPORT MED, V49, P951, DOI 10.1136/bjsports-2014-093889; Noll M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150542; Noormohammadpour P, 2016, EUR SPINE J, V25, P1196, DOI 10.1007/s00586-015-4034-7; Schulz SS, 2016, EUR SPINE J, V25, P1204, DOI 10.1007/s00586-015-4210-9; Shakeri H, 2013, J CHIROPR MED, V12, P160, DOI 10.1016/j.jcm.2013.08.005; Shan Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078109; Shehab DK, 2005, J ADOLESCENT HEALTH, V36, P32, DOI 10.1016/j.jadohealth.2003.12.011; SWARD L, 1990, SPINE, V15, P124; Trompeter K, 2017, SPORTS MED, V47, P1183, DOI 10.1007/s40279-016-0645-3; Tunas P, 2015, KNEE SURG SPORT TR A, V23, P2540, DOI 10.1007/s00167-014-3069-3; van Hilst J, 2015, J BACK MUSCULOSKELET, V28, P67, DOI 10.3233/BMR-140491; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4	44	16	16	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210429	10.1371/journal.pone.0210429	http://dx.doi.org/10.1371/journal.pone.0210429			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI8IY	30677044	Green Published, Green Submitted, gold			2022-12-26	WOS:000456700400015
J	Siegfried, L; Schmidt, M; Mohrholz, V; Pogrzeba, H; Nardini, P; Bottinger, M; Scheuermann, G				Siegfried, Lydia; Schmidt, Martin; Mohrholz, Volker; Pogrzeba, Hans; Nardini, Pascal; Boettinger, Michael; Scheuermann, Gerik			The tropical-subtropical coupling in the Southeast Atlantic from the perspective of the northern Benguela upwelling system	PLOS ONE			English	Article							SEASONAL VARIABILITY; FRONTAL ZONE; INTERANNUAL VARIABILITY; EQUATORIAL UNDERCURRENT; INTEROCEAN EXCHANGE; EASTERN EQUATORIAL; OCEAN CIRCULATION; STRATIFIED OCEAN; FLOW-ANALYSIS; WATER MASSES	In the Benguela upwelling system, the environmental conditions are determined to a large extent by central water masses advected from remote areas onto the shelf. The origin, spreading pathways and fate of those water masses are investigated with a regional ocean model that is analysed using Eulerian passive tracers and on the basis of Lagrangian trajectories. Two major water masses influencing the Benguela upwelling system are identified: tropical South Atlantic Central Water (SACW) and subtropical Eastern South Atlantic Central Water (ESACW). The spreading of tropical waters into the subtropical Benguela upwelling system is mediated by equatorial currents and their continuation in the Southeast Atlantic. This tropical-subtropical connection has been attributed to signal propagation in the equatorial and coastal waveguides. However, there exists an additional spreading path for tropical central water in the open ocean. This mass transport fluctuates on a seasonal scale around an averaged meridional transport in Sverdrup balance. The inter-annual variability of the advection of tropical waters is related to Benguela Ninos, as evidenced by the 2010/2011 event. The northern Benguela upwelling system is a transition zone between SACW and ESACW since they encounter each other at about 20 degrees S. Both water masses have seasonal variable shares in the upwelled water there. To summarise the main pathways of central water mass transport, an enhanced scheme for the subsurface circulation in the Southeast Atlantic is presented.	[Siegfried, Lydia; Schmidt, Martin; Mohrholz, Volker] Leibniz Inst Balt Sea Res Warnemuende, Rostock, Germany; [Pogrzeba, Hans; Nardini, Pascal; Scheuermann, Gerik] Univ Leipzig, Inst Comp Sci, Leipzig, Germany; [Boettinger, Michael] Deutsch Klimarechenzentrum DKRZ, Hamburg, Germany	Leipzig University	Siegfried, L (corresponding author), Leibniz Inst Balt Sea Res Warnemuende, Rostock, Germany.	lydia.siegfried@io-warnemuende.de		Bottinger, Michael/0000-0001-9704-8235; Mohrholz, Volker/0000-0003-0778-9182	European Union [603521]; German Federal Ministry of Education and Research within the project Southwest African Coastal Upwelling System and Benguela Ninos II [BMBF 03F0751B]; German Federal Ministry of Education and Research within the project Competence Center for Scalable Data Services and Solutions (ScaDS) Dresden/Leipzig [BMBF 01IS14014B]; Leibniz Association	European Union(European Commission); German Federal Ministry of Education and Research within the project Southwest African Coastal Upwelling System and Benguela Ninos II; German Federal Ministry of Education and Research within the project Competence Center for Scalable Data Services and Solutions (ScaDS) Dresden/Leipzig; Leibniz Association	This work was partially funded by the German Federal Ministry of Education and Research within the project Southwest African Coastal Upwelling System and Benguela Ninos II (BMBF 03F0751B) and within the project Competence Center for Scalable Data Services and Solutions (ScaDS) Dresden/Leipzig (BMBF 01IS14014B). This work has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no 603521. The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGENBAG JJ, 1988, S AFR J MARINE SCI, V6, P119, DOI 10.2989/025776188784480726; Agranovsky A, 2014, SYMP LARG DATA ANAL, P67, DOI 10.1109/LDAV.2014.7013206; ANDERSON DLT, 1975, DEEP-SEA RES, V22, P583, DOI 10.1016/0011-7471(75)90046-7; Aristegui J, 2009, PROG OCEANOGR, V83, P33, DOI 10.1016/j.pocean.2009.07.031; Arntz W. E., 2006, ADV GEOSCI, V6, P243, DOI DOI 10.5194/ADGE0-6-243-2006; Bachelery ML, 2016, J GEOPHYS RES-OCEANS, V121, P284, DOI 10.1002/2015JC011168; BELJAARS ACM, 1995, Q J ROY METEOR SOC, V121, P255, DOI 10.1002/qj.49712152203; Bentamy A, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007479; Blanke B, 1997, J PHYS OCEANOGR, V27, P1038, DOI 10.1175/1520-0485(1997)027<1038:KOTPEU>2.0.CO;2; Bodin S, 1979, SE60176 SWED MET HYD; Boebel O, 2003, DEEP-SEA RES PT II, V50, P57, DOI 10.1016/S0967-0645(02)00379-X; Born S, 2013, IEEE PAC VIS SYMP, P129, DOI 10.1109/PacificVis.2013.6596137; Born S, 2012, IEEE PAC VIS SYMP, P105, DOI 10.1109/PacificVis.2012.6183580; Bourles B, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015098; Brandt P, 2016, J PHYS OCEANOGR, V46, P3011, DOI 10.1175/JPO-D-15-0248.1; CARMACK EC, 1977, ESTUAR COAST MAR SCI, V5, P135, DOI 10.1016/0302-3524(77)90078-0; Chhak K, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030203; Colberg F, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002301; Danabasoglu G, 2006, J CLIMATE, V19, P2347, DOI 10.1175/JCLI3739.1; de Vries P, 2001, J ATMOS OCEAN TECH, V18, P1092; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Doglioli AM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026498; Doi T, 2007, J PHYS OCEANOGR, V37, P2698, DOI 10.1175/2007JPO3552.1; Donners J, 2005, J PHYS OCEANOGR, V35, P1841, DOI 10.1175/JPO2782.1; Donners J, 2004, J PHYS OCEANOGR, V34, P1019, DOI 10.1175/1520-0485(2004)034<1019:TLVOSA>2.0.CO;2; DOOS K, 1995, J GEOPHYS RES-OCEANS, V100, P13499, DOI 10.1029/95JC00337; Duncombe Rae C. M., 2005, AFRICAN J MARINE SCI, V27, P617, DOI DOI 10.2989/18142320509504122; Emeis K, 2017, J MARINE SYSTEMS; Fennel W, 1999, J PHYS OCEANOGR, V29, P177, DOI 10.1175/1520-0485(1999)029<0177:TOTBUS>2.0.CO;2; Fennel W., 1999, COMPUTERIZED MODELIN, P169; Fennel W, 2012, CONT SHELF RES, V45, P65, DOI 10.1016/j.csr.2012.06.004; Florenchie P, 2004, J CLIMATE, V17, P2318, DOI 10.1175/1520-0442(2004)017<2318:EOIWAC>2.0.CO;2; Gammelsrod T, 1998, J MARINE SCI, V19, P41, DOI [10.2989/025776198784126719, DOI 10.2989/025776198784126719]; GORDON AL, 1995, DEEP-SEA RES PT I, V42, P1, DOI 10.1016/0967-0637(94)00032-N; GORDON AL, 1991, DEEP-SEA RES, V38, pS323, DOI 10.1016/S0198-0149(12)80015-X; GORDON AL, 1992, J GEOPHYS RES-OCEANS, V97, P7223, DOI 10.1029/92JC00485; Griffies SM, 2007, ELEMENTS OF MOM4P1; Hardman-Mountford NJ, 2003, PROG OCEANOGR, V59, P181, DOI 10.1016/j.pocean.2003.10.001; Hart TJ, 1960, DISCOVERY REPORTS, VXXXI; Herzfeld M, 2011, OCEAN MODEL, V37, P1, DOI 10.1016/j.ocemod.2010.12.008; Hormann V, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003931; HUNDSDORFER W, 1994, APPL NUMER MATH, V13, P469, DOI 10.1016/0168-9274(94)90009-4; Huthnance JM, 1995, PROG OCEANOGR, V35, P353, DOI 10.1016/0079-6611(95)00012-6; Jackett DR, 2006, J ATMOS OCEAN TECH, V23, P1709, DOI 10.1175/JTECH1946.1; John HC, 2001, J MARINE SYST, V28, P91, DOI 10.1016/S0924-7963(00)00085-3; Johns WE, 2014, CLIM DYNAM, V43, P3047, DOI 10.1007/s00382-014-2136-2; Johnson GC, 1997, J PHYS OCEANOGR, V27, P2448, DOI 10.1175/1520-0485(1997)027<2448:TPSCAA>2.0.CO;2; JONES PGW, 1971, DEEP-SEA RES, V18, P193, DOI 10.1016/0011-7471(71)90109-4; Junker T, 2017, J MARINE SYST, V165, P36, DOI 10.1016/j.jmarsys.2016.09.003; Junker T, 2015, J MARINE SYST, V143, P1, DOI 10.1016/j.jmarsys.2014.10.006; Kolodziejczyk N, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004976; Kolodziejczyk N, 2014, CLIM DYNAM, V43, P3025, DOI 10.1007/s00382-014-2107-7; Koseki S, 2017, CLIMATE DYNAMICS; Koseki S, 2018, OCEAN SCI DISCUSSION, V2018, P1, DOI [10.5194/os-2018-801520-0485(2003)33%3C753:ESADOT%3E2.0.CO;2, DOI 10.5194/OS-2018-801520-0485(2003)33%3C753:ESADOT%3E2.0.CO;2]; Kostianoy AG, 1999, J GEOPHYS RES-OCEANS, V104, P20963, DOI 10.1029/1999JC900017; LARGE WG, 1994, REV GEOPHYS, V32, P363, DOI 10.1029/94RG01872; Lass HU, 2008, J MARINE SYST, V74, P1, DOI 10.1016/j.jmarsys.2007.09.008; Lass HU, 2000, J PHYS OCEANOGR, V30, P2589, DOI 10.1175/1520-0485(2000)030<2589:HACMIT>2.0.CO;2; Lett C, 2007, MARINE ECOLOGY PROGR; Louw DC, 2016, J MARINE SYST, V157, P124, DOI 10.1016/j.jmarsys.2016.01.009; Lubbecke JF, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005964; Lumpkin R, 2005, DEEP-SEA RES PT I, V52, P495, DOI 10.1016/j.dsr.2004.09.001; LUTJEHARMS JRE, 1987, S AFR J MARINE SCI, V5, P51, DOI 10.2989/025776187784522621; Manizza M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL020778; Marchesiello P, 2003, J PHYS OCEANOGR, V33, P753, DOI 10.1175/1520-0485(2003)33<753:ESADOT>2.0.CO;2; Martin B, 2015, MAR ECOL-EVOL PERSP, V36, P637, DOI 10.1111/maec.12173; MAZEIKA PA, 1967, LIMNOL OCEANOGR, V12, P537, DOI 10.4319/lo.1967.12.3.0537; MCCREARY JP, 1981, PHILOS T R SOC A, V302, P385, DOI 10.1098/rsta.1981.0176; MEEUWIS JM, 1990, S AFR J MARINE SCI, V9, P261; Menemenlis D., 2008, MERCAT OCEAN Q NEWSL, V31(October), P13; Mercier H, 2003, DEEP-SEA RES PT I, V50, P863, DOI 10.1016/S0967-0637(03)00071-2; Mohrholz V, 2008, CONT SHELF RES, V28, P424, DOI 10.1016/j.csr.2007.10.001; Mohrholz V, 2001, S AFR J SCI, V97, P199; Mohrholz V, 2014, J MARINE SYST, V140, P92, DOI 10.1016/j.jmarsys.2014.04.019; MOORE D, 1978, GEOPHYS RES LETT, V5, P637, DOI 10.1029/GL005i008p00637; Moroshkin KV, 1970, OKEANOLOGIYA, V10, P38; Muller A, 2013, THESIS; Muller AA, 2014, J MARINE SYST, V140, P82, DOI 10.1016/j.jmarsys.2014.02.007; Nardini P, 2017, WORKSH VIS ENV SCI E, P1; PETERSON RG, 1991, PROG OCEANOGR, V26, P1, DOI 10.1016/0079-6611(91)90006-8; PICAUT J, 1983, J PHYS OCEANOGR, V13, P18, DOI 10.1175/1520-0485(1983)013<0018:POTSUI>2.0.CO;2; Polo I, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004495; Poole R, 1999, DEEP-SEA RES PT I, V46, P1895, DOI 10.1016/S0967-0637(99)00025-4; Richter I, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044461; Rouault M, 2007, J MARINE SYST, V68, P473, DOI 10.1016/j.jmarsys.2006.11.010; Rouault M, 2018, J MARINE SYST, V188, P39, DOI 10.1016/j.jmarsys.2017.07.007; Rouault M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052099; Rowe GD, 2000, J PHYS OCEANOGR, V30, P1172, DOI 10.1175/1520-0485(2000)030<1172:PESCVT>2.0.CO;2; SALAT J, 1992, CONT SHELF RES, V12, P355, DOI 10.1016/0278-4343(92)90036-J; Salzbrunn T, 2008, VISUAL COMPUT, V24, P1039, DOI 10.1007/s00371-007-0204-x; Salzbrunn T, 2006, IEEE T VIS COMPUT GR, V12, P1601, DOI 10.1109/TVCG.2006.104; Schmid C, 2014, DEEP-SEA RES PT I, V91, P50, DOI 10.1016/j.dsr.2014.04.015; Schmidt M, 2014, TEMPERATURE BIAS CIR; Schmidt M, 2016, PROG OCEANOGR, V149, P145, DOI 10.1016/j.pocean.2016.09.004; Schouten MW, 2005, DEEP-SEA RES PT I, V52, P477, DOI 10.1016/j.dsr.2004.10.007; Shannon LV, 1996, SOUTH ATLANTIC, P163; SHANNON LV, 1987, S AFR J MARINE SCI, V5, P11, DOI 10.2989/025776187784522261; SHANNON LV, 1986, J MAR RES, V44, P495, DOI 10.1357/002224086788403105; Shannon LV, 1966, INVESTL REP DIV FISH, V58, P1; Shannon LV, 1989, OCEANS LIFE SO AFRIC, P12; Small RJ, 2015, J CLIMATE, V28, P9409, DOI 10.1175/JCLI-D-15-0192.1; STACEY MW, 1995, J PHYS OCEANOGR, V25, P1037, DOI 10.1175/1520-0485(1995)025<1037:ANMOTC>2.0.CO;2; Stramma L, 1999, J GEOPHYS RES-OCEANS, V104, P20863, DOI 10.1029/1999JC900139; Stramma L., 2001, ENCY OCEAN SCI, V2 nd, P718; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; SVERDRUP HU, 1947, P NATL ACAD SCI USA, V33, P318, DOI 10.1073/pnas.33.11.318; Tomczak M., 1994, REGIONAL OCEANOGRAPH; van Sebille E, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007684; Veitch JA, 2006, INT J REMOTE SENS, V27, P987, DOI 10.1080/01431160500127914; Veitch J, 2009, PROG OCEANOGR, V83, P296, DOI 10.1016/j.pocean.2009.07.008; Verstraete J. M., 1980, OCEANOGRAPHY SURFACE, V26, P343; VOITURIEZ B, 1981, OCEANOL ACTA, V4, P497; Voituriez B, 1982, RAPP PV C EXPLOR MER, V180, P107; von Bodungen B, 2008, J MARINE SYST, V74, P189, DOI 10.1016/j.jmarsys.2007.12.007; Wunsch C, 2011, J MAR RES, V69, P417, DOI 10.1357/002224011798765303; Xu Z, 2014, CLIM DYNAM, V43, P3123, DOI 10.1007/s00382-014-2247-9	116	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210083	10.1371/journal.pone.0210083	http://dx.doi.org/10.1371/journal.pone.0210083			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668590	Green Published, Green Submitted, gold			2022-12-26	WOS:000456306400005
J	Przekoracka-Krawczyk, A; Michalak, KP; Pyzalska, P				Przekoracka-Krawczyk, Anna; Michalak, Krzysztof Piotr; Pyzalska, Paulina			Deficient vergence prism adaptation in subjects with decompensated heterophoria	PLOS ONE			English	Article							FIXATION-DISPARITY CURVE; PHORIA ADAPTATION; EYE-MOVEMENTS; VISION; ACCOMMODATION; DISTANCE; LESIONS; VERMIS; REFLEX	Vergence prism adaptability was evaluated in subjects with high symptomatic and asymptomatic heterophoria and compared to individuals with a heterophoria within normal range ( the control group). A computer haploscope was used to measure phoria values and changes in the eye position after introducing 6 prism diopters base out in front of the right eye. Phoria values were measured with a nonius paradigm every minute for a period of 10 minutes during adaptation. The results showed that subjects with symptomatic heterophoria are characterized by a lower rate of prism adaptation and adapted to a smaller extent with respect to the control group. The group with high but asymptomatic heterophoria showed prolonged adaptation time but after several minutes of binocular viewing the subjects were able to adapt to the prism to a level similar to the control group. These findings suggest that an impairment in the slow vergence control system may be responsible for the inability to fully reduce vergence effort, which results in poor vergence ranges and asthenopic symptoms during prolonged viewing.	[Przekoracka-Krawczyk, Anna; Michalak, Krzysztof Piotr; Pyzalska, Paulina] Adam Mickiewicz Univ, Fac Phys, Lab Vis Sci & Optometry, Poznan, Poland; [Przekoracka-Krawczyk, Anna; Michalak, Krzysztof Piotr] Adam Mickiewicz Univ, NanoBioMed Ctr, Vis & Neurosci Lab, Poznan, Poland	Adam Mickiewicz University; Adam Mickiewicz University	Przekoracka-Krawczyk, A (corresponding author), Adam Mickiewicz Univ, Fac Phys, Lab Vis Sci & Optometry, Poznan, Poland.; Przekoracka-Krawczyk, A (corresponding author), Adam Mickiewicz Univ, NanoBioMed Ctr, Vis & Neurosci Lab, Poznan, Poland.	ania_pk@amu.edu.pl	Michalak, Krzysztof Piotr/O-7865-2018	Michalak, Krzysztof Piotr/0000-0002-0267-5605; Pyzalska, Paulina/0000-0002-9664-4278; Przekoracka-Krawczyk, Anna/0000-0003-2401-4135				Alvarez TL, 2013, INVEST OPHTH VIS SCI, V54, P4122, DOI 10.1167/iovs.13-11797; Aprile I, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00484; Brautaset RL, 2005, OPHTHAL PHYSL OPT, V25, P215, DOI 10.1111/j.1475-1313.2005.00276.x; Brautaset RL, 2005, OPHTHAL PHYSL OPT, V25, P211, DOI 10.1111/j.1475-1313.2005.00274.x; Brautaset RL, 2005, OPHTHAL PHYSL OPT, V25, P168, DOI 10.1111/j.1475-1313.2005.00275.x; Brautaset RL, 2006, INVEST OPHTH VIS SCI, V47, P2876, DOI 10.1167/iovs.04-1372; Brenk-Krakowska A, 2012, OPT APPL, V42, P805, DOI 10.5277/oa120412; Carter DB, 1963, OPTOMETRY VISION SCI, V40, P265; Cheng D, 2008, OPHTHAL PHYSL OPT, V28, P225, DOI 10.1111/j.1475-1313.2008.00560.x; DALZIEL CC, 1981, AM J OPTOM PHYS OPT, V58, P21; Deuschl G, 1996, J NEUROL NEUROSUR PS, V60, P515, DOI 10.1136/jnnp.60.5.515; Evans BJW, 2007, PICKWELLS BINOCULAR; Ezane MD, 2015, GRAEF ARCH CLIN EXP, V253, P1629, DOI 10.1007/s00417-015-3134-8; Furman JM, 1997, NEUROLOGY, V48, P5; Griffin J, 2002, BINOCULAR ANOMALIES, V4th; HAIN TC, 1990, INVEST OPHTH VIS SCI, V31, P1394; HENSON DB, 1980, AM J OPTOM PHYS OPT, V57, P129; Howard IP, 2008, SEEING IN DEPTH, V1; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; Jaschinski W, 2002, OPTOMETRY VISION SCI, V79, P158, DOI 10.1097/00006324-200203000-00010; Jaschinski W, 2008, VISION RES, V48, P253, DOI 10.1016/j.visres.2007.11.004; Jiang Bai-Chuan, 2007, Optometry, V78, P129, DOI 10.1016/j.optm.2006.08.017; Kim EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018472; Kim EH, 2010, INVEST OPHTH VIS SCI, V51, P4017, DOI 10.1167/iovs.09-4560; Kojima Y, 2010, J NEUROSCI, V30, P13; Kono R, 2002, INVEST OPHTH VIS SCI, V43, P673; Krishnan VV, 1977, SYSTEMS MAN CYBERN A, V24, P6; Lang CE, 1999, J NEUROPHYSIOL, V82, P2108, DOI 10.1152/jn.1999.82.5.2108; Lang CE, 2002, J NEUROPHYSIOL, V87, P1336, DOI 10.1152/jn.00368.2001; Maples WC, 2009, OPTOMETRY, V80, P688, DOI 10.1016/j.optm.2009.06.003; Martin TA, 1996, BRAIN, V119, P1183, DOI 10.1093/brain/119.4.1183; MAYS LE, 1986, J NEUROPHYSIOL, V56, P1007, DOI 10.1152/jn.1986.56.4.1007; MILDER DG, 1983, ARCH NEUROL-CHICAGO, V40, P339, DOI 10.1001/archneur.1983.04050060039005; Morton SM, 2004, J NEUROPHYSIOL, V92, P2497, DOI 10.1152/jn.00129.2004; Nawrot P, 2013, OPT APPL, V43, P551, DOI 10.5277/oa130314; Nilsson M, 2011, STRABISMUS, V19, P5, DOI 10.3109/09273972.2010.548845; Nitta T, 2008, CEREB CORTEX, V18, P1042, DOI 10.1093/cercor/bhm143; North R, 1981, AM J OPTOMETRY PHYSL, V58, P12; Ogle KN, 1967, OCULOMOTOR IMBALANCE; Optican LM, 1980, J NEUROPHYSIOL, V44, P18; Pisella L, 2005, NEUROLOGY, V65, P150, DOI 10.1212/01.wnl.0000167945.34177.5e; Przekoracka-Krawczyk A, 2015, J VISION, V15, DOI 10.1167/15.11.6; Przekoracka-Krawczyk A, 2018, OPHTHATHERAPY, V3, P201, DOI [10.24292/01.OT.300918.9, DOI 10.24292/01.OT.300918.9]; Przekoracka-Krawczyk A, 2017, INVEST OPHTH VIS SCI, V58, P6470, DOI 10.1167/iovs.16-21305; Przekoracka-Krawczyk A, 2014, VISION RES, V98, P35, DOI 10.1016/j.visres.2014.03.008; ROBINSON DA, 1976, J NEUROPHYSIOL, V39, P954, DOI 10.1152/jn.1976.39.5.954; Rosenfield M, 1994, OPHTHAL PHYSL OPT, V14, P13; Santos EM, 2018, VISION RES, V149, P59, DOI 10.1016/j.visres.2018.06.004; SCHOR CM, 1983, AM J OPTOM PHYS OPT, V60, P1; SCHOR CM, 1979, VISION RES, V19, P1359, DOI 10.1016/0042-6989(79)90208-6; SCHOR CM, 1979, VISION RES, V19, P757, DOI 10.1016/0042-6989(79)90151-2; Schor CM., 1983, VERGENCE EYE MOVEMEN; Sreenivasan V, 2015, VISION RES, V111, P105, DOI 10.1016/j.visres.2015.04.001; Sreenivasan V, 2014, VISION RES, V100, P99, DOI 10.1016/j.visres.2014.04.003; Takagi M, 2003, PROG BRAIN RES, V142, P19; Takagi M, 2001, VISION RES, V41, P3331, DOI 10.1016/S0042-6989(01)00016-5; Thiagarajan P., 2008, THESIS; Thiagarajan P, 2010, OPTOMETRY VISION SCI, V87, P487, DOI 10.1097/OPX.0b013e3181e19ec2; Wessel K, 1998, ARCH NEUROL-CHICAGO, V55, P949, DOI 10.1001/archneur.55.7.949	59	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0211039	10.1371/journal.pone.0211039	http://dx.doi.org/10.1371/journal.pone.0211039			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657792	Green Published, gold, Green Submitted			2022-12-26	WOS:000456017000027
J	Robson, JP; Remke, M; Kool, M; Julian, E; Korshunov, A; Pfister, SM; Osborne, GW; Taylor, MD; Wainwright, B; Reynolds, BA				Robson, Jonathan P.; Remke, Marc; Kool, Marcel; Julian, Elaine; Korshunov, Andrey; Pfister, Stefan M.; Osborne, Geoffrey W.; Taylor, Michael D.; Wainwright, Brandon; Reynolds, Brent A.			Identification of CD24 as a marker of Patched1 deleted medulloblastoma-initiating neural progenitor cells	PLOS ONE			English	Article							CANCER STEM-CELLS; INDEPENDENT PROGNOSTIC MARKER; PEDIATRIC MEDULLOBLASTOMAS; HEDGEHOG PATHWAY; ADULT; BRAIN; EXPRESSION; DISTINCT; GROWTH; PURIFICATION	High morbidity and mortality are common traits of malignant tumours and identification of the cells responsible is a focus of on-going research. Many studies are now reporting the use of antibodies specific to Clusters of Differentiation (CD) cell surface antigens to identify tumour-initiating cell (TIC) populations in neural tumours. Medulloblastoma is one of the most common malignant brain tumours in children and despite a considerable amount of research investigating this tumour, the identity of the TICs, and the means by which such cells can be targeted remain largely unknown. Current prognostication and stratification of medulloblastoma using clinical factors, histology and genetic profiling have classified this tumour into four main subgroups: WNT, Sonic hedgehog (SHH), Group 3 and Group 4. Of these subgroups, SHH remains one of the most studied tumour groups due to the ability to model medulloblastoma formation through targeted deletion of the Shh pathway inhibitor Patched1 (Ptch1). Here we sought to utilise CD antibody expression to identify and isolate TIC populations in Ptch1 deleted medulloblastoma, and determine if these antibodies can help classify the identity of human medulloblastoma subgroups. Using a fluorescence-activated cell sorted (FACS) CD antibody panel, we identified CD24 as a marker of TICs in Ptch1 deleted medulloblastoma. CD24 expression was not correlated with markers of astro-cytes or oligodendrocytes, but co-labelled with markers of neural progenitor cells. In conjunction with CD15, proliferating CD24+/CD15+ granule cell precursors (GCPs) were identified as a TIC population in Ptch1 deleted medulloblastoma. On human medulloblastoma, CD24 was found to be highly expressed on Group 3, Group 4 and SHH subgroups compared with the WNT subgroup, which was predominantly positive for CD15, suggesting CD24 is an important marker of non-WNT medulloblastoma initiating cells and a potential therapeutic target in human medulloblastoma. This study reports the use of CD24 and CD15 to isolate a GCP-like TIC population in Ptch1 deleted medulloblastoma, and suggests CD24 expression as a marker to help stratify human WNT tumours from other medulloblastoma subgroups.	[Robson, Jonathan P.; Julian, Elaine; Wainwright, Brandon] Univ Queensland, Div Mol Genet & Dev, Inst Mol Biosci, Brisbane, Qld, Australia; [Remke, Marc] Univ Hosp Dusseldorf, Dept Pediat Neurooncogen, German Canc Res Ctr, Dusseldorf, Germany; [Remke, Marc] Univ Hosp Dusseldorf, German Canc Consortium, Dusseldorf, Germany; [Remke, Marc] Univ Hosp Dusseldorf, Med Fac, Dept Pediat Oncol Hematol & Clin Immunol, Dusseldorf, Germany; [Remke, Marc] Heinrich Heine Univ Dusseldorf, Med Fac, Dept Neuropathol, Dusseldorf, Germany; [Kool, Marcel; Pfister, Stefan M.] Hopp Childrens Canc Ctr, Natl Ctr Tumor Dis, Heidelberg, Germany; [Kool, Marcel; Pfister, Stefan M.] German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany; [Korshunov, Andrey] Heidelberg Univ, German Canc Res Ctr, Div Clin Cooperat, Unit Neuropathol, Heidelberg, Germany; [Pfister, Stefan M.] Heidelberg Univ Hosp, Dept Pediat Hematol & Oncol, Heidelberg, Germany; [Osborne, Geoffrey W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Osborne, Geoffrey W.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia; [Taylor, Michael D.] Hosp Sick Children, Div Neurosurg, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON, Canada; [Reynolds, Brent A.] Univ Florida, McKnight Brain Inst, Dept Neurosurg, Gainesville, FL USA	University of Queensland; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Queensland; University of Queensland; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); State University System of Florida; University of Florida	Robson, JP (corresponding author), Univ Queensland, Div Mol Genet & Dev, Inst Mol Biosci, Brisbane, Qld, Australia.	jonathanprobson@gmail.com	Pfister, Stefan M/F-6860-2013	Pfister, Stefan M/0000-0002-5447-5322; Wainwright, Brandon/0000-0003-0406-2092; Korshunov, Andrey/0000-0002-5257-3623; Taylor, Michael/0000-0001-7009-3466	National Health and Medical Research Council (NHMRC) [301198, 143072]; Cancer Council Queensland [456144]; John Trivett Foundation [3BWF18/UQ2002000886]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Queensland(Cancer Council Queensland); John Trivett Foundation	For the work presented in this study, JPR, EJ, GWO, BW and BAR were funded in part through the National Health and Medical Research Council (NHMRC) grants 301198 (http://purl.org/au-research/grants/nhmrc/301198), and 143072 (http://purl.org/au-research/grants/nhmrc/143072); The Cancer Council Queensland grant 456144 (https://cancerqld.org.au/research/research-grants-program/); The John Trivett Foundation grant 3BWF18/UQ2002000886 (https://www.curebraincancer.org.au/page/114/the-john-trivett-foundation-). No specific funding was given for the analysis of CD24 on human tissue for this manuscript (re: MR, AK, MK, SMP and MDT). None of these funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Institute for Molecular Bioscience animal facility staff for all their support with animal maintenance and handling. We thank the University of Queensland ethics board for their assistance and support in carrying out the experiments. Special thanks to members of the Wainwright and Reynolds laboratories, past and present, for their technical support throughout the project. Thank you to the Queensland Brain Institute Flow Cytometry centre for all their assistance and support in carrying out the FACS experiments.	Adolphe C, 2006, CANCER RES, V66, P2081, DOI 10.1158/0008-5472.CAN-05-2146; Adolphe C, 2004, DEVELOPMENT, V131, P5009, DOI 10.1242/dev.01367; Ahlfeld J, 2013, CANCER RES, V73, P3796, DOI 10.1158/0008-5472.CAN-13-0238; Athar M, 2006, EXP DERMATOL, V15, P667, DOI 10.1111/j.1600-0625.2006.00473.x; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Bian YH, 2007, WORLD J GASTROENTERO, V13, P1659, DOI 10.3748/wjg.v13.i11.1659; Boon K, 2003, ONCOGENE, V22, P7687, DOI 10.1038/sj.onc.1207043; Calaora V, 1996, NEUROSCIENCE, V73, P581, DOI 10.1016/0306-4522(96)00042-5; Cano DA, 2006, GASTROENTEROLOGY, V131, P1856, DOI 10.1053/j.gastro.2006.10.050; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Codega P, 2014, NEURON, V82, P545, DOI 10.1016/j.neuron.2014.02.039; Corti S, 2007, EXP NEUROL, V205, P547, DOI 10.1016/j.expneurol.2007.03.021; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Della Corte CM, 2017, WORLD J GASTROENTERO, V23, P4330, DOI 10.3748/wjg.v23.i24.4330; Desiderio V, 2015, ONCOTARGET, V6, P71, DOI 10.18632/oncotarget.2698; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Ellis T, 2003, GENESIS, V36, P158, DOI 10.1002/gene.10208; Fattet S, 2009, J PATHOL, V218, P86, DOI 10.1002/path.2514; Fogel M, 1999, CANCER LETT, V143, P87, DOI 10.1016/S0304-3835(99)00195-0; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Harris LW, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-28; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Kim M, 2003, J NEUROSCI, V23, P10703; Kimura H, 2005, ONCOGENE, V24, P4026, DOI 10.1038/sj.onc.1208567; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Korshunov A, 2010, J CLIN ONCOL, V28, P3054, DOI 10.1200/JCO.2009.25.7121; Kristiansen G, 2003, CLIN CANCER RES, V9, P4906; Kristiansen G, 2003, BRIT J CANCER, V88, P231, DOI 10.1038/sj.bjc.6600702; Kristiansen G, 2002, AM J PATHOL, V161, P1215, DOI 10.1016/S0002-9440(10)64398-2; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Lee RTH, 2016, DEVELOPMENT, V143, P367, DOI 10.1242/dev.120154; Mao XG, 2009, TRANSL ONCOL, V2, P247, DOI 10.1593/tlo.09136; Marino S, 2000, GENE DEV, V14, P994; Morrison LC, 2013, NEOPLASIA, V15, P384, DOI 10.1593/neo.13148; Nieoullon V, 2005, MOL CELL NEUROSCI, V28, P462, DOI 10.1016/j.mcn.2004.10.007; Northcott PA, 2017, NATURE, V547, P311, DOI 10.1038/nature22973; Northcott PA, 2012, EXPERT REV NEUROTHER, V12, P871, DOI [10.1586/ERN.12.66, 10.1586/ern.12.66]; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Papaccio F, 2017, STEM CELL TRANSL MED, V6, P2115, DOI 10.1002/sctm.17-0138; Patru C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-66; Pfenninger CV, 2007, CANCER RES, V67, P5727, DOI 10.1158/0008-5472.CAN-07-0183; Pfister S, 2009, J CLIN ONCOL, V27, P1627, DOI 10.1200/JCO.2008.17.9432; Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Remke M, 2011, J CLIN ONCOL, V29, P3852, DOI 10.1200/JCO.2011.36.2798; Remke M, 2011, J CLIN ONCOL, V29, P2717, DOI 10.1200/JCO.2011.34.9373; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Roth RB, 2006, NEUROGENETICS, V7, P67, DOI 10.1007/s10048-006-0032-6; Senner V, 1999, J NEUROPATH EXP NEUR, V58, P795, DOI 10.1097/00005072-199908000-00002; Shu Q, 2008, STEM CELLS, V26, P1414, DOI 10.1634/stemcells.2007-1009; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Vanner RJ, 2014, CANCER CELL, V26, P33, DOI 10.1016/j.ccr.2014.05.005; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130; Ward RJ, 2009, CANCER RES, V69, P4682, DOI 10.1158/0008-5472.CAN-09-0342; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Yoshikawa K, 2009, J GASTROENTEROL, V44, P1113, DOI 10.1007/s00535-009-0110-2	71	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210665	10.1371/journal.pone.0210665	http://dx.doi.org/10.1371/journal.pone.0210665			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657775	Green Published, Green Submitted, gold			2022-12-26	WOS:000456017000016
J	Ingelse, SA; Juschten, J; Maas, MAW; Matute-Bello, G; Juffermans, NP; van Woensel, JBM; Bem, RA				Ingelse, Sarah A.; Juschten, Jenny; Maas, Martinus A. W.; Matute-Bello, Gustavo; Juffermans, Nicole P.; van Woensel, Job B. M.; Bem, Reinout A.			Fluid restriction reduces pulmonary edema in a model of acute lung injury in mechanically ventilated rats	PLOS ONE			English	Article							CRITICALLY-ILL CHILDREN; BALANCE; WATER; INFLAMMATION; MANAGEMENT; RESPONSES; OVERLOAD; REMOVAL	Experimental acute lung injury models are often used to increase our knowledge on the acute respiratory distress syndrome (ARDS), however, existing animal models often do not take into account the impact of specific fluid strategies on the development of lung injury. In contrast, the current literature strongly suggests that fluid management strategies have a significant impact on clinical outcome of patients with ARDS. Thus, it is important to characterize the role of fluid management strategies in experimental models of lung injury. In this study we investigated the effect of two different fluid strategies on commonly used outcome variables in a short-term model of acute lung injury, in relation to age. Infant (2-3 weeks) and adult (3-4 months) Wistar rats received intratracheal instillations of lipopolysaccharide and 24 hours later were mechanically ventilated for 6 hours. During mechanical ventilation, rats from both age groups were randomized to either a standard or conservative intravenous fluid strategy. We found that the hemodynamic response in infant and adult rats was similar in both fluid strategies. Lung wet-to-dry ratios were lower in adult, but not in infant rats receiving the conservative fluid strategy as compared to the standard fluid strategy. There were age-related differences in markers of alveolar capillary barrier disruption and alveolar fluid clearance, yet these were unaffected by fluid strategy. Finally, we found significantly higher IL-1 beta and TNF-alpha concentrations in the adult rats treated with the conservative as compared to the standard fluid regimen. In conclusion, the choice of fluid strategy in mechanically ventilated rats with experimental LPS-induced acute lung injury has a significant effect on pulmonary extravascular water, an important and well-recognized lung injury marker, and on the local pro-inflammatory cytokine profiles. We advocate the use of a more uniform, conservative, fluid strategy regimen in experimental models of acute lung injury.	[Ingelse, Sarah A.; van Woensel, Job B. M.; Bem, Reinout A.] Acad Med Ctr, Emma Childrens Hosp, Pediat Intens Care Unit, Amsterdam, Netherlands; [Ingelse, Sarah A.; Juschten, Jenny; Maas, Martinus A. W.; Juffermans, Nicole P.] Acad Med Ctr, LEICA, Amsterdam, Netherlands; [Juschten, Jenny; Juffermans, Nicole P.] Acad Med Ctr, Dept Intens Care, Amsterdam, Netherlands; [Juschten, Jenny] Vrije Univ Amsterdam Med Ctr, Dept Intens Care & Res VUmc Intens Care REVIVE, Amsterdam, Netherlands; [Matute-Bello, Gustavo] Univ Washington, Ctr Lung Biol, Div Pulm Crit Care & Sleep Med, Seattle, WA 98195 USA; [Matute-Bello, Gustavo] VA Puget Sound Healthcare Syst, Med Res Serv, Seattle, WA USA	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Ingelse, SA (corresponding author), Acad Med Ctr, Emma Childrens Hosp, Pediat Intens Care Unit, Amsterdam, Netherlands.; Ingelse, SA (corresponding author), Acad Med Ctr, LEICA, Amsterdam, Netherlands.	s.a.ingelse@amc.uva.nl	A., Reinout/AAN-1411-2021	Bem, Reinout Alexander/0000-0002-9454-5321	Ammodo Foundation; Foundation of Pediatric Intensive Care (SKIC) in the Netherlands; NIH	Ammodo Foundation; Foundation of Pediatric Intensive Care (SKIC) in the Netherlands(Netherlands Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the Ammodo Foundation and the Foundation of Pediatric Intensive Care (SKIC) in the Netherlands. This publication was also funded in part by the NIH. The sponsors had no role in the design and execution of the research, the writing of the report or the decision to submit the manuscript for publication.	Alobaidi R, 2018, JAMA PEDIATR, V172, P257, DOI 10.1001/jamapediatrics.2017.4540; Aloia JF, 1998, J LAB CLIN MED, V132, P483, DOI 10.1016/S0022-2143(98)90126-3; Avila-Diaz M, 2006, PERITON DIALYSIS INT, V26, P574; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; CHAPPELL D, 2014, CRIT CARE, V18; Copland IB, 2004, AM J RESP CRIT CARE, V169, P739, DOI 10.1164/rccm.200310-1417OC; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Flori HR, 2011, CRIT CARE RES PRACT, V2011, DOI 10.1155/2011/854142; Ingelse SA, 2017, PEDIATR CRIT CARE ME, V18, pE106, DOI 10.1097/PCC.0000000000001060; Ingelse SA, 2016, FRONT PEDIATR, V4, DOI 10.3389/fped.2016.00021; Ito Y, 2007, EXP LUNG RES, V33, P375, DOI 10.1080/01902140701634843; Katira BH, 2017, AM J RESP CRIT CARE, V196, P1411, DOI 10.1164/rccm.201611-2268OC; Kneyber MCJ, 2014, AM J RESP CRIT CARE, V190, P258, DOI 10.1164/rccm.201401-0168CP; Knoferl MW, 1999, J TRAUMA, V46, P23, DOI 10.1097/00005373-199901000-00005; Kornecki A, 2005, AM J RESP CRIT CARE, V171, P743, DOI 10.1164/rccm.200408-1053OC; Kuebler WM, 1999, J CLIN INVEST, V104, P495, DOI 10.1172/JCI6872; Mafia LDA, 2017, ANESTH ANALG, V125, P1364, DOI 10.1213/ANE.0000000000002348; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Milos S, 2017, AM J PHYSIOL-LUNG C, V313, pL524, DOI 10.1152/ajplung.00055.2017; Nusmeier A, 2015, PEDIATR CRIT CARE ME, V16, pE28, DOI 10.1097/PCC.0000000000000312; R Core Team, 2021, R LANGUAGE ENV STAT; Rosenberg Andrew L, 2009, J Intensive Care Med, V24, P35, DOI 10.1177/0885066608329850; Sakr Y, 2017, CRIT CARE MED, V45, P386, DOI 10.1097/CCM.0000000000002189; Schouten LRA, 2016, CRIT CARE MED, V44, P819, DOI [10.1097/CCM.0000000000001388, 10.1097/CCM.0000000000002008]; Schouten LR, 2016, CRIT CARE MED; Setzer F, 2013, CRIT CARE, V17, DOI 10.1186/cc12744; Sinitsky L, 2015, PEDIATR CRIT CARE ME, V16, P205, DOI 10.1097/PCC.0000000000000318; Valentine SL, 2012, CRIT CARE MED, V40, P2883, DOI 10.1097/CCM.0b013e31825bc54d; Weisberg JFS, 2011, R COMPANION APPL REG; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Willson DF, 2013, PEDIATR CRIT CARE ME, V14, P666, DOI 10.1097/PCC.0b013e3182917cb5	32	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210172	10.1371/journal.pone.0210172	http://dx.doi.org/10.1371/journal.pone.0210172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653512	gold, Green Published			2022-12-26	WOS:000456015500027
J	Perez-Lachaud, G; Rocha, FH; Valle-Mora, J; Henaut, Y; Lachaud, JP				Perez-Lachaud, Gabriela; Rocha, Franklin H.; Valle-Mora, Javier; Henaut, Yann; Lachaud, Jean-Paul			Fine-tuned intruder discrimination favors ant parasitoidism	PLOS ONE			English	Article							ECTATOMMA-TUBERCULATUM; PONERINE ANT; NESTMATE RECOGNITION; CHEMICAL MIMICRY; CUTICULAR HYDROCARBONS; CORPSE REMOVAL; HYMENOPTERA; FORMICIDAE; BEHAVIOR; HOST	A diversity of arthropods (myrmecophiles) thrives within ant nests, many of them unmolested though some, such as the specialized Eucharitidae parasitoids, may cause direct damage to their hosts. Ants are known to discriminate between nestmates and non-nest-mates, but whether they recognize the strength of a threat and their capacity to adjust their behavior accordingly have not been fully explored. We aimed to determine whether Ectatomma tuberculatum ants exhibited specific behavioral responses to potential or actual intruders posing different threats to the host colony and to contribute to an understanding of complex ant-eucharitid interactions. Behavioral responses differed significantly according to intruder type. Ants evicted intruders that represented a threat to the colony's health (dead ants) or were not suitable as prey items (filter paper, eucharitid parasitoid wasps, non myrmecophilous adult weevils), but killed potential prey (weevil larvae, termites). The timing of detection was in accordance with the nature and size of the intruder: corpses (a potential source of contamination) were detected faster than any other intruder and transported to the refuse piles within 15 min. The structure and complexity of behavioral sequences differed among those intruders that were discarded. Workers not only recognized and discriminated between several distinct intruders but also adjusted their behavior to the type of intruder encountered. Our results confirm the previously documented recognition capabilities of E. tuberculatum workers and reveal a very fine-tuned intruder discrimination response. Colony-level prophylactic and hygienic behavioral responses through effective removal of inedible intruders appears to be the most general and flexible form of defense in ants against a diverse array of intruders. However, this generalized response to both potentially lethal and harmless intruders might have driven the evolution of ant-eucharitid interactions, opening a window for parasitoid attack and allowing adult parasitoid wasps to quickly leave the natal nest unharmed.	[Perez-Lachaud, Gabriela; Rocha, Franklin H.; Henaut, Yann; Lachaud, Jean-Paul] Colegio Frontera Sur, Conservac Biodiversidad, Chetmal, Quintana Roo, Mexico; [Valle-Mora, Javier] Colegio Frontera Sur, Tapachula, Chiapas, Mexico; [Lachaud, Jean-Paul] Univ Toulouse, CBI, CRCA, Toulouse, France; [Lachaud, Jean-Paul] UPS, CNRS, Toulouse, France	El Colegio de la Frontera Sur (ECOSUR); El Colegio de la Frontera Sur (ECOSUR); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Perez-Lachaud, G (corresponding author), Colegio Frontera Sur, Conservac Biodiversidad, Chetmal, Quintana Roo, Mexico.	igperez@ecosur.mx	LACHAUD, Jean-Paul/ABG-3831-2021	LACHAUD, Jean-Paul/0000-0002-5082-8987; Henaut, Yann/0000-0002-8805-1739; Perez-Lachaud, Gabriela/0000-0002-8924-1606	Consejo Nacional de Ciencia y Tecnologia, Mexico [415149]	Consejo Nacional de Ciencia y Tecnologia, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was partially funded by Consejo Nacional de Ciencia y Tecnologia, Mexico (scholarship grant no. 415149 to FHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Akino T, 1996, JPN J APPL ENTOMOL Z, V40, P265, DOI 10.1303/jjaez.40.265; [Anonymous], [No title captured]; Atkinson EB, 2011, PHYSIOL ENTOMOL, V36, P282, DOI 10.1111/j.1365-3032.2010.00774.x; AYRE GL, 1962, CAN J ZOOLOG, V40, P157, DOI 10.1139/z62-020; Barbero F, 2009, J EXP BIOL, V212, P4084, DOI 10.1242/jeb.032912; Barbero F, 2009, SCIENCE, V323, P782, DOI 10.1126/science.1163583; Bengston SE, 2014, P ROY SOC LOND B BIO, V281; Boomsma JJ, P ROYAL ENT SOC 22 S; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; Breed MD, 1999, INSECT SOC, V46, P327, DOI 10.1007/s000400050153; Bruckner A, 2017, PEERJ, V5, DOI 10.7717/peerj.3870; Cerda X, PREDATION HYMENOPTER; CHAMPALBERT A, 1990, ANIM BEHAV, V39, P850, DOI 10.1016/S0003-3472(05)80949-2; Clausen C. P., 1923, Annals of the Entomological Society of America, V16, P195, DOI 10.1093/aesa/16.3.195; CLAUSEN C. P., 1941, PSYCHE, V48, P57, DOI 10.1155/1941/21539; CLAUSEN CURTIS P., 1940, JOUR WASHINGTON ACAD SCI, V30, P504; Cook OF, 1905, USDA TECHNICAL SERIE, V10, P1; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Cremer Sylvia, 2018, Annual Review of Entomology, V63, P105, DOI 10.1146/annurev-ento-020117-043110; Cremer S, 2009, PHILOS T R SOC B, V364, P129, DOI 10.1098/rstb.2008.0166; De la Mora A, 2008, BEHAV PROCESS, V78, P64, DOI 10.1016/j.beproc.2008.01.011; DEJEAN A, 1985, INSECT SOC, V32, P241, DOI 10.1007/BF02224914; DEJEAN A, 1992, INSECT SOC, V39, P129, DOI 10.1007/BF01249289; Dejean A., 1980, B SFECA, P43; Di Giulio A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130541; Diez L, 2015, BEHAV PROCESS, V116, P80, DOI 10.1016/j.beproc.2015.04.016; Diez L, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0306; Diez L, 2013, J CHEM ECOL, V39, P1424, DOI 10.1007/s10886-013-0365-1; Diez L, 2012, NATURWISSENSCHAFTEN, V99, P833, DOI 10.1007/s00114-012-0965-6; Elliot SL, 2010, ECOLOGY, V91, P65, DOI 10.1890/09-0424.1; Feneron R, 1996, INSECT SOC, V43, P131, DOI 10.1007/BF01242565; Feneron R, 2012, PSYCHE, DOI [10.1155/2012/573541, DOI 10.1155/2012/573541]; Franz NM, 2003, J INSECT BEHAV, V16, P381, DOI 10.1023/A:1024880110189; Fresneau D, 1984, PROCESSUS ACQUISITIO, P437; Galwey NW, 2006, INTRO MIXED MODELING; Halcroft M, 2011, INSECT SOC, V58, P245, DOI 10.1007/s00040-010-0142-x; Henaut Y, 2014, ANIM COGN, V17, P185, DOI 10.1007/s10071-013-0651-x; Heraty J. M, 2002, MEM AM ENTOMOL I, V68, P1; Heraty JM, 2015, ANN ENTOMOL SOC AM, V108, P865, DOI 10.1093/aesa/sav062; Hora RR, 2005, BEHAV ECOL SOCIOBIOL, V59, P285, DOI 10.1007/s00265-005-0040-9; Howard RW, 2002, ARCH INSECT BIOCHEM, V50, P75, DOI 10.1002/arch.10034; Howard RW, 2001, ANN ENTOMOL SOC AM, V94, P707, DOI 10.1603/0013-8746(2001)094[0707:CHOKSH]2.0.CO;2; Hughes DP, 2008, TRENDS ECOL EVOL, V23, P672, DOI 10.1016/j.tree.2008.07.011; Hughes DP, 2008, SOCIOBIOLOGY COMMUNI, P171; Ibarra-Nunez G, 2001, SOCIOBIOLOGY, V37, P723; JAFFE K, 1990, INSECT SOC, V37, P101, DOI 10.1007/BF02224024; Jandt JM, 2014, BIOL REV, V89, P48, DOI 10.1111/brv.12042; Kistner D. H., 1982, Social insects. Vol. III, P1; Krantz GW, 2007, ACAROLOGY, P29; Lachaud J-P, 2013, PSYCHE SPECIAL ISSUE; Lachaud J-P, 2012, ANTS THEIR PARASITES; Lachaud JP, 2016, SCI REP-UK, V6, DOI 10.1038/srep29995; Lachaud Jean-Paul, 2012, Psyche (Cambridge), V2012; Lachaud JP, 1998, FLA ENTOMOL, V81, P570, DOI 10.2307/3495962; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; Lhomme P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043053; Morgenstern D, 2013, TOXICON, V63, P120, DOI 10.1016/j.toxicon.2012.11.022; Murray EA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0495; Ostwald MM, 2018, J INSECT BEHAV, V31, P503, DOI 10.1007/s10905-018-9694-9; Parmentier T, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0583-6; Payne CM, 2004, ANN ZOOL FENN, V41, P843; Perez-Lachaud G, 2001, BIOL CONTROL, V22, P265, DOI 10.1006/bcon.2001.0976; Perez-Lachaud G, 2006, ANN ENTOMOL SOC AM, V99, P567, DOI 10.1603/0013-8746(2006)99[567:BABOKH]2.0.CO;2; Perez-Lachaud G, 2015, J INSECT PHYSIOL, V75, P63, DOI 10.1016/j.jinsphys.2015.03.003; Perez-Lachaud G, 2014, BIOL J LINN SOC, V111, P462, DOI 10.1111/bij.12220; Perez-Lachaud G, 2010, BIOL CONTROL, V52, P131, DOI 10.1016/j.biocontrol.2009.10.016; PERFECTO I, 1993, INSECT SOC, V40, P295, DOI 10.1007/BF01242365; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Richard FJ, 2004, CR BIOL, V327, P509, DOI 10.1016/j.crvi.2004.03.002; ROBERTSON PL, 1971, J INSECT PHYSIOL, V17, P691, DOI 10.1016/0022-1910(71)90117-X; Rocha FH, 2014, ETHOLOGY, V120, P1185, DOI 10.1111/eth.12291; Roche-Labarbe Nadege, 2004, Actes des Colloques Insectes Sociaux, V16, P52; Scharf I, 2011, ETHOLOGY, V117, P731, DOI 10.1111/j.1439-0310.2011.01926.x; SCHATZ B, 1994, ANIM BEHAV, V48, P236, DOI 10.1006/anbe.1994.1232; SCHMIDHEMPEL P, 1998, PARASITES SOCIAL INS; Simone-Finstrom M., 2017, Bee World, V94, P21, DOI 10.1080/0005772X.2017.1307800; Sobotnik J, 2010, J INSECT PHYSIOL, V56, P1012, DOI 10.1016/j.jinsphys.2010.02.012; Stroeymeyt N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013059; Sturgis SJ, 2012, MYRMECOL NEWS, V16, P101; Torrens J, 2016, SYST ENTOMOL, V41, P596, DOI 10.1111/syen.12176; Tranter C, 2015, BEHAV ECOL, V26, P396, DOI 10.1093/beheco/aru203; van Zweden JS, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P222, DOI 10.1017/CBO9780511711909.012; Vander Meer Robert K., 1998, P79; VANDERMEER RK, 1982, SCIENCE, V218, P806, DOI 10.1126/science.218.4574.806; VANDERMEER RK, 1989, J CHEM ECOL, V15, P2247, DOI 10.1007/BF01014113; Venables WN., 2002, MODERN APPL STAT S 4; von Beeren C, 2018, FRONT ZOOL, V15, DOI 10.1186/s12983-018-0249-x; von Beeren C, 2012, J CHEM ECOL, V38, P262, DOI 10.1007/s10886-012-0083-0; von Beeren C, 2011, EVOL ECOL, V25, P259, DOI 10.1007/s10682-010-9420-3; Wheeler W, 1910, AM NAT, V91, P5927; Wheeler WM, 1907, B AM MUS NAT HIST, V23, P1; Wickham H, 2007, J STAT SOFTW, V21, P1; WILSON EDWARD O., 1958, PSYCHE, V65, P108, DOI 10.1155/1958/69391; Wilson-Rich N, 2009, ANNU REV ENTOMOL, V54, P405, DOI 10.1146/annurev.ento.53.103106.093301	94	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210739	10.1371/journal.pone.0210739	http://dx.doi.org/10.1371/journal.pone.0210739			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653595	Green Published, Green Submitted, gold			2022-12-26	WOS:000456015500065
J	Versluis, D; Gonzalez, TDB; Zoetendal, EG; van Passel, MWJ; Smidt, H				Versluis, Dennis; Gonzalez, Teresita de J. Bello; Zoetendal, Erwin G.; van Passel, Mark W. J.; Smidt, Hauke			High throughput cultivation-based screening on porous aluminum oxide chips allows targeted isolation of antibiotic resistant human gut bacteria	PLOS ONE			English	Article							SELECTIVE DECONTAMINATION; DIGESTIVE-TRACT; INTENSIVE-CARE; FUNCTIONAL-CHARACTERIZATION; MICROBIOTA REVEALS; DIVERSITY; GROWTH; RESERVOIR; GENES	The emergence of bacterial pathogens that are resistant to clinical antibiotics poses an increasing risk to human health. An important reservoir from which bacterial pathogens can acquire resistance is the human gut microbiota. However, thus far, a substantial fraction of the gut microbiota remains uncultivated and has been little-studied with respect to its resistance reservoir-function. Here, we aimed to isolate yet uncultivated resistant gut bacteria by a targeted approach. Therefore, faecal samples from 20 intensive care patients who had received the prophylactic antibiotic treatment selective digestive decontamination (SDD), i.e. tobramycin, polymyxin E, amphotericin B and cefotaxime, were inoculated anaerobically on porous aluminium oxide chips placed on top of poor and rich agar media, including media supplemented with the SDD antibiotics. Biomass growing on the chips was analysed by 16S rRNA gene amplicon sequencing, showing large inter-individual differences in bacterial cultivability, and enrichment of a range of taxonomically diverse operational taxonomic units (OTUs). Furthermore, growth of Ruminococcaceae (2 OTUs), Enterobacteriaceae (6 OTUs) and Lachnospiraceae (4 OTUs) was significantly inhibited by the SDD antibiotics. Strains belonging to 16 OTUs were candidates for cultivation to pure culture as they shared <= 95% sequence identity with the closest type strain and had a relative abundance of >= 2%. Six of these OTUs were detected on media containing SDD antibiotics, and as such were prime candidates to be studied regarding antibiotic resistance. One of these six OTUs was obtained in pure culture using targeted isolation. This novel strain was resistant to the antibiotics metrodinazole and imipenem. It was initially classified as member of the Ruminococcaceae, though later it was found to share 99% nucleotide identity with the recently published Sellimonas intestinalis BR72(T). In conclusion, we show that high-throughput cultivation-based screening of microbial communities can guide targeted isolation of bacteria that serve as reservoirs of antibiotic resistance.	[Versluis, Dennis; Gonzalez, Teresita de J. Bello; Zoetendal, Erwin G.; van Passel, Mark W. J.; Smidt, Hauke] Wageningen Univ & Res, Lab Microbiol, Wageningen, Netherlands; [van Passel, Mark W. J.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands; [Versluis, Dennis] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, Wilhelmshaven, Germany; [Gonzalez, Teresita de J. Bello] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	Wageningen University & Research; Netherlands National Institute for Public Health & the Environment; Carl von Ossietzky Universitat Oldenburg; University of Glasgow	Versluis, D (corresponding author), Wageningen Univ & Res, Lab Microbiol, Wageningen, Netherlands.; Versluis, D (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, Wilhelmshaven, Germany.	dversluis@hotmail.com	Smidt, Hauke/D-7054-2014	Smidt, Hauke/0000-0002-6138-5026; Bello Gonzalez, Teresita de Jesus/0000-0001-5655-9370; Versluis, Dennis/0000-0001-8430-4500	European Union [282004]	European Union(European Commission)	This work was supported by the European Union through the EvoTAR project (Grant agreement no. 282004) to HS.	Al Naiemi N, 2006, J ANTIMICROB CHEMOTH, V58, P853, DOI 10.1093/jac/dkl316; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Atteia A, 2013, BBA-BIOENERGETICS, V1827, P210, DOI 10.1016/j.bbabio.2012.08.002; Baek SH, 2011, J FRESHWATER ECOL, V26, P547, DOI 10.1080/02705060.2011.582696; BLECHSCHMIDT B, 1992, J GEN MICROBIOL, V138, P1197, DOI 10.1099/00221287-138-6-1197; Bollmann A, 2007, APPL ENVIRON MICROB, V73, P6386, DOI 10.1128/AEM.01309-07; Browne HP, 2016, NATURE, V533, P543, DOI 10.1038/nature17645; Buelow E, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0309-z; Buelow E, 2014, J ANTIMICROB CHEMOTH, V69, P2215, DOI 10.1093/jac/dku092; Bulow E., 2015, THESIS; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cheng G, 2012, FEMS MICROBIOL LETT, V336, P11, DOI 10.1111/j.1574-6968.2012.02647.x; Clinical and Laboratory Standards Institute (CLSI), 2014, CLSI DOCUMENT M100 S; CLSI, 2012, CLSI DOCUMENT M11 A8; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Daneman N, 2013, LANCET INFECT DIS, V13, P328, DOI 10.1016/S1473-3099(12)70322-5; de Jonge E, 2003, LANCET, V362, P1011, DOI 10.1016/S0140-6736(03)14409-1; de Smet AMGA, 2009, NEW ENGL J MED, V360, P20, DOI 10.1056/NEJMoa0800394; de Smet AMGA, 2012, CURR OPIN INFECT DIS, V25, P211, DOI 10.1097/QCO.0b013e3283507f8c; Deak E, 1998, MICROBIOL-SGM, V144, P2169, DOI 10.1099/00221287-144-8-2169; EUCAST, 2015, BREAKP TABL INT MICS, DOI [10.1016/j.tibtech.2012.05.007, DOI 10.1016/J.TIBTECH.2012.05.007]; Falcon LI, 2010, ISME J, V4, P777, DOI 10.1038/ismej.2010.2; Ferrari BC, 2005, APPL ENVIRON MICROB, V71, P8714, DOI 10.1128/AEM.71.12.8714-8720.2005; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041294; Forslund K, 2013, GENOME RES, V23, P1163, DOI 10.1101/gr.155465.113; Gutleben J, 2018, CRIT REV MICROBIOL, V44, P212, DOI 10.1080/1040841X.2017.1332003; Hu YF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3151; Ingham CJ, 2007, P NATL ACAD SCI USA, V104, P18217, DOI 10.1073/pnas.0701693104; Jiang HC, 2006, APPL ENVIRON MICROB, V72, P3832, DOI 10.1128/AEM.02869-05; Kim BS, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/838040; Ma L, 2014, P NATL ACAD SCI USA, V111, P9768, DOI 10.1073/pnas.1404753111; Marshall B., 2009, MICROBE WASH 600, V4, P231, DOI [DOI 10.1128/MICROBE.4.231.1, 10.1128/microbe.4.231.1]; Pfleiderer A, 2013, EUR J CLIN MICROBIOL, V32, P1471, DOI 10.1007/s10096-013-1900-2; Pham VHT, 2012, TRENDS BIOTECHNOL, V30, P475, DOI 10.1016/j.tibtech.2012.05.007; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R development Core Team, 2010, R LANGUAGE AND ENVIR; Raes J, 2016, GUT, V65, P896, DOI 10.1136/gutjnl-2015-311015; Ramiro-Garcia Javier, 2016, F1000Res, V5, P1791, DOI 10.12688/f1000research.9227.2; Rettedal EA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5714; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Schauer M, 2000, FEMS MICROBIOL ECOL, V33, P51, DOI 10.1111/j.1574-6941.2000.tb00726.x; Seo B, 2016, INT J SYST EVOL MICR, V66, P951, DOI 10.1099/ijsem.0.000817; Smilauer P, 2014, MULTIVARIATE ANALYSI, V5; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Sommer MOA, 2015, CURR OPIN MICROBIOL, V27, P127, DOI 10.1016/j.mib.2015.08.004; Sommer MOA, 2010, VIRULENCE, V1, P299, DOI 10.4161/viru.1.4.12010; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; STAMS AJM, 1993, APPL ENVIRON MICROB, V59, P1114, DOI 10.1128/AEM.59.4.1114-1119.1993; Steinert G, 2014, MAR BIOTECHNOL, V16, P594, DOI 10.1007/s10126-014-9575-y; Tian LM, 2016, MOL NUTR FOOD RES, V60, P2256, DOI 10.1002/mnfr.201600149; Tripp HJ, 2008, NATURE, V452, P741, DOI 10.1038/nature06776; van den Bogert B, 2013, FEMS MICROBIOL ECOL, V85, P376, DOI 10.1111/1574-6941.12127; van den Bogert B, 2011, APPL ENVIRON MICROB, V77, P2071, DOI 10.1128/AEM.02477-10; van Lingen HJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00425; van Schaik W, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0087; Versluis D, 2015, SCI REP-UK, V5, DOI 10.1038/srep11981; Wolf M, 2004, INT J SYST EVOL MICR, V54, P871, DOI 10.1099/ijs.0.02868-0; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614	58	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210970	10.1371/journal.pone.0210970	http://dx.doi.org/10.1371/journal.pone.0210970			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653573	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000456015500093
J	Carlos, S; Lopez-del Burgo, C; Ndarabu, A; Osorio, A; Rico-Campa, A; Reina, G; Burgueno, E; de Irala, J				Carlos, Silvia; Lopez-del Burgo, Cristina; Ndarabu, Adolphe; Osorio, Alfonso; Rico-Campa, Anais; Reina, Gabriel; Burgueno, Eduardo; de Irala, Jokin			Heterosexual oral and anal sex in Kinshasa (D. R.Congo): Data from OKAPI prospective cohort	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; HIV-INFECTION; HUMAN-PAPILLOMAVIRUS; RISK BEHAVIORS; FORCED SEX; CONDOM USE; PREVALENCE; ADOLESCENTS; INTERCOURSE; WOMEN	Background Sexually transmitted infections can be spread through oral and anal heterosexual sex. There are few data on these practices in Sub-Saharan Africa. We analyzed the prevalence of heterosexual oral and anal sex among HIV Voluntary Counseling and Testing (VCT) attendees in Kinshasa and the associated sociodemographics, perceptions and behavioral factors. Methods OKAPI (Observational Kinshasa AIDS Prevention Initiative) prospective cohort study. It evaluates the VCT impact on HIV-related knowledge and behaviors at 6 and 12-month follow-up. Since April 2016 until April 2018, 797 persons aged 15-59 years were HIV tested and replied to a baseline interview, including information about anal and oral sex. Descriptive, bi- and multivariate analyses were performed using baseline data. Results Among 718 sexually active participants reporting heterosexual sex, 59% had had oral sex, 22% anal sex and 18% both practices. Among participants reporting "not" having had sex, 6% reported oral sex, 3% anal sex and 1% both. Oral sex was associated with a daily use of the Internet/mobile phone, perceiving low community HIV risk, reporting HIV-related behaviors (multiple partners, inconsistent condom use, anal, paid and forced sex) and having been pregnant. Being married-monogamous was inversely associated with oral sex. Anal sex was directly associated with having other risk sexual behaviors. Conclusions Oral and anal sex were common among people reporting heterosexual sex in Kinshasa. Perceiving a low community HIV risk and having other sexual risk behaviors are associated with these practices, which are commonly not considered as risky despite their strong association with HIV/STIs. They need to be considered when designing preventive strategies in Kinshasa.	[Carlos, Silvia; Lopez-del Burgo, Cristina; Rico-Campa, Anais; de Irala, Jokin] Univ Navarra, Prevent Med & Publ Hlth Dept, Pamplona, Spain; [Carlos, Silvia; Lopez-del Burgo, Cristina; Osorio, Alfonso; Rico-Campa, Anais; Reina, Gabriel; de Irala, Jokin] Navarra Inst Hlth Res, IdiSNA, Pamplona, Spain; [Carlos, Silvia; Lopez-del Burgo, Cristina; Osorio, Alfonso; de Irala, Jokin] Univ Navarra, ICS, Educ Affect & Human Sexual, Pamplona, Spain; [Ndarabu, Adolphe; Burgueno, Eduardo] Monkole Hosp, Kinshasa, DEM REP CONGO; [Osorio, Alfonso] Univ Navarra, Sch Educ & Psychol, Pamplona, Spain; [Rico-Campa, Anais] Biomed Res Ctr Network Obes & Nutr CIBERobn, Inst Hlth Carlos III, Madrid, Spain; [Reina, Gabriel] Clin Univ Navarra, Microbiol Serv, Pamplona, Spain; [Burgueno, Eduardo] Univ Mwene Ditu, Sch Med, Mwene Ditu, DEM REP CONGO	University of Navarra; University of Navarra; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Navarra	Carlos, S (corresponding author), Univ Navarra, Prevent Med & Publ Hlth Dept, Pamplona, Spain.; Carlos, S (corresponding author), Navarra Inst Hlth Res, IdiSNA, Pamplona, Spain.; Carlos, S (corresponding author), Univ Navarra, ICS, Educ Affect & Human Sexual, Pamplona, Spain.	scarlos@unav.es	Osorio, Alfonso/B-4644-2011; Martinez-Gonzalez, Miguel A./AAE-7669-2019; de Irala, Jokin/H-2936-2017; Burgo, Cristina Lopez-del/I-1963-2017; Reina, Gabriel/F-2709-2017; CARLOS, SILVIA/L-9123-2014	Osorio, Alfonso/0000-0003-4337-5382; de Irala, Jokin/0000-0002-7249-6581; Reina, Gabriel/0000-0003-4079-9753; CARLOS, SILVIA/0000-0002-4968-7080	Government of Spain (Fondo de Investigacion en Salud-FIS) [PI16/01908]; Government of Navarre [045-2015]; Institute for Culture and Society of the University of Navarra	Government of Spain (Fondo de Investigacion en Salud-FIS); Government of Navarre; Institute for Culture and Society of the University of Navarra	Funding was provided by the Government of Spain (Fondo de Investigacion en Salud-FIS) (PI16/01908 to GR/SC), the Government of Navarre (045-2015 to SC), and the Institute for Culture and Society of the University of Navarra (EASH to JI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaro LE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-54; Abdool Karim S. S., 2010, HIV AIDS S AFRICA; Abdul R, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3138-1; [Anonymous], 2014, ENQ DEM SANT REP DEM; Arulogun OS, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.2016.25.261.2630; Baggaley RF, 2013, AM J REPROD IMMUNOL, V69, P95, DOI 10.1111/aji.12064; Barnabas SL, 2018, INT J STD AIDS, V29, P531, DOI 10.1177/0956462417740487; Bavoil PM, 2017, J INFECT DIS, V216, P932, DOI 10.1093/infdis/jix419; Bruni L, 2017, SUMMARY REPORT, P27; Carlos S, 2015, SEX TRANSM INFECT, V91, P334, DOI 10.1136/sextrans-2014-051734; Carter-Wicker K, 2016, SAGE OPEN MED CASE R, V4, DOI 10.1177/2050313X16682132; CDC, 2017, FACT SHEETS; Chancellor JA, 2017, COMMUNITY DENT ORAL, V45, P20, DOI 10.1111/cdoe.12255; Chege W, 2012, J INFECT DEV COUNTR, V6, P870, DOI 10.3855/jidc.2636; Cherie A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-5; Chow EPF, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016779; Clutterbuck DJ, 2012, INT J STD AIDS, V23, P381, DOI 10.1258/ijsa.2012.200312; Davey DJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192982; Davidson CL, 2014, SAMJ S AFR MED J, V104, P358, DOI [10.7196/SAMJ.7542, 10.7196/samj.7542]; De Vries H, 2014, ARCH SEX BEHAV, V43, P1087, DOI 10.1007/s10508-014-0280-8; Dietrich JJ, 2018, AIDS BEHAV, V22, P2312, DOI 10.1007/s10461-018-2080-y; Duby Z, 2014, J SEX RES, V51, P863, DOI 10.1080/00224499.2013.871624; Folayan MO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155210; Folayan MO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129106; Gaffoor Zakir, 2013, BMC Res Notes, V6, P532, DOI 10.1186/1756-0500-6-532; Githuka G, 2014, JAIDS-J ACQ IMM DEF, V66, pS46, DOI 10.1097/QAI.0000000000000137; Goldberg SK, 2017, PERSPECT SEX REPRO H, V49, P55, DOI 10.1363/psrh.12020; Goldstein R, 2018, J ADOLESCENT HEALTH, V62, P363, DOI 10.1016/j.jadohealth.2018.01.002; Grabowski MK, 2017, NEW ENGL J MED, V377, P2154, DOI [10.1056/NEJMoa1702150, 10.1056/nejmoa1702150]; Green EC, 2011, AIDS BEHAVIOR AND CU; Halperin DT, 1999, AIDS PATIENT CARE ST, V13, P717, DOI 10.1089/apc.1999.13.717; Harling G, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0403-8; Herbenick D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181198; Hoffman S, 2017, AJAR-AFR J AIDS RES, V16, P1, DOI 10.2989/16085906.2016.1259171; Holway GV, 2018, J ADOLESCENT HEALTH, V62, P402, DOI 10.1016/j.jadohealth.2017.08.022; Holway GV, 2017, J FAM ISSUES, V38, P1675, DOI 10.1177/0192513X15613826; Hurley EA, 2017, J ADOLESCENT HEALTH, V60, P79, DOI 10.1016/j.jadohealth.2016.08.023; IACOBUCCI G, 2018, BMJ BRIT MED J, V361; Kakoko DCV, 2013, CULT HEALTH SEX, V15, P235, DOI 10.1080/13691058.2012.738829; Kalichman SC, 2009, SEX TRANSM INFECT, V85, P411, DOI 10.1136/sti.2008.035287; Kalichman SC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-807; Kapiga S, 2009, SEX TRANSM DIS, V36, P199, DOI 10.1097/OLQ.0b013e318191ba01; Lewis R, 2017, J ADOLESCENT HEALTH, V61, P694, DOI 10.1016/j.jadohealth.2017.07.004; Longo JD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187654; Maheu-Giroux M, 2018, AM J EPIDEMIOL, V187, P287, DOI 10.1093/aje/kwx244; Maswanya Edward S, 2012, East Afr J Public Health, V9, P39; Mazeingia Yohannes Teka, 2017, Glob Health Res Policy, V2, P27, DOI 10.1186/s41256-017-0047-6; Meque I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089705; Mmbaga EJ, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4245-4; Morris BJ, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0073-5; Moscicki AB, 2014, CLIN INFECT DIS, V58, P804, DOI 10.1093/cid/cit947; Mtenga S, 2015, SEX TRANSM INFECT, V91, P576, DOI 10.1136/sextrans-2015-052055; Muanda FM, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0517-4; Ndongmo Therese Ntigwa, 2017, Pan Afr Med J, V26, P71, DOI 10.11604/pamj.2017.26.71.11312; NGUYEN NP, 2016, MEDICINE, V95; Nsakala GV, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-21; O'Leary A, 2017, AIDS BEHAV, V21, P2895, DOI 10.1007/s10461-016-1635-z; Odimegwu C, 2018, J BIOSOC SCI, V10, P1; Owen BN, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21162; Parker L, 2013, EVAL PROGRAM PLANN, V36, P124, DOI 10.1016/j.evalprogplan.2012.09.002; Peltzer K, 2012, AFR HEALTH SCI, V12, P8; Peterman TA, 2018, SEX TRANSM DIS, V45, pE7, DOI [10.1097/OLQ.0000000000000737, 10.1097/olq.0000000000000737]; Le PT, 2017, J INFECT CHEMOTHER, V23, P668, DOI 10.1016/j.jiac.2017.06.011; Rice E, 2018, CHILD DEV, V89, P110, DOI 10.1111/cdev.12837; Rohde RL, 2018, VACCINE, V36, P3629, DOI 10.1016/j.vaccine.2018.05.022; Shayo Elizabeth H, 2017, BMC Res Notes, V10, P140, DOI 10.1186/s13104-017-2452-9; Shigeishi Hideo, 2016, J Clin Med Res, V8, P721, DOI 10.14740/jocmr2545w; Taberna M, 2017, CANCER-AM CANCER SOC, V123, P1156, DOI 10.1002/cncr.30564; Teasdale CA, 2017, ARCH SEX BEHAV, V46, P539, DOI 10.1007/s10508-016-0818-z; Torrone EA, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002511; Toska E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178106; UNAIDS, 2018, FAST TRACK COMM AIDS; UNAIDS, 2018, IND MON 2016 POL DEC; UNAIDS, 2017, UNAIDS DATA 2017; UNAIDS, 2018, RESP HIV W CENTR AFR; UNAIDS, 2015, INV HIV PREV; Vogt SL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00303; Watt MH, 2015, J INTERPERS VIOLENCE, V30, P1533, DOI 10.1177/0886260514540807; Wiebe ER, 2012, INT J GYNECOL OBSTET, V117, P185, DOI 10.1016/j.ijgo.2011.12.018; Woto-Gaye G, 2016, Bull Soc Pathol Exot, V109, P160, DOI 10.1007/s13149-016-0500-7; Ybarra M, 2018, AIDS CARE, V30, P821, DOI 10.1080/09540121.2018.1426824	81	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210398	10.1371/journal.pone.0210398	http://dx.doi.org/10.1371/journal.pone.0210398			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650137	Green Submitted, Green Published, gold			2022-12-26	WOS:000455813300056
J	Newbronner, E; Glendinning, C; Atkin, K; Wadman, R				Newbronner, Elizabeth; Glendinning, Caroline; Atkin, Karl; Wadman, Ruth			The health and quality of life of Thalidomide survivors as they age - Evidence from a UK survey	PLOS ONE			English	Article							PHYSICAL-DISABILITY; INDIVIDUALS; EPIDEMIOLOGY; EMBRYOPATHY; ADULTS	Background In the late 1950s and early 1960s the drug Thalidomide was marketed across the world as a non-addictive tranquilizer. Despite being given to pregnant women as a safe treatment for morning sickness, Thalidomide caused serious damage to the unborn child. Much has been written about the drug and the birth defects it caused but evidence about the health of Thalidomide survivors as they age is limited. Aim The aim of this study was to: explore the health and wellbeing UK Thalidomide survivors; document the health problems experienced by them as they reach their mid-50s; and examine the impacts on their health-related quality of life and employment. Methods A health and wellbeing survey of 351 UK Thalidomide survivors, which gathered information about home and employment circumstances, recent health problems, and health related quality of life (using SF12 Health Survey). Overall analysis focused on descriptive statistics; the association between respondents' health related quality of life and original impairment was examined using Pearson Correlation; and a three step Hierarchical Regression was used to explore the influence of five factors which narrative responses suggested might be important. Results As Thalidomide survivors reach their mid-50' s they are experiencing a wide range of secondary health problems, in particular musculoskeletal problems, and depression and anxiety, with multimorbidity a growing issue. These health problems are having a negative impact on their employment (two fifths are unable to work) and their physical health related quality of life, which is significantly poorer than the general population. Discussion Having lived relatively independent lives, many Thalidomide survivors are now having to adjust to growing disability. The study provides further evidence of the accumulative impact of disability over peoples' lifetimes and highlights the value of a life course perspective in understanding the complex experience of growing older with a disability.	[Newbronner, Elizabeth; Atkin, Karl; Wadman, Ruth] Univ York, Dept Hlth Sci, York, N Yorkshire, England; [Glendinning, Caroline] Univ York, Social Policy Res Unit, York, N Yorkshire, England	University of York - UK; University of York - UK	Newbronner, E (corresponding author), Univ York, Dept Hlth Sci, York, N Yorkshire, England.	liz.newbronner@york.ac.uk		Wadman, Ruth/0000-0003-4205-0631; Newbronner, Elizabeth/0000-0003-2366-9981	UK Thalidomide Trust	UK Thalidomide Trust	The survey was funded by the UK Thalidomide Trust who also gave permission for the data to be used in an independent (self-funded) doctoral study. The Thalidomide Trust did assist in the study design and data collection stages, as as the involvement of Thalidomide survivors was important for the acceptability of the study. However, the Trust had no role in analysis, decision to publish or preparation of the manuscript.; We would like to thank the UK Thalidomide Trust and its beneficiaries for all their support and assistance with this study.	[Anonymous], 2011, WORLD REP DIS; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Berghs Maria, 2016, PUBLIC HLTH RES, V4; Department for Work and Pensions, 2015, EMPL STAT WORK AG 50; Ekfeldt A, 2008, ACTA ODONTOL SCAND, V66, P300, DOI 10.1080/00016350802307638; Elder GH, 2003, HDB LIFE COURSE, P3, DOI DOI 10.1007/978-0-306-48247-2_1; Ferber Sarah, 2013, BIOETHICS HIST PERSP, P7; Grassman EJ, 2013, AGEING LIFECOURSE, P1, DOI 10.1332/policypress/9781447305224.001.0001; Hoy D, ANN RHEUMATIC DIS; Jahani SAG, 2016, J CHILD ORTHOP, V10, P691, DOI 10.1007/s11832-016-0797-6; Jahani SAG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155493; Jenkinson C, 1993, QUALITY LIFE MEASURE; Jensen MP, 2013, SPINAL CORD, V51, P882, DOI 10.1038/sc.2013.112; Kayamori R., 2013, JPN J REHABILIT MED, V50, P957; Kemp BJ, 2004, AGEING DISABILITY; Klingbeil H, 2004, ARCH PHYS MED REHAB, V85, pS68, DOI 10.1016/j.apmr.2004.03.014; Kruse A., 2013, REGULAR SURVEYS PROB; LaPlante MP, 2014, DISABIL HEALTH J, V7, pS44, DOI 10.1016/j.dhjo.2013.08.005; Meltzer H, 2012, DISABIL HEALTH J, V5, P102, DOI 10.1016/j.dhjo.2012.02.001; Mental Health Foundation, 2007, FUND FACTS; Molton IR, 2017, J GERONTOL B-PSYCHOL, V72, P290, DOI 10.1093/geronb/gbw122; Naidoo V, 2012, INT J INTEGR CARE, V12; Newbronner E, 2015, HLTH QUALITY LIFE EM; Newbronner E, 2018, DISABIL HEALTH J, V11, P184, DOI 10.1016/j.dhjo.2017.09.004; Office for National Statistics, 2013, HOM OWN RENT ENGL WA; Office for National Statistics, 2007, GEN HOUS SURV; Office for National Statistics, 2011, HIGH LEV QUAL ENGL W; Office for National Statistics Office for National Statistics, 2012, LAB FORC SURV; Office of National Statistics, 2014, LIV AL ENGL WASL; Papworth Trust, 2014, DIS UK 2014 FACTS FI; Peters K.M., 2015, NRW CTR HLTH; Power A, 2019, SOC SCI MED, V231, P55, DOI 10.1016/j.socscimed.2018.03.028; Priestley M., 2001, DISABILITY AND THE L; Scott C., 2015, SUNDAY TIMES; Shiga T, 2015, BIRTH DEFECTS RES A, V103, P787, DOI 10.1002/bdra.23363; SMITHELLS RW, 1992, J MED GENET, V29, P716, DOI 10.1136/jmg.29.10.716; Stephens T, 2001, DARK REMEDY; Turner RJ, 2006, REHABIL PSYCHOL, V51, P214, DOI 10.1037/0090-5550.51.3.214; Uppal S, 2006, SOC SCI MED, V63, P525, DOI 10.1016/j.socscimed.2006.01.016; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; Verbrugge L.M., 2002, J DISABIL POLICY STU, V12, P253, DOI [10.1177/104420730201200405, DOI 10.1177/104420730201200405]; Vermette N, 2013, STUDY CURRENT LIVING	42	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210222	10.1371/journal.pone.0210222	http://dx.doi.org/10.1371/journal.pone.0210222			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650111	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000455813300046
J	Ollinger, J; Kumar, A; Roberts, DM; Bailey, MA; Casey, A; Parish, T				Ollinger, Juliane; Kumar, Anuradha; Roberts, David M.; Bailey, Mai A.; Casey, Allen; Parish, Tanya			A high-throughput whole cell screen to identify inhibitors of Mycobacterium tuberculosis	PLOS ONE			English	Article							MOTILIN AGONIST; SMALL-MOLECULE; IDENTIFICATION; ASSAY; PHENOXYALKYLBENZIMIDAZOLES; HOMEOSTASIS; DISCOVERY; GSK962040	Tuberculosis is a disease of global importance for which novel drugs are urgently required. We developed a whole-cell phenotypic screen which can be used to identify inhibitors of Mycobacterium tuberculosis growth. We used recombinant strains of virulent M. tuberculosis which express far-red fluorescent reporters and used fluorescence to monitor growth in vitro. We optimized our high throughput assays using both 96-well and 384-well plates; both formats gave assays which met stringent reproducibility and robustness tests. We screened a compound set of 1105 chemically diverse compounds previously shown to be active against M. tuberculosis and identified primary hits which showed >= 90% growth inhibition. We ranked hits and identified three chemical classes of interest-the phenoxyalkylbenzamidazoles, the benzothiophene 1-1 dioxides, and the piperidinamines. These new compound classes may serve as starting points for the development of new series of inhibitors that prevent the growth of M. tuberculosis. This assay can be used for further screening, or could easily be adapted to other strains of M. tuberculosis.	[Ollinger, Juliane; Kumar, Anuradha; Roberts, David M.; Bailey, Mai A.; Casey, Allen; Parish, Tanya] Infect Dis Res Inst, Seattle, WA 98102 USA		Parish, T (corresponding author), Infect Dis Res Inst, Seattle, WA 98102 USA.	Tanya.Parish@idri.org	Parish, Tanya/A-8912-2014	Parish, Tanya/0000-0001-7507-0423	Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	The work at IDRI was funded in part by Eli Lilly and Company in support of the mission of the Lilly TB Drug Discovery Initiative. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded in part by Eli Lilly and Company in support of the mission of the Lilly TB Drug Discovery Initiative. There was no additional external funding received for this study.	Ananthan S, 2009, TUBERCULOSIS, V89, P334, DOI 10.1016/j.tube.2009.05.008; Anthony KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020374; Bhat J, 2006, J BIOMOL SCREEN, V11, P968, DOI 10.1177/1087057106291978; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; Carroll P, 2018, BIORXIV, DOI [10.1101/383836, DOI 10.1101/383836]; Carroll P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009823; Chandrasekera NS, 2017, ACS INFECT DIS, V3, P898, DOI 10.1021/acsinfecdis.7b00112; Chandrasekera NS, 2015, J MED CHEM, V58, P7273, DOI 10.1021/acs.jmedchem.5b00546; Chandrasekera NS, 2015, J NEGAT RESULTS BIOM, V14, DOI 10.1186/s12952-015-0024-x; Chandrasekera NS, 2014, PEERJ, V2, DOI 10.7717/peerj.612; Chapman MJ, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1420-4; Cheng N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096348; Cho SH, 2007, ANTIMICROB AGENTS CH, V51, P1380, DOI 10.1128/AAC.00055-06; Christophe T, 2010, FUTURE MED CHEM, V2, P1283, DOI [10.4155/fmc.10.223, 10.4155/FMC.10.223]; CHUNG GAC, 1995, ANTIMICROB AGENTS CH, V39, P2235, DOI 10.1128/AAC.39.10.2235; Darby CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068942; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Galandrin S, 2013, J BIOMOL SCREEN, V18, P576, DOI 10.1177/1087057112474691; Geist JG, 2010, CHEMMEDCHEM, V5, P1092, DOI 10.1002/cmdc.201000083; Gholap S, 2018, ARCH PHARM, V351, DOI 10.1002/ardp.201700294; Gold B, 2012, P NATL ACAD SCI USA, V109, P16004, DOI 10.1073/pnas.1214188109; Goldman RC, 2009, TUBERCULOSIS, V89, P331, DOI 10.1016/j.tube.2009.07.007; Gong YL, 2014, EUR J MED CHEM, V75, P336, DOI 10.1016/j.ejmech.2014.01.039; Grant SS, 2013, ACS CHEM BIOL, V8, P2224, DOI 10.1021/cb4004817; Gutierrez-Lugo MT, 2009, J BIOMOL SCREEN, V14, P643, DOI 10.1177/1087057109335743; He Y, 2003, BIOORG MED CHEM LETT, V13, P3253, DOI 10.1016/S0960-894X(03)00661-9; Hellstrom PM, 2016, BRIT J PHARMACOL, V173, P1768, DOI 10.1111/bph.13475; Humnabadkar V, 2011, J BIOMOL SCREEN, V16, P303, DOI 10.1177/1087057110394845; Ioerger TR, 2010, J BACTERIOL, V192, P3645, DOI 10.1128/JB.00166-10; Iversen PW, 2012, ASSAY GUIDANCE MANUA, P1; Kumar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072786; Maddry JA, 2009, TUBERCULOSIS, V89, P354, DOI 10.1016/j.tube.2009.07.006; Mak PA, 2012, ACS CHEM BIOL, V7, P1190, DOI 10.1021/cb2004884; Mann S, 2013, ANAL BIOCHEM, V432, P90, DOI 10.1016/j.ab.2012.09.038; Maria JPS, 2017, ACS CHEM BIOL, V12, P2448, DOI 10.1021/acschembio.7b00468; Ojima I, 2014, BIOORGAN MED CHEM, V22, P5060, DOI 10.1016/j.bmc.2014.02.036; Ollinger J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060531; Ozkay Y, 2010, EUR J MED CHEM, V45, P3293, DOI 10.1016/j.ejmech.2010.04.012; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Sha SS, 2012, J BIOMOL SCREEN, V17, P252, DOI 10.1177/1087057111421373; Simithy J, 2014, TUBERCULOSIS, V94, P152, DOI 10.1016/j.tube.2013.12.004; Singh U, 2006, J BIOMOL SCREEN, V11, P1035, DOI 10.1177/1087057106292798; Wang F, 2013, P NATL ACAD SCI USA, V110, pE2510, DOI 10.1073/pnas.1309171110; Westaway SM, 2009, J MED CHEM, V52, P1180, DOI 10.1021/jm801332q; White EL, 2007, J BIOMOL SCREEN, V12, P100, DOI 10.1177/1087057106296484; WHO, 2017, GLOB TUB REP 2017; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao N, 2015, ACS CHEM BIOL, V10, P364, DOI 10.1021/cb500746z	48	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0205479	10.1371/journal.pone.0205479	http://dx.doi.org/10.1371/journal.pone.0205479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650074	Green Published, Green Submitted, gold			2022-12-26	WOS:000455813300003
J	Wado, YD; Gurmu, E; Tilahun, T; Bangha, M				Wado, Yohannes Dibaba; Gurmu, Eshetu; Tilahun, Tizta; Bangha, Martin			Contextual influences on the choice of long-acting reversible and permanent contraception in Ethiopia: A multilevel analysis	PLOS ONE			English	Article							BARRIERS; TRENDS; WOMEN	Background Long acting reversible and permanent contraception (LARPs) offer promising opportunities for addressing the high and growing unmet need for modern contraception and helps to reduce unintended pregnancies and abortion rates in sub-Saharan Africa (SSA). This study examines the contextual factors that influence the use of long acting reversible and permanent contraception among married and fecund women in Ethiopia. Method We use data from the 2016 Ethiopian Demographic and Health Survey to examine the contextual factors that influence choice of long acting reversible and permanent contraception among married, non-pregnant and fecund women. The DHS collects detailed information on individual and household characteristics, contraception, and related reproductive behaviors from women of reproductive age. In addition, we created cluster level variables by aggregating individual level data to the cluster level. Analysis was done using a two-level multilevel logistic regression with data from 6994 married (weighted = 7352) women residing in 642 clusters (communities). Results In 2016, 12% of married, non-pregnant and 'fecund' women were using long-acting reversible and permanent methods of contraception in Ethiopia. A higher proportion of women with secondary and above education (17.6%), urban residents (19.7%), in the richest wealth quintile (18.3%) and in paid employment (18.3%) were using LARP methods compared to their counterparts. Regression analysis showed that community level variables such as women's empowerment, access to family planning information and services, region of residence and knowledge of methods were significantly associated with use of LARP methods. Age, wealth status, employment status and women's fertility preferences were among the individual and household level variables associated with choice of LARP methods. With regards to age, the odds of using LARP methods was significantly lower among adolescents OR, 0.53; 95% CI, 0.32-0.85) and women over the age of 40 ( OR, 0.63; 95% CI, 0.44-0.90) compared to women in their 20's. Conclusion The findings of this study indicate that the demand for long-acting reversible and permanent contraception is influenced not only by women's individual and household characteristics but also by the community's level of women's empowerment, socio-economic development, as well as access and exposure to family planning information and services. Thus, improving knowledge of long-acting reversible and permanent methods, improving women's decision making autonomy and upgrading the capacity and skills of health workers particularly the midlevel providers and community health extension workers on the provision of LARP methods and rights-based approach is important to improve the uptake of LARP methods.	[Wado, Yohannes Dibaba; Tilahun, Tizta; Bangha, Martin] African Populat & Hlth Res Ctr, Nairobi, Kenya; [Gurmu, Eshetu] Addis Ababa Univ, Ctr Populat Studies, Addis Ababa, Ethiopia; [Gurmu, Eshetu] Addis Ababa Univ, Inst Dev & Policy Res, Addis Ababa, Ethiopia	African Population & Health Research Centre; Addis Ababa University; Addis Ababa University	Wado, YD (corresponding author), African Populat & Hlth Res Ctr, Nairobi, Kenya.	ywado@aphrc.org		Wado, Yohannes Dibaba/0000-0002-7200-6116; Bangha, Martin/0000-0002-2201-8004				Adhikari R, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0305-7; Admassie A, 2009, J DEV EFFECT, V1, P430, DOI 10.1080/19439340903375724; Anguzu Ronald, 2014, BMC Res Notes, V7, P153, DOI 10.1186/1756-0500-7-153; [Anonymous], 2017, WORLD FAM PLANN; [Anonymous], 2017, WORLD POP DAT SHEET; [Anonymous], 2001, ETH DEM HLTH SURV 20; [Anonymous], 2018, IMPL GUID PROV COMPR; [Anonymous], 2017, WOMEN HLTH, P1; Asare O, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0286-5; Asnake Mengistu, 2013, Int J Gynaecol Obstet, V123 Suppl 1, pe29, DOI 10.1016/j.ijgo.2013.07.003; Bearak J, 2018, LANCET GLOB HEALTH, V6, pE380, DOI 10.1016/S2214-109X(18)30029-9; Blumenthal PD, 2011, HUM REPROD UPDATE, V17, P121, DOI 10.1093/humupd/dmq026; Etana D, E AFRICAN SOCIAL SCI, V34; Ethiopia CSA (CSA) [Ethiopia], 2017, ETH DEM HLTH SURV 20; Ganatra B, 2017, LANCET, V390, P2372, DOI 10.1016/S0140-6736(17)31794-4; Hardee K, 2014, STUD FAMILY PLANN, V45, P1, DOI 10.1111/j.1728-4465.2014.00373.x; Health Mo, 2016, NAT REPR HLTH STRAT; Jacobstein R, 2018, GLOB HEALTH-SCI PRAC, V6, P17, DOI 10.9745/GHSP-D-17-00396; Jain AK, 2017, STUD FAMILY PLANN, V48, P269, DOI 10.1111/sifp.12023; Jain Anrudh K, 2013, Int Perspect Sex Reprod Health, V39, P133, DOI 10.1363/3913313; Joshi R, 2015, INT J GYNECOL OBSTET, V131, pS60, DOI 10.1016/j.ijgo.2015.04.024; Kaggwa EB, 2008, INT FAM PLAN PERSPEC, V34, P79, DOI 10.1363/ifpp.34.079.08; Kumar N, 2016, J ADOLESCENT HEALTH, V59, P248, DOI 10.1016/j.jadohealth.2016.03.039; Magadi MA, 2003, STUD FAMILY PLANN, V34, P149, DOI 10.1111/j.1728-4465.2003.00149.x; Mangham-Jefferies L, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-61; Mekonnen G, 2014, PAN AFR MED J, V18, DOI 10.11604/pamj.2014.18.98.3421; Minister OotP, 1993, NAT POP POL ETH; MOH, 2016, COST IMPL PLAN FAM P; MOH, 2015, ETH HLTH SECT TRANST; Newman Karen., 2015, FAMILY PLANNING HUMA; Olson DJ, 2013, STUD FAMILY PLANN, V44, P445, DOI 10.1111/j.1728-4465.2013.00369.x; Puntscher S., 2017, WORKING PAPERS 2017; Robinson N, 2016, HEALTH CARE WOMEN IN, V37, P197, DOI 10.1080/07399332.2014.946511; Ross J, 2002, INT FAM PLAN PERSPEC, V28, P32, DOI 10.2307/3088273; Sedgh G., 2016, UNMET NEED CONTRACEP; Snijders T, 2014, MULTILEVEL ANAL INTR; Staveteig S., 2015, DHS ANAL STUDIES; Stephenson R, 2007, AM J PUBLIC HEALTH, V97, P1233, DOI 10.2105/AJPH.2005.071522; Taye A, 2015, J WOMENS HLTH CARE, V4, P217; USAID, 2012, 3 SUCC SUBS AFR FAM; Vasa P, 2013, 2013 CONFERENCE ON LASERS AND ELECTRO-OPTICS EUROPE AND INTERNATIONAL QUANTUM ELECTRONICS CONFERENCE (CLEO EUROPE/IQEC)	41	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209602	10.1371/journal.pone.0209602	http://dx.doi.org/10.1371/journal.pone.0209602			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650085	Green Published, gold, Green Submitted			2022-12-26	WOS:000455813300019
J	Wang, L; Ferrao, R; Li, QB; Hatcher, JM; Choi, HG; Buhrlage, SJ; Gray, NS; Wu, H				Wang, Li; Ferrao, Ryan; Li, Qiubai; Hatcher, John M.; Choi, Hwan Geun; Buhrlage, Sara J.; Gray, Nathanael S.; Wu, Hao			Conformational flexibility and inhibitor binding to unphosphorylated interleukin-1 receptor-associated kinase 4 (IRAK4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; structural biology; crystal structure; Toll-like receptor (TLR); drug development; inactive conformation; inflammation; IRAK4; kinase; type II inhibition	CRYSTAL-STRUCTURES; ACTIVATION; DISCOVERY; INNATE; MYD88; MODEL; OPTIMIZATION; INFECTIONS; MECHANISM; MUTATION	Interleukin-1 receptor-associated kinase 4 (IRAK4) is a key player in innate immune and inflammatory responses, performing a critical role in signal transduction downstream of Toll-like receptors and interleukin-1 (IL-1) receptors. Upon ligand binding and via its N-terminal death domain, IRAK4 is recruited to an oligomeric receptor that is proximal to the Myddosome signaling complex, inducing IRAK4 kinase domain dimerization, autophosphorylation, and activation. To date, all known IRAK4 structures are in the active conformation, precluding a good understanding of IRAK4's conformational dynamics. To address this issue, here we first solved three crystal structures of the IRAK4 kinase domain (at 2.6 resolution), in its unphosphorylated, inactive state bound to either the ATP analog AMP-PNP or to one of the two small-molecule inhibitors JH-I-25 and JH-I-17. The structures disclosed that although the structure in complex with AMP-PNP is in an C-out inactive conformation, those in complex with type I inhibitors assume an active Asp-Phe-Gly (DFG)-in and C-in conformation. The ability of unphosphorylated IRAK4 to take on variable conformations prompted us to screen for small-molecule inhibitors that bind preferentially to unphosphorylated IRAK4, leading to the identification of ponatinib and HG-12-6. Solving the structures of unphosphorylated IRAK4 in complex with these two inhibitors, we found that they both bind as type II inhibitors with IRAK4 in a DFG-out conformation. Collectively, these structures reveal conformational flexibility of unphosphorylated IRAK4 and provide unexpected insights into the potential use of small molecules to modulate IRAK4 activity in cancer, autoimmunity, and inflammation.	[Wang, Li; Ferrao, Ryan; Li, Qiubai; Hatcher, John M.; Choi, Hwan Geun; Buhrlage, Sara J.; Gray, Nathanael S.; Wu, Hao] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Wang, Li; Ferrao, Ryan; Li, Qiubai; Wu, Hao] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Hatcher, John M.; Choi, Hwan Geun; Buhrlage, Sara J.; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Dana-Farber Cancer Institute	Wu, H (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Wu, H (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.	wu@crystal.harvard.edu		, Hao/0000-0002-7281-8579	NIH-ORIP HEI Grant [S10 RR029205]; Department of Energy Office of Science [DE-AC02-06CH11357]; NIGMS, National Institutes of Health [P41 GM103403]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD087988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI050872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	NIH-ORIP HEI Grant; Department of Energy Office of Science(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Qun Liu for collecting data of IRAK4 bound to JH-I-25. The Pilatus 6M detector on 24-ID-C beam line is funded by NIH-ORIP HEI Grant S10 RR029205. This research used resources of the Advanced Photon Source, a U.S. Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. This work was partially based upon research conducted at the Northeastern Collaborative Access Team Beamlines, which are funded by NIGMS, National Institutes of Health Grant P41 GM103403.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Buckley GM, 2008, BIOORG MED CHEM LETT, V18, P3211, DOI 10.1016/j.bmcl.2008.04.058; Cameron B, 2012, J NEUROSCI, V32, P15112, DOI 10.1523/JNEUROSCI.1729-12.2012; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrao R, 2014, MOL CELL, V55, P891, DOI 10.1016/j.molcel.2014.08.006; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Hanisak J, 2016, BIOORG MED CHEM LETT, V26, P4250, DOI 10.1016/j.bmcl.2016.07.048; Hu JC, 2013, CELL, V154, P1036, DOI 10.1016/j.cell.2013.07.046; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Kim TW, 2011, J IMMUNOL, V186, P2871, DOI 10.4049/jimmunol.1002242; Koziczak-Holbro M, 2009, ARTHRITIS RHEUM-US, V60, P1661, DOI 10.1002/art.24552; Kuglstatter A, 2007, J IMMUNOL, V178, P2641, DOI 10.4049/jimmunol.178.5.2641; Lee KL, 2017, J MED CHEM, V60, P5521, DOI 10.1021/acs.jmedchem.7b00231; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Lim J, 2015, ACS MED CHEM LETT, V6, P683, DOI 10.1021/acsmedchemlett.5b00107; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lye E, 2008, EUR J IMMUNOL, V38, P870, DOI 10.1002/eji.200737429; McElroy WT, 2015, ACS MED CHEM LETT, V6, P677, DOI 10.1021/acsmedchemlett.5b00106; McElroy WT, 2015, BIOORG MED CHEM LETT, V25, P1836, DOI 10.1016/j.bmcl.2015.03.043; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; RAea Laskowski, 1993, J APPL CRYST, V26; Roskoski R, 2016, PHARMACOL RES, V103, P26, DOI 10.1016/j.phrs.2015.10.021; Schneider EV, 2011, J MOL BIOL, V412, P251, DOI 10.1016/j.jmb.2011.07.020; SchulzeGahmen U, 1996, J MED CHEM, V39, P4540, DOI 10.1021/jm960402a; Seganish WM, 2015, ACS MED CHEM LETT, V6, P942, DOI 10.1021/acsmedchemlett.5b00279; Shan YB, 2013, P NATL ACAD SCI USA, V110, P7270, DOI 10.1073/pnas.1220843110; Smith GF, 2017, BIOORG MED CHEM LETT, V27, P2721, DOI 10.1016/j.bmcl.2017.04.050; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Treon SP, 2012, NEW ENGL J MED, V367, P826, DOI 10.1056/NEJMoa1200710; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; von Bernuth H, 2012, EUR J IMMUNOL, V42, P3126, DOI 10.1002/eji.201242683; Wang ZL, 2006, STRUCTURE, V14, P1835, DOI 10.1016/j.str.2006.11.001; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	44	6	6	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4511	4519		10.1074/jbc.RA118.005428	http://dx.doi.org/10.1074/jbc.RA118.005428			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30679311	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000462969500019
J	Espana, G; Hogea, C; Guignard, A; ten Bosch, QA; Morrison, AC; Smith, DL; Scott, TW; Schmidt, A; Perkins, TA				Espana, Guido; Hogea, Cosmina; Guignard, Adrienne; ten Bosch, Quirine A.; Morrison, Amy C.; Smith, David L.; Scott, Thomas W.; Schmidt, Alexander; Perkins, T. Alex			Biased efficacy estimates in phase-III dengue vaccine trials due to heterogeneous exposure and differential detectability of primary infections across trial arms	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; CULICIDAE PRODUCTION; POPULATION-DYNAMICS; PUERTO-RICO; IQUITOS; MODEL; TRANSMISSION; VECTOR; CITY	Vaccine efficacy (VE) estimates are crucial for assessing the suitability of dengue vaccine candidates for public health implementation, but efficacy trials are subject to a known bias to estimate VE toward the null if heterogeneous exposure is not accounted for in the analysis of trial data. In light of many well-characterized sources of heterogeneity in dengue virus (DENV) transmission, our goal was to estimate the potential magnitude of this bias in VE estimates for a hypothetical dengue vaccine. To ensure that we realistically modeled heterogeneous exposure, we simulated city-wide DENV transmission and vaccine trial protocols using an agent-based model calibrated with entomological and epidemiological data from long-term field studies in Iquitos, Peru. By simulating a vaccine with a true VE of 0.8 in 1,000 replicate trials each designed to attain 90% power, we found that conventional methods underestimated VE by as much as 21% due to heterogeneous exposure. Accounting for the number of exposures in the vaccine and placebo arms eliminated this bias completely, and the more realistic option of including a frailty term to model exposure as a random effect reduced this bias partially. We also discovered a distinct bias in VE estimates away from the null due to lower detectability of primary DENV infections among seronegative individuals in the vaccinated group. This difference in detectability resulted from our assumption that primary infections in vaccinees who are seronegative at baseline resemble secondary infections, which experience a shorter window of detectable viremia due to a quicker immune response. This resulted in an artefactual finding that VE estimates for the seronegative group were approximately 1% greater than for the seropositive group. Simulation models of vaccine trials that account for these factors can be used to anticipate the extent of bias in field trials and to aid in their interpretation.	[Espana, Guido; ten Bosch, Quirine A.; Perkins, T. Alex] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Espana, Guido; ten Bosch, Quirine A.; Perkins, T. Alex] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [Hogea, Cosmina; Guignard, Adrienne; Schmidt, Alexander] GlaxoSmithKline, Rockville, MD USA; [Morrison, Amy C.] US Naval Med Res Unit 6, Lima, Peru; [Morrison, Amy C.; Scott, Thomas W.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA; [Smith, David L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	University of Notre Dame; University of Notre Dame; GlaxoSmithKline; Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6); University of California System; University of California Davis; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Espana, G; Perkins, TA (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.; Espana, G; Perkins, TA (corresponding author), Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.	guido.espana@nd.edu; taperkins@nd.edu	Morrison, Amy/AAU-6511-2020; Bosch, Quirine ten/H-6734-2019; Smith, David/L-8850-2013	Bosch, Quirine ten/0000-0002-5227-1406; Smith, David/0000-0003-4367-3849; Morrison, Amy/0000-0001-6224-5984; Camargo Espana, guido/0000-0002-9915-8056	US National Institutes of Health - National Institute of Allergy and Infectious Diseases (NIH/NIAID) [P01AI098670]; National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award [TL1 TR002531, UL1 TR002529]; GlaxoSmithKline Biologicals SA; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001107, UL1TR002529, TL1TR002531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI098670] Funding Source: NIH RePORTER	US National Institutes of Health - National Institute of Allergy and Infectious Diseases (NIH/NIAID); National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award; GlaxoSmithKline Biologicals SA(GlaxoSmithKline); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	GE, QAtB, ACM, TWS, and TAP acknowledge support from a grant from the US National Institutes of Health - National Institute of Allergy and Infectious Diseases (NIH/NIAID (https://www.niaid.nih.gov/)) award number P01AI098670 (to TWS). This publication was made possible with partial support (GE) from Grant Numbers TL1 TR002531 and UL1 TR002529 (A. Shekhar, PI) from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award. GlaxoSmithKline Biologicals SA provided support in the form of salaries for authors AG, AS and CH and of funding in the post-doctoral position of GE. GlaxoSmithKline Biologicals SA, through the affiliated authors, had also a role study design by defining the research question, reviewing and inputting on the model proposal and interpretation of the results. GlaxoSmithKline Biologicals SA had no role in the decision to publish or preparation of the manuscript. Authors affiliated to GSK reviewed and approved the manuscript for publication and are therefore compliant with ICMJE criteria for authorship.	Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Chang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040087; Clapham HE, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0094; Clapham HE, 2017, PLOS NEGLECT TROP D, V11, P1, DOI DOI 10.1371/J0URNAL.PNTD; ClinicalTrials.gov, PHAS 3 TRIAL EV EFF; ClinicalTrials.gov, EFF SAF IMM TAK TETR; Coudeville L, 2016, VACCINE, V34, P6426, DOI 10.1016/j.vaccine.2016.08.050; De Benedictis J, 2003, AM J TROP MED HYG, V68, P437, DOI 10.4269/ajtmh.2003.68.437; Dengue Branch C, 2011, CRITERIA PROCESSING; Edelman Robert, 2008, Vaccine, V26, P4113, DOI 10.1016/j.vaccine.2008.05.058; Ellis AM, 2011, AM J TROP MED HYG, V85, P257, DOI 10.4269/ajtmh.2011.10-0516; Espana G, 2018, BIORXIV, DOI [10.1101/367060, DOI 10.1101/367060]; Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590; Flasche S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002181; FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003; Gessner BD, 2017, VACCINE, V35, P3452, DOI 10.1016/j.vaccine.2017.05.003; Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494; Hadinegoro S, 2010, PROTOCOL; Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223; Halloran ME, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0985-3; Halloran ME, 2010, STAT BIOL HEALTH, P271, DOI 10.1007/978-0-387-68636-3_13; Halloran ME, 1996, AM J EPIDEMIOL, V144, P83, DOI 10.1093/oxfordjournals.aje.a008858; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Kahn R, 2019, AM J EPIDEMIOL, V188, P467, DOI 10.1093/aje/kwy239; LaCon G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003038; Liebman KA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002702; Longini IM, 1996, J R STAT SOC C-APPL, V45, P165; Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508; Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205; Morrison AC, 2006, ANN TROP MED PARASIT, V100, pS73, DOI 10.1179/136485906X105534; Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123; Morrison AC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000670; Morrow RH, 1996, SPECIAL PROGRAMME RE; O'Hagan JJ, 2014, EPIDEMIOLOGY, V25, P134, DOI 10.1097/EDE.0000000000000003; Osorio JE, 2015, VACCINE, V33, P7112, DOI 10.1016/j.vaccine.2015.11.022; Otero M, 2006, B MATH BIOL, V68, P1945, DOI 10.1007/s11538-006-9067-y; Paz-Soldan VA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002888; Paz-Soldan VA, 2010, AM J TROP MED HYG, V82, P723, DOI 10.4269/ajtmh.2010.09-0496; Perkins A, 2018, BIORXIV, DOI [10.1101/276006, DOI 10.1101/276006]; Perkins A, 2018, BIORXIV, DOI [10.1101/082396, DOI 10.1101/082396]; Perkins TA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0390; Perkins TA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0642; Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327; Precioso AR, 2015, VACCINE, V33, P7121, DOI 10.1016/j.vaccine.2015.09.105; R Core Team, 2013, R LANG ENV STAT COMP; Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414; Reiner R, 2018, BIORXIV, DOI [10.1101/265751, DOI 10.1101/265751]; Reiner Robert C Jr, 2016, PLoS Negl Trop Dis, V10, pe0004588, DOI 10.1371/journal.pntd.0004588; Reiner RC, 2014, P NATL ACAD SCI USA, V111, pE2694, DOI 10.1073/pnas.1314933111; Rodriguez-Barraquer I, 2013, PLOS NTD, V7, P1; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Salje H, 2016, P NATL ACAD SCI USA, V113, P13420, DOI 10.1073/pnas.1611391113; Salje H, 2017, SCIENCE, V355, P1302, DOI 10.1126/science.aaj9384; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8; Takken W., 2003, ECOLOGICAL ASPECTS A; ten Bosch QA, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006965; Therneau T., 2015, PACKAGE SURVIVAL ANA; United Nations Department of Economic and Social Affairs, 2015, WORLD POPULATION PRO; Vannice KS, 2016, VACCINE, V34, P2934, DOI 10.1016/j.vaccine.2015.12.073; Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037; White MT, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-82; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; World Health Organization, 2018, WHO VACC PIP TRACK; Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040	66	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210041	10.1371/journal.pone.0210041	http://dx.doi.org/10.1371/journal.pone.0210041			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682037	Green Submitted, Green Published, gold			2022-12-26	WOS:000457037500021
J	Li, XF; Rombouts, W; van der Gucht, J; de Vries, R; Dijksman, JA				Li, Xiufeng; Rombouts, Wolf; van der Gucht, Jasper; de Vries, Renko; Dijksman, Joshua A.			Mechanics of composite hydrogels approaching phase separation	PLOS ONE			English	Article							SECRETED PRODUCTION; TOUGH; GELATIN; GELS	For polymer-particle composites, limited thermodynamic compatibility of polymers and particles often leads to poor dispersal and agglomeration of the particles in the matrix, which negatively impacts the mechanics of composites. To study the impact of particle compatibility in polymer matrices on the mechanical properties of composites, we here study composite silica-protein based hydrogels. The polymer used is a previously studied telechelic protein-based polymer with end groups that form triple helices, and the particles are silica nanoparticles that only weakly associate with the polymer matrix. At 1mM protein polymer, up to 7% of silica nanoparticles can be embedded in the hydrogel. At higher concentrations the system phase separates. Oscillatory rheology shows that at high frequencies the particles strengthen the gels by acting as short-lived multivalent cross-links, while at low frequencies, the particles reduce the gel strength, presumably by sequestering part of the protein polymers in such a way that they can no longer contribute to the network strength. As is generally observed for polymer/particle composites, shear-induced polymer desorption from the particles leads to a viscous dissipation that strongly increases with increasing particle concentration. While linear rheological properties as function of particle concentration provide no signals for an approaching phase separation, this is very different for the non-linear rheology, especially fracture. Strain-at-break decreases rapidly with increasing particle concentration and vanishes as the phase boundary is approached, suggesting that the interfaces between regions of high and low particle densities in composites close to phase separation provide easy fracture planes.	[Li, Xiufeng; Rombouts, Wolf; van der Gucht, Jasper; de Vries, Renko; Dijksman, Joshua A.] Wageningen Univ & Res, Phys Chem & Soft Matter, Stippeneng 4, NL-6708WE Wageningen, Netherlands	Wageningen University & Research	Dijksman, JA (corresponding author), Wageningen Univ & Res, Phys Chem & Soft Matter, Stippeneng 4, NL-6708WE Wageningen, Netherlands.	joshua.dijksman@wur.nl	van der Gucht, Jasper/C-4639-2015	van der Gucht, Jasper/0000-0001-5525-8322; Li, Xiufeng/0000-0002-7615-4693	European Research Council [2015 CoG 682782]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Unilever; TKI Agro-Food: Industrial Partnership Program [i41]	European Research Council(European Research Council (ERC)European Commission); Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Unilever; TKI Agro-Food: Industrial Partnership Program	This work was supported by European Research Council (2015 CoG 682782, https://cordis.europa.eu/project/rcn/204138_en.html, JvdG) and Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Unilever, TKI Agro-Food: Industrial Partnership Program i41 (https://www.nwo-i.nl/en/nwo-domain-science/research-programmes/ipp/nr-i41-hybrid-soft-materials-from-physical-mechanisms-to-designer-products/, JvdG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal SK, 2008, LANGMUIR, V24, P13148, DOI 10.1021/la8015518; Balazs AC, 2007, NAT MATER, V6, P94, DOI 10.1038/nmat1820; Dadsetan M, 2008, BIOMATERIALS, V29, P2193, DOI 10.1016/j.biomaterials.2008.01.006; ESHELBY JD, 1957, PROC R SOC LON SER-A, V241, P376, DOI 10.1098/rspa.1957.0133; Gerth M, 2014, MACROMOL RAPID COMM, V35, P2065, DOI 10.1002/marc.201400543; GUTH E, 1945, J APPL PHYS, V16, P20, DOI 10.1063/1.1707495; Hooper JB, 2006, MACROMOLECULES, V39, P5133, DOI 10.1021/ma060577m; Hribar KC, 2014, ADV FUNCT MATER, V24, P4922, DOI 10.1002/adfm.201400274; Juby KA, 2012, CARBOHYD POLYM, V89, P906, DOI 10.1016/j.carbpol.2012.04.033; Lee JY, 2002, MACROMOLECULES, V35, P4855, DOI 10.1021/ma0200266; Lemmers M, 2012, LANGMUIR, V28, P12311, DOI 10.1021/la301917e; Pimenta AFR, 2016, INT J PHARMACEUT, V515, P467, DOI 10.1016/j.ijpharm.2016.10.047; Qiao R, 2011, J POLYM SCI POL PHYS, V49, P740, DOI 10.1002/polb.22236; Silva CIF, 2011, BIOTECHNOL BIOENG, V108, P2517, DOI 10.1002/bit.23228; Skrzeszewska PJ, 2010, MACROMOLECULES, V43, P3542, DOI 10.1021/ma1000173; Skrzeszewska PJ, 2009, SOFT MATTER, V5, P2057, DOI 10.1039/b819967a; Smallwood HM, 1944, J APPL PHYS, V15, P758, DOI 10.1063/1.1707385; Tang C, 2014, INT J PHARMACEUT, V465, P427, DOI 10.1016/j.ijpharm.2014.02.039; Teng WQ, 2014, BIOMATERIALS, V35, P8916, DOI 10.1016/j.biomaterials.2014.07.013; Thompson RB, 2001, SCIENCE, V292, P2469, DOI 10.1126/science.1060585; Vulic K, 2012, J AM CHEM SOC, V134, P882, DOI 10.1021/ja210638x; Wang LY, 2014, SOFT MATTER, V10, P3850, DOI 10.1039/c4sm00206g; Wang Q, 2012, SOFT MATTER, V8, P6048, DOI 10.1039/c2sm07233e; Warren SC, 2007, NAT MATER, V6, P156, DOI 10.1038/nmat1819; Werten MWT, 2009, BIOMACROMOLECULES, V10, P1106, DOI 10.1021/bm801299u; Werten MWT, 2001, PROTEIN ENG, V14, P447, DOI 10.1093/protein/14.6.447; Yue K, 2015, BIOMATERIALS, V73, P254, DOI 10.1016/j.biomaterials.2015.08.045; Zhang YL, 2012, CHEM COMMUN, V48, P9305, DOI 10.1039/c2cc34745h; Zhu JM, 2011, EXPERT REV MED DEVIC, V8, P607, DOI [10.1586/ERD.11.27, 10.1586/erd.11.27]	29	8	8	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211059	10.1371/journal.pone.0211059	http://dx.doi.org/10.1371/journal.pone.0211059			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682112	gold, Green Submitted, Green Published			2022-12-26	WOS:000457037500095
J	Chen, D; Tuan, HH; Zhou, EY; Liu, DH; Zhao, Y				Chen, Dian; Tuan, HsiaoHan; Zhou, Eray Yihui; Liu, Dehua; Zhao, Yi			Quality of life of adult vitiligo patients using camouflage: A survey in a Chinese vitiligo community	PLOS ONE			English	Article							EPIDERMAL-CELL SUSPENSION; STABLE VITILIGO; INDEX SCORE; IMPACT	Background Vitiligo is an acquired depigmented skin disease resulting in white macules, which may significantly impair the quality of life (QoL) of the patients. Objective To estimate the QoL in Chinese vitiligo patients using camouflage with a more detailed description, and to identify the possible risk factors related to poor QoL. Methods An online survey was conducted in vitiligo patients using camouflage from a vitiligo community. Survey questions included demographic, clinical information, dermatology-and vitiligo-specific QoL questionnaires. Multivariate logistic analysis was performed to identify risk factors that related to poor QoL. Results In total, 884 respondents were included in the analyses, of which 413 (46.7%) were male. The score of DLQI was 5.83 +/- 5.75 (mean +/- SD). Age, gender, marriage status, occupational status, anogenital involvement, patient-perceived severity (presented by VAS score), symptoms as itching, pain, sunburn and koebner phenomenon, total cost of treatment and degree of satisfaction in camouflage therapy were independently associated with DLQI score (p<0.05). Conclusion Vitiligo has considerable impact on QoL of affected patients in Chinese population even when they were using camouflage. Camouflage might be helpful to improve QoL of the patients.	[Chen, Dian; Tuan, HsiaoHan; Zhou, Eray Yihui; Liu, Dehua; Zhao, Yi] Tsinghua Univ, Dept Dermatol, Beijing Tsinghua Changgung Hosp, Beijing, Peoples R China	Tsinghua University	Zhao, Y (corresponding author), Tsinghua Univ, Dept Dermatol, Beijing Tsinghua Changgung Hosp, Beijing, Peoples R China.	zhaoyi@bjmu.edu.cn	Zhao, Yi/M-5881-2018; Zhou, Eray/HHC-3301-2022	Zhao, Yi/0000-0002-4531-8632; 	National Nature Science Foundation of China [81472898]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (81472898). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer AAA, 2016, INT J DERMATOL, V55, P608, DOI 10.1111/ijd.13198; Aust F, 2013, BEHAV RES METHODS, V45, P527, DOI 10.3758/s13428-012-0265-2; Bae JM, 2018, BRIT J DERMATOL, V178, P238, DOI 10.1111/bjd.15560; Bae JM, 2017, JAMA DERMATOL, V153, P666, DOI 10.1001/jamadermatol.2017.0002; Bin Saif GA, 2013, AM J CLIN DERMATOL, V14, P489, DOI 10.1007/s40257-013-0037-5; Budania A, 2012, BRIT J DERMATOL, V167, P1295, DOI 10.1111/bjd.12007; Dolatshahi M, 2008, INDIAN J DERMATOL VE, V74; Esmat SM, 2012, J EUR ACAD DERMATOL, V26, P1097, DOI 10.1111/j.1468-3083.2011.04215.x; Ezzedine K, 2015, LANCET, V386, P74, DOI 10.1016/S0140-6736(14)60763-7; Falabella R, 2005, DERMATOL SURG, V31, P1277, DOI 10.1097/00042728-200510000-00003; Gupta V, 2014, BRIT J DERMATOL, V171, P1084, DOI 10.1111/bjd.13093; Ingordo V, 2012, GIORN ITAL DERMAT V, V147, P83; Krishna GS, 2013, INDIAN J DERMATOL VE, V79, P205, DOI 10.4103/0378-6323.107637; Lilly E, 2013, J AM ACAD DERMATOL, V69, pE11, DOI 10.1016/j.jaad.2012.01.038; Mishra N, 2014, J CLIN DIAGN RES, V8, pYC1, DOI 10.7860/JCDR/2014/8248.4508; Ongenae K, 2006, J EUR ACAD DERMATOL, V20, P1, DOI 10.1111/j.1468-3083.2005.01369.x; Ongenae K, 2005, BRIT J DERMATOL, V152, P1165, DOI 10.1111/j.1365-2133.2005.06456.x; Ongenae K, 2005, DERMATOLOGY, V210, P279, DOI 10.1159/000084751; Parsad D, 2003, BRIT J DERMATOL, V148, P373, DOI 10.1046/j.1365-2133.2003.05097_9.x; Radtke MA, 2009, BRIT J DERMATOL, V161, P134, DOI 10.1111/j.1365-2133.2009.09091.x; Reips UD, 2008, INTERNET MEDIATED RE; Robaee AI AA, 2007, SAUDI MED J, V28, P1414; Sahni K, 2011, DERMATOL SURG, V37, P176, DOI 10.1111/j.1524-4725.2010.01847.x; Salzes C, 2016, J INVEST DERMATOL, V136, P52, DOI 10.1038/JID.2015.398; Sampogna F, 2008, BRIT J DERMATOL, V159, P351, DOI 10.1111/j.1365-2133.2008.08678.x; Senol A, 2013, DERMATOLOGY, V226, P185, DOI 10.1159/000348466; Silverberg JI, 2013, JAMA DERMATOL, V149, P159, DOI 10.1001/jamadermatol.2013.927; Singh C, 2013, BRIT J DERMATOL, V169, P287, DOI 10.1111/bjd.12325; Speeckaert R, 2017, AM J CLIN DERMATOL, P1, DOI 10.1007/S40257-016-0238-9; Tanioka M, 2010, J COSMET DERMATOL-US, V9, P72, DOI 10.1111/j.1473-2165.2010.00479.x; Wang KY, 2011, J EUR ACAD DERMATOL, V25, P429, DOI 10.1111/j.1468-3083.2010.03808.x; Wong SM, 2012, INT J DERMATOL, V51, P158, DOI 10.1111/j.1365-4632.2011.04932.x	32	14	14	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210581	10.1371/journal.pone.0210581	http://dx.doi.org/10.1371/journal.pone.0210581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677057	Green Published, gold, Green Submitted			2022-12-26	WOS:000456700400017
J	Han, SB; Jang, J; Yang, HK; Hwang, JM; Park, SK				Han, Sang Beom; Jang, Jieun; Yang, Hee Kyung; Hwang, Jeong-Min; Park, Sue K.			Prevalence and risk factors of myopia in adult Korean population: Korea national health and nutrition examination survey 2013-2014 (KNHANES VI)	PLOS ONE			English	Article							REFRACTIVE ERRORS; VITAMIN-D; OUTDOOR ACTIVITY; PARENTAL HISTORY; UNITED-STATES; FAMILY-HISTORY; YOUNG; ASSOCIATION; PROGRESSION; EDUCATION	Purpose To evaluate the prevalence and risk factors of myopia in adult Korean population. Methods Population-based cross-sectional data of 3,398 subjects aged 19 to 49 years was obtained using the Korea National Health and Nutrition Examination Survey 2013-2014 (KNHANES VI). Data, including refractive errors and potential risk factors were analyzed. The prevalence and risk factors of myopia, low myopia, and high myopia-defined as a spherical equivalent (SEQ) <= -0.5 diopters (D), -6.0 D < SEQ <-0.5 D, and SEQ <= -6.0 D, respectively-were evaluated. Results The prevalence of myopia and high myopia were 70.6 (standard error (SE), +/- 1.1)% and 8.0 (SE, +/- 0.6)%, respectively. In multivariable analysis, younger age, higher education (>= 12 years), parental myopia, lower serum 25-hydroxyvitamin D (25(OH)D) concentration (< 9 ng/mL), longer time spent on near work (>= 3 hours/day), and higher white blood cell (WBC) count (5-8.9 x 10(3)) were associated with increased prevalence of both myopia and high myopia. Serum 25(OH)D concentration of >= 9 ng/ml was significantly associated with decreased prevalence of high myopia in participants with near work of >= 3 hours/day, although the effect was not significant in myopia and low myopia. Conclusions The prevalence of myopia and high myopia in Korean adults was substantially high, which increased with decreasing age. In addition to parental myopia, the serum 25(OH)D concentration, near work and inflammation reflected by WBC counts may be associated with myopia.	[Han, Sang Beom] Kangwon Natl Univ, Grad Sch Med, Kangwon Natl Univ Hosp, Dept Ophthalmol, Chunchon, South Korea; [Jang, Jieun; Park, Sue K.] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Yang, Hee Kyung; Hwang, Jeong-Min] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea	Kangwon National University; Kangwon National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Park, SK (corresponding author), Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.; Hwang, JM (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.	hjm@snu.ac.kr; suepark@snu.ac.kr			National Research Foundation of Korea(NRF) - Korea government(MSIP) [2017R1A2B4011450]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2017R1D1A1B03029983]	National Research Foundation of Korea(NRF) - Korea government(MSIP); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This work was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MSIP) (No. 2017R1A2B4011450) & by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (Grant No. NRF-2017R1D1A1B03029983). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, COMPLEX SURVEY DATA; Braegger C, 2013, J PEDIATR GASTR NUTR, V56, P692, DOI 10.1097/MPG.0b013e31828f3c05; Choi HS, 2008, J CLIN ENDOCR METAB, V96, P643, DOI DOI 10.1210/JC.2010-2133; Choi JA, 2014, INVEST OPHTH VIS SCI, V55, P2041, DOI [10.1167/iovs.13-12853, 10.1167/IOVS.13-12853]; Chung M, 2011, ANN INTERN MED, V155, P827, DOI 10.7326/0003-4819-155-12-201112200-00005; Dirani M, 2009, BRIT J OPHTHALMOL, V93, P997, DOI 10.1136/bjo.2008.150979; Fan Q, 2014, HUM MOL GENET, V23, P546, DOI 10.1093/hmg/ddt431; Fernandez-Montero A, 2015, PREV MED, V71, P67, DOI 10.1016/j.ypmed.2014.12.005; Guggenheim JA, 2014, INVEST OPHTH VIS SCI, V55, P8550, DOI 10.1167/iovs.14-15839; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075260; Guo Y, 2013, OPHTHALMOLOGY, V120, P277, DOI 10.1016/j.ophtha.2012.07.086; Jones LA, 2007, INVEST OPHTH VIS SCI, V48, P3524, DOI 10.1167/iovs.06-1118; Jones-Jordan LA, 2010, INVEST OPHTH VIS SCI, V51, P115, DOI 10.1167/iovs.08-3210; Jung SK, 2012, INVEST OPHTH VIS SCI, V53, P5579, DOI 10.1167/iovs.12-10106; Kempen AH, 2004, ARCH OPHTHALMOL-CHIC, V122, P495; Kim EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080361; Konstantopoulos A, 2008, EYE, V22, P542, DOI 10.1038/sj.eye.6702693; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Kwon JW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005012; Lam DSC, 2008, INVEST OPHTH VIS SCI, V49, P873, DOI 10.1167/iovs.06-1097; Lee JH, 2013, INVEST OPHTH VIS SCI, V54, P5466, DOI 10.1167/iovs.13-12478; Lee YY, 2013, INVEST OPHTH VIS SCI, V54, P1026, DOI 10.1167/iovs.12-10480; Lee YA, 2014, PUBLIC HEALTH NUTR, V17, P764, DOI 10.1017/S1368980013000438; LEPPLEWIENHUES A, 1991, CURR EYE RES, V10, P983, DOI 10.3109/02713689109020335; Liang YB, 2009, OPHTHALMOLOGY, V116, P2119, DOI 10.1016/j.ophtha.2009.04.040; Lim HT, 2012, JPN J OPHTHALMOL, V56, P76, DOI 10.1007/s10384-011-0090-7; Lin HJ, 2016, EBIOMEDICINE, V10, P269, DOI 10.1016/j.ebiom.2016.07.021; Low W, 2010, BRIT J OPHTHALMOL, V94, P1012, DOI 10.1136/bjo.2009.173187; McCarthy CS, 2007, EXP EYE RES, V84, P100, DOI 10.1016/j.exer.2006.09.018; Midelfart A, 2002, ACTA OPHTHALMOL SCAN, V80, P501, DOI 10.1034/j.1600-0420.2002.800508.x; Morgan I, 2005, PROG RETIN EYE RES, V24, P1, DOI 10.1016/j.preteyeres.2004.06.004; Muller DN, 2011, J RENIN-ANGIO-ALDO S, V12, P125, DOI 10.1177/1470320311410924; Mutti DO, 2002, INVEST OPHTH VIS SCI, V43, P3633; Mutti DO, 2007, MOL VIS, V13, P1012; Mutti DO, 2011, INVEST OPHTH VIS SCI, V52, P3818, DOI 10.1167/iovs.10-6534; Mutti DO, 2011, OPTOMETRY VISION SCI, V88, P377, DOI 10.1097/OPX.0b013e31820b0385; Pan CW, 2013, AM J OPHTHALMOL, V155, P1129, DOI 10.1016/j.ajo.2013.01.009; Pan CW, 2011, INVEST OPHTH VIS SCI, V52, P3166, DOI 10.1167/iovs.10-6210; Rahi JS, 2011, OPHTHALMOLOGY, V118, P797, DOI 10.1016/j.ophtha.2010.09.025; Read SA, 2014, OPTOMETRY VISION SCI, V91, P330, DOI 10.1097/OPX.0000000000000160; Rim TH, 2016, SEMIN OPHTHALMOL, V32; Rim Tyler Hyungtaek, 2016, Korean J Ophthalmol, V30, P214, DOI 10.3341/kjo.2016.30.3.214; Rose KA, 2002, CLIN EXP OPHTHALMOL, V30, P168, DOI 10.1046/j.1442-9071.2002.00521.x; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Saw SM, 2008, OPHTHALMOLOGY, V115, P1713, DOI 10.1016/j.ophtha.2008.03.016; Saw SM, 2006, INVEST OPHTH VIS SCI, V47, P1839, DOI 10.1167/iovs.05-1081; Saw SM, 2005, BRIT J OPHTHALMOL, V89, P1489, DOI 10.1136/bjo.2005.071118; Saw SM, 2002, OPHTHALMOLOGY, V109, P2065, DOI 10.1016/S0161-6420(02)01220-4; Saw SM, 2002, INVEST OPHTH VIS SCI, V43, P332; Sawada A, 2008, OPHTHALMOLOGY, V115, P363, DOI 10.1016/j.ophtha.2007.03.075; Sherwin JC, 2012, OPHTHALMOLOGY, V119, P2141, DOI 10.1016/j.ophtha.2012.04.020; Shimizu N, 2003, JPN J OPHTHALMOL, V47, P6, DOI 10.1016/S0021-5155(02)00620-2; Slominski AT, 2016, EXP DERMATOL, V25, P231, DOI 10.1111/exd.12872; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Tan CSH, 2011, EYE, V25, P1294, DOI 10.1038/eye.2011.144; Tarczy-Hornoch K, 2006, INVEST OPHTH VIS SCI, V47, P1845, DOI 10.1167/iovs.05-1153; Tavera-Mendoza L, 2006, EMBO REP, V7, P180, DOI 10.1038/sj.embor.7400594; Vitale S, 2008, ARCH OPHTHALMOL-CHIC, V126, P1111, DOI 10.1001/archopht.126.8.1111; WANG Q, 1994, INVEST OPHTH VIS SCI, V35, P4344; Wong TY, 2000, INVEST OPHTH VIS SCI, V41, P2486; Wu HM, 2001, OPTOMETRY VISION SCI, V78, P234, DOI 10.1097/00006324-200104000-00012; Wu PC, 2013, OPHTHALMOLOGY, V120, P1080, DOI 10.1016/j.ophtha.2012.11.009; Wu PC, 2010, OPHTHAL EPIDEMIOL, V17, P338, DOI 10.3109/09286586.2010.508347; Yazar S, 2014, INVEST OPHTH VIS SCI, V55, P4552, DOI 10.1167/iovs.14-14589	65	18	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211204	10.1371/journal.pone.0211204	http://dx.doi.org/10.1371/journal.pone.0211204			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677087	Green Published, Green Submitted, gold			2022-12-26	WOS:000456700400060
J	Rosanowski, SM; Carpenter, TE; Adamson, D; Rogers, CW; Pearce, P; Burns, M; Cogger, N				Rosanowski, Sarah M.; Carpenter, Tim E.; Adamson, David; Rogers, Chris W.; Pearce, Patricia; Burns, Martin; Cogger, Naomi			An economic analysis of a contingency model utilising vaccination for the control of equine influenza in a non-endemic country	PLOS ONE			English	Article							NONCOMMERCIAL HORSE PROPERTIES; BIOSECURITY PRACTICES; OUTBREAK; SIMULATION; DISEASE; STRATEGIES; MANAGEMENT; H3N8	Background Equine influenza (EI) is an infectious respiratory disease of horses that has never been reported in New Zealand (NZ). However, the 2007 EI outbreak in Australia, previously EI free, spurred the NZ government and stakeholders into evaluating alternative EI control strategies in order to economically justify any future decision to eradicate or manage EI. To build on the policy debate, this paper presents an epinomic (epidemiologic and economic) modelling approach to evaluate alternative control strategies. An epidemiologic model to determine how alternative EI control strategies influence the distribution of EI. Model results were then input into a cost-benefit analysis framework, to identify the return and feasibility of alternative EI eradication strategies in NZ. Methods The article explores nine alternative eradication scenarios and two baseline strategies. The alternative scenarios consisted of three vaccination strategies (suppressive, protective or targeted) starting at three time points to reflect the commercial breeding-cycle. These alternatives were compared to two breeding-cycle adjusted baselines: movement restriction in the breeding season (August to January) or non-breeding season (February to July). The economic loss parameters were incursion response, impact to the commercial racing industry (breeding, sales and racing), horse morbidity and mortality, and compensation to industry participants. Results and conclusions Results suggest that the economic viability of the EI eradication programme is dependent on when within the breeding-cycle the EI outbreak occurs. If an outbreak were to occur, the return on each dollar invested for protective or suppressive vaccination strategies would be between NZD$3.67 to NZD$4.89 and between NZD$3.08 to NZD$3.50 in the breeding and non-breeding seasons, respectively. Therefore, protective or suppressive vaccination strategies could be prioritised, regardless of season. As multiple industry stakeholders benefit from these strategies, the study will enable policy development and to better formulate a user-pays eradication programme.	[Rosanowski, Sarah M.] City Univ Hong Kong, Ctr Appl One Hlth Res & Policy Advice, Jockey Club Coll Vet Med & Life Sci, Hong Kong, Peoples R China; [Rosanowski, Sarah M.; Carpenter, Tim E.; Cogger, Naomi] Massey Univ, Sch Vet Sci, Epictr, Palmerston North, New Zealand; [Adamson, David] Univ Adelaide, Fac Profess, Ctr Global Food & Resources, Adelaide, SA, Australia; [Adamson, David] Univ Liverpool, Epidemiol & Populat Hlth, Liverpool, Merseyside, England; [Rogers, Chris W.] Massey Univ, Sch Vet Sci, Anim Prod & Hlth Grp, Equine Res Ctr, Palmerston North, New Zealand; [Pearce, Patricia; Burns, Martin] New Zealand Equine Hlth Assoc, Wellington, New Zealand; [Carpenter, Tim E.] Univ Calif Davis, Dept Med & Epidemiol, Sch Vet Med, Davis, CA 95616 USA	City University of Hong Kong; Massey University; University of Adelaide; University of Liverpool; Massey University; University of California System; University of California Davis	Rosanowski, SM (corresponding author), City Univ Hong Kong, Ctr Appl One Hlth Res & Policy Advice, Jockey Club Coll Vet Med & Life Sci, Hong Kong, Peoples R China.; Rosanowski, SM (corresponding author), Massey Univ, Sch Vet Sci, Epictr, Palmerston North, New Zealand.	sarah.rosanowski@cityu.edu.hk	Rogers, Chris W./D-9812-2012; Rosanowski, Sarah/H-5374-2016; Adamson, David/A-5310-2011	Rogers, Chris W./0000-0002-4253-1825; Rosanowski, Sarah/0000-0002-7950-0029; Adamson, David/0000-0003-1616-968X	New Zealand Equine Trust	New Zealand Equine Trust	This study was funded by the New Zealand Equine Trust, with a project entitled "Multi Criteria Decision making to evaluate control strategies for an outbreak of equine influenza" (NC). The funder provided support in the form of partial salary for SMR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2009, EQUINE INFLUENZA 200; [Anonymous], 2010, SIZE SCOPE NZ RACING; [Anonymous], 2008, FISHERIES FORESTRY C; [Anonymous], 2017, CONS PRIC IND; Australian Racing Board, 2008, AUSTR RAC FACTB 2007; Bolwell CF, 2010, P NZ SOC ANIMAL PROD; Bolwell CF, 2018, COMMERCIAL EQUINE PR; Bolwell CF, 2016, ANIM PROD SCI, V56, P82, DOI 10.1071/AN13443; Bolwell CF, 2016, ANIM PROD SCI, V56, P77, DOI 10.1071/AN13442; Callinan I., THE AUGUST 2007 OUTB; Cogger N., 2010, 201160 MAF; Cowled B, 2009, PREV VET MED, V92, P60, DOI 10.1016/j.prevetmed.2009.08.006; Dhand NK, 2011, AUST VET J, V89, P70, DOI 10.1111/j.1751-0813.2011.00753.x; Dicken M., 2011, NZ VET J, V60, P42; George HEA, 2013, CROSS SECTIONAL SURV; GUO YJ, 1995, J GEN VIROL, V76, P2009, DOI 10.1099/0022-1317-76-8-2009; Loch A, 2014, J HYDROL, V518, P5, DOI 10.1016/j.jhydrol.2013.10.049; Matheson A, 2012, EC IMPACT REPORT NZ; Newton JR, 2006, VET REC, V158, P185, DOI 10.1136/vr.158.6.185; Rijssen J. D. van, 2010, Proceedings of the New Zealand Society of Animal Production, V70, P146; Rogers CW, 2007, NEW ZEAL VET J, V55, P302, DOI 10.1080/00480169.2007.36785; Rogers CW, 2009, P NZ AN PROD; Rosanowski SM, 2016, TRANSBOUND EMERG DIS, V63, P321, DOI 10.1111/tbed.12277; Rosanowski SM, 2015, ANIM PROD SCI, V55, P1075, DOI 10.1071/AN13345; Rosanowski SM, 2013, NEW ZEAL VET J, V61, P245, DOI 10.1080/00480169.2012.750571; Rosanowski SM, 2013, PREV VET MED, V108, P178, DOI 10.1016/j.prevetmed.2012.08.003; Rosanowski SM, 2012, PREV VET MED, V107, P85, DOI 10.1016/j.prevetmed.2012.05.001; SANSON RL, 1997, P 8 INT S VET EP EC; Smyth GB, 2011, AUST VET J, V89, P151, DOI 10.1111/j.1751-0813.2011.00777.x; Smyth GB, 2011, AUST VET J, V89, P23, DOI 10.1111/j.1751-0813.2011.00776.x; Stevenson MA, 2013, PREV VET MED, V109, P10, DOI 10.1016/j.prevetmed.2012.08.015; Ward MP, 2009, PREV VET MED, V88, P286, DOI 10.1016/j.prevetmed.2008.12.006; Webster WR, 2011, AUST VET J, V89, P3, DOI 10.1111/j.1751-0813.2011.00721.x; Yoon H, 2006, PREV VET MED, V74, P212, DOI 10.1016/j.prevetmed.2005.12.002	34	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210885	10.1371/journal.pone.0210885	http://dx.doi.org/10.1371/journal.pone.0210885			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677067	Green Published, gold, Green Submitted			2022-12-26	WOS:000456700400031
J	Bruckbauer, ST; Trimarco, JD; Henry, C; Wood, EA; Battista, JR; Cox, MM				Bruckbauer, Steven T.; Trimarco, Joseph D.; Henry, Camille; Wood, Elizabeth A.; Battista, John R.; Cox, Michael M.			A variant of the Escherichia coli anaerobic transcription factor FNR exhibiting diminished promoter activation function enhances ionizing radiation resistance	PLOS ONE			English	Article							GENE-EXPRESSION; DOSE-RATE; RNA; REQUIREMENTS; EVOLUTION; PROTEIN; O-2	We have previously generated four replicate populations of ionizing radiation (IR)-resistant Escherichia coli though directed evolution. Sequencing of isolates from these populations revealed that mutations affecting DNA repair (through DNA double-strand break repair and replication restart), ROS amelioration, and cell wall metabolism were prominent. Three mutations involved in DNA repair explained the IR resistance phenotype in one population, and similar DNA repair mutations were prominent in two others. The remaining population, IR-3-20, had no mutations in the key DNA repair proteins, suggesting that it had taken a different evolutionary path to IR resistance. Here, we present evidence that a variant of the anaerobic metabolism transcription factor FNR, unique to and isolated from population IR-3-20, plays a role in IR resistance. The F1861 allele of FNR exhibits a diminished ability to activate transcription from FNR-activatable promoters, and furthermore reduces levels of intracellular ROS. The FNR F1861 variant is apparently capable of enhancing resistance to IR under chronic irradiation conditions, but does not increase cell survival when exposed to acute irradiation. Our results underline the importance of dose rate on cell survival of IR exposure.	[Bruckbauer, Steven T.; Trimarco, Joseph D.; Henry, Camille; Wood, Elizabeth A.; Cox, Michael M.] Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA; [Battista, John R.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Battista, John R.] A&M Coll, Baton Rouge, LA USA	University of Wisconsin System; University of Wisconsin Madison; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Bruckbauer, ST (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.	steven.bruckbauer@gmail.com		Henry, Camille/0000-0002-4011-6767; Bruckbauer, Steven/0000-0002-1684-8466	National Institutes of Health [GM112757]; National Institute of General Medical Sciences (NIGMS) [GM112757]; Morgridge Biotechnology Scholarship from the Vice Chancellor's Office for Research and Graduate Education, (University of Wisconsin-Madison); Hilldale Undergraduate Fellowship (UW-Madison); Honors Senior Thesis Summer Research Grant (UWMadison); Biochemistry Undergraduate Summer Research Award (UW-Madison); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Morgridge Biotechnology Scholarship from the Vice Chancellor's Office for Research and Graduate Education, (University of Wisconsin-Madison); Hilldale Undergraduate Fellowship (UW-Madison); Honors Senior Thesis Summer Research Grant (UWMadison); Biochemistry Undergraduate Summer Research Award (UW-Madison); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been funded by the National Institutes of Health grant GM112757 (https://projectreporter.nih.gov/project_info_description.cfm?aid=9534117&icde=39759900) awarded to MMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grant GM112757 from the National Institute of General Medical Sciences (NIGMS). Steven Bruckbauer was supported by the Morgridge Biotechnology Scholarship from the Vice Chancellor's Office for Research and Graduate Education, (University of Wisconsin-Madison). Joseph Trimarco was supported by the Hilldale Undergraduate Fellowship (UW-Madison), the Honors Senior Thesis Summer Research Grant (UWMadison), and the Biochemistry Undergraduate Summer Research Award (UW-Madison).	Almond PR, 1999, MED PHYS, V26, P1847, DOI 10.1118/1.598691; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Boysen A, 2010, J BIOL CHEM, V285, P10690, DOI 10.1074/jbc.M109.089755; Byrne RT, 2014, ELIFE, V3, DOI 10.7554/eLife.01322; Daly Michael J, 2007, PLoS Biol, V5, pe92; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVIES R, 1973, J BACTERIOL, V114, P357, DOI 10.1128/JB.114.1.357-366.1973; DEALMODOVAR JMR, 1994, RADIAT RES, V138, pS93, DOI 10.2307/3578771; Durand S, 2010, MOL MICROBIOL, V75, P1215, DOI 10.1111/j.1365-2958.2010.07044.x; ERDMAN IE, 1961, CAN J MICROBIOL, V7, P207, DOI 10.1139/m61-027; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Gutierrez A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2607; HALL EJ, 1964, RADIAT RES, V22, P305, DOI 10.2307/3571661; Harris DR, 2009, J BACTERIOL, V191, P5240, DOI 10.1128/JB.00502-09; IMLAY JA, 1991, J BIOL CHEM, V266, P6957; Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005; Khoroshilova N, 1997, P NATL ACAD SCI USA, V94, P6087, DOI 10.1073/pnas.94.12.6087; LAMBDEN PR, 1976, J GEN MICROBIOL, V97, P145, DOI 10.1099/00221287-97-2-145; Lamberg KE, 2002, J MOL BIOL, V315, P275, DOI 10.1006/jmbi.2001.5241; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Matsuya Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26556-5; Mettert EL, 2008, J MOL BIOL, V384, P798, DOI 10.1016/j.jmb.2008.09.080; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Myers KS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003565; PARISI A, 1974, APPL MICROBIOL, V28, P41, DOI 10.1128/AEM.28.1.41-46.1974; Piechura JR, 2015, DNA REPAIR, V26, P30, DOI 10.1016/j.dnarep.2014.12.001; Salmon K, 2003, J BIOL CHEM, V278, P29837, DOI 10.1074/jbc.M213060200; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Weber KD, 2005, J BACTERIOL, V187, P1724, DOI 10.1128/JB.187.5.1724-1731.2005; Williams SM, 1997, NUCLEIC ACIDS RES, V25, P4028, DOI 10.1093/nar/25.20.4028; WING HJ, 1995, J BACTERIOL, V177, P6704, DOI 10.1128/jb.177.23.6704-6710.1995; WITKIN EM, 1982, MOL GEN GENET, V185, P43, DOI 10.1007/BF00333788	36	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0199482	10.1371/journal.pone.0199482	http://dx.doi.org/10.1371/journal.pone.0199482			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673695	Green Submitted, gold, Green Published			2022-12-26	WOS:000456442800003
J	Ceulemans, A; Bouzahzah, C; Prat, I; Urassa, W; Kestens, L				Ceulemans, Ann; Bouzahzah, Chaymae; Prat, Irena; Urassa, Willy; Kestens, Luc			CD4-T cell enumeration in human immunodeficiency virus (HIV)-infected patients: A laboratory performance evaluation of Muse Auto CD4/CD4% system by World Health Organization prequalification of in vitro diagnostics	PLOS ONE			English	Article							COUNT; AGREEMENT	Background CD4 T-cell counts are still widely used to assess treatment eligibility and follow-up of HIV-infected patients. The World Health Organization (WHO) prequalification of in vitro diagnostics requested a manufacturer independent laboratory evaluation of the analytical performance at the Institute of Tropical Medicine (ITM) Antwerp, Belgium, of the Muse Auto CD4/CD4% system (Millipore), a new small capillary-flow cytometer dedicated to count absolute CD4-T cells and percentages in venous blood samples from HIV-infected patients. Methods Two hundred and fifty (250) patients were recruited from the HIV outpatient clinic at ITM. Accuracy and precision of CD4 T cell counting on fresh EDTA anticoagulated venous blood samples were assessed in the laboratory on a Muse Auto CD4/CD4% system. Extensive precision analyses were performed both on fresh blood and on normal and low stabilized whole blood controls. Accuracy ((bias) was assessed by comparing results from Muse CD4/CD4% to the reference (single-platform FACSCalibur). Clinical misclassification was measured at 500, 350, 200 and 100 cells/mu L thresholds. Results Intra-assay precision was <5%, and inter-assay was <9%. CD4 T cell counts measured on Muse Auto CD4/CD4% System and on the reference instrument resulted in regression slopes of 0.97 for absolute counts and 1.03 for CD4 T cell percentages and a correlation coefficient of 0.99 for both. The average absolute bias as compared to the reference was negligible (4 cells/mu L or 0.5%). The absolute average bias on CD4 T cell percentages was <1%. Clinical misclassification at different CD4 T cell thresholds was small resulting in sensitivities and specificities equal or >90% at all thresholds except at 100 cells/mu L (sensitivity = 87%). All samples could be analyzed as there was no repetitive rejection errors recorded. Conclusions The Muse Auto CD4/CD4% System performed very well on fresh venous blood samples and met all WHO acceptance criteria for analytical performance of CD4 technologies.	[Ceulemans, Ann; Bouzahzah, Chaymae; Kestens, Luc] Inst Trop Med, Dept Biomed Sci, Immunol Lab, Antwerp, Belgium; [Prat, Irena; Urassa, Willy] WHO, Geneva, Switzerland; [Kestens, Luc] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium	Institute of Tropical Medicine (ITM); World Health Organization; University of Antwerp	Kestens, L (corresponding author), Inst Trop Med, Dept Biomed Sci, Immunol Lab, Antwerp, Belgium.; Kestens, L (corresponding author), Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium.	lkestens@itg.be		Ceulemans, Ann/0000-0002-1615-6785; Kestens, Luc/0000-0001-9374-1921	World Health Organization Prequalification of Diagnostics Programme; World Health Organization	World Health Organization Prequalification of Diagnostics Programme; World Health Organization(World Health Organization)	This study was partially funded by the World Health Organization Prequalification of Diagnostics Programme (http://www.who.int/diagnostics_laboratory/evaluations/alternative/en/). There was no additional external funding received for this study. The funder designed the generic protocol for the evaluation. Data collection and analysis, preparation of the manuscript and decision to publish was the decision of LK.; We are grateful to all patients who provided blood specimens and to all staff members involved in collecting and measuring samples. Funding of this work was partially provided by World Health Organization.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Budd J, 2014, EP09A3 CLSI, V33, P1; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Daneau G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170248; Efron B, 1993, INTRO BOOTSTRAP, DOI [DOI 10.1007/978-1-4899-4541-9, 10.1007/978-1-4899-4541-9]; Ford N, 2017, CURR OPIN HIV AIDS, V12, P123, DOI 10.1097/COH.0000000000000348; Ford N, 2015, LANCET INFECT DIS, V15, P241, DOI 10.1016/S1473-3099(14)70896-5; Isaksson A., 2018, INDEPENDENT THESIS A; Kahn JG, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6884; Kestens L, 2017, CYTOM PART B-CLIN CY, V92, P437, DOI 10.1002/cyto.b.21400; Kouabosso A, 2018, J IMMUNOL METHODS, V455, P95, DOI 10.1016/j.jim.2018.01.008; Mandy Francis F, 2003, MMWR Recomm Rep, V52, P1; Mossoro-Kpinde CD, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1082-7; PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709; Phillips A, 2015, NATURE, V528, pS68, DOI 10.1038/nature16046; Strauss K, 1996, COMMUNICATIONS CLIN, V26, DOI [10.1002/(SICI)1097-0320(19960315)26:1%3C52::AID-CYTO8%3E3.0.CO;2-I, DOI 10.1002/(SICI)1097-0320(19960315)26:1%3C52::AID-CYTO8%3E3.0.CO;2-I]; Tukey JW, 1977, EXPLORATORY DATA ANA; UNAIDS, 2017, FACT SHEET LAT GLOB; UNITAID, 2015, HIV AIDS DIAGN TECHN; Wade D, 2014, J ACQUIR IMMUNE DEFI, V66; WHO, 2014, SUMM STUD PROT MULT; World Health Organization, 2013, CONS GUID US ANT DRU, P148; World Health Organization, 2018, PQD032410600 WHO; World Health Organization, 2016, CONSOLIDATED GUIDELI, P480; World Health Organization, 2017, WHO PROT PERF EV LYM; World Health Organization, 2014, PREQ IN VITR DIAGN P; World Health Organssatioas, 2018, WHO MOD LIST ESS IN	27	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0209677	10.1371/journal.pone.0209677	http://dx.doi.org/10.1371/journal.pone.0209677			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673713	Green Published, gold, Green Submitted			2022-12-26	WOS:000456442800021
J	Lauzi, J; Anders, F; Liu, HH; Pfeiffer, N; Grus, F; Thanos, S; Arnhold, S; Prokosch, V				Lauzi, Jasmin; Anders, Fabian; Liu, Hanhan; Pfeiffer, Norbert; Grus, Franz; Thanos, Solon; Arnhold, Stefan; Prokosch, Verena			Neuroprotective and neuroregenerative effects of CRMP-5 on retinal ganglion cells in an experimental in vivo and in vitro model of glaucoma	PLOS ONE			English	Article							OPTIC-NERVE CRUSH; AXONAL REGENERATION; NEURITE OUTGROWTH; RAT; EXPRESSION; PATHWAY; SURVIVAL; AKT; PROTEIN-5; APOPTOSIS	Purpose To analyze the potential neuro-protective and neuro-regenerative effects of Collapsin-response-mediator-protein-5 (CRMP-5) on retinal ganglion cells (RGCs) using in vitro and in vivo animal models of glaucoma. Methods Elevated intraocular pressure (IOP) was induced in adult female Sprague-Dawley (SD) rats by cauterization of three episcleral veins. Changes in CRMP-5 expression within the retinal proteome were analyzed via label-free mass spectrometry. In vitro, retinal explants were cultured under elevated pressure (60 mmHg) within a high-pressure incubation chamber with and without addition of different concentrations of CRMP-5 (4 mu g/l, 200 mu g/l and 400 mu g/l). In addition, retinal explants were cultured under regenerative conditions with and without application of 200 mu g/l CRMP-5 after performing an optic nerve crush (ONC). Thirdly, an antibody against Protein Kinase B (PKB) was added to examine the possible effects of CRMP-5. RGC count was performed. Number and length of the axons were determined and compared. To undermine a signal-transduction pathway via CRMP-5 and PKB microarray and immunohistochemistry were performed. Results CRMP-5 was downregulated threefold in animals showing chronically elevated IOP. The addition of CRMP-5 to retinal culture significantly increased RGC numbers under pressure in a dose-dependent manner and increased and elongated outgrowing axons in retinal explants significantly which could be blocked by PKB. Especially the number of neurites longer than 400 mu m significantly increased after application of CRMP-5. CRMP-5 as well as PKB were detected higher in the experimental than in the control group. Conclusion CRMP-5 seems to play an important role in an animal model of glaucoma. Addition of CRMP-5 exerts neuro-protective and neuro-regenerative effects in vitro. This effect could be mediated via activation of PKB affecting intra-cellular apoptosis pathways.	[Lauzi, Jasmin; Anders, Fabian; Liu, Hanhan; Pfeiffer, Norbert; Grus, Franz; Prokosch, Verena] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Expt Ophthalmol, Mainz, Germany; [Thanos, Solon] Univ Munster, Sch Med, Dept Expt Ophthalmol, Munster, Germany; [Arnhold, Stefan] Justus Liebig Univ Giessen, Inst Vet Anat Histol & Embryol, Giessen, Germany	Johannes Gutenberg University of Mainz; University of Munster; Justus Liebig University Giessen	Prokosch, V (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Expt Ophthalmol, Mainz, Germany.	vprokosch@gmx.de	Pfeiffer, Norbert/AAO-7586-2020		Deutsche Forschungsgemeinschaft [PR1569/1-1 PD]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funded by Deutsche Forschungsgemeinschaft (PR1569/1-1 PD) to Dr. Verena Prokosch.	Ahmann P., 2003, IN VITRO STUDIE NEUR; Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Anders F, 2017, GRAEF ARCH CLIN EXP, V255, P1395, DOI 10.1007/s00417-017-3678-x; BAHR M, 1988, EXP BRAIN RES, V73, P393; BARRON KD, 1986, J NEUROCYTOL, V15, P345, DOI 10.1007/BF01611437; Bell K, 2016, J NEUROCHEM, V139, P256, DOI 10.1111/jnc.13765; Benowitz LI, 2017, EXP NEUROL, V287, P365, DOI 10.1016/j.expneurol.2015.12.015; Bohm MRR, 2015, CELL TRANSPLANT, V24, P1829, DOI 10.3727/096368914X684583; Bretin S, 2005, J COMP NEUROL, V486, P1, DOI 10.1002/cne.20465; Chang EE, 2012, OPHTHALMOLOGY, V119, P979, DOI 10.1016/j.ophtha.2011.11.003; Charrier E, 2003, MOL NEUROBIOL, V28, P51, DOI 10.1385/MN:28:1:51; Cross SA, 2003, ANN NEUROL, V54, P38, DOI 10.1002/ana.10587; Del Re DP, 2013, J BIOL CHEM, V288, P3977, DOI 10.1074/jbc.M112.436311; Engelsberg K, 2004, GRAEF ARCH CLIN EXP, V242, P229, DOI 10.1007/s00417-003-0780-z; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; Fischer D, 2001, EXP NEUROL, V172, P257, DOI 10.1006/exnr.2001.7822; Fischer D, 2000, INVASTIGATIVE OPHTHA, V41; FORDHOLEVINSKI T, 1986, DEV BRAIN RES, V28, P121, DOI 10.1016/0165-3806(86)90071-4; Fukada M, 2000, J BIOL CHEM, V275, P37957, DOI 10.1074/jbc.M003277200; GARCIAVALENZUELA E, 1995, EXP EYE RES, V61, P33, DOI 10.1016/S0014-4835(95)80056-5; Goldberg JL, 2016, INVEST OPHTH VIS SCI, V57, P1271, DOI 10.1167/iovs.15-18500; Goldberg JL, 2000, ANNU REV NEUROSCI, V23, P579, DOI 10.1146/annurev.neuro.23.1.579; Guo L, 2005, INVEST OPHTH VIS SCI, V46, P175, DOI 10.1167/iovs.04-0832; Horiuchi M, 2000, FEBS LETT, V480, P283, DOI 10.1016/S0014-5793(00)01952-9; Khwaja A, 1999, NATURE, V401, P33, DOI 10.1038/43354; Kunstle G, 2002, MOL CELL BIOL, V22, P1513, DOI 10.1128/MCB.22.5.1513-1525.2002; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Liu HH, 2017, INVEST OPHTH VIS SCI, V58, P5129, DOI 10.1167/iovs.17-22200; Lorber B, 2002, MOL CELL NEUROSCI, V21, P301, DOI 10.1006/mcne.2002.1175; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Meyronet D, 2008, AM J SURG PATHOL, V32, P1699, DOI 10.1097/PAS.0b013e31817dc37c; MISANTONE LJ, 1984, J NEUROCYTOL, V13, P449, DOI 10.1007/BF01148334; Moutal A, 2015, CANCER RES, V75, P3519, DOI 10.1158/0008-5472.CAN-14-0631; Nadal-Nicolas FM, 2015, INVEST OPHTH VIS SCI, V56, P6095, DOI 10.1167/iovs.15-17195; Nadal-Nicolas FM, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00099; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Ricard D, 2001, J NEUROSCI, V21, P7203, DOI 10.1523/JNEUROSCI.21-18-07203.2001; Rose K, 2004, SPEZIESSPEZIFISCHE P; SHAREEF SR, 1995, EXP EYE RES, V61, P379, DOI 10.1016/S0014-4835(05)80131-9; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Tan F, 2014, ONCOL LETT, V7, P1333, DOI 10.3892/ol.2014.1909; Terzic A, 2013, STEM CELLS DEV, V22, P20, DOI 10.1089/scd.2013.0448; Tezel G, 2001, GLIA, V34, P178, DOI 10.1002/glia.1052; Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Trost A, 2017, EXP EYE RES, V159, P30, DOI 10.1016/j.exer.2017.03.003; Veyrac A, 2005, EUR J NEUROSCI, V21, P2635, DOI 10.1111/j.1460-9568.2005.04112.x; Veyrac A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023721; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Xu P, 2010, J NEURO-ONCOL, V97, P41, DOI 10.1007/s11060-009-0007-1; Yamashita N, 2012, MOL NEUROBIOL, V45, P234, DOI 10.1007/s12035-012-8242-4; Yamashita N, 2011, J NEUROSCI, V31, P1773, DOI 10.1523/JNEUROSCI.5337-10.2011; Zhen PY, 2017, EXP EYE RES, V162, P97, DOI 10.1016/j.exer.2017.06.014	56	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0207190	10.1371/journal.pone.0207190	http://dx.doi.org/10.1371/journal.pone.0207190			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673694	Green Published, gold, Green Submitted			2022-12-26	WOS:000456442800007
J	Lillegraven, S; Greenberg, JD; Reed, GW; Saunders, K; Curtis, JR; Harrold, L; Hochberg, MC; Pappas, DA; Kremer, JM; Solomon, DH				Lillegraven, Siri; Greenberg, Jeffrey D.; Reed, George W.; Saunders, Katherine; Curtis, Jeffrey R.; Harrold, Leslie; Hochberg, Marc C.; Pappas, Dimitrios A.; Kremer, Joel M.; Solomon, Daniel H.			Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis	PLOS ONE			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; GLYCOSYLATED HEMOGLOBIN; PSORIATIC-ARTHRITIS; INSULIN-RESISTANCE; DISEASE-ACTIVITY; INFLAMMATION; HYDROXYCHLOROQUINE; ASSOCIATION; MELLITUS	Objective Inflammation and anti-inflammatory treatments might influence the risk of diabetes. The objective of this study was to assess factors associated with incident diabetes in rheumatoid arthritis (RA). Methods The study population consisted of RA patients from a multi-center cohort study, Corrona. To assess risk associated with disease modifying antirheumatic drug (DMARD) exposure, we assessed five mutually exclusive DMARD groups. Additionally, we assessed the risk associated with body mass index (BMI, <25, 25-30, >30 kg/m2) and glucocorticoid usage. Incident cases of diabetes were confirmed through adjudication, and Cox regression models were fit to estimate the risk of incident diabetes. Results We identified 21,775 DMARD treatment regimens, the mean (SD) age at the index visit was 58 (13) years, disease duration 10 (10) years, and 30% used oral glucocorticoids at the time. Eighty-four incident cases of diabetes were confirmed within the treatment exposure periods. The hazard ratio (HR, 95% confidence interval) for diabetes was significantly reduced in patients receiving TNF inhibitors, HR 0.35 (0.13, 0.91), compared to patients treated with non-biologic DMARDs other than hydroxychloroquine and methotrexate. Hydroxychloroquine, methotrexate and use of other biologic DMARDs had a numerically reduced risk compared to the same group. Patients prescribed >= 7.5 mg of glucocorticoids had a HR of 2.33 (1.68, 3.22) of incident diabetes compared with patients not prescribed oral glucocorticoids. RA patients with a BMI >30 had a HR of 6.27 (2.97, 13.25) compared to patients with BMI <= 25. Conclusion DMARDs, glucocorticoids and obesity influenced the risk of incident diabetes in a large cohort of RA patients. Monitoring for the occurrence of diabetes should be part of routine RA management with a focus on specific subgroups.	[Lillegraven, Siri] Diakonhjemmet Hosp, Oslo, Norway; [Greenberg, Jeffrey D.] NYU, Hosp Joint Dis, New York, NY USA; [Reed, George W.; Harrold, Leslie] Corrona LLC, Worcester, MA USA; [Reed, George W.] UMass Med Sch, Worcester, MA USA; [Saunders, Katherine] Corrona LLC, Southborough, MA USA; [Curtis, Jeffrey R.] Univ Alabama Birmingham, Birmingham, AL USA; [Harrold, Leslie] Univ Massachusetts, Sch Med, Worcester, MA USA; [Hochberg, Marc C.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Pappas, Dimitrios A.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Kremer, Joel M.] Albany Med Coll, Albany, NY 12208 USA; [Kremer, Joel M.] Ctr Rheumatol, Albany, NY USA; [Solomon, Daniel H.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Diakonhjemmet Hospital; New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; Corrona, LLC; University of Massachusetts System; University of Massachusetts Worcester; Corrona, LLC; University of Alabama System; University of Alabama Birmingham; University of Massachusetts System; University of Massachusetts Worcester; University System of Maryland; University of Maryland Baltimore; Columbia University; Albany Medical College; Harvard University; Brigham & Women's Hospital	Lillegraven, S (corresponding author), Diakonhjemmet Hosp, Oslo, Norway.	Siri.Lillegraven@gmail.com			National Institutes of Health [K24 AR055989]; Corrona LLC; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR055989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Corrona LLC; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Solomon receives grant support for mentoring from the National Institutes of Health (https://www.nih.gov), K24 AR055989. Corrona LLC funded the data collection and provided support in the form of salaries for authors KS and GR, but did not have any additional role in the study design, analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agca R, 2017, ANN RHEUM DIS, V76, P17, DOI 10.1136/annrheumdis-2016-209775; Ajeganova S, 2013, ARTHRIT CARE RES, V65, P78, DOI 10.1002/acr.21710; Aletaha D, 2007, BEST PRACT RES CL RH, V21, P663, DOI 10.1016/j.berh.2007.02.004; Antohe JL, 2012, ARTHRIT CARE RES, V64, P215, DOI 10.1002/acr.20657; Bili A, 2011, JCR-J CLIN RHEUMATOL, V17, P115, DOI 10.1097/RHU.0b013e318214b6b5; Boers M, 2013, ANN RHEUM DIS, V72, P406, DOI 10.1136/annrheumdis-2012-202333; Chatterjee S, 2017, LANCET, V389, P2239, DOI 10.1016/S0140-6736(17)30058-2; Chung CP, 2008, ARTHRITIS RHEUM-US, V58, P2105, DOI 10.1002/art.23600; Chung CP, 2008, ATHEROSCLEROSIS, V196, P756, DOI 10.1016/j.atherosclerosis.2007.01.004; de Rotte MCFJ, 2014, ARTHRITIS RHEUMATOL, V66, P2026, DOI 10.1002/art.38652; den Uyl D, 2012, ARTHRITIS RHEUM-US, V64, P639, DOI 10.1002/art.33378; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Giles JT, 2008, ARTHRIT RHEUM-ARTHR, V59, P1407, DOI 10.1002/art.24109; Greenberg JD, 2011, ANN RHEUM DIS, V70, P576, DOI 10.1136/ard.2010.129916; Han CL, 2006, J RHEUMATOL, V33, P2167; Kremer JM, 2006, AUTOIMMUN REV, V5, P46, DOI 10.1016/j.autrev.2005.07.006; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Liao KP, 2013, RHEUMATOLOGY, V52, P45, DOI 10.1093/rheumatology/kes243; Movahedi M, 2016, ARTHRITIS RHEUMATOL, V68, P1089, DOI 10.1002/art.39537; Ozen G, 2017, ANN RHEUM DIS, V76, DOI 10.1136/annrheumdis-2016-209954; PINCUS T, 1983, ARTHRITIS RHEUM-US, V26, P1346, DOI 10.1002/art.1780261107; Rasmussen SS, 2016, DIABETOLOGIA, V59, P989, DOI 10.1007/s00125-016-3887-6; Rekedal LR, 2010, ARTHRITIS RHEUM-US, V62, P3569, DOI 10.1002/art.27703; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Singh JA, 2016, ARTHRIT CARE RES, V68, P1, DOI 10.1002/acr.22783; Smolen JS, 2016, LANCET, V388, P2023, DOI 10.1016/S0140-6736(16)30173-8; Smolen JS, 2017, ANN RHEUM DIS, V76, P960, DOI 10.1136/annrheumdis-2016-210715; Solomon DH, 2011, JAMA-J AM MED ASSOC, V305, P2525, DOI 10.1001/jama.2011.878; Solomon DH, 2010, ANN RHEUM DIS, V69, P2114, DOI 10.1136/ard.2009.125476; Wasko MC, 2011, ARTHRIT CARE RES, V63, P512, DOI 10.1002/acr.20414; Wasko MCM, 2007, JAMA-J AM MED ASSOC, V298, P187, DOI 10.1001/jama.298.2.187	31	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210459	10.1371/journal.pone.0210459	http://dx.doi.org/10.1371/journal.pone.0210459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673733	Green Published, Green Submitted, gold			2022-12-26	WOS:000456442800042
J	Jacobsen, JV; Steen, K; Nilssen, KJ				Jacobsen, Julianne Valla; Steen, Klemet; Nilssen, Kjell J.			Anaesthetic efficacy of Aqui-S, Benzoak, and MS-222 on lumpfish (Cyclopterus lumpus) fries. Impact from temperature, salinity, and fasting	PLOS ONE			English	Article							COD GADUS-MORHUA; CLOVE OIL; METOMIDATE; BENZOCAINE; SEDATION	Large numbers of lumpfish are produced for the Norwegian salmon industry and are used to combat sea lice infestations. Periodically high mortality of farmed lumpfish demonstrates the need to improve farming conditions and animal welfare. As part of such efforts, the present work tested the efficacy of three anaesthetic chemicals on lumpfish fries (average weight of 0.97 g). The anaesthetic impact from salinity (15 ppt-18 ppt), temperature (12 degrees C versus 7 and 18 degrees C), and fasting conditions (three days) was also examined. Surgical anaesthesia was induced within 3 to 5 min (preferred time) at concentrations of 18 mg/L (Aqui-S), 37.5 mg/L (Benzoak), and 60 mg/L (buffered MS-222). Safety margins were regarded as low when using Aqui-S; therefore, this chemical was not considered suitable for prolonged exposures. The lumpfish made a rapid recovery from both Benzoak and MS-222 even after 20 min of exposure. A 6 degrees C increase in exposure temperature (reaching 18 degrees C) was found to delay or inhibit recovery. The effect of a 5 degrees C decrease (down to 7 degrees C) significantly reduced induction time for MS-222 and was insignificant for Aqui-S, while it prolonged Benzoak induction time significantly and gave a longer recovery period. Fasting resulted in 70% recovery after 20 min of Aqui-S exposure compared to 0% in fed fish but had only minor effects on Benzoak and MS-222. Use of brackish water (15 ppt-18 ppt) gave 20% recovery from Aqui-S and significantly shorter recovery time from MS-222 exposure, while the effects on Benzoak were insignificant.	[Jacobsen, Julianne Valla] Leroy Midt AS, Sandstad, Norway; [Steen, Klemet] Leroy Seafood Grp ASA, Bergen, Norway; [Nilssen, Kjell J.] Norwegian Univ Sci & Technol, Fac Sci & Technol, Dept Biol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Jacobsen, JV (corresponding author), Leroy Midt AS, Sandstad, Norway.	julianne.valla.jacobsen@leroymidt.no						Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Borno G, FISKEHELSERAPPORTEN, P70; Fiskeridirektoratet, 2017, OPPDR RENS; FRAZIER DT, 1975, EUR J PHARMACOL, V33, P313, DOI 10.1016/0014-2999(75)90175-2; Gismervik K., VETERINAERINSTITUTTE; Gomes DP, 2011, AQUAC RES, V42, P878, DOI 10.1111/j.1365-2109.2011.02864.x; Grontvedt R, FISKEHELSERAPPORTEN, P49; Haya K, 2005, HANDB ENVIRON CHEM, V5, P305, DOI 10.1007/b136016; Helgesen KO, 2015, AQUACULT REP, V1, P37, DOI 10.1016/j.aqrep.2015.01.001; Iversen A., 2017, 242017 NOFIMA; Iversen M, 2003, AQUACULTURE, V221, P549, DOI 10.1016/S0044-8486(03)00111-X; Kiessling A, 2009, AQUACULTURE, V286, P301, DOI 10.1016/j.aquaculture.2008.09.037; MARKING LL, 1985, FISHERIES, V10, P2, DOI 10.1577/1548-8446(1985)010<0002:ABANIF>2.0.CO;2; MATTSON NS, 1989, AQUACULTURE, V83, P89, DOI 10.1016/0044-8486(89)90063-X; MEHNER T, 1994, J FISH BIOL, V45, P325, DOI 10.1111/j.1095-8649.1994.tb01311.x; Mylonas CC, 2005, AQUACULTURE, V246, P467, DOI 10.1016/j.aquaculture.2005.02.046; Neiffer DL, 2009, ILAR J, V50, P343, DOI 10.1093/ilar.50.4.343; NEUMCKE B, 1981, PFLUG ARCH EUR J PHY, V390, P230, DOI 10.1007/BF00658267; Powell A., 2017, REV AQUACULTURE; Scanvacc, AQ S VET; Skar MW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179344; Sladky KK, 2001, AM J VET RES, V62, P337, DOI 10.2460/ajvr.2001.62.337; SSB, 2017, STAT NORW; Zahl IH, 2012, FISH PHYSIOL BIOCHEM, V38, P201, DOI 10.1007/s10695-011-9565-1; Zahl IH, 2011, AQUAC RES, V42, P1235, DOI 10.1111/j.1365-2109.2010.02711.x; Zahl IH, 2009, AQUACULTURE, V295, P52, DOI 10.1016/j.aquaculture.2009.06.019	26	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0211080	10.1371/journal.pone.0211080	http://dx.doi.org/10.1371/journal.pone.0211080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668593	Green Submitted, Green Published, gold			2022-12-26	WOS:000456306400031
J	Bartel, F; Vrenken, H; van Herk, M; de Ruiter, M; Belderbos, J; Hulshof, J; de Munck, JC				Bartel, Fabian; Vrenken, Hugo; van Herk, Marcel; de Ruiter, Michiel; Belderbos, Jose; Hulshof, Joost; de Munck, Jan C.			FAst Segmentation Through SURface Fairing (FASTSURF): A novel semi-automatic hippocampus segmentation method	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; AUTOMATED METHODS FREESURFER; ADNI HARMONIZED PROTOCOL; WHOLE-BRAIN RADIOTHERAPY; MANUAL SEGMENTATION; ATROPHY RATES; VOLUME; RELIABILITY; ROBUST; MRI	Objective The objective is to present a proof-of-concept of a semi-automatic method to reduce hippocampus segmentation time on magnetic resonance images (MRI). Materials and methods FAst Segmentation Through SURface Fairing (FASTSURF) is based on a surface fairing technique which reconstructs the hippocampus from sparse delineations. To validate FASTSURF, simulations were performed in which sparse delineations extracted from full manual segmentations served as input. On three different datasets with different diagnostic groups, FASTSURF hippocampi were compared to the original segmentations using Jaccard overlap indices and percentage volume differences (PVD). In one data set for which back-toback scans were available, unbiased estimates of overlap and PVD were obtained. Using longitudinal scans, we compared hippocampal atrophy rates measured by manual, FASTSURF and two automatic segmentations (FreeSurfer and FSL-FIRST). Results With only seven input contours, FASTSURF yielded mean Jaccard indices ranging from 72 (+/- 4.3)% to 83(+/- 2.6)% and PVDs ranging from 0.02(+/- 2.40)% to 3.2(+/- 3.40)% across the three datasets. Slightly poorer results were obtained for the unbiased analysis, but the performance was still considerably better than both tested automatic methods with only five contours. Conclusions FASTSURF segmentations have high accuracy and require only a fraction of the delineation effort of fully manual segmentation. Atrophy rate quantification based on completely manual segmentation is well reproduced by FASTSURF. Therefore, FASTSURF is a promising tool to be implemented in clinical workflow, provided a future prospective validation confirms our findings.	[Bartel, Fabian; Vrenken, Hugo; de Munck, Jan C.] Vrije Univ Amsterdam, Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands; [van Herk, Marcel] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Sch Med Sci,Manchester Canc Res Ctr,Div Canc Sci, Manchester, Lancs, England; [de Ruiter, Michiel] Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, Amsterdam, Netherlands; [Belderbos, Jose] Netherlands Canc Inst, Dept Radiotherapy, Amsterdam, Netherlands; [Hulshof, Joost] Vrije Univ Amsterdam, Dept Math, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Manchester; Netherlands Cancer Institute; Netherlands Cancer Institute; Vrije Universiteit Amsterdam	Bartel, F (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands.	f.bartel@vumc.nl	van Herk, Marcel/P-6307-2015	van Herk, Marcel/0000-0001-6448-898X; De Munck, Jan/0000-0002-5206-0086; Vrenken, Hugo/0000-0001-9106-1172	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; AbbVie; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; Transition Therapeutics; Canadian Institutes of Health Research; NIH [P30 AG010129, K01 AG030514]; ZonMW; Netherlands organisation for health research and development [104002006]; Netherlands Cancer Institute (NKI) in Amsterdam; Neurotrack Technologies; NATIONAL INSTITUTE ON AGING [P30AG010129] Funding Source: NIH RePORTER	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD ADNI (Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); AbbVie(AbbVie); Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen(Biogen); Bristol-Myers Squibb Company(Bristol-Myers Squibb); CereSpir, Inc.; Cogstate(CogState Limited); Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals, Inc.; Eli Lilly and Company(Eli Lilly); EuroImmun; F. Hoffmann-La Roche Ltd(Hoffmann-La Roche); Fujirebio; GE Healthcare(General ElectricGE Healthcare); IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.(Johnson & JohnsonJohnson & Johnson USA); Lumosity; Lundbeck(Lundbeck Corporation); Merck Co., Inc.(Merck & Company); Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Piramal Imaging; Servier(Servier); Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Transition Therapeutics; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ZonMW(Netherlands Organization for Health Research and Development); Netherlands organisation for health research and development(Netherlands Organization for Health Research and Development); Netherlands Cancer Institute (NKI) in Amsterdam; Neurotrack Technologies; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org).The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. This research was also supported by NIH grants P30 AG010129 and K01 AG030514. This study was funded by ZonMW, the Netherlands organisation for health research and development (Grand Number: 104002006), and Netherlands Cancer Institute (NKI) in Amsterdam.	Aoyama H, 2007, INT J RADIAT ONCOL, V68, P1388, DOI 10.1016/j.ijrobp.2007.03.048; Apostolova LG, 2006, BRAIN, V129, P2867, DOI 10.1093/brain/awl274; Barnes J, 2008, NEUROIMAGE, V40, P1655, DOI 10.1016/j.neuroimage.2008.01.012; Bartel F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0166785; Boccardi M, 2011, ADV ALZH DIS, V2, P111, DOI 10.3233/978-1-60750-793-2-111; Boccardi M, 2015, ALZHEIMERS DEMENT, V11, P175, DOI 10.1016/j.jalz.2014.12.002; Boccardi M, 2015, ALZHEIMERS DEMENT, V11, P126, DOI 10.1016/j.jalz.2014.02.009; Botsch M, 2010, POLYGON MESH PROCESS, V1, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; Chang EL, 2009, LANCET ONCOL, V10, P1037, DOI 10.1016/S1470-2045(09)70263-3; Cherbuin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005265; Dewey J, 2010, NEUROIMAGE, V51, P1334, DOI 10.1016/j.neuroimage.2010.03.033; Dill V, 2015, NEUROINFORMATICS, V13, P133, DOI 10.1007/s12021-014-9243-4; Doring TM, 2011, J MAGN RESON IMAGING, V33, P565, DOI 10.1002/jmri.22473; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Frisoni GB, 2015, ALZHEIMERS DEMENT, V11, P111, DOI 10.1016/j.jalz.2014.05.1756; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Germeyan SC, 2014, EPILEPSIA, V55, P1374, DOI 10.1111/epi.12694; Geuze E, 2005, MOL PSYCHIATR, V10, P147, DOI 10.1038/sj.mp.4001580; Giraud R, 2016, NEUROIMAGE, V124, P770, DOI 10.1016/j.neuroimage.2015.07.076; Gondi V, HIPPOCAMPAL CONTOURI; Gondi V, 2010, INT J RADIAT ONCOL, V78, P1244, DOI 10.1016/j.ijrobp.2010.01.039; Grimm O, 2015, J NEUROSCI METH, V253, P254, DOI 10.1016/j.jneumeth.2015.05.024; Henneman WJP, 2009, NEUROLOGY, V72, P999, DOI 10.1212/01.wnl.0000344568.09360.31; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; JACK CR, 1994, EPILEPSIA, V35, pS21, DOI 10.1111/j.1528-1157.1994.tb05986.x; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kim H, 2012, NEUROIMAGE, V59, P3178, DOI 10.1016/j.neuroimage.2011.11.040; Lehmann M, 2010, NEUROIMAGE, V49, P2264, DOI 10.1016/j.neuroimage.2009.10.056; Likeman M, 2005, ARCH NEUROL-CHICAGO, V62, P1410, DOI 10.1001/archneur.62.9.1410; Lotjonen JMP, 2010, NEUROIMAGE, V49, P2352, DOI 10.1016/j.neuroimage.2009.10.026; Morey RA, 2010, HUM BRAIN MAPP, V31, P1751, DOI 10.1002/hbm.20973; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Mulder ER, 2014, NEUROIMAGE, V92, P169, DOI 10.1016/j.neuroimage.2014.01.058; Nugent AC, 2013, HUM BRAIN MAPP, V34, P2313, DOI 10.1002/hbm.22068; Oskan F, 2014, STRAHLENTHER ONKOL, V190, P337, DOI 10.1007/s00066-013-0518-8; Pardoe HR, 2009, EPILEPSIA, V50, P2586, DOI 10.1111/j.1528-1167.2009.02243.x; Patenaude B., 2007, DEP CLIN NEUROL; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Press WH, 2007, NUMERICAL RECIPES; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Sanchez-Benavides G, 2010, PSYCHIAT RES-NEUROIM, V181, P219, DOI 10.1016/j.pscychresns.2009.10.011; Shen L, 2010, BRAIN IMAGING BEHAV, V4, P86, DOI 10.1007/s11682-010-9088-x; Tae WS, 2008, NEURORADIOLOGY, V50, P569, DOI 10.1007/s00234-008-0383-9; Tanskanen P, 2005, SCHIZOPHR RES, V75, P283, DOI 10.1016/j.schres.2004.09.022; van de Pol LA, 2007, NEUROLOGY, V69, P1491, DOI 10.1212/01.wnl.0000277458.26846.96; Wang JH, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00007; Welzel G, 2008, INT J RADIAT ONCOL, V72, P1311, DOI 10.1016/j.ijrobp.2008.03.009; Wenger E, 2014, HUM BRAIN MAPP, V35, P4236, DOI 10.1002/hbm.22473; Wu WC, 2005, AM J NEURORADIOL, V26, P1270; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	52	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210641	10.1371/journal.pone.0210641	http://dx.doi.org/10.1371/journal.pone.0210641			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657776	Green Published, Green Submitted, gold			2022-12-26	WOS:000456017000014
J	Basile, MS; Mazzon, E; Russo, A; Mammana, S; Longo, A; Bonfiglio, V; Fallico, M; Caltabiano, R; Fagone, P; Nicoletti, F; Avitabile, T; Reibaldi, M				Basile, Maria Sofia; Mazzon, Emanuela; Russo, Andrea; Mammana, Santa; Longo, Antonio; Bonfiglio, Vincenza; Fallico, Matteo; Caltabiano, Rosario; Fagone, Paolo; Nicoletti, Ferdinando; Avitabile, Teresio; Reibaldi, Michele			Differential modulation and prognostic values of immune-escape genes in uveal melanoma	PLOS ONE			English	Article							PD-L1 EXPRESSION; IFN-GAMMA	Uveal melanoma (UM) is the most common primary intraocular cancer in adults. In the present study, we aimed to characterize the immunological features of primary UM cancer and to provide an association with prognostic markers and outcome. Also, we assessed the influence of the microenvironment on the expression of inhibitory immune checkpoints in UM. Genes of interest included MHC Class I and Class II molecules, as well as inhibitory immune-checkpoints, i.e. PDL1, PDL2, B7-H3, B7-H4, TBFRSF6B, CD47, CD155, GAL9, HVEM and CD200. We observed significant lower levels of MHC genes in UM cells as compared to normal uveal melanocytes. Unexpectedly however, the expression levels of most of the analyzed inhibitory immune-checkpoint genes were not different in cancer cells as compared to normal melanocytes, with the exception of CD200 and HVEM, that resulted significantly reduced. On the other hand, PDL1 inversely correlated with OS, PFS and thickness of the tumor. Also, PDL1, along with PDL2, expression significantly increased under inflammatory conditions. Finally, for the first time, we propose a possible role for CD47 in the immune evasive properties of UM. We show here that CD47 is significantly upregulated by UM cells following inflammatory stimuli and that it represents a good independent predictor of disease progression. The results from this study may propel advances in the development of immune-based therapies for UM patients.	[Basile, Maria Sofia; Fagone, Paolo; Nicoletti, Ferdinando] Univ Catania, Dept Biomed & Biotechnol Sci, Catania, Italy; [Mazzon, Emanuela; Mammana, Santa] IRCCS, Ctr Neurolesi Bonino Pulejo, Messina, Italy; [Russo, Andrea; Longo, Antonio; Bonfiglio, Vincenza; Fallico, Matteo; Avitabile, Teresio; Reibaldi, Michele] Univ Catania, Dept Ophthalmol, Catania, Italy; [Caltabiano, Rosario] Univ Catania, Sect Anat Pathol, Dept GF Ingrassia, Catania, Italy	University of Catania; IRCCS Bonino Pulejo; University of Catania; University of Catania	Fagone, P (corresponding author), Univ Catania, Dept Biomed & Biotechnol Sci, Catania, Italy.	paolofagone@yahoo.it	Mazzon, Emanuela/AAL-4334-2020; Nicoletti, Ferdinando/M-4428-2016; Basile, Maria Sofia/AAC-3393-2019; Avitabile, Teresio/AAC-6076-2022; Fallico, Matteo/AAC-5284-2022; Russo, Andrea/AAC-5349-2022; Reibaldi, Michele/AAL-1113-2021; Longo, Antonio/AAC-6092-2022; Fagone, Paolo/Q-4455-2016	Nicoletti, Ferdinando/0000-0002-4570-8462; Basile, Maria Sofia/0000-0002-4811-4694; Russo, Andrea/0000-0002-7725-5971; LONGO, Antonio/0000-0002-9525-1800; Caltabiano, Rosario/0000-0001-8591-8010; mazzon, emanuela/0000-0002-5073-717X; FALLICO, MATTEO/0000-0003-2639-1321; Fagone, Paolo/0000-0002-6694-1992	IRCCS "Centro Neurolesi "Bonino Pulejo", Messina-Italy	IRCCS "Centro Neurolesi "Bonino Pulejo", Messina-Italy	This study was supported by current research funds 2016 of IRCCS "Centro Neurolesi "Bonino Pulejo", Messina-Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algazi AP, 2016, CANCER-AM CANCER SOC, V122, P3344, DOI 10.1002/cncr.30258; Bene L, 2004, BIOCHEM BIOPH RES CO, V322, P678, DOI 10.1016/j.bbrc.2004.07.171; Blom DJR, 1997, INVEST OPHTH VIS SCI, V38, P1865; Chattopadhyay C, 2016, CANCER-AM CANCER SOC, V122, P2299, DOI 10.1002/cncr.29727; Chen PW, 2007, EXP EYE RES, V85, P617, DOI 10.1016/j.exer.2007.07.014; DELACRUZ PO, 1990, CANCER-AM CANCER SOC, V65, P112; Duval C, 2015, EXP EYE RES, V135, P146, DOI 10.1016/j.exer.2015.03.001; Fagone P, 2017, SCI REP-UK, V7, DOI 10.1038/srep44564; Ge H, 2018, CLIN CHIM ACTA, V481, P126, DOI 10.1016/j.cca.2018.02.038; Javed A, 2017, IMMUNOTHERAPY-UK, V9, P1323, DOI 10.2217/imt-2017-0066; Jehs T, 2014, INVEST OPHTH VIS SCI, V55, P5169, DOI 10.1167/iovs.14-14394; Kaunitz GJ, 2017, LAB INVEST, V97, P1063, DOI 10.1038/labinvest.2017.64; Lagouros Evan, 2009, Trans Am Ophthalmol Soc, V107, P223; Mandai M, 2016, CLIN CANCER RES, V22, P2329, DOI 10.1158/1078-0432.CCR-16-0224; McKenna KC, 2010, OCUL IMMUNOL INFLAMM, V18, P80, DOI 10.3109/09273941003669950; McLaughlin CC, 2005, CANCER-AM CANCER SOC, V103, P1000, DOI 10.1002/cncr.20866; Niederkorn JY, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00148; Oliva M, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.05.04; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Robertson AG, 2017, CANCER CELL, V32, P204, DOI 10.1016/j.ccell.2017.07.003; Rodriguez A, 2016, MOL CLIN ONCOL, V5, P675, DOI 10.3892/mco.2016.1037; Rothermel LD, 2016, CLIN CANCER RES, V22, P2237, DOI 10.1158/1078-0432.CCR-15-2294; Tong B, 2018, FUTURE ONCOL, V14, P2179, DOI 10.2217/fon-2018-0035; van Essen TH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164292; Yang J, 2018, THER ADV MED ONCOL, V10, DOI 10.1177/1758834018757175; Yang WH, 2008, INVEST OPHTH VIS SCI, V49, P2518, DOI 10.1167/iovs.07-1606; Yu P, 2006, LAB INVEST, V86, P231, DOI 10.1038/labinvest.3700389; Zhou XX, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00452	28	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210276	10.1371/journal.pone.0210276	http://dx.doi.org/10.1371/journal.pone.0210276			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653520	Green Published, Green Submitted, gold			2022-12-26	WOS:000456015500031
J	Deshmukh, SS; Kornblatt, MJ; Kornblatt, JA				Deshmukh, Sasmit S.; Kornblatt, M. Judith; Kornblatt, Jack A.			The influence of truncating the carboxyterminal amino acid residues of streptococcal enolase on its ability to interact with canine plasminogen	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; DUAL-POLARIZATION INTERFEROMETRY; SIZE-DISTRIBUTION ANALYSIS; ALPHA-ENOLASE; CRYSTAL-STRUCTURE; ANALYTICAL ULTRACENTRIFUGATION; REAL-TIME; BINDING; PROTEIN; PNEUMONIAE	The native octameric structure of streptococcal enolase from Streptococcus pyogenes increasingly dissociates as amino acid residues are removed one by one from the carboxy-terminus. These truncations gradually convert native octameric enolase into monomers and oligomers. In this work, we investigated how these truncations influence the interaction between Streptococcal enolase and canine plasminogen. We used dual polarization interferometry (DPI), localized surface plasmon resonance (LSPR), and sedimentation velocity analytical ultracentrifugation (AUC) to study the interaction. The DPI was our first technique, was performed on all the truncations and used one exclusive kind of chip. The LSRP was used to show that the DPI results were not dependent on the type of chip used. The AUC was required to show that our surface results were not the result of selecting a minority population in any given sample; the majority of the protein was responsible for the binding phenomenon we observed. By comparing results from these techniques we identified one detail that is essential for streptococcal enolase to bind plasminogen: In our hands the individual monomers bind plasminogen; dimers, trimers, tetramers may or may not bind, the fully intact, native, octamer does not bind plasminogen. We also evaluated the contribution to the equilibrium constant made by surface binding as well as in solution. On a surface, the association coefficient is about twice that in solution. The difference is probably not significant. Finally, the fully octameric form of the protein that does not contain a hexa-his N-terminal peptide does not bind to a silicon oxynitride surface, does not bind to an Au-nanoparticle surface, does not bind to a surface coated with Ni-NTA nor does it bind to a surface coated with DPgn. The likelihood is great that the enolase species on the surface of Streptococcus pyogenes is an x-mer of the native octamer.	[Deshmukh, Sasmit S.] Concordia Univ, Dept Phys, Montreal, PQ, Canada; [Kornblatt, M. Judith] Concordia Univ, Dept Chem & Biochem, Montreal, PQ, Canada; [Kornblatt, Jack A.] Concordia Univ, Dept Biol, Montreal, PQ, Canada; [Deshmukh, Sasmit S.] Sanofi Pasteur, N York, ON, Canada	Concordia University - Canada; Concordia University - Canada; Concordia University - Canada; Sanofi-Aventis	Kornblatt, JA (corresponding author), Concordia Univ, Dept Biol, Montreal, PQ, Canada.	jack.kornblatt@concordia.ca		kornblatt, jack/0000-0002-9802-8321	Natural Sciences and Engineering Research Council of Canada [9988-2006]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by the Natural Sciences and Engineering Research Council of Canada (URL www.nserc-crsng.gc.ca), Grant Number 9988-2006 to JAK. The funder had no role in the study design, the data collection and analysis, the decision to publish, or the preparation of the manuscript.	ABAZA MSI, 1992, J PROTEIN CHEM, V11, P687, DOI 10.1007/BF01024970; Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; Bachmann F., 1994, MOL ASPECTS PLASMINO, P525; Balhara V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088395; Balhara V, 2013, BBA-BIOMEMBRANES, V1828, P2193, DOI 10.1016/j.bbamem.2013.05.027; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Coffey PD, 2013, RSC ADV, V3, P3316, DOI 10.1039/c2ra22911k; Cork AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121764; Cork AJ, 2009, J BIOL CHEM, V284, P17129, DOI 10.1074/jbc.M109.004317; Daghestani HN, 2010, SENSORS-BASEL, V10, P9630, DOI 10.3390/s101109630; Das A, 2009, ANAL CHEM, V81, P3754, DOI 10.1021/ac802612z; Derbise A, 2004, INFECT IMMUN, V72, P94, DOI 10.1128/IAI.72.1.94-105.2004; Ehinger S, 2004, J MOL BIOL, V343, P997, DOI 10.1016/j.jmb.2004.08.088; Feng XY, 2013, ANAL CHEM, V85, P2370, DOI 10.1021/ac303392a; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Fox D, 2001, MED MYCOL, V39, P495, DOI 10.1080/714031070; Hirst DJ, 2011, EUR BIOPHYS J BIOPHY, V40, P503, DOI 10.1007/s00249-010-0664-1; Karbassi F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008810; Kornblatt JA, 2005, BIOCHEMISTRY-US, V44, P13122, DOI 10.1021/bi050895y; Kornblatt JA, 2007, ANAL CHEM INSIGHTS, V2, P17; Kornblatt JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135754; Kornblatt MJ, 2013, YEAST, V30, P55, DOI 10.1002/yea.2940; Kornblatt MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028481; Law RHP, 2012, CELL REP, V1, P185, DOI 10.1016/j.celrep.2012.02.012; Lee TH, 2010, BBA-BIOMEMBRANES, V1798, P544, DOI 10.1016/j.bbamem.2010.01.014; Lottenberg Richard, 1994, Trends in Microbiology, V2, P20, DOI 10.1016/0966-842X(94)90340-9; Lu Q, 2012, PROTEIN CELL, V3, P769, DOI 10.1007/s13238-012-2040-7; Mayer KM, 2011, CHEM REV, V111, P3828, DOI 10.1021/cr100313v; McGurn LD, 2016, BIOCHEM J, V473, P4559, DOI 10.1042/BCJ20160773; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Philo JS, 2006, AAPS J, V8, pE564, DOI 10.1208/aapsj080365; Philo JS, 2006, ANAL BIOCHEM, V354, P238, DOI 10.1016/j.ab.2006.04.053; Piazza M., 2016, BIOCHEMISTRY; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P., 2016, SEDIMENTATION VELOCI, V1, P1; Schuck P., 2015, BASIC PRINCIPLES ANA, V1, P1; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Sumitomo T, 2016, SCI REP-UK, V6, DOI 10.1038/srep20069; Swann MJ, 2004, ANAL BIOCHEM, V329, P190, DOI 10.1016/j.ab.2004.02.019; Xue Y, 2012, J THROMB HAEMOST, V10, P1385, DOI 10.1111/j.1538-7836.2012.04765.x; Yonzon CR, 2004, J AM CHEM SOC, V126, P12669, DOI 10.1021/ja047118q; Zhao HY, 2011, METHODS, V54, P16, DOI 10.1016/j.ymeth.2011.01.010; Zhao J, 2006, NANOMEDICINE-UK, V1, P219, DOI 10.2217/17435889.1.2.219; Zhao J, 2006, J AM CHEM SOC, V128, P11004, DOI 10.1021/ja0636082	47	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0206338	10.1371/journal.pone.0206338	http://dx.doi.org/10.1371/journal.pone.0206338			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653526	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000456015500007
J	Shen, KY; Vesey, DA; Ellis, RJ; Del Vecchio, SJ; Cho, Y; Teixeira-Pinto, A; McGuckin, MA; Johnson, DW; Gobe, GC				Shen, Kunyu; Vesey, David A.; Ellis, Robert J.; Del Vecchio, Sharon Juliet; Cho, Yeoungjee; Teixeira-Pinto, Armando; McGuckin, Michael A.; Johnson, David W.; Gobe, Glenda C.			GRP78 expression in tumor and perinephric adipose tissue is not an optimal risk stratification marker for clear cell renal cell carcinoma	PLOS ONE			English	Article							QUANTIFICATION; PATHOLOGY; STRESS	Objective Clear cell renal cell carcinoma (ccRCC) is the most common subtype of kidney cancer, which is difficult to treat and lacks a reliable prognostic marker. A previous study showed that the endoplasmic reticulum stress marker, glucose-regulated-protein-78 (GRP78), is a potential prognostic marker for ccRCC. The present study aimed to: (1) examine whether GRP78 was upregulated in ccRCC compared with matched non-neoplastic renal tissue; and (2) investigate whether GRP78 expression in ccRCC tissue or perinephric adipose tissue has any association with ccRCC aggressiveness. Methods A retrospective cross-sectional study of 267 patients who underwent nephrectomy for renal tumors between June 2013 and October 2017 was conducted at Princess Alexandra Hospital, Brisbane, Australia. Software-assisted quantification of average grey value of staining intensity (staining intensity method) and proportion of positive pixels (positive pixel method) was applied to measure expression of GRP78 in archived specimens of renal tumor tissues (n = 114), adjacent non-neoplastic renal tissues (n = 68), and perinephric adipose tissues (n = 60) in participants diagnosed with ccRCC. Results GRP78 was not upregulated in renal tumor tissue compared with paired normal renal tissue. In tumor tissue, GRP78 expression did not show any association with ccRCC aggressiveness using either quantification method. In adipose tissue, downregulation of GRP78 demonstrated poor correlation with increased probability of metastasis, with one unit increase in average grey value of GRP78 staining weakly correlating with a 17% increase in the odds ratio of metastasis (95% confidence interval: 0.99 to 1.38, p = 0.07). Conclusion GRP78 is not valuable as a risk stratification marker for ccRCC.	[Shen, Kunyu; Vesey, David A.; Ellis, Robert J.; Del Vecchio, Sharon Juliet; Johnson, David W.; Gobe, Glenda C.] Univ Queensland, Ctr Kidney Dis Res, Brisbane, Qld, Australia; [Shen, Kunyu; Vesey, David A.; Ellis, Robert J.; Del Vecchio, Sharon Juliet; Johnson, David W.; Gobe, Glenda C.] Translat Res Inst, Brisbane, Qld, Australia; [Vesey, David A.; Ellis, Robert J.; Cho, Yeoungjee; Johnson, David W.] Princess Alexandra Hosp, Dept Nephrol, Brisbane, Qld, Australia; [Teixeira-Pinto, Armando] Childrens Hosp Westmead, Ctr Kidney Res, Kids Res, Westmead, NSW, Australia; [Teixeira-Pinto, Armando] Univ Sydney, Sch Publ Hlth, Fac Med & Hlth, Sydney, NSW, Australia; [McGuckin, Michael A.] Univ Melbourne, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia	University of Queensland; University of Sydney; University of Sydney; University of Melbourne	Gobe, GC (corresponding author), Univ Queensland, Ctr Kidney Dis Res, Brisbane, Qld, Australia.; Gobe, GC (corresponding author), Translat Res Inst, Brisbane, Qld, Australia.	g.gobe@uq.edu.au	McGuckin, Michael/G-2310-2010; Vesey, David A/C-2253-2011; Cho, Yeoungjee/G-6176-2013; Teixeira-Pinto, Armando/H-7947-2013; Ellis, Robert/C-7335-2016; Johnson, David/F-2897-2011	McGuckin, Michael/0000-0002-8375-2675; Vesey, David A/0000-0002-2856-6650; Cho, Yeoungjee/0000-0002-3502-9837; Teixeira-Pinto, Armando/0000-0002-9389-2516; Ellis, Robert/0000-0002-9755-9913; Johnson, David/0000-0001-5491-3460	China Scholarship Council [2016008440278]; Australian Government; Australian National Health and Medical Research Council	China Scholarship Council(China Scholarship Council); Australian Government(Australian GovernmentCGIAR); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	We acknowledge that the China Scholarship Council provides a PhD stipend for Kunyu Shen (File No. 2016008440278). An Australian Government Research Training Stipend was provided for Robert Ellis. An Australian National Health and Medical Research Council Practitioner Fellowship was provided for David Johnson".	Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Choi Y, 2013, INT J CANCER, V132, P625, DOI 10.1002/ijc.27639; Clapp WL, 2012, HISTOLOGY PATHOLOGIS, P893; Clarke HJ, 2014, CANCER CELL, V25, P563, DOI 10.1016/j.ccr.2014.03.015; Delahunt B, 2013, AM J SURG PATHOL, V37, P1490, DOI 10.1097/PAS.0b013e318299f0fb; Ellis Robert J, 2017, Asian Pac J Cancer Prev, V18, P3281; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fowler C, 2001, IMAGING, V13, P27; Fu WJ, 2010, UROLOGY, V75, P603, DOI 10.1016/j.urology.2009.05.007; Kim Y, 2009, CURR MOL MED, V9, P425, DOI 10.2174/156652409788167113; Labno, 2018, BAS INT QUANT IMAGEJ; Li T, 2016, CLIN GENITOURIN CANC, V14, pE553, DOI 10.1016/j.clgc.2016.03.017; Matsuo K, 2012, GYNECOL ONCOL; Moras M, 2017, FRONT PHYSIOL, V8, DOI [10.3389/FPHYS.2017.01076, 10.3389/fphys.2017.01076]; Muglia Valdair F., 2015, Radiol Bras, V48, P166, DOI 10.1590/0100-3984.2013.1927; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Patel HD, 2016, J UROLOGY, V195, P1340, DOI 10.1016/j.juro.2015.11.029; Pereira ER, 2014, J BIO CHEM; Rangan GK, 2007, NEPHROLOGY, V12, P553, DOI 10.1111/j.1440-1797.2007.00855.x; Samali A, 2010, INT J CELL BIOL, V2010, P11; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shu J, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-016-0161-6; Van Drie John H, 2011, Chin J Cancer, V30, P124; Vegiopoulos A, 2017, EMBO J, V36, P1999, DOI 10.15252/embj.201696206; Zhong YP, 2016, ONCOL LETT, V12, P2702, DOI 10.3892/ol.2016.5005	25	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210246	10.1371/journal.pone.0210246	http://dx.doi.org/10.1371/journal.pone.0210246			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653515	Green Published, gold			2022-12-26	WOS:000456015500030
J	Kislaya, I; Rodrigues, AP; Sousa-Uva, M; Gomez, V; Goncalves, P; Froes, F; Nunes, B				Kislaya, Irina; Rodrigues, Ana Paula; Sousa-Uva, Mafalda; Gomez, Veronica; Goncalves, Paulo; Froes, Filipe; Nunes, Baltazar			Indirect effect of 7-valent and 13-valent pneumococcal conjugated vaccines on pneumococcal pneumonia hospitalizations in elderly	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; VACCINATION; POPULATION; ADULTS; SEROTYPES; DISEASE; BURDEN; TRENDS; IMPACT; USA	Background Pneumonia is one of the leading causes of mortality and has a high burden in morbidity. In Portugal, 7-valent pneumococcal conjugated vaccine (PCV) was used since 2001 and PCV10/13 since 2009, being the last introduced into the National Immunization Program in 2015. Methods We conducted an ecological study to evaluate the impact of PCV7 and PCV13 on pneumococcal pneumonia (PP) hospitalizations in adults aged 65 years or more in Portugal. National hospital discharge registry data from 1998/99 to 2015/16 were used, and PP hospitalization was defined as any hospitalization coded in primary diagnosis as 481 (ICD-9-CM) or J18 (ICD-10-CM). Poisson regression models adjusted for seasonality, influenza-like illness and allowing for overdispersion was used to estimate annual average change of PP hospitalization rate. To assess PP hospitalization trends before and after PCV7 and PCV13 introduction interrupted time series analysis was performed. Results In 1998/99 PP hospitalization rate was 7.0 per 10,000 inhabitants, varying between 3.2 (females, 65-74 years) to 20.7 (males, + 85 years), and annually increasing by 16% during the pre-PCV7 period. Statistically significant reduction of 14% per year in PP hospitalization rate was observed after PCV7 introduction. Between 2004/05 and 2009/10 PP hospitalization rate decreased annually by 4% and after PCV13 introduction by 11% per year. In 2015/ 16 we found an overall reduction of 2.9 (CI 95%: 2.7; 3.1) PP hospitalizations per 10,000 inhabitants (598 hospitalizations) attributable to PCV13, varying from 2.2 (CI 95%: 1.3; 3.1) (female, 65-74 years) to 5.6 (CI 95%: 3.8; 7.5) (female, + 85 years). Conclusions Our results suggest that introduction of both PCV7 and PCV13 vaccines resulted in the reduction of PP hospitalizations rates among older adults.	[Kislaya, Irina; Rodrigues, Ana Paula; Sousa-Uva, Mafalda; Gomez, Veronica; Nunes, Baltazar] Inst Nacl Saude Doutor Ricardo Jorge, Dept Epidemiol, Lisbon, Portugal; [Kislaya, Irina; Sousa-Uva, Mafalda; Nunes, Baltazar] Univ Nova Lisboa, Escola Nacl Saude Publ, Ctr Invest Saude Publ, Lisbon, Portugal; [Goncalves, Paulo] Inst Nacl Saude Doutor Ricardo Jorge, Dept Doencas Infecciosas, Lisbon, Portugal; [Froes, Filipe] Ctr Hosp Lisboa Norte, Thorax Dept, Lisbon, Portugal	Instituto Nacional de Saude Dr. Ricardo Jorge; Universidade Nova de Lisboa; Instituto Nacional de Saude Dr. Ricardo Jorge; Universidade de Lisboa	Rodrigues, AP (corresponding author), Inst Nacl Saude Doutor Ricardo Jorge, Dept Epidemiol, Lisbon, Portugal.	ana.rodrigues@insa.min-saude.pt	Froes, Filipe/F-6607-2015; Kislaya, Irina/AFK-6244-2022; Kislaya, Irina/GSE-3763-2022; Kislaya, Irina/AAG-4539-2022; Kislaya, Irina/GVS-9537-2022; Gonçalves, Paulo B/G-9818-2012	Froes, Filipe/0000-0003-4135-6022; Kislaya, Irina/0000-0001-5772-2416; Kislaya, Irina/0000-0001-5772-2416; Kislaya, Irina/0000-0001-5772-2416; Gonçalves, Paulo B/0000-0002-0671-1466; Nunes, Baltazar/0000-0001-6230-7209; GONCALVES, PAULO/0000-0002-4633-6306	European Union's Horizon 2020 research and innovation programme [634446]	European Union's Horizon 2020 research and innovation programme	This work is part of I-MOVE+ (Integrated Monitoring of Vaccines in Europe) project that received funding from the European Union's Horizon 2020 research and innovation programme [grant agreement number 634446].	Aguiar SI, 2008, CLIN MICROBIOL INFEC, V14, P835, DOI 10.1111/j.1469-0691.2008.02031.x; Barreto M, 2016, 1O INQUERITO NACL SA; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; Direcao Geral da Saude (DGS), 2015, NORM 012 2015; Direcao Geral da Saude (DGS), 2015, NORM 08 2015; Geral da Saude (DGS), 2015, 0122015 DGS; Hammitt LL, 2006, J INFECT DIS, V193, P1487, DOI 10.1086/503805; Horacio AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103092; Horacio AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073704; Huss A, 2009, CAN MED ASSOC J, V180, P48, DOI 10.1503/cmaj.080734; Instituto Nacional de Estatistica, 2017, CAM HOSP 100000 HAB; Instituto Nacional de Estatistica (INE), 2014, POP SEX GRUP ET AN; Instituto Nacional de Estatistica (INE), 2015, CAM HOSP 100000 HAB; International Classification of Diseases, 9 REV CLIN MOD; Lindenauer PK, 2012, JAMA-J AM MED ASSOC, V307, P1405, DOI 10.1001/jama.2012.384; Menzies RI, 2015, CLIN INFECT DIS, V61, P927, DOI 10.1093/cid/civ429; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Nair H, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1693-x; Okasha O, 2018, THORAX, V73, P262, DOI 10.1136/thoraxjnl-2017-210440; Palmu AA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172690; Queiros L, 2004, ACTA MEDICA PORT, V17, P49; Rodrigo C, 2015, EUR RESPIR J, V45, P1632, DOI 10.1183/09031936.00183614; Rodrigues E, 2018, INFLUENZA OTHER RESP, V12, P153, DOI 10.1111/irv.12501; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; Shiri T, 2017, LANCET GLOB HEALTH, V5, pE51, DOI 10.1016/S2214-109X(16)30306-0; Shivaji T, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.50.20991; Simonsen L, 2014, LANCET RESP MED, V2, P387, DOI 10.1016/S2213-2600(14)70032-3; Simonsen L, 2011, MBIO, V2, DOI 10.1128/mBio.00309-10; Smith SB, 2014, JAMA INTERN MED, V174, P1837, DOI 10.1001/jamainternmed.2014.4344; Thorrington D, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1004-z; Tsaban G, 2017, VACCINE, V35, P2882, DOI 10.1016/j.vaccine.2017.04.032; van Werkhoven CH, 2016, VACCINE, V34, P3275, DOI 10.1016/j.vaccine.2016.05.002; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; World Health Organization, 2008, TOP 10 CAUS DEATHS; World Health Organization, 2019, INT CLASS DIS; Wroe PC, 2012, J INFECT DIS, V205, P1589, DOI 10.1093/infdis/jis240	36	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209428	10.1371/journal.pone.0209428	http://dx.doi.org/10.1371/journal.pone.0209428			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650091	Green Published, Green Submitted, gold			2022-12-26	WOS:000455813300015
J	Moore, W; Di Giulio, A				Moore, Wendy; Di Giulio, Andrea			Out of the burrow and into the nest: Functional anatomy of three life history stages of Ozaena lemoulti (Coleoptera: Carabidae) reveals an obligate life with ants	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; BEETLES COLEOPTERA; 1ST-INSTAR LARVA; PAUSSINAE; OZAENINI	The carabid subfamily Paussinae contains many species known to be obligately associated with ants during at least one stage of their life history. Myrmecophilous larvae have been documented for members of the tribe Paussini as well as several genera in the tribes Ozaenini, including Physea and Eustra. Here we describe the first instar larva of Ozaena lemoulti, and find it to be the most highly modified ozaenine larva that we have examined to date. Many structures of the larva suggest that it is a myrmecophile. Unlike all other described ozaenine larvae, which live in burrows that they construct and seal with their terminal disk, the completely unique larval morphology suggests Ozaena has adapted to living without the protection of a burrow and therefore must have a completely different feeding strategy than the typical ambush strategy of burrow dwelling larvae. We hypothesize that Ozaena larvae live in association with ants and use their long legs for running within the nest, and modifications of the mouthparts suggest the larva feeds on soft lightly sclerotized prey, such as ant brood. Our findings support an earlier hypothesis that Ozaena is mymecophilous during the adult stage. Comparisons of the functional anatomy of the eggs, larvae and adult between Ozaena lemoulti and the closely related, non-myrmecophilous general arthropod predator, Goniotropis kuntzeni, provide complementary, yet independent, evidence suggestive of this shift in lifestyle. We also examine and molecularly identify gut contents, providing direct evidence that adult Ozaena exclusively eat Camponotus ants. We conclude that Ozaena represents an independent shift to adopting a life of myrmecophily among beetles classified within the carabid subfamily Paussinae and document the morphological changes at each life history stage associated with the shift to a nest parasite lifestyle.	[Moore, Wendy] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Di Giulio, Andrea] Univ Roma Tre, Dept Sci, Rome, Italy	University of Arizona; Italfarmaco; Roma Tre University	Moore, W (corresponding author), Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA.	wmoore@email.arizona.edu		Moore, Wendy/0000-0003-4441-6203				Ball G.E., 1990, Quaestiones Entomologicae, V26, P30; BALL GE, 1990, CAN ENTOMOL, V122, P779, DOI 10.4039/Ent122779-9; BOUSQUET Y, 1986, CAN ENTOMOL, V118, P373, DOI 10.4039/Ent118373-4; BOUSQUET Y, 1984, CAN J ZOOL, V62, P573, DOI 10.1139/z84-085; Brandmayr T. Zetto, 1993, Tropical Zoology, V6, P299; CoSTA C, 1988, LARVAS COLEPTERA BRA; DARLINGTON P. J., 1950, TRANS AMER ENT SOC, V76, P47; Debout G, 2007, BIOL J LINN SOC, V90, P319, DOI 10.1111/j.1095-8312.2007.00728.x; Di Giulio A, 2017, RAFFLES B ZOOL, V65, P49; Di Giulio A, 2004, INVERTEBR SYST, V18, P101, DOI 10.1071/IS03028; Di Giulio A, 2003, SYST ENTOMOL, V28, P509, DOI 10.1046/j.1365-3113.2003.00227.x; Di Giulio A, 2001, TROP ZOOL, V14, P157, DOI 10.1080/03946975.2001.10531149; Di Giulio A, 2008, ZOOTAXA, P37; Di Giulio A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130541; Di Giulio A, 2014, EUR J ENTOMOL, V111, P692, DOI 10.14411/eje.2014.083; Di Giulio A, 2011, EUR J ENTOMOL, V108, P127, DOI 10.14411/eje.2011.016; Di Giulio A, 2009, AUST J ENTOMOL, V48, P140, DOI 10.1111/j.1440-6055.2009.00698.x; Di Giulio Andrea, 2000, P89; Erwin T.L., 1979, P479; ERWIN T L, 1981, Coleopterists Bulletin, V35, P53; Geiselhardt SF, 2007, NATURWISSENSCHAFTEN, V94, P871, DOI 10.1007/s00114-007-0271-x; Giglio A, 2008, ZOOL ANZ, V247, P209, DOI 10.1016/j.jcz.2007.12.001; Green P, 2002, PHRED VERSION 002042; Harris R.A., 1979, California Department of Food and Agriculture Laboratory Services-Entomology Occasional Papers, P1; Hinton H.E., 1981, BIOL INSECT EGGS, VI; Holldobler B., 1990, pi; Kaupp Andreas, 2000, P111; Lawrence J.F., 1991, IMMATURE INSECTS, V2, P144; Luna de Carvalho E, 1992, ELYTRON, V5, P285; Luna de Carvalho E, 1989, MEMORIAS I INVESTIGA; Maddison DR, 2017, CHROMASEQ MESQUITE P; Maddison W.P., 2018, MESQUITE MODULAR SYS; Maurizi E., 2012, Psyche: A Journal of Entomology, V2012, P940315, DOI 10.1155/2012/940315; Moore W, 2006, ZOOTAXA, P1; Moore W, 2008, ANN CARNEGIE MUS, V77, P79, DOI 10.2992/0097-4463-77.1.79; Moore W, 2008, PAN-PAC ENTOMOL, V84, P33, DOI 10.3956/2007-32.1; Moore W, 2014, CURR BIOL, V24, P2435, DOI 10.1016/j.cub.2014.09.022; Moore W, 2011, ZOOKEYS, P63, DOI 10.3897/zookeys.90.1136; Nagel P., 1979, MISCELLANEOUS PAPERS LANDBOUWHOGESCHOOL WAGENINGEN, P15; Oberprieler RG, 1985, INSECTS SO AFRICA, P196; Parker J, 2016, MYRMECOL NEWS, V22, P65; Robertson JA, 2017, SYST ENTOMOL, V42, P134, DOI 10.1111/syen.12205; Song XB, 2018, ZOOKEYS, P45, DOI 10.3897/zookeys.740.20458	43	3	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209790	10.1371/journal.pone.0209790	http://dx.doi.org/10.1371/journal.pone.0209790			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650132	Green Published, gold, Green Submitted			2022-12-26	WOS:000455813300027
J	Williams, KC; Cepeda, MA; Javed, S; Searle, K; Parkins, KM; Makela, AV; Hamilton, AM; Soukhtehzari, S; Kim, Y; Tuck, AB; Ronald, JA; Foster, PJ; Chambers, AF; Leong, HS				Williams, Karla C.; Cepeda, Mario A.; Javed, Sumreen; Searle, Karlee; Parkins, Katie M.; Makela, Ashley V.; Hamilton, Amanda M.; Soukhtehzari, Sepideh; Kim, Yohan; Tuck, Alan B.; Ronald, John A.; Foster, Paula J.; Chambers, Ann F.; Leong, Hon S.			Invadopodia are chemosensing protrusions that guide cancer cell extravasation to promote brain tropism in metastasis	ONCOGENE			English	Article							BREAST-CANCER; THERAPEUTIC TARGET; LIGHT-CHAIN; PROSTATE-CANCER; IN-VIVO; PHOSPHORYLATION; INVASION; KINASE; PAK1; ACTIVATION	Invadopodia are cell protrusions that mediate cancer cell extravasation but the microenvironmental cues and signaling factors that induce invadopodia formation during extravasation remain unclear. Using intravital imaging and loss of function experiments, we determined invadopodia contain receptors involved in chemotaxis, namely GABA receptor and EGFR. These chemotaxis capabilities are mediated in part by PAK1 which controls invadopodia responsiveness to ligands such as GABA and EGF via assembly, stability, and turnover of invadopodia in vivo. PAK1 knockdown rendered cells unresponsive to chemotactic stimuli present in the stroma, resulting in dramatically lower rates of cancer cell extravasation and metastatic colony formation compared to stimulated cancer cells. In an experimental mouse model of brain metastasis, inhibition of PAK1 significantly reduced overall tumor burden and reduced the average size of brain metastases. In summary, invadopodia contain chemotaxis receptors that can respond to microenvironmental cues to guide cancer cell extravasation, and when PAK1 is depleted, brain tropism of metastatic breast cancer cells is significantly reduced, blocking secondary colony growth at sites otherwise permissive for metastatic outgrowth.	[Williams, Karla C.; Cepeda, Mario A.; Searle, Karlee; Kim, Yohan; Leong, Hon S.] Western Univ, Schulich Sch Med & Dent, Dept Surg, Div Urol, London, ON, Canada; [Williams, Karla C.; Cepeda, Mario A.; Leong, Hon S.] Lawson Hlth Res Inst, Translat Prostate Canc Res Lab, London, ON, Canada; [Williams, Karla C.; Tuck, Alan B.; Chambers, Ann F.] Lawson Hlth Res Inst, Translat Breast Canc Res Unit, London, ON, Canada; [Williams, Karla C.; Javed, Sumreen; Searle, Karlee; Soukhtehzari, Sepideh] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [Cepeda, Mario A.; Leong, Hon S.] Mayo Clin, Dept Urol, Rochester, MN 55905 USA; [Parkins, Katie M.; Makela, Ashley V.; Hamilton, Amanda M.; Ronald, John A.; Foster, Paula J.] Western Univ, Schulich Sch Med & Dent, Dept Med Biophys, London, ON, Canada; [Parkins, Katie M.; Makela, Ashley V.; Hamilton, Amanda M.; Ronald, John A.; Foster, Paula J.] Western Univ, Robarts Res Inst, London, ON, Canada; [Tuck, Alan B.; Chambers, Ann F.] Western Univ, Schulich Sch Med & Dent, Dept Oncol, London, ON, Canada; [Tuck, Alan B.; Chambers, Ann F.] Western Univ, Schulich Sch Med & Dent, Dept Pathol & Lab Med, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); University of British Columbia; Mayo Clinic; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Williams, KC; Leong, HS (corresponding author), Western Univ, Schulich Sch Med & Dent, Dept Surg, Div Urol, London, ON, Canada.; Williams, KC; Leong, HS (corresponding author), Lawson Hlth Res Inst, Translat Prostate Canc Res Lab, London, ON, Canada.; Williams, KC (corresponding author), Lawson Hlth Res Inst, Translat Breast Canc Res Unit, London, ON, Canada.; Williams, KC (corresponding author), Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada.; Leong, HS (corresponding author), Mayo Clin, Dept Urol, Rochester, MN 55905 USA.	karla.williams@ubc.ca; leong.hon@mayo.edu	Ronald, John A/B-7123-2008	Ronald, John A/0000-0003-3665-173X; Williams, Karla/0000-0003-2954-2869; Leong, Hon/0000-0001-7801-1402	OICR High Impact Grant [SPS 0613-03]; Movember/PCC Rising Star Grants [RS-2013-55, RS-2016-1011]; CIHR Postdoctoral Fellowship [140880]; Breast Cancer Society of Canada	OICR High Impact Grant; Movember/PCC Rising Star Grants; CIHR Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); Breast Cancer Society of Canada	This work was supported by an OICR High Impact Grant (SPS 0613-03), Movember/PCC Rising Star Grants (RS-2013-55 and RS-2016-1011) awarded to H.S.L., CIHR Postdoctoral Fellowship (140880) awarded to K.C.W., and the Breast Cancer Society of Canada (K.C.W., K.P., A.M.).	Artym VV, 2015, J CELL BIOL, V208, P331, DOI 10.1083/jcb.201405099; Artym Vira V., 2009, V522, P211, DOI 10.1007/978-1-59745-413-1_15; Badowski C, 2008, MOL BIOL CELL, V19, P633, DOI 10.1091/mbc.E06-01-0088; BAND V, 1990, CANCER RES, V50, P7351; Barry DJ, 2015, J CELL BIOL, V209, P163, DOI 10.1083/jcb.201501081; Beach JR, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-52; Bowden ET, 1999, ONCOGENE, V18, P4440, DOI 10.1038/sj.onc.1202827; Burger KL, 2014, PROSTATE, V74, P134, DOI 10.1002/pros.22735; Calle Y, 2006, J CELL SCI, V119, P2375, DOI 10.1242/jcs.02939; Cepeda MA, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0547-x; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chew TL, 1998, J MUSCLE RES CELL M, V19, P839, DOI 10.1023/A:1005417926585; Coniglio SJ, 2008, MOL CELL BIOL, V28, P4162, DOI 10.1128/MCB.01532-07; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Gligorijevic B, 2012, J CELL SCI, V125, P724, DOI 10.1242/jcs.092726; Goicoechea SM, 2017, J CELL SCI, V130, P1064, DOI 10.1242/jcs.195552; Heyn C, 2006, MAGN RESON MED, V56, P1001, DOI 10.1002/mrm.21029; Jeannot P, 2017, ELIFE, V6, DOI [10.7554/eLife.22207, 10.7554/eLife.22207.001]; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Kim Y, 2016, NAT PROTOC, V11, P937, DOI 10.1038/nprot.2016.050; KOOP S, 1995, CANCER RES, V55, P2520; Koop S, 1996, P NATL ACAD SCI USA, V93, P11080, DOI 10.1073/pnas.93.20.11080; Leong HS, 2014, CELL REP, V8, P1558, DOI 10.1016/j.celrep.2014.07.050; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Lohmer LL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005786; Lohmer LL, 2014, CELL ADHES MIGR, V8, P246, DOI 10.4161/cam.28406; MORRIS VL, 1994, CLIN EXP METASTAS, V12, P357, DOI 10.1007/BF01755879; Moshfegh Y, 2014, NAT CELL BIOL, V16, P571, DOI 10.1038/ncb2972; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Murrell DH, 2015, TRANSL ONCOL, V8, P176, DOI 10.1016/j.tranon.2015.03.009; Neman J, 2014, P NATL ACAD SCI USA, V111, P984, DOI 10.1073/pnas.1322098111; Nicholas NS, 2016, ONCOTARGET, V7, P70881, DOI 10.18632/oncotarget.12282; Parkins KM, 2016, SCI REP-UK, V6, DOI 10.1038/srep35889; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Sharma VP, 2013, CURR BIOL, V23, P2079, DOI 10.1016/j.cub.2013.08.044; Sizemore GM, 2014, J BIOL CHEM, V289, P24102, DOI 10.1074/jbc.M114.593582; Souter LH, 2010, LAB INVEST, V90, P1247, DOI 10.1038/labinvest.2010.97; Steffen A, 2008, CURR BIOL, V18, P926, DOI 10.1016/j.cub.2008.05.044; Stoletov K, 2015, EXPERT REV ANTICANC, V15, P733, DOI 10.1586/14737140.2015.1058711; Stoletov K, 2014, AM J CLIN EXP UROL, V2, P45; Stylli SS, 2009, J CELL SCI, V122, P2727, DOI 10.1242/jcs.046680; Takizawa N, 2002, BIOCHEM BIOPH RES CO, V297, P773, DOI 10.1016/S0006-291X(02)02302-1; van den Dries K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2402; Viaud J, 2009, MOL CANCER THER, V8, P2559, DOI 10.1158/1535-7163.MCT-09-0102; Williams KC, 2016, CONVERG SCI PHYS ONC, V2, DOI 10.1088/2057-1739/2/2/023001; Williams KC, 2014, MOL BIOL CELL, V25, P2061, DOI 10.1091/mbc.E13-10-0582; Williams KC, 2014, J CELL SCI, V127, P1712, DOI 10.1242/jcs.134734; Wirth A, 2003, J PHYSIOL-LONDON, V549, P489, DOI 10.1113/jphysiol.2002.033167; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927; Zhang QB, 2010, INT J CANCER, V126, P2534, DOI 10.1002/ijc.24979; 2006, CANCER RES, V66, P3034, DOI DOI 10.1158/0008-5472.CAN-05-2177	53	31	31	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 9	2019	38	19					3598	3615		10.1038/s41388-018-0667-4	http://dx.doi.org/10.1038/s41388-018-0667-4			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HX4OU	30651600	hybrid, Green Published			2022-12-26	WOS:000467379600004
J	Llavero, F; Montoro, ML; Sastre, AA; Fernandez-Moreno, D; Lacerda, HM; Parada, LA; Lucia, A; Zugaza, JL				Llavero, Francisco; Luque Montoro, Miriam; Arrazola Sastre, Alazne; Fernandez-Moreno, David; Lacerda, Hadriano M.; Parada, Luis A.; Lucia, Alejandro; Zugaza, Jose L.			Epidermal growth factor receptor controls glycogen phosphorylase in T cells through small GTPases of the RAS family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epidermal growth factor receptor (EGFR); RAS protein; phosphorylase; adenylate cyclase (adenylyl cyclase); Raf kinase; glycogen phosphorylase; adaptive immunity; GTPase; cAMP-regulated guanine nucleotide exchange factor II (EPAC2); cell signaling	NUCLEOTIDE-EXCHANGE FACTOR; PROTEIN-KINASE-C; ALLOSTERIC TRANSITIONS; TUMOR-GROWTH; CYCLIC-AMP; ACTIVATION; CANCER; EGFR; EPAC; RAP1	We recently uncovered a regulatory pathway of the muscle isoform of glycogen phosphorylase (PYGM) that plays an important role in regulating immune function in T cells. Here, using various enzymatic, pulldown, and immunoprecipitation assays, we describe signaling cross-talk between the small GTPases RAS and RAP1A, member of RAS oncogene family (RAP1) in human Kit 225 lymphoid cells, which, in turn, is regulated by the epidermal growth factor receptor (EGFR). We found that this communication bridge is essential for glycogen phosphorylase (PYG) activation through the canonical pathway because this enzyme is inactive in the absence of adenylyl cyclase type 6 (ADCY6). PYG activation required stimulation of both exchange protein directly activated by cAMP 2 (EPAC2) and RAP1 via RAS and ADCY6 phosphorylation, with the latter being mediated by Raf-1 proto-oncogene, Ser/Thr kinase (RAF1). Consistent with this model, PYG activation was EGFR-dependent and may be initiated by the constitutively active form of RAS. Consequently, PYG activation in Kit 225 T cells could be blocked with specific inhibitors of RAS, EPAC, RAP1, RAF1, ADCY6, and cAMP-dependent protein kinase. Our results establish a new paradigm for the mechanism of PYG activation, which depends on the type of receptor involved.	[Llavero, Francisco; Luque Montoro, Miriam; Arrazola Sastre, Alazne; Zugaza, Jose L.] Univ Basque Country, Achucarro Basque Ctr Neurosci, Sci Pk, E-48940 Leioa, Spain; [Arrazola Sastre, Alazne; Zugaza, Jose L.] Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, Fac Sci & Technol, E-48940 Leioa, Spain; [Fernandez-Moreno, David; Lucia, Alejandro] Hosp 12 Octubre I 12, Res Inst, Madrid 28041, Spain; [Fernandez-Moreno, David; Lucia, Alejandro] Univ Europea Madrid, Fac Sports Sci, Madrid 28670, Spain; [Lacerda, Hadriano M.] Univ Basque Country, Three R Labs, Sci Pk, E-48940 Leioa, Spain; [Parada, Luis A.] Univ Nacl Salta, Inst Patol Expt, A4400, Salta, Argentina; [Zugaza, Jose L.] Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain	University of Basque Country; University of Basque Country; Hospital Universitario 12 de Octubre; European University of Madrid; University of Basque Country; Basque Foundation for Science	Zugaza, JL (corresponding author), Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain.; Llavero, F; Zugaza, JL (corresponding author), Univ Basque Country, Lab Small GTPases & Neurosignalling, Achucarro Basque Ctr Neurosci, Sci Pk,Sede Bldg,Third Floor,Barrio Sarriena S-N, E-48940 Leioa, Spain.	francisco.llavero@ehu.eus; joseluis.zugaza@ehu.es	; Zugaza, Jose L/B-8331-2012	Lucia, Alejandro/0000-0002-5565-0997; Zugaza, Jose L/0000-0002-9000-6398	Foundation "Jesus de Gangoiti y Barrera"; Basque Government Predoctoral Fellowship [PRE-2017-0016]; Spanish Ministry of Economy and Competitiveness (Fondo de Investigaciones Sanitarias (FIS)) [PI15/00558, PI18/00139]; Department of Economic Development and Competitiveness of the Basque Government [KK-2017/00084]; FIS [PI18/00207]	Foundation "Jesus de Gangoiti y Barrera"; Basque Government Predoctoral Fellowship; Spanish Ministry of Economy and Competitiveness (Fondo de Investigaciones Sanitarias (FIS)); Department of Economic Development and Competitiveness of the Basque Government; FIS(Instituto de Salud Carlos III)	Recipient of a fellowship from Foundation "Jesus de Gangoiti y Barrera."; Recipient of Basque Government Predoctoral Fellowship PRE-2017-0016.; Supported by Spanish Ministry of Economy and Competitiveness (Fondo de Investigaciones Sanitarias (FIS)) Grants PI15/00558 and PI18/00139.; Supported by the Department of Economic Development and Competitiveness of the Basque Government Grant KK-2017/00084 and FIS Grant PI18/00207.	Andersen B, 2002, BIOCHEM J, V367, P443, DOI 10.1042/BJ20020153; Arrizabalaga O, 2012, J BIOL CHEM, V287, P11878, DOI 10.1074/jbc.M111.297804; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Beazely MA, 2005, MOL PHARMACOL, V67, P250, DOI 10.1124/mol.104.001370; BECKNER SK, 1986, J BIOL CHEM, V261, P3043; BECKNER SK, 1988, J IMMUNOL, V140, P208; BLACK WJ, 1970, BIOCHIM BIOPHYS ACTA, V212, P257, DOI 10.1016/0005-2744(70)90206-8; Caloca MJ, 2008, J BIOL CHEM, V283, P36454, DOI 10.1074/jbc.M803814200; Caloca MJ, 2003, EMBO J, V22, P3326, DOI 10.1093/emboj/cdg316; Chan G, 2009, P NATL ACAD SCI USA, V106, P22369, DOI 10.1073/pnas.0908787106; Chen HJ, 2013, TETRAHEDRON LETT, V54, P1546, DOI 10.1016/j.tetlet.2013.01.024; Chiluiza D, 2013, J BIOL CHEM, V288, P18407, DOI 10.1074/jbc.M113.463059; DAVID ES, 1986, BIOCHIM BIOPHYS ACTA, V880, P78, DOI 10.1016/0304-4165(86)90122-4; de Luna N, 2014, NEUROMUSCULAR DISORD, V24, P1079, DOI 10.1016/j.nmd.2014.08.002; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Fuld S, 2005, EXP CELL RES, V309, P161, DOI 10.1016/j.yexcr.2005.05.016; Goldberg L, 2009, J MED CHEM, V52, P197, DOI 10.1021/jm801165r; Hariharan IK, 2005, DEV CELL, V8, P303, DOI 10.1016/j.devcel.2005.02.006; HORI T, 1987, BLOOD, V70, P1069; Imperial R, 2019, SEMIN CANCER BIOL, V54, P14, DOI 10.1016/j.semcancer.2017.11.016; KEPPENS S, 1975, FEBS LETT, V51, P29, DOI 10.1016/0014-5793(75)80848-9; Kesanakurti D, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.182; Krebs E G, 1981, Curr Top Cell Regul, V18, P401; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Lan RY, 2008, J AUTOIMMUN, V31, P7, DOI 10.1016/j.jaut.2008.03.002; Lanaya H, 2014, NAT CELL BIOL, V16, P972, DOI 10.1038/ncb3031; Lim SC, 2017, KOREAN J PHYSIOL PHA, V21, P397, DOI 10.4196/kjpp.2017.21.4.397; Liu C, 2008, MOL CELL BIOL, V28, P7109, DOI 10.1128/MCB.01060-08; Llavero F, 2016, CELL SIGNAL, V28, P1713, DOI 10.1016/j.cellsig.2016.07.014; Llavero F, 2015, J BIOL CHEM, V290, P9171, DOI 10.1074/jbc.M114.608414; MADSEN NB, 1978, J BIOL CHEM, V253, P9097; Mahtouk K, 2005, ONCOGENE, V24, P3512, DOI 10.1038/sj.onc.1208536; Maillet M, 2003, NAT CELL BIOL, V5, P633, DOI 10.1038/ncb1007; Martinelli E, 2017, CANCER TREAT REV, V53, P61, DOI 10.1016/j.ctrv.2016.12.001; McInerney M, 2002, BBA-GEN SUBJECTS, V1570, P53, DOI 10.1016/S0304-4165(02)00154-X; Minutti CM, 2017, IMMUNITY, V47, P710, DOI 10.1016/j.immuni.2017.09.013; Miquel K, 1997, CANCER RES, V57, P1846; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Muller MS, 2015, GLIA, V63, P154, DOI 10.1002/glia.22741; Riely GJ, 2011, J THORAC ONCOL, V6, P1435, DOI 10.1097/JTO.0b013e318223c099; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Scholes AGM, 2001, ARCH OPHTHALMOL-CHIC, V119, P373, DOI 10.1001/archopht.119.3.373; Simanshu DK, 2017, CELL, V170, P17, DOI 10.1016/j.cell.2017.06.009; Slack Cathy, 2017, Nutr Healthy Aging, V4, P195, DOI 10.3233/NHA-160021; Stork PJS, 2005, BLOOD, V106, P2952, DOI 10.1182/blood-2005-03-1062; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Vogt A, 1997, J BIOL CHEM, V272, P27224, DOI 10.1074/jbc.272.43.27224; WANG JH, 1968, J BIOL CHEM, V243, P4641; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wery-Zennaro S, 2000, ONCOGENE, V19, P1596, DOI 10.1038/sj.onc.1203458; Yarden Y, 2001, EUR J CANCER, V37, pS3; Zaiss DMW, 2013, IMMUNITY, V38, P275, DOI 10.1016/j.immuni.2012.09.023; Zaldua N, 2007, FEBS LETT, V581, P5814, DOI 10.1016/j.febslet.2007.11.053; Zhu YM, 2015, SCI REP-UK, V5, DOI 10.1038/srep09344; Zugaza JL, 2004, ONCOGENE, V23, P5823, DOI 10.1038/sj.onc.1207768; Zundelevich A, 2007, MOL CANCER THER, V6, P1765, DOI 10.1158/1535-7163.MCT-06-0706	58	8	8	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4345	4358		10.1074/jbc.RA118.005997	http://dx.doi.org/10.1074/jbc.RA118.005997			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30647127	Green Published, hybrid			2022-12-26	WOS:000462969500006
J	Wang, Z; Song, YD; Li, SB; Kurian, S; Xiang, R; Chiba, T; Wu, XH				Wang, Zi; Song, Yadong; Li, Shibo; Kurian, Sunil; Xiang, Rong; Chiba, Takuya; Wu, Xiaohua			DNA polymerase (POLQ) is important for repair of DNA double-strand breaks caused by fork collapse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA repair; DNA replication stress; genomic instability; breast cancer; inhibitor; ATR kinase; microhomology-mediated end joining; POLQ; DNA double-strand break repair; cancer; genome integrity	END RESECTION; CANCER-CELLS; THETA; REPLICATION; ATR; PATHWAYS; INHIBITION; MECHANISMS; DEFICIENT; LETHAL	DNA polymerase (POLQ) plays an important role in alternative nonhomologous end joining or microhomology-mediated end joining (alt-NHEJ/MMEJ). Here, we show that POLQ is not only required for MMEJ to repair DNA double-strand breaks (DSBs) generated by endonucleases such as I-SceI or Cas9, but is also needed for repair of DSBs derived from DNA nicks generated by Cas9 nickase. Consistently, we found that POLQ deficiency leads to sensitivity to topoisomerase inhibitors that cause DNA single-strand break (SSB) accumulation at replication forks and to ATR inhibitors that induce replication fork collapse. These studies support the function of POLQ in coping with replication stress and repairing DSBs upon fork collapse. POLQ overexpression is present in many cancer types and is associated with poor prognosis, including breast cancer regardless of BRCA1 status. We provide proof-of-concept evidence to support a novel cancer treatment strategy that combines POLQ inhibition with administration of topoisomerase or ATR inhibitors, which induces replication stress and fork collapse. Given the prevalence of POLQ overexpression in tumors, such strategy may have a significant impact on developing targeted cancer treatment.	[Wang, Zi; Song, Yadong; Li, Shibo; Wu, Xiaohua] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA; [Wang, Zi; Chiba, Takuya] Waseda Univ, Fac Human Sci, Biomed Gerontol Lab, 2-579-15 Mikajima, Tokorozawa, Saitama 3591192, Japan; [Song, Yadong; Xiang, Rong] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Kurian, Sunil] Scripps Hlth, Div Organ Transplant, La Jolla, CA 92037 USA	Scripps Research Institute; Waseda University; Nankai University	Wu, XH (corresponding author), Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA.	xiaohwu@scripps.edu	Kurian, Sunil/C-4493-2008	Kurian, Sunil/0000-0002-7782-7263	California Breast Cancer Research Program (CBCRP) [23IB]; National Institutes of Health [CA187052, CA197995, GM080677]; NATIONAL CANCER INSTITUTE [R01CA187052, R01CA197995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080677] Funding Source: NIH RePORTER	California Breast Cancer Research Program (CBCRP); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by California Breast Cancer Research Program (CBCRP) Grant 23IB and National Institutes of Health Grants CA187052, CA197995, and GM080677 (to X. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexander JL, 2016, P NATL ACAD SCI USA, V113, P13809, DOI 10.1073/pnas.1617110113; Anand RP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010397; Black SJ, 2016, GENES-BASEL, V7, DOI 10.3390/genes7090067; Ceccaldi R, 2015, NATURE, V518, P258, DOI 10.1038/nature14184; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; de Rugy TG, 2016, BIOL OPEN, V5, P1485, DOI 10.1242/bio.018028; Goff JP, 2009, RADIAT RES, V172, P165, DOI 10.1667/RR1598.1; Higgins GS, 2018, SCIENCE, V359, P1217, DOI 10.1126/science.aar5149; Higgins GS, 2010, ONCOTARGET, V1, P175, DOI 10.18632/oncotarget.124; Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karnitz LM, 2015, CLIN CANCER RES, V21, P4780, DOI 10.1158/1078-0432.CCR-15-0479; Kawamura K, 2004, INT J CANCER, V109, P9, DOI 10.1002/ijc.11666; Lemee F, 2010, P NATL ACAD SCI USA, V107, P13390, DOI 10.1073/pnas.0910759107; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Livraghi L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0425-1; Mateos-Gomez PA, 2017, NAT STRUCT MOL BIOL, V24, P1116, DOI 10.1038/nsmb.3494; Mateos-Gomez PA, 2015, NATURE, V518, P254, DOI 10.1038/nature14157; Mohni KN, 2014, CANCER RES, V74, P2835, DOI 10.1158/0008-5472.CAN-13-3229; Morgado-Palacin I, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad8243; Nieto-Soler M, 2016, ONCOTARGET, V7, P58759, DOI 10.18632/oncotarget.11643; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Quinet A, 2017, MOL CELL, V68, P830, DOI 10.1016/j.molcel.2017.11.022; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; Roerink SF, 2014, GENOME RES, V24, P954, DOI 10.1101/gr.170431.113; Seki M, 2003, NUCLEIC ACIDS RES, V31, P6117, DOI 10.1093/nar/gkg814; Seol JH, 2018, MUTAT RES-FUND MOL M, V809, P81, DOI 10.1016/j.mrfmmm.2017.07.002; Shima N, 2004, MOL CELL BIOL, V24, P10381, DOI 10.1128/MCB.24.23.10381-10389.2004; Shima N, 2003, GENETICS, V163, P1031; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Sultana R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057098; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Truong LN, 2013, P NATL ACAD SCI USA, V110, P7720, DOI 10.1073/pnas.1213431110; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Wang HL, 2012, J BIOL CHEM, V287, P21471, DOI 10.1074/jbc.M112.355354; Williamson CT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13837; Wyatt DW, 2016, MOL CELL, V63, P662, DOI 10.1016/j.molcel.2016.06.020; Yousefzadeh MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004654; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897	41	47	48	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					3909	3919		10.1074/jbc.RA118.005188	http://dx.doi.org/10.1074/jbc.RA118.005188			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30655289	hybrid, Green Published			2022-12-26	WOS:000461854400009
J	Hippner, P; Sumner, T; Houben, RMGJ; Cardenas, V; Vassall, A; Bozzani, F; Mudzengi, D; Mvusi, L; Churchyard, G; White, RG				Hippner, Piotr; Sumner, Tom; Houben, Rein M. G. J.; Cardenas, Vicky; Vassall, Anna; Bozzani, Fiammetta; Mudzengi, Don; Mvusi, Lindiwe; Churchyard, Gavin; White, Richard G.			Application of provincial data in mathematical modelling to inform sub-national tuberculosis program decision-making in South Africa	PLOS ONE			English	Article							TRANSMISSION; IMPACT; INDIA; CHINA	South Africa has the highest tuberculosis (TB) disease incidence rate in the world, and TB is the leading infectious cause of death. Decisions on, and funding for, TB prevention and care policies are decentralised to the provincial governments and therefore, tools to inform policy need to operate at this level. We describe the use of a mathematical model planning tool at provincial level in a high HIV and TB burden country, to estimate the impact on TB burden of achieving the 90-(90)-90 targets of the Stop TB Partnership Global Plan to End TB. "TIME Impact" is a freely available, user-friendly TB modelling tool. In collaboration with provincial TB programme staff, and the South African National TB Programme, models for three (of nine) provinces were calibrated to TB notifications, incidence, and screening data. Reported levels of TB programme activities were used as baseline inputs into the models, which were used to estimate the impact of scale-up of interventions focusing on screening, linkage to care and treatment success. All baseline models predicted a trend of decreasing TB incidence and mortality, consistent with recent data from South Africa. The projected impacts of the interventions differed by province and were greatly influenced by assumed current coverage levels. The absence of provincial TB burden estimates and uncertainty in current activity coverage levels were key data gaps. A user-friendly modelling tool allows TB burden and intervention impact projection at the sub-national level. Key sub-national data gaps should be addressed to improve the quality of sub-national model predictions.	[Hippner, Piotr; Cardenas, Vicky; Mudzengi, Don; Churchyard, Gavin] Aurum Inst, Johannesburg, South Africa; [Sumner, Tom; Houben, Rein M. G. J.; White, Richard G.] London Sch Hyg & Trop Med, TB Modelling Grp, TB Ctr, London, England; [Sumner, Tom; Houben, Rein M. G. J.; White, Richard G.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Vassall, Anna; Bozzani, Fiammetta] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England; [Mvusi, Lindiwe] Natl Dept Hlth, TB Control & Management, Pretoria, South Africa; [Churchyard, Gavin] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Churchyard, Gavin] South African Med Res Council, Adv Care & Treatment ACT TB HIV, Johannesburg, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand; South African Medical Research Council	Sumner, T (corresponding author), London Sch Hyg & Trop Med, TB Modelling Grp, TB Ctr, London, England.; Sumner, T (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.	tom.sumner@lshtm.ac.uk	Mudzengi, Don/ABC-3042-2021; White, Richard G/D-5407-2009	Mudzengi, Don/0000-0003-2759-3320; White, Richard G/0000-0003-4410-6635; Churchyard, Gavin/0000-0002-4269-3699; Vassall, Anna/0000-0002-2911-1375	Bill and Melinda Gates Foundation (SA Modelling for Policy) [OPP110334]; MRC [MR/P002404/1] Funding Source: UKRI	Bill and Melinda Gates Foundation (SA Modelling for Policy); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Bill and Melinda Gates Foundation (SA Modelling for Policy #OPP110334). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], S AFR TUB DRUG RES S; Avenir Health, 2017, SPECTR GLAST; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Blaser N, 2016, EPIDEMICS-NETH, V14, P54, DOI 10.1016/j.epidem.2015.10.001; Churchyard GJ, 2015, XPERT MTB RIF VERSUS, DOI [10.1016/S2214-109X(15)00100-X, DOI 10.1016/S2214-109X(15)00100-X]; Dowdy DW, 2008, P NATL ACAD SCI USA, V105, P11293, DOI 10.1073/pnas.0800965105; Dye C, 2012, ANN REV PUBLIC H; Gilbert JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126267; Health Systems Trust, 2016, HLTH IND; Houben RMGJ, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0608-4; Houben RMGJ, 2016, LANCET GLOB HEALTH, V4, pE806, DOI [10.1016/s2214-109x(16)30199-1, 10.1016/S2214-109X(16)30199-1]; Knight GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122514; MacPherson P, 2014, B WORLD HEALTH ORGAN, V92, P126, DOI 10.2471/BLT.13.124800; Menzies NA, 2016, LANCET GLOB HEALTH, V4, pE816, DOI [10.1016/S2214-109X(16)30265-0, 10.1016/s2214-109x(16)30265-0]; Nanoo A, 2015, LANCET INFECT DIS, V15, P1066, DOI 10.1016/S1473-3099(15)00147-4; National Department of Health, 2014, NAT TUB MAN GUID 201; National Department of Health South African National AIDS Council, 12016 NAT DEP HLTH S; Pretorius C, 2014, POTENTIAL EFFECTS CH; Shisana O, 2014, S AFRICAN NATL HIV P; Statistics South Africa, 2017, MORT CAUS DEATH S AF; Stop TB Partnership, 2016, PAR SHIFT 2016 2020; Treasury National, 2017, EST NAT EXP 2017; White RG, 2017, IJTLD; WHO, 2017, GLOB TUB REP	24	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0209320	10.1371/journal.pone.0209320	http://dx.doi.org/10.1371/journal.pone.0209320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682028	Green Published, gold, Green Submitted			2022-12-26	WOS:000457037500015
J	Miyoshi, S; Kimura, S; Ootsuki, R; Higaki, T; Nakamasu, A				Miyoshi, Saori; Kimura, Seisuke; Ootsuki, Ryo; Higaki, Takumi; Nakamasu, Akiko			Developmental analyses of divarications in leaves of an aquatic fern Microsorum pteropus and its varieties	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; LEAF DEVELOPMENT; GROWTH; ENDOPOLYPLOIDY; EVOLUTIONARY; PATTERNS; STRATEGY; PROGRAM; TISSUE; MODEL	Plant leaves occur in diverse shapes. Divarication patterns that develop during early growths are one of key factors that determine leaf shapes. We utilized leaves of Microsorum pteropus, a semi-aquatic fern, and closely related varieties to analyze a variation in the divarication patterns. The leaves exhibited three major types of divarication: no lobes, bifurcation, and trifurcation (i.e., monopodial branching). Our investigation of their developmental processes, using time-lapse imaging, revealed localized growths and dissections of blades near each leaf apex. Restricted cell divisions responsible for the apical growths were confirmed using a pulse-chase strategy for EdU labeling assays.	[Miyoshi, Saori; Kimura, Seisuke; Nakamasu, Akiko] Kyoto Sangyo Univ, Dept Bioresource & Environm Sci, Fac Life Sci, Kyoto, Japan; [Kimura, Seisuke] Kyoto Sangyo Univ, Ctr Ecol Evolutionary Dev Biol, Kyoto, Japan; [Ootsuki, Ryo] Komazawa Univ, Fac Arts & Sci, Dept Nat Sci, Tokyo, Japan; [Ootsuki, Ryo; Nakamasu, Akiko] Japan Womens Univ, Fac Chem & Biol Sci, Tokyo, Japan; [Higaki, Takumi] Kumamoto Univ, Int Res Org Adv Sci & Technol, Kumamoto, Japan; [Nakamasu, Akiko] Meiji Univ, Meiji Inst Adv Study Math Sci, Tokyo, Japan	Kyoto Sangyo University; Kyoto Sangyo University; Japan Womens University; Kumamoto University; Meiji University	Nakamasu, A (corresponding author), Kyoto Sangyo Univ, Dept Bioresource & Environm Sci, Fac Life Sci, Kyoto, Japan.; Nakamasu, A (corresponding author), Japan Womens Univ, Fac Chem & Biol Sci, Tokyo, Japan.; Nakamasu, A (corresponding author), Meiji Univ, Meiji Inst Adv Study Math Sci, Tokyo, Japan.	nakamasu@kumamoto-u.ac.jp			Japan Society for the Promotion of Science [12J10320, JP16H01472, JP16K07408, 26650146]; MEXT Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science & Technology of Japan [S1511023]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science & Technology of Japan	The Japan Society for the Promotion of Science provided grants to AK (12J10320), SK (JP16H01472 and JP16K07408), and RO (26650146). MEXT Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science & Technology of Japan provided support to SK (S1511023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriankaja M, 2012, DEV CELL, V22, P64, DOI 10.1016/j.devcel.2011.11.011; Bainard JD, 2011, CHROMOSOME RES, V19, P763, DOI 10.1007/s10577-011-9228-1; Barow M, 2003, PLANT CELL ENVIRON, V26, P571, DOI 10.1046/j.1365-3040.2003.00988.x; Bilsborough GD, 2011, P NATL ACAD SCI USA, V108, P3424, DOI 10.1073/pnas.1015162108; Blume KL, 1828, ENUMERATIO PLANTARUM, P125; Chitwood DH, 2016, CURR BIOL, V26, pR297, DOI 10.1016/j.cub.2016.02.033; Copeland EB, 1929, ORIENTAL GENERA POLY, P111; Das Gupta M, 2015, PLANT CELL, V27, P2785, DOI 10.1105/tpc.15.00196; De Veylder L, 2007, NAT REV MOL CELL BIO, V8, P655, DOI 10.1038/nrm2227; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; GREEN PB, 1976, BOT GAZ, V137, P187, DOI 10.1086/336858; Guo YN, 2014, J PHYSIOL-LONDON, V592, P313, DOI 10.1113/jphysiol.2013.261099; HASEBE M, 1994, P NATL ACAD SCI USA, V91, P5730, DOI 10.1073/pnas.91.12.5730; Ikeuchi M, 2013, AM J BOT, V100, P1116, DOI 10.3732/ajb.1200560; Kawamura E, 2010, PLANT J, V62, P429, DOI 10.1111/j.1365-313X.2010.04156.x; Kotogany E, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-5; Kreier HP, 2008, MOL PHYLOGENET EVOL, V48, P1155, DOI 10.1016/j.ympev.2008.05.001; MELARAGNO JE, 1993, PLANT CELL, V5, P1661, DOI 10.1105/tpc.5.11.1661; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Nakamasu A, 2017, DEV DYNAM, V246, P981, DOI [10.1002/DVDY.24587, 10.1002/dvdy.24587]; Nakamasu A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111615; Nakayama H, 2015, BIO-PROTOCOL, V5, pe1600, DOI DOI 10.21769/BioProtoc.1600; Nakayama H, 2014, PLANT CELL, V26, P4733, DOI 10.1105/tpc.114.130229; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Runions A, 2017, NEW PHYTOL, V216, P401, DOI 10.1111/nph.14449; Steeves TA, 1990, PATTERNS PLANT DEV; Tsukaya H, 2014, CURR OPIN PLANT BIOL, V17, P103, DOI 10.1016/j.pbi.2013.11.012; Warburton D, 2008, NATURE, V453, P733, DOI 10.1038/453733a; Xu H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174946; Yin XF, 2016, NEW PHYTOL, V211, P1462, DOI 10.1111/nph.13980	30	2	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210141	10.1371/journal.pone.0210141	http://dx.doi.org/10.1371/journal.pone.0210141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682033	Green Submitted, Green Published, gold			2022-12-26	WOS:000457037500025
J	Yun, JW; Choi, MJ; Shin, GS; Lim, JO; Noh, JY; Kim, YK; Song, JY; Kim, WJ; Choi, SE; Cheong, HJ				Yun, Jae-Won; Choi, Min Joo; Shin, Gyeong-Seon; Lim, Jae-Ok; Noh, Ji Yun; Kim, Yun-Kyung; Song, Joon Young; Kim, Woo Joo; Choi, Sang-Eun; Cheong, Hee Jin			Cost-effectiveness of influenza vaccine strategies for the elderly in South Korea	PLOS ONE			English	Article							HEALTH STATES; QUADRIVALENT; POPULATION; SAFETY; IMMUNOGENICITY; UTILITY; ADULTS	Objectives Despite a high vaccine uptake rate of over 80% in South Korea, the disease burden of influenza is still high among the elderly, which may be due to low effectiveness of vaccines. Therefore, the cost-effectiveness of use among the elderly was analyzed in order to compare the current trivalent influenza vaccine (TIV) with a quadrivalent influenza vaccine (QIV) or MF59-adjuvanted trivalent influenza vaccine (ATIV). Methods A static lifetime Markov model was used. It was assumed that the model would be repeated until individuals reached the age of 100. Cost-effectiveness was analyzed across three age groups (65-74 years, 75-84 years, and. 85 years), and the at-risk group was studied. Results Compared to the TIV, the QIV was expected to reduce the number of influenza infections by 342,873, complications by 17,011, hospitalizations by 8,568, and deaths by 2,031. The QIV was highly cost-effective when compared to the TIV, with a base case incremental cost-effectiveness ratio (ICER) estimated at USD 17,699/QALY (1USD = 1,151KRW), and the ICER decreased with age and was USD 3,431/QALY in the group aged 85 and above. Sensitivity analysis revealed that the ICER was sensitive to the QIV price, the proportion of influenza B, and vaccine mismatching. On the other hand, the ATIV was expected to reduce the number of influenza cases and complications by 1,812,395 and 89,747, respectively, annually, yielding cost-saving among all ages. ATIV price and vaccine efficacy were the most influential parameters for the ICER of ATIV. Conclusions The QIV and ATIV strategies were considered more cost-effective in comparison to the TIV for vaccination strategies implemented for the elderly. However, owing to a lack of data on the effectiveness of ATIV among the elderly, a large-scale effectiveness study is required.	[Yun, Jae-Won; Choi, Min Joo; Noh, Ji Yun; Song, Joon Young; Kim, Woo Joo; Cheong, Hee Jin] Korea Univ, Coll Med, Guro Hosp, Div Infect Dis,Dept Internal Med, Seoul, South Korea; [Shin, Gyeong-Seon; Lim, Jae-Ok; Choi, Sang-Eun] Korea Univ, Coll Pharm, Sejong, South Korea; [Kim, Yun-Kyung] Korea Univ, Coll Med, Ansan Hosp, Dept Pediat, Ansan, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University; Korea University Medicine (KU Medicine)	Cheong, HJ (corresponding author), Korea Univ, Coll Med, Guro Hosp, Div Infect Dis,Dept Internal Med, Seoul, South Korea.; Choi, SE (corresponding author), Korea Univ, Coll Pharm, Sejong, South Korea.	sechoi@korea.ac.kr; heejinmd@korea.ac.kr		Song, Joon Young/0000-0002-0148-7194; Cheong, Hee Jin/0000-0002-2532-1463	Korea Centers for Disease Control and Prevention [2016-E33009-00]	Korea Centers for Disease Control and Prevention	This research was supported by funding (code 2016-E33009-00) from the Korea Centers for Disease Control and Prevention.	Ambrose CS, 2012, HUM VACC IMMUNOTHER, V8, P81, DOI 10.4161/hv.8.1.17623; Ara R, 2011, VALUE HEALTH, V14, P539, DOI 10.1016/j.jval.2010.10.029; Belongia EA, 2015, VACCINE, V33, P246, DOI 10.1016/j.vaccine.2014.06.052; Bertram MY, 2016, B WORLD HEALTH ORGAN, V94, P925, DOI 10.2471/BLT.15.164418; Choi WS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172012; de Boer PT, 2017, EXPERT REV PHARM OUT, V17, P249, DOI 10.1080/14737167.2017.1343145; de Boer PT, 2016, VALUE HEALTH, V19, P964, DOI 10.1016/j.jval.2016.05.012; Edejer T, 2003, MAKING CHOICES HLTH; Eichner M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2399-4; ERICKSON P, 1995, YEARS HLTH LIFE; Fisman DN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027420; Frey SE, 2014, VACCINE, V32, P5027, DOI 10.1016/j.vaccine.2014.07.013; Garcia A, 2016, HUM VACC IMMUNOTHER, V12, P2269, DOI 10.1080/21645515.2016.1182275; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Gyu SN, 2015, REPORT KOREA HLTH PA; Hutubessy Raymond, 2003, Cost Eff Resour Alloc, V1, P8, DOI 10.1186/1478-7547-1-8; Irving SA, 2012, INFLUENZA OTHER RESP, V6, P37, DOI 10.1111/j.1750-2659.2011.00263.x; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub4; Jung YH, 2009, REPORT KOREA HLTH PA; KCDC, INFL WEEKL ANN REP; Kim JA, 2017, J KOREAN MED SCI, V32, P718, DOI 10.3346/jkms.2017.32.5.718; Kim WJ, 2016, INFLUENZA TRANSGOVER; KISSLING E, 2013, EUROSURVEILLANCE, V18, P33; Korean Centre for Disease Control and Prevention (KCDC), 2015 2016 INFL MAN G; Korean Centre for Disease Control and Prevention (KCDC), 2016, 2016 2017 INFL MAN G; Korean Ministry of Health and Welfare, 2015, RES REPORT; Mannino S, 2012, AM J EPIDEMIOL, V176, P527, DOI 10.1093/aje/kws313; Mauskopf JA, 2000, PHARMACOECONOMICS, V17, P611, DOI 10.2165/00019053-200017060-00007; Moa AM, 2016, VACCINE, V34, P4092, DOI 10.1016/j.vaccine.2016.06.064; Noh JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178010; Park Minah, 2016, Am J Prev Med, V50, pe111, DOI 10.1016/j.amepre.2015.09.028; Prosser LA, 2004, PEDIATRICS, V113, P283, DOI 10.1542/peds.113.2.283; Raviotta JM, 2016, J AM GERIATR SOC, V64, P2126, DOI 10.1111/jgs.14323; Robinson LA, 2017, HEALTH POLICY PLANN, V32, P141, DOI 10.1093/heapol/czw096; SACKETT DL, 1978, J CHRON DIS, V31, P697, DOI 10.1016/0021-9681(78)90072-3; Song JY, 2013, J MED VIROL, V85, P910, DOI 10.1002/jmv.23548; Suh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084121; Thommes EW, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1193-4; Tricco AC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-153; Van Bellinghen LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098437; Villa M, 2013, AM J EPIDEMIOL, V178, P1139, DOI 10.1093/aje/kwt078; Yang MC, 2017, HUM VACC IMMUNOTHER, V13, P81, DOI 10.1080/21645515.2016.1225636	42	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0209643	10.1371/journal.pone.0209643	http://dx.doi.org/10.1371/journal.pone.0209643			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682030	gold, Green Published, Green Submitted			2022-12-26	WOS:000457037500016
J	Sabo, MC; Balkus, JE; Richardson, BA; Srinivasan, S; Kimani, J; Anzala, O; Schwebke, J; Feidler, TL; Fredricks, DN; McClelland, RS				Sabo, Michelle C.; Balkus, Jennifer E.; Richardson, Barbra A.; Srinivasan, Sujatha; Kimani, Joshua; Anzala, Omu; Schwebke, Jane; Feidler, Tina L.; Fredricks, David N.; McClelland, R. Scott			Association between vaginal washing and vaginal bacterial concentrations	PLOS ONE			English	Article							INTRAVAGINAL METRONIDAZOLE; HIV ACQUISITION; INCREASED RISK; AFRICAN WOMEN; VAGINOSIS; INTERVENTION	Vaginal washing is a common practice associated with adverse outcomes including bacterial vaginosis (BV) and HIV infection. Prior studies have not examined the associations between vaginal washing and individual vaginal bacteria, or whether these associations are independent of the effect of vaginal washing on BV. The purpose of this study was to characterize the association between vaginal washing and the presence and concentrations of vaginal bacteria associated with optimal and sub-optimal vaginal states. The analysis utilized data from participants in the placebo arm of the Preventing Vaginal Infections trial, which enrolled HIV-uninfected women from the United States and Kenya. Detection of bacterial taxa associated with BV was compared between visits with versus without reported vaginal washing. The effect of vaginal washing on a number of vaginal bacteria differed substantially (p< 0.05) between the US and Kenya, so results were stratified by country. In US women, vaginal washing was associated with a significantly higher likelihood of detection of BV associated bacterium 1 (BVAB1) (relative risk [RR] 1.55, 95% confidence interval [CI] 1.15-2.09, p = 0.004), BVAB2 (RR 1.99, 95% CI 1.46-2.71, p< 0.001), Mageeibacillus indolicus (RR 2.08, 95% CI 1.46-2.96, p< 0.001), Atopobium vaginae (RR 1.34, 95% CI 1.13-1.59, p = 0.001), Leptotrichia/Sneathia species (RR 1.66, 95% CI 1.33-2.09, p< 0.001), Megasphaera species (RR 1.78, 95% CI 1.34-2.37, p< 0.001) and Gardnerella vaginalis (RR 1.08, 95% CI 1.01-1.16, p = 0.02). No significant association between vaginal washing and bacterial detection was found in Kenyan women. Adjustment for bacterial vaginosis diagnosed by Gram stain did not alter these results. This study provides evidence that the association between vaginal washing and detection of individual bacterial taxa can vary regionally. For some vaginal bacteria, the association with vaginal washing may be independent of the effect on Gram stain detection of BV. Larger prospective studies in diverse geographic settings should explore whether eliminating vaginal washing impacts the presence and concentrations of key vaginal bacteria.	[Sabo, Michelle C.; McClelland, R. Scott] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Balkus, Jennifer E.; Richardson, Barbra A.; Fredricks, David N.; McClelland, R. Scott] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Balkus, Jennifer E.; McClelland, R. Scott] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Balkus, Jennifer E.; Richardson, Barbra A.; Srinivasan, Sujatha; Feidler, Tina L.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Richardson, Barbra A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Kimani, Joshua; McClelland, R. Scott] Univ Nairobi, Inst Trop & Infect Dis, Nairobi, Kenya; [Anzala, Omu] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Schwebke, Jane] Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Nairobi; University of Nairobi; University of Alabama System; University of Alabama Birmingham	Sabo, MC (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	sabo@uw.edu		Fredricks, David/0000-0003-2735-6800; McClelland, Raymond Scott/0000-0003-2574-4201; Sabo, Michelle/0000-0002-5058-3166	National Institute of Allergy and Infectious Diseases [HHSN266200400073C, R01-AI099106]; University of Washington Center for AIDS Research [P30-AI27757, K24 HD88229]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD088229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007044, P30AI027757] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Washington Center for AIDS Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases (contract HHSN266200400073C [through the Sexually Transmitted Infections Clinical Trials Group] and grant R01-AI099106, awarded to RSM). The Mombasa research site receives logistical and infrastructure support from the University of Washington Center for AIDS Research (grant P30-AI27757). RSM receives funding for mentoring through K24 HD88229. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2009, SEX TRANSM INFECT, V85, P348, DOI 10.1136/sti.2008.035451; Balkus JE, 2017, J INFECT DIS, V215, P723, DOI 10.1093/infdis/jiw622; Brotman RM, 2008, AM J EPIDEMIOL, V168, P188, DOI 10.1093/aje/kwn103; Fredricks DN, 2009, J CLIN MICROBIOL, V47, P721, DOI 10.1128/JCM.01384-08; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gosmann C, 2017, IMMUNITY, V46, P29, DOI 10.1016/j.immuni.2016.12.013; Hassan WM, 2007, SEX TRANSM DIS, V34, P384, DOI 10.1097/01.olq.0000243624.74573.63; Hilber AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009119; Hilber AM, 2010, SOC SCI MED, V70, P392, DOI 10.1016/j.socscimed.2009.10.023; Hilbert DW, 2016, DIAGN MICR INFEC DIS, V86, P231, DOI 10.1016/j.diagmicrobio.2016.07.003; Jin L, 2007, J APPL MICROBIOL, V102, P1107, DOI 10.1111/j.1365-2672.2006.03147.x; Khot PD, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-73; Low N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000416; Masese L, 2013, SEX TRANSM INFECT, V89, P217, DOI 10.1136/sextrans-2012-050564; McClelland RS, 2008, SEX TRANSM DIS, V35, P617, DOI 10.1097/OLQ.0b013e31816907fa; McClelland RS, 2018, LANCET INFECT DIS, V18, P554, DOI 10.1016/S1473-3099(18)30058-6; McClelland RS, 2015, J INFECT DIS, V211, P1875, DOI 10.1093/infdis/jiu818; McClelland RS, 2006, AIDS, V20, P269, DOI 10.1097/01.aids.0000196165.48518.7b; Nagot N, 2007, SEX TRANSM INFECT, V83, P365, DOI 10.1136/sti.2007.024794; Nelson DB, 2015, MATERN CHILD HLTH J, V19, P2682, DOI 10.1007/s10995-015-1790-2; Nelson DB, 2014, PAEDIATR PERINAT EP, V28, P88, DOI 10.1111/ppe.12106; Ness RB, 2003, SEX TRANSM DIS, V30, P71, DOI 10.1097/00007435-200301000-00014; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Sivapalasingam S, 2014, AIDS RES HUM RETROV, V30, P1046, DOI 10.1089/aid.2013.0251; Srinivasan S, 2012, PLOS ONE, V7; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Verstraelen H, 2009, BMC MICROBIOL, V9	27	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210825	10.1371/journal.pone.0210825	http://dx.doi.org/10.1371/journal.pone.0210825			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677048	gold, Green Published, Green Submitted			2022-12-26	WOS:000456700400027
J	Sun, SZ; Miao, ZQ; Ratcliffe, B; Campbell, P; Pasch, B; El-Kassaby, YA; Balasundaram, B; Chen, C				Sun, Shuzhen; Miao, Zhuqi; Ratcliffe, Blaise; Campbell, Polly; Pasch, Bret; El-Kassaby, Yousry A.; Balasundaram, Balabhaskar; Chen, Charles			SNP variable selection by generalized graph domination	PLOS ONE			English	Article							GENOME-WIDE; LINKAGE-DISEQUILIBRIUM; GRASSHOPPER MOUSE; RIDGE-REGRESSION; FULL PEDIGREE; CHALLENGES; POPULATIONS; PERFORMANCE; MARKERS; VALUES	Background High-throughput sequencing technology has revolutionized both medical and biological research by generating exceedingly large numbers of genetic variants. The resulting datasets share a number of common characteristics that might lead to poor generalization capacity. Concerns include noise accumulated due to the large number of predictors, sparse information regarding the p >> n problem, and overfitting and model mis-identification resulting from spurious collinearity. Additionally, complex correlation patterns are present among variables. As a consequence, reliable variable selection techniques play a pivotal role in predictive analysis, generalization capability, and robustness in clustering, as well as interpretability of the derived models. Methods and findings K-dominating set, a parameterized graph-theoretic generalization model, was used to model SNP (single nucleotide polymorphism) data as a similarity network and searched for representative SNP variables. In particular, each SNP was represented as a vertex in the graph, (dis)similarity measures such as correlation coefficients or pairwise linkage disequilibrium were estimated to describe the relationship between each pair of SNPs; a pair of vertices are adjacent, i.e. joined by an edge, if the pairwise similarity measure exceeds a user-specified threshold. A minimum k-dominating set in the SNP graph was then made as the smallest subset such that every SNP that is excluded from the subset has at least k neighbors in the selected ones. The strength of k-dominating set selection in identifying independent variables, and in culling representative variables that are highly correlated with others, was demonstrated by a simulated dataset. The advantages of k-dominating set variable selection were also illustrated in two applications: pedigree reconstruction using SNP profiles of 1,372 Douglas-fir trees, and species delineation for 226 grasshopper mouse samples. A C++ source code that implements SNP-SELECT and uses Gurobi optimization solver for the k-dominating set variable selection is available (https://github.com/transgenomicsosu/SNP-SELECT).	[Sun, Shuzhen; Chen, Charles] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA; [Sun, Shuzhen; Ratcliffe, Blaise; El-Kassaby, Yousry A.] Univ British Columbia, Fac Forestry, Dept Forest & Conservat Sci, Vancouver, BC, Canada; [Miao, Zhuqi] Oklahoma State Univ, Ctr Hlth Syst Innovat, Stillwater, OK 74078 USA; [Campbell, Polly] Oklahoma State Univ, Dept Integrat Biol, Stillwater, OK 74078 USA; [Campbell, Polly] Univ Calif Riverside, Dept Evolut Ecol & Organismal Biol, Riverside, CA 92521 USA; [Pasch, Bret] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ USA; [Balasundaram, Balabhaskar] Oklahoma State Univ, Sch Ind Engn & Management, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater; University of British Columbia; Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater; University of California System; University of California Riverside; Northern Arizona University; Oklahoma State University System; Oklahoma State University - Stillwater	Chen, C (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.	charles.chen@okstate.edu		Balasundaram, Balabhaskar/0000-0002-3490-4257; Chen, Charles/0000-0002-2203-0433	Oklahoma Wheat Research Foundation; NSF-MRI [1626257]; NSF-IOS [1558109]; NSF-CMMI [1404971]; Cornell Lab of Ornithology; USDA HATCH project [OKL03011]; Genome Canada; Genome Alberta through Alberta Economic Trade and Development; Genome British Columbia; University of Alberta; University of Calgary; High Performance Computing Center Facilities of Oklahoma State University; Resilient Forests (RES-FOR): Climate, Pests & Policy-Genomic Applications project; OCAST [PS15-011]	Oklahoma Wheat Research Foundation; NSF-MRI(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF-IOS(National Science Foundation (NSF)); NSF-CMMI(National Science Foundation (NSF)); Cornell Lab of Ornithology; USDA HATCH project; Genome Canada(Genome Canada); Genome Alberta through Alberta Economic Trade and Development; Genome British Columbia; University of Alberta(University of Alberta); University of Calgary; High Performance Computing Center Facilities of Oklahoma State University; Resilient Forests (RES-FOR): Climate, Pests & Policy-Genomic Applications project; OCAST	This research is funded by Oklahoma Wheat Research Foundation, OCAST (PS15-011) and NSF-MRI 1626257 (CC), NSF-IOS 1558109 (CC and PC), NSF-CMMI 1404971 (BB), and a fellowship from the Cornell Lab of Ornithology (BP). The work presented in this report also reflects the support from the USDA HATCH project OKL03011 (CC). SS, BR, YAE and CC acknowledge cash funding for this research from Genome Canada, Genome Alberta through Alberta Economic Trade and Development, Genome British Columbia, the University of Alberta and University of Calgary and others, including the Alberta forest industry in support of the Resilient Forests (RES-FOR): Climate, Pests & Policy-Genomic Applications project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Michael Stoebr from the Ministry of Forests, Lands and Natural Resource Operations, British Columbia, for the use of Douglas-fir data. We are also grateful to Ashlee Rowe, and to the following institutions for providing grasshopper mouse tissue samples: Museum of Southwestern Biology, Museum of Vertebrate Zoology, Oklahoma State University Collection of Vertebrates. The project was completed with support from the High Performance Computing Center Facilities of Oklahoma State University.	Ayers KL, 2010, GENET EPIDEMIOL, V34, P879, DOI 10.1002/gepi.20543; Bakker MG, 2012, PLANT SOIL, V360, P1, DOI 10.1007/s11104-012-1361-x; Balasundaram B, 2006, HDB OPTIMIZATION TEL, P865; Bartlett CW, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S8-S8; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Bogdan M, 2015, ANN APPL STAT, V9, P1103, DOI 10.1214/15-AOAS842; Bonhomme M, 2010, GENETICS, V186, P241, DOI 10.1534/genetics.104.117275; Butenko S, 2004, COOPERAT SYST, V3, P61; Chelo IM, 2014, HEREDITY, V112, P248, DOI 10.1038/hdy.2013.100; Chen C, 2013, TREE GENET GENOMES, V9, P1537, DOI 10.1007/s11295-013-0657-1; Chen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046596; Cho S, 2010, ANN HUM GENET, V74, P416, DOI 10.1111/j.1469-1809.2010.00597.x; Christensen OF, 2012, ANIMAL, V6, P1565, DOI 10.1017/S1751731112000742; Degenhardt F, 2017, BRIEF BIOINFORM; Dehman A, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0556-6; El-Kassaby YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025737; El-Kassaby YA, 2009, GENET RES, V91, P111, DOI 10.1017/S001667230900007X; ELKASSABY YA, 1982, GENETICS, V101, P103; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Excoffier L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003905; Fan JQ, 2008, J R STAT SOC B, V70, P849, DOI 10.1111/j.1467-9868.2008.00674.x; Fan JQ, 2014, NATL SCI REV, V1, P293, DOI 10.1093/nsr/nwt032; Fan JQ, 2012, J R STAT SOC B, V74, P37, DOI 10.1111/j.1467-9868.2011.01005.x; Fan JQ, 2010, STAT SINICA, V20, P101; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gonzalez-Martinez SC, 2009, ASS MAPPING PLANTS, pix; Guo F, 2009, J AM STAT ASSOC, V104, P142, DOI 10.1198/jasa.2009.0010; Gurobi Optimization, 2018, GUROBI OPTIMIZER REF; Habier D, 2009, GENETICS, V182, P343, DOI 10.1534/genetics.108.100289; Habier D, 2013, GENETICS, V194, P597, DOI 10.1534/genetics.113.152207; Hainke K, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1762-1; Hall E. R., 1981, MAMMALS N AM; Hall P, 2008, J R STAT SOC B, V70, P159, DOI 10.1111/j.1467-9868.2007.00631.x; Haynes T. W., 1998, FUNDAMENTALS DOMINAT; He QC, 2011, BIOINFORMATICS, V27, P1, DOI 10.1093/bioinformatics/btq600; Heinze G, 2018, BIOMETRICAL J, V60, P431, DOI 10.1002/bimj.201700067; HENDERSON C. R., 1984, APPL LINEAR MODELS A, V11, P652; HINESLEY LL, 1979, J MAMMAL, V60, P117, DOI 10.2307/1379763; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Holderegger R, 2006, LANDSCAPE ECOL, V21, P793, DOI 10.1007/s10980-005-6058-6; Hong S, 2014, CANCER INFORM, V13, P55, DOI [10.4137/CIN.s16350, 10.4137/CIN.S16350]; Ishwaran H, 2014, CONTEMP MATH, V622, P81, DOI 10.1090/conm/622/12438; Jain AK., 1988, TECHNOMETRICS; JAMBU M., 1983, CLUSTER ANAL DATA AN; Jay JJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S7; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kirk H, 2011, INT J MOL SCI, V12, P3966, DOI 10.3390/ijms12063966; Kirpich A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197910; Klapste J, 2014, TREE GENET GENOMES, V10, P241, DOI 10.1007/s11295-013-0673-1; Legarra A, 2009, J DAIRY SCI, V92, P4656, DOI 10.3168/jds.2009-2061; Li Yixue, 2014, Genomics Proteomics & Bioinformatics, V12, P187, DOI 10.1016/j.gpb.2014.10.001; Liu GM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-66; Liu L, 2010, J COMPUT BIOL, V17, P21, DOI 10.1089/cmb.2007.0228; Long N, 2007, J ANIM BREED GENET, V124, P377, DOI 10.1111/j.1439-0388.2007.00694.x; Long N, 2011, J ANIM BREED GENET, V128, P247, DOI 10.1111/j.1439-0388.2011.00917.x; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Lynch M, 2014, GENETICS, V198, P269, DOI 10.1534/genetics.114.166843; Maechler M., 2022, CLUSTER CLUSTER ANAL; Marx V, 2013, NATURE, V498, P255, DOI 10.1038/498255a; May M, 2014, SCIENCE, V344, P1298, DOI 10.1126/science.opms.p1400086; Mehmood T, 2012, CHEMOMETR INTELL LAB, V118, P62, DOI 10.1016/j.chemolab.2012.07.010; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen THE, 2017, GENET SEL EVOL, V49, DOI 10.1186/s12711-017-0369-3; Michael RG., 1979, COMPUTERS INTRACTABI, P90; Misztal I, 2009, J DAIRY SCI, V92, P4648, DOI 10.3168/jds.2009-2064; Muca M, 2015, EUROPEAN SCI J ESJ, V11; Neves LG, 2013, PLANT J, V75, P146, DOI 10.1111/tpj.12193; Nielsen R, 2001, HEREDITY, V86, P641, DOI 10.1046/j.1365-2540.2001.00895.x; Pes B, 2017, INFORM FUSION, V35, P132, DOI 10.1016/j.inffus.2016.10.001; Powell JE, 2010, NAT REV GENET, V11, P800, DOI 10.1038/nrg2865; Ratcliffe B, 2017, GENETICS; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; ROBERTSON A, 1975, GENETICS, V81, P775; Santos JM, 2009, USE ADJUSTED RAND IN; Schulz-Streeck Torben, 2011, BMC Proc, V5 Suppl 3, pS12, DOI 10.1186/1753-6561-5-S3-S12; Shriver Mark D, 2004, Hum Genomics, V1, P274; Song JY, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-017-0715-8; Spath H., 1980, CLUSTER ANAL ALGORIT; SULLIVAN RM, 1986, J MAMMAL, V67, P640, DOI 10.2307/1381126; Szymczak S, 2016, BIODATA MIN, V9, DOI 10.1186/s13040-016-0087-3; Team R. D. C, 2011, R LANG ENV STAT COMP; Thistlethwaite FR, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4258-5; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Usai MG, 2009, GENET RES, V91, P427, DOI 10.1017/S0016672309990334; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vitti JJ, 2013, ANNU REV GENET, V47, P97, DOI 10.1146/annurev-genet-111212-133526; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Wang C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135918; Wang H, 2012, GENET RES, V94, P73, DOI 10.1017/S0016672312000274; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Wasserman L, 2009, ANN STAT, V37, P2178, DOI 10.1214/08-AOS646; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weigel KA, 2009, J DAIRY SCI, V92, P5248, DOI 10.3168/jds.2009-2092; Weng LJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-99; West D.B., 1996, INTRO GRAPH THEORY; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wimmer V, 2013, GENETICS, V195, P573, DOI 10.1534/genetics.113.150078; Wolsey L.A., 1998, INTEGER PROGRAMMING; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yeung KY, 2001, BIOINFORMATICS; Zhang M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-251; Zhang X, 2009, COE A GENERAL APPROA	106	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0203242	10.1371/journal.pone.0203242	http://dx.doi.org/10.1371/journal.pone.0203242			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677030	gold, Green Submitted, Green Published			2022-12-26	WOS:000456700400001
J	Doron, R; Sterkin, A; Fried, M; Yehezkel, O; Lev, M; Belkin, M; Rosner, M; Solomon, AS; Mandel, Y; Polat, U				Doron, Ravid; Sterkin, Anna; Fried, Moshe; Yehezkel, Oren; Lev, Maria; Belkin, Michael; Rosner, Mordechai; Solomon, Arieh S.; Mandel, Yossi; Polat, Uri			Spatial visual function in anomalous trichromats: Is less more?	PLOS ONE			English	Article							FOVEAL CONTRAST SENSITIVITY; COLOR-CAMOUFLAGED STIMULI; VISION DEFICIENCY; ADVANTAGE; DISCRIMINATION; DICHROMATS; BLINDNESS; ISHIHARA; ACUITY	Color deficiency is a common inherited disorder affecting 8% of Caucasian males with anomalous trichromacy (AT); it is the most common type of inherited color vision deficiency. Anomalous trichromacy is caused by alteration of one of the three cone-opsins' spectral sensitivity; it is usually considered to impose marked limitations for daily life as well as for choice of occupation. Nevertheless, we show here that anomalous trichromat subjects have superior basic visual functions such as visual acuity (VA), contrast sensitivity (CS), and stereo acuity, compared with participants with normal color vision. Both contrast sensitivity and stereo acuity performance were correlated with the severity of color deficiency. We further show that subjects with anomalous trichromacy exhibit a better ability to detect objects camouflaged in natural gray scale figures. The advantages of color-deficient subjects in spatial vision performance could explain the relatively high prevalence of color-vision polymorphism in humans.	[Doron, Ravid] Hadassah Acad Coll, Dept Optometry & Vis Sci, Jerusalem, Israel; [Sterkin, Anna; Fried, Moshe; Yehezkel, Oren; Belkin, Michael; Rosner, Mordechai; Solomon, Arieh S.] Tel Aviv Univ, Sackler Fac Med, Goldschleger Eye Res Inst, Tel Hashomer, Israel; [Lev, Maria; Mandel, Yossi; Polat, Uri] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Sch Optometry & Vis Sci, Ramat Gan, Israel; [Mandel, Yossi] Bar Ilan Univ, Bar Ilan Inst Nanotechnol & Adv Mat BINA, Ramat Gan, Israel	Tel Aviv University; Sackler Faculty of Medicine; Bar Ilan University; Bar Ilan University	Mandel, Y; Polat, U (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Sch Optometry & Vis Sci, Ramat Gan, Israel.; Mandel, Y (corresponding author), Bar Ilan Univ, Bar Ilan Inst Nanotechnol & Adv Mat BINA, Ramat Gan, Israel.	yossi.mandel@biu.ac.il; uri.polat@biu.ac.il	Solomon, Arieh/AAF-4361-2021		Israel Science Foundations (ISF) [ISF 188/10]; Israel Defense Force (IDF) IDF - 2010; Israel Science Foundation [ISF188/2010]	Israel Science Foundations (ISF); Israel Defense Force (IDF) IDF - 2010; Israel Science Foundation(Israel Science Foundation)	This study was supported by grants from the Israel Science Foundations (ISF) ISF 188/10 and the Israel Defense Force (IDF) IDF - 2010. There was no additional external funding received for this study.; This study was supported by grants from the Israel Science Foundation (ISF188/2010).	Abramov I, 2000, INVEST OPHTH VIS SCI, V41, pS731; ADAM A, 1969, SOC BIOL, V16, P197, DOI 10.1080/19485565.1969.9987819; [Anonymous], 1940, NATURE, V146, P226; Bartels A, 2000, EUR J NEUROSCI, V12, P172, DOI 10.1046/j.1460-9568.2000.00905.x; Birch J., 1993, DIAGNOSIS DEFECTIVE; Birch J, 2010, OPHTHAL PHYSL OPT, V30, P667, DOI 10.1111/j.1475-1313.2010.00770.x; Bonneh YS, 2007, VISION RES, V47, P1950, DOI 10.1016/j.visres.2007.02.015; Bosten JM, 2005, CURR BIOL, V15, pR950, DOI 10.1016/j.cub.2005.11.031; Clare G, 2010, BRIT J OPHTHALMOL, V94, P400, DOI 10.1136/bjo.2008.156323; Cockburn DM, 1999, OCCUP MED-OXFORD, V49, P247; Cole BL, 2007, CLIN EXP OPTOM, V90, P157, DOI 10.1111/j.1444-0938.2007.00135.x; Cole BL, 2006, CLIN EXP OPTOM, V89, P73, DOI 10.1111/j.1444-0938.2006.00015.x; Cumming BG, 2001, ANNU REV NEUROSCI, V24, P203, DOI 10.1146/annurev.neuro.24.1.203; Dain Stephen J, 2004, Clin Exp Optom, V87, P276; Davidoff C, 2016, TRANSL VIS SCI TECHN, V5, DOI 10.1167/tvst.5.5.2; ELLIOTT DB, 1995, OPTOMETRY VISION SCI, V72, P186, DOI 10.1097/00006324-199503000-00006; Gegenfurtner KR, 1998, VISION RES, V38, P1041, DOI 10.1016/S0042-6989(97)00200-9; Goldstein EB, 2016, SENSATION PERCEPTION; Gordon J, 2000, INVEST OPHTH VIS SCI, V41, pS807; Graham S. NV, 1989, VISUAL PATTERN ANAL; HALPERN DL, 1988, PERCEPTION, V17, P483, DOI 10.1068/p170483; Jagle H, 2006, GRAEF ARCH CLIN EXP, V244, P447, DOI 10.1007/s00417-005-0086-4; Janaky M, 2014, VISUAL NEUROSCI, V31, P99, DOI 10.1017/S0952523813000400; Judd DB, 1943, SCIENCE, V97, P544, DOI 10.1126/science.97.2529.544; Julesz B., 1971, FDN CYCLOPEAN PERCEP; Katz G, 2010, GRAEF ARCH CLIN EXP, V248, P1699, DOI 10.1007/s00417-010-1413-y; Kniestedt Christoph, 2003, Ophthalmol Clin North Am, V16, P155, DOI 10.1016/S0896-1549(03)00013-0; Lahav K, 2011, ARCH OPHTHALMOL-CHIC, V129, P16, DOI 10.1001/archophthalmol.2010.332; LEGGE GE, 1989, VISION RES, V29, P989, DOI 10.1016/0042-6989(89)90114-4; MCKEE SP, 1987, J OPT SOC AM A, V4, P1104, DOI 10.1364/JOSAA.4.001104; Melamud Alex, 2004, Ophthalmic Genet, V25, P159, DOI 10.1080/13816810490498341; Melin AD, 2007, ANIM BEHAV, V73, P205, DOI 10.1016/j.anbehav.2006.07.003; Morgan M, 1992, BIOL SCI; Polat U, 2009, SPATIAL VISION, V22, P179, DOI 10.1163/156856809787465609; Remichen T, 1987, SOC BIOL, V34, P1; Saito A, 2006, PERCEPT MOTOR SKILL, V102, P3, DOI 10.2466/PMS.102.1.3-12; Saito A, 2005, AM J PRIMATOL, V67, P425, DOI 10.1002/ajp.20197; Sharpe LT, 2006, J VISION, V6, P213, DOI 10.1167/6.3.3; Simunovic MP, 2001, INVEST OPHTH VIS SCI, V42, P3357; SNYDER CR, 1973, J SPEC EDUC, V7, P51, DOI 10.1177/002246697300700106; Spalding J Anthony B, 2004, Clin Exp Optom, V87, P344; Spalding JAB, 1999, OCCUP MED-OXFORD, V49, P247, DOI 10.1093/occmed/49.4.247; Sterkin A, 2017, VISION RES; STEWARD JM, 1989, OPTOMETRY VISION SCI, V66, P288, DOI 10.1097/00006324-198905000-00006; Tankus A, 2009, PHILOS T R SOC B, V364, P529, DOI 10.1098/rstb.2008.0211; THIBOS LN, 1992, APPL OPTICS, V31, P3594, DOI 10.1364/AO.31.003594; Troscianko J, 2017, BEHAV ECOL, V28, P556, DOI 10.1093/beheco/arw185; Verhulst S, 1998, VISION RES, V38, P3387, DOI 10.1016/S0042-6989(97)00339-8; Zaroff CM, 2003, INVEST OPHTH VIS SCI, V44, P891, DOI 10.1167/iovs.02-0361	49	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0209662	10.1371/journal.pone.0209662	http://dx.doi.org/10.1371/journal.pone.0209662			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI4TC	30673711	Green Published, Green Submitted, gold			2022-12-26	WOS:000456442800020
J	Welke, B; Jakubowitz, E; Seehaus, F; Daniilidis, K; Timpner, M; Tremer, N; Hurschler, C; Schwarze, M				Welke, Bastian; Jakubowitz, Eike; Seehaus, Frank; Daniilidis, Kiriakos; Timpner, Matthias; Tremer, Nils; Hurschler, Christof; Schwarze, Michael			The prevalence of osteoarthritis: Higher risk after transfemoral amputation?-A database analysis with 1,569 amputees and matched controls	PLOS ONE			English	Article							BACK-PAIN; LIMB; SECONDARY; KNEE	Background Several studies have shown that patients with a unilateral amputation have an increased risk of developing osteoarthritis (OA) in the knee of their sound leg. OBJECTIVE: The first objective was to investigate whether amputees are more frequently affected by gon-, cox- or polyarthritis as well as back pain or spinal disorders. We hypothesized that mobile and active transfemoral amputees more often experience OA and spinal disorders than non-amputees. The second objective was to compare the mean age of the patients with OA. Patients Patients with a unilateral transfemoral amputation (n = 1,569) and five abled-body control groups (each n = 1,569) matched in terms of age and gender resulting in total of 9,414 participants. Methods Groups were analyzed regarding the prevalence of six selected diagnoses regarding musculoskeletal disorders. Results A significantly decreased prevalence of OA and specific disorders of the spine in transfemoral amputees compared to a control group was found. The amputees with OA are significantly younger than patients with OA in the control group. Conclusion The results from the presented study contradict previously published literature. Apparently circumstances of life play an important role, like physical work and strenuous activities which are likely to be underrepresented in the amputee group. The results of the study need to be used cautiously due to the major limitation of the study which is the lack of detail in individual patients caused by the methodology.	[Welke, Bastian; Jakubowitz, Eike; Seehaus, Frank; Hurschler, Christof; Schwarze, Michael] Hannover Med Sch, Dept Orthopaed Surg, Lab Biomech & Biomat, Hannover, Germany; [Daniilidis, Kiriakos] Orthopadie Traumatol Ctr Regensburg, OTC, Regensburg, Germany; [Timpner, Matthias; Tremer, Nils] Techniker Krankenkasse, Hauptverwaltung Fachbereich GPH, Hamburg, Germany	Hannover Medical School	Welke, B (corresponding author), Hannover Med Sch, Dept Orthopaed Surg, Lab Biomech & Biomat, Hannover, Germany.	welke.bastian@mh-hannover.de	Schwarze, Michael/AEZ-2639-2022; Hurschler, Christof/AAF-8935-2019	Schwarze, Michael/0000-0001-5059-8029; Hurschler, Christof/0000-0001-8741-7463; Seehaus, Frank/0000-0002-1140-4196	Federal Ministry of Education and Research [BMBF FKZ 13EZ1112A-C]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The study was funded by Federal Ministry of Education and Research (BMBF FKZ 13EZ1112A-C "meb-GO - Messtechnikbasierte Gangbildoptimierung bei transfemoral Amputierten"). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner R, 2011, OPER ORTHOP TRAUMATO, V23, P289, DOI 10.1007/s00064-011-0041-y; Bieringer S., 2007, ORTHOP DIE UNF UP2DA, V2, P353, DOI [10.1055/s-2007-967065, DOI 10.1055/S-2007-967065]; BURKE MJ, 1978, ANN RHEUM DIS, V37, P252, DOI 10.1136/ard.37.3.252; Davies B, 2003, PROSTHET ORTHOT INT, V27, P186, DOI 10.1080/03093640308726681; Ehde DM, 2001, ARCH PHYS MED REHAB, V82, P731, DOI 10.1053/apmr.2001.21962; Ephraim PL, 2005, ARCH PHYS MED REHAB, V86, P1910, DOI 10.1016/j.apmr.2005.03.031; Friel K, 2005, J AM ACAD ORTHOP SUR, V13, P326, DOI 10.5435/00124635-200509000-00006; Gailey R, 2008, J REHABIL RES DEV, V45, P15, DOI 10.1682/JRRD.2006.11.0147; Gailey RS, 2002, ARCH PHYS MED REHAB, V83, P613, DOI 10.1053/ampr.2002.32309; Geertzen JHB, 2005, DISABIL REHABIL, V27, P101, DOI 10.1080/09638280400009345; Hammarlund CS, 2011, PROSTHET ORTHOT INT, V35, P97, DOI 10.1177/0309364610389357; Heller G, 2005, DEUT MED WOCHENSCHR, V130, P1689, DOI 10.1055/s-2005-871885; Holzer LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092943; Imhauser G, 1979, DER FUSS; Kulkarni J, 1998, CLIN REHABIL, V12, P348, DOI 10.1191/026921598672367610; LEMAIRE ED, 1994, ARCH PHYS MED REHAB, V75, P1094, DOI 10.1016/0003-9993(94)90084-1; Lloyd CH, 2010, GAIT POSTURE, V32, P296, DOI 10.1016/j.gaitpost.2010.05.003; Norvell DC, 2005, ARCH PHYS MED REHAB, V86, P487, DOI 10.1016/j.apmr.2004.04.034; Papazafiropoulou A, 2009, J DIABETES COMPLICAT, V23, P7, DOI 10.1016/j.jdiacomp.2007.11.008; Raspe H., 2012, GESUNDHEITSBERICHTER; Seidler A, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2085-8; Struyf PA, 2009, ARCH PHYS MED REHAB, V90, P440, DOI 10.1016/j.apmr.2008.08.220; Sulsky SI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031521; Walker BF, 2000, J SPINAL DISORD, V13, P205, DOI 10.1097/00002517-200006000-00003; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization (WHO), 2016, INT STAT CLASS DIS I; Ziegler-Graham K, 2008, ARCH PHYS MED REHAB, V89, P422, DOI 10.1016/j.apmr.2007.11.005	27	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210868	10.1371/journal.pone.0210868	http://dx.doi.org/10.1371/journal.pone.0210868			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668582	Green Published, gold, Green Submitted			2022-12-26	WOS:000456306400021
J	Grafe, K; Shanmugarajah, K; Zobel, T; Weidtkamp-Peters, S; Kleinschrodt, D; Smits, SHJ; Schmitt, L				Graefe, Katharina; Shanmugarajah, Kalpana; Zobel, Thomas; Weidtkamp-Peters, Stefanie; Kleinschrodt, Diana; Smits, Sander H. J.; Schmitt, Lutz			Cloning and expression of selected ABC transporters from the Arabidopsis thaliana ABCG family in Pichia pastoris	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTER; DRUG-RESISTANCE TRANSPORTER; HETEROLOGOUS PROTEIN EXPRESSION; ESCHERICHIA-COLI; NICOTIANA-TABACUM; RECOMBINANT EXPRESSION; TRANSLATION INITIATION; FUNCTIONAL EXPRESSION; MULTIDRUG TRANSPORTER; SECONDARY STRUCTURE	Phytohormones play a major role in plant growth and development. They are in most cases not synthesized in their target location and hence need to be transported to the site of action, by for instance ATP-binding cassette transporters. Within the ATP-binding cassette transporter family, Pleiotropic Drug Resistance transporters are known to be involved in phytohormone transport. Interestingly, PDRs are only present in plants and fungi. In contrast to fungi, there are few biochemical studies of plant PDRs and one major reason is that suitable overexpression systems have not been identified. In this study, we evaluate the expression system Pichia pastoris for heterologous overexpression of PDR genes of the model plant Arabidopsis thaliana. We successfully cloned and expressed the potential phytohormone transporters PDR2 and PDR8 in P. pastoris. Sucrose gradient centrifugation confirmed that the overexpressed proteins were correctly targeted to the plasma membrane of P. pastoris and initial functional studies demonstrated ATPase activity for WBC1. However, difficulties in cloning and heterologous overexpression might be particular obstacles of the PDR family, since cloning and overexpression of White Brown Complex 1, a half-size transporter of the same ABCG subfamily with comparable domain organization, was more easily achieved. We present strategies and highlight critical factors to successfully clone plant PDR genes and heterologously expressed in P. pastoris.	[Graefe, Katharina; Shanmugarajah, Kalpana; Kleinschrodt, Diana; Smits, Sander H. J.; Schmitt, Lutz] Heinrich Heine Univ, Inst Biochem, Dusseldorf, Germany; [Graefe, Katharina; Shanmugarajah, Kalpana; Schmitt, Lutz] Heinrich Heine Univ, Cluster Excellence Plant Sci, Dusseldorf, Germany; [Zobel, Thomas; Weidtkamp-Peters, Stefanie] Heinrich Heine Univ, Ctr Adv Imaging, Dusseldorf, Germany; [Kleinschrodt, Diana] Heinrich Heine Univ, Prot Prod Facil, Dusseldorf, Germany; [Zobel, Thomas] Univ Munster, Cells Mot Interfac Ctr, Munster, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Munster	Schmitt, L (corresponding author), Heinrich Heine Univ, Inst Biochem, Dusseldorf, Germany.; Schmitt, L (corresponding author), Heinrich Heine Univ, Cluster Excellence Plant Sci, Dusseldorf, Germany.	lutz.schmitt@hhu.de		Weidtkamp-Peters, Stefanie/0000-0001-7734-3771; Schmitt, Lutz/0000-0002-1167-9819	ECX 1028, CEPLAS, Deutsche Forschungsgemeinschaft	ECX 1028, CEPLAS, Deutsche Forschungsgemeinschaft	This work was supported by: LS, ECX 1028, CEPLAS, Deutsche Forschungsgemeinschaft, www.dfg.de, NO.	Alejandro S, 2012, CURR BIOL, V22, P1207, DOI 10.1016/j.cub.2012.04.064; Allan C, 2012, NAT METHODS, V9, P245, DOI [10.1038/NMETH.1896, 10.1038/nmeth.1896]; Badri DV, 2008, PLANT PHYSIOL, V146, P762, DOI 10.1104/pp.107.109587; Banasiak J, 2013, J EXP BOT, V64, P1005, DOI 10.1093/jxb/ers380; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Beaudet L, 1998, METHOD ENZYMOL, V292, P397; Bernaudat F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029191; Bessire M, 2011, PLANT CELL, V23, P1958, DOI 10.1105/tpc.111.083121; Biala W, 2017, J EXP BOT, V68, P3231, DOI 10.1093/jxb/erx059; Bienert MD, 2012, PLANT J, V72, P745, DOI 10.1111/j.1365-313X.2012.05108.x; Borghi L, 2015, BIOCHEM SOC T, V43, P924, DOI 10.1042/BST20150106; Busso D, 2003, J BIOCHEM BIOPH METH, V55, P233, DOI 10.1016/S0165-022X(03)00049-6; Byme B, 2015, CURR OPIN STRUC BIOL, V32, P9, DOI 10.1016/j.sbi.2015.01.005; Byrne JA, 2009, HEPATOLOGY, V49, P553, DOI 10.1002/hep.22683; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; CHEN GFT, 1990, NUCLEIC ACIDS RES, V18, P1465, DOI 10.1093/nar/18.6.1465; Chloupkova M, 2007, BIOCHEMISTRY-US, V46, P7992, DOI 10.1021/bi700020m; Choi H, 2014, PLANT CELL, V26, P310, DOI 10.1105/tpc.113.118935; Cohen E, 2005, J BIOL CHEM, V280, P16610, DOI 10.1074/jbc.M414290200; COLEMAN J, 1985, J MOL BIOL, V181, P139, DOI 10.1016/0022-2836(85)90332-8; Crouzet J, 2013, PLANT MOL BIOL, V82, P181, DOI 10.1007/s11103-013-0053-0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Demessie Z, 2017, PHYTOCHEMISTRY, V140, P118, DOI 10.1016/j.phytochem.2017.04.019; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; Drew DE, 2001, FEBS LETT, V507, P220, DOI 10.1016/S0014-5793(01)02980-5; EGNER R, 1995, MOL CELL BIOL, V15, P5879; Ellinger P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060620; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; Fu XQ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00723; Georgiou G, 1996, CURR OPIN BIOTECH, V7, P190, DOI 10.1016/S0958-1669(96)80012-7; Grisshammer R, 2006, CURR OPIN BIOTECH, V17, P337, DOI 10.1016/j.copbio.2006.06.001; Griswold KE, 2003, PROTEIN EXPRES PURIF, V27, P134, DOI 10.1016/S1046-5928(02)00578-8; Gul N, 2014, J MOL BIOL, V426, P136, DOI 10.1016/j.jmb.2013.09.009; Hannig G, 1998, TRENDS BIOTECHNOL, V16, P54, DOI 10.1016/S0167-7799(97)01155-4; Haviv H, 2007, BIOCHEMISTRY-US, V46, P12855, DOI 10.1021/bi701248y; Hellsberg E, 2015, PLANTA MED, V81, P474, DOI 10.1055/s-0035-1545880; HIGGINS CF, 1985, EMBO J, V4, P1033, DOI 10.1002/j.1460-2075.1985.tb03735.x; Huala E, 2001, NUCLEIC ACIDS RES, V29, P102, DOI 10.1093/nar/29.1.102; Hwang JU, 2016, MOL PLANT, V9, P338, DOI 10.1016/j.molp.2016.02.003; Ito H, 2006, PLANT PHYSIOL, V142, P63, DOI 10.1104/pp.106.084533; Kang J, 2017, TRENDS PLANT SCI, V22, P455, DOI 10.1016/j.tplants.2017.03.003; Kang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9113; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; Khare D, 2017, P NATL ACAD SCI USA, V114, pE5712, DOI 10.1073/pnas.1702259114; Kim DY, 2007, PLANT J, V50, P207, DOI 10.1111/j.1365-313X.2007.03044.x; Kim DY, 2010, PHYSIOL PLANTARUM, V139, P170, DOI 10.1111/j.1399-3054.2010.01353.x; Ko D, 2014, P NATL ACAD SCI USA, V111, P7150, DOI 10.1073/pnas.1321519111; Kolaczkowski M, 1996, J BIOL CHEM, V271, P31543, DOI 10.1074/jbc.271.49.31543; Kretzschmar T, 2012, NATURE, V483, P341, DOI 10.1038/nature10873; Kretzschmar T, 2011, ESSAYS BIOCHEM, V50, P145, DOI [10.1042/BSE0500145, 10.1042/bse0500145]; Kuromori T, 2014, PLANT PHYSIOL, V164, P1587, DOI 10.1104/pp.114.235556; Kuromori T, 2010, P NATL ACAD SCI USA, V107, P2361, DOI 10.1073/pnas.0912516107; Lee M, 2005, PLANT PHYSIOL, V138, P827, DOI 10.1104/pp.104.058107; Lefevre F, 2015, BIOCHEM SOC T, V43, P931, DOI 10.1042/BST20150108; Liepman AH, 2005, P NATL ACAD SCI USA, V102, P2221, DOI 10.1073/pnas.0409179102; Lu XL, 2015, PLANT PHYSIOL, V168, P814, DOI 10.1104/pp.15.00182; Lu YP, 1997, P NATL ACAD SCI USA, V94, P8243, DOI 10.1073/pnas.94.15.8243; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Midgett CR, 2007, J STRUCT BIOL, V160, P265, DOI 10.1016/j.jsb.2007.07.001; Musielak TJ, 2015, PLANT REPROD, V28, P161, DOI 10.1007/s00497-015-0267-1; Nies AT, 2002, EUR J BIOCHEM, V269, P1866, DOI 10.1046/j.1432-1033.2002.02832.x; Noe J, 2002, GASTROENTEROLOGY, V123, P1659, DOI 10.1053/gast.2002.36587; Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4; Park J, 2012, PLANT J, V69, P278, DOI 10.1111/j.1365-313X.2011.04789.x; RAMESH V, 1994, PROTEIN ENG, V7, P1053, DOI 10.1093/protein/7.8.1053; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; RINGQUIST S, 1992, MOL MICROBIOL, V6, P1219, DOI 10.1111/j.1365-2958.1992.tb01561.x; Ruzicka K, 2010, P NATL ACAD SCI USA, V107, P10749, DOI 10.1073/pnas.1005878107; Sachdev D, 1998, BIOCHEM BIOPH RES CO, V244, P933, DOI 10.1006/bbrc.1998.8365; Sami M, 1997, J FERMENT BIOENG, V84, P1, DOI 10.1016/S0922-338X(97)82778-X; Sanchez-Fernandez R, 2001, J BIOL CHEM, V276, P30231, DOI 10.1074/jbc.M103104200; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Sasse J, 2016, PLANT CELL ENVIRON, V39, P2725, DOI 10.1111/pce.12828; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schmidt FR, 2004, APPL MICROBIOL BIOT, V65, P363, DOI 10.1007/s00253-004-1656-9; Schmitt L, 2002, CURR OPIN STRUC BIOL, V12, P754, DOI 10.1016/S0959-440X(02)00399-8; Sheps JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r15; Shibata Y, 2016, PLANT CELL, V28, P1163, DOI 10.1105/tpc.15.00721; Shitan N, 2003, P NATL ACAD SCI USA, V100, P751, DOI 10.1073/pnas.0134257100; SIKORSKI RS, 1989, GENETICS, V122, P19; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; Stindt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020562; Strader LC, 2009, PLANT CELL, V21, P1992, DOI 10.1105/tpc.109.065821; Svensson J, 2006, PROTEIN EXPRES PURIF, V48, P134, DOI 10.1016/j.pep.2006.01.005; Takeuchi M, 2018, J PLANT RES, V131, P297, DOI 10.1007/s10265-017-0979-4; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; Theodoulou FL, 2000, BBA-BIOMEMBRANES, V1465, P79, DOI [10.1016/S0005-2736(00)00132-2, 10.1199/tab.0153]; Toussaint F, 2017, BIOCHEM J, V474, P1689, DOI 10.1042/BCJ20170108; TSCHOPP JF, 1987, NUCLEIC ACIDS RES, V15, P3859, DOI 10.1093/nar/15.9.3859; Underwood W, 2013, P NATL ACAD SCI USA, V110, P12492, DOI 10.1073/pnas.1218701110; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Wolters H, 2009, NAT REV GENET, V10, P305, DOI 10.1038/nrg2558; Yadav V, 2014, PLANT CELL, V26, P3569, DOI 10.1105/tpc.114.129049; Yazaki K, 2009, INT REV CEL MOL BIO, V276, P263, DOI 10.1016/S1937-6448(09)76006-X; ZEEVAART JAD, 1988, ANNU REV PLANT PHYS, V39, P439, DOI 10.1146/annurev.pp.39.060188.002255; Zhang KW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4274	98	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0211156	10.1371/journal.pone.0211156	http://dx.doi.org/10.1371/journal.pone.0211156			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657786	Green Submitted, Green Published, gold			2022-12-26	WOS:000456017000033
J	Hoos, LA; Buckel, JA; Boyd, JB; Loeffler, MS; Lee, LM				Hoos, Liza A.; Buckel, Jeffrey A.; Boyd, Jacob B.; Loeffler, Michael S.; Lee, Laura M.			Fisheries management in the face of uncertainty: Designing time-area closures that are effective under multiple spatial patterns of fishing effort displacement in an estuarine gill net fishery	PLOS ONE			English	Article							MARINE RESERVES; SEA-TURTLES; BY-CATCH; BYCATCH; CONSERVATION; BEHAVIOR; POPULATIONS; LINE	A commonly cited reason for the failure of time-area closures to achieve fisheries management goals is the displacement of fishing effort from inside the closure into the surrounding area still open to fishing. Designing time-area closures that are predicted to achieve management goals under multiple spatial patterns of effort redistribution will increase chances of success. Using data from an estuarine gill net fishery, we tested if there are time-area closures predicted to reduce bycatch of two protected species groups while maintaining target catch under four simulated effort redistribution patterns. We found that the pattern of effort redistribution had a substantial impact on the amount of predicted bycatch in each closure scenario. Multiple closures were predicted to reduce bycatch of these species under all four simulations of effort redistribution. However, some combinations of closure and effort redistribution pattern resulted in estimated bycatch being higher than without a closure. We did not find any time-area closures that resulted in a predicted reduction in bycatch while maintaining target catch at original levels. We demonstrate a simple way for fisheries managers to account for the uncertainty in fishers' behavior by designing time-area closures that are predicted to reduce bycatch under multiple potential patterns of spatial redistribution of fishing effort.	[Hoos, Liza A.; Buckel, Jeffrey A.] North Carolina State Univ, Ctr Marine Sci & Technol, Dept Appl Ecol, Morehead City, NC 28557 USA; [Boyd, Jacob B.; Lee, Laura M.] North Carolina Dept Environm Qual, North Carolina Div Marine Fisheries, Morehead City, NC USA; [Loeffler, Michael S.] North Carolina Dept Environm Qual, North Carolina Div Marine Fisheries, Elizabeth City, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill	Hoos, LA (corresponding author), North Carolina State Univ, Ctr Marine Sci & Technol, Dept Appl Ecol, Morehead City, NC 28557 USA.	liza.hoos@gmail.com			North Carolina Coastal Recreational Fisheries License Fund award [6431]; NC Sea Grant award [E/GS-6]	North Carolina Coastal Recreational Fisheries License Fund award; NC Sea Grant award	This study was completed while LAH was a Marine Fisheries Management Fellow supported by North Carolina Coastal Recreational Fisheries License Fund award 6431 and NC Sea Grant award E/GS-6. JAB was also supported by NC Sea Grant award E/GS-6 (URL: https://ncseagrant.ncsu.edu/) and North Carolina Coastal Recreational Fisheries License Fund award 6431 (URL: http://portal.ncdenr.org/web/mf/crfl-grants-projects-applications-procedures). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JK, 2012, ECOL APPL, V22, P762, DOI 10.1890/11-1319.1; Adlerstein SA, 1998, J SEA RES, V39, P153, DOI 10.1016/S1385-1101(97)00055-5; Agardy T, 2011, MAR POLICY, V35, P226, DOI 10.1016/j.marpol.2010.10.006; [Anonymous], 2005, DISCARDS WORLDS MARI; Bastardie F, 2013, DISPLACE DYNAMIC IND, P366, DOI [10.1093/icesjms/tsu130, DOI 10.1093/ICESJMS/TSU130]; Bastardie F, 2015, ICES J MAR SCI, V72, P824, DOI 10.1093/icesjms/fsu215; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Branch TA, 2008, CAN J FISH AQUAT SCI, V65, P1435, DOI 10.1139/F08-065; Collins MR, 2000, B MAR SCI, V66, P917; Crowder LB, 1998, FISHERIES, V23, P8, DOI 10.1577/1548-8446(1998)023&lt;0008:FBIFM&gt;2.0.CO;2; Diamond SL, 2010, CAN J FISH AQUAT SCI, V67, P1335, DOI 10.1139/F10-044; Dunn DC, 2016, P NATL ACAD SCI USA, V113, P668, DOI 10.1073/pnas.1513626113; Dunn DC, 2014, FISH FISH, V15, P359, DOI 10.1111/faf.12019; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Glaser SM, 2014, FISH FISH, V15, P616, DOI 10.1111/faf.12037; Greene K.E., 2009, ATLANTIC COAST DIADR; Greenstreet SPR, 2009, ICES J MAR SCI, V66, P90, DOI 10.1093/icesjms/fsn214; Hall MA, 2000, MAR POLLUT BULL, V41, P204, DOI 10.1016/S0025-326X(00)00111-9; Halpern BS, 2004, ECOL APPL, V14, P1248, DOI 10.1890/03-5136; Hiddink JG, 2006, ICES J MAR SCI, V63, P822, DOI 10.1016/j.icesjms.2006.02.006; Costa BHE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065057; Kellner JB, 2007, ECOL APPL, V17, P1039, DOI 10.1890/05-1845; Lewison RL, 2007, CONSERV BIOL, V21, P79, DOI 10.1111/j.1523-1739.2006.00592.x; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Mason J, 2012, MAR POLICY, V36, P1054, DOI 10.1016/j.marpol.2012.03.002; McClellan CM, 2011, MAR POLICY, V35, P241, DOI 10.1016/j.marpol.2010.10.008; Murawski SA, 2005, ICES J MAR SCI, V62, P1150, DOI 10.1016/j.icesjms.2005.04.005; Murray Kimberly T., 2000, Journal of Cetacean Research and Management, V2, P135; Murray Kimberly T., 2009, Endangered Species Research, V8, P211, DOI 10.3354/esr00211; National Marine Protected Areas Center, 2015, FRAM NAT SYST MAR PR; Needle CL, 2015, ICES J MAR SCI, V72, P151, DOI 10.1093/icesjms/fsu130; NMFS, 2006, FIN CONS ATL HIGHL M, P1600; North Carolina Division of Marine Fisheries, 2005, N CAR FISH MAN PLAN; O'Keefe CE, 2014, ICES J MAR SCI, V71, P1286, DOI 10.1093/icesjms/fst063; Powers JE, 2009, FISH RES, V99, P216, DOI 10.1016/j.fishres.2009.06.011; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Stelzenmuller V, 2008, MAR POLLUT BULL, V56, P2018, DOI 10.1016/j.marpolbul.2008.08.006; Valcic B, 2009, MAR POLICY, V33, P215, DOI 10.1016/j.marpol.2008.06.001; van der Lee A, 2013, CAN J FISH AQUAT SCI, V70, P973, DOI 10.1139/cjfas-2012-0341; Watson JT, 2009, CONSERV BIOL, V23, P626, DOI 10.1111/j.1523-1739.2008.01121.x; Watson Reg A., 1993, North American Journal of Fisheries Management, V13, P326, DOI 10.1577/1548-8675(1993)013<0326:CSATPF>2.3.CO;2; Wilen JE, 2002, B MAR SCI, V70, P553; Ye YM, 2000, FISH RES, V45, P9, DOI 10.1016/S0165-7836(99)00105-8; Zollett Erika A., 2009, Endangered Species Research, V9, P49, DOI 10.3354/esr00221	44	15	15	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0211103	10.1371/journal.pone.0211103	http://dx.doi.org/10.1371/journal.pone.0211103			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8XI	30657789	gold, Green Published, Green Submitted			2022-12-26	WOS:000456017000031
J	Yao, S; Tuo, TB; Gao, X; Han, CY; Yan, NN; Liu, AJ; Gao, HL; Gao, YL; Cui, HY; Liu, CJ; Zhang, YP; Qi, XL; Hussain, A; Wang, YQ; Wang, XM				Yao, Shuai; Tuo, Tianbei; Gao, Xiang; Han, Chunyan; Yan, Nana; Liu, Aijing; Gao, Honglei; Gao, Yulong; Cui, Hongyu; Liu, Changjun; Zhang, Yanping; Qi, Xiaole; Hussain, Altaf; Wang, Yongqiang; Wang, Xiaomei			Molecular epidemiology of chicken anaemia virus in sick chickens in China from 2014 to 2015	PLOS ONE			English	Article							BURSAL DISEASE VIRUS; PHYLOGENETIC ANALYSIS; AGENT CAA; PROTEIN; CLEAVAGE; PATHOGENICITY; IDENTIFICATION; REPLICATION; INFECTION; APOPTIN	Chicken anaemia virus (CAV), a member of the genus Gyrovirus, is the etiological agent of chicken infectious anaemia. CAV infects bone marrow-derived cells, resulting in severe anaemia and immunosuppression in young chickens and a compromised immune response in older birds. We investigated the molecular epidemiology of CAV in sick chickens in China from 2014 to 2015 and showed that the CAV-positive rate was 13.30%, in which mixed infection (55.56%) was the main type of infection. We isolated and identified 15 new CAV strains using different methods including indirect immunofluorescence assay and Western Blotting. We used overlapping polymerase chain reaction to map the whole genome of the strains. Phylogenetic analyses of the obtained sequences and related sequences available in GenBank generated four distinct groups (A-D). We built phylogenetic trees using predicted viral protein (VP) sequences. Unlike CAV VP2s and VP3s that were well conserved, the diversity of VP1s indicated that the new strains were virulent. Our epidemiological study provided new insights into the prevalence of CAV in clinical settings in recent years in China.	[Yao, Shuai; Tuo, Tianbei; Wang, Xiaomei] Northeast Agr Univ, Coll Vet Med, Harbin, Heilongjiang, Peoples R China; [Yao, Shuai; Tuo, Tianbei; Gao, Xiang; Han, Chunyan; Yan, Nana; Liu, Aijing; Gao, Honglei; Gao, Yulong; Cui, Hongyu; Liu, Changjun; Zhang, Yanping; Qi, Xiaole; Hussain, Altaf; Wang, Yongqiang; Wang, Xiaomei] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin, Heilongjiang, Peoples R China; [Han, Chunyan] Northeast Forestry Univ, Coll Wildlife Resource, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Northeast Forestry University - China	Wang, XM (corresponding author), Northeast Agr Univ, Coll Vet Med, Harbin, Heilongjiang, Peoples R China.; Wang, YQ; Wang, XM (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin, Heilongjiang, Peoples R China.	yqw@hvri.ac.cn; xmw@hvri.ac.cn	Gao, Yulong/HGE-6271-2022; yan, na/HDM-3747-2022	Gao, Yulong/0000-0002-0448-8467; 	China Agriculture Research System [CARS-41-G15]; Chinese Ministry of Agriculture	China Agriculture Research System; Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs)	This research was supported by China Agriculture Research System (CARS-41-G15), http://www.zgrj.org/expert.asp?smallclassname=%B9%A6%C4%DC%D1% D0%BE%BF%CA%D2&SpecialName=%BC%B2%B2%A1%BF%D8%D6%C6%D1%D0%BE%BF%CA%D2, the funding institution was Chinese Ministry of Agriculture, and XMW was the recipient of the fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Best SM, 2003, J VIROL, V77, P5305, DOI 10.1128/JVI.77.9.5305-5312.2003; Cheung AK, 2012, VIRUS RES, V164, P46, DOI 10.1016/j.virusres.2011.10.012; Chowdhury SMZH, 2003, ARCH VIROL, V148, P2437, DOI 10.1007/s00705-003-0189-3; CLOUD SS, 1992, VET IMMUNOL IMMUNOP, V34, P337, DOI 10.1016/0165-2427(92)90174-O; Diemer C, 2008, J MOL BIOL, V376, P23, DOI 10.1016/j.jmb.2007.11.081; Ducatez MF, 2008, AVIAN DIS, V52, P68, DOI 10.1637/8049-070407-Reg; Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429; Eltahir YM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-145; ENGSTROM BE, 1988, AVIAN PATHOL, V17, P33, DOI 10.1080/03079458808436426; Gao Q, 2014, J CLIN MICROBIOL, V52, P37, DOI 10.1128/JCM.02200-13; Grand RJA, 2002, VIROLOGY, V301, P255, DOI 10.1006/viro.2002.1586; Hailemariam Z, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-128; Haridy M, 2009, AVIAN PATHOL, V38, P469, DOI 10.1080/03079450903349162; Heilman DW, 2006, J VIROL, V80, P7535, DOI 10.1128/JVI.02741-05; Jiang LL, 2013, VET MICROBIOL, V166, P68, DOI 10.1016/j.vetmic.2013.05.008; Kaffashi A, 2015, ARCH VIROL, V160, P2557, DOI 10.1007/s00705-015-2542-8; Kucharski TJ, 2016, J VIROL, V90; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Los M, 2009, BBA-MOL CELL RES, V1793, P1335, DOI 10.1016/j.bbamcr.2009.04.002; MCCONNELL CDG, 1993, AVIAN DIS, V37, P358, DOI 10.2307/1591659; McNulty MS, 2008, LAB MANUAL ISOLATION, P3; Munger J, 2003, VIROLOGY, V305, P364, DOI 10.1006/viro.2002.1728; Varela APM, 2014, BIOLOGICALS, V42, P346, DOI 10.1016/j.biologicals.2014.08.002; Natesan S, 2006, VIRUS RES, V118, P78, DOI 10.1016/j.virusres.2005.11.017; Niagro FD, 1998, ARCH VIROL, V143, P1723, DOI 10.1007/s007050050412; Nogueira EO, 2007, COMP IMMUNOL MICROB, V30, P81, DOI 10.1016/j.cimid.2006.11.001; NOTEBORN MHM, 1994, J VIROL, V68, P346, DOI 10.1128/JVI.68.1.346-351.1994; NOTEBORN MHM, 1991, J VIROL, V65, P3131, DOI 10.1128/JVI.65.6.3131-3139.1991; Noteborn MHM, 1998, J GEN VIROL, V79, P3073, DOI 10.1099/0022-1317-79-12-3073; Oluwayelu DO, 2008, ONDERSTEPOORT J VET, V75, P353, DOI 10.4102/ojvr.v75i4.111; OTAKI Y, 1989, JPN J VET SCI, V51, P849; Peters MA, 2002, J BIOL CHEM, V277, P39566, DOI 10.1074/jbc.M201752200; Prasetyo AA, 2009, VIROLOGY, V385, P85, DOI 10.1016/j.virol.2008.10.043; Renshaw RW, 1996, J VIROL, V70, P8872, DOI 10.1128/JVI.70.12.8872-8878.1996; ROSENBERGER JK, 1989, AVIAN DIS, V33, P753, DOI 10.2307/1591156; ROSENBERGER JK, 1989, AVIAN DIS, V33, P707, DOI 10.2307/1591148; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Satoh S, 2000, VIROLOGY, V270, P476, DOI 10.1006/viro.2000.0287; Sauvage V, 2011, J VIROL, V85, P7948, DOI 10.1128/JVI.00639-11; Schat KA, 2009, CURR TOP MICROBIOL, V331, P151; Sommer F, 2003, AVIAN DIS, V47, P1466, DOI 10.1637/7048; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; TODD D, 1990, J GEN VIROL, V71, P819, DOI 10.1099/0022-1317-71-4-819; Todd D, 2000, AVIAN PATHOL, V29, P373, DOI 10.1080/030794500750047126; Toro H, 2006, AVIAN PATHOL, V35, P455, DOI 10.1080/03079450601028811; van Santen VL, 2007, AVIAN DIS, V51, P66, DOI 10.1637/0005-2086(2007)051[0066:BCOCAV]2.0.CO;2; von Bulow V, 1986, Zentralbl Veterinarmed B, V33, P717; Wang D, 2009, VIRUS GENES, V38, P259, DOI 10.1007/s11262-008-0316-z; Wang Xiaoyan, 2007, EPITOPES IDENTIFICAT; Wang Xiurong, 10 AC S CHIN AN HUSB; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; Yamaguchi S, 2001, J GEN VIROL, V82, P1233, DOI 10.1099/0022-1317-82-5-1233; YUASA N, 1979, AVIAN DIS, V23, P366, DOI 10.2307/1589567; YUASA N, 1985, AVIAN PATHOL, V14, P521, DOI 10.1080/03079458508436254; Zanella A, 2001, INTERACTION MAREKS D; Zhong L, 2016, SCI REP-UK, V6, DOI 10.1038/srep35271; Zhou WP, 1997, AVIAN DIS, V41, P361, DOI 10.2307/1592190; Zhou WP, 1996, AVIAN DIS, V40, P358, DOI 10.2307/1592232	59	13	15	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210696	10.1371/journal.pone.0210696	http://dx.doi.org/10.1371/journal.pone.0210696			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657774	Green Published, gold, Green Submitted			2022-12-26	WOS:000456017000017
J	Chard, AN; Trinies, V; Edmonds, CJ; Sogore, A; Freeman, MC				Chard, Anna N.; Trinies, Victoria; Edmonds, Caroline J.; Sogore, Assitan; Freeman, Matthew C.			The impact of water consumption on hydration and cognition among schoolchildren: Methods and results from a crossover trial in rural Mali	PLOS ONE			English	Article							HEAT-STRESS; VOLUNTARY DEHYDRATION; SANITATION PROGRAM; URINARY INDEXES; SCHOOL; EXERCISE; HYGIENE; PERFORMANCE	Adequate provision of safe water, basic sanitation, and hygiene (WASH) facilities and behavior change can reduce pupil absence and infectious disease. Increased drinking water quantity may also improve educational outcomes through the effect of hydration on attention, concentration, and short-term memory. A pilot study was conducted to adapt field measures of short-term cognitive performance and hydration, to evaluate levels of hydration, and to investigate the impact of providing supplementary drinking water on the cognitive performance of pupils attending water-scarce schools in rural Mali. Using a cross-over trial design, data were collected under normal school conditions (control condition) on one visit day; on the other, participants were given a bottle of water that was refilled throughout the day (water condition). Morning and afternoon hydration was assessed using specific gravity and urine color. Cognitive performance was evaluated using six paper-based tests. Three percent of pupils were dehydrated on the morning of each visit. The prevalence of dehydration increased in the afternoon, but was lower under the water condition. Although there was a trend indicating drinking water may improve cognitive test performance, as has been shown in studies in other settings, results were not statistically significant and were masked by a "practice effect."	[Chard, Anna N.; Trinies, Victoria; Freeman, Matthew C.] Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA; [Edmonds, Caroline J.] Univ East London, Sch Psychol, London, England; [Sogore, Assitan] Save Children Mali, Monitoring Evaluat & Learning Sect, Bamako, Mali	Emory University; Rollins School Public Health; University of East London; Save the Children	Freeman, MC (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA.	matthew.freeman@emory.edu	Freeman, Matthew/ABE-6245-2020	Freeman, Matthew/0000-0002-1517-2572; Trinies, Victoria/0000-0002-7863-7509; Edmonds, Caroline/0000-0001-7971-0918	Emory University Research Committee; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES012870] Funding Source: NIH RePORTER	Emory University Research Committee; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided by the Emory University Research Committee (http://www.urc.emory.edu/grants/urc/index.html). MCF received funding (grant number N/A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong LE, 2007, J AM COLL NUTR, V26, p575S, DOI 10.1080/07315724.2007.10719661; Armstrong LE, 2005, NUTR REV, V63, pS40, DOI 10.1111/j.1753-4887.2005.tb00153.x; Armstrong LE, 1998, INT J SPORT NUTR, V8, P345, DOI 10.1123/ijsn.8.4.345; ARMSTRONG LE, 1994, INT J SPORT NUTR, V4, P265, DOI 10.1123/ijsn.4.3.265; Baker LB, 2007, MED SCI SPORT EXER, V39, P976, DOI 10.1097/mss.0b013e3180471ff2; Bar-David Y, 2005, ACTA PAEDIATR, V94, P1667, DOI 10.1080/08035250500254670; Bar-David Y, 2009, J HUM NUTR DIET, V22, P455, DOI 10.1111/j.1365-277X.2009.00960.x; Benton D, 2009, APPETITE, V53, P143, DOI 10.1016/j.appet.2009.05.006; Bowen A, 2007, AM J TROP MED HYG, V76, P1166, DOI 10.4269/ajtmh.2007.76.1166; Cian C, 2001, INT J PSYCHOPHYSIOL, V42, P243, DOI 10.1016/S0167-8760(01)00142-8; Cian C, 2000, J PSYCHOPHYSIOL, V14, P29, DOI 10.1027//0269-8803.14.1.29; Edmonds CJ, 2009, APPETITE, V53, P469, DOI 10.1016/j.appet.2009.10.002; Edmonds CJ, 2009, APPETITE, V52, P776, DOI 10.1016/j.appet.2009.02.010; Fadda R, 2012, APPETITE, V59, P730, DOI 10.1016/j.appet.2012.07.005; Freeman MC, 2014, EPIDEMIOL INFECT, V142, P340, DOI 10.1017/S0950268813001118; Freeman MC, 2013, AM J TROP MED HYG, V89, P875, DOI 10.4269/ajtmh.13-0237; Freeman MC, 2012, TROP MED INT HEALTH, V17, P380, DOI 10.1111/j.1365-3156.2011.02927.x; GOPINATHAN PM, 1988, ARCH ENVIRON HEALTH, V43, P15, DOI 10.1080/00039896.1988.9934367; Grandjean AC, 2007, J AM COLL NUTR, V26, p549S, DOI 10.1080/07315724.2007.10719657; Kavouras SA, 2002, CURR OPIN CLIN NUTR, V5, P519, DOI 10.1097/00075197-200209000-00010; Rogers PJ, 2001, APPETITE, V36, P57, DOI 10.1006/appe.2000.0374; SHARMA VM, 1983, INT ARCH OCC ENV HEA, V52, P315, DOI 10.1007/BF02226897; Talaat M, 2011, EMERG INFECT DIS, V17, P619, DOI 10.3201/eid1704.101353; Trinies V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150071; UNICEF, 2013, UNICEF WATER SANITAT; Wong D L, 1988, Pediatr Nurs, V14, P9; WYON DP, 1979, SCAND J WORK ENV HEA, V5, P352, DOI 10.5271/sjweh.2646	27	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210568	10.1371/journal.pone.0210568	http://dx.doi.org/10.1371/journal.pone.0210568			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653554	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000456015500052
J	Mohammad, SF; Feng, Y; Yang, GY				Mohammad, Shah Faisal; Feng, Yan; Yang, Guangyu			Optimization of cell culture and cell disruption processes to enhance the production of thermophilic cellulase FnCel5A in E.coli using response surface methodology	PLOS ONE			English	Article							RECOMBINANT ESCHERICHIA-COLI; SOLID-STATE FERMENTATION; XYLANASE PRODUCTION; EXPRESSION; PROTEIN; IMPROVEMENT; RELEASE; OXIDASE	FnCel5A from Fervidobacterium nodosum is one of the most thermostable endoglucanases that have phenomenal characteristics, such as high activity, pH stability, and multi-specificity towards various substrates. However, large-scale thermophilic enzyme production is still a challenge. Herein, we focus on an optimization approach based on response surface methodology to improve the production of this enzyme. First, a Box-Behnken design was used to examine physiochemical parameters such as induction temperatures, isopropyl beta-D-1-thiogalactopyranoside concentrations and induction times on the heterogeneous expression of FnCel5A gene in E. coli. The best culture was collected after adding 0.56 mM IPTG and incubating it for 29.5 h at 24 degrees C. The highest enzymatic activity observed was 3.31 IU/ mL. Second, an economical " thermolysis" cell lysis method for the liberation of the enzymes was also optimized using Box-Behnken design. The optimal levels of the variables were temperature 77 degrees C, pH 7.71, and incubation time of 20 min, which gave about 74.3% higher activity than the well-established bead-milling cell disruption method. The maximum productivity of FnCel5A achieved (5772 IU/L) illustrated that its production increased significantly after combining both optimal models. This strategy can be scaled-up readily for overproduction of FnCel5A from recombinant E. coli to facilitate its usage in biomass energy production.	[Mohammad, Shah Faisal; Feng, Yan; Yang, Guangyu] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai, Peoples R China	Shanghai Jiao Tong University	Yang, GY (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai, Peoples R China.	yanggy@sjtu.edu.cn			National Natural Science Foundation of China [31670791]; Ministry of Science and Technology of the People's Republic of China [2017YFE0103300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was supported by National Natural Science Foundation of China (Grant No. 31670791) to GY, and Ministry of Science and Technology of the People's Republic of China (CN) (2017YFE0103300) to FY.	Alshaibani AM, 2014, BRAZ J CHEM ENG, V31, P69, DOI 10.1590/S0104-66322014000100008; Anderson M.J., 2016, RSM SIMPLIFIED OPTIM; Bhalla A, 2013, BIORESOURCE TECHNOL, V128, P751, DOI 10.1016/j.biortech.2012.10.145; Brijwani K, 2010, PROCESS BIOCHEM, V45, P120, DOI 10.1016/j.procbio.2009.08.015; BUNGE F, 1992, CHEM ENG SCI, V47, P225, DOI 10.1016/0009-2509(92)80216-Y; Cao Y, 2008, AFR J BIOTECHNOL, V7, P631; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Elleuche S, 2014, CURR OPIN BIOTECH, V29, P116, DOI 10.1016/j.copbio.2014.04.003; ESTERBAUER H, 1991, BIORESOURCE TECHNOL, V36, P51, DOI 10.1016/0960-8524(91)90099-6; Falconer RJ, 1998, BIOTECHNOL BIOENG, V57, P381, DOI 10.1002/(SICI)1097-0290(19980220)57:4<381::AID-BIT1>3.3.CO;2-D; FELIU JX, 1994, BIOTECHNOL TECH, V8, P509, DOI 10.1007/BF00222845; FISH NM, 1984, BIO-TECHNOL, V2, P623, DOI 10.1038/nbt0784-623; Gawande PV, 1999, J APPL MICROBIOL, V87, P511, DOI 10.1046/j.1365-2672.1999.00843.x; Geciova J, 2002, MILCHWISSENSCHAFT, V57, P509; Geciova J, 2002, INT DAIRY J, V12, P541, DOI 10.1016/S0958-6946(02)00038-9; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Haltrich D, 1996, BIORESOURCE TECHNOL, V58, P137, DOI 10.1016/S0960-8524(96)00094-6; Hsiung M. A, 1989, BIOTECHNOLOGY, P267; Huber R, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-42; Hughes DE, 1971, METHOD MICROBIOL, P1; Iandolo J J, 1996, J BACTERIOL, P134; Kaili Zhao, 2005, INT J CHEM REACT ENG, V1281, P1542; Karnaouri AC, 2014, APPL MICROBIOL BIOT, V98, P231, DOI 10.1007/s00253-013-4895-9; KATO C, 1987, GENE, V54, P197, DOI 10.1016/0378-1119(87)90487-2; Maciel GM, 2008, FOOD TECHNOL BIOTECH, V46, P183; Marco de A, 2007, BMC BIOTECHNOL, P7; Middleberg A. P. J, 1995, BIOTECHNOL ADV, P491; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Miller P. S, 2010, ENVIRON TECHNOL, P8; Moradpour Z, 2014, MINERVA BIOTECNOL, V26, P281; MOREIN S, 1994, ANAL BIOCHEM, V216, P47, DOI 10.1006/abio.1994.1006; Oberoi HS, 2012, FOOD BIOPROD PROCESS, V90, P257, DOI 10.1016/j.fbp.2011.05.002; OH S, 1995, APPL ENVIRON MICROB, V61, P3809, DOI 10.1128/AEM.61.11.3809-3814.1995; Paes G, 2006, J BIOTECHNOL, V125, P338, DOI 10.1016/j.jbiotec.2006.03.025; Park YS, 2002, APPL MICROBIOL BIOT, V58, P761, DOI 10.1007/s00253-002-0965-0; Ren XD, 2007, BIOCHEM ENG J, V33, P94, DOI 10.1016/j.bej.2006.09.017; Romano D, 2009, PROTEIN EXPRES PURIF, V68, P72, DOI 10.1016/j.pep.2009.05.013; SCHMITT B, 1976, BIOCHIMIE, V58, P1405; Schutte H, 1990, BEAD MILL DISRUPTION, P108; Shibasaki I, 1973, ACTA ALIMENT HUNG, P327; Szijarto N, 2011, BIOTECHNOL BIOFUELS, P1754; Viikari L, 2012, BIOMASS BIOENERG, V46, P13, DOI 10.1016/j.biombioe.2012.05.008; Virgilio C. D. E, 1991, FEBS LETT, P355; Wang HL, 2011, BIORESOURCE TECHNOL, V102, P6082, DOI 10.1016/j.biortech.2011.01.040; Wang K, 2014, APPL MICROBIOL BIOT, V98, P7051, DOI 10.1007/s00253-014-5680-0; Wang YH, 2005, PROCESS BIOCHEM, V40, P2721, DOI 10.1016/j.procbio.2004.12.024; Wang YG, 2010, J MOL CATAL B-ENZYM, V66, P294, DOI 10.1016/j.molcatb.2010.06.006; YU P, 1992, BIOTECHNOL PROGR, V8, P25, DOI 10.1021/bp00013a005; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003; Zheng BS, 2009, ACTA CRYSTALLOGR F, V65, P219, DOI 10.1107/S1744309109001316	50	5	5	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210595	10.1371/journal.pone.0210595	http://dx.doi.org/10.1371/journal.pone.0210595			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653549	Green Published, Green Submitted, gold			2022-12-26	WOS:000456015500054
J	Simpson, DA; Quigley, MA; Kurinczuk, JJ; Carson, C				Simpson, Deon A.; Quigley, Maria A.; Kurinczuk, Jennifer J.; Carson, Claire			Twenty-five-year trends in breastfeeding initiation: The effects of sociodemographic changes in Great Britain, 1985-2010	PLOS ONE			English	Article							MATERNAL SMOKING; DURATION; EXPERIENCES; EMPLOYMENT; EDUCATION; BEHAVIOR; CONTEXT; LEVEL; CHILD	Background Data from the UK Infant Feeding Surveys indicate that breastfeeding initiation increased between 1985 and 2010. During this period, societal changes in GB also influenced the sociodemographic characteristics of women in the childbearing population. As breastfeeding behaviour is highly socially patterned in GB, the increasing trend in breastfeeding initiation may have hidden inequalities in breastfeeding practices. This study examines the sociodemographic inequalities in breastfeeding initiation in GB between 1985 and 2010, exploring whether and how this may have been influenced by social and policy changes. Methods Data drawn from the nationally representative 1985, 1990, 1995, 2000, 2005 and 2010 Infant Feeding Surveys were used to estimate changes in the proportion of mothers in selected sociodemographic groups over time. Logistic regression models estimated the independent associations between breastfeeding initiation in each survey year and maternal sociodemographic characteristics. Associations were adjusted for maternal sociodemographic, pregnancy-related and support factors. Evidence of a change in the association between breastfeeding initiation and each sociodemographic characteristic over time was assessed using a test for statistical heterogeneity. Results The sociodemographic characteristics of mothers in GB changed substantially between 1985 and 2010. Mothers were increasingly more likely to be 30 or over; have higher education and socioeconomic status; and be single or cohabiting. An increasing proportion of mothers in GB identified as being of black or minority ethnic origin. Reported smoking in pregnancy declined. These same characteristics independently predicted higher odds of breastfeeding initiation; the associations between these characteristics and breastfeeding initiation did not vary significantly over time. Conclusions Marked inequalities in breastfeeding initiation persisted over the study period, hidden among the increasing initiation rate at the population level. The increasing overall rate of initiation was most likely driven by the rising prevalence of those groups of mothers who were, and remain, characteristically most likely to breastfeed.	[Simpson, Deon A.; Quigley, Maria A.; Kurinczuk, Jennifer J.; Carson, Claire] Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Oxford, England	University of Oxford	Simpson, DA (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Oxford, England.	deon.simpson@npeu.ox.ac.uk		Simpson, Deon/0000-0002-3421-2437; Quigley, Maria/0000-0002-8058-6181	Nuffield Department of Population Health, University of Oxford	Nuffield Department of Population Health, University of Oxford	This study was conducted as part of DAS' Doctor of Philosophy in Population Health at the University of Oxford. DAS received a fully funded doctoral research studentship from the Nuffield Department of Population Health, University of Oxford. URL: https://www.ndph.ox.ac.uk.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adda J, 2017, J POLIT ECON, V125, P293, DOI 10.1086/690952; Amir LH, 2001, EARLY HUM DEV, V64, P45, DOI 10.1016/S0378-3782(01)00170-0; [Anonymous], 2017, AD FOST SURR; Bar-Yam N B, 1997, J Hum Lact, V13, P45, DOI 10.1177/089033449701300116; Becares L, 2015, SOC SCI MED, V142, P128, DOI 10.1016/j.socscimed.2015.08.025; Becares L, 2009, HEALTH PLACE, V15, P700, DOI 10.1016/j.healthplace.2008.10.008; Blanden J, 2004, SCOT J POLIT ECON, V51, P230, DOI 10.1111/j.0036-9292.2004.00304.x; Colodro-Conde L, 2011, J HUM LACT, V27, P272, DOI 10.1177/0890334411403929; Dennis CL, 2002, JOGNN-J OBST GYN NEO, V31, P12, DOI 10.1111/j.1552-6909.2002.tb00019.x; Dex S, 1998, OXFORD B ECON STAT, V60, P79, DOI 10.1111/1468-0084.00087; European Statistics, 2015, PEOPL EU WHO AR WE D; Fitzpatrick KE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153447; Griffiths LJ, 2005, INT J EPIDEMIOL, V34, P1378, DOI 10.1093/ije/dyi162; Hawkins SS, 2007, PAEDIATR PERINAT EP, V21, P242, DOI 10.1111/j.1365-3016.2007.00812.x; HENDERSHOT GE, 1984, PEDIATRICS, V74, P591; Higgins J, 2011, COCHRANE COLLAB, V5, P1; Ingram J, 2008, MATERN CHILD NUTR, V4, P171, DOI 10.1111/j.1740-8709.2007.00129.x; Johns HM, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-212; Kelly YJ, 2006, PEDIATRICS, V118, pE1428, DOI 10.1542/peds.2006-0714; Kent K., 2009, EC LABOUR MARKET REV, V3, P30; Kiernan K, 2006, SOC SCI MED, V63, P335, DOI 10.1016/j.socscimed.2006.01.006; Kiernan KE, 1989, FAMILY FORMATION FIS, P27; Law C., 2009, UNDERSTANDING HLTH I, P37; LIESTOL K, 1988, J BIOSOC SCI, V20, P45, DOI 10.1017/S0021932000017247; Magnusson M, 2016, CHILD CARE HLTH DEV, V42, P415, DOI 10.1111/cch.12327; McAndrew F, 2012, INFANT FEEDING SURVE; McFadden A, 2013, HEALTH EXPECT, V16, pE124, DOI 10.1111/j.1369-7625.2012.00770.x; Mills M, 2011, HUM REPROD UPDATE, V17, P848, DOI 10.1093/humupd/dmr026; Napierala M, 2016, ENVIRON RES, V151, P321, DOI 10.1016/j.envres.2016.08.002; Oakley LL, 2016, MATERN CHILD NUTR, V12, P440, DOI 10.1111/mcn.12159; Oakley LL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002765; Office for National Statistics, 2016, FAM HOUS UK 2016; Organisation for Economic Co-operation and Development, 2009, OECD FAM DAT CHILD O; Public Health England, PUBL HLTH PROF CHILD; Public Health England, PUBL HLTH OUTC FRAM; Rempel LA, 2004, J SOC PERS RELAT, V21, P92, DOI 10.1177/0265407504039841; Rempel LA, 2011, J HUM LACT, V27, P115, DOI 10.1177/0890334410390045; Schafer Ellen J, 2017, Matern Child Health J, V21, P1288, DOI 10.1007/s10995-016-2228-1; Simpson D., 2017, THESIS; Skafida V, 2012, MATERN CHILD HLTH J, V16, P519, DOI 10.1007/s10995-011-0743-7; Skafida V, 2009, PUBLIC HEALTH NUTR, V12, P2285, DOI 10.1017/S1368980009004947; StataCorp, 2013, STATA STAT SOFTW REL; Thulier D, 2009, JOGNN-J OBST GYN NEO, V38, P259, DOI 10.1111/j.1552-6909.2009.01021.x; TRUSSELL J, 1992, POP STUD-J DEMOG, V46, P285, DOI 10.1080/0032472031000146246; Wambach K A, 2000, J Obstet Gynecol Neonatal Nurs, V29, P282, DOI 10.1111/j.1552-6909.2000.tb02050.x; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED; Wright CM, 2006, PUBLIC HEALTH NUTR, V9, P686, DOI 10.1079/PHN2005888	47	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210838	10.1371/journal.pone.0210838	http://dx.doi.org/10.1371/journal.pone.0210838			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653579	Green Published, Green Submitted, gold			2022-12-26	WOS:000456015500079
J	Iwasawa, T; Takahashi, K; Goto, M; Anzai, M; Shirasawa, H; Sato, W; Kumazawa, Y; Terada, Y				Iwasawa, Takuya; Takahashi, Kazumasa; Goto, Mayumi; Anzai, Mibuki; Shirasawa, Hiromitsu; Sato, Wataru; Kumazawa, Yukiyo; Terada, Yukihiro			Human frozen-thawed blastocyst morphokinetics observed using time-lapse cinematography reflects the number of trophectoderm cells	PLOS ONE			English	Article							LIVE BIRTH; HUMAN EMBRYOS; VITRIFICATION; OOCYTES; ANEUPLOIDY; COLLAPSE; REVEALS	Recent studies reported morphokinetic indices for optimal selection of embryos in assisted reproductive technology (ART). The morphokinetics in blastocyst stage include the collapse and re-expansion rates after thawing. However, evaluation methods using these morphokinetics have not been established, mainly because the underlying molecular mechanisms remain unclarified. In this study, we focused on the relationship between these morphokinetic observation of the blastocyst behaviour and the number of cells constituting the blastocyst. We evaluated 38 surplus human frozen-thawed blastocysts using time-lapse cinematography and recorded their expansion, contraction, and hatching. A total of 28 blastocysts expanded in culture (cross-sectional area >= 5,000 Pi mu m(2)). In comparison to the ones that did not, the expanded group presented significantly more number of inner cell mass (ICM) and trophectoderm (TE) cells, which eventually develop into the fetus and placenta, respectively (ICM: Expanded 10.2 +/- 6.3 vs. Non-Expanded 6.0 +/- 12.3, p<0.05; TE: Expanded 165.7 +/- 74.8 vs. Non-Expanded 57.0 +/- 29.4, p<0.05). Moreover, a positive correlation was found between the expansion rate (up to 4 h) and the number of TE cells (r=0.558, p=0.0021). Additionally, blastocysts that hatched had a significantly higher number of TE cells than those that did not (hatching 225.2 +/- 61.2 vs. no hatching 121.1 +/- 48.6, p<0.0001). The number of TE cells per unit of cross-sectional area correlated negatively with the contraction time (r=-0.601, p=0.0007). No correlation between the number of ICM cells and these morphokinetics was detected. In conclusion, our study demonstrates that different morphokinetics of frozen-thawed blastocysts reflect the number of TE cells. The differentiation of blastocysts containing sufficient TE cells would be beneficial for implantation and prognosis of a subsequent pregnancy. Thus, evaluation of these morphokinetics can be an effective method to screen good embryos for ART.	[Iwasawa, Takuya; Takahashi, Kazumasa; Goto, Mayumi; Anzai, Mibuki; Shirasawa, Hiromitsu; Sato, Wataru; Kumazawa, Yukiyo; Terada, Yukihiro] Akita Univ, Grad Sch Med, Dept Obstet & Gynecol, Akita, Japan	Akita University	Iwasawa, T (corresponding author), Akita Univ, Grad Sch Med, Dept Obstet & Gynecol, Akita, Japan.	iwasawat@med.akita-u.ac.jp			JSPS KAKENHI [17K11215]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (https://www.jsps.go.jp/english/index.html), Grant Number 17K11215. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson E, 2018, J BRAS REPROD ASSIST, V22, P228, DOI 10.5935/1518-0557.20180042; Alikani M, 2005, HUM REPROD, V20, P3369, DOI 10.1093/humrep/dei242; Antinori M, 2007, REPROD BIOMED ONLINE, V14, P72, DOI 10.1016/S1472-6483(10)60766-3; Armstrong S, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011320.pub3; Bell CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059528; Bodri D, 2016, FERTIL STERIL, V105, P1476, DOI 10.1016/j.fertnstert.2016.02.014; Campbell A, 2013, REPROD BIOMED ONLINE, V26, P477, DOI 10.1016/j.rbmo.2013.02.006; De Paepe C, 2013, HUM REPROD, V28, P740, DOI 10.1093/humrep/des432; Desai N, 2005, REPROD BIOMED ONLINE, V11, P349, DOI 10.1016/S1472-6483(10)60843-7; Desai N, 2018, FERTIL STERIL, V109, P665, DOI 10.1016/j.fertnstert.2017.12.025; Du QY, 2016, FERTIL STERIL, V105, P910, DOI 10.1016/j.fertnstert.2015.12.014; Ebner T, 2016, J ASSIST REPROD GEN, V33, P49, DOI 10.1007/s10815-015-0609-9; Fleming TP, 2001, FRONT BIOSCI-LANDMRK, V6, pD1000, DOI 10.2741/Fleming; Gardner DK, 2016, MOL HUM REPROD, V22, P704, DOI 10.1093/molehr/gaw057; Gardner DK, 1999, TOWARDS REPRODUCTIVE CERTAINTY, P378; Goto S, 2011, FERTIL STERIL, V95, P948, DOI 10.1016/j.fertnstert.2010.06.067; HARDY K, 1989, DEVELOPMENT, V107, P597; Huang TTF, 2016, REPROD BIOMED ONLINE, V33, P659, DOI 10.1016/j.rbmo.2016.08.020; Jurisicova A, 1996, MOL HUM REPROD, V2, P93, DOI 10.1093/molehr/2.2.93; Liu L, 2002, HUM REPROD, V17, P2678, DOI 10.1093/humrep/17.10.2678; Marcos J, 2015, HUM REPROD, V30, P2501, DOI 10.1093/humrep/dev216; Martinez-Burgos M, 2011, FERTIL STERIL, V95, P374, DOI 10.1016/j.fertnstert.2010.07.1089; Mio Y, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.07.023; Niakan KK, 2013, DEV BIOL, V375, P54, DOI 10.1016/j.ydbio.2012.12.008; Niimura S, 2003, J REPROD DEVELOP, V49, P413, DOI 10.1262/jrd.49.413; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Onodera Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175150; Sathananthan Henry, 2003, Reprod Biomed Online, V7, P228; Shimoda Y, 2016, J REPROD DEVELOP, V62, P187, DOI 10.1262/jrd.2015-150; Shu Y, 2009, FERTIL STERIL, V91, P401, DOI 10.1016/j.fertnstert.2007.11.083; Toyooka Y, 2016, DEV BIOL, V411, P50, DOI 10.1016/j.ydbio.2016.01.011; Vialard F, 2011, CYTOGENET GENOME RES, V133, P127, DOI 10.1159/000324231; Watson AJ, 2004, ANIM REPROD SCI, V82-3, P583, DOI 10.1016/j.anireprosci.2004.04.004; Yamagata K, 2010, DEV BIOL, V346, P90, DOI 10.1016/j.ydbio.2010.07.021; Ziebe S, 2001, ACTA OBSTET GYN SCAN, V80, P169, DOI 10.1034/j.1600-0412.2001.080002169.x	35	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210992	10.1371/journal.pone.0210992	http://dx.doi.org/10.1371/journal.pone.0210992			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650134	Green Published, gold, Green Submitted			2022-12-26	WOS:000455813300083
J	Wang, ID; Chien, WC; Chung, CH; Tsai, PY; Chang, SY; Meng, FC; Peng, CK				Wang, I-Duo; Chien, Wu-Chien; Chung, Chi-Hsiang; Tsai, Pei-Yi; Chang, Shan-Yueh; Meng, Fan-Chun; Peng, Chung-Kan			Non-Apnea Sleep Disorder associates with increased risk of incident heart failure-A nationwide population-based cohort study	PLOS ONE			English	Article							INSOMNIA	Purpose Non-apnea sleep disorder (NASD) increases the risk of cardiovascular events, such as hypertension and ischemic heart disease (IHD). Patients with heart failure (HF) are at higher risk for sleep disorder; however, there is no documentation on NASD's association with HF to date. Therefore, our study aimed to determine whether NASD increases the risk of incident HF. Materials and methods Using the outpatient and inpatient data from Taiwan's Longitudinal Health Insurance Database, we conducted a nationwide cohort study of patients with a first-time diagnosis of NASD in the year 2000 and followed up the risk of incident heart failure until December 31, 2013. We calculated risks and incidence ratios of HF for patients with NASD compared with the general population. The cumulative incidence of NASD and the subsequent risk of HF are assessed by the Kaplan-Meier method and Cox regression using a matched comparison cohort of HF patients without NASD. Results The NASD cohort had an adjusted hazard ratio (HR) of incident HF 19.7% higher than that of the cohort without NASD (95% CI = 1.130-1.270; p<0.001). In the NASD population, the mean interval to HF in males and females were 5.00 +/- 3.69 years and 5.00 +/- 3.66 years, respectively. The Kaplan-Meier analysis indicated that after the seventh year, the incidence of HF was higher in the NASD cohort than in the control cohort till the end of the follow up. Conclusions Our study demonstrates that NASD patients are associated with a higher risk of incident HF.	[Wang, I-Duo; Chang, Shan-Yueh; Meng, Fan-Chun; Peng, Chung-Kan] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taipei, Taiwan; [Chien, Wu-Chien] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chien, Wu-Chien; Chung, Chi-Hsiang] Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan; [Tsai, Pei-Yi] Natl Cheng Kung Univ Hosp, Dept Radiat Oncol, Tainan, Taiwan; [Peng, Chung-Kan] Natl Def Med Ctr, Triserv Gen Hosp, Sleep Med Ctr, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Defense Medical Center; Tri-Service General Hospital	Peng, CK (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taipei, Taiwan.; Peng, CK (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Sleep Med Ctr, Taipei, Taiwan.	kanpeng@mail.ndmctsgh.edu.tw	Chung, Chi-Hsiang/AAY-3386-2021	I DUO, WANG/0000-0002-3395-7728; Chang, Shan-Yueh/0000-0001-8944-174X	Tri-Service General Hospital [TSGH-C106-002]; National Defense Medical Center	Tri-Service General Hospital; National Defense Medical Center	The study was supported by National Defense Medical Center and Tri-Service General Hospital (TSGH-C106-002) to WCC https://wwwv.tsgh.ndmctsgh.edu.tw/Unit/102362/25530.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by National Defense Medical Center and Tri-Service General Hospital (TSGH-C106-002).	Portela PC, 2009, CEREBROVASC DIS, V27, P104, DOI 10.1159/000200447; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cheng TM., 2012, 6 COUNTRIES 6 REFORM, P171; Chung WS, 2013, SLEEP, V36, P1963, DOI 10.5665/sleep.3240; Erickson Virginia S, 2003, AACN Clin Issues, V14, P477, DOI 10.1097/00044067-200311000-00009; Huang ST, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000429; Huang WS, 2013, SLEEP MED, V14, P1341, DOI 10.1016/j.sleep.2013.07.017; Ingelsson E, 2007, EUR J HEART FAIL, V9, P184, DOI 10.1016/j.ejheart.2006.05.012; Lai YJ, 2013, SLEEP MED, V14, P913, DOI 10.1016/j.sleep.2013.03.024; Laugsand LE, 2014, EUR HEART J, V35, P1382, DOI 10.1093/eurheartj/eht019; Lin CL, 2017, J HUM HYPERTENS, V31, P220, DOI 10.1038/jhh.2016.55; Mezick EJ, 2011, SLEEP MED REV, V15, P51, DOI 10.1016/j.smrv.2010.03.001; Newman AB, 2000, J AM GERIATR SOC, V48, P115, DOI 10.1111/j.1532-5415.2000.tb03901.x; Niiranen TJ, 2016, SLEEP BREATH, V20, P589, DOI 10.1007/s11325-015-1253-4; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Redeker NS, 2006, HEART LUNG, V35, P252, DOI 10.1016/j.hrtlng.2005.10.007; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; Spiegelhalder K, 2010, NAT SCI SLEEP, V2, P71; Su TP, 2004, AUST NZ J PSYCHIAT, V38, P706, DOI 10.1111/j.1440-1614.2004.01444.x; Taiwan's National Health Insurance System, 2009, 6 COUNTRIES 6 REFORM, P171; Thorpy MJ, 2012, NEUROTHERAPEUTICS, V9, P687, DOI 10.1007/s13311-012-0145-6; Zhang B, 2006, SLEEP, V29, P85, DOI 10.1093/sleep/29.1.85	22	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209673	10.1371/journal.pone.0209673	http://dx.doi.org/10.1371/journal.pone.0209673			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650103	Green Published, Green Submitted, gold			2022-12-26	WOS:000455813300021
J	Lof, A; Konig, G; Schneppenheim, S; Schneppenheim, R; Benoit, M; Budde, U; Muller, JP; Brehm, MA				Loef, Achim; Koenig, Gesa; Schneppenheim, Sonja; Schneppenheim, Reinhard; Benoit, Martin; Budde, Ulrich; Mueller, Jochen P.; Brehm, Maria A.			Advancing multimer analysis of von Willebrand factor by single-molecule AFM imaging	PLOS ONE			English	Article							VONWILLEBRAND-FACTOR; DISEASE; SECRETION; DOMAIN; DIMERIZATION; STORAGE; PH; MUTATIONS; ADHESION	The formation of hemostatic plugs at sites of vascular injury crucially involves the multimeric glycoprotein von Willebrand factor (VWF). VWF multimers are linear chains of N-terminally linked dimers. The latter are formed from monomers via formation of the C-terminal disulfide bonds Cys2771-Cys2773', Cys2773-Cys2771', and Cys2811-Cys2811'. Mutations in VWF that impair multimerization can lead to subtype 2A of the bleeding disorder von Willebrand Disease (VWD). Commonly, the multimer size distribution of VWF is assessed by electrophoretic multimer analysis. Here, we present atomic force microscopy (AFM) imaging as a method to determine the size distribution of VWF variants by direct visualization at the single-molecule level. We first validated our approach by investigating recombinant wildtype VWF and a previously studied mutant (p. Cys1099Tyr) that impairs N-terminal multimerization. We obtained excellent quantitative agreement with results from earlier studies and with electrophoretic multimer analysis. We then imaged specific mutants that are known to exhibit disturbed C-terminal dimerization. For the mutants p. Cys2771Arg and p. Cys2773Arg, we found the majority of monomers (87 +/- 5% and 73 +/- 4%, respectively) not to be C-terminally dimerized. While these results confirm that Cys2771 and Cys2773 are crucial for dimerization, they additionally provide quantitative information on the mutants' different abilities to form alternative C-terminal disulfides for residual dimerization. We further mutated Cys2811 to Ala and found that only 23 +/- 3% of monomers are not C-terminally dimerized, indicating that Cys2811 is structurally less important for dimerization. Furthermore, for mutants p. Cys2771Arg, p. Cys2773Arg, and p. Cys2811Ala we found 'even-numbered' non-native multimers, i.e. multimers with monomers attached on both termini; a multimer species that cannot be distinguished from native multimers by conventional multimer analysis. Summarizing, we demonstrate that AFM imaging can provide unique insights into VWF processing defects at the single-molecule level that cannot be gained from established methods of multimer analysis.	[Loef, Achim; Benoit, Martin; Mueller, Jochen P.] Ludwig Maximilians Univ Munchen, Dept Phys, Munich, Germany; [Koenig, Gesa; Schneppenheim, Reinhard; Brehm, Maria A.] Ludwig Maximilians Univ Munchen, Ctr NanoSci, Munich, Germany; [Schneppenheim, Sonja; Budde, Ulrich] Univ Med Ctr Hamburg Eppendorf, Dept Pediat Hematol & Oncol, Hamburg, Germany	University of Munich; University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf	Brehm, MA (corresponding author), Ludwig Maximilians Univ Munchen, Ctr NanoSci, Munich, Germany.	m.brehm@uke.de		Lof, Achim/0000-0002-4301-2402; Brehm, Maria Alexandra/0000-0003-0416-8233	German Research foundation (DFG) [386143268]	German Research foundation (DFG)(German Research Foundation (DFG))	Funding was provided by the German Research foundation (DFG; www.dfg.de) to Research group FOR1543 (RS, MB) and to project 386143268 (MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brehm MA, 2014, THROMB HAEMOSTASIS, V112, P96, DOI 10.1160/TH13-11-0902; Budde U, 2008, J THROMB HAEMOST, V6, P762, DOI 10.1111/j.1538-7836.2008.02945.x; BUDDE U, 1990, THROMB HAEMOSTASIS, V63, P312; Castaman G, 2012, J THROMB HAEMOST, V10, P951, DOI 10.1111/j.1538-7836.2012.04702.x; GEISOW MJ, 1984, EXP CELL RES, V150, P36, DOI 10.1016/0014-4827(84)90699-2; Giblin JP, 2008, BLOOD, V112, P957, DOI 10.1182/blood-2007-12-130740; Groeneveld DJ, 2014, BRIT J HAEMATOL, V167, P529, DOI 10.1111/bjh.13074; Katsumi A, 2000, J BIOL CHEM, V275, P25585, DOI 10.1074/jbc.M002654200; Lippok S, 2016, BLOOD, V127, P1183, DOI 10.1182/blood-2015-04-641902; Lippok S, 2013, BIOPHYS J, V105, P1208, DOI 10.1016/j.bpj.2013.07.037; Lof A, 2018, J CELL PHYSIOL, V233, P799, DOI 10.1002/jcp.25887; Michaux G, 2006, DEV CELL, V10, P223, DOI 10.1016/j.devcel.2005.12.012; Michaux G, 2003, BLOOD, V102, P2452, DOI 10.1182/blood-2003-02-0599; Muller JP, 2016, BIOPHYS J, V111, P312, DOI 10.1016/j.bpj.2016.06.022; Muller JP, 2016, P NATL ACAD SCI USA, V113, P1208, DOI 10.1073/pnas.1516214113; Purvis AR, 2007, P NATL ACAD SCI USA, V104, P15647, DOI 10.1073/pnas.0705175104; Ruggeri ZM, 2006, BLOOD, V108, P1903, DOI 10.1182/blood-2006-04-011551; Sadler JE, 2006, J THROMB HAEMOST, V4, P2103, DOI 10.1111/j.1538-7836.2006.02146.x; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Schmidt TGM, 2013, PROTEIN EXPRES PURIF, V92, P54, DOI 10.1016/j.pep.2013.08.021; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; SCHNEPPENHEIM R, 1988, THROMB HAEMOSTASIS, V60, P133; Schneppenheim R, 1996, P NATL ACAD SCI USA, V93, P3581, DOI 10.1073/pnas.93.8.3581; Schneppenheim R, 2001, BLOOD, V97, P2059, DOI 10.1182/blood.V97.7.2059; Schneppenheim R, 2010, BLOOD, V115, P4894, DOI 10.1182/blood-2009-07-226324; SPORN LA, 1989, J CELL BIOL, V108, P1283, DOI 10.1083/jcb.108.4.1283; Springer TA, 2014, BLOOD, V124, P1412, DOI 10.1182/blood-2014-05-378638; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; White-Adams TC, 2016, THROMB RES, V145, P112, DOI 10.1016/j.thromres.2016.08.009; Yang J, 2006, P NATL ACAD SCI USA, V103, P13872, DOI 10.1073/pnas.0601455103; Zhou YF, 2014, BLOOD, V123, P1785, DOI 10.1182/blood-2013-11-523639; Zhou YF, 2011, EMBO J, V30, P4098, DOI 10.1038/emboj.2011.297	32	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210963	10.1371/journal.pone.0210963	http://dx.doi.org/10.1371/journal.pone.0210963			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645640	Green Published, Green Submitted, gold			2022-12-26	WOS:000455810200062
J	Comito, G; Iscaro, A; Bacci, M; Morandi, A; Ippolito, L; Parri, M; Montagnani, I; Raspollini, MR; Serni, S; Simeoni, L; Giannoni, E; Chiarugi, P				Comito, G.; Iscaro, A.; Bacci, M.; Morandi, A.; Ippolito, L.; Parri, M.; Montagnani, I.; Raspollini, M. R.; Serni, S.; Simeoni, L.; Giannoni, E.; Chiarugi, P.			Lactate modulates CD4(+) T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8/miR21 axis	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CANCER-ASSOCIATED FIBROBLASTS; FACTOR-KAPPA-B; LACTIC-ACID; TGF-BETA; TUMOR; METABOLISM; ACTIVATION; EXPRESSION; GLUTAMINE	Leukocyte infiltration plays an active role in controlling tumor development. In the early stages of carcinogenesis, T cells counteract tumor growth. However, in advanced stages, cancer cells and infiltrating stromal components interfere with the immune control and instruct immune cells to support, rather than counteract, tumor malignancy, via cell-cell contact or soluble mediators. In particular, metabolites are emerging as active players in driving immunosuppression. Here we demonstrate that in a prostate cancer model lactate released by glycolytic cancer-associated fibroblasts (CAFs) acts on CD4(+) T cells, shaping T-cell polarization. In particular, CAFs exposure (i) reduces the percentage of the antitumoral Th1 subset, inducing a lactate-dependent, SIRT1-mediated deacetylation/degradation of T-bet transcription factor; (ii) increases T-reg cells, driving naive T cells polarization, through a lactate-based NF-kB activation and FoxP3 expression. In turn, this metabolic-based CAF-immunomodulated environment exerts a pro-invasive effect on prostate cancer cells, by activating a previously unexplored miR21/TLR8 axis that sustains cancer malignancy.	[Comito, G.; Bacci, M.; Morandi, A.; Ippolito, L.; Parri, M.; Giannoni, E.; Chiarugi, P.] Univ Florence, Dept Expt & Clin Biomed Sci, I-50134 Florence, Italy; [Iscaro, A.] Univ Sheffield, Med Sch, Dept Oncol & Metab, Beech Hill Rd, Sheffield, S Yorkshire, England; [Montagnani, I.; Raspollini, M. R.] Univ Hosp Careggi, Histopathol & Mol Diagnost, Largo Brambilla 3, I-50134 Florence, Italy; [Serni, S.] Univ Florence, Careggi Hosp, Dept Urol Robot Surg & Renal Transplantat, I-50134 Florence, Italy; [Simeoni, L.] Otto Von Guericke Univ, Inst Mol & Clin Immunol, Leipziger Str 44, D-39120 Magdeburg, Germany; [Chiarugi, P.] Tuscany Tumor Inst ITT, I-50134 Florence, Italy; [Chiarugi, P.] Excellence Ctr Res Transfer & High Educ DenoTHE, I-50134 Florence, Italy	University of Florence; University of Sheffield; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; Azienda Ospedaliero Universitaria Careggi; Otto von Guericke University; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Giannoni, E (corresponding author), Univ Florence, Dept Expt & Clin Biomed Sci, I-50134 Florence, Italy.	elisa.giannoni@unifi.it	Morandi, Andrea/AAC-1901-2022; Bacci, Marina/AFN-8715-2022; Giannoni, Elisa/AAE-2092-2020; Chiarugi, Paola/CDD-7988-2022	Morandi, Andrea/0000-0002-9222-5332; Ippolito, Luigi/0000-0001-7927-8555; Chiarugi, Paola/0000-0001-7655-2969	Fondazione Umberto Veronesi; Associazione Italiana Ricerca sul Cancro (AIRC) [8797]; AIRC; Fondazione Cassa di Risparmio di Firenze [19515]; Istituto Toscano Tumori [0203607]; Programma operativo regionale Obiettivo "Competitivita regionale e occupazione" della Regione Toscana cofinanziato dal Fondo europeo di sviluppo regionale 2007-2013 (POR CReO FESR 2007-2013)	Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); AIRC(Fondazione AIRC per la ricerca sul cancro); Fondazione Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); Istituto Toscano Tumori; Programma operativo regionale Obiettivo "Competitivita regionale e occupazione" della Regione Toscana cofinanziato dal Fondo europeo di sviluppo regionale 2007-2013 (POR CReO FESR 2007-2013)	The work was supported by Fondazione Umberto Veronesi to GC and AM, Associazione Italiana Ricerca sul Cancro (AIRC) (grant 8797 to PC), AIRC and Fondazione Cassa di Risparmio di Firenze (grant 19515 to PC and AM), Istituto Toscano Tumori (grant 0203607 to PC), Programma operativo regionale Obiettivo "Competitivita regionale e occupazione" della Regione Toscana cofinanziato dal Fondo europeo di sviluppo regionale 2007-2013 (POR CReO FESR 2007-2013, grant to PC). The authors thank Dr. Lavinia Ferrone for technical support.	Alsaab HO, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00561; Anari F, 2018, FUTURE ONCOL, V14, P1409, DOI 10.2217/fon-2017-0585; Angelin A, 2017, CELL METAB, V25, P1282, DOI 10.1016/j.cmet.2016.12.018; Biswas SK, 2015, IMMUNITY, V43, P435, DOI 10.1016/j.immuni.2015.09.001; Brand A, 2016, CELL METAB, V24, P657, DOI 10.1016/j.cmet.2016.08.011; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Calcinotto A, 2012, CANCER RES, V72, P2746, DOI 10.1158/0008-5472.CAN-11-1272; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Costa A, 2018, CANCER CELL, V33, P463, DOI 10.1016/j.ccell.2018.01.011; Eidelman E, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00131; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Fang DF, 2017, J EXP MED, V214, P1861, DOI 10.1084/jem.20170494; Fiaschi Tania, 2012, Int J Cell Biol, V2012, P762825, DOI 10.1155/2012/762825; Fiaschi T, 2012, CANCER RES, V72, P5130, DOI 10.1158/0008-5472.CAN-12-1949; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; Flammiger A, 2013, EUR J CANCER, V49, P1273, DOI 10.1016/j.ejca.2012.11.035; Gambini J, 2011, ARCH BIOCHEM BIOPHYS, V512, P24, DOI 10.1016/j.abb.2011.04.020; Geltink RIK, 2018, ANNU REV IMMUNOL, V36, P461, DOI 10.1146/annurev-immunol-042617-053019; Giannoni E, 2015, ONCOTARGET, V6, P24061, DOI 10.18632/oncotarget.4448; Giannoni E, 2011, ANTIOXID REDOX SIGN, V14, P2361, DOI 10.1089/ars.2010.3727; Giannoni E, 2010, CANCER RES, V70, P6945, DOI 10.1158/0008-5472.CAN-10-0785; Gottfried E, 2006, BLOOD, V107, P2013, DOI 10.1182/blood-2005-05-1795; Guarente L, 2013, GENE DEV, V27, P2072, DOI 10.1101/gad.227439.113; Ha Tai-You, 2009, Immune Netw, V9, P209, DOI 10.4110/in.2009.9.6.209; Haas R, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002202; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Huber V, 2017, SEMIN CANCER BIOL, V43, P74, DOI 10.1016/j.semcancer.2017.03.001; Hude I, 2017, HAEMATOLOGICA, V102, P30, DOI 10.3324/haematol.2016.150656; Husain Z, 2013, J IMMUNOL, V191, P1486, DOI 10.4049/jimmunol.1202702; Johnston CJC, 2016, CELL IMMUNOL, V299, P14, DOI 10.1016/j.cellimm.2015.10.006; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Levine BL, 1997, J IMMUNOL, V159, P5921; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Lim S, 2017, CANCER RES, V77, P1245, DOI 10.1158/0008-5472.CAN-16-1647; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Ludin A, 2017, NATURE, V552, P41, DOI 10.1038/nature24759; Lyssiotis CA, 2017, TRENDS CELL BIOL, V27, P873, DOI 10.1016/j.tcb.2017.06.003; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Mendler AN, 2012, INT J CANCER, V131, P633, DOI 10.1002/ijc.26410; Metzler B, 2016, J IMMUNOL, V196, P3618, DOI 10.4049/jimmunol.1501756; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mishra R, 2018, J CLIN INVEST, V128, P4472, DOI 10.1172/JCI99397; Montanari M, 2017, ONCOTARGET, V8, P35376, DOI 10.18632/oncotarget.15686; Morrot A, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00081; Murray CM, 2005, NAT CHEM BIOL, V1, P371, DOI 10.1038/nchembio744; Neuzillet C, 2015, PHARMACOL THERAPEUT, V147, P22, DOI 10.1016/j.pharmthera.2014.11.001; Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238; Pearce EL, 2010, CURR OPIN IMMUNOL, V22, P314, DOI 10.1016/j.coi.2010.01.018; Pfeffer SR, 2015, DRUG DEVELOP RES, V76, P270, DOI 10.1002/ddr.21257; Polet F, 2013, J INTERN MED, V273, P156, DOI 10.1111/joim.12016; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Renner K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00248; Romero-Garcia S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00052; Ruan QG, 2012, ADV EXP MED BIOL, V946, P207, DOI 10.1007/978-1-4614-0106-3_12; Saada A, 2014, INT J BIOCHEM CELL B, V48, P60, DOI 10.1016/j.biocel.2013.12.010; Shime H, 2008, J IMMUNOL, V180, P7175, DOI 10.4049/jimmunol.180.11.7175; Siska PJ, 2015, TRENDS IMMUNOL, V36, P257, DOI 10.1016/j.it.2015.02.007; Sonveaux P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033418; Sotgia F, 2012, CELL CYCLE, V11, P1445, DOI 10.4161/cc.19841; Su SC, 2017, CELL RES, V27, P461, DOI 10.1038/cr.2017.34; Sugiura A, 2018, J IMMUNOL, V200, P400, DOI 10.4049/jimmunol.1701041; Thompson ED, 2010, J EXP MED, V207, P1791, DOI 10.1084/jem.20092454; van Loosdregt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019047; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; Wang F, 2012, ONCOGENE, V31, P1546, DOI 10.1038/onc.2011.347; Wang X, 2016, ONCOTARGETS THER, V9, P5023, DOI 10.2147/OTT.S105862; Wong N, 2014, CANCER INVEST, V32, P330, DOI 10.3109/07357907.2014.919306; Yoshida GJ, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0221-y; Zhang Q, 2009, CLIN CANCER RES, V15, P3557, DOI 10.1158/1078-0432.CCR-08-1656; Ziani L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00414	75	84	86	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 9	2019	38	19					3681	3695		10.1038/s41388-019-0688-7	http://dx.doi.org/10.1038/s41388-019-0688-7			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HX4OU	30664688				2022-12-26	WOS:000467379600009
J	Das, S; Nair, RS; Mishra, R; Sondarva, G; Viswakarma, N; Abdelkarim, H; Gaponenko, V; Rana, B; Rana, A				Das, Subhasis; Nair, Rakesh Sathish; Mishra, Rajakishore; Sondarva, Gautam; Viswakarma, Navin; Abdelkarim, Hazem; Gaponenko, Vadim; Rana, Basabi; Rana, Ajay			Mixed lineage kinase 3 promotes breast tumorigenesis via phosphorylation and activation of p21-activated kinase 1	ONCOGENE			English	Article							I-TASSER; SIGNALING PATHWAYS; PROTEIN-STRUCTURE; PAK1 KINASE; CANCER; TRANSLOCATION; LOCALIZATION; EXPRESSION; MECHANISM; APOPTOSIS	Mixed lineage kinase 3 (MLK3), a MAP3K member has been envisioned as a viable drug target in cancer, yet its detailed function and signaling is not fully elucidated. We identified that MLK3 tightly associates with an oncogene, PAK1. Mammalian PAK1 being a Ste20 (MAP4K) member, we tested whether it is an upstream regulator of MLK3. In contrast to our hypothesis, MLK3 activated PAK1 kinase activity directly, as well as in the cells. Although, MLK3 can phosphorylate PAK1 on Ser133 and Ser204 sites, PAK1S133A mutant is constitutively active, whereas, PAK1S204A is not activated by MLK3. Stable overexpression of PAK1S204A in breast cancer cells, impedes migration, invasion, and NF kappa B activity. In vivo breast cancer cell tumorigenesis is significantly reduced in tumors expressing PAK1S204A mutant. These results suggest that mammalian PAK1 does not act as a MAP4K and MLK3-induced direct activation of PAK1 plays a key role in breast cancer tumorigenesis.	[Das, Subhasis; Nair, Rakesh Sathish; Sondarva, Gautam; Viswakarma, Navin; Rana, Basabi; Rana, Ajay] Univ Illinois, Div Surg Oncol, Dept Surg, Chicago, IL 60612 USA; [Mishra, Rajakishore] Cent Univ Jharkhand, Sch Nat Sci, Ctr Life Sci, Ranchi 835205, Jharkhand, India; [Abdelkarim, Hazem; Gaponenko, Vadim] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Rana, Basabi; Rana, Ajay] Univ Illinois, Univ Illinois Hosp, Chicago, IL 60612 USA; [Rana, Basabi; Rana, Ajay] Univ Illinois, Hlth Sci Syst Canc Ctr, Chicago, IL 60612 USA; [Rana, Basabi; Rana, Ajay] Jesse Brown VA Med Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Central University of Jharkhand; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Rana, A (corresponding author), Univ Illinois, Div Surg Oncol, Dept Surg, Chicago, IL 60612 USA.; Rana, A (corresponding author), Univ Illinois, Univ Illinois Hosp, Chicago, IL 60612 USA.; Rana, A (corresponding author), Univ Illinois, Hlth Sci Syst Canc Ctr, Chicago, IL 60612 USA.; Rana, A (corresponding author), Jesse Brown VA Med Ctr, Chicago, IL 60612 USA.	arana@uic.edu	Mishra, Rajakishore/ABC-3550-2020; Rana, Ajay/ABE-3739-2020; Das, Subhasis/O-8421-2017	Rana, Ajay/0000-0003-0951-2566; Das, Subhasis/0000-0003-1032-4407; Gaponenko, Vadim/0000-0002-7891-9223	National Cancer Institute [CA 176846, CA 216410, CA 178063, CA 188427]; Veteran Administration Merit Awards [BX002703, BX003296]; NIH shared instrument grant [S100D018445]; NATIONAL CANCER INSTITUTE [R01CA176846, R01CA178063, R01CA188427] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003296] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veteran Administration Merit Awards; NIH shared instrument grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	We acknowledge funding support from National Cancer Institute to A.R. (CA 176846 and CA 216410), B.R. (CA 178063) and V.G. (CA 188427). Additional support came from Veteran Administration Merit Awards to A.R. (BX002703) and B.R. (BX003296). We also acknowledge the NIH shared instrument grant # S100D018445, awarded to U.A.M.S. Proteomics Core Lab, Little Rock, Arkansas, USA.	Bodner A, 2002, J NEUROCHEM, V82, P1424, DOI 10.1046/j.1471-4159.2002.01088.x; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; French JD, 2013, AM J HUM GENET, V92, P489, DOI 10.1016/j.ajhg.2013.01.002; Frost JA, 2000, J BIOL CHEM, V275, P19693, DOI 10.1074/jbc.M909860199; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Heo L, 2016, SCI REP-UK, V6, DOI 10.1038/srep32153; Holm C, 2006, JNCI-J NATL CANCER I, V98, P671, DOI 10.1093/jnci/djj185; Jha RK, 2011, J MOL BIOL, V413, P513, DOI 10.1016/j.jmb.2011.08.022; Knaus UG, 1998, INT J BIOCHEM CELL B, V30, P857, DOI 10.1016/S1357-2725(98)00059-4; Kumar R, 2002, J CELL PHYSIOL, V193, P133, DOI 10.1002/jcp.10167; Lee BN, 1999, P NATL ACAD SCI USA, V96, P12679, DOI 10.1073/pnas.96.22.12679; Letessier A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-245; Lu WG, 1999, ONCOGENE, V18, P797, DOI 10.1038/sj.onc.1202361; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; Mao K, 2008, J MOL CELL CARDIOL, V44, P429, DOI 10.1016/j.yjmcc.2007.10.016; Mayhew MW, 2007, J CELL SCI, V120, P3911, DOI 10.1242/jcs.008177; Misek SA, 2017, MOL CANCER RES, V15, P1085, DOI 10.1158/1541-7786.MCR-16-0318; Mishra P, 2010, MOL ENDOCRINOL, V24, P598, DOI 10.1210/me.2009-0387; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; Nheu TV, 2002, CANCER J, V8, P328, DOI 10.1097/00130404-200207000-00009; Ong CC, 2011, P NATL ACAD SCI USA, V108, P7177, DOI 10.1073/pnas.1103350108; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Qing HT, 2012, TUMOR BIOL, V33, P985, DOI 10.1007/s13277-012-0327-1; Radu M, 2014, NAT REV CANCER, V14, P13, DOI 10.1038/nrc3645; Rana A, 1996, J BIOL CHEM, V271, P19025, DOI 10.1074/jbc.271.32.19025; Rana Ajay, 2013, Genes Cancer, V4, P334, DOI 10.1177/1947601913485415; Rangasamy V, 2012, P NATL ACAD SCI USA, V109, P8149, DOI 10.1073/pnas.1200804109; Rangasamy V, 2010, CANCER RES, V70, P1731, DOI 10.1158/0008-5472.CAN-09-3492; Rattanasinchai C, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.44; Rider L, 2013, MOL ENDOCRINOL, V27, P1048, DOI 10.1210/me.2012-1322; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sancho D, 2002, J IMMUNOL, V169, P292, DOI 10.4049/jimmunol.169.1.292; Sathyanarayana P, 2002, MOL CELL, V10, P1527, DOI 10.1016/S1097-2765(02)00734-7; Shoulson I, 2007, NEUROLOGY, V69, P1480, DOI 10.1212/01.wnl.0000277648.63931.c0; Smith CM, 1997, GENOME RES, V7, P835, DOI 10.1101/gr.7.8.835; Tabusa H, 2013, MOL CANCER RES, V11, P109, DOI 10.1158/1541-7786.MCR-12-0466; Wang RA, 2002, EMBO J, V21, P5437, DOI 10.1093/emboj/cdf543; Wang ZP, 2013, J BIOL CHEM, V288, P20093, DOI 10.1074/jbc.M112.426023; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhou L, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-15; 2015, J BIOL CHEM, V290, P2170, DOI DOI 10.1074/JBC.M115.655563	46	10	10	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 9	2019	38	19					3569	3584		10.1038/s41388-019-0690-0	http://dx.doi.org/10.1038/s41388-019-0690-0			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HX4OU	30664689	Green Accepted			2022-12-26	WOS:000467379600002
J	Khan, CA; Meisburger, SP; Ando, N; Fitzpatrick, PF				Khan, Crystal A.; Meisburger, Steve P.; Ando, Nozomi; Fitzpatrick, Paul F.			The phenylketonuria-associated substitution R68S converts phenylalanine hydroxylase to a constitutively active enzyme but reduces its stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; small-angle X-ray scattering (SAXS); enzyme kinetics; analytical ultracentrifugation; hydroxylase; protein conformation; enzyme stability; phenylalanine hydroxylase; phenylketonuria; allostery; protein structure	BIOLOGICAL MACROMOLECULES; PHOSPHORYLATION STATE; LIMITED PROTEOLYSIS; STRUCTURAL BASIS; ACTIVATION; DOMAIN; MUTATIONS; MECHANISM; BINDING; LYSOLECITHIN	The naturally occurring R68S substitution of phenylalanine hydroxylase (PheH) causes phenylketonuria (PKU). However, the molecular basis for how the R68S variant leads to PKU remains unclear. Kinetic characterization of R68S PheH establishes that the enzyme is fully active in the absence of allosteric binding of phenylalanine, in contrast to the WT enzyme. Analytical ultracentrifugation establishes that the isolated regulatory domain of R68S PheH is predominantly monomeric in the absence of phenylalanine and dimerizes in its presence, similar to the regulatory domain of the WT enzyme. Fluorescence and small-angle X-ray scattering analyses establish that the overall conformation of the resting form of R68S PheH is different from that of the WT enzyme. The data are consistent with the substitution disrupting the interface between the catalytic and regulatory domains of the enzyme, shifting the equilibrium between the resting and activated forms approximate to 200-fold, so that the resting form of R68S PheH is approximate to 70% in the activated conformation. However, R68S PheH loses activity 2 orders of magnitude more rapidly than the WT enzyme at 37 degrees C and is significantly more sensitive to proteolysis. We propose that, even though this substitution converts the enzyme to a constitutively active enzyme, it results in PKU because of the decrease in protein stability.	[Khan, Crystal A.; Fitzpatrick, Paul F.] UT Hlth San Antonio, Dept Biochem & Struct Biol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Meisburger, Steve P.; Ando, Nozomi] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	University of Texas System; University of Texas Health San Antonio; Cornell University	Fitzpatrick, PF (corresponding author), UT Hlth San Antonio, Dept Biochem & Struct Biol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	fitzpatrickp@uthscsa.edu		Meisburger, Steve/0000-0001-6577-8719; Olivas, Crystal/0000-0001-7805-914X	Office of the Vice President for Research at UT Health San Antonio; National Science Foundation (NSF); National Institutes of Health (NIH)/NIGMS via NSF Grant [DMR-1332208]; NIH/NIGMS [GM-103485]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM124847, F31GM116452, P41GM103485, F32GM117757] Funding Source: NIH RePORTER	Office of the Vice President for Research at UT Health San Antonio; National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)/NIGMS via NSF Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Gregory Reinhart for helpful discussion during this work. Support for the Center for Macromolecular Interactions from the Office of the Vice President for Research at UT Health San Antonio is gratefully acknowledged. CHESS is supported by the National Science Foundation (NSF) and National Institutes of Health (NIH)/NIGMS via NSF Grant DMR-1332208, and the Mac-CHESS resource is supported by NIH/NIGMS Grant GM-103485.	ABITA JP, 1984, J BIOL CHEM, V259, P4560; Acerbo AS, 2015, J SYNCHROTRON RADIAT, V22, P180, DOI 10.1107/S1600577514020360; Arturo EC, 2016, P NATL ACAD SCI USA, V113, P2394, DOI 10.1073/pnas.1516967113; Bueno MA, 2012, METABOLISM, V61, P1809, DOI 10.1016/j.metabol.2012.07.015; CHANG N, 1979, J BIOL CHEM, V254, P2665; Couce ML, 2013, GENE, V521, P100, DOI 10.1016/j.gene.2013.03.004; Daubner SC, 1997, BIOCHEMISTRY-US, V36, P11574, DOI 10.1021/bi9711137; Daubner SC, 1997, ARCH BIOCHEM BIOPHYS, V348, P295, DOI 10.1006/abbi.1997.0435; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Eisensmith Randy C., 1992, Human Mutation, V1, P13, DOI 10.1002/humu.1380010104; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; FISHER DB, 1973, J BIOL CHEM, V248, P4345; FISHER DB, 1972, J BIOL CHEM, V247, P2250; Fitzpatrick PF, 2015, CURR OPIN STRUC BIOL, V35, P1, DOI 10.1016/j.sbi.2015.07.004; Fitzpatrick PF, 2012, ARCH BIOCHEM BIOPHYS, V519, P194, DOI 10.1016/j.abb.2011.09.012; Fitzpatrick PF, 2003, BIOCHEMISTRY-US, V42, P14083, DOI 10.1021/bi035656u; Flydal MI, 2013, IUBMB LIFE, V65, P341, DOI 10.1002/iub.1150; GIBBS BS, 1991, BIOCHEMISTRY-US, V30, P6795, DOI 10.1021/bi00241a024; Gjetting T, 2001, AM J HUM GENET, V68, P1353, DOI 10.1086/320604; Jennings IG, 2001, FEBS LETT, V488, P196, DOI 10.1016/S0014-5793(00)02426-1; Khan CA, 2018, BIOCHEMISTRY-US, V57, P6274, DOI 10.1021/acs.biochem.8b00919; Knappskog PM, 1997, FEBS LETT, V409, P7, DOI 10.1016/S0014-5793(97)00465-1; KNAPPSKOG PM, 1995, BIOCHEMISTRY-US, V34, P11790, DOI 10.1021/bi00037a017; Kobe B, 1999, NAT STRUCT BIOL, V6, P442, DOI 10.1038/8247; Lang EJM, 2014, CURR OPIN STRUC BIOL, V29, P102, DOI 10.1016/j.sbi.2014.10.007; Li J, 2011, ARCH BIOCHEM BIOPHYS, V505, P250, DOI 10.1016/j.abb.2010.10.009; McCulloch RI, 1999, ARCH BIOCHEM BIOPHYS, V367, P143, DOI 10.1006/abbi.1999.1259; Meisburger SP, 2016, J AM CHEM SOC, V138, P6506, DOI 10.1021/jacs.6b01563; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Parker MJ, 2018, P NATL ACAD SCI USA, V115, pE4594, DOI 10.1073/pnas.1800356115; PARNIAK MA, 1981, J BIOL CHEM, V256, P6876; Patel D, 2016, SCI REP-UK, V6, DOI 10.1038/srep23748; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; PHILLIPS RS, 1984, J BIOL CHEM, V259, P2474; Roberts KM, 2014, BIOCHEMISTRY-US, V53, P7846, DOI 10.1021/bi501183x; SHIMAN R, 1990, J BIOL CHEM, V265, P11633; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Thorolfsson M, 2003, BIOCHEMISTRY-US, V42, P3419, DOI 10.1021/bi034021s; Tyree TJ, 2018, ACTA CRYSTALLOGR D, V74, P471, DOI 10.1107/S2059798318003078; Williams Robin A, 2008, Clin Biochem Rev, V29, P31; Zhang SN, 2016, J BIOL CHEM, V291, P7418, DOI 10.1074/jbc.M115.709998; Zhang SN, 2014, BIOCHEMISTRY-US, V53, P6625, DOI 10.1021/bi501109s	42	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4359	4367		10.1074/jbc.RA118.006477	http://dx.doi.org/10.1074/jbc.RA118.006477			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30674554	hybrid, Green Published			2022-12-26	WOS:000462969500007
J	Khan, Z; Cao, DY; Giani, JF; Bernstein, EA; Veiras, LC; Fuchs, S; Wang, YZ; Peng, ZZ; Kalkum, M; Liu, GY; Bernstein, KE				Khan, Zakir; Cao, Duo-Yao; Giani, Jorge F.; Bernstein, Ellen A.; Veiras, Luciana C.; Fuchs, Sebastien; Wang, Yizhou; Peng, Zhenzi; Kalkum, Markus; Liu, George Y.; Bernstein, Kenneth E.			Overexpression of the C-domain of angiotensin-converting enzyme reduces melanoma growth by stimulating M1 macrophage polarization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						melanoma; macrophage; NF-kappa B (NF-KB); tumor necrosis factor (TNF); cellular immune response; ACE; Macrophage polarization; STAT	NECROSIS-FACTOR-ALPHA; TERMINAL CATALYTIC DOMAIN; EXPRESSION; ACE; INFLAMMATION; PROGRESSION; RESISTANT; ROLES	Angiotensin-converting enzyme (ACE) can hydrolyze many peptides and plays a central role in controlling blood pressure. Moreover, ACE overexpression in monocytes and macrophages increases resistance of mice to tumor growth. ACE is composed of two independent catalytic domains. Here, to investigate the specific role of each domain in tumor resistance, we overexpressed either WT ACE (Tg-ACE mice) or ACE lacking N- or C-domain catalytic activity (Tg-NKO and Tg-CKO mice) in the myeloid cells of mice. Tg-ACE and Tg-NKO mice exhibited strongly suppressed growth of B16-F10 melanoma because of increased ACE expression in macrophages, whereas Tg-CKO mice resisted melanoma no better than WT animals. The effect of ACE overexpression reverted to that of the WT enzyme with an ACE inhibitor but not with an angiotensin II type 1 (AT1) receptor antagonist. ACE C-domain overexpression in macrophages drove them toward a pronounced M1 phenotype upon tumor stimulation, with increased activation of NF-B and signal transducer and activator of transcription 1 (STAT1) and decreased STAT3 and STAT6 activation. Tumor necrosis factor (TNF) is important for M1 activation, and TNF blockade reverted Tg-NKO macrophages to a WT phenotype. Increased ACE C-domain expression increased the levels of reactive oxygen species (ROS) and of the transcription factor C/EBP in macrophages, important stimuli for TNF expression, and decreased expression of several M2 markers, including interleukin-4R. Natural ACE C-domain-specific substrates are not well-described, and we propose that the peptide(s) responsible for the striking ACE-mediated enhancement of myeloid function are substrates/products of the ACE C-domain.	[Khan, Zakir; Cao, Duo-Yao; Giani, Jorge F.; Bernstein, Ellen A.; Veiras, Luciana C.; Wang, Yizhou; Peng, Zhenzi; Liu, George Y.; Bernstein, Kenneth E.] Cedars Sinai Med Ctr, Dept Biomed Sci, Davis Res Bldg,Rm 2021,110 N George Burns Rd, Los Angeles, CA 90048 USA; [Khan, Zakir; Bernstein, Kenneth E.] Cedars Sinai Med Ctr, Dept Pathol, Davis Res Bldg,Rm 2021,110 N George Burns Rd, Los Angeles, CA 90048 USA; [Wang, Yizhou] Cedars Sinai Med Ctr, Dept Genom Core, Los Angeles, CA 90048 USA; [Liu, George Y.] Cedars Sinai Med Ctr, Div Pediat Infect Dis, Los Angeles, CA 90048 USA; [Liu, George Y.] Cedars Sinai Med Ctr, Div Immunol Res, Los Angeles, CA 90048 USA; [Fuchs, Sebastien] Western Univ Hlth Sci, Dept Basic Med Sci, Coll Osteopath Med Pacific, Pomona, CA 91766 USA; [Kalkum, Markus] City Hope Natl Med Ctr, Dept Mol Imaging & Therapy, Beckman Res Inst, Duarte, CA 91010 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Western University of Health Sciences; City of Hope; Beckman Research Institute of City of Hope	Bernstein, KE (corresponding author), Cedars Sinai Med Ctr, Dept Biomed Sci, Davis Res Bldg,Rm 2021,110 N George Burns Rd, Los Angeles, CA 90048 USA.; Bernstein, KE (corresponding author), Cedars Sinai Med Ctr, Dept Pathol, Davis Res Bldg,Rm 2021,110 N George Burns Rd, Los Angeles, CA 90048 USA.	Kenneth.Bernstein@cshs.org	wang, yizhou/CAJ-3518-2022	wang, yizhou/0000-0002-9378-745X; Cao, DuoYao/0000-0002-0455-4655; Kalkum, Markus/0000-0002-9506-671X; Veiras, Luciana/0000-0002-4635-7772	National Institutes of Health [P01HL129941, AI143599, R21AI114965, R01HL142672, P30DK063491]; American Heart Association [17GRNT33661206, 16SDG30130015]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL129941, R01HL142672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI114965, R01AI134714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants P01HL129941 (to K. E. B.), AI143599 (to K. E. B.), R21AI114965 (to K. E. B.), R01HL142672 (to J. F. G.), and P30DK063491 (to J. F. G.) and American Heart Association Grants 17GRNT33661206 (to K. E. B.) and 16SDG30130015 (to J. F. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Benigni A, 2010, EMBO MOL MED, V2, P247, DOI 10.1002/emmm.201000080; Bernstein KE, 2018, NAT REV NEPHROL, V14, P325, DOI 10.1038/nrneph.2018.15; Bernstein KE, 2014, BIOL CHEM, V395, P1173, DOI 10.1515/hsz-2013-0295; Bernstein KE, 2014, J CLIN INVEST, V124, P1000, DOI 10.1172/JCI66541; Bernstein KE, 2013, PHARMACOL REV, V65, P1, DOI 10.1124/pr.112.006809; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Diet F, 1996, CIRCULATION, V94, P2756, DOI 10.1161/01.CIR.94.11.2756; FIDLER IJ, 1976, JNCI-J NATL CANCER I, V57, P1199, DOI 10.1093/jnci/57.5.1199; Fuchs S, 2004, CURR HYPERTENS REP, V6, P124, DOI 10.1007/s11906-004-0087-4; Fuchs S, 2004, J BIOL CHEM, V279, P15946, DOI 10.1074/jbc.M400149200; Fuchs S, 2008, HYPERTENSION, V51, P267, DOI 10.1161/HYPERTENSIONAHA.107.097865; Hiyama A, 2016, J ORTHOP RES, V34, P865, DOI 10.1002/jor.23085; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Khan Z, 2017, BLOOD, V130, P328, DOI 10.1182/blood-2016-11-752006; Kim S, 2000, PHARMACOL REV, V52, P11; Kratochvill F, 2015, CELL REP, V12, P1902, DOI 10.1016/j.celrep.2015.08.033; LIEBERMAN J, 1975, AM J MED, V59, P365, DOI 10.1016/0002-9343(75)90395-2; Lin CT, 2011, FASEB J, V25, P1145, DOI 10.1096/fj.10-169433; Ma L, 2014, J BIOL CHEM, V289, P12457, DOI 10.1074/jbc.M113.521708; Ohishi M, 1997, J HYPERTENS, V15, P1295, DOI 10.1097/00004872-199715110-00014; OKABE T, 1985, J CLIN INVEST, V75, P911, DOI 10.1172/JCI111791; Okwan-Duodu D, 2010, J BIOL CHEM, V285, P39051, DOI 10.1074/jbc.M110.163782; POPE RM, 1994, J CLIN INVEST, V94, P1449, DOI 10.1172/JCI117482; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Romer F K, 1984, Acta Med Scand Suppl, V690, P3; Sasmono RT, 2007, J LEUKOCYTE BIOL, V82, P111, DOI 10.1189/jlb.1206713; Savov JD, 2002, AM J PHYSIOL-LUNG C, V283, pL952, DOI 10.1152/ajplung.00420.2001; Schleicher U, 2016, CELL REP, V15, P1062, DOI 10.1016/j.celrep.2016.04.001; Shah KH, 2015, CIRC RES, V117, P858, DOI 10.1161/CIRCRESAHA.115.306539; Shen XZ, 2007, AM J PATHOL, V170, P2122, DOI 10.2353/ajpath.2007.061205; Shen XZ, 2014, LAB INVEST, V94, P536, DOI 10.1038/labinvest.2014.41; Shen XZ, 2011, NAT IMMUNOL, V12, P1078, DOI 10.1038/ni.2107; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; WANG J, 1995, J BIOL CHEM, V270, P22044, DOI 10.1074/jbc.270.37.22044; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; Zhao TT, 2017, LAB INVEST, V97, P764, DOI 10.1038/labinvest.2017.32	37	18	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4368	4380		10.1074/jbc.RA118.006275	http://dx.doi.org/10.1074/jbc.RA118.006275			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30670595	Green Published, hybrid			2022-12-26	WOS:000462969500008
J	Loza-Correa, M; Ayala, JA; Perelman, I; Hubbard, K; Kalab, M; Yi, QL; Taha, M; de Pedro, MA; Ramirez-Arcos, S				Loza-Correa, Maria; Ayala, Juan A.; Perelman, Iris; Hubbard, Keith; Kalab, Miloslav; Yi, Qi-Long; Taha, Mariam; de Pedro, Miguel A.; Ramirez-Arcos, Sandra			The peptidoglycan and biofilm matrix of Staphylococcus epidermidis undergo structural changes when exposed to human platelets	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; TRANSFUSION REACTIONS; INDEPENDENT BIOFILM; EXTRACELLULAR DNA; RESISTANCE; STRAINS; ICA; ENDOPEPTIDASE; DYNAMICS; STORAGE	Staphylococcus epidermidis is a bacterium frequently isolated from contaminated platelet concentrates (PCs), a blood product used to treat bleeding disorders in transfusion patients. PCs offer an accidental niche for colonization of S. epidermidis by forming biofilms and thus avoiding clearance by immune factors present in this milieu. Using biochemical and micros-copy techniques, we investigated the structural changes of the peptidoglycan (PG) and the biofilm matrix of S. epidermidis biofilms formed in whole-blood derived PCs compared to biofilms grown in glucose-supplemented trypticase soy broth (TSBg). Both, the PG and the biofilm matrix are primary mechanisms of defense against environmental stress. Here we show that in PCs, the S. epidermidis biofilm matrix is mainly of a proteinaceous nature with extracellular DNA, in contrast to the predominant polysaccharide nature of the biofilm matrix formed in TSBg cultures. PG profile studies demonstrated that the PG of biofilm cells remodels during PC storage displaying fewer muropeptides variants than those observed in TSBg. The PG muropeptides contain two chemical modifications (amidation and O-acetylation) previously associated with resistance to antimicrobial agents by other staphylococci. Our study highlights two key structural features of S. epidermidis that are remodeled when exposed to human platelets and could be used as targets to reduce septic transfusions events.	[Loza-Correa, Maria; Perelman, Iris; Yi, Qi-Long; Taha, Mariam; Ramirez-Arcos, Sandra] Canadian Blood Serv, Ctr Innovat, Ottawa, ON, Canada; [Loza-Correa, Maria; Ramirez-Arcos, Sandra] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Ayala, Juan A.; de Pedro, Miguel A.] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Hubbard, Keith; Kalab, Miloslav] Agr & Agri Food Canada, Ottawa, ON, Canada	Canadian Blood Services; University of Ottawa; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Agriculture & Agri Food Canada	Ramirez-Arcos, S (corresponding author), Canadian Blood Serv, Ctr Innovat, Ottawa, ON, Canada.; Ramirez-Arcos, S (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	sandra.ramirez@blood.ca	Ayala, Juan A/AAI-4458-2021	Ayala, Juan A/0000-0002-0577-7498; Taha, Mariam/0000-0002-9147-4265; Ramirez-Arcos, Sandra/0000-0003-0705-4987	Canadian Blood Services; CONACyT; Canadian Blood Services and Health Canada;  [PT13/0001]	Canadian Blood Services; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Canadian Blood Services and Health Canada; 	Drs. M. Loza-Correa and M. Taha held a Postdoctoral Fellowship and a Graduate Student Scholarship from Canadian Blood Services, respectively. CONACyT provided additional funding to Dr. M. Loza-Correa for postdoctoral training. Canadian Blood Services and Health Canada provided financial support for this study; however, the views expressed herein do not necessarily represent those of the Canadian Federal government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the volunteer blood donors and staff at the Canadian Blood Services Network Centre for Applied Development (netCAD, Vancouver) for whole blood collection and PC manufacturing. We greatly thank Dr. D. Chabot (Ottawa Research and Development Centre, Agriculture and Agri-Food Canada) for analysis of the CLSM data and critical review of this manuscript. Molecular weight analysis by MS-MALDITOF was carried out in the CBMSO protein chemistry facility, that belongs to the ProteoRed, PRB2-ISCIII, supported by grant PT13/0001. Anti-Health System, Charlottesville, Virginia) and Dr. A.K. Brassinga (University of Manitoba, Winnipeg, Manitoba, Canada) for providing the S. epidermidis Hamburg 9142 and 9142 Delta icaA strains. Drs. S. Ramirez-Arcos and M. Loza-Correa are associated with the Department of Biochemistry, Microbiology and Immunology of the University of Ottawa.S. epidermidis PIA-specific antiserum was kindly provided by Dr. D. Mack (Swansea University, UK). The authors are thankful to Dr. C. Sifri (University of Virginia Health System, Charlottesville, Virginia) and Dr. A.K. Brassinga (University of Manitoba, Winnipeg, Manitoba, Canada) for providing the S. epidermidis Hamburg 9142 and 9142 Delta icaA strains. Drs. S. Ramirez-Arcos and M. Loza-Correa are associated with the Department of Biochemistry, Microbiology and Immunology of the University of Ottawa.	Alandullatif M, 2018, TRANSFUSION, V58, P2013, DOI 10.1111/trf.14646; Ali H, 2014, J MED MICROBIOL, V63, P884, DOI 10.1099/jmm.0.071449-0; Banner MA, 2007, J BACTERIOL, V189, P2793, DOI 10.1128/JB.00952-06; Baranwal G, 2017, INT J MED MICROBIOL, V307, P388, DOI 10.1016/j.ijmm.2017.08.002; Barker LM, 2010, TRANSFUSION, V50, P2731, DOI 10.1111/j.1537-2995.2010.02727.x; Batoni G, 2016, BBA-BIOMEMBRANES, V1858, P1044, DOI 10.1016/j.bbamem.2015.10.013; Deibert J, 2016, ANTIBIOTICS-BASEL, V5, DOI 10.3390/antibiotics5040033; Dengler V, 2015, J BACTERIOL, V197, P3779, DOI 10.1128/JB.00726-15; Desmarais SM, 2013, MOL MICROBIOL, V89, P1, DOI 10.1111/mmi.12266; Fagerlund A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00856; Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Folkesson A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001891; Foulston L, 2014, MBIO, V5, DOI 10.1128/mBio.01667-14; FREEMAN DJ, 1989, J CLIN PATHOL, V42, P872, DOI 10.1136/jcp.42.8.872; Gonzalez-Leiza SM, 2011, J BACTERIOL, V193, P6887, DOI 10.1128/JB.05764-11; Greco C, 2007, TRANSFUSION, V47, P1143, DOI 10.1111/j.1537-2995.2007.01249.x; Greco CA, 2010, TRANSFUSION, V50, P2344, DOI 10.1111/j.1537-2995.2010.02726.x; Greco-Stewart VS, 2012, VOX SANG, V102, P212, DOI 10.1111/j.1423-0410.2011.01550.x; Hennig S, 2007, INT J MED MICROBIOL, V297, P117, DOI 10.1016/j.ijmm.2006.12.001; Hobley L, 2015, FEMS MICROBIOL REV, V39, P649, DOI 10.1093/femsre/fuv015; Hodgson SD, 2014, TRANSFUSION, V54, P461, DOI 10.1111/trf.12308; Hong H, 2016, BLOOD, V127, P496, DOI 10.1182/blood-2015-07-655944; Jenkins C, 2011, TRANSFUSION, V51, P2555, DOI 10.1111/j.1537-2995.2011.03187.x; Johnson JW, 2013, ANN NY ACAD SCI, V1277, P54, DOI 10.1111/j.1749-6632.2012.06813.x; KLOOS WE, 1975, APPL MICROBIOL, V30, P381, DOI 10.1128/AEM.30.3.381-395.1975; Kogan G, 2006, FEMS MICROBIOL LETT, V255, P11, DOI 10.1111/j.1574-6968.2005.00043.x; Kraus D, 2007, INFECT IMMUN, V75, P2084, DOI 10.1128/IAI.01576-06; Levin E, 2008, TRANSFUSION, V48, P2331, DOI 10.1111/j.1537-2995.2008.01836.x; Lim Y, 2004, J BACTERIOL, V186, P722, DOI 10.1128/JB.186.3.722-729.2004; Loza-Correa M, 2017, VOX SANG, V112, P401, DOI 10.1111/vox.12513; Loza-Correa M, 2016, TRANSFUSION, V56, P1348, DOI 10.1111/trf.13557; Mack D, 2001, METHOD ENZYMOL, V336, P215, DOI 10.1016/S0076-6879(01)36592-8; Martin-Lorenzo M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09042-2; Mohan KVK, 2010, TRANSFUSION, V50, P166, DOI 10.1111/j.1537-2995.2009.02376.x; Nuri R, 2015, BBA-BIOMEMBRANES, V1848, P3089, DOI 10.1016/j.bbamem.2015.05.022; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; Okshevsky M, 2014, J MICROBIOL METH, V105, P102, DOI 10.1016/j.mimet.2014.07.010; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Otto M, 2012, SEMIN IMMUNOPATHOL, V34, P201, DOI 10.1007/s00281-011-0296-2; Otto Michael, 2010, Expert Rev Dermatol, V5, P183, DOI 10.1586/edm.10.6; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Percival SL, 2015, J MED MICROBIOL, V64, P323, DOI 10.1099/jmm.0.000032; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Ramirez-Arcos S, 2012, TRANSFUSION REACTION; Ramirez-Arcos S, 2017, TRANSFUSION, V57, P2174, DOI 10.1111/trf.14202; Ropy A, 2015, ANTIMICROB AGENTS CH, V59, P3925, DOI 10.1128/AAC.05150-14; Sadovskaya I, 2005, INFECT IMMUN, V73, P3007, DOI 10.1128/IAI.73.5.3007-3017.2005; Singh Shriti, 2017, Open Microbiol J, V11, P53, DOI 10.2174/1874285801711010053; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; Sugai M, 1997, J BACTERIOL, V179, P4311, DOI 10.1128/jb.179.13.4311-4318.1997; Taha M, 2018, J MED MICROBIOL, V67, P190, DOI 10.1099/jmm.0.000673; Toledo-Arana A, 2005, J BACTERIOL, V187, P5318, DOI 10.1128/JB.187.15.5318-5329.2005; Turner RD, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1025; Weisser M, 2010, J CLIN MICROBIOL, V48, P2407, DOI 10.1128/JCM.00492-10; Yeaman MR, 1999, DRUG RESIST UPDATE, V2, P116, DOI 10.1054/drup.1999.0069; Zhang YQ, 2003, MOL MICROBIOL, V49, P1577, DOI 10.1046/j.1365-2958.2003.03671.x	57	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211132	10.1371/journal.pone.0211132	http://dx.doi.org/10.1371/journal.pone.0211132			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682094	Green Submitted, Green Published, gold			2022-12-26	WOS:000457037500106
J	San, B; Rougeot, J; Voeltzke, K; van Vegchel, G; Aben, M; Andralojc, KM; Flik, G; Kamminga, LM				San, Bilge; Rougeot, Julien; Voeltzke, Kai; van Vegchel, Gertie; Aben, Marco; Andralojc, Karolina M.; Flik, Gert; Kamminga, Leonie M.			The ezh2(sa1199) mutant zebrafish display no distinct phenotype	PLOS ONE			English	Article							REPRESSIVE COMPLEX 2; MESSENGER-RNA DECAY; GROUP GENE EZH2; HISTONE METHYLTRANSFERASE; EMBRYONIC-DEVELOPMENT; POINT MUTATIONS; CELL; PROTEINS; DOMAIN; COPPER	Polycomb group (PcG) proteins are essential regulators of epigenetic gene silencing and development. The PcG protein enhancer of zeste homolog 2 (Ezh2) is a key component of the Polycomb Repressive Complex 2 and is responsible for placing the histone H3 lysine 27 trimethylation (H3K27me3) repressive mark on the genome through its methyltransferase domain. Ezh2 is highly conserved in vertebrates. We studied the role of ezh2 during development of zebrafish with the use of a mutant allele (ezh2(sa1199), R18STOP), which has a stop mutation in the second exon of the ezh2 gene. Two versions of the same line were used during this study. The first and original version of zygotic ezh2(sa1199) mutants unexpectedly retained ezh2 expression in brain, gut, branchial arches, and eyes at 3 days postfertilization (dpf), as revealed by in-situ hybridization. Moreover, the expression pattern in homozygous mutants was identical to that of wild types, indicating that mutant ezh2 mRNA is not subject to nonsense mediated decay (NMD) as predicted. Both wild type and ezh2 mutant embryos presented edemas at 2 and 3 dpf. The line was renewed by selective breeding to counter select the non-specific phenotypes and survival was assessed. In contrast to earlier studies on ezh2 mutant zebrafish, ezh2(sa1199) mutants survived until adulthood. Interestingly, the ezh2 mRNA and Ezh2 protein were present during adulthood (70 dpf) in both wild type and ezh2(sa1199) mutant zebrafish. We conclude that the ezh2 (sa1199) allele does not exhibit an ezh2 loss-of-function phenotype.	[San, Bilge; Aben, Marco; Kamminga, Leonie M.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Nijmegen, Netherlands; [Rougeot, Julien; Voeltzke, Kai; van Vegchel, Gertie; Aben, Marco; Andralojc, Karolina M.; Kamminga, Leonie M.] Radboud Univ Nijmegen, Fac Sci, Dept Mol Biol, Radboud Inst Mol Life Sci, Nijmegen, Netherlands; [Flik, Gert] Radboud Univ Nijmegen, Dept Anim Ecol & Physiol, Nijmegen, Netherlands; [Voeltzke, Kai] Heinrich Heine Univ, Med Fac, Clin Pediat Oncol Hematol & Clin Immunol, Dusseldorf, Germany; [van Vegchel, Gertie] UMC Utrecht, Div Labs Pharm & Biomed Genet, Genet Dept, Utrecht, Netherlands; [Aben, Marco] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands; [Andralojc, Karolina M.] Radboud Inst Mol Life Sci, Dept Biochem, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Heinrich Heine University Dusseldorf; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen	Kamminga, LM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Nijmegen, Netherlands.; Kamminga, LM (corresponding author), Radboud Univ Nijmegen, Fac Sci, Dept Mol Biol, Radboud Inst Mol Life Sci, Nijmegen, Netherlands.	l.kamminga@science.ru.nl	Rougeot, Julien/AAF-1269-2019; Kamminga, Leonie/O-5722-2019; Rougeot, Julien/GQI-4130-2022; Kamminga, Leonie M/E-1771-2012; Flik, Gert/C-8229-2011	Rougeot, Julien/0000-0001-6899-9306; Kamminga, Leonie M/0000-0002-0508-7796; Flik, Gert/0000-0001-9285-7957	Innovative Research scheme of the Netherlands Organisation for Scientific research [NWO-Vidi 864.12.009, NWO-Meervoud 836.13.003]; Radboud University Nijmegen Medical Centre tenure track fellowship; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant [705939]	Innovative Research scheme of the Netherlands Organisation for Scientific research; Radboud University Nijmegen Medical Centre tenure track fellowship; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant	The work was funded by the Innovative Research scheme of the Netherlands Organisation for Scientific research (www.nwo.nl, NWO-Vidi 864.12.009, NWO-Meervoud 836.13.003, L.M.K.), the Radboud University Nijmegen Medical Centre tenure track fellowship (www.radboudumc.nl, L.M.K.), and the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant Agreement No. 705939, K.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen IS, 2013, CURR TOP DEV BIOL, V104, P85, DOI 10.1016/B978-0-12-416027-9.00003-6; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Blackledge NP, 2015, NAT REV MOL CELL BIO, V16, P643, DOI 10.1038/nrm4067; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Corey DR, 2001, GENOME BIOL, V2; Craig PM, 2017, AM J PHYSIOL-REG I, V293, pR1882; Delgado-Olguin P, 2014, DEVELOPMENT, V141, P4610, DOI 10.1242/dev.112607; Denisenko O, 1998, MOL CELL BIOL, V18, P5634, DOI 10.1128/MCB.18.10.5634; Draper BW, 2004, METHOD CELL BIOL, V77, P91; Dupret B, 2017, BBA-GENE REGUL MECH, V1860, P1079, DOI 10.1016/j.bbagrm.2017.08.011; Guo Y, 2013, AM J HUM GENET, V93, P78, DOI 10.1016/j.ajhg.2013.05.022; Han ZF, 2007, STRUCTURE, V15, P1306, DOI 10.1016/j.str.2007.08.007; Hanke N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/658270; He AB, 2012, CIRC RES, V110, P406, DOI 10.1161/CIRCRESAHA.111.252205; Hill AJ, 2004, TOXICOL SCI, V78, P78, DOI 10.1093/toxsci/kfh056; Inacio A, 2004, J BIOL CHEM, V279, P32170, DOI 10.1074/jbc.M405024200; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Jeanray N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116989; Joshi P, 2008, J BIOL CHEM, V283, P27757, DOI 10.1074/jbc.M804442200; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Karpanen T, 2017, CIRC RES, V120, P1263, DOI 10.1161/CIRCRESAHA.116.308813; Kelsey L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003612; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Kettleborough RNW, 2011, METHOD CELL BIOL, V104, P121, DOI 10.1016/B978-0-12-374814-0.00006-9; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Koppens MAJ, 2016, GASTROENTEROLOGY, V151, P684, DOI 10.1053/j.gastro.2016.06.020; Le Faou P, 2011, GENE, V475, P10, DOI 10.1016/j.gene.2010.12.012; Li J, 1998, AQUAT TOXICOL, V43, P1, DOI 10.1016/S0166-445X(98)00047-2; Li MY, 2016, TRENDS GENET, V32, P815, DOI 10.1016/j.tig.2016.10.005; Lindeboom RGH, 2016, NAT GENET, V48, P1112, DOI 10.1038/ng.3664; Lindeman LC, 2011, DEV CELL, V21, P993, DOI 10.1016/j.devcel.2011.10.008; Lui JC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13685; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Madsen EC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000261; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; Mork L, 2015, CURR TOP DEV BIOL, V115, P235, DOI 10.1016/bs.ctdb.2015.07.001; Neu-Yilik G, 2011, RNA, V17, P843, DOI 10.1261/rna.2401811; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Panelli D, 2008, BIOCHIMIE, V90, P1452, DOI 10.1016/j.biochi.2008.04.017; Reynaud C, 2008, MATRIX BIOL, V27, P547, DOI 10.1016/j.matbio.2008.03.002; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rougeot J, 2018, BIORXIV; San B, 2018, EPIGENOMES, V2, DOI 10.3390/epigenomes2040019; San B, 2016, SCI REP-UK, V6, DOI 10.1038/srep24658; Sander JD, 2011, METHOD CELL BIOL, V104, P51, DOI 10.1016/B978-0-12-374814-0.00003-3; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Schwarz D, 2014, DEVELOPMENT, V141, P867, DOI 10.1242/dev.094342; Seok SH, 2006, J BIOTECHNOL, V126, P406, DOI 10.1016/j.jbiotec.2006.04.029; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shimizu T, 2016, J EXP MED, V213, P1479, DOI 10.1084/jem.20151136; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Stainier DYR, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007000; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Tsuruwaka Y, 2015, PEERJ, V3, DOI 10.7717/peerj.727; van der Velden YU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073997; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Wang W, 2015, MED RES REV, V35, P1220, DOI 10.1002/med.21358; Westerfield M., 2007, GUIDE LAB USE ZEBRAF; Wittkopp N, 2009, MOL CELL BIOL, V29, P3517, DOI 10.1128/MCB.00177-09; Yang XP, 2015, SCI REP-UK, V5, DOI 10.1038/srep10643; Yin J, 2015, P NATL ACAD SCI USA, V112, P15988, DOI 10.1073/pnas.1521740112; Zhong YB, 2018, NUCLEIC ACIDS RES, V46, P3382, DOI 10.1093/nar/gky101	68	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210217	10.1371/journal.pone.0210217	http://dx.doi.org/10.1371/journal.pone.0210217			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677064	Green Published, gold, Green Submitted			2022-12-26	WOS:000456700400011
J	Tang, QL; Ma, KS; Chi, H; Hou, YM; Gao, XW				Tang, Qiuling; Ma, Kangsheng; Chi, Hsin; Hou, Youming; Gao, Xiwu			Transgenerational hormetic effects of sublethal dose of flupyradifurone on the green peach aphid, Myzus persicae (Sulzer) (Hemiptera: Aphididae)	PLOS ONE			English	Article							INSECTICIDE-INDUCED HORMESIS; LIFE-TABLE; BROWN PLANTHOPPER; BIOLOGICAL TRAITS; POPULATION-GROWTH; FEEDING-BEHAVIOR; REPRODUCTION; FECUNDITY; RESISTANCE; HOMOPTERA	Both inhibitory and stimulatory (known as hormesis) effects of the sublethal flupyradifurone, a butenolide insecticide, on Myzus persicae Sulzer (Hemiptera: Aphididae) were investigated for incorporating it into integrated pest management (IPM). A leaf-dip bioassay showed that flupyradifurone was very toxic against adult M. persicae with a 48 h LC50 of 8.491 mg/L. Using the age-stage two-sex life table approach, we assessed the effects of LC25 of flupyradifurone on adult M. persicae and its progeny (F-1 and F-2). On the one hand, aphids exposed to flupyradifurone had significantly negative effects on the life history traits acrossing the generations, such as reduced the adult longevity and fecundity of F-0, shortened the duration of third instar and fourth instar nymphs, preadult period and the pre-reproductive period of F-1, and decreased the reproductive days and adult longevity of F-2. On the other hand, stimulatory effects on the duration of pre-adult, adult reproductive days, and reproduction of F-1 were observed in the flupyradifurone-treated aphids. Consistently with the stimulation on individual traits, a higher net reproductive rate (R-0) of F-1 and a shorter mean generation time (T) of F-2 were observed in the flupyradifurone-treated aphids, although the other population parameters including the intrinsic rate of increase (r), finite rate of increase (lambda) and T of F-1 and R-0, r and lambda of F-2 were not significantly affected. These results revealed that adult M. persicae exposed to sublethal concentration of flupyradifurone can induce hormetic effects on F-1, and also cause negative effects on F-2. Our results would be useful for assessing the overall effects of flupyradifurone on M. persicae and the hormetic effects should take into consideration when use flupyradifurone for control M. persicae.	[Tang, Qiuling; Hou, Youming] Fujian Agr & Forestry Univ, State Key Lab Ecol Pest Control Fujian & Taiwan C, Fuzhou, Fujian, Peoples R China; [Tang, Qiuling; Ma, Kangsheng; Gao, Xiwu] China Agr Univ, Dept Entomol, Beijing, Peoples R China; [Chi, Hsin] Nidge Omer Halisdemir Univ, Dept Plant Prod & Technol, Nigde, Turkey; [Hou, Youming] Fujian Agr & Forestry Univ, Dept Plant Protect, Fujian Prov Key Lab Insect Ecol, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; China Agricultural University; Fujian Agriculture & Forestry University	Hou, YM (corresponding author), Fujian Agr & Forestry Univ, State Key Lab Ecol Pest Control Fujian & Taiwan C, Fuzhou, Fujian, Peoples R China.; Gao, XW (corresponding author), China Agr Univ, Dept Entomol, Beijing, Peoples R China.; Hou, YM (corresponding author), Fujian Agr & Forestry Univ, Dept Plant Protect, Fujian Prov Key Lab Insect Ecol, Fuzhou, Fujian, Peoples R China.	ymhou@fafu.edu.cn; gaoxiwu@263.net.cn	Chi, Hsin/L-6860-2019	Chi, Hsin/0000-0001-8130-0248	National Key Research and Development Program [2016YFD0200506]	National Key Research and Development Program	This study was supported by the National Key Research and Development Program (Contract No. 2016YFD0200506) to XG.	Akca I, 2015, J ECON ENTOMOL, V108, P1466, DOI 10.1093/jee/tov187; [Anonymous], 1993, INTRO BOOTSTRAP; Ayyanath MM, 2015, CHEMOSPHERE, V128, P245, DOI 10.1016/j.chemosphere.2015.01.061; Ayyanath MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074532; Bao HB, 2009, PEST MANAG SCI, V65, P170, DOI 10.1002/ps.1664; Bass C, 2014, INSECT BIOCHEM MOLEC, V51, P41, DOI 10.1016/j.ibmb.2014.05.003; Biondi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076548; Blackman R.L., 2000, J ECON ENTOMOL, V2; Bonmatin JM, 2005, J AGR FOOD CHEM, V53, P5336, DOI 10.1021/jf0479362; Calabrese EJ, 2005, ENVIRON POLLUT, V138, P378, DOI 10.1016/j.envpol.2004.10.001; Calabrese EJ, 2003, NATURE, V421, P691, DOI 10.1038/421691a; Calabrese EJ, 1997, INT J TOXICOL, V16, P545, DOI 10.1080/109158197226874; Calabrese EJ, 2002, HUM EXP TOXICOL, V21, P91, DOI 10.1191/0960327102ht217oa; Carelli G, 2002, HUM EXP TOXICOL, V21, P113; CHELLIAH S, 1980, ENVIRON ENTOMOL, V9, P773, DOI 10.1093/ee/9.6.773; Chen XD, 2017, CROP PROT, V98, P102, DOI 10.1016/j.cropro.2017.03.017; Chen XW, 2016, ECOTOXICOLOGY, V25, P1841, DOI 10.1007/s10646-016-1732-9; CHI H, 1988, ENVIRON ENTOMOL, V17, P26, DOI 10.1093/ee/17.1.26; CHI H, 1985, Bulletin of the Institute of Zoology Academia Sinica (Taipei), V24, P225; Chi H., 2018, TWOSEX MS CHART COMP; Cho SR, 2011, J KOREAN SOC APPL BI, V54, P889, DOI 10.3839/jksabc.2011.135; Cohen E, 2006, PESTIC BIOCHEM PHYS, V85, P21, DOI 10.1016/j.pestbp.2005.09.002; Cutler GC, 2013, DOSE-RESPONSE, V11, P154, DOI 10.2203/dose-response.12-008.Cutler; Cutler GC, 2009, PEST MANAG SCI, V65, P205, DOI 10.1002/ps.1669; Desneux N, 2005, J ECON ENTOMOL, V98, P9, DOI 10.1603/0022-0493-98.1.9; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Devine GJ, 1996, PESTIC SCI, V48, P57, DOI 10.1002/(SICI)1096-9063(199609)48:1&lt;57::AID-PS435&gt;3.0.CO;2-9; Duke SO, 2014, PEST MANAG SCI, V70, P689, DOI 10.1002/ps.3756; European Food Safety Authority, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4020; Gong YH, 2015, ECOTOXICOLOGY, V24, P1141, DOI 10.1007/s10646-015-1461-5; GORDON PL, 1984, CAN ENTOMOL, V116, P783, DOI 10.4039/Ent116783-5; Guedes NMP, 2010, J APPL ENTOMOL, V134, P142, DOI 10.1111/j.1439-0418.2009.01462.x; Guedes RNC, 2016, ANNU REV ENTOMOL, V61, P43, DOI 10.1146/annurev-ento-010715-023646; Guedes RNC, 2017, CURR OPIN INSECT SCI, V21, P47, DOI 10.1016/j.cois.2017.04.010; Guedes RNC, 2014, PEST MANAG SCI, V70, P690, DOI 10.1002/ps.3669; Guo L, 2013, CROP PROT, V48, P29, DOI 10.1016/j.cropro.2013.02.009; Han WS, 2012, PEST MANAG SCI, V68, P1184, DOI 10.1002/ps.3282; HAYNES KF, 1988, ANNU REV ENTOMOL, V33, P149, DOI 10.1146/annurev.en.33.010188.001053; He YX, 2013, INT J BIOL SCI, V9, P246, DOI 10.7150/ijbs.5762; Huang HW, 2018, J ECON ENTOMOL, V111, P1, DOI 10.1093/jee/tox330; Huang YB, 2013, J APPL ENTOMOL, V137, P327, DOI 10.1111/jen.12002; Jeschke P, 2015, PESTIC BIOCHEM PHYS, V121, P31, DOI 10.1016/j.pestbp.2014.10.011; Kerns DL, 2000, ENTOMOL EXP APPL, V94, P41, DOI 10.1023/A:1003972510397; Lashkari MR, 2007, INSECT SCI, V14, P207, DOI 10.1111/j.1744-7917.2007.00145.x; Lee CY., 2000, J BIOSCIENCES, V11, P107, DOI DOI 10.5772/66461; Liu XL, 2017, ENTOMOL GEN, V36, P285, DOI 10.1127/entomologia/2017/0480; Liu YQ, 2008, J ECON ENTOMOL, V101, P1805, DOI 10.1603/0022-0493-101.6.1805; LOWERY DT, 1986, J ECON ENTOMOL, V79, P1530, DOI 10.1093/jee/79.6.1530; Lu YH, 2016, B ENTOMOL RES, V106, P551, DOI 10.1017/S0007485316000286; LUCKEY TD, 1968, J ECON ENTOMOL, V61, P7, DOI 10.1093/jee/61.1.7; MAGGI VL, 1983, J ECON ENTOMOL, V76, P20, DOI 10.1093/jee/76.1.20; Moores GD, 1996, PESTIC BIOCHEM PHYS, V56, P102, DOI 10.1006/pest.1996.0064; Morse JG, 1998, HUM EXP TOXICOL, V17, P266, DOI 10.1191/096032798678908738; MORSE JG, 1991, J ECON ENTOMOL, V84, P1169, DOI 10.1093/jee/84.4.1169; Nauen R, 2015, PEST MANAG SCI, V71, P850, DOI 10.1002/ps.3932; Robertson J. L., 1992, PESTICIDE BIOASSAYS; Smith HA, 2016, INSECTS, V7, DOI 10.3390/insects7040057; Sohrabi F, 2011, CROP PROT, V30, P1190, DOI 10.1016/j.cropro.2011.05.004; STEBBING ARD, 1982, SCI TOTAL ENVIRON, V22, P213, DOI 10.1016/0048-9697(82)90066-3; Tan Y, 2012, ECOTOXICOLOGY, V21, P1989, DOI 10.1007/s10646-012-0933-0; Tang QL, 2017, PESTIC BIOCHEM PHYS, V143, P39, DOI 10.1016/j.pestbp.2017.09.013; Tang QL, 2015, J ECON ENTOMOL, V108, P2720, DOI 10.1093/jee/tov221; Vogt C, 2007, CHEMOSPHERE, V67, P2192, DOI 10.1016/j.chemosphere.2006.12.025; Wang XY, 2008, J APPL ENTOMOL, V132, P135, DOI 10.1111/j.1439-0418.2007.01225.x; YOKOYAMA VY, 1984, J ECON ENTOMOL, V77, P876, DOI 10.1093/jee/77.4.876; Yu YS, 2010, PESTIC BIOCHEM PHYS, V98, P238, DOI 10.1016/j.pestbp.2010.06.013; Zalizniak L, 2006, ECOTOX ENVIRON SAFE, V64, P207, DOI 10.1016/j.ecoenv.2005.03.015; Zeng XY, 2016, J ECON ENTOMOL, V109, P1595, DOI 10.1093/jee/tow104; Zhang P, 2014, PESTIC BIOCHEM PHYS, V111, P31, DOI 10.1016/j.pestbp.2014.04.003; 2007, APHIDS CROP PESTS, P1	70	39	43	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0208058	10.1371/journal.pone.0208058	http://dx.doi.org/10.1371/journal.pone.0208058			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677036	Green Published, gold, Green Submitted			2022-12-26	WOS:000456700400005
J	Samojlik, T; Fedotova, A; Niechoda, T; Rotherham, ID				Samojlik, Tomasz; Fedotova, Anastasia; Niechoda, Tomasz; Rotherham, Ian D.			Culturally modified trees or wasted timber: Different approaches to marked trees in Poland's Biatowieza Forest	PLOS ONE			English	Article							BIALOWIEZA FOREST; LAND-USE; PRIMEVAL FOREST; FIRE; BARK; ARCHAEOLOGY; MANAGEMENT; SWEDEN; 19TH	Studies of past forest use traditions are crucial in both understanding the present state of the oldest European forests, and in guiding decisions on future forest conservation and management. Current management of Poland's Biatowieza Forest (BF), one of the best preserved forests of the European lowlands, is heavily influenced by anecdotal knowledge on forest history. Therefore, it is important to gain knowledge of the forest's past in order to answer questions about its historical administration, utilisation, and associated anthropogenic changes. Such understanding can then inform future management. This study, based on surveys in Belarussian and Russian archives and a preliminary field survey in ten forest compartments of BiatowieZa National Park, focuses on culturally-modified trees (CMTs), which in this case are by-products of different forms of traditional forest use. Information about the formation of the CMTs can then be used to provide insight into former forest usage. Two types of CMTs were discovered to be still present in the contemporary BF. One type found in two forms was of 1) pine trees scorched and chopped in the bottom part of the trunk and 2) pine trees with carved beehives. A second type based on written accounts, and therefore known to be present in the past (what we call a 'ghost CMT'), was of 3) lime-trees with strips of bark peeled from the trunk. Written accounts cover the period of transition between the traditional forest management (BF as a Polish royal hunting ground, until the end of the eighteenth century) and modern, "scientific" forestry (in most European countries introduced in the second half of the nineteenth century). These accounts document that both types of CMTs and the traditional forest uses responsible for their creation were considered harmful to "rational forestry" by the nineteenth-century forest administration. Thus the practices which created CMTs were banned and the trees gradually removed from the forest. Indeed, these activities drew the attention of forest administrators for several decades, and in our view delayed the introduction of new, timber-oriented, forest management in the BF.	[Samojlik, Tomasz] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland; [Fedotova, Anastasia] Russian Acad Sci, Inst Hist Sci & Technol, St Petersburg, Russia; [Fedotova, Anastasia] Max Planck Inst Hist Sci, Berlin, Germany; [Niechoda, Tomasz] Zespol Szkol Chem & Przemyslu Spozywczego Gen F K, Lublin, Poland; [Rotherham, Ian D.] Sheffield Hallam Univ, Dept Nat & Built Environm, Sheffield, S Yorkshire, England	Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; Russian Academy of Sciences; Vavilov Institute for the History of Science & Technology of the Russian Academy of Sciences; Max Planck Society; Sheffield Hallam University	Samojlik, T (corresponding author), Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland.	samojlik@ibs.bialowieza.pl	Fedotova, Anastasia A./B-9844-2011	Fedotova, Anastasia A./0000-0002-6647-2866; Samojlik, Tomasz/0000-0003-3822-1311	Mammal Research Institute, Polish Academy of Sciences, Bialowieza, Poland	Mammal Research Institute, Polish Academy of Sciences, Bialowieza, Poland	The research was supported by the resources of the Mammal Research Institute, Polish Academy of Sciences, Bialowieza, Poland.	Adamczyk W, 1935, BADANIA DZIEJOW SPOL, V17, P152; Andersson R, 2005, VEG HIST ARCHAEOBOT, V14, P149, DOI 10.1007/s00334-005-0066-y; [Anonymous], 1898, CENTURY FOREST DEP 1, P1; [Anonymous], 1861, TITLE ERROR; Bengtsson J, 2000, FOREST ECOL MANAG, V132, P39, DOI 10.1016/S0378-1127(00)00378-9; Bergman I., 2014, FENNOSCANDIA ARCHAEO, VXXXI, P45; Bernadzki E, 1998, J VEG SCI, V9, P229, DOI 10.2307/3237122; Blank-Weissberg S, 1937, BARCIE KLODY POLSCE, P1; Blicharska M, 2018, SCIENCE, V359, P646, DOI 10.1126/science.aar7173; Bobrovskii P, 1863, MAT DLA GEOGRAFII ST, P404; Brincken J., 1826, MEMOIRE DESCRIPTIF F, P1; Bronovskii Y, 1861, ZH MINISTERSTVA GOSU, V78, P57; Buhrich A, 2015, AUST ARCHAEOL, P91; Callaway E, 2017, NATURE, V552, P304, DOI 10.1038/d41586-017-08493-x; Eichwald CE, 1830, NATURHISTORISCHE SKI, P1; Eldridge A., 2013, CULTURALLY MODIFIED, P113; Ericsson TS, 2003, SILVA FENN, V37, P283, DOI 10.14214/sf.507; Falinski J.B., 1986, VEGETATION DYNAMICS, V1st ed., P1; Falinski JB, 1996, THESIS, V13, P1; FALINSKI JB, 1991, NASZE DRZEWA LESNE, V15, P145; Genko N., 1902, LESNOI Z, P22; Gloger Z, 1903, BIALOWIEZA W ALBUMIE, P1; Hedemann O, 1939, ROZPRAWY SPRAWOZDA A, V1, P1; Hedemann O., 1936, ECHA LESNE, V36, p[38, 39]; Hedemann O., 1934, DAWNE PUSZCZE I WODY, P1; Holzl R, 2010, SCI CULT-UK, V19, P431, DOI 10.1080/09505431.2010.519866; Hood S, 2015, ECOLOGY, V96, P1846, DOI 10.1890/14-0487.1; Jarocki FP., 1830, PUSZCZY BIALOWIEZKIE, P1; Jedrzejewska B., 1998, PREDATION VERTEBRATE, P1; Josefsson T, 2012, NAT AREA J, V32, P54, DOI 10.3375/043.032.0107; KARCOV G, 1903, BELOVEZSKAJA PUSCA A, P1; Karpiriski JJ, 1948, SLADY DAWNEGO BARTNI, P1; Keczynski A, 2008, MATECZNIK, V3, P14; KEPPEN PI, 1841, ZH MINISTERSTVA GOSU, V4, P13; Krasnodebski D., 2005, SPRAWOZDANIA ARCHEOL, V57, P555; Krasnodebski D, 2008, WIADOMOSCI ARCHEOLOG, V60, P361; Kujawa A, 2016, FOREST RES PAPERS, V77, P302, DOI DOI 10.1515/frp-2016-0032; Latalowa M, 2015, EUROPE'S CHANGING WOODS AND FORESTS FROM WILDWOOD TO MANAGED LANDSCAPES, P243, DOI 10.1079/9781780643373.0243; Lombardero MJ, 2006, FOREST ECOL MANAG, V225, P349, DOI 10.1016/j.foreco.2006.01.010; Long A., 2003, SCARRED TREES IDENTI; MacDonald LH, 2000, ENVIRON MANAGE, V26, P299, DOI 10.1007/s002670010088; Michalczuk C., 2001, PHYTOCOENOSIS S, V13, P1; Mikusinska A, 2013, APPL VEG SCI, V16, P217, DOI 10.1111/j.1654-109X.2012.01220.x; Morrison M, 2013, J FIELD ARCHAEOL, V38, P143, DOI 10.1179/0093469013Z.00000000044; Niklasson M., 1994, VEGET HIST ARCHAEOBO, V3, P183, DOI [DOI 10.1007/BF00202025, 10.1007/BF00202025]; Niklasson M, 2010, J ECOL, V98, P1319, DOI 10.1111/j.1365-2745.2010.01710.x; Ostlund L, 2003, SCAND J FOREST RES, V18, P78, DOI 10.1080/0891060310002363; Ostlund L, 2002, ENVIRON HIST-US, V7, P48, DOI 10.2307/3985452; Paczoski J., 1928, PRZEGLAD LESNICZY, V2, P1; Potujatiski A, 1854, OPISANIE LASOW KROLE, V2, P1; RHOADS JW, 1992, WORLD ARCHAEOL, V24, P198, DOI 10.1080/00438243.1992.9980203; Samojlik T., 2004, Sylwan, V148, P37; Samojlik T., 2005, ROCZNIK DENDROLOGICZ, V53, P55; Samojlik T, 2005, CONSERVATION HUNTING, P1; Samojlik T., 2013, CULTURAL SEVERANCE E, P191; Samojlik T., 2010, LANDSC ARCHAEOL ECOL, V8, P150; SAMOJLIK T, 2006, ROCZNIK DENDROLOGICZ, V54, P7; Samojlik T, 2007, THESIS, P1; Samojlik T, 2016, AMBIO, V45, P904, DOI 10.1007/s13280-016-0795-4; Samojlik T, 2013, ENVIRON HIST-US, V18, P576, DOI 10.1093/envhis/emt039; Swetnam Thomas W., 1984, J ETHNOBIOL, V4, P177; Teplouhov A., 1862, ZH MINISTERSTVA GOSU, V79, P164; Tomialojc L, 2004, J ORNITHOL, V145, P81, DOI 10.1007/s10336-003-0017-2; Wesolowski T, 2016, VOICE DEBATE; Wicko E, 1984, PUSZCZA BIALOWIESKA, P1; Wiecko E., 1963, KWARTALNIK HIST KULT, V11, P345; Wroblewski K, 1927, ZUBR PUSZCZY BIALOWI, P98; Zackrisson O, 2000, VEG HIST ARCHAEOBOT, V9, P99, DOI 10.1007/BF01300060; Zimny M, 2015, PARKI NARODOWE REZER, V35, P3; 1862, TITLE ERROR; 1844, TITLE ERROR; 1880, TITLE ERROR; 1816, TITLE ERROR, P196; 1850, TITLE ERROR, P67; 1862, TITLE ERROR, V80, P99	75	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211025	10.1371/journal.pone.0211025	http://dx.doi.org/10.1371/journal.pone.0211025			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673758	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000456442800067
J	Feinberg, I; Campbell, IG				Feinberg, Irwin; Campbell, Ian G.			Shorter sleep durations in adolescents reduce power density in a wide range of waking electroencephalogram frequencies	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; ATTENUATION; INCREASE	Despite sleep's recognized biological importance, it has been remarkably difficult to demonstrate changes in brain physiology with reduced sleep durations. In a study of adolescents, we varied sleep durations by restricting time in bed for four nights of either 10, 8.5 or 7 h. Shorter sleep durations significantly decreased waking electroencephalogram (EEG) power in a wide range of frequencies with both eyes closed and eyes open in central and occipital leads. These findings suggest new research directions and raise the possibility that waking EEG power density could provide a non-invasive test for biologically sufficient sleep.	[Feinberg, Irwin; Campbell, Ian G.] Univ Calif Davis, Dept Psychiat & Behav Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Campbell, IG (corresponding author), Univ Calif Davis, Dept Psychiat & Behav Sci, Davis, CA 95616 USA.	igcampbell@ucdavis.edu			United States Public Health Service [R01-HL116490]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116490] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	IF received United States Public Health Service grant R01-HL116490 for support of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry RJ, 2009, CLIN NEUROPHYSIOL, V120, P1806, DOI 10.1016/j.clinph.2009.08.006; BUCHSBAUM MS, 1989, LIFE SCI, V45, P1349, DOI 10.1016/0024-3205(89)90021-0; Campbell IG, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx046; Campbell IG, 2011, SLEEP, V34, P83, DOI 10.1093/sleep/34.1.83; EVARTS EV, 1962, J NEUROPHYSIOL, V25, P812, DOI 10.1152/jn.1962.25.6.812; FEINBERG I, 1991, SLEEP, V14, P316; Geller AS, 2014, CLIN NEUROPHYSIOL, V125, P1764, DOI 10.1016/j.clinph.2014.01.021; Kaida K, 2006, CLIN NEUROPHYSIOL, V117, P1574, DOI 10.1016/j.clinph.2006.03.011; MADSEN PL, 1991, J APPL PHYSIOL, V70, P2597, DOI 10.1152/jappl.1991.70.6.2597; MADSEN PL, 1991, BRAIN RES, V557, P217, DOI 10.1016/0006-8993(91)90137-K; MAQUET P, 1990, BRAIN RES, V513, P136, DOI 10.1016/0006-8993(90)91099-3; Moruzzi G, 1996, BRAIN CONSCIOUS EXPE, P345; Murta T, 2015, HUM BRAIN MAPP, V36, P391, DOI 10.1002/hbm.22623; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Stampi C, 1995, WORK STRESS, V9, P368, DOI 10.1080/02678379508256574; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117	16	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210649	10.1371/journal.pone.0210649	http://dx.doi.org/10.1371/journal.pone.0210649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668606	Green Published, gold, Green Submitted			2022-12-26	WOS:000456306400010
J	Lee, TL; Kao, FC; Hsu, YC; Lo, YY; Tu, YK				Lee, Thung-Lip; Kao, Feng-Chen; Hsu, Yao-Chun; Lo, Ying-Ying; Tu, Yuan-Kun			Perioperative acute myocardial infarction rate in chronic renal disease patients undergoing orthopedic surgery: Is there any difference between dialyzed and nondialyzed patients?	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; ACUTE CORONARY SYNDROME; POSTOPERATIVE MORBIDITY; DIALYSIS PATIENTS; CARDIAC RISK; MORTALITY; OUTCOMES; ISCHEMIA; REINFARCTION	Background The incidence of acute myocardial infarction (AMI) in healthy patients undergoing noncardiac surgery is <1%. When patients with chronic kidney disease (CKD) undergo orthopedic surgery, AMI incidence can be expected to be relatively high. However, data on a population-wide scale is lacking. Objective To investigate AMI incidence in patients with CKD (with and without dialysis) undergoing orthopedic surgery. Design A population-based study covering the period from January 1, 1997, to December 31, 2011. Setting Data from the Taiwan National Health Insurance Research Database. Participants Participants were 219,195 patients with CKD who underwent surgery between January 1, 1997, and December 31, 2011. Results AMI occurred in 2,708 participants (1.24%). The AMI incidence rate in the dialyzed group was 1.52%, which was higher than that in the nondialyzed group after propensity score matching. Dialysis (odds ratio [OR]: 1.79; 95% confidence interval [CI]: 1.62-1.98), male (OR: 1.42; 95% CI: 1.28-1.57), diabetes mellitus (OR: 1.61; 95% CI: 1.44-1.80), hyperlipidemia (OR: 1.88; 95% CI: 1.68-2.11), old myocardial infarction (OR: 18.87; 95% CI: 16.26-1.21.90), and cerebral vascular disease (CVA) (OR: 1.29; 95% CI: 1.30-1.47) were all associated with AMI in the patients with CKD. Conclusions The AMI risk was higher in the patients with CKD undergoing orthopedic surgery than in the general population, and the dialyzed group had a higher risk of AMI than did the nondialyzed group.	[Lee, Thung-Lip] E Da Hosp, Dept Cardiovasc, Kaohsiung, Taiwan; [Lee, Thung-Lip; Kao, Feng-Chen; Tu, Yuan-Kun] I Shou Univ, Sch Med, Kaohsiung, Taiwan; [Kao, Feng-Chen; Tu, Yuan-Kun] E Da Hosp, Dept Orthopaed, Kaohsiung, Taiwan; [Hsu, Yao-Chun] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Hsu, Yao-Chun] E Da Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Hsu, Yao-Chun] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Lo, Ying-Ying] I Shou Univ, Dept Healthcare Adm, Kaohsiung, Taiwan	E-Da Hospital; I Shou University; E-Da Hospital; Fu Jen Catholic University; E-Da Hospital; China Medical University Taiwan; I Shou University	Kao, FC (corresponding author), I Shou Univ, Sch Med, Kaohsiung, Taiwan.; Kao, FC (corresponding author), E Da Hosp, Dept Orthopaed, Kaohsiung, Taiwan.; Lo, YY (corresponding author), I Shou Univ, Dept Healthcare Adm, Kaohsiung, Taiwan.	ed100735@edah.org.tw; iilo991027@gmail.com		Kao, FengChen/0000-0002-6068-3144	E-Da Hospital [EDAHP103048]	E-Da Hospital	This study was funded by E-Da Hospital (EDAHP103048).; This study was based on data from the NHIRD (NHIRD-104-167, NHIRD-104-347) of the NHI Bureau, Taiwan Department of Health, which is managed by the NHRI. The interpretations and conclusions contained herein do not represent those of the NHI Bureau, the Department of Health, or the NHRI. The authors are grateful to Tzu-shan Chen for her assistance.	Ackland GL, 2011, ANESTH ANALG, V112, P1375, DOI 10.1213/ANE.0b013e3181ee8456; Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Baig Sara Z, 2009, Adv Perit Dial, V25, P147; Cai QJ, 2013, CURR CARDIOL REV, V9, P331, DOI 10.2174/1573403X10666140214122234; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Chou MT, 2013, INT J CARDIOL, V167, P2719, DOI 10.1016/j.ijcard.2012.06.108; FOLEY RN, 1995, KIDNEY INT, V47, P186, DOI 10.1038/ki.1995.22; French GWG, 1999, ANAESTHESIA, V54, P235, DOI 10.1046/j.1365-2044.1999.00713.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601; Han JH, 2006, AM J MED, V119, P248, DOI 10.1016/j.amjmed.2005.08.057; Herzog CA, 2002, CIRCULATION, V106, P2207, DOI 10.1161/01.CIR.0000035248.71165.EB; Keough-Ryan TM, 2005, AM J KIDNEY DIS, V46, P845, DOI 10.1053/j.ajkd.2005.07.043; Knapp RB, 1962, JAMA-J AM MED ASSOC, V182, P106; Kosuge M, 2006, CIRC J, V70, P222, DOI 10.1253/circj.70.222; Lee CH, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001066; Lee YC, 2015, SLEEP, V38, P213, DOI 10.5665/sleep.4400; LEPPO J, 1987, J AM COLL CARDIOL, V9, P269, DOI 10.1016/S0735-1097(87)80374-1; Mallinson T., 2010, FOCUS 1 AID, V15, P15; MANGANO DT, 1990, NEW ENGL J MED, V323, P1781, DOI 10.1056/NEJM199012273232601; MARSCH SCU, 1992, ANESTHESIOLOGY, V76, P518, DOI 10.1097/00000542-199204000-00006; Mathew A, 2008, KIDNEY INT, V73, P1069, DOI 10.1038/ki.2008.29; Mellord C, 2008, J AM COLL CARDIOL, V51, P991, DOI 10.1016/j.jacc.2007.11.045; Menendez ME, 2015, INT ORTHOP, V39, P777, DOI 10.1007/s00264-014-2502-z; RAO TLK, 1983, ANESTHESIOLOGY, V59, P499, DOI 10.1097/00000542-198312000-00003; RILES TS, 1979, SURGERY, V85, P249; Santopinto JJ, 2003, HEART, V89, P1003, DOI 10.1136/heart.89.9.1003; STEEN PA, 1978, JAMA-J AM MED ASSOC, V239, P2566, DOI 10.1001/jama.239.24.2566; TARHAN S, 1972, J AMER MED ASSOC, V220, P1451, DOI 10.1001/jama.220.11.1451; US Renal Data System, 1998, USRDS 1998 ANN DAT R; van Waes JAR, 2013, CIRCULATION, V127, P2264, DOI 10.1161/CIRCULATIONAHA.113.002128; Vashistha V, 2016, INT J CARDIOL, V223, P401, DOI 10.1016/j.ijcard.2016.07.175; VONKNORRING J, 1981, SURGERY, V90, P55; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Yin WH, 2016, INT J CARDIOL, V209, P103, DOI 10.1016/j.ijcard.2016.02.022	35	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210554	10.1371/journal.pone.0210554	http://dx.doi.org/10.1371/journal.pone.0210554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653544	gold, Green Submitted, Green Published			2022-12-26	WOS:000456015500049
J	Milic, V; Grujic, M; Barisic, J; Marinkovic-Eric, J; Duisin, D; Cirkovic, A; Damjanov, N				Milic, Vera; Grujic, Milica; Barisic, Jasmina; Marinkovic-Eric, Jelena; Duisin, Dragana; Cirkovic, Andja; Damjanov, Nemanja			Personality, depression and anxiety in primary Sjogren's syndrome - Association with sociodemographic factors and comorbidity	PLOS ONE			English	Article							QUALITY-OF-LIFE; SICCA SYMPTOMS; FATIGUE; NEUROTICISM; DISEASE; CLASSIFICATION; EXTROVERSION; FIBROMYALGIA; VALIDATION; COGNITIONS	Objective Patients with primary Sjogren's Syndrome (pSS) have diminished health quality and fatigue, arthralgia along with dryness of the mouth and eyes have major impact on their psychological and social aspects of life. The purpose of this study was to determine psychological features of patients with pSS. We analyzed personality, depression and anxiety of patients with primary Sjogren's Syndrome (pSS) in comparison with patients with rheumatoid arthritis (RA) and healthy controls (HC) and assessed their association with sociodemographic factors and comorbidity. Methods In 105 pSS patients (mean age 51.34 years, mean disease duration 5.98 years), 52 RA patients (mean age 51.37 years, mean disease duration 8.10 years) and 54 HC (mean age 51.35 years) clinical and sociodemographic characteristics were determined and results analyzed. At enrollment patients and controls completed the Revisited NEO Personality Inventory Five-Factor model (NEO-PI-R), the Zung Self-Rating Depression Scale and the Zung Self-Rating Anxiety Scale. Statistical analyses were performed using SPSS [Version 16.0]. The relative size of the effect was assessed based on standardized estimates of effect size (d). Results Patients with pSS, similarly to RA patients had higher scores of Neuroticism (d = 0.46, p = 0.007) and lower scores of Extraversion (d = 0.51, p = 0.001) and Openness for experience (d = 0.65, p = 0.013) compared to HC. There was no significant differences between pSS group and HC in the depression (d = 0.171, p>0.05). However, patients with pSS had higher anxiety in comparison to HC (p<0.0001). In multivariate models, education and satisfaction with family relationships were significant predictors for psychological characteristics of patients, independently of clinical diagnosis. Conclusions Our study is the first to show that patients with pSS scored high on neuroticism and anxiety and low on sociability. Education and satisfaction with family relationships predisposed to their psychological profile. Psychological assessment of patients with pSS may improve understanding and treatment of this clinical condition.	[Milic, Vera; Grujic, Milica; Damjanov, Nemanja] Univ Belgrade, Dept Rheumatol, Fac Med, Belgrade, Serbia; [Barisic, Jasmina; Duisin, Dragana] Clin Ctr Serbia, Dept Psychiat, Belgrade, Serbia; [Marinkovic-Eric, Jelena; Cirkovic, Andja] Univ Belgrade, Dept Med Stat, Fac Med, Belgrade, Serbia	University of Belgrade; Clinical Centre of Serbia; University of Belgrade	Milic, V (corresponding author), Univ Belgrade, Dept Rheumatol, Fac Med, Belgrade, Serbia.	veramilic1409@gmail.com		Cirkovic, Andja/0000-0002-7542-5690; Milic, Vera/0000-0003-1160-9674				ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Axelsson M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018241; Ben-Porath Y.S., 1992, PSYCHOL ASSESSMENT, V4, P14, DOI [https://doi.org/10.1037/1040-3590.4.1.14, DOI 10.1037/1040-3590.4.1.14]; Bibbey A, 2013, INT J PSYCHOPHYSIOL, V90, P28, DOI 10.1016/j.ijpsycho.2012.10.018; Boyle MP, 2013, J FLUENCY DISORD, V38, P368, DOI 10.1016/j.jfludis.2013.09.001; Bucourt E, 2017, JOINT BONE SPINE, V84, P203, DOI 10.1016/j.jbspin.2016.03.006; Cameron DS, 2015, HEALTH PSYCHOL REV, V9, P345, DOI 10.1080/17437199.2014.923164; Carver CS, 2010, ANNU REV PSYCHOL, V61, P679, DOI 10.1146/annurev.psych.093008.100352; Champey J, 2006, ARTHRIT RHEUM-ARTHR, V55, P451, DOI 10.1002/art.21990; Costa PT, 2005, J AFFECT DISORDERS, V89, P45, DOI 10.1016/j.jad.2005.06.010; Costa PTJ, 1992, THE REVISITED NEO PE; Eysenc H. J., 1969, PERSONALITY STRUCTUR; Fayard JV, 2012, J PERS, V80, P1, DOI 10.1111/j.1467-6494.2011.00720.x; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Griffith JW, 2010, PSYCHOL MED, V40, P1125, DOI 10.1017/S0033291709991449; Harboe E, 2009, ANN RHEUM DIS, V68, P1541, DOI 10.1136/ard.2008.098301; HERBERT TB, 1993, PSYCHOSOM MED, V55, P364, DOI 10.1097/00006842-199307000-00004; Ioannidis JPA, 2002, ARTHRITIS RHEUM, V46, P741, DOI 10.1002/art.10221; Jankovic S, 2007, EUR J PUBLIC HEALTH, V17, P80, DOI 10.1093/eurpub/ckl072; Jokela M, 2014, PSYCHOL MED, V44, P2629, DOI 10.1017/S0033291714000257; Judge TA, 2002, J PERS SOC PSYCHOL, V83, P693, DOI 10.1037//0022-3514.83.3.693; Jylha P, 2006, DEPRESS ANXIETY, V23, P281, DOI 10.1002/da.20167; Karageorgas T, 2016, ARTHRIT CARE RES, V68, P123, DOI 10.1002/acr.22720; Karaiskos D, 2010, RHEUMATOLOGY, V49, P1762, DOI 10.1093/rheumatology/keq158; Karsten J, 2012, J PSYCHIATR RES, V46, P644, DOI 10.1016/j.jpsychires.2012.01.024; Lackner A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172056; Littlejohn G., 2012, PAIN RES TREATMENT, V2012, P730; Lodi-Smith J, 2010, PSYCHOL HEALTH, V25, P305, DOI 10.1080/08870440902736964; Lucas RE, 2011, J PERS SOC PSYCHOL, V101, P847, DOI 10.1037/a0024298; Lukkahatai N, 2013, J PSYCHOSOM RES, V74, P100, DOI 10.1016/j.jpsychores.2012.11.006; MAGNUS K, 1993, J PERS SOC PSYCHOL, V65, P1046, DOI 10.1037/0022-3514.65.5.1046; McAdams DP, 2010, ANNU REV PSYCHOL, V61, P517, DOI 10.1146/annurev.psych.093008.100507; McCrae R. R., 1999, HDB PERSONALITY THEO, V2, P139; Meijer JM, 2009, RHEUMATOLOGY, V48, P1077, DOI 10.1093/rheumatology/kep141; Milin M, 2016, JOINT BONE SPINE, V83, P681, DOI 10.1016/j.jbspin.2015.10.005; Mirowsky J, 2007, AM J SOCIOL, V112, P1339, DOI 10.1086/511800; Morey LC, 2010, AM J PSYCHIAT, V167, P528, DOI 10.1176/appi.ajp.2009.09071023; Ode S, 2007, PERS INDIV DIFFER, V43, P2137, DOI 10.1016/j.paid.2007.06.035; Martinez MP, 2011, J CLIN PSYCHOL MED S, V18, P380, DOI 10.1007/s10880-011-9263-2; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Prins JB, 2006, LANCET, V367, P346, DOI 10.1016/S0140-6736(06)68073-2; Prins JB, 2004, PSYCHOTHER PSYCHOSOM, V73, P174, DOI 10.1159/000076455; Santiago T, 2015, CURR PHARM DESIGN, V21, P257; Savic D, 2000, PSYCHOBIOLOGY, V28, P581; Seror R, 2015, ANN RHEUM DIS, V74, P859, DOI 10.1136/annrheumdis-2013-204615; Shen CC, 2015, J RHEUMATOL, V42, P1203, DOI 10.3899/jrheum.141361; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Valtysdottir ST, 2000, CLIN EXP RHEUMATOL, V18, P597; van Leeuwen N, 2015, RHEUMATOLOGY, V54, P776, DOI 10.1093/rheumatology/keu387; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; WATSON D, 1985, PSYCHOL BULL, V98, P219, DOI 10.1037/0033-2909.98.2.219; Wortman J, 2012, PSYCHOL AGING, V27, P867, DOI 10.1037/a0029322; Wouters EJM, 2012, ANN RHEUM DIS, V71, P668, DOI 10.1136/ard.2011.154245; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	55	13	14	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210466	10.1371/journal.pone.0210466	http://dx.doi.org/10.1371/journal.pone.0210466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653543	Green Published, Green Submitted, gold			2022-12-26	WOS:000456015500039
J	Raasch-Fernandes, LD; Bonaldo, SM; Rodrigues, DD; Vieira, GM; Schwan-Estrada, KRF; da Silva, CR; Vercosa, AGA; de Oliveira, DL; Debiasi, BW				Raasch-Fernandes, Livia Deice; Bonaldo, Solange Maria; Rodrigues, Domingos de Jesus; Vieira-Junior, Gerardo Magela; Freitas Schwan-Estrada, Katia Regina; da Silva, Camila Rocco; Araujo Vercosa, Ana Gabriela; de Oliveira, Daiane Lopes; Debiasi, Bryan Wender			Induction of phytoalexins and proteins related to pathogenesis in plants treated with extracts of cutaneous secretions of southern Amazonian Bufonidae amphibians	PLOS ONE			English	Article							NATURAL-PRODUCTS; POSTHARVEST DISEASES; INDUCED RESISTANCE; ACTIVE COMPOUNDS; CHITOSAN; DEFENSE; L.; BUFADIENOLIDES; ACCUMULATION; DISCOVERY	Cutaneous secretions produced by amphibians of the family Bufonidae are rich sources of bioactive compounds that can be useful as new chemical templates for agrochemicals. In crop protection, the use of elicitors to induce responses offers the prospect of durable, broad-spectrum disease control using the plant's own resistance. Therefore, we evaluated the potential of methanolic extracts of cutaneous secretions of two species of amphibians of the family Bufonidae found in the Amazon biome-Rhaebo guttatus (species 1) and Rhinella marina (species 2)-in the synthesis of phytoalexins in soybean cotyledons, bean hypocotyls, and sorghum mesocotyls. Additionally, changes in the enzyme activity of beta-1,3-glucanase, peroxidase (POX), and polyphenol oxidase (PPO) and in the total protein content of soybean cotyledons were determined. In the soybean cultivar 'TMG 132 RR', our results indicated that the methanolic extract of R. guttatus cutaneous secretions suppressed glyceollin synthesis and beta-1,3-glucanase activity and increased POX and PPO activities at higher concentrations and total protein content at a concentration of 0.2 mg/mL. On the other hand, the methanolic extract of R. marina cutaneous secretions induced glyceollin synthesis in the soybean cultivars 'TMG 132 RR' and 'Monsoy 8372 IPRO' at 0.1-0.2 mg/mL and 0.2 mg/mL, respectively. The methanolic extract of R. marina cutaneous secretions also increased the specific activity of POX and PPO in 'Monsoy 8372 IPRO' and 'TMG 132 RR', respectively, and decreased the activity of beta-1,3-glucanases in 'Monsoy 8372 IPRO'. At 0.3 mg/mL, it stimulated phaseolin synthesis. The extracts did not express bioactivity in the synthesis of deoxyanthocyanidins in sorghum mesocotyls. The study in soybean suggests that the bioactivity in defense responses is influenced by cultivar genotypes. Therefore, these results provide evidence that extracts of cutaneous secretions of these amphibians species may contribute to the bioactivity of defense metabolites in plants.	[Raasch-Fernandes, Livia Deice] Univ Fed Mato Grosso, Postgrad Program Environm Sci, Sinop, MG, Brazil; [Bonaldo, Solange Maria; Rodrigues, Domingos de Jesus] Univ Fed Mato Grosso, Sinop, MG, Brazil; [Bonaldo, Solange Maria; Rodrigues, Domingos de Jesus] Postgrad Program Environm Sci, Sinop, MG, Brazil; [Vieira-Junior, Gerardo Magela] Univ Fed Piaui, Ministro Petronio Portela Campus, Teresina, Piaui State, Brazil; [Freitas Schwan-Estrada, Katia Regina] Univ Estadual Maringa, Maringa, Parana, Brazil; [da Silva, Camila Rocco] Univ Estadual Maringa, Grad Program Agron, Maringa, Parana, Brazil; [Araujo Vercosa, Ana Gabriela; de Oliveira, Daiane Lopes] Univ Fed Mato Grosso, Inst Agr & Environm Sci, Sinop, MG, Brazil; [Debiasi, Bryan Wender] Univ Fed Mato Grosso, Inst Hlth Sci, Sinop, MG, Brazil	Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso; Universidade Federal do Piaui; Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso	Bonaldo, SM (corresponding author), Univ Fed Mato Grosso, Sinop, MG, Brazil.; Bonaldo, SM (corresponding author), Postgrad Program Environm Sci, Sinop, MG, Brazil.	sbonaldo@ufmt.br	Junior, Gerardo Magela Vieira/W-7465-2019; Rodrigues, Domingos/D-6039-2013; Vieira, Gerardo Magela/AAP-2228-2021; Bonaldo, Solange Maria/N-1909-2019; Debiasi, Bryan Wender/ABD-2179-2021; Debiasi, Bryan Wender/M-2140-2018	Rodrigues, Domingos/0000-0002-8360-2036; Vieira, Gerardo Magela/0000-0001-8113-8957; Bonaldo, Solange Maria/0000-0002-2240-2700; Debiasi, Bryan Wender/0000-0001-8926-2362; Schwan Estrada, Katia Regina Freitas/0000-0001-8384-8557; /0000-0002-0062-525X	Foundation for Research Support of the State of Mato Grosso (FAPEMAT) [219465/2015]; Coordination for the Improvement of Higher Education Personnel (CAPES); National Council of Scientific and Technological Development (CNPq); Foundation for Research Support of the State of Mato Grosso (FAPEMAT)	Foundation for Research Support of the State of Mato Grosso (FAPEMAT)(Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council of Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation for Research Support of the State of Mato Grosso (FAPEMAT)(Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT))	Foundation for Research Support of the State of Mato Grosso (FAPEMAT) for the financial support to the project (Process No. 219465/2015). URL: http://www.fapemat.mt.gov.br. Coordination for the Improvement of Higher Education Personnel (CAPES) with the provision of a scholarship during the period of the Graduate Program in Environmental Sciences (PPGCAM). URL http://www.capes.gov.br. (Author: L.D.R.F). National Council of Scientific and Technological Development (CNPq) with the concession of scientific initiation grants. URL: http://cnpq.br. (Authors: A.G.A.V and D.L.O) Foundation for Research Support of the State of Mato Grosso (FAPEMAT) for the provision of a scientific initiation grant (Author: B.W.D). URL: http://www.fapemat.mt.gov.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaeil K, 2013, FRONT PLANT SCI, V4, P1; Ahmad I., 2013, AM-EURASIAN J AGRIC, V13, P539, DOI [10.1155/2014/215872, DOI 10.5829/idosi.aejaes.2013.13.04.1975]; Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Almagro L, 2009, J EXP BOT, V60, P377, DOI 10.1093/jxb/ern277; Andolfo G, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00987; ARRUDA R. S., 2012, BIOSCI J, V28, P164; Atanasov AG, 2015, BIOTECHNOL ADV, V33, P1582, DOI 10.1016/j.biotechadv.2015.08.001; Baldin D, 2013, C BRASILEIRO AGROECO, V8, P1; Banfi FF, 2016, KOREAN J PARASITOL, V54, P415, DOI 10.3347/kjp.2016.54.4.415; Barcelos RA, 2015, THESIS; Bhargava S, 2013, PLANT BREEDING, V132, P21, DOI 10.1111/pbr.12004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brennecke K, 2015, REV AGROGEOAMBIENTAL, V7, P19, DOI 10.18406/2316-1817v7n42015786; Bucar F, 2013, NAT PROD REP, V30, P525, DOI 10.1039/c3np20106f; Chen Y, 2017, J CHEM INF MODEL, V57, P2099, DOI 10.1021/acs.jcim.7b00341; Chen YH, 2015, ANNU REV ENTOMOL, V60, P35, DOI 10.1146/annurev-ento-010814-020601; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Cui XY, 2010, BIOL PHARM BULL, V33, P1728, DOI 10.1248/bpb.33.1728; Cabral LD, 2013, INT J FOOD MICROBIOL, V166, P1, DOI 10.1016/j.ijfoodmicro.2013.05.026; Curvelo CRD, 2013, BRAGANTIA, V72, P41, DOI 10.1590/S0006-87052013005000017; Solino AJD, 2017, REV CAATINGA, V30, P1073, DOI 10.1590/1983-21252017v30n429rc; Melo LGD, 2016, PESQUI AGROPECU BRAS, V51, P1703, DOI [10.1590/S0100-204X2016001000001, 10.1590/s0100-204x2016001000001]; De Sousa LQ, 2017, TOXICON, V127, P63, DOI 10.1016/j.toxicon.2017.01.004; Delaunois B, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00249; DIXON RA, 1990, ANNU REV PLANT PHYS, V41, P339, DOI 10.1146/annurev.pp.41.060190.002011; Duangmal K, 1999, FOOD CHEM, V64, P351, DOI 10.1016/S0308-8146(98)00127-7; Durango D, 2013, MOLECULES, V18, P10609, DOI 10.3390/molecules180910609; Ferreira DF., 2008, REV S, V6, P36, DOI DOI 10.1080/00103620903261577; Fesel PH, 2016, FUNGAL GENET BIOL, V90, P53, DOI 10.1016/j.fgb.2015.12.004; Filho GAC, 2005, TOXICON, V45, P777, DOI 10.1016/j.toxicon.2005.01.017; Fishal EMM, 2010, AGR SCI CHINA, V9, P1140, DOI 10.1016/S1671-2927(09)60201-7; Gao HM, 2010, J ETHNOPHARMACOL, V131, P368, DOI 10.1016/j.jep.2010.07.017; Garcia-Mier L, 2013, INT J MOL SCI, V14, P4203, DOI 10.3390/ijms14024203; Goel Navodit, 2015, Archives of Phytopathology and Plant Protection, V48, P555, DOI 10.1080/03235408.2015.1075296; Gozzo F, 2013, J AGR FOOD CHEM, V61, P12473, DOI 10.1021/jf404156x; Grant T, 2012, CHEMOECOLOGY, V22, P169, DOI 10.1007/s00049-012-0107-9; GUIMARÃES SS, 2015, Rev. bras. plantas med., V17, P143, DOI 10.1590/1983-084X/12_190; Heinrich M, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 3: DEVELOPMENT & MODIFICATION OF BIOACTIVITY, P351; Jain S, 2015, ADV PLANTS AGR RES, V3, P1, DOI DOI 10.15406/apar.2015.03.00077; Jeandet P, 2015, MOLECULES, V20, P2770, DOI 10.3390/molecules20022770; Jeandet P, 2014, MOLECULES, V19, P18033, DOI 10.3390/molecules191118033; Jeandet P, 2013, INT J MOL SCI, V14, P14136, DOI 10.3390/ijms140714136; Jiang L, 2015, PLOS ONE, V10, P1; Kamboj A., 2013, INT J PHARM PHARM SC, V5, P20; Kandasamy R, 2017, INSECT BIOCHEM MOLEC, V84, P32, DOI 10.1016/j.ibmb.2017.03.005; Kazan K, 2014, PLANT CELL, V26, P2285, DOI 10.1105/tpc.114.125419; Lahlou M., 2013, PHARM PHARMACOL-RUSS, V4, P17, DOI [10.4236/pp.2013.43A003, DOI 10.4236/PP.2013.43A003]; Lavanya SN, 2016, INT J LIFE SCI, V5, P46; Li BJ, 2015, FITOTERAPIA, V105, P7, DOI 10.1016/j.fitote.2015.05.013; Li YF, 2014, PROTEOMICS, V14, P1088, DOI 10.1002/pmic.201300104; Liu J, 2007, POSTHARVEST BIOL TEC, V44, P300, DOI 10.1016/j.postharvbio.2006.12.019; Liu YC, 2014, MOLECULES, V19, P568, DOI 10.3390/molecules19010568; Llorens E, 2017, SCI AGR, V74, P90, DOI [10.1590/1678-992x-2016-0012, 10.1590/1678-992X-2016-0012]; Lo SCC, 1999, PHYSIOL MOL PLANT P, V55, P263, DOI 10.1006/pmpp.1999.0231; Loiseleur O, 2017, CHIMIA, V71, P810, DOI 10.2533/chimia.2017.810; Lusso Marcos F. G., 1999, Summa Phytopathologica, V25, P244; Matiello J., 2013, Rev. bras. plantas med., V15, P541, DOI 10.1590/S1516-05722013000400010; Matiello J, 2016, REV AGRONEGOCIO MEIO, V9, P617; Mazaro S. M., 2015, Revista Brasileira de Ciencias Agrarias (Agraria), V10, P512, DOI 10.5039/agraria.v10i4a5190; Mazaro S.M., 2013, Rev. bras. plantas med., V15, P208, DOI 10.1590/S1516-05722013000200007; Meinerz C.C, 2014, Rev. bras. plantas med., V16, P794, DOI 10.1590/1983-084X/10_091; Mishra BB., 2017, MICROBIAL BIOTECHNOL, V1, P29, DOI DOI 10.1111/1751-7915.12231; Moreira D, 2016, CURR DRUG TARGETS, V17, P942, DOI 10.2174/1389450116666150416120559; Nascimento J., 2014, AGRARIANACADEMY, V1, P234, DOI [10.18677/Agrarian_Academy_2014_021, DOI 10.18677/AGRARIAN_ACADEMY_2014_021]; Oliveira J. S. B., 2014, African Journal of Agricultural Research, V9, P971; Owen WJ, 2017, PEST MANAG SCI, V73, P2005, DOI 10.1002/ps.4588; Park HL, 2013, PHYTOCHEMISTRY, V96, P57, DOI 10.1016/j.phytochem.2013.08.012; Passardi F, 2005, PLANT CELL REP, V24, P255, DOI 10.1007/s00299-005-0972-6; PAULA C. S., 2015, Rev. bras. plantas med., V17, P577, DOI 10.1590/1983-084X/13_079; Peiter-Beninca C., 2008, Arq. Inst. Biol., V75, P285, DOI 10.1590/1808-1657v75p2852008; Cordova WHP, 2016, TOXICON, V110, P27, DOI 10.1016/j.toxicon.2015.11.015; Phitaktim S, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0814-4; Ferreira PMP, 2013, TOXICON, V72, P43, DOI 10.1016/j.toxicon.2013.06.009; Poloni A, 2014, MOLECULES, V19, P9114, DOI 10.3390/molecules19079114; Purkayastha RP, 2017, HDB PHYTOALEXIN META, P1; Puschett JB, 2010, AM J KIDNEY DIS, V56, P359, DOI 10.1053/j.ajkd.2010.01.023; Qi FH, 2011, INT IMMUNOPHARMACOL, V11, P342, DOI 10.1016/j.intimp.2010.12.007; Racchi ML, 2013, ANTIOXIDANTS-BASEL, V2, P340, DOI 10.3390/antiox2040340; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Rodriguez C, 2017, J ETHNOPHARMACOL, V198, P235, DOI 10.1016/j.jep.2016.12.021; Rojas CM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00017; Romanazzi G, 2002, J FOOD SCI, V67, P1862, DOI 10.1111/j.1365-2621.2002.tb08737.x; Sarris PF, 2015, CELL, V161, P1089, DOI 10.1016/j.cell.2015.04.024; Saul N, 2013, CHEMOSPHERE, V93, P1005, DOI 10.1016/j.chemosphere.2013.05.069; Schmeda-Hirschmann G, 2014, J ETHNOPHARMACOL, V155, P1076, DOI 10.1016/j.jep.2014.06.025; Schmelz EA, 2014, PLANT J, V79, P659, DOI 10.1111/tpj.12436; Schwan-Estrada K.R.F., 2008, PLANT PATHOGEN INTER, P227; Shen JH, 2003, CURR MED CHEM, V10, P2327, DOI 10.2174/0929867033456729; Singh R., 2017, INT J CURR MICROBIOL, V6, P125, DOI [10.20546/ijcmas.2017.601.016, DOI 10.20546/IJCMAS.2017.601.016]; Sparks TC, 2017, PEST MANAG SCI, V73, P700, DOI 10.1002/ps.4458; Stangarlin JR., 2011, SCI AGRARIA PARANAEN, V6, P18, DOI DOI 10.1818/SAP.V10I1.5268; Sun DQ, 2013, SCI HORTIC-AMSTERDAM, V164, P484, DOI 10.1016/j.scienta.2013.10.011; Taranto F, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020377; Telaxka FJ, 2014, EUCALYPTUS GLOBULUS, V9, P1; Thakur Meenakshi, 2013, ISRN Biochem, V2013, P762412, DOI 10.1155/2013/762412; Tian HY, 2013, J NAT PROD, V76, P1842, DOI 10.1021/np400174f; Usman MG, 2018, PJSRR, V4, P54; VOGELSANG R, 1993, PLANTA, V189, P60, DOI 10.1007/BF00201344; Walters DR, 2013, J EXP BOT, V64, P1263, DOI 10.1093/jxb/ert026; Wang DL, 2011, CHEM BIODIVERS, V8, P559, DOI 10.1002/cbdv.201000283; Wojtasik W, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-10; Wulff N. A., 1998, Scientia Agricola, V55, P138, DOI 10.1590/S0103-90161998000100022; Xu HY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/658531; Yuan B, 2016, ONCOL REP, V36, P1377, DOI 10.3892/or.2016.4946; Zernova OV, 2014, MOLECULES, V19, P7480, DOI 10.3390/molecules19067480; Zhang DF, 2015, J AGR FOOD CHEM, V63, P7399, DOI 10.1021/acs.jafc.5b01566; Zhang DL, 1998, J HORTIC SCI BIOTECH, V73, P763, DOI 10.1080/14620316.1998.11511045; Zhang HY, 2014, J AGR FOOD CHEM, V62, P4214, DOI 10.1021/jf500065n; Zhu XY, 2006, TUMOR J WORLD, V5, P272; ZIEGLER E, 1982, PHYSIOL PLANT PATHOL, V20, P321, DOI 10.1016/0048-4059(82)90057-1	110	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0211020	10.1371/journal.pone.0211020	http://dx.doi.org/10.1371/journal.pone.0211020			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653617	gold, Green Published, Green Submitted			2022-12-26	WOS:000456015500098
J	Saberi, P; Ming, K; Legnitto, D; Neilands, TB; Gandhi, M; Johnson, MO				Saberi, Parya; Ming, Kristin; Legnitto, Dominique; Neilands, Torsten B.; Gandhi, Monica; Johnson, Mallory O.			Feasibility and acceptability of novel methods to estimate antiretroviral adherence: A longitudinal study	PLOS ONE			English	Article							REFILL MEASURE; SELF-REPORT; HIV; THERAPY; HAIR; EFAVIRENZ; PATIENT; PLASMA	Due to marked reductions in morbidity and mortality, antiretroviral (ARV) adherence monitoring is of high interest. Researchers and clinicians often resort to the most feasible and cost-effective adherence methods possible, which may result in biased or inaccurate estimates and require the physical presence of a participant at a research or clinic site. The objective of our study was to evaluate the feasibility and acceptability of three objective, innovative, and remote methods to estimate ARV adherence which may be conducted with less time and financial resources in a wide range of clinic and research settings. These three methods included: (a) text-messaged photographs of pharmacy refill dates to measure refill-based adherence, (b) text-messaged photographs of ARV medications to estimate pill-count-based adherence, and (c) home-collected hair samples for the measurement of ARV concentration to determine pharmacologic-based adherence. We conducted a pilot study from March through October 2017 to examine the feasibility and acceptability of these three adherence measures and the remotely conducted study procedures in 93 adults living with HIV nationwide. From our diverse national sample of participants, 95.7% were retained until the end of the study, 89.9% sent all text messages, and 84.3% sent all hair samples. Approximately 74.2% of participants reported excellent overall experience with the study, 60.2% were very or extremely satisfied with participating in a hair collection study, and 76.3% noted extremely high likelihood of participating in a similar study including text messaging pictures of medications or refill dates. We noted high levels of feasibility and acceptability with the remote study methodology, collection of photographed and text messaged pharmacy refill dates and pill counts, and home-collected hair samples. Here we describe the feasibility and acceptability metrics, results from the exit qualitative interviews with the participants, and lessons learned. These adherence measures represent innovative approaches to expand monitoring tools for HIV treatment and prevention adherence in future research.	[Saberi, Parya; Ming, Kristin; Legnitto, Dominique; Neilands, Torsten B.; Johnson, Mallory O.] Univ Calif San Francisco, Div Prevent Sci, Dept Med, San Francisco, CA USA; [Gandhi, Monica] Univ Calif San Francisco, Div HIV Infect Dis & Global Med, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Saberi, P (corresponding author), Univ Calif San Francisco, Div Prevent Sci, Dept Med, San Francisco, CA USA.	parya.saberi@ucsf.edu			National Institute of Mental Health [R21MH108414, K23MH097649, K24DA037034]; National Institute of Allergy and Infectious Diseases [R01AI098472]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246, R21MH108414, K23MH097649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA037034] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute of Mental Health (https://www.nimh.nih.gov/index.shtml), R21MH108414, to PS; by the National Institute of Mental Health, K23MH097649 to PS; by the National Institute of Mental Health, K24DA037034, to MOJ; by the National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov/), R01AI098472, to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, J INFECT DIS, V206, P1453, DOI [10.1093/infdis/jis508, DOI 10.1093/INFDIS/JIS508]; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Bangsberg DR., 2001, AIDS BEHAV, V5, P275, DOI DOI 10.1023/A:1011396711486; Beumer JH, 2001, INT J CLIN PRACT, V55, P353; Chesney MA, 2006, JAIDS-J ACQ IMM DEF, V43, pS149, DOI 10.1097/01.qai.0000243112.91293.26; DiClemente RJ, 2010, JAIDS-J ACQ IMM DEF, V54, pS12, DOI 10.1097/QAI.0b013e3181e1e2c0; DiFrancesco R, 2013, CLIN PHARMACOL THER, V93, P479, DOI 10.1038/clpt.2013.62; Duong M, 2001, CLIN INFECT DIS, V33, P386, DOI 10.1086/321876; Gandhi M, 2002, ANN INTERN MED, V137, P696, DOI 10.7326/0003-4819-137-8-200210150-00016; Gandhi M, 2012, J INFECT DIS, V206, P1453, DOI 10.1093/infdis/jis508; Grossberg R, 2004, J CLIN EPIDEMIOL, V57, P1107, DOI 10.1016/j.jclinepi.2004.04.002; Haberer JE, 2010, AIDS BEHAV, V14, P1340, DOI 10.1007/s10461-010-9799-4; Hall AK, 2015, ANNU REV PUBL HEALTH, V36, P393, DOI 10.1146/annurev-publhealth-031914-122855; Hugen PWH, 2002, J ACQ IMMUN DEF SYND, V30, P324, DOI [10.1097/00126334-200207010-00009, 10.1097/01.QAI.0000014768.35851.DB]; Kalichman SC, 2008, HIV CLIN TRIALS, V9, P298, DOI 10.1310/hct0905-298; Kalichman SC, 2007, J GEN INTERN MED, V22, P1003, DOI 10.1007/s11606-007-0171-y; Liu HH, 2001, ANN INTERN MED, V134, P968, DOI 10.7326/0003-4819-134-10-200105150-00011; Lu M, 2008, AIDS BEHAV, V12, P86, DOI 10.1007/s10461-007-9261-4; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Saberi P, 2008, AIDS CARE, V20, P741, DOI 10.1080/09540120701694006; Saberi P, 2018, PATIENT PREFER ADHER, V12, P1033, DOI 10.2147/PPA.S166380; Saberi P, 2017, JAIDS-J ACQ IMM DEF, V76, pE101, DOI 10.1097/QAI.0000000000001492; Walsh JC, 2002, AIDS, V16, P269, DOI 10.1097/00002030-200201250-00017	24	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210791	10.1371/journal.pone.0210791	http://dx.doi.org/10.1371/journal.pone.0210791			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645641	Green Published, gold, Green Submitted			2022-12-26	WOS:000455810200054
J	Gaspar, D; Ryan, CNM; Zeugolis, DI				Gaspar, Diana; Ryan, Christina N. M.; Zeugolis, Dimitrios I.			Multifactorial bottom-up bioengineering approaches for the development of living tissue substitutes	FASEB JOURNAL			English	Article						cell phenotype maintenance; cell differentiation; cell transdifferentiation; macromolecular crowding; mechanical stimulation	MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX DEPOSITION; ENGINEERED BLOOD-VESSEL; FOCAL ADHESION KINASE; I COLLAGEN-SYNTHESIS; CHONDROITIN-SULFATE; MECHANICAL STIMULATION; SUBSTRATE STIFFNESS; TENOGENIC DIFFERENTIATION; GENE-EXPRESSION	Bottom-up bioengineering utilizes the inherent capacity of cells to build highly sophisticated structures with high levels of biomimicry. Despite the significant advancements in the field, monodomain approaches require prolonged culture time to develop an implantable device, usually associated with cell phenotypic drift in culture. Herein, we assessed the simultaneous effect of macromolecular crowding (MMC) and mechanical loading in enhancing extracellular matrix (ECM) deposition while maintaining tenocyte (TC) phenotype and differentiating bone marrow stem cells (BMSCs) or transdifferentiating neonatal and adult dermal fibroblasts toward tenogenic lineage. At d 7, all cell types presented cytoskeleton alignment perpendicular to the applied load independently of the use of MMC. MMC enhanced ECM deposition in all cell types. Gene expression analysis indicated that MMC and mechanical loading maintained TC phenotype, whereas tenogenic differentiation of BMSCs or transdifferentiation of dermal fibroblasts was not achieved. Our data suggest that multifactorial bottom-up bioengineering approaches significantly accelerate the development of biomimetic tissue equivalents.	[Gaspar, Diana; Ryan, Christina N. M.; Zeugolis, Dimitrios I.] Natl Univ Ireland Galway, Regenerat Modular & Dev Engn Lab REMODEL, Galway, Ireland; [Gaspar, Diana; Ryan, Christina N. M.; Zeugolis, Dimitrios I.] Natl Univ Ireland Galway, Ctr Res Med Devices CURAM, Sci Fdn Ireland, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Zeugolis, DI (corresponding author), NUI Galway, Regenerat Modular & Dev Engn Lab, Biomed Sci Bldg, Galway H91 TK33, Ireland.	dimitrios.zeugolis@nuigalway.ie		zeugolis, dimitrios/0000-0002-7599-5191	NUI-Galway; Irish Government; Irish Research Council, Embark Initiative, Postgraduate Scholarship [RS/2012/82]; Health Research Board, Health Research Awards Programme [HRA_POR/2011/84]; Science Foundation Ireland, Career Development Award [15/CDA/3629]; Science Foundation Ireland; European Regional Development Fund [13/RC/2073]	NUI-Galway; Irish Government; Irish Research Council, Embark Initiative, Postgraduate Scholarship(Irish Research Council for Science, Engineering and Technology); Health Research Board, Health Research Awards Programme; Science Foundation Ireland, Career Development Award(Science Foundation Ireland); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Regional Development Fund(European Commission)	The authors thank Dr. Peadar Rooney [Science Foundation Ireland (SFI) Centre for Research in Medical Devices (CuRAM), National University of Ireland-Galway (NUI-Galway)] for his assistance with the gene expression analysis. The authors acknowledge the Centre for Microscopy and Imaging of the National Centre for Biomedical Engineering Science (NCBES) at NUI-Galway, which is funded by NUI-Galway and the Irish Government's Programme for Research in Third Level Institutions, Cycles 4 and 5, National Development Plan 2007-2013. This work was supported by the Irish Research Council, Embark Initiative, Postgraduate Scholarship (Grant RS/2012/82); Health Research Board, Health Research Awards Programme (Grant HRA_POR/2011/84); and Science Foundation Ireland, Career Development Award (Grant 15/CDA/3629). This work was also supported by Science Foundation Ireland and the European Regional Development Fund (Grant 13/RC/2073). The authors declare no conflicts of interest.	Abbah SA, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt426; Ang XM, 2014, TISSUE ENG PT A, V20, P966, DOI [10.1089/ten.TEA.2013.0337, 10.1089/ten.tea.2013.0337]; Barreira APB, 2008, INT J APPL RES VET M, V6, P46; BATEMAN JF, 1986, J BIOL CHEM, V261, P4198; BATEMAN JF, 1990, BIOCHEM J, V267, P573, DOI 10.1042/bj2670573; Becerra P, 2013, J ORTHOP RES, V31, P1096, DOI 10.1002/jor.22338; Birk DE, 2001, MICRON, V32, P223, DOI 10.1016/S0968-4328(00)00043-3; Boccafoschi F, 2007, CELL ADHES MIGR, V1, P124, DOI 10.4161/cam.1.3.5144; Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040; BUCK RC, 1980, EXP CELL RES, V127, P470, DOI 10.1016/0014-4827(80)90456-5; Chang CH, 2003, BIOMATERIALS, V24, P4853, DOI 10.1016/S0142-9612(03)00383-1; Chen B, 2016, PLAST RECONSTR SURG, V137, p536E, DOI 10.1097/01.prs.0000479980.83169.31; Chen C, 2011, ADV DRUG DELIVER REV, V63, P277, DOI 10.1016/j.addr.2011.03.003; Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3; Chen J, 2014, ADV FUNCT MATER, V24, P2216, DOI 10.1002/adfm.201302949; Chen WC, 2013, J TISSUE ENG REGEN M, V7, P665, DOI 10.1002/term.1463; Chen YL, 2007, BIOMATERIALS, V28, P2294, DOI 10.1016/j.biomaterials.2007.01.027; Chen YJ, 2008, CONNECT TISSUE RES, V49, P7, DOI 10.1080/03008200701818561; Cigognini D, 2016, SCI REP-UK, V6, DOI 10.1038/srep30746; Clarke AW, 2011, AM J SPORT MED, V39, P614, DOI 10.1177/0363546510387095; Darling EM, 2008, J BIOMECH, V41, P454, DOI 10.1016/j.jbiomech.2007.06.019; DARTSCH PC, 1986, ACTA ANAT, V125, P108; Deng D, 2009, BIOMATERIALS, V30, P6724, DOI 10.1016/j.biomaterials.2009.08.054; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Eastwood M, 1998, P I MECH ENG H, V212, P85, DOI 10.1243/0954411981533854; Ellis RJ, 2003, NATURE, V425, P27, DOI 10.1038/425027a; Engebretson B, 2018, CONNECT TISSUE RES, V59, P167, DOI 10.1080/03008207.2017.1324431; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; English A, 2012, J MATER SCI-MATER M, V23, P137, DOI 10.1007/s10856-011-4471-8; English A, 2015, ACTA BIOMATER, V27, P3, DOI 10.1016/j.actbio.2015.08.035; EVANKO SP, 1990, MATRIX, V10, P420, DOI 10.1016/S0934-8832(11)80150-2; Evans ND, 2009, EUR CELLS MATER, V18, P1; FLEISCHMAJER R, 1990, J STRUCT BIOL, V105, P162, DOI 10.1016/1047-8477(90)90110-X; Forte G, 2012, TISSUE ENG PT A, V18, P1837, DOI [10.1089/ten.tea.2011.0707, 10.1089/ten.TEA.2011.0707]; Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078; Galloway MT, 2013, J BONE JOINT SURG AM, V95A, P1620, DOI 10.2106/JBJS.L.01004; Garvin J, 2003, TISSUE ENG, V9, P967, DOI 10.1089/107632703322495619; Gaspar D, 2015, ADV DRUG DELIVER REV, V84, P240, DOI 10.1016/j.addr.2014.11.023; GAY S, 1976, P NATL ACAD SCI USA, V73, P4037, DOI 10.1073/pnas.73.11.4037; Goodman SA, 2004, BIORHEOLOGY, V41, P613; Gosiewska A, 2001, WOUND REPAIR REGEN, V9, P213, DOI 10.1046/j.1524-475x.2001.00213.x; Goude MC, 2014, CELLS TISSUES ORGANS, V199, P117, DOI 10.1159/000365966; GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665; Guillaumin S, 2017, J AM ACAD ORTHOP SUR, V25, pE144, DOI 10.5435/JAAOS-D-17-00324; Hayakawa K, 2001, EXP CELL RES, V268, P104, DOI 10.1006/excr.2001.5270; Heinemeier K, 2003, J APPL PHYSIOL, V95, P2390, DOI 10.1152/japplphysiol.00403.2003; Heinemeier KM, 2007, J PHYSIOL-LONDON, V582, P1303, DOI 10.1113/jphysiol.2007.127639; Holladay C, 2016, J TISSUE ENG REGEN M, V10, P783, DOI 10.1002/term.1852; Horimizu M, 2013, MICRON, V48, P1, DOI 10.1016/j.micron.2013.02.001; Huang AH, 2010, EUR CELLS MATER, V19, P72, DOI 10.22203/eCM.v019a08; Huang CYC, 2004, STEM CELLS, V22, P313, DOI 10.1634/stemcells.22-3-313; Huisman E, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-386; IBA T, 1991, MICROVASC RES, V42, P245, DOI 10.1016/0026-2862(91)90059-K; Jaasma MJ, 2006, ANN BIOMED ENG, V34, P759, DOI 10.1007/s10439-005-9052-x; Jarvinen TAH, 1999, J CELL SCI, V112, P3157; Jiang YK, 2011, BIOMATERIALS, V32, P4085, DOI 10.1016/j.biomaterials.2011.02.033; Juncosa-Melvin N, 2006, TISSUE ENG, V12, P2291, DOI 10.1089/ten.2006.12.2291; Jungbauer S, 2008, BIOPHYS J, V95, P3470, DOI 10.1529/biophysj.107.128611; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; KEENE DR, 1987, J CELL BIOL, V105, P2393, DOI 10.1083/jcb.105.5.2393; Kim TG, 2012, ADV FUNCT MATER, V22, P2446, DOI 10.1002/adfm.201103083; Ko CS, 2009, J BIOSCI BIOENG, V107, P177, DOI 10.1016/j.jbiosc.2008.09.020; Koike M, 2005, J BONE MINER METAB, V23, P219, DOI 10.1007/s00774-004-0587-y; Kumar P, 2015, TISSUE ENG PART C-ME, V21, P660, DOI [10.1089/ten.tec.2014.0387, 10.1089/ten.TEC.2014.0387]; Kumar P, 2015, SCI REP-UK, V5, DOI 10.1038/srep08729; Kuo CK, 2008, TISSUE ENG PT A, V14, P1615, DOI 10.1089/ten.tea.2006.0415; L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364; L'Heureux N, 2007, NEW ENGL J MED, V357, P1451, DOI 10.1056/NEJMc071536; Langberg H, 1999, J PHYSIOL-LONDON, V521, P299, DOI 10.1111/j.1469-7793.1999.00299.x; Lareu RR, 2007, FEBS LETT, V581, P2709, DOI 10.1016/j.febslet.2007.05.020; Lareu RR, 2007, TISSUE ENG, V13, P385, DOI 10.1089/ten.2006.0224; Lee IC, 2007, BIOCHEM BIOPH RES CO, V352, P147, DOI 10.1016/j.bbrc.2006.10.170; Li Z, 2010, J CELL MOL MED, V14, P1338, DOI 10.1111/j.1582-4934.2009.00780.x; Lim SH, 2010, BIOMATERIALS, V31, P9031, DOI 10.1016/j.biomaterials.2010.08.021; Liu W, 2006, TISSUE ENG, V12, P775, DOI 10.1089/ten.2006.12.775; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lohberger B, 2016, KNEE SURG SPORT TR A, V24, P3884, DOI 10.1007/s00167-015-3790-6; Mao AS, 2016, BIOMATERIALS, V98, P184, DOI 10.1016/j.biomaterials.2016.05.004; Mateu R, 2016, INT J MOL MED, V38, P1063, DOI 10.3892/ijmm.2016.2706; Merceron C, 2012, STEM CELLS, V30, P471, DOI 10.1002/stem.1686; Miller BF, 2005, J PHYSIOL-LONDON, V567, P1021, DOI 10.1113/jphysiol.2005.093690; Morita Y, 2013, ACTA BIOENG BIOMECH, V15, P71, DOI 10.5277/abb130309; Mwale F, 2006, J ORTHOP RES, V24, P1791, DOI 10.1002/jor.20200; Na J, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201604260; Neidlinger-Wilke C, 2002, J ORTHOPAED RES, V20, P953, DOI 10.1016/S0736-0266(02)00024-4; Neidlinger-Wilke C, 2001, J ORTHOP RES, V19, P286, DOI 10.1016/S0736-0266(00)00029-2; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Obaid H, 2012, J BONE JOINT SURG AM, V94A, P193, DOI [10.2106/JBJS.J.00781, 10.2106/JBJS.J.100781]; Park JS, 2004, BIOTECHNOL BIOENG, V88, P359, DOI 10.1002/bit.20250; Peck M, 2011, MATER TODAY, V14, P218, DOI 10.1016/S1369-7021(11)70117-1; Peroglio M, 2018, J ORTHOP RES, V36, P10, DOI 10.1002/jor.23655; Petersen W, 2004, J ORTHOP RES, V22, P847, DOI 10.1016/j.orthres.2003.11.009; Powell CA, 2002, AM J PHYSIOL-CELL PH, V283, pC1557, DOI 10.1152/ajpcell.00595.2001; Powell HM, 2010, TISSUE ENG PT A, V16, P1083, DOI [10.1089/ten.tea.2009.0542, 10.1089/ten.TEA.2009.0542]; Prewitz MC, 2015, BIOMATERIALS, V73, P60, DOI 10.1016/j.biomaterials.2015.09.014; Rashid R, 2014, TISSUE ENG PART C-ME, V20, P994, DOI [10.1089/ten.tec.2013.0733, 10.1089/ten.TEC.2013.0733]; Riboh J, 2008, J HAND SURG-AM, V33A, P1388, DOI 10.1016/j.jhsa.2008.04.019; Saber S, 2010, TISSUE ENG PT A, V16, P2085, DOI [10.1089/ten.tea.2010.0032, 10.1089/ten.TEA.2010.0032]; SANANTONIO JD, 1987, DEV BIOL, V123, P17; Satyam A, 2016, ACTA BIOMATER, V44, P221, DOI 10.1016/j.actbio.2016.08.008; Satyam A, 2014, ADV MATER, V26, P3024, DOI 10.1002/adma.201304428; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scott A, 2011, J MUSCULOSKEL NEURON, V11, P124; Seliktar D, 2003, TISSUE ENG, V9, P657, DOI 10.1089/107632703768247359; Shen WL, 2010, BIOMATERIALS, V31, P7239, DOI 10.1016/j.biomaterials.2010.05.040; SHIRINSKY VP, 1989, J CELL BIOL, V109, P331, DOI 10.1083/jcb.109.1.331; Smith RKW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075697; Sorushanova A, 2019, ADV MATER, V31, DOI 10.1002/adma.201801651; Spanoudes K, 2014, TRENDS BIOTECHNOL, V32, P474, DOI 10.1016/j.tibtech.2014.06.009; Sriram G, 2015, EUR J CELL BIOL, V94, P483, DOI 10.1016/j.ejcb.2015.08.001; Subramony SD, 2013, BIOMATERIALS, V34, P1942, DOI 10.1016/j.biomaterials.2012.11.012; Tang QM, 2014, SCI REP-UK, V4, DOI 10.1038/srep05515; Tilghman RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012905; Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108; van Susante JLC, 2001, BIOMATERIALS, V22, P2359, DOI 10.1016/S0142-9612(00)00423-3; Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002; Waldman SD, 2006, OSTEOARTHR CARTILAGE, V14, P323, DOI 10.1016/j.joca.2005.10.007; Wall ME, 2007, J BIOMECH, V40, P173, DOI 10.1016/j.jbiomech.2005.10.032; Wang A, 2013, AM J SPORT MED, V41, P2925, DOI 10.1177/0363546513504285; Wang HC, 1995, J BIOMECH, V28, P1543, DOI 10.1016/0021-9290(95)00101-8; Wang JHC, 2004, J BIOMECH, V37, P573, DOI 10.1016/j.jbiomech.2003.09.011; Wang JHC, 2005, ANN BIOMED ENG, V33, P337, DOI 10.1007/s10439-005-1736-8; Wang JHC, 2003, J BIOMECH, V36, P97, DOI 10.1016/S0021-9290(02)00233-6; Wang JHC, 2001, J BIOMECH, V34, P1563, DOI 10.1016/S0021-9290(01)00150-6; Wang PY, 2010, BIOTECHNOL BIOENG, V106, P285, DOI 10.1002/bit.22697; Wang W, 2007, INT J SPORTS MED, V28, P691, DOI 10.1055/s-2007-964864; Wenstrup RJ, 2011, J BIOL CHEM, V286, P20455, DOI 10.1074/jbc.M111.223693; WHITBY DJ, 1991, DEVELOPMENT, V112, P651; Wu JH, 2017, BONE JOINT RES, V6, P179, DOI 10.1302/2046-3758.63.BJR-2016-0207.R1; Xing Q, 2014, ADV FUNCT MATER, V24, P3027, DOI 10.1002/adfm.201303460; Xu BY, 2012, J CELL PHYSIOL, V227, P2722, DOI 10.1002/jcp.23016; Xu BY, 2011, CONNECT TISSUE RES, V52, P373, DOI 10.3109/03008207.2010.541961; Yao L, 2006, TISSUE ENG, V12, P1843, DOI 10.1089/ten.2006.12.1843; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Yin Z, 2010, BIOMATERIALS, V31, P2163, DOI 10.1016/j.biomaterials.2009.11.083; Zeiger AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037904; Zhang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071740; Zhang L, 2008, CELL BIOL INT, V32, P344, DOI 10.1016/j.cellbi.2007.12.018; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817	139	20	20	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5741	5754		10.1096/fj.201802451R	http://dx.doi.org/10.1096/fj.201802451R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30681885				2022-12-26	WOS:000462888500088
J	Etichetti, CB; Di Benedetto, C; Rossi, C; Baglioni, MV; Bicciato, S; Del Sal, G; Menacho-Marquez, M; Girardini, J				Borini Etichetti, Carla; Di Benedetto, Carolina; Rossi, Carolina; Virginia Baglioni, Maria; Bicciato, Silvio; Del Sal, Giannino; Menacho-Marquez, Mauricio; Girardini, Javier			Isoprenylcysteine carboxy methyltransferase (ICMT) is associated with tumor aggressiveness and its expression is controlled by the p53 tumor suppressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein isoprenylation; protein carboxylation; p53; cytoskeleton; breast cancer; lung cancer; cell signaling; gene regulation; post-translational modification (PTM); mutant p53	MUTANT P53; CELL-MIGRATION; K-RAS; CANCER; CARBOXYLMETHYLTRANSFERASE; RHO; TRANSFORMATION; METHYLATION; METASTASIS; DEFICIENCY	Isoprenyl cysteine carboxyl methyltransferase (ICMT) plays a key role in post-translational regulation of prenylated proteins. On the basis of previous results, we hypothesized that the p53 pathway and ICMT expression may be linked in cancer cells. Here, we studied whether WT p53 and cancer-associated p53 point mutants regulate ICMT levels and whether ICMT overexpression affects tumor progression. Studying the effect of p53 variants on ICMT mRNA and protein levels in cancer cells, we found that WT p53 and p53 mutants differentially affect ICMT expression, indicating that p53 status influences ICMT levels in tumors. To investigate the underlying mechanisms, we constructed ICMT-luciferase reporters and found that WT p53 represses ICMT transcription. In contrast, p53 mutants showed a positive effect on ICMT expression. Promoter truncation analyses pinpointed the repressive effect of WT p53 to the -209 and -14 region on the ICMT promoter, and ChIP assays indicated that WT p53 is recruited to this region. Instead, a different promoter region was identified as responsible for the mutant p53 effect. Studying the effect of ICMT overexpression on tumor-associated phenotypes in vitro and in vivo, and analyzing breast and lung cancer databases, we identified a correlation between p53 status and ICMT expression in breast and lung cancers. Moreover, we observed that ICMT overexpression is correlated with negative clinical outcomes. Our work unveils a link between postprenylation protein processing and the p53 pathway, indicating that the functional interplay between WT and mutant p53 alters ICMT levels, thereby affecting tumor aggressiveness.	[Borini Etichetti, Carla; Di Benedetto, Carolina; Rossi, Carolina; Girardini, Javier] Consejo Nacl Invest Cient & Tecn, Consejo Nacl Invest Cient & Tecn, Inst Biol Mol & Celular Rosario IBR, Fac Ciencias Med,Inst Genet Ex, RA-2000 Rosario, Santa Fe, Argentina; [Virginia Baglioni, Maria] Univ Nacl Rosario, RA-2000 Rosario, Santa Fe, Argentina; [Bicciato, Silvio] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy; [Del Sal, Giannino] Lab Nazl CIB, Area Sci Pk Padriciano, I-34149 Trieste, Italy; [Del Sal, Giannino] Univ Trieste, Dipartimento Sci Vita, I-34127 Trieste, Italy; [Menacho-Marquez, Mauricio] Univ Nacl Rosario, CONICET, IIDEFAR, Inst Invest El Descubrimiento Farmacos Rosario, RA-2000 Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Universita di Modena e Reggio Emilia; University of Trieste; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Girardini, J (corresponding author), Consejo Nacl Invest Cient & Tecn, Consejo Nacl Invest Cient & Tecn, Inst Biol Mol & Celular Rosario IBR, RA-2000 Rosario, Santa Fe, Argentina.	girardini@ibr-conicet.gov.ar	Bicciato, Silvio/C-9825-2009	Bicciato, Silvio/0000-0002-1944-7078; BORINI ETICHETTI, CARLA/0000-0002-1632-2819; Baglioni, Maria Virginia/0000-0002-1329-2757	Instituto Nacional del Cancer (INC) Asistencia Financiera III; Agencia Nacional de Promocion Cientifica y Tecnologica Grant ANPCyT [PICT 1221]	Instituto Nacional del Cancer (INC) Asistencia Financiera III; Agencia Nacional de Promocion Cientifica y Tecnologica Grant ANPCyT	This work was supported by Instituto Nacional del Cancer (INC) Asistencia Financiera III, 2015 grants (to J. G.) and Agencia Nacional de Promocion Cientifica y Tecnologica Grant ANPCyT. PICT 1221. The authors declare that they have no conflicts of interest with the contents of this article.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Backlund PS, 1997, J BIOL CHEM, V272, P33175, DOI 10.1074/jbc.272.52.33175; Bergo MO, 2004, J CLIN INVEST, V113, P539, DOI 10.1172/JCI200418829; Bergo MO, 2001, J BIOL CHEM, V276, P5841, DOI 10.1074/jbc.C000831200; Bouaoun L, 2016, HUM MUTAT, V37, P865, DOI 10.1002/humu.23035; BROWN MS, 1980, J LIPID RES, V21, P505; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; Court H, 2013, J CLIN INVEST, V123, P4681, DOI 10.1172/JCI65764; Cushman I, 2011, CELL ADHES MIGR, V5, P11, DOI 10.4161/cam.5.1.13196; Cushman I, 2009, J BIOL CHEM, V284, P27964, DOI 10.1074/jbc.M109.025296; Dai Q, 1998, J BIOL CHEM, V273, P15030, DOI 10.1074/jbc.273.24.15030; Do MT, 2017, ONCOGENE, V36, P5757, DOI 10.1038/onc.2017.183; Enzo E, 2015, EMBO J, V34, P1349, DOI 10.15252/embj.201490379; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Gentry LR, 2015, J BIOL CHEM, V290, P22851, DOI 10.1074/jbc.M115.656710; Girardini Javier E, 2014, Subcell Biochem, V85, P41, DOI 10.1007/978-94-017-9211-0_3; Girardini JE, 2011, CANCER CELL, V20, P79, DOI 10.1016/j.ccr.2011.06.004; Guida E, 2008, CANCER RES, V68, P6550, DOI 10.1158/0008-5472.CAN-08-0137; HABENICHT AJR, 1980, J BIOL CHEM, V255, P5134; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jansen S, 2018, PHARMACOL THERAPEUT, V183, P1, DOI 10.1016/j.pharmthera.2017.09.002; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kastenhuber ER, 2017, CELL, V170, P1062, DOI 10.1016/j.cell.2017.08.028; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Lau HY, 2017, ONCOGENE, V36, P3934, DOI 10.1038/onc.2016.508; Liang PH, 2002, EUR J BIOCHEM, V269, P3339, DOI 10.1046/j.1432-1033.2002.03014.x; Manolaridis I, 2013, NATURE, V504, P301, DOI 10.1038/nature12754; Mantovani F, 2007, NAT STRUCT MOL BIOL, V14, P912, DOI 10.1038/nsmb1306; Maurer-Stroh S, 2007, PLOS COMPUT BIOL, V3, P634, DOI 10.1371/journal.pcbi.0030066; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Nguyen UTT, 2009, NAT CHEM BIOL, V5, P227, DOI 10.1038/nchembio.149; QUESNEYHUNEEUS V, 1979, P NATL ACAD SCI USA, V76, P5056, DOI 10.1073/pnas.76.10.5056; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; SMELAND TE, 1994, P NATL ACAD SCI USA, V91, P10712, DOI 10.1073/pnas.91.22.10712; Sorrentino G, 2014, NAT CELL BIOL, V16, P357, DOI 10.1038/ncb2936; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Soussi T, 2007, CANCER CELL, V12, P303, DOI 10.1016/j.ccr.2007.10.001; Sullivan KD, 2018, CELL DEATH DIFFER, V25, P133, DOI 10.1038/cdd.2017.174; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wahlstrom AM, 2008, BLOOD, V112, P1357, DOI 10.1182/blood-2007-06-094060; Wang B, 2010, CELL CYCLE, V9, P870, DOI 10.4161/cc.9.5.10825; Wang M, 2016, NAT REV MOL CELL BIO, V17, P110, DOI 10.1038/nrm.2015.11; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Zandvakili I, 2017, ONCOGENE, V36, P3213, DOI 10.1038/onc.2016.473; Zhou HC, 2014, ONCOTARGET, V5, P12177, DOI 10.18632/oncotarget.2601	49	6	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5060	5073		10.1074/jbc.RA118.006037	http://dx.doi.org/10.1074/jbc.RA118.006037			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30655292	Green Published, hybrid			2022-12-26	WOS:000463985600028
J	Zhou, C; Wang, YZ; Zhang, JC; Su, JM; An, QL; Liu, X; Zhang, M; Wang, YS; Liu, J; Zhang, Y				Zhou, Chuan; Wang, Yizhi; Zhang, Jingcheng; Su, Jianmin; An, Quanli; Liu, Xin; Zhang, Min; Wang, Yongsheng; Liu, Jun; Zhang, Yong			H3K27me3 is an epigenetic barrier while KDM6A overexpression improves nuclear reprogramming efficiency	FASEB JOURNAL			English	Article						nuclear reprogramming barrier; cell adhesion; blastocyst formation; bovine	CLONING EFFICIENCY; X-CHROMOSOME; GERM-CELL; TRICHOSTATIN-A; METHYLATION; EXPRESSION; EMBRYOS; EZH2; PIG; PLACENTAS	Aberrant epigenetic reprogramming is a major factor of developmental failure of cloned embryos. Histone H3 lysine 27 trimethylation (H3K27me3), a histone mark for transcriptional repression, plays important roles in mammalian embryonic development and induced pluripotent stem cell (iPSC) generation. The global loss of H3K27me3 marks may facilitate iPSC generation in mice and humans. However, the H3K27me3 level and its role in bovine somatic cell nuclear transfer (SCNT) reprogramming remain poorly understood. Here, we show that SCNT embryos exhibit global H3K27me3 hypermethylation from the 2- to 8-cell stage and that its removal by ectopically expressed H3K27me3 lysine demethylase (KDM)6A greatly improves nuclear reprogramming efficiency. In contrast, H3K27me3 reduction by H3K27me3 methylase enhancer of zeste 2 polycomb repressive complex knockdown or donor cell treatment with the enhancer of zeste 2 polycomb repressive complex-selective inhibitor GSK343 suppressed blastocyst formation by SCNT embryos. KDM6A overexpression enhanced the transcription of genes involved in cell adhesion and cellular metabolism and X-linked genes. Furthermore, we identified methyl-CpG-binding domain protein 3-like 2, which was reactivated by KDM6A, as a factor that is required for effective reprogramming in bovines. These results show that H3K27me3 functions as an epigenetic barrier and that KDM6A overexpression improves SCNT efficiency by facilitating transcriptional reprogramming.Zhou, C., Wang, Y., Zhang, J., Su, J., An, Q., Liu, X., Zhang, M., Wang, Y., Liu, J., Zhang, Y. H3K27me3 is an epigenetic barrier while KDM6A overexpression improves nuclear reprogramming efficiency.	[Zhou, Chuan; Wang, Yizhi; Zhang, Jingcheng; Su, Jianmin; An, Quanli; Liu, Xin; Zhang, Min; Wang, Yongsheng; Liu, Jun; Zhang, Yong] Northwest A&F Univ, Coll Vet Med, Minist Agr, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Zhang, Y (corresponding author), Northwest A&F Univ, Key Lab Anim Biotechnol, 3 Taicheng Rd, Yangling 712100, Shaanxi, Peoples R China.	zhy1956@263.net			National High Technology Research and Development Program of China (863 Program) [2011AA100303]; National Major Project for Production of Transgenic Breeding [2016ZX08007-003]; National Natural Science Foundation of China [31772603]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Major Project for Production of Transgenic Breeding; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National High Technology Research and Development Program of China (863 Program) (2011AA100303); the National Major Project for Production of Transgenic Breeding (2016ZX08007-003); and the National Natural Science Foundation of China (31772603). The authors declare no conflicts of interest.	Auman HJ, 2002, DEVELOPMENT, V129, P2733; Bai GY, 2018, ZYGOTE, V26, P24, DOI 10.1017/S0967199417000673; Bao SQ, 2005, EMBO REP, V6, P748, DOI 10.1038/sj.embor.7400461; Bessonnard S, 2015, J CELL BIOL, V210, P1185, DOI 10.1083/jcb.201503042; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Bogliotti YS, 2012, EPIGENETICS-US, V7, P976, DOI 10.4161/epi.21615; Breton A, 2010, J REPROD DEVELOP, V56, P379, DOI 10.1262/jrd.09-182A; Calder MD, 2017, MOL HUM REPROD, V23, P771, DOI 10.1093/molehr/gax050; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Chung YG, 2015, CELL STEM CELL, V17, P758, DOI 10.1016/j.stem.2015.10.001; Dai XP, 2010, J BIOL CHEM, V285, P31002, DOI 10.1074/jbc.M110.136085; Erhardt S, 2003, DEVELOPMENT, V130, P4235, DOI 10.1242/dev.00625; Farin PW, 2006, THERIOGENOLOGY, V65, P178, DOI 10.1016/j.theriogenology.2005.09.022; Fu L, 2012, THERIOGENOLOGY, V78, P1929, DOI 10.1016/j.theriogenology.2012.07.017; Graf A, 2014, P NATL ACAD SCI USA, V111, P4139, DOI 10.1073/pnas.1321569111; Guo SJ, 2015, AUTOPHAGY, V11, P560, DOI 10.1080/15548627.2015.1017181; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang JJ, 2016, REPRODUCTION, V151, P39, DOI 10.1530/REP-15-0460; Huang XJ, 2014, REPROD FERT DEVELOP, V26, P1166, DOI 10.1071/RD13169; Huang YY, 2011, CELL REPROGRAM, V13, P513, DOI 10.1089/cell.2011.0032; Iager AE, 2008, CLONING STEM CELLS, V10, P371, DOI 10.1089/clo.2007.0002; Inoue A, 2017, GENE DEV, V31, P1927, DOI 10.1101/gad.304113.117; Inoue K, 2010, SCIENCE, V330, P496, DOI 10.1126/science.1194174; Jin SG, 2008, DEV DYNAM, V237, P3435, DOI 10.1002/dvdy.21767; Jin SG, 2005, J BIOL CHEM, V280, P12700, DOI 10.1074/jbc.M413492200; Jullien J, 2017, MOL CELL, V65, P873, DOI 10.1016/j.molcel.2017.01.030; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Li J, 2008, THERIOGENOLOGY, V70, P800, DOI 10.1016/j.theriogenology.2008.05.046; Liu TP, 2015, ANTI-CANCER DRUG, V26, P139, DOI 10.1097/CAD.0000000000000166; Liu X, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.158261; Liu YF, 2017, P NATL ACAD SCI USA, V114, pE3796, DOI 10.1073/pnas.1700909114; Loi P, 2016, TRENDS BIOTECHNOL, V34, P791, DOI 10.1016/j.tibtech.2016.03.008; Luo HN, 2016, BIOCHEM BIOPH RES CO, V479, P253, DOI 10.1016/j.bbrc.2016.09.055; Malouf GG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r144; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Matoba S, 2018, CELL STEM CELL, V23, P343, DOI 10.1016/j.stem.2018.06.008; Matoba S, 2014, CELL, V159, P884, DOI 10.1016/j.cell.2014.09.055; Modesti M, 2001, CURR BIOL, V11, pR229, DOI 10.1016/S0960-9822(01)00112-9; Moriwaki K, 2007, DEV BIOL, V312, P509, DOI 10.1016/j.ydbio.2007.09.049; Nakaki F, 2014, TRENDS BIOCHEM SCI, V39, P289, DOI 10.1016/j.tibs.2014.04.003; Nwadike C, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00023-18; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Peng L, 2016, J CELL SCI, V129, P1059, DOI 10.1242/jcs.179044; Rodriguez-Osorio N, 2012, THERIOGENOLOGY, V78, P1869, DOI 10.1016/j.theriogenology.2012.05.030; Ruan DG, 2018, STEM CELL REP, V10, P494, DOI 10.1016/j.stemcr.2017.12.015; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shpargel KB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004507; Su JM, 2011, THERIOGENOLOGY, V75, P1346, DOI 10.1016/j.theriogenology.2010.11.045; Su JM, 2015, J PINEAL RES, V59, P455, DOI 10.1111/jpi.12275; Taube JH, 2017, ONCOTARGET, V8, P65548, DOI 10.18632/oncotarget.19214; Terashima M, 2017, BIOCHEM BIOPH RES CO, V490, P1407, DOI 10.1016/j.bbrc.2017.07.048; Wang H, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.140244; Wang Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.198; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wilmut I, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0366; Xie BT, 2016, REPRODUCTION, V151, P9, DOI 10.1530/REP-15-0338; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/revreprod/3.3.155; Zenker J, 2018, CELL, V173, P776, DOI 10.1016/j.cell.2018.02.035; Zhang JC, 2017, J BIOL CHEM, V292, P15916, DOI 10.1074/jbc.M117.796771; Zhang M, 2009, J BIOL CHEM, V284, P24981, DOI 10.1074/jbc.M109.011973; Zhang S, 2016, SCI REP-UK, V6, DOI 10.1038/srep30345; Zhao JG, 2009, BIOL REPROD, V81, P525, DOI 10.1095/biolreprod.109.077016	66	31	34	2	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4638	4652		10.1096/fj.201801887R	http://dx.doi.org/10.1096/fj.201801887R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30673507	Bronze			2022-12-26	WOS:000459794800122
J	Kohler, M; Ehrenfeld, S; Halbach, S; Lauinger, M; Burk, U; Reischmannl, N; Cheng, SF; Spohr, C; Uhl, FM; Kohler, N; Ringwald, K; Braun, S; Peters, C; Zeiser, R; Reinheckel, T; Brummer, T				Koehler, Martin; Ehrenfeld, Sophia; Halbach, Sebastian; Lauinger, Manuel; Burk, Ulrike; Reischmannl, Nadine; Cheng, Shuofei; Spohr, Corinna; Uhl, Franziska Maria; Koehler, Natalie; Ringwald, Kathrin; Braun, Sandra; Peters, Christoph; Zeiser, Robert; Reinheckel, Thomas; Brummer, Tilman			B-Raf deficiency impairs tumor initiation and progression in a murine breast cancer model	ONCOGENE			English	Article							ERK ACTIVATION; MAPK PATHWAY; CATHEPSIN-B; BRAF; INHIBITORS; PHOSPHORYLATION; METASTASIS; EXPRESSION; CELLS; GENE	Copy number gains, point mutations and epigenetic silencing events are increasingly observed in genes encoding elements of the Ras/Raf/MEK/ERK signaling axis in human breast cancer. The three Raf kinases A-Raf, B-Raf, and Raf-1 have an important role as gatekeepers in ERK pathway activation and are often dysregulated by somatic alterations of their genes or by the aberrant activity of receptor tyrosine kinases (RTKs) and Ras-GTPases. B-Raf represents the most potent Raf isoform and a critical effector downstream of RTKs and RAS proteins. Aberrant RTK signaling is mimicked by the polyoma middle T antigen (PyMT), which activates various oncogenic signaling pathways, incl. the RAS/ERK axis, in a similar manner as RTKs in human breast cancer. Mammary epithelial cell directed expression of PyMT in mice by the MMTV-PyMT transgene induces mammary hyperplasia progressing over adenoma to metastatic breast cancer with an almost complete penetrance. To understand the functional role of B-Raf in this model for luminal type B breast cancer, we crossed MMTV-PyMT mice with animals that either lack B-Raf expression in the mammary gland or express the signaling impaired B-Raf(AVKA) mutant. The AVKA mutation prevents phosphorylation of T599 and S602 in the B-Raf activation loop and thereby activation of the kinase by upstream signals. We demonstrate for the first time that B-Raf expression and activation is important for tumor initiation in vivo as well as for lung metastasis. Isogenic tumor cell lines generated from conditional Braf knock-out or knock-in mice displayed a reduction in EGF-induced ERK pathway activity as well as in proliferation and invasive growth in three-dimensional matrigel cultures. Our results suggest that B-Raf, which has been hardly studied in the context of breast cancer, represents a critical effector of the PyMT oncoprotein and invite for an assessment of its functional role in human breast cancer.	[Koehler, Martin; Ehrenfeld, Sophia; Halbach, Sebastian; Lauinger, Manuel; Burk, Ulrike; Reischmannl, Nadine; Cheng, Shuofei; Spohr, Corinna; Ringwald, Kathrin; Braun, Sandra; Peters, Christoph; Reinheckel, Thomas; Brummer, Tilman] Univ Freiburg, Fac Med, Inst Mol Med & Cell Res, Freiburg, Germany; [Koehler, Martin; Halbach, Sebastian; Reischmannl, Nadine; Spohr, Corinna; Koehler, Natalie] Univ Freiburg, Spemann Grad Sch Biol & Med, Freiburg, Germany; [Koehler, Martin; Ehrenfeld, Sophia; Halbach, Sebastian; Lauinger, Manuel; Reischmannl, Nadine; Spohr, Corinna; Uhl, Franziska Maria; Koehler, Natalie; Ringwald, Kathrin] Univ Freiburg, Fac Biol, Freiburg, Germany; [Ehrenfeld, Sophia; Lauinger, Manuel; Peters, Christoph; Zeiser, Robert; Reinheckel, Thomas; Brummer, Tilman] German Consortium Translat Canc Res DKTK, Partner Site Freiburg, Heidelberg, Germany; [Ehrenfeld, Sophia; Lauinger, Manuel; Peters, Christoph; Zeiser, Robert; Reinheckel, Thomas; Brummer, Tilman] German Canc Res Ctr, Heidelberg, Germany; [Burk, Ulrike; Peters, Christoph; Zeiser, Robert; Reinheckel, Thomas; Brummer, Tilman] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, Freiburg, Germany; [Uhl, Franziska Maria; Koehler, Natalie; Zeiser, Robert] Univ Freiburg, Univ Med Ctr, Fac Med, Dept Hematol & Oncol, Freiburg, Germany; [Peters, Christoph; Zeiser, Robert; Reinheckel, Thomas; Brummer, Tilman] Comprehens Canc Ctr Freiburg, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg; University of Freiburg	Reinheckel, T; Brummer, T (corresponding author), Univ Freiburg, Fac Med, Inst Mol Med & Cell Res, Freiburg, Germany.; Reinheckel, T; Brummer, T (corresponding author), German Consortium Translat Canc Res DKTK, Partner Site Freiburg, Heidelberg, Germany.; Reinheckel, T; Brummer, T (corresponding author), German Canc Res Ctr, Heidelberg, Germany.; Reinheckel, T; Brummer, T (corresponding author), Univ Freiburg, Ctr Biol Signalling Studies BIOSS, Freiburg, Germany.; Reinheckel, T; Brummer, T (corresponding author), Comprehens Canc Ctr Freiburg, Freiburg, Germany.	thomas.reinheckel@mol-med.uni-freiburg.de; tilman.brummer@mol-med.uni-freiburg.de	Halbach, Sebastian/G-4021-2012; Brummer, Tilman/AAA-9428-2020; Köhler, Natalie/AAG-1712-2019; Brummer, Tilman/B-6218-2016; Reinheckel, Thomas/AAL-9761-2021	Halbach, Sebastian/0000-0002-6827-8178; Brummer, Tilman/0000-0003-4387-7905; Köhler, Natalie/0000-0002-7502-0431; Brummer, Tilman/0000-0003-4387-7905; Reinheckel, Thomas/0000-0001-9866-9105; Zeiser, Robert/0000-0001-6565-3393; Kohler, Martin/0000-0002-7248-6084	Deutsche Forschungsgemeinschaft (DFG) via the Collaborative Research Centre 850; Excellence Initiative of the German Federal and State Governments [EXC 294 BIOSS]; German Cancer Consortium (DKTK) [L627]; Spemann Graduate School for Biology and Medicine (SGBM) [GSC-4]; Emmy-Noether program of the DFG; Heisenberg program of the DFG	Deutsche Forschungsgemeinschaft (DFG) via the Collaborative Research Centre 850(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments; German Cancer Consortium (DKTK); Spemann Graduate School for Biology and Medicine (SGBM); Emmy-Noether program of the DFG(German Research Foundation (DFG)); Heisenberg program of the DFG	This work was funded by the Deutsche Forschungsgemeinschaft (DFG) via the Collaborative Research Centre 850 (projects B4; B7, and C6), the Excellence Initiative of the German Federal and State Governments (EXC 294 BIOSS), the German Cancer Consortium (DKTK, L627) and the Spemann Graduate School for Biology and Medicine (GSC-4; SGBM) via fellowships to MK, SH, NK, CK. and NR. TB was also supported by the Emmy-Noether and Heisenberg programs of the DFG. We would also like to thank Chris Ormandy for helpful discussions, Ricarda Herr for advice, and Nicole Klemm and Ulrike Reif for expert technical assistance.	Aceto N, 2012, NAT MED, V18, P529, DOI 10.1038/nm.2645; Adeyinka A, 2002, CLIN CANCER RES, V8, P1747; Ali NA, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0437-3; Balko JM, 2014, CANCER DISCOV, V4, P232, DOI 10.1158/2159-8290.CD-13-0286; Beliveau A, 2010, GENE DEV, V24, P2800, DOI 10.1101/gad.1990410; Ben-David U, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12160; Bengsch F, 2014, ONCOGENE, V33, P4474, DOI 10.1038/onc.2013.395; Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Chen AP, 2006, J NEUROSCI RES, V83, P28, DOI 10.1002/jnr.20703; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Desideri E, 2015, CELL, V161, P967, DOI 10.1016/j.cell.2015.04.045; Dilworth SM, 2002, NAT REV CANCER, V2, P951, DOI 10.1038/nrc946; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; Fantozzi A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1530; Fluck MM, 2009, MICROBIOL MOL BIOL R, V73, P542, DOI 10.1128/MMBR.00009-09; Galabova-Kovacs G, 2006, P NATL ACAD SCI USA, V103, P1325, DOI 10.1073/pnas.0507399103; Galabova-Kovacs G, 2008, J CELL BIOL, V180, P947, DOI 10.1083/jcb.200709069; Gillies TE, 2017, CELL SYST, V5, P549, DOI 10.1016/j.cels.2017.10.019; Girotti MR, 2015, CANCER CELL, V27, P85, DOI 10.1016/j.ccell.2014.11.006; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Ha JR, 2016, J CELL BIOCHEM, V117, P1971, DOI 10.1002/jcb.25561; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Haug S, 2015, INT J CANCER, V136, P2328, DOI 10.1002/ijc.29289; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Herr R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-17; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hillebrand LE, 2016, ONCOTARGET, V7, P58244, DOI 10.18632/oncotarget.11309; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Hu JC, 2013, CELL, V154, P1036, DOI 10.1016/j.cell.2013.07.046; Jacob LS, 2015, CANCER RES, V75, P3713, DOI 10.1158/0008-5472.CAN-15-0562; Kamata T, 2010, CANCER RES, V70, P8475, DOI 10.1158/0008-5472.CAN-10-0603; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kohler M, 2016, CELL CYCLE, V15, P1171, DOI 10.1080/15384101.2016.1159111; Kohler M, 2016, EMBO J, V35, P143, DOI 10.15252/embj.201592097; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Lan LX, 2015, EMBO J, V34, P1493, DOI 10.15252/embj.201489004; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Little AS, 2013, ONCOGENE, V32, P1207, DOI 10.1038/onc.2012.160; Liu H, 2018, CANCER DISCOV, V8, P354, DOI 10.1158/2159-8290.CD-17-0679; Marcotte R, 2012, P NATL ACAD SCI USA, V109, P2808, DOI 10.1073/pnas.1018861108; McLaughlin SK, 2013, CANCER CELL, V24, P365, DOI 10.1016/j.ccr.2013.08.004; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Nieto P, 2017, NATURE, V548, P239, DOI 10.1038/nature23297; O'Toole SA, 2013, J CLIN PATHOL, V66, P530, DOI 10.1136/jclinpath-2012-201361; Olsen SN, 2017, CANCER DISCOV, V7, P202, DOI 10.1158/2159-8290.CD-16-0520; Pearson GW, 2007, J CELL BIOL, V179, P1555, DOI 10.1083/jcb.200706099; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; PRITCHARD CA, 1995, MOL CELL BIOL, V15, P6430; Roring M, 2012, EMBO J, V31, P2629, DOI 10.1038/emboj.2012.100; Roering Michael, 2012, Critical Reviews in Oncogenesis, V17, P97; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Santarpia L, 2012, BREAST CANCER RES TR, V134, P333, DOI 10.1007/s10549-012-2035-3; Sears R, 2017, CANCER DISCOV, V7, P131, DOI 10.1158/2159-8290.CD-16-1423; Sevenich L, 2011, ONCOGENE, V30, P54, DOI 10.1038/onc.2010.387; Sevenich L, 2010, P NATL ACAD SCI USA, V107, P2497, DOI 10.1073/pnas.0907240107; Smith Brittni A, 2012, Genes Cancer, V3, P550, DOI 10.1177/1947601913475359; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Thevakumaran N, 2015, NAT STRUCT MOL BIOL, V22, P37, DOI 10.1038/nsmb.2924; Tilch E, 2014, BREAST CANCER RES TR, V143, P385, DOI 10.1007/s10549-013-2798-1; Varga A, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai8482; Wagner KU, 2002, DEVELOPMENT, V129, P1377; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Whyte J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2361; Wojnowski L, 2000, MECH DEVELOP, V91, P97, DOI 10.1016/S0925-4773(99)00276-2; Yaktapour N, 2014, J CLIN INVEST, V124, P5074, DOI 10.1172/JCI76539; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429; Zhang C, 2015, NATURE, V526, P583, DOI 10.1038/nature14982; Zhong J, 2007, NAT NEUROSCI, V10, P598, DOI 10.1038/nn1898; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	71	8	8	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 21	2019	38	8					1324	1339		10.1038/s41388-018-0663-8	http://dx.doi.org/10.1038/s41388-018-0663-8			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HM1XR	30659267				2022-12-26	WOS:000459249800013
J	Iga, N; Otsuka, A; Yamamoto, Y; Nakashima, C; Honda, T; Kitoh, A; Nakajima, S; Egawa, G; Nomura, T; Dainichi, T; Matsushita, S; Tanizaki, H; Yamamoto, Y; Funakoshi, T; Fujisawa, Y; Fujimura, T; Hata, H; Ishida, Y; Kabashima, K				Iga, Natsuko; Otsuka, Atsushi; Yamamoto, Yosuke; Nakashima, Chisa; Honda, Tetsuya; Kitoh, Akihiko; Nakajima, Saeko; Egawa, Gyohei; Nomura, Takashi; Dainichi, Teruki; Matsushita, Shigeto; Tanizaki, Hideaki; Yamamoto, Yuki; Funakoshi, Takeru; Fujisawa, Yasuhiro; Fujimura, Taku; Hata, Hiroo; Ishida, Yoshihiro; Kabashima, Kenji			Accumulation of exhausted CD8+T cells in extramammary Paget's disease	PLOS ONE			English	Article							CD8(+) T-LYMPHOCYTES; INDOLEAMINE 2,3-DIOXYGENASE; COLORECTAL-CANCER; IMMUNE CELLS; DYSFUNCTION; EXPRESSION; DOCETAXEL; PROGNOSIS; CARCINOMA; NIVOLUMAB	Cancer immunotherapy has highlighted the clinical relevance of enhancing anti-tumor response of CD8+ T cells in several cancer types. Little is known, however, about the involvement of the immune system in extramammary Paget's disease (EMPD). We examined the cytotoxicity and the effector functions of CD8+ T cells using paired samples of peripheral blood and tumors by flow cytometry. Expression levels of perforin, granzyme B, IFN-g, TNF-a, and IL-2 in CD8+ tumor-infiltrating lymphocytes (TILs) were significantly lower than those in CD8+ T cells of peripheral blood. Significantly higher expression of PD1 was found in CD8+ TILs than in CD8+ T cells of peripheral blood. A high number of CD8+ cells was significantly associated with poor overall survival (OS) adjusted with age, sex, and clinical stage (hazard ratio [HR] = 5.03, P = 0.045, 95% confidence interval [CI] 1.03-24.4). On the other hand, the number of PD-1+ cells was not associated with OS or disease-free survival (DFS). Moreover, we found that tumor cells produced immunosuppressive molecule indoleamine 2,3-dyoxygenae (IDO). In conclusion, CD8+ TILs displayed an exhausted phenotype in EMPD. IDO expression seemed more relevant in inducing CD8 exhaustion than PD-1 upregulation or PD-L1 expression by immune cells. Restoring the effector functions of CD8+ TILs could be an effective treatment strategy for advanced EMPD.	[Iga, Natsuko; Otsuka, Atsushi; Yamamoto, Yosuke; Nakashima, Chisa; Honda, Tetsuya; Kitoh, Akihiko; Nakajima, Saeko; Egawa, Gyohei; Nomura, Takashi; Dainichi, Teruki; Ishida, Yoshihiro; Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan; [Otsuka, Atsushi] Kyoto Univ, Grad Sch Med, Translat Res Dept Skin & Brain Dis, Kyoto, Japan; [Matsushita, Shigeto] Natl Hosp Org Kagoshima Med Ctr, Dept Dermatooncol Dermatol, Kagoshima, Japan; [Tanizaki, Hideaki] Osaka Med Coll, Dept Dermatol, Osaka, Japan; [Yamamoto, Yuki] Wakayama Med Univ, Dept Dermatol, Wakayama, Japan; [Funakoshi, Takeru] Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Fujisawa, Yasuhiro] Univ Tsukuba, Dept Dermatol, Tsukuba, Ibaraki, Japan; [Fujimura, Taku] Tohoku Univ, Grad Sch Med, Dept Dermatol, Sendai, Miyagi, Japan; [Hata, Hiroo] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido, Japan; [Kabashima, Kenji] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore; [Kabashima, Kenji] ASTAR, Inst Med Biol, Singapore, Singapore	Kyoto University; Kyoto University; Osaka Medical College; Wakayama Medical University; Keio University; University of Tsukuba; Tohoku University; Hokkaido University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Otsuka, A; Kabashima, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan.; Otsuka, A (corresponding author), Kyoto Univ, Grad Sch Med, Translat Res Dept Skin & Brain Dis, Kyoto, Japan.; Kabashima, K (corresponding author), ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore.; Kabashima, K (corresponding author), ASTAR, Inst Med Biol, Singapore, Singapore.	otsukamn@kuhp.kyoto-u.ac.jp; kaba@kuhp.kyoto-u.ac.jp	Dainichi, Teruki/AAL-5400-2020; Nakajima, Saeko/AAB-1577-2021; YAMAMOTO, Yosuke/HCH-0666-2022; Funakoshi, Takeru/A-7994-2015	Dainichi, Teruki/0000-0002-9497-0029; Funakoshi, Takeru/0000-0002-8893-4590; Nakajima, Saeko/0000-0003-0831-1447; Ishida, Yoshihiro/0000-0002-6210-5903; Fujisawa, Yasuhiro/0000-0003-3010-8496; Otsuka, Atsushi/0000-0001-7365-947X; Fujimura, Taku/0000-0001-6809-5833; Egawa, Gyohei/0000-0002-6101-4719				Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brandacher G, 2006, CLIN CANCER RES, V12, P1144, DOI 10.1158/1078-0432.CCR-05-1966; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Godin-Ethier J, 2009, J IMMUNOL, V183, P7752, DOI 10.4049/jimmunol.0901004; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Herrel LA, 2015, ANN SURG ONCOL, V22, P1625, DOI 10.1245/s10434-014-4139-y; Liu HZ, 2009, J IMMUNOL, V183, P1022, DOI 10.4049/jimmunol.0900408; Moon YW, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0094-9; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Nagaraj S, 2008, CANCER RES, V68, P2561, DOI 10.1158/0008-5472.CAN-07-6229; Nakano O, 2001, CANCER RES, V61, P5132; Ohara K, 2016, J DERMATOL SCI, V83, P234, DOI 10.1016/j.jdermsci.2016.06.004; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Takeuchi Y, 2016, INT IMMUNOL, V28, P401, DOI 10.1093/intimm/dxw025; Thompson RH, 2007, CLIN CANCER RES, V13, P1757, DOI 10.1158/1078-0432.CCR-06-2599; Thompson RH, 2006, CANCER RES, V66, P3381, DOI 10.1158/0008-5472.CAN-05-4303; Voskoboinik I, 2015, NAT REV IMMUNOL, V15, P388, DOI 10.1038/nri3839; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wu X, 2014, BRIT J CANCER, V111, P1391, DOI 10.1038/bjc.2014.416; Yoshino K, 2016, J DERMATOL, V43, P633, DOI 10.1111/1346-8138.13200; Zhang Y, 2010, CELL MOL IMMUNOL, V7, P389, DOI 10.1038/cmi.2010.28	27	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211135	10.1371/journal.pone.0211135	http://dx.doi.org/10.1371/journal.pone.0211135			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682105	Green Submitted, Green Published, gold			2022-12-26	WOS:000457037500108
J	Jia, J; Jiang, JP; Zhang, MH; Gao, KQ				Jia, Jia; Jiang, Jian-Ping; Zhang, Mei-Hua; Gao, Ke-Qin			Osteology of Batrachuperus yenyuanensis (Urodela, Hynobiidae), a high-altitude mountain stream salamander from western China	PLOS ONE			English	Article							AMBYSTOMA-TIGRINUM; COLUMELLA AURIS; AMPHIBIA; PHYLOGENY; APPARATUS; CAUDATA; MORPHOLOGY; EVOLUTION; PATTERNS	Batrachuperus yenyuanensis, commonly known as Yenyuan Stream Salamander, is a hynobiid species inhabiting high-altitude (2440-4025 m above sea level) mountain stream and pond environments along the eastern fringe of the Qinghai-Tibetan Plateau in western Sichuan Province, China. Although the species has been known for almost 70 years since its initial discovery in 1950, a thorough osteological description has never been provided. Our study provides a detailed account of the bony anatomy of this species, based on micro computed tomography scanning of multiple specimens collected from the type locality Shuangertang at Bailinshan, Yanyuan County, and several other localities in Sichuan Province. Our revised species diagnosis utilizes both bony and soft anatomical features. Comparative study of the specimens from the type locality in Yanyuan area with those from the nearby Xichang and Mianning areas confirms that they all pertain to Batrachuperus yenyuanensis, thereby removing doubt on the occurrence of the species in the latter areas. With this confirmation, the distribution of the species is extended from the type locality northwards some 180 km to the Mianning area, on both the west and east sides of the Yalong River, which is a major tributary of the upper Yangtze River. This distribution pattern indicates that the biogeographic origin and historical evolution of the species are closely associated with the orogeny of the Hengduan Mountains and formation of the Yalong River. Given the basalmost position of Batrachuperus yenyuanensis in relation to other congeneric species based on molecular studies, however, early expansion of the species distribution by dispersal is expected following the origin of the genus in early-middle Miocene in western Sichuan Province. Thus, the species may well have achieved its current distribution in western Sichuan before the drastic uplift of the Qinghai-Tibetan Plateau in Pliocene.	[Jia, Jia; Gao, Ke-Qin] Peking Univ, Sch Earth & Space Sci, Beijing, Peoples R China; [Jia, Jia] Chinese Acad Sci, Nanjing Inst Geol & Paleontol, Key Lab Econ Stratig & Palaeogeog, Nanjing, Jiangsu, Peoples R China; [Jiang, Jian-Ping; Zhang, Mei-Hua] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China	Peking University; Chinese Academy of Sciences; Nanjing Institute of Geology & Paleontology, CAS; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS	Gao, KQ (corresponding author), Peking Univ, Sch Earth & Space Sci, Beijing, Peoples R China.	kqgao@pku.edu.cn	JIA, JIA/AAL-9198-2020	Jia, Jia/0000-0002-8243-0156; Gao, Ke-Qin/0000-0002-5765-4596	National Natural Science Foundation of China [NSFC 41672003, NSFC 41702002]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA19050201]; National Key R & D Program of China [2017YFC0505202]; Key Laboratory of Economic Stratigraphy and Palaeogeography, Chinese Academy of Sciences (Nanjing Institute of Geology and Palaeontology) [2017KF03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Key R & D Program of China; Key Laboratory of Economic Stratigraphy and Palaeogeography, Chinese Academy of Sciences (Nanjing Institute of Geology and Palaeontology)	The following grant information was disclosed by the authors: National Natural Science Foundation of China: NSFC 41672003, NSFC 41702002 to Ke-Qin Gao. Strategic Priority Research Program of the Chinese Academy of Sciences (XDA19050201) to Jianping Jiang. National Key R & D Program of China (2017YFC0505202) to Jianping Jiang. Key Laboratory of Economic Stratigraphy and Palaeogeography, Chinese Academy of Sciences (Nanjing Institute of Geology and Palaeontology) (No. 2017KF03) to Jia Jia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AmphibiaWeb, INF AMPH BIOL CONS; AOYAMA FUMIO, 1930, ZEITSCHR GES ANAT ABT 1 ZEITSCHR ANAT U ENTWICKLUNGSGESCH, V93, P107, DOI 10.1007/BF02117847; ASHLEYROSS MA, 1992, J MORPHOL, V211, P147, DOI 10.1002/jmor.1052110204; Boulenger G.A., 1878, B SOC ZOOLOGIQUE FRA, V3, P71; Chen MY, 2015, MOL PHYLOGENET EVOL, V83, P1, DOI 10.1016/j.ympev.2014.10.010; Cope E.D., 1859, P ACAD NAT SCI PHILA, V11, P122; David A., 1871, NOUVELLES ARCH MUSEU, V7, P75; den Uber N, 1911, ANAT ANZEIGER, V38, P401; Duellman W. E., 1986, BIOL AMPHIBIANS; DUMERIL AMC, 1806, ZOOLOGIE ANAL OU MET; Dunn ER, 1922, AM NAT, V56, P418, DOI 10.1086/279882; Dunn ER, 1923, P AM ACAD ARTS SCI, V58, P445, DOI 10.2307/20026019; Edgeworth FH, 1935, CRANIAL MUSCLES VERT; EDWARDS JL, 1976, J MORPHOL, V148, P305, DOI 10.1002/jmor.1051480304; ELWOOD JRL, 1994, J MORPHOL, V220, P47, DOI 10.1002/jmor.1052200106; Favre A, 2015, BIOL REV, V90, P236, DOI 10.1111/brv.12107; Fei L., 2010, COLORED ATLAS CHINES; Fei L., 2016, AMPHIBIANS CHINA, V1; Fei L., 2006, FAUNA SINICA AMPHIBI, V1; Francis ETB, 1934, ANATOMY SALAMANDER; Frost D. R., 2018, AMPHIBIAN SPECIES WO; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Fu J, 2008, MOL ECOL, V17, P1469, DOI 10.1111/j.1365-294X.2007.03681.x; Fu JZ, 2001, COPEIA, P1100, DOI 10.1643/0045-8511(2001)001[1100:GDOEBC]2.0.CO;2; Gao KQ, 2012, P NATL ACAD SCI USA, V109, P5767, DOI 10.1073/pnas.1009828109; Hanken J., 1981, Functional Photography, V16, P22; Jia J, 2016, PEERJ, V4, DOI 10.7717/peerj.2499; Jia J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153834; Jiang JP, 2018, PEERJ, V6, DOI 10.7717/peerj.4517; Kingsbury BF, 1909, J MORPHOL, V20, P549, DOI 10.1002/jmor.1050200403; Kingsbury BF, 1908, ANAT REC, V2, P81, DOI 10.1002/ar.1090020302; Lapage EO, 1928, J MORPHOL PHYSIOL, V45, P441, DOI 10.1002/jmor.1050450203; LAUDER GV, 1988, J MORPHOL, V197, P249, DOI 10.1002/jmor.1051970302; Litvinchuk SN, 2003, CONTRIB ZOOL, V72, P195, DOI 10.1163/18759866-07204001; LIU CH'ENG-CHAO, 1950, FIELDIANA ZOOL MEM, V2, P1; Liu L., 1973, ANIMAL PRESERVATION, V5, P37; Noble G.K., 1931, BIOL AMPHIBIA; OLSON EC, 1966, AM ZOOL, V6, P399; Peng R, 2010, MOL PHYLOGENET EVOL, V56, P252, DOI 10.1016/j.ympev.2009.12.011; Rose Christopher S., 2003, Amphibian Biology, V5, P1684; Schmalhausen I. I., 1958, Zoologicheskii Zhurnal, V37, P570; Sun BN, 2011, PALAEOGEOGR PALAEOCL, V304, P328, DOI 10.1016/j.palaeo.2010.09.023; Trueb Linda, 1993, P255; Vassilieva AB, 2015, VERTEBR ZOOL, V65, P117; WAKE DB, 1967, J MORPHOL, V122, P265, DOI 10.1002/jmor.1051220402; Xiong JL, 2013, ZOOLOGY, V116, P99, DOI 10.1016/j.zool.2012.10.004; Zhang P, 2006, P NATL ACAD SCI USA, V103, P7360, DOI 10.1073/pnas.0602325103; Zheng YC, 2011, MOL BIOL EVOL, V28, P2521, DOI 10.1093/molbev/msr072	48	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211069	10.1371/journal.pone.0211069	http://dx.doi.org/10.1371/journal.pone.0211069			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682102	Green Submitted, Green Published, gold			2022-12-26	WOS:000457037500097
J	Uebayashi, K; Akasaka, K; Tamura, A; Otsudo, T; Sawada, Y; Okubo, Y; Hall, T				Uebayashi, Kazuma; Akasaka, Kiyokazu; Tamura, Akihiro; Otsudo, Takahiro; Sawada, Yutaka; Okubo, Yu; Hall, Toby			Characteristics of trunk and lower limb alignment at maximum reach during the Star Excursion Balance Test in subjects with increased knee valgus during jump landing	PLOS ONE			English	Article							CRUCIATE LIGAMENT INJURY; VIDEO ANALYSIS; BIOMECHANICAL MEASURES; POSTURAL STABILITY; TEAM HANDBALL; RISK-FACTORS; FEMALE; MECHANISMS; BASKETBALL; ASSOCIATION	Background The anterior cruciate ligament (ACL) is often injured during sport. The Star Excursion Balance Test (SEBT) has been used to evaluate ankle and knee stability of the supporting leg while reaching in eight different directions with the non-stance leg. We hypothesized that the SEBT might be useful in categorising ACL injury risk. The purpose of this study was to clarify the relationship between knee valgus alignment during single leg drop landing (SDL) and alignment of the trunk and lower limb during the SEBT. Methods A three-dimensional motion analysis system was used to measure the trunk, hip and knee angles during SDL and the SEBT. Groupings were allocated based on 5 degrees of knee valgus angle during SDL. Independent t-test's were used to identify differences in the trunk, hip and knee angles between the two groups. Results The knee valgus angles in the knee valgus group were greater than those in the control group in five directions of the SEBT (p < 0.05). In addition, the hip internal rotation angle in the knee valgus group was lower than that in the control group during two directions of the SEBT (p < 0.05). Furthermore, the knee flexion and trunk right rotation angles in the knee valgus group were lower than those in the control group in two directions of the SEBT (p < 0.05). Conclusion Decreases in hip internal rotation, knee flexion and trunk rotation to the supporting leg during the SEBT might be considered as risk factors for non-contact ACL injury.	[Uebayashi, Kazuma] Suzuki Clin Orthopaed River City, Dept Rehabil, Chuo Ku, Tokyo, Japan; [Akasaka, Kiyokazu; Otsudo, Takahiro; Okubo, Yu] Saitama Med Univ, Grad Sch Med, Moroyama, Saitama, Japan; [Akasaka, Kiyokazu; Otsudo, Takahiro; Sawada, Yutaka; Okubo, Yu] Saitama Med Univ, Sch Phys Therapy, Moroyama, Saitama, Japan; [Tamura, Akihiro] Int Univ Hlth & Welf, Dept Phys Therapy, Sch Hlth Sci Narita, Chiba, Japan; [Hall, Toby] Curtin Univ, Sch Physiotherapy & Exercise Sci, Perth, WA, Australia	Saitama Medical University; Saitama Medical University; International University of Health & Welfare; Curtin University	Akasaka, K (corresponding author), Saitama Med Univ, Grad Sch Med, Moroyama, Saitama, Japan.; Akasaka, K (corresponding author), Saitama Med Univ, Sch Phys Therapy, Moroyama, Saitama, Japan.	akasaka-smc@umin.ac.jp	Tamura, Akihiro/ABF-1688-2021; Akasaka, Kiyokazu/ABI-0104-2022	Tamura, Akihiro/0000-0003-2972-5745; Akasaka, Kiyokazu/0000-0003-2110-205X; Uebayashi, Kazuma/0000-0002-9126-6239; Hall, Toby/0000-0003-4461-7259				Agel J, 2005, AM J SPORT MED, V33, P524, DOI 10.1177/0363546504269937; Alentorn-Geli E, 2009, KNEE SURG SPORT TR A, V17, P705, DOI 10.1007/s00167-009-0813-1; Boden BP, 2009, AM J SPORT MED, V37, P252, DOI 10.1177/0363546508328107; Braun HJ, 2015, KNEE SURG SPORT TR A, V23, P1065, DOI 10.1007/s00167-014-2873-0; Delahunt E, 2013, J ATHL TRAINING, V48, P172, DOI 10.4085/1062-6050-48.2.05; Dempsey AR, 2007, MED SCI SPORT EXER, V39, P1765, DOI 10.1249/mss.0b013e31812f56d1; DiStefano LJ, 2009, AM J SPORT MED, V37, P495, DOI 10.1177/0363546508327542; Ford KR, 2003, MED SCI SPORT EXER, V35, P1745, DOI 10.1249/01.MSS.0000089346.85744.D9; Gribble PA, 2012, J ATHL TRAINING, V47, P339, DOI 10.4085/1062-6050-47.3.08; Griffin L Y, 2000, J Am Acad Orthop Surg, V8, P141; Hegedus EJ, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094341; Herrington L, 2009, KNEE, V16, P149, DOI 10.1016/j.knee.2008.10.004; Hertel J, 2006, J ORTHOP SPORT PHYS, V36, P131, DOI 10.2519/jospt.2006.36.3.131; Hewett TE, 2009, BRIT J SPORT MED, V43, P417, DOI 10.1136/bjsm.2009.059162; Hewett TE, 2006, AM J SPORT MED, V34, P299, DOI 10.1177/0363546505284183; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kinzey SJ, 1998, J ORTHOP SPORT PHYS, V27, P356, DOI 10.2519/jospt.1998.27.5.356; Koga H, 2010, AM J SPORT MED, V38, P2218, DOI 10.1177/0363546510373570; Krosshaug T, 2007, AM J SPORT MED, V35, P359, DOI 10.1177/0363546506293899; Lin CF, 2009, J BIOMECH, V42, P418, DOI 10.1016/j.jbiomech.2008.12.005; McLean SG, 2005, CLIN BIOMECH, V20, P863, DOI 10.1016/j.clinbiomech.2005.05.007; Olsen OE, 2004, AM J SPORT MED, V32, P1002, DOI 10.1177/0363546503261724; Paterno MV, 2010, AM J SPORT MED, V38, P1968, DOI 10.1177/0363546510376053; Russell KA, 2006, J ATHL TRAINING, V41, P166; Sigward SM, 2015, CLIN J SPORT MED, V25, P529, DOI 10.1097/JSM.0000000000000155	26	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211242	10.1371/journal.pone.0211242	http://dx.doi.org/10.1371/journal.pone.0211242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682114	gold, Green Published, Green Submitted			2022-12-26	WOS:000457037500134
J	Peng, QH; Mechanic, J; Shoieb, A; Pardo, ID; Schaevitz, L; Fenyk-Melody, J; Vitsky, A; Boucher, M; Somps, C; Cook, JC; Liu, CN				Peng, Qinghai; Mechanic, Jordan; Shoieb, Ahmed; Pardo, Ingrid D.; Schaevitz, Laura; Fenyk-Melody, Judith; Vitsky, Allison; Boucher, Magalie; Somps, Chris; Cook, Jon C.; Liu, Chang-Ning			g Circulating microRNA and automated motion analysis as novel methods of assessing chemotherapy-induced peripheral neuropathy in mice	PLOS ONE			English	Article							MECHANICAL ALLODYNIA; RAT MODEL; VINCRISTINE; PACLITAXEL; PAIN; EXPRESSION; NEURONS; INJURY	Chemotherapy-induced peripheral neuropathy (CiPN) is a serious adverse effect in the clinic, but nonclinical assessment methods in animal studies are limited to labor intensive behavioral tests or semi-quantitative microscopic evaluation. Hence, microRNA (miRNA) biomarkers and automated in-life behavioral tracking were assessed for their utility as non-invasive methods. To address the lack of diagnostic biomarkers, we explored miR-124, miR-183 and miR-338 in a CiPN model induced by paclitaxel, a well-known neurotoxic agent. In addition, conventional and Vium's innovative Digital Vivarium technology-based in-life behavioral tests and postmortem microscopic examination of the dorsal root ganglion (DRG) and the sciatic nerve were performed. Terminal blood was collected on days 8 or 16, after 20 mg/kg paclitaxel was administered every other day for total of 4 or 7 doses, respectively, for plasma miRNA quantification by RT-qPCR. DRG and sciatic nerve samples were collected from mice sacrificed on day 16 for miRNA quantification. Among the three miRNAs analyzed, only miR-124 was statistically significantly increased (5 fold and 10 fold on day 8 and day 16, respectively). The increase in circulating miR-124 correlated with cold allodynia and axonal degeneration in both DRG and sciatic nerve. Automated home cage motion analysis revealed for the first time that nighttime motion was significantly decreased (P < 0.05) in paclitaxel-dosed animals. Although both increase in circulating miR-124 and decrease in nighttime motion are compelling, our results provide positive evidence warranting further testing using additional peripheral nerve toxicants and diverse experimental CiPN models.	[Peng, Qinghai; Vitsky, Allison] Pfizer Worldwide Res & Dev, Drug Safety Res & Dev, La Jolla, CA USA; [Mechanic, Jordan; Schaevitz, Laura] Vium Inc, Milpitas, CA USA; [Shoieb, Ahmed; Pardo, Ingrid D.; Somps, Chris; Cook, Jon C.; Liu, Chang-Ning] Pfizer Worldwide Res & Dev, Drug Safety Res & Dev, Groton, CT 06340 USA; [Fenyk-Melody, Judith] Pfizer Worldwide Res & Dev, Comparat Med, Cambridge, MA USA; [Boucher, Magalie] Pfizer Worldwide Res & Dev, Drug Safety Res & Dev, Cambridge, MA USA	Pfizer; Pfizer; Pfizer; Pfizer	Liu, CN (corresponding author), Pfizer Worldwide Res & Dev, Drug Safety Res & Dev, Groton, CT 06340 USA.	chang-ning.liu@pfizer.com		Liu, Chang-Ning/0000-0002-2094-1401	Pfizer; Vium Inc.	Pfizer(Pfizer); Vium Inc.	The author(s) received no specific funding for this work. QP, AS, IP, JF-M, AV, MB, CS, JCC and C-NL are employed by Pfizer. Pfizer provided support in the form of salaries for authors QP, AS, IP, JF-M, AV, MB, CS, JCC and C-NL and scientific service fee to Vium Inc., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. JM and LS are employed by Vium Inc. Vium Inc. provided support in the form of salaries for authors JM and LS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aley KO, 1996, NEUROSCIENCE, V73, P259, DOI 10.1016/0306-4522(96)00020-6; Argyriou AA, 2008, CANCER TREAT REV, V34, P368, DOI 10.1016/j.ctrv.2008.01.003; ARMSTRONG JG, 1967, CANCER RES, V27, P221; Armstrong T, 2005, ONCOL NURS FORUM, V32, P305, DOI 10.1188/05.ONF.305-311; Aschrafi A, 2012, CELL MOL LIFE SCI, V69, P4017, DOI 10.1007/s00018-012-1064-8; Authier N, 1999, NEUROREPORT, V10, P965, DOI 10.1097/00001756-199904060-00013; Authier N, 2003, NEUROTOXICOLOGY, V24, P797, DOI 10.1016/S0161-813X(03)00043-3; Bali KK, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-22; Baroukh NN, 2009, FEBS J, V276, P6509, DOI 10.1111/j.1742-4658.2009.07353.x; Beyreuther B, 2006, EUR J PHARMACOL, V539, P64, DOI 10.1016/j.ejphar.2006.04.009; Bhagra Anjali, 2007, Curr Oncol Rep, V9, P290; Callizot N, 2008, CANCER CHEMOTH PHARM, V62, P995, DOI 10.1007/s00280-008-0689-7; Cavaletti G, 2008, FRONT BIOSCI-LANDMRK, V13, P3506, DOI 10.2741/2945; Cavaletti Guido, 2004, Expert Opin Drug Saf, V3, P535, DOI 10.1517/14740338.3.6.535; Costa R, 2011, BRIT J PHARMACOL, V164, P681, DOI 10.1111/j.1476-5381.2011.01408.x; DYER RS, 1985, FUND APPL TOXICOL, V5, P24, DOI 10.1016/0272-0590(85)90048-X; GLANTZ MJ, 1995, J NATL CANCER I, V87, P1077, DOI 10.1093/jnci/87.14.1077; Grisold W, 2012, NEURO-ONCOLOGY, V14, P45, DOI 10.1093/neuonc/nos203; Hausheer FH, 2006, SEMIN ONCOL, V33, P15, DOI 10.1053/j.seminoncol.2005.12.010; Higuera ES, 2004, METH MOLEC MED, P91; Huehnchen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076772; Lim MA, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00818; Lin CR, 2014, EUR J NEUROSCI, V39, P1682, DOI 10.1111/ejn.12522; Liu CN, 2018, J APPL TOXICOL, V38, P193, DOI 10.1002/jat.3513; Liu CN, 2000, PAIN, V85, P503, DOI 10.1016/S0304-3959(00)00251-7; MASON KA, 1995, INT J RADIAT ONCOL, V32, P1381, DOI 10.1016/0360-3016(95)00037-Y; MASUROVSKY EB, 1983, NEUROSCIENCE, V10, P491, DOI 10.1016/0306-4522(83)90148-3; Metpally Raghu Prasad Rao, 2013, Frontiers in Genetics, V4, P20, DOI 10.3389/fgene.2013.00020; Mishima T, 2007, BRAIN RES, V1131, P37, DOI 10.1016/j.brainres.2006.11.035; Muthuraman A, 2011, FOOD CHEM TOXICOL, V49, P2557, DOI 10.1016/j.fct.2011.06.069; Nakamura Y, 2001, NEUROSCI LETT, V304, P5, DOI 10.1016/S0304-3940(01)01720-7; Peng QH, 2014, J APPL TOXICOL, V34, P695, DOI 10.1002/jat.2930; Pike Crystal T, 2012, Chemother Res Pract, V2012, P913848, DOI 10.1155/2012/913848; Polomano RC, 2001, PAIN MED, V2, P8, DOI 10.1046/j.1526-4637.2001.002001008.x; Nieto FR, 2008, PAIN, V137, P520, DOI 10.1016/j.pain.2007.10.012; Rupp A, 2007, J NEUROSCI METH, V166, P266, DOI 10.1016/j.jneumeth.2007.07.015; Sakai A, 2013, BRAIN, V136, P2738, DOI 10.1093/brain/awt191; Seretny M, 2013, JAMA-J AM MED ASSOC, V310, P537, DOI 10.1001/jama.2013.7902; Smith SB, 2004, LIFE SCI, V74, P2593, DOI 10.1016/j.lfs.2004.01.002; Soreq H, 2011, TRENDS MOL MED, V17, P548, DOI 10.1016/j.molmed.2011.06.009; Stagg NJ, 2016, REGUL TOXICOL PHARM, V82, P1, DOI 10.1016/j.yrtph.2016.10.012; Starobova H, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00174; Strickland IT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023423; Sudoh Y, 2004, REGION ANESTH PAIN M, V29, P434, DOI 10.1016/j.rapm.2004.06.008; Tasnim A, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0285-4; von Schack D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017670; Vrinten DH, 2003, PAIN, V102, P203, DOI 10.1016/S0304-3959(02)00382-2; Wang ZF, 2018, MOL NEUROBIOL, V55, P5879, DOI 10.1007/s12035-017-0808-8; Wilkes Gail, 2007, Semin Oncol Nurs, V23, P162, DOI 10.1016/j.soncn.2007.05.001; Windebank AJ, 2008, J PERIPHER NERV SYST, V13, P27, DOI 10.1111/j.1529-8027.2008.00156.x; Wu D, 2011, NEUROSCIENCE, V190, P386, DOI 10.1016/j.neuroscience.2011.06.017; Yu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024612; Zhang HY, 2011, BRAIN RES, V1383, P62, DOI 10.1016/j.brainres.2011.01.067; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018; Zhou SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044768; Zhou SL, 2011, NEUROSCI LETT, V494, P89, DOI 10.1016/j.neulet.2011.02.064	56	15	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210995	10.1371/journal.pone.0210995	http://dx.doi.org/10.1371/journal.pone.0210995			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677061	Green Published, gold, Green Submitted			2022-12-26	WOS:000456700400041
J	Rydahl, E; Declercq, E; Juhl, M; Maimburg, RD				Rydahl, Eva; Declercq, Eugene; Juhl, Mette; Maimburg, Rikke Damkjaer			Cesarean section on a rise-Does advanced maternal age explain the increase? A population register-based study	PLOS ONE			English	Article							6 YEAR EXPERIENCE; DELIVERY OUTCOMES; EPIDURAL ANALGESIA; LABOR; WOMEN; IMPACT; BIRTH; INDUCTION; MOTHERS; TERM	Background In Denmark, the cesarean section rate has increased by 49% between 1998 and 2015 and accounts for 21% of all births. Cesarean sections may cause short-as well as long-term consequences for both the mother and the child and impose further risks in future pregnancies. Delaying pregnancy until advanced maternal age at childbirth has been suggested as contributing to the increase. The proportion of women giving birth at 35 years or above increased from 15% (1998) to 21% (2015). Advanced maternal age at childbirth has been found to be related to increased pre-pregnancy morbidity and associated risk factors that may contribute to an increased risk of cesarean section. The aim of this study was to examine the association between advanced maternal age and cesarean section in a Danish population and the influence of demographic, anthropometric, health, and obstetric factors on this association. Methods This study draws on a national population-based cohort study of all Danish births between 1998 and 2015 (N = 1,122,964). Maternal age less than 30 years serves as reference with the following age categories: (30-34 years); (35-39 years), and (40 years and above). The primary outcome was a cesarean section. Multivariate regression models with adjustment for demographic, health, pregnancy, fetal, and obstetric characteristics were performed with the results further stratified by parity. Results In general, a positive association between advanced maternal age and cesarean section was found. Only minor changes in the risk estimate occurred after adjustment for relevant confounders. In comparison with the reference category, nulliparous women aged 35-39-years had twice the risk for cesarean section (adjusted odds ratio (AOR) 2.18, 95% confidence interval (CI) [2.11-2.26]) whereas for women of 40 years or above, the risk was more than tripled (AOR 3.64, 95% CI [3.41-3.90]). For multiparous women aged 35-39-years the risk was more moderate, but still with an AOR of 1.56, 95% CI [1.53-1.60], and for those 40 years and above, the AOR was 2.02, 95% CI [1.92-2.09]. Conclusions Overall, cesarean section increased with increasing maternal age. Adjustment for maternal and obstetric risk factors had only a minor influence on the association. The association was stronger in nulliparous women compared to multiparous women. Given the lack of impact of demographic and health risks on the relationship between maternal age and cesarean section, the authors suggest obstetric culture could be added to the list of risk factors for a cesarean. Future research on obstetric culture is recommended as are studies on a possible age-related decrease in the ability to maintain the progression of labor.	[Rydahl, Eva; Juhl, Mette] Univ Coll Copenhagen, Dept Midwifery, Copenhagen, Denmark; [Rydahl, Eva; Maimburg, Rikke Damkjaer] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Declercq, Eugene] Boston Univ, Sch Publ Hlth, Dept Community Hlth Sci, Boston, MA USA; [Maimburg, Rikke Damkjaer] Aarhus Univ Hosp, Dept Obstet & Gynaecol, Aarhus, Denmark	University College Copenhagen; Aarhus University; Boston University; Aarhus University	Rydahl, E (corresponding author), Univ Coll Copenhagen, Dept Midwifery, Copenhagen, Denmark.; Rydahl, E (corresponding author), Aarhus Univ, Dept Clin Med, Aarhus, Denmark.	evry@kp.dk		Rydahl, Eva/0000-0001-6272-0466; Juhl, Mette/0000-0003-3156-9518	Sundhedsvidenskabeligt Fakultet, Aarhus Universitet [Faculty of Health and Medical Science]; Danish Association of Midwifery; Herlev Hospital; Hanne Kjaergaard Memorial Fund; University College Copenhagen; Aarhus University	Sundhedsvidenskabeligt Fakultet, Aarhus Universitet [Faculty of Health and Medical Science]; Danish Association of Midwifery; Herlev Hospital; Hanne Kjaergaard Memorial Fund; University College Copenhagen; Aarhus University	This work was supported by Sundhedsvidenskabeligt Fakultet, Aarhus Universitet [Faculty of Health and Medical Science], https://healthsciences.ku.dk/; Danish Association of Midwifery, http://www.jordemoderforeningen.dk/; Herlev Hospital, https://www.herlevhospital.dk/; Hanne Kjaergaard Memorial Fund, http://www.jordemoderforeningen.dk/aktuelt/nyheder/nyhed/artikel/hanne-kjaergaardsmindelegat-2/; and University College Copenhagen, https://www.kp.dk/.The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Boston University, School of Public Health, for the inspiration and goodwill to kick start the project and The Hanne Kjaergaard Memorial Fund for making a research stay in Boston possible. Furthermore, we thank Aarhus University, University College Copenhagen, Herlev Hospital and Danish Association of Midwifery for financial support.	[Anonymous], 2007, MED SOC; Bayrampour H, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-100; Bayrampour H, 2011, J OBSTET GYNAECOL CA, V33, P820, DOI 10.1016/S1701-2163(16)34985-4; BETRAN AP, 2016, PLOS ONE, V11; Bliddal M, 2018, EUR J EPIDEMIOL, V33, P27, DOI 10.1007/s10654-018-0356-1; Blomberg M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005840; Boerma T, 2018, LANCET, V392, P1341, DOI 10.1016/S0140-6736(18)31928-7; Cammu H, 2014, EUR J OBSTET GYN R B, V177, P106, DOI 10.1016/j.ejogrb.2014.04.008; Cheng ER, 2015, MATERN CHILD HLTH J, V19, P2578, DOI 10.1007/s10995-015-1776-0; Cleary-Goldman J, 2005, OBSTET GYNECOL, V105, P983, DOI 10.1097/01.AOG.0000158118.75532.51; Cohen WR, 2014, BJOG-INT J OBSTET GY, V121, P252, DOI 10.1111/1471-0528.12563; Crankshaw DJ, 2015, REPROD SCI, V22, P1229, DOI 10.1177/1933719115572483; Declercq E, 2015, BIRTH-ISS PERINAT C, V42, P309, DOI 10.1111/birt.12201; DeVries R, 2001, BIRTH BY DESIGN; Eriksen LM, 2011, BIRTH-ISS PERINAT C, V38, P317, DOI 10.1111/j.1523-536X.2011.00486.x; Essex HN, 2013, BJOG-INT J OBSTET GY, V120, P732, DOI 10.1111/1471-0528.12177; Fox B, 1999, GENDER SOC, V13, P326, DOI 10.1177/089124399013003004; Gerli S, 2015, J OBSTET GYNAECOL, V35, P435, DOI 10.3109/01443615.2014.960825; Glantz JC, 2010, OBSTET GYNECOL, V115, P70, DOI 10.1097/AOG.0b013e3181c4ef96; Greenberg MB, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.058; Herstad L, 2015, BJOG-INT J OBSTET GY, V122, P1642, DOI 10.1111/1471-0528.12962; Kenny LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056583; Klemetti R, 2016, ACTA OBSTET GYN SCAN, V95, P1368, DOI 10.1111/aogs.13020; Kozhimannil KB, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001745; Langhoff-Roos J, 2003, VALIDERING LANDSPATI; Langhoff-Roos J, 2014, ACTA OBSTET GYN SCAN, V93, P132, DOI 10.1111/aogs.12302; Li YM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004026; Martinelli KG, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311x00206116, 10.1590/0102-311X00206116]; Miller S, 2016, LANCET, V388, P2176, DOI 10.1016/S0140-6736(16)31472-6; Molina G, 2015, JAMA-J AM MED ASSOC, V314, P2263, DOI 10.1001/jama.2015.15553; Moore EK, 2014, J OBSTET GYNAECOL, V34, P238, DOI 10.3109/01443615.2013.838546; Moore LE, 2006, CLIN OBSTET GYNECOL, V49, P698, DOI 10.1097/00003081-200609000-00026; Oakley L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164462; Omih EE, 2016, J PERINAT MED, V44, P773, DOI 10.1515/jpm-2015-0128; Organisation for Economic Co-operation and Development O, 2015, HEALTH AT A GLANCE 2; Petropanagos A, 2015, AM J BIOETHICS, V15, P56, DOI 10.1080/15265161.2015.1088986; Poignant M, 2012, SEX REPROD HEALTHC, V3, P129, DOI 10.1016/j.srhc.2012.10.004; Richards MK, 2016, J PERINATOL, V36, P272, DOI 10.1038/jp.2015.204; Rossignol M, 2014, BIRTH-ISS PERINAT C, V41, P70, DOI 10.1111/birt.12088; Rydahl E, 2018, MED PREGNANCY CHILDB; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Smith GCS, 2008, PLOS MED, V5, P1123, DOI 10.1371/journal.pmed.0050144; Timofeev J, 2013, OBSTET GYNECOL, V122, P1184, DOI 10.1097/AOG.0000000000000017; VanGompel EW, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1756-7; Vaughan DA, 2014, BJOG-INT J OBSTET GY, V121, P261, DOI 10.1111/1471-0528.12311; Waldenstrom U, 2017, ACTA OBSTET GYN SCAN, V96, P1063, DOI 10.1111/aogs.13167; WHO, 2015, GUID TREATM MAL; Ye J, 2016, BJOG-INT J OBSTET GY, V123, P745, DOI 10.1111/1471-0528.13592; Zaki MN, 2013, OBSTET GYNECOL, V122, P1018, DOI 10.1097/AOG.0b013e3182a9c92c	49	41	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210655	10.1371/journal.pone.0210655	http://dx.doi.org/10.1371/journal.pone.0210655			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677047	Green Published, Green Submitted, gold			2022-12-26	WOS:000456700400022
J	Luplertlop, N; Muangkaew, W; Pumeesat, P; Suwanmanee, S; Singkum, P				Luplertlop, Natthanej; Muangkaew, Watcharamat; Pumeesat, Potjaman; Suwanmanee, San; Singkum, Pantira			Distribution of Scedosporium species in soil from areas with high human population density and tourist popularity in six geographic regions in Thailand	PLOS ONE			English	Article							PSEUDALLESCHERIA-BOYDII; APIOSPERMUM; TSUNAMI; SURVIVOR	Scedosporium is a genus comprising at least 10 species of airborne fungi (saprobes) that survive and grow on decaying organic matter. These fungi are found in high density in human-affected areas such as sewage-contaminated water, and five species, namely Scedosporium apiospermum, S. boydii, S. aurantiacum, S. dehoogii, and S. minutisporum, cause human infections. Thailand is a popular travel destination in the world, with many attractions present in densely populated areas; thus, large numbers of people may be exposed to pathogens present in these areas. We conducted a comprehensive survey of Scedosporium species in 350 soil samples obtained from 35 sites of high human population density and tourist popularity distributed over 23 provinces and six geographic regions of Thailand. Soil suspensions of each sample were inoculated on three plates of Scedo-Select III medium to isolate Scedosporium species. In total, 191 Scedosporium colonies were isolated from four provinces. The species were then identified using PCR and sequencing of the beta-tubulin (BT2) gene. Of the 191 isolates, 188 were S. apiospermum, one was S. dehoogii, and species of two could not be exactly identified. Genetic diversity analysis revealed high haplotype diversity of S. apiospermum. Soil is a major ecological niche for Scedosporium and may contain S. apiospermum populations with high genetic diversity. This study of Scedosporium distribution might encourage health care providers to consider Scedosporium infection in their patients.	[Luplertlop, Natthanej; Muangkaew, Watcharamat; Pumeesat, Potjaman; Suwanmanee, San; Singkum, Pantira] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand	Mahidol University	Luplertlop, N (corresponding author), Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand.	natthanej.lup@mahidol.ac.th		luplertlop, natthanej/0000-0001-7964-5298	Mahidol University [80/2560]; Health System Research Institute [HRSI-61-002]	Mahidol University; Health System Research Institute	This research project is supported by Mahidol University (contract no. 80/2560) and Health System Research Institute agreement no. HRSI-61-002 to Natthanej Luplertlop.	Bernhardt A, 2013, J CYST FIBROS, V12, P592, DOI 10.1016/j.jcf.2013.05.007; Chen M, 2016, FUNGAL BIOL-UK, V120, P137, DOI 10.1016/j.funbio.2015.09.003; Chen TC, 2016, J FORMOS MED ASSOC, V115, P213, DOI 10.1016/j.jfma.2015.02.007; Crous PW, 2016, PERSOONIA, V37, P218, DOI 10.3767/003158516X694499; Delhaes L, 2008, EMERG INFECT DIS, V14, P282, DOI 10.3201/eid1402.070920; Garzoni C, 2005, EMERG INFECT DIS, V11, P1591, DOI 10.3201/eid1110.050715; Gilgado F, 2005, J CLIN MICROBIOL, V43, P4930, DOI 10.1128/JCM.43.10.4930-4942.2005; Gilgado F, 2008, J CLIN MICROBIOL, V46, P766, DOI 10.1128/JCM.01122-07; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Leechawengwongs M, 2007, MYCOSES, V50, P512, DOI 10.1111/j.1439-0507.2007.01410.x; Lu QY, 2011, J CLIN MICROBIOL, V49, P960, DOI 10.1128/JCM.01813-10; Luplertlop N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159869; Nakamura Y, 2013, RESPIR INVESTIG, V51, P207, DOI 10.1016/j.resinv.2013.07.001; Rougeron A, 2018, MYCOPATHOLOGIA, V183, P185, DOI 10.1007/s11046-017-0200-2; Shimizu J, 2014, SPINE, V39, pE739, DOI 10.1097/BRS.0000000000000317; Tomasini N, 2013, INFECT GENET EVOL, V20, P188, DOI 10.1016/j.meegid.2013.08.029; Pham T, 2015, MED MYCOL, V53, P512, DOI 10.1093/mmy/myv015	18	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210942	10.1371/journal.pone.0210942	http://dx.doi.org/10.1371/journal.pone.0210942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673761	Green Published, Green Submitted, gold			2022-12-26	WOS:000456442800058
J	Song, JU; Jang, Y; Lim, SY; Ryu, S; Song, WJ; Byrne, CD; Sung, KC				Song, Jae-Uk; Jang, Yoonjung; Lim, Si-Young; Ryu, Seungho; Song, Won Jun; Byrne, Christopher D.; Sung, Ki-Chul			Decreased lung function is associated with risk of developing non-alcoholic fatty liver disease: A longitudinal cohort study	PLOS ONE			English	Article							KOREA NATIONAL-HEALTH; INSULIN-RESISTANCE; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; SMOKING; POPULATION; STEATOSIS; EPIDEMIOLOGY; FIBROSIS; WORKERS	Background Decreased lung function is associated with non-alcoholic fatty liver disease (NAFLD), based on linking mechanisms such as insulin resistance and systemic inflammation However, its association with the risk of developing NAFLD is unclear. Our aim was to investigate whether baseline lung function is associated with incident NAFLD in middle-aged healthy Koreans. Methods A cohort study of 96,104 subjects (mean age: 35.7 years) without NAFLD were followed up from 2002 to 2015. NAFLD was diagnosed by ultrasound after the exclusion of other possible causes of liver diseases. Baseline percent predicted forced expiratory volume in one second (FEV1%) and forced vital capacity (FVC%) were categorized in quartiles. Adjusted hazard ratios (aHR) and 95% confidence intervals (Cls) (using the highest quartile as reference) were calculated for incident NAFLD at follow-up, controlling for covariates and potential confounders. Results During 579,714.5 person-years of follow-up, 24,450 participants developed NAFLD (incidence rate, 42.2 per 1,000 person-years). The mean follow-up period was 5.9 +/- 3.4 years. Regardless of smoking history, the risk for incident NAFLD increased with decreasing quartiles of FEV1 (%) and FVC (%) in a dose-response manner (p for trend<0.001). In never smokers, the aHRs (95% Cls) for incident NAFLD were 1.15 (1.08-1.21), 1.11 (1.05-1.18), and 1.08 (1.02-1.14) in quartiles 1-3 for FEV1 (%) and 1.12 (1.06-1.18), 1.11 (1.05-1.18), and 1.09 (1.03-1.15) in quartiles 1-3 for FVC (%), compared with the highest quartile reference. Similar inverse association was present in smoke-exposed subjects (aHR for incident NAFLD were 1.14, 1.21, 1.13 and 1.17, 1.11, 1.09 across FEV1(%) and FVC(%) quartile in increasing order, respectively). Conclusions Reduced lung function was a risk factor for incident NAFLD in a large middle-aged Korean cohort with over half a million person-years of follow-up.	[Song, Jae-Uk; Jang, Yoonjung; Lim, Si-Young] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Div Pulm & Crit Care Med,Dept Internal Med, Seoul, South Korea; [Ryu, Seungho] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Ctr Cohort Studies,Total Healthcare Ctr, Seoul, South Korea; [Ryu, Seungho] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Occupat & Environm Med, Seoul, South Korea; [Ryu, Seungho] Sungkyunkwan Univ, SAIHST, Dept Clin Res Design & Evaluat, Seoul, South Korea; [Song, Won Jun] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Crit Care Med, Seoul, South Korea; [Byrne, Christopher D.] Univ Southampton, Southampton Gen Hosp, Nutr & Metab Grp, Southampton, Hants, England; [Byrne, Christopher D.] Univ Southampton, Southampton Gen Hosp, Southampton Natl Inst Hlth Res, Biomed Res Ctr, Southampton, Hants, England; [Sung, Ki-Chul] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Div Cardiol,Dept Internal Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; University of Southampton; University of Southampton; Sungkyunkwan University (SKKU); Samsung Medical Center	Sung, KC (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Div Cardiol,Dept Internal Med, Seoul, South Korea.	kcmd.sung@samsung.com		Byrne, Christopher D/0000-0001-6322-7753	Southampton National Institute for Health Research Biomedical Research Centre	Southampton National Institute for Health Research Biomedical Research Centre	We acknowledge the efforts of the health screening group at Kangbuk Samsung Hospital, Korea. CDB is supported in part by the Southampton National Institute for Health Research Biomedical Research Centre.	Adams LA, 2005, DIABETIC MED, V22, P1129, DOI 10.1111/j.1464-5491.2005.01748.x; ALBANES D, 1987, AM J PUBLIC HEALTH, V77, P439, DOI 10.2105/AJPH.77.4.439; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Association American Association for the Study of Liver Diseases and American College of Gastroenterology, GASTROENTEROLOGY, V142, P1592, DOI [10.1053/j.gastro.2012.04.001, DOI 10.1053/J.GASTRO.2012.04.001]; Ballestri S, 2017, METABOLISM, V72, P57, DOI 10.1016/j.metabol.2017.04.003; Ballestri S, 2016, J GASTROEN HEPATOL, V31, P936, DOI 10.1111/jgh.13264; Barzilay JI, 2009, DIABETES CARE, V32, P736, DOI 10.2337/dc08-1781; Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chavez-Tapia NC, 2006, WORLD J GASTROENTERO, V12, P5196; Choi JK, 2005, TUBERC RESPIR DIS, V58, P230, DOI 10.4046/trd.2005.58.3.230; Engstrom G, 2003, J INTERN MED, V253, P574, DOI 10.1046/j.1365-2796.2003.01138.x; Engstrom G, 2002, CIRCULATION, V106, P2555, DOI 10.1161/01.CIR.0000037220.00065.0D; Fan JG, 2009, J HEPATOL, V50, P204, DOI 10.1016/j.jhep.2008.10.010; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Hong HC, 2014, HEPATOLOGY, V59, P1772, DOI 10.1002/hep.26716; Jung DH, 2012, INTERN MED J, V42, P541, DOI 10.1111/j.1445-5994.2011.02644.x; Kato K, 2015, J DIABETES INVEST, V6, P158, DOI 10.1111/jdi.12271; Kim CW, 2013, J HEPATOL, V59, P351, DOI 10.1016/j.jhep.2013.03.035; Kwak MS, 2018, KOREAN J INTERN MED, V33, P64, DOI 10.3904/kjim.2017.343; Kwak MS, 2018, RESPIROLOGY, V23, P82, DOI 10.1111/resp.13127; Kwak MS, 2017, RESPIROLOGY; Kwon CH, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-38; Lazarus R, 1998, EUR RESPIR J, V12, P641, DOI 10.1183/09031936.98.12030641; Lee CH, 2018, LIVER INT; Leone N, 2009, AM J RESP CRIT CARE, V179, P509, DOI 10.1164/rccm.200807-1195OC; Liu Y, 2013, J EPIDEMIOL, V23, P115, DOI 10.2188/jea.JE20120067; Lonardo A, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00546-2017; Malavolti M, 2003, ANN HUM BIOL, V30, P380, DOI 10.1080/0301446031000095211; Mantovani A, 2018, METABOLISM, V79, P64, DOI 10.1016/j.metabol.2017.11.003; Mantovani A, 2018, DIABETES CARE, V41, P372, DOI 10.2337/dc17-1902; Mathiesen UL, 2002, DIGEST LIVER DIS, V34, P516, DOI 10.1016/S1590-8658(02)80111-6; Miele CH, 2018, THORAX; Moon SW, 2018, INT J CHRONIC OBSTR, V13, P2603, DOI 10.2147/COPD.S166902; MORRIS JF, 1971, AM REV RESPIR DIS, V103, P57; Munsterman ID, 2017, SCAND J GASTROENTERO, V52, P881, DOI 10.1080/00365521.2017.1315169; Nigam P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049286; Oh SW, 2005, DIABETES CARE, V28, P2064, DOI 10.2337/diacare.28.8.2064; PENG TC, 2015, MEDICINE, V94; Piazzolla G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186708; Polyzos SA, 2011, METABOLISM, V60, P313, DOI 10.1016/j.metabol.2010.09.003; Qin L, 2017, BMC ENDOCR DISORD, V17, DOI 10.1186/s12902-017-0168-4; Rezayat AA, 2018, SAGE OPEN MED, V6, DOI 10.1177/2050312117745223; RODE A, 1973, SCAND J RESPIR DIS, V54, P191; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Schick S, 2005, TOB CONTROL, V14, P396, DOI 10.1136/tc.2005.011288; Shaaban R, 2006, RESP MED, V100, P2112, DOI 10.1016/j.rmed.2006.03.027; Skogstad M, 2006, OCCUP ENVIRON MED, V63, P482, DOI 10.1136/oem.2005.024638; Sung KC, 2014, J HEPATOL, V60, P1040, DOI 10.1016/j.jhep.2014.01.009; Takamura T, 2012, ENDOCR J, V59, P745, DOI 10.1507/endocrj.EJ12-0228; Targher G, 2016, J HEPATOL, V65, P589, DOI 10.1016/j.jhep.2016.05.013; van Eeden SF, 2001, AM J RESP CRIT CARE, V164, P826, DOI 10.1164/ajrccm.164.5.2010160; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Viglino D, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01923-2016; Xu CF, 2010, HEPATOLOGY, V52, P803, DOI 10.1002/hep.23644	58	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0208736	10.1371/journal.pone.0208736	http://dx.doi.org/10.1371/journal.pone.0208736			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673698	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000456442800009
J	Gomez-Armayones, S; Chimenos-Kustner, E; Mari, A; Tous, S; Penin, R; Clavero, O; Quiros, B; Pavon, MA; Taberna, M; Alemany, L; Servitje, O; Mena, M				Gomez-Armayones, Sara; Chimenos-Kustner, Eduardo; Mari, Antonio; Tous, Sara; Penin, Rosa; Clavero, Omar; Quiros, Beatriz; Angel Pavon, Miguel; Taberna, Miren; Alemany, Laia; Servitje, Octavio; Mena, Marisa			Human papillomavirus in premalignant oral lesions: No evidence of association in a Spanish cohort	PLOS ONE			English	Article							POTENTIALLY MALIGNANT DISORDERS; SQUAMOUS-CELL CARCINOMA; LICHEN-PLANUS; MUCOSA; LEUKOPLAKIA; CAVITY; HPV; CLASSIFICATION; PREVALENCE; INFECTION	Background Human papillomavirus (HPV) is the cause of a fraction of head and neck squamous cell carcinoma. Although this relation is well-known, it is still not clear the role of HPV in premalignant oral lesions such as oral lichen planus (OLP) and dysplasia. We aimed to evaluate the HPV-DNA prevalence and type distribution in a set of oral biopsies obtained from patients diagnosed with OLP and dysplasia, as well as the role of HPV in these lesions. Methods A retrospective cohort of all premalignant oral lesions consecutively diagnosed from March 30th 1995 to May 21st 2014 at Hospital of Bellvitge and Odontological University Hospital of Bellvitge was identified and classified in four groups: OLP (groups 1 and 2) and dysplasias (groups 3 and 4) that progressed or not to invasive cancer during follow-up. A random selection targeting 25 cases was aimed to be performed for each group. All selected cases were subjected to pathological evaluation, DNA quality control and HPV-DNA detection. HPV-DNA positive samples were further subject to p16(INK4a) analysis. Results A total of 83 cases yielded a valid HPV-DNA result. From those, 7 and 34 cases were OLP that progressed or not to invasive cancer during follow-up, whereas 24 and 18 cases were displasias that progressed or not to invasive cancer during follow-up, respectively. HPV-DNA was detected in 4 samples (3 dysplastic lesions and 1 OLP). Two samples were HPV16 positive (2%), 1 sample HPV18 positive (1%) and 1 sample (1%) was HPV indeterminate. Two out of four HPV-DNA positive cases had high p16(INK4a) expression and none of the HPV positive cases progressed to invasive cancer during long-term follow-up. Conclusions We found a low HPV-DNA attributable fraction in premalignant lesions of the oral cavity, suggesting that HPV is unlikely to play a significant role in oral carcinogenesis in our setting.	[Gomez-Armayones, Sara; Servitje, Octavio] Bellvitge Univ Hosp, Dept Dermatol, Barcelona, Spain; [Gomez-Armayones, Sara; Mari, Antonio; Penin, Rosa; Servitje, Octavio] Bellvitge Univ Hosp, Dept Med, Barcelona, Spain; [Chimenos-Kustner, Eduardo] Odontol Univ Hosp Barcelona, Dept Odontostomatol, Barcelona, Spain; [Mari, Antonio] Bellvitge Univ Hosp, Dept Oral & Maxillofacial Surg, Barcelona, Spain; [Tous, Sara; Clavero, Omar; Quiros, Beatriz; Angel Pavon, Miguel; Alemany, Laia; Mena, Marisa] Catalan Inst Oncol ICO, Canc Epidemiol Res Program, IDIBELL, Barcelona, Spain; [Tous, Sara; Clavero, Omar; Quiros, Beatriz; Angel Pavon, Miguel; Mena, Marisa] CIBER Primary & Secondary Prevent Viral Induced C, Madrid, Spain; [Penin, Rosa] Bellvitge Univ Hosp, Dept Pathol, Barcelona, Spain; [Taberna, Miren] Catalan Inst Oncol ICO, Dept Med Oncol, ONCOBELL, IDIBELL, Barcelona, Spain; [Taberna, Miren] Univ Barcelona, Barcelona, Spain; [Alemany, Laia] Inst Salud Carlos III, CIBERESP, Epidemiol & Publ Hlth, Madrid, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Catalan Institute of Oncology; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III	Gomez-Armayones, S (corresponding author), Bellvitge Univ Hosp, Dept Dermatol, Barcelona, Spain.; Gomez-Armayones, S (corresponding author), Bellvitge Univ Hosp, Dept Med, Barcelona, Spain.	sara.gomez.armayones@gmail.com	Chimenos-Küstner, Eduardo/AAD-1050-2019; Alemany, Laia/G-9643-2015; Tous, Sara/G-5052-2015; Pavon, Miguel Angel/N-3538-2014; Mari, Antonio/D-4499-2014	Chimenos-Küstner, Eduardo/0000-0002-0728-1808; Alemany, Laia/0000-0003-0945-6015; Taberna, Miren/0000-0002-2446-186X; Tous, Sara/0000-0002-5423-7092; Pavon, Miguel Angel/0000-0003-3677-5329; Mari, Antonio/0000-0002-7213-0862				Al-Hashimi I, 2007, ORAL SURG ORAL MED O, V103, pS25, DOI 10.1016/j.tripleo.2006.11.001; Alemany L, 2016, EUR UROL, V69, P953, DOI 10.1016/j.eururo.2015.12.007; Amagasa T, 2011, INT J CLIN ONCOL, V16, P5, DOI 10.1007/s10147-010-0157-3; Arirachakaran P, 2013, ISRN DENT, V2013, P1; Campisi G, 2004, ORAL SURG ORAL MED O, V98, P705, DOI 10.1016/j.tripleo.2004.04.012; Campisi G, 2007, INT J ONCOL, V30, P813; Castellsague X, 2016, JNCI-J NATL CANCER I, V108, P1; de Martel C, 2017, INT J CANCER, V141, P664, DOI 10.1002/ijc.30716; de Medeiros Maia HC, 2016, EINSTEIN, V14; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Debanth S, 2009, ASIA-PAC J CLIN ONCO, V5, P111, DOI 10.1111/j.1743-7563.2009.01200.x; Epstein JB, 2003, ORAL SURG ORAL MED O, V96, P32, DOI 10.1016/S1079-2104(03)00161-6; Giovannelli L, 2006, MOL DIAGN THER, V10, P49, DOI 10.1007/BF03256442; Gorsky M, 2011, ORAL SURG ORAL MED O, V111, P461, DOI 10.1016/j.tripleo.2010.11.007; Halec G, 2013, BRIT J CANCER, V109, P172, DOI 10.1038/bjc.2013.296; Hirth JM, 2017, VACCINE, V35, P3446, DOI 10.1016/j.vaccine.2017.05.025; Ishibashi M, 2011, INT J CLIN ONCOL, V16, P646, DOI 10.1007/s10147-011-0236-0; Khovidhunkit SOP, 2008, ASIAN PAC J CANCER P, V9, P771; Kreimer AR, 2010, SEX TRANSM DIS, V37, P386, DOI 10.1097/OLQ.0b013e3181c94a3b; Leemans CR, 2018, NAT REV CANCER, V18, P269, DOI 10.1038/nrc.2018.11; Lingen MW, 2013, ORAL ONCOL, V49, P1, DOI 10.1016/j.oraloncology.2012.07.002; Llamas-Martinez S, 2008, ANTICANCER RES, V28, P3733; Lodi G, 2005, ORAL SURG ORAL MED O, V100, P164, DOI 10.1016/j.tripleo.2004.06.076; Ma J, 2016, PLOS ONE, V11, P1; Mattila R, 2012, ORAL ONCOL, V48, P980, DOI 10.1016/j.oraloncology.2012.04.009; Mehanna HM, 2009, HEAD NECK-J SCI SPEC, V31, P1600, DOI 10.1002/hed.21131; Mena M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184520; Miller CS, 1996, ORAL SURG ORAL MED O, V82, P57, DOI 10.1016/S1079-2104(96)80378-7; Mirghani H, 2015, ORAL ONCOL, V51, P229, DOI 10.1016/j.oraloncology.2014.11.011; Nankivell P, 2014, J ORAL PATHOL MED, V43, P245, DOI 10.1111/jop.12128; Pol CA, 2015, INT DENT J, V65, P11, DOI 10.1111/idj.12125; Prigge ES, EUROGIN 2017; Prigge ES, 2018, 2 INT S TUM HOST INT; Radochova V, 2015, ACTA VIROL, V59, P434, DOI 10.4149/av_2015_04_434; Rautava J, 2011, J AM DENT ASSOC, V142, P905, DOI 10.14219/jada.archive.2011.0297; Syrjanen S, 2011, ORAL DIS, V17, P58, DOI 10.1111/j.1601-0825.2011.01792.x; Szarka K, 2009, ORAL MICROBIOL IMMUN, V24, P314, DOI 10.1111/j.1399-302X.2009.00516.x; Van der Waal I., 2014, MED ORAL PATOL ORAL, V19, P1; van der Waal I, 2009, ORAL ONCOL, V45, P317, DOI 10.1016/j.oraloncology.2008.05.016; Warnakulasuriya S, 2007, J ORAL PATHOL MED, V36, P575, DOI 10.1111/j.1600-0714.2007.00582.x; Westra WH, 2014, ORAL ONCOL, V50, P771, DOI 10.1016/j.oraloncology.2014.05.004	41	15	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210070	10.1371/journal.pone.0210070	http://dx.doi.org/10.1371/journal.pone.0210070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650110	Green Submitted, Green Published, gold			2022-12-26	WOS:000455813300039
J	Zhou, YF; Chen, AQ; Wu, JH; Mao, L; Xia, YP; Jin, HJ; He, QW; Miao, QR; Yue, ZY; Liu, XL; Huang, M; Li, YN; Hu, B				Zhou, Yi-Fan; Chen, An-Qi; Wu, Jie-Hong; Mao, Ling; Xia, Yuan-Peng; Jin, Hui-Juan; He, Quan-Wei; Miao, Qing Robert; Yue, Zhen-Yu; Liu, Xiu-Li; Huang, Ming; Li, Ya-Nan; Hu, Bo			Sema3E/PlexinD1 signaling inhibits postischemic angiogenesis by regulating endothelial DLL4 and filopodia formation in a rat model of ischemic stroke	FASEB JOURNAL			English	Article						vascular network; endothelial cell; brain; F-actin; focal adhesion	MOLECULAR-MECHANISMS; GROWTH-FACTOR; RHO GTPASES; TIP CELLS; SEMAPHORIN; BRAIN; RAC1; JNK; STRATEGY; GUIDANCE	Angiogenesis is a crucial defense response to hypoxia that regulates the process of raising the promise of long-term neurologic recovery during the management of stroke. A high expression of antiangiogenic factors leads to the loss of neovascularization capacity in pathologic conditions. We have previously documented an impairment of the cerebral vessel perfusion and neovascularization in the cortex neighboring the stroke-induced lesion, which was accompanied by an activation of semaphorin 3E (Sema3E)/PlexinD1 after ischemic stroke. In this study, we employed micro-optical sectioning tomography to fully investigate the details of the vascular pattern, including the capillaries. We found that after transient middle cerebral artery occlusion, inhibiting PlexinD1 signaling led to an organized recovery of the vascular network in the ischemic area. We then further explored the possible mechanisms. In vivo, Sema3E substantially decreased dynamic delta-like 4 (DLL4) expression. In cultured brain microvascular endothelial cells, Sema3E down-regulated DLL4 expression via inhibiting Ras-related C3 botulinum toxin substrate 1-induced JNK phosphorylation. At the microcosmic level, Sema3E/PlexinD1 signaling promoted F-actin disassembly and focal adhesion reduction by activating the small guanosine triphosphatase Ras homolog family member J by releasing RhoGEF Tuba from direct binding to PlexinD1, thus mediating endothelial cell motility and filopodia retraction. Our study reveals that Sema3E/PlexinD1 signaling, which suppressed endothelial DLL4 expression, cell motility, and filopodia formation, is expected to be a novel druggable target for angiogenesis during poststroke progression.	[Zhou, Yi-Fan; Chen, An-Qi; Wu, Jie-Hong; Mao, Ling; Xia, Yuan-Peng; Jin, Hui-Juan; He, Quan-Wei; Li, Ya-Nan; Hu, Bo] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Neurol, 1277 Jiefang Dadao, Wuhan 430022, Hubei, Peoples R China; [Liu, Xiu-Li] Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Britton Chance Ctr Biomed Photon, Wuhan, Hubei, Peoples R China; [Liu, Xiu-Li] Huazhong Univ Sci & Technol, Key Lab Biomed Photon, Minist Educ, Dept Biomed Engn, Wuhan, Hubei, Peoples R China; [Miao, Qing Robert] Med Coll Wisconsin, Dept Surg, Div Pediat Surg, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA; [Miao, Qing Robert] Med Coll Wisconsin, Dept Pathol, Div Pediat Pathol, Childrens Res Inst, Milwaukee, WI 53226 USA; [Miao, Qing Robert] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Yue, Zhen-Yu] Icahn Sch Med Mt Sinai, Dept Neurol, Friedman Brain Inst, New York, NY 10029 USA; [Yue, Zhen-Yu] Icahn Sch Med Mt Sinai, Dept Neurosci, Friedman Brain Inst, New York, NY 10029 USA; [Huang, Ming] Three Gorges Univ, China Three Gorges Univ, Inst Translat Neurosci, Dept Neurol,Peoples Hosp,Coll Med, Yichang, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; China Three Gorges University	Li, YN; Hu, B (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Neurol, 1277 Jiefang Dadao, Wuhan 430022, Hubei, Peoples R China.	lyn.hust@qq.com; hubo@mail.hust.edu.cn	Miao, Qing/K-3186-2019	Miao, Qing/0000-0002-3125-1238	National Key Research and Development Program of China [2016YFC1300600]; National Natural Science Foundation of China [81571119, 81601027, 81571139, 81771249, 81400969, 81671147, 81400970]; Natural Science Foundation of Hubei Province of China [2016CFB518]; National Research Foundation for the Doctoral Program of Higher Education of China [20120142110068]; New Century Excellent Talents in University [NCET-10-0406]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province); National Research Foundation for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Key Research and Development Program of China (2018YFC1312200), National Natural Science Foundation of China (81571119 to B.H., 81601027 to Y.N.L., 81571139 to L.M., 81771249 to Y.P.X., 81400969 to Q.W.H., 81671147 to H.J.J., and 81400970 to M.L.), National Key Research and Development Program of China (no. 2016YFC1300600), Natural Science Foundation of Hubei Province of China (2016CFB518 to M.H.), National Research Foundation for the Doctoral Program of Higher Education of China (20120142110068 to B.H.), and New Century Excellent Talents in University (NCET-10-0406 to B.H.). The authors declare no conflicts of interest.	Abe T, 2003, J CELL SCI, V116, P155, DOI 10.1242/jcs.00208; Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875; Archibald A, 2015, ONCOGENE, V34, P3199, DOI 10.1038/onc.2014.242; Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Casazza A, 2010, J CLIN INVEST, V120, P2684, DOI 10.1172/JCI42118; Chauvet S, 2007, NEURON, V56, P807, DOI 10.1016/j.neuron.2007.10.019; Cristofaro B, 2013, DEVELOPMENT, V140, P1720, DOI 10.1242/dev.092304; De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165; Dietz DM, 2012, NAT NEUROSCI, V15, P891, DOI 10.1038/nn.3094; Dougherty CJ, 2004, FASEB J, V18, P1060, DOI 10.1096/fj.04-1505com; Du HJ, 2013, P NATL ACAD SCI USA, V110, P2377, DOI 10.1073/pnas.1221729110; Eichmann A, 2005, GENE DEV, V19, P1013, DOI 10.1101/gad.1305405; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Fukushima Y, 2011, J CLIN INVEST, V121, P1974, DOI 10.1172/JCI44900; Gay CM, 2011, DEV BIOL, V349, P1, DOI 10.1016/j.ydbio.2010.09.008; Gelfand MV, 2009, TRENDS CELL BIOL, V19, P99, DOI 10.1016/j.tcb.2009.01.001; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Hasan SS, 2017, NAT CELL BIOL, V19, P928, DOI 10.1038/ncb3574; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hernandez-Garcia R, 2015, VASC PHARMACOL, V74, P60, DOI 10.1016/j.vph.2015.10.003; Iglesias-Rey R, 2018, TRANSL STROKE RES, V9, P347, DOI 10.1007/s12975-017-0584-9; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Kaur S, 2011, ARTERIOSCL THROM VAS, V31, P657, DOI 10.1161/ATVBAHA.110.216341; Kim J, 2011, GENE DEV, V25, P1399, DOI 10.1101/gad.2042011; Lange C, 2016, NAT REV NEUROL, V12, P439, DOI 10.1038/nrneurol.2016.88; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; Li AA, 2010, SCIENCE, V330, P1404, DOI 10.1126/science.1191776; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Moriya J, 2010, CIRC RES, V106, P391, DOI 10.1161/CIRCRESAHA.109.210815; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Quaegebeur A, 2011, NEURON, V71, P406, DOI 10.1016/j.neuron.2011.07.013; RAMO K, 2016, R J, V5, DOI DOI 10.7554/ELIFE.18414; Salvucci O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7576; Sawada M, 2018, EMBO J, V37, DOI 10.15252/embj.201797404; Sharma M, 2012, J HEPATOL, V56, P192, DOI 10.1016/j.jhep.2011.03.019; Smith KR, 2017, J BIOL CHEM, V292, P20173, DOI 10.1074/jbc.M117.796292; Tata A, 2014, J CELL BIOL, V205, P573, DOI 10.1083/jcb.201309004; Thurston G, 2007, NAT REV CANCER, V7, P327, DOI 10.1038/nrc2130; UBEZIO B, 2016, SYNCHRONIZATION, V5, DOI DOI 10.7554/ELIFE.12167; Walchli T, 2015, NEURON, V87, P271, DOI 10.1016/j.neuron.2015.06.038; Wu JP, 2014, NEUROIMAGE, V87, P199, DOI 10.1016/j.neuroimage.2013.10.036; Xu B, 2004, J CEREBR BLOOD F MET, V24, P237, DOI 10.1097/01.WCB.0000107730.66603.51; Zhou YF, 2018, NEUROBIOL AGING, V70, P102, DOI 10.1016/j.neurobiolaging.2018.06.003; Zhou YF, 2018, FASEB J, V32, P2181, DOI 10.1096/fj.201700786RR	53	13	16	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4947	4961		10.1096/fj.201801706RR	http://dx.doi.org/10.1096/fj.201801706RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30653356	Bronze			2022-12-26	WOS:000462888500025
J	Eriksson, O; Chiu, J; Hogg, PJ; Atkinson, JP; Liszewski, MK; Flaumenhaft, R; Furie, B				Eriksson, Oskar; Chiu, Joyce; Hogg, Philip J.; Atkinson, John P.; Liszewski, M. Kathryn; Flaumenhaft, Robert; Furie, Bruce			Thiol isomerase ERp57 targets and modulates the lectin pathway of complement activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						redox regulation; mass spectrometry (MS); complement system; disulfide; innate immunity; ER protein 57 (ERp57); ficolin; lectin pathway; thiol isomerase	PROTEIN DISULFIDE-ISOMERASE; MANNAN-BINDING LECTIN; VON-WILLEBRAND-FACTOR; THROMBUS FORMATION; GENE ONTOLOGY; PLATELET; MOUSE; REDUCTION; REVEALS; PATTERN	ER protein 57 (ERp57), a thiol isomerase secreted from vascular cells, is essential for complete thrombus formation in vivo, but other extracellular ERp57 functions remain unexplored. Here, we employed a kinetic substrate-trapping approach to identify extracellular protein substrates of ERp57 in platelet-rich plasma. MS-based identification with immunochemical confirmation combined with gene ontology enrichment analysis revealed that ERp57 targets, among other substrates, components of the lectin pathway of complement activation: mannose-binding lectin, ficolin-2, ficolin-3, collectin-10, collectin-11, mannose-binding lectin-associated serine protease-1, and mannose-binding lectin-associated serine protease-2. Ficolin-3, the most abundant lectin pathway initiator in humans, circulates as disulfide-linked multimers of a monomer. ERp57 attenuated ficolin-3 ligand recognition and complement activation by cleaving intermolecular disulfide bonds in large ficolin-3 multimers, thereby reducing multimer size and ligand-binding affinity. We used MS to identify the disulfide-bonding pattern in ficolin-3 multimers and the disulfide bonds targeted by ERp57 and found that Cys(6) and Cys(23) in the N-terminal region of ficolin-3 form the intermolecular disulfide bonds in ficolin-3 multimers that are reduced by ERp57. Our results not only demonstrate that ERp57 can negatively regulate complement activation, but also identify a control mechanism for lectin pathway initiation in the vasculature. We conclude that extensive multimerization in large ficolin-3 multimers leads to a high affinity for ligands and strong complement-activating potential and that ERp57 suppresses complement activation by cleaving disulfide bonds in ficolin-3 and reducing its multimer size.	[Eriksson, Oskar; Flaumenhaft, Robert; Furie, Bruce] Beth Israel Deaconess Med Ctr, Div Hemostasis & Thrombosis, Ctr Life Sci CLS903,3 Blackfan Circle, Boston, MA 02115 USA; [Eriksson, Oskar; Flaumenhaft, Robert; Furie, Bruce] Harvard Med Sch, Boston, MA 02115 USA; [Chiu, Joyce; Hogg, Philip J.] Univ Sydney, Sydney Med Sch, Natl Hlth & Med Res Council, Centenary Inst,Clin Trials Ctr, Sydney, NSW 2006, Australia; [Atkinson, John P.; Liszewski, M. Kathryn] Washington Univ, Sch Med, Dept Med Rheumatol, St Louis, MO 63110 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Sydney; Centenary Institute; Washington University (WUSTL)	Furie, B (corresponding author), Beth Israel Deaconess Med Ctr, Div Hemostasis & Thrombosis, Ctr Life Sci CLS903,3 Blackfan Circle, Boston, MA 02115 USA.	bfurie@bidmc.harvard.edu	Chiu, Joyce/H-7772-2017	Chiu, Joyce/0000-0001-8910-8664; Furie, Bruce/0000-0001-7610-1076; Hogg, Philip/0000-0001-6486-2863; Atkinson, John/0000-0002-2514-3441	National Institutes of Health [U54 HL112303, R01 HL136394, R01 GM099111]; National Health and Medical Research Council of Australia; Helen and Robert Ellis Postdoctoral Fellowship from the Sydney Medical School Foundation; Tony Basten Postdoctoral Fellowship from Sydney Medical School Foundation; Swedish Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136394, U54HL112303, U54HL112302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Helen and Robert Ellis Postdoctoral Fellowship from the Sydney Medical School Foundation; Tony Basten Postdoctoral Fellowship from Sydney Medical School Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants U54 HL112303 and R01 HL136394 (to B. F.), National Institutes of Health Grant R01 GM099111 (to J. P. A.), a grant from the National Health and Medical Research Council of Australia (to P. J. H.), and the Helen and Robert Ellis Postdoctoral Fellowship and Tony Basten Postdoctoral Fellowship from the Sydney Medical School Foundation (to J. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by an international postdoctoral grant from the Swedish Research Council.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baldus IB, 2012, BIOPHYS J, V102, P622, DOI 10.1016/j.bpj.2011.12.039; Bowley SR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14151; Butera D, 2014, BLOOD, V123, P2000, DOI 10.1182/blood-2014-01-549816; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Chen JM, 2011, J CLIN INVEST, V121, P593, DOI 10.1172/JCI41062; Chiu J, 2014, BIOCHEMISTRY-US, V53, P7, DOI 10.1021/bi401518b; Cho J, 2008, J CLIN INVEST, V118, P1123, DOI 10.1172/JCI34134; Ellerman DA, 2006, DEV CELL, V10, P831, DOI 10.1016/j.devcel.2006.03.011; Ellgaard L, 2003, CELL BIOCHEM BIOPHYS, V39, P223, DOI 10.1385/CBB:39:3:223; Ellgaard L, 2016, TRAFFIC, V17, P615, DOI 10.1111/tra.12392; Endo Y, 2004, GENOMICS, V84, P737, DOI 10.1016/j.ygeno.2004.07.006; Feng SJ, 2015, BLOOD, V125, P1034, DOI 10.1182/blood-2014-06-585430; Flaumenhaft R, 2016, BLOOD, V128, P893, DOI 10.1182/blood-2016-04-636456; Frickel EM, 2004, J BIOL CHEM, V279, P18277, DOI 10.1074/jbc.M314089200; Garred P, 2016, IMMUNOL REV, V274, P74, DOI 10.1111/imr.12468; Gogia S, 2015, BIORHEOLOGY, V52, P319, DOI 10.3233/BIR-15061; Hamad OA, 2010, J IMMUNOL, V184, P2686, DOI 10.4049/jimmunol.0902810; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Hein E, 2013, MOL IMMUNOL, V56, P406, DOI 10.1016/j.molimm.2013.05.233; Hein E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015443; Holbrook LM, 2012, J THROMB HAEMOST, V10, P278, DOI 10.1111/j.1538-7836.2011.04593.x; Holbrook LM, 2018, J THROMB HAEMOST, V16, P367, DOI 10.1111/jth.13878; Holbrook LM, 2010, BRIT J HAEMATOL, V148, P627, DOI 10.1111/j.1365-2141.2009.07994.x; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Honore C, 2007, ARTHRITIS RHEUM, V56, P1598, DOI 10.1002/art.22564; Hummelshoj T, 2008, MOL IMMUNOL, V45, P1623, DOI 10.1016/j.molimm.2007.10.006; Java A, 2015, MOL IMMUNOL, V67, P584, DOI 10.1016/j.molimm.2015.07.016; King BC, 2012, J IMMUNOL, V188, P4103, DOI 10.4049/jimmunol.1101295; Kjaer TR, 2016, SCAND J IMMUNOL, V84, P12, DOI 10.1111/sji.12441; Liszewski MK, 2015, J INTERN MED, V277, P294, DOI 10.1111/joim.12338; Liu H, 2001, SCAND J IMMUNOL, V53, P489, DOI 10.1046/j.1365-3083.2001.00908.x; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Noone DG, 2016, KIDNEY INT, V90, P123, DOI 10.1016/j.kint.2016.03.023; Ohashi T, 2004, J BIOL CHEM, V279, P6534, DOI 10.1074/jbc.M310555200; Palarasah Y, 2011, CLIN EXP IMMUNOL, V164, P388, DOI 10.1111/j.1365-2249.2011.04322.x; Passam FH, 2015, BLOOD, V125, P2276, DOI 10.1182/blood-2013-12-547208; Petersen SV, 2001, J IMMUNOL METHODS, V257, P107, DOI 10.1016/S0022-1759(01)00453-7; Presanis JS, 2004, MOL IMMUNOL, V40, P921, DOI 10.1016/j.molimm.2003.10.013; Raturi A, 2007, FREE RADICAL BIO MED, V43, P62, DOI 10.1016/j.freeradbiomed.2007.03.025; Schulman S, 2016, ANTIOXID REDOX SIGN, V24, P1, DOI 10.1089/ars.2015.6530; Schwenk JM, 2017, J PROTEOME RES, V16, P4299, DOI 10.1021/acs.jproteome.7b00467; Teillet F, 2005, J IMMUNOL, V174, P2870, DOI 10.4049/jimmunol.174.5.2870; Walker KW, 1996, BIOCHEMISTRY-US, V35, P1972, DOI 10.1021/bi952157n; Wang L, 2013, BLOOD, V122, P3642, DOI 10.1182/blood-2013-06-506691; Wiita AP, 2006, P NATL ACAD SCI USA, V103, P7222, DOI 10.1073/pnas.0511035103; Xie LJ, 2001, J EXP MED, V193, P1341, DOI 10.1084/jem.193.12.1341; Yi MC, 2018, J BIOL CHEM, V293, P2640, DOI 10.1074/jbc.RA117.001382; Zacho RM, 2012, J BIOL CHEM, V287, P8071, DOI 10.1074/jbc.M111.301044; Zhou JS, 2017, BLOOD, V130, P817, DOI 10.1182/blood-2016-12-755587; Zhou JS, 2015, J CLIN INVEST, V125, P4391, DOI 10.1172/JCI80319; Zhu S, 2016, J THROMB HAEMOST, V14, P1070, DOI 10.1111/jth.13245	52	9	10	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4878	4888		10.1074/jbc.RA118.006792	http://dx.doi.org/10.1074/jbc.RA118.006792			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30670593	hybrid, Green Published			2022-12-26	WOS:000463985600013
J	Sahu, PK; Tomar, RS				Sahu, Pushpendra Kumar; Tomar, Raghuvir Singh			The natural anticancer agent cantharidin alters GPI-anchored protein sorting by targeting Cdc1-mediated remodeling in endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosylphosphatidylinositol (GPI-anchor); yeast genetics; anticancer drug; phospholipid; unfolded protein response (UPR); cell signaling; lipid metabolism; cantharidin; Cdc1; ER homeostasis; ER-Golgi transport; GPI-anchor remodeling; lipid phosphatase	CELL-WALL INTEGRITY; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR; SACCHAROMYCES-CEREVISIAE; PHOSPHATIDYLSERINE DECARBOXYLASE; CANCER CELLS; YEAST; IDENTIFICATION; PHOSPHATASE; INHIBITION; STRESS	Cantharidin (CTD) is a potent anticancer small molecule produced by several species of blister beetle. It has been a traditional medicine for the management of warts and tumors for many decades. CTD suppresses tumor growth by inducing apoptosis, cell cycle arrest, and DNA damage and inhibits protein phosphatase 2 phosphatase activator (PP2A) and protein phosphatase 1 (PP1). CTD also alters lipid homeostasis, cell wall integrity, endocytosis, adhesion, and invasion in yeast cells. In this study, we identified additional molecular targets of CTD using a Saccharomyces cerevisiae strain that expresses a cantharidin resistance gene (CRG1), encoding a SAM-dependent methyltransferase that methylates and inactivates CTD. We found that CTD specifically affects phosphatidylethanolamine (PE)-associated functions that can be rescued by supplementing the growth media with ethanolamine (ETA). CTD also perturbed endoplasmic reticulum (ER) homeostasis and cell wall integrity by altering the sorting of glycosylphosphatidylinositol (GPI)-anchored proteins. A CTD-dependent genetic interaction profile of CRG1 revealed that the activity of the lipid phosphatase cell division control protein 1 (Cdc1) in GPI-anchor remodeling is the key target of CTD, independently of PP2A and PP1 activities. Moreover, experiments with human cells further suggested that CTD functions through a conserved mechanism in higher eukaryotes. Altogether, we conclude that CTD induces cytotoxicity by targeting Cdc1 activity in GPI-anchor remodeling in the ER.	[Sahu, Pushpendra Kumar; Tomar, Raghuvir Singh] Indian Inst Sci Educ & Res, Dept Biol Sci, Lab Chromatin Biol, Bhopal 462066, Madhya Pradesh, India	Indian Institute of Science Education & Research (IISER) - Bhopal	Tomar, RS (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Lab Chromatin Biol, Bhopal 462066, Madhya Pradesh, India.	rst@iiserb.ac.in		Tomar, Raghuvir/0000-0002-3574-7839	Indian Institute of Science Education and Research Bhopal; SERB Government of India [EMR/2015/001797]; Department of Biotechnology (DBT)-India	Indian Institute of Science Education and Research Bhopal; SERB Government of India; Department of Biotechnology (DBT)-India(Department of Biotechnology (DBT) India)	This work was supported by funds from the Indian Institute of Science Education and Research Bhopal and partly by SERB Government of India Grant EMR/2015/001797 (to R.S.T.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Junior Research Fellow/Senior Research Fellow (JRF/SRF) fellowship from the Department of Biotechnology (DBT)-India.	Amm I, 2014, BBA-MOL CELL RES, V1843, P182, DOI 10.1016/j.bbamcr.2013.06.031; Ariyama H, 2010, J BIOL CHEM, V285, P22027, DOI 10.1074/jbc.M110.126870; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J LIPID RES, V50, pS69, DOI 10.1194/jlr.R800043-JLR200; Chen YL, 2010, MOL MICROBIOL, V75, P1112, DOI 10.1111/j.1365-2958.2009.07018.x; Costa-de-Oliveira S, 2013, CYTOM PART A, V83A, P324, DOI 10.1002/cyto.a.22250; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Delic M, 2012, FREE RADICAL BIO MED, V52, P2000, DOI 10.1016/j.freeradbiomed.2012.02.048; Duffy S, 2016, P NATL ACAD SCI USA, V113, P9967, DOI 10.1073/pnas.1611839113; Fujita M, 2008, BBA-GEN SUBJECTS, V1780, P410, DOI 10.1016/j.bbagen.2007.08.009; Fujita M, 2012, BBA-MOL CELL BIOL L, V1821, P1050, DOI 10.1016/j.bbalip.2012.01.004; Fujita M, 2009, CELL, V139, P352, DOI 10.1016/j.cell.2009.08.040; GARABEDIAN MJ, 1992, MOL BIOL CELL, V3, P1245, DOI 10.1091/mbc.3.11.1245; Gibellini F, 2010, IUBMB LIFE, V62, P414, DOI 10.1002/iub.337; Halbleib K, 2017, MOL CELL, V67, P673, DOI 10.1016/j.molcel.2017.06.012; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HONKANEN RE, 1993, FEBS LETT, V330, P283, DOI 10.1016/0014-5793(93)80889-3; Hoon S, 2008, NAT CHEM BIOL, V4, P498, DOI 10.1038/nchembio.100; Huang WW, 2011, INT J ONCOL, V38, P1067, DOI 10.3892/ijo.2011.922; Hughes WE, 2000, J BIOL CHEM, V275, P801, DOI 10.1074/jbc.275.2.801; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Jiang Y, 2006, MICROBIOL MOL BIOL R, V70, P440, DOI 10.1128/MMBR.00049-05; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Kim JA, 2013, J BIOL CHEM, V288, P28713, DOI 10.1074/jbc.M113.488346; Klis FM, 2007, YEAST, V24, P253, DOI 10.1002/yea.1476; Leung AKC, 2017, RECENT PATENTS INFLA, V11, P22, DOI 10.2174/1872213X11666170518114456; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Li HC, 2017, CELL PHYSIOL BIOCHEM, V43, P1829, DOI 10.1159/000484069; Li W, 2010, CANCER SCI, V101, P1226, DOI 10.1111/j.1349-7006.2010.01523.x; LI YM, 1992, P NATL ACAD SCI USA, V89, P11867, DOI 10.1073/pnas.89.24.11867; Lissina E, 2013, ACS CHEM BIOL, V8, P2785, DOI 10.1021/cb400607h; Lissina E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002332; Losev E, 2008, MOL CELL BIOL, V28, P3336, DOI 10.1128/MCB.00567-07; LOUKIN S, 1995, J CELL BIOL, V131, P1025, DOI 10.1083/jcb.131.4.1025; Lubeseder-Martellato C, 2016, ONCOTARGET, V7, P49156, DOI 10.18632/oncotarget.9402; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Mierke CT, 2011, J BIOL CHEM, V286, P34858, DOI 10.1074/jbc.M111.245183; Muniz M, 2014, J CELL SCI, V127, P2793, DOI 10.1242/jcs.148056; Nagamune K, 2000, P NATL ACAD SCI USA, V97, P10336, DOI 10.1073/pnas.180230697; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Paidhungat M, 1998, GENETICS, V148, P1777; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; Pittet M, 2007, BBA-MOL CELL BIOL L, V1771, P405, DOI 10.1016/j.bbalip.2006.05.015; Ray RM, 2005, J BIOL CHEM, V280, P31091, DOI 10.1074/jbc.M503041200; Rodicio R, 2010, YEAST, V27, P531, DOI 10.1002/yea.1785; Rolli E, 2009, MOL BIOL CELL, V20, P4856, DOI 10.1091/mbc.E08-11-1155; Ruan LH, 2017, NATURE, V543, P443, DOI 10.1038/nature21695; Sakoff JA, 2002, INVEST NEW DRUG, V20, P1, DOI 10.1023/A:1014460818734; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Scrimale T, 2009, MOL BIOL CELL, V20, P164, DOI 10.1091/mbc.E08-08-0809; Srivas R, 2016, MOL CELL, V63, P514, DOI 10.1016/j.molcel.2016.06.022; Storey MK, 2001, J BIOL CHEM, V276, P48539, DOI 10.1074/jbc.M109043200; STOUGHTON RB, 1959, J INVEST DERMATOL, V33, P287, DOI 10.1038/jid.1959.152; Su CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168095; Sun XY, 2016, MOL CELLS, V39, P869, DOI 10.14348/molcells.2016.0023; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; van Pel DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003254; Vazquez HM, 2014, MOL BIOL CELL, V25, P3375, DOI 10.1091/mbc.E14-06-1033; Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; WANG GS, 1989, J ETHNOPHARMACOL, V26, P147, DOI 10.1016/0378-8741(89)90062-7; Wang SX, 2014, P NATL ACAD SCI USA, V111, pE3976, DOI 10.1073/pnas.1411694111; WEAKLEY DR, 1962, J INVEST DERMATOL, V39, P39, DOI 10.1038/jid.1962.78; Wlodarchak N, 2016, CRIT REV BIOCHEM MOL, V51, P162, DOI 10.3109/10409238.2016.1143913; Wu GJ, 2006, CANCER RES, V66, P9829, DOI 10.1158/0008-5472.CAN-06-0506; Yang LH, 2016, J BIOL CHEM, V291, P3905, DOI 10.1074/jbc.M115.705830; YELL JA, 1994, BRIT J DERMATOL, V130, P148, DOI 10.1111/j.1365-2133.1994.tb02893.x; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zeeshan HMA, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030327; Zhang JT, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-193; Zhao P, 2012, J BIOL CHEM, V287, P25230, DOI 10.1074/jbc.M112.339465; Zheng LH, 2008, CANCER LETT, V272, P102, DOI 10.1016/j.canlet.2008.06.029; Zimmerman R, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.31	78	10	10	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					3837	3852		10.1074/jbc.RA118.003890	http://dx.doi.org/10.1074/jbc.RA118.003890			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30659098	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000461854400004
J	Latini, F; Fahlstrom, M; Berntsson, SG; Larsson, EM; Smits, A; Ryttlefors, M				Latini, Francesco; Fahlstrom, Markus; Berntsson, Shala G.; Larsson, Elna-Marie; Smits, Anja; Ryttlefors, Mats			A novel radiological classification system for cerebral gliomas: The Brain-Grid	PLOS ONE			English	Article							LOW-GRADE GLIOMAS; WHITE-MATTER TRACTS; DEFINITION FIBER TRACTOGRAPHY; CENTRAL-NERVOUS-SYSTEM; MATHEMATICAL-MODEL; II GLIOMAS; TUMOR; GROWTH; ATLAS; SURGERY	Purpose Standard radiological/topographical classifications of gliomas often do not reflect the real extension of the tumor within the lobar-cortical anatomy. Furthermore, these systems do not provide information on the relationship between tumor growth and the subcortical white matter architecture. We propose the use of an anatomically standardized grid system (the Brain-Grid) to merge serial morphological magnetic resonance imaging (MRI) scans with a representative tractographic atlas. Two illustrative cases are presented to show the potential advantages of this classification system. Methods MRI scans of 39 patients (WHO grade II and III gliomas) were analyzed with a standardized grid created by intersecting longitudinal lines on the axial, sagittal, and coronal planes. The anatomical landmarks were chosen from an average brain, spatially normalized to the Montreal Neurological Institute (MNI) space and the Talairach space. Major white matter pathways were reconstructed with a deterministic tracking algorithm on a reference atlas and analyzed using the Brain-Grid system. Results In all, 48 brain grid voxels (areas defined by 3 coordinates, axial (A), coronal (C), sagittal (S) and numbers from 1 to 4) were delineated in each MRI sequence and on the tractographic atlas. The number of grid voxels infiltrated was consistent, also in the MNI space. The subcortical insula/basal ganglia (A3-C2-S2) and the fronto-insular region (A3-C2-S1) were most frequently involved. The inferior fronto-occipital fasciculus, anterior thalamic radiation, uncinate fasciculus, and external capsule were the most frequently associated pathways in both hemispheres. Conclusions The Brain-Grid based classification system provides an accurate observational tool in all patients with suspected gliomas, based on the comparison of grid voxels on a morphological MRI and segmented white matter atlas. Important biological information on tumor kinetics including extension, speed, and preferential direction of progression can be observed and even predicted with this system. This novel classification can easily be applied to both prospective and retrospective cohorts of patients and increase our comprehension of glioma behavior.	[Latini, Francesco; Ryttlefors, Mats] Uppsala Univ, Dept Neurosci, Neurosurg, Uppsala, Sweden; [Fahlstrom, Markus; Larsson, Elna-Marie] Uppsala Univ, Dept Surg Sci, Radiol, Uppsala, Sweden; [Berntsson, Shala G.; Smits, Anja] Uppsala Univ, Dept Neurosci, Neurol, Uppsala, Sweden; [Smits, Anja] Univ Gothenburg, Inst Neurosci & Physiol, Dept Clin Neurosci, Sahlgrenska Acad, Gothenburg, Sweden	Uppsala University; Uppsala University; Uppsala University; University of Gothenburg	Latini, F (corresponding author), Uppsala Univ, Dept Neurosci, Neurosurg, Uppsala, Sweden.	francesco.latini@neuro.uu.se	Latini, Francesco/GQP-2206-2022; FahlstrÃm, Markus/AAT-4041-2020	Latini, Francesco/0000-0002-4702-526X; FahlstrÃm, Markus/0000-0002-2502-6026				Abhinav K, 2015, NEURO-ONCOLOGY, V17, P1199, DOI 10.1093/neuonc/nov113; Alfonso JCL, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0490; Berntsson SG, 2013, J NEURO-ONCOL, V114, P241, DOI 10.1007/s11060-013-1178-3; Burgel U, 2009, CENT EUR NEUROSURG, V70, P27, DOI 10.1055/s-0028-1087212; Burgess PK, 1997, J NEUROPATH EXP NEUR, V56, P704; Capelle L, 2013, J NEUROSURG, V118, P1157, DOI 10.3171/2013.1.JNS121; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Duffau H, 2004, CANCER-AM CANCER SOC, V100, P2622, DOI 10.1002/cncr.20297; Duffau H, 2014, WORLD NEUROSURG, V82, pE43, DOI 10.1016/j.wneu.2013.08.054; Duffau H, 2014, WORLD NEUROSURG, V81, P56, DOI 10.1016/j.wneu.2013.01.116; Duma CM, 2016, J NEUROSURG, V125, P40, DOI 10.3171/2016.7.GKS161460; Engwer C, 2015, J MATH BIOL, V71, P551, DOI 10.1007/s00285-014-0822-7; Farquharson S, 2013, J NEUROSURG, V118, P1367, DOI 10.3171/2013.2.JNS121294; Fernandez-Miranda JC, 2012, NEUROSURGERY, V71, P430, DOI 10.1227/NEU.0b013e3182592faa; Giese A, 1996, NEUROSURGERY, V39, P235, DOI 10.1097/00006123-199608000-00001; GIESE A, 1995, NEUROSURGERY, V37, P294, DOI 10.1227/00006123-199508000-00015; Gimenez U, 2016, NMR BIOMED, V29, P1553, DOI 10.1002/nbm.3608; Gungor A, 2017, J NEUROSURG, V126, P945, DOI 10.3171/2016.1.JNS152082; Guthrie B L, 1990, Neurosurg Clin N Am, V1, P37; Harsh GR, 1990, NEUROLOGICAL SURGERY, V5, P3040; Ius T, 2011, NEUROIMAGE, V56, P992, DOI 10.1016/j.neuroimage.2011.03.022; Jakola AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051450; Jakola AS, 2012, JAMA-J AM MED ASSOC, V308, P1881, DOI 10.1001/jama.2012.12807; Jbabdi S, 2005, MAGN RESON MED, V54, P616, DOI 10.1002/mrm.20625; Kansal AR, 2000, J THEOR BIOL, V203, P367, DOI 10.1006/jtbi.2000.2000; Lacadie CM, 2008, NEUROIMAGE, V42, P717, DOI 10.1016/j.neuroimage.2008.04.240; Lasocki A, 2018, J CLIN NEUROSCI, V47, P168, DOI 10.1016/j.jocn.2017.09.007; Latini F, 2017, CLIN NEURORADIOL, V27, P145, DOI 10.1007/s00062-015-0481-0; Latini F, 2017, BRAIN RES, V1675, P102, DOI 10.1016/j.brainres.2017.09.005; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Mandonnet E, 2006, J NEURO-ONCOL, V78, P179, DOI 10.1007/s11060-005-9084-y; Martino J, 2015, J NEUROSURG, V123, P1081, DOI 10.3171/2014.11.JNS141992; Meola A, 2016, NEUROSURGERY, V79, P437, DOI 10.1227/NEU.0000000000001224; Mori S., 2005, MRI ATLAS HUMAN WHIT; Nakamura H, 2011, INT J CLIN ONCOL, V16, P314, DOI 10.1007/s10147-010-0178-y; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI [10.1093/neuonc/noab200, 10.1093/neuonc/nov189, 10.1093/neuonc/noaa200]; Pallud J, 2014, BRAIN, V137, P449, DOI 10.1093/brain/awt345; Pallud J, 2013, NEURO-ONCOLOGY, V15, P595, DOI 10.1093/neuonc/nos331; Pallud J, 2010, ANN NEUROL, V68, P727, DOI 10.1002/ana.22106; Parisot S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144200; Potgieser ARE, 2014, CLIN NEUROL NEUROSUR, V124, P51, DOI 10.1016/j.clineuro.2014.06.009; Pujol S, 2015, J NEUROIMAGING, P1; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; Schucht P, 2013, J NEUROSURG, V119, P318, DOI 10.3171/2013.5.JNS122235; Schulter M, 2005, INT J MED ROBOT COMP, V1, P80; SCHWARTZ MS, 1991, CANCER RES, V51, P3595; Sotiropoulos SN, 2013, NEUROIMAGE, V80, P125, DOI 10.1016/j.neuroimage.2013.05.057; Swanson KR, 2000, CELL PROLIFERAT, V33, P317, DOI 10.1046/j.1365-2184.2000.00177.x; Swanson KR, 2003, J NEUROL SCI, V216, P1, DOI 10.1016/j.jns.2003.06.001; Swanson KR, 2002, BRIT J CANCER, V86, P14, DOI 10.1038/sj.bjc.6600021; Thiebaut de Schotten M, 2011, NEUROIMAGE, V54, P49, DOI 10.1016/j.neuroimage.2010.07.055; TRACQUI P, 1995, CELL PROLIFERAT, V28, P17, DOI 10.1111/j.1365-2184.1995.tb00036.x; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Verhoeven JS, 2010, HUM BRAIN MAPP, V31, P470, DOI 10.1002/hbm.20880; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713; Yeh FC, 2011, NEUROIMAGE, V58, P91, DOI 10.1016/j.neuroimage.2011.06.021; Zetterling M, 2016, J NEUROSURG, V125, P1155, DOI 10.3171/2015.10.JNS15583	59	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211243	10.1371/journal.pone.0211243	http://dx.doi.org/10.1371/journal.pone.0211243			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677090	Green Published, gold, Green Submitted			2022-12-26	WOS:000456700400066
J	Mai, ZL; Li, XX; Jiang, CH; Liu, YD; Chen, YW; Wu, WQ; Zeng, G				Mai, Zanlin; Li, Xiaoxia; Jiang, Chonghe; Liu, Yongda; Chen, Yiwen; Wu, Wenqi; Zeng, Guohua			Comparison of metabolic changes for stone risks in 24-hour urine between non- and postmenopausal women	PLOS ONE			English	Article							KIDNEY-STONES; MAGNESIUM; CALCIUM; PREVALENCE; ESTROGEN; EXCRETION; CITRATE; TRENDS	Background To explore the differences of 24-hour urine compositions associated with urolithiasis between non-and postmenopausal females. Methods The 24-hour urine samples of female participants were collected from May 2013 to July 2014 along with national cross-sectional study of urolithiasis among adults aged >= 18 years in China. The exclusion criteria for the participants were: serum creatinine > 133 mu mol/L, with urinary tract infection, gout, hyperthyroidism, malignancy, had a history of cancer, kidney stones, enterectomy, had taken thiazide diuretics, allopurinol, vitamin supplement, potassium citrate or calcium supplements during the past two weeks. The compositions associated with urinary stone in 24-hour urine were measured and compared between non-and postmenopausal women. Results A total of 603 24-hour urine samples of female participants were analyzed. 354 women with a mean age of 52.5 +/- 14.03 (range 19-84) years met the criteria, including 160 non-menopausal women and 194 postmenopausal women. Compared to the non-menopausal women, postmenopausal women had a lower secretion of citrate (p = 0.043), magnesium (p = 0.001) and creatinine (p = 0.001) in 24h urine. Multivariate linear regression analysis showed that the menopause status was associated with the changes in magnesium (p = 0.003) and creatinine (p = 0.002) secretion, whereas not with the changes in citrate (p = 0.402) secretion. Conclusions Postmenopausal women have a significant lower secretion of magnesium in their 24-hour urine than non-menopausal ones. We suppose that might be associated with increased risk of urinary stone formation among postmenopausal women.	[Mai, Zanlin; Liu, Yongda; Chen, Yiwen; Wu, Wenqi; Zeng, Guohua] Guangzhou Med Univ, Affiliated Hosp 1, Minimally Invas Surg Ctr, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Mai, Zanlin; Li, Xiaoxia; Liu, Yongda; Chen, Yiwen; Wu, Wenqi; Zeng, Guohua] Guangdong Key Lab Urol, Guangzhou, Guangdong, Peoples R China; [Li, Xiaoxia] Guangzhou Med Univ, Affiliated Hosp 1, Minimally Invas Surg Ctr, Dept Intens Care Unit, Guangzhou, Guangdong, Peoples R China; [Jiang, Chonghe] Guangzhou Med Univ, Affiliated Hosp 6, Dept Urol, Qingyuan, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University	Zeng, G (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Minimally Invas Surg Ctr, Dept Urol, Guangzhou, Guangdong, Peoples R China.; Zeng, G (corresponding author), Guangdong Key Lab Urol, Guangzhou, Guangdong, Peoples R China.	wwqwml@163.com; gzgyzgh@vip.sina.com			National Natural Science Foundation of China [81370804, 81670643]; Science and Technology Project in Guangdong, China [2014A020209085]; Guangzhou Science Technology and Innovation Commission [201604020001, 201704020193]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project in Guangdong, China; Guangzhou Science Technology and Innovation Commission	This work was financed by grants from National Natural Science Foundation of China (No. 81370804 and No. 81670643), http://www.nsfc.gov.cn/; the Science and Technology Project in Guangdong, China (No. 2014A020209085), http://www.gdstc.gov.cn/and Guangzhou Science Technology and Innovation Commission (No. 201604020001 and No. 201704020193) http://www.gzsi.gov.cn/.	Aydin H, 2010, BIOL TRACE ELEM RES, V133, P136, DOI 10.1007/s12011-009-8416-8; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Classen H G, 1990, Fortschr Med, V108, P198; Curhan GC, 2001, KIDNEY INT, V59, P2290, DOI 10.1046/j.1523-1755.2001.0590062290.x; Dey J, 2002, J UROLOGY, V167, P169, DOI 10.1016/S0022-5347(05)65405-5; Ganz PA, 2005, AM J MED, V118, P1410, DOI 10.1016/j.amjmed.2005.10.024; Ghanchilar N, 2005, J TABRIZ U MED SCI, V37, P54; Grober U, 2015, NUTRIENTS, V7, P8199, DOI 10.3390/nu7095388; HALLSON PC, 1982, CLIN SCI, V62, P17, DOI 10.1042/cs0620017; HEYMSFIELD SB, 1983, AM J CLIN NUTR, V37, P478, DOI 10.1093/ajcn/37.3.478; Hong YH, 2010, UROLOGY, V75, P1294, DOI 10.1016/j.urology.2009.08.061; Jahnen-Dechent W, 2012, CLIN KIDNEY J, V5, P3, DOI 10.1093/ndtplus/sfr163; Jaszmann L.J.B., 1976, MANAGEMENT MENOPAUSE, P11; Kramer HJM, 2003, J AM SOC NEPHROL, V14, P1272, DOI 10.1097/01.ASN.0000060682.25472.C3; LINDSAY R, 1980, CLIN SCI, V58, P255, DOI 10.1042/cs0580255; NICAR MJ, 1983, UROLOGY, V21, P8, DOI 10.1016/0090-4295(83)90113-9; Nordin BEC, 1999, OSTEOPOROSIS INT, V9, P351, DOI 10.1007/s001980050158; NORMAN RW, 1984, J UROLOGY, V132, P1137, DOI 10.1016/S0022-5347(17)50064-6; Padubidri VG, 2004, SHAWS TXB GYNECOLOGY, P56; Rude RK, 2012, MODERN NUTR HLTH DIS, P159; Sonu Y, 2016, INDIAN J CLIN BIOCHE, V31, P326, DOI 10.1007/s12291-015-0532-y; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; Tiselius HG, 2002, ENDOCRIN METAB CLIN, V31, P1031, DOI 10.1016/S0889-8529(02)00027-0; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Yasui T, 2008, UROLOGY, V71, P209, DOI 10.1016/j.urology.2007.09.034; Zeng GH, 2017, BJU INT, V120, P109, DOI 10.1111/bju.13828; Zhu W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150006	27	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0208893	10.1371/journal.pone.0208893	http://dx.doi.org/10.1371/journal.pone.0208893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677034	Green Submitted, Green Published, gold			2022-12-26	WOS:000456700400006
J	Infante, T; Forte, E; Schiano, C; Punzo, B; Cademartiri, F; Cavaliere, C; Salvatore, M; Napoli, C				Infante, Teresa; Forte, Ernesto; Schiano, Concetta; Punzo, Bruna; Cademartiri, Filippo; Cavaliere, Carlo; Salvatore, Marco; Napoli, Claudio			Evidence of association of circulating epigenetic-sensitive biomarkers with suspected coronary heart disease evaluated by Cardiac Computed Tomography	PLOS ONE			English	Article							BINDING PROTEIN (SREBP)-2; BLOOD MONONUCLEAR-CELLS; GENE-EXPRESSION; ARTERY-DISEASE; CT-ANGIOGRAPHY; ATHEROSCLEROSIS; PLAQUE; EXTENT; MACROPHAGES; CHALLENGES	Circulating biomarkers available in clinical practice do not allow to stratify patients with coronary heart disease (CHD) prior the onset of a clinically relevant event. We evaluated the methylation status of specific genomic segments and gene expression in peripheral blood of patients undergoing Cardiac Computed Tomography (CCT) for CHD (n = 95). We choose to investigate cholesterol metabolism. Methylation and gene expression of low density lipoprotein receptor (LDLR), sterol regulatory element-binding factor 2 (SREBF2) and ATP-binding cassette transporter 1 (ABCA1) were evaluated by qRT-PCR. Calcium score (CACS), stenosis degree, total plaque volume (TPV), calcified plaque volume (CPV), non-calcified plaque volume (NCPV) and plaque burden (PB) were assessed in all CHD patients (n = 65). The percentage of methylation at the specific analyzed segment of LDLR promoter was higher in CHD patients vs healthy subjects (HS) (n = 30) (p = 0.001). LDLR, SREBF2 and ABCA1 mRNAs were up-regulated in CHD patients vs HS (p = 0.02; p = 0.019; p = 0.008). SREBF2 was overexpressed in patients with coronary stenosis >50% vs subjects with stenosis <50% (p = 0.036). After adjustment for risk factors and clinical features, ABCA1 (p = 0.005) and SREBF2 (p = 0.010) gene expression were identified as independent predictors of CHD and severity. ROC curve analysis revealed a good performance of ABCA1 on predicting CHD (AUC = 0.768; p<0.001) and of SREBF2 for the prediction of disease severity (AUC = 0.815; p<0.001). Moreover, adjusted multivariate analysis demonstrated SREBF2 as independent predictor of CPV, NCPV and TPV (p = 0.022; p = 0.002 and p = 0.006) and ABCA1 as independent predictor of NCPV and TPV (p = 0.002 and p = 0.013). CHD presence and characteristics are related to selected circulating transcriptional and epigenetic-sensitive biomarkers linked to cholesterol pathway. More extensive analysis of CHD phenotypes and circulating biomarkers might improve and personalize cardiovascular risk stratification in the clinical settings.	[Infante, Teresa; Forte, Ernesto; Schiano, Concetta; Punzo, Bruna; Cademartiri, Filippo; Cavaliere, Carlo; Salvatore, Marco; Napoli, Claudio] IRCCS SDN, Naples, Italy; [Napoli, Claudio] Univ Campania Luigi Vanvitelli, Dept Med Surg Neurol Metab & Geriatr Sci, Naples, Italy	IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); Universita della Campania Vanvitelli	Infante, T (corresponding author), IRCCS SDN, Naples, Italy.	tinfante@sdn-napoli.it	Punzo, Bruna/Z-3067-2019; Schiano, Concetta/GOE-4310-2022; Cademartiri, Filippo/H-7336-2015; Infante, Teresa/K-8735-2016; Salvatore, Marco/K-8083-2016	Punzo, Bruna/0000-0003-0915-4682; Cademartiri, Filippo/0000-0002-0579-3279; Infante, Teresa/0000-0002-1764-9610; Salvatore, Marco/0000-0001-9734-7702	Italian Ministry of Health [GR-2011-02349436]	Italian Ministry of Health(Ministry of Health, Italy)	This study was supported by Italian Ministry of Health grants "Giovani Ricercatori 2011-12", project code GR-2011-02349436 (TI) and "Ricerca Corrente 2013-15" (CN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamberg F, 2012, INT J CARDIOVAS IMAG, V28, P183, DOI 10.1007/s10554-010-9773-2; Bobryshev YV, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9582430; Cademartiri F, 2017, HEART, V103, P975, DOI 10.1136/heartjnl-2016-310473; Canpolat U, 2013, INT J CARDIOVAS IMAG, V29, P1371, DOI 10.1007/s10554-013-0209-7; Chen HH, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0634-x; Clee SM, 2000, J CLIN INVEST, V106, P1263, DOI 10.1172/JCI10727; Dalen JE, 2014, AM J MED, V127, P807, DOI 10.1016/j.amjmed.2014.04.015; De Castro-Oros I, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-17; de Nigris F, 2018, JAMA CARDIOL, V3, P1184, DOI 10.1001/jamacardio.2018.3546; Demina EP, 2011, MOL BIOL+, V45, P258, DOI 10.1134/S0026893310061019; Duan L, 2018, GENE, V646, P91, DOI 10.1016/j.gene.2017.12.033; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Fan YM, 2008, THROMB J, V6, DOI 10.1186/1477-9560-6-17; Forte E, 2017, EUR HEART J-CARD IMG, V18, P1229, DOI 10.1093/ehjci/jew218; Forte E, 2016, SURG RADIOL ANAT, V38, P987, DOI 10.1007/s00276-016-1634-9; Friedlander Y, 2008, ATHEROSCLEROSIS, V196, P896, DOI 10.1016/j.atherosclerosis.2007.02.006; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Grimaldi V, 2015, CURR ATHEROSCLER REP, V17, DOI 10.1007/s11883-014-0476-3; Guaricci AI, 2017, EUR HEART J-CARD IMG, V18, P1049, DOI 10.1093/ehjci/jew173; Harada K, 2013, INT J CARDIOVAS IMAG, V29, P1149, DOI 10.1007/s10554-013-0181-2; Heo SH, 2018, J STROKE, V20, P80, DOI 10.5853/jos.2017.02390; Infante T, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00209; Infante T, 2017, AM J TRANSL RES, V9, P3148; Kontaraki JE, 2014, HELL J CARDIOL, V55, P119; Kunita E, 2012, CIRC J, V76, P1687, DOI 10.1253/circj.CJ-11-1442; Leipsic J, 2014, J CARDIOVASC COMPUT, V8, P342, DOI 10.1016/j.jcct.2014.07.003; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Liu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032060; Liu HF, 2012, EXP THER MED, V4, P297, DOI 10.3892/etm.2012.576; Maiwald S, 2013, CURR OPIN CLIN NUTR, V16, P411, DOI 10.1097/MCO.0b013e32836236f9; Mega JL, 2015, LANCET, V385, P2264, DOI 10.1016/S0140-6736(14)61730-X; Mirabelli P, 2017, OPEN J BIORES, V4, P2, DOI [10.5334/ojb.26, DOI 10.5334/OJB.26]; Miserez AR, 2002, ATHEROSCLEROSIS, V164, P15, DOI 10.1016/S0021-9150(01)00762-6; Mozzini C, 2014, FREE RADICAL BIO MED, V68, P178, DOI 10.1016/j.freeradbiomed.2013.12.017; Muller PY, 2002, J MED GENET, V39, P271, DOI 10.1136/jmg.39.4.271; Napoli C, 2016, WORLD J CARDIOL, V8, P211, DOI 10.4330/wjc.v8.i2.211; Napoli C, 2012, CIRCULATION, V125, P2363, DOI 10.1161/CIRCULATIONAHA.111.085787; Rienzo M, 2013, CLIN TRANSL ONCOL, V15, P211, DOI 10.1007/s12094-012-0904-1; Rizvi A, 2017, ATHEROSCLEROSIS, V258, P145, DOI 10.1016/j.atherosclerosis.2017.01.018; Romano M, 2010, ATHEROSCLEROSIS, V210, P493, DOI 10.1016/j.atherosclerosis.2009.11.051; Sato R, 2010, ARCH BIOCHEM BIOPHYS, V501, P177, DOI 10.1016/j.abb.2010.06.004; Schiano C, 2015, TRENDS PHARMACOL SCI, V36, P226, DOI 10.1016/j.tips.2015.02.005; Shchelkunova TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063374; Sinnaeve PR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007037; Song Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081148; Strang AC, 2009, AM J CARDIOL, V104, p22E, DOI 10.1016/j.amjcard.2009.09.016; Tabas I, 2017, IMMUNITY, V47, P621, DOI 10.1016/j.immuni.2017.09.008; ten Kate GJR, 2013, ATHEROSCLEROSIS, V227, P334, DOI 10.1016/j.atherosclerosis.2012.12.016; Voros S, 2014, ATHEROSCLEROSIS, V233, P284, DOI 10.1016/j.atherosclerosis.2013.12.045; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Westerterp M, 2014, CIRC RES, V114, P157, DOI 10.1161/CIRCRESAHA.114.300738; Wingrove JA, 2008, CIRC-CARDIOVASC GENE, V1, P31, DOI 10.1161/CIRCGENETICS.108.782730	52	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210909	10.1371/journal.pone.0210909	http://dx.doi.org/10.1371/journal.pone.0210909			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673762	Green Submitted, Green Published, gold			2022-12-26	WOS:000456442800057
J	Montesanto, S; Smithers, NP; Bucchieri, F; Brucato, V; La Carrubba, V; Davies, DE; Conforti, F				Montesanto, Salvatore; Smithers, Natalie P.; Bucchieri, Fabio; Brucato, Valerio; La Carrubba, Vincenzo; Davies, Donna E.; Conforti, Franco			Establishment of a pulmonary epithelial barrier on biodegradable poly-L-lactic-acid membranes	PLOS ONE			English	Article							PLLA; CULTURE; CELLS; LUNG; CARTILAGE; COLLAGEN; MODELS; GROWTH	Development of biocompatible and functional scaffolds for tissue engineering is a major challenge, especially for development of polarised epithelia that are critical structures in tissue homeostasis. Different in vitro models of the lung epithelial barrier have been characterized using non-degradable polyethylene terephthalate membranes which limits their uses for tissue engineering. Although poly-L-lactic acid (PLLA) membranes are biodegradable, those prepared via conventional Diffusion Induced Phase Separation (DIPS) lack open porous geometry and show limited permeability compromising their use for epithelial barrier studies. Here we used PLLA membranes prepared via a modification of the standard DIPS protocol to control the membrane surface morphology and permeability. These were bonded to cell culture inserts for use in barrier function studies. Pulmonary epithelial cells (H441) readily attached to the PLLA membranes and formed a confluent cell layer within two days. This was accompanied by a significant increase in trans-epithelial electrical resistance and correlated with the formation of tight junctions and vectorial cytokine secretion in response to TNF alpha. Our data suggest that a structurally polarized and functional epithelial barrier can be established on PLLA membranes produced via a non-standard DIPS protocol. Therefore, PLLA membranes have potential utility in lung tissue engineering applications requiring bio-absorbable membranes.	[Montesanto, Salvatore; Smithers, Natalie P.; Davies, Donna E.; Conforti, Franco] Univ Southampton, Fac Med, Brooke Lab Clin & Expt Sci, Southampton, Hants, England; [Montesanto, Salvatore; Brucato, Valerio; La Carrubba, Vincenzo] Univ Palermo, Dept Civil Environm Aerosp Mat Engn DICAM, Palermo, Italy; [Bucchieri, Fabio] Univ Palermo, Dept Expt Biomed & Clin Neurosci BIONEC, Palermo, Italy; [Brucato, Valerio; La Carrubba, Vincenzo] Interuniv Consortium Mat Sci & Technol INSTM, Res Unit Palermo, Palermo, Italy; [Davies, Donna E.; Conforti, Franco] Univ Hosp Southampton, NIHR Resp Biomed Res Unit, Southampton, Hants, England	University of Southampton; University of Palermo; University of Palermo	Conforti, F (corresponding author), Univ Southampton, Fac Med, Brooke Lab Clin & Expt Sci, Southampton, Hants, England.; Conforti, F (corresponding author), Univ Hosp Southampton, NIHR Resp Biomed Res Unit, Southampton, Hants, England.	F.Conforti@soton.ac.uk		BUCCHIERI, Fabio/0000-0002-0209-8668; Conforti, Franco/0000-0001-5305-3155; Davies, Donna/0000-0002-5117-2991; La Carrubba, Vincenzo/0000-0002-3185-8398	Medical Research Foundation [MRF-091-0003-RG-CONFO]; Medical Research Council [MRC-G0900453]; British Lung Foundation [IPFPG12-2]; MRC [G0900453] Funding Source: UKRI	Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Lung Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Medical Research Foundation (MRF-091-0003-RG-CONFO to F.C.), Medical Research Council (MRC-G0900453 to D.E.D.) and the British Lung Foundation (IPFPG12-2 to D.E.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blume C, 2015, TISSUE BARRIERS, V3, DOI 10.1080/15476286.2015.1062316; Brouwer KM, 2013, AM J RESP CRIT CARE, V187, P468, DOI 10.1164/rccm.201208-1558PP; Brune K, 2015, AM J PHYSIOL-LUNG C, V308, pL731, DOI 10.1152/ajplung.00309.2014; Cao Y, 1997, PLAST RECONSTR SURG, V100, P3; Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001; Chow AWM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012091; Davies Donna E, 2014, Ann Am Thorac Soc, V11 Suppl 5, pS244, DOI 10.1513/AnnalsATS.201407-304AW; Francois S, 2009, ACTA BIOMATER, V5, P2418, DOI 10.1016/j.actbio.2009.03.013; Goncalves F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152412; Gordon S, 2015, ALTEX-ALTERN ANIM EX, V32, P327, DOI 10.14573/altex.1510051; GRANGER DN, 1994, J LEUKOCYTE BIOL, V55, P662, DOI 10.1002/jlb.55.5.662; Granger DN, 2010, INFLAMMATION MICROCI, DOI DOI 10.4199/C00013ED1V01Y201006ISP008; Guillen GR, 2011, IND ENG CHEM RES, V50, P3798, DOI 10.1021/ie101928r; Hardyman MA, 2013, J ALLERGY CLIN IMMUN, V132, P665, DOI 10.1016/j.jaci.2013.03.005; Hermanns MI, 2010, J R SOC INTERFACE, V7, pS41, DOI 10.1098/rsif.2009.0288.focus; Hiemstra PS, 2015, EUR RESPIR J, V45, P1150, DOI 10.1183/09031936.00141514; Higuita-Castro N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12044-9; Holmes AM, 2011, DRUG DISCOV TODAY, V16, P659, DOI 10.1016/j.drudis.2011.05.014; KWON OJ, 1994, AM J PHYSIOL-LUNG C, V267, pL398, DOI 10.1152/ajplung.1994.267.4.L398; Lo CM, 1999, EXP CELL RES, V250, P576, DOI 10.1006/excr.1999.4538; Loxham M, 2017, J ALLERGY CLIN IMMUN, V139, P1736, DOI 10.1016/j.jaci.2017.04.005; Ma ZW, 2005, BIOMATERIALS, V26, P1253, DOI 10.1016/j.biomaterials.2004.04.031; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Montesanto S, 2016, MAT SCI ENG C-MATER, V69, P841, DOI 10.1016/j.msec.2016.07.030; Montesanto S, 2015, AIP CONF PROC, V1695, DOI 10.1063/1.4937319; Montesanto S, 1695, BIOL EVALUATION PLLA, DOI [10.1063/1.4937319, DOI 10.1063/1.4937319]; Montesanto S, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.42151; Ostwald J, 2003, LARYNGO RHINO OTOL, V82, P693; Pavia FC, 2013, POLYM ENG SCI, V53, P431, DOI 10.1002/pen.23273; Saini P, 2016, ADV DRUG DELIVER REV, V107, P47, DOI 10.1016/j.addr.2016.06.014; Salomon JJ, 2014, MOL PHARMACEUT, V11, P995, DOI 10.1021/mp4006535; Santos AR, 2001, ARTIF ORGANS, V25, P7, DOI 10.1046/j.1525-1594.2001.025001007.x; Schindler M, 2006, CELL BIOCHEM BIOPHYS, V45, P215, DOI 10.1385/CBB:45:2:215; Selvam S, 2009, TISSUE ENG PART C-ME, V15, P463, DOI 10.1089/ten.tec.2008.0431; Vandamme TF, 2014, J PHARM BIOALLIED SC, V6, P2, DOI 10.4103/0975-7406.124301; Whitsett JA, 2015, NAT IMMUNOL, V16, P27, DOI 10.1038/ni.3045; Williams JM, 2015, VET PATHOL, V52, P445, DOI 10.1177/0300985814559404; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Xing Q, 2013, POLYMER, V54, P5965, DOI 10.1016/j.polymer.2013.08.007; Zhu YB, 2004, J BIOMED MATER RES A, V69A, P436, DOI 10.1002/jbm.a.30007	41	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210830	10.1371/journal.pone.0210830	http://dx.doi.org/10.1371/journal.pone.0210830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653572	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000456015500077
J	Monczak, A; Ji, YM; Soueidan, J; Montie, EW				Monczak, Agnieszka; Ji, Yiming; Soueidan, Jamileh; Montie, Eric W.			Automatic detection, classification, and quantification of sciaenid fish calls in an estuarine soundscape in the Southeast United States	PLOS ONE			English	Article							PASSIVE ACOUSTICS; SONIFEROUS FISH; MECHANISM; HABITATS; WEAKFISH; MODEL; RIVER; GULF	In the Southeast USA, major contributors to estuarine soundscapes are the courtship calls produced by fish species belonging to the family Sciaenidae. Long-term monitoring of sciaenid courtship sounds may be valuable in understanding reproductive phenology, but this approach produces massive acoustic datasets. With this in mind, we designed a feature-based, signal detector for sciaenid fish calls and tested the efficacy of this detector against manually reviewed data. Acoustic recorders were deployed to collect sound samples for 2 min every 20 min at four stations in the May River estuary, South Carolina, USA from February to November, 2014. Manual analysis of acoustic files revealed that four fish species, belonging to the family Sciaenidae, were the major sound producers in this estuarine soundscape, and included black drum (Pogonias cromis), silver perch (Bairdiella chrysoura), spotted seatrout (Cynoscion nebulosus), and red drum (Sciaenops ocellatus). Recorded calls served as an acoustic library of signature features that were used to create a signal detector to automatically detect, classify, and quantify the number of calls in each acoustic file. Correlation between manual and automatic detection was significant and precision varied from 61% to 100%. Automatic detection provided quantitative data on calling rates for this long-term data set. Positive temperature anomalies increased calling rates of black drum, silver perch, and spotted seatrout, while negative anomalies increased calling rates of red drum. Acoustic monitoring combined with automatic detection could be an additional or alternative method for monitoring sciaenid spawning and changes in phenology associated with climate change.	[Monczak, Agnieszka; Soueidan, Jamileh; Montie, Eric W.] Univ South Carolina Beaufort, Dept Nat Sci, Bluffton, SC 29909 USA; [Ji, Yiming] Univ South Carolina Beaufort, Dept Math & Computat Sci, Bluffton, SC USA		Montie, EW (corresponding author), Univ South Carolina Beaufort, Dept Nat Sci, Bluffton, SC 29909 USA.	emontie@uscb.edu		Montie, Eric/0000-0003-4568-4963	ASPIRE II grant from the University of South Carolina; Palmetto Bluff Conservancy; Sea Island Institute of the University of South Carolina Beaufort; Port Royal Sound Foundation	ASPIRE II grant from the University of South Carolina; Palmetto Bluff Conservancy; Sea Island Institute of the University of South Carolina Beaufort; Port Royal Sound Foundation	This work was supported primarily by an ASPIRE II grant from the University of South Carolina and the Palmetto Bluff Conservancy. The Sea Island Institute of the University of South Carolina Beaufort and the Port Royal Sound Foundation provided additional funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo MA, 2009, ECOL INFORM, V4, P206, DOI 10.1016/j.ecoinf.2009.06.005; Amorim MCP, 2008, J FISH BIOL, V73, P1267, DOI 10.1111/j.1095-8649.2008.01974.x; Baumann-Pickering S, 2013, J ACOUST SOC AM, V134, P2293, DOI 10.1121/1.4817832; Baumgartner MF, 2011, J ACOUST SOC AM, V129, P2889, DOI 10.1121/1.3562166; Bittle M., 2013, P ANN C AUSTR AC SOC, P208; Bohnenstiehl DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0143691; Brown JC, 2010, J ACOUST SOC AM, V3, P93; Brown JC, 2009, J ACOUST SOC AM, V125, pEL221, DOI 10.1121/1.3124659; Butler J, 2016, J EXP MAR BIOL ECOL, V479, P89, DOI 10.1016/j.jembe.2016.03.006; Connaughton MA, 2000, J EXP BIOL, V203, P1503; Deecke VB, 2006, J ACOUST SOC AM, V119, P645, DOI 10.1121/1.2139067; Dugan PJ, APPL TECHN C LISAT 2, P1; Eggleston DB, 1998, MAR ECOL PROG SER, V174, P33, DOI 10.3354/meps174033; Erbe C, 2008, J ACOUST SOC AM, V124, P2833, DOI 10.1121/1.2982368; Frasier KE, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005823; Ghasemi A, 2012, INT J ENDOCRINOL MET, V10, P486, DOI 10.5812/ijem.3505; JOHNSON MW, 1947, BIOL BULL, V93, P122, DOI 10.2307/1538284; Jr Gilmore RG, 2003, BIOL SPOTTED SEATROU, P99; Kandia V, 2006, APPL ACOUST, V67, P1144, DOI 10.1016/j.apacoust.2006.05.007; Kim Hae-Young, 2013, Restor Dent Endod, V38, P52, DOI 10.5395/rde.2013.38.1.52; Ladich F., 2018, FISH FISH, V00, P1; Lillis A, 2014, MAR ECOL PROG SER, V505, P1, DOI 10.3354/meps10805; Lin TH, 2018, J ACOUST SOC AM, V143, pEL278, DOI 10.1121/1.5034169; Lowerre-Barbieri SK, 2008, T AM FISH SOC, V137, P562, DOI 10.1577/T04-226.1; Luczkovich JJ, 2008, T AM FISH SOC, V137, P576, DOI 10.1577/T05-290.1; Luczkovich Joseph J., 1999, Bioacoustics, V10, P143; Malfante M., 2018, J ACOUST SOC AM, V139, P2115, DOI [10.1121/1.4950295, DOI 10.1121/1.4950295]; Mann D, 2010, AQUAT BIOL, V10, P149, DOI 10.3354/ab00272; Mann David A., 1995, Bioacoustics, V6, P199; Mellinger DK, 2004, MAR MAMMAL SCI, V20, P48, DOI 10.1111/j.1748-7692.2004.tb01140.x; Monczak A, 2017, MAR ECOL PROG SER, V581, P1, DOI 10.3354/meps12322; Montie EW, 2016, J FISH BIOL, V88, P1776, DOI 10.1111/jfb.12938; Montie EW, 2017, PEERJ, V5, DOI 10.7717/peerj.2944; Montie EW, 2015, T AM FISH SOC, V144, P705, DOI 10.1080/00028487.2015.1037014; Mooney T.A., 2016, AQUAT BIOL, V24, P201; Nimon KF, 2012, FRONT PSYCHOL, V3, DOI [10.3389/fpsyg.2012.00322, 10.3389/fpsyg.2012.00102]; Pace F, 2012, P M AC 2012, V17, P70046; Pijanowski BC, 2011, BIOSCIENCE, V61, P203, DOI 10.1525/bio.2011.61.3.6; Ricci SW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182757; Ricci SW, 2016, MAR ECOL PROG SER, V550, P25, DOI 10.3354/meps11724; Roch MA, 2007, J ACOUST SOC AM, V121, P1737, DOI 10.1121/1.2400663; Rountree RA, 2006, FISHERIES, V31, P433, DOI 10.1577/1548-8446(2006)31[433:LTF]2.0.CO;2; Smott S, 2018, MAR POLLUT BULL, V133, P246, DOI 10.1016/j.marpolbul.2018.05.016; Sprague MW, 2000, J ACOUST SOC AM, V108, P2430, DOI 10.1121/1.1315296; Sprague MW, 2004, J ACOUST SOC AM, V116, P3186, DOI 10.1121/1.1802651; Stolkin R., 2007, P OCEANS 2007, P1; Stowell D, 2013, INT CONF ACOUST SPEE, P468, DOI 10.1109/ICASSP.2013.6637691; Vieira M, 2015, J ACOUST SOC AM, V138, P3941, DOI 10.1121/1.4936858; Wall CC, 2014, J FISH BIOL, V85, P1470, DOI 10.1111/jfb.12500; Walters S, 2009, T AM FISH SOC, V138, P88, DOI 10.1577/T07-106.1	50	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209914	10.1371/journal.pone.0209914	http://dx.doi.org/10.1371/journal.pone.0209914			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650120	Green Published, gold, Green Submitted			2022-12-26	WOS:000455813300034
J	Tenvooren, I; Jenks, MZ; Rashid, H; Cook, KL; Muhlemann, JK; Sistrunk, C; Holmes, J; Wang, K; Bonin, K; Hodges, K; Lo, HW; Shaikh, A; Camarillo, IG; Lelievre, SA; Seewaldt, V; Vidi, PA				Tenvooren, Iliana; Jenks, Monica Z.; Rashid, Hamza; Cook, Katherine L.; Muhlemann, Joelle K.; Sistrunk, Christopher; Holmes, Julia; Wang, Kevin; Bonin, Keith; Hodges, Kurt; Lo, Hui-Wen; Shaikh, Ayaz; Camarillo, Ignacio G.; Lelievre, Sophie A.; Seewaldt, Victoria; Vidi, Pierre-Alexandre			Elevated leptin disrupts epithelial polarity and promotes premalignant alterations in the mammary gland	ONCOGENE			English	Article							BREAST-CANCER RISK; CELL POLARITY; GROWTH-FACTOR; NUCLEAR-ORGANIZATION; SIGNALING PATHWAYS; CIRCULATING LEVELS; NORMAL-WEIGHT; OBESITY; ADIPONECTIN; AFADIN	Obesity is a highly prevalent and modifiable breast cancer risk factor. While the role of obesity in fueling breast cancer progression is well established, the mechanisms linking obesity to breast cancer initiation are poorly understood. A hallmark of breast cancer initiation is the disruption of apical polarity in mammary glands. Here we show that mice with diet-induced obesity display mislocalization of Par3, a regulator of cellular junctional complexes defining mammary epithelial polarity. We found that epithelial polarity loss also occurs in a 3D coculture system that combines acini with human mammary adipose tissue, and establish that a paracrine effect of the tissue adipokine leptin causes loss of polarity by overactivation of the PI3K/Akt pathway. Leptin sensitizes non-neoplastic cells to proliferative stimuli, causes mitotic spindle misalignment, and expands the pool of cells with stem/progenitor characteristics, which are early steps for cancer initiation. We also found that normal breast tissue samples with high leptin/adiponectin transcript ratio characteristic of obesity have an altered distribution of apical polarity markers. This effect is associated with increased epithelial cell layers. Our results provide a molecular basis for early alterations in epithelial architecture during obesity-mediated cancer initiation.	[Tenvooren, Iliana; Jenks, Monica Z.; Rashid, Hamza; Holmes, Julia; Lo, Hui-Wen; Vidi, Pierre-Alexandre] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA; [Cook, Katherine L.] Wake Forest Sch Med, Dept Surg, Winston Salem, NC 27157 USA; [Cook, Katherine L.; Vidi, Pierre-Alexandre] Wake Forest Univ, Ctr Comprehens Canc, Winston Salem, NC 27109 USA; [Muhlemann, Joelle K.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Sistrunk, Christopher; Seewaldt, Victoria] City Hope Natl Med Ctr, Dept Populat Sci, Duarte, CA 91010 USA; [Wang, Kevin; Bonin, Keith] Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA; [Hodges, Kurt] Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45219 USA; [Shaikh, Ayaz] Indiana Univ Sch Med, IU Hlth Arnett Hosp, Lafayette, IN 47905 USA; [Camarillo, Ignacio G.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Lelievre, Sophie A.] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA	Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; City of Hope; Wake Forest University; University System of Ohio; University of Cincinnati; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Vidi, PA (corresponding author), Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA.; Vidi, PA (corresponding author), Wake Forest Univ, Ctr Comprehens Canc, Winston Salem, NC 27109 USA.	pvidi@wakehealth.edu		LELIEVRE, Sophie/0000-0001-6606-2501; Muhlemann, Joelle/0000-0003-2431-4357; Sistrunk, Christopher/0000-0002-5951-1361; Cook, Katherine/0000-0001-6241-0214	National Institute of Health [R00CA163957]; Walther Cancer Foundation; Wake Forest Center for Molecular Signaling (CMS); National Cancer Institute's Cancer Center Support Grant [P30CA012197]; NATIONAL CANCER INSTITUTE [R01CA158668, R01CA192914, P30CA012197, R00CA163957] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Walther Cancer Foundation; Wake Forest Center for Molecular Signaling (CMS); National Cancer Institute's Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Kenneth Grant for assistance with electron microscopy and Dr. Fei Xing for assistance with stem cell analyses. The CA-Akt construct was a gift from Dr. Mong-Hong Lee (MD Anderson Cancer Center). NuMA B1C11 antibodies were kindly provided by Dr. J. Nickerson (University of Massachusetts). This work was funded by the National Institute of Health (R00CA163957 to PAV), the Walther Cancer Foundation (to SAL, PAV, and IGC), the Wake Forest Center for Molecular Signaling (CMS; to PAV and KB), and the National Cancer Institute's Cancer Center Support Grant award number P30CA012197 issued to the Wake Forest Baptist Comprehensive Cancer Center. SAL, VS, and PAV are members of the International Breast Cancer & Nutrition (IBCN) program.	Ando S, 2012, NAT REV ENDOCRINOL, V8, P263, DOI 10.1038/nrendo.2011.184; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Balda MS, 2000, EMBO J, V19, P2024, DOI 10.1093/emboj/19.9.2024; Bartella V, 2008, CANCER RES, V68, P4919, DOI 10.1158/0008-5472.CAN-08-0642; Bissell MJ, 1999, CANCER RES, V59, p1757S; BRIAND P, 1987, IN VITRO CELL DEV B, V23, P181, DOI 10.1007/BF02623578; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Carminati M, 2016, NAT STRUCT MOL BIOL, V23, P155, DOI 10.1038/nsmb.3152; Carpenter RL, 2015, ONCOGENE, V34, P546, DOI 10.1038/onc.2013.582; Cecchini RS, 2012, CANCER PREV RES, V5, P583, DOI 10.1158/1940-6207.CAPR-11-0482; Chandramouly G, 2007, J CELL SCI, V120, P1596, DOI 10.1242/jcs.03439; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Dietze EC, 2015, NAT REV CANCER, V15, P248, DOI 10.1038/nrc3896; Dubois V, 2014, NUTR CANCER, V66, P645, DOI 10.1080/01635581.2014.894104; Elloul S, 2014, MOL CANCER RES, V12, P464, DOI 10.1158/1541-7786.MCR-13-0398; Esper RM, 2015, CANCER PREV RES, V8, P1174, DOI 10.1158/1940-6207.CAPR-14-0334; Fan Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120775; Fang LH, 2007, CELL RES, V17, P100, DOI 10.1038/sj.cr.7310145; Feigin ME, 2014, CANCER RES, V74, P3180, DOI 10.1158/0008-5472.CAN-13-3415; Grafton MMG, 2011, INTEGR BIOL-UK, V3, P451, DOI [10.1039/c0ib00132e, 10.1039/c0ib00132c]; Grossmann ME, 2012, BIOCHIMIE, V94, P2164, DOI 10.1016/j.biochi.2012.06.013; Gunter MJ, 2009, JNCI-J NATL CANCER I, V101, P48, DOI 10.1093/jnci/djn415; Hao Y, 2010, CURR BIOL, V20, P1809, DOI 10.1016/j.cub.2010.09.032; Hu X, 2002, J NATL CANCER I, V94, P1704, DOI 10.1093/jnci/94.22.1704; Hursting SD, 2012, CANCER PREV RES, V5, P1260, DOI 10.1158/1940-6207.CAPR-12-0140; Ibarra-Drendall C, 2012, BREAST CANCER RES TR, V132, P487, DOI 10.1007/s10549-011-1609-9; Kim CS, 2006, INT J OBESITY, V30, P1347, DOI 10.1038/sj.ijo.0803259; Lelievre SA, 2010, J MAMMARY GLAND BIOL, V15, P49, DOI 10.1007/s10911-010-9168-y; Macara IG, 2014, CURR BIOL, V24, pR815, DOI 10.1016/j.cub.2014.06.068; Macis D, 2014, INT J EPIDEMIOL, V43, P1226, DOI 10.1093/ije/dyu088; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Matsubara M, 2002, EUR J ENDOCRINOL, V147, P173, DOI 10.1530/eje.0.1470173; McCaffrey LM, 2012, CANCER CELL, V22, P601, DOI 10.1016/j.ccr.2012.10.003; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Niu DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067456; Ogden Cynthia L, 2015, NCHS Data Brief, P1; Ooshio T, 2010, J BIOL CHEM, V285, P5003, DOI 10.1074/jbc.M109.043760; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Pierobon M, 2013, BREAST CANCER RES TR, V137, P307, DOI 10.1007/s10549-012-2339-3; Rangel MC, 2016, BREAST CANCER RES TR, V156, P211, DOI 10.1007/s10549-016-3746-7; Ray A, 2017, CYTOKINE GROWTH F R, V38, P80, DOI 10.1016/j.cytogfr.2017.11.002; Renehan AG, 2015, NAT REV CANCER, V15, P484, DOI 10.1038/nrc3967; Roignot J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013789; Royer C, 2011, CELL DEATH DIFFER, V18, P1470, DOI 10.1038/cdd.2011.60; Saxena NK, 2013, J MAMMARY GLAND BIOL, V18, P309, DOI 10.1007/s10911-013-9308-2; Schwartz GF, 2008, CANCER, V113, P2627, DOI 10.1002/cncr.23903; Sumis A, 2016, ENDOCR-RELAT CANCER, V23, P839, DOI 10.1530/ERC-16-0359; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Teixeira TFS, 2012, NUTR RES, V32, P637, DOI 10.1016/j.nutres.2012.07.003; Vidi Pierre-Alexandre, 2013, Methods Mol Biol, V945, P193, DOI 10.1007/978-1-62703-125-7_13; Vidi PA, 2012, J CELL SCI, V125, P350, DOI 10.1242/jcs.089177; Wang F, 2002, JNCI-J NATL CANCER I, V94, P1494, DOI 10.1093/jnci/94.19.1494; Wheatley KE, 2011, J OBES, V2011, DOI 10.1155/2011/265417; Wu MH, 2009, BRIT J CANCER, V100, P578, DOI 10.1038/sj.bjc.6604913; Xue GD, 2013, JNCI-J NATL CANCER I, V105, P393, DOI 10.1093/jnci/djs648; Zeidan A, 2007, J PHARMACOL EXP THER, V322, P1110, DOI 10.1124/jpet.107.122440	57	27	27	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 16	2019	38	20					3855	3870		10.1038/s41388-019-0687-8	http://dx.doi.org/10.1038/s41388-019-0687-8			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HY3OI	30670780	Green Accepted			2022-12-26	WOS:000468035600007
J	Gunaratna, RT; Santos, A; Luo, LJ; Nagi, C; Lambertz, I; Spier, M; Conti, CJ; Fuchs-Young, RS				Gunaratna, Ramesh T.; Santos, Andres; Luo, Linjie; Nagi, Chandandeep; Lambertz, Isabel; Spier, Madison; Conti, Claudio J.; Fuchs-Young, Robin S.			Dynamic role of the codon 72 p53 single-nucleotide polymorphism in mammary tumorigenesis in a humanized mouse model	ONCOGENE			English	Article							NF-KAPPA-B; BREAST-CANCER; CELLULAR SENESCENCE; R72P POLYMORPHISM; ANGIOGENIC SWITCH; TUMOR SUPPRESSION; ARGININE ALLELE; INFLAMMATION; EXPRESSION; ASSOCIATION	Female breast cancer (BrCa) is the most common noncutaneous cancer among women in the United States. Human epidemiological studies reveal that a p53 single-nucleotide polymorphism (SNP) at codon 72, encoding proline (P72) or arginine (R72), is associated with differential risk of several cancers, including BrCa. However, the molecular mechanisms by which these variants affect mammary tumorigenesis remain unresolved. To investigate the effects of this polymorphism on susceptibility to mammary cancer, we used a humanized p53 mouse model, homozygous for either P72 or R72. Our studies revealed that R72 mice had a significantly higher mammary tumor incidence and reduced latency in both DMBAinduced and MMTV-Erbb2/Neu mouse mammary tumor models compared to P72 mice. Analyses showed that susceptible mammary glands from E-R72 (R72 x MMTV-Erbb2/Neu) mice developed a senescence-associated secretory phenotype (SASP) with influx of proinflammatory macrophages, ultimately resulting in chronic, protumorigenic inflammation. Mammary tumors arising in E-R72 mice also had an increased influx of tumor-associated macrophages, contributing to angiogenesis and elevated tumor growth rates. These results demonstrate that the p53 R72 variant increased susceptibility to mammary tumorigenesis through chronic inflammation.	[Gunaratna, Ramesh T.; Fuchs-Young, Robin S.] Texas A&M Univ, Interdisciplinary Program Genet, College Stn, TX 77843 USA; [Gunaratna, Ramesh T.; Santos, Andres; Luo, Linjie; Lambertz, Isabel; Spier, Madison; Conti, Claudio J.; Fuchs-Young, Robin S.] Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77807 USA; [Gunaratna, Ramesh T.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Santos, Andres] Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, El Paso, TX USA; [Nagi, Chandandeep] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Conti, Claudio J.] Univ Carlos III Madrid, Dept Bioingn, Madrid, Spain; [Conti, Claudio J.] Fdn Jimenez Diaz IIS FJD, Fdn Inst Invest Sanitaria, Madrid, Spain; [Conti, Claudio J.] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Princeton University; Texas Tech University System; Texas Tech University; Baylor College of Medicine; Universidad Carlos III de Madrid; Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Fuchs-Young, RS (corresponding author), Texas A&M Univ, Interdisciplinary Program Genet, College Stn, TX 77843 USA.; Fuchs-Young, RS (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77807 USA.	fuchs-young@medicine.tamhsc.edu	Gunaratna, Ramesh/B-2256-2016	Gunaratna, Ramesh/0000-0002-8872-9984	National Institutes of Health [R01MD006228]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institutes of Health grant R01MD006228 (to RF-Y).	Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Aizat AAA, 2011, ASIAN PAC J CANCER P, V12, P2909; Alawadi S, 2011, MED ONCOL, V28, P709, DOI 10.1007/s12032-010-9505-4; Andrechek ER, 2003, CANCER RES, V63, P4920; Arendt LM, 2013, CANCER RES, V73, P6080, DOI 10.1158/0008-5472.CAN-13-0926; Azzam GA, 2011, CELL CYCLE, V10, P1352, DOI 10.4161/cc.10.9.15344; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Bergamaschi D, 2003, CANCER CELL, V3, P387, DOI 10.1016/S1535-6108(03)00079-5; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Bonafe M, 2003, CLIN CANCER RES, V9, P4860; Brady NJ, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/4549676; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Capell BC, 2016, GENE DEV, V30, P321, DOI 10.1101/gad.271882.115; Carron EC, 2017, ONCOTARGET, V8, P50731, DOI 10.18632/oncotarget.14913; Catena CS, 2015, FRONT MED-LAUSANNE, V2, DOI 10.3389/fmed.2015.00085; Cha YJ, 2018, BREAST CANCER RES TR, V170, P15, DOI 10.1007/s10549-018-4722-1; Chang SH, 2004, P NATL ACAD SCI USA, V101, P591, DOI 10.1073/pnas.2535911100; Costa Carla, 2007, Angiogenesis, V10, P149, DOI 10.1007/s10456-007-9074-0; Crespi E, 2016, CURR OPIN PHARMACOL, V31, P114, DOI 10.1016/j.coph.2016.11.004; Dakouras A, 2008, ANTICANCER RES, V28, P1039; Dastjerdi Mehdi Nikbahkt, 2011, Acta Med Iran, V49, P71; de Ostrovich KK, 2008, AM J PATHOL, V173, P824, DOI 10.2353/ajpath.2008.071005; Denisov EV, 2012, TUMOR SUPPRESSOR GEN; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Ehling J, 2014, GUT, V63, P1960, DOI 10.1136/gutjnl-2013-306294; Eren F, 2010, PATHOL ONCOL RES, V16, P563, DOI 10.1007/s12253-010-9255-9; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Frank AK, 2011, MOL CELL BIOL, V31, P1201, DOI 10.1128/MCB.01136-10; Gage M, 2012, J SURG ONCOL, V105, P444, DOI 10.1002/jso.21856; Garcia PB, 2014, SEMIN CELL DEV BIOL, V27, P74, DOI 10.1016/j.semcdb.2013.12.014; Georgakopoulou EA, 2013, AGING-US, V5, P37; Grochola LF, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001032; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Howe LR, 2005, CANCER RES, V65, P10113, DOI 10.1158/0008-5472.CAN-05-1524; Hursting SD, 2011, CANCER PREV RES, V4, P285, DOI 10.1158/1940-6207.CAPR-11-0056; Jackson JG, 2006, CANCER RES, V66, P8356, DOI 10.1158/0008-5472.CAN-06-1752; Jiang XG, 2014, MOL CELL ENDOCRINOL, V382, P673, DOI 10.1016/j.mce.2013.06.003; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Koutras A, 2015, PHARMACOGENOMICS, V16, P79, DOI [10.2217/PGS.14.148, 10.2217/pgs.14.148]; Kung CP, 2016, CELL REP, V14, P2413, DOI 10.1016/j.celrep.2016.02.037; Kung CP, 2015, MOL CANCER RES, V13, P250, DOI 10.1158/1541-7786.MCR-14-0385; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lopez-Arribillaga E, 2015, DEVELOPMENT, V142, P41, DOI 10.1242/dev.107714; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; MEDINA D, 1974, J NATL CANCER I, V53, P213, DOI 10.1093/jnci/53.1.213; Morris PG, 2011, CANCER PREV RES, V4, P1021, DOI 10.1158/1940-6207.CAPR-11-0110; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Padala C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184448; Papadakis ED, 2002, BRIT J CANCER, V87, P1013, DOI 10.1038/sj.bjc.6600595; Park SW, 2011, LAB INVEST, V91, P63, DOI 10.1038/labinvest.2010.151; Perez LO, 2006, WORLD J GASTROENTERO, V12, P1426, DOI 10.3748/wjg.v12.i9.1426; Pim D, 2004, INT J CANCER, V108, P196, DOI 10.1002/ijc.11548; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Rijnkels M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053270; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Rogler A, 2011, PATHOBIOLOGY, V78, P193, DOI 10.1159/000326767; Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider-Stock R, 2004, NEOPLASIA, V6, P529, DOI 10.1593/neo.04178; Shaked H, 2012, P NATL ACAD SCI USA, V109, P14007, DOI 10.1073/pnas.1211509109; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Siddique M, 2006, ONCOGENE, V25, P3489, DOI 10.1038/sj.onc.1209405; Surekha D, 2011, ASIAN PAC J CANCER P, V12, P1893; Svensson S, 2015, CLIN CANCER RES, V21, P3794, DOI 10.1158/1078-0432.CCR-15-0204; Takeuchi S, 2010, CANCER RES, V70, P9381, DOI 10.1158/0008-5472.CAN-10-0801; Volodko N, 2015, WORLD J GASTROENTERO, V21, P10358, DOI 10.3748/wjg.v21.i36.10358; Yoshimura T, 2017, CYTOKINE, V98, P71, DOI 10.1016/j.cyto.2017.02.001; You W, 2018, ADV BREAST CANC RES, V7, P1, DOI DOI 10.4236/ABCR.2018.71001; Zhang ZZ, 2010, BREAST CANCER RES TR, V120, P509, DOI 10.1007/s10549-009-0480-4; Zhu F, 2010, CANCER RES, V70, P5851, DOI 10.1158/0008-5472.CAN-09-4646	76	10	10	1	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 2	2019	38	18					3535	3550		10.1038/s41388-018-0630-4	http://dx.doi.org/10.1038/s41388-018-0630-4			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HW3RI	30651598	hybrid, Green Published			2022-12-26	WOS:000466610000015
J	Li, M; Tang, Y; Li, QS; Xiao, M; Yang, YY; Wang, YL				Li, Ming; Tang, Yi; Li, Qingshu; Xiao, Ming; Yang, Yaying; Wang, Yalan			Mono-ADP-ribosylation of H3R117 traps 5mC hydroxylase TET1 to impair demethylation of tumor suppressor gene TFPI2	ONCOGENE			English	Article							COLORECTAL-CANCER; DNA METHYLATION; 5-HYDROXYMETHYLCYTOSINE; EXPRESSION; 5-CARBOXYLCYTOSINE; 5-FORMYLCYTOSINE; HYPERMETHYLATION; 5-METHYLCYTOSINE; TRANSCRIPTION; INHIBITORS	Recently, nuclear poly-ADP-ribosylation had aroused research interest in epigenetics, but little attempt to explore functions of mono-ADP-ribosylation of histone, the major formation of histone ADP-ribosylated modification. We have previously reported a novel mono-ADP-ribosylation of H3R117, which promoted proliferation of LoVo cells. Here we showed that mono-ADP-ribosylated H3R117 of LoVo cells depressed demethylation of tumor suppressor TFPI2 promoter by suppressing TET1 expression and adjusting H3K9me3 enrichment of TFPI2 promoter to attenuate affinity of TET1, besides, since high H3K27me3 level was associated with hypermethylation, mono-ADP-ribosylated-H3R117-depended-H3K27me3 of TFPI2 promoter may contribute to hypermethylation of TFPI2. However, H3R117A mutation increased poly-ADPribosylated modification of TET1 promoter not TFPI2 promoter, which resulted in boosting transcription and expression of TET1 by altering DNA methylated modification, chromatin accessibility, and histone-methylated modification of TET1 promoter, while knockout TET1 of H3R117A LoVo cells directly led to hypermethylation of TFPI2 promoter and depression of TFPI2 secretion as well as enhanced proliferation, suggested that TET1 played a key role in demethylation of TFPI2, production of TFPI2, and cell proliferation. Bioinformatics analyses reveal prevalent hypermethylation of TFPI2 was an early event in tumorigenesis of colorectal caner, and expression of TET1 and TFPI2 was positive correlation in colorectal cancer and normal tissue. These data suggested that mono-ADP-ribosylation of H3R117 upregulated methylation of TFPI2 by impact TET1, since hypermethyaltion of TFPI2 was an early event in tumorigenesis, selectively target mono-ADP-ribosylation of H3R117 deficiency could be a feasible way to block tumorigenesis of colorectal cancer.	[Li, Ming; Tang, Yi; Li, Qingshu; Xiao, Ming; Yang, Yaying; Wang, Yalan] Chongqing Med Univ, Dept Pathol, Mol Med & Canc Res Ctr, Chongqing 400016, Peoples R China	Chongqing Medical University	Wang, YL (corresponding author), Chongqing Med Univ, Dept Pathol, Mol Med & Canc Res Ctr, Chongqing 400016, Peoples R China.	wangyalan074@126.com			Science and Technology Plan Projects of Yuzhong District in Chongqing [20170409, 20140106]; Scientific Research Foundation of Chongqing Medical University [201413]	Science and Technology Plan Projects of Yuzhong District in Chongqing; Scientific Research Foundation of Chongqing Medical University	We gratefully acknowledge Professor Wei-Xue Tang (Chongqing, China) for his gift of LoVo cell line. This work was supported by the Science and Technology Plan Projects of Yuzhong District in Chongqing [grant numbers 20170409 and 20140106], and the Scientific Research Foundation of Chongqing Medical University [grant number 201413].	BURZIO LO, 1979, J BIOL CHEM, V254, P3029; Ciccarone F, 2014, ONCOTARGET, V5, P10356, DOI 10.18632/oncotarget.1905; Gao Shenglan, 2017, Cell Cycle, V16, P2249, DOI 10.1080/15384101.2017.1373223; Glockner SC, 2009, CANCER RES, V69, P4691, DOI 10.1158/0008-5472.CAN-08-0142; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hibi K, 2012, ANTICANCER RES, V32, P787; Hibi K, 2011, CANCER LETT, V311, P96, DOI 10.1016/j.canlet.2011.07.006; Hottiger MO, 2015, ANNU REV BIOCHEM, V84, P227, DOI 10.1146/annurev-biochem-060614-034506; Huang WY, 2015, NUCLEIC ACIDS RES, V43, pD856, DOI 10.1093/nar/gku1151; Ichimura N, 2015, CANCER PREV RES, V8, P702, DOI 10.1158/1940-6207.CAPR-14-0306; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Kroeze LI, 2015, BBA-REV CANCER, V1855, P144, DOI 10.1016/j.bbcan.2015.01.001; Kudo Y, 2012, CANCER SCI, V103, P670, DOI 10.1111/j.1349-7006.2012.02213.x; Li YF, 2015, EPIGENETICS-US, V10, P229, DOI 10.1080/15592294.2015.1006506; Ling F, 2017, ONCOTARGET, V8, P72773, DOI 10.18632/oncotarget.20347; Liu ZJ, 2014, CLIN CANCER RES, V20, P4598, DOI 10.1158/1078-0432.CCR-13-3380; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Martinez-Zamudio R, 2012, MOL CELL BIOL, V32, P2490, DOI 10.1128/MCB.06667-11; McInnes T, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3226-4; Neri F, 2015, ONCOGENE, V34, P4168, DOI 10.1038/onc.2014.356; Neri F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r91; Nocchi L, 2011, J BIOL CHEM, V286, P19478, DOI 10.1074/jbc.M110.217331; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Putiri EL, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r81; Rasmussen SL, 2016, COLORECTAL DIS, V18, P549, DOI 10.1111/codi.13336; Rawluszko-Wieczorek AA, 2015, J CANCER RES CLIN, V141, P1379, DOI 10.1007/s00432-014-1901-2; Robertson J, 2011, BIOCHEM BIOPH RES CO, V411, P40, DOI 10.1016/j.bbrc.2011.06.077; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Thomson JP, 2016, CANCER RES, V76, P3097, DOI 10.1158/0008-5472.CAN-15-1910; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yamaguchi H, 2018, ONCOGENE, V37, P208, DOI 10.1038/onc.2017.311; Yuan XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep20005; Zampieri M, 2012, BIOCHEM J, V441, P645, DOI 10.1042/BJ20111417; Zampieri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004717; Zhou Z, 2018, J CELL PHYSIOL, V233, P1359, DOI 10.1002/jcp.26012; 1999, BIOL CHEM, V274, P1786	40	6	7	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 2	2019	38	18					3488	3503		10.1038/s41388-018-0671-8	http://dx.doi.org/10.1038/s41388-018-0671-8			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HW3RI	30651599	hybrid, Green Published			2022-12-26	WOS:000466610000012
J	Timpano, S; Guild, BD; Specker, EJ; Melanson, G; Medeiros, PJ; Sproul, SLJ; Uniacke, J				Timpano, Sara; Guild, Brianna D.; Specker, Erin J.; Melanson, Gaelan; Medeiros, Philip J.; Sproul, Shannon L. J.; Uniacke, James			Physioxic human cell culture improves viability, metabolism, and mitochondrial morphology while reducing DNA damage	FASEB JOURNAL			English	Article						physioxia; oxygen; oxidative stress	OXIDATIVE STRESS; OXYGEN CONCENTRATION; LIFE-SPAN; HYPOXIA; TRANSLATION; LYMPHOCYTES; EXPRESSION; PROMOTER; PROTEIN	Multicellular organisms balance oxygen delivery and toxicity by having oxygen pass through several barriers before cellular delivery. In human cell culture, these physiologic barriers are removed, exposing cells to higher oxygen levels. Human cells cultured in ambient air may appear normal, but this is difficult to assess without a comparison at physiologic oxygen. Here, we examined the effects of culturing human cells throughout the spectrum of oxygen availability on oxidative damage to macromolecules, viability, proliferation, the antioxidant and DNA damage responses, metabolism, and mitochondrial fusion and morphology. We surveyed 4 human cell lines cultured for 3 d at 7 oxygen conditions between 1 and 21% O-2. We show that oxygen levels and cellular benefit are not inversely proportional, but the benefit peaks within the physioxic range. Normoxic cells are in a perpetual state of responding to damaged macromolecules and mitochondrial networks relative to physioxic cells, which could compromise an investigation. These data contribute to the concept of an optimal oxygen availability for cell culture in the physioxic range where the oxygen is not too high to reduce oxidative damage, and not too low for efficient oxidative metabolism, but just right: the Goldiloxygen zone.	[Timpano, Sara; Guild, Brianna D.; Specker, Erin J.; Melanson, Gaelan; Medeiros, Philip J.; Sproul, Shannon L. J.; Uniacke, James] Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON, Canada; [Uniacke, James] Univ British Columbia, Vancouver, BC, Canada	University of Guelph; University of British Columbia	Uniacke, J (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON, Canada.	juniacke@uoguelph.ca			Natural Sciences and Engineering Council of Canada [04807]; Natural Sciences and Engineering Council of Canada Graduate Scholarship	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Council of Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors thank Katrina Sajewycz, Maria Berliant, David Dunbar, and Ahmed Al Khalil (all of the University of Guelph) for quantification of micrographs. The authors thank James Kirkland, Scott Ryan, and Michaela Strueder-Kypke (all of the University of Guelph) for technical advice. This work was funded by Natural Sciences and Engineering Council of Canada Grant 04807 to J.U. S.T. was supported by a Natural Sciences and Engineering Council of Canada Graduate Scholarship. The authors declare no conflicts of interest.	Abu-Amero KK, 2005, ARCH PATHOL LAB MED, V129, P1295; Al-Mehdi AB, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002712; Antoniali G, 2014, ANTIOXID REDOX SIGN, V20, P621, DOI 10.1089/ars.2013.5491; Atkuri KR, 2007, P NATL ACAD SCI USA, V104, P4547, DOI 10.1073/pnas.0611732104; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Clanton TL, 2007, J APPL PHYSIOL, V102, P2379, DOI 10.1152/japplphysiol.01298.2006; COOPER PD, 1958, NATURE, V182, P1508, DOI 10.1038/1821508b0; Gonzalez-Pinzon R, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG001965; Hermes-Lima M, 2002, COMP BIOCHEM PHYS C, V133, P537, DOI 10.1016/S1532-0456(02)00080-7; Ho JJD, 2016, CELL REP, V14, P1293, DOI 10.1016/j.celrep.2016.01.036; Hsia CCW, 2013, COMPR PHYSIOL, V3, P849, DOI 10.1002/cphy.c120003; Iordanov MS, 2000, CANCER RES, V60, P1983; Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3; Jendrach M, 2008, MITOCHONDRION, V8, P293, DOI 10.1016/j.mito.2008.06.001; Junop MS, 2000, EMBO J, V19, P5962, DOI 10.1093/emboj/19.22.5962; Keeley TP, 2019, PHYSIOL REV, V99, P161, DOI 10.1152/physrev.00041.2017; Keeley TP, 2017, FASEB J, V31, P5172, DOI 10.1096/fj.201700211R; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Leone A, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/2597581; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Liu ZW, 2013, CANCER BIOL THER, V14, P428, DOI 10.4161/cbt.23786; Mahalingaiah PKS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087371; Marzony ET, 2016, EXP LUNG RES, V42, P275, DOI 10.1080/01902148.2016.1205336; Marzony ET, 2016, EXP LUNG RES, V42, P217, DOI 10.1080/01902148.2016.1194501; McCarron JG, 2013, J VASC RES, V50, P357, DOI 10.1159/000353883; Miyazono Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18582-6; Morelra PI, 2008, FREE RADICAL BIO MED, V44, P1493, DOI 10.1016/j.freeradbiomed.2008.01.002; Mukherjee A, 2015, NEOPLASIA, V17, P723, DOI 10.1016/j.neo.2015.09.003; Newby D, 2005, PLACENTA, V26, P353, DOI 10.1016/j.placenta.2004.07.002; PACKER L, 1977, NATURE, V267, P423, DOI 10.1038/267423a0; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Pastukh V, 2015, AM J PHYSIOL-LUNG C, V309, pL1367, DOI 10.1152/ajplung.00236.2015; Rafelski SM, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-71; Ricciardi A, 2014, ANN MICROBIOL, V64, P1861, DOI 10.1007/s13213-014-0819-x; RICHTER A, 1972, J NATL CANCER I, V49, P1705, DOI 10.1093/jnci/49.6.1705; Rojo AI, 2004, J NEUROSCI, V24, P7324, DOI 10.1523/JNEUROSCI.2111-04.2004; Soldatenkov VA, 1999, ONCOGENE, V18, P3954, DOI 10.1038/sj.onc.1202778; Timpano S, 2016, J BIOL CHEM, V291, P10772, DOI 10.1074/jbc.M116.717363; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Zhou XL, 2016, CELL SIGNAL, V28, P1163, DOI 10.1016/j.cellsig.2016.05.021	44	9	9	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5716	5728		10.1096/fj.201802279R	http://dx.doi.org/10.1096/fj.201802279R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30649960				2022-12-26	WOS:000462888500086
J	Yam, KY; Schipper, L; Reemst, K; Ruigrok, SR; Abbink, MR; Hoeijmakers, L; Naninck, EFG; Zarekiani, P; Oosting, A; Van der Beek, EM; Lucassen, PJ; Korosi, A				Yam, Kit-Yi; Schipper, Lidewij; Reemst, Kitty; Ruigrok, Silvie R.; Abbink, Maralinde R.; Hoeijmakers, Lianne; Naninck, Eva F. G.; Zarekiani, Parand; Oosting, Annemarie; Van der Beek, Eline M.; Lucassen, Paul J.; Korosi, Aniko			Increasing availability of omega-3 fatty acid in the early-life diet prevents the early-life stress-induced cognitive impairments without affecting metabolic alterations	FASEB JOURNAL			English	Article						neurogenesis; cognition; metabolism; long-chain polyunsaturated fatty acids; microglia	POLYUNSATURATED FATTY-ACIDS; ALPHA-LINOLENIC ACID; N-3 PUFAS DEFICIENCY; INSULIN-RESISTANCE; HIPPOCAMPAL NEUROGENESIS; BRAIN-DEVELOPMENT; LASTINGLY ALTERS; ADIPOSE-TISSUE; MOUSE MODEL; LACTATION	Exposure to early-life stress (ES) is associated with cognitive and metabolic deficits in adulthood. The role of early nutrition in programming these long-term effects is largely unknown. We focused on essential omega-3 and omega-6 long-chain polyunsaturated fatty acids (LCPUFA) and investigated whether ES affects central and peripheral FA profiles, as well as if and how an early diet with increased availability of omega-3 LCPUFA (via lowering omega-6/omega-3 ratio) protects against ES-induced impairments. ES exposure [limited nesting and bedding paradigm from postnatal day (P)2 to P9] altered central and peripheral FA profiles in mice. An early diet with low omega-6/omega-3 ratio from P2 to P42 notably prevented the ES-induced cognitive impairments, and the alterations in hippocampal newborn cell survival and in CD68(+) microglia, without affecting the ES-induced metabolic alterations. Other markers for hippocampal plasticity, apoptosis, and maternal care were unaffected by ES or diet. Our findings highlight the importance of early dietary lipid quality for later cognition in ES-exposed populations.	[Yam, Kit-Yi; Reemst, Kitty; Ruigrok, Silvie R.; Abbink, Maralinde R.; Hoeijmakers, Lianne; Naninck, Eva F. G.; Zarekiani, Parand; Lucassen, Paul J.; Korosi, Aniko] Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands; [Schipper, Lidewij; Oosting, Annemarie; Van der Beek, Eline M.] Danone Nutr Res, Utrecht, Netherlands; [Van der Beek, Eline M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands	University of Amsterdam; Danone Nutricia; University of Groningen	Korosi, A (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands.	a.korosi@uva.nl	Lucassen, Paul/ABA-3113-2020	Lucassen, Paul/0000-0001-9708-9133; Yam, Kit-Yi/0000-0002-9181-5605; Zarekiani, Parand/0000-0001-7760-7247; Korosi, Aniko/0000-0001-9701-3331	JPI CogniPlast; Nederlands Organisatie voor Wetenschappelijk Onderzoek (NWO)-Meervoud; Alzheimer Nederland; Danone Nutricia Research; NWO Food, Cognition, and Brain Grant	JPI CogniPlast; Nederlands Organisatie voor Wetenschappelijk Onderzoek (NWO)-Meervoud(Netherlands Organization for Scientific Research (NWO)); Alzheimer Nederland; Danone Nutricia Research(Danone Nutricia); NWO Food, Cognition, and Brain Grant	A.K. is supported by JPI CogniPlast, Nederlands Organisatie voor Wetenschappelijk Onderzoek (NWO)-Meervoud, and the NWO Food, Cognition, and Brain Grant. P.J.L. is supported by Alzheimer Nederland. This work received cofunding from Danone Nutricia Research, employer of L.S., A.O., and E.M.V.D.B. The authors declare no conflicts of interest.	Abbink MR, 2017, HIPPOCAMPUS, V27, P839, DOI 10.1002/hipo.22745; Ailhaud G, 2006, PROG LIPID RES, V45, P203, DOI 10.1016/j.plipres.2006.01.003; Aizawa F, 2016, BIOL PHARM BULL, V39, P1100, DOI 10.1248/bpb.b15-01037; Bernardi JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062031; Bertrand PC, 2006, J NUTR, V136, P1570, DOI 10.1093/jn/136.6.1570; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brenna JT, 2011, MATERN CHILD NUTR, V7, P59, DOI 10.1111/j.1740-8709.2011.00301.x; Carlson SE, 1999, LIPIDS, V34, P171, DOI 10.1007/s11745-999-0351-2; Chistiakov DA, 2017, LAB INVEST, V97, P4, DOI 10.1038/labinvest.2016.116; Choi SS, 2008, CURR OPIN LIPIDOL, V19, P295, DOI 10.1097/MOL.0b013e3282ff5e55; Chugani HT, 2001, NEUROIMAGE, V14, P1290, DOI 10.1006/nimg.2001.0917; Clarke G, 2009, BEHAV BRAIN RES, V205, P319, DOI 10.1016/j.bbr.2009.07.008; Dalli J, 2018, CURR OPIN IMMUNOL, V50, P48, DOI 10.1016/j.coi.2017.10.007; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Delarue J, 2004, REPROD NUTR DEV, V44, P289, DOI 10.1051/rnd:2004033; Delpech JC, 2015, NEUROPSYCHOPHARMACOL, V40, P2774, DOI 10.1038/npp.2015.127; Diniz BS, 2012, J PSYCHIATR RES, V46, P1081, DOI 10.1016/j.jpsychires.2012.04.028; Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025; Ekdahl CT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00041; El-Badry AM, 2007, J HEPATOL, V47, P718, DOI 10.1016/j.jhep.2007.08.005; Fan CN, 2016, NUTR RES, V36, P1013, DOI 10.1016/j.nutres.2016.06.005; Farr OM, 2015, METABOLISM, V64, P114, DOI 10.1016/j.metabol.2014.07.004; Ferreira CF, 2013, PHARMACOL BIOCHEM BE, V107, P11, DOI 10.1016/j.pbb.2013.03.006; Gibson RA, 2011, MATERN CHILD NUTR, V7, P17, DOI 10.1111/j.1740-8709.2011.00299.x; Green P, 1998, J NEUROSCI RES, V52, P129, DOI 10.1002/(SICI)1097-4547(19980415)52:2<129::AID-JNR1>3.0.CO;2-C; Guilloux JP, 2011, J NEUROSCI METH, V197, P21, DOI 10.1016/j.jneumeth.2011.01.019; Guo M, 2013, INT J NEUROPSYCHOPH, V16, P857, DOI 10.1017/S1461145712000703; Harauma A, 2011, LIPIDS, V46, P409, DOI 10.1007/s11745-010-3523-z; He CW, 2009, P NATL ACAD SCI USA, V106, P11370, DOI 10.1073/pnas.0904835106; Hoeijmakers L, 2017, BRAIN BEHAV IMMUN, V63, P160, DOI 10.1016/j.bbi.2016.12.023; Innis SM, 2008, BRAIN RES, V1237, P35, DOI 10.1016/j.brainres.2008.08.078; Janssen CIF, 2015, J NUTR BIOCHEM, V26, P24, DOI 10.1016/j.jnutbio.2014.08.002; Jen KLC, 2009, PHYSIOL BEHAV, V98, P17, DOI 10.1016/j.physbeh.2009.03.031; Joffre C, 2014, PROSTAG LEUKOTR ESS, V91, P1, DOI 10.1016/j.plefa.2014.05.001; Jumpsen J, 1997, J NUTR, V127, P724, DOI 10.1093/jn/127.5.724; Korosi A, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.027.2009; Korotkova M, 2001, J LIPID RES, V42, P359; Lajud N, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00003; Larrieu T, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.77; Lauritzen L, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010006; Loi M, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00013; Lombardo YB, 2006, J NUTR BIOCHEM, V17, P1, DOI 10.1016/j.jnutbio.2005.08.002; Lucassen PJ, 2013, TRENDS NEUROSCI, V36, P621, DOI 10.1016/j.tins.2013.08.002; Madore C, 2014, BRAIN BEHAV IMMUN, V41, P22, DOI 10.1016/j.bbi.2014.03.021; Maniam J, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00073; Mathieu G, 2008, PROSTAG LEUKOTR ESS, V78, P391, DOI 10.1016/j.plefa.2008.05.003; Mathieu G, 2011, PROSTAG LEUKOTR ESS, V85, P129, DOI 10.1016/j.plefa.2011.07.001; McNamara RK, 2006, PROSTAG LEUKOTR ESS, V75, P329, DOI 10.1016/j.plefa.2006.07.010; Mennitti LV, 2015, J NUTR BIOCHEM, V26, P99, DOI 10.1016/j.jnutbio.2014.10.001; Milaneschi Y, 2017, BIOL PSYCHIAT, V81, P807, DOI 10.1016/j.biopsych.2015.10.023; Muhlhausler Beverly Sara, 2011, Frontiers in Genetics, V2, P48, DOI 10.3389/fgene.2011.00048; Murphy MO, 2017, AM J PHYSIOL-REG I, V313, pR1, DOI 10.1152/ajpregu.00185.2016; Naninck EFG, 2017, FASEB J, V31, P505, DOI 10.1096/fj.201600834R; Naninck EFG, 2015, HIPPOCAMPUS, V25, P309, DOI 10.1002/hipo.22374; Niculescu MD, 2011, INT J DEV NEUROSCI, V29, P795, DOI 10.1016/j.ijdevneu.2011.09.006; Oosting A, 2015, NUTR RES, V35, P800, DOI 10.1016/j.nutres.2015.06.010; Oosting A, 2010, PEDIATR RES, V68, P494, DOI 10.1203/PDR.0b013e3181f74940; Orr SK, 2013, PROSTAG LEUKOTR ESS, V88, P97, DOI 10.1016/j.plefa.2012.05.008; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pusceddu MM, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw078; Rapoport SI, 2007, PROSTAG LEUKOTR ESS, V77, P251, DOI 10.1016/j.plefa.2007.10.023; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Rey C, 2018, PROSTAG LEUKOTR ESS, V133, P1, DOI 10.1016/j.plefa.2018.04.003; Rice CJ, 2008, ENDOCRINOLOGY, V149, P4892, DOI 10.1210/en.2008-0633; Rincel M, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.235; Robertson RC, 2017, BRAIN BEHAV IMMUN, V59, P21, DOI 10.1016/j.bbi.2016.07.145; Roceri M, 2002, MOL PSYCHIATR, V7, P609, DOI 10.1038/sj.mp.4001036; Sakayori N, 2016, TOHOKU J EXP MED, V240, P31, DOI 10.1620/tjem.240.31; Salem N, 2001, J MOL NEUROSCI, V16, P299, DOI 10.1385/JMN:16:2-3:299; Sardinha FLC, 2013, AM J PHYSIOL-REG I, V304, pR313, DOI 10.1152/ajpregu.00392.2012; Schipper L, 2016, PROSTAG LEUKOTR ESS, V110, P8, DOI 10.1016/j.plefa.2016.05.001; Scorletti E, 2013, ANNU REV NUTR, V33, P231, DOI 10.1146/annurev-nutr-071812-161230; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Simopoulos Artemis P., 1999, Annals of Nutrition and Metabolism, V43, P127, DOI 10.1159/000012777; Simopoulos AP, 2009, WORLD REV NUTR DIET, V100, P1, DOI 10.1159/000235706; Spencer SJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00144; Tian CY, 2011, CLIN NUTR, V30, P659, DOI 10.1016/j.clnu.2011.03.002; Venna VR, 2009, PSYCHONEUROENDOCRINO, V34, P199, DOI 10.1016/j.psyneuen.2008.08.025; Walker CD, 2005, PROG NEURO-PSYCHOPH, V29, P1249, DOI 10.1016/j.pnpbp.2005.08.010; Walker CD, 2010, DEV PSYCHOBIOL, V52, P638, DOI 10.1002/dev.20492; Wohleb ES, 2017, PROG NEURO-PSYCHOPH, V79, P40, DOI 10.1016/j.pnpbp.2016.04.013; Yam KY, 2017, PSYCHONEUROENDOCRINO, V77, P186, DOI 10.1016/j.psyneuen.2016.12.012; Yehuda S, 2003, WORLD REV NUTR DIET, V92, P37	83	18	18	3	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5729	5740		10.1096/fj.201802297R	http://dx.doi.org/10.1096/fj.201802297R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30673509	Green Published, Green Submitted, Bronze			2022-12-26	WOS:000462888500087
J	Dlouhy, AC; Bailey, DK; Steimle, BL; Parker, HV; Kosman, DJ				Dlouhy, Adrienne C.; Bailey, Danielle K.; Steimle, Brittany L.; Parker, Haley V.; Kosman, Daniel J.			Fluorescence resonance energy transfer links membrane ferroportin, hephaestin but not ferroportin, amyloid precursor protein complex with iron efflux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						iron metabolism; metal homeostasis; amyloid precursor protein (APP); membrane transport; fluorescence resonance energy transfer (FRET); ferroportin; hephaestin; iron efflux	FERROXIDASE ACTIVITY; ENDOTHELIAL-CELLS; TRANSPORT; BINDING; APP; MECHANISMS; EXPRESSION; INTERNALIZATION; ACCUMULATION; DIMERIZATION	Iron efflux from mammalian cells is supported by the synergistic actions of the ferrous iron efflux transporter, ferroportin (Fpn) and a multicopper ferroxidase, that is, hephaestin (Heph), ceruloplasmin (Cp) or both. The two proteins stabilize Fpn in the plasma membrane and catalyze extracellular Fe3+ release. The membrane stabilization of Fpn is also stimulated by its interaction with a 22-amino acid synthetic peptide based on a short sequence in the extracellular E2 domain of the amyloid precursor protein (APP). However, whether APP family members interact with Fpn in vivo is unclear. Here, using cyan fluorescent protein (CFP)-tagged Fpn in conjunction with yellow fluorescent protein (YFP) fusions of Heph and APP family members APP, APLP1, and APLP2 in HEK293T cells we used fluorescence and surface biotinylation to quantify Fpn membrane occupancy and also measured Fe-59 efflux. We demonstrate that Fpn and Heph co-localize, and FRET analysis indicated that the two proteins form an iron-efflux complex. In contrast, none of the full-length, cellular APP proteins exhibited Fpn co-localization or FRET. Moreover, iron supplementation increased surface expression of the iron-efflux complex, and copper depletion knocked down Heph activity and decreased Fpn membrane localization. Whereas cellular APP species had no effects on Fpn and Heph localization, addition of soluble E2 elements derived from APP and APLP2, but not APLP1, increased Fpn membrane occupancy. We conclude that a ferroportin-targeting sequence, (K/R)EWEE, present in APP and APLP2, but not APLP1, helps modulate Fpn-dependent iron efflux in the presence of an active multicopper ferroxidase.	[Dlouhy, Adrienne C.; Bailey, Danielle K.; Steimle, Brittany L.; Parker, Haley V.; Kosman, Daniel J.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Biochem, Buffalo, NY 14203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Kosman, DJ (corresponding author), Suite 4102,955 Main St, Buffalo, NY 14203 USA.	camkos@buffalo.edu		Kosman, Daniel/0000-0003-3570-7682; , Brittany/0000-0003-3638-8767; Bailey, Danielle/0000-0001-9128-0199	National Institutes of Health NINDS [RO3NS095063, RO1NS102337]; Department of Health and Human Services USA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS102337, R03NS095063] Funding Source: NIH RePORTER	National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Health and Human Services USA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health NINDS Grants RO3NS095063 and RO1NS102337, from the Department of Health and Human Services USA (to D. J. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson GJ, 2002, BLOOD CELL MOL DIS, V29, P367, DOI 10.1006/bcmd.2002.0576; Aschemeyer S, 2018, BLOOD, V131, P899, DOI 10.1182/blood-2017-05-786590; Bajar BT, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16091488; Bousejra-ElGarah F, 2011, INORG CHEM, V50, P9024, DOI 10.1021/ic201233b; Chen HJ, 2006, J NUTR, V136, P1236, DOI 10.1093/jn/136.5.1236; Chen HJ, 2009, J CELL BIOCHEM, V107, P803, DOI 10.1002/jcb.22178; Cho HH, 2010, J BIOL CHEM, V285, P31217, DOI 10.1074/jbc.M110.149161; Chua K, 2015, BIOORG MED CHEM LETT, V25, P4961, DOI 10.1016/j.bmcl.2015.03.012; Coburger I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081926; Coffey R, 2017, J BIOL CHEM, V292, P12727, DOI 10.1074/jbc.R117.781823; D'Anna MC, 2009, J HISTOCHEM CYTOCHEM, V57, P9, DOI 10.1369/jhc.2008.951616; Dahms SO, 2012, J MOL BIOL, V416, P438, DOI 10.1016/j.jmb.2011.12.057; De Domenico I, 2005, P NATL ACAD SCI USA, V102, P8955, DOI 10.1073/pnas.0503804102; De Domenico I, 2007, EMBO J, V26, P2823, DOI 10.1038/sj.emboj.7601735; Delaby C, 2005, BLOOD, V106, P3979, DOI 10.1182/blood-2005-06-2398; Deshpande CN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05446-4; Devauges V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044434; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Drakesmith H, 2015, CELL METAB, V22, P777, DOI 10.1016/j.cmet.2015.09.006; Du F, 2015, MOL NEUROBIOL, V52, P101, DOI 10.1007/s12035-014-8847-x; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Duck KA, 2017, BIOCHEM BIOPH RES CO, V494, P70, DOI 10.1016/j.bbrc.2017.10.083; Duck KA, 2016, BIOMETALS, V29, P573, DOI 10.1007/s10534-016-9952-2; Frazer DM, 2017, AM J CLIN NUTR, V105, P1255, DOI 10.3945/ajcn.117.158188; Fung E, 2013, MOL PHARMACOL, V83, P681, DOI 10.1124/mol.112.083428; Fuqua BK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098792; Goncalves AS, 2006, BIOCHEM J, V396, P265, DOI 10.1042/BJ20051682; Han O, 2007, J CELL BIOCHEM, V101, P1000, DOI 10.1002/jcb.21392; Hick M, 2015, ACTA NEUROPATHOL, V129, P21, DOI 10.1007/s00401-014-1368-x; Hladky SB, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-26; Hoefgen S, 2014, J STRUCT BIOL, V187, P30, DOI 10.1016/j.jsb.2014.05.006; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Ji CY, 2018, CELL MOL NEUROBIOL, V38, P941, DOI 10.1007/s10571-017-0568-z; Jiang RW, 2015, J NUTR, V145, P1003, DOI 10.3945/jn.114.207316; Kaden D, 2009, J CELL SCI, V122, P368, DOI 10.1242/jcs.034058; Klevanski M, 2014, MOL CELL NEUROSCI, V61, P201, DOI 10.1016/j.mcn.2014.06.004; Kosman DJ, 2010, J BIOL CHEM, V285, P26729, DOI 10.1074/jbc.R110.113217; Kosman DJ, 2003, MOL MICROBIOL, V47, P1185, DOI 10.1046/j.1365-2958.2003.03368.x; Lee SM, 2012, BIOCHEM BIOPH RES CO, V421, P449, DOI 10.1016/j.bbrc.2012.04.008; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Marik SA, 2016, P NATL ACAD SCI USA, V113, P7912, DOI 10.1073/pnas.1604299113; McCarthy RC, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00031; McCarthy RC, 2015, CELL MOL LIFE SCI, V72, P709, DOI 10.1007/s00018-014-1771-4; McCarthy RC, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0065-7; McCarthy RC, 2014, EMBO REP, V15, P809, DOI 10.15252/embr.201338064; McCarthy RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089003; McCarthy RC, 2013, J BIOL CHEM, V288, P17932, DOI 10.1074/jbc.M113.455428; McCarthy RC, 2012, BIOMETALS, V25, P665, DOI 10.1007/s10534-012-9538-6; Muckenthaler MU, 2017, CELL, V168, P344, DOI 10.1016/j.cell.2016.12.034; Muller UC, 2017, NAT REV NEUROSCI, V18, P281, DOI 10.1038/nrn.2017.29; Muller UC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006288; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nittis T, 2004, J BIOL CHEM, V279, P25696, DOI 10.1074/jbc.M401151200; Philpott CC, 2017, J BIOL CHEM, V292, P12764, DOI 10.1074/jbc.R117.791962; Qiao B, 2012, CELL METAB, V15, P918, DOI 10.1016/j.cmet.2012.03.018; Rafiee A, 2012, IRAN J PUBLIC HEALTH, V41, P79; Rice AE, 2009, J MOL BIOL, V386, P717, DOI 10.1016/j.jmb.2008.12.063; Rishi G, 2017, AM J PHYSIOL-GASTR L, V313, pG157, DOI 10.1152/ajpgi.00004.2017; Rishi G, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150014; Rogers JT, 2002, J BIOL CHEM, V277, P45518, DOI 10.1074/jbc.M207435200; Ross SL, 2012, CELL METAB, V15, P905, DOI 10.1016/j.cmet.2012.03.017; Singh A, 2006, J BIOL CHEM, V281, P13355, DOI 10.1074/jbc.M512042200; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Terzulli AJ, 2009, J BIOL INORG CHEM, V14, P315, DOI 10.1007/s00775-008-0450-z; Tselepis C, 2010, BIOCHEM J, V427, P289, DOI 10.1042/BJ20091521; Wallace DF, 2017, AM J HEMATOL, V92, P1052, DOI 10.1002/ajh.24844; Ward DM, 2012, BBA-MOL CELL RES, V1823, P1426, DOI 10.1016/j.bbamcr.2012.03.004; Weyer SW, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-36; Yanatori I, 2016, J BIOL CHEM, V291, P17303, DOI 10.1074/jbc.M116.721936; Yeh KY, 2011, GASTROENTEROLOGY, V141, P292, DOI 10.1053/j.gastro.2011.03.059; Yeh KY, 2009, AM J PHYSIOL-GASTR L, V296, pG55, DOI 10.1152/ajpgi.90298.2008; Yu Y, 2006, CLIN CANCER RES, V12, P6876, DOI 10.1158/1078-0432.CCR-06-1954; Ziegler L, 2011, MOL MICROBIOL, V81, P473, DOI 10.1111/j.1365-2958.2011.07704.x	73	24	24	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4202	4214		10.1074/jbc.RA118.005142	http://dx.doi.org/10.1074/jbc.RA118.005142			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30647129	Green Published, hybrid			2022-12-26	WOS:000461854400031
J	Park, CH; Kim, TH; Lee, S; Moon, DH; Park, HS				Park, Chul Hwan; Kim, Tae Hoon; Lee, Sungsoo; Moon, Duk Hwan; Park, Heae Surng			Correlation between maximal tumor diameter of fresh pathology specimens and computed tomography images in lung adenocarcinoma	PLOS ONE			English	Article							FORMALIN FIXATION; SIZE; CT; NODULES; CANCER; ACCURACY; PET/CT	The authors compared maximal tumor diameters between fresh lung tissue and axial and multiplanar reformatted chest computed-tomography (CT) images in lung adenocarcinoma and investigated the factors affecting tumor-size discrepancies. This study included 135 surgically resected lung adenocarcinomas. An experienced pulmonary pathologist aimed to cut the largest tumor section and measured pathological tumor size (PTS) in fresh specimens. Radiological maximal tumor sizes (RTS) were retrospectively measured on axial (RTSax) and multiplanar reformatted (RTSre) chest CT images. Mean PTS, RTSax, and RTSre were 19.13 mm, 18.63 mm, and 20.80 mm, respectively. RTSre was significantly larger than PTS (mean difference, 1.68 mm; p<0.001). RTSax was also greater than PTS for 6-10-mm and 11-20-mm tumors. PTS and RTS were strongly positively correlated (RTSax, r(2) = 0.719, p<0.001; RTSre, r(2) = 0.833, p<0.001). The intraclass correlation coefficient was 0.915 between PTS and RTSax and 0.954 between PTS and RTSre. Postoperative down-staging occurred in 11.0% and 27.4% of tumors on performing radiological staging using RTSax and RTSre, respectively. Postoperative up-staging occurred in 12.3% and 1.4% of tumors on performing radiological staging using RTSax and RTSre, respectively. Multiple linear regression revealed that pleural dimpling (p = 0.024) was an independent factor affecting differences between PTS and RTSax. Specimen type (p = 0.012) and tumor location (p = 0.020) were independent factors affecting differences between PTS and RTSre. In conclusion, RTSre was significantly larger than PTS and caused postoperative down-staging in 27.4% of the tumors. Reliability analysis revealed that RTSre was more strongly correlated with PTS than RTSax. Specimen type and anatomical tumor location influenced the measured size differences between PTS and RTSre.	[Park, Chul Hwan; Kim, Tae Hoon] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Radiol,Res Inst Radiol Sci, Seoul, South Korea; [Lee, Sungsoo; Moon, Duk Hwan] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Thorac & Cardiovasc Surg, Seoul, South Korea; [Park, Heae Surng] Ewha Womans Univ, Mokdong Hosp, Dept Pathol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Ewha Womans University	Park, HS (corresponding author), Ewha Womans Univ, Mokdong Hosp, Dept Pathol, Seoul, South Korea.	turtle98p@naver.com		Park, Chul Hwan/0000-0002-0004-9475; Lee, Sungsoo/0000-0001-8998-9510; /0000-0003-3598-2529				Amin MB, 2017, AJCC CANC STAGING MA; Aydin F, 2013, DIAGN INTERV RADIOL, V19, P271, DOI 10.5152/dir.2013.053; Bankier AA, 2017, RADIOLOGY, V285, P584, DOI 10.1148/radiol.2017162894; Bhure UN, 2010, BRIT J RADIOL, V83, P841, DOI 10.1259/bjr/13711326; Heidinger BH, 2017, J THORAC ONCOL, V12, P1288, DOI 10.1016/j.jtho.2017.05.017; Heidinger BH, 2017, ACAD RADIOL, V24, P851, DOI 10.1016/j.acra.2017.01.009; Hsu PK, 2007, ANN THORAC SURG, V84, P1825, DOI 10.1016/j.athoracsur.2007.07.016; Isaka T, 2014, LUNG CANCER, V85, P40, DOI 10.1016/j.lungcan.2014.03.023; Jeffery NN, 2011, BMC UROL, V11, DOI 10.1186/1471-2490-11-2; Lampen-Sachar K, 2012, LUNG CANCER, V75, P332, DOI 10.1016/j.lungcan.2011.08.001; Lee KH, 2014, J THORAC ONCOL, V9, P74, DOI 10.1097/JTO.0000000000000019; Lee SE, 2010, WORLD J UROL, V28, P263, DOI 10.1007/s00345-010-0511-0; Park HS, 2017, HISTOPATHOLOGY, V71, P437, DOI 10.1111/his.13237; Pawaroo D, 2011, AM J ROENTGENOL, V196, P1176, DOI 10.2214/AJR.10.4980; Ridge CA, 2013, AM J ROENTGENOL, V201, P959, DOI 10.2214/AJR.12.10033; Sica GL, 2012, SEMIN DIAGN PATHOL, V29, P116, DOI 10.1053/j.semdp.2012.06.001; Travis WDBE., 2015, WHO CLASSIFICATION T, V4; Travis WD, 2016, J THORAC ONCOL, V11, P1204, DOI 10.1016/j.jtho.2016.03.025; Yu HM, 2009, EUR J RADIOL, V72, P104, DOI 10.1016/j.ejrad.2008.06.015	19	7	7	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211141	10.1371/journal.pone.0211141	http://dx.doi.org/10.1371/journal.pone.0211141			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682110	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500110
J	Di Matteo, S; Nevi, L; Costantini, D; Overi, D; Carpino, G; Safarikia, S; Giulitti, F; Napoletano, C; Manzi, E; De Rose, AM; Melandro, F; Bragazzi, M; Berloco, PB; Giuliante, F; Grazi, G; Giorgi, A; Cardinale, V; Adorini, L; Gaudio, E; Alvaro, D				Di Matteo, S.; Nevi, L.; Costantini, D.; Overi, D.; Carpino, G.; Safarikia, S.; Giulitti, F.; Napoletano, C.; Manzi, E.; De Rose, A. M.; Melandro, F.; Bragazzi, M.; Berloco, P. B.; Giuliante, F.; Grazi, G.; Giorgi, A.; Cardinale, V.; Adorini, L.; Gaudio, E.; Alvaro, D.			The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma	PLOS ONE			English	Article							FARNESOID-X-RECEPTOR; ENDOGENOUS BILE-ACIDS; NUCLEAR RECEPTOR; DOWN-REGULATION; DIAGNOSIS; CLASSIFICATION; IDENTIFICATION; PATHOGENESIS; METABOLISM; ACTIVATION	Cholangiocarcinoma (CCA) is an aggressive cancer with high resistance to chemotherapeutics. CCA is enriched in cancer stem cells, which correlate with aggressiveness and prognosis. FXR, a member of the metabolic nuclear receptor family, is markedly down-regulated in human CCA. Our aim was to evaluate, in primary cultures of human intrahepatic CCA (iCCA), the effects of the FXR agonist obeticholic acid (OCA), a semisynthetic bile acid derivative, on their cancerogenic potential. Primary human iCCA cell cultures were prepared from surgical specimens of mucinous or mixed iCCA subtypes. Increasing concentrations (0-2.5 mu M) of OCA were added to culture media and, after 3-10 days, effects on proliferation (MTS assay, cell population doubling time), apoptosis (annexin V-FITC/propidium iodide), cell migration and invasion (wound healing response and Matrigel invasion assay), and cancerogenic potential (spheroid formation, clonogenic assay, colony formation capacity) were evaluated. Results: FXR gene expression was downregulated (RT-qPCR) in iCCA cells vs normal human biliary tree stem cells (p < 0.05) and in mucinous iCCA vs mixed iCCA cells (p < 0.05) but was upregulated by addition of OCA. OCA significantly (p < 0.05) inhibited proliferation of both mucinous and mixed iCCA cells, starting at a concentration as low as 0.05 mu M. Also, CDCA (but not UDCA) inhibited cell proliferation, although to a much lower extent than OCA, consistent with its different affinity for FXR. OCA significantly induced apoptosis of both iCCA subtypes and decreased their in vitro cancerogenic potential, as evaluated by impairment of colony and spheroid formation capacity and delayed wound healing and Matrigel invasion. In general, these effects were more evident in mixed than mucinous iCCA cells. When tested together with Gemcitabine and Cisplatin, OCA potentiated the anti-proliferative and pro-apoptotic effects of these chemotherapeutics, but mainly in mixed iCCA cells. OCA abolished the capacity of both mucinous and mixed iCCA cells to form colonies when administered together with Gemcitabine and Cisplatin. In subcutaneous xenografts of mixed iCCA cells, OCA alone or combined with Gemcitabine or Cisplatin markedly reduced the tumor size after 5 weeks of treatment by inducing necrosis of tumor mass and inhibiting cell proliferation. In conclusion, FXR is down-regulated in iCCA cells, and its activation by OCA results in anti-cancerogenic effects against mucinous and mixed iCCA cells, both in vitro and in vivo. The effects of OCA predominated in mixed iCCA cells, consistent with the lower aggressiveness and the higher FXR expression in this CCA subtype. These results, showing the FXR-mediated capacity of OCA to inhibit cholangiocarcinogenesis, represent the basis for testing OCA in clinical trials of CCA patients.	[Di Matteo, S.; Nevi, L.; Costantini, D.; Safarikia, S.; Giorgi, A.; Alvaro, D.] Sapienza Univ Rome, Dept Translat & Precis Med, Rome, Italy; [Overi, D.; Gaudio, E.] Sapienza Univ Rome, Dept Anat Histol Forens Med & Orthoped Sci, Rome, Italy; [Carpino, G.; Giulitti, F.] Univ Rome Foro Italico, Div Hlth Sci, Dept Movement Human & Hlth Sci, Rome, Italy; [Napoletano, C.] Sapienza Univ Rome, Dept Expt Med, Rome, Italy; [Manzi, E.; Grazi, G.] Regina Elena Inst Canc Res, Gastroenterol Unit, Rome, Italy; [De Rose, A. M.; Giuliante, F.] Catholic Univ, Sacred Heart Sch Med, Hepatobiliary Unit, Rome, Italy; [Melandro, F.; Berloco, P. B.] Sapienza Univ Rome, Dept Gen Surg & Organ Transplantat, Rome, Italy; [Bragazzi, M.; Cardinale, V.] Sapienza Univ Rome, Med Surg & Biotechnol Sci, Rome, Italy; [Adorini, L.] Intercept Pharmaceut, New York, NY USA	Sapienza University Rome; Sapienza University Rome; Foro Italico University of Rome; Sapienza University Rome; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sapienza University Rome; Sapienza University Rome; Intercept Pharmaceuticals	Alvaro, D (corresponding author), Sapienza Univ Rome, Dept Translat & Precis Med, Rome, Italy.	domenico.alvaro@uniroma1.it	Di Matteo, Sabina/D-1876-2017; Cardinale, Vincenzo/AAB-9296-2019; Overi, Diletta/AAP-3632-2021; melandro, fabio/AAA-1996-2019; Nevi, Lorenzo/B-3289-2017; Carpino, Guido/AAB-9692-2019; GIULIANTE, FELICE/AAC-5066-2020; ALVARO, Domenico/J-8600-2018; De Rose, Agostino Maria/V-4910-2019; Adorini, Luciano/AAE-5149-2020	Di Matteo, Sabina/0000-0002-2586-7159; Cardinale, Vincenzo/0000-0003-0234-3341; melandro, fabio/0000-0003-4056-9245; Nevi, Lorenzo/0000-0003-0924-2551; GIULIANTE, FELICE/0000-0003-2087-2589; ALVARO, Domenico/0000-0003-3771-9644; De Rose, Agostino Maria/0000-0003-3310-8088; Overi, Diletta/0000-0003-3561-8903; safarikia, samira/0000-0002-7254-0634	Agenzia Regionale del Lazio per i trapianti e le patologieconnesse grant; FIRB grants [RBAP10Z7FS_001, RBAP10Z7FS_004]; Federate Athenaeum funds from the Sapienza University of Rome; InterceptPharma (New York, USA)	Agenzia Regionale del Lazio per i trapianti e le patologieconnesse grant; FIRB grants; Federate Athenaeum funds from the Sapienza University of Rome; InterceptPharma (New York, USA)	The study was supported by an Agenzia Regionale del Lazio per i trapianti e le patologieconnesse grant, FIRB grants #RBAP10Z7FS_001 and RBAP10Z7FS_004, and Federate Athenaeum funds from the Sapienza University of Rome (all to V.C., G.C., E.G., and D.A.) and a sponsored research grant from InterceptPharma (New York, USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aishima S, 2015, J HEPATO-BIL-PAN SCI, V22, P94, DOI 10.1002/jhbp.154; Banales JM, 2016, NAT REV GASTRO HEPAT, V13, P261, DOI 10.1038/nrgastro.2016.51; Bernstein C, 2011, ARCH TOXICOL, V85, P863, DOI 10.1007/s00204-011-0648-7; Blechacz B, 2011, NAT REV GASTRO HEPAT, V8, P512, DOI 10.1038/nrgastro.2011.131; Cardinale V, 2015, AM J PATHOL, V185, P1724, DOI 10.1016/j.ajpath.2015.02.010; Cardinale V, 2012, WORLD J GASTRO ONCOL, V4, P94, DOI 10.4251/wjgo.v4.i5.94; Carpino G, 2014, J HEPATOL, V60, P1194, DOI 10.1016/j.jhep.2014.01.026; Cha TL, 2005, CANCER RES, V65, P2287, DOI 10.1158/0008-5472.CAN-04-3250; Claudel T, 2005, ARTERIOSCL THROM VAS, V25, P2020, DOI 10.1161/01.ATV.0000178994.21828.a7; Dai JQ, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-41; Degirolamo C, 2015, HEPATOLOGY, V61, P161, DOI 10.1002/hep.27274; Deuschle U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043044; Edwards JE, 2016, CTS-CLIN TRANSL SCI, V9, P328, DOI 10.1111/cts.12421; Erice O, 2018, BBA-MOL BASIS DIS, V1864, P1335, DOI 10.1016/j.bbadis.2017.08.016; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Fraveto A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142124; Gadaleta RM, 2017, MOL ASPECTS MED, V56, P66, DOI 10.1016/j.mam.2017.04.002; Gardmo C, 2011, BBA-MOL BASIS DIS, V1812, P836, DOI 10.1016/j.bbadis.2011.03.009; Giordano C, 2011, ONCOGENE, V30, P4129, DOI 10.1038/onc.2011.124; Goldstein J., 2018, LIVER INT; Khan SA, 2012, GUT, V61, P1657, DOI 10.1136/gutjnl-2011-301748; Komuta M, 2012, HEPATOLOGY, V55, P1876, DOI 10.1002/hep.25595; Lax S, 2012, INT J CANCER, V130, P2232, DOI 10.1002/ijc.26293; Lee CH, 2016, ONCOTARGET, V7, P1215, DOI 10.18632/oncotarget.6261; Lee FY, 2006, TRENDS BIOCHEM SCI, V31, P572, DOI 10.1016/j.tibs.2006.08.002; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Liau JY, 2014, MODERN PATHOL, V27, P1163, DOI 10.1038/modpathol.2013.241; Liu XJ, 2015, ONCOTARGET, V6, P4226, DOI 10.18632/oncotarget.2899; Lustri AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183932; Lv B, 2018, CELL PHYSIOL BIOCHEM, V48, P158, DOI 10.1159/000491715; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maran RRM, 2009, J PHARMACOL EXP THER, V328, P469, DOI 10.1124/jpet.108.145409; Martinez-Becerra P, 2012, MOL PHARMACEUT, V9, P1693, DOI 10.1021/mp300028a; Nakanuma Y, 2010, WORLD J HEPATOL, V2, P419, DOI 10.4254/wjh.v2.i12.419; Nevi L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05858-0; Nevi L, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0492-7; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Pellicciari R, 2002, J MED CHEM, V45, P3569, DOI 10.1021/jm025529g; Pinter M, 2016, ESMO OPEN, V1, DOI 10.1136/esmoopen-2016-000042; Ramadori G, 2010, ANN HEPATOL, V9, P133, DOI 10.1016/S1665-2681(19)31651-5; Rizvi S, 2013, GASTROENTEROLOGY, V145, P1215, DOI 10.1053/j.gastro.2013.10.013; Roda A, 2017, CTS-CLIN TRANSL SCI, V10, P292, DOI 10.1111/cts.12468; Roda A, 2014, J PHARMACOL EXP THER, V350, P56, DOI 10.1124/jpet.114.214650; Schaap FG, 2014, NAT REV GASTRO HEPAT, V11, P55, DOI 10.1038/nrgastro.2013.151; Su HY, 2012, AM J PHYSIOL-GASTR L, V303, pG1245, DOI 10.1152/ajpgi.00439.2011; Thompson MD, 2018, HEPATOLOGY, V67, P955, DOI 10.1002/hep.29371; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; VAQUERO J, 1990, NEUROSURGERY, V27, P235, DOI 10.1227/00006123-199008000-00011; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang W, 2016, ONCOTARGET, V7, P34617, DOI 10.18632/oncotarget.8964; Wang YD, 2008, HEPATOLOGY, V48, P1632, DOI 10.1002/hep.22519; Xu Y, 2016, HEPATOLOGY, V64, P1072, DOI 10.1002/hep.28712; Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078; Zhang Y, 2017, PHARM RES PERSPECT, V5; Zhong XY, 2012, GENE, V493, P44, DOI 10.1016/j.gene.2011.11.028	55	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210077	10.1371/journal.pone.0210077	http://dx.doi.org/10.1371/journal.pone.0210077			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677052	Green Submitted, Green Published, gold			2022-12-26	WOS:000456700400010
J	Romanowski, K; Campbell, JR; Oxlade, O; Fregonese, F; Menzies, D; Johnston, JC				Romanowski, Kamila; Campbell, Jonathon R.; Oxlade, Olivia; Fregonese, Federica; Menzies, Dick; Johnston, James C.			The impact of improved detection and treatment of isoniazid resistant tuberculosis on prevalence of multi-drug resistant tuberculosis: A modelling study	PLOS ONE			English	Article								Introduction Isoniazid-resistant, rifampin susceptible tuberculosis (INHR-TB) is the most common form of drug resistant TB globally. Treatment of INHR-TB with standard first-line therapy is associated with high rates of multidrug resistant TB (MDR-TB). We modelled the potential impact of INHR-TB detection and appropriate treatment on MDR-TB prevalence. Methods A decision analysis model was developed to compare three different strategies for the detection of TB (AFB smear, Xpert MTB/RIF, and Line-Probe Assays (LPA)), combined with appropriate treatment. The population evaluated were patients with a globally representative prevalence of newly diagnosed, drug-susceptible (88.6%), isoniazid-resistant (7.3%), and multidrug resistant (4.1%) pulmonary TB. Our primary outcome was the proportion of patients with MDR-TB after initial attempt at diagnosis and treatment within a 2-year period. Secondary outcomes were the proportion of i) individuals with detected TB who acquired MDR-TB ii) individuals who died after initial attempt at diagnosis and treatment. Results After initial attempt at diagnosis and treatment, LPA combined with appropriate INHR-TB therapy resulted in a lower proportion of prevalent MDR-TB (1.61%; 95% Uncertainty Range (UR: 2.5th and 97.5th percentiles generated from 10 000 Monte Carlo simulation trials) 1.61-1.65), when compared to Xpert (1.84%; 95% UR 1.82-1.85) and AFB smear (3.21%; 95% UR 3.19-3.26). LPA also resulted in fewer cases of acquired MDR-TB in those with detected TB (0.35%; 95% UR 0.34-0.35), when compared to Xpert (0.67%; 95% UR 0.65-0.67) and AFB smear (0.68%; 95% UR 0.67-0.69). The majority of acquired MDR-TB arose from the treatment of INHR-TB in all strategies. Xpert-based strategies resulted in a lower proportion of death (2.89%; 95% UR 2.87-2.90) compared to LPA (2.93%; 95% UR 2.91-2.94) and AFB smear (3.21%; 95% UR 3.19-3.23). Conclusion Accurate diagnosis and tailored treatment of INHR-TB with LPA led to an almost 50% relative decrease in acquired MDR-TB when compared with an Xpert MTB/RIF strategy. Continued reliance on diagnostic and treatment protocols that ignore INHR-TB will likely result in further generation of MDR-TB.	[Romanowski, Kamila; Johnston, James C.] BC Ctr Dis Control, TB Serv, Vancouver, BC, Canada; [Campbell, Jonathon R.; Oxlade, Olivia; Fregonese, Federica; Menzies, Dick; Johnston, James C.] McGill Int TB Ctr, Montreal, PQ, Canada; [Menzies, Dick] McGill Univ, Div Resp Med, Dept Med, Montreal, PQ, Canada; [Johnston, James C.] Univ British Columbia, Dept Med, Div Resp Med, Vancouver, BC, Canada	McGill University; University of British Columbia	Johnston, JC (corresponding author), BC Ctr Dis Control, TB Serv, Vancouver, BC, Canada.; Johnston, JC (corresponding author), McGill Int TB Ctr, Montreal, PQ, Canada.; Johnston, JC (corresponding author), Univ British Columbia, Dept Med, Div Resp Med, Vancouver, BC, Canada.	james.johnston@bccdc.ca	Campbell, Jonathon/AAN-4252-2021	Campbell, Jonathon/0000-0003-2341-2166; Romanowski, Kamila/0000-0002-7027-3579; JOHNSTON, JAMES/0000-0002-8879-4989				Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; Bae JM, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014025; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Cohen KA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001880; Denkinger CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084197; Dheda K, 2017, LANCET RESP MED, V5, P291, DOI [10.1016/S2213-2600(17)30079-6, 10.1016/s2213-2600(17)30079-6]; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Fregonese F, 2018, LANCET RESP MED, V6, P265, DOI 10.1016/S2213-2600(18)30078-X; Gegia M, 2017, LANCET INFECT DIS, V17, P223, DOI 10.1016/S1473-3099(16)30407-8; HSE National Drug Treatment Centre, 2016, CERV SMEAR GUID; Jenkins HE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022927; Kendall EA, 2015, LANCET RESP MED, V3, P963, DOI 10.1016/S2213-2600(15)00458-0; Manson AL, 2017, NAT GENET, V49, P395, DOI 10.1038/ng.3767; Nathavitharana RR, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01075-2016; Stagg HR, 2017, INT J TUBERC LUNG D, V21, P129, DOI 10.5588/ijtld.16.0716; Steingart KR, 2013, COCHRANE DATABASE SY, V1; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; WHO, WHO TREATM GUID IS R; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2008, POL STAT, P27; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization, 2013, SYST SCREEN ACT TUB; World Health Organization, GLOB TUB REP 2017; Xie YL, 2017, NEW ENGL J MED, V377, P1043, DOI 10.1056/NEJMoa1614915	26	7	8	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211355	10.1371/journal.pone.0211355	http://dx.doi.org/10.1371/journal.pone.0211355			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677101	Green Published, Green Submitted, gold			2022-12-26	WOS:000456700400067
J	Toledo-Pons, N; van Boven, JFM; Roman-Rodriguez, M; Perez, N; Felices, JLV; Soriano, JB; Cosio, BG				Toledo-Pons, Nuria; van Boven, Job F. M.; Roman-Rodriguez, Miguel; Perez, Noemi; Valera Felices, Jose Luis; Soriano, Joan B.; Cosio, Borja G.			ACO: Time to move from the description of different phenotypes to the treatable traits	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; COPD OVERLAP SYNDROME; BLOOD EOSINOPHILS; ASTHMA; EXACERBATIONS; FEATURES	Background Asthma-COPD overlap (ACO) is a term that encompasses patients with characteristics of two conditions, smoking asthmatics or COPD patients with asthma-like features such as high bronchodilator response or blood eosinophil count. 300 cells/mu L. The aim of this study was to compare the different phenotypes inside the ACO definition in a real-life population cohort. Methods We analyzed patients from the MAJORICA cohort who had a diagnosis of asthma and/or COPD based on current guidelines, laboratory data in 2014 and follow-up until 2015. Prevalence of ACO according to the different criteria, demographic, clinical and functional characteristics, prescriptions and use of health resources data were compared between three groups. Results We included 603 patients. Prevalence of smoking asthmatics was 14%, COPD patients with high bronchodilator response 1.5% and eosinophilic COPD patients 12%. Smoking asthmatics were younger and used more rescue inhalers, corticosteroids and health resources. Conversely, eosinophilic COPD patients were older than the other groups, often treated with corticosteroids and had lower use of health resources. Most of the COPD patients with high bronchodilator response were included in the eosinophilic COPD group. Conclusions ACO includes two conditions (smoking asthmatics and eosinophilic COPD patients) with different medication requirement and prognosis that should not be pooled together. Use of >= 300 blood eosinophils/mu L as a treatable trait should be recommended.	[Toledo-Pons, Nuria; Cosio, Borja G.] Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid, Spain; [Toledo-Pons, Nuria; Valera Felices, Jose Luis; Cosio, Borja G.] Hosp Univ Son Espases, IdISBa, Dept Resp Med, Mallorca, Spain; [van Boven, Job F. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice & Elderly Care Med, Groningen Res Inst Asthma & COPD GRIAC, Groningen, Netherlands; [Roman-Rodriguez, Miguel] Inst Invest Sanitaria Islas Baleares IdISBa, Primary Care Resp Res Unit, Mallorca, Spain; [Perez, Noemi] Servicio Salud Islas Baleares, Gabinete Tecn Serv Cent, Mallorca, Spain; [Soriano, Joan B.] Univ Autonoma Madrid, Hop Univ Princesa, Madrid, Spain; [Soriano, Joan B.] SEPAR, Metodol & Invest, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Hospital Universitari Son Espases; Institut Investigacio Sanitaria Illes Balears (IdISBa); University of Groningen; Atencio Primaria de Mallorca; Institut Investigacio Sanitaria Illes Balears (IdISBa); Autonomous University of Madrid	Cosio, BG (corresponding author), Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid, Spain.; Cosio, BG (corresponding author), Hosp Univ Son Espases, IdISBa, Dept Resp Med, Mallorca, Spain.	borja.cosio@ssib.es	G.Cosio, Borja/P-4963-2017; Valera, Jose Luis/E-9615-2018; Soriano, Joan B/O-1215-2017	G.Cosio, Borja/0000-0002-6388-8209; Valera, Jose Luis/0000-0001-6360-4504; van Boven, Job/0000-0003-2368-2262; Soriano, Joan B/0000-0001-9740-2994	SEPAR travel fellowship [478/2017]	SEPAR travel fellowship	N. T.-P. was a recipient of a SEPAR travel fellowship (478/2017, https://www.separ.es/) aimed to set a collaboration with GRIAC for the purpose of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bafadhel M, 2012, AM J RESP CRIT CARE, V186, P48, DOI 10.1164/rccm.201108-1553OC; Brightling C E, 2013, Ann Am Thorac Soc, V10 Suppl, pS214, DOI 10.1513/AnnalsATS.201302-023AW; Calverley PMA, 2003, THORAX, V58, P659, DOI 10.1136/thorax.58.8.659; Casanova C, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.01162-2017; Cosio BG, 2016, CHEST, V149, P45, DOI 10.1378/chest.15-1055; Ghebre MA, 2015, J ALLERGY CLIN IMMUN, V135, P63, DOI 10.1016/j.jaci.2014.06.035; Gibson PG, 2009, THORAX, V64, P728, DOI 10.1136/thx.2008.108027; Gibson PG, 2015, THORAX, V70, P683, DOI 10.1136/thoraxjnl-2014-206740; GOLD G., 2015, ASTHMA COPD ASTHMA C, P1; Grootendorst Diana C, 2004, Proc Am Thorac Soc, V1, P77, DOI 10.1513/pats.2306025; Hardin M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-127; Hinds DR, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010099; Kim MH, 2018, INT J CHRONIC OBSTR, V13, P1251, DOI 10.2147/COPD.S152916; Miravitlles M, 2017, EUR RESPIR J, V49, P10; Noell G, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00075-2017; Perez DLL, 2018, ARCH BRONCONEUMOL, V54, P198, DOI DOI 10.1016/j.arbres.2017.10.007; Perez-De-Llano L, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0667-x; Sin DD, 2016, EUR RESPIR J, V48, P664, DOI 10.1183/13993003.00436-2016; Soriano JB, 2008, EUR RESPIR J, V31, P695, DOI 10.1183/09031936.00017008; Suzuki M, 2016, AM J RESP CRIT CARE, V194, P1358, DOI 10.1164/rccm.201602-0353OC; Turato G, 2017, AM J RESP CRIT CARE; van Boven JFM, 2016, CHEST, V149, P1011, DOI 10.1016/j.chest.2015.12.002; Vedel-Krogh S, 2016, AM J RESP CRIT CARE, V193, P965, DOI 10.1164/rccm.201509-1869OC; Zeki Amir A, 2011, J Allergy (Cairo), V2011, P861926, DOI 10.1155/2011/861926	24	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210915	10.1371/journal.pone.0210915	http://dx.doi.org/10.1371/journal.pone.0210915			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677059	Green Published, Green Submitted, gold			2022-12-26	WOS:000456700400034
J	Liu, YL; Rodriguez-Calvo, R; Wang, SJ; Zhu, XQ; Broers, JLV; Glatz, JFC; Luiken, JJFP; Neumann, D				Liu, Yilin; Rodriguez-Calvo, Ricardo; Wang, Shujin; Zhu, Xiaoqing; Broers, Jos L. V.; Glatz, Jan F. C.; Luiken, Joost J. F. P.; Neumann, Dietbert			Fluorescent labelling of membrane fatty acid transporter CD36 (SR-B2) in the extracellular loop	PLOS ONE			English	Article							RAT CARDIAC MYOCYTES; CONTRACTILE DYSFUNCTION; SARCOLEMMAL FAT/CD36; INSULIN; PROTEIN; TRANSLOCATION; METABOLISM; DIET	Context Upon palmitate oversupply, membrane fatty acid-transporter CD36 (SR-B2) permanently translocates from endosomal storage to the sarcolemma, inducing lipotoxicity. CD36 trans location results from endosomal alkalinisation elicited by palmitate-induced disattachment of the cytoplasmic V-1-subcomplex from the membrane-integrated V-0-subcomplex of vacuolar-type H+-ATPase. Objective Develop a CD36 fluorescent labeling technique as initial step towards live cell imaging. Methods Three human CD36 (hCD36) mutants were constructed via insertion of a tetracysteine motif at different positions within the extracellular domain. Constructs were lentivirally transduced for subsequent CD36 labeling with fluorescein-arsenical hairpin-binder (FlAsH). Cell imaging was combined with V-0/V-1 immunostaining and Western blotting. Results Transduction of hCD36-wildtype and mutants yielded corresponding proteins in HL-1 cardiomyocytes. Tetracysteine mutant-2 (hCD36-TC2) showed similar fatty acid uptake to wild type. FlAsH staining revealed a speckled pattern reminiscent of endosomes. We found decreased V-1 co-localization with CD36 upon high-palmitate culturing. Conversely, V-0 consistently co-localized with CD36. Conclusion hCD36-TC2 is a possible candidate for application of biarsenical dyes in live imaging studies pending further investigation. Our data is compatible with V-0/V-1 disassembly in high-palmitate-treated cells.	[Liu, Yilin; Rodriguez-Calvo, Ricardo; Wang, Shujin; Zhu, Xiaoqing; Glatz, Jan F. C.; Luiken, Joost J. F. P.; Neumann, Dietbert] Maastricht Univ, Dept Mol Genet, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands; [Broers, Jos L. V.] Maastricht Univ, Dept Mol Cell Biol, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands; [Rodriguez-Calvo, Ricardo] Univ Rovira & Virgili, Spanish Biomed Res Ctr Diabet & Associated Metab, Inst Invest Sanitaria Pere Virgili IISPV, Res Unit Lipids & Atherosclerosis,St Joan Univ Ho, Reus, Spain; [Neumann, Dietbert] Maastricht Univ, Dept Pathol, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands	Maastricht University; Maastricht University; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Maastricht University	Neumann, D (corresponding author), Maastricht Univ, Dept Mol Genet, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands.; Neumann, D (corresponding author), Maastricht Univ, Dept Pathol, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands.	d.neumann@maastrichtuniversity.nl	Rodriguez-Calvo, Ricardo/AAB-4054-2019	Rodriguez-Calvo, Ricardo/0000-0001-7513-0983; Neumann, Dietbert/0000-0002-4316-684X	Chinese Scholarship Council; Vidi Innovational Research Grant from the Netherlands Organization of Scientific Research (NWO-ALW) [864.10.007]	Chinese Scholarship Council(China Scholarship Council); Vidi Innovational Research Grant from the Netherlands Organization of Scientific Research (NWO-ALW)	Y.L. and X.Z. received support from the Chinese Scholarship Council. D.N. is recipient of a Vidi Innovational Research Grant from the Netherlands Organization of Scientific Research (NWO-ALW grant no. 864.10.007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Adams SR, 2008, NAT PROTOC, V3, P1527, DOI 10.1038/nprot.2008.144; Angin Y, 2012, BIOCHEM J, V448, P43, DOI 10.1042/BJ20120060; Coort SLM, 2004, DIABETES, V53, P1655, DOI 10.2337/diabetes.53.7.1655; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Glatz JFC, 2016, BBA-MOL CELL BIOL L, V1861, P1461, DOI 10.1016/j.bbalip.2016.04.008; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Hoffmann C, 2010, NAT PROTOC, V5, P1666, DOI 10.1038/nprot.2010.129; Holleran J, 2010, CYTOM PART A, V77A, P776, DOI 10.1002/cyto.a.20925; Kane PM, 2012, CURR PROTEIN PEPT SC, V13, P117; KANE PM, 1995, J BIOL CHEM, V270, P17025; Liu Y, 2017, DIABETES, V66, P1521, DOI 10.2337/db16-0727; Luiken JJFP, 2003, DIABETES, V52, P1627, DOI 10.2337/diabetes.52.7.1627; Luiken JJFP, 2002, DIABETES, V51, P3113, DOI 10.2337/diabetes.51.10.3113; Misteli T, 1997, NAT BIOTECHNOL, V15, P961, DOI 10.1038/nbt1097-961; Ouwens DM, 2007, DIABETOLOGIA, V50, P1938, DOI 10.1007/s00125-007-0735-8; Schwenk RW, 2010, DIABETOLOGIA, V53, P2209, DOI 10.1007/s00125-010-1832-7; Steinbusch LKM, 2010, AM J PHYSIOL-CELL PH, V298, pC1549, DOI 10.1152/ajpcell.00334.2009; Szent-Gyorgyi C, 2008, NAT BIOTECHNOL, V26, P235, DOI 10.1038/nbt1368; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; van Oort MM, 2008, BBA-MOL CELL BIOL L, V1781, P61, DOI 10.1016/j.bbalip.2007.11.006; Vistisen B, 2004, J LIPID RES, V45, P603, DOI 10.1194/jlr.M300424-JLR200; Wilson CR, 2007, BIOCHEM J, V406, P457, DOI 10.1042/BJ20070392; Zhang JS, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-24	26	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210704	10.1371/journal.pone.0210704	http://dx.doi.org/10.1371/journal.pone.0210704			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673728	Green Published, Green Submitted, gold			2022-12-26	WOS:000456442800050
J	Rod, KA; Um, W; Colby, SM; Rockhold, ML; Strickland, CE; Han, S; Kuprat, AP				Rod, Kenton A.; Um, Wooyong; Colby, Sean M.; Rockhold, Mark L.; Strickland, Christopher E.; Han, Sangsoo; Kuprat, Andrew P.			Relative permeability for water and gas through fractures in cement	PLOS ONE			English	Article							WELL CEMENT; 2-PHASE FLOW; FLUID-FLOW; CO2; TOMOGRAPHY; EQUATION; STRESS; CURVES	Relative permeability is an important attribute influencing subsurface multiphase flow. Characterization of relative permeability is necessary to support activities such as carbon sequestration, geothermal energy production, and oil and gas exploration. Previous research efforts have largely neglected the relative permeability of wellbore cement used to seal well bores where risks of leak are significant. Therefore this study was performed to evaluate fracturing on permeability and relative permeability of wellbore cement. Studies of relative permeability of water and air were conducted using ordinary Portland cement paste cylinders having fracture networks that exhibited a range of permeability values. The measured relative permeability was compared with three models, 1) Corey-curve, often used for modeling relative permeability in porous media, 2) X-curve, commonly used to represent relative permeability of fractures, and 3) Burdine model based on fitting the Brooks-Corey function to fracture saturation-pressure data inferred from x-ray computed tomography (XCT) derived aperture distribution results. Experimentally-determined aqueous relative permeability was best described by the Burdine model. Though water phase tended to follow the Corey-curve for the simple fracture system while air relative permeability was best described by the X-curve.	[Rod, Kenton A.; Um, Wooyong; Rockhold, Mark L.; Strickland, Christopher E.] Pacific Northwest Natl Lab, Energy & Environm Directorate, Richland, WA 99354 USA; [Um, Wooyong; Han, Sangsoo] Pohang Univ Sci & Technol POSTECH, Sch Environm Engn, Div Adv Nucl Engn, Pohang, South Korea; [Colby, Sean M.; Kuprat, Andrew P.] Pacific Northwest Natl Lab, Earth & Biol Sci Directorate, Richland, WA USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; Pohang University of Science & Technology (POSTECH); United States Department of Energy (DOE); Pacific Northwest National Laboratory	Rod, KA; Um, W (corresponding author), Pacific Northwest Natl Lab, Energy & Environm Directorate, Richland, WA 99354 USA.; Um, W (corresponding author), Pohang Univ Sci & Technol POSTECH, Sch Environm Engn, Div Adv Nucl Engn, Pohang, South Korea.	kenton.rod@pnnl.gov; wooyongum@postech.ac.kr	Rod, Kenton/R-5743-2019	Rod, Kenton/0000-0003-1818-9094; um, wooyong/0000-0002-3826-0030; Strickland, Chris/0000-0001-8289-5482	National Risk Assessment Partnership (NRAP) in the U.S. DOE Office of Fossil Energy's Carbon Sequestration Program; U.S. DOE [DE-AC06-76RLO 1830]; Korea Institute of Energy Technology Evaluation and Planning (KETEP) grant from the Ministry of Trade, Industry&Energy, Republic of Korea [20141720100610]	National Risk Assessment Partnership (NRAP) in the U.S. DOE Office of Fossil Energy's Carbon Sequestration Program; U.S. DOE(United States Department of Energy (DOE)); Korea Institute of Energy Technology Evaluation and Planning (KETEP) grant from the Ministry of Trade, Industry&Energy, Republic of Korea(Korea Institute of Energy Technology Evaluation & Planning (KETEP))	Funding of this research was provided by the National Risk Assessment Partnership (NRAP) in the U.S. DOE Office of Fossil Energy's Carbon Sequestration Program. PNNL is operated by Battelle for the U.S. DOE under Contract DE-AC06-76RLO 1830. Part of this research was performed at the W.R. Wiley Environmental Molecular Sciences Laboratory (EMSL), a national scientific user facility at PNNL managed by the Department of Energy's Office of Biological and Environmental Research. A portion of this work was supported by the Korea Institute of Energy Technology Evaluation and Planning (KETEP) grant from the Ministry of Trade, Industry&Energy, Republic of Korea (No. 20141720100610).	Bernsen J, 1986, INT C PATT REC ICPR; Blunt MJ, 2013, ADV WATER RESOUR, V51, P197, DOI 10.1016/j.advwatres.2012.03.003; Bradski G., 2000, DOBBS J SOFTWARE TOO; Brooks R.H., 1964, HYDROLOGY PAPERS COL, V7, P0026, DOI [10.13031/2013.40684, DOI 10.13031/2013.40684]; Brooks RH, 1966, P AM SOC CIVIL ENG, V92, P27; BURDINE NT, 1953, T AM I MIN MET ENG, V198, P71; Carey JW, 2007, INT J GREENH GAS CON, V1, P75, DOI 10.1016/S1750-5836(06)00004-1; Chen CY., 2005, LIQUID GAS RELATIVE; Chen S, 1998, ANNU REV FLUID MECH, V30, P329, DOI 10.1146/annurev.fluid.30.1.329; Clarkson CR, 2011, INT J COAL GEOL, V88, P204, DOI 10.1016/j.coal.2011.10.003; COREY AT, 1956, T AM I MIN MET ENG, V207, P358; Crow W, ENERGY PROCEDIA, P3561; Diomampo GP, 2001, RELATIVE PERMABILITY; FOURAR M, 1995, INT J MULTIPHAS FLOW, V21, P621, DOI 10.1016/0301-9322(95)00005-I; Hallaji M, 2015, CEMENT CONCRETE RES, V69, P10, DOI 10.1016/j.cemconres.2014.11.007; Hao L, 2010, INT J HEAT MASS TRAN, V53, P1908, DOI 10.1016/j.ijheatmasstransfer.2009.12.066; Huerta NJ, ENERGY PROCEDIA, P5398; Huo D, 2016, TRANSPORT POROUS MED, V113, P567, DOI 10.1007/s11242-016-0713-z; Iyer J, 2018, INT J GREENH GAS CON, V69, P72, DOI 10.1016/j.ijggc.2017.12.001; Jung HB, 2014, APPL GEOCHEM, V47, P1, DOI 10.1016/j.apgeochem.2014.04.010; Kabilan S, 2016, ENVIRON SCI TECHNOL, V50, P6180, DOI 10.1021/acs.est.6b00159; Kang QJ, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003951; Kim J, 2016, J PETROL SCI ENG, V139, P254, DOI 10.1016/j.petrol.2016.01.035; Klein NS, 2012, CEMENT CONCRETE RES, V42, P1611, DOI 10.1016/j.cemconres.2012.09.001; Klute A., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P687; Krevor SCM, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR010859; Kuprat A, 2001, J COMPUT PHYS, V172, P99, DOI 10.1006/jcph.2001.6816; Kutchko BG, 2007, ENVIRON SCI TECHNOL, V41, P4787, DOI 10.1021/es062828c; Kutchko BG, 2011, INT J GREENH GAS CON, V5, P880, DOI 10.1016/j.ijggc.2011.02.008; LaGriT, 2013, AL GRID TOOLB; Layssi H., 2015, CONCRETE INT, V37, P41; Lorensen W, 1987, 14 ANN C COMP GRAPH; Nicholl MJ, 1999, WATER RESOUR RES, V35, P3361, DOI 10.1029/1999WR900241; Okabe H, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066135; Pan C, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002120; Pereira GG, 2011, APPL MATH MODEL, V35, P1666, DOI 10.1016/j.apm.2010.09.043; Pernites RB, 2016, CEMENT CONCRETE COMP, V72, P89, DOI 10.1016/j.cemconcomp.2016.05.018; PERONA P, 1990, IEEE T PATTERN ANAL, V12, P629, DOI 10.1109/34.56205; Pineiro G, 2008, ECOL MODEL, V216, P316, DOI 10.1016/j.ecolmodel.2008.05.006; Porter ML, 2009, ADV WATER RESOUR, V32, P1632, DOI 10.1016/j.advwatres.2009.08.009; SAMET H, 1988, IEEE T PATTERN ANAL, V10, P579, DOI 10.1109/34.3918; Scheibe TD, 2015, WATER RESOUR RES, V51, P1023, DOI 10.1002/2014WR015959; Scheidegger A. E, 2008, PHYS LIQUID FLOW POR; Sengul O, 2008, ACI MATER J, V105, P541; Tang JS, 2013, IEEE SYS MAN CYBERN, P3026, DOI 10.1109/SMC.2013.516; Tartakovsky AM, 2009, COMPUT PHYS COMMUN, V180, P1874, DOI 10.1016/j.cpc.2009.06.002; TSANG YW, 1984, WATER RESOUR RES, V20, P1209, DOI 10.1029/WR020i009p01209; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; WANG JSY, 1985, WATER RESOUR RES, V21, P1861, DOI 10.1029/WR021i012p01861; Watanabe N, 2015, WATER RESOUR RES, V51, P2807, DOI 10.1002/2014WR016515; Wildenschild D, 2013, ADV WATER RESOUR, V51, P217, DOI 10.1016/j.advwatres.2012.07.018; Yan CL, 2014, ROCK MECH ROCK ENG, V47, P2199, DOI 10.1007/s00603-013-0496-2	54	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210741	10.1371/journal.pone.0210741	http://dx.doi.org/10.1371/journal.pone.0210741			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673742	Green Published, Green Submitted, gold			2022-12-26	WOS:000456442800051
J	Figueiro, TH; Arins, GCB; dos Santos, CES; Cembranel, F; de Medeiros, PA; d'Orsi, E; Rech, CR				Figueiro, Thamara Hubler; Budal Arins, Gabriel Claudino; Silva dos Santos, Carla Elane; Cembranel, Francieli; de Medeiros, Paulo Adao; d'Orsi, Eleonora; Rech, Cassiano Ricardo			Association of objectively measured sedentary behavior and physical activity with cardiometabolic risk markers in older adults	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIO-METABOLIC RISK; CARDIOVASCULAR-DISEASE; AEROBIC EXERCISE; LIGHT ACTIVITY; ALL-CAUSE; TIME; MORTALITY; HEALTH; FITNESS	Objective The aim of this study was to examine the associations between sedentary behavior and different intensities of physical activity with cardiometabolic risk, and to analyze the simultaneous effect of excess sedentary behavior and recommended levels of physical activity on cardiometabolic risk markers in older adults. Methods We conducted a population-based cross-sectional study on a sample of older adults (60+) living in Florianopolis, Brazil. The objectively measured predictors were sedentary time, light physical activity and moderate to vigorous physical activity, and the outcomes were markers of cardiometabolic risk. Data were considered valid when the participant had used the accelerometer for at least four days per week. Results The sample included 425 older adults (59.8% women), with a mean age of 73.9 years (95% CI: 73.5-74.4). Sedentary behavior was associated with lower systolic blood pressure levels (beta = -0.03; 95% CI: -0.05; -0.01) and lower HDL cholesterol (beta = -0.02; 95% CI: -0.02; -0.01). Light physical activity was not associated with any cardiovascular risk markers after adjustment. Each minute spent in moderate to vigorous physical activity was associated with lower waist circumference (beta = -0.15; 95% CI: -0.24; -0.05), systolic blood pressure (beta = -0.18; 95% CI: -0.32; -0.04) and plasma glucose (beta = -0.18; 95% CI: -0.33;-0.02), and with higher HDL cholesterol (beta = 0.10; 95% CI: 0.01;0.18). Moreover, physically inactive and sedentary individuals had a greater mean waist circumference and lower HDL cholesterol than physically active and non-sedentary subjects. Conclusion The results suggest that moderate to vigorous physical activity have a positive impact on cardiometabolic risk markers in older adults. Light physical activity does not appear to have a beneficial effect on the cardiometabolic markers, and despite the benefits provided by the different intensities of physical activity, the simultaneous presence of sedentary behavior and low physical activity level was associated with poor cardiometabolic risk markers.	[Figueiro, Thamara Hubler; de Medeiros, Paulo Adao] Univ Fed Santa Catarina, Postgrad Program Collect Hlth, Florianopolis, SC, Brazil; [Budal Arins, Gabriel Claudino; Silva dos Santos, Carla Elane] Univ Fed Santa Catarina, Postgrad Program Phys Educ, Florianopolis, SC, Brazil; [Cembranel, Francieli; d'Orsi, Eleonora] Univ Fed Santa Catarina, Dept Publ Hlth, Florianopolis, SC, Brazil; [d'Orsi, Eleonora] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Cardiovasc Hlth Program, Boston, MA USA; [Rech, Cassiano Ricardo] Univ Fed Santa Catarina, Dept Phys Educ, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); Harvard University; Harvard T.H. Chan School of Public Health; Universidade Federal de Santa Catarina (UFSC)	Figueiro, TH (corresponding author), Univ Fed Santa Catarina, Postgrad Program Collect Hlth, Florianopolis, SC, Brazil.	thamara.hf@gmail.com	Rech, Cassiano Ricardo/AAU-4340-2020; Figueiró, Thamara Hubler/AAE-8515-2019; Cembranel, Francieli/F-5788-2017; d'Orsi, Eleonora/D-1905-2015	Rech, Cassiano Ricardo/0000-0002-9647-3448; Figueiró, Thamara Hubler/0000-0001-6502-1396; Cembranel, Francieli/0000-0002-1205-0449; Arins, Gabriel/0000-0003-1057-2961; d'Orsi, Eleonora/0000-0003-2027-1089	Brazilian National Council for Scientific and Technological Development (CNPq) [475904/2013-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This article originates from the EpiFloripa Project 2013/2014 "Lipid profile, inflammatory markers, body composition, health conditions and habits of life in the elderly: a population-based longitudinal study in Florianopolis, SC, EpiFloripa 2013", Santa Catarina. This study was financed by the Brazilian National Council for Scientific and Technological Development (CNPq), grant number 475904/2013-3. This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001 and developed under the Postgraduate Program in Collective Health of the Federal University of Santa Catarina. The Bernard Lown Scholars in Cardiovascular Health Program from Harvard T.H. Chan School of Public Health payed the fees for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HM, 2016, AM J EPIDEMIOL, V183, P875, DOI 10.1093/aje/kwv305; Altenburg TM, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0090-3; [Anonymous], 2016, DEATHS CAUS AG SEX C; Bakrania K, 2015, BMC PUBLIC HEALTH, P16, DOI [10.1186/s12889-015-2621-5, DOI 10.1186/S12889-015-2621-5]; Barengo NC, 2017, J AM GERIATR SOC, V65, P504, DOI 10.1111/jgs.14694; Barreira TV, 2014, MAYO CLIN PROC, V89, P81, DOI 10.1016/j.mayocp.2013.10.001; Buman MP, 2014, AM J EPIDEMIOL, V179, P323, DOI 10.1093/aje/kwt292; Buonani C, 2013, MEDICINA, V46, P273; Carson V, 2014, PREV MED, V65, P23, DOI 10.1016/j.ypmed.2014.04.005; Celis-Morales CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036345; Schneider IJC, 2017, REV SAUDE PUBL, V51, DOI [10.11606/S1518-8787.2017051006776, 10.11606/s1518-8787.2017051006776]; Cleland VJ, 2008, AM J CLIN NUTR, V87, P1148, DOI 10.1093/ajcn/87.5.1148; deRezende LFM, 2014, COMPORTAMENTO SEDENT, DOI [10.11606/D.5.2014.tde-15082014, DOI 10.11606/D.5.2014.TDE-15082014]; Edwards MK, 2017, J CLIN LIPIDOL, V11, P119, DOI 10.1016/j.jacl.2016.10.014; Ferguson MA, 1998, J APPL PHYSIOL, V85, P1169, DOI 10.1152/jappl.1998.85.3.1169; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Gennuso KP, 2013, MED SCI SPORT EXER, V45, P1493, DOI 10.1249/MSS.0b013e318288a1e5; Gerage AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146078; Gorman E, 2014, EUR REV AGING PHYS A, V11, P35, DOI 10.1007/s11556-013-0132-x; Green AN, 2014, EUR J APPL PHYSIOL, V114, P907, DOI 10.1007/s00421-014-2822-0; Hamer M, 2014, MED SCI SPORT EXER, V46, P1946, DOI 10.1249/MSS.0000000000000317; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Harvey JA, 2015, J AGING PHYS ACTIV, V23, P471, DOI 10.1123/japa.2014-0164; Harvey JA, 2013, INT J ENV RES PUB HE, V10, P6645, DOI 10.3390/ijerph10126645; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Healy GN, 2011, AM J PREV MED, V41, P216, DOI 10.1016/j.amepre.2011.05.005; Henson J, 2013, DIABETOLOGIA, V56, P1012, DOI 10.1007/s00125-013-2845-9; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Holloszy JO, 2005, J APPL PHYSIOL, V99, P338, DOI 10.1152/japplphysiol.00123.2005; Howard B, 2015, MED SCI SPORT EXER, V47, P2093, DOI 10.1249/MSS.0000000000000631; Jefferis BJ, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0361-2; Jimenez-Pavon D, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-172; Judice PB, 2015, AGE, V37, DOI 10.1007/s11357-015-9760-6; Kim J, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-30; Knaeps S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160166; Kodama S, 2007, ARCH INTERN MED, V167, P999, DOI 10.1001/archinte.167.10.999; Kronenberg F, 2000, ATHEROSCLEROSIS, V153, P433, DOI 10.1016/S0021-9150(00)00426-3; Lamb MJE, 2016, DIABETOLOGIA, V59, P110, DOI 10.1007/s00125-015-3756-8; Lear SA, 2017, LANCET, V390, P2643, DOI 10.1016/S0140-6736(17)31634-3; Mann S, 2014, SPORTS MED, V44, P211, DOI 10.1007/s40279-013-0110-5; McPhee JS, 2016, BIOGERONTOLOGY, V17, P567, DOI 10.1007/s10522-016-9641-0; Migueles JH, 2017, SPORTS MED, V47, P1821, DOI 10.1007/s40279-017-0716-0; Mora S, 2007, CIRCULATION, V116, P2110, DOI 10.1161/CIRCULATIONAHA.107.729939; Myint PK, 2014, HEART, V100, P1613, DOI 10.1136/heartjnl-2014-305816; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; O'Donovan C, 2014, J PHYS ACT HEALTH, V11, P272, DOI 10.1123/jpah.2012-0075; PNUD IPEA FJP, 2013, ATL DES HUM; Qi QB, 2015, CIRCULATION, V132, P1560, DOI 10.1161/CIRCULATIONAHA.115.016938; Ramires VV, 2017, INT J BEHAV NUTR PHY, V14, P1, DOI [10.1186/s12966-016-0456-9, DOI 10.1186/S12966-016-0456-9]; Souza DD., 2010, REV BRAS HIPERTENS, V17, P103; Stamatakis E, 2012, INT J EPIDEMIOL, V41, P1328, DOI 10.1093/ije/dys077; Sun F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-449; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Tremblay MS, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0525-8; Ueshima K, 2010, AM J PREV MED, V38, P410, DOI 10.1016/j.amepre.2009.12.033; van der Velde JHPM, 2015, INT J ENV RES PUB HE, V12, P2330, DOI 10.3390/ijerph120302330; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wijndaele K, 2014, DIABETOLOGIA, V57, P305, DOI 10.1007/s00125-013-3102-y; Yano Y, 2015, J AM COLL CARDIOL, V65, P327, DOI 10.1016/j.jacc.2014.10.060	62	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210861	10.1371/journal.pone.0210861	http://dx.doi.org/10.1371/journal.pone.0210861			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657795	Green Published, Green Submitted, gold			2022-12-26	WOS:000456017000020
J	Souza, PWM; Giannini, TC; Jaffe, R; Giulietti, AM; Santos, DC; Nascimento, WR; Guimaraes, JTF; Costa, MF; Imperatriz-Fonseca, VL; Siqueira, JO				Souza-Filho, Pedro Walfir M.; Giannini, Tereza C.; Jaffe, Rodolfo; Giulietti, Ana M.; Santos, Diogo C.; Nascimento, Wilson R., Jr.; Guimaraes, Jose Tasso F.; Costa, Marlene F.; Imperatriz-Fonseca, Vera L.; Siqueira, Jose O.			Mapping and quantification of ferruginous outcrop savannas in the Brazilian Amazon: A challenge for biodiversity conservation	PLOS ONE			English	Article							LAND-USE; FOREST; CLASSIFICATION; DEFORESTATION; ACCURACY; IMPACTS; METAL	The eastern Brazilian Amazon contains many isolated ferruginous savanna ecosystem patches (locally known as 'canga vegetation') located on ironstone rocky outcrops on the top of plateaus and ridges, surrounded by tropical rainforests. In the Caraja's Mineral Province (CMP), these outcrops contain large iron ore reserves that have been exploited by opencast mining since the 1980s. The canga vegetation is particularly impacted by mining, since the iron ores that occur are associated with this type of vegetation and currently, little is known regarding the extent of canga vegetation patches before mining activities began. This information is important for quantifying the impact of mining, in addition to helping plan conservation programmes. Here, land cover changes of the Canga area in the CMP are evaluated by estimating the pre-mining area of canga patches and comparing it to the actual extent of canga patches. We mapped canga vegetation using geographic object-based image analysis (GEOBIA) from 1973 Landsat-1 MSS, 1984 and 2001 Landsat-5 TM, and 2016 Landsat-8 OLI images, and found that canga vegetation originally occupied an area of 144.2 km(2) before mining exploitation. By 2016, 19.6% of the canga area was lost in the CMP due to conversion to other land-use types (mining areas, pasturelands). In the Caraja's National Forest (CNF), located within the CMP, the original canga vegetation covered 105.2 km(2) (2.55% of the CNF total area), and in 2016, canga vegetation occupied an area of 77.2 km(2) (1.87%). Therefore, after more than three decades of mineral exploitation, less than 20% of the total canga area was lost. Currently, 21% of the canga area in the CMP is protected by the Campos Ferruginosos National Park. By documenting the initial extent of canga vegetation in the eastern Amazon and the extent to which it has been lost due to mining operations, the results of this work are the first step towards conserving this ecosystem.	[Souza-Filho, Pedro Walfir M.; Giannini, Tereza C.; Jaffe, Rodolfo; Giulietti, Ana M.; Nascimento, Wilson R., Jr.; Guimaraes, Jose Tasso F.; Imperatriz-Fonseca, Vera L.; Siqueira, Jose O.] Inst Tecnol Vale, Belem, Para, Brazil; [Souza-Filho, Pedro Walfir M.; Santos, Diogo C.] Univ Fed Para, Geosci Inst, Belem, Para, Brazil; [Costa, Marlene F.] Vale SA Parauapebas, Gerencia Meio Ambiente Minas Carajas, Dept Ferrosos Norte, Parauapebas, Para, Brazil	Instituto Tecnologico Vale Desenvolvimento Sustentavel; Universidade Federal do Para	Souza, PWM (corresponding author), Inst Tecnol Vale, Belem, Para, Brazil.; Souza, PWM (corresponding author), Univ Fed Para, Geosci Inst, Belem, Para, Brazil.	pedro.martins.souza@itv.org	Giannini, Tereza C/F-2676-2012; Imperatriz-Fonseca, Vera Lucia/AAU-7633-2021; Souza-Filho, Pedro Walfir M. M./J-4958-2012; Imperatriz-Fonseca, Vera Lucia/H-5582-2012; Jaffé, Rodolfo/K-3230-2013; Giulietti, Ana Maria/T-3917-2019; Guimarães, José Tasso Felix/D-2079-2013; Souza, Pedro/GZH-1275-2022; Giannini, Tereza Cristina/AAA-2958-2019	Imperatriz-Fonseca, Vera Lucia/0000-0002-1079-2158; Souza-Filho, Pedro Walfir M. M./0000-0003-0252-808X; Imperatriz-Fonseca, Vera Lucia/0000-0002-1079-2158; Jaffé, Rodolfo/0000-0002-2101-5282; Giulietti, Ana Maria/0000-0002-2754-0221; Guimarães, José Tasso Felix/0000-0002-5772-5104; Giannini, Tereza Cristina/0000-0001-9830-1204	Instituto Tecnologico Vale; Vale S.A.; CNPq	Instituto Tecnologico Vale; Vale S.A.; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study was funded by the Instituto Tecnologico Vale, a non-profit research institution. Vale S.A. provided support in the form of salary for author MFC but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The first (PWMSF), third (RJ), fourth (AMG), and seventh (JTFG) authors were supported by CNPq through research scholarships. The specific roles of this author are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Vale Institute of Technology (ITV) for its management support. The authors are also grateful to the Vale Mining Company for logistical support and to the United States Geological Survey (USGS) for providing the digital elevation model (SRTM, 1 arc-second) and Landsat images. The first (PWMSF), third (RJ), fourth (AMG), and seventh (JTFG) authors were supported by CNPq through research scholarships. This project was carried out in the Carajas National Forest under permission of IBAMA (SISBIO 35594-2).	Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; Blaschke T, 2014, ISPRS J PHOTOGRAMM, V87, P180, DOI 10.1016/j.isprsjprs.2013.09.014; Carmo FF, 2012, HOJE, V295, P49; Congalton R G, 2009, PHOTOGRAMM REC, V2, P183; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Desclee B, 2006, REMOTE SENS ENVIRON, V102, P1, DOI 10.1016/j.rse.2006.01.013; Dorr JohnVanN., 1964, ECON GEOL, V59, P1203, DOI DOI 10.2113/GSECONGEO.59.7.1203; Dragut L, 2010, INT J GEOGR INF SCI, V24, P859, DOI 10.1080/13658810903174803; Duveiller G, 2008, REMOTE SENS ENVIRON, V112, P1969, DOI 10.1016/j.rse.2007.07.026; Fearnside Philip M., 2013, Environment Development and Sustainability, V15, P325, DOI 10.1007/s10668-012-9412-2; Fernandes GW, 2014, NAT CONSERVACAO, V12, P162, DOI 10.1016/j.ncon.2014.08.003; Gastauer M, 2019, AMBIO, V48, P74, DOI 10.1007/s13280-018-1053-8; Gibson N, 2012, J ARID ENVIRON, V77, P25, DOI 10.1016/j.jaridenv.2011.08.021; Gibson N, 2010, BIODIVERS CONSERV, V19, P3951, DOI 10.1007/s10531-010-9939-1; Goncalves A.R., 2016, PLANO MANEJO FLOREST, V1; Goncalves A.R., 2016, PLANO MANEJO FLOREST, VII; Grainger CJ, 2008, ORE GEOL REV, V33, P451, DOI 10.1016/j.oregeorev.2006.10.010; Jacobi CM, 2007, BIODIVERS CONSERV, V16, P2185, DOI 10.1007/s10531-007-9156-8; Jacobi CM, 2011, AMBIO, V40, P540, DOI 10.1007/s13280-011-0151-7; Jaffe R, 2018, PEERJ, V6, DOI 10.7717/peerj.4531; Jaffe R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168348; Lanes EC, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00532; Lobo FD, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8070579; Lowe SH, 2011, IEEE J-STARS, V4, P890, DOI 10.1109/JSTARS.2011.2157659; Lu DS, 2013, INT J REMOTE SENS, V34, P5953, DOI 10.1080/01431161.2013.802825; Madeira JA, 2015, GEOSSISTEMAS FERRUGI, P521; Martins F.D., 2014, DIVERSIDADE CABE UNI, P580; Maurity Clovis Wagner, 1995, Boletim do Museu Paraense Emilio Goeldi Serie Ciencias da Terra, V7, P331; Morris RJ, 2010, PHILOS T R SOC B, V365, P3709, DOI 10.1098/rstb.2010.0273; Mota Nara Furtado de Oliveira, 2018, Rodriguésia, V69, P1435, DOI 10.1590/2175-7860201869336; Pilo LB, 2015, WOR GEOMORPHOL LANDS, P273, DOI 10.1007/978-94-017-8023-0_25; Radoux J, 2011, INT J GEOGR INF SCI, V25, P895, DOI 10.1080/13658816.2010.498378; Rasi R, 2011, REMOTE SENS ENVIRON, V115, P3659, DOI 10.1016/j.rse.2011.09.004; Rezende NP, 1972, DISTRITO FERRI UNPUB; Rizzini CT, 1979, TRATADO FITOGEOGRAFI; Sahoo PK, 2016, AN ACAD BRAS CIENC, V88, P2211, DOI 10.1590/0001-3765201620160354; Salomao GN, 2018, GEOCHIM BRAS, V21, DOI DOI 10.21715/GB2358-2812.2018322180; Sandstrom H, 2006, GEOCHEMICAL ATLAS 1; Silveira FAO, 2016, PLANT SOIL, V403, P129, DOI 10.1007/s11104-015-2637-8; Sonter LJ, 2014, CONSERV BIOL, V28, P1068, DOI 10.1111/cobi.12260; Sonter LJ, 2014, GLOBAL ENVIRON CHANG, V26, P63, DOI 10.1016/j.gloenvcha.2014.03.014; Souza CM, 2013, REMOTE SENS-BASEL, V5, P5493, DOI 10.3390/rs5115493; Souza PWM, 2015, INT ARCH PHOTOGRAMM, V47, P1491, DOI 10.5194/isprsarchives-XL-7-W3-1491-2015; Souza PWM, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10111683; STORY M, 1986, PHOTOGRAMM ENG REM S, V52, P397; Takahasi A., 2015, GEOSSISTEMAS FERRUGI, P317; TARPLEY JD, 1984, J CLIM APPL METEOROL, V23, P491, DOI 10.1175/1520-0450(1984)023<0491:GVIFTN>2.0.CO;2; Tassinari CCG, 1999, EPISODES, V22, P174; TOLBERT GE, 1971, ECON GEOL, V66, P985, DOI 10.2113/gsecongeo.66.7.985; Vale, 2012, VAL NOSS HIST; Vale, 2017, SUST REP 2017; Viana Pedro Lage, 2016, Rodriguésia, V67, P1107, DOI 10.1590/2175-7860201667501; Vidrih Ferreira GLB, 2011, MEIO AMBIENTE MINERA, V11, P111, DOI [10.15600/2238-1228/cd.v11n20p111-124, DOI 10.15600/2238-1228/CD.V11N20P111-124]	53	31	31	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0211095	10.1371/journal.pone.0211095	http://dx.doi.org/10.1371/journal.pone.0211095			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653607	Green Published, Green Submitted, gold			2022-12-26	WOS:000456015500099
J	Vanbutsele, G; Deliens, L; Cocquyt, V; Cohen, J; Pardon, K; Chambaere, K				Vanbutsele, Gaelle; Deliens, Luc; Cocquyt, Veronique; Cohen, Joachim; Pardon, Koen; Chambaere, Kenneth			Use and timing of referral to specialized palliative care services for people with cancer: A mortality follow-back study among treating physicians in Belgium	PLOS ONE			English	Article							OF-LIFE PRACTICES; SYMPTOM BURDEN; HEMATOLOGICAL MALIGNANCIES; PATIENT; INTEGRATION; OUTCOMES; HEALTH; EUTHANASIA; ENROLLMENT; BARRIERS	Background Referral to specialized palliative care services (SPCS) occurs often late in the illness trajectory but may differ across cancer types. We examined differences between cancer types in the use and timing of referral to specialized palliative care services (SPCS) and in the reasons for non-referral. Methods We conducted a population-based mortality follow-back survey among physicians who certified a representative sample of deaths in Flanders, Belgium. We focused only on sampled death cases of cancer (n = 2392). The questionnaire asked about the use of the existing types of SPCS and the timing of referral to these services. Results Response rate was 58% (1394/2392). Patients who died from breast, respiratory, head and neck, genitourinary or gastrointestinal cancer had higher chances of using SPCS compared to hematologic cancer patients. The most prevalent reason for non-referral was that regular care sufficiently addressed palliative and supportive care needs (51%). This differed significantly between cancer types ranging from 77,8% for breast cancer and 42.1% for hematologic cancer. A second prevalent reason for not using SPCS was that it was not meaningful (enough) (23.9%), particularly for hematologic malignancies (35,1%) and only in 5.3% for breast cancer. Conclusion Differences in referral across different types of cancer were found. Referral is more often delayed or not initiated for patients with hematologic cancer, possibly due to differences in illness trajectory. An influencing reason is that physicians perceive palliative care as not meaningful or not meaningful enough for these patients which may be linked to the uncertainty in the disease trajectory of hematologic malignancies.	[Vanbutsele, Gaelle; Deliens, Luc; Cohen, Joachim; Pardon, Koen; Chambaere, Kenneth] Vrije Univ Brussel, End Of Life Care Res Grp, Brussels, Belgium; [Vanbutsele, Gaelle; Deliens, Luc; Cohen, Joachim; Pardon, Koen; Chambaere, Kenneth] Univ Ghent, Brussels, Belgium; [Vanbutsele, Gaelle; Deliens, Luc; Chambaere, Kenneth] Univ Ghent, Dept Publ Hlth & Primary Care, Ghent, Belgium; [Cocquyt, Veronique] Ghent Univ Hosp, Dept Med Oncol, Ghent, Belgium	Vrije Universiteit Brussel; Ghent University; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital	Vanbutsele, G; Pardon, K; Chambaere, K (corresponding author), Vrije Univ Brussel, End Of Life Care Res Grp, Brussels, Belgium.; Vanbutsele, G; Pardon, K; Chambaere, K (corresponding author), Univ Ghent, Brussels, Belgium.; Vanbutsele, G; Chambaere, K (corresponding author), Univ Ghent, Dept Publ Hlth & Primary Care, Ghent, Belgium.	gaelle.vanbutsele@uzgent.be; koen.pardon@vub.be; Kenneth.chambaere@vub.be	Cohen, Joachim/B-6803-2008; Chambaere, Kenneth/ACV-2311-2022	Cohen, Joachim/0000-0002-7224-9476; Pardon, Koen/0000-0002-0571-709X; Vanbutsele, Gaelle/0000-0003-0284-8585	Flemish government agency for Innovation by Science and Technology (Agentschap voor Innovatie door Wetenschap en Technologie) (SBO IWT) [100036]; Research Foundation Flanders (Fonds Wetenschappelijk Onderzoek) (FWO) [G018012N]; Belgian society Kom Op Tegen Kanker; scientific fund Willy Gepts (UZ Brussel)	Flemish government agency for Innovation by Science and Technology (Agentschap voor Innovatie door Wetenschap en Technologie) (SBO IWT); Research Foundation Flanders (Fonds Wetenschappelijk Onderzoek) (FWO)(FWO); Belgian society Kom Op Tegen Kanker; scientific fund Willy Gepts (UZ Brussel)	This study is part of the 'Flanders Study to Improve End-of-Life Care and Evaluation Tools (FLIECE) project', a collaboration between the Vrije Universiteit Brussel, Ghent University, the Katholieke Universiteit Leuven, Belgium, and VU University Medical Centre Amsterdam, the Netherlands. This study is supported by a grant from the Flemish government agency for Innovation by Science and Technology (Agentschap voor Innovatie door Wetenschap en Technologie) (SBO IWT nr. 100036). The first author, Gaelle Vanbutsele, was funded by a grant from the Research Foundation Flanders (Fonds Wetenschappelijk Onderzoek) (FWO nr. G018012N), by the Belgian society Kom Op Tegen Kanker and by the scientific fund Willy Gepts (UZ Brussel). The funding sources had no role in the design and collection, analysis, and interpretation of data and in writing the manuscript.	Ahmed N, 2004, PALLIATIVE MED, V18, P525, DOI 10.1191/0269216304pm921oa; Ansell P, 2007, PALLIATIVE MED, V21, P487, DOI 10.1177/0269216307082020; Auret K, 2003, INTERN MED J, V33, P566, DOI 10.1111/j.1445-5994.2003.00490.x; Bakitas M, 2009, JAMA-J AM MED ASSOC, V302, P741, DOI 10.1001/jama.2009.1198; Bauman JR, 2014, J NATL COMPR CANC NE, V12, P1763, DOI 10.6004/jnccn.2014.0177; Beernaert K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137251; Beernaert K, 2014, PALLIATIVE MED, V28, P480, DOI 10.1177/0269216314522318; Beernaert K, 2013, RESP MED, V107, P1731, DOI 10.1016/j.rmed.2013.06.003; Bekelman JE, 2016, JAMA-J AM MED ASSOC, V315, P272, DOI 10.1001/jama.2015.18603; Bennett MI, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012576; Bilsen J, 2009, NEW ENGL J MED, V361, P1119, DOI 10.1056/NEJMc0904292; Brickner Leslea, 2004, J Palliat Med, V7, P411, DOI 10.1089/1096621041349518; Bruera E, 2010, J CLIN ONCOL, V28, P4013, DOI 10.1200/JCO.2010.29.5618; Burge F, 2002, PALLIATIVE MED, V16, P255, DOI 10.1191/0269216302pm550xx; Casarett D, 2006, J AM GERIATR SOC, V54, P472, DOI 10.1111/j.1532-5415.2005.00628.x; Chambaere K, 2015, NEW ENGL J MED, V372, P1179, DOI 10.1056/NEJMc1414527; Chambaere K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-299; Cheung WY, 2009, SUPPORT CARE CANCER, V17, P1223, DOI 10.1007/s00520-009-0577-7; Cleeland CS, 2013, CANCER-AM CANCER SOC, V119, P4333, DOI 10.1002/cncr.28376; Costantini M, 1999, J PAIN SYMPTOM MANAG, V18, P243, DOI 10.1016/S0885-3924(99)00084-6; Deliens L, 2000, LANCET, V356, P1806, DOI 10.1016/S0140-6736(00)03233-5; Fadul N, 2007, J PALLIAT MED, V10, P1146, DOI 10.1089/jpm.2006.0259; Fadul NA, 2008, J PALLIAT MED, V11, P422, DOI 10.1089/jpm.2007.0184; Federale Evaluatiecel Palliatieve Zorg, 2014, EV PALL ZORG; Good PD, 2004, J PAIN SYMPTOM MANAG, V27, P310, DOI 10.1016/j.jpainsymman.2003.12.011; Howell DA, 2011, PALLIATIVE MED, V25, P630, DOI 10.1177/0269216310391692; Hui D, 2015, ONCOLOGIST, V20, P77, DOI 10.1634/theoncologist.2014-0312; Hui D, 2014, CANCER-AM CANCER SOC, V120, P1743, DOI 10.1002/cncr.28628; Hui D, 2012, ONCOLOGIST, V17, P1574, DOI 10.1634/theoncologist.2012-0192; Hui D, 2010, JAMA-J AM MED ASSOC, V303, P1054, DOI 10.1001/jama.2010.258; Hunt RW, 2002, PALLIATIVE MED, V16, P403, DOI 10.1191/0269216302pm571oa; Johnson C, 2011, J PALLIAT MED, V14, P429, DOI 10.1089/jpm.2010.0259; Kaasa S, 2015, PALLIATIVE CARE ONCO, P299; Kavalieratos D, 2016, JAMA-J AM MED ASSOC, V316, P2104, DOI 10.1001/jama.2016.16840; Kwon JH, 2013, J PALLIAT MED, V16, P148, DOI 10.1089/jpm.2012.0344; Lamont EB, 2002, CANCER, V94, P2733, DOI 10.1002/cncr.10530; LeBlanc TW, 2015, J ONCOL PRACT, V11, pE230, DOI 10.1200/JOP.2014.001859; Love AW, 2014, PROG PALLIAT CARE, V22, P9, DOI 10.1179/1743291X13Y.0000000055; Manitta V, 2011, J PAIN SYMPTOM MANAG, V42, P432, DOI 10.1016/j.jpainsymman.2010.12.008; Manitta VJ, 2010, J PALLIAT MED, V13, P1021, DOI 10.1089/jpm.2009.0267; McCaughan D, 2018, BMC PALLIAT CARE, V17, DOI 10.1186/s12904-018-0289-1; McCaughan D, 2018, BMJ SUPPORT PALLIAT, V8, P78, DOI 10.1136/bmjspcare-2016-001289; McGrath P, 2007, EUR J CANCER CARE, V16, P164, DOI 10.1111/j.1365-2354.2006.00745.x; McGrath Pam, 2002, Am J Hosp Palliat Care, V19, P103, DOI 10.1177/104990910201900208; Morita T, 2002, PALLIATIVE MED, V16, P185, DOI 10.1191/0269216302pm524oa; Pardon K, 2013, J CLIN ONCOL, V31, P1450, DOI 10.1200/JCO.2012.44.5916; Quill TE, 2013, NEW ENGL J MED, V368, P1173, DOI 10.1056/NEJMp1215620; Rehse B, 2003, PATIENT EDUC COUNS, V50, P179; Rosenwax LK, 2006, PALLIATIVE MED, V20, P439, DOI 10.1191/0269216306pm1146oa; Schmidt H, 2015, J PAIN SYMPTOM MANAG, V49, P118, DOI 10.1016/j.jpainsymman.2014.04.007; Sepulveda C, 2002, J PAIN SYMPTOM MANAG, V24, P91, DOI 10.1016/S0885-3924(02)00440-2; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Vanbutsele G, 2018, LANCET ONCOL, V19, P394, DOI 10.1016/S1470-2045(18)30060-3; Walshe C, 2008, SOC SCI MED, V67, P137, DOI 10.1016/j.socscimed.2008.03.027; Zimmermann C, 2016, LEUKEMIA RES, V48, P78, DOI 10.1016/j.leukres.2016.07.012; Zimmermann C, 2014, LANCET, V383, P1721, DOI 10.1016/S0140-6736(13)62416-2	56	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210056	10.1371/journal.pone.0210056	http://dx.doi.org/10.1371/journal.pone.0210056			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653508	gold, Green Submitted, Green Published			2022-12-26	WOS:000456015500025
J	Sommer, K; Jakob, H; Badjlan, F; Henrich, D; Frank, J; Marz, I; Sander, AL				Sommer, Katharina; Jakob, Heike; Badjlan, Farsin; Henrich, Dirk; Frank, Johannes; Marz, Ingo; Sander, Anna Lena			11,12 and 14,15 epoxyeicosatrienoic acid rescue deteriorated wound healing in ischemia	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NEOVASCULARIZATION; EPITHELIALIZATION; PROLIFERATION; MIGRATION; BETA	Introduction Epoxyeicosatrienoic acids (EETs) are able to enhance angiogenesis and regulate inflammation that is especially important in wound healing under ischemic conditions. Thus, we evaluated the effect of local EET application on ischemic wounds in mice. Methods Ischemia was induced by cautherization of two of the three supplying vessels to the mouse ear. Wounding was performed on the ear three days later. Wounds were treated either with 11,12 or 14,15 EET and compared to untreated control and normal wounds. Epithelialization was measured every second day. VEGF, TNF-alpha, TGF-beta, matrix metalloproteinases (MMP), tissue inhibitors of metalloproteinases (TIMP), Ki67, and SDF-1 alpha were evaluated immuno-histochemically in wounds on day 3, 6, and 9. Results Ischemia delayed wound closure (12.8 days +/- 1.9 standard deviation (SD) for ischemia and 8.0 days +/- 0.94 SD for control). 11,12 and14,15 EET application ameliorated deteriorated wound healing on ischemic ears (7.6 +/- 1.3 SD for 11,12 EET and 9.2 +/- 1.4 SD for 14,15 EET). Ischemia did not change VEGF, TNF-alpha, TGF-beta, SDF-1 alpha, TIMP, MMP7 or MMP9 level significantly compared to control. Local application of 11,12 as well as 14,15 EET induced a significant elevation of VEGF, TGF-beta, and SDF-1 alpha expression as well as proliferation during the whole phase of wound healing compared to control and ischemia alone. Conclusion In summary, EET improve impaired wound healing caused by ischemia as they enhance neovascularization and alter inflammatory response in wounds. Thus elevating lipid mediator level as 11,12 and 14,15 EET in wounds might be a successful strategy for amelioration of deranged wound healing under ischemia.	[Sommer, Katharina; Badjlan, Farsin; Henrich, Dirk; Frank, Johannes; Marz, Ingo; Sander, Anna Lena] Hosp Johann Wolfgang Goethe Univ, Dept Trauma Hand & Reconstruct Surg, Frankfurt, Germany; [Jakob, Heike] Marienhausklin St Josef Kohlhof, Dept Trauma Hand & Reconstruct Surg, Neunkirchen, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital	Sommer, K (corresponding author), Hosp Johann Wolfgang Goethe Univ, Dept Trauma Hand & Reconstruct Surg, Frankfurt, Germany.	katharina.sommer@kgu.de						Barker John H., 1994, Wound Repair and Regeneration, V2, P138, DOI 10.1046/j.1524-475X.1994.20208.x; Bernatchez PN, 1999, J BIOL CHEM, V274, P31047, DOI 10.1074/jbc.274.43.31047; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chen WS, 2015, CELL PHYSIOL BIOCHEM, V35, P2043, DOI 10.1159/000374011; Faler Byron J, 2006, Perspect Vasc Surg Endovasc Ther, V18, P55, DOI 10.1177/153100350601800123; Florin L, 2005, J CELL SCI, V118, P1981, DOI 10.1242/jcs.02303; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; Jiang JG, 2007, CANCER RES, V67, P6665, DOI 10.1158/0008-5472.CAN-06-3643; KAMLER M, 1993, EUR SURG RES, V25, P30, DOI 10.1159/000129254; Kyriakides TR, 2009, MATRIX BIOL, V28, P65, DOI 10.1016/j.matbio.2009.01.001; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Michaelis UR, 2005, J CELL SCI, V118, P5489, DOI 10.1242/jcs.02674; Nissen NN, 1998, AM J PATHOL, V152, P1445; Panigrahy D, 2013, P NATL ACAD SCI USA, V110, P13528, DOI 10.1073/pnas.1311565110; RAPALA K, 1991, EUR SURG RES, V23, P261, DOI 10.1159/000129163; Rodero MP, 2010, INT J CLIN EXP PATHO, V3, P643; Sander AL, 2013, J SURG RES, V182, P362, DOI 10.1016/j.jss.2012.10.034; Sander AL, 2011, J SURG RES, V165, P165, DOI 10.1016/j.jss.2009.07.003; Sander AL, 2011, LANGENBECK ARCH SURG, V396, P1245, DOI 10.1007/s00423-011-0838-z; Silvestre JS, 2008, CARDIOVASC RES, V78, P242, DOI 10.1093/cvr/cvn027; Sommer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073992; STEENFOS HH, 1994, SCAND J PLAST RECONS, V28, P95, DOI 10.3109/02844319409071186; Toriseva M, 2009, CELL MOL LIFE SCI, V66, P203, DOI 10.1007/s00018-008-8388-4; Tredget EB, 2005, WOUND REPAIR REGEN, V13, P61, DOI 10.1111/j.1067-1927.2005.130108.x; Wang Y, 2005, J PHARMACOL EXP THER, V314, P522, DOI 10.1124/jpet.105.083477; Weinstein DA, 2010, J AM ACAD DERMATOL, V63, P146, DOI 10.1016/j.jaad.2009.08.004; Zhang F, 2003, BRIT J PLAST SURG, V56, P334, DOI 10.1016/S0007-1226(03)00175-9	28	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209158	10.1371/journal.pone.0209158	http://dx.doi.org/10.1371/journal.pone.0209158			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650075	gold, Green Published, Green Submitted			2022-12-26	WOS:000455813300008
J	Takagaki, M; Kinoshita, M; Kawaguchi, A; Murasawa, A; Nakao, K; Nakamura, H; Kishima, H				Takagaki, Masatoshi; Kinoshita, Manabu; Kawaguchi, Atsushi; Murasawa, Akira; Nakao, Kazutami; Nakamura, Hajime; Kishima, Haruhiko			Relationship between normalized distributional pattern and functional outcome in patients with acute cardiogenic cerebral embolism	PLOS ONE			English	Article							EARLY DECOMPRESSIVE CRANIECTOMY; IMAGING LESION VOLUME; ARTERY INFARCTION; INTRAVENOUS THROMBOLYSIS; ISCHEMIC-STROKE; DIFFUSION; PROPENSITY; PREDICTION; TRIAL	This study aimed to elucidate spatial characteristics for magnetic resonance imaging (MRI) of cardiogenic cerebral embolism, to determine imaging biomarkers predicting patient outcome and cerebral herniation in cardioembolic stroke. This retrospective study assessed 90 patients with cardiogenic cerebral embolism. All images from MRI were normalized using a voxel-based symptom lesion mapping technique. Patients were categorized into two sub-groups based on the outcome and presence of cerebral herniation. Each subgroup was assessed individually. The distribution map of all analyzed patients revealed accumulated ischemic lesions in bilateral middle cerebral artery areas. Ischemic lesions for the poor outcome group accumulated at the corona radiata on the right side and throughout the entire left hemisphere. Receiver operating characteristic (ROC) analysis suggested that a normalized ischemic volume of 62.8 mL allowed optimal differentiation between good and poor outcomes (sensitivity, 0.923; specificity, 0.923; area under the curve (AUC), 0.91) for left-side-dominant infarction. The distribution map for the cerebral herniation group revealed large ischemic areas in the left hemisphere. The analysis of differential involvement map with random permutation analysis showed that left anterior circulation infarcts were associated with midline shift. Receiver operating characteristic analysis revealed that a normalized infarction volume of 192.9 mL was highly predictive of cerebral herniation (sensitivity, 0.929; specificity, 0.750; AUC, 0.895). The medial frontal and occipital lobes, caudate head and basal ganglia were significantly involved in those patients who developed cerebral herniation. Ischemic volume contributed to outcomes and cerebral herniation. Ischemic lesions of the anterior and posterior cerebral arteries and basal ganglia in addition to middle cerebral artery area were identified as differences on MRI images between with and without cerebral herniation patients.	[Takagaki, Masatoshi; Murasawa, Akira; Nakao, Kazutami] Kawachi Gen Hosp, Dept Neurosurg, Osaka, Japan; [Takagaki, Masatoshi; Kinoshita, Manabu] Osaka Int Canc Inst, Dept Neurosurg, Osaka, Japan; [Takagaki, Masatoshi; Nakamura, Hajime; Kishima, Haruhiko] Osaka Univ, Grad Sch Med, Dept Neurosurg, Osaka, Japan; [Kawaguchi, Atsushi] Saga Univ, Fac Med, Ctr Comprehens Community Med, Saga, Japan	Osaka University; Saga University	Takagaki, M (corresponding author), Kawachi Gen Hosp, Dept Neurosurg, Osaka, Japan.; Takagaki, M (corresponding author), Osaka Int Canc Inst, Dept Neurosurg, Osaka, Japan.; Takagaki, M (corresponding author), Osaka Univ, Grad Sch Med, Dept Neurosurg, Osaka, Japan.	m-takagaki@nsurg.med.osaka-u.ac.jp	Nakamura, Hajime/GPK-0454-2022	Kinoshita, Manabu/0000-0001-7923-6902	Japan Society for the Promotion of Science KAKENHI [16K20032]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 16K20032 (https://www.jsps.go.jp/english/index.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiha T, 2017, J STROKE CEREBROVASC, V26, P1521, DOI 10.1016/j.jstrokecerebrovasdis.2017.02.038; Albers GW, 2006, ANN NEUROL, V60, P508, DOI 10.1002/ana.20976; Amarenco P, 2013, CEREBROVASC DIS, V36, P1, DOI 10.1159/000352050; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Carr IA, 2013, AM J PHYSIOL-HEART C, V305, pH732, DOI 10.1152/ajpheart.00320.2013; Cheng B, 2014, STROKE, V45, P1695, DOI 10.1161/STROKEAHA.114.005152; Cho DY, 2003, SURG NEUROL, V60, P227, DOI 10.1016/S0090-3019(03)00266-0; Ellingson BM, 2012, NEUROIMAGE, V59, P908, DOI 10.1016/j.neuroimage.2011.09.076; Golsari A, 2015, STROKE, V46, P1004, DOI 10.1161/STROKEAHA.114.007292; Goto Y, 2016, J STROKE CEREBROVASC, V25, P1389, DOI 10.1016/j.jstrokecerebrovasdis.2015.12.034; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kemmling A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071141; Kim HJ, 2011, STROKE, V42, P2323, DOI 10.1161/STROKEAHA.111.616573; Kinoshita M, 2014, NEURO-ONCOLOGY, V16, P728, DOI 10.1093/neuonc/not319; Kruetzelmann A, 2011, STROKE, V42, P1251, DOI 10.1161/STROKEAHA.110.600148; Meyer JS, 1971, STROKE, V2, P541, DOI 10.1161/01.STR.2.6.541; Meyer S, 2016, NEUROIMAGE-CLIN, V10, P257, DOI 10.1016/j.nicl.2015.12.005; Oppenheim C, 2000, STROKE, V31, P2175, DOI 10.1161/01.STR.31.9.2175; Park KY, 2014, SCAND CARDIOVASC J, V48, P335, DOI 10.3109/14017431.2014.983964; Payabvash S, 2017, BRIT J RADIOL, V90, DOI 10.1259/bjr.20160869; Rastogi V, 2015, J NEUROL SCI, V353, P20, DOI 10.1016/j.jns.2015.04.036; Rovira A, 2005, EUR RADIOL, V15, P416, DOI 10.1007/s00330-004-2633-5; Slezins J, 2012, MEDICINA-LITHUANIA, V48, P521, DOI 10.3390/medicina48100076; Streib CD, 2016, NEUROL-CLIN PRACT, V6, P433, DOI 10.1212/CPJ.0000000000000272; Takano K, 2015, NEURO-ONCOLOGY, P1, DOI [10.1093/neuonc/nou334, DOI 10.1093/NEUONC/NOU334]; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Yoo AJ, 2012, STROKE, V43, P1323, DOI 10.1161/STROKEAHA.111.639401; Yoo AJ, 2009, STROKE, V40, P2046, DOI 10.1161/STROKEAHA.108.541656; Zaidi SF, 2012, STROKE, V43, P3238, DOI 10.1161/STROKEAHA.112.671594	30	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210709	10.1371/journal.pone.0210709	http://dx.doi.org/10.1371/journal.pone.0210709			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645646	gold, Green Published, Green Submitted			2022-12-26	WOS:000455810200044
J	Yamazaki, D; Hasegawa, A; Funato, Y; Tran, HN; Mori, MX; Mori, Y; Sato, T; Miki, H				Yamazaki, Daisuke; Hasegawa, Ayaka; Funato, Yosuke; Ha Nam Tran; Mori, Masayuki X.; Mori, Yasuo; Sato, Toshiro; Miki, Hiroaki			Cnnm4 deficiency suppresses Ca2+ signaling and promotes cell proliferation in the colon epithelia	ONCOGENE			English	Article							CONE-ROD DYSTROPHY; ION-CHANNEL; SMALL-INTESTINE; STEM-CELLS; MG2+; MUTATIONS; ORGANOIDS	CNNM4 is a Mg2+ transporter highly expressed in the colon epithelia. Its importance in regulating intracellular Mg2+ levels and cancer development has been documented, but how CNNM4 function affects the dynamic homeostasis of the epithelial tissue remains unclear. Here, we show that Cnnm4 deficiency promotes cell proliferation and partly suppresses cell differentiation in the colon epithelia, making them vulnerable to cancer development. Such phenotypic characteristics are highly similar to those of mice lacking Trpv1, which encodes the cation channel involved in capsaicin-stimulated Ca2+ influx. Indeed, Ca2+-imaging analyses using the organoid culture reveal that Ca2+ influx stimulated by capsaicin is greatly impaired by Cnnm4 deficiency. Moreover, EGF receptor signaling is constitutively activated in the colon epithelia of Cnnm4-deficient mice, as is the case with Trpv1-deficient mice. The administration of gefitinib, a clinically available inhibitor of EGF receptor, cancels the augmented proliferation of cells observed in Cnnm4-deficient mice. Collectively, these results establish the functional interplay between Mg2+ and Ca2+ in the colon epithelia, which is crucial for maintaining the dynamic homeostasis of the epithelial tissue.	[Yamazaki, Daisuke; Hasegawa, Ayaka; Funato, Yosuke; Miki, Hiroaki] Osaka Univ, Microbial Dis Res Inst, Dept Cellular Regulat, Suita, Osaka 5650871, Japan; [Ha Nam Tran; Mori, Masayuki X.; Mori, Yasuo] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto 6158510, Japan; [Ha Nam Tran] Kyoto Univ, Grad Sch Global Environm Studies, Dept Technol & Ecol, Kyoto 6158510, Japan; [Sato, Toshiro] Keio Univ, Sch Med, Dept Gastroenterol, Shinjuku Ku, Tokyo 1608582, Japan	Osaka University; Kyoto University; Kyoto University; Keio University	Miki, H (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Cellular Regulat, Suita, Osaka 5650871, Japan.	hmiki@biken.osaka-u.ac.jp	Mori, Masayuki/AAI-6992-2020; Sato, Toshiro/J-3522-2014	TRAN, Ha Nam/0000-0002-4802-4541; Sato, Toshiro/0000-0001-8353-8137				Arteaga CL, 2001, CURR OPIN ONCOL, V13, P491, DOI 10.1097/00001622-200111000-00012; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Basak O, 2017, CELL STEM CELL, V20, P177, DOI 10.1016/j.stem.2016.11.001; Bessette DC, 2008, CANCER METAST REV, V27, P231, DOI 10.1007/s10555-008-9121-3; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; de Jong PR, 2014, J CLIN INVEST, V124, P3793, DOI 10.1172/JCI72340; Funato Y, 2018, J PHYSIOL-LONDON, V596, P743, DOI 10.1113/JP275248; Funato Y, 2014, J CLIN INVEST, V124, P5398, DOI 10.1172/JCI76614; Gimenez-Mascarell P, 2017, J BIOL CHEM, V292, P786, DOI 10.1074/jbc.M116.759944; Gunther T, 2006, MAGNESIUM RES, V19, P225; Gulerez I, 2016, EMBO REP, V17, P1890, DOI 10.15252/embr.201643393; Hardy S, 2015, ONCOGENE, V34, P986, DOI 10.1038/onc.2014.33; Hirata Y, 2014, J BIOL CHEM, V289, P14731, DOI 10.1074/jbc.M114.551176; ITO S, 1965, J CELL BIOL, V27, P475, DOI 10.1083/jcb.27.3.475; Luo JL, 2012, J INVEST DERMATOL, V132, P2158, DOI 10.1038/jid.2012.144; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; OCONNOR DT, 1983, LIFE SCI, V33, P1657, DOI 10.1016/0024-3205(83)90721-X; Parry DA, 2009, AM J HUM GENET, V84, P266, DOI 10.1016/j.ajhg.2009.01.009; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Polok B, 2009, AM J HUM GENET, V84, P259, DOI 10.1016/j.ajhg.2009.01.006; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Romani AMP, 2011, ARCH BIOCHEM BIOPHYS, V512, P1, DOI 10.1016/j.abb.2011.05.010; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Vinuesa AG, 2012, CANCER RES, V72, P1705, DOI 10.1158/0008-5472.CAN-11-3693; Yamazaki D, 2016, J CELL SCI, V129, P1940, DOI 10.1242/jcs.182220; Yamazaki D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003983; Yang F, 2014, J GEN PHYSIOL, V143, P91, DOI 10.1085/jgp.201311024	30	10	10	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 16	2019	38	20					3962	3969		10.1038/s41388-019-0682-0	http://dx.doi.org/10.1038/s41388-019-0682-0			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HY3OI	30670776				2022-12-26	WOS:000468035600014
J	Bagati, A; Moparthy, S; Fink, EE; Bianchi-Smiraglia, A; Yun, DH; Kolesnikova, M; Udartseva, OO; Wolff, DW; Roll, MV; Lipchick, BC; Han, ZN; Kozlova, NI; Jowdy, P; Berman, AE; Box, NF; Rodriguez, C; Bshara, W; Kandel, ES; Soengas, MS; Paragh, G; Nikiforov, MA				Bagati, Archis; Moparthy, Sudha; Fink, Emily E.; Bianchi-Smiraglia, Anna; Yun, Dong Hyun; Kolesnikova, Masha; Udartseva, Olga O.; Wolff, David W.; Roll, Matthew V.; Lipchick, Brittany C.; Han, Zhannan; Kozlova, Nadezhda I.; Jowdy, Peter; Berman, Albert E.; Box, Neil F.; Rodriguez, Cesar; Bshara, Wiam; Kandel, Eugene S.; Soengas, Maria S.; Paragh, Gyorgy; Nikiforov, Mikhail A.			KLF9-dependent ROS regulate melanoma progression in stage-specific manner	ONCOGENE			English	Article							KRUPPEL-LIKE FACTORS; OXIDATIVE STRESS; MITOCHONDRIAL THIOREDOXIN; KEAP1-NRF2 PATHWAY; KINASE; SENESCENCE; BRAF; PHOTOPROTECTION; DYSREGULATION; ACTIVATION	Although antioxidants promote melanoma metastasis, the role of reactive oxygen species (ROS) in other stages of melanoma progression is controversial. Moreover, genes regulating ROS have not been functionally characterized throughout the entire tumor progression in mouse models of cancer. To address this question, we crossed mice-bearing knock-out of Klf9, an ubiquitous transcriptional regulator of oxidative stress, with two conditional melanocytic mouse models: Braf(CA) mice, where Braf(V600E) causes premalignant melanocytic hyperplasia, and Braf(CA)/Pten(-/-) mice, where Braf(V600E) and loss of Pten induce primary melanomas and metastases. Klf9 deficiency inhibited premalignant melanocytic hyperplasia in Braf(CA) mice but did not affect formation and growth of Braf(CA)/Pten(-/-) primary melanomas. It also, as expected, promoted Braf(CA)/Pten(-/-) metastasis. Treatment with antioxidant N-acetyl cysteine phenocopied loss of Klf9 including suppression of melanocytic hyperplasia. We were interested in a different role of Klf9 in regulation of cell proliferation in Braf(CA) and Braf(CA)/Pten(-/-) melanocytic cells. Mechanistically, we demonstrated that BRAF(V600E) signaling transcriptionally upregulated KLF9 and that KLF9-dependent ROS were required for full-scale activation of ERK1/2 and induction of cell proliferation by BRAF(V600E). PTEN depletion in BRAF(V600E)-melanocytes did not further activate ERK1/2 and cell proliferation, but rendered these phenotypes insensitive to KLF9 and ROS. Our data identified an essential role of KLF9-dependent ROS in BRAF(V600E) signaling in premalignant melanocytes, offered an explanation to variable role of ROS in premalignant and transformed melanocytic cells and suggested a novel mechanism for suppression of premalignant growth by topical antioxidants.	[Bagati, Archis; Moparthy, Sudha; Fink, Emily E.; Bianchi-Smiraglia, Anna; Yun, Dong Hyun; Kolesnikova, Masha; Udartseva, Olga O.; Wolff, David W.; Roll, Matthew V.; Lipchick, Brittany C.; Han, Zhannan; Jowdy, Peter; Kandel, Eugene S.; Nikiforov, Mikhail A.] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA; [Wolff, David W.; Roll, Matthew V.; Lipchick, Brittany C.; Han, Zhannan; Rodriguez, Cesar; Nikiforov, Mikhail A.] Wake Forest Univ, Dept Canc Biol, Comprehens Canc Ctr, Winston Salem, NC 27109 USA; [Lipchick, Brittany C.] Wake Forest Univ, Dept Hematol & Oncol, Comprehens Canc Ctr, Winston Salem, NC 27109 USA; [Kozlova, Nadezhda I.; Berman, Albert E.] Orekhovich Inst Biomed Chem, Moscow 119121, Russia; [Box, Neil F.] Univ Colorado, Dept Dermatol, Anschutz Med Campus, Aurora, CO USA; [Bshara, Wiam] Roswell Pk Canc Inst, Dept Pathol Resource Network, Buffalo, NY 14263 USA; [Soengas, Maria S.] Spanish Natl Canc Res Ctr CNIO, Mol Oncol Programme, Melanoma Lab, Madrid 28029, Spain; [Paragh, Gyorgy] Roswell Pk Canc Inst, Dept Dermatol, Buffalo, NY 14263 USA; [Bagati, Archis] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Smith Bldg,SM-0728,450 Brookline Ave, Boston, MA 02215 USA	Roswell Park Cancer Institute; Wake Forest University; Wake Forest University; Russian Academy of Medical Sciences; Institute of Biomedical Chemistry; University of Colorado System; University of Colorado Anschutz Medical Campus; Roswell Park Cancer Institute; Centro Nacional de Investigaciones Oncologicas (CNIO); Roswell Park Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Nikiforov, MA (corresponding author), Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA.; Nikiforov, MA (corresponding author), Wake Forest Univ, Dept Canc Biol, Comprehens Canc Ctr, Winston Salem, NC 27109 USA.	mnikifor@wakehealth.edu	Udartseva, Olga/AAB-6216-2020; Soengas, Maria S/H-6455-2015; EBerman, Albert/F-5042-2017; Kozlova, Nadezda/ABD-7878-2020	Udartseva, Olga/0000-0003-2896-2300; Soengas, Maria S/0000-0003-0612-6299; Kolesnikova, Masha/0000-0001-7803-9632; Fink, Emily/0000-0003-2738-5732; Wolff, David/0000-0003-4201-3857	NCI [CA190533, CA193981, CA220096, CA224434, P30CA16056]; Program for Basic Research of Russian State Academies of Sciences; Russian Foundation for Basic Research [17-04-00716]; NATIONAL CANCER INSTITUTE [R01CA190533, P30CA016056, R01CA193981, R01CA224434, R21CA220096] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Program for Basic Research of Russian State Academies of Sciences; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been supported by the following NCI grants to MAN: CA190533, CA193981, CA220096, CA224434, by NCI P30CA16056 to Roswell Park Cancer Institute and partially supported by the Program for Basic Research of Russian State Academies of Sciences for 2013-2020, and by the Russian Foundation for Basic Research (grant No. 17-04-00716).	Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Bonett RM, 2009, ENDOCRINOLOGY, V150, P1757, DOI 10.1210/en.2008-1441; Bonham CA, 2009, J BIOL CHEM, V284, P22853, DOI 10.1074/jbc.M109.038612; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chen Y, 2006, FEBS LETT, V580, P6596, DOI 10.1016/j.febslet.2006.11.007; Chu JLY, 2016, CELL REP, V17, P374, DOI 10.1016/j.celrep.2016.09.006; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Cymerman RM, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw121; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Day CP, 2017, LAB INVEST, V97, P698, DOI 10.1038/labinvest.2016.155; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Denat L, 2014, J INVEST DERMATOL, V134, P1512, DOI 10.1038/jid.2014.65; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Ekwueme DU, 2011, J AM ACAD DERMATOL, V65, pS133, DOI 10.1016/j.jaad.2011.04.036; GAYNOR R, 1980, NATURE, V286, P400, DOI 10.1038/286400a0; Good KL, 2007, P NATL ACAD SCI USA, V104, P13420, DOI 10.1073/pnas.0703872104; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Jenkins NC, 2011, ONCOGENE, V30, P265, DOI 10.1038/onc.2010.419; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Kaneko T, 1996, MUTAT RES-DNAGING G, V316, P277, DOI 10.1016/S0921-8734(96)90010-7; Kansanen E, 2013, REDOX BIOL, V1, P45, DOI 10.1016/j.redox.2012.10.001; Kidger AM, 2016, SEMIN CELL DEV BIOL, V50, P125, DOI 10.1016/j.semcdb.2016.01.009; Kirsch J, 2016, ARTERIOSCL THROM VAS, V36, P1891, DOI 10.1161/ATVBAHA.116.307843; Le Gal K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad3740; Leinonen HM, 2014, ADV CANCER RES, V122, P281, DOI 10.1016/B978-0-12-420117-0.00008-6; Lin JY, 2003, J AM ACAD DERMATOL, V48, P866, DOI 10.1067/mjd.2003.425; Linos E, 2009, J INVEST DERMATOL, V129, P1666, DOI 10.1038/jid.2008.423; Matsui MS, 2009, J INVEST DERM SYMP P, V14, P56, DOI 10.1038/jidsymp.2009.14; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Morita M, 2003, MOL CELL BIOL, V23, P2489, DOI 10.1128/MCB.23.7.2489-2500.2003; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Qiao F, 2016, MOL CARCINOGEN, V55, P280, DOI 10.1002/mc.22277; Sander CS, 2003, BRIT J DERMATOL, V148, P913, DOI 10.1046/j.1365-2133.2003.05303.x; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Simmen FA, 2007, AM J PHYSIOL-GASTR L, V292, pG1757, DOI 10.1152/ajpgi.00013.2007; Simon JD, 2009, PIGM CELL MELANOMA R, V22, P563, DOI 10.1111/j.1755-148X.2009.00610.x; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Tetreault MP, 2013, NAT REV CANCER, V13, P701, DOI 10.1038/nrc3582; Tucker MA, 1997, JAMA-J AM MED ASSOC, V277, P1439, DOI 10.1001/jama.277.18.1439; Ying MY, 2011, STEM CELLS, V29, P20, DOI 10.1002/stem.561; Zhuang D, 2008, ONCOGENE, V27, P6623, DOI 10.1038/onc.2008.258; Zucker SN, 2014, MOL CELL, V53, P916, DOI 10.1016/j.molcel.2014.01.033; Zuo L, 2015, ACTA PHYSIOL, V214, P329, DOI 10.1111/apha.12515	46	32	33	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 9	2019	38	19					3585	3597		10.1038/s41388-019-0689-6	http://dx.doi.org/10.1038/s41388-019-0689-6			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HX4OU	30664687	Green Accepted			2022-12-26	WOS:000467379600003
J	Choi, RH; McConahay, A; Silvestre, JG; Moriscot, AS; Carson, JA; Koh, HJ				Choi, Ran Hee; McConahay, Abigail; Silvestre, Joao G.; Moriscot, Anselmo S.; Carson, James A.; Koh, Ho-Jin			TRB3 regulates skeletal muscle mass in food deprivation-induced atrophy	FASEB JOURNAL			English	Article						protein synthesis; protein degradation; Akt; mTOR; FOXO	UNFOLDED PROTEIN RESPONSE; UBIQUITIN LIGASES; TRIBBLES HOMOLOG; FIBER-TYPE; ER STRESS; INSULIN; PATHWAY; HYPERTROPHY; ACTIVATION; DEGRADATION	Tribbles 3 (TRB3) is a pseudokinase that has been found in multiple tissues in response to various stress stimuli, such as nutrient deprivation and endoplasmic reticulum (ER) stress. We recently found that TRB3 has the potential to regulate skeletal muscle mass at the basal state. However, it has not yet been explored whether TRB3 regulates skeletal muscle mass under atrophic conditions. Here, we report that food deprivation for 48 h in mice significantly reduces muscle mass by similar to 15% and increases TRB3 expression, which is associated with increased ER stress. Interestingly, inhibition of ER stress in C2C12 myotubes reduces food deprivation-induced expression of TRB3 and muscle-specific E3-ubiquitin ligases. In further in vivo experiments, muscle-specific TRB3 transgenic mice increase food deprivation-induced muscle atrophy compared with wild-type (WT) littermates presumably by the increased proteolysis. On the other hand, TRB3 knockout mice ameliorate food deprivation-induced atrophy compared with WT littermates by preserving a higher protein synthesis rate. These results indicate that TRB3 plays a pivotal role in skeletal muscle mass regulation under food deprivation-induced muscle atrophy and TRB3 could be a pharmaceutical target to prevent skeletal muscle atrophy.	[Choi, Ran Hee; McConahay, Abigail; Silvestre, Joao G.; Carson, James A.; Koh, Ho-Jin] Univ South Carolina, Dept Exercise Sci, Div Appl Physiol, Columbia, SC 29208 USA; [Silvestre, Joao G.; Moriscot, Anselmo S.] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, Brazil	University of South Carolina System; University of South Carolina Columbia; Universidade de Sao Paulo	Koh, HJ (corresponding author), Univ South Carolina, Arnold Sch Publ Hlth, Dept Exercise Sci, 921 Assembly St, Columbia, SC 29208 USA.	kohh@mailbox.sc.edu	Moriscot, Anselmo S./C-4506-2012; Silvestre, João Guilherme/G-3273-2015	Moriscot, Anselmo S./0000-0003-3098-4613; Silvestre, João Guilherme/0000-0001-9948-6351; Carson, James/0000-0003-3733-8796	U.S. National Institues of Health [R03AR066825, P20GM10909]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR066825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109091] Funding Source: NIH RePORTER	U.S. National Institues of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank M. Montminy (Salk Institute, La Jolla, CA, USA) for providing the muscle-specific TRB3 TG mice and Regeneron (Tarrytown, NY, USA) for KO mice. This work was supported by U.S. National Institues of Health grants to H.-J.K. [R03AR066825 (National Institute of Arthritis and Musculoskeletal and Skin Diseases) and P20GM10909 (National Institute of General Medical Sciences)], and a departmental start-up grant to H.-J.K. The authors declare no conflicts of interest.	An D, 2014, AM J PHYSIOL-REG I, V306, pR925, DOI 10.1152/ajpregu.00027.2014; Avery J, 2010, CIRC RES, V106, P1516, DOI 10.1161/CIRCRESAHA.109.211920; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bohnert KR, 2018, J CELL PHYSIOL, V233, P67, DOI 10.1002/jcp.25852; Choi RH, 2017, BIOCHEM BIOPH RES CO, V493, P1236, DOI 10.1016/j.bbrc.2017.09.134; Ciciliot S, 2013, INT J BIOCHEM CELL B, V45, P2191, DOI 10.1016/j.biocel.2013.05.016; Cohen S, 2015, NAT REV DRUG DISCOV, V14, P58, DOI 10.1038/nrd4467; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Hua F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8951; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Kammoun M, 2014, EUR J HISTOCHEM, V58, P163, DOI 10.4081/ejh.2014.2254; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; Koh HJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2851; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; LI JB, 1976, AM J PHYSIOL, V231, P441, DOI 10.1152/ajplegacy.1976.231.2.441; Liu JR, 2010, AM J PHYSIOL-ENDOC M, V298, pE565, DOI 10.1152/ajpendo.00467.2009; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Matsushima R, 2006, J BIOL CHEM, V281, P29719, DOI 10.1074/jbc.M511636200; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Ogata T, 2010, BIOCHEM BIOPH RES CO, V394, P136, DOI 10.1016/j.bbrc.2010.02.130; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Ord D, 2005, BIOCHEM BIOPH RES CO, V330, P210, DOI 10.1016/j.bbrc.2005.02.149; Ord D, 2003, EXP CELL RES, V286, P308, DOI 10.1016/S0014-4827(03)00070-3; Paul PK, 2012, MOL CELL BIOL, V32, P1248, DOI 10.1128/MCB.06351-11; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Xu JM, 2007, BBA-GEN SUBJECTS, V1770, P273, DOI 10.1016/j.bbagen.2006.09.025; Yu ZG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002321; Zhang W, 2016, DIABETES, V65, P2380, DOI 10.2337/db16-0154; Zhang W, 2013, DIABETES, V62, P4192, DOI 10.2337/db13-0312; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	44	9	10	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5654	5666		10.1096/fj.201802145RR	http://dx.doi.org/10.1096/fj.201802145RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30681896	Green Published, Bronze			2022-12-26	WOS:000462888500081
J	Zaman, F; Zhao, YH; Celvin, B; Mehta, HH; Wan, JX; Chrysis, D; Ohlsson, C; Fadeel, B; Cohen, P; Savendahl, L				Zaman, Farasat; Zhao, Yunhan; Celvin, Bettina; Mehta, Hemal H.; Wan, Junxiang; Chrysis, Dionisios; Ohlsson, Claes; Fadeel, Bengt; Cohen, Pinchas; Savendahl, Lars			Humanin is a novel regulator of Hedgehog signaling and prevents glucocorticoid-induced bone growth impairment	FASEB JOURNAL			English	Article						glucocorticoids; inflammation; chondrocytes; apoptosis	INDIAN HEDGEHOG; PROLIFERATIVE CHONDROCYTES; NEUROPROTECTIVE FACTOR; APOPTOSIS; CELL; DEXAMETHASONE; ACTIVATION; PLATE; DIFFERENTIATION; DISEASE	Glucocorticoids (GCs) are frequently used to treat chronic disorders in children, including inflammation and cancer. Prolonged treatment with GCs is well known to impair bone growth, an effect linked to increased apoptosis and suppressed proliferation in growth plate chondrocytes. We hypothesized that the endogenous antiapoptotic protein humanin (HN) may prevent these effects. Interestingly, GC-induced bone growth impairment and chondrocyte apoptosis was prevented in HN overexpressing mice, HN-treated wild-type mice, and in HN-treated cultured rat metatarsal bones. GC-induced suppression of chondrocyte proliferation was also prevented by HN. Furthermore, GC treatment reduced Indian Hedgehog expression in growth plates of wild-type mice but not in HN overexpressing mice or HN-treated wild-type animals. A Hedgehog (Hh) antagonist, vismodegib, was found to suppress the growth of cultured rat metatarsal bones, and this effect was also prevented by HN. Importantly, HN did not interfere with the desired anti-inflammatory effects of GCs. We conclude that HN is a novel regulator of Hh signaling preventing GC-induced bone growth impairment without interfering with desired effects of GCs. Our data may open for clinical studies exploring a new possible strategy to prevent GC-induced bone growth impairment by cotreating with HN.	[Zaman, Farasat; Zhao, Yunhan; Celvin, Bettina; Savendahl, Lars] Karolinska Inst, Dept Womens & Childrens Hlth, J9 30,Vis Gatan 4, SE-17174 Solna, Sweden; [Zaman, Farasat; Zhao, Yunhan; Celvin, Bettina; Savendahl, Lars] Karolinska Univ Hosp, Pediat Endocrinol Unit, J9 30,Vis Gatan 4, SE-17174 Solna, Sweden; [Mehta, Hemal H.; Wan, Junxiang; Cohen, Pinchas] Univ Southern Calif, Leonard Davis Sch Gerontol, Los Angeles, CA USA; [Chrysis, Dionisios] Univ Patras, Sch Med, Dept Pediat, Div Endocrinol, Patras, Greece; [Ohlsson, Claes] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, Gothenburg, Sweden; [Fadeel, Bengt] Karolinska Inst, Inst Environm Med, Div Mol Toxicol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Southern California; University of Patras; University of Gothenburg; Karolinska Institutet	Zaman, F (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, J9 30,Vis Gatan 4, SE-17174 Solna, Sweden.; Zaman, F (corresponding author), Karolinska Univ Hosp, Pediat Endocrinol Unit, J9 30,Vis Gatan 4, SE-17174 Solna, Sweden.	farasat.zaman@ki.se	CHRYSIS, DIONISIOS/HGB-4107-2022; Zaman, Farasat/AAE-1144-2020; Ohlsson, Claes/AGP-3544-2022	Ohlsson, Claes/0000-0002-9633-2805	Swedish Research Council [2015-02406]; Swedish Childhood Cancer Foundation [PR2014-0167, TJ2017-0089, PR2017-0167]; Stiftelsen Frimurare Barnhuset Stockholm; HKH Kronprinsessan Lovisas Forening for Barnasjukvard/Stiftelsen Axel Tielmans Minnesfond; Karolinska Institutet; AFAR BIG Award; U.S. National Institutes of Health, National Institute on Aging [1P01AG034906]; NATIONAL INSTITUTE ON AGING [P01AG034906] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Childhood Cancer Foundation(European Commission); Stiftelsen Frimurare Barnhuset Stockholm; HKH Kronprinsessan Lovisas Forening for Barnasjukvard/Stiftelsen Axel Tielmans Minnesfond; Karolinska Institutet(Karolinska Institutet); AFAR BIG Award; U.S. National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the Swedish Research Council (Grant 2015-02406, to L.S.), the Swedish Childhood Cancer Foundation (Grants PR2014-0167, TJ2017-0089, and PR2017-0167, to L.S. and F.Z.), Stiftelsen Frimurare Barnhuset Stockholm (to F.Z., L.S., and B.C.), HKH Kronprinsessan Lovisas Forening for Barnasjukvard/Stiftelsen Axel Tielmans Minnesfond (to F.Z. and L.S.), and Karolinska Institutet (to L.S.); and by an AFAR BIG Award and by Grant 1P01AG034906 from the U.S. National Institutes of Health, National Institute on Aging (to P.C.). The authors declare no conflicts of interest.	Adolphe C, 2004, DEVELOPMENT, V131, P5009, DOI 10.1242/dev.01367; BARON J, 1992, AM J PHYSIOL, V263, pE489; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Boon LM, 1999, PLAST RECONSTR SURG, V104, P1616, DOI 10.1097/00006534-199911000-00002; Chagin AS, 2007, BONE, V40, P1415, DOI 10.1016/j.bone.2006.12.066; Charununtakorn ST, 2016, CARDIOVASC THER, V34, P107, DOI 10.1111/1755-5922.12168; Chin YP, 2013, ENDOCRINOLOGY, V154, P3739, DOI 10.1210/en.2012-2004; Chrysis D, 2005, ENDOCRINOLOGY, V146, P1391, DOI 10.1210/en.2004-1152; Chrysis D, 2003, J ENDOCRINOL, V176, P331, DOI 10.1677/joe.0.1760331; Das S, 2009, J BIOL CHEM, V284, P22888, DOI 10.1074/jbc.M109.021949; Duan L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0512-2; Eriksson E, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt459; Farrera C, 2013, J IMMUNOL, V191, P2647, DOI 10.4049/jimmunol.1300436; Fernandez-Vojvodich P, 2013, ANN RHEUM DIS, V72, pE24, DOI 10.1136/annrheumdis-2013-204112; Forcioli-Conti N, 2015, BIOCHEM BIOPH RES CO, V458, P117, DOI 10.1016/j.bbrc.2015.01.078; Gidlund EK, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.13063; Gulino A, 2009, J CLIN INVEST, V119, P243, DOI 10.1172/JCI38387; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Hashimoto Y, 2001, J NEUROSCI, V21, P9235, DOI 10.1523/JNEUROSCI.21-23-09235.2001; Hashimoto Y, 2009, MOL BIOL CELL, V20, P2864, DOI 10.1091/mbc.E09-02-0168; Hoang PT, 2010, METABOLISM, V59, P343, DOI 10.1016/j.metabol.2009.08.001; Janzen C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193583; Jia Y, 2013, ANDROLOGY-US, V1, P651, DOI 10.1111/j.2047-2927.2013.00091.x; Jin H, 2010, NEUROCHEM INT, V56, P417, DOI 10.1016/j.neuint.2009.11.015; Juskewitch JE, 2012, AM J PATHOL, V180, P32, DOI 10.1016/j.ajpath.2011.10.001; Kim SJ, 2016, ONCOTARGET, V7, P46899, DOI 10.18632/oncotarget.10380; Konduru NV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004398; Lai HC, 2000, NEW ENGL J MED, V342, P851, DOI 10.1056/NEJM200003233421204; LOEB JN, 1976, NEW ENGL J MED, V295, P547, DOI 10.1056/NEJM197609022951007; Long FX, 2001, DEVELOPMENT, V128, P541; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Maeda Y, 2007, P NATL ACAD SCI USA, V104, P6382, DOI 10.1073/pnas.0608449104; Maeda Y, 2010, BONE, V46, P472, DOI 10.1016/j.bone.2009.09.009; Martensson K, 2004, J BONE MINER RES, V19, P1805, DOI 10.1359/JBMR.040805; Mushtaq T, 2004, ENDOCRINOLOGY, V145, P2478, DOI 10.1210/en.2003-1435; Mushtaq T, 2002, J ENDOCRINOL, V175, P705, DOI 10.1677/joe.0.1750705; Muzumdar RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006334; Noguchi KK, 2015, NEUROBIOL DIS, V83, P35, DOI 10.1016/j.nbd.2015.08.020; Oh YK, 2011, ATHEROSCLEROSIS, V219, P65, DOI 10.1016/j.atherosclerosis.2011.06.038; Robinson GW, 2017, ONCOTARGET, V8, P69295, DOI 10.18632/oncotarget.20619; Rooman RPA, 2003, ENDOCRINOLOGY, V144, P2553, DOI 10.1210/en.2003-0062; Savendahl L, 2005, HORM RES, V64, P94, DOI 10.1159/000087764; Savendahl L, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003484; Sekulic A, 2016, CELL, V164, P831, DOI 10.1016/j.cell.2016.02.021; Silva IN, 1997, ARCH DIS CHILD, V77, P214, DOI 10.1136/adc.77.3.214; Simon D, 2013, J CLIN ENDOCR METAB, V98, P2746, DOI 10.1210/jc.2012-4201; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Steinbicker AU, 2011, BLOOD, V117, P4915, DOI 10.1182/blood-2010-10-313064; Tajima H, 2002, NEUROSCI LETT, V324, P227, DOI 10.1016/S0304-3940(02)00199-4; TAKIGAWA M, 1989, CANCER RES, V49, P3996; Thompson CL, 2016, FASEB J, V30, P716, DOI 10.1096/fj.15-274944; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wang T, 2013, BEHAV BRAIN RES, V247, P132, DOI 10.1016/j.bbr.2013.03.023; Wei F, 2012, OSTEOARTHR CARTILAGE, V20, P755, DOI 10.1016/j.joca.2012.03.010; Xu XS, 2006, STROKE, V37, P2613, DOI 10.1161/01.STR.0000242772.94277.1f; Yamagishi Y, 2003, PEPTIDES, V24, P585, DOI 10.1016/S0196-9781(03)00106-2; Yang H, 2015, CANCER MED-US, V4, P245, DOI 10.1002/cam4.350; Yeh TF, 2004, NEW ENGL J MED, V350, P1304, DOI 10.1056/NEJMoa032089; Zaman F, 2007, CANCER RES, V67, P10078, DOI 10.1158/0008-5472.CAN-06-3982; Zaman F, 2014, TOXICOL LETT, V224, P196, DOI 10.1016/j.toxlet.2013.10.020; Zaman F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033168; Zhai DY, 2005, J BIOL CHEM, V280, P15815, DOI 10.1074/jbc.M411902200; Zhang WJ, 2012, PHARMACOL BIOCHEM BE, V100, P361, DOI 10.1016/j.pbb.2011.09.012; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3	64	23	27	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4962	4974		10.1096/fj.201801741R	http://dx.doi.org/10.1096/fj.201801741R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30657335	Green Published, Bronze			2022-12-26	WOS:000462888500026
J	Murugan, S; Jakka, P; Namani, S; Mujumdar, V; Radhakrishnan, G				Murugan, Subathra; Jakka, Padmaja; Namani, Swapna; Mujumdar, Varadendra; Radhakrishnan, Girish			The neurosteroid pregnenolone promotes degradation of key proteins in the innate immune signaling to suppress inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; Toll-like receptor (TLR); immunosuppression; inflammation; ubiquitylation (ubiquitination)	RECEPTOR; TLR2; CLIP-170; ENZYMES; BRAIN	Pregnenolone is a steroid hormone precursor that is synthesized in various steroidogenic tissues, in the brain, and in lymphocytes. In addition to serving as the precursor for other steroid hormones, pregnenolone exerts its own effect as an anti-inflammatory molecule to maintain immune homeostasis in various inflammatory conditions. Pregnenolone and its metabolic derivatives have been shown to have beneficial effects in the brain, including enhancing memory and learning, reversing depressive disorders, and modulating cognitive functions. A decreased level of pregnenolone has been observed in neuroinflammatory diseases, which emphasizes its role in neuroprotection and neuroregeneration. Although the anti-inflammatory property of pregnenolone was recognized several decades ago, its mechanism of action remains unknown. Here we report that pregnenolone promotes ubiquitination and degradation of the TLR2/4 adaptor protein TIRAP and TLR2 in macrophages and microglial cells. Pregnenolone and its metabolites suppressed the secretion of tumor necrosis factor and interleukin-6 mediated through TLR2 and TLR4 signaling. Pregnenolone has been reported to induce activation of cytoplasmic linker protein 170, and this protein has recently been shown to promote targeted degradation of TIRAP. We observed enhanced degradation of TIRAP and TLR4 suppression by cytoplasmic linker protein 170 in the presence of pregnenolone. Our experimental data reveal novel nongenomic targets of pregnenolone and provide important leads to understand its role in restoring immune homeostasis in various inflammatory conditions.	[Murugan, Subathra; Jakka, Padmaja; Namani, Swapna; Mujumdar, Varadendra; Radhakrishnan, Girish] Natl Inst Anim Biotechnol, Lab Immunol & Microbial Pathogenesis, Hyderabad 500032, Telangana, India; [Jakka, Padmaja; Namani, Swapna] Manipal Acad Higher Educ, Grad Studies, Manipal 576104, Karnataka, India	Department of Biotechnology (DBT) India; National Institute of Animal Biotechnology (NIAB); Manipal Academy of Higher Education (MAHE)	Radhakrishnan, G (corresponding author), Natl Inst Anim Biotechnol, Lab Immunol & Microbial Pathogenesis, Hyderabad 500032, Telangana, India.	girish@niab.org.in		Radhakrishnan, Girish/0000-0001-9088-0029	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR21564/BRB/10/1561/2016]; University Grant Commission, Government of India; INSPIRE, Department of Science and Technology, Government of India	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); University Grant Commission, Government of India(University Grants Commission, India); INSPIRE, Department of Science and Technology, Government of India	This work was funded by Department of Biotechnology, Ministry of Science and Technology, Government of India Grant BT/PR21564/BRB/10/1561/2016 (to G. R.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a postdoctoral fellowship from the University Grant Commission, Government of India.; Supported by a research fellowship for doctoral studies from INSPIRE, Department of Science and Technology, Government of India.	Agis-Balboa RC, 2006, P NATL ACAD SCI USA, V103, P14602, DOI 10.1073/pnas.0606544103; Baker PJ, 2015, EUR J IMMUNOL, V45, P2918, DOI 10.1002/eji.201545655; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Daugherty DJ, 2013, EMBO MOL MED, V5, P891, DOI 10.1002/emmm.201202124; DiSanto E, 1996, EUR J PHARMACOL, V299, P179, DOI 10.1016/0014-2999(95)00840-3; Fontaine-Lenoir V, 2006, P NATL ACAD SCI USA, V103, P4711, DOI 10.1073/pnas.0600113103; Gong LL, 2016, EUR J NEUROSCI, V43, P1674, DOI 10.1111/ejn.13257; HENDERSON E, 1950, J CLIN ENDOCRINOL, V10, P455, DOI 10.1210/jcem-10-4-455; Hoagland H, 1944, SCIENCE, V100, P63, DOI 10.1126/science.100.2587.63; Hoffmann O, 2007, J IMMUNOL, V178, P6476, DOI 10.4049/jimmunol.178.10.6476; Hossain MJ, 2017, J NEUROIMMUNOL, V304, P11, DOI 10.1016/j.jneuroim.2016.12.004; Jakka P, 2018, J IMMUNOL, V200, P704, DOI 10.4049/jimmunol.1601559; Jia Y, 2013, P NATL ACAD SCI USA, V110, P8152, DOI 10.1073/pnas.1216671110; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Lansbergen G, 2004, J CELL BIOL, V166, P1003, DOI 10.1083/jcb.200402082; Larti F, 2015, EUR J HUM GENET, V23, P416, DOI 10.1038/ejhg.2014.152; LAZAR G, 1992, FEBS LETT, V308, P137, DOI 10.1016/0014-5793(92)81261-J; Lei BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103969; Liu SR, 2012, J IMMUNOL, V188, P1098, DOI 10.4049/jimmunol.1101121; Mahata B, 2014, CELL REP, V7, P1130, DOI 10.1016/j.celrep.2014.04.011; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Masters CL, 2006, BRAIN, V129, P2823, DOI 10.1093/brain/awl251; MCGAVACK TH, 1951, J CLIN ENDOCRINOL, V11, P559, DOI 10.1210/jcem-11-6-559; Miranda-Hernandez S, 2011, J IMMUNOL, V187, P791, DOI 10.4049/jimmunol.1001992; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Naylor JC, 2010, BBA-MOL CELL BIOL L, V1801, P951, DOI 10.1016/j.bbalip.2010.05.006; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; PINCUS G, 1945, PSYCHOSOM MED, V7, P342, DOI 10.1097/00006842-194511000-00004; Ray Avijit, 2010, J Vis Exp, DOI 10.3791/1488; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Shih MCM, 2011, MOL CELL ENDOCRINOL, V336, P80, DOI 10.1016/j.mce.2010.12.017; Sloane JA, 2010, P NATL ACAD SCI USA, V107, P11555, DOI 10.1073/pnas.1006496107; Vallee M, 2001, BRAIN RES REV, V37, P301, DOI 10.1016/S0165-0173(01)00135-7; Vallee M, 2016, J STEROID BIOCHEM, V160, P78, DOI 10.1016/j.jsbmb.2015.09.030; Vallee M, 2014, SCIENCE, V343, P94, DOI 10.1126/science.1243985; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Weng JH, 2013, NAT CHEM BIOL, V9, P636, DOI [10.1038/NCHEMBIO.1321, 10.1038/nchembio.1321]	40	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4596	4607		10.1074/jbc.RA118.005543	http://dx.doi.org/10.1074/jbc.RA118.005543			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30647133	Green Published, hybrid			2022-12-26	WOS:000462969500026
J	Adams, JA; Uryash, A; Lopez, JR; Sackner, MA				Adams, Jose A.; Uryash, Arkady; Lopez, Jose R.; Sackner, Marvin A.			Whole body periodic acceleration improves survival and microvascular leak in a murine endotoxin model	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MYOCARDIAL DYSFUNCTION; SEPTIC SHOCK; DOUBLE-BLIND; MICE; PGZ; EXERCISE; SEPSIS; ENDOTHELIUM; INHIBITION	Sepsis is a life threatening condition which produces multi-organ dysfunction with profound circulatory and cellular derangements. Administration of E. Coli endotoxin (LPS) produces systemic inflammatory effects of sepsis including disruption of endothelial barrier, and if severe enough death. Whole body periodic acceleration (pGz) is the headward-footward motion of the body. pGz has been shown to induce pulsatile shear stress to the endothelium, thereby releasing vascular and cardio protective mediators. The purpose of this study was to determine whether or not pGz performed as a pre-treatment or post-treatment strategy improves survival in a lethal murine endotoxin model. This study was designed as a prospective randomized controlled study in mice. pGz was performed in mice as pre-treatment (pGz-LPS, 3 days prior to LPS), post-treatment (LPS-pGz, 30 min after LPS) strategies or Control (LPS-CONT), in a lethal murine model of endotoxemia. Endotoxemia was induced with intraperitoneal injection of E. Coli LPS (40mg/kg). In a separate group of mice, a nonspecific nitric oxide synthase inhibitor (L-NAME) was provided in their drinking water and pGz-LPS and LPS-pGz performed to determine the effect of nitric oxide (NO) inhibition on survival. In another subset of mice, micro vascular leakage was determined. Behavioral scoring around the clock was performed in all mice at 30 min intervals after LPS administration, until 48 hrs. survival or death. LPS induced 100% mortality in LPS-CONT animals by 30 hrs. In contrast, survival to 48 hrs. occurred in 60% of pGz-LPS and 80% of LPS-pGz. L-NAME abolished the survival effects of pGz. Microvascular leakage was markedly reduced in both pre and post pGz treated animals and was associated with increased tyrosine kinase endothelial-enriched tunica interna endothelial cell kinase 2 (TIE2) receptor and its phosphorylation (p-TIE2). In a murine model of lethal endotoxemia, pGz performed as a pre or post treatment strategy significantly improved survival, and markedly reduced microvascular leakage. The effect was modulated, in part, by NO since a non-selective inhibitor of NO abolished the pGz survival effect.	[Adams, Jose A.; Uryash, Arkady] Mt Sinai Med Ctr, Div Neonatol, Miami Beach, FL 33140 USA; [Lopez, Jose R.] Mt Sinai Med Ctr, Dept Res, Miami Beach, FL 33140 USA; [Sackner, Marvin A.] Mt Sinai Med Ctr, Med Serv, Miami Beach, FL 33140 USA	Mount Sinai Medical Center; Mount Sinai Medical Center; Mount Sinai Medical Center	Adams, JA (corresponding author), Mt Sinai Med Ctr, Div Neonatol, Miami Beach, FL 33140 USA.	tony-adams@msmc.com	Adams, Jose Antonio/AAI-2342-2020; Adams, Jose Antonio/ABC-2699-2021	Adams, Jose Antonio/0000-0002-9401-2226; Adams, Jose Antonio/0000-0002-9401-2226	Florida Heart Research Institute	Florida Heart Research Institute	This study was funded in part by a grant to JAA from the Florida Heart Research Institute (https://www.floridaheart.org). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. There was no additional external funding received for this study.	Adams JA, 2000, J APPL PHYSIOL, V89, P2447, DOI 10.1152/jappl.2000.89.6.2447; Adams JA, 2001, CRIT CARE MED, V29, P1983, DOI 10.1097/00003246-200110000-00022; Adams JA, 2008, PEDIATR RES, V64, P533, DOI 10.1203/PDR.0b013e318183f147; Adams Jose A, 2018, J Sports Med (Hindawi Publ Corp), V2018, P4340925, DOI 10.1155/2018/4340925; Adams JA, 2018, MED HYPOTHESES, V110, P144, DOI 10.1016/j.mehy.2017.12.008; Adams JA, 2010, LIFE SCI, V86, P707, DOI 10.1016/j.lfs.2010.02.022; Bassuk JA, 2008, RESUSCITATION, V77, P250, DOI 10.1016/j.resuscitation.2007.11.018; Bassuk JI, 2010, J SURG RES, V164, pE281, DOI 10.1016/j.jss.2010.07.047; Bougaki M, 2010, SHOCK, V34, P281, DOI 10.1097/SHK.0b013e3181cdc327; David S, 2011, AM J PHYSIOL-LUNG C, V300, pL851, DOI 10.1152/ajplung.00459.2010; Di Lorenzo A, 2013, J CELL SCI, V126, P5541, DOI 10.1242/jcs.115972; Duma D, 2011, EUR J PHARMACOL, V668, P285, DOI 10.1016/j.ejphar.2011.05.065; Farah C, 2018, NAT REV CARDIOL, V15, P292, DOI 10.1038/nrcardio.2017.224; Fink MP, 2014, VIRULENCE, V5, P143, DOI 10.4161/viru.26083; Gross CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119918; Han S, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9260; Hershey TB, 2017, NEW ENGL J MED, V376, P2311, DOI 10.1056/NEJMp1611928; Ichinose F, 2007, CIRC RES, V100, P130, DOI 10.1161/01.RES.0000253888.09574.7a; Ince C, 2016, SHOCK, V45, P259, DOI 10.1097/SHK.0000000000000473; Irahara T, 2016, J TRAUMA ACUTE CARE, V80, P933, DOI 10.1097/TA.0000000000001023; ISHIZASHI H, 1995, JPN J PHYSIOL, V45, P553, DOI 10.2170/jjphysiol.45.553; Kim YH, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-16; Leligdowicz A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00838; Lewis AJ, 2016, SURG INFECT, V17, P385, DOI 10.1089/sur.2016.021; Liaudet L, 1998, J INFECT DIS, V177, P127, DOI 10.1086/513813; Lopez A, 2004, CRIT CARE MED, V32, P21, DOI 10.1097/01.CCM.0000105581.01815.C6; Lopez JR, 2018, MOL NEUROBIOL, V55, P8680, DOI 10.1007/s12035-018-1018-8; Lopez JR, 2017, J MOL CELL CARDIOL, V108, P149, DOI 10.1016/j.yjmcc.2017.06.004; Macdonald J, 2003, BRIT J ANAESTH, V90, P221, DOI 10.1093/bja/aeg034; Mao KR, 2013, CELL RES, V23, P201, DOI 10.1038/cr.2013.6; Martin AB, 2016, HEALTH AFFAIR, V35, P150, DOI 10.1377/hlthaff.2015.1194; Martin SA, 2013, BRAIN BEHAV IMMUN, V29, P113, DOI 10.1016/j.bbi.2012.12.014; Martinez A, 2008, PEPTIDES, V29, P73, DOI 10.1016/j.peptides.2007.10.021; PERSICHINI T, 2006, ANTIOXIDANTS REDOX S, V8; Predescu D, 2005, AM J PHYSIOL-LUNG C, V289, pL371, DOI 10.1152/ajplung.00175.2004; Radu M, 2013, JOVE-J VIS EXP, DOI 10.3791/50062; Lopez JR, 2016, MED SCI SPORT EXER, V48, P1485, DOI 10.1249/MSS.0000000000000932; Reade MC, 2003, BRIT J ANAESTH, V90, P115, DOI 10.1093/bja/aeg033; Remick DG, 2005, SHOCK, V24, P7, DOI 10.1097/01.shk.0000191384.34066.85; Sackner MA, 2019, EUR J APPL PHYSIOL, V119, P201, DOI 10.1007/s00421-018-4016-7; Serravite DH, 2014, INT J SPORT PHYSIOL, V9, P985, DOI 10.1123/ijspp.2013-0512; Shrum Bradly, 2014, BMC Res Notes, V7, P233, DOI 10.1186/1756-0500-7-233; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stark RJ, 2018, FASEB J, V32, P945, DOI 10.1096/fj.201700410R; Uryash A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131392; Uryash A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121069; Uryash A, 2012, LIFE SCI, V91, P178, DOI 10.1016/j.lfs.2012.06.031; Uryash A, 2009, J APPL PHYSIOL, V106, P1840, DOI 10.1152/japplphysiol.91612.2008; van de Sandt AM, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0330-8; Wang W, 2004, AM J PHYSIOL-RENAL, V287, pF1044, DOI 10.1152/ajprenal.00136.2004; Watson D, 2004, CRIT CARE MED, V32, P13, DOI 10.1097/01.CCM.0000104209.07273.FC; WU CC, 1995, BRIT J PHARMACOL, V114, P1666, DOI 10.1111/j.1476-5381.1995.tb14955.x; Wu H., 2012, CARDIOVASC ENG TECHN, V3, P292; Wu H, 2009, NITRIC OXIDE-BIOL CH, V21, P63, DOI 10.1016/j.niox.2009.05.004; Yamashita T, 2000, CIRCULATION, V101, P931, DOI 10.1161/01.CIR.101.8.931; Young Rachel, 2018, Immunohorizons, V2, P27, DOI 10.4049/immunohorizons.1700073; Zeng H, 2016, SCI REP-UK, V6, DOI 10.1038/srep20931	57	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0208681	10.1371/journal.pone.0208681	http://dx.doi.org/10.1371/journal.pone.0208681			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682019	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500012
J	Modai, S; Farberov, L; Herzig, E; Isakov, O; Hizi, A; Shomron, N				Modai, Shira; Farberov, Luba; Herzig, Eytan; Isakov, Ofer; Hizi, Amnon; Shomron, Noam			HIV-1 infection increases microRNAs that inhibit Dicer1, HRB and HIV-EP2, thereby reducing viral replication	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEIN; PATHOGENESIS; TARGETS; GENE; DETERMINANTS; PATHWAY; ROLES; RNAS	HIV-1 is the causative agent of AIDS (Autoimmune Deficiency Syndrome). HIV-1 infection results in systemic CD4(+) T cell depletion, thereby impairing cell-mediated immunity. Micro-RNAs are short (similar to 22 nucleotides long), endogenous single-stranded RNA molecules that regulate gene expression by binding to the 3' untranslated regions (3' UTR) of mRNA transcripts. The relation between HIV-1 infection and human miRNA expression profile has been previously investigated, and studies have shown that the virus can alter miRNA expression and vice versa. Here, we broaden the understanding of the HIV-1 infection process, and show that miRNA-186, 210 and 222 are up-regulated following HIV-1 infection of human Sup-T1 cells. As a result, the host miRNA target genes: Dicer1 (Double-Stranded RNA-Specific Endoribonuclease), HRB (HIV-1 Rev-binding protein) and HIV-EP2 (Human Immunodeficiency Virus Type I Enhancer Binding Protein 2), are down-regulated. Moreover, testing the miRNA-gene anti-correlation on the Jurkat and the HeLa-MAGI cell lines demonstrated the ability of the miRNAs to down-regulate viral expression as well. To conclude, we found that human miR-186, 210 and 222 directly regulate the human genes Dicer1, HRB and HIV-EP2, thus may be filling key roles during HIV-1 replication and miRNA biogenesis. This finding may contribute to the development of new therapeutic strategies.	[Modai, Shira; Farberov, Luba; Herzig, Eytan; Isakov, Ofer; Hizi, Amnon; Shomron, Noam] Tel Aviv Univ, Fac Med, Tel Aviv, Israel; [Herzig, Eytan] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA	Tel Aviv University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Shomron, N (corresponding author), Tel Aviv Univ, Fac Med, Tel Aviv, Israel.	nshomron@post.tau.ac.il			Israel Science Foundation (ISF) [1852/16]; Israeli Ministry of Defense, Office of Assistant Minister of Defense for Chemical, Biological, Radiological and Nuclear (CBRN) Defense; Foundation Fighting Blindness; Edmond J. Safra Center for Bioinformatics at Tel Aviv University; Zimin Institute for Engineering Solutions Advancing Better Lives; Tel Aviv University Breakthrough Innovative Research Grants; Tel Aviv University Richard Eimert Research Fund on Solid Tumors; Djerassi-Elias Institute of Oncology; Canada-Montreal Friends of Tel Aviv University; Harold H. Marcus; Amy Friedkin; Garber Research Fund	Israel Science Foundation (ISF)(Israel Science Foundation); Israeli Ministry of Defense, Office of Assistant Minister of Defense for Chemical, Biological, Radiological and Nuclear (CBRN) Defense; Foundation Fighting Blindness(European Commission); Edmond J. Safra Center for Bioinformatics at Tel Aviv University; Zimin Institute for Engineering Solutions Advancing Better Lives; Tel Aviv University Breakthrough Innovative Research Grants; Tel Aviv University Richard Eimert Research Fund on Solid Tumors; Djerassi-Elias Institute of Oncology; Canada-Montreal Friends of Tel Aviv University; Harold H. Marcus; Amy Friedkin; Garber Research Fund	The Shomron laboratory is supported by the Israel Science Foundation (ISF, 1852/16); Israeli Ministry of Defense, Office of Assistant Minister of Defense for Chemical, Biological, Radiological and Nuclear (CBRN) Defense; Foundation Fighting Blindness; The Edmond J. Safra Center for Bioinformatics at Tel Aviv University; Zimin Institute for Engineering Solutions Advancing Better Lives; Tel Aviv University Breakthrough Innovative Research Grants; Tel Aviv University Richard Eimert Research Fund on Solid Tumors; Djerassi-Elias Institute of Oncology; Canada-Montreal Friends of Tel Aviv University; Harold H. Marcus; Amy Friedkin; Garber Research Fund; and a generous donation from the Adelis Foundation.	Ballegaard V, 2017, JAIDS-J ACQ IMM DEF, V74, pE104, DOI 10.1097/qai.0000000000001191; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bennasser Y, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-95; Berkhout B, 2007, J BIOL CHEM, V282, P26641, DOI 10.1074/jbc.R700023200; Bignami F, 2012, BLOOD, V119, P6259, DOI 10.1182/blood-2011-09-379503; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Catalfamo M, 2012, CYTOKINE GROWTH F R, V23, P207, DOI 10.1016/j.cytogfr.2012.05.007; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cohen J, 1997, SCIENCE, V277, P32, DOI 10.1126/science.277.5322.32; David D, 1998, P NATL ACAD SCI USA, V95, P11348, DOI 10.1073/pnas.95.19.11348; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Farberov L, 2015, J CELL SCI, V128, P1607, DOI 10.1242/jcs.167817; Fior J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037511; Foulkes WD, 2014, NAT REV CANCER, V14, P662, DOI 10.1038/nrc3802; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fritz CC, 1996, CURR BIOL, V6, P848, DOI 10.1016/S0960-9822(02)00608-5; FRITZ CC, 1995, NATURE, V376, P530, DOI 10.1038/376530a0; Gong QY, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20171157; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Herzig E, 2015, J VIROL, V89, P8119, DOI 10.1128/JVI.00809-15; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Isakov O, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks228; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Klase Z, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-63; Klase Z, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-18; Klockow LC, 2013, VIROLOGY, V444, P191, DOI 10.1016/j.virol.2013.06.010; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu C, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0517-y; Mor E, 2011, NUCLEIC ACIDS RES, V39, P3710, DOI 10.1093/nar/gkq1325; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakayama T, 2013, LANDES BIOSCIENCE; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; NOMURA N, 1991, J BIOL CHEM, V266, P8590; Omoto S, 2005, J GEN VIROL, V86, P751, DOI 10.1099/vir.0.80449-0; Orecchini E, 2014, RNA BIOL, V11, P334, DOI 10.4161/rna.28372; Poltronieri P, 2015, CURR GENOMICS, V16, P327, DOI 10.2174/1389202916666150707160613; Richman DD, 2001, NATURE, V410, P995, DOI 10.1038/35073673; Ronen R, 2010, BIOINFORMATICS, V26, P2615, DOI 10.1093/bioinformatics/btq493; Ruelas DS, 2015, J BIOL CHEM, V290, P13736, DOI 10.1074/jbc.M115.641837; Shomron N, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/594738; Squillace N, 2014, J ANTIMICROB CHEMOTH, V69, P3067, DOI 10.1093/jac/dku264; Staton TL, 2011, NATURE, V472, P105, DOI 10.1038/nature09848; Strebel K, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-48; Swaminathan S, 2013, IMMUNOL REV, V254, P265, DOI 10.1111/imr.12077; Tozser J, 2003, CURR TOP MED CHEM, V3, P1447, DOI 10.2174/1568026033451781; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Voronin N, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-60; WEISS RA, 1993, SCIENCE, V260, P1273, DOI 10.1126/science.8493571; Weng KF, 2014, NUCLEIC ACIDS RES, V42, P12789, DOI 10.1093/nar/gku952	53	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211111	10.1371/journal.pone.0211111	http://dx.doi.org/10.1371/journal.pone.0211111			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682089	Green Published, gold, Green Submitted			2022-12-26	WOS:000457037500102
J	Taylor-Brown, A; Booth, R; Gillett, A; Mealy, E; Ogbourne, SM; Polkinghorne, A; Conroy, GC				Taylor-Brown, Alyce; Booth, Rosie; Gillett, Amber; Mealy, Erica; Ogbourne, Steven M.; Polkinghorne, Adam; Conroy, Gabriel C.			The impact of human activities on Australian wildlife	PLOS ONE			English	Article							SOUTH-EAST QUEENSLAND; REHABILITATION CENTER; HEALTH-CENTER; CHLAMYDIAL INFECTIONS; HEALESVILLE SANCTUARY; EURASIAN LYNX; MORTALITY; URBAN; URBANIZATION; MORBIDITY	Increasing human population size and the concomitant expansion of urbanisation significantly impact natural ecosystems and native fauna globally. Successful conservation management relies on precise information on the factors associated with wildlife population decline, which are challenging to acquire from natural populations. Wildlife Rehabilitation Centres (WRC) provide a rich source of this information. However, few researchers have conducted large-scale longitudinal studies, with most focussing on narrow taxonomic ranges, suggesting that WRC-associated data remains an underutilised resource, and may provide a fuller understanding of the anthropogenic threats facing native fauna. We analysed admissions and outcomes data from a WRC in Queensland, Australia Zoo Wildlife Hospital, to determine the major factors driving admissions and morbidity of native animals in a region experiencing rapid and prolonged urban expansion. We studied 31,626 admissions of 83 different species of native birds, reptiles, amphibians, marsupials and eutherian mammals from 2006 to 2017. While marsupial admissions were highest (41.3%), admissions increased over time for all species and exhibited seasonal variation (highest in Spring to Summer), consistent with known breeding seasons. Causes for admission typically associated with human influenced activities were dominant and exhibited the highest mortality rates. Car strikes were the most common reason for admission (34.7%), with dog attacks (9.2%), entanglements (7.2%), and cat attacks (5.3%) also high. Admissions of orphaned young and overt signs of disease were significant at 24.6% and 9.7%, respectively. Mortality rates were highest following dog attacks (72.7%) and car strikes (69.1%) and lowest in orphaned animals (22.1%). Our results show that WRC databases offer rich opportunities for wildlife monitoring and provide quantification of the negative impacts of human activities on ecosystem stability and wildlife health. The imminent need for urgent, proactive conservation management to ameliorate the negative impacts of human activities on wildlife is clearly evident from our results.	[Taylor-Brown, Alyce; Ogbourne, Steven M.; Conroy, Gabriel C.] Univ Sunshine Coast, Genecol Res Ctr, Maroochydore, Qld, Australia; [Taylor-Brown, Alyce; Polkinghorne, Adam] Univ Sunshine Coast, Anim Res Ctr, Maroochydore, Qld, Australia; [Booth, Rosie; Gillett, Amber] Australia Zoo Wildlife Hosp, Beerwah, Qld, Australia; [Mealy, Erica] Univ Sunshine Coast, Fac Arts Business & Law, Maroochydore, Qld, Australia	University of the Sunshine Coast; University of the Sunshine Coast; University of the Sunshine Coast	Conroy, GC (corresponding author), Univ Sunshine Coast, Genecol Res Ctr, Maroochydore, Qld, Australia.	gconroy@usc.edu.au		Ogbourne, Steven/0000-0001-9812-4367; Polkinghorne, Adam/0000-0002-6567-2962	University of the Sunshine Coast; Australia Zoo Wildlife Hospital	University of the Sunshine Coast; Australia Zoo Wildlife Hospital	This study was funded by the University of the Sunshine Coast and the Australia Zoo Wildlife Hospital.	Abbott I, 2002, WILDLIFE RES, V29, P51, DOI 10.1071/WR01011; Ancillotto L, 2013, MAMM BIOL, V78, P369, DOI 10.1016/j.mambio.2013.01.003; Andersson MN, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00093; Andren H, 2006, BIOL CONSERV, V131, P23, DOI 10.1016/j.biocon.2006.01.025; [Anonymous], 2018, AUT SURV 2018 RES BI; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bereau of Meteorology, 2018, QUEENSL DEC 2010 WET; Beyer HL, 2018, J APPL ECOL, V55, P1966, DOI 10.1111/1365-2664.13127; Bouchon-Small A., 2015, THESIS; Brahmia Z, 2013, ENVIRON POLLUT, V174, P171, DOI 10.1016/j.envpol.2012.11.028; Brand CJ, 2013, ECOHEALTH, V10, P446, DOI 10.1007/s10393-013-0897-4; Brown JD, 2002, J WILDLIFE DIS, V38, P699, DOI 10.7589/0090-3558-38.4.699; Brunton Elizabeth A., 2018, Pacific Conservation Biology, V24, P63, DOI 10.1071/PC17034; Burbidge AA, 2017, AUST J ZOOL, V65, P183, DOI 10.1071/ZO17046; Bureau of Meteorlogy, 2018, BRISB NOV 2014 HOT M; Bureau of Meteorology, 2018, ANN CLIM STAT 2017; Bureau of Meteorology, 2018, QUEENSL SPRING 2014; Bureau of Meteorology, 2018, BRISB NOV 2016 VER W; Burton DL, 2004, P 4 INT URB WILDL S; Burton E, 2016, ANIMALS, V6, DOI 10.3390/ani6090056; CANFIELD PJ, 1991, J WILDLIFE DIS, V27, P657, DOI 10.7589/0090-3558-27.4.657; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Ceballos G., 2010, J COSMOL, V8, P1821; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Cook TC, 2013, BIOL CONSERV, V167, P310, DOI 10.1016/j.biocon.2013.08.016; Martinez JC, 2014, HYSTRIX, V25, P107, DOI 10.4404/hystrix-25.2-10248; Currumbin Wildlife Hospital Foundation, 2018, WILDL HOSP 2018; da Rosa CA, 2012, J ENVIRON MANAGE, V97, P1, DOI 10.1016/j.jenvman.2011.11.004; Denny E., 2010, REV CAT ECOLOGY MANA; Devereaux LN, 2003, SYST APPL MICROBIOL, V26, P245, DOI 10.1078/072320203322346092; Dickman C., 1996, OVERVIEW IMPACTS FER; Dickman Christopher R., 2009, Human-Wildlife Conflicts, V3, P41; Dique DS, 2003, WILDLIFE RES, V30, P419, DOI 10.1071/WR02029; Ellis WA, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0632; Erickson WP, 2005, SUMMARY COMP BIRD MO; FERRERAS P, 1992, BIOL CONSERV, V61, P197, DOI 10.1016/0006-3207(92)91116-A; Finn HC, 2017, WILDLIFE RES, V44, P377, DOI 10.1071/WR17018; Gaston KJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0133; Gebreab SZ, 2015, GEOSPATIAL HEALTH, V10, P205, DOI 10.4081/gh.2015.321; Glen AS, 2007, AUSTRAL ECOL, V32, P492, DOI 10.1111/j.1442-9993.2007.01721.x; Gonzalez-Astudillo V, 2017, SCI REP-UK, V7, DOI 10.1038/srep42587; Griffith JE, 2013, J WILDLIFE DIS, V49, P18, DOI 10.7589/2012-05-135; Grogan A, 2013, VET REC, V172, P211, DOI 10.1136/vr.101139; Hamer AJ, 2010, AUSTRAL ECOL, V35, P568, DOI 10.1111/j.1442-9993.2009.02068.x; Heigl F, 2017, BMC ECOL, V17, DOI 10.1186/s12898-017-0134-z; IBM, 2016, IBM SPSS STAT WINDOW; Isaksson C, 2015, FUNCT ECOL, V29, P913, DOI 10.1111/1365-2435.12477; ISO. International Organization for Standardization, PERS STOR MOD SQL PS; Johnson CN, 2007, P R SOC B, V274, P341, DOI 10.1098/rspb.2006.3711; Kelly A, 2006, J RAPTOR RES, V40, P231, DOI 10.3356/0892-1016(2006)40[231:ADAOFE]2.0.CO;2; Lai S, 2015, OCEAN COAST MANAGE, V103, P78, DOI 10.1016/j.ocecoaman.2014.11.006; Langen TA, 2009, J WILDLIFE MANAGE, V73, P104, DOI 10.2193/2008-017; Letnic M, 2012, BIOL REV, V87, P390, DOI 10.1111/j.1469-185X.2011.00203.x; Letnic M, 2009, P ROY SOC B-BIOL SCI, V276, P3249, DOI 10.1098/rspb.2009.0574; Lewis OT, 2006, PHILOS T R SOC B, V361, P163, DOI 10.1098/rstb.2005.1712; Loss SR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2380; Lowry H, 2013, BIOL REV, V88, P537, DOI 10.1111/brv.12012; McDonald R, 2011, URBAN ECOLOGY: PATTERNS, PROCESSES, AND APPLICATIONS, P193; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; MCORIST S, 1992, AVIAN PATHOL, V21, P503, DOI 10.1080/03079459208418868; Mcruer DL, 2017, J WILDLIFE MANAGE, V81, P163, DOI 10.1002/jwmg.21181; Moiron M, 2015, BEHAV ECOL, V26, P843, DOI 10.1093/beheco/arv026; Molina-Lopez R, 2011, ANIMAL BIODIVERSITY, P34; Molina-Lopez RA, 2011, ANIM BIODIV CONSERV, V34, P401; Molina-Lopez RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024603; Montesdeoca N, 2017, PLOS ONE, P12, DOI [10.1371/journal.pone.1077366, DOI 10.1371/JOURNAL.PONE.1077366]; Morner T, 2002, ANN NY ACAD SCI, V969, P34; Muhldorfer K, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-61; Mullineaux E, 2014, J SMALL ANIM PRACT, V55, P293, DOI 10.1111/jsap.12213; Mullineaux E, 2011, VET MICROBIOL, V151, P205, DOI 10.1016/j.vetmic.2011.02.045; NSW Government, 2018, DANG FEED LOR; Paltridge R, 2002, WILDLIFE RES, V29, P389, DOI 10.1071/WR00010; Pest & Disease Information Service, 2018, RAINB LOR MAN; Polkinghorne A, 2013, VET MICROBIOL, V165, P214, DOI 10.1016/j.vetmic.2013.02.026; Pyke Graham H., 2018, Pacific Conservation Biology, V24, P148, DOI 10.1071/PC18003; Pyke GH, 2018, CONSERV BIOL, V32, P50, DOI 10.1111/cobi.12937; Queensland Land for Wildlife, 2017, WILDL FRIENDL FENC N; Raidal SR, 2015, AUST VET J, V93, P466, DOI 10.1111/avj.12388; Risbey DA, 2000, WILDLIFE RES, V27, P223, DOI 10.1071/WR98092; Rodriguez B, 2010, J RAPTOR RES, V44, P30, DOI 10.3356/JRR-09-40.1; RSPCA, 2018, WILDL HOSP WHAT WE D; Salafsky N, 2008, CONSERV BIOL, V22, P897, DOI 10.1111/j.1523-1739.2008.00937.x; Santos SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079967; Scheelings TF, 2016, AUST VET J, V94, P121, DOI 10.1111/avj.12417; Scheelings TF, 2015, J WILDLIFE DIS, V51, P712, DOI 10.7589/2014-09-230; Scheelings TF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133638; Schenk AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093517; Schmidt-Posthaus H, 2002, J WILDLIFE DIS, V38, P84, DOI 10.7589/0090-3558-38.1.84; Seiler A, 2006, ENVIRONM POLLUT SER, V10, P165, DOI 10.1007/1-4020-4504-2_8; Sleeman Jonathan M., 2008, P97; Steyn L, 2015, J ORNITHOL, V156, P1085, DOI 10.1007/s10336-015-1209-2; Sumasgutner P, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-48; Tejera G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192731; Trocini S, 2008, NAT WILDL REH C CANB; [United Nations Department of Economic and Social Affairs PD], 2017, ESAPWP2482017 UN; Wendell MD, 2002, J WILDLIFE DIS, V38, P101, DOI 10.7589/0090-3558-38.1.101; Wimberger K, 2010, ANIM WELFARE, V19, P501; Woinarski JCZ, 2015, P NATL ACAD SCI USA, V112, P4531, DOI 10.1073/pnas.1417301112; Woinarski JCZ, 2011, CONSERV LETT, V4, P192, DOI 10.1111/j.1755-263X.2011.00164.x	99	28	32	7	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0206958	10.1371/journal.pone.0206958	http://dx.doi.org/10.1371/journal.pone.0206958			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673712	gold, Green Submitted, Green Published			2022-12-26	WOS:000456442800006
J	Wang, Y; Cobanoglu, MC; Li, J; Hidvegi, T; Hale, P; Ewing, M; Chu, AS; Gong, ZW; Muzumdar, R; Pak, SC; Silverman, GA; Bahar, I; Perlmutter, DH				Wang, Yan; Cobanoglu, Murat C.; Li, Jie; Hidvegi, Tunda; Hale, Pamela; Ewing, Michael; Chu, Andrew S.; Gong, Zhenwei; Muzumdar, Radhika; Pak, Stephen C.; Silverman, Gary A.; Bahar, Ivet; Perlmutter, David H.			An analog of glibenclamide selectively enhances autophagic degradation of misfolded alpha 1-antitrypsin Z	PLOS ONE			English	Article							C. ELEGANS MODEL	The classical form of alpha 1-antitrypsin deficiency (ATD) is characterized by intracellular accumulation of the misfolded variant alpha 1-antitrypsin Z (ATZ) and severe liver disease in some of the affected individuals. In this study, we investigated the possibility of discovering novel therapeutic agents that would reduce ATZ accumulation by interrogating a C. elegans model of ATD with high-content genome-wide RNAi screening and computational systems pharmacology strategies. The RNAi screening was utilized to identify genes that modify the intracellular accumulation of ATZ and a novel computational pipeline was developed to make high confidence predictions on repurposable drugs. This approach identified glibenclamide (GLB), a sulfonylurea drug that has been used broadly in clinical medicine as an oral hypoglycemic agent. Here we show that GLB promotes autophagic degradation of misfolded ATZ in mammalian cell line models of ATD. Furthermore, an analog of GLB reduces hepatic ATZ accumulation and hepatic fibrosis in a mouse model in vivo without affecting blood glucose or insulin levels. These results provide support for a drug discovery strategy using simple organisms as human disease models combined with genetic and computational screening methods. They also show that GLB and/or at least one of its analogs can be immediately tested to arrest the progression of human ATD liver disease.	[Wang, Yan; Li, Jie; Hidvegi, Tunda; Hale, Pamela; Ewing, Michael; Chu, Andrew S.; Gong, Zhenwei; Muzumdar, Radhika; Pak, Stephen C.; Silverman, Gary A.; Perlmutter, David H.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Cobanoglu, Murat C.; Bahar, Ivet] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA USA; [Li, Jie; Hidvegi, Tunda; Hale, Pamela; Pak, Stephen C.; Silverman, Gary A.; Perlmutter, David H.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL)	Perlmutter, DH (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA.; Perlmutter, DH (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	perlmutterd@wustl.edu	Bahar, Ivet/AAH-2921-2020; Silverman, Gary/AAJ-1269-2020	Pak, Stephen/0000-0002-8089-3237	U.S. National Institutes of Health [P01DK096990]; 2015 Pinnacle Research Award in Liver Disease, AASLD (American Association for the Study of Liver Diseases); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK096990] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 2015 Pinnacle Research Award in Liver Disease, AASLD (American Association for the Study of Liver Diseases); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by U.S. National Institutes of Health grants P01DK096990 and 2015 Pinnacle Research Award in Liver Disease by AASLD (American Association for the Study of Liver Diseases).	Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Filipeanu CM, 2000, FEBS LETT, V474, P107, DOI 10.1016/S0014-5793(00)01585-4; Golstein PE, 1999, PFLUG ARCH EUR J PHY, V437, P652, DOI 10.1007/s004240050829; Gosai SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015460; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Li J., 2014, ELECTRON J DIFFER EQ, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0089893; Long OS, 2014, HUM MOL GENET, V23, P5109, DOI 10.1093/hmg/ddu235; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Meyer M, 1999, BRIT J PHARMACOL, V128, P27, DOI 10.1038/sj.bjp.0702763; O'Reilly LP, 2014, HUM MOL GENET, V23, P5123, DOI 10.1093/hmg/ddu236; Payen L, 2001, BRIT J PHARMACOL, V132, P778, DOI 10.1038/sj.bjp.0703863; Perlmutter DH, 2011, ANNU REV MED, V62, P333, DOI 10.1146/annurev-med-042409-151920; Proks P, 2002, DIABETES, V51, pS368, DOI 10.2337/diabetes.51.2007.S368; Tafaleng EN, 2015, HEPATOLOGY, V62, P147, DOI 10.1002/hep.27753; Tsuboyama K, 2016, SCIENCE, V354, P1036, DOI 10.1126/science.aaf6136; Valcifahmetoglu-Norberg H, 2015, J CLIN INVEST, V125, P5, DOI 10.1172/JCI73937	19	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0209748	10.1371/journal.pone.0209748	http://dx.doi.org/10.1371/journal.pone.0209748			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673724	Green Published, gold, Green Submitted			2022-12-26	WOS:000456442800022
J	Bastin, L; Gorelick, N; Saura, S; Bertzky, B; Dubois, G; Fortin, MJ; Pekel, JF				Bastin, Lucy; Gorelick, Noel; Saura, Santiago; Bertzky, Bastian; Dubois, Gregoire; Fortin, Marie-Josee; Pekel, Jean-Francois			Inland surface waters in protected areas globally: Current coverage and 30-year trends	PLOS ONE			English	Article							ECOSYSTEM SERVICES; LONG-TERM; CONSERVATION; BIODIVERSITY; THREATS; PERFORMANCE; STRATEGIES; DIVERSITY; TARGETS; WETLAND	Inland waters are unique ecosystems offering services and habitat resources upon which many species depend. Despite the importance of, and threats to, inland water, global assessments of protected area (PA) coverage and trends have focused on land habitats or have assessed land and inland waters together. We here provide the first assessment of the level of protection of inland open surface waters and their trends (1984-2015) within PAs for all countries, using a globally consistent, high-resolution (30 m) and validated dataset on permanent and seasonal surface waters based on Landsat images. Globally, 15% of inland surface waters are covered by PAs with mapped boundaries. Estimated inland water protection increases to 16.4% if PAs with reported area but delineated only as points are included as circular buffers. These coverage estimates slightly exceed the comparable figure for land but fall below the 17% goal of the Convention on Biological Diversity's Aichi Target 11 for 2020. Protection levels are very uneven across countries, half of which do not yet meet the 17% target. The lowest coverage of surface water by PAs (<5%) was found in Africa and in parts of Asia. There was a global trend of permanent water losses and seasonal water gains within PAs, concomitant with an increase of both water types outside PAs. In 38% of countries, PAs lost over 5% of permanent water. Global protection targets for inland waters may well be met by 2020, but much stronger efforts are required to ensure their effective conservation, which will depend not only on sound PA governance and management but also on the sustainable use of water resources outside PAs. Given the pressures on water in a rapidly changing world, integrated management planning of water resources involving multiple sectors and entire basins is therefore necessary.	[Bastin, Lucy; Saura, Santiago; Bertzky, Bastian; Dubois, Gregoire; Pekel, Jean-Francois] European Commiss, Joint Res Ctr, Ispra, VA, Italy; [Bastin, Lucy] Aston Univ, Dept Comp Sci, Birmingham, W Midlands, England; [Gorelick, Noel] Google Inc, Zurich, Switzerland; [Fortin, Marie-Josee] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	European Commission Joint Research Centre; EC JRC ISPRA Site; Aston University; Google Incorporated; University of Toronto	Bastin, L (corresponding author), European Commiss, Joint Res Ctr, Ispra, VA, Italy.; Bastin, L (corresponding author), Aston Univ, Dept Comp Sci, Birmingham, W Midlands, England.	lucy.bastin@ec.europa.eu	Bastin, Lucy/ABD-2663-2021; Bastin, Lucy/ABE-1099-2021; Saura, Santiago/A-9994-2008; Dubois, Gregoire/AAM-6513-2020; Bertzky, Bastian/I-6909-2013	Bastin, Lucy/0000-0003-1321-0800; Bastin, Lucy/0000-0003-1321-0800; Saura, Santiago/0000-0002-5239-0763; Dubois, Gregoire/0000-0002-0515-7168; Bertzky, Bastian/0000-0001-7025-4733; Gorelick, Noel/0000-0002-5548-2436				Abell R, 2007, BIOL CONSERV, V134, P48, DOI 10.1016/j.biocon.2006.08.017; Abell R, 2017, CONSERV LETT, V10, P384, DOI 10.1111/conl.12312; Adams VM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0274; Alagador D, 2014, J APPL ECOL, V51, P703, DOI 10.1111/1365-2664.12230; [Anonymous], 2016, WORLD DAT PROT AR WD; [Anonymous], 2012, GLOB ADM AR GADM VER; Barnes MD, 2018, NAT ECOL EVOL, V2, P759, DOI 10.1038/s41559-018-0501-y; Britton AW, 2017, BIOL CONSERV, V212, P120, DOI 10.1016/j.biocon.2017.06.001; Brooks EGE, 2016, GLOBAL ECOL BIOGEOGR, V25, P553, DOI 10.1111/geb.12435; Bull JW, 2013, FRONT ECOL ENVIRON, V11, P203, DOI 10.1890/120020; Carpenter SR, 2011, ANNU REV ENV RESOUR, V36, P75, DOI 10.1146/annurev-environ-021810-094524; Castello L, 2016, GLOBAL CHANGE BIOL, V22, P990, DOI 10.1111/gcb.13173; CBD, 2010, 10 M C PART CONV BIO; Collen B, 2014, GLOBAL ECOL BIOGEOGR, V23, P40, DOI 10.1111/geb.12096; Davidson NC, 2014, MAR FRESHWATER RES, V65, P934, DOI 10.1071/MF14173; Dijkstra KDB, 2014, ANNU REV ENTOMOL, V59, P143, DOI 10.1146/annurev-ento-011613-161958; Dixon MJR, 2016, BIOL CONSERV, V193, P27, DOI 10.1016/j.biocon.2015.10.023; Dodds WK, 2013, ENVIRON SCI TECHNOL, V47, P9061, DOI 10.1021/es4021052; Dubois G, 2016, ISPRS INT J GEO-INF, V5, DOI 10.3390/ijgi5120242; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Gray CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12306; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Harrison IJ, 2016, AQUAT CONSERV, V26, P103, DOI 10.1002/aqc.2652; Hermoso V, 2016, AQUAT CONSERV, V26, P3, DOI 10.1002/aqc.2681; IUCN WCPA, 2018, DRAFT GUID REC REP O; Juffe-Bignoli D, 2014, PROTECTED PLANET REP; Juffe-Bignoli D, 2016, AQUAT CONSERV, V26, P133, DOI 10.1002/aqc.2638; Lantz V, 2013, REG ENVIRON CHANGE, V13, P939, DOI 10.1007/s10113-012-0393-3; Luck GW, 2009, CONSERV LETT, V2, P179, DOI 10.1111/j.1755-263X.2009.00064.x; Markert KN, 2018, RESULTS PHYS, V9, P275, DOI 10.1016/j.rinp.2018.02.054; Mascia MB, 2011, CONSERV LETT, V4, P9, DOI 10.1111/j.1755-263X.2010.00147.x; Moilanen A, 2014, BIOL CONSERV, V170, P188, DOI 10.1016/j.biocon.2014.01.001; Nel JL, 2007, DIVERS DISTRIB, V13, P341, DOI 10.1111/j.1472-4642.2007.00308.x; O'Connor JE, 2015, SCIENCE, V348, P496, DOI 10.1126/science.aaa9204; Pekel JF, 2014, REMOTE SENS ENVIRON, V140, P704, DOI 10.1016/j.rse.2013.10.008; Pekel JF, 2016, NATURE, V540, P418, DOI 10.1038/nature20584; Pittock J, 2015, PROTECTED AREA GOVERNANCE AND MANAGEMENT, P569; Rayfield B, 2008, BIOL CONSERV, V141, P438, DOI 10.1016/j.biocon.2007.10.013; Saura S, 2018, BIOL CONSERV, V219, P53, DOI 10.1016/j.biocon.2017.12.020; Saura S, 2017, ECOL INDIC, V76, P144, DOI 10.1016/j.ecolind.2016.12.047; Tognelli MF, 2017, FRESHWATER KEY BIODI; Trenberth KE, 2014, NAT CLIM CHANGE, V4, P17, DOI 10.1038/NCLIMATE2067; UNEP-WCMC and IUCN, 2016, PROTECTED PLANET REP; Visconti P, 2013, CONSERV BIOL, V27, P1000, DOI 10.1111/cobi.12095; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Watson JEM, 2016, CONSERV BIOL, V30, P243, DOI 10.1111/cobi.12645; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947; World Wildlife Fund, 2018, PADDDTRACKER TRACK P	48	27	27	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210496	10.1371/journal.pone.0210496	http://dx.doi.org/10.1371/journal.pone.0210496			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653553	Green Accepted, gold, Green Published			2022-12-26	WOS:000456015500043
J	Campolo, M; Siracusa, R; Cordaro, M; Filippone, A; Gugliandolo, E; Peritore, AF; Impellizzeri, D; Crupi, R; Paterniti, I; Cuzzocrea, S				Campolo, Michela; Siracusa, Rosalba; Cordaro, Marika; Filippone, Alessia; Gugliandolo, Enrico; Peritore, Alessio F.; Impellizzeri, Daniela; Crupi, Rosalia; Paterniti, Irene; Cuzzocrea, Salvatore			The association of adelmidrol with sodium hyaluronate displays beneficial properties against bladder changes following spinal cord injury in mice	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; URINARY-BLADDER; MAST-CELL; PALMITOYLETHANOLAMIDE ANALOG; INFLAMMATORY RESPONSE; NEUROTROPHIC FACTOR; FUNCTIONAL HISTORY; UNITED-STATES; MANAGEMENT; MODEL	The disruption of coordinated control between the brain, spinal cord and peripheral nervous system caused by spinal cord injury (SCI) leads to several secondary pathological conditions, including lower urinary tract dysfunction. In fact, urinary tract dysfunction associated with SCI is urinary dysfunction could be a consequence of a lack of neuroregeneration of supraspinal pathways that control bladder function. The object of the current research was to explore the effects of adelmidrol + sodium hyaluronate, on bladder damage generated after SCI in mice. Spinal cord was exposed via laminectomy, and SCI was induced by extradural compression at T6 to T7 level, by an aneurysm clip with a closing force of 24 g. Mice were treated intravesically with adelmidrol + sodium hyaluronate daily for 48 h and 7 days after SCI. Adelmidrol + sodium hyaluronate reduced significantly mast cell degranulation and down-regulated the nuclear factor-kappa B pathway in the bladder after SCI both at 48 h and 7days. Moreover, adelmidrol + sodium hyaluronate reduced nerve growth factor expression, suggesting an association between neurotrophins and bladder pressure. At 7 days after SCI, the bladder was characterized by a marked bacterial infection and proteinuria; surprisingly, adelmidrol + sodium hyaluronate reduced significantly both parameters. These data show the protective roles of adelmidrol + sodium hyaluronate on bladder following SCI, highlighting a potential therapeutic target for the reduction of bladder changes.	[Campolo, Michela; Siracusa, Rosalba; Cordaro, Marika; Filippone, Alessia; Gugliandolo, Enrico; Peritore, Alessio F.; Impellizzeri, Daniela; Crupi, Rosalia; Paterniti, Irene; Cuzzocrea, Salvatore] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Messina, Italy; [Cuzzocrea, Salvatore] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA	University of Messina; Saint Louis University	Cuzzocrea, S (corresponding author), Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Messina, Italy.; Cuzzocrea, S (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA.	salvator@unime.it	Gugliandolo, Enrico/AAB-9972-2019; Crupi, Rosalia/U-4364-2019; Campolo, Michela/K-6432-2016; Filippone, Alessia/AAC-3679-2022; Cordaro, Marika/K-7329-2016; Siracusa, Rosalba/AAC-3110-2022; Peritore, Alessio/HGB-1327-2022; Cuzzocrea, Salvatore/K-4734-2016	Gugliandolo, Enrico/0000-0001-6840-3154; Filippone, Alessia/0000-0002-9642-6844; Cordaro, Marika/0000-0002-3980-0043; Siracusa, Rosalba/0000-0001-7868-2505; Campolo, Michela/0000-0002-5124-3876; Cuzzocrea, Salvatore/0000-0001-6131-3690; peritore, alessio filippo/0000-0001-8545-990X; Impellizzeri, Daniela/0000-0001-9492-3161; Crupi, Rosalia/0000-0002-7629-3132				Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; ALOE L, 1993, AGENTS ACTIONS, V39, pC145, DOI 10.1007/BF01972748; Ambrozaitis K, 2005, MED LITH, V42, P255; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Bloemen-Vrencken JHA, 2005, DISABIL REHABIL, V27, P1381, DOI 10.1080/09638280500164685; Cameron AP, 2010, J UROLOGY, V184, P213, DOI 10.1016/j.juro.2010.03.008; Cerrato S, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-230; Costa B, 2008, PAIN, V139, P541, DOI 10.1016/j.pain.2008.06.003; Cruz CD, 2011, THESCIENTIFICWORLDJO, V11, P214, DOI 10.1100/tsw.2011.26; De Filippis D, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-3; De Filippis D, 2009, J CELL MOL MED, V13, P1086, DOI 10.1111/j.1582-4934.2008.00353.x; de Jong BWD, 2008, NEUROUROL URODYNAM, V27, P454, DOI 10.1002/nau.20567; de Jong BWD, 2007, BJU INT, V100, P846, DOI 10.1111/j.1464-410X.2007.07046.x; DEGROAT WC, 1990, CIBA F SYMP, V151, P27; Di Paola R, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1189-5; Dietz V, 2014, BRAIN, V137, P654, DOI 10.1093/brain/awt262; Esposito E, 2011, BRAIN BEHAV IMMUN, V25, P1099, DOI 10.1016/j.bbi.2011.02.006; Fehlings MG, 2005, INJURY, V36, P113, DOI 10.1016/j.injury.2005.06.022; Forner S, 2012, BRIT J PHARMACOL, V167, P1737, DOI 10.1111/j.1476-5381.2012.02127.x; Gamper M, 2015, J UROLOGY, V193, P1994, DOI 10.1016/j.juro.2015.01.036; Genovese T, 2008, J PHARMACOL EXP THER, V326, P12, DOI 10.1124/jpet.108.136903; Herrera JJ, 2010, J NEUROTRAUM, V27, P423, DOI 10.1089/neu.2009.0997; Howard PS, 2004, NEUROUROL URODYNAM, V23, P374, DOI 10.1002/nau.20032; Impellizzeri D, 2016, BIOCHEM PHARMACOL, V119, P27, DOI 10.1016/j.bcp.2016.09.001; Impellizzeri D, 2015, IMMUNOBIOLOGY, V220, P1039, DOI 10.1016/j.imbio.2015.05.013; Jain NB, 2015, JAMA-J AM MED ASSOC, V313, P2236, DOI 10.1001/jama.2015.6250; Janzen J, 1998, NEUROUROL URODYNAM, V17, P525; Janzen J, 2001, SPINAL CORD, V39, P568, DOI 10.1038/sj.sc.3101218; Juszczak K, 2009, J PHYSIOL PHARMACOL, V60, P85; Kreft ME, 2010, PROTOPLASMA, V246, P3, DOI 10.1007/s00709-010-0112-1; KRUSE MN, 1995, J AUTONOM NERV SYST, V54, P215, DOI 10.1016/0165-1838(95)00011-L; La Rosa G, 2004, J NEUROSURG-SPINE, V1, P311, DOI 10.3171/spi.2004.1.3.0311; Maier IC, 2006, PHILOS T R SOC B, V361, P1611, DOI 10.1098/rstb.2006.1890; Mastrofrancesco A, 2010, EXP DERMATOL, V19, P813, DOI 10.1111/j.1600-0625.2010.01107.x; National Spinal Cord Injury Statistical Center, 2013, J Spinal Cord Med, V36, P1, DOI 10.1179/1079026813Z.000000000136; Noli C, 2001, VET DERMATOL, V12, P303, DOI 10.1046/j.0959-4493.2001.00272.x; Ochodnicky P, 2011, NEUROUROL URODYNAM, V30, P1227, DOI 10.1002/nau.21022; Ostardo E, 2018, PHARMACOL RES, V134, P16, DOI 10.1016/j.phrs.2018.05.013; Prencipe G, 2014, J IMMUNOL, V192, P3345, DOI 10.4049/jimmunol.1300825; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; Pulvirenti N, 2007, ACTA DERMATOVENER CR, V15, P80; Rahnama'i MS, 2018, NEUROUROL URODYNAM, V37, pS99, DOI 10.1002/nau.23493; Reis LO, 2011, ACTA CIR BRAS, V26, P106, DOI 10.1590/S0102-86502011000800019; Rickard A, 2008, IN VITRO CELL DEV-AN, V44, P261, DOI 10.1007/s11626-008-9116-y; Saban R, 2002, AM J PHYSIOL-RENAL, V283, pF616, DOI 10.1152/ajprenal.00096.2002; SANT GR, 1994, UROL CLIN N AM, V21, P41; Simpson LA, 2012, J NEUROTRAUM, V29, P1548, DOI 10.1089/neu.2011.2226; Vizzard MA, 2000, EXP NEUROL, V161, P273, DOI 10.1006/exnr.1999.7254; Wada N, 2018, NEUROUROL URODYNAM, V37, P1889, DOI 10.1002/nau.23539; Wada N, 2017, NEUROUROL URODYNAM, V36, P1301, DOI 10.1002/nau.23120; Wang XC, 2000, J UROLOGY, V163, P993, DOI 10.1016/S0022-5347(05)67870-6; Yamagata K, 2003, GLIA, V41, P199, DOI 10.1002/glia.10180	52	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0208730	10.1371/journal.pone.0208730	http://dx.doi.org/10.1371/journal.pone.0208730			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653511	Green Submitted, Green Published, gold			2022-12-26	WOS:000456015500009
J	Drak, D; Barratt, H; Templeton, DJ; O'Connor, CC; Gracey, DM				Drak, Douglas; Barratt, Hamish; Templeton, David J.; O'Connor, Catherine C.; Gracey, David M.			Renal function and risk factors for renal disease for patients receiving HIV pre-exposure prophylaxis at an inner metropolitan health service	PLOS ONE			English	Article							TENOFOVIR DISOPROXIL FUMARATE; KIDNEY-FUNCTION; MEN; EXPOSURE; ASSOCIATION; ADHERENCE	Background Pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) significantly reduces the risk of HIV acquisition. TDF is a known nephrotoxin however, renal dysfunction from TDF is mostly reversible following discontinuation. Aims To describe the renal function, risk factors for renal disease and associated clinical testing practices in a cohort of PrEP patients. Methods A retrospective review was conducted of all PrEP patients commenced on TDF/FTC at an inner metropolitan sexual health clinic in Sydney, Australia between April 2016 and July 2017, with follow-up data obtained at 3-monthly intervals until 18 months. Results 525 patients met inclusion criteria. Patients were almost exclusively male and median age was 34 years (IQR: 28 to 42). At baseline, 1.5% had an estimated glomerular filtration rate (eGFR) < 70 mL/min/1.73m(2). A small significant drop in eGFR of -2.5 mL/min/1.73m(2) (p<0.05) occurred between PrEP commencement and the first follow-up period, followed by a progressive decline in eGFR of -0.38 mL/min/1.73m(2) per month (95% CI: -0.57 to -0.20; p<0.001). Renal impairment (eGFR < 70 mL/min/1.73m(2)) occurred in 6.5% of patients and persisted across consecutive follow-up periods in five (1.0%) patients. Patients aged. 40 years had a greater risk of renal impairment than younger patients (HR 3.9, 95% CI: 1.8 to 8.4; p<0.001), despite similar rates of eGFR decline (p = 0.19). PrEP was discontinued in two patients (0.4%) due to renal function concerns. Conclusion PrEP use led to an initial drop in eGFR and a more gradual progressive decline subsequently, but significant renal impairment remained uncommon up to 18 months of follow-up.	[Drak, Douglas; Barratt, Hamish] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Barratt, Hamish; Templeton, David J.; O'Connor, Catherine C.; Gracey, David M.] Univ Sydney, Cent Clin Sch, Sydney, NSW, Australia; [Templeton, David J.; O'Connor, Catherine C.] RPA Sexual Hlth, Sydney, NSW, Australia; [Templeton, David J.; O'Connor, Catherine C.] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia; [Gracey, David M.] Royal Prince Alfred Hosp, Renal Unit, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of New South Wales Sydney; Kirby Institute; University of Sydney	Drak, D (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.	douglas.drak@sydney.edu.au		Templeton, David/0000-0003-2157-9587				Gandhi M, 2016, LANCET HIV, V3, pE521, DOI 10.1016/S2352-3018(16)30153-9; Glidden DV, 2016, CLIN INFECT DIS, V62, P1172, DOI 10.1093/cid/ciw022; Health N, 2016, PREEXP PROPH HIV ANT, P42; Kakar S, 2017, NEPHROLOGY, V22, P174, DOI 10.1111/nep.12844; Laprise C, 2013, CLIN INFECT DIS, V56, P567, DOI 10.1093/cid/cis937; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Marcus JL, 2016, JAIDS-J ACQ IMM DEF, V73, P540, DOI 10.1097/QAI.0000000000001129; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Mocroft A, 2016, LANCET HIV, V3, pE23, DOI 10.1016/S2352-3018(15)00211-8; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Mugwanya K, 2016, J INFECT DIS, V214, P1050, DOI 10.1093/infdis/jiw125; Mugwanya KK, 2016, JAIDS-J ACQ IMM DEF, V71, P374, DOI 10.1097/QAI.0000000000000868; Mugwanya KK, 2015, JAMA INTERN MED, V175, P246, DOI 10.1001/jamainternmed.2014.6786; Pendergraft WF, 2014, CLIN J AM SOC NEPHRO, V9, P1996, DOI 10.2215/CJN.00360114; Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743; Solomon MM, 2014, AIDS, V28, P851, DOI 10.1097/QAD.0000000000000156; Suzuki S, 2017, AIDS PATIENT CARE ST, V31, P105, DOI 10.1089/apc.2016.0286; Tang EC, 2018, JAIDS-J ACQ IMM DEF, V77, P193, DOI 10.1097/QAI.0000000000001566; Wright E., 2018, J VIRUS ERAD, V2018, P143; Zablotska IB, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-5018-9; Zablotska IB, 2017, CURR HIV-AIDS REP, V14, P201, DOI 10.1007/s11904-017-0367-7	21	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210106	10.1371/journal.pone.0210106	http://dx.doi.org/10.1371/journal.pone.0210106			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653509	Green Submitted, Green Published, gold			2022-12-26	WOS:000456015500026
J	Kwon, JS; Lee, MJ; Kim, JY; Kim, D; Ryu, JH; Jang, S; Kim, KM; Hwang, CJ; Choi, SH				Kwon, Jae-Sung; Lee, Myung-Jin; Kim, Ji-Young; Kim, Dohyun; Ryu, Jeong-Hyun; Jang, Sungil; Kim, Kwang-Mahn; Hwang, Chung-Ju; Choi, Sung-Hwan			Novel anti-biofouling bioactive calcium silicate-based cement containing 2-methacryloyloxyethyl phosphorylcholine	PLOS ONE			English	Article							MINERAL TRIOXIDE AGGREGATE; ENTEROCOCCUS-FAECALIS; ENDODONTIC CEMENTS; PROTEIN-REPELLENT; FORMING ABILITY; ADHESIVE; BIOFILMS; CARIES; MTA	Calcium silicate-based cements (CSCs) are commonly used for endodontic procedures; however, their antibacterial effects are limited. The objective of this study was to develop a 2-methacryloyloxyethyl phosphorylcholine (MPC)-incorporated CSC with improved antibacterial properties, while maintaining the original advantageous features of CSC. MPC was incorporated into a commercial CSC (Endocem MTA) at 0 wt% (control), 1.5%, 3.0 wt%, 5.0 wt%, 7.5 wt%, and 10 wt%. The setting time, compressive strength, water sorption, and glycerol contact angle were measured. Protein absorption was measured and bacterial adhesion on the surface was evaluated using Enterococcus faecalis. The bactericidal effect was examined by the disc diffusion test. Mineralization ability was assessed based on calcium ion deposition, as assessed by alizarin red staining, after immersion into Hank's balanced salt solution for 7 days. High concentrations of MPC in CSC (7.5 wt% and 10 wt%) increased the setting time, reduced compressive strength, and reduced wettability. MPC (3 wt%) had greater protein repellent and anti-biofouling effects than those of control and test materials (P < 0.001). However, no bactericidal effect was observed for any control or test materials. There was greater calcium ion deposition on the surface of MPC-supplemented CSC than on the control (P < 0.001). The addition of 3 wt% MPC polymer to CSC confers protein-repellent properties and reduced bacterial attachment, with the potential for improved mineralization.	[Kwon, Jae-Sung; Lee, Myung-Jin; Ryu, Jeong-Hyun; Kim, Kwang-Mahn] Yonsei Univ, Coll Dent, Dept & Res Inst Dent Biomat & Bioengn, Seoul, South Korea; [Kim, Ji-Young; Hwang, Chung-Ju; Choi, Sung-Hwan] Yonsei Univ, Coll Dent, Inst Craniofacial Deform, Dept Orthodont, Seoul, South Korea; [Kim, Dohyun] Yonsei Univ, Coll Dent, Dept Conservat Dent, Seoul, South Korea; [Ryu, Jeong-Hyun; Jang, Sungil] Yonsei Univ, Coll Dent, BK21 PLUS Project, Seoul, South Korea; [Jang, Sungil] Yonsei Univ, Coll Dent, Dept Oral Biol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Choi, SH (corresponding author), Yonsei Univ, Coll Dent, Inst Craniofacial Deform, Dept Orthodont, Seoul, South Korea.	selfexam@yuhs.ac	Kim, Dohyun/ABG-2808-2020; Choi, Sung-Hwan/T-6925-2019; Kwon, Jae-Sung/M-5430-2018	Kim, Dohyun/0000-0002-0772-6985; Choi, Sung-Hwan/0000-0002-1150-0268; Kim, Ji-Yeong/0000-0002-8920-5170; Jang, Sungil/0000-0001-6144-6899; KIM, KWANG-MAHN/0000-0002-5235-0294; Kwon, Jae-Sung/0000-0001-9803-7730; Hwang, Chung-Ju/0000-0003-3024-4551	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2018R1C1B6000989]; Yonsei University College of Dentistry [6-2018-0021]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Yonsei University College of Dentistry	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) and funded by the Ministry of Science, ICT & Future Planning (NRF-2018R1C1B6000989) and Yonsei University College of Dentistry (6-2018-0021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, 99171 ISO; Biocanin V, 2018, J ENDODONT, V44, P816, DOI 10.1016/j.joen.2017.09.022; Bjorndal L, 2010, EUR J ORAL SCI, V118, P290, DOI 10.1111/j.1600-0722.2010.00731.x; Choi Y, 2013, J ENDODONT, V39, P467, DOI 10.1016/j.joen.2012.11.023; Exterkate RAM, 2010, CARIES RES, V44, P372, DOI 10.1159/000316541; Gandolfi MG, 2010, INT ENDOD J, V43, P917, DOI 10.1111/j.1365-2591.2010.01768.x; Gandolfi MG, 2013, J BIOMED MATER RES B, V101, P1107, DOI 10.1002/jbm.b.32920; Hori K, 2010, BIOCHEM ENG J, V48, P424, DOI 10.1016/j.bej.2009.11.014; Hubble TS, 2003, ORAL MICROBIOL IMMUN, V18, P121, DOI 10.1034/j.1399-302X.2003.00059.x; Hung CJ, 2014, J DENT SCI, V9, P158, DOI 10.1016/j.jds.2013.08.002; International Organization for Standardization, 2012, 68762020 ISO; Jang Ga-Yeon, 2013, Restor Dent Endod, V38, P248, DOI 10.5395/rde.2013.38.4.248; Jiang SY, 2010, ADV MATER, V22, P920, DOI 10.1002/adma.200901407; Kim RJY, 2015, ARCH ORAL BIOL, V60, P1497, DOI 10.1016/j.archoralbio.2015.07.014; Lai WY, 2015, MATERIALS, V8, P4491, DOI 10.3390/ma8074491; LEE SJ, 1993, J ENDODONT, V19, P541, DOI 10.1016/S0099-2399(06)81282-3; Lewis AL, 2002, BIOMATERIALS, V23, P1697, DOI 10.1016/S0142-9612(01)00297-6; Loison-Robert LS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190014; Moro T, 2009, BIOMATERIALS, V30, P2995, DOI 10.1016/j.biomaterials.2009.02.020; Parirokh M, 2018, INT ENDOD J, V51, P177, DOI 10.1111/iej.12841; Shin M, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2071247; Shinohara MS, 2009, DENT MATER, V25, P1383, DOI 10.1016/j.dental.2009.06.011; Siboni F, 2017, INT ENDOD J, V50, pE83, DOI 10.1111/iej.12787; Stuart CH, 2006, J ENDODONT, V32, P93, DOI 10.1016/j.joen.2005.10.049; Torabinejad M, 2018, INT ENDOD J, V51, P284, DOI 10.1111/iej.12843; TORABINEJAD M, 1995, J ENDODONT, V21, P349, DOI 10.1016/S0099-2399(06)80967-2; Tran XV, 2012, J DENT RES, V91, P1166, DOI 10.1177/0022034512460833; Turkcan I, 2018, J MATER SCI-MATER M, V29, DOI 10.1007/s10856-018-6116-7; Weng YM, 2012, J MATER SCI-MATER M, V23, P1553, DOI 10.1007/s10856-012-4629-z; Yang YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112549; Yassen GH, 2015, J ENDODONT, V41, P956, DOI 10.1016/j.joen.2015.02.023; Yildirim T, 2005, ORAL SURG ORAL MED O, V100, P120, DOI 10.1016/j.tripleo.2004.09.017; Zhang N, 2015, DENT MATER, V31, P1119, DOI 10.1016/j.dental.2015.06.010; Zhang N, 2015, J DENT, V43, P225, DOI 10.1016/j.jdent.2014.11.008; Zhang N, 2014, J DENT, V42, P1284, DOI 10.1016/j.jdent.2014.07.016	35	24	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0211007	10.1371/journal.pone.0211007	http://dx.doi.org/10.1371/journal.pone.0211007			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653611	Green Published, gold, Green Submitted			2022-12-26	WOS:000456015500097
J	Samelko, L; Caicedo, MS; Jacobs, J; Hallab, NJ				Samelko, Lauryn; Caicedo, Marco S.; Jacobs, Joshua; Hallab, Nadim James			Transition from metal-DTH resistance to susceptibility is facilitated by NLRP3 inflammasome signaling induced Th17 reactivity: Implications for orthopedic implants	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; TOTAL HIP-ARTHROPLASTY; IN-VITRO; T-CELLS; CYTOKINE PRODUCTION; MONONUCLEAR-CELLS; INTERFERON-GAMMA; ADVERSE-REACTION; IMMUNE-RESPONSE; NICKEL RELEASE	Metal hypersensitivity has been recognized as an adverse biologic reaction that can compromise total joint arthroplasty (TJA) performance. However, the etiology of metal hypersensitivity responses in TJAs remains unclear. Metal implant debris is known to act as a danger signal that drives NLRP3 inflammasome activation. It remains unknown if implant debris induced inflammasome activation regulates T cell lineage in TJA metal hypersensitivity responses. In this study, we show both in vivo and in vitro that the pathogenesis of metal hypersensitivity responses to implant debris are largely dependent on activation of the inflammasome/caspase-1 pathway and subsequent production of IL-17A/F by CD4+ T cells. Inhibiting either the inflammasome pathway or IL-17A bioactivity in vivo and in vitro (in vivo using NLRP3 and Caspase-1 deficient mice or in vitro using blocking agents such as Capase-1 inhibitor, IL-1Ra and anti-IL-17A), significantly (p<0.05) mitigated metal-DTH paw inflammation as well as lymphocyte cytokine (IFN-gamma and IL-17) and proliferation responses in metal-sensitized mice and primary human PBMCs. This study provides mechanistic insight into how in vivo exposure to orthopedic implant debris, and metals in general, elicits NLRP3 inflammasome activation that mediates the generation of IL-17A/F producing CD4+ T cells, leading to metal-delayed type hypersensitivity reactions.	[Samelko, Lauryn; Caicedo, Marco S.; Jacobs, Joshua; Hallab, Nadim James] Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA	Rush University	Hallab, NJ (corresponding author), Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA.	nhallab@rush.edu		Hallab, Nadim/0000-0001-6421-2836	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [AR060782]	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (https://www.niams.nih.gov/), and was received by corresponding author NJH, grant number: AR060782. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroukatos P, 2010, CLIN ORTHOP RELAT R, V468, P2135, DOI 10.1007/s11999-009-1187-x; Ashrin MN, 2014, J IMMUNOL, V192, P4025, DOI 10.4049/jimmunol.1300276; Atkinson SM, 2016, DIS MODEL MECH, V9, P427, DOI 10.1242/dmm.022905; Avau A, 2014, ARTHRITIS RHEUMATOL, V66, P1340, DOI 10.1002/art.38359; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barrett WP, 2012, J ARTHROPLASTY, V27, P976, DOI 10.1016/j.arth.2012.01.019; BASKETTER DA, 1993, CONTACT DERMATITIS, V28, P15, DOI 10.1111/j.1600-0536.1993.tb03318.x; Bechara R, 2017, J INVEST DERMATOL, V137, P2140, DOI 10.1016/j.jid.2017.05.025; BENSON MKD, 1975, BRIT MED J, V4, P374, DOI 10.1136/bmj.4.5993.374; Borg L, 2000, ARCH DERMATOL RES, V292, P285, DOI 10.1007/s004030000129; BROWN GC, 1977, J BONE JOINT SURG AM, V59, P164, DOI 10.2106/00004623-197759020-00004; Caicedo MS, 2013, J ORTHOP RES, V31, P1633, DOI 10.1002/jor.22411; Caicedo MS, 2010, J BIOMED MATER RES A, V93A, P1312, DOI 10.1002/jbm.a.32627; Caicedo MS, 2009, J ORTHOP RES, V27, P847, DOI 10.1002/jor.20826; CARLSSON AS, 1980, ACTA ORTHOP SCAND, V51, P57, DOI 10.3109/17453678008990769; Chang SH, 2007, CELL RES, V17, P435, DOI 10.1038/cr.2007.35; Chu CQ, 2007, ARTHRITIS RHEUM, V56, P1145, DOI 10.1002/art.22453; CRAMERS M, 1977, ACTA ORTHOP SCAND, V48, P245, DOI 10.3109/17453677708988763; Davies AP, 2005, J BONE JOINT SURG AM, V87A, P18, DOI 10.2106/JBJS.C.00949; DEUTMAN R, 1977, J BONE JOINT SURG AM, V59, P862, DOI 10.2106/00004623-197759070-00004; Dyring-Andersen B, 2013, CONTACT DERMATITIS, V68, P339, DOI 10.1111/cod.12043; Falsafi-Amin H, 2000, INT ARCH ALLERGY IMM, V123, P170, DOI 10.1159/000024437; Ferber IA, 1996, J IMMUNOL, V156, P5; FISCHER T, 1984, ACTA DERM-VENEREOL, V64, P121; FISHER AA, 1977, CUTIS, V19, P285; GAWKRODGER DJ, 1993, CONTACT DERMATITIS, V28, P257, DOI 10.1111/j.1600-0536.1993.tb03427.x; Hallab NJ, 2013, J ORTHOP RES, V31, P173, DOI 10.1002/jor.22214; Hallab Nadim James, 2008, J Orthop Surg Res, V3, P6, DOI 10.1186/1749-799X-3-6; Hallab NJ, 2010, J BIOMED MATER RES A, V92A, P667, DOI 10.1002/jbm.a.32368; Hallab NJ, 2004, J ARTHROPLASTY, V19, P88, DOI 10.1016/j.arth.2004.09.012; Hart AJ, 2014, J BONE JOINT SURG AM, V96A, P1091, DOI 10.2106/JBJS.M.00957; HAUDRECHY P, 1994, CONTACT DERMATITIS, V31, P249, DOI 10.1111/j.1600-0536.1994.tb01997.x; He D, 2006, J IMMUNOL, V177, DOI [10.1002/art.22453, DOI 10.1002/ART.22453]; Jacobs JJ, 2006, J BONE JOINT SURG AM, V88A, P1171, DOI 10.2106/JBJS.F.00453; Jakobson E, 2002, BRIT J DERMATOL, V147, P442, DOI 10.1046/j.1365-2133.2002.04850.x; KANERVA L, 1994, CONTACT DERMATITIS, V31, P299, DOI 10.1111/j.1600-0536.1994.tb02023.x; Kitchen CMR, 2009, AM J OPHTHALMOL, V147, P571, DOI 10.1016/j.ajo.2008.06.031; KONDO S, 1995, J INVEST DERMATOL, V105, P334, DOI 10.1111/1523-1747.ep12320329; Korovessis P, 2006, J BONE JOINT SURG AM, V88A, P1183, DOI 10.2106/JBJS.D.02916; KUBBA R, 1981, ARCH DERMATOL, V117, P554, DOI 10.1001/archderm.117.9.554; Kwon YM, 2011, J ARTHROPLASTY, V26, P511, DOI 10.1016/j.arth.2010.05.030; Kwon YM, 2010, J ORTHOP RES, V28, P444, DOI 10.1002/jor.21015; Langton DJ, 2011, J BONE JOINT SURG BR, V93B, P1011, DOI 10.1302/0301-620X.93B8.26040; Langton DJ, 2010, J BONE JOINT SURG BR, V92B, P38, DOI 10.1302/0301-620X.92B1.22770; Lee YP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176484; Liang SC, 2007, J IMMUNOL, V179, P7791, DOI 10.4049/jimmunol.179.11.7791; LIDEN C, 1994, ACTA DERM-VENEREOL, V74, P341; Liden C, 1995, SKIN, P447; Marshall D, 2014, J IMMUNOL, V193, P5525, DOI 10.4049/jimmunol.1402144; MAYOR MB, 1980, AM J SURG, V139, P477, DOI 10.1016/0002-9610(80)90323-2; Merritt K, 1996, CLIN ORTHOP RELAT R, P71; MERRITT K, 1984, BIOMATERIALS, V5, P47, DOI 10.1016/0142-9612(84)90066-8; MERRITT K, 1981, INT J DERMATOL, V20, P89, DOI 10.1111/j.1365-4362.1981.tb00408.x; Milosev I, 2006, J BONE JOINT SURG AM, V88A, P1173, DOI 10.2106/JBJS.E.00604; Minang JT, 2006, CLIN EXP IMMUNOL, V146, P417, DOI 10.1111/j.1365-2249.2006.03226.x; Mishra PK, 2011, J IMMUNOL, V187, P6491, DOI 10.4049/jimmunol.1101392; Morwood MP, 2015, J SHOULDER ELB SURG, V24, P1156, DOI 10.1016/j.jse.2015.01.015; Moser EK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004315; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Perry MJ, 1995, BRIT J RHEUMATOL, V34, P1127; PINKSTON JA, 1979, STAIN TECHNOL, V54, P233, DOI 10.3109/10520297909110677; Reito A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147872; Reito A, 2014, INT ORTHOP, V38, P2251, DOI 10.1007/s00264-014-2429-4; ROGERS HW, 1992, P NATL ACAD SCI USA, V89, P1011, DOI 10.1073/pnas.89.3.1011; ROGERS HW, 1994, J IMMUNOL, V153, P2093; ROOKER GD, 1980, J BONE JOINT SURG BR, V62, P502, DOI 10.1302/0301-620X.62B4.7430234; Samelko L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160141; Sato N, 2007, CLIN EXP ALLERGY, V37, P743, DOI 10.1111/j.1365-2222.2007.02705.x; Shornick LP, 2001, CELL IMMUNOL, V211, P105, DOI 10.1006/cimm.2001.1834; Summer B, 2010, CONTACT DERMATITIS, V63, P15, DOI 10.1111/j.1600-0536.2010.01744.x; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Thomas P, 2009, ALLERGY, V64, P1157, DOI 10.1111/j.1398-9995.2009.01966.x; TORGERSEN S, 1995, EUR J ORAL SCI, V103, P46, DOI 10.1111/j.1600-0722.1995.tb00010.x; Vermeire K, 1997, J IMMUNOL, V158, P5507; Willert HG, 2005, J BONE JOINT SURG AM, V87A, P28, DOI 10.2106/JBJS.A.02039pp; Zhao Y, 2009, BRIT J DERMATOL, V161, P1301, DOI 10.1111/j.1365-2133.2009.09400.x; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	77	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210336	10.1371/journal.pone.0210336	http://dx.doi.org/10.1371/journal.pone.0210336			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653583	Green Published, gold, Green Submitted			2022-12-26	WOS:000456015500035
J	Gejo, NG; Weldearegay, HG; Tinsaie, KTW; Mekango, DE; Woldemichael, ES; Buda, AS; Dinsa, LH; Alemayehu, M; Goba, G				Gejo, Negeso Gebeyehu; Weldearegay, Haftom Gebrehiwot; Tinsaie, Kidisti Tesfay W.; Mekango, Dejene Ermias; Woldemichael, Ermias Sahile; Buda, Alula Seyum; Dinsa, Leta Hinkosa; Alemayehu, Mussie; Goba, Gelila			Exclusive breastfeeding and associated factors among HIV positive mothers in Northern Ethiopia	PLOS ONE			English	Article								Background It is estimated that sub-optimal feeding, especially non-exclusive breastfeeding in the first 6months of life, results in 1.4million deaths and 10% of disease burden in children younger than five years. Worldwide, it is estimated that only 34.8% of infants are exclusively breastfed for the first 6months of life, the majority receiving some other food or fluid in the early months. Besides, the Ethiopian demographic and health survey (2016) stated that the median duration of exclusive breastfeeding in Tigray region was 3.8 months which is shorter than the recommended duration. The main purpose of this study was to determine the magnitude of exclusive breastfeeding practice and associated factors among HIV positive mothers in public hospitals of Tigray region, Northern Ethiopia. Methods A facility based cross-sectional study was conducted from July 9 to October 11, 2016, in public hospitals of Tigray region. Data was collected by using structured questionnaire using face-to-face interview among 304 eligible women through a systematic sampling technique. Data was analyzed using SPSS version 20.0. Binary and multiple variable logistic regressions ("odds ratio") analyses were calculated with 95% CI and p value <= 0.05 as significance were used. Result Two hundred seventy (88.8%) of mothers practiced exclusive breastfeeding for the first six months of life. Infant feeding counseling during antenatal care of last pregnancy [AOR = 6.9, 95% CI; 2.63, 17.99], knowledge on exclusive breastfeeding (AOR = 5.5, 95% CI; (2.12, 14.02] and attitude towards exclusive breastfeeding [AOR = 7.9; 95% CI; 2.96, 21.21] had significant association with exclusive breastfeeding practice. Conclusions A high proportion of mothers practiced exclusive breastfeeding for the first six months of life. Infant feeding counseling, knowledge and attitude towards exclusive breastfeeding practice were the predictors of exclusive breastfeeding among HIV positive mothers. Strengthening infant feeding counseling during antenatal care and improving mothers' knowledge and attitude on exclusive breastfeeding is essential.	[Gejo, Negeso Gebeyehu] Wachemo Univ, Dept Midwifery, Coll Med & Hlth Sci, Hosanna, Ethiopia; [Weldearegay, Haftom Gebrehiwot; Tinsaie, Kidisti Tesfay W.] Mekelle Univ, Dept Midwifery, Coll Hlth Sci, Mekelle, Ethiopia; [Mekango, Dejene Ermias] Wachemo Univ Hosanna, Dept Publ Hlth, Coll Med & Hlth Sci, Hosanna, Ethiopia; [Woldemichael, Ermias Sahile] Mizan Tepi Univ, Dept Midwifery, Coll Med & Hlth Sci, Mizan, Ethiopia; [Buda, Alula Seyum] Wachemo Univ, Dept Nursing, Coll Med & Hlth Sci, Hosanna, Ethiopia; [Dinsa, Leta Hinkosa] Wollega Univ, Dept Midwifery, Coll Med & Hlth Sci, Nekemte, Ethiopia; [Alemayehu, Mussie] Mekelle Univ, Dept Publ Hlth, Coll Hlth Sci, Mekelle, Ethiopia; [Goba, Gelila] Univ Illinois, Dept Obstet & Gynecol, Chicago, IL 60612 USA	Mekelle University; Mekelle University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gejo, NG (corresponding author), Wachemo Univ, Dept Midwifery, Coll Med & Hlth Sci, Hosanna, Ethiopia.	negiyeman@gmail.com	Alemayehu, Mussie/AAH-3016-2019	Alemayehu, Mussie/0000-0002-0035-631X; Dinsa, Leta Hinkosa Dinsa/0000-0003-2691-7071; Woldemichael, Ermias/0000-0001-9200-7098				Aishat U, 2015, PAN AFR MED J, V21, DOI 10.11604/pamj.2015.21.309.6498; Bekere A, 2014, J NUTR FOOD SCI, V4, P6, DOI DOI 10.4172/2155-9600.1000319; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Federal ministry of health Ethiopia (FMOH) and ICF,, 2016, ETH DEM HLTH SURV 20; Fletcher FE, 2008, THEOR MED BIOETH, V29, P307, DOI 10.1007/s11017-008-9083-z; Girma Y A, 2014, J HIV AIDS INFECT DI, V2; Hiwot A H, 2014, INT J PHARMA SCI RES, V5; Hunt DP, 2003, J INTELLECTUAL CAPIT, V4; Maru Y H., 2009, ETHIOP J HLTH DEV, V23; Modjo KE, 2015, AM J HLTH RES, V3, P105, DOI DOI 10.11648/J.AJHR.20150302.18; Muluye D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-435; Onono MA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-390; UNAIDS, 2020, GLOB HIV AIDS STAT F; UNICEF data, 2006, PROGR CHILDR REP CAR; World Health Organization, 2008, IND ASS INF YOUNG CH; Yalcin SS, 2016, PAEDIATR PERINAT EP, V30, P439, DOI 10.1111/ppe.12305; Zewdu MD A., 2014, AFRICAN J MIDWIFERY, V8	17	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210782	10.1371/journal.pone.0210782	http://dx.doi.org/10.1371/journal.pone.0210782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650156	Green Submitted, Green Published, gold			2022-12-26	WOS:000455813300077
J	Prukop, T; Stenzel, J; Wernick, S; Kungl, T; Mroczek, M; Adam, J; Ewers, D; Nabirotchkin, S; Nave, KA; Hajj, R; Cohen, D; Sereda, MW				Prukop, Thomas; Stenzel, Jan; Wernick, Stephanie; Kungl, Theresa; Mroczek, Magdalena; Adam, Julia; Ewers, David; Nabirotchkin, Serguei; Nave, Klaus-Armin; Hajj, Rodolphe; Cohen, Daniel; Sereda, Michael W.			Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A)	PLOS ONE			English	Article							AXONAL LOSS; GENE; NEUROPATHIES; MYELINATION; VARIABILITY; EXPRESSION; SUBTYPES	The most common type of Charcot-Marie-Tooth disease is caused by a duplication of PMP22 leading to dysmyelination, axonal loss and progressive muscle weakness ( CMT1A). Currently, no approved therapy is available for CMT1A patients. A novel polytherapeutic proof-of-principle approach using PXT3003, a low-dose combination of baclofen, naltrexone and sorbitol, slowed disease progression after long-term dosing in adult Pmp22 transgenic rats, a known animal model of CMT1A. Here, we report an early postnatal, short-term treatment with PXT3003 in CMT1A rats that delays disease onset into adulthood. CMT1A rats were treated from postnatal day 6 to 18 with PXT3003. Behavioural, electrophysiological, histological and molecular analyses were performed until 12 weeks of age. Daily oral treatment for approximately 2 weeks ameliorated motor deficits of CMT1A rats reaching wildtype levels. Histologically, PXT3003 corrected the disturbed axon calibre distribution with a shift towards large motor axons. Despite dramatic clinical amelioration, only distal motor latencies were improved and correlated with phenotype performance. On the molecular level, PXT3003 reduced Pmp22 mRNA overexpression and improved the misbalanced downstream PI3K-AKT / MEK-ERK signalling pathway. The improved differentiation status of Schwann cells may have enabled better long-term axonal support function. We conclude that short-term treatment with PXT3003 during early development may partially prevent the clinical and molecular manifestations of CMT1A. Since PXT3003 has a strong safety profile and is currently undergoing a phase III trial in CMT1A patients, our results suggest that PXT3003 therapy may be a bona fide translatable therapy option for children and young adolescent patients suffering from CMT1A.	[Prukop, Thomas; Stenzel, Jan; Wernick, Stephanie; Kungl, Theresa; Mroczek, Magdalena; Adam, Julia; Ewers, David; Nave, Klaus-Armin; Sereda, Michael W.] Max Planck Inst Expt Med, Dept Neurogenet, Gottingen, Germany; [Prukop, Thomas] Univ Med Ctr Gottingen, Inst Clin Pharmacol, Gottingen, Germany; [Nabirotchkin, Serguei; Hajj, Rodolphe; Cohen, Daniel] Pharnext, Issy Les Moulineaux, France; [Sereda, Michael W.] Univ Med Ctr Gottingen, Dept Clin Neurophysiol, Gottingen, Germany	Max Planck Society; University of Gottingen; University of Gottingen	Sereda, MW (corresponding author), Max Planck Inst Expt Med, Dept Neurogenet, Gottingen, Germany.; Sereda, MW (corresponding author), Univ Med Ctr Gottingen, Dept Clin Neurophysiol, Gottingen, Germany.	sereda@em.mpg.de	Mroczek, Magdalena/GNM-7358-2022; Ewers, David/AAG-8478-2021	Mroczek, Magdalena/0000-0002-8731-0540; Ewers, David/0000-0003-1037-1027	German Ministry of Education and Research (BMBF) [FKZ: 01ES0812, FKZ: 01GM1511C, FKZ: 01GM1605]; European Leukodystrophie Society [ELA 2014-020I1]; DFG [SPP1757]; DFG (CNMPB); Pharnext	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Leukodystrophie Society; DFG(German Research Foundation (DFG)); DFG (CNMPB)(German Research Foundation (DFG)); Pharnext	MWS was supported by the German Ministry of Education and Research (BMBF, CMT-BIO, FKZ: 01ES0812, CMT-NET, FKZ: 01GM1511C, CMT-NRG, ERA-NET 'ERARE3', FKZ: 01GM1605). MWS holds a DFG Heisenberg Professorship (SE 1944/1-1). TP was supported by the European Leukodystrophie Society (ELA 2014-020I1 to MWS). KAN is supported by the DFG (SPP1757 and CNMPB) and holds an ERC Advanced Grant. This trial was financially supported by Pharnext who provided support in the form of salaries for authors SN, RH and DC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ADLKOFER K, 1995, NAT GENET, V11, P274, DOI 10.1038/ng1195-274; Attarian S, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0463-6; Attarian S, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0199-0; Berciano J, 2009, ADV EXP MED BIOL, V652, P183, DOI 10.1007/978-90-481-2813-6_12; Braathen GJ, 2011, EUR J NEUROL, V18, P39, DOI 10.1111/j.1468-1331.2010.03037.x; Burns J, 2009, NEUROMUSCULAR DISORD, V19, P818, DOI 10.1016/j.nmd.2009.09.007; Chumakov I, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0201-x; Cornett KMD, 2016, JAMA NEUROL, V73, P645, DOI 10.1001/jamaneurol.2016.0171; Fledrich R, 2014, NAT MED, V20, P1055, DOI 10.1038/nm.3664; Fledrich R, 2012, BRIT MED BULL, V102, P89, DOI 10.1093/bmb/lds010; Fledrich R, 2012, BRAIN, V135, P72, DOI 10.1093/brain/awr322; Groh J, 2010, HUM MOL GENET, V19, P3530, DOI 10.1093/hmg/ddq269; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; LUPSKI JR, 1992, BRAIN PATHOL, V2, P337, DOI 10.1111/j.1750-3639.1992.tb00710.x; Horste GMZ, 2007, ANN NEUROL, V61, P61, DOI 10.1002/ana.21026; Micallef J, 2009, LANCET NEUROL, V8, P1103, DOI 10.1016/S1474-4422(09)70260-1; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Murphy SM, 2012, J NEUROL NEUROSUR PS, V83, P706, DOI 10.1136/jnnp-2012-302451; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Pareyson D, 2014, CURR MOL MED, V14, P1009, DOI 10.2174/1566524014666141010154205; Pareyson D, 2011, LANCET NEUROL, V10, P320, DOI 10.1016/S1474-4422(11)70025-4; PATEL PI, 1990, AM J HUM GENET, V47, P926; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; Rossor AM, 2016, CURR OPIN NEUROL, V29, P537, DOI 10.1097/WCO.0000000000000373; Rossor Alexander M, 2015, Pract Neurol, V15, P187, DOI 10.1136/practneurol-2015-001095; Rossor AM, 2013, NAT REV NEUROL, V9, P562, DOI 10.1038/nrneurol.2013.179; Rudnik-Schoneborn S, 2016, CLIN GENET, V89, P34, DOI 10.1111/cge.12594; Saporta ASD, 2011, ANN NEUROL, V69, P22, DOI 10.1002/ana.22166; Sereda M, 1996, NEURON, V16, P1049, DOI 10.1016/S0896-6273(00)80128-2; Sereda MW, 2003, NAT MED, V9, P1533, DOI 10.1038/nm957; Shy ME, 2018, J CLIN INVEST, V128, P110, DOI 10.1172/JCI98617; SKRE H, 1974, CLIN GENET, V6, P98; Sociali G, 2016, NEUROBIOL DIS, V95, P145, DOI 10.1016/j.nbd.2016.07.017; Timmerman V, 2014, GENES-BASEL, V5, P13, DOI 10.3390/genes5010013; Verhamme C, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-70; Visigalli D, 2016, HUM MUTAT, V37, P98, DOI 10.1002/humu.22921; Yiu EM, 2008, J PERIPHER NERV SYST, V13, P236, DOI 10.1111/j.1529-8027.2008.00182.x; Young P, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006052.pub2; Zhao H, 2017, TREE PHYSIOL, V22, P1, DOI DOI 10.1172/JCI96499	40	18	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209752	10.1371/journal.pone.0209752	http://dx.doi.org/10.1371/journal.pone.0209752			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650121	Green Submitted, Green Published, gold			2022-12-26	WOS:000455813300025
J	Zhang, XW; Wang, L; Ding, H				Zhang, Xiu Wei; Wang, Lei; Ding, Hong			Long noncoding RNA AK089579 inhibits epithelial-to-mesenchymal transition of peritoneal mesothelial cells by competitively binding to microRNA-296-3p via DOK2 in peritoneal fibrosis	FASEB JOURNAL			English	Article						JAK2/STAT3 signaling pathway; peritoneal fibrosis; ceRNA	INTEGRATIVE ANNOTATION; RAT MODEL; EXPRESSION; APOPTOSIS; MIR-296; PROLIFERATION; PROTEINS; THERAPY; COMPLEX; FLUID	Peritoneal fibrosis (PF) represents a well-recognized complication associated with continuous ambulatory peritoneal dialysis therapy, characterized by a reversible epithelial-to-mesenchymal transition (EMT) at the early stage. The aim of the current study was to investigate the effects linked with the long noncoding RNA (lncRNA) AK089579 on the EMT of peritoneal mesothelial cells (PMCs) as well as the associated regulatory mechanisms of AK089579 downstream of tyrosine kinase 2 (DOK2) and microRNA-296-3p (miR-296-3p). Enrichment analysis, gene intersection association analysis, and a gene-gene intersection network were initially constructed to ascertain whether AK089579 regulated the expression of DOK2 through the mediation of miR-296-3p via the Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) signaling pathway in PF. After the PF mouse model had been constructed, the expression of the proteins associated with the JAK2/STAT3 signaling pathway and EMT and PMC migration and invasion were all determined accordingly. Based on the obtained results, AK089579 was determined to function as a competing endogenous RNA for miR-296-3p while acting to up-regulate the expression of DOK2, which is a target gene of miR-296-3p. AK089579 was detected to confer an inhibitory effect on the activation of the JAK2/STAT3 signaling pathway, whereby the migration and invasion of PMCs among the mice models were suppressed. Meanwhile, up-regulated miR-296-3p and down-regulated DOK2 produced contrasting effects when compared with the aforementioned findings. Treatment with wp10066, a JAK2/STAS3 signaling pathway inhibitor, was shown to reverse the effects exerted by up-regulated miR-296-3p. Taken together, the central findings of the current study present evidence highlighting the capability of the lncRNA AK089579 to bind competitively to miR-296-3p and indirectly enhance the expression of DOK2, which in turn suppresses the activation of the JAK2/STAT3 signaling pathway, whereby the EMT, migration, and invasion of PMCs was inhibited in PF.	[Zhang, Xiu Wei] China Med Univ, Affiliated Hosp 4, Dept Pathol, Shenyang, Liaoning, Peoples R China; [Wang, Lei; Ding, Hong] China Med Univ, Affiliated Hosp 4, Dept Nephrol, 4 Chongshan East Rd, Shenyang 110032, Liaoning, Peoples R China	China Medical University; China Medical University	Ding, H (corresponding author), China Med Univ, Affiliated Hosp 4, Dept Nephrol, 4 Chongshan East Rd, Shenyang 110032, Liaoning, Peoples R China.	dinghong9209@126.com			Key Project of the Natural Science Foundation of Liaoning Province [20170541034]	Key Project of the Natural Science Foundation of Liaoning Province	The authors acknowledge the helpful comments on this paper received from reviewers. This study was supported by the Key Project of the Natural Science Foundation of Liaoning Province (20170541034). The authors declare no conflicts of interest.	Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chaudhary K, 2014, AM J PHYSIOL-RENAL, V307, pF777, DOI 10.1152/ajprenal.00653.2013; Che MW, 2017, J AM SOC NEPHROL, V28, P2459, DOI 10.1681/ASN.2016060663; Dinami R, 2017, ONCOTARGET, V8, P95674, DOI 10.18632/oncotarget.21180; Fu QF, 2017, CLIN CANCER RES, V23, P6336, DOI 10.1158/1078-0432.CCR-16-2813; Gunthner R, 2013, INT J MOL SCI, V14, P18124, DOI 10.3390/ijms140918124; Hong L, 2010, ANN SURG, V251, P1056, DOI 10.1097/SLA.0b013e3181dd4ea9; Huberdeau MQ, 2017, EMBO J, V36, P2088, DOI 10.15252/embj.201696386; Ishimatsu N, 2016, HISTOL HISTOPATHOL, V31, P1251, DOI 10.14670/HH-11-756; Karginov FV, 2013, GENE DEV, V27, P1624, DOI 10.1101/gad.215939.113; Kim H, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-528; Kuzuoglu-Ozturk D, 2016, EMBO J, V35, P1186, DOI 10.15252/embj.201592901; Li LK, 2018, KIDNEY INT, V93, P1384, DOI 10.1016/j.kint.2017.12.023; Li Q, 2018, MOL IMMUNOL, V94, P131, DOI 10.1016/j.molimm.2017.12.023; Lin F, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0039-z; Liu YL, 2015, GENE, V564, P210, DOI 10.1016/j.gene.2015.03.050; Lv LL, 2018, ONCOL RES, V26, P775, DOI 10.3727/096504017X15132494420120; Miguel V, 2016, FIBROGENESIS TISSUE, V9, DOI 10.1186/s13069-016-0044-2; Mizutani M, 2010, AM J PHYSIOL-RENAL, V298, pF721, DOI 10.1152/ajprenal.00368.2009; Morishita Y, 2016, TRANSL RES, V169, P47, DOI 10.1016/j.trsl.2015.10.009; Qu HY, 2017, J ETHNOPHARMACOL, V202, P28, DOI 10.1016/j.jep.2017.01.033; Rachagani S, 2015, ADV DRUG DELIVER REV, V81, P16, DOI 10.1016/j.addr.2014.10.020; Sakai N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05624-2; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Strippoli R, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/3543678; Suzu S, 2000, EMBO J, V19, P5114, DOI 10.1093/emboj/19.19.5114; van Baal JOAM, 2017, TISSUE CELL, V49, P95, DOI 10.1016/j.tice.2016.11.004; Vorobiov M, 2008, PERITON DIALYSIS INT, V28, P648; Wang HW, 2017, NUCLEIC ACIDS RES, V45, P2786, DOI 10.1093/nar/gkw909; Wang Hui-Chao, 2016, Shengli Xuebao, V68, P747, DOI 10.13294/j.aps.2016.0084; Wang LY, 2016, FEBS LETT, V590, P4252, DOI 10.1002/1873-3468.12442; Yu JW, 2014, LAB INVEST, V94, P978, DOI 10.1038/labinvest.2014.91; Yung S, 2003, PERITON DIALYSIS INT, V23, pS37; Zhang L, 2013, EXP THER MED, V6, P1189, DOI 10.3892/etm_2013.1281; Zhang SL, 2004, J IMMUNOL, V173, P6786, DOI 10.4049/jimmunol.173.11.6786; Zhou Q, 2013, AM J PATHOL, V183, P808, DOI 10.1016/j.ajpath.2013.05.019	37	9	10	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5112	5125		10.1096/fj.201801111RR	http://dx.doi.org/10.1096/fj.201801111RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30652956	Bronze			2022-12-26	WOS:000462888500040
J	Nguyen, KG; Gillam, FB; Hopkins, JJ; Jayanthi, S; Gundampati, RK; Su, GW; Bear, J; Pilkington, GR; Jalah, R; Felber, BK; Liu, J; Thallapuranam, SK; Zaharoff, DA				Nguyen, Khue G.; Gillam, Francis B.; Hopkins, Jared J.; Jayanthi, Srinivas; Gundampati, Ravi Kumar; Su, Guowei; Bear, Jenifer; Pilkington, Guy R.; Jalah, Rashmi; Felber, Barbara K.; Liu, Jian; Thallapuranam, Suresh Kumar; Zaharoff, David A.			Molecular mechanisms of heparin-induced modulation of human interleukin 12 bioactivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heparin; interleukin; glycosaminoglycan; cytokine; immunology; heparan sulfate; heparin-binding cytokine; IL-12	FIBROBLAST-GROWTH-FACTOR; CHAIN-LENGTH; BINDING; SULFATE; CELLS; IL-12; CYTOKINE; RECEPTOR; CLUSPRO; CLONING	Human interleukin-12 (hIL-12) is a heparin-binding cytokine whose activity was previously shown to be enhanced by heparin and other sulfated glycosaminoglycans. The current study investigated the mechanisms by which heparin increases hIL-12 activity. Using multiple human cell types, including natural killer cells, an IL-12 indicator cell line, and primary peripheral blood mononuclear and T cells, along with bioactivity, flow cytometry, and isothermal titration calorimetry assays, we found that heparin-dependent modulation of hIL-12 function correlates with several of heparin's biophysical characteristics, including chain length, sulfation level, and concentration. Specifically, only heparin molecules longer than eight saccharide units enhanced hIL-12 activity. Furthermore, heparin molecules with three sulfate groups per disaccharide unit outperformed heparin molecules with one or two sulfate groups per disaccharide unit in terms of enhanced hIL-12 binding and activity. Heparin also significantly reduced the EC50 value of hIL-12 by up to 11.8-fold, depending on the responding cell type. Cytokine-profiling analyses revealed that heparin affected the level, but not the type, of cytokines produced by lymphocytes in response to hIL-12. Interestingly, although murine IL-12 also binds heparin, heparin did not enhance its activity. Using the gathered data, we propose a model of hIL-12 stabilization in which heparin serves as a co-receptor enhancing the interaction between heterodimeric hIL-12 and its receptor subunits. The results of this study provide a foundation for further investigation of heparin's interactions with IL-12 family cytokines and for the use of heparin as an immunomodulatory agent.	[Nguyen, Khue G.; Zaharoff, David A.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Nguyen, Khue G.; Gillam, Francis B.; Hopkins, Jared J.; Zaharoff, David A.] Joint Dept Biomed Engn Univ North Carolina Chapel, Raleigh, NC 27695 USA; [Jayanthi, Srinivas; Gundampati, Ravi Kumar; Thallapuranam, Suresh Kumar] Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA; [Su, Guowei; Liu, Jian] Univ N Carolina, Div Chem Biol & Chem, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Bear, Jenifer; Pilkington, Guy R.; Jalah, Rashmi; Felber, Barbara K.] NCI, Human Retrovirus Pathogenesis Sect, Vaccine Branch, NIH, Frederick, MD 21702 USA; [Pilkington, Guy R.] ImQuest BioSci, Frederick, MD 21704 USA; [Jalah, Rashmi] GlaxoSmithKline GSK Vaccines, Rockville, MD 20850 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Arkansas System; University of Arkansas Fayetteville; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); GlaxoSmithKline	Zaharoff, DA (corresponding author), Joint Dept Biomed Engn Univ North Carolina Chapel, Raleigh, NC 27695 USA.	dazaharo@ncsu.edu	Gundampati, Ravi Kumar/AAL-7624-2020; Jayanthi, Srinivas/AAD-2808-2019; Nguyen, Khue G./T-2348-2019	Nguyen, Khue/0000-0003-4954-1126; Jayanthi, Srinivas/0000-0001-7357-760X	National Institutes of Health Grant from NCI; Arkansas Biosciences Institute; Intramural Research Program of the NCI, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094463] Funding Source: NIH RePORTER	National Institutes of Health Grant from NCI; Arkansas Biosciences Institute; Intramural Research Program of the NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant from NCI, the Arkansas Biosciences Institute, and by the Intramural Research Program of the NCI, National Institutes of Health (to B. K. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AlvarezSilva M, 1996, J LEUKOCYTE BIOL, V59, P435, DOI 10.1002/jlb.59.3.435; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Choijilsuren G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14573-9; CHUA AO, 1994, J IMMUNOL, V153, P128; CLARKE D, 1995, CYTOKINE, V7, P325, DOI 10.1006/cyto.1995.0041; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; da Costa DS, 2017, ANNU REV BIOMED ENG, V19, P1, DOI [10.1146/annurev-bioeng-071516044610, 10.1146/annurev-bioeng-071516-044610]; Fannon M, 2000, BIOCHEMISTRY-US, V39, P1434, DOI 10.1021/bi991895z; Fieschi C, 2004, BLOOD, V104, P2095, DOI 10.1182/blood-2004-02-0584; Garnier P, 2018, CYTOKINE, V110, P159, DOI 10.1016/j.cyto.2018.04.014; GUBLER U, 1991, P NATL ACAD SCI USA, V88, P4143, DOI 10.1073/pnas.88.10.4143; Hasan M, 1999, J IMMUNOL, V162, P1064; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Hochart H, 2008, THROMB HAEMOSTASIS, V99, P570, DOI 10.1160/TH07-06-0424; Jalah R, 2013, J BIOL CHEM, V288, P6763, DOI 10.1074/jbc.M112.436675; Jayanthi S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05382-1; Jayanthi S, 2014, PROTEIN EXPRES PURIF, V102, P76, DOI 10.1016/j.pep.2014.07.002; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Leonard JP, 1997, BLOOD, V90, P2541; Loo BM, 2001, J BIOL CHEM, V276, P16868, DOI 10.1074/jbc.M011226200; MCKEE RF, 1992, GUT, V33, P1549, DOI 10.1136/gut.33.11.1549; Mehrotra PT, 1998, J IMMUNOL, V160, P2637; Najjam S, 1998, GLYCOBIOLOGY, V8, P509, DOI 10.1093/glycob/8.5.509; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Rezaie AR, 2007, THROMB RES, V119, P481, DOI 10.1016/j.thromres.2006.01.009; Salek-Ardakani S, 2000, BLOOD, V96, P1879, DOI 10.1182/blood.V96.5.1879.h8001879_1879_1888; SCHOENHAUT DS, 1992, J IMMUNOL, V148, P3433; Schrodinger L., 2020, PYMOL; SCOTT JE, 1994, VIRCHOWS ARCH, V424, P89; Tam YK, 1999, HUM GENE THER, V10, P1359, DOI 10.1089/10430349950018030; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; WOLF SF, 1991, J IMMUNOL, V146, P3074; Xu XY, 2002, INT J BIOL MACROMOL, V30, P151, DOI 10.1016/S0141-8130(02)00015-6; Xu YM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan5954; Xu YM, 2014, NAT CHEM BIOL, V10, P248, DOI [10.1038/NCHEMBIO.1459, 10.1038/nchembio.1459]; Yang JH, 2017, CHEM COMMUN, V53, P1743, DOI 10.1039/c6cc08204a	41	15	15	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4412	4424		10.1074/jbc.RA118.006193	http://dx.doi.org/10.1074/jbc.RA118.006193			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30670588	Green Published, hybrid			2022-12-26	WOS:000462969500011
J	Ashari, ZE; Brayton, KA; Broschat, SL				Ashari, Zhila Esna; Brayton, Kelly A.; Broschat, Shira L.			Using an optimal set of features with a machine learning-based approach to predict effector proteins for Legionella pneumophila	PLOS ONE			English	Article							IV SECRETED EFFECTORS; TRANSLOCATED SUBSTRATE; SYSTEM; IDENTIFICATION; MACROPHAGES; REGULATOR; ALGORITHM	Type IV secretion systems exist in a number of bacterial pathogens and are used to secrete effector proteins directly into host cells in order to change their environment making the environment hospitable for the bacteria. In recent years, several machine learning algorithms have been developed to predict effector proteins, potentially facilitating experimental verification. However, inconsistencies exist between their results. Previously we analysed the disparate sets of predictive features used in these algorithms to determine an optimal set of 370 features for effector prediction. This study focuses on the best way to use these optimal features by designing three machine learning classifiers, comparing our results with those of others, and obtaining de novo results. We chose the pathogen Legionella pneumophila strain Philadelphia-1, a cause of Legionnaires' disease, because it has many validated effector proteins and others have developed machine learning prediction tools for it. While all of our models give good results indicating that our optimal features are quite robust, Model 1, which uses all 370 features with a support vector machine, has slightly better accuracy. Moreover, Model 1 predicted 472 effector proteins that are deemed highly probable to be effectors and include 94% of known effectors. Although the results of our three models agree well with those of other researchers, their models only predicted 126 and 311 candidate effectors.	[Ashari, Zhila Esna; Brayton, Kelly A.; Broschat, Shira L.] Washington State Univ, Sch Elect Engn & Comp Sci, Pullman, WA 99164 USA; [Brayton, Kelly A.; Broschat, Shira L.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Brayton, Kelly A.; Broschat, Shira L.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA	Washington State University; Washington State University; Washington State University	Ashari, ZE (corresponding author), Washington State Univ, Sch Elect Engn & Comp Sci, Pullman, WA 99164 USA.	z.esnaashariesfahan@wsu.edu		Esna Ashari, Zhila/0000-0003-0454-7794	National Institutes of Health [R01AI042792]; Carl M. Hansen Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carl M. Hansen Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant R01AI042792 by National Institutes of Health (K.A.B.) and by the Carl M. Hansen Foundation (Z.E.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abby SS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23080; Altman E, 2008, J BACTERIOL, V190, P1985, DOI 10.1128/JB.01493-07; An Y, 2018, BRIEF BIOINFORM, V19, P148, DOI 10.1093/bib/bbw100; An Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep41031; Ashari ZE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197041; Ashari ZE, 2017, ACM-BCB' 2017: PROCEEDINGS OF THE 8TH ACM INTERNATIONAL CONFERENCE ON BIOINFORMATICS, COMPUTATIONAL BIOLOGY,AND HEALTH INFORMATICS, P346, DOI 10.1145/3107411.3107416; Bardill JP, 2005, MOL MICROBIOL, V56, P90, DOI 10.1111/j.1365-2958.2005.04539.x; Bi DX, 2013, NUCLEIC ACIDS RES, V41, pD660, DOI 10.1093/nar/gks1248; Bruggemann H, 2006, CURR OPIN MICROBIOL, V9, P86, DOI 10.1016/j.mib.2005.12.009; Burstein D, 2009, INT J BIOCHEM CELL B, V5, DOI [10.1371/journal.ppat.1000508, DOI 10.1371/JOURNAL.PPAT.1000508]; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chen J, 2004, SCIENCE, V303, P1358, DOI 10.1126/science.1094226; Conover GM, 2003, MOL MICROBIOL, V48, P305, DOI 10.1046/j.1365-2958.2003.03400.x; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Crammer K, 2002, J MACH LEARN RES, V2, P265, DOI 10.1162/15324430260185628; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; de Felipe KS, 2005, J BACTERIOL, V187, P7716, DOI 10.1128/JB.187.22.7716-7726.2005; Han N, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/9415459; Heidtman M, 2009, CELL MICROBIOL, V11, P230, DOI 10.1111/j.1462-5822.2008.01249.x; Laguna RK, 2006, P NATL ACAD SCI USA, V103, P18745, DOI 10.1073/pnas.0609012103; Lockwood S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027724; McDermott JE, 2011, INFECT IMMUN, V79, P23, DOI 10.1128/IAI.00537-10; Meyer DF, 2013, NUCLEIC ACIDS RES, V41, P9218, DOI 10.1093/nar/gkt718; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Ninio S, 2005, MOL MICROBIOL, V55, P912, DOI 10.1111/j.1365-2958.2004.04435.x; Perry J.W., 1955, J ASSOCIAT INFORMAT, V6, P242, DOI DOI 10.1002/ASI.5090060411; Shohdy N, 2005, P NATL ACAD SCI, V102; STORMO GD, 1982, NUCLEIC ACIDS RES, V10, P2997, DOI 10.1093/nar/10.9.2997; Voth DE, 2012, FUTURE MICROBIOL, V7, P241, DOI [10.2217/fmb.11.150, 10.2217/FMB.11.150]; Voth DE, 2011, J BACTERIOL, V193, P1493, DOI 10.1128/JB.01359-10; Wang J, 2017, BRIEF BIOINFORM, V1-21, DOI [10.1093/bib/bbw003, DOI 10.1093/BIB/BBW003]; Wang JW, 2018, BIOINFORMATICS, V34, P2546, DOI 10.1093/bioinformatics/bty155; Wang JW, 2017, BIOINFORMATICS, V33, P2756, DOI 10.1093/bioinformatics/btx302; Wang JM, 2018, LECT NOTES COMPUT SC, V10968, P3, DOI 10.1007/978-3-319-94301-5_1; Wang YJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-50; Yu LZ, 2010, J THEOR BIOL, V267, P1, DOI 10.1016/j.jtbi.2010.08.001; Zeng C, 2017, BRIEF BIOINFORM, V1-20, DOI [10.1093/bib/bbw003, DOI 10.1093/BIB/BBW003]; Zou LY, 2013, BIOINFORMATICS, V29, P3135, DOI 10.1093/bioinformatics/btt554; Zusman T, 2008, INFECT IMMUN, V76, P4581, DOI 10.1128/IAI.00337-08; Zusman T, 2007, MOL MICROBIOL, V63, P1508, DOI 10.1111/j.1365-2958.2007.05604.x	40	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0202312	10.1371/journal.pone.0202312	http://dx.doi.org/10.1371/journal.pone.0202312			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682021	Green Published, gold, Green Submitted			2022-12-26	WOS:000457037500002
J	Nilsson, MI; Bourgeois, JM; Nederveen, JP; Leite, MR; Hettinga, BP; Bujak, AL; May, L; Lin, E; Crozier, M; Rusiecki, DR; Moffatt, C; Azzopardi, P; Young, J; Yang, YF; Nguyen, J; Adler, E; Lan, L; Tarnopolsky, MA				Nilsson, Mats I.; Bourgeois, Jacqueline M.; Nederveen, Joshua P.; Leite, Marlon R.; Hettinga, Bart P.; Bujak, Adam L.; May, Linda; Lin, Ethan; Crozier, Michael; Rusiecki, Daniel R.; Moffatt, Chris; Azzopardi, Paul; Young, Jacob; Yang, Yifan; Nguyen, Jenny; Adler, Ethan; Lan, Lucy; Tarnopolsky, Mark A.			Lifelong aerobic exercise protects against inflammaging and cancer	PLOS ONE			English	Article							MITOCHONDRIAL-LYSOSOMAL AXIS; TIME PHYSICAL-ACTIVITY; SKELETAL-MUSCLE; CELLULAR SENESCENCE; SECRETORY PHENOTYPE; ENZYME REPLACEMENT; MORTALITY; EXPRESSION; OBESITY; SPARC	Biological aging is associated with progressive damage accumulation, loss of organ reserves, and systemic inflammation ('inflammaging'), which predispose for a wide spectrum of chronic diseases, including several types of cancer. In contrast, aerobic exercise training (AET) reduces inflammation, lowers all-cause mortality, and enhances both health and lifespan. In this study, we examined the benefits of early-onset, lifelong AET on predictors of health, inflammation, and cancer incidence in a naturally aging mouse model (C57BL/J6). Lifelong, voluntary wheel-running (O-AET; 26-month-old) prevented age-related declines in aerobic fitness and motor coordination vs. age-matched, sedentary controls (O-SED). AET also provided partial protection against sarcopenia, dynapenia, testicular atrophy, and overall organ pathology, hence augmenting the 'physiologic reserve' of lifelong runners. Systemic inflammation, as evidenced by a chronic elevation in 17 of 18 pro- and anti-inflammatory cytokines and chemokines (P < 0.05 O-SED vs. 2-month-old Y-CON), was potently mitigated by lifelong AET (P < 0.05 O-AET vs. O-SED), including master regulators of the cytokine cascade and cancer progression (IL-1 beta, TNF-alpha, and IL-6). In addition, circulating SPARC, previously known to be upregulated in metabolic disease, was elevated in old, sedentary mice, but was normalized to young control levels in lifelong runners. Remarkably, malignant tumours were also completely absent in the O-AET group, whereas they were present in the brain (pituitary), liver, spleen, and intestines of sedentary mice. Collectively, our results indicate that early-onset, lifelong running dampens inflammaging, protects against multiple cancer types, and extends healthspan of naturally-aged mice.	[Nilsson, Mats I.] McMaster Univ, Med Ctr, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Nilsson, Mats I.; Hettinga, Bart P.; Bujak, Adam L.; Rusiecki, Daniel R.; Tarnopolsky, Mark A.] McMaster Univ, Med Ctr, Exerkine Corp, Hamilton, ON, Canada; [Bourgeois, Jacqueline M.; Nederveen, Joshua P.; Leite, Marlon R.; May, Linda; Lin, Ethan; Crozier, Michael; Moffatt, Chris; Azzopardi, Paul; Young, Jacob; Yang, Yifan; Nguyen, Jenny; Adler, Ethan; Lan, Lucy; Tarnopolsky, Mark A.] McMaster Univ, Med Ctr, Dept Pediat, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Nilsson, MI (corresponding author), McMaster Univ, Med Ctr, Dept Pathol & Mol Med, Hamilton, ON, Canada.; Nilsson, MI (corresponding author), McMaster Univ, Med Ctr, Exerkine Corp, Hamilton, ON, Canada.	mnilsson7714@gmail.com	Nilsson, Mats/AAG-2068-2021; Azzopardi, Paul/C-5694-2013; Rusiecki, Daniel/ABA-4010-2020	Nilsson, Mats/0000-0001-5656-5578; Azzopardi, Paul/0000-0001-7386-8191; Rusiecki, Daniel/0000-0002-8092-4427; Lin, Ethan/0000-0002-0101-7934; Lan, Lucy/0000-0003-4474-6018	CIHR [143325]; Exerkine Corporation	CIHR(Canadian Institutes of Health Research (CIHR)); Exerkine Corporation	This work was supported by CIHR 143325 Dr. Mark A. Tarnopolsky: "Characterization of novel exersomes that mediate the systemic prometabolic effects in exercise in aging and neuromuscular disorders", and Exerkine Corporation. Exerkine Corporation provided support in the form of salaries for authors [MIN, BPH, ALB, LM, and DR]. The specific roles of these authors are articulated in the 'author contributions' section. The funders of this study did not have additional roles in the study design, data collection and analyses, decision to publish, or preparation of the manuscript.	American College of Sports Medicine, 2009, Med Sci Sports Exerc, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; Arem H, 2015, JAMA INTERN MED, V175, P959, DOI 10.1001/jamainternmed.2015.0533; Ashcraft KA, 2016, CANCER RES, V76, P4032, DOI 10.1158/0008-5472.CAN-16-0887; Ballard-Barbash R, 2012, JNCI-J NATL CANCER I, V104, P815, DOI 10.1093/jnci/djs207; Baylis D, 2013, AGE, V35, P963, DOI 10.1007/s11357-012-9396-8; Baylis Daniel, 2013, Longev Healthspan, V2, P8, DOI 10.1186/2046-2395-2-8; Bloom DE, 2015, LANCET, V385, P649, DOI 10.1016/S0140-6736(14)61464-1; BOOTH FW, 1991, PHYSIOL REV, V71, P541, DOI 10.1152/physrev.1991.71.2.541; Bradshaw AD, 2010, AM J PHYSIOL-HEART C, V298, pH614, DOI 10.1152/ajpheart.00474.2009; Cahill LS, 2017, BRAIN STRUCTURE FUNC, P1; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Chakravarty EF, 2008, ARCH INTERN MED, V168, P1638, DOI 10.1001/archinte.168.15.1638; Cheng AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067970; Clark PJ, 2009, HIPPOCAMPUS, V19, P937, DOI 10.1002/hipo.20543; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Deleidi M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00172; Dethlefsen C, 2017, CANCER RES, V77, P4894, DOI 10.1158/0008-5472.CAN-16-3125; Dinarello C., 1992, IMMUNOL REV, V127, P119; DINARELLO CA, 1993, NEW ENGL J MED, V328, P106; Ding D, 2016, LANCET, V388, P1311, DOI 10.1016/S0140-6736(16)30383-X; Fiuza-Luces C, 2013, PHYSIOLOGY, V28, P330, DOI 10.1152/physiol.00019.2013; Flynn MG, 2007, AM J LIFESTYLE MED, V1, P220, DOI 10.1177/1559827607300283; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Franceschi C, 2000, EXP GERONTOL, V35, P879, DOI 10.1016/S0531-5565(00)00172-8; Franceschi C, 2017, TRENDS ENDOCRIN MET, V28, P199, DOI 10.1016/j.tem.2016.09.005; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Franco OH, 2005, ARCH INTERN MED, V165, P2355, DOI 10.1001/archinte.165.20.2355; Frangogiannis NG, 2012, PHYSIOL REV, V92, P635, DOI 10.1152/physrev.00008.2011; Garcia-Valles Rebeca, 2013, Longev Healthspan, V2, P14, DOI 10.1186/2046-2395-2-14; Grivennikov SI, 2011, ANN RHEUM DIS, V70, pI104, DOI 10.1136/ard.2010.140145; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hartwig S, 2014, BBA-PROTEINS PROTEOM, V1844, P1011, DOI 10.1016/j.bbapap.2013.08.004; Hayflick L, 2007, PLOS GENET, V3, P2351, DOI 10.1371/journal.pgen.0030220; Hojman P, 2017, BIOCHEM SOC T, V45, P905, DOI 10.1042/BST20160466; Holmes MD, 2005, JAMA-J AM MED ASSOC, V293, P2479, DOI 10.1001/jama.293.20.2479; Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134; Jorgensen LH, 2017, AM J PATHOL, V187, P457, DOI 10.1016/j.ajpath.2016.10.013; Kalyani RR, 2014, LANCET DIABETES ENDO, V2, P819, DOI 10.1016/S2213-8587(14)70034-8; Kenfield SA, 2011, J CLIN ONCOL, V29, P726, DOI 10.1200/JCO.2010.31.5226; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Konopka AR, 2014, EXERC SPORT SCI REV, V42, P53, DOI 10.1249/JES.0000000000000007; Kos K, 2010, NAT REV ENDOCRINOL, V6, P225, DOI 10.1038/nrendo.2010.18; Krupke DM, 2008, NAT REV CANCER, V8, P459, DOI 10.1038/nrc2390; Kwak JY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26617-9; Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195; Le Bihan MC, 2012, J PROTEOMICS, V77, P344, DOI 10.1016/j.jprot.2012.09.008; LeckaCzernik B, 1996, EXP GERONTOL, V31, P159, DOI 10.1016/0531-5565(95)02014-4; Lee D, 2017, I S BIOMED IMAGING, P15, DOI 10.1109/ISBI.2017.7950457; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee R, 2011, SCIENCE, V333, P569, DOI 10.1126/science.1208859; Lee SH, 2013, OBESITY, V21, P2296, DOI 10.1002/oby.20183; Lessard-Beaudoin M, 2015, EXP GERONTOL, V63, P27, DOI 10.1016/j.exger.2015.01.003; Marsik C, 2008, CLIN CHEM, V54, P343, DOI 10.1373/clinchem.2007.091959; Mazzolini G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18981-9; Meyerhardt JA, 2009, ARCH INTERN MED, V169, P2102, DOI 10.1001/archinternmed.2009.412; Minciullo PL, 2016, ARCH IMMUNOL THER EX, V64, P111, DOI 10.1007/s00005-015-0377-3; Mitchell WK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00260; Moore SC, 2016, JAMA INTERN MED, V176, P816, DOI 10.1001/jamainternmed.2016.1548; Naviaux RK, 2014, MITOCHONDRION, V16, P7, DOI 10.1016/j.mito.2013.08.006; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Nilsson MI, 2015, FREE RADICAL BIO MED, V87, P98, DOI 10.1016/j.freeradbiomed.2015.05.019; Nilsson MI, 2012, MOL GENET METAB, V107, P469, DOI 10.1016/j.ymgme.2012.09.010; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Ost M, 2016, FREE RADICAL BIO MED, V98, P78, DOI 10.1016/j.freeradbiomed.2016.02.018; Peake J, 2010, AM J PHYSIOL-REG I, V298, pR1485, DOI 10.1152/ajpregu.00467.2009; Peake JM, 2015, EXERC IMMUNOL REV, V21, P8; Pedersen L, 2016, CELL METAB, V23, P554, DOI 10.1016/j.cmet.2016.01.011; Pedersen L, 2015, CANCER J, V21, P111, DOI 10.1097/PPO.0000000000000096; Pedersen L, 2012, AM J PHYSIOL-ENDOC M, V302, pE831, DOI 10.1152/ajpendo.00339.2011; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Powell KE, 2011, ANNU REV PUBL HEALTH, V32, P349, DOI 10.1146/annurev-publhealth-031210-101151; Prince MJ, 2014, LANCET; Radak Z, 2008, AGEING RES REV, V7, P34, DOI 10.1016/j.arr.2007.04.004; Radak Z, 2017, REDOX BIOL, V12, P285, DOI 10.1016/j.redox.2017.02.015; Raschke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062008; Reimers C D, 2012, J Aging Res, V2012, P243958, DOI 10.1155/2012/243958; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; Santilli V, 2014, CLIN CASES MINER BON, V11, P177, DOI 10.11138/ccmbm/2014.11.3.177; Scheler M, 2013, AM J PHYSIOL-CELL PH, V305, pC877, DOI 10.1152/ajpcell.00043.2013; Schmid D, 2015, EUR J EPIDEMIOL, V30, P397, DOI 10.1007/s10654-015-0017-6; Shiba H, 2000, MECH AGEING DEV, V117, P69, DOI 10.1016/S0047-6374(00)00140-8; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Stessman J, 2009, ARCH INTERN MED, V169, P1476, DOI 10.1001/archinternmed.2009.248; Swain DP, 2006, AM J CARDIOL, V97, P141, DOI 10.1016/j.amjcard.2005.07.130; Tarnopolsky M., 2015, CELL METAB, V25, P978; Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598; Tichet M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7993; Trombetta JM, 2010, J HISTOCHEM CYTOCHEM, V58, P871, DOI 10.1369/jhc.2010.956144; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; von Haehling S, 2010, J CACHEXIA SARCOPENI, V1, P1, DOI 10.1007/s13539-010-0002-6; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; Williams PT, 2014, MED SCI SPORT EXER, V46, P927, DOI 10.1249/MSS.0000000000000176; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x; Zinger A, 2017, AGING DIS, V8, P611, DOI 10.14336/AD.2016.1230; Zong WX, 2016, MOL CELL, V61, P667, DOI 10.1016/j.molcel.2016.02.011	99	40	42	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210863	10.1371/journal.pone.0210863	http://dx.doi.org/10.1371/journal.pone.0210863			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682077	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500068
J	Rioux, CR; Clapper, ML; Cooper, HS; Michaud, J; St Amant, N; Koohsari, H; Workman, L; Kaunga, E; Hensley, H; Pilorget, A; Gerard, C				Rioux, Clement R.; Clapper, Margie L.; Cooper, Harry S.; Michaud, Jean; St Amant, Natalie; Koohsari, Hossein; Workman, Laura; Kaunga, Esther; Hensley, Harvey; Pilorget, Anthony; Gerard, Catherine			Self-antigen MASH2 combined with the AS15 immunostimulant induces tumor protection in colorectal cancer mouse models	PLOS ONE			English	Article							IMMUNE CELLS; T-CELLS; TARGETED THERAPIES; PRIMARY PREVENTION; ASPIRIN; ASCL2; IMMUNOTHERAPY; NEOPLASIA; CHECKPOINTS; METASTASES	Human achaete scute homolog 2 (HASH2) and its murine ortholog MASH2 are potential targets for colorectal cancer immunotherapy. We assessed immunogenicity and antitumor potential of recombinant MASH2 protein combined with AS15 immunostimulant (recMASH2+AS15) in CB6F1 and Apc(+/Min-FCCC) mice. CB6F1 mice received 4 injections of recMASH2+AS15 or AS15 alone before challenge with TC1-MASH2 tumor cells (Tumor Challenge). Apc(+/Min-FCCC) mice received 9 injections of recMASH2+AS15 or vehicle (phosphate buffer saline [PBS] or AS15 alone), before (two independent Prophylactic Studies) or after (Immunotherapy) colon adenomas were detectable by colonoscopy. CB6F1 mice immunized with recMASH2+AS15 had a significantly smaller mean tumor size and improved survival rate compared to controls (104 mm(2) vs. 197 mm(2) [p = 0.009] and 67% vs. 7% [p = 0.001], respectively). In Prophylactic Study 1, the mean number of colon adenomas was significantly lower in Apc(+/Min-FCCC) mice receiving recMASH2+AS15 compared to PBS (1.8 [95% confidence interval 1.0-3.3] vs. 5.2 [3.7-7.4], p = 0.003). Fewer microadenomas were observed in recMASH2+AS15 groups compared to PBS in both Prophylactic Studies (Study 1: mean 0.4 [0.2-1.0] vs. 1.5 [0.9-2.4], p = 0.009; Study 2: 0.4 [0.2-0.6] vs. 1.1 [0.8-1.5], p = 0.001). In the Immunotherapy Study, fewer colon adenomas tended to be observed in recMASH2+AS15-treated mice (4.1 [2.9-6.0]) compared to controls (AS15 4.7 [3.3-6.6]; PBS 4.9 [3.5-6.9]; no significant difference). recMASH2+AS15 induced MASH2-specific antibody and CD4+ responses in both mouse models. recMASH2+AS15 partially protected mice against MASH2-expressing tumors and reduced spontaneous colorectal adenomas in Apc(+/Min-FCCC) mice, indicating that MASH2/HASH2 antigens are targets for colorectal cancer immunotherapy.	[Rioux, Clement R.; Michaud, Jean; St Amant, Natalie; Koohsari, Hossein; Pilorget, Anthony] GSK, Laval, PQ, Canada; [Clapper, Margie L.; Cooper, Harry S.; Workman, Laura; Kaunga, Esther; Hensley, Harvey] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Gerard, Catherine] GSK, Rixensart, Belgium; [Koohsari, Hossein] Neomed Labs, Laval, PQ, Canada	GlaxoSmithKline; Fox Chase Cancer Center; GlaxoSmithKline	Clapper, ML (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	margie.clapper@fccc.edu		Pilorget, Anthony/0000-0003-3142-2698	GlaxoSmithKline Biologicals SA;  [CA-006927]	GlaxoSmithKline Biologicals SA(GlaxoSmithKline); 	GlaxoSmithKline Biologicals SA funded this study and the development of the manuscript. Experimentation at Fox Chase Cancer Center was supported partially by CA-006927 grant and an appropriation from the Commonwealth of Pennsylvania. The sponsor provided support in the form of salaries for authors [CR, JM, NSA, HK, AP and CG], set the study design, data collection and analysis, and decision to publish. Writing assistance provided by Urszula Miecielica (XPE Pharma & Science) was funded by GlaxoSmithKline Biologicals SA.	Aran V, 2016, CLIN COLORECTAL CANC, V15, P195, DOI 10.1016/j.clcc.2016.02.008; Arber N, 2008, CANCER EPIDEM BIOMAR, V17, P1852, DOI 10.1158/1055-9965.EPI-08-0167; Barker N, 2010, CELL STEM CELL, V7, P656, DOI 10.1016/j.stem.2010.11.016; Baxevanis CN, 2000, J IMMUNOL, V164, P3902, DOI 10.4049/jimmunol.164.7.3902; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Bultman SJ, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201500902; Chan AT, 2012, CANCER PREV RES, V5, P164, DOI 10.1158/1940-6207.CAPR-11-0391; Chan AT, 2010, GASTROENTEROLOGY, V138, P2029, DOI 10.1053/j.gastro.2010.01.057; Church SE, 2014, EUR J IMMUNOL, V44, P69, DOI 10.1002/eji.201343718; Cooper HS, 2005, MOL CARCINOGEN, V44, P31, DOI 10.1002/mc.20114; Coyle C, 2016, CURR COLORECT CANC R, V12, P27, DOI 10.1007/s11888-016-0306-9; Curtis NJ, 2012, EJSO-EUR J SURG ONC, V38, P889, DOI 10.1016/j.ejso.2012.05.011; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; Deschoolmeester V, 2013, CURR COLORECT CANC R, V9, P380, DOI 10.1007/s11888-013-0182-5; Dhodapkar KM, 2002, J EXP MED, V195, P125, DOI 10.1084/jem.20011097; Drew DA, 2016, NAT REV CANCER, V16, P173, DOI 10.1038/nrc.2016.4; Edwards BK, 2014, CANCER-AM CANCER SOC, V120, P1290, DOI 10.1002/cncr.28509; Espada J, 2009, CLIN TRANSL ONCOL, V11, P411, DOI 10.1007/s12094-009-0380-4; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gerard C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094883; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; Hardingham JE, 2015, MOL MED, V21, pS25, DOI 10.2119/molmed.2015.00149; Hensley HH, 2009, GASTROINTEST ENDOSC, V69, P742, DOI 10.1016/j.gie.2008.09.054; Jochems C, 2011, EXP BIOL MED, V236, P567, DOI 10.1258/ebm.2011.011007; Jubb AM, 2006, ONCOGENE, V25, P3445, DOI 10.1038/sj.onc.1209382; Kan S, 2012, ANTICANCER RES, V32, P5363; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kwon OH, 2013, CANCER SCI, V104, P391, DOI 10.1111/cas.12076; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Moriarity A, 2016, THER ADV MED ONCOL, V8, P276, DOI 10.1177/1758834016646734; Oberg A, 2002, INT J COLORECTAL DIS, V17, P25; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pernot S, 2014, WORLD J GASTROENTERO, V20, P3738, DOI 10.3748/wjg.v20.i14.3738; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Roncucci L, 2015, EUR J INTERN MED, V26, P752, DOI 10.1016/j.ejim.2015.08.019; Rothwell Peter M, 2013, Recent Results Cancer Res, V191, P121, DOI 10.1007/978-3-642-30331-9_7; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Saebo M, 2008, ANTICANCER RES, V28, P2289; Schnurr M, 2005, BLOOD, V105, P2465, DOI 10.1182/blood-2004-08-3105; Schuijers J, 2015, CELL STEM CELL, V16, P158, DOI 10.1016/j.stem.2014.12.006; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Singh PP, 2015, GASTROENTEROL REP, V3, P289, DOI 10.1093/gastro/gov053; Speetjens FM, 2011, EXPERT REV VACCINES, V10, P899, DOI [10.1586/ERV.11.63, 10.1586/erv.11.63]; Stange DE, 2010, GUT, V59, P1236, DOI 10.1136/gut.2009.195701; Stepan H, 2003, BIOL REPROD, V68, P40, DOI 10.1095/biolreprod.102.004945; Tariq K, 2016, CANCER BIOL MED, V13, P120, DOI 10.28092/j.issn.2095-3941.2015.0103; Teixeira MC, 2014, WORLD J GASTROENTERO, V20, P15060, DOI 10.3748/wjg.v20.i41.15060; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; World Cancer Research Fund/American Institute for Cancer Research, 2011, CONT UPD PROJ COL CA; Worthley Daniel L, 2010, Clin Biochem Rev, V31, P31	57	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210261	10.1371/journal.pone.0210261	http://dx.doi.org/10.1371/journal.pone.0210261			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682058	Green Published, gold, Green Submitted			2022-12-26	WOS:000457037500031
J	van der Pol, CW; van Roovert-Reijrink, IAM; Maatjens, CM; Gussekloo, SWS; Kranenbarg, S; Wijnen, J; Pieters, RPM; Schipper, H; Kemp, B; van den Brand, H				van der Pol, Carla W.; van Roovert-Reijrink, Inge A. M.; Maatjens, Conny M.; Gussekloo, Sander W. S.; Kranenbarg, Sander; Wijnen, Jan; Pieters, Remco P. M.; Schipper, Henk; Kemp, Bas; van den Brand, Henry			Light-dark rhythms during incubation of broiler chicken embryos and their effects on embryonic and post hatch leg bone development	PLOS ONE			English	Article							ENDOCHONDRAL OSSIFICATION; HATCHABILITY PERFORMANCE; TIBIAL DYSCHONDROPLASIA; MONOCHROMATIC LIGHT; HORMONE-SECRETION; GROWTH; MELATONIN; TEMPERATURE; PERIOD; EGGS	There are indications that lighting schedules applied during incubation can affect leg health at hatching and during rearing. The current experiment studied effects of lighting schedule: continuous light (24L), 12 hours of light, followed by 12 hours of darkness (12L:12D), or continuous darkness (24D) throughout incubation of broiler chicken eggs on the development and strength of leg bones, and the role of selected hormones in bone development. In the tibiatarsus and femur, growth and ossification during incubation and size and microstructure at day (D) 0, D21, and D35 post hatching were measured. Plasma melatonin, growth hormone, and IGF-I were determined perinatally. Incidence of tibial dyschondroplasia, a leg pathology resulting from poor ossification at the bone's epiphyseal plates, was determined at slaughter on D35. 24L resulted in lower embryonic ossification at embryonic day (E) 13 and E14, and lower femur length, and lower tibiatarsus weight, length, cortical area, second moment of area around the minor axis, and mean cortical thickness at hatching on D0 compared to 12L: 12D especially. Results were long term, with lower femur weight and tibiatarsus length, cortical and medullary area of the tibiatarsus, and second moment of area around the minor axis, and a higher incidence of tibial dyschondroplasia for 24L. Growth hormone at D0 was higher for 24D than for 12L: 12D, with 24L intermediate, but plasma melatonin and IGF-I did not differ between treatments, and the role of plasma melatonin, IGF-I, and growth hormone in this process was therefore not clear. To conclude, in the current experiment, 24L during incubation of chicken eggs had a detrimental effect on embryonic leg bone development and later life leg bone strength compared to 24D and 12L: 12D, while the light-dark rhythm of 12L: 12D may have a stimulating effect on leg health.	[van der Pol, Carla W.; van Roovert-Reijrink, Inge A. M.; Maatjens, Conny M.; Wijnen, Jan] HatchTech BV, Res Dept, Veenendaal, Netherlands; [van der Pol, Carla W.; Maatjens, Conny M.; Wijnen, Jan; Kemp, Bas; van den Brand, Henry] Wageningen Univ & Res, Adaptat Physiol Grp, Wageningen, Netherlands; [Gussekloo, Sander W. S.; Kranenbarg, Sander; Pieters, Remco P. M.; Schipper, Henk] Wageningen Univ & Res, Expt Zool Grp, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	van der Pol, CW (corresponding author), HatchTech BV, Res Dept, Veenendaal, Netherlands.; van der Pol, CW (corresponding author), Wageningen Univ & Res, Adaptat Physiol Grp, Wageningen, Netherlands.	cvdpol@hatchtech.nl	van der Pol, Carla/GQP-0559-2022; Gussekloo, Sander/AGI-4222-2022; Gussekloo, Sander W.S./D-4886-2012	van der Pol, Carla/0000-0001-7388-9734; Gussekloo, Sander/0000-0002-9691-4661; Gussekloo, Sander W.S./0000-0002-9691-4661; Wijnen, Jan H. J./0000-0003-1832-2078				Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Aota Y, 2013, SPINE J, V13, P1607, DOI 10.1016/j.spinee.2013.05.017; Archer GS, 2014, APPL ANIM BEHAV SCI, V152, P44, DOI 10.1016/j.applanim.2013.12.010; Augat P, 2006, AGE AGEING, V35, P27, DOI 10.1093/ageing/afl081; Bessei W, 2006, WORLD POULTRY SCI J, V62, P455, DOI 10.1079/WPS2005108; Cardinali DP, 2003, J PINEAL RES, V34, P81, DOI 10.1034/j.1600-079X.2003.00028.x; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; HARGEST TE, 1985, AM J PATHOL, V119, P175; Heetkamp MJW, 2015, INDIRECT CALORIMETRY: TECHNIQUES, COMPUTATIONS AND APPLICATIONS, P35, DOI 10.3920/978-90-8686-261-0_2; Herzog A, 2011, AM J PHYSIOL-REG I, V301, pR140, DOI 10.1152/ajpregu.00134.2011; Huth JC, 2015, POULTRY SCI; Jin EH, 2011, ANAT REC, V294, P1233, DOI 10.1002/ar.21408; KESTIN SC, 1992, VET REC, V131, P190, DOI 10.1136/vr.131.9.190; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kurtul I, 2009, KAFKAS UNIV VET FAK, V15, P869; Leach RM, 2007, POULTRY SCI, V86, P2053, DOI 10.1093/ps/86.10.2053; MACHIDA M, 1995, J BONE JOINT SURG BR, V77B, P134, DOI 10.1302/0301-620X.77B1.7822371; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; MILGROM C, 1989, J BIOMECH, V22, P1243, DOI 10.1016/0021-9290(89)90226-1; Ostrowska Z, 2002, NEUROENDOCRINOL LETT, V23, P417; Oviedo-Rondon EO, 2008, BRIT POULTRY SCI, V49, P666, DOI 10.1080/00071660802433149; Ozkan S, 2012, POULTRY SCI, V91, P2912, DOI 10.3382/ps.2012-02426; PECHAK DG, 1986, BONE, V7, P441, DOI 10.1016/8756-3282(86)90004-9; PECHAK DG, 1986, BONE, V7, P459, DOI 10.1016/8756-3282(86)90005-0; Potthoff T., 1984, American Society of Ichthyologists and Herpetologists Special Publication, P35; Roach HI, 1997, J BONE MINER RES, V12, P795, DOI 10.1359/jbmr.1997.12.5.795; Robson H, 2002, PEDIATR RES, V52, DOI 10.1203/01.PDR.0000023494.70201.1C; Rozenboim I, 2004, POULTRY SCI, V83, P1413, DOI 10.1093/ps/83.8.1413; Sanotra GS, 2001, WORLD POULTRY SCI J, V57, P55, DOI 10.1079/WPS20010006; Shafey TM, 2004, BRIT POULTRY SCI, V45, P223, DOI 10.1080/00071660410001715821; Shafey TM, 2002, ASIAN AUSTRAL J ANIM, V15, P1702, DOI 10.5713/ajas.2002.1702; van der Eerden BCJ, 2003, ENDOCR REV, V24, P782, DOI 10.1210/er.2002-0033; Yalcin S, 2007, POULTRY SCI, V86, P1772, DOI 10.1093/ps/86.8.1772; Zeman M, 1999, J PINEAL RES, V26, P28, DOI 10.1111/j.1600-079X.1999.tb00563.x; Zeman M, 1999, DOMEST ANIM ENDOCRIN, V17, P199, DOI 10.1016/S0739-7240(99)00037-5	35	14	14	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210886	10.1371/journal.pone.0210886	http://dx.doi.org/10.1371/journal.pone.0210886			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682088	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500071
J	Yamada, S; Shimada, M; Morine, Y; Imura, S; Ikemoto, T; Saito, Y; Takasu, C; Yoshikawa, M; Teraoku, H; Yoshimoto, T				Yamada, Shinichiro; Shimada, Mitsuo; Morine, Yuji; Imura, Satoru; Ikemoto, Tetsuya; Saito, Yu; Takasu, Chie; Yoshikawa, Masato; Teraoku, Hiroki; Yoshimoto, Toshiaki			A new formula to calculate the resection limit in hepatectomy based on Gd-EOB-DTPA-enhanced magnetic resonance imaging	PLOS ONE			English	Article							LIVER-FUNCTION; HEPATOBILIARY PHASE; HEPATIC RESECTION; MRI; FAILURE; REMNANT; SCINTIGRAPHY; DYSFUNCTION; PREDICTION; MORTALITY	Background and aim Dynamic magnetic resonance imaging with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (EOB-MRI) can be used not only to detect liver tumors but also to estimate liver function. The aim of this study was to establish a new EOB-MRI-based formula to determine the resection limit in patients undergoing hepatectomy. Methods Twenty-eight patients with a normal liver (NL group) and five with an unresectable cirrhotic liver (UL group) who underwent EOB-MRI were included. Standardized liver function (SLF) was calculated based on the signal intensity (SI), the volume of each subsegment (S1-S8), and body surface area. A formula defining the resection limit was devised based on the difference in the SLF values of patients in the NL and UL groups. The formula was validated in 50 patients who underwent EOB-MRI and hepatectomy. Results The average SLF value in the NL and UL groups was 2038 and 962 FV/m(2), respectively. The difference (1076 FV/m(2)) was consistent with a 70% in resection volume. Thus, the resection limit for hepatectomy was calculated as a proportion of 70%: 70x(SLF-962)/1076 (%). The one patient who underwent hepatectomy over the resection limit died due to liver failure. In other 49 patients, in whom the resection volume was less than the resection limit, procedures were safely performed. Conclusions Our formula for resection limit based on EOB-MRI can improve the safety of hepatectomy.	[Yamada, Shinichiro; Shimada, Mitsuo; Morine, Yuji; Imura, Satoru; Ikemoto, Tetsuya; Saito, Yu; Takasu, Chie; Yoshikawa, Masato; Teraoku, Hiroki; Yoshimoto, Toshiaki] Tokushima Univ, Dept Surg, Tokushima, Japan	Tokushima University	Yamada, S (corresponding author), Tokushima Univ, Dept Surg, Tokushima, Japan.	yamada.shinichirou@tokushima-u.ac.jp		Yamada, Shinichiro/0000-0003-3847-751X; Ikemoto, Tetsuya/0000-0001-9800-1359				Arii S, 2000, HEPATOLOGY, V32, P1224, DOI 10.1053/jhep.2000.20456; Bae KE, 2012, DIGEST DIS, V30, P617, DOI 10.1159/000343092; Balzan S, 2005, ANN SURG, V242, P824, DOI 10.1097/01.sla.0000189131.90876.9e; Bluemke DA, 2005, RADIOLOGY, V237, P89, DOI 10.1148/radiol.2371031842; Capussotti L, 2009, BRIT J SURG, V96, P88, DOI 10.1002/bjs.6429; CLAVIEN PA, 1992, SURGERY, V111, P518; Dinant S, 2007, J NUCL MED, V48, P685, DOI 10.2967/jnumed.106.038430; Forsgren MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095700; Guglielmi A, 2012, DIGEST SURG, V29, P6, DOI 10.1159/000335713; Kim T, 1997, JMRI-J MAGN RESON IM, V7, P683, DOI 10.1002/jmri.1880070413; Kokudo N, 2002, WORLD J SURG, V26, P1342, DOI 10.1007/s00268-002-6262-3; Kudo M, 2010, ONCOLOGY-BASEL, V78, P87, DOI 10.1159/000315235; Kwon A, 1997, HEPATOLOGY, V25, P426; MIYAGAWA S, 1995, AM J SURG, V169, P589, DOI 10.1016/S0002-9610(99)80227-X; Motosugi U, 2009, J MAGN RESON IMAGING, V30, P1042, DOI 10.1002/jmri.21956; Mullen JT, 2007, J AM COLL SURGEONS, V204, P854, DOI 10.1016/j.jamcollsurg.2006.12.032; Nanashima A, 2004, HEPATOL RES, V28, P184, DOI 10.1016/j.hepres.2003.11.010; Nilsson H, 2015, HPB, V17, P272, DOI 10.1111/hpb.12348; Ninomiya M, 2015, BRIT J SURG, V102, P944, DOI 10.1002/bjs.9820; Ryeom HK, 2004, KOREAN J RADIOL, V5, P231, DOI 10.3348/kjr.2004.5.4.231; SCHUHMANNGIAMPIERI G, 1992, RADIOLOGY, V183, P59, DOI 10.1148/radiology.183.1.1549695; Seyama Y, 2009, HEPATOL RES, V39, P107, DOI 10.1111/j.1872-034X.2008.00441.x; Shimizu J, 1999, DIGEST DIS SCI, V44, P1330, DOI 10.1023/A:1026679113772; Shirabe K, 1999, J AM COLL SURGEONS, V188, P304, DOI 10.1016/S1072-7515(98)00301-9; Sourbron S, 2012, RADIOLOGY, V263, P874, DOI 10.1148/radiol.12110337; Sumiyoshi T, 2013, WORLD J GASTROENTERO, V19, P3217, DOI 10.3748/wjg.v19.i21.3217; Tajima T, 2010, J COMPUT ASSIST TOMO, V34, P362, DOI 10.1097/RCT.0b013e3181cd3304; Utsunomiya T, 2012, J GASTROENTEROL, V47, P470, DOI 10.1007/s00535-011-0513-8; VERA DR, 1991, J NUCL MED, V32, P1169; Verloh N, 2014, EUR RADIOL, V24, P1013, DOI 10.1007/s00330-014-3108-y; Xiao YD, 2015, ONCOL LETT, V9, P1191, DOI 10.3892/ol.2014.2826; YAMANAKA N, 1994, ANN SURG, V219, P342, DOI 10.1097/00000658-199404000-00003	32	9	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210579	10.1371/journal.pone.0210579	http://dx.doi.org/10.1371/journal.pone.0210579			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682046	Green Published, gold			2022-12-26	WOS:000457037500048
J	Berg, L; Eckardt, J; Masseck, OA				Berg, Laura; Eckardt, Josephine; Masseck, Olivia Andrea			Enhanced activity of pyramidal neurons in the infralimbic cortex drives anxiety behavior	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; ELEVATED PLUS-MAZE; VENTRAL HIPPOCAMPUS; MICE LACKING; SEROTONIN; RECEPTORS; FEAR; AUTORECEPTOR; PROJECTIONS; MODULATION	We show that in an animal model of anxiety the overall excitation, particularly in the infralimbic region of the medial prefrontal cortex (IL), is increased and that the activity ratio between excitatory pyramidal neurons and inhibitory interneurons (AR PN/IN) is shifted towards excitation. The same change in AR PN/IN is evident for wildtype mice, which have been exposed to an anxiety stimulus. We hypothesize, that an elevated activity and the imbalance of excitation (PN) and inhibition (IN) within the neuronal microcircuitry of the prefrontal cortex is responsible for anxiety behaviour and employed optogenetic methods in freely moving mice to verify our findings. Consistent with our hypothesis elevation of pyramidal neuron activity in the infralimbic region of the prefrontal cortex significantly enhanced anxiety levels in several behavioural tasks by shifting the AR PN/IN to excitation, without affecting motor behaviour, thus revealing a novel mechanism by which anxiety is facilitated.	[Berg, Laura; Masseck, Olivia Andrea] Ruhr Univ Bochum, Adv Fluorescence Microscopy, Bochum, Germany; [Eckardt, Josephine] Ruhr Univ Bochum, Dept Syst Neurosci, Bochum, Germany; [Masseck, Olivia Andrea] Univ Bremen, Synthet Biol, Bremen, Germany	Ruhr University Bochum; Ruhr University Bochum; University of Bremen	Masseck, OA (corresponding author), Ruhr Univ Bochum, Adv Fluorescence Microscopy, Bochum, Germany.; Masseck, OA (corresponding author), Univ Bremen, Synthet Biol, Bremen, Germany.	masseck@uni-bremen.de		Ansorge, Josephine/0000-0002-1821-9698; Masseck, Olivia Andrea/0000-0002-1541-2388	DFG [MA4692/3-2]	DFG(German Research Foundation (DFG))	This work received support from a Grant awarded to Olivia Masseck (MA4692/3-2) from the DFG, http://www.dfg.de/.The funders had no role in study design, data collection and analysis, decision t publish, or preparation of the manuscript.	Adhikari A, 2011, NEURON, V71, P898, DOI 10.1016/j.neuron.2011.07.027; Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Akimova E, 2009, BIOL PSYCHIAT, V66, P627, DOI 10.1016/j.biopsych.2009.03.012; Albert PR, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00199; Altieri SC, 2013, ACS CHEM NEUROSCI, V4, P72, DOI 10.1021/cn3002174; AZMITIA EC, 1978, J COMP NEUROL, V179, P641, DOI 10.1002/cne.901790311; Bi LL, 2013, NEUROPHARMACOLOGY, V72, P148, DOI 10.1016/j.neuropharm.2013.04.048; Blier P, 2007, INT J PSYCHIAT CLIN, V11, P16, DOI 10.1080/13651500701388310; Bruening S, 2006, J NEUROCHEM, V99, P892, DOI 10.1111/j.1471-4159.2006.04129.x; Bystritsky A, 2001, NEUROREPORT, V12, P3953, DOI 10.1097/00001756-200112210-00020; Cassano Giovanni B, 2002, Dialogues Clin Neurosci, V4, P271; Cossart R, 2005, TRENDS NEUROSCI, V28, P108, DOI 10.1016/j.tins.2004.11.011; Felix-Ortiz AC, 2016, NEUROSCIENCE, V321, P197, DOI 10.1016/j.neuroscience.2015.07.041; Felix-Ortiz AC, 2013, NEURON, V79, P658, DOI 10.1016/j.neuron.2013.06.016; Forster GL, 2012, AMYGDALA - A DISCRETE MULTITASKING MANAGER, P61, DOI 10.5772/50323; Fuchikami M, 2015, P NATL ACAD SCI USA, V112, P8106, DOI 10.1073/pnas.1414728112; Garcia-Garcia AL, 2014, PSYCHOPHARMACOLOGY, V231, P623, DOI 10.1007/s00213-013-3389-x; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Gonzalez LE, 2000, BRAIN RES, V887, P7, DOI 10.1016/S0006-8993(00)02931-0; Gordon JA, 2005, J NEUROSCI, V25, P6509, DOI 10.1523/JNEUROSCI.1211-05.2005; Gross C, 2004, NAT REV NEUROSCI, V5, P545, DOI 10.1038/nrn1429; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Heisler LK, 1998, P NATL ACAD SCI USA, V95, P15049, DOI 10.1073/pnas.95.25.15049; HURLEY KM, 1991, J COMP NEUROL, V308, P249, DOI 10.1002/cne.903080210; Jinks AL, 1997, BRAIN RES, V772, P181, DOI 10.1016/S0006-8993(97)00810-X; Johnson NJT, 1996, PSYCHOPHARMACOLOGY, V124, P355, DOI 10.1007/BF02247441; Kehrer C, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02/006.2008; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kjaerby C, 2016, CELL REP, V17, P2882, DOI 10.1016/j.celrep.2016.11.036; Klein J, 2010, BEHAV BRAIN RES, V213, P73, DOI 10.1016/j.bbr.2010.04.036; Klemenhagen KC, 2006, NEUROPSYCHOPHARMACOL, V31, P101, DOI 10.1038/sj.npp.1300774; Lacroix L, 2000, BEHAV NEUROSCI, V114, P1119, DOI 10.1037//0735-7044.114.6.1119; Lisboa SF, 2010, NEUROSCIENCE, V171, P760, DOI 10.1016/j.neuroscience.2010.09.048; Liu ZX, 2014, NEURON, V81, P1360, DOI 10.1016/j.neuron.2014.02.010; Llado-Pelfort L, 2012, CEREB CORTEX, V22, P1487, DOI 10.1093/cercor/bhr220; Malizia AL, 1998, ARCH GEN PSYCHIAT, V55, P715, DOI 10.1001/archpsyc.55.8.715; Marek R, 2018, NAT NEUROSCI, V21, P384, DOI 10.1038/s41593-018-0073-9; Meunier CNJ, 2013, NEUROPHARMACOLOGY, V71, P37, DOI 10.1016/j.neuropharm.2013.03.003; Meunier Claire N J, 2017, Front Synaptic Neurosci, V9, P2, DOI 10.3389/fnsyn.2017.00002; Narboux-Neme N, 2011, NEUROPSYCHOPHARMACOL, V36, P2538, DOI 10.1038/npp.2011.142; Nelson SB, 2015, NEURON, V87, P684, DOI 10.1016/j.neuron.2015.07.033; Padilla-Coreano N, 2016, NEURON, V89, P857, DOI 10.1016/j.neuron.2016.01.011; Parfitt GM, 2017, NEUROPSYCHOPHARMACOL, V42, P1715, DOI 10.1038/npp.2017.56; Parks CL, 1998, P NATL ACAD SCI USA, V95, P10734, DOI 10.1073/pnas.95.18.10734; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Richardson-Jones JW, 2010, NEURON, V65, P40, DOI 10.1016/j.neuron.2009.12.003; Rippon G, 2007, INT J PSYCHOPHYSIOL, V63, P164, DOI 10.1016/j.ijpsycho.2006.03.012; Shah AA, 2004, BRAIN RES, V1028, P112, DOI 10.1016/j.brainres.2004.08.061; Singewald N, 2003, BIOL PSYCHIAT, V53, P275, DOI 10.1016/S0006-3223(02)01574-3; Suzuki S, 2016, BEHAV BRAIN RES, V304, P120, DOI 10.1016/j.bbr.2016.01.044; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	53	19	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210949	10.1371/journal.pone.0210949	http://dx.doi.org/10.1371/journal.pone.0210949			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677060	Green Published, Green Submitted, gold			2022-12-26	WOS:000456700400036
J	Almeida, C; Maniti, O; Di Pisa, M; Swiecicki, JM; Ayala-Sanmartin, J				Almeida, Claudia; Maniti, Ofelia; Di Pisa, Margherita; Swiecicki, Jean-Marie; Ayala-Sanmartin, Jesus			Cholesterol re-organisation and lipid de packing by arginine-rich cell penetrating peptides: Role in membrane translocation	PLOS ONE			English	Article							LARGE UNILAMELLAR VESICLES; SOLID-STATE NMR; PLASMA-MEMBRANE; DEPENDENT TRANSLOCATION; DOMAIN SEPARATION; PORE FORMATION; INTERNALIZATION; ORGANIZATION; MECHANISM; BILAYERS	Cell penetrating peptides (CPPs) are able to transport hydrophilic molecules inside cells. To reach the cytosol, the peptide associated with a cargo must cross the plasma or the endosomal membrane. Different molecular mechanisms for peptide internalisation into cells have been proposed and it is becoming clear that the cellular internalisation mechanisms are different depending on the peptide sequence and structure and the target membrane. Herein, the penetration of three peptides into large unilamellar vesicles were studied: the homeodomain derived 16-residues penetratin, nona-arginine (R9), and a small peptide containing 6 arginine and 3 tryptophan residues (RW9). The membrane models were composed of phospholipids from natural sources containing different molecular species. We observed that among the three peptides, only the amphipathic peptide RW9 was able to cross the membrane vesicles in the liquid disordered state. The changes in the distribution of the previously characterized cholesterol-pyrene probe show that cholesterol-pyrene molecules dissociate from clusters upon membrane interaction with the three peptides and that the cholesterol environment becomes more disordered in the presence of RW9. Finally, we studied the effect of the peptides on lipid ordering on giant plasma membrane vesicles. The amphipathic peptides RW9 and its longer homologue RW16 induced lipid de-packing in plasma membrane vesicles. Overall, the data suggest that a disordered membrane favours the translocation of RW9, that the membrane cholesterol is redistributed during peptide interaction, and that the peptide amphipathic character is important to increase membrane fluidity and peptide membrane translocation.	[Almeida, Claudia; Maniti, Ofelia; Di Pisa, Margherita; Swiecicki, Jean-Marie; Ayala-Sanmartin, Jesus] Sorbonne Univ, Univ PSL, Ecole Normale Super, CNRS,Lab Biomol, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite	Ayala-Sanmartin, J (corresponding author), Sorbonne Univ, Univ PSL, Ecole Normale Super, CNRS,Lab Biomol, Paris, France.	jesus.ayala-sanmartin@sorbonne-universite.fr	DE ALMEIDA, CARLOS CAETANO/K-4265-2016; Maniti, Ofélia/AAQ-5624-2021	DE ALMEIDA, CARLOS CAETANO/0000-0002-3215-5731; Ayala-Sanmartin, Jesus/0000-0002-1215-0159				Alhakamy NA, 2013, LANGMUIR, V29, P15336, DOI 10.1021/la403370p; Almeida C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201373; Almeida C, 2016, BBA-BIOMEMBRANES, V1858, P2584, DOI 10.1016/j.bbamem.2016.07.012; Alvarez-Guaita A, 2015, BRIT J PHARMACOL, V172, P1677, DOI 10.1111/bph.13022; Amaro M, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa5dbc; Arsov Z, 2008, J PEPT SCI, V14, P1303, DOI 10.1002/psc.1062; Avci FG, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8030077; Ayala-Sanmartin J, 2004, ANNEXINS, V1, P19; Ayala-Sanmartin J, 2008, BBA-BIOMEMBRANES, V1778, P472, DOI 10.1016/j.bbamem.2007.11.004; Binder H, 2003, BIOPHYS J, V85, P982, DOI 10.1016/S0006-3495(03)74537-8; Caesar CEB, 2006, BIOCHEMISTRY-US, V45, P7682, DOI 10.1021/bi052095t; Delaroche D, 2010, J BIOL CHEM, V285, P7712, DOI 10.1074/jbc.M109.045872; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Di Pisa M, 2015, BIOCHEMISTRY-US, V54, P194, DOI 10.1021/bi501392n; Dinic J, 2011, BBA-BIOMEMBRANES, V1808, P298, DOI 10.1016/j.bbamem.2010.10.002; Eiriksdottir E, 2010, BBA-BIOMEMBRANES, V1798, P1119, DOI 10.1016/j.bbamem.2010.03.005; Fretz MM, 2007, BIOCHEM J, V403, P335, DOI 10.1042/BJ20061808; Futaki S, 2017, ACCOUNTS CHEM RES, V50, P2449, DOI 10.1021/acs.accounts.7b00221; Gomara MJ, 2003, BBA-BIOMEMBRANES, V1612, P83, DOI 10.1016/S0005-2736(03)00107-X; Hedegaard SF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24154-z; Herce HD, 2009, BIOPHYS J, V97, P1917, DOI 10.1016/j.bpj.2009.05.066; Huster D, 1998, BIOCHEMISTRY-US, V37, P17299, DOI 10.1021/bi980078g; Illien F, 2012, BBA-BIOMEMBRANES, V1818, P2892, DOI 10.1016/j.bbamem.2012.07.012; Jin L, 2006, BIOPHYS J, V90, P2563, DOI 10.1529/biophysj.105.072884; Kauffman WB, 2015, TRENDS BIOCHEM SCI, V40, P749, DOI 10.1016/j.tibs.2015.10.004; Lagane B, 2002, BIOPHYS CHEM, V95, P7, DOI 10.1016/S0301-4622(01)00235-6; Lamaziere A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001938; Lamaziere A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000201; Lamaziere A, 2010, BBA-BIOMEMBRANES, V1798, P2223, DOI 10.1016/j.bbamem.2009.12.024; Lamaziere Antonin, 2009, Commun Integr Biol, V2, P223; Lamaziere Antonin, 2006, Journal de la Societe de Biologie, V200, P229, DOI 10.1051/jbio:2006026; Le Guyader L, 2007, BIOPHYS J, V93, P4462, DOI 10.1529/biophysj.107.112821; Levental I, 2016, J MOL BIOL, V428, P4749, DOI 10.1016/j.jmb.2016.08.022; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Lorents A, 2018, BIOCONJUGATE CHEM, V29, P1168, DOI 10.1021/acs.bioconjchem.7b00805; Mae M, 2006, CURR OPIN PHARMACOL, V6, P509, DOI 10.1016/j.coph.2006.04.004; Maniti O, 2014, INT J BIOCHEM CELL B, V50, P73, DOI 10.1016/j.biocel.2014.02.017; Maniti O, 2012, INT J BIOCHEM CELL B, V44, P869, DOI 10.1016/j.biocel.2012.02.010; Maniti O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015819; Mishra VK, 1996, BIOCHEMISTRY-US, V35, P11210, DOI 10.1021/bi960760f; Murayama T, 2017, ANGEW CHEM INT EDIT, V56, P7644, DOI 10.1002/anie.201703578; Owen DM, 2012, NAT PROTOC, V7, P24, DOI 10.1038/nprot.2011.419; Pae J, 2014, J CONTROL RELEASE, V192, P103, DOI 10.1016/j.jconrel.2014.07.002; Pan JJ, 2016, J PHYS CHEM B, V120, P4625, DOI 10.1021/acs.jpcb.6b02332; PASENKIEWICZGIERULA M, 1991, BIOCHIMIE, V73, P1311, DOI 10.1016/0300-9084(91)90094-H; Rothbard JB, 2004, J AM CHEM SOC, V126, P9506, DOI 10.1021/ja0482536; Saalik P, 2011, J CONTROL RELEASE, V153, P117, DOI 10.1016/j.jconrel.2011.03.011; Sakagami K, 2018, MOL PHARMACEUT, V15, P1332, DOI 10.1021/acs.molpharmaceut.7b01130; Schmid F, 2017, BBA-BIOMEMBRANES, V1859, P509, DOI 10.1016/j.bbamem.2016.10.021; Sezgin E, 2017, NAT REV MOL CELL BIO, V18, P361, DOI 10.1038/nrm.2017.16; Sharmin S, 2016, BIOCHEMISTRY-US, V55, P4154, DOI 10.1021/acs.biochem.6b00189; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Su Y, 2008, J AM CHEM SOC, V130, P8856, DOI 10.1021/ja802383t; Swiecicki JM, 2015, BIOPOLYMERS, V104, P533, DOI 10.1002/bip.22652; Swiecicki JM, 2014, CHEMBIOCHEM, V15, P884, DOI 10.1002/cbic.201300742; Takayama K, 2012, MOL PHARMACEUT, V9, P1222, DOI 10.1021/mp200518n; Terrone D, 2003, BIOCHEMISTRY-US, V42, P13787, DOI 10.1021/bi035293y; Thoren PEG, 2000, FEBS LETT, V482, P265, DOI 10.1016/S0014-5793(00)02072-X; Via MA, 2018, LANGMUIR, V34, P3102, DOI 10.1021/acs.langmuir.7b04038; Walrant A, 2012, BBA-BIOMEMBRANES, V1818, P1755, DOI 10.1016/j.bbamem.2012.02.024; Witte K, 2013, BBA-BIOMEMBRANES, V1828, P824, DOI 10.1016/j.bbamem.2012.11.014; Zhou L, 2014, COLLOID SURFACE B, V123, P419, DOI 10.1016/j.colsurfb.2014.09.037	62	5	5	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210985	10.1371/journal.pone.0210985	http://dx.doi.org/10.1371/journal.pone.0210985			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673771	Green Published, Green Submitted, gold			2022-12-26	WOS:000456442800060
J	Caruso, G; Zarco-Tejada, PJ; Gonzalez-Dugo, V; Moriondo, M; Tozzini, L; Palai, G; Rallo, G; Hornero, A; Primicerio, J; Gucci, R				Caruso, Giovanni; Zarco-Tejada, Pablo J.; Gonzalez-Dugo, Victoria; Moriondo, Marco; Tozzini, Letizia; Palai, Giacomo; Rallo, Giovanni; Hornero, Alberto; Primicerio, Jacopo; Gucci, Riccardo			High-resolution imagery acquired from an unmanned platform to estimate biophysical and geometrical parameters of olive trees under different irrigation regimes	PLOS ONE			English	Article							OLEA-EUROPAEA L.; AERIAL VEHICLE UAV; WATER REQUIREMENTS; CROP COEFFICIENTS; RANGING LIDAR; AIRBORNE; OIL; ORCHARDS; FRUIT; EVAPOTRANSPIRATION	The experiments were conducted in a fully-productive olive orchard (cv. Frantoio) at the experimental farm of University of Pisa at Venturina (Italy) in 2015 to assess the ability of an unmanned aerial vehicle (UAV) equipped with RGB-NIR cameras to estimate leaf area index (LAI), tree height, canopy diameter and canopy volume of olive trees that were either irrigated or rainfed. Irrigated trees received water 4-5 days a week (1348 m(3) ha(-1)), whereas the rainfed ones received a single irrigation of 19 m(3) ha(-1) to relieve the extreme stress. The flight altitude was 70 m above ground level (AGL), except for one flight (50 m AGL). The Normalized Difference Vegetation Index (NDVI) was calculated by means of the map algebra technique. Canopy volume, canopy height and diameter were obtained from the digital surface model (DSM) obtained through automatic aerial triangulation, bundle block adjustment and camera calibration methods. The NDVI estimated on the day of the year (DOY) 130 was linearly correlated with both LAI and leaf chlorophyll measured on the same date (R-2 = 0.78 and 0.80, respectively). The correlation between the on ground measured canopy volumes and the ones by the UAV-RGB camera techniques yielded an R-2 of 0.71-0.86. The monthly canopy volume increment estimated from UAV surveys between (DOY) 130 and 244 was highly correlated with the daily water stress integral of rainfed trees (R-2 = 0.99). The effect of water stress on the seasonal pattern of canopy growth was detected by these techniques in correspondence of the maximum level of stress experienced by the rainfed trees. The highest level of accuracy (RMSE = 0.16 m) in canopy height estimation was obtained when the flight altitude was 50 m AGL, yielding an R-2 value of 0.87 and an almost 1:1 ratio of measured versus estimated canopy height.	[Caruso, Giovanni; Tozzini, Letizia; Palai, Giacomo; Rallo, Giovanni; Gucci, Riccardo] Univ Pisa, Dipartimento Sci Agr Alimentari & Agroambientali, Pisa, Italy; [Zarco-Tejada, Pablo J.; Gonzalez-Dugo, Victoria; Hornero, Alberto] CSIC, IAS, Cordoba, Spain; [Zarco-Tejada, Pablo J.] Univ Melbourne, FVAS, Sch Agr & Food, Melbourne, Vic, Australia; [Zarco-Tejada, Pablo J.] Univ Melbourne, MSE, Dept Infrastruct Engn, Melbourne, Vic, Australia; [Moriondo, Marco; Primicerio, Jacopo] CNR, IBIMET, Ist Biometeorol, Florence, Italy; [Hornero, Alberto] Swansea Univ, Dept Geog, Swansea, W Glam, Wales	University of Pisa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); University of Melbourne; University of Melbourne; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biometeorologia (IBIMET-CNR); Swansea University	Caruso, G (corresponding author), Univ Pisa, Dipartimento Sci Agr Alimentari & Agroambientali, Pisa, Italy.	giovanni.caruso@unipi.it	PRIMICERIO, JACOPO/AAD-2660-2022; Moriondo, Marco/H-5279-2019; Caruso, Giovanni/O-1428-2015; Zarco-Tejada, Pablo J./A-6874-2012; Zarco-Tejada, Pablo J./AAZ-3704-2020; Rallo, Giovanni/D-2358-2013; Hornero, Alberto/AAB-1123-2021	PRIMICERIO, JACOPO/0000-0001-8707-9185; Moriondo, Marco/0000-0002-8356-7517; Caruso, Giovanni/0000-0002-9694-7180; Zarco-Tejada, Pablo J./0000-0003-1433-6165; Rallo, Giovanni/0000-0002-8405-8618; Hornero, Alberto/0000-0002-8434-2168; PALAI, GIACOMO/0000-0002-6666-5764	UNAPROL-Italy projects [867/2008]	UNAPROL-Italy projects	Research supported by UNAPROL-Italy projects Reg. EU no. 867/2008. The funder had no role in the study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	Ben-Gal A, 2011, IRRIGATION SCI, V29, P253, DOI 10.1007/s00271-010-0237-1; Berenguer MJ, 2006, HORTSCIENCE, V41, P427, DOI 10.21273/HORTSCI.41.2.427; Berni JAJ, 2009, IEEE T GEOSCI REMOTE, V47, P722, DOI 10.1109/TGRS.2008.2010457; Caruso G, 2017, VITIS, V56, P63, DOI 10.5073/vitis.2017.56.63-70; Caruso G, 2017, J SCI FOOD AGR, V97, P3530, DOI 10.1002/jsfa.8207; Caruso G, 2014, AGR WATER MANAGE, V134, P94, DOI 10.1016/j.agwat.2013.12.003; Caruso G, 2013, IRRIGATION SCI, V31, P37, DOI 10.1007/s00271-011-0286-0; Cherbiy-Hoffmann SU, 2013, SCI HORTIC-AMSTERDAM, V150, P110, DOI 10.1016/j.scienta.2012.10.027; Connor DJ, 2005, AUST J AGR RES, V56, P1181, DOI 10.1071/AR05169; Diaz-Varela RA, 2015, REMOTE SENS-BASEL, V7, P4213, DOI 10.3390/rs70404213; Edson C, 2011, REMOTE SENS-BASEL, V3, P2494, DOI 10.3390/rs3112494; Escola A, 2017, PRECIS AGRIC, V18, P111, DOI 10.1007/s11119-016-9474-5; Gomez JA, 2011, AGRON J, V103, P644, DOI 10.2134/agronj2010.0449; Grattan SR, 2006, AGR WATER MANAGE, V85, P133, DOI 10.1016/j.agwat.2006.04.001; Gucci R., 2000, PRUNING TRAINING SYS; Hernandez-Clemente R, 2014, REMOTE SENS-BASEL, V6, P11627, DOI 10.3390/rs61111627; Iniesta F, 2009, EUR J AGRON, V30, P258, DOI 10.1016/j.eja.2008.12.004; Jimenez-Brenes FM, 2017, PLANT METHODS, V13, DOI 10.1186/s13007-017-0205-3; Li WK, 2012, PHOTOGRAMM ENG REM S, V78, P75, DOI 10.14358/PERS.78.1.75; Lichtenthaler H., 1983, BIOCHEM SOC T, V11, P591, DOI [10.1042/bst0110591, 10.1042/BST0110591, DOI 10.1042/BST0110591]; Lim C, 2007, THESIS; Lovell JL, 2003, CAN J REMOTE SENS, V29, P607, DOI 10.5589/m03-026; Marra FP, 2016, IRRIGATION SCI, V34, P313, DOI 10.1007/s00271-016-0505-9; Mateos L, 2013, AGR WATER MANAGE, V125, P81, DOI 10.1016/j.agwat.2012.11.005; Miranda-Fuentes A, 2015, SENSORS-BASEL, V15, P3671, DOI 10.3390/s150203671; MORAN R, 1980, PLANT PHYSIOL, V65, P478, DOI 10.1104/pp.65.3.478; MYERS BJ, 1988, TREE PHYSIOL, V4, P315, DOI 10.1093/treephys/4.4.315; Nardino M, 2013, PHOTOSYNTHETICA, V51, P63, DOI 10.1007/s11099-012-0079-6; Niblack W., 1986, INTRO DIGITAL IMAGE; Orgaz F, 2006, IRRIGATION SCI, V24, P77, DOI 10.1007/s00271-005-0012-x; ORGAZ F, 1999, CULTIVO OLIVO, P269; Orgaz F, 2007, FUNCT PLANT BIOL, V34, P178, DOI 10.1071/FP06306; Perez-Lopez D, 2007, AGR WATER MANAGE, V89, P297, DOI 10.1016/j.agwat.2007.01.015; Rosell JR, 2012, COMPUT ELECTRON AGR, V81, P124, DOI 10.1016/j.compag.2011.09.007; Rouse Haas, 1973, MONITORING VERNAL AD, DOI DOI 10.1002/MRM.26868; Sauvola J, 2000, PATTERN RECOGN, V33, P225, DOI 10.1016/S0031-3203(99)00055-2; Scandellari F, 2016, EUR J HORTIC SCI, V81, P106, DOI 10.17660/eJHS.2016/81.2.4; Selby S.M., 1973, CRC STANDARD MATH TA; Testi L, 2006, IRRIGATION SCI, V24, P69, DOI 10.1007/s00271-005-0011-y; Tognetti R, 2006, EUR J AGRON, V25, P356, DOI 10.1016/j.eja.2006.07.003; Torres-Sanchez J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130479; TURNER NC, 1988, IRRIGATION SCI, V9, P289, DOI 10.1007/BF00296704; Verma NK, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8050388; VILLALOBOS FJ, 1995, AGR FOREST METEOROL, V73, P29, DOI 10.1016/0168-1923(94)02175-J; WELLES JM, 1991, AGRON J, V83, P818, DOI 10.2134/agronj1991.00021962008300050009x; Zaman Q. U., 2005, Precision Agriculture, V6, P467, DOI 10.1007/s11119-005-4243-x; Zarco-Tejada PJ, 2014, EUR J AGRON, V55, P89, DOI 10.1016/j.eja.2014.01.004	47	38	38	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210804	10.1371/journal.pone.0210804	http://dx.doi.org/10.1371/journal.pone.0210804			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668591	Green Published, gold, Green Submitted			2022-12-26	WOS:000456306400014
J	Matijevich, ES; Branscombe, LM; Scott, LR; Zelik, KE				Matijevich, Emily S.; Branscombe, Lauren M.; Scott, Leon R.; Zelik, Karl E.			Ground reaction force metrics are not strongly correlated with tibial bone load when running across speeds and slopes: Implications for science, sport and wearable tech	PLOS ONE			English	Article							STRESS-FRACTURE; STANCE PHASE; RISK-FACTORS; IN-VIVO; RUNNERS; FATIGUE; MODEL; ANKLE; ATTENUATION; KINEMATICS	Introduction Tibial stress fractures are a common overuse injury resulting from the accumulation of bone microdamage due to repeated loading. Researchers and wearable device developers have sought to understand or predict stress fracture risks, and other injury risks, by monitoring the ground reaction force (GRF, the force between the foot and ground), or GRF correlates (e.g., tibial shock) captured via wearable sensors. Increases in GRF metrics are typically assumed to reflect increases in loading on internal biological structures (e.g., bones). The purpose of this study was to evaluate this assumption for running by testing if increases in GRF metrics were strongly correlated with increases in tibial compression force over a range of speeds and slopes. Methods Ten healthy individuals performed running trials while we collected GRFs and kinematics. We assessed if commonly-used vertical GRF metrics (impact peak, loading rate, active peak, impulse) were strongly correlated with tibial load metrics (peak force, impulse). Results On average, increases in GRF metrics were not strongly correlated with increases in tibial load metrics. For instance, correlating GRF impact peak and loading rate with peak tibial load resulted in r = -0.29 +/- 0.37 and r = -0.20 +/- 0.35 (inter-subject mean and standard deviation), respectively. We observed high inter-subject variability in correlations, though most coefficients were negligible, weak or moderate. Seventy-six of the 80 subject-specific correlation coefficients computed indicated that higher GRF metrics were not strongly correlated with higher tibial forces. Conclusions These results demonstrate that commonly-used GRF metrics can mislead our understanding of loading on internal structures, such as the tibia. Increases in GRF metrics should not be assumed to be an indicator of increases in tibial bone load or overuse injury risk during running. This has important implications for sports, wearable devices, and research on running-related injuries, affecting >50 scientific publications per year from 2015-2017.	[Matijevich, Emily S.; Branscombe, Lauren M.; Zelik, Karl E.] Vanderbilt Univ, Dept Mech Engn, Nashville, TN 37235 USA; [Scott, Leon R.] Vanderbilt Univ, Dept Orthopaed, 221 Kirkland Hall, Nashville, TN 37235 USA; [Zelik, Karl E.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Zelik, Karl E.] Vanderbilt Univ, Dept Phys Med & Rehabil, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Matijevich, ES (corresponding author), Vanderbilt Univ, Dept Mech Engn, Nashville, TN 37235 USA.	emily.matijevich@vanderbilt.edu	Matijevich, Emily/AAQ-4402-2021	Zelik, Karl/0000-0002-5054-2479	National Institutes of Health [NIH K12HD073945]; NIH; Vanderbilt University School of Engineering; CTSA award from the National Center for Advancing Translational Sciences [UL1 TR002243]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD073945] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University School of Engineering; CTSA award from the National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was supported by funding from the National Institutes of Health (NIH K12HD073945), the NIH-funded Clinical and Translational Science Award at the Vanderbilt University Medical Center, and institutional funds from the Vanderbilt University School of Engineering. This research was also supported by CTSA award No. UL1 TR002243 from the National Center for Advancing Translational Sciences. Its contents are solely the responsibility of the authors and do not necessarily represent official views of the National Center for Advancing Translational Sciences or the National Institutes of Health.	[Anonymous], FAQ, DOI [10.1115/1.3118762, DOI 10.1115/1.3118762]; Bennell K, 2004, MED SCI SPORT EXER, V36, P397, DOI 10.1249/01.MSS.0000117116.90297.E1; Bennell KL, 1996, AM J SPORT MED, V24, P810, DOI 10.1177/036354659602400617; Besier TF, 2018, CISC VIS NETW IND GL; Borelli GA, 1608, MOVEMENT ANIMALS; Bredeweg SW, 2013, J SCI MED SPORT, V16, P205, DOI 10.1016/j.jsams.2012.08.002; Brukner PD, 1996, CLIN J SPORT MED, DOI [10.1007/s00167-012-2160-x, DOI 10.1007/S00167-012-2160-X]; BURDETT RG, 1982, MED SCI SPORT EXER, V14, P308, DOI 10.1249/00005768-198204000-00010; CALER WE, 1989, J BIOMECH, V22, P625, DOI 10.1016/0021-9290(89)90013-4; CALHOUN JH, 1994, FOOT ANKLE INT, V15, P125, DOI 10.1177/107110079401500307; CARTER DR, 1985, J ORTHOPAED RES, V3, P84, DOI 10.1002/jor.1100030110; CHAN CS, 1988, PERCEPT MOTOR SKILL, V66, P875, DOI 10.2466/pms.1988.66.3.875; Chen TL, 2016, CLIN BIOMECH, V33, P49, DOI 10.1016/j.clinbiomech.2016.02.013; Clark KP, 2017, J EXP BIOL, V220, P247, DOI 10.1242/jeb.138057; COLLINS JJ, 1989, CLIN BIOMECH, V4, P179, DOI 10.1016/0268-0033(89)90023-5; Corey DM, 1998, J GEN PSYCHOL, V125, P245, DOI 10.1080/00221309809595548; Cosman F, 2013, BONE, V55, P359, DOI 10.1016/j.bone.2013.04.011; Creaby MW, 2008, MED SCI SPORT EXER, V40, P1669, DOI 10.1249/MSS.0b013e31817571ae; Crossley KM, 1999, MED SCI SPORTS EXERC, P419, DOI [10.1016/j.clinbiomech.2005.11.009, DOI 10.1016/J.CLINBIOMECH.2005.11.009]; Crowell HP, 2010, J ORTHOP SPORT PHYS, V40, P206, DOI 10.2519/jospt.2010.3166; Currey J.D., 2013, BONES STRUCTURE MECH; D'Lima DD, 2006, J ARTHROPLASTY, V21, P255, DOI 10.1016/j.arth.2005.07.011; Davis IS, 2017, J SPORT HEALTH SCI, V6, P154, DOI 10.1016/j.jshs.2017.03.013; Davis IS, 2016, BRIT J SPORT MED, V50, P887, DOI 10.1136/bjsports-2015-094579; Derrick TR, 2016, J BIOMECH, V49, P429, DOI 10.1016/j.jbiomech.2016.01.003; Dixon SJ, 2006, CLIN BIOMECH, V21, P412, DOI 10.1016/j.clinbiomech.2005.11.009; Dudley RI, 2017, HUM MOVEMENT SCI, V52, P197, DOI 10.1016/j.humov.2017.02.007; Dziewiecki K, 2013, BIOL SPORT, V30, P103, DOI 10.5604/20831862.1044225; Edwards WB, 2018, EXERC SPORT SCI REV, V46, P224, DOI 10.1249/JES.0000000000000163; Edwards WB, 2010, CLIN BIOMECH, V25, P372, DOI 10.1016/j.clinbiomech.2010.01.001; Edwards WB, 2009, MED SCI SPORT EXER, V41, P2177, DOI 10.1249/MSS.0b013e3181a984c4; Edwards WB, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118762; Farris DJ, 2012, P NATL ACAD SCI USA, V109, P977, DOI 10.1073/pnas.1107972109; Ferber R., 2002, MED SCI SPORTS EXER, V34, DOI [10.1097/00005768-200205001-00025, DOI 10.1097/00005768-200205001-00025]; Gallagher S, 2017, ERGONOMICS, V60, P255, DOI 10.1080/00140139.2016.1208848; Giandolini M, 2016, J BIOMECH, V49, P1765, DOI 10.1016/j.jbiomech.2016.04.001; HAMILL J, 1995, HUM MOVEMENT SCI, V14, P45, DOI 10.1016/0167-9457(95)00004-C; Hamill J, 2018, CURR ISSUES SPORT SC; Hennig E. M., 1993, USE GROUND REACTION, V9, DOI DOI 10.1123/JAB.9.4.306,10.1123/JAB.9.4.306; Honert EC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163169; Hreljac A, 2000, MED SCI SPORT EXER, V32, P1635; HULKKO A, 1987, INT J SPORTS MED, V8, P221, DOI 10.1055/s-2008-1025659; JOHANSSON C, 1992, Scandinavian Journal of Medicine and Science in Sports, V2, P87; Kernozek T, 2017, J SPORT SCI, V35, P2073, DOI 10.1080/02640414.2016.1255769; Kiernan D, 2018, J BIOMECH, V73, P201, DOI 10.1016/j.jbiomech.2018.04.001; KOMI PV, 1990, J BIOMECH, V23, P23, DOI 10.1016/0021-9290(90)90038-5; Kuhman DJ, 2016, HUM MOVEMENT SCI, V47, P9, DOI 10.1016/j.humov.2016.01.013; LANYON LE, 1975, ACTA ORTHOP SCAND, V46, P256, DOI 10.3109/17453677508989216; Loundagin LL, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038288; Martin JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03797-6; MATHESON GO, 1987, AM J SPORT MED, V15, P46, DOI 10.1177/036354658701500107; Matijevich ES, 2018, J BIOMECH, V72, P200, DOI 10.1016/j.jbiomech.2018.03.013; McBryde A M, 1982, Orthopedics, V5, P913, DOI 10.3928/0147-7447-19820701-12; McBryde AM, 1982, ORTHOP THOROFARE, V5, P918; McBryde AM, 1982, ORTHOP THOROFARE, V5, P920; McBryde AM, 1982, ORTHOP THOROFARE, V5, P915; Meardon SA, 2015, CLIN BIOMECH, V30, P895, DOI 10.1016/j.clinbiomech.2015.07.012; Messier SP, 2018, AM J SPORT MED, V46, P2211, DOI 10.1177/0363546518773755; Miller RH, 2014, MED SCI SPORT EXER, V46, P572, DOI 10.1249/MSS.0000000000000135; Miller RH, 2009, COMPUT METHOD BIOMEC, V12, P481, DOI 10.1080/10255840802695437; Milner CE, 2006, MED SCI SPORT EXER, V38, P323, DOI 10.1249/01.mss.0000183477.75808.92; Napier C, 2018, SCAND J MED SCI SPOR, V28, P2164, DOI 10.1111/sms.13228; Neugebauer JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099023; Nigg B, 2017, CURR ISSUES SPORT SC, DOI [10.1080/10255840802695437, DOI 10.1080/10255840802695437]; Nigg BM, 2015, BRIT J SPORT MED, V49, P1290, DOI 10.1136/bjsports-2015-095054; Nigg B. M., 2010, BIOMECHANICS SPORTS; Nigg BM, 2001, CLIN J SPORT MED, V11, P2, DOI 10.1097/00042752-200101000-00002; Paquette MR, 2018, CURR ISSUES SPORT SC; Peake JM, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00743; Pollard CD, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118775720; RADIN EL, 1973, J BIOMECH, V6, P51, DOI 10.1016/0021-9290(73)90037-7; Ritchie RO, 2005, FATIGUE FRACT ENG M, V28, P345, DOI 10.1111/j.1460-2695.2005.00878.x; Sasimontonkul S, 2007, J BIOMECH, V40, P3503, DOI 10.1016/j.jbiomech.2007.05.024; SCHAFFLER MB, 1989, BONE, V10, P207, DOI 10.1016/8756-3282(89)90055-0; Schmitt S, 2011, ARCH APPL MECH, V81, P887, DOI 10.1007/s00419-010-0458-z; SCOTT SH, 1990, MED SCI SPORT EXER, V22, P357; Sharkey NA, 1998, CLIN BIOMECH, V13, P420, DOI 10.1016/S0268-0033(98)00003-5; SIMON SR, 1972, J BIOMECH, V5, P267, DOI 10.1016/0021-9290(72)90042-5; Suresh S., 1998, FATIGUE MAT; van der Worp H, 2016, BRIT J SPORT MED, V50, P450, DOI 10.1136/bjsports-2015-094924; VANDENBOGERT A, 1996, P 9 BIENN C CAN SOC; Wells MD, 2020, SPORT BIOMECH, V19, P333, DOI 10.1080/14763141.2018.1510538; Yagi S, 2013, KNEE SURG SPORT TR A, V21, P556, DOI 10.1007/s00167-012-2160-x; Yong JR, 2018, J BIOMECH, V76, P1, DOI 10.1016/j.jbiomech.2018.05.017; Zadpoor AA, 2011, CLIN BIOMECH, V26, P23, DOI 10.1016/j.clinbiomech.2010.08.005; Zioupos P, 2001, J THEOR BIOL, V210, P389, DOI 10.1006/jtbi.2001.2316	86	77	78	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210000	10.1371/journal.pone.0210000	http://dx.doi.org/10.1371/journal.pone.0210000			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653510	Green Published, gold, Green Submitted			2022-12-26	WOS:000456015500024
J	Shah, S; Meganathan, K; Christianson, AL; Leonard, AC; Thakar, CV				Shah, Silvi; Meganathan, Karthikeyan; Christianson, Annette L.; Leonard, Anthony C.; Thakar, Charuhas V.			Pre-dialysis acute care hospitalizations and clinical outcomes in dialysis patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS; PRACTICE PATTERNS; ASSOCIATION; PREVALENCE; PREDICTORS; MORTALITY; SURVIVAL; VISITS; HEALTH	Background Patients with chronic kidney disease (CKD), a precursor of end stage renal disease (ESRD), face an increasing burden of hospitalizations. Although mortality on dialysis is highest during the first year, the impact of pre-dialysis acute hospitalizations on clinical outcomes in dialysis patients remains unknown. Methods We evaluated 170,897 adult patients who initiated dialysis between 1/1/2010 and 12/31/2014 with linked Medicare claims from the United States Renal Data System. Using logistic regression models, we examined the association of 2-year pre-dialysis hospitalization on the primary outcome of 1-year all-cause mortality. Secondary outcomes included 90-day mortality, type of initial dialysis modality and type of vascular access at hemodialysis initiation. Results Mean age was 72.7 +/- 11.0 years. In the study sample, 76.0% of patients had at least one pre-dialysis hospitalization. Compared to patients with no pre-dialysis hospitalization, the adjusted 1-year mortality was higher with pre-dialysis cardiovascular related hospitalization (odds ratio [OR], 1.63; 95% confidence interval [CI], 1.57-1.68), infection related hospitalization (OR, 1.51; CI, 1.45-1.57), both cardiovascular and infection hospitalization (OR, 1.91; CI, 1.83-1.99), and neither-cardiovascular nor-infection hospitalization (OR, 1.23; CI, 1.19-1.27). Additionally, the adjusted odds of hemodialysis vs. peritoneal dialysis as the initial dialysis modality were higher, whereas adjusted odds to initiate hemodialysis with an arteriovenous access vs. central venous catheter were lower in patients with any type of hospitalization. Conclusion Pre-dialysis hospitalization is an independent predictor of 1-year mortality in dialysis patients. Reducing the risk of pre-dialysis hospitalization may provide opportunities to improve quality of care in ESRD.	[Shah, Silvi; Thakar, Charuhas V.] Univ Cincinnati, Kidney CARE Program, Div Nephrol, Cincinnati, OH 45220 USA; [Meganathan, Karthikeyan; Christianson, Annette L.] Univ Cincinnati, Dept Biomed Informat, Cincinnati, OH USA; [Leonard, Anthony C.] Univ Cincinnati, Dept Family & Community Med, Cincinnati, OH USA; [Thakar, Charuhas V.] VA Med Ctr, Div Nephrol, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Shah, S (corresponding author), Univ Cincinnati, Kidney CARE Program, Div Nephrol, Cincinnati, OH 45220 USA.	shah2sv@ucmail.uc.edu	shah, silvi/AAA-4368-2020		Junior Pilot Faculty Award from University of Cincinnati's Department of Internal Medicine	Junior Pilot Faculty Award from University of Cincinnati's Department of Internal Medicine	Silvi Shah is supported by a Junior Pilot Faculty Award from University of Cincinnati's Department of Internal Medicine. The study was a part of Silvi Shah's masters of clinical and translational research thesis at University of Cincinnati.	Boulware LE, 2006, AM J KIDNEY DIS, V48, P192, DOI 10.1053/j.ajkd.2006.04.073; Bowman B, 2018, AM J KIDNEY DIS, V72, P278, DOI 10.1053/j.ajkd.2018.01.035; Bradbury BD, 2007, CLIN J AM SOC NEPHRO, V2, P89, DOI 10.2215/CJN.01170905; Chan KE, 2009, KIDNEY INT, V76, P331, DOI 10.1038/ki.2009.199; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Crews DC, 2014, J AM SOC NEPHROL, V25, P370, DOI 10.1681/ASN.2013050567; Dalrymple LS, 2012, AM J KIDNEY DIS, V59, P356, DOI 10.1053/j.ajkd.2011.07.012; Erickson KF, 2015, J AM SOC NEPHROL, V26, P1990, DOI 10.1681/ASN.2014050464; Erickson KF, 2014, J AM SOC NEPHROL, V25, P2079, DOI 10.1681/ASN.2013080879; Gillespie BW, 2015, CLIN KIDNEY J, V8, P772, DOI 10.1093/ckj/sfv103; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Holland DC, 2000, NEPHROL DIAL TRANSPL, V15, P650, DOI 10.1093/ndt/15.5.650; Honeycutt AA, 2013, J AM SOC NEPHROL, V24, P1478, DOI 10.1681/ASN.2012040392; Kucirka LM, 2011, JAMA-J AM MED ASSOC, V306, P620, DOI 10.1001/jama.2011.1127; Mix TCH, 2003, AM J KIDNEY DIS, V42, P972, DOI 10.1016/j.ajkd.2003.06.001; Murphy D, 2016, ANN INTERN MED, V165, P473, DOI 10.7326/M16-0273; Naqvi SB, 2006, ADV CHRONIC KIDNEY D, V13, P199, DOI 10.1053/j.ackd.2006.04.004; Nitsch D, 2011, AM J KIDNEY DIS, V57, P664, DOI 10.1053/j.ajkd.2010.09.026; O'Hare AM, 2012, AM J KIDNEY DIS, V59, P513, DOI 10.1053/j.ajkd.2011.11.044; Rayner HC, 2004, NEPHROL DIAL TRANSPL, V19, P108, DOI 10.1093/ndt/gfg483; Saran R, 2018, AM J KIDNEY DIS, V71, pS1, DOI 10.1053/j.ajkd.2018.01.002; Shah S, 2018, BMC NEPHROL, V19, DOI 10.1186/s12882-018-0898-1; Siew ED, 2012, J AM SOC NEPHROL, V23, P305, DOI 10.1681/ASN.2011030315; United States Renal Data System, 2016, USRDS ANN DAT REP EP; US Renal Data System, 2015, 2015 RES GUID USRDS; Wong JS, 1999, KIDNEY INT, V55, P2515, DOI 10.1046/j.1523-1755.1999.00464.x; Yang JY, 2017, AM J KIDNEY DIS, V70, P164, DOI 10.1053/j.ajkd.2016.12.018	27	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209578	10.1371/journal.pone.0209578	http://dx.doi.org/10.1371/journal.pone.0209578			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650094	Green Submitted, gold, Green Published			2022-12-26	WOS:000455813300018
J	Cannataro, VL; Gaffney, SG; Sasaki, T; Issaeva, N; Grewal, NKS; Grandis, JR; Yarbrough, WG; Burtness, B; Anderson, KS; Townsend, JP				Cannataro, Vincent L.; Gaffney, Stephen G.; Sasaki, Tomoaki; Issaeva, Natalia; Grewal, Nicholas K. S.; Grandis, Jennifer R.; Yarbrough, Wendell G.; Burtness, Barbara; Anderson, Karen S.; Townsend, Jeffrey P.			APOBEC-induced mutations and their cancer effect size in head and neck squamous cell carcinoma	ONCOGENE			English	Article							PAPILLOMAVIRUS-ASSOCIATED HEAD; FBW7 UBIQUITIN LIGASE; CYTOSINE DEAMINATION; OROPHARYNGEAL CANCER; SOMATIC MUTATIONS; GERMLINE VARIANTS; GENETIC LANDSCAPE; GENOMIC ANALYSIS; STRUCTURAL BASIS; DNA CYTOSINE	Recent studies have revealed the mutational signatures underlying the somatic evolution of cancer, and the prevalences of associated somatic genetic variants. Here we estimate the intensity of positive selection that drives mutations to high frequency in tumors, yielding higher prevalences than expected on the basis of mutation and neutral drift alone. We apply this approach to a sample of 525 head and neck squamous cell carcinoma exomes, producing a rank-ordered list of gene variants by selection intensity. Our results illustrate the complementarity of calculating the intensity of selection on mutations along with tallying the prevalence of individual substitutions in cancer: while many of the most prevalently-altered genes were heavily selected, their relative importance to the cancer phenotype differs from their prevalence and from their P value, with some infrequent variants exhibiting evidence of strong positive selection. Furthermore, we extend our analysis of effect size by quantifying the degree to which mutational processes (such as APOBEC mutagenesis) contributes mutations that are highly selected, driving head and neck squamous cell carcinoma. We calculate the substitutions caused by APOBEC mutagenesis that make the greatest contribution to cancer phenotype among patients. Lastly, we demonstrate via in vitro biochemical experiments that the APOBEC3B protein can deaminate the cytosine bases at two sites whose mutant states are subject to high net realized selection intensities-PIK3CA E545K and E542K. By quantifying the effects of mutations, we deepen the molecular understanding of carcinogenesis in head and neck squamous cell carcinoma.	[Cannataro, Vincent L.; Gaffney, Stephen G.; Townsend, Jeffrey P.] Yale Sch Publ Hlth, Dept Biostat, New Haven, CT 06510 USA; [Sasaki, Tomoaki; Anderson, Karen S.] Yale Univ, Dept Pharmacol, New Haven, CT USA; [Issaeva, Natalia; Yarbrough, Wendell G.; Burtness, Barbara; Anderson, Karen S.] Yale Univ, Yale Canc Ctr, New Haven, CT USA; [Issaeva, Natalia; Yarbrough, Wendell G.] Yale Sch Med, Dept Surg, Div Otolaryngol, New Haven, CT USA; [Grewal, Nicholas K. S.; Townsend, Jeffrey P.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Grandis, Jennifer R.] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA USA; [Yarbrough, Wendell G.] Yale Univ, Yale Sch Med, Dept Pathol, New Haven, CT USA; [Burtness, Barbara] Yale Univ, Yale Sch Med, Dept Med, New Haven, CT USA; [Anderson, Karen S.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [Townsend, Jeffrey P.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Yale University; University of California System; University of California San Francisco; Yale University; Yale University; Yale University; Yale University	Townsend, JP (corresponding author), Yale Sch Publ Hlth, Dept Biostat, New Haven, CT 06510 USA.; Townsend, JP (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.; Townsend, JP (corresponding author), Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA.	Jeffrey.Townsend@Yale.edu	; Townsend, Jeffrey/D-6457-2017	Issaeva, Natalia/0000-0001-5483-6610; Grewal, Nicholas/0000-0001-5118-7774; Cannataro, Vincent/0000-0002-6364-7747; Gaffney, Stephen/0000-0002-5490-2945; Townsend, Jeffrey/0000-0002-9890-3907	Yale Cancer Center TTARE pilot award; American Cancer Society; NIH [R01DE023685, P50CA097190]; Department of Defence [W81XWH-15-1-0290]; Notsew Orm Sands Foundation; Gilead Sciences, Inc; NATIONAL CANCER INSTITUTE [R35CA231998, T32CA193200, P50CA097190] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023685] Funding Source: NIH RePORTER	Yale Cancer Center TTARE pilot award; American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defence; Notsew Orm Sands Foundation; Gilead Sciences, Inc(Gilead Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was funded by a Yale Cancer Center TTARE pilot award to WGY and BB, by grants from The American Cancer Society and NIH grants R01DE023685 and P50CA097190 to JRG, by award W81XWH-15-1-0290 from the Department of Defence to KA, and by support from the Notsew Orm Sands Foundation to JPT. Whole-exome sequencing of tumor tissue was supported by funding from Gilead Sciences, Inc to JRG and JPT. Funders had no role in the study design, collection, analysis or interpretation of the data, writing the manuscript, or the decision to submit the paper for publication.	Adolph MB, 2017, NUCLEIC ACIDS RES, V45, P11925, DOI 10.1093/nar/gkx832; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Alexandrov LB, 2015, NAT GENET, V47, P1402, DOI 10.1038/ng.3441; Alexandrov LB, 2014, CURR OPIN GENET DEV, V24, P52, DOI 10.1016/j.gde.2013.11.014; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Applebaum KM, 2007, JNCI-J NATL CANCER I, V99, P1801, DOI 10.1093/jnci/djm233; Bhatia A, 2015, J CLIN ONCOL, V33, P3243, DOI 10.1200/JCO.2015.61.2358; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Cannataro VL, 2018, ONCOGENE, V37, P2444, DOI 10.1038/s41388-017-0105-z; Cao S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28294; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chaussade C, 2009, BIOCHEM BIOPH RES CO, V381, P577, DOI 10.1016/j.bbrc.2009.02.081; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Davis RJ, 2014, CANCER CELL, V26, P455, DOI 10.1016/j.ccell.2014.09.013; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Faden DL, 2017, ORAL ONCOL, V74, P8, DOI 10.1016/j.oraloncology.2017.09.002; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Flores-Obando RE, 2010, BIOMARKERS, V15, P379, DOI 10.3109/13547501003797664; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Fu Y, 2015, BIOCHEM J, V471, P25, DOI 10.1042/BJ20150382; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Glaser AP, 2018, ONCOTARGET, V9, P4537, DOI 10.18632/oncotarget.23344; Grossman RL, 2016, NEW ENGL J MED, V375, P1109, DOI 10.1056/NEJMp1607591; Hajek M, 2017, CANCER-AM CANCER SOC, V123, P1778, DOI 10.1002/cncr.30570; Hammerman PS, 2015, CANCER DISCOV, V5, P239, DOI 10.1158/2159-8290.CD-14-1205; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HAUSEN HZ, 1991, SCIENCE, V254, P1167, DOI 10.1126/science.1659743; Hayes DN, 2015, J CLIN ONCOL, V33, P3227, DOI 10.1200/JCO.2015.62.1086; Hayes DN, 2015, J CLIN INVEST, V125, P462, DOI 10.1172/JCI68339; Hedberg ML, 2016, J CLIN INVEST, V126, P169, DOI 10.1172/JCI82066; Henderson S, 2014, CELL REP, V7, P1833, DOI 10.1016/j.celrep.2014.05.012; Hoopes JI, 2016, CELL REP, V14, P1273, DOI 10.1016/j.celrep.2016.01.021; Huang KL, 2018, CELL, V173, P355, DOI 10.1016/j.cell.2018.03.039; Jiron J, 2014, AM J OTOLARYNG, V35, P147, DOI 10.1016/j.amjoto.2013.09.004; Kazanov MD, 2015, CELL REP, V13, P1103, DOI 10.1016/j.celrep.2015.09.077; Kox C, 2010, LEUKEMIA, V24, P2005, DOI 10.1038/leu.2010.203; Krupar R, 2014, EUR ARCH OTO-RHINO-L, V271, P1737, DOI 10.1007/s00405-013-2693-8; Kwon YW, 2012, MOL CANCER RES, V10, P834, DOI 10.1158/1541-7786.MCR-12-0025; Lawrence M, 2009, BIOINFORMATICS, V25, P1841, DOI 10.1093/bioinformatics/btp328; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; LECHNER M, 2013, GENOME MED, V5; Lewis JS, 2018, ARCH PATHOL LAB MED, V142, P559, DOI 10.5858/arpa.2017-0286-CP; Lui VWY, 2013, CANCER DISCOV, V3, P761, DOI 10.1158/2159-8290.CD-13-0103; Martin D, 2014, ONCOTARGET, V5, P8906, DOI 10.18632/oncotarget.2417; Martincorena I, 2017, CELL, V171, P1029, DOI 10.1016/j.cell.2017.09.042; McGranahan N., 2015, SCI TRANSL MED, V7; Mirghani H, 2018, CLIN TRANSL RAD ONCO, V8, P4, DOI 10.1016/j.ctro.2017.10.005; Montgomery ND, 2018, J MOL DIAGN, V20, P123, DOI 10.1016/j.jmoldx.2017.09.008; Mori S, 2017, J VIROL, V91, DOI 10.1128/JVI.02413-16; Mori S, 2015, BIOCHEM BIOPH RES CO, V460, P555, DOI 10.1016/j.bbrc.2015.03.068; Mroz EA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001786; Nik-Zainal S, 2014, NAT GENET, V46, P487, DOI 10.1038/ng.2955; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Ramakodi MP, 2017, CANCER-AM CANCER SOC, V123, P849, DOI 10.1002/cncr.30457; Ramakodi MP, 2016, GENOMICS, V107, P76, DOI 10.1016/j.ygeno.2015.12.004; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Rosenthal R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0893-4; Rous P, 1911, J EXP MED, V13, P397, DOI 10.1084/jem.13.4.397; Seiwert TY, 2015, CLIN CANCER RES, V21, P632, DOI 10.1158/1078-0432.CCR-13-3310; Shi K, 2017, NAT STRUCT MOL BIOL, V24, P131, DOI 10.1038/nsmb.3344; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Sun W, 2018, NUCLEIC ACIDS RES, V46, P3009, DOI 10.1093/nar/gky131; Teng CL, 2012, CELL CYCLE, V11, P4059, DOI 10.4161/cc.22381; Theurer JA, 2016, PATHOL ONCOL RES, V22, P35, DOI 10.1007/s12253-015-9970-3; Venkatesan S, 2018, ANN ONCOL, V29, P563, DOI 10.1093/annonc/mdy003; Vieira VC, 2014, MBIO, V5, DOI 10.1128/mBio.02234-14; VIEIRA VC, 2013, BIOMED RES INT, V2013, P1; Wang XJ, 2011, J VIROL, V85, P3142, DOI 10.1128/JVI.02049-10; Weinberger PM, 2006, J CLIN ONCOL, V24, P736, DOI 10.1200/JCO.2004.00.3335; Weiss RA, 2011, J EXP MED, V208, P2351, DOI 10.1084/jem.20112160; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wu ES, 2016, HEAD NECK-J SCI SPEC, V38, P1234, DOI 10.1002/hed.24420	78	53	53	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 2	2019	38	18					3475	3487		10.1038/s41388-018-0657-6	http://dx.doi.org/10.1038/s41388-018-0657-6			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HW3RI	30647454	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000466610000011
J	Schrader, JM; Irving, CM; Octeau, JC; Christian, JA; Aballo, TJ; Kareemo, DJ; Conti, J; Camberg, JL; Lane, JR; Javitch, JA; Kovoor, A				Schrader, Joseph M.; Irving, Craig M.; Octeau, J. Christopher; Christian, Joseph A.; Aballo, Timothy J.; Kareemo, Dean J.; Conti, Joseph; Camberg, Jodi L.; Lane, J. Robert; Javitch, Jonathan A.; Kovoor, Abraham			The differential actions of clozapine and other antipsychotic drugs on the translocation of dopamine D2 receptors to the cell surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						D2 dopamine receptor; protein misfolding; G protein-coupled receptor (GPCR); receptor trafficking; schizophrenia; antipsychotic drug; clozapine; pharmacological chaperone; pharmacoperone; receptor up-regulation; receptor supersensitivity	ISOFORMS; BINDING; SUPERSENSITIVITY; GLYCOSYLATION; LOCALIZATION; HALOPERIDOL; TRAFFICKING; EXPRESSION; PSYCHOSIS; PATHWAYS	Most clinically available antipsychotic drugs (APDs) bind dopamine D2 receptors (D2R) at therapeutic concentrations, and it is thought that they suppress psychotic symptoms by serving as competitive antagonists of dopamine at D2R. Here, we present data that demonstrate that APDs act independently of dopamine at an intracellular pool of D2R to enhance transport of D2R to the cell surface and suggest that APDs can act as pharmacological chaperones at D2R. Among the first- and second-generation APDs that we tested, clozapine exhibited the lowest efficacy for translocating D2R to the cell surface. Thus, our observations could provide a cellular explanation for some of the distinct therapeutic characteristics of clozapine in schizophrenia. They also suggest that differential intracellular actions of APDs at their common G protein-coupled receptor (GPCR) target, D2R, could contribute to differences in their clinical profiles.	[Schrader, Joseph M.; Irving, Craig M.; Octeau, J. Christopher; Christian, Joseph A.; Aballo, Timothy J.; Kareemo, Dean J.; Kovoor, Abraham] Univ Rhode Isl, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA; [Conti, Joseph; Camberg, Jodi L.] Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA; [Lane, J. Robert] Univ Nottingham, Sch Life Sci, Queens Med Ctr, Div Pharmacol Physiol & Neurosci, Nottingham NG7 2UH, England; [Lane, J. Robert] Univ Birmingham, Ctr Membrane Prot & Receptors, Birmingham, W Midlands, England; [Lane, J. Robert] Univ Nottingham, Nottingham, England; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Psychiat, 722 W 168th St, New York, NY 10032 USA; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Pharmacol, 630 W 168th St, New York, NY 10032 USA; [Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA	University of Rhode Island; University of Rhode Island; University of Nottingham; University of Birmingham; University of Nottingham; Columbia University; Columbia University; New York State Psychiatry Institute	Kovoor, A (corresponding author), Univ Rhode Isl, Coll Pharm, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA.	abekovoor@uri.edu	Camberg, Jodi/AAX-3737-2020	Kareemo, Dean/0000-0002-9575-0407; Lane, J. Robert/0000-0002-7361-7875; Aballo, Timothy/0000-0003-1164-5966; Octeau, Chris/0000-0001-6462-9439	Institutional Development Award (IDeA) Network for Biomedical Research Excellence from the NIGMS, National Institutes of Health [P20GM103430]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103430] Funding Source: NIH RePORTER	Institutional Development Award (IDeA) Network for Biomedical Research Excellence from the NIGMS, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Institutional Development Award (IDeA) Network for Biomedical Research Excellence from the NIGMS, National Institutes of Health, Grant P20GM103430. Abraham Kovoor is a co-founder and owns shares of Cortagenix, LLC, a neuroscience drug-discovery company. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen JA, 2011, P NATL ACAD SCI USA, V108, P18488, DOI 10.1073/pnas.1104807108; Arshavsky Vadim Y, 2014, Cell Logist, V4, pe29390; Beaulieu JM, 2015, BRIT J PHARMACOL, V172, P1, DOI 10.1111/bph.12906; Bernier V, 2006, J AM SOC NEPHROL, V17, P232, DOI 10.1681/ASN.2005080854; Boxberger KH, 2014, DRUG METAB DISPOS, V42, P990, DOI 10.1124/dmd.113.055095; Celver J, 2012, J NEUROCHEM, V120, P56, DOI 10.1111/j.1471-4159.2011.07559.x; Celver J, 2010, J NEUROCHEM, V114, P739, DOI 10.1111/j.1471-4159.2010.06805.x; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; deOliveira IR, 1996, J CLIN PHARM THER, V21, P229; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; FISHBURN CS, 1995, J BIOL CHEM, V270, P29819; Free RB, 2007, J BIOL CHEM, V282, P21285, DOI 10.1074/jbc.M701555200; Friedman JH, 2013, BEHAV NEUROL, V27, P469, DOI [10.1155/2013/645429, 10.3233/BEN-129016]; Garzya V, 2007, BIOORG MED CHEM LETT, V17, P400, DOI 10.1016/j.bmcl.2006.10.036; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Herenbrink CK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10842; JUDD AM, 1991, EUR J PHARMACOL, V195, P101, DOI 10.1016/0014-2999(91)90386-5; Kang X, 2010, J CLIN PSYCHIAT, V71, P982, DOI 10.4088/JCP.09com05497yel; Kapur S, 2000, J PSYCHIATR NEUROSCI, V25, P161; Kapur S, 2003, PROG NEURO-PSYCHOPH, V27, P1081, DOI 10.1016/j.pnpbp.2003.09.004; Kobayashi H, 2009, TRAFFIC, V10, P1019, DOI 10.1111/j.1600-0854.2009.00932.x; Kovoor A, 2005, J NEUROSCI, V25, P2157, DOI 10.1523/JNEUROSCI.2840-04.2005; Kubale V, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071152; Kumagai H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129394; Lan TH, 2012, TRAFFIC, V13, P1450, DOI 10.1111/j.1600-0854.2012.01401.x; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Lewis S, 2008, BRIT J PSYCHIAT, V192, P161, DOI 10.1192/bjp.bp.107.037218; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Masuho Ikuo, 2015, Methods Mol Biol, V1335, P107, DOI 10.1007/978-1-4939-2914-6_8; Meltzer HY, 2013, ANNU REV MED, V64, P393, DOI 10.1146/annurev-med-050911-161504; Meltzer Herbert Y, 2012, Clin Schizophr Relat Psychoses, V6, P134; Min CC, 2015, BBA-MOL CELL RES, V1853, P41, DOI 10.1016/j.bbamcr.2014.09.024; MONSMA FJ, 1989, NATURE, V342, P926, DOI 10.1038/342926a0; Mouillac B., 2017, TOPICS MED CHEM, P1; Octeau JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105791; Peprah K, 2012, BIOORGAN MED CHEM, V20, P1291, DOI 10.1016/j.bmc.2011.12.019; Pereira JND, 2014, AAPS J, V16, P1247, DOI 10.1208/s12248-014-9649-9; Prou D, 2001, J CELL SCI, V114, P3517; Sahlholm K, 2016, EUR NEUROPSYCHOPHARM, V26, P467, DOI 10.1016/j.euroneuro.2016.01.001; Samad TA, 1997, P NATL ACAD SCI USA, V94, P14349, DOI 10.1073/pnas.94.26.14349; Samaha AN, 2007, J NEUROSCI, V27, P2979, DOI 10.1523/JNEUROSCI.5416-06.2007; Scatton B, 2001, EUR PSYCHIAT, V16, p29S; Sedaghat K, 2006, MOL BIOTECHNOL, V34, P1, DOI 10.1385/MB:34:1:1; SEEMAN P, 1988, J CLIN PSYCHOPHARM, V8, pS3, DOI 10.1097/00004714-198808001-00002; SEEMAN P, 1975, P NATL ACAD SCI USA, V72, P4376, DOI 10.1073/pnas.72.11.4376; SEEMAN P, 1976, NATURE, V261, P717, DOI 10.1038/261717a0; Seeman P, 2014, ACS CHEM NEUROSCI, V5, P24, DOI 10.1021/cn400189s; Sharma M, 2013, J BIOL CHEM, V288, P12554, DOI 10.1074/jbc.M112.443945; Silvestri S, 2000, PSYCHOPHARMACOLOGY, V152, P174, DOI 10.1007/s002130000532; Siskind D, 2016, BRIT J PSYCHIAT, V209, P387, DOI 10.1192/bjp.bp.115.177261; Stahl S. M., 2013, STAHLS ESSENTIAL PSY, P180; Suzuki T, 2015, PSYCHIAT RES, V227, P278, DOI 10.1016/j.psychres.2015.02.021; Sykes DA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00716-z; Takeuchi Y, 2003, J NEUROCHEM, V85, P1064, DOI 10.1046/j.1471-4159.2003.01763.x; Tao YX, 2014, ENDOCR REV, V35, P602, DOI 10.1210/er.2013-1121; Trifilieff P, 2011, BIOTECHNIQUES, V51, P111, DOI 10.2144/000113719; Ulloa-Aguirre A, 2011, RECENT PATENTS ENDOC, V5, P13, DOI 10.2174/187221411794351851; VENTRA C, 1995, J MOL ENDOCRINOL, V14, P375, DOI 10.1677/jme.0.0140375; Wenthur CJ, 2013, ACS CHEM NEUROSCI, V4, P1018, DOI 10.1021/cn400121z; Wisler JW, 2014, CURR OPIN CELL BIOL, V27, P18, DOI 10.1016/j.ceb.2013.10.008; Zurek N, 2011, TRAFFIC, V12, P28, DOI 10.1111/j.1600-0854.2010.01134.x	63	7	7	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5604	5615		10.1074/jbc.RA118.004682	http://dx.doi.org/10.1074/jbc.RA118.004682			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology	HT4EU	30670597	Green Published, hybrid			2022-12-26	WOS:000464517500029
J	Mero, B; Radnai, L; Gogl, G; Toke, O; Leveles, I; Koprivanacz, K; Szeder, B; Dulk, M; Kudlik, G; Vas, V; Cserkaszky, A; Sipeki, S; Nyitray, L; Vertessy, BG; Buday, L				Mero, Balazs; Radnai, Laszlo; Gogl, Gergo; Toke, Orsolya; Leveles, Ibolya; Koprivanacz, Kitti; Szeder, Balint; Dulk, Metta; Kudlik, Gyoengyi; Vas, Virag; Cserkaszky, Anna; Sipeki, Szabolcs; Nyitray, Laszlo; Vertessy, Beata G.; Buday, Laszlo			Structural insights into the tyrosine phosphorylation-mediated inhibition of SH3 domain-ligand interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphotyrosine signaling; ABL tyrosine kinase; Src homology 3 domain (SH3 domain); X-ray crystallography; nuclear magnetic resonance (NMR); 3BP-2; ABI2; ligand binding; post translational modification (PTM); protein phosphorylation; small-angle X-ray scattering (SAXS)	C-ABL KINASE; RESOLUTION CRYSTAL-STRUCTURES; SRC FAMILY KINASES; CIRCULAR-DICHROISM; HETERONUCLEAR NMR; BACKBONE DYNAMICS; PROTEIN; BINDING; ACTIVATION; GRB2	Src homology 3 (SH3) domains bind proline-rich linear motifs in eukaryotes. By mediating inter- and intramolecular interactions, they regulate the functions of many proteins involved in a wide variety of signal transduction pathways. Phosphorylation at different tyrosine residues in SH3 domains has been reported previously. In several cases, the functional consequences have also been investigated. However, a full understanding of the effects of tyrosine phosphorylation on the ligand interactions and cellular functions of SH3 domains requires detailed structural, atomic-resolution studies along with biochemical and biophysical analyses. Here, we present the first crystal structures of tyrosine-phosphorylated human SH3 domains derived from the Abelson-family kinases ABL1 and ABL2 at 1.6 and 1.4 angstrom resolutions, respectively. The structures revealed that simultaneous phosphorylation of Tyr(89) and Tyr(134) in ABL1 or the homologous residues Tyr(116) and Tyr(161) in ABL2 induces only minor structural perturbations. Instead, the phosphate groups sterically blocked the ligand-binding grooves, thereby strongly inhibiting the interaction with proline-rich peptide ligands. Although some crystal contact surfaces involving phosphotyrosines suggested the possibility of tyrosine phosphorylation-induced dimerization, we excluded this possibility by using small-angle X-ray scattering (SAXS), dynamic light scattering (DLS), and NMR relaxation analyses. Extensive analysis of relevant databases and literature revealed not only that the residues phosphorylated in our model systems are well-conserved in other human SH3 domains, but that the corresponding tyrosines are known phosphorylation sites in vivo in many cases. We conclude that tyrosine phosphorylation might be a mechanism involved in the regulation of the human SH3 interactome.	[Mero, Balazs; Radnai, Laszlo; Leveles, Ibolya; Koprivanacz, Kitti; Szeder, Balint; Dulk, Metta; Kudlik, Gyoengyi; Vas, Virag; Cserkaszky, Anna; Vertessy, Beata G.; Buday, Laszlo] Hungarian Acad Sci, RCNS, Inst Enzymol, Magyar Tudosok Korutja 2, H-1117 Budapest, Hungary; [Toke, Orsolya] Hungarian Acad Sci, RCNS, Lab NMR Spect, Magyar Tudosok Korutja 2, H-1117 Budapest, Hungary; [Gogl, Gergo; Nyitray, Laszlo] Eotvos Lorand Univ, Dept Biochem, Pazmany Peter Setany 1-C, H-1117 Budapest, Hungary; [Leveles, Ibolya; Vertessy, Beata G.] Budapest Univ Technol & Econ, Dept Appl Biotechnol & Food Sci, Szt Gellert ter 4, H-1111 Budapest, Hungary; [Sipeki, Szabolcs; Buday, Laszlo] Semmelweis Univ, Sch Med, Dept Med Chem, Tuzolto U 37-47, H-1094 Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Hungarian Academy of Sciences; Eotvos Lorand University; Budapest University of Technology & Economics; Semmelweis University	Buday, L (corresponding author), Hungarian Acad Sci, RCNS, Inst Enzymol, Magyar Tudosok Korutja 2, H-1117 Budapest, Hungary.; Radnai, L (corresponding author), Scripps Res Inst, Dept Mol Med, 130 Scripps Way, Jupiter, FL 33458 USA.	lradnai@scripps.edu; buday.laszlo@ttk.mta.hu	Vas, Virag/B-8067-2016; Gogl, Gergo/ABH-4309-2020; Nyitray, László/AAE-5910-2020	Vas, Virag/0000-0001-7249-6816; Gogl, Gergo/0000-0002-8597-3711; Nyitray, László/0000-0003-4717-5994; Mero, Balazs/0000-0001-9517-6460; Radnai, Laszlo/0000-0001-6843-3740; Szeder, Balint/0000-0003-3264-3900; Dulk, Metta/0000-0001-9364-2587; Vertessy, Beata G./0000-0002-1288-2982	BioStruct-X	BioStruct-X	We thank Laszlo Drahos and Oliver Ozohanics (Instrumentation Center, MTA TTK) for help in MS measurements. Special thanks are due to Zita Solti for assistance in the expression and purification of recombinant proteins, Protein crystallization and in-house X-ray scattering experiments were performed at the Biostruct Laboratory. We thank BioStruct-X for funding the X-ray crystallography and small-angle X-ray scattering measurements in EMBL Hamburg and ESRF Grenoble.	Adams G, 2016, J BIOL CHEM, V291, P20692, DOI 10.1074/jbc.M116.732719; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andreotti AH, 1997, NATURE, V385, P93, DOI 10.1038/385093a0; Anselmi F, 2012, ANGIOGENESIS, V15, P187, DOI 10.1007/s10456-012-9252-6; Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; Barreira M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004993; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; Broome MA, 1997, ONCOGENE, V14, P17, DOI 10.1038/sj.onc.1200798; Chen S, 2008, J MOL BIOL, V383, P414, DOI 10.1016/j.jmb.2008.08.040; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; Dionne U, 2018, MOL CELL, V70, P995, DOI 10.1016/j.molcel.2018.05.013; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan HP, 2013, J BIOL CHEM, V288, P3322, DOI 10.1074/jbc.M112.420497; Fan PD, 2003, CANCER RES, V63, P873; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Gmeiner WH, 2001, CELL BIOCHEM BIOPHYS, V35, P127, DOI 10.1385/CBB:35:2:127; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Haines E, 2009, MOL CELL BIOL, V29, P2505, DOI 10.1128/MCB.00034-09; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; JOHN BK, 1992, J MAGN RESON, V98, P200, DOI 10.1016/0022-2364(92)90125-Q; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kristensen O, 2006, EMBO J, V25, P785, DOI 10.1038/sj.emboj.7600982; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Kurochkina Natalya, 2013, Biophys Rev, V5, P29, DOI 10.1007/s12551-012-0081-z; Levinson NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007683; Li SG, 2001, EMBO J, V20, P6793, DOI 10.1093/emboj/20.23.6793; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; Maru Y, 1996, J BIOL CHEM, V271, P15353, DOI 10.1074/jbc.271.26.15353; Matsumura Y, 2013, BIOPHYS CHEM, V175, P39, DOI 10.1016/j.bpc.2013.02.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyn MA, 2006, J BIOL CHEM, V281, P30907, DOI 10.1074/jbc.M605902200; Micsonai A, 2018, NUCLEIC ACIDS RES, V46, pW315, DOI 10.1093/nar/gky497; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Morrogh LM, 1999, EUR J IMMUNOL, V29, P2269; MUSACCHIO A, 1994, NAT STRUCT BIOL, V1, P546, DOI 10.1038/nsb0894-546; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nisitani S, 1999, P NATL ACAD SCI USA, V96, P2221, DOI 10.1073/pnas.96.5.2221; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Ross B, 2007, BIOCHEM BIOPH RES CO, V353, P463, DOI 10.1016/j.bbrc.2006.12.044; Saksela K, 2012, FEBS LETT, V586, P2609, DOI 10.1016/j.febslet.2012.04.042; Sato M, 2011, FEBS LETT, V585, P834, DOI 10.1016/j.febslet.2011.02.012; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith KM, 2001, J BIOL CHEM, V276, P24372, DOI 10.1074/jbc.M100786200; Srinivasan D, 2009, CELL SIGNAL, V21, P1143, DOI 10.1016/j.cellsig.2009.03.003; Steen H, 2003, MOL CELL PROTEOMICS, V2, P138, DOI 10.1074/mcp.M300001-MCP200; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tatarova Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036310; Wahl MI, 1997, P NATL ACAD SCI USA, V94, P11526, DOI 10.1073/pnas.94.21.11526; Wilcox HM, 2003, J BIOL CHEM, V278, P37112, DOI 10.1074/jbc.M304811200; Wilson MB, 2002, ONCOGENE, V21, P8075, DOI 10.1038/sj.onc.1206008; Woessner DW, 2015, LEUKEMIA, V29, P1668, DOI 10.1038/leu.2015.53; Wu XY, 2005, DEV CELL, V9, P185, DOI 10.1016/j.devcel.2005.06.006	61	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4608	4620		10.1074/jbc.RA118.004732	http://dx.doi.org/10.1074/jbc.RA118.004732			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30659095	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-26	WOS:000462969500027
J	Wang, PC; Leng, JP; Wang, YS				Wang, Pengcheng; Leng, Jiapeng; Wang, Yinsheng			DNA replication studies of N-nitroso compound-induced O-6-alkyl-2-deoxyguanosine lesions in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA polymerase; DNA replication; DNA damage; mutagenesis; mass spectrometry (MS); DNA alkylation; N-nitroso compounds; translesion synthesis	TANDEM MASS-SPECTROMETRY; TRANSLESION SYNTHESIS; MUTAGENIC PROPERTIES; IN-VITRO; ADDUCTS; BYPASS; 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE; REPAIR; RATS; PYRIDYLOXOBUTYL	N-Nitroso compounds (NOCs) are common DNA-alkylating agents, are abundantly present in food and tobacco, and can also be generated endogenously. Metabolic activation of some NOCs can give rise to carboxymethylation and pyridyloxobutylation/pyridylhydroxybutylation of DNA, which are known to be carcinogenic and can lead to gastrointestinal and lung cancer, respectively. Herein, using the competitive replication and adduct bypass (CRAB) assay, along with MS- and NMR-based approaches, we assessed the cytotoxic and mutagenic properties of three O-6-alkyl-2-deoxyguanosine (O-6-alkyl-dG) adducts, i.e. O-6-pyridyloxobutyl-dG (O-6-POB-dG) and O-6-pyridylhydroxybutyl-dG (O-6-PHB-dG), derived from tobacco-specific nitrosamines, and O-6-carboxymethyl-dG (O-6-CM-dG), induced by endogenous N-nitroso compounds. We also investigated two neutral analogs of O-6-CM-dG, i.e. O-6-aminocarbonylmethyl-dG (O-6-ACM-dG) and O-6-hydroxyethyl-dG (O-6-HOEt-dG). We found that, in Escherichia coli cells, these lesions mildly (O-6-POB-dG), moderately (O-6-PHB-dG), or strongly (O-6-CM-dG, O-6-ACM-dG, and O-6-HOEt-dG) impede DNA replication. The strong blockage effects of the last three lesions were attributable to the presence of hydrogen-bonding donor(s) located on the alkyl functionality of these lesions. Except for O-6-POB-dG, which also induced a low frequency of G T transversions, all other lesions exclusively stimulated G A transitions. SOS-induced DNA polymerases played redundant roles in bypassing all the O-6-alkyl-dG lesions investigated. DNA polymerase IV (Pol IV) and Pol V, however, were uniquely required for inducing the G A transition for O-6-CM-dG exposure. Together, our study expands our knowledge about the recognition of important NOC-derived O-6-alkyl-dG lesions by the E. coli DNA replication machinery.	[Wang, Pengcheng; Leng, Jiapeng; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Wang, Pengcheng] Univ Jinan, Inst Surface Anal & Chem Biol, Jinan 250022, Shandong, Peoples R China	University of California System; University of California Riverside; University of Jinan	Wang, YS (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	Yinsheng.Wang@ucr.edu	Wang, Yin/HCI-9352-2022	Wang, Pengcheng/0000-0003-4581-983X	National Institutes of Health [R01 ES025121]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES025121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grant R01 ES025121. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balbo S, 2014, CARCINOGENESIS, V35, P2798, DOI 10.1093/carcin/bgu204; BOGOVSKI P, 1981, INT J CANCER, V27, P471, DOI 10.1002/ijc.2910270408; BUSBY WF, 1985, CANCER RES, V45, P1367; Carlson ES, 2018, CHEM RES TOXICOL, V31, P358, DOI 10.1021/acs.chemrestox.8b00056; Choi JY, 2008, J BIOL CHEM, V283, P23645, DOI 10.1074/jbc.M801686200; Choi JY, 2006, J BIOL CHEM, V281, P38244, DOI 10.1074/jbc.M608369200; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; Cross AJ, 2003, CANCER RES, V63, P2358; de Groot PM, 2018, TRANSL LUNG CANCER R, V7, P220, DOI 10.21037/tlcr.2018.05.06; Delaney JC, 2006, METHOD ENZYMOL, V408, P1, DOI 10.1016/S0076-6879(06)08001-3; Du H, 2018, J BIOL CHEM, V293, P11100, DOI 10.1074/jbc.RA118.003477; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; Fuchs RP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012682; Gottschalg E, 2007, CARCINOGENESIS, V28, P356, DOI 10.1093/carcin/bgl150; Harrison KL, 1999, CHEM RES TOXICOL, V12, P106, DOI 10.1021/tx980057n; Harrison KL, 1997, CHEM RES TOXICOL, V10, P652, DOI 10.1021/tx960203u; Hecht SS, 1998, CHEM RES TOXICOL, V11, P559, DOI 10.1021/tx980005y; International Agency for Research on Cancer, 2007, IARC MONOGR EVAL CAR, V89; Jakszyn P, 2006, CARCINOGENESIS, V27, P1497, DOI 10.1093/carcin/bgl019; Janion C, 2008, INT J BIOL SCI, V4, P338; Johnson SJ, 2004, CELL, V116, P803, DOI 10.1016/S0092-8674(04)00252-1; Lao YB, 2007, CHEM RES TOXICOL, V20, P246, DOI 10.1021/tx060208j; Lao YB, 2006, CHEM RES TOXICOL, V19, P674, DOI 10.1021/tx050351x; Leng JP, 2017, ANAL CHEM, V89, P9124, DOI 10.1021/acs.analchem.7b01857; Lewin MH, 2006, CANCER RES, V66, P1859, DOI 10.1158/0008-5472.CAN-05-2237; LI BFL, 1989, BIOCHEMISTRY-US, V28, P5779, DOI 10.1021/bi00440a012; Li L, 2009, CHEM RES TOXICOL, V22, P1464, DOI 10.1021/tx9001572; Meikrantz W, 1998, CARCINOGENESIS, V19, P369, DOI 10.1093/carcin/19.2.369; Minko IG, 2008, CHEM RES TOXICOL, V21, P1983, DOI 10.1021/tx800174a; MIRVISH SS, 1995, CANCER LETT, V93, P17, DOI 10.1016/0304-3835(95)03786-V; Neeley WL, 2007, J BIOL CHEM, V282, P12741, DOI 10.1074/jbc.M700575200; Pauly GT, 2002, CHEM RES TOXICOL, V15, P165, DOI 10.1021/tx0101245; Peterson LA, 2001, CANCER RES, V61, P5757; PETERSON LA, 1991, CANCER RES, V51, P5557; RONAI ZA, 1993, CARCINOGENESIS, V14, P2419, DOI 10.1093/carcin/14.11.2419; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Shrivastav N, 2010, CARCINOGENESIS, V31, P59, DOI 10.1093/carcin/bgp262; SMITH CA, 1990, CARCINOGENESIS, V11, P811, DOI 10.1093/carcin/11.5.811; SWANN PF, 1990, MUTAT RES, V233, P81, DOI 10.1016/0027-5107(90)90153-U; Tricker AR, 1997, EUR J CANCER PREV, V6, P226, DOI 10.1097/00008469-199706000-00003; Upadhyaya P, 2008, CHEM RES TOXICOL, V21, P1468, DOI 10.1021/tx8001109; Urban AM, 2012, CHEM RES TOXICOL, V25, P2167, DOI 10.1021/tx300245w; Vaisman Alexandra, 2012, EcoSal Plus, V5, DOI 10.1128/ecosalplus.7.2.2; Wang JS, 2010, NUCLEIC ACIDS RES, V38, P6774, DOI 10.1093/nar/gkq458; Wang JS, 2009, NUCLEIC ACIDS RES, V37, P336, DOI 10.1093/nar/gkn946; Wang LJ, 1999, CHEM RES TOXICOL, V12, P127, DOI 10.1021/tx980251+; Wang PC, 2018, J BIOL CHEM, V293, P15033, DOI 10.1074/jbc.RA118.004676; Wang PC, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv941; Warren JJ, 2006, P NATL ACAD SCI USA, V103, P19701, DOI 10.1073/pnas.0609580103; Washington MT, 2004, MOL CELL BIOL, V24, P5687, DOI 10.1128/MCB.24.13.5687-5693.2004; Wu J, 2017, NUCLEIC ACIDS RES, V45, P7276, DOI 10.1093/nar/gkx442; Xu YZ, 2000, TETRAHEDRON, V56, P6075, DOI 10.1016/S0040-4020(00)00556-1; Yang J, 2016, CHEM RES TOXICOL, V29, P87, DOI 10.1021/acs.chemrestox.5b00425; Yu Y, 2016, ANAL CHEM, V88, P8036, DOI 10.1021/acs.analchem.6b01349; Yuan BF, 2008, P NATL ACAD SCI USA, V105, P8679, DOI 10.1073/pnas.0711546105; Yuan BF, 2011, J BIOL CHEM, V286, P17503, DOI 10.1074/jbc.M111.232835; Zhai QQ, 2014, NUCLEIC ACIDS RES, V42, P10529, DOI 10.1093/nar/gku748; Zhang F, 2013, NUCLEIC ACIDS RES, V41, P5524, DOI 10.1093/nar/gkt198; Zhang SY, 2009, CHEM RES TOXICOL, V22, P926, DOI 10.1021/tx900015d	59	8	8	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					3899	3908		10.1074/jbc.RA118.007358	http://dx.doi.org/10.1074/jbc.RA118.007358			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30655287	Green Published, hybrid			2022-12-26	WOS:000461854400008
J	Haddad, M; Prince, MS; Zarrouk, N; Tabben, M; Behm, DG; Chamari, K				Haddad, Monoem; Prince, Mohammad Shoaib; Zarrouk, Nidhal; Tabben, Montassar; Behm, David G.; Chamari, Karim			Dynamic stretching alone can impair slower velocity isokinetic performance of young male handball players for at least 24 hours	PLOS ONE			English	Article							VERTICAL JUMP PERFORMANCE; WARM-UP; STATIC STRETCH; SPRINT PERFORMANCE; FORCE-VELOCITY; MUSCLE DAMAGE; REACTION-TIME; JOINT-ANGLE; PEAK TORQUE; ACUTE BOUT	There are many adult studies reporting static stretch (SS)-induced deficits and dynamic stretch (DS) performance improvements shortly after the intervention. However, there is only a single study examining stretch-induced performance changes with youth at 24 hours' post-stretch. The objective of this study was to examine physiological responses of young trained athletes at 24-hours after experiencing SS or DS protocols. Eight young male, elite handball players (age: 16.1 +/- 5.1 years) were tested prior to-, 3-minutes and 24-hours following the three conditions (DS, SS, Control) in a randomized and counterbalanced order. Similar volumes of SS (2 repetitions of 75s for each leg) and DS (5 repetitions of 30s for each leg) involved one stretch each for the quadriceps and hamstrings. Tests included (i) two 4s maximal voluntary isometric contractions (MVC) at 60 degrees of knee flexion with 2-min rest, (ii) two maximal isokinetic contractions each at 60 degrees/sec and 300 degrees/sec with 1-min rest, and (iii) two drop jumps with 30-sec rest. To simulate a full warm-up, dynamic activity including 5 minutes of aerobic cycling (70 rpm; 1 kilopond), 4 submaximal isometric contractions and 4 drop jumps were instituted before the pre-tests and following the interventions. Two-way repeated measures ANOVAs revealed that 1) both the SS and control conditions exhibited knee extensor 60 degrees.s(-1) (SS:-10.3%; p = 0.04, Control: -8.7%; p = 0.07) and 300 degrees.s(-1) (SS: -12.9%; p = 0.005, Control: -16.3%; p = 0.02) isokinetic deficits at post-test, 2) DS impaired knee flexor 60 degrees.s(-1) isokinetic work and power-related measures at post-test (Work: -10.1%; p = 0.0006; Power: -19.1%; p = 0.08) and at 24-hours' post-test (Work: 9.9%; p = 0.023; Power: -9.6%; p = 0.01), 3) DS (12.07% and 10.47%) and SS (13.7% and 14.6%) enhanced knee flexor 300 degrees.s(-1) isokinetic force and power-related measures compared to control. In conclusion, testing-induced knee extensor isokinetic impairments were counterbalanced by DS, however the hip flexion DS could have produced minor muscle damage for at least 24-hours decreasing knee flexor forces and power at 60 degrees.s(-1).	[Haddad, Monoem; Prince, Mohammad Shoaib] Qatar Univ, Coll Arts & Sci, Sport Sci Program, Doha, Qatar; [Zarrouk, Nidhal] Aspetar Orthoped & Sports Med Hosp, Excellence Football Project, Natl Sports Med Programme, Doha, Qatar; [Tabben, Montassar] Aspetar Orthoped & Sports Med Hosp, ASPREV Dept, Doha, Qatar; [Behm, David G.] Mem Univ Newfoundland, Sch Human Kinet & Recreat, St John, NF, Canada; [Chamari, Karim] Qatar Orthopaed & Sports Med Hosp, Aspetar, AHP Res Ctr, Doha, Qatar	Qatar University; Aspetar Orthopaedic & Sports Medicine Hospital; Aspetar Orthopaedic & Sports Medicine Hospital; Memorial University Newfoundland; Aspetar Orthopaedic & Sports Medicine Hospital	Behm, DG (corresponding author), Mem Univ Newfoundland, Sch Human Kinet & Recreat, St John, NF, Canada.	dbehm@mun.ca	Behm, David George/I-6509-2019; Haddad, Monoem/D-4999-2014; CHAMARI, Karim/AAJ-7938-2021	Behm, David George/0000-0002-9406-6056; Haddad, Monoem/0000-0001-5989-1627; CHAMARI, Karim/0000-0001-9178-7678	Qatar University - University Grant [QUUG-CAS-DSSP-15\16-15]; Qatar National Library	Qatar University - University Grant; Qatar National Library(Qatar National Research Fund (QNRF))	This work was supported by Qatar University - University Grant QUUG-CAS-DSSP-15\16-15. The publication of this article was funded by the Qatar National Library.	Alter M.J., 1996, SCI FLEXIBILITY; Ayala F, 2014, J SPORT SCI, V32, P817, DOI 10.1080/02640414.2013.861606; Behm DG, 2007, EUR J APPL PHYSIOL, V101, P587, DOI 10.1007/s00421-007-0533-5; Behm DG, 2016, APPL PHYSIOL NUTR ME, V41, P1, DOI 10.1139/apnm-2015-0235; Behm DG, 2011, APPL PHYSIOL NUTR ME, V36, P790, DOI [10.1139/h11-107, 10.1139/H11-107]; Behm DG, 2011, EUR J APPL PHYSIOL, V111, P2633, DOI 10.1007/s00421-011-1879-2; Behm DG, 2016, EUR J APPL PHYSIOL, V116, P241, DOI 10.1007/s00421-015-3270-1; Behm DG, 2006, J SPORT SCI MED, V5, P33; Behm DG, 2004, MED SCI SPORT EXER, V36, P1397, DOI 10.1249/01.MSS.0000135788.23012.5F; Behm DG, 2004, CAN J APPL PHYSIOL, V29, P274, DOI 10.1139/h04-019; Behm DG, 2001, CAN J APPL PHYSIOL, V26, P261, DOI 10.1139/h01-017; Behm DG, 2001, J STRENGTH COND RES, V15, P255; Bishop D, 2003, SPORTS MED, V33, P439, DOI 10.2165/00007256-200333060-00005; Blazevich AJ, 2018, MED SCI SPORT EXER, V50, P1258, DOI 10.1249/MSS.0000000000001539; Bradley PS, 2007, J STRENGTH COND RES, V21, P223, DOI 10.1519/00124278-200702000-00040; BROOKS SV, 1995, J PHYSIOL-LONDON, V488, P459, DOI 10.1113/jphysiol.1995.sp020980; Chaouachi A, 2008, EUR J APPL PHYSIOL, V104, P515, DOI 10.1007/s00421-008-0799-2; Chaouachi A, 2010, J STRENGTH COND RES, V24, P2001, DOI 10.1519/JSC.0b013e3181aeb181; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costa PB, 2014, MED SCI SPORT EXER, V46, P586, DOI 10.1249/MSS.0000000000000138; Costa PB, 2009, J STRENGTH COND RES, V23, P141, DOI 10.1519/JSC.0b013e31818eb052; Cramer JT, 2007, J ORTHOP SPORT PHYS, V37, P130, DOI 10.2519/jospt.2007.2389; Cramer JT, 2004, J STRENGTH COND RES, V18, P236, DOI 10.1519/00124278-200405000-00006; Curry BS, 2009, J STRENGTH COND RES, V23, P1811, DOI 10.1519/JSC.0b013e3181b73c2b; de Hoyo M, 2016, J SPORT SCI, V34, P1363, DOI 10.1080/02640414.2016.1150603; DEKONING FL, 1985, EUR J APPL PHYSIOL O, V54, P89, DOI 10.1007/BF00426305; Duncan M.J., 2006, J EXERC PHYSL, V9, P9; Faigenbaum AD, 2010, PEDIATR EXERC SCI, V22, P266, DOI 10.1123/pes.22.2.266; Falk B, 2006, EXERC SPORT SCI REV, V34, P107, DOI 10.1249/00003677-200607000-00004; Fletcher IM, 2007, J STRENGTH COND RES, V21, P784; Fletcher IM, 2010, EUR J APPL PHYSIOL, V109, P491, DOI 10.1007/s00421-010-1386-x; Fletcher IM, 2004, J STRENGTH COND RES, V18, P885; Fowles JR, 2000, J APPL PHYSIOL, V89, P1179, DOI 10.1152/jappl.2000.89.3.1179; Haddad M, 2014, J STRENGTH COND RES, V28, P140, DOI 10.1519/JSC.0b013e3182964836; Haghshenas R T-B I., 2014, INT J SPORT STUDIES, V4, P907; Halperin I, 2018, INT J SPORT PHYSIOL, V13, P127, DOI 10.1123/ijspp.2017-0322; Herda TJ, 2013, J SPORT SCI, V31, P479, DOI 10.1080/02640414.2012.736632; Hermens HJ., 1999, EUROPEAN RECOMMENDAT, DOI DOI 10.1016/S1050-6411(00)00027-4; Hough PA, 2009, J STRENGTH COND RES, V23, P507, DOI 10.1519/JSC.0b013e31818cc65d; Huijing PA, 1999, J BIOMECH, V32, P329, DOI 10.1016/S0021-9290(98)00186-9; INGEMANNHANSEN T, 1979, SCAND J REHABIL MED, V11, P85; Jaggers JR, 2008, J STRENGTH COND RES, V22, P1844, DOI 10.1519/JSC.0b013e3181854a3d; Janes WCI, 2016, APPL PHYSIOL NUTR ME, V41, P1052, DOI 10.1139/apnm-2016-0241; Kay AD, 2008, EUR J SPORT SCI, V8, P41, DOI 10.1080/17461390701855505; Kay AD, 2012, MED SCI SPORT EXER, V44, P154, DOI 10.1249/MSS.0b013e318225cb27; Kay AD, 2010, J APPL PHYSIOL, V108, P637, DOI 10.1152/japplphysiol.01135.2009; Kay AD, 2009, J APPL PHYSIOL, V106, P1249, DOI 10.1152/japplphysiol.91476.2008; Kirmizigil B, 2014, J STRENGTH COND RES, V28, P1263, DOI 10.1519/JSC.0000000000000268; Kokkonen J, 1998, RES Q EXERCISE SPORT, V69, P411, DOI 10.1080/02701367.1998.10607716; Mizuno T, 2013, INT J SPORTS MED, V34, P484, DOI 10.1055/s-0032-1327655; Morse CI, 2008, J PHYSIOL-LONDON, V586, P97, DOI 10.1113/jphysiol.2007.140434; Murphy JR, 2014, EUR J APPL PHYSIOL, V114, P825, DOI 10.1007/s00421-013-2809-2; Nelson AG, 2005, J SPORT SCI, V23, P449, DOI 10.1080/02640410410001730205; Nelson AG, 2001, RES Q EXERCISE SPORT, V72, P415, DOI 10.1080/02701367.2001.10608978; Nelson AG, 2001, RES Q EXERCISE SPORT, V72, P68, DOI 10.1080/02701367.2001.10608934; Papadopoulos G, 2005, ISOKINET EXERC SCI, V13, P285, DOI 10.3233/IES-2005-0216; Pearce AJ, 2009, EUR J APPL PHYSIOL, V105, P175, DOI 10.1007/s00421-008-0887-3; Perrier ET, 2011, J STRENGTH COND RES, V25, P1925, DOI 10.1519/JSC.0b013e3181e73959; PERRINE JJ, 1978, MED SCI SPORT EXER, V10, P159; PERRY J, 1981, CRIT REV BIOMED ENG, V7, P1; Power K, 2004, MED SCI SPORT EXER, V36, P1389, DOI 10.1249/01.MSS.0000135775.51937.53; Ratel S, 2006, SPORTS MED, V36, P1031, DOI 10.2165/00007256-200636120-00004; Reid JJ, 2016, PEDIAT EXERC SCI; Reid JC, 2018, EUR J APPL PHYSIOL, V118, P1427, DOI 10.1007/s00421-018-3874-3; SOLOMONOW M, 1990, Electromyography and Clinical Neurophysiology, V30, P141; Torres EM, 2008, J STRENGTH COND RES, V22, P1279, DOI 10.1519/JSC.0b013e31816eb501; Torres JB, 2009, BIOMED HUM KINET, V1, P52, DOI 10.2478/v10101-009-0013-y; Turki O, 2011, J STRENGTH COND RES, V25, P2453, DOI 10.1519/JSC.0b013e31822a5a79; Weir DE, 2005, EUR J APPL PHYSIOL, V93, P614, DOI 10.1007/s00421-004-1265-4; Winchester JB, 2009, RES Q EXERCISE SPORT, V80, P257, DOI 10.1080/02701367.2009.10599560; Yamaguchi T, 2005, J STRENGTH COND RES, V19, P677; Yamaguchi T, 2007, J STRENGTH COND RES, V21, P1238, DOI 10.1519/00124278-200711000-00044; Young WB, 2002, STRENGTH COND J, V24, P33, DOI 10.1519/1533-4295(2002)024<0033:SSSBUD>2.0.CO;2	73	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210318	10.1371/journal.pone.0210318	http://dx.doi.org/10.1371/journal.pone.0210318			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682044	gold, Green Published, Green Submitted			2022-12-26	WOS:000457037500034
J	Stenehjem, DD; Hahn, AW; Gill, DM; Albertson, D; Gowrishankar, B; Merriman, J; Agarwal, AM; Thodima, V; Harrington, EB; Au, TH; Maughan, BL; Houldsworth, J; Pal, SK; Agarwal, N				Stenehjem, David D.; Hahn, Andrew W.; Gill, David M.; Albertson, Daniel; Gowrishankar, Banumathy; Merriman, Joseph; Agarwal, Archana M.; Thodima, Venkata; Harrington, Erik B.; Au, Trang H.; Maughan, Benjamin L.; Houldsworth, Jane; Pal, Sumanta K.; Agarwal, Neeraj			Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma	PLOS ONE			English	Article							BIOMARKERS; MUTATIONS; SUNITINIB	Background First-line treatment for metastatic renal cell carcinoma (mRCC) is rapidly changing. It currently includes VEGF targeted therapies (TT), multi-target tyrosine kinase inhibitors (TKIs), mTOR inhibitors, and immunotherapy. To optimize outcomes for individual patients, genomic markers of response to therapy are needed. Here, we aim to identify tumor-based genomic markers of response to VEGF TT to optimize treatment selection. Methods From an institutional database, primary tumor tissue was obtained from 79 patients with clear cell mRCC, and targeted sequencing was performed. Clinical outcomes were obtained retrospectively. Progression-free survival (PFS) on first-line VEGF TT was correlated to genomic alterations (GAs) using Kaplan-Meier methodology and Cox proportional hazard models. A composite model of significant GAs predicting PFS in the first-line setting was developed. Results Absence of VHL mutation was associated with inferior PFS on first-line VEGF TT. A trend for inferior PFS was observed with GAs in TP53 and FLT1 C/C variant. A composite model of these 3 GAs was associated with inferior PFS in a dose-dependent manner. Conclusion In mRCC, a composite model of TP53 mutation, wild type VHL, and FLT1 C/C variant strongly predicted PFS on first-line VEGF TT in a dose-dependent manner. These findings require external validation.	[Stenehjem, David D.] Univ Minnesota, Coll Pharm, Duluth, MN 55812 USA; [Hahn, Andrew W.; Gill, David M.; Merriman, Joseph; Maughan, Benjamin L.; Agarwal, Neeraj] Univ Utah, Dept Internal Med, Div Med Oncol, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Albertson, Daniel; Agarwal, Archana M.] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Albertson, Daniel; Agarwal, Archana M.] ARUP Labs, Salt Lake City, UT USA; [Gowrishankar, Banumathy; Thodima, Venkata; Houldsworth, Jane] Canc Genet Inc, Rutherford, NJ USA; [Harrington, Erik B.; Au, Trang H.] Univ Utah, Coll Pharm, PORC, Salt Lake City, UT 84112 USA; [Houldsworth, Jane] Mt Sinai Sch Med, Dept Pathol, New York, NY USA; [Pal, Sumanta K.] City Hope Comprehens Canc Ctr, Dept Med Oncol & Expt Therapeut, Duarte, CA USA	University of Minnesota System; University of Minnesota Duluth; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories; Utah System of Higher Education; University of Utah; Icahn School of Medicine at Mount Sinai; City of Hope	Agarwal, N (corresponding author), Univ Utah, Dept Internal Med, Div Med Oncol, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.	neeraj.agarwal@hci.utah.edu		Stenehjem, David/0000-0002-1831-285X	Pfizer; EMD Serono; Eisai	Pfizer(Pfizer); EMD Serono; Eisai(Eisai Co Ltd)	NA receives salary support from Pfizer, Exelixis, Merck, Argos, EMD Serono, and Eisai, and he receives research funding from Pfizer, EMD Serono, and Eisai. SKP receives salary support from Exelixis, BMS, GSK, Novartis, Pfizer, Astellas, and Genentech. BG, VT, and JH have received salary support from Cancer Genetics, Inc. The funders provided support in the form of salaries for authors NA, SKP, BG, VT, and JH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Beuselinck B, 2016, BJU INT, V118, P890, DOI 10.1111/bju.13585; Beuselinck B, 2014, ACTA ONCOL, V53, P103, DOI 10.3109/0284186X.2013.770600; Carlo MI, 2017, KIDNEY CANCER, V1, P49, DOI 10.3233/KCA-160003; Che M, 2007, INT J RADIAT ONCOL, V69, P1117, DOI 10.1016/j.ijrobp.2007.04.070; Choueiri TK, 2008, J UROLOGY, V180, P860, DOI 10.1016/j.juro.2008.05.015; Choueiri TK, 2013, CLIN CANCER RES, V19, P5218, DOI 10.1158/1078-0432.CCR-13-0491; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Escudier B, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.4511; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Ho TH, 2016, EUR UROL FOCUS, V2, P204, DOI 10.1016/j.euf.2015.11.007; Hsieh JJ, 2017, EUR UROL, V71, P405, DOI 10.1016/j.eururo.2016.10.007; Janzen NK, 2003, UROL CLIN N AM, V30, P843, DOI 10.1016/S0094-0143(03)00056-9; Ko JJ, 2015, LANCET ONCOL, V16, P293, DOI 10.1016/S1470-2045(14)71222-7; Lambrechts D, 2012, LANCET ONCOL, V13, P724, DOI 10.1016/S1470-2045(12)70231-0; Loo LWM, 2011, BREAST CANCER RES TR, V127, P297, DOI 10.1007/s10549-010-1297-x; McKay RR, 2018, J CLIN ONCOL, V36, P3615, DOI 10.1200/JCO.2018.79.0253; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207; Olivier M, 2006, CLIN CANCER RES, V12, P1157, DOI 10.1158/1078-0432.CCR-05-1029; Pal SK, 2017, EUR UROL, V72, P557, DOI 10.1016/j.eururo.2017.03.046; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; Ricketts CJ, 2018, CELL REP, V23, P313, DOI [10.1016/j.celrep.2018.03.075, 10.1016/j.celrep.2018.06.032]; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138	23	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210415	10.1371/journal.pone.0210415	http://dx.doi.org/10.1371/journal.pone.0210415			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682039	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500035
J	Walker, FR; Thomson, A; Pfingst, K; Vlemincx, E; Aidman, E; Nalivaiko, E				Walker, Frederick R.; Thomson, Ashley; Pfingst, Kane; Vlemincx, Elke; Aidman, Eugene; Nalivaiko, Eugene			Habituation of the electrodermal response - A biological correlate of resilience?	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; FEAR-POTENTIATED STARTLE; HEART-RATE; PHYSIOLOGICAL REACTIVITY; RESPIRATORY VARIABILITY; VIETNAM VETERANS; PANIC DISORDER; SCALES DASS; DEPRESSION; ANXIETY	Current approaches to quantifying resilience make extensive use of self-reported data. Problematically, this type of scales is plagued by response distortions-both deliberate and unintentional, particularly in occupational populations. The aim of the current study was to develop an objective index of resilience. The study was conducted in 30 young healthy adults. Following completion of the Connor-Davidson Resilience Scale (CD-RISC) and Depression/Anxiety/Stress Scale (DASS), they were subjected to a series of 15 acoustic startle stimuli (95 dB, 50 ms) presented at random intervals, with respiration, skin conductance and ECG recorded. As expected, resilience (CD-RISC) significantly and negatively correlated with all three DASS subscales-Depression (r = -0.66, p<0.0001), Anxiety (r = -0.50, p<0.005) and Stress (r = -0.48, p<0.005). Acoustic stimuli consistently provoked transient skin conductance (SC) responses, with SC slopes indexing response habituation. This slope significantly and positively correlated with DASS-Depression (r = 0.59, p<0.005), DASS-Anxiety (r = 0.35, p<0.05) and DASS-Total (r = 0.50, p<0.005) scores, and negatively with resilience score (r = -0.47; p = 0.006), indicating that high-resilience individuals are characterized by steeper habituation slopes compared to low-resilience individuals. Our key finding of the connection between habituation of the skin conductance responses to repeated acoustic startle stimulus and resilience-related psychometric constructs suggests that response habituation paradigm has the potential to characterize important attributes of cognitive fitness and well-being-such as depression, anxiety and resilience. With steep negative slopes reflecting faster habituation, lower depression/anxiety and higher resilience, and slower or no habituation characterizing less resilient individuals, this protocol may offer a distortion-free method for objective assessment and monitoring of psychological resilience.	[Walker, Frederick R.; Thomson, Ashley; Nalivaiko, Eugene] Univ Newcastle, Newcastle, NSW, Australia; [Pfingst, Kane] Australian Army, Canberra, ACT, Australia; [Vlemincx, Elke] Queen Mary Univ London, London, England; [Aidman, Eugene] DST Grp, Adelaide, SA, Australia	University of Newcastle; University of London; Queen Mary University London	Nalivaiko, E (corresponding author), Univ Newcastle, Newcastle, NSW, Australia.	Eugene.nalivaiko@newcastle.edu.au		AIDMAN, Eugene/0000-0002-7711-794X; Thomson, Ashley/0000-0002-4489-6588; Nalivaiko, Eugene/0000-0002-6449-8181				Abelson JL, 2001, BIOL PSYCHIAT, V49, P588, DOI 10.1016/S0006-3223(00)01078-7; Aidman E., 2017, J SCI MED SPORT, V20, pS50, DOI [10.1016/j.jsams.2017.09.159, DOI 10.1016/J.JSAMS.2017.09.159]; BARTLETT D, 1971, RESP PHYSIOL, V12, P230, DOI 10.1016/0034-5687(71)90055-7; Bell HJ, 2009, AM J PHYSIOL-REG I, V296, pR334, DOI 10.1152/ajpregu.90680.2008; Beutel ME, 2010, AGING MALE, V13, P32, DOI 10.3109/13685530903296698; BLANCHARD EB, 1989, BEHAV THER, V20, P535, DOI 10.1016/S0005-7894(89)80132-7; Blechert J, 2007, PSYCHOSOM MED, V69, P935, DOI 10.1097/PSY.0b013e31815a8f6b; Block J., 1950, THESIS; BOITEN FA, 1994, INT J PSYCHOPHYSIOL, V17, P103, DOI 10.1016/0167-8760(94)90027-2; Brady KT, 2000, J CLIN PSYCHIAT, V61, P22; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Burrell BD, 2001, J NEUROSCI, V21, P1401; Carnevali L, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00228; Carson MA, 2007, J TRAUMA STRESS, V20, P657, DOI 10.1002/jts.20218; Charney Dennis S, 2003, Dialogues Clin Neurosci, V5, P207; Charney DS, 2004, AM J PSYCHIAT, V161, P195, DOI 10.1176/appi.ajp.161.2.195; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Crawford JR, 2003, BRIT J CLIN PSYCHOL, V42, P111, DOI 10.1348/014466503321903544; Davis M, 1984, HABITUATION SENSITIZ, P283; Donaldson SI, 2002, J BUS PSYCHOL, V17, P245, DOI 10.1023/A:1019637632584; EMBREE BG, 1993, J STUD ALCOHOL, V54, P334, DOI 10.15288/jsa.1993.54.334; Feder A, 2009, NAT REV NEUROSCI, V10, P446, DOI 10.1038/nrn2649; FERRIS BG, 1960, J CLIN INVEST, V39, P143, DOI 10.1172/JCI104012; Fletcher D, 2013, EUR PSYCHOL, V18, P12, DOI 10.1027/1016-9040/a000124; Fowles DC., 1986, PSYCHOPHYSIOLOGY SYS, V1, P51, DOI DOI 10.1016/J.NEUBIOREV.2013.03.024; FREDRIKSON M, 1982, BIOL PSYCHOL, V15, P63, DOI 10.1016/0301-0511(82)90031-X; Freud S., 1921, GROUP PSYCHOL ANAL E; Gillie BL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00758; Grillon C, 1998, AM J PSYCHIAT, V155, P812; Hegney DG, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01613; Jones-Alexander J, 2005, APPL PSYCHOPHYS BIOF, V30, P115, DOI 10.1007/s10484-005-4307-8; Jovanovic T, 2009, INT J PSYCHOPHYSIOL, V71, P264, DOI 10.1016/j.ijpsycho.2008.10.007; Joyce S, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017858; Keane TM, 1998, J CONSULT CLIN PSYCH, V66, P914, DOI 10.1037/0022-006X.66.6.914; Keary TA, 2009, INT J PSYCHOPHYSIOL, V73, P257, DOI 10.1016/j.ijpsycho.2009.04.003; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; McDonagh-Coyle A, 2001, J TRAUMA STRESS, V14, P667, DOI 10.1023/A:1013081803429; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; MCILROY MB, 1962, J APPL PHYSIOL, V17, P701, DOI 10.1152/jappl.1962.17.4.701; Metzger LJ, 1999, J ABNORM PSYCHOL, V108, P347, DOI 10.1037/0021-843X.108.2.347; MORGAN CA, 1995, BIOL PSYCHIAT, V38, P378, DOI 10.1016/0006-3223(94)00321-S; Orr S.P., 2004, ASSESSING PSYCHOL TR, P289; Orr SP, 1998, J TRAUMA STRESS, V11, P155, DOI 10.1023/A:1024421502881; Phillips AC, 2011, PSYCHOPHYSIOLOGY, V48, P142, DOI 10.1111/j.1469-8986.2010.01045.x; Pole N, 2003, J TRAUMA STRESS, V16, P471, DOI 10.1023/A:1025758411370; Pole N, 2007, PSYCHOL BULL, V133, P725, DOI 10.1037/0033-2909.133.5.725; Sahar T, 2001, BIOL PSYCHIAT, V49, P637, DOI 10.1016/S0006-3223(00)01045-3; Schwartz GE, 1996, ANXIETY, V2, P145, DOI 10.1002/(SICI)1522-7154(1996)2:3<145::AID-ANXI6>3.0.CO;2-O; Seppala EM, 2014, J TRAUMA STRESS, V27, P397, DOI 10.1002/jts.21936; SHALEV AY, 1992, ARCH GEN PSYCHIAT, V49, P870; Shalev AY, 2000, AM J PSYCHIAT, V157, P255, DOI 10.1176/appi.ajp.157.2.255; SLOAN RP, 1991, PHYSIOL BEHAV, V50, P1039, DOI 10.1016/0031-9384(91)90434-P; Steiner GZ, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00014; TOBIN MJ, 1983, CHEST, V84, P286, DOI 10.1378/chest.84.3.286; Vlemincx E, 2010, PHYSIOL BEHAV, V101, P67, DOI 10.1016/j.physbeh.2010.04.015; Vlemincx E, 2016, PHYSIOL BEHAV, V165, P127, DOI 10.1016/j.physbeh.2016.07.004; Vlemincx E, 2015, PSYCHOPHYSIOLOGY, V52, P657, DOI 10.1111/psyp.12396; Vlemincx E, 2013, BIOL PSYCHOL, V93, P24, DOI 10.1016/j.biopsycho.2012.12.001; Vlemincx E, 2012, PHYSIOL BEHAV, V107, P1, DOI 10.1016/j.physbeh.2012.05.013; Vlemincx E, 2011, PSYCHOPHYSIOLOGY, V48, P117, DOI 10.1111/j.1469-8986.2010.01043.x; Walker FR, 2017, NEUROSCI BIOBEHAV R, V74, P310, DOI 10.1016/j.neubiorev.2016.05.003; Widjaja D., 2013, COMPUT MATH METHODS, V2013, DOI DOI 10.1155/2013/451857; Wilhelm FH, 2001, PSYCHOSOM MED, V63, P638, DOI 10.1097/00006842-200107000-00017; Wilhelm FH, 2001, BIOL PSYCHIAT, V49, P596, DOI 10.1016/S0006-3223(00)01000-3; Wilhelm FH, 2001, BIOL PSYCHIAT, V49, P606, DOI 10.1016/S0006-3223(00)01014-3; Zoladz PR, 2013, NEUROSCI BIOBEHAV R, V37, P860, DOI 10.1016/j.neubiorev.2013.03.024	67	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210078	10.1371/journal.pone.0210078	http://dx.doi.org/10.1371/journal.pone.0210078			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682040	gold, Green Published, Green Submitted			2022-12-26	WOS:000457037500022
J	Cameron, A; Barbieri, R; Read, R; Church, D; Adator, EH; Zaheer, R; McAllister, TA				Cameron, Andrew; Barbieri, Ruth; Read, Ron; Church, Deirdre; Adator, Emelia H.; Zaheer, Rahat; McAllister, Tim A.			Functional screening for triclosan resistance in a wastewater metagenome and isolates of Escherichia coli and Enterococcus spp. from a large Canadian healthcare region	PLOS ONE			English	Article							AEROMONAS-HYDROPHILA; CLINICAL STRAINS; ENOYL REDUCTASE; BIOCIDE; IDENTIFICATION; INHIBITION; SEQUENCE; FABV	The biocide triclosan is in many consumer products and is a frequent contaminant of wastewater (WW) such that there is concern that triclosan promotes resistance to important antibiotics. This study identified functional mechanisms of triclosan resistance (TCSR) in WW metagenomes, and assessed the frequency of TCSR in WW-derived and clinical isolates of Escherichia coli and Enterococcus spp. Metagenomic DNA extracted from WW was used to profile the microbiome and construct large-insert cosmid libraries, which were screened for TCSR. Resistant cosmids were sequenced and the TCSR determinant identified by transposon mutagenesis. Wastewater Enterococcus spp. (N = 94) and E. coli (N = 99) and clinical Enterococcus spp. (N = 146) and vancomycin-resistant E. faecium (VRE; N = 149) were collected and tested for resistance to triclosan and a comprehensive drug panel. Functional metagenomic screening revealed diverse FabV homologs as major WW TCSR determinants. Resistant clones harboured sequences likely originating from Aeromonas spp., a common WW microbe. The triclosan MIC90s for E. coli, E. faecalis, and E. faecium isolates were 0.125, 32, and 32 mg/L, respectively. For E. coli, there was no correlation between the triclosan MIC and any drug tested. Negative correlations were detected between the triclosan MIC and levofloxacin resistance for E. faecalis, and between triclosan and vancomycin, teicoplanin, and ampicillin resistance for E. faecium. Thus, FabV homologs were the major contributor to the WW triclosan resistome and high-level TCSR was not observed in WW or clinical isolates. Elevated triclosan MICs were not positively correlated with antimicrobial resistance to any drug tested.	[Cameron, Andrew] Univ Calgary, Fac Vet Med, Calgary, AB, Canada; [Cameron, Andrew; Barbieri, Ruth; Zaheer, Rahat; McAllister, Tim A.] Lethbridge Res & Dev Ctr, Lethbridge, AB, Canada; [Read, Ron; Church, Deirdre] Univ Calgary, Fac Med, Calgary, AB, Canada; [Church, Deirdre] Calgary Lab Serv, Calgary, AB, Canada; [Adator, Emelia H.] Univ Manitoba, Dept Food & Human Nutr Sci, Winnipeg, MB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Manitoba	McAllister, TA (corresponding author), Lethbridge Res & Dev Ctr, Lethbridge, AB, Canada.	tim.mcallister@canada.ca			Alberta Agriculture and Forestry Strategic Research and Development; Beef Cattle Research Council (BCRC)-Agriculture and Agri-Food Canada beef cluster; GRDI program of Agriculture and Agri-Food Canada; University of Manitoba; Calgary Laboratory Services; NSERC Postdoctoral Fellowship	Alberta Agriculture and Forestry Strategic Research and Development; Beef Cattle Research Council (BCRC)-Agriculture and Agri-Food Canada beef cluster; GRDI program of Agriculture and Agri-Food Canada; University of Manitoba; Calgary Laboratory Services; NSERC Postdoctoral Fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by funding from Alberta Agriculture and Forestry Strategic Research and Development and the Beef Cattle Research Council (BCRC)-Agriculture and Agri-Food Canada beef cluster, and the GRDI program of Agriculture and Agri-Food Canada. A. C. is supported by an NSERC Postdoctoral Fellowship. E.H.A. is supported by a Graduate Fellowship from the University of Manitoba. Calgary Laboratory Services provided support in the form of salaries for D.L.C., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmyr M, 2006, SCI TOTAL ENVIRON, V372, P87, DOI 10.1016/j.scitotenv.2006.08.007; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Calafat AM, 2003, ENVIRON HEALTH PERSP, V111, P151, DOI 10.1289/ehp.5644; Carey DE, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00780; Ciusa ML, 2012, INT J ANTIMICROB AG, V40, P210, DOI 10.1016/j.ijantimicag.2012.04.021; Clinical and Laboratory Standards Institute (CLSI), 2015, PERF STAND ANT DISK, V12th; CLSI, 2016, M100 PERF STAND ANT, V26; Cullinan MP, 2012, SCI TOTAL ENVIRON, V416, P75, DOI 10.1016/j.scitotenv.2011.11.063; Darzentas N., 2010, BIOINFORMATICS, V26; Dhillon GS, 2015, INT J ENV RES PUB HE, V12, P5657, DOI 10.3390/ijerph120505657; Freundlich JS, 2009, CHEMMEDCHEM, V4, P241, DOI 10.1002/cmdc.200800261; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goodman M, 2018, CRIT REV TOXICOL, V48, P1, DOI 10.1080/10408444.2017.1350138; Halden RU, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP1788; Hinther A, 2011, ENVIRON SCI TECHNOL, V45, P5395, DOI 10.1021/es1041942; Ikram A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34254-5; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Jang CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057075; Khan R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192277; Khan R, 2016, SCI REP-UK, V6, DOI 10.1038/srep32322; Khan R, 2015, J MICROBIOL BIOTECHN, V25, P511, DOI 10.4014/jmb.1407.07021; Lam KN, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01196; Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149; Li H., 2013, ARXIV PREPRINT; Massengo-Tiasse RP, 2008, J BIOL CHEM, V283, P1308, DOI 10.1074/jbc.M708171200; McLeod R, 2001, INT J PARASITOL, V31, P109, DOI 10.1016/S0020-7519(01)00111-4; McMurry LM, 1998, FEMS MICROBIOL LETT, V166, P305, DOI 10.1016/S0378-1097(98)00347-4; Morrissey I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086669; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Parikh SL, 2000, BIOCHEMISTRY-US, V39, P7645, DOI 10.1021/bi0008940; Persson S, 2015, J CLIN MICROBIOL, V53, P653, DOI 10.1128/JCM.01963-14; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanchez P, 2005, ANTIMICROB AGENTS CH, V49, P781, DOI 10.1128/AAC.49.2.781-782.2005; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Seshadri R, 2006, J BACTERIOL, V188, P8272, DOI 10.1128/JB.00621-06; Singer H, 2002, ENVIRON SCI TECHNOL, V36, P4998, DOI 10.1021/es025750i; Taupp Marcus, 2009, J Vis Exp, DOI 10.3791/1387; USEPA, 2002, 1600 USEPA OFF WAT W; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Wu CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117821; Yazdankhah SP, 2006, MICROB DRUG RESIST, V12, P83, DOI 10.1089/mdr.2006.12.83; Zaheer R, 2012, J MICROBIOL METH, V89, P174, DOI 10.1016/j.mimet.2012.03.012; Zhu L, 2010, ANTIMICROB AGENTS CH, V54, P689, DOI 10.1128/AAC.01152-09	45	11	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211144	10.1371/journal.pone.0211144	http://dx.doi.org/10.1371/journal.pone.0211144			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677104	gold, Green Published, Green Submitted			2022-12-26	WOS:000456700400052
J	Hariono, M; Choi, SB; Roslim, RF; Nawi, MS; Tan, ML; Kamarulzaman, EE; Mohamed, N; Yusof, R; Othman, S; Abd Rahman, N; Othman, R; Wahab, HA				Hariono, Maywan; Choi, Sy Bing; Roslim, Ros Fatihah; Nawi, Mohamed Sufian; Tan, Mei Lan; Kamarulzaman, Ezatul Ezleen; Mohamed, Nornisah; Yusof, Rohana; Othman, Shatrah; Abd Rahman, Noorsaadah; Othman, Rozana; Wahab, Habibah A.			Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling	PLOS ONE			English	Article							DENGUE VIRUS PROTEASE; SERINE-PROTEASE; NS3 PROTEASE; ANTIVIRAL ACTIVITY; PEPTIDE-HYBRIDS; DISCOVERY; TYPE-2; IDENTIFICATION; OPTIMIZATION; FLAVONOIDS	Dengue virus Type 2 (DENV-2) is predominant serotype causing major dengue epidemics. There are a number of studies carried out to find its effective antiviral, however to date, there is still no molecule either from peptide or small molecules released as a drug. The present study aims to identify small molecules inhibitor from National Cancer Institute database through virtual screening. One of the hits, D0713 (IC50 = 62 mu M) bearing thioguanine scaffold was derivatised into 21 compounds and evaluated for DENV-2 NS2B/NS3 protease inhibitory activity. Compounds 18 and 21 demonstrated the most potent activity with IC50 of 0.38 mu M and 16 mu M, respectively. Molecular dynamics and MM/PBSA free energy of binding calculation were conducted to study the interaction mechanism of these compounds with the protease. The free energy of binding of 18 calculated by MM/PBSA is -16.10 kcal/mol compared to the known inhibitor, panduratin A (-11.27 kcal/mol), which corroborates well with the experimental observation. Results from molecular dynamics simulations also showed that both 18 and 21 bind in the active site and stabilised by the formation of hydrogen bonds with Asn174.	[Hariono, Maywan; Choi, Sy Bing; Roslim, Ros Fatihah; Nawi, Mohamed Sufian; Kamarulzaman, Ezatul Ezleen; Mohamed, Nornisah; Wahab, Habibah A.] Univ Sains Malaysia, Sch Pharmaceut Sci, Minden, Pulau Pinang, Malaysia; [Hariono, Maywan] Sanata Dharma Univ, Fac Pharm, Sleman, Yogyakarta, Indonesia; [Choi, Sy Bing] Perdana Univ, Sch Data Sci, Blok B & D1,MARDI Complex,Jalan MAEPS Perdana, Serdang, Selangor, Malaysia; [Nawi, Mohamed Sufian] Int Islamic Univ Malaysia, Kulliyah Pharm, Dept Pharmaceut Chem, Kuantan, Pahang, Malaysia; [Tan, Mei Lan] Univ Sains Malaysia, Adv Med & Dent Inst, Bertam, Pulau Pinang, Malaysia; [Yusof, Rohana] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia; [Othman, Shatrah; Abd Rahman, Noorsaadah] Univ Malaya, Fac Sci, Dept Chem, Kuala Lumpur, Malaysia; [Othman, Rozana] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Wahab, Habibah A.] Minist Sci Technol & Innovat, Malaysian Inst Pharmaceut & Nutraceut, Bayan Lepas, Pulau Pinang, Malaysia	Universiti Sains Malaysia; Perdana University; International Islamic University Malaysia; Universiti Sains Malaysia; Universiti Malaya; Universiti Malaya; Universiti Malaya	Wahab, HA (corresponding author), Univ Sains Malaysia, Sch Pharmaceut Sci, Minden, Pulau Pinang, Malaysia.; Wahab, HA (corresponding author), Minist Sci Technol & Innovat, Malaysian Inst Pharmaceut & Nutraceut, Bayan Lepas, Pulau Pinang, Malaysia.	habibahw@usm.my	Choi, Sy Bing/AGZ-6475-2022; Wahab, Habibah A/D-2976-2011; Wahab, Habibah A/AAJ-6267-2020; OTHMAN, SHATRAH/B-9768-2010; OTHMAN, ROZANA/B-9628-2010; Rahman, Noorsaadah Abd./B-9291-2010; Tan, Mei Lan/E-3500-2012	Wahab, Habibah A/0000-0002-8353-8679; OTHMAN, ROZANA/0000-0002-8260-9252; Rahman, Noorsaadah Abd./0000-0001-5847-8961; Choi, Sy Bing/0000-0003-3189-904X; Tan, Mei Lan/0000-0001-6565-699X	Science Fund Grant [02-05-23-SF0019]; Research University Grant for Team (RUT) [1001/PKIMIA/855006]; Universiti Sains Malaysia; Malaysian Ministry of Science and Technology Innovation [02-05-23-SF0019]	Science Fund Grant; Research University Grant for Team (RUT); Universiti Sains Malaysia(Universiti Sains Malaysia); Malaysian Ministry of Science and Technology Innovation	This work is funded under Science Fund Grant No. 02-05-23-SF0019 and Research University Grant for Team (RUT) No. 1001/PKIMIA/855006. MH thanked Universiti Sains Malaysia for the USM Fellowship Award (2011-2012) and the Malaysian Ministry of Science and Technology Innovation for research assistantship under ScienceFund Grant No. 02-05-23-SF0019 (2014-2015). We thank National Cancer Institute, US for the complementary samples of the 20 NCI hit compounds.	ADAMSON PC, 1994, LEUKEMIA RES, V18, P805, DOI 10.1016/0145-2126(94)90159-7; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P349; [Anonymous], HYPERCHEM TM PROF 8; Aravapalli S, 2012, BIOORGAN MED CHEM, V20, P4140, DOI 10.1016/j.bmc.2012.04.055; Behnam MAM, 2016, J MED CHEM, V59, P5622, DOI 10.1021/acs.jmedchem.5b01653; Behnam MAM, 2015, J MED CHEM, V58, P9354, DOI 10.1021/acs.jmedchem.5b01441; Behnam MAM, 2014, ACS MED CHEM LETT, V5, P1037, DOI 10.1021/ml500245v; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Cabarcas-Montalvo M, 2016, EUR J MED CHEM, V110, P87, DOI 10.1016/j.ejmech.2015.12.030; Chanprapaph S, 2005, BIOCHEM BIOPH RES CO, V330, P1237, DOI 10.1016/j.bbrc.2005.03.107; Chaput L, 2016, J CHEMINFORMATICS, V8, DOI 10.1186/s13321-016-0167-x; Chuang S-J, 2018, SCI REP, V8, P1, DOI DOI 10.1038/s41598-017-17765-5; ELION GB, 1989, BIOSCIENCE REP, V9, P509, DOI 10.1007/BF01119794; Frecer V, 2010, J COMPUT AID MOL DES, V24, P195, DOI 10.1007/s10822-010-9326-8; de Sousa LRF, 2015, BIOORGAN MED CHEM, V23, P466, DOI 10.1016/j.bmc.2014.12.015; Frimayanti Neni, 2011, In Silico Biology, V11, P29, DOI 10.3233/ISB-2012-0442; Galula JU, 2014, J VIROL, V88, P10813, DOI 10.1128/JVI.00810-14; Genheden S, 2015, EXPERT OPIN DRUG DIS, V10, P449, DOI 10.1517/17460441.2015.1032936; Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9; Hariono M, 2014, ACTA CRYSTALLOGR E, V70, pO288, DOI 10.1107/S1600536814001986; Hariono M, 2012, ACTA CRYSTALLOGR E, V68, pO35, DOI 10.1107/S1600536811051269; Heh CH, 2013, CHEM BIOL DRUG DES, V82, P1, DOI 10.1111/cbdd.12122; HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990; Katzenmeier G., 2004, Dengue Bulletin, V28, P58; Kiat TS, 2006, BIOORG MED CHEM LETT, V16, P3337, DOI 10.1016/j.bmcl.2005.12.075; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Le Grand S, 2013, COMPUT PHYS COMMUN, V184, P374, DOI 10.1016/j.cpc.2012.09.022; Lee Y.K., 2007, ASIA PAC J MOL BIOL, V15, P53; Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200; Liu HL, 2014, BIOORGAN MED CHEM, V22, P6344, DOI 10.1016/j.bmc.2014.09.057; Morris GM, 2009, J COMPUT CHEM, V28, P73; Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440; Natarajan S, 2010, GENET MOL BIOL, V33, P214, DOI 10.1590/S1415-47572010000200002; Nitsche C, 2013, J MED CHEM, V56, P8389, DOI 10.1021/jm400828u; Nitsche C, 2012, ANTIVIR RES, V94, P72, DOI 10.1016/j.antiviral.2012.02.008; Nitsche C, 2011, BIOORGAN MED CHEM, V19, P7318, DOI 10.1016/j.bmc.2011.10.061; Normile D., 2013, HEALTH; Osterman MT, 2006, GASTROENTEROLOGY, V130, P1047, DOI 10.1053/j.gastro.2006.01.046; Othman Rozana, 2007, In Silico Biology, V7, P215; Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008; PRAKASH C, 1983, ANAL BIOCHEM, V128, P41, DOI 10.1016/0003-2697(83)90341-X; Prusis P, 2013, BIOCHEM BIOPH RES CO, V434, P767, DOI 10.1016/j.bbrc.2013.03.139; Qiagen, 2003, QIA EXPR HDB HIGH LE; Rahman N. A., 2006, Dengue Bulletin, V30, P260; Ramajayam R, 2010, BIOORG MED CHEM LETT, V20, P3569, DOI 10.1016/j.bmcl.2010.04.118; Raut R, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0248-x; Rothan HA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-314; Rothan HA, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251482; Saudi M, 2014, EUR J MED CHEM, V87, P529, DOI 10.1016/j.ejmech.2014.09.062; Shityakov Sergey, 2014, Adv Appl Bioinform Chem, V7, P23, DOI 10.2147/AABC.S63749; Simmons CP, 2015, VACCINE, V33, P7061, DOI 10.1016/j.vaccine.2015.09.103; Steuer C, 2011, BIOORGAN MED CHEM, V19, P4067, DOI 10.1016/j.bmc.2011.05.015; Steuer C, 2009, J BIOMOL SCREEN, V14, P1102, DOI 10.1177/1087057109344115; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Viswanathan U, 2014, J CHEM INF MODEL, V54, P2816, DOI 10.1021/ci500531r; Wahab HA, 2007, CURR COMPUT-AID DRUG, V3, P101, DOI 10.2174/157340907780809499; Wang QY, 2011, J VIROL, V85, P6548, DOI 10.1128/JVI.02510-10; WHO, 2009, WHO TECH REP SER, V958, P1; Wichapong K, 2010, J MOL RECOGNIT, V23, P283, DOI 10.1002/jmr.977; Xu SQ, 2012, J MED CHEM, V55, P6881, DOI 10.1021/jm300655h; Yang CC, 2011, ANTIMICROB AGENTS CH, V55, P229, DOI 10.1128/AAC.00855-10; Yin Z, 2006, BIOORG MED CHEM LETT, V16, P40, DOI 10.1016/j.bmcl.2005.09.049; Yotmanee P, 2015, J MOL GRAPH MODEL, V60, P24, DOI 10.1016/j.jmgm.2015.05.008; Yusof R, 2000, J BIOL CHEM, V275, P9963, DOI 10.1074/jbc.275.14.9963; Yusof R, 2008, DESIGN CHEMOTHERAPEU; Zandi K, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-91	67	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210869	10.1371/journal.pone.0210869	http://dx.doi.org/10.1371/journal.pone.0210869			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677071	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000456700400029
J	Matsuzaki, R; Nozaki, H; Takeuchi, N; Hara, Y; Kawachi, M				Matsuzaki, Ryo; Nozaki, Hisayoshi; Takeuchi, Nozomu; Hara, Yoshiaki; Kawachi, Masanobu			Taxonomic re-examination of "Chloromonas nivalis (Volvocales, Chlorophyceae) zygotes" from Japan and description of C-muramotoi sp. nov.	PLOS ONE			English	Article							UPSTATE NEW-YORK; SNOW ALGA; MOLECULAR PHYLOGENY; ELECTRON-MICROSCOPY; GENUS CHLOROMONAS; LIFE-HISTORY; COMB-NOV; REVISION; ITS2; ECOLOGY	Recent molecular data has strongly suggested that field-collected cysts of snow algae that are morphologically identifiable as the zygotes of Chloromonas nivalis are composed of multiple species. Motile vegetative cells, however, have not been directly obtained from these cysts because of the difficulties involved in inducing their germination. Recently, our comparative molecular analyses, using both field-collected and cultured materials, demonstrated that one Japanese lineage of "C. nivalis zygotes" belongs to C. miwae. Herein, we examined another Japanese lineage of field-collected "C. nivalis zygotes" and a new strain originating from Japan. Our molecular data demonstrated that these two different life cycle stages are conspecific, and that they represent a new species that we herein describe as C. muramotoi sp. nov., based on the vegetative and asexual morphological characteristics of the strain. Multigene phylogenetic analyses showed that this new species was sister to C. miwae. Scanning electron microscopy demonstrated that the cysts of C. muramotoi are different from those of C. miwae, based on the arrangement of the flanges developing on the cell wall.	[Matsuzaki, Ryo; Kawachi, Masanobu] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan; [Nozaki, Hisayoshi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan; [Takeuchi, Nozomu] Chiba Univ, Grad Sch Sci, Dept Earth Sci, Inage Ward, Chiba, Chiba, Japan; [Hara, Yoshiaki] Yamagata Univ, Inst Arts & Sci, Yamagata, Yamagata, Japan	National Institute for Environmental Studies - Japan; University of Tokyo; Chiba University; Yamagata University	Matsuzaki, R (corresponding author), Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan.	matsuzaki.ryo@nies.go.jp	Takeuchi, Nozomu/Q-7869-2016	Takeuchi, Nozomu/0000-0002-3267-5534; Matsuzaki, Ryo/0000-0002-8989-5933; Kawachi, Masanobu/0000-0001-9911-0688	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI [16J09828]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI	RM was supported by Grant-in-Aid for JSPS Research Fellow (No. 16J09828) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI (https://www.jsps.go.jp/english/e-grants/).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, NON TRADITIONAL REF; Coleman AW, 2007, NUCLEIC ACIDS RES, V35, P3322, DOI 10.1093/nar/gkm233; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Coleman AW, 2003, TRENDS GENET, V19, P370, DOI 10.1016/S0168-9525(03)00118-5; Ettl H., 1970, Beih. Nova Hedwigia, VNo. 34, P1; Ettl H., 1961, ARCH PROTISTENKD, V105, P273; Ettl H, 1983, SUSSWASSERFLORA MITT, V9; HOHAM R W, 1975, Phycologia, V14, P213, DOI 10.2216/i0031-8884-14-4-213.1; Hoham R.W., 1980, Developments in Marine Biology, V2, P61; HOHAM R W, 1977, Phycologia, V16, P53, DOI 10.2216/i0031-8884-16-1-53.1; Hoham RW, 2008, ARCT ANTARCT ALP RES, V40, P355, DOI 10.1657/1523-0430(07-038)[HOHAM]2.0.CO;2; Hoham Ronald W., 2001, P168; HOHAM RW, 1978, PHYCOLOGIA, V17, P106, DOI 10.2216/i0031-8884-17-1-106.1; Hoham RW, 2006, PHYCOLOGIA, V45, P319, DOI 10.2216/04-103.1; Hoham RW, 2002, J PHYCOL, V38, P1051, DOI 10.1046/j.1529-8817.2002.t01-1-01227.x; HOHAM RW, 1979, PHYCOLOGIA, V18, P55, DOI 10.2216/i0031-8884-18-1-55.1; Kawachi M, 2013, LIST OF STRAINS; Kawai-Toyooka H, 2004, PLANT CELL PHYSIOL, V45, P1648, DOI 10.1093/pcp/pch186; Kol E, 1968, BINNENGEWASSER, P1; Komarek Jiri, 2007, V11; Ling HU, 1998, POLAR BIOL, V20, P320, DOI 10.1007/s003000050309; Matsuzaki R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193603; Matsuzaki R, 2015, PHYCOLOGIA, V54, P491, DOI 10.2216/15-33.1; Matsuzaki R, 2014, PHYCOLOGIA, V53, P293, DOI 10.2216/14-3.1; Matsuzaki R, 2013, PHYCOLOGIA, V52, P239, DOI 10.2216/12-083.1; Matsuzaki R, 2012, PHYCOLOGIA, V51, P74, DOI 10.2216/11-18.1; Muller T, 1998, POLAR BIOL, V20, P14, DOI 10.1007/s003000050272; Muramoto K, 2008, CYTOLOGIA, V73, P91, DOI 10.1508/cytologia.73.91; Muramoto K, 2010, EUR J PHYCOL, V45, P27, DOI 10.1080/09670260903272607; Nakada T, 2008, J PHYCOL, V44, P751, DOI 10.1111/j.1529-8817.2008.00525.x; Nakada T, 2008, MOL PHYLOGENET EVOL, V48, P281, DOI 10.1016/j.ympev.2008.03.016; Nakada T, 2016, J PHYCOL, V52, P283, DOI 10.1111/jpy.12397; Nakada T, 2010, J PLANT RES, V123, P67, DOI 10.1007/s10265-009-0266-0; Nozaki H, 2002, J MOL EVOL, V55, P414, DOI 10.1007/s00239-002-2338-9; Nozaki H, 2010, J PHYCOL, V46, P195, DOI 10.1111/j.1529-8817.2009.00773.x; Prochazkova L, 2018, FOTTEA, V18, P1, DOI 10.5507/fot.2017.010; Proschold T, 2001, PROTIST, V152, P265, DOI 10.1078/1434-4610-00068; Proschold T., 2007, TAXON, V56, P595; Remias D, 2018, PHYCOLOGIA, V57, P581, DOI 10.2216/18-45.1; Remias D, 2012, PLANTS IN ALPINE REGIONS: CELL PHYSIOLOGY OF ADAPTION AND SURVIVAL STRATEGIES, P175, DOI 10.1007/978-3-7091-0136-0_13; Remias D, 2010, PROTOPLASMA, V243, P73, DOI 10.1007/s00709-010-0123-y; Schultz J, 2005, RNA, V11, P361, DOI 10.1261/rna.7204505; Schultz J, 2009, MOL PHYLOGENET EVOL, V52, P520, DOI 10.1016/j.ympev.2009.01.008; Segawa T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05521-w; Segawa T, 2011, POLAR SCI, V5, P41, DOI 10.1016/j.polar.2010.12.002; Seibel Philipp N, 2008, BMC Res Notes, V1, P91, DOI 10.1186/1756-0500-1-91; SEIBEL PN, 2006, BMC BIOINFORMATICS, V7; Wawrik F., 1974, Nova Hedwigia, V25, P665; Wille N., 1903, Nyt Magazin for Naturvidenskaberne, Vxli, P89	49	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210986	10.1371/journal.pone.0210986	http://dx.doi.org/10.1371/journal.pone.0210986			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677063	Green Submitted, gold, Green Published			2022-12-26	WOS:000456700400039
J	Abdallah, AM; Weerdenburg, EM; Guan, QT; Ummels, R; Borggreve, S; Adroub, SA; Malas, TB; Naeem, R; Zhang, HM; Otto, TD; Bitter, W; Pain, A				Abdallah, Abdallah M.; Weerdenburg, Eveline M.; Guan, Qingtian; Ummels, Roy; Borggreve, Stephanie; Adroub, Sabir A.; Malas, Tareq B.; Naeem, Raeece; Zhang, Huoming; Otto, Thomas D.; Bitter, Wilbert; Pain, Arnab			Integrated transcriptomic and proteomic analysis of pathogenic mycobacteria and their esx-1 mutants reveal secretion -dependent regulation of ESX-1 substrates and WhiB6 as a transcriptional regulator	PLOS ONE			English	Article							BOVIS BCG; CELL-DIVISION; GENE-CLUSTER; TUBERCULOSIS; VIRULENCE; MARINUM; PROTEIN; SYSTEM; ESAT-6; MICE	The mycobacterial type VII secretion system ESX-1 is responsible for the secretion of a number of proteins that play important roles during host infection. The regulation of the expression of secreted proteins is often essential to establish successful infection. Using transcriptome sequencing, we found that the abrogation of ESX-1 function in Mycobacterium marinum leads to a pronounced increase in gene expression levels of the espA operon during the infection of macrophages. In addition, the disruption of ESX-1-mediated protein secretion also leads to a specific down-regulation of the ESX-1 substrates, but not of the structural components of this system, during growth in culture medium. This effect is observed in both M. marinum and M. tuberculosis. We established that down-regulation of ESX-1 substrates is the result of a regulatory process that is influenced by the putative transcriptional regulator whib6, which is located adjacent to the esx-1 locus. In addition, the overexpression of the ESX-1-associated PE35/PPE68 protein pair resulted in a significantly increased secretion of the ESX-1 substrate EsxA, demonstrating a functional link between these proteins. Taken together, these data show that WhiB6 is required for the secretion dependent regulation of ESX-1 substrates and that ESX-1 substrates are regulated independently from the structural components, both during infection and as a result of active secretion.	[Abdallah, Abdallah M.; Guan, Qingtian; Adroub, Sabir A.; Malas, Tareq B.; Naeem, Raeece; Pain, Arnab] King Abdullah Univ Sci & Technol, BESE Div, Pathogen Genom Lab, Thuwal Jeddah, Saudi Arabia; [Weerdenburg, Eveline M.; Ummels, Roy; Borggreve, Stephanie; Bitter, Wilbert] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands; [Zhang, Huoming] King Abdullah Univ Sci & Technol, Biosci Core Lab, Thuwal Jeddah, Saudi Arabia; [Otto, Thomas D.] Wellcome Trust Sanger Inst, Pathogen Genom, Cambridge, England	King Abdullah University of Science & Technology; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; King Abdullah University of Science & Technology; Wellcome Trust Sanger Institute	Abdallah, AM; Pain, A (corresponding author), King Abdullah Univ Sci & Technol, BESE Div, Pathogen Genom Lab, Thuwal Jeddah, Saudi Arabia.; Bitter, W (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands.	abdallah.abdallah@kaust.edu.sa; w.bitter@vumc.nl; arnab.pain@kaust.edu.sa	Bitter, W/CAJ-5778-2022; Abdallah, Abdallah Musa/AAW-1826-2020; Bitter, Wilbert/AAA-6872-2019; Bitter, Wilbert/ABG-3726-2020; Otto, Thomas/ABE-7632-2020; Pain, Arnab/L-5766-2015	Bitter, Wilbert/0000-0001-8347-6511; Abdallah, Abdallah Musa/0000-0002-9773-8700; Pain, Arnab/0000-0002-1755-2819; Zhang, Huoming/0000-0001-5416-0358; Otto, Thomas/0000-0002-1246-7404; Guan, Qingtian/0000-0001-5903-1774	KAUST faculty baseline fund [BAS/1/1020-01-01]	KAUST faculty baseline fund	Work in AP's laboratory is supported by the KAUST faculty baseline fund (BAS/1/1020-01-01).	Abdallah AM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15443; Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abramovitch RB, 2011, MOL MICROBIOL, V80, P678, DOI 10.1111/j.1365-2958.2011.07601.x; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Asensio JAG, 2008, EXPERT OPIN BIOL TH, V8, P201, DOI 10.1517/14712598.8.2.201 ; Ates LS, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0011-2015; Ates LS, 2018, NAT MICROBIOL, V3, P181, DOI 10.1038/s41564-017-0090-6; Ates LS, 2017, MOL MICROBIOL, V103, P7, DOI 10.1111/mmi.13579; Ates LS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005696; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Bosserman RE, 2017, P NATL ACAD SCI USA, V114, pE10772, DOI 10.1073/pnas.1710167114; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Broset E, 2015, MBIO, V6, DOI 10.1128/mBio.01289-15; Cao GX, 2015, MICROBIOL-SGM, V161, P477, DOI 10.1099/mic.0.000023; Carlsson F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000285; Chen ZK, 2016, CELL REP, V16, P2512, DOI 10.1016/j.celrep.2016.07.080; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Coros A, 2008, MOL MICROBIOL, V69, P794, DOI 10.1111/j.1365-2958.2008.06299.x; Daleke MH, 2012, J BIOL CHEM, V287, P31939, DOI 10.1074/jbc.M112.397596; Daleke MH, 2012, P NATL ACAD SCI USA, V109, P11342, DOI 10.1073/pnas.1119453109; Das C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027980; de Jonge MI, 2007, J BACTERIOL, V189, P6028, DOI 10.1128/JB.00469-07; De Leon J, 2012, J BIOL CHEM, V287, P44184, DOI 10.1074/jbc.M112.420869; den Hengst CD, 2008, BBA-GEN SUBJECTS, V1780, P1201, DOI 10.1016/j.bbagen.2008.01.008; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Gordon BRG, 2010, P NATL ACAD SCI USA, V107, P5154, DOI 10.1073/pnas.0913551107; Groschel MI, 2017, CELL REP, V18, P2752, DOI 10.1016/j.celrep.2017.02.057; Groschel MI, 2016, NAT REV MICROBIOL, V14, P677, DOI 10.1038/nrmicro.2016.131; Hagedorn M, 2009, SCIENCE, V323, P1729, DOI 10.1126/science.1169381; Houben D, 2012, CELL MICROBIOL, V14, P1287, DOI 10.1111/j.1462-5822.2012.01799.x; Hunt DM, 2012, J BACTERIOL, V194, P2307, DOI 10.1128/JB.00142-12; Jamwal SV, 2016, SCI REP-UK, V6, DOI 10.1038/srep23089; Joshi SA, 2012, CHEM BIOL, V19, P372, DOI 10.1016/j.chembiol.2012.01.008; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; Liu KY, 2003, MICROBIOL-SGM, V149, P1829, DOI 10.1099/mic.0.26234-0; Ma Y, 2015, J BIOL CHEM, V290, P7314, DOI 10.1074/jbc.M114.622076; MacGurn JA, 2005, MOL MICROBIOL, V57, P1653, DOI 10.1111/j.1365-2958.2005.04800.x; Manganelli R, 1999, MOL MICROBIOL, V31, P715, DOI 10.1046/j.1365-2958.1999.01212.x; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Mohn WW, 2008, J BIOL CHEM, V283, P35368, DOI 10.1074/jbc.M805496200; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Otto TD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1268; Otto TD, 2010, BIOINFORMATICS, V26, P1704, DOI 10.1093/bioinformatics/btq269; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Pang XH, 2013, J BACTERIOL, V195, P66, DOI 10.1128/JB.01067-12; Pastoret S, 2004, J BACTERIOL, V186, P8370, DOI 10.1128/JB.186.24.8370-8379.2004; Phan TH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007247; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raghavan S, 2008, NATURE, V454, P717, DOI 10.1038/nature07219; Rickman L, 2005, MOL MICROBIOL, V56, P1274, DOI 10.1111/j.1365-2958.2005.04609.x; Sambandamurthy VK, 2006, VACCINE, V24, P6309, DOI 10.1016/j.vaccine.2006.05.097; Sambandamurthy VK, 2005, INFECT IMMUN, V73, P1196, DOI 10.1128/IAI.73.2.1196-1203.2005; Sani M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000794; Schmidt KL, 2004, J BACTERIOL, V186, P785, DOI 10.1128/JB.186.3.785-793.2004; Shadforth IP, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-145; Simeone R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004650; Solans L, 2014, INFECT IMMUN, V82, P3446, DOI 10.1128/IAI.01824-14; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Stoop EJM, 2011, DIS MODEL MECH, V4, P526, DOI 10.1242/dmm.006676; van der Sar AM, 2004, INFECT IMMUN, V72, P6306, DOI 10.1128/IAI.72.11.6306-6312.2004; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; van Leeuwen LM, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12858; van Winden VJC, 2016, MBIO, V7, DOI 10.1128/mBio.01471-16; Waldbauer JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043432; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Weerdenburg EM, 2015, INFECT IMMUN, V83, P1778, DOI 10.1128/IAI.03050-14; Weston A, 1998, TUBERCLE LUNG DIS, V78, P123, DOI 10.1016/S0962-8479(98)80005-1; Zhang M, 2014, MOL MICROBIOL, V93, P1057, DOI 10.1111/mmi.12718; Zheng F, 2012, CELL BIOCHEM BIOPHYS, V63, P103, DOI 10.1007/s12013-012-9348-z; Zhu J, 2014, PROTEOMICS, V14, P1688, DOI 10.1002/pmic.201400009	75	9	11	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211003	10.1371/journal.pone.0211003	http://dx.doi.org/10.1371/journal.pone.0211003			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673778	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000456442800064
J	Barbiero, C; Montico, M; Lonciari, I; Monasta, L; Penge, R; Vio, C; Tressoldi, PE; Carrozzi, M; De Petris, A; De Cagno, AG; Crescenzi, F; Tinarelli, G; Leccese, A; Pinton, A; Belacchi, C; Tucci, R; Musinu, M; Tossali, ML; Antonucci, AM; Perrone, A; Graziano, ML; Ronfani, L; Aiello, R; Andreuzzi, P; Ansuini, V; Ardu, S; Arnesano, D; Arrivas, M; Aventaggiato, F; Baciarelli, M; Barberini, MT; Bigoni, A; Bruni, L; Carloni, L; Ciufici, S; Corrias, A; D'Amato, C; Delogu, MV; Di Campli, I; Di Girolamo, MR; Di Sano, S; Dosso, G; Epifanio, G; Falciglia, G; Fancello, G; Fascetti, G; Fazioli, S; Ferluga, V; Filauri, AV; Fornaseri, R; Gambella, T; Gennaro, E; Gentile, F; Gialluca, E; Ghilardi, MS; Lauri, E; Legge, MP; Leonio, F; Lopez, M; Manca, S; Mancini, L; Mariani, E; Mirone, S; Mocci, A; Monasterio, M; Mura, MA; Nonne, G; Oneddu, T; Pagini, K; Palladino, D; Pieretti, M; Plevano, W; Rossini, G; Sansonetti, R; Santoro, S; Sau, G; Signoretto, R; Strever, G; Tullio, A; Veste, A; Zaccaria, A; Zamponi, FM				Barbiero, Chiara; Montico, Marcella; Lonciari, Isabella; Monasta, Lorenzo; Penge, Roberta; Vio, Claudio; Tressoldi, Patrizio Emanuele; Carrozzi, Marco; De Petris, Anna; De Cagno, Anna Giulia; Crescenzi, Flavia; Tinarelli, Giovanna; Leccese, Antonella; Pinton, Alessandra; Belacchi, Carmen; Tucci, Renzo; Musinu, Maria; Tossali, Maria Letizia; Antonucci, Anna Maria; Perrone, Anna; Graziano, Mara Lentini; Ronfani, Luca; Aiello, Rosaria; Andreuzzi, Paola; Ansuini, Valeria; Ardu, Stefania; Arnesano, Daniela; Arrivas, Marina; Aventaggiato, Federica; Baciarelli, Manuela; Barberini, Maria Teresa; Bigoni, Anna; Bruni, Lavinia; Carloni, Laura; Ciufici, Sandro; Corrias, Alessandra; D'Amato, Carmina; Delogu, Maria Vittoria; Di Campli, Irene; Di Girolamo, Maria Rosaria; Di Sano, Sergio; Dosso, Giulia; Epifanio, Giuseppina; Falciglia, Giuseppina; Fancello, Graziella; Fascetti, Giulia; Fazioli, Sonia; Ferluga, Valentina; Filauri, Anna Vittoria; Fornaseri, Raffaella; Gambella, Tommaso; Gennaro, Elena; Gentile, Francesca; Gialluca, Emanuela; Ghilardi, Marzia Selene; Lauri, Elisa; Legge, Maria Pia; Leonio, Franca; Lopez, Michela; Manca, Silvia; Mancini, Lucia; Mariani, Enrica; Mirone, Sara; Mocci, Anna; Monasterio, Mara; Mura, Maria Angelica; Nonne, Grazia; Oneddu, Teresa; Pagini, Karol; Palladino, Dominga; Pieretti, Manuela; Plevano, Wilma; Rossini, Giovanna; Sansonetti, Rosanna; Santoro, Stefania; Sau, Giovanna; Signoretto, Roberta; Strever, Giulia; Tullio, Alessia; Veste, Adele; Zaccaria, Antonella; Zamponi, Francesco Matteo		EpiDIt Epidemiology Dyslexia Italy	The lost children: The underdiagnosis of dyslexia in Italy. A cross-sectional national study	PLOS ONE			English	Article							QUALITY-OF-LIFE; READING-DISABILITY; LEARNING-DISABILITIES; PREVALENCE; DISORDERS; STIGMA; SAMPLE; BOYS	Background Developmental dyslexia is one of the most common neurobehavioral disorders affecting children, but prevalence data on this condition are poor. The objective of the present study is to determine the prevalence of dyslexia in Italy in an unselected school population, using clearly defined diagnostic criteria and methods. Methods Cross-sectional study carried out in nine Italian Regions: two located in Northern Italy (Friuli Venezia Giulia and Veneto), three in Central Italy (Marche, Lazio and Umbria) and four in Southern Italy (Abruzzo, Molise, Puglia and Sardegna). Three consecutive levels of screening were carried out: the first two at school, to screen the population and identify children with suspect dyslexia; the last in centers with multi-professional staff specialized in learning disabilities to confirm the diagnosis. The key outcome measure is the prevalence of dyslexia, defined as the ratio between the number of children confirmed positive at the third level of screening and the total number of children enrolled in the study. Results We finally recruited 11094 children aged 8-10 years, of which 9964 constituted the final working sample after applying exclusion criteria and including only children who received parents' consent to participate. The prevalence of dyslexia in the whole sample was 3.5% (95% CI 3.2-3.9%), with little differences between Northern, Central and Southern Italy (respectively 3.6%, 3.2% and 3.7%). In almost two out of three children with dyslexia the disorder had not been previously diagnosed. Conclusions This study confirms that in primary school children at the age of 8-10 years in Italy dyslexia is widely underestimated. Reliable data on dyslexia prevalence are needed to allocate necessary human and financial resources both to Health Services and Schools, ensuring timely support to children and families.	[Barbiero, Chiara; Montico, Marcella; Monasta, Lorenzo; Ronfani, Luca] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Clin Epidemiol & Publ Hlth Res Unit, Trieste, Italy; [Barbiero, Chiara; Lonciari, Isabella; Carrozzi, Marco] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Child Neurol & Psychiat Ward, Trieste, Italy; [Penge, Roberta] UOC NPI B La Sapienza Univ, Child Neuropsychiat Dept, Rome, Italy; [Vio, Claudio] Hosp San Dona di Piave, Child Neuropsychiat Unit, San Dona Di Piave, Italy; [Tressoldi, Patrizio Emanuele] Univ Padua, Dept Gen Psychol, Padua, Italy; [De Petris, Anna] Santo Spirito Hosp, Dept Otolaryngol & Head & Neck Surg, Pescara, Italy; [De Cagno, Anna Giulia; Crescenzi, Flavia] ASL Rm3, Rome, Italy; [Tinarelli, Giovanna] Ctr Neuropsicol Clin Eta Evolut Giorgio Sabbadini, Perugia, Italy; [Leccese, Antonella; Pinton, Alessandra] SSLI, Campobasso, Italy; [Belacchi, Carmen] Univ Urbino Carlo Bo, Dept Commun Sci Humanities & Int Studies, Urbino, Italy; [Tucci, Renzo] Studio Psicol & Logopedia, Verona, Italy; [Musinu, Maria] AIRIPA, Padua, Italy; [Tossali, Maria Letizia] Unita Operat Complessa NPI ASL Viterbo, Civita Castellana, Italy; [Antonucci, Anna Maria; Perrone, Anna; Graziano, Mara Lentini] Assoc Italiana Dislessia, Bologna, Italy	IRCCS Burlo Garofolo; IRCCS Burlo Garofolo; ULSS 4 Veneto Orientale; Ospedale di San Dona di Piave; University of Padua; University of Urbino	Ronfani, L (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Clin Epidemiol & Publ Hlth Res Unit, Trieste, Italy.	luca.ronfani@burlo.trieste.it	Montico, Marcella/B-5290-2013; Monasta, Lorenzo/B-1388-2012; gennaro, elena/ABC-2425-2020	Montico, Marcella/0000-0003-0377-8232; Monasta, Lorenzo/0000-0001-7774-548X; Carrozzi, Marco/0000-0001-6282-4417	Regional Health Agency of Friuli Venezia Giulia Region [42]; Institute for Maternal and Child Health, IRCCS "Burlo Garofolo" Research Project [63/07]; Associazione Italiana per la Ricerca e l'Intervento nella Psicopatologia dell'Apprendimento (AIRIPA); Foundation "Banca del Monte"	Regional Health Agency of Friuli Venezia Giulia Region; Institute for Maternal and Child Health, IRCCS "Burlo Garofolo" Research Project; Associazione Italiana per la Ricerca e l'Intervento nella Psicopatologia dell'Apprendimento (AIRIPA); Foundation "Banca del Monte"	The study in the Friuli Venezia Giulia Region received a grant by the Regional Health Agency of Friuli Venezia Giulia Region Resolution no 42, April 4, 2008 and by internal research funds of the Institute for Maternal and Child Health, IRCCS "Burlo Garofolo" Research Project 63/07. Furthermore, the study received a donation from the heirs of Mrs. Iole Vicinanza that allowed us to cover the cost of local supervision in the areas involved. The study in the Marche and Veneto Regions received a grant from the Associazione Italiana per la Ricerca e l'Intervento nella Psicopatologia dell'Apprendimento (AIRIPA). The Italian Dyslexia Association (Associazione Italiana Dislessia-AID) Foggia received a grant by the Foundation "Banca del Monte" to carry out the study in the Puglia Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldini G, 1958, INFANZIA ANORMALE, V26, P167; Barbiero C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048082; Belacchi C., 2008, CPM COLOURED PROGRES; BERGER M, 1975, BRIT J PSYCHIAT, V126, P510, DOI 10.1192/bjp.126.6.510; Bisiacchi P, 1978, FORMAZIONE CAMBIAMEN, V1, P3; Cappa C, 2012, DISLESSIA, V9, P1; Cassini A., 1984, ETA EVOLUTIVA, V18, P66; Chan Y, 2017, RES DEV DISABIL, V68, P131, DOI 10.1016/j.ridd.2017.07.014; Cornoldi C., 2010, DISLESSIA, V7, P89; Cornoldi C, 2004, PROVE DI LETTURA MT; Coscarella C, 2001, PSICHIATRIA INFANZIA, V68, P7; Daniel SS, 2006, J LEARN DISABIL-US, V39, P507, DOI 10.1177/00222194060390060301; Demonet JF, 2004, LANCET, V363, P1451, DOI 10.1016/S0140-6736(04)16106-0; Faglioni P., 1967, INFANZIA ANORMALE, V81, P628; Feola A, 2015, CLIN TER, V166, pE177, DOI [10.7417/CT.2015.1851, 10.7417/T.2015.1851]; Gibson S, 2010, SUPPORT LEARN, V25, P187, DOI 10.1111/j.1467-9604.2010.01465.x; Ginieri-Coccossis M, 2013, CHILD CARE HLTH DEV, V39, P581, DOI 10.1111/j.1365-2214.2012.01369.x; Goodman R, 2003, INT REV PSYCHIATR, V15, P166, DOI 10.1080/0954026021000046128; Interagency Commission on Learning Disabilities, 1987, LEARNING DISABILITIE; Katusic SK, 2001, MAYO CLIN PROC, V76, P1081, DOI 10.4065/76.11.1081; Levi G., 1982, NEUROPSICHIATRIA INF, V250, P439; LINDGREN SD, 1985, CHILD DEV, V56, P1404, DOI 10.1111/j.1467-8624.1985.tb00206.x; Masala C., 1998, PSICHIATRIA INFANZIA, V65, P648; MCGEE R, 1986, J CHILD PSYCHOL PSYC, V27, P597, DOI 10.1111/j.1469-7610.1986.tb00185.x; Mugnaini D, 2009, WORLD J PEDIATR, V5, P255, DOI 10.1007/s12519-009-0049-7; Nelson JM, 2011, J LEARN DISABIL-US, V44, P3, DOI 10.1177/0022219409359939; Orsini A, 2006, WISC III CONTRIBUTO; Peterson RL, 2012, LANCET, V379, P1997, DOI 10.1016/S0140-6736(12)60198-6; Raven JC., 2006, CPM COLOURED PROGRES; Roberto M., 2005, DISLESSIA, V2, P135; RUTTER M, 1974, ARCH DIS CHILD, V49, P249, DOI 10.1136/adc.49.4.249; Sartori G, 2007, DDE 2 BATTERIA PER L; Sava D, 1981, GIORNALE ITALIANO PS, V8, P405; SHAYWITZ SE, 1994, TOP LANG DISORD, V14, P1, DOI 10.1097/00011363-199408000-00003; SHAYWITZ SE, 1990, JAMA-J AM MED ASSOC, V264, P998, DOI 10.1001/jama.264.8.998; Shifrer D, 2013, J HEALTH SOC BEHAV, V54, P462, DOI 10.1177/0022146513503346; Toro Krisztina, 2015, Neuropsychopharmacol Hung, V17, P99; Toro KT, 2018, J LEARN DISABIL-US, V51, P158, DOI 10.1177/0022219417704169; Tressoldi PE, 2000, BATTERIA PER LA VALU; Wechsler D, 2006, WISC III WECHSLER IN; WHITAKER S, 2004, BRIT J LEARNING DISA, V32, P139, DOI DOI 10.1111/J.1468-3156.2004.00264.X; Willcutt EG, 2000, J CHILD PSYCHOL PSYC, V41, P1039, DOI 10.1017/S0021963099006368; Wilson AM, 2009, J LEARN DISABIL-US, V42, P24, DOI 10.1177/0022219408326216	43	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210448	10.1371/journal.pone.0210448	http://dx.doi.org/10.1371/journal.pone.0210448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI4TC	30673720	Green Submitted, Green Published, gold			2022-12-26	WOS:000456442800041
J	Costa, MJ; Fuentes-Perez, JF; Boavida, I; Tuhtan, JA; Pinheiro, AN				Costa, M. J.; Fuentes-Perez, J. F.; Boavida, I.; Tuhtan, J. A.; Pinheiro, A. N.			Fish under pressure: Examining behavioural responses of Iberian barbel under simulated hydropeaking with instream structures	PLOS ONE			English	Article							JUVENILE ATLANTIC SALMON; TROUT SALVELINUS-FONTINALIS; LATERAL-LINE; BROWN TROUT; RAINBOW-TROUT; PASSAGE PERFORMANCE; FLUCTUATING FLOW; STREAM FISHES; RIVER; TURBULENCE	Hydropeaking is the rapid change in the water flow downstream of a hydropower plant, driven by changes in daily electricity demand. These fluctuations may produce negative effects in freshwater fish. To minimize these impacts, previous studies have proposed habitat enhancement structures as potential mitigation measures for salmonids. However, the recommendation of these mitigation measures for cyprinids remains scarce and their effects unknown. In this study, the effects of potential habitat mitigation structures under simulated hydropeaking and base-flow conditions are examined for Iberian barbel (Luciobarbus bocagel) in an indoor flume. Solid triangular pyramids and v-shaped structures were evaluated as potential flow-refuging areas and compared with a configuration without structures. A novel, interdisciplinary approach is applied to investigate individual and group responses to rapidly changing flows, by assessing physiological (glucose and lactate), movement behaviour (structure use, sprints and drifts) and the pressure distribution using a fish-inspired artificial lateral line flow sensor. The major findings of this study are four-fold: 1) Under hydropeaking conditions, the v-shaped structures triggered a lactate response and stimulated individual structure use, whereas solid structures did not elicit physiological adjustments and favoured individual and group structure use. Overall, both solid structures and their absence stimulated sprints and drifts. 2) The hydrodynamic conditions created in hydropeaking did not always reflect increased physiological responses or swimming activity. 3) Each event-structure combination resulted in unique hydrodynamic conditions which were reflected in the different fish responses. 4) The most relevant flow variable measured was the pressure asymmetry, which is caused by the vortex size and shedding frequency of the structures. Considering the non-uniform nature of hydropeaking events, and the observation that the fish responded differently to specific flow event-structure combinations, a diverse set of instream structures should be considered for habitat-based hydropeaking mitigation measures for Iberian barbel.	[Costa, M. J.; Boavida, I.; Pinheiro, A. N.] Univ Lisbon, Inst Super Tecn, Civil Engn Res & Innovat Sustainabil, Lisbon, Portugal; [Costa, M. J.] Univ Lisbon, Ctr Estudos Florestais, Inst Super Agron, Lisbon, Portugal; [Fuentes-Perez, J. F.; Tuhtan, J. A.] Tallinn Univ Technol, Ctr Biorobot, Tallinn, Estonia	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Tallinn University of Technology	Costa, MJ (corresponding author), Univ Lisbon, Inst Super Tecn, Civil Engn Res & Innovat Sustainabil, Lisbon, Portugal.; Costa, MJ (corresponding author), Univ Lisbon, Ctr Estudos Florestais, Inst Super Agron, Lisbon, Portugal.	mariajcosta@tecnico.ulisboa.pt	Pinheiro, António N./E-2520-2012; Costa, Maria João F R/I-2781-2017; Tuhtan, Jeffrey Andrew/AAQ-5037-2020; Fuentes, Juan Francisco/N-3312-2015; Boavida, Isabel/F-5306-2012	Pinheiro, António N./0000-0002-1423-5391; Costa, Maria João F R/0000-0001-6395-6868; Tuhtan, Jeffrey Andrew/0000-0003-0832-7334; Fuentes, Juan Francisco/0000-0003-2384-9085; Boavida, Isabel/0000-0001-6005-3751	FLUVIO - River Restoration and Management Doctoral Programme from the Fundacao para a Ciencia e Tecnologia [SFRH/BD/52517/2014]; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BPD/90832/2012]; European Union's Horizon 2020 research and innovation programme [727830]; Sihtasutus Eesti Teadusagentuur (ETAg), Estonia, through the project "Bioinspired Ecohydraulic Sensor Array for Laboratory and Insitu Flow Measurements" [PUT1690]; Sihtasutus Eesti Teadusagentuur (ETAg), Estonia, through the project "Octavo" [B53]	FLUVIO - River Restoration and Management Doctoral Programme from the Fundacao para a Ciencia e Tecnologia; Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); European Union's Horizon 2020 research and innovation programme; Sihtasutus Eesti Teadusagentuur (ETAg), Estonia, through the project "Bioinspired Ecohydraulic Sensor Array for Laboratory and Insitu Flow Measurements"; Sihtasutus Eesti Teadusagentuur (ETAg), Estonia, through the project "Octavo"	MJC was funded by the FLUVIO - River Restoration and Management Doctoral Programme from the Fundacao para a Ciencia e Tecnologia, https://www.fct.pt/, Portugal (grant No SFRH/BD/52517/2014). IB was funded by Fundacao para a Ciencia e Tecnologia, https://www.fct.pt/, Portugal (grant No SFRH/BPD/90832/2012). This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 727830, http://www.fithydro.eu/.JAT contribution has been funded in part by the Sihtasutus Eesti Teadusagentuur (ETAg), https://www.etis.ee/, Estonia, through the projects "Bioinspired Ecohydraulic Sensor Array for Laboratory and Insitu Flow Measurements" (grant agreement No PUT1690) and "Octavo" (grant agreement No B53). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 2001, WILDLIFE SOC B, V29, P1294; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Arnekleiv JV, 2004, J FISH BIOL, V64, P541, DOI 10.1111/j.0022-1112.2004.00320.x; Auer S, 2017, SCI TOTAL ENVIRON, V575, P1515, DOI 10.1016/j.scitotenv.2016.10.029; Barton BA, 2002, BIOLOGICAL INDICATORS OF AQUATIC ECOSYSTEM STRESS, P111; Beamish F.W., 1979, FISH PHYSL LOCOMOTIO, P101, DOI DOI 10.1139/cjfas-2015-0209; Bejarano MD, 2018, BIOL REV, V93, P658, DOI 10.1111/brv.12362; Bejarano MD, 2017, J HYDROL, V550, P186, DOI 10.1016/j.jhydrol.2017.04.023; Bleckmann H, 2008, J COMP PHYSIOL A, V194, P145, DOI 10.1007/s00359-007-0282-2; Bleckmann H, 1994, PROGRESS IN ZOOLOGY; Boavida I, 2017, HYDROBIOLOGIA, V785, P261, DOI 10.1007/s10750-016-2931-3; Boavida I, 2015, J HYDRO-ENVIRON RES, V9, P237, DOI 10.1016/j.jher.2014.07.009; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Borcard D., 2011, MATISSE, V77, P332, DOI DOI 10.1007/978-1-4419-7976-6; Branco P, 2013, HYDROBIOLOGIA, V714, P145, DOI 10.1007/s10750-013-1532-7; Branco P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065089; Bruno M, 2014, 10 ISE 2014 TRONDH N; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; Burnett NJ, 2014, PHYSIOL BIOCHEM ZOOL, V87, P587, DOI 10.1086/677219; Capra H, 2017, SCI TOTAL ENVIRON, V578, P109, DOI 10.1016/j.scitotenv.2016.10.155; Casas-Mulet R, 2015, RIVER RES APPL, V31, P433, DOI 10.1002/rra.2827; CEN, 2003, WAT QUAL SAMPL FISH, P1; Chan M.D., 2001, FISH ECOMORPHOLOGY P; Chen K, 2017, IEEE T INSTRUM MEAS, V66, P651, DOI 10.1109/TIM.2017.2658278; Chun SN, 2011, ENVIRON BIOL FISH, V90, P43, DOI 10.1007/s10641-010-9716-8; CollaresPereira MJ, 1996, FOLIA ZOOL, V45, P65; Costa MJ, 2018, ECOHYDROLOGY, V11, DOI 10.1002/eco.1983; Costa MJ, 2019, ECOL ENG, V127, P567, DOI 10.1016/j.ecoleng.2018.07.029; COSTA MJ, 2017, J ECOHYDRAUL, V2, P68, DOI DOI 10.1080/24705357.2017.1287531; CUSHMAN R M, 1985, North American Journal of Fisheries Management, V5, P330, DOI 10.1577/1548-8659(1985)5<330:ROEEOR>2.0.CO;2; De Vocht A., 2003, 5 C FISH TEL, P35; DIJKGRAAF S, 1963, BIOL REV, V38, P51, DOI 10.1111/j.1469-185X.1963.tb00654.x; Enders EC, 2005, CAN J FISH AQUAT SCI, V62, P1079, DOI 10.1139/F05-007; Flodmark LEW, 2006, ECOL FRESHW FISH, V15, P57, DOI 10.1111/j.1600-0633.2006.00127.x; Flodmark LEW, 2002, J FISH BIOL, V60, P238, DOI 10.1006/jfbi.2001.1845; Fuentes-Perez JF, 2018, ECOL ENG, V125, P131, DOI 10.1016/j.ecoleng.2018.10.014; Fuentes-Perez JF, 2015, ECOL ENG, V85, P296, DOI 10.1016/j.ecoleng.2015.10.008; Gasith A, 1999, ANNU REV ECOL SYST, V30, P51, DOI 10.1146/annurev.ecolsys.30.1.51; Goettel MT, 2015, ECOL ENG, V74, P230, DOI 10.1016/j.ecoleng.2014.10.012; Greimel F, 2018, AQUAT ECOL SER, V8, P91, DOI 10.1007/978-3-319-73250-3_5; Harby A, 2013, ECOHYDRAULICS: AN INTEGRATED APPROACH, P323; Harvey-Lavoie S, 2016, ECOHYDROLOGY, V9, P1687, DOI 10.1002/eco.1758; Heimerl S, 2008, HYDROBIOLOGIA, V609, P197, DOI 10.1007/s10750-008-9414-0; Jones NE, 2015, RIVER RES APPL, V31, P1109, DOI 10.1002/rra.2810; Kelly B, 2017, ECOL FRESHW FISH, V26, P666, DOI 10.1111/eff.12310; Kemp PS, 2003, RIVER RES APPL, V19, P569, DOI 10.1002/rra.727; Korman J, 2011, T AM FISH SOC, V140, P487, DOI 10.1080/00028487.2011.572015; Krimmer AN, 2011, J FISH BIOL, V79, P707, DOI 10.1111/j.1095-8649.2011.03053.x; Larranaga N, 2018, RIVER RES APPL, V34, P348, DOI 10.1002/rra.3256; Liao JC, 2007, PHILOS T R SOC B, V362, P1973, DOI 10.1098/rstb.2007.2082; Liao JC, 2006, J EXP BIOL, V209, P4077, DOI 10.1242/jeb.02487; Liao JC, 2004, J EXP BIOL, V207, P3495, DOI 10.1242/jeb.01125; MAGALHAES MF, 1992, J FISH BIOL, V40, P123, DOI 10.1111/j.1095-8649.1992.tb02559.x; Martinez Capel F., 1999, Limnetica, V17, P71; Mittelbach GG, 2014, CAN J FISH AQUAT SCI, V71, P927, DOI 10.1139/cjfas-2013-0558; Monk SK., 2012, THESIS; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; Oksanen J., 2020, COMMUNITY ECOL PACKA; Oksanen J., 2015, MULTIVARIATE ANAL EC, P43; Oliveira JM, 2002, J APPL ICHTHYOL, V18, P134, DOI 10.1046/j.1439-0426.2002.00333.x; Pankhurst NW, 2011, GEN COMP ENDOCR, V170, P265, DOI 10.1016/j.ygcen.2010.07.017; Pohlert T., 2014, PAIRWISE MULTIPLE CO; Popper AN, 1996, MAR FRESHW BEHAV PHY, V27, P95, DOI 10.1080/10236249609378957; Ribi JM, 2014, AQUAT SCI, V76, P527, DOI 10.1007/s00027-014-0351-x; Ribi J-M, 2010, PROCEEDINGS OF THE 8, P675; RODRIGUEZRUIZ A, 1992, J FISH BIOL, V41, P545, DOI 10.1111/j.1095-8649.1992.tb02682.x; Romao F, 2018, WATER-SUI, V10, DOI 10.3390/w10040395; Salumae T, 2013, P ROY SOC A-MATH PHY, V469, DOI 10.1098/rspa.2012.0671; Santos JM, 2018, AQUAT CONSERV, V28, P26, DOI 10.1002/aqc.2839; Santos JM, 2014, ECOL ENG, V73, P335, DOI 10.1016/j.ecoleng.2014.09.065; Sauterleute JF, 2014, ENVIRON MODELL SOFTW, V55, P266, DOI 10.1016/j.envsoft.2014.02.004; Schmutz S, 2015, RIVER RES APPL, V31, P919, DOI 10.1002/rra.2795; Schreck CB, 2000, BIOLOGY OF ANIMAL STRESS, P147, DOI 10.1079/9780851993591.0147; Scruton DA, 2005, N AM J FISH MANAGE, V25, P964, DOI 10.1577/M04-133.1; Scruton DA, 2003, RIVER RES APPL, V19, P577, DOI 10.1002/rra.733; Shen Y, 2010, J HYDRAUL ENG, V136, P1053, DOI 10.1061/(ASCE)HY.1943-7900.0000112; Silva AT, 2011, RIVER RES APPL, V27, P360, DOI 10.1002/rra.1363; Smith DL, 2014, REV FISH SCI AQUAC, V22, P123, DOI 10.1080/10641262.2013.803516; Smith DL, 2005, T AM FISH SOC, V134, P741, DOI 10.1577/T04-069.1; Standen EM, 2002, CAN J FISH AQUAT SCI, V59, P1809, DOI 10.1139/F02-151; Stevenson C, 2009, FISH PASSAGE AUCKLAN; Stoot L.J., 2014, CONSERV PHYSIOL, V2, P1, DOI DOI 10.1093/C0NPHYS/C0U011; Sumpter J.P., 1997, P95; Tang M, 2000, CAN J FISH AQUAT SCI, V57, P1482, DOI 10.1139/cjfas-57-7-1482; Tanner RK, 2010, EUR J APPL PHYSIOL, V109, P551, DOI 10.1007/s00421-010-1379-9; Taylor MK, 2014, RIVER RES APPL, V30, P756, DOI 10.1002/rra.2673; Taylor MK, 2014, ECOHYDROLOGY, V7, P1079, DOI 10.1002/eco.1429; Taylor MK, 2012, ENVIRON REV, V20, P211, DOI [10.1139/A2012-009, 10.1139/a2012-009]; Taylor MK, 2012, ECOL FRESHW FISH, V21, P609, DOI 10.1111/j.1600-0633.2012.00582.x; Thompson LC, 2011, ENVIRON BIOL FISH, V90, P253, DOI 10.1007/s10641-010-9738-2; Tonolla D, 2017, SCI TOTAL ENVIRON, V574, P594, DOI 10.1016/j.scitotenv.2016.09.101; Tudorache C, 2008, ECOL FRESHW FISH, V17, P284, DOI 10.1111/j.1600-0633.2007.00280.x; Tuhtan, 2017, HYDROSENSOFT INT S E, P1; Tuhtan JA, 2011, PHYS LIFE REV, V8, P253, DOI 10.1016/j.plrev.2011.07.002; Tuhtan JA, 2018, BIOINSPIR BIOMIM, V13, DOI 10.1088/1748-3190/aabc79; Tuhtan JA, 2017, FLOW MEAS INSTRUM, V54, P1, DOI 10.1016/j.flowmeasinst.2016.10.017; van Netten SM, 2014, SPRINGER HANDB AUDIT, V48, P99, DOI 10.1007/2506_2013_14; Vehanen T, 2000, J FISH BIOL, V56, P923, DOI 10.1111/j.1095-8649.2000.tb00882.x; Beecham RV, 2006, N AM J AQUACULT, V68, P291, DOI 10.1577/A05-074.1; Walters K, 2006, J EXP MAR BIOL ECOL, V330, P81, DOI 10.1016/j.jembe.2005.12.018; Wang H, 2018, RIVER RES APPL, V34, P244, DOI 10.1002/rra.3245; Young PS, 2011, REV FISH BIOL FISHER, V21, P713, DOI 10.1007/s11160-011-9211-0; Zarfl C, 2015, AQUAT SCI, V77, P161, DOI 10.1007/s00027-014-0377-0; Zimmerman JKH, 2010, RIVER RES APPL, V26, P1246, DOI 10.1002/rra.1324; Zolezzi G, 2011, ECOHYDROLOGY, V4, P564, DOI 10.1002/eco.132	105	18	18	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211115	10.1371/journal.pone.0211115	http://dx.doi.org/10.1371/journal.pone.0211115			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673767	Green Submitted, Green Published, gold			2022-12-26	WOS:000456442800075
J	Hansen, SG; Womack, J; Scholz, I; Renner, A; Edgel, KA; Xu, GW; Ford, JC; Grey, M; St Laurent, B; Turner, JM; Planer, S; Legasse, A; Richie, TL; Aguiar, JC; Axthelm, MK; Villasante, ED; Weiss, W; Edlefsen, PT; Picker, LJ; Fruh, K				Hansen, Scott G.; Womack, Jennie; Scholz, Isabel; Renner, Andrea; Edgel, Kimberly A.; Xu, Guangwu; Ford, Julia C.; Grey, Mikayla; St Laurent, Brandyce; Turner, John M.; Planer, Shannon; Legasse, Al W.; Richie, Thomas L.; Aguiar, Joao C.; Axthelm, Michael K.; Villasante, Eileen D.; Weiss, Walter; Edlefsen, Paul T.; Picker, Louis J.; Fruh, Klaus			Cytomegalovirus vectors expressing Plasmodium knowlesi antigens induce immune responses that delay parasitemia upon sporozoite challenge	PLOS ONE			English	Article							HIGHLY PATHOGENIC SIV; T-CELL RESPONSES; MALARIA VACCINE; RHESUS-MONKEYS; STERILE PROTECTION; ME-TRAP; IMMUNIZATION; FALCIPARUM; NAIVE; EFFICACY	The development of a sterilizing vaccine against malaria remains one of the highest priorities for global health research. While sporozoite vaccines targeting the pre-erythrocytic stage show great promise, it has not been possible to maintain efficacy long-term, likely due to an inability of these vaccines to maintain effector memory T cell responses in the liver. Vaccines based on human cytomegalovirus (HCMV) might overcome this limitation since vectors based on rhesus CMV (RhCMV), the homologous virus in rhesus macaques (RM), elicit and indefinitely maintain high frequency, non-exhausted effector memory T cells in extralymphoid tissues, including the liver. Moreover, RhCMV strain 68-1 elicits CD8+ T cells broadly recognizing unconventional epitopes exclusively restricted by MHC-II and MHC-E. To evaluate the potential of these unique immune responses to protect against malaria, we expressed four Plasmodium knowlesi (Pk) antigens (CSP, AMA1, SSP2/TRAP, MSP1c) in RhCMV 68-1 or in Rh189-deleted 68-1, which additionally elicits canonical MHC-la-restricted CD8+ T cells. Upon inoculation of RM with either of these Pk Ag expressing RhCMV vaccines, we obtained T cell responses to each of the four Pk antigens. Upon challenge with Pk sporozoites we observed a delayed appearance of blood stage parasites in vaccinated RM consistent with a 75-80% reduction of parasite release from the liver. Moreover, the Rh189-deleted RhCMV/Pk vectors elicited sterile protection in one RM. Once in the blood, parasite growth was not affected. In contrast to T cell responses induced by Pk infection, RhCMV vectors maintained sustained T cell responses to all four malaria antigens in the liver post-challenge. The delayed appearance of blood stage parasites is thus likely due to a T cell-mediated inhibition of liver stage parasite development. As such, this vaccine approach can be used to efficiently test new T cell antigens, improve current vaccines targeting the liver stage and complement vaccines targeting erythrocytic antigens.	[Hansen, Scott G.; Womack, Jennie; Scholz, Isabel; Xu, Guangwu; Ford, Julia C.; Grey, Mikayla; Axthelm, Michael K.; Picker, Louis J.; Fruh, Klaus] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97239 USA; [Hansen, Scott G.; Turner, John M.; Planer, Shannon; Legasse, Al W.; Axthelm, Michael K.; Picker, Louis J.; Fruh, Klaus] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Renner, Andrea; Edgel, Kimberly A.; Richie, Thomas L.; Aguiar, Joao C.; Villasante, Eileen D.; Weiss, Walter] Naval Med Res Ctr, US Mil Malaria Vaccine Program, Silver Spring, MD USA; [St Laurent, Brandyce] NIH, Lab Malaria & Vector Res, Malaria Pathogenesis & Human Immun Unit, Rockville, MD USA; [Edlefsen, Paul T.] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Scholz, Isabel] Olology, Frederick, MD USA; [Renner, Andrea] USAMRMC, Ft Detrick, MD USA; [Richie, Thomas L.] Sanaria Inc, Rockville, MD USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Naval Medical Research Center (NMRC); National Institutes of Health (NIH) - USA; Fred Hutchinson Cancer Center; Sanaria Inc.	Fruh, K (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97239 USA.	fruehk@ohsu.edu		St. Laurent, Brandyce/0000-0002-2957-5364; Frueh, Klaus/0000-0001-8014-3877; Richie, Thomas/0000-0002-2946-5456	Military Infectious Disease Research Program [F0351_13_NM]; Naval Medical Research Center [N62645-13-D-4021]; National Institute of Health [R21AI103498, R01AI059457, R01AI123182]; National Center for Research Resources; Office of Research Infrastructure Programs of the NIH [P510D011092]; NIH Nonhuman Primate Reagent Resource [R24 RR016001]; National Institute of Allergy and Infectious Diseases [HHSN 2722000900037C];  [A1256]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059457, R21AI103498, R01AI123182, R56AI059457] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	Military Infectious Disease Research Program; Naval Medical Research Center; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Nonhuman Primate Reagent Resource; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported/funded by work unit number A1256, by the Military Infectious Disease Research Program project number F0351_13_NM, Naval Medical Research Center grant N62645-13-D-4021, and by the National Institute of Health grants R21AI103498, R01AI059457 and R01AI123182. This project was also supported by the National Center for Research Resources and the Office of Research Infrastructure Programs of the NIH through grant P510D011092 as well as NIH Nonhuman Primate Reagent Resource (R24 RR016001) and National Institute of Allergy and Infectious Diseases contract (HHSN 2722000900037C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2015, FUTURE MICROBIOL, V10, P1553, DOI 10.2217/fmb.15.90; Aguiar JC, 2001, VACCINE, V20, P275, DOI 10.1016/S0264-410X(01)00273-0; Aguiar Joao C, 2015, PLoS One, V10, pe0136109, DOI 10.1371/journal.pone.0136109; Best D. J., 1975, Applied Statistics, V24, P377, DOI 10.2307/2347111; Bijker EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112910; Chang WLW, 2003, J VIROL, V77, P5073, DOI 10.1128/JVI.77.9.5073-5083.2003; Chuang I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055571; Cicin-Sain L, 2007, P NATL ACAD SCI USA, V104, P19960, DOI 10.1073/pnas.0705905104; Cicin-Sain L, 2011, J IMMUNOL, V187, P1722, DOI 10.4049/jimmunol.1100560; Davies DH, 2015, VACCINE, V33, P7496, DOI 10.1016/j.vaccine.2015.09.059; de Barra E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115161; Douradinha Bruno, 2011, J Immune Based Ther Vaccines, V9, P6, DOI 10.1186/1476-8518-9-6; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Epstein JE, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89154; Epstein JE, 2013, CURR OPIN INFECT DIS, V26, P420, DOI 10.1097/QCO.0000000000000002; Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836; FRUH K, 1991, INFECT IMMUN, V59, P1319; Fruh K, 2017, CURR OPIN IMMUNOL, V47, P52, DOI 10.1016/j.coi.2017.06.010; Good MF, 2010, IMMUNITY, V33, P555, DOI 10.1016/j.immuni.2010.10.005; Gupta S, 2005, CURR OPIN MICROBIOL, V8, P428, DOI 10.1016/j.mib.2005.06.011; Hansen SG, 2018, NAT MED, V24, P130, DOI 10.1038/nm.4473; Hansen SG, 2016, SCIENCE, V351, P714, DOI 10.1126/science.aac9475; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2010, SCIENCE, V328, P102, DOI 10.1126/science.1185350; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hill AVS, 2011, PHILOS T R SOC B, V366, P2806, DOI 10.1098/rstb.2011.0091; Hodgson SH, 2015, J INFECT DIS, V211, P1076, DOI 10.1093/infdis/jiu579; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Ishizuka AS, 2016, NAT MED, V22, P614, DOI 10.1038/nm.4110; Jiang G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006559; Kimani D, 2014, MOL THER, V22, P1992, DOI 10.1038/mt.2014.109; Lyke KE, 2017, P NATL ACAD SCI USA, V114, P2711, DOI 10.1073/pnas.1615324114; Masopust D, 2012, J IMMUNOL, V188, P5811, DOI 10.4049/jimmunol.1102695; Moorthy VS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-312; Mordmuller B, 2017, NATURE, V542, P445, DOI 10.1038/nature21060; Murphy JR, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-215; Offeddu V, 2012, INT J PARASITOL, V42, P535, DOI 10.1016/j.ijpara.2012.03.011; Ogwang C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2373; Pichyangkul S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171826; Plowe CV, 2009, J INFECT DIS, V200, P1646, DOI 10.1086/646613; R Core Team, 2013, R LANG ENV STAT COMP; Rieckmann K H, 1979, Bull World Health Organ, V57 Suppl 1, P261; Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Rogers WO, 2002, INFECT IMMUN, V70, P4329, DOI 10.1128/IAI.70.8.4329-4335.2002; Rogers WO, 2001, INFECT IMMUN, V69, P5565, DOI 10.1128/IAI.69.9.5565-5572.2001; Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105; Schmidt NW, 2011, J IMMUNOL, V186, P3836, DOI 10.4049/jimmunol.1003949; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Sheehy SH, 2012, MOL THER, V20, P2355, DOI 10.1038/mt.2012.223; Singh B, 2013, CLIN MICROBIOL REV, V26, P165, DOI 10.1128/CMR.00079-12; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Teirlinck AC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002389; Weiss WR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001063; Weiss WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031247; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; 2013, WORLD MAL REP 2013, P1	60	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210252	10.1371/journal.pone.0210252	http://dx.doi.org/10.1371/journal.pone.0210252			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673723	Green Submitted, gold, Green Published			2022-12-26	WOS:000456442800035
J	Yokoya, M; Higuchi, Y				Yokoya, Masana; Higuchi, Yukito			Day length may make geographical difference in body size and proportions: An ecological analysis of Japanese children and adolescents	PLOS ONE			English	Article							LIGHT EXPOSURE; GROWTH; SEASONALITY; HORMONE	There is a north-south gradient in the body heights of Japanese children. A hypothesis had previously been proposed that differences in thyroid hormone activity induced by geographical differences in effective day length (duration of photoperiod exceeding a predetermined light intensity) might cause the differences in height. If thyroid hormone is involved, the effect should extend to body weight. This study examined whether geographical differences in body height and weight can be explained in terms of thyroid hormone activity induced by geographical differences in the photoperiodic environment using prefecture-level anatomical data and Japanese Mesh Climatic Data. Multiple regression analysis demonstrated that the combination of effective day length and weight was statistically significant as a predictor of height. Controlling for body weight revealed that effective day length was inversely correlated with height. Multiple regression analysis revealed that a combination of effective day length and height was statistically significant as a predictor of weight. Controlling for height demonstrated that effective day length was positively correlated with weight. Assuming an inverse correlation between effective day length and thyroid hormone activity, these results appear to show that short day-length will increase the activity of thyroid hormone and contribute to increasing height, but will inhibit weight gain; in contrast, long day-length will decrease the activity of thyroid hormone and contribute to increasing weight but will inhibit height gain. Geographical differences in height, and weight, and part of the prevalence of obesity in Japanese children and early adolescents may be explained by geographical differences in effective day length.	[Yokoya, Masana] Shimonoseki Jr Coll, Shimonoseki, Yamaguchi, Japan; [Higuchi, Yukito] Kyushu Kyoritsu Univ, Yahatanishi Ku, Kitakyushu, Fukuoka, Japan		Yokoya, M (corresponding author), Shimonoseki Jr Coll, Shimonoseki, Yamaguchi, Japan.	m.yokoya@shimonoseki-jc.ac.jp		Yokoya, Masana/0000-0002-1122-9500				Biondi B, 2010, J CLIN ENDOCR METAB, V95, P3614, DOI 10.1210/jc.2010-1245; CABELLO G, 1989, REPROD NUTR DEV, V29, P387, DOI 10.1051/rnd:19890401; Dardente H, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00019; De Leonibus C, 2016, PHARMACOGENOMICS J, V16, P540, DOI 10.1038/tpj.2015.67; Ebling FJP, 2014, HORM BEHAV, V66, P56, DOI 10.1016/j.yhbeh.2014.03.009; Edwards L., 2002, LIT REV EFFECTS NATU; ENDO A, 1993, AM J PHYS ANTHROPOL, V91, P299, DOI 10.1002/ajpa.1330910305; Kooijman S, 2015, P NATL ACAD SCI USA, V112, P6748, DOI 10.1073/pnas.1504239112; Kouchi M, 1983, B U MUSEUM U TOKYO, V22, P1; Land C, 2005, EUR J ENDOCRINOL, V152, P727, DOI 10.1530/eje.1.01899; Laurberg P, 2012, EUR THYROID J, V1, P159, DOI 10.1159/000342994; Matsuda S, 1998, J BIOSOC SCI, V30, P85, DOI 10.1017/S0021932098000856; Mesh Climatic Data, 2000, MESH CLIM DAT 2000; Ministry of Education, 2013, CULT SPORTS SCI TECH; Reid KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092251; SAVIDES TJ, 1986, PHYSIOL BEHAV, V38, P571, DOI 10.1016/0031-9384(86)90427-0; Shulman DI, 2013, INT J PEDIAT ENDOCRI, V2; Stevenson TJ, 2013, P NATL ACAD SCI USA, V110, P16651, DOI 10.1073/pnas.1310643110; Wright KP, 2013, CURR BIOL, V23, P1554, DOI 10.1016/j.cub.2013.06.039; Yokoya Masana, 2016, Journal of Circadian Rhythms, V14, P7, DOI 10.5334/jcr.142; Yokoya M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050994; Yokoya M, 2011, INT J ENV RES PUB HE, V8, P4272, DOI 10.3390/ijerph8114272	22	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210265	10.1371/journal.pone.0210265	http://dx.doi.org/10.1371/journal.pone.0210265			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668608	Green Submitted, gold, Green Published			2022-12-26	WOS:000456306400007
J	Rodriguez-Pascual, F				Rodriguez-Pascual, Fernando			How evolution made the matrix punch at the multicellularity party	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							ORIGIN	The basement membrane is a specialized sheet-like form of the extracellular matrix that provides structural support to epithelial cells and tissues, while influencing multiple biological functions, and was essential in the transition to multicellularity. By exploring a variety of genomes, Darris et al. provide evidence that the emergence and divergence of a multifunctional Goodpasture antigen-binding protein (GPBP), a basement membrane constituent, played a role in this transition. These findings help to explain how GPBP contributed to the formation of these extracellular matrices and to more precisely define the transition to multicellular organisms.	[Rodriguez-Pascual, Fernando] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Nicolas Cabrera 1, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Rodriguez-Pascual, F (corresponding author), UAM, CSIC, Ctr Biol Mol Severo Ochoa, Nicolas Cabrera 1, E-28049 Madrid, Spain.	frodriguez@cbm.csic.es	Rodríguez-Pascual, Fernando/Q-5100-2019	Rodríguez-Pascual, Fernando/0000-0002-9765-9578				Brown KL, 2017, PROTEIN SCI, V26, P2151, DOI 10.1002/pro.3283; Brunet T, 2017, DEV CELL, V43, P124, DOI 10.1016/j.devcel.2017.09.016; Darris C, 2019, J BIOL CHEM, V294, P759, DOI 10.1074/jbc.RA118.006225; Fahey B, 2012, MOL BIOL EVOL, V29, P1823, DOI 10.1093/molbev/mss060; Fidler AL, 2017, ELIFE, V6, DOI 10.7554/eLife.24176; Germer J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140100; Grau-Bove X, 2017, ELIFE, V6, DOI 10.7554/eLife.26036; Grau-Bove X, 2015, SCI REP-UK, V5, DOI 10.1038/srep10568; Mencarelli C, 2010, J NEUROCHEM, V113, P1369, DOI 10.1111/j.1471-4159.2010.06673.x; Sebe-Pedros A, 2016, CELL, V165, P1224, DOI 10.1016/j.cell.2016.03.034	10	1	1	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					770	771		10.1074/jbc.H118.006972	http://dx.doi.org/10.1074/jbc.H118.006972			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30659161	Green Published, hybrid			2022-12-26	WOS:000458670200003
J	Rettig, TA; Bye, BA; Nishiyama, NC; Hlavacek, S; Ward, C; Pecaut, MJ; Chapes, SK				Rettig, Trisha A.; Bye, Bailey A.; Nishiyama, Nina C.; Hlavacek, Savannah; Ward, Claire; Pecaut, Michael J.; Chapes, Stephen K.			Effects of skeletal unloading on the antibody repertoire of tetanus toxoid and/or CpG treated C57BL/6J mice	PLOS ONE			English	Article							PERIPHERAL-BLOOD LEUKOCYTES; IMMUNE-RESPONSES; SPACE-FLIGHT; ANTIORTHOSTATIC SUSPENSION; MONOCLONAL-ANTIBODIES; IMMUNOGLOBULIN HEAVY; AFFINITY MATURATION; GENE-EXPRESSION; CELL-FUNCTION; PLASMA-CELLS	Spaceflight affects the immune system, but the effects on the antibody repertoire, responsible for humoral immunity, has not been well explored. In particular, the complex gene assembly and expression process; including mutations, might make this process vulnerable. Complementarity determining region 3 (CDR3), composed of parts of the V-(D-) J-gene segments, is very important for antigen binding and can be used as an important measure of variability. Skeletal unloading, and the physiological effects of it, parallel many impacts of space flight. Therefore, we explored the impact of skeletal unloading using the antiorthostatic suspension (AOS) model. Animals were experimentally challenged with tetanus toxoid (TT) and/or the adjuvant CpG. Blood was analyzed for anti-TT antibody and corticosterone concentrations. Whole spleen tissue was prepared for repertoire characterization. AOS animals showed higher levels of corticosterone levels, but AOS alone did not affect anti-TT serum antibody levels. Administration of CpG significantly increased the circulating anti-TT antibody concentrations. AOS did alter constant gene usage resulting in higher levels of IgM and lower levels of IgG. CpG also altered constant gene region usage increasing usage of IgA. Significant changes could be detected in multiple V-, D-, and J-gene segments in both the heavy and light chains in response to AOS, TT, and CpG treatments. Analysis of class-switched only transcripts revealed a different pattern of V-gene segment usage than detected in the whole repertoire and also showed significant alterations in gene segment usage after challenge. Alterations in V/J pairing were also detected in response to challenge. CDR3 amino acid sequence overlaps were similar among treatment groups, though the addition of CpG lowered overlap in the heavy chain. We isolated 3,045 whole repertoire and 98 potentially TT-specific CDR3 sequences for the heavy chain and 569 for the light chain. Our results demonstrate that AOS alters the repertoire response to challenge with TT and/or CpG.	[Rettig, Trisha A.; Bye, Bailey A.; Hlavacek, Savannah; Ward, Claire; Chapes, Stephen K.] Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA; [Nishiyama, Nina C.; Pecaut, Michael J.] Loma Linda Univ, Div Biomed Engn Sci, Loma Linda, CA 92350 USA	Kansas State University; Loma Linda University	Chapes, SK (corresponding author), Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA.	skcbiol@ksu.edu	Pecaut, Michael J/P-6481-2015	Pecaut, Michael J/0000-0002-2915-9686; Ward, Claire/0000-0002-1486-4403; Rettig, Trisha/0000-0001-7434-9182	National Aeronautics and Space Administration [NNX13AN34G, NNX15AB45G]; National Institute of Health [GM103418]; College of Veterinary Medicine at Kansas State University; Kansas State University Johnson Cancer - Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103418] Funding Source: NIH RePORTER	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Veterinary Medicine at Kansas State University; Kansas State University Johnson Cancer - Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NNX13AN34G and NNX15AB45G from National Aeronautics and Space Administration (https://www.nasa.gov/) (SKC and MJP); GM103418 from the National Institute of Health (https://www.nih.gov/) (SKC); College of Veterinary Medicine at Kansas State University (http://www.vet.k-state.edu/); and Kansas State University Johnson Cancer - Research Center (http://cancer.k-state.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allebban Z, 1996, J APPL PHYSIOL, V81, P117, DOI 10.1152/jappl.1996.81.1.117; ALLEBBAN Z, 1994, J LEUKOCYTE BIOL, V55, P209, DOI 10.1002/jlb.55.2.209; Atkinson W, 2012, CTR DIS CONTROL PREV, DOI [10.1126/science.1135299, DOI 10.1126/SCIENCE.1135299]; Bascove M, 2011, FASEB J, V25, P2947, DOI 10.1096/fj.11-185215; Bascove M, 2009, FASEB J, V23, P1607, DOI 10.1096/fj.08-121327; Bauer K, 2002, J IMMUNOL, V169, P1349, DOI 10.4049/jimmunol.169.3.1349; BERRY CA, 1970, AEROSPACE MED, V41, P500; BIKLE DD, 1994, AM J PHYSIOL-ENDOC M, V267, pE822, DOI 10.1152/ajpendo.1994.267.6.E822; Blanc S, 1998, NEUROCHEM INT, V33, P375, DOI 10.1016/S0197-0186(98)00042-4; Bode C, 2011, EXPERT REV VACCINES, V10, P499, DOI [10.1586/erv.10.174, 10.1586/ERV.10.174]; Boxio R, 2005, J APPL PHYSIOL, V98, P905, DOI 10.1152/japplphysiol.00957.2004; Cao YR, 2010, J IMMUNOL METHODS, V358, P56, DOI 10.1016/j.jim.2010.03.009; Chapes SK, 1999, J APPL PHYSIOL, V86, P2065, DOI 10.1152/jappl.1999.86.6.2065; CHAPES SK, 1993, J LEUKOCYTE BIOL, V54, P227, DOI 10.1002/jlb.54.3.227; Chevillard C, 2002, J IMMUNOL, V168, P5659, DOI 10.4049/jimmunol.168.11.5659; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Cogoli A, 1990, ESA, P89; Collins AM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0236; Congdon CC, 1996, J APPL PHYSIOL, V81, P172, DOI 10.1152/jappl.1996.81.1.172; de Kruif J, 2009, J MOL BIOL, V387, P548, DOI 10.1016/j.jmb.2009.02.009; DeKosky BJ, 2015, NAT MED, V21, P86, DOI 10.1038/nm.3743; DeKosky BJ, 2013, NAT BIOTECHNOL, V31, P166, DOI 10.1038/nbt.2492; Diwan M, 2002, J CONTROL RELEASE, V85, P247, DOI 10.1016/S0168-3659(02)00275-4; DURNOVA GN, 1976, AVIAT SPACE ENVIR MD, V47, P588; Fitzgerald W, 2009, IN VITRO CELL DEV-AN, V45, P622, DOI 10.1007/s11626-009-9225-2; Frippiat JP, 2013, MOL IMMUNOL, V56, P434, DOI 10.1016/j.molimm.2013.06.011; Frolich D, 2010, J IMMUNOL, V185, P3103, DOI 10.4049/jimmunol.1000911; FUCHS BB, 1993, J LEUKOCYTE BIOL, V54, P245, DOI 10.1002/jlb.54.3.245; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; GOULD CL, 1987, AVIAT SPACE ENVIR MD, V58, P983; Greiff V, 2017, CELL REP, V19, P1467, DOI 10.1016/j.celrep.2017.04.054; GRIGORIEV AI, 1993, ACTA ASTRONAUT, V29, P581, DOI 10.1016/0094-5765(93)90073-6; GRINDELAND RE, 1990, FASEB J, V4, P105, DOI 10.1096/fasebj.4.1.2295371; GROVE DS, 1995, EXP CELL RES, V219, P102, DOI 10.1006/excr.1995.1210; Halliley JL, 2015, IMMUNITY, V43, P132, DOI 10.1016/j.immuni.2015.06.016; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hornung V, 2002, J IMMUNOLOGY, V168; HUGHESFULFORD M, 1991, EXP GERONTOL, V26, P247, DOI 10.1016/0531-5565(91)90017-G; Ichiki AT, 1996, J LEUKOCYTE BIOL, V60, P37, DOI 10.1002/jlb.60.1.37; Jahns G, 1992, 43 CONGRESSTHE INT A; Kamgang RK, 2008, MED MICROBIOL IMMUN, V197, P369, DOI 10.1007/s00430-008-0081-6; Kimzey S.L., 1977, BIOMEDICAL RESULTS S; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Klinman DM, 2000, SPRINGER SEMIN IMMUN, V22, P173, DOI 10.1007/s002810050027; Konstantinova I.V., 1973, SPACE BIOL MED, V7, P48; KOPYDLOWSKI KM, 1992, J LEUKOCYTE BIOL, V52, P202, DOI 10.1002/jlb.52.2.202; Krieg AM, 1996, TRENDS MICROBIOL, V4, P73, DOI 10.1016/0966-842X(96)81515-0; Krohn TC, 2006, ANIM WELFARE, V15, P343; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lavinder JJ, 2014, P NATL ACAD SCI USA, V111, P2259, DOI 10.1073/pnas.1317793111; Lescale C, 2015, FASEB J, V29, P455, DOI 10.1096/fj.14-259770; Lesnyak A, 1996, J APPL PHYSIOL, V81, P178, DOI 10.1152/jappl.1996.81.1.178; LESNYAK AT, 1993, J LEUKOCYTE BIOL, V54, P214, DOI 10.1002/jlb.54.3.214; Maldonado MA, 1999, J IMMUNOL, V162, P6322; MANDEL AD, 1977, AVIAT SPACE ENVIR MD, V48, P1051; MANSER T, 1984, SCIENCE, V226, P1283, DOI 10.1126/science.6334361; MANSER T, 1990, IMMUNOL TODAY, V11, P305, DOI 10.1016/0167-5699(90)90124-R; MANSER T, 1985, IMMUNOL TODAY, V6, P94, DOI 10.1016/0167-5699(85)90024-6; MEEHAN R, 1993, J LEUKOCYTE BIOL, V54, P236, DOI 10.1002/jlb.54.3.236; MEEHAN RT, 1992, IMMUNOLOGY, V76, P491; MERRILL AH, 1992, J APPL PHYSIOL, V73, pS132, DOI 10.1152/jappl.1992.73.2.S132; MILLER ES, 1995, J APPL PHYSIOL, V78, P810, DOI 10.1152/jappl.1995.78.3.810; MOREYHOLTON E, 1981, PHYSIOLOGIST S, V24, pS45; NASH PV, 1992, EXP CELL RES, V202, P125, DOI 10.1016/0014-4827(92)90411-Z; NASH PV, 1992, J APPL PHYSIOL, V73, pS186; Nasonkin IO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028355; Pecaut MJ, 2000, AM J PHYSIOL-REG I, V279, DOI [10.1152/jappl.1998.85.1.279, DOI 10.1152/JAPPL.1998.85.1.279]; PERSSON MAA, 1991, P NATL ACAD SCI USA, V88, P2432, DOI 10.1073/pnas.88.6.2432; Poulsen TR, 2007, J IMMUNOL, V179, P3841, DOI 10.4049/jimmunol.179.6.3841; Poulsen TR, 2011, J IMMUNOL, V187, P4229, DOI 10.4049/jimmunol.1000928; Rettig TA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190982; Rettig Trisha A, 2017, Gravit Space Res, V5, P2; Scheule RK, 2000, ADV DRUG DELIVER REV, V44, P119, DOI 10.1016/S0169-409X(00)00090-9; Serova L V, 1980, Physiologist, V23, pS22; Sonnenfeld G, 1998, INT J SPORTS MED, V19, pS195, DOI 10.1055/s-2007-971992; SONNENFELD G, 1990, AVIAT SPACE ENVIR MD, V61, P648; SONNENFELD G, 1992, J APPL PHYSIOL, V73, pS191, DOI 10.1152/jappl.1992.73.2.S191; Sonnenfeld G, 1998, J APPL PHYSIOL, V85, P1429, DOI 10.1152/jappl.1998.85.4.1429; Spielmann G, 2019, J APPL PHYSIOL, V126, P469, DOI 10.1152/japplphysiol.00789.2018; STEIN TP, 1994, AM J PHYSIOL, V266, pE448, DOI 10.1152/ajpendo.1994.266.3.E448; Steinhagen F, 2011, VACCINE, V29, P3341, DOI 10.1016/j.vaccine.2010.08.002; Stowe RP, 1999, J LEUKOCYTE BIOL, V65, P179, DOI 10.1002/jlb.65.2.179; Stowe RP, 2003, AVIAT SPACE ENVIR MD, V74, P1281; Stowe RP, 2001, PSYCHOSOM MED, V63, P891, DOI 10.1097/00006842-200111000-00007; Stowe RP, 2001, AVIAT SPACE ENVIR MD, V72, P884; Takeshita F, 2001, J IMMUNOL, V167, P3555, DOI 10.4049/jimmunol.167.7.3555; Tascher G, 2019, FASEB J, V33, P3772, DOI 10.1096/fj.201801463R; TAYLOR GR, 1986, AVIAT SPACE ENVIR MD, V57, P213; TAYLOR GR, 1983, AVIAT SPACE ENVIR MD, V54, pS55; Truck J, 2015, J IMMUNOL, V194, P252, DOI 10.4049/jimmunol.1401405; UDDEN MM, 1995, AVIAT SPACE ENVIR MD, V66, P557; Vogel FR, 2000, CLIN INFECT DIS, V30, pS266, DOI 10.1086/313883; VOLK WA, 1984, INFECT IMMUN, V45, P604, DOI 10.1128/IAI.45.3.604-609.1984; VOSS EW, 1984, SCIENCE, V225, P214, DOI 10.1126/science.6729476; Ward C, 2018, LIFE SCI SPACE RES, V16, P63, DOI 10.1016/j.lssr.2017.11.003; WOLOSCHAK GE, 1987, MOL IMMUNOL, V24, P751, DOI 10.1016/0161-5890(87)90058-7; Wronski TJ, 1998, J APPL PHYSIOL, V85, P279, DOI 10.1152/jappl.1998.85.1.279	97	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210284	10.1371/journal.pone.0210284	http://dx.doi.org/10.1371/journal.pone.0210284			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653556	Green Submitted, gold, Green Published			2022-12-26	WOS:000456015500032
J	Liu, MH; Wang, Z; Ren, MM; Yang, X; Liu, BY; Qi, H; Yu, M; Song, S; Chen, SY; Liu, L; Zhang, Y; Zou, JH; Zhu, WG; Yin, YX; Luo, JY				Liu, Minghui; Wang, Zhe; Ren, Mengmeng; Yang, Xin; Liu, Boya; Qi, Hao; Yu, Miao; Song, Shi; Chen, Shuaiyi; Liu, Lu; Zhang, Yu; Zou, Junhua; Zhu, Wei-Guo; Yin, Yuxin; Luo, Jianyuan			SIRT4 regulates PTEN stability through IDE in response to cellular stresses	FASEB JOURNAL			English	Article						sirtuin 4; protein stability; insulin degrading enzyme; autophagy	INSULIN-DEGRADING ENZYME; TUMOR-SUPPRESSOR; PHOSPHATASE-ACTIVITY; INDUCED AUTOPHAGY; NUCLEAR PTEN; MALONYL-COA; METABOLISM; UBIQUITINATION; GENE; SIRTUINS	Tumor suppressor phosphatase and tensin homolog deleted on chromosome 10 (PTEN) plays a critical role in regulating cell survival, cell growth, and proliferation by antagonizing the PI3K-AKT-mTOR pathway. The regulatory mechanism of PTEN protein is still not completely understood. Here, we found that Sirtuin 4 (SIRT4) interacts with PTEN and regulates its stability. Overexpression of SIRT4 in cells causes down-regulation of PTEN. This regulation is independent of PTEN acetylation and ubiquitination. We further found that SIRT4 degrades PTEN through lysosome pathway mediated by insulin degrading enzyme (IDE). SIRT4 bridges PTEN and IDE for degradation in response to nutritional starvation stresses. Our results suggest that when cells were exposed to nutritional starvation, SIRT4 was induced and cooperated with IDE to degrade PTEN; low levels of PTEN promote cells to survive from cellular stress. Our findings provide a new regulation of PTEN in response to cellular stresses.	[Liu, Minghui; Wang, Zhe; Ren, Mengmeng; Yang, Xin; Liu, Boya; Qi, Hao; Yu, Miao; Song, Shi; Chen, Shuaiyi; Liu, Lu; Zhang, Yu; Zou, Junhua; Luo, Jianyuan] Peking Univ, Ctr Med Genet, Dept Med Genet, Hlth Sci Ctr, 38 Xueyuan Rd, Beijing 100191, Peoples R China; [Yin, Yuxin] Peking Univ, Hlth Sci Ctr, Inst Syst Biomed, Beijing, Peoples R China; [Zhu, Wei-Guo] Shenzhen Univ, Sch Med, Dept Biochem & Mol Biol, Shenzhen, Peoples R China; [Luo, Jianyuan] Univ Maryland, Sch Med, Dept Med & Res Technol, Baltimore, MD 21201 USA	Peking University; Peking University; Shenzhen University; University System of Maryland; University of Maryland Baltimore	Luo, JY (corresponding author), Peking Univ, Ctr Med Genet, Dept Med Genet, Hlth Sci Ctr, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	luojianyuan@bjmu.edu.cn	Luo, Jianyuan/ABI-7585-2020	Luo, Jianyuan/0000-0001-6057-2914; Zhu, Wei-Guo/0000-0001-8385-6581; Yang, Xin/0000-0003-0222-5839	National Natural Science Foundation of China [81671389, 81874147, 81621063, 81270427, 81471405]; National Research Program of China (973 Program) [2013CB530801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (81671389, 81874147, 81621063, 81270427, 81471405) and the National Research Program of China (973 Program, 2013CB530801). The authors declare no conflicts of interest.	Adey NB, 2000, CANCER RES, V60, P35; Alam N, 1998, BIOCHEM J, V334, P233, DOI 10.1042/bj3340233; Anderson KA, 2017, CELL METAB, V25, P838, DOI 10.1016/j.cmet.2017.03.003; Araki S, 2015, CIRCULATION, V132, P1081, DOI 10.1161/CIRCULATIONAHA.114.014821; Cao JX, 2013, MOL CELL, V51, P409, DOI 10.1016/j.molcel.2013.08.010; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Cho CS, 2017, HEPATOLOGY, V66, P700, DOI 10.1002/hep.29271; De Melo J, 2014, INT J MOL MED, V34, P835, DOI 10.3892/ijmm.2014.1840; de Tullio MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059113; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Georgescu MM, 1999, P NATL ACAD SCI USA, V96, P10182, DOI 10.1073/pnas.96.18.10182; Georgescu MM, 2000, CANCER RES, V60, P7033; Guarente L, 2000, GENE DEV, V14, P1021; Guo J, 2017, SCI REP-UK, V7, DOI 10.1038/srep39899; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; He LZ, 2010, J CLIN INVEST, V120, P2094, DOI 10.1172/JCI40778; Ho J, 2015, METHODS, V77-78, P104, DOI 10.1016/j.ymeth.2015.01.006; Huynh FK, 2018, J INHERIT METAB DIS, V41, P59, DOI 10.1007/s10545-017-0069-8; Ikenoue T, 2008, CANCER RES, V68, P6908, DOI 10.1158/0008-5472.CAN-08-1107; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jeong SM, 2013, CANCER CELL, V23, P450, DOI 10.1016/j.ccr.2013.02.024; KIRSCHNER RJ, 1983, J BIOL CHEM, V258, P967; Kurochkin IV, 2001, TRENDS BIOCHEM SCI, V26, P421, DOI 10.1016/S0968-0004(01)01876-X; Laurent G, 2013, MOL CELL, V50, P686, DOI 10.1016/j.molcel.2013.05.012; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee JT, 2013, CELL RES, V23, P552, DOI 10.1038/cr.2013.27; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li L, 2013, CELL SIGNAL, V25, P50, DOI 10.1016/j.cellsig.2012.09.020; Liang H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14771; Liang H, 2014, CELL METAB, V19, P836, DOI 10.1016/j.cmet.2014.03.023; Ho L, 2013, AGING-US, V5, P835, DOI 10.18632/aging.100616; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Malaney P, 2013, MOL BIOSYST, V9, P2877, DOI 10.1039/c3mb70267g; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Mathias RA, 2014, CELL, V159, P1615, DOI 10.1016/j.cell.2014.11.046; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Okumura K, 2006, J BIOL CHEM, V281, P26562, DOI 10.1074/jbc.M605391200; Pillai VB, 2014, CIRC RES, V114, P368, DOI 10.1161/CIRCRESAHA.113.300536; Polletta L, 2015, AUTOPHAGY, V11, P253, DOI 10.1080/15548627.2015.1009778; Salcher S, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0661-4; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Steneberg P, 2013, DIABETES, V62, P2004, DOI 10.2337/db12-1045; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Tundo GR, 2013, J BIOL CHEM, V288, P2281, DOI 10.1074/jbc.M112.393108; Van Themsche C, 2009, J BIOL CHEM, V284, P20462, DOI 10.1074/jbc.C109.009522; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wood JG, 2018, P NATL ACAD SCI USA, V115, P1564, DOI 10.1073/pnas.1720673115; Yang X, 2018, CANCER RES, V78, P372, DOI 10.1158/0008-5472.CAN-17-1912; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069	58	22	22	2	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5535	5547		10.1096/fj.201801987R	http://dx.doi.org/10.1096/fj.201801987R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30649986				2022-12-26	WOS:000462888500072
J	van den Bijgaart, RJE; Kroesen, M; Wassink, M; Brok, IC; Kers-Rebel, ED; Boon, L; Heise, T; van Scherpenzeel, M; Lefeber, DJ; Boltje, TJ; den Brok, MH; Hoogerbrugge, PM; Bull, C; Adema, GJ				van den Bijgaart, Renske J. E.; Kroesen, Michiel; Wassink, Melissa; Brok, Ingrid C.; Kers-Rebel, Esther D.; Boon, Louis; Heise, Torben; van Scherpenzeel, Monique; Lefeber, Dirk J.; Boltje, Thomas J.; den Brok, Martijn H.; Hoogerbrugge, Peter M.; Buell, Christian; Adema, Gosse J.			Combined sialic acid and histone deacetylase (HDAC) inhibitor treatment up-regulates the neuroblastoma antigen GD2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neuroblastoma; sialic acid; histone deacetylase inhibitor (HDAC inhibitor) (HDI); sialyltransferase; cancer; glycosyltransferase; disialoganglioside; GD2	N-GLYCOLYLNEURAMINIC ACID; COLONY-STIMULATING FACTOR; HIGH-RISK NEUROBLASTOMA; MONOCLONAL-ANTIBODY; ANTITUMOR-ACTIVITY; T-CELLS; ANTI-GD2 ANTIBODY; CANCER; GANGLIOSIDES; SUPPRESSION	Neuroblastoma cells highly express the disialoganglioside GD2, a tumor-associated carbohydrate antigen, which is only sparsely expressed on healthy tissue. GD2 is a primary target for the development of immunotherapy for neuroblastoma. Immunotherapy with monoclonal anti-GD2 antibodies has proven safety and efficacy in clinical trials and is included in the standard treatment for children with high-risk neuroblastoma. Strategies to modulate GD2 expression in neuroblastoma could further improve anti-GD2-targeted immunotherapy. Here, we report that the cellular sialylation pathway, as well as epigenetic reprogramming, strongly modulates GD2 expression in human and mouse neuroblastoma cell lines. Recognition of GD2 by the 14G2a antibody is sialic acid-dependent and was blocked with the fluorinated sialic acid mimetic Ac(5)3F(ax)Neu5Ac. Interestingly, sialic acid supplementation using a cell-permeable sialic acid analogue (Ac(5)Neu5Ac) boosted GD2 expression without or with minor alterations in overall cell surface sialylation. Furthermore, sialic acid supplementation with Ac(5)Neu5Ac combined with various histone deacetylase (HDAC) inhibitors, including vorinostat, enhanced GD2 expression in neuroblastoma cells beyond their individual effects. Mechanistic studies revealed that Ac(5)Neu5Ac supplementation increased intracellular CMP-Neu5Ac concentrations, thereby providing higher substrate levels for sialyltransferases. Furthermore, HDAC inhibitor treatment increased mRNA expression of the sialyltransferases GM3 synthase (ST3GAL5) and GD3 synthase (ST8SIA1), both of which are involved in GD2 biosynthesis. Our findings reveal that sialic acid analogues and HDAC inhibitors enhance GD2 expression and could potentially be employed to boost anti-GD2 targeted immunotherapy in neuroblastoma patients.	[van den Bijgaart, Renske J. E.; Wassink, Melissa; Brok, Ingrid C.; Kers-Rebel, Esther D.; den Brok, Martijn H.; Buell, Christian; Adema, Gosse J.] Radboud Univ Nijmegen, Med Ctr, Radiotherapy & OncoImmunol Lab, Dept Radiat Oncol, NL-6525 GA Nijmegen, Netherlands; [Kroesen, Michiel] Erasmus MC, Dept Radiotherapy, NL-3000 CA Rotterdam, Netherlands; [Boon, Louis] Bioceros, NL-3584 CM Utrecht, Netherlands; [Heise, Torben; Boltje, Thomas J.] Radboud Univ Nijmegen, Cluster Mol Chem, Inst Mol & Mat, NL-6525 AJ Nijmegen, Netherlands; [van Scherpenzeel, Monique; Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Translat Metab Lab, Dept Lab Med, NL-6525 DA Nijmegen, Netherlands; [Hoogerbrugge, Peter M.] Princess Maxima Ctr Pediat Oncol, NL-3584 CS Utrecht, Netherlands	Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; Radboud University Nijmegen	Adema, GJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radiotherapy & OncoImmunol Lab, Dept Radiat Oncol, NL-6525 GA Nijmegen, Netherlands.	gosse.adema@radboudumc.nl	Büll, Christian/L-9417-2013; Boltje, Thomas/F-9695-2015; Brok, Martijn H den/O-1054-2013; van den Bijgaart, Renske/I-8030-2016; Büll, Christian/AAN-1946-2021; Lefeber, Dirk DJ/A-2146-2014; Wassink, Melissa/J-1855-2018; Boon, Laurence/HCI-3629-2022; Adema, G.J./H-8007-2014	Büll, Christian/0000-0001-7785-2920; Büll, Christian/0000-0001-7785-2920; van den Bijgaart, Renske/0000-0003-0941-267X; Kroesen, Michiel/0000-0002-1346-2277; Boon, Louis/0000-0002-0937-9171; den Brok, Martijn/0000-0002-2368-0411	KWF Kankerbestrijding (Dutch Cancer Society) [KUN2015-7604]; Villa Joep Foundation; Stichting Vrienden KOC Nijmegen	KWF Kankerbestrijding (Dutch Cancer Society); Villa Joep Foundation; Stichting Vrienden KOC Nijmegen	This work was supported by Grant KUN2015-7604 (to G. J. A., T. J. B., and C. B.) from the KWF Kankerbestrijding (Dutch Cancer Society) and by continuous financial support from the Villa Joep Foundation (to P. M. H. and G. J. A.) and Stichting Vrienden KOC Nijmegen (to P. M. H. and G. J. A.). The authors declare no potential conflicts of interest.	Ahmed M, 2014, FEBS LETT, V588, P288, DOI 10.1016/j.febslet.2013.11.030; Alvarez-Rueda N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025220; Battula VL, 2012, J CLIN INVEST, V122, P2066, DOI 10.1172/JCI59735; Brinkman-Van der Linden ECM, 2000, J BIOL CHEM, V275, P8633, DOI 10.1074/jbc.275.12.8633; Bull C, 2018, CANCER RES, V78, P3574, DOI 10.1158/0008-5472.CAN-17-3376; Bull C, 2017, IMMUNOL CELL BIOL, V95, P408, DOI 10.1038/icb.2016.105; Bull C, 2015, ACS CHEM BIOL, V10, P2353, DOI 10.1021/acschembio.5b00501; Bull C, 2014, BBA-REV CANCER, V1846, P238, DOI 10.1016/j.bbcan.2014.07.005; Bull C, 2014, CANCER RES, V74, P3199, DOI 10.1158/0008-5472.CAN-14-0728; Bull C, 2013, MOL CANCER THER, V12, P1935, DOI 10.1158/1535-7163.MCT-13-0279; Burkart MD, 1999, CHEM COMMUN, P1525, DOI 10.1039/a903362i; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Cheng B, 2016, CHEMBIOCHEM, V17, P11, DOI 10.1002/cbic.201500344; Cheung NKV, 2014, INT J CANCER, V135, P2199, DOI 10.1002/ijc.28851; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; CHEUNG NKV, 1985, CANCER RES, V45, P2642; Davies LRL, 2015, TOP CURR CHEM, V366, P31, DOI 10.1007/128_2013_419; Dobrenkov K, 2014, SEMIN ONCOL, V41, P589, DOI 10.1053/j.seminoncol.2014.07.003; Fest S, 2006, CANCER RES, V66, P10567, DOI 10.1158/0008-5472.CAN-06-1158; Fukuda M, 1998, INT J MOL MED, V2, P471; Gargett T, 2016, MOL THER, V24, P1135, DOI 10.1038/mt.2016.63; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Kroesen M, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1164919; Kroesen M, 2014, INT J CANCER, V134, P1335, DOI 10.1002/ijc.28463; Kroesen M, 2012, IMMUNOTHERAPY-UK, V4, P163, DOI [10.2217/imt.11.169, 10.2217/IMT.11.169]; Kushner BH, 2014, CLIN CANCER RES, V20, P1375, DOI 10.1158/1078-0432.CCR-13-1012; Louis CU, 2015, ANNU REV MED, V66, P49, DOI 10.1146/annurev-med-011514-023121; Louis CU, 2011, BLOOD, V118, P6050, DOI 10.1182/blood-2011-05-354449; Mackall CL, 2014, NAT REV CLIN ONCOL, V11, P693, DOI 10.1038/nrclinonc.2014.177; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Matthay KK, 2012, CLIN CANCER RES, V18, P2740, DOI 10.1158/1078-0432.CCR-11-1939; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Mora J, 2016, EXPERT REV CLIN PHAR, V9, P647, DOI 10.1586/17512433.2016.1160775; MUJOO K, 1989, CANCER RES, V49, P2857; MUJOO K, 1987, CANCER RES, V47, P1098; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Schnaar R.L., 2015, ESSENTIALS GLYCOBIOL, P125; SJOBERG ER, 1993, J BIOL CHEM, V268, P10185; SJOBERG ER, 1992, J BIOL CHEM, V267, P16200; Sorkin LS, 2010, PAIN, V149, P135, DOI 10.1016/j.pain.2010.01.024; Sphyris N, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.975068; Suzuki Y, 2011, J NEUROCHEM, V116, P874, DOI 10.1111/j.1471-4159.2010.07042.x; SVENNERHOLM L, 1994, BBA-LIPID LIPID MET, V1214, P115, DOI 10.1016/0005-2760(94)90034-5; Tarek N, 2012, J CLIN INVEST, V122, P3260, DOI 10.1172/JCI62749; Varki A., 2017, ESSENTIALS GLYCOBIOL, V3, P179; Wang ZY, 2009, CURR OPIN CHEM BIOL, V13, P565, DOI 10.1016/j.cbpa.2009.08.001; YAMAGUCHI H, 1990, P NATL ACAD SCI USA, V87, P3333, DOI 10.1073/pnas.87.9.3333; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123	52	16	16	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4437	4449		10.1074/jbc.RA118.002763	http://dx.doi.org/10.1074/jbc.RA118.002763			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30670592	Green Published, hybrid			2022-12-26	WOS:000462969500013
J	Kam, A; Loo, S; Dutta, B; Sze, SK; Tam, JP				Kam, Antony; Loo, Shining; Dutta, Bamaprasad; Sze, Siu Kwan; Tam, James P.			Plant-derived mitochondria-targeting cysteine-rich peptide modulates cellular bioenergetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioenergetics; cell-penetrating peptide (CPP); peptides; peptide chemical synthesis; peptide interaction; mitochondria	LIVER ALDEHYDE DEHYDROGENASE; ALPHA-AMYLASE INHIBITORS; PENETRATING PEPTIDES; NEUTROPHIL ELASTASE; PROTEIN IMPORT; TRANSLOCATION; ANTIOXIDANTS; PRESEQUENCE; CYCLOTIDES; MECHANISM	Mitochondria are attractive therapeutic targets for developing agents to delay age-related frailty and diseases. However, few promising leads have been identified from natural products. Previously, we identified roseltide rT1, a hyperstable 27-residue cysteine-rich peptide from Hibiscus sabdariffa, as a knottin-type neutrophil elastase inhibitor. Here, we show that roseltide rT1 is also a cell-penetrating, mitochondria-targeting peptide that increases ATP production. Results from flow cytometry, live-cell imaging, pulldown assays, and genetically-modified cell lines supported that roseltide rT1 enters cells via glycosaminoglycan-dependent endocytosis, and enters the mitochondria through TOM20, a mitochondrial protein import receptor. We further showed that roseltide rT1 increases cellular ATP production via mitochondrial membrane hyperpolarization. Using biotinylated roseltide rT1 for target identification and proteomic analysis, we showed that human mitochondrial membrane ATP synthase subunit O is an intramitochondrial target. Collectively, these data support our discovery that roseltide rT1 is a first-in-class mitochondria-targeting, cysteine-rich peptide with potentials to be developed into tools to further our understanding of mitochrondria-related diseases.	[Kam, Antony; Loo, Shining; Dutta, Bamaprasad; Sze, Siu Kwan; Tam, James P.] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tam, JP (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	JPTam@ntu.edu.sg	Tam, James P/A-2176-2011; LOO, Shining/AAT-2864-2021; Dutta, Bamaprasad/AAH-4006-2020; Sze, Siu Kwan/AAO-3342-2020; Kam, Antony/P-5978-2019	Tam, James P/0000-0003-4433-198X; LOO, Shining/0000-0002-2220-8297; Dutta, Bamaprasad/0000-0002-2309-8771; Sze, Siu Kwan/0000-0002-5652-1687; Kam, Antony/0000-0003-2155-6887	Competitive Research Grant from the National Research Foundation in Singapore [NRF-CRP8-2011-05]; Nanyang Technological University Internal Funding-Synzymes and Natural Products (SYNC); AcRF Tier 3 Grant [MOE2016-T3-1-003]	Competitive Research Grant from the National Research Foundation in Singapore(National Research Foundation, Singapore); Nanyang Technological University Internal Funding-Synzymes and Natural Products (SYNC)(Nanyang Technological University); AcRF Tier 3 Grant	This work was supported in part by Competitive Research Grant NRF-CRP8-2011-05 from the National Research Foundation in Singapore, Nanyang Technological University Internal Funding-Synzymes and Natural Products (SYNC), and AcRF Tier 3 Grant MOE2016-T3-1-003. The authors declare that they have no conflicts of interest with the contents of this article.	Armstrong JA, 2018, J BIOL CHEM, V293, P8032, DOI 10.1074/jbc.RA118.003200; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; CHEN HM, 1995, GENOMICS, V28, P470, DOI 10.1006/geno.1995.1176; Cheng ZY, 2013, ANTIOXID REDOX SIGN, V19, P240, DOI 10.1089/ars.2013.5255; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; de Cavanagh EMV, 2011, CARDIOVASC RES, V89, P31, DOI 10.1093/cvr/cvq285; Dumont M, 2011, FREE RADICAL BIO MED, V51, P1014, DOI 10.1016/j.freeradbiomed.2010.11.026; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Ferrari R, 1996, J CARDIOVASC PHARM, V28, pS1; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Galluzzi L, 2012, CIRC RES, V111, P1198, DOI 10.1161/CIRCRESAHA.112.268946; Garcia Angie E, 2010, Curr Mol Pharmacol, V3, P153; Hammen PK, 1996, J BIOL CHEM, V271, P21041, DOI 10.1074/jbc.271.35.21041; Han TS, 2008, CURR PHARM DESIGN, V14, P2462, DOI 10.2174/138161208785777469; Horton KL, 2008, CHEM BIOL, V15, P375, DOI 10.1016/j.chembiol.2008.03.015; Hoshino A, 2004, MICROBIOL IMMUNOL, V48, P985, DOI 10.1111/j.1348-0421.2004.tb03621.x; Huang JG, 2011, NANO TODAY, V6, P478, DOI 10.1016/j.nantod.2011.08.002; Jagadish K, 2010, BIOPOLYMERS, V94, P611, DOI 10.1002/bip.21433; Kloss A, 2009, EUR J PHARM BIOPHARM, V72, P219, DOI 10.1016/j.ejpb.2008.10.016; LEMIRE BD, 1989, J BIOL CHEM, V264, P20206; Loo SN, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02162; Loo SN, 2016, SCI REP-UK, V6, DOI 10.1038/srep39401; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; NAVIA MA, 1989, P NATL ACAD SCI USA, V86, P7, DOI 10.1073/pnas.86.1.7; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Nguyen KNT, 2016, FEBS J, V283, P2067, DOI 10.1111/febs.13720; Nguyen PQT, 2015, J NAT PROD, V78, P695, DOI 10.1021/np500866c; Nguyen PQT, 2014, FEBS J, V281, P4351, DOI 10.1111/febs.12939; Otvos Laszlo Jr., 2008, V494, P263, DOI 10.1007/978-1-59745-419-3_15; Pae J, 2016, BBA-BIOMEMBRANES, V1858, P1860, DOI 10.1016/j.bbamem.2016.04.010; Parker GC, 2009, STEM CELLS DEV, V18, P803, DOI 10.1089/scd.2009.1806.edi; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Ross MF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P222, DOI 10.1007/s10541-005-0104-5; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Saitoh T, 2007, EMBO J, V26, P4777, DOI 10.1038/sj.emboj.7601888; Salvioli S, 2001, FEBS LETT, V492, P9, DOI 10.1016/S0014-5793(01)02199-8; Sheu SS, 2006, BBA-MOL BASIS DIS, V1762, P256, DOI 10.1016/j.bbadis.2005.10.007; SNOW AD, 1987, LAB INVEST, V57, P687; Suomalainen A, 2011, SEMIN FETAL NEONAT M, V16, P236, DOI 10.1016/j.siny.2011.05.003; Szeto H. H., 2008, DRUG ADDICTION, P535; Szeto HH, 2006, AAPS J, V8, pE521, DOI 10.1208/aapsj080362; THORNTON K, 1993, J BIOL CHEM, V268, P19906; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; WANG Y, 1993, J BIOL CHEM, V268, P4759; Weber TA, 2010, EXP GERONTOL, V45, P503, DOI 10.1016/j.exger.2010.03.018; WEISS MJ, 1987, P NATL ACAD SCI USA, V84, P5444, DOI 10.1073/pnas.84.15.5444; Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200; Yamamoto H, 2011, P NATL ACAD SCI USA, V108, P91, DOI 10.1073/pnas.1014918108; Yang W, 2016, CELL, V167, P985, DOI 10.1016/j.cell.2016.10.016; Yousif LF, 2009, CHEMBIOCHEM, V10, P2081, DOI 10.1002/cbic.200900017; Yousif LF, 2009, CHEMBIOCHEM, V10, P1939, DOI 10.1002/cbic.200900185; Zhang XY, 2016, ONCOL LETT, V12, P4887, DOI 10.3892/ol.2016.5302; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010	58	15	15	4	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4000	4011		10.1074/jbc.RA118.006693	http://dx.doi.org/10.1074/jbc.RA118.006693			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30674551	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000461854400016
J	Ruegsegger, GN; Manjunatha, S; Summer, P; Gopala, S; Zabeilski, P; Dasari, S; Vanderboom, PM; Lanza, IR; Klaus, KA; Nair, KS				Ruegsegger, Gregory N.; Manjunatha, Shankarappa; Summer, Priska; Gopala, Srinivas; Zabeilski, Piotr; Dasari, Surendra; Vanderboom, Patrick M.; Lanza, Ian R.; Klaus, Katherine A.; Nair, K. Sreekumaran			Insulin deficiency and intranasal insulin alter brain mitochondrial function: a potential factor for dementia in diabetes	FASEB JOURNAL			English	Article						ketones; mitochondrial biogenesis; proteomics; reactive oxygen species	ALZHEIMERS-DISEASE; PROTEIN-SYNTHESIS; BARRIER PERMEABILITY; IMPROVES COGNITION; OXIDATIVE STRESS; ATP PRODUCTION; CHOLESTEROL; HYPERGLYCEMIA; DYSFUNCTION; SYSTEM	Despite the strong association between diabetes and dementia, it remains to be fully elucidated how insulin deficiency adversely affects brain functions. We show that insulin deficiency in streptozotocin-induced diabetic mice decreased mitochondrial ATP production and/or citrate synthase and cytochrome oxidase activities in the cerebrum, hypothalamus, and hippocampus. Concomitant decrease in mitochondrial fusion proteins and increased fission proteins in these brain regions likely contributed to altered mitochondrial function. Although insulin deficiency did not cause any detectable increase in reactive oxygen species (ROS) emission, inhibition of monocarboxylate transporters increased ROS emission and further reduced ATP production, indicating the causative roles of elevated ketones and lactate in counteracting oxidative stress and as a fuel source for ATP production during insulin deficiency. Moreover, in healthy mice, intranasal insulin administration increased mitochondrial ATP production, demonstrating a direct regulatory role of insulin on brain mitochondrial function. Proteomics analysis of the cerebrum showed that although insulin deficiency led to oxidative post-translational modification of several proteins that cause tau phosphorylation and neurofibrillary degeneration, insulin administration enhanced neuronal development and neurotransmission pathways. Together these results render support for the critical role of insulin to maintain brain mitochondrial homeostasis and provide mechanistic insight into the potential therapeutic benefits of intranasal insulin.Ruegsegger, G. N., Manjunatha, S., Summer, P., Gopala, S., Zabeilski, P., Dasari, S., Vanderboom, P. M., Lanza, I. R., Klaus, K. A., Nair, K. S. Insulin deficiency and intranasal insulin alter brain mitochondrial function: a potential factor for dementia in diabetes.	[Ruegsegger, Gregory N.; Manjunatha, Shankarappa; Summer, Priska; Gopala, Srinivas; Zabeilski, Piotr; Vanderboom, Patrick M.; Lanza, Ian R.; Klaus, Katherine A.; Nair, K. Sreekumaran] Mayo Clin, Div Endocrinol Diabet Metab & Nutr, Rochester, MN USA; [Dasari, Surendra] Mayo Clin, Div Biomed Stat & Informat, 200 First St SW,Joseph 5-194, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Nair, KS (corresponding author), Mayo Clin, Div Biomed Stat & Informat, 200 First St SW,Joseph 5-194, Rochester, MN 55905 USA.	nair@mayo.edu		Gopala, Srinivas/0000-0001-5885-6256; Summer, Priska/0000-0002-3779-2895	U.S. National Institutes of Health, National Institute of Aging [P50-AG-016574, T32-AG-49672]; Mayo Clinic Metabolomics Resource Core Grant [U24-DK-100469]; Molecular Transducers of Physical Activity (MoTrPAC) Chemical Analysis Center Grant [U24-DK-112326]; American Diabetes Association; Indian Council of Medical Research (ICMR) International Fellowship [INDO/FRC/(Y-17)/2013-IHD]; David H. Murdock-Dole Food Company Professorship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK100469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG049672] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Mayo Clinic Metabolomics Resource Core Grant; Molecular Transducers of Physical Activity (MoTrPAC) Chemical Analysis Center Grant; American Diabetes Association(American Diabetes Association); Indian Council of Medical Research (ICMR) International Fellowship; David H. Murdock-Dole Food Company Professorship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support for this work was provided by U.S. National Institutes of Health, National Institute of Aging Grants P50-AG-016574 and T32-AG-49672; Mayo Clinic Metabolomics Resource Core Grant U24-DK-100469; Molecular Transducers of Physical Activity (MoTrPAC) Chemical Analysis Center Grant U24-DK-112326; an American Diabetes Association mentor-based fellowship grant (to S.M.); the Indian Council of Medical Research (ICMR) International Fellowship Grant INDO/FRC/(Y-17)/2013-IHD (to S.G.); and the David H. Murdock-Dole Food Company Professorship (to K.S.N.). The authors declare no conflicts of interest.	Banks WA, 1997, PEPTIDES, V18, P1577, DOI 10.1016/S0196-9781(97)00238-6; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Blachnio-Zabielska AU, 2012, RAPID COMMUN MASS SP, V26, P1134, DOI 10.1002/rcm.6216; Boirie Y, 2001, DIABETES, V50, P2652, DOI 10.2337/diabetes.50.12.2652; Bouchard P, 2002, DIABETOLOGIA, V45, P1017, DOI 10.1007/s00125-002-0853-2; Cardoso S, 2010, BBA-MOL BASIS DIS, V1802, P942, DOI 10.1016/j.bbadis.2010.07.001; Claxton A, 2015, J ALZHEIMERS DIS, V44, P897, DOI 10.3233/JAD-141791; Clodfelder-Miller BJ, 2006, DIABETES, V55, P3320, DOI 10.2337/db06-0485; De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595; Gasior M, 2006, BEHAV PHARMACOL, V17, P431, DOI 10.1097/00008877-200609000-00009; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Gellerich FN, 2008, J BIOL CHEM, V283, P30715, DOI 10.1074/jbc.M709555200; Ghersi E, 2004, J BIOL CHEM, V279, P49105, DOI 10.1074/jbc.M405329200; Gouspillou G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020709; Gratuze M, 2017, SCI REP-UK, V7, DOI 10.1038/srep46359; Guo ZY, 2017, SCI REP-UK, V7, DOI 10.1038/srep45971; Hanson Leah R, 2013, J Vis Exp, DOI 10.3791/4440; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; Hawkins BT, 2007, DIABETOLOGIA, V50, P202, DOI 10.1007/s00125-006-0485-z; Huang SB, 2015, DIABETES, V64, P1728, DOI 10.2337/db14-0758; Huber JD, 2006, AM J PHYSIOL-HEART C, V291, pH2660, DOI 10.1152/ajpheart.00489.2006; Jana A, 2009, J NEUROL SCI, V278, P5, DOI 10.1016/j.jns.2008.12.010; Johri A, 2012, J PHARMACOL EXP THER, V342, P619, DOI 10.1124/jpet.112.192138; Karakelides H, 2007, DIABETES, V56, P2683, DOI 10.2337/db07-0378; Kim DY, 2007, J NEUROCHEM, V101, P1316, DOI 10.1111/j.1471-4159.2007.04483.x; Kleinridders A, 2014, DIABETES, V63, P2232, DOI 10.2337/db14-0568; Kornhuber J, 2014, TRENDS PHARMACOL SCI, V35, P293, DOI 10.1016/j.tips.2014.04.003; Krumschnabel Gerhard, 2015, Methods Mol Biol, V1264, P245, DOI 10.1007/978-1-4939-2257-4_22; Kullmann S, 2016, PHYSIOL REV, V96, P1169, DOI 10.1152/physrev.00032.2015; Lacy ME, 2018, DIABETES CARE, V41, P2339, DOI 10.2337/dc18-0073; LaManna JC, 2009, ADV EXP MED BIOL, V645, P301, DOI 10.1007/978-0-387-85998-9_45; Lanza IR, 2012, CELL METAB, V16, P777, DOI 10.1016/j.cmet.2012.11.003; Lark DS, 2016, AM J PHYSIOL-CELL PH, V311, pC239, DOI 10.1152/ajpcell.00124.2016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065; Martin DR, 2016, SCI REP-UK, V6, DOI 10.1038/srep23658; Mason GF, 2006, DIABETES, V55, P929, DOI 10.2337/diabetes.55.04.06.db05-1325; Mattson MP, 2018, NAT REV NEUROSCI, V19, P81, DOI 10.1038/nrn.2017.156; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; MOORADIAN AD, 1987, DIABETES, V36, P1094, DOI 10.2337/diabetes.36.10.1094; Moreira PI, 2004, J NEUROENDOCRINOL, V16, P32, DOI 10.1111/j.1365-2826.2004.01107.x; Musselman DL, 2003, BIOL PSYCHIAT, V54, P317, DOI 10.1016/S0006-3223(03)00569-9; Osorio-Paz I, 2018, MOL BIOL REP, V45, P871, DOI 10.1007/s11033-018-4233-5; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Pei JJ, 2002, MOL BRAIN RES, V109, P45, DOI 10.1016/S0169-328X(02)00488-6; Prast H, 2001, PROG NEUROBIOL, V64, P51, DOI 10.1016/S0301-0082(00)00044-7; Price TO, 2012, ENDOCRINOLOGY, V153, P362, DOI 10.1210/en.2011-1638; Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345; Qian W, 2010, J ALZHEIMERS DIS, V19, P1221, DOI [10.3233/JAD-2009-1317, 10.3233/JAD-2010-1317]; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Robinson MM, 2017, CELL METAB, V25, P581, DOI 10.1016/j.cmet.2017.02.009; Robinson MM, 2014, J CLIN ENDOCR METAB, V99, pE2574, DOI 10.1210/jc.2014-2736; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Ruegsegger GN, 2018, J CLIN INVEST, V128, P3671, DOI 10.1172/JCI120843; Russell JW, 2002, FASEB J, V16, P1738, DOI 10.1096/fj.01-1027com; Shobab LA, 2005, LANCET NEUROL, V4, P841, DOI 10.1016/S1474-4422(05)70248-9; Sivitz WI, 2010, ANTIOXID REDOX SIGN, V12, P537, DOI 10.1089/ars.2009.2531; Stump CS, 2003, P NATL ACAD SCI USA, V100, P7996, DOI 10.1073/pnas.1332551100; Suzuki R, 2010, CELL METAB, V12, P567, DOI 10.1016/j.cmet.2010.11.006; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Wang XT, 2012, ACTA PHARMACOL SIN, V33, P909, DOI 10.1038/aps.2012.50; Ye J, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004754; Zabielski P, 2016, DIABETES, V65, P561, DOI 10.2337/db15-0823; Zabielski P, 2014, AM J PHYSIOL-ENDOC M, V306, pE529, DOI 10.1152/ajpendo.00610.2012; Zhao N, 2017, NEURON, V96, P115, DOI 10.1016/j.neuron.2017.09.003	67	28	29	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4458	4472		10.1096/fj.201802043R	http://dx.doi.org/10.1096/fj.201802043R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30676773	Green Published, Bronze			2022-12-26	WOS:000459794800108
J	Chetty-Makkan, CM; Grund, JM; Munyai, R; Gadla, V; Chihota, V; Maraisane, M; Charalambous, S				Chetty-Makkan, Candice M.; Grund, Jonathan M.; Munyai, Reuben; Gadla, Vuyokazi; Chihota, Violet; Maraisane, Mpho; Charalambous, Salome			"To speak or not to speak": A qualitative analysis on the attitude and willingness of women to start conversations about voluntary medical male circumcision with their partners in a peri-urban area, South Africa	PLOS ONE			English	Article							HIV PREVENTION; MEN	Introduction Voluntary medical male circumcision (VMMC) reduces the risk of HIV infection in heterosexual men and has long-term indirect protection for women, yet VMMC uptake in South Africa remains low (49.8%) in men (25-49 years). We explored the attitude and willingness of women to start conversations on VMMC with their sexual partners in a South African periurban setting to increase VMMC uptake. Methods Thirty women with median age of 30 years (inter-quartile range 26-33 years) were interviewed in a language of their choice. Key questions included: types of approach to use, gender roles, benefits and barriers to introducing the topic of VMMC, and perceptions of VMMC. Interviews were digitally-recorded, transcribed, and translated. Through a standard iterative process, a codebook was developed (QSR NVIVO 10 software) and inductive thematic analysis applied. Results Most women were willing talk to their sexual partners about circumcision, but indicated that the decision to circumcise remained that of their sexual partner. Women felt that they should encourage their partners, show more interest in circumcision, be patient, speak in a caring and respectful tone, choose a correct time when their partner was relaxed and talk in a private space about VMMC. Using magazine/newspaper articles, pamphlets or advertisements were identified as tools that could aid their discussion. Substantial barriers to initiating conversations on VMMC included accusations by partner on infidelity, fear of gender-based violence, cultural restrictions and hesitation to speak to a mature partner about circumcision. Conclusions Women need to ensure that before talking to their partner about circumcision, the environment and approach that they use are conducive. Female social network forums could be used to educate women on conversation techniques, skills to use when talking to their partners and how to address communication challenges about circumcision. Involvement of women in VMMC awareness campaigns could encourage circumcision uptake among men.	[Chetty-Makkan, Candice M.; Munyai, Reuben; Gadla, Vuyokazi; Chihota, Violet; Maraisane, Mpho; Charalambous, Salome] Aurum Inst, Parktown, South Africa; [Grund, Jonathan M.] Ctr Dis Control & Prevent, Div Global HIV & TB, Pretoria, South Africa; [Charalambous, Salome] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa	University of Witwatersrand	Chetty-Makkan, CM (corresponding author), Aurum Inst, Parktown, South Africa.	cchetty@auruminstitute.org	Chihota, Violet/DWH-9372-2022	Chihota, Violet/0000-0003-1444-9266; Chetty-Makkan, Candice/0000-0001-9292-9586; Charalambous, Salome/0000-0001-7143-1009	President's Emergency Plan for AIDS Relief (PEPFAR) through Centers for Disease Control and Prevention (CDC) [5U01 GH000522-02]	President's Emergency Plan for AIDS Relief (PEPFAR) through Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through Centers for Disease Control and Prevention (CDC) under the terms of the Cooperative Agreement Number 5U01 GH000522-02. The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the official position of the funding agencies.	Anderson C, 2010, AM J PHARM EDUC, V74, DOI 10.5688/aj7408141; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; AVAC, 2008, M REP CIV SOC DIAL M; Baeten JM, 2009, LANCET, V374, P182, DOI 10.1016/S0140-6736(09)61311-8; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Chatzichristodoulou M, 2009, DIGIT RES ARTS HUM, P1; Feuer C., 2010, CAUTIOUS NOD CUT WOM, P63; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Grund JM, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5729-6; Hallett TB, 2008, UNDERSTANDING IMPACT, V3, P1; Hankins C, 2007, REPROD HEALTH MATTER, V15, P62, DOI 10.1016/S0968-8080(07)29311-5; Hatzold K, 2015, PLOS ONE, V9, P1; Ikwegbue JN, 2007, AFR J PRIM HEALTH CA, V7, P1; Jones D, 2014, AIDS BEHAV, V18, P278, DOI 10.1007/s10461-013-0530-0; Lanham M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044825; Layer EH, 2014, CULT HEALTH SEX, V16, P258, DOI 10.1080/13691058.2013.873481; Layer EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074391; Mantell JE, 2009, CULT HEALTH SEX, V11, P139, DOI 10.1080/13691050802521155; Milford C, 2015, INT J NURS STUD, V53, P1; Nagelkerke NJD, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-16; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Osaki H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139009; Plotkin M, 2013, GLOB HEALTH-SCI PRAC, V1, P108, DOI 10.9745/GHSP-D-12-00037; Pope C, 2000, BMJ-BRIT MED J, V320, P5; Riess TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097748; Ryan G.W., 2000, HDB QUALITATIVE RES; Sardi L, 2015, MCN-AM J MATERN-CHIL, V40, P110, DOI 10.1097/NMC.0000000000000112; Sawires SR, 2014, NIH PUBLIC ACCESS, V369, P708; Shisana O., 2014, AFRICAN NATL HIV P; Tiemstra JD, 2019, J AM BOARD FAM PRACT, V12, P16; Weiss HA, 2009, LANCET INFECT DIS, V9, P669, DOI 10.1016/S1473-3099(09)70235-X; WHO, 2007, WHO TECH REP SER, V935, P1; World Health Organization & World Health Organization, 2009, WHO HDB INDOOR RADON	33	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210480	10.1371/journal.pone.0210480	http://dx.doi.org/10.1371/journal.pone.0210480			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682057	gold, Green Published, Green Submitted			2022-12-26	WOS:000457037500038
J	Qi, WJ; Allen, AS; Li, YJ				Qi, Wenjing; Allen, Andrew S.; Li, Yi-Ju			Family-based association tests for rare variants with censored traits	PLOS ONE			English	Article							AGE-AT-ONSET; QUANTITATIVE TRAITS; ALZHEIMER-DISEASE; SEQUENCING DATA; LINKAGE; MODELS; LOCI	We propose a set of family-based burden and kernel tests for censored traits (FamBAC and FamKAC). Here, censored traits refer to time-to-event outcomes, for instance, age-at-onset of a disease. To model censored traits in family-based designs, we used the frailty model, which incorporated not only fixed genetic effects of rare variants in a region of interest but also random polygenic effects shared within families. We first partitioned genotype scores of rare variants into orthogonal between- and within-family components, and then derived their corresponding efficient score statistics from the frailty model. Finally, FamBAC and FamKAC were constructed by aggregating the weighted efficient scores of the within-family components across rare variants and subjects. FamBAC collapsed rare variants within subject first to form a burden test that followed a chi-squared distribution; whereas FamKAC was a variant component test following a mixture of chi-squared distributions. For FamKAC, p-values can be computed by permutation tests or for computational efficiency by approximation methods. Through simulation studies, we showed that type I error was correctly controlled by FamBAC for various variant weighting schemes ( 0.0371 to 0.0527). However, FamKAC type I error rates based on approximation methods were deflated (max 0.0376) but improved by permutation tests. Our simulations also demonstrated that burden test FamBAC had higher power than kernel test FamKAC when high proportion (e.g. >= 80%) of causal variants had effects in the same direction. In contrast, when the effects of causal variants on the censored trait were in mixed directions, FamKAC outperformed FamBAC and had comparable or higher power than an existing method, RVFam. Our proposed framework has the flexibility to accommodate general nuclear families, and can be used to analyze sequence data for censored traits such as age-at-onset of a complex disease of interest.	[Qi, Wenjing; Allen, Andrew S.; Li, Yi-Ju] Duke Univ, Dept Biostat & Bioinformat, Durham, NC 27708 USA; [Qi, Wenjing; Li, Yi-Ju] Duke Univ, Duke Mol Physiol Inst, Durham, NC 27708 USA; [Allen, Andrew S.] Duke Univ, Ctr Stat Genet & Genom, Durham, NC USA	Duke University; Duke University; Duke University	Li, YJ (corresponding author), Duke Univ, Dept Biostat & Bioinformat, Durham, NC 27708 USA.; Li, YJ (corresponding author), Duke Univ, Duke Mol Physiol Inst, Durham, NC 27708 USA.	yiju.li@duke.edu		Allen, Andrew/0000-0002-7232-2143; Li, Yi-Ju/0000-0001-6996-4834	Faculty Methodology Award from Department of Biostatistics and Bioinformatics at Duke University; Duke Clinical and Translational Science Institute (Duke CTSI) - Duke CTSA grant from National Institute of Health (NIH) [NIH UL1TR001117]; R01 grant from National Institute of Aging of NIH [1R01AG060472-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG060472] Funding Source: NIH RePORTER	Faculty Methodology Award from Department of Biostatistics and Bioinformatics at Duke University; Duke Clinical and Translational Science Institute (Duke CTSI) - Duke CTSA grant from National Institute of Health (NIH); R01 grant from National Institute of Aging of NIH; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Faculty Methodology Award from Department of Biostatistics and Bioinformatics at Duke University and Duke Clinical and Translational Science Institute (Duke CTSI), which is supported in part by the Duke CTSA grant NIH UL1TR001117 from National Institute of Health (NIH), and the R01 grant from National Institute of Aging of NIH (1R01AG060472-01) to Y.J.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Cai TX, 2011, BIOMETRICS, V67, P975, DOI 10.1111/j.1541-0420.2010.01544.x; Chen H, 2014, GENET EPIDEMIOL, V38, P191, DOI 10.1002/gepi.21791; Chen H, 2013, GENET EPIDEMIOL, V37, P196, DOI 10.1002/gepi.21703; Chen MH, 2016, BIOINFORMATICS, V32, P624, DOI 10.1093/bioinformatics/btv609; Chien LC, 2017, GENET EPIDEMIOL, V41, P511, DOI 10.1002/gepi.22054; Davies RB, 1980, APPLIED STATISTICS, V29, P323, DOI DOI 10.2307/2346911; Daw EW, 2000, AM J HUM GENET, V66, P196, DOI 10.1086/302710; De G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048495; Do R, 2012, HUM MOL GENET, V21, pR1, DOI 10.1093/hmg/dds387; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Hill-Burns EM, 2016, HUM MOL GENET, V25, P3849, DOI 10.1093/hmg/ddw206; Jiang D, 2014, GENET EPIDEMIOL, V38, P10, DOI 10.1002/gepi.21775; Jiang Y, 2017, GENET EPIDEMIOL, V41, P98, DOI 10.1002/gepi.22022; Jiang YX, 2014, GENET EPIDEMIOL, V38, P542, DOI 10.1002/gepi.21839; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li YJ, 2002, AM J HUM GENET, V70, P985, DOI 10.1086/339815; Li YJ, 2003, HUM MOL GENET, V12, P3259, DOI 10.1093/hmg/ddg357; Lin XY, 2011, GENET EPIDEMIOL, V35, P620, DOI 10.1002/gepi.20610; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Naj AC, 2014, JAMA NEUROL, V71, P1394, DOI 10.1001/jamaneurol.2014.1491; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Pan W, 2009, GENET EPIDEMIOL, V33, P497, DOI 10.1002/gepi.20402; Ripatti S, 2000, BIOMETRICS, V56, P1016, DOI 10.1111/j.0006-341X.2000.01016.x; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Schifano ED, 2012, GENET EPIDEMIOL, V36, P797, DOI 10.1002/gepi.21676; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Sha QY, 2012, GENET EPIDEMIOL, V36, P561, DOI 10.1002/gepi.21649; Therneau TM, 2003, J COMPUT GRAPH STAT, V12, P156, DOI 10.1198/1061860031365; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zawistowski M, 2014, EUR J HUM GENET, V22, P1137, DOI 10.1038/ejhg.2013.297; Zhang L, 2009, AM J HUM GENET, V84, P431, DOI 10.1016/j.ajhg.2009.02.010; Zollner S, 2012, EUR J HUM GENET, V20, P1085, DOI 10.1038/ejhg.2012.58	37	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210870	10.1371/journal.pone.0210870	http://dx.doi.org/10.1371/journal.pone.0210870			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682063	Green Published, gold, Green Submitted			2022-12-26	WOS:000457037500070
J	Minematsu, A; Miyazaki, T; Shimamura, S; Nishikawa, H; Nakayama, H; Takazono, T; Saijo, T; Yamamoto, K; Imamura, Y; Yanagihara, K; Kohno, S; Mukae, H; Izumikawa, K				Minematsu, Asuka; Miyazaki, Taiga; Shimamura, Shintaro; Nishikawa, Hiroshi; Nakayama, Hironobu; Takazono, Takahiro; Saijo, Tomomi; Yamamoto, Kazuko; Imamura, Yoshifumi; Yanagihara, Katsunori; Kohno, Shigeru; Mukae, Hiroshi; Izumikawa, Koichi			Vacuolar proton-translocating ATPase is required for antifungal resistance and virulence of Candida glabrata	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST; ACIDIFICATION; MEMBRANE; ALBICANS; BAFILOMYCINS; CALCINEURIN; HOMEOSTASIS; MECHANISMS; EVOLUTION	Vacuolar proton-translocating ATPase (V-ATPase) is located in fungal vacuolar membranes. It is involved in multiple cellular processes, including the maintenance of intracellular ion homeostasis by maintaining acidic pH within the cell. The importance of V-ATPase in virulence has been demonstrated in several pathogenic fungi, including Candida albicans. However, it remains to be determined in the clinically important fungal pathogen Candida glabrata. Increasing multidrug resistance of C. glabrata is becoming a critical issue in the clinical setting. In the current study, we demonstrated that the plecomacrolide V-ATPase inhibitor bafilomycin B1 exerts a synergistic effect with azole antifungal agents, including fluconazole and voriconazole, against a C. glabrata wild-type strain. Furthermore, the deletion of the VPH2 gene encoding an assembly factor of V-ATPase was sufficient to interfere with V-ATPase function in C. glabrata, resulting in impaired pH homeostasis in the vacuole and increased sensitivity to a variety of environmental stresses, such as alkaline conditions (pH 7.4), ion stress (Na+, Ca2+, Mn2+, and Zn2+ stress), exposure to the calcineurin inhibitor FK506 and antifungal agents (azoles and amphotericin B), and iron limitation. In addition, virulence of C. glabrata Delta vph2 mutant in a mouse model of disseminated candidiasis was reduced in comparison with that of the wild-type and VPH2-reconstituted strains. These findings support the notion that V-ATPase is a potential attractive target for the development of effective antifungal strategies.	[Minematsu, Asuka; Miyazaki, Taiga; Takazono, Takahiro; Izumikawa, Koichi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Infect Dis, Nagasaki, Japan; [Minematsu, Asuka; Miyazaki, Taiga; Shimamura, Shintaro; Nishikawa, Hiroshi; Takazono, Takahiro; Saijo, Tomomi; Yamamoto, Kazuko; Imamura, Yoshifumi; Kohno, Shigeru; Mukae, Hiroshi] Nagasaki Univ Hosp, Dept Resp Med, Nagasaki, Japan; [Nakayama, Hironobu] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Mie, Japan; [Yanagihara, Katsunori] Nagasaki Univ, Grad Sch Biomed Sci, Dept Lab Med, Nagasaki, Japan; [Nishikawa, Hiroshi] Otsuka Pharmaceut Co Ltd, Infect Dis Unit, Dept Med Innovat, New Drug Res Div, Tokushima, Japan	Nagasaki University; Nagasaki University; Nagasaki University; Otsuka Pharmaceutical	Miyazaki, T (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Infect Dis, Nagasaki, Japan.; Miyazaki, T (corresponding author), Nagasaki Univ Hosp, Dept Resp Med, Nagasaki, Japan.	taiga-m@nagasaki-u.ac.jp		Takazono, Takahiro/0000-0002-0696-5386	Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development (AMED) [JP18fk0108008]	Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was partially supported by the Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development (AMED) (https://www.amed.go.jp/en/program/list/01/06/002.html) (grant number JP18fk0108008 to T.M. and S.K.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Arendrup MC, 2017, J INFECT DIS, V216, pS445, DOI 10.1093/infdis/jix131; Bairwa G, 2014, BIOCHEM J, V458, P323, DOI 10.1042/BJ20130757; Bond S, 2008, J BIOL CHEM, V283, P36513, DOI 10.1074/jbc.M805232200; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; CLINICAL AND LABORATORY STANDARDS INSTITUTE (CLSI), 2012, REFERENCE METHOD BRO, V4th; Committee for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A, V8th; Davis-Kaplan SR, 2006, J BIOL CHEM, V281, P32025, DOI 10.1074/jbc.M606451200; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Erickson T, 2001, MOL MICROBIOL, V42, P1121, DOI 10.1046/j.1365-2958.2001.02712.x; Finnigan GC, 2012, NATURE, V481, P360, DOI 10.1038/nature10724; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; GARRETTENGELE P, 1995, MOL CELL BIOL, V15, P4103; Graham LA, 1999, J BIOENERG BIOMEMBR, V31, P39, DOI 10.1023/A:1005492429471; Graham LA, 1998, J CELL BIOL, V142, P39, DOI 10.1083/jcb.142.1.39; Gray KC, 2012, P NATL ACAD SCI USA, V109, P2234, DOI 10.1073/pnas.1117280109; Hayek SR, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00004; HEMENWAY CS, 1995, GENETICS, V141, P833; Hilty J, 2008, MOL MICROBIOL, V70, P127, DOI 10.1111/j.1365-2958.2008.06395.x; HIRATA R, 1993, J BIOL CHEM, V268, P961; Huss M, 2011, EUR J CELL BIOL, V90, P688, DOI 10.1016/j.ejcb.2011.04.009; Jefferies KC, 2008, ARCH BIOCHEM BIOPHYS, V476, P33, DOI 10.1016/j.abb.2008.03.025; Jia N, 2002, ANTIMICROB AGENTS CH, V46, P947, DOI 10.1128/AAC.46.4.947-957.2002; Johnson MD, 2004, ANTIMICROB AGENTS CH, V48, P693, DOI 10.1128/AAC.48.3.693-715.2004; Johnson RM, 2010, ANAL BIOCHEM, V398, P203, DOI 10.1016/j.ab.2009.12.020; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; Kane PM, 2012, CURR PROTEIN PEPT SC, V13, P117; Kullberg BJ, 2015, NEW ENGL J MED, V373, P1445, DOI 10.1056/NEJMra1315399; MARCIREAU C, 1990, ANTIMICROB AGENTS CH, V34, P989, DOI 10.1128/AAC.34.6.989; Miyazaki T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003160; Nagayoshi Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180990; Nishikawa H, 2016, FEMS YEAST RES, V16, DOI 10.1093/femsyr/fow054; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Patenaude C, 2013, J BIOL CHEM, V288, P26256, DOI 10.1074/jbc.M113.494815; Perlin DS, 2017, LANCET INFECT DIS, V17, pE383, DOI 10.1016/S1473-3099(17)30316-X; Pfaller MA, 2012, J CLIN MICROBIOL, V50, P1199, DOI 10.1128/JCM.06112-11; Poltermann S, 2005, MICROBIOL-SGM, V151, P1645, DOI 10.1099/mic.0.27505-0; Rahman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055704; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Weissman Z, 2008, MOL MICROBIOL, V69, P201, DOI 10.1111/j.1365-2958.2008.06277.x; Whaley SG, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02173; Wiederhold NP, 2017, INFECT DRUG RESIST, V10, P249, DOI 10.2147/IDR.S124918; Zhang YQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000939	45	9	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210883	10.1371/journal.pone.0210883	http://dx.doi.org/10.1371/journal.pone.0210883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673768	Green Submitted, Green Published, gold			2022-12-26	WOS:000456442800055
J	Mir, RA; Kleinhenz, MD; Coetzee, JF; Allen, HK; Kudva, IT				Mir, Raies A.; Kleinhenz, Michael D.; Coetzee, Johann F.; Allen, Heather K.; Kudva, Indira T.			Fecal microbiota changes associated with dehorning and castration stress primarily affects light-weight dairy calves	PLOS ONE			English	Article							PLASMA-CORTISOL; LOCAL-ANESTHESIA; HEAT-STRESS; RESPONSES; CATTLE; PAIN; INFECTION; BEHAVIOR; DISTRESS; PIPELINE	Gastrointestinal tract (GIT) microbiota and stress can impact animal health. Studies have shown that perturbations in the GIT microbiota can influence host health and productivity by affecting physiological homeostasis, metabolism, hematopoiesis and inflammation. The present study aimed to evaluate possible effects of dehorning and castration stress on the GIT microbiota of dairy calves. Dehorning and castration are routinely performed on over 90% of dairy farms, and analgesics like flunixin meglumine (FLU) are given at the time of these procedures to reduce pain. We analyzed fecal microbiota of 24 weaned male dairy calves at two different stages in their life (at 10 weeks for dehorning and 36 weeks age for castration) to determine any GIT microbiota changes due to these stressful procedures and the FLU treatment. Dehorning was performed using an electrocautery dehorner applied to the horn for 10 seconds, and surgical castration was used as the castration method. Our analysis showed that the Shannon diversity index was significantly higher in animals that were not dehorned compared to dehorned animals. Castration stress also resulted in a significant decrease in Shannon diversity index, which was more pronounced in lower weight calves. Body weight and stress had significant effects on the taxonomic profiles of the GIT microbiota. There was a significant difference in the GIT bacterial community structure between heavy- and light-weight calves at Day 3 after castration but not at Day 0 (prior to castration). Our results indicate that dehorning and castration stress reduced microbial diversity of the GIT microbiota, but only in light-weight calves. This work is important for elucidating biological effects of stress on dairy calves and identifying potential modulation points in the microbiota of these food-producing animals to improve animal health and production.	[Mir, Raies A.; Allen, Heather K.; Kudva, Indira T.] ARS, Food Safety & Enter Pathogens Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50010 USA; [Mir, Raies A.] ARS, ORISE, Res Participat Program, Oak Ridge, TN USA; [Kleinhenz, Michael D.] Iowa State Univ, Coll Vet Med, Vet Diagnost & Prod Anim Med, Ames, IA USA; [Kleinhenz, Michael D.; Coetzee, Johann F.] Kansas State Univ, Coll Vet Med, Dept Anat & Physiol, Manhattan, KS 66506 USA	United States Department of Agriculture (USDA); Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; Iowa State University; Kansas State University	Allen, HK; Kudva, IT (corresponding author), ARS, Food Safety & Enter Pathogens Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50010 USA.	Heather.Allen@ars.usda.gov; Indira.Kudva@ars.usda.gov	Kleinhenz, Michael/AAD-4696-2021; Coetzee, Hans/GOK-3477-2022	Coetzee, Hans/0000-0003-1802-3991	USDA-ARS CRIS projects [5030-32000-112-00D, 5030-32000-004-00D]	USDA-ARS CRIS projects(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by USDA-ARS CRIS projects 5030-32000-112-00D and 5030-32000-004-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aich P, 2007, OMICS, V11, P413, DOI 10.1089/omi.2007.0023; Allen Heather K, 2016, BMC Res Notes, V9, P380, DOI 10.1186/s13104-016-2172-6; Auffret MD, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0378-z; Ballou MA, 2013, VET IMMUNOL IMMUNOP, V151, P285, DOI 10.1016/j.vetimm.2012.11.018; Bates AJ, 2016, NEW ZEAL VET J, V64, P282, DOI 10.1080/00480169.2016.1196626; Baumgard LH, 2011, J DAIRY SCI, V94, P5620, DOI 10.3168/jds.2011-4462; Burrow HM, 1997, AUST J EXP AGR, V37, P407, DOI 10.1071/EA96148; Carlson DF, 2016, NAT BIOTECHNOL, V34, P479, DOI 10.1038/nbt.3560; CHASE CC, 1995, J ANIM SCI, V73, P975; Chen LM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01688; Chen Y, 2015, ANIMALS-BASEL, V5, P1268, DOI 10.3390/ani5040411; Coetzee JF, 2011, APPL ANIM BEHAV SCI, V135, P192, DOI 10.1016/j.applanim.2011.10.016; Cox LM, 2016, ANIM FRONT, V6, P8, DOI 10.2527/af.2016-0028; Deng LX, 2017, ANIM SCI J, V88, P790, DOI 10.1111/asj.12615; Dinan TG, 2012, PSYCHONEUROENDOCRINO, V37, P1369, DOI 10.1016/j.psyneuen.2012.03.007; Dockweiler JC, 2013, J DAIRY SCI, V96, P4340, DOI 10.3168/jds.2012-6274; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Eshar D, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-62; Fisher AD, 2001, AUST VET J, V79, P279, DOI 10.1111/j.1751-0813.2001.tb11981.x; FUQUAY JW, 1981, J ANIM SCI, V52, P164, DOI 10.2527/jas1981.521164x; Gareau MG, 2011, GUT, V60, P307, DOI 10.1136/gut.2009.202515; Huazano-Garcia A, 2017, NUTRIENTS, V9, DOI [10.3390/nu9090821, 10.3390/nu9080821]; Khan MA, 2016, J DAIRY SCI, V99, P885, DOI 10.3168/jds.2015-9975; KING BD, 1991, CAN J ANIM SCI, V71, P257, DOI 10.4141/cjas91-033; Kleinhenz MD, 2018, LIVEST SCI, V212, P1, DOI 10.1016/j.livsci.2018.03.016; Kleinhenz MD, 2017, J ANIM SCI, V95, P1993, DOI 10.2527/jas.2016.1138; Kling-Eveillard F, 2015, LIVEST SCI, V179, P12, DOI 10.1016/j.livsci.2015.05.012; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Liang X, 2015, ELIFE, V4, DOI 10.7554/eLife.08973; Lyte M, 2006, PHYSIOL BEHAV, V89, P350, DOI 10.1016/j.physbeh.2006.06.019; Malmuthuge N, 2014, APPL ENVIRON MICROB, V80, P2021, DOI 10.1128/AEM.03864-13; Mao SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16116; McGlone J, 2010, GUIDE CARE USE AGRIC, P1; Meale SJ, 2017, J DAIRY SCI, V100, P5984, DOI 10.3168/jds.2016-12474; Rodriguez JM, 2015, MICROB ECOL HEALTH D, V26, DOI 10.3402/mehd.v26.26050; Moggy MA, 2017, J ANIM SCI, V95; Noel SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173819; Paz HA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01206; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rault JL, 2011, APPL ANIM BEHAV SCI, V135, P214, DOI 10.1016/j.applanim.2011.10.017; Rea K, 2016, NEUROBIOL STRESS, V4, P23, DOI 10.1016/j.ynstr.2016.03.001; ROBERTSON IS, 1994, RES VET SCI, V56, P8, DOI 10.1016/0034-5288(94)90189-9; Rogers MAM, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.10.003; Romero-Perez GA, 2011, APPL ENVIRON MICROB, V77, P258, DOI 10.1128/AEM.01289-09; Salas-Mani A, 2018, J ANIM SCI, V96, P3102, DOI 10.1093/jas/sky193; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Stafford KJ, 2005, VET J, V169, P337, DOI 10.1016/j.tvjl.2004.02.005; Stilwell G, 2010, RES VET SCI, V88, P188, DOI 10.1016/j.rvsc.2009.06.012; Stock ML, 2015, J DAIRY SCI, V98, P6058, DOI 10.3168/jds.2014-8877; Syer SD, 2015, J GASTROENTEROL, V50, P387, DOI 10.1007/s00535-014-1032-1; Sylvester SP, 1998, AUST VET J, V76, P118, DOI 10.1111/j.1751-0813.1998.tb14542.x; Thompson NM, 2017, J DAIRY SCI, V100, P4941, DOI 10.3168/jds.2016-12099; Underwood WJ, 2002, J AM VET MED ASSOC, V221, P208, DOI 10.2460/javma.2002.221.208; USDA APHIS, 2014, 3 USDA APHIS CO US, P62; Voisinet BD, 1997, J ANIM SCI, V75, P892; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yun Y, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1052-0	57	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210203	10.1371/journal.pone.0210203	http://dx.doi.org/10.1371/journal.pone.0210203			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673718	Green Published, Green Submitted, gold			2022-12-26	WOS:000456442800034
J	Tuanthap, S; Vongpunsawad, S; Luengyosluechakul, S; Sakkaew, P; Theamboonlers, A; Amonsin, A; Poovorawan, Y				Tuanthap, Supansa; Vongpunsawad, Sompong; Luengyosluechakul, Supol; Sakkaew, Phanlert; Theamboonlers, Apiradee; Amonsin, Alongkorn; Poovorawan, Yong			Genome constellations of 24 porcine rotavirus group A strains circulating on commercial Thai swine farms between 2011 and 2016	PLOS ONE			English	Article							GENETIC DIVERSITY; PROVIDES EVIDENCE; CHIANG-MAI; DIARRHEA; ORIGIN; CLASSIFICATION; REVEALS; PIGLETS; MC323; RARE	Rotavirus A (RVA) infection is a major cause of diarrhea-related illness in young children. RVA is also one of the most common enteric viruses detected on pig farms and contributes to substantial morbidity and mortality in piglets. Long-term multi-site surveillance of RVA on Thai swine farms to determine the diversity of RVA strains in circulation is currently lacking. In this study, we characterized the 11 segments of the RVA genome from 24 Thai porcine RVA strains circulating between 2011 and 2016. We identified G9 (15/24) and P[13] (12/24) as the dominant genotypes. The dominant G and P combinations were G9P[13] (n = 6), G9P[23] (n = 6), G3P[13] (n = 5), G9P[19] (n = 3), G4P[6] (n = 2), G4P[19] (n = 1), and G5P [13] (n = 1). Genome constellation of the Thai strains showed the predominance of Wa-like genotype (Gx-P[x]-11/15-R1-C1-M1-A8-N1-T1/T7-E1/E9-H1) with evidence of reassortment between the porcine and human RVA strains (e.g., G4-P[6]-I1-R1-C1-M1-A8-N1-T1-E1-H1 and G9-P[19]-15-R1-C1-M1-A8-N1-T7-E9-H1). To assess the potential effectiveness of rotavirus vaccination, the Thai RVA strains were compared to the RVA strains represented in the swine rotavirus vaccine, which showed residue variations in the antigenic epitope on VP7 and shared amino acid identity below 90% for G4 and G5 strain. Several previous studies suggested these variations might effect on virus neutralization specificity and vaccine efficacy. Our study illustrates the importance of RVA surveillance beyond the G/P genotyping on commercial swine farms, which is crucial for controlling viral transmission.	[Tuanthap, Supansa] Chulalongkorn Univ, Grad Sch, Interdisciplinary Program Biomed Sci, Bangkok, Thailand; [Vongpunsawad, Sompong; Theamboonlers, Apiradee; Poovorawan, Yong] Chulalongkorn Univ, Ctr Excellence Clin Virol, Fac Med, Bangkok, Thailand; [Luengyosluechakul, Supol] Chulalongkorn Univ, Dept Vet Med, Fac Vet Sci, Bangkok, Thailand; [Sakkaew, Phanlert] Chulalongkorn Univ, Dept Vet Publ Hlth, Fac Vet Sci, Bangkok, Thailand; [Amonsin, Alongkorn] Chulalongkorn Univ, Ctr Excellence Emerging & Reemerging Infect Dis A, Fac Vet Sci, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Ctr Excellence Clin Virol, Fac Med, Bangkok, Thailand.; Amonsin, A (corresponding author), Chulalongkorn Univ, Ctr Excellence Emerging & Reemerging Infect Dis A, Fac Vet Sci, Bangkok, Thailand.	alongkom.a@chula.ac.th; yong.p@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	Poovorawan, Yong/0000-0002-2337-6807; Tuanthap, Supansa/0000-0001-9167-194X; vongpunsawad, sompong/0000-0001-7520-8728	100th Anniversary Chulalongkorn University Fund; Research Chair Grant from NSTDA [P-15-50004]; Thailand Research Fund [RTA6080012]; Center of Excellence in Clinical Virology [GCE 59- 009-30-005]	100th Anniversary Chulalongkorn University Fund; Research Chair Grant from NSTDA; Thailand Research Fund(Thailand Research Fund (TRF)); Center of Excellence in Clinical Virology	This work was supported by The 100th Anniversary Chulalongkorn University Fund for doctoral scholarship to Supansa Tuanthap, The Research Chair Grant from NSTDA (P-15-50004), Thailand Research Fund (RTA6080012), and The Center of Excellence in Clinical Virology (GCE 59- 009-30-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Estes M.K., 2013, FIELDS VIROLOGY, V6th, P1347; Ghosh S, 2012, INFECT GENET EVOL, V12, P471, DOI 10.1016/j.meegid.2011.12.012; Greenberg HB, 2009, GASTROENTEROLOGY, V136, P1939, DOI 10.1053/j.gastro.2009.02.076; Khamrin P, 2008, EMERG INFECT DIS, V14, P686, DOI 10.3201/eid1404.071111; Komoto S, 2017, J GEN VIROL, V98, P532, DOI 10.1099/jgv.0.000722; Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238; Maneekarn N, 2006, J CLIN MICROBIOL, V44, P4113, DOI 10.1128/JCM.00954-06; Martel-Paradis O, 2013, VET MICROBIOL, V162, P94, DOI 10.1016/j.vetmic.2012.08.028; Martella V, 2010, VET MICROBIOL, V140, P246, DOI 10.1016/j.vetmic.2009.08.028; Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Matthijnssens J, 2012, ARCH VIROL, V157, P1177, DOI 10.1007/s00705-012-1273-3; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Midgley SE, 2012, VET MICROBIOL, V156, P238, DOI 10.1016/j.vetmic.2011.10.027; Naseer O, 2017, VIROLOGY, V507, P53, DOI 10.1016/j.virol.2017.03.008; Okitsu S, 2013, INFECT GENET EVOL, V18, P74, DOI 10.1016/j.meegid.2013.05.005; Okitsu S, 2011, J CLIN MICROBIOL, V49, P442, DOI 10.1128/JCM.02263-10; Papp H, 2013, VET MICROBIOL, V165, P190, DOI 10.1016/j.vetmic.2013.03.020; Pesavento JB, 2006, CURR TOP MICROBIOL, V309, P189; Pickering AJ, 2012, ENVIRON SCI TECHNOL, V46, P5736, DOI 10.1021/es300022c; Saif LJ, 1996, J INFECT DIS, V174, pS98, DOI 10.1093/infdis/174.Supplement_1.S98; Saikruang W, 2013, VET MICROBIOL, V161, P255, DOI 10.1016/j.vetmic.2012.07.036; Shi HY, 2012, ARCH VIROL, V157, P1897, DOI 10.1007/s00705-012-1363-2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tate JE, 2014, CLIN INFECT DIS, V59, P1291, DOI 10.1093/cid/ciu564; Theuns S, 2015, J VIROL, V89, P1043, DOI 10.1128/JVI.02513-14; Tuanthap S, 2018, PEERJ, V6, DOI 10.7717/peerj.4724; URASAWA S, 1992, J INFECT DIS, V166, P227, DOI 10.1093/infdis/166.2.227; Vesikari T, 2012, CLIN MICROBIOL INFEC, V18, P57, DOI 10.1111/j.1469-0691.2012.03981.x; Vlasova AN, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9030048; Yodmeeklin A, 2017, INFECT GENET EVOL, V47, P99, DOI 10.1016/j.meegid.2016.11.021; Yodmeeklin A, 2016, ARCH VIROL, V161, P2843, DOI 10.1007/s00705-016-2976-7	32	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211002	10.1371/journal.pone.0211002	http://dx.doi.org/10.1371/journal.pone.0211002			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673764	Green Submitted, Green Published, gold			2022-12-26	WOS:000456442800063
J	Yadav, MK; Aravindan, S; Ngangkham, U; Raghu, S; Prabhukarthikeyan, SR; Keerthana, U; Marndi, BC; Adak, T; Munda, S; Deshmukh, R; Pramesh, D; Samantaray, S; Rath, PC				Yadav, Manoj Kumar; Aravindan, S.; Ngangkham, Umakanta; Raghu, S.; Prabhukarthikeyan, S. R.; Keerthana, U.; Marndi, B. C.; Adak, Totan; Munda, Susmita; Deshmukh, Rupesh; Pramesh, D.; Samantaray, Sanghamitra; Rath, P. C.			Blast resistance in Indian rice landraces: Genetic dissection by gene specific markers	PLOS ONE			English	Article							BROAD-SPECTRUM RESISTANCE; ORYZA-SATIVA L.; DURABLE RESISTANCE; REPEAT PROTEIN; IDENTIFICATION; SOFTWARE; DISEASE; GENOMICS; ENCODES; COMPLEX	Understanding of genetic diversity is important to explore existing gene in any crop breeding program. Most of the diversity preserved in the landraces which are well known reservoirs of important traits for biotic and abiotic stresses. In the present study, the genetic diversity at twenty-four most significant blast resistance gene loci using twenty-eight gene specific markers were investigated in landraces originated from nine diverse rice ecologies of India. Based on phenotypic evaluation, landraces were classified into three distinct groups: highly resistant (21), moderately resistant (70) and susceptible (70). The landraces harbour a range of five to nineteen genes representing blast resistance allele with the frequency varied from 4.96% to 100%. The cluster analysis grouped entire 161 landraces into two major groups. Population structure along with other parameters was also analyzed to understand the evolution of blast resistance gene in rice. The population structure analysis and principal coordinate analysis classified the landraces into two sub populations. Analysis of molecular variance showed maximum (93%) diversity within the population and least (7%) between populations. Five markers viz; K3957, Pikh, Pi2-i, RM212and RM302 were strongly associated with blast disease with the phenotypic variance of 1.4% to 7.6%. These resistant land races will serve as a valuable genetic resource for future genomic studies, host pathogen interaction, identification of novel R genes and rice improvement strategies.	[Yadav, Manoj Kumar; Aravindan, S.; Ngangkham, Umakanta; Raghu, S.; Prabhukarthikeyan, S. R.; Keerthana, U.; Marndi, B. C.; Adak, Totan; Munda, Susmita; Samantaray, Sanghamitra; Rath, P. C.] ICAR Natl Rice Res Inst, Cuttack, Orissa, India; [Deshmukh, Rupesh] Natl Agri Food Biotechnol Inst NABI, Mohali, Punjab, India; [Pramesh, D.] Univ Agr Sci, AICRIP, Rice Pathol Lab, Raichur, India; [Ngangkham, Umakanta] ICAR Res Complex North East Hill Reg, Umiam, Meghalaya, India	Indian Council of Agricultural Research (ICAR); ICAR - National Rice Research Institute; Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI); Indian Council of Agricultural Research (ICAR); ICAR - ICAR Research Complex for NEH Region	Yadav, MK (corresponding author), ICAR Natl Rice Res Inst, Cuttack, Orissa, India.	m.yadav14@gmail.com	Devanna, Pramesh/AAE-2090-2021; Adak, Totan/K-4221-2012; Deshmukh, Rupesh Kailasrao/C-6479-2012	Devanna, Pramesh/0000-0002-5229-443X; Adak, Totan/0000-0001-5971-1008; Deshmukh, Rupesh Kailasrao/0000-0003-4167-6552; Ngangkham, Umakanta/0000-0001-5792-0615				Ashikawa I, 2008, GENETICS, V180, P2267, DOI 10.1534/genetics.108.095034; Berruyer R, 2003, THEOR APPL GENET, V107, P1139, DOI 10.1007/s00122-003-1349-2; BONMAN JM, 1992, EUPHYTICA, V63, P115, DOI 10.1007/BF00023917; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brar DS, 1997, PLANT MOL BIOL, V35, P35, DOI 10.1023/A:1005825519998; Campbell MA, 2004, PHYTOPATHOLOGY, V94, P302, DOI 10.1094/PHYTO.2004.94.3.302; Chen XW, 2006, PLANT J, V46, P794, DOI 10.1111/j.1365-313X.2006.02739.x; Choudhury DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113094; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fuentes JL, 2008, EUPHYTICA, V160, P295, DOI 10.1007/s10681-007-9497-0; Fukuoka S, 2012, THEOR APPL GENET, V125, P551, DOI 10.1007/s00122-012-1852-4; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; Gao LiJun, 2010, Southwest China Journal of Agricultural Sciences, V23, P77; Ghaley BB, 2012, EUPHYTICA, V184, P119, DOI 10.1007/s10681-011-0582-z; Hayashi K, 2010, THEOR APPL GENET, V121, P1357, DOI 10.1007/s00122-010-1393-7; Hayashi K, 2006, JPN J OPHTHALMOL, V50, P345, DOI 10.1007/s10384-006-0335-z; Hittalmani S, 2000, THEOR APPL GENET, V100, P1121, DOI 10.1007/s001220051395; Imam J, 2014, EUPHYTICA, V196, P199, DOI 10.1007/s10681-013-1024-x; Ingole KD, 2014, INDIAN J GENET PL BR, V74, P378, DOI 10.5958/0975-6906.2014.00857.8; Jeon JS, 2003, MOL GENET GENOMICS, V269, P280, DOI 10.1007/s00438-003-0834-2; Jia YL, 2004, PHYTOPATHOLOGY, V94, P296, DOI 10.1094/PHYTO.2004.94.3.296; Jia YL, 2002, CROP SCI, V42, P2145, DOI 10.2135/cropsci2002.2145; Jiang HC, 2012, MOL BREEDING, V30, P1679, DOI 10.1007/s11032-012-9751-6; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; Koide Y, 2010, PLANT BREEDING, V129, P670, DOI 10.1111/j.1439-0523.2010.01781.x; Lin F, 2007, GENETICS, V177, P1871, DOI 10.1534/genetics.107.080648; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu XQ, 2005, MOL GENET GENOMICS, V274, P394, DOI 10.1007/s00438-005-0032-5; Liu Y, 2013, THEOR APPL GENET, V126, P985, DOI 10.1007/s00122-012-2031-3; Mahender A., 2012, African Journal of Biotechnology, V11, P1321; Marathi B, 2015, EUPHYTICA, V201, P1, DOI 10.1007/s10681-014-1251-9; McCouch SR, 2012, AM J BOT, V99, P407, DOI 10.3732/ajb.1100385; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Ngangkham U, 2010, MOL BREEDING, V26, P275, DOI 10.1007/s11032-010-9397-1; Okuyama Y, 2011, PLANT J, V66, P467, DOI 10.1111/j.1365-313X.2011.04502.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Qu SH, 2006, GENETICS, V172, P1901, DOI 10.1534/genetics.105.044891; Ramkumar G, 2011, MOL BREEDING, V27, P129, DOI 10.1007/s11032-010-9538-6; RoyChowdhury M, 2012, PHYTOPATHOLOGY, V102, P700, DOI 10.1094/PHYTO-02-12-0026-R; RoyChowdhury M, 2012, EUPHYTICA, V184, P35, DOI 10.1007/s10681-011-0481-3; Seck PA, 2012, FOOD SECUR, V4, P7, DOI 10.1007/s12571-012-0168-1; Sharma TR, 2012, AGR RES, V1, P37, DOI 10.1007/s40003-011-0003-5; Shikari AB, 2014, INDIAN J GENET PL BR, V74, P286, DOI 10.5958/0975-6906.2014.00846.3; Singh AK, 2015, PLANT PATHOLOGY J, V31, P12, DOI 10.5423/PPJ.OA.06.2014.0054; Su J, 2015, THEOR APPL GENET, V128, P2213, DOI 10.1007/s00122-015-2579-9; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Vasudevan K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00915; WANG GL, 1994, GENETICS, V136, P1421; Warschefsky E, 2014, AM J BOT, V101, P1791, DOI 10.3732/ajb.1400116; Wu JL, 2005, THEOR APPL GENET, V111, P50, DOI 10.1007/s00122-005-1971-2; Yadav MK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176236; Yang YY, 2017, EUR J PLANT PATHOL, V148, P567, DOI 10.1007/s10658-016-1112-6; Zhai C, 2011, NEW PHYTOL, V189, P321, DOI 10.1111/j.1469-8137.2010.03462.x; Zheng WJ, 2016, THEOR APPL GENET, V129, P1035, DOI 10.1007/s00122-016-2681-7; Zhu D, 2016, RICE, V9, DOI 10.1186/s12284-016-0116-3; Zhu YY, 2005, PHYTOPATHOLOGY, V95, P433, DOI 10.1094/PHYTO-95-0433; 조영찬, 2007, Journal of Crop Science and Biotechnology, V10, P265	62	17	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211061	10.1371/journal.pone.0211061	http://dx.doi.org/10.1371/journal.pone.0211061			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673751	Green Published, gold, Green Submitted			2022-12-26	WOS:000456442800071
J	Suh, MJ; Park, JA; Chang, SW; Kim, JH; Lee, KH; Hong, SC; Lee, HS; Kang, JW				Suh, Michelle J.; Park, Jin A.; Chang, Suk Won; Kim, Jeong Hong; Lee, Keun-Hwa; Hong, Seong-Chul; Lee, Hye-Sook; Kang, Ju Wan			Chronological changes in rhinitis symptoms present in school-aged children with allergic sensitization	PLOS ONE			English	Article							PREVALENCE; SKIN; INFLAMMATION; SENSITIVITY; ASSOCIATION; POPULATION; ADULTS; ASTHMA; RISK; IGE	Introduction It is difficult to accurately predict the natural course of allergic rhinitis (AR), because it is affected by a wide variety of environmental influences, as well as genetic predisposition. Considering the high prevalence of allergic rhinitis in children and adolescents, caregivers should be given appropriate information regarding the disease course. This study aimed to understand the prognosis of allergic rhinitis by examining the relationship between allergic sensitization and rhinitis symptoms during this developmental period. Methods This cross-sectional study included 1069 children aged 9-16 years from the Korean International Study of Asthma and Allergies in Childhood Survey database who had completed health questionnaires, and for whom skin prick test results were available. Data were collected during May 2016. The distribution of sensitization and allergic symptoms was compared by age groups (elementary, middle, and high school). Data were analyzed using linear-by-linear analysis. Results Sensitization to at least one tested allergen differed by age (59.2%, 58.3%, 68.2%, in elementary, middle, and high school students, respectively; p = 0.025), and seasonal allergen sensitization (35.0%, 37.1%, 53.9%, respectively) increased with age (p < 0.001). Conversely, the proportion of rhinitis symptoms among sensitized children decreased as age increased (58.80%, 52.90%, 49.70%, respectively; p = 0.047). However, the rate of non-allergic rhinitis was age-independent. Conclusion With increasing age during childhood and adolescence, symptomatic allergic rhinitis decreases; thus, subclinical allergic rhinitis increases. This suggests that the symptoms of later-sensitized children are less clearly manifested, or that the symptoms reduce as previously sensitized children mature. This should be clarified further in a longitudinal study.	[Suh, Michelle J.; Park, Jin A.; Chang, Suk Won; Kim, Jeong Hong; Kang, Ju Wan] Jeju Natl Univ, Sch Med, Dept Otorhinolaryngol, Jeju, South Korea; [Kim, Jeong Hong; Lee, Keun-Hwa; Hong, Seong-Chul; Lee, Hye-Sook; Kang, Ju Wan] Jeju Natl Univ, Environm Hlth Ctr Atop Dermatitis & Allerg Rhinit, Jeju, South Korea	Jeju National University; Jeju National University	Kang, JW (corresponding author), Jeju Natl Univ, Sch Med, Dept Otorhinolaryngol, Jeju, South Korea.; Kang, JW (corresponding author), Jeju Natl Univ, Environm Hlth Ctr Atop Dermatitis & Allerg Rhinit, Jeju, South Korea.	juwankangmd@gmail.com	suh, michelle j./AAD-4055-2019	Kang, Ju Wan/0000-0002-6260-0680; suh, michellej/0000-0001-6345-7671	Environmental Health Center (Atopic dermatitis & Allergic rhinitis); Jeju National University - Ministry of Environment, Republic of Korea	Environmental Health Center (Atopic dermatitis & Allergic rhinitis); Jeju National University - Ministry of Environment, Republic of Korea	This study was supported by grants from the Environmental Health Center (Atopic dermatitis & Allergic rhinitis), Jeju National University funded by the Ministry of Environment, Republic of Korea (http://eng.me.go.kr/eng/web/main.do).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study. And there were no authors who received salary or other funding from commercial companies. There was no additional external funding received for this study.	Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; BARBEE RA, 1981, J ALLERGY CLIN IMMUN, V68, P15, DOI 10.1016/0091-6749(81)90117-2; Blomme K, 2013, INT ARCH ALLERGY IMM, V160, P200, DOI 10.1159/000339853; Bodtger U, 2003, J ALLERGY CLIN IMMUN, V111, P149, DOI 10.1067/mai.2003.37; Ellwood P, 2005, INT J TUBERC LUNG D, V9, P10; Eriksson J, 2011, INT ARCH ALLERGY IMM, V154, P155, DOI 10.1159/000320230; Fineman SM, 2002, ANN ALLERG ASTHMA IM, V88, P2, DOI 10.1016/S1081-1206(10)62022-4; FREIDHOFF LR, 1984, J ALLERGY CLIN IMMUN, V73, P490, DOI 10.1016/0091-6749(84)90360-9; Govaere E, 2007, PEDIAT ALLERG IMM-UK, V18, P671, DOI 10.1111/j.1399-3038.2007.00570.x; Grimshaw KEC, 2005, CURR PAEDIAT, V15, P221; Haanpaa L, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019281; Hoffmann-Petersen B, 2013, PEDIAT ALLERG IMM-UK, V24, P727, DOI 10.1111/pai.12133; Kim BK, 2016, ALLERGOL INT, V65, P186, DOI 10.1016/j.alit.2015.11.002; Kim Hyeong Yun, 2013, Korean J Pediatr, V56, P338, DOI 10.3345/kjp.2013.56.8.338; Kim SH, 2002, CLIN EXP ALLERGY, V32, P1054, DOI 10.1046/j.1365-2222.2002.01431.x; Mediaty Anja, 2005, Immun Ageing, V2, P9, DOI 10.1186/1742-4933-2-9; Meltzer EO, 2009, J ALLERGY CLIN IMMUN, V124, pS43, DOI 10.1016/j.jaci.2009.05.013; Park SC, 2016, INT J PEDIATR OTORHI, V86, P167, DOI 10.1016/j.ijporl.2016.05.005; Passalacqua G, 2001, RESP RES, V2, P320, DOI 10.1186/rr80; Plaschke P, 1999, J ALLERGY CLIN IMMUN, V104, P58, DOI 10.1016/S0091-6749(99)70114-4; Rhee CS, 2014, AM J RHINOL ALLERGY, V28, pE107, DOI 10.2500/ajra.2014.28.4040; Ricca V, 2000, J ALLERGY CLIN IMMUN, V105, P54, DOI 10.1016/S0091-6749(00)90177-5; Sherrill D, 1999, CLIN EXP ALLERGY, V29, P905; Simola M, 1999, ANN ALLERG ASTHMA IM, V82, P152, DOI 10.1016/S1081-1206(10)62589-6	24	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210840	10.1371/journal.pone.0210840	http://dx.doi.org/10.1371/journal.pone.0210840			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653594	Green Published, Green Submitted, gold			2022-12-26	WOS:000456015500080
J	Takahashi, Y; Konishi, T; Yamaki, K				Takahashi, Yoko; Konishi, Tomokazu; Yamaki, Kohji			Tofu and fish oil independently modulate serum lipid profiles in rats: Analyses of 10 class lipoprotein profiles and the global hepatic transcriptome	PLOS ONE			English	Article							FATTY-ACID OXIDATION; APOLIPOPROTEIN-B; GENE-EXPRESSION; CARDIOVASCULAR-DISEASE; LDL-CHOLESTEROL; PROTEIN; LIVER; METABOLISM; DISCORDANCE; ISOFLAVONE	Soy protein and fish oil are food components that decrease the risk of cardiovascular disease. Previous studies demonstrated that these food components reduced serum cholesterol levels and suppressed hepatic lipogenesis. However, the underlying mechanisms of action of these food components remain unclear. Ten classes of serum lipoprotein profiles showed that dietary tofu, a soybean curd, suppressed cholesterol absorption, while fish oil reduced most of the lipoprotein classes in rats. Tofu and fish oil both halved the level of the lipoprotein class LAC1 (LDL-anti-protease complex), a 15-nm LDL-anti-protease complex, which is speculated to be a cause of atherosclerosis. Moreover, a global transcriptome analysis revealed that tofu inhibited the mRNA expression of genes involved in hepatic lipogenesis, while fish oil stimulated that of genes related to fatty acid degradation. Therefore, tofu and fish oil independently regulate lipid metabolism. The decrease observed in LAC1 may have been due to reduced cholesterol absorption in the tofu diet group and the interference of lipogenesis via the activation of polyunsaturated fatty acid detoxification in the fish oil group.	[Takahashi, Yoko; Yamaki, Kohji] Natl Agr & Food Res Org NARO, Food Res Inst, Tsukuba, Ibaraki, Japan; [Konishi, Tomokazu] Akita Prefectural Univ, Grad Sch Bioresource Sci, Akita, Japan	National Agriculture & Food Research Organization - Japan; Akita Prefectural University	Takahashi, Y (corresponding author), Natl Agr & Food Res Org NARO, Food Res Inst, Tsukuba, Ibaraki, Japan.	youkot@affrc.go.jp	Stefanadis, Christodoulos/ABH-2232-2020; Konishi, Tomokazu/K-8067-2012	Stefanadis, Christodoulos/0000-0001-5974-6454; Konishi, Tomokazu/0000-0003-4826-6265	Research Project on the Development of Evaluation and Management Methods for the Supply of Safe, Reliable and Functional Food and Farm produce, from the Ministry of Agriculture, Forestry and Fisheries, Japan	Research Project on the Development of Evaluation and Management Methods for the Supply of Safe, Reliable and Functional Food and Farm produce, from the Ministry of Agriculture, Forestry and Fisheries, Japan	This study was supported by the Research Project on the Development of Evaluation and Management Methods for the Supply of Safe, Reliable and Functional Food and Farm produce, from the Ministry of Agriculture, Forestry and Fisheries, Japan (YT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, BMC MED, V11, P117, DOI [10.1186/1741-7015-11-117, DOI 10.1186/1741-7015-11-117]; Badimon L, 2014, J INTERN MED, V276, P618, DOI 10.1111/joim.12296; BAUM CL, 1990, J BIOL CHEM, V265, P19263; BENHIZIA F, 1994, AM J PHYSIOL-ENDOC M, V267, pE975, DOI 10.1152/ajpendo.1994.267.6.E975; Das UN, 2006, CURR PHARM BIOTECHNO, V7, P467, DOI 10.2174/138920106779116856; DIETSCHY JM, 1984, KLIN WOCHENSCHR, V62, P338, DOI 10.1007/BF01716251; Eilat-Adar S, 2013, NUTRIENTS, V5, P3646, DOI 10.3390/nu5093646; FOLCH J, 1957, J BIOL CHEM, V226, P497; Food and Agriculture Organization of United Nations, 1996, COD GEN STAND FOOD A; Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301; GLICKMAN RM, 1986, P NATL ACAD SCI USA, V83, P5296, DOI 10.1073/pnas.83.14.5296; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Grossman A, ENDOTEXT; HUFF MW, 1980, J LIPID RES, V21, P546; IDE T, 1978, J NUTR, V108, P601, DOI 10.1093/jn/108.4.601; IDE T, 1981, J BIOL CHEM, V256, P247; Ide T, 2000, BBA-MOL CELL BIOL L, V1485, P23, DOI 10.1016/S1388-1981(00)00026-3; Iritani N, 1996, J NUTR, V126, P380, DOI 10.1093/jn/126.2.380; Klett EL, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-5; Konishi T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192955; Konishi T, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S18-S7; Konishi T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003555; Kromhout D, 2012, EUR HEART J, V33, P436, DOI 10.1093/eurheartj/ehr362; Lee JM, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010023; Lu H, 2015, ARTERIOSCL THROM VAS, V35, P485, DOI 10.1161/ATVBAHA.115.305380; Mora S, 2014, CIRCULATION, V129, P553, DOI 10.1161/CIRCULATIONAHA.113.005873; MYANT NB, 1977, J LIPID RES, V18, P135; Robins SJ, 1999, HEPATOLOGY, V29, P1541, DOI 10.1002/hep.510290518; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Shimanaka Y, 2017, NAT MED, V23, P1287, DOI 10.1038/nm.4417; SMIT MJ, 1991, J CLIN INVEST, V88, P943, DOI 10.1172/JCI115397; Stradling Clare, 2013, Cardiovascular & Hematological Disorders - Drug Targets, V13, P208; Takahashi Y, 2008, J NUTR BIOCHEM, V19, P682, DOI 10.1016/j.jnutbio.2007.09.003; Takahashi Y, 2017, FOOD SCI TECHNOL RES, V23, P163, DOI 10.3136/fstr.23.163; Takahashi Y, 2011, J AGR FOOD CHEM, V59, P8976, DOI 10.1021/jf201403u; TERPSTRA AHM, 1983, ANN NUTR METAB, V27, P132, DOI 10.1159/000176632; Tousoulis D, 2003, HEART, V89, P993, DOI 10.1136/heart.89.9.993; Usui S, 2002, J LIPID RES, V43, P805; Viola J, 2015, SEMIN IMMUNOL, V27, P184, DOI 10.1016/j.smim.2015.03.013; Wilkins JT, 2016, J AM COLL CARDIOL, V67, P193, DOI 10.1016/j.jacc.2015.10.055; Yamori Yukio, 2006, Exp Clin Cardiol, V11, P94; ZAK B, 1957, AM J CLIN PATHOL, V27, P583, DOI 10.1093/ajcp/27.5_ts.583	42	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210950	10.1371/journal.pone.0210950	http://dx.doi.org/10.1371/journal.pone.0210950			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653569	Green Submitted, Green Published, gold			2022-12-26	WOS:000456015500091
J	Hong, EH; Ryu, SJ; Kang, MH; Seong, M; Cho, H; Yeom, JH; Shin, YU				Hong, Eun Hee; Ryu, So Jung; Kang, Min Ho; Seong, Mincheol; Cho, Heeyoon; Yeom, Jong Hun; Shin, Yong Un			Comparison of repeatability of swept-source and spectral-domain optical coherence tomography for measuring inner retinal thickness in retinal disease	PLOS ONE			English	Article							NERVE-FIBER LAYER; CHOROIDAL THICKNESS; EPIRETINAL MEMBRANE; REPRODUCIBILITY; AGREEMENT; EYES	Purpose To compare repeatability between SS-OCT and SD-OCT for measurement of macular, macular retinal nerve fiber (mRNFL), and ganglion cell-inner plexiform layer (GC-IPL) thickness in various retinal diseases. Methods One hundred and fourteen eyes of 114 subjects were investigated. Seventy-eight eyes with retinal disease and 36 normal eyes underwent two consecutive measurements of macular, mRNFL, and GC-IPL thickness using SS-OCT and SD-OCT. The data were obtained using the Early Treatment Diabetic Retinopathy Study (ETDRS) protocol. The eyes with retinal diseases were divided into three subgroups according to central macular thickness (CMT) for analysis. The intraclass correlation coefficient (ICC) was calculated to determine the repeatability of OCT device. Results In normal eyes, both OCT devices showed excellent repeatability of macula, mRNFL, and GC-IPL thickness measurements with high ICCs in all ETDRS subfields. In eyes with retinal disease, although SS-OCT showed better repeatability for inner retinal thickness measurements than SD-OCT, the overall ICCs were lower than those in normal eyes. In subgroup analysis, the ICCs in the low CMT group were lower than those in the normal and high CMT groups, particularly when using SD-OCT. Conclusions Both OCT devices had comparable repeatability for retinal thickness measurement in normal eyes and eyes with retinal disease. However, the possibility of measurement error should be considered in eyes with a thin and atrophic retina.	[Hong, Eun Hee; Ryu, So Jung; Kang, Min Ho; Seong, Mincheol; Cho, Heeyoon; Shin, Yong Un] Hanyang Univ, Dept Ophthalmol, Coll Med, Seoul, South Korea; [Yeom, Jong Hun] Hanyang Univ, Dept Anesthesiol & Pain Med, Coll Med, Seoul, South Korea	Hanyang University; Hanyang University	Shin, YU (corresponding author), Hanyang Univ, Dept Ophthalmol, Coll Med, Seoul, South Korea.	syu2000@hanmail.net	SHIN, Yong-Un/AAI-9824-2020; Shin, Yong Un/V-7668-2017	Shin, Yong Un/0000-0003-1251-8985	Hanyang University [HY-201800000000614]	Hanyang University	This work was supported by the research fund of Hanyang University (HY-201800000000614) (YUS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshareef RA, 2016, BRIT J OPHTHALMOL, V100, P1506, DOI 10.1136/bjophthalmol-2015-308106; Branchini L, 2012, OPHTHALMOLOGY, V119, P119, DOI 10.1016/j.ophtha.2011.07.002; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Copete S, 2014, BRIT J OPHTHALMOL, V98, P334, DOI 10.1136/bjophthalmol-2013-303904; Donner A, 2002, J ROY STAT SOC D-STA, V51, P367, DOI 10.1111/1467-9884.00324; Gabriele ML, 2011, INVEST OPHTH VIS SCI, V52, P2425, DOI 10.1167/iovs.10-6312; Gao E, 2015, COMP RETINAL THICKNE, V10; Hirata M, 2011, INVEST OPHTH VIS SCI, V52, P4971, DOI 10.1167/iovs.11-7729; Kafieh Raheleh, 2013, J Med Signals Sens, V3, P45; Keane PA, 2009, BRIT J OPHTHALMOL, V93, P1461, DOI 10.1136/bjo.2008.155846; Krebs I, 2010, OPHTHALMOLOGY, V117, P1577, DOI 10.1016/j.ophtha.2010.04.032; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee EK, 2014, OPHTHALMOLOGY, V121, P1579, DOI 10.1016/j.ophtha.2014.02.010; Lee HJ, 2015, INVEST OPHTH VIS SCI, V56, P4554, DOI 10.1167/iovs.15-16949; Lee HJ, 2015, AM J OPHTHALMOL, V160, P283, DOI 10.1016/j.ajo.2015.05.015; Lee SY, 2017, J GLAUCOMA, V26, pE46, DOI [10.1097/IJG.000000000000536, 10.1097/IJG.0000000000000536]; Mansouri K, 2014, AM J OPHTHALMOL, V157, P1022, DOI 10.1016/j.ajo.2014.02.008; Matlach J, 2014, INVEST OPHTH VIS SCI, V55, P6536, DOI 10.1167/iovs.14-15072; Min JK, 2017, CURR EYE RES, V42, P307, DOI 10.3109/02713683.2016.1170855; Mrejen S, 2013, SURV OPHTHALMOL, V58, P387, DOI 10.1016/j.survophthal.2012.12.001; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P8323, DOI 10.1167/iovs.11-7962; Polito A, 2002, AM J OPHTHALMOL, V134, P240, DOI 10.1016/S0002-9394(02)01528-3; PULIAFITO CA, 1995, OPHTHALMOLOGY, V102, P217; Regatieri CV, 2012, RETINA-J RET VIT DIS, V32, P563, DOI [10.1097/IAE.0B013E31822F5678, 10.1097/IAE.0b013e31822f5678]; Sabater AL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/458631; Seong M, 2010, INVEST OPHTH VIS SCI, V51, P1446, DOI 10.1167/iovs.09-4258; Shin IH, 2018, RETINA-J RET VIT DIS, V38, P253, DOI 10.1097/IAE.0000000000001535; Tan CS, 2015, OSLI RETINA, V46, P172, DOI 10.3928/23258160-20150213-23; Toteberg-Harms M, 2012, GRAEF ARCH CLIN EXP, V250, P279, DOI 10.1007/s00417-011-1811-9; Wu HJ, 2011, J GLAUCOMA, V20, P470, DOI 10.1097/IJG.0b013e3181f3eb64; Yasuno Y, 2007, OPT EXPRESS, V15, P6121, DOI 10.1364/OE.15.006121	31	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210729	10.1371/journal.pone.0210729	http://dx.doi.org/10.1371/journal.pone.0210729			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650130	Green Published, Green Submitted, gold			2022-12-26	WOS:000455813300073
J	Huh, G; Yoon, H; Choi, YJ; Shin, CM; Park, YS; Kim, N; Lee, DH; Kim, JS				Huh, Gunn; Yoon, Hyuk; Choi, Yoon Jin; Shin, Cheol Min; Park, Young Soo; Kim, Nayoung; Lee, Dong Ho; Kim, Joo Sung			Trends in emergency department visits and hospitalization rates for inflammatory bowel disease in the era of biologics	PLOS ONE			English	Article							ULCERATIVE-COLITIS; CROHNS-DISEASE; NATURAL-HISTORY; EPIDEMIOLOGY; METAANALYSIS; CHILDREN; SURGERY; KOREA; TIME	Background The use of biologics in inflammatory bowel disease (IBD) has increased recently. However, studies on whether the proportion of IBD patient visits to the emergency department (ED) has decreased are scarce. We investigated the trends in IBD-related ED visits and hospitalization rates. Methods Medical records of IBD-related visits to the ambulatory department (AD) and the ED of the Seoul National University Bundang Hospital in 2007, 2009, 2012, and 2014 were reviewed. Multiple-variable logistic regression analysis was used to identify significant risk factors for hospitalization. Results The proportion of IBD patients who visited ED was 12.3% in 2007, 9.7% in 2009, 8.3% in 2012, and 6.4% in 2014 (P = 0.002). The most common chief complaints were abdominal pain (66.9%) in Crohn's disease (CD) patients and hematochezia (36.5%) in ulcerative colitis (UC) patients. The hospitalization rate following ED visits was 47.2% in CD patients and 55.6% in UC patients (P = 0.100). Multiple-variable analysis showed that significant risk factors associated with hospitalization in CD were aggressive disease behavior (odds ratio[OR] 3.54, P = 0.017) and presence of steroid exposure (OR 2.35, P = 0.047). Elevated C-reactive protein (CRP) (>0.5 mg/dL) (OR 5.40, P = 0.016) was the only risk factor associated with hospitalization in UC. Conclusions The proportion of ED visits decreased from 2007 to 2014; there was no significant change in hospitalization rates. Disease behavior/presence of steroid exposure and elevated CRP were associated with hospitalization among CD and UC patients who visited the ED, respectively.	[Huh, Gunn; Kim, Nayoung; Lee, Dong Ho; Kim, Joo Sung] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Yoon, Hyuk; Choi, Yoon Jin; Shin, Cheol Min; Park, Young Soo; Kim, Nayoung; Lee, Dong Ho] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Yoon, H (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea.	bodnsoul@hanmail.net	Yoon, Hyuk/AAT-4978-2020	Yoon, Hyuk/0000-0002-2657-0349; Choi, Yoon Jin/0000-0002-1922-9388				Ananthakrishnan AN, 2010, AM J GASTROENTEROL, V105, P363, DOI 10.1038/ajg.2009.580; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Frolkis AD, 2013, GASTROENTEROLOGY, V145, P996, DOI 10.1053/j.gastro.2013.07.041; Gajendran M, 2016, DIGEST DIS SCI, V61, P389, DOI 10.1007/s10620-015-3895-2; Hou JK, 2009, AM J GASTROENTEROL, V104, P2100, DOI 10.1038/ajg.2009.190; Jung YS, 2017, DIGEST DIS SCI, V62, P2102, DOI 10.1007/s10620-017-4640-9; Kappelman MD, 2011, INFLAMM BOWEL DIS, V17, P62, DOI 10.1002/ibd.21371; Kappelman MD, 2008, GASTROENTEROLOGY, V135, P1907, DOI 10.1053/j.gastro.2008.09.012; Kim HJ, 2015, INFLAMM BOWEL DIS, V21, P623, DOI 10.1097/MIB.0000000000000313; Kim JW, 2018, J GASTROEN HEPATOL, V33, P847, DOI 10.1111/jgh.14027; Langholz E, 1996, SCAND J GASTROENTERO, V31, P260, DOI 10.3109/00365529609004876; Lichtenstein GR, 2004, AM J GASTROENTEROL, V99, P91, DOI 10.1046/j.1572-0241.2003.04010.x; Mao EJ, 2017, ALIMENT PHARM THER, V45, P3, DOI 10.1111/apt.13847; Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0; Ng WK, 2016, INTEST RES, V14, P111, DOI 10.5217/ir.2016.14.2.111; Nugent Z, 2016, INFLAMM BOWEL DIS, V22, P2907, DOI 10.1097/MIB.0000000000000965; Park SH, 2007, INFLAMM BOWEL DIS, V13, P278, DOI 10.1002/ibd.20015; Reich KM, 2014, ALIMENT PHARM THER, V40, P629, DOI 10.1111/apt.12873; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Yang SK, 2008, INFLAMM BOWEL DIS, V14, P542, DOI 10.1002/ibd.20310	21	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210703	10.1371/journal.pone.0210703	http://dx.doi.org/10.1371/journal.pone.0210703			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650133	Green Published, Green Submitted, gold			2022-12-26	WOS:000455813300070
J	Yen, HH; Murray, CM; Washington, EA; Kimpton, WG; Davies, HMS				Yen, Hung-Hsun; Murray, Christina M.; Washington, Elizabeth A.; Kimpton, Wayne G.; Davies, Helen M. S.			Characterisation of ovine lymphatic vessels in fresh specimens	PLOS ONE			English	Article							THORACIC-DUCT CANNULATION; AFFERENT LYMPH; COLLECTION; MODEL; SHEEP; RECIRCULATION; THORACOTOMY	Background and aim The development and use of experimental models using lymphatic cannulation techniques have been hampered by the lack of high-quality colour imaging of lymphatic vessels in situ. Most descriptions of lymphatic anatomy in sheep have historically depended on schematic diagrams due to limitations in the ability to publish colour images of the lymphatic vessels with decent resolution. The aim of this work was to encourage more widespread use of the ovine cannulation model by providing clear photographic images identifying the location and anatomical layout of some major lymphatic ducts and their in situ relationship to surrounding tissues. Methods The cadavers of the sheep were collected after they had been euthanized at the end of animal trials not associated with this study. The lymphatics were dissected and exposed to show their appearance in the surrounding tissues and their relationship to other organs. Patent Blue was used to locate lymphatic vessels in exploratory preparations. However, in order to present the natural appearance of the vessels, we used minimal dissection and dye was not used for the photographed examples. Instead, we have indicated the course of the vessels with lines where their position is less clear. Results and conclusion In this paper, we have used sheep specimens as examples to show characteristic images of lymphatic vessels. The images of in situ lymphatics and lymph nodes combined with schematic summaries provide a concise illustration of the lymphatic drainage scheme in sheep.	[Yen, Hung-Hsun; Murray, Christina M.; Washington, Elizabeth A.; Kimpton, Wayne G.; Davies, Helen M. S.] Univ Melbourne, Melbourne Vet Sch, Parkville, Vic, Australia; [Yen, Hung-Hsun] Natl Pingtung Univ Sci & Technol, Res Ctr Anim Biol, Neipu, Taiwan	University of Melbourne; National Pingtung University Science & Technology	Yen, HH (corresponding author), Univ Melbourne, Melbourne Vet Sch, Parkville, Vic, Australia.; Yen, HH (corresponding author), Natl Pingtung Univ Sci & Technol, Res Ctr Anim Biol, Neipu, Taiwan.	hyen@unimelb.edu.au	Washington, Elizabeth A/K-5185-2015; Davies, Helen/K-6343-2015	Washington, Elizabeth A/0000-0002-2905-0912; Davies, Helen/0000-0002-5110-2002; Yen, Hung-Hsun/0000-0002-1911-1646				Burke ML, 2014, INNATE IMMUN-LONDON, V20, P501, DOI 10.1177/1753425913501213; HEATH TJ, 1986, J ANAT, V144, P61; Hein WR, 2004, J IMMUNOL METHODS, V293, P153, DOI 10.1016/j.jim.2004.07.008; Hein WR, 2003, NAT REV IMMUNOL, V3, P79, DOI 10.1038/nri977; KIMPTON WG, 1989, IMMUNOLOGY, V66, P69; LANDOLT CC, 1981, J APPL PHYSIOL, V50, P1372, DOI 10.1152/jappl.1981.50.6.1372; LASCELLES A, 1961, Q J EXP PHYSIOL CMS, V46, P199, DOI 10.1113/expphysiol.1961.sp001536; PEARSON LD, 1976, J EXP MED, V143, P167, DOI 10.1084/jem.143.1.167; Saar LI, 1975, SISSON GROSSMANS ANA, V1, P1042; SALAZAR I, 1984, LYMPHOLOGY, V17, P46; Scheerlinck JPY, 2006, VACCINE, V24, P3929, DOI 10.1016/j.vaccine.2006.02.032; STAUB NC, 1975, J SURG RES, V19, P315, DOI 10.1016/0022-4804(75)90056-6; Tanudimadja K., 1973, THESIS; UHLEY H, 1963, P SOC EXP BIOL MED, V112, P684; Washington EA, 2018, J IMMUNOL METHODS, V457, P6, DOI 10.1016/j.jim.2018.03.011; Wilkens B., 1981, CIRCULATORY SYSTEM S; Yen HH, 2006, METHODS, V38, P117, DOI 10.1016/j.ymeth.2005.09.011; Yen HH, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0908-0; Yen HH, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0808-3; Yen HH, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0430-9; Yen HH, 2009, VET IMMUNOL IMMUNOP, V129, P76, DOI 10.1016/j.vetimm.2008.12.014	21	1	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209414	10.1371/journal.pone.0209414	http://dx.doi.org/10.1371/journal.pone.0209414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650093	Green Published, gold			2022-12-26	WOS:000455813300014
J	Velez, MVL; Verhaegh, GW; Smit, F; Sedelaar, JPM; Schalken, JA				Velez, Maria V. Luna; Verhaegh, Gerald W.; Smit, Frank; Sedelaar, J. P. Michiel; Schalken, Jack A.			Suppression of prostate tumor cell survival by antisense oligonucleotide-mediated inhibition of AR-V7 mRNA synthesis	ONCOGENE			English	Article							ANDROGEN-RECEPTOR; SPLICE VARIANTS; POLY(ADP-RIBOSE) POLYMERASE; RESISTANT; CANCER; ENZALUTAMIDE; PREDICTION; THERAPY; FUSION; IDENTIFICATION	One of the mechanisms by which advanced prostate cancer develops resistance to androgen deprivation therapy is the elevated expression of C-terminally truncated androgen receptor (AR) variants. These variants, such as AR-V7, originate from aberrant splicing of the AR pre-mRNA and the inclusion of a cryptic exon containing a premature stop codon in the mRNA. The resulting loss of the ligand-binding domain allows AR-V7 to act as a constitutively active transcription factor. Here, we designed two antisense oligonucleotides (AONs) directed against cryptic splicing signals within the AR pre-mRNA. These two AONs, AON-ISE and AON-ESE, demonstrated high efficiency in silencing AR-V7 splicing without affecting full-length AR expression. The subsequent downregulation of AR-V7-target gene UBE2C was accompanied by inhibition of androgen-independent cell proliferation and induction of apoptosis in castration-resistant prostate cancer (CRPC)-derived cell line models 22Rv1, DuCaP, and VCaP. Our results show that splicing-directed AONs can efficiently prevent expression of AR-V7, providing an attractive new therapeutic option for the treatment of CRPC.	[Velez, Maria V. Luna; Verhaegh, Gerald W.; Sedelaar, J. P. Michiel; Schalken, Jack A.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Urol, Nijmegen, Netherlands; [Smit, Frank] MDxHealth, Nijmegen, Netherlands	Radboud University Nijmegen	Schalken, JA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Urol, Nijmegen, Netherlands.	Jack.Schalken@radboudumc.nl	Schalken, Jack A/B-1277-2014; Sedelaar, Michiel/L-4643-2015	Schalken, Jack A/0000-0001-8274-7797; Sedelaar, Michiel/0000-0002-3768-7374; Verhaegh, Gerald/0000-0003-0227-2280	NWO [022.003.007]	NWO(Netherlands Organization for Scientific Research (NWO))	The authors would like to thank Sophie Cools, Cornelius Jansen, and Mirjam de Weijert for their excellent technical assistance. We also would like to thank Dr. Kenneth J. Pienta M.D. from Johns Hopkins for kindly providing us with the DuCaP and VCaP cell lines. This work was sponsored by an NWO grant (Project number: 022.003.007).	Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Armstrong AJ, 2010, CLIN CANCER RES, V16, P203, DOI 10.1158/1078-0432.CCR-09-2514; Beer TM, 2017, LANCET ONCOL, V18, P1532, DOI 10.1016/S1470-2045(17)30605-8; Bianchini D, 2013, BRIT J CANCER, V109, P2579, DOI 10.1038/bjc.2013.619; Cai CM, 2011, CANCER CELL, V20, P457, DOI 10.1016/j.ccr.2011.09.001; Cao B, 2014, ONCOTARGET, V5, P1646, DOI 10.18632/oncotarget.1802; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chiriboga CA, 2016, NEUROLOGY, V86, P890, DOI 10.1212/WNL.0000000000002445; Chou CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093934; Cornford P, 2017, EUR UROL, V71, P630, DOI 10.1016/j.eururo.2016.08.002; D'Amours D, 1998, RADIAT RES, V150, P3, DOI 10.2307/3579638; De Clercq E, 1969, Antimicrob Agents Chemother (Bethesda), V9, P187; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Ding Y, 2004, NUCLEIC ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; Geary RS, 2015, ADV DRUG DELIVER REV, V87, P46, DOI 10.1016/j.addr.2015.01.008; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Hache M, 2016, J CHILD NEUROL, V31, P899, DOI 10.1177/0883073815627882; Havens MA, 2016, NUCLEIC ACIDS RES, V44, P6549, DOI 10.1093/nar/gkw533; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Hessels D, 2007, CLIN CANCER RES, V13, P5103, DOI 10.1158/1078-0432.CCR-07-0700; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Hu R, 2012, CANCER RES, V72, P3457, DOI 10.1158/0008-5472.CAN-11-3892; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; KRONGRAD A, 1991, MOL CELL ENDOCRINOL, V76, P79, DOI 10.1016/0303-7207(91)90262-Q; Leyten GHJM, 2015, CLIN CANCER RES, V21, P3061, DOI 10.1158/1078-0432.CCR-14-3334; Li YM, 2013, CANCER RES, V73, P483, DOI 10.1158/0008-5472.CAN-12-3630; Liu LL, 2014, ONCOGENE, V33, P3140, DOI 10.1038/onc.2013.284; Manoharan M, 1999, BBA-GENE STRUCT EXPR, V1489, P117, DOI 10.1016/S0167-4781(99)00138-4; Mendell JR, 2016, ANN NEUROL, V79, P257, DOI 10.1002/ana.24555; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Moulder SL, 2008, CLIN CANCER RES, V14, P7909, DOI 10.1158/1078-0432.CCR-08-1104; Mounir Z, 2015, ONCOGENE, V34, P3815, DOI 10.1038/onc.2014.308; Nadiminty N, 2013, MOL CANCER THER, V12, P1629, DOI 10.1158/1535-7163.MCT-13-0027; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sazani P, 2003, J CLIN INVEST, V112, P481, DOI 10.1172/JCI200319547; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Scoles DR, 2017, NATURE, V544, P362, DOI 10.1038/nature22044; Sedelaar JPM, 2009, PROSTATE, V69, P1724, DOI 10.1002/pros.21028; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; SPROAT BS, 1989, NUCLEIC ACIDS RES, V17, P3373, DOI 10.1093/nar/17.9.3373; Swayampakula AK, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.11550; Tasfaout H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15661; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Verhaart IEC, 2013, NUCLEIC ACID THER, V23, P228, DOI 10.1089/nat.2012.0398; Voit T, 2014, LANCET NEUROL, V13, P987, DOI 10.1016/S1474-4422(14)70195-4; WAGNER RW, 1994, NATURE, V372, P333, DOI 10.1038/372333a0; Wang JH, 2008, CANCER RES, V68, P8516, DOI 10.1158/0008-5472.CAN-08-1147; Wheeler TM, 2012, NATURE, V488, P111, DOI 10.1038/nature11362; Wraight CJ, 2000, NAT BIOTECHNOL, V18, P521, DOI 10.1038/75382; Yamamoto Y, 2015, CLIN CANCER RES, V21, P1675, DOI 10.1158/1078-0432.CCR-14-1108; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zhang XT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027970	53	17	17	2	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 9	2019	38	19					3696	3709		10.1038/s41388-019-0696-7	http://dx.doi.org/10.1038/s41388-019-0696-7			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HX4OU	30664691	Green Published, hybrid			2022-12-26	WOS:000467379600010
J	Kerruth, S; Coates, C; Durst, CD; Oertner, TG; Torok, K				Kerruth, Silke; Coates, Catherine; Duerst, Celine D.; Oertner, Thomas G.; Torok, Katalin			The kinetic mechanisms of fast-decay red-fluorescent genetically encoded calcium indicators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; calcium imaging; fluorescence; kinetics; biosensor	NEURAL ACTIVITY; CALMODULIN; PROTEINS; INHIBITION; PEPTIDES	Genetically encoded calcium indicators (GECIs) are useful reporters of cell-signaling, neuronal, and network activities. We have generated novel fast variants and investigated the kinetic mechanisms of two recently developed red-fluorescent GECIs (RGECIs), mApple-based jRGECO1a and mRuby-based jRCaMP1a. In the formation of fluorescent jRGECO1a and jRCaMP1a complexes, calcium binding is followed by rate-limiting isomerization. However, fluorescence decay of calcium-bound jRGECO1a follows a different pathway from its formation: dissociation of calcium occurs first, followed by the peptide, similarly to GCaMP-s. In contrast, fluorescence decay of calcium-bound jRCaMP1a occurs by the reversal of the on-pathway: peptide dissociation is followed by calcium. The mechanistic differences explain the generally slower off-kinetics of jRCaMP1a-type indicators compared with GCaMP-s and jRGECO1a-type GECI: the fluorescence decay rate of f-RCaMP1 was 21 s(-1), compared with 109 s(-1) for f-RGECO1 and f-RGECO2 (37 degrees C). Thus, the CaM-peptide interface is an important determinant of the kinetic responses of GECIs; however, the topology of the structural link to the fluorescent protein demonstrably affects the internal dynamics of the CaM-peptide complex. In the dendrites of hippocampal CA3 neurons, f-RGECO1 indicates calcium elevation in response to a 100 action potential train in a linear fashion, making the probe particularly useful for monitoring large-amplitude, fast signals, e.g. those in dendrites, muscle cells, and immune cells.	[Kerruth, Silke; Coates, Catherine; Torok, Katalin] St Georges Univ London, Mol & Clin Sci Res Inst, Cranmer Terrace, London SW17 0RE, England; [Duerst, Celine D.; Oertner, Thomas G.] Ctr Mol Neurobiol Hamburg, Inst Synapt Physiol, D-20251 Hamburg, Germany	St Georges University London	Torok, K (corresponding author), St Georges Univ London, Mol & Clin Sci Res Inst, Cranmer Terrace, London SW17 0RE, England.	k.torok@sgul.ac.uk	Oertner, Thomas/F-2214-2010	Oertner, Thomas/0000-0002-2312-7528; Coates, Catherine/0000-0002-8538-5901; Torok, Katalin/0000-0002-3107-4534; Durst, Celine/0000-0003-3821-2888	Biotechnology and Biological Sciences Research Council [BB/M02556X/1]; BBSRC [BB/M02556X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by Biotechnology and Biological Sciences Research Council Grant BB/M02556X/1 (to K. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Badura A, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.2.025008; Barnett LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170934; Broussard GJ, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00097; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Dana H., 2018, HIGH PERFORMANCE GFP, DOI [10.1101/434589, DOI 10.1101/434589]; Dana H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205444; Dana H, 2016, ELIFE, V5, DOI 10.7554/eLife.12727; Ding JJ, 2014, SCI CHINA LIFE SCI, V57, P269, DOI 10.1007/s11427-013-4599-5; Faas GC, 2011, NAT NEUROSCI, V14, P301, DOI 10.1038/nn.2746; Gee Christine E, 2017, Cold Spring Harb Protoc, V2017, DOI 10.1101/pdb.prot094888; GEISER JR, 1991, CELL, V65, P949, DOI 10.1016/0092-8674(91)90547-C; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Gutfreund H., 1995, KINETICS LIFE SCI, P216; Helassa N, 2016, SCI REP-UK, V6, DOI 10.1038/srep38276; Helassa N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15978; Inoue M, 2015, NAT METHODS, V12, P64, DOI [10.1038/NMETH.3185, 10.1038/nmeth.3185]; Jama AM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.157057; Lin MZ, 2016, NAT NEUROSCI, V19, P1142, DOI 10.1038/nn.4359; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Montagni E, 2019, J PHYS D APPL PHYS, V52, DOI 10.1088/1361-6463/aaf26c; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ohkura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051286; Ohkura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039933; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Shen Y, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0480-0; Sun XNR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3170; Suter BA, 2010, FRONT NEURAL CIRCUIT, V4, P100, DOI DOI 10.3389/FNCIR.2010.00100; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Torok K, 1998, BIOCHEMISTRY-US, V37, P6188, DOI 10.1021/bi972773e; Wabnig S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135584; Wiegert J Simon, 2017, Cold Spring Harb Protoc, V2017, DOI 10.1101/pdb.prot094904; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Zhao YJ, 2017, NEURON, V96, P355, DOI 10.1016/j.neuron.2017.09.041; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	39	12	12	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					3934	3946		10.1074/jbc.RA118.004543	http://dx.doi.org/10.1074/jbc.RA118.004543			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30651353	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000461854400011
J	Ciesielska, S; Bil, P; Gajda, K; Poterala-Hejmo, A; Hudy, D; Rzeszowska-Wolny, J				Ciesielska, Sylwia; Bil, Patryk; Gajda, Karolina; Poterala-Hejmo, Aleksandra; Hudy, Dorota; Rzeszowska-Wolny, Joanna			Cell type-specific differences in redox regulation and proliferation after low UVA doses	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; HYDROGEN-PEROXIDE; ROS PRODUCTION; SUPEROXIDE; OXYGEN; PROTEIN; PEROXYNITRITE; ACTIVATION; GROWTH; TETRAHYDROBIOPTERIN	Ultraviolet A (UVA) radiation is harmful for living organisms but in low doses may stimulate cell proliferation. Our aim was to examine the relationships between exposure to different low UVA doses, cellular proliferation, and changes in cellular reactive oxygen species levels. In human colon cancer (HCT116) and melanoma (Me45) cells exposed to UVA doses comparable to environmental, the highest doses (30-50 kJ/m(2)) reduced clonogenic potential but some lower doses (1 and 10 kJ/m(2)) induced proliferation. This effect was cell type and dose specific. In both cell lines the levels of reactive oxygen species and nitric oxide fluctuated with dynamics which were influenced differently by UVA; in Me45 cells decreased proliferation accompanied the changes in the dynamics of H2O2 while in HCT116 cells those of superoxide. Genes coding for proteins engaged in redox systems were expressed differently in each cell line; transcripts for thioredoxin, peroxiredoxin and glutathione peroxidase showed higher expression in HCT116 cells whereas those for glutathione transferases and copper chaperone were more abundant in Me45 cells. We conclude that these two cell types utilize different pathways for regulating their redox status. Many mechanisms engaged in maintaining cellular redox balance have been described. Here we show that the different cellular responses to a stimulus such as a specific dose of UVA may be consequences of the use of different redox control pathways. Assays of superoxide and hydrogen peroxide level changes after exposure to UVA may clarify mechanisms of cellular redox regulation and help in understanding responses to stressing factors.	[Ciesielska, Sylwia; Bil, Patryk; Gajda, Karolina; Poterala-Hejmo, Aleksandra; Hudy, Dorota; Rzeszowska-Wolny, Joanna] Silesian Tech Univ, Inst Automat Control, Biosyst Grp, Gliwice, Poland	Silesian University of Technology	Rzeszowska-Wolny, J (corresponding author), Silesian Tech Univ, Inst Automat Control, Biosyst Grp, Gliwice, Poland.	joanna.rzeszowska@polsl.pl		Gajda, Karolina/0000-0002-0447-3628; Ciesielska, Sylwia/0000-0002-1051-0632; Rzeszowska-Wolny, Joanna/0000-0002-5804-4757; Hudy, Dorota/0000-0002-9110-2314	Polish National Science Center Grant [2015/19/B/ST7/02984]	Polish National Science Center Grant	This work was supported by the Polish National Science Center Grant #2015/19/B/ST7/02984. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre J, 2010, FREE RADICAL BIO MED, V49, P1342, DOI 10.1016/j.freeradbiomed.2010.07.027; [Anonymous], 2005, IARC WORK GROUP REP, V1; Arnold RS, 2001, P NATL ACAD SCI USA, V98, P5550, DOI 10.1073/pnas.101505898; Bachelor MA, 2004, SEMIN CANCER BIOL, V14, P131, DOI 10.1016/j.semcancer.2003.09.017; Bartesaghi S, 2018, REDOX BIOL, V14, P618, DOI 10.1016/j.redox.2017.09.009; Bates TE, 1996, BIOCHEM BIOPH RES CO, V218, P40, DOI 10.1006/bbrc.1996.0008; BATES TE, 1995, BIOCHEM BIOPH RES CO, V213, P896, DOI 10.1006/bbrc.1995.2213; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Benson MA, 2013, J BIOL CHEM, V288, P29836, DOI 10.1074/jbc.M113.493023; Berton TR, 1997, J INVEST DERMATOL, V109, P340, DOI 10.1111/1523-1747.ep12335984; Boonstra J, 2004, GENE, V337, P1, DOI 10.1016/j.gene.2004.04.032; Bossi O, 2008, J CELL BIOCHEM, V105, P194, DOI 10.1002/jcb.21817; BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S; Burdon RH, 1996, BIOCHEM SOC T, V24, P1028, DOI 10.1042/bst0241028; BURDON RH, 1989, FREE RADICAL RES COM, V7, P149, DOI 10.3109/10715768909087937; Cai S, 2002, CARDIOVASC RES, V55, P838, DOI 10.1016/S0008-6363(02)00460-1; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Chen K, 2010, BRAIN STRUCT FUNCT, V214, P219, DOI 10.1007/s00429-009-0226-4; Crabtree MJ, 2013, J BIOL CHEM, V288, P561, DOI 10.1074/jbc.M112.415992; Culotta VC, 2006, BBA-MOL CELL RES, V1763, P747, DOI 10.1016/j.bbamcr.2006.05.003; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; El-Abaseri TB, 2006, CARCINOGENESIS, V27, P225, DOI 10.1093/carcin/bgi220; Finkel T, 2012, J BIOL CHEM, V287, P4434, DOI 10.1074/jbc.R111.271999; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Foksinski M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188856; Forman HJ, 2016, FREE RADICAL BIO MED, V97, P398, DOI 10.1016/j.freeradbiomed.2016.07.003; Ghafourifar P, 2005, TRENDS PHARMACOL SCI, V26, P190, DOI 10.1016/j.tips.2005.02.005; Grossman N, 1998, LASER SURG MED, V22, P212, DOI 10.1002/(SICI)1096-9101(1998)22:4<212::AID-LSM5>3.0.CO;2-S; Han CY, 2011, BIOCHEM BIOPH RES CO, V410, P68, DOI 10.1016/j.bbrc.2011.05.106; Hanschmann EM, 2013, ANTIOXID REDOX SIGN, V19, P1539, DOI 10.1089/ars.2012.4599; Hatanaka E, 2011, CLIN EXP IMMUNOL, V163, P362, DOI 10.1111/j.1365-2249.2010.04300.x; Hatori Y, 2017, IUBMB LIFE, V69, P246, DOI 10.1002/iub.1620; Ignarro LJ, 2001, P NATL ACAD SCI USA, V98, P4202, DOI 10.1073/pnas.071054698; IKEBUCHI Y, 1991, J BIOL CHEM, V266, P13233; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jaksik R, 2014, MUTAT RES-GEN TOX EN, V764, P64, DOI 10.1016/j.mrgentox.2013.09.003; JANSSEN YMW, 1993, LAB INVEST, V69, P261; Kanai AJ, 2001, P NATL ACAD SCI USA, V98, P14126, DOI 10.1073/pnas.241380298; Kannouche P, 1998, CARCINOGENESIS, V19, P781, DOI 10.1093/carcin/19.5.781; Klotz LO, 1999, EUR J BIOCHEM, V260, P917, DOI 10.1046/j.1432-1327.1999.00255.x; Knoops B, 2011, ANTIOXID REDOX SIGN, V15, P817, DOI 10.1089/ars.2010.3584; Krzywon A, 2018, J PHOTOCH PHOTOBIO B, V178, P505, DOI 10.1016/j.jphotobiol.2017.12.012; Lacza Z, 2001, FREE RADICAL BIO MED, V31, P1609, DOI 10.1016/S0891-5849(01)00754-7; Liu ZR, 2012, INT J PHOTOENERGY, V2012, DOI 10.1155/2012/167425; Menon SG, 2007, ONCOGENE, V26, P1101, DOI 10.1038/sj.onc.1209895; Moreira JD, 2015, THEOR BIOL MED MODEL, V12, DOI 10.1186/s12976-015-0005-2; MURRELL GAC, 1990, BIOCHEM J, V265, P659, DOI 10.1042/bj2650659; Napoli C, 2013, J AM COLL CARDIOL, V62, P89, DOI 10.1016/j.jacc.2013.03.070; Owczarzy R, 2008, NUCLEIC ACIDS RES, V36, pW163, DOI 10.1093/nar/gkn198; Ozumi K, 2012, HYPERTENSION, V60, P476, DOI 10.1161/HYPERTENSIONAHA.111.189571; POU S, 1992, J BIOL CHEM, V267, P24173; Radi R, 2002, BIOL CHEM, V383, P401, DOI 10.1515/BC.2002.044; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Radi R, 2013, J BIOL CHEM, V288, P26464, DOI 10.1074/jbc.R113.472936; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Reiner M, 2001, J HISTOCHEM CYTOCHEM, V49, P1605, DOI 10.1177/002215540104901214; Robinson KM, 2008, NAT PROTOC, V3, P941, DOI 10.1038/nprot.2008.56; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Sarsour EH, 2009, ANTIOXID REDOX SIGN, V11, P2985, DOI [10.1089/ars.2009.2513, 10.1089/ARS.2009.2513]; Skonieczna M, 2017, OXIDATIVE MED CELLUL, V2017; Sluyter R, 2000, CARCINOGENESIS, V21, P1801, DOI 10.1093/carcin/21.10.1801; STABERG B, 1983, J INVEST DERMATOL, V81, P517, DOI 10.1111/1523-1747.ep12522855; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; UBEZIO P, 1994, FREE RADICAL BIO MED, V16, P509, DOI 10.1016/0891-5849(94)90129-5; VANDEPUTTE C, 1994, CELL BIOL TOXICOL, V10, P415, DOI 10.1007/BF00755791; Vasquez-Vivar J, 2000, FEBS LETT, V481, P305, DOI 10.1016/S0014-5793(00)02001-9; Villalobo A, 2006, FEBS J, V273, P2329, DOI 10.1111/j.1742-4658.2006.05250.x; Walbrecq G, 2015, FREE RADICAL BIO MED, V84, P215, DOI 10.1016/j.freeradbiomed.2015.02.032; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; World Health Organization (WHO), 2002, GLOB SOL UV IND; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	74	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0205215	10.1371/journal.pone.0205215	http://dx.doi.org/10.1371/journal.pone.0205215			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682016	Green Published, gold, Green Submitted			2022-12-26	WOS:000457037500007
J	Shimamura, H; Nagano, M; Nakajima, K; Toshima, JY; Toshima, J				Shimamura, Hiroki; Nagano, Makoto; Nakajima, Keita; Toshima, Junko Y.; Toshima, Jiro			Rab5-independent activation and function of yeast Rab7-like protein, Ypt7p, in the AP-3 pathway	PLOS ONE			English	Article							SNARE COMPLEX; NUCLEOTIDE EXCHANGE; SORTING PATHWAYS; VACUOLE FUSION; MON1-CCZ1 GEF; RAB GTPASES; LATE GOLGI; TRANSPORT; HOMOLOG; IDENTIFICATION	The small GTPases, Rab5 and Rab7, are key regulators at multiple stages of the endocytic/endolysosomal pathway, including fusion and maturation of endosomes. In yeast, Vps21p (Rab5 homolog) recruits a GEF for Rab7 and activates the downstream Ypt7p (Rab7 homolog) on endosomal membrane. Although the model of this sequential activation from Vps21p to Ypt7p in the endocytic pathway has been established, activation mechanism of Ypt7p in the Vps21p-independent pathway has not been completely clarified. Here we show that Ypt7p is activated and mediates vacuolar fusion in cells lacking all yeast Rab5 genes, VPS21, YPT52, and YPT53. We also demonstrate that deletion of both VPS21 and YPT7 genes cause severe defect in the AP-3 pathway as well as the CPY pathway although the AP-3 pathway is mostly intact in each vps21 Delta or ypt7 Delta mutant. Interestingly, in vps21 Delta ypt7 Delta mutant cargos trafficked via the VPS or endocytic pathway accumulate beside nucleus whereas cargo trafficked via the AP-3 pathway disperse in the cytosol. These findings suggest that Ypt7p is activated and plays a Rab5-independent role in the AP-3-mediated pathway.	[Shimamura, Hiroki; Nagano, Makoto; Nakajima, Keita; Toshima, Jiro] Tokyo Univ Sci, Dept Biol Sci & Technol, Katsushika Ku, Tokyo, Japan; [Toshima, Junko Y.] Tokyo Univ Technol, Sch Hlth Sci, Ota Ku, Tokyo, Japan	Tokyo University of Science; Tokyo University of Technology	Toshima, J (corresponding author), Tokyo Univ Sci, Dept Biol Sci & Technol, Katsushika Ku, Tokyo, Japan.; Toshima, JY (corresponding author), Tokyo Univ Technol, Sch Hlth Sci, Ota Ku, Tokyo, Japan.	toshimajk@stf.teu.ac.jp; jtosiscb@rs.noda.tus.ac.jp	純子, 十島 Y/GRS-7321-2022; Nagano, Makoto/J-7050-2015	Nagano, Makoto/0000-0002-1948-1591	JSPS KAKENHI [26440067, 16K07303]; Takeda Science Foundation; Novartis Foundation (Japan); Uehara Memorial Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Novartis Foundation (Japan)(Novartis); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by JSPS KAKENHI GRANT #26440067, the Takeda Science Foundation, the Novartis Foundation (Japan) to JYT and JSPS KAKENHI GRANT #16K07303, the Uehara Memorial Foundation and the Takeda Science Foundation to JT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; Balderhaar HJK, 2013, J CELL SCI, V126, P1307, DOI 10.1242/jcs.107805; Balderhaar HJK, 2013, P NATL ACAD SCI USA, V110, P3823, DOI 10.1073/pnas.1221785110; Balderhaar HJK, 2010, J CELL SCI, V123, P4085, DOI 10.1242/jcs.071977; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Brocker C, 2012, P NATL ACAD SCI USA, V109, P1991, DOI 10.1073/pnas.1117797109; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Burd CG, 1998, SEMIN CELL DEV BIOL, V9, P527, DOI 10.1006/scdb.1998.0255; Cabrera M, 2014, J CELL SCI, V127, P1043, DOI 10.1242/jcs.140921; Cabrera M, 2013, J BIOL CHEM, V288, P28704, DOI 10.1074/jbc.M113.488213; Cabrera M, 2010, J CELL BIOL, V191, P845, DOI 10.1083/jcb.201004092; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Conibear E, 1998, BBA-MOL CELL RES, V1404, P211, DOI 10.1016/S0167-4889(98)00058-5; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Kinchen JM, 2010, NATURE, V464, P778, DOI 10.1038/nature08853; KLIONSKY DJ, 1988, MOL CELL BIOL, V8, P2105, DOI 10.1128/MCB.8.5.2105; Kramer L, 2011, MOL BIOL CELL, V22, P2601, DOI 10.1091/mbc.E11-02-0104; Kucharczyk R, 2000, J CELL SCI, V113, P4301; Lachmann J, 2012, MOL BIOL CELL, V23, P2516, DOI 10.1091/mbc.E11-12-1030; Lawrence G, 2014, MOL BIOL CELL, V25, P1608, DOI 10.1091/mbc.E13-08-0460; Mullins C, 2001, BIOESSAYS, V23, P333, DOI 10.1002/bies.1048; Nickerson DP, 2012, TRAFFIC, V13, P1411, DOI 10.1111/j.1600-0854.2012.01390.x; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Peterson MR, 2001, TRAFFIC, V2, P476, DOI 10.1034/j.1600-0854.2001.20705.x; Piper RC, 1997, J CELL BIOL, V138, P531, DOI 10.1083/jcb.138.3.531; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Press B, 1998, J CELL BIOL, V140, P1075, DOI 10.1083/jcb.140.5.1075; Price A, 2000, J CELL BIOL, V148, P1231, DOI 10.1083/jcb.148.6.1231; Rana M, 2015, MOL BIOL CELL, V26, P2535, DOI 10.1091/mbc.E15-02-0062; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Reggiori F, 2000, MOL BIOL CELL, V11, P3737, DOI 10.1091/mbc.11.11.3737; Rehling P, 1999, NAT CELL BIOL, V1, P346, DOI 10.1038/14037; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rivera-Molina FE, 2009, P NATL ACAD SCI USA, V106, P14408, DOI 10.1073/pnas.0906536106; Sato TK, 1998, MOL CELL BIOL, V18, P5308, DOI 10.1128/MCB.18.9.5308; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283; Toshima J, 2005, NAT CELL BIOL, V7, P246, DOI 10.1038/ncb1229; Toshima JY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4498; Ungermann C, 1998, EMBO J, V17, P3269, DOI 10.1093/emboj/17.12.3269; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	47	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210223	10.1371/journal.pone.0210223	http://dx.doi.org/10.1371/journal.pone.0210223			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682048	gold, Green Published, Green Submitted			2022-12-26	WOS:000457037500029
J	Valenca-Barbosa, C; do Bomfim, TCB; Teixeira, BR; Gentile, R; Neto, SFD; Magalhaes, BSN; Balthazar, DD; da Silva, FA; Biot, R; Levy, CMD; Santos, HLC				Valenca-Barbosa, Carolina; Bergamo do Bomfim, Teresa Cristina; Teixeira, Bernardo Rodrigues; Gentile, Rosana; da Costa Neto, Socrates Fraga; Neil Magalhaes, Barbara Souza; Balthazar, Daniel de Almeida; da Silva, Fabio Alves; Biot, Renata; d'Avila Levy, Claudia Masini; Carneiro Santos, Helena Lucia			Molecular epidemiology of Blastocystis isolated from animals in the state of Rio de Janeiro, Brazil	PLOS ONE			English	Article							GENETIC DIVERSITY; ZOO ANIMALS; SCHISTOSOMA-MANSONI; HUMANS; IDENTIFICATION; SUBTYPES; HOMINIS; REGION; PCR; PHYLOGENIES	The enteric protist Blastocystis is one of the most frequently reported parasites infecting both humans and many other animal hosts worldwide. A remarkable genetic diversity has been observed in the species, with 17 different subtypes (STs) on a molecular phylogeny based on small subunit RNA genes (SSU rDNA). Nonetheless, information regarding its distribution, diversity and zoonotic potential remains still scarce, especially in groups other than primates. In Brazil, only a few surveys limited to human isolates have so far been conducted on Blastocystis STs. The aim of this study is to determine the occurrence of Blastocystis subtypes in non-human vertebrate and invertebrate animal groups in different areas of the state of Rio de Janeiro, Brazil. A total of 334 stool samples were collected from animals representing 28 different genera. Blastocystis cultivated samples were subtyped using nuclear small subunit ribosomal DNA (SSU rDNA) sequencing. Phylogenetic analyses and BLAST searches revealed six subtypes: ST5 (28.8%), ST2 (21.1%), ST1 and ST8 (19.2%), ST3 (7.7%) and ST4 (3.8%). Our findings indicate a considerable overlap between STs in humans and other animals. This highlights the importance of investigating a range of hosts for Blastocystis to understand the eco-epidemiological aspects of the parasite and its host specificity.	[Valenca-Barbosa, Carolina; d'Avila Levy, Claudia Masini; Carneiro Santos, Helena Lucia] Fiocruz MS, Inst Oswaldo Cruz, Lab Estudos Integrados Protozool, Rio De Janeiro, RJ, Brazil; [Bergamo do Bomfim, Teresa Cristina] Univ Rural Rio de Janeiro, Dept Parasitol Anim, Seropedica, RJ, Brazil; [Teixeira, Bernardo Rodrigues; Gentile, Rosana; da Costa Neto, Socrates Fraga] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol & Parasitol Mamiferos Silvestres Reserva, Rio De Janeiro, RJ, Brazil; [Neil Magalhaes, Barbara Souza; Balthazar, Daniel de Almeida] Fundacao Jardim Zool Cidade Rio de Janeiro, Parque Quinta da Boa Vista, Rio De Janeiro, Brazil; [da Silva, Fabio Alves] Fiocruz MS, Inst Ciencia & Tecnol Biomodelos, Rio De Janeiro, Brazil; [Biot, Renata] Univ Fed Fluminense, Hosp Univ Antonio Pedro, Dept Patol, Lab Parasitol, Niteroi, RJ, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal Fluminense	Santos, HLC (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Estudos Integrados Protozool, Rio De Janeiro, RJ, Brazil.	helenalucias@ioc.fiocruz.br	Teixeira, Bernardo R/D-7664-2013; Gentile, Rosana/C-3101-2013; santos, Helena/AAA-5514-2020; d'Avila-Levy, Claudia M/O-7192-2014	Teixeira, Bernardo R/0000-0001-9013-9492; Gentile, Rosana/0000-0001-9160-1204; Valenca-Barbosa, Carolina/0000-0001-9579-8710; Santos, Helena/0000-0002-5240-5662; d'Avila-Levy, Claudia M/0000-0001-8042-4695	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/202.779/2015-FAPERJ]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [407768/2012-2 CNPq]	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (No E-26/202.779/2015-FAPERJ), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (No 407768/2012-2 CNPq).	Abe N, 2002, VET PARASITOL, V106, P203, DOI 10.1016/S0304-4017(02)00050-X; Alfellani MA, 2013, PROTIST, V164, P497, DOI 10.1016/j.protis.2013.05.003; Arisue N, 2002, J EUKARYOT MICROBIOL, V49, P42, DOI 10.1111/j.1550-7408.2002.tb00339.x; Balint A, 2014, PARASITOL RES, V113, P1585, DOI 10.1007/s00436-014-3805-0; Barbosa CV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193860; Barbosa CV, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2458-0; Betts E. L., 2018, PARASITOLOGY, P1; Caceres NC, 2004, MAMM BIOL, V69, P430, DOI 10.1078/1616-5047-00165; Santos HLC, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-207; Cian A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169659; Clark CG, 2013, ADV PARASIT, V82, P1, DOI 10.1016/B978-0-12-407706-5.00001-0; Clark CG, 2002, CLIN MICROBIOL REV, V15, P329, DOI 10.1128/CMR.15.3.329-341.2002; D'Andrea PS, 2000, PARASITOLOGY, V120, P573, DOI 10.1017/S0031182099005892; David EB, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0714-8; Ramirez JD, 2016, INFECT GENET EVOL, V41, P32, DOI 10.1016/j.meegid.2016.03.017; Ramirez JD, 2014, INFECT GENET EVOL, V22, P223, DOI 10.1016/j.meegid.2013.07.020; Eisenberg FJ, 1999, MAMMALS NEOTROPICS, V3, P624; Fayer R, 2012, PARASITOL RES, V111, P1349, DOI 10.1007/s00436-012-2971-1; Forsell J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1637-8; Freitas Simone R., 1997, Revista Brasileira de Biologia, V57, P93; GARDNER A. L., 2007, MARSUPIALS XENARTHRA, VI, p[xx, 669]; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Haziqah MTF, 2017, TROP BIOMED, V34, P741; Hoevers JD, 2005, PARASITOLOGY, V131, P187, DOI 10.1017/S0031182005007596; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Lee LI, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-130; Maldonado A, 2006, J HELMINTHOL, V80, P369, DOI 10.1017/JOH2006366; Malheiros AF, 2011, AM J TROP MED HYG, V85, P1050, DOI 10.4269/ajtmh.2011.11-0481; Mattiucci S, 2016, EPIDEMIOL INFECT, V144, P635, DOI 10.1017/S0950268815001697; Melo G. B., 2017, Parasitology Open, V3, pe3, DOI 10.1017/pao.2017.3; Meloni D, 2012, PARASITOL INT, V61, P719, DOI 10.1016/j.parint.2012.05.012; Mohamed AM, 2017, INFECT AGENTS CANCER, V12, DOI 10.1186/s13027-017-0131-z; Nagel R, 2012, INTERN MED J, V42, P1187, DOI 10.1111/j.1445-5994.2011.02626.x; Navarro C, 2008, VET PARASITOL, V153, P347, DOI 10.1016/j.vetpar.2008.02.003; Noel C, 2005, J CLIN MICROBIOL, V43, P348, DOI 10.1128/JCM.43.1.348-355.2005; Oliveira-Arbex AP, 2018, INFECT GENET EVOL, V57, P59, DOI 10.1016/j.meegid.2017.11.005; Paglia A.P., 2012, ARLINGTON CONSERVATI, V6, P76; Parkar U, 2007, PARASITOLOGY, V134, P359, DOI 10.1017/S0031182006001582; Parkar U, 2010, VET PARASITOL, V169, P8, DOI 10.1016/j.vetpar.2009.12.032; Petrasova J, 2011, INT J PARASITOL, V41, P1113, DOI 10.1016/j.ijpara.2011.06.010; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rivera WL, 2008, VET PARASITOL, V156, P178, DOI 10.1016/j.vetpar.2008.06.001; Roberts T, 2013, EUR J CLIN MICROBIOL, V32, P335, DOI 10.1007/s10096-012-1746-z; Salim HR, 1999, PARASITOL RES, V85, P1032, DOI 10.1007/s004360050677; Santin M, 2011, PARASITOL RES, V109, P205, DOI 10.1007/s00436-010-2244-9; Santori RT, 1995, MAMMALIA, V59, P511, DOI 10.1515/mamm.1995.59.4.511; Silberman JD, 1996, NATURE, V380, P398, DOI 10.1038/380398a0; Snell-Castro R, 2005, FEMS MICROBIOL ECOL, V52, P229, DOI 10.1016/j.femsec.2004.11.016; Song JK, 2017, ACTA TROP, V176, P277, DOI 10.1016/j.actatropica.2017.08.028; Stensvold CR, 2007, DIAGN MICR INFEC DIS, V59, P303, DOI 10.1016/j.diagmicrobio.2007.06.003; Stensvold CR, 2009, INT J PARASITOL, V39, P473, DOI 10.1016/j.ijpara.2008.07.006; Stensvold CR, 2013, J CLIN MICROBIOL, V51, P190, DOI 10.1128/JCM.02541-12; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan KSW, 2008, CLIN MICROBIOL REV, V21, P639, DOI 10.1128/CMR.00022-08; Tan KSW, 2004, VET PARASITOL, V126, P121, DOI 10.1016/j.vetpar.2004.09.017; Thathaisong U, 2003, J CLIN MICROBIOL, V41, P967, DOI 10.1128/JCM.41.3.967-975.2003; Vaisusuk K, 2018, ACTA TROP, V184, P78, DOI 10.1016/j.actatropica.2017.09.002; Villanueva-Garcia C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169637; Wang WQ, 2014, VET PARASITOL, V203, P264, DOI 10.1016/j.vetpar.2014.04.006; Wilson D.E., 1993, TAXONOMIC GEOGRAPHIC, V2nd ed.; Yan Y, 2007, PARASITOL RES, V101, P1527, DOI 10.1007/s00436-007-0672-y; Yoshikawa H, 2004, PARASITOL RES, V94, P391, DOI 10.1007/s00436-004-1230-5; Yoshikawa H, 2004, MICROBIOL-SGM, V150, P1147, DOI 10.1099/mic.0.26899-0; Yoshikawa H, 2000, J CLIN MICROBIOL, V38, P1324, DOI 10.1128/JCM.38.4.1324-1330.2000; Yoshikawa H, 2007, J EUKARYOT MICROBIOL, V54, P33, DOI 10.1111/j.1550-7408.2006.00141.x; Yoshikawa H, 2016, PARASITOL INT, V65, P750, DOI 10.1016/j.parint.2016.04.004; Yoshikawa H, 2009, VET PARASITOL, V160, P295, DOI 10.1016/j.vetpar.2008.11.029; Zanzani SA, 2016, PARASITOL RES, V115, P307, DOI 10.1007/s00436-015-4748-9	69	32	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210740	10.1371/journal.pone.0210740	http://dx.doi.org/10.1371/journal.pone.0210740			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682075	gold, Green Published, Green Submitted			2022-12-26	WOS:000457037500058
J	Nishimura, T; Takami, T; Sasaki, R; Aibe, Y; Matsuda, T; Fujisawa, K; Matsumoto, T; Yamamoto, N; Tani, K; Taura, Y; Sakaida, I				Nishimura, Tatsuro; Takami, Taro; Sasaki, Ryo; Aibe, Yuki; Matsuda, Takashi; Fujisawa, Koichi; Matsumoto, Toshihiko; Yamamoto, Naoki; Tani, Kenji; Taura, Yasuho; Sakaida, Isao			Liver regeneration therapy through the hepatic artery-infusion of cultured bone marrow cells in a canine liver fibrosis model	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; CIRRHOSIS; TRANSPLANTATION; DELIVERY; MIGRATION; MICE	Background We previously reported regenerative therapies for decompensated cirrhosis based on peripheral venous drip infusion using non-cultured whole bone marrow (BM) cells, or the less invasive cultured BM-derived mesenchymal stem cells (BMSCs). Here, we assessed the efficacy and safety of hepatic arterial infusion using cultured autologous BMSCs, comparing it with peripheral infusion, using our established canine liver fibrosis model. Methods Canine BM cells were harvested and cultured, and the resultant BMSCs were returned to carbon tetrachloride (CCl4)-induced liver cirrhosis model canines via either a peripheral vein (Vein group) or hepatic artery (Artery group). A variety of assays were performed before and 4, 8, and 12 weeks after BMSC infusion, and liver fibrosis and indocyanine green (ICG) half-life (t(1/2)) were compared to those in a control group that received CCI4 but not BMSCs. The safety of this approach was evaluated by contrast-enhanced computed tomography (CT) and serial blood examinations after infusion. Results Four weeks after infusing BMSCs, a significant improvement was observed in the Vein group (n = 8) compared to outcome in the Control group (n = 10), along with a decrease in ICG t(1/2). In the Artery group (n = 4), ICG t(1/2) was significantly shorter than that in the Vein group at 8 weeks (Delta t(1/2):-3.8 +/- 1.7 min vs. +0.4 +/- 2.4 min; p < 0.01) and 12 weeks (Delta t(1/2): -4.2 +/- 1.7 min vs. +0.4 +/- 2.7 min; p < 0.01) after BMSC administration. Post-infusion contrast-enhanced CT showed no liver infarction, and blood tests showed no elevations in either serum lactate dehydrogenase concentrations or hypercoagulability. Conclusions We confirmed the efficacy and safety of the hepatic arterial infusion of cultured autologous BMSCs using a canine model, thereby providing non-clinical proof-of-concept.	[Nishimura, Tatsuro; Takami, Taro; Sasaki, Ryo; Aibe, Yuki; Matsuda, Takashi; Sakaida, Isao] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Ube, Yamaguchi, Japan; [Takami, Taro; Sakaida, Isao] Yamaguchi Univ, Ctr Regenerat & Cell Therapy, Org Res Initiat, Ube, Yamaguchi, Japan; [Fujisawa, Koichi; Sakaida, Isao] Yamaguchi Univ, Grad Sch Med, Ctr Reparat Med, Ube, Yamaguchi, Japan; [Matsumoto, Toshihiko] Yamaguchi Univ, Grad Sch Med, Dept Oncol & Lab Med, Ube, Yamaguchi, Japan; [Yamamoto, Naoki] Yamaguchi Univ, Hlth Adm Ctr, Yamaguchi, Yamaguchi, Japan; [Tani, Kenji; Taura, Yasuho] Joint Fac Vet Med, Dept Vet Surg, Yamaguchi, Yamaguchi, Japan	Yamaguchi University; Yamaguchi University; Yamaguchi University; Yamaguchi University; Yamaguchi University	Takami, T (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Ube, Yamaguchi, Japan.; Takami, T (corresponding author), Yamaguchi Univ, Ctr Regenerat & Cell Therapy, Org Res Initiat, Ube, Yamaguchi, Japan.	t-takami@yamaguchi-u.ac.jp	fujisawa, koichi/AAC-1392-2022		Japanese Highway Program for the Realization of Regenerative Medicine, Japan Science and Technology Agency (JST); Japan Agency for Medical Research and Development (AMED); Japan Society for the Promotion of Science JSPS KAKENHI [JP17H04162]	Japanese Highway Program for the Realization of Regenerative Medicine, Japan Science and Technology Agency (JST); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The development of this model was supported by the Japanese Highway Program for the Realization of Regenerative Medicine by the Japan Science and Technology Agency (JST) and the Japan Agency for Medical Research and Development (AMED). The Project of Promotion for The Research and Development (R&D) Center on Regenerative Medicine in Yamaguchi Prefecture. Japan Society for the Promotion of Science JSPS KAKENHI Grant Numbers JP17H04162.	Assis ACM, 2010, CELL TRANSPLANT, V19, P219, DOI 10.3727/096368909X479677; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; BOOTHE DM, 1992, AM J VET RES, V53, P382; Cho KA, 2009, CELL BIOL INT, V33, P772, DOI 10.1016/j.cellbi.2009.04.023; Cohen-Naftaly Michal, 2011, Therap Adv Gastroenterol, V4, P391, DOI 10.1177/1756283X11413002; Eggenhofer E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00297; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Gholamrezanezhad A, 2011, NUCL MED BIOL, V38, P961, DOI 10.1016/j.nucmedbio.2011.03.008; Hardjo M, 2009, CELL TRANSPLANT, V18, P89, DOI 10.3727/096368909788237140; Huang B, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0792-1; Kanemoto H, 2011, VET PATHOL, V48, P839, DOI 10.1177/0300985810388523; Kim G, 2015, GUT LIVER, V9, P701, DOI 10.5009/gnl14451; Maeda M, 2012, J GASTROEN HEPATOL, V27, P104, DOI 10.1111/j.1440-1746.2011.07016.x; Makela T, 2015, CYTOTHERAPY, V17, P392, DOI 10.1016/j.jcyt.2014.12.004; Matsuda T, 2017, HEPATOL COMMUN, V1, P691, DOI 10.1002/hep4.1071; Nagaishi K, 2014, HEPATOLOGY, V59, P1816, DOI 10.1002/hep.26975; NAGINO M, 1995, HEPATOLOGY, V21, P434, DOI 10.1016/0270-9139(95)90104-3; Nanashima A, 2004, HEPATOL RES, V28, P184, DOI 10.1016/j.hepres.2003.11.010; Oishi Y, 2015, J VET MED SCI, V77, P925, DOI 10.1292/jvms.14-0469; Quintanilha LF, 2014, HEPATOL RES, V44, pE206, DOI 10.1111/hepr.12204; Shin TH, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.442; Singal AK, 2011, WORLD J HEPATOL, V3, P215, DOI 10.4254/wjh.v3.i8.215; Suk KT, 2016, HEPATOLOGY, V64, P2185, DOI 10.1002/hep.28693; Suk Ki Tae, 2012, Korean J Hepatol, V18, P1, DOI 10.3350/kjhep.2012.18.1.1; Terai S, 2006, STEM CELLS, V24, P2292, DOI 10.1634/stemcells.2005-0542; Terai S, 2011, J HEPATO-BIL-PAN SCI, V18, P23, DOI 10.1007/s00534-010-0305-1; Walczak P, 2008, STROKE, V39, P1569, DOI 10.1161/STROKEAHA.107.502047; Wang Y, 2009, TRANSPL P, V41, P4352, DOI 10.1016/j.transproceed.2009.08.072	29	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210588	10.1371/journal.pone.0210588	http://dx.doi.org/10.1371/journal.pone.0210588			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673721	gold, Green Published, Green Submitted			2022-12-26	WOS:000456442800047
J	Noguchi, K; Tomita, H; Kanayama, T; Niwa, A; Hatano, Y; Hoshi, M; Sugie, S; Okada, H; Niwa, M; Hara, A				Noguchi, Kei; Tomita, Hiroyuki; Kanayama, Tomohiro; Niwa, Ayumi; Hatano, Yuichiro; Hoshi, Masato; Sugie, Shigeyuki; Okada, Hideshi; Niwa, Masayuki; Hara, Akira			Time-course analysis of cardiac and serum galectin-3 in viral myocarditis after an encephalomyocarditis virus inoculation	PLOS ONE			English	Article							HEART-FAILURE; BINDING PROTEIN; FIBROSIS; EXPRESSION; INFLAMMATION; ASSOCIATION; MACROPHAGES; DYSFUNCTION; MARKER; MAC-2	Galectin-3 is a P-galactoside-binding lectin which is important in cell proliferation and apoptotic regulation. Recently, serum galectin-3 has been shown to have prognostic value as a biomarker in heart failure. Encephalomyocarditis virus (EMCV) can cause severe myocarditis, congestive heart failure and dilated cardiomyopathy as well as encephalitis in various animals including mice. The pathophysiological role of galectin-3 in acute myocarditis following viral infection is not fully understood. The goal of this study is to determine the cardiac localization and the time-course of galectin-3 expression in heart failure after viral inoculation with EMCV. At 12, 24, 48, 96 hours, 7 and 10 days after intraperitoneal EMCV inoculation, animals were examined histologically and analyzed for the expression of galectin-3 and lba1. Galectin-3 was up-regulated in degenerated fibrotic lesions of cardiac tissues 96 hours after viral inoculation and were followed by myocardial fibrosis. At the same time, lba1 positive macrophages were observed within the inflammatory sites. A time-course correlation between the number of galectin-3 positive cells and the cardiac area of degenerated fibrotic lesions was detected serum galectin-3 increased at 96 hours and correlated well with the number of cardiac galectin-3 positive cells. Our results indicate that galectin-3 expression may be a useful biomarker of cardiac fibrotic degeneration in acute myocarditis following viral infection. In addition, measuring serum galectin-3 levels might be an early diagnostic method for detecting cardiac degeneration in acute myocarditis.	[Noguchi, Kei; Tomita, Hiroyuki; Kanayama, Tomohiro; Niwa, Ayumi; Hatano, Yuichiro; Hara, Akira] Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu, Japan; [Hoshi, Masato] Fujita Hlth Univ, Grad Sch Hlth Sci, Dept Biochem & Analyt Sci, Toyoake, Aichi, Japan; [Sugie, Shigeyuki] Asahi Univ, Murakami Mem Hosp, Dept Pathol, Gifu, Japan; [Okada, Hideshi] Gifu Univ, Grad Sch Med, Dept Emergency & Disaster Med, Gifu, Japan; [Niwa, Masayuki] Gifu Univ, Div Med Sci, United Grad Sch Drug Discovery & Med Informat Sci, Gifu, Japan	Gifu University; Fujita Health University; Asahi University; Gifu University; Gifu University	Tomita, H (corresponding author), Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu, Japan.	h_tomita@gifu-u.ac.jp	Tomita, Hiroyuki/L-5571-2019; Hatano, Yuichiro/K-7454-2013	Tomita, Hiroyuki/0000-0002-3291-0274; Hatano, Yuichiro/0000-0002-5121-6325; Okada, Hideshi/0000-0002-7775-4308	Ministry of Education, Culture, Sports, Science and Technology of Japan [15K11289, 24590911]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research is supported by Grants-in-Aid for Scientific Research of the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant Number: 15K11289 and 24590911) (A.H. and H.T.).	[Anonymous], 2015, EUR J HEART FAIL, V17, p[764, 985], DOI [10.1016/j.jacc.2012.04.053, DOI 10.1016/J.JACC.2012.04.053]; Besler C, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.116.003804; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Carocci M, 2012, VIRULENCE, V3, P351, DOI 10.4161/viru.20573; CHERAYIL BJ, 1989, J EXP MED, V170, P1959, DOI 10.1084/jem.170.6.1959; de Boer RA, 2012, J INTERN MED, V272, P55, DOI 10.1111/j.1365-2796.2011.02476.x; Souza BSD, 2017, AM J PATHOL, V187, P1134, DOI 10.1016/j.ajpath.2017.01.016; Diaz-Alvarez L, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9247574; Edelmann F, 2015, EUR J HEART FAIL, V17, P214, DOI 10.1002/ejhf.203; Ho JE, 2012, J AM COLL CARDIOL, V60, P1249, DOI 10.1016/j.jacc.2012.04.053; Hrynchyshyn N, 2013, ARCH CARDIOVASC DIS, V106, P541, DOI 10.1016/j.acvd.2013.06.054; HUGHES RC, 1994, GLYCOBIOLOGY, V4, P5, DOI 10.1093/glycob/4.1.5; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Ishibashi-Ueda H, 2017, CIRC J, V81, P417, DOI 10.1253/circj.CJ-16-0927; de Giusti CJ, 2015, J MOL CELL CARDIOL, V85, P58, DOI 10.1016/j.yjmcc.2015.05.010; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kobayashi K, 2015, NEUROSCI LETT, V592, P107, DOI 10.1016/j.neulet.2015.02.061; Kuusisto J, 2012, HEART, V98, P1007, DOI 10.1136/heartjnl-2011-300960; Liu YH, 2009, AM J PHYSIOL-HEART C, V296, pH404, DOI 10.1152/ajpheart.00747.2008; Lopez B, 2015, J AM COLL CARDIOL, V65, P2449, DOI 10.1016/j.jacc.2015.04.026; Lopez-Andres N, 2012, EUR J HEART FAIL, V14, P74, DOI 10.1093/eurjhf/hfr151; MATSUMORI A, 1993, CLIN IMMUNOL IMMUNOP, V68, P215, DOI 10.1006/clin.1993.1121; Mueller KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135295; Ohsawa K, 2004, J NEUROCHEM, V88, P844, DOI 10.1046/j.1471-4159.2003.02213.x; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592; Sharma UC, 2004, CIRCULATION, V110, P3121, DOI 10.1161/01.CIR.0000147181.65298.4D; Sundblad V, 2011, HISTOL HISTOPATHOL, V26, P247, DOI 10.14670/HH-26.247; Travers JG, 2016, CIRC RES, V118, P1021, DOI 10.1161/CIRCRESAHA.115.306565; van Kimmenade RR, 2006, J AM COLL CARDIOL, V48, P1217, DOI 10.1016/j.jacc.2006.03.061	31	13	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210971	10.1371/journal.pone.0210971	http://dx.doi.org/10.1371/journal.pone.0210971			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673749	Green Submitted, gold, Green Published			2022-12-26	WOS:000456442800059
J	Medina-Trillo, C; Aroca-Aguilar, JD; Ferre-Fernandez, JJ; Alexandre-Moreno, S; Morales, L; Mendez-Hernandez, CD; Garcia-Feijoo, J; Escribano, J				Medina-Trillo, Cristina; Aroca-Aguilar, Jose-Daniel; Ferre-Fernandez, Jesus-Jose; Alexandre-Moreno, Susana; Morales, Laura; Mendez-Hernandez, Carmen-Dora; Garcia-Feijoo, Julian; Escribano, Julio			Role of FOXC2 and PITX2 rare variants associated with mild functional alterations as modifier factors in congenital glaucoma	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTORS; CYTOCHROME P4501B1 CYP1B1; AXENFELD-RIEGER-SYNDROME; HEREDITARY LYMPHEDEMA; FACTOR GENE; MUTATIONS; EXPRESSION; IDENTIFICATION; UNDERLIE; FAMILIES	Congenital glaucoma (CG) is a severe and inherited childhood optical neuropathy that leads to irreversible visual loss and blindness in children. CG pathogenesis remains largely unexplained in most patients. Herein we have extended our previous studies to evaluate the role of FOXC2 and PITX2 variants in CG. Variants of the proximal promoter and transcribed sequence of these two genes were analyzed by Sanger sequencing in a cohort of 133 CG families. To investigate possible oligogenic inheritance involving FOXC2 or PITX2 and CYP1B1, we also analyzed FOXC2 and PITX2 variants in a group of 25 CG cases who were known to carry CYP1B1 glaucoma-associated genotypes. The functional effect of three identified variants was assessed by transactivation luciferase reporter assays, protein stability and subcellular localization analyses. We found eight probands (6.0%) who carried four rare FOXC2 variants in the heterozygous state. In addition, we found an elevated frequency (8%) of heterozygous and rare PITX2 variants in the group of CG cases who were known to carry CYP1B1 glaucoma-associated genotypes, and one of these PITX2 variants arose de novo. To the best of our knowledge, two of the identified variants (FOXC2: c.1183C>A, p.(H395N); and PITX2: c.535C>A, p.(P179T)) have not been previously identified. Examination of the genotype-phenotype correlation in this group suggests that the presence of the infrequent PITX2 variants increase the severity of the phenotype. Transactivation reporter analyses showed partial functional alteration of three identified amino acid substitutions (FOXC2: p.(C498R) and p.(H395N); PITX2: p.(P179T)). In summary, the increased frequency in PCG patients of rare FOXC2 and PITX2 variants with mild functional alterations, suggests they play a role as putative modifier factors in this disease further supporting that CG is not a simple monogenic disease and provides novel insights into the complex pathological mechanisms that underlie CG.	[Medina-Trillo, Cristina; Aroca-Aguilar, Jose-Daniel; Ferre-Fernandez, Jesus-Jose; Alexandre-Moreno, Susana; Escribano, Julio] Univ Castilla La Mancha, Fac Med, Area Genet, Albacete, Spain; [Medina-Trillo, Cristina; Aroca-Aguilar, Jose-Daniel; Ferre-Fernandez, Jesus-Jose; Alexandre-Moreno, Susana; Escribano, Julio] Univ Castilla La Mancha, Inst Invest Discapacidades Neurol IDINE, Albacete, Spain; [Medina-Trillo, Cristina; Aroca-Aguilar, Jose-Daniel; Ferre-Fernandez, Jesus-Jose; Alexandre-Moreno, Susana; Morales, Laura; Mendez-Hernandez, Carmen-Dora; Garcia-Feijoo, Julian; Escribano, Julio] Inst Salud Carlos III, Cooperat Res Network Prevent Early Detect & Treat, Madrid, Spain; [Morales, Laura; Mendez-Hernandez, Carmen-Dora; Garcia-Feijoo, Julian] Hosp San Carlos, Serv Oftalmol, Madrid, Spain; [Morales, Laura; Mendez-Hernandez, Carmen-Dora; Garcia-Feijoo, Julian] Hosp Clin San Carlos, Inst Invest Sanitaria, Madrid, Spain	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Instituto de Salud Carlos III; Hospital Clinico San Carlos; Hospital Clinico San Carlos	Escribano, J (corresponding author), Univ Castilla La Mancha, Fac Med, Area Genet, Albacete, Spain.; Escribano, J (corresponding author), Univ Castilla La Mancha, Inst Invest Discapacidades Neurol IDINE, Albacete, Spain.; Escribano, J (corresponding author), Inst Salud Carlos III, Cooperat Res Network Prevent Early Detect & Treat, Madrid, Spain.	julio.escribano@uclm.es	Mendez-Hernandez, Carmen/D-6385-2017; Escribano, Julio/D-9742-2015; Aroca-Aguilar, Jose Daniel/R-5513-2019; Aroca-Aguilar, J.Daniel/B-7842-2008; Fernandez, Jesus J Ferre/AAA-3760-2021	Mendez-Hernandez, Carmen/0000-0003-3413-5248; Escribano, Julio/0000-0002-8919-8134; Aroca-Aguilar, Jose Daniel/0000-0001-6487-1612; Aroca-Aguilar, J.Daniel/0000-0001-6487-1612; Fernandez, Jesus J Ferre/0000-0002-9511-2894	Instituto de Salud Carlos III/FEDER [RD12/0034/0003, RD16/0008/0019, PI11/00662, PI15/01193]	Instituto de Salud Carlos III/FEDER(Instituto de Salud Carlos IIIEuropean Commission)	This study has been supported by research grants (to JE) from the "Instituto de Salud Carlos III/FEDER" (http://www.isciii.es, RD12/0034/0003, RD16/0008/0019, PI11/00662 and PI15/01193).	Acharya M, 2011, HUM MOL GENET, V20, P1610, DOI 10.1093/hmg/ddr038; Ali M, 2009, AM J HUM GENET, V84, P664, DOI 10.1016/j.ajhg.2009.03.017; [Anonymous], 2013, CHILDHOOD GLAUCOMA 9; [Anonymous], 1970, CONGENITAL PEDIAT GL, P37; Aroca-Aguilar JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054385; Azmanov DN, 2011, EUR J HUM GENET, V19, P326, DOI 10.1038/ejhg.2010.181; Bagiyeva S, 2007, MOL VIS, V13, P1458; Berry FB, 2006, HUM MOL GENET, V15, P905, DOI 10.1093/hmg/ddl008; Berry FB, 2005, HUM MOL GENET, V14, P2619, DOI 10.1093/hmg/ddi295; Campos-Mollo E, 2009, MOL VIS, V15, P417; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Cella W, 2006, INVEST OPHTH VIS SCI, V47, P1803, DOI 10.1167/iovs.05-0979; Ceroni F, 2019, HUM GENET, V138, P1027, DOI 10.1007/s00439-018-1875-2; Chakrabarti S, 2009, INVEST OPHTH VIS SCI, V50, P75, DOI 10.1167/iovs.08-2253; Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; Cox CJ, 2002, J BIOL CHEM, V277, P25001, DOI 10.1074/jbc.M201737200; D'haene B, 2011, INVEST OPHTH VIS SCI, V52, P324, DOI 10.1167/iovs.10-5309; Dipple KM, 2001, MOL GENET METAB, V74, P45, DOI 10.1006/mgme.2001.3227; ELDER MJ, 1993, BRIT J OPHTHALMOL, V77, P413, DOI 10.1136/bjo.77.7.413; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; Ferre-Fernandez JJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep46175; FRANCOIS J, 1980, OPHTHALMOLOGICA, V181, P61, DOI 10.1159/000309028; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; Gencik A, 1989, Dev Ophthalmol, V16, P76; Hayashi H, 2008, BIOCHEM BIOPH RES CO, V367, P584, DOI 10.1016/j.bbrc.2007.12.183; Hiemisch H, 1998, MECH DEVELOP, V73, P129, DOI 10.1016/S0925-4773(98)00039-2; Kaur K, 2005, CLIN GENET, V67, P335, DOI 10.1111/j.1399-0004.2005.00411.x; Kozlowski K, 2000, HUM MOL GENET, V9, P2131, DOI 10.1093/hmg/9.14.2131; Kume T, 2001, GENE DEV, V15, P2470, DOI 10.1101/gad.907301; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; Lopez-Garrido MP, 2013, OPHTHALMOLOGY, V120, P716, DOI 10.1016/j.ophtha.2012.09.016; Mashima Y, 2001, INVEST OPHTH VIS SCI, V42, P2211; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Mears AJ, 1998, AM J HUM GENET, V63, P1316, DOI 10.1086/302109; Medina-Trillo C, 2016, EUR J HUM GENET, V24, P672, DOI 10.1038/ejhg.2015.169; Medina-Trillo Cristina, 2015, Microrna, V4, P50; Medina-Trillo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119272; Narooie-Nejad M, 2009, HUM MOL GENET, V18, P3969, DOI 10.1093/hmg/ddp338; Sampaolesi R, 2009, THE GLAUCOMAS, P1; Sanchez-Sanchez F, 2007, J BIOL CHEM, V282, P27810, DOI 10.1074/jbc.M609608200; Sarfarazi M, 2000, EYE, V14, P422, DOI 10.1038/eye.2000.126; Seifi M, 2018, CLIN GENET, V93, P1123, DOI 10.1111/cge.13148; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Souma T, 2016, J CLIN INVEST, V126, P2575, DOI 10.1172/JCI85830; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Vincent AL, 2002, AM J HUM GENET, V70, P448, DOI 10.1086/338709; Winnier GE, 1997, GENE DEV, V11, P926, DOI 10.1101/gad.11.7.926; Xu D, 2013, PROTEINS, V81, P229, DOI 10.1002/prot.24179; Zhang CL, 2017, CANCER LETT, V396, P66, DOI 10.1016/j.canlet.2017.03.018	49	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0211029	10.1371/journal.pone.0211029	http://dx.doi.org/10.1371/journal.pone.0211029			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657791	gold, Green Published, Green Submitted			2022-12-26	WOS:000456017000026
J	Agemi, Y; Shimokawa, T; Sasaki, J; Miyazaki, K; Misumi, Y; Sato, A; Aida, S; Ishii, M; Nakamura, Y; Naoki, K; Okamoto, H				Agemi, Yoko; Shimokawa, Tsuneo; Sasaki, Jiichiro; Miyazaki, Kazuhito; Misumi, Yuki; Sato, Akira; Aida, Shinzi; Ishii, Mari; Nakamura, Yukiko; Naoki, Katsuhiko; Okamoto, Hiroaki			Prospective evaluation of the G8 screening tool for prognostication of survival in elderly patients with lung cancer: A single-institution study	PLOS ONE			English	Article							COMPREHENSIVE GERIATRIC ASSESSMENT; MINI NUTRITIONAL ASSESSMENT; OLDER PATIENTS; CHEMOTHERAPY TOXICITY; IDENTIFICATION; RECOMMENDATIONS; SOCIETY; UPDATE; ADULTS; RISK	The G8 questionnaire is a quick and easy-to-use screening tool. Several studies reported that the G8 questionnaire had a high sensitivity for predicting abnormalities in the full comprehensive geriatric assessment and predicted functional decline and survival in elderly cancer patients. The present study aimed to evaluate the role of the G8 questionnaire for predicting clinical outcomes and overall survival (OS) in elderly patients with lung cancer, who received chemotherapy or chemoradiotherapy. The data of 101 lung cancer patients aged. 70 years, who were hospitalized between September 2011 and August 2014, were analyzed. Of these patients (median age, 77 years), 83 (82%) had impaired G8 scores. The proportion of patients with an impaired G8 score was significantly higher in patients aged. 80 years than those aged <80 years (p = 0.04). All 18 patients with a normal G8 score possessed an Eastern Cooperative Oncology Group performance status (ECOG PS) of 0 or 1, and none of the patients with a normal G8 score had an ECOG PS of >= 2 (p < 0.0001). An impaired G8 score tended to correlate with a relative dose intensity of <0.65 in patients who received chemotherapy or chemoradiotherapy (p = 0.05, odds ratio = 5.40). In the univariate analysis, an ECOG PS of. 2 and an impaired G8 score were significantly associated with a poor OS (p = 0.009 and p = 0.003, respectively). Moreover, in the multivariate analysis, an ECOG PS of >= 2 (HR 2.55; 95% CI, 1.23-5.30; p = 0.01) and an impaired G8 score (HR 3.86; 95% CI, 1.44-13.36; p = 0.006) were remained independent prognostic factor for OS. G8 screening tool is useful for the prognostication of elderly lung cancer patients treated with chemotherapy. These finding suggest that the G8 questionnaire could be a useful tool in treatment decision-making to predict prognosis and prevent patients from receiving inappropriate anti-cancer treatment near the end of life.	[Agemi, Yoko; Shimokawa, Tsuneo; Miyazaki, Kazuhito; Misumi, Yuki; Aida, Shinzi; Nakamura, Yukiko; Okamoto, Hiroaki] Yokohama Municipal Citizens Hosp, Dept Resp Med, Yokohama, Kanagawa, Japan; [Agemi, Yoko; Sasaki, Jiichiro; Naoki, Katsuhiko] Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, Japan; [Sato, Akira] Osaka Int Canc Inst, Canc Control Ctr, Dept Canc Strategy, Osaka, Japan; [Ishii, Mari; Okamoto, Hiroaki] Yokohama Municipal Citizens Hosp, Dept Med Oncol, Yokohama, Kanagawa, Japan	Kitasato University	Agemi, Y (corresponding author), Yokohama Municipal Citizens Hosp, Dept Resp Med, Yokohama, Kanagawa, Japan.; Agemi, Y (corresponding author), Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, Japan.	yama.yoko.c9@gmail.com		Miyazaki, Kazuhito/0000-0002-0079-2883				Aapro M, 2000, ANN ONCOL, V11, P223, DOI 10.1023/A:1011156805700; Azzoli CG, 2011, J CLIN ONCOL, V29, P3825, DOI 10.1200/JCO.2010.34.2774; Baitar A, 2015, J GERIATR ONCOL, V6, P401, DOI 10.1016/j.jgo.2015.07.005; Bellera CA, 2012, ANN ONCOL, V23, P2166, DOI 10.1093/annonc/mdr587; Corre R, 2016, J CLIN ONCOL, V34, P1476, DOI 10.1200/JCO.2015.63.5839; Decoster L, 2015, ANN ONCOL, V26, P288, DOI 10.1093/annonc/mdu210; Dubruille S, 2015, J GERIATR ONCOL, V6, P362, DOI 10.1016/j.jgo.2015.07.006; Extermann M, 2005, CRIT REV ONCOL HEMAT, V55, P241, DOI 10.1016/j.critrevonc.2005.06.003; Extermann M, 2004, CRIT REV ONCOL HEMAT, V49, P69, DOI 10.1016/S1040-8428(03)00099-4; Extermann M, 2012, CANCER-AM CANCER SOC, V118, P3377, DOI 10.1002/cncr.26646; Ferlay J, 2018, EUR J CANCER, V103, P356, DOI 10.1016/j.ejca.2018.07.005; Giannousi Z, 2012, SUPPORT CARE CANCER, V20, P1823, DOI 10.1007/s00520-011-1282-x; Hamaker ME, 2014, ANN HEMATOL, V93, P1031, DOI 10.1007/s00277-013-2001-0; Hoppe S, 2013, J CLIN ONCOL, V31, P3877, DOI 10.1200/JCO.2012.47.7430; Hurria A, 2011, J CLIN ONCOL, V29, P3457, DOI 10.1200/JCO.2011.34.7625; Kenis C, 2014, J CLIN ONCOL, V32, P19, DOI 10.1200/JCO.2013.51.1345; Liuu E, 2014, J GERIATR ONCOL, V5, P11, DOI 10.1016/j.jgo.2013.08.003; Matsuda T, 2008, JPN J CLIN ONCOL, V38, P641, DOI 10.1093/jjco/hyn074; Owonikoko TK, 2007, J CLIN ONCOL, V25, P5570, DOI 10.1200/JCO.2007.12.5435; Ramsdale E, 2013, J AM GERIATR SOC, V61, P2043, DOI 10.1111/jgs.12536; Ross PJ, 2004, BRIT J CANCER, V90, P1905, DOI 10.1038/sj.bjc.6601781; Schulkes KJG, 2017, CLIN LUNG CANCER, V18, P660, DOI 10.1016/j.cllc.2017.02.006; Simmons CP, 2015, LUNG CANCER, V88, P304, DOI 10.1016/j.lungcan.2015.03.020; Soubeyran P, 2014, PLOS ONE, V9, P40, DOI [10.1007/s00277-013-2001-0Epub2014Feb2, DOI 10.1007/S00277-013-2001-0EPUB2014FEB2]; Soubeyran P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115060; Statistics and Information Department Minister's Secretariat Ministry of Health Labour and Welfare, VIT STAT JAP; Takahashi M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179694; Valentini A, 2018, CLIN INTERV AGING, V13, P1237, DOI 10.2147/CIA.S164174; Vellas B, 1999, NUTRITION, V15, P116, DOI 10.1016/S0899-9007(98)00171-3	29	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210499	10.1371/journal.pone.0210499	http://dx.doi.org/10.1371/journal.pone.0210499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653558	gold, Green Published, Green Submitted			2022-12-26	WOS:000456015500044
J	Park, B; Cho, HN; Choi, E; Seo, DH; Kim, S; Park, YR; Choi, KS; Rhee, Y				Park, Boyoung; Cho, Ha Na; Choi, Eunji; Seo, Da Hea; Kim, Sue; Park, Yeong-Ran; Choi, Kui Son; Rhee, Yumie			Self-perceptions of body weight status according to age-groups among Korean women: A nationwide population-based survey	PLOS ONE			English	Article							MASS INDEX; CONTROL BEHAVIORS; OBESITY STIGMA; OVERWEIGHT; YOUNG; IMAGE; PREVALENCE; ADULTS; MISPERCEPTION; ASSOCIATION	While numerous studies have investigated body image, including body weight perception, most of which have focused on adolescents or young women, few studies have attempted to evaluate body weight perceptions in adult women according to age groups. This study was conducted to investigate the accuracy of self-perceived weight and actual body mass index (BMI) values among adult Korean women according to age. We used data from the 2016 Korean Study of Women's Health Related Issues, a population-based, nationwide, cross-sectional survey. BMI was calculated from self-reported weight and height. Participants were asked to describe their body image by choosing one of the following descriptions: very underweight, underweight, about right, overweight, or obese. The proportions of women aged 20-29, 30-39, 40-49, 50-59, 60-69, and 70-79 years who underestimated their body weight relative to their actual BMI category were 12.6%, 15.1%, 22.2%, 34.0%, 45.6%, and 50.7%, respectively; those who overestimated their body weight comprised 18.7%, 17.8%, 14.3%, 10.8%, and 7.4%. In all BMI categories, the proportion of those who overestimated their weight status increased as age decreased, while those who underestimated their weight status increased as age increased. After adjusting for possible covariates, age was strongly associated with both underestimation and overestimation. The odds ratio for underestimating one's weight status among women aged 70-79 yeas was 2.96 (95% CI: 2.10-4.18), and that for overestimation was 0.52 (95% CI: 0.35-0.79), compared to women aged 20-29 years. Age is the most important factor associated with weight perceptions among Korean women, affecting both underestimation and overestimation of weight status.	[Park, Boyoung] Hanyang Univ, Coll Med, Dept Med, Seoul, South Korea; [Park, Boyoung; Cho, Ha Na; Choi, Eunji; Choi, Kui Son] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Control & Populat Hlth, Goyang, South Korea; [Seo, Da Hea] Inha Univ, Sch Med, Dept Endocrinol & Metab, Incheon, South Korea; [Kim, Sue] Yonsei Univ, Coll Nursing, Seoul, South Korea; [Park, Yeong-Ran] Kangnam Univ, Dept Silver Ind, Yongin, South Korea; [Rhee, Yumie] Yonsei Univ, Coll Med, Severance Hosp, Dept Internal Med,Endocrine Res Inst, Seoul, South Korea	Hanyang University; National Cancer Center - Korea (NCC); Inha University; Yonsei University; Yonsei University Health System; Kangnam University; Yonsei University; Yonsei University Health System	Choi, KS (corresponding author), Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Control & Populat Hlth, Goyang, South Korea.; Rhee, Y (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Internal Med,Endocrine Res Inst, Seoul, South Korea.	kschoi@ncc.re.kr; yumie@yuhs.ac	Rhee, Yumie/L-8020-2019; Kim, Sue/AAB-4253-2021	Rhee, Yumie/0000-0003-4227-5638; Kim, Sue/0000-0003-3785-2445; Choi, Kui Son/0000-0001-5336-3874	Center for Disease Control and Prevention, Korea [2015ER630300]; National Cancer Center of Korea [1610401]	Center for Disease Control and Prevention, Korea; National Cancer Center of Korea	The study was funded from the Center for Disease Control and Prevention, Korea (http://www.cdc.go.kr/CDC/main.jsp) (2015ER630300), and the National Cancer Center of Korea (http://www.ncc.re.kr) (#1610401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern Amy L, 2008, Eat Disord, V16, P294, DOI 10.1080/10640260802115852; Alwan H, 2011, J OBES, V2011, DOI 10.1155/2011/817242; Bhanji S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-363; Brewis AA, 2017, AM J HUM BIOL, V29, DOI 10.1002/ajhb.22972; Burke MA, 2010, OBESITY, V18, P1226, DOI 10.1038/oby.2009.369; Chisuwa-Hayami N, 2017, HEALTH PROMOT PERSPE, V7, P80, DOI 10.15171/hpp.2017.15; Cho HN, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4531-1; Choi Y, 2015, J KOREAN MED SCI, V30, P1558, DOI 10.3346/jkms.2015.30.11.1558; Chu NF, 2005, OBES REV, V6, P271, DOI 10.1111/j.1467-789X.2005.00175.x; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Committee S, 2000, AS PAC PERSP RED OB, P11; Craig BM, 2009, MATERN CHILD HLTH J, V13, P489, DOI 10.1007/s10995-008-0384-7; Daniels Judi, 2005, J Pediatr Health Care, V19, P33; Duncan DT, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-20; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; Fruh SM, 2016, JNP-J NURSE PRACT, V12, P425, DOI 10.1016/j.nurpra.2016.05.013; Gutierrez-Fisac JL, 2002, EUR J CLIN NUTR, V56, P866, DOI 10.1038/sj.ejcn.1601404; Ikeda N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148297; Jeong JS, 2007, KOREAN J PREV MED PU, V40, P197, DOI DOI 10.3961/JPMPH.2007.40.3.197; Joh HK, 2013, OBESITY FACTS, V6, P17, DOI 10.1159/000346805; Johnson C, 2014, BMJ OPEN, V4, DOI [10.1136/bmjopen-2014-005561, 10.1136/bmjopen-2014-006629]; Johnson F, 2008, BMJ-BRIT MED J, V337, pa494, DOI DOI 10.1136/BMJ.A494; Jung J, 2007, PSYCHOL WOMEN QUART, V31, P381, DOI 10.1111/j.1471-6402.2007.00387.x; Kang HT, 2014, J EPIDEMIOL, V24, P109, DOI 10.2188/jea.JE20130017; Kanter R, 2012, ADV NUTR, V3, P491, DOI 10.3945/an.112.002063; Kim CS, 2014, DIABETES METAB J, V38, P35, DOI 10.4093/dmj.2014.38.1.35; Kim Dong-Sik, 2008, J Prev Med Public Health, V41, P323, DOI 10.3961/jpmph.2008.41.5.323; KIM JH, 2016, BMJ OPEN, V6, DOI DOI 10.1136/BMJOPEN-2015-010183; Kim S, 2016, OBES RES CLIN PRACT, V14, P30030; Kim Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198841; Lemon SC, 2009, BODY IMAGE, V6, P90, DOI 10.1016/j.bodyim.2008.11.004; Marini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083543; Monteagudo C, 2015, J NUTR HEALTH AGING, V19, P612, DOI 10.1007/s12603-015-0486-z; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Noh JW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183881; Park B, 2011, J KOREAN MED SCI, V26, P711, DOI 10.3346/jkms.2011.26.6.711; Perloff RM, 2014, SEX ROLES, V71, P363, DOI 10.1007/s11199-014-0384-6; Pruis TA, 2010, J GEN PSYCHOL, V137, P225, DOI 10.1080/00221309.2010.484446; Puhl RM, 2006, OBESITY, V14, P1802, DOI 10.1038/oby.2006.208; Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491; Rahman M, 2010, OBSTET GYNECOL, V116, P1274, DOI 10.1097/AOG.0b013e3181fdfc47; Robertson A, 2014, APPETITE, V75, P157, DOI 10.1016/j.appet.2014.01.006; Rochelle TL, 2017, PSYCHOL HEALTH MED, V22, P310, DOI 10.1080/13548506.2016.1226507; RODIN M, 1989, PERS SOC PSYCHOL B, V15, P439, DOI 10.1177/0146167289153013; Shin Jaeyong, 2015, J Prev Med Public Health, V48, P94, DOI 10.3961/jpmph.14.055; Skeie G, 2015, CLIN EPIDEMIOL, V7, P313, DOI 10.2147/CLEP.S83839; Suh M, 2016, CANCER RES TREAT, V48, P1, DOI 10.4143/crt.2014.204; Talamayan KS, 2006, THESCIENTIFICWORLDJO, V6, P365, DOI 10.1100/tsw.2006.70; Tang Wesley, 2016, BMC Obes, V3, P11, DOI 10.1186/s40608-016-0088-2; Viner RM, 2006, INT J OBESITY, V30, P1514, DOI 10.1038/sj.ijo.0803352; Wang A, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150070; Wardle J, 2006, INT J OBESITY, V30, P644, DOI 10.1038/sj.ijo.0803050; World Health Organization, OB OV, DOI [10.3945/an.112.002063, DOI 10.3945/AN.112.002063]; Yaemsiri S, 2011, INT J OBESITY, V35, P1063, DOI 10.1038/ijo.2010.229; Yoshiike N, 2002, Obes Rev, V3, P183, DOI 10.1046/j.1467-789X.2002.00070.x; Yost J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-465	57	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210486	10.1371/journal.pone.0210486	http://dx.doi.org/10.1371/journal.pone.0210486			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653596	gold, Green Published, Green Submitted			2022-12-26	WOS:000456015500042
J	He, J; Tang, F; Chen, DW; Yu, B; Luo, YH; Zheng, P; Mao, XB; Yu, J; Yu, F				He, Jun; Tang, Feng; Chen, Daiwen; Yu, Bing; Luo, Yuheng; Zheng, Ping; Mao, Xiangbing; Yu, Jie; Yu, Feng			Design, expression and functional characterization of a thermostable xylanase from Trichoderma reesei	PLOS ONE			English	Article							BACILLUS-CIRCULANS XYLANASE; MICROBIAL XYLANASES; THERMOTOGA-MARITIMA; DISULFIDE BRIDGE; RESIDUES; YEAST; GLYCOSYLATION; THERMOSTABILIZATION; IDENTIFICATION; OPTIMIZATION	Xylanases isolated from microorganisms such as the Trichoderma reesei have attracted considerable research interest because of their potential in various industrial applications. However, naturally isolated xylanases cannot withstand harsh conditions such as high temperature and basic pH. In this study, we performed structural analysis of the major T. reesei xylanase (Xyn2), and novel flexible regions of the enzyme were identified based on B-factor, a molecular dynamics (MD) parameter. To improve thermostability of the Xyn2, disulfide bonds were introduced into the unstable flexible region by using site-directed mutagenesis and two recombinant xylanases, XM1 (Xyn2(Cys12-52)) and XM2 (Xyn2(Cys59-149)) were successfully expressed in Pichia pastoris. Secreted recombinant Xyn2 was estimated by SDS-PAGE to be 24 kDa. Interestingly, the half-lives of XM1 and XM2 at 60 degrees C were 2.5- and 1.8-fold higher, respectively than those of native Xyn2. The XM1 also exhibited improved pH stability and maintained more than 60% activity over pH values ranging from 2.0 to 10.0. However, the specific activity and catalytic efficiency of XM1 was decreased as compared to those of XM2 and native Xyn2. Our results will assist not only in elucidating of the interactions between protein structure and function, but also in rational target selection for improving the thermostability of enzymes.	[He, Jun; Tang, Feng; Chen, Daiwen; Yu, Bing; Luo, Yuheng; Zheng, Ping; Mao, Xiangbing; Yu, Jie; Yu, Feng] Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University	He, J (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China.	hejun8067@163.com			Key Research and Development Program of Sichuan Province [2018NZDZX0005]; Fok Ying Tung Education Foundation [141027]; Opening Grant of Guangdong Key Laboratory for Innovative Development and Utilization of Forest Plant Germplasm	Key Research and Development Program of Sichuan Province; Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation); Opening Grant of Guangdong Key Laboratory for Innovative Development and Utilization of Forest Plant Germplasm	JH: the Key Research and Development Program of Sichuan Province [2018NZDZX0005], and the Fok Ying Tung Education Foundation [no. 141027] to HJ.; This work was supported by the Key Research and Development Program of Sichuan Province [2018NZDZX0005], and the Fok Ying Tung Education Foundation [no. 141027], and Opening Grant of Guangdong Key Laboratory for Innovative Development and Utilization of Forest Plant Germplasm.	Badieyan S, 2012, BIOTECHNOL BIOENG, V109, P31, DOI 10.1002/bit.23280; Basu M, 2018, CURR PROTEIN PEPT SC, V19, P87, DOI 10.2174/1389203718666161122110200; Baweja M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00965; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Bhardwaj A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011347; Biely P, 1997, J BIOTECHNOL, V57, P151, DOI 10.1016/S0168-1656(97)00096-5; BUCKHOLZ RG, 1991, BIO-TECHNOL, V9, P1067, DOI 10.1038/nbt1191-1067; CREIGHTON TE, 1992, BIOESSAYS, V14, P195, DOI 10.1002/bies.950140310; Hamilton SR, 2007, CURR OPIN BIOTECH, V18, P387, DOI 10.1016/j.copbio.2007.09.001; Hamilton SR, 2015, METHODS MOL BIOL, V1321, P73, DOI 10.1007/978-1-4939-2760-9_6; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Jiang ZQ, 2004, J BIOTECHNOL, V114, P125, DOI 10.1016/j.jbiotec.2004.05.007; Jiang ZQ, 2004, J MOL CATAL B-ENZYM, V27, P207, DOI 10.1016/j.molcatb.2003.11.012; Joo JC, 2011, J BIOTECHNOL, V151, P56, DOI 10.1016/j.jbiotec.2010.10.002; JUN H., 2010, BRIT J NUTR, V103, P1507, DOI [10.1016/j.jbiotec.2006.04.031, DOI 10.1016/J.JBIOTEC.2006.04.031]; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Kumar V, 2018, MOL BIOTECHNOL, V60, P226, DOI 10.1007/s12033-018-0059-6; Kumar V, 2017, BIORESOURCE TECHNOL, V243, P1009, DOI 10.1016/j.biortech.2017.07.094; Ludwiczek ML, 2007, J MOL BIOL, V373, P337, DOI 10.1016/j.jmb.2007.07.057; MATSUMURA M, 1989, SCIENCE, V243, P792, DOI 10.1126/science.2916125; MIAO SC, 1994, BIOCHEMISTRY-US, V33, P7027, DOI 10.1021/bi00189a002; Muta K, 2014, BIOCHEM PHARMACOL, V87, P352, DOI 10.1016/j.bcp.2013.10.001; Paes G, 2012, BIOTECHNOL ADV, V30, P564, DOI 10.1016/j.biotechadv.2011.10.003; PULS J, 1993, PORT PR R M, V4, P1; Roberge M, 1999, PROTEIN ENG, V12, P251, DOI 10.1093/protein/12.3.251; ROMANOS MA, 1992, YEAST, V8, P423, DOI 10.1002/yea.320080602; Satyanarayana DVT, 2013, J IND MICROBIOL BIOT, V40, P1373, DOI 10.1007/s10295-013-1347-6; Seelhorst K, 2013, GLYCOBIOLOGY, V23, P559, DOI 10.1093/glycob/cws219; Sriprang R, 2006, J BIOTECHNOL, V126, P454, DOI 10.1016/j.jbiotec.2006.04.031; Taherzadeh MJ, 2008, INT J MOL SCI, V9, P1621, DOI 10.3390/ijms9091621; TORRONEN A, 1992, BIO-TECHNOL, V10, P1461, DOI 10.1038/nbt1192-1461; Turunen O, 2001, J BIOTECHNOL, V88, P37, DOI 10.1016/S0168-1656(01)00253-X; WAKARCHUK WW, 1994, PROTEIN ENG, V7, P1379, DOI 10.1093/protein/7.11.1379; Wang YW, 2012, BIORESOURCE TECHNOL, V112, P275, DOI 10.1016/j.biortech.2012.02.092; WITHERS SG, 1995, PROTEIN SCI, V4, P361; Yang HM, 2007, J IND MICROBIOL BIOT, V34, P213, DOI 10.1007/s10295-006-0188-y; Yang Hao-Meng, 2006, Sheng Wu Gong Cheng Xue Bao, V22, P26, DOI 10.1016/S1872-2075(06)60003-4; Zhang HM, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-3; Zhang S, 2010, BIOCHEM BIOPH RES CO, V395, P200, DOI 10.1016/j.bbrc.2010.03.159	39	11	13	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210548	10.1371/journal.pone.0210548	http://dx.doi.org/10.1371/journal.pone.0210548			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650138	gold, Green Published, Green Submitted			2022-12-26	WOS:000455813300060
J	Pellegrino, M; Crino, A; Rosado, MM; Fierabracci, A				Pellegrino, Marsha; Crino, Antonino; Rosado, Manuela M.; Fierabracci, Alessandra			Identification and functional characterization of CD8(+) T regulatory cells in type 1 diabetes patients	PLOS ONE			English	Article							LOW-DOSE INTERLEUKIN-2; REMITTING MULTIPLE-SCLEROSIS; PRIMARY IMMUNE-RESPONSE; INCREASED SUSCEPTIBILITY; PROGRAMMED DEATH-1; MICE; PD-1; GENERATION; SUPPRESSES; POPULATION	Type 1 diabetes is an autoimmune disease where autoreactive T lymphocytes destroy pancreatic beta cells. We previously reported a defect in CD4(+) Tregs cell proliferation and reduced CD4(+) Tregs PD-1 expression in patients. Another 'memory-like' regulatory subset, CD8(+) Tregs, evaluated as CD8(+)CD25(+)FOXP3(+), has recently raised interest for their effective suppressive activity. Different CD8(+) T cell populations, their proliferation capacity and expression of PD-1 molecule were evaluated by flow-cytometer analysis in newly diagnosed, long-term Type 1 diabetes patients compared to healthy normal donors. Under basal conditions, CD8(+) Tregs and CD8(+) Teffs were seemingly represented among study groups while there was evidence of diminished expression of PD-1 in Teff subsets of long-term patients. After 3 days of PMA/ionomycin stimulation, patients CD8(+) Tregs showed decreased percentage in respect to control group. CD8(+) Teffs were instead increased in long-term diabetics versus controls. PD-1(+)CD8(+) Tregs were represented at a much lower percentage in long-term diabetic patients, in respect to controls. Importantly, patients CD8(+) Tregs and CD8(+) Teffs presented a significant proliferation defect in respect to the control group. In conclusion, our study indicates that a defect of CD8(+) Tregs is observed in diabetics. This subset could thus represent a novel target of immunotherapy in patients.	[Pellegrino, Marsha; Fierabracci, Alessandra] Bambino Gesu Pediat Hosp, Infectivol & Clin Trials Res Div, Rome, Italy; [Crino, Antonino] Bambino Gesu Pediat Hosp, Endocrinol Dept, Rome, Italy; [Rosado, Manuela M.] Bambino Gesu Pediat Hosp, Res Labs, Rome, Italy	IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu	Fierabracci, A (corresponding author), Bambino Gesu Pediat Hosp, Infectivol & Clin Trials Res Div, Rome, Italy.	alessandra.fierabracci@opbg.net	Fierabracci, Alessandra/K-5930-2016; Rosado, Maria Manuela/AAX-6495-2020; Pellegrino, Marsha/K-4500-2016	Fierabracci, Alessandra/0000-0003-3078-9754; Pellegrino, Marsha/0000-0002-9002-3622; Crino, Antonino/0000-0003-3548-7114	Italian Ministry of Health Ricerca corrente RC201702P003967	Italian Ministry of Health Ricerca corrente RC201702P003967	This work was supported by Italian Ministry of Health Ricerca corrente RC201702P003967 (AF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari MJI, 2003, J EXP MED, V198, P63, DOI 10.1084/jem.20022125; Berger CT, 2016, J CLIN INVEST, V126, P1646, DOI 10.1172/JCI87429; Bisikirska B, 2005, J CLIN INVEST, V115, P2904, DOI 10.1172/JCI23961; Churlaud G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00171; Correale J, 2010, ANN NEUROL, V67, P625, DOI 10.1002/ana.21944; Eibl N, 2002, CLIN IMMUNOL, V103, P249, DOI 10.1006/clim.2002.5220; Fenoglio D, 2008, HUM IMMUNOL, V69, P745, DOI 10.1016/j.humimm.2008.08.282; Field AC, 2003, J AUTOIMMUN, V21, P201, DOI 10.1016/S0896-8411(03)00118-5; Fierabracci A, 2011, AUTOIMMUN REV, V10, P137, DOI 10.1016/j.autrev.2010.08.019; Fierabracci A, 2011, DIABETES-METAB RES, V27, P216, DOI 10.1002/dmrr.1165; Filaci G, 2011, AUTOIMMUNITY, V44, P51, DOI 10.3109/08916931003782171; Filaci Gilberto, 2002, Autoimmunity Reviews, V1, P279, DOI 10.1016/S1568-9972(02)00065-4; Frisullo G, 2010, HUM IMMUNOL, V71, P437, DOI 10.1016/j.humimm.2010.01.024; Fujisawa R, 2015, CLIN EXP IMMUNOL, V180, P452, DOI 10.1111/cei.12603; Gianchecchi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110755; Gilliet M, 2002, J EXP MED, V195, P695, DOI 10.1084/jem.20011603; Grinberg-Bleyer Y, 2010, J EXP MED, V207, P1871, DOI 10.1084/jem.20100209; Hartemann A, 2013, LANCET DIABETES ENDO, V1, P295, DOI 10.1016/S2213-8587(13)70113-X; Hu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059545; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Huo CY, 2017, MICROB PATHOGENESIS, V113, P233, DOI 10.1016/j.micpath.2017.10.026; Jebbawi F, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0218-x; Kumar V, 2001, IMMUNOL REV, V182, P113, DOI 10.1034/j.1600-065X.2001.1820109.x; Lau D, 2013, THORAX, V68, P658, DOI 10.1136/thoraxjnl-2012-203109; Lu LR, 2008, CELL MOL IMMUNOL, V5, P401, DOI 10.1038/cmi.2008.50; Mahic M, 2008, EUR J IMMUNOL, V38, P640, DOI 10.1002/eji.200737529; Morikawa H, 2014, IMMUNOL REV, V259, P192, DOI 10.1111/imr.12174; Muller LMAJ, 2005, CLIN INFECT DIS, V41, P281, DOI 10.1086/431587; Nanda NK, 1996, J EXP MED, V184, P1037, DOI 10.1084/jem.184.3.1037; Nenna R, 2011, INT J IMMUNOPATH PH, V24, P651, DOI 10.1177/039463201102400311; Pauken KE, 2013, DIABETES, V62, P2859, DOI 10.2337/db12-1475; Perri V, 2015, INT J MOL SCI, V16, P22584, DOI 10.3390/ijms160922584; Putnam AL, 2005, J AUTOIMMUN, V24, P55, DOI 10.1016/j.jaut.2004.11.004; Reading PC, 1998, J VIROL, V72, P6884, DOI 10.1128/JVI.72.8.6884-6887.1998; Rosenzwajg M, 2015, J AUTOIMMUN, V58, P48, DOI 10.1016/j.jaut.2015.01.001; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; Saresella M, 2008, FASEB J, V22, P3500, DOI 10.1096/fj.08-110650; Shameli A, 2013, EUR J IMMUNOL, V43, P394, DOI 10.1002/eji.201242845; Spatz M, 2003, CELL IMMUNOL, V221, P15, DOI 10.1016/S0008-8749(03)00043-1; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tang XL, 2005, CELL MOL IMMUNOL, V2, P11; Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015; Tsutsumi Y, 2006, DIABETIC MED, V23, P1145, DOI 10.1111/j.1464-5491.2006.01951.x; Wang H, 2013, TRANSPL P, V45, P1822, DOI 10.1016/j.transproceed.2012.10.061; Wang J, 2005, P NATL ACAD SCI USA, V102, P11823, DOI 10.1073/pnas.0505497102; Wang YS, 2017, ONCOTARGET, V8, P60201, DOI 10.18632/oncotarget.18732; Wong MD, 2013, J IMMUNOL, V190, P5402, DOI 10.4049/jimmunol.1202382; Xystrakis E, 2004, BLOOD, V104, P3294, DOI 10.1182/blood-2004-03-1214; Zhao H, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01578; Zimring JC, 2004, IMMUNOL RES, V29, P303, DOI 10.1385/IR:29:1-3:303	50	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210839	10.1371/journal.pone.0210839	http://dx.doi.org/10.1371/journal.pone.0210839			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650147	Green Published, Green Submitted, gold			2022-12-26	WOS:000455813300080
J	Sin, CZ; Wang, TS; Chiu, HY; Tsai, TF				Sin, Chi-Zai; Wang, Ting-Shun; Chiu, Hsien-Yi; Tsai, Tsen-Fang			Human leukocyte antigen and demographic characteristics in Chinese patients with active peripheral type psoriatic arthritis who had inadequate response to conventional disease-modifying antirheumatic drugs in a single dermatologic clinic	PLOS ONE			English	Article							HLA-C LOCUS; DOUBLE-BLIND; GENETIC SUSCEPTIBILITY; MONOCLONAL-ANTIBODY; USTEKINUMAB; PLACEBO; ALLELES; HLA-CW6; RISK; POLYMORPHISM	Background Correlation between severity of psoriasis and psoriatic arthritis (PsA) is inconsistent. Also, human leukocyte antigen (HLA)-Cw6 was found to be underrepresented in severe psoriasis who failed conventional systemic therapies, but the effect of HLA polymorphism on PsA severity needs to be confirmed. Objectives To describe the severity of psoriasis, demographic features and HLA polymorphism among Chinese patients with active peripheral type PsA who had inadequate response to conventional disease-modifying antirheumatic drugs. Methods We included all patients with PsA who had at least 3 tender and swollen peripheral joints despite at least two conventional non-biologic treatments in our clinic. Demographic results were compared with global pivotal studies of biologics for PsA. HLA-Cw and HLA-DRB1 genotyping was also analyzed. Results We identified 60 patients who met our inclusion criteria. The male to female ratio was 1.31:1. The majority of patients presented with psoriasis first (81.7%). The mean interval between psoriasis and PsA was 7.2 +/- 8.1 years (mean +/- SD). The baseline number of tender and swollen joints was 14.9 +/- 10.7 and 11.3 +/- 10.2, respectively. In total, 41.7% subjects had more than 3% body surface area involvement of psoriasis. Genotyping of HLA-Cw and HLA-DRB1 was performed in 47 subjects. HLA-Cw*0702 was the most frequent allele (29.8%), followed by HLA-Cw*01 (26.6%). The frequency of HLA-Cw*0602 allele was similar to normal population. The most frequent HLA-DRB1 allele was HLA-DRB1*04 (20.2%), followed by HLA-DRB1*08 (16.0%). No cases carrying HLA-DRB1*13 were detected. Conclusions Compared with Western population, our patients had less psoriasis and PsA burden. The frequencies of HLA-Cw*06, HLA-Cw*12, and HLA-DRB1*07 were not increased. In contrast, HLA-Cw*0702 and HLA-DRB1*08 allele frequencies were increased compared with psoriasis patients and normal population in Taiwan. Future studies are still needed to characterize the demographic and genetic features of high need PsA patients.	[Sin, Chi-Zai; Wang, Ting-Shun; Chiu, Hsien-Yi; Tsai, Tsen-Fang] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan; [Sin, Chi-Zai; Wang, Ting-Shun; Chiu, Hsien-Yi; Tsai, Tsen-Fang] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Wang, Ting-Shun] Chung Shan Med Univ Hosp, Div Dermatol, Taichung, Taiwan; [Chiu, Hsien-Yi] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Dermatol, Hsinchu, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Chung Shan Medical University; Chung Shan Medical University Hospital; National Taiwan University; National Taiwan University Hospital	Tsai, TF (corresponding author), Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan.; Tsai, TF (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.	tftsai@yahoo.com		Chiu, Hsien-Yi/0000-0002-0493-9707; Sin, Chi-Zai/0000-0002-0597-6964; TSAI, TSEN-FANG/0000-0002-1498-1474				Al-Heresh AM, 2002, RHEUMATOLOGY, V41, P525, DOI 10.1093/rheumatology/41.5.525; Alamanos Y, 2008, J RHEUMATOL, V35, P1354; Antoni C, 2005, ANN RHEUM DIS, V64, P1150, DOI 10.1136/ard.2004.032268; Baek HJ, 2000, RHEUMATOL INT, V19, P89, DOI 10.1007/s002960050109; Blanco EA, 2013, ANN RHEUMATIC DIS S3, V72, pA965, DOI [10.1136/annrheumdis-2013-eular, DOI 10.1136/ANNRHEUMDIS-2013-EULAR]; Chandran V, 2013, HUM IMMUNOL, V74, P1333, DOI 10.1016/j.humimm.2013.07.014; Chiu HY, 2014, BRIT J DERMATOL, V171, P1181, DOI 10.1111/bjd.13056; Chiu HY, 2012, BRIT J DERMATOL, V166, P288, DOI 10.1111/j.1365-2133.2011.10688.x; Christophers E, 2010, J EUR ACAD DERMATOL, V24, P548, DOI 10.1111/j.1468-3083.2009.03463.x; Dobosz AS, 2005, INT J IMMUNOGENET, V32, P389, DOI 10.1111/j.1744-313X.2005.00543.x; EASTMOND CJ, 1994, BAILLIERE CLIN RHEUM, V8, P263, DOI 10.1016/S0950-3579(94)80018-9; Eder L, 2012, ANN RHEUM DIS, V71, P50, DOI 10.1136/ard.2011.155044; Schneeberger EE, 2015, CLIN RHEUMATOL, V34, P1413, DOI 10.1007/s10067-014-2739-3; Edwards CJ, 2016, ANN RHEUM DIS, DOI [10.1136/ard.2004.032268, DOI 10.1136/ARD.2004.032268]; Enerback C, 1997, ACTA DERM-VENEREOL, V77, P273; Fan X, 2007, ACTA DERM-VENEREOL, V87, P335, DOI 10.2340/00015555-0253; Feng BJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000606; Galluzzo M, 2016, DERMATOLOGY, V232, P230, DOI 10.1159/000441719; GERBER LH, 1982, J RHEUMATOL, V9, P703; Gladman DD, 1999, HUM IMMUNOL, V60, P259, DOI 10.1016/S0198-8859(98)00123-2; GLADMAN DD, 1995, ARTHRITIS RHEUM, V38, P845, DOI 10.1002/art.1780380619; GLADMAN DD, 1986, J RHEUMATOL, V13, P586; Gonzalez S, 2002, J RHEUMATOL, V29, P973; Ho PYPC, 2007, ANN RHEUM DIS, V66, P807, DOI 10.1136/ard.2006.064972; Jee SH, 1998, BRIT J DERMATOL, V139, P978, DOI 10.1046/j.1365-2133.1998.02552.x; Kavanaugh A, 2012, ARTHRITIS RHEUM-US, V64, P2504, DOI 10.1002/art.34436; Kim TG, 2000, J INVEST DERMATOL, V114, P309, DOI 10.1046/j.1523-1747.2000.00863.x; Korendowych E, 2003, J RHEUMATOL, V30, P96; Lai MJ, 2010, HUM IMMUNOL, V71, P777, DOI 10.1016/j.humimm.2010.05.013; Leung YY, 2017, CLIN RHEUMATOL, V36, P125, DOI 10.1007/s10067-016-3460-1; Liao HT, 2008, J RHEUMATOL, V35, P891; Lin M, 2000, TISSUE ANTIGENS, V55, P1, DOI 10.1034/j.1399-0039.2000.550101.x; Mason KJ, 2018, JAMA DERMATOL, V154, P581, DOI 10.1001/jamadermatol.2018.0183; Mease P, 2017, NEW ENGL J MED, V377, P1537, DOI 10.1056/NEJMoa1615975; Mease PJ, 2014, ANN RHEUM DIS, V73, P48, DOI 10.1136/annrheumdis-2013-203696; Mease PJ, 2017, ANN RHEUM DIS, V76, P1550, DOI 10.1136/annrheumdis-2016-210724; Mease PJ, 2015, NEW ENGL J MED, V373, P1329, DOI 10.1056/NEJMoa1412679; Mease PJ, 2014, NEW ENGL J MED, V370, P2295, DOI 10.1056/NEJMoa1315231; Mease PJ, 2005, ARTHRITIS RHEUM-US, V52, P3279, DOI 10.1002/art.21306; Mease PJ, 2000, LANCET, V356, P385, DOI 10.1016/S0140-6736(00)02530-7; MURRAY C, 1980, J CLIN INVEST, V66, P670, DOI 10.1172/JCI109903; NAKAGAWA H, 1991, ARCH DERMATOL RES, V283, P281, DOI 10.1007/BF00376613; Nash P, 2017, LANCET; Ohara Y, 2015, J RHEUMATOL, V42, P1439, DOI 10.3899/jrheum.141598; Popa OM, 2011, TISSUE ANTIGENS, V77, P325, DOI 10.1111/j.1399-0039.2010.01624.x; Prasad PVS, 2007, INDIAN J DERMATOL VE, V73, P166, DOI 10.4103/0378-6323.32739; Queiro R, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2097; Queiro-Silva R, 2004, SCAND J RHEUMATOL, V33, P318, DOI 10.1080/03009740410005953; Rahman P, 2005, ANN RHEUM DIS, V64, P37, DOI 10.1136/ard.2004.030775; Ritchlin C, 2014, ANN RHEUM DIS, V73, P990, DOI 10.1136/annrheumdis-2013-204655; Rouzaud M, 2014, J EUR ACAD DERMATOL, V28, P17, DOI 10.1111/jdv.12562; SALVARANI C, 1989, CLIN EXP RHEUMATOL, V7, P391; SCHMITTEGENOLF M, 1993, J INVEST DERMATOL, V100, P749, DOI 10.1111/1523-1747.ep12476080; Shaw CK, 1999, TISSUE ANTIGENS, V53, P51, DOI 10.1034/j.1399-0039.1999.530106.x; Shin D, 2016, RHEUMATOL INT, V36, P207, DOI 10.1007/s00296-015-3365-3; Talamonti M, 2017, BRIT J DERMATOL, V177, P489, DOI 10.1111/bjd.15387; Talamonti M, 2013, BRIT J DERMATOL, V169, P458, DOI 10.1111/bjd.12331; Talamonti M, 2016, J AM ACAD DERMATOL, V74, P374, DOI 10.1016/j.jaad.2015.08.055; Tam LS, 2009, RHEUMATOLOGY, V48, P1473, DOI 10.1093/rheumatology/kep230; Thorarensen SM, 2017, ANN RHEUM DIS, V76, P521, DOI 10.1136/annrheumdis-2016-209334; Tsai TF, 2002, ARCH DERMATOL RES, V294, P214, DOI 10.1007/s00403-002-0324-0; Tsai YC, 2016, GIORN ITAL DERMAT V, V151, P412; Tsai Yi-Giien, 2003, Journal of Microbiology Immunology and Infection, V36, P101; Wang TS, 2016, J DERMATOL SCI, V84, P340, DOI 10.1016/j.jdermsci.2016.08.535; West J, 2017, CLIN EXP DERMATOL, V42, P651, DOI 10.1111/ced.13100; Wittkowski KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020279; Yang Q, 2011, J EUR ACAD DERMATOL, V25, P1409, DOI 10.1111/j.1468-3083.2011.03985.x	67	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210076	10.1371/journal.pone.0210076	http://dx.doi.org/10.1371/journal.pone.0210076			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650098	Green Submitted, gold, Green Published			2022-12-26	WOS:000455813300041
J	Icli, B; Wu, W; Ozdemir, D; Li, H; Haemmig, S; Liu, X; Giatsidis, G; Cheng, HS; Avci, SN; Kurt, M; Lee, N; Guimaraes, RB; Manica, A; Marchini, JF; Rynning, SE; Risnes, I; Hollan, I; Croce, K; Orgill, DP; Feinberg, MW				Icli, Basak; Wu, Winona; Ozdemir, Denizhan; Li, Hao; Haemmig, Stefan; Liu, Xin; Giatsidis, Giorgio; Cheng, Henry S.; Avci, Seyma Nazli; Kurt, Merve; Lee, Nathan; Guimaraes, Raphael Boesche; Manica, Andre; Marchini, Julio F.; Rynning, Stein Erik; Risnes, Ivar; Hollan, Ivana; Croce, Kevin; Orgill, Dennis P.; Feinberg, Mark W.			MicroRNA-135a-3p regulates angiogenesis and tissue repair by targeting p38 signaling in endothelial cells	FASEB JOURNAL			English	Article						VEGF; diabetic wounds; human organoid	HUNTINGTIN-INTERACTING PROTEIN-1; CRITICAL LIMB ISCHEMIA; GROWTH-FACTOR; DOUBLE-BLIND; INTERMITTENT CLAUDICATION; MYOCARDIAL-INFARCTION; IMPAIRED ANGIOGENESIS; DIABETES-MELLITUS; GENE-THERAPY; KINASE	Angiogenesis is a critical process in repair of tissue injury that is regulated by a delicate balance between pro- and antiangiogenic factors. In disease states associated with impaired angiogenesis, we identified that miR-135a-3p is rapidly induced and serves as an antiangiogenic microRNA (miRNA) by targeting endothelial cell (EC) p38 signaling in vitro and in vivo. MiR-135a-3p overexpression significantly inhibited EC proliferation, migration, and network tube formation in matrigel, whereas miR-135-3p neutralization had the opposite effects. Mechanistic studies using transcriptomic profiling, bioinformatics, 3'-UTR reporter and miRNA ribonucleoprotein complex -immunoprecipitation assays, and small interfering RNA dependency studies revealed that miR-135a-3p inhibits the p38 signaling pathway in ECs by targeting huntingtin-interacting protein 1 (HIP1). Local delivery of miR-135a-3p inhibitors to wounds of diabetic db/db mice markedly increased angiogenesis, granulation tissue thickness, and wound closure rates, whereas local delivery of miR-135a-3p mimics impaired these effects. Finally, through gain- and loss-of-function studies in human skin organoids as a model of tissue injury, we demonstrated that miR-135a-3p potently modulated p38 signaling and angiogenesis in response to VEGF stimulation by targeting HIP1. These findings establish miR-135a-3p as a pivotal regulator of pathophysiological angiogenesis and tissue repair by targeting a VEGF-HIP1-p38K signaling axis, providing new targets for angiogenic therapy to promote tissue repair.	[Icli, Basak; Wu, Winona; Ozdemir, Denizhan; Li, Hao; Haemmig, Stefan; Liu, Xin; Cheng, Henry S.; Avci, Seyma Nazli; Kurt, Merve; Lee, Nathan; Hollan, Ivana; Croce, Kevin; Feinberg, Mark W.] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, Dept Med, 77 Ave Louis Pasteur,NRB-742F, Boston, MA 02115 USA; [Giatsidis, Giorgio; Orgill, Dennis P.] Harvard Med Sch, Brigham & Womens Hosp, Dept Surg, Div Plast Surg, Boston, MA 02115 USA; [Ozdemir, Denizhan] Hacettepe Univ, Dept Med Biol, Ankara, Turkey; [Guimaraes, Raphael Boesche; Manica, Andre] Fundacao Univ Cardiol ICFUC, Inst Cardiol Rio Grande Sul, Porto Alegre, RS, Brazil; [Marchini, Julio F.] Univ Sao Paulo, Med Sch, Heart Inst, Sao Paulo, Brazil; [Rynning, Stein Erik; Risnes, Ivar] LHL Hosp Gardermoen, Dept Cardiac Surg, Jessheim, Norway; [Hollan, Ivana] Lillehamer Hosp Rheumat Dis, Rheumatol Dept, Lillehamer, Norway; [Hollan, Ivana] Innlandet Hosp Trust, Res Dept, Brumunddal, Norway	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Hacettepe University; Fundacao Universitaria de Cardiologia; Universidade de Sao Paulo; Innlandet Hospital Trust	Feinberg, MW (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, Dept Med, 77 Ave Louis Pasteur,NRB-742F, Boston, MA 02115 USA.	mfeinberg@bwh.harvard.edu	Marchini, Júlio F./G-7569-2012; Haemmig, Stefan/V-6585-2019	Marchini, Júlio F./0000-0002-2279-1945; Haemmig, Stefan/0000-0001-5014-4393; Guimaraes, Raphael/0000-0002-7883-828X; Ozdemir, Denizhan/0000-0002-8822-6842; Cheng, Henry/0000-0002-4254-962X; Feinberg, Mark/0000-0001-9523-3859	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [P30DK034854]; NIH National Heart, Lung, and Blood Institute [HL115141, HL117994, HL134849]; NIH National Institute of General Medical Sciences [GM115605]; Arthur K. Watson Charitable Trust; Dr. Ralph and Marian Falk Medical Research Trust (Bank of America); American Heart Association [18SFRN33900144]; American Diabetes Association [1-16-JDF-046]; Watkins Discovery Award; Lerner Young Investigator Award; Tubitak Predoctoral Scholarship; South-Eastern Regional Health Authorities; Norwegian Women's Public Health Association, Norway; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115141, R01HL117994, R01HL134849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115605] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Arthur K. Watson Charitable Trust; Dr. Ralph and Marian Falk Medical Research Trust (Bank of America); American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); Watkins Discovery Award; Lerner Young Investigator Award; Tubitak Predoctoral Scholarship(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); South-Eastern Regional Health Authorities; Norwegian Women's Public Health Association, Norway; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Lay-Hong Ang (Beth Israel Deaconess Medical Center, Boston, MA, USA) for confocal microscopy technical assistance, and the Harvard Digestive Disease Center and U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grant P30DK034854 This work was supported by the NIH National Heart, Lung, and Blood Institute Grants HL115141, HL117994, and HL134849, and NIH National Institute of General Medical Sciences Grant GM115605 (to M.W.F.); the Arthur K. Watson Charitable Trust (to M.W.F.); the Dr. Ralph and Marian Falk Medical Research Trust (Bank of America, N.A., Trustee; to M.W.F.); the American Heart Association Grant 18SFRN33900144 (to M.W.F.); the American Diabetes Association Grant 1-16-JDF-046 (to B.I.); the Watkins Discovery Award (to B.I.); the Lerner Young Investigator Award (to B.I.); a Tubitak Predoctoral Scholarship (to D.O.); and a grant from South-Eastern Regional Health Authorities and from Norwegian Women's Public Health Association, Norway (to I.H.). The authors declare no conflicts of interest.	Avogaro A, 2011, DIABETES CARE, V34, pS285, DOI 10.2337/dc11-s239; Balaji S, 2014, J SURG RES, V190, P358, DOI 10.1016/j.jss.2014.02.027; Belch J, 2011, LANCET, V377, P1929, DOI 10.1016/S0140-6736(11)60394-2; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bernardo BC, 2012, P NATL ACAD SCI USA, V109, P17615, DOI 10.1073/pnas.1206432109; Bonauer A, 2010, CURR DRUG TARGETS, V11, P943, DOI 10.2174/138945010791591313; Bradley SV, 2007, CANCER RES, V67, P3609, DOI 10.1158/0008-5472.CAN-06-4803; Cannizzo CM, 2018, FASEB J, V32, P2911, DOI 10.1096/fj.201700617R; Caputo M, 2015, ADV DRUG DELIVER REV, V88, P78, DOI 10.1016/j.addr.2015.05.003; Chamorro-Jorganes A, 2013, PHARMACOL RES, V75, P15, DOI 10.1016/j.phrs.2013.04.002; Creager MA, 2011, CIRCULATION, V124, P1765, DOI 10.1161/CIRCULATIONAHA.110.009407; Cully M, 2010, MOL CELL BIOL, V30, P481, DOI 10.1128/MCB.00688-09; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Erba P, 2011, ANN SURG, V253, P402, DOI 10.1097/SLA.0b013e31820563a8; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Findley CM, 2008, J AM COLL CARDIOL, V52, P387, DOI 10.1016/j.jacc.2008.02.045; Gee E, 2010, J CELL PHYSIOL, V222, P120, DOI 10.1002/jcp.21924; Ghosh G, 2010, J CLIN INVEST, V120, P4141, DOI 10.1172/JCI42980; Goligorsky MS, 2005, AM J PHYSIOL-RENAL, V288, pF871, DOI 10.1152/ajprenal.00333.2004; Goveia J, 2014, EMBO MOL MED, V6, P1105, DOI 10.15252/emmm.201404156; Greene AK, 2006, ANN PLAS SURG, V56, P418, DOI 10.1097/01.sap.0000202831.43294.02; Grossman PM, 2007, AM HEART J, V153, P874, DOI 10.1016/j.ahj.2007.01.038; Hazarika S, 2007, CIRC RES, V101, P948, DOI 10.1161/CIRCRESAHA.107.160630; Hojo Y, 2000, J AM COLL CARDIOL, V35, P968, DOI 10.1016/S0735-1097(99)00632-4; Icli B, 2016, J MOL CELL CARDIOL, V91, P151, DOI 10.1016/j.yjmcc.2016.01.007; Icli B, 2013, CIRC RES, V113, P1231, DOI 10.1161/CIRCRESAHA.113.301780; Iyer Sunil R, 2017, JACC Basic Transl Sci, V2, P503, DOI 10.1016/j.jacbts.2017.07.012; Jones WS, 2007, CURR OPIN CARDIOL, V22, P458, DOI 10.1097/HCO.0b013e328236741b; Kawamoto A, 1998, INT J CARDIOL, V67, P47, DOI 10.1016/S0167-5273(98)00251-4; Kir D, 2018, ANGIOGENESIS, V21, P699, DOI 10.1007/s10456-018-9632-7; Krishna SM, 2015, INT J MOL SCI, V16, P11294, DOI 10.3390/ijms160511294; Kusumanto YH, 2006, HUM GENE THER, V17, P683, DOI 10.1089/hum.2006.17.683; Landskroner-Eiger S, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006643; Laragione T, 2018, ANN RHEUM DIS, V77, P1627, DOI 10.1136/annrheumdis-2018-213498; Lee R, 2012, CURR VASC PHARMACOL, V10, P77, DOI 10.2174/157016112798829751; Li J, 1996, AM J PHYSIOL-HEART C, V270, pH1803, DOI 10.1152/ajpheart.1996.270.5.H1803; Ma N, 2013, GENETICS, V195, P457, DOI 10.1534/genetics.113.154674; Matsumoto T, 2002, J CELL BIOL, V156, P149, DOI 10.1083/jcb.200103096; Medicherla S, 2009, DIABET METAB SYND OB, V2, P91; Melero-Martin JM, 2008, METHOD ENZYMOL, V445, P303, DOI 10.1016/S0076-6879(08)03013-9; Menghini R, 2009, CIRCULATION, V120, P1524, DOI 10.1161/CIRCULATIONAHA.109.864629; Nakajima K, 2004, CLIN CARDIOL, V27, P281, DOI 10.1002/clc.4960270509; Nebbioso A, 2010, J MOL ENDOCRINOL, V45, P219, DOI 10.1677/JME-10-0043; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Ozdemir D, 2019, TRENDS CARDIOVAS MED, V29, P131, DOI 10.1016/j.tcm.2018.08.002; Peng C, 2011, PLAST RECONSTR SURG, V128, p673E, DOI 10.1097/PRS.0b013e318230c521; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Powell RJ, 2008, CIRCULATION, V118, P58, DOI 10.1161/CIRCULATIONAHA.107.727347; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; Rajagopalan S, 2003, CIRCULATION, V108, P1933, DOI 10.1161/01.CIR.0000093398.16124.29; Rao DS, 2003, CANCER CELL, V3, P471, DOI 10.1016/S1535-6108(03)00107-7; Rao DS, 2002, J CLIN INVEST, V110, P351, DOI 10.1172/JCI200215529; Rose BA, 2017, J BIOL CHEM, V292, P12787, DOI 10.1074/jbc.M117.784553; Sacilotto N, 2016, GENE DEV, V30, P2297, DOI 10.1101/gad.290619.116; Song GD, 2010, WOUND REPAIR REGEN, V18, P426, DOI 10.1111/j.1524-475X.2010.00595.x; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Sun L, 2009, AGEING RES REV, V8, P306, DOI 10.1016/j.arr.2009.04.003; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495; Turkson J, 1999, MOL CELL BIOL, V19, P7519; Wara AK, 2011, BLOOD, V118, P6461, DOI 10.1182/blood-2011-06-363457; Wara AK, 2011, BLOOD, V118, P6450, DOI 10.1182/blood-2011-06-363713; Welti J, 2013, J CLIN INVEST, V123, P3190, DOI 10.1172/JCI70212; Yoshizuka N, 2012, MOL CELL BIOL, V32, P606, DOI 10.1128/MCB.06301-11; Yu JQ, 2004, J BIOL CHEM, V279, P50446, DOI 10.1074/jbc.M409221200	65	37	38	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5599	5614		10.1096/fj.201802063RR	http://dx.doi.org/10.1096/fj.201802063RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30668922	Green Published, Bronze			2022-12-26	WOS:000462888500077
J	Mohammad-Beigi, H; Aliakbari, F; Sahin, C; Lomax, C; Tawfike, A; Schafer, NP; Amiri-Nowdijeh, A; Eskandari, H; Moller, IM; Hosseini-Mazinani, M; Christiansen, G; Ward, JL; Morshedi, D; Otzen, DE				Mohammad-Beigi, Hossein; Aliakbari, Farhang; Sahin, Cagla; Lomax, Charlotte; Tawfike, Ahmed; Schafer, Nicholas P.; Amiri-Nowdijeh, Alireza; Eskandari, Hoda; Moller, Ian Max; Hosseini-Mazinani, Mehdi; Christiansen, Gunna; Ward, Jane L.; Morshedi, Dina; Otzen, Daniel E.			Oleuropein derivatives from olive fruit extracts reduce -synuclein fibrillation and oligomer toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Parkinson disease; protein aggregation; amyloid; -synuclein (-synuclein); neurodegeneration; cell toxicity; Mediterranean diet; membrane permeabilization; oligomerization; olive polyphenols	ALPHA-SYNUCLEIN; MEDITERRANEAN DIET; PHENOLIC-COMPOUNDS; AGGREGATION; OIL; CONFORMATION; ASSOCIATION; POLYPHENOLS; ADHERENCE	Aggregation of -synuclein (SN) is implicated in neuronal degeneration in Parkinson's disease and has prompted searches for natural compounds inhibiting SN aggregation and reducing its tendency to form toxic oligomers. Oil from the olive tree (Olea europaea L.) represents the main source of fat in the Mediterranean diet and contains variable levels of phenolic compounds, many structurally related to the compound oleuropein. Here, using SN aggregation, fibrillation, size-exclusion chromatography-multiangle light scattering (SEC-MALS)-based assays, and toxicity assays, we systematically screened the fruit extracts of 15 different olive varieties to identify compounds that can inhibit SN aggregation and oligomer toxicity and also have antioxidant activity. Polyphenol composition differed markedly among varieties. The variety with the most effective antioxidant and aggregation activities, Koroneiki, combined strong inhibition of SN fibril nucleation and elongation with strong disaggregation activity on preformed fibrils and prevented the formation of toxic SN oligomers. Fractionation of the Koroneiki extract identified oleuropein aglycone, hydroxyl oleuropein aglycone, and oleuropein as key compounds responsible for the differences in inhibition across the extracts. These phenolic compounds inhibited SN amyloidogenesis by directing SN monomers into small SN oligomers with lower toxicity, thereby suppressing the subsequent fibril growth phase. Our results highlight the molecular consequences of differences in the level of effective phenolic compounds in different olive varieties, insights that have implications for long-term human health.	[Mohammad-Beigi, Hossein; Aliakbari, Farhang; Sahin, Cagla; Schafer, Nicholas P.; Eskandari, Hoda; Otzen, Daniel E.] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark; [Aliakbari, Farhang; Morshedi, Dina] Natl Inst Genet Engn & Biotechnol, Dept Ind & Environm Biotechnol, POB 1417863171, Tehran, Iran; [Amiri-Nowdijeh, Alireza; Hosseini-Mazinani, Mehdi] Natl Inst Genet Engn & Biotechnol, Dept Agr Biotechnol, POB 1417863171, Tehran, Iran; [Sahin, Cagla; Moller, Ian Max] Aarhus Univ, Dept Mol Biol & Genet, Forsogsvej 1, DK-4200 Slagelse, Denmark; [Lomax, Charlotte; Tawfike, Ahmed; Ward, Jane L.] Rothamsted Res, Computat & Analyt Sci Dept, Harpenden AL5 2JQ, Herts, England; [Christiansen, Gunna] Aarhus Univ, Dept Biomed Med Microbiol & Immunol, DK-8000 Aarhus C, Denmark; [Otzen, Daniel E.] Aarhus Univ, Dept Mol Biol & Genet, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark; [Schafer, Nicholas P.] Rice Univ, Dept Chem, Ctr Theoret Biol Phys, Houston, TX 77005 USA	Aarhus University; Aarhus University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Aarhus University; Aarhus University; Rice University	Mohammad-Beigi, H; Otzen, DE (corresponding author), Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark.; Morshedi, D (corresponding author), Natl Inst Genet Engn & Biotechnol, Dept Ind & Environm Biotechnol, POB 1417863171, Tehran, Iran.; Otzen, DE (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	beigi@inano.au.dk; morshedi@nigeb.ac.ir; dao@inano.au.dk	Mohammad-Beigi, Hossein/AAP-8565-2020; Aliakbari, Farhang/GZM-7193-2022; Tawfike, Ahmed Fares/O-4310-2017	Mohammad-Beigi, Hossein/0000-0003-2303-795X; Tawfike, Ahmed Fares/0000-0003-2061-3093; Christiansen, Gunna/0000-0003-0540-1367; Lomax, Charlotte/0000-0002-6303-4000; Sahin, Cagla/0000-0002-2889-5200; Aliakbari, Farhang/0000-0002-0928-3743	Center for International Scientific Studies and Collaboration (CISSC) [982]; Independent Research Fund of Denmark, Technology and Production [4005-00082]; Biotechnology and Biological Sciences Research Council (BBSRC) of theUK; Tailoring Plant Metabolism Institute Strategic Programme - BBSRC [BB/E/C/000I0410]; BBSRC [BBS/E/C/000I0410] Funding Source: UKRI	Center for International Scientific Studies and Collaboration (CISSC); Independent Research Fund of Denmark, Technology and Production; Biotechnology and Biological Sciences Research Council (BBSRC) of theUK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Tailoring Plant Metabolism Institute Strategic Programme - BBSRC; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grant 982 from the Center for International Scientific Studies and Collaboration (CISSC) (to H. M. B., F. A., and D. M.), Grant 4005-00082 from the Independent Research Fund of Denmark, Technology and Production (to H. E., N. P. S., C. S., I. M. M., G. C., and D. E. O.), a grant to Rothamsted Research from the Biotechnology and Biological Sciences Research Council (BBSRC) of theUK(to C. L., A. T., and J. L. W.), and Tailoring Plant Metabolism Institute Strategic Programme Grant BB/E/C/000I0410 funded by the BBSRC (to J. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Ahmad E, 2011, BIOCHIMIE, V93, P793, DOI 10.1016/j.biochi.2010.12.012; Aliakbari F, 2017, SCI IRAN, V24, P3542, DOI 10.24200/sci.2017.4419; Amiri-Nowdijeh A, 2018, J AGR SCI TECH-IRAN, V20, P347; Angelova PR, 2018, FEBS LETT, V592, P692, DOI 10.1002/1873-3468.12964; Caruana M, 2011, FEBS LETT, V585, P1113, DOI 10.1016/j.febslet.2011.03.046; Casamenti F, 2017, EXPERT REV NEUROTHER, V17, P345, DOI 10.1080/14737175.2017.1245617; Chen L, 2007, BIOCHEM BIOPH RES CO, V356, P548, DOI 10.1016/j.bbrc.2007.02.163; Daccache A, 2011, NEUROCHEM INT, V58, P700, DOI 10.1016/j.neuint.2011.02.010; Dai J, 2008, AM J CLIN NUTR, V88, P1364, DOI 10.3945/ajcn.2008.26528; Diomede L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058893; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Fink Anthony L., 2006, P265; Gaskins AJ, 2010, AM J CLIN NUTR, V92, P1461, DOI 10.3945/ajcn.110.000026; Giehm L, 2010, ANAL BIOCHEM, V400, P270, DOI 10.1016/j.ab.2010.02.001; Hardy J, 2003, LANCET NEUROL, V2, P221, DOI 10.1016/S1474-4422(03)00350-8; Hosseini-Mazinani M., 2013, IRANIAN OLIVE CATALO, DOI [10.1007/s10727-013-0071-4, DOI 10.1007/S10727-013-0071-4]; Ingelsson M, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00408; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; KEYS A, 1986, AM J EPIDEMIOL, V124, P903, DOI 10.1093/oxfordjournals.aje.a114480; Kjaer L, 2009, BIOPHYS J, V96, P2857, DOI 10.1016/j.bpj.2008.12.3940; Lorenzen N, 2014, J BIOL CHEM, V289, P21299, DOI 10.1074/jbc.M114.554667; Lorenzen N, 2014, J AM CHEM SOC, V136, P3859, DOI 10.1021/ja411577t; Mandel S, 2004, FREE RADICAL BIO MED, V37, P304, DOI 10.1016/j.freeradbiomed.2004.04.012; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Mohammad-Beigi H, 2016, RSC ADV, V6, P85312, DOI 10.1039/c6ra08502d; Mohammad-Beigi H, 2015, NANOSCALE, V7, P19627, DOI 10.1039/c5nr05663b; Morris AM, 2008, BIOCHEMISTRY-US, V47, P2413, DOI 10.1021/bi701899y; Nakamura K, 2013, NEUROTHERAPEUTICS, V10, P391, DOI 10.1007/s13311-013-0182-9; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nesgaard L, 2009, BBA-PROTEINS PROTEOM, V1794, P84, DOI 10.1016/j.bbapap.2008.09.021; Omar SH, 2018, FITOTERAPIA, V128, P118, DOI 10.1016/j.fitote.2018.05.011; Palazzi L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26645-5; Paslawski W, 2014, BIOCHEMISTRY-US, V53, P6252, DOI 10.1021/bi5007833; Paslawski W, 2014, ANGEW CHEM INT EDIT, V53, P7560, DOI 10.1002/anie.201400491; Perni M, 2017, P NATL ACAD SCI USA, V114, pE1009, DOI 10.1073/pnas.1610586114; Petridis A, 2012, HORTSCIENCE, V47, P339, DOI 10.21273/HORTSCI.47.3.339; Prots I, 2013, J BIOL CHEM, V288, P21742, DOI 10.1074/jbc.M113.451815; Rigacci S, 2011, CURR ALZHEIMER RES, V8, P841, DOI 10.2174/156720511798192682; Rigacci S, 2010, J NUTR BIOCHEM, V21, P726, DOI 10.1016/j.jnutbio.2009.04.010; Romero C, 2017, J SCI FOOD AGR, V97, P1725, DOI 10.1002/jsfa.7920; Sahin C, 2017, BIOPHYS CHEM, V220, P34, DOI 10.1016/j.bpc.2016.11.002; Servili M, 2002, EUR J LIPID SCI TECH, V104, P602, DOI 10.1002/1438-9312(200210)104:9/10<602::AID-EJLT602>3.0.CO;2-X; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tripoli E, 2005, NUTR RES REV, V18, P98, DOI 10.1079/NRR200495; van Rooijen BD, 2009, J MOL BIOL, V394, P826, DOI 10.1016/j.jmb.2009.10.021; Vossen P.M., 2007, ORGANIC OLIVE PRODUC; Wu C, 2006, BIOPHYS J, V91, P3664, DOI 10.1529/biophysj.106.081877; Zhao J, 2017, RSC ADV, V7, P32508, DOI 10.1039/c7ra03752j	51	30	31	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4215	4232		10.1074/jbc.RA118.005723	http://dx.doi.org/10.1074/jbc.RA118.005723			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30655291	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000461854400032
J	Bui, JK; Cyktor, JC; Fyne, E; Campellone, S; Mason, SW; Mellors, JW				Bui, John K.; Cyktor, Joshua C.; Fyne, Elizabeth; Campellone, Shalyn; Mason, Stephen W.; Mellors, John W.			Blockade of the PD-1 axis alone is not sufficient to activate HIV-1 virion production from CD4(+) T cells of individuals on suppressive ART	PLOS ONE			English	Article							ANTI-PD-L1 ANTIBODY; IMMUNE ACTIVATION; IN-VIVO; PHASE-I; NIVOLUMAB; EXHAUSTION; RESERVOIR; IPILIMUMAB; SAFETY; PERSISTENCE	Blockade of the programmed cell death protein/ligand 1 (PD-1/PD-L1) pathway with monoclonal antibodies (mAb) is now commonly used for cancer immunotherapy and has therapeutic potential in chronic viral infections including HIV-1. PD-1/PD-L1 blockade could augment HIV-1-specific immune responses and reverse HIV-1 latency, but the latter effect has not been clearly shown. We tested the ability of the human anti-PD-L1 mAb BMS-936559 and the human anti-PD-1 mAb nivolumab to increase HIV-1 virion production ex vivo from different peripheral blood mononuclear cell populations obtained from donors on suppressive antiretroviral therapy (ART). Fresh peripheral blood mononuclear cells (PBMC), CD8-depleted PBMC, total CD4(+) T cells, and resting CD4(+) T cells were purified from whole blood of HIV-1-infected donors and cultured in varying concentrations of BMS-936559 (20, 5, or 1.25 mu g/mL) or nivolumab (5 or 1.25 mu g/mL), with or without anti-CD3/CD28 stimulatory antibodies. Culture supernatants were assayed for virion HIV-1 RNA by qRT-PCR. Ex vivo exposure to BMS-936559 or nivolumab, with or without anti-CD3/CD28 stimulation, did not consistently increase HIV-1 virion production from blood mononuclear cell populations. Modest (2-fold) increases in virus production were observed in a subset of donors and in some cell types but were not reproducible in longitudinal samples. Cell surface expression of PD-1 and PD-L1 were not associated with changes in virus production. Ex vivo blockade of the PD-1 axis alone has limited effects on HIV-1 latency.	[Bui, John K.; Cyktor, Joshua C.; Fyne, Elizabeth; Mellors, John W.] Univ Pittsburgh, Dept Med, Div Infect Dis, Pittsburgh, PA 15260 USA; [Bui, John K.] Howard Hughes Med Inst, Howard Hughes Med Res Fellows Program, Bethesda, MD 20817 USA; [Campellone, Shalyn; Mason, Stephen W.] Bristol Myers Squibb, Discovery Virol, Wallingford, CT USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Howard Hughes Medical Institute; Bristol-Myers Squibb	Mellors, JW (corresponding author), Univ Pittsburgh, Dept Med, Div Infect Dis, Pittsburgh, PA 15260 USA.	jwm1@pitt.edu		Mason, Stephen/0000-0002-6662-9624	Howard Hughes Medical Institute (HHMI) Medical Research Fellows Program; Bristol-Myers Squibb (BMS) Company	Howard Hughes Medical Institute (HHMI) Medical Research Fellows Program; Bristol-Myers Squibb (BMS) Company	Bristol-Myers Squibb (BMS) Company provided support for the salaries of authors SC and SWM, and funding for some of the experimental work performed at the University of Pittsburgh. BMS also provided proprietary anti-PD-L1 and anti-PD-1 monoclonal antibodies at no cost. SC provided technical assistance in performing some flow of the data from cytometric assays of PD-1 and PDL1 expression that are included in the paper. Other flow cytometric assays of PD-1 and PD-L1 expression were performed by authors JB and JC from the University of Pittsburgh. Author EF from the University of Pittsburgh provided technical expertise in designing and conducting experiments and reviewed the manuscript. SWM provided input in the design of some of the experiments but did not generate data or analyze it. He reviewed and provided some edits of the manuscript and approved it for submission. Additional funding was provided from the Howard Hughes Medical Institute (HHMI) Medical Research Fellows Program to John K Bui.	Amancha PK, 2013, J IMMUNOL, V191, P6060, DOI 10.4049/jimmunol.1302044; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Banga R, 2016, NAT MED, V22, P754, DOI 10.1038/nm.4113; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Bui JK, 2015, AIDS, V29, P1911, DOI 10.1097/QAD.0000000000000788; Callahan MK, 2016, IMMUNITY, V44, P1069, DOI 10.1016/j.immuni.2016.04.023; Chew GM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005349; Chomont N., 2013, INT WORKSH HIV HEP V; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Cillo AR, 2018, AIDS, V32, P699, DOI [10.1097/QAD.0000000000001748, 10.1097/qad.0000000000001748]; Cillo AR, 2014, J CLIN MICROBIOL, V52, P3944, DOI 10.1128/JCM.02060-14; DAFONSECA S, 2010, J INT AIDS SOC, V13, pO15; Davar D, 2015, CASE REP ONCOL MED, V2015, DOI 10.1155/2015/737389; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Deeks SG, 2016, NAT MED, V22, P839, DOI 10.1038/nm.4108; Eron J. J., 2016, C RETR OPP INF CROI; Finnefrock AC, 2009, J IMMUNOL, V182, P980, DOI 10.4049/jimmunol.182.2.980; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fromentin R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005761; Gay CL, 2017, J INFECT DIS, V215, P1725, DOI 10.1093/infdis/jix191; Grabmeier-Pfistershammer K, 2017, CLIN IMMUNOL, V183, P167, DOI 10.1016/j.clim.2017.09.002; Guihot A, 2018, ANN ONCOL, V29, P517, DOI 10.1093/annonc/mdx696; Hatano H, 2013, J INFECT DIS, V208, P50, DOI 10.1093/infdis/jis630; Heppt MV, 2017, ANN ONCOL, V28, P3104, DOI 10.1093/annonc/mdx538; Hoffmann M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005661; Hong FY, 2016, J CLIN MICROBIOL, V54, P902, DOI 10.1128/JCM.02904-15; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Hurst J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9495; Joos B, 2008, P NATL ACAD SCI USA, V105, P16725, DOI 10.1073/pnas.0804192105; Kamphorst AO, 2017, SCIENCE, V355, P1423, DOI 10.1126/science.aaf0683; Kearney MF, 2016, J VIROL, V90, P1369, DOI 10.1128/JVI.02139-15; Kearney MF, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004010; Le Garff G, 2017, AIDS, V31, P1048, DOI 10.1097/QAD.0000000000001429; Mason S, 2013, 6 HIV PERS WORKSH SE; Morris VK, 2017, LANCET ONCOL, V18, P446, DOI 10.1016/S1470-2045(17)30104-3; Nakayama K, 2012, AIDS RES HUM RETROV, V28, P702, DOI [10.1089/aid.2011.0073, 10.1089/AID.2011.0073]; Pallikkuth S, 2016, J VIROL, V90, P2718, DOI 10.1128/JVI.02883-15; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Sachdeva M, 2010, JAIDS-J ACQ IMM DEF, V54, P447, DOI 10.1097/QAI.0b013e3181e0c7d0; Samri A, IMMUNOVIROLOGICAL EV; Schadendorf D, 2015, J CLIN ONCOL, V33, P1889, DOI 10.1200/JCO.2014.56.2736; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Tomsitz D, 2018, J EUR ACAD DERMATOL, V32, pE26, DOI 10.1111/jdv.14450; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wei DG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004071; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yamamoto N, 2017, INVEST NEW DRUG, V35, P207, DOI 10.1007/s10637-016-0411-2; Yamamoto T, 2011, BLOOD, V117, P4805, DOI 10.1182/blood-2010-11-317297; Zhang JY, 2007, BLOOD, V109, P4671, DOI 10.1182/blood-2006-09-044826	65	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211112	10.1371/journal.pone.0211112	http://dx.doi.org/10.1371/journal.pone.0211112			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682108	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500103
J	Conroy, GC; Shimizu-Kimura, Y; Lamont, RW; Ogbourne, SM				Conroy, Gabriel C.; Shimizu-Kimura, Yoko; Lamont, Robert W.; Ogbourne, Steven M.			A multidisciplinary approach to inform assisted migration of the restricted rainforest tree, Fontainea rostrata	PLOS ONE			English	Article							TRIUNIA-ROBUSTA PROTEACEAE; CLIMATE-CHANGE; SPECIES DISTRIBUTION; GENETIC DIVERSITY; COMPUTER-PROGRAM; POPULATION-STRUCTURE; HUMID TROPICS; CONSERVATION; RARE; BIODIVERSITY	Assisted migration can aid in the conservation of narrowly endemic species affected by habitat loss, fragmentation and climate change. Here, we employ a multidisciplinary approach by examining the population genetic structure of a threatened, dioecious rainforest tree of the subtropical notophyll vine forests of eastern Australia, Fontainea rostrata, and its potential requirements for population enhancement and translocation to withstand the effects of anthropogenic fragmentation and climate change. We used microsatellite markers to gain an understanding of the way genetic diversity is partitioned within and among the nine extant populations of F. rostrata identified in this study. We combined the results with species distribution modelling to identify populations vulnerable to possible future range shifts based on climate change projections. We found regional differences between the species' main distribution in the south and a disjunct northern population cluster (F-RT = 0.074, F-SR = 0.088, F-ST = 0.155), in mean allelic richness (A(R) = 2.77 vs 2.33, p < 0.05), expected heterozygosity (H-E = 0.376 vs 0.328), and inbreeding (F = 0.116 vs 0.219). Species distribution models predicted that while southern populations of F. rostrata are likely to persist for the next 50 years under the RCP6.0 climate change scenario, with potential for a small-scale expansion to the south-east, the more highly inbred and less genetically diverse northern populations will come under increasing pressure to expand southwards as habitat suitability declines. Given the species' genetic structure and with the aim to enhance genetic diversity and maximise the likelihood of reproductive success, we recommend that plant reintroductions to supplement existing populations should be prioritised over translocation of the species to new sites. However, future conservation efforts should be directed at translocation to establish new sites to increase population connectivity, focussing particularly on habitat areas identified as persisting under conditions of climate change.	[Conroy, Gabriel C.; Shimizu-Kimura, Yoko; Lamont, Robert W.; Ogbourne, Steven M.] Univ Sunshine Coast, Genecol Res Ctr, Maroochydore, Qld, Australia	University of the Sunshine Coast	Conroy, GC (corresponding author), Univ Sunshine Coast, Genecol Res Ctr, Maroochydore, Qld, Australia.	gconroy@usc.edu.au		Ogbourne, Steven/0000-0001-9812-4367	Burnett-Mary Regional Group; University of the Sunshine Coast	Burnett-Mary Regional Group; University of the Sunshine Coast	The authors wish to thank the Burnett-Mary Regional Group and the University of the Sunshine Coast for financial support.	Agostini C, 2013, MOL ECOL RESOUR, V13, P966, DOI 10.1111/1755-0998.12140; Tiscar PA, 2018, FOREST ECOL MANAG, V409, P719, DOI 10.1016/j.foreco.2017.12.014; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Bonebrake TC, 2014, CONSERV BIOL, V28, P1057, DOI 10.1111/cobi.12253; Broadhurst L, 2017, DIVERS DISTRIB, V23, P41, DOI 10.1111/ddi.12505; Brodie J, 2012, TRENDS ECOL EVOL, V27, P145, DOI 10.1016/j.tree.2011.09.008; Byrne M, 1996, AUST J BOT, V44, P331, DOI 10.1071/BT9960331; CLIMsystems Ltd, 2013, SIMCLIM 2013 DAT MAN; Conlisk E, 2013, GLOBAL CHANGE BIOL, V19, P858, DOI 10.1111/gcb.12090; Corlett RT, 2012, BIOL CONSERV, V151, P22, DOI 10.1016/j.biocon.2011.11.027; Costion CM, 2015, BIOL CONSERV, V191, P322, DOI 10.1016/j.biocon.2015.07.022; Department of Natural Resources and Mines, 2007, MET DRAIN 25K QUEENS; Department of Natural Resources and Mines, 2011, MET DET SOL GEOL QUE; Dudik M, 2007, J MACH LEARN RES, V8, P1217; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edenhofer O., 2014, CONTRIBUTION WORKING; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Ellstrand NC, 2014, AM J BOT, V101, P737, DOI 10.3732/ajb.1400024; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Finger A, 2011, MOL ECOL, V20, P3773, DOI 10.1111/j.1365-294X.2011.05228.x; Fitzpatrick MC, 2008, GLOBAL CHANGE BIOL, V14, P1337, DOI 10.1111/j.1365-2486.2008.01559.x; Forster Paul I., 1997, Austrobaileya, V5, P29; Forster PI, CENSUS QUEENSLAND FL; Frankham R, 2003, CR BIOL, V326, pS22, DOI 10.1016/S1631-0691(03)00023-4; Frankham R., 2002, INTRO CONSERVATION G, DOI 10.1017/CBO9780511808999; Frankham R, 2015, MOL ECOL, V24, P2610, DOI 10.1111/mec.13139; Frankham R, 2013, TRENDS ECOL EVOL, V28, P187, DOI 10.1016/j.tree.2013.01.002; Gitzendanner MA, 2000, AM J BOT, V87, P783, DOI 10.2307/2656886; Graham CH, 2010, ECOGRAPHY, V33, P1062, DOI 10.1111/j.1600-0587.2010.06430.x; Grant EL, 2017, IND CROP PROD, V108, P416, DOI 10.1016/j.indcrop.2017.07.013; Halbur MM, 2014, CONSERV GENET, V15, P679, DOI 10.1007/s10592-014-0569-0; Harden G.J., 2006, RAINFOREST TREES SHR; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hilbert DW, 2001, AUSTRAL ECOL, V26, P590, DOI 10.1046/j.1442-9993.2001.01137.x; Hulce D, 2011, J BIOMOL TECH, V22, pS35, DOI DOI 10.1111/J.1556-4029.2010.01565.X; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jones TH, 2007, MOL ECOL, V16, P697, DOI 10.1111/j.1365-294X.2006.03180.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Karron JD, 1987, EVOL ECOL, V1, P47, DOI 10.1007/BF02067268; KERSHAW AP, 1994, PALAEOGEOGR PALAEOCL, V109, P399, DOI 10.1016/0031-0182(94)90188-0; Kirst M, 2005, J HERED, V96, P161, DOI 10.1093/jhered/esi023; Kramer AT, 2009, TRENDS PLANT SCI, V14, P599, DOI 10.1016/j.tplants.2009.08.005; Lamont RW, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0743-2; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Liu J, 2014, GENET MOL RES, V13, P4579, DOI 10.4238/2014.June.17.10; Louys J, 2014, ECOL EVOL, V4, P4380, DOI 10.1002/ece3.1287; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Maggini R., 2013, PROTECTING RESTORING; MANTEL N, 1967, CANCER RES, V27, P209; Martins E, 2015, CONSERV GENET, V16, P1, DOI 10.1007/s10592-014-0635-7; McKenzie N., 2000, CSIRO LAND WATER TEC, V11, P1; McPherson H, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-8; Memmott J, 2007, ECOL LETT, V10, P1; Monks L, 2012, PLANT REINTRODUCTION; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; NEI M, 1974, GENETICS, V76, P379; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; O'Connor K, 2015, BIOL CONSERV, V191, P504, DOI 10.1016/j.biocon.2015.08.001; Ouborg NJ, 2006, J ECOL, V94, P1233, DOI 10.1111/j.1365-2745.2006.01167.x; Park A, 2018, CLIMATIC CHANGE, P1; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Porfirio LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113749; Possley J, 2009, RESTOR ECOL, V17, P668, DOI 10.1111/j.1526-100X.2008.00395.x; Powell M, 2005, BIOL CONSERV, V123, P165, DOI 10.1016/j.biocon.2004.11.004; Pritchard JK, 2000, GENETICS, V155, P945; Queensland Herbarium, 2013, SURV MAPP 2011 VEG C; Ren H, 2010, PLANT SPEC BIOL, V25, P43, DOI 10.1111/j.1442-1984.2009.00261.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rossetto M, 2005, J ECOL, V93, P906, DOI 10.1111/j.1365-2745.2005.01046.x; Rossetto M, 2015, P R SOC B; Rossetto M, 2008, AM J BOT, V95, P321, DOI 10.3732/ajb.95.3.321; Rossetto M, 2015, J BIOGEOGR, V42, P2172, DOI 10.1111/jbi.12571; Shimizu-Kimura Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep46399; Shoo LP, 2014, REG ENVIRON CHANGE, V14, P435, DOI 10.1007/s10113-012-0385-3; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Todesco M, 2016, EVOL APPL, V9, P892, DOI 10.1111/eva.12367; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; Walck JL, 2011, GLOBAL CHANGE BIOL, V17, P2145, DOI 10.1111/j.1365-2486.2010.02368.x; Webb L. J., 1994, AUSTR VEGETATION, P87; Weber LC, 2014, J BIOGEOGR, V41, P222, DOI 10.1111/jbi.12219; Weeks AR, 2011, EVOL APPL, V4, P709, DOI 10.1111/j.1752-4571.2011.00192.x; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450	90	7	7	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210560	10.1371/journal.pone.0210560	http://dx.doi.org/10.1371/journal.pone.0210560			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682049	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500046
J	Ibrahim, N; Honein-AbouHaidar, G; Jomaa, L				Ibrahim, Nadiya; Honein-AbouHaidar, Gladys; Jomaa, Lamis			Perceived impact of community kitchens on the food security of Syrian refugees and kitchen workers in Lebanon: Qualitative evidence in a displacement context	PLOS ONE			English	Article							COLLECTIVE KITCHENS; HEALTH-PROMOTION; CANADA; INCOME; PERU	Community kitchens (CKs) have been recommended as public health strategies with social and nutritional health benefits for low-income participants and their families in different settings. The benefit of CKs in improving the food security status of participants in the context of conflict and displacement is less conclusive. This study aimed to qualitatively explore the impact of CKs on the food security status of community kitchen workers (CWs) and Syrian refugee (SR) families in Lebanon. An exploratory qualitative descriptive approach was adopted. Focus group discussions were conducted with 15 CWs and 49 SRs, and transcripts were analyzed thematically. Emerging themes included: motivation to join the CKs (CWs only), perception towards CKs, impact of these CKs, and their sustainability (both groups). Motivating factors for CWs included financial, internal and societal drivers, and the favorable type of work in kitchens. The perception towards CKs was overall positive among CWs and SR beneficiaries. Both groups reported the positive impact of CKs on their food security and financial status, which in turn affected positively their psychological health. At the social level, CWs indicated that the kitchen's friendly atmosphere increased social cohesion and companionship between Syrians and Lebanese within the kitchen. In addition, CWs reported increased sense of empathy towards SRs benefiting from the CK services. According to study participants, the positive impact of the CKs was almost completely reversed when their operation and services were interrupted for two months. Both CWs and SRs identified facilitators and barriers that can affect the sustainability of the kitchens, including financial and entrepreneurial skills. In conclusion, findings from this study highlight that CKs can be promising programs to improve the food security and livelihoods of participants, while also increasing social cohesion and integration of refugees within host communities in protracted crisis contexts.	[Ibrahim, Nadiya] Amer Univ Beirut, Fac Agr & Food Sci, Rural & Community Dev Program, Beirut, Lebanon; [Honein-AbouHaidar, Gladys] Amer Univ Beirut, Rafic Hariri Sch Nursing, Beirut, Lebanon; [Honein-AbouHaidar, Gladys; Jomaa, Lamis] Amer Univ Beirut, Global Hlth Inst, Refugee Hlth Program, Beirut, Lebanon; [Jomaa, Lamis] Amer Univ Beirut, Fac Agr & Food Sci, Dept Nutr & Food Sci, Beirut, Lebanon	American University of Beirut; American University of Beirut; American University of Beirut; American University of Beirut	Jomaa, L (corresponding author), Amer Univ Beirut, Global Hlth Inst, Refugee Hlth Program, Beirut, Lebanon.; Jomaa, L (corresponding author), Amer Univ Beirut, Fac Agr & Food Sci, Dept Nutr & Food Sci, Beirut, Lebanon.	lj18@aub.edu.lb	Honein-AbouHaidar, Gladys N./M-4308-2013	Honein-AbouHaidar, Gladys N./0000-0001-6208-7859; Jomaa, Lamis/0000-0002-3046-4581	University Research Board at the American University of Beirut, Lebanon	University Research Board at the American University of Beirut, Lebanon	This project was funded by the University Research Board at the American University of Beirut, Lebanon. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Mourad TA, 2004, PUBLIC HEALTH, V118, P131, DOI 10.1016/j.puhe.2003.09.002; [Anonymous], 2018, SYR REG REF RESP; Bhattacharyya J., 2004, J COMMUNITY DEV SOC, V34, P5, DOI DOI 10.1080/15575330409490110; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Cherri Z, 2016, RISK MANAG HEALTHC P, V9, P165, DOI 10.2147/RMHP.S106068; Colorafi KJ, 2016, HERD-HEALTH ENV RES, V9, P16, DOI 10.1177/1937586715614171; Crawford S, 1997, CAN J DIET PRACT RES; El Harake MD, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070913; Engler-Stringer R, 2005, CAN J DIET PRACT RES, V66, P246, DOI 10.3148/66.4.2005.246; Engler-Stringer R, 2007, QUAL HEALTH RES, V17, P75, DOI 10.1177/1049732306296451; Engler-Stringer R, 2006, CAN J DIET PRACT RES, V67, P178, DOI 10.3148/67.4.2006.178; Fano TJ, 2004, CAN J DIET PRACT RES, V65, P72, DOI 10.3148/65.2.2004.72; Freedman DA, 2013, J COMMUNITY PRACT, V21, P379, DOI 10.1080/10705422.2013.842197; Ghattas H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130724; Iacovou M, 2013, PUBLIC HEALTH NUTR, V16, P535, DOI 10.1017/S1368980012002753; Immink MDC, 2001, ECOL FOOD NUTR, V40, P699, DOI 10.1080/03670244.2001.9991678; International Orthodox Christian Charities (IOCC), COMM KITCH ADDR MALN; Johnson L, 2006, GENDER PLACE CULT, V13, P647, DOI 10.1080/09663690601019802; Kukrety N, 2018, POVERTY INEQUALITY S; Lee JH, 2010, HEALTH PROMOT J AUST, V21, P183; Linkogle S., 1998, B LAT AM RES, V17, P93; Marquis S, 2001, CAN J DIET PRACT RES, V62, P130; Maxwell D, 2012, P NATL ACAD SCI USA, V109, P12321, DOI 10.1073/pnas.0913215108; Mundel E, 2010, HEALTH PROMOT INT, V25, P166, DOI 10.1093/heapro/daq016; REACH. Lebanese Communities Hosting Syrain Refugees, 2018, LEB COMM HOST SYR RE; Schroeder K, 2006, GENDER PLACE CULT, V13, P663, DOI 10.1080/09663690601019844; Spence F, 2005, INT J HEALTH PROMOT, V43, P59, DOI 10.1080/14635240.2005.10708040; Tarasuk V, 1999, CAN J DIET PRACT RES, V60, P11; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tufford L, 2012, QUAL SOC WORK, V11, P80, DOI 10.1177/1473325010368316; UNHCR & Government of Lebanon, 2018, LEB CRIS RESP PLAN 2; United Nations High Commissioner for Refugees (UNHCR), 2017, REG REF RES PLAN 201; World Food Programme (WFP), 2018, VASYR 2017 VULN ASS	33	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210814	10.1371/journal.pone.0210814	http://dx.doi.org/10.1371/journal.pone.0210814			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682079	gold, Green Submitted, Green Published			2022-12-26	WOS:000457037500064
J	Sannelli, C; Vidaurre, C; Muller, KR; Blankertz, B				Sannelli, Claudia; Vidaurre, Carmen; Mueller, Klaus-Robert; Blankertz, Benjamin			A large scale screening study with a SMR-based BCI: Categorization of BCI users and differences in their SMR activity	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACE; SPATIAL FILTERS; DIFFERENT REFERENCES; MU-RHYTHMS; EEG; PERFORMANCE; CLASSIFICATION; MOVEMENT; IMAGERY; DESYNCHRONIZATION	Brain-Computer Interfaces (BCIs) are inefficient for a non-negligible part of the population, estimated around 25%. To understand this phenomenon in Sensorimotor Rhythm (SMR) based BCIs, data from a large-scale screening study conducted on 80 novice participants with the Berlin BCI system and its standard machine-learning approach were investigated. Each participant performed one BCI session with resting state Encephalography, Motor Observation, Motor Execution and Motor Imagery recordings and 128 electrodes. A significant portion of the participants (40%) could not achieve BCI control (feedback performance > 70%). Based on the performance of the calibration and feedback runs, BCI users were stratified in three groups. Analyses directed to detect and elucidate the differences in the SMR activity of these groups were performed. Statistics on reactive frequencies, task prevalence and classification results are reported. Based on their SMR activity, also a systematic list of potential reasons leading to performance drops and thus hints for possible improvements of BCI experimental design are given. The categorization of BCI users has several advantages, allowing researchers 1) to select subjects for further analyses as well as for testing new BCI paradigms or algorithms, 2) to adopt a better subject-dependent training strategy and 3) easier comparisons between different studies.	[Sannelli, Claudia; Blankertz, Benjamin] Tech Univ Berlin, Dept Neurotechnol, Berlin, Germany; [Vidaurre, Carmen; Mueller, Klaus-Robert] Tech Univ Berlin, Dept Machine Learning, Berlin, Germany; [Vidaurre, Carmen] Univ Publ Navarra, Dept Math, Pamplona, Spain; [Mueller, Klaus-Robert] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Mueller, Klaus-Robert] Max Planck Inst Informat, Saarbrucken, Germany	Technical University of Berlin; Technical University of Berlin; Universidad Publica de Navarra; Korea University; Max Planck Society	Blankertz, B (corresponding author), Tech Univ Berlin, Dept Neurotechnol, Berlin, Germany.; Muller, KR (corresponding author), Tech Univ Berlin, Dept Machine Learning, Berlin, Germany.; Muller, KR (corresponding author), Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea.; Muller, KR (corresponding author), Max Planck Inst Informat, Saarbrucken, Germany.	klaus-robert.mueller@tu-berlin.de; benjamin.blankertz@tu-berlin.de	Mueller, Klaus-Robert/Y-3547-2019	Mueller, Klaus-Robert/0000-0002-3861-7685; Blankertz, Benjamin/0000-0002-2437-4846; Vidaurre, Carmen/0000-0003-3740-049X	German Ministry for Education and Research (BMBF) [01IS14013A-E, 01GQ1115, 01GQ0850]; Deutsche Forschungsgesellschaft (DFG) [MU 987/19-1, MU987/14-1]; DFG [MU 987/3-2]; Brain Korea 21 Plus Program; Institute for Information & Communications Technology Promotion (IITP) grant - Korea government [2017-0-00451]; Spanish Ministry of Economy [RYC-2014-15671]	German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgesellschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Brain Korea 21 Plus Program; Institute for Information & Communications Technology Promotion (IITP) grant - Korea government(Institute for Information & Communication Technology Planning & Evaluation (IITP), Republic of Korea); Spanish Ministry of Economy(Spanish Government)	This work was supported by German Ministry for Education and Research (BMBF) under Grants 01IS14013A-E, 01GQ1115 and 01GQ0850; Deutsche Forschungsgesellschaft (DFG) under Grant MU 987/19-1, MU987/14-1 and DFG MU 987/3-2; Brain Korea 21 Plus Program and by the Institute for Information & Communications Technology Promotion (IITP) grant funded by the Korea government (No. 2017-0-00451); and Spanish Ministry of Economy RYC-2014-15671.	Acqualagna L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148886; Ahn M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00848; Ahn M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080886; Allison B, 2010, IEEE T NEUR SYS REH, V18, P107, DOI 10.1109/TNSRE.2009.2039495; Ang KK, 2011, CLIN EEG NEUROSCI, V42, P253, DOI 10.1177/155005941104200411; Babiloni C, 1999, NEUROIMAGE, V10, P658, DOI 10.1006/nimg.1999.0504; Birbaumer N, 2009, INT REV NEUROBIOL, V86, P107, DOI 10.1016/S0074-7742(09)86008-X; Blankertz B., 2008, ADV NEURAL INFORM PR, V20, P113; Blankertz B, 2008, IEEE T BIO-MED ENG, V55, P2452, DOI 10.1109/TBME.2008.923152; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Blankertz B, 2007, NEUROIMAGE, V37, P539, DOI 10.1016/j.neuroimage.2007.01.051; Blankertz B, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00530; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Blankertz B, 2010, FRONT COLLECT, P113, DOI 10.1007/978-3-642-02091-9_7; Blankertz B, 2010, NEUROIMAGE, V51, P1303, DOI 10.1016/j.neuroimage.2010.03.022; Botrel L, 2017, INT J PSYCHOPHYSIOL, V121, P29, DOI 10.1016/j.ijpsycho.2017.08.007; Brickenkamp R., 1998, D2 TEST ATTENTION, V1st; Burde W, 2006, P 3 INT BRAIN COMP I, P76; Cochin S, 1999, EUR J NEUROSCI, V11, P1839, DOI 10.1046/j.1460-9568.1999.00598.x; Dornhege G., 2007, BRAIN COMPUTER INTER; Dornhege G, 2006, IEEE T BIO-MED ENG, V53, P2274, DOI 10.1109/TBME.2006.883649; Faller J, 2012, IEEE T NEUR SYS REH, V20, P313, DOI 10.1109/TNSRE.2012.2189584; Grosse-Wentrup M, 2011, NEUROIMAGE, V56, P837, DOI 10.1016/j.neuroimage.2010.04.265; Grosse-Wentrup M, 2009, IEEE T BIO-MED ENG, V56, P1209, DOI 10.1109/TBME.2008.2009768; Guger C, 2003, IEEE T NEUR SYS REH, V11, P145, DOI 10.1109/TNSRE.2003.814481; Guger C, 2009, NEUROSCI LETT, V462, P94, DOI 10.1016/j.neulet.2009.06.045; Halder S, 2011, NEUROIMAGE, V55, P1779, DOI 10.1016/j.neuroimage.2011.01.021; Halder S, 2013, FRONT HUM NEUROSCI, P7; Hammer EM, 2012, BIOL PSYCHOL, V89, P80, DOI 10.1016/j.biopsycho.2011.09.006; Holzapfel S, 1998, PRADIKTOREN SELBSTRE; Hu S, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00297; Hu S, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aaa13f; Isaac A.R., 1986, J MENT IMAG, V10, P23, DOI DOI 10.1037/T07980-000; Jeunet C, 2016, PROG BRAIN RES, V228, P3, DOI 10.1016/bs.pbr.2016.04.002; Jeunet C, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/3/036024; Jeunet C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143962; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Kai Keng Ang, 2013, Journal of Computing Science and Engineering, V7, P139, DOI 10.5626/JCSE.2013.7.2.139; Kawanabe M, 2014, NEURAL COMPUT, V26, P349, DOI 10.1162/NECO_a_00544; Kubler A, 2004, J PSYCHOPHYSIOL, V18, P121, DOI 10.1027/0269-8803.18.23.121; Kubler A, 2006, IEEE T NEUR SYS REH, V14, P131, DOI 10.1109/TNSRE.2006.875585; Ledoit O, 2004, J MULTIVARIATE ANAL, V88, P365, DOI 10.1016/S0047-259X(03)00096-4; Lemm S, 2005, IEEE T BIO-MED ENG, V52, P1541, DOI 10.1109/TBME.2005.851521; Lemm S, 2011, NEUROIMAGE, V56, P387, DOI 10.1016/j.neuroimage.2010.11.004; Li Y, 2010, IEEE T BIO-MED ENG, V57, P1318, DOI 10.1109/TBME.2009.2039997; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Lorenz R, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/035007; Lotte F, 2011, IEEE T BIO-MED ENG, V58, P355, DOI 10.1109/TBME.2010.2082539; McFarland DJ, 2015, INT J PSYCHOPHYSIOL, V97, P271, DOI 10.1016/j.ijpsycho.2014.07.009; McFarland DJ, 1997, ELECTROEN CLIN NEURO, V103, P386, DOI 10.1016/S0013-4694(97)00022-2; Millan JDR, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00161; Mora N, 2017, MED BIOL ENG COMPUT, V55, P1339, DOI 10.1007/s11517-016-1596-4; Muller JS, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa620b; Muthukumaraswamy SD, 2004, PSYCHOPHYSIOLOGY, V41, P152, DOI 10.1046/j.1469-8986.2003.00129.x; Myrden A, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00308; Neumann N, 2003, J NEUROL NEUROSUR PS, V74, P1117, DOI 10.1136/jnnp.74.8.1117; Neuper C, 2005, COGNITIVE BRAIN RES, V25, P668, DOI 10.1016/j.cogbrainres.2005.08.014; Neuper C, 2009, CLIN NEUROPHYSIOL, V120, P239, DOI 10.1016/j.clinph.2008.11.015; Nierhaus T, 2018, IMMEDIATE BRAIN PLAS; Nijboer F, 2008, J NEUROSCI METH, V167, P43, DOI 10.1016/j.jneumeth.2007.02.009; Nijboer F, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00055; Nijholt A, 2008, IEEE INTELL SYST, V23, P72, DOI 10.1109/MIS.2008.41; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 1997, INT J PSYCHOPHYSIOL, V26, P121, DOI 10.1016/S0167-8760(97)00760-5; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pineda JA, 2005, BRAIN RES REV, V50, P57, DOI 10.1016/j.brainresrev.2005.04.005; Pineda JA, 2000, IEEE T REHABIL ENG, V8, P219, DOI 10.1109/86.847822; Qin Y, 2010, CLIN NEUROPHYSIOL, V121, P1981, DOI 10.1016/j.clinph.2010.03.056; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Samek W, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa8232; Samek W, 2016, NEUROIMAGE, V141, P291, DOI 10.1016/j.neuroimage.2016.06.056; Samek Wojciech, 2014, IEEE Rev Biomed Eng, V7, P50, DOI 10.1109/RBME.2013.2290621; Samek W, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026013; Sannelli C, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/4/046003; Sannelli C, 2012, IEEE ENG MED BIO, P4744, DOI 10.1109/EMBC.2012.6347027; Sannelli C, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025012; SEBER GAF, 1984, MULTIVARIATE OBSERVA; Shenoy P, 2006, J NEURAL ENG, V3, pR13, DOI 10.1088/1741-2560/3/1/R02; Sugiyama M, 2007, J MACH LEARN RES, V8, P985; Suk HI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087056; Thompson M. C., 2018, SCI ENG ETHICS, P1; Tomioka R, 2010, NEUROIMAGE, V49, P415, DOI 10.1016/j.neuroimage.2009.07.045; Varkuti B, 2011, P 5 INT BCI C, P104; VIDAL JJ, 1973, ANNU REV BIOPHYS BIO, V2, P157, DOI 10.1146/annurev.bb.02.060173.001105; Vidaurre C, 2011, IEEE T BIO-MED ENG, V58, P587, DOI 10.1109/TBME.2010.2093133; Vidaurre C, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025009; Vidaurre C, 2011, NEURAL COMPUT, V23, P791, DOI 10.1162/NECO_a_00089; Vidaurre C, 2009, NEURAL NETWORKS, V22, P1313, DOI 10.1016/j.neunet.2009.07.020; Vogt S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00807; von Bunau P, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.214101; Wolpaw J.R., 2012, BRAIN COMPUTER INTER, DOI [10.1093/acprof:oso/9780195388855.001.0001, DOI 10.1093/ACPROF:OSO/9780195388855.001.0001]; Wolpaw JR, 2007, J PHYSIOL-LONDON, V579, P613, DOI 10.1113/jphysiol.2006.125948; Yao DZ, 2005, PHYSIOL MEAS, V26, P173, DOI 10.1088/0967-3334/26/3/003; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305	95	41	41	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0207351	10.1371/journal.pone.0207351	http://dx.doi.org/10.1371/journal.pone.0207351			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682025	Green Published, gold, Green Submitted			2022-12-26	WOS:000457037500009
J	Jeong, BH; Na, SJ; Lee, DS; Chung, CR; Suh, GY; Jeon, K				Jeong, Byeong-Ho; Na, Soo Jin; Lee, Dae-Sang; Chung, Chi Ryang; Suh, Gee Young; Jeon, Kyeongman			Readmission and hospital mortality after ICU discharge of critically ill cancer patients	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; AFTER-HOURS DISCHARGE; RISK-FACTORS; OUTCOMES; MALIGNANCIES; ADMISSION; INCREASES; SEVERITY; ILLNESS	Background Intensive care unit (ICU) readmission is generally associated with increased hospital stays and increased mortality. However, there are limited data on ICU readmission in critically ill cancer patients. Method We conducted a retrospective cohort study based on the prospective registry of all critically ill cancer patients admitted to the oncology medical ICU between January 2012 and December 2013. After excluding patients who were discharged to another hospital or decided to end-of-life care, we divided the enrolled patients into four groups according to the time period from ICU discharge to unexpected events (ICU readmission or ward death) as follows: no (without ICU readmission or death, n = 456), early (within 2 days, n = 42), intermediate (between 2 and 7 days, n = 64), and late event groups (after 7 days of index ICU discharge, n = 129). The independent risk factors associated with ICU readmission or unexpected death after ICU discharge were also analyzed using multinomial logistic regression model. Results There were no differences in the reasons for ICU readmission across the groups. ICU mortality did not differ among the groups, but hospital mortality was significantly higher in the late event group than in the early event group. Mechanical ventilation during ICU stay, tachycardia, decreased mental status, and thrombocytopenia on the day of index ICU discharge increased the risk of early ICU readmission or unexpected ward death, while admission through the emergency room and sepsis and respiratory failure as the reasons for index ICU admission were associated with increased risk of late readmission or unexpected ward death. Interestingly, recent chemotherapy within 4 weeks before index ICU admission was inversely associated with the risk of late readmission or unexpected ward death. Conclusion In critically ill cancer patients, patient characteristics predicting ICU readmission or unexpected ward death were different according to the time period between index ICU discharge and the events.	[Jeong, Byeong-Ho; Chung, Chi Ryang; Suh, Gee Young; Jeon, Kyeongman] Sungkyunkwan Univ, Div Pulm & Crit Care Med, Dept Med, Samsung Med Ctr,Sch Med, Seoul, South Korea; [Na, Soo Jin; Lee, Dae-Sang; Suh, Gee Young; Jeon, Kyeongman] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Jeon, K (corresponding author), Sungkyunkwan Univ, Div Pulm & Crit Care Med, Dept Med, Samsung Med Ctr,Sch Med, Seoul, South Korea.; Jeon, K (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea.	kjeon@skku.edu	Suh, Gee Young/O-3676-2019; Jeon, Kyeongman/F-5963-2019	Suh, Gee Young/0000-0001-5473-1712; Jeon, Kyeongman/0000-0002-4822-1772; Jeong, Byeong-Ho/0000-0002-3124-1718	Samsung Medical Center grant [OTA1602901]	Samsung Medical Center grant(Samsung)	This work was supported by a Samsung Medical Center grant (OTA1602901) to KJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoulay E, 2013, J CLIN ONCOL, V31, P2810, DOI 10.1200/JCO.2012.47.2365; Baldwin MR, 2014, J CRIT CARE, V29, P401, DOI 10.1016/j.jcrc.2013.12.019; Benoit DD, 2006, INTENS CARE MED, V32, P93, DOI 10.1007/s00134-005-2836-5; Brown SES, 2012, AM J RESP CRIT CARE, V185, P955, DOI 10.1164/rccm.201109-1720OC; Chrusch CA, 2009, CRIT CARE MED, V37, P2753, DOI 10.1097/CCM.0b013e3181a57b0c; Darmon M, 2005, CRIT CARE MED, V33, P2488, DOI 10.1097/01.CCM.0000181728.13354.0A; Frost SA, 2009, RESUSCITATION, V80, P505, DOI 10.1016/j.resuscitation.2009.02.015; Gantner D, 2014, INTENS CARE MED, V40, P1528, DOI 10.1007/s00134-014-3438-x; Hosein FS, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0715-6; Kramer AA, 2013, CRIT CARE MED, V41, P24, DOI 10.1097/CCM.0b013e3182657b8a; Kramer AA, 2012, CRIT CARE MED, V40, P3, DOI 10.1097/CCM.0b013e31822d751e; Lee DS, 2015, CRIT CARE MED, V43, P1439, DOI 10.1097/CCM.0000000000000989; Lee H, 2015, ANAESTH INTENS CARE, V43, P175, DOI 10.1177/0310057X1504300206; Nates JL, 2016, CRIT CARE MED, V44, P1553, DOI 10.1097/CCM.0000000000001856; Ouanes I, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.08.003; Pilcher DV, 2007, ANAESTH INTENS CARE, V35, P477, DOI 10.1177/0310057X0703500403; Ponzoni CR, 2017, ANN AM THORAC SOC, V14, P1312, DOI 10.1513/AnnalsATS.201611-851OC; Ranzani OT, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.10.013; Renton J, 2011, INTENS CARE MED, V37, P1800, DOI 10.1007/s00134-011-2318-x; Rhodes A, 2012, INTENS CARE MED, V38, P1647, DOI 10.1007/s00134-012-2627-8; Rodrigues Cinthia Mendes, 2016, Rev. bras. ter. intensiva, V28, P33, DOI 10.5935/0103-507X.20160011; Rosa RG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143127; Rosenberg AL, 2000, CHEST, V118, P492, DOI 10.1378/chest.118.2.492; Shankar-Hari M, 2016, CURR INFECT DIS REP, V18, DOI 10.1007/s11908-016-0544-7; Soares M, 2010, CRIT CARE MED, V38, P9, DOI 10.1097/CCM.0b013e3181c0349e; Song JU, 2012, INTENS CARE MED, V38, P1505, DOI 10.1007/s00134-012-2594-0; Song JU, 2011, SUPPORT CARE CANCER, V19, P491, DOI 10.1007/s00520-010-0841-x; Song SW, 2007, ANN THORAC SURG, V84, P1838, DOI 10.1016/j.athoracsur.2007.06.074; Taccone FS, 2009, CRIT CARE, V13, DOI 10.1186/cc7713; Town JA, 2014, CRIT CARE MED, V42, P2037, DOI 10.1097/CCM.0000000000000401; van Vliet M, 2014, INTENS CARE MED, V40, P1275, DOI 10.1007/s00134-014-3373-x; VANSLUISVELD N, 2017, BMC HEALTH SERV RES, V17, P46319; Yoo H, 2013, CRIT CARE, V17, DOI 10.1186/cc12829	33	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211240	10.1371/journal.pone.0211240	http://dx.doi.org/10.1371/journal.pone.0211240			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677085	gold, Green Published, Green Submitted			2022-12-26	WOS:000456700400064
J	Qi, RH; Otting, G				Qi, Ruhu; Otting, Gottfried			Mutant T4 DNA polymerase for easy cloning and mutagenesis	PLOS ONE			English	Article							LIGATION-INDEPENDENT CLONING; ESCHERICHIA-COLI; RECOMBINANT-DNA; PROTEIN	The advent of high-fidelity DNA polymerases that can be used to linearize and amplify whole plasmids by PCR opened the door to greatly simplified cloning and mutagenesis protocols. Commercially available kits work well, but often have been optimized using undisclosed or proprietory components. Here we show that a mutant T4 DNA polymerase (Y320A) with attenuated 3'-exonuclease activity is uniquely suited to generate single stranded DNA overhangs of uniform length in a more easily controllable manner than the wild-type enzyme, and this can be used to increase the yields of colonies containing correctly modified plasmids in cloning and mutagenesis experiments, which is particularly useful when E. co/icells are of relatively low competency. Standard protocols using the mutant T4 DNA polymerase are provided for the sequence and ligation independent cloning (SLIC) method and a modified QuikChange method, where the mutant enzyme enhances the yield of correctly mutated plasmid and further suppresses parental plasmid during digestion with Dpnl. Single-stranded DNA overhangs generated by the mutant T4 DNA polymerase facilitate subsequent plasmid circularization, annealing and ligation in E. coli.	[Qi, Ruhu; Otting, Gottfried] Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia	Australian National University	Otting, G (corresponding author), Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia.	gottfried.otting@anu.edu.au	Otting, Gottfried/H-8413-2014	Otting, Gottfried/0000-0002-0563-0146	Australian Research Council [DP170100162, FL170100019]	Australian Research Council(Australian Research Council)	Financial support was obtained from the Australian Research Council (https://www.arc.gov.au), grants DP170100162 and FL170100019 to G. O. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Aslanidis C, 2009, GENOME RES, V4, P172; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; CAPSON TL, 1992, BIOCHEMISTRY-US, V31, P10984, DOI 10.1021/bi00160a007; da Silva EF, 2007, NUCLEIC ACIDS RES, V35, P5452, DOI 10.1093/nar/gkm591; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Green MR, 2012, MOL CLONING LAB MANU, V1; Huang FQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183974; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Ishmael FT, 2003, J BIOL CHEM, V278, P3145, DOI 10.1074/jbc.M209858200; Islam MN, 2017, BIOTECHNIQUES, V63, P125, DOI 10.2144/000114588; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; LIN TC, 1994, J BIOL CHEM, V269, P19286; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Neylon C, 2000, BIOCHEMISTRY-US, V39, P11989, DOI 10.1021/bi001174w; REDDY MK, 1992, J BIOL CHEM, V267, P14157; Reha-Krantz LJ, 2010, BBA-PROTEINS PROTEOM, V1804, P1049, DOI 10.1016/j.bbapap.2009.06.012; REHAKRANTZ LJ, 1993, J BIOL CHEM, V268, P27100; Sattar AKMA, 1996, BIOCHEMISTRY-US, V35, P16621, DOI 10.1021/bi961552q; Stevenson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083888; Tan A, 2018, PEERJ, V6, DOI 10.7717/peerj.5383; Thieme F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020556; Unger T, 2010, J STRUCT BIOL, V172, P34, DOI 10.1016/j.jsb.2010.06.016; Wang J, 1996, BIOCHEMISTRY-US, V35, P8110, DOI 10.1021/bi960178r; Xia YZ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1189; YANG YS, 1993, NUCLEIC ACIDS RES, V21, P1889, DOI 10.1093/nar/21.8.1889; Young DD, 2011, BIOCHEMISTRY-US, V50, P1894, DOI 10.1021/bi101929e; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	30	3	5	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211065	10.1371/journal.pone.0211065	http://dx.doi.org/10.1371/journal.pone.0211065			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673756	Green Published, gold, Green Submitted			2022-12-26	WOS:000456442800072
J	Sayas, CL; Medina, M; Cuadros, R; Olla, I; Garcia, E; Perez, M; Ferrer, I; Hernandez, F; Avila, J				Laura Sayas, C.; Medina, Miguel; Cuadros, Raquel; Olla, Ivanna; Garcia, Esther; Perez, Mar; Ferrer, Isidro; Hernandez, Felix; Avila, Jesus			Role of tau N-terminal motif in the secretion of human tau by End Binding proteins	PLOS ONE			English	Article							EXTRACELLULAR TAU; MICROTUBULES; PHOSPHORYLATION; OVEREXPRESSION; TRANSMISSION; FILAMENT; TRACKING; EB3	For unknown reasons, humans appear to be particular susceptible to developing tau pathology leading to neurodegeneration. Transgenic mice are still undoubtedly the most popular and extensively used animal models for studying Alzheimer's disease and other tauopathies. While these murine models generally overexpress human tau in the mouse brain or specific brain regions, there are differences between endogenous mouse tau and human tau protein. Among them, a main difference between human and mouse tau is the presence of a short motif spanning residues 18 to 28 in the human tau protein that is missing in murine tau, and which could be at least partially responsible for that different susceptibility across species. Here we report novel data using affinity chromatography analysis indicating that the sequence containing human tau residues 18 to 28 acts a binding motif for End Binding proteins and that this interaction could facilitate tau secretion to the extracellular space.	[Laura Sayas, C.] ULL, Inst Biomed Technol ITB, Ctr Biomed Res Canary Isl CIBICAN, Tenerife, Spain; [Medina, Miguel; Olla, Ivanna; Ferrer, Isidro; Hernandez, Felix; Avila, Jesus] Network Ctr Biomed Res Neurodegenerat Dis CIBERNE, Madrid, Spain; [Medina, Miguel; Olla, Ivanna; Ferrer, Isidro; Hernandez, Felix; Avila, Jesus] CIEN Fdn, Queen Sofia Fdn Alzheimer Ctr, Madrid, Spain; [Cuadros, Raquel; Garcia, Esther; Hernandez, Felix; Avila, Jesus] UAM, CSIC, CBMSO, Madrid, Spain; [Perez, Mar] UAM, Fac Med, Dept Anat Histol & Neurociencia, Madrid, Spain; [Ferrer, Isidro] Univ Barcelona, Dept Pathol & Expt Therapeut, Barcelona, Spain; [Ferrer, Isidro] Bellvitge Univ Hosp, Serv Pathol Anat, Barcelona, Spain; [Ferrer, Isidro] Univ Barcelona, Inst Neurosci, Lhospitalet De Llobregat, Spain	Universidad de la Laguna; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Barcelona	Avila, J (corresponding author), Network Ctr Biomed Res Neurodegenerat Dis CIBERNE, Madrid, Spain.; Avila, J (corresponding author), CIEN Fdn, Queen Sofia Fdn Alzheimer Ctr, Madrid, Spain.; Avila, J (corresponding author), UAM, CSIC, CBMSO, Madrid, Spain.	javila@cbm.csic.es	Hernandez, Felix/L-2114-2015; Medina, Miguel/J-1642-2019; Avila, Jesus/I-2610-2015; Mar, Perez/Y-2055-2019; Medina, Miguel/H-5676-2012	Hernandez, Felix/0000-0001-8753-8249; Avila, Jesus/0000-0002-6288-0571; Mar, Perez/0000-0002-8477-9554; Medina, Miguel/0000-0002-7016-5340	Spanish Ministry of Economy and Competitiveness [SAF-2014-53040-P, SAF2016-78603-R, BFU2016-77885-P]; Fundacion Ramon Areces; Banco Santander; Centro de Investigascion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, ISCIII)	Spanish Ministry of Economy and Competitiveness(Spanish Government); Fundacion Ramon Areces; Banco Santander; Centro de Investigascion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, ISCIII)	This study was funded by grants from the Spanish Ministry of Economy and Competitiveness (SAF-2014-53040-P (Jesus Avila), SAF2016-78603-R (Miguel Medina) and BFU2016-77885-P (Felix Hernandez), the Centro de Investigascion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, ISCIII) (Jesus Avila). Institutional grants from the Fundacion Ramon Areces and Banco Santander to the CBMSO are also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVILA J, 1994, INT J DEV BIOL, V38, P13; Bolos M, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0200-1; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; CORREAS I, 1990, BIOCHEM J, V269, P61, DOI 10.1042/bj2690061; DEGARCINI EM, 1994, MOL CELL BIOCHEM, V130, P187; Geraldo S, 2008, NAT CELL BIOL, V10, P1181, DOI 10.1038/ncb1778; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; Gomez-Ramos A, 2008, MOL CELL NEUROSCI, V37, P673, DOI 10.1016/j.mcn.2007.12.010; Gomez-Ramos A, 2006, FEBS LETT, V580, P4842, DOI 10.1016/j.febslet.2006.07.078; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Komarova YA, 2002, J CELL BIOL, V159, P589, DOI 10.1083/jcb.200208058; LEE G, 1988, SCIENCE, V239, P285, DOI 10.1126/science.3122323; Leon-Espinosa G, 2013, J NEUROSCI RES, V91, P954, DOI 10.1002/jnr.23220; Leterrier C, 2011, P NATL ACAD SCI USA, V108, P8826, DOI 10.1073/pnas.1018671108; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Medina M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00113; Mudher A, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0488-7; Narasimhan S, 2017, J NEUROSCI, V37, P11406, DOI 10.1523/JNEUROSCI.1230-17.2017; Nelson PT, 1996, J NEUROCHEM, V67, P1622; Perez M, 2001, BIOCHEMISTRY-US, V40, P5983, DOI 10.1021/bi002961w; Ramirez-Rios S, 2016, MOL BIOL CELL, V27, P2924, DOI 10.1091/mbc.E16-01-0029; Santa-Maria I, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-17; Sayas CL, 2015, J NEUROCHEM, V133, P653, DOI 10.1111/jnc.13091; Simon D, 2012, FEBS LETT, V586, P47, DOI 10.1016/j.febslet.2011.11.022; Skrabana R, 2006, CELL MOL NEUROBIOL, V26, P1085, DOI 10.1007/s10571-006-9083-3; Stepanova T, 2010, CURR BIOL, V20, P1023, DOI 10.1016/j.cub.2010.04.024; van de Willige D, 2016, CELL MOL LIFE SCI, V73, P2053, DOI 10.1007/s00018-016-2168-3; Wang LJ, 2014, J BIOL CHEM, V289, P29322, DOI 10.1074/jbc.M114.559153	30	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210864	10.1371/journal.pone.0210864	http://dx.doi.org/10.1371/journal.pone.0210864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668577	Green Published, gold, Green Submitted			2022-12-26	WOS:000456306400020
J	Tessa, C; Toschi, N; Orsolini, S; Valenza, G; Lucetti, C; Barbieri, R; Diciotti, S				Tessa, Carlo; Toschi, Nicola; Orsolini, Stefano; Valenza, Gaetano; Lucetti, Claudio; Barbieri, Riccardo; Diciotti, Stefano			Central modulation of parasympathetic outflow is impaired in de novo Parkinson's disease patients	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; SYMPATHETIC-NERVE ACTIVITY; BRAIN-STEM NUCLEI; AUTONOMIC DYSFUNCTION; ESSENTIAL TREMOR; FMRI; FLUCTUATIONS; METAANALYSIS; ASSOCIATION; PROGRESSION	Task- and stimulus-based neuroimaging studies have begun to unveil the central autonomic network which modulates autonomic nervous system activity. In the present study, we aimed to evaluate the central autonomic network without the bias constituted by the use of a task. Additionally, we assessed whether this circuitry presents signs of dysregulation in the early stages of Parkinson's disease (PD), a condition which may be associated with dysautonomia. We combined heart-rate-variability based methods for time-varying assessments of the autonomic nervous system outflow with resting-state fMRI in 14 healthy controls and 14 de novo PD patients, evaluating the correlations between fMRI time-series and the instantaneous high-frequency component of the heart-rate-variability power spectrum, a marker of parasympathetic outflow. In control subjects, the high-frequency component of the heart-rate-variability power spectrum was significantly anti-correlated with fMRI time-series in several cortical, subcortical and brainstem regions. This complex central network was not detectable in PD patients. In between-group analysis, we found that in healthy controls the brain activation related to the high-frequency component of the heart-rate-variability power spectrum was significantly less than in PD patients in the mid and anterior cingulum, sensorimotor cortex and supplementary motor area, insula and temporal lobe, prefrontal cortex, hippocampus and in a region encompassing posterior cingulum, precuneus and parieto-occipital cortex. Our results indicate that the complex central network which modulates parasympathetic outflow in the resting state is impaired in the early clinical stages of PD.	[Tessa, Carlo] Azienda USL Toscana Nord Ovest, Versilia Hosp, Dept Radiol & Nucl Med, Lido Di Camaiore, Lu, Italy; [Toschi, Nicola] Univ Roma Tor Vergata, Med Phys Sect, Dept Biomed & Prevent, Rome, Italy; [Toschi, Nicola] Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Boston, MA USA; [Toschi, Nicola] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA; [Orsolini, Stefano; Diciotti, Stefano] Univ Bologna, Dept Elect Elect & Informat Engn Guglielmo Marcon, Cesena, Italy; [Valenza, Gaetano; Barbieri, Riccardo] Massachusetts Gen Hosp, Dept Anesthesia, Boston, MA 02114 USA; [Valenza, Gaetano] Univ Pisa, Sch Engn, Res Ctr E Piaggio, Pisa, Italy; [Valenza, Gaetano] Univ Pisa, Sch Engn, Dept Informat Engn, Pisa, Italy; [Lucetti, Claudio] Azienda USL Toscana Nord Ovest, Versilia Hosp, Div Neurol, Lido Di Camaiore, Lu, Italy; [Barbieri, Riccardo] Politecn Milan, Dept Elect Informat & Bioengn, Milan, Italy	Ospedale Versilia; University of Rome Tor Vergata; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Bologna; Harvard University; Massachusetts General Hospital; University of Pisa; University of Pisa; Ospedale Versilia; Polytechnic University of Milan	Tessa, C (corresponding author), Azienda USL Toscana Nord Ovest, Versilia Hosp, Dept Radiol & Nucl Med, Lido Di Camaiore, Lu, Italy.	ctessa@sirm.org	Diciotti, Stefano/C-4167-2008; Barbieri, Riccardo/AAC-5310-2022; Toschi, Nicola/J-2555-2012	Diciotti, Stefano/0000-0001-8778-7819; Barbieri, Riccardo/0000-0001-9381-3833; Toschi, Nicola/0000-0003-1929-5833; Valenza, Gaetano/0000-0001-6574-1879; Orsolini, Stefano/0000-0002-9024-314X				American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; ANAND BK, 1956, J NEUROPHYSIOL, V19, P393, DOI 10.1152/jn.1956.19.5.393; Andersson JLR., 2007, NONLINEAR REGISTRATI; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Barbieri R, 2005, AM J PHYSIOL-HEART C, V288, pH424, DOI 10.1152/ajpheart.00482.2003; Barbieri R, 2014, COMP CARD C CINC; Barbieri R, 2013, COMP CARD C CINC; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Beissner F, 2015, CLIN NEURORADIOL, V25, P251, DOI 10.1007/s00062-015-0404-0; Beissner F, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00116; Beissner F, 2013, J NEUROSCI, V33, P10503, DOI 10.1523/JNEUROSCI.1103-13.2013; Bianciardi M, 2015, BRAIN CONNECT, V5, P597, DOI 10.1089/brain.2015.0347; Birn RM, 2008, NEUROIMAGE, V40, P644, DOI 10.1016/j.neuroimage.2007.11.059; Bonuccelli U, 2003, ARCH NEUROL-CHICAGO, V60, P1400, DOI 10.1001/archneur.60.10.1400; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Braak H, 2008, NEUROLOGY, V70, P1916, DOI 10.1212/01.wnl.0000312279.49272.9f; Braak H, 2017, J PARKINSON DIS, V7, pS73, DOI 10.3233/JPD-179001; BRADLEY DJ, 1991, NEUROSCI RES, V12, P45, DOI 10.1016/0168-0102(91)90099-K; Brisinda D, 2014, J NEUROL SCI, V336, P197, DOI 10.1016/j.jns.2013.10.039; Brooks JCW, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00623; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Camm AJ, 1996, CIRCULATION, V93, P1043; Castle M, 2005, NEUROSCIENCE, V134, P657, DOI 10.1016/j.neuroscience.2005.04.031; Cechetto DF, 2009, NEUROIMAGE, V47, P795, DOI 10.1016/j.neuroimage.2009.05.024; Cechetto DF., 1990, CENTRAL REGULATION A, P208; Chang C, 2013, NEUROIMAGE, V68, P93, DOI 10.1016/j.neuroimage.2012.11.038; Chang C, 2009, NEUROIMAGE, V44, P857, DOI 10.1016/j.neuroimage.2008.09.029; Citi L, 2012, IEEE T BIO-MED ENG, V59, P2828, DOI 10.1109/TBME.2012.2211356; Cohen J, 1992, CURRENT DIRECTIONS P, V1, P98, DOI DOI 10.1111/1467-8721.EP10768783; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coon EA, 2018, MOVEMENT DISORD, V33, P349, DOI 10.1002/mds.27186; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Danti S, 2015, EUR J NEUROL, V22, P1564, DOI 10.1111/ene.12785; De Pablo-Fernandez E, 2017, JAMA NEUROL, V74, P970, DOI 10.1001/jamaneurol.2017.1125; Dickson DW, 2018, PARKINSONISM RELAT D, V46, pS30, DOI 10.1016/j.parkreldis.2017.07.033; Ewing DJ, 1988, AUTONOMIC FAILURE, P667; Fahn S, RECENT DEV PARKINSOS; Friedrich C, 2010, MOVEMENT DISORD, V25, P315, DOI 10.1002/mds.22844; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; James C, 2013, NEUROIMAGE, V74, P188, DOI 10.1016/j.neuroimage.2013.02.030; James C, 2013, NEUROIMAGE, V70, P59, DOI 10.1016/j.neuroimage.2012.12.047; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kallio M, 2000, EUR J NEUROL, V7, P667, DOI 10.1046/j.1468-1331.2000.00127.x; Lee HM, 2014, PARKINSONISM RELAT D, V20, P622, DOI 10.1016/j.parkreldis.2014.03.009; Lucetti C, 2006, PARKINSONISM RELAT D, V12, P279, DOI 10.1016/j.parkreldis.2005.12.005; Mascalchi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089410; Menke RAL, 2014, HUM BRAIN MAPP, V35, P1681, DOI 10.1002/hbm.22282; Mumford JA, 2012, SOC COGN AFFECT NEUR, V7, P738, DOI 10.1093/scan/nss059; Napadow V, 2008, NEUROIMAGE, V42, P169, DOI 10.1016/j.neuroimage.2008.04.238; Nisimaru N, 2004, JPN J PHYSIOL, V54, P431, DOI 10.2170/jjphysiol.54.431; Palma JA, 2018, MOVEMENT DISORD, V33, P372, DOI 10.1002/mds.27344; PASTAKIA B, 1986, RADIOLOGY, V159, P499, DOI 10.1148/radiology.159.2.3961183; Pattinson KTS, 2009, NEUROIMAGE, V44, P295, DOI 10.1016/j.neuroimage.2008.09.007; Pazo JH, 2002, CELL MOL NEUROBIOL, V22, P645, DOI 10.1023/A:1021844605250; Pereira JB, 2014, NEUROLOGY, V82, P2017, DOI [10.1212/WNL.0000000000000483, 10.1212/01.wnl.0000457455.74798.9a]; Poldrack RA, 2011, HANDBOOK OF FUNCTION; del Paso GAR, 2013, PSYCHOPHYSIOLOGY, V50, P477, DOI 10.1111/psyp.12027; Salsone M, 2016, PARKINSONISM RELAT D, V33, P134, DOI 10.1016/j.parkreldis.2016.09.027; Sclocco R, 2016, CEREB CORTEX, V26, P485, DOI 10.1093/cercor/bhu172; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Spyer KM, 1999, AUTONOMIC FAILURE TX, P45; Tessa C, 2014, HUM BRAIN MAPP, V35, P3932, DOI 10.1002/hbm.22449; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Valenza G, 2018, J APPL PHYSIOL, V125, P19, DOI 10.1152/japplphysiol.00842.2017; Valenza G, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052803; Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037/0003-066X.54.8.594; Worsley K.J., 2001, FUNCTIONAL MRI AN IN, P251, DOI [10.1093/acprof:oso/ 9780192630711.003.0014, DOI 10.1093/ACPROF:OSO/9780192630711.003.0014]; Yarkoni T, 2009, PERSPECT PSYCHOL SCI, V4, P294, DOI 10.1111/j.1745-6924.2009.01127.x; Yoon JH, 2016, J NEUROL SCI, V368, P55, DOI 10.1016/j.jns.2016.06.059	74	12	12	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210324	10.1371/journal.pone.0210324	http://dx.doi.org/10.1371/journal.pone.0210324			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653564	Green Published, gold, Green Submitted			2022-12-26	WOS:000456015500034
J	Barboza, GE; Garcia, CC; Gonzalez, SL; Scaldaferro, M; Reyes, X				Barboza, Gloria E.; Carrizo Garcia, Carolina; Leiva Gonzalez, Segundo; Scaldaferro, Marisel; Reyes, Ximena			Four new species of Capsicum (Solanaceae) from the tropical Andes and an update on the phylogeny of the genus	PLOS ONE			English	Article							CHILI-PEPPERS CAPSICUM; DIVERSIFICATION; REGIONS	Four new species of Capsicum (Capsiceae, Solanaceae) from Andean tropical forests in South America are described. Capsicum benoistii Hunz. ex Barboza sp. nov. (incertae sedis) is endemic to a restricted area in south-central Ecuador and is most similar to the more widespread C. geminifolium (Dammer) Hunz. (Colombia, Ecuador, and Peru). Capsicum piuranum Barboza & S. Leiva sp. nov. (Andean clade) is found in northern Peru (Department Piura) and is morphologically most similar to C. caballeroi M. Nee of the Bolivian yungas (Departments Santa Cruz and Cochabamba) but closely related to C. geminifolium and C. lycianthoides Bitter. Capsicum longifolium Barboza & S. Leiva sp. nov. (Andean clade) occurs from northern Peru (Departments Amazonas, Cajamarca, and Piura) to southern Ecuador (Province Zamora-Chinchipe), and is morphologically most similar to C. dimorphum (Miers) Kuntze (Colombia, Ecuador, and Peru). Capsicum neei Barboza & X. Reyes sp. nov. (Bolivian clade) is endemic to southeastern Bolivia (Departments Chuquisaca and Santa Cruz) in the Boliviano-Tucumano Forest, is morphologically most similar to another Bolivian endemic species C. minutiflorum Rusby (Hunz.), and is closely related to C. caballeroi. Complete descriptions, illustrations, distributions and conservation assessments of all new species are given. Chromosome numbers for C. piuranum and C. longifolium are also provided. Three of the new species were included in a new phylogenetic analysis for Capsicum; their positions were strongly resolved within clades previously recognized in the genus.	[Barboza, Gloria E.; Carrizo Garcia, Carolina; Reyes, Ximena] Consejo Nacl Invest Cient & Tecn, Inst Multidisciplinario Biol Vegetal IMBIV, Cordoba, Argentina; [Barboza, Gloria E.] Univ Nacl Cordoba, Fac Ciencias Quim, Cordoba, Argentina; [Carrizo Garcia, Carolina] Univ Vienna, Dept Bot & Biodivers Res, Vienna, Austria; [Leiva Gonzalez, Segundo] Univ Privada Antenor Orrego, Museo Hist Nat, Trujillo, Peru; [Scaldaferro, Marisel] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Cordoba, Argentina; [Reyes, Ximena] Ctr Invest Fitoecogenet Pairumani, Cochabamba, Bolivia	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; University of Vienna; Universidad Privada Antenor Orrego; National University of Cordoba	Barboza, GE (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Multidisciplinario Biol Vegetal IMBIV, Cordoba, Argentina.; Barboza, GE (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Cordoba, Argentina.	gbarboza@imbiv.unc.edu.ar	Gonzalez, Sophia/GWM-7305-2022	Barboza, Gloria Estela/0000-0003-1085-036X	National Science Foundation [DEB 1457366]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PID 11220170100147CO]; Joint Project CONICET-FWF, Argentina-Austria; Secretaria de Ciencia y Tecnologia, SECYT-UNC, Argentina [411/18]; Fondo para la Investigacion Cientifica y Tecnologica, FONCyT, Argentina [PICT 2015-3022]; FWF Lise Meitner, Austria [M2282-B29]; Centro de Investigaciones Fitoecogeneticas de Pairumani, Cochabamba, Bolivia	National Science Foundation(National Science Foundation (NSF)); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Joint Project CONICET-FWF, Argentina-Austria; Secretaria de Ciencia y Tecnologia, SECYT-UNC, Argentina; Fondo para la Investigacion Cientifica y Tecnologica, FONCyT, Argentina(FONCyT); FWF Lise Meitner, Austria; Centro de Investigaciones Fitoecogeneticas de Pairumani, Cochabamba, Bolivia	Financial assistance was provided by National Science Foundation, DEB 1457366 (GEB); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, PID 11220170100147CO (GEB); Joint Project CONICET-FWF, Argentina-Austria (GEB & CCG); Secretaria de Ciencia y Tecnologia, SECYT-UNC Res. 411/18, Argentina (GEB); Fondo para la Investigacion Cientifica y Tecnologica, FONCyT, PICT 2015-3022, Argentina (CCG); FWF Lise Meitner M2282-B29, Austria (CCG); Centro de Investigaciones Fitoecogeneticas de Pairumani, Cochabamba, Bolivia (XR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bachman S, 2011, ZOOKEYS, P117, DOI 10.3897/zookeys.150.2109; Barboza GE, 2013, SOLANACEAE FLORA ARG, V13, P21; Basu SK, 2003, MED AROM PLANTS, V33, P1; Garcia CC, 2016, ANN BOT-LONDON, V118, P35, DOI 10.1093/aob/mcw079; Castro L, 2011, PUEBLOS PLANTAS CHUQ, P345; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De AK., 2003, CAPSICUM GENUS CAPSI; GeoCAT, GEOSP CONS ASS TOOL; Hunziker A.T., 2001, GENERA SOLANACEAE; Hunziker Armando T., 1998, Kurtziana, V26, P23; IUCN Standards and Petitions Subcommittee, 2017, GUID US IUCN RED LIS; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Libreros D, 2014, CATALOGO AJIES NATIV; Miller JS, 2009, SYST BOT, V34, P796, DOI 10.1600/036364409790139709; Moscone EA, 1996, PLANT SYST EVOL, V202, P37, DOI 10.1007/BF00985817; MOSCONE EA, 1993, PLANT SYST EVOL, V186, P213, DOI 10.1007/BF00940799; Navarro G., 2011, PUEBLOS PLANTAS CHUQ, P25; Olmstead RG, 2008, TAXON, V57, P1159, DOI 10.1002/tax.574010; Papoiu ADP, 2010, EXPERT OPIN PHARMACO, V11, P1359, DOI 10.1517/14656566.2010.481670; Pickersgill B, 1997, EUPHYTICA, V96, P129, DOI 10.1023/A:1002913228101; Pruthi JS, 2003, MED AROM PLANTS, V33, P25; Sarkinen T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-214; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Scaldaferro MA, 2011, BAG-J BASIC APPL GEN, V41, P31; Scaldaferro MA, 2018, BIOL J LINN SOC, V124, P466, DOI 10.1093/biolinnean/bly062; Scaldaferro MA, 2013, GENET RESOUR CROP EV, V60, P693, DOI 10.1007/s10722-012-9867-x; Schweizer D, METHODS MOL BIOL 29; Spalink D, 2018, MOL PHYLOGENET EVOL, V126, P293, DOI 10.1016/j.ympev.2018.04.030; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Thampi PSS, 2003, MED AROM PLANTS, V33, P16; Thiers B., 2018, INDEX HERBARIORUM GL; Tong N., 1997, CAPSICUM EGGPLANT NE, V16, P42; Ulloa CU, 2017, SCIENCE, V358, P1614, DOI 10.1126/science.aao0398; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354	36	34	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209792	10.1371/journal.pone.0209792	http://dx.doi.org/10.1371/journal.pone.0209792			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650102	Green Published, gold, Green Submitted			2022-12-26	WOS:000455813300028
J	Daniels, DR				Daniels, D. R.			Transport of solid bodies along tubular membrane tethers	PLOS ONE			English	Article							FLUCTUATING LIPID-BILAYER; FLUID MEMBRANES; NANOTUBES	We study the crucial role of membrane fluctuations in maintaining a narrow gap between a fluid membrane tube and an enclosed solid particle. Solvent flows can occur in this gap, hence giving rise to a finite particle mobility along the tube. While our study has relevance for how cells are able to transport large organelles or other cargo along connecting membrane tubes, known as tunneling nanotubes, our calculations are also framed so that they can be tested by a specific in vitro experiment: A tubular membrane tether can be pulled from a membrane reservoir, such as an aspirated Giant Unilamellar Vesicle (GUV), e.g. using a conjugated bead that binds to the membrane and is held in a laser trap. We compute the subsequent mobility of colloidal particles trapped in the tube, focusing on the case when the particle is large compared to the equilibrium tube radius. We predict that the particle mobility should scale as similar to sigma(-2/3), with sigma the membrane tension.	[Daniels, D. R.] Swansea Univ, Coll Engn, Bay Campus, Swansea, W Glam, Wales	Swansea University	Daniels, DR (corresponding author), Swansea Univ, Coll Engn, Bay Campus, Swansea, W Glam, Wales.	d.r.daniels@swansea.ac.uk						Bruce A., 2002, MOL BIOL CELL, V4th ed.; CRICK FHC, 1950, EXP CELL RES, V1, P505, DOI 10.1016/0014-4827(50)90002-4; Cuvelier D, 2005, EUROPHYS LETT, V71, P1015, DOI 10.1209/epl/i2005-10173-4; DAI JW, 1995, BIOPHYS J, V68, P988, DOI 10.1016/S0006-3495(95)80274-2; Daniels DR, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.238101; Davis DM, 2008, NAT REV MOL CELL BIO, V9, P431, DOI 10.1038/nrm2399; Derenyi I, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.238101; Deserno M, 2015, CHEM PHYS LIPIDS, V185, P11, DOI 10.1016/j.chemphyslip.2014.05.001; Dommersnes PG, 2005, EUROPHYS LETT, V70, P271, DOI 10.1209/epl/i2004-10477-9; Ferrati S, 2012, SMALL, V8, P3151, DOI 10.1002/smll.201200472; Gerdes HH, 2008, CURR OPIN CELL BIOL, V20, P470, DOI 10.1016/j.ceb.2008.03.005; Gerdes HH, 2007, FEBS LETT, V581, P2194, DOI 10.1016/j.febslet.2007.03.071; Happel J., 1983, LOW REYNOLDS NUMBER; HELFRICH W, 1978, Z NATURFORSCH A, V33, P305; Hochmuth RM, 1996, BIOPHYS J, V70, P358, DOI 10.1016/S0006-3495(96)79577-2; Hurtig J, 2010, WIRES NANOMED NANOBI, V2, P260, DOI 10.1002/wnan.80; JOHNSON SJ, 1991, BIOPHYS J, V59, P289, DOI 10.1016/S0006-3495(91)82222-6; Lamb H, 1997, HYDRODYNAMICS; Landau L. D., 1976, MECHANICS, V1; Li ZW, 2002, BIOPHYS J, V82, P1386, DOI 10.1016/S0006-3495(02)75493-3; Marzo L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00072; Mecke KR, 2003, LANGMUIR, V19, P2080, DOI 10.1021/la026606d; Muller MM, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.061407; Nelson D, 1989, STAT MECH MEMBRANES; Niwayama R, 2011, P NATL ACAD SCI USA, V108, P11900, DOI 10.1073/pnas.1101853108; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; PODGORNIK R, 1992, LANGMUIR, V8, P557, DOI 10.1021/la00038a041; Raucher D, 1999, BIOPHYS J, V77, P1992, DOI 10.1016/S0006-3495(99)77040-2; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Safran S. A., 1994, STAT THERMODYNAMICS; SEIFERT U, 1995, PHYS REV LETT, V74, P5060, DOI 10.1103/PhysRevLett.74.5060; Sigurdsson JK, 2013, J COMPUT PHYS, V252, P65, DOI 10.1016/j.jcp.2013.06.016; Sigurdsson JK, 2016, SOFT MATTER, V12, P6685, DOI 10.1039/c6sm00194g; Sun MZ, 2005, BIOPHYS J, V89, P4320, DOI 10.1529/biophysj.104.058180; Zhong-can, 1989, Phys Rev A Gen Phys, V39, P5280, DOI 10.1103/PhysRevA.39.5280	36	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210259	10.1371/journal.pone.0210259	http://dx.doi.org/10.1371/journal.pone.0210259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650122	Green Submitted, Green Published, gold			2022-12-26	WOS:000455813300048
J	Biswas, M; Chatterjee, SS; Boila, LD; Chakraborty, S; Banerjee, D; Sengupta, A				Biswas, Mayukh; Chatterjee, Shankha Subhra; Boila, Liberalis Debraj; Chakraborty, Sayan; Banerjee, Debasis; Sengupta, Amitava			MBD3/NuRD loss participates with KDM6A program to promote DOCK5/8 expression and Rac GTPase activation in human acute myeloid leukemia	FASEB JOURNAL			English	Article						chromatin remodeling; KDM6A; epistasis	HISTONE DEMETHYLASE UTX; CHROMATIN REMODELER MI-2-BETA; CANCER CELLS; NURD; DEACETYLATION; INHIBITION; COMPLEX; TARGETS; BINDING; PLURIPOTENCY	Cancer genome sequencing studies have focused on identifying oncogenic mutations. However, mutational profiling alone may not always help dissect underlying epigenetic dependencies in tumorigenesis. Nucleosome remodeling and deacetylase (NuRD) is an ATP-dependent chromatin remodeling complex that regulates transcriptional architecture and is involved in cell fate commitment. We demonstrate that loss of MBD3, an important NuRD scaffold, in human primary acute myeloid leukemia (AML) cells associates with leukemic NuRD. Interestingly, CHD4, an intact ATPase subunit of leukemic NuRD, coimmunoprecipitates and participates with H3K27Me3/2-demethylase KDM6A to induce expression of atypical guanine nucleotide exchange factors, dedicator of cytokinesis (DOCK) 5 and 8 (DOCK5/8), promoting Rac GTPase signaling. Mechanistically, MBD3 deficiency caused loss of histone deacytelase 1 occupancy with a corresponding increase in KDM6A, CBP, and H3K27Ac on DOCK5/8 loci, leading to derepression of gene expression. Importantly, the Cancer Genome Atlas AML cohort reveals that DOCK5/8 levels are correlated with MBD3 and KDM6A, and DOCK5/8 expression is significantly increased in patients who are MBD3 low and KDM6A high with a poor survival. In addition, pharmacological inhibition of DOCK signaling selectively attenuates AML cell survival. Because MBD3 and KDM6A have been implicated in metastasis, our results may suggest a general phenomenon in tumorigenesis. Collectively, these findings provide evidence for MBD3-deficient NuRD in leukemia pathobiology and inform a novel epistasis between NuRD and KDM6A toward maintenance of oncogenic gene expression in AML.	[Biswas, Mayukh; Chatterjee, Shankha Subhra; Boila, Liberalis Debraj; Chakraborty, Sayan; Sengupta, Amitava] IICB, CSIR, TRUE, Stem Cell & Leukemia Lab, Kolkata, W Bengal, India; [Biswas, Mayukh; Chatterjee, Shankha Subhra; Boila, Liberalis Debraj; Chakraborty, Sayan; Sengupta, Amitava] IICB, CSIR, Canc Biol & Inflammatory Disorder Div, Kolkata, W Bengal, India; [Banerjee, Debasis] Pk Clin, Gorky Terrace, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Sengupta, A (corresponding author), Indian Inst Chem Biol, Council Sci & Ind Res, CN-6,Sect 5, Kolkata 700091, India.	amitava.iicb@gmail.com		Biswas, Mayukh/0000-0003-1670-8161	Council of Scientific and Industrial Research (CSIR) [BSC 0120]; Department of Biotechnology (DBT) [BT/RLF/RE-ENTRY/06/2010]; Ramalingaswami Fellowship; DBT [BT/PR13023/MED/31/311/2015]; Department of Science and Technology (DST), Government of India [SB/SO/HS-053/2013]; University Grants Commission (UGC); CSIR	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Ramalingaswami Fellowship; DBT(Department of Biotechnology (DBT) India); Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); University Grants Commission (UGC)(University Grants Commission, India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	The authors thank Dr. Prasanta Mukhopadhyay for providing umbilical cord blood samples; Dr. Jose Silva (University of Cambridge, Cambridge, United Kingdom), Dr. Keisuke Kaji (The University of Edinburgh, Edinburgh, United Kingdom), and Dr. Jose Cancelas (Cincinnati Children's Hospital, OH, USA) for sharing plasmids; and Addgene (Watertown, MA, USA) for shipping DNA constructs. CB-AE and CB-MA9 acute myeloid leukemia cells were generous gifts from Dr. James Mulloy (Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA). MDS-L cells were obtained from Dr. Daniel Starczynowski (Cincinnati Children's Hospital Medical Center) with consent from Dr. Kaoru Tohyama (Kawasaki Medical School, Kurashiki, Japan). The authors thank Dr. Arindam Maitra and Dr. Subrata Patra [Core Technologies Research Initiative (CoTERI), National Institute of Biomedical Genomics (NIBMG), Kalyani, India] for chromatin immunoprecipitation sequencing (ChIP-seq) and next-generation sequencing experiments and Dr. Madavan Vasudevan and Shemi Ramesh (Bionivid Technology, Bangalore, India) for RNA sequencing (RNA-seq) experiments, ChIP-seq, and RNA-seq analysis; and Indian Institute of Chemical Biology (IICB) flow cytometry and mass spectrometry cores for services. This study is supported by funding from the Council of Scientific and Industrial Research (CSIR) (NWP/BioDiscovery, BSC 0120), Department of Biotechnology (DBT) (BT/RLF/RE-ENTRY/06/2010), Ramalingaswami Fellowship (to A.S.), DBT (BT/PR13023/MED/31/311/2015) (to A.S.), and Department of Science and Technology (DST) (SB/SO/HS-053/2013), Government of India (to A.S.). M.B., S.C., and S.S.C. acknowledge fellowships from the University Grants Commission (UGC) and CSIR, respectively. L.D.B. is CSIR-Shyama Prasad Mukherjee Fellow. The authors declare no conflicts of interest.	Aguilera C, 2011, NATURE, V469, P231, DOI 10.1038/nature09607; Appelbaum FR, 2006, BLOOD, V107, P3481, DOI 10.1182/blood-2005-09-3724; Benyoucef A, 2016, GENE DEV, V30, P508, DOI 10.1101/gad.276790.115; Boila L. D., 2017, EXP HEMATOL; Boila LD, 2018, EXP HEMATOL, V58, P44, DOI 10.1016/j.exphem.2017.10.002; Bradner JE, 2017, CELL, V168, P629, DOI 10.1016/j.cell.2016.12.013; Chatterjee SS, 2018, MOL CANCER RES, V16, P791, DOI 10.1158/1541-7786.MCR-17-0493; Dhar SS, 2016, NUCLEIC ACIDS RES, V44, P3659, DOI 10.1093/nar/gkv1516; dos Santos RL, 2014, CELL STEM CELL, V15, P102, DOI 10.1016/j.stem.2014.04.019; Ezponda T, 2017, CELL REP, V21, P628, DOI 10.1016/j.celrep.2017.09.078; Fang J, 2016, NAT MED, V22, P727, DOI 10.1038/nm.4127; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gozdecka M, 2018, NAT GENET, V50, P883, DOI 10.1038/s41588-018-0114-z; Greif PA, 2018, CLIN CANCER RES, V24, P1716, DOI 10.1158/1078-0432.CCR-17-2344; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hojfeldt JW, 2013, NAT REV DRUG DISCOV, V12, P917, DOI 10.1038/nrd4154; Hwei LS, 2016, BLOOD, V128; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Laurin M, 2013, P NATL ACAD SCI USA, V110, P7434, DOI 10.1073/pnas.1213050110; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Li Q, 2011, CANCER RES, V71, P6899, DOI 10.1158/0008-5472.CAN-11-1523; Li QT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6780; Li RZ, 2017, ONCOTARGET, V8, P6067, DOI 10.18632/oncotarget.13496; Loughran SJ, 2017, J EXP MED, V214, P3085, DOI 10.1084/jem.20161827; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; Mizukawa B, 2011, BLOOD, V118, P5235, DOI 10.1182/blood-2011-04-351817; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Nishikimi A, 2012, CHEM BIOL, V19, P488, DOI 10.1016/j.chembiol.2012.03.008; Ntziachristos P, 2014, NATURE, V514, P513, DOI 10.1038/nature13605; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Priam P, 2017, NAT GENET, V49, P753, DOI 10.1038/ng.3812; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Rath BH, 2018, MOL CANCER THER, V17, P1070, DOI 10.1158/1535-7163.MCT-17-1053; Raza A, 2012, NAT REV CANCER, V12, P849, DOI 10.1038/nrc3321; Reynolds N, 2013, DEVELOPMENT, V140, P505, DOI 10.1242/dev.083105; Reynolds N, 2012, EMBO J, V31, P593, DOI 10.1038/emboj.2011.431; Rhyasen GW, 2014, LEUKEMIA, V28, P1142, DOI 10.1038/leu.2013.372; Sengupta A, 2010, BLOOD, V116, P81, DOI 10.1182/blood-2009-10-247437; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Sinha S, 2018, EXP HEMATOL, V62, P39, DOI 10.1016/j.exphem.2018.03.005; Spensberger D, 2008, BIOCHEMISTRY-US, V47, P6418, DOI 10.1021/bi800267f; Sperlazza J, 2015, BLOOD, V126, P1462, DOI 10.1182/blood-2015-03-631606; Tajiri H, 2017, CELL REP, V19, P969, DOI 10.1016/j.celrep.2017.04.016; Thieme S, 2013, BLOOD, V121, P2462, DOI 10.1182/blood-2012-08-452003; Thomas EK, 2007, CANCER CELL, V12, P467, DOI 10.1016/j.ccr.2007.10.015; Tie F, 2012, MOL CELL BIOL, V32, P2323, DOI 10.1128/MCB.06392-11; Vishwakarma BA, 2016, LEUKEMIA, V30, P200, DOI 10.1038/leu.2015.200; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Watanabe M, 2014, J IMMUNOL, V193, P5660, DOI 10.4049/jimmunol.1400885; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Wei Y, 2013, LEUKEMIA, V27, P2177, DOI 10.1038/leu.2013.91; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Witzel M, 2017, NAT GENET, V49, P742, DOI 10.1038/ng.3833; Xu M, 2017, BRIT J CANCER, V116, P91, DOI 10.1038/bjc.2016.397; Yoshida T, 2008, GENE DEV, V22, P1174, DOI 10.1101/gad.1642808; Zha L, 2015, J BIOL CHEM, V290, P25151, DOI 10.1074/jbc.M115.662650; Zhang JW, 2012, NAT IMMUNOL, V13, P86, DOI 10.1038/ni.2150; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	60	20	21	2	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5268	5286		10.1096/fj.201801035R	http://dx.doi.org/10.1096/fj.201801035R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30668141	Bronze			2022-12-26	WOS:000462888500052
J	Zheng, YF; Ming, PP; Zhu, CL; Si, Y; Xu, SL; Chen, AD; Wang, J; Zhang, BH				Zheng, Yongfa; Ming, Pingpo; Zhu, Chengliang; Si, Yu; Xu, Shilei; Chen, Aidong; Wang, Jun; Zhang, Binghong			Hepatitis B virus X protein-induced SH2 domain-containing 5 (SH2D5) expression promotes hepatoma cell growth via an SH2D5-transketolase interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hepatitis B virus (HBV; Hep B); cancer biology; cell migration; interleukin 6 (IL-6); inflammation; HBV X protein; HBV-associated HCC; IL-6-STAT3 signaling; SH2D5; transketolase	NF-KAPPA-B; CANCER; STAT3; LIVER; TRANSCRIPTION; ACTIVATION; INDUCTION; CARCINOMA; IL-6; RNA	Hepatitis B virus X protein (HBx) critically contributes to the development of hepatocellular carcinoma (HCC). However, the mechanisms by which HBx promotes HCC remain unclear. In the present study, using a combination of gene expression profiling and immunohistochemistry, we found higher levels of SH2 domain-containing 5 (SH2D5) in liver tissue from HBV-associated HCC (HBV-HCC) patients than in adjacent nontumor tissues. Moreover, HBV infection elevated SH2D5 levels, and we observed that HBx plays an important role in SH2D5 induction. We also found that HBx triggers SH2D5 expression through the NF-kappa B and c-Jun kinase pathways. Employing SH2D5 overexpression or knockdown, we further demonstrate that SH2D5 promotes HCC cell proliferation both in vitro and in vivo. While investigating the mechanism of SH2D5-mediated stimulation of HCC cell proliferation, we noted that HBV induces SH2D5 binding to transketolase (TKT), a pentose phosphate pathway enzyme, thereby promoting an interaction between and signal transducer and activator of transcription 3 (STAT3). Furthermore, HBx stimulated STAT3 phosphorylation at Tyr-705 and promoted the activity and downstream signaling pathway of STAT3 via the SH2D5-TKT interaction. Taken together, our results suggest that SH2D5 is an HBV-induced protein capable of binding to TKT, leading to induction of HCC cell proliferation.	[Zheng, Yongfa; Ming, Pingpo] Wuhan Univ, Renmin Hosp, Dept Oncol, Wuhan 430060, Hubei, Peoples R China; [Zhu, Chengliang] Wuhan Univ, Renmin Hosp, Dept Clin Lab, Wuhan 430060, Hubei, Peoples R China; [Zhang, Binghong] Wuhan Univ, Renmin Hosp, Dept Neonatol, Hubei Zhang Rd,Wuchang Dist 99,Jiefang Rd 238, Wuhan 430060, Hubei, Peoples R China; [Si, Yu] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Otolaryngol Head & Neck Surg, Guangzhou 510120, Guangdong, Peoples R China; [Xu, Shilei] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Gen Surg, Guangzhou 510530, Guangdong, Peoples R China; [Chen, Aidong] Nanjing Med Univ, Dept Physiol, Nanjing 211166, Jiangsu, Peoples R China; [Wang, Jun] Jiangnan Univ, Peoples Hosp Wuxi 5, Ctr Clin Lab, Wuxi 214005, Jiangsu, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Sun Yat Sen University; Sun Yat Sen University; Nanjing Medical University; Jiangnan University	Zhang, BH (corresponding author), Wuhan Univ, Renmin Hosp, Dept Neonatol, Hubei Zhang Rd,Wuchang Dist 99,Jiefang Rd 238, Wuhan 430060, Hubei, Peoples R China.	binghongzhangrm@126.com			Quality Test and Operation with the Anesthesia Center of Experimental Animal of Hubei Province Research Grant [2060403]; National Natural Science Foundation of China [81703035, 81600794, 31571168]; National Key R&D Program of China [2016YFC1303800]	Quality Test and Operation with the Anesthesia Center of Experimental Animal of Hubei Province Research Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China	This work was supported by Quality Test and Operation with the Anesthesia Center of Experimental Animal of Hubei Province Research Grant 2060403, Key Program of National Natural Science Foundation of China Research Grant 81703035, the National Natural Science Foundation of China Research Grants 81600794 and 31571168, and National Key R&D Program of China Research Grant 2016YFC1303800. The authors declare that they have no conflicts of interest with the contents of this article.	Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Chen SZ, 2017, CANCER LETT, V394, P22, DOI 10.1016/j.canlet.2017.02.011; Chen XY, 2017, J BIOL CHEM, V292, P21291, DOI 10.1074/jbc.M117.805937; Diaz-Moralli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025323; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Gray EJ, 2014, J BIOL CHEM, V289, P35397, DOI 10.1074/jbc.M114.615112; Gui SL, 2015, FEBS LETT, V589, P4112, DOI 10.1016/j.febslet.2015.11.011; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Hsieh A, 2011, CANCER LETT, V300, P162, DOI 10.1016/j.canlet.2010.09.018; Jing MZ, 2016, VACCINE, V34, P516, DOI 10.1016/j.vaccine.2015.11.069; Ki SH, 2010, HEPATOLOGY, V52, P1291, DOI 10.1002/hep.23837; Kitamura H, 2017, CANCER SCI, V108, P1947, DOI 10.1111/cas.13332; Krockenberger M, 2010, ANTICANCER RES, V30, P1653; Li Y, 2012, NAT REV GASTRO HEPAT, V9, P32, DOI 10.1038/nrgastro.2011.196; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Liu BA, 2012, PHILOS T R SOC B, V367, P2556, DOI 10.1098/rstb.2012.0107; Liu D, 2016, HEPATOLOGY, V64, P390, DOI 10.1002/hep.28594; Liu S, 2015, J HEPATOL, V62, P1015, DOI 10.1016/j.jhep.2014.11.035; Liu S, 2012, HEPATOLOGY, V56, P57, DOI 10.1002/hep.25642; Liu Y, 2010, J BIOL CHEM, V285, P27429, DOI 10.1074/jbc.M110.142752; Neuveut C, 2010, J HEPATOL, V52, P594, DOI 10.1016/j.jhep.2009.10.033; Peng NF, 2016, J IMMUNOL, V196, P2753, DOI 10.4049/jimmunol.1501481; Sansone P, 2012, J CLIN ONCOL, V30, P1005, DOI 10.1200/JCO.2010.31.8907; Schenk G, 1998, INT J BIOCHEM CELL B, V30, P1297, DOI 10.1016/S1357-2725(98)00095-8; Schultz H, 2008, DIAGN PATHOL, V3, DOI 10.1186/1746-1596-3-35; STEIN B, 1995, MOL CELL BIOL, V15, P4971; Svinka J, 2014, HEPAT ONCOL, V1, P106, DOI [10.2217/HEP.13.7, 10.2217/hep.13.7]; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Xia LM, 2012, J HEPATOL, V57, P600, DOI 10.1016/j.jhep.2012.04.020; Xu IMJ, 2016, P NATL ACAD SCI USA, V113, pE725, DOI 10.1073/pnas.1508779113; Xu XJ, 2009, INT J CANCER, V124, P1330, DOI 10.1002/ijc.24078; Yang H, 2016, AM J CANCER RES, V6, P2690; Yang PY, 2012, CANCER CELL, V22, P291, DOI 10.1016/j.ccr.2012.07.023; Zhang JW, 2018, HEPATOLOGY, V67, P171, DOI 10.1002/hep.29405	37	12	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4815	4827		10.1074/jbc.RA118.005739	http://dx.doi.org/10.1074/jbc.RA118.005739			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30659097	Green Published, hybrid			2022-12-26	WOS:000463985600008
J	Nguyen, KT; Kim, JM; Park, SE; Hwang, CS				Kha The Nguyen; Kim, Jeong-Mok; Park, Sang-Eun; Hwang, Cheol-Sang			N-terminal methionine excision of proteins creates tertiary destabilizing N-degrons of the Arg/N-end rule pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin; ubiquitin ligase; protein degradation; proteasome; acetylation; N-end rule; N-terminal acetylation; N-terminal amidase; N-terminal arginylation; N-terminal methionine excision	IN-VIVO; CELLULAR-PROTEINS; UBIQUITIN LIGASES; DEGRADATION; ACETYLATION; TFG; SPECIFICITY; INTERACTS; ACETYLTRANSFERASES; COMPLEXES	All organisms begin protein synthesis with methionine (Met). The resulting initiator Met of nascent proteins is irreversibly processed by Met aminopeptidases (MetAPs). N-terminal (Nt) Met excision (NME) is an evolutionarily conserved and essential process operating on up to two-thirds of proteins. However, the universal function of NME remains largely unknown. MetAPs have a well-known processing preference for Nt-Met with Ala, Ser, Gly, Thr, Cys, Pro, or Val at position 2, but using CHX-chase assays to assess protein degradation in yeast cells, as well as protein-binding and RT-qPCR assays, we demonstrate here that NME also occurs on nascent proteins bearing Met-Asn or Met-Gln at their N termini. We found that the NME at these termini exposes the tertiary destabilizing Nt residues (Asn or Gln) of the Arg/N-end rule pathway, which degrades proteins according to the composition of their Nt residues. We also identified a yeast DNA repair protein, MQ-Rad16, bearing a Met-Gln N terminus, as well as a human tropomyosin-receptor kinase-fused gene (TFG) protein, MN-TFG, bearing a Met-Asn N terminus as physiological, MetAP-processed Arg/N-end rule substrates. Furthermore, we show that the loss of the components of the Arg/N-end rule pathway substantially suppresses the growth defects of naa20 yeast cells lacking the catalytic subunit of NatB Nt acetylase at 37 degrees C. Collectively, the results of our study reveal that NME is a key upstream step for the creation of the Arg/N-end rule substrates bearing tertiary destabilizing residues in vivo.	[Kha The Nguyen; Kim, Jeong-Mok; Park, Sang-Eun; Hwang, Cheol-Sang] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 37673, Gyeongbuk, South Korea	Pohang University of Science & Technology (POSTECH)	Hwang, CS (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang 37673, Gyeongbuk, South Korea.	cshwang@postech.ac.kr	Hwang, Cheol-Sang/Q-7391-2019	Hwang, Cheol-Sang/0000-0002-0105-5957; Kim, Jeong-Mok/0000-0002-7223-248X	Samsung Science and Technology Foundation [SSTF-BA1401-17]; National Research Foundation of Korea (NRF) - Korean Government (MSIP) [NRF-2017R1A5A1015366]; BK21 Plus Program; POSCO Green Science and Innovation Grant	Samsung Science and Technology Foundation(Samsung); National Research Foundation of Korea (NRF) - Korean Government (MSIP); BK21 Plus Program; POSCO Green Science and Innovation Grant	This work was supported by the Samsung Science and Technology Foundation Grant SSTF-BA1401-17, National Research Foundation of Korea (NRF) Grant NRF-2017R1A5A1015366 funded by the Korean Government (MSIP), the BK21 Plus Program, and the POSCO Green Science and Innovation Grant. The authors declare that they have no conflicts of interest with the contents of this article.	ARFIN SM, 1988, BIOCHEMISTRY-US, V27, P7979, DOI 10.1021/bi00421a001; Avci D, 2014, MOL CELL, V56, P630, DOI 10.1016/j.molcel.2014.10.012; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bonissone S, 2013, MOL CELL PROTEOMICS, V12, P14, DOI 10.1074/mcp.M112.019075; Cha-Molstad H, 2015, NAT CELL BIOL, V17, P917, DOI 10.1038/ncb3177; Chen SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aal3655; Chen SP, 2002, ARCH BIOCHEM BIOPHYS, V398, P87, DOI 10.1006/abbi.2001.2675; Dissmeyer N, 2018, NEW PHYTOL, V218, P929, DOI 10.1111/nph.14619; Dong C, 2018, NAT CHEM BIOL, V14, P466, DOI 10.1038/s41589-018-0036-1; Dougan DA, 2012, BBA-MOL CELL RES, V1823, P83, DOI 10.1016/j.bbamcr.2011.07.002; Eldeeb M, 2016, PROTEIN PEPTIDE LETT, V23, P343, DOI 10.2174/0929866523666160108115809; Frottin F, 2016, ONCOTARGET, V7, P63306, DOI 10.18632/oncotarget.11216; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Gibbs DJ, 2014, TRENDS CELL BIOL, V24, P603, DOI 10.1016/j.tcb.2014.05.001; Gibbs DJ, 2011, NATURE, V479, P415, DOI 10.1038/nature10534; Gietz RD, 2014, METHODS MOL BIOL, V1163, P33, DOI 10.1007/978-1-4939-0799-1_4; Giglione C, 2003, EMBO J, V22, P13, DOI 10.1093/emboj/cdg007; Giglione C, 2015, BIOCHIMIE, V114, P134, DOI 10.1016/j.biochi.2014.11.008; Goder V, 2008, FEBS LETT, V582, P1575, DOI 10.1016/j.febslet.2008.03.056; Hanna MG, 2017, P NATL ACAD SCI USA, V114, pE7707, DOI 10.1073/pnas.1709120114; Hernandez L, 1999, BLOOD, V94, P3265; Hisaoka M, 2004, GENE CHROMOSOME CANC, V40, P325, DOI 10.1002/gcc.20044; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hwang CS, 2010, NAT CELL BIOL, V12, P1177, DOI 10.1038/ncb2121; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Kats I, 2018, MOL CELL, V70, P488, DOI 10.1016/j.molcel.2018.03.033; Nguyen KT, 2019, J BIOL CHEM, V294, P379, DOI 10.1074/jbc.RA118.005556; Nguyen KT, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0097-y; Kim HK, 2014, CELL, V156, P158, DOI 10.1016/j.cell.2013.11.031; Kim I, 2013, MOL CELL PROTEOMICS, V12, P3370, DOI 10.1074/mcp.O113.031708; Kim JM, 2018, SCIENCE, V362, P1019, DOI 10.1126/science.aat0174; Kim JM, 2014, CELL CYCLE, V13, P1366, DOI 10.4161/cc.28751; Lee JH, 2015, TRENDS PHARMACOL SCI, V36, P782, DOI 10.1016/j.tips.2015.07.004; Lee KE, 2016, MOL CELLS, V39, P169, DOI 10.14348/molcells.2016.2329; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Licausi F, 2011, NATURE, V479, P419, DOI 10.1038/nature10536; Lim B, 2012, CARCINOGENESIS, V33, P1450, DOI 10.1093/carcin/bgs164; Meinnel T, 2008, PROTEOMICS, V8, P626, DOI 10.1002/pmic.200700592; Miranda C, 2006, J CELL PHYSIOL, V208, P154, DOI 10.1002/jcp.20644; Neal S, 2018, MOL CELL, V69, P915, DOI 10.1016/j.molcel.2018.02.014; Park SE, 2015, SCIENCE, V347, P1249, DOI 10.1126/science.aaa3844; Piatkov KI, 2015, MICROB CELL, V2, P376, DOI 10.15698/mic2015.10.231; Polevoda B, 2003, J BIOL CHEM, V278, P30686, DOI 10.1074/jbc.M304690200; Qian SB, 2006, J BIOL CHEM, V281, P392, DOI 10.1074/jbc.M509126200; Ree R, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0116-z; SADIS S, 1995, MOL CELL BIOL, V15, P4086; Sato BK, 2006, YEAST, V23, P1053, DOI 10.1002/yea.1407; SCHILD D, 1992, YEAST, V8, P385, DOI 10.1002/yea.320080506; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Stolz A, 2010, TRAFFIC, V11, P1363, DOI 10.1111/j.1600-0854.2010.01093.x; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Van Damme P, 2015, PROTEOMICS, V15, P2436, DOI 10.1002/pmic.201400575; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Wadas B, 2016, J BIOL CHEM, V291, P17178, DOI 10.1074/jbc.M116.734640; Walker KW, 1999, J BIOL CHEM, V274, P13403, DOI 10.1074/jbc.274.19.13403; Xu F, 2015, PLANT CELL, V27, P1547, DOI 10.1105/tpc.15.00173; Zattas D, 2013, MOL BIOL CELL, V24, P890, DOI 10.1091/mbc.E12-11-0838	61	19	19	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4464	4476		10.1074/jbc.RA118.006913	http://dx.doi.org/10.1074/jbc.RA118.006913			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30674553	hybrid, Green Published			2022-12-26	WOS:000462969500015
J	Kubota-Kawai, H; Burton-Smith, RN; Tokutsu, R; Song, CH; Akimoto, S; Yokono, M; Ueno, Y; Kim, E; Watanabe, A; Murata, K; Minagawa, J				Kubota-Kawai, Hisako; Burton-Smith, Raymond N.; Tokutsu, Ryutaro; Song, Chihong; Akimoto, Seiji; Yokono, Makio; Ueno, Yoshifumi; Kim, Eunchul; Watanabe, Akimasa; Murata, Kazuyoshi; Minagawa, Jun			Ten antenna proteins are associated with the core in the supramolecular organization of the photosystem I supercomplex in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						photosynthesis; Chlamydomonas; light-harvesting complex (antenna complex); cryo-electron microscopy; single-particle analysis; green algae; LHCI; photosystem I; Chlamydomonas reinhardtii; cryo-electron microscopy (cryo-EM); photosynthesis; outer antenna; photosynthetic efficiency	LIGHT-HARVESTING-COMPLEX; PSI-LHCI; PROTEOMICS; EVOLUTION; INSIGHTS; SITE	Photosystem I (PSI) is a large pigment-protein complex mediating light-driven charge separation and generating a highly negative redox potential, which is eventually utilized to produce organic matter. In plants and algae, PSI possesses outer antennae, termed light-harvesting complex I (LHCI), which increase the energy flux to the reaction center. The number of outer antennae for PSI in the green alga Chlamydomonas reinhardtii is known to be larger than that of land plants. However, their exact number and location remain to be elucidated. Here, applying a newly established sample purification procedure, we isolated a highly pure PSI-LHCI supercomplex containing all nine LHCA gene products under state 1 conditions. Single-particle cryo-EM revealed the 3D structure of this supercomplex at 6.9 resolution, in which the densities near the PsaF and PsaJ subunits were assigned to two layers of LHCI belts containing eight LHCIs, whereas the densities between the PsaG and PsaH subunits on the opposite side of the LHCI belt were assigned to two extra LHCIs. Using single-particle cryo-EM, we also determined the 2D projection map of the lhca2 mutant, which confirmed the assignment of LHCA2 and LHCA9 to the densities between PsaG and PsaH. Spectroscopic measurements of the PSI-LHCI supercomplex suggested that the bound LHCA2 and LHCA9 proteins have the ability to increase the light-harvesting energy for PSI. We conclude that the PSI in C. reinhardtii has a larger and more distinct outer-antenna organization and higher light-harvesting capability than that in land plants.	[Kubota-Kawai, Hisako; Burton-Smith, Raymond N.; Tokutsu, Ryutaro; Kim, Eunchul; Watanabe, Akimasa; Minagawa, Jun] Natl Inst Basic Biol, Div Environm Photobiol, Okazaki, Aichi 4448585, Japan; [Kubota-Kawai, Hisako; Burton-Smith, Raymond N.; Tokutsu, Ryutaro; Watanabe, Akimasa; Minagawa, Jun] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Saitama 3320012, Japan; [Tokutsu, Ryutaro; Watanabe, Akimasa; Minagawa, Jun] Grad Univ Adv Studies SOKENDAI, Dept Basic Biol, Sch Life Sci, Okazaki, Aichi 4448585, Japan; [Murata, Kazuyoshi] Grad Univ Adv Studies SOKENDAI, Dept Physiol Sci, Sch Life Sci, Okazaki, Aichi 4448585, Japan; [Song, Chihong; Murata, Kazuyoshi] Natl Inst Physiol Sci, Okazaki, Aichi 4448585, Japan; [Akimoto, Seiji; Ueno, Yoshifumi] Kobe Univ, Grad Sch Sci, Kobe, Hyogo 6578501, Japan; [Yokono, Makio] Nippon Flour Mills Co Ltd, Innovat Ctr, Atsugi, Kanagawa 2430041, Japan; [Kubota-Kawai, Hisako] Yamagata Univ, Fac Sci, Yamagata 9908560, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Japan Science & Technology Agency (JST); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Kobe University; Yamagata University	Minagawa, J (corresponding author), Natl Inst Basic Biol, Div Environm Photobiol, Okazaki, Aichi 4448585, Japan.	minagawa@nibb.ac.jp	Tokutsu, Ryutaro/V-7596-2019; Tokutsu, Ryutaro/GRF-0208-2022; Kim, Eunchul/E-9565-2013; Yokono, Makio/N-8425-2015	Tokutsu, Ryutaro/0000-0003-2037-255X; Kim, Eunchul/0000-0003-3380-3953; Watanabe, Akimasa/0000-0001-6068-1328; Kubota-Kawai, Hisako/0000-0001-7804-102X; Yokono, Makio/0000-0002-4813-2120; Murata, Kazuyoshi/0000-0001-9446-3652; Minagawa, Jun/0000-0002-3028-3203	Japan Society for the Promotion of Science (JSPS) KAKENHI [16H06553, 17J40032, 16H06280]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant-in-Aid 16H06553 (to R. T., S. A., and J. M.) and 17J40032 (to H. K.-K.) and by Advanced Bioimaging Support (ABiS) from Grant-in-Aid for Scientific Research on Innovative Areas 16H06280 (to K. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Akimoto S, 2012, BBA-BIOENERGETICS, V1817, P1483, DOI 10.1016/j.bbabio.2012.01.006; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baker DR, 2014, J PHYS CHEM B, V118, P2703, DOI 10.1021/jp407948p; BASSI R, 1992, J BIOL CHEM, V267, P25714; Bazzacco P, 2012, BIOCHEMISTRY-US, V51, P1416, DOI 10.1021/bi201862v; Drop B, 2014, PLANT J, V78, P181, DOI 10.1111/tpj.12459; Drop B, 2011, J BIOL CHEM, V286, P44878, DOI 10.1074/jbc.M111.301101; Germano M, 2002, FEBS LETT, V525, P121, DOI 10.1016/S0014-5793(02)03100-9; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Hippler M, 2001, PLANT J, V28, P595, DOI 10.1046/j.1365-313X.2001.01175.x; Iwai M, 2010, NATURE, V464, P1210, DOI 10.1038/nature08885; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Kargul J, 2005, FEBS J, V272, P4797, DOI 10.1111/j.1742-4658.2005.04894.x; Kargul J, 2003, J BIOL CHEM, V278, P16135, DOI 10.1074/jbc.M300262200; Koziol AG, 2007, PLANT PHYSIOL, V143, P1802, DOI 10.1104/pp.092536; Kubota-Kawai H, 2018, NAT PLANTS, V4, P218, DOI 10.1038/s41477-018-0130-0; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/NMETH.2727, 10.1038/nmeth.2727]; Le Quiniou C, 2015, BBA-BIOENERGETICS, V1847, P458, DOI 10.1016/j.bbabio.2015.02.001; Marco P, 2018, BBA-BIOENERGETICS, V1859, P234, DOI 10.1016/j.bbabio.2018.01.001; Mazor Y, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.14; Mazor Y, 2015, ELIFE, V4, DOI 10.7554/eLife.07433; Mozzo M, 2010, BBA-BIOENERGETICS, V1797, P212, DOI 10.1016/j.bbabio.2009.10.005; Mutoh R, 2015, BIOCHEMISTRY-US, V54, P6052, DOI 10.1021/acs.biochem.5b00601; Nelson N, 2005, BIOESSAYS, V27, P914, DOI 10.1002/bies.20278; O'Connor D. V., 1984, TIME CORRELATED SING; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Ozawa SI, 2018, PLANT PHYSIOL, V178, P583, DOI 10.1104/pp.18.00749; Pi X, 2018, P NATL ACAD SCI USA, V115, P4423, DOI 10.1073/pnas.1722482115; Qin XC, 2015, SCIENCE, V348, P989, DOI 10.1126/science.aab0214; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Scheller HV, 2001, BBA-BIOENERGETICS, V1507, P41, DOI 10.1016/S0005-2728(01)00196-7; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sharma KS, 2012, LANGMUIR, V28, P4625, DOI 10.1021/la205026r; Stauber EJ, 2009, PROTEOMICS, V9, P398, DOI 10.1002/pmic.200700620; Stauber EJ, 2003, EUKARYOT CELL, V2, P978, DOI 10.1128/EC.2.5.978-994.2003; Steinbeck J, 2018, P NATL ACAD SCI USA, V115, P10517, DOI 10.1073/pnas.1809973115; Subramanyam R, 2006, FEBS LETT, V580, P233, DOI 10.1016/j.febslet.2005.12.003; SUEOKA N, 1960, P NATL ACAD SCI USA, V46, P83, DOI 10.1073/pnas.46.1.83; Takahashi Y, 2004, BIOCHEMISTRY-US, V43, P7816, DOI 10.1021/bi035988z; Tokutsu R, 2004, PLANT CELL PHYSIOL, V45, P138, DOI 10.1093/pcp/pch013; Tokutsu R, 2012, J BIOL CHEM, V287, P31574, DOI 10.1074/jbc.M111.331991; Watanabe M, 2011, PLANT CELL PHYSIOL, V52, P162, DOI 10.1093/pcp/pcq183	45	20	21	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4304	4314		10.1074/jbc.RA118.006536	http://dx.doi.org/10.1074/jbc.RA118.006536			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30670590	Green Published, hybrid			2022-12-26	WOS:000462969500003
J	Li, NY; Fu, QL; Guo, B; Liu, C; Li, H; Ding, YZ				Li, Ningyu; Fu, Qinglin; Guo, Bin; Liu, Chen; Li, Hua; Ding, Yongzhen			Adsorption of Pb2+ by ameliorated alum plasma in water and soil	PLOS ONE			English	Article							HEAVY-METAL IMMOBILIZATION; CONTAMINATED SOILS; RED MUD; CADMIUM; STABILIZATION; REMEDIATION; POLLUTANTS; AMENDMENTS; ISOTHERMS; REMOVAL	Four methods, including hot acid treatment, hot alkali treatment, calcination treatment and sulfhydrylation treatment, were applied to activate alum plasma in order to obtain new Pb2+ adsorbents. The corresponding adsorption isotherm satisfies the Langmuir equation, and the maximum adsorption of the alum plasma after hot acid treatment, hot alkali treatment and high-temperature calcination were 18.9, 57.3 and 10.9 mg.g(-1), respectively, and in the range of 1.23-6.57 times greater than the adsorption capacity of the original alum plasma. The soil culture experiments indicated that the effective Pb content in the soils treated with hot alkali ameliorated alum plasma was significantly lower (p < 0.05) than those treated with the other three types of alum plasma. For example, if the additive content is 5.0%, after a storage period of 16 weeks, the effective Pb content becomes 19.87 mg.kg(-1), which corresponds to a reduction of 60.9% in comparison with the control sample. In addition, Specific surface area (BET), Scanning electron microscopy (SEM) and Fourier transform infrared spectroscopy (FIR) were used to characterize the microstructure of alum plasma before and after amelioration. It was evident that hot alkali treatment of alum plasma resulted in smaller particles, a significantly higher specific area and lower mineral crystallinity, which improved the adsorption performance of Pb2+. In conclusion, hot alkali treatment of alum plasma indicates relatively good Pb2+ adsorption ability, and is a promising novel adsorbents that could ameliorate soils that have been polluted by heavy metal Pb.	[Li, Ningyu; Fu, Qinglin; Guo, Bin; Liu, Chen; Li, Hua] Zhejiang Acad Agr Sci, Inst Environm Resource Soil & Fertilizer, Hangzhou, Zhejiang, Peoples R China; [Ding, Yongzhen] Minist Agr, Agroenvironm Protect Inst, Tianjin, Peoples R China	Zhejiang Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Agro-Environmental Protection Institute, CAAS; Ministry of Agriculture & Rural Affairs	Ding, YZ (corresponding author), Minist Agr, Agroenvironm Protect Inst, Tianjin, Peoples R China.	dingyongzhen@caas.cn	Fu, Qinglin/R-2887-2019	li, ningyu/0000-0003-1561-1683	National Natural Science Foundation of China [41501340]; Zhejiang Provincial Natural Science Foundation of China [LQ16D010007]; National Science and Technology Support Program of China [2015BAL01B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Science and Technology Support Program of China	The study is jointly supported by the grants from National Natural Science Foundation of China (No. 41501340 to NL), and the Zhejiang Provincial Natural Science Foundation of China (No. LQ16D010007). It is also financed by the National Science and Technology Support Program of China (2015BAL01B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaroai YA, 2014, ENVIRON EARTH SCI, V71, P1289, DOI 10.1007/s12665-013-2533-6; Bailey SE, 1999, WATER RES, V33, P2469, DOI 10.1016/S0043-1354(98)00475-8; Beesley L, 2011, ENVIRON POLLUT, V159, P3269, DOI 10.1016/j.envpol.2011.07.023; Bhatnagar A, 2011, ENVIRON TECHNOL, V32, P231, DOI 10.1080/09593330.2011.560615; Bolan N, 2014, J HAZARD MATER, V266, P141, DOI 10.1016/j.jhazmat.2013.12.018; Bradl HB, 2004, J COLLOID INTERF SCI, V277, P1, DOI 10.1016/j.jcis.2004.04.005; BUCHTER B, 1989, SOIL SCI, V148, P370, DOI 10.1097/00010694-198911000-00008; Cao XD, 2009, J HAZARD MATER, V164, P555, DOI 10.1016/j.jhazmat.2008.08.034; Castaldi P, 2005, CHEMOSPHERE, V60, P365, DOI 10.1016/j.chemosphere.2004.11.098; Chrysochoou M, 2006, J HAZARD MATER, V136, P20, DOI 10.1016/j.jhazmat.2005.11.008; Daorattanachai P, 2015, CHEM ENG J, V278, P92, DOI 10.1016/j.cej.2014.12.029; ELPRINCE AM, 1981, SOIL SCI SOC AM J, V45, P277, DOI 10.2136/sssaj1981.03615995004500020010x; Gray CW, 2006, ENVIRON POLLUT, V142, P530, DOI 10.1016/j.envpol.2005.10.017; Kumpiene J, 2008, WASTE MANAGE, V28, P215, DOI 10.1016/j.wasman.2006.12.012; [李凝玉 Li Ningyu], 2014, [农业环境科学学报, Journal of Agro-Environment Science], V33, P1526; Lin CF, 1998, J HAZARD MATER, V60, P217, DOI 10.1016/S0304-3894(98)00092-2; Liu YJ, 2011, GEODERMA, V163, P1, DOI 10.1016/j.geoderma.2011.04.002; Mitch ML, 2002, J ENVIRON QUAL, V31, P109; Nagodavithane CL, 2014, SOIL RES, V52, P155, DOI 10.1071/SR13187; Ogura M, 2001, APPL CATAL A-GEN, V219, P33, DOI 10.1016/S0926-860X(01)00645-7; Pang YX, 2003, J EUR CERAM SOC, V23, P1697, DOI 10.1016/S0955-2219(02)00413-2; Papageorgiou SK, 2009, J HAZARD MATER, V162, P1347, DOI 10.1016/j.jhazmat.2008.06.022; Pentrak M, 2009, CLAY MINER, V44, P511, DOI 10.1180/claymin.2009.044.4.511; SCHULTHESS CP, 1990, SOIL SCI SOC AM J, V54, P679, DOI 10.2136/sssaj1990.03615995005400030008x; Tica D, 2011, CHEMOSPHERE, V85, P577, DOI 10.1016/j.chemosphere.2011.06.085; Usman A, 2005, J SOIL SEDIMENT, V5, P245, DOI 10.1065/jss2005.05.141; Valipour M, 2016, CLEAN-SOIL AIR WATER, V44, P572, DOI 10.1002/clen.201300827; Verwilghen C, 2004, ENVIRON CHEM LETT, V2, P15, DOI 10.1007/s10311-003-0050-7; Wang P, 2015, J HAZARD MATER, V286, P533, DOI 10.1016/j.jhazmat.2014.12.034; Wen J, 2016, J ENVIRON MANAGE, V178, P63, DOI 10.1016/j.jenvman.2016.04.046	30	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210614	10.1371/journal.pone.0210614	http://dx.doi.org/10.1371/journal.pone.0210614			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682059	Green Published, gold, Green Submitted			2022-12-26	WOS:000457037500050
J	Carrasco, JM; Gomez-Baceiredo, B; Navas, A; Krawczyk, M; Garcia, M; Centeno, C				Miguel Carrasco, Jose; Gomez-Baceiredo, Beatriz; Navas, Alejandro; Krawczyk, Marian; Garcia, Miriam; Centeno, Carlos			Social representation of palliative care in the Spanish printed media: A qualitative analysis	PLOS ONE			English	Article							COVERAGE; BARRIERS	Background Lack of social awareness is a major barrier to the development of palliative care. Mass media influences public opinion, and frequently deal with palliative care contributing to its image and public understanding. Aim To analyse how palliative care is portrayed in Spanish newspapers, as well as the contribution made by the press to its social representation. Design Based on criteria of scope and editorial plurality, four print newspapers were selected. Using the newspaper archive MyNews (www.mynews.es), articles published between 2009 and 2014 containing the words "palliative care" or "palliative medicine" were identified. Sociological discourse analysis was performed on the identified texts on two levels: a) contextual analysis, focusing on the message as a statement; b) interpretative analysis, considering the discourse as a social product. Results We examined 262 articles. Politician and healthcare professionals were the main representatives transmitting messages on palliative care. The discourses identified were characterised by: strong ideological and moral content focusing on social debate, strong ties linking palliative care and death and, to a lesser degree, as a healthcare service. The messages transmitted by representatives with direct experience in palliative care (professionals, patients and families) contributed the most to building a positive image of this healthcare practice. Overall, media reflect different interests in framing public understanding about palliative care. Conclusion The knowledge generated about how palliative care is reflected in the printed media may help to understand better one of the main barriers to its development not only in Spain, but also in other contexts.	[Miguel Carrasco, Jose; Centeno, Carlos] Univ Navarra, Inst Culture & Soc, ATLANTES Res Program, Pamplona, Spain; [Gomez-Baceiredo, Beatriz] Univ Navarra, Sch Commun, Journalism Projects Dept, Pamplona, Spain; [Navas, Alejandro] Univ Navarra, Sch Commun, Publ Commun Dept, Pamplona, Spain; [Krawczyk, Marian] Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada; [Krawczyk, Marian] Trinity Western Univ, Langley, BC, Canada; [Garcia, Miriam] Errea Comunicac, Pamplona, Spain; [Centeno, Carlos] Univ Navarra, Univ Navarra Clin, Pamplona, Spain; [Centeno, Carlos] Navarra Inst Hlth Res IdiSNA, Pamplona, Spain	University of Navarra; University of Navarra; University of Navarra; Trinity Western University; University of Navarra	Carrasco, JM (corresponding author), Univ Navarra, Inst Culture & Soc, ATLANTES Res Program, Pamplona, Spain.	jmcarrascog@unav.es	Gomez, Beatriz/AAF-1391-2021; Centeno, Carlos/H-3430-2013; Krawczyk, Marian/AAC-1956-2019; Carrasco, Jose Miguel/I-3482-2015	Gomez, Beatriz/0000-0001-5332-0698; Centeno, Carlos/0000-0003-3395-7039; Carrasco, Jose Miguel/0000-0002-3847-8312	Institute for Culture and Society (ICS) of the University Navarra	Institute for Culture and Society (ICS) of the University Navarra	Support for this work was received from the Institute for Culture and Society (ICS) of the University Navarra. The funder provided support in the form of salaries for authors [JMC, CC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of the authors [MG] is employed by a commercial company [Errea Comunicacion], but the company did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aguiar F, 2013, ADV APPL SOCIOLOGY, V3, P124; Akintola O, 2015, HEALTH RES POLICY SY, V13, DOI 10.1186/s12961-015-0051-6; Asociacion para la investigacion de medios de comunicacion, 2011, PRENS DIG VS PAP; Asociacion para la Investigacion de Medios de Comunicacion, 2014, EST GEN MED; Berger P., 1967, SOCIAL CONSTRUCTION; Brown P, 2001, SOCIOL HEALTH ILL, V23, P747, DOI 10.1111/1467-9566.00274; Centeno C, 2016, PALLIATIVE MED, V30, P351, DOI 10.1177/0269216315598671; Conde F, 2009, CUADERNOS METODOLOGI, P43; Daw JR, 2013, HEALTH POLICY, V110, P67, DOI 10.1016/j.healthpol.2013.01.006; De Leon E, 2014, J MED INTERNET RES, V16, P119, DOI 10.2196/jmir.2837; Doblado R, 2006, DIRECTORIO RECURSOS; Duran M.A., 2004, REV ESP INVESTIG SOC, V106, P9; Gysels M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034188; Habermas J., 1981, HIST CRITICA OPINION; Husemann S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1742-1; Khaw KT, 1999, BRIT MED J, V319, P1350, DOI 10.1136/bmj.319.7221.1350; Lupton D., 1999, HEALTH, V3, P259, DOI [10.177/136345939900300301, DOI 10.1177/136345939900300301]; Lynch T, 2010, PALLIATIVE MED, V24, P812, DOI 10.1177/0269216310368578; Lynch T, 2009, J PAIN SYMPTOM MANAG, V37, P305, DOI 10.1016/j.jpainsymman.2008.03.011; Lyons A C, 2000, J Health Psychol, V5, P349, DOI 10.1177/135910530000500307; McIlfatrick S, 2014, PALLIATIVE MED, V28, P273, DOI 10.1177/0269216313502372; McIlfatrick S, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-34; Carrasco JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184806; Muszbek K, 2007, J PAIN SYMPTOM MANAG, V33, P605, DOI 10.1016/j.jpainsymman.2007.02.027; Naugle DA, 2014, J HEALTH COMMUN, V19, P190, DOI 10.1080/10810730.2014.918217; Oliver D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4846; Peel E, 2014, SOCIOL HEALTH ILL, V36, P885, DOI 10.1111/1467-9566.12122; Ruiz J. R., 2009, FORUM QUALITATIVE SO, V10, P2; Strydom P, 2000, SOCIOLOGICAL DISCOUR; Taiwo R., 2007, PERSPECTIVES MEDIA D; Taylor Steven, 2016, INTRO QUALITATIVE RE, V4th; Van den Berg R, 2011, EUR J GEN PRACT, V17, P14, DOI 10.3109/13814788.2010.549224; van Dijk T.A., 1988, NEWS DISCOURSE; World Health Organization, 2013, EUR HLTH REP 2012 CH; World Health Organization, 2014, DEF PALL CAR, DOI [10.1186/1472-684X-13-34, DOI 10.1186/1472-684X-13-34]; World Palliative Care Alliance World Health Organization, 2014, GLOBAL ATLAS PALLIAT; Wurz A, 2013, J HEALTH COMMUN, V18, P1566, DOI 10.1080/10810730.2013.840698; 2013, WORLD MAL REP 2013, P1	39	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211106	10.1371/journal.pone.0211106	http://dx.doi.org/10.1371/journal.pone.0211106			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682109	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000457037500101
J	Govender, A; Groeneveld, J; Singh, S; Willows-Munro, S				Govender, Ashrenee; Groeneveld, Johan; Singh, Sohana; Willows-Munro, Sandi			The design and testing of mini-barcode markers in marine lobsters	PLOS ONE			English	Article							OXIDASE SUBUNIT-I; PHYLOGENETIC-RELATIONSHIPS; DECAPODA ACHELATA; DNA; IDENTIFICATION; MITOCHONDRIAL; SPINY; PHYLLOSOMA; GLYPHEIDEA; ASTACIDEA	Full-length mitochondrial cytochrome c oxidase I (COI) sequence information from lobster phyllosoma larvae can be difficult to obtain when DNA is degraded or fragmented. Primers that amplify smaller fragments are also more useful in metabarcoding studies. In this study, we developed and tested a method to design a taxon-specific mini-barcode primer set for marine lobsters. The shortest, most informative portion of the COI gene region was identified in silico, and a DNA barcode gap analysis was performed to assess its reliability as species diagnostic marker. Primers were designed, and cross-species amplification success was tested on DNA extracted from a taxonomic range of spiny-, clawed-, slipper-and blind lobsters. The mini-barcode primers successfully amplified both adult and phyllosoma COI fragments, and were able to successfully delimit all species analyzed. Previously published universal primer sets were also tested and sometimes failed to amplify COI from phyllosoma samples. The newly designed taxon-specific mini-barcode primers will increase the success rate of species identification in bulk environmental samples and add to the growing DNA metabarcoding toolkit.	[Govender, Ashrenee; Groeneveld, Johan; Willows-Munro, Sandi] Univ KwaZulu Natal, Sch Life Sci, Pietermaritzburg, South Africa; [Govender, Ashrenee; Groeneveld, Johan; Singh, Sohana] Oceanog Res Inst, Durban, KwaZulu Natal, South Africa	University of Kwazulu Natal	Willows-Munro, S (corresponding author), Univ KwaZulu Natal, Sch Life Sci, Pietermaritzburg, South Africa.	willows-munro@ukzn.ac.za		Govender, Ashrenee/0000-0002-2860-4610; Willows-Munro, Sandi/0000-0003-0572-369X; Singh, Sohana/0000-0003-3484-7800				Arif IA, 2011, GENET MOL RES, V10, P3559, DOI 10.4238/2011.October.31.3; Baird DJ, 2011, J N AM BENTHOL SOC, V30, P125, DOI 10.1899/10-013.1; BAR W, 1988, FORENSIC SCI INT, V39, P59, DOI 10.1016/0379-0738(88)90118-1; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Berry PF, 1974, PALINURID SCYLLARID; BOOTH JD, 1994, CRUSTACEANA, V66, P271, DOI 10.1163/156854094X00035; Boyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038215; Bracken-Grissom HD, 2014, SYST BIOL, V63, P457, DOI 10.1093/sysbio/syu008; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Bucklin A, 2016, J PLANKTON RES, V38, P393, DOI 10.1093/plankt/fbw023; Chan TY, 2010, RAFFLES B ZOOL, P153; Chow S, 2006, MAR BIOTECHNOL, V8, P260, DOI 10.1007/s10126-005-5151-9; Dabboor M, 2014, INT J REMOTE SENS, V35, P6859, DOI 10.1080/01431161.2014.960614; Dong WP, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0138-z; Dubey B, 2011, FORENSIC SCI INT-GEN, V5, P181, DOI 10.1016/j.fsigen.2010.03.001; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Genis-Armero R, 2017, ZOOTAXA, V4306, P325, DOI 10.11646/zootaxa.4306.3.2; Hajibabaei M, 2012, METHODS MOL BIOL MET; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Holthuis LB, 1991, FAO FISH SYNOP, V13, pI; Jeena NS, 2016, MITOCHONDRIAL DNA A, V27, P2700, DOI 10.3109/19401736.2015.1046160; Ji YQ, 2013, ECOL LETT, V16, P1245, DOI 10.1111/ele.12162; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lambert DM, 2005, J HERED, V96, P279, DOI 10.1093/jhered/esi035; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Meyer CP, 2003, BIOL J LINN SOC, V79, P401, DOI 10.1046/j.1095-8312.2003.00197.x; Modave E, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix052; O'Rorke R, 2013, J EXP MAR BIOL ECOL, V441, P1, DOI 10.1016/j.jembe.2013.01.003; Palero F, 2016, ZOOTAXA, V4139, P481, DOI 10.11646/zootaxa.4139.4.2; Palero F, 2009, MOL PHYLOGENET EVOL, V50, P152, DOI 10.1016/j.ympev.2008.10.003; Phillips BF, 1980, BIOL MANAGEMENT LOBS; Prasad RR, 1975, J MAR BIOL ASSOC IND, V17, P56; Proutski V, 1998, BIOINFORMATICS, V14, P467, DOI 10.1093/bioinformatics/14.5.467; Schander C, 2005, MAR BIOL RES, V1, P79, DOI 10.1080/17451000510018962; Soria-Carrasco V, 2007, BIOINFORMATICS, V23, P2954, DOI 10.1093/bioinformatics/btm466; Stat M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12501-5; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trigg S, 2001, INT J REMOTE SENS, V22, P2641, DOI 10.1080/01431160110053185; Webb KE, 2006, DEEP-SEA RES PT II, V53, P1053, DOI 10.1016/j.dsr2.2006.02.013; Zwickl D. J, 2006, GENETIC ALGORITHM AP	48	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210492	10.1371/journal.pone.0210492	http://dx.doi.org/10.1371/journal.pone.0210492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677051	Green Published, gold			2022-12-26	WOS:000456700400016
J	Song, XY; Grilo, SA; Mathur, S; Lutalo, T; Ssekubugu, R; Nalugoda, F; Santelli, JS				Song, Xiaoyu; Grilo, Stephanie A.; Mathur, Sanyukta; Lutalo, Tom; Ssekubugu, Robert; Nalugoda, Fred; Santelli, John S.			Differential Impacts of HIV status on short-term fertility desires among couples in Rakai, Uganda	PLOS ONE			English	Article							DECISION-MAKING; INTENTIONS; MEN	Background Fertility desires of female and male partners in current relationships are often correlated. We examined the influence of HIV seropositive status of female and male partners on short-term fertility desires in Rakai, Uganda, a setting with high fertility and HIV infection rates. Methods Participants were couples (15-49 years old) enrolled in the Rakai Community Cohort Study, from 2011 to 2013 (n = 2,291). Cohen's kappa coefficient was used to measure the correlation of female and male partners' short-term fertility desires (measured as 'wanting a child in the next 12 months'), in both total sample and stratified serostatus groups. HIV serostatus and additional characteristics of female and male partners were included in Poisson regression models to estimate the rate ratios (RR) for each partner's short-term fertility desires. Individual and partner characteristics included HIV status, partner HIV status, age in years, partner age in years, educational attainment, number of living children, community of residence, and socioeconomic status (SES). Results Short-term fertility desires among female and male partners were moderately associated (Kappa = 0.37, p-value<0.001). The association was weakest among female sero-positive and male sero-negative couples (Kappa = 0.29, p-value<0.001). When adjusting for parity and other covariates in the model, women's short-term fertility desires were significantly associated with their positive sero-status regardless of male partners' sero-status (adjRR = 1.58, p<0.001 for F+M-; adjRR = 1.33, p = 0.001 for F+M+; in comparison with F-M-). Men's short-term fertility desires were significantly associated with their positive sero-status, in addition to their female partners' positive sero-status (adjRR = 1.23 with p-value = 0.022 for F-M+; adjRR = 1.42 with p-value<0.001 for F+M-; adjRR = 1.26 with p-value<0.001 for F+M+; in comparison with F-M-). When the differential effect of parity was included in the model, similar associations remained for both female and male partners when the number of living children was small, but largely reduced when the number of living children was large (3 or more). Conclusion Female and male partners in couple dyads demonstrated moderate agreements about short-term fertility desires. The HIV seropositive status of female partners was most strongly associated with short-term fertility desires of both genders, and this association was even stronger for women who had few or no living children.	[Song, Xiaoyu] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA; [Song, Xiaoyu] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Grilo, Stephanie A.; Santelli, John S.] Columbia Univ, Mailman Sch Publ Hlth, Heilbrunn Dept Populat & Family Hlth, New York, NY 10032 USA; [Grilo, Stephanie A.] Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY 10032 USA; [Mathur, Sanyukta] Populat Council, Washington, DC USA; [Lutalo, Tom; Ssekubugu, Robert; Nalugoda, Fred] RHSP, Rakai Dist, Uganda	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Columbia University; Columbia University; Population Council	Grilo, SA (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Heilbrunn Dept Populat & Family Hlth, New York, NY 10032 USA.; Grilo, SA (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY 10032 USA.	Sag2179@cumc.columbia.edu	Santelli, John/AAG-3046-2021	Song, Xiaoyu/0000-0003-1909-6244	National Institute of Child Health and Human Development [1 RO1 Hd072595-01]	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institute of Child Health and Human Development, 1 RO1 Hd072595-01. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, NAT POP HOUS CENS 20; Cooper D, 2007, SOC SCI MED, V65, P274, DOI 10.1016/j.socscimed.2007.03.019; DeRose LF, 2010, POPUL RES POLICY REV, V29, P423, DOI 10.1007/s11113-009-9151-8; Galiwango RM, 2013, J VIROL METHODS, V192, P25, DOI 10.1016/j.jviromet.2013.04.003; Heck CJ, 2018, IT IS MY BUSINESS MI; Homsy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004149; Kabagenyi A, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-21; Kagulire SC, 2011, INT J STD AIDS, V22, P308, DOI 10.1258/ijsa.2009.009352; Kanniappan S, 2008, AIDS CARE, V20, P625, DOI 10.1080/09540120701660361; Makumbi F, 2010, AFRICAN J REPROD HLT, V14; Makumbi FE, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/519492; Maternowska M. Catherine, 2006, REPROD INEQUITIES PO; Matovu JKB, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-016-0272-3; Miller WB, 2004, POP STUD-J DEMOG, V58, P193, DOI 10.1080/0032472042000213712; Myer L, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000229; Myer L, 2009, JAIDS-J ACQ IMM DEF, V52, pS52, DOI 10.1097/QAI.0b013e3181bbc818; Nakayiwa S, 2006, AIDS BEHAV, V10, pS95, DOI 10.1007/s10461-006-9126-2; Nattabi B, 2009, AIDS BEHAV, V13, P949, DOI 10.1007/s10461-009-9537-y; Paiva V, 2003, REPROD HEALTH MATTER, V11, P91, DOI 10.1016/S0968-8080(03)02293-6; Pintye J, 2015, AIDS PATIENT CARE ST, V29, P510, DOI 10.1089/apc.2015.0063; Rispel LC, 2015, SAHARA J-J SOC ASP H, V12, P10, DOI 10.1080/17290376.2015.1014403; Rutenberg N, 2000, INT FAM PLAN PERSPEC, V26, P124, DOI 10.2307/2648301; SCOTT JW, 1986, AM HIST REV, V91, P1053, DOI 10.2307/1864376; StataCorp, 2015, STAT SOFTW REL 14; Stephens Sharon, 1995, CONCEIVING NEW WORLD, P270; UNAIDS, COUNTR FACTSH UGANDA; Wawer MJ, 1998, AIDS, V12, P1211, DOI 10.1097/00002030-199810000-00014; World Bank, FERT RAT TOT BIRTHS	28	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210935	10.1371/journal.pone.0210935	http://dx.doi.org/10.1371/journal.pone.0210935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI8IY	30677068	Green Published, Green Submitted, gold			2022-12-26	WOS:000456700400035
J	Spitzer, SA; Vail, D; Tennakoon, L; Rajasingh, C; Spain, DA; Weiser, TG				Spitzer, Sarabeth A.; Vail, Daniel; Tennakoon, Lakshika; Rajasingh, Charlotte; Spain, David A.; Weiser, Thomas G.			Readmission risk and costs of firearm injuries in the United States, 2010-2015	PLOS ONE			English	Article							HOSPITALIZATIONS; VIOLENCE	Background In 2015 there were 36,252 firearm-related deaths and 84,997 nonfatal injuries in the United States. The longitudinal burden of these injuries through readmissions is currently underestimated. We aimed to determine the 6-month readmission risk and hospital costs for patients injured by firearms. Methods We used the Nationwide Readmission Database 2010-2015 to assess the frequency of readmissions at 6 months, and hospital costs associated with readmissions for patients with firearm-related injuries. We produced nationally representative estimates of readmission risks and costs. Results Of patients discharged following a firearm injury, 15.6% were readmitted within 6 months. The average annual cost of inpatient hospitalizations for firearm injury was over $911 million, 9.5% of which was due to readmissions. Medicare and Medicaid covered 45.2% of total costs for the 5 years, and uninsured patients were responsible for 20.1%. Conclusions From 2010-2015, the average total cost of hospitalization for firearm injuries per patient was $32,700, almost 10% of which was due to readmissions within 6 months. Government insurance programs and the uninsured shouldered most of this.	[Spitzer, Sarabeth A.; Vail, Daniel] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Tennakoon, Lakshika; Rajasingh, Charlotte; Spain, David A.; Weiser, Thomas G.] Stanford Div Gen Surg, Sect Trauma & Crit Care, Stanford, CA USA	Stanford University	Spitzer, SA (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.	spitzers@stanford.edu	Weiser, Thomas G/AAC-4609-2022	Weiser, Thomas G/0000-0002-3118-3888; Vail, Daniel/0000-0001-8769-2369	Stanford Medical Scholars Research Program	Stanford Medical Scholars Research Program	Sarabeth A. Spitzer was funded by the Stanford Medical Scholars Research Program for this work.	Agency for Healthcare Research and Quality, 2017, HEALTHC COSTS UT PRO; [Anonymous], 2013, INT CLASS DIS 9 REV; [Anonymous], 2017, NRD OV HEALTHC COST; [Anonymous], 2017, NRD DAT DOC HEALTHC; [Anonymous], 2017, HEALTHC COST UT PROJ; [Anonymous], BUR LAB STAT DAT HOS; Centers for Disease Control and Prevention, 2003, WEB BAS INJ STAT QUE; Clark DE OT, 2010, ICDPIC STATA MODULE; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Follman M., 2018, MOTHER JONES; Fowler KA, 2015, PREV MED, V79, P5, DOI 10.1016/j.ypmed.2015.06.002; Friedman B, 2004, MED CARE RES REV, V61, P225, DOI 10.1177/1077558704263799; Grinshteyn E, 2016, AM J MED, V129, P266, DOI 10.1016/j.amjmed.2015.10.025; Ponzer S, 1996, PUBLIC HEALTH, V110, P41, DOI 10.1016/S0033-3506(96)80034-5; Rattan R, 2018, ANN SURG, V267, P810, DOI 10.1097/SLA.0000000000002529; Salemi JL, 2015, FAM MED COMMUNITY HE, V3, P8, DOI 10.15212/FMCH.2015.0115; Smith M, 2018, INJURY PREV, V24, P332, DOI 10.1136/injuryprev-2017-042373; Spitzer SA, 2017, AM J PUBLIC HEALTH, V107, P770, DOI 10.2105/AJPH.2017.303684; Wintemute GJ, 2015, ANNU REV PUBL HEALTH, V36, P5, DOI 10.1146/annurev-publhealth-031914-122535; WINTEMUTE GJ, 1992, J TRAUMA, V33, P556, DOI 10.1097/00005373-199210000-00011; Yoon F, 201701 HCUP US AG HE	21	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0209896	10.1371/journal.pone.0209896	http://dx.doi.org/10.1371/journal.pone.0209896			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI8IY	30677032	Green Published, Green Submitted, gold			2022-12-26	WOS:000456700400008
J	Alitto, RAD; Amaral, ACZ; de Oliveira, LD; Serrano, H; Seger, KR; Guilherme, PDB; Di Domenico, M; Christensen, AB; Lourenco, LB; Tavares, M; Borges, M				dos Santos Alitto, Renata Aparecida; Zacagnini Amaral, Antonia Cecilia; de Oliveira, Leticia Dias; Serrano, Helena; Seger, Karin Regina; Borges Guilherme, Pablo Damian; Di Domenico, Maikon; Christensen, Ana Beardsley; Lourenco, Luciana Bolsoni; Tavares, Marcos; Borges, Michela			Atlantic West Ophiothrix spp. in the scope of integrative taxonomy: Confirming the existence of Ophiothrix trindadensis Tommasi, 1970	PLOS ONE			English	Article							BRITTLE STARS ECHINODERMATA; SYSTEMATIC POSITION; OPHIUROIDEA; RATES; BABY	We re-describe and confirm the validity of Ophiothrix trindadensis Tommasi, 1970 (Echinodermata: Ophiuroidea). This is a native species from Brazil, however it lacked a type series deposited in scientific collections. The recognition of O. trindadensis was made possible using integrative taxonomy applied to many specimens from the type locality (Trindade Island) as well as from different locations along the Brazilian coast (Araca Bay and Estuarine Complex of Paranagua). Initially, 835 specimens were studied and divided into four candidate species (CS) inferred from external morphological characters. Afterwards, the CSs were compared using integrative taxonomy based on external morphology, arm microstructures morphology (arm ossicle), morphometry, and molecular studies (fragments of the mitochondrial genes 16S and COI). Analyses indicated CS1 and CS2 as O. trindadensis, and CS3 as O. angulata, both valid species. CS4 remains O. cf. angulata as more data, including their ecology and physiology, are needed to be definitively clarified. Our integrative investigation using specimens from the type locality overcame the lack of type specimens and increased the reliable identification of O. trindadensis and O. angulata.	[dos Santos Alitto, Renata Aparecida; de Oliveira, Leticia Dias; Serrano, Helena; Seger, Karin Regina; Borges, Michela] Univ Estadual Campinas, Dept Biol Anim, Campinas, SP, Brazil; [dos Santos Alitto, Renata Aparecida; Zacagnini Amaral, Antonia Cecilia; de Oliveira, Leticia Dias; Serrano, Helena; Borges, Michela] Univ Estadual Campinas, Museu Zool Adao Jose Cardoso, Campinas, SP, Brazil; [Seger, Karin Regina; Lourenco, Luciana Bolsoni] Univ Estadual Campinas, Dept Biol Celular, Campinas, SP, Brazil; [Borges Guilherme, Pablo Damian] Univ Estadual Parana, Lab Biol Marinha, Paranagua, Parana, Brazil; [Di Domenico, Maikon] Univ Fed Parana, Ctr Estudos Mar, Pontal Do Parana, Parana, Brazil; [Christensen, Ana Beardsley] Lamar Univ, Dept Biol, Beaumont, TX 77710 USA; [Tavares, Marcos] Univ Sao Paulo, Museu Zool, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Federal do Parana; Texas State University System; Lamar University; Universidade de Sao Paulo	Alitto, RAD (corresponding author), Univ Estadual Campinas, Dept Biol Anim, Campinas, SP, Brazil.; Alitto, RAD (corresponding author), Univ Estadual Campinas, Museu Zool Adao Jose Cardoso, Campinas, SP, Brazil.	renataalitto@gmail.com	Lourenço, Luciana Bolsoni/AAD-4667-2021; Alitto, Renata/AAE-2297-2019; Tavares, Marcos/F-7151-2012; Lourenço, Luciana B/B-5971-2013; Guilherme, Pablo Damian Borges/C-1584-2014	Alitto, Renata/0000-0001-9732-4877; Tavares, Marcos/0000-0002-7186-5787; Lourenço, Luciana B/0000-0001-6602-6850; Guilherme, Pablo Damian Borges/0000-0001-7471-6907; Serrano, Helena/0000-0003-0656-6526; Borges, Michela/0000-0001-6261-5228; Christensen, Ana/0000-0003-2513-7479	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/50317-5, 2011/50724-0]; Fundo de Apoio ao Ensino, a Pesquisa e Extensao da Unicamp (FAEPEX) [2101/16]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [403940/2012-5, 303122/2016-1]; FAPESP [2016/06877-0, 2016/08869-4]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; CAPES [PDSE-88881.131940/2016-01]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundo de Apoio ao Ensino, a Pesquisa e Extensao da Unicamp (FAEPEX); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The development of this study was funded by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Proc. No. 2011/50317-5 to ACZA and 2011/50724-0 to MB; Fundo de Apoio ao Ensino, a Pesquisa e Extensao da Unicamp (FAEPEX) Proc. No. 2101/16 to MB; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) ProTrindade Project Proc. No. 403940/2012-5 to MT and 303122/2016-1 to MT. In addition, FAPESP provided fellowships for LDO (Proc. No. 2016/06877-0 to LDO) and for HS (Proc. No. 2016/08869-4 to HS). This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001. CAPES also provided a fellowship for RASA (Proc. No. PDSE-88881.131940/2016-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBUQUERQUE MN, 1991, B MUSEU NACL, V353, P1; ALBUQUERQUE MN, 1986, THESIS; Alitto RAS, 2018, ZOOTAXA, V4405, P1, DOI 10.11646/zootaxa.4405.1.1; Almeida F.F.M., 2006, TERRAE DID ATICA, V2, P3, DOI [10.1007/BF01915460, DOI 10.20396/TD.V2I1.8637462]; Amaral ACZ., 2016, LIFE ARACA BAY DIVER; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anker A, 2016, ZOOTAXA, V4138, P1, DOI 10.11646/zootaxa.4138.1.1; [Anonymous], 1995, SEA STARS SEA URCHIN; Arribas P, 2013, ZOOL SCR, V42, P182, DOI 10.1111/zsc.12000; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Baric S, 1999, MOL PHYLOGENET EVOL, V11, P157, DOI 10.1006/mpev.1998.0551; Thuy B, 2011, ZOOTAXA, P1; Borges M., 2005, MANUAL IDENTIFICACAO, P237; Borges Michela, 2002, Biota Neotrop., V2, P1, DOI 10.1590/S1676-06032002000200010; Borges M, 2015, REV BIOL TROP, V63, P361, DOI 10.15517/rbt.v63i2.23170; CLARK AM, 1966, ANN MAG NAT HIST, V9, P637, DOI 10.1080/00222936608651676; de Barros Lima Eduardo Jose, 2009, Revista Brasileira de Zoociencias, V11, P55; De Moura Barboza Carlos Alberto, 2015, Marine Biodiversity Records, V8, pe16, DOI 10.1017/S1755267214001511; Barboza CAD, 2012, ZOOTAXA, P1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EDWARDS A, 1983, J BIOGEOGR, V10, P65, DOI 10.2307/2844583; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hart MW, 2005, MOL PHYLOGENET EVOL, V34, P438, DOI 10.1016/j.ympev.2004.09.011; Hendler G, 2005, CARIBB J SCI, V41, P583; Hotchkiss FHC, 2012, ZOOSYMPOSIA, V7, P121, DOI 10.11646/zoosymposia.7.1.12; Hotchkiss Frederick H. C., 2007, Sbornik Narodniho Muzea v Praze Rada B Prirodni Vedy, V63, P3; ICZN, 1999, INT CODE ZOOLOGICAL; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kokorin AI, 2014, PALEONTOL J+, V48, P1532, DOI 10.1134/S0031030114140056; Kokorin Aleksandr, 2015, Cuadernos del Museo Geominero, V19, P83; Korshunova T, 2017, ZOOKEYS, P1, DOI 10.3897/zookeys.717.21885; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lana PC, 2001, ECOL STU AN, V144, P131; LeClair EE, 1996, J ZOOL, V240, P245, DOI 10.1111/j.1469-7998.1996.tb05283.x; LeClair EE, 1997, BIOL BULL, V193, P77, DOI 10.2307/1542737; LITVINOVA NM, 1994, ECHINODERMS THROUGH TIME, P449; Ludwig H, 1882, MEMOIRES COURONNES S, V44, P1; Martynov A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139463; Martynov Alexander, 2010, Zootaxa, V2697, P1; Muths D, 2009, AQUAT BIOL, V5, P117, DOI 10.3354/ab00138; O'Hara TD, 2018, EUR J TAXON, V416, P1, DOI 10.5852/ejt.2018.416; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Perez-Portela R, 2013, ZOOL SCR, V42, P151, DOI 10.1111/j.1463-6409.2012.00573.x; R Development Core Team, 2018, R A LANGUAGE AND ENV; Santana A, 2017, ZOOTAXA, V4344, P291, DOI 10.11646/zootaxa.4344.2.5; Say T., 1825, J ACAD NATURAL SCI P, V5, P141; Schobbenhaus C, 2002, SITIOS GEOLOGICOS PA, V1st, P369; Stohr S, 2005, ZOOL J LINN SOC-LOND, V143, P543, DOI 10.1111/j.1096-3642.2005.00155.x; Stohr S, 2008, ZOOL J LINN SOC-LOND, V153, P545; Stohr S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031940; Taboada S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32425; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; The University of Texas at Austin, TEX HIGH SCH COAST M; Thuy B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156140; TOMMASI L R, 1970, Contribuicoes Avulsas do Instituto Oceanografico Sao Paulo, P1; Venables WN., 2002, MODERN APPL STAT S, V4, DOI 10.1007/978-0-387-21706-2; Viana DL, 2017, PETER PAUL ARCHIPELA; Wickham H., 2009, MEDIA, V35, P10, DOI 10.1007/978-0-387-98141-3; WRIGHT S, 1978, P580; Amaral ACZ, 2010, BIOTA NEOTROP, V10, P219, DOI 10.1590/S1676-06032010000100022; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	65	10	12	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210331	10.1371/journal.pone.0210331	http://dx.doi.org/10.1371/journal.pone.0210331			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673722	gold, Green Published, Green Submitted			2022-12-26	WOS:000456442800040
J	Duran, GE; Sikic, BI				Duran, George E.; Sikic, Branimir I.			The Syk inhibitor R406 is a modulator of P-glycoprotein (ABCB1)-mediated multidrug resistance	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CONFERS PACLITAXEL RESISTANCE; EXPRESSION; CELLS; TUBULIN; CHEMORESISTANCE; FORMULATIONS; MECHANISMS; LEADS	In a previously published study, higher levels of spleen tyrosine kinase (Syk) were observed in recurrent post-chemotherapy ovarian cancers compared to primary tumors. Syk inhibition was found to stabilize microtubules and potentiate paclitaxel activity in cellular models of taxane-resistant ovarian cancers. We further studied the effects of Syk inhibition on paclitaxel activity in Syk(+) ovarian cancer cell models and in variants selected for taxane resistance. Syk inhibition was accomplished using RNAi and by exposure to the small molecule competitive inhibitor R406, the active metabolite of fostamatinib. Exposure to R406 or to a SYK-specific pool of siRNAs did not alter taxane activity in the OVCAR-3 cell line, which has the most Syk content in our panel of nine human ovarian cancer cell lines. However, treatment with R406 sensitised the multidrug resistant (MDR) variants MES-SA/Dx5 and SKOV-3/TR to paclitaxel in a dose-dependent manner resulting from the inhibition of the ABCB1/P-glycoprotein (P-gp) drug transporter. These observations are Syk-independent since both MDR cell models are Syk negative. R406 modulated resistance to other known P-gp substrates, and we observed orthovanadate-sensitive ATPase stimulation resulting from treatment with R406. These data indicate that the chemo-sensitizing effect of R406 in taxane-resistant cells previously reported was not associated with Syk but resulted from the modulation of P-gp-mediated MDR.	[Duran, George E.; Sikic, Branimir I.] Stanford Univ, Dept Med, Sch Med, Div Oncol, Stanford, CA 94305 USA	Stanford University	Duran, GE (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Oncol, Stanford, CA 94305 USA.	george.duran@stanford.edu			U. S. National Institutes of Health (NIH) through the National Cancer Institute [R01 CA184968]; NATIONAL CANCER INSTITUTE [R01CA184968] Funding Source: NIH RePORTER	U. S. National Institutes of Health (NIH) through the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a grant from the U. S. National Institutes of Health (NIH) through the National Cancer Institute (Grant R01 CA184968 to BIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyerinas B, 2011, INT J CANC; Chabalier C, 2006, CELL CYCLE, V5, P1001, DOI 10.4161/cc.5.9.2726; Dumontet C, 1996, CANCER RES, V56, P1091; Duran GE, 2015, MOL CANCER THER, V14, P193, DOI 10.1158/1535-7163.MCT-14-0155; Faruki S, 2000, J CELL SCI, V113, P2557; Ganta S, 2009, MOL PHARMACEUT, V6, P928, DOI 10.1021/mp800240j; Hari M, 2003, CELL MOTIL CYTOSKEL, V56, P45, DOI 10.1002/cm.10132; HARKER WG, 1985, CANCER RES, V45, P4091; Hazama R, 2009, GENES CELLS, V14, P871, DOI 10.1111/j.1365-2443.2009.01317.x; Horwitz Susan Band, 1993, Journal of the National Cancer Institute Monographs, V0, P55; Huisman MT, 2005, INT J CANCER, V116, P824, DOI 10.1002/ijc.21013; Iseri OD, 2011, BIOMED PHARMACOTHER, V65, P40, DOI 10.1016/j.biopha.2010.10.004; Jaffrezou JP, 1995, ONCOL RES, V7, P517; Kajiyama H, 2007, INT J ONCOL, V31, P277; Kavallaris M, 1999, BRIT J CANCER, V80, P1020, DOI 10.1038/sj.bjc.6690507; Lafarge S, 2001, ONCOGENE, V20, P6597, DOI 10.1038/sj.onc.1204812; Lancet JE, 2009, LEUKEMIA RES, V33, P1055, DOI 10.1016/j.leukres.2008.09.015; Malofeeva EV, 2012, CANCER RES, V72, P6457, DOI 10.1158/0008-5472.CAN-12-1340; Quinn JE, 2003, CANCER RES, V63, P6221; Spicakova T, 2010, MOL CANCER THER, V9, P2970, DOI 10.1158/1535-7163.MCT-10-0780; Strobel T, 1998, CANCER RES, V58, P4776; Sulimenko V, 2006, J IMMUNOL, V176, P7243, DOI 10.4049/jimmunol.176.12.7243; Sung M, 2013, ONCOGENE, P1; TANG C, 1994, LEUKEMIA, V8, P1960; Wang YC, 2006, GENE CHROMOSOME CANC, V45, P365, DOI 10.1002/gcc.20300; Wei W, 2015, CANCER CELL, V28, P7, DOI 10.1016/j.ccell.2015.06.008; Yadav S, 2009, CANCER CHEMOTH PHARM, V63, P711, DOI 10.1007/s00280-008-0790-y; Yang Q, 2014, BRIT J CANCER, V110, P1958, DOI 10.1038/bjc.2014.136; Yang XQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08509; Yu Y, 2015, CANCER CELL, V28, P82, DOI 10.1016/j.ccell.2015.05.009	30	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210879	10.1371/journal.pone.0210879	http://dx.doi.org/10.1371/journal.pone.0210879			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668583	Green Submitted, gold, Green Published			2022-12-26	WOS:000456306400023
J	Bello-Perez, M; Falco, A; Novoa, B; Perez, L; Coll, J				Bello-Perez, Melissa; Falco, Alberto; Novoa, Beatriz; Perez, Luis; Coll, Julio			Hydroxycholesterol binds and enhances the anti-viral activities of zebrafish monomeric creactive protein isoforms	PLOS ONE			English	Article							C-REACTIVE PROTEIN; VIRUS-INFECTION; SWISS-MODEL; INFLAMMATION; PENTRAXINS; MEMBRANE; CRP; CHOLESTEROL; 25-HYDROXYCHOLESTEROL; ATHEROSCLEROSIS	C-reactive proteins (CRPs) are among the faster acute-phase inflammation-responses proteins encoded by one gene (hcrp) in humans and seven genes (crp1-7) in zebrafish (Danio rerio) with importance in bacterial and viral infections. In this study, we described novel preferential bindings of 25-hydroxycholesterol (25HOCh) to CRP1-7 compared with other lipids and explored the antiviral effects of both 25HOCh and CRP1-7 against spring viremia carp virus (SVCV) infection in zebrafish. Both in silico and in vitro results confirmed the antiviral effect of 25HOCh and CRP1-7 interactions, thereby showing that the crosstalk between them differed among the zebrafish isoforms. The presence of oxidized cholesterols in human atherosclerotic plaques amplifies the importance that similar interactions may occur for vascular and/or neurodegenerative diseases during viral infections. In this context, the zebrafish model offers a genetic tool to further investigate these interactions.	[Bello-Perez, Melissa; Falco, Alberto; Perez, Luis] Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche, Spain; [Novoa, Beatriz] CSIC, Inst Marine Res IIM, Vigo, Spain; [Coll, Julio] Inst Nacl Invest & Tecnol Agr & Alimentarias, INIA, Dept Biotechnol, Madrid, Spain	Universidad Miguel Hernandez de Elche; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Coll, J (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentarias, INIA, Dept Biotechnol, Madrid, Spain.	juliocoll@inia.es	Novoa, Beatriz/K-3785-2014; Coll, julio/M-6071-2019; Falco, Alberto/A-3250-2012	Coll, julio/0000-0001-8496-3493; Falco, Alberto/0000-0001-7726-6577; Novoa, Beatriz/0000-0003-4888-8419; Perez Garcia-Estan, Luis/0000-0003-4078-8763; Bello Perez, Melissa/0000-0002-9212-083X	Generalidad Valenciana, fellowship ACIF/2016; CICYT of the Ministerio de Economia, Industria y Competitividad of Spain [AGL2014-51773-C3-R, BIO2017-82851]	Generalidad Valenciana, fellowship ACIF/2016; CICYT of the Ministerio de Economia, Industria y Competitividad of Spain	Melissa Bello-Perez was financed by the Generalidad Valenciana, fellowship ACIF/2016. This work was supported by CICYT projects AGL2014-51773-C3-R and BIO2017-82851 of the Ministerio de Economia, Industria y Competitividad of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Paula Perez Gonzalez who helped with the experimentation. Dr. Jose Antonio Encinar and Dra. Marcela Giudici from the IBMC-UMH, revised the docking prediction data and helped to perform gel electrophoresis experiments under native conditions, respectively. Melissa Bello-Perez was supported by the Generalidad Valenciana, fellowship ACIF/2016.	Adinolfi LE, 2014, WORLD J GASTROENTERO, V20, P3410, DOI 10.3748/wjg.v20.i13.3410; AGRAWAL A, 1992, J BIOL CHEM, V267, P25352; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bang R, 2005, J BIOL CHEM, V280, P25095, DOI 10.1074/jbc.M504782200; Bello-Perez M, 2017, MOL IMMUNOL, V91, P145, DOI 10.1016/j.molimm.2017.09.005; Bello-Perez M, 2017, DEV COMP IMMUNOL, V69, P33, DOI 10.1016/j.dci.2016.12.001; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Biro A, 2007, J LIPID RES, V48, P19, DOI 10.1194/jlr.M600158-JLR200; Bottazzi B, 2016, J HEPATOL, V64, P1416, DOI 10.1016/j.jhep.2016.02.029; Braig D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14188; Caprio V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01089; Chen R, 2015, J STRUCT BIOL, V189, P259, DOI 10.1016/j.jsb.2015.01.001; Civra A, 2014, SCI REP-UK, V4, DOI 10.1038/srep07487; Coll JM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00039; Dallakyan S, 2015, METHODS MOL BIOL, V1263, P243, DOI 10.1007/978-1-4939-2269-7_19; Danthi P, 2004, J VIROL, V78, P33, DOI 10.1128/JVI.78.1.33-41.2004; Deng LT, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0159458, 10.137]; Desplanques AS, 2008, VIROLOGY, V376, P339, DOI 10.1016/j.virol.2008.03.039; Dong H, 2018, ANTIVIR THER; Eisenhardt SU, 2009, TRENDS CARDIOVAS MED, V19, P232, DOI 10.1016/j.tcm.2010.02.002; Eisenhardt SU, 2009, CELL CYCLE, V8, P3885, DOI 10.4161/cc.8.23.10068; Estepa A, 1996, VIROLOGY, V216, P60, DOI 10.1006/viro.1996.0034; Estepa AM, 2001, J BIOL CHEM, V276, P46268, DOI 10.1074/jbc.M108682200; Estepa A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135483; Falco A, 2012, DEV COMP IMMUNOL, V37, P127, DOI 10.1016/j.dci.2011.10.005; Filjan N, 1971, Vet Arhiv, V41, P125; Fujita H, 2011, ARCH VIROL, V156, P995, DOI 10.1007/s00705-011-0938-7; Garcia-Valtanen P, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00121; Glisoni RJ, 2015, J NANOSCI NANOTECHNO, V15, P4224, DOI 10.1166/jnn.2015.9613; Gold ES, 2014, P NATL ACAD SCI USA, V111, P10666, DOI 10.1073/pnas.1404271111; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; ICTV, 2015, IMPL TAX WID NONL BI, V9, P430, DOI [10.1016/j.virol.2007.03.016, DOI 10.1016/J.VIROL.2007.03.016]; Inforzato A, 2013, SEMIN IMMUNOL, V25, P79, DOI 10.1016/j.smim.2013.05.002; Ji SR, 2007, FASEB J, V21, P284, DOI 10.1096/fj.06-6722com; Li HY, 2016, J BIOL CHEM, V291, P8795, DOI 10.1074/jbc.M115.695023; Lu JH, 2012, IMMUNOL REV, V250, P230, DOI 10.1111/j.1600-065X.2012.01162.x; Lv JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20014-y; Magnadottir B, 2018, DEV COMP IMMUNOL, V87, P1, DOI 10.1016/j.dci.2018.05.014; Mariani V, 2011, PROTEINS, V79, P37, DOI 10.1002/prot.23177; McFadyen JD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01351; McKibben RA, 2016, J INFECT DIS, V213, P257, DOI 10.1093/infdis/jiv396; Neron B, 2009, BIOINFORMATICS, V25, P3005, DOI 10.1093/bioinformatics/btp493; PEPYS MB, 1981, LANCET, V1, P653; Pereiro P, 2017, ANTIVIR RES, V145, P146, DOI 10.1016/j.antiviral.2017.08.003; Perez-Filgueira DM, 2007, VIROLOGY, V364, P422, DOI 10.1016/j.virol.2007.03.016; POTEMPA LA, 1983, MOL IMMUNOL, V20, P1165, DOI 10.1016/0161-5890(83)90140-2; Potempa Lawrence A, 2015, Biophys Rep, V1, P18; Shah S, 2015, AIDS, V29, P1325, DOI 10.1097/QAD.0000000000000654; Shityakov Sergey, 2014, Adv Appl Bioinform Chem, V7, P23, DOI 10.2147/AABC.S63749; Shrivastava AK, 2015, EGYPT HEART J, V67, P89, DOI 10.1016/j.ehj.2014.11.005; Shrivastava-Ranjan P, 2016, MBIO, V7; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; TANAKA T, 1983, J IMMUNOL METHODS, V65, P333, DOI 10.1016/0022-1759(83)90128-X; Taylor KE, 2007, IMMUNOLOGY, V120, P404, DOI 10.1111/j.1365-2567.2006.02516.x; Tian ZY, 2017, EUR J MED CHEM, V134, P133, DOI 10.1016/j.ejmech.2017.03.087; Torrent F, 2016, ARCH VIROL, V161, P2653, DOI 10.1007/s00705-016-2934-4; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vilahur G, 2015, VASC PHARMACOL, V73, P38, DOI 10.1016/j.vph.2015.05.001; Volanakis JE, 2001, MOL IMMUNOL, V38, P189, DOI 10.1016/S0161-5890(01)00042-6; Voulgaris Theodoros, 2016, Hepat Res Treat, V2016, P7629318, DOI 10.1155/2016/7629318; Wang JH, 2015, ATHEROSCLEROSIS, V239, P343, DOI 10.1016/j.atherosclerosis.2015.01.024; Wang MY, 2011, FASEB J, V25, P3186, DOI 10.1096/fj.11-182741; Widziolek M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36023; Wu Y, 2015, BIOL CHEM, V396, P1181, DOI 10.1515/hsz-2015-0149; Yang J, 2017, ORG BIOMOL CHEM, V15, P4644, DOI 10.1039/c7ob00684e; Yang Q, 2015, VIROLOGY, V484, P170, DOI 10.1016/j.virol.2015.06.005; Zhu XL, 2018, EUR J MED CHEM, V146, P194, DOI 10.1016/j.ejmech.2018.01.040; Zieden B, 1999, ARTERIOSCL THROM VAS, V19, P967, DOI 10.1161/01.ATV.19.4.967	68	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0201509	10.1371/journal.pone.0201509	http://dx.doi.org/10.1371/journal.pone.0201509			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653529	Green Published, gold, Green Submitted			2022-12-26	WOS:000456015500002
J	Levitzky, N; Smith, E; Lachman, O; Luria, N; Mizrahi, Y; Bakelman, H; Sela, N; Laskar, O; Milrot, E; Dombrovsky, A				Levitzky, Naama; Smith, Elisheva; Lachman, Oded; Luria, Neta; Mizrahi, Yaniv; Bakelman, Helen; Sela, Noa; Laskar, Orly; Milrot, Elad; Dombrovsky, Aviv			The bumblebee Bombus terrestris carries a primary inoculum of Tomato brown rugose fruit virus contributing to disease spread in tomatoes	PLOS ONE			English	Article							MOSAIC-VIRUS; POLLINATION; HYMENOPTERA; TRANSMISSION; APIDAE; CROPS	The bumblebee Bombus terrestris is a beneficial pollinator extensively used in tomato production. Our hypothesis was that bumblebee hives collected from a Tomato brown rugose fruit virus (ToBRFV) infected tomato greenhouse, preserve an infectious primary inoculum. Placing a bumblebee hive collected from a ToBRFV contaminated greenhouse, in a glass-/net-house containing only uninfected healthy tomato plants, spread ToBRFV disease. Control uninfected tomato plants grown in a glass-/net-house devoid of any beehive remained uninfected. ToBRFV-contaminated hives carried infectious viral particles as demonstrated in a biological assay on laboratory test plants of virus extracted from hive components. Viral particles isolated from a contaminated hive had a typical tobamovirus morphology observed in transmission electron microscopy. Assembly of ToBRFV genome was achieved by next generation sequencing analysis of RNA adhering to the bumblebee body. Bumblebee dissection showed that ToBRFV was mostly present in the abdomen suggesting viral disease spread via buzz pollination. These results demonstrate that bumblebee hives collected from ToBRFV-contaminated greenhouses carry a primary inoculum that reflects the status of viruses in the growing area. This new mode of ToBRFV spread by pollinators opens an avenue for detection of viruses in a growing area through analysis of the pollinators, as well as emphasizes the need to reevaluate the appropriate disease management protocols.	[Levitzky, Naama; Smith, Elisheva; Lachman, Oded; Luria, Neta; Mizrahi, Yaniv; Bakelman, Helen; Sela, Noa; Dombrovsky, Aviv] Volcani Ctr, ARO, Dept Plant Pathol, Rishon Leziyyon, Israel; [Levitzky, Naama] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Mizrahi, Yaniv] Hebrew Univ Jerusalem, Agroecol & Plant Hlth, Rehovot, Israel; [Laskar, Orly; Milrot, Elad] IIBR, Ness Ziona, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Bar Ilan University; Hebrew University of Jerusalem	Dombrovsky, A (corresponding author), Volcani Ctr, ARO, Dept Plant Pathol, Rishon Leziyyon, Israel.	aviv@volcani.agri.gov.il	Sela, Noa/C-5133-2008	Sela, Noa/0000-0002-8282-215X	Ministry of Agriculture [20-10-0070]	Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi)	This research was supported by the Israeli Chief Scientist, Ministry of Agriculture on ToBRFV grant number: 20-10-0070 to AD; https://agriscience.co.il/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antignus Y, 2007, PLANT DIS, V91, P47, DOI 10.1094/PD-91-0047; Asada S, 1996, APPL ENTOMOL ZOOL, V31, P581, DOI 10.1303/aez.31.581; Banda H, 1990, 6 INT S POLL, V288; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Darzi E, 2017, PLANT PATHOLOGY; Dogterom MH, 1998, J ECON ENTOMOL, V91, P71, DOI 10.1093/jee/91.1.71; Dombrovsky A., 2017, ADV SEED BIOL; Galbraith DA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27164-z; Genda Y, 2011, J GEN PLANT PATHOL, V77, P201, DOI 10.1007/s10327-011-0307-0; Granberg F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057459; Groen SC, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005790; Kawai Y, 2009, ECOL RES, V24, P215, DOI 10.1007/s11284-008-0500-6; KOENIG R, 1981, J GEN VIROL, V55, P53, DOI 10.1099/0022-1317-55-1-53; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li RG, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00794-13; Luria N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170429; Matsuura S, 2010, EUR J PLANT PATHOL, V126, P111, DOI 10.1007/s10658-009-9515-2; Morandin LA, 2001, J ECON ENTOMOL, V94, P172, DOI 10.1603/0022-0493-94.1.172; Moreira SR, CARACTERIZACAO NOVA; Okada Kiyotsugu, 2000, Journal of General Plant Pathology, V66, P71, DOI 10.1007/PL00012924; Salem N, 2016, ARCH VIROL, V161, P503, DOI 10.1007/s00705-015-2677-7; Sastry KS., 2013, SEED BORNE PLANT VIR; Schoonvaere K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168456; Shipp JL, 2008, ANN APPL BIOL, V153, P149, DOI 10.1111/j.1744-7348.2008.00245.x; Sui XL, 2017, PLANT DIS, V101, P704, DOI [10.1094/PDIS-10-16-1504-RE, 10.1094/pdis-10-16-1504-re]; TAYLOR RH, 1961, PHYTOPATHOLOGY, V51, P837; Webster CG, 2014, PLANT HLTH PROG, V15, P2; Winter K, 2006, IMPORTATION NONNATIV, P33, DOI DOI 10.1016/J.VIROL.2016.10.017; Zheng Y, 2017, VIROLOGY, V500, P130, DOI 10.1016/j.virol.2016.10.017	29	37	42	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210871	10.1371/journal.pone.0210871	http://dx.doi.org/10.1371/journal.pone.0210871			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653593	Green Published, Green Submitted, gold			2022-12-26	WOS:000456015500082
J	McMillan, TM; Graham, L; Pell, JP; McConnachie, A; Mackay, DF				McMillan, T. M.; Graham, L.; Pell, J. P.; McConnachie, A.; Mackay, D. F.			The lifetime prevalence of hospitalised head injury in Scottish prisons: A population study	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; ASSOCIATION	Background There is mounting evidence that associates brain injury and offending behaviour, and there is a need to understand the epidemiology of head injury in prisoners in order to plan interventions to reduce associated disability and risk of reoffending. This is the first study to determine the lifetime prevalence of hospitalised head injury (HHI) in a national population of current prison inmates. In addition characteristics of prisoners with HHI and were compared to prisoners without HHI to discover whether those with HI differed demographically. Methods Whole life hospital records of everyone aged 35 years or younger and resident in a prison in Scotland on a census date in 2015 were electronically linked via their unique NHS identifier and checked for ICD-9 and 10 codes for head injury. Using a case-control design, these data were compared with a sample from the general population matched 3: 1 for age, gender and area-based social deprivation. Comparison of demographic variables was made between prisoners with and without HHI. Results HHI was found in 24.7% (1,080/4,374) of prisoners and was significantly more prevalent than found in the matched general population sample (18.2%; 2394/13122; OR 2.10; 95% CI 1.87, 2.16). The prevalence of HHI in prisoners and controls was similar with the exception of a higher risk of HHI in prisoners in lower deprivation quintiles. Having three or more HHI was more common in prisoners (OR 3.04; 95% CI 2.33, 3.97) as were HHI with ICD codes for intracranial injuries (OR 1.81; 95% CI 1.54, 2.11), suggesting that more severe HHI is more prevalent in prisoners than the general population. The distributions within demographic variables and the characteristics of HHI admissions in prisoners with and without a history of HHI were similar. Conclusion Prisoners in Scotland aged 35 years or younger have a higher lifetime prevalence of HHI than the general population and are more likely to have had repeated HI or intracranial injuries. Further work is required to elucidate the correspondence between self-report of HI and hospitalised records and to ascertain persisting effects of HI in prisoners and the need for services to reduce associated disability and risk of reoffending.	[McMillan, T. M.; Pell, J. P.; McConnachie, A.; Mackay, D. F.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Graham, L.] NHS Natl Serv Scotland, Informat Serv Div, Edinburgh, Midlothian, Scotland	University of Glasgow; NHS National Services Scotland	McMillan, TM (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland.	Thomas.mcmillan@glasgow.ac.uk	McMillan, Thomas/K-2055-2015	McMillan, Thomas/0000-0002-5278-9889	NHS Scotland National Prisoner Healthcare Network	NHS Scotland National Prisoner Healthcare Network	Funded by NHS Scotland National Prisoner Healthcare Network.	Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centre for Mental Health, 2016, TRAUM BRAIN INJ OFF; Chen AY, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-4; Colantonio A, 2014, J CORRECT HEALTH CAR, V20, P271, DOI 10.1177/1078345814541529; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Farrington D. P., 2006, CRIMINAL CAREERS AGE; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; HIRSCHI T, 1983, AM J SOCIOL, V89, P552, DOI 10.1086/227905; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McIsaac Kathryn E, 2016, CMAJ Open, V4, pE746, DOI 10.9778/cmajo.20160072; McKinlay A, 2016, J INT NEUROPSYCH SOC, V22, P717, DOI 10.1017/S1355617716000497; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P507, DOI 10.1097/HTR.0000000000000000; McMillan TM, 2017, NEUROBEHAVIOURAL DIS, P57; Morrell R.F., 1998, J OFFENDER REHABIL, V27, P1, DOI [DOI 10.1300/J076V27N03_01, 10.1300/J076v27n03_01]; Moynan CR, 2018, J HEAD TRAUMA REHAB, V33, P275, DOI 10.1097/HTR.0000000000000354; National Prisoner Healthcare Network, 2016, BRAIN INJ OFF; Nordstrom A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f723; Piccolino AL, 2014, J CORRECT HEALTH CAR, V20, P203, DOI 10.1177/1078345814530871; Roworth MA, 1998, COM MED, V10, P327; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Schofield PW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132558; Scottish Executive, 2012, SCOTT IND MULT DEPR; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tardif PA, 2017, INJURY, V48, P94, DOI 10.1016/j.injury.2016.10.042; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Williams WH, 2018, LANCET PSYCHIAT, V5, P836, DOI 10.1016/S2215-0366(18)30062-2; Worthington A, 2017, NEUROBEHAVIOURAL DIS, P3	31	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210427	10.1371/journal.pone.0210427	http://dx.doi.org/10.1371/journal.pone.0210427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653552	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000456015500038
J	Pinguet, CE; Ryll, E; Steinschulte, AA; Hoffmann, JM; Brugnoni, M; Sybachin, A; Woll, D; Yaroslavov, A; Richtering, W; Plamper, FA				Pinguet, Camille E.; Ryll, Esther; Steinschulte, Alexander A.; Hoffmann, Jon M.; Brugnoni, Monia; Sybachin, Andrey; Woell, Dominik; Yaroslavov, Alexander; Richtering, Walter; Plamper, Felix A.			PEO-b-PPO star-shaped polymers enhance the structural stability of electrostatically coupled liposome/polyelectrolyte complexes	PLOS ONE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; TRIBLOCK COPOLYMERS; SENSITIVE LIPOSOMES; ANIONIC LIPOSOMES; BLOCK-COPOLYMERS; DRUG; RELEASE; MEMBRANES; VESICLES; POLYELECTROLYTE	We propose a strategy to counteract the salt-driven disassembly of multiliposomal complexes made by electrostatic co-assembly of anionic small unilamellar liposomes and cationic star-shaped polyelectrolytes (made of quaternized poly(dimethylaminoethyl methacrylate) (qPDMAEMA(100))(3.1)). The combined action of (qPDMAEMA(100))(3.1) and a nonionic star-shaped polymer (PEO12-b-PPO45)(4), which comprises diblock copolymer arms uniting a poly(ethylene oxide) PEO inner block and a poly(propylene oxide) PPO terminal block, leads to a stabilization of these complexes against disintegration in saline solutions. Hereby, the anchoring of the PPO terminal blocks to the lipid bilayer and the bridging between several liposomes are at the origin of the promoted structural stability. Two-focus fluorescence correlation spectroscopy verifies the formation of multiliposomal complexes with (PEO12-b-PPO45)(4). The polyelectrolyte and the amphiphilic polymer work synergistically, as the joint action still assures some membrane integrity, which is not seen for the mere (PEO12-b-PPO45)(4)-liposome interaction alone.	[Pinguet, Camille E.; Ryll, Esther; Steinschulte, Alexander A.; Hoffmann, Jon M.; Brugnoni, Monia; Woell, Dominik; Richtering, Walter; Plamper, Felix A.] Rhein Westfal TH Aachen, Inst Phys Chem, Aachen, Germany; [Sybachin, Andrey; Yaroslavov, Alexander] Moscow MV Lomonosov State Univ, Dept Chem, Moscow, Russia; [Plamper, Felix A.] TU Bergakad Freiberg, Inst Phys Chem, Freiberg, Germany	RWTH Aachen University; Lomonosov Moscow State University; Technical University Freiberg	Plamper, FA (corresponding author), Rhein Westfal TH Aachen, Inst Phys Chem, Aachen, Germany.; Plamper, FA (corresponding author), TU Bergakad Freiberg, Inst Phys Chem, Freiberg, Germany.	felix.plamper@chemie.tu-freiberg.de	Richtering, Walter/E-4130-2012; Sybachin, Andrey/L-1613-2013; Sybachin, Andrey/AAN-4279-2021; Wöll, Dominik/F-9768-2012; Yaroslavov, Alexander/V-2496-2019	Richtering, Walter/0000-0003-4592-8171; Sybachin, Andrey/0000-0002-4860-5565; Wöll, Dominik/0000-0001-5700-4182; Brugnoni, Monia/0000-0003-2220-3645; Shoba, Sergei/0000-0001-9889-5831	German Research Foundation (DFG) [RI 560/22-1]; Russian Science Foundation (RSF) [19-43-04104]	German Research Foundation (DFG)(German Research Foundation (DFG)); Russian Science Foundation (RSF)(Russian Science Foundation (RSF))	The work of C.P., W.R. (project RI 560/22-1) and F.P. was funded by the German Research Foundation (DFG; www.dfg.de). The work of A.S. and A.Y. (project 19-43-04104) was funded by the Russian Science Foundation (RSF; http://rscf.ru/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; Amaro M, 2016, PHYS CHEM CHEM PHYS, V18, P7042, DOI 10.1039/c5cp05238f; BURCHARD W, 1989, PROG COLL POL SCI S, V80, P151; Cheng CY, 2012, BIOMACROMOLECULES, V13, P2624, DOI 10.1021/bm300848c; Deng NN, 2016, J AM CHEM SOC, V138, P7584, DOI 10.1021/jacs.6b02107; Dertinger T, 2007, CHEMPHYSCHEM, V8, P433, DOI 10.1002/cphc.200600638; Duzgunes N, 2003, METHOD ENZYMOL, V367, P23; Enderlein J, 2005, CHEMPHYSCHEM, V6, P2324, DOI 10.1002/cphc.200500414; Enderlein J, 2004, CURR PHARM BIOTECHNO, V5, P155, DOI 10.2174/1389201043377020; Firestone MA, 2003, BIOMACROMOLECULES, V4, P1539, DOI 10.1021/bm034134r; Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017; Gibbs BF, 1999, INT J FOOD SCI NUTR, V50, P213, DOI 10.1080/096374899101256; Godoy-Gallardo M, 2017, ACS APPL MATER INTER, V9, P15907, DOI 10.1021/acsami.6b16275; Hashizaki K, 2003, CHEM PHARM BULL, V51, P815; Haustein E, 2007, ANNU REV BIOPH BIOM, V36, P151, DOI 10.1146/annurev.biophys.36.040306.132612; Hebbeker P, 2017, LANGMUIR, V33, P4091, DOI 10.1021/acs.langmuir.6b04602; Hezaveh S, 2012, J PHYS CHEM B, V116, P14333, DOI 10.1021/jp306565e; Johnsson M, 2001, LANGMUIR, V17, P3902, DOI 10.1021/la0101245; Lasic DD, 1998, TRENDS BIOTECHNOL, V16, P307, DOI 10.1016/S0167-7799(98)01220-7; Lee BK, 2015, CHEM ENG SCI, V125, P158, DOI 10.1016/j.ces.2014.06.042; Lopes NA, 2017, FOOD HYDROCOLLOID, V70, P1, DOI 10.1016/j.foodhyd.2017.03.016; Maskarinec SA, 2002, BIOPHYS J, V82, P1453, DOI 10.1016/S0006-3495(02)75499-4; Mergel O, 2019, CHEM SCI, V10, P1844, DOI 10.1039/c8sc04369h; Milla P, 2012, CURR DRUG METAB, V13, P105, DOI 10.2174/138920012798356934; Muller CB, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/46001; Ogawa K, 2015, ADV COLLOID INTERFAC, V226, P115, DOI 10.1016/j.cis.2015.09.005; Paleos CM, 2013, J CONTROL RELEASE, V170, P141, DOI 10.1016/j.jconrel.2013.05.011; Pasut G, 2015, J CONTROL RELEASE, V199, P106, DOI 10.1016/j.jconrel.2014.12.008; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Pinguet CE, 2017, POLYMER, V121, P320, DOI 10.1016/j.polymer.2017.05.041; Plamper FA, 2007, MACROMOLECULES, V40, P5689, DOI 10.1021/ma070452x; Ramezanzade L, 2017, FOOD CHEM, V234, P220, DOI 10.1016/j.foodchem.2017.04.177; Shum HC, 2011, ANGEW CHEM INT EDIT, V50, P1648, DOI 10.1002/anie.201006023; Steinschulte AA, 2014, PHYS CHEM CHEM PHYS, V16, P4917, DOI 10.1039/c3cp54707h; Sybachin AV, 2016, MENDELEEV COMMUN, V26, P276, DOI 10.1016/j.mencom.2016.07.002; Sybachin AV, 2016, POLYMER, V93, P198, DOI 10.1016/j.polymer.2016.04.025; Sybachin AV, 2012, LANGMUIR, V28, P16108, DOI 10.1021/la3024265; SZOKA F, 1980, ANNU REV BIOPHYS BIO, V9, P467, DOI 10.1146/annurev.bb.09.060180.002343; Tavano L, 2016, COLLOID SURFACE B, V147, P161, DOI 10.1016/j.colsurfb.2016.07.060; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; van Elk M, 2015, EUR POLYM J, V72, P620, DOI 10.1016/j.eurpolymj.2015.03.013; Wang JY, 2012, BIOMACROMOLECULES, V13, P2616, DOI 10.1021/bm300847x; Wang JH, 2018, ANGEW CHEM INT EDIT, V57, P12680, DOI 10.1002/anie.201805707; Woll D, 2014, RSC ADV, V4, P2447, DOI 10.1039/c3ra44909b; Yaroslavov A, 2017, NANOMED-NANOTECHNOL, V13, P1491, DOI 10.1016/j.nano.2017.02.001; Yaroslavov AA, 2014, MACROMOL BIOSCI, V14, P491, DOI 10.1002/mabi.201300436; Yaroslavov AA, 2010, J AM CHEM SOC, V132, P5948, DOI 10.1021/ja1012323; Zhang R, 2017, BIOMATERIALS, V138, P13, DOI 10.1016/j.biomaterials.2017.05.025; Zhang WJ, 2017, LANGMUIR, V33, P12624, DOI 10.1021/acs.langmuir.7b02279	49	5	5	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210898	10.1371/journal.pone.0210898	http://dx.doi.org/10.1371/journal.pone.0210898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653618	Green Published, gold, Green Submitted			2022-12-26	WOS:000456015500086
J	Potenza, MA; Sgarra, L; Nacci, C; Leo, V; Salvia, MA; Montagnani, M				Potenza, Maria Assunta; Sgarra, Luca; Nacci, Carmela; Leo, Valentina; De Salvia, Maria Antonietta; Montagnani, Monica			Activation of AMPK/SIRT1 axis is required for adiponectin-mediated preconditioning on myocardial ischemia-reperfusion (I/R) injury in rats	PLOS ONE			English	Article							PROTEIN-KINASE; NITRIC-OXIDE; CARDIAC DYSFUNCTION; SIRT1; AMPK; INFARCTION; METABOLISM; SURVIVAL; HEART; AKT	Background Adiponectin (AD) cardioprotective activities are mediated by AMPK, a fuel-sensing molecule sharing common targets and cellular activities with SIRT-1. Whether AD preconditioning may involve SIRT-1 activity is not known; however, the protective role of SIRT-1 during ischemia and the potential interplay between AMPK and SIRT-1 suggest this possibility. Methods Isolated hearts from male Sprague-Dawley rats (n = 85) underwent ischemia/reperfusion (I/R, 30/180 min). Preconditioning with resveratrol (RSV, SIRT-1 activator) was compared to preconditioning with AD alone, or in combination with compound C (CC, AMPK inhibitor) or sirtinol (STN, SIRT-1 inhibitor). For each heart, left ventricular end-diastolic pressure (LVEDP), left ventricular developed pressure (dLVP), coronary flow (CF) and left ventricular infarct mass (IM) were measured, together with the phosphorylation/activation status of AMPK, LKB1, eNOS and SIRT-1, at the beginning (15 min) and at the end (180 min) of reperfusion. Results and conclusions When compared to I/R, both RSV and AD improved cardiac function and reduced IM (p < 0.01, p < 0.05, respectively). Cardioprotective effects of AD were completely reversed in the AD+CC group, and significantly attenuated in the AD+STN group. Both RSV and AD increased eNOS, AMPK and LKB1 phosphorylation (for each parameter: p < 0.05 vs. I/R, in both RSV and AD treatment groups) at 15 min of reperfusion, and SIRT-1 activity at the end of reperfusion (p < 0.01, p < 0.05 vs. I/R, respectively). Interestingly, AD-mediated phosphorylation of AMPK and LKB1, and SIRT-1 deacetylation activity was markedly reduced in both the AD+CC and AD+STN groups (p < 0.05 vs. AD). Thus, AD-mediated cardioprotection requires both AMPK and SIRT-1 signaling pathways, that act as a component of a cycle and regulate each other's activities.	[Potenza, Maria Assunta; Nacci, Carmela; Leo, Valentina; De Salvia, Maria Antonietta; Montagnani, Monica] Univ Bari Aldo Moro, Dept Biomed Sci & Human Oncol, Med Sch, Pharmacol Sect, Bari, Italy; [Sgarra, Luca] Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat, Med Sch, Sect Cardiovasc Dis, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Montagnani, M (corresponding author), Univ Bari Aldo Moro, Dept Biomed Sci & Human Oncol, Med Sch, Pharmacol Sect, Bari, Italy.	monica.montagnani@uniba.it	Montagnani, Monica/AAV-2057-2020; Sgarra, Luca/AAC-4773-2022	Montagnani, Monica/0000-0002-5697-8185; Sgarra, Luca/0000-0001-8475-8270; De Salvia, Maria Antonietta/0000-0001-5326-792X	Italian Ministry of University (MIUR) [PRIN 2010YK7Z5K_008]; University of Bari [CUP H96J15001610005]	Italian Ministry of University (MIUR)(Ministry of Education, Universities and Research (MIUR)); University of Bari	This work was supported, in part, by the Italian Ministry of University (MIUR) research grant award (PRIN 2010YK7Z5K_008) to M.M. and, in part, by the University of Bari Research funds (CUP H96J15001610005) to M.M.	Addabbo F, 2011, AM J PHYSIOL-ENDOC M, V301, pE1143, DOI 10.1152/ajpendo.00208.2011; Aksentijevic D, 2016, EXP PHYSIOL, V101, P282, DOI 10.1113/EP085380; Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Alcendor RR, 2004, CIRC RES, V95, P971, DOI 10.1161/01.RES.0000147557.75257.ff; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calvert JW, 2008, DIABETES, V57, P696, DOI 10.2337/db07-1098; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Carvajal K, 2007, AM J PHYSIOL-HEART C, V292, pH3136, DOI 10.1152/ajpheart.00683.2006; Cattelan A, 2015, VASC PHARMACOL, V70, P35, DOI 10.1016/j.vph.2015.02.004; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cotton JM, 2002, HEART, V88, P564, DOI 10.1136/heart.88.6.564; Debinski M, 2011, INT J MOL MED, V27, P775, DOI 10.3892/ijmm.2011.643; Ferdinandy P, 2014, PHARMACOL REV, V66, P1142, DOI 10.1124/pr.113.008300; FERRARI R, 1995, AM J CARDIOL, V76, pB17; Finley LWS, 2009, AGEING RES REV, V8, P173, DOI 10.1016/j.arr.2009.03.003; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Galvao J, 2014, FASEB J, V28, P1317, DOI 10.1096/fj.13-235440; Gonon AT, 2008, CARDIOVASC RES, V78, P116, DOI 10.1093/cvr/cvn017; Gu XS, 2014, GENET MOL RES, V13, P323, DOI 10.4238/2014.January.17.17; Hattori Y, 2003, DIABETOLOGIA, V46, P1543, DOI 10.1007/s00125-003-1224-3; Hausenloy DJ, 2016, NAT REV CARDIOL, V13, P193, DOI 10.1038/nrcardio.2016.5; Heusch G, 2000, CIRC RES, V87, P146, DOI 10.1161/01.RES.87.2.146; Hostrup A, 2012, CELL PHYSIOL BIOCHEM, V30, P642, DOI 10.1159/000341445; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Hsu CP, 2010, CIRCULATION, V122, P2170, DOI 10.1161/CIRCULATIONAHA.110.958033; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jungtrakoon P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026792; Kojima S, 2003, HEART, V89, P667, DOI 10.1136/heart.89.6.667; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Kwon HS, 2008, TRENDS BIOCHEM SCI, V33, P517, DOI 10.1016/j.tibs.2008.08.001; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Lecour S, 2005, CIRCULATION, V112, P3911, DOI 10.1161/CIRCULATIONAHA.105.581058; Li J L, 2017, INT J AEROSPACE ENG, V2017, P1, DOI DOI 10.1155/2017/7584691; Li L, 2007, REGUL PEPTIDES, V139, P72, DOI 10.1016/j.regpep.2006.10.007; Liu YG, 1996, CIRC RES, V78, P443, DOI 10.1161/01.RES.78.3.443; Nadtochiy SM, 2011, AM J PHYSIOL-HEART C, V301, pH1506, DOI 10.1152/ajpheart.00587.2011; Nadtochiy SM, 2011, CARDIOVASC RES, V89, P643, DOI 10.1093/cvr/cvq287; Nanayakkara G, 2012, AM J CARDIOVASC DIS, V2, P253; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Nystrom T, 2006, CLIN SCI, V110, P673, DOI 10.1042/CS20050353; Ohashi K, 2006, HYPERTENSION, V47, P1108, DOI 10.1161/01.HYP.0000222368.43759.a1; Ouchi N, 2007, CLIN CHIM ACTA, V380, P24, DOI 10.1016/j.cca.2007.01.026; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Qi D, 2015, TRENDS ENDOCRIN MET, V26, P422, DOI 10.1016/j.tem.2015.05.010; Rosano GMC, 2008, CURR PHARM DESIGN, V14, P2551, DOI 10.2174/138161208786071317; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Sgarra L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088542; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Skyschally A, 2015, CIRC RES, V117, P279, DOI 10.1161/CIRCRESAHA.117.306878; Sulaiman M, 2010, AM J PHYSIOL-HEART C, V298, pH833, DOI 10.1152/ajpheart.00418.2009; Suleman N, 2008, CARDIOVASC RES, V79, P127, DOI 10.1093/cvr/cvn067; Suwa M, 2008, METABOLISM, V57, P986, DOI 10.1016/j.metabol.2008.02.017; Thirunavukkarasu M, 2007, FREE RADICAL BIO MED, V43, P720, DOI 10.1016/j.freeradbiomed.2007.05.004; Wang L, 2018, CARDIOVASC RES, P781, DOI [10.3892/ijmm.2011.643, DOI 10.3892/IJMM.2011.643]; Wang YJ, 2009, CIRCULATION, V119, P835, DOI 10.1161/CIRCULATIONAHA.108.815043; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Winnik S, 2012, CURR VASC PHARMACOL, V10, P693, DOI 10.2174/157016112803520756; Young LH, 2005, TRENDS CARDIOVAS MED, V15, P110, DOI 10.1016/j.tcm.2005.04.005	65	44	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210654	10.1371/journal.pone.0210654	http://dx.doi.org/10.1371/journal.pone.0210654			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653603	Green Submitted, Green Published, gold			2022-12-26	WOS:000456015500061
J	Bedford, JG; O'Keeffe, M; Reading, PC; Wakim, LM				Bedford, James G.; O'Keeffe, Meredith; Reading, Patrick C.; Wakim, Linda M.			Rapid interferon independent expression of IFITM3 following T cell activation protects cells from influenza virus infection	PLOS ONE			English	Article							PROTEINS; RESISTANCE; BINDING; RISK	Interferon-induced transmembrane protein 3 (IFITM3) is a potent antiviral protein that enhances cellular resistance to a variety of pathogens, including influenza virus. Classically defined as an interferon-stimulated gene, expression of IFITM3 on cells is rapidly up-regulated in response to type I and II interferon. Here we found that IFITM3 is rapidly up-regulated by T cells following their activation and this occurred independently of type I and II interferon and the interferon regulatory factors 3 and 7. Up-regulation of IFITM3 on effector T cells protected these cells from virus infection and imparted a survival advantage at sites of virus infection. Our results show that IFITM3 expression on effector T cells is crucial for these cells to mediate their effector function and highlights an interferon independent pathway for the induction of IFITM3 which, if targeted, could be an effective approach to harness the activity of IFITM3 for infection prevention.	[Bedford, James G.; Reading, Patrick C.; Wakim, Linda M.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [O'Keeffe, Meredith] Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Melbourne, Vic, Australia; [O'Keeffe, Meredith] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Reading, Patrick C.] WHO, Peter Doherty Inst Infect & Immun, Victorian Infect Dis Reference Lab, Collaborating Ctr Reference & Res Influenza, Melbourne, Vic, Australia	University of Melbourne; Monash University; Monash University; Victorian Infectious Diseases Reference Laboratory; World Health Organization	Wakim, LM (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia.	wakiml@unimelb.edu.au	O'Keeffe, Meredith/U-9347-2017	O'Keeffe, Meredith/0000-0002-0779-4654; Bedford, James/0000-0001-5216-1779	National Health and Medical Research Council (NHMRC) of Australia; Australian Research Council (ARC); Australian Government Department of Health	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing)	This work was supported by National Health and Medical Research Council (NHMRC) of Australia and the Australian Research Council (ARC) (LMW). The Melbourne World Health Organization Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health (PR).	Allen EK, 2017, NAT MED, V23, P975, DOI 10.1038/nm.4370; ANDERS EM, 1994, J GEN VIROL, V75, P615, DOI 10.1099/0022-1317-75-3-615; Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Bailey CC, 2014, ANNU REV VIROL, V1, P261, DOI 10.1146/annurev-virology-031413-085537; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Chesarino NM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005095; Chesarino NM, 2014, FUTURE MICROBIOL, V9, P1151, DOI [10.2217/FMB.14.65, 10.2217/fmb.14.65]; Chesarino NM, 2014, J BIOL CHEM, V289, P11986, DOI 10.1074/jbc.M114.557694; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Everitt AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080723; Everitt AR, 2012, NATURE; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Infusini G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143539; Jenkins MR, 2006, J IMMUNOL, V177, P2917, DOI 10.4049/jimmunol.177.5.2917; Jia R, 2014, CELL MICROBIOL, V16, P1080, DOI 10.1111/cmi.12262; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Narayana SK, 2015, J BIOL CHEM, V290, P25946, DOI 10.1074/jbc.M115.657346; Wakim LM, 2013, NAT IMMUNOL, V14, P238, DOI 10.1038/ni.2525; Wakim LM, 2012, J IMMUNOL, V189, P3462, DOI 10.4049/jimmunol.1201305; Wang ZF, 2014, P NATL ACAD SCI USA, V111, P769, DOI 10.1073/pnas.1321748111; Xuan Y, 2015, EPIDEMIOL INFECT, V143, P2975, DOI 10.1017/S0950268815000278; Yount JS, 2012, J BIOL CHEM, V287, P19631, DOI 10.1074/jbc.M112.362095; Zhang YZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2830	27	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210132	10.1371/journal.pone.0210132	http://dx.doi.org/10.1371/journal.pone.0210132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650117	gold, Green Published, Green Submitted			2022-12-26	WOS:000455813300044
J	Machnowska, P; Meixenberger, K; Schmidt, D; Jessen, H; Hillenbrand, H; Gunsenheimer-Bartmeyer, B; Hamouda, O; Kucherer, C; Bannert, N; Knechten, H; Panstruga, P; Arasteh, K; Rittweger, M; Schurmann, M; Wesselmann, H; Moll, A; Bohr, U; Jessen, AB; Schulbin, H; Schmidt, W; Karcher, H; Fischer, K; Schranz, D; Vallee, M; Claus, JA; Thomas, C; Grimm, R; Klausen, G; Cordes, C; Brockmeyer, NH; Potthoff, A; Rossler, S; Hower, M; Bachmann, C; Spornraft-Ragaller, P; Teichmann, D; Haussinger, D; Jensen, B; Arbter, PA; Haars, U; Esser, S; Schenk-Westkamp, P; Usadel, S; Muller, MC; Kreft, B; Lange, D; Polywka, S; Degen, O; Plettenbger, A; Kuhlendahl, F; Wiemer, D; Schmidt, RE; Behrens, G; Pletz, MW; Schleenvoigt, BT; Rieke, A; Schneeweiss, SM; Scholten, SHA; Grunewald, T; Weidemann, S; Claus, B; Galle, PR; Sprinzl, M; Ebert, MP; Vogelmann, R; Roider, J; Bogner, J; Todorova, A; Traidl-Hoffmann, C; Jager, H; Muck, B; Pauli, R; Spinner, CD; Schneider, J; Postel, N; Anzbock, M; Baumann, R; Schubel, N; Berning, C; Audebert, F; Trein, A; Schnaitmann, E; Ulmer, A; Muller, M; Harter, G; Gruner, B				Machnowska, Patrycja; Meixenberger, Karolin; Schmidt, Daniel; Jessen, Heiko; Hillenbrand, Heribert; Gunsenheimer-Bartmeyer, Barbara; Hamouda, Osamah; Kuecherer, Claudia; Bannert, Norbert; Knechten, H.; Panstruga, P.; Arasteh, K.; Rittweger, M.; Schuermann, M.; Wesselmann, H.; Moll, A.; Bohr, U.; Jessen, A. B.; Schulbin, H.; Schmidt, W.; Karcher, H.; Fischer, K.; Schranz, D.; Vallee, M.; Claus, J. A.; Thomas, C.; Grimm, R.; Klausen, G.; Cordes, C.; Brockmeyer, N. H.; Potthoff, A.; Roessler, S.; Hower, M.; Bachmann, C.; Spornraft-Ragaller, P.; Teichmann, D.; Haeussinger, D.; Jensen, B.; Arbter, P. A.; Haars, U.; Esser, S.; Schenk-Westkamp, P.; Usadel, S.; Mueller, M. C.; Kreft, B.; Lange, D.; Polywka, S.; Degen, O.; Plettenbger, A.; Kuhlendahl, F.; Wiemer, D.; Schmidt, R. E.; Behrens, G.; Pletz, M. W.; Schleenvoigt, B. T.; Rieke, A.; Schneeweiss, S. M.; Scholten, S. H. A.; Gruenewald, T.; Weidemann, S.; Claus, B.; Galle, P. R.; Sprinzl, M.; Ebert, M. P.; Vogelmann, R.; Roider, J.; Bogner, J.; Todorova, A.; Traidl-Hoffmann, C.; Jaeger, H.; Mueck, B.; Pauli, R.; Spinner, C. D.; Schneider, J.; Postel, N.; Anzboeck, M.; Baumann, R.; Schuebel, N.; Berning, C.; Audebert, F.; Trein, A.; Schnaitmann, E.; Ulmer, A.; Mueller, M.; Haerter, G.; Gruener, B.		German HIV-1 Seroconverter Study	Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort	PLOS ONE			English	Article							NONNUCLEOSIDE REVERSE-TRANSCRIPTASE; TREATMENT-EXPERIENCED PATIENTS; TREATMENT-NAIVE PATIENTS; TRANSMISSION; POPULATION; PROTEASE; FAILURE; SURVEILLANCE; INDIVIDUALS; RILPIVIRINE	The prevalence of transmitted drug resistance (TDR) in antiretroviral therapy (ART)-naive individuals remains stable in most developed countries despite a decrease in the prevalence of acquired drug resistance. This suggests that persistence and further transmission of HIV-1 that encodes transmitted drug resistance mutations (TDRMs) is occurring in ART-naive individuals. In this study, we analysed the prevalence and persistence of TDRMs in the protease and reverse transcriptase-sequences of ART-naive patients within the German HIV-1 Seroconverter Study Cohort who were infected between 1996 and 2017. The prevalence of TDRMs and baseline susceptibility to antiretroviral drugs were assessed using the Stanford HIVdb list and algorithm. Mean survival times of TDRMs were calculated by Kaplan-Meier analysis. The overall prevalence of TDR was 17.2% (95% CI 15.7-18.6, N = 466/2715). Transmitted NNRTI resistance was observed most frequently with 7.8% (95% CI 6.8-8.8), followed by NRTI resistance (5.0%, 95% CI 4.2-5.9) and PI resistance (2.8%, 95% CI 2.2-3.4). Total TDR (OR = 0.89, p = 0.034) and transmitted NRTI resistance (OR = 0.65, p = 0.000) decreased between 1996 and 2017 but has remained stable during the last decade. Viral susceptibility to NNRTIs (6.5%-6.9% for individual drugs) was mainly reduced, while <3% of the recommended NRTIs and PIs were affected. The longest mean survival times were calculated for the NNRTI mutations K103N (5.3 years, 95% CI 4.2-5.6) and E138A/G/K (8.0 years, 95% CI 5.8-10.2/7.9 years, 95% CI 5.4-10.3/6.7 years, 95% CI 6.7-6.7) and for the NRTI mutation M41L (6.4 years, 95% CI 6.0-6.7). The long persistence of single TDRMs indicates that onward transmission from ART-naive individuals is the main cause for TDR in Germany. Transmitted NNRTI resistance was the most frequent TDR, showing simultaneously the highest impact on baseline ART susceptibility and on TDRMs with prolonged persistence. These results give cause for concern regarding the use of NNRTI in first-line regimens.	[Machnowska, Patrycja; Meixenberger, Karolin; Kuecherer, Claudia; Bannert, Norbert] Robert Koch Inst, Div HIV & Other Retroviruses, Berlin, Germany; [Schmidt, Daniel; Gunsenheimer-Bartmeyer, Barbara; Hamouda, Osamah] Robert Koch Inst, Div HIV AIDS STI & Blood Borne Infect, Berlin, Germany; [Jessen, Heiko] Med Care Ctr Jessen, Berlin, Germany; [Hillenbrand, Heribert] Med Care Ctr City Ost, Berlin, Germany; [Bannert, Norbert] Charite Univ Med Berlin, Inst Virol, Berlin, Germany; [Knechten, H.; Panstruga, P.] Praxis Knechten, Berlin, Germany; Robert Koch Inst, Berlin, Germany	Robert Koch Institute; Robert Koch Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robert Koch Institute	Machnowska, P; Bannert, N (corresponding author), Robert Koch Inst, Div HIV & Other Retroviruses, Berlin, Germany.; Machnowska, P; Bannert, N (corresponding author), Robert Koch Inst, Div HIV AIDS STI & Blood Borne Infect, Berlin, Germany.; Bannert, N (corresponding author), Charite Univ Med Berlin, Inst Virol, Berlin, Germany.	MachnowskaP@rki.de; BannertN@rki.de	Roider, Julia/ADV-9989-2022; Jessen, Heiko/P-2192-2019; Spinner, Christoph/H-7039-2019; Pletz, Mathias Wilhelm/H-9782-2019; Grünewald, Thomas G. P./O-2317-2013; Galle, Peter R/T-5292-2018; Schranz, Dietmar/AAU-3268-2021	Spinner, Christoph/0000-0002-3875-5367; Pletz, Mathias Wilhelm/0000-0001-8157-2753; Grünewald, Thomas G. P./0000-0003-0920-7377; Galle, Peter R/0000-0001-8294-0992; Klink, Patrycja/0000-0001-6139-9199	Federal Ministry of Health (BMG); Federal Ministry of Education and Research (BMBF)	Federal Ministry of Health (BMG); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The German Seroconverter Study was partially funded by the Federal Ministry of Health (BMG) and the Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Initials of authors who were receiving funds is not applicable.; The German Seroconverter Study was partially funded by the Federal Ministry of Health (BMG) and the Federal Ministry of Education and Research (BMBF).	Alteri C, 2011, J ANTIMICROB CHEMOTH, V66, P2615, DOI 10.1093/jac/dkr354; AMBROSIONI J, 2015, PLOS ONE, V10, P10; ANDER H, 2017, EPID BULL, V2017; Bartmeyer B, 2010, PLOS ONE, V5, P12718; Bartmeyer B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012718; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bezemer D, 2010, AIDS, V24, P271, DOI 10.1097/QAD.0b013e328333ddee; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Castro H, 2013, J INFECT DIS, V208, P1459, DOI 10.1093/infdis/jit345; Clutter DS, 2017, J INFECT DIS, V216, P387, DOI 10.1093/infdis/jix338; CONG ME, 1941, PUBMED; Cunningham E, 2017, J ANTIMICROB CHEMOTH, V72, P227, DOI 10.1093/jac/dkw404; Dauwe K, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1217-0; De Luca A, 2006, ANTIRETROVIRAL RESIS; De Luca A, 2015, J INFECT DIS, V212, P5, DOI 10.1093/infdis/jiv008; Drescher SM, 2014, CLIN INFECT DIS, V58, P285, DOI 10.1093/cid/cit694; Frentz D, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-407; Hauser A, 2017, EUROSURVEILLANCE, V22, P7, DOI 10.2807/1560-7917.ES.2017.22.2.30436; HAUSER A, 2018, 16TH EUROPEAN MEETIN, V2018, pP27; HAUSER A, 2018, PUBMED, V13, P8827; Hofstra LM, 2016, CLIN INFECT DIS, V62, P655, DOI 10.1093/cid/civ963; HTTPS, 1995, PUBMED; HTTPS, 2015, PUBMED, V212, P28; HTTPS, PUBMED; HTTPS, 1979, PUBMED; HTTPS, 1989, PUBMED; Hu ZX, 2014, J VIROL, V88, P9268, DOI 10.1128/JVI.00695-14; Jain V, 2011, J INFECT DIS, V203, P1174, DOI 10.1093/infdis/jiq167; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Little SJ, 2008, J VIROL, V82, P5510, DOI 10.1128/JVI.02579-07; Martinez-Picado J, 1999, J VIROL, V73, P3744, DOI 10.1128/JVI.73.5.3744-3752.1999; McCallum M, 2013, ANTIMICROB AGENTS CH, V57, P4681, DOI 10.1128/AAC.01029-13; Meixenberger K, 2014, J CLIN MICROBIOL, V52, P2977, DOI 10.1128/JCM.03289-13; Mourad R, 2015, AIDS, V29, P1917, DOI 10.1097/QAD.0000000000000768; Olson A, 2018, AIDS, V32, P161, DOI 10.1097/QAD.0000000000001689; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Paraskevis D, 2017, INFECT GENET EVOL, V54, P183, DOI [10., 10.1016/j.meegid.2017.07.003]; Parczewski M, 2015, J ANTIMICROB CHEMOTH, V70, P233, DOI 10.1093/jac/dku372; Pineda-Pena AC, 2014, EUROPEAN AIDS CLINIC, V9, DOI 10.1371/journal.pone.0101738; Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032; PINEDAPENA AC, 2014, PUBMED, V9, P3369; Pingen M, 2013, HIV MED, V14, P176, DOI 10.1111/j.1468-1293.2012.01037.x; Pingen M, 2011, J ANTIMICROB CHEMOTH, V66, P1467, DOI 10.1093/jac/dkr157; POURAN Y, 2016, J ACQ IMMUN DEF SYND, V73, P356; PROGRAMME TS, 2008, AIDS, V22, P625; Ragonnet-Cronin M, 2016, J INFECT DIS, V213, P1410, DOI 10.1093/infdis/jiv758; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Rimsky L, 2012, JAIDS-J ACQ IMM DEF, V59, P39, DOI 10.1097/QAI.0b013e31823df4da; Sachdeva Naresh, 2005, MedGenMed, V7, P68, DOI 10.1186/1758-2652-7-3-68; SCHMIDT D, 2017, 16TH EUROPEAN AIDS C, V16, P2017; SCHMIDT D, 2014, PUBMED, V9, P8412; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; SINGH K, 2012, J BIOL CHEM, V287, P3811; Stella-Ascariz N, 2017, J INFECT DIS, V216, pS847, DOI 10.1093/infdis/jix430; Taiwo B, 2009, INT J INFECT DIS, V13, P552, DOI 10.1016/j.ijid.2008.10.008; Toni TA, 2009, ANTIMICROB AGENTS CH, V53, P1670, DOI 10.1128/AAC.01494-08; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Violin M, 2004, AIDS, V18, P227, DOI 10.1097/00002030-200401230-00012; von Wyl V, 2009, CLIN INFECT DIS, V48, P979, DOI 10.1086/597352; Walter H, 1999, J CLIN VIROL, V13, P71, DOI 10.1016/S1386-6532(99)00010-4; WHO, 2017, WHO; Xu HT, 2013, ANTIMICROB AGENTS CH, V57, P3100, DOI 10.1128/AAC.00348-13; YANG WL, MUTATIONS, P1; YANG WL, 2015, PUBMED, V11, P8934; Yerly S, 2009, AIDS, V23, P1415, DOI 10.1097/QAD.0b013e32832d40ad; Zaccarelli M, 2005, AIDS, V19, P1081, DOI 10.1097/01.aids.0000174455.01369.ad; ZUKNYPHAUSEN F, 2014, PUBMED, V9, P8613	68	21	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209605	10.1371/journal.pone.0209605	http://dx.doi.org/10.1371/journal.pone.0209605			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650082	gold, Green Published, Green Submitted			2022-12-26	WOS:000455813300020
J	Steven, B; Lange, L; Schulz, H; Bleich, C				Steven, Berenike; Lange, Lukas; Schulz, Holger; Bleich, Christiane			Views of psycho-oncologists, physicians, and nurses on cancer care-A qualitative study	PLOS ONE			English	Article							SHARED DECISION-MAKING; EARLY PALLIATIVE CARE; BREAKING BAD-NEWS; OF-LIFE; COMMUNICATION; DISTRESS; PATIENT; PARTICIPATION; SURGERY; SUPPORT	Background As worldwide cancer prevalence continues to increase, the challenges facing cancer care are also increasing. Various topics related to deficiencies in cancer care have been discussed repeatedly in the literature. The most frequently stated topics are the unmet psychosocial support needs of cancer patients, difficulties in multidisciplinary teamwork, difficulties in communication between physicians and patients, and issues in palliative care settings. However, there is little research regarding the views of health care providers on these topics. With the aim of gaining abundant information regarding the care of German cancer patients, this study explores the stances of psycho-oncologists, physicians, and nurses regarding the quality of cancer care. Materials and methods Semi-structured interviews were conducted at the University Medical Center Hamburg-Eppendorf (UKE) and in different oncological outpatient offices in Hamburg; twenty-five interviews in total were conducted with health care providers. Interviews were semi-structured to gain a broad range of information on cancer care. The data were analyzed using thematic analysis by Braun and Clarke with an inductive, constant comparison approach to identify themes and categorized codes. Results The following five principle themes were identified in the interviews: "psycho-oncological care", "cooperation of health care providers", "palliative care", "health care provider-patient contact", and "coordination and organization of care". Participants seemed satisfied with the overall quality of cancer care in Germany. Nevertheless, the results showed deficiencies regarding communication among different health care providers and between health care providers and patients. Important findings in conjunction with these communication problems were a lack of psycho-oncological support, shortages in the oncology work force, language and cultural barriers, and deficient education in the communication of providers. Conclusions The statements of psycho-oncologists, physicians, and nurses on cancer care provide a suitable basis to conduct further focused research on the studied deficiencies in cancer care. In particular, communication in psycho-oncological care, communication within multi-disciplinary teams, and health care provider-patient communication should be further explored with the aim of developing new ideas for improvements and thereby enhancing the quality of cancer care.	[Steven, Berenike; Lange, Lukas; Schulz, Holger; Bleich, Christiane] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Lange, L (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany.	lu.lange@uke.de		Lange-Drenth, Lukas/0000-0002-4877-2005; Steven, Berenike/0000-0002-4862-1733				Alelwani Somia M, 2014, J Educ Health Promot, V3, P51, DOI 10.4103/2277-9531.134737; Alt-Epping B, 2015, BUNDESGESUNDHEITSBLA, V58, P430, DOI 10.1007/s00103-015-2125-6; Atun R, 2009, ANAL NATL CANC CONTR; Bakitas MA, 2015, J CLIN ONCOL, V33, P1438, DOI 10.1200/JCO.2014.58.6362; Barnett MM, 2007, MED EDUC, V41, P947, DOI 10.1111/j.1365-2923.2007.02832.x; Borras JM, 2014, EUR J CANCER, V50, P475, DOI 10.1016/j.ejca.2013.11.012; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bultz BD, 2011, PSYCHO-ONCOLOGY, V20, P569, DOI 10.1002/pon.1986; Burton MV, 1997, PSYCHO-ONCOL, V6, P47, DOI 10.1002/(SICI)1099-1611(199703)6:1<47::AID-PON248>3.0.CO;2-S; Carlson LE, 2004, BRIT J CANCER, V90, P2297, DOI 10.1038/sj.bjc.6601887; Clover KA, 2015, PSYCHO-ONCOLOGY, V24, P812, DOI 10.1002/pon.3729; Crowe M, 2015, AUST NZ J PSYCHIAT, V49, P616, DOI 10.1177/0004867415582053; Delgado-Guay M, 2009, SUPPORT CARE CANCER, V17, P573, DOI 10.1007/s00520-008-0529-7; Eakin EG, 2001, PSYCHO-ONCOL, V10, P103, DOI 10.1002/pon.500; Fallowfield L, 2001, BRIT J CANCER, V84, P1011, DOI 10.1054/bjoc.2001.1724; Fleissig A, 2006, LANCET ONCOL, V7, P935, DOI 10.1016/S1470-2045(06)70940-8; Friedrichsen M, 2006, J PALLIAT MED, V9, P673, DOI 10.1089/jpm.2006.9.673; Goldstein D, 2014, ANN ONCOL, V25, P1643, DOI 10.1093/annonc/mdu182; Harter M, 2011, Z EVIDENZ FORTBILD Q, V105, P263, DOI 10.1016/j.zefq.2011.04.002; Hahlweg P, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3768-5; Harrison JD, 2009, SUPPORT CARE CANCER, V17, P1117, DOI 10.1007/s00520-009-0615-5; Hillen MA, 2014, ANN ONCOL, V25, P896, DOI 10.1093/annonc/mdu027; Hillen MA, 2011, PSYCHO-ONCOLOGY, V20, P227, DOI 10.1002/pon.1745; Horlait M, 2016, SUPPORT CARE CANCER, V24, P3873, DOI 10.1007/s00520-016-3211-5; Hui D, 2010, JAMA-J AM MED ASSOC, V303, P1054, DOI 10.1001/jama.2010.258; Jacobsen PB, 2009, CANCER-AM CANCER SOC, V115, P4419, DOI 10.1002/cncr.24589; Jain AK, 2016, J ONCOL PRACT, V12, P1000, DOI 10.1200/JOP.2016.013300; Jansky M, 2011, Z PALLIATMEDIZIN, V12, P164, DOI 10.1055/s-0031-1276839; Jordhoy MS, 2000, LANCET, V356, P888, DOI 10.1016/S0140-6736(00)02678-7; Kaatsch P, 2016, CANC GERMANY 2011 20; Kamradt M, 2015, FAM PRACT, V32, P686, DOI 10.1093/fampra/cmv069; Kane HL, 2014, CA-CANCER J CLIN, V64, P377, DOI 10.3322/caac.21245; Kolva E, 2011, J PAIN SYMPTOM MANAG, V42, P691, DOI 10.1016/j.jpainsymman.2011.01.013; Kowalski C, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3824-1; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Kullberg A, 2015, EUR J ONCOL NURS, V19, P142, DOI 10.1016/j.ejon.2014.10.005; Laidsaar-Powell R, 2017, EUR J CANCER CARE, V26, DOI 10.1111/ecc.12470; Laidsaar-Powell R, 2016, SUPPORT CARE CANCER, V24, P4131, DOI 10.1007/s00520-016-3237-8; Lancaster G, 2015, J NURS SCHOLARSHIP, V47, P275, DOI 10.1111/jnu.12130; Lee Sunmin, 2012, J Behav Health, V1, DOI 10.5455/jbh.20120403024919; Levit L, 2010, J ONCOL PRACT, V6, P7, DOI 10.1200/JOP.091067; McDonald J, 2017, ANN ONCOL, V28, P163, DOI 10.1093/annonc/mdw438; McNair AGK, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2292-3; Mechanic D, 2000, SOC SCI MED, V51, P657, DOI 10.1016/S0277-9536(00)00014-9; Mehnert A, 2014, J CLIN ONCOL, V32, P3540, DOI 10.1200/JCO.2014.56.0086; O'Reilly M, 2013, QUAL RES, V13, P190, DOI 10.1177/1468794112446106; Owen R, 2008, EUR J CANCER, V44, P1163, DOI 10.1016/j.ejca.2008.02.029; Paap JV, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0130-z; Paika V, 2010, PSYCHO-ONCOLOGY, V19, P273, DOI 10.1002/pon.1563; Patlak M., 2009, ENSURING QUALITY CAN; Perneger TV, 2015, QUAL LIFE RES, V24, P147, DOI 10.1007/s11136-014-0752-2; Ringdal GI, 2001, J PAIN SYMPTOM MANAG, V22, P1016, DOI 10.1016/S0885-3924(01)00363-3; Rummans TA, 2006, J CLIN ONCOL, V24, P635, DOI 10.1200/JCO.2006.06.209; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Schneider W, 2015, GESUNDHEITSWESEN, V77, P219, DOI 10.1055/s-0034-1382041; Sepulveda C, 2002, J PAIN SYMPTOM MANAG, V24, P91, DOI 10.1016/S0885-3924(02)00440-2; Silow-Carroll Sharon, 2012, Issue Brief (Commonw Fund), V17, P1; Siminoff LA, 2006, PATIENT EDUC COUNS, V62, P355, DOI 10.1016/j.pec.2006.06.011; Sollner W, 2004, PSYCHO-ONCOL, V13, P893, DOI 10.1002/pon.897; Spinks TE, 2014, HEALTHCARE-J DEL SCI, V2, P53, DOI 10.1016/j.hjdsi.2013.11.003; Spinks TE, 2011, HEALTH AFFAIR, V30, P664, DOI 10.1377/hlthaff.2011.0089; Srivastava R, 2013, NEW ENGL J MED, V368, P302, DOI 10.1056/NEJMp1212410; Sullivan R, 2015, LANCET ONCOL, V16, P1193, DOI 10.1016/S1470-2045(15)00223-5; Sutton Jane, 2015, Can J Hosp Pharm, V68, P226; Taplin SH, 2015, J ONCOL PRACT, V11, P231, DOI 10.1200/JOP.2014.003376; Taylor E J, 2001, Semin Oncol Nurs, V17, P197, DOI 10.1053/sonu.2001.25949; Temel JS, 2017, J CLIN ONCOL, V35, P834, DOI 10.1200/JCO.2016.70.5046; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Voerman B, 2007, PSYCHO-ONCOL, V16, P1092, DOI 10.1002/pon.1160; Walsh J, 2011, EUR J CANCER CARE, V20, P220, DOI 10.1111/j.1365-2354.2010.01187.x; Wangmo T, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14309; Wentlandt K, 2016, J PAIN SYMPTOM MANAG, V51, P184, DOI 10.1016/j.jpainsymman.2015.10.006; Wentlandt K, 2014, SUPPORT CARE CANCER, V22, P2315, DOI 10.1007/s00520-014-2203-6; Wild C, 2013, EUR J CANCER CARE, V22, P773, DOI 10.1111/ecc.12089; Zimmermann C, 2014, LANCET, V383, P1721, DOI 10.1016/S0140-6736(13)62416-2	77	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210325	10.1371/journal.pone.0210325	http://dx.doi.org/10.1371/journal.pone.0210325			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650112	Green Published, Green Submitted, gold			2022-12-26	WOS:000455813300051
J	Dodd, SAS; Cave, NJ; Adolphe, JL; Shoveller, AK; Verbrugghe, A				Dodd, Sarah A. S.; Cave, Nick J.; Adolphe, Jennifer L.; Shoveller, Anna K.; Verbrugghe, Adronie			Plant-based (vegan) diets for pets: A survey of pet owner attitudes and feeding practices	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; LIFE-STYLE; CONSCIENTIOUS OMNIVORES; VEGETARIAN DIETS; MEAT-EATERS; HEALTH; FOOD; CONSUMPTION; CATS; DOGS	People who avoid eating animals tend to share their homes with animal companions, and moral dilemma may arise when they are faced with feeding animal products to their omnivorous dogs and carnivorous cats. One option to alleviate this conflict is to feed pets a diet devoid of animal ingredients-a 'plant-based' or 'vegan' diet. The number of pet owners who avoid animal products, either in their own or in their pets' diet, is not currently known. The objective of this study was to estimate the number of meat-avoiding pet owners, identify concerns regarding conventional animal- and plant-based pet food, and estimate the number of pets fed a plant-based diet. A questionnaire was disseminated online to English-speaking pet owners (n = 3,673) to collect data regarding pet owner demographics, diet, pet type, pet diet, and concerns regarding pet foods. Results found that pet owners were more likely to be vegetarian (6.2%; 229/3,673) or vegan (5.8%; 212/3,673) than previously reported for members of the general population. With the exception of one dog owned by a vegetarian, vegans were the only pet owners who fed plant-based diets to their pets (1.6%; 59/3,673). Of the pet owners who did not currently feed plant-based diets but expressed interest in doing so, a large proportion (45%; 269/599) desired more information demonstrating the nutritional adequacy of plant-based diets. Amongst all pet owners, the concern most commonly reported regarding meat-based pet foods was for the welfare of farm animals (39%; 1,275/3,231). The most common concern regarding strictly plant-based pet foods was regarding the nutritional completeness of the diet (74%; 2,439/3,318). Amongst vegans, factors which predicted the feeding of plant-based diets to their pets were concern regarding the cost of plant-based diets, a lack of concern regarding plant-based diets being unnatural, and reporting no concern at all regarding plant-based diets for pets. Given these findings, further research is warranted to investigate plant-based nutrition for domestic dogs and cats.	[Dodd, Sarah A. S.; Verbrugghe, Adronie] Univ Guelph, Dept Clin Studies, Ontario Vet Coll, Guelph, ON, Canada; [Cave, Nick J.] Massey Univ, Sch Vet Sci, Palmerston North, New Zealand; [Adolphe, Jennifer L.] Petcurean Pet Nutr, Chilliwack, BC, Canada; [Shoveller, Anna K.] Univ Guelph, Dept Anim Biosci, Guelph, ON, Canada	University of Guelph; Massey University; University of Guelph	Verbrugghe, A (corresponding author), Univ Guelph, Dept Clin Studies, Ontario Vet Coll, Guelph, ON, Canada.	averbrug@uoguelph.ca	Cave, Nick/AAQ-9789-2021	Cave, Nick/0000-0002-6037-5942; Dodd, Sarah/0000-0002-8151-5844	Petcurean Pet Nutrition; Mitacs Accelerate program; Mitacs Accelerate award [IT10206]	Petcurean Pet Nutrition; Mitacs Accelerate program; Mitacs Accelerate award	One of the authors, Dr. Jennifer Adolphe, is employed by the commercial company Petcurean Pet Nutrition. Petcurean Pet Nutrition also provided financial support for the MSc stipend for the primary author, Dr. Sarah Dodd, in association with the Mitacs Accelerate program. The funder provided support in the form of salaries for Dr. Adolphe and partial support for Dr. Dodd, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Indeed, study design, data collection and analysis had all been performed prior to Dr. Adolphe's inclusion in the project and prior to Dr. Dodd's Mitacs Accelerate award (IT10206). The specific roles of these authors are articulated in the 'author contributions' section.	Agency FS, 2006, GUID VEG VEG LAB; Allen MW, 2000, J SOC PSYCHOL, V140, P405, DOI 10.1080/00224540009600481; [Anonymous], 2017, ASS AM FEED CONTROL; [Anonymous], 2014, BOO RIPENED HUMAN DE; [Anonymous], 2017, US WORLD POP CLOCK; Appleby PN, 2016, P NUTR SOC, V75, P287, DOI 10.1017/S0029665115004334; *AVMA, 2002, US PET OWN DEM SOURC; Bates B, 2009, NATL DIET NUTR SURVE; BAUDRY J, 2017, NUTRIENTS, V9, DOI DOI 10.3390/NU9091023; Beaton L., 2018, Petfood Industry, V60, P22; Bella F, 2017, INT J FOOD SCI NUTR, V68, P402, DOI 10.1080/09637486.2016.1261087; Berschneider HM, 2002, CLIN TECH SMALL AN P, V17, P1, DOI 10.1053/svms.2002.27782; Brown W. Y., 2009, RECENT ADV ANIM NUTR, V17, P137; Brown WY, 2009, BRIT J NUTR, V102, P1318, DOI 10.1017/S0007114509389254; Case L, 2008, J ANIM SCI, V86, P3245, DOI 10.2527/jas.2008-1147; Chambers L, 2018, NUTR BULL, V43, P46, DOI 10.1111/nbu.12305; Connolly KM, 2014, JAVMA-J AM VET MED A, V245, P669, DOI 10.2460/javma.245.6.669; Craig WJ, 2009, AM J CLIN NUTR, V89, pS1627, DOI 10.3945/ajcn.2009.26736N; Davey GK, 2003, PUBLIC HEALTH NUTR, V6, P259, DOI 10.1079/PHN2002430; de Boer J, 2011, ECOL ECON, V70, P1259, DOI 10.1016/j.ecolecon.2011.03.001; de Fomel-Thibaud P, 2007, J AM ANIM HOSP ASSOC, V43, P52, DOI 10.5326/0430052; DEFRA, 2007, REP QUEST DAT TABL F; Deng P, 2015, J ANIM SCI, V93, P823, DOI 10.2527/jas.2014-8520; Dillitzer N, 2011, BRIT J NUTR, V106, pS53, DOI 10.1017/S0007114511002765; European Pet Food Industry Federation (FEDIAF), 2017, NUTR GUID COMPL COMP; Fardet A, 2014, NUTR REV, V72, P741, DOI 10.1111/nure.12153; Filippi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010847; Fox N, 2008, APPETITE, V50, P422, DOI 10.1016/j.appet.2007.09.007; GlobalData, 2017, TOP TRENDS PREP FOOD; Gosper EC, 2016, AUST VET J, V94, P12, DOI 10.1111/avj.12397; Graca J, 2015, APPETITE, V95, P113, DOI 10.1016/j.appet.2015.06.024; Graca J, 2015, APPETITE, V90, P80, DOI 10.1016/j.appet.2015.02.037; Gray CM, 2004, JAVMA-J AM VET MED A, V225, P1670, DOI 10.2460/javma.2004.225.1670; Health Navigator, 2017, VEG VEG; Hedenus F, 2014, CLIMATIC CHANGE, V124, P79, DOI 10.1007/s10584-014-1104-5; Henderson L, 2002, NATL DIET NUTR SURVE, V1; Herzog Jr H. A., 1991, ANTHROZO, V4, p184?191, DOI [10.2752/089279391787057170, DOI 10.2752/089279391787057170]; Hill D., 2004, PET FOOD ASS CAN FAL; Hill RC, 2009, JAVMA-J AM VET MED A, V234, P347, DOI 10.2460/javma.234.3.347; Hoek AC, 2004, APPETITE, V42, P265, DOI 10.1016/j.appet.2003.12.003; Hutchinson D, 2012, JAVMA-J AM VET MED A, V241, P477, DOI 10.2460/javma.241.4.477; Janssen M, 2016, APPETITE, V105, P643, DOI 10.1016/j.appet.2016.06.039; Kanakubo K, 2015, JAVMA-J AM VET MED A, V247, P385, DOI 10.2460/javma.247.4.385; Kerschke-Risch P., 2015, Ernahrungs Umschau, V62, P98; Kienzle E., 2001, COMPENDIUM, V23, P81; Kivimaki H., 2013, CROSS SECTIONAL STUD; Knight A, 2016, ANIMALS, V6, DOI 10.3390/ani6090057; Kosonen H, 2005, SOZ PRAVENTIV MED, V50, P142, DOI 10.1007/s00038-005-3167-6; Lauten S. D., 2005, Journal of Veterinary Internal Medicine, V19, P476; Lawton R, 2009, HEALTH PSYCHOL, V28, P56, DOI 10.1037/a0013424; Lummis D., NATURAL ORGANIC ECO; Lund TB, 2016, ANTHROZOOS, V29, P89, DOI 10.1080/08927936.2015.1083192; Macdiarmid JI, 2016, APPETITE, V96, P487, DOI 10.1016/j.appet.2015.10.011; Maine IR, 2015, ACTA VET SCAND, V57, P1, DOI 10.1186/s13028-015-0097-z; Mangels AR, 2003, J AM DIET ASSOC, V103, P748, DOI 10.1053/jada.2003.50142; McDonald B, 2000, SOC ANIM, V8, P1, DOI 10.1163/156853000X00011; Meeker DL, 2015, J ANIM SCI, V93, P835, DOI 10.2527/jas.2014-8524; Mekonnen MM, 2012, ECOSYSTEMS, V15, P401, DOI 10.1007/s10021-011-9517-8; Michel KE, 2006, VET CLIN N AM-SMALL, V36, P1269, DOI 10.1016/j.cvsm.2006.08.003; Michel KE, 2008, JAVMA-J AM VET MED A, V233, P1699, DOI 10.2460/javma.233.11.1699; Morgan R., 2016, SLOW STEADY RISE VEG; Morgan SK, 2017, PEERJ, V5, DOI 10.7717/peerj.3031; Morris JG, 2002, NUTR RES REV, V15, P153, DOI 10.1079/NRR200238; Nath J, 2010, HEALTH SOCIOL REV, V19, P356, DOI 10.5172/hesr.2010.19.3.356; National Research Council, 2006, NUTR REQ DOGS CATS; Newport F, 2012, US 5 CONSIDER THEMSE; Okin GS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181301; Parr JM, 2014, VET CLIN N AM-SMALL, V44, P667, DOI 10.1016/j.cvsm.2014.03.006; Paul ES, 2000, ANTHROZOOS, V13, P194, DOI 10.2752/089279300786999699; PFI, 2015, PET FOOD TRENDS FOLL; Pimentel D, 2003, AM J CLIN NUTR, V78, p660S, DOI 10.1093/ajcn/78.3.660S; Preylo BD, 2008, ANTHROZOOS, V21, P387, DOI 10.2752/175303708X371654; Prunty J, 2013, ANTHROZOOS, V26, P265, DOI 10.2752/175303713X13636846944367; Radnitz C, 2015, APPETITE, V90, P31, DOI 10.1016/j.appet.2015.02.026; Rahaman S, 2000, COMPENDIUM CONTINUIN, V22, P70; Rajagopaul S, 2016, J SMALL ANIM PRACT, V57, P484, DOI 10.1111/jsap.12526; Remillard RL, 2008, TOP COMPANION ANIM M, V23, P137, DOI 10.1053/j.tcam.2008.04.006; Rothgerber H, 2015, APPETITE, V87, P251, DOI 10.1016/j.appet.2014.12.206; Rothgerber H, 2014, ANTHROZOOS, V27, P485, DOI 10.2752/089279314X14072268687844; Rothgerber H, 2015, APPETITE, V84, P196, DOI 10.1016/j.appet.2014.10.012; Rothgerber H, 2013, APPETITE, V68, P76, DOI 10.1016/j.appet.2013.04.012; Roudebush Philip, 1992, Vet Dermatol, V3, P23, DOI 10.1111/j.1365-3164.1992.tb00139.x; Scarborough P, 2014, CLIMATIC CHANGE, V125, P179, DOI 10.1007/s10584-014-1169-1; Semp P., 2014, THESIS VET U VIENNA; Spencer EH, 2007, J AM DIET ASSOC, V107, P72, DOI 10.1016/j.jada.2006.10.034; Stockman J, 2013, JAVMA-J AM VET MED A, V242, P1500, DOI 10.2460/javma.242.11.1500; Swanson KS, 2013, ADV NUTR, V4, P141, DOI 10.3945/an.112.003335; Sydney N, 2013, SURV 1202 AUSTR WHET; Taylor N, 2005, ANTHROZOOS, V18, P18, DOI 10.2752/089279305785594342; Verbrugghe A, 2011, VLAAMS DIERGEN TIJDS, V80, P61; Verbrugghe A, 2012, CRITICAL REV FOOD SC, V52, P203; Vinnari M, 2007, PUBLIC HEALTH NUTR, V12, P481; Vinnari M, 2009, PUBLIC HEALTH NUTR, V12, P481, DOI 10.1017/S1368980008002486; Wakefield LA, 2006, JAVMA-J AM VET MED A, V229, P70, DOI 10.2460/javma.229.1.70; Yeliosof O, 2018, J PEDIATR ENDOCR MET, V31, P91, DOI 10.1515/jpem-2017-0082; Yip CSC, 2013, INT J PUBLIC HEALTH, V58, P683, DOI 10.1007/s00038-013-0484-z	96	30	30	9	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210806	10.1371/journal.pone.0210806	http://dx.doi.org/10.1371/journal.pone.0210806			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6AH	30645644	Green Published, gold, Green Submitted			2022-12-26	WOS:000455810200057
J	Emmott, E; de Rougemont, A; Hosmillo, M; Lu, J; Fitzmaurice, T; Haas, J; Goodfellow, I				Emmott, Edward; de Rougemont, Alexis; Hosmillo, Myra; Lu, Jia; Fitzmaurice, Timothy; Haas, Juergen; Goodfellow, Ian			Polyprotein processing and intermolecular interactions within the viral replication complex spatially and temporally control norovirus protease activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protease; fluorescence resonance energy transfer (FRET); viral replication; plus-stranded RNA virus; RNA virus; Calicivirus; Norovirus; Precursor	MURINE NOROVIRUS; RNA-SYNTHESIS; PROTEINASE-POLYMERASE; VIRUS; CLEAVAGE; INITIATION; VPG; DISCOVERY; PRECURSOR; RECEPTOR	Norovirus infections are a major cause of acute viral gastroenteritis and a significant burden on global human health. A vital process for norovirus replication is the processing of the nonstructural polyprotein by a viral protease into the viral components required to form the viral replication complex. This cleavage occurs at different rates, resulting in the accumulation of stable precursor forms. Here, we characterized how precursor forms of the norovirus protease accumulate during infection. Using stable forms of the protease precursors, we demonstrated that all of them are proteolytically active in vitro, but that when expressed in cells, their activities are determined by both substrate and protease localization. Although all precursors could cleave a replication complex-associated substrate, only a subset of precursors lacking the NS4 protein were capable of efficiently cleaving a cytoplasmic substrate. By mapping the full range of protein-protein interactions among murine and human norovirus proteins with the LUMIER assay, we uncovered conserved interactions between replication complex members that modify the localization of a protease precursor subset. Finally, we demonstrate that fusion to the membrane-bound replication complex components permits efficient cleavage of a fused substrate when active polyprotein-derived protease is provided in trans. These findings offer a model for how norovirus can regulate the timing of substrate cleavage throughout the replication cycle. Because the norovirus protease represents a key target in antiviral therapies, an improved understanding of its function and regulation, as well as identification of interactions among the other nonstructural proteins, offers new avenues for antiviral drug design.	[Emmott, Edward; Hosmillo, Myra; Lu, Jia; Fitzmaurice, Timothy; Goodfellow, Ian] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Div Virol, Hills Rd, Cambridge CB2 0QQ, England; [de Rougemont, Alexis] Univ Hosp Dijon Bourgogne, Natl Reference Ctr Gastroenteritis Viruses Labol, F-21700 Dijon, France; [de Rougemont, Alexis] Bourgogne Franche Comte Univ, AgroSup Dijon, PAM, UMR A 02 102, F-21000 Dijon, France; [Haas, Juergen] Univ Edinburgh, Med Sch, Div Infect & Pathway Med, Edinburgh EH16 4SB, Midlothian, Scotland	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne; University of Edinburgh	Goodfellow, I (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Div Virol, Hills Rd, Cambridge CB2 0QQ, England.; Emmott, E (corresponding author), Northeastern Univ, Dept Bioengn, 360 Huntington Ave, Boston, MA 02115 USA.	e.emmott@northeastern.edu; ig299@cam.ac.uk	de ROUGEMONT, Alexis/M-1090-2016	de ROUGEMONT, Alexis/0000-0002-3084-9414; Fitzmaurice, Tim/0000-0003-1403-2495; Lu, Jia/0000-0003-3995-324X; Goodfellow, Ian/0000-0002-9483-510X; Emmott, Edward/0000-0002-3239-8178; Hosmillo, Myra/0000-0002-3514-7681	Cambridge National Institute for Health Research Cambridge Biomedical Research Centre Cell Phenotyping Hub; BBSRC [BB/I012303/1, BB/N001176/1] Funding Source: UKRI	Cambridge National Institute for Health Research Cambridge Biomedical Research Centre Cell Phenotyping Hub; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Cambridge National Institute for Health Research Cambridge Biomedical Research Centre Cell Phenotyping Hub. The authors declare that they have no conflicts of interest with the contents of this article.	Arias A, 2012, JOVE-J VIS EXP, DOI 10.3791/4145; Arias A, 2013, FUTURE MICROBIOL, V8, P1475, DOI 10.2217/fmb.13.109; Bailey D, 2010, J GEN VIROL, V91, P739, DOI 10.1099/vir.0.016279-0; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Barrios-Rodiles M, 2017, METHODS MOL BIOL, V1550, P137, DOI 10.1007/978-1-4939-6747-6_11; Belliot G, 2005, J VIROL, V79, P2393, DOI 10.1128/JVI.79.4.2393-2403.2005; Cameron CE, 2010, FUTURE MICROBIOL, V5, P867, DOI 10.2217/FMB.10.40; Chaudhry Y, 2007, J GEN VIROL, V88, P2091, DOI 10.1099/vir.0.82940-0; Chung L, 2014, J BIOL CHEM, V289, P21738, DOI 10.1074/jbc.M114.550657; Cotton BT, 2017, J VIROL, V91, DOI 10.1128/JVI.02138-16; den Boon JA, 2010, CELL HOST MICROBE, V8, P77, DOI 10.1016/j.chom.2010.06.010; Emmott E, 2017, MOL CELL PROTEOMICS, V16, pS215, DOI 10.1074/mcp.M116.062448; Emmott E, 2015, J BIOL CHEM, V290, P27841, DOI 10.1074/jbc.M115.688234; Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211; Haga K, 2016, P NATL ACAD SCI USA, V113, pE6248, DOI 10.1073/pnas.1605575113; Holden Paul, 2009, BMC Res Notes, V2, P243, DOI 10.1186/1756-0500-2-243; Hwang S., 2014, CURR PROTOC MICROBIO, V33, p15K21, DOI DOI 10.1002/9780471729259.MC15K02S33; Hyde JL, 2010, VIROLOGY, V406, P138, DOI 10.1016/j.virol.2010.06.047; Hyde JL, 2009, J VIROL, V83, P9709, DOI 10.1128/JVI.00600-09; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Kaiser WJ, 2006, J GEN VIROL, V87, P363, DOI 10.1099/vir.0.81456-0; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Karst SM, 2016, J MED VIROL, V88, P1837, DOI 10.1002/jmv.24559; Karst SM, 2015, ANNU REV VIROL, V2, P525, DOI 10.1146/annurev-virology-100114-055204; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; May J, 2013, VIROLOGY, V444, P218, DOI 10.1016/j.virol.2013.06.013; Medvedev A, 2017, VIROLOGY, V503, P37, DOI 10.1016/j.virol.2017.01.003; Nice TJ, 2013, J VIROL, V87, P327, DOI 10.1128/JVI.01864-12; Oh HS, 2009, J VIROL, V83, P9370, DOI 10.1128/JVI.02076-08; Olspert A, 2016, PEERJ, V4, DOI 10.7717/peerj.2134; Orchard RC, 2016, SCIENCE, V353, P933, DOI 10.1126/science.aaf1220; Pathak Harsh B, 2008, J Biol Chem, V283, P30677, DOI 10.1074/jbc.M806101200; Pfister T, 2001, J VIROL, V75, P1611, DOI 10.1128/JVI.75.4.1611-1619.2001; Reid CR, 2015, VIRUSES-BASEL, V7, P4385, DOI 10.3390/v7082825; Rocha-Pereira J, 2016, CURR OPIN VIROL, V20, P92, DOI 10.1016/j.coviro.2016.09.009; Rohayem J, 2006, J VIROL, V80, P7060, DOI 10.1128/JVI.02195-05; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Scheffler U, 2007, J GEN VIROL, V88, P2013, DOI 10.1099/vir.0.82797-0; SHIRAKO Y, 1994, J VIROL, V68, P1874, DOI 10.1128/JVI.68.3.1874-1885.1994; Sosnovtsev SV, 2006, J VIROL, V80, P7816, DOI 10.1128/JVI.00532-06; Subba-Reddy CV, 2011, J VIROL, V85, P13027, DOI 10.1128/JVI.06191-11; Thorne L, 2012, J VIROL, V86, P11441, DOI 10.1128/JVI.00439-12; Thorne LG, 2014, J GEN VIROL, V95, P278, DOI 10.1099/vir.0.059634-0; Vashist S, 2012, J VIROL, V86, P11977, DOI 10.1128/JVI.00432-12; Vashist S, 2012, J VIROL METHODS, V184, P69, DOI 10.1016/j.jviromet.2012.05.012; Viswanathan P, 2013, VIROLOGY, V438, P20, DOI 10.1016/j.virol.2013.01.006; Wei L, 2001, J VIROL, V75, P1211, DOI 10.1128/JVI.75.3.1211-1219.2001	48	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4259	4271		10.1074/jbc.RA118.006780	http://dx.doi.org/10.1074/jbc.RA118.006780			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30647130	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000461854400035
J	Nakamichi, Y; Fouquet, T; Ito, S; Watanabe, M; Matsushika, A; Inoue, H				Nakamichi, Yusuke; Fouquet, Thierry; Ito, Shotaro; Watanabe, Masahiro; Matsushika, Akinori; Inoue, Hiroyuki			Structural and functional characterization of a bifunctional GH30-7 xylanase B from the filamentous fungus Talaromyces cellulolyticus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoside hydrolase; X-ray crystallography; enzyme structure; polysaccharide; mass spectrometry (MS); glucuronoxylanase; glycoside hydrolase family 30; Talaromyces cellulolyticus; xylobiohydrolase; xylooligosaccharide	HYDROLASE FAMILY 30; GLUCURONOXYLAN-SPECIFIC XYLANASE; ACREMONIUM-CELLULOLYTICUS; THERMOTOGA-MARITIMA; EXO-MODE; STRAIN; SYSTEM; IMPROVEMENT; RECOGNITION; ENZYMES	Glucuronoxylanases are endo-xylanases and members of the glycoside hydrolase family 30 subfamilies 7 (GH30-7) and 8 (GH30-8). Unlike for the well-studied GH30-8 enzymes, the structural and functional characteristics of GH30-7 enzymes remain poorly understood. Here, we report the catalytic properties and three-dimensional structure of GH30-7 xylanase B (Xyn30B) identified from the cellulolytic fungus Talaromyces cellulolyticus. Xyn30B efficiently degraded glucuronoxylan to acidic xylooligosaccharides (XOSs), including an -1,2-linked 4-O-methyl-d-glucuronosyl substituent (MeGlcA). Rapid analysis with negative-mode electrospray-ionization multistage MS (ESI(-)-MSn) revealed that the structures of the acidic XOS products are the same as those of the hydrolysates (MeGlcA(2)Xyl(n), n > 2) obtained with typical glucuronoxylanases. Acidic XOS products were further degraded by Xyn30B, releasing first xylobiose and then xylotetraose and xylohexaose as transglycosylation products. This hydrolase reaction was unique to Xyn30B, and the substrate was cleaved at the xylobiose unit from its nonreducing end, indicating that Xyn30B is a bifunctional enzyme possessing both endo-glucuronoxylanase and exo-xylobiohydrolase activities. The crystal structure of Xyn30B was determined as the first structure of a GH30-7 xylanase at 2.25 resolution, revealing that Xyn30B is composed of a pseudo-(/)(8)-catalytic domain, lacking an 6 helix, and a small -rich domain. This structure and site-directed mutagenesis clarified that Arg(46), conserved in GH30-7 glucuronoxylanases, is a critical residue for MeGlcA appendage-dependent xylan degradation. The structural comparison between Xyn30B and the GH30-8 enzymes suggests that Asn(93) in the 2-2 loop is involved in xylobiohydrolase activity. In summary, our findings indicate that Xyn30B is a bifunctional endo- and exo-xylanase.	[Nakamichi, Yusuke; Watanabe, Masahiro; Matsushika, Akinori; Inoue, Hiroyuki] Natl Inst Adv Ind Sci & Technol, Bioconvers Grp, 3-11-32 Kagamiyama, Hiroshima 7390046, Japan; [Ito, Shotaro] Natl Inst Adv Ind Sci & Technol, Res Inst Sustainable Chem, Biobased Mat Chem, 3-11-32 Kagamiyama, Hiroshima 7390046, Japan; [Fouquet, Thierry] AIST, Res Inst Sustainable Chem, Polymer Chem Grp, 1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan; [Matsushika, Akinori] Hiroshima Univ, Grad Sch Adv Sci Matter, 1-3-1 Kagamiyama, Hiroshima 7398530, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Hiroshima University	Inoue, H (corresponding author), Natl Inst Adv Ind Sci & Technol, Inst Sustainable Chem, Hiroshima 7390046, Japan.	inoue-h@aist.go.jp	Nakamichi, Yusuke/Y-2830-2019; Nakamichi, Yusuke/H-1221-2018; Ito, Shotaro/L-5701-2016; Inoue, Hiroyuki/AAQ-3226-2020; Fouquet, Thierry/O-1679-2013; Inoue, Hiroyuki/L-9990-2016; Matsushika, Akinori/B-8721-2018	Nakamichi, Yusuke/0000-0001-7089-663X; Nakamichi, Yusuke/0000-0001-7089-663X; Ito, Shotaro/0000-0001-5212-7466; Inoue, Hiroyuki/0000-0003-0190-2893; Fouquet, Thierry/0000-0002-9473-9425; Inoue, Hiroyuki/0000-0003-0190-2893; Matsushika, Akinori/0000-0002-5283-2875; Watanabe, Masahiro/0000-0001-5211-1333				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adav SS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012419; [Anonymous], 2018, PYMOL MOL GRAPHICS S; Biely P, 2014, FEBS J, V281, P3894, DOI 10.1111/febs.12925; Bunkoczi G, 2011, ACTA CRYSTALLOGR D, V67, P303, DOI 10.1107/S0907444910051218; Cartmell A, 2008, J BIOL CHEM, V283, P34403, DOI 10.1074/jbc.M804053200; Cataldi TRI, 2000, FRESEN J ANAL CHEM, V368, P739, DOI 10.1007/s002160000588; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fang X, 2009, J BIOSCI BIOENG, V107, P256, DOI 10.1016/j.jbiosc.2008.11.022; Fouquet T, 2019, J MASS SPECTROM, V54, P213, DOI 10.1002/jms.4321; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Fujii T, 2018, FUNGAL CELLULOLYTIC, P58; Fujii T, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00014-15; Fujii T, 2012, BIOSCI BIOTECH BIOCH, V76, P245, DOI 10.1271/bbb.110498; Fushinobu S, 2005, J BIOL CHEM, V280, P17180, DOI 10.1074/jbc.M413693200; Gatard S, 2017, CARBOHYD RES, V451, P72, DOI 10.1016/j.carres.2017.09.012; Hurlbert JC, 2001, J BACTERIOL, V183, P2093, DOI 10.1128/JB.183.6.2093-2100.2001; Inoue H, 2013, J IND MICROBIOL BIOT, V40, P823, DOI 10.1007/s10295-013-1286-2; Jiang ZQ, 2004, J BIOTECHNOL, V114, P125, DOI 10.1016/j.jbiotec.2004.05.007; Jiang ZQ, 2001, J BIOSCI BIOENG, V92, P423, DOI [10.1263/jbb.92.423, 10.1016/S1389-1723(01)80290-5]; John FJS, 2006, J BACTERIOL, V188, P8617, DOI 10.1128/JB.01283-06; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karnaouri A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00281; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; Kolbusz MA, 2014, FUNGAL GENET BIOL, V72, P10, DOI 10.1016/j.fgb.2014.05.006; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larson SB, 2003, BIOCHEMISTRY-US, V42, P8411, DOI 10.1021/bi034144c; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luo HY, 2010, APPL MICROBIOL BIOT, V86, P1829, DOI 10.1007/s00253-009-2410-0; Maehara T, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01850-17; McIlvaine TC, 1921, J BIOL CHEM, V49, P183; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Nielsen H, 2017, METHODS MOL BIOL, V1611, P59, DOI 10.1007/978-1-4939-7015-5_6; Padilha IQM, 2014, INT MICROBIOL, V17, P175, DOI 10.2436/20.1501.01.220; Peterson R, 2012, MICROBIOL-SGM, V158, P58, DOI 10.1099/mic.0.054031-0; Proctor MR, 2005, P NATL ACAD SCI USA, V102, P2697, DOI 10.1073/pnas.0500051102; Reis A, 2003, CARBOHYD RES, V338, P1497, DOI 10.1016/S0008-6215(03)00196-4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santos CR, 2014, J BIOL CHEM, V289, P7362, DOI 10.1074/jbc.M113.537167; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; St John F.J., 2016, J MOL CATAL B-ENZYM, V133, pS445, DOI [10.1016/j.molcatb.2017.03.008, DOI 10.1016/J.MOLCATB.2017.03.008]; St John FJ, 2018, BIOCHEM J, V475, P1533, DOI 10.1042/BCJ20180050; St John FJ, 2014, ACTA CRYSTALLOGR D, V70, P2950, DOI 10.1107/S1399004714019531; St John FJ, 2011, J MOL BIOL, V407, P92, DOI 10.1016/j.jmb.2011.01.010; St John FJ, 2010, FEBS LETT, V584, P4435, DOI 10.1016/j.febslet.2010.09.051; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Suchova K, 2018, ARCH BIOCHEM BIOPHYS, V643, P42, DOI 10.1016/j.abb.2018.02.014; Tenkanen M, 2013, FEBS J, V280, P285, DOI 10.1111/febs.12069; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Urbanikova L, 2011, FEBS J, V278, P2105, DOI 10.1111/j.1742-4658.2011.08127.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Valenzuela SV, 2012, APPL ENVIRON MICROB, V78, P3923, DOI 10.1128/AEM.07932-11; Vrsanska M, 2007, FEBS J, V274, P1666, DOI 10.1111/j.1742-4658.2007.05710.x; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yao YY, 2008, PROTEIN ENG DES SEL, V21, P561, DOI 10.1093/protein/gzn033; Yaoi K, 2007, J MOL BIOL, V370, P53, DOI 10.1016/j.jmb.2007.04.035; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4	59	30	30	0	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4065	4078		10.1074/jbc.RA118.007207	http://dx.doi.org/10.1074/jbc.RA118.007207			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30655295	Green Published, hybrid			2022-12-26	WOS:000461854400020
J	Lumley, S; Green, C; Rafferty, H; Smith, C; Harber, M; O'Beirne, J; Jones, G; Thorburn, D; Marshall, A; Shah, T; Zuhair, M; Rothwell, E; Atabani, S; Haque, T; Griffiths, P				Lumley, Sheila; Green, Cameron; Rafferty, Hannah; Smith, Colette; Harber, Mark; O'Beirne, James; Jones, Gareth; Thorburn, Douglas; Marshall, Aileen; Shah, Tina; Zuhair, Mohamed; Rothwell, Emily; Atabani, Sowsan; Haque, Tanzina; Griffiths, Paul			Cytomegalovirus viral load parameters associated with earlier initiation of pre-emptive therapy after solid organ transplantation	PLOS ONE			English	Article							RECIPIENTS; KINETICS; DISEASE	Background Human cytomegalovirus (HCMV) can be managed by monitoring HCMV DNA in the blood and giving valganciclovir when viral load exceeds a defined value. We hypothesised that such pre-emptive therapy should occur earlier than the standard 3000 genomes/ml (2520 IU/ml) when a seropositive donor transmitted virus to a seronegative recipient (D+R-) following solid organ transplantation (SOT). Methods Our local protocol was changed so that D+R-SOT patients commenced valganciclovir once the viral load exceeded 200 genomes/ml; 168 IU/ml (new protocol). The decision point remained at 3000 genomes/ml (old protocol) for the other two patient subgroups (D+R+, D-R+). Virological outcomes were assessed three years later, when 74 D+R- patients treated under the old protocol could be compared with 67 treated afterwards. The primary outcomes were changes in peak viral load, duration of viraemia and duration of treatment in the D+R-group. The secondary outcome was the proportion of D+R- patients who developed subsequent viraemia episodes. Findings In the D+R- patients, the median values of peak viral load (30,774 to 11,135 genomes/ml, p<0.0215) were significantly reduced on the new protocol compared to the old, but the duration of viraemia and duration of treatment were not. Early treatment increased subsequent episodes of viraemia from 33/58 (57%) to 36/49 (73%) of patients (p<0.0743) with a significant increase (p = 0.0072) in those episodes that required treatment (16/58; 27% versus 26/49; 53%). Median peak viral load increased significantly (2,103 to 3,934 genomes/ml, p<0.0249) in the D+R+ but not in the D-R+ patient subgroups. There was no change in duration of viraemia or duration of treatment for any patient subgroup. Interpretation Pre-emptive therapy initiated at the first sign of viraemia post-transplant significantly reduced the peak viral load but increased later episodes of viraemia, consistent with the hypothesis of reduced antigenic stimulation of the immune system.	[Lumley, Sheila; Green, Cameron; Rafferty, Hannah; Zuhair, Mohamed; Rothwell, Emily; Atabani, Sowsan; Haque, Tanzina; Griffiths, Paul] UCL, Med Sch, Ctr Virol, London, England; [Smith, Colette] UCL, Inst Global Hlth, London, England; [Harber, Mark; Jones, Gareth] Royal Free Hosp, Renal Transplant Unit, London, England; [O'Beirne, James; Thorburn, Douglas; Marshall, Aileen; Shah, Tina] Royal Free Hosp, Royal Free Sheila Sherlock Liver Ctr, London, England; [Lumley, Sheila] Oxford Univ Hosp NHS Fdn Trust, Oxford, England; [O'Beirne, James] Sunshine Coast Univ Hosp, Birtinya, Qld, Australia; [Atabani, Sowsan] Univ Hosp Birmingham, Natl Infect Serv, Publ Hlth England Birmingham Lab, Birmingham, W Midlands, England	University of London; University College London; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Oxford University Hospitals NHS Foundation Trust; University of Birmingham	Griffiths, P (corresponding author), UCL, Med Sch, Ctr Virol, London, England.	p.griffiths@ucl.ac.uk	O'Beirne, James/I-8251-2019	O'Beirne, James/0000-0003-3400-2816; Rafferty, Hannah/0000-0002-0398-1567; Braddy-Green, Cameron/0000-0002-5288-1044; Smith, Colette/0000-0003-2847-3355; Lumley, Sheila/0000-0001-6825-9324	Wellcome Trust [078332]	Wellcome Trust(Wellcome TrustEuropean Commission)	No specific research grant was obtained for this audit, but CMV research is supported by the Wellcome Trust through grant 078332 to PDG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, GUIDE MANAGING ETHIC; Atabani SF, 2012, AM J TRANSPLANT, V12, P2457, DOI 10.1111/j.1600-6143.2012.04087.x; Cope AV, 1997, J INFECT DIS, V176, P1484, DOI 10.1086/514145; Emery VC, 2000, LANCET, V355, P2032, DOI 10.1016/S0140-6736(00)02350-3; Emery VC, 1999, J EXP MED, V190, P177, DOI 10.1084/jem.190.2.177; Fisher CE, 2017, CLIN INFECT DIS, V65, P57, DOI 10.1093/cid/cix259; Fryer JF., 2010, EXPERT COMMITTEE BIO; Griffiths PD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163722; Griffiths PD, 2011, LANCET, V377, P1256, DOI 10.1016/S0140-6736(11)60136-0; Humar A, 2010, AM J TRANSPLANT, V10, P1228, DOI 10.1111/j.1600-6143.2010.03074.x; Kotton CN, 2013, TRANSPLANTATION, V96, P333, DOI 10.1097/TP.0b013e31829df29d; Ljungman P, 2017, CLIN INFECT DIS, V64, P87, DOI 10.1093/cid/ciw668; Mattes FM, 2005, J INFECT DIS, V191, P89, DOI 10.1086/425905; Natori Y, 2018, CLIN INFECT DIS, V66, P617, DOI 10.1093/cid/cix793; Owers DS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005133.pub3; Singh N, 2006, REV MED VIROL, V16, P281, DOI 10.1002/rmv.513	16	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210420	10.1371/journal.pone.0210420	http://dx.doi.org/10.1371/journal.pone.0210420			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682032	Green Published, gold, Green Submitted			2022-12-26	WOS:000457037500036
J	Opoka, RO; Ssemata, AS; Oyang, W; Nambuya, H; John, CC; Karamagi, C; Tumwine, JK				Opoka, Robert O.; Ssemata, Andrew S.; Oyang, William; Nambuya, Harriet; John, Chandy C.; Karamagi, Charles; Tumwine, James K.			Adherence to clinical guidelines is associated with reduced inpatient mortality among children with severe anemia in Ugandan hospitals	PLOS ONE			English	Article							KENYAN HOSPITALS; SERIOUS ILLNESS; PEDIATRIC CARE; QUALITY; MALARIA; SCORE	Background In resource limited settings, there is variability in the level of adherence to clinical guidelines in the inpatient management of children with common conditions like severe anemia. However, there is limited data on the effect of adherence to clinical guidelines on inpatient mortality in children managed for severe anemia. Methods We analyzed data from an uncontrolled before and after in-service training intervention to improve quality of care in Lira and Jinja regional referral hospitals in Uganda. Inpatient records of children aged 0 to 5 years managed as cases of ` severe anemia (SA)' were reviewed to ascertain adherence to clinical guidelines and compare inpatient deaths in SA children managed versus those not managed according to clinical guidelines. Logistic regression analysis was conducted to evaluate the relationship between clinical care factors and inpatient deaths amongst patients managed for SA. Results A total of 1,131 children were assigned a clinical diagnosis of ` severe anemia' in the two hospitals. There was improvement in the level of care after the in-service training intervention with more children being managed according to clinical guidelines compared to the period before, 218/510 (42.7%) vs 158/621 (25.4%) (p < 0.001). Overall, children managed according to clinical guidelines had reduced risk of inpatient mortality compared to those not managed according to clinical guidelines, [OR 0.28, (95%, CI 0.14, 0.55), p = 0.001]. Clinical care factors associated with decreased risk of inpatient death included, having pre-transfusion hemoglobin done to confirm diagnosis [OR 0.5; 95% CI 0.29, 0.87], a co-morbid diagnosis of severe malaria [OR 0.4; 95% CI 0.25, 0.76], and being reviewed after admission by a clinician [OR 0.3; 95% CI 0.18, 0.59], while a co-morbid diagnosis of severe acute malnutrition was associated with increased risk of inpatient death [OR 4.2; 95% CI 2.15, 8.22]. Conclusion Children with suspected SA who are managed according to clinical guidelines have lower in-hospital mortality than those not managed according to the guidelines. Efforts to reduce inpatient mortality in SA children in resource-limited settings should focus on training and supporting health workers to adhere to clinical guidelines.	[Opoka, Robert O.; Karamagi, Charles; Tumwine, James K.] Makerere Univ, Dept Paediat & Child Hlth, Coll Hlth Sci, Kampala, Uganda; [Ssemata, Andrew S.] Makerere Univ, Dept Psychiat, Coll Hlth Sci, Kampala, Uganda; [Oyang, William] Lira Reg Referral Hosp, Childrens Ward, Lira, Uganda; [Nambuya, Harriet] Jinja Reg Referral Hosp, Nalufenya Childrens Ward, Jinja, Uganda; [John, Chandy C.] Indiana Univ Sch Med, Ryan White Ctr Pediat Infect Dis & Global Hlth, Indianapolis, IN 46202 USA	Makerere University; Makerere University; Indiana University System; Indiana University Bloomington	Opoka, RO (corresponding author), Makerere Univ, Dept Paediat & Child Hlth, Coll Hlth Sci, Kampala, Uganda.	opokabob@yahoo.com	John, Chandy/GNP-8431-2022	John, Chandy/0000-0002-1634-1411; Opoka, Robert/0000-0003-3240-2058	National Institutes of Health [D43TW010132]; Fogarty International Centre [D43 NS078280]; FOGARTY INTERNATIONAL CENTER [D43TW010132, D43TW010928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Centre(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by funding from grant number D43TW010132 from National Institutes of Health and a Fogarty International Centre grant number D43 NS078280, awarded to CCJ. The funders played not role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this work are solely the responsibility of the authors and do not necessarily represent the official views of the funders.	Ayieko P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001018; Bachou Hanifa, 2006, BMC Pediatr, V6, P7, DOI 10.1186/1471-2431-6-7; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; English M, 2004, LANCET, V363, P1948, DOI 10.1016/S0140-6736(04)16408-8; English M, 2002, LANCET, V359, P494, DOI 10.1016/S0140-6736(02)07666-3; English M, 2011, ARCH DIS CHILD, V96, P285, DOI 10.1136/adc.2010.189126; Ernest S K, 2002, West Afr J Med, V21, P177; Hoque DME, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-197; Hospital Care for Children, 2013, GUID MAN COMM CHILDH; Hossain M, 2017, J PAEDIATR CHILD H, V53, P474, DOI 10.1111/jpc.13443; Idro R, 2006, TROP MED INT HEALTH, V11, P115, DOI 10.1111/j.1365-3156.2005.01518.x; Idro Richard, 2004, Afr Health Sci, V4, P50; Irimu G, 2008, ARCH DIS CHILD, V93, P799, DOI 10.1136/adc.2007.126508; Irimu GW, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-59; Irimu GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039964; Kiggundu VL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082455; Kiguli S, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0246-7; Koram KA, 2000, AM J TROP MED HYG, V62, P670, DOI 10.4269/ajtmh.2000.62.670; Muoneke VU, 2012, INDIAN PEDIATR, V49, P119, DOI 10.1007/s13312-012-0026-4; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; Nzinga J, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-45; Okechukwu A A, 2011, Niger J Med, V20, P109; Opoka RO, 2017, J PEDIATR INFECT DIS, V6, pE41, DOI 10.1093/jpids/piw060; Opondo C, 2018, LANCET GLOB HEALTH, V6, pE203, DOI 10.1016/S2214-109X(17)30484-9; Opondo C, 2016, TROP MED INT HEALTH, V21, P1334, DOI 10.1111/tmi.12752; Sears D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127192; Shari Catherine R, 2017, BMC Hematol, V17, P19, DOI 10.1186/s12878-017-0091-y; Tuyisenge L, 2014, ARCH DIS CHILD, V99, P993, DOI 10.1136/archdischild-2014-306078	28	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210982	10.1371/journal.pone.0210982	http://dx.doi.org/10.1371/journal.pone.0210982			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682097	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000457037500084
J	Pasznik, P; Rutkowska, E; Niewieczerzal, S; Cielecka-Piontek, J; Latek, D				Pasznik, Pawel; Rutkowska, Ewelina; Niewieczerzal, Szymon; Cielecka-Piontek, Judyta; Latek, Dorota			Potential off-target effects of beta-blockers on gut hormone receptors: In silico study including GUT-DOCK-A web service for small-molecule docking	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; GLUCAGON-LIKE PEPTIDE-1; DIABETES-MELLITUS; BINDING-AFFINITY; MEMBRANE-BUILDER; ACCURATE DOCKING; SCORING FUNCTION; AUTODOCK VINA; SOFTWARE NEWS; HYPERTENSION	The prolonged use of many currently available drugs results in the severe side effect of the disruption of glucose metabolism leading to type 2 diabetes mellitus (T2DM. Gut hormone receptors including glucagon receptor (GCGR) and the incretin hormone receptors: glucagon-like peptide 1 receptor (GLP1R) and gastric inhibitory polypeptide receptor (GIPR) are important drug targets for the treatment of T2DM, as they play roles in the regulation of glucose and insulin levels and of food intake. In this study, we hypothesized that we could compensate for the negative influences of specific drugs on glucose metabolism by the positive incretin effect enhanced by the off-target interactions with incretin GPCR receptors. As a test case, we chose to examine beta-blockers because beta-adrenergic receptors and incretin receptors are expressed in a similar location, making off-target interactions possible. The binding affinity of drugs for incretin receptors was approximated by using two docking scoring functions of Autodock VINA (GUT-DOCK) and Glide (Schrodinger) and juxtaposing these values with the medical information on drug-induced T2DM. We observed that beta-blockers with the highest theoretical binding affinities for gut hormone receptors were reported as the least harmful to glucose homeostasis in clinical trials. Notably, a recently discovered beta-blocker compound 15 ([4-((2S)-3-(((S)-3-(3-bromophenyl)-1-(methylamino)-1-oxopropan-2-yl)amino)-2-(2-cyclohexyl-2-phenylacetamido)-3-oxopropyl)benzamide was among the top-scoring drugs, potentially supporting its use in the treatment of hypertension in diabetic patients. Our recently developed web service GUT-DOCK (gut-dock.miningmembrane.com) allows for the execution of similar studies for any drug-like molecule. Specifically, users can compute the binding affinities for various class B GPCRs, gut hormone receptors, VIPR1 and PAC1R.	[Pasznik, Pawel; Rutkowska, Ewelina; Niewieczerzal, Szymon; Latek, Dorota] Univ Warsaw, Fac Chem, Warsaw, Poland; [Cielecka-Piontek, Judyta] Poznan Univ Med Sci, Fac Pharm, Dept Pharmacognosy, Poznan, Poland	University of Warsaw; Poznan University of Medical Sciences	Latek, D (corresponding author), Univ Warsaw, Fac Chem, Warsaw, Poland.	dlatek@chem.uw.edu.pl		Latek, Dorota/0000-0002-0429-0637; Cielecka-Piontek, Judyta/0000-0003-0891-5419	National Science Centre in Poland [DEC-2012/07/D/NZ1/04244]	National Science Centre in Poland(National Science Centre, Poland)	DL acknowledges National Science Centre in Poland (https://www.ncn.gov.pl) for financing (Grant No. DEC-2012/07/D/NZ1/04244) and Faculty of Chemistry (http://www.chem.uw.edu.pl), Biological and Chemical Research Centre (http://cnbch.uw.edu.pl) of University of Warsaw for providing the infrastructure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2017, P NATL ACAD SCI USA, V114, P1708, DOI 10.1073/pnas.1620645114; Anyanwagu U, 2016, CLIN PHARMACOL THER, V99, P390, DOI 10.1002/cpt.274; Bakris GL, 2006, KIDNEY INT, V70, P1905, DOI 10.1038/sj.ki.5001835; Bakris GL, 2004, JAMA-J AM MED ASSOC, V292, P2227, DOI 10.1001/jama.292.18.2227; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cereto-Massague A, 2015, METHODS, V71, P98, DOI 10.1016/j.ymeth.2014.09.006; Ceriello A, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0440-3; Chen WJ, 2016, INT J MED SCI, V13, P955, DOI 10.7150/ijms.17290; Choi YJ, 2016, CARDIOVASC THER, V34, P268, DOI 10.1111/1755-5922.12197; Cordomi A, 2016, CURR OPIN PHARMACOL, V31, P63, DOI 10.1016/j.coph.2016.09.001; de Graaf C, 2016, PHARMACOL REV, V68, P954, DOI 10.1124/pr.115.011395; DiNicolantonio JJ, 2015, OPEN HEART, V2, DOI [10.1136/openhrt-2014-000230, 10.1136/openhrt-2015-000326]; Edgerton DS, 2011, DIABETES, V60, P377, DOI 10.2337/db10-1594; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Fan F, 2015, TOXICOL SCI, V145, P283, DOI 10.1093/toxsci/kfv052; Fan H, 2009, J CHEM INF MODEL, V49, P2512, DOI 10.1021/ci9003706; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gilson MK, 2016, NUCLEIC ACIDS RES, V44, pD1045, DOI 10.1093/nar/gkv1072; Giugliano D, 1997, ANN INTERN MED, V126, P955, DOI 10.7326/0003-4819-126-12-199706150-00004; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hirst JA, 2015, BRIT J CLIN PHARMACO, V79, P733, DOI 10.1111/bcp.12543; Hollenstein K, 2014, TRENDS PHARMACOL SCI, V35, P12, DOI 10.1016/j.tips.2013.11.001; Imatoh T, 2017, J CLIN PHARM THER, V42, P215, DOI 10.1111/jcpt.12499; Izzedine Hassane, 2005, Expert Opin Drug Saf, V4, P1097, DOI 10.1517/14740338.4.6.1097; Jaghoori MM, 2016, J COMPUT AID MOL DES, V30, P237, DOI 10.1007/s10822-016-9900-9; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; Kalsbeek A, 2014, MOL METAB, V3, P372, DOI 10.1016/j.molmet.2014.03.002; Kim D, 2016, BIOCHEM BIOPH RES CO, V469, P399, DOI 10.1016/j.bbrc.2015.11.095; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Labbe CM, 2015, NUCLEIC ACIDS RES, V43, pW448, DOI 10.1093/nar/gkv306; Ladage D, 2013, CARDIOVASC THER, V31, P76, DOI 10.1111/j.1755-5922.2011.00306.x; Latek D, 2018, DRUG INDUCED DIABETE; Latek D, 2016, J CHEM INF MODEL, V56, P630, DOI 10.1021/acs.jcim.5b00451; Latek D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056742; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Lexa KW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093323; Liu JF, 2013, J CHEM INF MODEL, V53, P1306, DOI 10.1021/ci400067c; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Ong KL, 2014, AM HEART J, V167, P421, DOI 10.1016/j.ahj.2013.12.025; Ozyildiz AG, 2017, J CARDIOVASC PHARM T, V22, P65, DOI 10.1177/1074248416644987; Paoletta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097858; Pissarek M., 2015, WORLD J NEUROSCIENCE, V5, P364; Ren JY, 2010, NUCLEIC ACIDS RES, V38, pW724, DOI 10.1093/nar/gkq503; Rentzsch R, 2015, BRIEF BIOINFORM, V16, P1045, DOI 10.1093/bib/bbv008; Riddy DM, 2018, PHARMACOL REV, V70, P39, DOI 10.1124/pr.117.014373; Sandal M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074092; Sander GE, 2011, J CLIN HYPERTENS, V13, P296, DOI 10.1111/j.1751-7176.2011.00454.x; Sassoon DJ, 2017, DIABETES, V66, P2230, DOI 10.2337/db16-1206; Schneider G, 2017, EXPERT OPIN DRUG DIS, V12, P271, DOI 10.1080/17460441.2017.1274727; Shepherd G, 2006, AM J HEALTH-SYST PH, V63, P1828, DOI 10.2146/ajhp060041; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Song GJ, 2017, NATURE, V546, P312, DOI 10.1038/nature22378; Sowers JR, 2010, J HYPERTENS, V28, P1761, DOI 10.1097/HJH.0b013e32833af380; Strange PG, 2008, BRIT J PHARMACOL, V153, P1353, DOI 10.1038/sj.bjp.0707672; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e; van Waterschoot RAB, 2018, NAT REV DRUG DISCOV, V17, P299, DOI 10.1038/nrd.2018.26; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang L, 2013, AAPS J, V15, P53, DOI 10.1208/s12248-012-9413-y; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Warshaviak DT, 2014, J CHEM INF MODEL, V54, P1941, DOI 10.1021/ci500175r; Woetzel N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049242; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Yang LL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8859; Zhang HN, 2018, NATURE, V553, P106, DOI 10.1038/nature25153; Zhang HN, 2017, NATURE, V546, P259, DOI 10.1038/nature22363; Zhang XM, 2014, SAUDI MED J, V35, P165	73	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210705	10.1371/journal.pone.0210705	http://dx.doi.org/10.1371/journal.pone.0210705			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682072	gold, Green Published, Green Submitted			2022-12-26	WOS:000457037500053
J	Rodriguez-Sanchez, L; Fernandez-Navarro, P; Lopez-Abente, G; Nunez, O; de Larrea-Baz, NF; Jimenez-Moleon, JJ; Borda, AP; Pollan, M; Perez-Gomez, B				Rodriguez-Sanchez, Lara; Fernandez-Navarro, Pablo; Lopez-Abente, Gonzalo; Nunez, Olivier; Fernandez de larrea-Baz, Nerea; Juan Jimenez-Moleon, Jose; Paez Borda, Alvaro; Pollan, Marina; Perez-Gomez, Beatriz			Different spatial pattern of municipal prostate cancer mortality in younger men in Spain	PLOS ONE			English	Article							GENETIC RISK; PESTICIDES; SURVIVAL; SELENIUM; OBESITY; DEATH	Background Prostate cancer (PC) primarily affects elderly men. However, the specific features of cases diagnosed at younger ages (<65 years) suggest that they may represent a different clinical subtype. Our aim was to assess this suggestion by contrasting the geographical PC mortality and hospital admissions patterns in Spain for all ages to those in younger men. Methods The Spanish National Institute of Statistics supplied data on PC mortality, hospital admission, and population data. We estimated the expected town-specific number of deaths and calculated the standardized mortality ratios. Spatial autoregressive models of Besag-York-Mollie provided smoother municipal estimators of PC mortality risk (all ages; < 65 years). We computed the provincial age-standardized rate ratios of PC hospital admissions (all men; < 60 years) using Spanish rates as the reference. Results A total of 29,566 PC deaths (6% among those < 65 years) were registered between 2010-2014, with three high-mortality risk zones: Northwest Spain; Southwest Andalusia & Granada; and a broad band extending from the Pyrenees Mountains to the north of Valencia. In younger men, the spatial patterns shared the high risk of mortality in the Northwest but not the central band. The PC hospital discharge rates confirmed a North-South gradient but also low mortality/high admission rates in Madrid and Barcelona and the opposite in Southwest Andalusia. Conclusion The consistent high PC mortality/morbidity risk in the Northwest of Spain indicates an area with a real excess of risk. The different spatial pattern in younger men suggests that some factors associated with geographical risk might have differential effects by age. Finally, the regional divergences in mortality and morbidity hint at clinical variability as a source of inequity within Spain.	[Rodriguez-Sanchez, Lara; Paez Borda, Alvaro] Fuenlabrada Gen Hosp, Urol Dept, Fuenlabrada, Spain; [Rodriguez-Sanchez, Lara; Paez Borda, Alvaro] Rey Juan Carlos Univ, Mostoles, Spain; [Fernandez-Navarro, Pablo; Lopez-Abente, Gonzalo; Nunez, Olivier; Fernandez de larrea-Baz, Nerea; Pollan, Marina; Perez-Gomez, Beatriz] Carlos III Inst Hlth, Dept Epidemiol Chron Dis, Canc & Environm Epidemiol Unit, Natl Ctr Epidemiol, Madrid, Spain; [Fernandez-Navarro, Pablo; Lopez-Abente, Gonzalo; Nunez, Olivier; Fernandez de larrea-Baz, Nerea; Juan Jimenez-Moleon, Jose; Pollan, Marina; Perez-Gomez, Beatriz] CIBERESP, Madrid, Spain; [Juan Jimenez-Moleon, Jose] Inst Invest Biosanitaria Granada Ibs GRANADA, Granada, Spain; [Juan Jimenez-Moleon, Jose] Complejo Hosp Univ, Granada, Spain; [Juan Jimenez-Moleon, Jose] Univ Granada, Dept Prevent Med & Publ Hlth, Granada, Spain; [Perez-Gomez, Beatriz] Carlos III Inst Hlth, Dept Epidemiol Chron Dis, Cardiovasc & Metab Dis Unit, Natl Ctr Epidemiol, Madrid, Spain	Hospital Universitario Fuenlabrada; Universidad Rey Juan Carlos; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; Instituto de Salud Carlos III	Perez-Gomez, B (corresponding author), Carlos III Inst Hlth, Dept Epidemiol Chron Dis, Canc & Environm Epidemiol Unit, Natl Ctr Epidemiol, Madrid, Spain.; Perez-Gomez, B (corresponding author), CIBERESP, Madrid, Spain.; Perez-Gomez, B (corresponding author), Carlos III Inst Hlth, Dept Epidemiol Chron Dis, Cardiovasc & Metab Dis Unit, Natl Ctr Epidemiol, Madrid, Spain.	bperez@isciii.es	Perez-Gomez, Beatriz/C-4715-2012; Jimenez-Moleon, Jose J/O-2519-2016; Pollan, Marina/M-3259-2014	Perez-Gomez, Beatriz/0000-0002-4299-8214; Jimenez-Moleon, Jose J/0000-0001-7917-6145; Pollan, Marina/0000-0002-4328-1565; RODRIGUEZ SANCHEZ, LARA/0000-0001-6939-2645; Nunez, Olivier/0000-0002-6651-8879	Spanish Health Research Fund ISCIII - FEDER funds -a way to build Europe [FIS PI11/00871, FIS PI12/00150, PI17CIII/00034, PI14CIII/00050, PI15/00914]; Joint Action InfAct (European Commission) [HP-JA-06-2017]	Spanish Health Research Fund ISCIII - FEDER funds -a way to build Europe; Joint Action InfAct (European Commission)	The study was supported by research grants from the Spanish Health Research Fund ISCIII cofunded by FEDER funds -a way to build Europe (http://www.isciii.es/): PFN: FIS PI11/00871, BPG: FIS PI12/00150, PI17CIII/00034, GLA: PI14CIII/00050, JJJM: PI15/00914; Joint Action InfAct (European Commission): BPG: HP-JA-06-2017, PFN: HP-JA-06-2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and there was no additional external funding received for this study.	Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Aranceta-Bartrina J, 2016, REV ESP CARDIOL, V69, P579, DOI [10.1016/j.rec.2016.02.009, 10.1016/j.recesp.2016.02.010]; Benafif S, 2016, BRIT MED BULL, V120, P75, DOI 10.1093/bmb/ldw039; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Casta MSL, 2015, ARCH ESP UROL, V68, P554; Castello A, 2018, J UROLOGY, V199, P430, DOI 10.1016/j.juro.2017.08.087; Chen YC, 2008, PROSTATE, V68, P1582, DOI 10.1002/pros.20825; Chirlaque MD, 2018, CLIN TRANSL ONCOL, V20, P201, DOI 10.1007/s12094-017-1710-6; Clark LC, 1998, BRIT J UROL, V81, P730; CNE-ISCIII, MORT CANC OTR CAUS E; Diet nutrition physical activity and breast cancer, 2018, DIET NUTR PHYS ACT C; Ding YC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006477; European Union, 2018, ECIS EUR CANC INF SY; Fall K, 2008, SCAND J UROL NEPHROL, V42, P352, DOI 10.1080/00365590802078583; Ferlay, 2016, CANC TODAY; Galceran J, 2014, ESTIMACIONES INCIDEN; Hoffman RM, 2003, ANN EPIDEMIOL, V13, P450, DOI 10.1016/S1047-2797(02)00439-8; International Agency for Research on Cancer (IARC), 2012, MON EV CARC RISKS HU; Jedroszka D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188842; Ribal MJ, 2015, PROSTATE CANCER, V2015, DOI 10.1155/2015/186740; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Lange EM, 2016, CANCER EPIDEM BIOMAR, V25, P766, DOI 10.1158/1055-9965.EPI-14-0995; Larranaga N, 2010, ANN ONCOL, V21, piii83, DOI 10.1093/annonc/mdq087; Lewis-Mikhael AM, 2016, OCCUP ENVIRON MED, V73, P134, DOI 10.1136/oemed-2014-102692; Lin DW, 2009, CANCER-AM CANCER SOC, V115, P2863, DOI 10.1002/cncr.24324; Locutura JF, ATLAS GEOQUIMICO MAD; Loeb S, 2015, CANCER EPIDEM BIOMAR, V24, P213, DOI 10.1158/1055-9965.EPI-14-0786-T; Lopez-Abente G, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-874; Lopez-Abente G, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-535; MAPAMA, PAN CONS AL; Ministerio de Sanidad Servicios Sociales e Igualdad, 2013, ENC NAC SALUD ESP 20; Mnif W, 2011, INT J ENV RES PUB HE, V8, P2265, DOI 10.3390/ijerph8062265; Nunez O, 2016, ENVIRON SCI POLLUT R, V23, P17664, DOI 10.1007/s11356-016-6806-y; Oliva G, 2009, VARIACIONES HOSP CIR; Perez-Cornago A, 2017, BRIT J CANCER, V117, P1562, DOI 10.1038/bjc.2017.312; Perez-Gomez Beatriz, 2006, Gac Sanit, V20 Suppl 3, P42, DOI 10.1157/13101089; Pollan M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-78; Preston MA, 2014, EUR UROL, V66, P1012, DOI 10.1016/j.eururo.2014.04.027; Ramis R, 2011, ENVIRON INT, V37, P577, DOI 10.1016/j.envint.2010.12.001; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Salinas CA, 2014, NAT REV UROL, V11, P317, DOI 10.1038/nrurol.2014.91; Szymanski KM, 2010, AM J CLIN NUTR, V92, P1223, DOI 10.3945/ajcn.2010.29530; Thorstenson A, 2017, J UROLOGY, V197, P61, DOI 10.1016/j.juro.2016.06.080; Vidal AC, 2014, CANCER EPIDEM BIOMAR, V23, P2936, DOI 10.1158/1055-9965.EPI-14-0795; Zeegers MPA, 2003, CANCER-AM CANCER SOC, V97, P1894, DOI 10.1002/cncr.11262; Zhou CK, 2016, INT J CANCER, V138, P1388, DOI 10.1002/ijc.29894	46	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210980	10.1371/journal.pone.0210980	http://dx.doi.org/10.1371/journal.pone.0210980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682085	Green Submitted, Green Published, gold			2022-12-26	WOS:000457037500083
J	Solvang, HK; Subbey, S				Solvang, Hiroko Kato; Subbey, Sam			An improved methodology for quantifying causality in complex ecological systems	PLOS ONE			English	Article							CAPELIN; MODEL; FEEDBACK	This paper provides a statistical methodology for quantifying causality in complex dynamical systems, based on analysis of multidimensional time series data of the state variables. The methodology integrates Granger's causality analysis based on the log-likelihood function expansion (Partial pair-wise causality), and Akaike's power contribution approach over the whole frequency domain (Total causality). The proposed methodology addresses a major drawback of existing methodologies namely, their inability to use time series observation of state variables to quantify causality in complex systems. We first perform a simulation study to verify the efficacy of the methodology using data generated by several multivariate auto-regressive processes, and its sensitivity to data sample size. We demonstrate application of the methodology to real data by deriving inter-species relationships that define key food web drivers of the Barents Sea ecosystem. Our results show that the proposed methodology is a useful tool in early stage causality analysis of complex feedback systems.	[Solvang, Hiroko Kato] Inst Marine Res, Marine Mammals Res Grp, Bergen, Norway; [Subbey, Sam] Inst Marine Res, Res Grp Fisheries Dynam, Bergen, Norway; [Subbey, Sam] Cornell Univ, Dept Nat Resources, Fernow Hall, Ithaca, NY 14853 USA	Institute of Marine Research - Norway; Institute of Marine Research - Norway; Cornell University	Solvang, HK (corresponding author), Inst Marine Res, Marine Mammals Res Grp, Bergen, Norway.	hiroko.solvang@hi.no			IMR Research Programs-MarPro-PROVEN [14412]; Barents Sea Program (Management Strategies for the Barents Sea) [84126]; Reduced Uncertainty in Stock Assessments (REDUS, Project) [14809-01]	IMR Research Programs-MarPro-PROVEN; Barents Sea Program (Management Strategies for the Barents Sea); Reduced Uncertainty in Stock Assessments (REDUS, Project)	This work has been partly funded by the following IMR Research Programs-MarPro-PROVEN (Project #14412), the Barents Sea Program (Management Strategies for the Barents Sea, Project #84126) and Reduced Uncertainty in Stock Assessments (REDUS, Project #14809-01).	AKAIKE H, 1968, ANN I STAT MATH, V20, P425, DOI 10.1007/BF02911655; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akaike H., 1994, PRACTICE TIME SERIES; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Bogstad B, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00029; Bosch-Bayard J, 2012, FORMATH, V11, P121; Cheung WWL, 2013, NATURE, V497, P365, DOI 10.1038/nature12156; Francis T., 2014, PLOS ONE, V9, P425; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; Gjosaeter H, 2002, ICES J MAR SCI, V59, P1086, DOI 10.1006/jmsc.2002.1238; Gjosaeter H, 2009, MAR BIOL RES, V5, P40, DOI 10.1080/17451000802454866; Gjosteater H, 2015, ICES J MAR SCI; GLASS L, 1988, MATH BIOSCI, V90, P111, DOI 10.1016/0025-5564(88)90060-0; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hallfredsson EH, 2009, CAN J FISH AQUAT SCI, V66, P1693, DOI 10.1139/F09-105; Hampton SE, 2006, LIMNOL OCEANOGR, V51, P2042, DOI 10.4319/lo.2006.51.5.2042; Hjermann DO, 2004, MAR ECOL PROG SER, V273, P229, DOI 10.3354/meps273229; Johannesen E, 2012, ICES J MAR SCI, V69, P880, DOI 10.1093/icesjms/fss046; Kato H, 1996, J ECONOMETRICS, V75, P147, DOI 10.1016/0304-4076(95)01774-7; Kolmogorov A. N., 1941, B ACAD SCI USSR    M, P3; Mann K.H., 2005, DYNAMICS MARINE ECOS, V3rd ed., P163; Orlova EL, 2005, ICES J MAR SCI, V62, P1281, DOI 10.1016/j.icesjms.2005.05.020; Ozaki T., 2012, TIME SERIES MODELING; Sugihara G, 2012, SCIENCE, V338, P496, DOI 10.1126/science.1227079; Tanokura Y., 2004, ADV APPL STAT, V4, P65; Tett P, 2013, MAR ECOL PROG SER, V494, P1, DOI 10.3354/meps10539; Ushakov NG., 2003, P 10 NORW RUSS S BER, P8; Wiener N., 1956, MODERN MATH ENG, P165	29	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0208078	10.1371/journal.pone.0208078	http://dx.doi.org/10.1371/journal.pone.0208078			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682020	gold, Green Submitted, Green Published			2022-12-26	WOS:000457037500011
J	Fries, CA; Lawson, SD; Wang, LC; Slaughter, KV; Vemula, PK; Dhayani, A; Joshi, N; Karp, JM; Rickard, RF; Gorantla, VS; Davis, MR				Fries, C. Anton; Lawson, Shari D.; Wang, Lin C.; Slaughter, Kai V.; Vemula, Praveen K.; Dhayani, Ashish; Joshi, Nitin; Karp, Jeffrey M.; Rickard, Rory F.; Gorantla, Vijay S.; Davis, Michael R.			Graft-implanted, enzyme responsive, tacrolimus-eluting hydrogel enables long-term survival of orthotopic porcine limb vascularized composite allografts: A proof of concept study	PLOS ONE			English	Article							UPPER EXTREMITY TRANSPLANTATION; ALLOTRANSPLANTATION; IMMUNOSUPPRESSION; ALEMTUZUMAB; REJECTION; DELIVERY; SKIN; MAINTENANCE; PRODRUGS; MODEL	Background Currently, patients receiving vascularized composite allotransplantation (VCA) grafts must take long-term systemic immunosuppressive therapy to prevent immunologic rejection. The morbidity and mortality associated with these medications is the single greatest barrier to more patients being able to receive these life-enhancing transplants. In contrast to solid organs, VCA, exemplified by hand or face transplants, allow visual diagnosis of clinical acute rejection (AR), directed biopsy and targeted graft therapies. Local immunosuppression in VCA could reduce systemic drug exposure and limit adverse effects. This proof of concept study evaluated, in a large animal forelimb VCA model, the efficacy and tolerability of a novel graft-implanted enzyme-responsive, tacrolimus (TAC)-eluting hydrogel platform, in achieving long-term graft survival. Methods Orthotopic forelimb VCA were performed in single haplotype mismatched mini-swine. Controls (n = 2) received no treatment. Two groups received TAC hydrogel: high dose (n = 4, 91 mg TAC) and low dose (n = 4, 49 mg TAC). The goal was to find a dose that was tolerable and resulted in long-term graft survival. Limbs were evaluated for clinical and histopathological signs of AR. TAC levels were measured in serial blood and skin tissue samples. Tolerability of the dose was evaluated by monitoring animal feeding behavior and weight. Results Control limbs underwent Banff Grade IV AR by post-operative day six. Low dose TAC hydrogel treatment resulted in long-term graft survival time to onset of Grade IV AR ranging from 56 days to 93 days. High dose TAC hydrogel also resulted in long-term graft survival (24 to 42 days), but was not well tolerated. Conclusion Graft-implanted TAC-loaded hydrogel delays the onset of Grade IV AR of mismatched porcine forelimb VCA grafts, resulting in long term graft survival and demonstrates dose-dependent tolerability.	[Fries, C. Anton; Lawson, Shari D.; Wang, Lin C.; Davis, Michael R.] US Army Inst Surg Res, San Antonio, TX 78234 USA; [Fries, C. Anton; Rickard, Rory F.] Royal Ctr Def Med, ICT Ctr, Birmingham, W Midlands, England; [Slaughter, Kai V.; Joshi, Nitin; Karp, Jeffrey M.] Brigham & Womens Hosp, Ctr Nanomed, 75 Francis St, Boston, MA 02115 USA; [Slaughter, Kai V.; Joshi, Nitin; Karp, Jeffrey M.] Brigham & Womens Hosp, Dept Med, Div Engn Med, 75 Francis St, Boston, MA 02115 USA; [Vemula, Praveen K.; Dhayani, Ashish] Inst Stem Cell Biol & Regenerat Med InStem, UAS GKVK Campus, Bangalore, Karnataka, India; [Dhayani, Ashish] SASTRA Univ, Sch Chem & Biotechnol, Thanjavur, India; [Joshi, Nitin; Karp, Jeffrey M.] Harvard Med Sch, Boston, MA USA; [Gorantla, Vijay S.] Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC USA; [Gorantla, Vijay S.; Davis, Michael R.] 59th MDW Sci & Technol, RESTOR Program, Joint Base San Antonio, TX USA	United States Department of Defense; United States Army; Royal Centre for Defence Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; University of Agricultural Sciences Bangalore; Shanmugha Arts, Science, Technology & Research Academy (SASTRA); Harvard University; Harvard Medical School; Wake Forest University; Wake Forest Baptist Medical Center	Fries, CA (corresponding author), US Army Inst Surg Res, San Antonio, TX 78234 USA.; Fries, CA (corresponding author), Royal Ctr Def Med, ICT Ctr, Birmingham, W Midlands, England.	antonfries@gmail.com	Joshi, Nitin/AAE-1435-2020	Dhayani, Ashish/0000-0002-5488-8952; Joshi, Nitin/0000-0001-8138-7611; Karp, Jeffrey/0000-0002-4752-7374; Fries, Charles Anton/0000-0003-0128-5688	US Air Force Medical Service Agency (59MDW Office of Science and Technology); Department of Defense [W81XWH-15-2-0047 Log MR141085]; United Kingdom Ministry of Defence; Department of Defense (DOD) [W81XWH-14-1-0229]; Rheumatology Research Foundation; King Abdulaziz City for Science and Technology through the Center of Excellence for Biomedicine (CEBM); Football Players Health Study at Harvard; National Football League Players Association	US Air Force Medical Service Agency (59MDW Office of Science and Technology); Department of Defense(United States Department of Defense); United Kingdom Ministry of Defence; Department of Defense (DOD)(United States Department of Defense); Rheumatology Research Foundation; King Abdulaziz City for Science and Technology through the Center of Excellence for Biomedicine (CEBM); Football Players Health Study at Harvard; National Football League Players Association	The studies were supported by intramural grant funding from the US Air Force Medical Service Agency (59MDW Office of Science and Technology) and in part by extramural funding from Department of Defense Grant W81XWH-15-2-0047 Log MR141085 (Reconstructive Transplant Research Program). CAF was funded by a fellowship from the United Kingdom Ministry of Defence. J.M.K. and N.J. were financially supported by Department of Defense (DOD) award W81XWH-14-1-0229, a Disease Targeted Innovative Research Grant from Rheumatology Research Foundation, a grant from King Abdulaziz City for Science and Technology through the Center of Excellence for Biomedicine (CEBM) and with the support of the Football Players Health Study at Harvard. The Football Players Health Study is funded by a grant from the National Football League Players Association. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Medical School, Harvard University or its affiliated academic health care centers, the National Football League Players Association, or the Brigham and Women's Hospital.	Ana Luisa R P, 2011, UNDERSTANDING COMPLE, DOI [10.5772/17632, DOI 10.5772/17632]; [Anonymous], 2016, ANESTHESIA PERIOPERA, DOI DOI 10.1007/978-1-4939-6377-5_44; Barbero AM, 2009, TOXICOL IN VITRO, V23, P1, DOI 10.1016/j.tiv.2008.10.008; Cendales LC, 2008, AM J TRANSPLANT, V8, P1396, DOI 10.1111/j.1600-6143.2008.02243.x; Fine RN, 2009, AM J TRANSPLANT, V9, P35, DOI 10.1111/j.1600-6143.2008.02495.x; Fries CA, 2016, PLAST RECONSTR SURG, V138, p461E, DOI 10.1097/PRS.0000000000002451; Fries CA, 2015, CURR TRANSPLANT REP, V2, P284, DOI [10.1007/s40472- 015- 0071- 8, DOI 10.1007/S40472-015-0071-8]; Gajanayake T, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008778; Gorantla V, 2001, EUR J TRAUMA, V27, P267, DOI DOI 10.1007/S00068-001-1152-1; Gorantla VS, 2011, HAND CLIN, V27, P511, DOI 10.1016/j.hcl.2011.08.008; Gorantla VS, 2011, HAND CLIN, V27, P481, DOI 10.1016/j.hcl.2011.08.006; Gorantla Vijay S., 2008, P215, DOI 10.1007/978-0-387-74682-1_16; Gorantla VS, 2000, MICROSURG, V20, P420, DOI 10.1002/1098-2752(2000)20:8<420::AID-MICR13>3.0.CO;2-O; Ho CS, 2010, DEV COMP IMMUNOL, V34, P250, DOI 10.1016/j.dci.2009.09.006; Ho CS, 2009, HUM IMMUNOL, V70, pS3, DOI 10.1016/j.humimm.2009.09.015; Howsare M, 2017, CURR OPIN ORGAN TRAN, V22, P463, DOI 10.1097/MOT.0000000000000456; Joshi N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03691-1; Khalil AA, 2006, PLAST RECONSTR SURG, V117, P1024, DOI 10.1097/01.prs.0000204766.17127.54; Kirresh T, 2017, J PHARMACEUT BIOMED, V136, P32, DOI 10.1016/j.jpba.2016.12.034; LaMattina JC, 2012, TRANSPL INT, V25, P518, DOI 10.1111/j.1432-2277.2012.01448.x; Messner F, 2016, CURR OPIN ORGAN TRAN, V21, P503, DOI 10.1097/MOT.0000000000000343; Monziois M, 2007, MEAT SCI, V76, P54, DOI 10.1016/j.meatsci.2006.10.013; Pruett T L, 2009, YB OF SURG, V2009, P109; Rosenblum D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03705-y; Schneeberger S, 2009, TRANSPL P, V41, P472, DOI 10.1016/j.transproceed.2009.01.019; Schneeberger S, 2009, TRANSPL P, V41, P499, DOI 10.1016/j.transproceed.2009.01.018; Schnider JT, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/495212; Spiller KL, 2017, ADV DRUG DELIVER REV, V122, P74, DOI 10.1016/j.addr.2017.05.010; Surnmerfield A, 2015, MOL IMMUNOL, V66, P14, DOI 10.1016/j.molimm.2014.10.023; Urello MA, 2019, ENCYCLOPEDIA OF BIOMEDICAL ENGINEERING, VOL 1, P565, DOI 10.1016/B978-0-12-801238-3.99892-1; Valeur E, 2017, DRUG DISCOV TODAY, V22, P841, DOI 10.1016/j.drudis.2016.12.004; Vemula PK, 2009, BIOMATERIALS, V30, P383, DOI 10.1016/j.biomaterials.2008.09.045; Vemula PK, 2013, CURR OPIN BIOTECH, V24, P1174, DOI 10.1016/j.copbio.2013.02.006; Venkataramanan R, 1995, CLIN PHARMACOKINET, V29, P404, DOI 10.2165/00003088-199529060-00003; Weissenbasher A, 2010, IMMUNOTHERAPY-UK, V2, P783, DOI 10.2217/IMT.10.68; Zhang SF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5657	36	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210914	10.1371/journal.pone.0210914	http://dx.doi.org/10.1371/journal.pone.0210914			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677062	Green Published, gold, Green Submitted			2022-12-26	WOS:000456700400033
J	Hill, AO; Bavinton, BR; Armstrong, G				Hill, Adam O.; Bavinton, Benjamin R.; Armstrong, Gregory			Prevalence and correlates of lifetime and recent HIV testing among men who have sex with men (MSM) who use mobile geo-social networking applications in Greater Tokyo	PLOS ONE			English	Article							RISK BEHAVIOR; BISEXUAL MEN; YOUNG MEN; PREVENTION; INFECTIONS; APPS; GAY; PARTNERS; SEEKING; COHORT	Men who have sex with men (MSM) are disproportionately burdened by the human immunodeficiency virus (HIV), accounting for 78% of all Japanese male HIV cases in 2016. Over 30% of newly identified HIV infections in Japan are diagnosed as AIDS annually, suggesting a large proportion of people living with HIV were unaware of their own infection status. An estimated two-thirds of Japanese men who have sex with men (MSM) are not attached to the gay community, and previous studies have largely sampled gay venues, thus, previous studies have likely failed to reach many men in this population. This study therefore examined HIV testing prevalence and correlates among MSM in Greater Tokyo who use gay mobile geo-social networking applications (gay mobile apps), which have been found to increase access to MSM not traditionally accessible through venue-based surveys. Among a sample of 1657 MSM recruited through advertisements on gay mobile apps, the prevalence of lifetime and six-monthly HIV testing was 72.8% and 29.7% respectively. In multiple regression analysis, higher lifetime HIV testing was associated with older age, education, HIV knowledge, anal intercourse with regular and casual male partners, and gay venue attendance. Testing was negatively associated with regular male partner condom use, marriage, residing outside central Tokyo and having both male and female partners. These results indicated that MSM who use gay mobile apps in Greater Tokyo do not meet the CDC yearly testing recommendations for high risk populations. Considering limited HIV prevention funding in Japan for MSM, moderate lifetime and recent testing, and the large number of gay mobile app users, utilization of popular gay mobile apps to promote nearby HIV testing facilities may be an effective prevention policy to target non-community attached MSM, particularly at-risk youth and individuals at risk of sudden-onset AIDS.	[Hill, Adam O.] Univ Melbourne, Fac Arts, Sch Social & Polit Sci, Parkville, Vic, Australia; [Bavinton, Benjamin R.] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia; [Armstrong, Gregory] Univ Melbourne, Nossal Inst Global Hlth, Melbourne Sch Populat & Global Hlth, Parkville, Vic, Australia	University of Melbourne; University of New South Wales Sydney; Kirby Institute; University of Melbourne	Hill, AO (corresponding author), Univ Melbourne, Fac Arts, Sch Social & Polit Sci, Parkville, Vic, Australia.	orlandohill@gmail.com	Armstrong, Gregory/K-1068-2015	Armstrong, Gregory/0000-0002-8073-9213; Bavinton, Benjamin Robert/0000-0001-5834-8278; hill, adam/0000-0001-5874-9821	Australian Government Research Training Program (RTP) Stipend Scholarship & International Postgraduate Research Scholarship; University of Melbourne Faculty of Arts Graduate School of Social and Political Sciences; National Health and Medical Research Council in Australia [APP1138096]	Australian Government Research Training Program (RTP) Stipend Scholarship & International Postgraduate Research Scholarship; University of Melbourne Faculty of Arts Graduate School of Social and Political Sciences; National Health and Medical Research Council in Australia(National Health and Medical Research Council (NHMRC) of Australia)	The authors wish to acknowledge the funding and support of the Australian Government Research Training Program (RTP) Stipend Scholarship & International Postgraduate Research Scholarship, and the University of Melbourne Faculty of Arts Graduate School of Social and Political Sciences. Additionally, Dr Gregory Armstrong is funded by an Early Career Fellowship with the National Health and Medical Research Council in Australia (APP1138096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, NON TRADITIONAL REF; Bavinton BR, 2018, LANCET HIV, V5, pE438, DOI 10.1016/S2352-3018(18)30132-2; Beymer MR, 2014, SEX TRANSM INFECT, V90, P567, DOI 10.1136/sextrans-2013-051494; Bien CH, 2015, AIDS BEHAV, V19, P941, DOI 10.1007/s10461-014-0994-6; Brito AM, 2015, PMID, V10, DOI [10.1371/journal.pone.0130445, DOI 10.1186/1471-2458-13-1236]; Carballo-Dieguez A, 2012, AIDS BEHAV, V16, P1753, DOI 10.1007/s10461-012-0274-2; CDC FACT SHEET, 2014, HIV AFR AM, P1; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; DiStefano AS, 2016, SSM-POPUL HLTH, V2, P436, DOI 10.1016/j.ssmph.2016.05.010; Down I, 2017, AIDS BEHAV, V21, P2543, DOI 10.1007/s10461-017-1747-0; Ezoe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031184; Gilmour S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043473; Goedel WC, 2016, J URBAN HEALTH, V93, P400, DOI 10.1007/s11524-016-0043-z; Grindr. Grindr, 2018, ANNUAL REPORT OF A R; Grosskopf NA, 2014, AM J MENS HEALTH, V8, P510, DOI 10.1177/1557988314527311; HIV/AIDS in Japan, 2016, IASR; Hoff CC, 2012, AIDS PATIENT CARE ST, V26, P738, DOI 10.1089/apc.2012.0198; Holloway IW, 2014, AIDS BEHAV, V18, P285, DOI 10.1007/s10461-013-0671-1; Holt M, 2012, AIDS BEHAV, V16, P13, DOI 10.1007/s10461-010-9872-z; ICHIKAWA S., 2017, J AIDS RES, V19, P71; Inoue Yoji, 2015, Nihon Koshu Eisei Zasshi, V62, P106, DOI 10.11236/jph.62.3_106; Jin FY, 2009, AIDS, V23, P243, DOI 10.1097/QAD.0b013e32831fb51a; Kelly CA, 2013, INT PERSPECT SEX R H, V39, P14, DOI 10.1363/3901413; Kirwan P. D., 2016, HIV in the UK: 2016 report; Landovitz RJ, 2013, J URBAN HEALTH, V90, P729, DOI 10.1007/s11524-012-9766-7; Lehmiller JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086603; Li DL, 2010, AIDS PATIENT CARE ST, V24, P595, DOI 10.1089/apc.2010.0083; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; McKenney J, 2017, AIDS BEHAV; Mor Z, 2011, SEX TRANSM INFECT, V87, P532, DOI 10.1136/sextrans-2011-050048; Munoz FA, 2010, AIDS EDUC PREV, V22, P455, DOI 10.1521/aeap.2010.22.5.455; Mustanski BS, 2011, J SEX RES, V48, P218, DOI 10.1080/00224499.2011.558645; Nishijima T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143874; Page C., 2014, FRAUD ON THE LINE JA, P21; Page C., 2014, KYUSHU ASS EC SCI, V52, P21; Phillips G, 2014, AIDS BEHAV, V18, P1630, DOI 10.1007/s10461-014-0760-9; Pottie K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006859; Rendina HJ, 2014, AIDS BEHAV, V18, P41, DOI 10.1007/s10461-013-0573-2; Rhodes SD, 2016, CLIN INFECT DIS, V62, P1450, DOI 10.1093/cid/ciw127; Rice E., 2012, Journal of AIDS and Clinical Research, P005; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Rolander A., 2014, THESIS; Ross MW, 2013, BMJ OPEN, V3, DOI [10.1136/bmjopen-2014-006175, 10.1136/bmjopen-2012-001928]; Shiono S., 2013, ANN REPORT RES GROUP, P247; Shiono Satoshi, 2013, Nihon Koshu Eisei Zasshi, V60, P639; Sohn Aeree, 2012, Osong Public Health Res Perspect, V3, P156, DOI 10.1016/j.phrp.2012.07.001; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Sullivan PS, 2009, AIDS, V23, P1153, DOI 10.1097/QAD.0b013e32832baa34; Tateyama M, 2013, KOKURITSU KANSEN KEN; TATEYAMA M, 2013, NIHONJIJOUHO; UNAIDS, 2014, 90 90 90 AMB TREATM; Witzel TC, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011372; Yehadji D, 2015, THESIS; Young SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103790; Zhang L, 2013, SEX TRANSM DIS, V40, P235, DOI 10.1097/OLQ.0b013e31827ca6b9; Zou HC, 2017, ARCH SEX BEHAV, V46, P885, DOI 10.1007/s10508-016-0709-3	57	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0209933	10.1371/journal.pone.0209933	http://dx.doi.org/10.1371/journal.pone.0209933			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI4TC	30673729	Green Published, gold			2022-12-26	WOS:000456442800025
J	Kobelt, G; Teich, V; Cavalcanti, M; Canzonieri, AM				Kobelt, Gisela; Teich, Vanessa; Cavalcanti, Marcela; Canzonieri, Ana Maria			Burden and cost of multiple sclerosis in Brazil	PLOS ONE			English	Article							LIFE	Background The objective of this study was to estimate costs to society and patients' quality of life (QoL) at all levels of disease severity (measured with the Expanded Disability Status Scale, EDSS) in Brazil. Methods The study was part of an international, cross-sectional burden-of-illness study carried out in collaboration with national MS patient organizations. All information was collected directly from patients using a validated questionnaire. Direct costs were estimated both from societal and payer perspectives, while total costs are presented as societal costs. Results The survey included 694 patients (response rate 21%; mean age 40.8 years). 95% of patients were of working age, and around half were working. The mean EDSS score was 3.2 (62.5% of patients with EDSS <3). Relapses were reported by 18.9% of patients. Fatigue affected almost all patients (94%) regardless of EDSS level, and cognitive difficulties were reported by 69.1% of patients. Mean utility ranged from 0.77 at EDSS 0 to negative values at EDSS 9, with a mean score of 0.58; utility was affected by relapses. Total mean annual cost was R$33,872 ((sic) 8,000) per patient in the societal perspective, with direct costs representing 81% (R$ 27,355, (sic) 6,500). Direct costs for the payer amounted to R$ 16,793 ((sic) 4,000)/patient. Conclusions This study included a population with relatively mild and early disease, with a majority of patients with relapsing disease and thus on DMD treatment. It is not possible to conclude directly on the total cost of MS in Brazil. Nevertheless, resource quantities used, QoL and MS symptoms are very similar to what was seen in the European survey.	[Kobelt, Gisela] European Hlth Econ, Stockholm, Sweden; [Teich, Vanessa; Cavalcanti, Marcela] Sense Co, Sao Paulo, Brazil; [Canzonieri, Ana Maria] ABEM, Sao Paulo, Brazil		Kobelt, G (corresponding author), European Hlth Econ, Stockholm, Sweden.	gk@healtheconomics.se			Biogen	Biogen(Biogen)	The authors disclose the following financial support for the research, authorship and publication of this article: The study was funded through an investigator-initiated study grant from Biogen to Sense Company of which V Teich and M Cavalcanti were employees. Neither the funder (Biogen) nor Sense Company did play a role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2018, RECOMMENDATION REPOR; *BRAZ I GEOGR STAT, GDP PER CAPITA 2010, P2010; Brazilian Institute of Geography and Statistics, PRICES PANEL; DAGPEREIRA A, 2015, MULT SCLER RELAT DIS, V4, P572; Fragoso YD, 2010, ARQ NEURO-PSIQUIAT, V68, P914, DOI 10.1590/S0004-282X2010000600016; Kobelt G, 2017, MULT SCLER J, V23, P4, DOI 10.1177/1352458517708097; Kobelt G, 2017, MULT SCLER J, V23, P1123, DOI 10.1177/1352458517694432; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Machado S., 2012, ATLAS MULTIPLE SCLER; *MIN HLTH, 2017, RECOMMENDATION REPOR, P286; *MIN HLTH, 2009, ECONOMIC EVALUATION; Ministerio da Saude (Brasil). Secretaria de Atenc Saude, 2015, APROVA O PROTOCOLO C, P1; Ministry of Health. Secretary of Science Technology and Strategic Inputs, ACADEMIA BRASILEIRA; Ministry of Health. Secretary of Science Technology and Strategic Inputs, 2017, ORDINANCE N 391; Ministry of Health. Secretary of Science Technology and Strategic Inputs, MANAGEMENT SYSTEM OF; Ministry of Planning Development and Management, INFORMATICS DEPARTME; SAU P, 2015, PORTARIA, P1; Takemoto MLS, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0318-1; Takemoto ML, 2015, OFFICIAL JOURNAL, V13, P119; Viegas Andrade Monica, 2013, Value Health Reg Issues, V2, P405, DOI 10.1016/j.vhri.2013.01.009; World Health Organization (WHO) Multiple Sclerosis Inernational Federation, 2008, PORTARIA	21	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0208837	10.1371/journal.pone.0208837	http://dx.doi.org/10.1371/journal.pone.0208837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673707	Green Published, gold, Green Submitted			2022-12-26	WOS:000456442800011
J	Cobussen, M; Stassen, PM; Posthouwer, D; van Tiel, FH; Savelkoul, PHM; Havenith, T; Haeseker, MB				Cobussen, Maarten; Stassen, Patricia M.; Posthouwer, Dirk; van Tiel, Frank H.; Savelkoul, Paul H. M.; Havenith, Thomas; Haeseker, Michiel B.			Improving peak concentrations of a single dose regime of gentamicin in patients with sepsis in the emergency department	PLOS ONE			English	Article							SEPTIC SHOCK; PHARMACOKINETICS; THERAPY; PROGRAM; DEFINITIONS; EXPERIENCE; RISK	Objective To achieve an optimal effect in patients with sepsis at the emergency department (ED), the gentamicin peak-concentration should be sufficiently high (i.e. peak-concentration/MIC >= 8-10). ICU patients with sepsis often need higher gentamicin doses to achieve sufficiently high peak-concentrations. The aim of this study is to investigate which dose is needed to reach adequate peak-concentrations in patients presenting with sepsis at the ED. Methods Patients with sepsis at the ED were included from August 2015 until February 2017. Peak-concentrations were measured in blood 30 minutes after the first gentamicin dose. The study consisted of three phases. In the first phase, peak-concentrations were measured after a standard dose of 5mg/kg. In the second phase, a simulation ((peak-concentration/actual dose) x simulated dose) was performed to determine which dose was needed to reach adequate gentamicin peak-concentrations of >= 16mg/L. In the third phase, peak-concentrations were measured for the best simulated dose. Results In phase one, of 86 patients who received a dose of 5mg/kg, 34 (39.5%) patients did not reach the target peak-concentration of >= 16mg/L, and 73 (84.9%) did not reach >= 20mg/L. In phase two, the simulation showed that with a dose of 7mg/kg 83 (96.5%) patients would reach peak-concentrations >= 16mg/L, and 67 (77.9%) of >= 20mg/L. In phase three, 53 patients received a dose of 7mg/kg, of whom 45 (84.9%) reached peak-concentrations of >= 16mg/L, and 31 (58.5%) of >= 20mg/L. Conclusion Patients with sepsis at the ED need higher doses of gentamicin. A dose of 7mg/kg is needed to achieve adequate peak-concentrations in the majority of patients.	[Cobussen, Maarten; van Tiel, Frank H.; Savelkoul, Paul H. M.; Haeseker, Michiel B.] Maastricht Univ, Med Ctr, Dept Med Microbiol, Maastricht, Netherlands; [Stassen, Patricia M.; Posthouwer, Dirk] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands; [Havenith, Thomas] Maastricht Univ, Med Ctr, Dept Clin Pharm, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University	Cobussen, M (corresponding author), Maastricht Univ, Med Ctr, Dept Med Microbiol, Maastricht, Netherlands.	maarten.cobussen@mumc.nl		Haeseker, Michiel/0000-0001-7902-2744				Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Blot SI, 2014, ADV DRUG DELIVER REV, V77, P3, DOI 10.1016/j.addr.2014.07.006; Buijk SE, 2002, INTENS CARE MED, V28, P936, DOI 10.1007/s00134-002-1313-7; Cobussen M, 2016, INFECT DIS-NOR, V48, P274, DOI 10.3109/23744235.2015.1109136; DASTA JF, 1988, CRIT CARE MED, V16, P327, DOI 10.1097/00003246-198804000-00004; de Greeff SC., 2017, NETHMAP 2017 CONSUMP; Dutch Working Party on Antibiotic Policy (SWAB), 2010, SWAB GUIDELINES ANTI; European Centre for Disease Prevention and Control, 2017, ANN REP EUR ANT RES; European Society of Clinical Microbiology and Infectious Diseases (EUCAST), 2009, GENT RAT EUCAST CLIN; Goncalves-Pereira J, 2010, CLIN MICROBIOL INFEC, V16, P1258, DOI 10.1111/j.1469-0691.2009.03074.x; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Kashuba ADM, 1999, ANTIMICROB AGENTS CH, V43, P623, DOI 10.1128/AAC.43.3.623; Lacy MK, 1998, CLIN INFECT DIS, V27, P23, DOI 10.1086/514620; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; MOORE RD, 1984, ANN INTERN MED, V100, P352, DOI 10.7326/0003-4819-100-3-352; NICOLAU DP, 1995, ANTIMICROB AGENTS CH, V39, P650, DOI 10.1128/AAC.39.3.650; Ong DSY, 2017, CLIN INFECT DIS, V64, P1731, DOI 10.1093/cid/cix186; Rea RS, 2008, THER DRUG MONIT, V30, P674, DOI 10.1097/FTD.0b013e31818b6b2f; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Tang GJ, 1999, ACTA ANAESTH SCAND, V43, P726, DOI 10.1034/j.1399-6576.1999.430707.x; TRAYNOR AM, 1995, ANTIMICROB AGENTS CH, V39, P545, DOI 10.1128/AAC.39.2.545	23	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210012	10.1371/journal.pone.0210012	http://dx.doi.org/10.1371/journal.pone.0210012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668571	Green Published, Green Submitted, gold			2022-12-26	WOS:000456306400003
J	ElZohary, L; Weglicki, WB; Chmielinska, JJ; Kramer, JH; Mak, IT				ElZohary, Lama; Weglicki, William B.; Chmielinska, Joanna J.; Kramer, Jay H.; Mak, I. Tong			Mg-supplementation attenuated lipogenic and oxidative/nitrosative gene expression caused by Combination Antiretroviral Therapy (cART) in HIV-1-transgenic rats	PLOS ONE			English	Article							OXIDATIVE STRESS; ENDOTHELIAL DYSFUNCTION; F-2-ISOPROSTANE LEVELS; MAGNESIUM INTAKE; HIV-1; DISEASES; PLASMA; INFLAMMATION; TOXICITY; HEART	We determined if HIV-1 expression in transgenic (HIV-1-Tg) rats enhanced hepatic genomic changes related to oxidative/nitrosative stress and lipogenesis during cART-treatment, and assessed effects of Mg-supplementation. A clinically used cART (atazanavir-ritonavir+Truvada) was given orally to control and HIV-1-Tg rats (18 weeks) with normal or 6-fold dietary-Mg. Oxidative/nitrosative and lipogenic genes were determined by real-time RT-PCR. cART induced a 4-fold upregulation of sterol regulatory element-binding protein-1 (SREBP-1) in HIV-1-Tg-rats, but not in controls; Tg rats displayed a 2.5-fold higher expression. Both were completely prevented by Mg-supplementation. Nrf2 (Nuclear erythroid-derived factor 2), a master transcription factor controlling redox homeostasis, was down-regulated 50% in HIV-Tg rats, and reduced further to 25% in Tg+cART-rats. Two downstream antioxidant genes, heme oxygenase-1(HmOX1) and Glutathione-S-transferase(GST), were elevated in HIV-Tg alone but were suppressed by cART treatment. Decreased Nrf2 in Tg +/- cART were normalized by Mg-supplementation along with the reversal of altered HmOX1 and GST expression. Concomitantly, iNOS (inducible nitric oxide synthase) was upregulated 2-fold in Tg+cART rats, which was reversed by Mg-supplementation. In parallel, cART-treatment led to substantial increases in plasma 8-isoprostane, nitrotyrosine, and RBC-GSSG (oxidized glutathione) levels in HIV-1-Tg rats; all indices of oxidative/nitrosative stress were suppressed by Mg-supplementation. Both plasma triglyceride and cholesterol levels were elevated in Tg+cART rats, but were lowered by Mg-supplementation. Thus, the synergistic effects of cART and HIV-1 expression on lipogenic and oxidative/nitrosative effects were revealed at the genomic and biochemical levels. Down-regulation of Nrf2 in the Tg+cART rats suggested their antioxidant response was severely compromised; these abnormal metabolic and oxidative stress effects were effectively attenuated by Mg-supplementation at the genomic level.	[ElZohary, Lama; Weglicki, William B.; Chmielinska, Joanna J.; Kramer, Jay H.; Mak, I. Tong] George Washington Univ, Schoold Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC 20052 USA	George Washington University	Mak, IT (corresponding author), George Washington Univ, Schoold Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC 20052 USA.	itmak@gwu.edu			NIH [R21-HL-125038]; George Washington University McCormick Genomic & Proteomic Center Supplemental Fund	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George Washington University McCormick Genomic & Proteomic Center Supplemental Fund	The study was funded by NIH R21-HL-125038 (to I.T. Mak), and in part by The George Washington University McCormick Genomic & Proteomic Center Supplemental Fund (to I.T. Mak). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOT J, 1990, CAN J CHEM, V68, P1537, DOI 10.1139/v90-237; Arts EJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007161; Borsa M, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0298-0; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Chacko SA, 2010, DIABETES CARE, V33, P304, DOI 10.2337/dc09-1402; Chen X, 2014, FREE RADICAL BIO MED, V69, P77, DOI 10.1016/j.freeradbiomed.2014.01.011; Davinelli S, 2014, BIOGERONTOLOGY, V15, P449, DOI 10.1007/s10522-014-9511-6; Fan X, 2013, AM J PHYSIOL-LUNG C, V305, P1267, DOI 10.1152/ajplung.00288.2012; Fan Y, 2016, J BIOL CHEM, V291, P22819, DOI 10.1074/jbc.M116.731828; FDA, 2005, EST MAX SAF START DO; Ferdin J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191613; Global HIV & AIDS statistics-2018 fact sheet, NON TRADITIONAL REF; Hatziioannou T, 2012, NAT REV MICROBIOL, V10, P852, DOI 10.1038/nrmicro2911; Haynes RL, 2009, ACTA NEUROPATHOL, V118, P391, DOI 10.1007/s00401-009-0540-1; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; ISERI LT, 1984, AM HEART J, V108, P188, DOI 10.1016/0002-8703(84)90572-6; Letendre Scott, 2011, Top Antivir Med, V19, P137; Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201; Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Mak IT, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082409; Mak IT, 2013, AM J PHYSIOL-REG I, V305, pR1102, DOI 10.1152/ajpregu.00268.2013; Mak IT, 2009, CARDIOVASC TOXICOL, V9, P78, DOI 10.1007/s12012-009-9040-8; Mak IT, 2000, CELL MOL BIOL, V46, P1337; Peng JS, 2010, J NEUROIMMUNOL, V218, P94, DOI 10.1016/j.jneuroim.2009.09.014; Pokan R, 2006, BRIT J SPORT MED, V40, P773, DOI 10.1136/bjsm.2006.027250; Poorolajal J, 2016, PUBLIC HEALTH, V139, P3, DOI 10.1016/j.puhe.2016.05.004; Rathbun RC, 2018, MEDSCAPE; Redhage LA, 2009, HIV CLIN TRIALS, V10, P181, DOI 10.1310/hct1003-181; Reid W, 2001, P NATL ACAD SCI USA, V98, P9271, DOI 10.1073/pnas.161290298; Reyskens KMSE, 2014, BBA-MOL BASIS DIS, V1842, P256, DOI 10.1016/j.bbadis.2013.11.019; Shah A, 2016, SCI REP-UK, V6, DOI 10.1038/srep18929; Sharp PM, 2010, PHILOS T R SOC B, V365, P2487, DOI 10.1098/rstb.2010.0031; Shen GX, 2009, BIOPHARM DRUG DISPOS, V30, P345, DOI 10.1002/bdd.680; Song YQ, 2007, AM J CLIN NUTR, V85, P1068, DOI 10.1093/ajcn/85.4.1068; Sontia B, 2007, ARCH BIOCHEM BIOPHYS, V458, P33, DOI 10.1016/j.abb.2006.05.005; Staitieh BS, 2017, J LEUKOCYTE BIOL, V102, P517, DOI 10.1189/jlb.4A0616-282RR; Taha AY, 2012, PROSTAG LEUKOTR ESS, V87, P91, DOI 10.1016/j.plefa.2012.07.006; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; van Wijk JPH, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/201027; van 't Erve TJ, 2017, REDOX BIOL, V12, P582, DOI 10.1016/j.redox.2017.03.024; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; Zhao MM, 2015, J PHARMACOL SCI, V129, P143, DOI 10.1016/j.jphs.2015.08.001	43	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210107	10.1371/journal.pone.0210107	http://dx.doi.org/10.1371/journal.pone.0210107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668566	Green Published, Green Submitted, gold			2022-12-26	WOS:000456306400006
J	Trotta, MC; Maisto, R; Guida, F; Boccella, S; Luongo, L; Balta, C; D'Amico, G; Herman, H; Hermenean, A; Bucolo, C; D'Amico, M				Trotta, Maria Consiglia; Maisto, Rosa; Guida, Francesca; Boccella, Serena; Luongo, Livio; Balta, Cornel; D'Amico, Giovanbattista; Herman, Hildegard; Hermenean, Anca; Bucolo, Claudio; D'Amico, Michele			The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome	PLOS ONE			English	Article							JUNCTION INTERCELLULAR COMMUNICATION; NICOTINIC-ACID; CONNEXIN-43 EXPRESSION; PUMA-G; APOPTOSIS; INSULIN; GPR109A; CELL; IDENTIFICATION; RELEVANCE	Objective The role of the hydroxycarboxylic acid receptor 2 (HCA(2)) in the retinal damage induced by diabetes has never been explored. In this context, the present study highlights an upregulation of retinal HCA2 receptors in diabetic C57BL6J mice. Moreover, we illustrate that HCA(2) receptors exert an anti-inflammatory effect on the retinal damage induced by diabetes when activated by the endogenous ligand beta-hydroxybutyrate, Methodology Seven-to-10-week-old C57BL6J mice were rendered diabetic by a single intraperitoneal injection of streptozotocin (75 mg/kg of body weight) and monitored intermittently over a 10-week period extending from the initial diabetes assessment. Mice with a fasting blood glucose level higher than 250 mg/dl for 2 consecutive weeks after streptozotocin injection were treated twice a week with intraperitoneal injections of 25-50-100 mg/kg beta-hydroxybutyrate. Results Interestingly, while the retinal endoplasmic reticulum stress markers (pPERK, pIRE1, ATF-6 alpha) were elevated in diabetic C57BL6J mice, their levels were significantly reduced by the systemic intraperitoneal treatment with 50 mg/kg and 100 mg/kg beta-hydroxybutyrate. These mice also exhibited high NLRP3 inflammasome activity and proinflammatory cytokine levels. In fact, the elevated levels of retinal NLRP3 inflammasome activation markers (NLRP3, ASC, caspase-1) and of the relative proinflammatory cytokines (IL-1 beta, IL-18) were significantly reduced by 50 mg/kg and 100 mg/kg beta-hydroxybutyrate treatment. These doses also reduced the high apoptotic cell number exhibited by the diabetic mice in the retinal outer nuclear layer (ONL) and increased the ONL low connexin 43 expression, leading to an improvement in retinal permeability and homeostasis. Conclusions These data suggest that the systemic treatment of diabetic C57BL6J mice with BHB activates retinal HCA(2) and inhibits local damage.	[Trotta, Maria Consiglia; Maisto, Rosa; Guida, Francesca; Boccella, Serena; Luongo, Livio; D'Amico, Michele] Univ Campania Luigi Vanvitelli, Dept Expt Med, Naples, Italy; [Balta, Cornel; D'Amico, Giovanbattista; Herman, Hildegard; Hermenean, Anca] Vasile Goldis Western Univ Arad, Inst Life Sci, Arad, Romania; [Hermenean, Anca] Univ Bucharest, Dept Biochem & Mol Biol, Bucharest, Romania; [Bucolo, Claudio] Univ Catania, Sch Med, Dept Biomed & Biotechnol Sci, Catania, Italy; [Bucolo, Claudio] Univ Catania, Ctr Res Ocular Pharmacol CERFO, Catania, Italy	Universita della Campania Vanvitelli; Vasile Goldis Western University of Arad; University of Bucharest; University of Catania; University of Catania	D'Amico, M (corresponding author), Univ Campania Luigi Vanvitelli, Dept Expt Med, Naples, Italy.	michele.damico@unicampania.it	Luongo, Livio/GXV-1993-2022; Herman, Hildegard/H-8449-2016; Hermenean, Anca/G-5360-2010; Balta, Cornel/AAS-6798-2021	Herman, Hildegard/0000-0002-6741-0245; Hermenean, Anca/0000-0001-8510-6653; Balta, Cornel/0000-0001-5734-0071; Trotta, Maria Consiglia/0000-0001-9813-5955; maisto, rosa/0000-0003-2952-8493; Bucolo, Claudio/0000-0002-4879-4140				Ahmed Kashan, 2011, Front Endocrinol (Lausanne), V2, P51, DOI 10.3389/fendo.2011.00051; Ahmed K, 2009, J BIOL CHEM, V284, P21928, DOI 10.1074/jbc.M109.019455; ALM A, 1985, OPHTHALMIC RES, V17, P181, DOI 10.1159/000265371; Bae HR, 2016, ONCOTARGET, V7, P66444, DOI 10.18632/oncotarget.12119; Benyo Z, 2005, J CLIN INVEST, V115, P3634, DOI 10.1172/JCI23626; Benyo Z, 2006, MOL PHARMACOL, V70, P1844, DOI 10.1124/mol.106.030833; Bobbie MW, 2010, INVEST OPHTH VIS SCI, V51, P3758, DOI 10.1167/iovs.09-4489; Boccella S, 2019, FASEB J, V33, P1062, DOI 10.1096/fj.201801033R; Chaurasia SS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21198-z; Chen H, 2018, INVEST OPHTH VIS SCI, V59, P978, DOI 10.1167/iovs.17-22816; Chiu R. W. K., 2002, Hong Kong Medical Journal, V8, P172; De Nardo D, 2011, TRENDS IMMUNOL, V32, P373, DOI 10.1016/j.it.2011.05.004; Dedkova EN, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00260; Demirtas L, 2016, INDIAN J MED RES, V144, P515, DOI 10.4103/0971-5916.200887; Deng Yaqin, 2018, Biophys Rep, V4, P39, DOI 10.1007/s41048-018-0048-0; Detrick B, 2010, IMMUNOL RES, V47, P153, DOI 10.1007/s12026-009-8146-1; Di Filippo C, 2004, J LEUKOCYTE BIOL, V75, P453, DOI 10.1189/jlb.0703303; Eledrisi MS, 2006, AM J MED SCI, V331, P243, DOI 10.1097/00000441-200605000-00002; Frank RN, 2004, NEW ENGL J MED, V350, P48, DOI 10.1056/NEJMra021678; Gambhir D, 2012, INVEST OPHTH VIS SCI, V53, P2208, DOI 10.1167/iovs.11-8447; Goldberg EL, 2017, CELL REP, V18, P2077, DOI 10.1016/j.celrep.2017.02.004; Goubaeva F, 2007, BIOCHEM BIOPH RES CO, V352, P97, DOI 10.1016/j.bbrc.2006.10.177; Graff EC, 2016, METABOLISM, V65, P102, DOI 10.1016/j.metabol.2015.10.001; Guo M, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00086; Haneklaus M, 2015, IMMUNOL REV, V265, P53, DOI 10.1111/imr.12285; Iacobas DA, 2008, CELL COMMUN ADHES, V15, P195, DOI 10.1080/15419060802014222; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Jing-Xu, 2018, CELL PHYSIOL BIOCHEM, V48, P705, DOI 10.1159/000491897; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Klen J, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/616747; Kostylina G, 2008, CELL DEATH DIFFER, V15, P134, DOI 10.1038/sj.cdd.4402238; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee HM, 2013, DIABETES, V62, P194, DOI 10.2337/db12-0420; Li AF, 2003, INVEST OPHTH VIS SCI, V44, P5376, DOI 10.1167/iovs.03-0360; Li AF, 2009, INVEST OPHTH VIS SCI, V50, P1400, DOI 10.1167/iovs.07-1519; Loukovaara S, 2017, ACTA OPHTHALMOL, V95, P803, DOI 10.1111/aos.13427; Ma WX, 2016, ADV EXP MED BIOL, V854, P73, DOI 10.1007/978-3-319-17121-0_11; Maciejewski-Lenoir D, 2006, J INVEST DERMATOL, V126, P2637, DOI 10.1038/sj.jid.5700586; Maisto R, 2017, J CELL MOL MED, V21, P968, DOI 10.1111/jcmm.13036; Martin PM, 2009, MOL VIS, V15, P362; Muto T, 2014, INVEST OPHTH VIS SCI, V55, P4327, DOI 10.1167/iovs.14-14606; Patel Nishal, 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P222; Penfold PL, 2001, PROG RETIN EYE RES, V20, P385, DOI 10.1016/S1350-9462(00)00025-2; Polotsky VY, 2001, AM J RESP CRIT CARE, V163, P624, DOI 10.1164/ajrccm.163.3.2007120; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Redza-Dutordoir M, 2016, BBA-MOL CELL RES, V1863, P2977, DOI 10.1016/j.bbamcr.2016.09.012; Rose KL, 2007, PEDIATR RES, V61, P301, DOI 10.1203/pdr.0b013e318030d193; Rossi S, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/7368389; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Schaub A, 2001, EUR J IMMUNOL, V31, P3714, DOI 10.1002/1521-4141(200112)31:12<3714::AID-IMMU3714>3.0.CO;2-1; Shao BZ, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00262; Simo R, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/190724; Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5; Sparrrow JR, 2010, CURR MOL MED, V10, P802; Suzuki M, 2001, JPN J PHARMACOL, V87, P143, DOI 10.1254/jjp.87.143; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Tang H, 2008, BIOCHEM BIOPH RES CO, V375, P562, DOI 10.1016/j.bbrc.2008.08.041; Trotta Maria Consiglia, 2018, Oncotarget, V9, P17257, DOI 10.18632/oncotarget.23270; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wise A, 2004, ANNU REV PHARMACOL, V44, P43, DOI 10.1146/annurev.pharmtox.44.101802.121419; Yamanashi T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08055-1; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Yu AL, 2014, CURR EYE RES, V39, P487, DOI 10.3109/02713683.2013.848900; Zheng YY, 2013, GENE, V530, P151, DOI 10.1016/j.gene.2013.07.082	66	28	29	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0211005	10.1371/journal.pone.0211005	http://dx.doi.org/10.1371/journal.pone.0211005			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657794	Green Published, gold, Green Submitted			2022-12-26	WOS:000456017000025
J	Prufer, TL; Rohde, J; Verspohl, J; Rohde, M; de Greeff, A; Willenborg, J; Valentin-Weigand, P				Prufer, T. Louise; Rohde, Judith; Verspohl, Jutta; Rohde, Manfred; de Greeff, Astrid; Willenborg, Joerg; Valentin-Weigand, Peter			Molecular typing of Streptococcus suis strains isolated from diseased and healthy pigs between 1996-2016	PLOS ONE			English	Article							SYNTHESIS GENE LOCI; CAPSULAR TYPES; SEROTYPE; VIRULENCE; PATHOGENESIS; BACTERIN; PHAGOCYTOSIS; MENINGITIS; INFECTION; SWINE	Streptococcus suis is an economically important pathogen of pigs as well as a zoonotic cause of human disease. Serotyping is used for further characterization of isolates; some serotypes seem to be more virulent and more widely spread than others. This study characterizes a collection of German field isolates of Streptococcus suis from pigs dating from 1996 to 2016 with respect to capsular genes (cps) specific for individual serotypes and pathotype by multiplex PCR and relates results to the clinical background of these isolates. The most prominent finding was the reduction in prevalence of serotype-2/serotype-1/2 among invasive isolates during this sampling period, which might be attributed to widely implemented autogenous vaccination programs in swine against serotype 2 in Germany. In diseased pigs (systemically ill; respiratory disease) isolates of serotype-1/serotype-14, serotype-2/serotype-1/2, serotype 3 to 5 and 7 to 9 were most frequent while in carrier isolates a greater variety of cps types was found. Serotype-1/serotype-14 seemed to be preferentially located in joints, serotype 4 and serotype 3 in the central nervous system, respectively. The virulence associated extracellular protein factor was almost exclusively associated with invasive serotype-1/serotype-14 and serotype-2/serotype-1/2 isolates. In contrast, lung isolates of serotype-2/serotype-1/2 mainly harbored the gene for muramidase-released protein. Serotype 4 and serotype 9 isolates from clinically diseased pigs most frequently carried the muramidase-released protein gene and the suilysin gene. When examined by transmission electron microscopy all but one of the isolates which were non-typable by molecular and serological methods showed various amounts of capsular material indicating potentially new serotypes among these isolates. Given the variety of cps types/serotypes detected in pigs, not only veterinarians but also medical doctors should consider other serotypes than just serotype 2 when investigating potential human cases of Streptococcus suis infection.	[Prufer, T. Louise; Rohde, Judith; Verspohl, Jutta; Willenborg, Joerg; Valentin-Weigand, Peter] Univ Vet Med, Inst Microbiol, Hannover, Germany; [Rohde, Manfred] Helmholtz Ctr Infect Res, Cent Facil Microscopy, Braunschweig, Germany; [de Greeff, Astrid] Wageningen Biovet Res, Lelystadt, Netherlands; [Prufer, T. Louise] Lower Saxony State Off Consumer Protect & Food Sa, Hannover, Germany; [Willenborg, Joerg] Bayer Anim Hlth GmbH, Leverkusen, Germany	University of Veterinary Medicine Hannover, Foundation; Helmholtz Association; Helmholtz-Center for Infection Research; Wageningen University & Research; Bayer AG	Rohde, J (corresponding author), Univ Vet Med, Inst Microbiol, Hannover, Germany.	Judith.Rohde@tiho-hannover.de		Rohde, Judith/0000-0002-4671-2164				Baig A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01191; Baums Christoph Georg, 2009, Animal Health Research Reviews, V10, P65, DOI 10.1017/S146625230999003X; Baums CG, 2009, CLIN VACCINE IMMUNOL, V16, P200, DOI 10.1128/CVI.00371-08; Benga L, 2004, CELL MICROBIOL, V6, P867, DOI 10.1111/j.1462-5822.2004.00409.x; Buttner N, 2012, VET IMMUNOL IMMUNOP, V146, P191, DOI 10.1016/j.vetimm.2012.03.012; Chabot-Roy G, 2006, MICROB PATHOGENESIS, V41, P21, DOI 10.1016/j.micpath.2006.04.001; Charland N, 2000, INFECT IMMUN, V68, P637, DOI 10.1128/IAI.68.2.637-643.2000; Coffey TJ, 1998, MOL MICROBIOL, V27, P73, DOI 10.1046/j.1365-2958.1998.00658.x; Dekker CNT, 2012, VACCINE, V30, P1379, DOI 10.1016/j.vaccine.2011.12.035; Feng YJ, 2014, VIRULENCE, V5, P477, DOI 10.4161/viru.28595; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; GOTTSCHALK M, 1989, J CLIN MICROBIOL, V27, P2633, DOI 10.1128/JCM.27.12.2633-2636.1989; GOTTSCHALK M, 1993, J CLIN MICROBIOL, V31, P2192, DOI 10.1128/JCM.31.8.2192-2194.1993; Gottschalk M, 2000, VET MICROBIOL, V76, P259, DOI 10.1016/S0378-1135(00)00250-9; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; Goyette-Desjardins G, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.45; Higgins R, 1990, J Vet Diagn Invest, V2, P249; Ishida S, 2014, J MICROBIOL METH, V107, P66, DOI 10.1016/j.mimet.2014.09.003; Kerdsin A, 2014, J MED MICROBIOL, V63, P824, DOI 10.1099/jmm.0.069757-0; Le HTT, 2013, VET MICROBIOL, V162, P842, DOI 10.1016/j.vetmic.2012.11.001; Li J, 2016, EXPERT OPIN THER TAR, V20, P7, DOI 10.1517/14728222.2016.1121236; Liu ZQ, 2013, PLASMONICS, V8, P1285, DOI 10.1007/s11468-013-9551-9; Manso AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6055; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Okura M, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5030045; Okura M, 2014, J CLIN MICROBIOL, V52, P1714, DOI 10.1128/JCM.03411-13; Pan ZH, 2015, APPL ENVIRON MICROB, V81, P976, DOI 10.1128/AEM.02962-14; Segura M, 2004, INFECT IMMUN, V72, P5322, DOI 10.1128/IAI.72.9.5322-5330.2004; Segura M, 2015, EXPERT REV VACCINES, V14, P1587, DOI 10.1586/14760584.2015.1101349; Silva LMG, 2006, VET MICROBIOL, V115, P117, DOI 10.1016/j.vetmic.2005.12.013; Soares TCS, 2014, CAN J VET RES, V78, P145; Smith HE, 1999, INFECT IMMUN, V67, P1750; Staats JJ, 1997, VET RES COMMUN, V21, P381, DOI 10.1023/A:1005870317757; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Willemse N, 2016, SCI REP-UK, V6, DOI 10.1038/srep28984; Willenborg J, 2011, MICROBIOL-SGM, V157, P1823, DOI 10.1099/mic.0.046417-0; Wisselink HJ, 2000, VET MICROBIOL, V74, P237, DOI 10.1016/S0378-1135(00)00188-7; Zheng H, 2017, VET RES, V48, DOI 10.1186/s13567-017-0417-6; Zheng H, 2015, APPL ENVIRON MICROB, V81, P4111, DOI 10.1128/AEM.00315-15; Zou G, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02590-17	41	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210801	10.1371/journal.pone.0210801	http://dx.doi.org/10.1371/journal.pone.0210801			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653570	gold, Green Submitted, Green Published			2022-12-26	WOS:000456015500072
J	Althagafi, II; Ahmed, SA; El-Saidid, WA				Althagafi, Ismail I.; Ahmed, Saleh A.; El-Saidid, Waleed A.			Fabrication of gold/graphene nanostructures modified ITO electrode as highly sensitive electrochemical detection of Aflatoxin B1	PLOS ONE			English	Article							GOLD NANOPARTICLE; GRAPHENE; IMMUNOSENSOR; BIOSENSOR; ASSAY; SUBSTRATE; AU; AG	Aflatoxins (AFs) are a family of fungal toxins that produced in food and feed by two Aspergillus species (Aspergillus flavus and Aspergillus parasiticus). Several techniques have been reported for AFs detection including high-pressure liquid chromatography, enzyme-linked immunosorbent assay, surface plasmon resonance and recombinant immune blotting assay. But, these methods are disadvantaged because they consumed a long time for analysis; in addition, they required a piece of complicated and expensive equipment. Therefore, developing of inexpensive sensors with high selectivity and sensitivity for detecting of AFs levels without extensive sample preparation has received great attention. Several Ielectrochemical AFs sensors have been reported; however, there is still a need for developing a new, simple and rapid electrochemical AFs sensor. Here, we have developed a new AFs sensor based on Au nanostructures/graphene nanosheets modified ITO substrate that could enhance the Raman effect and the electrochemical conductivity. The modified electrode was prepared based on layer-by-layer electrochemical deposition method. AFs antibody was immobilized onto the Au nanostructures/graphene nanosheets; then it was used as a probe for rapid, simple and cheap detection of AFs level using Raman spectroscopy and electrochemical techniques. Our results demonstrated that the developed system showed a simple, easy and sensitive sensor for monitoring low concentrations of AFB1 with a detection limit of about 6.9 pg/mL, also it allowed the determination of AFB1 in spiked food samples.	[Althagafi, Ismail I.; Ahmed, Saleh A.] Umm Al Qura Univ, Fac Appl Sci, Chem Dept, Mecca, Saudi Arabia; [Ahmed, Saleh A.; El-Saidid, Waleed A.] Assiut Univ, Dept Chem, Fac Sci, Assiut, Egypt	Umm Al Qura University; Egyptian Knowledge Bank (EKB); Assiut University	Althagafi, II (corresponding author), Umm Al Qura Univ, Fac Appl Sci, Chem Dept, Mecca, Saudi Arabia.	iithagafi@uqu.edu.sa	El-Said, Waleed/X-9913-2018	El-Said, Waleed/0000-0002-7052-7612; Althagafi, Ismail/0000-0002-9343-2595	Deanship of the Scientific Research (DSR), Umm Al-Qura University [15-SCI-3-1-0013]	Deanship of the Scientific Research (DSR), Umm Al-Qura University	The Authors are highly indebted to the Deanship of the Scientific Research (DSR), Umm Al-Qura University for full financial support of this work through the project number 15-SCI-3-1-0013. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Authors are highly indebted to the Deanship of the Scientific Research (DSR), Umm Al-Qura University for full financial support of this work through the project number 15-SCI-3-1-0013.	Abdallah M. I. M., 2012, EGYPTAIN J APPL SCI, V27, P40; Arati Sharma A., 2017, ELECTROCHEMICAL IMMU, DOI [10.1016/j.msec.2017.03.146, DOI 10.1016/J.MSEC.2017.03.146]; Badea M, 2016, INT J ELECTROCHEM SC, V11, P6719, DOI 10.20964/2016.08.21; Chauhan R, 2015, FOOD CONTROL, V52, P60, DOI 10.1016/j.foodcont.2014.12.009; Chen YH, 2016, ELECTROCHIM ACTA, V205, P124, DOI 10.1016/j.electacta.2016.04.111; Eaton D.L., 1994, TOXICOLOGY AFLATOXIN, P521; El-Said WA, 2014, ELECTROCHIM ACTA, V123, P51, DOI 10.1016/j.electacta.2013.12.144; El-Said WA, 2011, J NANOSCI NANOTECHNO, V11, P6539, DOI 10.1166/jnn.2011.4377; El-Said WA, 2011, J NANOSCI NANOTECHNO, V11, P768, DOI 10.1166/jnn.2011.3268; El-Said WA, 2010, ULTRAMICROSCOPY, V110, P676, DOI 10.1016/j.ultramic.2010.02.031; Evtugyn G, 2014, ELECTROANAL, V26, P2100, DOI 10.1002/elan.201400328; Gu H, 2013, ACS APPL MATER INTER, V5, P6762, DOI 10.1021/am401738k; Guermoune A, 2011, CARBON, V49, P4204, DOI 10.1016/j.carbon.2011.05.054; Huang X, 2012, CHEM SOC REV, V41, P666, DOI 10.1039/c1cs15078b; Jiang Chaoyi, SCI CHINA CHEM, DOI [10.1007/s11426-016-0015-2.2, DOI 10.1007/S11426-016-0015-2.2]; Lee KM, 2014, J AGR FOOD CHEM, V62, P4466, DOI 10.1021/jf500854u; Li PW, 2009, FOOD CHEM, V115, P313, DOI 10.1016/j.foodchem.2008.11.052; Liu YD, 2017, BIOSENS BIOELECTRON, V87, P101, DOI 10.1016/j.bios.2016.08.015; Lu YH, 2007, BIOELECTROCHEMISTRY, V71, P211, DOI 10.1016/j.bioelechem.2007.05.003; Moon J, 2012, MATERIALS, V5, P634, DOI 10.3390/ma5040634; Owino JHO, 2007, ANAL BIOANAL CHEM, V388, P1069, DOI 10.1007/s00216-007-1333-9; Owino JHO, 2008, SENSORS-BASEL, V8, P8262, DOI 10.3390/s8128262; Rameshkumar P, 2015, J ELECTROANAL CHEM, V754, P118, DOI 10.1016/j.jelechem.2015.07.011; Shim WB, 2014, BIOSENS BIOELECTRON, V62, P288, DOI 10.1016/j.bios.2014.06.059; Shim WB, 2014, FOOD CONTROL, V36, P30, DOI 10.1016/j.foodcont.2013.07.042; Shin JW, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17122771; Soldatkin OO, 2013, SENSOR ACTUAT B-CHEM, V188, P999, DOI 10.1016/j.snb.2013.06.107; Srivastava S, 2014, APPL BIOCHEM BIOTECH, V174, P960, DOI 10.1007/s12010-014-0965-4; Tan Y, 2009, ANAL BIOCHEM, V387, P82, DOI 10.1016/j.ab.2008.12.030; Wang D, 2015, BIOSENS BIOELECTRON, V63, P185, DOI 10.1016/j.bios.2014.06.070; Williams JH, 2004, AM J CLIN NUTR, V80, P1106, DOI 10.1093/ajcn/80.5.1106; Xu X, 2013, BIOSENS BIOELECTRON, V47, P361, DOI 10.1016/j.bios.2013.03.048; Yong Zhang, RSC ADV, DOI [10.1039/x0xx00000x, DOI 10.1039/X0XX00000X]; Zhou LT, 2012, SENSOR ACTUAT B-CHEM, V174, P359, DOI 10.1016/j.snb.2012.06.051	34	23	24	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210652	10.1371/journal.pone.0210652	http://dx.doi.org/10.1371/journal.pone.0210652			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650140	Green Published, gold, Green Submitted			2022-12-26	WOS:000455813300068
J	Apollo, A; Ortenzi, V; Scatena, C; Zavaglia, K; Aretini, P; Lessi, F; Franceschi, S; Tomei, S; Sepich, CA; Viacava, P; Mazzanti, CM; Naccarato, AG				Apollo, Alessandro; Ortenzi, Valerio; Scatena, Cristian; Zavaglia, Katia; Aretini, Paolo; Lessi, Francesca; Franceschi, Sara; Tomei, Sara; Sepich, Carlo Alberto; Viacava, Paolo; Mazzanti, Chiara Maria; Naccarato, Antonio Giuseppe			Molecular characterization of low grade and high grade bladder cancer	PLOS ONE			English	Article							E-CADHERIN; EXPRESSION; CARCINOMA; DIAGNOSIS; PROGNOSIS; SURVIVIN; MARKERS; FGFR3; TIME	Background Bladder cancer (BC) is the 9th most common cancer diagnosis worldwide. Low grade (LG) represents 70% of all BCs, characterized by recurrence and rare ability (10-15%) to progress to high grade (HG) and invade. The remaining 30% is high grade (HG), fast invasive BC, which is resistant to therapy. Identifying biomarkers for predicting those tumors able to progress is a key goal for patient outcome improvement. This study focuses on the most promising prognostic markers. Materials and methods TP53 and FGFR3 mutational status, Survivin, CK19, CK20, E-cadherin and CD44 gene expression analysis were performed on 66 BCs. Results Survivin was found associated to tumor grade (p<0.05). Moreover, Survivin correlated with CD44 in TP53 wild type (p = 0.0242) and FGFR3 wild type (p = 0.0036) tumors. In particular the Survivin-CD44 correlation was associated to HG FGFR3 wild type BCs (p = 0.0045). Unsupervised hierarchical clustering based on gene expression data identified four distinct molecular groups reflecting the patient histology (p = 0.038). Conclusion We suggest Survivin, both as a biomarker associated to G3 BCs but negatively related to TP53 mutational status, and as a potential novel therapeutic target.	[Apollo, Alessandro] Univ Pisa, Biol Dept, Genet Unit, Pisa, Italy; [Ortenzi, Valerio; Scatena, Cristian; Zavaglia, Katia; Naccarato, Antonio Giuseppe] Univ Hosp Pisa, Dept Pathol, Pisa, Italy; [Aretini, Paolo; Lessi, Francesca; Franceschi, Sara; Mazzanti, Chiara Maria] Fdn Pisana Sci, Sect Canc Gen, Pisa, Italy; [Tomei, Sara] Sidra Med, Omics Core & Biorepository, Doha, Qatar; [Sepich, Carlo Alberto] Versilia Hosp, Div Urol, Lido Di Camaiore, Italy; [Viacava, Paolo] Hosp Livorno, Div Pathol, Livorno, Italy	University of Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Sidra Medical & Research Center; Ospedale Versilia	Apollo, A (corresponding author), Univ Pisa, Biol Dept, Genet Unit, Pisa, Italy.	alessandro.apollo@hotmail.com	Mazzanti, Chiara/AAX-6539-2021; Lessi, Francesca/AAE-6812-2022; Aretini, Paolo/AAF-1205-2020	Lessi, Francesca/0000-0002-3346-4296; Aretini, Paolo/0000-0003-1075-4319; Franceschi, Sara/0000-0002-4246-4407				Antoni S, 2017, EUR UROL, V71, P96, DOI 10.1016/j.eururo.2016.06.010; Bachir BG, 2012, EXPERT REV ANTICANC, V12, P1499, DOI [10.1586/ERA.12.140, 10.1586/era.12.140]; Bassily NH, 2000, AM J CLIN PATHOL, V113, P383, DOI 10.1309/G1RA-EU9X-X6VV-3W79; Billerey C, 2001, AM J PATHOL, V158, P1955, DOI 10.1016/S0002-9440(10)64665-2; Chen XC, 2013, ONCOL LETT, V5, P1278, DOI 10.3892/ol.2013.1150; Cheng LA, 2011, HUM PATHOL, V42, P455, DOI 10.1016/j.humpath.2010.07.007; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Hussain SA, 2005, SEMIN RADIAT ONCOL, V15, P3, DOI 10.1016/j.semradonc.2004.07.007; Jeon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076719; Khorrami MH, 2012, UROL J, V9, P581; Kirkali Z, 2005, UROLOGY, V66, P4, DOI 10.1016/j.urology.2005.07.062; Lamm D, 2014, J UROLOGY, V191, P20, DOI 10.1016/j.juro.2013.07.102; Lamy A, 2006, J UROLOGY, V176, P2686, DOI 10.1016/j.juro.2006.07.132; McConkey DJ, 2009, CANCER METAST REV, V28, P335, DOI 10.1007/s10555-009-9194-7; MOLL R, 1992, AM J PATHOL, V140, P427; Neuzillet Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048993; Omran OM, 2012, J ENVIRON PATHOL TOX, V31, P203, DOI 10.1615/JEnvironPatholToxicolOncol.v31.i3.20; Omran OM, 2012, ULTRASTRUCT PATHOL, V36, P145, DOI 10.3109/01913123.2011.651522; Ramirez D, 2016, BJU INT, V117, P783, DOI 10.1111/bju.13345; Remy E, 2015, CANCER RES, V75, P4042, DOI 10.1158/0008-5472.CAN-15-0602; Sanli O, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.22; Southgate J, 1999, HISTOL HISTOPATHOL, V14, P657, DOI 10.14670/HH-14.657; Sugino T, 1996, AM J PATHOL, V149, P873; Urquidi V, 2012, CURR MED CHEM, V19, P3653, DOI 10.2174/092986712801661103; Weyerer V, 2017, J CANCER, V8, P323, DOI 10.7150/jca.17482; Wu CT, 2017, J CANCER, V8, P1137, DOI 10.7150/jca.18297; Xi RC, 2013, J SURG ONCOL, V107, P550, DOI 10.1002/jso.23272; Yang R, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0569-4; Zhao J, 2014, INT BRAZ J UROL, V40, P179, DOI 10.1590/S1677-5538.IBJU.2014.02.07	29	11	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210635	10.1371/journal.pone.0210635	http://dx.doi.org/10.1371/journal.pone.0210635			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650148	Green Published, Green Submitted, gold			2022-12-26	WOS:000455813300066
J	Somers, K; Wen, VW; Middlemiss, SMC; Osborne, B; Forgham, H; Jung, M; Karsa, M; Clifton, M; Bongers, A; Gao, JX; Mayoh, C; Raoufi-Rad, N; Kusnadi, EP; Hannan, KM; Scott, DA; Kwek, A; Liu, B; Flemming, C; Chudakova, DA; Pandher, R; Failes, TW; Lim, J; Angeli, A; Osterman, AL; Imamura, T; Kees, UR; Supuran, CT; Pearson, RB; Hannan, RD; Davis, TP; McCarroll, J; Kavallaris, M; Turner, N; Gudkov, AV; Haber, M; Norris, MD; Henderson, MJ				Somers, Klaartje; Wen, Victoria W.; Middlemiss, Shiloh M. C.; Osborne, Brenna; Forgham, Helen; Jung, MoonSun; Karsa, Mawar; Clifton, Molly; Bongers, Angelika; Gao, Jixuan; Mayoh, Chelsea; Raoufi-Rad, Newsha; Kusnadi, Eric P.; Hannan, Kate M.; Scott, David A.; Kwek, Alan; Liu, Bing; Flemming, Claudia; Chudakova, Daria A.; Pandher, Ruby; Failes, Tim W.; Lim, James; Angeli, Andrea; Osterman, Andrei L.; Imamura, Toshihiko; Kees, Ursula R.; Supuran, Claudiu T.; Pearson, Richard B.; Hannan, Ross D.; Davis, Thomas P.; McCarroll, Joshua; Kavallaris, Maria; Turner, Nigel; Gudkov, Andrei V.; Haber, Michelle; Norris, Murray D.; Henderson, Michelle J.			A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction	ONCOGENE			English	Article							TARGETING MITOCHONDRIA; THERAPEUTIC STRATEGY; CARBONIC-ANHYDRASES; OXIDATIVE STRESS; MEIS1; CANCER; INHIBITION; EXPRESSION; METABOLISM; TRANSLOCATIONS	Survival rates for pediatric patients suffering from mixed lineage leukemia (MLL)-rearranged leukemia remain below 50% and more targeted, less toxic therapies are urgently needed. A screening method optimized to discover cytotoxic compounds selective for MLL-rearranged leukemia identified CCI-006 as a novel inhibitor of MLL-rearranged and CALM-AF10 translocated leukemias that share common leukemogenic pathways. CCI-006 inhibited mitochondrial respiration and induced mitochondrial membrane depolarization and apoptosis in a subset (7/11, 64%) of MLL-rearranged leukemia cell lines within a few hours of treatment. The unresponsive MLL-rearranged leukemia cells did not undergo mitochondrial membrane depolarization or apoptosis despite a similar attenuation of mitochondrial respiration by the compound. In comparison to the sensitive cells, the unresponsive MLL-rearranged leukemia cells were characterized by a more glycolytic metabolic phenotype, exemplified by a more pronounced sensitivity to glycolysis inhibitors and elevated HIF1 alpha expression. Silencing of HIF1 alpha expression sensitized an intrinsically unresponsive MLL-rearranged leukemia cell to CCI-006, indicating that this pathway plays a role in determining sensitivity to the compound. In addition, unresponsive MLL-rearranged leukemia cells expressed increased levels of MEIS1, an important leukemogenic MLL target gene that plays a role in regulating metabolic phenotype through HIF1 alpha. MEIS1 expression was also variable in a pediatric MLL-rearranged ALL patient dataset, highlighting the existence of a previously undescribed metabolic variability in MLL-rearranged leukemia that may contribute to the heterogeneity of the disease. This study thus identified a novel small molecule that rapidly kills MLL-rearranged leukemia cells by targeting a metabolic vulnerability in a subset of low HIF1 alpha/low MEIS1-expressing MLL-rearranged leukemia cells.	[Somers, Klaartje; Wen, Victoria W.; Middlemiss, Shiloh M. C.; Forgham, Helen; Jung, MoonSun; Karsa, Mawar; Clifton, Molly; Bongers, Angelika; Gao, Jixuan; Mayoh, Chelsea; Raoufi-Rad, Newsha; Kwek, Alan; Liu, Bing; Flemming, Claudia; Chudakova, Daria A.; Pandher, Ruby; Failes, Tim W.; Lim, James; McCarroll, Joshua; Kavallaris, Maria; Haber, Michelle; Norris, Murray D.; Henderson, Michelle J.] UNSW, Childrens Canc Inst, Lowy Canc Res Ctr, Randwick, NSW, Australia; [Osborne, Brenna; Turner, Nigel] UNSW, Sch Med Sci, Mitochondrial Bioenerget Lab, Randwick, NSW, Australia; [Forgham, Helen; McCarroll, Joshua; Kavallaris, Maria] UNSW Australia, Australian Ctr NanoMed, ARC Ctr Excellence Convergent Bionano Sci & Techn, Sydney, NSW, Australia; [Kusnadi, Eric P.; Pearson, Richard B.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Hannan, Kate M.; Hannan, Ross D.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT, Australia; [Scott, David A.; Osterman, Andrei L.] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA; [Failes, Tim W.] UNSW, ACRF Drug Discovery Ctr, Childrens Canc Inst, Lowy Canc Res Ctr, Sydney, NSW, Australia; [Angeli, Andrea; Supuran, Claudiu T.] Univ Florence, Neurofarba Dept, Florence, Italy; [Imamura, Toshihiko] Kyoto Prefectural Univ Med, Dept Pediat, Kyoto, Japan; [Kees, Ursula R.] Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia; [Davis, Thomas P.] Monash Univ, ARC Ctr Excellence Convergent Bionano Sci & Techn, Monash Inst Pharmaceut Sci, Clayton, Vic, Australia; [Davis, Thomas P.] Univ Warrick, Dept Chem, Coventry, W Midlands, England; [Gudkov, Andrei V.] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA; [Gudkov, Andrei V.] Oncotartis Inc, Buffalo, NY USA; [Norris, Murray D.] UNSW Ctr Childhood Canc Res, Sydney, NSW, Australia	Children's Cancer Institute; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; Peter Maccallum Cancer Center; Australian National University; John Curtin School of Medical Research; Sanford Burnham Prebys Medical Discovery Institute; Children's Cancer Institute; University of New South Wales Sydney; University of Florence; Kyoto Prefectural University of Medicine; Telethon Kids Institute; University of Western Australia; Monash University; University of Warwick; Roswell Park Cancer Institute	Henderson, MJ (corresponding author), UNSW, Childrens Canc Inst, Lowy Canc Res Ctr, Randwick, NSW, Australia.	mhenderson@ccia.unsw.edu.au	Davis, Thomas/B-6395-2008; Chudakova, Daria/ABB-3032-2020; Mayoh, Chelsea/AAE-7349-2021; Turner, Nigel/H-7176-2013; Osborne, Brenna/F-5950-2018; McCarroll, Joshua/E-8481-2010	Davis, Thomas/0000-0003-2581-4986; Mayoh, Chelsea/0000-0002-6398-3046; Turner, Nigel/0000-0002-0119-9328; Osborne, Brenna/0000-0002-0197-3010; McCarroll, Joshua/0000-0001-8807-3623; Supuran, Claudiu/0000-0003-4262-0323; Karsa, Mawar/0000-0001-9682-1118; Scott, David/0000-0002-8668-2449; Forgham, Helen/0000-0002-6871-3213; Haber, Michelle/0000-0003-2036-8817; Gao, Jixuan/0000-0002-2209-3143; Hannan, Katherine/0000-0003-4186-8167; angeli, andrea/0000-0002-1470-7192; Kavallaris, Maria/0000-0003-2309-898X	NHMRC; Leukemia Foundation; NSW Cancer Council; Cancer Institute NSW; Tenix Foundation; ISG Foundation; Children's Leukemia & Cancer Research Foundation, Perth; NCI Cancer Center Support Grant [P30 CA30199]; Anthony Rothe Memorial Trust; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Leukemia Foundation; NSW Cancer Council(Cancer Council New South Wales); Cancer Institute NSW; Tenix Foundation; ISG Foundation; Children's Leukemia & Cancer Research Foundation, Perth; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Anthony Rothe Memorial Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by NHMRC, Leukemia Foundation, Anthony Rothe Memorial Trust, NSW Cancer Council, Cancer Institute NSW, Tenix Foundation, ISG Foundation and the Children's Leukemia & Cancer Research Foundation, Perth. Metabolic analysis was performed at the Cancer Metabolism Core, SBP Medical Discovery Institute, with assistance from Olga Zagnitko and support of NCI Cancer Center Support Grant P30 CA30199.	Appleby RD, 1999, EUR J BIOCHEM, V262, P108, DOI 10.1046/j.1432-1327.1999.00350.x; Arechederra RL, 2013, BIOORGAN MED CHEM, V21, P1544, DOI 10.1016/j.bmc.2012.06.053; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Bao XR, 2016, ELIFE, V5, DOI 10.7554/eLife.10575; BLISS CI, 1956, BACTERIOL REV, V20, P243, DOI 10.1128/MMBR.20.4.243-258.1956; Cardaci S, 2012, J BIOENERG BIOMEMBR, V44, P17, DOI 10.1007/s10863-012-9422-7; Caudell D, 2007, CANCER RES, V67, P8022, DOI 10.1158/0008-5472.CAN-06-3749; Chen L, 2013, LEUKEMIA, V27, P813, DOI 10.1038/leu.2012.327; Chen LL, 2016, ONCOTARGET, V7, P25208, DOI 10.18632/oncotarget.8199; Cole A, 2015, CANCER CELL, V27, P864, DOI 10.1016/j.ccell.2015.05.004; Daigle SR, 2013, BLOOD, V122, P1017, DOI 10.1182/blood-2013-04-497644; Driessen EMC, 2016, LEUKEMIA, V30, P1184, DOI 10.1038/leu.2015.246; Faber J, 2009, BLOOD, V113, P2375, DOI 10.1182/blood-2007-09-113597; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hulbert AJ, 2006, J COMP PHYSIOL B, V176, P93, DOI 10.1007/s00360-005-0025-z; Hulleman E, 2009, BLOOD, V113, P2014, DOI 10.1182/blood-2008-05-157842; Jhas B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058367; Kees UR, 2003, MOL CANCER THER, V2, P671; Klaus CR, 2014, J PHARMACOL EXP THER, V350, P646, DOI 10.1124/jpet.114.214577; Kocabas F, 2012, BLOOD, V120, P4963, DOI 10.1182/blood-2012-05-432260; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Kuhn A, 2016, ONCOTARGET, V7, P35341, DOI 10.18632/oncotarget.9241; Kumar AR, 2009, BLOOD, V113, P1756, DOI 10.1182/blood-2008-06-163287; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; Lee EA, 2015, CANCER RES, V75, P2478, DOI 10.1158/0008-5472.CAN-14-2676; MacArthur DG, 2008, HUM MOL GENET, V17, P1076, DOI 10.1093/hmg/ddm380; Marin-Hernandez A, 2009, MINI-REV MED CHEM, V9, P1084, DOI 10.2174/138955709788922610; Marschalek R, 2016, ANN LAB MED, V36, P85, DOI 10.3343/alm.2016.36.2.85; Orlovsky K, 2011, P NATL ACAD SCI USA, V108, P7956, DOI 10.1073/pnas.1103154108; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pieters R, 2007, LANCET, V370, P240, DOI 10.1016/S0140-6736(07)61126-X; Quiros PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058; Ratnikov B, 2015, ONCOTARGET, V6, P7379, DOI 10.18632/oncotarget.3132; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roychoudhury J, 2015, BLOOD, V125, P2544, DOI 10.1182/blood-2014-09-599258; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Shah GN, 2013, J PHARMACOL EXP THER, V344, P637, DOI 10.1124/jpet.112.201400; Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015; Somers K, 2016, ONCOTARGET, V7, P46067, DOI 10.18632/oncotarget.10022; Sriskanthadevan S, 2015, BLOOD, V125, P2120, DOI 10.1182/blood-2014-08-594408; Stam RW, 2010, BLOOD, V115, P2835, DOI 10.1182/blood-2009-07-233049; Stein EM, 2018, BLOOD, V131, P2661, DOI 10.1182/blood-2017-12-818948; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Teo J, 2016, BIOMACROMOLECULES, V17, P2337, DOI 10.1021/acs.biomac.6b00185; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; Trentin L, 2009, EUR J HAEMATOL, V83, P406, DOI 10.1111/j.1600-0609.2009.01305.x; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Unnisa Z, 2012, BLOOD, V120, P4973, DOI 10.1182/blood-2012-06-435800; van der Linden MH, 2009, BLOOD, V114, P3764, DOI 10.1182/blood-2009-02-204214; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712; Wong P, 2007, GENE DEV, V21, P2762, DOI 10.1101/gad.1602107; Zhao W, 2014, J BIOMOL SCREEN, V19, P817, DOI 10.1177/1087057114521867	55	13	13	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 16	2019	38	20					3824	3842		10.1038/s41388-018-0666-5	http://dx.doi.org/10.1038/s41388-018-0666-5			19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HY3OI	30670779	Green Published, hybrid			2022-12-26	WOS:000468035600005
J	Chakravorty, S; Shipelskiy, Y; Kumar, A; Majumdar, A; Yang, TH; Nairn, BL; Newton, SM; Klebba, PE				Chakravorty, Somnath; Shipelskiy, Yan; Kumar, Ashish; Majumdar, Aritri; Yang, Taihao; Nairn, Brittany L.; Newton, Salete M.; Klebba, Phillip E.			Universal fluorescent sensors of high-affinity iron transport, applied to ESKAPE pathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane transport; fluorescence; ligand-binding protein; siderophore; pathogenesis; iron; spectroscopy; heme; ESKAPE pathogen	FERRIC ENTEROBACTIN; SALMONELLA-ENTERICA; ESCHERICHIA-COLI; TONB; PROTEINS; BINDING; SORTASE; CLONING; TYPHIMURIUM; HEMOGLOBIN	Sensitive assays of biochemical specificity, affinity, and capacity are valuable both for basic research and drug discovery. We created fluorescent sensors that monitor high-affinity binding reactions and used them to study iron acquisition by ESKAPE bacteria, which are frequently responsible for antibiotic-resistant infections. By introducing site-directed Cys residues in bacterial iron transporters and modifying them with maleimide fluorophores, we generated living cells or purified proteins that bind but do not transport target compounds. These constructs sensitively detected ligand concentrations in solution, enabling accurate, real-time spectroscopic analysis of membrane transport by other cells. We assessed the efficacy of these fluorescent decoy (FD) sensors by characterizing active iron transport in the ESKAPE bacteria. The FD sensors monitored uptake of both ferric siderophores and hemin by the pathogens. An FD sensor for a particular ligand was universally effective in observing the uptake of that compound by all organisms we tested. We adapted the FD sensors to microtiter format, where they allow high-throughput screens for chemicals that block iron uptake, without genetic manipulations of the virulent target organisms. Hence, screening assays with FD sensors facilitate studies of mechanistic biochemistry, as well as discovery of chemicals that inhibit prokaryotic membrane transport. With appropriate design, FD sensors are potentially applicable to any pro- or eukaryotic high-affinity ligand transport process.	[Chakravorty, Somnath; Shipelskiy, Yan; Kumar, Ashish; Majumdar, Aritri; Yang, Taihao; Newton, Salete M.; Klebba, Phillip E.] Kansas State Univ, Dept Biochem & Mol Biophys, 141 Chalmers Hall, Manhattan, KS 66506 USA; [Nairn, Brittany L.] Bethel Univ, Dept Biol Sci, St Paul, MN 55112 USA; [Chakravorty, Somnath] Jacobs Sch Med & Biomed Sci, Buffalo, NY 14203 USA; [Shipelskiy, Yan] Pueblo Chem Depot PCAPP, Battelle Mem Inst, Pueblo, CO 81006 USA	Kansas State University	Klebba, PE (corresponding author), Kansas State Univ, Dept Biochem & Mol Biophys, 141 Chalmers Hall, Manhattan, KS 66506 USA.	peklebba@ksu.edu			NIAID, National Institutes of Health [R21AI115187]; Kansas IDeA Network of Biomedical Research Excellence (K-INBRE; National Institute of General Medical Sciences of the National Institutes of Health) [P20GM103418]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103418] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Kansas IDeA Network of Biomedical Research Excellence (K-INBRE; National Institute of General Medical Sciences of the National Institutes of Health); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIAID, National Institutes of Health Award R21AI115187 (to P. E. K. and S. M. N.) and a Kansas IDeA Network of Biomedical Research Excellence (K-INBRE; National Institute of General Medical Sciences of the National Institutes of Health Grant P20GM103418) postdoctoral research award (to S. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bachman MA, 2012, MBIO, V3, DOI 10.1128/mBio.00224-11; Bierne H, 2004, J BACTERIOL, V186, P1972, DOI 10.1128/JB.186.7.1972-1982.2004; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Elemam A, 2009, CLIN INFECT DIS, V49, P271, DOI 10.1086/600042; Fisher JF, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a025221; Ginalski K, 2006, CURR OPIN STRUC BIOL, V16, P172, DOI 10.1016/j.sbi.2006.02.003; Hammer ND, 2011, ANNU REV MICROBIOL, V65, P129, DOI 10.1146/annurev-micro-090110-102851; Hanson M, 2016, J BIOMOL SCREEN, V21, P316, DOI 10.1177/1087057115613788; HASHIMOTOGOTOH T, 1986, GENE, V41, P125; HENDERSON DP, 1993, MOL MICROBIOL, V7, P461, DOI 10.1111/j.1365-2958.1993.tb01137.x; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Jordan LD, 2013, P NATL ACAD SCI USA, V110, P11553, DOI 10.1073/pnas.1304243110; Khan SN, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00174; KLEBBA PE, 1982, J BACTERIOL, V149, P880, DOI 10.1128/JB.149.3.880-888.1982; Klebba PE, 2016, J BACTERIOL, V198, P1013, DOI 10.1128/JB.00823-15; KONOPKA K, 1982, BIOCHEMISTRY-US, V21, P6503, DOI 10.1021/bi00268a028; Lery LMS, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-41; Letoffe S, 2001, MOL MICROBIOL, V41, P439, DOI 10.1046/j.1365-2958.2001.02530.x; Ma L, 2007, J BIOL CHEM, V282, P397, DOI 10.1074/jbc.M605333200; Malmirchegini GR, 2014, J BIOL CHEM, V289, P34886, DOI 10.1074/jbc.M114.583013; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Nagy TA, 2013, INFECT IMMUN, V81, P4063, DOI 10.1128/IAI.00412-13; Nairn BL, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00889-16; NEILANDS JB, 1952, J AM CHEM SOC, V74, P4846, DOI 10.1021/ja01139a033; Newton SM, 2010, J BIOL CHEM, V285, P17488, DOI 10.1074/jbc.M109.100206; Newton SMC, 2005, MOL MICROBIOL, V55, P927, DOI 10.1111/j.1365-2958.2004.04436.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Ostberg KL, 2013, INFECT IMMUN, V81, P3442, DOI 10.1128/IAI.00280-13; Parrow NL, 2013, INFECT IMMUN, V81, P3503, DOI 10.1128/IAI.00602-13; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; Pi HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050020; Rouault TA, 2017, J BIOL CHEM, V292, P12744, DOI 10.1074/jbc.R117.789537; Russo TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026734; RUTZ JM, 1991, J BACTERIOL, V173, P5964, DOI 10.1128/jb.173.19.5964-5974.1991; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; Scott DC, 2001, J BIOL CHEM, V276, P13025, DOI 10.1074/jbc.M011282200; Smallwood CR, 2014, J GEN PHYSIOL, V144, P201, DOI 10.1085/jgp.20131115907012014c; Smith KD, 2007, INT J BIOCHEM CELL B, V39, P1776, DOI 10.1016/j.biocel.2007.07.003; Stokes-Rees I, 2010, P NATL ACAD SCI USA, V107, P21476, DOI 10.1073/pnas.1012095107; Tacconelli E, 2017, GLOBAL PRIORITY LIST; Thulasiraman P, 1998, J BACTERIOL, V180, P6689, DOI 10.1128/JB.180.24.6689-6696.1998; TRIEUCUOT P, 1990, NUCLEIC ACIDS RES, V18, P4296, DOI 10.1093/nar/18.14.4296; Tsolis RM, 1996, INFECT IMMUN, V64, P4549, DOI 10.1128/IAI.64.11.4549-4556.1996; Valdebenito M, 2007, FEMS MICROBIOL LETT, V277, P182, DOI 10.1111/j.1574-6968.2007.00956.x; Williams PH, 2006, VACCINE, V24, P3840, DOI 10.1016/j.vaccine.2005.07.020; WILLIAMS PH, 1979, INFECT IMMUN, V26, P925, DOI 10.1128/IAI.26.3.925-932.1979; Xiao QB, 2011, MOL MICROBIOL, V80, P1581, DOI 10.1111/j.1365-2958.2011.07667.x	49	4	4	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4682	4692		10.1074/jbc.RA118.006921	http://dx.doi.org/10.1074/jbc.RA118.006921			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30679312	Green Published, hybrid			2022-12-26	WOS:000462969500033
J	Ying, GX; Frederick, JM; Baehr, W				Ying, Guoxin; Frederick, Jeanne M.; Baehr, Wolfgang			Deletion of both centrin 2 (CETN2) and CETN3 destabilizes the distal connecting cilium of mouse photoreceptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						retina; retina degeneration; phototransduction; photoreceptor; cilia; gene knockout; calcium-binding protein; centrin; centriole; connecting cilium; electroretinography; transition zone	MEMBRANE-PROTEIN; GENE; MICE; LOCALIZATION; CELLS; CILIARY; IDENTIFICATION; DEGENERATION; MICROTUBULES; DUPLICATION	Centrins (CETN1-4) are ubiquitous and conserved EF-hand-family Ca2+-binding proteins associated with the centrosome, basal body, and transition zone. Deletion of CETN1 or CETN2 in mice causes male infertility or dysosmia, respectively, without affecting photoreceptor function. However, it remains unclear to what extent centrins are redundant with each other in photoreceptors. Here, to explore centrin redundancy, we generated Cetn3(GT/GT) single-knockout and Cetn2(-/-);Cetn3(GT/GT) double-knockout mice. Whereas the Cetn3 deletion alone did not affect photoreceptor function, simultaneous ablation of Cetn2 and Cetn3 resulted in attenuated scotopic and photopic electroretinography (ERG) responses in mice at 3 months of age, with nearly complete retina degeneration at 1 year. Removal of CETN2 and CETN3 activity from the lumen of the connecting cilium (CC) destabilized the photoreceptor axoneme and reduced the CC length as early as postnatal day 22 (P22). In Cetn2(-/-);Cetn3(GT/GT) double-knockout mice, spermatogenesis-associated 7 (SPATA7), a key organizer of the photoreceptor-specific distal CC, was depleted gradually, and CETN1 was condensed to the mid-segment of the CC. Ultrastructural analysis revealed that in this double knockout, the axoneme of the CC expanded radially at the distal end, with vertically misaligned outer segment discs and membrane whorls. These observations suggest that CETN2 and CETN3 cooperate in stabilizing the CC/axoneme structure.	[Ying, Guoxin; Frederick, Jeanne M.; Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Ophthalmol, Salt Lake City, UT 84132 USA; [Baehr, Wolfgang] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA; [Baehr, Wolfgang] Univ Utah, Dept Biol, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Ying, GX; Baehr, W (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Ophthalmol, Salt Lake City, UT 84132 USA.	g.ying@utah.edu; wbaehr@hsc.utah.edu			National Institutes of Health [1R01 EY08123, 1R01 EY019298]; NEI [1P30 EY014800-039003]; University of Utah Dept. of Ophthalmology from Research to Prevent Blindness (RPB, New York); RPB Senior Investigator award; RPB Nelson Trust award; NATIONAL EYE INSTITUTE [R01EY019298, P30EY014800, R01EY008123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); University of Utah Dept. of Ophthalmology from Research to Prevent Blindness (RPB, New York); RPB Senior Investigator award; RPB Nelson Trust award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants 1R01 EY08123 and 1R01 EY019298 (to W. B.) and 1P30 EY014800-039003 from the NEI (NEI core grant). This work also was supported by unrestricted grants to the University of Utah Dept. of Ophthalmology from Research to Prevent Blindness (RPB, New York). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of an RPB Senior Investigator award and an RPB Nelson Trust award.	Avasthi P, 2013, J CELL SCI, V126, P3204, DOI 10.1242/jcs.128587; BARON AT, 1992, BIOL CELL, V76, P383, DOI 10.1016/0248-4900(92)90442-4; BARON AT, 1988, J CELL BIOL, V107, P2669, DOI 10.1083/jcb.107.6.2669; BAUM P, 1986, P NATL ACAD SCI USA, V83, P5512, DOI 10.1073/pnas.83.15.5512; Bicek AD, 2009, MOL BIOL CELL, V20, P2943, DOI 10.1091/mbc.E08-09-0909; Bornens M, 2007, ADV EXP MED BIOL, V607, P119; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Coleman JA, 2014, J CELL SCI, V127, P1138, DOI 10.1242/jcs.145052; Dantas TJ, 2012, CELL MOL LIFE SCI, V69, P2979, DOI 10.1007/s00018-012-0961-1; Dantas TJ, 2011, J CELL BIOL, V193, P307, DOI 10.1083/jcb.201012093; Davis EE, 2012, CURR OPIN GENET DEV, V22, P290, DOI 10.1016/j.gde.2012.04.006; Delaval B, 2011, CELL CYCLE, V10, P3964, DOI 10.4161/cc.10.22.18150; Dharmat R, 2018, J CELL BIOL, V217, P2851, DOI 10.1083/jcb.201712117; Eblimit A, 2015, HUM MOL GENET, V24, P1584, DOI 10.1093/hmg/ddu573; Friedberg F, 2006, MOL BIOL REP, V33, P243, DOI 10.1007/s11033-006-9004-z; Gao JG, 2002, P NATL ACAD SCI USA, V99, P5698, DOI 10.1073/pnas.042122399; Gavet O, 2003, MOL BIOL CELL, V14, P1818, DOI 10.1091/mbc.E02-11-0709; Giessl A, 2004, J BIOL CHEM, V279, P51472, DOI 10.1074/jbc.M406770200; Haire SE, 2006, INVEST OPHTH VIS SCI, V47, P3745, DOI 10.1167/iovs.06-0086; Hart PE, 1999, GENOMICS, V60, P111, DOI 10.1006/geno.1999.5880; Hartman H, 2002, P NATL ACAD SCI USA, V99, P1420, DOI 10.1073/pnas.032658599; Hong DH, 2001, J BIOL CHEM, V276, P12091, DOI 10.1074/jbc.M009351200; Hong DH, 2000, P NATL ACAD SCI USA, V97, P3649, DOI 10.1073/pnas.060037497; Karlstetter M, 2014, HUM MOL GENET, V23, P5197, DOI 10.1093/hmg/ddu242; Kim GW, 2013, J BIOL CHEM, V288, P20334, DOI 10.1074/jbc.M113.464792; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Koblenz B, 2003, J CELL SCI, V116, P2635, DOI 10.1242/jcs.00497; Liu Q, 2004, J NEUROSCI, V24, P6427, DOI 10.1523/JNEUROSCI.1335-04.2004; Liu Q, 2003, INVEST OPHTH VIS SCI, V44, P4171, DOI 10.1167/iovs.03-0410; Liu Q, 2002, INVEST OPHTH VIS SCI, V43, P22; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Marshall WF, 2001, CURR BIOL, V11, P308, DOI 10.1016/S0960-9822(01)00094-X; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Middendorp S, 1997, P NATL ACAD SCI USA, V94, P9141, DOI 10.1073/pnas.94.17.9141; Middendorp S, 2000, J CELL BIOL, V148, P405, DOI 10.1083/jcb.148.3.405; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; Moritz OL, 1996, INVEST OPHTH VIS SCI, V37, P352; Paoletti A, 1996, J CELL SCI, V109, P3089; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Portran D, 2017, NAT CELL BIOL, V19, P391, DOI 10.1038/ncb3481; Prosser SL, 2015, J CELL BIOL, V208, P693, DOI 10.1083/jcb.201411070; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Pulvermuller A, 2002, MOL CELL BIOL, V22, P2194, DOI 10.1128/MCB.22.7.2194-2203.2002; Rachel RA, 2012, J CLIN INVEST, V122, P1233, DOI 10.1172/JCI60981; Robison P, 2016, SCIENCE, V352, DOI 10.1126/science.aaf0659; Salisbury JL, 2007, J CELL PHYSIOL, V213, P420, DOI 10.1002/jcp.21226; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; SCHIEBEL E, 1995, TRENDS CELL BIOL, V5, P197, DOI 10.1016/S0962-8924(00)88999-0; Sedmak T, 2010, J CELL BIOL, V189, P171, DOI 10.1083/jcb.200911095; Sharif AS, 2018, J NEUROSCI, V38, P3160, DOI 10.1523/JNEUROSCI.2964-17.2018; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004; Stuck MW, 2016, PROG RETIN EYE RES, V52, P47, DOI 10.1016/j.preteyeres.2015.12.002; Thompson JR, 2006, J BIOL CHEM, V281, P18746, DOI 10.1074/jbc.M513667200; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Wu S, 2008, NAT PROTOC, V3, P1056, DOI 10.1038/nprot.2008.70; Xu ZJ, 2017, SCIENCE, V356, P328, DOI 10.1126/science.aai8764; Yang CH, 2010, MOL BIOL CELL, V21, P4361, DOI 10.1091/mbc.E10-04-0298; Yang ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891; Ying GX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161236; Ying GX, 2014, J NEUROSCI, V34, P6377, DOI 10.1523/JNEUROSCI.0067-14.2014; Zhu XM, 2002, MOL VIS, V8, P462	64	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					3957	3973		10.1074/jbc.RA118.006371	http://dx.doi.org/10.1074/jbc.RA118.006371			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30647131	Green Published, hybrid			2022-12-26	WOS:000461854400013
J	Ichimiya, I; Ichimiya, H				Ichimiya, Issei; Ichimiya, Hiroko			Complex tone stimulation may induce binaural diplacusis with low-tone hearing loss	PLOS ONE			English	Article							ENDOLYMPHATIC HYDROPS; PITCH	To clarify the possible mechanism causing binaural diplacusis with low-tone hearing loss, two psychoacoustic experiments were performed with 20 healthy subjects, using harmonic complex tones. In the first experiment, two tones were presented unilaterally, either from the right or left side. One of the tones presented was higher in frequency in terms of the fundamental component, but lower or equal in frequency in terms of the highest component, than the other tone. The subjects were asked which tone was higher in pitch after listening to both tones. They were also asked to compare tones in which low-tone components were eliminated. In the second experiment, the subjects heard these complex tones binaurally, with low-tone components eliminated in one ear. In the first experiment, most subjects perceived pitch direction, that is, higher or lower, in a reverse way when low-tone components were eliminated from the complex tones. In the second experiment, approximately half of all subjects heard the tones at different pitches in both ears. Under certain conditions, complex tone stimulation may induce binaural diplacusis when low-tone hearing is lost in one ear.	[Ichimiya, Issei; Ichimiya, Hiroko] Ichimiya Clin, Kitsuki City, Oita, Japan		Ichimiya, I (corresponding author), Ichimiya Clin, Kitsuki City, Oita, Japan.	ich-oit@umin.ac.jp		Ichimiya, Issei/0000-0002-1004-175X				Brannstrom KJ, 2008, INT J AUDIOL, V47, P675, DOI 10.1080/14992020802215870; Colin D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159975; DEUTSCH D, 1974, NATURE, V251, P307, DOI 10.1038/251307a0; GAETH JH, 1965, J SPEECH HEAR RES, V8, P63, DOI 10.1044/jshr.0801.63; Goebel JA, 2016, OTOLARYNG HEAD NECK, V154, P403, DOI 10.1177/0194599816628524; ICHIMIYA I, 1994, ANN OTO RHINOL LARYN, V103, P457; Ichimiya I, 2016, AURIS NASUS LARYNX, V43, P68, DOI 10.1016/j.anl.2015.07.002; Ladd DR, 2013, J EXP PSYCHOL HUMAN, V39, P1386, DOI 10.1037/a0031261; Moore BCJ, 2013, INTRO PSYCHOL HEARIN, DOI [10.1121/1.4978009, DOI 10.1121/1.4978009]; Ogura M, 2003, INT J AUDIOL, V42, P297, DOI 10.3109/14992020309101321; PAPARELLA MM, 1991, ACTA OTO-LARYNGOL, P26; Reiss LAJ, 2017, J ACOUST SOC AM, V141, P1909, DOI 10.1121/1.4978009; SCHUKNECHT HF, 1983, ANN OTO RHINOL LARYN, V92, P1; TONNDORF J, 1976, ARCH OTO-RHINO-LARYN, V212, P293, DOI 10.1007/BF00453677	14	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210939	10.1371/journal.pone.0210939	http://dx.doi.org/10.1371/journal.pone.0210939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682080	Green Submitted, gold, Green Published			2022-12-26	WOS:000457037500076
J	Gietzen, T; Brylka, R; Achenbach, J; zum Hebel, K; Schomer, E; Botsch, M; Schwanecke, U; Schulze, R				Gietzen, Thomas; Brylka, Robert; Achenbach, Jascha; zum Hebel, Katja; Schoemer, Elmar; Botsch, Mario; Schwanecke, Ulrich; Schulze, Ralf			A method for automatic forensic facial reconstruction based on dense statistics of soft tissue thickness	PLOS ONE			English	Article							REGISTRATION; ADULTS	In this paper, we present a method for automated estimation of a human face given a skull remain. Our proposed method is based on three statistical models. A volumetric (tetrahedral) skull model encoding the variations of different skulls, a surface head model encoding the head variations, and a dense statistic of facial soft tissue thickness (FSTT). All data are automatically derived from computed tomography (CT) head scans and optical face scans. In order to obtain a proper dense FSTT statistic, we register a skull model to each skull extracted from a CT scan and determine the FSTT value for each vertex of the skull model towards the associated extracted skin surface. The FSTT values at predefined landmarks from our statistic are well in agreement with data from the literature. To recover a face from a skull remain, we first fit our skull model to the given skull. Next, we generate spheres with radius of the respective FSTT value obtained from our statistic at each vertex of the registered skull. Finally, we fit a head model to the union of all spheres. The proposed automated method enables a probabilistic face-estimation that facilitates forensic recovery even from incomplete skull remains. The FSTT statistic allows the generation of plausible head variants, which can be adjusted intuitively using principal component analysis. We validate our face recovery process using an anonymized head CT scan. The estimation generated from the given skull visually compares well with the skin surface extracted from the CT scan itself.	[Gietzen, Thomas; Brylka, Robert; Schwanecke, Ulrich] RheinMain Univ Appl Sci Wiesbaden Russelsheim, Comp Vis & Mixed Real Grp, Wiesbaden, Germany; [Achenbach, Jascha; Botsch, Mario] Bielefeld Univ, Comp Graph Grp, Bielefeld, Germany; [zum Hebel, Katja] Johannes Gutenberg Univ Mainz, Dept Prosthet Dent, Univ Med Ctr, Mainz, Germany; [Schoemer, Elmar] Johannes Gutenberg Univ Mainz, Inst Comp Sci, Mainz, Germany; [Schulze, Ralf] Johannes Gutenberg Univ Mainz, Sect Oral Radiol, Univ Med Ctr, Mainz, Germany	University of Bielefeld; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Gietzen, T (corresponding author), RheinMain Univ Appl Sci Wiesbaden Russelsheim, Comp Vis & Mixed Real Grp, Wiesbaden, Germany.	thomas.gietzen@hs-rm.de	Schulze, Ralf/S-9500-2019	Schulze, Ralf/0000-0002-7880-0046; Botsch, Mario/0000-0001-9954-120X	Federal Ministry of Education and Research (BMBF); Cluster of Excellence Cognitive Interaction Technology "CITEC" (EXC 277) at Bielefeld University - German Research Foundation (DFG)	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Cluster of Excellence Cognitive Interaction Technology "CITEC" (EXC 277) at Bielefeld University - German Research Foundation (DFG)	The results from this study are part of the research projects "Kephalos" and "KogniHome" funded by the Federal Ministry of Education and Research (BMBF https://www.bmbf.de/).The work was also supported by the Cluster of Excellence Cognitive Interaction Technology "CITEC" (EXC 277) at Bielefeld University, which is funded by the German Research Foundation (DFG http://www.dfg.de/).We gratefully acknowledge the Department of Diagnostic and Interventional Radiology (http://www.unimedizin-mainz.de/radiologie/startseite.html), University Medical Center of the Johannes Gutenberg University Mainz, Germany for providing us with the DICOM-data of the human heads.; The results from this study are part of the research projects "Kephalos" and "KogniHome" funded by the Federal Ministry of Education and Research (BMBF). The work was also supported by the Cluster of Excellence Cognitive Interaction Technology "CITEC" (EXC 277) at Bielefeld University, which is funded by the German Research Foundation (DFG). We gratefully acknowledge the Department of Diagnostic and Interventional Radiology, University Medical Center of the Johannes Gutenberg University Mainz, Germany for providing us with the DICOM data of the human heads.	Achenbach J, 2017, P ACM S VIRT REAL SO, P1; Achenbach J., 2015, P VIS MOD VIS, P1; Ackerman J L, 1999, Clin Orthod Res, V2, P49; Aspert N, 2002, IEEE INTERNATIONAL CONFERENCE ON MULTIMEDIA AND EXPO, VOL I AND II, PROCEEDINGS, P705, DOI 10.1109/ICME.2002.1035879; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Caple J, 2016, INT J LEGAL MED, V130, P863, DOI 10.1007/s00414-015-1292-1; Cha KS, 2013, KOREAN J ORTHOD, V43, P178, DOI 10.4041/kjod.2013.43.4.178; Claes P., 2006, Journal of Computing and Information Technology - CIT, V14, P21, DOI 10.2498/cit.2006.01.03; Deuss Mario, 2015, SHAPEOP ROBUST EXTEN, P505, DOI DOI 10.1007/978-3-319-24208-8_42; Garland M., 1997, Computer Graphics Proceedings, SIGGRAPH 97, P209, DOI 10.1145/258734.258849; Gietzen T, 2017, INFORM 2017 GESELLSC, P891; HORN BKP, 1987, J OPT SOC AM A, V4, P629, DOI 10.1364/JOSAA.4.000629; Hwang HS, 2015, J FORENSIC SCI, V60, P957, DOI 10.1111/1556-4029.12766; Kahler K, 2003, ACM T GRAPHIC, V22, P554, DOI 10.1145/882262.882307; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; Miranda GE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196770; Romeiro R, 2014, 2014 27TH SIBGRAPI CONFERENCE ON GRAPHICS, PATTERNS AND IMAGES (SIBGRAPI), P266, DOI 10.1109/SIBGRAPI.2014.25; Rynn C, 2010, FORENSIC SCI MED PAT, V6, P20, DOI 10.1007/s12024-009-9124-6; Shui WY, 2017, COMPUT BIOL MED, V90, P33, DOI 10.1016/j.compbiomed.2017.08.023; Shui WY, 2016, FORENSIC SCI INT, V266, DOI 10.1016/j.forsciint.2016.07.017; Stephan CN, 2008, J FORENSIC SCI, V53, P1257, DOI 10.1111/j.1556-4029.2008.00852.x; Stephan CN, 2017, FORENSIC SCI INT, V280, P113, DOI 10.1016/j.forsciint.2017.09.016; Tu P., 2007, P IEEE C COMP VIS PA, P1, DOI [10.1109/CVPR.2007.383060, DOI 10.1109/CVPR.2007.383060]; Turner WD, 2005, FORENSIC SCI INT, V154, P149, DOI 10.1016/j.forsciint.2004.10.003; Utsuno H, 2014, FORENSIC SCI INT, V236, P175, DOI 10.1016/j.forsciint.2013.12.040; Wilkinson C, 2010, J ANAT, V216, P235, DOI 10.1111/j.1469-7580.2009.01182.x; Zhou QY, 2016, LECT NOTES COMPUT SC, V9906, P766, DOI 10.1007/978-3-319-46475-6_47	27	15	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210257	10.1371/journal.pone.0210257	http://dx.doi.org/10.1371/journal.pone.0210257			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673719	gold, Green Published, Green Submitted			2022-12-26	WOS:000456442800036
J	Imaeda, T; Nakada, T; Abe, R; Oda, S				Imaeda, Taro; Nakada, Taka-aki; Abe, Ryuzo; Oda, Shigeto			Decreased total iron binding capacity upon intensive care unit admission predicts red blood cell transfusion in critically ill patients	PLOS ONE			English	Article							ANEMIA; ERYTHROPOIETIN; HEPCIDIN; SEPSIS; SERUM	Introduction Red blood cell (RBC) transfusion is associated with poor clinical outcome in critically ill patients. We investigated the predictive value of biomarkers on intensive care units (ICU) admission for RBC transfusion within 28 days. Methods Critically ill patients (n = 175) who admitted to our ICU with organ dysfunction and an expected stay of >= 48 hours, without hemorrhage, were prospectively studied (derivation cohort, n = 121; validation cohort, n = 54). Serum levels of 12 biomarkers (hemoglobin, creatinine, albumin, interleukin-6 [IL-6], erythropoietin, Fe, total iron binding capacity [TIBC], transferrin, ferritin, transferrin saturation, folate, and vitamin B12) were measured upon ICU admission, days 7, 14, 21 and 28. Results Among the 12 biomarkers measured upon ICU admission, levels of hemoglobin, albumin, IL-6, TIBC, transferrin and ferritin were statistically different between transfusion and non-transfusion group. Of 6 biomarkers, TIBC upon ICU admission had the highest area under the curve value (0.835 [95% confidence interval] = 0.765-0.906) for predicting RBC transfusion (cut-off value = 234.5 mu g/dL; sensitivity = 0.906, specificity = 0.632). This result was confirmed in validation cohort, whose sensitivity and specificity were 0.888 and 0.694, respectively. Measurement of these biomarkers every seven days revealed that albumin, TIBC and transferrin were statistically different between groups throughout hospitalization until 28 days. In validation cohort, patients in the transfusion group had significantly higher serum hepcidin levels than those in the non-transfusion group (P = 0.004). In addition, joint analysis across derivation and validation cohorts revealed that the serum IL-6 levels were higher in the transfusion group (P = 0.0014). Conclusion Decreased TIBC upon ICU admission has high predictive value for RBC transfusion unrelated to hemorrhage within 28 days.	[Imaeda, Taro; Nakada, Taka-aki; Abe, Ryuzo; Oda, Shigeto] Chiba Univ, Grad Sch Med, Dept Emergency & Crit Care Med, Chiba, Japan	Chiba University	Nakada, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Emergency & Crit Care Med, Chiba, Japan.	taka.nakada@chiba-u.jp			JSPS KAKENHI [JP15K15660]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP15K15660 to SO (https://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by JSPS KAKENHI Grant Number JP15K15660.	[Anonymous], 1999, Crit Care Med, V27, P639; Astin R, 2014, EXTREME PHYSIOL MED, V3, DOI 10.1186/2046-7648-3-4; Corwin HL, 2004, CRIT CARE, V8, pS42, DOI 10.1186/cc2411; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; Elliot JM, 2003, CRIT CARE, V7, pR35, DOI 10.1186/cc2185; ERSLEV AJ, 1991, NEW ENGL J MED, V324, P1339, DOI 10.1056/NEJM199105093241907; Fernandez R, 2010, ANESTHESIOLOGY, V112, P1211, DOI 10.1097/ALN.0b013e3181d74f87; Gambino R, 1997, CLIN CHEM, V43, P2408; Ganz T, 2011, ANNU REV MED, V62, P347, DOI 10.1146/annurev-med-050109-142444; Hayden SJ, 2012, AM J RESP CRIT CARE, V185, P1049, DOI 10.1164/rccm.201110-1915CI; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Heming N, 2011, CRIT CARE, V15, DOI 10.1186/cc9992; Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617; JELKMANN W, 1992, PHYSIOL REV, V72, P449, DOI 10.1152/physrev.1992.72.2.449; Juffermans NP, 2011, SHOCK, V35, P355, DOI 10.1097/SHK.0b013e3182086094; Kasvosve I, 2002, CLIN CHEM LAB MED, V40, P1014, DOI 10.1515/CCLM.2002.176; Khorramian E, 2017, SHOCK, V48, P490, DOI 10.1097/SHK.0000000000000886; Lasocki S, 2011, ANESTHESIOLOGY, V114, P688, DOI 10.1097/ALN.0b013e3182065c57; Lasocki S, 2010, INTENS CARE MED, V36, P1044, DOI 10.1007/s00134-010-1794-8; Litton E, 2016, INTENSIVE CARE MED; Loftus TJ, 2018, AM J RESP CRIT CARE; Maynor L, 2007, ANN PHARMACOTHER, V41, P1476, DOI 10.1345/aph.1K187; Mukhopadhyay A, 2010, CRIT CARE, V14, DOI 10.1186/cc8859; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Ramsay WNM, 1997, CLIN CHIM ACTA, V259, P25, DOI 10.1016/S0009-8981(96)06489-3; Retter A, 2013, BRIT J HAEMATOL, V160, P445, DOI 10.1111/bjh.12143; Rodriquez RM, 2001, J CRIT CARE, V16, P36, DOI 10.1053/jcrc.2001.21795; Salisbury AC, 2011, ARCH INTERN MED, V171, P1646, DOI 10.1001/archinternmed.2011.361; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Vincent JL, 2014, SHOCK, V41, P98, DOI 10.1097/SHK.0000000000000090; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809	32	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210067	10.1371/journal.pone.0210067	http://dx.doi.org/10.1371/journal.pone.0210067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673726	Green Published, Green Submitted, gold			2022-12-26	WOS:000456442800030
J	Rosel, JF; Jara, P; Machancoses, FH; Pallares, J; Torrente, P; Puchol, S; Canales, JJ				Rosel, Jesus F.; Jara, Pilar; Machancoses, Francisco H.; Pallares, Jacinto; Torrente, Pedro; Puchol, Sara; Canales, Juan J.			Intensive longitudinal modelling predicts diurnal activity of salivary alpha-amylase	PLOS ONE			English	Article							POOLED TIME-SERIES; STRESS; PSYCHOLOGY; BEHAVIOR	Salivary alpha-amylase (sAA) activity has been widely used in psychological and medical research as a surrogate marker of sympathetic nervous system activation, though its utility remains controversial. The aim of this work was to compare alternative intensive longitudinal models of sAA data: (a) a traditional model, where sAA is a function of hour (hr) and hr squared (sAA(j,t) = f(hr, hr(2)), and (b) an autoregressive model, where values of sAA are a function of previous values (sAA(j,t) = f(sAA(j,t-1), sAA(j/t-2), sAA(j,t-p)). Nineteen normal subjects (9 males and 10 females) participated in the experiments and measurements were performed every hr between 9:00 and 21:00 hr. Thus, a total of 13 measurements were obtained per participant. The Napierian logarithm of the enzymatic activity of sAA was analysed. Data showed that a second-order autoregressive (AR(2)) model was more parsimonious and fitted better than the traditional multilevel quadratic model. Therefore, sAA follows a process whereby, to forecast its value at any given time, sAA values one and two hr prior to that time (sAA(j,t)=f(SAA(j,t-1), SAA(j,t-2)) are most predictive, thus indicating that sAA has its own inertia, with a "memory" of the two previous hr. These novel findings highlight the relevance of intensive longitudinal models in physiological data analysis and have considerable implications for physiological and biobehavioural research involving sAA measurements and other stress-related biomarkers.	[Rosel, Jesus F.; Jara, Pilar; Pallares, Jacinto; Torrente, Pedro] Univ Jaume 1, Dept Dev Educ & Social Psychol & Methodol, Castellon de La Plana, Spain; [Machancoses, Francisco H.] FABIS, Huelva, Spain; [Puchol, Sara] CSIC, IATS, Torre De La Sal, Spain; [Canales, Juan J.] Univ Tasmania, Sch Med, Div Psychol, Hobart, Tas, Australia	Universitat Jaume I; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS); University of Tasmania	Canales, JJ (corresponding author), Univ Tasmania, Sch Med, Div Psychol, Hobart, Tas, Australia.	juan.canales@utas.edu.au	Machancoses, Francisco Herrero/O-7744-2014	Machancoses, Francisco Herrero/0000-0003-0280-5972; Canales, Juan J./0000-0003-2884-5227; , SARA/0000-0003-4881-0478				Andre&beta; HJ., 2013, APPL PANEL DATA ANAL; [Anonymous], 2013, DECL HELS ETH PRINC; [Anonymous], 2012, BASIC ECONOMETRICS; [Anonymous], 2009, HDB ADV MULTILEVEL A; [Anonymous], 2014, APPL REGRESSION ANAL; Banuelos Maria S, 2017, J Undergrad Neurosci Educ, V16, pA23; Bear MF, 2007, NEUROSCIENCE EXPLORI, DOI [10.1093/brain/awm203, DOI 10.1093/BRAIN/AWM203]; Bolger N, 2013, INTENSIVE LONGITUDIN; Bollen KA, 2004, SOCIOL METHOD RES, V32, P336, DOI 10.1177/0049124103260222; Bosch JA, 2011, PSYCHONEUROENDOCRINO, V36, P449, DOI 10.1016/j.psyneuen.2010.12.019; Box G. E. P., 2016, TIME SERIES ANAL FOR; Brown H, 2015, APPL MIXED MODELS ME, DOI [10.1097/MD.0000000000000683, DOI 10.1097/MD.0000000000000683]; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Claeskens, 2010, MODEL SELECTION MODE; Curran PJ, 2001, DECADE BEHAV, P107, DOI 10.1037/10409-004; CZEISLER CA, 1986, SCIENCE, V233, P667, DOI 10.1126/science.3726555; DAWES C, 1974, International Journal of Chronobiology, V2, P253; DIELMAN TE, 1989, POOLED CROSS SECTION; ENGLE RF, 1987, ECONOMETRICA, V55, P251, DOI 10.2307/1913236; Freedman D, 2009, STAT MODELS CAUSAL I; Frees E.W., 2004, LONGITUDINAL PANEL D, DOI 10.1198/jasa.2006.s88; GOLDSTEIN H, 1994, STAT MED, V13, P1643, DOI 10.1002/sim.4780131605; Goldstein H., 2011, MULTILEVEL STAT MODE, V4th; Goodwin MS, 2008, BEHAV RES METHODS, V40, P328, DOI 10.3758/BRM.40.1.328; Hedeker D., 2006, LONGITUDINAL DATA AN; Hoeppner BB, 2007, MULTIVAR BEHAV RES, V42, P707, DOI 10.1080/00273170701755291; Hox JJ, 2010, MULTILEVEL TECHNIQUE; Johnson DR, 1995, J MARRIAGE FAM, V57, P1065, DOI 10.2307/353423; Kang Y, 2010, NURS HEALTH SCI, V12, P477, DOI 10.1111/j.1442-2018.2010.00562.x; Kirk R., 2014, EXPT DESIGN PROCEDUR, DOI [10.4135/9781483384733, DOI 10.4135/9781483384733]; Klein EG, 2009, PREV SCI, V10, P168, DOI 10.1007/s11121-009-0122-4; Kmenta J., 1971, ELEMENTS ECONOMETRIC, V2nd; Leyland AH, 2001, MULTILEVEL MODELLING; McGirr A, 2010, J PSYCHIATR NEUROSCI, V35, P399, DOI 10.1503/jpn.090121; Messerli-Burgy N, 2018, DEV PSYCHOBIOL, V60, P1009, DOI 10.1002/dev.21782; MIKLICH DR, 1975, AM PSYCHOL, V30, P419; Miller AL, 2015, PSYCHONEUROENDOCRINO, V53, P40, DOI 10.1016/j.psyneuen.2014.12.011; MOORE KJ, 1994, J CONSULT CLIN PSYCH, V62, P718, DOI 10.1037/0022-006X.62.4.718; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P392, DOI 10.1016/j.psyneuen.2007.02.007; NAVAZESH M, 1993, ANN NY ACAD SCI, V694, P72, DOI 10.1111/j.1749-6632.1993.tb18343.x; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Rodrigues M. I., 2015, EXPT DESIGN PROCESS; Rohleder N, 2004, ANN NY ACAD SCI, V1032, P258, DOI 10.1196/annals.1314.033; Rohleder N, 2006, PSYCHOPHYSIOLOGY, V43, P645, DOI 10.1111/j.1469-8986.2006.00457.x; Rosel J, 2000, HEALTH PLACE, V6, P309, DOI 10.1016/S1353-8292(00)00012-5; Rovine M.J., 2006, MODELS INTENSIVE LON; Sayrs LS., 1989, CHARACTERISTICS GPCO; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Snijders T, 2011, RB MULTILEVEL ANAL I; Soliday E, 2002, J PEDIATR PSYCHOL, V27, P67, DOI 10.1093/jpepsy/27.1.67; SPEIRS RL, 1974, ARCH ORAL BIOL, V19, P747, DOI 10.1016/0003-9969(74)90161-7; SPSS, 2015, IBM SPSS STAT 23; StataCorp, 2015, DATA PROTECTION DESI; Sun YM, 2002, J MARRIAGE FAM, V64, P472, DOI 10.1111/j.1741-3737.2002.00472.x; van Stegeren A, 2006, PSYCHONEUROENDOCRINO, V31, P137, DOI 10.1016/j.psyneuen.2005.05.012; van Veen JF, 2008, PSYCHONEUROENDOCRINO, V33, P1313, DOI 10.1016/j.psyneuen.2008.07.004; Velicer W. F., 2013, HDB PSYCHOL, V2, P628; VELICER WF, 1997, SCI PREVENTION METHO, P211; Walls T. A., 2006, MODELS INTENSIVE LON; Walls TA, 2013, OXFORD HDB QUANTITAT, V2; Wilcox RR, 2014, PHYSIOL BEHAV, V129, P11, DOI 10.1016/j.physbeh.2014.02.012; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1	64	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0209475	10.1371/journal.pone.0209475	http://dx.doi.org/10.1371/journal.pone.0209475			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI4TC	30673704	Green Published, gold, Green Accepted			2022-12-26	WOS:000456442800018
J	Amei, A; Zhou, SL				Amei, Amei; Zhou, Shilei			Inferring the distribution of selective effects from a time inhomogeneous model	PLOS ONE			English	Article							ADAPTIVE PROTEIN EVOLUTION; AMINO-ACID REPLACEMENTS; RANDOM-FIELD MODEL; NUCLEOTIDE POLYMORPHISM; DROSOPHILA-MELANOGASTER; DIRECTIONAL SELECTION; POPULATION-GENETICS; MOLECULAR EVOLUTION; POSITIVE SELECTION; DIVERGENCE	We have developed a Poisson random field model for estimating the distribution of selective effects of newly arisen nonsynonymous mutations that could be observed as polymorphism or divergence in samples of two related species under the assumption that the two species populations are not at mutation-selection-drift equilibrium. The model is applied to 91 Drosophila genes by comparing levels of polymorphism in an African population of D. melanogaster with divergence to a reference strain of D. simulans. Based on the difference of gene expression level between testes and ovaries, the 91 genes were classified as 33 male-biased, 28 female-biased, and 30 sex-unbiased genes. Under a Bayesian framework, Markov chain Monte Carlo simulations are implemented to the model in which the distribution of selective effects is assumed to be Gaussian with a mean that may differ from one gene to the other to sample key parameters. Based on our estimates, the majority of newly-arisen nonsynonymous mutations that could contribute to polymorphism or divergence in Drosophila species are mildly deleterious with a mean scaled selection coefficient of -2.81, while almost 86% of the fixed differences between species are driven by positive selection. There are only 16.6% of the nonsynonymous mutations observed in sex-unbiased genes that are under positive selection in comparison to 30% of male-biased and 46% of female-biased genes that are beneficial. We also estimated that D. melanogaster and D. simulans may have diverged 1.72 million years ago.	[Amei, Amei] Univ Nevada, Dept Math Sci, Las Vegas, NV 89154 USA; [Zhou, Shilei] 54 Crescent Ave,Apt G, Dorchester, MA USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Amei, A (corresponding author), Univ Nevada, Dept Math Sci, Las Vegas, NV 89154 USA.	amei.amei@unlv.edu						Abel HJ, 2009, THESIS, DOI [10.1073/pnas.1833064100, DOI 10.1073/PNAS.1833064100]; Akashi H, 1999, GENETICS, V151, P221; Amei A, 2014, G3-GENES GENOM GENET, V4, P2425, DOI 10.1534/g3.114.014969; Amei A, 2014, GENETICS, V196, P225, DOI 10.1534/genetics.113.157776; Amei A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034413; Amei A, 2010, ANN APPL PROBAB, V20, P1663, DOI 10.1214/09-AAP668; Bai Y., 2009, ADAPTIVE DIRECTIONAL; Baines JF, 2008, MOL BIOL EVOL, V25, P1639, DOI 10.1093/molbev/msn111; Bierne N, 2004, MOL BIOL EVOL, V21, P1350, DOI 10.1093/molbev/msh134; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Bustamante CD, 2002, NATURE, V416, P531, DOI 10.1038/416531a; Bustamante CD, 2001, GENETICS, V159, P1779; CACCONE A, 1988, GENETICS, V118, P671; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Clark AG, 2003, CURR OPIN GENET DEV, V13, P296, DOI 10.1016/S0959-437X(03)00056-X; Dongarra JJ, 1995, COMMUNICATIONS ACM; Durrett R., 2002, PROB APPL S; Eyre-Walker A, 2002, GENETICS, V162, P2017; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; Fay JC, 2002, NATURE, V415, P1024, DOI 10.1038/4151024a; Fay JC, 2001, GENETICS, V158, P1227; Gelman A., 1996, INFERENCE MONITORING; Glinka S, 2003, GENETICS, V165, P1269; Haario H, 2001, BERNOULLI, V7, P223, DOI 10.2307/3318737; Hartl :D. L, 2000, PRIMER POPULATION GE; HARTL DL, 1994, GENETICS, V138, P227; HUDSON RR, 1987, GENETICS, V116, P153; KEIGHTLEY PD, 1994, GENETICS, V138, P1315; Keightley PD, 2007, GENETICS, V177, P2251, DOI 10.1534/genetics.107.080663; KREITMAN M, 1983, NATURE, V304, P412, DOI 10.1038/304412a0; Lemeunier F, 1986, GENETICS BIOL DROSOP; Li W. H, 1997, MOL EVOLUTION; Loewe L, 2006, GENETICS, V172, P1079, DOI 10.1534/genetics.105.047217; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Meiklejohn CD, 2004, GENETICS, V168, P265, DOI 10.1534/genetics.103.025494; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Ometto L, 2005, MOL BIOL EVOL, V22, P2119, DOI 10.1093/molbev/msi207; Piganeau G, 2003, P NATL ACAD SCI USA, V100, P10335, DOI 10.1073/pnas.1833064100; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Proschel M, 2006, GENETICS, V174, P893, DOI 10.1534/genetics.106.058008; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Roberts GO, 2007, J APPL PROBAB, V44, P458, DOI 10.1239/jap/1183667414; SAWYER SA, 1992, GENETICS, V132, P1161; Sawyer SA, 2003, J MOL EVOL, V57, pS154, DOI 10.1007/s00239-003-0022-3; SAWYER SA, 1987, P NATL ACAD SCI USA, V84, P6225, DOI 10.1073/pnas.84.17.6225; Sawyer SA, 1994, NONNEUTRAL EVOLUTION; Sawyer SA, 2007, P NATL ACAD SCI USA, V104, P6504, DOI 10.1073/pnas.0701572104; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Wakeley J, 2003, GENETICS, V163, P411; Williamson S, 2004, GENETICS, V168, P463, DOI 10.1534/genetics.103.024745; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102; Zhu L, 2005, GENETICS, V170, P1411, DOI 10.1534/genetics.104.035097	55	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0194709	10.1371/journal.pone.0194709	http://dx.doi.org/10.1371/journal.pone.0194709			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657757	Green Published, gold			2022-12-26	WOS:000456017000001
J	Mrkvicova, A; Chmelarova, M; Peterova, E; Havelek, R; Baranova, I; Kazimirova, P; Rudolf, E; Rezacova, M				Mrkvicova, Alena; Chmelarova, Marcela; Peterova, Eva; Havelek, Radim; Baranova, Ivana; Kazimirova, Petra; Rudolf, Emil; Rezacova, Martina			The effect of sodium butyrate and cisplatin on expression of EMT markers	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HISTONE DEACETYLASE INHIBITORS; OVARIAN-CARCINOMA CELLS; E-CADHERIN; MOLECULAR-MECHANISMS; GENE-EXPRESSION; VALPROIC ACID; UP-REGULATION; CANCER; METHYLATION	Histone modifications play a key role in the epigenetic regulation of gene transcription in cancer cells. Histone acetylations are regulated by two classes of enzymes, histone acetyltransferases (HATs) and histone deacetylases (HDACs). HDACs are increased in ovarian carcinomas and they are involved in carcinogenesis and resistance to chemotherapeutic agents. In our study we investigated anticancer effect of HDAC inhibitor sodium butyrate (NaBu) on cisplatin-sensitive and cisplatin-resistant ovarian cell lines A2780 and A2780cis. A2780 and A2780cis were treated with NaBu alone or in combination with cisplatin (CP). NaBu inhibited the growth of both cell lines and enhanced cytotoxic effect of CP. Exposure to NaBu for 24 h induced cell cycle arrest. The expressions of EMT-related genes and proteins were further investigated by qPCR and western blot analysis. Loss of E-cadherin has been shown to be crucial in ovarian cancer development. We found that NaBu dramatically induce expression of E-cadherin gene (CDH1) and protein levels in A2780 and A2780cis. We investigated correlation between transcription and methylation of CDH1gene. Methylation level analysis in 32 CpG sites in CDH1 gene (promoter/exon1 regions) was performed using bisulfite NGS (Next Generation Sequencing). We found that cisplatin-resistant cell line A2780cis cells differ from their cisplatin-sensitive counterparts in the CDH1 methylation. Methylation in A2780cis cells is elevated compared to A2780. However, NaBu-induced expression of CDH1 was not accompanied by CDH1 demethylation. NaBu treatment induced changes in expression of EMT-related genes and proteins. Interestingly E-cadherin zinc finger transcriptional repressor SNAIL1 was upregulated in both cell lines. Mesenchymal marker vimentin was downregulated. Matrix metalloproteases (MMPs) are necessary for pericellular proteolysis and facilitate migration and invasion of tumour cells. NaBu induced mRNA expression of MMPs, mild changes in activities of gelatinases MMP2 and MMP9 were detected. Our data demonstrate that NaBu sensitizes cisplatin-resistant ovarian cancer cells, re-established E-cadherin expression, but it was not able to reverse the EMT phenotype completely.	[Mrkvicova, Alena; Peterova, Eva; Havelek, Radim; Kazimirova, Petra; Rezacova, Martina] Charles Univ Prague, Fac Med Hradec Kralove, Dept Med Biochem, Hradec Kralove, Czech Republic; [Mrkvicova, Alena; Chmelarova, Marcela; Baranova, Ivana] Charles Univ Prague, Fac Med Hradec Kralove, Inst Clin Biochem & Diagnost, Hradec Kralove, Czech Republic; [Mrkvicova, Alena; Chmelarova, Marcela; Peterova, Eva; Baranova, Ivana] Univ Hosp Hradec Kralove, Hradec Kralove, Czech Republic; [Peterova, Eva] Charles Univ Prague, Fac Med Hradec Kralove, Dept Internal Med Gastroenterol 2, Hradec Kralove, Czech Republic; [Rudolf, Emil] Charles Univ Prague, Fac Med Hradec Kralove, Dept Biol, Hradec Kralove, Czech Republic	Charles University Prague; University Hospital Hradec Kralove; Charles University Prague; University Hospital Hradec Kralove; University Hospital Hradec Kralove; Charles University Prague; University Hospital Hradec Kralove; Charles University Prague; University Hospital Hradec Kralove	Mrkvicova, A (corresponding author), Charles Univ Prague, Fac Med Hradec Kralove, Dept Med Biochem, Hradec Kralove, Czech Republic.; Mrkvicova, A (corresponding author), Charles Univ Prague, Fac Med Hradec Kralove, Inst Clin Biochem & Diagnost, Hradec Kralove, Czech Republic.; Mrkvicova, A (corresponding author), Univ Hosp Hradec Kralove, Hradec Kralove, Czech Republic.	mrkvicovaa@lfhk.cuni.cz	Rudolf, Emil/B-5956-2017; Baranová, Ivana/S-5881-2016; Rezacova, Martina/A-2046-2009; Baranová, Ivana/AAH-4713-2020; Havelek, Radim/S-5723-2016; Peterova, Eva/S-5665-2016; Mrkvicova, Alena/A-4414-2017	Rudolf, Emil/0000-0002-9526-3174; Baranová, Ivana/0000-0001-8273-2595; Rezacova, Martina/0000-0001-5370-2290; Baranová, Ivana/0000-0001-8273-2595; Havelek, Radim/0000-0003-0528-1334; Peterova, Eva/0000-0001-7866-9722; Mrkvicova, Alena/0000-0001-7802-5564; /0000-0002-7891-9979	Charles University, Czech Republic [Progres/UK Q40/01]; Ministry of Health, Czech Republic - conceptual development of research organization MH CZ-DRO [00179906]	Charles University, Czech Republic(Czech Republic Government); Ministry of Health, Czech Republic - conceptual development of research organization MH CZ-DRO	This work was supported by Progres/UK Q40/01 Charles University, Czech Republic, https://www.cuni.cz/UK-7368.html, and by Ministry of Health, Czech Republic - conceptual development of research organization MH CZ-DRO 00179906 (University Hospital Hradec Kralove), https://www.mzcr.cz/obsah/institucionalni-podpora_978_3.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton CA, 2008, GYNECOL ONCOL, V109, P129, DOI 10.1016/j.ygyno.2007.12.017; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Boettcher M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011002; Brozovic A, 2015, MOL ONCOL, V9, P1678, DOI 10.1016/j.molonc.2015.04.015; Chen CA, 2015, AM J TRANSL RES, V7, P139; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; Davidson B, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00033; Eckstein N, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-91; Feng JT, 2015, CELL ADHES MIGR, V9, P495, DOI 10.1080/19336918.2015.1112486; Ganatra DA, 2015, EYE, V29, P828, DOI 10.1038/eye.2015.29; Gilardini Montani MS, 2017, CELL ONCOL, V40, P167, DOI 10.1007/s13402-017-0314-z; Giudice FS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058672; Issa ME, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0319-5; Januchowski R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/365867; Javaid S, 2013, CELL REP, V5, P1679, DOI 10.1016/j.celrep.2013.11.034; Jiang GM, 2013, BBA-MOL CELL RES, V1833, P663, DOI 10.1016/j.bbamcr.2012.12.002; Jin Ke Long, 2008, J Gynecol Oncol, V19, P185, DOI 10.3802/jgo.2008.19.3.185; Jolly MK, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00155; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kim MG, 2012, J GYNECOL ONCOL, V23, P182, DOI 10.3802/jgo.2012.23.3.182; Koberle B, 2010, BBA-REV CANCER, V1806, P172, DOI 10.1016/j.bbcan.2010.07.004; Koprinarova M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-49; Kwiecinska P, 2014, TOXICOL LETT, V224, P225, DOI 10.1016/j.toxlet.2013.10.035; Labrie M, 2013, CELL MOL LIFE SCI, V70, P3109, DOI 10.1007/s00018-012-1214-z; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lapinska K, 2016, ANTICANCER RES, V36, P5731, DOI 10.21873/anticanres.11156; Lei WW, 2010, INT J BIOCHEM CELL B, V42, P1489, DOI 10.1016/j.biocel.2010.05.006; Lu HG, 2014, MOL MED REP, V10, P2595, DOI 10.3892/mmr.2014.2517; Muenyi CS, 2014, TOXICOL SCI, V139, P74, DOI 10.1093/toxsci/kfu029; Noguchi S, 2015, LUNG, V193, P691, DOI 10.1007/s00408-015-9776-9; Nural-Guvener HF, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-10; Pani E, 2007, CELL CYCLE, V6, P1796, DOI 10.4161/cc.6.14.4472; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Reid BM, 2017, CANCER BIOL MED, V14, P9, DOI 10.20892/j.issn.2095-3941.2016.0084; Sanchez-Tillo E, 2010, ONCOGENE, V29, P3490, DOI 10.1038/onc.2010.102; Sarkar S, 2011, ANTICANCER RES, V31, P2723; Sato T, 2006, INT J ONCOL, V28, P1233; Takai N, 2004, CANCER-AM CANCER SOC, V101, P2760, DOI 10.1002/cncr.20709; Tian XJ, 2013, BIOPHYS J, V105, P1079, DOI 10.1016/j.bpj.2013.07.011; Wang G, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.242; Wilkins DE, 1997, CANCER CHEMOTH PHARM, V40, P159, DOI 10.1007/s002800050641; Yoshikawa M, 2007, J AM SOC NEPHROL, V18, P58, DOI 10.1681/ASN.2005111187; Zeller C, 2012, ONCOGENE, V31, P4567, DOI 10.1038/onc.2011.611; Zhang WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031450	45	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210889	10.1371/journal.pone.0210889	http://dx.doi.org/10.1371/journal.pone.0210889			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653577	Green Published, Green Submitted, gold			2022-12-26	WOS:000456015500085
J	Price, J; Pettifor, A; Selin, A; Wagner, RG; MacPhail, C; Agyei, Y; Gomez-Olive, FX; Kahn, K				Price, Jessica; Pettifor, Audrey; Selin, Amanda; Wagner, Ryan G.; MacPhail, Catherine; Agyei, Yaw; Gomez-Olive, F. Xavier; Kahn, Kathleen			The association between perceived household educational support and HIV risk in young women in a rural South African community (HPTN 068): A cross sectional study	PLOS ONE			English	Article							CONDITIONAL CASH TRANSFER; PARENTAL INVOLVEMENT; ACADEMIC-ACHIEVEMENT; TRANSFER PROGRAM; SEXUAL-BEHAVIOR; ADOLESCENTS; HEALTH; SURVEILLANCE; PERCEPTIONS; PREVALENCE	Objective To characterise perceived household support for female education and the associations between educational support and HIV prevalence, HSV-2 prevalence and sexual risk behaviours. Methods This cross-sectional study used baseline survey data from the Swa Koteka HPTN 068 trial undertaken in Mpumalanga, South Africa. The study included 2533 young women aged 13-20, in grades 8-11 at baseline. HIV and HSV-2 status were determined at baseline. Information about patterns of sexual behaviour and household support for education was collected during the baseline survey. Linear regression and binary logistic regression were used to determine associations between household support for education and both biological and behavioural outcomes. Results High levels of educational support were reported across all measures. HIV prevalence was 3.2% and HSV-2 prevalence was 4.7%, both increasing significantly with age. Over a quarter (26.6%) of young women reported vaginal sex, with 60% reporting condom use at last sex. The median age of sexual debut was 16 years. Household educational support was not significantly associated with HIV or HSV-2; however, the odds of having had vaginal sex were significantly lower in those who reported greater homework supervision (OR 0.82, 95% CI: 0.72-0.94), those who engaged in regular discussion of school marks with a caregiver (OR 0.82, 95% CI: 0.71-0.95) and when caregivers had greater educational goals for the young woman (OR 0.82, 95% CI: 0.71-0.96). In contrast, greater caregiver disappointment at dropout was significantly associated with reported vaginal sex (OR 1.29, 95% CI: 1.14-1.46). Conclusion Young women in rural South Africa report experiencing high levels of household educational support. This study suggests that greater household educational support is associated with lower odds of having vaginal sex and engaging in risky sexual behaviour, though not with HIV or HSV-2 prevalence.	[Price, Jessica] Univ Cape Town, Fac Hlth Sci, Sch Publ Hlth & Family Med, Cape Town, South Africa; [Price, Jessica] Univ Oxford, Div Med Sci, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Pettifor, Audrey] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Pettifor, Audrey; Wagner, Ryan G.; MacPhail, Catherine; Gomez-Olive, F. Xavier; Kahn, Kathleen] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa; [Pettifor, Audrey; Selin, Amanda] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27515 USA; [Pettifor, Audrey; MacPhail, Catherine] Univ Witwatersrand, Sch Clin Med, Fac Hlth Sci, Wits Reprod Hlth & HIV Inst WRHI, Johannesburg, South Africa; [Wagner, Ryan G.; Kahn, Kathleen] Umea Univ, Umea Ctr Global Hlth Res, Umea, Sweden; [MacPhail, Catherine] Univ Wollongong, Sch Hlth & Soc, Wollongong, NSW, Australia; [Agyei, Yaw] Johns Hopkins Univ, Sch Med, Dept Pathol, HPTN Lab Ctr, Baltimore, MD 21205 USA	University of Cape Town; University of Oxford; University of North Carolina; University of North Carolina Chapel Hill; University of Witwatersrand; University of North Carolina; University of North Carolina Chapel Hill; University of Witwatersrand; Umea University; University of Wollongong; Johns Hopkins University	Price, J (corresponding author), Univ Cape Town, Fac Hlth Sci, Sch Publ Hlth & Family Med, Cape Town, South Africa.; Price, J (corresponding author), Univ Oxford, Div Med Sci, Nuffield Dept Primary Care Hlth Sci, Oxford, England.	jessica.price@gtc.ox.ac.uk	Gómez-Olivé, Francesc Xavier/AAP-7673-2021; Wagner, Ryan G/AFK-7323-2022; MacPhail, Catherine/N-4234-2014	Gómez-Olivé, Francesc Xavier/0000-0002-4876-0848; Wagner, Ryan G/0000-0003-2741-3676; Kahn, Kathleen/0000-0003-3339-3931; Price, Jessica/0000-0002-4020-6850; Pettifor, Audrey/0000-0002-3387-0817; MacPhail, Catherine/0000-0002-0614-0157	HIV Prevention Trials Network (HPTN), through the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [UM1AI068619, UM1AI068617, UM1AI068613]; National Institute of Mental Health (NIMH) of the National Institutes of Health (NIH) [UM1AI068619, UM1AI068617, UM1AI068613]; National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH) [UM1AI068619, UM1AI068617, UM1AI068613]; Division of Intramural Research NIAID; Wellcome Trust [058893/Z/99/A, 069683/Z/02/Z, 085477/Z/08/Z, 085477/B/08/Z]; University of the Witwatersrand; Medical Research Council, South Africa;  [5R01MH087118-02];  [R24 HD050924]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410, UM1AI068617, UM1AI069423, UM1AI068619, UM1AI068613] Funding Source: NIH RePORTER	HIV Prevention Trials Network (HPTN), through the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH); National Institute of Mental Health (NIMH) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH); Division of Intramural Research NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission); University of the Witwatersrand; Medical Research Council, South Africa(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for the HPTN 068 study was provided by the HIV Prevention Trials Network (HPTN), funded through the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute of Mental Health (NIMH) and the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH) under Award Numbers UM1AI068619 (HPTN Leadership and Operations Center), UM1AI068617 (HPTN Statistical and Data Management Center), and UM1AI068613 (HPTN Laboratory Center). The study was also funded under Award Number 5R01MH087118-02 and R24 HD050924 to the Carolina Population Center. Additional funding was provided by the Division of Intramural Research NIAID. HPTN 068 is nested within the Agincourt Health and socio-Demographic Surveillance System, with funding from the Wellcome Trust (058893/Z/99/A; 069683/Z/02/Z; 085477/Z/08/Z; 085477/B/08/Z), University of the Witwatersrand, and Medical Research Council, South Africa.	[Anonymous], 2012 NAT ANT SENT HI; Baird S, 2010, HEALTH ECON, V19, P55, DOI 10.1002/hec.1569; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Biraro S, 2011, SEX TRANSM DIS, V38, P140, DOI 10.1097/OLQ.0b013e3181f0bafb; Borawski EA, 2003, J ADOLESCENT HEALTH, V33, P60, DOI 10.1016/S1054-139X(03)00100-9; Brook DW, 2006, AIDS EDUC PREV, V18, P259, DOI 10.1521/aeap.2006.18.3.259; Carranza FD, 2009, ADOLESCENCE, V44, P313; Desforges C., 2003, THE IMPACT OF PARENT; DiClemente RJ, 2001, PEDIATRICS, V107, P1363, DOI 10.1542/peds.107.6.1363; Duflo E, 2006, ED HIV AIDS PREVENTI; Fan X, 2001, ED PSYCHOL REV; Fylkesnes K, 2001, AIDS, V15, P907, DOI 10.1097/00002030-200105040-00011; Gonzalez-DeHass AR, 2005, EDUC PSYCHOL REV, V17, P95, DOI 10.1007/s10648-005-3949-7; Hargreaves JR, 2008, AIDS, V22, P403, DOI 10.1097/QAD.0b013e3282f2aac3; Hoover-Dempsey KV, 2001, EDUC PSYCHOL-US, V36, P195, DOI 10.1207/S15326985EP3603_5; Huebner AJ, 2003, J ADOLESCENT HEALTH, V33, P71, DOI 10.1016/S1054-139X(03)00141-1; Jeynes WH, 2007, URBAN EDUC, V42, P82, DOI 10.1177/0042085906293818; Kahn K, 2012, INT J EPIDEMIOL, V41, P988, DOI 10.1093/ije/dys115; Kapiga SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068825; Li XM, 2000, J ADOLESCENT HEALTH, V27, P43, DOI 10.1016/S1054-139X(99)00077-4; Mensch BS, 2003, DEMOGRAPHY, V40, P247, DOI 10.1353/dem.2003.0017; Michelo C, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-279; Peltzer K, 2010, ACTA PAEDIATR, V99, P1242, DOI 10.1111/j.1651-2227.2010.01874.x; Peng SS, J ED RES; Perrino T, 2000, Clin Child Fam Psychol Rev, V3, P81, DOI 10.1023/A:1009571518900; Pettifor A, 2016, LANCET GLOB HEALTH, V4, pE978, DOI [10.1016/S2214-109X(16)30253-4, 10.1016/s2214-109x(16)30253-4]; Pettifor A, 2016, AIDS BEHAV, V20, P1863, DOI 10.1007/s10461-015-1270-0; Ryan J., 2015, OPEN FAMILY STUDIES, V7, P7, DOI [10.2174/1874922401507010012, DOI 10.2174/1874922401507010012]; Shisana O, 2012, S AFRICAN NATL HIV P; Silverberg S, 1991, PARENTING MONITORING; Singh P, 2006, S AFRICAN J ED, P301; SMALL SA, 1993, J MARRIAGE FAM, V55, P941, DOI 10.2307/352774; Spera C, 2006, J EARLY ADOLESCENCE, V26, P456, DOI 10.1177/0272431606291940; Stephenson R, 2014, J HEALTH POPUL NUTR, V32, P161; SuiChu EH, 1996, SOCIOL EDUC, V69, P126, DOI 10.2307/2112802; [UNICEF UNICEF], 2018, PROT CAR SUPP CHILDR; van Wyk N, 2007, S AFRICAN J ED, P27; Waruru Anthony K, 2005, BMC Med Inform Decis Mak, V5, P24, DOI 10.1186/1472-6947-5-24; WHO, EST GLOB PREV INC HE; Wight D, 2006, J ADOLESCENCE, V29, P473, DOI 10.1016/j.adolescence.2005.08.007	40	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210632	10.1371/journal.pone.0210632	http://dx.doi.org/10.1371/journal.pone.0210632			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653540	Green Published, Green Submitted, gold			2022-12-26	WOS:000456015500057
J	Ballaro, R; Beltra, M; De Lucia, S; Pin, F; Ranjbar, K; Hulmi, JJ; Costelli, P; Penna, F				Ballaro, Riccardo; Beltra, Marc; De Lucia, Serena; Pin, Fabrizio; Ranjbar, Kia; Hulmi, Juha J.; Costelli, Paola; Penna, Fabio			Moderate exercise in mice improves cancer plus chemotherapy-induced muscle wasting and mitochondrial alterations	FASEB JOURNAL			English	Article						cancer cachexia; mitochondria; autophagy; PGC-1 alpha; survival	PROTEIN-SYNTHESIS; ANIMAL-MODEL; CACHEXIA; PREVENTION; RESISTANCE; MECHANISMS; ATROPHY; IMPACT	Cancer cachexia is a multifactorial syndrome characterized by anorexia, body wasting, and muscle and adipose tissue loss, impairing patient's tolerance to anticancer treatments and survival. The aim of the present study was to compare the effects induced in mice by tumor growth alone (C26) or in combination with chemotherapy [C26 oxaliplatin and 5-fluorouracil (oxfu)] and to evaluate the potential of moderate exercise. Oxfu administration to C26 mice exacerbated muscle wasting and triggered autophagy or mitophagy, decreased protein synthesis, and induced mitochondrial alterations. Exercise in C26 oxfu mice counteracted the loss of muscle mass and strength, partially rescuing autophagy and mitochondrial function. Nevertheless, exercise worsened survival in C26 oxfu mice in late stages of cachexia. In summary, chemotherapy further impinges on cancer-induced alterations, worsening muscle wasting. An ideal multifactorial and early intervention to prevent cancer cachexia could take advantage of exercise, improving patient's energy metabolism, mobility, and quality of life.	[Ballaro, Riccardo; Beltra, Marc; De Lucia, Serena; Costelli, Paola; Penna, Fabio] Univ Torino, Expt Med & Clin Pathol Unit, Dept Clin & Biol Sci, Turin, Italy; [Ballaro, Riccardo; Beltra, Marc; De Lucia, Serena; Costelli, Paola; Penna, Fabio] Interuniv Inst Myol, Assisi, Italy; [Pin, Fabrizio] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Ranjbar, Kia] Univ Tarbiat Modares, Fac Phys Educ & Sport Sci, Dept Exercise Physiol, Tehran, Iran; [Hulmi, Juha J.] Univ Jyvaskyla, Fac Sport & Hlth Sci, Biol Phys Act, Neuromuscular Res Ctr, Jyvaskyla, Finland	University of Turin; Indiana University System; Indiana University Bloomington; Tarbiat Modares University; University of Jyvaskyla	Penna, F (corresponding author), Univ Torino, Dept Clin & Biol Sci, Corso Raffaello 30, I-10125 Turin, Italy.	fabio.penna@unito.it	Ballarò, Riccardo/ABC-1988-2020; Beltrà, Marc/AFR-7797-2022; Penna, Fabio/K-5090-2016	Ballarò, Riccardo/0000-0001-5505-9024; Beltrà, Marc/0000-0001-6070-9861; Penna, Fabio/0000-0002-2774-6027	Associazione Italiana per la Ricerca sul Cancro [AIRC], Milano [IG9153]; University of Torino; Academy of Finland [275922]	Associazione Italiana per la Ricerca sul Cancro [AIRC], Milano(Fondazione AIRC per la ricerca sul cancro); University of Torino; Academy of Finland(Academy of Finland)	The authors thank Juulia Lautaoja (Neuromuscular Research Center, Biology of Physical Activity, Faculty of Sport and Health Sciences, University of Jyvaskyla) for technical assistance. This work was supported by Associazione Italiana per la Ricerca sul Cancro [AIRC; Grant IG9153 (to P.C.)] Milano, University of Torino (ex-60% funds), and by Academy of Finland Grant 275922 (to J.J.H.). The authors declare no conflicts of interest.	Argiles JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829; Argiles JM, 2012, J CACHEXIA SARCOPENI, V3, P73, DOI 10.1007/s13539-012-0067-5; Aversa Z, 2017, THER ADV MED ONCOL, V9, P369, DOI 10.1177/1758834017698643; Ballaro R, 2016, CURR OPIN SUPPORT PA, V10, P281, DOI 10.1097/SPC.0000000000000233; Barreto R, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00472; Barreto R, 2016, ONCOTARGET, V7, P43442, DOI 10.18632/oncotarget.9779; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106489; Bredahl EC, 2016, MED SCI SPORT EXER, V48, P1468, DOI 10.1249/MSS.0000000000000926; Brown JL, 2017, J CACHEXIA SARCOPENI, V8, P926, DOI 10.1002/jcsm.12232; Cao SS, 1996, J NATL CANCER I, V88, P430, DOI 10.1093/jnci/88.7.430; Chacon-Cabrera A, 2017, J CELL PHYSIOL, V232, P3744, DOI 10.1002/jcp.25851; Chen JA, 2015, J CACHEXIA SARCOPENI, V6, P132, DOI 10.1002/jcsm.12023; Damrauer J.S., 2008, BASIC APPL MYOL, V18, P139, DOI [10.4081/ejtm.2018.7590, DOI 10.4081/EJTM.2018.7590, DOI 10.4081/ejtm.2018.7590]; Engelen MPKJ, 2016, CURR OPIN CLIN NUTR, V19, P39, DOI 10.1097/MCO.0000000000000236; Gilliam LAA, 2016, AM J PHYSIOL-ENDOC M, V311, pE293, DOI 10.1152/ajpendo.00540.2015; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Goodman CA, 2013, EXERC SPORT SCI REV, V41, P107, DOI 10.1097/JES.0b013e3182798a95; Grande AJ, 2015, J CACHEXIA SARCOPENI, V6, P208, DOI 10.1002/jcsm.12055; Hatakeyama S, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0098-2; Heywood R, 2018, ARCH PHYS MED REHAB, V99, P2595, DOI 10.1016/j.apmr.2018.04.008; Hojman P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109030; Kazemi-Bajestani SMR, 2016, SEMIN CELL DEV BIOL, V54, P2, DOI 10.1016/j.semcdb.2015.09.001; Keizman D, 2010, CANCER, V116, P251, DOI 10.1002/cncr.24710; Khamoui AV, 2016, METABOLISM, V65, P685, DOI 10.1016/j.metabol.2016.01.014; LEBRICON T, 1995, METABOLISM, V44, P1340, DOI 10.1016/0026-0495(95)90040-3; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; MacDonald AJ, 2015, CLIN CANCER RES, V21, P1734, DOI 10.1158/1078-0432.CCR-14-2004; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Miyamoto Y, 2015, ANN SURG ONCOL, V22, P2663, DOI 10.1245/s10434-014-4281-6; Nissinen TA, 2018, J CACHEXIA SARCOPENI, V9, P514, DOI 10.1002/jcsm.12310; Padilha CS, 2017, APPL PHYSIOL NUTR ME, V42, P916, DOI 10.1139/apnm-2016-0436; Penna F, 2016, EXPERT OPIN INV DRUG, V25, P63, DOI 10.1517/13543784.2016.1117072; Penna F, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7153610; Penna F, 2016, J CACHEXIA SARCOPENI, V7, P345, DOI 10.1002/jcsm.12050; Penna F, 2016, SEMIN CELL DEV BIOL, V54, P20, DOI 10.1016/j.semcdb.2015.09.002; Penna F, 2013, AM J PATHOL, V182, P1367, DOI 10.1016/j.ajpath.2012.12.023; Penna F, 2011, J CACHEXIA SARCOPENI, V2, P95, DOI 10.1007/s13539-011-0028-4; Penna F, 2010, INT J CANCER, V127, P1706, DOI 10.1002/ijc.25146; Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011; Pigna E, 2016, SCI REP-UK, V6, DOI 10.1038/srep26991; Pin F, 2015, ONCOTARGET, V6, P43202, DOI 10.18632/oncotarget.6439; Robinson SM, 2013, J HEPATOL, V59, P318, DOI 10.1016/j.jhep.2013.04.014; Sandri M, 2016, SEMIN CELL DEV BIOL, V54, P11, DOI 10.1016/j.semcdb.2015.11.002; Toledo M, 2016, J CACHEXIA SARCOPENI, V7, P48, DOI 10.1002/jcsm.12035; von Haehling S, 2014, J CACHEXIA SARCOPENI, V5, P261, DOI 10.1007/s13539-014-0164-8; White JP, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-14; White JP, 2011, AM J PHYSIOL-REG I, V300, pR201, DOI 10.1152/ajpregu.00300.2010; White J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022339; Yan Z, 2012, EXERC SPORT SCI REV, V40, P159, DOI 10.1097/JES.0b013e3182575599	50	46	46	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5482	5494		10.1096/fj.201801862R	http://dx.doi.org/10.1096/fj.201801862R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30653354	Bronze			2022-12-26	WOS:000462888500068
J	Fergie, N; Todd, N; McClements, L; McAuley, D; O'Kane, C; Krasnodembskaya, A				Fergie, Nicola; Todd, Naomi; McClements, Lana; McAuley, Danny; O'Kane, Cecilia; Krasnodembskaya, Anna			Hypercapnic acidosis induces mitochondrial dysfunction and impairs the ability of mesenchymal stem cells to promote distal lung epithelial repair	FASEB JOURNAL			English	Article						ARDS; hypercapnic acidosis; mitochondrial transfer; wound healing	STROMAL CELLS; IN-VITRO; ENDOTHELIAL-CELLS; EXPRESSION; INJURY; MODELS; INFLAMMATION; VENTILATION; CAVEOLIN-1; MORTALITY	Acute respiratory distress syndrome (ARDS) is a devastating disorder characterized by diffuse inflammation and edema formation. The main management strategy, low tidal volume ventilation, can be associated with the development of hypercapnic acidosis (HCA). Mesenchymal stem cells (MSCs) are a promising therapeutic candidate currently in early-phase clinical trials. The effects of HCA on the alveolar epithelium and capillary endothelium are not well established. The therapeutic efficacy of MSCs has never been reported in HCA. In the present study, we evaluated the effects of HCA on inflammatory response and reparative potential of the primary human small airway epithelial and lung microvasculature endothelial cells as well as on the capacity of bone marrow-derived MSCs to promote wound healing in vitro. We demonstrate that HCA attenuates the inflammatory response and reparative potential of primary human small airway epithelium and capillary endothelium and induces mitochondrial dysfunction. It was found that MSCs promote lung epithelial wound repair via the transfer of functional mitochondria; however, this proreparative effect of MSCs was lost in the setting of HCA. Therefore, HCA may adversely impact recovery from ARDS at the cellular level, whereas MSCs may not be therapeutically beneficial in patients with ARDS who develop HCA.	[Fergie, Nicola; Todd, Naomi; McClements, Lana; McAuley, Danny; O'Kane, Cecilia; Krasnodembskaya, Anna] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Expt Med, Room 2-059,Wellcome Wolfson Bldg,97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland	Queens University Belfast	Krasnodembskaya, A (corresponding author), Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Expt Med, Room 2-059,Wellcome Wolfson Bldg,97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	a.krasnodembskaya@qub.ac.uk	McClements, Lana/S-9458-2019; Krasnodembskaya, Anna D./I-1225-2019	McClements, Lana/0000-0002-4911-1014; Krasnodembskaya, Anna D./0000-0002-2380-5069; McAuley, Daniel/0000-0002-3283-1947; O'Kane, Cecilia/0000-0002-7138-5396	Medical Research Council (MRC) [MR/L017229/1]; MRC Queen's University of Belfast (QUB) [CD1516-CIC4]; Department for Education (DfE); National Institute of General Medical Sciences (NIGMS) of the U.S. National Institutes of Health [P40RR017447]; MRC [MR/M009149/1, MR/L017229/1] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Queen's University of Belfast (QUB); Department for Education (DfE); National Institute of General Medical Sciences (NIGMS) of the U.S. National Institutes of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council (MRC) (MR/L017229/1), MRC Queen's University of Belfast (QUB) (CD1516-CIC4), and the Department for Education (DfE) (PhD studentship). Some of the materials employed in this work were provided by the Texas A&M Health Science Center College of Medicine Institute for Regenerative Medicine at Baylor Scott and White Hospital through a grant from the National Institute of General Medical Sciences (NIGMS) of the U.S. National Institutes of Health (Grant No. P40RR017447). The authors declare no conflicts of interest.	Akram KM, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-9; Boyle AJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-166; Briva A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001238; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Burg J, 2002, AM J PHYSIOL-LUNG C, V283, pL460, DOI 10.1152/ajplung.00249.2001; Campbell L, 1999, BIOCHEM BIOPH RES CO, V262, P744, DOI 10.1006/bbrc.1999.1280; Contreras M, 2012, CRIT CARE MED, V40, P2622, DOI 10.1097/CCM.0b013e318258f8b4; Cummins EP, 2010, J IMMUNOL, V185, P4439, DOI 10.4049/jimmunol.1000701; Curley GF, 2013, ANESTHESIOLOGY, V118, P924, DOI 10.1097/ALN.0b013e318287ba08; Curley GF, 2012, THORAX, V67, P496, DOI 10.1136/thoraxjnl-2011-201059; Dada LA, 2015, MOL CELL BIOL, V35, P3962, DOI 10.1128/MCB.00813-15; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fang XH, 2010, J BIOL CHEM, V285, P26211, DOI 10.1074/jbc.M110.119917; Fergie N., 2017, THORAX, V72, pA018; Fuchs S, 2003, CELL TISSUE RES, V311, P31, DOI 10.1007/s00441-002-0653-5; GEAR ARL, 1974, J BIOL CHEM, V249, P3628; Geys J, 2006, TOXICOL LETT, V160, P218, DOI 10.1016/j.toxlet.2005.07.005; Godfrey RWA, 1997, MICROSC RES TECHNIQ, V38, P488, DOI 10.1002/(SICI)1097-0029(19970901)38:5<488::AID-JEMT5>3.0.CO;2-E; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Higgins BD, 2009, ANESTHESIOLOGY, V111, P1317, DOI 10.1097/ALN.0b013e3181ba3c11; Hillyer P, 2003, CLIN EXP IMMUNOL, V134, P431, DOI 10.1111/j.1365-2249.2003.02323.x; Horie S, 2016, INTENS CARE MED, V42, P779, DOI 10.1007/s00134-015-4140-3; Horie Shahd, 2016, Intensive Care Med Exp, V4, P8, DOI 10.1186/s40635-016-0081-6; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Jackson MV, 2016, STEM CELLS, V34, P2210, DOI 10.1002/stem.2372; Krasnodembskaya A, 2012, AM J PHYSIOL-LUNG C, V302, pL1003, DOI 10.1152/ajplung.00180.2011; Kregenow DA, 2006, CRIT CARE MED, V34, P1, DOI 10.1097/01.CCM.0000194533.75481.03; Laffey JG, 1999, LANCET, V354, P1283, DOI 10.1016/S0140-6736(99)02388-0; Larson-Casey JL, 2016, IMMUNITY, V44, P582, DOI 10.1016/j.immuni.2016.01.001; Liu YL, 2008, CYTOKINE, V44, P108, DOI 10.1016/j.cyto.2008.06.016; Martinez-Reyes I, 2016, MOL CELL, V61, P199, DOI 10.1016/j.molcel.2015.12.002; Matthay MA, 2019, LANCET RESP MED, V7, P154, DOI 10.1016/S2213-2600(18)30418-1; McAuley DF, 2014, AM J PHYSIOL-LUNG C, V306, pL809, DOI 10.1152/ajplung.00358.2013; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Morrison T, 2015, J Intensive Care Soc, V16, P320, DOI 10.1177/1751143715586420; Morrison TJ, 2017, AM J RESP CRIT CARE, V196, P1275, DOI 10.1164/rccm.201701-0170OC; Muller AM, 2002, EXP MOL PATHOL, V73, P171, DOI 10.1006/exmp.2002.2446; Nardelli LM, 2015, RESP PHYSIOL NEUROBI, V205, P1, DOI 10.1016/j.resp.2014.09.007; Niu ZD, 2016, ENVIRON TOXICOL PHAR, V45, P212, DOI 10.1016/j.etap.2016.06.006; O'Toole D, 2009, THORAX, V64, P976, DOI 10.1136/thx.2008.110304; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Patel AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121246; Piantadosi CA, 2017, ANNU REV PHYSIOL, V79, P495, DOI 10.1146/annurev-physiol-022516-034322; Rydkina E, 2010, INFECT IMMUN, V78, P2599, DOI 10.1128/IAI.01335-09; Scott BB, 2005, BIOCHEM BIOPH RES CO, V328, P409, DOI 10.1016/j.bbrc.2004.12.180; Shelton JL, 2006, MICROVASC RES, V71, P40, DOI 10.1016/j.mvr.2005.11.003; SMITH MF, 1994, J IMMUNOL, V153, P3584; Swain RJ, 2010, BIOPHYS J, V98, P1703, DOI 10.1016/j.bpj.2009.12.4289; Takeshita K, 2003, AM J RESP CELL MOL, V29, P124, DOI 10.1165/rcmb.2002-0126OC; Tsuji Takao, 2013, Open Respir Med J, V7, P6, DOI 10.2174/1874306401307010006; Vadasz I, 2008, J CLIN INVEST, V118, P752, DOI 10.1172/JCI29723; Vadasz I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046696; Vohwinkel CU, 2011, J BIOL CHEM, V286, P37067, DOI 10.1074/jbc.M111.290056; Welch LC, 2010, FEBS LETT, V584, P3985, DOI 10.1016/j.febslet.2010.08.002; Williams AE, 2014, AM J PHYSIOL-LUNG C, V306, pL217, DOI 10.1152/ajplung.00311.2013; Wilson JG, 2015, LANCET RESP MED, V3, P24, DOI [10.1016/S2213-2600(14)70291-7, 10.1016/s2213-2600(14)70291-7]; Witherden IR, 2004, AM J RESP CELL MOL, V30, P500, DOI 10.1165/rcmb.4890; Wu GJ, 2005, ANN NY ACAD SCI, V1042, P168, DOI 10.1196/annals.1338.019; Wu SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074742; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zheng GP, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-39	61	25	25	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5585	5598		10.1096/fj.201802056R	http://dx.doi.org/10.1096/fj.201802056R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30649987	Green Published, hybrid			2022-12-26	WOS:000462888500076
J	Wang, J; Zheng, X; Qin, ZL; Wei, LY; Lu, YJ; Peng, Q; Gao, YX; Zhang, XM; Zhang, XY; Li, ZS; Fu, YX; Liu, PS; Liu, C; Yan, Q; Xiong, W; Li, GY; Lu, JH; Ma, J				Wang, Jia; Zheng, Xiang; Qin, Zailong; Wei, Lingyu; Lu, Yuanjun; Peng, Qiu; Gao, Yingxue; Zhang, Xuemei; Zhang, Xiaoyue; Li, Zhengshuo; Fu, Yuxin; Liu, Peishan; Liu, Can; Yan, Qun; Xiong, Wei; Li, Guiyuan; Lu, Jianhong; Ma, Jian			Epstein-Barr virus miR-BART3-3p promotes tumorigenesis by regulating the senescence pathway in gastric cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA viruses; microRNA (miRNA); cellular senescence; gastric cancer; p53; Epstein-Barr virus; miR-BART3-3p	TUMOR-SUPPRESSOR; CELLULAR SENESCENCE; ENCODED MICRORNAS; IN-VIVO; CARCINOMA; P53; PROTEIN; CELLS; LMP1; SURVEILLANCE	Epstein-Barr virus-associated gastric cancer (EBVaGC) accounts for about 10% of all gastric cancer cases and has unique pathological and molecular characteristics. EBV encodes a large number of microRNAs, which actively participate in the development of EBV-related tumors. Here, we report that EBV-miR-BART3-3p (BART3-3p) promotes gastric cancer cell growth in vitro and in vivo. Moreover, BART3-3p inhibits the senescence of gastric cancer cells induced by an oncogene (RAS(G12V)) or chemotherapy (irinotecan). LMP1 and EBNA3C encoded by EBV have also been reported to have antisenescence effects; however, in EBVaGC specimens, LMP1 expression is very low, and EBNA3C is not expressed. BART3-3p inhibits senescence of gastric cancer cells in a nude mouse model and inhibits the infiltration of natural killer cells and macrophages in tumor by altering the senescence-associated secretory phenotype (SASP). Mechanistically, BART3-3p directly targeted the tumor suppressor gene TP53 and caused down-regulation of p53's downstream target, p21. Analysis from clinical EBVaGC samples also showed a negative correlation between BART3-3p and TP53 expression. It is well known that mutant oncogene RAS(G12V) or chemotherapeutic drugs can induce senescence, and here we show that both RAS(G12V) and a chemotherapy drug also can induce BART3-3p expression in EBV-positive gastric cancer cells, forming a feedback loop that keeps the EBVaGC senescence at a low level. Our results suggest that, although TP53 is seldom mutated in EBVaGC, its expression is finely regulated such that EBV-encoded BART3-3p may play an important role by inhibiting the senescence of gastric cancer cells.	[Wang, Jia; Ma, Jian] Cent S Univ, Hunan Canc Hosp, Changsha 410013, Hunan, Peoples R China; [Wang, Jia; Ma, Jian] Cent S Univ, Affiliated Canc Hosp, Xiangya Sch Med, Changsha 410013, Hunan, Peoples R China; [Wang, Jia; Zheng, Xiang; Qin, Zailong; Wei, Lingyu; Lu, Yuanjun; Peng, Qiu; Gao, Yingxue; Zhang, Xuemei; Zhang, Xiaoyue; Li, Zhengshuo; Fu, Yuxin; Liu, Peishan; Liu, Can; Xiong, Wei; Li, Guiyuan; Lu, Jianhong; Ma, Jian] Cent S Univ, Sch Basic Med Sci, Dept Microbiol, Canc Res Inst, Changsha 410078, Hunan, Peoples R China; [Wang, Jia] Changzhi Med Coll, Dept Immunol, Changzhi 046000, Shanxi, Peoples R China; [Zheng, Xiang] Hunan Key Lab Translat Radiat Oncol, Changsha 410013, Hunan, Peoples R China; [Qin, Zailong; Ma, Jian] Third Xiangya Hosp, Hunan Key Lab Nonresolving Inflammat & Canc, Changsha 410013, Hunan, Peoples R China; [Wei, Lingyu; Xiong, Wei; Li, Guiyuan; Ma, Jian] Cent S Univ, Natl Hlth Commiss, Key Lab Carcinogenesis, Changsha 410078, Hunan, Peoples R China; [Lu, Yuanjun; Xiong, Wei; Li, Guiyuan; Ma, Jian] Minist Educ, Key Lab Carcinogenesis & Canc Invas, Changsha 410078, Hunan, Peoples R China; [Yan, Qun] Cent S Univ, Xiangya Hosp, Dept Clin Lab, Changsha 410008, Hunan, Peoples R China	Central South University; Central South University; Central South University; Changzhi Medical College; Central South University; Central South University; Central South University	Ma, J (corresponding author), Cent S Univ, Hunan Canc Hosp, Changsha 410013, Hunan, Peoples R China.; Ma, J (corresponding author), Cent S Univ, Affiliated Canc Hosp, Xiangya Sch Med, Changsha 410013, Hunan, Peoples R China.; Lu, JH; Ma, J (corresponding author), Cent S Univ, Sch Basic Med Sci, Dept Microbiol, Canc Res Inst, Changsha 410078, Hunan, Peoples R China.; Ma, J (corresponding author), Third Xiangya Hosp, Hunan Key Lab Nonresolving Inflammat & Canc, Changsha 410013, Hunan, Peoples R China.; Ma, J (corresponding author), Cent S Univ, Natl Hlth Commiss, Key Lab Carcinogenesis, Changsha 410078, Hunan, Peoples R China.; Ma, J (corresponding author), Minist Educ, Key Lab Carcinogenesis & Canc Invas, Changsha 410078, Hunan, Peoples R China.	jianhlu@csu.edu.cn; majian@csu.edu.cn	Lu, Jianhong/AAM-8841-2020	Lu, Jianhong/0000-0002-4436-1217; Wang, Jia/0000-0002-9107-9433; Ma, Jian/0000-0001-9395-0416	National Natural Science Foundation of China [81472694, 81672889, 81672993, 31670171]; China 111 Project [111-2-12]; Hunan Province Science and Technology Project [2016JC2035]; Key Laboratory of Translational Radiation Oncology Hunan Province Open Research Fund Program [2015TP1009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China 111 Project(Ministry of Education, China - 111 Project); Hunan Province Science and Technology Project; Key Laboratory of Translational Radiation Oncology Hunan Province Open Research Fund Program	This work was supported by National Natural Science Foundation of China Grants 81472694, 81672889, 81672993, and 31670171; China 111 Project Grant 111-2-12; Hunan Province Science and Technology Project Grant 2016JC2035; and Key Laboratory of Translational Radiation Oncology Hunan Province Open Research Fund Program Grant 2015TP1009. The authors declare that they have no conflicts of interest with the contents of this article.	Albanese M, 2016, P NATL ACAD SCI USA, V113, pE6467, DOI 10.1073/pnas.1605884113; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Borza CM, 2002, NAT MED, V8, P594, DOI 10.1038/nm0602-594; Cai LM, 2015, ONCOGENE, V34, P2156, DOI 10.1038/onc.2014.341; Cai LM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8353; Chan JM, 2010, CARCINOGENESIS, V31, P812, DOI 10.1093/carcin/bgq034; Chen JN, 2012, J CLIN GASTROENTEROL, V46, P262, DOI 10.1097/MCG.0b013e318249c4b8; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Eggert T, 2016, CANCER CELL, V30, P533, DOI 10.1016/j.ccell.2016.09.003; Fan CM, 2018, J CANCER, V9, P2852, DOI 10.7150/jca.25460; Hausser J, 2013, GENOME RES, V23, P604, DOI 10.1101/gr.139758.112; He BY, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.253; Imig J, 2011, NUCLEIC ACIDS RES, V39, P1880, DOI 10.1093/nar/gkq1043; Ito Y, 2017, TRENDS CELL BIOL, V27, P830, DOI 10.1016/j.tcb.2017.07.004; Jiang C, 2018, INT J CANCER, V143, P3209, DOI 10.1002/ijc.31642; Jung YJ, 2014, J VIROL, V88, P9027, DOI 10.1128/JVI.00721-14; Kang D, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004979; Lee E, 2018, ONCOGENE, V37, P5858, DOI 10.1038/s41388-018-0367-0; Lee JH, 2009, J GASTROEN HEPATOL, V24, P354, DOI 10.1111/j.1440-1746.2009.05775.x; Lei T, 2013, INT J CANCER, V133, P79, DOI 10.1002/ijc.28007; LEVINE PH, 1995, INT J CANCER, V60, P642, DOI 10.1002/ijc.2910600513; Lu YJ, 2017, J INNATE IMMUN, V9, P574, DOI 10.1159/000479749; Luo B, 2005, WORLD J GASTROENTERO, V11, P629, DOI 10.3748/wjg.v11.i5.629; Marquitz AR, 2012, P NATL ACAD SCI USA, V109, P9593, DOI 10.1073/pnas.1202910109; Menendez JA, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00049; Milanovic M, 2018, NATURE, V553, P96, DOI 10.1038/nature25167; Murphy G, 2009, GASTROENTEROLOGY, V137, P824, DOI 10.1053/j.gastro.2009.05.001; Neault M, 2016, CELL REP, V14, P1966, DOI 10.1016/j.celrep.2016.01.068; Nikitin PA, 2010, CELL HOST MICROBE, V8, P510, DOI 10.1016/j.chom.2010.11.004; Nishikawa J, 1999, J VIROL, V73, P1286, DOI 10.1128/JVI.73.2.1286-1292.1999; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Qiu J, 2014, P NATL ACAD SCI USA, V111, P11157, DOI 10.1073/pnas.1406136111; Saab R, 2011, SEMIN CANCER BIOL, V21, P385, DOI 10.1016/j.semcancer.2011.09.013; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Shinozaki-Ushiku A, 2015, J VIROL, V89, P5581, DOI 10.1128/JVI.03639-14; Speck O, 2015, APPL IMMUNOHISTO M M, V23, P633, DOI 10.1097/PAI.0000000000000122; Verhoeven RJA, 2016, J VIROL, V90, P6475, DOI 10.1128/JVI.00613-16; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vredeveld LCW, 2012, GENE DEV, V26, P1055, DOI 10.1101/gad.187252.112; Xin BZ, 2001, J VIROL, V75, P3010, DOI 10.1128/JVI.75.6.3010-3015.2001; Yang XH, 2000, ONCOGENE, V19, P2002, DOI 10.1038/sj.onc.1203515; Ye ZM, 2016, CANCER LETT, V370, P216, DOI 10.1016/j.canlet.2015.10.023; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Zhang XM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01774; Zheng X, 2018, J VIROL, V92, DOI 10.1128/JVI.01022-18	49	25	26	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4854	4866		10.1074/jbc.RA118.006853	http://dx.doi.org/10.1074/jbc.RA118.006853			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30674552	Green Published, hybrid			2022-12-26	WOS:000463985600011
J	Kronfel, CM; Hernandez, CV; Frick, JP; Hernandez, LS; Gutu, A; Karty, JA; Boutaghou, MN; Kehoe, DM; Cole, RB; Schluchter, WM				Kronfel, Christina M.; Hernandez, Carla V.; Frick, Jacob P.; Hernandez, Leanora S.; Gutu, Andrian; Karty, Jonathan A.; Boutaghou, M. Nazim; Kehoe, David M.; Cole, Richard B.; Schluchter, Wendy M.			CpeF is the bilin lyase that ligates the doubly linked phycoerythrobilin on -phycoerythrin in the cyanobacterium Fremyella diplosiphon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyanobacteria; post-translational modification (PTM); light-harvesting complex (antenna complex); mass spectrometry (MS); fluorescence; photosynthesis; photosynthetic pigment; bilin lyase; phycobiliprotein; phycobilisome	CHROMATICALLY ADAPTING CYANOBACTERIUM; SYNECHOCOCCUS SP PCC-7002; CHROMOPHORE ATTACHMENT; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; BETA-PHYCOCYANIN; ENERGY-TRANSFER; CPCF GENES; SUBUNIT; BIOSYNTHESIS	Phycoerythrin (PE) is a green light-absorbing protein present in the light-harvesting complex of cyanobacteria and red algae. The spectral characteristics of PE are due to its prosthetic groups, or phycoerythrobilins (PEBs), that are covalently attached to the protein chain by specific bilin lyases. Only two PE lyases have been identified and characterized so far, and the other bilin lyases are unknown. Here, using in silico analyses, markerless deletion, biochemical assays with purified and recombinant proteins, and site-directed mutagenesis, we examined the role of a putative lyase-encoding gene, cpeF, in the cyanobacterium Fremyella diplosiphon. Analyzing the phenotype of the cpeF deletion, we found that cpeF is required for proper PE biogenesis, specifically for ligation of the doubly linked PEB to Cys-48/Cys-59 residues of the CpeB subunit of PE. We also show that in a heterologous host, CpeF can attach PEB to Cys-48/Cys-59 of CpeB, but only in the presence of the chaperone-like protein CpeZ. Additionally, we report that CpeF likely ligates the A ring of PEB to Cys-48 prior to the attachment of the D ring to Cys-59. We conclude that CpeF is the bilin lyase responsible for attachment of the doubly ligated PEB to Cys-48/Cys-59 of CpeB and together with other specific bilin lyases contributes to the post-translational modification and assembly of PE into mature light-harvesting complexes.	[Kronfel, Christina M.; Hernandez, Carla V.; Frick, Jacob P.; Hernandez, Leanora S.; Schluchter, Wendy M.] Univ New Orleans, Dept Biol Sci, 2000 Lakeshore Dr, New Orleans, LA 70148 USA; [Boutaghou, M. Nazim; Cole, Richard B.] Univ New Orleans, Dept Chem, New Orleans, LA 70148 USA; [Gutu, Andrian; Kehoe, David M.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Karty, Jonathan A.] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Cole, Richard B.] Sorbonne Univ Paris 06, F-75252 Paris, France; [Kronfel, Christina M.] USDA, Southern Reg Res Ctr, 1100 Robert E Lee Blvd, New Orleans, LA 70124 USA; [Gutu, Andrian] Janelia Res Campus Med, Howard Hughes Med Inst, 19700 Helix Dr, Ashburn, VA 20147 USA; [Boutaghou, M. Nazim] Shimadzu Sci Instruments, 7102 Riverwood Dr, Columbia, MD 21046 USA	University of Louisiana System; University of New Orleans; University of Louisiana System; University of New Orleans; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; UDICE-French Research Universities; Sorbonne Universite; United States Department of Agriculture (USDA); Howard Hughes Medical Institute	Schluchter, WM (corresponding author), Univ New Orleans, Dept Biol Sci, 2000 Lakeshore Dr, New Orleans, LA 70148 USA.	wschluch@uno.edu		Karty, Jonathan/0000-0003-1022-9100	National Science Foundation [MCB-1029414, MCB-1818187, MCB-1244339, MCB-0843664]; University of New Orleans Graduate School performance and accountability fellowship; Div Of Molecular and Cellular Bioscience [1244339] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of New Orleans Graduate School performance and accountability fellowship; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grants MCB-1029414 and MCB-1818187 (to D. M. K.) and MCB-1244339 and MCB-0843664 (to W. M. S.) and by a University of New Orleans Graduate School performance and accountability fellowship (to C. M. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvey RM, 2003, PLANT CELL, V15, P2448, DOI 10.1105/tpc.015016; Anderson LK, 1998, MOL MICROBIOL, V30, P467, DOI 10.1046/j.1365-2958.1998.01081.x; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; [Anonymous], [No title captured]; Bezy RP, 2011, P NATL ACAD SCI USA, V108, P18542, DOI 10.1073/pnas.1107427108; BHALERAO RP, 1994, PLANT MOL BIOL, V26, P313, DOI 10.1007/BF00039542; Biswas A, 2011, J BIOL CHEM, V286, P35509, DOI 10.1074/jbc.M111.284281; Biswas A, 2010, APPL ENVIRON MICROB, V76, P2729, DOI 10.1128/AEM.03100-09; Blot N, 2009, J BIOL CHEM, V284, P9290, DOI 10.1074/jbc.M809784200; Bohm S, 2007, J BIOL CHEM, V282, P25357, DOI 10.1074/jbc.M702669200; Bolte K, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-56; Bretaudeau A, 2013, NUCLEIC ACIDS RES, V41, pD396, DOI 10.1093/nar/gks1091; Chang WR, 1996, J MOL BIOL, V262, P721, DOI 10.1006/jmbi.1996.0547; COBLEY JG, 1993, PLASMID, V30, P90, DOI 10.1006/plas.1993.1037; Cobley JG, 2002, MOL MICROBIOL, V44, P1517, DOI 10.1046/j.1365-2958.2002.02966.x; COBLEY JG, 1983, J BACTERIOL, V153, P1486, DOI 10.1128/JB.153.3.1486-1492.1983; Dammeyer T, 2008, J BIOL CHEM, V283, P27547, DOI 10.1074/jbc.M803765200; Dammeyer T, 2008, CURR BIOL, V18, P442, DOI 10.1016/j.cub.2008.02.067; Dammeyer T, 2006, J BIOL CHEM, V281, P27081, DOI 10.1074/jbc.M605154200; DELORIMIER R, 1993, PLANT MOL BIOL, V21, P225, DOI 10.1007/BF00019939; DEMARSAC NT, 1977, J BACTERIOL, V130, P82, DOI 10.1128/JB.130.1.82-91.1977; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P8686; FAIRCHILD CD, 1992, P NATL ACAD SCI USA, V89, P7017, DOI 10.1073/pnas.89.15.7017; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P28988; FICNER R, 1992, J MOL BIOL, V228, P935, DOI 10.1016/0022-2836(92)90876-L; Gasper R, 2017, J BIOL CHEM, V292, P3089, DOI 10.1074/jbc.M116.769703; GINDT YM, 1994, BBA-BIOENERGETICS, V1186, P153, DOI 10.1016/0005-2728(94)90174-0; GLAZER AN, 1994, J APPL PHYCOL, V6, P105, DOI 10.1007/BF02186064; GLAZER AN, 1989, J BIOL CHEM, V264, P1; Gutu A, 2013, P NATL ACAD SCI USA, V110, P16253, DOI 10.1073/pnas.1306332110; Gutu A, 2012, MOL PLANT, V5, P1, DOI 10.1093/mp/ssr054; JUNG LJ, 1995, J BIOL CHEM, V270, P12877, DOI 10.1074/jbc.270.21.12877; Kehoe DM, 2006, ANNU REV PLANT BIOL, V57, P127, DOI 10.1146/annurev.arplant.57.032905.105215; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kronfel CM, 2013, BIOCHEMISTRY-US, V52, P8663, DOI 10.1021/bi401192z; Martinez-Oyanedel J, 2004, BIOL RES, V37, P733, DOI 10.4067/S0716-97602004000500003; Noubir S, 2002, MOL MICROBIOL, V43, P749, DOI 10.1046/j.1365-2958.2002.02783.x; ONG LJ, 1991, J BIOL CHEM, V266, P9515; Ritter S, 1999, J STRUCT BIOL, V126, P86, DOI 10.1006/jsbi.1999.4106; Saunee NA, 2008, J BIOL CHEM, V283, P7513, DOI 10.1074/jbc.M708165200; Scheer H, 2008, MOL MICROBIOL, V68, P263, DOI 10.1111/j.1365-2958.2008.06160.x; Schluchter WM, 2010, ADV EXP MED BIOL, V675, P211, DOI 10.1007/978-1-4419-1528-3_12; Seib LO, 2002, J BACTERIOL, V184, P962, DOI 10.1128/jb.184.4.962-970.2002; Shen G, 2008, J BIOL CHEM, V283, P7503, DOI 10.1074/jbc.M708164200; Shen G, 2006, J BIOL CHEM, V281, P17768, DOI 10.1074/jbc.M602563200; Shukla A, 2012, P NATL ACAD SCI USA, V109, P20136, DOI 10.1073/pnas.1211777109; Six C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r259; Storf M, 2001, BIOCHEMISTRY-US, V40, P12444, DOI 10.1021/bi010776s; SWANSON RV, 1992, J BIOL CHEM, V267, P16146; Toole CM, 1998, MOL MICROBIOL, V30, P475, DOI 10.1046/j.1365-2958.1998.01082.x; WILBANKS SM, 1993, J BIOL CHEM, V268, P1226; Yerrapragada S, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00355-15; Zhao C, 2017, P NATL ACAD SCI USA, V114, P13170, DOI 10.1073/pnas.1715495114; Zhao KH, 2007, J BIOL CHEM, V282, P34093, DOI 10.1074/jbc.M703038200; Zhao KH, 2007, P NATL ACAD SCI USA, V104, P14300, DOI 10.1073/pnas.0706209104; Zhao KH, 2005, BIOCHEMISTRY-US, V44, P8126, DOI 10.1021/bi0500168; Zhou J., 1992, THESIS; ZHOU JH, 1992, J BIOL CHEM, V267, P16138; Zhou W, 2014, J BIOL CHEM, V289, P26677, DOI 10.1074/jbc.M114.586743	61	10	10	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					3987	3999		10.1074/jbc.RA118.007221	http://dx.doi.org/10.1074/jbc.RA118.007221			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30670589	Green Published, hybrid			2022-12-26	WOS:000461854400015
J	Menezes, SV; Kovacevic, Z; Richardson, DR				Menezes, Sharleen V.; Kovacevic, Zaklina; Richardson, Des R.			The metastasis suppressor NDRG1 down-regulates the epidermal growth factor receptor via a lysosomal mechanism by up-regulating mitogen-inducible gene 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anti-cancer drug; molecular pharmacology; cancer; epidermal growth factor receptor (EGFR); cancer biology; metastasis suppressor; mitogen-inducible gene 6 (MIG6); NDRG1; oncogenic signaling	EFFECTIVE ANTIPROLIFERATIVE AGENTS; EPITHELIAL-MESENCHYMAL TRANSITION; ISONICOTINOYL HYDRAZONE CLASS; SELECTIVE ANTITUMOR-ACTIVITY; IRON CHELATORS; EGF RECEPTOR; PANCREATIC-CANCER; MOLECULAR TARGETS; TUMOR-METASTASIS; KINASE DOMAIN	The metastasis suppressor, N-Myc downstream-regulated gene-1 (NDRG1) inhibits a plethora of oncogenic signaling pathways by down-regulating the epidermal growth factor receptor (EGFR). Herein, we examined the mechanism involved in NDRG1-mediated EGFR down-regulation. NDRG1 overexpression potently increased the levels of mitogen-inducible gene 6 (MIG6), which inhibits EGFR and facilitates its lysosomal processing and degradation. Conversely, silencing NDRG1 in multiple human cancer cell types decreased MIG6 expression, demonstrating the regulatory role of NDRG1. Further, NDRG1 overexpression facilitated MIG6-EGFR association in the cytoplasm, possibly explaining the significantly (p <0.001) increased half-life of MIG6 from 1.6 +/- 0.2 h under control conditions to 7.9 +/- 0.4 h after NDRG1 overexpression. The increased MIG6 levels enhanced EGFR co-localization with the late endosome/lysosomal marker, lysosomal-associated membrane protein 2 (LAMP2). An increase in EGFR levels after MIG6 silencing was particularly apparent when NDRG1 was overexpressed, suggesting a role for MIG6 in NDRG1-mediated down-regulation of EGFR. Silencing phosphatase and tensin homolog (PTEN), which facilitates early to late endosome maturation, decreased MIG6, and also increased EGFR levels in both the presence and absence of NDRG1 overexpression. These results suggest a role for PTEN in regulating MIG6 expression. Anti-tumor drugs of the di-2-pyridylketone thiosemicarbazone class that activate NDRG1 expression also potently increased MIG6 and induced its cytosolic co-localization with NDRG1. This was accompanied by a decrease in activated and total EGFR levels and its redistribution to late endosomes/lysosomes. In conclusion, NDRG1 promotes EGFR down-regulation through the EGFR inhibitor MIG6, which leads to late endosomal/lysosomal processing of EGFR.	[Menezes, Sharleen V.; Kovacevic, Zaklina; Richardson, Des R.] Univ Sydney, Mol Pharmacol & Pathol Program, Dept Pathol, Med Fdn Bldg K25, Sydney, NSW 2006, Australia; [Menezes, Sharleen V.; Kovacevic, Zaklina; Richardson, Des R.] Univ Sydney, Bosch Inst, Med Fdn Bldg K25, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Kovacevic, Z; Richardson, DR (corresponding author), Univ Sydney, Mol Pharmacol & Pathol Program, Dept Pathol, Med Fdn Bldg K25, Sydney, NSW 2006, Australia.	zaklina.kovacevic@sydney.edu.au; d.richardson@med.usyd.edu.au	Kovacevic, Zaklina/ABD-9581-2021	Kovacevic, Zaklina/0000-0002-4742-4690; Richardson, Des/0000-0002-5506-3274	National Health and Medical Research Council of Australia (NHMRC) [1060482]; Cure Cancer Australia Foundation; Cancer Australia; Australian Postgraduate Award from the University of Sydney; NHMRC Senior Principal Research Fellowship [1062607]; NHMRC Peter Doherty Early Career Fellowship [1037323]; Cancer Institute New South Wales Early Career Fellowship [12-ECF2-17]; NHMRC RD Wright Fellowship [APP1140447]; Cancer Institute New South Wales Career Development Fellowship [CDF171126]; Priority-driven Collaborative Cancer Research Scheme Grant [1086449]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cure Cancer Australia Foundation; Cancer Australia; Australian Postgraduate Award from the University of Sydney; NHMRC Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Peter Doherty Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute New South Wales Early Career Fellowship; NHMRC RD Wright Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute New South Wales Career Development Fellowship; Priority-driven Collaborative Cancer Research Scheme Grant	This work was supported by National Health and Medical Research Council of Australia (NHMRC) Project Grant 1060482 (to D. R. R. and Z. K.), Priority-driven Collaborative Cancer Research Scheme Grant 1086449, Cure Cancer Australia Foundation, and Cancer Australia (to Z. K.). This work was also supported by an Australian Postgraduate Award from the University of Sydney (to S. V. M), an NHMRC Senior Principal Research Fellowship (1062607) (to D. R. R.), an NHMRC Peter Doherty Early Career Fellowship (1037323) (to Z. K), a Cancer Institute New South Wales Early Career Fellowship (12-ECF2-17), an NHMRC RD Wright Fellowship (APP1140447), and a Cancer Institute New South Wales Career Development Fellowship (CDF171126). The authors declare that they have no conflicts of interest with the contents of this article.	Accornero P, 2010, J MOL ENDOCRINOL, V44, P115, DOI 10.1677/JME-09-0035; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Anastasi S, 2005, ONCOGENE, V24, P4540, DOI 10.1038/sj.onc.1208658; Bandyopadhyay S, 2004, ONCOGENE, V23, P5675, DOI 10.1038/sj.onc.1207734; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Carpenter G, 2009, EXP CELL RES, V315, P1556, DOI 10.1016/j.yexcr.2008.09.027; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Chu FY, 2017, P NATL ACAD SCI USA, V114, P10338, DOI 10.1073/pnas.1702226114; Darnell G., 1999, Blood, V94, P781; Dixon KM, 2013, BRIT J CANCER, V108, P409, DOI 10.1038/bjc.2012.582; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Ferby I, 2006, NAT MED, V12, P568, DOI 10.1038/nm1401; Fiorini M, 2002, ONCOGENE, V21, P6530, DOI 10.1038/sj.onc.1205823; Frosi Y, 2010, J CELL BIOL, V189, P557, DOI 10.1083/jcb.201002032; Fry WHD, 2009, EXP CELL RES, V315, P697, DOI 10.1016/j.yexcr.2008.07.022; Fu D, 2007, BLOOD, V110, P752, DOI 10.1182/blood-2007-03-076737; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Ghalayini MK, 2013, BIOSCIENCE REP, V33, P451, DOI 10.1042/BSR20130042; Gosney JA, 2018, J BIOL CHEM, V293, P5895, DOI 10.1074/jbc.RA117.000632; Guang RJ, 2000, CANCER RES, V60, P749; Guo ZL, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0330-x; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jansson PJ, 2015, PHARMACOL RES, V100, P255, DOI 10.1016/j.phrs.2015.08.013; Jin RS, 2014, J CELL SCI, V127, P3116, DOI 10.1242/jcs.147835; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Kim-Fuchs C, 2014, DIGEST SURG, V31, P135, DOI 10.1159/000363065; Kokame K, 1996, J BIOL CHEM, V271, P29659, DOI 10.1074/jbc.271.47.29659; Kovacevic Z, 2016, J BIOL CHEM, V291, P1029, DOI 10.1074/jbc.M115.689653; Kovacevic Z, 2013, ANTIOXID REDOX SIGN, V18, P874, DOI 10.1089/ars.2011.4273; Kovacevic Z, 2011, MOL PHARMACOL, V80, P598, DOI 10.1124/mol.111.073627; Krall JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015945; Kurdistani SK, 1998, CANCER RES, V58, P4439; Lane DJR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057273; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Lee JC, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091435; Lee KH, 2006, BIOCHIMIE, V88, P163, DOI 10.1016/j.biochi.2005.07.011; Li PC, 2016, AM J TRANSL RES, V8, P5370; Liang SX, 2003, CARCINOGENESIS, V24, P1601, DOI 10.1093/carcin/bgg116; Liu W, 2012, EMBO MOL MED, V4, P93, DOI 10.1002/emmm.201100190; Liu WS, 2015, ONCOTARGET, V6, P35522, DOI 10.18632/oncotarget.5849; Liu WS, 2015, ONCOTARGET, V6, P8851, DOI 10.18632/oncotarget.3316; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Lovejoy DB, 2012, J MED CHEM, V55, P7230, DOI 10.1021/jm300768u; Lui GYL, 2015, MOL PHARMACOL, V87, P543, DOI 10.1124/mol.114.096529; Maruyama Y, 2006, CANCER RES, V66, P6233, DOI 10.1158/0008-5472.CAN-06-0183; Menezes SV, 2019, CARCINOGENESIS, V40, P805, DOI 10.1093/carcin/bgy178; Menezes SV, 2017, J BIOL CHEM, V292, P12772, DOI 10.1074/jbc.R117.776393; MORGAN EH, 1981, BIOCHIM BIOPHYS ACTA, V642, P119, DOI 10.1016/0005-2736(81)90143-7; Nishimura Y, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-42; Park E, 2015, NAT STRUCT MOL BIOL, V22, P703, DOI 10.1038/nsmb.3074; Park KC, 2018, BBA-MOL BASIS DIS, V1864, P2644, DOI 10.1016/j.bbadis.2018.04.011; PATERSON S, 1984, J CELL PHYSIOL, V120, P225, DOI 10.1002/jcp.1041200217; Pietiainen V, 2013, J CELL SCI, V126, P3961, DOI 10.1242/jcs.128132; Qu XH, 2002, MOL CELL BIOCHEM, V229, P35, DOI 10.1023/A:1017934810825; RICHARDSON D, 1994, CANCER RES, V54, P685; Richardson DR, 2006, J MED CHEM, V49, P6510, DOI 10.1021/jm0606342; RICHARDSON DR, 1994, J CELL PHYSIOL, V161, P160, DOI 10.1002/jcp.1041610119; Rojas M, 1996, J BIOL CHEM, V271, P27456, DOI 10.1074/jbc.271.44.27456; Saarikoski ST, 2002, FEBS LETT, V530, P186, DOI 10.1016/S0014-5793(02)03475-0; Saletta F, 2010, MOL PHARMACOL, V77, P443, DOI 10.1124/mol.109.061028; Seebacher NA, 2016, J BIOL CHEM, V291, P3796, DOI 10.1074/jbc.M115.682450; Shinde SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10689; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Stacy AE, 2016, J MED CHEM, V59, P8601, DOI 10.1021/acs.jmedchem.6b01050; Sun J, 2013, MOL PHARMACOL, V83, P454, DOI 10.1124/mol.112.083097; vanBelzen N, 1997, LAB INVEST, V77, P85; Wang YQ, 2010, CELL ADHES MIGR, V4, P7, DOI 10.4161/cam.4.1.10497; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; WICK M, 1995, EXP CELL RES, V219, P527, DOI 10.1006/excr.1995.1261; Xi RX, 2017, MOL PHARMACOL, V91, P499, DOI 10.1124/mol.116.107870; Xu DZ, 2005, J BIOL CHEM, V280, P2924, DOI 10.1074/jbc.M408907200; Xu YX, 2018, ONCOL LETT, V15, P7999, DOI 10.3892/ol.2018.8279; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998	78	26	25	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4045	4064		10.1074/jbc.RA118.006279	http://dx.doi.org/10.1074/jbc.RA118.006279			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30679310	hybrid, Green Published			2022-12-26	WOS:000461854400019
J	Goffaux, V				Goffaux, Valerie			Fixed or flexible? Orientation preference in identity and gaze processing in humans	PLOS ONE			English	Article							EMOTION RECOGNITION; INVERSION LEADS; EYE GAZE; FACE; DIRECTION; PERCEPTION; LOOKING; ME	Vision begins with the encoding of contrast at specific orientations. Several works showed that humans identify their conspecifics best based on the horizontally-oriented information contained in the face image; this range conveys the main morphological features of the face. In contrast, the vertical structure of the eye region seems to deliver optimal cues to gaze direction. The present work investigates whether the human face processing system flexibly tunes to vertical information contained in the eye region when processing gaze direction. Alternatively, face processing may invariantly rely on the horizontal range, supporting the domain specificity of orientation tuning for faces and the gateway role of horizontal content to access any type of facial information. Participants judged the gaze direction of faces staring at a range of lateral positions. They additionally performed an identification task with upright and inverted face stimuli. Across tasks, stimuli were filtered to selectively reveal horizontal (H), vertical (V), or combined (HV) information. Most participants identified faces better based on horizontal than vertical information confirming the horizontal tuning of face identification. In contrast, they showed a vertically-tuned sensitivity to gaze direction. The logistic functions fitting the "left" and "right" response proportion as a function of gaze direction were indeed steeper when based on vertical than on horizontal information. The finding of a vertically-tuned processing of gaze direction favours the hypothesis that visual encoding of face information flexibly switches to the orientation channel carrying the cues most relevant to the task at hand. It suggests that horizontal structure, though predominant in the face stimulus, is not a mandatory gateway for efficient face processing. The present evidence may help better understand how visual signals travel the visual system to enable rich and complex representations of naturalistic stimuli such as faces.	[Goffaux, Valerie] UC Louvain, Psychol Sci Res Inst IPSY, Louvain La Neuve, Belgium; [Goffaux, Valerie] UC Louvain, Inst Neurosci IONS, Brussels, Belgium; [Goffaux, Valerie] Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands	Universite Catholique Louvain; Universite Catholique Louvain; Maastricht University	Goffaux, V (corresponding author), UC Louvain, Psychol Sci Res Inst IPSY, Louvain La Neuve, Belgium.; Goffaux, V (corresponding author), UC Louvain, Inst Neurosci IONS, Brussels, Belgium.; Goffaux, V (corresponding author), Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands.	Valerie.goffaux@uclouvain.be	Goffaux, Valerie/H-2019-2014	Goffaux, Valerie/0000-0003-3182-7011	Belgian National fund for Research (F.R.S.-F.N.R.S.)	Belgian National fund for Research (F.R.S.-F.N.R.S.)(Fonds de la Recherche Scientifique - FNRS)	The author is supported by the Belgian National fund for Research (F.R.S.-F.N.R.S.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando S, 2004, PERCEPTION, V33, P1173, DOI 10.1068/p5297; Ando S, 2002, PERCEPTION, V31, P657, DOI 10.1068/p3332; ANSTIS SM, 1969, AM J PSYCHOL, V82, P474, DOI 10.2307/1420441; Balas B, 2015, J EXP CHILD PSYCHOL, V140, P171, DOI 10.1016/j.jecp.2015.07.006; Burton AM, 2015, PERSPECT PSYCHOL SCI, V10, P482, DOI 10.1177/1745691615583129; Cabeza R, 2000, PSYCHOL SCI, V11, P429, DOI 10.1111/1467-9280.00283; Calder AJ, 2008, J EXP PSYCHOL GEN, V137, P244, DOI 10.1037/0096-3445.137.2.244; Cheleski DJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1049; Dakin SC, 2009, J VISION, V9, DOI 10.1167/9.2.13; DEVALOIS RL, 1980, ANNU REV PSYCHOL, V31, P309, DOI 10.1146/annurev.ps.31.020180.001521; Duncan J, 2017, J VISION, V17, DOI 10.1167/17.14.7; Gamer M, 2007, J EXP PSYCHOL HUMAN, V33, P705, DOI 10.1037/0096-1523.33.3.705; Goffaux V, 2008, ACTA PSYCHOL, V128, P119, DOI 10.1016/j.actpsy.2007.11.005; Goffaux V, 2007, J EXP PSYCHOL HUMAN, V33, P995, DOI 10.1037/0096-1523.33.4.995; Goffaux V, 2016, SCI REP-UK, V6, DOI 10.1038/srep34204; Goffaux V, 2016, NEUROPSYCHOLOGIA, V81, P1, DOI 10.1016/j.neuropsychologia.2015.12.004; Goffaux V, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00143; Gosselin F, 2001, VISION RES, V41, P2261, DOI 10.1016/S0042-6989(01)00097-9; Hashemi A, 2019, VISION RES, V157, P12, DOI 10.1016/j.visres.2018.02.006; Hedges L. V., 1981, J ED STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.3102/10769986006002107]; Huynh CM, 2014, ATTEN PERCEPT PSYCHO, V76, P1381, DOI 10.3758/s13414-014-0669-4; Jacques C, 2014, J VISION, V14, DOI 10.1167/14.2.5; Kalpadakis-Smith AV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30900-0; Keil MS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000329; Konar Y, 2010, PSYCHOL SCI, V21, P38, DOI 10.1177/0956797609356508; Langton SRH, 2000, TRENDS COGN SCI, V4, P50, DOI 10.1016/S1364-6613(99)01436-9; Macrae CN, 2002, PSYCHOL SCI, V13, P460, DOI 10.1111/1467-9280.00481; Mareschal I, 2013, J VISION, V13, DOI 10.1167/13.5.18; Mareschal I, 2013, CURR BIOL, V23, P717, DOI 10.1016/j.cub.2013.03.030; Mason MF, 2004, MEMORY, V12, P637, DOI 10.1080/09658210344000152; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Nummenmaa L, 2009, TRENDS COGN SCI, V13, P135, DOI 10.1016/j.tics.2008.12.006; Pachai MV, 2019, VISION RES, V157, P24, DOI 10.1016/j.visres.2018.04.003; Pachai MV, 2018, PERCEPTION, V47, P397, DOI 10.1177/0301006618754479; Pachai MV, 2017, J VISION, V17, DOI 10.1167/17.6.5; Pachai MV, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00074; Pellicano E, 2013, NEUROPSYCHOLOGIA, V51, P1504, DOI 10.1016/j.neuropsychologia.2013.03.021; RHODES G, 1993, COGNITION, V47, P25, DOI 10.1016/0010-0277(93)90061-Y; Rossion B, 2008, ACTA PSYCHOL, V128, P274, DOI 10.1016/j.actpsy.2008.02.003; Schyns PG, 1997, PERCEPTION, V26, P1027, DOI 10.1068/p261027; Sekuler AB, 2004, CURR BIOL, V14, P391, DOI 10.1016/j.cub.2004.02.028; Smith AD, 2006, DEVELOPMENTAL SCI, V9, P465, DOI 10.1111/j.1467-7687.2006.00513.x; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Taubert J, 2016, SCI REP-UK, V6, DOI 10.1038/srep21189; Vida MD, 2012, J EXP CHILD PSYCHOL, V112, P243, DOI 10.1016/j.jecp.2012.02.002; Yu DY, 2018, VISION RES, V150, P29, DOI 10.1016/j.visres.2018.07.001	46	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210503	10.1371/journal.pone.0210503	http://dx.doi.org/10.1371/journal.pone.0210503			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682035	gold, Green Published, Green Submitted			2022-12-26	WOS:000457037500040
J	Mamman, M; Hanapi, ZM; Abdullah, A; Muhammed, A				Mamman, Maharazu; Hanapi, Zurina Mohd; Abdullah, Azizol; Muhammed, Abdullah			Quality of Service Class Identifier (QCI) radio resource allocation algorithm for LTE downlink	PLOS ONE			English	Article							PERFORMANCE; NETWORKS; SCHEDULER	The increasing demand for network applications, such as teleconferencing, multimedia messaging and mobile TV, which have diverse requirements, has resulted in the introduction of Long Term Evolution (LTE) by the Third Generation Partnership Project (3GPP). LTE networks implement resource allocation algorithms to distribute radio resource to satisfy the bandwidth and delay requirements of users. However, the scheduling algorithm problem of distributing radio resources to users is not well defined in the LTE standard and thus considerably affects transmission order. Furthermore, the existing radio resource algorithm suffers from performance degradation under prioritised conditions because of the minimum data rate used to determine the transmission order. In this work, a novel downlink resource allocation algorithm that uses quality of service (QoS) requirements and channel conditions to address performance degradation is proposed. The new algorithm is formulated as an optimisation problem where network resources are allocated according to users' priority, whereas the scheduling algorithm decides on the basis of users' channel status to satisfy the demands of QoS. Simulation is used to evaluate the performance of the proposed algorithm, and results demonstrate that it performs better than do all other algorithms according to the measured metrics.	[Mamman, Maharazu; Hanapi, Zurina Mohd; Abdullah, Azizol; Muhammed, Abdullah] Univ Putra Malaysia, Dept Commun Technol & Networking, Fac Comp Sci & Informat Technol, Upm Serdang, Selangor, Malaysia	Universiti Putra Malaysia	Mamman, M; Hanapi, ZM (corresponding author), Univ Putra Malaysia, Dept Commun Technol & Networking, Fac Comp Sci & Informat Technol, Upm Serdang, Selangor, Malaysia.	maharazu2003@yahoo.com; zurinamh@upm.edu.my		Mohd Hanapi, Zurina/0000-0002-8079-1791; Abdullah, Azizol/0000-0001-8321-9259	Universiti Putra Malaysia [UPM-FRGS-08-02-13-1364FR]	Universiti Putra Malaysia	This work was supported by research grant UPM-FRGS-08-02-13-1364FR from the Universiti Putra Malaysia to ZMH.; This work was supported by research grant UPM-FRGS-08-02-13-1364FR.	Ameigeiras P, 2016, EURASIP J WIREL COMM, DOI 10.1186/s13638-016-0565-9; Andrews JG, 2014, IEEE J SEL AREA COMM, V32, P1065, DOI 10.1109/JSAC.2014.2328098; Biernacki A, 2014, WIRELESS PERS COMMUN, V74, P585, DOI 10.1007/s11277-013-1308-4; Both C. C., 2016, P 8 IEEE LAT AM C CO, P1; Capozzi F, 2013, IEEE COMMUN SURV TUT, V15, P678, DOI 10.1109/SURV.2012.060912.00100; Chadchan S. M., 2013, International Journal of Computer Network and Information Security, V5, P34, DOI 10.5815/ijcnis.2013.06.05; Erpek T, 2015, 2015 INTERNATIONAL CONFERENCE ON COMPUTING, NETWORKING AND COMMUNICATIONS (ICNC), P275, DOI 10.1109/ICCNC.2015.7069354; Ferdosian N., 2014, P 1 INT C ADV DAT IN, V285, P597, DOI [DOI 10.1007/978-981-4585-18-7_67, 10.1007/978-981-4585-18-7_67.]; Fu W., 2013, APPL MECH MAT, P2468; Gayathri S, 2016, INDIAN J SCI TECHNOL, V9, DOI 10.17485/ijst/2016/v9i10/88887; Gui X, 1999, IEEE T COMMUN, V47, P1084, DOI 10.1109/26.774858; Hindia MN, 2015, INT J DISTRIB SENS N, DOI 10.1155/2015/604752; Ikuno J. C., 2010, VEH TECHN C VTC 2010, P1, DOI DOI 10.1109/VETECS.2010.5494007; Iturralde M, 2013, WIRELESS PERS COMMUN, V72, P1415, DOI 10.1007/s11277-013-1086-z; Jain R., 1984, QUANTITATIVE MEASURE, V38; Kwan R, 2009, IEEE SIGNAL PROC LET, V16, P461, DOI 10.1109/LSP.2009.2016449; Lai WK, 2013, COMPUT NETW, V57, P1689, DOI 10.1016/j.comnet.2013.02.017; Li YP, 2016, 2016 IEEE INFORMATION TECHNOLOGY, NETWORKING, ELECTRONIC AND AUTOMATION CONTROL CONFERENCE (ITNEC), P706, DOI 10.1109/ITNEC.2016.7560452; Masoudi M, 2018, WIREL NETW, V24, P1841, DOI 10.1007/s11276-016-1442-5; Mushtaq MS, 2015, J NETW COMPUT APPL, V51, P29, DOI 10.1016/j.jnca.2014.02.001; Rebekka B, 2015, WIRELESS PERS COMMUN, V83, P1643, DOI 10.1007/s11277-015-2468-1; Sadiq B, 2009, EURASIP J WIREL COMM, V2009, P510; Sulthana SF, 2015, WIRELESS PERS COMMUN, V83, P841, DOI 10.1007/s11277-015-2429-8; Trifan RF, 2015, 2015 IEEE 81 VEH TEC, P1; TS, 2010, TS23401V8120 3GPP GP; Wang CP, 2014, IET COMMUN, V8, P3105, DOI 10.1049/iet-com.2014.0167; Wang YC, 2016, COMPUT NETW, V94, P344, DOI 10.1016/j.comnet.2015.11.002; Xu L, 2014, WIRELESS PERS COMMUN, V79, P1591, DOI 10.1007/s11277-014-2028-0; Yang HT, 2010, COMPUT SCI TECH APPL, P1	29	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210310	10.1371/journal.pone.0210310	http://dx.doi.org/10.1371/journal.pone.0210310			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682038	Green Published, gold, Green Submitted			2022-12-26	WOS:000457037500032
J	McCurdy, SR; Ntranos, V; Pachter, L				McCurdy, Shannon R.; Ntranos, Vasilis; Pachter, Lior			Deterministic column subset selection for single-cell RNA-Seq	PLOS ONE			English	Article							VISUALIZATION	Analysis of single-cell RNA sequencing (scRNA-Seq) data often involves filtering out uninteresting or poorly measured genes and dimensionality reduction to reduce noise and simplify data visualization. However, techniques such as principal components analysis (PCA) fail to preserve non-negativity and sparsity structures present in the original matrices, and the coordinates of projected cells are not easily interpretable. Commonly used thresholding methods to filter genes avoid those pitfalls, but ignore collinearity and covariance in the original matrix. We show that a deterministic column subset selection (DCSS) method possesses many of the favorable properties of common thresholding methods and PCA, while avoiding pitfalls from both. We derive new spectral bounds for DCSS. We apply DCSS to two measures of gene expression from two scRNA-Seq experiments with different clustering workflows, and compare to three thresholding methods. In each case study, the clusters based on the small subset of the complete gene expression profile selected by DCSS are similar to clusters produced from the full set. The resulting clusters are informative for cell type.	[McCurdy, Shannon R.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Ntranos, Vasilis] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Pachter, Lior] CALTECH, Dept Comp & Math Sci, Div Biol & Biol Engn, Pasadena, CA 91125 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; California Institute of Technology	McCurdy, SR (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.	smccurdy@berkeley.edu		Pachter, Lior/0000-0002-9164-6231; McCurdy, Shannon/0000-0002-2813-6781	National Human Genome Research Institute [F32HG008713]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG008713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH114830] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	SRM is funded by Award Number F32HG008713 from the National Human Genome Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews T. S., 2018, BIORXIV; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Calculate and Draw Custom Venn Diagrams, CALC DRAW CUST VENN; Chatterjee S., 1986, STAT SCI, V1, P379, DOI [10.1214/ss/1177013622, DOI 10.1214/SS/1177013622]; Drineas P, 2008, SIAM J MATRIX ANAL A, V30, P844, DOI 10.1137/07070471X; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Jolliffe I.T., 1986, PRINCIPAL COMPONENT, P487, DOI [DOI 10.1007/B98835, 10.1007/978-1-4757-1904-8_8]; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/nmeth.2967]; Kwon H, 2017, BIORXIV; Lin PJ, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1188-0; Lun Aaron T L, 2016, F1000Res, V5, P2122; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; Nicolae M, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-9; Ntranos V, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0970-8; Papailiopoulos D., 2014, P 20 ACM SIGKDD INT, P997, DOI DOI 10.1016/J.CELL.2015.11.013; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Pierson E, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0805-z; Rao C.R, 1973, WILEY SERIES PROBABI, DOI [10.1002/9780470316436, DOI 10.1002/9780470316436]; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Setty M, 2016, NAT BIOTECHNOL, V34, P637, DOI 10.1038/nbt.3569; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Stegle O, 2015, NAT REV GENET, V16, P133, DOI 10.1038/nrg3833; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Tropp JA, 2009, PROCEEDINGS OF THE TWENTIETH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P978; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; VELLEMAN PF, 1981, AM STAT, V35, P234, DOI 10.2307/2683296; Wagner A, 2016, NAT BIOTECHNOL, V34, P1145, DOI 10.1038/nbt.3711; Wang B, 2017, NAT METHODS, V14, P414, DOI 10.1038/nmeth.4207; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	34	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210571	10.1371/journal.pone.0210571	http://dx.doi.org/10.1371/journal.pone.0210571			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682053	Green Submitted, Green Published, gold			2022-12-26	WOS:000457037500047
J	Matiz, A; Crescentini, C; Fabbro, A; Budai, R; Bergamasco, M; Fabbro, F				Matiz, Alessio; Crescentini, Cristiano; Fabbro, Anastasia; Budai, Riccardo; Bergamasco, Massimo; Fabbro, Franco			Spontaneous eye movements during focused-attention mindfulness meditation	PLOS ONE			English	Article							MENTAL TIME-TRAVEL; INDEPENDENT COMPONENT ANALYSIS; WORKING-MEMORY; VISUAL-IMAGERY; WANDERING MIND; EXPERIENCE; THOUGHT; NETWORK; EEG; FLUCTUATIONS	Oculometric measures have been proven to be useful markers of mind-wandering during visual tasks such as reading. However, little is known about ocular activity during mindfulness meditation, a mental practice naturally involving mind-wandering episodes. In order to explore this issue, we extracted closed-eyes ocular movement measurements via a covert technique (EEG recordings) from expert meditators during two repetitions of a 7-minute mindfulness meditation session, focusing on the breath, and two repetitions of a 7-minute instructed mind-wandering task. Power spectral density was estimated on both the vertical and horizontal components of eye movements. The results show a significantly smaller average amplitude of eye movements in the delta band (1-4 Hz) during mindfulness meditation than instructed mind-wandering. Moreover, participants' meditation expertise correlated significantly with this average amplitude during both tasks, with more experienced meditators generally moving their eyes less than less experienced meditators. These findings suggest the potential use of this measure to detect mind-wandering episodes during mindfulness meditation and to assess meditation performance.	[Matiz, Alessio; Bergamasco, Massimo; Fabbro, Franco] Scuola Super Sant Anna, PERCRO Lab, Pisa, Italy; [Crescentini, Cristiano] Univ Udine, Commun Educ & Soc, Dept Languages & Literatures, Udine, Italy; [Fabbro, Anastasia] Univ Roma La Sapienza, Dept Psychol, Rome, Italy; [Fabbro, Anastasia; Fabbro, Franco] Univ Udine, Dept Med, Udine, Italy; [Budai, Riccardo] Univ Hosp S Maria Misericordia, Dept Neurosci, Udine, Italy	Scuola Superiore Sant'Anna; University of Udine; Sapienza University Rome; University of Udine; Hospital Santa Maria della Misericordia	Matiz, A (corresponding author), Scuola Super Sant Anna, PERCRO Lab, Pisa, Italy.	matiz.alessio@spes.uniud.it		CRESCENTINI, CRISTIANO/0000-0002-3154-3687; Matiz, Alessio/0000-0001-6785-3102	Scuola Superiore "Sant'Anna"	Scuola Superiore "Sant'Anna"	This work was supported by Scuola Superiore "Sant'Anna" (https://www.santannapisa.it/) Phd program to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTROBUS JS, 1964, J ABNORM SOC PSYCH, V69, P244, DOI 10.1037/h0041846; BAHILL A T, 1975, Mathematical Biosciences, V24, P191, DOI 10.1016/0025-5564(75)90075-9; Baird B, 2012, PSYCHOL SCI, V23, P1117, DOI 10.1177/0956797612446024; Baird B, 2011, CONSCIOUS COGN, V20, P1604, DOI 10.1016/j.concog.2011.08.007; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bhikkhu B, 1980, ANAPANASATI MINDFULN; Bixler R, 2016, USER MODEL USER-ADAP, V26, P33, DOI 10.1007/s11257-015-9167-1; Bloom HS, 2005, EVALUATION REV, V19, P547; Bonnet C, 2013, CLIN NEUROPHYSIOL, V124, P2216, DOI 10.1016/j.clinph.2013.05.002; Bortolussi M., 2015, INVESTIGATIONS PHENO, V81, P31, DOI [10.1007/978-3-319-14090-2_3, DOI 10.1007/978-3-319-14090-2_3]; Braboszcz C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170647; Brandmeyer T, 2018, EXP BRAIN RES, V236, P2519, DOI 10.1007/s00221-016-4811-5; BRANDT SA, 1989, P IEEE EMBS, V11, P278, DOI 10.1109/IEMBS.1989.95721; Brandt SA, 1997, J COGNITIVE NEUROSCI, V9, P27, DOI 10.1162/jocn.1997.9.1.27; Brefczynski-Lewis JA, 2007, P NATL ACAD SCI USA, V104, P11483, DOI 10.1073/pnas.0606552104; Brewer JA, 2011, P NATL ACAD SCI USA, V108, P20254, DOI 10.1073/pnas.1112029108; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cahn BR, 2013, SOC COGN AFFECT NEUR, V8, P100, DOI 10.1093/scan/nss060; Cahn BR, 2010, COGN PROCESS, V11, P39, DOI 10.1007/s10339-009-0352-1; Cahn BR, 2009, INT J PSYCHOPHYSIOL, V72, P51, DOI 10.1016/j.ijpsycho.2008.03.013; Cahn BR, 2006, PSYCHOL BULL, V132, P180, DOI 10.1037/0033-2909.132.2.180; Campanella F, 2014, COMPR PSYCHIAT, V55, P1269, DOI 10.1016/j.comppsych.2014.03.009; Chaumon M, 2015, J NEUROSCI METH, V250, P47, DOI 10.1016/j.jneumeth.2015.02.025; Christoff K, 2016, NAT REV NEUROSCI, V17, P718, DOI 10.1038/nrn.2016.113; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Crescentini Cristiano, 2018, Int J MS Care, V20, P101, DOI 10.7224/1537-2073.2016-093; Crescentini C, 2016, COMPUT HUM BEHAV, V59, P304, DOI 10.1016/j.chb.2016.02.031; Crescentini C, 2015, J ADDICT DIS, V34, P75, DOI 10.1080/10550887.2014.991657; Crescentini C, 2014, CONSCIOUS COGN, V30, P266, DOI 10.1016/j.concog.2014.09.013; Davidson RJ, 2015, AM PSYCHOL, V70, P581, DOI 10.1037/a0039512; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; DEMENT W, 1957, J EXP PSYCHOL, V53, P339, DOI 10.1037/h0048189; Deng YQ, 2014, MINDFULNESS, V5, P124, DOI 10.1007/s12671-012-0157-7; DeRosario-Martinez H, 2015, PACKAGE PHIA VERSION; Dowiasch S, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00046; Ehrlichman H, 2007, BRAIN COGNITION, V64, P7, DOI 10.1016/j.bandc.2006.10.001; Ehrlichman H, 2012, CURR DIR PSYCHOL SCI, V21, P96, DOI 10.1177/0963721412436810; Fabbro F, 2016, RICERCHE PSICOLOGIA, V4, P457, DOI DOI 10.3280/RIP2016-004001; Fabbro F, 2014, WORLD FUTURES, V70, P386; Faber M, 2018, BEHAV RES METHODS, V50, P134, DOI 10.3758/s13428-017-0857-y; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Findlay JM, 1999, BEHAV BRAIN SCI, V22, P661, DOI 10.1017/S0140525X99002150; Forster S, 2009, COGNITION, V111, P345, DOI 10.1016/j.cognition.2009.02.006; Fourtassi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068560; Fox KCR, 2015, NEUROIMAGE, V111, P611, DOI 10.1016/j.neuroimage.2015.02.039; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hartmann M, 2014, CONSCIOUS COGN, V30, P201, DOI 10.1016/j.concog.2014.09.007; Hasenkamp W, 2012, NEUROIMAGE, V59, P750, DOI 10.1016/j.neuroimage.2011.07.008; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; HOLM S, 1979, SCAND J STAT, V6, P65; Johansson R, 2006, COGNITIVE SCI, V30, P1053, DOI 10.1207/s15516709cog0000_86; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Kam JWY, 2011, J COGNITIVE NEUROSCI, V23, P460, DOI 10.1162/jocn.2010.21443; Kane MJ, 2007, PSYCHOL SCI, V18, P614, DOI 10.1111/j.1467-9280.2007.01948.x; Kaur Chamandeep, 2015, Adv Prev Med, V2015, P614723, DOI 10.1155/2015/614723; Nguyen KV, 2014, SCI STUD READ, V18, P274, DOI 10.1080/10888438.2013.876424; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Kruis A, 2016, PSYCHOPHYSIOLOGY, V53, P749, DOI 10.1111/psyp.12619; Kumari V, 2017, CONSCIOUS COGN, V48, P66, DOI 10.1016/j.concog.2016.10.008; Laeng B, 2002, COGNITIVE SCI, V26, P207, DOI 10.1016/S0364-0213(01)00065-9; Laeng B, 2014, COGNITION, V131, P263, DOI 10.1016/j.cognition.2014.01.003; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lawrence MA, 2016, PACKAGE EZ VERSION 4; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Leigh RJ, 2004, BRAIN, V127, P460, DOI 10.1093/brain/awh035; Levinson DB, 2012, PSYCHOL SCI, V23, P375, DOI 10.1177/0956797611431465; Makeig S, 1996, ADV NEUR IN, V8, P145; Malinowski P, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00008; Manna A, 2010, BRAIN RES BULL, V82, P46, DOI 10.1016/j.brainresbull.2010.03.001; Martinez-Conde S, 2009, TRENDS NEUROSCI, V32, P463, DOI 10.1016/j.tins.2009.05.006; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McVay JC, 2012, J EXP PSYCHOL GEN, V141, P302, DOI 10.1037/a0025250; Micic D, 2010, BRAIN COGNITION, V74, P210, DOI 10.1016/j.bandc.2010.07.014; Mooneyham BW, 2013, CAN J EXP PSYCHOL, V67, P11, DOI 10.1037/a0031569; Munoz DP, 1998, EXP BRAIN RES, V121, P391, DOI 10.1007/s002210050473; Ospina Maria B, 2007, Evid Rep Technol Assess (Full Rep), P1; Pace TWW, 2009, PSYCHONEUROENDOCRINO, V34, P87, DOI 10.1016/j.psyneuen.2008.08.011; R Core Team, 2021, R LANGUAGE ENV STAT; Ramot M, 2011, NEUROIMAGE, V58, P213, DOI 10.1016/j.neuroimage.2011.06.015; Randall JG, 2014, PSYCHOL BULL, V140, P1411, DOI 10.1037/a0037428; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Reichle ED, 2010, PSYCHOL SCI, V21, P1300, DOI 10.1177/0956797610378686; Renoult L, 2015, J COGNITIVE NEUROSCI, V27, P57, DOI 10.1162/jocn_a_00689; Rubin DC, 2003, MEM COGNITION, V31, P887, DOI 10.3758/BF03196443; Schacter DL, 2007, NATURE, V445, P27, DOI 10.1038/445027a; Schad DJ, 2012, COGNITION, V125, P179, DOI 10.1016/j.cognition.2012.07.004; Schooler JW, 2011, TRENDS COGN SCI, V15, P319, DOI 10.1016/j.tics.2011.05.006; Schooler JW, 2004, THINKING AND SEEING, P203; Seli P, 2016, TRENDS COGN SCI, V20, P605, DOI 10.1016/j.tics.2016.05.010; Seli P, 2015, PSYCHOL RES-PSYCH FO, V79, P750, DOI 10.1007/s00426-014-0617-x; Short EB, 2010, EVID-BASED COMPL ALT, V7, P121, DOI 10.1093/ecam/nem163; Signorell A., 2020, DESCTOOLS TOOLS DESC; Smallwood J, 2004, CONSCIOUS COGN, V13, P657, DOI 10.1016/j.concog.2004.06.003; Smallwood JM, 2003, CONSCIOUS COGN, V12, P452, DOI 10.1016/S1053-8100(03)00018-7; Smallwood J, 2008, MEM COGNITION, V36, P1144, DOI 10.3758/MC.36.6.1144; Smallwood J, 2008, J COGNITIVE NEUROSCI, V20, P458, DOI 10.1162/jocn.2008.20037; Smallwood J, 2007, COGNITION EMOTION, V21, P816, DOI 10.1080/02699930600911531; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smallwood J, 2011, CONSCIOUS COGN, V20, P1120, DOI 10.1016/j.concog.2010.12.017; Smallwood J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018298; Smallwood J, 2009, CONSCIOUS COGN, V18, P118, DOI 10.1016/j.concog.2008.11.004; Smilek D, 2010, PSYCHOL SCI, V21, P786, DOI 10.1177/0956797610368063; Soltanlou M, 2017, COGN AFFECT BEHAV NE, V17, P724, DOI 10.3758/s13415-017-0508-x; Song XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044423; Spivey MJ, 2001, PSYCHOL RES-PSYCH FO, V65, P235, DOI 10.1007/s004260100059; Stawarczyk D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00425; Stawarczyk D, 2011, ACTA PSYCHOL, V136, P370, DOI 10.1016/j.actpsy.2011.01.002; Suddendorf T, 2007, BEHAV BRAIN SCI, V30, P299, DOI 10.1017/S0140525X07001975; Suddendorf T, 2009, PHILOS T R SOC B, V364, P1317, DOI 10.1098/rstb.2008.0301; Tomasino B, 2013, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00346; Uzzaman S, 2011, CONSCIOUS COGN, V20, P1882, DOI 10.1016/j.concog.2011.09.010; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Winkler I, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/035013; Winkler I, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-30	118	5	5	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210862	10.1371/journal.pone.0210862	http://dx.doi.org/10.1371/journal.pone.0210862			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI8IY	30677056	gold, Green Published			2022-12-26	WOS:000456700400028
J	Shao, GF; Li, DY; Zhang, JF; Yang, JB; Shangguan, YL				Shao, Guifang; Li, Dongyao; Zhang, Junfa; Yang, Jianbo; Shangguan, Yali			Automatic microarray image segmentation with clustering-based algorithms	PLOS ONE			English	Article							CDNA MICROARRAY; SPOTS; MODEL; INTENSITY	Image segmentation, as a key step of microarray image processing, is crucial for obtaining the spot expressions simultaneously. However, state-of-art clustering-based segmentation algorithms are sensitive to noises. To solve this problem and improve the segmentation accuracy, in this article, several improvements are introduced into the fast and simple clustering methods (K-means and Fuzzy C means). Firstly, a contrast enhancement algorithm is implemented in image preprocessing to improve the gridding precision. Secondly, the data-driven means are proposed for cluster center initialization, instead of usual random setting. The third improvement is that the multi features, including intensity features, spatial features, and shape features, are implemented in feature selection to replace the sole pixel intensity feature used in the traditional clustering-based methods to avoid taking noises as spot pixels. Moreover, the principal component analysis is adopted for various feature extraction. Finally, an adaptive adjustment algorithm is proposed based on data mining and learning for further dealing with the missing spots or low contrast spots. Experiments on real and simulation data sets indicate that the proposed improvements made our proposed method obtains higher segmented precision than the traditional K-means and Fuzzy C means clustering methods.	[Shao, Guifang; Li, Dongyao; Zhang, Junfa; Yang, Jianbo; Shangguan, Yali] Xiamen Univ, Dept Automat, Xiamen, Peoples R China	Xiamen University	Shao, GF (corresponding author), Xiamen Univ, Dept Automat, Xiamen, Peoples R China.	gfshao@xmu.edu.cn		Yang, Jian-Bo/0000-0002-1368-5294	National Natural Science Foundation of China [61403318]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China with grant no. 61403318 to G.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo Jesus, 2008, Image Analysis & Stereology, V27, P107, DOI 10.5566/ias.v27.p107-124; [Anonymous], 1999, GSI LUMONICS QUANTAR; [Anonymous], 2004, SPOTF ONL MAN; Athanasiadis E, 2011, COMPUT METH PROG BIO, V104, P307, DOI 10.1016/j.cmpb.2011.03.007; Axon Instruments Inc, 1997, GENEPIX 4000A US GUI; Battiato S, 2007, J ELECTRON IMAGING, V16, DOI 10.1117/1.2816445; Belean B, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0842-3; Biju V., 2012, INT J COMPUT APPL, V52, P42; Biju VG, 2017, CURR SCI INDIA, V113, P1072, DOI 10.18520/cs/v113/i06/1072-1080; Biju VG, 2015, PROCEDIA COMPUT SCI, V46, P417, DOI 10.1016/j.procs.2015.02.039; Blekas K, 2005, IEEE T MED IMAGING, V24, P901, DOI 10.1109/TMI.2005.848358; Bozinov D, 2002, BIOINFORMATICS, V18, P747, DOI 10.1093/bioinformatics/18.5.747; Buckley MJ, 2000, NON TRADITIONAL REF; Carlisle AJ, 2000, MOL CARCINOGEN, V28, P12, DOI 10.1002/(SICI)1098-2744(200005)28:1<12::AID-MC3>3.0.CO;2-Q; Deepa J, 2009, WOR CONG NAT BIOL, P1468; Eisen M.B, 1997, SCANALYZE; Farouk RM, 2014, INT J ARTIFICIAL INT, V5, P21; Giannakeas N, 2013, COMPUT BIOL MED, V43, P705, DOI 10.1016/j.compbiomed.2013.03.003; Giannakeas N, 2009, COMPUT MED IMAG GRAP, V33, P40, DOI 10.1016/j.compmedimag.2008.10.003; Harikiran J, 2012, INT J COMPUTER SCI I, V9, P316; Heyer LJ, 2005, BIOINFORMATICS, V21, P2114, DOI 10.1093/bioinformatics/bti247; Ho J, 2008, IEEE T MED IMAGING, V27, P847, DOI 10.1109/TMI.2008.915697; Nguyen HN, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2111-8; Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902; Katsigiannis S, 2017, IEEE J BIOMED HEALTH, V21, P867, DOI 10.1109/JBHI.2016.2537922; Khalilabad ND, 2017, COMPUT BIOL MED, V81, P139, DOI 10.1016/j.compbiomed.2016.12.012; Li QH, 2005, BIOINFORMATICS, V21, P2875, DOI 10.1093/bioinformatics/bti447; Li Y, 2017, THEOR COMPUT SCI, V701, P174, DOI 10.1016/j.tcs.2017.04.013; Maguluri LP, 2013, INT J EMERGING SCI E, V1, P27; Manjunath SS, 2013, INT J INNOVATIVE TEC, V2, P189; Nagarajan R, 2003, IEEE T MED IMAGING, V22, P882, DOI 10.1109/TMI.2003.815063; Ni SH, 2009, ROM J INF SCI TECH, V12, P249; Raghavarao S, 2011, GLOBAL J COMPUTER SC, V11, P30; Rahnenfuhrer J, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-47; Rajashekhar C. M, 2015, INT J INNOVATIVE RES, V3, P140; Rajkumar P, 2013, INT J COMPUTER SCI E, V5, P528; Ramgopal Kashyap, 2013, INT J COMPUTER SCI E, V2, P67; Saadelgawady A, 2015, INT J COMPUTER APPL, V110, P30; Shao GF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133025; Thamaraimanalan P., 2014, INT J COMPUTER SCI M, V3, P353; Uslan V, 2010, MATH COMPUT APPL, V15, P240, DOI 10.3390/mca15020240; Zacharia E, 2011, EVOLUTIONARY ALGORITHMS, P459; [No title captured]	43	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210075	10.1371/journal.pone.0210075	http://dx.doi.org/10.1371/journal.pone.0210075			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668601	Green Submitted, Green Published, gold			2022-12-26	WOS:000456306400004
J	Sant'Anna, ID; Ferreira, RADC; Nascimento, M; Silva, GN; Carneiro, VQ; Cruz, CD; Oliveira, MS; Chagas, FE				Sant'Anna, Isabela de Castro; Diniz Cabral Ferreira, Ricardo Augusto; Nascimento, Moyses; Silva, Gabi Nunes; Carneiro, Vinicius Quintao; Cruz, Cosme Damiao; Oliveira, Marciane Silva; Chagas, Francyse Edith			Multigenerational prediction of genetic values using genome-enabled prediction	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; SELECTION; RECOMBINATION; INFORMATION; ACCURACY; LOCUS	The identification of elite individuals is a critical component of most breeding programs. However, the achievement of this goal is limited by the high cost of phenotyping and experimental research. A significant benefit of genomic selection (GS) to plant breeding is the identification of elite individuals without the need for phenotyping. This study aimed to propose different calibration strategies using combinations between generations from different genetic backgrounds to improve the reliability of GS and to investigate the effects of LD in different types of mating systems: outcrossing (A(n)) self-pollination (S-n) and hybridization (H-n). For this purpose, we simulated a genome with 10 linkage groups. In each group, two QTL were simulated. Subsequently, an F-2 population was created, followed by four generations of inbreeding (S-1 to S-4, H-1 to H-4, A(1), to A(4),). Quantitative traits were simulated in three scenarios considering three degrees of dominance (d/a = 0, 0.5 and 1) and two broad sense heritabilities (h(2) = 0.30 and 0.70), totaling six genetic architectures. To evaluate prediction reliability, a model (RR-BLUP) was trained in one generation and used to predict the following generations of mating systems. For example, the marker effects estimated in the F-2 population were used to estimate the expected genomic breeding value (GEBV) in populations S-1 through A(4). The squared correlation between the GEBV and the true genetic value were used to measure the reliability of the predictions. Independently of the population used to estimate the marker effect, reliability showed the lowest values in the scenario where d = 1. For any scenario, the use of the multigenerational prediction methodology improved the reliability of GS.	[Sant'Anna, Isabela de Castro; Nascimento, Moyses] Univ Fed Vicosa, Dept Stat, Vicosa, MG, Brazil; [Diniz Cabral Ferreira, Ricardo Augusto] Syngenta Seeds Prod Res, Uberlandia, MG, Brazil; [Silva, Gabi Nunes] Fed Univ Rondonia, Dept Stat, Rondonia, Ji Parana, Brazil; [Carneiro, Vinicius Quintao; Cruz, Cosme Damiao; Oliveira, Marciane Silva; Chagas, Francyse Edith] Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Syngenta; Universidade Federal de Rondonia; Universidade Federal de Vicosa	Sant'Anna, ID (corresponding author), Univ Fed Vicosa, Dept Stat, Vicosa, MG, Brazil.	isabelacsantanna@gmail.com	CARNEIRO, VINICIUS QUINTAO/AAM-3006-2020; Nascimento, Moyses/Y-8767-2019	Nascimento, Moyses/0000-0001-5886-9540	CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; FAPEMIG - Fundacao de Amparo a Pesquisa do Estado de Minas Gerais; CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEMIG - Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -, FAPEMIG - Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - and CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo CF, ACTA SCI; Calus M P L, 2008, Genetics, V178, P553, DOI 10.1534/genetics.107.080838; Crossa J, 2017, TRENDS PLANT SCI, V22, P961, DOI 10.1016/j.tplants.2017.08.011; Cruz CD, 2013, ACTA SCI-AGRON, V35, P271, DOI 10.4025/actasciagron.v35i3.21251; Daetwyler HD, 2007, J ANIM BREED GENET, V124, P369, DOI 10.1111/j.1439-0388.2007.00693.x; Daetwyler HD, 2013, GENETICS, V193, P347, DOI 10.1534/genetics.112.147983; Dekkers JCM, 2007, J ANIM SCI, V85, P2104, DOI 10.2527/jas.2006-683; Dekkers JCM, 1998, GENET RES, V71, P257, DOI 10.1017/S0016672398003267; Denis M, 2013, TREE GENET GENOMES, V9, P927, DOI [10.1007/s11295-013-0606-z, 10.1007/s11295-012-0528-1]; Desta ZA, 2014, TRENDS PLANT SCI, V19, P592, DOI 10.1016/j.tplants.2014.05.006; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Garris AJ, 2003, GENETICS, V165, P759; Goddard ME, 2007, J ANIM BREED GENET, V124, P323, DOI 10.1111/j.1439-0388.2007.00702.x; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Kumar S, 2012, TREE GENET GENOMES, V8, P1, DOI 10.1007/s11295-011-0425-z; Meuwissen THE, 2001, GENETICS, V157, P1819; Muir WM, 2007, J ANIM BREED GENET, V124, P342, DOI 10.1111/j.1439-0388.2007.00700.x; Nordborg M, 2000, GENETICS, V154, P923; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; RESENDE M. D. V., 2014, ESTATISTICA MATEMATI; Romay MC, HEREDITY; Santos VS, 2016, GENET MOL RES, V15; Solberg TR, 2008, J ANIM SCI, V86, P2447, DOI 10.2527/jas.2007-0010; Sorkheh K, 2008, GENET MOL BIOL, V31, P805, DOI 10.1590/S1415-47572008000500001; Spindel J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004982; Toro MA, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-33; WEIR BS, 1986, AM J HUM GENET, V38, P776; Wientjes YCJ, 2013, GENETICS, V193, P621, DOI 10.1534/genetics.112.146290; Xu Y, 2018, RICE, V11, DOI 10.1186/s12284-018-0223-4; Zhao H, 2005, GENET RES, V86, P77, DOI 10.1017/S001667230500769X	31	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210531	10.1371/journal.pone.0210531	http://dx.doi.org/10.1371/journal.pone.0210531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653561	Green Published, gold, Green Submitted			2022-12-26	WOS:000456015500048
J	Stark, PB; Miller, D; Carlson, TJ; de Vasquez, KR				Stark, Philip B.; Miller, Daphne; Carlson, Thomas J.; de Vasquez, Kristen Rasmussen			Open-source food: Nutrition, toxicology, and availability of wild edible greens in the East Bay	PLOS ONE			English	Article							PLANTS; ACCUMULATION; HEALTH; RISK	Significance Foraged leafy greens are consumed around the globe, including in urban areas, and may play a larger role when food is scarce or expensive. It is thus important to assess the safety and nutritional value of wild greens foraged in urban environments. Methods Field observations, soil tests, and nutritional and toxicology tests on plant tissue were conducted for three sites, each roughly 9 square blocks, in disadvantaged neighborhoods in the East San Francisco Bay Area in 2014-2015. The sites included mixed-use areas and areas with high vehicle traffic. Results Edible wild greens were abundant, even during record droughts. Soil at some survey sites had elevated concentrations of lead and cadmium, but tissue tests suggest that rinsed greens of the tested species are safe to eat. Daily consumption of standard servings comprise less than the EPA reference doses of lead, cadmium, and other heavy metals. Pesticides, glyphosate, and PCBs were below detection limits. The nutrient density of 6 abundant species compared favorably to that of the most nutritious domesticated leafy greens. Conclusions Wild edible greens harvested in industrial, mixed-use, and high-traffic urban areas in the San Francisco East Bay area are abundant and highly nutritious. Even grown in soils with elevated levels of heavy metals, tested species were safe to eat after rinsing in tap water. This does not mean that all edible greens growing in contaminated soil are safe to eat-tests on more species, in more locations, and over a broader range of soil chemistry are needed to determine what is generally safe and what is not. But it does suggest that wild greens could contribute to nutrition, food security, and sustainability in urban ecosystems. Current laws, regulations, and public-health guidance that forbid or discourage foraging on public lands, including urban areas, should be revisited.	[Stark, Philip B.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Miller, Daphne] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Miller, Daphne] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA; [Carlson, Thomas J.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [de Vasquez, Kristen Rasmussen] Univ Calif Berkeley, Dept Nutr & Toxicol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Stark, PB (corresponding author), Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA.	stark@stat.berkeley.edu		Miller, Daphne/0000-0002-2974-4893; Stark, Philip/0000-0002-3771-9604	Berkeley Food Institute	Berkeley Food Institute	This research was supported by the Berkeley Food Institute, Dr. Lorraine Schnurr, and from The Oxalis Prize, funded by Ms. Jenny Hammer. These funders did not play any role in the research, data collection, analysis, decision to publish, or preparation of the manuscript.	Altieri M, 2014, AGROECOLOGICAL SURVE; Bianco VV, 1998, ACTA HORTIC, P71, DOI 10.17660/ActaHortic.1998.467.7; Ceuterick M, 2008, J ETHNOPHARMACOL, V120, P342, DOI 10.1016/j.jep.2008.09.004; Chang CY, 2014, ENVIRON MONIT ASSESS, V186, P1547, DOI 10.1007/s10661-013-3472-0; Charnley S, 2018, SOC NATUR RESOUR, V31, P1; COWAN JW, 1963, J SCI FOOD AGR, V14, P484, DOI 10.1002/jsfa.2740140707; Dabady S, 2017, URBAN FORAGING MUNIC; Dudka S, 1999, J ENVIRON SCI HEAL B, V34, P681, DOI 10.1080/03601239909373221; Farhangi MA, 2018, BMC CARDIOVASC DISOR, V18, DOI 10.1186/s12872-018-0807-3; Gholizadeh F, 2018, PRIM CARE DIABETES, P1; Guil JL, 1997, PLANT FOOD HUM NUTR, V51, P99, DOI 10.1023/A:1007988815888; Guil-Guerrero JL, 1998, J SCI FOOD AGR, V76, P628, DOI [10.1002/(SICI)1097-0010(199804)76:4<628::AID-JSFA997>3.3.CO;2-L, 10.1002/(SICI)1097-0010(199804)76:4&lt;628::AID-JSFA997&gt;3.0.CO;2-U]; Holm LG., 1977, WORLDS WORST WEEDS D; James Sarah W, 2015, Public Health Nutr, V18, P2498, DOI 10.1017/S1368980015000610; Jensen DA, 2015, FOOD MICROBIOL, V46, P428, DOI 10.1016/j.fm.2014.08.025; Licata M, 2016, J ETHNOBIOL ETHNOMED, V12, DOI 10.1186/s13002-015-0074-7; Maroyi A., 2014, J ETHNOBIOL ETHNOMED, V10, P1, DOI DOI 10.1186/1746-; Maroyi A, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-60; Matzrafi M, 2016, PLANTA, V244, P1217, DOI 10.1007/s00425-016-2577-4; McLain RJ, 2014, LOCAL ENVIRON, V19, P220, DOI 10.1080/13549839.2013.841659; MERCADANTE AZ, 1990, INT J FOOD SCI TECH, V25, P213, DOI 10.1111/j.1365-2621.1990.tb01077.x; Milovanovic M, 2002, J SERB CHEM SOC, V67, P7, DOI 10.2298/JSC0201007M; Phillips KM, 2014, J FOOD COMPOS ANAL, V34, P136, DOI 10.1016/j.jfca.2014.02.010; Ramesh K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00095; Renna M, 2015, FOOD CHEM, V177, P29, DOI 10.1016/j.foodchem.2014.12.069; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Rivera L., 2017, INDEPENDENT; Robbins P, 2008, AREA, V40, P265, DOI 10.1111/j.1475-4762.2008.00794.x; Saumel I, 2012, ENVIRON POLLUT, V165, P124, DOI 10.1016/j.envpol.2012.02.019; Sansanelli S, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-69; SENGUPTA SR, 1970, J SCI FOOD AGR, V21, P215, DOI 10.1002/jsfa.2740210412; SRIDHAR R, 1993, J AGR FOOD CHEM, V41, P61, DOI 10.1021/jf00025a013; Synk CM, 2017, GATHERING BALTIMORES, P2; Tareau MA, 2017, J ETHNOPHARMACOL, V203, P200, DOI 10.1016/j.jep.2017.03.031; U.S. Department of Agriculture, 2018, ALL VEG GROUP; Vadiveloo M, 2015, J NUTR, V145, P555, DOI 10.3945/jn.114.199067; Vorstenbosch T, 2017, J ETHNOBIOL ETHNOMED, V13, DOI 10.1186/s13002-017-0190-7; ZENNIE TM, 1977, ECON BOT, V31, P76, DOI 10.1007/BF02860657; Zhang LL, 2016, J ETHNOBIOL ETHNOMED, V12, DOI 10.1186/s13002-016-0113-z	39	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0202450	10.1371/journal.pone.0202450	http://dx.doi.org/10.1371/journal.pone.0202450			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653545	Green Published, gold, Green Submitted			2022-12-26	WOS:000456015500003
J	Balde, A; Lang, S; Wagner, A; Ferrieres, J; Montaye, M; Tattevin, P; Cotte, L; Aslangul, E; Bidegain, F; Cheret, A; Mary-Krause, M; Meynard, JL; Molina, JM; Partisani, M; Roger, PM; Boccara, F; Costagliola, D				Balde, Aliou; Lang, Sylvie; Wagner, Aline; Ferrieres, Jean; Montaye, Michele; Tattevin, Pierre; Cotte, Laurent; Aslangul, Elisabeth; Bidegain, Frederic; Cheret, Antoine; Mary-Krause, Murielle; Meynard, Jean-Luc; Molina, Jean-Michel; Partisani, Marialuisa; Roger, Pierre-Marie; Boccara, Franck; Costagliola, Dominique			Trends in the risk of myocardial infarction among HIV-1-infected individuals relative to the general population in France: Impact of gender and immune status	PLOS ONE			English	Article							FRENCH-HOSPITAL-DATABASE; CORONARY-HEART-DISEASE; HIV-INFECTION; ANTIRETROVIRAL DRUGS; IMMUNODEFICIENCY; AIDS; AGE; DIAGNOSIS; CANCER; ACCESS	We examined trends in the MI incidence and age at MI diagnosis among adults living with HIV-1 between 2000 and 2009, by comparison with the French MI registries, by gender. Age standardized incidence rates and standardized incidence-ratios (SIRs) were estimated for individuals included in the French hospital database on HIV (n = 71 204, MI = 663) during three periods: 2000-2002, 2003-2005 and 2006-2009. Median ages at MI diagnosis were compared using the Brown-Mood test. Over the study periods, the absolute rate difference and relative risks were higher in women than in men in 2000- 2002 and 2006-2009, with respective SIRs 1.99 (1.39-2.75) and 1.12 (0.99-1.27) in 2006-2009. The trends were different for men and women with a decreasing trend in SIRs in men and no change in women. In both sexes, among individuals with CD4 >= 500/mu L and controlled viral-load on cART, the risk was no longer elevated. Age at MI diagnosis was significantly younger than in the general population, especially among women (-6.2 years, p<0.001; men: -2.1 years, p = 0.02). In HIV-1-positive adults, absolute rate difference and relative risks and trends of MI were different between men and women and there was no additional risk among individuals on effective cART.	[Balde, Aliou; Lang, Sylvie; Mary-Krause, Murielle; Costagliola, Dominique] Sorbonne Univ, INSERM, Inst Pierre Louis Epidemiol & Sante Publ, IPLESP, Paris, France; [Wagner, Aline] Univ Strasbourg, Lab Epidemiol & Sante Publ, Strasbourg, France; [Ferrieres, Jean] Univ Toulouse, CHU Rangueil, Serv Cardiol B, Toulouse, France; [Montaye, Michele] Univ Lille, CHU Lille, Inst Pasteur Lille, INSERM, Lille, France; [Tattevin, Pierre] Hop Univ Pontchaillou, Serv Malad Infect, Rennes, France; [Tattevin, Pierre] USI, Rennes, France; [Cotte, Laurent] Hosp Civils Lyon, Hop Croix Rousse, INSERM, U1052,Serv Malad Infect & Trop, Lyon, France; [Aslangul, Elisabeth] Univ Paris 05, Sorbonne Paris Cite, Hotel Dieu, AP HP,Serv Med Interne, Paris, France; [Bidegain, Frederic] Hop Avicenne, AP HP, Serv Malad Infect, Bobigny, France; [Cheret, Antoine] Univ Paris 05, Sorbonne Paris Cite, Ctr Hosp Tourcoing, Serv Malad Infect, Tourcoing, France; [Meynard, Jean-Luc] Hop St Antoine, AP HP, Serv Malad Infect & Trop, Paris, France; [Molina, Jean-Michel] Univ Paris Diderot Paris, Sorbonne Paris Cite, Hop St Louis, INSERM,AP HP,Serv Malad Infect & Trop,UMRS 941, Paris, France; [Partisani, Marialuisa] Hop Univ Strasbourg, Le Trait Union, Ctr Soins Infect VIH, Strasbourg, France; [Roger, Pierre-Marie] Univ Nice Sophia Antipolis, CHU Nice, Grp Hosp Archet, Serv Infect, Nice, France; [Boccara, Franck] Sorbonne Univ, Hop St Antoine, AP HP, INSERM,Serv Cardiol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Toulouse; Universite de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; CHU Rennes; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Balde, A (corresponding author), Sorbonne Univ, INSERM, Inst Pierre Louis Epidemiol & Sante Publ, IPLESP, Paris, France.	aliou.balde@iplesp.upmc.fr	Costagliola, Dominique/H-5849-2011	Costagliola, Dominique/0000-0003-0765-0869; Balde, Aliou/0000-0001-5956-698X	Sorbonne Universites UPMC Paris Univ 06; Boehringer-Ingelheim; ViiV Healthcare; BMS; Amgen; Merck; Sanofi; Pfizer; Bristol-Myers-Squibb; Janssen; Merck and Gilead Sciences; AstraZeneca; Boehringer Ingelheim; Gilead Sciences, Glaxo-Smith-Kline; Roche; Agence Nationale de Recherches sur le Sida (ANRS); Institut National de la Sante et de la Recherche Medicale (INSERM); French Ministry of Health; FOGARTY INTERNATIONAL CENTER [D43TW010350] Funding Source: NIH RePORTER	Sorbonne Universites UPMC Paris Univ 06; Boehringer-Ingelheim(Boehringer Ingelheim); ViiV Healthcare; BMS(Bristol-Myers Squibb); Amgen(Amgen); Merck(Merck & Company); Sanofi; Pfizer(Pfizer); Bristol-Myers-Squibb(Bristol-Myers Squibb); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck and Gilead Sciences; AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Gilead Sciences, Glaxo-Smith-Kline(Gilead SciencesGlaxoSmithKline); Roche(Roche Holding); Agence Nationale de Recherches sur le Sida (ANRS)(ANRSFrench National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); French Ministry of Health; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Aliou BALDE is supported by a doctoral contract from Sorbonne Universites UPMC Paris Univ 06. All authors declare no conflict of interest, although several members of the group have, at some stage in the past, received funding from a variety of pharmaceutical companies for research, travel grants, speaking engagements or consultancy fees. Sylvie Lang has received travel grants from Boehringer-Ingelheim. Laurent Cotte has received study grants from ViiV Healthcare and MSD; personal fees from BMS, Gilead Sciences, Janssen, MSD and ViiV healthcare. Jean Ferrieres has received grants and lecture fees from Amgen, Merck, and Sanofi. Elisabeth Aslangul has received travel grants from Sanofi, Pfizer and Bristol-Myers-Squibb. Antoine Cheret has received study grants from Merck and personal fees from Gilead, ViiV Healthcare, and Janssen. Jean-Luc Meynard has received honoraria from Gilead, Abbott, ViiV Healthcare and BMS. Jean-Michel Molina has received study grants from Merck and Gilead Sciences; advisory board member for Merck, Gilead Sciences, Janssen, ViiV Healthcare, BMS, and Teva, and a speakers' bureau for Gilead. Franck Boccara has received study grant from Amgen, speaker fees from AstraZeneca, Merck; advisory board member for Amgen, Sanofi, Gilead, and ViiV Healthcare. Dominique Costagliola has received travel grants, consultancy fees, honoraria or study grants from Abbott, Boehringer Ingelheim, Bristol-Myers-Squibb, Gilead Sciences, Glaxo-Smith-Kline, Janssen, Merck and Roche. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; FHDH is supported by Agence Nationale de Recherches sur le Sida (ANRS), Institut National de la Sante et de la Recherche Medicale (INSERM) and the French Ministry of Health.	Althoff KN, 2015, CLIN INFECT DIS, V60, P627, DOI 10.1093/cid/ciu869; Arveiler D, 2005, EUR J CARDIOV PREV R, V12, P209, DOI 10.1097/00149831-200506000-00004; Badejo OA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/246870; Breslow NE, 1987, STAT METHODS CANC RE; Brown G.W., 1951, P 2 BERK S MATH STAT, P159; Chaturvedi AK, 2008, ANN EPIDEMIOL, V18, P230, DOI 10.1016/j.annepidem.2007.10.005; De Francesco D, 2018, AIDS; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Klein DB, 2015, CLIN INFECT DIS, V60, P1278, DOI 10.1093/cid/civ014; Lang S, 2012, CLIN INFECT DIS, V55, P600, DOI 10.1093/cid/cis489; Lang S, 2010, ARCH INTERN MED, V170, P1228, DOI 10.1001/archinternmed.2010.197; Lang S, 2010, AIDS, V24, P1228, DOI 10.1097/QAD.0b013e328339192f; Mary-Krause M, 2003, AIDS, V17, P2479, DOI 10.1097/00002030-200311210-00010; Mary-Krause M, 2014, INT J EPIDEMIOL, V43, P1425, DOI 10.1093/ije/dyu002; Monforte AD, 2013, AIDS, V27, P407, DOI 10.1097/QAD.0b013e32835b2ef1; Obel N, 2007, CLIN INFECT DIS, V44, P1625, DOI 10.1086/518285; Rasmussen LD, 2015, LANCET HIV, V2, pE288, DOI 10.1016/S2352-3018(15)00077-6; Rosenblatt L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1827-1; Rothman K., 1998, MODERN EPIDEMIOLOGY; Ryom L, 2017, CROI; Saves M, 2003, CLIN INFECT DIS, V37, P292, DOI 10.1086/375844; Shiels MS, 2010, ANN INTERN MED, V153, P452, DOI 10.7326/0003-4819-153-7-201010050-00008; Silverberg MJ, 2014, JAIDS-J ACQ IMM DEF, V65, P160, DOI 10.1097/QAI.0000000000000009; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Tygesen K, 2007, CIRCULATION, V116, P2634; WHO, 2019, INT STAT CLASS DIS R, V10th; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897	27	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210253	10.1371/journal.pone.0210253	http://dx.doi.org/10.1371/journal.pone.0210253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650119	Green Published, gold, Green Submitted			2022-12-26	WOS:000455813300047
J	Valdivia, A; Wolf, S; Suckling, K				Valdivia, Abel; Wolf, Shaye; Suckling, Kieran			Marine mammals and sea turtles listed under the US Endangered Species Act are recovering	PLOS ONE			English	Article							CLIMATE-CHANGE; POPULATION RECOVERY; EXCLUDER DEVICES; EXTINCTION RISK; PACIFIC SALMON; FISHERIES; CONSERVATION; WHALES; SURVIVAL; BYCATCH	The U.S. Endangered Species Act (ESA) is a powerful environmental law protecting imperiled plants and animals, and a growing number of marine species have been protected under this law as extinction risk in the oceans has increased. Marine mammals and sea turtles comprise 38% of the 163 ESA-listed marine "species", which includes subspecies and distinct population segments, yet analyses of recovery trends after listing are lacking. Here we gathered the best available annual abundance estimates for geographically delimited populations of all 62 marine mammal and sea turtle species listed under the ESA. Of these, we chose representative populations of species that were listed before 2012, occur and reproduce in U.S. waters, and have data of sufficient quality and timespan for trend analyses. Thus, we quantitatively analyzed population trends, magnitude of population change, and recovery status for 23 and 8 representative populations of 14 marine mammal and 5 sea turtle species, respectively. Using generalized linear and non-linear models, we found that 18 marine mammal (78%) and 6 sea turtle (75%) populations significantly increased after listing; 3 marine mammal (13%) and 2 sea turtle (25%) populations showed non-significant changes; while 2 marine mammal (9%), but no sea turtle populations declined after ESA protection. Overall, the 24 populations that increased in abundance were from species listed for 20 years or more (e.g., large whales, manatees, and sea turtles). Conservation measures triggered by ESA listing such as ending exploitation, tailored species management, and fishery regulations, and other national and international measures, appear to have been largely successful in promoting species recovery, leading to the delisting of some species and to increases in most populations. These findings underscore the capacity of marine mammal and sea turtle species to recover from substantial geographical population declines when conservation actions are implemented in a timely and effective manner.	[Valdivia, Abel; Wolf, Shaye] Ctr Biol Divers, Oakland, CA 94612 USA; [Suckling, Kieran] Ctr Biol Divers, Tucson, AZ USA; [Valdivia, Abel] RARE, Arlington, VA 22201 USA		Valdivia, A (corresponding author), Ctr Biol Divers, Oakland, CA 94612 USA.; Valdivia, A (corresponding author), RARE, Arlington, VA 22201 USA.	avaldivia@rare.org						Andersson D, 2008, LECT NOTES COMPUT SC, V5028, P1, DOI 10.1007/978-3-540-69407-6_1; [Anonymous], 2016, FED REGISTER, V81, P62259; Baker CS, 2004, TRENDS ECOL EVOL, V19, P365, DOI 10.1016/j.tree.2004.05.005; Baker JD, 2007, MAR ECOL PROG SER, V346, P277, DOI 10.3354/meps06968; Balazs GH, 2004, BIOL CONSERV, V117, P491, DOI 10.1016/j.biocon.2003.08.008; Barton K., 2016, MUMIN MULTI MODEL IN; Bettridge S, 2015, NOAATMNMFSSWFSC540; Boersma PD, 2001, BIOSCIENCE, V51, P643; de Morais IOB, 2017, MAMMAL REV, V47, P11, DOI 10.1111/mam.12073; Broderick AC, 2001, P ROY SOC B-BIOL SCI, V268, P1481, DOI 10.1098/rspb.2001.1695; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Caillouet CW, 2015, HERPETOL CONSERV BIO, V10, P309; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Carroll C, 2010, CONSERV BIOL, V24, P395, DOI 10.1111/j.1523-1739.2009.01435.x; Collette BB, 2011, SCIENCE, V333, P291, DOI 10.1126/science.1208730; Conant TA, 2009, REP LOGGERHEAD BIOL, V222, P5; Conn PB, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00004.1; Crowder LB, 1995, COPEIA, P773, DOI 10.2307/1447026; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Elphick CS, 2001, CONSERV BIOL, V15, P1285, DOI 10.1046/j.1523-1739.2001.00356.x; Estes JA, 2016, P NATL ACAD SCI USA, V113, P880, DOI 10.1073/pnas.1502552112; Evans D.M., 2016, ISSUES ECOL, V20, P1, DOI 10.22201/ib.20078706e.2020.91.2909; Federal Register, 2016, FED REGISTER, V81, P20057; Ferraro PJ, 2007, J ENVIRON ECON MANAG, V54, P245, DOI 10.1016/j.jeem.2007.01.002; Finkbeiner EM, 2011, BIOL CONSERV, V144, P2719, DOI 10.1016/j.biocon.2011.07.033; Foley CM, 2017, BIOSCIENCE, V67, P627, DOI 10.1093/biosci/bix027; Ford JKB, 2010, BIOL LETTERS, V6, P139, DOI 10.1098/rsbl.2009.0468; Fritz L, 2008, AERIAL SHIP LAND BAS, V183, P81; Fritz LW, 2016, NMFSAFSC321 AL FISH; FWC, 2017, SEA TURT MON SNBS IN; Gerber LR, 2002, ECOL APPL, V12, P668; Gibbs KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035730; Good TP, 2007, FISHERIES, V32, P426, DOI 10.1577/1548-8446(2007)32[426:RPFESL]2.0.CO;2; Halpern BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8615; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Hanson B, 2014, SAL SEA EC C; Hastie T., 1986, STAT SCI, V1, P297; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Holt M.M., 2008, BIOACOUSTICS, V17, P164, DOI [10.1080/09524622.2008.9753802, DOI 10.1080/09524622.2008.9753802]; Hui TCY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123786; Humber F, 2014, DIVERS DISTRIB, V20, P579, DOI 10.1111/ddi.12183; Islam MS, 2004, MAR POLLUT BULL, V48, P624, DOI 10.1016/j.marpolbul.2003.12.004; Jenkins Lekelia D., 2012, U S National Marine Fisheries Service Marine Fisheries Review, V74, P26; Johnson A, 2005, MAR MAMMAL SCI, V21, P635, DOI 10.1111/j.1748-7692.2005.tb01256.x; Johnson DS, 2014, METHODS ECOL EVOL, V5, P1110, DOI 10.1111/2041-210X.12231; Kerkvliet J, 2007, ECOL ECON, V63, P499, DOI 10.1016/j.ecolecon.2006.12.007; Kraus SD, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00137; Laist DW, 2006, MAR MAMMAL SCI, V22, P472, DOI 10.1111/j.1748-7692.2006.00027.x; Leonard DL, 2008, BIOL CONSERV, V141, P2054, DOI 10.1016/j.biocon.2008.06.001; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Lewison RL, 2003, CONSERV BIOL, V17, P1089, DOI 10.1046/j.1523-1739.2003.02057.x; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lotze HK, 2009, TRENDS ECOL EVOL, V24, P254, DOI 10.1016/j.tree.2008.12.004; Lusseau David, 2009, Endangered Species Research, V6, P211, DOI 10.3354/esr00154; Luther D, 2016, BIOL CONSERV, V197, P229, DOI 10.1016/j.biocon.2016.03.019; Magera AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077908; Malcom JW, 2015, P NATL ACAD SCI USA, V112, P15844, DOI 10.1073/pnas.1516938112; Male TD, 2005, ECOL LETT, V8, P986, DOI 10.1111/j.1461-0248.2005.00806.x; Matkin CO, 2017, REV RECENT RES SO RE, DOI [10.1575/1912/8803, DOI 10.1575/1912/8803]; Mazaris AD, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600730; McCarthy DP, 2012, SCIENCE, V338, P946, DOI 10.1126/science.1229803; McCauley DJ, 2015, SCIENCE, V347, DOI 10.1126/science.1255641; McClenachan L, 2008, P ROY SOC B-BIOL SCI, V275, P1351, DOI 10.1098/rspb.2007.1757; McClenachan L, 2006, FRONT ECOL ENVIRON, V4, P290, DOI 10.1890/1540-9295(2006)4[290:CIOHST]2.0.CO;2; Miller JK, 2002, BIOSCIENCE, V52, P163, DOI 10.1641/0006-3568(2002)052[0163:TESADA]2.0.CO;2; Moore E, 2009, MAR POLLUT BULL, V58, P1045, DOI 10.1016/j.marpolbul.2009.02.006; Muto MM, 2016, NOAATMAFSC355; National Marine Fisheries Service, 2016, MAIN HAW ISL MONK SE; National Marine Fisheries Service (DFO), 2008, REC PLAN SO RES KILL, P251; Neel MC, 2012, BIOSCIENCE, V62, P646, DOI 10.1525/bio.2012.62.7.7; Nester L. R., 2006, THESIS; NMFS, 2017, FED REGISTER, V82, P24944; NMFS, 2007, REC PLAN HAW MONK SE; NMFS, 1995, FED REGISTER, V60, P3775; NMFS, 2003, FED REGISTER, V68, P204; NMFS, 1995, FED REGISTER, V60, P48000; NMFS, 2001, FED REGISTER, V66, P29502; NMFS (National Marine Fisheries Service), 2017, MONK SEAL POP SIZ TH; NMFS (National Marine Fisheries Service), 2017, REC PLAN COOK INL BE; NMFS USFWS, 2013, LEATH SEA TURTL DERM; NOAA, 2011, FED REGISTER, V76, P20870; NOAA Fisheries, 2016, SPEC SPOTL SURV THRI; NOAA Fisheries, 2015, END THREAT MAR SPEC; Norman Stephanie A., 2015, U S National Marine Fisheries Service Marine Fisheries Review, V77, P89; NRC (National Research Council), 2010, ASSESSMENT SEA TURTL, DOI [10.17226/12889, DOI 10.17226/12889]; O'Neill SM, 2014, ENDANGER SPECIES RES, V25, P265, DOI 10.3354/esr00631; Pace RM, 2017, ECOL EVOL, V7, P8730, DOI 10.1002/ece3.3406; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; Perry Simona A., 1999, U S National Marine Fisheries Service Marine Fisheries Review, V61, P1; Pettis H. M., 2017, N ATLANTIC RIGHT WHA; Pinheiro J., 2017, LINEAR NONLINEAR MIX, DOI DOI 10.1186/1742-9994-4-11; Polidoro BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010095; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; R Core Team, 2018, R LANG ENV STAT COMP; Rice D. W., 1973, IUCN PUBLICATIONS NE, P98; Rohlf D., 1989, ENDANGERED SPECIES A; Roman J, 2014, FRONT ECOL ENVIRON, V12, P377, DOI 10.1890/130220; Roman J, 2013, ANN NY ACAD SCI, V1286, P29, DOI 10.1111/nyas.12040; Salmon Michael, 2006, P141; Schwartz MW, 2008, ANNU REV ECOL EVOL S, V39, P279, DOI 10.1146/annurev.ecolsys.39.110707.173538; Scott JM, 2005, FRONT ECOL ENVIRON, V3, P383, DOI 10.1890/1540-9295(2005)003[0383:ROISUT]2.0.CO;2; Scott JM., 2006, ENDANGERED SPECIES A; Sease JL, 2002, AERIAL LAND BASED SU; SEASE JL, 2001, NMFSAFSC122; Seminoff J.A., 2015, NOAATMNMFSSWFSC539; Short FT, 2011, BIOL CONSERV, V144, P1961, DOI 10.1016/j.biocon.2011.04.010; Stewart KR, 2014, BIOL CONSERV, V176, P117, DOI 10.1016/j.biocon.2014.05.008; Suckling K., 2016, WILD SUCCESS SYSTEMA; Surma S, 2015, FISH OCEANOGR, V24, P291, DOI 10.1111/fog.12109; Swimmer Y, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00260; Taylor MFJ, 2005, BIOSCIENCE, V55, P360, DOI 10.1641/0006-3568(2005)055[0360:TEOTES]2.0.CO;2; U.S. Fish and Wildlife Service; Marine Mammals Management Office, 2013, SW AL DIST POP SEG N; [U. S. Fish & Wildlife Service U. S. Fish and Wildlife Service], 2017, ECOS ENV CONV ONL SY; USFWS NMFS, 1996, FED REGISTER, V61, P4722; van der Hoop JM, 2015, CONSERV LETT, V8, P24, DOI 10.1111/conl.12105; Van Houtan KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019043; Wallace BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015465; Walls SC, 2017, BIOSCIENCE, V67, P156, DOI 10.1093/biosci/biw153; Waples RS, 2013, BIOSCIENCE, V63, P723, DOI 10.1525/bio.2013.63.9.8; Waring Gordon T., 2015, NOAA Technical Memorandum NMFS-NE, V231, P1; Waring GT, 2016, NMFSNE238 NOAA; Wasser SK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179824; Webb TJ, 2015, CURR BIOL, V25, P506, DOI 10.1016/j.cub.2014.12.023; Wickham H, 2009, GGPLOT2, DOI [10.1007/978-0-387-98141-3, DOI 10.1007/978-0-387-98141-3]; Wiley DN, 2008, CONSERV BIOL, V22, P450, DOI 10.1111/j.1523-1739.2008.00897.x; Williams T. H., 2016, NOAATMNMFSSWFSC564; Wolf S, 2015, BIOSCIENCE, V65, P200, DOI 10.1093/biosci/biu218; Zirbel K, 2011, MAR POLLUT BULL, V63, P40, DOI 10.1016/j.marpolbul.2011.03.018; Zuur Alain F., 2009, P1	129	26	27	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210164	10.1371/journal.pone.0210164	http://dx.doi.org/10.1371/journal.pone.0210164			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650125	Green Submitted, Green Published, gold			2022-12-26	WOS:000455813300045
J	Xiao, W; Yang, JH; Fang, HY; Zhuang, JT; Ku, YD				Xiao, Wen; Yang, Jianhong; Fang, Huaiying; Zhuang, Jiangteng; Ku, Yuedong			Development of online classification system for construction waste based on industrial camera and hyperspectral camera	PLOS ONE			English	Article								Construction waste is a serious problem that should be addressed to protect environment and save resources, some of which have a high recovery value. To efficiently recover construction waste, an online classification system is developed using an industrial near-infrared hyperspectral camera. This system uses the industrial camera to capture a region of interest and a hyperspectral camera to obtain the spectral information about objects corresponding to the region of interest. The spectral information is then used to build classification models based on extreme learning machine and resemblance discriminant analysis. To further improve this system, an online particle swarm optimization extreme learning machine is developed. The results indicate that if a near-infrared hyperspectral camera is used in conjunction with an industrial camera, construction waste can be efficiently classified. Therefore, extreme learning machine and resemblance discriminant analysis can be used to classify construction waste. Particle swarm optimization can be used to further enhance the proposed system.	[Xiao, Wen; Yang, Jianhong; Fang, Huaiying; Zhuang, Jiangteng; Ku, Yuedong] Huaqiao Univ, Fujian Prov Univ, Key Lab Proc Monitoring & Syst Optimizat Mech & E, Xiamen, Fujian, Peoples R China	Fuzhou University; Huaqiao University	Yang, JH (corresponding author), Huaqiao Univ, Fujian Prov Univ, Key Lab Proc Monitoring & Syst Optimizat Mech & E, Xiamen, Fujian, Peoples R China.	yjhong@hqu.edu.cn		xiao, wen/0000-0002-7860-0087	Major Project Foundation of Science and Technology in Fujian Province [2016H6013]; Joint Innovation Project of Industrial Technology in Fujian Province [2016H6013]; Quanzhou Science and Technology Plan Project [2018C100R]	Major Project Foundation of Science and Technology in Fujian Province; Joint Innovation Project of Industrial Technology in Fujian Province; Quanzhou Science and Technology Plan Project	This work was financially supported by the Major Project Foundation of Science and Technology in Fujian Province (2016H6013), and Joint Innovation Project of Industrial Technology in Fujian Province. Jianhong Yang received the funding, grant numbers: 2016H6013, urls: http://xmgl.fjkjt.gov.cn/. This work was also supported by the Quanzhou Science and Technology Plan Project (2018C100R); Huaiying Fang received the funding, grant numbers: 2018C100R.	Arguello F, 2015, INT J REMOTE SENS, V36, P645, DOI 10.1080/01431161.2014.999882; Bi H, 2013, J ZHENGZHOU U, V45, P100, DOI [10.3969/j.issn.1671-6841.2013.01.024, DOI 10.3969/J.ISSN.1671-6841.2013.01.024]; Chen YS, 2016, IEEE T GEOSCI REMOTE, V54, P6232, DOI 10.1109/TGRS.2016.2584107; Demir B, 2010, INT GEOSCI REMOTE SE, P488, DOI 10.1109/IGARSS.2010.5652698; Dmitriev EV, 2014, IZV ATMOS OCEAN PHY+, V50, P929, DOI 10.1134/S0001433814090072; Guo C.-A., 2013, THESIS; Heras DB, 2014, INT J REMOTE SENS, V35, P401, DOI 10.1080/01431161.2013.869633; Huang G. B., 2005, P IEEE INT JOINT C N, V2, P985; Ivorra E, 2013, J FOOD ENG, V117, P342, DOI 10.1016/j.jfoodeng.2013.02.022; Kumar S, 2001, IEEE T GEOSCI REMOTE, V39, P1368, DOI 10.1109/36.934070; Le JH, 2015, LECT NOTES COMPUT SC, V9474, P682, DOI 10.1007/978-3-319-27857-5_61; Ma R., 2012, NO ENV, V4, P33; Marquetti I, 2016, COMPUT ELECTRON AGR, V121, P313, DOI 10.1016/j.compag.2015.12.018; Nakamura RYM, 2014, IEEE T GEOSCI REMOTE, V52, P2126, DOI 10.1109/TGRS.2013.2258351; Ni QianQian, 2016, Journal of Zhejiang A&F University, V33, P489; Palsson F, 2017, IEEE GEOSCI REMOTE S, V14, P639, DOI 10.1109/LGRS.2017.2668299; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Serranti S, 2012, RESOUR CONSERV RECY, V61, P52, DOI 10.1016/j.resconrec.2012.01.007	18	4	5	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0208706	10.1371/journal.pone.0208706	http://dx.doi.org/10.1371/journal.pone.0208706			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650081	gold, Green Published, Green Submitted			2022-12-26	WOS:000455813300006
J	Kim, J; Pajarillo, E; Rizor, A; Son, DS; Lee, J; Aschner, M; Lee, E				Kim, Judong; Pajarillo, Edward; Rizor, Asha; Son, Deok-Soo; Lee, Jayden; Aschner, Michael; Lee, Eunsook			LRRK2 kinase plays a critical role in manganese-induced inflammation and apoptosis in microglia	PLOS ONE			English	Article							NF-KAPPA-B; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; TAMOXIFEN PROTECT; OXIDATIVE DAMAGE; DAXX TRAFFICKING; GENE-EXPRESSION; ALPHA-SYNUCLEIN; MOUSE MODEL; CELL-DEATH	Long-term exposure to elevated levels of manganese (Mn) causes manganism, a neurodegenerative disorder with Parkinson's disease (PD)-like symptoms. Increasing evidence suggests that leucine-rich repeat kinase 2 (LRRK2), which is highly expressed in microglia and macrophages, contributes to the inflammation and neurotoxicity seen in autosomal dominant and sporadic PD. As gene-environment interactions have emerged as important modulators of PD-associated toxicity, LRRK2 may also mediate Mn-induced inflammation and pathogenesis. In this study, we investigated the role of LRRK2 in Mn-induced toxicity using human microglial cells (HMC3), LRRK2-wild-type (WT) and LRRK2-knockout (KO) RAW264.7 macrophage cells. Results showed that Mn activated LRRK2 kinase by phosphorylation of its serine residue at the 1292 position (S1292) as a marker of its kinase activity in macrophage and microglia, while inhibition with GSK2578215A (GSK) and MLi-2 abolished Mn-induced LRRK2 activation. LRRK2 deletion and its pharmacological inhibition attenuated Mn-induced apoptosis in macrophages and microglia, along with concomitant decreases in the pro-apoptotic Bcl-2-associated X (Bax) protein. LRRK2 deletion also attenuated Mn-induced production of reactive oxygen species (ROS) and the pro-inflammatory cytokine TNF-alpha. Mn-induced phosphorylation of mitogen-activated protein kinase (MAPK) p38 and ERK signaling proteins was significantly attenuated in LRRK2 KO cells and GSK-treated cells. Moreover, inhibition of MAPK p38 and ERK as well as LRRK2 attenuated Mn-induced oxidative stress and cytotoxicity. These findings suggest that LRRK2 kinase activity plays a critical role in Mn-induced toxicity via downstream activation of MAPK signaling in macrophage and microglia. Collectively, these results suggest that LRRK2 could be a potential molecular target for developing therapeutics to treat Mn-related neurodegenerative disorders.	[Kim, Judong; Pajarillo, Edward; Rizor, Asha; Lee, Eunsook] Florida A&M Univ, Coll Pharm, Dept Pharmaceut Sci, Tallahassee, FL 32307 USA; [Son, Deok-Soo] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA; [Lee, Jayden] Boston Univ, Dept Speech Language & Hearing Sci, Boston, MA 02215 USA; [Aschner, Michael] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA	State University System of Florida; Florida A&M University; Meharry Medical College; Boston University; Yeshiva University; Albert Einstein College of Medicine	Lee, E (corresponding author), Florida A&M Univ, Coll Pharm, Dept Pharmaceut Sci, Tallahassee, FL 32307 USA.	eunsook.lee@famu.edu	Pajarillo, Edward Alain/ABF-9202-2021	Pajarillo, Edward Alain/0000-0002-5044-7607	National Institute of Environmental Health Sciences [R01 ES024756, R01 ES10563, 1R03 ES024849, 1R21 ES025415]; National Cancer Institute [SC1 CA200519]; NATIONAL CANCER INSTITUTE [SC1CA200519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010563, R03ES024849, R21ES025415, R01ES024756] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided by the National Institute of Environmental Health Sciences, grants R01 ES024756 (EL), R01 ES10563 (MA), 1R03 ES024849 (MA) and 1R21 ES025415 (MA) and the National Cancer Institute SC1 CA200519 (DS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21931-8; Aschner M, 2009, NEUROMOL MED, V11, P252, DOI 10.1007/s12017-009-8083-0; Atashrazm F, 2016, CLIN PHARMACOL-ADV A, V8, P177, DOI 10.2147/CPAA.S102191; BARBEAU A, 1984, NEUROTOXICOLOGY, V5, P13; Barbeito AG, 2010, J NEURAL TRANSM, V117, P981, DOI 10.1007/s00702-010-0429-0; Bosgraaf L, 2003, BBA-MOL CELL RES, V1643, P5, DOI 10.1016/j.bbamcr.2003.08.008; Brockmann K, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0588-5; Caesar M, 2013, NEUROBIOL DIS, V54, P280, DOI 10.1016/j.nbd.2012.12.019; CALNE DB, 1994, NEUROLOGY, V44, P1583, DOI 10.1212/WNL.44.9.1583; Cao J, 2018, NEUROBIOL DIS, V119, P53, DOI 10.1016/j.nbd.2018.07.024; Chen CY, 2012, CELL DEATH DIFFER, V19, P1623, DOI 10.1038/cdd.2012.42; Chen JY, 2018, BIOCHEM BIOPH RES CO, V498, P171, DOI 10.1016/j.bbrc.2018.02.007; Chuang SM, 2000, CARCINOGENESIS, V21, P1423, DOI 10.1093/carcin/21.7.1423; Cirnaru MD, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00049; Cook DA, 2017, NPJ PARKINSONS DIS, V3, DOI 10.1038/s41531-017-0010-8; Cookson MR, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0564-y; Cooper-Knock J, 2012, NAT REV NEUROL, V8, P518, DOI 10.1038/nrneurol.2012.156; Dahlke C, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0435-0; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Di Maio R, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar5429; Diaz-Aparicio I, 2016, NEURAL REGEN RES, V11, P1533, DOI 10.4103/1673-5374.193220; Dun YY, 2013, NEUROPHARMACOLOGY, V67, P168, DOI 10.1016/j.neuropharm.2012.10.031; El Mchichi B, 2007, CELL DEATH DIFFER, V14, P1826, DOI 10.1038/sj.cdd.4402187; Elmazoglu Z, 2020, DRUG CHEM TOXICOL, V43, P96, DOI 10.1080/01480545.2018.1504961; Exil V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094753; Filipov NM, 2012, J APPL TOXICOL, V32, P310, DOI 10.1002/jat.1762; Games D, 2014, J NEUROSCI, V34, P9441, DOI 10.1523/JNEUROSCI.5314-13.2014; Games D, 2013, AM J PATHOL, V182, P940, DOI 10.1016/j.ajpath.2012.11.018; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Giguere N, 2018, J BIOL CHEM, V293, P9580, DOI 10.1074/jbc.RA117.000499; Gillardon F, 2009, J NEUROCHEM, V110, P1514, DOI 10.1111/j.1471-4159.2009.06235.x; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Goldwurm S, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.035568; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Greggio E, 2012, BIOCHEM SOC T, V40, P1058, DOI 10.1042/BST20120054; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Guilarte TR, 2010, ENVIRON HEALTH PERSP, V118, P1071, DOI [10.1289/ehp.0901748, 10.1590/S1413-81232011001200028]; Hartmann Andreas, 2004, Dialogues Clin Neurosci, V6, P281; Heo HY, 2010, EXP CELL RES, V316, P649, DOI 10.1016/j.yexcr.2009.09.014; Howlett EH, 2017, HUM MOL GENET, V26, P4340, DOI 10.1093/hmg/ddx320; Hsu CH, 2010, J NEUROCHEM, V112, P1593, DOI 10.1111/j.1471-4159.2010.06568.x; Islam MS, 2017, BIOCHEM SOC T, V45, P163, DOI 10.1042/BST20160264; Johnson J, 2018, NEUROTOXICOLOGY, V64, P230, DOI 10.1016/j.neuro.2017.06.007; Kanao T, 2010, HUM MOL GENET, V19, P3747, DOI 10.1093/hmg/ddq289; Karki P, 2015, J BIOL CHEM, V290, P23725, DOI 10.1074/jbc.M115.649327; Karunakaran S, 2007, FASEB J, V21, P2226, DOI 10.1096/fj.06-7580com; Keen CL, 1999, NEUROTOXICOLOGY, V20, P213; Kim B.H., 2012, PLOS ONE, V7; Kim T, 2017, J CEREBR BLOOD F MET, V37, P1910, DOI 10.1177/0271678X17694186; Kirkley KS, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0871-0; Kluss JH, 2018, NPJ PARKINSON DIS, V4, DOI 10.1038/s41531-018-0049-1; Kwon SH, 2011, NEUROCHEM INT, V58, P533, DOI 10.1016/j.neuint.2011.01.012; Lee ESY, 2009, TOXICOL SCI, V110, P156, DOI 10.1093/toxsci/kfp081; Lee ESY, 2009, J NEUROCHEM, V110, P530, DOI 10.1111/j.1471-4159.2009.06105.x; Liou AKF, 2008, NEUROBIOL DIS, V32, P116, DOI 10.1016/j.nbd.2008.06.016; Loeffler DA, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00089; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Martinez M, 2000, BRAIN RES, V869, P216, DOI 10.1016/S0006-8993(00)02363-5; Matta S, 2012, NEURON, V75, P1008, DOI 10.1016/j.neuron.2012.08.022; Miklossy J, 2007, ACTA NEUROPATHOL, V114, P243, DOI 10.1007/s00401-007-0230-9; Milatovic D, 2007, TOXICOL SCI, V98, P198, DOI 10.1093/toxsci/kfm095; Milatovic D, 2011, TOXICOL APPL PHARM, V256, P219, DOI 10.1016/j.taap.2011.06.001; Milatovic D, 2009, TOXICOL APPL PHARM, V240, P219, DOI 10.1016/j.taap.2009.07.004; Moehle MS, 2012, J NEUROSCI, V32, P1602, DOI 10.1523/JNEUROSCI.5601-11.2012; Moreno JA, 2011, TOXICOL SCI, V122, P121, DOI 10.1093/toxsci/kfr091; Muda K, 2014, P NATL ACAD SCI USA, V111, pE34, DOI 10.1073/pnas.1312701111; Munoz L, 2015, EUR J MED CHEM, V95, P29, DOI 10.1016/j.ejmech.2015.03.003; Niu YL, 2011, ARCH BIOCHEM BIOPHYS, V515, P89, DOI 10.1016/j.abb.2011.07.016; Orenstein SJ, 2013, NAT NEUROSCI, V16, P394, DOI 10.1038/nn.3350; Pajarillo E, 2019, BBA-MOL BASIS DIS, V1865, P1992, DOI 10.1016/j.bbadis.2018.11.017; Pajarillo E, 2018, NEUROTOXICOLOGY, V65, P280, DOI 10.1016/j.neuro.2017.11.008; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Puccini JM, 2015, J NEUROSCI, V35, P5271, DOI 10.1523/JNEUROSCI.0650-14.2015; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Rogers J, 2007, INT REV NEUROBIOL, V82, P235, DOI 10.1016/S0074-7742(07)82012-5; Russo I, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-52; Schapansky J, 2014, HUM MOL GENET, V23, P4201, DOI 10.1093/hmg/ddu138; Sheng ZJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004485; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Song JJ, 2003, J BIOL CHEM, V278, P47245, DOI 10.1074/jbc.M213201200; Stanwood GD, 2009, J NEUROCHEM, V110, P378, DOI 10.1111/j.1471-4159.2009.06145.x; Steger M, 2016, ELIFE, V5, DOI 10.7554/eLife.12813; Streck L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17070981; Tibbles LA, 1999, CELL MOL LIFE SCI, V55, P1230, DOI 10.1007/s000180050369; Tjalkens Ronald B, 2017, Adv Neurobiol, V18, P159, DOI 10.1007/978-3-319-60189-2_8; Tsika Elpida, 2013, Small GTPases, V4, P164, DOI 10.4161/sgtp.25130; Tsika E, 2012, CURR NEUROL NEUROSCI, V12, P251, DOI 10.1007/s11910-012-0265-8; Wang CY, 2018, CELL BIOL INT, V42, P84, DOI 10.1002/cbin.10864; Wang Jingcai, 2012, Commun Integr Biol, V5, P319, DOI 10.4161/cib.20216; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Zhao Y, 2011, NEUROBIOL AGING, V32, P1990, DOI 10.1016/j.neurobiolaging.2009.11.019; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	93	31	31	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210248	10.1371/journal.pone.0210248	http://dx.doi.org/10.1371/journal.pone.0210248			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645642	Green Submitted, Green Published, gold			2022-12-26	WOS:000455810200023
J	Wang, DW; Xu, QQ; Yuan, Q; Jia, MQ; Niu, HM; Liu, XF; Zhang, JS; Young, CY; Yuan, HQ				Wang, Dawei; Xu, Qingqing; Yuan, Quan; Jia, Mengqi; Niu, Huanmin; Liu, Xiaofei; Zhang, Jinsan; Young, Charles Yf; Yuan, Huiqing			Proteasome inhibition boosts autophagic degradation of ubiquitinated-AGR2 and enhances the antitumor efficiency of bevacizumab	ONCOGENE			English	Article							PRO-METASTATIC PROTEIN; ANTERIOR GRADIENT 2; SELECTIVE AUTOPHAGY; CANCER; AGR2; EXPRESSION; BORTEZOMIB; RECEPTOR; GENES; COMBINATION	Anterior gradient 2 (AGR2), a protein belonging to the protein disulfide isomerase (PDI) family, is overexpressed in multiple cancers and promotes angiogenesis to drive cancer progression. The mechanisms controlling AGR2 abundance in cancer remain largely unknown. Here, we observed that AGR2 expression is significantly suppressed by proteasome inhibitor MG132/bortezomib at mRNA and protein levels in lung cancer cells. MG132-mediated repression of AGR2 transcription was independent of ROS generation and ER stress induction, but partially resulted from the downregulated E2F1. Further investigation revealed that MG132 facilitated polyubiquitinated AGR2 degradation through activation of autophagy, as evidenced by predominant restoration of AGR2 level in cells genetic depletion of Atg5 and Atg7, or by autophagy inhibitors. Activation of autophagy by rapamycin noticeably reduced the AGR2 protein in cells and in the mouse tissue samples administrated with bortezomib. We also provided evidence identifying the K48-linked polyubiquitin chains conjugating onto K89 of AGR2 by an E3 ligase UBR5. In addition, an autophagy receptor NBR1 was demonstrated to be important in polyubiquitinated AGR2 clearance in response to MG132 or bortezomib. Importantly, downregulation of AGR2 by proteasome inhibition significantly enhanced antitumor activity of bevacizumab, highlighting the importance of AGR2 as a predictive marker for selection of subgroup patients in chemotherapy.	[Wang, Dawei; Xu, Qingqing; Yuan, Quan; Jia, Mengqi; Niu, Huanmin; Liu, Xiaofei; Yuan, Huiqing] Shandong Univ, Hosp 2, Inst Med Sci, Key Lab Expt Teratol,Minist Educ, Jinan, Shandong, Peoples R China; [Zhang, Jinsan; Young, Charles Yf] Mayo Clin, Coll Med, Dept Urol, Rochester, MN USA	Shandong University; Mayo Clinic	Yuan, HQ (corresponding author), Shandong Univ, Hosp 2, Inst Med Sci, Key Lab Expt Teratol,Minist Educ, Jinan, Shandong, Peoples R China.	lyuanhq@sdu.edu.cn		Xu, Qingqing/0000-0002-7703-5872	973 Program [2013CB910900]; National Natural Science Foundation of China [81473238, 81872896]; Shandong key innovative research program [2018CXGC1216]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong key innovative research program	We would like to thank Professor Srikumar P. Chellappan for kindly providing the plasmid of E2F1, Professor Xuejun Jiang for the gift of GFP-LC3B construct, and Professor Chengjiang Gao for the gift of HA-K48, HA-63, HA-K48R, and HA-63R plasmids (Department of Immunology, School of Medicine of Shandong University, China). This work was supported by 973 Program (2013CB910900), the National Natural Science Foundation of China (81473238, 81872896), and Shandong key innovative research program (2018CXGC1216).	Bu H, 2013, FEBS J, V280, P1249, DOI 10.1111/febs.12118; Chevet E, 2013, ONCOGENE, V32, P2499, DOI 10.1038/onc.2012.346; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Chung Kyukwang, 2012, Osaka City Med J, V58, P13; Dasgupta P, 2011, JNCI-J NATL CANCER I, V103, P317, DOI 10.1093/jnci/djq541; Fritzsche FR, 2007, HISTOL HISTOPATHOL, V22, P703, DOI 10.14670/HH-22.703; Gao ZH, 2010, AUTOPHAGY, V6, P126, DOI 10.4161/auto.6.1.10928; Ge PF, 2009, ACTA PHARMACOL SIN, V30, P1046, DOI 10.1038/aps.2009.71; Grice GL, 2016, CELL MOL LIFE SCI, V73, P3497, DOI 10.1007/s00018-016-2255-5; Guo H, 2017, ONCOGENE, V36, P5098, DOI 10.1038/onc.2017.132; Guo YY, 2017, J NEUROSCI, V37, P5978, DOI 10.1523/JNEUROSCI.3148-16.2017; Hengel SM, 2011, J PROTEOME RES, V10, P4567, DOI 10.1021/pr2004117; Hideshima T, 2005, P NATL ACAD SCI USA, V102, P8567, DOI 10.1073/pnas.0503221102; Higa A, 2011, J BIOL CHEM, V286, P44855, DOI 10.1074/jbc.M111.275529; Hrstka R, 2010, ONCOGENE, V29, P4838, DOI 10.1038/onc.2010.228; Hu ZY, 2012, CARCINOGENESIS, V33, P1178, DOI 10.1093/carcin/bgs141; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Jia MQ, 2018, BBA-MOL BASIS DIS, V1864, P1622, DOI 10.1016/j.bbadis.2018.01.021; Kawaguchi T, 2011, INT J ONCOL, V38, P643, DOI 10.3892/ijo.2010.882; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Khaminets A, 2016, TRENDS CELL BIOL, V26, P6, DOI 10.1016/j.tcb.2015.08.010; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Krig SR, 2007, J BIOL CHEM, V282, P9703, DOI 10.1074/jbc.M611752200; Li SR, 2012, DEVELOPMENT, V139, P2500, DOI 10.1242/dev.079699; Lim JH, 2004, BIOCHEM BIOPH RES CO, V318, P868, DOI 10.1016/j.bbrc.2004.04.103; Lin HK, 2002, J BIOL CHEM, V277, P36570, DOI 10.1074/jbc.M204751200; Liu ZZ, 2014, CANCER CELL, V26, P106, DOI 10.1016/j.ccr.2014.05.015; Mancias JD, 2016, J MOL BIOL, V428, P1659, DOI 10.1016/j.jmb.2016.02.027; Nakajima S, 2011, FEBS LETT, V585, P2249, DOI 10.1016/j.febslet.2011.05.047; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Piperdi B, 2012, J THORAC ONCOL, V7, P1032, DOI 10.1097/JTO.0b013e31824de2fa; Pohler E, 2004, MOL CELL PROTEOMICS, V3, P534, DOI 10.1074/mcp.M300089-MCP200; Tang CH, 2014, BBA-GENE REGUL MECH, V1839, P425, DOI 10.1016/j.bbagrm.2014.04.017; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Thompson DA, 1998, BIOCHEM BIOPH RES CO, V251, P111, DOI 10.1006/bbrc.1998.9440; Vanderlaag KE, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2586; Wang XJ, 2013, AUTOPHAGY, V9, P1500, DOI 10.4161/auto.25573; Waters S, 2009, FEBS LETT, V583, P1846, DOI 10.1016/j.febslet.2009.04.049; White D, 2013, CANCER-AM CANCER SOC, V119, P339, DOI 10.1002/cncr.27745; Wu WKK, 2008, BIOCHEM BIOPH RES CO, V374, P258, DOI 10.1016/j.bbrc.2008.07.031; Yu HX, 2012, MOL BIOSYST, V8, P2710, DOI 10.1039/c2mb25160d; Yuan C, 2012, J BIOL CHEM, V287, P17006, DOI 10.1074/jbc.M112.341198; Zhao LL, 2009, CANCER RES, V69, P7696, DOI 10.1158/0008-5472.CAN-08-4901; 2014, J BIOL CHEM, V289, P1389, DOI DOI 10.1074/JBC.M114.555441; 2011, J BIOL CHEM, V286, P1830, DOI DOI 10.1074/JBC.M110.215707; 2011, CANCER RES, V71, P7091, DOI DOI 10.1158/0008-5472.CAN-11-1367	46	34	34	3	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 2	2019	38	18					3458	3474		10.1038/s41388-019-0675-z	http://dx.doi.org/10.1038/s41388-019-0675-z			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HW3RI	30647455	Green Published, hybrid			2022-12-26	WOS:000466610000010
J	Cai, JR; Jiao, XY; Fang, Y; Yu, XF; Ding, XQ				Cai, Jieru; Jiao, Xiaoyan; Fang, Yi; Yu, Xiaofang; Ding, Xiaoqiang			The orphan nuclear receptor ROR alpha is a potential endogenous protector in renal ischemia/reperfusion injury	FASEB JOURNAL			English	Article						ROR; AKI; apoptosis	ACUTE KIDNEY INJURY; OXIDATIVE STRESS; CELL-DEATH; RAT MODEL; MELATONIN; ACTIVATION; EXPRESSION; APOPTOSIS; GAMMA	Emerging evidence indicates that retinoid-related orphan receptor (ROR)alpha, a member of the ROR nuclear receptor subfamily, mediates key cellular adaptions to hypoxia and contributes to the pathophysiology of many disease states. However, the effects of ROR alpha in renal ischemia/reperfusion (I/R) injury remain unclear. Wild-type (WT) C57 black 6 (C57BL/6) mice and ROR alpha-deficient stagger [ROR(sg/sg)] mice and their WT littermates were used for in vivo studies. The renal I/R injury model was induced by bilateral renal pedicle clamping for 35 min. Human proximal tubule cell line cells were treated with hypoxia (1% oxygen) to establish the cell hypoxia/reoxygenation (H/R) model. We investigated the renal expression and biologic function of ROR alpha, and we found that ROR alpha was significantly down-regulated after renal I/R injury. ROR(sg/sg) mice displayed dramatically augmented renal dysfunction and morphologic damage compared with WT mice at 24 h post-I/R. Further study revealed that the detrimental effects of ROR alpha deficiency were attributable to tubular epithelial cell apoptosis and, consequently, renal inflammation and oxidative stress. The proapoptotic effect of ROR alpha deficiency was associated with aggravated mitochondrial dysfunction in renal tubular cells after I/R. However, pretreatment of C57BL/6 mice with the ROR alpha agonist SR1078 ameliorated I/R-induced renal dysfunction and damage and elicited a concomitant decrease in tubular epithelial cell apoptosis. In summary, our study provides experimental evidence showing that ROR alpha is a novel endogenous protector against renal I/R injury and that ROR-alpha activation is a promising therapeutic strategy for the prevention of acute kidney injury.	[Cai, Jieru; Jiao, Xiaoyan; Fang, Yi; Yu, Xiaofang; Ding, Xiaoqiang] Fudan Univ, Shanghai Med Coll, Zhongshan Hosp, Dept Nephrol, Shanghai, Peoples R China; [Cai, Jieru; Jiao, Xiaoyan; Fang, Yi; Yu, Xiaofang; Ding, Xiaoqiang] Shanghai Key Lab Kidney & Blood Purificat, Shanghai, Peoples R China; [Cai, Jieru; Jiao, Xiaoyan; Fang, Yi; Yu, Xiaofang; Ding, Xiaoqiang] Shanghai Med Ctr Kidney Dis, Shanghai, Peoples R China; [Fang, Yi; Yu, Xiaofang; Ding, Xiaoqiang] Shanghai Inst Kidney & Dialysis, Shanghai, Peoples R China	Fudan University	Yu, XF; Ding, XQ (corresponding author), Fudan Univ, Zhongshan Hosp, 180 Fenglin Rd, Shanghai 200032, Peoples R China.	yu.xiaofang@zs-hospital.sh.cn; ding.xiaoqiang@zs-hospital.sh.cn			National Natural Science Foundation of China [81600517, 81570600]; Shanghai Sailing Plan [15YF1402100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Sailing Plan	The authors thank Dr. Ding Song (Renji Hospital School of Medicine, Shanghai Jiao Tong University, Shanghai, China) for providing the retinoid-related orphan receptor -deficient stagger mice. This work was supported by National Natural Science Foundation of China Grants 81600517 and 81570600, and Shanghai Sailing Plan 15YF1402100. The authors declare no conflicts of interest.	Agarwal A, 2016, J AM SOC NEPHROL, V27, P1288, DOI 10.1681/ASN.2015070740; Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Arici M, 2003, J AM SOC NEPHROL, V14, P17, DOI 10.1097/01.ASN.0000042167.66685.EA; Balasubramanian S, 2012, J AM SOC NEPHROL, V23, P674, DOI 10.1681/ASN.2011070646; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; BECKERANDRE M, 1993, BIOCHEM BIOPH RES CO, V194, P1371, DOI 10.1006/bbrc.1993.1976; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boukhtouche F, 2006, J NEUROCHEM, V96, P1778, DOI 10.1111/j.1471-4159.2006.03708.x; Cal JR, 2014, AM J NEPHROL, V39, P466, DOI 10.1159/000362623; Cook Donald N, 2015, Nucl Receptor Res, V2; Daemen MARC, 1999, J CLIN INVEST, V104, P541, DOI 10.1172/JCI6974; Delerive P, 2001, EMBO REP, V2, P42, DOI 10.1093/embo-reports/kve007; Dong W, 2015, J AM SOC NEPHROL, V26, P2789, DOI 10.1681/ASN.2014080846; Fang Y, 2015, HEMODIAL INT, V19, P2, DOI 10.1111/hdi.12193; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Han YH, 2014, ANTIOXID REDOX SIGN, V21, P2083, DOI 10.1089/ars.2013.5655; He B, 2016, J PINEAL RES, V60, P313, DOI 10.1111/jpi.12312; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Julien O, 2017, CELL DEATH DIFFER, V24, P1380, DOI 10.1038/cdd.2017.44; Kaushal GP, 2014, J AM SOC NEPHROL, V25, P877, DOI 10.1681/ASN.2013070780; Kim EJ, 2008, ARTERIOSCL THROM VAS, V28, P1796, DOI 10.1161/ATVBAHA.108.171546; Kojetin DJ, 2014, NAT REV DRUG DISCOV, V13, P197, DOI 10.1038/nrd4100; Kurcer Z, 2007, J PINEAL RES, V43, P172, DOI 10.1111/j.1600-079X.2007.00459.x; Lazar MA, 2017, J CLIN INVEST, V127, P1123, DOI 10.1172/JCI92949; Lee JM, 2010, MOL CELL, V37, P183, DOI 10.1016/j.molcel.2009.12.022; Letavernier E, 2005, J AM SOC NEPHROL, V16, P2395, DOI 10.1681/ASN.2004090802; Li SY, 2009, KIDNEY INT, V76, P1049, DOI 10.1038/ki.2009.330; Linkermann A, 2014, J AM SOC NEPHROL, V25, P2689, DOI 10.1681/ASN.2014030262; Marciano DP, 2014, CELL METAB, V19, P193, DOI 10.1016/j.cmet.2013.12.009; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; Opie LH, 2016, EUR HEART J-CARD PHA, V2, P258, DOI 10.1093/ehjcvp/pvv037; Sancho-Martinez SM, 2015, CLIN KIDNEY J, V8, P548, DOI 10.1093/ckj/sfv069; Sladek FM, 2011, MOL CELL ENDOCRINOL, V334, P3, DOI 10.1016/j.mce.2010.06.018; Tilley SL, 2007, J IMMUNOL, V178, P3208, DOI 10.4049/jimmunol.178.5.3208; Tomas-Zapico C, 2005, J PINEAL RES, V39, P21, DOI 10.1111/j.1600-079X.2005.00210.x; Vanmassenhove J, 2017, LANCET, V389, P2139, DOI 10.1016/S0140-6736(17)31329-6; Volt H, 2016, J PINEAL RES, V60, P193, DOI 10.1111/jpi.12303; Wagner J, 2000, J AM SOC NEPHROL, V11, P1479, DOI 10.1681/ASN.V1181479; Wang JL, 2015, CIRCULATION, V132, P1909, DOI 10.1161/CIRCULATIONAHA.115.016457; Wang YJ, 2010, ACS CHEM BIOL, V5, P1029, DOI 10.1021/cb100223d; Weidemann A, 2008, J AM SOC NEPHROL, V19, P486, DOI 10.1681/ASN.2007040419; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhang HM, 2014, J PINEAL RES, V57, P131, DOI 10.1111/jpi.12162; Zhao YC, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12378	44	9	10	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5704	5715		10.1096/fj.201802248R	http://dx.doi.org/10.1096/fj.201802248R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30673513				2022-12-26	WOS:000462888500085
J	Reyes, JL; Lopes, F; Leung, G; Jayme, TS; Matisz, CE; Shute, A; Burkhard, R; Carneiro, M; Workentine, ML; Wang, A; Petri, B; Beck, PL; Geuking, MB; McKay, DM				Reyes, Jose L.; Lopes, Fernando; Leung, Gabriella; Jayme, Timothy S.; Matisz, Chelsea E.; Shute, Adam; Burkhard, Regula; Carneiro, Matheus; Workentine, Matthew L.; Wang, Arthur; Petri, Bjorn; Beck, Paul L.; Geuking, Markus B.; McKay, Derek M.			Macrophages treated with antigen from the tapeworm Hymenolepis diminuta condition CD25(+) T cells to suppress colitis	FASEB JOURNAL			English	Article						helminth; intestine; inflammatory bowel disease; macrophage; interleukin-10	ALTERNATIVELY ACTIVATED MACROPHAGES; INFLAMMATORY RESPONSES; ADOPTIVE TRANSFER; DENDRITIC CELLS; TH2 RESPONSES; HELMINTH; INDUCTION; INFECTION; IMMUNITY; PROTECTS	Macrophages play central roles in immunity as early effectors and modulating adaptive immune reponses; we implicated macrophages in the anticolitic effect of infection with the tapeworm Hymenolepis diminuta. Here, gene arrays revealed that H. diminuta antigen (HdAg) evoked a program in murine macrophages distinct from that elicited by IL-4. Further, HdAg suppressed LPS-evoked release of TNF-alpha and IL-1 beta from macrophages via autocrine IL-10 signaling. In assessing the ability of macrophages treated in vitro with an extract of H. diminuta [M-(HdAg)] to affect disease, intravenous, but not peritoneal, injection of M-(HdAg) protected wild-type but not RAG1(-/-) mice from dinitrobenzene sulphonic acid (DNBS)-induced colitis. Administration of splenic CD4(+) T cells from in vitro cocultures with M-(HdAg), but not those cocultured with M(IL-4) cells, inhibited DNBS-induced colitis; fractionation of the T-cell population indicated that the CD4(+)CD25(+) T cells from cocultures with M-(HdAg) drove the suppression of DNBS-induced colitis. Use of IL-4(-/-) or IL-10(-/-) CD4(+) T cells revealed that neither cytokine alone from the donor cells was essential for the anticolitic effect. These data illustrate that HdAg evokes a unique regulatory program in macrophages, identifies HdAg-evoked IL-10 suppression of macrophage activation, and reveals the ability of HdAg-treated macrophages to educate (i.e., condition) and mobilize CD4(+)CD25(+) T cells, which could be deployed to treat colonic inflammation.	[Reyes, Jose L.; Lopes, Fernando; Leung, Gabriella; Jayme, Timothy S.; Matisz, Chelsea E.; Shute, Adam; Burkhard, Regula; Wang, Arthur; Beck, Paul L.; Geuking, Markus B.; McKay, Derek M.] Univ Calgary, Dept Physiol & Pharmacol, 1877 HSC,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada; [Petri, Bjorn] Univ Calgary, Calvin Joan & Phoebe Snyder Inst Chron Dis, Mouse Phen Resource Lab, Calgary, AB, Canada; [Burkhard, Regula; Carneiro, Matheus; Petri, Bjorn; Geuking, Markus B.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Beck, Paul L.] Univ Calgary, Dept Med, Cumming Sch Med, Calgary, AB, Canada; [Workentine, Matthew L.] Univ Calgary, Fac Vet Med, Calgary, AB, Canada; [Reyes, Jose L.] UNAM, FES, Unidad Invest Biomed UBIMED, Lab Inmunol Expt & Regulac Inflamac Hepatointesti, Tlalnepantla de Baz, Mexico	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; Universidad Nacional Autonoma de Mexico	McKay, DM (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, 1877 HSC,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	dmckay@ucalgary.ca	Wang, Arthur/AAE-3368-2019; McKay, Derek/HCH-3240-2022; Reyes, Jose Luis/D-8322-2018	Workentine, Matthew/0000-0002-6415-2797; Reyes, Jose Luis/0000-0003-0089-0261; Burkhard, Regula/0000-0002-5117-0937; Leung, Gabriella/0000-0002-8754-1621	Canadian Institutes for Health Research (CIHR)/Canadian Association of Gastroenterology (CAG)/Janssen; Alberta Innovates-Health Solutions (AI-HS); Natural Sciences and Engineering Research Council (NSERC) Create Host-Parasite Interactions (HPI) program at the University of Calgary; Beverly Philips Snyder Institute University of Calgary; Natural Sciences and Engineering Research Council (NSERC) Create Host-Parasite Interactions (HPI); Canadian Association of Gastroenterology (CAG); Calvin, Joan and Phoebe Snyder Institute for Chronic Diseases; Allergan	Canadian Institutes for Health Research (CIHR)/Canadian Association of Gastroenterology (CAG)/Janssen(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions (AI-HS); Natural Sciences and Engineering Research Council (NSERC) Create Host-Parasite Interactions (HPI) program at the University of Calgary; Beverly Philips Snyder Institute University of Calgary; Natural Sciences and Engineering Research Council (NSERC) Create Host-Parasite Interactions (HPI); Canadian Association of Gastroenterology (CAG); Calvin, Joan and Phoebe Snyder Institute for Chronic Diseases; Allergan(AbbVieAllergan)	J.L.R. and F.L. were recipients of Canadian Institutes for Health Research (CIHR)/Canadian Association of Gastroenterology (CAG)/Janssen or Allergan, and Alberta Innovates-Health Solutions (AI-HS) postdoctoral fellowships. C.E.M. held AI-HS and CIHR Ph.D. studentships. G.L. held an AI-HS Ph.D. studentship. T.S.J was supported, in part, by a stipend from the Natural Sciences and Engineering Research Council (NSERC) Create Host-Parasite Interactions (HPI) program at the University of Calgary. A.S. was supported by a Beverly Philips Snyder Institute University of Calgary, Natural Sciences and Engineering Research Council (NSERC) Create Host-Parasite Interactions (HPI), and Canadian Association of Gastroenterology (CAG) graduate studentships. D.M.M. holds a Canada Research Chair (Tier 1) in Intestinal Immunophysiology in Health and Disease. The Snyder Mouse Phenomics Resources Laboratory, funded by the Calvin, Joan and Phoebe Snyder Institute for Chronic Diseases and the Flow Cytometry supported this work. The authors declare no conflicts of interest.	Aira N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005390; [Anonymous], 2021, LANG ENV STAT COMP; Arora S, 2018, IMMUNOBIOLOGY, V223, P383, DOI 10.1016/j.imbio.2017.11.001; Cao Q, 2010, J AM SOC NEPHROL, V21, P933, DOI 10.1681/ASN.2009060592; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; DiNardo AR, 2016, J INFECT DIS, V214, P479, DOI 10.1093/infdis/jiw156; Donnelly S, 2008, FASEB J, V22, P4022, DOI 10.1096/fj.08-106278; Du LL, 2011, DIGEST DIS SCI, V56, P2810, DOI 10.1007/s10620-011-1689-8; Eason RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep37276; Esser-von Bieren Julia, 2015, J Immunol, V194, P1154, DOI 10.4049/jimmunol.1401645; Everts B, 2012, J EXP MED, V209, P1753, DOI 10.1084/jem.20111381; Fernando ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099050; Figueiredo AS, 2009, FEBS J, V276, P3454, DOI 10.1111/j.1742-4658.2009.07068.x; Finlay CM, 2014, IMMUNOL REV, V259, P206, DOI 10.1111/imr.12164; Fleming BD, 2015, J LEUKOCYTE BIOL, V98, P395, DOI 10.1189/jlb.2A1114-560R; Fleming JO, 2013, INT J PARASITOL, V43, P259, DOI 10.1016/j.ijpara.2012.10.025; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Hang L, 2016, J IMMUNOL, V197, P2948, DOI 10.4049/jimmunol.1600063; Hang L, 2013, J IMMUNOL, V191, P1927, DOI 10.4049/jimmunol.1201457; Hartmann S, 2003, INT J PARASITOL, V33, P1291, DOI 10.1016/S0020-7519(03)00163-2; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Heylen M, 2015, INFLAMM BOWEL DIS, V21, P48, DOI 10.1097/MIB.0000000000000246; Hunter MM, 2010, GASTROENTEROLOGY, V138, P1395, DOI 10.1053/j.gastro.2009.12.041; Hunter MM, 2005, J IMMUNOL, V174, P7368, DOI 10.4049/jimmunol.174.11.7368; Hussaarts L, 2013, IMMUNOL CELL BIOL, V91, P486, DOI 10.1038/icb.2013.31; Jenkins SJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/262609; Johnston MJG, 2010, INFECT IMMUN, V78, P1364, DOI 10.1128/IAI.01349-08; Klotz C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001248; Kraaij MD, 2010, P NATL ACAD SCI USA, V107, P17686, DOI 10.1073/pnas.1012016107; Ledesma-Soto Y, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/563425; Leung G, 2015, MOL MED, V21, P924, DOI 10.2119/molmed.2015.00193; Leung G, 2013, AM J PHYSIOL-GASTR L, V304, pG781, DOI 10.1152/ajpgi.00055.2013; Cancado GGL, 2011, INFLAMM BOWEL DIS, V17, P2275, DOI 10.1002/ibd.21629; Lopes F, 2016, INFLAMM BOWEL DIS, V22, P2499, DOI 10.1097/MIB.0000000000000889; Maizels RM, 2016, J ALLERGY CLIN IMMUN, V138, P666, DOI 10.1016/j.jaci.2016.07.007; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Matisz CE, 2017, SCI REP-UK, V7, DOI 10.1038/srep40631; Matisz CE, 2015, EUR J IMMUNOL, V45, P3126, DOI 10.1002/eji.201545579; Nickles D., 2016, NANOSTRINGQCPRO QUAL; Pineda MA, 2014, MOL BIOCHEM PARASIT, V194, P1, DOI 10.1016/j.molbiopara.2014.03.003; Rausch S, 2009, EUR J IMMUNOL, V39, P3066, DOI 10.1002/eji.200939644; Reyes JL, 2007, PARASITE IMMUNOL, V29, P609, DOI 10.1111/j.1365-3024.2007.00973.x; Reyes JL, 2016, INFECT IMMUN, V84, P3471, DOI 10.1128/IAI.00681-16; Reyes JL, 2015, J IMMUNOL, V194, P364, DOI 10.4049/jimmunol.1400738; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rizzo A, 2012, INFLAMM BOWEL DIS, V18, P449, DOI 10.1002/ibd.21799; Rolot M, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/2790627; Sanin DE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004841; Savage NDL, 2008, J IMMUNOL, V181, P2220, DOI 10.4049/jimmunol.181.3.2220; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schnoeller C, 2008, J IMMUNOL, V180, P4265, DOI 10.4049/jimmunol.180.6.4265; Schuijs MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161885; Shepherd C, 2015, PARASITE IMMUNOL, V37, P293, DOI 10.1111/pim.12192; Smith H, 2018, EXPERT REV GASTROENT, V12, P997, DOI 10.1080/17474124.2018.1505498; Smith KA, 2016, MUCOSAL IMMUNOL, V9, P428, DOI 10.1038/mi.2015.73; Smits HH, 2010, CURR ALLERGY ASTHM R, V10, P3, DOI 10.1007/s11882-009-0085-3; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Taylor MD, 2012, TRENDS IMMUNOL, V33, P181, DOI 10.1016/j.it.2012.01.001; Terrazas CA, 2011, INT J BIOL SCI, V7, P1391, DOI 10.7150/ijbs.7.1391; Waggott D., 2015, NANOSTRINGNORML NORM; Weisser SB, 2014, EUR J IMMUNOL, V44, P3353, DOI 10.1002/eji.201343981; Wi HJ, 2012, CYTOKINE, V59, P237, DOI 10.1016/j.cyto.2012.04.021; Wolfs IMJ, 2014, FASEB J, V28, P288, DOI 10.1096/fj.13-235911; Yang CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065070; Zawistowska-Deniziak A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00148; Ziegler T, 2015, J IMMUNOL, V194, P1555, DOI 10.4049/jimmunol.1401217	66	5	6	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5676	5689		10.1096/fj.201802160R	http://dx.doi.org/10.1096/fj.201802160R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30668930	Bronze			2022-12-26	WOS:000462888500083
J	Coutand, C; Adam, B; Ploquin, S; Moulia, B				Coutand, Catherine; Adam, Boris; Ploquin, Stephane; Moulia, Bruno			A method for the quantification of phototropic and gravitropic sensitivities of plants combining an original experimental device with model-assisted phenotyping: Exploratory test of the method on three hardwood tree species	PLOS ONE			English	Article							AVENA COLEOPTILES; SHAPE REGULATION; GROWTH STRESSES; SIMULATE; TROPISMS	Perception of inclination in the gravity field and perception of light direction are two important environmental signals implicated in the control of plant shape and habit. However, their quantitative study in light-grown plants remains a challenge. We present a novel method here to determine the sensitivities to gravitropism and phototropism. The method combines: (i) an original experimental device of isotropic light to disentangle gravitropic and phototropic plant responses; and (ii) model-assisted phenotyping using recent models of tropism perception-the AC model for gravitropism alone and the ArC model for gravitropism combined with phototropism. We first assessed the validity of the AC and ArC models on poplar, the classical species model for woody plants. We then tested the method on three woody species contrasted by their habit and tolerance to shade: poplar (Populus tremula* alba), oak (Quercus petraea) and beech (Fagus sylvatica). The method was found to be effective to quantitatively discriminate the tested species by their ratio of tropistic sensitivities. The method thus appears as an interesting tool to quantitatively determine tropistic sensitivities, a prerequisite for assessing the role of tropisms in the control of the variability of the habit and/or tolerance to shade of woody species in the future.	[Coutand, Catherine] INRA, UR 1115 PSH, Avignon, France; [Adam, Boris; Ploquin, Stephane; Moulia, Bruno] Univ Clermont Auvergne, INRA, PIAF, Clermont Ferrand, France	INRAE; INRAE; Universite Clermont Auvergne (UCA)	Coutand, C (corresponding author), INRA, UR 1115 PSH, Avignon, France.	catherine.coutand@inra.fr			Agence Nationale de la Recherche [ANR-11-BSV7-0012 TROPIC]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Agence Nationale de la Recherche, ANR-11-BSV7-0012 TROPIC.	Almeras T, 2009, J THEOR BIOL, V256, P370, DOI 10.1016/j.jtbi.2008.10.011; Bastien R, 2014, FRONT PLANT SCI, V2014, P127; Bastien R, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004037; Bastien R, 2013, P NATL ACAD SCI USA, V110, P755, DOI 10.1073/pnas.1214301109; Collet C, 2011, ANN BOT-LONDON, V107, P1345, DOI 10.1093/aob/mcr058; Correll MJ, 2002, J PLANT GROWTH REGUL, V21, P89, DOI 10.1007/s003440010056; Coutand C, 2007, PLANT PHYSIOL, V144, P1166, DOI [10.1104/pp.106.088153, 10.1104/PP.106.088153]; Coutand C, 2011, J THEOR BIOL, V273, P115, DOI 10.1016/j.jtbi.2010.12.027; DenDulk J. A., 1989, INTERPRETATION REMOT; Digby J, 2002, J EXP BOT, V53, P377, DOI 10.1093/jexbot/53.367.377; Digby J, 1995, PLANT CELL ENVIRON, V18, P1434, DOI 10.1111/j.1365-3040.1995.tb00205.x; Fourcaud T, 2003, TREES-STRUCT FUNCT, V17, P31, DOI 10.1007/s00468-002-0203-5; Fourcaud T, 2003, TREES-STRUCT FUNCT, V17, P23, DOI 10.1007/s00468-002-0202-6; Fournier Meriem, 1994, Biomimetics, V2, P229; Galland P, 2002, PLANTA, V215, P779, DOI 10.1007/s00425-002-0813-6; Galland P, 2002, J PLANT RES, V115, P131, DOI 10.1007/s102650200018; Iino M, 2006, CURR OPIN PLANT BIOL, V9, P89, DOI 10.1016/j.pbi.2005.11.012; Matsuzaki J, 2007, PLANT CELL ENVIRON, V30, P646, DOI 10.1111/j.1365-3040.2007.01656.x; Matsuzaki J, 2006, ANN BOT-LONDON, V98, P573, DOI 10.1093/aob/mcl127; Moulia B, 2009, J EXP BOT, V60, P461, DOI 10.1093/jxb/ern341; Nicolini E, 1991, THESIS; Pot G, 2014, TREES-STRUCT FUNCT, V28, P1235, DOI 10.1007/s00468-014-1033-y; Pouliquen O, 2017, PHYS BIOL, V14, DOI 10.1088/1478-3975/aa6876; Sierra-De-Grado R, 2008, TREE PHYSIOL, V28, P835, DOI 10.1093/treephys/28.6.835; SierradeGrado R, 1997, TREES-STRUCT FUNCT, V11, P455, DOI 10.1007/s004680050107; SILK WK, 1978, AM J BOT, V65, P310, DOI 10.2307/2442271; SILK WK, 1984, ANNU REV PLANT PHYS, V35, P479, DOI 10.1146/annurev.pp.35.060184.002403; Vandenbrink JP, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00563	28	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0209973	10.1371/journal.pone.0209973	http://dx.doi.org/10.1371/journal.pone.0209973			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682051	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500019
J	Kumagai, G; Wada, K; Kudo, H; Asari, T; Chiba, D; Ota, S; Takeda, O; Koyama, K; Nakaji, S; Ishibashi, Y				Kumagai, Gentaro; Wada, Kanichiro; Kudo, Hitoshi; Asari, Toru; Chiba, Daisuke; Ota, Seiya; Takeda, On; Koyama, Kazushige; Nakaji, Shigeyuki; Ishibashi, Yasuyuki			Associations between cervical disc degeneration and muscle strength in a cross-sectional population-based study	PLOS ONE			English	Article							ROENTGENOGRAPHIC FINDINGS; NECK SYMPTOMS; SPINE; AGE; PREVALENCE; LUMBAR; PAIN	The physical and biochemical factors related to cervical disc degeneration (CDD), which is involved in several spinal disorders, remain uncertain. We investigated associations between CDD and muscle strength in a general Japanese population. We used mid-sagittal-plane MRIs to assess CDD in 344 subjects recruited from participants in our community health-check project, and measured body mass index (BMI),skeletal muscle index (SMI), and muscle strength in the neck, trunk, hands, and legs. CDD was scored based on the prevalence and severity of intravertebral disc degeneration. Spearman correlation coefficients were used to evaluate whether the SMI or muscle-strength values were correlated with the disc degenerative score. Stepwise multiple linear regression analyses were then conducted with the CDD score as the dependent variable, and age, sex, BMI, and muscle strength as independent variables, for each gender. These analyses used the muscle strength parameters that were found to be correlated with the CDD scores in the single correlation analyses. The CDD scores were similar in men and women. Men had significantly more muscle strength in the neck, trunk, hands, and legs. There was a significant negative corelation between the CDD score and the trunk strength in both sexes, handgrip in men, and leg strength in women in the single-variable correlation analysis. Including age and the limb- or trunk-muscle strength comprehensively, multiple linear regression analyses showed that age was the strongest factor that was independently associated with CDD in both sexes, and that the effects were attenuated by limb and trunk muscle strength.	[Kumagai, Gentaro; Wada, Kanichiro; Kudo, Hitoshi; Asari, Toru; Chiba, Daisuke; Ota, Seiya; Takeda, On; Koyama, Kazushige; Ishibashi, Yasuyuki] Hirosaki Univ, Grad Sch Med, Dept Orthopaed Surg, Hirosaki, Aomori, Japan; [Nakaji, Shigeyuki] Hirosaki Univ, Grad Sch Med, Dept Social Med, Hirosaki, Aomori, Japan	Hirosaki University; Hirosaki University	Kumagai, G (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Orthopaed Surg, Hirosaki, Aomori, Japan.	gen722@hirosaki-u.ac.jp		Takeda, On/0000-0001-5212-8813	Ministry of Education, Culture, Sports, Science and Technology of Japan [18200044]; Japanese Society for the Promotion of Science [21500676]; JOA-Subsidized Science Project Research from the Japanese Orthopaedic Association	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JOA-Subsidized Science Project Research from the Japanese Orthopaedic Association	This study was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 18200044), by the Japanese Society for the Promotion of Science (No. 21500676), and by JOA-Subsidized Science Project Research from the Japanese Orthopaedic Association (No.2015-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battie MC, 2009, SPINE J, V9, P47, DOI 10.1016/j.spinee.2008.11.011; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P1178, DOI 10.2106/00004623-199072080-00008; BRAIN WR, 1948, P ROY SOC MED, V41, P509; BRATTBERG G, 1989, PAIN, V37, P215, DOI 10.1016/0304-3959(89)90133-4; Chiba D, 2016, J ORTHOP SCI, V21, P366, DOI 10.1016/j.jos.2016.02.006; Gore DR, 2001, SPINE, V26, P2463, DOI 10.1097/00007632-200111150-00013; GORE DR, 1986, SPINE, V11, P521, DOI 10.1097/00007632-198607000-00003; Hakkaku T, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117735830; Inoue R, 2011, OSTEOARTHR CARTILAGE, V19, P51, DOI 10.1016/j.joca.2010.10.021; Janssen I, 2000, J APPL PHYSIOL, V89, P465, DOI 10.1152/jappl.2000.89.2.465; Kato F, 2012, EUR SPINE J, V21, P1499, DOI 10.1007/s00586-012-2176-4; Kumagai G, 2018, J ORTHOP SCI, V23, P277, DOI 10.1016/j.jos.2017.11.002; Kumagai G, 2014, J ORTHOP SCI, V19, P390, DOI 10.1007/s00776-014-0549-8; Matsumoto M, 1998, J BONE JOINT SURG BR, V80B, P19, DOI 10.1302/0301-620X.80B1.7929; Matsumoto M, 2013, EUR SPINE J, V22, P708, DOI 10.1007/s00586-012-2500-z; Muhle C, 1998, AM J NEURORADIOL, V19, P1763; Nagata K, 2012, SPINE, V37, P1892, DOI 10.1097/BRS.0b013e31825a2619; NURICK S, 1972, BRAIN, V95, P87; Okada E, 2011, EUR SPINE J, V20, P1567, DOI 10.1007/s00586-011-1774-x; Okada E, 2009, SPINE, V34, P706, DOI 10.1097/BRS.0b013e31819c2003; Omair A, 2016, EUR SPINE J, V25, P2, DOI 10.1007/s00586-015-4181-x; Sasaki E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192687; Sun D, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1522-4; Takamiya Y, 2006, J ORTHOP SCI, V11, P235, DOI 10.1007/s00776-006-1005-1; Teichtahl AJ, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1297-z; Teraguchi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147565; Wada K, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2055-1	27	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210802	10.1371/journal.pone.0210802	http://dx.doi.org/10.1371/journal.pone.0210802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682082	Green Submitted, Green Published, gold			2022-12-26	WOS:000457037500063
J	Moon, YJ; Kim, JW; Bang, YS; Lim, YS; Ki, Y; Sang, BH				Moon, Young-Jin; Kim, Jung-Won; Bang, Yun-Sic; Lim, Young Su; Ki, Yumin; Sang, Bo-Hyun			Prediction of all-cause mortality after liver transplantation using left ventricular systolic and diastolic function assessment	PLOS ONE			English	Article							HEART-FAILURE; EUROPEAN-ASSOCIATION; EJECTION FRACTION; AMERICAN-SOCIETY; E/A RATIO; DYSFUNCTION; ECHOCARDIOGRAPHY; RECOMMENDATIONS; IMPACT	Although pretransplant cardiac dysfunction is considered a major predictor of poor outcomes after liver transplantation (LT), the ability of left ventricular (LV) systolic/diastolic function (LVSF/LVDF), together or individually, to predict mortality after LT is poorly characterized. We retrospectively evaluated pretransplant clinical and Doppler echocardiographic data of 839 consecutive LT recipients from 2009 to 2012 aged 18-60 years. The primary endpoint was all-cause mortality at 4 years. The overall survival rate was 91.2%. In multivariate Cox analysis, reduced LV ejection fraction (LVEF, P = 0.014) and decreased transmitral E/A ratio(P = 0.022) remained significant prognosticators. In LVSF analysis, patients with LVEF <= 60% (quartile [Q]1) had higher mortality than those with LVEF>60% (hazard ratio = 1.90, 95% confidence interval = 1.15-3.15, P = 0.012). In LVDF analysis, patients with an E/A ratio<0.9(Q1) had a 2.19-fold higher risk of death (95% confidence interval = 1.11-4.32, P = 0.024) than those with an E/A ratio>1.4(Q4). In combined LVDF and LVSF analysis, patients with an E/A ratio<0.9 and LVEF <= 60% had poorer survival outcomes than patients with an E/A ratio >= 0.9 and LVEF>60% (79.5% versus 93.3%, P = 0.001). Patients with an early mitral inflow velocity/annular velocity (E/e' ratio) >11.5(Q4) and LV stroke volume index (LVSVI)< 33mL/m(2) (Q1) showed worse survival than those with an E/e' ratio. 11.5 and LVSVI. 33mL/m(2) (78.4% versus 92.2%, P = 0.003). A combination of LVSF and LVDF is a better predictor of survival than LVSF or LVDF alone.	[Moon, Young-Jin] Univ Ulsan, Dept Anesthesiol & Pain Med, Lab Cardiovasc Dynam, Asan Med Ctr,Coll Med, Seoul, South Korea; [Kim, Jung-Won; Bang, Yun-Sic; Lim, Young Su; Sang, Bo-Hyun] Catholic Kwandong Univ Korea, Coll Med, Dept Anesthesiol & Pain Med, Int St Marys Hosp, Incheon, South Korea; [Ki, Yumin] CHA Univ, Dept Anesthesiol & Pain Med, CHA Bundang Med Ctr, Seongnam, South Korea	University of Ulsan; Asan Medical Center; Catholic Kwandong University; Pochon Cha University	Sang, BH (corresponding author), Catholic Kwandong Univ Korea, Coll Med, Dept Anesthesiol & Pain Med, Int St Marys Hosp, Incheon, South Korea.	perhaps125@naver.com		Moon, Young-Jin/0000-0003-3719-1691; Sang, Bo-Hyun/0000-0001-6890-4629				Abeles RD, 2007, GUT, V56, P1642; Bianchi G, 2008, LIVER TRANSPLANT, V14, P1648, DOI 10.1002/lt.21588; Choi Jin-Oh, 2015, J Cardiovasc Ultrasound, V23, P158, DOI 10.4250/jcu.2015.23.3.158; Dowsley TF, 2012, TRANSPLANTATION, V94, P646, DOI 10.1097/TP.0b013e31825f0f97; Flu WJ, 2010, ANESTHESIOLOGY, V112, P1316, DOI 10.1097/ALN.0b013e3181da89ca; Garg A, 2013, JACC-CARDIOVASC IMAG, V6, P105, DOI 10.1016/j.jcmg.2012.11.002; Higashi M, 2013, ACTA ANAESTH SCAND, V57, P1154, DOI 10.1111/aas.12168; Josefsson A, 2012, LIVER INT, V32, P1262, DOI 10.1111/j.1478-3231.2012.02818.x; Kong YG, 2015, BRIT J ANAESTH, V114, P437, DOI 10.1093/bja/aeu384; Kuwaki H, 2014, JACC-CARDIOVASC IMAG, V7, P749, DOI 10.1016/j.jcmg.2014.05.002; Landesberg G, 2012, EUR HEART J, V33, P895, DOI 10.1093/eurheartj/ehr351; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lavi R, 2007, ANESTHESIOLOGY, V107, P1018, DOI 10.1097/01.anes.0000287613.49204.94; Licker M, 2010, CRIT CARE, V14, DOI 10.1186/cc9040; Mahadevan G, 2008, HEART, V94, P426, DOI 10.1136/hrt.2007.123877; Mittal C, 2014, DIGEST DIS SCI, V59, P674, DOI 10.1007/s10620-013-2955-8; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Qureshi W, 2013, LIVER TRANSPLANT, V19, P701, DOI 10.1002/lt.23654; Rabie RN, 2009, AM J GASTROENTEROL, V104, P2458, DOI 10.1038/ajg.2009.321; Raevens S, 2014, ACTA CARDIOL, V69, P273, DOI 10.1080/AC.69.3.3027830; Raval Z, 2011, J AM COLL CARDIOL, V58, P223, DOI 10.1016/j.jacc.2011.03.026; Ruiz-del-Arbol L, 2013, HEPATOLOGY, V58, P1732, DOI 10.1002/hep.26509; SPIRITO P, 1988, BRIT HEART J, V59, P672; Tajik AJ, 2014, JACC-CARDIOVASC IMAG, V7, P759, DOI 10.1016/j.jcmg.2014.05.003; Therapondos G, 2004, LIVER TRANSPLANT, V10, P1441, DOI 10.1002/lt.20298; Unzek S, 2011, JACC-CARDIOVASC IMAG, V4, P460, DOI 10.1016/j.jcmg.2011.01.016; VanWagner LB, 2014, LIVER TRANSPLANT, V20, P1306, DOI 10.1002/lt.23950; Wiese S, 2014, NAT REV GASTRO HEPAT, V11, P177, DOI 10.1038/nrgastro.2013.210; Yip GW, 2002, CLIN SCI, V102, P515, DOI 10.1042/CS20010196; Yu CM, 2007, J AM COLL CARDIOL, V49, P1903, DOI 10.1016/j.jacc.2007.01.078; Yuksel V, 2015, J CARDIOVASC SURG, V56, P655; Zambruni A, 2006, J HEPATOL, V44, P994, DOI 10.1016/j.jhep.2005.10.034; Zardi EM, 2010, J AM COLL CARDIOL, V56, P539, DOI 10.1016/j.jacc.2009.12.075	35	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0209100	10.1371/journal.pone.0209100	http://dx.doi.org/10.1371/journal.pone.0209100			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682022	Green Submitted, Green Published, gold			2022-12-26	WOS:000457037500013
J	Theuerkauf, SJ; Eggleston, DB; Puckett, BJ				Theuerkauf, Seth J.; Eggleston, David B.; Puckett, Brandon J.			Integrating ecosystem services considerations within a GIS-based habitat suitability index for oyster restoration	PLOS ONE			English	Article							CRASSOSTREA-VIRGINICA; NORTH-CAROLINA; CHLOROPHYLL-A; NEUSE RIVER; ESTUARY; MODEL; HYPOXIA; GROWTH; CONSEQUENCES; BIODIVERSITY	Geospatial habitat suitability index (HSI) models have emerged as powerful tools that integrate pertinent spatial information to guide habitat restoration efforts, but have rarely accounted for spatial variation in ecosystem service provision. In this study, we utilized satellite-derived chlorophyll a concentrations for Pamlico Sound, North Carolina, USA in conjunction with data on water flow velocities and dissolved oxygen concentrations to identify potential restoration locations that would maximize the oyster reef-associated ecosystem service of water filtration. We integrated these novel factors associated with oyster water filtration ecosystem services within an existing, 'Metapopulation Persistence' focused GIS-based, HSI model containing biophysical (e.g., salinity, oyster larval connectivity) and logistical(e.g., distance to nearest restoration material stockpile site) factors to identify suitable locations for oyster restoration that maximize long-term persistence of restored oyster populations and water filtration ecosystem service provision. Furthermore, we compared the 'Water Filtration' optimized HSI with the HSI optimized for 'Metapopulation Persistence,' as well as a hybrid model that optimized for both water filtration and metapopulation persistence. Optimal restoration locations (i.e., locations corresponding to the top 1% of suitability scores) were identified that were consistent among the three HSI scenarios (i.e., "win-win" locations), as well as optimal locations unique to a given HSI scenario (i.e., "tradeoff" locations). The modeling framework utilized in this study can provide guidance to restoration practitioners to maximize the cost-efficiency and ecosystem services value of habitat restoration efforts. Furthermore, the functional relationships between oyster water filtration and chlorophyll a concentrations, water flow velocities, and dissolved oxygen applied in this study can guide field- and lab-testing of hypotheses related to optimal conditions for oyster reef restoration to maximize water quality enhancement benefits.	[Theuerkauf, Seth J.; Eggleston, David B.; Puckett, Brandon J.] North Carolina State Univ, Dept Marine Earth & Atmospher Sci, Ctr Marine Sci & Technol, Morehead City, NC 28557 USA; [Puckett, Brandon J.] North Carolina Coastal Reserve & Natl Estuarine R, Beaufort, NC USA	University of North Carolina; North Carolina State University	Theuerkauf, SJ (corresponding author), North Carolina State Univ, Dept Marine Earth & Atmospher Sci, Ctr Marine Sci & Technol, Morehead City, NC 28557 USA.	sjtheuer@ncsu.edu	Theuerkauf, Seth/AAB-3290-2020	Theuerkauf, Seth/0000-0003-2556-5174; Puckett, Brandon/0000-0001-9615-6242; Eggleston, David/0000-0001-7840-2665	North Carolina Sea Grant [R12-HCE-2]; North Carolina Space Grant Fellowship; National Defense Science and Engineering Graduate Fellowship - Department of Defense, Air Force Office of Scientific Research [FA9550-11-C-0028]; National Defense Science and Engineering Graduate Fellowship - American Society for Engineering Education [32 CFR 168a]; North Carolina Coastal Conservation Association Scholarship; Beneath the Sea Foundation Scholarship; National Science Foundation, Division of Ocean Sciences [OCE-1155609]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R13ES027302] Funding Source: NIH RePORTER	North Carolina Sea Grant; North Carolina Space Grant Fellowship; National Defense Science and Engineering Graduate Fellowship - Department of Defense, Air Force Office of Scientific Research; National Defense Science and Engineering Graduate Fellowship - American Society for Engineering Education; North Carolina Coastal Conservation Association Scholarship; Beneath the Sea Foundation Scholarship; National Science Foundation, Division of Ocean Sciences(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding for the project and completion of the manuscript was provided by a North Carolina Sea Grant and North Carolina Space Grant Fellowship, a National Defense Science and Engineering Graduate Fellowship (contract FA9550-11-C-0028 awarded by the Department of Defense, Air Force Office of Scientific Research, 32 CFR 168a, American Society for Engineering Education), a North Carolina Coastal Conservation Association Scholarship, and a Beneath the Sea Foundation Scholarship to S. Theuerkauf, as well as North Carolina Sea Grant (R12-HCE-2) and the National Science Foundation, Division of Ocean Sciences (OCE-1155609) to D. Eggleston. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes TK, 2007, J SHELLFISH RES, V26, P949, DOI 10.2983/0730-8000(2007)26[949:AHSIMF]2.0.CO;2; Battista T, 1999, THESIS; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Bernard FR, 1983, PHYSL MARICULTURE SO, V63; Brooks RP, 1997, WILDLIFE SOC B, V25, P163; BROWN J R, 1988, Aquaculture and Fisheries Management, V19, P109, DOI 10.1111/j.1365-2109.1988.tb00414.x; Bullock JM, 2011, TRENDS ECOL EVOL, V26, P541, DOI 10.1016/j.tree.2011.06.011; Burkholder J, 2004, P NATL ACAD SCI USA, V101, P9291, DOI 10.1073/pnas.0306842101; Cake E.W, 1983, HABITAT SUITABILITY; CERCO CF, 1995, J ENVIRON ENG-ASCE, V121, P549, DOI 10.1061/(ASCE)0733-9372(1995)121:8(549); Cerco CF, 2005, ASSESSING 10 FOLD IN; Cho Y, 2012, OCEAN COAST MANAGE, V56, P10, DOI 10.1016/j.ocecoaman.2011.10.009; Cloern JE, 1982, MARINE ECOLOGY PROGR, V9, P192; Coen LD, 2000, ECOL ENG, V15, P323, DOI 10.1016/S0925-8574(00)00084-7; Conomos T. J., 1979, SAN FRANCISCO BAY UR, P47; Crossman ND, 2013, ECOSYST SERV, V4, P4, DOI 10.1016/j.ecoser.2013.02.001; DAME RF, 1989, MAR ECOL PROG SER, V54, P249, DOI 10.3354/meps054249; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Epperly S. P, 1986, NMFSSEFC175 NAT OC A; FALKOWSKI P, 1985, J PLANKTON RES, V7, P715, DOI 10.1093/plankt/7.5.715; Grizzle RE, 2008, ESTUAR COAST, V31, P1208, DOI 10.1007/s12237-008-9098-8; Grizzle RE, 2001, DEV AQUAC FISH SCI, V31, P305; Haase AT, 2012, ESTUAR COAST SHELF S, V101, P33, DOI 10.1016/j.ecss.2012.02.011; Harsh Deborah A., 1999, P251; Housego RM, 2016, ESTUAR COAST, V39, P495, DOI 10.1007/s12237-015-9998-3; Keith DJ, 2014, REMOTE SENS ENVIRON, V153, P61, DOI 10.1016/j.rse.2014.05.019; Kellogg ML, 2014, ESTUAR COAST SHELF S, V151, P156, DOI 10.1016/j.ecss.2014.09.025; Kellogg ML, 2013, MAR ECOL PROG SER, V480, P1, DOI 10.3354/meps10331; Kennedy V.S., 1996, E OYSTER CRASSOSTREA; Koch EW, 2009, FRONT ECOL ENVIRON, V7, P29, DOI 10.1890/080126; KORRINGA P., 1952, QUART REV BIOL, V27, P266, DOI 10.1086/399023; Lenihan HS, 1998, ECOL APPL, V8, P128, DOI 10.2307/2641316; Lenihan HS, 1996, LIMNOL OCEANOGR, V41, P1359, DOI 10.4319/lo.1996.41.6.1359; Luettich R., 1992, CERCTRDRP926; Luettich RA, 2002, CONT SHELF RES, V22, P1669, DOI 10.1016/S0278-4343(02)00031-6; Paerl HW, 1999, MAR ECOL PROG SER, V186, P307, DOI 10.3354/meps186307; Paerl HW, 1998, MAR ECOL PROG SER, V166, P17, DOI 10.3354/meps166017; Palmer MA, 2009, SCIENCE, V325, P575, DOI 10.1126/science.1172976; Peters JW, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00326; Pietrafesa Leonard J, 1986, UNC SEA GRANT PUBLIC; Puckett BJ, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00076; Puckett BJ, 2014, FISH OCEANOGR, V23, P342, DOI 10.1111/fog.12067; Puckett BJ, 2012, MAR COAST FISH, V4, P605, DOI 10.1080/19425120.2012.713892; R Core Team, 2021, R LANG ENV STAT; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Reyns NB, 2006, LIMNOL OCEANOGR, V51, P1982, DOI 10.4319/lo.2006.51.5.1982; ROELOFS E. W., 1953, BULL MARINE SCI GULF AND CARIBBEAN, V3, P181; Roloff GJ, 1999, WILDLIFE SOC B, V27, P973; Sokoletsky LG, 2011, REMOTE SENS-BASEL, V3, P684, DOI 10.3390/rs3040684; SONIAT TM, 1988, ESTUARIES, V11, P87, DOI 10.2307/1351995; Swannack TM, 2014, J SHELLFISH RES, V33, P395, DOI 10.2983/035.033.0208; Theuerkauf SJ, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00064; Theuerkauf SJ, 2015, J SHELLFISH RES, V34, P241, DOI 10.2983/035.034.0205; Wildish D., 1997, BENTHIC SUSPENSION F; WilsonOrmond EA, 1997, MAR ECOL-P S Z N I, V18, P1, DOI 10.1111/j.1439-0485.1997.tb00424.x	55	16	16	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210936	10.1371/journal.pone.0210936	http://dx.doi.org/10.1371/journal.pone.0210936			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682064	gold, Green Submitted, Green Published			2022-12-26	WOS:000457037500075
J	Houle, SKD; Eurich, DT				Houle, Sherilyn K. D.; Eurich, Dean T.			Completion of multiple-dose travel vaccine series and the availability of pharmacist immunizers: A retrospective analysis of administrative data in Alberta, Canada	PLOS ONE			English	Article							INTERNATIONAL TRAVELERS; PREVENTABLE DISEASES; PATIENT ACCESS; CHILDREN	Pharmacists in a number of countries are being trained in the administration of injections with the aim of improving access and adherence to vaccinations. However, little is known about population-level adherence to multiple-dose travel vaccines, and whether the availability of pharmacist immunizers is associated with adherence. Health administrative data from Alberta, Canada, from April 2008 to May 2017 identified adults dispensed at least one vaccine for hepatitis A, hepatitis B, Japanese encephalitis, or rabies. Individuals were coded as completers or non-completers of the vaccine series based on the number of doses dispensed over a time period comprising the duration of the standard series plus 6 months to account for late doses. The association between the proportion of Alberta pharmacists with injection authorization (according to pharmacist registration data) and completion of vaccine series was assessed using linear regression. Over the study period, 24,164 patients initiated a vaccine series for hepatitis A monovalent, 195,480 for hepatitis B monovalent, 169,802 for combined hepatitis A&B, 1,726 for Japanese encephalitis, and 1,908 for rabies. There were fewer than 5 individuals receiving Japanese encephalitis vaccine per year from 2008-2010 or rabies vaccine from 2008-2009. While statistically significant positive associations were seen across all vaccines except for Japanese encephalitis, the magnitude of these associations was small. Each 1% increase in the proportion of injections-authorized pharmacists saw a corresponding increase in the proportion of individuals with completed vaccine series by 0.31% for hepatitis A monovalent, 0.19% for hepatitis B monovalent, 0.22% for combined hepatitis A&B, and 0.21% for rabies. This may suggest that challenges remain with implementing reminder systems to ensure adherence among travellers. Strategies to develop or improve patient and clinician reminder systems in pharmacies for travel vaccines should therefore be explored.	[Houle, Sherilyn K. D.] Univ Waterloo, Sch Pharm, Waterloo, ON, Canada; [Eurich, Dean T.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada	University of Waterloo; University of Alberta	Houle, SKD (corresponding author), Univ Waterloo, Sch Pharm, Waterloo, ON, Canada.	sherilyn.houle@uwaterloo.ca			International Society for Travel Medicine; 2016/2017 International Society of Travel Medicine Research Award	International Society for Travel Medicine; 2016/2017 International Society of Travel Medicine Research Award	Both authors received funding for this study from the International Society for Travel Medicine Research Award (2016/2017 cycle, http://www.istm.org/researchgrantsactivities).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a 2016/2017 International Society of Travel Medicine Research Award. This study is based in part on data provided by Alberta Health. The interpretation and conclusions contained herein are those of the researchers and do not necessarily represent the views of the Government of Alberta. Neither the Government nor Alberta Health express any opinion in relation to this study.	Boggild AK, 2010, VACCINE, V28, P7389, DOI 10.1016/j.vaccine.2010.09.009; Centers for Disease Control (CDC), 2017, CDC YELL BOOK 2020 H; D'Alessandro A, 2018, HUM VACC IMMUNOTHER, V14, P1573, DOI 10.1080/21645515.2018.1483809; Eilers R, 2014, PREV MED, V69, P224, DOI 10.1016/j.ypmed.2014.10.017; Foong EAL, 2017, CAN PHARM J, V150, P387, DOI 10.1177/1715163517732089; Gai YW, 2017, J AM PHARM ASSOC, V57, P474, DOI 10.1016/j.japh.2017.03.011; Gautret P, 2012, CLIN MICROBIOL INFEC, V18, P77, DOI 10.1111/j.1469-0691.2012.03940.x; Goad JA, 2013, ANN FAM MED, V11, P429, DOI 10.1370/afm.1542; Grabenstein JD, 1998, VACCINE, V16, P1705, DOI 10.1016/S0264-410X(98)00131-5; Heywood AE, 2016, J TRAVEL MED, V24; Houle SKD, 2019, J AM PHARM ASSOC, V59, P89, DOI [10.1016/j.japh.2018.07.002, 10.1177/1715163518811065]; Houle Sherilyn K D, 2013, Can Pharm J (Ott), V146, P353, DOI 10.1177/1715163513506369; International Pharmaceutical Federation (FIP), 2016, AN OVERVIEW OF CURRE; Isenor JE, 2016, VACCINE, V34, P5708, DOI 10.1016/j.vaccine.2016.08.085; Jacob L, 2017, CLIN MICROBIOL INFEC, V23, P460, DOI 10.1016/j.cmi.2017.01.012; Kennedy A, 2011, PEDIATRICS, V127, pS92, DOI 10.1542/peds.2010-1722N; Lane S, 2018, VACCINE, V36, P3861, DOI 10.1016/j.vaccine.2018.03.063; Nelson JC, 2009, AM J PUBLIC HEALTH, V99, pS389, DOI 10.2105/AJPH.2008.151332; Papastergiou John, 2014, Can Pharm J (Ott), V147, P359, DOI 10.1177/1715163514552557; del Corro MR, 2009, HUM VACCINES, V5, P98, DOI 10.4161/hv.5.2.6588; Shah PD, 2018, CANCER EPIDEM BIOMAR, V27, P970, DOI 10.1158/1055-9965.EPI-18-0380; Statistics Canada, 2017, ALB CAN TABL CENS PR; Steffen R, 2015, J TRAVEL MED, V22, P1, DOI 10.1111/jtm.12171; Wu SS, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017459	24	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211006	10.1371/journal.pone.0211006	http://dx.doi.org/10.1371/journal.pone.0211006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673765	gold, Green Published, Green Submitted			2022-12-26	WOS:000456442800065
J	Adedimeji, A; Sinayobye, JD; Asiimwe-Kateera, B; Chaudhry, J; Buzinge, L; Gitembagara, A; Murenzi, G; Mugenzi, P; Patel, VV; Castle, PE; Mutesa, L; Palefsky, J; Anastos, KM				Adedimeji, Adebola; Sinayobye, Jean d'Amour; Asiimwe-Kateera, Brenda; Chaudhry, Junaid; Buzinge, Lydia; Gitembagara, Andre; Murenzi, Gad; Mugenzi, Pacifique; Patel, Viraj V.; Castle, Philip E.; Mutesa, Leon; Palefsky, Joel; Anastos, Kathryn M.			Social contexts as mediator of risk behaviors in Rwandan men who have sex with men (MSM): Implications for HIV and STI transmission	PLOS ONE			English	Article							AFRICAN-AMERICAN MEN; SAN-FRANCISCO; BLACK-MEN; SUPPORT; WOMEN; PARTNERSHIPS; PREVALENCE; PREVENTION; INFECTION; INSIGHTS	Introduction Men who have sex with men (MSM) are disproportionately impacted by HIV/AIDS resulting from risky sexual behaviors. Social and contextual factors are known to mediate risk behaviors, but there is limited information about the prevalence of risky sexual practices of Rwandan MSM and the concomitant socio-contextual determinants making it difficult to assess implications for preventing HIV/STI transmission in this key population. Methods Using exploratory qualitative design, we obtained socio-contextual information regarding prevalence of risky sexual behavior and assessed implications for HIV/STIs transmission and preventive measures taken by MSM to improve sexual health and wellbeing. Thirty MSM were recruited to participate in in-depth interviews using respondent-driven sampling from LGBT associations in Kigali. Data were analyzed using standard qualitative data analysis procedures. Results Respondents' were between 18-40 years old; all completed primary education and are mostly low-socioeconomic status. Risky sexual practices were common, but differed by peculiar individual and contextual factors. Older MSM often reported occasional sexual relations with women to avoid suspicion and social stigma. Younger MSM's risky sexual practices are mostly transactional and mediated by the need for social acceptance and support. Knowledge of STIs was poor, but prevalence, especially of HPV was high. The options for improving sexual wellbeing are limited and mostly clandestine. Conclusion Risky sexual behavior of Rwandan MSM has major implications for HIV/STI transmission. An environment of intense social stigma and social isolation makes it difficult to obtain information or services to improve sexual health. Effective interventions that address individual and contextual determinants of risk and access to health services are urgently needed to limit the consequence of MSM as a bridge for HIV transmission to the general population.	[Adedimeji, Adebola; Chaudhry, Junaid; Castle, Philip E.; Anastos, Kathryn M.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Sinayobye, Jean d'Amour; Buzinge, Lydia; Murenzi, Gad; Mugenzi, Pacifique] Rwanda Mil Hosp, Div Res & Med Educ, Kanombe, Kigali, Rwanda; [Asiimwe-Kateera, Brenda] AIDS Healthcare Fdn Rwanda, Kigali, Rwanda; [Gitembagara, Andre] Rwanda Nurses & Midwives Union, Kigali, Rwanda; [Patel, Viraj V.] Albert Einstein Coll Med, Montefiore Hlth Syst, Div Gen Internal Med, Bronx, NY 10467 USA; [Mutesa, Leon] Univ Rwanda, Coll Hlth Sci, Kigali, Rwanda; [Palefsky, Joel] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Rwanda; University of California System; University of California San Francisco	Adedimeji, A (corresponding author), Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA.	adebola.adedimeji@einstein.yu.edu	Castle, Philip/AAP-6395-2020	Castle, Philip/0000-0003-1082-6554; Murenzi, Gad/0000-0002-5513-5522; Asiimwe Kateera, Brenda/0000-0001-6134-1042	National Institutes of Health/National Cancer Institute [1 U54 CA 190163-01]; NATIONAL CANCER INSTITUTE [U54CA190163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI096299, P30AI124414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH102118] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding for the study was received from the National Institutes of Health/National Cancer Institute (1 U54 CA 190163-01) for the HIV malignancies research capacity building program.	Baral S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004997; Baxter C, 2016, AJAR-AFR J AIDS RES, V15, P109, DOI 10.2989/16085906.2016.1196224; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Chapman J, 2011, AIDS CARE, V23, P449, DOI 10.1080/09540121.2010.507758; Cowan FM, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.7.21101; Fernando D, 2017, PREV MED, V105, P368, DOI 10.1016/j.ypmed.2017.06.013; Garcia J, 2016, HEALTH EDUC BEHAV, V43, P217, DOI 10.1177/1090198115599398; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Lapinski MK, 2010, J HOMOSEXUAL, V57, P610, DOI 10.1080/00918361003712020; Levy ME, 2016, AIDS CARE, V28, P660, DOI 10.1080/09540121.2015.1120266; Maksut JL, 2016, J BEHAV MED, V39, P665, DOI 10.1007/s10865-016-9734-x; Mantell JE, 2016, GLOB PUBLIC HEALTH, V11, P953, DOI 10.1080/17441692.2016.1142592; Mayer KH, 2016, J ACQUIR IMMUNE D S3, V72; Muraguri N., 2012, J SAHARA J J SOCIAL, V9; Pando MA, 2013, AIDS BEHAV, V17, P1305, DOI 10.1007/s10461-012-0404-x; Parker CM, 2017, CULT HEALTH SEX, V19, P323, DOI 10.1080/13691058.2016.1216604; Phillips G, 2016, LGBT HEALTH, V3, P225, DOI 10.1089/lgbt.2015.0122; Pope Z, 2017, AIDS CARE, V29, P782, DOI 10.1080/09540121.2016.1255706; Prejean J., 2008, Morbidity and Mortality Weekly Report, V57, P985; Provalis Research, QDA MIN; Raymond HF, 2013, JAIDS-J ACQ IMM DEF, V62, P584, DOI 10.1097/QAI.0b013e318285febf; Raymond HF, 2009, AIDS BEHAV, V13, P630, DOI 10.1007/s10461-009-9574-6; Republic of Rwanda, COUNTR OP PLAN COP 2; Republic of Rwanda Ministry of Health, RWAND HIV AIDS NAT S; Sathane I, 2016, AIDS BEHAV, V20, P2296, DOI 10.1007/s10461-016-1390-1; Scheer S, 2008, SEX TRANSM INFECT, V84, P493, DOI 10.1136/sti.2008.031823; Schneider John A, 2013, Am J Public Health, V103, pe28, DOI 10.2105/AJPH.2012.301003; Smith AD, 2015, AIDS, V29, pS201, DOI 10.1097/QAD.0000000000000889; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Stahlman S, 2016, INT J SOC PSYCHIATR, V62, P522, DOI 10.1177/0020764016663969; Stahlman S, 2015, REPROD HEALTH MATTER, V23, P127, DOI 10.1016/j.rhm.2015.11.017; Stall R, 2009, AIDS BEHAV, V13, P615, DOI 10.1007/s10461-008-9509-7; Storholm ED, 2017, PREV SCI, V18, P737, DOI 10.1007/s11121-017-0799-8; Suominen T, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2203-5; The Demographic and Health Survey Program/ ICF International, RWAND DEM HLTH SURV; Truong HHM, 2015, SEX TRANSM INFECT, V91, P220, DOI 10.1136/sextrans-2014-051660; van Griensven F, 2009, J ACQUIR IMMUNE DEFI; Wohl AR, 2011, AIDS BEHAV, V15, P1098, DOI 10.1007/s10461-010-9833-6; Yang HT, 2010, SEX TRANSM DIS, V37, P208, DOI 10.1097/OLQ.0b013e3181d13c59	39	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0211099	10.1371/journal.pone.0211099	http://dx.doi.org/10.1371/journal.pone.0211099			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8XI	30657797	gold, Green Submitted, Green Published			2022-12-26	WOS:000456017000030
J	Wu, PX; Wu, FM; Yan, S; Liu, C; Shen, ZJ; Xiong, XF; Li, Z; Zhang, QW; Liu, XX				Wu, Pengxiang; Wu, Fengming; Yan, Shuo; Liu, Chang; Shen, Zhongjian; Xiong, Xiaofei; Li, Zhen; Zhang, Qingwen; Liu, Xiaoxia			Developmental cost of leg-regenerated Coccinella septempunctata (Coleoptera: Coccinellidae)	PLOS ONE			English	Article							IMAGINAL DISCS; LIMB REGENERATION; ECDYSTEROID TITERS; INDUCED DELAY; DROSOPHILA; LARVAL; GROWTH; MUTANTS; CELL; PUPARIATION	As larval cannibalism is common under intensive rearing conditions, leg regeneration can help ladybugs adapt to the competitive environment, but whether the leg regeneration leads to side effects on development remains unclear. To analyze the potentially developmental cost of leg regeneration, the developmental period and weight of leg-regenerated Coccinella septempunctata were studied in the laboratory. The results showed that, when the time intervals between the emergency of 4th-instar larva and leg amputation increased, the developmental period of leg-regenerated 4th-instar larvae was gradually prolonged. Significantly developmental delay were also examined at prepupal and pupal stages, and various timings of leg amputation affected the periods of leg-regenerated prepupae/pupae similarly. After the leg was amputated at different larval instars, the developmental delay only occurred at the larval instar when the leg was amputated, whereas other larval instars failed to be extended, and the developmental periods of leg-regenerated prepupae/pupae were affected similarly by the instars of leg amputation. Developmental delays possibly resulted in more consumption by leg-regenerated larvae, and then weight gains at prepupal/pupal stages, but different larval instars of leg amputation affected the weight gain similarly. Both the developmental delay (at 4th-instar larval, prepupal and pupal stages) and weight gain (at pupal and adult stages) in complete/bilateral amputation were longer or greater than those in half/unilateral amputation. However, the thoracic locations of leg amputation impacted the developmental delay and weight gain similarly. Our study indicates that although leg regeneration triggers the developmental cost decreasing the competitive superiority or agility, C. septempunctata larvae still choose to completely regenerate the leg to adapt to complex environments. Thus, in order to remain competitive at adult stages, leg-impaired larvae may make an investment tradeoff between leg regeneration and developmental cost.	[Wu, Pengxiang; Wu, Fengming; Yan, Shuo; Shen, Zhongjian; Xiong, Xiaofei; Li, Zhen; Zhang, Qingwen; Liu, Xiaoxia] China Agr Univ, Dept Entomol, Beijing, Peoples R China; [Liu, Chang] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA; [Wu, Fengming] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China; [Wu, Fengming] Univ Chinese Acad Sci, Beijing, Peoples R China	China Agricultural University; State University System of Florida; University of Florida; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, XX (corresponding author), China Agr Univ, Dept Entomol, Beijing, Peoples R China.	liuxiaoxia611@cau.edu.cn			National Key Research and Development program of China [2017YFD0201900]	National Key Research and Development program of China	This study was funded by the National Key Research and Development program of China (2017YFD0201900 to XL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRES AJ, 1992, DEVELOPMENT, V116, P865; Atli E, 2006, INT J RADIAT BIOL, V82, P435, DOI 10.1080/09553000600798849; BODENSTEIN D, 1957, J EXP ZOOL, V136, P89, DOI 10.1002/jez.1401360107; BOHN H, 1974, J EMBRYOL EXP MORPH, V32, P81; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; BOURGIN RC, 1956, RADIAT RES, V5, P657, DOI 10.2307/3570585; Brindley H, 1897, ZOOL SOC P, P907, DOI [10.1111/j.1096-3642.1898.tb01392.x, DOI 10.1111/J.1096-3642.1898.TB01392.X]; BRYANT PJ, 1971, DEV BIOL, V26, P606, DOI 10.1016/0012-1606(71)90146-1; BRYANT PJ, 1971, DEV BIOL, V24, P233, DOI 10.1016/0012-1606(71)90097-2; Bulliere D, 1985, REGENERATION COMPREH, P371; Chen Shuchun, 1999, Acta Entomologica Sinica, V42, P159; Colombani J, 2012, SCIENCE, V336, P582, DOI 10.1126/science.1216689; DEWES E, 1973, ROUX ARCH DEV BIOL, V172, P349, DOI 10.1007/BF00577885; DEWES E, 1975, ROUX ARCH DEV BIOL, V178, P167, DOI 10.1007/BF00848395; Emmel VE, 1907, SCIENCE, V26, P83, DOI 10.1126/science.26.655.83; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; Frasnelli E, 2012, NEUROSCI BIOBEHAV R, V36, P1273, DOI 10.1016/j.neubiorev.2012.02.006; French V, 1976, DEV GENES EVOL, V179, P57, DOI [10.1007/BF00857640, DOI 10.1007/BF00857640]; Garelli A, 2012, SCIENCE, V336, P579, DOI 10.1126/science.1216735; GATEFF E, 1974, ROUX ARCH DEV BIOL, V176, P23, DOI 10.1007/BF00577830; GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525; Hackney JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049105; Hadorn E, 1937, P NATL ACAD SCI USA, V23, P478, DOI 10.1073/pnas.23.9.478; Halme A, 2010, CURR BIOL, V20, P458, DOI 10.1016/j.cub.2010.01.038; Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295; Johnson SA, 1999, ANIM BEHAV, V57, P957, DOI 10.1006/anbe.1998.1058; KISS I, 1980, J INSECT PHYSIOL, V26, P391, DOI 10.1016/0022-1910(80)90010-4; KNOBLOCH CA, 1988, J INSECT PHYSIOL, V34, P507, DOI 10.1016/0022-1910(88)90192-8; Kramer Jamie M, 2003, BMC Dev Biol, V3, P5, DOI 10.1186/1471-213X-3-5; Kumar A, 2007, CR BIOL, V330, P485, DOI 10.1016/j.crvi.2007.01.006; KUNKEL JG, 1977, BIOL BULL, V153, P145, DOI 10.2307/1540698; LAKES R, 1989, J EXP ZOOL, V250, P176, DOI 10.1002/jez.1402500209; Lee AK, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-20; Li Hua, 2007, Chinese Bulletin of Entomology, V44, P419; MADHAVAN K, 1969, BIOL BULL-US, V137, P321, DOI 10.2307/1540104; Maginnis TL, 2006, BEHAV ECOL, V17, P857, DOI 10.1093/beheco/arl010; MALA J, 1987, ARCH INSECT BIOCHEM, V4, P113, DOI 10.1002/arch.940040205; MALEVILLE A, 1981, J INSECT PHYSIOL, V27, P35, DOI 10.1016/0022-1910(81)90029-9; MARKS EP, 1970, SCIENCE, V167, P61, DOI 10.1126/science.167.3914.61; Marsh JL, 1999, SEMIN CELL DEV BIOL, V10, P365, DOI 10.1006/scdb.1999.0323; MARTIN P, 1977, DEV BIOL, V55, P213, DOI 10.1016/0012-1606(77)90168-3; O'FARRELL A. F., 1956, AUSTRALIAN JOUR BIOL SCI, V9, P406; OFARRELL AF, 1954, AUST J BIOL SCI, V7, P525, DOI 10.1071/BI9540525; OFARRELL AF, 1953, AUST J BIOL SCI, V6, P485, DOI 10.1071/BI9530485; PARVIN DE, 1968, ANN ENTOMOL SOC AM, V61, P784, DOI 10.1093/aesa/61.3.784; Pohley H, 1965, REGENERATION ANIMALS, P324; Pohley J, 1959, DEV GENES EVOL, V151, P323; POODRY CA, 1990, ROUX ARCH DEV BIOL, V199, P219, DOI 10.1007/BF01682081; RAHN P, 1972, ROUX ARCH DEV BIOL, V170, P48, DOI 10.1007/BF00575521; RIDDIFORD LM, 1993, AM ZOOL, V33, P340; Saxena S, 2016, J ASIA-PAC ENTOMOL, V19, P829, DOI 10.1016/j.aspen.2016.07.012; SEHNAL F, 1993, J INSECT PHYSIOL, V39, P1051, DOI 10.1016/0022-1910(93)90129-F; Shah MV, 2011, MECH DEVELOP, V128, P342, DOI 10.1016/j.mod.2011.07.001; SHAW VK, 1974, J INSECT PHYSIOL, V20, P1849, DOI 10.1016/0022-1910(74)90214-5; SHEARN A, 1971, P NATL ACAD SCI USA, V68, P2594, DOI 10.1073/pnas.68.10.2594; Shi W, 2003, GENETICS, V165, P1869; Shingleton AW, 2005, PLOS BIOL, V3, P1607, DOI 10.1371/journal.pbio.0030289; Shock BC, 2009, J CRUSTACEAN BIOL, V29, P293, DOI 10.1651/08-2990.1; SIMPSON P, 1980, J EMBRYOL EXP MORPH, V57, P155; SIMPSON P, 1975, ROUX ARCH DEV BIOL, V178, P247, DOI 10.1007/BF00848432; Smith-Bolton RK, 2009, DEV CELL, V16, P797, DOI 10.1016/j.devcel.2009.04.015; STEVENS ME, 1986, GENETICS, V112, P217; STEWART M, 1972, DEV BIOL, V27, P71, DOI 10.1016/0012-1606(72)90113-3; Stieper BC, 2008, DEV BIOL, V321, P18, DOI 10.1016/j.ydbio.2008.05.556; STOCK A, 1954, AUST J BIOL SCI, V7, P302, DOI 10.1071/BI9540302; SZABAD J, 1982, DEV BIOL, V93, P240, DOI 10.1016/0012-1606(82)90256-1; Tan LF, 2013, B INSECTOL, V66, P173; Tan Liang-Fei, 2004, Acta Entomologica Sinica, V47, P719; TANAKA A, 1987, GROWTH, V51, P282; TRUBY PR, 1983, J EMBRYOL EXP MORPH, V75, P151; VILLEE CA, 1946, J EXP ZOOL, V101, P261, DOI 10.1002/jez.1401010206; WADDINGT.CH, 1969, NATURE, V221, P933, DOI 10.1038/221933a0; Wang S, 2015, B ENTOMOL RES, V105, P245, DOI 10.1017/S0007485315000036; Wolpert L, 2011, J THEOR BIOL, V269, P359, DOI 10.1016/j.jtbi.2010.10.034; WOODS DF, 1989, DEV BIOL, V134, P222, DOI 10.1016/0012-1606(89)90092-4; Worley MI, 2012, ANNU REV GENET, V46, P289, DOI 10.1146/annurev-genet-110711-155637; Wu PX, 2015, FLA ENTOMOL, V98, P193, DOI 10.1653/024.098.0133; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608; Yi M., 2002, DEV BIOL	79	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210615	10.1371/journal.pone.0210615	http://dx.doi.org/10.1371/journal.pone.0210615			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657777	gold, Green Published, Green Submitted			2022-12-26	WOS:000456017000013
J	Ayre, J; Bonner, C; Cvejic, E; McCaffery, K				Ayre, Julie; Bonner, Carissa; Cvejic, Erin; McCaffery, Kirsten			Randomized trial of planning tools to reduce unhealthy snacking: Implications for health literacy	PLOS ONE			English	Article							BRIEF PSYCHOLOGICAL INTERVENTION; PHYSICAL-ACTIVITY INTERVENTIONS; VOLITIONAL HELP SHEET; IMPLEMENTATION INTENTIONS; COGNITIVE IMPAIRMENT; SELF-EFFICACY; WEIGHT-LOSS; BEHAVIOR; CARE; IF	Objective Guidance to address health literacy often focuses on health education rather than tools to facilitate action, despite action being important for self-management. This study evaluated an online intervention informed by health literate design principles and behavior change theory to reduce unhealthy snacking. Methods 440 participants were recruited online and randomized to an intervention: 1) Health-literate action plan (guided implementation intention); 2) Standard action plan (self-guided implementation intention); 3) Education (healthy snacking fact-sheet). The primary outcome was self-reported unhealthy snacking. Follow-up was at 1 month. Results 373 participants (84.8%) completed follow-up. Half the sample had adequate health literacy (52%), and the other half had low (24%) or possibly low (25%) health literacy, as measured by Newest Vital Sign (NVS). At follow-up, lower health literacy was associated with more unhealthy snacks and there was no overall difference between intervention groups. However, participants with lower health literacy who used the health-literate action plan reported less unhealthy snacking compared to the standard action plan; the reverse was true for those with higher health literacy scores (b = 1.7, p = 0.03). People scoring 2 points below the mean NVS (M = 3.4, SD = 2.0) using the health-literate action plan reported eating 8 fewer serves of unhealthy snacks, whereas people scoring 2 points above the mean NVS reported eating 6 more serves of unhealthy snacks using the same tool. Conclusions These findings suggest that the universal precautions approach currently recommended for health information may be less effective for facilitating action than tailoring to health literacy level.	[Ayre, Julie; Bonner, Carissa; McCaffery, Kirsten] Univ Sydney, Sch Publ Hlth, Fac Med & Hlth, Sydney Hlth Literacy Lab, Sydney, NSW, Australia; [Cvejic, Erin] Univ Sydney, Sch Publ Hlth, Fac Med & Hlth, Sydney, NSW, Australia	University of Sydney; University of Sydney	McCaffery, K (corresponding author), Univ Sydney, Sch Publ Hlth, Fac Med & Hlth, Sydney Hlth Literacy Lab, Sydney, NSW, Australia.	Kirsten.mccaffery@sydney.edu.au	Cvejic, Erin/P-2665-2016; McCaffery, Kirsten/K-7945-2019; Ayre, Julie/ABA-5914-2020	Cvejic, Erin/0000-0002-6043-6071; McCaffery, Kirsten/0000-0003-2696-5006; Ayre, Julie/0000-0002-5279-5189	Australian Government Research Training Program (RTP) Scholarship	Australian Government Research Training Program (RTP) Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	This research is supported by an Australian Government Research Training Program (RTP) Scholarship; We would like to thank Tessa Copp, University of Sydney, for her contribution to the content analysis of standard action plans. We would also like to acknowledge the CSIRO for their permission to use items from the discretionary foods components of the CSIRO diet score. This research is supported by an Australian Government Research Training Program (RTP) Scholarship	Adriaanse MA, 2011, APPETITE, V56, P183, DOI 10.1016/j.appet.2010.10.012; Al Sayah F, 2013, J GEN INTERN MED, V28, P444, DOI 10.1007/s11606-012-2241-z; Armitage CJ, 2008, HEALTH PSYCHOL, V27, P557, DOI 10.1037/0278-6133.27.5.557; Armitage CJ, 2017, PREV SCI, V18, P976, DOI 10.1007/s11121-017-0807-z; Armitage CJ, 2015, J PUBLIC HEALTH-UK, V37, P438, DOI 10.1093/pubmed/fdv054; Armitage CJ, 2015, J BEHAV MED, V38, P599, DOI 10.1007/s10865-015-9634-5; Armitage CJ, 2014, BEHAV THER, V45, P700, DOI 10.1016/j.beth.2014.04.001; Armitage CJ, 2010, PSYCHOL HEALTH, V25, P1129, DOI 10.1080/08870440903121638; Bailey SC, 2014, DIABETES EDUCATOR, V40, P581, DOI 10.1177/0145721714540220; Barry MM, 2013, J HEALTH COMMUN, V18, P1507, DOI 10.1080/10810730.2013.840699; Belanger-Gravel A, 2013, HEALTH PSYCHOL REV, V7, P23, DOI 10.1080/17437199.2011.560095; Berger I, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0745-9; Berkman Nancy D, 2011, Evid Rep Technol Assess (Full Rep), P1; Brega A.G., 2015, AHRQ HLTH LITERACY U, V2nd Edn; Cheng G, 2012, INTERN MED J, V42, P484, DOI 10.1111/j.1445-5994.2012.02758.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; de Vries H, 2005, PATIENT EDUC COUNS, V56, P154, DOI 10.1016/j.pec.2004.01.002; Eggermont LHP, 2012, HEART, V98, P1334, DOI 10.1136/heartjnl-2012-301682; Gawrilow C, 2011, J SOC CLIN PSYCHOL, V30, P616, DOI 10.1521/jscp.2011.30.6.616; Gollwitzer P. M., 1990, HDB MOTIVATION COGNI, V2, P53; Greaves CJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-119; Hagger MS, 2014, EXERC SPORT SCI REV, V42, P62, DOI 10.1249/JES.0000000000000008; Hall PA, 2012, J EXP SOC PSYCHOL, V48, P432, DOI 10.1016/j.jesp.2011.09.004; Hayes A. F., 2013, INTRO MEDIATION MODE, DOI DOI 10.1111/JEDM.12050; Healthdirect, 2018, SMART GOALS 2018; HECKHAUSEN H, 1987, MOTIV EMOTION, V11, P101, DOI 10.1007/BF00992338; Hendrie GA, 2017, NUTRIENTS, V9, DOI 10.3390/nu9010047; Kelly J.R., 2010, THEN MIRACLE OCCURS, P137, DOI DOI 10.1093/ACPROF:OSO/9780195377798.003.0008; Kim SH, 2016, WORLDV EVID-BASED NU, V13, P324, DOI 10.1111/wvn.12157; Lara J, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0177-3; Latham GP, 2013, NEW DEV GOAL SETTING, DOI [10.1111/j.1445-5994.2012.02758.x, DOI 10.1111/J.1445-5994.2012.02758.X]; McEwan D, 2016, HEALTH PSYCHOL REV, V10, P67, DOI 10.1080/17437199.2015.1104258; Meppelink CS, 2016, J HEALTH COMMUN, V21, P109, DOI 10.1080/10810730.2016.1193920; Michie S, 2009, HEALTH PSYCHOL, V28, P690, DOI 10.1037/a0016136; National Diabetes Services Scheme, 2016, HLTH SNACKS NAT DIAB; O'Brien N, 2015, HEALTH PSYCHOL REV, V9, P417, DOI 10.1080/17437199.2015.1012177; Office of Disease Prevention and Health Promotion, 2015, HLTH LIT ONL GUID SI; Olander Ellinor K, 2013, Int J Behav Nutr Phys Act, V10, P29, DOI 10.1186/1479-5868-10-29; Plain Language Action and Information Network, 2011, FED PLAIN LANG GUID; Prestwich A, 2005, PREDICTING HLTH BEHA; Schaffler J, 2018, J GEN INTERN MED, V33, P510, DOI 10.1007/s11606-017-4265-x; Schwarzer R, 2008, APPL PSYCHOL-INT REV, V57, P1, DOI 10.1111/j.1464-0597.2007.00325.x; Sheeran P, 2016, SOC PERSONAL PSYCHOL, V10, P503, DOI 10.1111/spc3.12265; Sheridan SL, 2011, J HEALTH COMMUN, V16, P30, DOI 10.1080/10810730.2011.604391; Sniehotta FF, 2005, PSYCHOL HEALTH, V20, P143, DOI 10.1080/08870440512331317670; Soureti A, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1773; Verhoeven AAC, 2014, PSYCHOL HEALTH, V29, P1476, DOI 10.1080/08870446.2014.950658; Verhoeven AAC, 2013, EUR J SOC PSYCHOL, V43, P344, DOI 10.1002/ejsp.1963; Verplanken B, 2003, J APPL SOC PSYCHOL, V33, P1313, DOI 10.1111/j.1559-1816.2003.tb01951.x; Vila I, 2017, BRIT J HEALTH PSYCH, V22, P281, DOI 10.1111/bjhp.12230; Webb TL, 2008, BRIT J SOC PSYCHOL, V47, P373, DOI 10.1348/014466607X267010; Webb TL, 2004, EUR J SOC PSYCHOL, V34, P407, DOI 10.1002/ejsp.205; Weiss BD, 2005, ANN FAM MED, V3, P514, DOI 10.1370/afm.405; Wilson EAH, 2009, PATIENT EDUC COUNS, V74, P318, DOI 10.1016/j.pec.2008.11.005	54	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0209863	10.1371/journal.pone.0209863	http://dx.doi.org/10.1371/journal.pone.0209863			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653531	Green Published, Green Submitted, gold			2022-12-26	WOS:000456015500015
J	Hu, HP; Chan, H; Ujiie, H; Bernards, N; Fujino, K; Irish, JC; Zheng, JZ; Yasufuku, K				Hu, Hsin-pei; Chan, Harley; Ujiie, Hideki; Bernards, Nicholas; Fujino, Kosuke; Irish, Jonathan C.; Zheng, Jinzi; Yasufuku, Kazuhiro			Nanoparticle-based CT visualization of pulmonary vasculature for minimally-invasive thoracic surgery planning	PLOS ONE			English	Article							CELL LUNG-CANCER; ACTIVATION-RELATED PSEUDOALLERGY; BEAM COMPUTED-TOMOGRAPHY; COMPLEMENT ACTIVATION; SUBLOBAR RESECTION; IMAGE GUIDANCE; TASK WORKLOAD; LOBECTOMY; SEGMENTECTOMY; SURVIVAL	Purpose To evaluate CF800, a novel lipid-based liposomal nanoparticle that co-encapsulates indocyanine green (ICG) and iohexol, for CT imaging of pulmonary vasculature in minimally-invasive thoracic surgery planning. Methods CF800 was intravenously administered to 7 healthy rabbits. In vivo CT imaging was performed 15 min post-injection, with a subset of animals imaged at 24h, 48h, and 72h post injection. Signal-to-background ratios (SBR) were calculated at the inferior vena cava and compared across time-points. A similar protocol was applied to 2 healthy pigs to evaluate the feasibility and efficacy in a large animal model. To evaluate the feasibility of clinical application, a survey was completed by 7 surgical trainees to assess pre- and post-injection CT images of rabbits and pigs. Responses on the discernibility of pulmonary vasculature sub-branches and comfort level to use the images for pre- operative planning were collected and analyzed. Results CF800 injection improved visualization of pulmonary vessels in both rabbit and pig models. The SBR of rabbit pulmonary vasculature was significantly higher after CF800 injection (range 3.7-4.4) compared to pre- injection (range 3.3-3.8, n = 7; p<0.05). SBR remained significantly different up to 24 hours after injection (range 3.7-4.3, n = 4; p<0.05). Trainees' evaluation found the post-injection CT images had significantly higher discernibility at the second vessel branch generation in both rabbit and pig models. Trainees identified smaller vasculature branch generations in the post-injection images compared to the pre- treatment images in both rabbit (mean 6.7 +/- 1.8 vs 5.4 +/- 2.1; p<0.05) and pig (mean 6.7 +/- 1.8 vs 5.4 +/- 2.1; p<0.05). Trainees were significantly more comfortable using post-injection images for surgical planning compared to the pre-injection images (rabbit: 8.1 +/- 1.1 vs. 4.7 +/- 2.1; pig: 7.6 +/- 2.1 vs. 4.9 +/- 2.2; p<0.05). Conclusion CF800 provides SBR and contrast enhancement of pulmonary vasculature which may assist in pre-surgical CT planning of minimally invasive thoracic surgery.	[Hu, Hsin-pei; Ujiie, Hideki; Fujino, Kosuke; Yasufuku, Kazuhiro] Univ Hlth Network, Toronto Gen Hosp, Div Thorac Surg, Toronto, ON, Canada; [Chan, Harley; Bernards, Nicholas; Irish, Jonathan C.; Zheng, Jinzi; Yasufuku, Kazuhiro] Univ Hlth Network, TECHNA Inst, Toronto, ON, Canada; [Irish, Jonathan C.; Zheng, Jinzi; Yasufuku, Kazuhiro] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Yasufuku, K (corresponding author), Univ Hlth Network, Toronto Gen Hosp, Div Thorac Surg, Toronto, ON, Canada.; Yasufuku, K (corresponding author), Univ Hlth Network, TECHNA Inst, Toronto, ON, Canada.; Yasufuku, K (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.	kazuhiro.yasufuku@uhn.ca	Ujiie, Hideki/I-1939-2019	Ujiie, Hideki/0000-0001-6119-8776; Hu, Hsin-pei/0000-0001-9604-2587	Canadian Cancer Society [702900]	Canadian Cancer Society(Canadian Cancer Society (CCS))	This research was funded by the Canadian Cancer Society (grant 702900).	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Adibi S, 2012, J DENT EDUC, V76, P1437; Altorki NK, 2014, J THORAC CARDIOV SUR, V147, P754, DOI 10.1016/j.jtcvs.2013.09.065; [Anonymous], 2017, CANCER; Bachar G, 2009, LARYNGOSCOPE, V119, P434, DOI 10.1002/lary.20089; Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020; Barrett JF, 2004, RADIOGRAPHICS, V24, P1679, DOI 10.1148/rg.246045065; Bedetti B, 2017, J THORAC DIS, V9, P1615, DOI 10.21037/jtd.2017.05.79; BEST PV, 1961, CIRC RES, V9, P288, DOI 10.1161/01.RES.9.2.288; Cao C, 2015, LUNG CANCER, V89, P121, DOI 10.1016/j.lungcan.2015.05.010; Charloux A, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0079-2017; Dixon BJ, 2012, INT FORUM ALLERGY RH, V2, P405, DOI 10.1002/alr.21049; Dixon BJ, 2011, LARYNGOSCOPE, V121, P2060, DOI 10.1002/lary.22153; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Fukuhara K, 2008, EUR J CARDIO-THORAC, V34, P875, DOI 10.1016/j.ejcts.2008.07.014; Gabizon A, 2003, CLIN PHARMACOKINET, V42, P419, DOI 10.2165/00003088-200342050-00002; Ginsberg Robert J., 1995, Annals of Thoracic Surgery, V60, P615, DOI 10.1016/0003-4975(95)00537-U; Gossot D, 2013, J THORAC DIS, V5, pS200, DOI 10.3978/j.issn.2072-1439.2013.06.25; Imperatori Andrea, 2008, Int J Surg, V6 Suppl 1, pS78, DOI 10.1016/j.ijsu.2008.12.014; Jackman JA, 2016, NANOMED-NANOTECHNOL, V12, P933, DOI 10.1016/j.nano.2015.12.377; Kates M, 2011, CHEST, V139, P491, DOI 10.1378/chest.09-2547; Keenan RJ, 2004, ANN THORAC SURG, V78, P228, DOI 10.1016/j.athoracsur.2004.01.024; Khullar OV, 2015, J THORAC ONCOL, V10, P1625, DOI 10.1097/JTO.0000000000000664; Kobayashi E, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-8; Landreneau RJ, 2014, J CLIN ONCOL, V32, P2449, DOI 10.1200/JCO.2013.50.8762; Lenz HJ, 2007, ONCOLOGIST, V12, P601, DOI 10.1634/theoncologist.12-5-601; Lochowski MP, 2014, VIDEOSURGERY MINIINV, V9, P495, DOI 10.5114/wiitm.2014.44250; Meacci Elisa, 2018, J Vis Surg, V4, P17, DOI 10.21037/jovs.2017.12.16; Misaki N, 2009, J THORAC CARDIOV SUR, V138, P613, DOI 10.1016/j.jtcvs.2009.01.003; Moon MH, 2018, RESPIROLOGY, V23, P695, DOI 10.1111/resp.13277; Nakamura H, 2011, THORAC CARDIOV SURG, V59, P137, DOI 10.1055/s-0030-1250377; Nishio W, 2016, ANN THORAC SURG, V102, P1702, DOI 10.1016/j.athoracsur.2016.05.071; Nomori H, 2018, EUR J CARDIO-THORAC, V53, P640, DOI 10.1093/ejcts/ezx357; Oizumi H, 2014, ANN CARDIOTHORAC SUR, V3, P170, DOI 10.3978/j.issn.2225-319X.2014.02.03; Oizumi H, 2011, J THORAC CARDIOV SUR, V141, P678, DOI 10.1016/j.jtcvs.2010.08.027; Pardolesi A, 2014, J THORAC CARDIOV SUR, V148, P737, DOI 10.1016/j.jtcvs.2014.03.001; Patel P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161991; Rotolo N, 2016, EUR RADIOL, V26, P381, DOI 10.1007/s00330-015-3861-6; Saito H, 2014, WORLD J SURG, V38, P2025, DOI 10.1007/s00268-014-2521-3; Sato Toshihiko, 2017, J Vis Surg, V3, P26, DOI 10.21037/jovs.2016.12.14; Seguin-Givelet A, 2018, J THORAC DIS, V10, pS1187, DOI 10.21037/jtd.2018.02.21; Sekine Y, 2012, J THORAC CARDIOV SUR, V143, P1330, DOI 10.1016/j.jtcvs.2012.01.079; She XW, 2018, THORAC CANCER, V9, P305, DOI 10.1111/1759-7714.12585; Sheng DL, 2018, BIOMATERIALS, V165, P1, DOI 10.1016/j.biomaterials.2018.02.041; Shimizu Kimihiro, 2017, J Vis Surg, V3, P88, DOI 10.21037/jovs.2017.05.10; Siewerdsen JH, 2009, HIGH PERFORMANCE INT, DOI [10.1117/12.813747, DOI 10.1117/12.813747]; Subotich D, 2009, CLIN ANAT, V22, P698, DOI 10.1002/ca.20834; Sugimoto S, 2011, J THORAC CARDIOV SUR, V141, P1325, DOI 10.1016/j.jtcvs.2010.09.029; Suzuki H, 2017, SURG TODAY, V47, P463, DOI 10.1007/s00595-016-1387-4; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; Szebeni J, 2006, AM J PHYSIOL-HEART C, V290, pH1050, DOI 10.1152/ajpheart.00622.2005; Szebeni J, 2005, TOXICOLOGY, V216, P106, DOI 10.1016/j.tox.2005.07.023; Szebeni J, 2014, MOL IMMUNOL, V61, P163, DOI 10.1016/j.molimm.2014.06.038; Szebeni J, 2012, NANOMED-NANOTECHNOL, V8, P176, DOI 10.1016/j.nano.2011.06.003; Szebeni J, 2011, ADV DRUG DELIVER REV, V63, P1020, DOI 10.1016/j.addr.2011.06.017; Tanvetyanon T, 2013, ANN ONCOL, V24, P889, DOI 10.1093/annonc/mds495; Wada H, 2018, ANN THORAC SURG; Watanabe S, 2003, ANN THORAC SURG, P75; Whitson BA, 2011, ANN THORAC SURG, V92, P1943, DOI 10.1016/j.athoracsur.2011.05.091; Yamashita S, 2013, ANN THORAC SURG, V95, P994, DOI 10.1016/j.athoracsur.2012.11.005; Yoshimoto K, 2010, EUR J CARDIO-THORAC, V37, P36, DOI 10.1016/j.ejcts.2009.07.002; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zaiontz C., 2018, REAL STAT USING EXCE; Zheng J, 2004, MOL IMAGING CONTRAST; Zheng JZ, 2015, BIOMATERIALS, V67, P160, DOI 10.1016/j.biomaterials.2015.07.010; Zheng JZ, 2010, CONTRAST MEDIA MOL I, V5, P147, DOI 10.1002/cmmi.378; Zheng J, 2009, MOL PHARMACEUT, V6, P571, DOI 10.1021/mp800234r	67	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0209501	10.1371/journal.pone.0209501	http://dx.doi.org/10.1371/journal.pone.0209501			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653521	gold, Green Submitted, Green Published			2022-12-26	WOS:000456015500013
J	Islam, MN; Wang, AM; Pedersen, JS; Sorensen, JN; Korner, O; Edelenbos, M				Islam, Md. Nahidul; Wang, Aimei; Pedersen, Jakob Skov; Sorensen, Jorn Nygaard; Koerner, Oliver; Edelenbos, Merete			Online measurement of temperature and relative humidity as marker tools for quality changes in onion bulbs during storage	PLOS ONE			English	Article							ALLIUM-CEPA L.; RESPIRATION RATE; CHEMICAL-COMPOSITION; HARVEST; DISEASE	A long shelf life of onions (Allium cepa L.) is of high importance in the onion industry. Onions are dried and stored in large wooden boxes that are difficult to access. Monitoring temperature and relative humidity during these processes is challenging. Moreover, quality may change in storage without being noticed. Therefore, there is a need to find alternative methods for monitoring and controlling the drying and storage processes of onions and to identify early changes in quality during storage. The potential use of online measurements of temperature and relative humidity (RH) in the vicinity of onions was evaluated during drying and long-term storage of six onion batches (four cultivars and three selections of one of the cultivars) in commercial storage. The batches varied in bulb weight, dry matter content, firmness and disease incidence. The dry matter content and firmness decreased during storage, while the respiration rate and incidences of individual and total disease increased. Two of the batches had low storability with high disease incidences and high average temperatures and variations in the RH. The results showed that tracking the temperature and RH in the vicinity of the onions is a promising tool for improving the drying and storage processes in commercial storage and for identifying onion batches with reduced storability early in storage.	[Islam, Md. Nahidul; Wang, Aimei; Sorensen, Jorn Nygaard; Edelenbos, Merete] Aarhus Univ, Dept Food Sci, Aarslev, Denmark; [Pedersen, Jakob Skov] Danish Technol Inst, Taastrup, Denmark; [Koerner, Oliver] Leibniz Inst Vegetable & Ornamental Crops, Grossbeeren, Germany	Aarhus University; Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ)	Edelenbos, M (corresponding author), Aarhus Univ, Dept Food Sci, Aarslev, Denmark.	merete.edelenbos@food.au.dk	Körner, Oliver/AAG-9942-2021; Islam, Nahidul/C-3395-2012	Körner, Oliver/0000-0002-3241-481X; Islam, Nahidul/0000-0002-2797-410X; Wang, Aimei/0000-0002-6575-4028	Innovation Fund Denmark [1382-00057B]	Innovation Fund Denmark	Grant no. 1382-00057B from Innovation Fund Denmark funded this work (https://innovationsfonden.dk/en). All authors of this manuscript received funding from this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benkeblia N, 2004, SCI AGR, V61, P281, DOI 10.1590/S0103-90162004000300007; Benkeblia N, 2002, INT J FOOD SCI TECH, V37, P169, DOI 10.1046/j.1365-2621.2002.00554.x; Brewster J. L., 2008, Onions and other vegetable alliums, DOI 10.1079/9781845933999.0000; Chope GA, 2006, POSTHARVEST BIOL TEC, V39, P233, DOI 10.1016/j.postharvbio.2005.10.010; Coolong TW, 2008, HORTSCIENCE, V43, P465, DOI 10.21273/HORTSCI.43.2.465; Coolong TW, 2008, J SCI FOOD AGR, V88, P1277, DOI 10.1002/jsfa.3219; Eshel D, 2014, POSTHARVEST BIOL TEC, V88, P34, DOI 10.1016/j.postharvbio.2013.09.002; Galsurker O, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02031; Gashua I. B., 2014, EUR J APPL SCI, V6, P07; Harrow KM, 2012, NZ J AGR RES, V12, P592, DOI [10.1080/00288233.1969.10421244, DOI 10.1080/00288233.1969.10421244]; Hoffmann T, 2007, AGR ENG; Islam MN, 2017, ACTA HORTIC, V1154, P229, DOI [10.17660/ActaHortic.2017.1154.30, 10.17660/actahortic.2017.1154.30]; Islam MN, 2018, J FOOD SCI TECH MYS, V55, P3314, DOI 10.1007/s13197-018-3268-x; Islam MN, 2018, APPL SPECTROSC, V72, P1467, DOI 10.1177/0003702818792282; Islam MN, 2018, THESIS, DOI [10.13140/RG.2.2.27905.97124, DOI 10.13140/RG.2.2.27905.97124]; Kader AA, 2002, POSTHARVEST TECHNOLO, DOI [10.1016/s0925-5214(00)00133-2, DOI 10.1016/S0925-5214(00)00133-2]; Kays SJ, 2004, POSTHARVEST BIOL, P79, DOI DOI 10.1007/978-1-4684-8255-3_3; Ko SS, 2002, J AM SOC HORTIC SCI, V127, P848, DOI 10.21273/JASHS.127.5.848; KOLE NK, 1994, INT J REFRIG, V17, P199, DOI 10.1016/0140-7007(94)90019-1; MAUDE RB, 1977, ANN APPL BIOL, V86, P163, DOI 10.1111/j.1744-7348.1977.tb01829.x; Paull RE, 1999, POSTHARVEST BIOL TEC, V15, P263, DOI 10.1016/S0925-5214(98)00090-8; Petropoulos SA, 2016, FOOD CHEM, V201, P168, DOI 10.1016/j.foodchem.2016.01.095; Schroeder BK, 2012, PLANT DIS, V96, P1548, DOI 10.1094/PDIS-02-12-0117-RE; Schwartz HF, 2016, COMPENDIUM ONION GAR, DOI [10.1094/9780890545003, DOI 10.1094/9780890545003]; Sharma K, 2016, J FOOD SCI TECH MYS, V53, P1620, DOI 10.1007/s13197-015-2076-9; Snowden A.L., 1992, POSTHARVEST DIS DISO, V2, DOI [10.1201/b18215, DOI 10.1201/B18215]; Tanaka M, 1985, RESEARCH BULLETIN OF; Toivonen PMA, 2008, POSTHARVEST BIOL TEC, V48, P1, DOI 10.1016/j.postharvbio.2007.09.004; Vahling-Armstrong C, 2016, PLANT PATHOL, V65, P536, DOI 10.1111/ppa.12438; Vinay Kumar, 2015, International Journal of Current Microbiology and Applied Sciences, V4, P737; Walters DR, 2015, RESPIRATION PLANTS I, P88, DOI [10.1002/9781118783054.ch4, DOI 10.1002/9781118783054.CH4]; Wang A, 2016, ACTA HORTIC, V1144, P333, DOI 10.17660/ActaHortic.2016.1144.49; WARD CM, 1979, ANN APPL BIOL, V91, P113, DOI 10.1111/j.1744-7348.1979.tb07420.x; Watkins CB, 2012, PRODUCTION GUIDE STO, P67; Yemane Kahsay, 2013, Journal of Plant Breeding and Crop Science, V5, P127	35	4	4	9	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210577	10.1371/journal.pone.0210577	http://dx.doi.org/10.1371/journal.pone.0210577			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653555	Green Published, Green Submitted, gold			2022-12-26	WOS:000456015500053
J	Smajla, D; Garcia-Ramos, A; Tomazin, K; Strojnik, V				Smajla, Darjan; Garcia-Ramos, Amador; Tomazin, Katja; Strojnik, Vojko			Selective effect of static stretching, concentric contractions, and a balance task on ankle force sense	PLOS ONE			English	Article							POSITION SENSE; MUSCLE STRENGTH; PEAK TORQUE; FATIGUE; KNEE; PREVENTION; INJURIES; KINESTHESIA; MOVEMENT; EXERCISE	Proper ankle motor control is critical for balance in the human body during functional activities such as standing, walking, and running. Different exercise modalities are often performed during the same training session where earlier activities may influence later ones. The purpose of the current study was to determine the acute effects of different exercise modalities on ankle force sense. Seventeen subjects performed four different intervention protocols (static stretching, balance task, concentric contractions, and control) in random order. Each session comprised measurements before and after the intervention protocol of the force sense of the ankle plantar flexors (PF) and dorsal flexors (DF) at 10% and 30% of maximal voluntary isometric contraction (MVC). Absolute errors (AE) were calculated separately for each force level and muscle group. An overall PF error (PF-SUM = PF at 10% MVC + PF at 30% MVC), DF error (DF-SUM = DF at 10% MVC + DF at 30% MVC) and ankle error (PF-DF-SUM = PF-SUM + DF-SUM) were also calculated. The main effect of time generally revealed that ankle force sense was significantly reduced after static stretching (PF-DF-SUM: Pre: 6.11 +/- 2.17 Nm, Post: 8.03 +/- 3.28 Nm; p < 0.05), but no significant differences were observed for the concentric contractions (PF-DF-SUM: Pre: 6.01 +/- 1.97 Nm, Post: 6.50 +/- 2.28 Nm) and the balance task (PF-DF-SUM: Pre: 5.25 +/- 1.97 Nm, Post: 5.50 +/- 1.26 Nm). The only significant interaction was observed for the PF-DF-SUM (F = 4.48, p = 0.008) due to greater error scores after stretching (+31.4%) compared to the concentric (+8.2%), balance (+4.8%), and control (-3.5%) conditions. Based on these results, static stretching should not be performed before activities that require a high ankle force sense such as balance, coordination, and precision tasks.	[Smajla, Darjan; Tomazin, Katja; Strojnik, Vojko] Univ Ljubljana, Fac Sport, Ljubljana, Slovenia; [Garcia-Ramos, Amador] Univ Granada, Fac Sport Sci, Dept Phys Educ & Sport, Granada, Spain; [Garcia-Ramos, Amador] Catholic Univ Most Holy Concepcion, Dept Sports Sci & Phys Conditioning, Fac Educ, CIEDE, Concepcion, Chile	University of Ljubljana; University of Granada; Universidad Catolica de la Santisima Concepcion	Smajla, D (corresponding author), Univ Ljubljana, Fac Sport, Ljubljana, Slovenia.	darjan.smajla@fsp.uni-lj.si	Ramos, Amador Garcia/S-6982-2016	Ramos, Amador Garcia/0000-0003-0608-8755; Smajla, Darjan/0000-0001-5441-8988	Javna Agencija za Raziskovalno Dejavnost RS (SI) [P5-0142]	Javna Agencija za Raziskovalno Dejavnost RS (SI)	This work was supported by Javna Agencija za Raziskovalno Dejavnost RS (SI) (P5-0142 to DS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amako M, 2003, MIL MED, V168, P442, DOI 10.1093/milmed/168.6.442; Asslander L, 2014, J NEUROPHYSIOL, V111, P1852, DOI 10.1152/jn.00669.2013; Behm DG, 2016, APPL PHYSIOL NUTR ME, V41, P1, DOI 10.1139/apnm-2015-0235; Behm DG, 2004, MED SCI SPORT EXER, V36, P1397, DOI 10.1249/01.MSS.0000135788.23012.5F; Behm DG, 2001, CAN J APPL PHYSIOL, V26, P261, DOI 10.1139/h01-017; Bernardino S, 2014, EFFECTS DYNAMIC STRE, P586, DOI [10.1249/MSS.0000000000000138, DOI 10.1249/MSS.0000000000000138]; Billot M, 2010, EUR J APPL PHYSIOL, V109, P669, DOI 10.1007/s00421-010-1397-7; Bixler B, 1992, Fam Pract Res J, V12, P131; Bjorklund M, 2006, J ATHL TRAINING, V41, P270; Brindle TJ, 2010, SCAND J MED SCI SPOR, V20, P262, DOI 10.1111/j.1600-0838.2009.00887.x; Brockett C, 1997, BRAIN RES, V771, P251, DOI 10.1016/S0006-8993(97)00808-1; Brzycki M., 1993, J PHYS ED REC DANCE, V64, P88, DOI [10.1080/07303084.1993.10606684, DOI 10.1080/07303084.1993.10606684]; Chalmers GR, 2002, J GERONTOL A-BIOL, V57, pB321, DOI 10.1093/gerona/57.8.B321; COREN S, 1993, B PSYCHONOMIC SOC, V31, P1, DOI 10.3758/bf03334122; Costa PB, 2013, SCAND J MED SCI SPOR, V23, P38, DOI 10.1111/j.1600-0838.2011.01348.x; Costa PB, 2009, J SPORT MED PHYS FIT, V49, P401; Costa PB, 2009, INT J SPORTS MED, V30, P60, DOI 10.1055/s-2008-1038738; Costa PB, 2018, J SPORT MED PHYS FIT, V58, P957, DOI 10.23736/S0022-4707.17.07072-4; Docherty CL, 2008, J ORTHOP RES, V26, P1489, DOI 10.1002/jor.20682; EKSTRAND J, 1983, AM J SPORT MED, V11, P116, DOI 10.1177/036354658301100302; Fischer M, 2005, BRAIN RES, V1043, P163, DOI 10.1016/j.brainres.2005.02.059; Forestier N, 2002, MED SCI SPORT EXER, V34, P117, DOI 10.1097/00005768-200201000-00018; Garcia-Ramos A, 2017, EUR J SPORT SCI, V17, P690, DOI 10.1080/17461391.2017.1304999; Guissard N, 2006, EXERC SPORT SCI REV, V34, P154, DOI 10.1249/01.jes.0000240023.30373.eb; Hadala M, 2009, MED SCI SPORT EXER, V41, P1587, DOI 10.1249/MSS.0b013e31819c0de7; Hemmati L, 2016, ANN REHABIL MED-ARM, V40, P845, DOI 10.5535/arm.2016.40.5.845; Hopkins W, 2000, CALCULATIONS RELIABI; Hortobagyi T, 2004, ARTHRIT RHEUM-ARTHR, V51, P562, DOI 10.1002/art.20545; Kiers H, 2012, EUR J APPL PHYSIOL, V112, P1577, DOI 10.1007/s00421-011-2124-8; Lima BN, 2014, J SPORT SCI MED, V13, P564; Magnusson SP, 1996, J PHYSIOL-LONDON, V497, P291, DOI 10.1113/jphysiol.1996.sp021768; Marek SM, 2005, J ATHL TRAINING, V40, P94; Milani J, 2000, J EXERC PHYSL ONLINE, V3, P14; Okamura Y, 2004, EFFECT LOCAL GEN FAT, V20, P414, DOI [10.1016/j.arthro.2004.01.007, DOI 10.1016/J.ARTHRO.2004.01.007]; Proske U, 2006, MUSCLE NERVE, V34, P545, DOI 10.1002/mus.20627; Proske U, 2009, J PHYSIOL-LONDON, V587, P4139, DOI 10.1113/jphysiol.2009.175372; Ribeiro F., 2011, BIOMECHANICS APPL, DOI [10.5772/20335, DOI 10.5772/20335]; Ribeiro F, 2007, EUR J APPL PHYSIOL, V99, P379, DOI 10.1007/s00421-006-0357-8; Riemann BL, 2002, J ATHL TRAINING, V37, P71; Robbins S, 1998, SPORTS MED, V25, P63, DOI 10.2165/00007256-199825010-00005; Rosker J, 2010, SPORT SCI REV, V4, P165, DOI DOI 10.2478/V10237-011-0037-4; South M, 2007, PHYS THER SPORT, V8, P82, DOI 10.1016/j.ptsp.2006.12.001; Taube W, 2008, ACTA PHYSIOL, V193, P101, DOI 10.1111/j.1748-1716.2008.01850.x; Torres R, 2012, J HUM KINET, V34, P33, DOI 10.2478/v10078-012-0061-1; Trimble MH, 2001, INT J NEUROSCI, V106, P1, DOI 10.3109/00207450109149734; Tripp BL, 2006, CLIN BIOMECH, V21, P466, DOI 10.1016/j.clinbiomech.2005.12.015; van der Kooij H, 2011, J COMPUT NEUROSCI, V30, P759, DOI 10.1007/s10827-010-0291-y; van Dieen JH, 2015, J NEUROPHYSIOL, V114, P2967, DOI 10.1152/jn.00434.2015; Vuillerme N, 2008, GAIT POSTURE, V28, P521, DOI 10.1016/j.gaitpost.2008.03.005; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Westlake KP, 2007, PHYS THER, V87, P1274, DOI 10.2522/ptj.20060263; WIKTORSSONMOLLER M, 1983, AM J SPORT MED, V11, P249, DOI 10.1177/036354658301100412	52	1	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210881	10.1371/journal.pone.0210881	http://dx.doi.org/10.1371/journal.pone.0210881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653585	gold, Green Published, Green Submitted			2022-12-26	WOS:000456015500109
J	Tat, RM; Golea, A; Vesa, SC; Ionescu, D				Tat, Raluca Mihaela; Golea, Adela; Vesa, Stefan Cristian; Ionescu, Daniela			Resistin-Can it be a new early marker for prognosis in patients who survive after a cardiac arrest? A pilot study	PLOS ONE			English	Article							RESUSCITATION COUNCIL GUIDELINES; NEURON-SPECIFIC ENOLASE; CARDIOPULMONARY-RESUSCITATION; LIFE-SUPPORT; BIOMARKERS; SERUM; S100B; PREDICTORS; MANAGEMENT	Aim The aim of our study was to evaluate the potential role of resistin in estimating the 30 days prognosis in patients with hypoxic-ischemic organ injury who survived after a cardiac arrest (CA). Materials and methods The study included 40 patients resuscitated after a non-traumatic out-of-hospital CA admitted in Emergency Department (ED). All patients were followed for 30 days after CA or until death. Clinical data on admission were recorded. Blood samples were collected on admission in ED (0-time interval), and at 6, 12, 24, 48- and 72-hours following resuscitation. Serum concentrations of resistin, S100B and neuron specific enolase (NSE) were measured. Several predictive scores for the mortality at 30 days were created with logistic regressions. Results At each time interval, median serum levels of resistin and S100 B were significantly higher in non-survivors compared to survivors. For NSE, plasma levels were significantly lower in survivors as compared to non-survivors at 48 and 72 hours, respectively. Accurate predictive scores for 30-days mortality were the ones which included the values of resistin and S100B measured at 12 hours after admittance [AUC 0.938 (0.813-0.989), sensitivity 85.71% (67.3%-96%), specificity 91.67% (61.5%'99.8%), p<0.001], which included the values of all three markers measured at 12 hours after admittance [AUC 0.955 (0.839-0.995), sensitivity 82.14% (63.1%'93.9%), specificity 100.00% (73.5%'100.0%), p<0.001] and the that included the values of resistin and S-100B at 6 hours together with serum lactate on admission [AUC = 0.994 (0.901-1.0), sensitivity 96.4% (81.7%'99.9%), specificity 100.00% (73.5%'100.0%), p<0.001]. Conclusion In our study, serum levels of resistin or a combination of resistin with S-100B or resistin with S-100B and lactate, were highly predictive for 30 days mortality in resuscitated patients after CA. Further studies on large number of patients are needed to confirm our data.	[Tat, Raluca Mihaela; Ionescu, Daniela] Iuliu Hatieganu Univ Med & Pharm, Dept Anesthesia & Intens Care 1, Cluj Napoca, Cluj, Romania; [Golea, Adela] Iuliu Hatieganu Univ Med & Pharm, Surg Dept, Cluj Napoca, Cluj, Romania; [Vesa, Stefan Cristian] Iuliu Hatieganu Univ Med & Pharm, Dept Pharmacol Toxicol & Clin Pharmacol, Cluj Napoca, Cluj, Romania; [Ionescu, Daniela] Outcome Res Consortium, Cleveland, OH USA	Iuliu Hatieganu University of Medicine & Pharmacy; Iuliu Hatieganu University of Medicine & Pharmacy; Iuliu Hatieganu University of Medicine & Pharmacy	Vesa, SC (corresponding author), Iuliu Hatieganu Univ Med & Pharm, Dept Pharmacol Toxicol & Clin Pharmacol, Cluj Napoca, Cluj, Romania.	stefanvesa@gmail.com	Golea, Adela/M-7834-2019; Vesa, Stefan Cristian/I-2481-2019	Vesa, Stefan Cristian/0000-0003-4549-3526	"Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca [7690/42/15.04.2016]	"Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca	This study was partially funded by the "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, through the Doctoral Research Project-2015 (No. 7690/42/15.04.2016). The financial support allocated from the grant was used for the acquisition of biomarkers and laboratory supplies. The sponsor had no involvement in study design, collection, analysis and interpretation of data, writing of the manuscript or decision to submit the manuscript for publication. There was no additional external funding received for this study (the authors supported part of the study).; This study was partially funded by the "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, through the Doctoral Research Project-2015 (No. 7690/42/15.04.2016). The financial support allocated from the grant was used for the acquisition of biomarkers and laboratory supplies.	Calderon LM, 2014, RESUSCITATION, V85, P1025, DOI 10.1016/j.resuscitation.2014.04.020; Callaway CW, 2015, CIRCULATION, V132, pS84, DOI 10.1161/CIR.0000000000000273; Chen CY, 2010, AM J PHYSIOL-HEART C, V299, pH193, DOI 10.1152/ajpheart.00431.2009; Daubin C, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-48; Donnino MW, 2014, CRIT CARE MED, V42, P1804, DOI 10.1097/CCM.0000000000000332; Einav S, 2013, RESUSCITATION, V84, P1083, DOI 10.1016/j.resuscitation.2013.01.031; Einav S, 2012, J AM COLL CARDIOL, V60, P304, DOI 10.1016/j.jacc.2012.04.020; Elmer J, 2016, CRIT CARE MED, V44, P111, DOI 10.1097/CCM.0000000000001357; Fain JN, 2003, BIOCHEM BIOPH RES CO, V300, P674, DOI 10.1016/S0006-291X(02)02864-4; Jamaluddin MS, 2012, BRIT J PHARMACOL, V165, P622, DOI 10.1111/j.1476-5381.2011.01369.x; Koch A, 2009, CRIT CARE, V13, DOI 10.1186/cc7925; Langeland H, 2018, JMIR RES PROTOC, V7, DOI 10.2196/resprot.8558; Macdonald SPJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110678; Nolan JP, 2015, RESUSCITATION, V95, P202, DOI 10.1016/j.resuscitation.2015.07.018; Park YJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190519; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Perkins GD, 2015, RESUSCITATION, V95, P81, DOI 10.1016/j.resuscitation.2015.07.015; Scolletta S, 2012, EXPERT REV CLIN PHAR, V5, P687, DOI [10.1586/ecp.12.64, 10.1586/ECP.12.64]; Soar J, 2015, RESUSCITATION, V95, P100, DOI 10.1016/j.resuscitation.2015.07.016; Stammet P, 2015, J AM COLL CARDIOL, V65, P2104, DOI 10.1016/j.jacc.2015.03.538; Stammet P, 2013, J AM COLL CARDIOL, V62, P851, DOI 10.1016/j.jacc.2013.04.039; Sun BD, 2013, WORLD J EMERG MED, V4, P165, DOI [10.5847/wjem.j.issn.1920-8642.2013.03.001, 10.5847/wjem.j.1920-8642.2013.03.001]; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wiberg S, 2017, RESUSCITATION, V121, P49, DOI 10.1016/j.resuscitation.2017.10.006; Wiberg S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168894	25	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210666	10.1371/journal.pone.0210666	http://dx.doi.org/10.1371/journal.pone.0210666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650128	gold, Green Published, Green Submitted			2022-12-26	WOS:000455813300069
J	Kim, I; Shin, SH; Lee, JE; Park, JW				Kim, Iljin; Shin, Seung-Hyun; Lee, Jae Eun; Park, Jong-Wan			Oxygen sensor FIH inhibits HACE1-dependent ubiquitination of Rac1 to enhance metastatic potential in breast cancer cells	ONCOGENE			English	Article							ANKYRIN REPEAT DOMAIN; INDUCIBLE FACTOR FIH; ASPARAGINYL HYDROXYLATION; LIGASE HACE1; TRANSCRIPTIONAL ACTIVITY; PROTEIN INTERACTIONS; DUCTAL CARCINOMA; HYPOXIA; TUMOR; UBIQUITYLATION	Oxygen is an indispensable element for cell survival and maintenance. Eukaryotic cells are equipped with a series of signaling pathways that cope with hypoxia. The dioxygenase factor inhibiting HIF (FIH) is an oxygen sensor that regulates the transcriptional activity of hypoxia-inducible factor (HIF) through asparaginyl hydroxylation. Given that HACE1 was detected as an FIH-interacting protein in a previous proteomics study, we tested whether the E3 ubiquitin ligase HACE1 is a substrate for FIH. FIH interacted with HACE1, in cells and in vitro, and was determined to hydroxylate HACE1 at the N191 residue within the ankyrin repeat domain. Hydroxylation disrupted the physical association between HACE1 and its representative target, Rac1. Under hypoxic conditions, HACE1 is less hydroxylated due to the inactivation of FIH, and subsequently functions to ubiquitinate the active form of Rac1, leading to the proteasomal degradation of Rac1. Since Rac1 stimulates cell movement, HACE1 inhibits cell migration and invasion in breast cancer by removing active Rac1. Such an effect of HACE1 is reinforced under hypoxia because HACE1 escapes from FIH-mediated hydroxylation. In clinical datasets, HACE1 downregulation is associated with poor outcomes in patients with breast cancer. Taken together, FIH is likely to act as an oxygen sensor that determines oxygen-dependent cancer progression.	[Kim, Iljin; Shin, Seung-Hyun; Lee, Jae Eun; Park, Jong-Wan] Seoul Natl Univ, Coll Med, Dept Biomed Sci, 103 Daehak Ro, Seoul, South Korea; [Kim, Iljin; Shin, Seung-Hyun; Lee, Jae Eun; Park, Jong-Wan] Seoul Natl Univ, Coll Med, Hypox Dis Inst, Canc Res Inst & Ischem, 103 Daehak Ro, Seoul, South Korea; [Shin, Seung-Hyun; Park, Jong-Wan] Seoul Natl Univ, Coll Med, Dept Pharmacol, 103 Daehak Ro, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Park, JW (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, 103 Daehak Ro, Seoul, South Korea.; Park, JW (corresponding author), Seoul Natl Univ, Coll Med, Hypox Dis Inst, Canc Res Inst & Ischem, 103 Daehak Ro, Seoul, South Korea.; Park, JW (corresponding author), Seoul Natl Univ, Coll Med, Dept Pharmacol, 103 Daehak Ro, Seoul, South Korea.	parkjw@snu.ac.kr		Park, Jong-Wan/0000-0003-4676-5191; Lee, Judy/0000-0001-9862-3502	National Research Foundation of Korea [2017R1A4A1015015]	National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by a grant from the National Research Foundation of Korea (2017R1A4A1015015; to J.W.P).	Andrio E, 2017, SCI REP-UK, V7, DOI 10.1038/srep44779; Anglesio MS, 2004, HUM MOL GENET, V13, P2061, DOI 10.1093/hmg/ddh215; Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Brunner AL, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r71; Castillo-Lluva S, 2013, ONCOGENE, V32, P1735, DOI 10.1038/onc.2012.189; Chun YS, 2000, BIOCHEM BIOPH RES CO, V268, P652, DOI 10.1006/bbrc.2000.2180; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Cockman ME, 2009, ANN NY ACAD SCI, V1177, P9, DOI 10.1111/j.1749-6632.2009.05042.x; Cockman ME, 2009, MOL CELL PROTEOMICS, V8, P535, DOI 10.1074/mcp.M800340-MCP200; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Daugaard M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3180; Ferguson JE, 2007, MOL CELL BIOL, V27, P6407, DOI 10.1128/MCB.00511-07; Giaccia A, 2003, NAT REV DRUG DISCOV, V2, P803, DOI 10.1038/nrd1199; Goka ET, 2015, ONCOGENE, V34, P5395, DOI 10.1038/onc.2014.468; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hewitson KS, 2008, J BIOL CHEM, V283, P25971, DOI 10.1074/jbc.M804999200; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Hyseni A, 2011, CELL ONCOL, V34, P565, DOI 10.1007/s13402-011-0053-5; Janke K, 2013, J CELL SCI, V126, P2629, DOI 10.1242/jcs.117564; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Karttunen S, 2015, J CELL SCI, V128, P225, DOI 10.1242/jcs.158451; Kretschmer C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-15; Lachance V, 2014, J CELL SCI, V127, P111, DOI 10.1242/jcs.132944; Lancaster DE, 2004, BIOCHEM SOC T, V32, P943, DOI 10.1042/BST0320943; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lee GY, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0089-y; Lee SD, 2016, CANCER LETT, V373, P138, DOI 10.1016/j.canlet.2016.01.031; Lesurf R, 2016, CELL REP, V16, P1166, DOI 10.1016/j.celrep.2016.06.051; Linke S, 2004, J BIOL CHEM, V279, P14391, DOI 10.1074/jbc.M313614200; Liu ZZ, 2014, CANCER CELL, V26, P106, DOI 10.1016/j.ccr.2014.05.015; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Masson N, 2012, EMBO REP, V13, P251, DOI 10.1038/embor.2012.9; Palicharla VR, 2015, CELL SIGNAL, V27, P2355, DOI 10.1016/j.cellsig.2015.09.001; PETTERSEN EO, 1986, CANCER RES, V46, P4346; Rankin EB, 2016, SCIENCE, V352, P175, DOI 10.1126/science.aaf4405; Rodriguez J, 2016, CELL REP, V14, P2745, DOI 10.1016/j.celrep.2016.02.043; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Scholz CC, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002347; Semenza GL, 2007, J MOL MED-JMM, V85, P1293, DOI 10.1007/s00109-007-0285-z; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2016, BBA-MOL CELL RES, V1863, P382, DOI 10.1016/j.bbamcr.2015.05.036; So JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109517; Tan EY, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1838; Torrino S, 2011, DEV CELL, V21, P959, DOI 10.1016/j.devcel.2011.08.015; Tortola L, 2016, CELL REP, V16, P3414, DOI 10.1016/j.celrep.2016.08.072; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wilkins SE, 2016, CHEMMEDCHEM, V11, P773, DOI 10.1002/cmdc.201600012; Yan M, 2009, BRIT J CANCER, V101, P1168, DOI 10.1038/sj.bjc.6605287; Yang M, 2011, FEBS J, V278, P1086, DOI 10.1111/j.1742-4658.2011.08022.x; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zhang L, 2007, NAT MED, V13, P1060, DOI 10.1038/nm1621; Zhang LY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4430; Zucchi I, 2004, P NATL ACAD SCI USA, V101, P18147, DOI 10.1073/pnas.0408260101; 2003, J BIOL CHEM, V278, P1802, DOI DOI 10.1074/JBC.C200644200; 2001, GENE DEV, V15, P2675	57	13	13	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 9	2019	38	19					3651	3666		10.1038/s41388-019-0676-y	http://dx.doi.org/10.1038/s41388-019-0676-y			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HX4OU	30659265				2022-12-26	WOS:000467379600007
J	Sepult, C; Bellefroid, M; Rocks, N; Donati, K; Gerard, C; Gilles, C; Ludwig, A; Duysinx, B; Noel, A; Cataldo, D				Sepult, Christelle; Bellefroid, Marine; Rocks, Natacha; Donati, Kim; Gerard, Catherine; Gilles, Christine; Ludwig, Andreas; Duysinx, Bernard; Noel, Agnes; Cataldo, Didier			ADAM10 mediates malignant pleural mesothelioma invasiveness	ONCOGENE			English	Article							ALPHA-SECRETASE ADAM10; N-CADHERIN; CLEAVAGE; GROWTH; MIGRATION; METALLOPROTEINASES; DISINTEGRIN; INVASION	Malignant pleural mesothelioma (MPM) is an aggressive cancer with limited therapeutic options and treatment efficiency. Even if the latency period between asbestos exposure, the main risk factor, and mesothelioma development is very long, the local invasion of mesothelioma is very rapid leading to a mean survival of one year after diagnosis. ADAM10 (A Disintegrin And Metalloprotease) sheddase targets membrane-bound substrates and its overexpression is associated with progression in several cancers. However, nothing is known about ADAM10 implication in MPM. In this study, we demonstrated higher ADAM10 expression levels in human MPM as compared to control pleural samples and in human MPM cell line. This ADAM10 overexpression was also observed in murine MPM samples. Two mouse mesothelioma cell lines were used in this study including one primary cell line obtained by repeated asbestos fibre injections. We show, in vitro, that ADAM10 targeting through shRNA and pharmacological (GI254023X) approaches reduced drastically mesothelioma cell migration and invasion, as well as for human mesothelioma cells treated with siRNA targeting ADAM10. Moreover, ADAM10 downregulation in murine mesothelioma cells significantly impairs MPM progression in vivo after intrapleural cell injection. We also demonstrate that ADAM10 sheddase downregulation decreases the production of a soluble N-cadherin fragment through membrane N-cadherin, which stimulated mesothelioma cell migration. Taken together, we demonstrate that ADAM10 is overexpressed in MPM and takes part to MPM progression through the generation of N-cadherin fragment that stimulates mesothelioma cell migration. ADAM10 inhibition is worth considering as a therapeutic perspective in mesothelioma context.	[Sepult, Christelle; Bellefroid, Marine; Rocks, Natacha; Donati, Kim; Gerard, Catherine; Gilles, Christine; Noel, Agnes; Cataldo, Didier] Univ Liege, Lab Tumour & Dev Biol, GIGA Canc, Ave Hippocrate 13, B-4000 Liege, Belgium; [Ludwig, Andreas] Rhein Westfal TH Aachen, Inst Pharmacol & Toxicol, Aachen, Germany; [Duysinx, Bernard; Cataldo, Didier] CHU Liege, Dept Resp Dis, Ave Hippocrate 13, B-4000 Liege, Belgium; [Duysinx, Bernard; Cataldo, Didier] Univ Liege, Ave Hippocrate 13, B-4000 Liege, Belgium	University of Liege; RWTH Aachen University; University of Liege; University of Liege	Cataldo, D (corresponding author), Univ Liege, Lab Tumour & Dev Biol, GIGA Canc, Ave Hippocrate 13, B-4000 Liege, Belgium.; Cataldo, D (corresponding author), CHU Liege, Dept Resp Dis, Ave Hippocrate 13, B-4000 Liege, Belgium.; Cataldo, D (corresponding author), Univ Liege, Ave Hippocrate 13, B-4000 Liege, Belgium.	didier.cataldo@uliege.be	Ludwig, Andreas/I-5685-2012; Cataldo, Didier/GPG-3453-2022	Ludwig, Andreas/0000-0001-8536-4986; Noel, Agnes/0000-0002-7670-6179	Fonds National pour la Recherche Scientifique (FRS-FNRS Televie) [7463213 F, 7457116 F]; Centre AntiCancereux (University of Liege); foundation Leon Fredericq (University of Liege); Foundation against Cancer, Belgium [FA/2014/314]; Interuniversity Attraction Poles Program-Belgian State-Belgian Science Policy [P7/30]	Fonds National pour la Recherche Scientifique (FRS-FNRS Televie)(Fonds de la Recherche Scientifique - FNRS); Centre AntiCancereux (University of Liege)(University of Liege); foundation Leon Fredericq (University of Liege); Foundation against Cancer, Belgium; Interuniversity Attraction Poles Program-Belgian State-Belgian Science Policy(Belgian Federal Science Policy Office)	The authors acknowledge the contribution of the GIGA Viral Vectors Platform, of Silvia Blacher for the statistical analysis, and Vincent Heinen for his contribution to human sample collection. The authors thank Pascale Heneaux, Fabienne Perin and especially Christine Fink and Celine Vanwinge for technical support. This study was financially supported by grants from the Fonds National pour la Recherche Scientifique (FRS-FNRS Televie, Grants no 7463213 F and no 7457116 F), the Centre AntiCancereux (University of Liege), The foundation Leon Fredericq (University of Liege), the Foundation against Cancer (FA/2014/314), Belgium, Interuniversity Attraction Poles Program-Belgian State-Belgian Science Policyproject P7/30.	Altomare DA, 2005, ONCOGENE, V24, P6080, DOI 10.1038/sj.onc.1208744; Altomare DA, 2005, CANCER RES, V65, P8090, DOI 10.1158/0008-5472.CAN-05-2312; Andreini C, 2005, J PROTEOME RES, V4, P881, DOI 10.1021/pr0500096; Bononi A, 2015, EXPERT REV RESP MED, V9, P633, DOI 10.1586/17476348.2015.1081066; Bot J, 2003, PATHOL RES PRACT, V199, P341, DOI 10.1078/0344-0338-00427; Brooks AN, 2012, CLIN CANCER RES, V18, P1855, DOI 10.1158/1078-0432.CCR-11-0699; Carnet O, 2015, NEOPLASIA, V17, P552, DOI 10.1016/j.neo.2015.07.002; Chae YK, 2017, ONCOTARGET, V8, P16052, DOI 10.18632/oncotarget.14109; Derycke L, 2006, CLIN EXP METASTAS, V23, P187, DOI 10.1007/s10585-006-9029-7; Donaldson K, 2013, ADV DRUG DELIVER REV, V65, P2078, DOI 10.1016/j.addr.2013.07.014; Donati K, 2017, CANCER GROWTH METAST, V10, DOI 10.1177/1179064417738513; Dreymueller D, 2017, PLATELETS, V28, P354, DOI 10.1080/09537104.2016.1203396; Dreymueller D, 2015, AM J PHYSIOL-LUNG C, V308, pL325, DOI 10.1152/ajplung.00294.2014; Fu L, 2014, TUMOR BIOL, V35, P9263, DOI 10.1007/s13277-014-2201-9; Guo JL, 2012, ONCOL REP, V28, P1709, DOI 10.3892/or.2012.2003; Huang YH, 2017, J ADOLESCENT HEALTH, V61, P527, DOI 10.1016/j.jadohealth.2017.05.003; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Kern A, 2006, J BIOL CHEM, V281, P2405, DOI 10.1074/jbc.M505625200; Kim JB, 2000, J CELL BIOL, V151, P1193, DOI 10.1083/jcb.151.6.1193; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Liu SY, 2015, MOL MED REP, V11, P597, DOI 10.3892/mmr.2014.2652; Madoux F, 2016, SCI REP-UK, V6, DOI 10.1038/s41598-016-0013-4; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Mezzapelle R, 2016, SCI REP, V6, P1; Moss ML, 2008, CURR PHARM BIOTECHNO, V9, P2, DOI 10.2174/138920108783497613; Moss ML, 2007, J BIOL CHEM, V282, P35712, DOI 10.1074/jbc.M703231200; Mullooly M, 2015, BRIT J CANCER, V113, P945, DOI 10.1038/bjc.2015.288; Otjacques E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062818; PARADIES NE, 1993, J NEUROSCI RES, V36, P33, DOI 10.1002/jnr.490360105; Paulissen G, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-127; Pruessmeyer J, 2014, BLOOD, V123, P4077, DOI 10.1182/blood-2013-09-511543; Quispel-Janssen JM, 2018, CLIN CANCER RES, V24, P84, DOI 10.1158/1078-0432.CCR-17-1172; Ray M, 2009, CHEST, V136, P888, DOI 10.1378/chest.08-2665; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Rocks N, 2008, BIOCHIMIE, V90, P369, DOI 10.1016/j.biochi.2007.08.008; Rocks N, 2006, BRIT J CANCER, V94, P724, DOI 10.1038/sj.bjc.6602990; Schnell J, 2017, DTSCH ARZTEBL INT, V114, P739, DOI 10.3238/arztebl.2017.0739; Schuck F, 2016, J ALZHEIMERS DIS, V50, P817, DOI 10.3233/JAD-150737; Shackleton B, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0038-x; Sun YZ, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317712592; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Nguyen T, 2016, EUR J CELL BIOL, V95, P415, DOI 10.1016/j.ejcb.2016.05.002; Utton MA, 2001, J NEUROCHEM, V76, P1421, DOI 10.1046/j.1471-4159.2001.00140.x; Vincent B, 2016, BRAIN RES BULL, V126, P154, DOI 10.1016/j.brainresbull.2016.03.020; Yap TA, 2017, NAT REV CANCER, V17, P475, DOI 10.1038/nrc.2017.42; Yaziji H, 2006, MODERN PATHOL, V19, P514, DOI 10.1038/modpathol.3800534; Yilmaz M, 2010, MOL CANCER RES, V8, P629, DOI 10.1158/1541-7786.MCR-10-0139; You B, 2015, CANCER SCI, V106, P1506, DOI 10.1111/cas.12800; Zhang WQ, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.07.03	49	17	18	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 2	2019	38	18					3521	3534		10.1038/s41388-018-0669-2	http://dx.doi.org/10.1038/s41388-018-0669-2			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HW3RI	30651596	Green Published, hybrid			2022-12-26	WOS:000466610000014
J	Schmelzer, CEH; Heinz, A; Troilo, H; Lockhart-Cairns, MP; Jowitt, TA; Marchand, MF; Bidault, L; Bignon, M; Hedtke, T; Barret, A; McConnell, JC; Sherratt, MJ; Germain, S; Hulmes, DJS; Baldock, C; Muller, L				Schmelzer, Christian E. H.; Heinz, Andrea; Troilo, Helen; Lockhart-Cairns, Michael P.; Jowitt, Thomas A.; Marchand, Marion F.; Bidault, Laurent; Bignon, Marine; Hedtke, Tobias; Barret, Alain; McConnell, James C.; Sherratt, Michael J.; Germain, Stephane; Hulmes, David J. S.; Baldock, Clair; Muller, Laurent			Lysyl oxidase-like 2 (LOXL2)-mediated cross-linking of tropoelastin	FASEB JOURNAL			English	Article						matrix remodeling; elastin; protein structure; SAXS; proteomics	ELASTIN; PROTEIN; EXPRESSION; MATURATION; DOMAINS; COACERVATION; SCATTERING; PRECURSOR; SYSTEM; TISSUE	Lysyl oxidases (LOXs) play a central role in extracellular matrix remodeling during development and tumor growth and fibrosis through cross-linking of collagens and elastin. We have limited knowledge of the structure and substrate specificity of these secreted enzymes. LOXs share a conserved C-terminal catalytic domain but differ in their N-terminal region, which is composed of 4 repeats of scavenger receptor cysteine-rich (SRCR) domains in LOX-like (LOXL) 2. We investigated by X-ray scattering and electron microscopy the low-resolution structure of the full-length enzyme and the structure of a shorter form lacking the catalytic domain. Our data demonstrate that LOXL2 has a rod-like structure with a stalk composed of the SRCR domains and the catalytic domain at its tip. We detected direct interaction between LOXL2 and tropoelastin (TE) and also LOXL2-mediated deamination of TE. Using proteomics, we identified several allysines together with cross-linked TE peptides. The elastin-like material generated was resistant to trypsin proteolysis and displayed mechanical properties similar to mature elastin. Finally, we detected the codistribution of LOXL2 and elastin in the vascular wall. Altogether, these data suggest that LOXL2 could participate in elastogenesis in vivo and could be used as a means of cross-linking TE in vitro for biomimetic and cell-compatible tissue engineering purposes.	[Schmelzer, Christian E. H.; Hedtke, Tobias] IMWS, Halle, Saale, Germany; [Schmelzer, Christian E. H.; Heinz, Andrea; Hedtke, Tobias] Martin Luther Univ Halle Wittenberg, Inst Pharm, Halle, Saale, Germany; [Heinz, Andrea] Univ Copenhagen, Dept Pharm, Copenhagen, Denmark; [Troilo, Helen; Lockhart-Cairns, Michael P.; Jowitt, Thomas A.; Baldock, Clair] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England; [Troilo, Helen; Lockhart-Cairns, Michael P.; Jowitt, Thomas A.; McConnell, James C.; Sherratt, Michael J.; Baldock, Clair] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Cell Matrix Biol & Regenerat Med, Manchester, Lancs, England; [Marchand, Marion F.; Bidault, Laurent; Bignon, Marine; Barret, Alain; Germain, Stephane; Muller, Laurent] PSL Res Univ, CNRS, INSERM, Coll France,CIRB, Paris, France; [Marchand, Marion F.] Sorbonne Univ, Coll Doctoral, Paris, France; [Hulmes, David J. S.] Univ Lyon, Lab Biol Tissulaire & Ingenierie Therapeut LBTI, CNRS, UMR 5305, Lyon, France	Martin Luther University Halle Wittenberg; University of Copenhagen; University of Manchester; University of Manchester; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Muller, L (corresponding author), CNRS, Coll France, Ctr Interdisciplinary Res Biol, INSERM,U1050,UMR 7241, 11 Pl Marcelin Berthelot, F-75005 Paris, France.	laurent.muller@college-de-france.fr	Germain, Stephane/E-2301-2016; Lockhart-Cairns, Michael/AAJ-3888-2021; Schmelzer, Christian/AAG-1246-2019; Heinz, Andrea/ABL-8318-2022; muller, laurent/S-1990-2016; Heinz, Andreas/ABB-7736-2020	Germain, Stephane/0000-0001-5992-1275; Lockhart-Cairns, Michael/0000-0003-2289-1281; Schmelzer, Christian/0000-0002-1180-0201; Heinz, Andrea/0000-0002-8609-4460; muller, laurent/0000-0001-9634-4323; Heinz, Andreas/0000-0001-5405-9065; Baldock, Clair/0000-0003-3497-1959; Hedtke, Tobias/0000-0002-2662-6576; marchand, marion/0000-0001-7247-5003; Jowitt, Thomas/0000-0002-4045-0933	European Synchrotron Radiation Facility (ESRF) [283570 Midland BAG MX1783]; Fraunhofer Internal Programs [069-608203]; European Regional Development Fund in Saxony-Anhalt; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L00612X/1]; LEO Foundation [LF17063]; Prevent Breast Cancer; Federation pour la Recherche Medicale [FRM-ECO2016-0736055]; BBSRC [BB/L00612X/1] Funding Source: UKRI	European Synchrotron Radiation Facility (ESRF); Fraunhofer Internal Programs; European Regional Development Fund in Saxony-Anhalt; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); LEO Foundation(LEO Pharma); Prevent Breast Cancer; Federation pour la Recherche Medicale(Fondation pour la Recherche Medicale); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank the Structure Federative de Recherche Biosciences (UMS3444/CNRS), US8/INSERM, Ecole Normale Superieure de Lyon, Universite Claude Bernard Lyon 1 Protein Science Facility for access to the circular dichroism instrument. The authors thank Christian Ihling (Martin Luther University Halle-Wittenberg, Germany) for assistance with mass spectrometry measurements, Prof. Tony Weiss (University of Sydney, Sydney, NSW, Australia) for providing the recombinant tropoelastin used in surface plasmon resonance experiments, Markus Pietzsch (Martin Luther University Halle-Wittenberg) for providing the recombinant tropoelastin used in other experiments, and Jurgen Brinckmann (University of Lubeck, Germany) for the amino acid analysis, and Dr. Catherine Moali (Universite de Lyon, France) for helpful discussions and reading the manuscript, as well as providing BMP-1 and PCPE-1. The authors thank staff in the University of Manchester Biomolecular Analysis Core Facility and Electron Microscopy Centre for assistance and Diamond Light Source and European Synchrotron Radiation Facility (ESRF) (BioStruct-X FP7-Infractrustures Project 283570 Midland BAG MX1783) for beamtime. The work was supported by the Fraunhofer Internal Programs (Attract Grant 069-608203 to C.E.H.S.), the European Regional Development Fund in Saxony-Anhalt (project ElastoHEAL; to CEHS), the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/L00612X/1 to C.B.), the LEO Foundation (Grant LF17063 to A.H.), and Prevent Breast Cancer (to M.J.S.). M.F.M. was supported by Federation pour la Recherche Medicale (FRM-ECO2016-0736055). The authors declare no conflicts of interest.	Alsofi L, 2016, CALCIFIED TISSUE INT, V98, P172, DOI 10.1007/s00223-015-0076-4; Anazco C, 2016, J BIOL CHEM, V291, P25999, DOI 10.1074/jbc.M116.738856; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Bignon M, 2011, BLOOD, V118, P3979, DOI 10.1182/blood-2010-10-313296; Blanc G, 2007, J BIOL CHEM, V282, P16924, DOI 10.1074/jbc.M701610200; Borel A, 2001, J BIOL CHEM, V276, P48944, DOI 10.1074/jbc.M109499200; Bourhis JM, 2013, P NATL ACAD SCI USA, V110, P6394, DOI 10.1073/pnas.1300480110; BRESSAN GM, 1986, J ULTRA MOL STRUCT R, V94, P209, DOI 10.1016/0889-1605(86)90068-6; CRONSHAW AD, 1995, BIOCHEM J, V306, P279, DOI 10.1042/bj3060279; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gambichler T, 2019, CLIN EXP DERMATOL, V44, P47, DOI 10.1111/ced.13652; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Heinz A, 2014, MATRIX BIOL, V38, P12, DOI 10.1016/j.matbio.2014.07.006; Hohenester E, 1999, NAT STRUCT BIOL, V6, P228, DOI 10.1038/6669; Hornstra IK, 2003, J BIOL CHEM, V278, P14387, DOI 10.1074/jbc.M210144200; Iftikhar M, 2011, J BIOL CHEM, V286, P909, DOI 10.1074/jbc.M110.155622; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozel BA, 2003, J BIOL CHEM, V278, P18491, DOI 10.1074/jbc.M212715200; Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297; Lopez-Jimenez AJ, 2017, J BIOL CHEM, V292, P16970, DOI 10.1074/jbc.M117.798603; Lopez-Luppo M, 2017, INVEST OPHTH VIS SCI, V58, P2832, DOI 10.1167/iovs.16-20312; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; Martin A, 2015, EMBO J, V34, P1090, DOI 10.15252/embj.201489975; MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M; Moon HJ, 2014, BIOORG CHEM, V57, P231, DOI 10.1016/j.bioorg.2014.07.003; Petoukhov MV, 2006, EUR BIOPHYS J BIOPHY, V35, P567, DOI 10.1007/s00249-006-0063-9; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reichheld SE, 2014, J BIOL CHEM, V289, P10057, DOI 10.1074/jbc.M113.533893; Sato F, 2007, J MOL BIOL, V369, P841, DOI 10.1016/j.jmb.2007.03.060; Schmelzer CEH, 2012, FEBS J, V279, P4191, DOI 10.1111/febs.12012; Schrader CU, 2018, J BIOL CHEM, V293, P15107, DOI 10.1074/jbc.RA118.004322; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Trackman PC, 2018, METHOD CELL BIOL, V143, P147, DOI 10.1016/bs.mcb.2017.08.009; Trackman PC, 2016, MATRIX BIOL, V52-54, P7, DOI 10.1016/j.matbio.2016.01.001; Urban Z, 2007, INVEST OPHTH VIS SCI, V48, P3209, DOI 10.1167/iovs.07-0107; Uzel MI, 2001, J BIOL CHEM, V276, P22537, DOI 10.1074/jbc.M102352200; Vrhovski B, 1997, EUR J BIOCHEM, V250, P92, DOI 10.1111/j.1432-1033.1997.00092.x; Xu L, 2013, J BIOL CHEM, V288, P5357, DOI 10.1074/jbc.C112.421768; Yang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13710; Yeo GC, 2011, ADV COLLOID INTERFAC, V167, P94, DOI 10.1016/j.cis.2010.10.003; Zhang X, 2018, P NATL ACAD SCI USA, V115, P3828, DOI 10.1073/pnas.1720859115	44	33	35	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5468	5481		10.1096/fj.201801860RR	http://dx.doi.org/10.1096/fj.201801860RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30676771	Green Published, hybrid			2022-12-26	WOS:000462888500067
J	Bai, Y; Lang, EJM; Nazmi, AR; Parker, EJ				Bai, Yu; Lang, Eric J. M.; Nazmi, Ali Reza; Parker, Emily J.			Domain cross-talk within a bifunctional enzyme provides catalytic and allosteric functionality in the biosynthesis of aromatic amino acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; protein domain; enzyme catalysis; enzyme structure; multifunctional enzyme; 3-deoxy-d-arabino-heptulosonate 7-phosphate synthase; Bifunctional enzyme; chorismate mutase; conformational change; DAHPS	3-DEOXY-D-ARABINO-HEPTULOSONATE 7-PHOSPHATE SYNTHASE; 3-DEOXY-D-MANNO-OCTULOSONATE 8-PHOSPHATE SYNTHASE; CHORISMATE MUTASE; PREVOTELLA-NIGRESCENS; SUBSTRATE AMBIGUITY; CRYSTAL-STRUCTURE; DAHP SYNTHASE; PROTEIN; PURIFICATION; COMPLEX	Because of their special organization, multifunctional enzymes play crucial roles in improving the performance of metabolic pathways. For example, the bacterium Prevotella nigrescens contains a distinctive bifunctional protein comprising a 3-deoxy-D-arabino heptulosonate-7-phosphate synthase (DAH7PS), catalyzing the first reaction of the biosynthetic pathway of aromatic amino acids, and a chorismate mutase (CM), functioning at a branch of this pathway leading to the synthesis of tyrosine and phenylalanine. In this study, we characterized this P. nigrescens enzyme and found that its two catalytic activities exhibit substantial hetero-interdependence and that the separation of its two distinct catalytic domains results in a dramatic loss of both DAH7PS and CM activities. The protein displayed a unique dimeric assembly, with dimerization solely via the CM domain. Small angle X-ray scattering (SAXS)-based structural analysis of this protein indicated a DAH7PS-CM hetero-interaction between the DAH7PS and CM domains, unlike the homo-association between DAH7PS domains normally observed for other DAH7PS proteins. This hetero-interaction provides a structural basis for the functional interdependence between the two domains observed here. Moreover, we observed that DAH7PS is allosterically inhibited by prephenate, the product of the CM-catalyzed reaction. This allostery was accompanied by a striking conformational change as observed by SAXS, implying that altering the hetero-domain interaction underpins the allosteric inhibition. We conclude that for this C-terminal CM-linked DAH7PS, catalytic function and allosteric regulation appear to be delivered by a common mechanism, revealing a distinct and efficient evolutionary strategy to utilize the functional advantages of a bifunctional enzyme.	[Bai, Yu; Parker, Emily J.] Victoria Univ Wellington, Ferrier Res Inst, Maurice Wilkins Ctr, Wellington 6012, New Zealand; [Lang, Eric J. M.; Nazmi, Ali Reza; Parker, Emily J.] Univ Canterbury, Maurice Wilkins Ctr, Biomol Interact Ctr, Christchurch 8041, New Zealand; [Lang, Eric J. M.; Nazmi, Ali Reza; Parker, Emily J.] Univ Canterbury, Dept Chem, Christchurch 8041, New Zealand; [Lang, Eric J. M.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; [Nazmi, Ali Reza] Scion, Biotransformat, Rotorua 3020, New Zealand	Victoria University Wellington; University of Canterbury; University of Canterbury; University of Bristol; Scion	Parker, EJ (corresponding author), Private Bag 600, Wellington, New Zealand.	emily.parker@vuw.ac.nz		Nazmi, Ali Reza/0000-0003-1262-5078; Parker, Emily/0000-0002-9571-9987; Bai, Yu/0000-0002-5698-0023; Lang, Eric/0000-0002-3808-054X	Marsden Fund (Royal Society of New Zealand Marsden Fund) [UOC1105]; University of Canterbury; Maurice Wilkins Centre	Marsden Fund (Royal Society of New Zealand Marsden Fund); University of Canterbury; Maurice Wilkins Centre	This work was supported by Marsden Fund (Royal Society of New Zealand Marsden Fund) Grant UOC1105, the University of Canterbury, and the Maurice Wilkins Centre. The authors declare that they have no conflicts of interest with the contents of this article.	Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Blackmore NJ, 2015, J BIOL CHEM, V290, P18187, DOI 10.1074/jbc.M115.638700; BLACKMORE PF, 1976, FEBS LETT, V64, P222, DOI 10.1016/0014-5793(76)80288-8; Burschowsky D, 2018, BIOCHEMISTRY-US, V57, P557, DOI 10.1021/acs.biochem.7b01018; Cross PJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145187; Cross PJ, 2013, FEBS LETT, V587, P3063, DOI 10.1016/j.febslet.2013.07.044; Cross PJ, 2013, PROTEIN SCI, V22, P1087, DOI 10.1002/pro.2293; Cross PJ, 2013, P NATL ACAD SCI USA, V110, P2111, DOI 10.1073/pnas.1217923110; Cross PJ, 2011, J BIOL CHEM, V286, P10216, DOI 10.1074/jbc.M110.209924; Curien G, 2008, PLANT PHYSIOL BIOCH, V46, P325, DOI 10.1016/j.plaphy.2007.12.006; Fan YF, 2018, P NATL ACAD SCI USA, V115, P3006, DOI 10.1073/pnas.1717621115; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Fukui K, 1999, J CLIN MICROBIOL, V37, P3141, DOI 10.1128/JCM.37.10.3141-3145.1999; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; GRAY JV, 1990, BIOCHEMISTRY-US, V29, P376, DOI 10.1021/bi00454a011; Hammel M, 2012, EUR BIOPHYS J BIOPHY, V41, P789, DOI 10.1007/s00249-012-0820-x; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; HYDE CC, 1988, J BIOL CHEM, V263, P17857; Jensen RA, 2002, J MOL EVOL, V54, P416, DOI 10.1007/s00239-001-0031-z; Jiao WT, 2012, J MOL BIOL, V415, P716, DOI 10.1016/j.jmb.2011.11.037; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Kirby NM, 2013, J APPL CRYSTALLOGR, V46, P1670, DOI 10.1107/S002188981302774X; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lang EJM, 2014, CURR OPIN STRUC BIOL, V29, P102, DOI 10.1016/j.sbi.2014.10.007; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lee D., 2005, PDB ID 1YBZ CONSERVE, DOI [10.2210/odb1YBZ/odb, DOI 10.2210/ODB1YBZ/ODB]; Light SH, 2013, PROTEIN SCI, V22, P395, DOI 10.1002/pro.2233; Light SH, 2012, PROTEIN SCI, V21, P887, DOI 10.1002/pro.2075; Liu YJ, 2008, APPL ENVIRON MICROB, V74, P5497, DOI 10.1128/AEM.00262-08; Nazmi AR, 2016, J BIOL CHEM, V291, P21836, DOI 10.1074/jbc.M116.741637; Nazmi AR, 2014, J MOL BIOL, V426, P656, DOI 10.1016/j.jmb.2013.11.008; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Palmer T., 2007, ENZYMES BIOCH BIOTEC; PARAVICINI G, 1989, EUR J BIOCHEM, V186, P361, DOI 10.1111/j.1432-1033.1989.tb15217.x; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pratap S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06578-1; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Sasso S, 2009, EMBO J, V28, P2128, DOI 10.1038/emboj.2009.165; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schofield LR, 2005, BIOCHEMISTRY-US, V44, P11950, DOI 10.1021/bi050577z; Schofield LR, 2004, PROTEIN EXPRES PURIF, V34, P17, DOI 10.1016/j.pep.2003.11.008; SCHONER R, 1976, J BIOL CHEM, V251, P5440; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shumilin IA, 2004, J MOL BIOL, V341, P455, DOI 10.1016/j.jmb.2004.05.077; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh H, 2014, P NATL ACAD SCI USA, V111, P3389, DOI 10.1073/pnas.1321621111; STEPHENS CM, 1991, J BIOL CHEM, V266, P20810; Stingu CS, 2013, J INVESTIG CLIN DENT, V4, P20, DOI 10.1111/j.2041-1626.2012.00129.x; Subramaniam PS, 1998, J BACTERIOL, V180, P119, DOI 10.1128/JB.180.1.119-127.1998; Walker GE, 1996, MICROBIOL-SGM, V142, P1973, DOI 10.1099/13500872-142-8-1973; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Webby CJ, 2005, J MOL BIOL, V354, P927, DOI 10.1016/j.jmb.2005.09.093; Wu J, 2006, J BIOL CHEM, V281, P4042, DOI 10.1074/jbc.M512223200; Wu J, 2003, J BIOL CHEM, V278, P27525, DOI 10.1074/jbc.M304631200; Yakob M, 2011, J PERIODONTAL RES, V46, P749, DOI 10.1111/j.1600-0765.2011.01398.x; Zhou L, 2012, BIOORG CHEM, V40, P79, DOI 10.1016/j.bioorg.2011.09.002	60	7	7	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4828	4842		10.1074/jbc.RA118.005220	http://dx.doi.org/10.1074/jbc.RA118.005220			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30670586	Green Published, hybrid			2022-12-26	WOS:000463985600009
J	Vlieg, HC; Huizinga, EG; Janssen, BJC				Vlieg, Hedwich C.; Huizinga, Eric G.; Janssen, Bert J. C.			Structure and flexibility of the extracellular region of the PirB receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						receptor; crystal structure; neurobiology; cell signaling; synaptic plasticity; surface plasmon resonance (SPR); immunoglobulin-like domain	IMMUNOGLOBULIN-LIKE RECEPTOR; MYELIN-ASSOCIATED GLYCOPROTEIN; MHC CLASS-I; CRYSTAL-STRUCTURE; INHIBITORY-RECEPTOR; ACTIVATING RECEPTOR; NOGO RECEPTOR; BINDING; PROTEIN; IDENTIFICATION	Murine paired immunoglobulin receptor B (PirB) and its human ortholog leukocyte immunoglobulin-like receptor B2 (LILRB2) are widely expressed inhibitory receptors that interact with a diverse set of extracellular ligands and exert functions ranging from down-regulation of immune responses to inhibition of neuronal growth. However, structural information that could shed light on how PirB interacts with its ligands is lacking. Here, we report crystal structures of the PirB ectodomain; the first full ectodomain structure for a LILR family member, at 3.3-4.5 resolution. The structures reveal that PirB's six Ig-like domains are arranged at acute angles, similar to the structures of leukocyte immunoglobulin-like receptor (LILR) and killer-cell immunoglobulin-like receptor (KIR). We observe that this regular arrangement is followed throughout the ectodomain, resulting in an extended zigzag conformation. In two out of the five structures reported here, the repeating zigzag is broken by the first domain that can adopt two alternative orientations. Quantitative binding experiments revealed a 9 m dissociation constant for PirB-myelin-associated glycoprotein (MAG) ectodomain interactions. Taken together, these structural findings and the observed PirBMAG interactions are compatible with a model for intercellular signaling in which the PirB extracellular domains, which point away from the cell surface, enable interaction with ligands in trans.	[Vlieg, Hedwich C.; Huizinga, Eric G.; Janssen, Bert J. C.] Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, Crystal & Struct Chem,Dept Chem, NL-3584 CH Utrecht, Netherlands	Utrecht University	Janssen, BJC (corresponding author), Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, Crystal & Struct Chem,Dept Chem, NL-3584 CH Utrecht, Netherlands.	b.j.c.janssen@uu.nl	Janssen, Bert/I-3338-2016	Janssen, Bert/0000-0002-8101-8370	Netherland Organization for Scientific Research (NWO) VIDI Grant [723.012.002]; NWO [01.80.104.00]	Netherland Organization for Scientific Research (NWO) VIDI Grant; NWO(Netherlands Organization for Scientific Research (NWO))	This work was supported by Netherland Organization for Scientific Research (NWO) VIDI Grant 723.012.002 and NWO Grant 01.80.104.00. The authors declare that they have no conflicts of interest with the contents of this article.	Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Baldwin KT, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00023; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Berg KL, 1998, ONCOGENE, V17, P2535, DOI 10.1038/sj.onc.1202203; Blery M, 1998, P NATL ACAD SCI USA, V95, P2446, DOI 10.1073/pnas.95.5.2446; Bochner DN, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010157; Boghdadi AG, 2018, MOL NEUROBIOL, V55, P1831, DOI 10.1007/s12035-017-0433-6; Chapman TL, 2000, IMMUNITY, V13, P727, DOI 10.1016/S1074-7613(00)00071-6; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Cheng H, 2011, J BIOL CHEM, V286, P18013, DOI 10.1074/jbc.M111.221028; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fan QR, 1997, NATURE, V389, P96, DOI 10.1038/38028; Fan XM, 2014, BLOOD, V124, P2421, DOI 10.1182/blood-2014-03-557645; Graef T, 2009, J EXP MED, V206, P2557, DOI 10.1084/jem.20091010; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Headd JJ, 2012, ACTA CRYSTALLOGR D, V68, P381, DOI 10.1107/S0907444911047834; Ho LH, 1999, P NATL ACAD SCI USA, V96, P15086, DOI 10.1073/pnas.96.26.15086; Hudson LE, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00281; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Kottis V, 2002, J NEUROCHEM, V82, P1566, DOI 10.1046/j.1471-4159.2002.01146.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel Evgeny, 2012, J Mol Biochem, V1, P76; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; Maeda A, 1999, ONCOGENE, V18, P2291, DOI 10.1038/sj.onc.1202552; Maeda A, 1998, J EXP MED, V187, P1355, DOI 10.1084/jem.187.8.1355; Maenaka K, 1999, STRUCTURE, V7, P391, DOI 10.1016/S0969-2126(99)80052-5; Masuda A, 2007, J EXP MED, V204, P907, DOI 10.1084/jem.20060631; Matsushita H, 2011, J BIOL CHEM, V286, P25739, DOI 10.1074/jbc.M110.157859; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Moradi S, 2015, J BIOL CHEM, V290, P10460, DOI 10.1074/jbc.M114.612291; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nam G, 2013, PROTEIN CELL, V4, P761, DOI 10.1007/s13238-013-3908-x; Pronker MF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13584; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Ryu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019245; Saulquin X, 2003, J EXP MED, V197, P933, DOI 10.1084/jem.20021624; Schimmele B, 2005, J MOL BIOL, V352, P229, DOI 10.1016/j.jmb.2005.06.073; Shiroishi M, 2006, P NATL ACAD SCI USA, V103, P16412, DOI 10.1073/pnas.0605228103; Shiroishi M, 2006, J BIOL CHEM, V281, P19536, DOI 10.1074/jbc.M603076200; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Takai T, 2005, IMMUNOLOGY, V115, P433, DOI 10.1111/j.1365-2567.2005.02177.x; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517; Willcox BE, 2003, NAT IMMUNOL, V4, P913, DOI 10.1038/ni961; Yang ZR, 2008, P NATL ACAD SCI USA, V105, P10095, DOI 10.1073/pnas.0804551105; Zander H, 2007, J MOL RECOGNIT, V20, P185, DOI 10.1002/jmr.823; Zhang H, 2005, IMMUNITY, V22, P235, DOI 10.1016/j.immuni.2005.01.004; Zheng JK, 2012, NATURE, V485, P656, DOI 10.1038/nature11095	52	2	2	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4634	4643		10.1074/jbc.RA118.004396	http://dx.doi.org/10.1074/jbc.RA118.004396			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30674550	hybrid, Green Published			2022-12-26	WOS:000462969500029
J	Heinzel, A; Marhold, M; Mayer, P; Schwarz, M; Tomasich, E; Lukas, A; Krainer, M; Perco, P				Heinzel, Andreas; Marhold, Maximilian; Mayer, Paul; Schwarz, Michael; Tomasich, Erwin; Lukas, Arno; Krainer, Michael; Perco, Paul			Synthetic lethality guiding selection of drug combinations in ovarian cancer	PLOS ONE			English	Article							1ST-LINE TREATMENT; PHASE-II; CHEMOTHERAPY; BEVACIZUMAB; CELLS; MULTICENTER; OLAPARIB; CYTOTOXICITY; TRASTUZUMAB; RESISTANCE	Background Synthetic lethality describes a relationship between two genes where single loss of either gene does not trigger significant impact on cell viability, but simultaneous loss of both gene functions results in lethality. Targeting synthetic lethal interactions with drug combinations promises increased efficacy in tumor therapy. Materials and methods We established a set of synthetic lethal interactions using publicly available data from yeast screens which were mapped to their respective human orthologs using information from orthology databases. This set of experimental synthetic lethal interactions was complemented by a set of predicted synthetic lethal interactions based on a set of protein metadata like e.g. molecular pathway assignment. Based on the combined set, we evaluated drug combinations used in late stage clinical development (clinical phase III and IV trials) or already in clinical use for ovarian cancer with respect to their effect on synthetic lethal interactions. We furthermore identified a set of drug combinations currently not being tested in late stage ovarian cancer clinical trials that however have impact on synthetic lethal interactions thus being worth of further investigations regarding their therapeutic potential in ovarian cancer. Results Twelve of the tested drug combinations addressed a synthetic lethal interaction with the anti-VEGF inhibitor bevacizumab in combination with paclitaxel being the most studied drug combination addressing the synthetic lethal pair between VEGFA and BCL2. The set of 84 predicted drug combinations for example holds the combination of the PARP inhibitor olaparib and paclitaxel, which showed efficacy in phase II clinical studies. Conclusion A set of drug combinations currently not tested in late stage ovarian cancer clinical trials was identified having impact on synthetic lethal interactions thus being worth of further investigations regarding their therapeutic potential in ovarian cancer.	[Heinzel, Andreas; Mayer, Paul; Lukas, Arno; Perco, Paul] Emergentec Biodev GmbH, Vienna, Austria; [Heinzel, Andreas] Med Univ Vienna, Dept Internal Med 3, Vienna, Austria; [Marhold, Maximilian; Schwarz, Michael; Tomasich, Erwin; Krainer, Michael] Med Univ Vienna, Dept Oncol, Div Internal Med 1, Vienna, Austria; [Perco, Paul] Med Univ Innsbruck, Dept Internal Med 4, Innsbruck, Austria	Emergentec Biodevelopment GmbH; Medical University of Vienna; Medical University of Vienna; Medical University of Innsbruck	Perco, P (corresponding author), Emergentec Biodev GmbH, Vienna, Austria.; Krainer, M (corresponding author), Med Univ Vienna, Dept Oncol, Div Internal Med 1, Vienna, Austria.; Perco, P (corresponding author), Med Univ Innsbruck, Dept Internal Med 4, Innsbruck, Austria.	michael.krainer@meduniwien.ac.at; paul.perco@emergentec.com	Perco, Paul/U-2489-2019; Marhold, Maximilian/AAF-4671-2021	Perco, Paul/0000-0003-2087-5691; Schwarz, Michael/0000-0002-2587-1385	European Community [279113]	European Community(European Commission)	The research leading to these results has received funding from the European Community's Seventh Framework Programme under grant agreement no. 279113 (OCTIPS).	Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146; Altenhoff AM, 2011, NUCLEIC ACIDS RES, V39, pD289, DOI 10.1093/nar/gkq1238; Andorfer P, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0278-z; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bronte G, 2016, THER ADV MED ONCOL, V8, P188, DOI 10.1177/1758834016630976; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Byrne AT, 2017, NAT REV CANCER, V17, P254, DOI 10.1038/nrc.2016.140; Candelaria M, 2007, ANN ONCOL, V18, P1529, DOI 10.1093/annonc/mdm204; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dallinger C, 2016, J CLIN PHARMACOL, V56, P1387, DOI 10.1002/jcph.752; DeLuca TF, 2012, BIOINFORMATICS, V28, P715, DOI 10.1093/bioinformatics/bts006; DOBZHANSKY T, 1946, GENETICS, V31, P269; Dutta C, 2012, CANCER RES, V72, P4193, DOI 10.1158/0008-5472.CAN-11-4204; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fechete R., 2013, J COMPUT SCI SYST BI, V6, P73; Fechete R, 2011, MOL BIOSYST, V7, P200, DOI 10.1039/c0mb00082e; Forment JV, 2017, NAT CHEM BIOL, V13, P12, DOI [10.1038/NCHEMBIO.2226, 10.1038/nchembio.2226]; Fotopoulou C, 2014, ANN ONCOL, V25, P160, DOI 10.1093/annonc/mdt515; Fuh KC, 2015, GYNECOL ONCOL, V139, P413, DOI 10.1016/j.ygyno.2015.06.041; Gao H, 2015, NAT MED, V21, P1318, DOI 10.1038/nm.3954; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; Hijaz M, 2016, GYNECOL ONCOL, V142, P323, DOI 10.1016/j.ygyno.2016.06.005; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kemmer D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001440; Kersey PJ, 2014, NUCLEIC ACIDS RES, V42, pD546, DOI 10.1093/nar/gkt979; Kim G, 2015, CLIN CANCER RES, V21, P4257, DOI 10.1158/1078-0432.CCR-15-0887; Lee MJ, 2012, CELL, V149, P780, DOI 10.1016/j.cell.2012.03.031; Li YF, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00058; Liu N, 2011, INT IMMUNOPHARMACOL, V11, P212, DOI 10.1016/j.intimp.2010.11.021; Lord CJ, 2016, NAT REV CANCER, V16, P110, DOI 10.1038/nrc.2015.21; Meulendijks D, 2016, INVEST NEW DRUG, V34, P119, DOI 10.1007/s10637-015-0309-4; Nijman SMB, 2011, FEBS LETT, V585, P1, DOI 10.1016/j.febslet.2010.11.024; Oza AM, 2015, LANCET ONCOL, V16, P928, DOI 10.1016/S1470-2045(15)00086-8; Oza AM, 2015, LANCET ONCOL, V16, P87, DOI 10.1016/S1470-2045(14)71135-0; Papanikolaou V, 2015, CELL ONCOL, V38, P155, DOI 10.1007/s13402-014-0213-5; Plummer R, 2008, CLIN CANCER RES, V14, P7917, DOI 10.1158/1078-0432.CCR-08-1223; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Schwartzberg LS, 2014, CLIN BREAST CANCER, V14, P161, DOI 10.1016/j.clbc.2013.12.003; Sollner J, 2012, MOL BIOSYST, V8, P3197, DOI 10.1039/c2mb25256b; Sollner Johannes, 2008, Immunome Res, V4, P1, DOI 10.1186/1745-7580-4-1; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Wang YF, 2015, TARGET ONCOL, V10, P575, DOI 10.1007/s11523-015-0370-0; Yilmaz A, 2016, WSPOLCZESNA ONKOL, V20, P28, DOI 10.5114/wo.2016.58498; Zhang S, 2011, GYNECOL ONCOL, V121, P25, DOI [10.1038/nrc3144, DOI 10.1038/NRC3144]	47	12	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210859	10.1371/journal.pone.0210859	http://dx.doi.org/10.1371/journal.pone.0210859			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682083	Green Published, gold, Green Submitted			2022-12-26	WOS:000457037500067
J	Mohammed, SH; Habtewold, TD; Tegegne, BS; Birhanu, MM; Sissay, TA; Larijani, B; Esmaillzadeh, A				Mohammed, Shimels Hussien; Habtewold, Tesfa Dejenie; Tegegne, Balewgizie Sileshi; Birhanu, Mulugeta Molla; Sissay, Tesfamichael Awoke; Larijani, Bagher; Esmaillzadeh, Ahmad			Dietary and non-dietary determinants of linear growth status of infants and young children in Ethiopia: Hierarchical regression analysis	PLOS ONE			English	Article							COUNTRIES	Introduction Childhood growth faltering remains a major public health problem in developing countries. We aimed to identify the distal, underlying, and proximal dietary and non-dietary factors associated with length-for-age (LFA) of infants and young children in Ethiopia. Methods We used a nationally representative sample of 2,932 children aged 6-23 months from the Ethiopian demographic and health survey (EDHS) conducted in 2016. Hierarchical regression analysis was done to identify the factors associated with LFA. Findings Pastoral residence (adjusted (a beta) = -0.56, 95% CI = -0.82, -0.31, P< 0.001) and poorest household wealth category (a beta = -0.57, 95% CI = -0.66, -0.48, P< 0.001) were the basic factors negatively associated with LFA. Among underlying factors, maternal wasting (a beta = -0.43, 95% CI = -0.58, -0.28, P< 0.001), and unimproved toilet facility (a beta = -0.48, 95% CI = -0.73, -0.23, P< 0.001) were negatively associated with LFA. Proximal factors found positively associated with LFA were dietary diversity (a beta = 0.09, 95% CI = 0.043, 0.136, P< 0.001), meal frequency (a beta = 0.04, 95% CI = 0.00, 0.08, P = 0.042), and vitamin A supplementation (a beta = 0.16, 95% CI = 0.03, 0.29, P = 0.020). Male sex (a beta = -0.26, 95% CI = -0.39, -0.14, P< 0.001), age (a beta = -0.12, 95% CI = -0.13, -0.10, P = 0.001), small birth size (a beta = -0.45, 95% CI = -0.62, -0.29, P< 0.001), and not currently breastfeeding (a beta = -0.29, 95% CI = -0.47, -0.11, P = 0.003) were negatively associated with LFA. Conclusion LFA was associated with various influences at distal, underlying, and proximal levels. A multi-pronged approach, addressing the various factors comprehensively, would represent an important consideration to promote linear growth in early childhood in Ethiopia.	[Mohammed, Shimels Hussien] TUMS IC, Dept Community Nutr, Sch Nutr Sci & Dietet, Tehran, Iran; [Habtewold, Tesfa Dejenie; Tegegne, Balewgizie Sileshi; Sissay, Tesfamichael Awoke] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Birhanu, Mulugeta Molla] Mekelle Univ, Sch Nursing, Coll Hlth Sci, Mekelle, Ethiopia; [Larijani, Bagher] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran; [Esmaillzadeh, Ahmad] Univ Tehran Med Sci, Obes & Eating Habits Res Ctr, Endocrinol & Metab Mol Cellular Sci Inst, Tehran, Iran; [Esmaillzadeh, Ahmad] Univ Tehran Med Sci, Dept Community Nutr, Sch Nutr Sci & Dietet, Tehran, Iran; [Esmaillzadeh, Ahmad] Isfahan Univ Med Sci, Dept Community Nutr, Food Secur Res Ctr, Esfahan, Iran	University of Groningen; Mekelle University; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Isfahan University Medical Science	Esmaillzadeh, A (corresponding author), Univ Tehran Med Sci, Obes & Eating Habits Res Ctr, Endocrinol & Metab Mol Cellular Sci Inst, Tehran, Iran.; Esmaillzadeh, A (corresponding author), Univ Tehran Med Sci, Dept Community Nutr, Sch Nutr Sci & Dietet, Tehran, Iran.; Esmaillzadeh, A (corresponding author), Isfahan Univ Med Sci, Dept Community Nutr, Food Secur Res Ctr, Esfahan, Iran.	a.esmaillzadeh@gmail.com	Mohammed, Shimels Hussien/G-4569-2017; Esmaillzadeh, Ahmad/N-5704-2014; larijani, Bagher/ABE-3315-2020; Tegegne, Balewgizie Sileshi/K-6117-2016	Mohammed, Shimels Hussien/0000-0001-8231-4158; Esmaillzadeh, Ahmad/0000-0002-8735-6047; larijani, Bagher/0000-0001-5386-7597; Birhanu, Mulugeta/0000-0003-0364-279X; Habtewold, Tesfa Dejenie/0000-0003-4476-518X; Tegegne, Balewgizie Sileshi/0000-0001-9420-0043				Agize A, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7204562; Aheto JMK, 2015, PAEDIATR PERINAT EP, V29, P552, DOI 10.1111/ppe.12222; Akombi BJ, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080863; [Anonymous], 2020, BMC PUBLIC HEALTH; [Anonymous], NAT NUTR PROGR; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Central Statistical Agency, 2011, ETH DEM HLTH SURV; Danaei G, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002164; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; de Onis M, 2016, MATERN CHILD NUTR, V12, P12, DOI 10.1111/mcn.12231; Dearden KA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4033-1; Derso T, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0848-2; Endris N, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6587853; Fabic MS, 2012, B WORLD HEALTH ORGAN, V90, P604, DOI 10.2471/BLT.11.095513; Fikadu T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-800; Geberselassie SB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195361; GREENLAND S, 1994, ENVIRON HEALTH PERSP, V102, P33, DOI 10.1289/ehp.94102s833; Jelenkovic A, 2016, SCI REP-UK, V6, DOI 10.1038/srep28496; Kajimura S, 2005, P NATL ACAD SCI USA, V102, P1240, DOI 10.1073/pnas.0407443102; Leroy JL, 2014, J NUTR, V144, P1460, DOI 10.3945/jn.114.191981; Liu J, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003150; Martorell R, 2012, PAEDIATR PERINAT EP, V26, P302, DOI 10.1111/j.1365-3016.2012.01298.x; Mohammed SH, 2017, BRIT J NUTR, V118, P730, DOI 10.1017/S0007114517002677; Sachdev HPS, 2006, PUBLIC HEALTH NUTR, V9, P904, DOI 10.1017/PHN2005918; Stevens GA, 2012, LANCET, V380, P824, DOI 10.1016/S0140-6736(12)60647-3; Svefors P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149700; UNICEF, 1991, INDIAN J PEDIATR, V58, P13, DOI [10.1007/BF02810402, DOI 10.1007/BF02810402]; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Woodruff BA, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12307; World Health Organization, 2014, GLOBAL NUTR TARGETS; World Health Organization, 2013, ESS NUTR ACT IMPR MA	33	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0209220	10.1371/journal.pone.0209220	http://dx.doi.org/10.1371/journal.pone.0209220			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682027	Green Submitted, gold, Green Published			2022-12-26	WOS:000457037500014
J	Paczkowska, M; Szymanowska-Powalowska, D; Mizera, M; Siakowska, D; Blaszczak, W; Piotrowska-Kempisty, H; Cielecka-Piontek, J				Paczkowska, Magdalena; Szymanowska-Powalowska, Daria; Mizera, Mikolaj; Siakowska, Dominika; Blaszczak, Wioletta; Piotrowska-Kempisty, Hanna; Cielecka-Piontek, Judyta			Cyclodextrins as multifunctional excipients: Influence of inclusion into beta-cyclodextrin on physicochemical and biological properties of tebipenem pivoxil	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; INTESTINAL-ABSORPTION; MOLECULAR INCLUSION; LACTAM ANTIBIOTICS; SOLID-STATE; IN-VITRO; COMPLEXATION; CARBAPENEMS; DEGRADATION; MECHANISMS	A novel approach for drug design based on the oral carbapenem analog tebipenem pivoxil (TP) has been proposed. The formation of the tebipenem pivoxil-beta-cyclodextrin (TP-beta-CD) complex resulted in changes concerning physicochemical properties of TP, which is significant for planning the development of an innovative pharmaceutical formulation as well as in the modifications of biological activity profile of the studied delivery system. The inclusion of TP into beta-cyclodextrin (beta-CD) was confirmed by spectral (infrared and Raman spectroscopies) and thermal method (differential scanning calorimetry). Precise indications of TP domains responsible for interaction with beta-CD were possible through a theoretical approach. The most important physicochemical modifications obtained as an effect of TP inclusion were changes in solubility and its rate depending on acceptor fluids, and an increase in chemical stability in the solid state. Biologically essential effects of TP and beta-CD interactions were decreased TP permeability through Caco-2 cell monolayers with the use of efflux effect inhibition and increased antibacterial activity. The proposed approach is an opportunity for development of the treatment in resistant bacterial infections, in which along with physicochemical modifications induced by a drug carrier impact, a carrier synergy with a pharmacological potential of an active pharmaceutical substance could be used.	[Paczkowska, Magdalena; Mizera, Mikolaj; Siakowska, Dominika; Cielecka-Piontek, Judyta] Poznan Univ Med Sci, Dept Pharmacognosy, Poznan, Poland; [Szymanowska-Powalowska, Daria] Poznan Univ Life Sci, Dept Biotechnol & Food Microbiol, Poznan, Poland; [Blaszczak, Wioletta] Polish Acad Sci, Inst Anim Reprod & Food Res, Tuwima, Olsztyn, Poland; [Piotrowska-Kempisty, Hanna] Poznan Univ Med Sci, Fac Pharm, Dept Toxicol, Poznan, Poland	Poznan University of Medical Sciences; Poznan University of Life Sciences; Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences; Poznan University of Medical Sciences	Cielecka-Piontek, J (corresponding author), Poznan Univ Med Sci, Dept Pharmacognosy, Poznan, Poland.	jpiontek@ump.edu.pl	; BLASZCZAK, Wioletta/H-7161-2017	Piotrowska-Kempisty, Hanna/0000-0002-8904-2885; BLASZCZAK, Wioletta/0000-0002-5989-7858; Paczkowska-Walendowska, Magdalena/0000-0002-0418-9336; Cielecka-Piontek, Judyta/0000-0003-0891-5419	National Science Centre (Preludium) [2015/17/N/NZ7/00937]; JC-P, Infrastruktura PL-Grid drugmod5; Polpharma Scientific Foundation	National Science Centre (Preludium); JC-P, Infrastruktura PL-Grid drugmod5; Polpharma Scientific Foundation	This study was supported by a grant from the National Science Centre (Preludium, 2015/17/N/NZ7/00937) to MP and JC-P, Infrastruktura PL-Grid drugmod5 to MM, and Polpharma Scientific Foundation to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleem O, 2008, J PHARMACEUT BIOMED, V47, P535, DOI 10.1016/j.jpba.2008.02.006; [Anonymous], GAUSSIAN 09; [Anonymous], 1996, P INT C HARM ICH COM; Athanassiou G, 2003, J PHARM PHARMACOL, V55, P291, DOI 10.1211/002235702649; Bhargava S., 2008, Current Drug Delivery, V5, P1; Bonfiglio G, 2002, EXPERT OPIN INV DRUG, V11, P529; Cielecka-Piontek J, 2015, J CHROMATOGR SCI, V53, P325, DOI 10.1093/chromsci/bmu063; Cielecka-Piontek J, 2011, CURR PHARM ANAL, V7, P213, DOI 10.2174/157341211797457989; Cielecka-Piontek J, 2011, REACT KINET MECH CAT, V102, P37, DOI 10.1007/s11144-010-0249-0; Del Valle EMM, 2004, PROCESS BIOCHEM, V39, P1033, DOI 10.1016/S0032-9592(03)00258-9; Dua K, 2011, J PHARM BIOALLIED SC, V3, P417, DOI 10.4103/0975-7406.84457; Eida EEM, 2011, CARBOHYDRPOLYM, V83, P1701; Flanner H.H., 1996, PHARM TECHNOL, V20, P64; GANAPATHY ME, 1995, J BIOL CHEM, V270, P25672, DOI 10.1074/jbc.270.43.25672; Garcia A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088234; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Higuchi T., 1965, ADV ANAL CHEM INSTRU, V4, P117; Karginov VA, 2013, CURR OPIN PHARMACOL, V13, P717, DOI 10.1016/j.coph.2013.08.007; Kato K, 2010, MOL PHARMACEUT, V7, P1747, DOI 10.1021/mp100130b; Kijima Koji, 2009, Jpn J Antibiot, V62, P214; Lennernas H, 1996, INT J PHARM, V127, P103, DOI 10.1016/0378-5173(95)04204-0; Manosroi J, 2016, CHIANG MAI J SCI, V43, P631; Meletis G, 2012, HIPPOKRATIA, V16, P303; Merkys A, 2016, J APPLCRYST, V49; Mizera M, 2015, TALANTA, V137, P174, DOI 10.1016/j.talanta.2015.01.032; Morrill HJ, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv050; Nicolau DP, 2008, EXPERT OPIN PHARMACO, V9, P23, DOI 10.1517/14656566.9.1.23; Ono S, 2005, ANTIMICROB AGENTS CH, V49, P2954, DOI 10.1128/AAC.49.7.2954-2958.2005; Paczkowska M, 2017, J MOL STRUCT, V1134, P135, DOI 10.1016/j.molstruc.2016.12.074; Paczkowska M, 2016, EUR J PHARM BIOPHARM, V99, P24, DOI 10.1016/j.ejpb.2015.10.013; Papp-Wallace KM, 2011, ANTIMICROB AGENTS CH, V55, P4943, DOI 10.1128/AAC.00296-11; Prochowicz D, 2016, COORDIN CHEM REV, V306, P331, DOI 10.1016/j.ccr.2015.07.016; Ragle BE, 2010, ANTIMICROB AGENTS CH, V54, P298, DOI 10.1128/AAC.00973-09; Rajewski RA, 1996, J PHARM SCI, V85, P1142, DOI 10.1021/js960075u; Sato N, 2008, DRUG METAB PHARMACOK, V23, P434, DOI 10.2133/dmpk.23.434; Sun HK., 2011, AM J MICROBIOL, V2, P1, DOI DOI 10.3844/AJMSP.2011.1.8; Talaczynska A, 2016, DRUG DEV IND PHARM, V42, P238, DOI 10.3109/03639045.2015.1044902; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsai YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120395; Wang Y, 2006, DRUG FUTURE, V31, P676, DOI 10.1358/dof.2006.031.08.1015461; Yao Q, 2016, MOLECULES, V21, DOI 10.3390/molecules21010062; Yee SY, 1997, PHARMACEUT RES, V14, P763, DOI 10.1023/A:1012102522787; Zhanel GG, 2007, DRUGS, V67, P1027, DOI 10.2165/00003495-200767070-00006	43	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210694	10.1371/journal.pone.0210694	http://dx.doi.org/10.1371/journal.pone.0210694			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682086	gold, Green Published, Green Submitted			2022-12-26	WOS:000457037500052
J	Snodderly, DM; Ellisid, KM; Lieberman, SR; Link, A; Fernandez-Duque, E; Di Fiore, A				Snodderly, D. Max; Ellisid, Kelsey M.; Lieberman, Sarina R.; Link, Andres; Fernandez-Duque, Eduardo; Di Fiore, Anthony			Initiation of feeding by four sympatric Neotropical primates (Ateles belzebuth, Lagothrix lagotricha poeppigii, Plecturocebus (Callicebus) discolor, and Pithecia aequatorialis) in Amazonian Ecuador: Relationships to photic and ecological factors	PLOS ONE			English	Article							MARMOSETS CALLITHRIX-GEOFFROYI; LUMINANCE CONTRAST SENSITIVITY; COLOR-VISION; BEHAVIORAL THERMOREGULATION; SPIDER MONKEYS; FORAGING ADVANTAGE; WOOLLY MONKEYS; PATTERNS; FOREST; TIME	We examined photic and ecological factors related to initiation of feeding by four sympatric primates in the rain forest of Amazonian Ecuador. With rare exceptions, morning activities of all taxa began only after the onset of nautical twilight, which occurred 47-48 min before sunrise. The larger spider and woolly monkeys, Ateles belzebuth and Lagothrix lagotricha poeppigii, left their sleeping trees before sunrise about half the time, while the smaller sakis and titi monkeys, Pithecia aequatorialis and Plecturocebus (formerly Callicebus) discolor, did not emerge until sunrise or later. None of the four taxa routinely began feeding before sunrise. Pithecia began feeding a median 2.17 h after sunrise, at least 0.8 h later than the median feeding times of the other three taxa. The early movement of Ateles and Lagothrix, and late initiation of feeding by Pithecia are consistent with temporal niche partitioning. Among most New World primate species, all males and many females, have dichromatic color vision, with only two cone photopigments, while some females are trichromats with three cone photopigments. Current evidence indicates that the dichromats have a foraging advantage in dim light, which could facilitate utilization of twilight periods and contribute to temporal niche partitioning. However, in our study, dichromatic males did not differentially exploit the dim light of twilight, and times of first feeding bouts of female Ateles and Lagothrix were similar to those of males. First feeding bouts followed a seasonal pattern, occurring latest in May-August, when ripe fruit abundance and ambient temperature were both relatively low. The most frugivorous taxon, Ateles, exhibited the greatest seasonality, initiating feeding 1.4 h later in May-August than in January-April. This pattern may imply a strategy of conserving energy when ripe fruit is scarcer, but starting earlier to compete successfully when fruit is more abundant. Lower temperatures were associated with later feeding of Ateles (by 26 min / degrees C) and perhaps Pithecia, but not Lagothrix or Plecturocebus. The potential for modification of temporal activity patterns and temporal niche partitioning by relatively small changes in temperature should be considered when predicting the effects of climate change.	[Snodderly, D. Max; Lieberman, Sarina R.] Univ Texas Austin, Dept Neurosci, Austin, TX 78712 USA; [Ellisid, Kelsey M.; Di Fiore, Anthony] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Link, Andres] Univ Los Andes, Dept Biol Sci, Bogota, Colombia; [Link, Andres] Univ Los Andes, Sch Management, Bogota, Colombia; [Fernandez-Duque, Eduardo] Yale Univ, Dept Anthropol, New Haven, CT 06520 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Universidad de los Andes (Colombia); Universidad de los Andes (Colombia); Yale University	Snodderly, DM (corresponding author), Univ Texas Austin, Dept Neurosci, Austin, TX 78712 USA.	dmsnodderly@gmail.com		Snodderly, Donald/0000-0002-3428-609X	National Science Foundation [BCS-1062540, IOS-0843354, BCS-1638822, BCS-DDRI-1540403]; Wenner-Gren Foundation for Anthropological Research; L.S.B. Leakey Foundation; Harry Frank Guggenheim Foundation; J. William Fulbright Scholar Program; Primate Conservation, Inc.; Idea Wild; National Geographic Society; New York Consortium in Evolutionary Primatology; New York University; Zoological Society of San Diego; University of Pennsylvania; University of Texas at Austin; Yale University	National Science Foundation(National Science Foundation (NSF)); Wenner-Gren Foundation for Anthropological Research; L.S.B. Leakey Foundation; Harry Frank Guggenheim Foundation; J. William Fulbright Scholar Program; Primate Conservation, Inc.; Idea Wild; National Geographic Society(National Geographic Society); New York Consortium in Evolutionary Primatology; New York University; Zoological Society of San Diego; University of Pennsylvania; University of Texas at Austin; Yale University	This project received financial support from the National Science Foundation (https://www.nsf.gov/) (Grants BCS-1062540 (ADF, AL), IOS-0843354 (DMS, SRL), BCS-1638822 (ADF), BCS-DDRI-1540403 (KME, ADF); the Wenner-Gren Foundation for Anthropological Research (http://www.wennergren.org/) (Grants to AD, AD & EFD, ADF & AL), L.S.B. Leakey Foundation (https://leakeyfoundation.org/) (Grants to ADF, EFD & AD, KME), and Harry Frank Guggenheim Foundation (http://www.hfg.org/) (ADF & AL); the J. William Fulbright Scholar Program (https://www.cies.org/) (ADF); Primate Conservation, Inc. (http://www.primate.org/) (KE); Idea Wild (http://www.ideawild.org/) (KME); the National Geographic Society (https://www.nationalgeographic.org/) (Grants to EFD, ADF, AL); the New York Consortium in Evolutionary Primatology (ADF, AL); New York University (ADF, AL); the Zoological Society of San Diego (EFD); the University of Pennsylvania (EFD): the University of Texas at Austin (ADF, KME, DMS, SRL); and Yale University (EFD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2021, LANG ENV STAT COMP; Bass MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008767; Bennie JJ, 2014, P NATL ACAD SCI USA, V111, P13727, DOI 10.1073/pnas.1216063110; Boinski S, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P43; Boyle SA, 2016, AM J PRIMATOL, V78, P493, DOI 10.1002/ajp.22422; Caine NG, 2010, BIOL LETTERS, V6, P36, DOI 10.1098/rsbl.2009.0591; Caine NG, 2000, P ROY SOC B-BIOL SCI, V267, P439, DOI 10.1098/rspb.2000.1019; CAROTHERS JH, 1984, OIKOS, V42, P403, DOI 10.2307/3544413; Caselli CB, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22688; Caselli CB, 2011, PRIMATES, V52, P351, DOI 10.1007/s10329-011-0266-2; CAVENEY S, 1995, OECOLOGIA, V103, P444, DOI 10.1007/BF00328682; CHAPMAN CA, 1992, BIOTROPICA, V24, P527, DOI 10.2307/2389015; CHAPMAN CA, 1989, AM J PRIMATOL, V18, P53, DOI 10.1002/ajp.1350180106; Cisneros-Heredia DF., 2005, NEOTROP PRIMATES, V13, P11, DOI [10.1896/1413-4705.13.3.11, DOI 10.1896/1413-4705.13.3.11, DOI 10.11606/T.47.2011]; de Luna AG, 2010, FOLIA PRIMATOL, V81, P86, DOI 10.1159/000314948; DEVALOIS RL, 1974, VISION RES, V14, P53, DOI 10.1016/0042-6989(74)90116-3; DEVALOIS RL, 1974, VISION RES, V14, P75, DOI 10.1016/0042-6989(74)90118-7; DEVALOIS RL, 1968, SCIENCE, V162, P533, DOI 10.1126/science.162.3853.533; Dew JL, 2005, INT J PRIMATOL, V26, P1107, DOI 10.1007/s10764-005-6461-5; Di Fiore A, 2004, INT J PRIMATOL, V25, P767, DOI 10.1023/B:IJOP.0000029122.99458.26; Di Fiore A, 2008, CAM S BIO EVOL ANTHR, V55, P81; Di Fiore A, 2009, BEHAVIOUR, V146, P437, DOI 10.1163/156853909X426345; Donati G, 2011, AM J PHYS ANTHROPOL, V144, P355, DOI 10.1002/ajpa.21415; Fernandez-Duque E, 2006, FOLIA PRIMATOL, V77, P123, DOI 10.1159/000089699; Fernandez-Duque Eduardo, 2012, P43; Finlay BL, 2008, VISUAL NEUROSCI, V25, P289, DOI 10.1017/S0952523808080371; FLEAGLE JG, 1980, AM J PHYS ANTHROPOL, V52, P301, DOI 10.1002/ajpa.1330520302; Gestich CC, 2014, ETHOLOGY, V120, P331, DOI 10.1111/eth.12203; Hanya G, 2007, AM J PRIMATOL, V69, P802, DOI 10.1002/ajp.20397; Hanya G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190631; Hart D, 2007, DEV PRIMATOL-PROG PR, P27, DOI 10.1007/978-0-387-34810-0_2; Hemingway CA, 2005, CAM S BIO EVOL ANTHR, V44, P57, DOI 10.1017/CBO9780511542343.004; Hill RA, 2006, AM J PHYS ANTHROPOL, V129, P242, DOI 10.1002/ajpa.20264; Isbell LA, 2017, AM J PHYS ANTHR; Jacobs GH, 2008, VISUAL NEUROSCI, V25, P619, DOI 10.1017/S0952523808080760; JACOBS GH, 1973, AM J PHYS ANTHROPOL, V38, P371, DOI 10.1002/ajpa.1330380235; Janaky M, 2014, VISUAL NEUROSCI, V31, P99, DOI 10.1017/S0952523813000400; Janmaat KRL, 2014, P NATL ACAD SCI USA, V111, P16343, DOI 10.1073/pnas.1407524111; Kawamura S, 2016, GENES GENOM, P1; Kelley EA, 2016, AM J PRIMATOL, V78, P745, DOI 10.1002/ajp.22538; KINZEY WG, 1990, AM J PHYS ANTHROPOL, V81, P5, DOI 10.1002/ajpa.1330810103; Korstjens AH, 2016, INTRODUCTION TO PRIMATE CONSERVATION, P175, DOI 10.1093/acprof:oso/9780198703389.003.0011; Kosheleff VP, 2009, AM J PHYS ANTHROPOL, V139, P172, DOI 10.1002/ajpa.20970; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; KUNZ TH, 1973, J MAMMAL, V54, P14, DOI 10.2307/1378869; Link A, 2006, J TROP ECOL, V22, P235, DOI 10.1017/S0266467405003081; Link A, 2013, AM J PHYS ANTHROPOL, V150, P579, DOI 10.1002/ajpa.22230; Lopes KGD, 2017, J THERM BIOL, V69, P104, DOI 10.1016/j.jtherbio.2017.06.010; Martin GR, 2017, SENSORY ECOLOGY BIRD; Melin A. D., 2017, P NATL ACAD SCI USA; Melin AD, 2007, ANIM BEHAV, V73, P205, DOI 10.1016/j.anbehav.2006.07.003; Melin AD, 2010, CURR ZOOL, V56, P300, DOI 10.1093/czoolo/56.3.300; MERIGAN WH, 1976, VISION RES, V16, P375, DOI 10.1016/0042-6989(76)90199-1; MOLLON JD, 1984, PROC R SOC SER B-BIO, V222, P373, DOI 10.1098/rspb.1984.0071; Ni QY, 2015, PRIMATES, V56, P351, DOI 10.1007/s10329-015-0481-3; Norconk MA, 2007, PRIMATES PERSPECTIVE, P123, DOI DOI 10.1017/CBO9781139034210.023.; Palacios E, 2013, EVOLUTIONARY BIOL CO; Pessoa DMA, 2005, AM J PRIMATOL, V67, P487, DOI 10.1002/ajp.20202; Planka E.R., 1973, Annual Rev Ecol Syst, V4, P53; Porter AM, 2015, FOLIA PRIMATOL, V86, P455, DOI 10.1159/000441811; Saito A, 2005, AM J PRIMATOL, V67, P471, DOI 10.1002/ajp.20201; Saito A, 2005, AM J PRIMATOL, V67, P425, DOI 10.1002/ajp.20197; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; Sha JCM, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22694; Sheth SN, 2009, J TROP ECOL, V25, P571, DOI 10.1017/S0266467409990216; Smith AC, 2003, J EXP BIOL, V206, P3159, DOI 10.1242/jeb.00536; Smith AC, 2012, ANIM BEHAV, V83, P479, DOI 10.1016/j.anbehav.2011.11.023; Snodderly M, 2018, AM J PHYS ANTHROPOL, V165, P258; Souza-Alves JP, 2011, AM J PRIMATOL, V73, P1199, DOI 10.1002/ajp.20990; Spence-Aizenberg A, 2016, PRIMATES, V57, P103, DOI 10.1007/s10329-015-0489-8; STEVENSON PR, 1994, AM J PRIMATOL, V32, P123, DOI 10.1002/ajp.1350320205; Stevenson PR., 2004, CALADONIA, V26, P125; STRIER KB, 1992, AM J PHYS ANTHROPOL, V88, P515, DOI 10.1002/ajpa.1330880407; Surridge AK, 2003, TRENDS ECOL EVOL, V18, P198, DOI 10.1016/S0169-5347(03)00012-0; SYMINGTON MM, 1988, BEHAVIOUR, V105, P117; Takemoto H, 2004, AM J PHYS ANTHROPOL, V124, P81, DOI 10.1002/ajpa.10342; Terborgh J., 1986, Tasks for Vegetation Science, V15, P371; Terborgh J, 1983, 5 NEW WORLD PRIMATES; Van Belle S, 2018, AM J PHYS ANTHROPOL, V167, P701, DOI 10.1002/ajpa.23645; Van Belle S, 2016, AM J PRIMATOL, V78, P204, DOI 10.1002/ajp.22493; VANSCHAIK CP, 1993, ANNU REV ECOL SYST, V24, P353, DOI 10.1146/annurev.es.24.110193.002033; Veiga LM, 2013, EVOLUTIONARY BIOL CO; Veilleux CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep38418; Yamashita N, 2005, BEHAV ECOL SOCIOBIOL, V58, P618, DOI 10.1007/s00265-005-0936-4; Youlatos D, 1999, ANN SCI NAT ZOOL, V20, P161, DOI 10.1016/S0003-4339(00)88884-X	86	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210494	10.1371/journal.pone.0210494	http://dx.doi.org/10.1371/journal.pone.0210494			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI4TC	30673746	Green Published, Green Submitted, gold			2022-12-26	WOS:000456442800045
J	Alzamora, MT; Fores, R; Pera, G; Baena-Diez, JM; Valverde, M; Toran, P				Teresa Alzamora, M.; Fores, Rosa; Pera, Guillem; Miguel Baena-Diez, Jose; Valverde, Marta; Toran, Pere			Low, borderline and normal ankle-brachial index as a predictor of incidents outcomes in the Mediterranean based-population ARTPER cohort after 9 years follow-up	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; CARDIOVASCULAR-DISEASE; MORTALITY; RISK; EVENTS; ASSOCIATION	Background Guidelines recommended adopting the same cardiovascular risk modification strategies used for coronary disease in case of low Ankle-brachial index (ABI), but here exist few studies on long-term cardiovascular outcomes in patients with borderline ABI and even fewer on the general population. Aim The aim of the present study was to analyze the relationship between long-term cardiovascular events and low, borderline and normal ABI after a 9-year follow up of a Mediterranean population with low cardiovascular risk. Design and setting A population-based prospective cohort study was performed in the province of Barcelona, Spain. Method A total of 3,786 subjects >49 years were recruited from 2006-2008. Baseline ABI was 1.08 +/- 0.16. Subjects were followed from the time of enrollment to the end of follow-up in 2016 via phone calls every 6 months, systematic reviews of primary-care and hospital medical records and analysis of the SIDIAP (Information System for Primary Care Research) database to confirm the possible appearance of cardiovascular events. Results 3146 individuals participated in the study. 2,420 (77%) subjects had normal ABI, 524 (17%) had borderline ABI, and 202 (6.4%) had low ABI. In comparison with normal and borderline subjects, patients with lower ABI had more comorbidities, such as hypertension, hypercholesterolemia and diabetes. Cumulative MACE incidence at 9 years was 20% in patients with low ABI, 6% in borderline ABI and 5% in normal ABI. The annual MACE incidence after 9 years follow-up was significantly higher in people with low ABI (26.9/1000py) (p<0.001) than in borderline (6.6/1000py) and in normal ABI (5.6/1000py). Subjects with borderline ABI are at significantly higher risk for coronary disease (HR: 1.58; 95% CI: 1.02-2, 43; p = 0,040) compared to subjects with normal ABI, after adjustment. Conclusion The results of the present study support that low ABI was independently associated with higher incidence of MACE, ICE, cardiovascular and no cardiovascular mortality; while borderline ABI had significantly moderate risk for coronary disease than normal ABI.	[Teresa Alzamora, M.; Fores, Rosa] Inst Catala Salut, Direccio Atencio Primaria Barcelones Nord & Mares, Ctr Atencio Primaria Riu Nord Riu Sud Santa Colom, Barcelona, Spain; [Teresa Alzamora, M.; Fores, Rosa; Pera, Guillem; Toran, Pere] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca Metropolitana Nord, Mataro, Spain; [Fores, Rosa] Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain; [Miguel Baena-Diez, Jose] Inst Catala Salut, Direccio Atencio Primaria Barcelona Ciutat, Ctr Atencio Primaria La Marina, Barcelona, Spain; [Miguel Baena-Diez, Jose; Valverde, Marta] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca Barcelona, Barcelona, Spain; [Valverde, Marta] Hosp Nostra Senyora de Meritxell, Escaldes Engordany, Andorra	Autonomous University of Barcelona	Alzamora, MT (corresponding author), Inst Catala Salut, Direccio Atencio Primaria Barcelones Nord & Mares, Ctr Atencio Primaria Riu Nord Riu Sud Santa Colom, Barcelona, Spain.; Alzamora, MT (corresponding author), Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca Metropolitana Nord, Mataro, Spain.	maiteal2007@gmail.com	Torán-Monserrat, Pere/AAY-4396-2021	Torán-Monserrat, Pere/0000-0002-9865-7427; Fores Raurell, Rosa/0000-0001-7803-7442; Alzamora, M Teresa/0000-0002-0094-6547; Pera, Guillem/0000-0003-3188-7268	Instituto de Salud Carlos III [PI15/00510, PI11/00765, PI07/90415]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	Funding was provided by Instituto de Salud Carlos III (PI15/00510, PI11/00765, PI07/90415) to MTA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboyans V, 2018, REV ESP CARDIOL, V71, P111, DOI 10.1016/j.rec.2017.12.014; Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb; ANKLE B, ATHEROSCLEROSIS; Criqui MH, 2010, J AM COLL CARDIOL, V56, P1506, DOI 10.1016/j.jacc.2010.04.060; DAVIES J, 2017, BR J GEN PRACT, V67, P655; Davies Jane H, 2017, CG147, V67; Diehm C, 2006, EUR HEART J, V27, P1743, DOI 10.1093/eurheartj/ehl092; FORE P, 2018, PLOS ONE, V16, P13; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Gerhard-Herman MD, 2017, J AM COLL CARDIOL, V69, pE71, DOI 10.1016/j.jacc.2016.11.007; Hajibandeh S, 2017, VASCULAR, V25, P208, DOI 10.1177/1708538116658392; J, GROUP; Kojima I, 2014, J ATHEROSCLER THROMB, V21, P966, DOI 10.5551/jat.22608; McDermott MM, 2005, AM J EPIDEMIOL, V162, P33, DOI 10.1093/aje/kwi167; Menke A, 2006, AM J CARDIOL, V98, P1226, DOI 10.1016/j.amjcard.2006.05.056; Meves SH, 2010, CEREBROVASC DIS, V29, P546, DOI 10.1159/000306640; Miura T, 2017, ATHEROSCLEROSIS, V12, DOI 10.1371/journal.pone.0177609; MIURA T, 2017, PLOS ONE, V12, P6; Murphy TP, 2012, ATHEROSCLEROSIS, V220, P160, DOI 10.1016/j.atherosclerosis.2011.10.037; Natsuaki C, 2014, ATHEROSCLEROSIS, V234, P360, DOI 10.1016/j.atherosclerosis.2014.03.018; Newman AB, 1999, ARTERIOSCL THROM VAS, V19, P538, DOI 10.1161/01.ATV.19.3.538; Tanaka S, 2016, ATHEROSCLEROSIS, V250, P69, DOI 10.1016/j.atherosclerosis.2016.05.014; Alzamora MT, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-015-0170-6; Alzamora MT, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-119; Alzamora MT, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-38	26	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0209163	10.1371/journal.pone.0209163	http://dx.doi.org/10.1371/journal.pone.0209163			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673706	Green Published, Green Submitted, gold			2022-12-26	WOS:000456442800013
J	Trifonova, N; Karnauskas, M; Kelble, C				Trifonova, Neda; Karnauskas, Mandy; Kelble, Christopher			Predicting ecosystem components in the Gulf of Mexico and their responses to climate variability with a dynamic Bayesian network model	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; BROWN SHRIMP; FISH PRODUCTION; SHIFTS; CONSEQUENCES; DIAGNOSIS; KNOWLEDGE; IMPACTS; HYPOXIA; AZTECUS	The Gulf of Mexico is an ecologically and economically important marine ecosystem that is affected by a variety of natural and anthropogenic pressures. These complex and interacting pressures, together with the dynamic environment of the Gulf, present challenges for the effective management of its resources. The recent adoption of Bayesian networks to ecology allows for the discovery and quantification of complex interactions from data after making only a few assumptions about observations of the system. In this study, we apply Bayesian network models, with different levels of structural complexity and a varying number of hidden variables to account for uncertainty when modeling ecosystem dynamics. From these models, we predict focal ecosystem components within the Gulf of Mexico. The predictive ability of the models varied with their structure. The model that performed best was parameterized through data-driven learning techniques and accounted for multiple ecosystem components' associations and their interactions with human and natural pressures over time. Then, we altered sea surface temperature in the best performing model to explore the response of different ecosystem components to increased temperature. The magnitude and even direction of predicted responses varied by ecosystem components due to heterogeneity in driving factors and their spatial overlap. Our findings suggest that due to varying components' sensitivity to drivers, changes in temperature will potentially lead to trade-offs in terms of population productivity. We were able to discover meaningful interactions between ecosystem components and their environment and show how sensitive these relationships are to climate perturbations, which increases our understanding of the potential future response of the system to increasing temperature. Our findings demonstrate that accounting for additional sources of variation, by incorporating multiple interactions and pressures in the model layout, has the potential for gaining deeper insights into the structure and dynamics of ecosystems.	[Trifonova, Neda] Univ Miami, CIMAS, Miami, FL 33149 USA; [Trifonova, Neda; Kelble, Christopher] NOAA, Atlantic Oceanog & Meteorol Lab, Miami, FL 33149 USA; [Karnauskas, Mandy] NOAA, Southeast Fisheries Sci Ctr, Natl Marine Fisheries Serv, Miami, FL USA	University of Miami; National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML); National Oceanic Atmospheric Admin (NOAA) - USA	Trifonova, N (corresponding author), Univ Miami, CIMAS, Miami, FL 33149 USA.; Trifonova, N (corresponding author), NOAA, Atlantic Oceanog & Meteorol Lab, Miami, FL 33149 USA.	nitrifo@gmail.com	Kelble, Christopher R/A-8511-2008	Kelble, Christopher R/0000-0003-0914-4134; Karnauskas, Mandy/0000-0002-6631-0592; Trifonova, Neda/0000-0003-3332-4901	Cooperative Institute for Marine and Atmospheric Studies (CIMAS); Cooperative Institute of the University of Miami; National Oceanic and Atmospheric Administration [NA10OAR4320143]; National Oceanic and Atmospheric Administration's Integrated Ecosystem Assessment (NOAA IEA) Program	Cooperative Institute for Marine and Atmospheric Studies (CIMAS); Cooperative Institute of the University of Miami; National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); National Oceanic and Atmospheric Administration's Integrated Ecosystem Assessment (NOAA IEA) Program	This research was carried out in part under the auspices of the Cooperative Institute for Marine and Atmospheric Studies (CIMAS), a Cooperative Institute of the University of Miami and the National Oceanic and Atmospheric Administration, cooperative agreement #NA10OAR4320143. This paper is NOAA IEA Program contribution #2018_4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was carried out in part under the auspices of the Cooperative Institute for Marine and Atmospheric Studies (CIMAS), a Cooperative Institute of the University of Miami and the National Oceanic and Atmospheric Administration, cooperative agreement #NA10OAR4320143. This paper is a result of research, supported by the National Oceanic and Atmospheric Administration's Integrated Ecosystem Assessment (NOAA IEA) Program. This paper is NOAA IEA Program contribution #2018_4.	Adams CM, 2004, OCEAN COAST MANAGE, V47, P565, DOI 10.1016/j.ocecoaman.2004.12.002; Barange M, 2014, NAT CLIM CHANGE, V4, P211, DOI [10.1038/NCLIMATE2119, 10.1038/nclimate2119]; Barile P. J., 2013, SEDAR38DW07; Bilmes J. A., 1998, INT COMPUTER SCI I, V4, P126, DOI DOI 10.1080/0042098032000136147; Blanchard JL, 2012, PHILOS T R SOC B, V367, P2979, DOI 10.1098/rstb.2012.0231; Bo P, 2004, IEEE T BIO-MED ENG, V51, P1803, DOI 10.1109/TBME.2004.831534; Brooks EN, 2015, CAN J FISH AQUAT SCI, V72, P634, DOI 10.1139/cjfas-2014-0231; Ceccon S, 2011, LECT NOTES COMPUT SC, V7014, P101, DOI 10.1007/978-3-642-24800-9_12; Chen SH, 2012, ENVIRON MODELL SOFTW, V37, P134, DOI 10.1016/j.envsoft.2012.03.012; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Cofino AS, 2002, FR ART INT, V77, P695; Craig JK, 2005, MAR ECOL PROG SER, V294, P79, DOI 10.3354/meps294079; Drinkwater KF, 2010, J MARINE SYST, V79, P374, DOI 10.1016/j.jmarsys.2008.12.014; Edwards M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057212; Elliott DT, 2012, J PLANKTON RES, V34, P602, DOI 10.1093/plankt/fbs029; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; Faisal A, 2010, ECOL INFORM, V5, P451, DOI 10.1016/j.ecoinf.2010.06.005; Fernandes JA, 2013, GLOBAL CHANGE BIOL, V19, P2596, DOI 10.1111/gcb.12231; Fodrie FJ, 2010, GLOBAL CHANGE BIOL, V16, P48, DOI 10.1111/j.1365-2486.2009.01889.x; Franco C, 2016, ENVIRON MODELL SOFTW, V80, P132, DOI 10.1016/j.envsoft.2016.02.029; Friedman N, 1999, IJCAI-99: PROCEEDINGS OF THE SIXTEENTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOLS 1 & 2, P1300; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Ghahramani Z, 1996, ADV NEUR IN, V8, P472; Hamilton SH, 2015, ECOL MODEL, V299, P64, DOI 10.1016/j.ecolmodel.2014.12.004; Hare JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146756; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; Huang BY, 2015, J CLIMATE, V28, P911, DOI 10.1175/JCLI-D-14-00006.1; Jensen FV, 2001, SERIES STAT ENG INFO; JOHNSON AG, 1994, FISH B-NOAA, V92, P91; Karnauskas M, 2017, ECOSYSTEM STATUS REP, V706, P56; Karnauskas M, 2015, GLOBAL CHANGE BIOL, V21, P2554, DOI 10.1111/gcb.12894; Keister JE, 2012, ZOOPLANKTON POPULATI, P347; Krivtsov V, 2004, ECOL MODEL, V174, P37, DOI 10.1016/j.ecolmodel.2003.12.042; Levontin P, 2011, ICES J MAR SCI, V68, P632, DOI 10.1093/icesjms/fsr004; Li JK, 2005, ESTUAR COAST SHELF S, V64, P261, DOI 10.1016/j.ecss.2005.02.019; Little S, 2017, UN BOUNDED BOUNDARIE, P311; Liu YY, 2015, J MARINE SYST, V148, P56, DOI 10.1016/j.jmarsys.2015.01.007; Morley JW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196127; Murphy K., 2001, COMPUTING SCI STAT, V33, P1024; Nielsen A, 2014, FISH RES, V158, P96, DOI 10.1016/j.fishres.2014.01.014; Nikovski D, 2000, IEEE T KNOWL DATA EN, V12, P509, DOI 10.1109/69.868904; Nye JA, 2014, J MARINE SYST, V133, P103, DOI 10.1016/j.jmarsys.2013.02.006; Ogden JC, 2014, ECOL INDIC, V44, P148, DOI 10.1016/j.ecolind.2014.03.007; Olden JD, 2002, FRESHWATER BIOL, V47, P1976, DOI 10.1046/j.1365-2427.2002.00945.x; Pinsky ML, 2012, CLIMATIC CHANGE, V115, P883, DOI 10.1007/s10584-012-0599-x; Powers SP, 2018, T AM FISH SOC, DOI [10.1002/tafs.10051, DOI 10.1002/TAFS.10051]; Robinson JW, 2010, J MACH LEARN RES, V11, P3647; Sanchez-Rubio G, 2015, FISHERY B, V113; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schindler DE, 2015, SCIENCE, V347, P953, DOI 10.1126/science.1261824; Shackell NL, 2012, ICES J MAR SCI, V69, P151, DOI 10.1093/icesjms/fsr195; Tam JC, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00282; Trifonova N, 2017, ICES J MAR SCI, V74, P1334, DOI 10.1093/icesjms/fsw231; Trifonova N, 2015, ECOL INFORM, V30, P142, DOI 10.1016/j.ecoinf.2015.10.003; Tucker A., 2004, Intelligent Data Analysis, V8, P469; Uusitalo L, 2007, ECOL MODEL, V203, P312, DOI 10.1016/j.ecolmodel.2006.11.033; Uusitalo L, 2012, INTEGR ENVIRON ASSES, V8, P445, DOI 10.1002/ieam.180; Vert-pre KA, 2013, P NATL ACAD SCI USA, V110, P1779, DOI 10.1073/pnas.1214879110; ZEINELDIN ZP, 1986, MAR FISH REV, V48, P9	60	5	5	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0209257	10.1371/journal.pone.0209257	http://dx.doi.org/10.1371/journal.pone.0209257			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673705	Green Submitted, Green Published, gold			2022-12-26	WOS:000456442800015
J	Jolliffe, CD; Mccauley, RD; Gavrilov, AN; Jenner, KCS; Jenner, MNM; Duncan, AJ				Jolliffe, Capri D.; Mccauley, Robert D.; Gavrilov, Alexander N.; Jenner, K. Curt S.; Jenner, Micheline-Nicole M.; Duncan, Alec J.			Song variation of the South Eastern Indian Ocean pygmy blue whale population in the Perth Canyon, Western Australia	PLOS ONE			English	Article							RESIDENT KILLER WHALES; HUMPBACK WHALES; BALAENOPTERA-MUSCULUS; MEGAPTERA-NOVAEANGLIAE; BEHAVIOR; CULTURE; SIZE; CLASSIFICATION; VARIABILITY; REPERTOIRE	Sea noise collected over 2003 to 2017 from the Perth Canyon, Western Australia was analysed for variation in the South Eastern Indian Ocean pygmy blue whale song structure. The primary song-types were: P3, a three unit phrase (I, II and III) repeated with an inter-song interval (ISI) of 170-194 s; P2, a phrase consisting of only units II & III repeated every 84-96 s; and P1 with a phrase consisting of only unit II repeated every 45-49 s. The different ISI values were approximate multiples of each other within a season. When comparing data from each season, across seasons, the ISI value for each song increased significantly through time (all fits had p << 0.001), at 0.30 s/Year (95% CI 0.217-0.383), 0.8 s/Year (95% CI 0.655-1.025) and 1.73 s/Year (95% CI 1.264-2.196) for the P1, P2 and P3 songs respectively. The proportions of each song-type averaged at 21.5, 24.2 and 56% for P1, P2 and P3 occurrence respectively and these ratios could vary by up to +/- 8% (95% CI) amongst years. On some occasions animals changed the P3 ISI to be significantly shorter (120-160 s) or longer (220-280 s). Hybrid song patterns occurred where animals combined multiple phrase types into a repeated song. In recent years whales introduced further complexity by splitting song units. This variability of song-type and proportions implies abundance measure for this whale sub population based on song detection needs to factor in trends in song variability to make data comparable between seasons. Further, such variability in song production by a sub population of pygmy blue whales raises questions as to the stability of the song types that are used to delineate populations. The high level of song variability may be driven by an increasing number of background whale callers creating 'noise' and so forcing animals to alter song in order to 'stand out' amongst the crowd.	[Jolliffe, Capri D.; Mccauley, Robert D.; Gavrilov, Alexander N.; Duncan, Alec J.] Curtin Univ, Ctr Marine Sci & Technol, Perth, WA, Australia; [Jenner, K. Curt S.; Jenner, Micheline-Nicole M.] Ctr Whale Res WA Inc, Fremantle, WA, Australia	Curtin University	Mccauley, RD (corresponding author), Curtin Univ, Ctr Marine Sci & Technol, Perth, WA, Australia.	r.mccauley@cmst.curtin.edu.au	Duncan, Alec J/B-7514-2015	Duncan, Alec J/0000-0002-2179-727X; Gavrilov, Alexander/0000-0003-1907-458X; McCauley, Robert/0000-0002-7401-8751				Adi K, 2010, J ACOUST SOC AM, V127, P874, DOI 10.1121/1.3273887; Agafonov AV, 2017, ZH OBSHCH BIOL, V78, P38; [Anonymous], 2010, R LANG ENV STAT COMP; Attard CRM, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.170925; Attard CRM, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.1037; Attard CRM, 2010, CONSERV GENET, V11, P2437, DOI 10.1007/s10592-010-0121-9; AUGUST PV, 1987, J MAMMAL, V68, P1, DOI 10.2307/1381039; Bottcher A, 2018, J ACOUST SOC AM, V144, P365, DOI 10.1121/1.5047657; Branch TA, 2007, MAMMAL REV, V37, P116, DOI 10.1111/j.1365-2907.2007.00106.x; Brunel-Pons O, 2011, ANIM BEHAV, V81, P231, DOI 10.1016/j.anbehav.2010.10.010; Buchan SJ, 2014, ENDANGER SPECIES RES, V23, P241, DOI 10.3354/esr00566; Cantor M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9091; Cerchio S, 2001, ANIM BEHAV, V62, P313, DOI 10.1006/anbe.2001.1747; Cholewiak DM, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171298; Creanza N, 2016, EVOL ECOL, V30, P285, DOI 10.1007/s10682-015-9796-1; Deecke VB, 2000, ANIM BEHAV, V60, P629, DOI 10.1006/anbe.2000.1454; Double MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093578; Dunlop RA, 2017, J ACOUST SOC AM, V141, P2204, DOI 10.1121/1.4978615; Dunlop RA, 2016, BEHAV ECOL SOCIOBIOL, V70, P2149, DOI 10.1007/s00265-016-2218-8; Erbe C, 2015, PROG OCEANOGR, V137, P38, DOI 10.1016/j.pocean.2015.05.015; Filatova OA, 2015, BEHAVIOUR, V152, P2001, DOI 10.1163/1568539X-00003317; Galef BG, 2001, BEHAV BRAIN SCI, V24, P335, DOI 10.1017/S0140525X01343960; Garland EC, 2017, J ACOUST SOC AM, V142, P460, DOI 10.1121/1.4991320; Garland EC, 2017, P NATL ACAD SCI USA, V114, P7822, DOI 10.1073/pnas.1621072114; Garland EC, 2015, CONSERV BIOL, V29, P1198, DOI 10.1111/cobi.12492; Gavrilov A.N., 2012, P 11 EUR C UND AC JU, V3, P34; Gavrilov AN, 2014, ACOUST AUST, V42, P190; Gavrilov AN, 2013, J ACOUST SOC AM, V134, P2505, DOI 10.1121/1.4816576; Hammond P, 2017, NAT HIST, V125, P30; Hedwig D, 2015, AM J PRIMATOL, V77, P1239, DOI 10.1002/ajp.22462; Helweg DA, 1998, BEHAVIOUR, V135, P1; Herman LM, 2017, BIOL REV, V92, P1795, DOI 10.1111/brv.12309; Herman LM, 2013, BEHAV ECOL SOCIOBIOL, V67, P1653, DOI 10.1007/s00265-013-1576-8; Janik VM, 2014, CURR OPIN NEUROBIOL, V28, P60, DOI 10.1016/j.conb.2014.06.010; Janik VM, 1999, ANIM BEHAV, V57, P133, DOI 10.1006/anbe.1998.0923; Janik VM, 2000, ANIM BEHAV, V60, P1, DOI 10.1006/anbe.2000.1410; Janik VM, ADV STUDY BEHAV, V26, P59; Kershenbaum A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1370; Lewis LA, 2018, MAR MAMMAL SCI, V34, P311, DOI 10.1111/mms.12458; Ljungblad Donald K., 1998, Report of the International Whaling Commission, V48, P439; Lucas JR, 1996, ANIM BEHAV, V51, P501, DOI 10.1006/anbe.1996.0056; Mann J, 2017, DEEP THINKERS; Marler P, 1997, J NEUROBIOL, V33, P501; McCauley RD, 2010, SC62SH26 INT WHAL CO; McCauley RD, 2006, J ACOUST SOC AM, V120, P3266, DOI DOI 10.1121/1.4776880; McCauley RD, 2004, R200429 CURT U TECHN; McCauley RD, 2018, DEEP-SEA RES PT II, V157, P154, DOI 10.1016/j.dsr2.2018.09.006; McCauley RD, 2017, ACOUST AUST, V45, P301, DOI 10.1007/s40857-017-0113-8; McDonald MA, 2003, SCIENCE, V55; Mercado E, 2005, ANIM COGN, V8, P93, DOI 10.1007/s10071-004-0238-7; Mercado E, 2018, FRONT PSYCHOL, V9, P20; Mori C, 2018, SCI REP, V8, P10; Noad MJ, 2000, NATURE, V408, P537, DOI 10.1038/35046199; Oleson EM, 2007, MAR ECOL PROG SER, V330, P269, DOI 10.3354/meps330269; Oleson EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115678; PAYNE K, 1985, Z TIERPSYCHOL, V68, P89; Rehn N, 2007, BEHAVIOUR, V144, P307, DOI 10.1163/156853907780425703; Rekdahl ML, 2013, J ACOUST SOC AM, V133, P1785, DOI 10.1121/1.4789941; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Rennie S, 2009, J MARINE SYST, V77, P21, DOI 10.1016/j.jmarsys.2008.11.008; Riesch R, 2006, ANIM BEHAV, V71, P79, DOI 10.1016/j.anbehav.2005.03.026; Ronald KL, 2015, ETHOLOGY, V121, P1104, DOI 10.1111/eth.12425; Samaran F., 2008, CAN ACOUST, V36, P93; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Sirovic A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09979-4; Smith R, 2014, ENTROPY-SWITZ, V16, P526, DOI 10.3390/e16010526; Stafford KM, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2018.0056; Stafford KM, 2011, MAR MAMMAL SCI, V27, P828, DOI 10.1111/j.1748-7692.2010.00437.x; Tripovich JS, 2015, J MAMMAL, V96, P603, DOI 10.1093/jmammal/gyv065; Truskanov N, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0050; Ward S, 2003, ANIM BEHAV, V66, P893, DOI 10.1006/anbe.2003.2250; Whitehead H., 2014, CULTURAL LIVES WHALE; Whiteway T. G., 2009, GEOSCI AUSTR REC; Wiggins GA, 2015, PHILOS T R SOC B, V370, P129, DOI 10.1098/rstb.2014.0099	74	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0208619	10.1371/journal.pone.0208619	http://dx.doi.org/10.1371/journal.pone.0208619			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668600	gold, Green Submitted, Green Published			2022-12-26	WOS:000456306400001
J	Curveira-Santos, G; Pedroso, NM; Barros, AL; Santos-Reis, M				Curveira-Santos, Goncalo; Pedroso, Nuno M.; Barros, Ana Luisa; Santos-Reis, Margarida			Mesocarnivore community structure under predator control: Unintended patterns in a conservation context	PLOS ONE			English	Article							CATS FELIS-SILVESTRIS; FERAL DOMESTIC CATS; FOX VULPES-VULPES; RED FOX; CARNIVORE DIVERSITY; PHOTOGRAPHIC RATES; EUROPEAN WILDCAT; GAME MANAGEMENT; TOP PREDATORS; FOREST COVER	Across the Mediterranean, conservation programmes often operate concomitantly with hunting interests within game-lands. Carnivore guilds lie at the interface between contrasting management goals, being simultaneously fundamental components of ecosystems and targets of predator control to reduce predation on game species. Here, we evaluate the composition and spatial structure of a mesocarnivore community in a protected area of Southeast Portugal, with high economic investment in conservation and significant hunting activity. Between June and August 2015, we deployed 77 camera-traps across a similar to 80 km(2) area. We report on interspecific disparities in mesocarnivore occupancy and associated environmental determinants. Contrasting occupancy states suggest an unbalanced community, biased towards the widespread occurrence of the red fox Vulpes vulpes ((psi) over cap = 0.92 +/- 0.04) compared to other species (stone marten Martes foina, European badger Meles meles, Egyptian mongoose Herpestes ichneumon, common genet Genetta genetta, and Eurasian otter Lutra lutra) exhibiting spatially-restricted occupancy patterns ((psi) over cap /naive occupancy < 0.35). The feral cat Felis silvestris catus was the exception (<(psi)over cap> = 0.48 +/- 0.11) and, together with the stone marten, exhibited a positive association with human settlements. These findings are consistent with theoretical predictions on how mesocarnivore communities are shaped by the effects of non-selective predator control, paradoxically favouring species with higher population growth rates and dispersal abilities, such as the red fox. Our results reinforce the need to understand the role of predator control as a community structuring agent with potential unintended effects, while exposing issues hindering such attempts, namely non-selective illegal killing or biased/concealed information on legal control measures.	[Curveira-Santos, Goncalo; Pedroso, Nuno M.; Barros, Ana Luisa; Santos-Reis, Margarida] Univ Lisbon, Fac Ciencias, CE3c Ctr Ecol Evolut & Environm Changes, Lisbon, Portugal; [Pedroso, Nuno M.] Univ Sao Paulo, CENA, Piracicaba, SP, Brazil	Universidade de Lisboa; Universidade de Sao Paulo	Curveira-Santos, G (corresponding author), Univ Lisbon, Fac Ciencias, CE3c Ctr Ecol Evolut & Environm Changes, Lisbon, Portugal.	goncalo-cs@hotmail.com	Santos-Reis, Margarida/H-4064-2011; Pedroso, Nuno Miguel Peres Sampaio/I-6295-2013	Pedroso, Nuno Miguel Peres Sampaio/0000-0001-6486-130X; Barros, Ana Luisa/0000-0003-1363-1509; Curveira-Santos, Goncalo/0000-0002-7136-5088; Santos-Reis, Margarida/0000-0002-0337-963X	LIFE+ Nature project - Life Programme - European Commission [LIFE13 NAT/PT/001300]; Fundacao para a Ciencia e a Tecnologia (FCT) [PD/BD/114037/2015, UID/BIA/00329/2013]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo Research Foundation (FAPESP)) [2014/08601-6]; Sao Paulo Research Foundation (FAPESP) [2014/08601-6]; FCT [UID/BIA/00329/2013]; Liga para a Proteccao da Natureza [LIFE08 NAT/P/000227]; Life Programme-European Commission [LIFE13 NAT/PT/001300]	LIFE+ Nature project - Life Programme - European Commission; Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo Research Foundation (FAPESP))(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Liga para a Proteccao da Natureza; Life Programme-European Commission	Funding was received from the LIFE+ Nature project LIFE13 NAT/PT/001300 (http://ec.europa.eu/environment/life/), supported 75% by the Life Programme - European Commission. We would like to thank Liga para a Proteccao da Natureza for the vegetation geographic information system coverage available for GVNP, produced under the LIFE Project "Enhancing habitat for the Iberian Lynx and Black Vulture in the Southeast of Portugal" - LIFE08 NAT/P/000227. GCS (PD/BD/114037/2015), MSR and ALB (UID/BIA/00329/2013) were supported by Fundacao para a Ciencia e a Tecnologia (FCT) (www.fct.pt). NMP was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo Research Foundation (FAPESP)) (#2014/08601-6) (www.fapesp.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was conducted under the LIFE+ Nature project "Conservation of the Spanish Imperial Eagle (Aquila adalberti) in Portugal"-LIFE13 NAT/PT/001300, supported 75% by the Life Programme-European Commission. We would like to thank Liga para a Proteccao da Natureza for the vegetation geographic information system coverage available for GVNP, produced under the LIFE Project " Enhancing habitat for the Iberian Lynx and Black Vulture in the Southeast of Portugal"-LIFE08 NAT/P/000227. We would also thank Ricardo Martins for all his support in fieldwork and to Barbara Madeira for her field and photo identification work. We also thank the feedback from two anonymous reviewers which led to substantial improvements. During the writing phase of the manuscript, GCS was funded by a doctoral grant from Fundacao para a Ciencia e a Tecnologia (FCT) (PD/BD/114037/2015). NMP was supported by grant #2014/08601-6, Sao Paulo Research Foundation (FAPESP). MSR and ALB had support from FCT (UID/BIA/00329/2013).	[Anonymous], 2015, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2015-2.RLTS.T12520A50655794.EN; [Anonymous], 2005, PROGRAM MARK GENTLE; Baker PJ, 2006, EUR J WILDLIFE RES, V52, P99, DOI 10.1007/s10344-005-0018-y; Barea-Azcon JM, 2007, BIODIVERS CONSERV, V16, P1213, DOI 10.1007/s10531-006-9114-x; Barrull J, 2014, MAMM BIOL, V79, P123, DOI 10.1016/j.mambio.2013.11.004; Barrull J, 2014, ITAL J ZOOL, V81, P271, DOI 10.1080/11250003.2014.893378; Barrull J, 2011, MAMMALIA, V75, P363, DOI 10.1515/MAMM.2011.052; Beja P, 2009, EUR J WILDLIFE RES, V55, P227, DOI 10.1007/s10344-008-0236-1; Biro Z, 2005, J ZOOL, V266, P187, DOI 10.1017/S0952836905006771; Blondel J, 2006, HUM ECOL, V34, P713, DOI 10.1007/s10745-006-9030-4; BRIGHT PW, 1993, MAMMAL REV, V23, P101, DOI 10.1111/j.1365-2907.1993.tb00420.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cabral M.J., 2005, LIVRO VERMELHO VERTE; Carbone C, 2001, ANIM CONSERV, V4, P75, DOI 10.1017/S1367943001001081; Carlsson NOL, 2010, BIOL INVASIONS, V12, P633, DOI 10.1007/s10530-009-9470-z; Casanovas JG, 2012, ECOL RES, V27, P603, DOI 10.1007/s11284-012-0931-y; Caut S, 2007, AUSTRAL ECOL, V32, P858, DOI 10.1111/j.1442-9993.2007.01770.x; Cruz J, 2015, J MAMMAL, V96, P854, DOI 10.1093/jmammal/gyv109; Curveira-Santos G, 2017, AGR ECOSYST ENVIRON, V237, P280, DOI 10.1016/j.agee.2016.12.037; Delibes-Mateos M, 2008, CONSERV BIOL, V22, P1106, DOI 10.1111/j.1523-1739.2008.00993.x; Delibes-Mateos M, 2008, BIODIVERS CONSERV, V17, P559, DOI 10.1007/s10531-007-9272-5; Delibes-Mateos M, 2013, ECOL SOC, V18, DOI 10.5751/ES-05367-180228; Di Bitetti Mario S, 2014, Mastozool. neotrop., V21, P37; Diaz-Ruiz F, 2013, MAMMAL REV, V43, P59, DOI 10.1111/j.1365-2907.2011.00206.x; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dorresteijn I, 2015, P ROY SOC B-BIOL SCI, V282, P105, DOI 10.1098/rspb.2015.1602; Duarte A, 2012, VET MICROBIOL, V158, P400, DOI 10.1016/j.vetmic.2012.02.033; Dubois S, 2017, CONSERV BIOL, V31, P753, DOI 10.1111/cobi.12896; Fedriani JM, 1999, OECOLOGIA, V121, P138, DOI 10.1007/s004420050915; FERREIRA JP, 2011, PLOS ONE, V6, P38426; Ferreras P, 2017, J ZOOL, V301, P23, DOI 10.1111/jzo.12386; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Galvez N, 2013, ORYX, V47, P251, DOI 10.1017/S0030605312000099; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; Germain E, 2008, J ZOOL, V276, P195, DOI 10.1111/j.1469-7998.2008.00479.x; Graham K, 2005, BIOL CONSERV, V122, P159, DOI 10.1016/j.biocon.2004.06.006; Grilo C, 2009, BIOL CONSERV, V142, P301, DOI 10.1016/j.biocon.2008.10.026; Harding EK, 2001, CONSERV BIOL, V15, P1114, DOI 10.1046/j.1523-1739.2001.0150041114.x; Herr J, 2009, J ZOOL, V277, P54, DOI 10.1111/j.1469-7998.2008.00510.x; Jaeger JAG, 2005, ECOL MODEL, V185, P329, DOI 10.1016/j.ecolmodel.2004.12.015; Kauhala K, 1999, IMPACT PREDATOR REMO, P139; Kays Roland W., 2008, P110; Kilshaw K, 2010, SCOTTISH WILDCAT COM; Kuijper DPJ, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1625; LISZKA T, 1984, INT J NUMER METH ENG, V20, P1599, DOI 10.1002/nme.1620200905; Long RA, 2011, LANDSCAPE ECOL, V26, P327, DOI 10.1007/s10980-010-9547-1; LOSS SR, 2013, NAT COMMUN, V4; Lozano J, 2013, ANIM BIODIV CONSERV, V36, P37; MacKenzie D. I., 2004, Animal Biodiversity and Conservation, V27, P461; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Martinez J., 2002, SOCIOECONOMIC ASPECT; McDonald RA, 2002, J APPL ECOL, V39, P793, DOI 10.1046/j.1365-2664.2002.00757.x; Monterroso P, 2014, EUR J WILDLIFE RES, V60, P279, DOI 10.1007/s10344-013-0780-1; Newsome TM, 2014, EUR J WILDLIFE RES, V60, P749, DOI 10.1007/s10344-014-0844-x; O'Bryan CJ, 2018, NAT ECOL EVOL, V2, P229, DOI 10.1038/s41559-017-0421-2; Oldfield TEE, 2003, NATURE, V423, P531, DOI 10.1038/nature01678; Oliveira R, 2008, CONSERV GENET, V9, P1, DOI 10.1007/s10592-007-9297-z; PALOMARES F, 1993, J APPL ECOL, V30, P752, DOI 10.2307/2404253; PALOMARES F, 1995, CONSERV BIOL, V9, P295, DOI 10.1046/j.1523-1739.1995.9020295.x; Pita R, 2009, AGR ECOSYST ENVIRON, V132, P57, DOI 10.1016/j.agee.2009.02.008; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; Recio MR, 2015, CURR ZOOL, V61, P793, DOI 10.1093/czoolo/61.5.793; Reynolds JC, 1996, CONTROL MAMMALIAN PR, P26; Ritchie EG, 2012, TRENDS ECOL EVOL, V27, P265, DOI 10.1016/j.tree.2012.01.001; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Roemer GW, 2009, BIOSCIENCE, V59, P165, DOI 10.1525/bio.2009.59.2.9; Rosalino LM, 2010, ANN ZOOL FENN, V47, P195, DOI 10.5735/086.047.0304; Santos MJ, 2010, EUR J WILDLIFE RES, V56, P275, DOI 10.1007/s10344-009-0317-9; SANTOS MJ, 2007, WEB ECOL, V7, P53, DOI DOI 10.5194/WE-7-53-2007; Santos-Reis M, 2004, MARTENS AND FISHERS (MARTES) IN HUMAN-ALTERED ENVIRONMENTS: AN INTERNATIONAL PERSPECTIVE, P147; Sarmento P, 1996, ACTA THERIOL, V41, P409, DOI 10.4098/AT.arch.96-39; Sarmento P, 2009, EUR J WILDLIFE RES, V55, P247, DOI 10.1007/s10344-008-0240-5; Sarmento PB, 2011, EUR J WILDLIFE RES, V57, P119, DOI 10.1007/s10344-010-0405-x; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Sillero-Zubiri C., 2004, P257; Swann DE, 2004, WILDLIFE SOC B, V32, P357, DOI 10.2193/0091-7648(2004)32[357:ICFDWA]2.0.CO;2; Tapper SC, 1996, J APPL ECOL, V33, P965, DOI 10.2307/2404678; Team QGD, 2017, QUANT GIS GEOGR INF; Team RDC, 2011, R LANG ENV STAT COMP; Villafuerte R, 1998, BIOL CONSERV, V84, P181, DOI 10.1016/S0006-3207(97)00094-3; Virgos E, 2005, BIODIVERS CONSERV, V14, P3475, DOI 10.1007/s10531-004-0823-8; Virgos E, 2002, ACTA OECOL, V23, P231, DOI 10.1016/S1146-609X(02)01142-6; Virgos E, 2001, BIODIVERS CONSERV, V10, P1039, DOI 10.1023/A:1016684428664; Virgos E, 2016, BIODIVERS CONSERV, V25, P1409, DOI 10.1007/s10531-016-1117-7; Whitfield DP, 2003, BIOL CONSERV, V114, P157, DOI 10.1016/S0006-3207(03)00019-3	87	6	6	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210661	10.1371/journal.pone.0210661	http://dx.doi.org/10.1371/journal.pone.0210661			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653547	gold, Green Submitted, Green Published			2022-12-26	WOS:000456015500062
J	Hjelmgren, O; Stromberg, U; Gellerman, K; Thurin, A; Zetterberg, M; Bergstrom, G				Hjelmgren, Ola; Stromberg, Ulf; Gellerman, Karl; Thurin, Anders; Zetterberg, Madeleine; Bergstrom, Goran			Does retinopathy predict stroke recurrence in type 2 diabetes patients: A retrospective study?	PLOS ONE			English	Article							VASCULAR RISK-FACTORS; CARDIOVASCULAR EVENTS; GENERAL-POPULATION; CAROTID STENOSIS; DISEASE; MORTALITY; MICROANGIOPATHY; ATHEROSCLEROSIS; ENDARTERECTOMY; COMPLICATIONS	Aims To study if retinopathy increases the risk of stroke recurrence in stroke patients with type 2 diabetes. Also, to study if stroke patients with type 2 diabetes have an increased risk of stroke recurrence compared to non-diabetics and if stroke patients with type 2 diabetes, regardless of retinopathy, have a higher incidence of carotid stenosis. Also, to study if stroke patients with type 2 diabetes retinopathy have increased incidence of carotid stenosis. Methods We included 445 patients with type 2 diabetes mellitus and a matched control group of 445 patients without diabetes, who had all suffered their first stroke or TIA. Information on retinopathy, risk factors and stroke recurrence were obtained from registers and medical records. Results Retinopathy did not increase the risk of stroke recurrence in diabetes patients, HR 0.89 (0.51-1.53), p = 0.67. The risk of stroke recurrence was not increased in diabetics compared to non-diabetes. Diabetes patients had an increased prevalence of carotid stenosis compared to non-diabetics, 1.69 (1.15-2.48), p = 0.008. The prevalence of carotid stenosis in diabetics with retinopathy was not increased compared to diabetics without retinopathy. Conclusion Retinopathy is not a predictor of stroke recurrence or carotid stenosis in type 2 diabetes patients.	[Hjelmgren, Ola; Gellerman, Karl; Bergstrom, Goran] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Wallenberg Lab,Dept Mol & Clin Med, Gothenburg, Sweden; [Hjelmgren, Ola; Thurin, Anders; Bergstrom, Goran] Sahlgrens Univ Hosp, Dept Clin Physiol, Gothenburg, Sweden; [Stromberg, Ulf] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Hlth Metr Unit, Gothenburg, Sweden; [Zetterberg, Madeleine] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil Ophthalmol, Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; University of Gothenburg	Hjelmgren, O (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Wallenberg Lab,Dept Mol & Clin Med, Gothenburg, Sweden.; Hjelmgren, O (corresponding author), Sahlgrens Univ Hosp, Dept Clin Physiol, Gothenburg, Sweden.	ola.hjelmgren@wlab.gu.se		Bergstrom, Goran/0000-0003-4289-5722; Hjelmgren, Ola/0000-0002-8639-6928	Swedish Heart Lung Foundation [20150372]; Swedish government; ALF [ALFGBG-718851]	Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish government; ALF	This work was supported by the Swedish Heart Lung Foundation (20150372) to GB and the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALFGBG-718851) to GB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Cardoso CRL, 2012, J HYPERTENS, V30, P940, DOI 10.1097/HJH.0b013e328352aba6; Cheung N, 2008, PROG RETIN EYE RES, V27, P161, DOI 10.1016/j.preteyeres.2007.12.001; Cheung N, 2007, STROKE, V38, P398, DOI 10.1161/01.STR.0000254547.91276.50; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; de Kreutzenberg SV, 2011, NUTR METAB CARDIOVAS, V21, P286, DOI 10.1016/j.numecd.2009.10.003; de Weerd M, 2010, STROKE, V41, P1294, DOI 10.1161/STROKEAHA.110.581058; Fuller JH, 2001, DIABETOLOGIA, V44, pS54, DOI 10.1007/PL00002940; Gerstein HC, 2013, DIABETES CARE, V36, P1266, DOI 10.2337/dc12-1311; GUO V, 2016, STROKE, V4, P14, DOI DOI 10.1016/J.JSTR0KECEREBR0VASDIS.2016.03.009; Hankey GJ, 2013, J NEUROL NEUROSUR PS, V84, P281, DOI 10.1136/jnnp-2012-303365; HELLINGS WE, CIRCULATION, P1941, DOI DOI 10.1161/CIRCULATI0NAHA.109.887497; Joakimsen O, 2000, STROKE, V31, P1871, DOI 10.1161/01.STR.31.8.1871; Kawasaki R, 2013, OPHTHALMOLOGY, V120, P574, DOI 10.1016/j.ophtha.2012.08.029; Kawasaki R, 2011, OPHTHALMOLOGY, V118, P860, DOI 10.1016/j.ophtha.2010.08.040; KLEIN R, 1992, DIABETES CARE, V15, P1875, DOI 10.2337/diacare.15.12.1875; Klein R, 1999, ARCH OPHTHALMOL-CHIC, V117, P1487; Klein R, 2002, BRIT J OPHTHALMOL, V86, P84, DOI 10.1136/bjo.86.1.84; Klein R, 2002, OPHTHALMOLOGY, V109, P1225, DOI 10.1016/S0161-6420(02)01074-6; Kramer CK, 2011, DIABETES CARE, V34, P1238, DOI 10.2337/dc11-0079; Miyamoto M, 2012, ACTA DIABETOL, V49, P63, DOI 10.1007/s00592-011-0287-8; MRCEUROPEAN C, LANCET, V70, P99; PMID, PUBMED; PMID, 2010, PUBMED, V8, P40; Rosenson RS, 2011, ATHEROSCLEROSIS, V218, P13, DOI 10.1016/j.atherosclerosis.2011.06.029; Rothwell PM, 2004, LANCET, V363, P915, DOI 10.1016/S0140-6736(04)15785-1; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Schulz UGR, 2003, STROKE, V34, P2050, DOI 10.1161/01.STR.0000079818.08343.8C; Sluimer JC, 2009, J PATHOL, V218, P7, DOI 10.1002/path.2518; Son JW, 2011, DIABETES RES CLIN PR, V91, P253, DOI 10.1016/j.diabres.2010.11.005; VISONA A, 1995, ANGIOLOGY, V46, P793, DOI 10.1177/000331979504600905; Arcidiacono MV, 2013, ATHEROSCLEROSIS, V228, P142, DOI 10.1016/j.atherosclerosis.2013.02.011; Yla-Herttuala S, 2013, EUR HEART J, V34, P3251, DOI 10.1093/eurheartj/eht301; Yun Yong Woon, 2011, J Prev Med Public Health, V44, P260, DOI 10.3961/jpmph.2011.44.6.260	35	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210832	10.1371/journal.pone.0210832	http://dx.doi.org/10.1371/journal.pone.0210832			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653584	gold, Green Submitted, Green Published			2022-12-26	WOS:000456015500078
J	Yang, ZC; Yang, CC; Wang, ZY; Yang, Z; Chen, DY; Wu, YJ				Yang, Zhenchao; Yang, Chengcheng; Wang, Zhengyan; Yang, Zhao; Chen, Danyan; Wu, Yongjun			LncRNA expression profile and ceRNA analysis in tomato during flowering	PLOS ONE			English	Article							LONG NONCODING RNAS; NATURAL ANTISENSE TRANSCRIPTS; GENOME-WIDE ANALYSIS; FUNCTIONAL PREDICTION; GENE; IDENTIFICATION; ROLES; PROTEIN; COOLAIR; FLC	Long non-coding RNAs (lncRNAs) are a class of non-coding RNAs that play essential regulatory roles in various developmental processes and stress responses. However, the functions of lncRNAs during the flowering period of tomato are largely unknown. To explore the lncRNA profiles and functions during flowering in tomato, we performed strand-specific paired-end RNA sequencing of tomato leaves, flowers and roots, with three biological replicates. We identified 10919 lncRNAs including 248 novel lncRNAs, of which 65 novel lncRNAs were significantly differentially expressed (DE) in the flowers, leaves, and roots. The Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were carried out to identify the cis target gene of DE lncRNAs. The results showed that the lncRNAs might play an important role in the growth, development, and apoptosis of flowering tomato plant by regulating the formation of intima in flower tissues, binding to various molecules, influencing metabolic pathways, and inducing apoptosis. Moreover, we identified the interaction between 32, 78, and 397 kinds of miRNAs, lncRNAs, and mRNAs. The results suggest that the lncRNAs can regulate the expression of mRNA during flowering period in tomato by forming competitive endogenous RNA, and further regulate various biological metabolism pathways in tomato.	[Yang, Zhenchao; Yang, Chengcheng; Wang, Zhengyan; Yang, Zhao; Chen, Danyan; Wu, Yongjun] Northwest A&F Univ, Coll Life Sci, Coll Hort, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Wu, YJ (corresponding author), Northwest A&F Univ, Coll Life Sci, Coll Hort, Yangling, Shaanxi, Peoples R China.	yjwu669@163.com			National Key R&D Program, "Integrated Research and Demonstration of Fertilizer and Pesticide Reduction Technology in Open Field Vegetables" [2018YFD0201200]; Agricultural Science and Technology Innovation Integration Promotion Project of Shaanxi Provincial Department of Agriculture [NYKJ-2018-YL22, 2017-TS-2]	National Key R&D Program, "Integrated Research and Demonstration of Fertilizer and Pesticide Reduction Technology in Open Field Vegetables"; Agricultural Science and Technology Innovation Integration Promotion Project of Shaanxi Provincial Department of Agriculture	This work was supported by the National Key R&D Program, "Integrated Research and Demonstration of Fertilizer and Pesticide Reduction Technology in Open Field Vegetables" (2018YFD0201200), Agricultural Science and Technology Innovation Integration Promotion Project of Shaanxi Provincial Department of Agriculture (NYKJ-2018-YL22 and 2017-TS-2) (ZY) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Ben Amor B, 2009, GENOME RES, V19, P57, DOI 10.1101/gr.080275.108; Bhatia Garima, 2017, Non-Coding RNA, V3, P16, DOI 10.3390/ncrna3020016; Boerner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043047; Celton JM, 2014, NEW PHYTOL, V203, P287, DOI 10.1111/nph.12787; Chen LL, 2016, TRENDS BIOCHEM SCI, V41, P761, DOI 10.1016/j.tibs.2016.07.003; Csorba T, 2014, P NATL ACAD SCI USA, V111, P16160, DOI 10.1073/pnas.1419030111; Dai XB, 2018, NUCLEIC ACIDS RES, V46, pW49, DOI 10.1093/nar/gky316; Deng FN, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1238-0; Deng PC, 2018, SCI CHINA LIFE SCI, V61, P190, DOI 10.1007/s11427-017-9174-9; Di C, 2014, PLANT J, V80, P848, DOI 10.1111/tpj.12679; Fernandez MV, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007045; He L, 2018, EPIGENOMICS-UK, V10, P661, DOI 10.2217/epi-2017-0176; Heo JB, 2013, CHROMOSOME RES, V21, P685, DOI 10.1007/s10577-013-9392-6; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Hotto AM, 2011, G3-GENES GENOM GENET, V1, P559, DOI 10.1534/g3.111.000752; Kim ED, 2012, TRENDS PLANT SCI, V17, P16, DOI 10.1016/j.tplants.2011.10.008; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; LI L, 2014, GENOME BIOL, V15; Li R, 2018, PLANT J, V94, P513, DOI 10.1111/tpj.13872; Li S, 2013, GENOME RES, V23, P1730, DOI 10.1101/gr.149310.112; Liao Q, 2011, NUCLEIC ACIDS RES, V39, P3864, DOI 10.1093/nar/gkq1348; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Liu X, 2015, GENOM PROTEOM BIOINF, V13, P137, DOI 10.1016/j.gpb.2015.02.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu Chang, 2017, Yichuan, V39, P1054, DOI 10.16288/j.yczz.17-120; Lu TT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-721; Marquardt S, 2014, MOL CELL, V54, P156, DOI 10.1016/j.molcel.2014.03.026; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nejat N, 2018, CRIT REV BIOTECHNOL, V38, P93, DOI 10.1080/07388551.2017.1312270; Osato N, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2003-5-1-r5; PACHNIS V, 1988, EMBO J, V7, P673, DOI 10.1002/j.1460-2075.1988.tb02862.x; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Riffo-Campos AL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17121987; Rubio-Somoza I, 2011, CELL, V147, P1431, DOI 10.1016/j.cell.2011.12.003; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Shafiq S, 2016, BBA-GENE REGUL MECH, V1859, P155, DOI 10.1016/j.bbagrm.2015.06.009; Shuai P, 2014, J EXP BOT, V65, P4975, DOI 10.1093/jxb/eru256; Signal B, 2016, TRENDS GENET, V32, P620, DOI 10.1016/j.tig.2016.08.004; Song DD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S36; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang H, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r92; Wang H, 2014, GENOME RES, V24, P444, DOI 10.1101/gr.165555.113; Wang JY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16946; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang RH, 2018, ECOL EVOL, V8, P6034, DOI 10.1002/ece3.4152; Wang XJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r30; Wang YQ, 2014, MOL PLANT, V7, P514, DOI 10.1093/mp/sst177; Wang Z, 2018, BMC GENET, V19, DOI 10.1186/s12863-018-0671-2; Wen Jiayu, 2007, In Silico Biology, V7, P485; Wu HJ, 2012, NUCLEIC ACIDS RES, V40, pW22, DOI 10.1093/nar/gks554; Xin MM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-61; Xu XW, 2016, SCI REP-UK, V6, DOI 10.1038/srep20715; YOUNG MD, 2010, GENOME BIOL, V11; Yu X, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-208; Zhang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098958; Zhang YC, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0512-1; Zhang YC, 2013, BIOCHEM BIOPH RES CO, V436, P111, DOI 10.1016/j.bbrc.2013.05.086; Zhou XF, 2009, GENOME RES, V19, P70, DOI 10.1101/gr.084806.108; Zhu BZ, 2015, J EXP BOT, V66, P4483, DOI 10.1093/jxb/erv203; Zhu M, 2017, GENES-BASEL, V8, DOI 10.3390/genes8100274	66	17	17	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210650	10.1371/journal.pone.0210650	http://dx.doi.org/10.1371/journal.pone.0210650			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653557	Green Submitted, gold, Green Published			2022-12-26	WOS:000456015500059
J	Akami, M; Andongma, AA; Chen, ZZ; Nan, J; Khaeso, K; Jurkevitch, E; Niu, CY; Yuval, B				Akami, Mazarin; Andongma, Awawing A.; Chen Zhengzhong; Nan, Jiang; Khaeso, Kanjana; Jurkevitch, Edouard; Niu, Chang-Ying; Yuval, Boaz			Intestinal bacteria modulate the foraging behavior of the oriental fruit fly Bactrocera dorsalis (Diptera: Tephritidae)	PLOS ONE			English	Article							GUT MICROBIOTA; CULTIVABLE BACTERIA; FLIES; STATE; HOST; COMMUNITIES; POPULATIONS; DROSOPHILA; DIVERSITY; MANIPULATION	The gut microbiome of insects directly or indirectly affects the metabolism, immune status, sensory perception and feeding behavior of its host. Here, we examine the hypothesis that in the oriental fruit fly (Bactrocera dorsalis, Diptera: Tephritidae), the presence or absence of gut symbionts affects foraging behavior and nutrient ingestion. We offered protein-starved flies, symbiotic or aposymbiotic, a choice between diets containing all amino acids or only the non-essential ones. The different diets were presented in a foraging arena as drops that varied in their size and density, creating an imbalanced foraging environment. Suppressing the microbiome resulted in significant changes of the foraging behavior of both male and female flies. Aposymbiotic flies responded faster to the diets offered in experimental arenas, spent more time feeding, ingested more drops of food, and were constrained to feed on time-consuming patches (containing small drops of food), when these offered the full complement of amino acids. We discuss these results in the context of previous studies on the effect of the gut microbiome on host behavior, and suggest that these be extended to the life history dimension.	[Akami, Mazarin; Andongma, Awawing A.; Chen Zhengzhong; Nan, Jiang; Khaeso, Kanjana; Niu, Chang-Ying] Huazhong Agr Univ, Coll Plant Sci & Technol, Dept Plant Protect, Wuhan, Hubei, Peoples R China; [Akami, Mazarin] Univ Ngaoundere, Fac Sci, Dept Biol Sci, Ngaoundere, Cameroon; [Jurkevitch, Edouard] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Microbiol & Plant Dis, Rehovot, Israel; [Yuval, Boaz] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Entomol, Rehovot, Israel	Huazhong Agricultural University; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Niu, CY (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Dept Plant Protect, Wuhan, Hubei, Peoples R China.; Yuval, B (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Entomol, Rehovot, Israel.	niuchangying88@163.com; boaz.yuval@mail.huji.ac.il	Andongma, Awawing/AAN-3813-2020; Yuval, Boaz/C-3447-2009	Yuval, Boaz/0000-0002-6864-3825	Israel Science Foundation [2482/16]; Science Foundation of China [2482/16]; National Natural Science Foundation of China [31661143045]; International Atomic Energy Agency (CRP) [17153, 18269]; Agricultural public welfare industry research - Ministry of Agriculture of People's Republic of China [201503137]; Fundamental Research Funds for the Central Universities [2662015PY148]	Israel Science Foundation(Israel Science Foundation); Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Atomic Energy Agency (CRP)(International Atomic Energy Agency); Agricultural public welfare industry research - Ministry of Agriculture of People's Republic of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was funded by the Joint programme of the Israel Science Foundation and the Science Foundation of China (2482/16), National Natural Science Foundation of China (31661143045), International Atomic Energy Agency (CRP No. 17153 and No. 18269), Agricultural public welfare industry research supported by Ministry of Agriculture of People's Republic of China (201503137) and the Fundamental Research Funds for the Central Universities (2662015PY148).	Alcock J, 2014, BIOESSAYS, V36, P940, DOI 10.1002/bies.201400071; Andongma AA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09470; Barton Browne L., 1975, Advances Insect Physiol, V11, P1; Behar A, 2008, MOL ECOL, V17, P1375, DOI 10.1111/j.1365-294X.2008.03674.x; Behar A, 2005, MOL ECOL, V14, P2637, DOI 10.1111/j.1365-294X.2005.02615.x; Behar Adi, 2009, P251; Ben Ami E, 2010, ISME J, V4, P28, DOI 10.1038/ismej.2009.82; Ben-Yosef M, 2014, J EVOLUTION BIOL, V27, P2695, DOI 10.1111/jeb.12527; Ben-Yosef M, 2008, PHYSIOL ENTOMOL, V33, P145, DOI 10.1111/j.1365-3032.2008.00617.x; Ben-Yosef M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150170; Ben-Yosef M, 2010, P ROY SOC B-BIOL SCI, V277, P1545, DOI 10.1098/rspb.2009.2102; Berasategui A, 2017, MOL ECOL, V26, P4099, DOI 10.1111/mec.14186; Catalan TP, 2011, EVOL ECOL RES, V13, P711; Chapman RF, 2003, ANNU REV ENTOMOL, V48, P455, DOI 10.1146/annurev.ento.48.091801.112629; Chapman RF., 1995, REGULATORY MECH INSE, Vvol. 1995; Dong YC, 2013, J PEST SCI, V86, P429, DOI 10.1007/s10340-013-0493-y; Drew RAI, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P731; Eisthen HL, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0052; Gadenne C, 2016, ANNU REV ENTOMOL, V61, P317, DOI 10.1146/annurev-ento-010715-023523; Gujjar NR, 2017, PHYTOPARASITICA, V45, P453, DOI 10.1007/s12600-017-0604-z; Guo ZJ, 2017, APPL MICROBIOL BIOT, V101, P8543, DOI 10.1007/s00253-017-8551-7; Hoskins AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079484; Hosokawa T, 2008, BIOL LETTERS, V4, P45, DOI 10.1098/rsbl.2007.0510; Jin S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00672; Khaeso K, 2018, SYMBIOSIS, V74, P97, DOI 10.1007/s13199-017-0493-4; Leitao-Goncalves R, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000862; Liu LJ, 2016, B ENTOMOL RES, V106, P718, DOI 10.1017/S0007485316000390; Mayer EA, 2015, J CLIN INVEST, V125, P926, DOI 10.1172/JCI76304; Mazzon L, 2010, MOL PHYLOGENET EVOL, V56, P312, DOI 10.1016/j.ympev.2010.02.016; Nash WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086029; Newell PD, 2014, APPL ENVIRON MICROB, V80, P788, DOI 10.1128/AEM.02742-13; Peng Y, 2008, APPL ENVIRON MICROB, V74, P3943, DOI 10.1128/AEM.02607-07; Pramanik M. K., 2014, Research Journal of Microbiology, V9, P278; PROKOPY RJ, 1991, OECOLOGIA, V87, P394, DOI 10.1007/BF00634597; Raubenheimer D, 2009, FUNCT ECOL, V23, P4, DOI 10.1111/j.1365-2435.2009.01522.x; Reyes H, 2017, PHYSIOL ENTOMOL, V42, P17, DOI 10.1111/phen.12157; Ridley EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036765; Roeder KA, 2014, FUNCT ECOL, V28, P1135, DOI 10.1111/1365-2435.12262; Sengupta L, 2013, CURR OPIN NEUROBIOL, V23, P68, DOI 10.1016/j.conb.2012.08.001; Shi ZH, 2012, INT J MOL SCI, V13, P6266, DOI 10.3390/ijms13056266; Simpson SJ, 2015, ANNU REV ENTOMOL, V60, P293, DOI 10.1146/annurev-ento-010814-020917; Slansky Frank Jr., 1993, P29; Stephens D.W., 1986, pi; Toshima N, 2012, J EXP BIOL, V215, P2827, DOI 10.1242/jeb.069146; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611; Wang H, 2011, J APPL MICROBIOL, V110, P1390, DOI 10.1111/j.1365-2672.2011.05001.x; Wang HX, 2014, PEST MANAG SCI, V70, P80, DOI 10.1002/ps.3528; Wong ACN, 2015, APPL ENVIRON MICROB, V81, P6232, DOI 10.1128/AEM.01442-15; Wong ACN, 2014, J EXP BIOL, V217, P1894, DOI 10.1242/jeb.101725; Wong ACN, 2017, CURR BIOL, V27, P2397, DOI 10.1016/j.cub.2017.07.022; Yuval B, 2017, CURR BIOL, V27, pR746, DOI 10.1016/j.cub.2017.06.050	51	43	43	7	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210109	10.1371/journal.pone.0210109	http://dx.doi.org/10.1371/journal.pone.0210109			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650116	Green Published, Green Submitted, gold			2022-12-26	WOS:000455813300043
J	Kim, MS; Kim, Y; Lee, S; Lee, S; Golmie, N				Kim, Mun-Suk; Kim, Yena; Lee, SeungSeob; Lee, SuKyoung; Golmie, Nada			A user application-based access point selection algorithm for dense WLANs	PLOS ONE			English	Article								The current commercial access point (AP) selection schemes are mostly based on received signal strength, but perform poorly in many situations. To address this problem, a number of alternative schemes collect and analyze the actual load of every candidate AP. However, these schemes may incur significant latency and signaling overhead in dense wireless local area networks (WLANs). To mitigate such overhead, we propose a user application-based AP selection scheme that considers historical information about AP performance. Without inducing any signaling activity, our scheme monitors the amount of network traffic used by applications and estimates the achievable throughput of APs. Our scheme employs the characteristics of application traffic with the intent of accurately predicting AP performance. Using a measurement study in dense WLAN environments, we show that our scheme achieves higher throughput and lower association latency than those of existing schemes in places highly accessible to the user.	[Kim, Mun-Suk; Kim, Yena; Golmie, Nada] NIST, Gaithersburg, MD 20899 USA; [Lee, SeungSeob; Lee, SuKyoung] Yonsei Univ, Dept Comp Sci, Seoul, South Korea	National Institute of Standards & Technology (NIST) - USA; Yonsei University	Lee, S (corresponding author), Yonsei Univ, Dept Comp Sci, Seoul, South Korea.	sklee@yonsei.ac.kr		Lee, Seung-seob/0000-0002-5224-8599	National Research Foundation of Korea (NRF) - Korea government (MSIT) [NRF-2017R1A2B4002000]	National Research Foundation of Korea (NRF) - Korea government (MSIT)	This work has supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. NRF-2017R1A2B4002000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auld T, 2007, IEEE T NEURAL NETWOR, V18, P223, DOI 10.1109/TNN.2006.883010; Bellalta B, 2017, IEEE COMMUN LETT, V21, P592, DOI 10.1109/LCOMM.2016.2632109; Debele FG, 2015, IEEE J SEL AREA COMM, V33, P2494, DOI 10.1109/JSAC.2015.2482007; Hong K, 2016, PERVASIVE MOB COMPUT, V30, P58, DOI 10.1016/j.pmcj.2015.10.018; Im Y, 2013, IEEE INFOCOM SER, P435; Kim D. H., 2010, P 8 ACM C EMB NETW S, P43, DOI DOI 10.1145/1869983.1869989; Kim H, 2017, IEEE T MOBILE COMPUT, V16, P2366, DOI 10.1109/TMC.2016.2618790; Kim S, 2016, P 2016 IEEE INT C PE; Kim Y., 2017, P IEEE ACM INT S LOW, P1, DOI 10.1109/SMARTCOMP.2017.7946985; Kornycky J, 2017, IEEE ACM T NETWORK, V25, P56, DOI 10.1109/TNET.2016.2562259; Lee K, 2013, IEEE ACM T NETWORK, V21, P536, DOI 10.1109/TNET.2012.2218122; Lei T, 2017, IEEE ACCESS, V5, P15332, DOI 10.1109/ACCESS.2017.2733083; Michael A. K. J., 2017, NETWORK TRAFFIC CLAS; Moh S, 2007, IEEE ICC, P3636, DOI 10.1109/ICC.2007.599; Moore A. W., 2005, Performance Evaluation Review, V33, P50, DOI 10.1145/1071690.1064220; Neal R.M., 2004, SOFTWARE FLEXIBLE BA; Nguyen TTT, 2008, IEEE COMMUN SURV TUT, V10, P56, DOI 10.1109/SURV.2008.080406; Nicholson AJ, P 4 INT C MOB SYST A; Pang J, 2010, IEEE T MOBILE COMPUT, V9, P1713, DOI 10.1109/TMC.2010.151; Park JH, 2018, IEEE ACCESS, V6, P11482, DOI 10.1109/ACCESS.2018.2799384; Press W H, 1992, NUMERICAL RECIPES C; Raschella A, 2017, IEEE T NETW SERV MAN, V14, P441, DOI 10.1109/TNSM.2017.2678021; Sanchez MI, 2016, IEEE WIREL COMMUN, V23, P48, DOI 10.1109/MWC.2016.7422405; Shafigh AS, 2016, IEEE ACM T NETWORK, V24, P717, DOI 10.1109/TNET.2014.2383437; Sohn I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116592; Sun TT, 2016, IEEE T MOBILE COMPUT, V15, P1157, DOI 10.1109/TMC.2015.2442254; Wu H, 2007, IEEE INFOCOM SER, P749, DOI 10.1109/INFCOM.2007.93	27	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210738	10.1371/journal.pone.0210738	http://dx.doi.org/10.1371/journal.pone.0210738			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650150	gold, Green Published, Green Submitted			2022-12-26	WOS:000455813300074
J	Sloot, YJE; Rabold, K; Netea, MG; Smit, JWA; Hoogerbrugge, N; Netea-Maier, RT				Sloot, Yvette J. E.; Rabold, Katrin; Netea, Mihai G.; Smit, Johannes W. A.; Hoogerbrugge, Nicoline; Netea-Maier, Romana T.			Effect of PTEN inactivating germline mutations on innate immune cell function and thyroid cancer-induced macrophages in patients with PTEN hamartoma tumor syndrome	ONCOGENE			English	Article							HEMATOPOIETIC STEM-CELLS; COWDEN SYNDROME; METFORMIN; MTOR; MYELOPOIESIS; REINFECTION; EXPRESSION; PROTECTION; MONOCYTES; KINASE	PTEN hamartoma tumor syndrome (PHTS) is caused by inactivating germline PTEN mutations with subsequent activation of Akt-mTOR signaling, leading to an increased risk of developing thyroid carcinoma (TC). Activation of Akt-mTOR signaling is essential for innate immune cell activation and reprogramming of TC-induced macrophages. Here, we aim to assess the effect of PTEN mutations on innate immune cell function in PHTS patients, especially in the context of TC, using a unique ex vivo model. Monocyte-derived cytokine responses were assessed in 29 PHTS patients and 29 controls. To assess the functional profile of TC-induced-macrophages, a co-culture model with two TC cell lines was performed. Rapamycin, a lactate transport blocker and metformin were used as modulators of the Akt-mTOR pathway and cell metabolism. Monocytes from PHTS patients showed increased production of IL-6, TNF-alpha, IL-8 and MCP-1, and higher lactate production. After co-culture with TC cell lines, TC-induced macrophages showed significantly increased production of cytokines in both patients and controls, especially after co-culture with a PTEN-deficient TC cell line; these effects were abolished after use of rapamycin or a lactate transport blocker. Metformin blocked the production of anti-inflammatory cytokines. In conclusion, innate immune cells from PHTS patients have increased lactate production and a more proinflammatory phenotype, especially after co-culture with PTEN-deficient TC. Metformin promotes a proinflammatory phenotype by blocking anti-inflammatory cytokine response, whereas rapamycin reduces production of proinflammatory cytokines. This indicates that PHTS patients may benefit from treatment with mTOR blocking agents to limit the inflammatory response in the tumor microenvironment.	[Sloot, Yvette J. E.; Rabold, Katrin; Smit, Johannes W. A.; Netea-Maier, Romana T.] Radboud Univ Nijmegen, Med Ctr, Div Endocrinol, Dept Internal Med, Nijmegen, Netherlands; [Rabold, Katrin] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, Radiotherapy & OncoImmunol Lab, Nijmegen, Netherlands; [Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis RCI, Nijmegen, Netherlands; [Hoogerbrugge, Nicoline] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Netea-Maier, RT (corresponding author), Radboud Univ Nijmegen, Med Ctr, Div Endocrinol, Dept Internal Med, Nijmegen, Netherlands.	romana.netea-maier@radboudumc.nl	Netea, Mihai/N-5155-2014; Rabold, Katrin/R-9495-2017	Netea, Mihai/0000-0003-2421-6052	Netherlands Cancer Foundation (KWF) [10559]; Spinoza grant of the Netherlands Organization for Scientific Research	Netherlands Cancer Foundation (KWF); Spinoza grant of the Netherlands Organization for Scientific Research	This work was supported by a grant from the Netherlands Cancer Foundation (KWF) [grant number #10559, 2017]. MGN was supported by a Spinoza grant of the Netherlands Organization for Scientific Research.	Aguirre-Gamboa R, 2016, CELL REP, V17, P2474, DOI 10.1016/j.celrep.2016.10.053; Amer M, 2011, INT J DERMATOL, V50, P516, DOI 10.1111/j.1365-4632.2010.04669.x; Arts RJW, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1229725; Arts RJW, 2016, CELL REP, V17, P2562, DOI 10.1016/j.celrep.2016.11.011; Bekkering S, 2016, CLIN VACCINE IMMUNOL, V23, P926, DOI 10.1128/CVI.00349-16; Bridges HR, 2014, BIOCHEM J, V462, P475, DOI 10.1042/BJ20140620; Caillou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022567; Chen HH, 2017, J ALLERGY CLIN IMMUN, V139, P607, DOI 10.1016/j.jaci.2016.03.059; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Fu YC, 2004, BLOOD CELL MOL DIS, V32, P182, DOI 10.1016/j.bcmd.2003.09.002; Han BY, 2015, TUMOR BIOL, V36, P6295, DOI 10.1007/s13277-015-3315-4; Heindl M, 2012, GASTROENTEROLOGY, V142, P1093, DOI 10.1053/j.gastro.2012.01.011; Hou P, 2007, CLIN CANCER RES, V13, P1161, DOI 10.1158/1078-0432.CCR-06-1125; Jang EK, 2015, EUR THYROID J, V4, P181, DOI 10.1159/000437365; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Klubo-Gwiezdzinska J, 2013, J CLIN ENDOCR METAB, V98, P3269, DOI 10.1210/jc.2012-3799; Kozicky LK, 2015, SEMIN IMMUNOL, V27, P276, DOI 10.1016/j.smim.2015.07.001; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Mehta A, 2018, CANCER DISCOV, V8, P935, DOI 10.1158/2159-8290.CD-17-1178; Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034; Molnarfi N, 2007, J IMMUNOL, V178, P446, DOI 10.4049/jimmunol.178.1.446; Morani F, 2014, J MOL ENDOCRINOL, V53, P247, DOI 10.1530/JME-14-0118; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Netea MG, 2017, J LEUKOCYTE BIOL, V102, P1323, DOI 10.1189/jlb.5RI0217-064RR; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Newton RH, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00151; Nieuwenhuis MH, 2014, FAM CANCER, V13, P57, DOI 10.1007/s10689-013-9674-3; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Peng WY, 2016, CANCER DISCOV, V6, P202, DOI 10.1158/2159-8290.CD-15-0283; Phadngam S, 2016, ONCOTARGET, V7, P84999, DOI 10.18632/oncotarget.13113; Pilarski R, 2013, JNCI-J NATL CANCER I, V105, P1607, DOI 10.1093/jnci/djt277; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Ryder M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054302; Saccardi A, 1994, Minerva Stomatol, V43, P417; Sarrazy V, 2016, CIRC RES, V118, P1062, DOI 10.1161/CIRCRESAHA.115.307599; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; STARINK TM, 1986, CLIN GENET, V29, P222; Xie SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094496; Xu J, 2012, CRIT REV FOOD SCI, V52, P373, DOI 10.1080/10408398.2010.500245; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; 1989, OBSTET GYNECOL 2, V73, P890	47	16	17	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 9	2019	38	19					3743	3755		10.1038/s41388-019-0685-x	http://dx.doi.org/10.1038/s41388-019-0685-x			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HX4OU	30670777				2022-12-26	WOS:000467379600013
J	Heitz, SD; Hamelin, DJ; Hoffmann, RM; Greenberg, N; Salloum, G; Erami, Z; Khalil, BD; Shymanets, A; Steidle, EA; Gong, GQ; Nurnberg, B; Burke, JE; Flanagan, JU; Bresnick, AR; Backer, JM				Heitz, Samantha D.; Hamelin, David J.; Hoffmann, Reece M.; Greenberg, Nili; Salloum, Gilbert; Erami, Zahra; Khalil, Bassem D.; Shymanets, Aliaksei; Steidle, Elizabeth A.; Gong, Grace Q.; Nuernberg, Bernd; Burke, John E.; Flanagan, Jack U.; Bresnick, Anne R.; Backer, Jonathan M.			A single discrete Rab5-binding site in phosphoinositide 3-kinase is required for tumor cell invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphoinositide 3-kinase (PI 3-kinase); Rab; G protein-coupled receptor (GPCR); receptor tyrosine kinase; GTPase; breast cancer; chemotaxis; invasion; matrix degradation; p85; PIK3CB; PIK3R1	SUBUNIT; PI3K-ALPHA; MUTATIONS; GTPASE; GROWTH; BETA; P85	Phosphoinositide 3-kinase (PI3K) is regulated by receptor tyrosine kinases (RTKs), G protein-coupled receptors (GPCRs), and small GTPases such as Rac1 and Rab5. Our lab previously identified two residues (Gln(596) and Ile(597)) in the helical domain of the catalytic subunit (p110) of PI3K whose mutation disrupts binding to Rab5. To better define the Rab5-p110 interface, we performed alanine-scanning mutagenesis and analyzed Rab5 binding with an in vitro pulldown assay with GST-Rab5(GTP). Of the 35 p110 helical domain mutants assayed, 11 disrupted binding to Rab5 without affecting Rac1 binding, basal lipid kinase activity, or G-stimulated kinase activity. These mutants defined the Rab5-binding interface within p110 as consisting of two perpendicular -helices in the helical domain that are adjacent to the initially identified Gln(596) and Ile(597) residues. Analysis of the Rab5-PI3K interaction by hydrogen-deuterium exchange MS identified p110 peptides that overlap with these helices; no interactions were detected between Rab5 and other regions of p110 or p85. Similarly, the binding of Rab5 to isolated p85 could not be detected, and mutations in the Ras-binding domain (RBD) of p110 had no effect on Rab5 binding. Whereas soluble Rab5 did not affect PI3K activity in vitro, the interaction of these two proteins was critical for chemotaxis, invasion, and gelatin degradation by breast cancer cells. Our results define a single, discrete Rab5-binding site in the p110 helical domain, which may be useful for generating inhibitors to better define the physiological role of Rab5-PI3K coupling in vivo.	[Heitz, Samantha D.; Greenberg, Nili; Salloum, Gilbert; Erami, Zahra; Khalil, Bassem D.; Steidle, Elizabeth A.; Backer, Jonathan M.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Bresnick, Anne R.; Backer, Jonathan M.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Hamelin, David J.; Hoffmann, Reece M.; Burke, John E.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8P 3E6, Canada; [Shymanets, Aliaksei; Nuernberg, Bernd] Eberhard Karls Univ Tubingen, Inst Pharmacol & Toxicol, Dept Pharmacol & Expt Therapy, D-72074 Tubingen, Germany; [Shymanets, Aliaksei; Nuernberg, Bernd] Eberhard Karls Univ Tubingen, Interfac Ctr Pharmacogen & Pharma Res, D-72074 Tubingen, Germany; [Gong, Grace Q.; Flanagan, Jack U.] Univ Auckland, Maurice Wilkins Ctr Biodiscovery, Mol Med & Pathol, Auckland Private Bag 92019, New Zealand; [Khalil, Bassem D.] Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, New York, NY 10065 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Victoria; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; University of Auckland; Memorial Sloan Kettering Cancer Center	Backer, JM (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA.; Bresnick, AR; Backer, JM (corresponding author), Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA.	anne.bresnick@einstein.yu.edu; jonathan.backer@einstein.yu.edu	Burke, John/H-3922-2019	Burke, John/0000-0001-7904-9859; Salloum, Gilbert/0000-0002-7137-6772; Hamelin, David/0000-0001-8201-0664; Gong, Grace/0000-0002-7609-0466; Nurnberg, Bernd/0000-0002-5995-6555; Steidle, Elizabeth/0000-0002-8225-7197	National Institutes of Health [T32AG023475, K12-GM102779, R01 GM119279, T32GM007491]; Macromolecular Therapeutics Core of the Albert Einstein Cancer Center through NCI, National Institutes of Health [CA013330]; Deutsche Forschungsgemeinschaft [GRK 1302, NU 53/13-1]; Maurice Wilkins Centre for Biodiscovery; Cancer Research Society Operating Grant [CRS-22641]; Health Research Council of New Zealand [13-763]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM102779, R01GM119279, T32GM007491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG023475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Macromolecular Therapeutics Core of the Albert Einstein Cancer Center through NCI, National Institutes of Health; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Maurice Wilkins Centre for Biodiscovery; Cancer Research Society Operating Grant; Health Research Council of New Zealand(Health Research Council of New Zealand); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants T32AG023475 (to S. D. H., Z. E., and E. A. S.), K12-GM102779 (to E. A. S.), R01 GM119279 (to J. M. B and A. R. B), and T32GM007491 (to N. G.) and the Macromolecular Therapeutics Core of the Albert Einstein Cancer Center through NCI, National Institutes of Health Grant CA013330. J. M. B. is on the scientific advisory board of Karus Therapeutics. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Deutsche Forschungsgemeinschaft Grants GRK 1302 and NU 53/13-1.; Supported by the Maurice Wilkins Centre for Biodiscovery.; Supported by Cancer Research Society Operating Grant CRS-22641.; Supported by Health Research Council of New Zealand Grant 13-763.	Chamberlain MD, 2004, J BIOL CHEM, V279, P48607, DOI 10.1074/jbc.M409769200; Chen PI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090384; Chen PI, 2009, J BIOL CHEM, V284, P30328, DOI 10.1074/jbc.M109.034546; Chiariello M, 1999, FEBS LETT, V453, P20, DOI 10.1016/S0014-5793(99)00686-9; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Ciraolo E, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1161577; Dbouk HA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003264; Dbouk HA, 2010, P NATL ACAD SCI USA, V107, P19897, DOI 10.1073/pnas.1008739107; Dornan GL, 2017, P NATL ACAD SCI USA, V114, P1982, DOI 10.1073/pnas.1617244114; Dou ZX, 2013, MOL CELL, V50, P29, DOI 10.1016/j.molcel.2013.01.022; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Frittoli E, 2014, J CELL BIOL, V206, P307, DOI 10.1083/jcb.201403127; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Jaiswal BS, 2009, CANCER CELL, V16, P463, DOI 10.1016/j.ccr.2009.10.016; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Jimenez C, 1998, EMBO J, V17, P743, DOI 10.1093/emboj/17.3.743; Khalil BD, 2016, CANCER RES, V76, P2944, DOI 10.1158/0008-5472.CAN-15-1675; Knight ZA, 2007, NAT PROTOC, V2, P2459, DOI 10.1038/nprot.2007.361; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; Langemeyer L, 2014, ELIFE, V3, DOI 10.7554/eLife.01623; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Mandelker D, 2009, P NATL ACAD SCI USA, V106, P16996, DOI 10.1073/pnas.0908444106; Salamon Rachel S, 2015, Methods Mol Biol, V1298, P271, DOI 10.1007/978-1-4939-2569-8_23; Shymanets A, 2015, BIOCHEM J, V469, P59, DOI 10.1042/BJ20150099; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Whitecross DE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16029-6; Wu HY, 2009, P NATL ACAD SCI USA, V106, P20258, DOI 10.1073/pnas.0902369106; Yuzugullu H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9501; Zhang XX, 2011, MOL CELL, V41, P567, DOI 10.1016/j.molcel.2011.01.026; ZHENG Y, 1994, J BIOL CHEM, V269, P18727	34	7	7	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4621	4633		10.1074/jbc.RA118.006032	http://dx.doi.org/10.1074/jbc.RA118.006032			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30659094	Green Published, hybrid			2022-12-26	WOS:000462969500028
J	Rosario-Cruz, Z; Eletsky, A; Daigham, NS; Al-Tameemi, H; Swapna, GVT; Kahn, PC; Szyperski, T; Montelione, GT; Boyd, JM				Rosario-Cruz, Zuelay; Eletsky, Alexander; Daigham, Nourhan S.; Al-Tameemi, Hassan; Swapna, G. V. T.; Kahn, Peter C.; Szyperski, Thomas; Montelione, Gaetano T.; Boyd, Jeffrey M.			The copBL operon protects Staphylococcus aureus from copper toxicity: CopL is an extracellular membrane-associated copper-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						copper; lipoprotein; metal homeostasis; methicillin-resistant Staphylococcus aureus (MRSA); structural biology; virulence factor; metal; arginine-catabolic mobile element (ACME); redox homeostasis	CIS PEPTIDE-BONDS; P-TYPE ATPASES; ESCHERICHIA-COLI; NMR STRUCTURE; IRON; CLUSTER; HOMEOSTASIS; VIRULENCE; EFFLUX; IDENTIFICATION	As complications associated with antibiotic resistance have intensified, copper (Cu) is attracting attention as an antimicrobial agent. Recent studies have shown that copper surfaces decrease microbial burden, and host macrophages use Cu to increase bacterial killing. Not surprisingly, microbes have evolved mechanisms to tightly control intracellular Cu pools and protect against Cu toxicity. Here, we identified two genes (copB and copL) encoded within the Staphylococcus aureus arginine-catabolic mobile element (ACME) that we hypothesized function in Cu homeostasis. Supporting this hypothesis, mutational inactivation of copB or copL increased copper sensitivity. We found that copBL are co-transcribed and that their transcription is increased during copper stress and in a strain in which csoR, encoding a Cu-responsive transcriptional repressor, was mutated. Moreover, copB displayed genetic synergy with copA, suggesting that CopB functions in Cu export. We further observed that CopL functions independently of CopB or CopA in Cu toxicity protection and that CopL from the S. aureus clone USA300 is a membrane-bound and surface-exposed lipoprotein that binds up to four Cu+ ions. Solution NMR structures of the homologous Bacillus subtilis CopL, together with phylogenetic analysis and chemical-shift perturbation experiments, identified conserved residues potentially involved in Cu+ coordination. The solution NMR structure also revealed a novel Cu-binding architecture. Of note, a CopL variant with defective Cu+ binding did not protect against Cu toxicity in vivo. Taken together, these findings indicate that the ACME-encoded CopB and CopL proteins are additional factors utilized by the highly successful S. aureus USA300 clone to suppress copper toxicity.	[Rosario-Cruz, Zuelay; Al-Tameemi, Hassan; Kahn, Peter C.; Montelione, Gaetano T.; Boyd, Jeffrey M.] Rutgers State Univ, Dept Biochem & Microbiol, New Brunswick, NJ 08901 USA; [Daigham, Nourhan S.; Swapna, G. V. T.; Montelione, Gaetano T.] Rutgers State Univ, Dept Mol Biol & Biochem, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Daigham, Nourhan S.; Swapna, G. V. T.; Montelione, Gaetano T.] Rutgers State Univ, Northeast Struct Genom Consortium, Piscataway, NJ 08854 USA; [Eletsky, Alexander; Szyperski, Thomas] SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA; [Eletsky, Alexander; Szyperski, Thomas] Northeast Struct Genom Consortium, Buffalo, NY 14260 USA; [Montelione, Gaetano T.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA; [Eletsky, Alexander] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Rutgers State University New Brunswick; Rutgers State University Medical Center; University System of Georgia; University of Georgia	Montelione, GT (corresponding author), Dept Mol Biol & Biochem, 679 Hoes Lane, Piscataway, NJ 08854 USA.; Boyd, JM (corresponding author), Dept Biochem & Microbiol, 76 Lipman Dr, New Brunswick, NJ 08901 USA.	gtm@rutgers.edu; jeffboyd@SEBS.rutgers.edu	Al-Tameemi, Hassan/X-8418-2019	Al-Tameemi, Hassan/0000-0002-1947-798X; Boyd, Jeffrey/0000-0001-7721-3926; Montelione, Gaetano/0000-0002-9440-3059	Rutgers University; Charles and Johanna Busch Foundation; United States Department of Agriculture MRF Project [NE-1028]; National Institute of Allergy and Infectious Diseases (NIAID) [1R01AI139100-01]; Community Outreach Project of the National Institutes of Health NIGMS Protein Structure Initiative Grant [U54 GM094597]; NIGMS [R01 GM120574, S10 OD018207]; James Macmillan Endowed Fellowship; Jerome and Lorraine Aresty Chair Endowment and National Institutes of Health Grant [R01 GM120574]; National Science Foundation [MCB-1615570]; National Institutes of Health Award from NIAID [1R01AI139100-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI139100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120574] Funding Source: NIH RePORTER	Rutgers University; Charles and Johanna Busch Foundation; United States Department of Agriculture MRF Project; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Community Outreach Project of the National Institutes of Health NIGMS Protein Structure Initiative Grant; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); James Macmillan Endowed Fellowship; Jerome and Lorraine Aresty Chair Endowment and National Institutes of Health Grant; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health Award from NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Rutgers University, the Charles and Johanna Busch Foundation, the United States Department of Agriculture MRF Project NE-1028 (to J. M. B.), National Institute of Allergy and Infectious Diseases (NIAID) grant 1R01AI139100-01 (to J. M. B.) and as a Community Outreach Project of the National Institutes of Health NIGMS Protein Structure Initiative Grant U54 GM094597 (to G. T. M. and T. S.). Support was also provide by NIGMS Grants R01 GM120574 (to G. T. M.) and S10 OD018207 (to G. T. M.). G. T. M. is a founder of Nexomics Biosciences, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the James Macmillan Endowed Fellowship and Rutgers University.; Supported by the Jerome and Lorraine Aresty Chair Endowment and National Institutes of Health Grant R01 GM120574.; Supported by National Science Foundation Grant MCB-1615570.; Supported by National Institutes of Health Award 1R01AI139100-01 from NIAID.	Achard MES, 2012, BIOCHEM J, V444, P51, DOI 10.1042/BJ20112180; Acton TB, 2011, METHOD ENZYMOL, V493, P21, DOI 10.1016/B978-0-12-381274-2.00002-9; Arguello JM, 2011, BIOCHEMISTRY-US, V50, P9940, DOI 10.1021/bi201418k; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Arguello JM, 2016, METALLOMICS, V8, P906, DOI 10.1039/c6mt00089d; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Badarau A, 2011, J AM CHEM SOC, V133, P2983, DOI 10.1021/ja1091547; Bagchi P, 2013, J AM CHEM SOC, V135, P18549, DOI 10.1021/ja408827d; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Baker J, 2011, ENVIRON MICROBIOL, V13, P2495, DOI 10.1111/j.1462-2920.2011.02522.x; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Bertini I, 2010, COORDIN CHEM REV, V254, P506, DOI 10.1016/j.ccr.2009.07.024; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bose JL, 2013, APPL ENVIRON MICROB, V79, P2218, DOI 10.1128/AEM.00136-13; BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chillappagari S, 2010, J BACTERIOL, V192, P2512, DOI 10.1128/JB.00058-10; Claus H, 2003, ARCH MICROBIOL, V179, P145, DOI 10.1007/s00203-002-0510-7; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delmar JA, 2013, BIOMETALS, V26, P593, DOI 10.1007/s10534-013-9628-0; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Ding C, 2013, CELL HOST MICROBE, V13, P265, DOI 10.1016/j.chom.2013.02.002; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; Fung DKC, 2013, J BACTERIOL, V195, P4556, DOI 10.1128/JB.00543-13; Goddard D., 2008, SPARKY 3; Grossoehme N, 2011, J BIOL CHEM, V286, P13522, DOI 10.1074/jbc.M111.220012; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUNTERT P, 1992, J BIOMOL NMR, V2, P619, DOI 10.1007/BF02192850; GUNTHER MR, 1995, ARCH BIOCHEM BIOPHYS, V316, P515, DOI 10.1006/abbi.1995.1068; Hao XL, 2015, APPL MICROBIOL BIOT, V99, P5817, DOI 10.1007/s00253-015-6749-0; Harris RK, 2008, PURE APPL CHEM, V80, P59, DOI 10.1351/pac200880010059; Helbig K, 2008, J BACTERIOL, V190, P5431, DOI 10.1128/JB.00271-08; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Huang YJ, 2006, PROTEINS, V62, P587, DOI 10.1002/prot.20820; Huang YJ, 2005, J AM CHEM SOC, V127, P1665, DOI 10.1021/ja047109h; Hutchings MI, 2009, TRENDS MICROBIOL, V17, P13, DOI 10.1016/j.tim.2008.10.001; Jabs A, 1999, J MOL BIOL, V286, P291, DOI 10.1006/jmbi.1998.2459; Jansson M, 1996, J BIOMOL NMR, V7, P131; Joshi GS, 2011, MOL MICROBIOL, V82, P9, DOI 10.1111/j.1365-2958.2011.07809.x; Joska TM, 2014, J MICROBIOL METH, V100, P46, DOI 10.1016/j.mimet.2013.11.013; Kay KL, 2016, METALLOMICS, V8, P709, DOI 10.1039/c6mt00036c; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Keller RLJ, 2004, COMPUTER AIDED RESON, P1; Kiedrowski MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095574; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Ma Z, 2009, J AM CHEM SOC, V131, P18044, DOI 10.1021/ja908372b; Ma Z, 2009, BIOCHEMISTRY-US, V48, P3325, DOI 10.1021/bi900115w; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Malone CL, 2009, J MICROBIOL METH, V77, P251, DOI 10.1016/j.mimet.2009.02.011; Perez-Perez JM, 2009, TRENDS GENET, V25, P368, DOI 10.1016/j.tig.2009.06.004; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Mashruwala AA, 2017, ELIFE, V6, DOI 10.7554/eLife.23845; Mashruwala AA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006233; Mashruwala AA, 2016, METHODS MOL BIOL, V1373, P33, DOI 10.1007/7651_2015_275; Mashruwala AA, 2015, MOL MICROBIOL, V95, P383, DOI 10.1111/mmi.12860; Mikolay A, 2010, APPL MICROBIOL BIOT, V87, P1875, DOI 10.1007/s00253-010-2640-1; Montelione G.T., 2012, BIOL REP, V4, P7, DOI DOI 10.3410/B4-7; Navarre WW, 1996, J BACTERIOL, V178, P441, DOI 10.1128/jb.178.2.441-446.1996; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; ODERMATT A, 1993, J BIOL CHEM, V268, P12775; Olson Bradley J S C, 2007, Curr Protoc Protein Sci, VChapter 3, DOI 10.1002/0471140864.ps0304s48; Osman D, 2013, MOL MICROBIOL, V87, P466, DOI 10.1111/mmi.12107; OSTERBERG R, 1979, J INORG BIOCHEM, V10, P341, DOI 10.1016/S0162-0134(00)80200-7; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Pal D, 1999, J MOL BIOL, V294, P271, DOI 10.1006/jmbi.1999.3217; Pang YY, 2014, J INNATE IMMUN, V6, P353, DOI 10.1159/000355915; PELTON JG, 1993, PROTEIN SCI, V2, P543; Planet PJ, 2015, J INFECT DIS, V212, P1874, DOI 10.1093/infdis/jiv320; Planet PJ, 2013, MBIO, V4, DOI 10.1128/mBio.00889-13; Purves J, 2018, ENVIRON MICROBIOL, V20, P1576, DOI 10.1111/1462-2920.14088; Radford DS, 2003, FEMS MICROBIOL LETT, V220, P105, DOI 10.1016/S0378-1097(03)00095-8; Rahman O, 2008, WORLD J MICROB BIOT, V24, P2377, DOI 10.1007/s11274-008-9795-2; Rajkarnikar A, 2013, BIOCHEM BIOPH RES CO, V436, P128, DOI 10.1016/j.bbrc.2013.04.027; Ranjit DK, 2011, J BACTERIOL, V193, P2468, DOI 10.1128/JB.01545-10; Resch G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058187; Roberts CA, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00100-17; Rosario-Cruz Z, 2015, MOL MICROBIOL, V98, P218, DOI 10.1111/mmi.13115; Rubino JT, 2012, J INORG BIOCHEM, V107, P129, DOI 10.1016/j.jinorgbio.2011.11.024; Rutherford JC, 2004, EUKARYOT CELL, V3, P1, DOI 10.1128/EC.3.1.1-13.2004; Schmidt MG, 2012, J CLIN MICROBIOL, V50, P2217, DOI 10.1128/JCM.01032-12; Scholz C, 1998, BIOL CHEM, V379, P361; Schrodinger L., 2015, PYMOL MOL GRAPHICS S; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Singleton C, 2007, BIOMETALS, V20, P275, DOI 10.1007/s10534-006-9068-1; Singleton C, 2009, BIOCHEM J, V424, P347, DOI 10.1042/BJ20091079; Singleton C, 2009, DALTON T, P688, DOI 10.1039/b810412c; Sitthisak S, 2005, APPL ENVIRON MICROB, V71, P5650, DOI 10.1128/AEM.71.9.5650-5653.2005; Sitthisak S, 2007, MICROBIOL-SGM, V153, P4274, DOI 10.1099/mic.0.2007/009860-0; Smaldone GT, 2007, MICROBIOL-SGM, V153, P4123, DOI 10.1099/mic.0.2007/011742-0; Sousa FL, 2012, BBA-BIOENERGETICS, V1817, P629, DOI 10.1016/j.bbabio.2011.09.020; Talan DA, 2011, CLIN INFECT DIS, V53, P144, DOI 10.1093/cid/cir308; Tan GQ, 2014, MOL MICROBIOL, V93, P629, DOI 10.1111/mmi.12676; Tavares P, 2006, J INORG BIOCHEM, V100, P2087, DOI 10.1016/j.jinorgbio.2006.09.003; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; Thurlow LR, 2013, CELL HOST MICROBE, V13, P100, DOI 10.1016/j.chom.2012.11.012; Tjandra N, 1996, J AM CHEM SOC, V118, P6264, DOI 10.1021/ja960106n; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; Xiao R, 2010, J STRUCT BIOL, V172, P21, DOI 10.1016/j.jsb.2010.07.011; Xiao ZG, 2004, J AM CHEM SOC, V126, P3081, DOI 10.1021/ja0390350; Xiao ZG, 2013, METALLOMICS, V5, P501, DOI 10.1039/c3mt00032j; Zapotoczna M, 2018, MBIO, V9, DOI 10.1128/mBio.00550-18; Zhang YQ, 2003, MOL MICROBIOL, V49, P1577, DOI 10.1046/j.1365-2958.2003.03671.x	113	22	22	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4027	4044		10.1074/jbc.RA118.004723	http://dx.doi.org/10.1074/jbc.RA118.004723			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30655293	Green Published, hybrid			2022-12-26	WOS:000461854400018
J	Gardinier, JD; Daly-Seiler, C; Rostami, N; Kundal, S; Zhang, CB				Gardinier, Joseph D.; Daly-Seiler, Conor; Rostami, Niloufar; Kundal, Siddharth; Zhang, Chunbin			Loss of the PTH/PTHrP receptor along the osteoblast lineage limits the anabolic response to exercise	PLOS ONE			English	Article							PARATHYROID-HORMONE PTH; BONE MASS; CORTICAL BONE; MAINTENANCE; PEPTIDE; DIFFERENTIATION; HEDGEHOG; SYSTEM; CELLS; MICE	Exercise and physical activity are critical to maintain bone mass and strength throughout life. Both exercise and physical activity subject bone to a unique combination of stimuli in the forms of dynamic loading and a systemic increase in parathyroid hormone (PTH). Although dynamic loading is considered to be the primary osteogenic stimuli, the influence of increasing PTH levels remains unclear. We hypothesize that activation of the PTH/PTH-related peptide type 1 receptor (PPR) along the osteoblast lineage facilitates bone formation and improved mechanical properties in response to exercise. To test this hypothesis, conditional PPR-knockout mice (PPRcKO) were generated in which PPR expression was deleted along the osteoblast lineage under the osterix promoter. At 8-weeks of age, both PPRfl/fl and PPR cKO mice were subjected to treadmill running or sedentary conditions for 5-weeks. Under sedentary conditions, PPRcKO mice displayed significantly less bone mass as well as smaller structural-level strength (yield-load and ultimate load), while tissue level properties were largely unaffected. However, PPRcKO mice exposed to exercise displayed significantly less structural-level and tissue-level mechanical properties when compared to exercised PPRfl/fl mice. Overall, these data demonstrate that PPR expression along the osteoblast lineage is essential for exercise to improve the mechanical properties of cortical bone. Furthermore, the influence of PPR activation on material properties is unique to exercise and not during normal growth and development.	[Gardinier, Joseph D.; Daly-Seiler, Conor; Rostami, Niloufar; Zhang, Chunbin] Henry Ford Hosp, Bone & Joint Ctr, Detroit, MI 48202 USA; [Kundal, Siddharth] Wayne State Univ, Biomed Phys Dept, Detroit, MI USA	Henry Ford Health System; Henry Ford Hospital; Wayne State University	Gardinier, JD (corresponding author), Henry Ford Hosp, Bone & Joint Ctr, Detroit, MI 48202 USA.	jgardin2@hfhs.org		Locke, Conor/0000-0002-4463-0173; Gardinier, Joseph/0000-0002-8651-8913	Henry Ford Health System [A20041]	Henry Ford Health System	;The Osx-Cre mice in the study were provided by Dr. Yuji Mishina at the University of Michigan and the PPRfl/fl mice were provided by Dr. Henry Kronenberg at the Massachusetts General Hospital. Further funding from the Henry Ford Health System (grant number A20041). These contributors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron U, 2000, METHOD ENZYMOL, V327, P401, DOI 10.1016/S0076-6879(00)27292-3; Chow JWM, 1998, AM J PHYSIOL-ENDOC M, V274, pE146, DOI 10.1152/ajpendo.1998.274.1.E146; Cupp ME, 2013, J PHARMACOL EXP THER, V345, P404, DOI 10.1124/jpet.112.199752; Das AT, 2016, CURR GENE THER, V16, P156, DOI 10.2174/1566523216666160524144041; Davey RA, 2012, TRANSGENIC RES, V21, P885, DOI 10.1007/s11248-011-9581-z; Delgado-Calle J, 2017, J BONE MINER RES, V32, P522, DOI 10.1002/jbmr.3011; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Gardinier JD, 2018, BONE, V117, P130, DOI 10.1016/j.bone.2018.09.019; Gardinier Joseph D, 2018, Bone Rep, V8, P29, DOI 10.1016/j.bonr.2018.01.003; Gardinier JD, 2016, MATRIX BIOL, V52-54, P162, DOI 10.1016/j.matbio.2016.02.010; Gardinier JD, 2015, J BONE MINER RES, V30, P1053, DOI 10.1002/jbmr.2432; Gensure RC, 2005, BIOCHEM BIOPH RES CO, V328, P666, DOI 10.1016/j.bbrc.2004.11.069; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Goltzman D, 2018, HISTOCHEM CELL BIOL, V149, P305, DOI 10.1007/s00418-018-1648-y; Kobayashi T, 2002, DEVELOPMENT, V129, P2977; Kohn DH, 2009, CELLS TISSUES ORGANS, V189, P33, DOI 10.1159/000151452; Liu F, 2010, BLOOD, V116, P4806, DOI 10.1182/blood-2010-06-288589; Maimoun L, 2005, BRIT J SPORT MED, V39, P497, DOI 10.1136/bjsm.2004.013151; Maimoun L, 2009, J SCI MED SPORT, V12, P463, DOI 10.1016/j.jsams.2008.05.004; Maimoun L, 2009, CALCIFIED TISSUE INT, V85, P277, DOI 10.1007/s00223-009-9277-z; Maycas M, 2015, J BONE MINER RES, V30, P1231, DOI 10.1002/jbmr.2439; McNerny EMB, 2015, BONE, V81, P327, DOI 10.1016/j.bone.2015.07.030; Nakamichi Y, 2017, J BONE MINER RES, V32, P1297, DOI 10.1002/jbmr.3096; NISHIYAMA S, 1988, CALCIFIED TISSUE INT, V43, P150, DOI 10.1007/BF02571312; Onyia JE, 2005, J CELL BIOCHEM, V95, P403, DOI 10.1002/jcb.20438; Qiu T, 2015, J BONE MINER RES, V30, P309, DOI 10.1002/jbmr.2327; Razidlo DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011492; Reginster JY, 2006, BONE, V38, pS2, DOI 10.1016/j.bone.2006.01.150; Reimann DA, 1997, APPL RADIAT ISOTOPES, V48, P1433, DOI 10.1016/S0969-8043(97)00139-5; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Rong H, 1997, SCAND J MED SCI SPOR, V7, P152; Saini V, 2013, J BIOL CHEM, V288, P20122, DOI 10.1074/jbc.M112.441360; Schluter KD, 1999, NEWS PHYSIOL SCI, V14, P243; Silva BC, 2015, CURR OPIN PHARMACOL, V22, P41, DOI 10.1016/j.coph.2015.03.005; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Wallace JM, 2007, BONE, V40, P1120, DOI 10.1016/j.bone.2006.12.002; Wallace JM, 2010, ANN BIOMED ENG, V38, P1607, DOI 10.1007/s10439-009-9881-0; Wang L, 2015, CALCIFIED TISSUE INT, V96, P129, DOI 10.1007/s00223-014-9945-5; Weaver CM, 2016, OSTEOPOROSIS INT, V27, P1281, DOI 10.1007/s00198-015-3440-3; Yamamoto Y, 2013, ENDOCRINOLOGY, V154, P1008, DOI 10.1210/en.2012-1542	41	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211076	10.1371/journal.pone.0211076	http://dx.doi.org/10.1371/journal.pone.0211076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682096	Green Submitted, Green Published, gold			2022-12-26	WOS:000457037500098
J	Liu, WH; Chang, PY; Chang, SC; Lu, JJ; Wu, CM				Liu, Wei-Hsiu; Chang, Pi-Yueh; Chang, Shih-Cheng; Lu, Jang-Jih; Wu, Che-Ming			Mutation screening in non-syndromic hearing loss patients with cochlear implantation by massive parallel sequencing in Taiwan	PLOS ONE			English	Article							ACTG1 MUTATIONS; DFNA20/26 FAMILY; DEAFNESS; DOMINANT; CHILDREN; GENE; IMPAIRMENT; PERFORMANCE; SPECTRUM; OUTCOMES	Objectives To explore the molecular epidemiology of rare deafness genes in Taiwanese sensorineural hearing impairment (SNHI) patients with cochlear implantation (CI) by performing massive parallel sequencing (MPS) and correlating genetic factors and CI outcomes. Methods We enrolled 41 Taiwanese non-syndromic deafness patients with CI that lacked known mutations in common deafness genes. All probands were screened by a targeted exon amplification method that used massively parallel sequencing to screen a customized panel that included 40 relatively rare non-syndromic deafness genes. Results Thirteen candidate variants in nine relatively rare deafness genes (MYO15A, TMC1, MYH14, MYO3A, ACTG1, COL11A2, DSPP, GRHL2, and WFS1) were identified in 24.4% (10/41) of the non-syndromic deafness probands with CI. According to the ACMG Standards and Guidelines, five variants in MYO15A and ACTG1 were classified as likely pathogenic variants. Two of three multi-generational pedigrees exhibiting deafness were analyzed for the segregation of the disorder with the possible disease-causing variants. Patients with variants detected in most of the identified variant-bearing genes showed relatively good CI outcomes. Conclusions We successfully identified candidate variants in partially deaf Taiwanese probands who lacked the known mutations in common deafness genes. Comparing the progress of hearing rehabilitation in CI patients with their apparent causative variants and the expression profiles of their altered genes allowed us to speculate on how alterations in specific gene sets may influence outcomes in hearing rehabilitation after CI.	[Liu, Wei-Hsiu] Chang Gung Univ, Dept Lab Med, Chang Gung Mem Hosp, Linkou Branch,Coll Med, Taoyuan, Taiwan; [Liu, Wei-Hsiu; Wu, Che-Ming] Chang Gung Univ, Dept Otolaryngol Head & Neck Surg, Chang Gung Mem Hosp, Linkou Branch,Coll Med, Taoyuan, Taiwan; [Chang, Pi-Yueh; Chang, Shih-Cheng; Lu, Jang-Jih] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Chang, Pi-Yueh; Chang, Shih-Cheng; Lu, Jang-Jih] Chang Gung Univ, Dept Med Res, Chang Gung Mem Hosp, Taoyuan, Taiwan; [Chang, Pi-Yueh; Chang, Shih-Cheng; Lu, Jang-Jih] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Wu, CM (corresponding author), Chang Gung Univ, Dept Otolaryngol Head & Neck Surg, Chang Gung Mem Hosp, Linkou Branch,Coll Med, Taoyuan, Taiwan.; Lu, JJ (corresponding author), Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan.; Lu, JJ (corresponding author), Chang Gung Univ, Dept Med Res, Chang Gung Mem Hosp, Taoyuan, Taiwan.; Lu, JJ (corresponding author), Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan.	jjlpcp@adm.cgmh.org.tw; bobwu506@hotmail.com		CHE-MING, WU/0000-0001-5245-0482	Chang-Gung Memorial Hospital Research Program [CMRPG3C1403]	Chang-Gung Memorial Hospital Research Program(Chang Gung Memorial Hospital)	This study was supported by the Chang-Gung Memorial Hospital Research Program CMRPG3C1403 to CMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allen C, 2001, OTOL NEUROTOL, V22, P631, DOI 10.1097/00129492-200109000-00012; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Archbold S, 1998, BRIT J AUDIOL, V32, P7, DOI 10.3109/03005364000000045; Brownstein Z, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-245; Chang Mun Young, 2014, Korean J Audiol, V18, P45, DOI 10.7874/kja.2014.18.2.45; Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918; Cullen RD, 2004, LARYNGOSCOPE, V114, P2218, DOI 10.1097/01.mlg.0000149462.88327.7f; Dahl HHM, 2003, AUDIOL NEURO-OTOL, V8, P263, DOI 10.1159/000071998; de Heer AMR, 2009, ANN OTO RHINOL LARYN, V118, P382, DOI 10.1177/000348940911800511; Donaudy F, 2004, AM J HUM GENET, V74, P770, DOI 10.1086/383285; Eppsteiner RW, 2012, HEARING RES, V292, P51, DOI 10.1016/j.heares.2012.08.007; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Hogewind BFT, 2010, MOL VIS, V16, P26; Khaitlina SY, 2001, INT REV CYTOL, V202, P35, DOI 10.1016/S0074-7696(01)02003-4; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Lalwani AK, 2000, AM J HUM GENET, V67, P1121, DOI 10.1016/S0002-9297(07)62942-5; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liu P, 2008, J GENET GENOMICS, V35, P553, DOI 10.1016/S1673-8527(08)60075-2; Mhatre AN, 2004, J NEUROSCI RES, V76, P296, DOI 10.1002/jnr.20065; Miyagawa M, 2016, OTOL NEUROTOL, V37, pE126, DOI 10.1097/MAO.0000000000000936; Miyagawa M, 2015, ANN OTO RHINOL LARYN, V124, p158S, DOI 10.1177/0003489415575058; Miyagawa M, 2015, ANN OTO RHINOL LARYN, V124, p148S, DOI 10.1177/0003489415575055; Miyagawa M, 2015, ANN OTO RHINOL LARYN, V124, p84S, DOI 10.1177/0003489415575057; Miyagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075793; Miyagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071381; Morin M, 2009, HUM MOL GENET, V18, P3075, DOI 10.1093/hmg/ddp249; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nikolopoulos TP, 1999, LARYNGOSCOPE, V109, P595, DOI 10.1097/00005537-199904000-00014; Niparko JK, 2010, JAMA-J AM MED ASSOC, V303, P1498, DOI 10.1001/jama.2010.451; Nishio S, 2015, ANN OTO RHINOL LARYN, V124, p49S, DOI 10.1177/0003489415575059; Papsin Blake C, 2005, Laryngoscope, V115, P1, DOI 10.1097/00005537-200501001-00001; Rendtorff ND, 2006, EUR J HUM GENET, V14, P1097, DOI 10.1038/sj.ejhg.5201670; Rennels M, 2005, LANCET, V365, P2085, DOI 10.1016/S0140-6736(05)66724-4; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shearer AE, 2010, P NATL ACAD SCI USA, V107, P21104, DOI 10.1073/pnas.1012989107; Sinnathuray AR, 2003, OTOL NEUROTOL, V24, P418, DOI 10.1097/00129492-200305000-00012; van Wijk E, 2003, J MED GENET, V40, P879, DOI 10.1136/jmg.40.12.879; Walsh T, 2002, P NATL ACAD SCI USA, V99, P7518, DOI 10.1073/pnas.102091699; Walton J, 2008, OTOL NEUROTOL, V29, P302, DOI 10.1097/MAO.0b013e318164d0f6; Waltzman SB, 2005, PEDIATRICS, V116, pE487, DOI 10.1542/peds.2005-0282; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; Wu CC, 2008, AUDIOL NEURO-OTOL, V13, P172, DOI 10.1159/000112425; Wu CC, 2008, ARCH PEDIAT ADOL MED, V162, P269, DOI 10.1001/archpediatrics.2007.59; Wu CC, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001073; Wu CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057369; Wu CC, 2011, LARYNGOSCOPE, V121, P1287, DOI 10.1002/lary.21751; Wu CC, 2009, LARYNGOSCOPE, V119, P2411, DOI 10.1002/lary.20621; Yang H, 2015, NAT PROTOC, V10, P1556, DOI 10.1038/nprot.2015.105; Yang T, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-85	53	19	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211261	10.1371/journal.pone.0211261	http://dx.doi.org/10.1371/journal.pone.0211261			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682115	gold, Green Published, Green Submitted			2022-12-26	WOS:000457037500137
J	Crisostomo, L; Soriano, AM; Mendez, M; Graves, D; Pelka, P				Crisostomo, Leandro; Soriano, Andrea Michelle; Mendez, Megan; Graves, Drayson; Pelka, Peter			Temporal dynamics of adenovirus 5 gene expression in normal human cells	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; MESSENGER-RNAS; TRANSCRIPTION; E1A; PROMOTER	Adenovirus executes a finely tuned transcriptional program upon infection of a cell. To better understand the temporal dynamics of the viral transcriptional program we performed highly sensitive digital PCR on samples extracted from arrested human lung fibroblasts infected with human adenovirus 5 strain dl309. We show that the first transcript made from viral genomes is the virus associated non-coding RNA, in particular we detected abundant levels of virus associated RNA II four hours after infection. Activation of E1 and E4 occurred nearly simultaneously later in infection, followed by other early genes as well as late genes. Our study determined that genomes begin to replicate between 29 and 30 hours after infection. This study provides a comprehensive view of viral mRNA steady-state kinetics in arrested human cells using digital PCR.	[Crisostomo, Leandro; Soriano, Andrea Michelle; Mendez, Megan; Graves, Drayson; Pelka, Peter] Univ Manitoba, Dept Microbiol, Winnipeg, MB, Canada; [Pelka, Peter] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Pelka, P (corresponding author), Univ Manitoba, Dept Microbiol, Winnipeg, MB, Canada.; Pelka, P (corresponding author), Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada.	peter.pelka@umanitoba.ca			Natural Sciences and Engineering Research Council [RGPIN/435375-2013]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council (Grant number: RGPIN/435375-2013, http://www.nserccrsng.gc.ca/Professors-Professeurs/Grants-Subs/index_eng.asp) to PP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKUSJARVI G, 1981, NATURE, V292, P420, DOI 10.1038/292420a0; AKUSJARVI G, 1985, J VIROL, V56, P879; Berk AJ, 2013, FIELDS VIROLOGY; BETT AJ, 1995, VIRUS RES, V39, P75; BINGER MH, 1984, VIROLOGY, V136, P387, DOI 10.1016/0042-6822(84)90175-2; Crisostomo L, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120387; Dean JD, 2002, PLANT MOL BIOL REP, V20, P347, DOI 10.1007/BF02772122; Etemadi MR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176947; Farley DC, 2004, J VIROL, V78, P1782, DOI 10.1128/JVI.78.4.1782-1791.2004; FLINT SJ, 1976, J MOL BIOL, V106, P749, DOI 10.1016/0022-2836(76)90263-1; Frost JR, 2018, J VIROL, V92, DOI 10.1128/JVI.00439-18; Frost JR, 2017, VIROLOGY, V500, P11, DOI 10.1016/j.virol.2016.10.004; GLENN GM, 1988, VIRUS RES, V9, P73, DOI 10.1016/0168-1702(88)90051-2; Greber UF, 1997, EMBO J, V16, P5998, DOI 10.1093/emboj/16.19.5998; HARLOW E, 1985, J VIROL, V55, P533, DOI 10.1128/JVI.55.3.533-546.1985; HEARING P, 1983, CELL, V33, P695, DOI 10.1016/0092-8674(83)90012-0; JONES N, 1979, CELL, V17, P683, DOI 10.1016/0092-8674(79)90275-7; Jung R, 2016, J VIROL, V90, P1931, DOI 10.1128/JVI.02392-15; Kallsten M, 2017, VIROLOGY, V511, P240, DOI 10.1016/j.virol.2017.08.032; Krzywkowski T, 2017, J VIROL, V91, DOI 10.1128/JVI.00166-17; MATHEWS MB, 1975, CELL, V6, P223, DOI 10.1016/0092-8674(75)90013-6; Miller DL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r58; MONTELL C, 1982, NATURE, V295, P380, DOI 10.1038/295380a0; NEVINS JR, 1978, J VIROL, V25, P811, DOI 10.1128/JVI.25.3.811-823.1978; PILDER S, 1986, MOL CELL BIOL, V6, P470, DOI 10.1128/MCB.6.2.470; Pohl G, 2004, EXPERT REV MOL DIAGN, V4, P41, DOI 10.1586/14737159.4.1.41; Radko S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140124; Radko S, 2014, J VIROL, V88, P13469, DOI 10.1128/JVI.02538-14; REICH NC, 1983, VIROLOGY, V128, P480, DOI 10.1016/0042-6822(83)90274-X; REICHEL PA, 1985, NATURE, V313, P196, DOI 10.1038/313196a0; SHAW AR, 1980, CELL, V22, P905, DOI 10.1016/0092-8674(80)90568-1; SODERLUND H, 1976, CELL, V7, P585, DOI 10.1016/0092-8674(76)90209-9; WEINMANN R, 1974, P NATL ACAD SCI USA, V71, P3426, DOI 10.1073/pnas.71.9.3426; WINBERG G, 1984, EMBO J, V3, P1907, DOI 10.1002/j.1460-2075.1984.tb02066.x; Zhao HX, 2014, VIROLOGY, V456, P329, DOI 10.1016/j.virol.2014.04.006; Zhao HX, 2012, VIROLOGY, V424, P115, DOI 10.1016/j.virol.2011.12.006; ZIFF EB, 1978, CELL, V15, P1463, DOI 10.1016/0092-8674(78)90070-3	37	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211192	10.1371/journal.pone.0211192	http://dx.doi.org/10.1371/journal.pone.0211192			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677073	gold, Green Submitted, Green Published			2022-12-26	WOS:000456700400058
J	Mirab, F; Kang, YJ; Majd, S				Mirab, Fereshtehsadat; Kang, You Jung; Majd, Sheereen			Preparation and characterization of size-controlled glioma spheroids using agarose hydrogel microwells	PLOS ONE			English	Article							ANTITUMOR-ACTIVITY; CELL; ARRAYS; DP44MT	Treatment of glioblastoma, the most common and aggressive type of primary brain tumors, is a major medical challenge and the development of new alternatives requires simple yet realistic models for these tumors. In vitro spheroid models offer attractive platforms to mimic the tumor behavior in vivo and have thus, been increasingly applied for assessment of drug efficacy in various tumors. The aim of this study was to produce and characterize size-controlled U251 glioma spheroids towards application in glioma drug evaluation studies. To this end, we fabricated agarose hydrogel microwells with cylindrical shape and diameters of 70700 mu m and applied these wells without any surface modification for glioma spheroid formation. The resultant spheroids were homogeneous in size and shape, exhibited high cell viability (>90%), and had a similar growth rate to that of natural brain tumors. The final size of spheroids depended on cell seeding density and microwell size. The spheroids' volume increased linearly with the cell seeding density and the rate of this change increased with the well size. Lastly, we tested the therapeutic effect of an anti-cancer drug, Di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT) on the resultant glioma spheroids and demonstrated the applicability of this spheroid model for drug efficacy studies.	[Mirab, Fereshtehsadat; Majd, Sheereen] Univ Houston, Dept Biomed Engn, Houston, TX 77004 USA; [Kang, You Jung] Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA	University of Houston System; University of Houston; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Majd, S (corresponding author), Univ Houston, Dept Biomed Engn, Houston, TX 77004 USA.	smajd9@uh.edu		Majd, Sheereen/0000-0002-3131-9845; Mirab, Fereshtehsadat/0000-0002-2178-3863				Adamson C, 2009, EXPERT OPIN INV DRUG, V18, P1061, DOI 10.1517/13543780903052764; Badiga AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020614; Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; Bauer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050491; Elliott NT, 2011, J PHARM SCI-US, V100, P59, DOI 10.1002/jps.22257; Fan YT, 2015, IEEE J TRANSL ENG HE, V3, DOI 10.1109/JTEHM.2015.2410277; Ferreira LP, 2018, ACTA BIOMATER, V75, P11, DOI 10.1016/j.actbio.2018.05.034; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Fukuda J, 2006, BIOMATERIALS, V27, P5259, DOI 10.1016/j.biomaterials.2006.05.044; Gallego O, 2015, CURR ONCOL, V22, pE273, DOI 10.3747/co.22.2436; Gencoglu MF, 2018, ACS BIOMATER SCI ENG, V4, P410, DOI 10.1021/acsbiomaterials.7b00069; Gong X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130348; Holley C K, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P5733, DOI 10.1109/EMBC.2018.8513598; Kang LF, 2010, J BIOMED MATER RES A, V93A, P547, DOI 10.1002/jbm.a.32557; Kang YJ, 2017, IEEE ENG MED BIO, P309, DOI 10.1109/EMBC.2017.8036824; Kang YJ, 2013, ADV MATER, V25, P6834, DOI 10.1002/adma.201303290; Karp JM, 2007, LAB CHIP, V7, P786, DOI 10.1039/b705085m; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Li YF, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aas8998; Lovejoy DB, 2011, CANCER RES, V71, P5871, DOI 10.1158/0008-5472.CAN-11-1218; Madhankumar AB, 2009, MOL CANCER THER, V8, P648, DOI 10.1158/1535-7163.MCT-08-0853; Majd S, 2005, ANGEW CHEM INT EDIT, V44, P6697, DOI 10.1002/anie.200502189; Napolitano AP, 2007, BIOTECHNIQUES, V43, P494, DOI 10.2144/000112591; Noulsri E, 2009, AM J HEMATOL, V84, P170, DOI 10.1002/ajh.21350; Peela N, 2016, BIOMATERIALS, V81, P72, DOI 10.1016/j.biomaterials.2015.11.039; Stensjoen AL, 2015, NEURO-ONCOLOGY, V17, P1402, DOI 10.1093/neuonc/nov029; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; Tang YD, 2016, MICROELECTRON ENG, V158, P41, DOI 10.1016/j.mee.2016.03.009; Tekin H, 2010, LAB CHIP, V10, P2411, DOI 10.1039/c004732e; Tung YC, 2011, ANALYST, V136, P473, DOI 10.1039/c0an00609b; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Weiswald LB, 2015, NEOPLASIA, V17, P1, DOI 10.1016/j.neo.2014.12.004; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; Wlodkowic D., 2009, FLOW CYTOMETRY BASED, P19; Yuan XG, 2018, BIOCHEM ENG J, V131, P39, DOI 10.1016/j.bej.2017.12.011	35	38	39	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211078	10.1371/journal.pone.0211078	http://dx.doi.org/10.1371/journal.pone.0211078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677075	Green Published, gold, Green Submitted			2022-12-26	WOS:000456700400047
J	Xiao, T; Yu, H; Song, YB; Jiang, YP; Zeng, B; Dong, M				Xiao, Tao; Yu, Hua; Song, Yao-Bin; Jiang, Yue-Ping; Zeng, Bo; Dong, Ming			Nutrient enhancement of allelopathic effects of exotic invasive on native plant species	PLOS ONE			English	Article							ALTERNANTHERA-PHILOXEROIDES; NITROGEN DEPOSITION; COMPETITIVE ABILITY; ECOSYSTEM SERVICES; FRESH-WATER; EUTROPHICATION; SUCCESS; PHOSPHORUS; ENRICHMENT; MECHANISM	Many ecosystems may suffer from both nutrient enrichment and exotic plant invasions simultaneously. Much has been known that nutrient inputs can promote growth and expansion of exotic invasive plants in wetlands, and that allelopathic effects of the exotic invasive plants can inhibit the growth of coexisting native plants, contributing to their invasion success. Thus, we hypothesized that allelopathic effects of exotics on natives in invaded ecosystems can be enhanced by nutrient enrichment. To test this hypothesis, we conducted two greenhouse hydroponic experiments. One is the monoculture experiment in which a widespread exotic invasive perennial Alternanthera philoxeroides and a native perennial Ludwigia peploides subsp. stipulacea in monoculture were subjected to five levels of nutrient supply. The other is the mixture experiment in which the two species in mixture were subjected to five levels of nutrient supply, each with and without activated carbon addition. Both A. philoxeroides and L. peploides grew better under higher level of nutrient availability in monoculture experiment. In the mixture experiment, A. philoxeroides formed less total and root biomass while L. peploides formed more in response to activated carbon addition and all of the responses had larger degree at higher level of nutrient availability, indicating A. philoxeroides had significant allelopathic effects on L. peploides and the effects was significantly enhanced by nutrient enrichment. Such results support our hypothesis and reveal a novel mechanism for exotic plant invasion in eutrophicated and invaded wetlands, i.e. nutrient enhancement of allelopathic effects of exotics on natives.	[Xiao, Tao; Zeng, Bo; Dong, Ming] Southwest Univ, Chongqing Key Lab Plant Ecol & Resources Three Go, Key Lab Ecoenvironm Three Gorges Reservoir Reg, Minist Educ,Sch Life Sci, Chongqing, Peoples R China; [Xiao, Tao; Yu, Hua; Song, Yao-Bin; Dong, Ming] Hangzhou Normal Univ, Coll Life & Environm Sci, Key Lab Hangzhou City Ecosyst Protect & Restorat, Hangzhou, Zhejiang, Peoples R China; [Jiang, Yue-Ping] Hangzhou Xixi Natl Wetland Pk Res Ctr Ecol Sci, Hangzhou, Zhejiang, Peoples R China	Southwest University - China; Hangzhou Normal University	Zeng, B; Dong, M (corresponding author), Southwest Univ, Chongqing Key Lab Plant Ecol & Resources Three Go, Key Lab Ecoenvironm Three Gorges Reservoir Reg, Minist Educ,Sch Life Sci, Chongqing, Peoples R China.; Dong, M (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Key Lab Hangzhou City Ecosyst Protect & Restorat, Hangzhou, Zhejiang, Peoples R China.	bzeng@swu.edu.cn; dongming@hznu.edu.cn			National Key R&D Program of China [2017YFC0506200]; National Natural Science Foundation of China [316704290, 31700475]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key R&D Program of China (http://service.most.gov.cn/; grant: 2017YFC0506200) and National Natural Science Foundation of China (http://www.nsfc.gov.cn/; grants: 316704290 and 31700475). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becerra PI, 2018, GLOBAL ECOL BIOGEOGR, V27, P68, DOI 10.1111/geb.12676; Bergstrom AK, 2006, GLOBAL CHANGE BIOL, V12, P635, DOI 10.1111/j.1365-2486.2006.01129.x; Bradley BA, 2012, FRONT ECOL ENVIRON, V10, P20, DOI 10.1890/110145; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Bridgham SD, 1998, ECOLOGY, V79, P1545, DOI 10.1890/0012-9658(1998)079[1545:CNAPMI]2.0.CO;2; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.1890/1540-9295(2004)002[0436:NWISAT]2.0.CO;2; Carpenter SR, 2005, P NATL ACAD SCI USA, V102, P10002, DOI 10.1073/pnas.0503959102; Dodds WK, 2016, INLAND WATERS, V6, P155, DOI 10.5268/IW-6.2.909; Ehrenfeld JG, 2008, J APPL ECOL, V45, P1160, DOI 10.1111/j.1365-2664.2008.01476.x; Fleming JP, 2015, HYDROBIOLOGIA, V746, P23, DOI 10.1007/s10750-014-2026-y; Gao C, 2010, AMBIO, V39, P385, DOI 10.1007/s13280-010-0040-5; Grasset C, 2016, FRESHWATER BIOL, V61, P1405, DOI 10.1111/fwb.12780; Gruntman M, 2016, OIKOS, V125, P59, DOI 10.1111/oik.02109; He WM, 2011, ECOGRAPHY, V34, P1059, DOI 10.1111/j.1600-0587.2011.06835.x; Hettiarachchi M, 2013, ENVIRON CONSERV, V41, P276, DOI [10.1017/80376892913000519, DOI 10.1017/80376892913000519]; Hobbie SE, 2017, P NATL ACAD SCI USA, V114, P4177, DOI 10.1073/pnas.1618536114; Isbell F, 2013, P NATL ACAD SCI USA, V110, P11911, DOI 10.1073/pnas.1310880110; Jarchow ME, 2009, PLANT ECOL, V204, P113, DOI 10.1007/s11258-009-9573-8; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; Liu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep39468; McInnes RJ, 2017, WETLANDS, V37, P123, DOI 10.1007/s13157-016-0849-1; Meza-Lopez MM, 2017, PLANT ECOL, V218, P835, DOI 10.1007/s11258-017-0733-y; Ning L, 2016, BIOL INVASIONS, V18, P3481, DOI 10.1007/s10530-016-1239-6; Pan XY, 2006, ACTA OECOL, V30, P333, DOI 10.1016/j.actao.2006.03.003; Perry LG, 2005, RESTOR ECOL, V13, P725, DOI 10.1111/j.1526-100X.2005.00092.x; Qin TJ, 2018, MAR FRESHWATER RES, V69, P811, DOI [10.1071/MF17335, 10.1071/mf17335]; Rickey MA, 2004, J APPL ECOL, V41, P888, DOI 10.1111/j.0021-8901.2004.00948.x; Roley SS, 2018, FRESHWATER BIOL, V63, P353, DOI 10.1111/fwb.13073; Sanchez-Carrillo S, 2011, EUTROPHICATION: CAUSES, CONSEQUENCES AND CONTROL, P195, DOI 10.1007/978-90-481-9625-8_9; Smith VH, 2003, ENVIRON SCI POLLUT R, V10, P126, DOI 10.1065/espr2002.12.142; Street LE, 2015, NEW PHYTOL, V206, P682, DOI 10.1111/nph.13265; Sun Y, 2017, J VEG SCI, V28, P1250, DOI 10.1111/jvs.12582; Svensson JR, 2013, J ECOL, V101, P140, DOI 10.1111/1365-2745.12028; Tyler AC, 2007, ECOL APPL, V17, P1886, DOI 10.1890/06-0822.1; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Wang BR, 2005, AQUAT BOT, V81, P277, DOI 10.1016/j.aquabot.2005.01.004; Ye WH, 2003, WEED RES, V43, P297, DOI 10.1046/j.1365-3180.2003.00346.x; You WH, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00568; You WH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097246; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248; Zedler JB, 2004, CRIT REV PLANT SCI, V23, P431, DOI 10.1080/07352680490514673; Zhang HJ, 2017, ENVIRON EXP BOT, V135, P118, DOI 10.1016/j.envexpbot.2016.12.014; Zheng YL, 2015, NEW PHYTOL, V205, P1350, DOI 10.1111/nph.13135; Zuo SP, 2012, WEED BIOL MANAG, V12, P123, DOI 10.1111/j.1445-6664.2012.00443.x	45	4	5	6	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0206165	10.1371/journal.pone.0206165	http://dx.doi.org/10.1371/journal.pone.0206165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673697	Green Submitted, Green Published, gold			2022-12-26	WOS:000456442800004
J	Church, B; Wall, E; Webb, JR; Cameron, CE				Church, Brigette; Wall, Erika; Webb, John R.; Cameron, Caroline E.			Interaction of Treponema pallidum, the syphilis spirochete, with human platelets	PLOS ONE			English	Article							LYME-DISEASE; INTEGRIN ALPHA(IIB)BETA(3); BORRELIA-BURGDORFERI; OCULAR SYPHILIS; FIBRONECTIN; ACTIVATION; ATTACHMENT; NEUTROPHILS; METASTASIS; CLEARANCE	Extracellular bacteria that spread via the vasculature employ invasive mechanisms that mirror those of metastatic tumor cells, including intravasation into the bloodstream and survival during hematogenous dissemination, arrestation despite blood flow, and extravasation into distant tissue sites. Several invasive bacteria have been shown to exploit normal platelet function during infection. Due to their inherent ability to interact with and influence other cell types, platelets play a critical role in alteration of endothelial barrier permeability, and their role in cancer metastasis has been well established. The highly invasive bacterium and causative agent of syphilis, Treponema pallidum subspecies pallidum, readily crosses the endothelial, blood-brain and placental barriers. However, the mechanisms underlying this unusual and important aspect of T. pallidum pathogenesis are incompletely understood. In this study we use darkfield microscopy in combination with flow cytometry to establish that T. pallidum interacts with platelets. We also investigate the dynamics of this interaction and show T. pallidum is able to activate platelets and preferentially interacts with activated platelets. Platelet-interacting treponemes consistently exhibit altered kinematic (movement) parameters compared to free treponemes, and T. pallidum-platelet interactions are reversible. This study provides insight into host cell interactions at play during T. pallidum infection and suggests that T. pallidum may exploit platelet function to aid in establishment of disseminated infection.	[Church, Brigette; Wall, Erika; Webb, John R.; Cameron, Caroline E.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada; [Webb, John R.] British Columbia Canc Agcy, Trev & Joyce Deeley Res Ctr, Victoria, BC, Canada	University of Victoria; British Columbia Cancer Agency	Cameron, CE (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada.	caroc@uvic.ca	Cameron, Caroline/HIR-2880-2022	Cameron, Caroline/0000-0002-8786-4359; Church, Brigette/0000-0003-0054-7607	Public Health Service Grant from the National Institutes of Health [AI-051334]; Natural Sciences and Engineering Research Council of Canada [327186]; Canadian Institutes for Health Research Canada Research Chair program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051334, R37AI051334] Funding Source: NIH RePORTER	Public Health Service Grant from the National Institutes of Health; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes for Health Research Canada Research Chair program(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by a Public Health Service Grant (AI-051334) from the National Institutes of Health to CEC and a Discovery Grant (327186) from the Natural Sciences and Engineering Research Council of Canada. CEC gratefully acknowledges the Canadian Institutes for Health Research Canada Research Chair program for salary support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed Sudheer, 2009, Oman Med J, V24, P134, DOI 10.5001/omj.2009.29; Alugupalli KR, 2003, BLOOD, V102, P2843, DOI 10.1182/blood-2003-02-0426; Alugupalli KR, 2001, MOL MICROBIOL, V39, P330, DOI 10.1046/j.1365-2958.2001.02201.x; [Anonymous], 2011, PREVALENCE INCIDENCE; Berthet J, 2012, CLIN IMMUNOL, V145, P189, DOI 10.1016/j.clim.2012.09.004; Bhat P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095248; Binsker U, 2018, THROMB HAEMOSTASIS, V118, P745, DOI 10.1055/s-0038-1637735; Blaschitz A, 2015, PLACENTA, V36, P1333, DOI 10.1016/j.placenta.2015.09.002; Bodis J, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-55; Boulaftali Y, 2018, RES PRACT THROMB HAE, V2, P228, DOI 10.1002/rth2.12092; Centers for Disease Control & Prevention, 2017, 2016 SEX TRANSM DIS; Cloutier N, 2012, BLOOD, V120, P1334, DOI 10.1182/blood-2012-02-413047; COBURN J, 1993, P NATL ACAD SCI USA, V90, P7059, DOI 10.1073/pnas.90.15.7059; COBURN J, 1994, INFECT IMMUN, V62, P5559, DOI 10.1128/IAI.62.12.5559-5567.1994; Cognasse F, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00083; COX DL, 1990, APPL ENVIRON MICROB, V56, P3063, DOI 10.1128/AEM.56.10.3063-3072.1990; COX DL, 1994, METHOD ENZYMOL, V236, P390; Dai T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1586-z; de Voux A, 2017, MMWR-MORBID MORTAL W, V66, P349, DOI 10.15585/mmwr.mm6613a1; Dickerson MT, 2012, BIOCONJUGATE CHEM, V23, P184, DOI 10.1021/bc200436x; Estevez B, 2017, PHYSIOLOGY, V32, P162, DOI 10.1152/physiol.00020.2016; FIELDSTEEL AH, 1981, INFECT IMMUN, V32, P908, DOI 10.1128/IAI.32.2.908-915.1981; Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425; FITZGERALD TJ, 1977, INFECT IMMUN, V18, P467, DOI 10.1128/IAI.18.2.467-478.1977; FITZGERALD TJ, 1984, BRIT J VENER DIS, V60, P357; FITZGERALD TJ, 1975, INFECT IMMUN, V11, P1133; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Golebiewska EM, 2015, BLOOD REV, V29, P153, DOI 10.1016/j.blre.2014.10.003; Gros A, 2015, BLOOD, V126, P1017, DOI 10.1182/blood-2014-12-617159; Haemmerle M, 2018, CANCER CELL, V33, P965, DOI 10.1016/j.ccell.2018.03.002; Hamzeh-Cognasse H, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00082; Handtke S, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00017; Harman M, 2013, BIOPHYS J, V105, P2273, DOI 10.1016/j.bpj.2013.10.004; Haworth JA, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12667; Ho-Tin-Noe B, 2011, J THROMB HAEMOST, V9, P56, DOI 10.1111/j.1538-7836.2011.04317.x; Izard J, 2009, J BACTERIOL, V191, P7566, DOI 10.1128/JB.01031-09; Jones LD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151702; Joo SJ, 2012, KOREAN CIRC J, V42, P295, DOI 10.4070/kcj.2012.42.5.295; Jun HK, 2008, INFECT IMMUN, V76, P2428, DOI 10.1128/IAI.01128-07; Kahn F, 2013, MICROBES INFECT, V15, P669, DOI 10.1016/j.micinf.2013.05.003; Kerrigan SW, 2015, PLATELETS, V26, P293, DOI 10.3109/09537104.2014.997690; LaFond RE, 2006, CLIN MICROBIOL REV, V19, P29, DOI 10.1128/CMR.19.1.29-49.2006; Leblanc R, 2016, BLOOD, V128, P24, DOI 10.1182/blood-2016-01-636399; Li NL, 2016, INT J CANCER, V138, P2078, DOI 10.1002/ijc.29847; Liu LL, 2012, J NEUROL SCI, V317, P35, DOI 10.1016/j.jns.2012.03.003; Lukehart S. A., 2007, CURT PROTOC MICROBIO, V12, P1, DOI DOI 10.1002/9780471729259.MC12A01S7; LUKEHART SA, 1988, ANN INTERN MED, V109, P855, DOI 10.7326/0003-4819-109-11-855; Ma RS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04773-8; Malawista SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001633; Manfredi AA, 2010, CURR OPIN HEMATOL, V17, P3, DOI 10.1097/MOH.0b013e3283324f97; Maugeri N, 2009, BLOOD, V113, P5254, DOI 10.1182/blood-2008-09-180794; McNicol A, 2015, PLATELETS, V26, P309, DOI 10.3109/09537104.2015.1014470; Menter DG, 2017, CANCER METAST REV, V36, P199, DOI 10.1007/s10555-017-9682-0; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Nair Madhavan, 2015, J Alcohol Drug Depend, V3, P182; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; Niddam AF, 2017, P NATL ACAD SCI USA, V114, pE3490, DOI 10.1073/pnas.1615007114; O'Brien KA, 2012, ARTERIOSCL THROM VAS, V32, P2232, DOI 10.1161/ATVBAHA.112.254680; Parker ML, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005919; Paulo N, 2012, INTERACT CARDIOV TH, V14, P223, DOI 10.1093/icvts/ivr067; Petri B, 2010, BLOOD, V116, P4712, DOI 10.1182/blood-2010-03-276311; Radolf JD, 2016, NAT REV MICROBIOL, V14, P744, DOI 10.1038/nrmicro.2016.141; Rainger GE, 2015, PLATELETS, V26, P507, DOI 10.3109/09537104.2015.1064881; Roberts WC, 2015, AM J CARDIOL, V116, P1298, DOI 10.1016/j.amjcard.2015.07.030; Rondina M., 2017, PLATELETS THROMBOTIC, P1071; Sanchez-Cortes J, 2009, CHEM BIOL, V16, P990, DOI 10.1016/j.chembiol.2009.08.012; Santis M. de, 2012, Infectious Diseases in Obstetrics and Gynecology, V2012, P430585, DOI 10.1155/2012/430585; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schlesinger M, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0669-2; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen J, 2015, INT J CLIN EXP MED, V8, P7770; Shin EK, 2017, BIOMOL THER, V25, P223, DOI 10.4062/biomolther.2016.138; Singh AK, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00774-16; Srivastava Kalyan, 2008, Cell Host Microbe, V4, P179, DOI 10.1016/j.chom.2008.07.003; SZANTO SF, 1971, BRIT J VENER DIS, V47, P14; Tesfamariam B, 2016, PHARMACOL THERAPEUT, V157, P112, DOI 10.1016/j.pharmthera.2015.11.005; THOMAS DD, 1988, P NATL ACAD SCI USA, V85, P3608, DOI 10.1073/pnas.85.10.3608; Tuominen-Gustafsson H, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-92; Yakovenko O, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00160-18; Yun SH, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9060143; Zhao JJ, 2015, INT J BIOCHEM CELL B, V68, P176, DOI 10.1016/j.biocel.2015.08.007; Zuchtriegel G, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002459	82	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210902	10.1371/journal.pone.0210902	http://dx.doi.org/10.1371/journal.pone.0210902			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657796	Green Published, gold, Green Submitted			2022-12-26	WOS:000456017000022
J	Steiner, M; Schneider, L; Yillah, J; Gerlach, K; Kuvardina, ON; Meyer, A; Maring, A; Bonig, H; Seifried, E; Zornig, M; Lausenid, J				Steiner, Marlene; Schneider, Lucas; Yillah, Jasmin; Gerlach, Katharina; Kuvardina, Olga N.; Meyer, Annekarin; Maring, Alisa; Bonig, Halvard; Seifried, Erhard; Zoernig, Martin; Lausenid, Joern			FUSE binding protein 1 (FUBP1) expression is upregulated by T-cell acute lymphocytic leukemia protein 1 (TAL1) and required for efficient erythroid differentiation	PLOS ONE			English	Article							HEMATOPOIETIC STEM; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; TARGET GENES; ERYTHROPOIESIS; LACKING; SCL; MYC; ACTIVATION; CHROMATIN	During erythropoiesis, haematopoietic stem cells (HSCs) differentiate in successive steps of commitment and specification to mature erythrocytes. This differentiation process is controlled by transcription factors that establish stage-and cell type-specific gene expression. In this study, we demonstrate that FUSE binding protein 1 (FUBP1), a transcriptional regulator important for HSC self-renewal and survival, is regulated by T-cell acute lymphocytic leukaemia 1 (TAL1) in erythroid progenitor cells. TAL1 directly activates the FUBP1 promoter, leading to increased FUBP1 expression during erythroid differentiation. The binding of TAL1 to the FUBP1 promoter is highly dependent on an intact GATA sequence in a combined E-box/GATA motif. We found that FUBP1 expression is required for efficient erythropoiesis, as FUBP1-deficient progenitor cells were limited in their potential of erythroid differentiation. Thus, the finding of an interconnection between GATA1/TAL1 and FUBP1 reveals a molecular mechanism that is part of the switch from progenitor-to erythrocyte-specific gene expression. In summary, we identified a TAL1/FUBP1 transcriptional relationship, whose physiological function in haematopoiesis is connected to proper erythropoiesis.	[Steiner, Marlene; Gerlach, Katharina; Maring, Alisa; Zoernig, Martin] Georg Speyer Haus, Inst Tumor Biol & Expt Therapy, Frankfurt, Germany; [Schneider, Lucas; Yillah, Jasmin; Kuvardina, Olga N.; Meyer, Annekarin; Bonig, Halvard; Seifried, Erhard; Lausenid, Joern] Goethe Univ, Inst Transfus Med & Immunohematol, Frankfurt, Germany; [Schneider, Lucas; Yillah, Jasmin; Kuvardina, Olga N.; Meyer, Annekarin; Bonig, Halvard; Seifried, Erhard; Lausenid, Joern] German Red Cross Blood Serv, Frankfurt, Germany; [Gerlach, Katharina] Fresenius Kabi Deutschland GmbH, Oberursel, Germany	Octapharma; Goethe University Frankfurt	Zornig, M (corresponding author), Georg Speyer Haus, Inst Tumor Biol & Expt Therapy, Frankfurt, Germany.; Lausenid, J (corresponding author), Goethe Univ, Inst Transfus Med & Immunohematol, Frankfurt, Germany.; Lausenid, J (corresponding author), German Red Cross Blood Serv, Frankfurt, Germany.	zoernig@gsh.uni-frankfurt.de; j.lausen@blutspende.de	Bönig, Halvard/AAG-3029-2021	Bönig, Halvard/0000-0003-0088-2675; Maring, Alisa/0000-0001-8904-3151				Bonifer C, 2008, SEMIN IMMUNOL, V20, P257, DOI 10.1016/j.smim.2008.05.001; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Capellera-Garcia S, 2016, CELL REP, V15, P2550, DOI 10.1016/j.celrep.2016.05.027; Chacon D, 2014, NUCLEIC ACIDS RES, V42, pD172, DOI 10.1093/nar/gkt1036; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Chung HJ, 2005, MOL CELLS, V20, P157; DavisSmyth T, 1996, J BIOL CHEM, V271, P31679, DOI 10.1074/jbc.271.49.31679; Dixit U, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-925; Eggold JT, 2019, BONE, V119, P36, DOI 10.1016/j.bone.2018.03.014; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Haas N, 2015, CELL DEATH DIFFER, V22, P790, DOI 10.1038/cdd.2014.172; Hall MA, 2005, MOL CELL BIOL, V25, P6355, DOI 10.1128/MCB.25.15.6355-6362.2005; Han GC, 2016, MOL CELL BIOL, V36, P157, DOI 10.1128/MCB.00806-15; Herglotz J, 2013, ONCOGENE, V32, P2565, DOI 10.1038/onc.2012.274; Herkt SC, 2018, HAEMATOLOGICA, V103, P18, DOI 10.3324/haematol.2017.174516; Hewitt KJ, 2016, CURR TOP DEV BIOL, V118, P45, DOI 10.1016/bs.ctdb.2016.01.002; Higgins JM, 2015, CLIN LAB MED, V35, P43, DOI 10.1016/j.cll.2014.10.002; Hoang T, 2016, CURR TOP DEV BIOL, V118, P163, DOI 10.1016/bs.ctdb.2016.01.004; Jayapal S, 2010, J BIOL CHEM, V285, P40252, DOI 10.1074/jbc.M110.181073; Kassouf MT, 2008, BLOOD, V112, P1056, DOI 10.1182/blood-2007-12-128900; Kim SI, 2007, MOL CELL BIOL, V27, P4551, DOI 10.1128/MCB.00235-07; Kuvardina ON, 2015, BLOOD, V125, P3570, DOI 10.1182/blood-2014-11-610519; Lacombe J, 2010, BLOOD, V115, P792, DOI 10.1182/blood-2009-01-201384; Liu JH, 2011, EMBO J, V30, P846, DOI 10.1038/emboj.2011.11; Love PE, 2014, TRENDS GENET, V30, P1, DOI 10.1016/j.tig.2013.10.001; O'Donnell KA, 2006, MOL CELL BIOL, V26, P2373, DOI 10.1128/MCB.26.6.2373-2386.2006; Perry C, 2002, EUR J BIOCHEM, V269, P3607, DOI 10.1046/j.1432-1033.2002.02999.x; PEVNY L, 1995, DEVELOPMENT, V121, P163; Porcher C, 2017, BLOOD, V129, P2051, DOI 10.1182/blood-2016-12-754051; Rabenhorst U, 2015, CELL REP, V11, P1847, DOI 10.1016/j.celrep.2015.05.038; Rabenhorst U, 2009, HEPATOLOGY, V50, P1121, DOI 10.1002/hep.23098; Robb L, 1996, EMBO J, V15, P4123, DOI 10.1002/j.1460-2075.1996.tb00787.x; Rodriguez-Fraticelli AE, 2018, NATURE, V553, P212, DOI 10.1038/nature25168; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Sivertsen EA, 2006, BRIT J HAEMATOL, V135, P117, DOI 10.1111/j.1365-2141.2006.06252.x; Suzuki M, 2013, GENES CELLS, V18, P921, DOI 10.1111/gtc.12086; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; Tsiftsoglou AS, 2009, IUBMB LIFE, V61, P800, DOI 10.1002/iub.226; Tusi BK, 2018, NATURE, V555, P54, DOI 10.1038/nature25741; Wesely J, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/5762301; Wu KJ, 1999, SCIENCE, V283, P676, DOI 10.1126/science.283.5402.676; Wu WS, 2014, GENOME RES, V24, P1945, DOI 10.1101/gr.164830.113; Zhang J, 2013, ONCOGENE, V32, P2907, DOI 10.1038/onc.2012.350; Zheng YH, 2011, INT J BIOCHEM CELL B, V43, P1641, DOI 10.1016/j.biocel.2011.08.001	45	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210515	10.1371/journal.pone.0210515	http://dx.doi.org/10.1371/journal.pone.0210515			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653565	gold, Green Published, Green Submitted			2022-12-26	WOS:000456015500047
J	Wakayama, A; Matsumoto, C; Ayato, Y; Shimomura, Y				Wakayama, Akemi; Matsumoto, Chota; Ayato, Yoriko; Shimomura, Yoshikazu			Comparison of monocular sensitivities measured with and without occlusion using the head-mounted perimeter imo	PLOS ONE			English	Article							BINOCULAR SUMMATION; FIELD; TRANSLUCENT; ADAPTATION; BLANKOUT	Purpose Using a head-mounted perimeter imo that can measure monocular sensitivity with both eyes open, we investigated the difference between monocular sensitivities measured with and without occlusion of the fellow eye and if the difference was influenced by eccentricity. Methods Using the perimeter imo, monocular sensitivities with/without occlusion and binocular sensitivity were measured and compared. Three test conditions for monocular sensitivity without occlusion were: with/without a fusional fixation target, and a binocular random single eye test in which the target was randomly presented to either eye and the examinee was not aware of the tested eye. Within the central 25 degrees visual field (VF), 29 points located at the fovea and on the 45 degrees, 135 degrees, 225 degrees, and 315 degrees meridians with 3 degrees intervals were tested. Differences among the four monocular sensitivities with/without occlusion were further evaluated at the fovea, within and beyond the central 5 degrees VF. Results Sixteen visually normal volunteers (mean age, 28.6 +/- 4.6 years) were included in this study. Except at the fovea, monocular sensitivities measured without occlusion were significantly higher than those with occlusion (P < 0.01). No significant difference was seen among the three monocular sensitivities without occlusion (P = 0.82). Conclusions Except at the fovea, monocular sensitivities measured with and without occlusion significantly differed. This indicates that without occlusion, binocular interaction is activated and affects not only binocular sensitivity but also monocular sensitivity.	[Wakayama, Akemi; Matsumoto, Chota; Ayato, Yoriko; Shimomura, Yoshikazu] Kindai Univ, Fac Med, Dept Ophthalmol, Osakasayama City, Osaka, Japan		Wakayama, A (corresponding author), Kindai Univ, Fac Med, Dept Ophthalmol, Osakasayama City, Osaka, Japan.	akemi-wakayama@med.kindai.ac.jp			CREWT Medical Systems, Inc.; CREWT	CREWT Medical Systems, Inc.; CREWT	YS and CM received funding from CREWT Medical Systems, Inc. CREWT made a custom program for "imo" in this study. The funders had no additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AJ, 2002, OPTOMETRY VISION SCI, V79, P88, DOI 10.1097/00006324-200202000-00009; Anderson AJ, 2007, INVEST OPHTH VIS SCI, V48, P943, DOI 10.1167/iovs.06-0685; Aydin P, 1997, NEURO-OPHTHALMOLOGY, V17, P185, DOI 10.3109/01658109709044664; BANTON T, 1991, J OPT SOC AM A, V8, P673, DOI 10.1364/JOSAA.8.000673; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; BOLANOWSKI SJ, 1987, VISION RES, V27, P967, DOI 10.1016/0042-6989(87)90012-5; Breese BB, 1909, PSYCHOL REV, V16, P410, DOI 10.1037/h0075805; FUHR PS, 1990, ARCH OPHTHALMOL-CHIC, V108, P983, DOI 10.1001/archopht.1990.01070090085045; Goseki T, 2016, NEURO-OPHTHALMOLOGY, V40, P281, DOI 10.1080/01658107.2016.1220593; GRIGSBY SS, 1994, VISION RES, V34, P2841, DOI 10.1016/0042-6989(94)90053-1; LIU L, 1992, VISION RES, V32, P1471, DOI 10.1016/0042-6989(92)90203-U; Matsumoto C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161974; MUELLER TJ, 1989, BIOL CYBERN, V61, P223, DOI 10.1007/BF00198769; Spry PGD, 2002, OPTOMETRY VISION SCI, V79, P93, DOI 10.1097/00006324-200202000-00010; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Wakayama A, 2005, INVEST OPHTH VIS SCI, V46, P2810, DOI 10.1167/iovs.04-1421; Wakayama A, 2002, GRAEF ARCH CLIN EXP, V240, P743, DOI 10.1007/s00417-002-0526-3; Wakayama A, 2012, INVEST OPHTH VIS SCI, V53, P387, DOI 10.1167/iovs.11-8022; Wakayama A, 2011, VISION RES, V51, P174, DOI 10.1016/j.visres.2010.11.002	19	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210691	10.1371/journal.pone.0210691	http://dx.doi.org/10.1371/journal.pone.0210691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653560	gold, Green Published, Green Submitted			2022-12-26	WOS:000456015500063
J	Aghdam, AG; Moradhaseli, S; Jafari, F; Motahari, P; Samavat, S; Mahboudi, R; Maleknia, S				Aghdam, Atefeh Ghorbani; Moradhaseli, Saeed; Jafari, Farnoush; Motahari, Paria; Samavat, Sepideh; Mahboudi, Rasoul; Maleknia, Shayan			Therapeutic Fc fusion protein misfolding: A three-phasic cultivation experimental design	PLOS ONE			English	Article							CULTURE TEMPERATURE; PRODUCTIVITY; CELLS; ERYTHROPOIETIN; CHROMATOGRAPHY; AGGREGATION; EXPRESSION; STRATEGIES; SHIFT; TOOL	Cell culture process optimization is a critical solution to most of the challenges faced by the pharmaceutical manufacturing. One of the major problems encountered in large-scale production of therapeutic proteins is misfolded protein production. The accumulation of misfolded therapeutic proteins is an immunogenic signal and a risk factor for immunogenicity of the final product. The aim of this study was the statistical optimization of three-phasic temperature shift and timing for enhanced production of correctly folded Fc-fusion protein. The effect of culture temperatures were investigated using the biphasic culture system. Box-Behnken design was then used to compute temperature and time of shifting optimum. Response surface methodology revealed that maximum production with low level of misfolded protein was achieved at two-step temperature shift from 37 degrees C to 30 degrees C during the late logarithmic phase and 30 degrees C to 28 degrees C in the mid-stationary phase. The optimized condition gave the best results of 1860 mg L-1 protein titer with 24.5% misfolding level. The validation experiments were carried out under optimal conditions with three replicates and the protein misfolding level was decreased by two times while productivity increased by similar to 1.3-fold. Large-scale production in 250 L bioreactor under the optimum conditions was also verified the effectiveness and the accuracy of the model. The results showed that by utilizing two-step temperature shift, productivity and the quality of target protein have been improved simultaneously. This model could be successfully applied to other products.	[Aghdam, Atefeh Ghorbani; Moradhaseli, Saeed; Jafari, Farnoush; Motahari, Paria; Samavat, Sepideh; Mahboudi, Rasoul; Maleknia, Shayan] Alborz Univ Med Sci, Aryogen Pharmed Inc, Biopharmaceut Res Ctr, Karaj, Iran		Maleknia, S (corresponding author), Alborz Univ Med Sci, Aryogen Pharmed Inc, Biopharmaceut Res Ctr, Karaj, Iran.	Maleknias@aryogen.com			Aryogen Pharmed Inc.	Aryogen Pharmed Inc.	Aryogen Pharmed Inc., provided all funding supports during this specific study. The authors declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We have no conflict of interest to disclose. The authors declare that the funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agarabi CD, 2015, J PHARM SCI-US, V104, P1919, DOI 10.1002/jps.24420; Beck A, 2011, MABS-AUSTIN, V3, P415, DOI 10.4161/mabs.3.5.17334; Bedoya-Lopez A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151529; Berger S., 2015, MABS-AUSTIN, V7, P456, DOI 10.1080/19420862.2015.1019788; Campos JLS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01097-5; Chaturvedi SK, 2016, PROCESS BIOCHEM, V51, P1183, DOI 10.1016/j.procbio.2016.05.015; Cynthia C., 2016, PROTEIN IMPURITIES P, P30; del Monte F, 2014, PROTEOM CLIN APPL, V8, P534, DOI 10.1002/prca.201400037; Dinarvand M, 2017, BRAZ J MICROBIOL, V48, P427, DOI 10.1016/j.bjm.2016.10.026; Elkhidir, 2011, TREN APPL SCI RES, V6, P121, DOI DOI 10.3923/tasr.2011.121.129; Estes B, 2015, BIOTECHNOL PROGR, V31, P258, DOI 10.1002/btpr.2021; Fairbrass DL, 2016, THESIS; Freund NW, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020385; Gilbert A, 2014, PHARM BIOPROCESS, V2, P519, DOI 10.4155/PBP.14.35; Hackl M., 2009, THESIS; Haverick M, 2014, MABS-AUSTIN, V6, P852, DOI 10.4161/mabs.28693; Howard R, 2017, G3-GENES GENOM GENET, V7, P3103, DOI 10.1534/g3.117.044453; J Masterton R, 2014, IMPACT PROCESS TEMPE, P49; Jose Manuel G, 2008, US, Patent No. 12107533; Kallberg K, 2012, BIOTECHNOL J, V7, P1485, DOI 10.1002/biot.201200074; Kaufmann H, 1999, BIOTECHNOL BIOENG, V63, P573, DOI 10.1002/(SICI)1097-0290(19990605)63:5<573::AID-BIT7>3.0.CO;2-Y; Kaufmann H, 1999, INFLUENCE LOW TEMPER, P573; Kelly P., 2014, THESIS; Kim JY, 2012, APPL MICROBIOL BIOT, V93, P917, DOI 10.1007/s00253-011-3758-5; Kumar N, 2007, CYTOTECHNOLOGY, V53, P33, DOI 10.1007/s10616-007-9047-6; Kumar N, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-42; Li F, 2010, MABS-AUSTIN, V2, P466, DOI 10.4161/mabs.2.5.12720; Maas C, 2007, J BIOL CHEM, V282, P2229, DOI 10.1074/jbc.M605984200; Mammar K., 2013, LEONARDO J SCI, V23, P84; Marchant RJ, 2008, MOL BIOTECHNOL, V39, P69, DOI 10.1007/s12033-008-9032-0; Mason M, 2014, ANTIBODIES, V3, P253, DOI 10.3390/antib3030253; MdLV Suberbie, 2013, THESIS; MIZOCK BA, 1995, AM J MED, V98, P75, DOI 10.1016/S0002-9343(99)80083-7; Moore A, 1997, CYTOTECHNOLOGY, V23, P47, DOI 10.1023/A:1007919921991; Ozturk S, 2005, CELL CULTURE TECHNOL, P47, DOI [10.1023/A:1007919921991, DOI 10.1023/A:1007919921991]; Pasma SA, 2013, INT J POLYM SCI, V2013, DOI 10.1155/2013/104502; Rath T, 2015, CRIT REV BIOTECHNOL, V35, P235, DOI 10.3109/07388551.2013.834293; Rieder CL, 2002, CELL CYCLE, V1, P169, DOI 10.4161/cc.1.3.119; Siew A., 2015, ANAL PROTEIN AGGREGA, P40; Son YJ, 2007, BIOTECHNOL BIOPROC E, V12, P556, DOI 10.1007/BF02931354; Sou SN, 2018, BIOTECHNOL BIOENG, V115, P512, DOI 10.1002/bit.26456; Strnad J, 2010, BIOTECHNOL PROGR, V26, P653, DOI 10.1002/btpr.390; Terova O, 2018, OVERCOMING DOWNSTREA, P101; Tjeldhorn L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024009; Torkashvand F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140597; Trummer E, 2006, BIOTECHNOL BIOENG, V94, P1045, DOI 10.1002/bit.20958; Vergara M, 2013, BMC P S6, V7, P108; Walsh G, 2014, NAT BIOTECHNOL, V32, P992, DOI 10.1038/nbt.3040; Yoon SK, 2003, BIOTECHNOL BIOENG, V82, P289, DOI 10.1002/bit.10566; Zhang TC, 2015, P 2 INT C APPL BIOT, VI	50	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210712	10.1371/journal.pone.0210712	http://dx.doi.org/10.1371/journal.pone.0210712			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650123	gold, Green Published			2022-12-26	WOS:000455813300072
J	Lewis, TW; Mellersh, CS				Lewis, T. W.; Mellersh, C. S.			Changes in mutation frequency of eight Mendelian inherited disorders in eight pedigree dog populations following introduction of a commercial DNA test	PLOS ONE			English	Article							ROD-CONE DEGENERATION	Introduction DNA testing for autosomal recessive disease mutations in many dog breeds is now relatively commonplace. There have, however, been few efforts made to determine changes in the frequency of disease causing mutations as a result of probable selection based on the results of DNA testing. This study makes use of genotype data from both DNA test results reported to the UK Kennel Club and where known from a 'hereditary status' (where a definitive genotype may be inferred and ascribed based on known parental genotypes) to do so. Results The results, using all known genotype data, show a general and sizeable decline in disease causing mutation frequency across eight diseases in eight breeds (by between 12-86% in dogs born 2-4 years after publication of the mutation, and by nearly 90% or more in those born 8-10 years after). In contrast, data from test results only, while revealing an almost complete and immediate end to the production of affected individuals, show little general decline in either the derived mutation frequency or the proportion of heterozygote carriers. It appears that the numerical size of the breed is an important determinant on the rate of uptake of a DNA test (as judged by the proportion of a breed born four years after publication of the disease-causing mutation with a known genotype). Conclusion These results show that dog breeders appear to be incorporating the results of DNA testing into their selection strategies to successfully decrease the frequency of the mutation. It is shown that use of DNA test result data alone does not reveal such trends, possibly as some breeders undertake testing to determine clear stock which can then be used to produce future disease-free generations in the knowledge they are not carrying the disease causing mutation.	[Lewis, T. W.] Kennel Club, London, England; [Lewis, T. W.] Univ Nottingham, Sch Vet Med & Sci, Sutton Bonington Campus, Loughborough, Leics, England; [Mellersh, C. S.] Anim Hlth Trust, Kennel Club Genet Ctr, Newmarket, Suffolk, England	University of Nottingham; Animal Health Trust	Lewis, TW (corresponding author), Kennel Club, London, England.; Lewis, TW (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Sutton Bonington Campus, Loughborough, Leics, England.	tom.lewis@thekennelclub.org.uk		Lewis, Thomas/0000-0003-4166-7955				AGUIRRE G, 1982, INVEST OPHTH VIS SCI, V23, P610; Ahonen Saija, 2018, Canine Genet Epidemiol, V5, P2, DOI 10.1186/s40575-018-0058-8; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Donner J, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007361; Donner J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161005; Downs LM, 2013, ANIM GENET, V44, P169, DOI 10.1111/j.1365-2052.2012.02379.x; Farias FHG, 2010, INVEST OPHTH VIS SCI, V51, P4716, DOI 10.1167/iovs.09-5142; Forman OP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064627; Forman OP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002462; Gill JL, 2012, NEUROBIOL DIS, V45, P130, DOI 10.1016/j.nbd.2011.07.014; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; Marsden CD, 2016, P NATL ACAD SCI USA, V113, P152, DOI 10.1073/pnas.1512501113; Mellersh CS, 2006, VET OPHTHALMOL, V9, P369, DOI 10.1111/j.1463-5224.2006.00496.x; Online Mendelian Inheritance in Animals OMIA, ONL MEND INH AN OMIA; Patterson EE, 2008, NAT GENET, V40, P1235, DOI 10.1038/ng.224; Zangerl B, 2006, GENOMICS, V88, P551, DOI 10.1016/j.ygeno.2006.07.007	16	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209864	10.1371/journal.pone.0209864	http://dx.doi.org/10.1371/journal.pone.0209864			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650096	Green Published, gold, Green Submitted			2022-12-26	WOS:000455813300032
J	Zhou, H; Wang, AQ; Huang, XN; Guo, SF; Yang, YN; Martin, K; Tian, XB; Josephs-Spaulding, J; Ma, CY; Scherpbier, RW; Wang, Y				Zhou, Hong; Wang, Anqi; Huang, Xiaona; Guo, Sufang; Yang, Yuning; Martin, Kathryn; Tian, Xiaobo; Josephs-Spaulding, Jonathan; Ma, Chuyang; Scherpbier, Robert W.; Wang, Yan			Quality antenatal care protects against low birth weight in 42 poor counties of Western China	PLOS ONE			English	Article							PRENATAL-CARE; SUPPLEMENTATION; PREGNANCY; MOTHERS	Limited data exist related to low birth weight (LBW) incidence and risk factors in Western China. This paper aims to assess LBW and its relationship with antenatal care (ANC) in the poor counties of Western China. A community-based study in rural Western China was conducted in 2011. A kernel distribution was used to estimate the adjusted LBW incidence, and associations between LBW and socio-demographic or maternal factors were examined using multilevel logistic regression. Among 8,964 participants, 65.7% were weighed at birth. Crude LBW incidence was 6.6% and the adjusted rate was 9.3%. The study revealed that risk factors of LBW are being female, raised within a minority group, and with a family income below the national poverty line. For maternal risk factors, LBW was positively associated with not attending at least five or eight ANC visits, not receiving any ANC during the first trimester, and not having access to assess certain ANC content (weight, blood pressure, blood test, urine test, B-scan ultrasound, and folic acid supplement). There is urgent need to promote quality ANC in poor and rural areas of Western China and to prioritize vulnerable women and children who will benefit from quality ANC.	[Zhou, Hong; Wang, Anqi; Wang, Yan] Peking Univ, Sch Publ Hlth, Dept Maternal & Child Hlth, Beijing, Peoples R China; [Zhou, Hong; Wang, Yan] Natl Human Genet Resources Ctr, Environm & Spatial Epidemiol Res Ctr, Beijing, Peoples R China; [Wang, Anqi] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Huang, Xiaona; Yang, Yuning; Martin, Kathryn; Tian, Xiaobo; Scherpbier, Robert W.] UNICEF China, Beijing, Peoples R China; [Guo, Sufang] UNICEF Reg Off South Asia, Leknath Marg, Kathmandu, Nepal; [Josephs-Spaulding, Jonathan] Christian Albrechts Univ Kiel, Inst Expt Med, Kiel, Germany; [Ma, Chuyang] Beijing Lu He Int Acad, Beijing, Peoples R China	Peking University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Kiel	Wang, Y (corresponding author), Peking Univ, Sch Publ Hlth, Dept Maternal & Child Hlth, Beijing, Peoples R China.; Wang, Y (corresponding author), Natl Human Genet Resources Ctr, Environm & Spatial Epidemiol Res Ctr, Beijing, Peoples R China.; Scherpbier, RW (corresponding author), UNICEF China, Beijing, Peoples R China.	rscherpbier@unicef.org; wangyan@bjmu.edu.cn	Josephs-Spaulding, Jonathan/T-7730-2019	Josephs-Spaulding, Jonathan/0000-0001-9828-0685	UNICEF China [YH702]	UNICEF China	This work was funded by a grant from UNICEF China (YH702 to YW); https://www.unicef.org/infobycountry/china.html.The funders participated the process of study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balazs P, 2013, EUR J PUBLIC HEALTH, V23, P480, DOI 10.1093/eurpub/cks089; Bener Abdulbari, 2012, ISRN Obstet Gynecol, V2012, P540495; Bian YH, 2013, J BIOMED RES, V27, P14, DOI 10.7555/JBR.27.20120046; Blanc AK, 2005, B WORLD HEALTH ORGAN, V83, P178; Borah Madhur, 2015, J Family Med Prim Care, V4, P380, DOI 10.4103/2249-4863.161326; da Fonseca CRB, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-255; Charnigo R, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-37; Chinese Nutrition Society, 2016, CHIN DIET GUID; Cui Hao, 2015, Zhonghua Yu Fang Yi Xue Za Zhi, V49, P161; Demelash H, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0677-y; Department of Household Surveys National Bureau of Statistics of China, 2016, POV MON REP RUR CHIN; Dijkhuizen MA, 2004, AM J CLIN NUTR, V80, P1299, DOI 10.1093/ajcn/80.5.1299; Division UNP, 2017, SEX RAT BIRTH REF MA; Keen CL, 2003, J NUTR, V133, p1597S, DOI 10.1093/jn/133.5.1597S; Khanal V, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-4; Khatun S, 2008, J BIOSOC SCI, V40, P321, DOI 10.1017/S0021932007002532; Kirkham C, 2005, AM FAM PHYSICIAN, V71, P1307; Lin Liangming, 2002, Zhonghua Yufang Yixue Zazhi, V36, P149; Pinzon-Rondon AM, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0541-0; Martinez-Mesa J, 2013, OSTEOPOROSIS INT, V24, P7, DOI 10.1007/s00198-012-2114-7; Matthews T J, 2013, Natl Vital Stat Rep, V62, P1; Nation Health and Family Planning Commission of the People's Republic of China, 2011, NAT BAS PUBL HLTH SE; National Bureau of Statistics, 2011, 2010 POP CENS PEOPL; National Bureau of Statistics of China, NAT DAT ANN 2010; National Health and Family Planning Commission of China, 2011, ADM HLTH CARE PREGN; Rao JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21771-6; Servan-Mori E, 2016, HEALTH POLICY PLANN, V31, P444, DOI 10.1093/heapol/czv082; Shan XY, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-105; State Council of the People's Republic of China, 2009, OP CENTR COMM COMM P; Tang L, 2013, BIRTH-ISS PERINAT C, V40, P134, DOI 10.1111/birt.12038; United Nations Children's Fund (UNICEF), MULT IND CLUST SURV; Van Kerm P, 2003, STATA J, V3, P148, DOI 10.1177/1536867X0300300204; Van Kerm P, 2012, STATA J, V12, P543, DOI 10.1177/1536867X1201200313; Wang YP, 2016, LANCET, V387, P273, DOI 10.1016/S0140-6736(15)00554-1; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; WHO, 2022, WHO RECOMMENDATIONS; WHO, 2004, LOW BIRTHW COUNTR RE; WHO, 2018, GUIDELINES OPTIMAL F; World Health Organization, 2015, PREGN CHILDB POSTP N; Xiao PL, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0684-z; Ye F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134756; Zarrati M, 2013, ANN NUTR METAB, V63, P69, DOI 10.1159/000351869	42	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210393	10.1371/journal.pone.0210393	http://dx.doi.org/10.1371/journal.pone.0210393			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650127	Green Submitted, gold, Green Published			2022-12-26	WOS:000455813300055
J	Avraham, S; Korin, B; Aviram, S; Shechter, D; Shaked, Y; Aronheim, A				Avraham, Shimrit; Korin, Ben; Aviram, Sharon; Shechter, Dvir; Shaked, Yuval; Aronheim, Ami			ATF3 and JDP2 deficiency in cancer associated fibroblasts promotes tumor growth via SDF-1 transcription	ONCOGENE			English	Article							JUN DIMERIZATION PROTEIN-2; ADAPTIVE-RESPONSE; AP-1 REPRESSOR; CELLS; MICROENVIRONMENT; ANGIOGENESIS; SDF-1/CXCL12; FACTOR-3; GENE; BETA	The activating transcription factor 3 (ATF3) and the c-Jun dimerization protein 2 (JDP2) are members of the basic leucine zipper (bZIP) family of transcription factors. These proteins share a high degree of homology and both can activate or repress transcription. Deficiency of either one of them in the non-cancer host cells was shown to reduce metastases. As ATF3 and JDP2 compensate each other's function, we studied the double deficiency of ATF3 and JDP2 in the stromal tumor microenvironment. Here, we show that mice with ATF3 and JDP2 double deficiency (designated thereafter dKO) developed larger tumors with high vascular perfusion and increased cell proliferation rate compared to wild type (WT) mice. We further identify that the underlying mechanism involves tumor associated fibroblasts which secrete high levels of stromal cell-derived factor 1 (SDF-1) in dKO fibroblasts. SDF-1 depletion in dKO fibroblasts dampened tumor growth and blood vessel perfusion. Furthermore, ATF3 and JDP2 were found to regulate SDF-1 transcription and secretion in fibroblasts, a phenomenon that is potentiated in the presence of cancer cells. Collectively, our results suggest that ATF3 and JDP2 regulate the expression of essential tumor promoting factors expressed by fibroblasts within the tumor microenvironment, and thus restrain tumor growth.	[Avraham, Shimrit; Aviram, Sharon; Shechter, Dvir; Shaked, Yuval; Aronheim, Ami] Technion Israel Inst Technol, Dept Cell Biol & Canc Sci, Rappaport Fac Med B, Haifa, Israel; [Korin, Ben] Technion Israel Inst Technol, Dept Immunol, Rappaport Fac Med B, Dept Neurosci, Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology	Shaked, Y; Aronheim, A (corresponding author), Technion Israel Inst Technol, Dept Cell Biol & Canc Sci, Rappaport Fac Med B, Haifa, Israel.	yshaked@technion.ac.il; aronheim@technion.ac.il			Israel Science Foundation [731/17]; European Research Council H2020 [771112]; United States-Israel Binational grant [2015139]	Israel Science Foundation(Israel Science Foundation); European Research Council H2020; United States-Israel Binational grant	This research work was partially supported by the Israel Science Foundation grant #731/17 to A.A, the United States-Israel Binational grant #2015139 to A.A and the European Research Council H2020 (No. 771112) given to YS.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Barbarov Y, 2015, ONCOTARGET, V6, P37737, DOI 10.18632/oncotarget.5648; Bastian Seubert, 2015, HEPATOLOG, V61, P238; Bitton-Worms K, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-54; Buganim Y, 2011, CARCINOGENESIS, V32, P1749, DOI 10.1093/carcin/bgr203; Chang YS, 2017, P NATL ACAD SCI USA, V114, pE7159, DOI 10.1073/pnas.1700455114; Chen BPC, 1996, MOL CELL BIOL, V16, P1157, DOI 10.1128/mcb.16.3.1157; Christopher W, 2003, NAT MED, V9, P8; Darlyuk-Saadon I, 2013, BIOCHIM BIOPHYS ACTA, V10, P54; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; FOLKMAN J, 1986, CANCER RES, V46, P467; Franco M, 2006, CANCER RES, V66, P3639, DOI 10.1158/0008-5472.CAN-05-3295; Franco OE, 2010, SEMIN CELL DEV BIOL, V21, P33, DOI 10.1016/j.semcdb.2009.10.010; Garcia-Moruja C, 2005, J MOL BIOL, V348, P43, DOI 10.1016/j.jmb.2005.02.016; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Heinrich R, 2004, J BIOL CHEM, V279, P5708, DOI 10.1074/jbc.M307608200; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Jin CY, 2001, FEBS LETT, V489, P34, DOI 10.1016/S0014-5793(00)02387-5; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kalfon R, 2017, INT J CARDIOL, V249, P357, DOI 10.1016/j.ijcard.2017.08.074; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Katz S, 2001, FEBS LETT, V506, P196, DOI 10.1016/S0014-5793(01)02907-6; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Kryczek I, 2007, AM J PHYSIOL-CELL PH, V292, pC987, DOI 10.1152/ajpcell.00406.2006; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158; Madlambayan GJ, 2009, BLOOD, V114, P4310, DOI 10.1182/blood-2009-03-211342; Mao Y, 2013, CANCER METAST REV, V32, P303, DOI 10.1007/s10555-012-9415-3; Mashima T, 2001, J CELL PHYSIOL, V188, P352, DOI 10.1002/jcp.1130; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pan J, 2010, ONCOGENE, V29, P6245, DOI 10.1038/onc.2010.355; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaked Y, 2008, CANCER CELL, V14, P263, DOI 10.1016/j.ccr.2008.08.001; Sharon Y, 2013, JOVE-J VIS EXP, DOI 10.3791/4425; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Timaner M, 2016, CURR PROTOC CELL BIO, V2016; Tsai MH, 2016, GENE, V590, P193, DOI 10.1016/j.gene.2016.03.048; Urruticoechea A, 2005, J CLIN ONCOL, V23, P7212, DOI 10.1200/JCO.2005.07.501; Wardell SE, 2002, MOL CELL BIOL, V22, P5451, DOI 10.1128/MCB.22.15.5451-5466.2002; Weidenfeld-Baranboim K, 2008, NUCLEIC ACIDS RES, V36, P3608, DOI 10.1093/nar/gkn268; Wolford CC, 2013, J CLIN INVEST, V123, P2893, DOI 10.1172/JCI64410; Yin X, 2008, ONCOGENE, V27, P2118, DOI 10.1038/sj.onc.1210861	49	15	15	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 16	2019	38	20					3812	3823		10.1038/s41388-019-0692-y	http://dx.doi.org/10.1038/s41388-019-0692-y			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HY3OI	30670778	hybrid, Green Published			2022-12-26	WOS:000468035600004
J	Ma, XY; Das, NK; Castillo, C; Gourani, A; Perekatt, AO; Verzi, MP; Shah, YM				Ma, Xiaoya; Das, Nupur K.; Castillo, Cristina; Gourani, Ayla; Perekatt, Ansu O.; Verzi, Michael P.; Shah, Yatrik M.			SMAD family member 3 (SMAD3) and SMAD4 repress HIF2-dependent iron-regulatory genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hypoxia; iron; iron metabolism; gene expression; SMAD transcription factor; DMT1; HIF; Iron; SMAD	HYPOXIA-INDUCIBLE FACTOR; DNA-BINDING ACTIVITY; GROWTH-FACTOR-BETA; FACTOR-I; CANCER PROGRESSION; STRUCTURAL BASIS; TGF-BETA; METABOLISM; DOMAIN; PHOSPHORYLATION	Hypoxia-inducible factor 2 (HIF2) directly regulates a battery of genes essential for intestinal iron absorption. Interestingly, iron deficiency and overload disorders do not result in increased intestinal expression of glycolytic or angiogenic HIF2 target genes. Similarly, inflammatory and tumor foci can induce a distinct subset of HIF2 target genes in vivo. These observations indicate that different stimuli activate distinct subsets of HIF2 target genes via mechanisms that remain unclear. Here, we conducted a high-throughput siRNA-based screen to identify genes that regulate HIF2's transcriptional activity on the promoter of the iron transporter gene divalent metal transporter-1 (DMT1). SMAD family member 3 (SMAD3) and SMAD4 were identified as potential transcriptional repressors. Further analysis revealed that SMAD4 signaling selectively represses iron-absorptive gene promoters but not the inflammatory or glycolytic HIF2 or HIF1 target genes. Moreover, the highly homologous SMAD2 did not alter HIF2 transcriptional activity. During iron deficiency, SMAD3 and SMAD4 expression was significantly decreased via proteasomal degradation, allowing for derepression of iron target genes. Several iron-regulatory genes contain a SMAD-binding element (SBE) in their proximal promoters; however, mutation of the putative SBE on the DMT1 promoter did not alter the repressive function of SMAD3 or SMAD4. Importantly, the transcription factor forkhead box protein A1 (FOXA1) was critical in SMAD4-induced DMT1 repression, and DNA binding of SMAD4 was essential for the repression of HIF2 activity, suggesting an indirect repressive mechanism through DNA binding. These results provide mechanistic clues to how HIF signaling can be regulated by different cellular cues.	[Ma, Xiaoya; Das, Nupur K.; Castillo, Cristina; Gourani, Ayla; Shah, Yatrik M.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Shah, Yatrik M.] Univ Michigan, Sch Med, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Perekatt, Ansu O.; Verzi, Michael P.] Rutgers State Univ, Inst Human Genet, Dept Genet, Piscataway, NJ 08854 USA; [Perekatt, Ansu O.; Verzi, Michael P.] Rutgers State Univ, Rutgers Canc Inst, Piscataway, NJ 08854 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Shah, YM (corresponding author), Dept Mol & Integrat Physiol, 1137 Catherine St,MSII R7712B, Ann Arbor, MI 48109 USA.	shahy@umich.edu	Das, Nupur/AAK-7877-2020	Das, Nupur/0000-0002-5652-1134; Castillo Apaza, Cristina/0000-0001-6125-1813	National Institutes of Health [CA148828, DK095201, CA190558]; NATIONAL CANCER INSTITUTE [R01CA148828, R01CA190558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants CA148828 and DK095201 (to Y. M. S.) and CA190558 (to M. P. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson ER, 2012, MOL CELL BIOL, V32, P4068, DOI 10.1128/MCB.00723-12; Barsoum IB, 2014, CANCER RES, V74, P665, DOI 10.1158/0008-5472.CAN-13-0992; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Brahimi-Horn MC, 2007, BIOCHEM PHARMACOL, V73, P450, DOI 10.1016/j.bcp.2006.10.013; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Chacko BM, 2001, NAT STRUCT BIOL, V8, P248, DOI 10.1038/84995; Chen YG, 2012, CELL STEM CELL, V10, P231, DOI 10.1016/j.stem.2012.02.008; Endo H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098858; Friedl W, 1999, GENE CHROMOSOME CANC, V25, P403, DOI 10.1002/(SICI)1098-2264(199908)25:4<403::AID-GCC15>3.3.CO;2-G; Hata A, 1997, NATURE, V388, P82, DOI 10.1038/40424; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Hubert N, 2002, P NATL ACAD SCI USA, V99, P12345, DOI 10.1073/pnas.192423399; Jones JB, 2000, NUCLEIC ACIDS RES, V28, P2363, DOI 10.1093/nar/28.12.2363; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kuang CZ, 2004, ONCOGENE, V23, P1021, DOI 10.1038/sj.onc.1207219; Ma XY, 2017, J BIOL CHEM, V292, P17046, DOI 10.1074/jbc.M117.805655; Ma XY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179889; Ma XY, 2013, INT J SPORT NUTR EXE, V23, P513, DOI 10.1123/ijsnem.23.5.513; Maesawa C, 1997, JPN J CANCER RES, V88, P340, DOI 10.1111/j.1349-7006.1997.tb00386.x; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mimeault M, 2013, J CELL MOL MED, V17, P30, DOI 10.1111/jcmm.12004; Muz B, 2015, HYPOXIA, V3, P83, DOI 10.2147/HP.S93413; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Qiu GZ, 2017, TRENDS PHARMACOL SCI, V38, P669, DOI 10.1016/j.tips.2017.05.002; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Shah YM, 2014, GASTROENTEROLOGY, V146, P630, DOI 10.1053/j.gastro.2013.12.031; Shah YM, 2009, CELL METAB, V9, P152, DOI 10.1016/j.cmet.2008.12.012; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi YG, 1997, NATURE, V388, P87, DOI 10.1038/40431; Shuttleworth VG, 2018, J CELL SCI, V131, DOI 10.1242/jcs.207761; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Taube JH, 2010, J BIOL CHEM, V285, P16135, DOI 10.1074/jbc.M109.088096; Taylor M, 2011, GASTROENTEROLOGY, V140, P2044, DOI 10.1053/j.gastro.2011.03.007; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Triner D, 2016, J CLIN INVEST, V126, P3689, DOI 10.1172/JCI84430; Uchida K, 1996, CANCER RES, V56, P5583; Wan M, 2004, J BIOL CHEM, V279, P14484, DOI 10.1074/jbc.C400005200; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; WANG GL, 1993, J BIOL CHEM, V268, P21513; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Xie LW, 2014, MOL CELL BIOL, V34, P3013, DOI 10.1128/MCB.00324-14; Xue X, 2016, CELL METAB, V24, P447, DOI 10.1016/j.cmet.2016.07.015; Xue X, 2013, GASTROENTEROLOGY, V145, P831, DOI 10.1053/j.gastro.2013.07.010; Xue X, 2013, CARCINOGENESIS, V34, P163, DOI 10.1093/carcin/bgs313; Xue X, 2012, CANCER RES, V72, P2285, DOI 10.1158/0008-5472.CAN-11-3836; Yang Y, 2015, CURR MED CHEM, V22, P4189, DOI 10.2174/0929867322666150825163318	49	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					3974	3986		10.1074/jbc.RA118.005549	http://dx.doi.org/10.1074/jbc.RA118.005549			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30659096	hybrid, Green Published			2022-12-26	WOS:000461854400014
J	Backhaus, SJ; Metschies, G; Billing, M; Kowallick, JT; Gertz, RJ; Lapinskas, T; Pieske, B; Lotz, J; Bigalke, B; Kutty, S; Hasenfuss, G; Beerbaum, P; Kelle, S; Schuster, A				Backhaus, Soeren J.; Metschies, Georg; Billing, Marcus; Kowallick, Johannes T.; Gertz, Roman J.; Lapinskas, Tomas; Pieske, Burkert; Lotz, Joachim; Bigalke, Boris; Kutty, Shelby; Hasenfuss, Gerd; Beerbaum, Philipp; Kelle, Sebastian; Schuster, Andreas			Cardiovascular magnetic resonance imaging feature tracking: Impact of training on observer performance and reproducibility	PLOS ONE			English	Article							SPECKLE-TRACKING; MYOCARDIAL-INFARCTION; LONGITUDINAL STRAIN; HEART-FAILURE; DEFORMATION; STRATIFICATION; VARIABILITY; SURVIVAL	Background Cardiovascular magnetic resonance feature tracking (CMR-FT) is increasingly used for myocardial deformation assessment including ventricular strain, showing prognostic value beyond established risk markers if used in experienced centres. Little is known about the impact of appropriate training on CMR-FT performance. Consequently, this study aimed to evaluate the impact of training on observer variance using different commercially available CMR-FT software. Methods Intra- and inter-observer reproducibility was assessed prior to and after dedicated one-hour observer training. Employed FT software included 3 different commercially available platforms (TomTec, Medis, Circle). Left (LV) and right (RV) ventricular global longitudinal as well as LV circumferential and radial strains (GLS, GCS and GRS) were studied in 12 heart failure patients and 12 healthy volunteers. Results Training improved intra- and inter-observer reproducibility. GCS and LV GLS showed the highest reproducibility before (ICC>0.86 and >0.81) and after training (ICC>0.91 and >0.92). RV GLS and GRS were more susceptible to tracking inaccuracies and reproducibility was lower. Inter-observer reproducibility was lower than intra-observer reproducibility prior to training with more pronounced improvements after training. Before training, LV strain reproducibility was lower in healthy volunteers as compared to patients with no differences after training. Whilst LV strain reproducibility was sufficient within individual software solutions inter-software comparisons revealed considerable software related variance. Conclusion Observer experience is an important source of variance in CMR-FT derived strain assessment. Dedicated observer training significantly improves reproducibility with most profound benefits in states of high myocardial contractility and potential to facilitate widespread clinical implementation due to optimized robustness and diagnostic performance.	[Backhaus, Soeren J.; Metschies, Georg; Billing, Marcus; Gertz, Roman J.; Hasenfuss, Gerd; Schuster, Andreas] Georg August Univ, Univ Med Ctr Gottingen, Dept Cardiol & Pneumol, Gottingen, Germany; [Backhaus, Soeren J.; Metschies, Georg; Billing, Marcus; Kowallick, Johannes T.; Gertz, Roman J.; Lotz, Joachim; Hasenfuss, Gerd; Schuster, Andreas] German Ctr Cardiovasc Res DZHK, Partner Site Gottingen, Gottingen, Germany; [Kowallick, Johannes T.; Lotz, Joachim] Georg August Univ, Univ Med Ctr Gottingen, Inst Diagnost & Intervent Radiol, Gottingen, Germany; [Lapinskas, Tomas; Pieske, Burkert; Kelle, Sebastian] Univ Berlin, German Heart Ctr Berlin DHZB, Dept Internal Med Cardiol, Charite Campus Virchow Clin, Berlin, Germany; [Lapinskas, Tomas] DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany; [Bigalke, Boris] Univ Med Ctr Berlin, Dept Cardiol & Pneumol, Charite Campus Benjamin Franklin, Berlin, Germany; [Kutty, Shelby] Univ Nebraska, Coll Med, Childrens Hosp & Med Ctr, Omaha, NE 68198 USA; [Beerbaum, Philipp] Hannover Med Sch, Dept Pediat Cardiol & Intens Care, Hannover, Germany; [Schuster, Andreas] Univ Sydney, Dept Cardiol, Royal North Shore Hosp, Kolling Inst,Nothern Clin Sch, Sydney, NSW, Australia	University of Gottingen; German Centre for Cardiovascular Research; University of Gottingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Heart Center Berlin; German Centre for Cardiovascular Research; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Nebraska System; Hannover Medical School; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research	Schuster, A (corresponding author), Georg August Univ, Univ Med Ctr Gottingen, Dept Cardiol & Pneumol, Gottingen, Germany.; Schuster, A (corresponding author), German Ctr Cardiovasc Res DZHK, Partner Site Gottingen, Gottingen, Germany.; Schuster, A (corresponding author), Univ Sydney, Dept Cardiol, Royal North Shore Hosp, Kolling Inst,Nothern Clin Sch, Sydney, NSW, Australia.	andreas_schuster@gmx.net	Kelle, Sebastian/ABH-7348-2020; Lotz, Joachim/G-3376-2015; Lapinskas, Tomas/V-5482-2019; Pieske, Burkert/M-8089-2016	Lotz, Joachim/0000-0002-1412-2741; Lapinskas, Tomas/0000-0001-7726-6948; Pieske, Burkert/0000-0002-6466-5306; Kelle, Sebastian/0000-0001-8105-6599; Backhaus, Soren/0000-0002-2683-6418	German Center for Cardiovascular Research (DZHK)	German Center for Cardiovascular Research (DZHK)	This study was supported by a German Center for Cardiovascular Research (DZHK) research grant awarded to Sebastian Kelle and Andreas Schuster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRON JL, 1994, INT J COMPUT VISION, V12, P43, DOI 10.1007/BF01420984; Beerbaum P, 2009, J MAGN RESON IMAGING, V30, P956, DOI 10.1002/jmri.21948; Biering-Sorensen T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158280; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Buss SJ, 2015, EUR HEART J-CARD IMG, V16, P307, DOI 10.1093/ehjci/jeu181; Cao JJ, 2018, J CARDIOVASC MAGN R, V20, DOI 10.1186/s12968-018-0448-9; Cheng S, 2013, J AM SOC ECHOCARDIOG, V26, P1258, DOI 10.1016/j.echo.2013.07.002; Donekal S, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-37; Eitel I, 2018, JACC-CARDIOVASC IMAG, V11, P1433, DOI 10.1016/j.jcmg.2017.11.034; Eitel I, 2014, J AM COLL CARDIOL, V64, P1217, DOI 10.1016/j.jacc.2014.06.1194; Ersboll M, 2013, J AM COLL CARDIOL, V61, P2365, DOI 10.1016/j.jacc.2013.02.061; Feisst A, 2018, IJC HEART VASC, V18, P46, DOI 10.1016/j.ijcha.2018.02.007; Gavara J, 2018, JACC-CARDIOVASC IMAG, V11, P1448, DOI 10.1016/j.jcmg.2017.09.017; Gertz RJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193746; Heermann P, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0075-z; Karamiltsos TD, 2007, J CARDIOVASC MAGN R, V9, P777, DOI 10.1080/10976640701545073; Kowallick JT, 2016, J MAGN RESON IMAGING, V43, P128, DOI 10.1002/jmri.24979; Kowallick JT, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0060-6; Maceira AM, 2018, J MAGN RESON IMAGING, V47, P1415, DOI 10.1002/jmri.25894; de Siqueira MEM, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0258-x; Morton G, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-43; Orwat S, 2014, KARDIOL POL, V72, P363, DOI 10.5603/KP.a2013.0319; Paetsch I, 2006, EUR HEART J, V27, P1459, DOI 10.1093/eurheartj/ehi883; Pedrizzetti G, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0269-7; Pennell DJ, 2010, CIRCULATION, V121, P692, DOI 10.1161/CIRCULATIONAHA.108.811547; Romano S, 2018, JACC-CARDIOVASC IMAG, V11, P1419, DOI 10.1016/j.jcmg.2017.10.024; Rouleau JL, 1996, J AM COLL CARDIOL, V27, P1119, DOI 10.1016/0735-1097(95)00599-4; Russo C, 2014, EUR J HEART FAIL, V16, P1301, DOI 10.1002/ejhf.154; Sakata K, 2016, J ECHOCARDIOGR, V14, P30, DOI 10.1007/s12574-015-0270-4; Schuster A, 2015, CLIN RADIOL, V70, P989, DOI 10.1016/j.crad.2015.05.006; Schuster A, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.004077; Schuster A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122858; Schuster A, 2013, EUR J RADIOL, V82, P296, DOI 10.1016/j.ejrad.2012.11.012; Schuster A, 2013, INT J CARDIOL, V166, P413, DOI 10.1016/j.ijcard.2011.10.137; Schuster A, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-58; Steinmetz M, 2018, INT J CARDIOL, V257, P54, DOI 10.1016/j.ijcard.2017.11.097; Voigt JU, 2015, EUR HEART J-CARD IMG, V16, P1, DOI 10.1093/ehjci/jeu184; WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44	38	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210127	10.1371/journal.pone.0210127	http://dx.doi.org/10.1371/journal.pone.0210127			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682045	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500024
J	Bernhard, A; Rasinger, JD; Betancor, MB; Caballero, MJ; Berntssen, MHG; Lundebye, AK; Ornsrud, R				Bernhard, Annette; Rasinger, Josef D.; Betancor, Monica B.; Jose Caballero, Maria; Berntssen, Marc H. G.; Lundebye, Anne-Katrine; Ornsrud, Robin			Tolerance and dose-response assessment of subchronic dietary ethoxyquin exposure in Atlantic salmon (Salmo salar L.)	PLOS ONE			English	Article							SYNTHETIC ANTIOXIDANT ETHOXYQUIN; FED GRADED-LEVELS; DNA-DAMAGE; BUTYLATED HYDROXYANISOLE; OXIDATIVE STRESS; GLUTATHIONE; METABOLISM; EXPRESSION; GROWTH; BIOTRANSFORMATION	Ethoxyquin (EQ; 6-Ethoxy-2,2,4-trimethyl-1,2-dihydroquinoline) has been used as an antioxidant in feed components for pets, livestock and aquaculture. However, possible risks of EQ used in aquafeed for fish health have not yet been characterized. The present study investigated the toxicity and dose-response of subchronic dietary EQ exposure at doses ranging from 41 to 9666 mg EQ/kg feed in Atlantic salmon (Salmo salar L.). Feed at concentrations higher than 1173 mg EQ/kg were rejected by the fish, resulting in reduced feed intake and growth performance. No mortality was observed in fish exposed to any of the doses. A multi-omic screening of metabolome and proteome in salmon liver indicated an effect of dietary EQ on bioenergetics pathways and hepatic redox homeostasis in fish fed concentrations above 119 mg EQ/kg feed. Increased energy expenditure associated with an upregulation of hepatic fatty acid beta-oxidation and induction and carbohydrate catabolic pathways resulted in a dose- dependent depletion of intracytoplasmic lipid vacuoles in liver histological sections, decreasing whole body lipid levels and altered purine/pyrimidine metabolism. Increased GSH and TBARS in the liver indicated a state of oxidative stress, which was associated with activation of the NRF2-mediated oxidative stress response and glutathione-mediated detoxification processes. However, no oxidative DNA damage was observed. As manifestation of altered energy metabolism, the depletion of liver intracytoplasmic lipid vacuoles was considered the critical endpoint for benchmark dose assessment, and a BMDL10 of 243 mg EQ/kg feed was derived as a safe upper limit of EQ exposure in Atlantic salmon.	[Bernhard, Annette; Rasinger, Josef D.; Berntssen, Marc H. G.; Lundebye, Anne-Katrine; Ornsrud, Robin] Inst Marine Res, Bergen, Norway; [Betancor, Monica B.] Univ Stirling, Fac Nat Sci, Inst Aquaculture, Stirling, Scotland; [Jose Caballero, Maria] Univ Las Palmas Gran Canaria, Sch Vet, Dept Morphol, Las Palmas Gran Canaria, Spain	Institute of Marine Research - Norway; University of Stirling; Universidad de Las Palmas de Gran Canaria	Ornsrud, R (corresponding author), Inst Marine Res, Bergen, Norway.	robin.ornsrud@hi.no	Caballero, Maria Jose/J-6599-2017; Berntssen, Marc/O-9406-2018; Caballero, Maria Jose/U-7580-2019; Rasinger, Josef Daniel/AAO-3687-2020	Caballero, Maria Jose/0000-0002-2575-0997; Caballero, Maria Jose/0000-0002-2575-0997; Rasinger, Josef Daniel/0000-0002-9424-4414; Bernhard, Annette/0000-0003-2542-8583; Betancor, Monica/0000-0003-1626-7458	Norwegian Seafood Research Fund (FHF); Marine Ingredients Organisation (IFFO) Marine Harvest ASA; EWOS AS/Cargill Aqua Nutrition; Biomar AS; Skretting AS; Europharma (FHF project) [901327]	Norwegian Seafood Research Fund (FHF); Marine Ingredients Organisation (IFFO) Marine Harvest ASA; EWOS AS/Cargill Aqua Nutrition; Biomar AS; Skretting AS; Europharma (FHF project)	This study was financed by the Norwegian Seafood Research Fund (FHF; https://www.fhf.no/), the Marine Ingredients Organisation (IFFO) Marine Harvest ASA, EWOS AS/Cargill Aqua Nutrition, Biomar AS, Skretting AS and Europharma (FHF project no. 901327). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; AOAC, 1995, 99215 AOAC; Blaszczyk A, 2006, TOXICOL LETT, V163, P77, DOI 10.1016/j.toxlet.2005.09.040; Blaszczyk A, 2005, CELL MOL BIOL LETT, V10, P15; Blaszczyk Alina, 2005, Acta Pol Pharm, V62, P111; Blaszczyk Alina, 2013, Int J Food Sci, V2013, P585931, DOI 10.1155/2013/585931; Bohne VJB, 2008, FOOD CHEM TOXICOL, V46, P1834, DOI 10.1016/j.fct.2008.01.028; Bohne VJB, 2007, FOOD CHEM TOXICOL, V45, P733, DOI 10.1016/j.fct.2006.10.020; Bohne VJB, 2006, TOXICOL SCI, V93, P11, DOI 10.1093/toxsci/kfl044; de Koning AJ, 2002, INT J FOOD PROP, V5, P451, DOI 10.1081/JFP-120005797; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; Dibner JJ, 1996, ANIM FEED SCI TECH, V62, P1, DOI 10.1016/S0377-8401(96)01000-0; EFSA, 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.229r; European Food Safety Authority (EFSA), 2015, EFSA J, V13, P58; Hamre K, 2001, AQUACULT NUTR, V7, P123, DOI 10.1046/j.1365-2095.2001.00162.x; Han H, 2002, J ANIM SCI, V80, P1117; Hardy A, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.4970; Hayes JD, 2000, BIOCHEM SOC T, V28, P33, DOI 10.1042/bst0280033; He P, 2000, J FOOD SCI, V65, P1312, DOI 10.1111/j.1365-2621.2000.tb10603.x; Kestemont P, 2001, AQUACULTURE, V203, P85, DOI 10.1016/S0044-8486(01)00615-9; Krumsiek C. L., 1998, Animal Science Research Report - Agricultural Experiment Station, Oklahoma State University, P64; Laohabanjong R, 2009, AQUACULTURE, V286, P283, DOI 10.1016/j.aquaculture.2008.09.038; LIE O, 1994, FISH PHYSIOL BIOCHEM, V13, P241, DOI 10.1007/BF00004362; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Lundebye AK, 2010, FOOD ADDIT CONTAM A, V27, P1652, DOI 10.1080/19440049.2010.508195; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Marnett LJ, 1999, MUTAT RES-FUND MOL M, V424, P83, DOI 10.1016/S0027-5107(99)00010-X; Ornsrud R, 2011, J FOOD PROTECT, V74, P1574, DOI 10.4315/0362-028X.JFP-10-547; Penninks A, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.4920; Rasinger JD, 2014, TOXICOLOGY, V321, P1, DOI 10.1016/j.tox.2014.03.006; Rychen G, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.5023; SANDNES K, 1988, J FISH BIOL, V32, P129, DOI 10.1111/j.1095-8649.1988.tb05341.x; Saxena TB, 2000, COMP BIOCHEM PHYS C, V127, P1, DOI 10.1016/S0742-8413(00)00131-6; Schlenk Daniel, 2008, P683, DOI 10.1201/9780203647295.ch16; SHI MM, 1994, J BIOL CHEM, V269, P26512; Skolimowski JJ, 2010, TOXICOL LETT, V193, P194, DOI 10.1016/j.toxlet.2010.01.006; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Tyanova S, 2015, PROTEOMICS, V15, P1453, DOI 10.1002/pmic.201400449; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; Wang J, 2010, AQUACULTURE, V306, P80, DOI 10.1016/j.aquaculture.2010.06.024; WHO, 2009, PRINC METH RISK ASS, P240; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wolf JC, 2005, TOXICOL PATHOL, V33, P75, DOI 10.1080/01926230590890187; Yamane Y, 1998, J BIOL CHEM, V273, P31075, DOI 10.1074/jbc.273.47.31075; Yamashita Y, 2009, AQUACULT NUTR, V15, P144, DOI 10.1111/j.1365-2095.2008.00577.x	45	6	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211128	10.1371/journal.pone.0211128	http://dx.doi.org/10.1371/journal.pone.0211128			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682099	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500104
J	Casal, J; Saegerman, C; Bertagnoli, S; Meyer, G; Ganiere, JP; Caufour, P; De Clercq, K; Jacquiet, P; Hautefeuille, C; Etore, F; Napp, S				Casal, Jordi; Saegerman, Claude; Bertagnoli, Stephane; Meyer, Gilles; Ganiere, Jean Pierre; Caufour, Philippe; De Clercq, Kris; Jacquiet, Philippe; Hautefeuille, Claire; Etore, Florence; Napp, Sebastian			A simple method to estimate the number of doses to include in a bank of vaccines. The case of Lumpy Skin Disease in France	PLOS ONE			English	Article								A simple method to estimate the size of the vaccine bank needed to control an epidemic of an exotic infectious disease in case of introduction into a country is presented. The method was applied to the case of a Lumpy Skin disease (LSD) epidemic in France. The size of the stock of vaccines needed was calculated based on a series of simple equations that use some trigonometric functions and take into account the spread of the disease, the time required to obtain good vaccination coverage and the cattle density in the affected region. Assuming a 7-weeks period to vaccinate all the animals and a spread of the disease of 7.3 km/week, the vaccination of 740 716 cattle would be enough to control an epidemic of LSD in France in 90% of the simulations (608 196 cattle would cover 75% of the simulations). The results of this simple method were then validated using a dynamic simulation model, which served as reference for the calculation of the vaccine stock required. The differences between both models in different scenarios, related with the time needed to vaccinate the animals, ranged from 7% to 10.5% more vaccines using the simple method to cover 90% of the simulations, and from 9.0% to 13.8% for 75% of the simulations. The model is easy to use and may be adapted for the control of different diseases in different countries, just by using some simple formulas and few input data.	[Casal, Jordi] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Bellaterra, Spain; [Casal, Jordi; Napp, Sebastian] UAB, Ctr Recerca Sanitat Anim CReSA, IRTA, Barcelona, Spain; [Casal, Jordi; Saegerman, Claude; Meyer, Gilles; Ganiere, Jean Pierre] Expert Comm Anim Hlth & Welf ANSES, Maisons Alfort, France; [Saegerman, Claude] Univ Liege, Fundamental & Appl Res Anim & Hlth FARAH Ctr, Liege, Belgium; [Bertagnoli, Stephane; Meyer, Gilles; Jacquiet, Philippe] Univ Toulouse, IHAP, INRA, ENVT, Toulouse, France; [Ganiere, Jean Pierre] ONIRIS, Nantes, France; [Caufour, Philippe] CIRAD, Dept BIOS, UMR, INRA,ASTRE, Montpellier, France; [De Clercq, Kris] CERVA, CODA, Unit Vesicular & Exot Dis, Uccle, Belgium; [Hautefeuille, Claire; Etore, Florence] Agence Natl Securite Sanit Alimentat Environm & T, Maisons Alfort, France	Autonomous University of Barcelona; Autonomous University of Barcelona; IRTA; Ecole Nationale Veterinaire d'Alfort (ENVA); University of Liege; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; CIRAD; INRAE; Ecole Nationale Veterinaire d'Alfort (ENVA)	Casal, J (corresponding author), Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Bellaterra, Spain.; Casal, J (corresponding author), UAB, Ctr Recerca Sanitat Anim CReSA, IRTA, Barcelona, Spain.; Casal, J; Saegerman, C (corresponding author), Expert Comm Anim Hlth & Welf ANSES, Maisons Alfort, France.; Saegerman, C (corresponding author), Univ Liege, Fundamental & Appl Res Anim & Hlth FARAH Ctr, Liege, Belgium.	Jordi.casal@uab.cat; claude.saegerman@ulg.ac.be	Casal, Jordi/F-3020-2016; Napp, Sebastian/F-3331-2016	Casal, Jordi/0000-0002-6909-9366; Napp, Sebastian/0000-0001-5813-7286; , Etore/0000-0001-7225-4323; Saegerman, Claude/0000-0001-9087-7436				Al-Salihi KA, 2015, TRANSBOUND EMERG DIS, V62, P457, DOI 10.1111/tbed.12386; [Anonymous], 2014, R LANG ENV STAT COMP; Beltran-Beck B, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.5051; De Clercq K, 2008, TRANSBOUND EMERG DIS, V55, P46, DOI 10.1111/j.1865-1682.2007.01012.x; Forman AJ, 2002, REV SCI TECH OIE, V21, P601, DOI 10.20506/rst.21.3.1359; Mercier A, 2018, TRANSBOUND EMERG DIS, V65, P240, DOI 10.1111/tbed.12624; Muleme M, 2012, TROP ANIM HEALTH PRO, V45, P35, DOI 10.1007/s11250-012-0254-6; OIE, VACC BANKS; Pebesma E.J., 2005, R NEWS, V5, P9; Perkins NR, 2011, AUST VET J, V89, P126, DOI 10.1111/j.1751-0813.2011.00766.x; PROZESKY L, 1982, ONDERSTEPOORT J VET, V49, P167; Rivas AL, 2012, TRANSBOUND EMERG DIS, V59, P464, DOI 10.1111/j.1865-1682.2011.01301.x; Tasioudi KE, 2016, TRANSBOUND EMERG DIS, V63, P260, DOI 10.1111/tbed.12497; Tuppurainen ESM, 2012, TRANSBOUND EMERG DIS, V59, P40, DOI 10.1111/j.1865-1682.2011.01242.x	14	1	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210317	10.1371/journal.pone.0210317	http://dx.doi.org/10.1371/journal.pone.0210317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682041	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500033
J	Castiglione, S; Serio, C; Mondanaro, A; Di Febbraro, M; Profico, A; Girardi, G; Raia, P				Castiglione, S.; Serio, C.; Mondanaro, A.; Di Febbraro, M.; Profico, A.; Girardi, G.; Raia, P.			Simultaneous detection of macroevolutionary patterns in phenotypic means and rate of change with and within phylogenetic trees including extinct species	PLOS ONE			English	Article							BODY-SIZE EVOLUTION; MORPHOLOGICAL DIVERSIFICATION; ECOLOGICAL OPPORTUNITY; ADAPTIVE RADIATIONS; TRAIT EVOLUTION; INNOVATION; MAMMALS; TEMPO; RULE	Recognizing evolutionary trends in phenotypic means and rates requires the application of phylogenetic comparative methods (PCMs). Most PCMs are unsuited to make full use of fossil information, which is a drawback, given the inclusion of such data improves, and in some cases even corrects, the proper understanding of trait evolution. Here we present a new computer application, written in R, that allows the simultaneous computation of temporal trends in phenotypic mean and evolutionary rate along a phylogeny, and to contrast such patterns among different clades within the tree. By using simulation experiments, we show the new implementation, names search. trend is as powerful as existing PCM tools in discerning macroevolutionary patterns in phenotypic means and rates, but differently from any other PCM allows comparing individual clades to each other, and provides rich information about trait evolution for all lineages in the tree.	[Castiglione, S.; Serio, C.; Mondanaro, A.; Girardi, G.; Raia, P.] Univ Naples Federico II, Dept Earth Sci Environm & Resources, Naples, Italy; [Mondanaro, A.] Univ Florence, Dept Earth Sci, Florence, Italy; [Di Febbraro, M.] Univ Molise, Environmetr Lab, Dept Biosci & Terr DiBT, Pesche, Italy; [Profico, A.] Univ Roma Sapienza, Dipartimento Biol Ambientale, Rome, Italy	University of Naples Federico II; University of Florence; University of Molise; Sapienza University Rome	Raia, P (corresponding author), Univ Naples Federico II, Dept Earth Sci Environm & Resources, Naples, Italy.	pasquale.raia@unina.it	Mondanaro, Alessandro/F-6893-2017; Di Febbraro, Mirko/GQA-4462-2022; Castiglione, Silvia/F-6840-2017; Profico, Antonio/Q-3208-2018; Raia, Pasquale/I-8600-2012; Serio, Carmela/F-6854-2017; Di Febbraro, Mirko/I-3167-2019	Mondanaro, Alessandro/0000-0003-0325-7066; Castiglione, Silvia/0000-0002-6140-1495; Profico, Antonio/0000-0003-2884-7118; Raia, Pasquale/0000-0002-4593-8006; Serio, Carmela/0000-0001-5256-5511; Di Febbraro, Mirko/0000-0001-8898-7046				Arbour JH, 2017, EVOLUTION, V71, P1600, DOI 10.1111/evo.13237; Burbrink FT, 2010, EVOLUTION, V64, P934, DOI 10.1111/j.1558-5646.2009.00888.x; Butler RJ, 2008, J EVOLUTION BIOL, V21, P1673, DOI 10.1111/j.1420-9101.2008.01594.x; Cantalapiedra JL, 2017, SCIENCE, V355, P627, DOI 10.1126/science.aag1772; Castiglione S, 2018, METHODS ECOL EVOL, V9, P974, DOI 10.1111/2041-210X.12954; Clavel J, 2017, P NATL ACAD SCI USA, V114, P4183, DOI 10.1073/pnas.1606868114; Finarelli JA, 2006, SYST BIOL, V55, P301, DOI 10.1080/10635150500541698; Foote M., 1997, ANNU REV ECOL SYST, DOI [10.1146/annurev.ecolsys.28.1.85, DOI 10.1146/ANNUREV.ECOLSYS.28.1.85]; Grant PR, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0146; HALDANE JBS, 1949, EVOLUTION, V3, P51, DOI 10.2307/2405451; Harmon LJ, 2003, SCIENCE, V301, P961, DOI 10.1126/science.1084786; Hunt G, 2015, P NATL ACAD SCI USA, V112, P4885, DOI 10.1073/pnas.1403662111; Hunt G, 2012, PALEOBIOLOGY, V38, P351, DOI 10.1666/11047.1; HUNTER JP, 1995, P NATL ACAD SCI USA, V92, P10718, DOI 10.1073/pnas.92.23.10718; Jablonski D., 1986, Life Sciences Research Report, P313; Kratsch C, 2014, BIOINFORMATICS, V30, pI527, DOI 10.1093/bioinformatics/btu477; Lee MSY, 2014, SCIENCE, V345, P562, DOI 10.1126/science.1252243; Li Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep18627; Liow LH, 2007, EVOLUTION, V61, P885, DOI 10.1111/j.1558-5646.2007.00077.x; Lomolino MV, 2005, J BIOGEOGR, V32, P1683, DOI 10.1111/j.1365-2699.2005.01314.x; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; Mahler DL, 2010, EVOLUTION, V64, P2731, DOI 10.1111/j.1558-5646.2010.01026.x; Martin CH, 2011, EVOLUTION, V65, P2197, DOI 10.1111/j.1558-5646.2011.01294.x; Meloro C, 2010, EVOL BIOL, V37, P177, DOI 10.1007/s11692-010-9094-3; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Montgomery SH, 2013, EVOLUTION, V67, P3339, DOI 10.1111/evo.12197; Pagel M., 2009, MORPHOLOGY SHAPE PHY, P269, DOI [10.1201/9780203165171.ch13, DOI 10.1201/9780203165171.CH13]; Paradis Emmanuel, 2019, Bioinformatics, V35, P526, DOI 10.1093/bioinformatics/bty633; Pinto G, 2008, P ROY SOC B-BIOL SCI, V275, P2749, DOI 10.1098/rspb.2008.0686; Rabosky DL, 2014, SYST BIOL, V63, P610, DOI 10.1093/sysbio/syu025; Raia P, 2012, AM NAT, V179, P328, DOI 10.1086/664081; Raia P, 2006, EVOLUTION, V60, P1731; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Roopnarine PD, 2003, ANNU REV ECOL EVOL S, V34, P605, DOI 10.1146/annurev.ecolsys.34.011802.132407; Schnitzler J, 2017, EVOL ECOL RES, V18, P187; Simpson G.G., 1944, TEMPO MODE EVOLUTION, DOI DOI 10.1073/pnas.1821292116; Slater GJ, 2015, P NATL ACAD SCI USA, V112, P4897, DOI 10.1073/pnas.1403666111; Slater GJ, 2012, EVOLUTION, V66, P3931, DOI 10.1111/j.1558-5646.2012.01723.x; Van Valkenburgh B, 2004, SCIENCE, V306, P101, DOI 10.1126/science.1102417	39	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210101	10.1371/journal.pone.0210101	http://dx.doi.org/10.1371/journal.pone.0210101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682060	Green Published, gold, Green Submitted			2022-12-26	WOS:000457037500023
J	Wei, LP; Chang, JR; Han, Z; Wang, RH; Song, LH				Wei, Lianping; Chang, Jianrong; Han, Zhen; Wang, Ronghai; Song, Lihua			Recombinant human growth hormone (rhGH) treatment of MKN-45 xenograft mice improves nutrition status and strengthens immune function without promoting tumor growth	PLOS ONE			English	Article							CACHEXIA; CANCER; THERAPY; GH	The aim of this study was to clarify the combined effects and dose-effect relationships of rhGH on tumor growth, nutrition status, and immune function in MKN-45 xenograft mice. In this study, animal models were induced in nude mice using the subcutaneous transplantation of MKN-45 cells, and rhGH was injected daily for 14 days. Three rhGH treatment dosages were set with reference to the equivalent dosage converted from human clinical dosage, including 2 IU (0.67 mg), 10 IU (3.35 mg) and 50 IU (16.75 mg) per kg body weight. The tumor volume, body weight and food intake were measured every two or three days. After 14 days of rhGH treatment, the tumors were isolated and weighed. The expression levels of Ki-67, vascular endothelial growth factor (VEGF) and CD31in tumor tissues were detected by immunohistochemistry (IHC). The protein expression levels of pJAK2, JAK2, pSTAT3, STAT3, pAKT, AKT, pERK and ERK were measured by western blotting. The percentage of active NK cells in peripheral blood mononuclear cells (PBMCs) was detected by fluorescence-activated cell sorting (FACS). The results showed that rhGH had improved the food intake, increased the body weight and strengthened the immune function of MKN-45 xenograft mice but had not promote tumor growth. MKN-45 xenograft mice treated with rhGH at a higher dosage gained more weight, while those treated with rhGH at a lower dosage showed stronger immune function and smaller tumor volume.	[Wei, Lianping; Han, Zhen; Song, Lihua] Anhui Agr Univ, Coll Life Sci, Hefei, Anhui, Peoples R China; [Chang, Jianrong] Benbu Med Coll, Sci Res Ctr, Benbu, Anhui, Peoples R China; [Wang, Ronghai; Song, Lihua] AnHui Anke Biotechnol Grp Co Ltd, Hefei, Anhui, Peoples R China	Anhui Agricultural University	Song, LH (corresponding author), Anhui Agr Univ, Coll Life Sci, Hefei, Anhui, Peoples R China.; Song, LH (corresponding author), AnHui Anke Biotechnol Grp Co Ltd, Hefei, Anhui, Peoples R China.	Songlh@ankebio.com			Natural Science Research Project of Universities in Anhui [KJ2017A148]; Project of the State Key Laboratory of Crop Biology in Anhui Agricultural University [2014KQJ007]	Natural Science Research Project of Universities in Anhui; Project of the State Key Laboratory of Crop Biology in Anhui Agricultural University	This work was supported by the Natural Science Research Project of Universities in Anhui (http://202.38.95.119/srmis), Award Number KJ2017A148 to L.W.; and the Project of the State Key Laboratory of Crop Biology in Anhui Agricultural University (https://kjc.ahau.edu.cn), Award Number 2014KQJ007 to L.W. Authors Ronghai Wang and Lihua Song are employed by An Hui Anke Biotechnology (Group) Co., Ltd. An Hui Anke Biotechnology (Group) Co., Ltd provided support in the form of salaries for authors R.W. and L.S., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bauhofer A, 2001, LANGENBECK ARCH SURG, V386, P132, DOI 10.1007/s004230100206; Beentjes JAM, 2000, CLIN ENDOCRINOL, V52, P457, DOI 10.1046/j.1365-2265.2000.00993.x; Colao A, 2004, ENDOCR REV, V25, P102, DOI 10.1210/er.2002-0022; Dehkhoda F, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00035; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fiebig HH, 2000, ANTI-CANCER DRUG, V11, P659, DOI 10.1097/00001813-200009000-00011; Grofte T, 1997, HEPATOLOGY, V25, P964, DOI 10.1002/hep.510250429; Guevara-Aguirre J, 2018, GROWTH HORM IGF RES, V38, P34, DOI 10.1016/j.ghir.2017.12.006; Gullett N. P., 2010, CURR OPIN CLIN NUTR, V91, P1143, DOI DOI 10.3945/AJCN.2010; Jiang XY, 2017, INT IMMUNOPHARMACOL, V48, P135, DOI 10.1016/j.intimp.2017.05.004; Laviano A, 2005, NAT CLIN PRACT ONCOL, V2, P158, DOI 10.1038/ncponc0112; Lenk K, 2010, J CACHEXIA SARCOPENI, V1, P9, DOI 10.1007/s13539-010-0007-1; Li SY, 2010, TUMORI J, V96, P282, DOI 10.1177/030089161009600216; Lin Y, 2011, J ENDOCRINOL, V211, P249, DOI 10.1530/JOE-11-0100; Muscaritoli M, 2006, EUR J CANCER, V42, P31, DOI 10.1016/j.ejca.2005.07.026; Pazaitou-Panayiotou K, 2007, EUR J ENDOCRINOL, V156, P187, DOI 10.1530/EJE-06-0611; Perry JK, 2006, GROWTH HORM IGF RES, V16, P277, DOI 10.1016/j.ghir.2006.09.006; Rudd MF, 2006, GENOME RES, V16, P693, DOI 10.1101/gr.5120106; Schmidt K, 2011, J CACHEXIA SARCOPENI, V2, P105, DOI 10.1007/s13539-011-0029-3; Shen Q, 2007, ENDOCRINOLOGY, V148, P4536, DOI 10.1210/en.2007-0513; Sun L, 2015, NUTR CANCER, V67, P1056, DOI 10.1080/01635581.2015.1073753; Terawaki K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173113; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; von Haehling S, 2010, J CACHEXIA SARCOPENI, V1, P1, DOI 10.1007/s13539-010-0002-6; von Haehling S, 2009, PHARMACOL THERAPEUT, V121, P227, DOI 10.1016/j.pharmthera.2008.09.009; Wiren S, 2014, CANCER CAUSE CONTROL, V25, P151, DOI 10.1007/s10552-013-0317-7	26	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210613	10.1371/journal.pone.0210613	http://dx.doi.org/10.1371/journal.pone.0210613			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673747	Green Published, Green Submitted, gold			2022-12-26	WOS:000456442800049
J	Huang, GC; Kaufman, AJ; Ryan, RJH; Romin, Y; Huryn, L; Bains, S; Manova-Todorova, K; Morris, PL; Hunnicutt, GR; Adelman, CA; Petrini, JHJ; Ramanathan, Y; Singh, B				Huang, Guochang; Kaufman, Andrew J.; Ryan, Russell J. H.; Romin, Yevgeniy; Huryn, Laryssa; Bains, Sarina; Manova-Todorova, Katia; Morris, Patricia L.; Hunnicutt, Gary R.; Adelman, Carrie A.; Petrini, John H. J.; Ramanathan, Y.; Singh, Bhuvanesh			Mouse DCUN1D1 (SCCRO) is required for spermatogenetic individualization	PLOS ONE			English	Article							EARLY EMBRYONIC LETHALITY; INTERCELLULAR BRIDGES; CULLIN; PROTEIN; NEDD8; PROLIFERATION; ACTIVATION; COMPLEX; TEX14	Squamous cell carcinoma-related oncogene (SCCRO, also known as DCUN1D1) is a component of the E3 for neddylation. As such, DCUN1D1 regulates the neddylation of cullin family members. Targeted inactivation of DCUN1D1 in mice results in male-specific infertility. Infertility in DCUN1D1(-/-) mice is secondary to primary defects in spermatogenesis. Time-dam experiments mapped the onset of the defect in spermatogenesis to 5.5 to 6 weeks of age, which temporally corresponds to defects in spermiogenesis. Although the first round of spermatogenesis progressed normally, the number of spermatozoa released into the seminiferous lumen and epididymis of DCUN1D1(-/-) mice was significantly reduced. Spermatozoa in DCUN1D1(-/-) mice had multiple abnormalities, including globozoospermia, macrocephaly, and multiple flagella. Many of the malformed spermatozoa in DCUN1D1(-/-) mice were multinucleated, with supernumerary and malpositioned centrioles, suggesting a defect in the resolution of intercellular bridges. The onset of the defect in spermatogenesis in DCUN1D1(-/-) mice corresponds to an increase in DCUN1D1 expression observed during normal spermatogenesis. Moreover, consistent with its known function as a component of the E3 in neddylation, the pattern of DCUN1D1 expression temporally correlates with an increase in the neddylated cullin fraction and stage-specific increases in the total ubiquitinated protein pool in wild-type mice. Levels of neddylated Cul3 were decreased in DCUN1D1(-/-) mice, and ubiquitinated proteins did not accumulate during the stages in which DCUN1D1 expression peaks during spermatogenesis in wild-type mice. Combined, these findings suggest that DCUN1D1(-/-) mice fail to release mature spermatozoa into the seminiferous lumen, possibly due to unresolved intercellular bridges. Furthermore, the effects of DCUN1D1 on spermatogenesis likely involve its regulation of cullin-RING-ligase (CRL)-type ubiquitin E3 activity during spermiogenesis through its role in promoting Cul3 neddylation. The specific CRLs required for spermiogenesis and their protein targets require identification.	[Huang, Guochang; Kaufman, Andrew J.; Ryan, Russell J. H.; Huryn, Laryssa; Bains, Sarina; Ramanathan, Y.; Singh, Bhuvanesh] Mem Sloan Kettering Canc Ctr, Dept Surg, Lab Epithelial Canc Biol, 1275 York Ave, New York, NY 10021 USA; [Romin, Yevgeniy; Manova-Todorova, Katia] Mem Sloan Kettering Canc Ctr, Mol Cytol Core Facil, 1275 York Ave, New York, NY 10021 USA; [Morris, Patricia L.; Hunnicutt, Gary R.] Populat Council, 1230 York Ave, New York, NY 10021 USA; [Morris, Patricia L.; Hunnicutt, Gary R.] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA; [Adelman, Carrie A.; Petrini, John H. J.] Mem Sloan Kettering Canc Ctr, Dept Mol Biol, 1275 York Ave, New York, NY 10021 USA; [Kaufman, Andrew J.; Ramanathan, Y.] Mt Sinai Med Ctr, Dept Cardiothorac Surg, New York, NY 10029 USA; [Ryan, Russell J. H.] Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA; [Huryn, Laryssa] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA; [Bains, Sarina] St Barnabas Hosp, Livingston, NJ USA; [Hunnicutt, Gary R.] NIH, Cellular Mol & Integrat Reprod, Ctr Sci Review, Bldg 10, Bethesda, MD 20892 USA; [Adelman, Carrie A.] AstraZeneca, Cambridge, England	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Population Council; Rockefeller University; Memorial Sloan Kettering Cancer Center; Icahn School of Medicine at Mount Sinai; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA	Singh, B (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Lab Epithelial Canc Biol, 1275 York Ave, New York, NY 10021 USA.	singhb@mskcc.org			American College of Surgeons (George H.A. Clowes Memorial Research Career Development Award); Hackers for Hope; National Institutes of Health [R01HD038807, P30 CA008748]; Matheson Fellowship; NATIONAL CANCER INSTITUTE [K08CA208013, P30CA008748] Funding Source: NIH RePORTER	American College of Surgeons (George H.A. Clowes Memorial Research Career Development Award); Hackers for Hope; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Matheson Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by the American College of Surgeons (George H.A. Clowes Memorial Research Career Development Award to B.S.); Hackers for Hope (to B.S.); the Matheson Fellowship (to Y.R.); and the National Institutes of Health (R01HD038807 to G.H. and P30 CA008748). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman CA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000042; Arama E, 2007, PLOS BIOL, V5, P2745, DOI 10.1371/journal.pbio.0050251; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Brill JA, 2000, DEVELOPMENT, V127, P3855; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Dealy MJ, 1999, NAT GENET, V23, P245, DOI 10.1038/13886; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Fu WM, 2016, J BIOL CHEM, V291, P6200, DOI 10.1074/jbc.M115.692756; Greenbaum MP, 2007, DEV BIOL, V305, P389, DOI 10.1016/j.ydbio.2007.02.025; Greenbaum MP, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005850; Greenbaum MP, 2009, BIOL REPROD, V80, P449, DOI 10.1095/biolreprod.108.070649; Greenbaum MP, 2006, P NATL ACAD SCI USA, V103, P4982, DOI 10.1073/pnas.0505123103; Hotton SK, 2008, ANNU REV PLANT BIOL, V59, P467, DOI 10.1146/annurev.arplant.58.032806.104011; Huang GC, 2017, J BIOL CHEM, V292, P15254, DOI 10.1074/jbc.M117.778530; Huang GC, 2011, J BIOL CHEM, V286, P10297, DOI 10.1074/jbc.M110.203729; Jenab S, 1998, ENDOCRINOLOGY, V139, P1883, DOI 10.1210/en.139.4.1883; Kim AY, 2008, J BIOL CHEM, V283, P33211, DOI 10.1074/jbc.M804440200; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Kwitny S, 2010, BIOL REPROD, V82, P669, DOI 10.1095/biolreprod.109.079566; Li BH, 2002, MOL CELL BIOL, V22, P4997, DOI 10.1128/MCB.22.14.4997-5005.2002; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Russell LD, 1990, HISTOLOGICAL HISTOPA, pxiv; Scott DC, 2010, MOL CELL, V39, P784, DOI 10.1016/j.molcel.2010.08.030; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Tan M, 2009, P NATL ACAD SCI USA, V106, P6203, DOI 10.1073/pnas.0812425106; Tateishi K, 2001, J CELL BIOL, V155, P571, DOI 10.1083/jcb.200104035; Wang YS, 1999, CURR BIOL, V9, P1191, DOI 10.1016/S0960-9822(00)80024-X; Weber EM, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-83	32	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0209995	10.1371/journal.pone.0209995	http://dx.doi.org/10.1371/journal.pone.0209995			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653527	Green Published, gold, Green Submitted			2022-12-26	WOS:000456015500022
J	Linnemann, J; Poll, G; Jakob, S; Ferreira-Cerca, S; Griesenbeck, J; Tschochner, H; Milkereit, P				Linnemann, Jan; Poell, Gisela; Jakob, Steffen; Ferreira-Cerca, Sebastien; Griesenbeck, Joachim; Tschochner, Herbert; Milkereit, Philipp			Impact of two neighbouring ribosomal protein clusters on biogenesis factor binding and assembly of yeast late small ribosomal subunit precursors	PLOS ONE			English	Article							TANDEM AFFINITY PURIFICATION; TRANSLATION INITIATION; CYTOPLASMIC MATURATION; EUKARYOTIC RIBOSOME; RNA; LTV1; PROCESSOME; EXPRESSION; MARKERS; 3'-END	Many of the small ribosomal subunit proteins are required for the stabilisation of late small ribosomal subunit (SSU) precursors and for final SSU rRNA processing in S. cerevisiae. Among them are ribosomal proteins (r-proteins) which form a protein cluster around rpS0 (uS2) at the "neck" of the SSU (S0-cluster) and others forming a nearby protein cluster around rpS3 (uS3) at the SSU "beak". Here we applied semi-quantitative proteomics together with complementary biochemical approaches to study how incomplete assembly of these two r-protein clusters affects binding and release of SSU maturation factors and assembly of other r-proteins in late SSU precursors in S. cerevisiae. For each of the two clusters specific impairment of the local r-protein assembly state was observed in Rio2 associated SSU precursors. Besides, cluster-specific effects on the association of biogenesis factors were detected. These suggested a role of S0-cluster formation for the efficient release of the two nuclear export factors Rrp12 and Slx9 from SSU precursors and for the correct incorporation of the late acting biogenesis factor Rio2. Based on our and on previous results we propose the existence of at least two different r-protein assembly checkpoints during late SSU maturation in S. cerevisiae. We discuss in the light of recent SSU precursor structure models how r-protein assembly states might be sensed by biogenesis factors at the S0-cluster checkpoint.	[Linnemann, Jan; Poell, Gisela; Jakob, Steffen; Ferreira-Cerca, Sebastien; Griesenbeck, Joachim; Tschochner, Herbert; Milkereit, Philipp] Univ Regensburg, Lehrstuhl Biochem 3, Regensburg, Germany; [Linnemann, Jan] Evotec Munchen GmbH, Martinsried, Germany; [Poell, Gisela] Sandoz GmbH, Langkampfen, Austria	University of Regensburg; Evotec; Novartis; Sandoz	Griesenbeck, J; Tschochner, H; Milkereit, P (corresponding author), Univ Regensburg, Lehrstuhl Biochem 3, Regensburg, Germany.	joachim.griesenbeck@vkl.uni-regensburg.de; herbert.tschochner@vkl.uni-regensburg.de; philipp.milkereit@vkl.uni-regensburg.de	Ferreira-Cerca, Sébastien/P-2065-2019	Ferreira-Cerca, Sébastien/0000-0002-0522-843X	Deutsche Forschungsgemeinschaft [SFB 960]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant which was given in the collaborative research center SFB 960, from the "Deutsche Forschungsgemeinschaft" (www.dfg.de) to JG, HT and PM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameismeier M, 2018, NATURE, V558, P249, DOI 10.1038/s41586-018-0193-0; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Barandun J, 2018, CURR OPIN STRUC BIOL, V49, P85, DOI 10.1016/j.sbi.2018.01.008; Barandun J, 2017, NAT STRUCT MOL BIOL, V24, P944, DOI 10.1038/nsmb.3472; Bax R, 2006, RNA, V12, P2005, DOI 10.1261/rna.159406; Belhabich-Baumas K, 2017, NUCLEIC ACIDS RES, V45, P10824, DOI 10.1093/nar/gkx734; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Chaker-Margot M, 2018, RNA, V24, P881, DOI 10.1261/rna.066985.118; Chaker-Margot M, 2015, NAT STRUCT MOL BIOL, V22, P920, DOI 10.1038/nsmb.3111; Chen WD, 2003, NUCLEIC ACIDS RES, V31, P690, DOI 10.1093/nar/gkg145; de la Cruz J, 2015, ANNU REV BIOCHEM, V84, P93, DOI 10.1146/annurev-biochem-060614-033917; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Espinar-Marchena FJ, 2017, MICROB CELL, V4, P144, DOI 10.15698/mic2017.05.572; Fassio CA, 2010, GENETICS, V185, P199, DOI 10.1534/genetics.110.115584; Fatica A, 2003, MOL CELL BIOL, V23, P1798, DOI 10.1128/MCB.23.5.1798-1807.2003; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Ferreira-Cerca S, 2014, NUCLEIC ACIDS RES, V42, P8635, DOI 10.1093/nar/gku542; Ferreira-Cerca S, 2012, NAT STRUCT MOL BIOL, V19, P1316, DOI 10.1038/nsmb.2403; Fischer U, 2015, ELIFE, V4, DOI 10.7554/eLife.05745; Ford CL, 1999, CANCER RES, V59, P704; Garcia-Gomez JJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004205; Geerlings TH, 2003, J BIOL CHEM, V278, P22537, DOI 10.1074/jbc.M300759200; Gelperin D, 2001, RNA, V7, P1268, DOI 10.1017/S1355838201013073; Ghalei H, 2017, MOL CELL, V68, P1155, DOI 10.1016/j.molcel.2017.12.001; Ghalei H, 2015, J CELL BIOL, V208, P745, DOI 10.1083/jcb.201409056; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hector RD, 2014, NUCLEIC ACIDS RES, V42, P12138, DOI 10.1093/nar/gku815; Heuer A, 2017, ELIFE, V6, DOI 10.7554/eLife.30189; Jakob S., 2011, ANAL RELATIONSHIP RI; Jakob S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032552; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Johnson MC, 2017, STRUCTURE, V25, P329, DOI 10.1016/j.str.2016.12.011; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Knuppel R, 2018, NUCLEIC ACIDS RES, V46, P1441, DOI 10.1093/nar/gkx1236; LAFONTAINE D, 1995, GENE DEV, V9, P2470, DOI 10.1101/gad.9.20.2470; Lebaron S, 2012, NAT STRUCT MOL BIOL, V19, P744, DOI 10.1038/nsmb.2308; Leger-Silvestre I, 2004, EMBO J, V23, P2336, DOI 10.1038/sj.emboj.7600252; Llacer JL, 2015, MOL CELL, V59, P399, DOI 10.1016/j.molcel.2015.06.033; Loar JW, 2004, GENETICS, V168, P1877, DOI 10.1534/genetics.104.032656; Mitterer V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10336; Moriggi G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004836; MORITZ M, 1990, J CELL BIOL, V111, P2261, DOI 10.1083/jcb.111.6.2261; Neueder A., 2011, CHARACTERIZATION R P; Neueder A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010194; Oeffinger M, 2004, GENE DEV, V18, P196, DOI 10.1101/gad.285604; Pena C, 2016, ELIFE, V5, DOI 10.7554/eLife.21755; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sambrook J, 1989, MOL CLONING LAB MANU, DOI [10.1002/jcc.20084, DOI 10.1002/JCC.20084]; Scaiola A, 2018, EMBO J, V37, DOI 10.15252/embj.201798499; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schutz S, 2014, ELIFE, V3, DOI 10.7554/eLife.03473; Smith JS, 2014, METHODS MOL BIOL, V1205, P1, DOI 10.1007/978-1-4939-1363-3; Soudet J, 2010, EMBO J, V29, P80, DOI 10.1038/emboj.2009.307; Strunk BS, 2012, CELL, V150, P111, DOI 10.1016/j.cell.2012.04.044; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; Sturm M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02199-4; Sun Q, 2017, ELIFE, V6, DOI 10.7554/eLife.22086; Tabb-Massey A, 2003, NUCLEIC ACIDS RES, V31, P6798, DOI 10.1093/nar/gkg899; Turowski TW, 2014, NUCLEIC ACIDS RES, V42, P12189, DOI 10.1093/nar/gku878; Vanrobays E, 2004, RNA, V10, P645, DOI 10.1261/rna.5162204; Vanrobays E, 2003, MOL CELL BIOL, V23, P2083, DOI 10.1128/MCB.23.6.2083-2095.2003; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Wyler E, 2011, RNA, V17, P189, DOI 10.1261/rna.2325911; Zhang LM, 2016, GENE DEV, V30, P718, DOI 10.1101/gad.274688.115	70	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0203415	10.1371/journal.pone.0203415	http://dx.doi.org/10.1371/journal.pone.0203415			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653518	Green Published, gold, Green Submitted			2022-12-26	WOS:000456015500004
J	Blume, C; Ost, J; Muhlenbruch, M; Peterhansel, C; Laxa, M				Blume, Christian; Ost, Julia; Muehlenbruch, Marco; Peterhaensel, Christoph; Laxa, Miriam			Low CO2 induces urea cycle intermediate accumulation in Arabidopsis thaliana	PLOS ONE			English	Article							ORNITHINE-DELTA-AMINOTRANSFERASE; PROLINE DEHYDROGENASE GENES; TRANSCRIPTIONAL REGULATION; SALT STRESS; WILD WATERMELON; DROUGHT STRESS; AMINO-ACIDS; METABOLISM; LEAVES; PLANTS	The non-proteinogenic amino acid ornithine links several stress response pathways. From a previous study we know that ornithine accumulates in response to low CO2. To investigate ornithine accumulation in plants, we shifted plants to either low CO2 or low light. Both conditions increased carbon limitation, but only low CO2 also increased the rate of photorespiration. Changes in metabolite profiles of light- and CO2-limited plants were quite similar. Several amino acids that are known markers of senescence accumulated strongly under both conditions. However, urea cycle intermediates respond differently between the two treatments. While the levels of both ornithine and citrulline were much higher in plants shifted to 100 ppm CO2 compared to those kept in 400 ppm CO2, their metabolite abundance did not significantly change in response to a light limitation. Furthermore, both ornithine and citrulline accumulation is independent from sugar starvation. Exogenous supplied sugar did not significantly change the accumulation of the two metabolites in low CO2-stressed plants, while the accumulation of other amino acids was reduced by about 50%. Gene expression measurements showed a reduction of the entire arginine biosynthetic pathway in response to low CO2. Genes in both proline biosynthesis and degradation were induced. Hence, proline did not accumulate in response to low CO2 like observed for many other stresses. We propose that excess of nitrogen re-fixed during photorespiration can be alternatively stored in ornithine and citrulline under low CO2 conditions. Furthermore, ornithine is converted to pyrroline-5-carboxylate by the action of delta OAT.	[Blume, Christian; Ost, Julia; Muehlenbruch, Marco; Peterhaensel, Christoph; Laxa, Miriam] Leibniz Univ Hannover, Inst Bot, Hannover, Germany; [Laxa, Miriam] Univ Bielefeld, Plant Biochem & Physiol Plants, Bielefeld, Germany	Leibniz University Hannover; University of Bielefeld	Laxa, M (corresponding author), Leibniz Univ Hannover, Inst Bot, Hannover, Germany.; Laxa, M (corresponding author), Univ Bielefeld, Plant Biochem & Physiol Plants, Bielefeld, Germany.	miriam.laxa@uni-bielefeld.de			Open Access Fund of the Leibniz Universitat Hannover	Open Access Fund of the Leibniz Universitat Hannover	The publication of this article was funded by the Open Access Fund of the Leibniz Universitat Hannover.	ADAMS E, 1980, ANNU REV BIOCHEM, V49, P1005, DOI 10.1146/annurev.bi.49.070180.005041; Akashi K, 2001, FEBS LETT, V508, P438, DOI 10.1016/S0014-5793(01)03123-4; An YY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0077897, 10.1371/journal.pone.0069942]; Araujo WL, 2010, PLANT CELL, V22, P1549, DOI 10.1105/tpc.110.075630; Armengaud P, 2004, PHYSIOL PLANTARUM, V120, P442, DOI 10.1111/j.0031-9317.2004.00251.x; Bloom AJ, 2002, P NATL ACAD SCI USA, V99, P1730, DOI 10.1073/pnas.022627299; Bourrellier ABF, 2009, BIOCHEM BIOPH RES CO, V387, P700, DOI 10.1016/j.bbrc.2009.07.088; Brouquisse R, 1998, PLANT PHYSIOL, V117, P1281, DOI 10.1104/pp.117.4.1281; Brownfield DL, 2008, PLANT MOL BIOL, V67, P429, DOI 10.1007/s11103-008-9336-2; BUCCI LR, 1991, J NUTR BIOCHEM, V2, P363, DOI 10.1016/0955-2863(91)90092-J; Bundig C, 2016, PLANT CELL TISS ORG, V127, P195, DOI 10.1007/s11240-016-1042-1; Caldana C, 2011, PLANT J, V67, P869, DOI 10.1111/j.1365-313X.2011.04640.x; Chellamuthu VR, 2014, CELL, V159, P1188, DOI 10.1016/j.cell.2014.10.015; Crawford NM, 2006, J EXP BOT, V57, P471, DOI 10.1093/jxb/erj050; DELAUNEY AJ, 1993, J BIOL CHEM, V268, P18673; Dellero Y, 2015, PLANT J, V83, P1005, DOI 10.1111/tpj.12945; Eisenhut M, 2017, MOL PLANT, V10, P47, DOI 10.1016/j.molp.2016.09.011; Engineer CB, 2016, TRENDS PLANT SCI, V21, P16, DOI 10.1016/j.tplants.2015.08.014; Fahnenstich H, 2007, PLANT PHYSIOL, V145, P640, DOI 10.1104/pp.107.104455; Ferrario-Mery S, 2006, FEBS LETT, V580, P2015, DOI 10.1016/j.febslet.2006.02.075; Flexas J, 2002, ANN BOT-LONDON, V89, P183, DOI 10.1093/aob/mcf027; Florez-Sarasa I, 2012, NEW PHYTOL, V195, P136, DOI 10.1111/j.1469-8137.2012.04153.x; Forde BG, 2007, J EXP BOT, V58, P2339, DOI 10.1093/jxb/erm121; Funck D, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-40; Geiger M, 1998, PLANT CELL ENVIRON, V21, P253, DOI 10.1046/j.1365-3040.1998.00277.x; Girousse C, 1996, PLANT PHYSIOL, V111, P109, DOI 10.1104/pp.111.1.109; Halket JM, 2005, J EXP BOT, V56, P219, DOI 10.1093/jxb/eri069; Hanfrey C, 2001, PLANT J, V27, P551, DOI 10.1046/j.1365-313X.2001.01100.x; Hashimoto M, 2006, NAT CELL BIOL, V8, P391, DOI 10.1038/ncb1387; Hayashi F, 2000, PLANT CELL PHYSIOL, V41, P1096, DOI 10.1093/pcp/pcd036; Hayat S, 2012, PLANT SIGNAL BEHAV, V7, P1456, DOI 10.4161/psb.21949; Hildebrandt TM, 2015, MOL PLANT, V8, P1563, DOI 10.1016/j.molp.2015.09.005; Hsieh MH, 1998, P NATL ACAD SCI USA, V95, P13965, DOI 10.1073/pnas.95.23.13965; Igarashi D, 2006, PLANT PHYSIOL, V142, P901, DOI 10.1104/pp.106.085514; Kalamaki MS, 2009, J EXP BOT, V60, P1859, DOI 10.1093/jxb/erp072; Kawasaki S, 2000, PLANT CELL PHYSIOL, V41, P864, DOI 10.1093/pcp/pcd005; Kusvuran S, 2013, SCI WORLD J, DOI 10.1155/2013/253414; Laxa M, 2018, CURR PLANT BIOL, V14, P2, DOI 10.1016/j.cpb.2018.09.001; Lea PJ, 2007, ANN APPL BIOL, V150, P1, DOI 10.1111/j.1744-7348.2006.00104.x; Li YY, 2014, J EXP BOT, V65, P3657, DOI 10.1093/jxb/eru193; Liang XW, 2013, ANTIOXID REDOX SIGN, V19, P998, DOI 10.1089/ars.2012.5074; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Matt P, 2001, PLANT CELL ENVIRON, V24, P177, DOI 10.1111/j.1365-3040.2001.00676.x; Miller G, 2005, PLANTA, V222, P70, DOI 10.1007/s00425-005-1518-4; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Minocha R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00175; Nakashima K, 1997, PLANT J, V12, P851, DOI 10.1046/j.1365-313X.1997.12040851.x; Niessen M, 2012, J EXP BOT, V63, P2705, DOI 10.1093/jxb/err453; Novitskaya L, 2002, PLANT CELL ENVIRON, V25, P821, DOI 10.1046/j.1365-3040.2002.00866.x; Peng Z, 1996, MOL GEN GENET, V253, P334, DOI 10.1007/s004380050329; Peterhansel Christoph, 2010, Arabidopsis Book, V8, pe0130, DOI 10.1199/tab.0130; Rachmilevitch S, 2004, P NATL ACAD SCI USA, V101, P11506, DOI 10.1073/pnas.0404388101; Raymond MJ, 2002, ANN BOT-LONDON, V89, P813, DOI 10.1093/aob/mcf082; REHFELD DW, 1972, J BIOL CHEM, V247, P4803; Roosens NHCJ, 1998, PLANT PHYSIOL, V117, P263, DOI 10.1104/pp.117.1.263; Saha J, 2015, FRONT ENV SCI-SWITZ, V3, DOI 10.3389/fenvs.2015.00021; Schertl P, 2014, FEBS J, V281, P2794, DOI 10.1111/febs.12821; Servet C, 2012, FRONT BIOSCI-LANDMRK, V17, P607, DOI 10.2741/3947; SHARGOOL PD, 1988, PHYTOCHEMISTRY, V27, P1571, DOI 10.1016/0031-9422(88)80404-7; SHARKEY TD, 1985, BOT REV, V51, P53, DOI 10.1007/BF02861058; Sharma S, 2010, PLANT CELL ENVIRON, V33, P1838, DOI 10.1111/j.1365-3040.2010.02188.x; Slocum RD, 2005, PLANT PHYSIOL BIOCH, V43, P729, DOI 10.1016/j.plaphy.2005.06.007; Stranska J, 2008, PLANT SIGNAL BEHAV, V3, P929, DOI 10.4161/psb.6771; Taira M, 2004, PLANT CELL, V16, P2048, DOI 10.1105/tpc.104.022046; Uhrig RG, 2009, TRENDS PLANT SCI, V14, P505, DOI 10.1016/j.tplants.2009.07.003; Vankova R, 2012, PLANT SIGNAL BEHAV, V7, P19, DOI 10.4161/psb.7.1.18375; Verbruggen N, 1996, P NATL ACAD SCI USA, V93, P8787, DOI 10.1073/pnas.93.16.8787; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Verma S, 2005, J PLANT PHYSIOL, V162, P669, DOI 10.1016/j.jplph.2004.08.008; Voss I, 2013, PLANT BIOLOGY, V15, P713, DOI 10.1111/j.1438-8677.2012.00710.x; Weckwerth W, 2004, PROTEOMICS, V4, P78, DOI 10.1002/pmic.200200500; Wingler A, 2000, PHILOS T R SOC B, V355, P1517, DOI 10.1098/rstb.2000.0712; Xue XN, 2009, BMB REP, V42, P28, DOI 10.5483/BMBRep.2009.42.1.028; Yang CW, 1999, PLANT GROWTH REGUL, V27, P189; Yoshiba Y, 1997, PLANT CELL PHYSIOL, V38, P1095, DOI 10.1093/oxfordjournals.pcp.a029093; You J, 2012, PLANT SCI, V197, P59, DOI 10.1016/j.plantsci.2012.09.002; Zarattini M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00927	77	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210342	10.1371/journal.pone.0210342	http://dx.doi.org/10.1371/journal.pone.0210342			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650113	Green Published, gold, Green Submitted			2022-12-26	WOS:000455813300052
J	Guell, X; Goncalves, M; Kaczmarzyk, JR; Gabrieli, JDE; Schmahmann, JD; Ghosh, SS				Guell, Xavier; Goncalves, Mathias; Kaczmarzyk, Jakub R.; Gabrieli, John D. E.; Schmahmann, Jeremy D.; Ghosh, Satrajit S.			LittleBrain: A gradient-based tool for the topographical interpretation of cerebellar neuroimaging findings	PLOS ONE			English	Article							FUNCTIONAL TOPOGRAPHY; ORGANIZATION; THOUGHT; CONNECTIVITY; OPTIMIZATION; REGISTRATION; PARCELLATION; PROJECTIONS; DYSFUNCTION; DYSMETRIA	Gradient-based approaches to brain function have recently unmasked fundamental properties of brain organization. Diffusion map embedding analysis of resting-state fMRI data revealed a primary-to-transmodal axis of cerebral cortical macroscale functional organization. The same method was recently used to analyze resting-state data within the cerebellum, revealing for the first time a sensorimotor-fugal macroscale organization principle of cerebellar function. Cerebellar gradient 1 extended from motor to non-motor task-unfocused (default-mode network) areas, and cerebellar gradient 2 isolated task-focused processing regions. Here we present a freely available and easily accessible tool that applies this new knowledge to the topographical interpretation of cerebellar neuroimaging findings. Little-Brain illustrates the relationship between cerebellar data (e.g., volumetric patient study clusters, task activation maps, etc.) and cerebellar gradients 1 and 2. Specifically, LittleBrain plots all voxels of the cerebellum in a two-dimensional scatterplot, with each axis corresponding to one of the two principal functional gradients of the cerebellum, and indicates the position of cerebellar neuroimaging data within these two dimensions. This novel method of data mapping provides alternative, gradual visualizations that complement discrete parcellation maps of cerebellar functional neuroanatomy. We present application examples to show that LittleBrain can also capture subtle, progressive aspects of cerebellar functional neuroanatomy that would be difficult to visualize using conventional mapping techniques. Download and use instructions can be found at https://xaviergp.github.io/littlebrain.	[Guell, Xavier; Goncalves, Mathias; Kaczmarzyk, Jakub R.; Gabrieli, John D. E.; Ghosh, Satrajit S.] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Guell, Xavier; Schmahmann, Jeremy D.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Lab Neuroanat & Cerebellar Neurobiol, Boston, MA 02115 USA; [Schmahmann, Jeremy D.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Ataxia Unit,Cognit Behav Neurol Unit, Boston, MA USA; [Ghosh, Satrajit S.] Harvard Med Sch, Dept Otolaryngol, Boston, MA USA	Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Guell, X (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Guell, X (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Lab Neuroanat & Cerebellar Neurobiol, Boston, MA 02115 USA.	xaviergp@mit.edu	Schmahmann, Jeremy/ABF-1215-2021; Gabrieli, John/AAJ-2869-2020	Schmahmann, Jeremy/0000-0003-0706-5125; Ghosh, Satrajit/0000-0002-5312-6729; Guell, Xavier/0000-0002-0684-0954	La Caixa Banking Foundation; MGH ECOR Fund for Medical Discovery Postdoctoral Fellowship Award; MINDLink foundation; National Institutes of Health [R01 EB020740, P41 EB019936]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB020740, P41EB019936] Funding Source: NIH RePORTER	La Caixa Banking Foundation(La Caixa Foundation); MGH ECOR Fund for Medical Discovery Postdoctoral Fellowship Award; MINDLink foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was supported by La Caixa Banking Foundation (XG), the MGH ECOR Fund for Medical Discovery Postdoctoral Fellowship Award (XG), the MINDLink foundation (JDS), and National Institutes of Health R01 EB020740 (SSG) and P41 EB019936 (SSG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Arnold Anteraper S, 2018, BRAIN CONNECT; Baillieux H, 2008, CLIN NEUROL NEUROSUR, V110, P763, DOI 10.1016/j.clineuro.2008.05.013; Bajada CJ, 2017, NEUROIMAGE, V155, P503, DOI 10.1016/j.neuroimage.2017.04.016; Baldassano C, 2017, NEURON, V95, P709, DOI 10.1016/j.neuron.2017.06.041; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Cerliani L, 2012, HUM BRAIN MAPP, V33, P2005, DOI 10.1002/hbm.21338; Chirigati F, 2016, P 2016 INT C MAN DAT; Coifman RR, 2005, P NATL ACAD SCI USA, V102, P7432, DOI 10.1073/pnas.0500896102; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Gabrieli JDE, 2015, NEURON, V85, P11, DOI 10.1016/j.neuron.2014.10.047; Gorgolewski KJ, 2016, NEUROIMAGE, V124, P1242, DOI 10.1016/j.neuroimage.2015.04.016; Guell X, 2018, XAVIERGP LITTLEBRAIN; Guell X, 2018, ELIFE, V7, DOI 10.7554/eLife.36652; Guell X, 2018, CORTEX, V100, P140, DOI 10.1016/j.cortex.2017.07.005; Guell X, 2018, NEUROIMAGE, V172, P437, DOI 10.1016/j.neuroimage.2018.01.082; Guell X, 2015, CEREBELLUM, V14, P50, DOI 10.1007/s12311-014-0630-z; Guo CC, 2016, BRAIN, V139, P1527, DOI 10.1093/brain/aww003; Haak KV, 2018, NEUROIMAGE, V170, P83, DOI 10.1016/j.neuroimage.2017.06.075; Hoche F, 2016, CEREBELLUM, V15, P732, DOI 10.1007/s12311-015-0746-9; Hoche F, 2018, BRAIN, V141, P248, DOI 10.1093/brain/awx317; Huntenburg JM, 2018, TRENDS COGN SCI, V22, P21, DOI 10.1016/j.tics.2017.11.002; Huntenburg JM, 2017, CEREB CORTEX, V27, P981, DOI 10.1093/cercor/bhx030; Huth AG, 2016, NATURE, V532, P453, DOI 10.1038/nature17637; Jackson RL, 2018, NEUROIMAGE, V170, P385, DOI 10.1016/j.neuroimage.2017.04.024; Jbabdi S, 2013, CURR OPIN NEUROBIOL, V23, P207, DOI 10.1016/j.conb.2012.12.004; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Kaczmarzyk J, 2018, KACZMARJ NEURO DOCKE; Keren-Happuch E, 2014, HUM BRAIN MAPP, V35, P593, DOI 10.1002/hbm.22194; Kim H, 2015, NEUROIMAGE-CLIN, V7, P667, DOI 10.1016/j.nicl.2015.02.022; Kluyver T, 2016, POSITIONING AND POWER IN ACADEMIC PUBLISHING: PLAYERS, AGENTS AND AGENDAS, P87, DOI 10.3233/978-1-61499-649-1-87; Koziol LF, 2014, CEREBELLUM, V13, P151, DOI 10.1007/s12311-013-0511-x; Leite AJB, 2006, STROKE, V37, P105, DOI 10.1161/01.STR.0000196984.90718.8a; Lesage E, 2017, J NEUROSCI, V37, P6231, DOI 10.1523/JNEUROSCI.3203-16.2017; Levisohn L, 2000, BRAIN, V123, P1041, DOI 10.1093/brain/123.5.1041; Marcus Daniel S, 2011, Front Neuroinform, V5, P4, DOI 10.3389/fninf.2011.00004; Margulies DS, 2016, P NATL ACAD SCI USA, V113, P12574, DOI 10.1073/pnas.1608282113; Marquand AF, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0146; Merkel Dirk, 2014, LINUX J, V239, P2, DOI DOI 10.5555/2600239.2600241; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Phillips JR, 2015, FRONT PUBLIC HEALTH, P3; Ravizza SM, 2006, BRAIN, V129, P306, DOI 10.1093/brain/awh685; Riva D, 2000, BRAIN, V123, P1051, DOI 10.1093/brain/123.5.1051; Schmahmann JD, 1997, INT REV NEUROBIOL, V41, P31, DOI 10.1016/S0074-7742(08)60346-3; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schmahmann JD, 1997, J NEUROSCI, V17, P438, DOI 10.1523/JNEUROSCI.17-01-00438.1997; Schmahmann JD, 1996, HUM BRAIN MAPP, V4, P174, DOI 10.1002/(SICI)1097-0193(1996)4:3<174::AID-HBM3>3.0.CO;2-0; SCHMAHMANN JD, 1991, J COMP NEUROL, V308, P224, DOI 10.1002/cne.903080209; Schmahmann JD, 2007, CEREBELLUM, V6, P254, DOI 10.1080/14734220701490995; Schroder TN, 2015, ELIFE, V4, DOI 10.7554/eLife.06738; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Tedesco AM, 2011, BRAIN, V134, P3669, DOI 10.1093/brain/awr266; Thompson RF, 2009, NEUROSCIENCE, V162, P732, DOI 10.1016/j.neuroscience.2009.01.041; Wang T, 2016, SCI REP, P6; Wilkins A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00312; Wolf RC, 2015, J NEUROL, V262, P859, DOI 10.1007/s00415-015-7642-6; Wu T, 2013, BRAIN, V136, P696, DOI 10.1093/brain/aws360; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	62	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210028	10.1371/journal.pone.0210028	http://dx.doi.org/10.1371/journal.pone.0210028			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650101	Green Published, Green Submitted, gold			2022-12-26	WOS:000455813300038
J	van der Cruijsen, R; Murphy, J; Bird, G				van der Cruijsen, Renske; Murphy, Jennifer; Bird, Geoffrey			Alexithymic traits can explain the association between puberty and symptoms of depression and anxiety in adolescent females	PLOS ONE			English	Article							PSYCHIATRIC-DISORDERS; GENDER-DIFFERENCES; SEX-DIFFERENCES; INDIVIDUAL-DIFFERENCES; UNITED-STATES; PREVALENCE; PSYCHOPATHOLOGY; GIRLS; AGE; INTEROCEPTION	Symptoms of internalizing disorders such as depression and anxiety increase in adolescence, especially in females. However, gender differences in depression and anxiety symptoms emerge only after puberty onset. Levels of alexithymia, characterized by difficulties identifying and describing one's emotions, are elevated in depression and anxiety, and fluctuate across adolescence in a gender-specific manner. This study investigated changes in alexithymia across adolescence, and explored the potential role of alexithymia in the development of depression and anxiety, separately for females and males. Accordingly, 140 adolescents aged 11 to 21 years (77 female) completed self-report measures of alexithymia, depression and anxiety, and pubertal development. For females alone, pubertal maturation was associated with alexithymic traits (specifically difficulties identifying and describing feelings), as well as symptoms of depression and anxiety. After accounting for alexithymia, the relationship between puberty and depression and anxiety was absent or reduced in females. Thus, alexithymic traits may have differential consequences for males and females, and possibly contribute towards increased depression and anxiety symptoms in females during adolescence. We propose that developmental changes in alexithymia should be considered when studying the onset and development of internalizing psychological disorders during adolescence.	[van der Cruijsen, Renske] Leiden Univ, Dept Dev Psychol, Leiden, Netherlands; [Murphy, Jennifer; Bird, Geoffrey] Kings Coll London, Inst Psychiat Psychol & Neurosci, Genet & Dev Psychiat Ctr, MRC Social, London, England; [Bird, Geoffrey] Univ Oxford, Dept Expt Psychol, Oxford, England	Leiden University; Leiden University - Excl LUMC; University of London; King's College London; University of Oxford	van der Cruijsen, R (corresponding author), Leiden Univ, Dept Dev Psychol, Leiden, Netherlands.	l.w.p.van.der.cruijsen@fsw.leidenuniv.nl	Bird, Geoff/AAA-3652-2020	Bird, Geoffrey/0000-0002-2310-0202	Netherlands Organization for Scientific Research (NWO-VICI) [453-14-001]; Economic and Social Research Council [1599941, ES/J500057/1]; Baily Thomas Trust	Netherlands Organization for Scientific Research (NWO-VICI)(Netherlands Organization for Scientific Research (NWO)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Baily Thomas Trust	This work was supported by a grant from The Netherlands Organization for Scientific Research (NWO-VICI 453-14-001 E.A.C.). Additionally, JM was supported by a doctoral studentship from the Economic and Social Research Council [1599941; ES/J500057/1] and GB by the Baily Thomas Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloy LB, 2016, CLIN PSYCHOL SCI, V4, P867, DOI 10.1177/2167702616643008; Altemus M, 2014, FRONT NEUROENDOCRIN, V35, P320, DOI 10.1016/j.yfrne.2014.05.004; Angold A, 1998, PSYCHOL MED, V28, P51, DOI 10.1017/S003329179700593X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Chorpita BF, 2000, BEHAV RES THER, V38, P835, DOI 10.1016/S0005-7967(99)00130-8; COLE DA, 1990, J ABNORM PSYCHOL, V99, P422, DOI 10.1037/0021-843X.99.4.422; Cole DA, 2003, J ABNORM PSYCHOL, V112, P558, DOI 10.1037/0021-843X.112.4.558; Conley CS, 2009, DEV PSYCHOPATHOL, V21, P593, DOI 10.1017/S0954579409000327; Copeland WE, 2014, J AM ACAD CHILD PSY, V53, P21, DOI 10.1016/j.jaac.2013.09.017; Costello EJ, 2003, ARCH GEN PSYCHIAT, V60, P837, DOI 10.1001/archpsyc.60.8.837; Courty A, 2015, COMPR PSYCHIAT, V56, P217, DOI 10.1016/j.comppsych.2014.09.011; Craig A.D., 2002, DO YOU FEEL INTEROCE, V3; Dahl RE, 2004, ANN NY ACAD SCI, V1021, P1, DOI 10.1196/annals.1308.001; Dorn L. D., 2006, APPL DEV SCI, V10, P30, DOI [10.1207/s1532480xads1001_3, DOI 10.1207/S1532480XADS1001_3]; Dorn LD, 2003, J YOUTH ADOLESCENCE, V32, P157, DOI 10.1023/A:1022590818839; Ellis BJ, 1999, J PERS SOC PSYCHOL, V77, P387, DOI 10.1037/0022-3514.77.2.387; Ellis BJ, 2000, CHILD DEV, V71, P485, DOI 10.1111/1467-8624.00159; Field AP, 2017, BEHAV RES THER, V98, P19, DOI 10.1016/j.brat.2017.05.013; Fustos J, 2013, SOC COGN AFFECT NEUR, V8, P911, DOI 10.1093/scan/nss089; Gatta M, 2014, NEUROSCIENCE MED, V5, P60, DOI DOI 10.4236/NM.2014.51009; Gohm CL, 2000, PERS SOC PSYCHOL B, V26, P679, DOI 10.1177/0146167200268004; Grabauskaite A, 2017, CONSCIOUS COGN, V48, P129, DOI 10.1016/j.concog.2016.11.002; Graber JA, 2004, J AM ACAD CHILD PSY, V43, P718, DOI 10.1097/01.chi.0000120022.14101.11; Grant BF, 2005, J CLIN PSYCHIAT, V66, P1351, DOI 10.4088/JCP.v66n1102; Griffin C, 2016, AUTISM RES, V9, P773, DOI 10.1002/aur.1569; Hankin BL, 2009, J CLIN CHILD ADOLESC, V38, P460, DOI 10.1080/15374410902976288; Hankin BL, 1998, J ABNORM PSYCHOL, V107, P128, DOI 10.1037/0021-843X.107.1.128; Hankin BL, 2015, J ABNORM PSYCHOL, V73, P389; Harter S., 2012, CONSTRUCTION SELF, DOI 10.1017/CBO9781107415324.004; Hayward C, 2002, J ADOLESCENT HEALTH, V30, P49, DOI 10.1016/S1054-139X(02)00336-1; HENDRYX MS, 1991, J PERS ASSESS, V56, P227, DOI 10.1207/s15327752jpa5602_4; Honkalampi K, 2000, J PSYCHOSOM RES, V48, P99, DOI 10.1016/S0022-3999(99)00083-5; Honkalampi K, 2009, COMPR PSYCHIAT, V50, P263, DOI 10.1016/j.comppsych.2008.08.007; Joukamaa M, 2007, J PSYCHOSOM RES, V63, P373, DOI 10.1016/j.jpsychores.2007.01.018; Kajanoja J, 2017, J PSYCHOSOM RES, V97, P111, DOI 10.1016/j.jpsychores.2017.04.010; Kaltiala-Heino R, 2003, J ADOLESCENCE, V26, P531, DOI 10.1016/S0140-1971(03)00053-8; Karukivi M, 2010, J AFFECT DISORDERS, V125, P383, DOI 10.1016/j.jad.2010.02.126; Karukivi Max, 2010, Eat Disord, V18, P226, DOI 10.1080/10640261003719518; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Khalsa SS, 2018, BIOL PSYCHIAT-COGN N, V3, P501, DOI 10.1016/j.bpsc.2017.12.004; Khalsa SS, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00121; Klabunde M, 2013, EAT BEHAV, V14, P488, DOI 10.1016/j.eatbeh.2013.08.002; Lewinsohn PM, 2000, AM J PSYCHIAT, V157, P1584, DOI 10.1176/appi.ajp.157.10.1584; Lombardo MV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000883; Marchesi C, 2000, J PSYCHOSOM RES, V49, P43, DOI 10.1016/S0022-3999(00)00084-2; Maxwell SE, 2007, PSYCHOL METHODS, V12, P23, DOI 10.1037/1082-989X.12.1.23; McLaughlin KA, 2015, J ABNORM CHILD PSYCH, V43, P311, DOI 10.1007/s10802-014-9898-1; Mendle J, 2007, DEV REV, V27, P151, DOI 10.1016/j.dr.2006.11.001; Mendle J, 2014, CHILD DEV PERSPECT, V8, P218, DOI 10.1111/cdep.12092; Murphy J, 2017, J EXP PSYCHOL GEN, V44, P1; Murphy J, 2018, BIOL PSYCHOL, V136, P189, DOI 10.1016/j.biopsycho.2018.05.010; Murphy J, 2017, DEV COGN NEUROS-NETH, V23, P45, DOI 10.1016/j.dcn.2016.12.006; Nolen-Hoeksema S, 1999, J PERS SOC PSYCHOL, V77, P1061, DOI 10.1037/0022-3514.77.5.1061; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Pollatos O, 2009, DEPRESS ANXIETY, V26, P167, DOI 10.1002/da.20504; Quattrocki E, 2014, NEUROSCI BIOBEHAV R, V47, P410, DOI 10.1016/j.neubiorev.2014.09.012; Reardon LE, 2009, CLIN PSYCHOL REV, V29, P1, DOI 10.1016/j.cpr.2008.09.005; Rieffe C, 2006, PERS INDIV DIFFER, V40, P123, DOI 10.1016/j.paid.2005.05.013; Robins RW, 2005, CURR DIR PSYCHOL SCI, V14, P158, DOI 10.1111/j.0963-7214.2005.00353.x; Sakkinen P, 2007, PSYCHOSOMATICS, V48, P154, DOI 10.1176/appi.psy.48.2.154; Salminen JK, 1999, J PSYCHOSOM RES, V46, P75, DOI 10.1016/S0022-3999(98)00053-1; SCHANDRY R, 1981, PSYCHOPHYSIOLOGY, V18, P483, DOI 10.1111/j.1469-8986.1981.tb02486.x; Schuch JJJ, 2014, J AFFECT DISORDERS, V156, P156, DOI 10.1016/j.jad.2013.12.011; SIFNEOS PE, 1973, PSYCHOTHER PSYCHOSOM, V22, P255, DOI 10.1159/000286529; Sowislo JF, 2013, PSYCHOL BULL, V139, P213, DOI 10.1037/a0028931; Spilt JL, 2014, CHILD DEV, V85, P1248, DOI 10.1111/cdev.12181; Taylor GJ, 2016, NEUROSCI BIOBEHAV R, V68, P1006, DOI 10.1016/j.neubiorev.2016.05.025; Tondo L, 2017, EUR PSYCHIAT, V39, P80, DOI 10.1016/j.eurpsy.2016.08.001; van der Meer L, 2009, PSYCHIAT RES, V170, P108, DOI 10.1016/j.psychres.2009.07.010; Van Oort FVA, 2009, J CHILD PSYCHOL PSYC, V50, P1209, DOI 10.1111/j.1469-7610.2009.02092.x; van 't Wout M, 2007, COMPR PSYCHIAT, V48, P27, DOI 10.1016/j.comppsych.2006.07.003; Wasserman RM, 2012, J PEDIATR PSYCHOL, V37, P755, DOI 10.1093/jpepsy/jsr121; Werner NS, 2010, BIOL PSYCHOL, V85, P370, DOI 10.1016/j.biopsycho.2010.08.008; Werner NS, 2009, J PSYCHOPHYSIOL, V23, P35, DOI 10.1027/0269-8803.23.1.35; Wiens S, 2000, COGNITION EMOTION, V14, P417, DOI 10.1080/026999300378905	77	13	15	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210519	10.1371/journal.pone.0210519	http://dx.doi.org/10.1371/journal.pone.0210519			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650139	Green Published, gold			2022-12-26	WOS:000455813300058
J	Wu, CY; Yu, SL; Chen, YT; Chen, YH; Hsiao, PW; Chow, YH; Chen, JR				Wu, Chia-Ying; Yu, Shu-Ling; Chen, Yung-Tsung; Chen, Yi-Hsuan; Hsiao, Pei-Wen; Chow, Yen-Hung; Chen, Juine-Ruey			The mature EV71 virion induced a broadly cross-neutralizing VP1 antibody against subtypes of the EV71 virus	PLOS ONE			English	Article							ENTEROVIRUS 71 VACCINE; MECHANISM; CLEAVAGE; DISEASE	Enterovirus 71 (EV71) has emerged as a neurological virus causing life-threatening diseases in young children and infants. Although EV71 vaccines in development have presented promising results in several clinical trials, the identified key antigen for improving the broad protective efficacy of EV71 vaccines has not been well investigated. In this report, we show that different multiplicities of infection (MOIs) of the B4(E59) virus significantly affect EV71 vaccine production in a serum-free microcarrier bioreactor system. The antigens produced from high MOIs of 10(-1) and 10(-2) exhibited higher yield and more infectious full particle (FP) contents in the EV71 vaccines than those produced with low MOIs of 10(-4) and 10(-6), leading to better cross-neutralizing efficacy. The C4(E36) neutralization results showed that only antisera raised from EV71 FPs provided substantial neutralizing titers against C4(E36), whereas empty particles (EPs) of EV71 conferred no efficacy. Competitive ELISA showed that anti-FP mainly binds to FPs and that 20% of antibodies bind to EPs, whereas most anti-EP binds EPs, with only 10% antibodies binding to FPs. VP1-adsorbed anti-FP lost most of the virus neutralization efficiency, suggesting that the VP1 subunit of FP is the major immunogenic antigen determining the ability of the EV71 vaccine to elicit cross-neutralizing antibodies against EV71 virus subtypes. These findings demonstrate that the high-MOI production approach is significantly correlated with FP productivity, thereby improving the cross-neutralization efficacy of an EV71 vaccine and providing the basis for a better vaccine design against widespread EV71 viruses.	[Wu, Chia-Ying; Chen, Yung-Tsung; Chen, Yi-Hsuan; Chen, Juine-Ruey] Adimmune Corp, Taichung, Taiwan; [Yu, Shu-Ling; Chow, Yen-Hung] Natl Hlth Res Inst, Inst Infect Dis & Vaccinol, Zhunan, Miaoli County, Taiwan; [Hsiao, Pei-Wen] Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan; [Chow, Yen-Hung] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan	National Health Research Institutes - Taiwan; Academia Sinica - Taiwan; China Medical University Taiwan	Chen, JR (corresponding author), Adimmune Corp, Taichung, Taiwan.; Chow, YH (corresponding author), Natl Hlth Res Inst, Inst Infect Dis & Vaccinol, Zhunan, Miaoli County, Taiwan.; Chow, YH (corresponding author), China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan.	choeyenh@nhri.org.tw; juinerueychen@gmail.com		Chen, Juine Ruey/0000-0002-4751-1217	Adimmune Corporation; Ministry of Economic Affairs [101-EC-17-A-20-I1-0054]	Adimmune Corporation; Ministry of Economic Affairs	This study was supported by funds from Adimmune Corporation (http://www.adimmune.com.tw/index.php) and a Ministry of Economic Affairs grant (101-EC-17-A-20-I1-0054). Coauthors C.Y.W., Y.T.C., Y.H. Chen., and J.R.C. are all employees of Adimmune Corporation. The parties provided the financial support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions'' section.	ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; BASAVAPPA R, 1994, PROTEIN SCI, V3, P1651, DOI 10.1002/pro.5560031005; Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461; Chong P, 2015, CLIN INFECT DIS, V60, P797, DOI 10.1093/cid/ciu852; Chong P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049973; Chou AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079783; Chou AH, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/831282; Chou AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034834; CHOW M, 1982, P NATL ACAD SCI-BIOL, V79, P7518, DOI 10.1073/pnas.79.23.7518; Chu SC, 2013, J FORMOS MED ASSOC, V112, P508, DOI 10.1016/j.jfma.2012.12.001; Curry S, 1997, J VIROL, V71, P9743, DOI 10.1128/JVI.71.12.9743-9752.1997; Dai DX, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121231; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li RC, 2014, NEW ENGL J MED, V370, P829, DOI 10.1056/NEJMoa1303224; Liu CC, 2011, J VIROL METHODS, V176, P60, DOI 10.1016/j.jviromet.2011.06.001; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Liu CC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020005, 10.1371/journal.pone.0021464]; Mao QY, 2010, CHINESE MED J-PEKING, V123, P1679, DOI 10.3760/cma.j.issn.0366-6999.2010.13.012; Mao QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079599; REED L. J., 1938, AMER JOUR HYG, V27, P493; Shingler KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003240; Wang XX, 2012, NAT STRUCT MOL BIOL, V19, P424, DOI 10.1038/nsmb.2255; Wu CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136420; Wu YY, 2005, ACTA CRYSTALLOGR F, V61, P902, DOI 10.1107/S1744309105027132; Yi EJ, 2017, CLIN EXP VACCINE RES, V6, P4, DOI [10.7774/cevr.2017.6.1.4, 10.7774/cevr.2017.6.1.4.]; Yip Cyril C Y, 2013, Emerg Health Threats J, V6, P19780, DOI 10.3402/ehtj.v6i0.19780; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94	27	5	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210553	10.1371/journal.pone.0210553	http://dx.doi.org/10.1371/journal.pone.0210553			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650163	gold, Green Published			2022-12-26	WOS:000455813300061
J	De Marchi, E; Orioli, E; Pegoraro, A; Sangaletti, S; Portararo, P; Curti, A; Colombo, MP; Di Virgilio, F; Adinolfi, E				De Marchi, Elena; Orioli, Elisa; Pegoraro, Anna; Sangaletti, Sabina; Portararo, Paola; Curti, Antonio; Colombo, Mario Paolo; Di Virgilio, Francesco; Adinolfi, Elena			The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment	ONCOGENE			English	Article							P2X(7) RECEPTOR; INCREASES; CANCER; OX40; MICROVESICLES; INFLAMMATION; STIMULATION; MACROPHAGES; INVOLVEMENT; PANNEXIN-1	In the tumor microenvironment (TME) ATP and its receptor P2X7 exert a pivotal influence on cancer growth and tumor-host interactions. Here we analyzed the different effect of P2X7 genetic deficiency versus its antagonism on response against P2X7-expressing implanted tumors. We focused on immune cell expression of ATP degrading enzymes CD39 and CD73 and in vivo measured TME's ATP. The immune infiltrate of tumors growing in P2X7 null mice shows a decrease in CD8(+) cells and an increased number of Tregs, overexpressing the fitness markers OX40, PD-1, and CD73. A similar Treg phenotype is also present in the spleen of tumor-bearing P2X7 null mice and it is paralleled by a decrease in proinflammatory cytokines and an increase in TGF-beta. Differently, systemic administration of the P2X7 blocker A740003 in wild-type mice left unaltered the number of tumor-infiltrating CD8(+) and Treg lymphocytes but increased CD4(+) effector cells and decreased their expression of CD39 and CD73. P2X7 blockade did not affect spleen immune cell composition or ectonucleotidase expression but increased circulating INF-gamma. Augmented CD73 in P2X7 null mice was mirrored by a decrease in TME ATP concentration and nucleotide reduced secretion from immune cells. On the contrary, TME ATP levels remained unaltered upon P2X7 antagonism, owing to release of ATP from cancerous cells and diminished ectonucleotidase expression by CD4(+) and dendritic cells. These data point at P2X7 receptor as a key determinant of TME composition due to its combined action on immune cell infiltrate, ectonucleotidases, and ATP release.	[De Marchi, Elena; Orioli, Elisa; Pegoraro, Anna; Di Virgilio, Francesco; Adinolfi, Elena] Univ Ferrara, Sect Pathol Oncol & Expt Biol, Dept Morphol Surg & Expt Med, Via Luigi Borsari 46, I-44121 Ferrara, Italy; [Sangaletti, Sabina; Portararo, Paola; Colombo, Mario Paolo] Ist Nazl Tumori IRCCS, Mol Immunol Unit, Dept Expt Oncol, Via Amadeo 42, I-20133 Milan, Italy; [Curti, Antonio] Univ Bologna, S Orsola Malpighi Hosp, Inst Hematol L & A Seragnoli, Dept Expt Diagnost & Specialty Med, Via Massarenti 9, I-40138 Bologna, Italy	University of Ferrara; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Adinolfi, E (corresponding author), Univ Ferrara, Sect Pathol Oncol & Expt Biol, Dept Morphol Surg & Expt Med, Via Luigi Borsari 46, I-44121 Ferrara, Italy.	elena.adinolfi@unife.it	DI VIRGILIO, Francesco/O-4634-2019; Di Virgilio, Francesco/J-3754-2018; Sangaletti, Sabina/AAB-5873-2019; Adinolfi, Elena/F-9169-2010; Colombo, Mario P./V-7166-2017; Portararo, Paola/P-8231-2019; Curti, Antonio/AAB-9461-2019; Pegoraro, Anna/AAC-4573-2022; Pegoraro, Anna/AAV-7894-2021	DI VIRGILIO, Francesco/0000-0003-3566-1362; Di Virgilio, Francesco/0000-0003-3566-1362; Sangaletti, Sabina/0000-0001-7047-287X; Adinolfi, Elena/0000-0001-8129-9929; Colombo, Mario P./0000-0003-0042-7955; Portararo, Paola/0000-0003-0085-6901; Curti, Antonio/0000-0002-7752-6049; De Marchi, Elena/0000-0003-0064-4335; Pegoraro, Anna/0000-0002-7045-5161	Italian Association for Cancer Research Investigator Grant (AIRC) [IG 16812, IG 13025, IG 18581]	Italian Association for Cancer Research Investigator Grant (AIRC)(Fondazione AIRC per la ricerca sul cancro)	The authors thank Marzia Scarletti, Federica Poletti, and Asia Milani for technical assistance. This study was funded by an Italian Association for Cancer Research Investigator Grant to EA (AIRC, IG 16812) and to FDV (AIRC, IG 13025 and IG 18581).	Adinolfi E, 2005, MOL BIOL CELL, V16, P3260, DOI 10.1091/mbc.E04-11-1025; Adinolfi E, 2018, BIOCHEM PHARMACOL, V151, P234, DOI 10.1016/j.bcp.2017.12.021; Adinolfi E, 2015, CANCER RES, V75, P635, DOI 10.1158/0008-5472.CAN-14-1259; Adinolfi E, 2012, CANCER RES, V72, P2957, DOI 10.1158/0008-5472.CAN-11-1947; Adinolfi E, 2010, FASEB J, V24, P3393, DOI 10.1096/fj.09-153601; Adinolfi E, 2009, J BIOL CHEM, V284, P10120, DOI 10.1074/jbc.M805805200; Allard B, 2017, IMMUNOL REV, V276, P121, DOI 10.1111/imr.12528; Allard D., 2018, IMMUNOL LETT; Amores-Iniesta J, 2017, CELL REP, V21, P3414, DOI 10.1016/j.celrep.2017.11.079; Amoroso F, 2015, ONCOGENE, V34, P5240, DOI 10.1038/onc.2014.444; Amoroso F, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.105; Amoroso F, 2016, ONCOTARGET, V7, P49664, DOI 10.18632/oncotarget.10430; Anderson KG, 2017, CANCER CELL, V31, P311, DOI 10.1016/j.ccell.2017.02.008; Savio LEB, 2017, MOL NEUROBIOL, V54, P6459, DOI 10.1007/s12035-016-0168-9; Baroni M, 2007, FASEB J, V21, P1926, DOI 10.1096/fj.06-7238com; Buchan SL, 2018, BLOOD, V131, P39, DOI 10.1182/blood-2017-07-741025; Castro F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00847; Colombo MP, 2017, CLIN CANCER RES, V23, P5999, DOI 10.1158/1078-0432.CCR-17-2332; De Marchi E, 2016, ADV PROTEIN CHEM STR, V104, P39, DOI 10.1016/bs.apcsb.2015.11.004; Di Virgilio F, 2017, ONCOGENE, V36, P293, DOI 10.1038/onc.2016.206; Di Virgilio F, 2018, NAT REV CANCER, V18, P601, DOI 10.1038/s41568-018-0037-0; Di Virgilio F, 2017, IMMUNITY, V47, P15, DOI 10.1016/j.immuni.2017.06.020; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Furler RL, 2018, CANCERS, V10, DOI 10.3390/cancers10060199; Giannuzzo A, 2016, INT J CANCER, V139, P2540, DOI 10.1002/ijc.30380; Giuliani AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107224; Gulinelli S, 2012, EUR J IMMUNOL, V42, P3334, DOI 10.1002/eji.201142268; Hattori F, 2012, EUR J PHARMACOL, V695, P20, DOI 10.1016/j.ejphar.2012.09.001; Hofman P, 2015, CANCER RES, V75, P835, DOI 10.1158/0008-5472.CAN-14-1778; Honore P, 2006, J PHARMACOL EXP THER, V319, P1376, DOI 10.1124/jpet.106.111559; Hyman MC, 2009, J CLIN INVEST, V119, P1136, DOI 10.1172/JCI36433; Janssen B, 2014, J LABELLED COMPD RAD, V57, P509, DOI 10.1002/jlcr.3206; Kepp O, 2017, IMMUNOL REV, V280, P83, DOI 10.1111/imr.12571; Kuhny M, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0040-3; Lecciso M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01918; Lemaire I, 2006, J IMMUNOL, V177, P7257, DOI 10.4049/jimmunol.177.10.7257; Lemaire I, 2011, J IMMUNOL, V187, P3878, DOI 10.4049/jimmunol.1002780; Levesque SA, 2010, EUR J IMMUNOL, V40, P1473, DOI 10.1002/eji.200939741; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Orioli E, 2017, CURR MED CHEM, V24, P2261, DOI 10.2174/0929867324666170303161659; Pellegatti P, 2005, MOL BIOL CELL, V16, P3659, DOI 10.1091/mbc.E05-03-0222; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Piconese S, 2010, EUR J IMMUNOL, V40, P2902, DOI 10.1002/eji.201040505; Pietrocola F, 2016, CANCER CELL, V30, P147, DOI 10.1016/j.ccell.2016.05.016; Pizzirani C, 2007, BLOOD, V109, P3856, DOI 10.1182/blood-2005-06-031377; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Salaro E, 2016, SCI REP-UK, V6, DOI 10.1038/srep26280; Shitara K, 2018, ANN NY ACAD SCI, V1417, P104, DOI 10.1111/nyas.13625; Syberg S, 2012, J OSTEOPOROS, V2012, DOI 10.1155/2012/391097; Vandenabeele P, 2016, ADV EXP MED BIOL, V930, P133, DOI 10.1007/978-3-319-39406-0_6; Vijayan D, 2017, NAT REV CANCER, V17, P765, DOI 10.1038/nrc.2017.110; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Yang DH, 2015, IMMUNITY, V43, P923, DOI 10.1016/j.immuni.2015.10.009; Younas M, 2013, J IMMUNOL, V191, P3161, DOI 10.4049/jimmunol.1203547; 2018, NATURE, V559, P264, DOI DOI 10.1038/S41586-018-0282-0	55	100	100	2	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 9	2019	38	19					3636	3650		10.1038/s41388-019-0684-y	http://dx.doi.org/10.1038/s41388-019-0684-y			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HX4OU	30655604	Green Published, hybrid			2022-12-26	WOS:000467379600006
J	Mancuso, P; Tricarico, R; Bhattacharjee, V; Cosentino, L; Kadariya, Y; Jelinek, J; Nicolas, E; Einarson, M; Beeharry, N; Devarajan, K; Katz, RA; Dorjsuren, DG; Sun, H; Simeonov, A; Giordano, A; Testa, JR; Davidson, G; Davidson, I; Larue, L; Sobol, RW; Yen, TJ; Bellacosa, A				Mancuso, Pietro; Tricarico, Rossella; Bhattacharjee, Vikram; Cosentino, Laura; Kadariya, Yuwaraj; Jelinek, Jaroslav; Nicolas, Emmanuelle; Einarson, Margret; Beeharry, Neil; Devarajan, Karthik; Katz, Richard A.; Dorjsuren, Dorjbal G.; Sun, Hongmao; Simeonov, Anton; Giordano, Antonio; Testa, Joseph R.; Davidson, Guillaume; Davidson, Irwin; Larue, Lionel; Sobol, Robert W.; Yen, Timothy J.; Bellacosa, Alfonso			Thymine DNA glycosylase as a novel target for melanoma	ONCOGENE			English	Article							BASE EXCISION-REPAIR; TRANSCRIPTION FACTOR; READ ALIGNMENT; SENESCENCE; DEMETHYLATION; MUTATIONS; GENES; 5-HYDROXYMETHYLCYTOSINE; 5-CARBOXYLCYTOSINE; DISCOVERY	Melanoma is an aggressive neoplasm with increasing incidence that is classified by the NCI as a recalcitrant cancer, i.e., a cancer with poor prognosis, lacking progress in diagnosis and treatment. In addition to conventional therapy, melanoma treatment is currently based on targeting the BRAF/MEK/ERK signaling pathway and immune checkpoints. As drug resistance remains a major obstacle to treatment success, advanced therapeutic approaches based on novel targets are still urgently needed. We reasoned that the base excision repair enzyme thymine DNA glycosylase (TDG) could be such a target for its dual role in safeguarding the genome and the epigenome, by performing the last of the multiple steps in DNA demethylation. Here we show that TDG knockdown in melanoma cell lines causes cell cycle arrest, senescence, and death by mitotic alterations; alters the transcriptome and methylome; and impairs xenograft tumor formation. Importantly, untransformed melanocytes are minimally affected by TDG knockdown, and adult mice with conditional knockout of Tdg are viable. Candidate TDG inhibitors, identified through a high-throughput fluorescence-based screen, reduced viability and clonogenic capacity of melanoma cell lines and increased cellular levels of 5-carboxylcytosine, the last intermediate in DNA demethylation, indicating successful on-target activity. These findings suggest that TDG may provide critical functions specific to cancer cells that make it a highly suitable anti-melanoma drug target. By potentially disrupting both DNA repair and the epigenetic state, targeting TDG may represent a completely new approach to melanoma therapy.	[Mancuso, Pietro; Tricarico, Rossella; Cosentino, Laura; Nicolas, Emmanuelle; Einarson, Margret; Katz, Richard A.; Bellacosa, Alfonso] Fox Chase Canc Ctr, Canc Epigenet Program, 333 Cottman Ave, Philadelphia, PA 19111 USA; [Mancuso, Pietro; Giordano, Antonio] Univ Siena, Dept Med Biotechnol, Siena, Italy; [Mancuso, Pietro] PSL Res Univ, Inst Curie, INSERM, U1021 Normal & Pathol Dev Melanocytes, F-91405 Orsay, France; [Bhattacharjee, Vikram; Kadariya, Yuwaraj; Beeharry, Neil; Testa, Joseph R.; Yen, Timothy J.] Fox Chase Canc Ctr, Canc Biol Program, 333 Cottman Ave, Philadelphia, PA 19111 USA; [Jelinek, Jaroslav] Temple Univ, Sch Med, Fels Inst Canc & Mol Biol, Philadelphia, PA 19140 USA; [Devarajan, Karthik] Fox Chase Canc Ctr, Dept Biostat, 333 Cottman Ave, Philadelphia, PA 19111 USA; [Dorjsuren, Dorjbal G.; Sun, Hongmao; Simeonov, Anton] NIH, Div Preclin Innovat, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA; [Giordano, Antonio] Temple Univ, Coll Sci & Technol, Dept Biol, Sbarro Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA; [Davidson, Guillaume; Davidson, Irwin] ULP, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Davidson, Irwin; Larue, Lionel] Equipe Labellisee Ligue Canc, Orsay, France; [Larue, Lionel] Univ Paris Saclay, Univ Paris Sud, CNRS, UMR3347, Orsay, France; [Sobol, Robert W.] Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, Mobile, AL 36604 USA	Fox Chase Cancer Center; University of Siena; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Fox Chase Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Fox Chase Cancer Center; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; University of South Alabama	Bellacosa, A (corresponding author), Fox Chase Canc Ctr, Canc Epigenet Program, 333 Cottman Ave, Philadelphia, PA 19111 USA.	Alfonso.Bellacosa@fccc.edu	Mancuso, Pietro/J-1636-2019; Sobol, Robert/E-4125-2013; Giordano, Antonio/F-1927-2010	Sobol, Robert/0000-0001-7385-3563; TRICARICO, ROSSELLA/0000-0001-7055-7208; Davidson, Guillaume/0000-0001-9272-3924; Davidson, Irwin/0000-0001-5533-1171; Giordano, Antonio/0000-0002-5959-016X	Edwards Family; David A. Hungerford Endowed Fund in Basic Chromosome Research; NIH [CA78412, CA191956, CA06927]; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH); PA Department of Health C.U.R.E.; Commonwealth of Pennsylvania; INCa Project [PLBIO11-027]; William J. Avery Endowed Postdoctoral Fellowship; National Institutes of Health [CA148629, ES025138]; Ligue Nationale Contre le Cancer; INCa; ITMO cancer; program "Investissements d'Avenir" [ANR-11-LBX-0038, ANR-10-IDEX-0001-02 PSL]; Ligue National contre le cancer; Labex INRT [ANR-10-IDEX-0001-02]; IGBMC high-throughput sequencing facility, a member of "France Genomique" consortium [ANR10-INBS-09-08]; NATIONAL CANCER INSTITUTE [R01CA175691, P30CA006927, R21CA191956, R50CA211479, R01CA148629] Funding Source: NIH RePORTER	Edwards Family; David A. Hungerford Endowed Fund in Basic Chromosome Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); PA Department of Health C.U.R.E.; Commonwealth of Pennsylvania; INCa Project; William J. Avery Endowed Postdoctoral Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); INCa(Institut National du Cancer (INCA) France); ITMO cancer; program "Investissements d'Avenir"(French National Research Agency (ANR)); Ligue National contre le cancer(Ligue nationale contre le cancer); Labex INRT; IGBMC high-throughput sequencing facility, a member of "France Genomique" consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. P. Abbosh and Dr. I. Astsaturov for critical reading of the manuscript; Dr. R. Zaidi for comments and advice; L. Cathay for secretarial assistance; and John and Robin Spurlino and the Edwards Family for their generous support of this research. We would like to thank Alice M. Hungerford for her philanthropic funding through the David A. Hungerford Endowed Fund in Basic Chromosome Research, honoring her late husband's legacy as a renowned scientist and the co-discoverer of the Philadelphia Chromosome. We thank the following core services at Fox Chase Cancer Center: Genomics, Cell Culture, Cell Sorting, Biological Imaging, High-Throughput Screening, Biostatistics and Bioinformatics, and Laboratory Animal Facilities. This study was supported by NIH grants CA78412 (to A. Bellacosa), CA191956 (to A. Bellacosa and T. Yen), and CA06927; the intramural research program of the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), PA Department of Health C.U.R.E. and an appropriation from the Commonwealth of Pennsylvania to the Fox Chase Cancer Center. PM was supported in part by INCa Project PLBIO11-027. RT was supported in part by a William J. Avery Endowed Postdoctoral Fellowship. RWS was supported by grants from the National Institutes of Health (CA148629 and ES025138) and is an Abraham A. Mitchell Distinguished Investigator. LL was supported by a grant from Ligue Nationale Contre le Cancer, INCa, ITMO cancer, and is under the program "Investissements d'Avenir" launched by the French Government and implemented by ANR Labex CelTisPhyBio (ANR-11-LBX-0038 and ANR-10-IDEX-0001-02 PSL). Work in the laboratory of ID was supported by grants from the INCa, the Ligue National contre le cancer, and the Labex INRT (ANR-10-IDEX-0001-02). RNA-seq was performed at the IGBMC high-throughput sequencing facility, a member of "France Genomique" consortium (ANR10-INBS-09-08). LL and ID are "equipes labelisees of the Ligue National Contre le cancer." AB would like to dedicate this article to the memory of his mother Maria, who showed that strength and tenderness, elegance and simplicity, resilience and joyfulness can coexist, and who will be missed tremendously.	Arantes-Rodrigues R, 2012, LAB ANIMAL, V41, P129, DOI 10.1038/laban0512-129; Bandyopadhyay D, 2002, CANCER RES, V62, P6231; Beeharry N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040342; Bellacosa A, 2015, DNA REPAIR, V32, P33, DOI 10.1016/j.dnarep.2015.04.011; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Chong CR, 2006, NAT CHEM BIOL, V2, P415, DOI 10.1038/nchembio806; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Dalton SR, 2012, EPIGENOMICS-UK, V4, P459, DOI [10.2217/EPI.12.36, 10.2217/epi.12.36]; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Eichenbaum G, 2011, J APPL TOXICOL, V31, P342, DOI 10.1002/jat.1592; Fitzgerald ME, 2008, J BIOL CHEM, V283, P32680, DOI 10.1074/jbc.M805504200; Gambichler T, 2013, MELANOMA RES, V23, P218, DOI 10.1097/CMR.0b013e32835f9bd4; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Giuliano S, 2011, PIGM CELL MELANOMA R, V24, P295, DOI 10.1111/j.1755-148X.2010.00820.x; Giuliano S, 2010, CANCER RES, V70, P3813, DOI 10.1158/0008-5472.CAN-09-2913; Goding CR, 2016, CANCER CELL, V29, P619, DOI 10.1016/j.ccell.2016.04.010; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Ha GH, 2009, CELL DEATH DIFFER, V16, P483, DOI 10.1038/cdd.2008.182; Hayward NK, 2017, NATURE, V545, P175, DOI 10.1038/nature22071; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Henry RA, 2016, BIOCHEMISTRY-US, V55, P6766, DOI 10.1021/acs.biochem.6b00841; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Huang JM, 2017, DERMATOL CLIN, V35, P85, DOI 10.1016/j.det.2016.08.001; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Jelinek J, 2012, EPIGENETICS-US, V7, P1368, DOI 10.4161/epi.22552; Joshi S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006600; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Krauthammer M, 2015, NAT GENET, V47, P996, DOI 10.1038/ng.3361; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leucci E, 2016, NATURE, V531, P518, DOI 10.1038/nature17161; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Ohanna M, 2011, GENE DEV, V25, P1245, DOI 10.1101/gad.625811; Petronzelli F, 2000, J BIOL CHEM, V275, P32422, DOI 10.1074/jbc.M004535200; Prieur A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1473; Rambow F, 2015, CELL REP, V13, P840, DOI 10.1016/j.celrep.2015.09.037; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sato S, 1997, ONCOGENE, V14, P3083, DOI 10.1038/sj.onc.1201298; Sato T, 2017, CANCER RES, V77, P470, DOI 10.1158/0008-5472.CAN-16-0834; Shikama N, 1997, TRENDS CELL BIOL, V7, P230, DOI 10.1016/S0962-8924(97)01048-9; Song FJ, 2014, CARCINOGENESIS, V35, P2097, DOI 10.1093/carcin/bgu140; Strub T, 2011, ONCOGENE, V30, P2319, DOI 10.1038/onc.2010.612; Svilar D, 2012, JOVE-J VIS EXP, DOI 10.3791/4168; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Turner DP, 2006, CANCER RES, V66, P7686, DOI 10.1158/0008-5472.CAN-05-4488; Xu JF, 2017, ONCOTARGET, V8, P89988, DOI 10.18632/oncotarget.21219; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; 2003, AM J PATHOL, V163, P333	61	22	22	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 9	2019	38	19					3710	3728		10.1038/s41388-018-0640-2	http://dx.doi.org/10.1038/s41388-018-0640-2			19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HX4OU	30674989	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000467379600011
J	Isaji, T; Im, S; Kameyama, A; Wang, YQ; Fukuda, T; Gu, JG				Isaji, Tomoya; Im, Sanghun; Kameyama, Akihiko; Wang, Yuqin; Fukuda, Tomohiko; Gu, Jianguo			A complex between phosphatidylinositol 4-kinase II alpha and integrin alpha 3 beta 1 is required for N-glycan sialylation in cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycobiology; integrin; phosphatidylinositol kinase (PI kinase); sialic acid; glycosylation; epithelial-mesenchymal transition (EMT); integrin 31; phosphatidylinositol 4-kinase II; posttranslational modification; sialylation	BETA-PROPELLER DOMAIN; BREAST-CANCER; GOLGI LOCALIZATION; ADHESION; GLYCOSYLATION; EXPRESSION; GROWTH; PROTEIN; GOLPH3; GLYCOSYLTRANSFERASES	Aberrant N-glycan sialylation of glycoproteins is closely associated with malignant phenotypes of cancer cells and metastatic potential, which includes cell adhesion, migration, and growth. Recently, phosphatidylinositol 4-kinase II (PI4KII), which is localized to the trans-Golgi network, was identified as a regulator of Golgi phosphoprotein 3 (GOLPH3) and of vesicle transport in the Golgi apparatus. GOLPH3 is a target of PI4KII and helps anchor sialyltransferases and thereby regulates sialylation of cell surface receptors. However, how PI4KII-mediated sialyation of cell surface proteins is regulated remains unclear. In this study, using several cell lines, CRISPR/Cas9-based gene knockout and short hairpin RNA-mediated silencing, RT-PCR, lentivirus-mediated overexpression, and immunoblotting methods, we confirmed that PI4KII knockdown suppresses the sialylation of N-glycans on the cell surface, in Akt phosphorylation and activation, and integrin 3-mediated cell migration of MDA-MB-231 breast cancer cells. Interestingly, both integrin 31 and PI4KII co-localized to the trans-Golgi network, where they physically interacted with each other, and PI4KII specifically associated with integrin 3 but not 5. Furthermore, overexpression of both integrin 31 and PI4KII induced hypersialylation. Conversely, integrin 3 knockout significantly inhibited the sialylation of membrane proteins, such as the epidermal growth factor receptor, as well as in total cell lysates. These findings suggest that the malignant phenotype of cancer cells is affected by a sialylation mechanism that is regulated by a complex between PI4KII and integrin 31.	[Isaji, Tomoya; Im, Sanghun; Fukuda, Tomohiko; Gu, Jianguo] Tohoku Med & Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan; [Kameyama, Akihiko] Natl Inst Adv Ind Sci & Technol, Dept Life Sci & Biotechnol, 1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan; [Wang, Yuqin] Nantong Univ, Dept Pharmacol, Coll Pharm, Nantong 226001, Jiangsu, Peoples R China	Tohoku Medical & Pharmaceutical University; National Institute of Advanced Industrial Science & Technology (AIST); Nantong University	Gu, JG (corresponding author), Tohoku Med & Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-mpu.ac.jp	Gu, Jianguo/ABC-9257-2020; Isaji, Tomoya/ABC-9285-2021		Japan Society for the Promotion of Science, National Natural Science Foundation of China [15H04354, JP17H03808]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [31670807, 18H04868]	Japan Society for the Promotion of Science, National Natural Science Foundation of China; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research 15H04354 (to J. G.) and JP17H03808 (to A. K.) from the Japan Society for the Promotion of Science, National Natural Science Foundation of China Grant 31670807, and Grant-in-Aid for Scientific Research on Innovative Areas 18H04868 (to J. G.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Ali MF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.346528; Balla A, 2005, MOL BIOL CELL, V16, P1282, DOI 10.1091/mbc.E04-07-0578; Baumlova A, 2014, EMBO REP, V15, P1085, DOI 10.15252/embr.201438841; Berditchevski F, 1997, J BIOL CHEM, V272, P2595, DOI 10.1074/jbc.272.5.2595; Bhide GP, 2017, HISTOCHEM CELL BIOL, V147, P149, DOI 10.1007/s00418-016-1520-x; Boura E, 2015, EXP CELL RES, V337, P136, DOI 10.1016/j.yexcr.2015.03.028; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Cagnet S, 2014, ONCOGENE, V33, P4286, DOI 10.1038/onc.2013.391; Christie DR, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-3; Chu KME, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.84; Clayton EL, 2013, PROG LIPID RES, V52, P294, DOI 10.1016/j.plipres.2013.04.002; Coleman DT, 2016, ONCOTARGET, V7, P32664, DOI 10.18632/oncotarget.8706; D'Angelo G, 2008, J CELL SCI, V121, P1955, DOI 10.1242/jcs.023630; Dall'Olio F, 2014, BBA-GEN SUBJECTS, V1840, P2752, DOI 10.1016/j.bbagen.2014.06.006; Dalziel M, 2004, EUR J BIOCHEM, V271, P3623, DOI 10.1111/j.1432-1033.2004.04284.x; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Dogic D, 1998, J CELL SCI, V111, P793; Eckert ESP, 2014, J BIOL CHEM, V289, P31319, DOI 10.1074/jbc.M114.608182; Goldfinger LE, 1999, J CELL SCI, V112, P2615; Grabenhorst E, 1999, J BIOL CHEM, V274, P36107, DOI 10.1074/jbc.274.51.36107; Grottke A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146370; Guo HB, 2002, CANCER RES, V62, P6837; Hang QL, 2016, SCI REP-UK, V6, DOI 10.1038/srep33507; Hasehira K, 2017, GLYCOCONJUGATE J, V34, P797, DOI 10.1007/s10719-016-9699-6; Hedlund M, 2008, CANCER RES, V68, P388, DOI 10.1158/0008-5472.CAN-07-1340; Hou S, 2016, FASEB J, V30, P4120, DOI 10.1096/fj.201600665R; Hou S, 2016, SCI REP-UK, V6, DOI 10.1038/srep18430; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Isaji T, 2014, J BIOL CHEM, V289, P20694, DOI 10.1074/jbc.M113.542688; Itakura Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061160; JONJIC N, 1993, PATHOL RES PRACT, V189, P979; Kameyama A, 2019, BBA-PROTEINS PROTEOM, V1867, P76, DOI 10.1016/j.bbapap.2018.05.006; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Li J, 2010, ONCOGENE, V29, P2550, DOI 10.1038/onc.2010.14; Lin SQ, 2002, EXP CELL RES, V276, P101, DOI 10.1006/excr.2002.5521; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; Lu DM, 2012, J BIOL CHEM, V287, P21856, DOI 10.1074/jbc.M112.348094; Lu JS, 2016, J BIOL CHEM, V291, P5708, DOI 10.1074/jbc.M115.712836; Lu JS, 2015, MOLECULES, V20, P7509, DOI 10.3390/molecules20057509; Lu JS, 2014, J BIOL CHEM, V289, P34627, DOI 10.1074/jbc.M114.593392; Maeda Y, 2008, NAT CELL BIOL, V10, P1135, DOI 10.1038/ncb1773; Matoba K, 2017, CELL REP, V18, P32, DOI 10.1016/j.celrep.2016.12.017; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Minogue S, 2006, J CELL SCI, V119, P571, DOI 10.1242/jcs.02752; Mitchell K, 2010, CANCER RES, V70, P6359, DOI 10.1158/0008-5472.CAN-09-4283; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moravcevic K, 2012, STRUCTURE, V20, P15, DOI 10.1016/j.str.2011.11.012; Morini M, 2000, INT J CANCER, V87, P336, DOI 10.1002/1097-0215(20000801)87:3<336::AID-IJC5>3.0.CO;2-3; Morrow AA, 2014, MOL CANCER RES, V12, P1492, DOI 10.1158/1541-7786.MCR-13-0604; Ng MM, 2013, MOL BIOL CELL, V24, P796, DOI 10.1091/mbc.E12-07-0525; Nishikaze T, 2017, ANAL CHEM, V89, P2353, DOI 10.1021/acs.analchem.6b04150; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Pereira NA, 2014, J BIOL CHEM, V289, P14762, DOI 10.1074/jbc.M114.548305; Qin YB, 2009, J BIOL CHEM, V284, P22544, DOI 10.1074/jbc.M109.014399; RABOUILLE C, 1995, J CELL SCI, V108, P1617; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sato Y, 2001, J BIOL CHEM, V276, P11956, DOI 10.1074/jbc.M008551200; Sato Y, 2009, J BIOL CHEM, V284, P11873, DOI 10.1074/jbc.M807660200; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Seales EC, 2003, ONCOGENE, V22, P7137, DOI 10.1038/sj.onc.1206834; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Swindall AF, 2013, CANCER RES, V73, P2368, DOI 10.1158/0008-5472.CAN-12-3424; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Tanabe K, 2006, ANAL BIOCHEM, V348, P324, DOI 10.1016/j.ab.2005.10.035; Tokuda E, 2014, CANCER RES, V74, P3054, DOI 10.1158/0008-5472.CAN-13-2441; Toyoda M, 2016, GLYCOCONJUGATE J, V33, P917, DOI 10.1007/s10719-016-9700-4; Varki A, 2015, ESSENTIALS GLYCOBIOL, DOI DOI 10.1101/GLYCOBIOLOGY.3E.047; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Wang YC, 2015, 2015 14TH IAPR INTERNATIONAL CONFERENCE ON MACHINE VISION APPLICATIONS (MVA), P1, DOI 10.1109/MVA.2015.7153119; Weixel KM, 2005, J BIOL CHEM, V280, P10501, DOI 10.1074/jbc.M414304200; Woodard-Grice AV, 2008, J BIOL CHEM, V283, P26364, DOI 10.1074/jbc.M800836200; Yamabhai M, 2002, J BIOL CHEM, V277, P24843, DOI 10.1074/jbc.C200277200; Yanagida K, 1999, ANAL BIOCHEM, V274, P229, DOI 10.1006/abio.1999.4263; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Yao ES, 2007, CANCER RES, V67, P659, DOI 10.1158/0008-5472.CAN-06-2768; Yauch RL, 1998, MOL BIOL CELL, V9, P2751, DOI 10.1091/mbc.9.10.2751; Yauch RL, 2000, BIOCHEM J, V351, P629, DOI 10.1042/0264-6021:3510629; Ye X, 2015, TRENDS CELL BIOL, V25, P675, DOI 10.1016/j.tcb.2015.07.012; Zeng ZL, 2012, CLIN CANCER RES, V18, P4059, DOI 10.1158/1078-0432.CCR-11-3156; Zhou QJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4552; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200	88	14	15	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4425	4436		10.1074/jbc.RA118.005208	http://dx.doi.org/10.1074/jbc.RA118.005208			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30659093	Green Published, hybrid			2022-12-26	WOS:000462969500012
J	Koyama, Y; Sumie, S; Nakano, Y; Nagao, T; Tokumaru, S; Michinaga, S				Koyama, Yutaka; Sumie, Satoshi; Nakano, Yasutaka; Nagao, Tomoya; Tokumaru, Shiho; Michinaga, Shotaro			Endothelin-1 stimulates expression of cyclin D1 and S-phase kinase-associated protein 2 by activating the transcription factor STAT3 in cultured rat astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						astrocyte; STAT3; cell cycle; cyclin D1; gene transcription; endothelin; neurobiology; astrocytic activation; SKP2; G1; S phase transition; brain injury; nerve damage	SPINAL-CORD; SCAR FORMATION; SERINE PHOSPHORYLATION; REACTIVE ASTROCYTES; CEREBRAL-ISCHEMIA; NEUROPATHIC PAIN; D3 EXPRESSION; DUAL ROLE; IN-VITRO; PROLIFERATION	Brain injury-mediated induction of reactive astrocytes often leads to glial scar formation in damaged brain regions. Activation of signal transducer and activator of transcription 3 (STAT3), a member of the STAT family of transcription factors, plays a pivotal role in inducing reactive astrocytes and glial scar formation. Endothelin-1 (ET-1) is a vasoconstrictor peptide, and its levels increase in brain disorders and promote astrocytic proliferation through ETB receptors. To clarify the mechanisms underlying ET-1-mediated astrocytic proliferation, here we examined its effects on STAT3 in cultured rat astrocytes. ET-1 treatment stimulated Ser-727 phosphorylation of STAT3 in the astrocytes, but Tyr-705 phosphorylation was unaffected, and ET-induced STAT3 Ser-727 phosphorylation was reduced by the ETB antagonist BQ788. ET-1 stimulated STAT3 binding to its consensus DNA-binding motifs. Monitoring G(1)/S phase cell cycle transition through bromodeoxyuridine (BrdU) incorporation, we found that ET-1 increases BrdU incorporation into the astrocytic nucleus, indicating cell cycle progression. Of note, STAT3 chemical inhibition (with stattic or 5,15-diphenyl-porphine (5,15-DPP)) or siRNA-mediated STAT3 silencing reduced ET-induced BrdU incorporation. Moreover, ET-1 increased astrocytic expression levels of cyclin D1 and S-phase kinase-associated protein 2 (SKP2), which were reduced by stattic, 5,15-DPP, and STAT3 siRNA. ChIP-based PCR analysis revealed that ET-1 promotes the binding of SAT3 to the 5-flanking regions of rat cyclin D1 and SKP2 genes. Our results suggest that STAT3-mediated regulation of cyclin D1 and SKP2 expression underlies ET-induced astrocytic proliferation.	[Koyama, Yutaka] Kobe Pharmaceut Univ, Pharmacol Lab, Higashinada Ku, 4-19-1 Motoyamakita, Kobe, Hyogo 6588558, Japan; [Sumie, Satoshi; Nakano, Yasutaka; Nagao, Tomoya; Tokumaru, Shiho; Michinaga, Shotaro] Osaka Ohtani Univ, Fac Pharm, Pharmacol Lab, Kita Ku, 3-11-1 Nishikiori, Tondabayashi, Osaka 5848540, Japan	Kobe Pharmaceutical University	Koyama, Y (corresponding author), Kobe Pharmaceut Univ, Pharmacol Lab, Higashinada Ku, 4-19-1 Motoyamakita, Kobe, Hyogo 6588558, Japan.	koyama-y@kobepharma-u.ac.jp		Koyama, Yutaka/0000-0002-6508-0094	MEXT/Japan Society for the Promotion of Science (JSPS) [15K07981]	MEXT/Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by MEXT/Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (C) 15K07981 (to Y. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Aziz MH, 2007, CANCER RES, V67, P8828, DOI 10.1158/0008-5472.CAN-07-1604; Ben Haim L, 2015, J NEUROSCI, V35, P2817, DOI 10.1523/JNEUROSCI.3516-14.2015; Booz GW, 2002, MOL CELL BIOCHEM, V240, P39, DOI 10.1023/A:1020648425895; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Ceyzeriat K, 2016, NEUROSCIENCE, V330, P205, DOI 10.1016/j.neuroscience.2016.05.043; Chelsky ZL, 2015, MOL PHARMACOL, V88, P524, DOI 10.1124/mol.115.099093; Choi JS, 2003, GLIA, V41, P237, DOI 10.1002/glia.10186; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; Gorshkov K, 2018, DRUG DISCOV TODAY, V23, P673, DOI 10.1016/j.drudis.2018.01.011; Hernandez-Negrete I, 2011, BIOCHEM J, V436, P133, DOI 10.1042/BJ20101798; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hostenbach S, 2016, PROG NEUROBIOL, V144, P88, DOI 10.1016/j.pneurobio.2016.04.009; Huang HH, 2012, BIOCHEM BIOPH RES CO, V418, P186, DOI 10.1016/j.bbrc.2012.01.004; Ishikawa N, 1997, EUR J NEUROSCI, V9, P895, DOI 10.1111/j.1460-9568.1997.tb01440.x; Justicia C, 2000, GLIA, V30, P253, DOI 10.1002/(SICI)1098-1136(200005)30:3<253::AID-GLIA5>3.0.CO;2-O; Kitazawa S, 1999, J BIOL CHEM, V274, P28787, DOI 10.1074/jbc.274.40.28787; Koyama Y, 2004, J NEUROCHEM, V90, P904, DOI 10.1111/j.1471-4159.2004.02546.x; Koyama Y, 1999, GLIA, V26, P268, DOI 10.1002/(SICI)1098-1136(199905)26:3<268::AID-GLIA8>3.0.CO;2-G; Koyama Y, 2012, GLIA, V60, P1954, DOI 10.1002/glia.22411; Koyama Y, 2012, J PHARMACOL SCI, V118, P401, DOI 10.1254/jphs.11R13CP; Kuroki M, 1999, BIOCHEM J, V341, P691, DOI 10.1042/0264-6021:3410691; LeComte MD, 2015, P NATL ACAD SCI USA, V112, P8726, DOI 10.1073/pnas.1501029112; Lim CP, 1999, J BIOL CHEM, V274, P31055, DOI 10.1074/jbc.274.43.31055; Liu YH, 2010, J NEUROTRAUM, V27, P361, DOI 10.1089/neu.2008.0581; Liu ZW, 2016, PROG NEUROBIOL, V144, P103, DOI 10.1016/j.pneurobio.2015.09.008; Lu JQ, 2013, J NEUROPATH EXP NEUR, V72, P1135, DOI 10.1097/NEN.0000000000000011; Michinaga S, 2018, J NEUROTRAUM, V35, P1481, DOI 10.1089/neu.2017.5421; Michinaga S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102009; Morga E, 2000, J NEUROCHEM, V74, P603, DOI 10.1046/j.1471-4159.2000.740603.x; Naito Y, 2014, LIFE SCI, V118, P340, DOI 10.1016/j.lfs.2014.03.012; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Oliva AA, 2012, J NEUROCHEM, V120, P710, DOI 10.1111/j.1471-4159.2011.07610.x; Ostrow LW, 2005, BRAIN RES REV, V48, P488, DOI 10.1016/j.brainresrev.2004.09.005; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Peters CM, 2003, EXP NEUROL, V180, P1, DOI 10.1016/S0014-4886(02)00023-7; Qin AC, 2015, BIOCHEM BIOPH RES CO, V457, P681, DOI 10.1016/j.bbrc.2015.01.048; Renault-Mihara F, 2017, J CELL BIOL, V216, P2533, DOI 10.1083/jcb.201610102; Rogers SD, 2003, GLIA, V41, P180, DOI 10.1002/glia.10173; Schuringa JJ, 2001, FEBS LETT, V495, P71, DOI 10.1016/S0014-5793(01)02354-7; Shi SX, 2007, J MOL NEUROSCI, V32, P64, DOI 10.1007/s12031-007-0015-6; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Teixeira A, 2000, J NEUROCHEM, V74, P1034, DOI 10.1046/j.1471-4159.2000.0741034.x; Tkach M, 2013, ENDOCR-RELAT CANCER, V20, P197, DOI 10.1530/ERC-12-0194; Tsuda M, 2011, BRAIN, V134, P1127, DOI 10.1093/brain/awr025; Tsunoda T, 1999, BIOINFORMATICS, V15, P622, DOI 10.1093/bioinformatics/15.7.622; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Washburn KB, 2006, NEUROSCIENCE, V142, P411, DOI 10.1016/j.neuroscience.2006.06.034; Wei Z, 2013, CELL SIGNAL, V25, P931, DOI 10.1016/j.cellsig.2013.01.011; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wu JF, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-169; Yamasaki R, 2016, J NEUROSCI, V36, P11929, DOI 10.1523/JNEUROSCI.1981-16.2016; Yeo S, 2013, GLIA, V61, P1488, DOI 10.1002/glia.22536; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhu Z, 2007, GLIA, V55, P546, DOI 10.1002/glia.20476	59	12	13	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					3920	3933		10.1074/jbc.RA118.005614	http://dx.doi.org/10.1074/jbc.RA118.005614			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30670587	hybrid, Green Published			2022-12-26	WOS:000461854400010
J	Masuda, Y; Kanao, R; Kawai, H; Kukimoto, I; Masutani, C				Masuda, Yuji; Kanao, Rie; Kawai, Hidehiko; Kukimoto, Iwao; Masutani, Chikahide			Preferential digestion of PCNA-ubiquitin and p53-ubiquitin linkages by USP7 to remove polyubiquitin chains from substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						deubiquitylation (deubiquitination); DNA damage response; enzyme kinetics; p53; proliferating cell nuclear antigen (PCNA)	MONOUBIQUITINATED PCNA; BINDING; DOMAIN; RECOGNITION; P53; DEUBIQUITINATION; MECHANISM; REVEALS; ZRANB3; LIGASE	Ubiquitin-specific protease 7 (USP7) regulates various cellular pathways through its deubiquitination activity. Despite the identification of a growing number of substrates of USP7, the molecular mechanism by which USP7 removes ubiquitin chains from polyubiquitinated substrates remains unexplored. The present study investigated the mechanism underlying the deubiquitination of Lys(63)-linked polyubiquitinated proliferating cell nuclear antigen (PCNA). Biochemical analyses demonstrated that USP7 efficiently removes polyubiquitin chains from polyubiquitinated PCNA by preferential cleavage of the PCNA-ubiquitin linkage. This property was largely attributed to the poor activity toward Lys(63)-linked ubiquitin chains. The preferential cleavage of substrate-ubiquitin linkages was also observed for Lys(48)-linked polyubiquitinated p53 because of the inefficient cleavage of the Lys(48)-linked ubiquitin chains. The present findings suggest a mechanism underlying the removal of polyubiquitin signals by USP7.	[Masuda, Yuji; Kanao, Rie; Masutani, Chikahide] Nagoya Univ, Res Inst Environm Med, Dept Genome Dynam, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan; [Masuda, Yuji; Kanao, Rie; Masutani, Chikahide] Nagoya Univ, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan; [Kawai, Hidehiko] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan; [Kukimoto, Iwao] Natl Inst Infect Dis, Pathogen Genom Ctr, 4-7-1 Gakuen, Tokyo 2080011, Japan	Nagoya University; Nagoya University; Hiroshima University; National Institute of Infectious Diseases (NIID)	Masuda, Y (corresponding author), Nagoya Univ, Res Inst Environm Med, Dept Genome Dynam, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	masuda@riem.nagoya-u.ac.jp	Masuda, Yuji/I-6315-2014; Masutani, Chikahide/I-6160-2014	Masuda, Yuji/0000-0002-6229-1988; Kawai, Hidehiko/0000-0003-2213-7166; Masutani, Chikahide/0000-0002-8600-8227	Japan Society for the Promotion of Science (JSPS) KAKENHI [15H02818, 18H03371, 16K12594, 18K11638]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [16H01775]; Takeda Science Foundation	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI 15H02818, 18H03371, and 16K12594 (to Y. M.) and 18K11638 (to R. K.); by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI 16H01775 (to C. M.); and by the Takeda Science Foundation (to R. K. and C. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bozza WP, 2012, BIOCHEMISTRY-US, V51, P10075, DOI 10.1021/bi3009104; Canning M, 2004, J BIOL CHEM, V279, P38160, DOI 10.1074/jbc.M402885200; Cheng JD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8023; Ciccia A, 2012, MOL CELL, V47, P396, DOI 10.1016/j.molcel.2012.05.024; Faesen AC, 2011, CHEM BIOL, V18, P1550, DOI 10.1016/j.chembiol.2011.10.017; Faesen AC, 2011, MOL CELL, V44, P147, DOI 10.1016/j.molcel.2011.06.034; Fernandez-Montalvan A, 2007, FEBS J, V274, P4256, DOI 10.1111/j.1742-4658.2007.05952.x; FUKUDA K, 1995, J BIOL CHEM, V270, P22527, DOI 10.1074/jbc.270.38.22527; Gilljam KM, 2009, J CELL BIOL, V186, P645, DOI 10.1083/jcb.200903138; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang AD, 2011, J MOL BIOL, V410, P424, DOI 10.1016/j.jmb.2011.04.051; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kashiwaba S, 2015, CELL REP, V13, P2072, DOI 10.1016/j.celrep.2015.11.014; Kategaya L, 2017, NATURE, V550, P534, DOI 10.1038/nature24006; Kim RQ, 2017, J MOL BIOL, V429, P3395, DOI 10.1016/j.jmb.2017.05.028; Kim RQ, 2016, J STRUCT BIOL, V195, P11, DOI 10.1016/j.jsb.2016.05.005; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Masuda Y, 2015, NUCLEIC ACIDS RES, V43, P7898, DOI 10.1093/nar/gkv712; Masuda Y, 2012, NUCLEIC ACIDS RES, V40, P10394, DOI 10.1093/nar/gks763; Masuda Y, 2012, NUCLEIC ACIDS RES, V40, P1065, DOI 10.1093/nar/gkr805; Masuda Y, 2010, J MOL BIOL, V396, P487, DOI 10.1016/j.jmb.2010.01.003; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Pfoh R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004950; Piao JH, 2015, J BIOCHEM, V158, P477, DOI 10.1093/jb/mvv063; Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rouge L, 2016, STRUCTURE, V24, P1335, DOI 10.1016/j.str.2016.05.020; Saridakis V, 2005, MOL CELL, V18, P25, DOI 10.1016/j.molcel.2005.02.029; Sarkari F, 2013, J BIOL CHEM, V288, P16975, DOI 10.1074/jbc.M113.469262; Schaefer JB, 2011, J BIOL CHEM, V286, P45186, DOI 10.1074/jbc.M111.310094; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Weston R, 2012, GENE DEV, V26, P1558, DOI 10.1101/gad.193516.112; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yuan JS, 2012, MOL CELL, V47, P410, DOI 10.1016/j.molcel.2012.05.025; Zhang WF, 2011, BIOCHEMISTRY-US, V50, P4775, DOI 10.1021/bi101958h	42	9	10	4	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4177	4187		10.1074/jbc.RA118.005167	http://dx.doi.org/10.1074/jbc.RA118.005167			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30647135	hybrid, Green Published			2022-12-26	WOS:000461854400029
J	Legido-Quigley, H; Naheed, A; de Silva, HA; Jehan, I; Haldane, V; Cobb, B; Tavajoh, S; Chakma, N; Kasturiratne, A; Siddiqui, S; Jafar, TH; Clemens, JD; Hasnat, M; Hameed, A; Khan, AZ; Ranasinha, C; Finkelstein, E; Bilger, M; Pryseley, A; Gandhi, M; Ebrahim, S; Turner, E				Legido-Quigley, Helena; Naheed, Aliya; de Silva, H. Asita; Jehan, Imtiaz; Haldane, Victoria; Cobb, Benjamin; Tavajoh, Saeideh; Chakma, Nantu; Kasturiratne, Anuradhani; Siddiqui, Sahar; Jafar, Tazeen H.; Clemens, John D.; Hasnat, M.; Hameed, Aamir; Khan, Ayesha Z.; Ranasinha, Channa; Finkelstein, Eric; Bilger, Marcel; Pryseley, Assam; Gandhi, Mihir; Ebrahim, Shah; Turner, Elizabeth		COBRA-BPS Study Grp	Patients' experiences on accessing health care services for management of hypertension in rural Bangladesh, Pakistan and Sri Lanka: A qualitative study	PLOS ONE			English	Article							BLOOD-PRESSURE; GLOBAL BURDEN	Hypertension is the leading risk factor for cardiovascular disease and leading cause of premature death globally. In 2008, approximately 40% of adults were diagnosed with hypertension, with more than 1.5 billion people estimated to be affected globally by 2025. Hypertension disproportionally affects low-and middle-income countries, where the prevalence is higher and where the health systems are more fragile. This qualitative study explored patients' experiences on the management and control of hypertension in rural Bangladesh, Sri Lanka and Pakistan. We conducted sixty semi-structured interviews, with 20 participants in each country. Hypertensive individuals were recruited based on age, gender and hypertensive status. Overall, patients' reported symptoms across the three countries were quite similar, although perceptions of hypertension were mixed. The majority of patients reported low knowledge on how to prevent or treat hypertension. The main barriers to accessing health services, as reported by participants, were inadequate services and poor quality of existing facilities, shortage of medicine supplies, busyness of doctors due to high patient load, long travel distance to facilities, and long waiting times once facilities were reached. Patients also mentioned that cost was a barrier to accessing services and adhering to medication. Many patients, when asked for areas of improvement, reported on the importance of the provider-patient relationship and mentioned valuing doctors who spent time with them, provided advice, and could be trusted. However, most patients reported that, especially at primary health care level and in government hospitals, the experience with their doctor did not meet their expectations. Patients in the three countries reported desire for good quality local medical services, the need for access to doctors, medicine and diagnostics and decreased cost for medication and medical services. Patients also described welcoming health care outreach activities near their homes. Areas of improvement could focus on reorienting community health workers' activities; involving family members in comprehensive counseling for medication adherence; providing appropriate training for health care staff to deliver effective information and services for controlling hypertension to patients; enhancing primary health care and specialist services; improving supplies of hypertensive medication in public facilities; taking into account patients' cultural and social background when providing services; and facilitating access and treatment to those who are most vulnerable.	[Legido-Quigley, Helena; Haldane, Victoria] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Naheed, Aliya; Chakma, Nantu; Clemens, John D.; Hasnat, M.] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [de Silva, H. Asita; Kasturiratne, Anuradhani] Univ Kelaniya, Fac Med, Clin Trials Unit, Dept Pharmacol, Kelaniya, Sri Lanka; [Jehan, Imtiaz; Siddiqui, Sahar] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Cobb, Benjamin; Jafar, Tazeen H.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27706 USA; [Tavajoh, Saeideh; Jafar, Tazeen H.] Duke NUS Med Sch, Program Hlth Serv & Syst Res, Singapore, Singapore; [Hameed, Aamir; Khan, Ayesha Z.] Aga Khan Univ, Karachi, Pakistan; [Ranasinha, Channa] Univ Kelaniya, Colombo, Sri Lanka; [Finkelstein, Eric; Bilger, Marcel; Pryseley, Assam; Gandhi, Mihir] Duke NUS Med Sch, Singapore, Singapore; [Ebrahim, Shah] London Sch Hyg & Trop Med, London, England; [Turner, Elizabeth] Duke Global Hlth Inst, Durham, NC USA	National University of Singapore; International Centre for Diarrhoeal Disease Research (ICDDR); University Kelaniya; Aga Khan University; Duke University; National University of Singapore; Aga Khan University; University Kelaniya; National University of Singapore; University of London; London School of Hygiene & Tropical Medicine; Duke University	Jafar, TH (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27706 USA.; Jafar, TH (corresponding author), Duke NUS Med Sch, Program Hlth Serv & Syst Res, Singapore, Singapore.	tazeen.jafar@duke-nus.edu.sg	A, Naheed/AHB-2940-2022; A, Naheed/AHB-2941-2022	A, Naheed/0000-0002-6016-5603; A, Naheed/0000-0002-6016-5603; Chakma, Nantu/0000-0003-4535-9503	MRC/DFId/Wellcome Trust, UK [MR/N006178/1]; MRC [MR/N006178/1] Funding Source: UKRI	MRC/DFId/Wellcome Trust, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study is supported by a research award: Grant Ref No: MR/N006178/1 from the MRC/DFId/Wellcome Trust, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, ECONOMIST; Chowdhury MAB, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0197-3; Corsi DJ, 2013, AM HEART J, V166, P636, DOI 10.1016/j.ahj.2013.04.019; Forouzanfar MH, 2017, JAMA-J AM MED ASSOC, V317, P165, DOI 10.1001/jama.2016.19043; Jafar TH, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2018-0; Jafar TH, 2016, J HYPERTENS, V34, P1872, DOI 10.1097/HJH.0000000000001014; Jafar TH, 2009, ANN INTERN MED, V151, P593, DOI 10.7326/0003-4819-151-9-200911030-00004; Jafar TH, 2003, J HYPERTENS, V21, P905, DOI 10.1097/00004872-200305000-00014; Jin C, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0195-6; Katulanda P, 2014, CLIN EXP HYPERTENS, V36, P484, DOI 10.3109/10641963.2013.863321; Khatib R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084238; Legido-Quigley H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122112; Legido-Quigley H, 2014, SOCIOL HEALTH ILL, V36, P1243, DOI 10.1111/1467-9566.12163; Levesque JF, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-18; Maimaris W, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001490; Meehan SA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2173-8; Misra A, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1420; Olsen MH, 2016, LANCET, V388, P2665, DOI 10.1016/S0140-6736(16)31134-5; Melo ECP, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0435-4; Qureshi NN, 2007, BMJ-BRIT MED J, V335, P1030, DOI 10.1136/bmj.39360.617986.AE; Rahman Mosiur, 2015, JRSM Open, V6, p2054270415608118, DOI 10.1177/2054270415608118; Ranawaka UK, 2016, CEYLON MED J, V61, P11, DOI 10.4038/cmj.v61i1.8253; Szczech LA, 2010, NEPHROL DIAL TRANSPL, V25, P2368, DOI 10.1093/ndt/gfq218; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Bank Group, 2016, SRI LANK COUNTR PROF; World Bank Group, 2016, BANGL COUNTR PROF; World Bank Group, 2016, PAK COUNTR PROF; WPRO, 2015, PEOPL REP BANGL HIT	28	26	26	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211100	10.1371/journal.pone.0211100	http://dx.doi.org/10.1371/journal.pone.0211100			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682093	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500100
J	Pugliese, M; Ramsay, T; Shamloul, R; Mallet, K; Zakutney, L; Corbett, D; Dukelow, S; Stotts, G; Shamy, M; Wilson, K; Guerinet, J; Dowlatshahi, D				Pugliese, Michael; Ramsay, Tim; Shamloul, Rany; Mallet, Karen; Zakutney, Lise; Corbett, Dale; Dukelow, Sean; Stotts, Grant; Shamy, Michel; Wilson, Kumanan; Guerinet, Julien; Dowlatshahi, Dar			RecoverNow: A mobile tablet-based therapy platform for early stroke rehabilitation	PLOS ONE			English	Article							POSTSTROKE DEPRESSION; CLINICAL-TRIALS; TELEREHABILITATION	Introduction Stroke survivors frequently experience a range of post-stroke deficits. Specialized stroke rehabilitation improves recovery, especially if it is started early post-stroke. However, resource limitations often preclude early rehabilitation. Mobile technologies may provide a platform for stroke survivors to begin recovery when they might not be able to otherwise. The study objective was to demonstrate the feasibility of RecoverNow, a tablet-based stroke recovery platform aimed at delivering speech and cognitive therapy. Methods We recruited a convenience sample of 30 acute stroke patients to use RecoverNow for up to 3 months. Allied health professionals assigned specific applications based on standard of care assessments. Participants were encouraged to take home the RecoverNow tablets upon discharge from acute care. The study team contacted participants to return for a follow-up interview 3 months after enrollment. The primary outcome of interest was feasibility, defined using 5 facets: recruitment rate, adherence rate, retention rate, the proportion of successful follow-up interventions, and protocol deviations. We tracked barriers to tablet-based care as a secondary outcome. Results We successfully recruited 30 of 62 eligible patients in 15 weeks (48% recruitment rate). Participants were non-adherent to tablet-based therapy inside and outside of acute care, using RecoverNow for a median of 12 minutes a day. Retention was high with 23 of 30 patients participating in follow-up interviews (77% retention rate) and all but 3 of the 23 interviews (87%) were successfully completed. Only 2 major protocol deviations occurred: one enrollment failure and one therapy protocol violation. Barriers to tablet-based care were frequently encountered by study participants with many expressing the assigned applications were either too easy or too difficult. Conclusions Acute stroke patients are interested in attempting tablet-based stroke rehabilitation and are easily recruited early post-stroke. However, tablet-based therapy may be challenging due to patient, device and system-related barriers. Reducing the frequency of common barriers will be essential to keeping patients engaged in tablet-based therapy.	[Pugliese, Michael; Ramsay, Tim; Wilson, Kumanan; Dowlatshahi, Dar] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Ramsay, Tim; Shamloul, Rany; Mallet, Karen; Stotts, Grant; Shamy, Michel; Wilson, Kumanan; Guerinet, Julien; Dowlatshahi, Dar] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Mallet, Karen; Zakutney, Lise; Stotts, Grant; Shamy, Michel; Dowlatshahi, Dar] Champlain Reg Stroke Network, Ottawa, ON, Canada; [Mallet, Karen; Zakutney, Lise; Stotts, Grant; Shamy, Michel; Wilson, Kumanan; Dowlatshahi, Dar] Ottawa Hosp, Ottawa, ON, Canada; [Mallet, Karen; Corbett, Dale; Dukelow, Sean; Dowlatshahi, Dar] Canadian Partnership Stroke Recovery, Ottawa, ON, Canada; [Corbett, Dale] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Corbett, Dale; Stotts, Grant; Dowlatshahi, Dar] Univ Ottawa, Brain & Mind Res Inst, Ottawa, ON, Canada; [Dukelow, Sean] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Calgary	Pugliese, M (corresponding author), Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.	mpugl038@uottawa.ca		Pugliese, Michael/0000-0003-2794-1436; Dowlatshahi, Dar/0000-0003-1379-3612	Canadian Institutes of Health Research Canadian Graduate Scholarship Master's Award; University of Ottawa Ontario Graduate Scholarship; University of Ottawa Brain and Mind Research Institute; Canadian Partnership for Stroke Recovery; University of Ottawa Department of Medicine	Canadian Institutes of Health Research Canadian Graduate Scholarship Master's Award; University of Ottawa Ontario Graduate Scholarship; University of Ottawa Brain and Mind Research Institute; Canadian Partnership for Stroke Recovery; University of Ottawa Department of Medicine	This work was supported by a Canadian Institutes of Health Research Canadian Graduate Scholarship Master's Award (http://www.cihr-irsc.gc.ca/e/49440.html; M.P.), a University of Ottawa Ontario Graduate Scholarship (https://www.uottawa.ca/graduate-studies/students/awards/ontario-graduate-scholarship; M.P.), the University of Ottawa Brain and Mind Research Institute (https://www.uottawa.ca/brain/; D.D), the Canadian Partnership for Stroke Recovery (http://www.canadianstroke.ca/en/; D.D.), and the University of Ottawa Department of Medicine (https://med.uottawa.ca/en; D.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, MORBITY MORTAL WKLY, V56, P504; Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Bernhardt J, 2004, STROKE, V35, P1005, DOI 10.1161/01.STR.0000120727.40792.40; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Burton LJ, 2015, PSYCHOL MED, V45, P29, DOI 10.1017/S0033291714000336; Carabeo CGG, 2014, SIMULAT GAMING, V45, P151, DOI 10.1177/1046878114531102; Choi YH, 2016, TELEMED E-HEALTH, V22, P434, DOI 10.1089/tmj.2015.0138; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, pS35, DOI 10.1016/S0003-9993(99)90101-6; Crotty M, 2014, J TELEMED TELECARE, V20, P370, DOI 10.1177/1357633X14552382; de Man-van Ginkel JM, 2012, NURS RES, V61, P333, DOI 10.1097/NNR.0b013e31825d9e9e; Des Roches CA, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01015; Faltynek P, 2018, EVIDENCE BASED REV S; Heart and Stroke Foundation, 2014, TOG RIS TID ADV STRO; Hoover EL, 2014, SEMIN SPEECH LANG, V35, P25, DOI 10.1055/s-0033-1362990; Hussein N., 2018, EVIDENCE BASED REV S; Jang SH, 2016, SOMATOSENS MOT RES, V33, P124, DOI 10.1080/08990220.2016.1197117; Katalinic O, 2013, J TELEMED TELECARE, V19, P418, DOI 10.1177/1357633X13506513; Kizony R, 2016, J NEUROL PHYS THER, V40, P31, DOI 10.1097/NPT.0000000000000110; Krakauer JW, 2015, GETTING NEUROREHABIL, V26, P923, DOI [10.1177/1545968312440745.Getting, DOI 10.1177/1545968312440745.GETTING]; Kurland J, 2014, CLIN APHASIOLOGY C, V35, P51; Lavoie M, 2016, NEUROCASE, V22, P109, DOI 10.1080/13554794.2015.1051055; MAHONEY F I, 1965, Md State Med J, V14, P61; Mallet K, 2019, INT J STROKE, V14, P174, DOI 10.1177/1747493018790031; Mallet KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167950; Meader N, 2014, J NEUROL NEUROSUR PS, V85, P198, DOI 10.1136/jnnp-2012-304194; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; NAKAYAMA H, 1994, ARCH PHYS MED REHAB, V75, P394, DOI 10.1016/0003-9993(94)90161-9; OTTENBACHER KJ, 1993, ARCH NEUROL-CHICAGO, V50, P37, DOI 10.1001/archneur.1993.00540010033014; Pugliese M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191566; Quinn TJ, 2011, STROKE, V42, P1146, DOI 10.1161/STROKEAHA.110.598540; Rand D., 2013, 2013 International Conference on Virtual Rehabilitation (ICVR), P109, DOI 10.1109/ICVR.2013.6662068; Routhier S, 2016, APHASIOLOGY, V30, P269, DOI 10.1080/02687038.2014.973361; Salter K, 2018, EVIDENCE BASED REV S; Stark BC, 2018, NEUROPSYCHOL REHABIL, V28, P818, DOI 10.1080/09602011.2016.1146150; Swartz RH, 2016, INT J STROKE, V11, P509, DOI 10.1177/1747493016641968; White JH, 2015, DISABIL REHABIL, V37, P593, DOI 10.3109/09638288.2014.935876; Zhou X, 2018, TOP STROKE REHABIL, V25, P489, DOI 10.1080/10749357.2018.1482446	37	11	11	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210725	10.1371/journal.pone.0210725	http://dx.doi.org/10.1371/journal.pone.0210725			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682076	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500056
J	Arnaldo, P; Cambe, MI; Magaco, A; Chicumbe, S; Rovira-Vallbona, E; Rosanas-Urgell, A; Enosse, SM				Arnaldo, Paulo; Cambe, Maria Isabel; Magaco, Amilcar; Chicumbe, Sergio; Rovira-Vallbona, Eduard; Rosanas-Urgell, Anna; Enosse, Sonia M.			Access to and use of preventive intermittent treatment for Malaria during pregnancy: A qualitative study in the Chokwe district, Southern Mozambique	PLOS ONE			English	Article								Background Malaria remains a significant health problem in Mozambique, particularly in the case of pregnant women and children less than five years old. Intermittent preventive treatment with sulfadoxine-pyrimethamine (IPT-SP) is recommended for preventing malaria in pregnancy (MiP). Despite the widespread use and cost-effectiveness of IPTp-SP, coverage remains low. In this study, we explored factors limiting access to and use of IPTp-SP in a rural part of Mozambique. Methods and findings We performed a qualitative study using semi-structured interviews to collect data from 46 pregnant women and four health workers in Chokwe, a rural area of southern Mozambique. Data were transcribed, translated where appropriate, manually coded, and the content analyzed according to key themes. The women interviewed were not aware of the risks of MiP or the benefits of its prevention. Delays in accessing antenatal care, irregular attendance of visits, and insufficient time for proper antenatal care counselling by health workers were driving factors for inadequate IPTp delivery. Conclusions Pregnant women face substantial barriers in terms of optimal IPTp-SP uptake. Health system barriers and poor awareness of the risks and consequences of MiP and of the measures available for its prevention were identified as the main factors influencing access to and use of IPTp-SP. Implementation of MiP prevention strategies must be improved through intensive community health education and increased access to other sources of information. Better communication between health workers and ANC clients and better knowledge of national ANC and IPTp policies are important.	[Arnaldo, Paulo; Enosse, Sonia M.] Inst Nacl Saude, Plataforma Parasitol Mol, Maputo, Mozambique; [Arnaldo, Paulo; Rovira-Vallbona, Eduard; Rosanas-Urgell, Anna] Inst Trop Med Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Arnaldo, Paulo] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Cambe, Maria Isabel; Magaco, Amilcar; Chicumbe, Sergio] Inst Nacl Saude, Programa Sistemas Saude, Maputo, Mozambique	Institute of Tropical Medicine (ITM); University of Antwerp	Arnaldo, P (corresponding author), Inst Nacl Saude, Plataforma Parasitol Mol, Maputo, Mozambique.; Arnaldo, P (corresponding author), Inst Trop Med Antwerp, Dept Biomed Sci, Antwerp, Belgium.; Arnaldo, P (corresponding author), Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium.	pauloarnaldo554@hotmail.com	Chicumbe, Sergio Antonio Rodrigues/GXA-1921-2022	Chicumbe, Sergio Antonio Rodrigues/0000-0002-2498-9373; Enosse, Sonia Maria Mauricio/0000-0002-2586-2083; Rovira-Vallbona, Eduard/0000-0002-4765-1076	Flemish International Cooperation Agency under the BICMINS project ITM-INS; "Fundo National de Investigacao" (FNI)	Flemish International Cooperation Agency under the BICMINS project ITM-INS; "Fundo National de Investigacao" (FNI)	This research was undertaken as part of PhD program which is supported by the Flemish International Cooperation Agency under the BICMINS project ITM-INS and the "Fundo National de Investigacao" (FNI). None of the funders had a role in study design, data collection, and analysis, the decision to publish and/or manuscript conception.	Andrews KG, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1033-4; [Anonymous], 2004, STRATEGIC FRAMEWORK; Arnaldo P, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2255-z; Boene H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086038; Brabin L, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-25; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Desai M, 2016, CLIN INFECT DIS, V62, P323, DOI 10.1093/cid/civ881; Florey L, 2013, DHS ANAL STUDIES, V39, P1; Hill J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001488; Hurley EA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160008; Mason L, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0453-z; Mbonye AK, 2007, HEALTH POLICY, V81, P228, DOI 10.1016/j.healthpol.2006.05.018; Menendez C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009438; MISAU, 2006, NORMAS MANEJO CASOS; MISAU INE ICF, 2018, INQ IND IM MAL HIV S; Mubyazi GM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-54; Munguambe K, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0141-0; Onoka CA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-317; Pell C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053747; Pell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022452; PNCM, 2015, REL AN PROGR NAC CON; PNCM inform and LSHTM, 2017, MOZ PROF MAL CONTR E; Pool R, 2012, SOCIAL CULTURAL FACT, V6, DOI [10.1371/journal.pone.0022452, DOI 10.1371/JOURNAL.PONE.0022452]; Rassi C, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1589-7; Sangare LR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015066; Some TD, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-3; Stephen AAI, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.supp.2016.25.1.6169; van Eijk AM, 2011, LANCET INFECT DIS, V11, P190, DOI 10.1016/S1473-3099(10)70295-4; WHO, 2013, UPD WHO POL REC INT; WHO, 2015, WORLD MAL REP 2015; World Health Organization, 2017, GLOB HEP REP, DOI DOI 10.1071/EC12504	31	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0203740	10.1371/journal.pone.0203740	http://dx.doi.org/10.1371/journal.pone.0203740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677039	Green Published, Green Submitted, gold			2022-12-26	WOS:000456700400002
J	Huang, KC; Tsay, YS; Lin, FM; Lee, CC; Chang, JW				Huang, Kun-Chih; Tsay, Yaw-Shyan; Lin, Fang-Ming; Lee, Ching-Chang; Chang, Jung-Wei			Efficiency and performance tests of the sorptive building materials that reduce indoor formaldehyde concentrations	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; INITIAL EMITTABLE CONCENTRATION; COMPOUNDS EMISSION; VOC EMISSIONS; TEMPERATURE; IMPACT; MODEL; PARTICLEBOARD; VALIDATION; HUMIDITY	The adsorption of volatile organic compounds by building materials reduces the pollutant concentrations in indoor air. We collected three interior building materials with adsorption potentials-latex paint, micro-carbonized plywood, and moisture-buffering siding-used the sorptive building materials test (SBMT) to determine how much they reduced indoor formaldehyde (HCHO) concentrations, and then assessed the consequent reduction in human cancer risk from HCHO inhalation. Adsorption of HCHO by building materials significantly improved the effective ventilation efficiency. For example, the equivalent ventilation rate for Celite siding-used for humidity control-was 1.44 m(3)/(m(2).h) at 25 degrees C, 50% relative humidity (RH); the loading factor (L) was 0.4 m(2)/m(3), and the HCHO concentration was 0.2 ppm; this effect is equivalent to a higher ventilation rate of approximately 0.6 air changes per hour in a typical Taiwanese dwelling. There was also a substantial reduction of risk in Case MCP-2 (C-in,C-te: 245 mu g/m(3), 30 degrees C, 50% RH): males: down 5.73 x 10(-4); females: down 4.84 x 10(-4)). The selection of adsorptive building materials for interior surfaces, therefore, significantly reduces human inhalation of HCHO. Our findings should encourage developing and using innovative building materials that help improve indoor air quality and thus provide building occupants with healthier working and living environments.	[Huang, Kun-Chih; Tsay, Yaw-Shyan] Natl Cheng Kung Univ, Coll Engn, Dept Architecture, Tainan, Taiwan; [Lin, Fang-Ming] Natl Pingtung Univ Sci & Technol, Dept Wood Sci & Design, Pingtung, Taiwan; [Lee, Ching-Chang] Natl Cheng Kung Univ, Med Coll, Dept Environm & Occupat Hlth, Tainan, Taiwan; [Chang, Jung-Wei] Natl Yang Ming Univ, Sch Med, Inst Environm & Occupat Hlth Sci, Taipei, Taiwan	National Cheng Kung University; National Pingtung University Science & Technology; National Cheng Kung University; National Yang Ming Chiao Tung University	Lee, CC (corresponding author), Natl Cheng Kung Univ, Med Coll, Dept Environm & Occupat Hlth, Tainan, Taiwan.; Chang, JW (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Environm & Occupat Hlth Sci, Taipei, Taiwan.	cclee@mail.ncku.edu.tw; jungwei723@gmail.com	Tsay, Yaw-Shyan/M-5980-2017	Tsay, Yaw-Shyan/0000-0001-6935-784X	Architecture and Building Research Institute, Taiwan Ministry of the Interior	Architecture and Building Research Institute, Taiwan Ministry of the Interior	This work was funded by Architecture and Building Research Institute, Taiwan Ministry of the Interior. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Toxic Substances and Disease Registry (ASTDR), 1999, TOX PROF FORM; ANDERSEN I, 1975, ATMOS ENVIRON, V9, P1121, DOI 10.1016/0004-6981(75)90188-2; [Anonymous], 2009, 1600023 ISO; [Anonymous], 2007, A19051 JIS, P6568, DOI [10.1016/j.biortech.2010.03.059, DOI 10.1016/J.BIORTECH.2010.03.059]; [Anonymous], 2006, ASTM INT STAND; [Anonymous], 2001, D664601 ASTM; [Anonymous], 2002, 600702 ASTM; [Anonymous], [No title captured]; [Anonymous], 2006, E133390 ASTM; [Anonymous], 2006, 1600011 ISO; [Anonymous], 2004, 7171 EN; Anses, 2008, TOX FORM ET CONN CAR; Arts JHE, 2006, REGUL TOXICOL PHARM, V44, P144, DOI 10.1016/j.yrtph.2005.11.006; BACHMANN MO, 1995, SOC SCI MED, V40, P245, DOI 10.1016/0277-9536(94)E0068-4; Chiang CM, 2011, ADV MATER RES-SWITZ, V314-316, P1435, DOI 10.4028/www.scientific.net/AMR.314-316.1435; Chiang CM, 1994, J HOUSING STUDIES, V2, P107; Cox SS, 2002, ENVIRON SCI TECHNOL, V36, P709, DOI 10.1021/es010802+; Crawford S, 2011, SCI TOTAL ENVIRON, V409, P3403, DOI 10.1016/j.scitotenv.2011.05.042; Dar UI, 2015, BUILD SIMUL-CHINA, V8, P499, DOI 10.1007/s12273-015-0230-y; Deng QQ, 2009, ATMOS ENVIRON, V43, P2080, DOI 10.1016/j.atmosenv.2008.12.052; Deng QQ, 2011, BUILD SCI, V27; Deng QQ, 2009, HVAC, V39; DOH, 2008, COMP EXP FACT; Fabi V, 2013, BUILD SIMUL-CHINA, V6, P415, DOI 10.1007/s12273-013-0119-6; Frihart C.R., 2010, P INT CONV SOC WOOD, P1; Frihart CR, 2012, FOREST PROD J, V62, P551; HCN, 2003, FORM REP 2003, V2003; Health Canada, 2006, RES IND AIR QUAL GUI; Hsu Yu-Lun, 2007, THESIS; Huang H, 2002, BUILD ENVIRON, V37, P1349, DOI 10.1016/S0360-1323(01)00116-0; Huang KC, 2011, IND AIR 12 INT C TEX, V6, pa719; Huang SD, 2015, ENVIRON SCI TECHNOL, V49, P1537, DOI 10.1021/es5051875; Kato S, 2002, P IND AIR 2002 9 INT, V2, P658; Kato S, 2001, ANN M J ARCHIT D, VD-2, P809; Kim S, 2010, BIORESOURCE TECHNOL, V101, P6562, DOI 10.1016/j.biortech.2010.03.059; Lin CC, 2009, BUILD ENVIRON, V44, P525, DOI 10.1016/j.buildenv.2008.04.015; LITTLE JC, 1994, ATMOS ENVIRON, V28, P227, DOI 10.1016/1352-2310(94)90097-3; Liu WW, 2012, CHINESE SCI BULL, V57, P2533, DOI 10.1007/s11434-012-5208-x; MATTHEWS TG, 1987, ENVIRON SCI TECHNOL, V21, P629, DOI 10.1021/es00161a002; MYERS GE, 1981, WOOD SCI, V13, P140; MYERS GE, 1985, FOREST PROD J, V35, P20; NEG, 2003, NORD EXP GROUP CRIT, V132; Nielsen GD, 2010, ARCH TOXICOL, V84, P423, DOI 10.1007/s00204-010-0549-1; Parthasarathy S, 2011, J AIR WASTE MANAGE, V61, P689, DOI 10.3155/1047-3289.61.6.689; Saeki K, 2014, J HUM HYPERTENS, V28, P482, DOI 10.1038/jhh.2014.4; Salthammer T, 2010, CHEM REV, V110, P2536, DOI 10.1021/cr800399g; Schulte A, 2006, N850000 BFR CAS; Seo J., 2008, J ENV ENG T AIJ, V73, P751; Seo J, 2009, BUILD ENVIRON, V44, P207, DOI 10.1016/j.buildenv.2008.02.013; Shen XZ, 2010, BUILD ENVIRON, V45, P1470, DOI 10.1016/j.buildenv.2009.12.010; Shyng JH, 2005, THESIS; Sima E, 2015, BUILD SIMUL-CHINA, V8, P711, DOI 10.1007/s12273-015-0247-2; USEPA, 2005, TOX REV TOL SUPP SUM; USEPA, 1989, EPA600889043; USEPA, 1988, EPA6001085362 ENV CR; Wadden RA, 1983, INDOOR AIR POLLUTION, P105; WHO, 1989, IND AIR QUAL ORG POL; Won DY, 2001, ATMOS ENVIRON, V35, P4479, DOI 10.1016/S1352-2310(01)00223-0; World Health Organization, 2000, AIR QUALITY GUIDELIN, V2nd; Xiong J, 2010, INDOOR AIR, V20, P523, DOI 10.1111/j.1600-0668.2010.00675.x; Xiong JY, 2013, ENVIRON SCI TECHNOL, V47, P8540, DOI 10.1021/es401173d; Xu J, 2011, BUILD ENVIRON, V46, P1785, DOI 10.1016/j.buildenv.2011.02.007; Xu Y, 2003, ATMOS ENVIRON, V37, P2497, DOI 10.1016/S1352-2310(03)00160-2; Yang X, 2001, ATMOS ENVIRON, V35, P1291, DOI 10.1016/S1352-2310(00)00397-6; Zhang YP, 2007, ATMOS ENVIRON, V41, P3203, DOI 10.1016/j.atmosenv.2006.10.081	65	9	9	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210416	10.1371/journal.pone.0210416	http://dx.doi.org/10.1371/journal.pone.0210416			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677054	Green Published, gold, Green Submitted			2022-12-26	WOS:000456700400014
J	Lande, MS; Rosenvinge, JH; Skeie, G; Rylander, C				Lande, Marie Sigstad; Rosenvinge, Jan H.; Skeie, Guri; Rylander, Charlotta			Prevalence and correlates of self-reported disordered eating: A cross-sectional study among 90 592 middle-aged Norwegian women	PLOS ONE			English	Article							QUESTIONNAIRE EDE-Q; BODY-MASS INDEX; ANOREXIA-NERVOSA; PHYSICAL-ACTIVITY; PSYCHIATRIC COMORBIDITY; SUBSTANCE USE; TIME TRENDS; COMMUNITY; VALIDITY; WEIGHT	Disordered eating (DE) is extensively studied among adolescents and young women. However, there is growing evidence that DE as well as the clinical eating disorders may occur at any age from childhood to advanced years. This study aimed to determine the prevalence and correlates of DE in a representative sample of middle-aged women from Norway. The study included 90 592 women (median age: 55 years) from the Norwegian Women and Cancer study who responded to a questionnaire between the years 2002-2005. Correlates of self-reported DE were assessed by logistic regression analyses. The overall period prevalence of DE between 2002-2005 was 0.28 (95% confidence interval 0.25-0.31) %, and was highest among women > 66 years: 0.65 (0.60-0.70) %. DE was strongly associated with depression (Odds ratio [OR] 3.34 [95% confidence interval 2.53-4.41]), being unemployed (OR 1.78 [1.32-2.40]) and single (OR 1.66 [1.25-2.20]). Women with DE were more likely to report low energy intake (OR 1.41 [1.08-1.86]) and were less likely to be moderately physically active (OR 0.67 [0.47-0.95]). Using the largest study sample in the literature, the present findings confirm smaller studies showing that DE do occur in women in mid-life and older age as well. Our results contribute to address a somewhat under-communicated community health problem that needs attention in terms of age-specific treatment and prevention.	[Lande, Marie Sigstad; Skeie, Guri; Rylander, Charlotta] UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway; [Rosenvinge, Jan H.] UiT Arctic Univ Norway, Dept Psychol, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso	Rylander, C (corresponding author), UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway.	charlotta.rylander@uit.no	Rylander, Charlotta/AAE-2033-2022		UiT The Arctic University of Norway	UiT The Arctic University of Norway	This study was funded by a summer grant from UiT The Arctic University of Norway. The publication charges for this article have been funded by a grant from the publication fund of UiT The Arctic University of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannon KL, 2009, INT J EAT DISORDER, V42, P118, DOI 10.1002/eat.20588; Beck D, 1996, INT J EAT DISORDER, V20, P389; Becker CB, 2013, J EAT DISORD, V1, DOI 10.1186/2050-2974-1-6; Borch KB, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-2; Bratland-Sanda S, 2010, INT J EAT DISORDER, V43, P88, DOI 10.1002/eat.20753; Cederlof M, 2015, WORLD PSYCHIATRY, V14, P333, DOI 10.1002/wps.20251; Conceicao EM, 2017, INT J EAT DISORDER, V50, P793, DOI 10.1002/eat.22700; Currin L, 2005, BRIT J PSYCHIAT, V186, P132, DOI 10.1192/bjp.186.2.132; Ebneter DS, 2013, J NERV MENT DIS, V201, P281, DOI 10.1097/NMD.0b013e318288e23f; Eik-Nes T, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008125; Eiliv L, 2003, CANCER CAUSE CONTROL, V14, P1001, DOI 10.1023/B:CACO.0000007982.18311.2e; El Ghoch M, 2013, INT J EAT DISORDER, V46, P709, DOI 10.1002/eat.22140; Fairburn Christopher G., 1993, P317; Fouladi F, 2015, EUR EAT DISORD REV, V23, P531, DOI 10.1002/erv.2410; Gadalla T, 2007, ARCH WOMEN MENT HLTH, V10, P133, DOI 10.1007/s00737-007-0184-x; Gadalla T, 2008, WOMEN HEALTH, V48, P467, DOI 10.1080/03630240802575104; Gadalla T, 2008, ARCH WOMEN MENT HLTH, V11, P357, DOI 10.1007/s00737-008-0031-8; Gagne DA, 2012, INT J EAT DISORDER, V45, P832, DOI 10.1002/eat.22030; Godart NT, 2007, J AFFECT DISORDERS, V97, P37, DOI 10.1016/j.jad.2006.06.023; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Harris M, 2006, J PSYCHOSOC NURS MEN, V44, P21, DOI 10.3928/02793695-20060401-06; Hay P, 2015, J EAT DISORD, V3, DOI 10.1186/s40337-015-0056-0; Hechler T, 2008, ADAPT PHYS ACT Q, V25, P159, DOI 10.1123/apaq.25.2.159; Hjartaker A, 2007, PUBLIC HEALTH NUTR, V10, P1094, DOI 10.1017/S1368980007702872; Hoek HW, 2016, CURR OPIN PSYCHIATR, V29, P336, DOI 10.1097/YCO.0000000000000282; Hsu LKG, 1988, INT J EAT DISORDER, P32, DOI [10.1016/j.jpsychires.2009.04.003, DOI 10.1016/J.JPSYCHIRES.2009.04.003]; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Janelli L M, 1986, Rehabil Nurs, V11, P6; Lapid MI, 2010, INT PSYCHOGERIATR, V22, P523, DOI 10.1017/S1041610210000104; Litmanen J, 2017, NORD J PSYCHIAT, V71, P61, DOI 10.1080/08039488.2016.1224272; Lund E, 2008, INT J EPIDEMIOL, V37, P36, DOI 10.1093/ije/dym137; Mangweth-Matzek B, 2006, INT J EAT DISORDER, V39, P583, DOI 10.1002/eat.20327; Mangweth-Matzek B, 2014, INT J EAT DISORDER, V47, P320, DOI 10.1002/eat.22232; McCabe RE, 2001, INT J EAT DISORDER, V29, P59, DOI 10.1002/1098-108X(200101)29:1&lt;59::AID-EAT9&gt;3.0.CO;2-#; Meyer C, 2009, EUR EAT DISORD REV, V17, P366, DOI 10.1002/erv.950; Micali N, 2017, BMC MED, V15, DOI 10.1186/s12916-016-0766-4; Mitchison D, 2014, CLIN EPIDEMIOL, V6, P89, DOI 10.2147/CLEP.S40841; Mond JM, 2004, BEHAV RES THER, V42, P551, DOI 10.1016/S0005-7967(03)00161-X; MURRAY S, 1990, INT J EAT DISORDER, V9, P87, DOI 10.1002/1098-108X(199001)9:1&lt;87::AID-EAT2260090110&gt;3.0.CO;2-2; Ng ISF, 2013, J AGING HEALTH, V25, P1106, DOI 10.1177/0898264313494798; Pettersen Gunn, 2008, Eat Disord, V16, P204, DOI 10.1080/10640260802016696; Preti A, 2009, J PSYCHIATR RES, V43, P1125, DOI 10.1016/j.jpsychires.2009.04.003; Ro O, 2012, EAT BEHAV, V13, P158, DOI 10.1016/j.eatbeh.2011.12.001; Roehrig JP, 2010, INT J EAT DISORDER, V43, P671, DOI 10.1002/eat.20760; Root TL, 2010, PSYCHOL MED, V40, P105, DOI 10.1017/S0033291709005662; Rosenvinge J.H., 2015, ADV EAT DISORD, V3, P198, DOI [DOI 10.1080/21662630.2014.940549, 10.1080/21662630.2014.940549]; Runfola CD, 2013, EUR EAT DISORD REV, V21, P52, DOI 10.1002/erv.2201; Seigel K, 2001, Eat Weight Disord, V6, P32; Skeie G, 2015, CLIN EPIDEMIOL, V7, P313, DOI 10.2147/CLEP.S83839; Slane JD, 2014, INT J EAT DISORDER, V47, P793, DOI 10.1002/eat.22329; Steinhausen HC, 2015, INT J EAT DISORDER, V48, P845, DOI 10.1002/eat.22402; Stewart MC, 2006, INT J EAT DISORDER, V39, P320, DOI 10.1002/eat.20262; Swanson SA, 2011, ARCH GEN PSYCHIAT, V68, P714, DOI 10.1001/archgenpsychiatry.2011.22; Veierod MB, 2012, MED STAT CLIN EPIDEM, DOI [10.1111/j.1467-789X.2007.00347.x, DOI 10.1111/J.1467-789X.2007.00347.X]; Welch E, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0840-7	55	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211056	10.1371/journal.pone.0211056	http://dx.doi.org/10.1371/journal.pone.0211056			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI4TC	30673772	Green Published, Green Submitted, gold			2022-12-26	WOS:000456442800070
J	Masenga, GG; Shayo, BC; Msuya, S; Rasch, V				Masenga, Gileard G.; Shayo, Benjamin C.; Msuya, Sia; Rasch, Vibeke			Urinary incontinence and its relation to delivery circumstances: A population-based study from rural Kilimanjaro, Tanzania	PLOS ONE			English	Article							QUALITY-OF-LIFE; RISK-FACTORS; CONTINENCE SOCIETY; OBSTETRIC FISTULA; PREVALENCE; WOMEN; TERMINOLOGY; STANDARDIZATION; QUESTIONNAIRE; ASSOCIATION	Objectives To investigate the prevalence and risk factors of urinary incontinence (UI), the different UI subtypes and the association between UI and delivery circumstances. Design Cross-sectional population-based study conducted in Kilimanjaro Region, Tanzania. Participants and settings 1048 women aged 18-90 women living in rural Kilimanjaro. Simple random sampling was done to select villages, households and participants. Community health workers helped in identifying eligible women and trained nurses/midwives conducted face-to-face interviews. Data were analysed using descriptive statistics and Univariate and Multivariate logistic regression modelling. Results The overall prevalence rate of UI was 42%. When focusing on the different types of UI, 17% of the women had stress UI, 9% had urge UI and 16% had mixed UI. Only one woman (0.1%) with vesico-vaginal fistula was identified. UI was found to be significantly associated with increasing parity (OR = 2.41 (1.55-3.74). In addition, women who in relation to their first delivery had delivered at home or had been in labour for more than 24 hours, had increased adjusted ORs of 1.70(1.08-2.68) and 2.10(1.08-4.10), respectively, for having UI. Conclusion UI is common in rural Tanzania and of the subtypes of UI, Stress Urinary Incontinence (SUI) is the commonest followed by Mixed Urinary Incontinence (MUI). Home delivery, prolonged labour and increasing parity especially having 5 or more deliveries are associated with increased risk for developing UI.	[Masenga, Gileard G.; Msuya, Sia] Kilimanjaro Christian Med Univ Coll, Moshi, Klimanjaro, Tanzania; [Masenga, Gileard G.; Shayo, Benjamin C.] Kilimanjaro Christian Med Ctr, Dept Obstet & Gynecol, Moshi, Klimanjaro, Tanzania; [Rasch, Vibeke] Odense Univ Hosp, Dept Obstet & Gynecol, Odense, Denmark; [Rasch, Vibeke] Univ Southern Denmark, Dept Clin Res, Odense, Denmark	Kilimanjaro Christian Medical Centre; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Masenga, GG (corresponding author), Kilimanjaro Christian Med Univ Coll, Moshi, Klimanjaro, Tanzania.; Masenga, GG (corresponding author), Kilimanjaro Christian Med Ctr, Dept Obstet & Gynecol, Moshi, Klimanjaro, Tanzania.	drgmasenga@yahoo.com	Rasch, Vibeke/G-9393-2019	Rasch, Vibeke/0000-0001-6557-0985; Shayo, Benjamin C/0000-0001-8544-437X	Building Stronger University (BSU) - DANIDA (the Danish International Development Agency)	Building Stronger University (BSU) - DANIDA (the Danish International Development Agency)	This research was conducted under the auspices of the Building Stronger University (BSU), which is funded by DANIDA (the Danish International Development Agency). The funders had no role in study design, data collection and analysis, manuscript preparation or decision to publish.	Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Barber MD, 2006, AM J OBSTET GYNECOL, V194, P1492, DOI 10.1016/j.ajog.2006.01.076; Basak T, 2013, INT NURS REV, V60, P448, DOI 10.1111/inr.12048; Biadgilign S, 2013, REPROD HEALTH, V10, DOI [10.1186/1742-4755-10-14, 10.1186/1742-4755-10-52]; Botlero R, 2011, J UROLOGY, V185, P1331, DOI 10.1016/j.juro.2010.11.080; Brown SJ, 2011, BJOG-INT J OBSTET GY, V118, P991, DOI 10.1111/j.1471-0528.2011.02928.x; Bulchandani S, 2015, BJOG-INT J OBSTET GY, V122, P1157, DOI 10.1111/1471-0528.13431; Cerruto MA, 2013, UROL INT, V90, P1, DOI 10.1159/000339929; Cowgill KD, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0592-2; Espuna Pons M, 2007, Actas Urol Esp, V31, P502; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Hannestad YS, 2003, BJOG-INT J OBSTET GY, V110, P247, DOI 10.1016/S1470-0328(02)02927-0; Haylen BT, 2009, INT UROGYNECOL J, V20, pS87; Hunskaar S, 2004, BJU INT, V93, P324, DOI 10.1111/j.1464-410X.2003.04609.x; Jansova M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189842; Jokhio AH, 2013, BJOG-INT J OBSTET GY, V120, P180, DOI 10.1111/1471-0528.12074; Matthews CA, 2014, CURR OPIN OBSTET GYN, V26, P393, DOI 10.1097/GCO.0000000000000094; Megabiaw B, 2013, INT UROGYNECOL J, V24, P1135, DOI 10.1007/s00192-012-1981-y; Melah GS, 2007, J OBSTET GYNAECOL, V27, P819, DOI 10.1080/01443610701709825; Minassian VA, 2008, OBSTET GYNECOL, V111, P324, DOI 10.1097/01.AOG.0000267220.48987.17; Muleta M, 2004, ETHIOPIAN MED J, V42, P9; Muleta M, 2010, ACTA OBSTET GYN SCAN, V89, P945, DOI 10.3109/00016341003801698; National Bureau of statistics, 2016, KEY FIND 2015 2016 T; Niang L, 2010, PROG UROL, V20, P1213, DOI 10.1016/j.purol.2010.01.014; Nygaard I, 2008, JAMA-J AM MED ASSOC, V300, P1311, DOI 10.1001/jama.300.11.1311; Obioha KC, 2015, INT UROGYNECOL J, V26, P1347, DOI 10.1007/s00192-015-2690-0; Ojengbede OA, 2011, BJU INT, V107, P1793, DOI 10.1111/j.1464-410X.2010.09758.x; Okonkwo JEN, 2001, INT J GYNECOL OBSTET, V74, P301, DOI 10.1016/S0020-7292(01)00378-2; Patrick DL, 2013, CLIN THER, V35, P836, DOI 10.1016/j.clinthera.2013.04.013; Pedersen LS, 2017, ACTA OBSTET GYN SCAN, V96, P939, DOI 10.1111/aogs.13149; Rortveit G, 2001, OBSTET GYNECOL, V98, P1004, DOI 10.1016/S0029-7844(01)01566-6; Van Kessel K, 2001, AM J OBSTET GYNECOL, V184, P1571, DOI 10.1067/mob.2001.114856; Walker GJA, 2011, INT UROGYNECOL J, V22, P127, DOI 10.1007/s00192-010-1215-0; Weber AM, 2001, INT UROGYNECOL J PEL, V12, P178, DOI 10.1007/PL00004033; Wood LN, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4531	35	3	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0208733	10.1371/journal.pone.0208733	http://dx.doi.org/10.1371/journal.pone.0208733			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673696	Green Submitted, Green Published, gold			2022-12-26	WOS:000456442800008
J	Chen, XC; Riley, BT; de Veer, SJ; Hoke, DE; Van Haeften, J; Leahy, D; Swedberg, JE; Brattsand, M; Hartfield, PJ; Buckle, AM; Harris, JM				Chen, Xingchen; Riley, Blake T.; de Veer, Simon J.; Hoke, David E.; Van Haeften, Jessica; Leahy, Darren; Swedberg, Joakim E.; Brattsand, Maria; Hartfield, Perry J.; Buckle, Ashley M.; Harris, Jonathan M.			Potent, multi-target serine protease inhibition achieved by a simplified beta-sheet motif	PLOS ONE			English	Article							PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; LEKTI; PARAMETERS; MECHANISM; DESIGN; LIBRARY; CASCADE	Engagement of an extended beta-sheet is a common substrate/inhibitor interaction at the active site of serine proteases and is an important feature of Laskowski mechanism inhibitors that present a substrate-like loop to a target protease. This loop is cleaved but subsequently relegated forming a stable inhibitor/protease complex. Laskowski inhibitors are ubiquitous in nature and are used extensively in serine protease inhibitor design. However, most studies concentrate on introducing new sidechain interactions rather than the direct contributions of the substrate-like beta-sheet to enzyme inhibition. Here we report the crystal structure of an simplified beta-sheet inhibitory motif within the Sunflower Trypsin Inhibitor (SFTI) in complex with trypsin. We show that the intramolecular hydrogen bond network of this SFTI variant (SFTI-TCTR) engages the inhibitor sidechains that would normally interact with a target protease, giving mainchain interactions a more prominent role in complex formation. Despite having reduced sidechain interactions, this SFTI variant is remarkably potent and inhibits a diverse range of serine proteases. Crystal structural analysis and molecular modelling of SFTI-TCTR complexes again indicates an interface dominated by beta-sheet interactions, highlighting the importance of this motif and the adaptability of SFTI as a scaffold for inhibitor design.	[Chen, Xingchen; Van Haeften, Jessica; Leahy, Darren; Hartfield, Perry J.; Harris, Jonathan M.] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld, Australia; [Riley, Blake T.; Hoke, David E.; Buckle, Ashley M.] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [de Veer, Simon J.; Swedberg, Joakim E.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Brattsand, Maria] Umea Univ, Dept Med Biosci, Umea, Sweden	Queensland University of Technology (QUT); Monash University; University of Queensland; Umea University	Harris, JM (corresponding author), Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld, Australia.	j2.harris@qut.edu.au	Riley, Blake T./ABD-8129-2020; Brattsand, Maria/AAG-7777-2019	Riley, Blake T./0000-0003-2176-0503; Brattsand, Maria/0000-0001-7175-1336; Buckle, Ashley/0000-0003-2943-9044	Australian National Health and Medical Research Council [1059410]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a grant from the Australian National Health and Medical Research Council to JMH, #1059410. The organization played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bachovchin DA, 2012, NAT REV DRUG DISCOV, V11, P52, DOI 10.1038/nrd3620; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BIDSTRUP BP, 1989, J THORAC CARDIOV SUR, V97, P364; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Case D.A., 2022, AMBER; Chan WC, 2000, FMOC SOLID PHASE PEP; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Cicardi M, 2010, NEW ENGL J MED, V363, P523, DOI 10.1056/NEJMoa0905079; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Veer SJ, 2015, J MED CHEM, V58, P8257, DOI 10.1021/acs.jmedchem.5b01148; de Veer SJ, 2015, BIOCHEM J, V469, P243, DOI 10.1042/BJ20150412; de Veer SJ, 2013, BIOPOLYMERS, V100, P510, DOI [10.1002/bip.22231, 10.1002/peps.22231]; Debela M, 2007, P NATL ACAD SCI USA, V104, P16086, DOI 10.1073/pnas.0707811104; Debowski D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089465; Deraison C, 2007, MOL BIOL CELL, V18, P3607, DOI 10.1091/mbc.E07-02-0124; deVeer SJ, 2016, J INVESTIGATIVE DERM; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fortugno P, 2011, J INVEST DERMATOL, V131, P2223, DOI 10.1038/jid.2011.174; Gitlin A, 2015, CHEMBIOCHEM, V16, P1601, DOI 10.1002/cbic.201500200; Hachem JP, 2006, J INVEST DERMATOL, V126, P1609, DOI 10.1038/sj.jid.5700288; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jones E., 2001, SCIPY OPEN SOURCE SC; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Li P, 2007, J MED CHEM, V50, P5976, DOI 10.1021/jm0704898; Li PF, 2013, J CHEM THEORY COMPUT, V9, P2733, DOI 10.1021/ct400146w; Lu WY, 1997, J MOL BIOL, V266, P441, DOI 10.1006/jmbi.1996.0781; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; Magert HJ, 1999, J BIOL CHEM, V274, P21499, DOI 10.1074/jbc.274.31.21499; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Oliveira JPC, 2014, ACS MED CHEM LETT, V5, P128, DOI 10.1021/ml4003698; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Puente XS, 2004, GENOME RES, V14, P609, DOI 10.1101/gr.1946304; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Scheidig AJ, 1997, PROTEIN SCI, V6, P1806, DOI 10.1002/pro.5560060902; Schrodinger L.L.C.,, 2015, PYMOL MOL GRAPHICS S; Scott CJ, 2010, BIOCHIMIE, V92, P1681, DOI 10.1016/j.biochi.2010.03.010; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Swedberg JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019302; Swedberg JE, 2010, BIOL CHEM, V391, P357, DOI 10.1515/BC.2010.037; Swedberg JE, 2009, CHEM BIOL, V16, P633, DOI 10.1016/j.chembiol.2009.05.008; Wernet P, 2004, SCIENCE, V304, P995, DOI 10.1126/science.1096205	53	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210842	10.1371/journal.pone.0210842	http://dx.doi.org/10.1371/journal.pone.0210842			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668585	Green Published, Green Submitted, gold			2022-12-26	WOS:000456306400019
J	Hindberg, K; Hannig, J; Godtliebsen, F				Hindberg, Kristian; Hannig, Jan; Godtliebsen, Fred			A novel scale-space approach for multinormality testing and the k-sample problem in the high dimension low sample size scenario	PLOS ONE			English	Article							GOODNESS-OF-FIT; VARIANCE TEST; MULTIVARIATE; NORMALITY; SHAPIRO; UNIVARIATE; POWERFUL; WILK	Two classical multivariate statistical problems, testing of multivariate normality and the k-sample problem, are explored by a novel analysis on several resolutions simultaneously. The presented methods do not invert any estimated covariance matrix. Thereby, the methods work in the High Dimension Low Sample Size situation, i.e. when n <= p. The output, a significance map, is produced by doing a one-dimensional test for all possible resolution/position pairs. The significance map shows for which resolution/position pairs the null hypothesis is rejected. For the testing of multinormality, the Anderson-Darling test is utilized to detect potential departures from multinormality at different combinations of resolutions and positions. In the k-sample case, it is tested whether k data sets can be said to originate from the same unspecified discrete or continuous multivariate distribution. This is done by testing the k vectors corresponding to the same resolution/position pair of the k different data sets through the k-sample Anderson-Darling test. Successful demonstrations of the new methodology on artificial and real data sets are presented, and a feature selection scheme is demonstrated.	[Hindberg, Kristian; Godtliebsen, Fred] Univ Tromso, Dept Math & Stat, Tromso, Norway; [Hannig, Jan] Univ N Carolina, Dept Stat & Operat Res, Chapel Hill, NC 27515 USA	UiT The Arctic University of Tromso; University of North Carolina; University of North Carolina Chapel Hill	Hindberg, K (corresponding author), Univ Tromso, Dept Math & Stat, Tromso, Norway.	kristian.hindberg@uit.no	Hannig, Jan/T-1862-2019	Hannig, Jan/0000-0002-4164-0173	National Science Foundation of the United States [1512945, 1633074l]; eVita program of the Norwegian Research Council [176872/V30]	National Science Foundation of the United States(National Science Foundation (NSF)); eVita program of the Norwegian Research Council	J.H. received funding from the National Science Foundation of the United States (https://www.nsf.gov/) under Grant No. 1512945 and 1633074l. F.G. received funding from the eVita program (grant number 176872/V30) of the Norwegian Research Council (https://www.forskningsradet.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON TW, 1954, J AM STAT ASSOC, V49, P765, DOI 10.2307/2281537; ANDERSON TW, 1952, ANN MATH STAT, V23, P193, DOI 10.1214/aoms/1177729437; Aslan B, 2005, NUCL INSTRUM METH A, V537, P626, DOI 10.1016/j.nima.2004.08.071; Baringhaus L, 2004, J MULTIVARIATE ANAL, V88, P190, DOI 10.1016/S0047-259X(03)00079-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chaudhuri P, 2000, ANN STAT, V28, P408, DOI 10.1214/aos/1016218224; Chaudhuri P, 1999, J AM STAT ASSOC, V94, P807, DOI 10.2307/2669996; COX DR, 1994, APPL STAT-J ROY ST C, V43, P347, DOI 10.2307/2986025; DAgostino R. B., 1986, GOODNESS OF FIT TECH, V68; DAGOSTINO RB, 1990, AM STAT, V44, P316, DOI 10.2307/2684359; Doornik JA, 2008, OXFORD B ECON STAT, V70, P927, DOI 10.1111/j.1468-0084.2008.00537.x; Farrell PJ, 2007, J STAT COMPUT SIM, V77, P1053, DOI 10.1080/10629360600878449; FRIEDMAN JH, 1979, ANN STAT, V7, P697, DOI 10.1214/aos/1176344722; Godtliebsen F, 2004, IMAGE VISION COMPUT, V22, P1093, DOI 10.1016/j.imavis.2004.05.002; Godtliebsen F, 2002, J COMPUT GRAPH STAT, V11, P1, DOI 10.1198/106186002317375596; Hall P, 2002, BIOMETRIKA, V89, P359, DOI 10.1093/biomet/89.2.359; Hanusz Z, 2012, J STAT COMPUT SIM, V82, P1743, DOI 10.1080/00949655.2011.594051; Hastie T., 2009, UNSUPERVISED LEARNIN; HENZE N, 1988, ANN STAT, V16, P772, DOI 10.1214/aos/1176350835; Hochberg Y., 1987, WILEY SERIES PROBABI; Holmstrom L, 2017, INT STAT REV, V85, P1, DOI 10.1111/insr.12155; JARQUE CM, 1980, ECON LETT, V6, P255, DOI 10.1016/0165-1765(80)90024-5; KIEFER J, 1959, ANN MATH STAT, V30, P420, DOI 10.1214/aoms/1177706261; Lehmann E.L., 1998, ELEMENTS LARGE SAMPL; LEWIS PA, 1961, ANN MATH STAT, V32, P1118, DOI 10.1214/aoms/1177704850; Liang JJ, 2009, COMPUT STAT DATA AN, V53, P3883, DOI 10.1016/j.csda.2009.04.016; Liang JJ, 2000, J STAT PLAN INFER, V86, P129, DOI 10.1016/S0378-3758(99)00168-8; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; LOONEY SW, 1995, AM STAT, V49, P64, DOI 10.2307/2684816; Lopes M., 2011, ADV NEURAL INFORM PR, P1206; MAAG UR, 1966, BIOMETRIKA, V53, P579; MARDIA KV, 1970, BIOMETRIKA, V57, P519, DOI 10.1093/biomet/57.3.519; Marsaglia G, 2005, J STAT SOFTW, V14; Mecklin CJ, 2004, INT STAT REV, V72, P123; Oigard TA, 2006, COMPUT STAT DATA AN, V51, P1719, DOI 10.1016/j.csda.2006.07.034; PEARSON ES, 1977, BIOMETRIKA, V64, P231; PETTITT AN, 1976, BIOMETRIKA, V63, P161, DOI 10.2307/2335097; Rahman MM, 1997, J APPL STAT, V24, P219, DOI 10.1080/02664769723828; ROMEU JL, 1993, J MULTIVARIATE ANAL, V46, P309, DOI 10.1006/jmva.1993.1063; Royston P, 1992, STAT COMPUT, V2, P117, DOI [DOI 10.1007/BF01891203, 10.1007/BF01891203]; SCHOLZ FW, 1987, J AM STAT ASSOC, V82, P918, DOI 10.2307/2288805; SHAPIRO SS, 1972, J AM STAT ASSOC, V67, P215, DOI 10.2307/2284728; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; SINCLAIR CD, 1988, J AM STAT ASSOC, V83, P1190, DOI 10.2307/2290155; Sorbye SH, 2009, COMPUT STAT DATA AN, V53, P3746, DOI 10.1016/j.csda.2009.03.020; STEPHENS MA, 1968, BIOMETRIKA, V55, P428, DOI 10.2307/2334889; STEPHENS MA, 1974, J AM STAT ASSOC, V69, P730, DOI 10.2307/2286009; STEPHENS MA, 1965, BIOMETRIKA, V52, P309, DOI 10.1093/biomet/52.3-4.309; Surucu B, 2006, COMMUN STAT-THEOR M, V35, P1319, DOI 10.1080/03610920600628999; Szekely G.J., 2004, INTERSTAT, V5, P1; Thode H.C., 2002, TESTING NORMALITY; Alva JAV, 2009, COMMUN STAT-THEOR M, V38, P1870, DOI 10.1080/03610920802474465; Wand M.P., 1995, MONOGRAPHS STAT APPL, V60; WATSON GS, 1961, BIOMETRIKA, V48, P109, DOI 10.2307/2333135; Wei S, 2016, J COMPUT GRAPH STAT, V25, P549, DOI 10.1080/10618600.2015.1027773; Witkin AP, IEEE INT C ICASSP 84, V9, P150; Witkin AP, 8 INT JOINT C ART IN, P1010	57	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0211044	10.1371/journal.pone.0211044	http://dx.doi.org/10.1371/journal.pone.0211044			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668596	Green Published, gold, Green Submitted			2022-12-26	WOS:000456306400028
J	Gehrig, S; Schluter, A; Hammerstein, P				Gehrig, Stefan; Schlueter, Achim; Hammerstein, Peter			Sociocultural heterogeneity in a common pool resource dilemma	PLOS ONE			English	Article							ARTIFACTUAL FIELD EXPERIMENTS; COLLECTIVE ACTION; PUBLIC-GOODS; COOPERATION; EVOLUTION; FISHERIES; TRAGEDY; TRUST; GAME; SUSTAINABILITY	Collective action of resource users is essential for sustainability. Yet, often user groups are socioculturally heterogeneous, which requires cooperation to be established across salient group boundaries. We explore the effect of this type of heterogeneity on resource extraction in lab-in-the-field Common Pool Resource (CPR) experiments in Zanzibar, Tanzania. We create heterogeneous groups by mixing fishers from two neighbouring fishing villages which have distinct social identities, a history of conflict and diverging resource use practices and institutions. Additionally, we analyse between-village differences in extraction behaviour in the heterogeneous setting to assess if out-group cooperation in a CPR dilemma is associated with a community's institutional scope in the economic realm (e.g., degree of market integration). We find no aggregate effect of heterogeneity on extraction. However, this is because fishers from the two villages behave differently in the heterogeneity treatment. We find support for the hypothesis that cooperation under sociocultural heterogeneity is higher for fishers from the village with larger institutional scope. In line with this explanation, cooperation under heterogeneity also correlates with a survey measure of individual fishers' radius of trust. We discuss implications for resource governance and collective action research.	[Gehrig, Stefan; Schlueter, Achim] Leibniz Ctr Trop Marine Res ZMT, Dept Social Sci, Bremen, Germany; [Schlueter, Achim] Jacobs Univ, Dept Econ & Business, Bremen, Germany; [Hammerstein, Peter] Humboldt Univ, Inst Theoret Biol, Berlin, Germany	Leibniz Zentrum fur Marine Tropenforschung (ZMT); Jacobs University; Humboldt University of Berlin	Gehrig, S (corresponding author), Leibniz Ctr Trop Marine Res ZMT, Dept Social Sci, Bremen, Germany.	stefan-gehrig@t-online.de	Gehrig, Stefan/L-7990-2019	Gehrig, Stefan/0000-0002-5270-9578	Leibniz Association [SAW-2013-ZMT-4 234]; Leibniz Center for Tropical Marine Research (ZMT) within the project Sustainable Use of Tropical Aquatic Systems (SUTAS)	Leibniz Association; Leibniz Center for Tropical Marine Research (ZMT) within the project Sustainable Use of Tropical Aquatic Systems (SUTAS)	The work was funded by the Leibniz Association (SAW-2013-ZMT-4 234) and the Leibniz Center for Tropical Marine Research (ZMT) within the project Sustainable Use of Tropical Aquatic Systems (SUTAS).	Adger WN, 2003, ECON GEOGR, V79, P387; Agrawal A, 2001, WORLD DEV, V29, P1649, DOI 10.1016/S0305-750X(01)00063-8; Alvard MS, 2004, ULTIMATUM GAME FAIRN, P413; Anderies JM, 2011, ECOL ECON, V70, P1571, DOI 10.1016/j.ecolecon.2011.01.011; Andrews J, 2018, SUSTAIN SCI, P1; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Apesteguia J, 2006, J CONFLICT RESOLUT, V50, P646, DOI 10.1177/0022002706290433; Balliet D, 2014, PSYCHOL BULL, V140, P1556, DOI 10.1037/a0037737; Bardhan Pranab K., 2002, DRAMA COMMONS, P87; Basurto X, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501220; Beckenkamp M., 2006, CENTRAL EUROPEAN J O, V14, P337, DOI DOI 10.1007/S10100-006-0008-5; Berkes F, 2000, ECOL APPL, V10, P1251, DOI 10.1890/1051-0761(2000)010[1251:ROTEKA]2.0.CO;2; Bowles S., 2004, ROUNDTABLE SER BEHAV; Burns J, 2015, J ECON BEHAV ORGAN, V118, P110, DOI 10.1016/j.jebo.2015.02.018; Carballo DM, 2014, J ARCHAEOL METHOD TH, V21, P98, DOI 10.1007/s10816-012-9147-2; Cardenas JC, 2004, AGR SYST, V82, P307, DOI 10.1016/j.agsy.2004.07.008; Carpenter J, 2011, ECON INQ, V49, P612, DOI 10.1111/j.1465-7295.2009.00268.x; Castillo D, 2011, ECOL ECON, V70, P1609, DOI 10.1016/j.ecolecon.2011.05.011; Chen Y, 2009, AM ECON REV, V99, P431, DOI 10.1257/aer.99.1.431; Christensen RHB., 2015, ORDINAL REGRESSION M; Cinner JE, 2009, CURR BIOL, V19, P206, DOI 10.1016/j.cub.2008.11.055; Croissant Y, 2008, J STAT SOFTW, V27, P1; Cumming GS, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12376; de la Torre-Castro M., 2012, PEOPLE NATURE RES CH; de la Torre- Castro M, 2012, MANAGEMENT CHALLENGE, P279; de la Torre-Castro M, 2006, ECOL SOC, V11; de la Torre-Castro M, 2014, MAR POLLUT BULL, V83, P398, DOI 10.1016/j.marpolbul.2014.03.034; de la Torre-Castro M, 2010, MAR POLICY, V34, P77, DOI 10.1016/j.marpol.2009.04.012; de Melo G, 2015, ECOL ECON, V120, P376, DOI 10.1016/j.ecolecon.2015.05.011; Elsner W, 2014, J I ECON, V10, P107, DOI 10.1017/S1744137413000179; Eriksson K, 2014, JUDGM DECIS MAK, V9, P360; FEENY D, 1990, HUM ECOL, V18, P1, DOI 10.1007/BF00889070; Fehr E, 2011, J PUBLIC ECON, V95, P1144, DOI 10.1016/j.jpubeco.2011.05.013; Gehrig S, 2018, MAR POLICY, V96, P100, DOI 10.1016/j.marpol.2018.06.017; Gelcich S, 2013, ECOL SOC, V18, DOI 10.5751/ES-05598-180302; Gneezy U, 2016, ECON J, V126, P1856, DOI 10.1111/ecoj.12209; Gowdy J, 2013, ECOL ECON, V95, P137, DOI 10.1016/j.ecolecon.2013.08.006; Guerrero AM, 2015, CONSERV LETT, V8, P107, DOI 10.1111/conl.12112; Gurven MD, 2018, P NATL ACAD SCI USA, V115, P11420, DOI 10.1073/pnas.1720433115; Hagen EH, 2006, THEOR POPUL BIOL, V69, P339, DOI 10.1016/j.tpb.2005.09.005; Hakansson E, 2012, PEOPLE NATURE RES CH, P234; Handberg ON, 2015, J ECON BEHAV ORGAN, V118, P346, DOI 10.1016/j.jebo.2015.03.007; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Henningsen A., 2017, CENSREG CENSORED REG; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; HIRSCHMAN AO, 1982, J ECON LIT, V20, P1463; Hruschka DJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00559; Jiddawi N., 2012, PEOPLE NATURE RES CH, P23; Jiddawi N. S., 2012, PEOPLE NATURE RES CH, P193; Jiddawi NS, 2002, AMBIO, V31, P518, DOI 10.1639/0044-7447(2002)031[0518:MFIT]2.0.CO;2; Kasper C, 2015, CURR ANTHROPOL, V56, P701, DOI 10.1086/683024; Khadjavi M, 2017, SOCIAL CAPITAL LARGE; Kinship Enke B., Q J EC; Kline MA, 2018, SUSTAIN SCI, V13, P9, DOI 10.1007/s11625-017-0509-2; Lamba S, 2011, P NATL ACAD SCI USA, V108, P14426, DOI 10.1073/pnas.1105186108; Lindstrom L, 2015, PROMOTING GOVERNABIL, P671; Lindstrom L, 2015, MARE PUBL SER, V13, P671, DOI 10.1007/978-3-319-17034-3_34; Mulder M.B., 2005, CONSERVATION LINKING; Myers GA, 2002, AREA, V34, P149, DOI 10.1111/1475-4762.00067; Nee V, 2018, ORGAN SCI, V29, P969, DOI 10.1287/orsc.2018.1213; Ortmann A., 2005, FIELD EXPT EC, P51; Ostrom E, 2000, J ECON PERSPECT, V14, P137, DOI 10.1257/jep.14.3.137; Ostrom E, 1994, GAMES COMMON POOL RE; Ostrom E., 1990, GOVERNING COMMONS EV; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104; Paciotti B, 2003, CURR ANTHROPOL, V44, P427, DOI 10.1086/374903; Pakenham R. H. W., 1947, LAND TENURE WAHADIMU; Pisor AC, 2018, PEERJ PREPR; Pretty J, 2003, SCIENCE, V302, P1912, DOI 10.1126/science.1090847; Rehren J., 2017, THESIS U BREMEN U BR; Richerson P.J., 1996, PRINCIPLES HUMAN ECO; Romano A, 2017, P NATL ACAD SCI USA, V114, P12702, DOI 10.1073/pnas.1712921114; Rommel J, 2015, ENVIRON SCI POLICY, V53, P96, DOI 10.1016/j.envsci.2014.05.006; Rustagi D, 2010, SCIENCE, V330, P961, DOI 10.1126/science.1193649; Ruttan LM, 2006, CURR ANTHROPOL, V47, P843, DOI 10.1086/507185; Schaub Max, 2017, Proc Biol Sci, V284, DOI 10.1098/rspb.2017.1560; Schroeder KB, 2014, PEERJ, V2, DOI 10.7717/peerj.450; TAJFEL H., 1986, DIFFERENTIATION SOCI, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; Torres-Guevara LE, 2016, ECOL ECON, V128, P187, DOI 10.1016/j.ecolecon.2016.04.022; Varughese G, 2001, WORLD DEV, V29, P747, DOI 10.1016/S0305-750X(01)00012-2; Voors M, 2011, AM ECON REV, V101, P329, DOI 10.1257/aer.101.3.329; Wallner-Hahn S, 2016, MAR POLICY, V72, P199, DOI 10.1016/j.marpol.2016.07.001; Waring TM, 2015, ECOL SOC, V20, DOI 10.5751/ES-07634-200234; Welzel C, 2015, J CROSS CULT PSYCHOL, V46, P875, DOI 10.1177/0022022115588366; Wible B, 2018, SCIENCE, V362, P1236, DOI 10.1126/science.aaw0911	86	7	7	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210561	10.1371/journal.pone.0210561	http://dx.doi.org/10.1371/journal.pone.0210561			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653546	Green Published, Green Submitted, gold			2022-12-26	WOS:000456015500051
J	Forczek, W; Maslon, A; Fraczek, B; Curylo, M; Salamaga, M; Suder, A				Forczek, Wanda; Maslon, Agata; Fraczek, Barbara; Curylo, Marta; Salamaga, Marcin; Suder, Agnieszka			Does the first trimester of pregnancy induce alterations in the walking pattern?	PLOS ONE			English	Article							WAIST CIRCUMFERENCE; PLANTAR PRESSURE; LUMBAR LORDOSIS; ARCH INDEX; FOOT ARCH; GAIT; WOMEN; PAIN; ADAPTATIONS; PARAMETERS	Introduction From among many studies observing the walking pattern throughout pregnancy, only two items monitor the influence of pregnancy on the movement system during gait considering the period before gestation. Research question Does the women's gait pattern at the end of the first trimester undergo changes in comparison to body movement pattern before pregnancy? Methods All subjects who met the inclusion criteria gave signed and informed consent before the study. Two experimental sessions were arranged according to the same protocol: (P0) before pregnancy and (P1) at the end of the first trimester of pregnancy (12th week of gestation). At first the anthropometric measures were taken. Then, walking trials at a self-selected speed along a walkway were registered with Vicon 250 (Oxford Metrics Ltd.; Oxford, UK) and FreeMED force platform (Sensor Medica, Italy). Results An analysis of anthropometric parameters in 12 th pregnancy week demonstrated significant changes in mean values of waist circumference and waist to hip ratio as well as waist to height ratio indexes compared to the results before pregnancy. No significant differences were found in the basic kinematic gait parameters between experimental conditions. Significant increase of mean inter-ankle distance during double support phase occurred during the first trimester of pregnancy. Also, the ratio of the ankle separation width to the pelvic width was noticeably higher in gestation. Then, angular changes of the pelvis in coronal and transverse planes throughout gait cycle during pregnancy demonstrated significant differences compared to those measured before pregnancy. At the same time in the first trimester of pregnancy no adaptive changes in the pattern of feet loading take place. Significance Since our study is of longitudinal character, in the course of pregnancy we expect compensatory mechanisms more clearly demonstrated. Therefore, we hope to identify a strategy of the gravid body progression in space.	[Forczek, Wanda] Univ Phys Educ, Fac Phys Educ & Sport, Sect Biomech, Krakow, Poland; [Maslon, Agata] Univ Phys Educ, Fac Motor Rehabil, Sect Rehabil Orthopaed, Dept Clin Rehabil, Krakow, Poland; [Maslon, Agata] Univ Phys Educ, Fac Motor Rehabil, Lab Pathol Musculoskeletal Syst, Krakow, Poland; [Fraczek, Barbara] Univ Phys Educ, Fac Phys Educ & Sport, Sect Human Nutr, Krakow, Poland; [Curylo, Marta] Univ Phys Educ, Fac Motor Rehabil, Dept Clin Rehabil, Sect Rehabil Internal Dis, Krakow, Poland; [Salamaga, Marcin] Cracow Univ Econ, Dept Stat, Krakow, Poland; [Suder, Agnieszka] Univ Phys Educ, Fac Motor Rehabil, Sect Anat, Dept Physiotherapy, Krakow, Poland	Cracow University of Economics	Forczek, W (corresponding author), Univ Phys Educ, Fac Phys Educ & Sport, Sect Biomech, Krakow, Poland.	wanda.forczek@awf.krakow.pl	Forczek, Wanda/AAM-8461-2020; Suder, Agnieszka/GZA-5397-2022; Salamaga, Marcin/T-3370-2018	Forczek, Wanda/0000-0002-6890-2823; Fraczek, Barbara/0000-0002-5673-6135; Salamaga, Marcin/0000-0003-0225-6651; Maslon, Agata/0000-0001-5081-2179; Suder, Agnieszka/0000-0001-6135-8274	 [99/BS/INB/2016]		Sources of financing: Research project No 99/BS/INB/2016 realised within statutory activities.	ALVAREZ R, 1988, J BONE JOINT SURG AM, V70A, P271, DOI 10.2106/00004623-198870020-00017; Bertuit J, 2015, ACTA BIOENG BIOMECH, V17, P93, DOI 10.5277/ABB-00092-2014-03; Blaszczyk JW, 2016, GAIT POSTURE, V43, P160, DOI 10.1016/j.gaitpost.2015.09.016; Branchtein L, 1997, DIABETES CARE, V20, P509, DOI 10.2337/diacare.20.4.509; Branco M, 2015, 3 DIMENSIONAL KINETI, DOI [10.1155/2015/580374, DOI 10.1155/2015/580374]; Branco Marco, 2014, ScientificWorldJournal, V2014, P527940, DOI 10.1155/2014/527940; Branco MAC, 2016, ACTA BIOENG BIOMECH, V18, P153, DOI 10.5277/ABB-00418-2015-05; Bus SA, 2005, CLIN BIOMECH, V20, P892, DOI 10.1016/j.clinbiomech.2005.05.004; Butler EE, 2006, AM J OBSTET GYNECOL, V195, P1104, DOI 10.1016/j.ajog.2006.06.015; Carpes FP., 2008, BRAZILIAN J BIOMECH, V9, P33; CAVANAGH PR, 1987, J BIOMECH, V20, P547, DOI 10.1016/0021-9290(87)90255-7; Conti MHS, 2003, FEMINA, V31, P531; Dumas GA, 1997, J ORTHOP SPORT PHYS, V26, P2, DOI 10.2519/jospt.1997.26.1.2; Dunning K, 2010, MATERN CHILD HLTH J, V14, P720, DOI 10.1007/s10995-009-0511-0; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Forczek W, 2018, GAIT POSTURE, V62, P7, DOI 10.1016/j.gaitpost.2018.02.024; Forczek W, 2012, ACTA BIOENG BIOMECH, V14, P113, DOI 10.5277/abb120413; Foti T, 2000, J BONE JOINT SURG AM, V82A, P625, DOI 10.2106/00004623-200005000-00003; Gilleard WL, 2018, L N COMPUT VIS BIOME, V29, P109, DOI 10.1007/978-3-319-71574-2_9; Gilleard WL, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-71; Goldberg J, 2002, OBSTET GYNECOL, V99, P395, DOI 10.1016/S0029-7844(01)01756-2; Hagan L., 2010, J WOMENS HLTH PHYS T, V34, P46, DOI DOI 10.1097/JWH.0B013E3181E8FD4D; Jelen K, 2005, NEUROENDOCRINOL LETT, V26, P752; Karadag-Saygi E, 2010, FOOT ANKLE INT, V31, P153, DOI 10.3113/FAI.2010.0153; Krkeljas Z, 2018, HUM MOVEMENT SCI, V58, P315, DOI 10.1016/j.humov.2017.12.011; Levine D, 1996, J ORTHOP SPORT PHYS, V24, P130, DOI 10.2519/jospt.1996.24.3.130; Nyska M, 1997, ISRAEL J MED SCI, V33, P139; Ojukwu CP, 2017, MED PRIN PRACT, V26, P480, DOI 10.1159/000481622; Perry J., 1992, GAIT ANAL NORMAL PAT; Ribeiro AP, 2013, WOMENS HEALTH, V9, P99, DOI [10.2217/WHE.12.59, 10.2217/whe.12.59]; Ribeiro AP, 2011, J AM PODIATR MED ASS, V101; SAUNDERS JBDM, 1953, J BONE JOINT SURG AM, V35-A, P543, DOI 10.2106/00004623-195335030-00003; Segal NA., 2015, MUSCULOSKELETAL HLTH, P1, DOI [10.1007/ 978-3-319-14319-4_1, DOI 10.1007/978-3-319-14319-4_1, 10.1007/978-3-319-14319-4_1]; Segal NA, 2013, AM J PHYS MED REHAB, V92, P232, DOI 10.1097/PHM.0b013e31827443a9; SHIRAZIADL A, 1987, J BIOMECH, V20, P601, DOI 10.1016/0021-9290(87)90281-8; Sunaga Y, 2013, APPL ERGON, V44, P792, DOI 10.1016/j.apergo.2013.01.010; Weiner J. S., 1969, IBP HDB, V9; Wendland EMDR, 2007, CAD SAUDE PUBLICA, V23, P391, DOI 10.1590/S0102-311X2007000200015; Whitcome KK, 2007, NATURE, V450, P1075, DOI 10.1038/nature06342; Yoo H, 2015, J PHYS THER SCI, V27, P279, DOI 10.1589/jpts.27.279	40	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209766	10.1371/journal.pone.0209766	http://dx.doi.org/10.1371/journal.pone.0209766			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650108	Green Published, Green Submitted, gold			2022-12-26	WOS:000455813300026
J	McGinnis, RS; McGinnis, EW; Hruschak, J; Lopez-Duran, NL; Fitzgerald, K; Rosenblum, KL; Muzik, M				McGinnis, Ryan S.; McGinnis, Ellen W.; Hruschak, Jessica; Lopez-Duran, Nestor L.; Fitzgerald, Kate; Rosenblum, Katherine L.; Muzik, Maria			Rapid detection of internalizing diagnosis in young children enabled by wearable sensors and machine learning	PLOS ONE			English	Article							PRESCHOOL DEPRESSION; BEHAVIOR CHECKLIST; ANXIETY DISORDERS; EMOTION REGULATION; EARLY-CHILDHOOD; MENTAL-HEALTH; AGES 3; PARENT; PSYCHOPATHOLOGY; ADOLESCENCE	There is a critical need for fast, inexpensive, objective, and accurate screening tools for childhood psychopathology. Perhaps most compelling is in the case of internalizing disorders, like anxiety and depression, where unobservable symptoms cause children to go unassessed-suffering in silence because they never exhibiting the disruptive behaviors that would lead to a referral for diagnostic assessment. If left untreated these disorders are associated with long-term negative outcomes including substance abuse and increased risk for suicide. This paper presents a new approach for identifying children with internalizing disorders using an instrumented 90-second mood induction task. Participant motion during the task is monitored using a commercially available wearable sensor. We show that machine learning can be used to differentiate children with an internalizing diagnosis from controls with 81% accuracy (67% sensitivity, 88% specificity). We provide a detailed description of the modeling methodology used to arrive at these results and explore further the predictive ability of each temporal phase of the mood induction task. Kinematical measures most discriminative of internalizing diagnosis are analyzed in detail, showing affected children exhibit significantly more avoidance of ambiguous threat. Performance of the proposed approach is compared to clinical thresholds on parent-reported child symptoms which differentiate children with an internalizing diagnosis from controls with slightly lower accuracy (.68-. 75 vs. .81), slightly higher specificity (.88-1.00 vs. .88), and lower sensitivity (.00-. 42 vs. .67) than the proposed, instrumented method. These results point toward the future use of this approach for screening children for internalizing disorders so that interventions can be deployed when they have the highest chance for long-term success.	[McGinnis, Ryan S.] Univ Vermont, Dept Elect & Biomed Engn, Burlington, VT USA; [McGinnis, Ellen W.] Univ Vermont, Dept Psychiat, Burlington, VT 05405 USA; [McGinnis, Ellen W.; Lopez-Duran, Nestor L.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Hruschak, Jessica; Fitzgerald, Kate; Rosenblum, Katherine L.; Muzik, Maria] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA	University of Vermont; University of Vermont; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	McGinnis, EW (corresponding author), Univ Vermont, Dept Psychiat, Burlington, VT 05405 USA.; McGinnis, EW (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	ryan.mcginnis@uvm.edu	Rosenblum, Katherine/AAC-5921-2019; Fitzgerald, Kate D./AAV-7278-2020	McGinnis, Ryan/0000-0001-8396-6967; Lopez-Duran, Nestor/0000-0003-0666-496X	Michigan Institute for Clinical and Health Research [UL1TR000433]; Blue Cross Blue Shield of Michigan Foundation [1982.SAP]; Brain Behavior Research Foundation; National Institute of Mental Health [R03MH102648]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002240, UL1TR000433] Funding Source: NIH RePORTER	Michigan Institute for Clinical and Health Research; Blue Cross Blue Shield of Michigan Foundation; Brain Behavior Research Foundation(NARSAD); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work received support from the following sources: Michigan Institute for Clinical and Health Research (UL1TR000433, PI: Muzik; Biomedical and Social Sciences Scholar Program, University of Michigan PI: E.W. McGinnis); Blue Cross Blue Shield of Michigan Foundation Grant (1982.SAP, PI: E.W. McGinnis); Brain Behavior Research Foundation (PI: Fitzgerald); National Institute of Mental Health R03MH102648 (PI: Fitzgerald; Rosenblum). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHENBACH TM, 1991, MONOGR SOC RES CHILD, V56, pR5; Achenbach TM, 2001, ASEBA SCHOOL AGE FOR; Adrian M, 2011, J EXP CHILD PSYCHOL, V110, P171, DOI 10.1016/j.jecp.2011.03.009; [Anonymous], JOURNALIST DC IS A F; Aschenbrand SG, 2005, J CLIN CHILD ADOLESC, V34, P735, DOI 10.1207/s15374424jccp3404_15; Beesdo K, 2007, ARCH GEN PSYCHIAT, V64, P903, DOI 10.1001/archpsyc.64.8.903; Belden AC, 2012, J AM ACAD CHILD PSY, V51, P889, DOI 10.1016/j.jaac.2012.06.018; Bittner A, 2007, J CHILD PSYCHOL PSYC, V48, P1174, DOI 10.1111/j.1469-7610.2007.01812.x; Bufferd SJ, 2012, AM J PSYCHIAT, V169, P1157, DOI 10.1176/appi.ajp.2012.12020268; Bufferd SJ, 2011, COMPR PSYCHIAT, V52, P359, DOI 10.1016/j.comppsych.2010.08.006; Calkins SD, 2008, DEV PSYCHOBIOL, V50, P751, DOI 10.1002/dev.20344; Chansky TE, 1997, J ANXIETY DISORD, V11, P347, DOI 10.1016/S0887-6185(97)00015-7; Chorney JM, 2015, J PEDIATR PSYCHOL, V40, P154, DOI 10.1093/jpepsy/jsu099; Cole DA, 1998, J CONSULT CLIN PSYCH, V66, P451, DOI 10.1037/0022-006X.66.3.451; Compton SN, 2002, J CONSULT CLIN PSYCH, V70, P1240, DOI 10.1037//0022-006X.70.6.1240; Craske MG, 2016, LANCET, V388, P3048, DOI 10.1016/S0140-6736(16)30381-6; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; de la Osa N, 2016, EUR CHILD ADOLES PSY, V25, P17, DOI 10.1007/s00787-015-0694-4; De Los Reyes A, 2015, PSYCHOL BULL, V141, P858, DOI 10.1037/a0038498; Durbin CE, 2007, EMOTION, V7, P388, DOI 10.1037/1528-3542.7.2.388; Egger HL, 2006, J CHILD PSYCHOL PSYC, V47, P313, DOI 10.1111/j.1469-7610.2006.01618.x; Elenko E, 2015, NAT BIOTECHNOL, DOI [10.1038/nbt0715-683a, DOI 10.1038/NBT0715-683A]; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gaffrey MS, 2012, KIDDIE SCHEDULE FOR; Garber J, 2000, J CLIN CHILD PSYCHOL, V29, P509, DOI 10.1207/S15374424JCCP2904_5; Gould MS, 1998, J AM ACAD CHILD PSY, V37, P915, DOI 10.1097/00004583-199809000-00011; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Herjanic B, 1997, J ABNORM CHILD PSYCH, V25, P21, DOI 10.1023/A:1025703323438; Hudziak JJ, 2004, J CHILD PSYCHOL PSYC, V45, P1299, DOI 10.1111/j.1469-7610.2004.00314.x; Isaksson A, 2008, PATTERN RECOGN LETT, V29, P1960, DOI 10.1016/j.patrec.2008.06.018; KAMINER Y, 1995, ADOLESCENCE, V30, P483; Kataoka SH, 2002, AM J PSYCHIAT, V159, P1548, DOI 10.1176/appi.ajp.159.9.1548; Kendall PC, 2004, J CONSULT CLIN PSYCH, V72, P276, DOI 10.1037/0022-006X.72.2.276; KOLKO DJ, 1993, J CHILD PSYCHOL PSYC, V34, P991, DOI 10.1111/j.1469-7610.1993.tb01103.x; Konnopka A, 2009, J AFFECT DISORDERS, V114, P14, DOI 10.1016/j.jad.2008.07.014; Lavigne J, 2009, J CLIN CHILD ADOLESC, V38, P315, DOI 10.1080/15374410902851382; Lee J, 2013, IEEE T BIO-MED ENG, V60, P203, DOI 10.1109/TBME.2012.2208112; Lopez-Duran NL, 2009, J EXP CHILD PSYCHOL, V103, P285, DOI 10.1016/j.jecp.2009.03.008; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Luby JL, 2003, J AM ACAD CHILD PSY, V42, P340, DOI 10.1097/00004583-200303000-00015; Luby JL, 2003, AM J PSYCHIAT, V160, P1169, DOI 10.1176/appi.ajp.160.6.1169; Luby JL, 2010, CURR DIR PSYCHOL SCI, V19, P91, DOI 10.1177/0963721410364493; Luby JL, 2009, ARCH GEN PSYCHIAT, V66, P897, DOI 10.1001/archgenpsychiatry.2009.97; Luby JL, 2009, J AFFECT DISORDERS, V112, P111, DOI 10.1016/j.jad.2008.03.026; MARTIN M, 1990, CLIN PSYCHOL REV, V10, P669, DOI 10.1016/0272-7358(90)90075-L; Mash EJ, 2001, PSYCHOL ASSESSMENT, V13, P86, DOI 10.1037//1040-3590.13.1.86; MAZIADE M, 1992, AM J PSYCHIAT, V149, P1674; McGinnis EW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195598; McGinnis EW, 2017, IEEE J BIOMED HEALTH, V21, P1460, DOI 10.1109/JBHI.2016.2603159; McGinnis RS, 2018, 2018 ANNUAL INTERNAT; McGinnis RS, 2018, 2018 IEEE INTERNATIO; McGinnis RS, 2014, VALIDATION COMPLEMEN, DOI [10.1115/IMECE2014-36909, DOI 10.1115/IMECE2014-36909]; McGinnis RS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178366; McGinnis W., 2017, PYGEOHASH; McTeague LM, 2012, DEPRESS ANXIETY, V29, P264, DOI 10.1002/da.21891; Mian ND, 2014, CLIN CHILD FAM PSYCH, V17, P85, DOI 10.1007/s10567-013-0152-0; Moon Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171346; Patel S, 2009, IEEE T INF TECHNOL B, V13, P864, DOI 10.1109/TITB.2009.2033471; Pavuluri MN, 1996, J AM ACAD CHILD PSY, V35, P215, DOI 10.1097/00004583-199602000-00015; Pine DS, 2005, AM J PSYCHIAT, V162, P291, DOI 10.1176/appi.ajp.162.2.291; Rapee RM, 2009, ANNU REV CLIN PSYCHO, V5, P311, DOI 10.1146/annurev.clinpsy.032408.153628; RENOUF AG, 1994, J AM ACAD CHILD PSY, V33, P208, DOI 10.1097/00004583-199402000-00008; Rishel CW, 2005, RES SOCIAL WORK PRAC, V15, P195, DOI 10.1177/1049731504270382; Santafe G, 2015, ARTIF INTELL REV, V44, P467, DOI 10.1007/s10462-015-9433-y; Son D, 2014, NAT NANOTECHNOL, V9, P397, DOI [10.1038/nnano.2014.38, 10.1038/NNANO.2014.38]; Sun Ruopeng, 2018, Digit Biomark, V2, P1, DOI 10.1159/000485958; Tandon M, 2009, CHILD ADOL PSYCH CL, V18, P593, DOI 10.1016/j.chc.2009.03.004; Topol EJ, 2015, JAMA-J AM MED ASSOC, V313, P353, DOI 10.1001/jama.2014.17125; Towe-Goodman NR, 2014, J AM ACAD CHILD PSY, V53, P437, DOI [10.1016/j.jaac.2013.12,017, 10.1016/j.jaac.2013.12.017]; Vasey MW, 1996, CHILD DEV, V67, P1173, DOI 10.2307/1131886; Warnick EM, 2008, CHILD ADOL MENT H-UK, V13, P140, DOI 10.1111/j.1475-3588.2007.00461.x; Whalen DJ, 2017, CHILD ADOL PSYCH CL, V26, P503, DOI 10.1016/j.chc.2017.02.006; Wittchen H-U, 2000, EUROPEAN NEUROPSYCHO, V10, P119, DOI DOI 10.1016/S0924-977X(00)80014-0	73	21	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210267	10.1371/journal.pone.0210267	http://dx.doi.org/10.1371/journal.pone.0210267			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650109	Green Published, Green Submitted, gold			2022-12-26	WOS:000455813300049
J	Chang, HW; Kim, MR; Lee, HJ; Lee, HM; Kim, GC; Lee, YS; Nam, HY; Lee, M; Jang, HJ; Lee, KE; Lee, JC; Byun, Y; Kim, SW; Kim, SY				Chang, Hyo Won; Kim, Mi Ra; Lee, Hyang Ju; Lee, Hye Min; Kim, Gui Chul; Lee, Yoon Sun; Nam, Hae Yun; Lee, Myungjin; Jang, Hye Jin; Lee, Kyung Eun; Lee, Jong Cheol; Byun, Youngro; Kim, Seong Who; Kim, Sang Yoon			p53/BNIP3-dependent mitophagy limits glycolytic shift in radioresistant cancer	ONCOGENE			English	Article							MITOCHONDRIAL FISSION; RADIATION-RESISTANCE; P53; PARKIN; HEAD; AUTOPHAGY; BNIP3; METABOLISM; INHIBITION; MECHANISMS	The role of p53 in genotoxic therapy-induced metabolic shift in cancers is not yet known. In this study, we investigated the role of p53 in the glycolytic shift in head and neck squamous cell carcinoma cell lines following irradiation. Isogenic p53-null radioresistant cancer cells established through cumulative irradiation showed decreased oxygen consumption and increased glycolysis with compromised mitochondria, corresponding with their enhanced sensitivity to drugs that target glycolysis. In contrast, radioresistant cancer cells with wild-type p53 preserved their primary metabolic profile with intact mitophagic processes and maintained their mitochondrial integrity. Moreover, we identified a previously unappreciated link between p53 and mitophagy, which limited the glycolytic shift through the BNIP3-dependent clearance of abnormal mitochondria. Thus, drugs targeting glycolysis could be used as an alternative strategy for overcoming radioresistant cancers, and the p53 status could be used as a biomarker for selecting participants for clinical trials.	[Chang, Hyo Won; Lee, Hye Min; Kim, Gui Chul; Lee, Yoon Sun; Lee, Myungjin; Jang, Hye Jin; Kim, Sang Yoon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Otolaryngol, Seoul, South Korea; [Kim, Mi Ra] Inje Univ, Coll Med, Haeundae Paik Hosp, Dept Otorhinolaryngol Head & Neck Surg, Busan, South Korea; [Lee, Hyang Ju; Nam, Hae Yun; Kim, Seong Who] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Biochem & Mol Biol, Seoul, South Korea; [Lee, Kyung Eun; Kim, Sang Yoon] Korea Inst Sci & Technol, Biomed Res Inst, Seoul, South Korea; [Lee, Jong Cheol] Ulsan Univ Hosp, Dept Otolaryngol, Ulsan, South Korea; [Byun, Youngro] Seoul Natl Univ, Coll Pharm, Pharmaceut Res Inst, Seoul, South Korea	University of Ulsan; Asan Medical Center; Inje University; University of Ulsan; Asan Medical Center; Korea Institute of Science & Technology (KIST); University of Ulsan; Ulsan University Hospital; Seoul National University (SNU)	Kim, SY (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Otolaryngol, Seoul, South Korea.; Kim, SW (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Biochem & Mol Biol, Seoul, South Korea.; Kim, SY (corresponding author), Korea Inst Sci & Technol, Biomed Res Inst, Seoul, South Korea.	swhokim@gmail.com; sykim3715@gmail.com			Basic Science Research Program through the National Research Foundation of Korea (NRF) - the Ministry of Science, ICT and Future planning [2018R1A2A1A05020064, 2014R1A1A1003484, 2015R1A2A2A01003235]; Ministry of Education [2018R1D1A1B07042783]; MRC grant - Korean government (MSIT) [2018R1A5A2020732]; Global High-tech Biomedicine Technology Development Program of the NRF; Korea Health Industry Development Institute (KHIDI) (MSIPMOHW) [2015M3D6A1065364]; Asan Institute for Life Science [2017-073]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - the Ministry of Science, ICT and Future planning; Ministry of Education; MRC grant - Korean government (MSIT); Global High-tech Biomedicine Technology Development Program of the NRF; Korea Health Industry Development Institute (KHIDI) (MSIPMOHW); Asan Institute for Life Science	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future planning (2018R1A2A1A05020064, 2014R1A1A1003484, 2015R1A2A2A01003235), the Ministry of Education (2018R1D1A1B07042783), MRC grant funded by the Korean government (MSIT) (2018R1A5A2020732), the Global High-tech Biomedicine Technology Development Program of the NRF & Korea Health Industry Development Institute (KHIDI) (MSIP&MOHW) (2015M3D6A1065364), and the Asan Institute for Life Science (2017-073).	Bansal N, 2014, ANTIOXID REDOX SIGN, V21, P221, DOI 10.1089/ars.2013.5690; Bernardini JP, 2017, ONCOGENE, V36, P1315, DOI 10.1038/onc.2016.302; Chang HW, 2016, HEAD NECK-J SCI SPEC, V38, pE1909, DOI 10.1002/hed.24347; Chourasia AH, 2015, EMBO REP, V16, P1145, DOI 10.15252/embr.201540759; Feng X, 2011, EMBO J, V30, P3397, DOI 10.1038/emboj.2011.248; Galluzzi L, 2013, NAT REV DRUG DISCOV, V12, P829, DOI 10.1038/nrd4145; Guo K, 2001, CELL DEATH DIFFER, V8, P367, DOI 10.1038/sj.cdd.4400810; Gustafsson AB, 2011, PEDIATR CARDIOL, V32, P267, DOI 10.1007/s00246-010-9876-5; Hamacher-Brady A, 2016, CELL MOL LIFE SCI, V73, P775, DOI 10.1007/s00018-015-2087-8; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; Hollville E, 2014, MOL CELL, V55, P451, DOI 10.1016/j.molcel.2014.06.001; Hoshino A, 2014, P NATL ACAD SCI USA, V111, P3116, DOI 10.1073/pnas.1318951111; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007; Lall R, 2014, CELL DEATH DIFFER, V21, P836, DOI 10.1038/cdd.2014.24; Lambrecht M, 2009, RADIOTHER ONCOL, V93, P498, DOI 10.1016/j.radonc.2009.08.038; Lee Y, 2011, AM J PHYSIOL-HEART C, V301, pH1924, DOI 10.1152/ajpheart.00368.2011; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Li GB, 2018, ONCOGENE, V37, P1485, DOI 10.1038/s41388-017-0064-4; Liu K, 2016, J BIOL CHEM, V291, P10307, DOI 10.1074/jbc.M115.703066; Lu HQ, 2013, AUTOPHAGY, V9, P1720, DOI 10.4161/auto.26550; Maes H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.94; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mauro-Lizcano M, 2015, AUTOPHAGY, V11, P833, DOI 10.1080/15548627.2015.1034403; Mims J, 2015, RADIAT RES, V183, P291, DOI 10.1667/RR13828.1; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Palikaras K, 2018, NAT CELL BIOL, V20, P1013, DOI 10.1038/s41556-018-0176-2; Rajeshkumar NV, 2015, CANCER RES, V75, P3355, DOI 10.1158/0008-5472.CAN-15-0108; Sancho P, 2015, CELL METAB, V22, P590, DOI 10.1016/j.cmet.2015.08.015; Skinner HD, 2012, CLIN CANCER RES, V18, P290, DOI 10.1158/1078-0432.CCR-11-2260; Tang L, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0758-7; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; Tracy K, 2007, AUTOPHAGY, V3, P616, DOI 10.4161/auto.4892; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Villa E, 2017, CELL REP, V20, P2846, DOI 10.1016/j.celrep.2017.08.087; VOKES EE, 1993, NEW ENGL J MED, V328, P184, DOI 10.1056/NEJM199301213280306; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Vyas S, 2016, CELL, V166, P555, DOI 10.1016/j.cell.2016.07.002; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wauer T, 2015, NATURE, V524, P370, DOI 10.1038/nature14879; Wu HM, 2015, SCI REP-UK, V5, DOI 10.1038/srep12291; Yan C, 2017, CANCER LETT, V388, P34, DOI 10.1016/j.canlet.2016.11.018; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3935; Zhang C, 2011, P NATL ACAD SCI USA, V108, P16259, DOI 10.1073/pnas.1113884108; Zhang J, 2015, CANCER LETT, V363, P108, DOI 10.1016/j.canlet.2015.04.015; Zhang TM, 2016, J BIOL CHEM, V291, P21616, DOI 10.1074/jbc.M116.733410	49	19	19	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 9	2019	38	19					3729	3742		10.1038/s41388-019-0697-6	http://dx.doi.org/10.1038/s41388-019-0697-6			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HX4OU	30664690				2022-12-26	WOS:000467379600012
J	Cheng, MS; Sheng, L; Gao, Q; Xiong, QC; Zhang, HJ; Wu, MQ; Liang, Y; Zhu, FY; Zhang, YY; Zhang, XH; Yuan, Q; Li, Y				Cheng, Maosheng; Sheng, Lu; Gao, Qian; Xiong, Qiuchan; Zhang, Haojie; Wu, Mingqing; Liang, Yu; Zhu, Fengyu; Zhang, Yingyin; Zhang, Xiuhong; Yuan, Quan; Li, Yang			The m(6)A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-kappa B/MYC signaling network	ONCOGENE			English	Article							MYC INHIBITOR KSI-3716; MESSENGER-RNA; C-MYC; ELONGATION COMPLEX; ANTITUMOR-ACTIVITY; NUCLEAR-RNA; N-6-METHYLADENOSINE; METHYLATION; TRANSLATION; N6-METHYLADENOSINE	N-6-methyladenosine (m6A) is the most abundant modification in eukaryotic messenger RNAs (mRNAs), and plays important roles in many bioprocesses. However, its functions in bladder cancer (BCa) remain elusive. Here, we discovered that methyltransferase-like 3 (METTL3), a major RNA N-6-adenosine methyltransferase, was significantly up-regulated in human BCa. Knockdown of METTL3 drastically reduced BCa cell proliferation, invasion, and survival in vitro and tumorigenicity in vivo. On the other hand, overexpression of METTL3 significantly promoted BCa cell growth and invasion. Through transcriptome sequencing, m(6)A sequencing and m(6)A methylated RNA immuno-precipitation quantitative reverse-transcription polymerase chain reaction, we revealed the profile of METTL3-mediated m(6)A modification in BCa cells for the first time. AF4/FMR2 family member 4 (AFF4), two key regulators of NF-kappa B pathway (IKBKB and RELA) and MYC were further identified as direct targets of METTL3-mediated m(6)A modification. In addition, we showed that besides NF-kappa B, AFF4 binds to the promoter of MYC and promotes its expression, implying a novel multilevel regulatory network downstream of METTL3. Our results uncovered an AFF4/NF-kappa B/MYC signaling network operated by METTL3-mediated m6A modification and provided insight into the mechanisms of BCa progression.	[Cheng, Maosheng; Gao, Qian; Wu, Mingqing; Liang, Yu; Zhu, Fengyu; Zhang, Yingyin; Zhang, Xiuhong; Li, Yang] Anhui Med Univ, Sch Life Sci, Dept Genet, Hefei 230031, Anhui, Peoples R China; [Sheng, Lu; Zhang, Haojie] Fudan Univ, Huadong Hosp, Dept Urol, Shanghai 200040, Peoples R China; [Xiong, Qiuchan; Yuan, Quan] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China; [Xiong, Qiuchan; Yuan, Quan] Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, Chengdu, Sichuan, Peoples R China	Anhui Medical University; Fudan University; Sichuan University; Sichuan University	Li, Y (corresponding author), Anhui Med Univ, Sch Life Sci, Dept Genet, Hefei 230031, Anhui, Peoples R China.	liyang@ahmu.edu.cn	yuan, quan/GZM-5597-2022	Yuan, Quan/0000-0002-2836-1081	National Natural Science Foundation of China [81872313, 81672776, 81802391, 31501838]; Anhui Provincial Natural Science Foundation [1808085QH266]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province)	This work was supported by the National Natural Science Foundation of China (81872313 and 81672776 to YL, 81802391 to QG, 31501838 to XH Z), and Anhui Provincial Natural Science Foundation (1808085QH266 to QG)	Alarcon CR, 2015, NATURE, V519, P482, DOI 10.1038/nature14281; Barbieri I, 2017, NATURE, V552, P126, DOI 10.1038/nature24678; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; BOKAR JA, 1994, J BIOL CHEM, V269, P17697; Cai XL, 2018, CANCER LETT, V415, P11, DOI 10.1016/j.canlet.2017.11.018; Cao GC, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160003; Chen MN, 2018, HEPATOLOGY, V67, P2254, DOI 10.1002/hep.29683; Choe J, 2018, NATURE, V561, P556, DOI 10.1038/s41586-018-0538-8; Cui Q, 2017, CELL REP, V18, P2622, DOI 10.1016/j.celrep.2017.02.059; Deng P, 2018, CARCINOGENESIS, V39, P937, DOI 10.1093/carcin/bgy046; Deng XL, 2018, CELL RES, V28, P507, DOI 10.1038/s41422-018-0034-6; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Doyle GAR, 1998, NUCLEIC ACIDS RES, V26, P5036, DOI 10.1093/nar/26.22.5036; DUYAO MP, 1990, P NATL ACAD SCI USA, V87, P4727, DOI 10.1073/pnas.87.12.4727; El-Sheikh A, 2010, PEDIATR BLOOD CANCER, V55, P35, DOI 10.1002/pbc.22465; Felsenstein KM, 2018, NAT REV UROL, V15, P92, DOI 10.1038/nrurol.2017.179; Gabay M, 2014, COLD SPRING HARBOR P, V4; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Jeong KC, 2014, J UROLOGY, V191, P510, DOI 10.1016/j.juro.2013.07.019; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kamat AM, 2009, CANCER RES, V69, P8958, DOI 10.1158/0008-5472.CAN-09-2045; Li Y, 2015, ONCOTARGET, V6, P10195, DOI 10.18632/oncotarget.3555; Li Y, 2013, BIOMED REP, V1, P918, DOI 10.3892/br.2013.157; Li YF, 2013, CELL TISSUE RES, V354, P533, DOI 10.1007/s00441-013-1715-6; Liang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep29479; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Luo ZJ, 2012, MOL CELL BIOL, V32, P2608, DOI 10.1128/MCB.00182-12; Ma JZ, 2017, HEPATOLOGY, V65, P529, DOI 10.1002/hep.28885; Mahe M, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708163; Merkurjev D, 2018, NAT NEUROSCI, V21, P1004, DOI 10.1038/s41593-018-0173-6; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785; Mukherjee N, 2015, CARCINOGENESIS, V36, P299, DOI 10.1093/carcin/bgu321; Niu Yamei, 2013, Genomics Proteomics & Bioinformatics, V11, P8, DOI 10.1016/j.gpb.2012.12.002; Oing C, 2016, J UROLOGY, V195, P254, DOI 10.1016/j.juro.2015.06.115; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Ribas A, 2014, CLIN CANCER RES, V20, P4982, DOI 10.1158/1078-0432.CCR-14-0933; Seo HK, 2014, ONCOTARGET, V5, P326, DOI 10.18632/oncotarget.1545; Shi HL, 2018, NATURE, V563, P249, DOI 10.1038/s41586-018-0666-1; Shiina H, 2002, J UROLOGY, V168, P2220, DOI 10.1016/S0022-5347(05)64359-5; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Stine ZE, 2015, CANCER DISCOV, V5, P1024, DOI 10.1158/2159-8290.CD-15-0507; Su R, 2018, CELL, V172, P90, DOI 10.1016/j.cell.2017.11.031; Tabach Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014632; Taketo K, 2018, INT J ONCOL, V52, P621, DOI 10.3892/ijo.2017.4219; Tong JY, 2018, CELL RES, V28, P253, DOI 10.1038/cr.2018.7; van Kessel KEM, 2015, NAT REV UROL, V12, P681, DOI 10.1038/nrurol.2015.231; Visvanathan A, 2018, ONCOGENE, V37, P522, DOI 10.1038/onc.2017.351; Vu LP, 2017, NAT MED, V23, P1369, DOI 10.1038/nm.4416; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Watters AD, 2002, BRIT J CANCER, V87, P654, DOI 10.1038/sj.bjc.6600531; Weng HY, 2018, CELL STEM CELL, V22, P191, DOI 10.1016/j.stem.2017.11.016; Weng YL, 2018, NEURON, V97, P313, DOI 10.1016/j.neuron.2017.12.036; Wu YS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06898-4; Wu YS, 2018, CURR STEM CELL RES T, V13, P31, DOI 10.2174/1574888X12666170621125457; Zhang CZ, 2016, P NATL ACAD SCI USA, V113, pE2047, DOI 10.1073/pnas.1602883113; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zheng J, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3401-7; Zheng QL, 2017, NAT IMMUNOL, V18, P1094, DOI 10.1038/ni.3830; Zhu FY, 2017, STEM CELL REP, V9, P429, DOI 10.1016/j.stemcr.2017.07.004; Zhu JL, 2017, NEOPLASIA, V19, P672, DOI 10.1016/j.neo.2017.06.002	66	214	221	6	84	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 9	2019	38	19					3667	3680		10.1038/s41388-019-0683-z	http://dx.doi.org/10.1038/s41388-019-0683-z			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HX4OU	30659266				2022-12-26	WOS:000467379600008
J	Vitiello, M; Evangelista, M; Di Lascio, N; Kusmic, C; Massa, A; Orso, F; Sarti, S; Marranci, A; Rodzik, K; Germelli, L; Chandra, D; Salvetti, A; Pucci, A; Taverna, D; Faita, F; Gravekamp, C; Poliseno, L				Vitiello, Marianna; Evangelista, Monica; Di Lascio, Nicole; Kusmic, Claudia; Massa, Annamaria; Orso, Francesca; Sarti, Samanta; Marranci, Andrea; Rodzik, Katarzyna; Germelli, Lorenzo; Chandra, Dinesh; Salvetti, Alessandra; Pucci, Angela; Taverna, Daniela; Faita, Francesco; Gravekamp, Claudia; Poliseno, Laura			Antitumoral effects of attenuated Listeria monocytogenes in a genetically engineered mouse model of melanoma	ONCOGENE			English	Article							VACCINE; IMMUNOTHERAPY	Attenuated Listeria monocytogenes (Lm(at)-LLO) represents a valuable anticancer vaccine and drug delivery platform. Here we show that in vitro Lm(at)-LLO causes ROS production and, in turn, apoptotic killing of a wide variety of melanoma cells, irrespectively of their stage, mutational status, sensitivity to BRAF inhibitors or degree of stemness. We also show that, when administered in the therapeutic setting to Braf/Pten genetically engineered mice, Lm(at)-LLO causes a strong decrease in the size and volume of primary melanoma tumors, as well as a reduction of the metastatic burden. At the molecular level, we confirm that the anti-melanoma activity exerted in vivo by Lm(at)-LLO depends also on its ability to potentiate the immune response of the organism against the infected tumor. Our data pave the way to the preclinical testing of listeria-based immunotherapeutic strategies against metastatic melanoma, using a genetically engineered mouse rather than xenograft models.	[Vitiello, Marianna; Evangelista, Monica; Di Lascio, Nicole; Kusmic, Claudia; Sarti, Samanta; Marranci, Andrea; Germelli, Lorenzo; Faita, Francesco; Poliseno, Laura] CNR, Inst Clin Physiol, Pisa, Italy; [Vitiello, Marianna; Sarti, Samanta; Marranci, Andrea; Germelli, Lorenzo; Poliseno, Laura] ISPRO, Core Res Lab, Oncogen Unit, Pisa, Italy; [Massa, Annamaria; Orso, Francesca; Taverna, Daniela] Univ Torino, MBC, Turin, Italy; [Massa, Annamaria; Orso, Francesca; Taverna, Daniela] Univ Torino, Dept Mol Biotechnol & Hlth Sci, Turin, Italy; [Orso, Francesca; Taverna, Daniela] Univ Torino, Ctr Complex Syst Mol Biol & Med, Turin, Italy; [Rodzik, Katarzyna] Ctr Postgrad Med Educ, Dept Biochem & Mol Biol, Warsaw, Poland; [Chandra, Dinesh; Gravekamp, Claudia] Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY USA; [Salvetti, Alessandra] Univ Pisa, Dept Clin & Expt Med, Unit Expt Biol & Genet, Pisa, Italy; [Pucci, Angela] Pisa Univ Hosp, Dept Histopathol, Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Turin; University of Turin; University of Turin; Centre of Postgraduate Medical Education - Poland; Yeshiva University; University of Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana	Vitiello, M; Poliseno, L (corresponding author), CNR, Inst Clin Physiol, Pisa, Italy.; Vitiello, M; Poliseno, L (corresponding author), ISPRO, Core Res Lab, Oncogen Unit, Pisa, Italy.	mariannavitiello@live.it; laura.poliseno@cnr.it	Vitiello, Marianna/AAC-3659-2022; Marranci, Andrea/AAA-7874-2019; Pucci, Angela/A-6509-2013; Rodzik, Katarzyna/V-1038-2019; Chandra, Dinesh/P-4377-2014; Massa, Annamaria/AAB-9872-2019; Kusmic, Claudia/AGY-5715-2022; Orso, Francesca/B-1985-2014; Poliseno, Laura/B-5711-2012; Faita, Francesco/K-6681-2016	Vitiello, Marianna/0000-0001-7443-2728; Marranci, Andrea/0000-0002-8334-8795; Pucci, Angela/0000-0001-8110-4458; Chandra, Dinesh/0000-0001-5763-1645; Massa, Annamaria/0000-0002-8156-3037; GERMELLI, LORENZO/0000-0002-7318-7545; Orso, Francesca/0000-0003-4706-6464; Faita, Francesco/0000-0002-6201-1843	MFAG grant - Associazione Italiana per la Ricerca sul Cancro (AIRC) [17095]; ITT-Istituto Toscano Tumori; ISPRO-Istituto per lo Studio, la Prevenzione e la Rete Oncologica; Italian Ministry of Health [GR-2011-02348535]; EMBO short-term fellowship; AIRC fellowship	MFAG grant - Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); ITT-Istituto Toscano Tumori; ISPRO-Istituto per lo Studio, la Prevenzione e la Rete Oncologica; Italian Ministry of Health(Ministry of Health, Italy); EMBO short-term fellowship(European Molecular Biology Organization (EMBO)); AIRC fellowship(Fondazione AIRC per la ricerca sul cancro)	The authors would like to thank all the Poliseno lab members for their insightful discussions; S. Burchielli (FTGM, Pisa) for her assistance with animal procedures; D. Colecchia (IFC-CNR, ISPRO, Siena) for his assistance in preparing the figures; M. La Ferla (Fondazione Pisana per la Scienza, Pisa) for his assistance with the detection of listeria by FACS; G. Pelosi (IFC-CNR, Pisa) for his assistance with light microscopy; A. Ripoli (IFC-CNR, Pisa) for his support with statistical analyses; B. Stecca (ISPRO, Firenze) for providing us with the Aldefluor (TM). This work was supported by MFAG #17095 grant awarded by Associazione Italiana per la Ricerca sul Cancro (AIRC) to LP; start up funding awarded by ITT-Istituto Toscano Tumori and ISPRO-Istituto per lo Studio, la Prevenzione e la Rete Oncologica to LP. It was also supported by GR-2011-02348535 grant awarded by Italian Ministry of Health to LP. MV was supported by an EMBO short-term fellowship and an AIRC fellowship.	Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Buonaguro L, 2011, CLIN VACCINE IMMUNOL, V18, P23, DOI 10.1128/CVI.00286-10; Chandra D, 2017, ONCOTARGET, V8, P20729, DOI 10.18632/oncotarget.15117; Damsky WE, 2011, CANCER CELL, V20, P741, DOI 10.1016/j.ccr.2011.10.030; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Deng WW, 2018, P NATL ACAD SCI USA, V115, P8179, DOI 10.1073/pnas.1801910115; Flickinger JC, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6030048; Grzywa TM, 2017, TRANSL ONCOL, V10, P956, DOI 10.1016/j.tranon.2017.09.007; Hellmann MD, 2017, IMMUNITY, V47, P221, DOI 10.1016/j.immuni.2017.08.001; Jahangir A, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1342025; Karachaliou N, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.06.47; Kee D, 2017, EJSO-EUR J SURG ONC, V43, P594, DOI 10.1016/j.ejso.2016.07.014; Kim SH, 2008, BRIT J CANCER, V99, P741, DOI 10.1038/sj.bjc.6604526; Kim SH, 2009, CANCER RES, V69, P5860, DOI 10.1158/0008-5472.CAN-08-4855; Klein WM, 2007, MODERN PATHOL, V20, P102, DOI 10.1038/modpathol.3800720; Liao W, 2011, CURR OPIN IMMUNOL, V23, P598, DOI 10.1016/j.coi.2011.08.003; Menzies AM, 2016, JAMA ONCOL, V2, P1259, DOI 10.1001/jamaoncol.2016.3418; Ott PA, 2017, NATURE, V547, P217, DOI 10.1038/nature22991; Pan ZK, 1999, CANCER RES, V59, P5264; Quispe-Tintaya W, 2013, P NATL ACAD SCI USA, V110, P8668, DOI 10.1073/pnas.1211287110; Sahin U, 2017, NATURE, V547, P222, DOI 10.1038/nature23003; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Vitiello M, 2017, ONCOTARGET, V8, P25395, DOI 10.18632/oncotarget.15915; Wood LM, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00051; Xin G, 2017, P NATL ACAD SCI USA, V114, P740, DOI 10.1073/pnas.1614315114; Yuan P, 2013, P NATL ACAD SCI USA, V110, P18226, DOI 10.1073/pnas.1317577110	26	15	16	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 9	2019	38	19					3756	3762		10.1038/s41388-019-0681-1	http://dx.doi.org/10.1038/s41388-019-0681-1			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HX4OU	30664692	Green Published, hybrid			2022-12-26	WOS:000467379600014
J	Wan, P; Zhang, Q; Liu, WY; Jia, YL; Ai, S; Wang, TC; Wang, WB; Pan, P; Yang, G; Xiang, Q; Huang, SY; Yang, QY; Zhang, W; Liu, F; Tan, QP; Zhang, W; Wu, KL; Liu, YL; Wu, JG				Wan, Pin; Zhang, Qi; Liu, Weiyong; Jia, Yaling; Ai, Sha; Wang, Tianci; Wang, Wenbiao; Pan, Pan; Yang, Ge; Xiang, Qi; Huang, Siyu; Yang, Qingyu; Zhang, Wei; Liu, Fang; Tan, Qiuping; Zhang, Wen; Wu, Kailang; Liu, Yingle; Wu, Jianguo			Cullin1 binds and promotes NLRP3 ubiquitination to repress systematic inflammasome activation	FASEB JOURNAL			English	Article						innate immune response; interleukin 1 beta, IL-1 beta; proinflammatory cytokines; Skp1-Cullin1-F-box complex; ubiquitin-proteasome system	PATTERN-RECOGNITION RECEPTORS; PROTEIN; LIGASE; DEUBIQUITINATION; DESTRUCTION; DEGRADATION; CASPASE-1; INNATE; DOMAIN	Activation of the NACHT, leucine-rich repeat, and pyrin domains-containing protein 3 (collectively known as NLRP3) inflammasome plays a key role in host immune response, which is the first line of defense against cellular stresses and pathogen infections. However, excessive inflammasome activation damages host cells, and therefore it must be precisely controlled. Here, we discover that Cullin1 (CUL1), a key component of the Skp1-Cullin1-F-box E3 ligase, plays a critical role in controlling the NLRP3 inflammasome. CUL1 represses inflammasome assembly in cultured cells, suppresses NLRP3 function in human monocytic cell line macrophages, and attenuates inflammatory responses in mouse model. Detailed studies demonstrate that CUL1 interacts with NLRP3 and promotes NLRP3 ubiquitination, but not protein degradation, to repress the NLRP3 inflammasome activation. Moreover, upon inflammatory stimuli, including ATP and nigericin treatments, CUL1 disassociates from NLRP3 to release the repression of the NLRP3 inflammasome. Thus, this study reveals a distinct and unique mechanism underlying the control of systematic activation of the NLRP3 inflammasome.	[Wan, Pin; Zhang, Qi; Liu, Weiyong; Jia, Yaling; Ai, Sha; Wang, Tianci; Pan, Pan; Yang, Ge; Xiang, Qi; Huang, Siyu; Yang, Qingyu; Zhang, Wei; Liu, Fang; Wu, Kailang; Liu, Yingle; Wu, Jianguo] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Wang, Wenbiao; Liu, Yingle; Wu, Jianguo] Jinan Univ, Inst Med Microbiol, Key Lab Virol Guangzhou, Guangzhou, Guangdong, Peoples R China; [Tan, Qiuping; Zhang, Wen] Guangdong LongFan Biol Sci & Technol Co, Foshan, Peoples R China	Wuhan University; Jinan University	Liu, YL; Wu, JG (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.; Wu, JG (corresponding author), Wuhan Univ, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.; Wu, JG (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.	mvlwu@whu.edu.cn; jwu@whu.edu.cn	wang, wenbiao/AAQ-9104-2021; Yang, Heroine/GRY-2630-2022; Liu, Fang/HCH-6710-2022	Liu, Fang/0000-0003-0972-9968; Wu, Jianguo/0000-0002-8326-2895	National Natural Science Foundation of China [81730061, 31230005, 81471942, 31200134, 31270206]; National Health and Family Planning Commission of China (National Mega Project on Major Infectious Disease Prevention) [2017ZX10103005, 2017ZX10202201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Health and Family Planning Commission of China (National Mega Project on Major Infectious Disease Prevention)	The authors thank Dr. Jiahuai Han (State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Fujian, China) for kindly providing the cDNA of genes Cullin1 and NLRP3. This work was supported by National Natural Science Foundation of China (81730061, 31230005, 81471942, 31200134, and 31270206) and the National Health and Family Planning Commission of China (National Mega Project on Major Infectious Disease Prevention) (2017ZX10103005 and 2017ZX10202201). The authors declare no conflicts of interest.	Burrows AC, 2012, J BIOL CHEM, V287, P39021, DOI 10.1074/jbc.M112.390328; Dealy MJ, 1999, NAT GENET, V23, P245, DOI 10.1038/13886; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Elliott EI, 2015, IMMUNOL REV, V265, P35, DOI 10.1111/imr.12286; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Han S, 2015, J BIOL CHEM, V290, P18124, DOI 10.1074/jbc.M115.645549; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Kawashima A, 2017, J IMMUNOL, V199, P3614, DOI 10.4049/jimmunol.1700184; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Leemans JC, 2011, IMMUNOL REV, V243, P152, DOI 10.1111/j.1600-065X.2011.01043.x; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Moriyama M, 2016, J VIROL, V90, P4105, DOI 10.1128/JVI.00120-16; Park S, 2013, J IMMUNOL, V191, P4358, DOI 10.4049/jimmunol.1301170; Petrilli V, 2005, CURR BIOL, V15, pR581, DOI 10.1016/j.cub.2005.07.049; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Proell M, 2013, BIOCHEM J, V449, P613, DOI 10.1042/BJ20121198; Py BF, 2013, MOL CELL, V49, P331, DOI 10.1016/j.molcel.2012.11.009; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Song H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13727; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Sun Y, 2006, NEOPLASIA, V8, P645, DOI 10.1593/neo.06376; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Vajjhala PR, 2012, J BIOL CHEM, V287, P41732, DOI 10.1074/jbc.M112.381228; Walsh JG, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-35; Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Winkler S, 2015, SEMIN IMMUNOPATHOL, V37, P419, DOI 10.1007/s00281-015-0494-4; Yan YQ, 2015, CELL, V160, P62, DOI 10.1016/j.cell.2014.11.047; Yang CS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7115	43	28	29	1	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5793	5807		10.1096/fj.201801681R	http://dx.doi.org/10.1096/fj.201801681R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30653357	Bronze			2022-12-26	WOS:000462888500092
J	Theofilopoulos, S; de Oliveira, WAA; Yang, SS; Yutuc, E; Saeed, A; Abdel-Khalik, J; Ullgren, A; Cedazo-Minguez, A; Bjorkhem, I; Wang, YQ; Griffiths, WJ; Arenas, E				Theofilopoulos, Spyridon; de Oliveira, Willy Antoni Abreu; Yang, Shanzheng; Yutuc, Eylan; Saeed, Ahmed; Abdel-Khalik, Jonas; Ullgren, Abbe; Cedazo-Minguez, Angel; Bjorkhem, Ingemar; Wang, Yuqin; Griffiths, William J.; Arenas, Ernest			24(S),25-Epoxycholesterol and cholesterol 24S-hydroxylase (CYP46A1) overexpression promote midbrain dopaminergic neurogenesis in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						development; lipid metabolism; MS; neurodegenerative disease; neurogenesis; CYP46A1; dopamine neuron; liver X receptor; midbrain; oxysterol	CHOLESTEROL 24-HYDROXYLASE; NUCLEAR RECEPTORS; CYTOCHROME-P450 46A1; BRAIN; OXYSTEROLS; ENZYME; MOUSE; 24S-HYDROXYCHOLESTEROL; DEGRADATION; TURNOVER	The liver X receptors Lxr/NR1H3 and Lxr/NR1H2 are ligand-dependent nuclear receptors critical for midbrain dopaminergic (mDA) neuron development. We found previously that 24(S),25-epoxycholesterol (24,25-EC), the most potent and abundant Lxr ligand in the developing mouse midbrain, promotes mDA neurogenesis in vitro. In this study, we demonstrate that 24,25-EC promotes mDA neurogenesis in an Lxr-dependent manner in the developing mouse midbrain in vivo and also prevents toxicity induced by the Lxr inhibitor geranylgeranyl pyrophosphate. Furthermore, using MS, we show that overexpression of human cholesterol 24S-hydroxylase (CYP46A1) increases the levels of both 24(S)-hydroxycholesterol (24-HC) and 24,25-EC in the developing midbrain, resulting in a specific increase in mDA neurogenesis in vitro and in vivo, but has no effect on oculomotor or red nucleus neurogenesis. 24-HC, unlike 24,25-EC, did not affect in vitro neurogenesis, indicating that the neurogenic effect of 24,25-EC on mDA neurons is specific. Combined, our results indicate that increased levels of 24,25-EC in vivo, by intracerebroventricular delivery in WT mice or by overexpression of its biosynthetic enzyme CYP46A1, specifically promote mDA neurogenesis. We propose that increasing the levels of 24,25-EC in vivo may be a useful strategy to combat the loss of mDA neurons in Parkinson's disease.	[Theofilopoulos, Spyridon; de Oliveira, Willy Antoni Abreu; Yang, Shanzheng; Ullgren, Abbe; Arenas, Ernest] Karolinska Inst, Dept Med Biochem & Biophys, Lab Mol Neurobiol, S-17177 Stockholm, Sweden; [Theofilopoulos, Spyridon] Swansea Univ, Med Sch, Inst Life Sci, Regenerat Neurobiol Lab, 1 Singleton Pk, Swansea SA2 8PP, W Glam, Wales; [Yutuc, Eylan; Abdel-Khalik, Jonas; Wang, Yuqin; Griffiths, William J.] Swansea Univ, Med Sch, Inst Life Sci, ILS1 Bldg,Singleton Pk, Swansea SA2 8PP, W Glam, Wales; [Saeed, Ahmed; Bjorkhem, Ingemar] Karolinska Inst, Dept Lab Med, Div Clin Chem, S-14157 Stockholm, Sweden; [Saeed, Ahmed; Bjorkhem, Ingemar] Karolinska Univ, Huddinge Hosp, S-14157 Stockholm, Sweden; [Ullgren, Abbe; Cedazo-Minguez, Angel] Karolinska Inst, Div Neurogeriatr, Dept Neurobiol Care Sci & Soc, Ctr Alzheimer Res, S-14157 Stockholm, Sweden	Karolinska Institutet; Swansea University; Swansea University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Theofilopoulos, S; Arenas, E (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Lab Mol Neurobiol, S-17177 Stockholm, Sweden.	s.theofilopoulos@swansea.ac.uk; ernest.arenas@ki.se	Yutuc, Eylan/AAD-7282-2019; Yutuc, Eylan/G-7360-2019; Theofilopoulos, Spyridon/B-2075-2015; Arenas, Ernest/AAO-5231-2020; Griffiths, William/N-4641-2016; Cedazo-Minguez, Angel/C-6707-2012	Yutuc, Eylan/0000-0001-9971-1950; Yutuc, Eylan/0000-0001-9971-1950; Theofilopoulos, Spyridon/0000-0003-1986-0943; Arenas, Ernest/0000-0003-0197-6577; Griffiths, William/0000-0002-4129-6616; Bjorkhem, Ingemar/0000-0002-0575-9425; Cedazo-Minguez, Angel/0000-0003-4626-4864; Abreu de Oliveira, Willy Antoni/0000-0003-1783-4522	Swedish Research Council (VR projects: DBRM) [2011-3116, 2011-3318, 2016-01526]; European Union (NeuroStemcellRepair); European Union (DDPD); Swedish Foundation for Strategic Research (DBRM); Swedish Foundation for Strategic Research (SRL program); Swedish Foundation for Strategic Research [SB16-0065]; Hjarnfonden [FO2015: 0202, FO2017-0059]; Cancerfonden [CAN 2016/572]; Karolinska Institutet (SFO Strat Regen, senior grant 2018); Ser Cymru II Rising Stars grant from the Welsh Government; Biotechnology and Biological Sciences Research Council [BB/I001735/1, B/N015932/1, BB/L001942/1]; Imperial College Healthcare Charities; Hjarnfonden; Stockholm County Council (ALF); Stiftelsen for Gamla Tjanarinnor; BBSRC [BB/I001735/1, BB/N015932/1, BB/L001942/1] Funding Source: UKRI	Swedish Research Council (VR projects: DBRM)(Swedish Research Council); European Union (NeuroStemcellRepair); European Union (DDPD); Swedish Foundation for Strategic Research (DBRM)(Swedish Foundation for Strategic Research); Swedish Foundation for Strategic Research (SRL program)(Swedish Foundation for Strategic Research); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Hjarnfonden; Cancerfonden(Swedish Cancer Society); Karolinska Institutet (SFO Strat Regen, senior grant 2018); Ser Cymru II Rising Stars grant from the Welsh Government; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Imperial College Healthcare Charities; Hjarnfonden; Stockholm County Council (ALF)(Stockholm County Council); Stiftelsen for Gamla Tjanarinnor; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funding from the Swedish Research Council (VR projects: DBRM, 2011-3116, 2011-3318, and 2016-01526), the European Union (NeuroStemcellRepair and DDPD), the Swedish Foundation for Strategic Research (DBRM, SRL program, and SB16-0065), Hjarnfonden (FO2015: 0202 and FO2017-0059), Cancerfonden (CAN 2016/572), and Karolinska Institutet (SFO Strat Regen, senior grant 2018) (to E. A.); by a Ser Cymru II Rising Stars grant from the Welsh Government (to S. T.); by the Biotechnology and Biological Sciences Research Council (BB/I001735/1 and B/N015932/1 to W. J. G. and BB/L001942/1 to Y. W.); by a PhD studentship from Imperial College Healthcare Charities (to J. A.-K.); and by Hjarnfonden, the Stockholm County Council (ALF), and Stiftelsen for Gamla Tjanarinnor (to I. B.). The derivatization method used for the LC-MS analysis of sterols has been licensed to Avanti Polar Lipids Inc. and Cayman Chemical by Swansea Innovations Ltd., a wholly owned subsidiary of Swansea University.	Ayciriex S, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00211; Boussicault L, 2016, BRAIN, V139, P953, DOI 10.1093/brain/awv384; Bryleva EY, 2010, P NATL ACAD SCI USA, V107, P3081, DOI 10.1073/pnas.0913828107; Burlot MA, 2015, HUM MOL GENET, V24, P5965, DOI 10.1093/hmg/ddv268; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Crick PJ, 2015, CLIN CHEM, V61, P400, DOI 10.1373/clinchem.2014.231332; Dai YB, 2012, P NATL ACAD SCI USA, V109, P13112, DOI 10.1073/pnas.1210833109; Djelti F, 2015, BRAIN, V138, P2383, DOI 10.1093/brain/awv166; Fakheri RJ, 2012, STEROIDS, V77, P575, DOI 10.1016/j.steroids.2012.02.006; Ferri ALM, 2007, DEVELOPMENT, V134, P2761, DOI 10.1242/dev.000141; Forthmann B, 2015, J CELL PHYSIOL, V230, P2875, DOI 10.1002/jcp.25036; Goyal S, 2014, J LIPID RES, V55, P1933, DOI 10.1194/jlr.M051508; Griffiths WJ, 2016, BIOCHEM SOC T, V44, P652, DOI 10.1042/BST20150255; Griffiths WJ, 2011, BBA-MOL CELL BIOL L, V1811, P784, DOI 10.1016/j.bbalip.2011.05.012; Hudry E, 2010, MOL THER, V18, P44, DOI 10.1038/mt.2009.175; Katayama K, 2005, J PHARMACOL SCI, V97, P171, DOI 10.1254/jphs.FMJ04008X3; Kotti TJ, 2006, P NATL ACAD SCI USA, V103, P3869, DOI 10.1073/pnas.0600316103; La Manno G, 2016, CELL, V167, P566, DOI 10.1016/j.cell.2016.09.027; Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Maioli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068534; Mast N, 2003, BIOCHEMISTRY-US, V42, P14284, DOI 10.1021/bi035512f; Mast N, 2017, NEUROPHARMACOLOGY, V123, P465, DOI 10.1016/j.neuropharm.2017.06.026; Meljon A, 2014, BIOCHEM BIOPH RES CO, V446, P768, DOI 10.1016/j.bbrc.2014.01.153; NELSON JA, 1981, J BIOL CHEM, V256, P1067; Ogundare M, 2010, J BIOL CHEM, V285, P4666, DOI 10.1074/jbc.M109.086678; Pikuleva IA, 2006, DRUG METAB DISPOS, V34, P513, DOI 10.1124/dmd.105.008789; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Russell DW, 2009, ANNU REV BIOCHEM, V78, P1017, DOI 10.1146/annurev.biochem.78.072407.103859; Sacchetti P, 2009, CELL STEM CELL, V5, P409, DOI 10.1016/j.stem.2009.08.019; Shafaati M, 2011, J INTERN MED, V270, P377, DOI 10.1111/j.1365-2796.2011.02389.x; Smith JS, 2014, PROTEOMICS, V14, P1102, DOI 10.1002/pmic.201300241; Theofilopoulos Spyridon, 2015, F1000Prime Rep, V7, P37, DOI 10.12703/P7-37; Theofilopoulos S, 2014, J CLIN INVEST, V124, P4829, DOI 10.1172/JCI68506; Theofilopoulos S, 2013, NAT CHEM BIOL, V9, P126, DOI [10.1038/NCHEMBIO.1156, 10.1038/nchembio.1156]; van den Munckhof P, 2003, DEVELOPMENT, V130, P2535, DOI 10.1242/dev.00464; Wang YQ, 2009, MOL BIOSYST, V5, P529, DOI 10.1039/b819502a; Yang SZ, 2013, DEVELOPMENT, V140, P4554, DOI 10.1242/dev.098145	38	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4169	4176		10.1074/jbc.RA118.005639	http://dx.doi.org/10.1074/jbc.RA118.005639			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30655290	Green Published, hybrid			2022-12-26	WOS:000461854400028
J	Kim, JY; Seo, C; Hong, S; Lee, S; Eo, SH				Kim, Jin-Yong; Seo, Changwan; Hong, Seungbum; Lee, Sanghun; Eo, Soo Hyung			Altitudinal range-size distribution of breeding birds and environmental factors for the determination of species richness: An empirical test of altitudinal Rapoport's rule and non-directional rescue effect on a local scale	PLOS ONE			English	Article							ELEVATIONAL GRADIENTS; GEOGRAPHICAL RANGE; PATTERNS; DIVERSITY; IMPACTS; DENSITY; ENERGY	Range-size distributions are important for understanding species richness patterns and led to the development of the controversial Rapoport's rule and Rapoport-rescue effect. This study aimed to understand the relationship between species richness and range-size distribution in relation to environmental factors. The present study tested the following: (1) altitudinal Rapoport's rule, and a subsequent test on climatic and ambient energy hypotheses, (2) non-directional rescue effect, and a subsequent test on effect of environmental factors associated with the distribution of narrowest to widest-range species. Altitudinal species range-size distribution increased with increasing altitude and showed a negative relationship with climatic variables. These results support the altitudinal Rapoport's rule and climatic hypothesis; however, they do not fully support the ambient energy hypothesis. Results from testing the non-directional rescue effect showed that the inflow intensity of species from both directions (high and low elevations) affected species richness. And we found that the species with intermediate range-size, rather than narrowest or widest range-size were the main cause of a mid-peak of species richness and the non-directional rescue effect. Additionally, the richness of species with intermediate range-size was highly related to minimum temperature, habitat heterogeneity, or primary productivity. Although altitudinal range-size distribution results were similar to the phenomenon of altitudinal Rapoport's rule, the mid-peak pattern of species richness could not be explained by the underlying mechanism of Rapoport's-rescue effect; however, the non-directional rescue effect could explain a mid-peak pattern of species richness along altitudinal gradient.	[Kim, Jin-Yong; Hong, Seungbum] Natl Inst Ecol, Div Ecosyst Serv & Res Planning, Seocheon, South Korea; [Kim, Jin-Yong; Eo, Soo Hyung] Kongju Natl Univ, Dept Forest Resources, Chungnam, South Korea; [Seo, Changwan] Natl Inst Ecol, Div Ecol Assessment Res, Seocheon, South Korea; [Lee, Sanghun] Natl Inst Ecol, Div Basic Ecol, Seocheon, South Korea	National Institute of Ecology; Kongju National University; National Institute of Ecology; National Institute of Ecology	Eo, SH (corresponding author), Kongju Natl Univ, Dept Forest Resources, Chungnam, South Korea.	eosh@kongju.ac.kr			National Institute of Ecology through the project of assessment of climate change risk for ecosystem in Korea [NIE-BR-2019-11, NIE-BR-2015-11]; Korea Environment Industry & Technology Institute (KEITI) through the climate change response technology project - Korea Ministry of Environment [2014001310009]	National Institute of Ecology through the project of assessment of climate change risk for ecosystem in Korea; Korea Environment Industry & Technology Institute (KEITI) through the climate change response technology project - Korea Ministry of Environment	This study was supported by the National Institute of Ecology through the project of assessment of climate change risk for ecosystem in Korea (NIE-BR-2019-11; NIE-BR-2015-11) and Korea Environment Industry & Technology Institute (KEITI) through the climate change response technology project, funded by Korea Ministry of Environment (2014001310009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Almeida-Neto M, 2006, J BIOGEOGR, V33, P361, DOI 10.1111/j.1365-2699.2005.01389.x; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Chan WP, 2016, SCIENCE, V351, P1437, DOI 10.1126/science.aab4119; Cho HH, 2018, PEERJ, V6, DOI 10.7717/peerj.5982; Colles A, 2009, ECOL LETT, V12, P849, DOI 10.1111/j.1461-0248.2009.01336.x; COLWELL RK, 1994, AM NAT, V144, P570, DOI 10.1086/285695; Fleishman E, 1998, ECOLOGY, V79, P2482, DOI 10.1890/0012-9658(1998)079[2482:AETORS]2.0.CO;2; Gaston KJ, 1998, TRENDS ECOL EVOL, V13, P70, DOI 10.1016/S0169-5347(97)01236-6; Gaston KJ, 1996, TRENDS ECOL EVOL, V11, P197, DOI 10.1016/0169-5347(96)10027-6; Grytnes JA, 2002, AM NAT, V159, P294, DOI 10.1086/338542; Grytnes JA, 2003, ECOGRAPHY, V26, P291, DOI 10.1034/j.1600-0587.2003.03358.x; Hawkins BA, 2006, GLOBAL ECOL BIOGEOGR, V15, P461, DOI 10.1111/j.1466-822x.2006.00243.x; Jetz W, 2002, SCIENCE, V297, P1548, DOI 10.1126/science.1072779; Kerr JT, 1997, NATURE, V385, P252, DOI 10.1038/385252a0; Koh CN, 2006, DIVERS DISTRIB, V12, P546, DOI 10.1111/j.1366-9516.2006.00238.x; Lepczyk CA, 2008, CONSERV BIOL, V22, P405, DOI 10.1111/j.1523-1739.2008.00881.x; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Luo ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027975; McCain CM, 2013, GLOBAL ECOL BIOGEOGR, V22, P750, DOI 10.1111/geb.12014; Pan XY, 2016, PEERJ, V4, DOI 10.7717/peerj.2636; Presley S.J., 2018, ENCY ANTHROPOCENE, V1-5, P13, DOI [10.1016/B978-0-12-809665-9.09809-8, DOI 10.1016/B978-0-12-809665-9.09809-8]; ROHDE K, 1993, AM NAT, V142, P1, DOI 10.1086/285526; Rohde Klaus, 1996, Biodiversity Letters, V3, P10, DOI 10.2307/2999704; ROY K, 1994, P NATL ACAD SCI USA, V91, P8871, DOI 10.1073/pnas.91.19.8871; Royall R, 2017, STAT EVIDENCE LIKELI, DOI [10.1201/9780203738665, DOI 10.1201/9780203738665]; Sanders NJ, 2002, ECOGRAPHY, V25, P25, DOI 10.1034/j.1600-0587.2002.250104.x; Sheldon KS, 2011, ECOL LETT, V14, P1191, DOI 10.1111/j.1461-0248.2011.01689.x; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; Storch D, 2006, ECOL LETT, V9, P1308, DOI 10.1111/j.1461-0248.2006.00984.x; White RL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121849; Williams YM, 2006, BIOL LETT-UK, V2, P532, DOI 10.1098/rsbl.2006.0541	35	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0203511	10.1371/journal.pone.0203511	http://dx.doi.org/10.1371/journal.pone.0203511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682009	gold, Green Published, Green Submitted			2022-12-26	WOS:000457037500004
J	Mancosu, M; Bobba, G				Mancosu, Moreno; Bobba, Giuliano			Using deep-learning algorithms to derive basic characteristics of social media users: The Brexit campaign as a case study	PLOS ONE			English	Article							POLITICAL-PARTICIPATION; FACEBOOK; ONLINE; TWITTER; AGE; ENGAGEMENT; TWEET; PREFERENCES; DIVIDE; VOTE	A recurrent criticism concerning the use of online social media data in political science research is the lack of demographic information about social media users. By employing a face-recognition algorithm to the profile pictures of Facebook users, the paper derives two fundamental demographic characteristics (age and gender) of a sample of Facebook users who interacted with the most relevant British parties in the two weeks before the Brexit referendum of 23 June 2016. The article achieves the goals of (i) testing the precision of the algorithm, (ii) testing its validity, (iii) inferring new evidence on digital mobilisation, and (iv) tracing the path for future developments and application of the algorithm. The findings show that the algorithm is reliable and that it can be fruitfully used in political and social sciences both to confirm the validity of survey data and to obtain information from populations that are generally unavailable within traditional surveys.	[Mancosu, Moreno; Bobba, Giuliano] Coll Carlo Alberto, Turin, Italy; [Bobba, Giuliano] Univ Turin, Dept Cultures Polit & Soc, Turin, Italy	Collegio Carlo Alberto; University of Turin	Mancosu, M (corresponding author), Coll Carlo Alberto, Turin, Italy.	moreno.mancosu@carloalberto.org	Mancosu, Moreno/ABF-1348-2020					Aldrich JH, 2016, PARTY POLIT, V22, P165, DOI 10.1177/1354068815605304; Auter ZJ, 2018, SOC SCI QUART, V99, P185, DOI 10.1111/ssqu.12391; Barbera P, 2017, R PACKAGE VERSION 0; Barbera P, 2015, POLIT ANAL, V23, P76, DOI 10.1093/pan/mpu011; Bekafigo MA, 2013, SOC SCI COMPUT REV, V31, P625, DOI 10.1177/0894439313490405; Bishop C.M., 1995, NEURAL NETWORKS PATT; Bode L, J POLITICAL MARKETIN; Bond R, 2015, AM POLIT SCI REV, V109, P62, DOI 10.1017/S0003055414000525; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Burnap P, 2016, ELECT STUD, V41, P230, DOI 10.1016/j.electstud.2015.11.017; Carlisle JE, 2013, POLIT RES QUART, V66, P883, DOI 10.1177/1065912913482758; Ceron A, 2014, NEW MEDIA SOC, V16, P340, DOI 10.1177/1461444813480466; Chen SX, 2017, PROC CVPR IEEE, P742, DOI 10.1109/CVPR.2017.86; Cho H, 2014, INT J ADV ROBOT SYST, V11, DOI 10.5772/58473; Coffe H, 2010, SEX ROLES, V62, P318, DOI 10.1007/s11199-009-9729-y; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Dehghan A, 2017, ARXIV170204280; Del Vicario M, 2017, SOC NETWORKS, V50, P6, DOI 10.1016/j.socnet.2017.02.002; DiGrazia J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079449; Facebook Help Centre, 2017, DO I REP CHILD AG 13; Fieldhouse E., 2016, BRIT ELECTION STUDY, P1, DOI DOI 10.15127/1.293723; Freelon D, COMPUTATIONAL RES PO; Freeman B, 2015, PUBLIC HEALTH RES PR, V25, DOI 10.17061/phrp2521517; Gayo-Avello D., 2012, ARXIV PREPRINT ARXIV, DOI DOI 10.1234/12345678; Gayo-Avello D., 2011, 5 INT AAAI C WEBL SO; Gentry J, 2016, R PACK VERS 1 1 9; Gerodimos R, 2015, J INF TECHNOL POLITI, V12, P113, DOI 10.1080/19331681.2014.982266; Goodwin MJ, 2016, POLIT QUART, V87, P323, DOI 10.1111/1467-923X.12285; Guo GD, 2012, STUD COMPUT INTELL, V409, P101; Gustafsson N, 2012, NEW MEDIA SOC, V14, P1111, DOI 10.1177/1461444812439551; Halpern D, 2013, COMPUT HUM BEHAV, V29, P1159, DOI 10.1016/j.chb.2012.10.008; Hobolt SB, 2016, J EUR PUBLIC POLICY, V23, P1259, DOI 10.1080/13501763.2016.1225785; Howard PN, 2016, EARLYVIEW; Huberty M, 2015, INT J FORECASTING, V31, P992, DOI 10.1016/j.ijforecast.2014.08.005; Hum NJ, 2011, COMPUT HUM BEHAV, V27, P1828, DOI 10.1016/j.chb.2011.04.003; Hurlimann M, 2016, P 12 INT C SEM SYST, DOI DOI 10.1145/2993318.2993350; Jung S. G., 2018, INT AAAI C WEB SOC M, P624; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Levi Gil, 2015, 2015 IEEE Conference on Computer Vision and Pattern Recognition Workshops (CVPRW), P34, DOI 10.1109/CVPRW.2015.7301352; Lian JW, 2014, COMPUT HUM BEHAV, V37, P133, DOI 10.1016/j.chb.2014.04.028; Loader BD, 2014, INFORM COMMUN SOC, V17, P143, DOI 10.1080/1369118X.2013.871571; McKelvey K, 2014, INFORM COMMUN SOC, V17, P436, DOI 10.1080/1369118X.2014.892149; Metaxas P., 2011, 2011 IEEE 3 INT C PR, P165, DOI [10.1109/PASSAT/SocialCom.2011.98, DOI 10.1109/PASSAT/SOCIALCOM.2011.98]; Mislove A, P 5 INT AAAI C WEBL, P554; NIU ZX, 2016, PROC CVPR IEEE, P4920, DOI DOI 10.1109/CVPR.2016.532; Norris P., 2004, YOUNG PEOPLE POLITIC; Pfeil U, 2009, COMPUT HUM BEHAV, V25, P643, DOI 10.1016/j.chb.2008.08.015; Rothe R, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION WORKSHOP (ICCVW), P252, DOI 10.1109/ICCVW.2015.41; Schwartz HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073791; Seaton J, 2016, POLIT QUART, V87, P333, DOI 10.1111/1467-923X.12296; Sebastiani F, 2002, ACM COMPUT SURV, V34, P1, DOI 10.1145/505282.505283; Si J, 2015, LECT NOTES COMPUT SC, V9428, P677, DOI 10.1007/978-3-319-25417-3_79; Sloan L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115545; Sloan L, 2013, SOCIOL RES ONLINE, V18, DOI 10.5153/sro.3001; Smets K, 2012, J ELECT PUBLIC OPIN, V22, P407, DOI 10.1080/17457289.2012.728221; Thimm C, 2014, MEDIATIZED WORLDS: CULTURE AND SOCIETY IN A MEDIA AGE, P253; Vaccari C, 2016, SOC MEDIA SOC, V2, DOI 10.1177/2056305116664221; Vaccari C, 2017, POLIT COMMUN, V34, P69, DOI 10.1080/10584609.2016.1201558; Vaccari C, 2015, J COMPUT-MEDIAT COMM, V20, P221, DOI 10.1111/jcc4.12108; Vedaldi A, 2010, P 18 ACM INT C MULT, P1469, DOI DOI 10.1145/1873951.1874249; Vinyals O, 2015, PROC CVPR IEEE, P3156, DOI 10.1109/CVPR.2015.7298935; Vissers S, 2014, INFORM COMMUN SOC, V17, P937, DOI 10.1080/1369118X.2013.867356; Weaver J, 2013, SEMANT WEB, V4, P245, DOI 10.3233/SW-2012-0078; Wilson RE, 2012, PERSPECT PSYCHOL SCI, V7, P203, DOI 10.1177/1745691612442904; Yamamoto M, 2015, NEW MEDIA SOC, V17, P880, DOI 10.1177/1461444813518390	67	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211013	10.1371/journal.pone.0211013	http://dx.doi.org/10.1371/journal.pone.0211013			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682111	Green Published, gold, Green Submitted			2022-12-26	WOS:000457037500090
J	Egan, AN; Moore, S; Stellari, GM; Kang, BC; Jahn, MM				Egan, Ashley N.; Moore, Shanna; Stellari, Giulia Marina; Kang, Byoung-Cheorl; Jahn, Molly M.			Tandem gene duplication and recombination at the AT3 locus in the Solanaceae, a gene essential for capsaicinoid biosynthesis in Capsicum	PLOS ONE			English	Article							CHILI-PEPPERS CAPSICUM; PHYLOGENETIC-RELATIONSHIPS; PROVIDES INSIGHTS; EXPRESSION ANALYSIS; MOSAIC STRUCTURE; GENOME SEQUENCE; DNA-SEQUENCES; PUNGENCY; EVOLUTION; TOMATO	Capsaicinoids are compounds synthesized exclusively in the genus Capsicum and are responsible for the burning sensation experienced when consuming hot pepper fruits. To date, only one gene, AT3, a member of the BAHD family of acyltransferases, is currently known to have a measurable quantitative effect on capsaicinoid biosynthesis. Multiple AT3 paralogs exist in the Capsicum genome, but their evolutionary relationships have not been characterized well. Recessive alleles at this locus result in absence of capsaicinoids in pepper fruit. To explore the evolution of AT3 in Capsicum and the Solanaceae, we sequenced this gene from diverse Capsicum genotypes and species, along with a number of representative solanaceous taxa. Our results revealed that the coding region of AT3 is highly conserved throughout the family. Further, we uncovered a tandem duplication that predates the diversification of the Solanaceae taxa sampled in this study. This pair of tandem duplications were designated AT3-1 and AT3-2. Sequence alignments showed that the AT3-2 locus, a pseudogene, retains regions of amino acid conservation relative to AT3-1. Gene tree estimation demonstrated that AT3-1 and AT3-2 form well supported, distinct clades. In C. rhomboideum, a non-pungent basal Capsicum species, we describe a recombination event between AT3-1 and AT3-2 that modified the putative active site of AT3-1, also resulting in a frame-shift mutation in the second exon. Our data suggest that duplication of the original AT3 representative, in combination with divergence and pseudogene degeneration, may account for the patterns of sequence divergence and punctuated amino acid conservation observed in this study. Further, an early rearrangement in C. rhomboidium could account for the absence of pungency in this Capsicum species.	[Egan, Ashley N.] George Washington Univ, Computat Biol Inst, Ashburn, VA USA; [Moore, Shanna] Cornell Univ, Dept Phys, Howard Hughes Med Inst, Ithaca, NY 14853 USA; [Stellari, Giulia Marina] Cornell Univ, Dept Plant Biol, Ithaca, NY USA; [Kang, Byoung-Cheorl] Seoul Natl Univ, Dept Hort, Seoul, South Korea; [Jahn, Molly M.] Univ Wisconsin, Dept Agron, USDA FPL, 1575 Linden Dr, Madison, WI 53706 USA	George Washington University; Cornell University; Howard Hughes Medical Institute; Cornell University; Seoul National University (SNU); University of Wisconsin System; University of Wisconsin Madison	Jahn, MM (corresponding author), Univ Wisconsin, Dept Agron, USDA FPL, 1575 Linden Dr, Madison, WI 53706 USA.	molly.jahn@wisc.edu	Egan, Ashley N/AAZ-1187-2021; Kang, Byoung-Cheorl/Q-6174-2019	Egan, Ashley N/0000-0001-7803-4444; Jahn, Molly/0000-0003-0181-0374; Moore, Shanna/0000-0001-5578-8868	NSF Metabolic Biochemistry Award [0412056]; USDA NRI Plant Genome [2004-35300-14596]; NSF Graduate Research Fellowship; SUNY Stony Brook	NSF Metabolic Biochemistry Award; USDA NRI Plant Genome(United States Department of Agriculture (USDA)); NSF Graduate Research Fellowship(National Science Foundation (NSF)); SUNY Stony Brook	Funding for this work was provided by: NSF Metabolic Biochemistry Award No. 0412056, https://www.nsf.gov/[MMJ]; USDA NRI Plant Genome Award No. 2004-35300-14596, https://www.usda.gov/[MMJ, SM]; NSF Graduate Research Fellowship, https://www.nsf.gov/[GMS]; The Dean's fund at SUNY Stony Brook, https://www.stonybrook.edu/[GMS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Bohs L, 1997, SYST BOT, V22, P5, DOI 10.2307/2419674; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Garcia CC, 2016, ANN BOT-LONDON, V118, P35, DOI 10.1093/aob/mcw079; Chapa-Oliver AM, 2016, MOLECULES, V21, DOI 10.3390/molecules21080931; D'Auria JC, 2002, PLANT PHYSIOL, V130, P466, DOI 10.1104/pp.006460; D'Auria JC, 2006, CURR OPIN PLANT BIOL, V9, P331, DOI 10.1016/j.pbi.2006.03.016; Doyle JJ, 2010, NEW PHYTOL, V186, P73, DOI 10.1111/j.1469-8137.2009.03118.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egan AN, 2010, SYST BIOL, V59, P534, DOI 10.1093/sysbio/syq041; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Garces-Claver A, 2007, THEOR APPL GENET, V115, P907, DOI 10.1007/s00122-007-0617-y; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gottlieb LD, 1997, MOL BIOL EVOL, V14, P125, DOI 10.1093/oxfordjournals.molbev.a025745; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hayman M., 2008, CURR ANAESTH CRIT CA, V19, P338, DOI [10.1016/j.cacc.2008.07.003, DOI 10.1016/J.CACC.2008.07.003]; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hill TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056200; Hulse-Kemp AM, 2018, HORTIC RES-ENGLAND, V5, DOI 10.1038/s41438-017-0011-0; Johnson DA, 2007, MOL BIOL EVOL, V24, P2412, DOI 10.1093/molbev/msm184; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kim S, 2014, NAT GENET, V46, P270, DOI 10.1038/ng.2877; Lang YQ, 2006, BREEDING SCI, V56, P55, DOI 10.1270/jsbbs.56.55; Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Lynch M, 2000, GENETICS, V154, P459; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Martins TR, 2005, SYST BOT, V30, P435, DOI 10.1600/0363644054223675; Moore S, 2005, J EXP BOT, V56, P2885, DOI 10.1093/jxb/eri283; Ogawa K, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0476-7; Ohno S., 1970, EVOLUTION GENE DUPLI; Olmstead RG, 2008, TAXON, V57, P1159, DOI 10.1002/tax.574010; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Qin C, 2014, P NATL ACAD SCI USA, V111, P5135, DOI 10.1073/pnas.1400975111; Sarkinen T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-214; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Scaldaferro MA, 2013, GENET RESOUR CROP EV, V60, P693, DOI 10.1007/s10722-012-9867-x; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; SMITH JM, 1992, J MOL EVOL, V34, P126; Spalink D, 2018, MOL PHYLOGENET EVOL, V126, P293, DOI 10.1016/j.ympev.2018.04.030; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stellari GM, 2010, HEREDITY, V104, P460, DOI 10.1038/hdy.2009.131; Stewart C, 2005, PLANT J, V42, P675, DOI 10.1111/j.1365-313X.2005.02410.x; Stewart C, 2007, J EXP BOT, V58, P979, DOI 10.1093/jxb/erl243; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; TANKSLEY SD, 1992, GENETICS, V132, P1141; Tasma IM, 2008, PLANT PHYSIOL BIOCH, V46, P627, DOI 10.1016/j.plaphy.2008.04.015; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Tewksbury JJ, 2001, NATURE, V412, P403, DOI 10.1038/35086653; VOELKER TA, 1986, EMBO J, V5, P3075, DOI 10.1002/j.1460-2075.1986.tb04613.x; Walsh BM, 2001, INT J PLANT SCI, V162, P1409, DOI 10.1086/323273; WEBBER H, 1911, AM BREED ASS ANN REP, V7, P188; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu XH, 2009, PLANT MOL BIOL, V70, P421, DOI 10.1007/s11103-009-9482-1; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang ZX, 2016, SCI REP-UK, V6, DOI 10.1038/srep34121	62	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210510	10.1371/journal.pone.0210510	http://dx.doi.org/10.1371/journal.pone.0210510			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673734	gold, Green Published			2022-12-26	WOS:000456442800046
J	Laas, E; Hamy, AS; Michel, AS; Panchbhaya, N; Faron, M; Lam, T; Carrez, S; Pierga, JY; Rouzier, R; Lerebours, F; Feron, JG; Reyal, F				Laas, Enora; Hamy, Anne-Sophie; Michel, Anne-Sophie; Panchbhaya, Nabilah; Faron, Matthieu; Lam, Thanh; Carrez, Sophie; Pierga, Jean-Yves; Rouzier, Roman; Lerebours, Florence; Feron, Jean-Guillaume; Reyal, Fabien			Impact of time to local recurrence on the occurrence of metastasis in breast cancer patients treated with neoadjuvant chemotherapy: A random forest survival approach	PLOS ONE			English	Article							SURGICAL ADJUVANT BREAST; TUMOR RECURRENCE; PREOPERATIVE CHEMOTHERAPY; LOCOREGIONAL RECURRENCES; PROGNOSTIC-SIGNIFICANCE; CONSERVATIVE SURGERY; DISTANT METASTASES; THERAPY; RECOMMENDATIONS; CARCINOMA	Background We studied the relationship between time to ipsilateral breast tumor recurrence (IBTR) and distant metastasis-free survival (DMFS) in patients with breast cancer treated by neoadjuvant chemotherapy (NAC). Methods Between 2002 and 2012, 1199 patients with primary breast cancer were treated with NAC. Clinical, radiological and pathological data were retrieved from medical records. Multivariate analysis was performed with the random survival forest (RSF) method, to evaluate the relationship between time to local recurrence and DMFS. Results Time to IBTR, local recurrence and molecular subtype were the factors most strongly associated with DMFS. In the total population, DMFS increased linearly with recurrence time, up to 50 months. For recurrences after 50 months, DMFS was similar for all times to recurrence. Considering molecular subtypes separately, the threshold was similar for the TNBC subtype (50 months), but appeared to occur later for the luminal and HER2-positive subtypes (75 months). Conclusion A threshold of 50 months seems to differentiate between early and late recurrences and could be used to guide the medical management of local breast tumour recurrences.	[Laas, Enora; Michel, Anne-Sophie; Panchbhaya, Nabilah; Carrez, Sophie; Rouzier, Roman; Feron, Jean-Guillaume; Reyal, Fabien] Inst Curie, Dept Surg, Paris, France; [Hamy, Anne-Sophie; Reyal, Fabien] PSL Res Univ, Translat Res Dept, Inst Curie, RT2Lab, Paris, France; [Hamy, Anne-Sophie; Reyal, Fabien] INSERM, Immun & Canc U932, Paris, France; [Faron, Matthieu] Inst Gustave Roussy, Dept Surg, Villejuif, France; [Lam, Thanh] Geneva Univ Hosp, Dept Obstet & Gynaecol, Geneva, Switzerland; [Pierga, Jean-Yves; Lerebours, Florence] Inst Curie, Dept Med Oncol, Paris, France; [Pierga, Jean-Yves] Paris Descartes Univ, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; University of Geneva; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Cite	Reyal, F (corresponding author), Inst Curie, Dept Surg, Paris, France.; Reyal, F (corresponding author), PSL Res Univ, Translat Res Dept, Inst Curie, RT2Lab, Paris, France.; Reyal, F (corresponding author), INSERM, Immun & Canc U932, Paris, France.	fabien.reyal@curie.fr			Roche France; ITMO-INSERM-AVIESAN cancer translational research grant; Roche* France	Roche France(Roche Holding); ITMO-INSERM-AVIESAN cancer translational research grant; Roche* France(Roche Holding)	This work was supported by Roche France: financial support for the construction of the Institut Curie neoadjuvant database (NEOREP), http://www.roche.fr, the funder had no role in study design, analysis, decision to publish, or preparation of the manuscript, the only role was for data collection; ITMO-INSERM-AVIESAN cancer translational research grant, https://www.aviesan.fr (ASH), the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Roche* France for financial support for the construction of the Institut Curie neoadjuvant database (NEOREP). The funding source had no role in data analysis and interpretation or in the writing of the manuscript.; AS Hamy was supported by an ITMO-INSERM-AVIESAN cancer translational research grant.	Anderson SJ, 2009, J CLIN ONCOL, V27, P2466, DOI 10.1200/JCO.2008.19.8424; Balaton AJ, 1999, ANN PATHOL, V19, P336; Baulies S, 2015, BRIT J CANCER, V113, P30, DOI 10.1038/bjc.2015.174; Bellera CA, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-20; Chen X, 2012, GENOMICS, V99, P323, DOI 10.1016/j.ygeno.2012.04.003; Datema FR, 2012, HEAD NECK-J SCI SPEC, V34, P50, DOI 10.1002/hed.21698; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; FISHER B, 1991, LANCET, V338, P327, DOI 10.1016/0140-6736(91)90475-5; Fisher B, 1997, J CLIN ONCOL, V15, P2483, DOI 10.1200/JCO.1997.15.7.2483; Fisher B, 1998, J CLIN ONCOL, V16, P2672, DOI 10.1200/JCO.1998.16.8.2672; Fortin A, 1999, J CLIN ONCOL, V17, P101, DOI 10.1200/JCO.1999.17.1.101; Fredriksson I, 2002, EUR J CANCER, V38, P1860, DOI 10.1016/S0959-8049(02)00219-8; Friedel G, 2013, ANTICANCER RES, V33, P1609; Ghadiani Mohammad Hassan, 2012, Arab J Nephrol Transplant, V5, P19; Gosset M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159888; Haffty BG, 1996, J CLIN ONCOL, V14, P52, DOI 10.1200/JCO.1996.14.1.52; Hamidi O, 2016, IRAN J PUBLIC HEALTH, V45, P27; Hsich E, 2011, CIRC-CARDIOVASC QUAL, V4, P39, DOI 10.1161/CIRCOUTCOMES.110.939371; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Karabicak I, 2011, CLIN TRANSPLANT, V25, pE264, DOI 10.1111/j.1399-0012.2011.01412.x; KURTZ JM, 1990, INT J RADIAT ONCOL, V18, P87, DOI 10.1016/0360-3016(90)90271-K; Lee JS, 2011, J BREAST CANCER, V14, P191, DOI 10.4048/jbc.2011.14.3.191; Mauri D, 2005, JNCI-J NATL CANCER I, V97, P188, DOI 10.1093/jnci/dji021; Mauriac L, 1999, ANN ONCOL, V10, P47, DOI 10.1023/A:1008337009350; Mieog JSD, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005002.pub2; Mogensen UB, 2012, J STAT SOFTW, V50, P1; Park S, 2012, BREAST, V21, P50, DOI 10.1016/j.breast.2011.07.008; Rouzier R, 2001, J CLIN ONCOL, V19, P3828, DOI 10.1200/JCO.2001.19.18.3828; Savignoni A, 2012, STAT MED, V31, P4444, DOI 10.1002/sim.5631; Touboul E, 1999, INT J RADIAT ONCOL, V43, P25, DOI 10.1016/S0360-3016(98)00365-4; van der Hage JA, 2001, J CLIN ONCOL, V19, P4224, DOI 10.1200/JCO.2001.19.22.4224; van der Sangen MJC, 2006, EJSO-EUR J SURG ONC, V32, P34, DOI 10.1016/j.ejso.2005.10.005; VERONESI U, 1995, J NATL CANCER I, V87, P19, DOI 10.1093/jnci/87.1.19; Voogd AC, 1999, CANCER-AM CANCER SOC, V85, P437, DOI 10.1002/(SICI)1097-0142(19990115)85:2<437::AID-CNCR23>3.0.CO;2-1; Wapnir IL, 2006, J CLIN ONCOL, V24, P2028, DOI 10.1200/JCO.2005.04.3273; WHELAN T, 1994, INT J RADIAT ONCOL, V30, P11, DOI 10.1016/0360-3016(94)90513-4; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yin WJ, 2009, BREAST CANCER RES TR, V114, P527, DOI 10.1007/s10549-008-0022-5	38	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0208807	10.1371/journal.pone.0208807	http://dx.doi.org/10.1371/journal.pone.0208807			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673703	gold, Green Submitted, Green Published			2022-12-26	WOS:000456442800010
J	Lee, HY; Yang, HK; Song, HJ; Chang, HJ; Kang, JY; Lee, SH; Han, S; Kim, YK				Lee, Hea Yon; Yang, Hae Kyung; Song, Ho Jin; Chang, Hee Jae; Kang, Ji Young; Lee, Sang Haak; Han, Solji; Kim, Young Kyoon			Metabolic health is more closely associated with decrease in lung function than obesity	PLOS ONE			English	Article							BODY-MASS INDEX; NORMAL-WEIGHT MONW; NATIONAL-HEALTH; CARDIOVASCULAR MORTALITY; VENTILATORY FUNCTION; BLOOD-PRESSURE; RISK; POPULATION; PARADOX; DISEASE	Objective Previous studies have evaluated the link between metabolic syndrome and obesity with impaired lung function, however findings have been controversial. We aimed to compare lung function among subjects with different metabolic health and obesity status. Methods Total 10,071 participants were evaluated at the Health Promotion Center in Seoul St. Mary's Hospital between January 2012 and December 2014. Being metabolically healthy was defined as having fewer than three of the following risk factors: high blood pressure, high fasting blood glucose, high triglyceride, low high-density lipoprotein cholesterol and abdominal obesity. Obesity status was defined as body mass index (BMI) higher than 25 kg/m(2). Analyses of pulmonary function were performed in four groups divided according to metabolic health and obesity: metabolically healthy non-obese (MHNO), metabolically health obese (MHO), metabolically unhealthy non-obese (MUHNO), and metabolically unhealthy obese (MUHO). Results Metabolically unhealthy subjects were more prone to decreased lung function compared with their metabolically healthy counterparts, regardless of obesity status. When multinomial logistic regression analysis was performed according to quartiles of forced vital capacity (FVC) or forced expiratory volume in 1 second (FEV1) (% pred), after adjusting for age, sex, and smoking status, odds ratio (OR) for the lowest FVC and FEV1 (% pred) quartiles were significantly higher in MUHO subjects (1.788 [95% CI, 1.531-2.089] and 1.603 [95% CI, 1.367-1.881]) and lower in MHO subjects (0.768 [95% CI, 0.654-0.902] and 0.826 [95% CI, 0.700-0.976]) with MHNO group as the reference, when OR for highest FVC and FEV1 quartiles were considered as 1.0 Conclusion Metabolic health is more closely associated with impaired lung function than obesity.	[Lee, Hea Yon; Song, Ho Jin; Chang, Hee Jae] Catholic Univ Korea, Coll Med, Dept Hlth Promot Med, Seoul, South Korea; [Lee, Hea Yon; Yang, Hae Kyung] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Kang, Ji Young; Lee, Sang Haak; Kim, Young Kyoon] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Pulm Med, Seoul, South Korea; [Han, Solji] Yonsei Univ, Dept Appl Stat, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Yonsei University	Kim, YK (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Pulm Med, Seoul, South Korea.	youngkim@catholic.ac.kr		Lee, Heayon/0000-0001-7389-2343				Aguilar-Salinas CA, 2008, J CLIN ENDOCR METAB, V93, P4075, DOI 10.1210/jc.2007-2724; Aung K, 2014, J CLIN ENDOCR METAB, V99, P462, DOI 10.1210/jc.2013-2832; Baffi CW, 2016, CHEST, V149, P1525, DOI 10.1016/j.chest.2015.12.034; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Beltran-Sanchez H, 2013, J AM COLL CARDIOL, V62, P697, DOI 10.1016/j.jacc.2013.05.064; Tran BT, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3936-6; BJORNTORP P, 1987, ANN NY ACAD SCI, V499, P66, DOI 10.1111/j.1749-6632.1987.tb36198.x; Brumpton BM, 2013, EUR RESPIR J, V42, P1495, DOI 10.1183/09031936.00046013; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Choi JK, 2005, TUBERC RESPIR DIS, V58, P230, DOI 10.4046/trd.2005.58.3.230; Conus F, 2004, J CLIN ENDOCR METAB, V89, P5013, DOI 10.1210/jc.2004-0265; Cotes JE, 2001, THORAX, V56, P839, DOI 10.1136/thorax.56.11.839; Cottrell L, 2011, AM J RESP CRIT CARE, V183, P441, DOI 10.1164/rccm.201004-0603OC; Dekkers BGJ, 2009, AM J RESP CELL MOL, V41, P494, DOI 10.1165/rcmb.2008-0251OC; Engstrom G, 2002, DIABETIC MED, V19, P167, DOI 10.1046/j.1464-5491.2002.00652.x; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hainer V, 2013, DIABETES CARE, V36, pS276, DOI 10.2337/dcS13-2023; Jeon YK, 2015, OSTEOPOROSIS INT, V26, P2423, DOI 10.1007/s00198-015-3152-8; Karelis AD, 2005, J CLIN ENDOCR METAB, V90, P4145, DOI 10.1210/jc.2005-0482; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Lavie CJ, 2015, JACC-HEART FAIL, V3, P927, DOI 10.1016/j.jchf.2015.07.009; Lazarus R, 1998, AM J CLIN NUTR, V68, P35, DOI 10.1093/ajcn/68.1.35; Lazarus R, 1998, EUR RESPIR J, V12, P635, DOI 10.1183/09031936.98.12030635; Lee EJ, 2009, J ASTHMA, V46, P339, DOI 10.1080/02770900802660931; Lee HM, 2010, EUR RESPIR J, V36, P1002, DOI 10.1183/09031936.00042410; Lee K, 2009, ASIA PAC J CLIN NUTR, V18, P280; Lee SY, 2007, DIABETES RES CLIN PR, V75, P72, DOI 10.1016/j.diabres.2006.04.013; Lee SH, 2011, CLIN ENDOCRINOL, V75, P475, DOI 10.1111/j.1365-2265.2011.04085.x; Leone N, 2009, AM J RESP CRIT CARE, V179, P509, DOI 10.1164/rccm.200807-1195OC; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mannino DM, 2003, AM J MED, V114, P758, DOI 10.1016/S0002-9343(03)00185-2; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moon JH, 2015, J KOREAN MED SCI, V30, P1682, DOI 10.3346/jkms.2015.30.11.1682; Morkedal B, 2011, EUR J EPIDEMIOL, V26, P457, DOI 10.1007/s10654-011-9572-7; Park HY, 2010, RESP MED, V104, P1326, DOI 10.1016/j.rmed.2010.02.024; Price GM, 2006, AM J CLIN NUTR, V84, P449; Salome CM, 2010, J APPL PHYSIOL, V108, P206, DOI 10.1152/japplphysiol.00694.2009; Seo MH, 2014, ENDOCRINOL METAB, V29, P427, DOI 10.3803/EnM.2014.29.4.427; Sin DD, 2003, THORAX, V58, P695, DOI 10.1136/thorax.58.8.695; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; Soutar A, 1997, THORAX, V52, P166, DOI 10.1136/thx.52.2.166; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Standl E, 2013, DIABETES CARE, V36, pS282, DOI 10.2337/dcS13-2040; Steier J, 2014, THORAX, V69, P752, DOI 10.1136/thoraxjnl-2014-205148; Stump CS, 2006, ANN MED, V38, P389, DOI 10.1080/07853890600888413; Uretsky S, 2007, AM J MED, V120, P863, DOI 10.1016/j.amjmed.2007.05.011; Wang B, 2015, HORM METAB RES, V47, P839, DOI 10.1055/s-0035-1559767; WHO, 2008, WAIST CIRCUMFERENCE; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Yang HK, 2016, SCI REP-UK, V6, DOI 10.1038/srep30329	54	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0209575	10.1371/journal.pone.0209575	http://dx.doi.org/10.1371/journal.pone.0209575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673715	gold, Green Published, Green Submitted			2022-12-26	WOS:000456442800019
J	Wagner, J; Eiken, B; Haubitz, I; Lichthardt, S; Matthes, N; Lob, S; Klein, I; Germer, CT; Wiegering, A				Wagner, Johanna; Eiken, Barbara; Haubitz, Imme; Lichthardt, Sven; Matthes, Niels; Loeb, Stefan; Klein, Ingo; Germer, Christoph-Thomas; Wiegering, Armin			Suprapubic bladder drainage and epidural catheters following abdominal surgery-A risk for urinary tract infections?	PLOS ONE			English	Article							ENHANCED RECOVERY; EARLY REMOVAL; PREVENTION; MANAGEMENT	Background Epidural catheters are state of the art for postoperative analgesic in abdominal surgery. Due to neurolysis it can lead to postoperative urinary tract retention (POUR), which leads to prolonged bladder catheterization, which has an increased risk for urinary tract infections (UTI). Our aim was to identify the current perioperative management of urinary catheters and, second, to identify the optimal time of suprapubic bladder catheter removal in regard to the removal of the epidural catheter. Methods We sent a questionnaire to 102 German hospitals and analyzed the 83 received answers to evaluate the current handling of bladder drainage and epidural catheters. Then, we conducted a retrospective study including 501 patients, who received an epidural and suprapubic catheter after abdominal surgery at the University Hospital Wurzburg. We divided the patients into three groups according to the point in time of suprapubic bladder drainage removal in regard to the removal of the epidural catheter and analyzed the onset of a UTI. Results Our survey showed that in almost all hospitals (98.8%), patients received an epidural catheter and a bladder drainage after abdominal surgery. The point in time of urinary catheter removal was equally distributed between before, simultaneously and after the removal of the epidural catheter (respectively:-28-29%). The retrospective study showed a catheter-associated UTI in 6.7%. Women were affected significantly more often than men (10,7% versus 2,5%, p<0.001). There was a non-significant trend to more UTIs when the suprapubic catheter was removed after the epidural catheter (before: 5.7%, after: 8.4%). Conclusion The point in time of suprapubic bladder drainage removal in relation to the removal of the epidural catheter does not seem to correlate with the rate of UTIs. The current handling in Germany is inhomogeneous, so further studies to standardize treatment are recommended.	[Wagner, Johanna; Eiken, Barbara; Haubitz, Imme; Lichthardt, Sven; Matthes, Niels; Loeb, Stefan; Klein, Ingo; Germer, Christoph-Thomas; Wiegering, Armin] Univ Hosp Wurzburg, Dept Gen Visceral Vasc & Pediat Surg, Wurzburg, Germany; [Loeb, Stefan; Klein, Ingo; Germer, Christoph-Thomas; Wiegering, Armin] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, Core Unit Bioinformat, Bioctr, Wurzburg, Germany; [Wiegering, Armin] Univ Wurzburg, Theodor Boveri Inst, Bioctr, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Wagner, J (corresponding author), Univ Hosp Wurzburg, Dept Gen Visceral Vasc & Pediat Surg, Wurzburg, Germany.	Wagner_J6@ukw.de	Wagner, Johanna/AAN-2289-2020; Klein, Ingo/AAY-3371-2020; Wiegering, Armin/X-7541-2018	Wagner, Johanna/0000-0002-2999-6900; Klein, Ingo/0000-0003-1097-0986; Wiegering, Armin/0000-0001-7777-0909	University of Wuerzburg	University of Wuerzburg	This publication was funded by the University of Wuerzburg in the funding program Open Access Publishing.	Benoist S, 1999, SURGERY, V125, P135, DOI 10.1067/msy.2099.94988; Bonkat G, 2013, WORLD J UROL, V31, P565, DOI 10.1007/s00345-012-0930-1; Bouchet-Doumenq C, 2016, INT J COLORECTAL DIS, V31, P511, DOI 10.1007/s00384-015-2471-8; Branagan GW, 2002, DIS COLON RECTUM, V45, P1104, DOI 10.1007/s10350-004-6368-9; GARIBALDI RA, 1982, INFECT CONT HOSP EP, V3, P466, DOI 10.1017/S0195941700056599; GIVENS CD, 1980, J UROLOGY, V124, P646, DOI 10.1016/S0022-5347(17)55596-2; Gould CV, 2010, INFECT CONT HOSP EP, V31, P319, DOI 10.1086/651091; Hoffmann H, 2012, EUR SURG RES, V49, P24, DOI 10.1159/000339859; Hu Y, 2014, J CARDIOTHOR VASC AN, V28, P1302, DOI 10.1053/j.jvca.2014.05.009; Hughes MJ, 2014, JAMA SURG, V149, P1224, DOI 10.1001/jamasurg.2014.210; Jorgensen H., 2000, COCHRANE DATABASE SY; Kim JY, 2006, BRIT J ANAESTH, V97, P414, DOI 10.1093/bja/ael172; Kuipers PW, 2004, ANESTHESIOLOGY, V100, P1497, DOI 10.1097/00000542-200406000-00023; Kwaan MR, 2015, DIS COLON RECTUM, V58, P401, DOI 10.1097/DCR.0000000000000317; Niel-Weise BS, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005428; Orikasa S, 2012, INT J UROL, V19, P587, DOI 10.1111/j.1442-2042.2012.02980.x; RAWAL N, 1983, ANESTH ANALG, V62, P641; Saint S, 2002, ANN INTERN MED, V137, P125, DOI 10.7326/0003-4819-137-2-200207160-00012; Statistisches Bundesamt, 2016, FALLP KRANK DRG STAT; Tenke P, 2008, INT J ANTIMICROB AG, V31, pS68, DOI 10.1016/j.ijantimicag.2007.07.033; Tenke P, 2014, CURR OPIN INFECT DIS, V27, P102, DOI 10.1097/QCO.0000000000000031; Wald HL, 2008, ARCH SURG-CHICAGO, V143, P551, DOI 10.1001/archsurg.143.6.551	22	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0209825	10.1371/journal.pone.0209825	http://dx.doi.org/10.1371/journal.pone.0209825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673740	Green Submitted, gold, Green Published			2022-12-26	WOS:000456442800023
J	Reshmi, RS; Dinachandra, K; Bhanot, A; Unisa, S; Menon, GT; Agrawal, N; Bhatia, V; Ruikar, M; Daniel, A; Bhattacharjee, S; Parhi, RN; Sachdev, HPS; Gope, RK; De Wagt, A; Sethi, V				Reshmi, R. S.; Dinachandra, Konsam; Bhanot, Arti; Unisa, Sayeed; Menon, Gopinath T.; Agrawal, Neeraj; Bhatia, Vikas; Ruikar, Manisha; Daniel, Abner; Bhattacharjee, Sourav; Parhi, Rabi N.; Sachdev, H. P. S.; Gope, Raj Kumar; De Wagt, Arjan; Sethi, Vani			Context for layering women's nutrition interventions on a large scale poverty alleviation program: Evidence from three eastern Indian states	PLOS ONE			English	Article								Over 70 million women of reproductive age are undernourished in India. Most poverty alleviation programs have not been systematically evaluated to assess impact on women's empowerment and nutrition outcomes. National Rural Livelihoods Mission's poverty alleviation and livelihoods generation initiative is an opportune platform to layer women's nutrition interventions being tapped by project Swabhimaan in three eastern Indian states-Bihar, Chhattisgarh and Odisha. A cross-sectional baseline survey covering 8755 mothers of children under-two years of age, one of the three primary target groups of program are presented. Standardized questionnaire was administered and anthropometric measurements were undertaken from October 2016 to January 2017. 21 indicators on women's empowerment, Body Mass Index and Mid-upper Arm Circumference for nutrition status, food insecurity indicators as per the Food Insecurity Experience Scale and selected indicators for assessing women's access to basic health services were included. National Rural Livelihoods Mission operates in contexts with stark social and gender inequalities. Self-help group members exhibited better control on financial resources and participation in community activities than non-members. Using Body Mass Index, at least 45% mothers were undernourished irrespective of their enrolment in self-help groups. Higher proportion of self-help group members (77%-87%) belonged to food insecure households than non-members (66%-83%). Proportion of mothers reporting receipt of various components of antenatal care service package varied from over 90% for tetanus toxoid vaccination to less than 10% for height measurement. Current use of family planning methods was excruciatingly low (8.2%-32.4%) in all states but positively skewed towards self-help group members. Participation in monthly fixed day health camps was a concern in Bihar. Layering women's nutrition interventions as stipulated under Swabhimaan may yield better results for women's empowerment and nutrition status under National Rural Livelihoods Mission. While this opportunity exists in all three states, Bihar with a higher proportion of matured self-help groups offers more readiness for Swabhimaan implementation.	[Reshmi, R. S.; Dinachandra, Konsam; Unisa, Sayeed] Int Inst Populat Sci, Mumbai, India; [Menon, Gopinath T.] SPARSH Ctr Participatory Learning, Mumbai, India; [Agrawal, Neeraj] AIIMS, Patna, Bihar, India; [Bhatia, Vikas] AIIMS, Bhubaneswar, India; [Ruikar, Manisha] AIIMS, Raipur, Madhya Pradesh, India; [Daniel, Abner; De Wagt, Arjan; Sethi, Vani] UNICEF India, Country Off, Nutr Sect, New Delhi, India; [Bhattacharjee, Sourav] UNICEF India, Field Off Odisha, Bhubaneswar, India; [Parhi, Rabi N.] UNICEF India, Field Off Bihar, Patna, Bihar, India; [Sachdev, H. P. S.] Sitaram Bhartia Inst Sci & Res, New Delhi, India; [Gope, Raj Kumar] Ekjut, Jharkhand, India	International Institute for Population Sciences; All India Institute of Medical Sciences (AIIMS) Patna; All India Institute of Medical Sciences (AIIMS) Bhubaneswar; All India Institute of Medical Sciences (AIIMS) Raipur; Sitaram Bhartia Institute of Science & Research	Sethi, V (corresponding author), UNICEF India, Country Off, Nutr Sect, New Delhi, India.	vsethi@unicef.org	Unisa, Sayeed/AAS-9588-2020; Ruikar, Manisha/AAD-8926-2022	Dinachandra Singh, Konsam/0000-0001-9071-0601; Sachdev, Harshpal Singh/0000-0002-4956-9391; Ruikar, Manisha/0000-0003-3928-4576	UNICEF, India	UNICEF, India	UNICEF, India. The funders helped in the study design and preparation of manuscript.	[Anonymous], 1995, Bull World Health Organ, V73 Suppl, P1; [Anonymous], 2017, SWABH 2016 202 UNPUB; [Anonymous], 2012, NAT RUR LIV MISS; [Anonymous], 2018, MAT NUTR CAR NRC; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Central TB. Division Ministry of Health and Family Welfare, 2017, GUID DOC NUTR CAR SU; Datta U, SOCIOECONOMIC EFFECT; Deininger K, 2013, WORLD DEV, V43, P149, DOI 10.1016/j.worlddev.2012.09.019; FAO, 2017, FOOD INS EXP SCAL ME; George V, 2017, KUDUMBASHREE RETHINK; Institute of Medicine, 2009, WEIGHT GAIN PREGN RE, P370; Inter-Parliamentary Union and World Health Organization, 2016, CHILD EARL FORC MARR; International Institute of Population Sciences, 2017, NAT FAM HLTH SURV 4; KAMALADOSS T, 1992, Indian Journal of Pediatrics, V59, P299, DOI 10.1007/BF02821792; Kishor S., 2004, EC POLITICAL WEEKLY, V39, P694; Kumar N, 2018, GLOB FOOD SECUR-AGR, V17, P172, DOI 10.1016/j.gfs.2017.11.002; Kumar P, 2018, INDIAN J COMMUN MED, V43, P132, DOI 10.4103/ijcm.IJCM_248_17; Ministry of Health and Family Welfare, 2015, HLTH FAM WELF STAT I; Park A, 2010, DP7856 CEPR; Sethi V, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-017-0099-8; Tang AM., 2016, DETERMINING GLOBAL M; Wodon Q, 2017, EC IMPACTS CHILD MAR; World Health Organization (WHO), 1995, WHO TECHN RES SER	23	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210836	10.1371/journal.pone.0210836	http://dx.doi.org/10.1371/journal.pone.0210836			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668595	Green Submitted, Green Published, gold			2022-12-26	WOS:000456306400018
J	Chang, TC; Wei, PL; Makondi, PT; Chen, WT; Huang, CY; Chang, YJ				Chang, Tung-Cheng; Wei, Po-Li; Makondi, Precious Takondwa; Chen, Wei-Ting; Huang, Chien-Yu; Chang, Yu-Jia			Bromelain inhibits the ability of colorectal cancer cells to proliferate via activation of ROS production and autophagy	PLOS ONE			English	Article							INDUCED CYTOKINE PRODUCTION; INDUCED APOPTOSIS; OXIDATIVE STRESS; STATISTICS; PATHWAY; LC3; EXPRESSION; AIF	Advanced colorectal cancer (CRC) survival rates are still low despite advances in cytotoxic and targeted therapies. The development of new effective or alternative therapies is therefore urgently needed. Bromelain, an extract of pineapple, was shown to have anticancer effects, but its mechanisms in CRC have not been fully explored. Therefore, the roles of bromelain in CRC progression were investigated using different CRC cell lines, a zebrafish model, and a xenograft mouse model. The anticancer mechanisms were explored by assessing the role of bromelain in inducing reactive oxygen species (ROS), superoxide, autophagosomes, and lysosomes. The role of bromelain in the induction of apoptosis was also assessed. It was found that bromelain inhibited CRC cell growth in cell lines and tumor growth in the zebrafish and xenograft mouse models. It also induced high levels of ROS and superoxide, plus autophagosome and lysosome formation. High levels of apoptosis were also induced, which were associated with elevated amounts of apoptotic proteins like apoptotic induction factor, Endo G, and caspases-3, -8, and -9 according to a qPCR analysis. In a Western blot analysis, increases in levels of ATG5/12, beclin, p62, and LC3 conversion rates were found after bromelain treatment. Levels of cleaved caspase-3, caspase-8, caspase-9, and poly(ADP ribose) polymerase (PARP)-1 increased after bromelain exposure. This study explored the role of bromelain in CRC while giving insights into its mechanisms of action. This compound can offer a cheap alternative to current therapies.	[Chang, Tung-Cheng; Wei, Po-Li; Makondi, Precious Takondwa; Chen, Wei-Ting; Chang, Yu-Jia] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Chang, Tung-Cheng; Wei, Po-Li; Huang, Chien-Yu] Taipei Med Univ, Coll Med, Dept Surg, Taipei, Taiwan; [Chang, Tung-Cheng; Huang, Chien-Yu] Taipei Med Univ, Shuang Ho Hosp, Div Gen Surg, Dept Surg, New Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Taipei Med Univ Hosp, Dept Surg, Div Colorectal Surg, Taipei, Taiwan; [Wei, Po-Li; Chang, Yu-Jia] Taipei Med Univ, Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan; [Wei, Po-Li; Chang, Yu-Jia] Taipei Med Univ, Taipei Med Univ Hosp, Dept Med Res, Translat Lab, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Makondi, Precious Takondwa; Chang, Yu-Jia] Taipei Med Univ, Int PhD Program Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University	Chang, YJ (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.; Huang, CY (corresponding author), Taipei Med Univ, Coll Med, Dept Surg, Taipei, Taiwan.; Huang, CY (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Div Gen Surg, Dept Surg, New Taipei, Taiwan.; Chang, YJ (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan.; Chang, YJ (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Dept Med Res, Translat Lab, Taipei, Taiwan.; Chang, YJ (corresponding author), Taipei Med Univ, Int PhD Program Med, Taipei, Taiwan.	cyh@tmu.edu.tw; r5424012@tmu.edu.tw			Taipei Medical University; Shuang Ho Hospital [105TMU-SHH-19]; Shuang Ho Hospital, Taipei Medical University [105TMU-SHH-19]	Taipei Medical University; Shuang Ho Hospital; Shuang Ho Hospital, Taipei Medical University	This work was supported by a grant form Taipei Medical University and Shuang Ho Hospital (105TMU-SHH-19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from Taipei Medical University and Shuang Ho Hospital, Taipei Medical University (105TMU-SHH-19).	Amini A, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0092-7; Baez R, 2007, PLANTA MED, V73, P1377, DOI 10.1055/s-2007-990221; Bhui K, 2012, MOL CARCINOGEN, V51, P231, DOI 10.1002/mc.20769; Bhui K, 2009, CANCER LETT, V282, P167, DOI 10.1016/j.canlet.2009.03.003; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Brien S, 2004, EVID-BASED COMPL ALT, V1, P251, DOI 10.1093/ecam/neh035; Cadwell K, 2018, J CELL BIOL, V217, P813, DOI 10.1083/jcb.201706157; Castell JV, 1997, AM J PHYSIOL-GASTR L, V273, pG139, DOI 10.1152/ajpgi.1997.273.1.G139; Cheng P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.17; Chobotova K, 2010, CANCER LETT, V290, P148, DOI 10.1016/j.canlet.2009.08.001; Davalli P, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2389523; Novaes LCD, 2016, BIOTECHNOL PROGR, V32, P5, DOI 10.1002/btpr.2190; Dhandayuthapani S, 2012, J MED FOOD, V15, P344, DOI 10.1089/jmf.2011.0145; Dolman NJ, 2013, AUTOPHAGY, V9, P1653, DOI 10.4161/auto.24001; FELTON GE, 1980, MED HYPOTHESES, V6, P1123, DOI 10.1016/0306-9877(80)90134-6; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; GERARD G, 1972, AGRESSOLOGIE, V13, P261; Glaser D, 2006, PLATELETS, V17, P37, DOI 10.1080/09537100500197489; Goldstein N, 1975, Hawaii Med J, V34, P91; GUM JR, 1992, AM J RESP CELL MOL, V7, P557, DOI 10.1165/ajrcmb/7.6.557; Hou RCW, 2006, J AGR FOOD CHEM, V54, P2193, DOI 10.1021/jf052390k; Huang JR, 2008, IMMUNOL INVEST, V37, P263, DOI 10.1080/08820130802083622; Joza N, 2009, ANN NY ACAD SCI, V1171, P2, DOI 10.1111/j.1749-6632.2009.04681.x; Juhasz B, 2008, AM J PHYSIOL-HEART C, V294, pH1365, DOI 10.1152/ajpheart.01005.2007; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kalra N, 2008, TOXICOL APPL PHARM, V226, P30, DOI 10.1016/j.taap.2007.08.012; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kuo LJ, 2013, J SURG RES, V185, P264, DOI 10.1016/j.jss.2013.05.020; Levy JMM, 2017, NAT REV CANCER, V17, P528, DOI 10.1038/nrc.2017.53; Li DY, 2017, EUR REV MED PHARMACO, V21, P5548, DOI 10.26355/eurrev_201712_13991; Liang HH, 2013, TUMOR BIOL, V34, P3209, DOI 10.1007/s13277-013-0891-z; Liu KC, 2011, INT J ONCOL, V38, P787, DOI 10.3892/ijo.2010.894; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Matsuda K, 2008, SCAND J GASTROENTERO, V43, P25, DOI 10.1080/00365520701579795; Maurer HR, 2001, CELL MOL LIFE SCI, V58, P1234, DOI 10.1007/PL00000936; McNicol Archibald, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P99, DOI 10.2174/187152908784533739; Mokarram P, 2017, AUTOPHAGY, V13, P781, DOI 10.1080/15548627.2017.1290751; MORITA AH, 1979, ARCH INT PHARMACOD T, V239, P340; Park S, 2014, AUTOPHAGY, V10, P1906, DOI 10.4161/auto.32177; Pavan Rajendra, 2012, Biotechnol Res Int, V2012, P976203, DOI 10.1155/2012/976203; Qi Rong, 2006, Int J Biomed Sci, V2, P211; Rathnavelu V, 2016, BIOMED REP, V5, P283, DOI 10.3892/br.2016.720; Romano B, 2014, MOL NUTR FOOD RES, V58, P457, DOI 10.1002/mnfr.201300345; Rosenberg L, 2015, Ann Burns Fire Disasters, V28, P264; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; She C, 2014, CELL SIGNAL, V26, P1, DOI 10.1016/j.cellsig.2013.08.046; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; TAUSSIG SJ, 1985, PLANTA MED, V51, P538, DOI 10.1055/s-2007-969596; TAUSSIG SJ, 1975, HIROSHIMA J MED SCI, V24, P185; Twayana KS, 2018, LIFE SCI, V205, P73, DOI 10.1016/j.lfs.2018.05.002; Tysnes BB, 2001, NEOPLASIA, V3, P469, DOI 10.1038/sj.neo.7900196; VanKlinken BJW, 1996, GLYCOCONJUGATE J, V13, P757, DOI 10.1007/BF00702340; Wurzer B, 2015, ELIFE, V4, DOI 10.7554/eLife.08941; Yang J, 2017, ONCOTARGET, V8, P23492, DOI 10.18632/oncotarget.15626; Yonezawa S, 2011, PATHOL INT, V61, P697, DOI 10.1111/j.1440-1827.2011.02734.x; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	59	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210274	10.1371/journal.pone.0210274	http://dx.doi.org/10.1371/journal.pone.0210274			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657763	gold, Green Submitted, Green Published			2022-12-26	WOS:000456017000008
J	Berkhout, ED; Malan, M; Kram, T				Berkhout, Ezra D.; Malan, Mandy; Kram, Tom			Better soils for healthier lives? An econometric assessment of the link between soil nutrients and malnutrition in Sub-Saharan Africa	PLOS ONE			English	Article							NUTRITION; ZINC; FOOD; UNDERNUTRITION; FORTIFICATION; EMISSIONS; MALARIA; GROWTH; POOR	Malnutrition, the suboptimal consumption of essential nutrients like zinc, severely affects human health. This burden of malnutrition falls disproportionally heavy on developing countries, directly increasing child mortality and childhood stunting, or reducing people's ability mending diseases. One option to combat malnutrition is to blend missing nutrients in crop fertilizers, thereby increasing crop yields and possibly the nutrient density in harvested crop products, thus enriching crop products destined for human consumption. But, the effectiveness of so-called agronomic fortification remains ill-understood, primarily due to a paucity of field trials. We hypothesize that, if at all this is an effective strategy, there should exist a causal link between malnutrition and natural variation in the quality of soils to begin with. Until now, data limitations prevented the establishment of such a link, but new soil micronutrient maps for Sub-Saharan Africa allow for a detailed assessment. In doing so, we find statistically significant relations between soil nutrients and child mortality, stunting, wasting and underweight. For instance, a simultaneous increase in soil densities of copper, manganese and zinc by one standard deviation reduces child mortality by 4-6 per mille points, but only when malaria pressure is modest. The effects of soil nutrients on health dissipate when malaria pressure increases. Yet, the effects are fairly small in magnitude suggesting that except for a few regions, agronomic fortification is a relatively cost ineffective means to combat malnutrition.	[Berkhout, Ezra D.; Kram, Tom] PBL Netherlands Environm Assessment Agcy, The Hague, Netherlands; [Malan, Mandy] Int Inst Trop Agr, Kampala, Uganda; [Malan, Mandy] Wageningen Univ & Res, Dev Econ Grp, Wageningen, Netherlands	Wageningen University & Research	Berkhout, ED (corresponding author), PBL Netherlands Environm Assessment Agcy, The Hague, Netherlands.	ezra.berkhout@pbl.nl		Berkhout, Ezra/0000-0003-2536-8912; Malan, Mandy/0000-0003-1565-005X	Netherlands Ministry of Foreign Affairs; Directorate-General for International Cooperation (DGIS)	Netherlands Ministry of Foreign Affairs; Directorate-General for International Cooperation (DGIS)	PBL Netherlands Environmental Assessment Agency received funding from the Netherlands Ministry of Foreign Affairs, specifically the Directorate-General for International Cooperation (DGIS), for conducting this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, CONDITIONS AGR GROWT; [Anonymous], 2017, LONDON METAL EXCHANG; Barrett CB, 2015, NAT GEOSCI, V8, P907, DOI [10.1038/ngeo2591, 10.1038/NGEO2591]; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Berkhout E, 2017, MICRONUTRIENTS AGR I; Bevis L.E.M., 2015, SPRINGER SCI REV, V3, P77, DOI [DOI 10.1007/S40362-014-0026-Y, 10.1007/S40362-014-0026-Y]; Bevis LEM, 2015, WHO SUPPLIES NUTRIEN; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Boulder CO, 2017, NIGHTT LIGHTS; Briggs RC, 2018, WORLD DEV, V103, P133, DOI 10.1016/j.worlddev.2017.10.020; Cakmak I, 2010, CEREAL CHEM, V87, P10, DOI 10.1094/CCHEM-87-1-0010; Cameron AC, 2011, J BUS ECON STAT, V29, P238, DOI 10.1198/jbes.2010.07136; CIESIN Center for International Earth Science Information Network Columbia University, 2016, GRIDD POP WORLD VERS, DOI 10.7927/H4NP22DQ; Correia S., 2014, REGHDFE STATA MODULE; Deaton A., 2013, GREAT ESCAPE HLTH WE; Deaton A., 127352006 NBER; DeVellis R. F., 2003, SCALE DEVELOPMENT TH; Diao X, 2007, MARKET OPPORTUNITIES; Dimkpa CO, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-015-0346-6; Elvidge CD, 1997, INT J REMOTE SENS, V18, P1373, DOI 10.1080/014311697218485; Fiedler JL, 2013, FOOD NUTR BULL, V34, P480, DOI 10.1177/156482651303400412; Fink G, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-852; Gilmore E, 2005, CONFLICT MANAG PEACE, V22, P257, DOI 10.1080/07388940500201003; Goheen MM, 2016, EBIOMEDICINE, V14, P123, DOI 10.1016/j.ebiom.2016.11.011; Gregory PJ, 2017, GLOB FOOD SECUR-AGR, V15, P1, DOI 10.1016/j.gfs.2017.03.003; Harou A., 2015, GLOB FOOD SEC C 2015; Henderson V, 2011, AM ECON REV, V101, P194, DOI 10.1257/aer.101.3.194; Hengl T, 2017, NUTR CYCL AGROECOSYS, V109, P77, DOI 10.1007/s10705-017-9870-x; Horton S, 2008, MICRONUTRIENT SUPPLE; Horton S., 2014, BENEFITS COSTS FOOD, DOI DOI 10.1017/CBO9781107415324.004; JOHNSTON CC, 1992, NEW ENGL J MED, V327, P82, DOI 10.1056/NEJM199207093270204; Joy EJM, 2017, PLANT SOIL, V411, P139, DOI 10.1007/s11104-016-2961-7; Joy EJM, 2015, PLANT SOIL, V389, P1, DOI 10.1007/s11104-015-2430-8; Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658; Kihara J, 2017, AGRON SUSTAIN DEV, V37, DOI 10.1007/s13593-017-0431-0; Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lomborg B., 2014, SPEND 75 BILLION MAK; Lujala P, 2005, 37 CONFLICT MANAGEME, V24, P239; Lyons G., 2012, FERTILIZING CROPS IM; Meenakshi JV, 2010, WORLD DEV, V38, P64, DOI 10.1016/j.worlddev.2009.03.014; Michalopoulos S, 2013, ECONOMETRICA, V81, P113, DOI 10.3982/ECTA9613; Muller O, 2005, CAN MED ASSOC J, V173, P279, DOI 10.1503/cmaj.050342; Murdock G.P., 1967, ETHNOGRAPHIC ATLAS; Osgood-Zimmerman A, 2018, NATURE, V555, P41, DOI 10.1038/nature25760; Population Facts, 2018, SPEED URB WORLD POP; Poulton C, 2006, DEV POLICY REV, V24, P243, DOI 10.1111/j.1467-7679.2006.00324.x; Program TD, 2018, DEM HLTH SURV SPAT D; Pruss-Ustun A., 2003, INTRO METHODS ASSESS; Ros GH, 2016, PLANT SOIL, V404, P99, DOI 10.1007/s11104-016-2830-4; Stein AJ, 2014, GLOB FOOD SECUR-AGR, V3, P193, DOI 10.1016/j.gfs.2014.09.003; Teklic T, 2013, FOOD ENERGY SECUR, V2, P81, DOI 10.1002/fes3.24; Thomas David, 2007, Nutrition and Health (Bicester), V19, P21; Wang YH, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-016-0382-x; Weidmann NB, 2017, J PEACE RES, V54, P125, DOI 10.1177/0022343316630359	56	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210642	10.1371/journal.pone.0210642	http://dx.doi.org/10.1371/journal.pone.0210642			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653538	Green Submitted, gold, Green Published			2022-12-26	WOS:000456015500058
J	Lohsoonthorn, V; Rattananupong, T; Wynne, K; Thomas, C; Chahal, HS; Berhane, HY; Mostofsky, E; Wuttithai, N; Gelaye, B				Lohsoonthorn, Vitool; Rattananupong, Thanapoom; Wynne, Keona; Thomas, Colbren; Chahal, Harpreet S.; Berhane, Hanna Y.; Mostofsky, Elizabeth; Wuttithai, Nudsinee; Gelaye, Bizu			Immediate risk of myocardial infarction following physical exertion, tea, and coffee: A case-crossover study in Thailand	PLOS ONE			English	Article							ACUTE CARDIAC EVENTS; CARDIOVASCULAR EVENTS; SEXUAL-ACTIVITY; CONSUMPTION; CAFFEINE; TRIGGERS; ASSOCIATION; MECHANISMS; IMPACT; ONSET	Background Physical exertion and caffeine consumption are associated with acute myocardial infarction (MI). However, physical exertion and caffeine consumption have not been examined as immediate triggers of MI in low and middle-income countries. Objective Using a self-matched case-crossover design, we examined the acute risk of MI in the hour following episodes of physical exertion, caffeinated coffee, and tea consumption among MI survivors in Thailand. Methods A total of 506 Thai participants (women = 191, men = 315) were interviewed between 2014 and 2017 after sustaining an acute MI. We compared each subject's exposure to physical exertion and consumption of caffeine-containing beverages in the hour preceding the onset of MI with the subject's expected usual frequency in the prior year to calculate relative risks (RRs) and 95% confidence intervals (95% CIs). Results Of the 506 participants, 47 (9.3%) engaged in moderate or heavy physical exertion, 6 (1.2%) consumed tea, and 21 (4.2%) consumed coffee within the hour before MI. The relative risk of MI after moderate or heavy physical exertion was 3.0 (95% CI 2.2-4.2) compared to periods of no exertion, with a higher risk among more sedentary participants compared to active participants. Compared to times with no caffeinated beverage consumption, there was a higher risk of MI in the hour following consumption of caffeinated tea (RR = 3.7; 95% CI: 1.5-9.3) and coffee (RR = 2.3; 95% CI: 1.4-3.6). Conclusion Physical exertion, coffee and tea consumption were associated with a higher risk of MI in the subsequent hour compared to times when the participants were sedentary or did not consume caffeinated beverages. Our study identifies high-risk populations for targeted screening and intervention to prevent acute MI.	[Lohsoonthorn, Vitool; Rattananupong, Thanapoom] Chulalongkorn Univ, Fac Med, Bangkok, Thailand; [Wynne, Keona; Thomas, Colbren; Chahal, Harpreet S.; Mostofsky, Elizabeth; Gelaye, Bizu] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Chahal, Harpreet S.] Univ Toronto Mississauga, Mississauga Acad Med, Mississauga, ON, Canada; [Berhane, Hanna Y.] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia; [Wuttithai, Nudsinee] Chiangrai Prachanukroh Hosp, Chiangrai, Thailand	Chulalongkorn University; Harvard University; Harvard T.H. Chan School of Public Health; University of Toronto; University Toronto Mississauga; Addis Continental Institute of Public Health	Gelaye, B (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	bgelaye@hsph.harvard.edu			National Institutes of Minority Health and Health Disparities [T37-MD001449]; National Institute on Minority Health and Health Disparities [T37MD001449] Funding Source: NIH RePORTER	National Institutes of Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Our work is supported by an award from the National Institutes of Minority Health and Health Disparities (T37-MD001449). Ms. Keona Wynne and Mr. Colbren Thomas were research training fellows with the Multidisciplinary International Research Training (MIRT) Program of the Harvard T. H. Chan School of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylin A, 2007, ANN EPIDEMIOL, V17, P112, DOI 10.1016/j.annepidem.2006.05.004; Baylin A, 2006, EPIDEMIOLOGY, V17, P506, DOI 10.1097/01.ede.0000229444.55718.96; Boehme AK, 2017, CIRC RES, V120, P472, DOI 10.1161/CIRCRESAHA.116.308398; Campa C, 2005, FOOD CHEM, V91, P633, DOI 10.1016/j.foodchem.2004.06.032; Cano-Marquina A, 2013, MATURITAS, V75, P7, DOI 10.1016/j.maturitas.2013.02.002; Caprioli G, 2014, INT J FOOD SCI NUTR, V65, P465, DOI 10.3109/09637486.2013.873890; Dahabreh IJ, 2011, JAMA-J AM MED ASSOC, V305, P1225, DOI 10.1001/jama.2011.336; de Mejia EG, 2014, TRENDS ENDOCRIN MET, V25, P489, DOI 10.1016/j.tem.2014.07.003; Duffy SJ, 2001, CIRCULATION, V104, P151, DOI 10.1161/01.CIR.104.2.151; Godos J, 2014, INT J FOOD SCI NUTR, V65, P925, DOI 10.3109/09637486.2014.940287; Hallqvist J, 2000, AM J EPIDEMIOL, V151, P459, DOI 10.1093/oxfordjournals.aje.a010231; Kleemola P, 2000, ARCH INTERN MED, V160, P3393, DOI 10.1001/archinte.160.22.3393; LANDOLFI R, 1984, BIOCHEM PHARMACOL, V33, P1525, DOI 10.1016/0006-2952(84)90423-4; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Maclure M, 2007, PHARMACOEPIDEM DR S, V16, P850, DOI 10.1002/pds.1438; Mendis S, 2011, INT J EPIDEMIOL, V40, P139, DOI 10.1093/ije/dyq165; [Ministry of Public Health Bureau of Policy and Strategy Ministry of Public Health], 2017, THAIL PUBL HLTH STAT; MITTLEMAN MA, 1993, NEW ENGL J MED, V329, P1677, DOI 10.1056/NEJM199312023292301; MITTLEMAN MA, 1995, AM J EPIDEMIOL, V142, P91, DOI 10.1093/oxfordjournals.aje.a117550; MITTLEMAN MA, 1995, CIRCULATION, V92, P1720, DOI 10.1161/01.CIR.92.7.1720; Mittleman MA, 2011, CIRCULATION, V124, P346, DOI 10.1161/CIRCULATIONAHA.110.968776; Mostofsky E, 2018, EPIDEMIOLOGY, V29, P804, DOI 10.1097/EDE.0000000000000904; Mostofsky E, 2016, CIRCULATION, V133, P979, DOI 10.1161/CIRCULATIONAHA.115.019743; Mukamal KJ, 2002, CIRCULATION, V105, P2476, DOI 10.1161/01.CIR.0000017201.88994.F7; Muller JE, 1997, CIRCULATION, V96, P3233, DOI 10.1161/01.CIR.96.9.3233; Nazari S, 2015, J BIOSTAT EPIDEMIOL, V1, P59; Nurminen ML, 1999, EUR J CLIN NUTR, V53, P831, DOI 10.1038/sj.ejcn.1600899; Oliveira Gustavo B F, 2015, Front Cardiovasc Med, V2, P32, DOI 10.3389/fcvm.2015.00032; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Smyth A, 2016, CIRCULATION, V134, P1059, DOI 10.1161/CIRCULATIONAHA.116.023142; Somogyi LP, 2012, CAFFEINE INTAKE US P; Willich SN, 1999, VASC MED, V4, P41, DOI 10.1191/135886399670596924; WILLICH SN, 1991, CIRCULATION, V84, P62; Wu JN, 2009, INT J CARDIOL, V137, P216, DOI 10.1016/j.ijcard.2008.06.051; Yoshida H, 1999, BIOCHEM PHARMACOL, V58, P1695, DOI 10.1016/S0006-2952(99)00256-7	35	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210959	10.1371/journal.pone.0210959	http://dx.doi.org/10.1371/journal.pone.0210959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653616	Green Submitted, Green Published, gold			2022-12-26	WOS:000456015500092
J	Meiners, JM; Griswold, TL; Carril, OM				Meiners, Joan M.; Griswold, Terry L.; Carril, Olivia Messinger			Decades of native bee biodiversity surveys at Pinnacles National Park highlight the importance of monitoring natural areas over time	PLOS ONE			English	Article							HYMENOPTERA APOIDEA; WILD BEES; COMMUNITIES; POLLINATION; RESPONSES; FAUNA; CHRONOSEQUENCE; POPULATIONS; GRASSLANDS; DIVERSITY	Thousands of species of bees are in global decline, yet research addressing the ecology and status of these wild pollinators lags far behind work being done to address similar impacts on the managed honey bee. This knowledge gap is especially glaring in natural areas, despite knowledge that protected habitats harbor and export diverse bee communities into nearby croplands where their pollination services have been valued at over $3 billion per year. Surrounded by ranches and farmlands, Pinnacles National Park in the Inner South Coast Range of California contains intact Mediterranean chaparral shrubland. This habitat type is among the most valuable for bee biodiversity worldwide, as well as one of the most vulnerable to agricultural conversion, urbanization and climate change. Pinnacles National Park is also one of a very few locations where extensive native bee inventory efforts have been repeated over time. This park thus presents a valuable and rare opportunity to monitor long-term trends and baseline variability of native bees in natural habitats. Fifteen years after a species inventory marked Pinnacles as a biodiversity hotspot for native bees, we resurveyed these native bee communities over two flowering seasons using a systematic, plot-based design. Combining results, we report a total of 450 bee species within this 109km(2) natural area of California, including 48 new species records as of 2012 and 95 species not seen since 1999. As far as we are aware, this species richness marks Pinnacles National Park as one of the most densely diverse places known for native bees. We explore patterns of bee diversity across this protected landscape, compare results to other surveyed natural areas, and highlight the need for additional repeated inventories in protected areas over time amid widespread concerns of bee declines.	[Meiners, Joan M.] Univ Florida, Sch Nat Resources & Environm, Gainesville, FL 32611 USA; [Griswold, Terry L.] Utah State Univ, USDA ARS, Pollinating Insects Res Unit, Logan, UT 84322 USA	State University System of Florida; University of Florida; United States Department of Agriculture (USDA); Utah System of Higher Education; Utah State University	Meiners, JM (corresponding author), Univ Florida, Sch Nat Resources & Environm, Gainesville, FL 32611 USA.	joan.meiners@gmail.com		Meiners, Joan/0000-0001-9369-9313	Pinnacles National Park through the Great Basin Cooperative Ecosystem Studies Unit [P10AC00577]; University of Florida Biodiversity Institute Graduate Fellowship; Utah State University Ecology Center	Pinnacles National Park through the Great Basin Cooperative Ecosystem Studies Unit; University of Florida Biodiversity Institute Graduate Fellowship; Utah State University Ecology Center	This project was funded by Pinnacles National Park through the Great Basin Cooperative Ecosystem Studies Unit (Task Agreement number P10AC00577 awarded to TLG). (http://www.cesu.psu.edu/unit_portals/unit_materials/cooperative_agreements/GRBA/GRBA_CESU_2016_AMD01. pdf). JMM was supported by a University of Florida Biodiversity Institute Graduate Fellowship, and by the Utah State University Ecology Center. (https://biodiversity.institute.ufl.edu/; https://ecology.usu.edu/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2012, SCIENCE, V335, P1486, DOI 10.1126/science.1215320; Albrecht M, 2010, OIKOS, V119, P1610, DOI 10.1111/j.1600-0706.2010.18376.x; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Baldi A, 2008, J BIOGEOGR, V35, P675, DOI 10.1111/j.1365-2699.2007.01825.x; Baldwin B.G., 2012, JEPSON MANUAL VASCUL, V2nd ed.; Bartomeus I, 2013, P NATL ACAD SCI USA, V110, P4656, DOI 10.1073/pnas.1218503110; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bohart G, 1973, P UT AC SCI ARTS LET; Bommarco R, 2010, P ROY SOC B-BIOL SCI, V277, P2075, DOI 10.1098/rspb.2009.2221; Brown John W., 2008, Bulletin of the Biological Society of Washington, V15, P54, DOI 10.2988/0097-0298(2008)15[54:TIIFOP]2.0.CO;2; Cane JH, 2006, ECOL APPL, V16, P632, DOI 10.1890/1051-0761(2006)016[0632:CRWADB]2.0.CO;2; Cardoso P, 2011, BIOL CONSERV, V144, P2647, DOI 10.1016/j.biocon.2011.07.024; Chaplin-Kramer R, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1799; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Cornelissen T, 2011, NEOTROP ENTOMOL, V40, P155, DOI 10.1590/S1519-566X2011000200001; Debano SJ, 2006, BIODIVERS CONSERV, V15, P2547, DOI 10.1007/s10531-005-2786-9; Deyrup M, DIVERSITY FLORAL HOS; Donovan B.J., 1980, New Zealand Journal of Ecology, V3, P104; Drons DJ, 2012, INVENTORY NATIVE BEE; FISCHER AG, 1960, EVOLUTION, V14, P64, DOI 10.2307/2405923; Foden WB, 2019, WIRES CLIM CHANGE, V10, DOI 10.1002/wcc.551; Forrest JRK, 2011, ECOL MONOGR, V81, P469, DOI 10.1890/10-1885.1; Frankie GW, 2009, CALIF AGR, V63, P113, DOI 10.3733/ca.v063n03p113; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Giles V, 2006, J HYMENOPT RES, V15, P208; Gonzalez VH, 2013, SYST ENTOMOL, V38, P645, DOI 10.1111/syen.12029; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Greenleaf SS, 2006, P NATL ACAD SCI USA, V103, P13890, DOI 10.1073/pnas.0600929103; Griffin SR, 2017, RESTOR ECOL, V25, P650, DOI 10.1111/rec.12481; Griswold TL, 1999, SURVEY RARE BEES CLA; Grundel R, 2011, J KANSAS ENTOMOL SOC, V84, P105, DOI 10.2317/JKES101027.1; Holt RD, 1999, ECOLOGY, V80, P1495, DOI 10.2307/176542; Iles DT, 2018, J APPL ECOL, V55, P2802, DOI 10.1111/1365-2664.13175; Klausmeyer KR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006392; Kremen C, 2004, ECOL LETT, V7, P1109, DOI 10.1111/j.1461-0248.2004.00662.x; Kremen C, 2000, CONSERV BIOL, V14, P1226, DOI 10.1046/j.1523-1739.2000.00013.x; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Kuhlman M, BIODIVERS DATA J; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; LeBuhn G., 2003, STANDARDIZED METHOD; LINSLEY E. GORTON, 1958, HILGARDIA, V27, P543; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Marlin JC, 2007, ECOL SOC; MATTHEWS V, 1976, AAPG BULL, V60, P2128; Meiners J., 2018, NATIVE BEE BIODIVERS; Meiners JM, 2015, NATIVE BEES PINNACLE, P76; Meiners JM, 2016, BIODIVERSITY COMMUNI; Meiners JM, 2017, AM NAT, V190, P281, DOI 10.1086/692437; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Messinger O., 2006, SURVEY BEES GRAND ST; Messinger O, 2003, FREMONTIA, V30, P32; Michener C.D., 2007, BEES WORLD, Vsecond; MICHENER CD, 1979, ANN MO BOT GARD, V66, P277, DOI 10.2307/2398833; MICHENER CD, 1947, AM MIDL NAT, V38, P443, DOI 10.2307/2421575; Minckley R, 2008, APIDOLOGIE, V39, P176, DOI 10.1051/apido:2007062; Minckley RL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2703; MOLDENKE A R, 1976, Phytologia, V34, P305; Moldenke AR, 1976, WASMANN J BIOL, V34, P147; Morandin LA, 2013, ECOL APPL, V23, P829, DOI 10.1890/12-1051.1; Morse R, 2001, BEE CULT, V128; NPS, 2015, NAT PINN NAT PARK; Ockinger E, 2007, J APPL ECOL, V44, P50, DOI 10.1111/j.1365-2664.2006.01250.x; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Potts SG, 2003, ECOLOGY, V84, P2628, DOI 10.1890/02-0136; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; R-Core-Team, 2015, LANG ENV STAT COMP; Rhoades Paul, 2017, Journal of Melittology, V66, P1; Romero GQ, 2018, NAT CLIM CHANGE, V8, P1087, DOI 10.1038/s41558-018-0347-y; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Roubik DW, 2001, UPS DOWNS POLLINATOR; Rust R, 1985, ENTOMOLOGY OF THE CA, P22; Smith BA, 2012, J KANSAS ENTOMOL SOC, V85, P32, DOI 10.2317/JKES111025.1; Tepedino V.J., 1979, Great Basin Naturalist Memoirs, P139; Tepedino V.J., 1998, NATL MONUMENT SCI S, P175; TEPEDINO VJ, 1981, OIKOS, V36, P35, DOI 10.2307/3544376; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Tscharntke T, 2002, ECOL RES, V17, P229, DOI 10.1046/j.1440-1703.2002.00482.x; Tucker S, 2006, B CALIF LICHEN SOC, V13, P8; Vilela AA, 2018, ARTHROPOD-PLANT INTE, V12, P215, DOI 10.1007/s11829-017-9572-y; Williams NM, 2010, BIOL CONSERV, V143, P2280, DOI 10.1016/j.biocon.2010.03.024; Williams NM, 2001, CONSERV ECOL, V5; Wilson JS, 2009, J ARID ENVIRON, V73, P666, DOI 10.1016/j.jaridenv.2009.01.004; Wilson JS, 2010, WEST N AM NATURALIST, V70, P198, DOI 10.3398/064.070.0206; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; Wolf Amy T., 2008, Great Lakes Entomologist, V41, P129	90	18	18	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0207566	10.1371/journal.pone.0207566	http://dx.doi.org/10.1371/journal.pone.0207566			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653514	Green Submitted, gold, Green Published			2022-12-26	WOS:000456015500008
J	Pilch, Z; Tonecka, K; Skorzynski, M; Sas, Z; Braniewska, A; Kryczka, T; Boon, L; Golab, J; Meyaard, L; Rygiel, TP				Pilch, Zofia; Tonecka, Katarzyna; Skorzynski, Marcin; Sas, Zuzanna; Braniewska, Agata; Kryczka, Tomasz; Boon, Louis; Golab, Jakub; Meyaard, Linde; Rygiel, Tomasz P.			The pro-tumor effect of CD200 expression is not mimicked by agonistic CD200R antibodies	PLOS ONE			English	Article							MACROPHAGE ACTIVATION; PROGNOSTIC-FACTOR; DOWN-REGULATION; LIGAND; METASTASIS; RESPONSES; PROTEIN; CELLS; HOST	Tumor-infiltrating immune cells can impact tumor growth and progression. The inhibitory CD200 receptor (CD200R) suppresses the activation of myeloid cells and lack of this pathway results in a reduction of tumor growth, conversely a tumorigenic effect of CD200R triggering was also described. Here we investigated the role of CD200R activation in syngeneic mouse tumor models. We showed that agonistic CD200R antibody reached tumors, but had no significant impact on tumor growth and minor effect on infiltration of immune myeloid cells. These effects were reproduced using two different anti-CD200R clones. In contrast, we showed that CD200-deficiency did decrease melanoma tumor burden. The presence of either endogenous or tumor-expressed CD200 restored the growth of metastatic melanoma foci. On the basis of these findings, we conclude that blockade of the endogenous ligand CD200 prevented the tumorigenic effect of CD200R-expressing myeloid cells in the tumor microenvironment, whereas agonistic anti-CD200R has no effect on tumor development.	[Pilch, Zofia; Tonecka, Katarzyna; Skorzynski, Marcin; Sas, Zuzanna; Braniewska, Agata; Golab, Jakub; Rygiel, Tomasz P.] Med Univ Warsaw, Dept Immunol, Warsaw, Poland; [Kryczka, Tomasz] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Expt Pharmacol, Warsaw, Poland; [Boon, Louis] Bioceros BV, Utrecht, Netherlands; [Golab, Jakub] Med Univ Warsaw, Ctr Preclin Res & Technol, Warsaw, Poland; [Meyaard, Linde] Univ Med Ctr Utrecht, Dept Immunol, Lab Translat Immunol, Utrecht, Netherlands; [Meyaard, Linde] Univ Med Ctr Utrecht, Oncode Inst, Utrecht, Netherlands	Medical University of Warsaw; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Bioceros B.V.; Medical University of Warsaw; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Rygiel, TP (corresponding author), Med Univ Warsaw, Dept Immunol, Warsaw, Poland.	trygiel@wum.edu.pl	Braniewska, Agata/AAJ-1627-2021; Golab, Jakub/K-6974-2013; Boon, Laurence/HCI-3629-2022; Kryczka, Tomasz/T-2056-2018	Braniewska, Agata/0000-0002-2525-1290; Golab, Jakub/0000-0002-2830-5100; Rygiel, Tomasz/0000-0003-4746-6505; Skorzynski, Marcin/0000-0001-6665-9041; Meyaard, Linde/0000-0003-0707-4793; Kryczka, Tomasz/0000-0003-2607-1651; Boon, Louis/0000-0002-0937-9171	Polish National Science Center (NCN) [2011/03/D/NZ6/03685]	Polish National Science Center (NCN)	This work was financed by Polish National Science Center (NCN) under grant no. 2011/03/D/NZ6/03685 (to TPR). The funding organization (NCN) did not play a role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries to ZP, KT and TPR. The commercial company (Bioceros BV) did not play a role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript and only provided research materials (antibodies).	Akkaya M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063325; Cameron CM, 2005, J VIROL, V79, P6052, DOI 10.1128/JVI.79.10.6052-6067.2005; Erin N, 2015, ONCOGENE, V34, P3860, DOI 10.1038/onc.2014.317; Foster-Cuevas M, 2004, J VIROL, V78, P7667, DOI 10.1128/JVI.78.14.7667-7676.2004; Gorczynski R, 2004, J IMMUNOL, V172, P7744, DOI 10.4049/jimmunol.172.12.7744; Gorczynski RM, 2013, BREAST CANCER RES TR, V142, P271, DOI 10.1007/s10549-013-2735-3; Hatherley D, 2005, J IMMUNOL, V175, P2469, DOI 10.4049/jimmunol.175.4.2469; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Jenmalm MC, 2006, J IMMUNOL, V176, P191, DOI 10.4049/jimmunol.176.1.191; Karnam G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002710; Koning N, 2010, J INNATE IMMUN, V2, P195, DOI 10.1159/000252803; Kretz-Rommel A, 2007, J IMMUNOL, V178, P5595, DOI 10.4049/jimmunol.178.9.5595; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Moreaux J, 2006, BLOOD, V108, P4194, DOI 10.1182/blood-2006-06-029355; Mukhopadhyay S, 2010, CELL HOST MICROBE, V8, P236, DOI 10.1016/j.chom.2010.08.005; Pilch Z, 2018, CANCER IMMUNOL RES, V6, P930, DOI 10.1158/2326-6066.CIR-17-0454; Pingwara R, 2017, J PHYSIOL PHARMACOL, V68, P573; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Rygiel TP, 2012, ONCOGENE, V31, P2979, DOI 10.1038/onc.2011.477; Rygiel TF, 2012, CURR OPIN IMMUNOL, V24, P233, DOI 10.1016/j.coi.2012.01.002; Rygiel TP, 2009, J IMMUNOL, V183, P1990, DOI 10.4049/jimmunol.0900252; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Stumpfova M, 2010, CANCER RES, V70, P2962, DOI 10.1158/0008-5472.CAN-09-4380; Talebian F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031442; Tonks A, 2007, LEUKEMIA, V21, P566, DOI 10.1038/sj.leu.2404559; Vaine CA, 2014, ADV IMMUNOL, V121, P191, DOI 10.1016/B978-0-12-800100-4.00005-2	27	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210796	10.1371/journal.pone.0210796	http://dx.doi.org/10.1371/journal.pone.0210796			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653571	Green Submitted, Green Published, gold			2022-12-26	WOS:000456015500071
J	Sudarski, S; Haubenreisser, H; Henzler, T; Reischauer, C; Kolokythas, O; Matoori, S; Herzog, BA; Schonberg, SO; Gutzeit, A				Sudarski, Sonja; Haubenreisser, Holger; Henzler, Thomas; Reischauer, Carolin; Kolokythas, Orpheus; Matoori, Simon; Herzog, Bernhard A.; Schoenberg, Stefan O.; Gutzeit, Andreas			Incidence of transient interruption of contrast (TIC) - A retrospective single-centre analysis in CT pulmonary angiography exams acquired during inspiratory breath-hold with the breathing command: "Please inspire gently!"	PLOS ONE			English	Article							REDUCE INSPIRATION; DEEP-INSPIRATION; BLOOD-FLOW; DYNAMICS; EMBOLISM; IMPROVE; ENHANCEMENT; RESISTANCE; ARTERY	Objectives To assess the occurrence of transient interruption of contrast (TIC) phenomenon in pulmonary computed tomography angiography (CTPA) exams performed in inspiratory breath-hold after patients were told to inspire gently. Methods In this retrospective single-centre study, CTPA exams of 225 consecutive patients scanned on a 16-slice CT scanner system were analysed. A-priori to measurements, exams were screened for inadequate pulmonary artery contrast due to incorrect bolus tracking or failure of i.v. contrast administration. Those exams were excluded. Attenuation values in the thoracic aorta and in the pulmonary trunk were assessed in duplicate measurements (M1 and M2) and the aorto-pulmonary density ratio was calculated. An aorto-pulmonary ratio > 1 with still contrast inflow being visible within the superior vena cava was defined as TIC. Results 3 patients were excluded due to incorrect bolus tracking. Final analysis was performed in 222 patients (mean age 65 +/- 19 years, range 18 to 99 years). Mean density in the pulmonary trunk was 275 +/- 17 HU, in the aorta 208 +/- 15 HU. Mean aorto-pulmonary ratio was 0.81 +/- 0.29. 48 patients (21.6%) had an aorto-pulmonary ratio > 1. Correlation of mean aorto-pulmonary ratio and age was: -0.213 (p = 0.001). Age was not significantly different for an aorto-pulmonary ratio > 1 vs. <= 1 (p = 0.122). Both in M1 and M2, 33/222 patients presented with absolute HU values of < 200 HU within the pulmonary artery. In M1 measurements, 24 of these 33 patients (72%) fulfilled TIC criteria (M2: 25/33 patients (75%)). Conclusions TIC is a common phenomenon in CTPA studies with inspiratory breath-hold commands after patients were told to inspire gently with an incidence of 22% in our retrospective cohort. Occurrence of TIC shows a significant negative correlation with increasing age and disproportionately often occurs in patients with lower absolute contrast density values within their pulmonary arteries.	[Sudarski, Sonja; Haubenreisser, Holger; Henzler, Thomas; Schoenberg, Stefan O.] Heidelberg Univ, Med Fac Mannheim, Univ Med Ctr Mannheim, Inst Clin Radiol & Nucl Med, Mannheim, Germany; [Reischauer, Carolin; Matoori, Simon; Gutzeit, Andreas] Hirslanden Hosp St Anna, Clin Res Unit, Inst Radiol & Nucl Med, Luzern, Switzerland; [Kolokythas, Orpheus] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Matoori, Simon; Gutzeit, Andreas] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Dept Chem & Appl Biosci, Zurich, Switzerland; [Herzog, Bernhard A.] HerzClin Luzern, Luzern, Switzerland; [Gutzeit, Andreas] Paracelsus Med Univ, Dept Radiol, Salzburg, Austria	Ruprecht Karls University Heidelberg; University of Washington; University of Washington Seattle; Swiss Federal Institutes of Technology Domain; ETH Zurich; Paracelsus Private Medical University	Sudarski, S (corresponding author), Heidelberg Univ, Med Fac Mannheim, Univ Med Ctr Mannheim, Inst Clin Radiol & Nucl Med, Mannheim, Germany.	sonja.sudarski@medma.uni-heidelberg.de		Matoori, Simon/0000-0002-1559-0950; Reischauer, Carolin/0000-0002-6624-6615				Bernabe-Garcia JM, 2012, INSIGHTS IMAGING, V3, P505, DOI 10.1007/s13244-012-0182-z; Chen YH, 2008, EMERG RADIOL, V15, P161, DOI 10.1007/s10140-007-0695-9; Estrada-Y-Martin RM, 2011, INT J COMPUT ASS RAD, V6, P557, DOI 10.1007/s11548-010-0526-4; Gosselin MV, 2004, J THORAC IMAG, V19, P1, DOI 10.1097/00005382-200401000-00001; Gossner J, 2012, J CLIN IMAG SCI, V2, DOI 10.4103/2156-7514.100999; Gutzeit A, 2015, EUR RADIOL, V25, P3133, DOI 10.1007/s00330-015-3735-y; Gutzeit A, 2014, EUR RADIOL, V24, P3034, DOI 10.1007/s00330-014-3328-1; Hamilton MCK, 2013, CLIN RADIOL, V68, pE99, DOI 10.1016/j.crad.2012.10.015; Henk CB, 2003, RADIOLOGY, V226, P749, DOI 10.1148/radiol.2263012200; Kuzo RS, 2007, AM J ROENTGENOL, V188, P839, DOI 10.2214/AJR.06.5035; Mortimer AM, 2011, CLIN RADIOL, V66, P1159, DOI 10.1016/j.crad.2011.06.012; Renne J, 2014, ACTA RADIOL, V55, P932, DOI 10.1177/0284185113507712; Ridge CA, 2009, AM J ROENTGENOL, V193, P1223, DOI 10.2214/AJR.09.2360; Wang M, 2015, EUR RADIOL, V25, P2541, DOI 10.1007/s00330-015-3664-9; Wittram C, 2007, J THORAC IMAG, V22, P125, DOI 10.1097/01.rti.0000213566.78785.26	15	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210473	10.1371/journal.pone.0210473	http://dx.doi.org/10.1371/journal.pone.0210473			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653548	Green Submitted, Green Published, gold			2022-12-26	WOS:000456015500040
J	Wei, PL; Huang, CY; Chang, YJ				Wei, Po-Li; Huang, Chien-Yu; Chang, Yu-Jia			Propyl gallate inhibits hepatocellular carcinoma cell growth through the induction of ROS and the activation of autophagy	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; OXIDATIVE STRESS; HELA-CELLS; APOPTOSIS; CYTOTOXICITY; TOXICITY; CURCUMIN	The poor prognosis of hepatocellular carcinoma (HCC) has been attributed to a high frequency of tumor metastasis and recurrence even after successful surgical resection. With less than 30% of patients benefiting from curative treatment, alternative treatment regimens for patients with advanced HCC are needed. Propyl gallate (PG), a synthetic antioxidant used in preserving food and medicinal preparations, has been shown to induce cancer cell death, but the anticancer effects of PG in HCC are unclear. In the present study, we demonstrated that PG inhibited HCC cell proliferation in vitro and in zebrafish models in vivo in a dose-and time-dependent manner. PG also induced cell apoptosis and increased the number of necrotic cells in a time-and dose-dependent manner as determined using a high-content analysis system. We found that PG also increased the intracellular levels of superoxide and reactive oxidative stress as well as the formation of autophagosomes and lysosomes. Regarding the molecular mechanism, PG did not alter the levels of autophagy-related 5 (ATG5), ATG5/12 or Beclin-1 but increased the rate of the LC3-I to LC3-II conversion, suggesting autophagy induction. PG exposure increased the levels of the pro-apoptotic proteins cleaved caspase-3, cleaved PARP, Bax, and Bad and a decreased level of the anti-apoptotic protein Bcl-2. In conclusion, we demonstrate that PG inhibits HCC cell proliferation through enhanced ROS production and autophagy activation. Finally, PG-treated cells induced cell apoptosis and may be a new candidate for HCC therapy.	[Wei, Po-Li; Huang, Chien-Yu] Taipei Med Univ, Dept Surg, Coll Med, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Taipei Med Univ Hosp, Div Colorectal Surg, Dept Surg, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Wei, Po-Li; Chang, Yu-Jia] Taipei Med Univ, Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan; [Wei, Po-Li; Chang, Yu-Jia] Taipei Med Univ, Taipei Med Univ Hosp, Dept Med Res, Translat Lab, Taipei, Taiwan; [Huang, Chien-Yu] Taipei Med Univ, Shuang Ho Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan; [Chang, Yu-Jia] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Chang, Yu-Jia] Taipei Med Univ, Int PhD Program Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University	Huang, CY (corresponding author), Taipei Med Univ, Dept Surg, Coll Med, Taipei, Taiwan.; Chang, YJ (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan.; Chang, YJ (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Dept Med Res, Translat Lab, Taipei, Taiwan.; Huang, CY (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan.; Chang, YJ (corresponding author), Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan.; Chang, YJ (corresponding author), Taipei Med Univ, Int PhD Program Med, Taipei, Taiwan.	cyh@tmu.edu.tw; r5424012@tmu.edu.tw			Taipei Medical University; Taipei Medical University Hospital [106TMU-TMUH-07]	Taipei Medical University; Taipei Medical University Hospital	This work was supported by a grant from Taipei Medical University and Taipei Medical University Hospital (106TMU-TMUH-07) to PLW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2009, PROSTAG LEUKOTR ESS, V81, P391, DOI 10.1016/j.plefa.2009.08.003; Amaravadi R, 2016, GENE DEV, V30, P1913, DOI 10.1101/gad.287524.116; Bao W, 2010, J ETHNOPHARMACOL, V128, P549, DOI 10.1016/j.jep.2010.01.029; Bi Q, 2015, CLIN EXP METASTAS, V32, P301, DOI 10.1007/s10585-015-9706-5; Brentnall M, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-32; Cabrera R, 2010, ALIMENT PHARM THER, V31, P461, DOI 10.1111/j.1365-2036.2009.04200.x; Cadenas Enrique, 2004, Molecular Aspects of Medicine, V25, P17, DOI 10.1016/j.mam.2004.02.005; Che XH, 2012, ARCH PHARM RES, V35, P2205, DOI 10.1007/s12272-012-1219-z; Chen C, 2017, NITRIC OXIDE-BIOL CH, V70, P31, DOI 10.1016/j.niox.2017.07.005; Chen CH, 2011, FOOD CHEM TOXICOL, V49, P494, DOI 10.1016/j.fct.2010.11.031; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Cheng P, 2013, CELL DEATH DIS, V4; Eler GJ, 2009, CHEM-BIOL INTERACT, V181, P390, DOI 10.1016/j.cbi.2009.07.006; Farrell GC, 2010, J GASTROEN HEPATOL, V25, P657, DOI 10.1111/j.1440-1746.2009.06167.x; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Fujita N, 2008, J VIRAL HEPATITIS, V15, P498, DOI 10.1111/j.1365-2893.2008.00972.x; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Ha HL, 2010, WORLD J GASTROENTERO, V16, P6035, DOI 10.3748/wjg.v16.i48.6035; Hamishehkar H, 2014, DRUG CHEM TOXICOL, V37, P241, DOI 10.3109/01480545.2013.838776; Han LL, 2014, WORLD J GASTROENTERO, V20, P10249, DOI 10.3748/wjg.v20.i30.10249; Han YH, 2009, FOOD CHEM TOXICOL, V47, P2531, DOI 10.1016/j.fct.2009.07.013; Han YH, 2009, ARCH TOXICOL, V83, P825, DOI 10.1007/s00204-009-0430-2; Hsieh YH, 2004, CARCINOGENESIS, V25, P2023, DOI 10.1093/carcin/bgh207; Jacobi H, 1998, FREE RADICAL BIO MED, V24, P972, DOI 10.1016/S0891-5849(97)00400-0; Jung HJ, 2011, INFLAMMATION, V34, P352, DOI 10.1007/s10753-010-9241-0; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Ktistakis NT, 2016, TRENDS CELL BIOL, V26, P624, DOI 10.1016/j.tcb.2016.03.006; Kuczynski EA, 2015, CANCER RES, V75, P2510, DOI 10.1158/0008-5472.CAN-14-3687; Li YJ, 2017, CHIN J CANCER, V52, DOI 10.1186/s40880-017-0219-2; Liang HH, 2018, LIFE SCI, V209, P43, DOI 10.1016/j.lfs.2018.07.047; Liang HH, 2013, TUMOR BIOL, V34, P3209, DOI 10.1007/s13277-013-0891-z; Liu ZK, 2017, CELL PHYSIOL BIOCHEM, V44, P1856, DOI 10.1159/000485821; Luo KW, 2011, CHEMOTHERAPY, V57, P449, DOI 10.1159/000331641; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Makhov P, 2014, BRIT J CANCER, V110, P899, DOI 10.1038/bjc.2013.810; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Moniruzzaman M, 2018, BIOL RES, V51, DOI 10.1186/s40659-018-0168-5; NAKAGAWA Y, 1995, MOL PHARMACOL, V47, P1021; Nakagawa Y, 1996, TOXICOLOGY, V114, P135, DOI 10.1016/S0300-483X(96)03479-8; Panchenko L. E., 2013, Biomeditsinskaya Khimiya, V59, P452; Park EJ, 2000, J PHARM PHARMACOL, V52, P437, DOI 10.1211/0022357001774048; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371; QuilletMary A, 1997, J BIOL CHEM, V272, P21388, DOI 10.1074/jbc.272.34.21388; Ravanan P, 2017, LIFE SCI, V188, P53, DOI 10.1016/j.lfs.2017.08.029; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Reddan JR, 2003, EXP EYE RES, V76, P49, DOI 10.1016/S0014-4835(02)00256-7; Ronis MJ, 2010, ALCOHOL, V44, P157, DOI 10.1016/j.alcohol.2009.11.002; ROSIN MP, 1980, J ENVIRON PATHOL TOX, V4, P159; Severi T, 2006, MOL CELL BIOCHEM, V290, P79, DOI 10.1007/s11010-006-9167-x; Shaker E, 2010, FOOD CHEM TOXICOL, V48, P803, DOI 10.1016/j.fct.2009.12.011; Shingai Y, 2011, J AGR FOOD CHEM, V59, P8180, DOI 10.1021/jf202561p; SUGIOKA A, 1993, SURGERY, V113, P612; Trevisani F, 2008, CARCINOGENESIS, V29, P1299, DOI 10.1093/carcin/bgn113; Wang RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139232; Wang WL, 2015, CANCER LETT, V358, P47, DOI 10.1016/j.canlet.2014.12.025; Wang YB, 2017, EBIOMEDICINE, V17, P45, DOI 10.1016/j.ebiom.2017.02.019; Wang ZP, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/7891574; White E, 2015, J CLIN INVEST, V125, P42, DOI 10.1172/JCI73941; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Xu J, 2008, ANTIVIR RES, V78, P242, DOI 10.1016/j.antiviral.2007.11.011; Xu Yan, 2006, Zhonghua Yan Ke Za Zhi, V42, P309; Yang JT, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/9489383; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047; You BR, 2011, ONCOL REP, V25, P871, DOI 10.3892/or.2010.1121; Zaidi S M Kashif R, 2005, Drugs R D, V6, P157, DOI 10.2165/00126839-200506030-00004	66	25	26	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210513	10.1371/journal.pone.0210513	http://dx.doi.org/10.1371/journal.pone.0210513			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653551	gold, Green Submitted, Green Published			2022-12-26	WOS:000456015500046
J	Rossi, F; Legnini, I; Megiorni, F; Colantoni, A; Santini, T; Morlando, M; Di Timoteo, G; Dattilo, D; Dominici, C; Bozzoni, I				Rossi, Francesca; Legnini, Ivano; Megiorni, Francesca; Colantoni, Alessio; Santini, Tiziana; Morlando, Mariangela; Di Timoteo, Gaia; Dattilo, Dario; Dominici, Carlo; Bozzoni, Irene			Circ-ZNF609 regulates G1-S progression in rhabdomyosarcoma	ONCOGENE			English	Article							E2F TARGET GENES; CIRCULAR RNAS; CELL-PROLIFERATION; PROMOTES; PATHWAY; IDENTIFICATION; TRANSLATION; MECHANISMS; EXPRESSION; CIRCRNAS	Circular RNAs (circRNAs) represent a class of covalently closed RNAs, derived from non-canonical splicing events, which are expressed in all eukaryotes and often conserved among different species. We previously showed that the circRNA originating from the ZNF609 locus (circ-ZNF609) acts as a crucial regulator of human primary myoblast growth: indeed, the downregulation of the circRNA, and not of its linear counterpart, strongly reduced the proliferation rate of in vitro cultured myoblasts. To deepen our knowledge about circ-ZNF609 role in cell cycle regulation, we studied its expression and function in rhabdomyosarcoma (RMS), a pediatric skeletal muscle malignancy. We found that circ-ZNF609 is upregulated in biopsies from the two major RMS subtypes, embryonal (ERMS) and alveolar (ARMS). Moreover, we discovered that in an ERMS-derived cell line circ-ZNF609 knock-down induced a specific block at the G1-S transition, a strong decrease of p-Akt protein level and an alteration of the pRb/Rb ratio. Regarding p-Akt, we were able to show that circ-ZNF609 acts by counteracting p-Akt proteasome-dependent degradation, thus working as a new regulator of cell proliferation-related pathways. As opposed to ERMS-derived cells, the circRNA depletion had no cell cycle effects in ARMS-derived cells. Since in these cells the p53 gene resulted downregulated, with a concomitant upregulation of its cell cycle-related target genes, we suggest that this could account for the lack of circ-ZNF609 effect in ARMS.	[Rossi, Francesca; Legnini, Ivano; Colantoni, Alessio; Morlando, Mariangela; Di Timoteo, Gaia; Dattilo, Dario; Bozzoni, Irene] Sapienza Univ Rome, Dept Biol & Biotechnol Charles Darwin, Rome, Italy; [Megiorni, Francesca; Dominici, Carlo] Sapienza Univ Rome, Dept Pediat, Rome, Italy; [Santini, Tiziana; Bozzoni, Irene] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Istituto Italiano di Tecnologia - IIT	Bozzoni, I (corresponding author), Sapienza Univ Rome, Dept Biol & Biotechnol Charles Darwin, Rome, Italy.; Bozzoni, I (corresponding author), Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy.	irene.bozzoni@uniroma1.it	di timoteo, gaia/AAD-1952-2021; Megiorni, Francesca/AAC-1597-2019	Megiorni, Francesca/0000-0003-3705-3248; Di TIMOTEO, Gaia/0000-0003-4516-9945; COLANTONI, ALESSIO/0000-0001-7402-0176; Morlando, Mariangela/0000-0002-8327-4423; Rossi, Francesca/0000-0001-7327-6364; bozzoni, irene/0000-0002-3485-8537; Legnini, Ivano/0000-0002-8984-5215; Dattilo, Dario/0000-0003-2774-3835	ERC-2013 [AdG 340172-MUNCODD]; Telethon [GGP16213]; Human Frontiers Science Program Award [RGP0009/2014]; Parent Project Italia; AFM-Telethon [17835]; Epigen-Epigenomics Flagship Project; EU-H2020 Marie Sklodowska-Curie Action (circRTrain) [721890]	ERC-2013; Telethon(Fondazione Telethon); Human Frontiers Science Program Award; Parent Project Italia; AFM-Telethon(Association Francaise contre les Myopathies); Epigen-Epigenomics Flagship Project; EU-H2020 Marie Sklodowska-Curie Action (circRTrain)	The authors acknowledge O. Sthandier and M. Marchioni for technical help, S. Camero and M. Guarnacci for experimental support, M. Caruso for anti-Rb and anti-phospho-Rb antibodies, B. Pizer and R. Shukla for biological samples. The Telethon Network Genetic Biobanks (GTB12001F) and EuroBioBank are acknowledged for biological samples. This work was partially supported by grants from: ERC-2013 (AdG 340172-MUNCODD), Telethon (GGP16213), Human Frontiers Science Program Award RGP0009/2014, Parent Project Italia, AFM-Telethon (17835), Epigen-Epigenomics Flagship Project and EU-H2020 Marie Sklodowska-Curie Action (721890, circRTrain).	Abdelmohsen K, 2017, RNA BIOL, V14, P361, DOI 10.1080/15476286.2017.1279788; Ahmed I, 2016, ONCOTARGET, V7, P36366, DOI 10.18632/oncotarget.8917; Alvarez MJ, 2016, NAT GENET, V48, P838, DOI 10.1038/ng.3593; Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Bonizzato A, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.81; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Chen TD, 2012, J BIOL CHEM, V287, P37540, DOI 10.1074/jbc.M111.260679; CLEMENS MJ, 1985, BIOCHEM J, V226, P345, DOI 10.1042/bj2260345; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Du WW, 2016, NUCLEIC ACIDS RES, V44, P2846, DOI 10.1093/nar/gkw027; Egas-Bejar D, 2014, ADOLESC HEALTH MED T, V5, P115, DOI 10.2147/AHMT.S44582; Endo H, 2012, J BIOCHEM, V151, P139, DOI 10.1093/jb/mvr128; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; FELIX CA, 1992, CANCER RES, V52, P2243; Feng GG, 2017, FEBS LETT, V591, P760, DOI 10.1002/1873-3468.12587; Galea GL, 2017, GENE, V599, P36, DOI 10.1016/j.gene.2016.11.006; Geistlinger L, 2011, BIOINFORMATICS, V27, pI366, DOI 10.1093/bioinformatics/btr228; Guarnerio J, 2016, CELL, V165, P289, DOI 10.1016/j.cell.2016.03.020; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; HERTZOG PJ, 1994, MOL REPROD DEV, V39, P226; Hinson ARP, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00183; Iwanaga R, 2006, ONCOGENE, V25, P1786, DOI 10.1038/sj.onc.1209210; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Krautkramer KA, 2013, AM J PHYSIOL-ENDOC M, V305, pE600, DOI 10.1152/ajpendo.00147.2013; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Legnini I, 2017, MOL CELL, V66, P22, DOI 10.1016/j.molcel.2017.02.017; Liu PJ, 2009, CELL CYCLE, V8, P125, DOI 10.4161/cc.8.1.7528; Megiorni F, 2016, ONCOTARGET, V7, P79328, DOI 10.18632/oncotarget.12688; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Mio C, 2016, ENDOCR-RELAT CANCER, V23, P335, DOI 10.1530/ERC-15-0322; Miyachi M, 2009, CLIN CANCER RES, V15, P4077, DOI 10.1158/1078-0432.CCR-08-2955; Mori K, 2016, CANCER SCI, V107, P963, DOI 10.1111/cas.12953; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Pamudurti NR, 2017, MOL CELL, V66, P9, DOI 10.1016/j.molcel.2017.02.021; Patop IL, 2018, CURR OPIN GENET DEV, V48, P121, DOI 10.1016/j.gde.2017.11.007; Peng L, 2017, ONCOTARGET, V8, P808, DOI 10.18632/oncotarget.13656; Piwecka M, 2017, SCIENCE, V357, DOI 10.1126/science.aam8526; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Qu K, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.352; Remoli ME, 2002, J IMMUNOL, V169, P366, DOI 10.4049/jimmunol.169.1.366; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Sangfelt O, 2000, FRONT BIOSCI-LANDMRK, V5, pD479, DOI 10.2741/Sangfelt; Schaaf GJ, 2005, FASEB J, V19, P404, DOI 10.1096/fj.04-2104fje; Sun Xin, 2015, Sarcoma, V2015, P232010, DOI 10.1155/2015/232010; Tang CM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40342; Taylor AC, 2000, MED PEDIATR ONCOL, V35, P96, DOI 10.1002/1096-911X(200008)35:2<96::AID-MPO2>3.0.CO;2-Z; Wang S, 2017, ONCOL REP, V38, P735, DOI 10.3892/or.2017.5769; Xia WJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep35576; Ying HN, 2018, ONCOTARGETS THER, V11, P689, DOI 10.2147/OTT.S152138; Zhang ML, 2018, ONCOGENE, V37, P1805, DOI 10.1038/s41388-017-0019-9; Zheng QP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11215	52	62	65	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 16	2019	38	20					3843	3854		10.1038/s41388-019-0699-4	http://dx.doi.org/10.1038/s41388-019-0699-4			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HY3OI	30670781	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000468035600006
J	Wu, Y; Zhang, JZ; Fang, L; Lee, HC; Zhao, YJ				Wu, Yang; Zhang, Jingzi; Fang, Lei; Lee, Hon Cheung; Zhao, Yong Juan			A cytosolic chaperone complex controls folding and degradation of type III CD38	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CD38; chaperone; heat shock protein (HSP); protein degradation; protein folding; cyclic ADP ribose (cADPR); heat shock protein 90 (Hsp90); cytosolic soluble CD38; hsp70; Hsp70-interacting protein (Hip); lysosomal degradation; type III CD38	CYCLIC ADP-RIBOSE; HEAT-SHOCK-PROTEIN; ACTIVATION; HIP; INHIBITION; HYDROLYSIS; EXPRESSION; MATURATION; HSP90; HSP70	Cluster of differentiation 38 (CD38) is the best-studied enzyme catalyzing the synthesis of the Ca2+ messenger cyclic ADP-ribose. It is a single-pass transmembrane protein, but possesses dual orientations. We have documented the natural existence of type III CD38 in cells and shown that it is regulated by a cytosolic activator, calcium- and integrin-binding 1 (CIB1). However, how type III CD38 can be folded correctly in the reductive cytosol has not been addressed. Using the yeast two-hybrid technique with CD38's catalytic domain (sCD38) as bait, here we identified a chaperone, Hsp70-interacting protein (Hip), that specifically interacts with both the type III CD38 and sCD38. Immunoprecipitation coupled with MS identified a chaperone complex associated specifically with sCD38. Pharmacological and siRNA-mediated knockdown of Hsp90 chaperones decreased the expression levels of both sCD38 and type III CD38, suggesting that these chaperones facilitate their folding. Moreover, knockdown of Hsc70 or DNAJA2 increased the levels of both CD38 types, consistent with the roles of these proteins in mediating CD38 degradation. Notably, Hip knockdown decreased type III CD38 substantially, but only marginally affected sCD38, indicating that Hip was selective for the former. More remarkably, DNAJA1 knockdown decreased sCD38 but increased type III CD38 levels. Mechanistically, we show that Hsc70 mediates lysosomal degradation of type III CD38, requiring the lysosomal receptor Lamp2A and the C19-motif in the C terminus of CD38. Our results indicate that folding and degradation of type III CD38 is effectively controlled in cells, providing further strong support of its physiological relevance.	[Wu, Yang; Lee, Hon Cheung; Zhao, Yong Juan] Peking Univ, Shenzhen Grad Sch, Key Lab Chem Gen, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R China; [Zhang, Jingzi; Fang, Lei] Nanjing Univ, Med Sch, Jiangsu Key Lab Mol Med, Nanjing 210093, Jiangsu, Peoples R China	Peking University; University Town of Shenzhen; Nanjing University	Lee, HC; Zhao, YJ (corresponding author), Peking Univ, Shenzhen Grad Sch, Key Lab Chem Gen, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R China.; Fang, L (corresponding author), Nanjing Univ, Med Sch, Jiangsu Key Lab Mol Med, Nanjing 210093, Jiangsu, Peoples R China.	njfanglei@nju.edu.cn; leehoncheung@gmail.com; zhaoyongjuan@pku.edu.cn	Lee, Hon Cheung/C-4329-2009; Zhao, Yongjuan/AAS-9919-2021	Zhao, Yong Juan/0000-0003-4564-1912; Fang, Lei/0000-0002-2582-4845	Shenzhen Governments Grants [JCYJ20160608091848749, JCYJ20170412150609690]; National Science Foundation of China [31571438, 31671463, 31500664, 31770838]; Natural Science Foundation of Jiangsu Province [BK20171338]; Fundamental Research Funds for the Central Universities [021414380334]	Shenzhen Governments Grants; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by Shenzhen Governments Grants JCYJ20160608091848749 (to Y. J. Z.) and JCYJ20170412150609690 (to H. C. L.); National Science Foundation of China Grants 31571438 (to Y. J. Z.), 31671463 (to H. C. L.), and 31500664 and 31770838 (to L. F.); Natural Science Foundation of Jiangsu Province Grant BK20171338 (to L. F.); and the Fundamental Research Funds for the Central Universities Grant 021414380334 (to L. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Abisambra JF, 2012, J MOL BIOL, V421, P653, DOI 10.1016/j.jmb.2012.02.003; Avci D, 2015, TRENDS CELL BIOL, V25, P611, DOI 10.1016/j.tcb.2015.07.003; Craig EA, 2017, TRENDS BIOCHEM SCI, V42, P355, DOI 10.1016/j.tibs.2017.02.007; CUERVO AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1200, DOI 10.1152/ajpcell.1995.269.5.C1200; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; DICE JF, 1982, J BIOL CHEM, V257, P4624; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Durig J, 2002, LEUKEMIA, V16, P30, DOI 10.1038/sj.leu.2402339; Fan GH, 2002, J BIOL CHEM, V277, P6590, DOI 10.1074/jbc.M110588200; Fang L, 2012, MOL CELL PROTEOMICS, V11, P138, DOI 10.1074/mcp.M111.016352; Finn PE, 2005, AUTOPHAGY, V1, P141, DOI 10.4161/auto.1.3.2000; Galluzzi L, 2017, EMBO J, V36, P1811, DOI 10.15252/embj.201796697; GIORGI JV, 1994, J INFECT DIS, V170, P775, DOI 10.1093/infdis/170.4.775; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; HOHFELD J, 1995, CELL, V83, P589; Hoshino S, 1997, J IMMUNOL, V158, P741; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; JACKSON DG, 1990, J IMMUNOL, V144, P2811; Kaushik S, 2018, NAT REV MOL CELL BIO, V19, P365, DOI 10.1038/s41580-018-0001-6; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Liu J, 2017, P NATL ACAD SCI USA, V114, P8283, DOI 10.1073/pnas.1703718114; Lopez T, 2015, J MOL BIOL, V427, P2919, DOI 10.1016/j.jmb.2015.04.013; Mo Y, 1996, Zhonghua Zhong Liu Za Zhi, V18, P241; Nelson GM, 2004, MOL ENDOCRINOL, V18, P1620, DOI 10.1210/me.2004-0054; Noormohammadi A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13649; Orthwein A, 2012, EMBO J, V31, P679, DOI 10.1038/emboj.2011.417; Parrales A, 2016, NAT CELL BIOL, V18, P1233, DOI 10.1038/ncb3427; Pedrozo Z, 2013, CARDIOVASC RES, V98, P277, DOI 10.1093/cvr/cvt029; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Radons J, 2016, CELL STRESS CHAPERON, V21, P379, DOI 10.1007/s12192-016-0676-6; RUIZARGUELLES GJ, 1994, MAYO CLIN PROC, V69, P684, DOI 10.1016/S0025-6196(12)61350-0; Shen SS, 2009, J CELL BIOL, V185, P629, DOI 10.1083/jcb.200810183; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; TAKASAWA S, 1993, J BIOL CHEM, V268, P26052; Terada K, 2000, J BIOL CHEM, V275, P24728, DOI 10.1074/jbc.M002021200; Terada K, 2010, J BIOL CHEM, V285, P16789, DOI 10.1074/jbc.M110.101501; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Williamson DS, 2009, J MED CHEM, V52, P1510, DOI 10.1021/jm801627a; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Zhao YJ, 2015, BBA-MOL CELL RES, V1853, P2095, DOI 10.1016/j.bbamcr.2014.10.028; Zhao YJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002700; Zhao YJ, 2011, J BIOL CHEM, V286, P22170, DOI 10.1074/jbc.M111.228379	44	5	5	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4247	4258		10.1074/jbc.RA118.005844	http://dx.doi.org/10.1074/jbc.RA118.005844			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30670591	Green Published, hybrid			2022-12-26	WOS:000461854400034
J	Armstrong, AW; Huang, A; Wang, L; Miao, R; Patel, MY; Gadkari, A; Mallya, UG; Chao, JD				Armstrong, April W.; Huang, Ahong; Wang, Li; Miao, Raymond; Patel, Miraj Y.; Gadkari, Abhijit; Mallya, Usha G.; Chao, Jingdong			Real-world utilization patterns of systemic immunosuppressants among US adult patients with atopic dermatitis	PLOS ONE			English	Article							NATIONAL-HEALTH; COMORBIDITY; GUIDELINES; MANAGEMENT; CARE; BURDEN	At the time of this study, prior to the introduction of biologics in the US, systemic therapies used for the treatment of moderate-to-severe atopic dermatitis included off-label immunosuppressants and corticosteroids. Immunosuppressant therapy is associated with a substantial risk of side-effects, therefore needing clinical monitoring, and is likely to incur a significant healthcare burden for patients and payers. This retrospective cohort study based on claims data measured immunosuppressant use and its associated burden among US adult patients with atopic dermatitis covered under commercial or Medicare Supplemental insurance from January 01, 2010, to September 30, 2015. Overall, based on age, gender, region, and index year, 4201 control patients with atopic dermatitis without immunosuppressant use were matched with 4204 patients treated with immunosuppressants. The majority (68.5%) of patients using immunosuppressants were non-persistent with immunosuppressant treatment during the 12-month follow-up period after a mean (standard deviation) of 88.1 (70.7) days of immunosuppressant use; 72.3% required systemic steroid rescue treatment. Immunosuppressant users had higher incidence of immunosuppressant-related clinical events than controls; in addition, a larger proportion of immunosuppressant users versus controls developed cancer (0.28% vs 0.14%, respectively; P < 0.0001). Healthcare utilization and costs associated with clinical events and monitoring were also higher for immunosuppressant users compared with controls (total costs, $9516 vs $1630, respectively; P < 0.0001; monitoring costs, $363 vs $54, respectively; P < 0.0001). This study revealed that patients treated with systemic immunosuppressants often require systemic steroids or changes to treatment. The increase in immunosuppressant-related clinical events, including the need for increased monitoring with immunosuppressant treatment, compared with controls demonstrates a substantial treatment burden and highlights the unmet need for more effective long-term therapies for atopic dermatitis with improved safety profiles and reduced monitoring requirements.	[Armstrong, April W.] Univ Southern Calif, Keck Sch Med, Dept Dermatol, Los Angeles, CA 90007 USA; [Huang, Ahong; Wang, Li] STATinMED Res SIMR Inc, Plano, TX USA; [Miao, Raymond; Patel, Miraj Y.; Mallya, Usha G.] Sanofi, Bridgewater, NJ USA; [Gadkari, Abhijit; Chao, Jingdong] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA	University of Southern California; Sanofi-Aventis; Regeneron	Armstrong, AW (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Dermatol, Los Angeles, CA 90007 USA.	aprilarmstrong@post.harvard.edu		Patel, Miraj/0000-0002-3543-1420	Sanofi; Regeneron Pharmaceuticals, Inc.	Sanofi(Sanofi-Aventis); Regeneron Pharmaceuticals, Inc.(Regeneron)	Study funded by Sanofi and Regeneron Pharmaceuticals, Inc. No specific grants were issued to individual authors. Medical writing support was provided by Elien Moes, PhD, ISMPP CMPP (TM) and Sam Lewtas, MRPharmS, of Prime, Knutsford, UK, and funded by Sanofi and Regeneron Pharmaceuticals, Inc. The authors were responsible for all content and editorial decisions, and received no honoraria related to the development of this publication. All authors had full access to all the data in this study and take complete responsibility for the integrity of the data and accuracy of the data analysis. All named authors meet the International Committee of Medical Journal Editors criteria for authorship for this manuscript, take responsibility for the integrity of the work and have given final approval for the version to be published. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chaplin S, 2016, PRESCRIBER, V27, P30, DOI DOI 10.1002/PSB.1505; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Cookson H, 2012, CLIN MED, V12, P172, DOI 10.7861/clinmedicine.12-2-172; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Eckert L, 2018, J AM ACAD DERMATOL, V78, P54, DOI 10.1016/j.jaad.2017.08.002; Eckert L, 2017, J AM ACAD DERMATOL, V77, P274, DOI 10.1016/j.jaad.2017.04.019; Eichenfield LF, 2017, J ALLERGY CLIN IMMUN, V139, pS49, DOI 10.1016/j.jaci.2017.01.009; Eichenfield LF, 2014, J AM ACAD DERMATOL, V70, P338, DOI 10.1016/j.jaad.2013.10.010; Food and Drugs Administration, 2018, LAB CELLCEPT MYCOPH; Food and Drugs Administration, 2018, LAB ENBREL ET INJ 20; Food and Drugs Administration, 2018, LAB METHOTREXATE TAB; Food and Drugs Administration, 2018, LAB NEORAL SOFT GEL; Food and Drugs Administration, 2018, LAB IMURAN AZ 50 MG; Garritsen FM, 2015, J EUR ACAD DERMATOL, V29, P1905, DOI 10.1111/jdv.13064; Gelbard Christina M, 2008, Patient Prefer Adherence, V2, P387; Lipozencic J, 2007, DERMATOL CLIN, V25, P605, DOI 10.1016/j.det.2007.06.009; Sidbury R, 2014, J AM ACAD DERMATOL, V71, P327, DOI 10.1016/j.jaad.2014.03.030; Simpson EL, 2017, J AM ACAD DERMATOL, V77, P623, DOI 10.1016/j.jaad.2017.06.042; Simpson EL, 2016, J AM ACAD DERMATOL, V74, P491, DOI 10.1016/j.jaad.2015.10.043; Truven Health Analytics, 2018, RES DAT AN TOOLS 201	21	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210517	10.1371/journal.pone.0210517	http://dx.doi.org/10.1371/journal.pone.0210517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682042	Green Published, gold, Green Submitted			2022-12-26	WOS:000457037500043
J	Chen, W; He, Y; Chen, CS; Zhu, M; Bi, SY; Liu, J; Xia, MR; Lin, QX; Wang, YW; Wang, WJ				Chen, Wen; He, Yong; Chen, Chuansheng; Zhu, Ming; Bi, Suyu; Liu, Jin; Xia, Mingrui; Lin, Qixiang; Wang, Yiwen; Wang, Wenjing			Long-term Chinese calligraphic handwriting training has a positive effect on brain network efficiency	PLOS ONE			English	Article							MEMORY-SYSTEMS; FUNCTIONAL CONNECTIVITY; CORTICAL NETWORKS; CAUDATE-NUCLEUS; HIPPOCAMPUS; PATTERNS; EMOTION; MOTION	As a visual art form, Chinese calligraphic handwriting (CCH) has been found to correlate with certain brain activity and to induce functional connectivity reorganization of the brain. This study investigated the effect of long-term CCH training on brain functional plasticity as assessed with network measures. With the resting-state fMRI data from 31 participants with at least five years of CCH training and 40 controls, we constructed brain functional networks, examined group differences at both the whole brain and modular levels, and correlated the topological characteristics with calligraphy skills. We found that, compared to the control group, the CCH group showed shorter characteristic path lengths and higher local efficiency in certain brain areas in the frontal and parietal cortices, limbic system, basal ganglia, and thalamus. Moreover, these network measures in the cingulate cortex, caudate nucleus, and thalamus were associated with CCH performance (i.e., copying and creating skills). These results suggest that long-term CCH training has a positive effect on the topological characteristics of brain networks.	[Chen, Wen] Beijing Normal Univ, Adv Innovat Ctr Future Educ, Beijing, Peoples R China; [Chen, Wen; He, Yong; Zhu, Ming; Liu, Jin; Xia, Mingrui; Lin, Qixiang; Wang, Wenjing] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China; [Chen, Wen; He, Yong; Zhu, Ming; Liu, Jin; Xia, Mingrui; Lin, Qixiang; Wang, Wenjing] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China; [Chen, Wen] Beijing Normal Univ, Coll Informat Sci & Technol, Beijing, Peoples R China; [Chen, Chuansheng] Univ Calif Irvine, Dept Psychol Sci, Irvine, CA USA; [Bi, Suyu] Beijing Foreign Studies Univ, Sch Int Journalism & Commun, Beijing, Peoples R China; [Bi, Suyu; Wang, Yiwen] Beijing Normal Univ, Sch Arts & Media, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University; Beijing Normal University; Beijing Normal University; University of California System; University of California Irvine; Beijing Foreign Studies University; Beijing Normal University	Wang, WJ (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China.; Wang, WJ (corresponding author), Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China.; Wang, YW (corresponding author), Beijing Normal Univ, Sch Arts & Media, Beijing, Peoples R China.	wyiw@sina.com; wangwenjing@bnu.edu.cn	Wang, Yijun/GXW-1763-2022; Wang, Yin/HCI-9352-2022; wang, yi/GVT-8516-2022; Xia, Mingrui/J-3267-2019; Lin, Qixiang/GXG-3598-2022; wang, yixuan/GXW-2866-2022; He, Yong/Q-5756-2018; Wang, Yixuan/GZK-6559-2022	Xia, Mingrui/0000-0003-4615-9132; Lin, Qixiang/0000-0002-1718-6855; He, Yong/0000-0002-7039-2850; Chen, Chuansheng/0000-0002-8224-1005; Chen, Wen/0000-0001-7563-4495	Project of the Ministry of Education of the People's Republic of China [14YJAZH081]; National Natural Science Foundation of the People's Republic of China [31221003]	Project of the Ministry of Education of the People's Republic of China; National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC))	This study was supported by the 14YJAZH081 (received by WW) Project of the Ministry of Education of the People's Republic of China (http://en.moe.gov.cn/) and the No. 31221003 (received by YH) Project of the National Natural Science Foundation of the People's Republic of China (http://www.nsfc.gov.cn/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the 14YJAZH081 Project of the Ministry of Education of China and the No. 31221003 Project of the National Natural Science Foundation of China. We thank all graduate research assistants who helped with data collection.	Akbar N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145906; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Beaty RE, 2018, P NATL ACAD SCI USA, V115, P1087, DOI 10.1073/pnas.1713532115; Beaty RE, 2016, TRENDS COGN SCI, V20, P87, DOI 10.1016/j.tics.2015.10.004; Bender AD, 2017, NEUROIMAGE, V158, P455, DOI 10.1016/j.neuroimage.2016.10.035; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Burkhouse KL, 2018, PROG NEURO-PSYCHOPH, V84, P250, DOI 10.1016/j.pnpbp.2018.03.013; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Chang WH, 2012, RESTOR NEUROL NEUROS, V30, P179, DOI 10.3233/RNN-2012-110162; Chen CY, 2009, NEUROIMAGE, V44, P537, DOI 10.1016/j.neuroimage.2008.09.005; Chen W, 2016, 22 ANN M ORG HUM BRA, DOI [10.1371/journal.pone.0145906, DOI 10.1371/JOURNAL.PONE.0145906]; Chen W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170660; de Manzano O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010670; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Ellamil M, 2012, NEUROIMAGE, V59, P1783, DOI 10.1016/j.neuroimage.2011.08.008; Floden D, 2006, J COGNITIVE NEUROSCI, V18, P1843, DOI 10.1162/jocn.2006.18.11.1843; Freedberg D, 2007, TRENDS COGN SCI, V11, P197, DOI 10.1016/j.tics.2007.02.003; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hannon EE, 2005, P NATL ACAD SCI USA, V102, P12639, DOI 10.1073/pnas.0504254102; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2009, BRAIN, V132, P3366, DOI 10.1093/brain/awp089; Hosseini SMH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040709; Iaria G, 2003, J NEUROSCI, V23, P5945; Kruschwitz JD, 2015, J NEUROSCI METH, V245, P107, DOI 10.1016/j.jneumeth.2015.02.021; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Lin CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066761; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lu J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12277; Maguire EA, 2006, HIPPOCAMPUS, V16, P1091, DOI 10.1002/hipo.20233; MCDONALD RJ, 1994, BEHAV NEURAL BIOL, V61, P260, DOI 10.1016/S0163-1047(05)80009-3; Min BK, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-10; Molnar-Szakacs I, 2006, SOC COGN AFFECT NEUR, V1, P235, DOI 10.1093/scan/nsl029; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Petrella JR, 2011, RADIOLOGY, V259, P317, DOI 10.1148/radiol.11110380; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Pinho AL, 2014, J NEUROSCI, V34, P6156, DOI 10.1523/JNEUROSCI.4769-13.2014; Postle BR, 1999, COGNITIVE BRAIN RES, V8, P107, DOI 10.1016/S0926-6410(99)00010-5; Sarkamo T, 2018, DEMENTIA-LONDON, V17, P670, DOI 10.1177/1471301217729237; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; Schwabe L, 2013, BIOL PSYCHIAT, V74, P801, DOI 10.1016/j.biopsych.2013.06.001; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Steele CJ, 2013, J NEUROSCI, V33, P1282, DOI 10.1523/JNEUROSCI.3578-12.2013; Tian F, 2018, NEUROSCI LETT, V683, P104, DOI 10.1016/j.neulet.2018.06.036; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; White NM, 2002, NEUROBIOL LEARN MEM, V77, P125, DOI 10.1006/nlme.2001.4008; WINOCUR G, 1985, BEHAV BRAIN RES, V16, P135, DOI 10.1016/0166-4328(85)90088-9; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yoshino A, 2018, PSYCHOL MED, V48, P1148, DOI 10.1017/S0033291717002598	53	2	2	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210962	10.1371/journal.pone.0210962	http://dx.doi.org/10.1371/journal.pone.0210962			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682084	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500080
J	Basoli, V; Santaniello, S; Rinaldi, S; Fontani, V; Pigliaru, G; Wieser, M; Strajeriu, A; Castagna, A; Redl, H; Ventura, C; Grillari, R; Maioli, M				Basoli, Valentina; Santaniello, Sara; Rinaldi, Salvatore; Fontani, Vania; Pigliaru, Gianfranco; Wieser, Matthias; Strajeriu, Agata; Castagna, Alessandro; Redl, Heinz; Ventura, Carlo; Grillari, Regina; Maioli, Margherita			Physical stimulation by REAC and BMP4/WNT-1 inhibitor synergistically enhance cardiogenic commitment in iPSCs	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; CARDIAC DIFFERENTIATION; TECHNOLOGY; CARDIOMYOCYTES; FIBROBLASTS; MODEL	It is currently known that pluripotent stem cells can be committed in vitro to the cardiac lineage by the modulation of specific signaling pathways, but it is also well known that, despite the significant increase in cardiomyocyte yield provided by the currently available conditioned media, the resulting cardiogenic commitment remains a highly variable process. Previous studies provided evidence that radio electric fields asymmetrically conveyed through the Radio Electric Asymmetric Conveyer (REAC) technology are able to commit R1 embryonic stem cells and human adipose derived stem cells toward a cardiac phenotype. The present study aimed at investigating whether the effect of physical stimulation by REAC in combination with specific chemical inductors enhance the cardiogenic potential in human induced pluripotent stem cells (iPSCs). The appearance of a cardiac-like phenotype in iPSCs cultured in the presence of a cardiogenic medium, based upon BMP4 and a WNT-inhibitor, was consistently increased by REAC treatment used only during the early fate differentiation for the first 72 hours. REAC-exposed iPSCs exhibited an upregulation in the expression of specific cardiogenic transcripts and morphologically in the number of beating clusters, as compared to cells cultured in the cardiogenic medium alone. Our results indicate that physical modulation of cellular dynamics provided by the REAC offers an affordable strategy to mimic iPSC cardiac-like fates in the presence of a cardiogenic milieu.	[Basoli, Valentina; Santaniello, Sara; Pigliaru, Gianfranco; Maioli, Margherita] Univ Sassari, Dept Biomed Sci, Sassari, Italy; [Basoli, Valentina; Rinaldi, Salvatore; Fontani, Vania] Rinaldi Fontani Fdn, Res Dept, Florence, Italy; [Basoli, Valentina; Grillari, Regina] Univ Nat Resources & Life Sci, Dept Biotechnol, Vienna, Austria; [Santaniello, Sara; Pigliaru, Gianfranco; Ventura, Carlo] CNR, Natl Lab Mol Biol & Stem Cell Engn, Natl Inst Biostruct & Biosyst, Eldor Lab,Innovat Accelerators, Bologna, Italy; [Rinaldi, Salvatore; Fontani, Vania; Castagna, Alessandro; Ventura, Carlo] Rinaldi Fontani Inst, Dept Regenerat Med, Florence, Italy; [Rinaldi, Salvatore; Fontani, Vania; Maioli, Margherita] IRF Shanghai Med Sci, Shanghai, Peoples R China; [Wieser, Matthias; Strajeriu, Agata; Grillari, Regina] Evercyte GmbH, Vienna, Austria; [Wieser, Matthias; Strajeriu, Agata; Redl, Heinz] Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria; [Wieser, Matthias; Strajeriu, Agata; Redl, Heinz; Grillari, Regina] Austrian Cluster Tissue Regenerat, Vienna, Austria; [Maioli, Margherita] Univ Sassari, Ctr Dev Biol & Reprogramming CEDEBIOR, Dept Biomed Sci, Sassari, Italy; [Maioli, Margherita] Natl Inst Biostruct & Biosyst, Sassari, Italy	University of Sassari; University of Natural Resources & Life Sciences, Vienna; Consiglio Nazionale delle Ricerche (CNR); Ludwig Boltzmann Institute; University of Sassari	Rinaldi, S (corresponding author), Rinaldi Fontani Fdn, Res Dept, Florence, Italy.; Rinaldi, S (corresponding author), Rinaldi Fontani Inst, Dept Regenerat Med, Florence, Italy.; Rinaldi, S (corresponding author), IRF Shanghai Med Sci, Shanghai, Peoples R China.	srinaldi@irf.it	Ventura, Carlo/AAV-3658-2020; Basoli, Valentina/AEX-6502-2022; Redl, Heinz/AAD-8157-2019	Rinaldi, Salvatore/0000-0002-8961-6316; Basoli, Valentina/0000-0002-4703-7308; Fontani, Vania/0000-0003-0141-6270	Regione Autonoma della Sardegna; Fundamental Research Program [CRP - 60208, CRP - 59886 AMBROSIA, 7/2007]; Banco di Sardegna Foundation [U858.2014/AI.741.MGB Prat.2014.0178]; Evercyte GmbH, Vienna; IRF Shanghai Medical Sciences	Regione Autonoma della Sardegna(Regione Sardegna); Fundamental Research Program; Banco di Sardegna Foundation(Fondazione Banco di Sardegna); Evercyte GmbH, Vienna; IRF Shanghai Medical Sciences	M.M. received specific funding from Regione Autonoma della Sardegna (www.regione.sardegna.it), Fundamental Research Program, L.R. 7/2007 "Promotion of the scientific research and technological innovation in Sardinia" under grant agreement CRP - 60208 and CRP - 59886 AMBROSIA Project, by Banco di Sardegna Foundation (Prot. U858.2014/AI.741.MGB Prat.2014.0178). M.W. and A.S. are employed by Evercyte GmbH, Vienna, but this commercial company only provided financial support in the form of research materials. S.R. and V.F. are partners in IRF Shanghai Medical Sciences, but this company only provided funds for research. All 3 of these funders did not play a role in the study design, data collection and analysis, preparation of the manuscript and decision to publish. The specific roles of M.W, A.S., S.R. and V.F. are articulated in the author contributions' section.	Basoli V, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050981; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Berlinguer F, 2017, REPROD BIOL ENDOCRIN, V15, P1, DOI 10.1186/s12958-017-0229-6; Cao N, 2012, CELL RES, V22, P219, DOI 10.1038/cr.2011.195; Cibrian-Uhalte E, 2006, ENCY REFERENCE GENOM, P237; Collodel G, 2013, CLIN INTERV AGING, V8, P309, DOI 10.2147/CIA.S42229; Hernandez D, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1718041; Kempf H, 2015, NAT PROTOC, V10, P1345, DOI 10.1038/nprot.2015.089; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Luca L, 2016, SCI REP-UK, V6, DOI 10.1038/srep35719; Maioli M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192178; Maioli M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28682; Maioli M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10439; Maioli M, 2014, CELL TRANSPLANT, V23, P1489, DOI 10.3727/096368913X672037; Maioli M, 2014, AGE, V36, P9, DOI 10.1007/s11357-013-9537-8; Maioli M, 2013, CELL TRANSPLANT, V22, P1227, DOI 10.3727/096368912X657297; Maioli M, 2012, CELL TRANSPLANT, V21, P1225, DOI 10.3727/096368911X600966; Maioli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015151; Martins AM, 2014, STEM CELL REV REP, V10, P177, DOI 10.1007/s12015-013-9487-7; Merks AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04566-1; Nsair A, 2011, ADV DRUG DELIVER REV, V63, P324, DOI 10.1016/j.addr.2011.01.013; Panaro MA, 2018, NEUROSCI BULL, V34, P270, DOI 10.1007/s12264-017-0188-0; Passino ES, 2017, CLIN INTERV AGING, V12, P1471, DOI 10.2147/CIA.S140976; RINALDI S, 2014, SCI REP UK, V4; Rinaldi S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200128; Rinaldi S, 2012, CLIN INTERV AGING, V7, P191, DOI 10.2147/CIA.S33312; Santos CXC, 2011, FREE RADICAL BIO MED, V50, P777, DOI 10.1016/j.freeradbiomed.2011.01.003; Serena E, 2009, EXP CELL RES, V315, P3611, DOI 10.1016/j.yexcr.2009.08.015; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tohyama S, 2016, ETIOLOGY AND MORPHOG, P25; Trollinger DR, 2002, J CELL PHYSIOL, V193, P1, DOI 10.1002/jcp.10144; Trounson A, 2016, NAT REV MOL CELL BIO, V17, P194, DOI 10.1038/nrm.2016.10; Ventura C, 2004, FASEB J, V18, P155, DOI 10.1096/fj.04-2695fje; Weng ZH, 2014, STEM CELLS DEV, V23, P1704, DOI 10.1089/scd.2013.0509; Xue YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070573; Yang YZ, 2015, ANNU REV CELL DEV BI, V31, P623, DOI 10.1146/annurev-cellbio-100814-125315; Yassa ME, 2018, LIFE SCI, V196, P38, DOI 10.1016/j.lfs.2018.01.009; Zhou T, 2012, NAT PROTOC, V7, P2080, DOI 10.1038/nprot.2012.115	39	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211188	10.1371/journal.pone.0211188	http://dx.doi.org/10.1371/journal.pone.0211188			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673752	gold, Green Published			2022-12-26	WOS:000456442800079
J	Cozzi, L; Comito, T; Fogliata, A; Franzese, C; Franceschini, D; Bonifacio, C; Tozzi, A; Di Brina, L; Clerici, E; Tomatis, S; Reggiori, G; Lobefalo, F; Stravato, A; Mancosu, P; Zerbi, A; Sollini, M; Kirienko, M; Chiti, A; Scorsetti, M				Cozzi, Luca; Comito, Tiziana; Fogliata, Antonella; Franzese, Ciro; Franceschini, Davide; Bonifacio, Cristiana; Tozzi, Angelo; Di Brina, Lucia; Clerici, Elena; Tomatis, Stefano; Reggiori, Giacomo; Lobefalo, Francesca; Stravato, Antonella; Mancosu, Pietro; Zerbi, Alessandro; Sollini, Martina; Kirienko, Margarita; Chiti, Arturo; Scorsetti, Marta			Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma	PLOS ONE			English	Article							PET RADIOMICS; RADIOTHERAPY; CANCER; GEMCITABINE; RADIOCHEMOTHERAPY; ADENOCARCINOMA; IMAGES; TRIAL; HEAD	Purpose To appraise the ability of a radiomics signature to predict clinical outcome after stereotactic body radiation therapy (SBRT) for pancreas carcinoma. Methods A cohort of 100 patients was included in this retrospective, single institution analysis. Radiomics texture features were extracted from computed tomography (CT) images obtained for the clinical target volume. The cohort of patients was randomly divided into two separate groups for the training (60 patients) and validation (40 patients). Cox regression models were built to predict overall survival and local control. The significant predictors at univariate analysis were included in a multivariate model. The quality of the models was appraised by means of area under the curve and concordance index. Results A clinical-radiomic signature associated with Overall Survival (OS) was found significant in both training and validation sets (p = 0.01 and 0.05 and concordance index 0.73 and 0.75 respectively). Similarly, a signature was found for Local Control (LC) with p = 0.007 and 0.004 and concordance index 0.69 and 0.75. In the low risk group, the median OS and LC in the validation group were 14.4 and 28.6 months while in the high-risk group were 9.0 and 17.5 months respectively. Conclusion A CT based radiomic signature was identified which correlate with OS and LC after SBRT and allowed to identify low and high-risk groups of patients.	[Cozzi, Luca; Chiti, Arturo; Scorsetti, Marta] Humanitas Univ, Dept Biomed Sci, Milan, Italy; [Cozzi, Luca; Comito, Tiziana; Fogliata, Antonella; Franzese, Ciro; Franceschini, Davide; Tozzi, Angelo; Di Brina, Lucia; Clerici, Elena; Tomatis, Stefano; Reggiori, Giacomo; Lobefalo, Francesca; Stravato, Antonella; Mancosu, Pietro; Scorsetti, Marta] Humanitas Clin & Res Ctr, Radiotherapy & Radiosurg, Milan, Italy; [Bonifacio, Cristiana] Humanitas Clin & Res Ctr, Diagnost Radiol, Milan, Italy; [Zerbi, Alessandro] Humanitas Clin & Res Ctr, Pancreat Surg, Milan, Italy; [Sollini, Martina; Kirienko, Margarita; Chiti, Arturo] Humanitas Clin & Res Ctr, Nucl Med, Milan, Italy	Humanitas University	Cozzi, L (corresponding author), Humanitas Univ, Dept Biomed Sci, Milan, Italy.; Cozzi, L (corresponding author), Humanitas Clin & Res Ctr, Radiotherapy & Radiosurg, Milan, Italy.	luca.cozzi@humanitas.it	Mancosu, Pietro/AAB-9807-2019; franzese, ciro/P-5195-2019; Sollini, Martina/K-6527-2016; Clerici, Elena/GZG-1993-2022; Franzese, Ciro/AAJ-7311-2020; cozzi, luca/GZL-4895-2022; Chiti, Arturo/K-6524-2016; Franceschini, Davide/AAB-3871-2019; Tomatis, Stefano/AAA-6002-2021; TOZZi, ANGELO/AAP-9979-2020; Mancosu, Pietro/HBQ-0722-2022; Reggiori, Giacomo/HDM-8974-2022; Kirienko, Margarita/K-6552-2016	Mancosu, Pietro/0000-0002-0165-7931; Sollini, Martina/0000-0003-2214-6492; Clerici, Elena/0000-0002-1765-863X; Franzese, Ciro/0000-0001-6893-6284; cozzi, luca/0000-0001-7862-898X; Chiti, Arturo/0000-0002-5806-1856; Franceschini, Davide/0000-0003-1142-2439; TOZZi, ANGELO/0000-0001-7815-4788; Mancosu, Pietro/0000-0002-0165-7931; Tomatis, Stefano/0000-0002-4791-0373; Kirienko, Margarita/0000-0002-3923-1151; reggiori, giacomo/0000-0003-3336-5690; BONIFACIO, CRISTIANA/0000-0002-8551-6801; comito, tiziana/0000-0002-5667-0535; LOBEFALO, FRANCESCA/0000-0003-3634-2582; Scorsetti, Marta/0000-0003-0320-559X; zerbi, alessandro/0000-0002-9176-0448				Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Ben-Josef E, 2012, INT J RADIAT ONCOL, V84, P1166, DOI 10.1016/j.ijrobp.2012.02.051; Bogowicz M, 2017, RADIOTHER ONCOL, V125, P385, DOI 10.1016/j.radonc.2017.10.023; Bogowicz M, 2017, INT J RADIAT ONCOL, V99, P921, DOI 10.1016/j.ijrobp.2017.06.002; Brunner TB, 2015, RADIOTHER ONCOL, V114, P109, DOI 10.1016/j.radonc.2014.10.015; Chang DT, 2009, CANCER-AM CANCER SOC, V115, P665, DOI 10.1002/cncr.24059; Chen XJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178961; Chuong MD, 2013, INT J RADIAT ONCOL, V86, P516, DOI 10.1016/j.ijrobp.2013.02.022; Comito T, 2017, TECHNOL CANCER RES T, V16, P295, DOI 10.1177/1533034616650778; Cozzi L, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3847-7; Eilaghi A, 2017, BMC MED IMAGING, V17, DOI 10.1186/s12880-017-0209-5; Hanania AN, 2016, ONCOTARGET, V7, P85776, DOI 10.18632/oncotarget.11769; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Herman JM, 2015, CANCER-AM CANCER SOC, V121, P1128, DOI 10.1002/cncr.29161; Kirienko M, 2018, EUR J NUCL MED MOL I, V45, P207, DOI 10.1007/s00259-017-3837-7; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Mahadevan A, 2011, INT J RADIAT ONCOL, V81, pE615, DOI 10.1016/j.ijrobp.2011.04.045; Nioche C, 2018, CANCER RES, V78, P4786, DOI 10.1158/0008-5472.CAN-18-0125; Permuth JB, 2016, ONCOTARGET, V7, P85785, DOI 10.18632/oncotarget.11768; Polistina F, 2010, ANN SURG ONCOL, V17, P2092, DOI 10.1245/s10434-010-1019-y; R Core Team, R LANG ENV STAT COMP; Rwigema JCM, 2011, AM J CLIN ONCOL-CANC, V34, P63, DOI 10.1097/COC.0b013e3181d270b4; Schellenberg D, 2011, INT J RADIAT ONCOL, V81, P181, DOI 10.1016/j.ijrobp.2010.05.006; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sollini M, 2017, EUR J HYBRID IMAG, V1, DOI 10.1186/s41824-017-0009-8; Sollini M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00426-y; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Yue Y, 2017, J GASTROINTEST ONCOL, V8, P127, DOI 10.21037/jgo.2016.12.04	28	38	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210758	10.1371/journal.pone.0210758	http://dx.doi.org/10.1371/journal.pone.0210758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657785	Green Submitted, Green Published, gold			2022-12-26	WOS:000456017000018
J	Koushyar, H; Bieryla, KA; Nussbaum, MA; Madigan, ML				Koushyar, Hoda; Bieryla, Kathleen A.; Nussbaum, Maury A.; Madigan, Michael L.			Age-related strength loss affects non-stepping balance recovery	PLOS ONE			English	Article							JOINT ANGLE; ANKLE; MECHANISMS; STRATEGIES; TORQUE	Aging is associated with a higher risk of falls, and an impaired ability to recover balance after a postural perturbation is an important contributing factor. In turn, this impaired recovery ability likely stems from age-related decrements in lower limb strength. The purpose of this study was to investigate the effects of age-related strength loss on non-stepping balance recovery capability after a perturbation while standing, without constraining movements to the ankle as in prior reports. Two experiments were conducted. In the first, five young adults (ages 20-30) and six community-dwelling older adults (ages 70-80) recovered their balance, without stepping, from a backward displacement of a support surface. Balance recovery capability was quantified as the maximal backward platform displacement that a subject could withstand without stepping. The maximal platform displacement was 27% smaller among the older group (11.8 +/- 2.1 cm) vs. the young group (16.2 +/- 2.6 cm). In the second experiment, forward dynamic simulations of a two-segment, rigid-body model were used to investigate the effects of manipulating strength in the hip extensors/flexors and ankle plantar flexors/dorsiflexors. In these, typical age-related reductions in strength were included. The model predicted lower maximal platform displacements with age-related reductions only in plantar flexion and hip flexion strength. These findings support the previously reported age-related loss of balance recovery ability, and an important role for plantar flexor strength in this ability.	[Koushyar, Hoda] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA USA; [Bieryla, Kathleen A.] Univ Portland, Dept Mech & Biomed Engn, Portland, OR 97203 USA; [Nussbaum, Maury A.; Madigan, Michael L.] Virginia Tech, Dept Ind & Syst Engn, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; University of Portland; Virginia Polytechnic Institute & State University	Madigan, ML (corresponding author), Virginia Tech, Dept Ind & Syst Engn, Blacksburg, VA 24061 USA.	mlm@vt.edu	Nussbaum, Maury A/A-9655-2008	Nussbaum, Maury A/0000-0002-1887-8431	Centers for Disease Control and Prevention (CDC) [R01OH009880]	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by award R01OH009880 from the Centers for Disease Control and Prevention (CDC). The contents of this paper are solely the responsibility of the authors, and do not necessarily represent the official views of CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DE, 2007, J BIOMECH, V40, P3105, DOI 10.1016/j.jbiomech.2007.03.022; Ashby BM, 2006, J BIOMECH, V39, P1726, DOI 10.1016/j.jbiomech.2005.04.017; Barrett RS, 2008, J THEOR BIOL, V254, P546, DOI 10.1016/j.jtbi.2008.06.018; Cheng KYB, 2008, J BIOMECH, V41, P1847, DOI 10.1016/j.jbiomech.2008.04.004; de Leva P, 1996, J BIOMECH, V29, P1231, DOI 10.1016/0021-9290(96)00021-8; Harbo T, 2012, EUR J APPL PHYSIOL, V112, P267, DOI 10.1007/s00421-011-1975-3; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Horlings CGC, 2009, NEUROSCIENCE, V164, P1876, DOI 10.1016/j.neuroscience.2009.09.063; KUO AD, 1993, J BIOMECH, V26, P137, DOI 10.1016/0021-9290(93)90085-S; Liu W, 2003, NEUROSCI LETT, V336, P1, DOI 10.1016/S0304-3940(02)01215-6; Mackey DC, 2006, GAIT POSTURE, V23, P59, DOI 10.1016/j.gaitpost.2004.11.009; MANCHESTER D, 1989, J GERONTOL, V44, pM118; Mansfield A, 2009, J BIOMECH, V42, P1023, DOI 10.1016/j.jbiomech.2009.02.007; Matrangola SL, 2011, HUM MOVEMENT SCI, V30, P584, DOI 10.1016/j.humov.2010.11.007; Matrangola SL, 2009, MED SCI SPORT EXER, V41, P1488, DOI 10.1249/MSS.0b013e31819bd4bd; Riener R, 1999, J BIOMECH, V32, P539, DOI 10.1016/S0021-9290(99)00009-3; Robinovitch SN, 2002, J NEUROPHYSIOL, V88, P613, DOI 10.1152/jn.2002.88.2.613; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Runge CF, 1999, GAIT POSTURE, V10, P161, DOI 10.1016/S0966-6362(99)00032-6; Selbie WS, 1996, J BIOMECH, V29, P1137, DOI 10.1016/0021-9290(96)00030-9; Simoneau E, 2007, J ELECTROMYOGR KINES, V17, P307, DOI 10.1016/j.jelekin.2006.04.005; Vincent G, 2010, NEXT 4 DECADES OLDER, P25; WOOLLACOTT MH, 1993, J GERONTOL, V48, P56, DOI 10.1093/geronj/48.Special_Issue.56; Yang F, 2008, J BIOMECH, V41, P1823, DOI 10.1016/j.jbiomech.2008.04.005; Yeadon MR, 2002, J APPL BIOMECHANICS, V18	25	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210049	10.1371/journal.pone.0210049	http://dx.doi.org/10.1371/journal.pone.0210049			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657760	gold, Green Submitted, Green Published			2022-12-26	WOS:000456017000006
J	Yogalingam, G; Luu, AR; Prill, H; Lo, MJ; Yip, B; Holtzinger, J; Christianson, T; Aoyagi-Scharber, M; Lawrence, R; Crawford, BE; LeBowitz, JH				Yogalingam, Gouri; Luu, Amanda R.; Prill, Heather; Lo, Melanie J.; Yip, Bryan; Holtzinger, John; Christianson, Terri; Aoyagi-Scharber, Mika; Lawrence, Roger; Crawford, Brett E.; LeBowitz, Jonathan H.			BMN 250, a fusion of lysosomal alpha-N-acetylglucosaminidase with IGF2, exhibits different patterns of cellular uptake into critical cell types of Sanfilippo syndrome B disease pathogenesis	PLOS ONE			English	Article							MUCOPOLYSACCHARIDOSIS TYPE VI; HEPARAN-SULFATE; CLEARANCE; DELIVERY; STORAGE; MODEL; IIIB	Sanfilippo syndrome type B (Sanfilippo B; Mucopolysaccharidosis type IIIB) occurs due to genetic deficiency of lysosomal alpha-N-acetylglucosaminidase (NAGLU) and subsequent lysosomal accumulation of heparan sulfate (HS), which coincides with devastating neurodegenerative disease. Because NAGLU expressed in Chinese hamster ovary cells is not mannose-6-phosphorylated, we developed an insulin-like growth factor 2 (IGF2)-tagged NAGLU molecule (BMN 250; tralesinidase alfa) that binds avidly to the IGF2 / cation-independent mannose 6-phosphate receptor (CI-MPR) for glycosylation independent lysosomal targeting. BMN 250 is currently being developed as an investigational enzyme replacement therapy for Sanfilippo B. Here we distinguish two cellular uptake mechanisms by which BMN 250 is targeted to lysosomes. In normal rodent-derived neurons and astrocytes, the majority of BMN250 uptake over 24 hours reaches saturation, which can be competitively inhibited with IGF2, suggestive of CI-MPR-mediated uptake. K-uptake, defined as the concentration of enzyme at half-maximal uptake, is 5 nM and 3 nM in neurons and astrocytes, with a maximal uptake capacity (V-max) corresponding to 764 nmol/hr/mg and 5380 nmol/hr/mg, respectively. Similar to neurons and astrocytes, BMN 250 uptake in Sanfilippo B patient fibroblasts is predominantly CI-MPR-mediated, resulting in augmentation of NAGLU activity with doses of enzyme that fall well below the K-uptake (5 nM), which are sufficient to prevent HS accumulation. In contrast, uptake of the untagged recombinant human NAGLU (rhNAGLU) enzyme in neurons, astrocytes and fibroblasts is negligible at the same doses tested. In microglia, receptor-independent uptake, defined as enzyme uptake resistant to competition with excess IGF2, results in appreciable lysosomal delivery of BMN 250 and rhNAGLU (V-max = 12,336 nmol/hr/mg and 5469 nmol/hr/mg, respectively). These results suggest that while receptor-independent mechanisms exist for lysosomal targeting of rhNAGLU in microglia, BMN 250, by its IGF2 tag moiety, confers increased CI-MPR-mediated lysosomal targeting to neurons and astrocytes, two additional critical cell types of Sanfilippo B disease pathogenesis.	[Yogalingam, Gouri; Luu, Amanda R.; Prill, Heather; Lo, Melanie J.; Yip, Bryan; Holtzinger, John; Christianson, Terri; Aoyagi-Scharber, Mika; Lawrence, Roger; Crawford, Brett E.; LeBowitz, Jonathan H.] BioMarin Pharmaceut Inc, Res, Novato, CA 94949 USA	BioMarin Pharmaceutical Inc.	Yogalingam, G (corresponding author), BioMarin Pharmaceut Inc, Res, Novato, CA 94949 USA.	gyogalingam@bmrn.com		Crawford, Brett/0000-0002-7811-4564				Andrade F, 2015, PEDIATR INT, V57, P331, DOI 10.1111/ped.12636; Aoyagi-Scharber M, 2017, MOL THER-METH CLIN D, V6, P43, DOI 10.1016/j.omtm.2017.05.009; Archer LD, 2014, J INHERIT METAB DIS, V37, P1, DOI 10.1007/s10545-013-9613-3; Christianson HC, 2014, MATRIX BIOL, V35, P51, DOI 10.1016/j.matbio.2013.10.004; Clark WT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200008; CONZELMANN E, 1984, DEV NEUROSCI-BASEL, V6, P58, DOI 10.1159/000112332; Crawley AC, 1998, J CLIN INVEST, V101, P109, DOI 10.1172/JCI935; Ellinwood NM, 2018, MOL GENET METAB, V123, pS42, DOI 10.1016/j.ymgme.2017.12.091; Kan S, 2014, P NATL ACAD SCI USA, V111, P14870, DOI 10.1073/pnas.1416660111; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Lawrence R, 2012, NAT CHEM BIOL, V8, P197, DOI 10.1038/nchembio.766; LeBowitz JH, 2004, P NATL ACAD SCI USA, V101, P3083, DOI 10.1073/pnas.0308728100; Li HH, 2002, J NEUROSCI RES, V69, P30, DOI 10.1002/jnr.10278; Maga JA, 2013, J BIOL CHEM, V288, P1428, DOI 10.1074/jbc.M112.438663; Mulloy B, 2006, BIOCHEM SOC T, V34, P409, DOI 10.1042/BST0340409; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Ohmi K, 2009, P NATL ACAD SCI USA, V106, P8332, DOI 10.1073/pnas.0903223106; Poswar F, 2017, EXPERT OPIN INV DRUG, V26, P1331, DOI 10.1080/13543784.2017.1397130; Prill H., RAPID EFFICIEN UNPUB; Yogalingam G, 1998, J BIOL CHEM, V273, P13421, DOI 10.1074/jbc.273.22.13421; Yogalingam G, 2000, BBA-MOL BASIS DIS, V1502, P415, DOI 10.1016/S0925-4439(00)00066-1; Yogalingam G, 2001, HUM MUTAT, V18, P264, DOI 10.1002/humu.1189; Zhao KW, 2000, PROTEIN EXPRES PURIF, V19, P202, DOI 10.1006/prep.2000.1230	25	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0207836	10.1371/journal.pone.0207836	http://dx.doi.org/10.1371/journal.pone.0207836			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657762	Green Published, Green Submitted, gold			2022-12-26	WOS:000456017000004
J	Garcia-Heras, MS; Arroyo, B; Mougeot, F; Bildstein, K; Therrien, JF; Simmons, RE				Garcia-Heras, Marie-Sophie; Arroyo, Beatriz; Mougeot, Francois; Bildstein, Keith; Therrien, Jean-Francois; Simmons, Robert E.			Migratory patterns and settlement areas revealed by remote sensing in an endangered intra-African migrant, the Black Harrier (Circus maurus)	PLOS ONE			English	Article							SOUTH-AFRICA; HOME-RANGE; SATELLITE-TRACKING; BREEDING DISPERSAL; PRAIRIE FALCONS; HABITAT; MOVEMENTS; SURVIVAL; FLEXIBILITY; POPULATION	Annual movements have been widely described for birds migrating across the Americas and between Eurasia and Africa, yet relatively little information exists for intra-African migrants. Identifying the areas used throughout a species annual cycle by understanding migratory patterns and settlement areas during breeding and non-breeding seasons is essential for conservation initiatives. Here, we describe for the first time, the migratory patterns and settlement areas of an endangered raptor endemic to Southern Africa, the Black Harrier (Circus maurus). From 2008 to 2015, thirteen breeding adult Black Harriers were trapped in south-western South Africa and fitted either with a GPS-GSM or with a PTT tracker device. Adults were monitored for 365 +/- 198 days (range: 56-819 days) revealing great individual variability in annual movements. Most Black Harriers performed an unusual West-East migration from their breeding areas, but routes of all migrating individuals covered the entire southern land area of South Africa and Lesotho. The distance travelled averaged 814 +/- 324 km, but unlike many other species, migrants travelled faster during post-breeding (i.e. austral summer) (207.8 +/- 113.2 km.day(-1)) than during pre-breeding (i.e. austral winter/spring) migrations (143.8 +/- 32.2 km.day(-1)). Although most marked individuals displayed movements similar to those that bred following pre-breeding migrations, only two of thirteen were confirmed as breeders the year after being tagged. This suggests that individuals may sometimes take a sabbatical year in reproduction, although this requires confirmation. Most tagged birds died on migration or during the non-breeding season. Adults frequently returned to the same non-breeding settlement areas, and often used up to 3 different locations an average of about 200 km apart. On the other hand, there was wide variation in distance between subsequent reproductive events. We discuss the implications of our study for the conservation of Black Harriers and more broadly for intra-African bird migrants.	[Garcia-Heras, Marie-Sophie] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA; [Garcia-Heras, Marie-Sophie; Simmons, Robert E.] Univ Cape Town, DST NRF Ctr Excellence, FitzPatrick Inst African Ornithol, Cape Town, South Africa; [Arroyo, Beatriz; Mougeot, Francois] UCLM, CSIC, JCCM, Inst Invest Recursos Cineget IREC, Ciudad Real, Spain; [Bildstein, Keith; Therrien, Jean-Francois] Acopian Ctr Conservat Learning, Hawk Mt Sanctuary, Orwigsburg, PA USA	Oregon State University; National Research Foundation - South Africa; University of Cape Town; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha	Garcia-Heras, MS (corresponding author), Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA.; Garcia-Heras, MS (corresponding author), Univ Cape Town, DST NRF Ctr Excellence, FitzPatrick Inst African Ornithol, Cape Town, South Africa.	ms.garciaheras@oregonstate.edu	Mougeot, Francois/Y-9569-2019; Arroyo, Beatriz/A-3504-2013; Simmons, Robert E/AAE-3915-2020	Mougeot, Francois/0000-0002-5819-6275; Arroyo, Beatriz/0000-0002-4657-6609; Garcia-Heras, Marie-Sophie/0000-0002-3460-5484; Simmons, Robert/0000-0003-4964-8126	National Research Foundation of South Africa [90582]; DST-NRF Centre of Excellence at the Percy FitzPatrick Institute (University of Cape Town); Consejo Superior de Investigaciones Cientificas [PIE 201330E106]; Hawk Mountain Sanctuary (USA); BirdLife South Africa, Inkwazi and Wits Bird Club; Jakkalsfontein Private Nature Reserve; Two Oceans Slope Soarers (TOSS); Natural Research UK; Peregrine Fund; UCT	National Research Foundation of South Africa(National Research Foundation - South Africa); DST-NRF Centre of Excellence at the Percy FitzPatrick Institute (University of Cape Town)(Department of Science & Technology (India)); Consejo Superior de Investigaciones Cientificas; Hawk Mountain Sanctuary (USA); BirdLife South Africa, Inkwazi and Wits Bird Club; Jakkalsfontein Private Nature Reserve; Two Oceans Slope Soarers (TOSS); Natural Research UK; Peregrine Fund; UCT	This study was supported financially by the National Research Foundation of South Africa (Grant no. 90582 to RES), the DST-NRF Centre of Excellence at the Percy FitzPatrick Institute (University of Cape Town), CoE 2014 PhD bursary to M.S.G.H. through G. Cummings, the Consejo Superior de Investigaciones Cientificas (PIE 201330E106 to BA), and private landowners and organizations. Particular thanks for economic support are due to Hawk Mountain Sanctuary (USA), to "Golden Fleece Merino", BirdLife South Africa, Inkwazi and Wits Bird Club, Jakkalsfontein Private Nature Reserve, the Two Oceans Slope Soarers (TOSS), Natural Research UK, the Peregrine Fund, Sven Carlsson-Smith, Nial Perrins, Chris Cory, Gisela Ortner and James Smith. FM and BA thank UCT for financial support (2015 Science Faculty Distinguished Visitor award to FM; and Foreign Research Fellowship to BA).	Alerstam T, 2006, ANIM BEHAV, V71, P555, DOI 10.1016/j.anbehav.2005.05.016; Arroyo B, 2014, BIRD STUDY, V61, P48, DOI 10.1080/00063657.2013.874976; Arroyo BE, 2007, IBIS, V149, P806, DOI 10.1111/j.1474-919X.2007.00716.x; Bates D., 2012, IME4 LINEAR MIXED EF; Berthold P., 2001, OXFORD ORNITHOLOGY S, V12; Bildstein K. L., 2006, MIGRATING RAPTORS WO; Bivand R, 2014, RDAL BINDINGS GEOSPA; Bosch R, 2010, IBIS, V152, P105, DOI 10.1111/j.1474-919X.2009.00985.x; Calenge C., 2011, HOME RANGE ESTIMATIO; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Curtis O, 2004, BIRD CONSERV INT, V14, P233, DOI 10.1017/S0959270904000310; Curtis O, 2005, THESIS; del Hoyo J., 1992, P1; Dodge S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0195; DOLMAN PM, 1995, IBIS, V137, pS38, DOI 10.1111/j.1474-919X.1995.tb08456.x; Fuchs J, 2014, IBIS, V156, P227, DOI 10.1111/ibi.12103; Garbett R, 2018, SCI TOTAL ENVIRON, V630, P1654, DOI 10.1016/j.scitotenv.2018.02.220; Garcia-Heras M- S, 2017, THESIS; Garcia-Heras MS, 2018, ENVIRON POLLUT, V232, P440, DOI 10.1016/j.envpol.2017.09.059; Garcia-Heras MS, 2017, SCI TOTAL ENVIRON, V603, P299, DOI 10.1016/j.scitotenv.2017.06.048; Garcia-Heras MS, 2017, IBIS, V159, P567, DOI 10.1111/ibi.12478; Garcia-Heras MS, 2017, OSTRICH, V88, P1, DOI 10.2989/00306525.2016.1257515; Garcia-Heras MS, 2016, NAT CONSERV-BULGARIA, P23, DOI 10.3897/natureconservation.15.9800; Gschweng M, 2008, P ROY SOC B-BIOL SCI, V275, P2887, DOI 10.1098/rspb.2008.0575; Gunnarsson TG, 2005, P ROY SOC B-BIOL SCI, V272, P2319, DOI 10.1098/rspb.2005.3214; Hays GC, 2001, ANIM BEHAV, V61, P1035, DOI 10.1006/anbe.2001.1685; Kenward RE, 2001, ECOLOGY, V82, P1905, DOI 10.2307/2680056; Klaassen RHG, 2014, J ANIM ECOL, V83, P176, DOI 10.1111/1365-2656.12135; Klaassen RHG, 2011, P ROY SOC B-BIOL SCI, V278, P1339, DOI 10.1098/rspb.2010.2106; Kruger AC, 2010, STRONG WIND CLIMATIC, V13; Liminana R, 2007, J ORNITHOL, V148, P517, DOI 10.1007/s10336-007-0182-9; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; McGrady MJ, 2002, CONDOR, V104, P39, DOI 10.1650/0010-5422(2002)104[0039:MAROPF]2.0.CO;2; Mellone U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039833; Meyburg Bernd-U., 2007, P242; Meyburg BU, 1995, OSTRICH, V66, P135, DOI 10.1080/00306525.1995.9632720; Meynard CN, 2012, ECOL EVOL, V2, P1008, DOI 10.1002/ece3.219; Mokotjomela T, 2010, AFR ZOOL, V45, P225, DOI 10.3377/004.045.0201; Monti F, 2018, MIGRATION WINTERING, V4, P554; Mucina L., 2006, VEGETATION S AFRICA; Nater CR, 2016, OIKOS, V125, P1838, DOI 10.1111/oik.03384; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Newton I., 1979, POPULATION ECOLOGY R; Newton I, 2006, ARDEA, V94, P433; Norris DR, 2004, P ROY SOC B-BIOL SCI, V271, P59, DOI 10.1098/rspb.2003.2569; Ogada D, 2016, CONSERV LETT, V9, P89, DOI 10.1111/conl.12182; Paijmans DM, 2017, OSTRICH, V88, P163, DOI 10.2989/00306525.2017.1337051; PEACH W, 1991, IBIS, V133, P300, DOI 10.1111/j.1474-919X.1991.tb04573.x; Peery MZ, 2000, AUK, V117, P511, DOI 10.1642/0004-8038(2000)117[0511:FAIVIH]2.0.CO;2; PERRIN MR, 1981, S AFR J ZOOL, V16, P248; QGIS Development Team, 2015, QGIS GEOGR INF SYST; Reid T, 2015, J APPL ECOL, V52, P881, DOI 10.1111/1365-2664.12468; Robillard A, 2018, J AVIAN BIOL, V49, DOI 10.1111/jav.01707; Robinson WD, 2010, FRONT ECOL ENVIRON, V8, P354, DOI 10.1890/080179; Rodriguez-Riuz J, 2018, BIRD CONSERVATION IN; Rymer TL, 2013, SUSTAINABILITY-BASEL, V5, P163, DOI 10.3390/su5010163; Schlaich AE, 2016, J ANIM ECOL, V85, P1491, DOI 10.1111/1365-2656.12583; Schradin C, 2004, J COMP PSYCHOL, V118, P37, DOI 10.1037/0735-7036.118.1.37; Simmons R. E., 2000, HARRIERS WORLD THEIR; Simmons R. E., 2015, BIRDS WATCH NAMIBIA; Simmons RE, 1997, BEHAV ECOL, V8, P544, DOI 10.1093/beheco/8.5.544; Steenhof K, 2005, CONDOR, V107, P481, DOI 10.1650/0010-5422(2005)107[0481:LMABDO]2.0.CO;2; Steenhof K, 2006, WILDLIFE SOC B, V34, P116, DOI 10.2193/0091-7648(2006)34[116:EOROPF]2.0.CO;2; Szep T, 2006, J ORNITHOL, V147, P245, DOI 10.1007/s10336-006-0060-x; Tarboton WR, 1984, STATUS CONSERVATION; Taylor M., 2015, 2015 ESKOM RED DATA, P125; Terraube J, 2012, BIODIVERS CONSERV, V21, P1835, DOI 10.1007/s10531-012-0282-6; Terraube J, 2012, DIVERS DISTRIB, V18, P401, DOI 10.1111/j.1472-4642.2011.00830.x; Terraube J., 2011, THESIS; The R foundation for statistical computing, 2015, R FDN STAT COMP WOOD; Therrien JF, 2014, J AVIAN BIOL, V45, P536, DOI 10.1111/jav.00426; Thiollay JM, 2006, IBIS, V148, P240, DOI 10.1111/j.1474-919X.2006.00531.x; Trierweiler C, 2010, THESIS; Trierweiler C, 2013, J ANIM ECOL, V82, P107, DOI 10.1111/j.1365-2656.2012.02036.x; Underhill L.G., 2016, BIODIVERS OBS, V7, P1, DOI DOI 10.1080/09766901.2016.11884754; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; WORTON BJ, 1995, J WILDLIFE MANAGE, V59, P794, DOI 10.2307/3801959	78	6	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210756	10.1371/journal.pone.0210756	http://dx.doi.org/10.1371/journal.pone.0210756			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653592	Green Submitted, Green Published, gold			2022-12-26	WOS:000456015500066
J	Tomiyama, T; Goto, K; Tanaka, Y; Maruta, T; Ogawa, T; Sawa, Y; Ito, T; Ishikawa, T				Tomiyama, Takuya; Goto, Kyo; Tanaka, Yuji; Maruta, Takanori; Ogawa, Takahisa; Sawa, Yoshihiro; Ito, Takuro; Ishikawa, Takahiro			A major isoform of mitochondrial trans-2-enoyl-CoA reductase is dispensable for wax ester production in Euglena gracilis under anaerobic conditions	PLOS ONE			English	Article							FATTY-ACID SYNTHETASES; FERMENTATION; PURIFICATION	Under anaerobic conditions, Euglena gracilis produces a large amount of wax ester through mitochondrial fatty acid synthesis from storage polysaccharides termed paramylon, to generate ATP. Trans-2-enoyl-CoA reductases (TERs) in mitochondria have been considered to play a key role in this process, because the enzymes catalyze the reduction of short chain length CoA-substrates (such as crotonyl-CoA). A TER enzyme (EgTER1) has been previously identified and enzymologically characterized; however, its physiological significance remained to be evaluated by genetic analysis. We herein generated EgTER1-knockdown Euglena cells, in which total crotonyl-CoA reductase activity was decreased to 10% of control value. Notably, the knockdown cells showed a severe bleaching phenotype with deficiencies in chlorophylls and glycolipids, but grew normally under heterotrophic conditions (with glucose supplementation). Moreover, the knockdown cells accumulated much greater quantities of wax ester than control cells before and after transfer to anaerobic conditions, which was accompanied by a large metabolomic change. Furthermore, we failed to find any contribution of other potential TER genes in wax ester production. Our findings propose a novel role of EgTER1 in the greening process and demonstrate that this enzyme is dispensable for wax ester production under anaerobic conditions.	[Tomiyama, Takuya; Goto, Kyo; Tanaka, Yuji; Maruta, Takanori; Ogawa, Takahisa; Sawa, Yoshihiro; Ishikawa, Takahiro] Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane, Japan; [Tanaka, Yuji; Maruta, Takanori; Ogawa, Takahisa; Ishikawa, Takahiro] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo, Japan; [Ito, Takuro] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Ito, Takuro] Keio Univ, Grad Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa, Japan	Shimane University; Japan Science & Technology Agency (JST); Keio University; Keio University	Ishikawa, T (corresponding author), Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane, Japan.; Ishikawa, T (corresponding author), Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo, Japan.	ishikawa@life.shimane-u.ac.jp	Ishikawa, Takahiro/AAX-5792-2021; Sawa, Yoshihiro/F-8295-2017	Sawa, Yoshihiro/0000-0002-2379-470X; Maruta, Takanori/0000-0003-4144-7821; Ito, Takuro/0000-0001-5043-1886; Ishikawa, Takahiro/0000-0002-5834-2922	Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (JST)	Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This study was supported by the Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (JST) (YT, TM, TO, TI), http://www.jst.go.jp/presto/bioenergy/english/index.html.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Barras D. R., 1968, P149; Barsanti L, 2001, J APPL PHYCOL, V13, P59, DOI 10.1023/A:1008105416065; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; CRAMER M, 1952, ARCH MIKROBIOL, V17, P384, DOI 10.1007/BF00410835; DELO J, 1971, ARCH BIOCHEM BIOPHYS, V143, P384, DOI 10.1016/0003-9861(71)90225-6; Durnford DG, 2006, EUKARYOT CELL, V5, P2079, DOI 10.1128/EC.00222-06; ERNSTFONBERG ML, 1971, ARCH BIOCHEM BIOPHYS, V143, P392, DOI 10.1016/0003-9861(71)90226-8; HENDREN RW, 1980, J BIOL CHEM, V255, P1504; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Hoffmeister M, 2005, J BIOL CHEM, V280, P4329, DOI 10.1074/jbc.M411010200; Ikeda K, 2009, J CHROMATOGR B, V877, P2639, DOI 10.1016/j.jchromb.2009.03.047; INUI H, 1984, EUR J BIOCHEM, V142, P121, DOI 10.1111/j.1432-1033.1984.tb08258.x; INUI H, 1986, J BIOCHEM, V100, P995, DOI 10.1093/oxfordjournals.jbchem.a121813; INUI H, 1983, AGR BIOL CHEM TOKYO, V47, P2669, DOI 10.1080/00021369.1983.10866013; INUI H, 1982, FEBS LETT, V150, P89, DOI 10.1016/0014-5793(82)81310-0; Inui H, 2017, ADV EXP MED BIOL, V979, P269, DOI 10.1007/978-3-319-54910-1_13; Ito T, 2013, METABOLOMICS, V9, pS178, DOI 10.1007/s11306-012-0463-z; KISS JZ, 1988, PROTOPLASMA, V146, P150, DOI 10.1007/BF01405924; KOREN LE, 1967, J PROTOZOOL, VS 14, P17; Kuda T, 2009, J FUNCT FOODS, V1, P399, DOI 10.1016/j.jff.2009.08.003; Nakazawa M, 2018, FEBS LETT, V592, P4020, DOI 10.1002/1873-3468.13276; ODA Y, 1982, J GEN MICROBIOL, V128, P853; Soga T, 2009, ANAL CHEM, V81, P6165, DOI 10.1021/ac900675k; Sugimoto M, 2010, J AGR FOOD CHEM, V58, P374, DOI 10.1021/jf903680d; Tanaka Y, 2017, FEBS LETT, V591, P1360, DOI 10.1002/1873-3468.12659; Tomiyama T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14077-6; Winkler U, 2003, PLANT PHYSIOL, V131, P753, DOI 10.1104/pp.013151; Yoshida Y, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2540-6	29	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210755	10.1371/journal.pone.0210755	http://dx.doi.org/10.1371/journal.pone.0210755			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650145	Green Submitted, Green Published, gold			2022-12-26	WOS:000455813300076
J	Carrero, I; Liu, HC; Sikora, AG; Milosavljevic, A				Carrero, Ivenise; Liu, Hsuan-Chen; Sikora, Andrew G.; Milosavljevic, Aleksandar			Histoepigenetic analysis of HPV- and tobacco-associated head and neck cancer identifies both subtype-specific and common therapeutic targets despite divergent microenvironments	ONCOGENE			English	Article							SQUAMOUS-CELL CARCINOMA; DNA METHYLATION DATA; HUMAN-PAPILLOMAVIRUS; GENE-EXPRESSION; POSITIVE HEAD; SURVIVAL; GENOME; EPIDEMIOLOGY; SIGNATURE; MUTATION	Although head and neck squamous cell carcinoma (HNSCC) has in the past been largely associated with tobacco use, human papillomavirus (HPV+) oropharynx cancer has in recent years emerged as the fastest growing type of HNSCC. Patients with HPV+ HNSCC have a better prognosis; however, the 5-year survival for both HPV+ and HPV- subtypes with recurrent or metastatic disease is poor. To gain insights into the tumor microenvironments of both HNSCC subtypes and identify potential therapeutic targets, we performed epigenomic deconvolution on 580 HNSCC samples from the TCGA dataset. Deconvolution revealed distinct molecular and histoepigenetic profiles of the two tumor subtypes, including their cellular composition, epigenomic profiles and gene expression for constituent cell types, and potential cancer cell-specific targets. Our analyses show that high abundance of both CD8 T-cells and B-cells explains better prognosis in HPV+ HNSCC. Deconvolution of gene expression profiles revealed higher expression of the immunotherapy target PD-1 in HPV+ immune cells compared to HPV- cells, suggesting that HPV+ tumors may preferentially benefit from PD-1 targeted therapy. Further analyses identified HPV+ and HPV- cancer cell surface proteins that can also serve as potential targets for therapy. Specifically, Wnt pathway receptor ROR2 is preferentially overexpressed in HPV+ subtypes, suggesting opportunities for development of targeted therapy based on HPV status. In summary, the comprehensive molecular and histoepigenetic analysis of tumor microenvironments by epigenomic deconvolution reveals potential novel biomarkers and targets for precision therapy of HNSCC.	[Carrero, Ivenise; Milosavljevic, Aleksandar] Baylor Coll Med, Mol & Human Genet Dept, Houston, TX 77030 USA; [Carrero, Ivenise; Milosavljevic, Aleksandar] Baylor Coll Med, Epigenome Ctr, Houston, TX 77030 USA; [Liu, Hsuan-Chen] Baylor Coll Med, Translat Biol & Mol Med Program, Houston, TX 77030 USA; [Liu, Hsuan-Chen; Sikora, Andrew G.] Baylor Coll Med, Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA; [Milosavljevic, Aleksandar] Baylor Coll Med, Program Quantitat & Computat Biosci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Milosavljevic, A (corresponding author), Baylor Coll Med, Mol & Human Genet Dept, Houston, TX 77030 USA.; Milosavljevic, A (corresponding author), Baylor Coll Med, Epigenome Ctr, Houston, TX 77030 USA.; Sikora, AG (corresponding author), Baylor Coll Med, Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA.; Milosavljevic, A (corresponding author), Baylor Coll Med, Program Quantitat & Computat Biosci, Houston, TX 77030 USA.	Andrew.Sikora@bcm.edu; amilosav@bcm.edu		Liu, Hsuan-Chen/0000-0001-7857-0204	Common Fund of the National Institutes of Health (NIH) [5U54 DA036134]; Carolyn Weiss Law Foundation for Academic Excellence; Baylor College of Medicine Dan L. Duncan Cancer Center Pilot Grant; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA036134] Funding Source: NIH RePORTER	Common Fund of the National Institutes of Health (NIH); Carolyn Weiss Law Foundation for Academic Excellence; Baylor College of Medicine Dan L. Duncan Cancer Center Pilot Grant; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a grant from the Common Fund of the National Institutes of Health (NIH) (5U54 DA036134) (to A. M.), the Carolyn Weiss Law Foundation for Academic Excellence (to AS), and the Baylor College of Medicine Dan L. Duncan Cancer Center Pilot Grant (to AS).	Afghahi A, 2015, CANCER J, V21, P294, DOI 10.1097/PPO.0000000000000135; Ahmed S, 2015, BREAST CANCER-TOKYO, V22, P101, DOI 10.1007/s12282-015-0587-x; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Aran D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9971; Argiris A, 2009, CANCER-AM CANCER SOC, V115, P4504, DOI 10.1002/cncr.24528; Assenov Y, 2014, NAT METHODS, V11, P1138, DOI [10.1038/NMETH.3115, 10.1038/nmeth.3115]; Bausch-Fluck D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121314; Becht E, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1070-5; Becht E, 2016, ADV IMMUNOL, V130, P95, DOI 10.1016/bs.ai.2015.12.002; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Castiglioni P, 2005, EUR J IMMUNOL, V35, P1360, DOI 10.1002/eji.200425530; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Chen AX, 2016, INT J CLIN EXP PATHO, V9, P10981; Clements WM, 2002, CANCER RES, V62, P3503; Dalen AGD, 2003, INT J CANCER, V103, P768, DOI 10.1002/ijc.10903; Debey S, 2004, PHARMACOGENOMICS J, V4, P193, DOI 10.1038/sj.tpj.6500240; Esposti DD, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0419-z; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Ford CE, 2013, INT J CANCER, V133, P779, DOI 10.1002/ijc.27984; Forster MD, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00310; Ganguly KK, 2013, CELL ADHES MIGR, V7, P251, DOI 10.4161/cam.23840; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Gutman DA, 2013, J AM MED INFORM ASSN, V20, P1091, DOI 10.1136/amiajnl-2012-001469; Houseman EA, 2014, CANCER INFORM, V13, P53, DOI 10.4137/CIN.S13980; Houseman EA, 2014, BIOINFORMATICS, V30, P1431, DOI 10.1093/bioinformatics/btu029; Ishikawa N, 2007, CANCER RES, V67, P11601, DOI 10.1158/0008-5472.CAN-07-3243; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Knights Alexander J, 2012, Trends Cancer Res, V8, P61; Kong HK, 2012, J BIOL CHEM, V287, P38889, DOI 10.1074/jbc.M112.394270; Koshizuka K, 2018, ONCOTARGET, V9, P3663, DOI 10.18632/oncotarget.23194; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Li Y, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S5-S11; Litwin TR, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9080206; Lleras RA, 2013, CLIN CANCER RES, V19, P5444, DOI 10.1158/1078-0432.CCR-12-3280; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mandal R, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89829; McCormack PL, 2008, DRUGS, V68, P487, DOI 10.2165/00003495-200868040-00009; McKaig RG, 1998, HEAD NECK-J SCI SPEC, V20, P250, DOI 10.1002/(SICI)1097-0347(199805)20:3<250::AID-HED11>3.0.CO;2-O; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mroz Edmund A, 2016, World J Otorhinolaryngol Head Neck Surg, V2, P60, DOI 10.1016/j.wjorl.2016.05.007; Nulton TJ, 2017, ONCOTARGET, V8, P17684, DOI 10.18632/oncotarget.15179; Onuchic V, 2016, CELL REP, V17, P2075, DOI 10.1016/j.celrep.2016.10.057; Orentas RJ, 2012, FRONT ONCOL, V2, DOI [10.3389/FONC.2012.00194/ABSTRACT, DOI 10.3389/FONC.2012.00194/ABSTRACT]; Organization WH, 2014, REV CANC MED WHO LIS, P1; Ragin CCR, 2007, J DENT RES, V86, P104, DOI 10.1177/154405910708600202; Riaz N, 2014, GENES DIS, V1, P75, DOI 10.1016/j.gendis.2014.07.002; Rieke DT, 2016, ONCOL RES TREAT, V39, P780, DOI 10.1159/000452432; Sakamoto T, 2017, ORAL ONCOL, V69, P15, DOI 10.1016/j.oraloncology.2017.03.019; Seguin L, 2015, TRENDS CELL BIOL, V25, P234, DOI 10.1016/j.tcb.2014.12.006; Seiwert TY, 2015, CLIN CANCER RES, V21, P632, DOI 10.1158/1078-0432.CCR-13-3310; Smith EM, 2008, ORAL ONCOL, V44, P133, DOI 10.1016/j.oraloncology.2007.01.010; Snell LM, 2017, TRENDS IMMUNOL, V38, P542, DOI 10.1016/j.it.2017.05.005; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tagliamonte M, 2014, HUM VACC IMMUNOTHER, V10, P3332, DOI 10.4161/21645515.2014.973317; Tong CCL, 2012, IMMUNOL RES, V54, P266, DOI 10.1007/s12026-012-8306-6; Voloshanenko O, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20641-5; Wang B, 2015, GENET MOL RES, V14, P17406, DOI 10.4238/2015.December.21.10; Wang JP, 2015, ONCOTARGET, V6, P18162, DOI 10.18632/oncotarget.4216; Yearley JH, 2017, CLIN CANCER RES, V23, P3158, DOI 10.1158/1078-0432.CCR-16-1761; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304; Zhang YX, 2016, CLIN CANCER RES, V22, P4735, DOI 10.1158/1078-0432.CCR-16-0323	62	17	17	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 9	2019	38	19					3551	3568		10.1038/s41388-018-0659-4	http://dx.doi.org/10.1038/s41388-018-0659-4			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HX4OU	30655605	Green Published, hybrid			2022-12-26	WOS:000467379600001
J	Kumar, R; Njauw, CN; Reddy, BY; Ji, ZY; Rajadurai, A; Klebanov, N; Tsao, HS				Kumar, Raj; Njauw, Ching-Ni; Reddy, Bobby Y.; Ji, Zhenyu; Rajadurai, Anpuchchelvi; Klebanov, Nikolai; Tsao, Hensin			Growth suppression by dual BRAF(V600E) and NRAS(Q61) oncogene expression is mediated by SPRY4 in melanoma	ONCOGENE			English	Article							GENE-EXPRESSION; SINGLE-CELL; B-RAF; SENESCENCE; BRAF; RESISTANCE; PATHWAYS; MITF; INHIBITOR; MUTATIONS	The underlying forces that shape mutational patterns within any type of cancer have been poorly characterized. One of the best preserved exclusionary relationships is that between BRAF(V600E) and NRAS(Q61) in melanomas. To explore possible mechanisms which could explain this phenomenon, we overexpressed NRAS(Q61) in a set of BRAF(V600E) melanoma lines and vice versa. Controlled expression of a second activating oncogene led to growth arrest ("synthetic suppression") in a subset of cells, which was accompanied by cell cycle arrest and senescence in several melanoma cell lines along with apoptosis. Through differential gene expression analysis, we identified SPRY4 as the potential mediator of this synthetic response to dual oncogene suppression. Ectopic introduction of SPRY4 recapitulated the growth arrest phenotype of dual BRAF(V600E)/NRAS(Q61) expression while SPRY4 depletion led to a partial rescue from oncogenic antagonism. This study thus defined SPRY4 as a potential mediator of synthetic suppression, which is likely to contribute to the observed exclusivity between BRAF(V600E) and NRAS(Q61R) mutations in melanoma. Further leverage of the SPRY4 pathway may also hold therapeutic promise for NRAS(Q61) melanomas.	[Kumar, Raj; Njauw, Ching-Ni; Reddy, Bobby Y.; Ji, Zhenyu; Rajadurai, Anpuchchelvi; Klebanov, Nikolai; Tsao, Hensin] Harvard Med Sch, Dept Dermatol, Massachusetts Gen Hosp, Edwards 211 50 Blossom St, Boston, MA 02115 USA; [Kumar, Raj; Njauw, Ching-Ni; Reddy, Bobby Y.; Ji, Zhenyu; Rajadurai, Anpuchchelvi; Klebanov, Nikolai] Harvard Med Sch, Wellman Ctr Photomed, Massachusetts Gen Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Tsao, HS (corresponding author), Harvard Med Sch, Dept Dermatol, Massachusetts Gen Hosp, Edwards 211 50 Blossom St, Boston, MA 02115 USA.	htsao@partners.org			Melanoma Research Alliance; NIH [K24 CA149202]; CDMRP grant: Department of Defense [CA160385]; Massachusetts General Hospital; NATIONAL CANCER INSTITUTE [K24CA149202] Funding Source: NIH RePORTER	Melanoma Research Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CDMRP grant: Department of Defense(United States Department of Defense); Massachusetts General Hospital(General Electric); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. Jie Zhao, and technical assistants, Danian Cao, Jermaine Henderson and Neema Kumar for performing FACS, H&E and IHC staining (MGH). Technical Associate, Jennifer Love, for performing mRNA microarray (MIT). We thank the MGH-IACUC for animal care. This research was partially supported by grants from the Melanoma Research Alliance and NIH (K24 CA149202), CDMRP grant: Department of Defense CA160385 and by the generous donors at the Massachusetts General Hospital.	Alani RM, 2001, P NATL ACAD SCI USA, V98, P7812, DOI 10.1073/pnas.141235398; Beloribi-Djefaflia S, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.49; Bloethner S, 2005, CARCINOGENESIS, V26, P1224, DOI 10.1093/carcin/bgi066; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Freeman AK, 2013, MOL CELL, V49, P751, DOI 10.1016/j.molcel.2012.12.018; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Ji ZY, 2015, J INVEST DERMATOL, V135, P1863, DOI 10.1038/jid.2015.105; Kumar R, 2015, J INVEST DERMATOL, V135, P1089, DOI 10.1038/jid.2014.528; Lackner DH, 2014, AGING CELL, V13, P946, DOI 10.1111/acel.12234; Lu C, 2015, J INVEST DERMATOL, V135, P816, DOI 10.1038/jid.2014.425; Miao BC, 2015, CANCER DISCOV, V5, P274, DOI 10.1158/2159-8290.CD-14-0295; O'Neil NJ, 2017, NAT REV GENET, V18, P613, DOI 10.1038/nrg.2017.47; Opriessnig T, 2003, VET PATHOL, V40, P521, DOI 10.1354/vp.40-5-521; Pavey S, 2004, ONCOGENE, V23, P4060, DOI 10.1038/sj.onc.1207563; Petti C, 2006, CANCER RES, V66, P6503, DOI 10.1158/0008-5472.CAN-05-4671; Sasaki A, 2003, CELL CYCLE, V2, P281, DOI 10.4161/cc.2.4.418; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sensi M, 2006, ONCOGENE, V25, P3357, DOI 10.1038/sj.onc.1209379; Seo H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17591-9; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Stein GH, 1999, MOL CELL BIOL, V19, P2109; Tennis MA, 2010, MOL CANCER RES, V8, P833, DOI 10.1158/1541-7786.MCR-09-0400; Tsavachidou D, 2004, CANCER RES, V64, P5556, DOI 10.1158/0008-5472.CAN-04-1669; van Tuyn J, 2017, J INVEST DERMATOL, V137, P2197, DOI 10.1016/j.jid.2017.05.030; Vizioli MG, 2014, ONCOTARGET, V5, P8270, DOI 10.18632/oncotarget.2013; Wagatsuma A, 2005, J EXP BIOL, V208, P2389, DOI 10.1242/jeb.01625; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Xu YX, 2014, TRENDS BIOCHEM SCI, V39, P268, DOI 10.1016/j.tibs.2014.04.004; 2016, ONCOTARGET, V7, P7716, DOI DOI 10.18632/ONCOTARGET.12848	32	6	6	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 2	2019	38	18					3504	3520		10.1038/s41388-018-0632-2	http://dx.doi.org/10.1038/s41388-018-0632-2			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HW3RI	30651601	Green Published, hybrid			2022-12-26	WOS:000466610000013
J	Michael, ES; Covic, L; Kuliopulos, A				Michael, Emily S.; Covic, Lidija; Kuliopulos, Athan			Trace amine-associated receptor 1 (TAAR1) promotes anti-diabetic signaling in insulin-secreting cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; calcium; pancreas; G protein-coupled receptor (GPCR); insulin secretion	GLUCAGON-LIKE PEPTIDE-1; PROTEIN-KINASE; BETA-CELLS; ACTIVATION; GLUCOSE; CAMP; LISDEXAMFETAMINE; PROLIFERATION; AMPHETAMINE; DYSFUNCTION	Pancreatic -cell failure in type 2 diabetes mellitus is a serious challenge that results in an inability of the pancreas to produce sufficient insulin to properly regulate blood glucose levels. Trace amine-associated receptor 1 (TAAR1) is a G protein-coupled receptor expressed by -cells that has recently been proposed as a potential target for improving glycemic control and suppressing binge eating behaviors. We discovered that TAAR1 is coupled to G(s)-signaling pathways in insulin-secreting -cells to cause protein kinase A (PKA)/exchange protein activated by cAMP (Epac)-dependent release of insulin, activation of RAF proto-oncogene, Ser/Thr kinase (Raf)-mitogen-activated protein kinase (MAPK) signaling, induction of cAMP response element-binding protein (CREB)-insulin receptor substrate 2 (Irs-2), and increased -cell proliferation. Interestingly, TAAR1 triggered cAMP-mediated calcium influx and release from internal stores, both of which were required for activation of a MAPK cascade utilizing calmodulin-dependent protein kinase II (CaMKII), Raf, and MAPK/ERK kinase 1/2 (MEK1/2). Together, these data identify TAAR1/G(s)-mediated signaling pathways that promote insulin secretion, improved -cell function and proliferation, and highlight TAAR1 as a promising new target for improving -cell health in type 2 diabetes mellitus.	[Michael, Emily S.; Covic, Lidija; Kuliopulos, Athan] Tufts Univ, Sch Med, Dept Med,Sch Grad Biomed Sci Biochem, Ctr Hemostasis & Thrombosis Res,Tufts Med Ctr, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Kuliopulos, A (corresponding author), Box 7510,800 Washington St, Boston, MA 02111 USA.	athan.kuliopulos@tufts.edu			NIDDK, National Institutes of Health [DK101240]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R44DK101240] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded in whole or in part by NIDDK, National Institutes of Health Grant DK101240 (to A. K. and L. C.). Dr. Kuliopulos and Dr. Covic serve as scientific founders of Oasis Pharmaceuticals. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alenkvist I, 2017, DIABETES, V66, P2610, DOI 10.2337/db17-0050; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bradaia A, 2009, P NATL ACAD SCI USA, V106, P20081, DOI 10.1073/pnas.0906522106; Bunzow JR, 2001, MOL PHARMACOL, V60, P1181, DOI 10.1124/mol.60.6.1181; Chheda MG, 2001, NAT CELL BIOL, V3, P331, DOI 10.1038/35070000; Covic L, 2000, BIOCHEMISTRY-US, V39, P5458, DOI 10.1021/bi9927078; Drucker DJ, 2003, DIABETES CARE, V26, P2929, DOI 10.2337/diacare.26.10.2929; Duan LL, 2010, P NATL ACAD SCI USA, V107, P22314, DOI 10.1073/pnas.1016630108; Easom RA, 1999, DIABETES, V48, P675, DOI 10.2337/diabetes.48.4.675; Emery AC, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003993; Ferragud A, 2017, NEUROPSYCHOPHARMACOL, V42, P1458, DOI 10.1038/npp.2016.233; Foster LJ, 1998, BIOCHEMISTRY-US, V37, P11089, DOI 10.1021/bi980253t; FRODIN M, 1995, J BIOL CHEM, V270, P7882, DOI 10.1074/jbc.270.14.7882; Fu Z, 2010, ENDOCRINOLOGY, V151, P3026, DOI 10.1210/en.2009-1294; Galley G, 2016, ACS MED CHEM LETT, V7, P192, DOI 10.1021/acsmedchemlett.5b00449; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Ha TY, 2014, ARCH PHARM RES, V37, P671, DOI 10.1007/s12272-013-0209-0; Hermansen K, 2007, DRUG SAFETY, V30, P1127, DOI 10.2165/00002018-200730120-00005; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Illario M, 2003, J BIOL CHEM, V278, P45101, DOI 10.1074/jbc.M305355200; Jacobo SMP, 2009, J PHARMACOL EXP THER, V331, P724, DOI 10.1124/jpet.109.158519; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Khoo S, 1997, P NATL ACAD SCI USA, V94, P5599, DOI 10.1073/pnas.94.11.5599; Kubota N, 2004, J CLIN INVEST, V114, P917, DOI 10.1172/JCI200421484; Lang JC, 1999, EUR J BIOCHEM, V259, P3, DOI 10.1046/j.1432-1327.1999.00043.x; Lawrence M, 2008, ACTA PHYSIOL, V192, P11, DOI 10.1111/j.1748-1716.2007.01785.x; Lee YS, 2014, METABOLISM, V63, P9, DOI 10.1016/j.metabol.2013.09.010; Leech CA, 2010, ISLETS, V2, P72, DOI 10.4161/isl.2.2.10582; Luttrell LM, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat7650; McElroy SL, 2015, JAMA PSYCHIAT, V72, P235, DOI 10.1001/jamapsychiatry.2014.2162; Meece J, 2007, CURR MED RES OPIN, V23, P933, DOI 10.1185/030079906X167336; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; Michael ES, 2013, AM J PHYSIOL-GASTR L, V304, pG516, DOI 10.1152/ajpgi.00296.2012; Mohanty S, 2005, EXP CELL RES, V303, P68, DOI 10.1016/j.yexcr.2004.09.011; Nakagawa Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005106; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Panse M, 2015, CELL PHYSIOL BIOCHEM, V35, P1537, DOI 10.1159/000373969; PRENTKI M, 1987, FEBS LETT, V220, P103, DOI 10.1016/0014-5793(87)80884-0; Raab S, 2016, MOL METAB, V5, P47, DOI 10.1016/j.molmet.2015.09.015; Reese EA, 2007, J PHARMACOL EXP THER, V321, P178, DOI 10.1124/jpet.106.115402; Revel FG, 2013, MOL PSYCHIATR, V18, P543, DOI 10.1038/mp.2012.57; Revel FG, 2011, P NATL ACAD SCI USA, V108, P8485, DOI 10.1073/pnas.1103029108; Scanlan TS, 2009, ENDOCRINOLOGY, V150, P1108, DOI 10.1210/en.2008-1596; Sevigny LM, 2011, ARTERIOSCL THROM VAS, V31, pE100, DOI 10.1161/ATVBAHA.111.238261; Shearer AM, 2016, J BIOL CHEM, V291, P23188, DOI 10.1074/jbc.M116.732743; Tengholm A, 2012, UPSALA J MED SCI, V117, P355, DOI 10.3109/03009734.2012.724732; Trumper J, 2005, DIABETOLOGIA, V48, P1534, DOI 10.1007/s00125-005-1820-5; Vickers SP, 2015, J PSYCHOPHARMACOL, V29, P1290, DOI 10.1177/0269881115615107; Vuchak LA, 2009, MOL PHARMACOL, V76, P1123, DOI 10.1124/mol.109.060129; Ward K, 2018, EXPERT OPIN DRUG MET, V14, P229, DOI 10.1080/17425255.2018.1420163; WAUGH N, 2010, HEALTH TECHNOL ASSES, V14, P1; Yang HH, 2016, J MOL ENDOCRINOL, V57, pR93, DOI 10.1530/JME-15-0316; Zucchi R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00402	56	17	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4401	4411		10.1074/jbc.RA118.005464	http://dx.doi.org/10.1074/jbc.RA118.005464			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30670596	Green Published, hybrid			2022-12-26	WOS:000462969500010
J	Saleeb, RS; Kavanagh, DM; Dun, AR; Dalgarno, PA; Duncan, RR				Saleeb, Rebecca S.; Kavanagh, Deirdre M.; Dun, Alison R.; Dalgarno, Paul A.; Duncan, Rory R.			A VPS33A-binding motif on syntaxin 17 controls autophagy completion in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; SNARE proteins; imaging; fluorescence resonance energy transfer (FRET); membrane; syntaxin 17; FLIM-FRET; membrane trafficking; protein degradation; lysosome; phagosome; VPS33A	SNARE COMPLEXES; HOMOTYPIC FUSION; ENERGY-TRANSFER; PROTEIN VPS33; HOPS COMPLEX; BINDS; MATURATION; LYSOSOME; FEATURES; PLATFORM	Autophagy is an intracellular degradation pathway that transports cytoplasmic material to the lysosome for hydrolysis. It is completed by SNARE-mediated fusion of the autophagosome and endolysosome membranes. This process must be carefully regulated to maintain the organization of the membrane system and prevent mistargeted degradation. As yet, models of autophagosomal fusion have not been verified within a cellular context because of difficulties with assessing protein interactions in situ. Here, we used high-resolution fluorescence lifetime imaging (FLIM)-FRET of HeLa cells to identify protein interactions within the spatiotemporal framework of the cell. We show that autophagosomal syntaxin 17 (Stx17) heterotrimerizes with synaptosome-associated protein 29 (SNAP29) and vesicle-associated membrane protein 7 (VAMP7) in situ, highlighting a functional role for VAMP7 in autophagosome clearance that has previously been sidelined in favor of a role for VAMP8. Additionally, we identified multimodal regulation of SNARE assembly by the Sec1/Munc18 (SM) protein VPS33A, mirroring other syntaxin-SM interactions and therefore suggesting a unified model of SM regulation. Contrary to current theoretical models, we found that the Stx17 N-peptide appears to interact in a positionally conserved, but mechanistically divergent manner with VPS33A, providing a late go, no-go step for autophagic fusion via a phosphoserine master-switch. Our findings suggest that Stx17 fusion competency is regulated by a phosphosite in its N-peptide, representing a previously unknown regulatory step in mammalian autophagy.	[Saleeb, Rebecca S.; Kavanagh, Deirdre M.; Dun, Alison R.; Dalgarno, Paul A.; Duncan, Rory R.] Heriot Watt Univ, Sch Engn & Phys Sci, Edinburgh Super Resolut Imaging Consortium, Inst Biol Chem Biophys & Bioengn, Edinburgh EH14 4AS, Midlothian, Scotland; [Kavanagh, Deirdre M.] Univ Birmingham, Ctr Membrane Proteins & Receptors COMPARE, Birmingham B15 2TT, W Midlands, England	Heriot Watt University; University of Birmingham	Saleeb, RS (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, Charterhouse Sq, London EC1M 6BQ, England.; Duncan, RR (corresponding author), Heriot Watt Univ, Inst Biol Chem Biophys & Bioengn, Sch Engn & Phys Sci, Edinburgh EH14 4AS, Midlothian, Scotland.	r.saleeb@qmul.ac.uk; r.r.duncan@hw.ac.uk		Dalgarno, Paul/0000-0001-7701-373X; Duncan, Rory/0000-0003-0693-910X; Kavanagh, Deirdre/0000-0003-1531-6617	Medical Research Council [MR/K01563X/1]; MRC [G0901607, MR/K01563X/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Award MR/K01563X/1 (to R. R. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbe E., 1881, J ROYAL MICROSCOPICA, V1, P388, DOI DOI 10.1111/J.1365-2818.1881.TB05909.X; Akrap N, 2010, ANAL BIOCHEM, V402, P105, DOI 10.1016/j.ab.2010.03.026; Baker RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067409; Balderhaar HJK, 2013, J CELL SCI, V126, P1307, DOI 10.1242/jcs.107805; Bethani I, 2009, TRAFFIC, V10, P1543, DOI 10.1111/j.1600-0854.2009.00959.x; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Brandhorst D, 2006, P NATL ACAD SCI USA, V103, P2701, DOI 10.1073/pnas.0511138103; Brocker C, 2012, P NATL ACAD SCI USA, V109, P1991, DOI 10.1073/pnas.1117797109; Carlsson SR, 2015, J CELL SCI, V128, P193, DOI 10.1242/jcs.141036; Carpp LN, 2006, J CELL BIOL, V173, P927, DOI 10.1083/jcb.200512024; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Diao JJ, 2015, NATURE, V520, P563, DOI 10.1038/nature14147; Dikic I, 2018, NAT REV MOL CELL BIO, V19, P349, DOI 10.1038/s41580-018-0003-4; Dilcher M, 2001, J BIOL CHEM, V276, P34537, DOI 10.1074/jbc.M101551200; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Furuta N, 2010, MOL BIOL CELL, V21, P1001, DOI 10.1091/mbc.E09-08-0693; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; Graham SC, 2013, P NATL ACAD SCI USA, V110, P13345, DOI 10.1073/pnas.1307074110; Groenewoud MJ, 2013, BIOCHEM SOC T, V41, P951, DOI 10.1042/BST20130037; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Jiang P, 2014, MOL BIOL CELL, V25, P1327, DOI 10.1091/mbc.E13-08-0447; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kavanagh DM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6774; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Lobingier BT, 2012, MOL BIOL CELL, V23, P4611, DOI 10.1091/mbc.E12-05-0343; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Fader CM, 2009, BBA-MOL CELL RES, V1793, P1901, DOI 10.1016/j.bbamcr.2009.09.011; Martinez-Arca S, 2000, J CELL BIOL, V149, P889, DOI 10.1083/jcb.149.4.889; Matsui T, 2018, J CELL BIOL, V217, P2633, DOI 10.1083/jcb.201712058; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mauvezin C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8007; McLelland GL, 2016, J CELL BIOL, V214, P275, DOI 10.1083/jcb.201603105; Mertins P, 2014, MOL CELL PROTEOMICS, V13, P1690, DOI 10.1074/mcp.M113.036392; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023; Munson M, 2000, NAT STRUCT BIOL, V7, P894; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; Ossig R, 2000, EMBO J, V19, P6000, DOI 10.1093/emboj/19.22.6000; Pieren M, 2010, NAT STRUCT MOL BIOL, V17, P710, DOI 10.1038/nsmb.1809; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Rickman C, 2010, J BIOL CHEM, V285, P3965, DOI 10.1074/jbc.M109.040402; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Steegmaier M, 1998, J BIOL CHEM, V273, P34171, DOI 10.1074/jbc.273.51.34171; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Takats S, 2013, J CELL BIOL, V201, P531, DOI 10.1083/jcb.201211160; Uematsu M, 2017, AUTOPHAGY, V13, P1452, DOI 10.1080/15548627.2017.1327940; Vicidomini G, 2011, NAT METHODS, V8, P571, DOI [10.1038/NMETH.1624, 10.1038/nmeth.1624]; Xu H, 2010, EMBO J, V29, P1948, DOI 10.1038/emboj.2010.97	64	13	13	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4188	4201		10.1074/jbc.RA118.005947	http://dx.doi.org/10.1074/jbc.RA118.005947			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30655294	hybrid, Green Published			2022-12-26	WOS:000461854400030
J	Hoffmeister, H; Fuchs, A; Strobl, L; Sprenger, F; Grobner-Ferreira, R; Michaelis, S; Hoffmann, P; Nazet, J; Merkl, R; Langst, G				Hoffmeister, Helen; Fuchs, Andreas; Strobl, Laura; Sprenger, Frank; Groebner-Ferreira, Regina; Michaelis, Stefanie; Hoffmann, Petra; Nazet, Julian; Merkl, Rainer; Laengst, Gernot			Elucidation of the functional roles of the Q and I motifs in the human chromatin-remodeling enzyme BRG1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; chromatin remodeling; ATPase; nucleosome; tumor suppressor gene; ATP; cell proliferation; ATPase domain; BRG1; SF2 helicase family	SWI-SNF COMPLEX; ATP-HYDROLYSIS; RETINOBLASTOMA PROTEIN; TUMOR-SUPPRESSOR; DNA; BINDING; CYCLE; IDENTIFICATION; HELICASES; GROWTH	The Snf2 proteins, comprising 53 different enzymes in humans, belong to the SF2 family. Many Snf2 enzymes possess chromatin-remodeling activity, requiring a functional ATPase domain consisting of conserved motifs named Q and I-VII. These motifs form two recA-like domains, creating an ATP-binding pocket. Little is known about the function of the conserved motifs in chromatin-remodeling enzymes. Here, we characterized the function of the Q and I (Walker I) motifs in hBRG1 (SMARCA4). The motifs are in close proximity to the bound ATP, suggesting a role in nucleotide binding and/or hydrolysis. Unexpectedly, when substituting the conserved residues Gln(758) (Q motif) or Lys(785) (I motif) of both motifs, all variants still bound ATP and exhibited basal ATPase activity similar to that of wildtype BRG1 (wtBRG1). However, all mutants lost the nucleosome-dependent stimulation of the ATPase domain. Their chromatin-remodeling rates were impaired accordingly, but nucleosome binding was retained and still comparable with that of wtBRG1. Interestingly, a cancer-relevant substitution, L754F (Q motif), displayed defects similar to the Gln(758) variant(s), arguing for a comparable loss of function. Because we excluded a mutual interference of ATP and nucleosome binding, we postulate that both motifs stimulate the ATPase and chromatin-remodeling activities upon binding of BRG1 to nucleosomes, probably via allosteric mechanisms. Furthermore, mutations of both motifs similarly affect the enzymatic functionality of BRG1 in vitro and in living cells. Of note, in BRG1-deficient H1299 cells, exogenously expressed wtBRG1, but not BRG1 Q758A and BRG1 K785R, exhibited a tumor suppressor-like function.	[Hoffmeister, Helen; Fuchs, Andreas; Strobl, Laura; Groebner-Ferreira, Regina; Laengst, Gernot] Univ Regensburg, Dept Biochem 3, D-93053 Regensburg, Germany; [Nazet, Julian; Merkl, Rainer] Univ Regensburg, Dept Biochem 2, D-93053 Regensburg, Germany; [Sprenger, Frank] Univ Regensburg, Inst Biochem Genet & Microbiol, Cell Cycle Control, D-93053 Regensburg, Germany; [Michaelis, Stefanie] Univ Regensburg, Inst Analyt Chem Chemo & Biosensors, Fraunhofer Res Inst Microsyst & Solid State Techn, Fraunhofer Einrichtung Mikrosyst & Festkorper Tec, D-93053 Regensburg, Germany; [Hoffmann, Petra] Univ Regensburg, Cent FACS Facil, Regensburg Ctr Intervent Immunol, D-93053 Regensburg, Germany; [Hoffmann, Petra] Univ Hosp Regensburg, Dept Internal Med 3, D-93059 Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg	Hoffmeister, H; Langst, G (corresponding author), Univ Regensburg, Dept Biochem 3, D-93053 Regensburg, Germany.	Helen.Hoffmeister@vkl.uni-regensburg.de; Gernot.Laengst@vkl.uni-regensburg.de	Langst, Gernot/G-5287-2015; Merkl, Rainer/A-4534-2008	Langst, Gernot/0000-0002-8232-1179; Fuchs, Andreas/0000-0002-7230-4121; Merkl, Rainer/0000-0002-3521-2957	Die Bildung von Ribosomen, Grundlagen der RNP-Biogenese und Kontrolle ihrer Funktion of the Deutsche Forschungsgemeinschaf [SFB 960]	Die Bildung von Ribosomen, Grundlagen der RNP-Biogenese und Kontrolle ihrer Funktion of the Deutsche Forschungsgemeinschaf	This work was supported by Grant SFB 960 from Die Bildung von Ribosomen, Grundlagen der RNP-Biogenese und Kontrolle ihrer Funktion of the Deutsche Forschungsgemeinschaft. The authors declare that they have no conflicts of interest with the contents of this article.	Aalfs JD, 2001, J BIOL CHEM, V276, P34270, DOI 10.1074/jbc.M104163200; Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; ANDERSEN HC, 1980, J CHEM PHYS, V72, P2384, DOI 10.1063/1.439486; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bouazoune K, 2012, P NATL ACAD SCI USA, V109, P19238, DOI 10.1073/pnas.1213825109; Brahma S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15616; Breiling A, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0016-6; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Cordin O, 2004, EMBO J, V23, P2478, DOI 10.1038/sj.emboj.7600272; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; Ding H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140755; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Eustermann S, 2018, NATURE, V556, P386, DOI 10.1038/s41586-018-0029-y; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Fitzgerald DJ, 2004, EMBO J, V23, P3836, DOI 10.1038/sj.emboj.7600364; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Foster David A, 2010, Genes Cancer, V1, P1124, DOI 10.1177/1947601910392989; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; Hoffmeister H, 2017, NUCLEIC ACIDS RES, V45, P10534, DOI 10.1093/nar/gkx711; HUANG RCC, 1969, J MOL BIOL, V39, P365, DOI 10.1016/0022-2836(69)90323-4; Johnson TA, 2008, MOL BIOL CELL, V19, P3308, DOI 10.1091/mbc.E08-02-0123; Kang H, 2004, MOL CELL BIOL, V24, P1188, DOI 10.1128/MCB.24.3.1188-1199.2004; Khan I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113293; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Knudsen Erik S, 2003, Methods Mol Biol, V218, P3; Kovac K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04503-2; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Naidu SR, 2009, ONCOGENE, V28, P2492, DOI 10.1038/onc.2009.121; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Nongkhlaw M, 2012, BIOCHEMISTRY-US, V51, P3711, DOI 10.1021/bi2014757; Nongkhlaw M, 2009, NUCLEIC ACIDS RES, V37, P3332, DOI 10.1093/nar/gkp178; Phelan ML, 2000, MOL CELL BIOL, V20, P6380, DOI 10.1128/MCB.20.17.6380-6389.2000; Porter IM, 2004, CURR BIOL, V14, pR554, DOI 10.1016/j.cub.2004.07.009; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Reis T, 2004, CELL, V117, P253, DOI 10.1016/S0092-8674(04)00247-8; Reiter A, 2012, EMBO J, V31, P3480, DOI 10.1038/emboj.2012.185; Richmond E, 1996, NUCLEIC ACIDS RES, V24, P3685, DOI 10.1093/nar/24.19.3685; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rodriguez-Campos A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001182; Romero OA, 2012, EMBO MOL MED, V4, P603, DOI 10.1002/emmm.201200236; Shanahan F, 1999, MOL CELL BIOL, V19, P1460; Smith CL, 2005, MOL CELL BIOL, V25, P5880, DOI 10.1128/MCB.25.14.5880-5892.2005; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Tong YK, 1999, CHINESE SCI BULL, V44, P1157, DOI 10.1007/BF02885957; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; Wong AKC, 2000, CANCER RES, V60, P6171; Wu YL, 2012, J BIOL CHEM, V287, P21699, DOI 10.1074/jbc.M112.351338; Xie WB, 2012, P NATL ACAD SCI USA, V109, P8161, DOI 10.1073/pnas.1201262109; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Ye JQ, 2004, BBA-BIOENERGETICS, V1659, P1, DOI 10.1016/j.bbabio.2004.06.003	56	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3294	3310		10.1074/jbc.RA118.005685	http://dx.doi.org/10.1074/jbc.RA118.005685			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30647132	Green Published, hybrid			2022-12-26	WOS:000464980100026
J	Cho, YY; Kwon, OH; Park, MK; Kim, TW; Chung, S				Cho, Yoon Young; Kwon, Oh-Hoon; Park, Myoung Kyu; Kim, Tae-Wan; Chung, Sungkwon			Elevated cellular cholesterol in Familial Alzheimer's presenilin 1 mutation is associated with lipid raft localization of beta-amyloid precursor protein	PLOS ONE			English	Article							ACTIVE GAMMA-SECRETASE; MEMBRANE CHOLESTEROL; IN-VITRO; A-BETA; DISEASE; DETERGENT; DOMAIN; BRAIN; METABOLISM; PEPTIDES	Familial Alzheimer's disease (FAD)-associated presenilin 1 (PS1) serves as a catalytic subunit of.-secretase complex, which mediates the proteolytic liberation of beta-amyloid (A beta) from ss-amyloid precursor protein (APP). In addition to its proteolytic role, PS1 is involved in non-proteolytic functions such as protein trafficking and ion channel regulation. Furthermore, postmortem AD brains as well as AD patients showed dysregulation of cholesterol metabolism. Since cholesterol has been implicated in regulating A beta production, we investigated whether the FAD PS1-associated cholesterol elevation could influence APP processing. We found that in CHO cells stably expressing FAD-associated PS1.E9, total cholesterol levels are elevated compared to cells expressing wild-type PS1. We also found that localization of APP in cholesterol-enriched lipid rafts is substantially increased in the mutant cells. Reducing the cholesterol levels by either methyl-beta-cyclodextrin or an inhibitor of CYP51, an enzyme mediating the elevated cholesterol in PS1.E9-expressing cells, significantly reduced lipid raft-associated APP. In contrast, exogenous cholesterol increased lipid raftassociated APP. These data suggest that in the FAD PS1.E9 cells, the elevated cellular cholesterol level contributes to the altered APP processing by increasing APP localized in lipid rafts.	[Cho, Yoon Young; Kwon, Oh-Hoon; Park, Myoung Kyu; Chung, Sungkwon] Sungkyunkwan Univ, Sch Med, Dept Physiol, Suwon, South Korea; [Kim, Tae-Wan] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10027 USA; [Kim, Tae-Wan] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, Med Ctr, New York, NY 10027 USA	Sungkyunkwan University (SKKU); Columbia University; Columbia University	Chung, S (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Physiol, Suwon, South Korea.; Kim, TW (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10027 USA.; Kim, TW (corresponding author), Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, Med Ctr, New York, NY 10027 USA.	twk16@cumc.columbia.edu; schung@skku.edu	CHUNG, SUNGKWON/ABF-8293-2021	Chung, Sungkwon/0000-0003-0505-8773	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [2016R1D1A1A099]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2016R1D1A1A099) to SC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbor Sage C., 2016, Yale Journal of Biology and Medicine, V89, P5; Askarova S., 2011, INT J ALZHEIMERS DIS; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Beel AJ, 2008, BIOCHEMISTRY-US, V47, P9428, DOI 10.1021/bi800993c; Beel AJ, 2010, BBA-MOL CELL BIOL L, V1801, P975, DOI 10.1016/j.bbalip.2010.03.008; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Bergmans BA, 2010, LANCET NEUROL, V9, P215, DOI 10.1016/S1474-4422(09)70332-1; Bhattacharyya R, 2013, J NEUROSCI, V33, P11169, DOI 10.1523/JNEUROSCI.4704-12.2013; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Chamberlain LH, 2004, FEBS LETT, V559, P1, DOI 10.1016/S0014-5793(04)00050-X; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; Cossec JC, 2010, BBA-MOL CELL BIOL L, V1801, P846, DOI 10.1016/j.bbalip.2010.05.010; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Dislich B, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00008; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Duggan SP, 2016, CELL SIGNAL, V28, P1, DOI 10.1016/j.cellsig.2015.10.006; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fabelo N, 2014, NEUROBIOL AGING, V35, P1801, DOI 10.1016/j.neurobiolaging.2014.02.005; Fernandez MA, 2014, J BIOL CHEM, V289, P31043, DOI 10.1074/jbc.M114.581165; Grimm MOW, 2006, ACTA NEUROL SCAND, V114, P27, DOI 10.1111/j.1600-0404.2006.00682.x; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Hargrove TY, 2012, J LIPID RES, V53, P311, DOI 10.1194/jlr.M021865; Heverin M, 2004, J LIPID RES, V45, P186, DOI 10.1194/jlr.M300320-JLR200; Hicks DA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00189; Hur JY, 2008, FEBS J, V275, P1174, DOI 10.1111/j.1742-4658.2008.06278.x; Iwatsubo T, 2004, CURR OPIN NEUROBIOL, V14, P379, DOI 10.1016/j.conb.2004.05.010; JARVIK GP, 1995, NEUROLOGY, V45, P1092, DOI 10.1212/WNL.45.6.1092; Kang MS, 2013, J BIOL CHEM, V288, P20868, DOI 10.1074/jbc.M112.445734; Kosicek M, 2010, BIOCHEM BIOPH RES CO, V393, P404, DOI 10.1016/j.bbrc.2010.02.007; Landman N, 2006, P NATL ACAD SCI USA, V103, P19524, DOI 10.1073/pnas.0604954103; Lepesheva GI, 2007, BBA-GEN SUBJECTS, V1770, P467, DOI 10.1016/j.bbagen.2006.07.018; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Ludtmann MHR, 2014, J CELL SCI, V127, P1576, DOI 10.1242/jcs.140939; Marquer C, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-60; Marquer C, 2011, FASEB J, V25, P1295, DOI 10.1096/fj.10-168633; Maulik M, 2013, MOL NEUROBIOL, V47, P37, DOI 10.1007/s12035-012-8337-y; Nierzwicki L, 2015, J PHYS CHEM LETT, V6, P784, DOI 10.1021/acs.jpclett.5b00197; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Ostrom Rennolds S., 2007, V400, P459; Otto GP, 2016, J ALZHEIMERS DIS, V52, P1177, DOI 10.3233/JAD-150940; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Quintero-Monzon O, 2011, BIOCHEMISTRY-US, V50, P9023, DOI 10.1021/bi2007146; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Schneider A, 2006, NEUROBIOL DIS, V23, P573, DOI 10.1016/j.nbd.2006.04.015; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Song YL, 2013, BIOCHEMISTRY-US, V52, P5051, DOI 10.1021/bi400735x; Sot J, 2002, LANGMUIR, V18, P2828, DOI 10.1021/la011381c; Sun LF, 2017, P NATL ACAD SCI USA, V114, pE476, DOI 10.1073/pnas.1618657114; Tamboli IY, 2008, J NEUROSCI, V28, P12097, DOI 10.1523/JNEUROSCI.2635-08.2008; van Echten-Deckert G, 2012, PROG LIPID RES, V51, P378, DOI 10.1016/j.plipres.2012.07.001; Vanmierlo T, 2010, J ALZHEIMERS DIS, V19, P117, DOI 10.3233/JAD-2010-1209; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2010, BBA-MOL CELL BIOL L, V1801, P860, DOI 10.1016/j.bbalip.2010.03.007; Walter J, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-34; Xiong HQ, 2008, NEUROBIOL DIS, V29, P422, DOI 10.1016/j.nbd.2007.10.005	64	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210535	10.1371/journal.pone.0210535	http://dx.doi.org/10.1371/journal.pone.0210535			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682043	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500044
J	Durteste, M; Kyselyova, G; Volokha, A; Judd, A; Thorne, C; Cortina-Borja, M; Malyuta, R; Martsynovska, V; Nizova, N; Bailey, H; Baryshnikova, J; Kaleeva, T; Raus, I; Vihtyuk, N; Mostovenko, O; Kyselyova, G				Durteste, Marion; Kyselyova, Galyna; Volokha, Alla; Judd, Ali; Thorne, Claire; Cortina-Borja, Mario; Malyuta, Ruslan; Martsynovska, Violeta; Nizova, Nataliya; Bailey, Heather; Baryshnikova, Julia; Kaleeva, Tatyana; Raus, Irina; Vihtyuk, Natalia; Mostovenko, Olga; Kyselyova, Galyna		Study Young People Living HIV Ukra	Anxiety symptoms and felt stigma among young people living with perinatally or behaviourally-acquired HIV in Ukraine: A cross-sectional survey	PLOS ONE			English	Article							QUALITY-OF-LIFE; MEDICATION ADHERENCE; HOSPITAL ANXIETY; DRUG-USE; AUDIT-C; DEPRESSION; YOUTH; WOMEN; DISORDERS; CARE	Background Ukraine has the second largest European HIV epidemic. This study aimed to describe stigma, demographic and social factors and their association with anxiety among perinatally and behaviourally-HIV-infected (PHIV; BHIV) young people in Kiev and Odessa. Methods 104 PHIV and 100 BHIV young people aged 13-25 years completed a confidential tablet-based survey. Survey tools included the Hospital Anxiety and Depression Scale (HADS) (anxiety sub-scale scores of 8-10 indicating mild and >= 11 moderate/severe symptoms in last 7 days), Rosenberg Self-Esteem Scale (RSES) and HIV Stigma Scale (HSS) (short version, composite of disclosure, negative self-image and public attitudes sub-scales). Unadjusted Poisson regression models were fitted to explore factors associated with moderate/severe anxiety symptoms. Results PHIV and BHIV young people were of median age 15.5 [IQR 13.9-17.1] and 23.0 [21.0-24.3] years, having registered for HIV care a median 12.3 [10.3-14.4] and 0.9 [0.2-2.4] years previously; 97% (97/100) and 66% (65/99) respectively were on ART. Overall 43% (95% CI 36-50%) reported any and 13% (95% CI 9-19%) moderate/severe anxiety symptoms, with no difference by HIV acquisition mode (p = 0.405) or gender (p = 0.700). 42% (75/180) reported history of an emotional health problem for which they had not been referred/attended for care. Moderate/severe anxiety symptoms were associated with HIV-related stigma (prevalence ratio (PR) 1.24 95% CI 1.14-1.34 per HSS unit increase), lower self-esteem (PR 0.83 95% CI 0.78-0.90 per RSES point increase), CD4 <= 350 cells/mm(3) (PR 2.29 95% CI 1.06-4.97), having no-one at home who knew the respondent's HIV status (PR 9.15 95% CI 3.40-24.66 vs all know) and, among BHIV, less stable living situation (PR 6.83 95% CI 1.99-23.48 for >= 2 vs no home moves in last 3 years) and history of drug use (PR 4.65 95% CI 1.83-11.85). Conclusions Results indicated unmet need for psychosocial support. Further work is needed to explore strategies for mental health support, particularly around disclosure, self-esteem and stigma.	[Durteste, Marion; Thorne, Claire; Cortina-Borja, Mario; Bailey, Heather] UCL, UCL Great Ormond St Inst Child Hlth, Populat Policy & Practice Programme, London, England; [Kyselyova, Galyna; Volokha, Alla] Shupyk Natl Med Acad Postgrad Educ, Kiev, Ukraine; [Judd, Ali] UCL, Inst Clin Trials & Methodol, MRC Clin Trials Unit, London, England; [Malyuta, Ruslan] Perinatal Prevent AIDS Initiat, Odessa, Ukraine; [Martsynovska, Violeta; Nizova, Nataliya] Minist Hlth Ukraine, Publ Hlth Ctr, Kiev, Ukraine; [Martsynovska, Violeta] Inst Epidemiol & Infect Dis NAMS, Kiev, Ukraine; [Baryshnikova, Julia; Kaleeva, Tatyana] Odessa Reg Ctr HIV AIDS, Odessa, Ukraine; [Vihtyuk, Natalia; Mostovenko, Olga] Kiev City Ctr HIV AIDS, Kiev, Ukraine; [Kyselyova, Galyna] Shupyk Natl Med Acad Postgrad Educ, Kiev, Ukraine	University of London; University College London; Shupyk National Healthcare University of Ukraine; Medical Research Council Clinical Trials Unit; University of London; University College London; Ministry of Health of Ukraine; National Academy of Medical Sciences of Ukraine; L. V. Gromashevsky Institute of Epidemiology & Infectious Diseases of the National Academy of Medical Sciences of Ukraine; Shupyk National Healthcare University of Ukraine	Bailey, H (corresponding author), UCL, UCL Great Ormond St Inst Child Hlth, Populat Policy & Practice Programme, London, England.	heather.bailey@ucl.ac.uk; monovetgalyna@gmail.com	Volokha, Alla/F-8020-2019; Thorne, Claire/C-5943-2008; Borja, Mario Cortina/A-3847-2009	Volokha, Alla/0000-0003-3092-2228; Thorne, Claire/0000-0003-0389-1956; Borja, Mario Cortina/0000-0003-0627-2624; Bailey, Heather/0000-0003-3266-1041	CIPHER grant from the International AIDS Society; NIHR Great Ormond Street Hospital Biomedical Research Centre; Child Health Research Charitable Incorporated Organisation Vacation Studentship at the UCL Great Ormond Street Institute of Child Health; PENTA Foundation; MRC [MC_UU_12023/17] Funding Source: UKRI	CIPHER grant from the International AIDS Society; NIHR Great Ormond Street Hospital Biomedical Research Centre; Child Health Research Charitable Incorporated Organisation Vacation Studentship at the UCL Great Ormond Street Institute of Child Health; PENTA Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this project was made possible by a CIPHER grant from the International AIDS Society (https://www.iasociety.org/cipher) held by HB. This research was also supported by the NIHR Great Ormond Street Hospital Biomedical Research Centre. MD was supported by a Child Health Research Charitable Incorporated Organisation Vacation Studentship at the UCL Great Ormond Street Institute of Child Health. The Ukraine Paediatric HIV Cohort is funded by the PENTA Foundation (https://penta-id.org/).The views expressed in written materials or publications do not necessarily reflect the official policies of the International AIDS Society or the views of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JV, 2016, AIDS BEHAV, V20, P174, DOI 10.1007/s10461-015-1089-8; Andrinopoulos K, 2011, AIDS EDUC PREV, V23, P367, DOI 10.1521/aeap.2011.23.4.367; [Anonymous], 2017, HIV INFECTION IN UKR; Bailey H, 2016, INT AIDS C DURB; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; Bhana A, 2016, AIDS CARE, V28, P49, DOI 10.1080/09540121.2016.1176676; Bhatia S, 2002, J CLIN ONCOL, V20, P4692, DOI 10.1200/JCO.2002.05.103; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Brown LK, 2015, AIDS PATIENT CARE ST, V29, P212, DOI 10.1089/apc.2014.0113; Cosco TD, 2012, J PSYCHOSOM RES, V72, P180, DOI 10.1016/j.jpsychores.2011.06.008; Dawson DA, 2005, ALCOHOL CLIN EXP RES, V29, P844, DOI 10.1097/01.ALC.0000164374.32229.A2; Delany-Moretlwe S, 2015, J INT AIDS SOC, V18, P29, DOI 10.7448/IAS.18.2.19833; Demchenko I, 2014, PEOPLE LIVING HIV ST; Dumchev K, 2018, INT J STD AIDS, V29, P1337, DOI 10.1177/0956462418784096; Gadow KD, 2012, J DEV BEHAV PEDIATR, V33, P456, DOI 10.1097/DBP.0b013e31825b8482; Gnambs T, 2015, BEHAV RES METHODS, V47, P1237, DOI 10.3758/s13428-014-0533-4; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Ivanova EL, 2012, AIDS BEHAV, V16, P2181, DOI 10.1007/s10461-011-0133-6; Kapetanovic S, 2011, AIDS PATIENT CARE ST, V25, P493, DOI 10.1089/apc.2011.0107; Kiriazova TK, 2013, HIV MED, V14, P38, DOI 10.1111/hiv.12059; Kiseleva G, 2016, FEATURES PROBLEMS HL; Kuhns LM, 2016, AIDS PATIENT CARE ST, V30, P185, DOI 10.1089/apc.2015.0328; Le Prevost M, 2018, AIDS CARE, V30, P1040, DOI 10.1080/09540121.2018.1441972; Lekhan V. N., 2015, HLTH SYSTEMS TRANSIT; Lewis JV, 2015, AIDS CARE, V27, P1265, DOI 10.1080/09540121.2015.1050984; MacDonell K, 2013, AIDS BEHAV, V17, P86, DOI 10.1007/s10461-012-0364-1; Malee KM, 2011, AIDS CARE, V23, P1533, DOI 10.1080/09540121.2011.575120; Malyuta R, 2012, 19 INT AIDS C WASH D; Mellins CA, 2012, AIDS CARE, V24, P953, DOI 10.1080/09540121.2012.668174; Michaud P-A., 2007, ADOLESCENT CHRONIC C; Mutumba M, 2016, J ADOLESCENT HEALTH, V58, P460, DOI 10.1016/j.jadohealth.2015.12.014; Myers B, 2014, PSYCHOL ADDICT BEHAV, V28, P1117, DOI 10.1037/a0037459; Roberts B, 2019, EPIDEMIOL PSYCH SCI, V28, P100, DOI 10.1017/S2045796017000385; Rosenberg M, 1989, SOC ADOLESCENT SELF; Rydstrom LL, 2016, AIDS CARE, V28, P665, DOI 10.1080/09540121.2015.1120267; Sareen J, 2006, PSYCHIAT RES, V142, P11, DOI 10.1016/j.psychres.2006.01.009; Simmons R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137062; Sowislo JF, 2013, PSYCHOL BULL, V139, P213, DOI 10.1037/a0028931; State Institution Public Health Center of the Ministry of Health of Ukraine, HIV INF UKR INF B, V47; Tanney MR, 2012, J PEDIATR HEALTH CAR, V26, P300, DOI 10.1016/j.pedhc.2011.02.014; Thorne C, 2012, ADDICTION, V107, P118, DOI 10.1111/j.1360-0443.2011.03609.x; UNAIDS, 2017, END AIDS PROGR 90 90; VREEMAN RC, 2017, J INT AIDS SOC S3, V20; Walsh AS, 2017, AIDS CARE, V29, P851, DOI 10.1080/09540121.2017.1281878; Wei W, 2016, AIDS CARE, V28, P161, DOI 10.1080/09540121.2016.1178974; Winkler P, 2017, LANCET PSYCHIAT, V4, P634, DOI 10.1016/S2215-0366(17)30135-9; Wright K, 2007, J ADOLESCENT HEALTH, V40, P96, DOI 10.1016/j.jadohealth.2006.08.001; Yankovskyy S, 2016, TRANSCULT PSYCHIATRY, V53, P612, DOI 10.1177/1363461516660900; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	50	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210412	10.1371/journal.pone.0210412	http://dx.doi.org/10.1371/journal.pone.0210412			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI8IY	30677778	Green Published, gold, Green Submitted			2022-12-26	WOS:000456700400013
J	Lee, DH; Yu, EJ; Aldahl, J; Yang, JL; He, YF; Hooker, E; Le, V; Mi, JQ; Olson, A; Wu, HQ; Geradts, J; Xiao, GQ; Gonzalgo, ML; Cardiff, RD; Sun, ZJ				Lee, Dong-Hong; Yu, Eun-Jeong; Aldahl, Joseph; Yang, Julie; He, Yongfeng; Hooker, Erika; Le, Vien; Mi, Jiaqi; Olson, Adam; Wu, Huiqing; Geradts, Joseph; Xiao, Guang Q.; Gonzalgo, Mark L.; Cardiff, Robert D.; Sun, Zijie			Deletion of the p16(INK4a) tumor suppressor and expression of the androgen receptor induce sarcomatoid carcinomas with signet ring cells in the mouse prostate	PLOS ONE			English	Article							INTRAEPITHELIAL NEOPLASIA; CANCER; ACTIVATION; P16; METHYLATION; CASTRATION; INHIBITOR; FREQUENCY; CLONING; PROTEIN	The tumor suppressor p16(Ink4a), encoded by the INK4a gene, is an inhibitor of cyclin D-dependent kinases 4 and 6, CDK4 and CDK6. This inhibition prevents the phosphorylation of the retinoblastoma protein (pRb), resulting in cellular senescence through inhibition of E2F-mediated transcription of S phase genes required for cell proliferation. The p16(Ink4a) plays an important role in tumor suppression, whereby its deletion, mutation, or epigenetic silencing is a frequently observed genetic alteration in prostate cancer. To assess its roles and related molecular mechanisms in prostate cancer initiation and progression, we generated a mouse model with conditional deletion of p16(Ink4a) in prostatic luminal epithelium. The mice underwent oncogenic transformation and developed prostatic intraepithelial neoplasia (PIN) from eight months of age, but failed to develop prostatic tumors. Given the prevalence of aberrant androgen signaling pathways in prostate cancer initiation and progression, we then generated R26hAR(L/wt):p16(L/L): PB-Cre4 compound mice, in which conditional expression of the human AR transgene and deletion of p16(Ink4a) co-occur in prostatic luminal epithelial cells. While R26hAR(L/wt):PB-Cre4 mice showed no visible pathological changes, R26hAR(L/wt):p16(L/L): PB-Cre4 compound mice displayed an early onset of high-grade PIN (HGPIN), prostatic carcinoma, and metastatic lesions. Strikingly, we observed tumors resembling human sarcomatoid carcinoma with intermixed focal regions of signet ring cell carcinoma (SRCC) in the prostates of the compound mice. Further characterization of these tumors showed they were of luminal epithelial cell origin, and featured characteristics of epithelial to mesenchymal transition (EMT) with enhanced proliferative and invasive capabilities. Our results not only implicate a biological role for AR expression and p16(Ink4a) deletion in the pathogenesis of prostatic SRCC, but also provide a new and unique genetically engineered mouse (GEM) model for investigating the molecular mechanisms for SRCC development.	[Lee, Dong-Hong; Yu, Eun-Jeong; Aldahl, Joseph; Yang, Julie; He, Yongfeng; Hooker, Erika; Le, Vien; Mi, Jiaqi; Olson, Adam; Sun, Zijie] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [Wu, Huiqing] City Hope Natl Med Ctr, Beckman Res Inst, Dept Pathol, Duarte, CA USA; [Geradts, Joseph] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA USA; [Xiao, Guang Q.] Univ South Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA USA; [Gonzalgo, Mark L.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Urol, Miami, FL 33136 USA; [Cardiff, Robert D.] Univ Calif Davis, Comparat Med, Davis, CA 95616 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; University of Southern California; University of Miami; University of California System; University of California Davis	Sun, ZJ (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA.	zjsun@coh.org	He, Yongfeng/AAR-8257-2020; le, vien/GWV-7308-2022; Mi, Jiaqi/GVU-4732-2022	Mi, Jiaqi/0000-0002-6537-7795; Aldahl, Joseph/0000-0001-9664-5644; Hooker, Erika/0000-0002-4515-4041; Olson, Adam W./0000-0003-3118-0393	 [NIHR01CA070297];  [NIHR01CA151623];  [NIHR01CA166894];  [NIHR21CA190021];  [NIHR01DK104941];  [NIHP30CA033572]; NATIONAL CANCER INSTITUTE [R01CA070297, P30CA093373, R01CA166894, P30CA033572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104941] Funding Source: NIH RePORTER	; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIHR01CA070297 for ZJS, NIHR01CA151623 for ZJS, NIHR01CA166894 for ZJS, NIHR21CA190021 for ZJS, NIHR01DK104941 for ZJS, and NIHP30CA033572 for JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Agus DB, 1999, J NATL CANCER I, V91, P1869, DOI 10.1093/jnci/91.21.1869; Balk SP, 2002, UROLOGY, V60, P132, DOI 10.1016/S0090-4295(02)01593-5; Chakravarti A, 2003, J CLIN ONCOL, V21, P3328, DOI 10.1200/JCO.2003.12.151; Chakravarti A, 2007, J CLIN ONCOL, V25, P3082, DOI 10.1200/JCO.2006.08.4152; CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chi SG, 1997, CLIN CANCER RES, V3, P1889; Chrysanthos NV, 2018, AM J GASTROENTEROL, V113, P1427, DOI 10.1038/s41395-018-0099-3; Culig ZR, 2003, J UROLOGY, V170, P1363, DOI 10.1097/01.ju.0000075099.20662.7f; D'Abronzo LS, 2017, ONCOGENE, V36, P6359, DOI 10.1038/onc.2017.233; D'Amico M, 2004, CANCER RES, V64, P4122, DOI 10.1158/0008-5472.CAN-03-2519; DUNDORE PA, 1995, CANCER, V76, P1035, DOI 10.1002/1097-0142(19950915)76:6<1035::AID-CNCR2820760618>3.0.CO;2-8; Feng W, 2015, J BUON, V20, P1074; Fujita K, 2004, INT J UROL, V11, P178, DOI 10.1111/j.1442-2042.2003.00763.x; Gadhikar MA, 2018, CANCER RES, V78, P781, DOI 10.1158/0008-5472.CAN-17-2802; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; GUERIN D, 1993, HISTOPATHOLOGY, V22, P367, DOI 10.1111/j.1365-2559.1993.tb00137.x; Hansel DE, 2006, AM J SURG PATHOL, V30, P1316, DOI 10.1097/01.pas.0000209838.92842.bf; HOHAUS S, 1995, MOL CELL BIOL, V15, P5830; Huggins C, 2002, J UROLOGY, V168, P9, DOI 10.1016/S0022-5347(05)64820-3; Ittmann M, 2013, CANCER RES, V73, P2718, DOI 10.1158/0008-5472.CAN-12-4213; Jarrard DF, 1997, GENE CHROMOSOME CANC, V19, P90, DOI 10.1002/(SICI)1098-2264(199706)19:2<90::AID-GCC4>3.0.CO;2-V; JENSTER G, 1991, MOL ENDOCRINOL, V5, P1396, DOI 10.1210/mend-5-10-1396; Kubota Y, 1995, PROSTATE, V27, P314, DOI 10.1002/pros.2990270604; KYPRIANOU N, 1988, ENDOCRINOLOGY, V122, P552, DOI 10.1210/endo-122-2-552; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; LUKAS J, 1995, NATURE, V375, P503, DOI 10.1038/375503a0; MEDEMA RH, 1995, P NATL ACAD SCI USA, V92, P6289, DOI 10.1073/pnas.92.14.6289; Monahan KB, 2010, ONCOGENE, V29, P5809, DOI 10.1038/onc.2010.314; Nichetti F, 2017, TUMORI; Ortiz B, 2014, P NATL ACAD SCI USA, V111, P8149, DOI 10.1073/pnas.1401952111; Pang A, 2018, J CLIN ONCOL, V36, P210, DOI 10.1200/JCO.2017.74.9523; Paplomata E, 2011, J CLIN ONCOL, V29, pE627, DOI 10.1200/JCO.2011.35.2385; PATEL D, 1991, BIOCHEM PHARMACOL, V42, P1577, DOI 10.1016/0006-2952(91)90427-7; Perinchery G, 1999, INT J CANCER, V83, P610, DOI 10.1002/(SICI)1097-0215(19991126)83:5<610::AID-IJC7>3.0.CO;2-2; Qian JQ, 1997, HUM PATHOL, V28, P143, DOI 10.1016/S0046-8177(97)90097-6; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Rodrigues DN, 2015, HISTOPATHOLOGY, V66, P898, DOI 10.1111/his.12493; Saito S, 1999, UROLOGY, V54, P141, DOI 10.1016/S0090-4295(98)00595-0; SAKR WA, 1993, J UROLOGY, V150, P379, DOI 10.1016/S0022-5347(17)35487-3; SANCHEZ ER, 1990, BIOCHEMISTRY-US, V29, P5145, DOI 10.1021/bi00473a021; SHANNON RL, 1992, CANCER, V69, P2676, DOI 10.1002/1097-0142(19920601)69:11<2676::AID-CNCR2820691109>3.0.CO;2-P; Stanbrough M, 2001, P NATL ACAD SCI USA, V98, P10823, DOI 10.1073/pnas.191235898; Sullivan W. P., 1992, J STEROID BIOCHEM, V43, P37; Wang Y, 2017, PHARMACOGENOMICS, V18, P77, DOI 10.2217/pgs-2016-0075; Warner JN, 2010, MAYO CLIN PROC, V85, P1130, DOI 10.4065/mcp.2010.0463; Wei LY, 2017, J ZHEJIANG UNIV-SC B, V18, P1026, DOI 10.1631/jzus.B1700159; Witkiewicz AK, 2011, CELL CYCLE, V10, P2497, DOI 10.4161/cc.10.15.16776; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Zhu CF, 2011, J BIOL CHEM, V286, P33478, DOI 10.1074/jbc.M111.269894; Zhu ML, 2008, ENDOCR-RELAT CANCER, V15, P841, DOI 10.1677/ERC-08-0084; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	57	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211153	10.1371/journal.pone.0211153	http://dx.doi.org/10.1371/journal.pone.0211153			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677079	gold, Green Published, Green Submitted			2022-12-26	WOS:000456700400054
J	Provost, KA; Smith, M; Miller-Larsson, A; Gudleski, GD; Sethi, S				Provost, Karin A.; Smith, Miyuki; Miller-Larsson, Anna; Gudleski, Gregory D.; Sethi, Sanjay			Bacterial regulation of macrophage bacterial recognition receptors in COPD are differentially modified by budesonide and fluticasone propionate	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NONTYPABLE HAEMOPHILUS-INFLUENZAE; COMMUNITY-ACQUIRED PNEUMONIA; INHALED CORTICOSTEROID USE; HUMAN ALVEOLAR MACROPHAGES; RISK; EXACERBATIONS; SALMETEROL/FLUTICASONE; PHAGOCYTOSIS; EXPRESSION	Rationale Patients with COPD have an increased risk for community-acquired pneumonia, which is further increased by inhaled corticosteroids. Objective To assess effects of the corticosteroids, budesonide and fluticasone propionate, on macrophage bacterial responses in COPD. Methods Monocyte-derived macrophages (MDMs) generated from blood monocytes from 10 nonsmoker controls (NoS), 20 smokers without COPD (Sm), and 40 subjects with moderate to severe COPD (21 ex-smokers (COPD-ES) and 19 current smokers (COPD-S)) were pre-treated with budesonide or fluticasone (10 nM-1 mu M) and challenged with live non-typeable Haemophilus influenzae (NTHI) or Streptococcus pneumoniae (SP). Cell surface bacterial recognition receptor expression (flow cytometry) and cytokine release (bead array) were analyzed. Results NTHI and SP reduced bacterial recognition receptor expression on MDMs from COPD and Sm, but not NoS (except TLR4). SR-AI and MARCO were reduced by both NTHI and SP, whereas other receptors by either NTHI or SP. Among COPD subjects, COPD-ES demonstrated a greater number of reductions as compared to COPD-S. NTHI reduced SR-AI, MARCO, CD11b, CD35 and CD206 in COPD-ES while only SR-AI and CD11b in COPD-S. SP reduced SRA-1, CD1d, TLR2 and TLR4 in both COPD-ES and COPD-S, and reduced MARCO and CD93 only in COPD-ES. All receptors reduced in COPD by NTHI and most by SP, were also reduced in Sm. Budesonide counteracted the receptor reductions induced by both NTHI (CD206 p = 0.03, MARCO p = 0.08) and SP (SR-AI p = 0.02) in COPD-ES. Fluticasone counteracted only SP-induced reductions in TLR2 (p = 0.008 COPD-ES and p = 0.04 COPD-S) and TLR4 (p = 0.02 COPD-ES). Cytokine release was equivalently reduced by both corticosteroids. Conclusions Reduction in macrophage bacterial recognition receptors during bacterial exposure could provide a mechanism for the increased pneumonia risk in COPD. Differential effects of budesonide and fluticasone propionate on macrophage bacterial recognition receptor expression may contribute to the higher pneumonia incidence reported with fluticasone propionate.	[Provost, Karin A.; Smith, Miyuki; Sethi, Sanjay] Vet Affairs Western New York Healthcare Syst Buff, Div Pulm Crit Care & Sleep Med, Vet Hlth Adm, Buffalo, NY 14215 USA; [Provost, Karin A.; Sethi, Sanjay] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Div Pulm Crit Care & Sleep Med, Buffalo, NY 14260 USA; [Miller-Larsson, Anna] AstraZeneca Gothenburg, Resp GMed, Molndal, Sweden; [Gudleski, Gregory D.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Med, Buffalo, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; AstraZeneca; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Provost, KA (corresponding author), Vet Affairs Western New York Healthcare Syst Buff, Div Pulm Crit Care & Sleep Med, Vet Hlth Adm, Buffalo, NY 14215 USA.; Provost, KA (corresponding author), SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Div Pulm Crit Care & Sleep Med, Buffalo, NY 14260 USA.	kprovost@buffalo.edu			AstraZeneca [D589BN00039]; VA Western New York Healthcare System	AstraZeneca(AstraZeneca); VA Western New York Healthcare System	The funding from AstraZeneca was provided under the Investigator Initiated Grant mechanism (D589BN00039), which was administered by the Buffalo Institute of Medical Research, the non-profit organization associated with the VA Western New York Healthcare System to administer non-VA grant funding. Sponsor had no role in the data collection, analysis, or the decision to publish. Author Miyuki Smith, the lab technician, received support in the form of a salary from the grant funding. Author Anna Miller-Larsson was a full-time employee of AstraZeneca, and participated in the initial study design, particularly with focus on drug solubility and ensuring equal and appropriate drug concentrations for the experimental design. She did not have any additional role in the study design, data collection and analysis or decision to publish the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almirall J, 1999, EUR RESPIR J, V13, P349, DOI 10.1183/09031936.99.13234999; Almirall J, 1999, CHEST, V116, P375, DOI 10.1378/chest.116.2.375; Berenson CS, 2006, J INFECT DIS, V194, P1375, DOI 10.1086/508428; Berenson CS, 2006, AM J RESP CRIT CARE, V174, P31, DOI 10.1164/rccm.200509-1461OC; Berenson CS, 2014, THORAX, V69, P811, DOI 10.1136/thoraxjnl-2013-203669; Berenson CS, 2013, J INFECT DIS, V208, P2036, DOI 10.1093/infdis/jit400; Bhatt SP, 2018, THORAX, V73, P414, DOI 10.1136/thoraxjnl-2017-210722; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Calverley PMA, 2011, CHEST, V139, P505, DOI 10.1378/chest.09-2992; Crim C, 2009, EUR RESPIR J, V34, P641, DOI 10.1183/09031936.00193908; Dorrington MG, 2013, J IMMUNOL, V190, P250, DOI 10.4049/jimmunol.1202113; Dransfield MT, 2013, LANCET RESP MED, V1, P210, DOI 10.1016/S2213-2600(13)70040-7; Droemann D, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-68; Ek A, 1999, ALLERGY, V54, P691, DOI 10.1034/j.1398-9995.1999.00087.x; Ernst P, 2007, AM J RESP CRIT CARE, V176, P162, DOI 10.1164/rccm.200611-1630OC; Ganesan S, 2012, AM J PATHOL, V180, P61, DOI 10.1016/j.ajpath.2011.09.029; Halpin DMG, 2011, INT J CLIN PRACT, V65, P764, DOI 10.1111/j.1742-1241.2011.02685.x; Harvey CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002042; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Hodge S, 2007, AM J RESP CELL MOL, V37, P748, DOI 10.1165/rcmb.2007-0025OC; Hodge S, 2011, AM J RESP CELL MOL, V44, P673, DOI 10.1165/rcmb.2009-0459OC; Holguin F, 2005, CHEST, V128, P2005, DOI 10.1378/chest.128.4.2005; JANSON C, 2013, BMJ BRIT MED J, V346, P46319; Ji J, 2016, INT J CHRONIC OBSTR, V11, P1035, DOI 10.2147/COPD.S102668; Li ZG, 2017, J IMMUNOL, V199, P3176, DOI 10.4049/jimmunol.1700140; Liu Y, 2015, INT J CHRONIC OBSTR, V10, P1409, DOI 10.2147/COPD.S82259; Lofdahl JM, 2006, CLIN EXP IMMUNOL, V145, P428, DOI 10.1111/j.1365-2249.2006.03154.x; MacRedmond RE, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-84; Magnussen H, 2014, NEW ENGL J MED, V371, P1285, DOI 10.1056/NEJMoa1407154; Marinelli C, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0458-6; Morjaria JB, 2017, LUNG, V195, P281, DOI 10.1007/s00408-017-9990-8; Pons AR, 2005, EUR RESPIR J, V25, P647, DOI 10.1183/09031936.05.00062304; Provost KA, 2015, AM J RESP CELL MOL, V52, P728, DOI 10.1165/rcmb.2014-0172OC; Skold CM, 1996, CLIN EXP IMMUNOL, V106, P108, DOI 10.1046/j.1365-2249.1996.d01-805.x; Suissa S, 2015, CHEST, V148, P1177, DOI 10.1378/chest.15-0627; Suissa S, 2013, THORAX, V68, P1029, DOI 10.1136/thoraxjnl-2012-202872; Szafranski W, 2003, EUR RESPIR J, V21, P74, DOI 10.1183/09031936.03.00031402; Taylor AE, 2010, EUR RESPIR J, V35, P1039, DOI 10.1183/09031936.00036709; ten Oever J, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0055-y; van den Brink KIM, 2008, BRIT J CLIN PHARMACO, V66, P27, DOI 10.1111/j.1365-2125.2008.03164.x; van der Valk P, 2002, AM J RESP CRIT CARE, V166, P1358, DOI 10.1164/rccm.200206-512OC; von Scheele I, 2010, INHAL TOXICOL, V22, P493, DOI 10.3109/08958370903521216; Wedzicha JA, 2008, AM J RESP CRIT CARE, V177, P19, DOI 10.1164/rccm.200707-973OC; Wedzicha JA, 2016, NEW ENGL J MED, V374, P2222, DOI 10.1056/NEJMoa1516385; Winkler AR, 2008, EXP LUNG RES, V34, P599, DOI 10.1080/01902140802366261; Wouters EFM, 2005, THORAX, V60, P480, DOI 10.1136/thx.2004.034280; Yeager MP, 2004, ACTA ANAESTH SCAND, V48, P799, DOI 10.1111/j.1399-6576.2004.00434.x	47	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0207675	10.1371/journal.pone.0207675	http://dx.doi.org/10.1371/journal.pone.0207675			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677037	Green Published, Green Submitted, gold			2022-12-26	WOS:000456700400004
J	Fallon, SJ; Mcdougall, AJ; Espinoza, T; Roberts, DT; Brooks, S; Kind, PK; Kennard, MJ; Bond, N; Marshall, SM; Schmidt, D; Hughes, J				Fallon, Stewart J.; Mcdougall, Andrew J.; Espinoza, Tom; Roberts, David T.; Brooks, Steven; Kind, Peter K.; Kennard, Mark J.; Bond, Nick; Marshall, Sharon M.; Schmidt, Dan; Hughes, Jane			Age structure of the Australian lungfish (Neoceratodus forsteri)	PLOS ONE			English	Article							BOMB RADIOCARBON; GROWTH; VALIDATION; OTOLITHS; LENGTH; C-14; RECRUITMENT; REEF; DRUM	The Australian lungfish has been studied for more than a century without any knowledge of the longevity of the species. Traditional methods for ageing fish, such as analysis of otolith (ear stone) rings is complicated in that lungfish otoliths differ from teleost fish in composition. As otolith sampling is also lethal, this is not appropriate for a protected species listed under Australian legislation. Lungfish scales were removed from 500 fish from the Brisbane, Burnett and Mary rivers. A sub-sample of scales (85) were aged using bomb radiocarbon techniques and validated using scales marked previously with oxytetracycline. Lungfish ages ranged from 2.5-77 years of age. Estimated population age structures derived using an Age Length Key revealed different recruitment patterns between river systems. There were statistically significant von Bertalanffy growth model parameters estimated for each of the three rivers based on limited sample sizes. In addition, length frequency distributions between river systems were also significantly different. Further studies will be conducted to review drivers that may explain these inter-river differences.	[Fallon, Stewart J.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Mcdougall, Andrew J.; Espinoza, Tom; Marshall, Sharon M.] Queensland Dept Nat Resources Mines & Energy, Bundaberg, Qld, Australia; [Roberts, David T.] Seqwater, Brisbane, Qld, Australia; [Brooks, Steven; Kind, Peter K.] Queensland Dept Agr & Fisheries, Brisbane, Qld, Australia; [Kennard, Mark J.; Bond, Nick; Schmidt, Dan; Hughes, Jane] Griffith Univ, Brisbane, Qld, Australia; [Bond, Nick] La Trobe Univ, Murray Darling Basin Freshwater Res Ctr, Albury Wodonga, Vic, Australia	Australian National University; Griffith University; La Trobe University	Fallon, SJ (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia.	stewart.fallon@anu.edu.au	Fallon, Stewart J/G-6645-2011; Bond, Nick R./A-1129-2016; McDougall, Andrew/AAA-8657-2019; Kennard, Mark James/C-3425-2008; Roberts, David/AGK-0029-2022; Roberts, David/W-3004-2019; Schmidt, Daniel/I-9289-2014	Fallon, Stewart J/0000-0002-8064-5903; Bond, Nick R./0000-0003-4294-6008; McDougall, Andrew/0000-0003-3304-984X; Kennard, Mark James/0000-0003-4383-4999; Roberts, David/0000-0002-9768-6314; Schmidt, Daniel/0000-0001-5638-497X	Australian Research Council Linkage Projects grant scheme [LP130100118]; SEQWater	Australian Research Council Linkage Projects grant scheme(Australian Research Council); SEQWater	We received funding from the Australian Research Council Linkage Projects grant scheme, LP130100118 to JH. The purpose of "The Linkage Projects scheme promotes national, and international, collaboration and research partnerships between key stakeholders in research and innovation including higher education institutions, government, business, industry and end-users. Research and development is undertaken to apply advanced knowledge to problems, acquire new knowledge and as a basis for securing commercial and other benefits of research"(https://www.arc.gov.au/grants/linkage-program/linkage-projects).Our commercial partner SEQWater provided funds to the Australian Research Council which were then distributed to the Australian National University and Griffith University. Their funds covered salaries for DS and technician support at ANU. The funds also covered the radiocarbon sample analysis. DTR (SEQWater) is their scientific research officer and his specific role is articulated in the 'author contributions' section. SEQWater did not play a role in any decision to publish.	Andrews AH, 2016, J GEOPHYS RES-OCEANS, V121, P6351, DOI 10.1002/2016JC012043; Andrews AH, 2016, CAN J FISH AQUAT SCI, V73, P1575, DOI 10.1139/cjfas-2016-0019; Arthington AH, 2009, ENVIRON BIOL FISH, V84, P211, DOI 10.1007/s10641-008-9414-y; Baker MS, 2001, LIMNOL OCEANOGR, V46, P1819; Bishop CR, 2017, CONSERVATION GENETIC; Braaten PJ, 2015, J APPL ICHTHYOL, V31, P821, DOI 10.1111/jai.12873; Brooks S, 1995, SHORT TERM STUDY BRE; Brooks SG, 2002, QUEENSLAND REFERENCE; Bruch RM, 2009, T AM FISH SOC, V138, P361, DOI 10.1577/T08-098.1; Campana SE, 2002, CAN J FISH AQUAT SCI, V59, P450, DOI 10.1139/F02-027; Campana SE, 2001, CAN J FISH AQUAT SCI, V58, P30, DOI 10.1139/f00-177; Campana SE, 1998, FISH B-NOAA, V96, P185; Campana SE, 2008, CAN J FISH AQUAT SCI, V65, P733, DOI 10.1139/F08-012; CHEN Y, 1992, CAN J FISH AQUAT SCI, V49, P1228, DOI 10.1139/f92-138; Davis-Foust SL, 2009, T AM FISH SOC, V138, P385, DOI 10.1577/T08-097.1; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Espinoza T, 2013, RIVER RES APPL, V29, P1215, DOI 10.1002/rra.2607; Fallon SJ, 2015, RADIOCARBON, V57, P195, DOI 10.2458/azu_rc.57.18199; Francis MP, 2007, MAR FRESHWATER RES, V58, P10, DOI 10.1071/MF06069; Francis R.I.C.C., 1988, New Zealand Journal of Marine and Freshwater Research, V22, P42; Francis RICC, 2016, FISH RES, V180, P77, DOI 10.1016/j.fishres.2015.02.018; Francis RICC, 2005, MAR FRESHWATER RES, V56, P735, DOI 10.1071/MF04127; Fridriksson A., 1934, RAPPORTS PROCES VERB, V86, P1; GAULDIE RW, 1986, NEW ZEAL J MAR FRESH, V20, P81, DOI 10.1080/00288330.1986.9516132; Hamady LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084006; Hamel OS, 2008, T AM FISH SOC, V137, P852, DOI 10.1577/T07-144.1; Hernaman V, 2005, MAR ECOL PROG SER, V290, P207, DOI 10.3354/meps290207; Hua Q., 2013, RADIOCARBON, V55, P1; Hughes JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121858; Hydrobiology Pty Ltd, 2007, 11 DAM EIS HYDR PTY; Illidge T, 1893, P ROYAL SOC QUEENSLA, V10, P40; James KM, 2010, RADIOCARBON, V52, P1084, DOI 10.1017/S0033822200046166; Kastelle CR, 2016, ECOL MODEL, V320, P79, DOI 10.1016/j.ecolmodel.2015.09.013; Kemp A, 2015, J MORPHOL; Kemp A, 2014, AUST J ZOOL, V62, P63, DOI 10.1071/ZO13038; Ketchen K. S., 1950, Transactions of the American Fisheries Society, V79, P205, DOI 10.1577/1548-8659(1949)79[205:SSFDAD]2.0.CO;2; KIMURA DK, 1977, J FISH RES BOARD CAN, V34, P317, DOI 10.1139/f77-052; Kind P.K, 2002, MOVEMENT PATTERNS HA; Kind Peter K., 2011, P61; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; LAINE A O, 1991, North American Journal of Fisheries Management, V11, P220, DOI 10.1577/1548-8675(1991)011<0220:AOUSAC>2.3.CO;2; Lorenzen K, 2002, P ROY SOC B-BIOL SCI, V269, P49, DOI 10.1098/rspb.2001.1853; Marshall SM, 2015, RIVER RES APPL, V31, P552, DOI 10.1002/rra.2754; MARTIN I, 1990, J CONSEIL, V46, P178; Newman SJ, 1996, MAR FRESHWATER RES, V47, P575, DOI 10.1071/MF9960575; Pardo SA, 2013, METHODS ECOL EVOL, V4, P353, DOI 10.1111/2041-210x.12020; Philippsen B, 2013, HERIT SCI, V1, DOI 10.1186/2050-7445-1-24; Pusey B., 2004, FRESHWATER FISHES N, DOI DOI 10.1071/9780643092082; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Reimer PJ, 2004, RADIOCARBON, V46, P1299; Roberts DT, 2014, J FISH BIOL, V84, P163, DOI 10.1111/jfb.12264; Schmidt DJ, 2018, MOL ECOL, V27, P3231, DOI 10.1111/mec.14791; Smart JJ, 2013, AQUAT CONSERV, V23, P124, DOI 10.1002/aqc.2274; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Threatened Species Scientific Committee, 2003, COMM LIST ADV NEOC F; Turnbull JC, 2017, ATMOS CHEM PHYS, V17, P14771, DOI 10.5194/acp-17-14771-2017; Villamor B, 2011, FISH OCEANOGR, V20, P397, DOI 10.1111/j.1365-2419.2011.00592.x; Wischniowski SG, 2015, CAN J FISH AQUAT SCI, V72, P879, DOI 10.1139/cjfas-2014-0225; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	59	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210168	10.1371/journal.pone.0210168	http://dx.doi.org/10.1371/journal.pone.0210168			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673738	Green Published, gold, Green Submitted			2022-12-26	WOS:000456442800033
J	Shamu, S; Slabbert, J; Guloba, G; Blom, D; Khupakonke, S; Masihleho, N; Kamera, J; Johnson, S; Farirai, T; Nkhwashu, N				Shamu, Simukai; Slabbert, Jean; Guloba, Geoffrey; Blom, Dalene; Khupakonke, Sikhulile; Masihleho, Nomea; Kamera, Julius; Johnson, Suzanne; Farirai, Thato; Nkhwashu, Nkhensani			Linkage to care of HIV positive clients in a community based HIV counselling and testing programme: A success story of non-governmental organisations in a South African district	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; RETENTION; OUTREACH; HEALTH	Introduction Although current data projects South Africa potentially meeting the UN target to test 90% of all people living with HIV by 2020, linking them to HIV care remains a big challenge. In an effort to increase linkage to care (LTC) of HIV positive clients an innovative collaborative intervention between two non-governmental organisations was developed and implemented between 2016 and 2017. This paper investigated the outcome of this collaborative intervention. Methods We used a mixed methods approach to assess the outcome of the innovative relationship. This was done by analysing routine programmatic quantitative data on LTC between 2015 and 2017 and qualitatively interviewing five programme managers, four programme implementers and five HIV positive clients on their perceived success/failure factors. Qualitative data were analysed using thematic content analysis while LTC rates were descriptively analysed. Two consultative meetings presented draft findings to programme managers (n = 7) and implementers (n = 10) for feedback, results verification and confirmation. Results In 2015 cumulative LTC rate was 27% and it rose to 85% two years post-intervention in 2017. Six themes emerged as success factors at the health system and structural levels and these include: provision of client escort services, health facility human resource capacity strengthening, inter and intra-organisational teamwork, onsite LTC, facilitated and expedited jumping of queues and shifting administrative tasks to non-clinical staff to protect nurses' time on ART initiation. These measures in turn ensured increased, affordable and swift ART initiation of clients while strengthening client support. Conclusions We concluded that multi-faceted interventions that target both health system challenges including staff shortages, efficiencies, and extended facility opening times, and structural inadequacies, including client time and resource limitations due to poverty or nature of jobs, can help to increase LTC.	[Shamu, Simukai; Slabbert, Jean; Guloba, Geoffrey; Blom, Dalene; Khupakonke, Sikhulile; Johnson, Suzanne; Farirai, Thato; Nkhwashu, Nkhensani] Fdn Profess Dev, Hlth Syst Strengthening Div, Pretoria, South Africa; [Shamu, Simukai] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Masihleho, Nomea; Kamera, Julius] USAID, Pretoria, South Africa	University of Witwatersrand; United States Agency for International Development (USAID)	Shamu, S (corresponding author), Fdn Profess Dev, Hlth Syst Strengthening Div, Pretoria, South Africa.; Shamu, S (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.	shamuts@yahoo.com		Shamu, Simukai/0000-0002-2290-0515	United States President's Emergency Plan for AIDS Relief (PEPFAR); Foundation for Professional Development (FPD)	United States President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Foundation for Professional Development (FPD)	The work on this paper was funded by The United States President's Emergency Plan for AIDS Relief (PEPFAR) and Foundation for Professional Development (FPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnabas RV, 2016, LANCET HIV, V3, pE212, DOI 10.1016/S2352-3018(16)00020-5; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Coleman SM, 2009, AIDS PATIENT CARE ST, V23, P639, DOI 10.1089/apc.2008.0092; Craw JA, 2008, JAIDS-J ACQ IMM DEF, V47, P597, DOI 10.1097/QAI.0b013e3181684c51; Faal M, 2011, JAIDS-J ACQ IMM DEF, V58, pE54, DOI 10.1097/QAI.0b013e3182303921; Fereday J., 2006, INT J QUAL METH, V5, P80, DOI [DOI 10.1177/160940690600500107, 10.1177/160940690600500107]; FPD, 2017, IMPR LINK CAR COMM B; Gardner LI, 2005, AIDS, V19, P423, DOI 10.1097/01.aids.0000161772.51900.eb; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Govindasamy D, 2011, JAIDS-J ACQ IMM DEF, V58, P344, DOI 10.1097/QAI.0b013e31822e0c4c; Hatcher AM, 2012, AIDS BEHAV, V16, P1295, DOI 10.1007/s10461-011-0065-1; Hightow-Weidman LB, 2011, AIDS PATIENT CARE ST, V25, pS31, DOI 10.1089/apc.2011.9878; Hoffman S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162085; Ingle SM, 2010, AIDS, V24, P2717, DOI 10.1097/QAD.0b013e32833fb71f; Iwuji CC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002107; Johnson RB, 2007, J MIX METHOD RES, V1, P112, DOI 10.1177/1558689806298224; Kranzer K, 2010, PLOS ONE, V5, P1; Larson BA, 2012, JAIDS-J ACQ IMM DEF, V61, pE13, DOI 10.1097/QAI.0b013e31825eec60; Leon N, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-350; Liau A, 2013, AIDS BEHAV, V17, P1941, DOI 10.1007/s10461-013-0435-y; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; MacPherson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044794; Mazars C, 2014, STOP VIOLENCE WOMEN; Medley A, 2013, AIDS BEHAV, V17, P224, DOI 10.1007/s10461-012-0344-5; Mugglin C, 2012, TROP MED INT HEALTH, V17, P1509, DOI 10.1111/j.1365-3156.2012.03089.x; Naik R, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19843; Naik R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-824; Nakigozi G, 2011, AIDS CARE, V23, P764, DOI 10.1080/09540121.2010.525614; Pfeiffer J, 2008, AM J PUBLIC HEALTH, V98, P2134, DOI 10.2105/AJPH.2007.125989; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Sharma M, 2016, NATURE, V528, P1; Siedner MJ, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0397-1; Stats SA; South African Medical Research Council (SAMRC); ICF, 2017, S AFR DEM HLTH SURV; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Ulett KB, 2009, AIDS PATIENT CARE ST, V23, P41, DOI 10.1089/apc.2008.0132; UNAIDS, UN ACC HIV PREV TREA; UNAIDS, 2014, 90 90 90 AMB TREATM; van Rooyen H, 2013, JAIDS-J ACQ IMM DEF, V64, pE1, DOI 10.1097/QAI.0b013e31829b567d; van Zyl MA, 2015, AIDS CARE, V27, P921, DOI 10.1080/09540121.2015.1015483; WHO, 2015, CONSOLIDATED GUIDELI; World Health Organization, 2015, GUID START ANT THER, P1; World Health Organization (WHO), 2011, COUNTR REG HIGH LEV; Wynberg E, 2014, JIAS, V17, P1, DOI DOI 10.7448/IAS.17.1.18809	45	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210826	10.1371/journal.pone.0210826	http://dx.doi.org/10.1371/journal.pone.0210826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI2WF	30668598	Green Submitted, Green Published, gold			2022-12-26	WOS:000456306400016
J	Ramirez-Cruz, GA; Solano-Zavaleta, I; Mendoza-Hernandez, PE; Mendez-Janovitz, M; Suarez-Rodriguez, M; Zuniga-Vega, JJ				Ramirez-Cruz, Gonzalo A.; Solano-Zavaleta, Israel; Mendoza-Hernandez, Pedro E.; Mendez-Janovitz, Marcela; Suarez-Rodriguez, Monserrat; Zuniga-Vega, J. Jaime			This town ain't big enough for both of us. . .or is it? Spatial co-occurrence between exotic and native species in an urban reserve	PLOS ONE			English	Article							RED-BELLIED SQUIRREL; ECOLOGICAL RESERVE; INVASIVE ALIEN; SAN ANGEL; BIOLOGICAL INVASIONS; POPULATION-DYNAMICS; ECOSYSTEM SERVICES; RESOURCE USE; DRY FOREST; COMPETITION	Exotic species pose a threat to most ecosystems because of their potential to establish negative interactions with native biota. However, exotic species can also offer resources to native species, especially within highly modified environments such as urban ecosystems. We studied 17 exotic-native pairs of species with the potential to compete with one another, or in which one of the species could offer resources to the other, in an urban ecological reserve located within Mexico City. We used two-species occupancy models to analyze the potential association between the presence of the exotic species and the spatial distribution of the native species, as well as to assess if these species tend to avoid each other (negative spatial interaction) or to co-occur more often than expected under the hypothesis of independent occurrences (positive spatial interaction). Our results revealed few cases in which the exotic species influenced occupancy of the native species, and these spatial interactions were mainly positive, indicated by the fact that the occupancy of the native species was usually higher when the exotic species was also present. Seven of the eight observed non-independent patterns of co-occurrence were evident during the dry months of the year, when resources become scarce for most species. Our results also demonstrate that the observed patterns of species co-occurrence depend on the distance to the nearest urban structure and the amount of herb, shrub, and tree cover, indicating that these habitat features influence whether native species avoid or co-occur with exotic species. Our study represents an important contribution to the understanding of temporal dynamics in the co-occurrence between exotic and native species within urban ecological reserves.	[Ramirez-Cruz, Gonzalo A.] Univ Nacl Autonoma Mexico, Posgrad Ciencias Biol, Fac Ciencias, Ciudad Univ, Mexico City, DF, Mexico; [Solano-Zavaleta, Israel; Mendoza-Hernandez, Pedro E.; Suarez-Rodriguez, Monserrat; Zuniga-Vega, J. Jaime] Univ Nacl Autonoma Mexico, Dept Ecol & Recursos Nat, Fac Ciencias, Ciudad Univ, Mexico City, DF, Mexico; [Mendez-Janovitz, Marcela] Univ Nacl Autonoma Mexico, Posgrad Ciencias Biol, Inst Ecol, Ciudad Univ, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Zuniga-Vega, JJ (corresponding author), Univ Nacl Autonoma Mexico, Dept Ecol & Recursos Nat, Fac Ciencias, Ciudad Univ, Mexico City, DF, Mexico.	jzuniga@ciencias.unam.mx		Ramirez-Cruz, Gonzalo A./0000-0002-6587-7554; Zuniga-Vega, Jose Jaime/0000-0002-9661-1521	Direccion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico [PAPIIT IV200117, IV210117]; Consejo Nacional de Ciencia y Tecnologia [440952/270133]	Direccion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was funded by Direccion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico through the projects PAPIIT IV200117 and IV210117 awarded to the corresponding author, as well as through Consejo Nacional de Ciencia y Tecnologia through a scholarship awarded to the first author (scholarship no. 440952/270133). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Rodriguez S, 2006, TREES-STRUCT FUNCT, V20, P253, DOI 10.1007/s00468-005-0007-5; Aguirre-Acosta N, 2014, BIOL INVASIONS, V16, P1397, DOI 10.1007/s10530-013-0577-x; Aizen MA, 2011, BIOL INVASIONS, V13, P2901, DOI 10.1007/s10530-011-9972-3; Albins MA, 2013, BIOL INVASIONS, V15, P29, DOI 10.1007/s10530-012-0266-1; Alvey Alexis A., 2006, Urban Forestry & Urban Greening, V5, P195, DOI 10.1016/j.ufug.2006.09.003; Anderies JM, 2007, J THEOR BIOL, V247, P36, DOI 10.1016/j.jtbi.2007.01.030; Anderson T.R, 2006, BIOL UBIQUITOUS HOUS; [Anonymous], 2009, BIODIVERSIDAD ECOSIS; [Anonymous], ESC NAC CIENCIAS BIO; Ares A, 2001, CAN J FOREST RES, V31, P132, DOI 10.1139/cjfr-31-1-132; Asner GP, 2008, P NATL ACAD SCI USA, V105, P4519, DOI 10.1073/pnas.0710811105; Badyaev A.V., 2012, BIRDS N AM, DOI [10.2173/bna.46, DOI 10.2173/BNA.46]; Balachowski JA, 2016, ANN BOT-LONDON, V118, P357, DOI 10.1093/aob/mcw109; Balicevic R., 2015, Herbologia, V15, P19; Bartowitz KJ, 2016, J VEG SCI, V27, P789, DOI 10.1111/jvs.12397; BEGON M, 2006, ECOLOGY FROM INDIVID; Bertness MD, 2013, ECOLOGY, V94, P1937, DOI 10.1890/12-2150.1; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Botello F, 2007, SOUTHWEST NAT, V52, P326, DOI 10.1894/0038-4909(2007)52[326:NROTRS]2.0.CO;2; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; BROWN LN, 1975, J MAMMAL, V56, P405, DOI 10.2307/1379370; Burghardt KT, 2009, CONSERV BIOL, V23, P219, DOI 10.1111/j.1523-1739.2008.01076.x; Burnham K. P., 2002, MODEL SELECTION AND; Castillo-Arguero S., 2009, BIODIVERSIDAD ECOSIS, P107; Cavin JS, 2017, BIOL INVASIONS, V19, P3471, DOI 10.1007/s10530-017-1588-9; Chase J.M., 2009, ECOLOGICAL NICHES LI; Cooper CB, 2007, ECOLOGY, V88, P864, DOI 10.1890/06-0855; Cove MV, 2018, ECOL EVOL, V8, P4042, DOI 10.1002/ece3.3954; Del Fabbro C, 2015, PERSPECT PLANT ECOL, V17, P87, DOI 10.1016/j.ppees.2015.02.002; Dickie IA, 2014, BIOL INVASIONS, V16, P705, DOI 10.1007/s10530-013-0609-6; Ehrenfeld JG, 2010, ANNU REV ECOL EVOL S, V41, P59, DOI 10.1146/annurev-ecolsys-102209-144650; Elton C., 1958; Eschtruth AK, 2009, ECOL MONOGR, V79, P265, DOI 10.1890/08-0221.1; Estay SA, 2012, BIODIVERS CONSERV, V21, P3699, DOI 10.1007/s10531-012-0391-2; Estevo CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179489; Farris ZJ, 2016, ANIM CONSERV, V19, P189, DOI 10.1111/acv.12233; Farris ZJ, 2017, BIOL CONSERV, V210, P116, DOI 10.1016/j.biocon.2017.04.010; Folberth GA, 2015, ENVIRON POLLUT, V203, P235, DOI 10.1016/j.envpol.2014.09.004; Francis RA, 2015, GEOGRAPHY, V100, P144; Francis RA, 2012, APPL GEOGR, V32, P514, DOI 10.1016/j.apgeog.2011.06.013; Fransen B, 2001, ECOLOGY, V82, P2534, DOI 10.1890/0012-9658(2001)082[2534:SNHACB]2.0.CO;2; Gaertner M, 2017, BIOL INVASIONS, V19, P3461, DOI 10.1007/s10530-017-1598-7; Garcia E., 1988, MODIFICACIONES SISTE; Garcia S, 1998, FOREST ECOL MANAG, V110, P151, DOI 10.1016/S0378-1127(98)00287-4; Google, 2017, GOOGLE EARTH MOUNTAI; Griffis-Kyle KL, 2005, AM MIDL NAT, V153, P436, DOI 10.1674/0003-0031(2005)153[0436:MSASPO]2.0.CO;2; Harvey JA, 2012, ENTOMOL EXP APPL, V144, P14, DOI 10.1111/j.1570-7458.2012.01252.x; Hasegawa M, 2014, BEHAV ECOL, V25, DOI 10.1093/beheco/aru034; Haynes TB, 2014, J AVIAN BIOL, V45, P296, DOI 10.1111/jav.00394; Hejda M, 2017, DIVERS DISTRIB, V23, P997, DOI 10.1111/ddi.12596; Hinchliffe S., 2006, SCI CULT-UK, V15, P123, DOI DOI 10.1080/09505430600707988; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Hortelano-Moncada Y, 2009, REV MEX BIODIVERS, V80, P507; Hossack BR, 2017, BIOL CONSERV, V209, P377, DOI 10.1016/j.biocon.2017.03.004; Howell SN, 1995, A GUIDE TO THE BIRDS; Hulme PE, 2003, ORYX, V37, P178, DOI 10.1017/S003060530300036X; Iles DT, 2013, J ANIM ECOL, V82, P683, DOI 10.1111/1365-2656.12038; Iponga DM, 2008, J ARID ENVIRON, V72, P612, DOI 10.1016/j.jaridenv.2007.10.001; Jarrad FC, 2011, BIOL INVASIONS, V13, P803, DOI 10.1007/s10530-010-9870-0; Jordan NR, 2008, BIOL INVASIONS, V10, P177, DOI 10.1007/s10530-007-9121-1; Kaiser BA, 2010, RESOUR ENERGY ECON, V32, P566, DOI 10.1016/j.reseneeco.2010.04.007; KARR JR, 1983, ECOLOGY, V64, P1481, DOI 10.2307/1937503; Kennedy ED, 2013, BIRDS N AM, DOI [10.2173/bna.315, DOI 10.2173/BNA.315]; Kowarik I, 2011, ENVIRON POLLUT, V159, P1974, DOI 10.1016/j.envpol.2011.02.022; Lincango P, 2015, J WILDLIFE DIS, V51, P907, DOI 10.7589/2015-01-025; Lopez-Gomez V, 2010, ENTOMOL SCI, V13, P174, DOI 10.1111/j.1479-8298.2010.00381.x; MacGregor-Fors I, 2010, BIOL INVASIONS, V12, P87, DOI 10.1007/s10530-009-9432-5; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MacKenzie D.I., 2018, OCCUPANCY ESTIMATION, V2nd, DOI DOI 10.1016/B978-0-12-407197-1.00015-6; MacKenzie DI, 2006, J WILDLIFE MANAGE, V70, P367, DOI 10.2193/0022-541X(2006)70[367:MTPORU]2.0.CO;2; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; Malo AF, 2013, BEHAV ECOL, V24, P759, DOI 10.1093/beheco/ars202; Martin-Albarracin VL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143070; Mayle BA, 2013, PEST MANAG SCI, V69, P323, DOI 10.1002/ps.3458; Mazzamuto MV, 2017, BIOL INVASIONS, V19, P1863, DOI 10.1007/s10530-017-1396-2; McClure CJW, 2011, CONDOR, V113, P462, DOI 10.1525/cond.2011.100061; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Montesinos D, 2016, ACTA OECOL, V74, P46, DOI 10.1016/j.actao.2016.06.002; Montgomery WI, 2012, BIOL INVASIONS, V14, P1111, DOI 10.1007/s10530-011-0142-4; Mosher ES, 2009, BIOL INVASIONS, V11, P2317, DOI 10.1007/s10530-008-9418-8; Mueller AJ, 2004, THE BIRDS OF NORTH A, DOI [10.2173/bna.28, DOI 10.2173/BNA.28]; Oguchi Y, 2018, CONDOR, V120, P81, DOI [10.1650/CONDOR-17-27.1, 10.1650/condor-17-27.1]; Orozco Silvia, 2009, Actu Biol, V31, P31; Ortega YK, 2006, OECOLOGIA, V149, P340, DOI 10.1007/s00442-006-0438-8; Palacio Prieto José Luis, 2015, Bol. Soc. Geol. Mex, V67, P227; Pangle KL, 2006, FRESHWATER BIOL, V51, P1070, DOI 10.1111/j.1365-2427.2006.01555.x; Peck HL, 2014, BEHAV ECOL, V25, P582, DOI 10.1093/beheco/aru025; Pejchar L, 2009, TRENDS ECOL EVOL, V24, P497, DOI 10.1016/j.tree.2009.03.016; Peralta-Higuera A, 2009, BIODIVERSIDAD ECOSIS, P27; Possley J, 2006, NAT AREA J, V26, P391, DOI 10.3375/0885-8608(2006)26[391:CEOTIG]2.0.CO;2; Pugnaire FI, 2001, OIKOS, V93, P42, DOI 10.1034/j.1600-0706.2001.930104.x; Ramirez-Albores JE, 2013, B RED LATINOAMERICAN, V3, P4; Ramirez-Cruz GA, 2018, NAT AREA J, V38, P68, DOI 10.3375/043.038.0108; Ramos-Lara N, 2011, SOUTHWEST NAT, V56, P400, DOI 10.1894/N02-RTS-11.1; Razo-Gonzalez M, 2014, APPL SOIL ECOL, V83, P88, DOI 10.1016/j.apsoil.2014.02.007; Richmond OMW, 2010, ECOL APPL, V20, P2036, DOI 10.1890/09-0470.1; Rodewald AD, 2010, BIOL INVASIONS, V12, P33, DOI 10.1007/s10530-009-9426-3; Rotherham ID, 2005, J PRACT ECOL CONSERV, V52-62, P3469, DOI [10.1007/s10530-017-1598-7, DOI 10.1007/S10530-017-1598-7]; Rothstein DE, 2004, ECOSYSTEMS, V7, P805, DOI 10.1007/s10021-004-0009-y; RUOA, 2018, PROGRAMA DE ESTACION; Rzedowski J, 1978, VEGETACION MEXICO; Schlaepfer MA, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005568; Schlaepfer MA, 2011, CONSERV BIOL, V25, P428, DOI 10.1111/j.1523-1739.2010.01646.x; Schlossberg S, 2010, J WILDLIFE MANAGE, V74, P1513, DOI 10.2193/2008-601; Schooler SS, 2010, BIOL INVASIONS, V12, P3289, DOI 10.1007/s10530-010-9722-y; Shochat E, 2004, OIKOS, V106, P622, DOI 10.1111/j.0030-1299.2004.13159.x; SIBLEY CG, 1973, AUK, V90, P394; Sibley DA, 2000, THE SIBLEY GUIDE TO; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Sloane SA, 2001, THE BIRDS OF NORTH A, DOI [10.2173/bna.598, DOI 10.2173/BNA.598]; Smith HM, 2017, BIOL INVASIONS, V19, P1315, DOI 10.1007/s10530-016-1340-x; Sousa R, 2011, BIOL INVASIONS, V13, P1055, DOI 10.1007/s10530-011-9947-4; Sridhar H, 2009, ANIM BEHAV, V78, P337, DOI 10.1016/j.anbehav.2009.05.008; Srinivas M, 2014, J ADV RES DYN CONTRO, V6, P62; Stensland E, 2003, MAMMAL REV, V33, P205, DOI 10.1046/j.1365-2907.2003.00022.x; Sthultz CM, 2007, NEW PHYTOL, V173, P135, DOI 10.1111/j.1469-8137.2006.01915.x; Thomas CD, 2015, P NATL ACAD SCI USA, V112, P4387, DOI 10.1073/pnas.1423995112; Thomsen MS, 2011, ENVIRON RES, V111, P899, DOI 10.1016/j.envres.2011.05.024; Vanderhoff N, 2016, BIRDS N AM, DOI [10.2173/bna.462, DOI 10.2173/BNA.462]; Vitousek PM, 1996, AM SCI, V84, P468; Wang F, 2015, BIOL CONSERV, V186, P319, DOI 10.1016/j.biocon.2015.03.032; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; With KA, 2002, CONSERV BIOL, V16, P1192, DOI 10.1046/j.1523-1739.2002.01064.x; Zambrano L, 2016, LA RESERVA ECOLOGICA; Zambrano L, 2006, CAN J FISH AQUAT SCI, V63, P1903, DOI 10.1139/F06-088; Zarzoso-Lacoste D, 2016, BIOL CONSERV, V193, P134, DOI 10.1016/j.biocon.2015.11.018; Zhou AM, 2015, AGR FOREST ENTOMOL, V17, P389, DOI 10.1111/afe.12119	127	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0211050	10.1371/journal.pone.0211050	http://dx.doi.org/10.1371/journal.pone.0211050			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657793	Green Submitted, gold, Green Published			2022-12-26	WOS:000456017000028
J	Silvestrini, A; Bruno, C; Vergani, E; Venuti, A; Favuzzi, AMR; Guidi, F; Nicolotti, N; Meucci, E; Mordente, A; Mancini, A				Silvestrini, Andrea; Bruno, Carmine; Vergani, Edoardo; Venuti, Angela; Favuzzi, Angela Maria Rita; Guidi, Francesco; Nicolotti, Nicola; Meucci, Elisabetta; Mordente, Alvaro; Mancini, Antonio			Circulating irisin levels in heart failure with preserved or reduced ejection fraction: A pilot study	PLOS ONE			English	Article							ASSOCIATION; PLASMA; SERUM	Irisin, a recently discovered myokine, has been considered a prognostic factor in several cardiovascular diseases. Nevertheless, no data are available on the role of irisin in patients with heart failure (HF), both with preserved (HFpEF) or reduced (HFrEF) ejection fraction. We have therefore evaluated the circulating irisin levels in HFpEF and HFrEF patients, correlating them with metabolic parameters and total antioxidant capacity (TAC), as index of oxidative stress. Irisin was significantly higher in HFpEF than in HFrEF patients (7.72 +/- 0.76 vs 2.77 +/- 0.77 ng/ml, respectively). An inverse correlation between irisin and TAC was found in HFpEF, but not in HFrEF. Conversely, no correlation was present with HOMA index. These data support the hypothesis that a different pathophysiological mechanism is involved in the two HF subtypes, and oxidative stress modulates irisin secretion.	[Silvestrini, Andrea; Meucci, Elisabetta; Mordente, Alvaro] Roma Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Inst Biochem & Clin Biochem, Rome, Italy; [Bruno, Carmine; Vergani, Edoardo; Mancini, Antonio] Roma Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Div Endocrinol, Internal Med Dept, Rome, Italy; [Venuti, Angela; Favuzzi, Angela Maria Rita] Roma Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Div Internal Med & Cardiovasc Dis, Internal Med Dept, Rome, Italy; [Guidi, Francesco] Roma Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Inst Gen Pathol, Rome, Italy; [Nicolotti, Nicola] Roma Univ Cattolica Sacro Cuore, Hosp Med Direct, Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Silvestrini, A (corresponding author), Roma Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Inst Biochem & Clin Biochem, Rome, Italy.; Mancini, A (corresponding author), Roma Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Div Endocrinol, Internal Med Dept, Rome, Italy.	andrea.silvestrini@unicatt.it; mancini.giac@mclink.it	Guidi, Francesco/AAS-9209-2021; Nicolotti, Nicola/K-1846-2018; Mordente, Alvaro/AAB-7290-2019; Vergani, Edoardo/GLT-3879-2022; Nicolotti, Nicola/P-9895-2019; Silvestrini, Andrea/B-3410-2009	Nicolotti, Nicola/0000-0002-3096-6397; Vergani, Edoardo/0000-0002-8444-0091; Nicolotti, Nicola/0000-0002-3096-6397; Silvestrini, Andrea/0000-0002-2005-3746; Bruno, Carmine/0000-0002-3489-0238				Aronis KN, 2015, INT J OBESITY, V39, P156, DOI 10.1038/ijo.2014.101; Aydin S, 2014, PEPTIDES, V52, P68, DOI 10.1016/j.peptides.2013.11.024; Borlaug BA, 2011, CARDIOL CLIN, V29, P447, DOI 10.1016/j.ccl.2011.06.004; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Gouni-Berthold I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072858; Han F, 2015, AM J PHYSIOL-HEART C, V309, pH1501, DOI 10.1152/ajpheart.00443.2015; Hosmer DW, 1997, STAT MED, V16, P965; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Lu JY, 2015, ATHEROSCLEROSIS, V243, P438, DOI 10.1016/j.atherosclerosis.2015.10.020; Mancini A, 2008, METABOLISM, V57, P1384, DOI 10.1016/j.metabol.2008.05.007; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Perakakis N, 2017, NAT REV ENDOCRINOL, V13, P324, DOI 10.1038/nrendo.2016.221; Polyzos SA, 2018, ENDOCRINE, V59, P260, DOI 10.1007/s12020-017-1476-1; Polyzos SA, 2015, METABOLISM, V64, P937, DOI 10.1016/j.metabol.2015.06.005; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Reddy YNV, 2016, CURR PROB CARDIOLOGY, V41, P145, DOI 10.1016/j.cpcardiol.2015.12.002; RICEEVANS C, 1994, METHOD ENZYMOL, V234, P279; Tromp J, 2017, JACC-HEART FAIL, V5, P507, DOI 10.1016/j.jchf.2017.04.007; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	20	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210320	10.1371/journal.pone.0210320	http://dx.doi.org/10.1371/journal.pone.0210320			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657767	Green Published, Green Submitted, gold			2022-12-26	WOS:000456017000009
J	Peretti, DE; Garcia, DV; Reesink, FE; van der Goot, T; De Deyn, PP; de Jong, BM; Dierckx, RAJO; Boellaard, R				Peretti, Debora E.; Garcia, David Vallez; Reesink, Fransje E.; van der Goot, Tim; De Deyn, Peter P.; de Jong, Bauke M.; Dierckx, Rudi A. J. O.; Boellaard, Ronald			Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer's disease PET studies	PLOS ONE			English	Article							REFERENCE TISSUE MODEL; BLOOD-FLOW; SENILE PLAQUES; EARLY-PHASE; BRAIN; DIAGNOSIS; IMAGES; F-18-FDG-PET; CEREBELLUM; METABOLISM	In Alzheimer's Disease (AD) dual-tracer positron emission tomography (PET) studies with 2-[F-18]-fluoro-2-deoxy-D-glucose (FDG) and C-11-labelled Pittsburgh Compound B (PIB) are used to assess metabolism and cerebral amyloid-beta deposition, respectively. Regional cerebral metabolism and blood flow (rCBF) are closely coupled, both providing an index for neuronal function. The present study compared PIB-derived rCBF, estimated by the ratio of tracer influx in target regions relative to reference region (R-1) and early-stage PIB uptake (ePIB), to FDG scans. Fifteen PIB positive (+) patients and fifteen PIB negative (-) subjects underwent both FDG and PIB PET scans to assess the use of R-1 and ePIB as a surrogate for FDG. First, subjects were classified based on visual inspection of the PIB PET images. Then, discriminative performance (PIB+ versus PIB-) of rCBF methods were compared to normalized regional FDG uptake. Strong positive correlations were found between analyses, suggesting that PIB-derived rCBF provides information that is closely related to what can be seen on FDG scans. Yet group related differences between method's distributions were seen as well. Also, a better correlation with FDG was found for R-1 than for ePIB. Further studies are needed to validate the use of R-1 as an alternative for FDG studies in clinical applications.	[Peretti, Debora E.; Garcia, David Vallez; van der Goot, Tim; Dierckx, Rudi A. J. O.; Boellaard, Ronald] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands; [Reesink, Fransje E.; De Deyn, Peter P.; de Jong, Bauke M.] Univ Groningen, Univ Med Ctr Groningen, Alzheimer Res Ctr, Dept Neurol, Groningen, Netherlands; [De Deyn, Peter P.] Univ Antwerp, Lab Neurochem & Behav, Inst Born Bunge, Antwerp, Belgium	University of Groningen; University of Groningen; University of Antwerp	Garcia, DV (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands.	d.vallez-garcia@umcg.nl	García, David Vállez/N-2348-2015	García, David Vállez/0000-0003-3308-3167; Peretti, Debora Elisa/0000-0002-3033-8817; De Deyn, Peter Paul/0000-0002-2228-2964; de Jong, Bauke M./0000-0002-6568-5739				Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Blomquist Gunnar, 2008, Open Neuroimag J, V2, P114, DOI 10.2174/1874440000802010114; Chen YJ, 2015, J NUCL MED, V56, P1199, DOI 10.2967/jnumed.114.152405; Daerr S, 2017, NEUROIMAGE-CLIN, V14, P77, DOI 10.1016/j.nicl.2016.10.005; Forsberg A, 2012, BBA-MOL BASIS DIS, V1822, P380, DOI 10.1016/j.bbadis.2011.11.006; Gjedde A, 2013, FRONT AGING NEUROSCI, V5, P1, DOI DOI 10.3389/FNAGI.2013.00001; Gomperts SN, 2008, NEUROLOGY, V71, P903, DOI 10.1212/01.wnl.0000326146.60732.d6; Greve DN, 2016, NEUROIMAGE, V132, P334, DOI 10.1016/j.neuroimage.2016.02.042; Greve DN, 2014, NEUROIMAGE, V92, P225, DOI 10.1016/j.neuroimage.2013.12.021; Grimmer T, 2009, NEUROBIOL AGING, V30, P1902, DOI 10.1016/j.neurobiolaging.2008.01.016; Gur RC, 2009, CEREB CORTEX, V19, P375, DOI 10.1093/cercor/bhn087; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Hsiao IT, 2013, EUR J NUCL MED MOL I, V40, P908, DOI 10.1007/s00259-013-2350-x; Hsiao IT, 2012, EUR J NUCL MED MOL I, V39, P613, DOI 10.1007/s00259-011-2051-2; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jagust W, 2007, NEUROLOGY, V69, P871, DOI 10.1212/01.wnl.0000269790.05105.16; JOACHIM CL, 1989, AM J PATHOL, V135, P309; JUEPTNER M, 1995, NEUROIMAGE, V2, P148, DOI 10.1006/nimg.1995.1017; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Krouwer JS, 2008, STAT MED, V27, P778, DOI 10.1002/sim.3086; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Lopresti BJ, 2005, J NUCL MED, V46, P1959; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Meyer PT, 2011, J NUCL MED, V52, P393, DOI 10.2967/jnumed.110.083683; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Morbelli S, 2015, J ALZHEIMERS DIS, V44, P815, DOI 10.3233/JAD-142229; Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7; Nordberg A, 2010, NAT REV NEUROL, V6, P78, DOI 10.1038/nrneurol.2009.217; Paulson OB, 2010, J CEREBR BLOOD F MET, V30, P2, DOI 10.1038/jcbfm.2009.188; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Price JC, 2005, J CEREBR BLOOD F MET, V25, P1528, DOI 10.1038/sj.jcbfm.9600146; R Development Core Team, 2017, R A LANGUAGE AND ENV; Rodriguez-Vieitez E, 2017, J CEREBR BLOOD F MET, V37, P740, DOI 10.1177/0271678X16645593; Rodriguez-Vieitez E, 2016, J NUCL MED, V57, P1071, DOI 10.2967/jnumed.115.168732; Rostomian AH, 2011, J NUCL MED, V52, P173, DOI 10.2967/jnumed.110.082057; Rousset OG, 1998, J NUCL MED, V39, P904; Rowe CC, 2007, NEUROLOGY, V68, P1718, DOI 10.1212/01.wnl.0000261919.22630.ea; Teipel S, 2015, LANCET NEUROL, V14, P1037, DOI 10.1016/S1474-4422(15)00093-9; Teune LK, 2010, MOVEMENT DISORD, V25, P2395, DOI 10.1002/mds.23291; Tiepolt S, 2016, EUR J NUCL MED MOL I, V43, P1700, DOI 10.1007/s00259-016-3353-1; Wu YJ, 2002, J CEREBR BLOOD F MET, V22, P1440, DOI 10.1097/01.WCB.0000033967.83623.34; YAMAGUCHI H, 1989, ACTA NEUROPATHOL, V77, P314, DOI 10.1007/BF00687584; Yaqub M, 2008, NEUROIMAGE, V42, P76, DOI 10.1016/j.neuroimage.2008.04.251; Zhou Y, 2007, NEUROIMAGE, V36, P298, DOI 10.1016/j.neuroimage.2007.03.004	46	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0211000	10.1371/journal.pone.0211000	http://dx.doi.org/10.1371/journal.pone.0211000			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653612	Green Published, Green Submitted, gold			2022-12-26	WOS:000456015500096
J	Simonsen, C; Thorsteinsson, K; Mortensen, RN; Torp-Pedersen, C; Kjaergaard, B; Andreasen, JJ				Simonsen, Carsten; Thorsteinsson, Kristinn; Mortensen, Rikke Normark; Torp-Pedersen, Christian; Kjaergaard, Benedict; Andreasen, Jan Jesper			Carbon monoxide poisoning in Denmark with focus on mortality and factors contributing to mortality	PLOS ONE			English	Article							HYPERBARIC-OXYGEN THERAPY; LONG-TERM MORTALITY; SUICIDE	Introduction Carbon monoxide (CO) poisoning is frequent worldwide but knowledge regarding the epidemiology is insufficient. The aim of this study was to clarify the extent of this intoxication, its mortality and factors associated with mortality. Materials and methods National databases from Statistics Denmark were used to identify individuals who suffered from CO-poisoning during 1995-2015, as well as information regarding co-morbidities, mortality and manner of death. Results During the period from 1995 to 2015, 22,930 patients suffered from CO-poisoning in Denmark, and 21,138 of these patients (92%) were hospitalized. A total of 2,102 patients died within the first 30 days after poisoning (9.2%). Among these, 1,792 (85% of 2,102) were declared dead at the scene and 310 (15% of 2,102) died during hospitalization. Deaths due to CO-poisoning from smoke were intentional in 6.3% of cases, whereas deaths due to CO containing gases were intentional in 98.0% of cases. Among patients who survived > 30 days, there was no significant difference in survival when comparing hyperbaric oxygen therapy (HBO) treatment with no HBO treatment after adjustment for age and co-morbidities such as drug abuse, psychiatric disease, stroke, alcohol abuse, arterial embolism, chronic obstructive pulmonary disease, cerebrovascular disease and atrial fibrillation. Several co-morbidities predicted poorer outcomes for patients who survived the initial 30 days. Conclusions Poisoning from smoke and/or CO is a frequent incident in Denmark accounting for numerous contacts with hospitals and deaths. Both intoxication and mortality are highly associated with co-morbidities interfering with cognitive and physical function. Treatment with HBO was not seen to have an effect on survival.	[Simonsen, Carsten; Thorsteinsson, Kristinn; Kjaergaard, Benedict; Andreasen, Jan Jesper] Aalborg Univ Hosp, Dept Cardiothorac Surg, Aalborg, Denmark; [Simonsen, Carsten; Andreasen, Jan Jesper] Aalborg Univ, Dept Clin Med, Aalborg, Denmark; [Mortensen, Rikke Normark; Torp-Pedersen, Christian] Aalborg Univ Hosp, Unit Epidemiol & Biostat, Aalborg, Denmark; [Kjaergaard, Benedict] Biomed Res Lab, Aalborg, Denmark	Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University; Aalborg University Hospital	Simonsen, C (corresponding author), Aalborg Univ Hosp, Dept Cardiothorac Surg, Aalborg, Denmark.; Simonsen, C (corresponding author), Aalborg Univ, Dept Clin Med, Aalborg, Denmark.	carsten.simonsen@rn.dk	Kjaergaard, Benedict/HHD-1772-2022	Kjaergaard, Benedict/0000-0001-5797-7638	Brodrene Hartmanns Fond [A31510]	Brodrene Hartmanns Fond	This research received funding from "Brodrene Hartmanns Fond," application number A31510 to CS; www.hartmannfonden.dk.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelborg K, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012817; Al-Moamary MS, 2000, SAUDI MED J, V21, P361; Alonso JR, 2003, PHARMACOL TOXICOL, V93, P142, DOI 10.1034/j.1600-0773.2003.930306.x; Braubach M, 2013, INDOOR AIR, V23, P115, DOI 10.1111/ina.12007; Buckley NA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002041.pub3; Dalgaard Jorgen B., 1961, ACTA JUTL, V33; Graversen Rie, 2017, COFORGIFTNING VISITA; Guzman JA, 2012, CRIT CARE CLIN, V28, P537, DOI 10.1016/j.ccc.2012.07.007; Hampson NB, 2007, UNDERSEA HYPERBAR M, V34, P163; Hampson NB, 2016, ANN AM THORAC SOC, V13, P1768, DOI 10.1513/AnnalsATS.201604-318OC; Hampson NB, 2015, UNDERSEA HYPERBAR M, V42, P159; Hampson NB, 2009, CRIT CARE MED, V37, P1941, DOI 10.1097/CCM.0b013e3181a0064f; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Huang CC, 2018, J CLIN MED, V7, DOI 10.3390/jcm7100349; Huang CC, 2017, CHEST, V152, P943, DOI 10.1016/j.chest.2017.03.049; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Lee FY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000624; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Madsen T, 2013, J CLIN PSYCHIAT, V74, pE1190, DOI 10.4088/JCP.13m08656; Mimura K, 1999, Seishin Shinkeigaku Zasshi, V101, P592; Mutluoglu M, 2016, UNDERSEA HYPERBAR M, V43, P49; Neuman TS., 2008, PHYSL MED HYPERBARIC; Nordentoft M, 2007, DAN MED BULL, V54, P306; Rix TA, 2012, SCAND CARDIOVASC J, V46, P149, DOI 10.3109/14017431.2012.673728; Rose JJ, 2018, CRIT CARE MED, V46, pE649, DOI 10.1097/CCM.0000000000003135; Rose JJ, 2017, AM J RESP CRIT CARE, V195, P596, DOI 10.1164/rccm.201606-1275CI; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Sundhedsstyrelsen, 2003, VISITATION OVERFLYTN; Tapeantong Toungrat, 2009, Journal of the Medical Association of Thailand, V92, P1374; Thomsen AH, 2006, FORENSIC SCI INT, V161, P41, DOI 10.1016/j.forsciint.2005.10.022; Thomsen Asser Hedegard, 2007, Ugeskr Laeger, V169, P2020; Van Sickle D, 2006, CLIN CHEM, V52, P338, DOI 10.1373/clinchem.2005.061911; Vest-Hansen Betina, 2013, Clin Epidemiol, V5, P129, DOI 10.2147/CLEP.S41905	33	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210767	10.1371/journal.pone.0210767	http://dx.doi.org/10.1371/journal.pone.0210767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653615	Green Submitted, Green Published, gold			2022-12-26	WOS:000456015500069
J	Tonn, B; Porath, I; Lattanzi, FA; Isselstein, J				Tonn, Bettina; Porath, Ina; Lattanzi, Fernando A.; Isselstein, Johannes			Urine effects on grass and legume nitrogen isotopic composition: Pronounced short-term dynamics of delta N-15	PLOS ONE			English	Article							NATURAL N-15 ABUNDANCE; AMMONIA VOLATILIZATION; OXIDE EMISSIONS; GRAZED PASTURE; SOIL; VEGETATION; PLANTS; FATE; PHOSPHORUS; PARAMETERS	Nitrogen stable isotope (N-15) natural abundance is widely used to study nitrogen cycling. In grazed ecosystems, urine patches are hot-spots of nitrogen inputs, losses, and changes in delta N-15. Understanding delta N-15 dynamics in urine-affected vegetation is therefore crucial for accurate inferences from N-15 natural abundance in grasslands. We hypothesized that leaf delta N-15 following urine deposition varies with time and plant functional group. Specifically, we expected (i) short-term decreases in delta N-15 due to foliar absorption of N-15-depleted volatilized ammonia, (ii) followed by increases in delta N-15 due to uptake of N-15-enriched soil inorganic nitrogen, and (iii) that the magnitude of these changes is less in legumes than in grasses. The latter should be expected because ammonia absorption depends on leaf nitrogen concentration, which is higher in legumes than grasses, and because biological nitrogen fixation will modify the influence of urine-derived nitrogen on delta N-15 in legumes. We applied cattle urine to a mixture of Lolium perenne and Trifolium repens in a pot experiment. Nitrogen concentration and delta N-15 were determined for successive leaf cohorts and bulk biomass either 17 (early) or 32 (late) days after urine application. Early after urine application, leaves of L. perenne were N-15-depleted compared to control plants (delta N-15 0.1 vs. 5.8 parts per thousand, respectively), but leaves of T. repens were not (-1.1 vs. -1.1 parts per thousand, respectively). Later, both species increased their delta N-15, but T. repens (4.5 parts per thousand) less so than L. perenne (5.9 parts per thousand). Vegetation sampled within and outside urine patches in the field further supported these results. Our findings confirm that foliar ammonia uptake can substantially decrease grass foliar delta N-15, and that in both grass and legume the direction of the delta N-15 response to urine changes over time. Temporal dynamics of plant delta N-15 at urine patches therefore need to be explicitly addressed when N-15 natural abundance is used to study nitrogen cycling in grazed grasslands.	[Tonn, Bettina; Porath, Ina; Isselstein, Johannes] Univ Goettingen, Dept Crop Sci, Grassland Sci, Gottingen, Germany; [Lattanzi, Fernando A.] Tech Univ Munich, Lehrstuhl Grunlandlehre, Freising Weihenstephan, Germany; [Lattanzi, Fernando A.] Inst Nacl Invest Agr INIA Uruguay, INIA La Estanzuela, Colonia, Uruguay; [Isselstein, Johannes] Ctr Biodivers & Sustainable Land Use, Gottingen, Germany	University of Gottingen; Technical University of Munich; Instituto Nacional de Investigacion Agropecuaria Uruguay (INIA)	Tonn, B (corresponding author), Univ Goettingen, Dept Crop Sci, Grassland Sci, Gottingen, Germany.	btonn@gwdg.de	Lattanzi, Fernando/A-5609-2009; Tonn, Bettina/AAH-5302-2019	Lattanzi, Fernando/0000-0002-2682-3692; Tonn, Bettina/0000-0003-1086-1990				[Anonymous], 2014, AGR ECOSYST ENVIRON, V184, P158, DOI [10.1016/j.agee.2013.11.028, DOI 10.1016/J.AGEE.2013.11.028]; Aranibar JN, 2008, J ARID ENVIRON, V72, P326, DOI 10.1016/j.jaridenv.2007.06.007; Barton K., 2016, MUMIN MULTIMODEL INF; Cameron KC, 2014, NEW ZEAL J AGR RES, V57, P251, DOI 10.1080/00288233.2013.797914; CARLSON GE, 1966, CROP SCI, V6, P293, DOI 10.2135/cropsci1966.0011183X000600030024x; Craine JM, 2015, PLANT SOIL, V396, P1, DOI 10.1007/s11104-015-2542-1; Craine JM, 2012, PLANT SOIL, V356, P395, DOI 10.1007/s11104-012-1141-7; Decau ML, 2003, J ENVIRON QUAL, V32, P1405, DOI 10.2134/jeq2003.1405; Dennis SJ, 2013, GRASS FORAGE SCI, V68, P378, DOI 10.1111/gfs.12000; Eriksen J, 1998, PLANT SOIL, V205, P67, DOI 10.1023/A:1004353229409; Erskine PD, 1998, OECOLOGIA, V117, P187, DOI 10.1007/s004420050647; FARQUHAR GD, 1980, PLANT PHYSIOL, V66, P710, DOI 10.1104/pp.66.4.710; Frank DA, 2004, BIOGEOCHEMISTRY, V68, P169, DOI 10.1023/B:BIOG.0000025736.19381.91; Frank DA, 1997, ECOLOGY, V78, P2238, DOI 10.1890/0012-9658(1997)078[2238:EONGOG]2.0.CO;2; Guodong HD, 2008, AGR ECOSYST ENVIRON, V125, P21, DOI 10.1016/j.agee.2007.11.009; HAYNES RJ, 1993, ADV AGRON, V49, P119, DOI 10.1016/S0065-2113(08)60794-4; Hogberg P, 1997, NEW PHYTOL, V137, P179, DOI 10.1046/j.1469-8137.1997.00808.x; Kriszan M, 2014, AGR ECOSYST ENVIRON, V184, P158, DOI 10.1016/j.agee.2013.11.028; LEDGARD SF, 1982, NEW ZEAL J AGR RES, V25, P541, DOI 10.1080/00288233.1982.10425219; Li CL, 2010, J PLANT NUTR SOIL SC, V173, P946, DOI 10.1002/jpln.200900243; Massad RS, 2010, ATMOS CHEM PHYS, V10, P10359, DOI 10.5194/acp-10-10359-2010; Moir JL, 2011, J AGR SCI-CAMBRIDGE, V149, P473, DOI 10.1017/S0021859610001012; PARSONS AJ, 1991, J AGR SCI, V116, P47, DOI 10.1017/S0021859600076139; Pinheiro J, R PACKAGE VERSION; R Core Team, 2013, R LANG ENV STAT COMP; Robinson D, 2001, TRENDS ECOL EVOL, V16, P153, DOI 10.1016/S0169-5347(00)02098-X; Rui YC, 2011, J SOIL SEDIMENT, V11, P903, DOI 10.1007/s11368-011-0388-6; Schjoerring JK, 1998, ATMOS ENVIRON, V32, P491, DOI 10.1016/S1352-2310(97)00006-X; Schnyder H, 2006, GLOBAL CHANGE BIOL, V12, P1315, DOI 10.1111/j.1365-2486.2006.01169.x; Schwertl M, 2005, AGR ECOSYST ENVIRON, V109, P153, DOI 10.1016/j.agee.2005.01.015; Sparks JP, 2009, OECOLOGIA, V159, P1, DOI 10.1007/s00442-008-1188-6; THOMAS RJ, 1988, PLANT SOIL, V107, P173, DOI 10.1007/BF02370544; Wachendorf C, 2008, J PLANT NUTR SOIL SC, V171, P171, DOI 10.1002/jpln.200625217; Watzka M, 2006, SOIL BIOL BIOCHEM, V38, P1564, DOI 10.1016/j.soilbio.2005.11.007; Wells NS, 2015, AGR ECOSYST ENVIRON, V199, P290, DOI 10.1016/j.agee.2014.10.001; Whitehead CD, 2000, NUTR ELEMENTS GRASSL; WHITEHEAD DC, 1991, BIOL FERT SOILS, V11, P279, DOI 10.1007/BF00335848; Wittmer MHOM, 2011, PLANT SOIL, V340, P25, DOI 10.1007/s11104-010-0411-5; Wrage N, 2011, NUTR CYCL AGROECOSYS, V90, P189, DOI 10.1007/s10705-011-9421-9; Xu YQ, 2010, J PLANT ECOL-UK, V3, P201, DOI 10.1093/jpe/rtq023	40	5	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210623	10.1371/journal.pone.0210623	http://dx.doi.org/10.1371/journal.pone.0210623			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650124	Green Submitted, Green Published, gold			2022-12-26	WOS:000455813300064
J	Benazzo, A; Schwarz, S; Muckenhuber, M; Schweiger, T; Murakozy, G; Moser, B; Siguenza, JM; Lang, G; Taghavi, S; Klepetko, W; Hoetzenecker, K; Jaksch, P; Lambers, C				Benazzo, Alberto; Schwarz, Stefan; Muckenhuber, Moritz; Schweiger, Thomas; Murakoezy, Gabriela; Moser, Bernhard; Sigueenza, Jose Matilla; Lang, Gyoergy; Taghavi, Shahrokh; Klepetko, Walter; Hoetzenecker, Konrad; Jaksch, Peter; Lambers, Cristopher			Alemtuzumab induction combined with reduced maintenance immunosuppression is associated with improved outcomes after lung transplantation: A single centre experience	PLOS ONE			English	Article							ANTI-THYMOCYTE GLOBULIN; RECIPIENTS RECEIVING ALEMTUZUMAB; BRONCHIOLITIS-OBLITERANS; ACUTE REJECTION; CAMPATH-1H; BASILIXIMAB; INFECTIONS; DACLIZUMAB; SURVIVAL	Question addressed by the study The value of induction therapy in lung transplantation is controversial. According to the ISHLT, only about 50% of patients transplanted within the last 10 years received induction therapy. We reviewed our institutional experience to investigate the impact of induction therapy on short-and long-term outcomes. Materials/Patients and methods Between 2007 and 2015, 446 patients with a complete follow-up were included in this retrospective analysis. Analysis comprised long-term kidney function, infectious complications, incidence of rejection and overall survival. Results A total of 231 patients received alemtuzumab, 50 patients antithymocyte globulin (ATG) and 165 patients did not receive induction therapy (NI). The alemtuzumab group revealed the lowest rate of chronic kidney insufficiency (NI: 52.2%; ATG: 60%; alemtuzumab: 36.6%; p = 0.001). Both, the NI group (p<0.001) and the ATG group (p = 0.010) showed a significant increase of serum creatinine during follow-up compared to alemtuzumab patients. Furthermore, alemtuzumab group experienced the lowest rate of infection in the first year after transplantation. Finally, improved survival, low rates of acute cellular rejection (ACR), lymphocytic bronchiolitis (LB) and chronic lung allograft dysfunction (CLAD) were found in patients treated either with alemtuzumab or ATG. Conclusion Alemtuzumab induction therapy followed by reduced maintenance immunosuppression is associated with a better kidney function compared to no induction and ATG. Survival rate as well as freedom from ACR and CLAD were comparable between alemtuzumab and ATG.	[Benazzo, Alberto; Schwarz, Stefan; Muckenhuber, Moritz; Schweiger, Thomas; Murakoezy, Gabriela; Moser, Bernhard; Sigueenza, Jose Matilla; Lang, Gyoergy; Taghavi, Shahrokh; Klepetko, Walter; Hoetzenecker, Konrad; Jaksch, Peter; Lambers, Cristopher] Med Univ Vienna, Div Thorac Surg, Dept Surg, Vienna, Austria	Medical University of Vienna	Jaksch, P (corresponding author), Med Univ Vienna, Div Thorac Surg, Dept Surg, Vienna, Austria.	peter.jaksch@meduniwien.ac.at	Benazzo, Alberto/AAU-2742-2021; Moser, Bernhard/ABA-9436-2020; Lang, György/O-5256-2017	Benazzo, Alberto/0000-0002-3549-4720; Moser, Bernhard/0000-0002-6037-5475; Lang, György/0000-0002-8839-6649; jaksch, peter/0000-0003-4635-3242				Ailawadi G, 2008, J THORAC CARDIOV SUR, V135, P594, DOI 10.1016/j.jtcvs.2007.10.044; Borro JM, 2005, TRANSPL P, V37, P3996, DOI 10.1016/j.transproceed.2005.09.192; Burton CM, 2006, J HEART LUNG TRANSPL, V25, P638, DOI 10.1016/j.healun.2006.01.011; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Floreth T, 2010, SEMIN RESP CRIT CARE, V31, P172, DOI 10.1055/s-0030-1249112; Furuya Y, 2016, AM J TRANSPLANT; Garrity ER, 2001, TRANSPLANTATION, V71, P773, DOI 10.1097/00007890-200103270-00015; Hachem RR, 2005, J HEART LUNG TRANSPL, V24, P1320, DOI 10.1016/j.healun.2004.09.002; Hartwig MG, 2008, J HEART LUNG TRANSPL, V27, P547, DOI 10.1016/j.healun.2008.01.022; Heidt S, 2012, AM J TRANSPLANT, V12, P1784, DOI 10.1111/j.1600-6143.2012.04012.x; Hopkins PM, 2008, CURR OPIN ORGAN TRAN, V13, P477, DOI 10.1097/MOT.0b013e32831040bf; Jaksch P, 2014, AM J TRANSPLANT, V14, P1839, DOI 10.1111/ajt.12824; Kaufman DB, 2006, AM J TRANSPLANT, V6, P331, DOI 10.1111/j.1600-6143.2005.01166.x; Khalifah AP, 2005, AM J TRANSPLANT, V5, P2022, DOI 10.1111/j.1600-6143.2005.00953.x; Knechtle SJ, 2004, SURGERY, V136, P754, DOI 10.1016/j.surg.2004.06.015; Ljungman P, 2017, CLIN INFECT DIS, V64, P87, DOI 10.1093/cid/ciw668; Malek SK, 2006, TRANSPLANTATION, V81, P17, DOI 10.1097/01.tp.0000189713.14993.db; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Meyer KC, 2014, EUR RESPIR J, V44, P1479, DOI 10.1183/09031936.00107514; Morris PJ, 2006, TRANSPLANTATION, V81, P1361, DOI 10.1097/01.tp.0000219235.97036.9c; Mullen JC, 2007, J HEART LUNG TRANSPL, V26, P504, DOI 10.1016/j.healun.2007.01.032; Nath DS, 2005, TRANSPL P, V37, P934, DOI 10.1016/j.transproceed.2005.01.054; Newell KA, 2010, J CLIN INVEST, V120, P1836, DOI 10.1172/JCI39933; Noris M, 2007, J AM SOC NEPHROL, V18, P1007, DOI 10.1681/ASN.2006101143; Palmer SM, 1999, CHEST, V116, P127, DOI 10.1378/chest.116.1.127; Peleg AY, 2007, CLIN INFECT DIS, V44, P204, DOI 10.1086/510388; Scheffert JL, 2014, J THORAC DIS, V6, P1039, DOI 10.3978/j.issn.2072-1439.2014.04.23; Sharples LD, 2002, J HEART LUNG TRANSPL; Shyu S, 2011, J HEART LUNG TRANSPL, V30, P743, DOI 10.1016/j.healun.2011.01.714; Silveira FP, 2006, J INFECTION, V53, P241, DOI 10.1016/j.jinf.2005.11.017; Tzakis AG, 2003, TRANSPLANTATION, V75, P1512, DOI 10.1097/01.TP.0000060250.50591.39; van Loenhout KCJ, 2010, INTERACT CARDIOV TH, V10, P190, DOI 10.1510/icvts.2009.213892; Whited LK, 2015, TRANSPLANTATION, V99, P2190, DOI 10.1097/TP.0000000000000687; Yusen RD, 2016, J HEART LUNG TRANSPL, V35, P1170, DOI 10.1016/j.healun.2016.09.001	34	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210443	10.1371/journal.pone.0210443	http://dx.doi.org/10.1371/journal.pone.0210443			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645645	gold, Green Published, Green Submitted			2022-12-26	WOS:000455810200031
J	Fang, LY; Sun, XH; Wang, Y; Du, LQ; Ji, KH; Wang, JH; He, NN; Liu, Y; Wang, Q; Zhai, HZ; Hao, JX; Xu, C; Liu, Q				Fang, Lianying; Sun, Xiaohui; Wang, Yan; Du, Liqing; Ji, Kaihua; Wang, Jinhan; He, Ningning; Liu, Yang; Wang, Qin; Zhai, Hezheng; Hao, Jianxiu; Xu, Chang; Liu, Qiang			RMI1 contributes to DNA repair and to the tolerance to camptothecin	FASEB JOURNAL			English	Article						double-strand breaks; RAD51; genome instability	HUMAN RECQ HELICASES; REPLICATION STRESS; MRN COMPLEX; DAMAGE RESPONSE; ACTIVATION; DISTINCT	Maintenance of genome integrity is critical for faithful propagation of genetic information and the prevention of the mutagenesis induced by various DNA damage events. RecQ-mediated genome instability protein 1 (RMI1), together with Bloom syndrome protein and topoisomerase III alpha, form an evolutionarily conserved complex that is critical for the maintenance of genomic stability. Herein, we report that RMI1 depletion increases cell sensitivity to camptothecin treatment, as shown by an elevation of genotoxic stress-induced DNA double-strand breaks, a stronger activation of the DNA damage response, and a greater G2/M cell cycle delay. Our findings support that, upon DNA damage, RMI1 forms nuclear foci at the damaged regions, interacts with RAD51, and facilitates the recruitment of RAD51 to initiate homologous recombination. Our data reveal the importance of RMI1 in response to DNA double-strand breaks and shed light on the molecular mechanisms by which RMI1 contributes to maintain genome stability.	[Fang, Lianying; Sun, Xiaohui; Wang, Yan; Du, Liqing; Ji, Kaihua; Wang, Jinhan; He, Ningning; Liu, Yang; Wang, Qin; Zhai, Hezheng; Hao, Jianxiu; Xu, Chang; Liu, Qiang] Chinese Acad Med Sci, Inst Radiat Med, Tianjin Key Lab Radiat Med & Mol Nucl Med, 238 Baidi Rd, Tianjin, Peoples R China; [Fang, Lianying; Sun, Xiaohui; Wang, Yan; Du, Liqing; Ji, Kaihua; Wang, Jinhan; He, Ningning; Liu, Yang; Wang, Qin; Zhai, Hezheng; Hao, Jianxiu; Xu, Chang; Liu, Qiang] Peking Union Med Coll, 238 Baidi Rd, Tianjin, Peoples R China; [Fang, Lianying] Shandong Acad Med Sci, Radiat Med Inst, Jinan, Peoples R China; [Xu, Chang] Nankai Univ, State Key Lab Med Chem Biol, Tianjin, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Radiation Medicine - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Nankai University	Xu, C; Liu, Q (corresponding author), Chinese Acad Med Sci, Inst Radiat Med, Tianjin Key Lab Radiat Med & Mol Nucl Med, 238 Baidi Rd, Tianjin, Peoples R China.; Xu, C; Liu, Q (corresponding author), Peking Union Med Coll, 238 Baidi Rd, Tianjin, Peoples R China.	xuchang@irm-cams.ac.cn; liuqiang@irm-cams.ac.cn	Liu, Qiang/AFK-6590-2022; Liu, Qiang/HHZ-3181-2022; liu, liu yang/Y-8494-2019	Liu, Qiang/0000-0002-7668-6868; Sun, Xiaohui/0000-0001-8218-1885	National Natural Science Foundation of China [31670859, 31200634]; CAMS Innovation Fund for Medical Science [2017-I2M-1-016, 2017-I2M-1-021]; Natural Science Foundation of Tianjin [15KPXM01SF056]; Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences [2016ZX310068, 2016ZX310198, 2016RC310019, 2016RC310017]; Fundamental Research Funds for the Central Universities [10023201601602]; Research Funds for the Innovation Team of IRM-CAMS Grant [1650]; PUMC Youth Fund [3332016100, 3332015101]; Fundamental Research Funds for CAMS PUMC Grant [2016ZX310074]; State Key Laboratory of Medicinal Chemical Biology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Innovation Fund for Medical Science; Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Research Funds for the Innovation Team of IRM-CAMS Grant; PUMC Youth Fund; Fundamental Research Funds for CAMS PUMC Grant; State Key Laboratory of Medicinal Chemical Biology	This study was supported by National Natural Science Foundation of China Grants 31670859 and 31200634; CAMS Innovation Fund for Medical Science Grants 2017-I2M-1-016 and 2017-I2M-1-021); Natural Science Foundation of Tianjin Grant 15KPXM01SF056; Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences Grants 2016ZX310068, 2016ZX310198, 2016RC310019, and 2016RC310017; Fundamental Research Funds for the Central Universities Grant 10023201601602; Research Funds for the Innovation Team of IRM-CAMS Grant 1650; PUMC Youth Fund Grants 3332016100 and 3332015101; Fundamental Research Funds for CAMS & PUMC Grant 2016ZX310074; and the State Key Laboratory of Medicinal Chemical Biology. The authors declare no conflicts of interest.	Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; Berniak K, 2013, CYTOM PART A, V83, P913, DOI 10.1002/cyto.a.22327; Brandsma Inger, 2012, Genome Integr, V3, P9, DOI 10.1186/2041-9414-3-9; Budzowska M, 2009, CELL BIOCHEM BIOPHYS, V53, P17, DOI 10.1007/s12013-008-9039-y; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Croteau DL, 2014, ANNU REV BIOCHEM, V83, P519, DOI 10.1146/annurev-biochem-060713-035428; Cruz C, 2018, ANN ONCOL, V29, P1203, DOI 10.1093/annonc/mdy099; Davis AJ, 2013, TRANSL CANCER RES, V2, P130, DOI 10.3978/j.issn.2218-676X.2013.04.02; Davis L, 2014, P NATL ACAD SCI USA, V111, pE924, DOI 10.1073/pnas.1400236111; Goldstein M, 2015, ANNU REV MED, V66, P129, DOI 10.1146/annurev-med-081313-121208; Haber JE, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201700229; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Jeggo P, 2007, ONCOGENE, V26, P7717, DOI 10.1038/sj.onc.1210868; Khan FA, 2017, J NUCLEIC ACIDS, V2017, DOI 10.1155/2017/6439169; Khurana S, 2015, GENES-BASEL, V6, P858, DOI 10.3390/genes6030858; Lavin MF, 2015, BIOMOLECULES, V5, P2877, DOI 10.3390/biom5042877; Lawrence KS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005150; Lee J, 2013, MOL BIOL CELL, V24, P1343, DOI 10.1091/mbc.E13-01-0025; Lu LC, 2014, ADV EXP MED BIOL, V804, P129, DOI 10.1007/978-3-319-04843-7_7; Magdalou I, 2014, SEMIN CELL DEV BIOL, V30, P154, DOI 10.1016/j.semcdb.2014.04.035; Mavragani IV, 2017, CANCERS, V9, DOI 10.3390/cancers9070091; Mazouzi A, 2014, EXP CELL RES, V329, P85, DOI 10.1016/j.yexcr.2014.09.030; Monnat RJ, 2010, SEMIN CANCER BIOL, V20, P329, DOI 10.1016/j.semcancer.2010.10.002; Ozer O, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180018; Rothkamm K, 2015, ENVIRON MOL MUTAGEN, V56, P491, DOI 10.1002/em.21944; Sulli G, 2012, NAT REV CANCER, V12, DOI 10.1038/nrc3344; Sung P, 2018, J BIOL CHEM, V293, P10500, DOI 10.1074/jbc.TM118.003212; Tripathi V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03393-8; Tubbs A, 2017, CELL, V168, DOI 10.1016/j.cell.2017.01.002; Urban V, 2017, BIOPHYS CHEM, V225, P20, DOI 10.1016/j.bpc.2016.11.005; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; von Morgen P, 2018, BIOL CELL, V110, P137, DOI 10.1111/boc.201700067; Wang W., 2017, BIOMED RES INT, V2017; West SC, 2015, COLD SH Q B, V80, P103, DOI 10.1101/sqb.2015.80.027649; Xu C, 2017, BIOCHEM BIOPH RES CO, V494, P158, DOI 10.1016/j.bbrc.2017.10.062; Xue XY, 2013, J BIOL CHEM, V288, P14221, DOI 10.1074/jbc.M113.465609; Zhang TY, 2012, CELL REP, V2, P1498, DOI 10.1016/j.celrep.2012.11.002	38	6	6	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5561	5570		10.1096/fj.201802014R	http://dx.doi.org/10.1096/fj.201802014R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30676768	Bronze			2022-12-26	WOS:000462888500074
J	Zhang, X; Wang, LQ; Qiu, K; Xu, DD; Yin, JD				Zhang, Xin; Wang, Liqi; Qiu, Kai; Xu, Doudou; Yin, Jingdong			Dynamic membrane proteome of adipogenic and myogenic precursors in skeletal muscle highlights EPHA2 may promote myogenic differentiation through ERK signaling	FASEB JOURNAL			English	Article						cell membrane proteins; adipogenesis; myogenesis	STEM-CELLS; PROLIFERATION; ACTIVATION; KINASE; APOPTOSIS; FUSION; MODEL; RAP1	The balance of myogenic and adipogenic differentiation is crucial for skeletal muscle homeostasis. Given the vital role of membrane proteins (MBPs) in cell signal perception, membrane proteomics was conducted to delineate mechanisms regulating differentiation of adipogenic and myogenic precursors in skeletal muscle. Adipogenic and myogenic precursors with divergent differentiation potential were isolated from the longissimus dorsi muscle of neonatal pigs by the preplate method. A total of 85 differentially expressed MBPs (P < 0.05 and fold change 1.2 or 0.83) between 2 precursors were detected via isobaric tags for relative and absolute quantitation (iTRAQ) assay, including 67 up-regulated and 18 down-regulated in myogenic precursors. Functional enrichment analysis uncovered that myogenic and adipogenic precursors showed significant differences in cytoskeleton organization, syncytium formation, environmental information processing, and organismal systems. Furthermore, key MBPs in regulating cell differentiation were also characterized, including ITGB3, ITGAV, ITPR3, and EPHA2. Noteworthily, EPHA2 was required for myogenic differentiation, and it may promote myogenic differentiation through ERK signaling. Collectively, our study provided an insight into the distinct MBP profile between myogenic and adipogenic precursors in skeletal muscle and served as a solid basis for supporting the role of MBPs in regulating differentiation.	[Zhang, Xin; Wang, Liqi; Qiu, Kai; Xu, Doudou; Yin, Jingdong] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China	China Agricultural University	Yin, JD (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China.	yinjd@cau.edu.cn		Qiu, Kai/0000-0002-6575-5346; Zhang, Xin/0000-0003-2632-4567; Yin, Jingdong/0000-0003-4623-0568	Major Project of National Natural Science Foundation of China [31790412]; National Key R&D Program of China [2018YFD0500402]; National Natural Science Foundation of China [31672431]	Major Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the Major Project of National Natural Science Foundation of China (Grant No. 31790412), National Key R&D Program of China (Grant No. 2018YFD0500402), and National Natural Science Foundation of China (Grant No. 31672431). The authors declare no conflicts of interest.	Agley CC, 2013, J CELL SCI, V126, P5610, DOI 10.1242/jcs.132563; Alonso-Martin S, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00058; Antigny F, 2014, CELL CALCIUM, V56, P513, DOI 10.1016/j.ceca.2014.10.014; Bassols A, 2014, PROTEOM CLIN APPL, V8, P715, DOI 10.1002/prca.201300099; Benoit B, 2017, NAT MED, V23, P990, DOI 10.1038/nm.4363; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Brunelli S, 2007, DEV BIOL, V304, P604, DOI 10.1016/j.ydbio.2007.01.006; Castiglioni A, 2014, STEM CELL REP, V2, P92, DOI 10.1016/j.stemcr.2013.12.006; Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Chen XF, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0770-z; Doherty KR, 2008, J BIOL CHEM, V283, P20252, DOI 10.1074/jbc.M802306200; Du M, 2013, J ANIM SCI, V91, P1419, DOI 10.2527/jas.2012-5670; Elia D, 2007, BBA-MOL CELL RES, V1773, P1438, DOI 10.1016/j.bbamcr.2007.06.006; Elsafadi M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.196; Feng Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.462; Gharaibeh B, 2008, NAT PROTOC, V3, P1501, DOI 10.1038/nprot.2008.142; Hindi SM, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003832; Hong HN, 2018, J CANCER RES CLIN, V144, P1649, DOI 10.1007/s00432-018-2683-8; Flamini MI, 2017, HORM CANCER-US, V8, P16, DOI 10.1007/s12672-016-0280-3; Kabbani N, 2008, PROTEOMICS, V8, P4146, DOI 10.1002/pmic.200800139; Keefe AC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8087; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Klymiuk N, 2013, HUM MOL GENET, V22, P4368, DOI 10.1093/hmg/ddt287; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lecourt S, 2010, EXP CELL RES, V316, P2513, DOI 10.1016/j.yexcr.2010.04.020; Lee SJ, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.296; Liu HJ, 2011, FASEB J, V25, P1914, DOI 10.1096/fj.10-170449; Liu N, 2017, NAT CELL BIOL, V19, P202, DOI 10.1038/ncb3477; Michailovici I, 2014, DEVELOPMENT, V141, P2611, DOI 10.1242/dev.107078; Milanesi A, 2016, ENDOCRINOLOGY, V157, P4, DOI 10.1210/en.2015-1443; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Minami M, 2011, MOL BIOL CELL, V22, P3508, DOI 10.1091/mbc.E11-03-0183; Morandi EM, 2016, SCI REP-UK, V6, DOI 10.1038/srep28889; Nowak SJ, 2009, J CELL SCI, V122, P3282, DOI 10.1242/jcs.047597; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pisani DF, 2010, STEM CELLS, V28, P753, DOI 10.1002/stem.317; Pizon V, 1996, EUR J CELL BIOL, V69, P224; Pizon V, 2000, ONCOGENE, V19, P6074, DOI 10.1038/sj.onc.1203984; Qiu K, 2018, J PROTEOME RES, V17, P3853, DOI 10.1021/acs.jproteome.8b00530; ROSS SE, 2000, SCIENCE, V0289, P00950, DOI [DOI 10.1126/SCIENCE.289.5481.950, DOI 10.1126/science.289.5481.950, 10.1126/science.289.5481.950]; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sohn J, 2015, HUM MOL GENET, V24, P3814, DOI 10.1093/hmg/ddv125; Song MY, 2004, AM J CLIN NUTR, V79, P874; Sun WJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep44133; Swartz ME, 2001, DEVELOPMENT, V128, P4669; Takasugi M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15728; Takegahara Y, 2014, EXP CELL RES, V324, P105, DOI 10.1016/j.yexcr.2014.03.021; Uezumi A, 2016, STEM CELL REP, V7, P263, DOI 10.1016/j.stemcr.2016.07.004; Uezumi A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00068; Xu BY, 2014, J BIOSCI BIOENG, V117, P624, DOI 10.1016/j.jbiosc.2013.10.018; Yeung F, 2013, CELL REP, V3, P1847, DOI 10.1016/j.celrep.2013.05.032; Zhang Q, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15664	54	10	12	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5495	5509		10.1096/fj.201801907R	http://dx.doi.org/10.1096/fj.201801907R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30668921	Green Published, hybrid			2022-12-26	WOS:000462888500069
J	Zhou, L; Gao, W; Wang, K; Huang, Z; Zhang, L; Zhang, Z; Zhou, J; Nice, EC; Huang, CH				Zhou, Li; Gao, Wei; Wang, Kui; Huang, Zhao; Zhang, Lu; Zhang, Zhe; Zhou, Jing; Nice, Edouard C.; Huang, Canhua			Brefeldin A inhibits colorectal cancer growth by triggering Bip/Akt-regulated autophagy	FASEB JOURNAL			English	Article						cancer therapy; ER stress; autophagic flux	ER STRESS; CELL-DEATH; APOPTOSIS; MITOCHONDRIAL; STATISTICS; RESISTANCE	Colorectal cancer (CRC) is one of the most prevalent neoplastic diseases worldwide, and effective treatment remains a challenge. Here, we found that the macrolide antibiotic brefeldin A (BFA) exhibits considerable antitumor activity both in vitro and in vivo. Induction of complete autophagic flux is characterized as a key event in BFA-induced CRC suppression. Mechanistically, BFA provokes endoplasmic reticulum stress-mediated binding immunoglobulin protein (Bip) expression, leading to increased Bip/Akt interaction and resultant decreased Akt phosphorylation, thereby activating autophagy. Autophagy inhibition or Bip suppression relieves BFA-induced cell death, suggesting a key role for Bip-regulated autophagy in the antitumor properties of BFA. Moreover, BFA acts synergistically with paclitaxel or 5-fluorouracil in CRC suppression. Collectively, our study provides an important molecular basis for BFA-induced autophagy and suggests that the antibiotic BFA could be repositioned as a potential anticancer drug for CRC treatment.	[Zhou, Li; Gao, Wei; Wang, Kui; Huang, Zhao; Zhang, Lu; Zhang, Zhe; Zhou, Jing; Huang, Canhua] Sichuan Univ, West China Hosp, State Key Lab Biotherapy & Canc Ctr, Deans Off 17,Sect 3,South Renmin Rd, Chengdu 610041, Sichuan, Peoples R China; [Zhou, Li; Gao, Wei; Wang, Kui; Huang, Canhua] Sichuan Univ, West China Sch Basic Sci & Forens Med, Chengdu, Sichuan, Peoples R China; [Zhou, Li; Gao, Wei; Huang, Canhua] Hainan Med Univ, Affiliated Hosp 2, Dept Oncol, Haikou, Hainan, Peoples R China; [Nice, Edouard C.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	Sichuan University; Sichuan University; Hainan Medical University; Monash University	Huang, CH (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy & Canc Ctr, Deans Off 17,Sect 3,South Renmin Rd, Chengdu 610041, Sichuan, Peoples R China.	hcanhua@scu.edu.cn	Kang, Jeong-Han/J-3541-2019	Kang, Jeong-Han/0000-0002-9693-0696; Huang, Zhao/0000-0001-9994-2070	Chinese National Natural Science Foundation of China (NSFC) [81430071, 81790251, 81672381, 81602194]; National Key Research and Development Program of China [2016YFC1200203]	Chinese National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was supported by grants from the Chinese National Natural Science Foundation of China (NSFC; 81430071, 81790251, 81672381, 81602194) and the National Key Research and Development Program of China (2016YFC1200203). The authors declare no conflicts of interest.	B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; de la Cruz-Morcillo MA, 2012, ONCOGENE, V31, P1073, DOI 10.1038/onc.2011.321; Dou QH, 2016, CANCER RES, V76, P4457, DOI 10.1158/0008-5472.CAN-15-2887; El-Shami K, 2015, CA-CANCER J CLIN, V65, P427, DOI 10.3322/caac.21286; Galluzzi L, 2017, NAT REV DRUG DISCOV, V16, P487, DOI 10.1038/nrd.2017.22; Gao M, 2014, ONCOGENE, V33, P745, DOI 10.1038/onc.2013.2; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; Huang HR, 2017, BIOORG MED CHEM LETT, V27, P2286, DOI 10.1016/j.bmcl.2017.04.047; Huang YH, 2018, GUT, V67, P307, DOI 10.1136/gutjnl-2016-311909; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Lee H, 2012, HUM MOL GENET, V21, P101, DOI 10.1093/hmg/ddr445; Lee SA, 2013, BASIC CLIN PHARMACOL, V113, P329, DOI 10.1111/bcpt.12107; Levy JMM, 2017, NAT REV CANCER, V17, P528, DOI 10.1038/nrc.2017.53; Ma XH, 2014, J CLIN INVEST, V124, P1406, DOI 10.1172/JCI70454; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Moon JL, 2012, BIOCHEM BIOPH RES CO, V417, P760, DOI 10.1016/j.bbrc.2011.12.030; PELHAM HRB, 1991, CELL, V67, P449, DOI 10.1016/0092-8674(91)90517-3; Rashid HO, 2015, AUTOPHAGY, V11, P1956, DOI 10.1080/15548627.2015.1091141; Sausville E A, 1996, Cancer J Sci Am, V2, P52; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; TAMURA G, 1968, J ANTIBIOT, V21, P160, DOI 10.7164/antibiotics.21.160; Tang B, 2015, AUTOPHAGY, V11, P344, DOI 10.1080/15548627.2015.1023682; Tseng CN, 2014, MOLECULES, V19, P17464, DOI 10.3390/molecules191117464; Tseng CN, 2013, MOLECULES, V18, P10242, DOI 10.3390/molecules180910242; Wang K, 2011, AUTOPHAGY, V7, P966, DOI 10.4161/auto.7.9.15863; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wey S, 2012, BLOOD, V119, P817, DOI 10.1182/blood-2011-06-357384; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Yu TC, 2017, CELL, V170, P548, DOI 10.1016/j.cell.2017.07.008; Yung HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017894; Zhang HH, 2015, CANCER LETT, V356, P781, DOI 10.1016/j.canlet.2014.10.029; Zhang ZD, 2016, GENE, V584, P75, DOI 10.1016/j.gene.2016.03.012	37	21	22	4	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5520	5534		10.1096/fj.201801983R	http://dx.doi.org/10.1096/fj.201801983R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30668917				2022-12-26	WOS:000462888500071
J	Ohm, AM; Affandi, T; Reyland, ME				Ohm, Angela M.; Affandi, Trisiani; Reyland, Mary E.			EGF receptor and PKC kinase activate DNA damage-induced pro-survival and pro-apoptotic signaling via biphasic activation of ERK and MSK1 kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; protein kinase C (PKC); signal transduction; mitogen-activated protein kinase (MAPK); DNA damage; epidermal growth factor receptor (EGFR); extracellular signal-regulated kinase (ERK); cell signaling; kinase cascade; mitogen-sensitive kinase (MSK)	C-DELTA; SALIVARY-GLAND; DRUG-SENSITIVITY; NUCLEAR IMPORT; PHOSPHORYLATION; CISPLATIN; DEATH; INHIBITION; REPAIR; MKP-1	DNA damage-mediated activation of extracellular signal-regulated kinase (ERK) can regulate both cell survival and cell death. We show here that ERK activation in this context is biphasic and that early and late activation events are mediated by distinct upstream signals that drive cell survival and apoptosis, respectively. We identified the nuclear kinase mitogen-sensitive kinase 1 (MSK1) as a downstream target of both early and late ERK activation. We also observed that activation of ERKMSK1 up to 4 h after DNA damage depends on epidermal growth factor receptor (EGFR), as EGFR or mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK)/ERK inhibitors or short hairpin RNA-mediated MSK1 depletion enhanced cell death. This prosurvival response was partially mediated through enhanced DNA repair, as EGFR or MEK/ERK inhibitors delayed DNA damage resolution. In contrast, the second phase of ERKMSK1 activation drove apoptosis and required protein kinase C (PKC) but not EGFR. Genetic disruption of PKC reduced ERK activation in an in vivo irradiation model, as did short hairpin RNA-mediated depletion of PKC in vitro. In both models, PKC inhibition preferentially suppressed late activation of ERK. We have shown previously that nuclear localization of PKC is necessary and sufficient for apoptosis. Here we identified a nuclear PKCERKMSK1 signaling module that regulates apoptosis. We also show that expression of nuclear PKC activates ERK and MSK1, that ERK activation is required for MSK1 activation, and that both ERK and MSK1 activation are required for apoptosis. Our findings suggest that location-specific activation by distinct upstream regulators may enable distinct functional outputs from common signaling pathways.	[Ohm, Angela M.; Affandi, Trisiani; Reyland, Mary E.] Univ Colorado Anschutz Med Campus, Dept Craniofacial Biol, Sch Dent Med, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Reyland, ME (corresponding author), Univ Colorado Anschutz Med Campus, Dept Craniofacial Biol, Aurora, CO 80045 USA.	Mary.Reyland@ucdenver.edu		Affandi, Trisiani/0000-0002-2307-0357; Ohm, Angela/0000-0002-4495-5103	NIDCR, National Institutes of Health [R01DE027517, R01 DE015648]; NATIONAL CANCER INSTITUTE [T32CA190216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE027517, R01DE015648] Funding Source: NIH RePORTER	NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIDCR, National Institutes of Health Grants R01DE027517 and R01 DE015648 (to A. M. O., T. A., and M. E. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adewumi Ifeoluwa, 2019, Advances in Biological Regulation, V71, P147, DOI 10.1016/j.jbior.2018.09.010; Adwan TS, 2011, J BIOL CHEM, V286, P35716, DOI 10.1074/jbc.M111.255950; Allen-Petersen BL, 2014, ONCOGENE, V33, P1306, DOI 10.1038/onc.2013.59; Allen-Petersen BL, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.20; Arany S, 2013, MOL THER, V21, P1182, DOI 10.1038/mt.2013.42; Bagnyukova TV, 2013, BRIT J CANCER, V109, P1063, DOI 10.1038/bjc.2013.353; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Chou RH, 2014, DEV CELL, V30, P224, DOI 10.1016/j.devcel.2014.06.008; DeVries TA, 2004, J BIOL CHEM, V279, P45603, DOI 10.1074/jbc.M407448200; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; DeVries-Seimon TA, 2007, J BIOL CHEM, V282, P22307, DOI 10.1074/jbc.M703661200; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Drobic B, 2010, NUCLEIC ACIDS RES, V38, P3196, DOI 10.1093/nar/gkq030; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; Hsu SC, 2009, AM J TRANSL RES, V1, P249; Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200; Kolb RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050281; Kucharska A, 2009, CELL SIGNAL, V21, P1794, DOI 10.1016/j.cellsig.2009.07.015; Lang E, 2015, SCI REP-UK, V5, DOI 10.1038/srep17316; Leitges M, 2001, J CLIN INVEST, V108, P1505; Liccardi G, 2011, CANCER RES, V71, P1103, DOI 10.1158/0008-5472.CAN-10-2384; Liu H, 2007, MOL CELL BIOL, V27, P8480, DOI 10.1128/MCB.01126-07; Lomonaco SL, 2008, J BIOL CHEM, V283, P17731, DOI 10.1074/jbc.M801727200; Matassa A, 2003, CELL DEATH DIFFER, V10, P269, DOI 10.1038/sj.cdd.4401149; Matassa AA, 2001, J BIOL CHEM, V276, P29719, DOI 10.1074/jbc.M100273200; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Nyati MK, 2006, CANCER RES, V66, P11554, DOI 10.1158/0008-5472.CAN-06-1935; Ohm AM, 2017, ONCOGENE, V36, P4370, DOI 10.1038/onc.2017.27; Pabla N, 2011, J CLIN INVEST, V121, P2709, DOI 10.1172/JCI45586; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Quissell DO, 1998, IN VITRO CELL DEV-AN, V34, P58; Reyland ME, 2016, PHARMACOL THERAPEUT, V165, P1, DOI 10.1016/j.pharmthera.2016.05.001; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; Reyskens KMSE, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00056; Rodemann HP, 2007, INT J RADIAT BIOL, V83, P781, DOI 10.1080/09553000701769970; Sawicka A, 2014, GENOME RES, V24, P1808, DOI 10.1101/gr.176255.114; Shi GX, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.384248; Symonds JM, 2011, CANCER RES, V71, P2087, DOI 10.1158/0008-5472.CAN-10-1511; Tentner AR, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.1; Vissink A, 2010, INT J RADIAT ONCOL, V78, P983, DOI 10.1016/j.ijrobp.2010.06.052; Wei F, 2011, CURR MED CHEM, V18, P5476, DOI 10.2174/092986711798194388; Wie SM, 2017, MOL CANCER THER, V16, P1989, DOI 10.1158/1535-7163.MCT-17-0267; Wie SM, 2014, J BIOL CHEM, V289, P10900, DOI 10.1074/jbc.M114.551366; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367	45	14	16	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4488	4497		10.1074/jbc.RA118.006944	http://dx.doi.org/10.1074/jbc.RA118.006944			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30679314	Green Published, hybrid			2022-12-26	WOS:000462969500017
J	Waller, R; Baxter, L; Fillingham, DJ; Coelho, S; Pozo, JM; Mozumder, M; Frangi, AF; Ince, PG; Simpson, JE; Highley, JR				Waller, Rachel; Baxter, Lynne; Fillingham, Daniel J.; Coelho, Santiago; Pozo, Jose M.; Mozumder, Meghdoot; Frangi, Alejandro F.; Ince, Paul G.; Simpson, Julie E.; Highley, J. Robin			Iba-1(-)/CD68(+) microglia are a prominent feature of age-associated deep subcortical white matter lesions	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CEREBRAL WHITE; ALZHEIMERS-DISEASE; COGNITIVE FUNCTION; UNSELECTED COHORT; PATHOLOGY; HYPERINTENSITIES; DYSFUNCTION; ACTIVATION; MYELIN	Deep subcortical lesions (DSCL) of the brain, are present in similar to 60% of the ageing population, and are linked to cognitive decline and depression. DSCL are associated with demyelination, blood brain barrier (BBB) dysfunction, and microgliosis. Microglia are the main immune cell of the brain. Under physiological conditions microglia have a ramified morphology, and react to pathology with a change to a more rounded morphology as well as showing protein expression alterations. This study builds on previous characterisations of DSCL and radiologically 'normal-appearing' white matter (NAWM) by performing a detailed characterisation of a range of microglial markers in addition to markers of vascular integrity. The Cognitive Function and Ageing Study (CFAS) provided control white matter (WM), NAWM and DSCL human post mortem tissue for immunohistochemistry using microglial markers (Iba-1, CD68 and MHCII), a vascular basement membrane marker (collagen IV) and markers of BBB integrity (fibrinogen and aquaporin 4). The immunoreactive profile of CD68 increased in a stepwise manner from controlWM to NAWM to DSCL. This correlated with a shift from small, ramified cells, to larger, more rounded microglia. While there was greater Iba-1 immunoreactivity in NAWM compared to controls, in DSCL, Iba-1 levels were reduced to control levels. A prominent feature of these DSCL was a population of Iba-1(-)/CD68(+) microglia. There were increases in collagen IV, but no change in BBB integrity. Overall the study shows significant differences in the immunoreactive profile of microglial markers. Whether this is a cause or effect of lesion development remains to be elucidated. Identifying microglia subpopulations based on their morphology and molecular markers may ultimately help decipher their function and role in neurodegeneration. Furthermore, this study demonstrates that Iba-1 is not a pan-microglial marker, and that a combination of several microglial markers is required to fully characterise the microglial phenotype.	[Waller, Rachel; Baxter, Lynne; Fillingham, Daniel J.; Ince, Paul G.; Simpson, Julie E.; Highley, J. Robin] Univ Sheffield, Sheffield Inst Translat Neurosci, Dept Neurosci, Sheffield, S Yorkshire, England; [Coelho, Santiago; Pozo, Jose M.; Frangi, Alejandro F.] Univ Leeds, Sch Comp, Ctr Computat Imaging & Simulat Technol Biomed, Leeds, W Yorkshire, England; [Mozumder, Meghdoot] Univ Sheffield, Dept Engn, Ctr Computat Imaging & Simulat Technol Biomed, Sheffield, S Yorkshire, England	University of Sheffield; University of Leeds; University of Sheffield	Waller, R (corresponding author), Univ Sheffield, Sheffield Inst Translat Neurosci, Dept Neurosci, Sheffield, S Yorkshire, England.	R.Waller@Sheffield.ac.uk	Pozo, Jose M/M-7604-2016; Waller, Rachel/I-7008-2019; Mozumder, Meghdoot/J-9393-2019; Frangi, Alejandro F/C-6500-2008	Pozo, Jose M/0000-0002-0759-3510; Waller, Rachel/0000-0001-5815-8829; Mozumder, Meghdoot/0000-0002-0656-4291; Frangi, Alejandro F/0000-0002-2675-528X; Coelho, Santiago/0000-0002-1039-4803	OCEAN project - Engineering and Physical Sciences Research Council (EPSRC) [EP/M006328/1]; MedIAN Network - Engineering and Physical Sciences Research Council (EPSRC) [EP/N026993/1]; European Commission FP7 Project VPH-DARE@IT [FP7-ICT-2011-9-601055]; Department of Health; Medical Research Council [MRC/G9901400, MRC U.1052.00.0013]; UKNIHR Biomedical Research Centre for Ageing and Age-related Disease Award; NIHR Cambridge Biomedical Research Centre; Cambridgeshire and Peterborough NIHR CLAHRC; Nottingham University Hospitals NHS Trust; University of Sheffield; Sheffield Teaching Hospitals NHS Foundation Trust; Oxford Biomedical Research Centre; Walton Centre NHS Foundation Trust, Liverpool; bet365/Denise Coates Foundation; EPSRC [EP/M000133/1, EP/M006328/1, EP/M006328/2, EP/N026993/1] Funding Source: UKRI; MRC [G1100540, G9901400] Funding Source: UKRI	OCEAN project - Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MedIAN Network - Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Commission FP7 Project VPH-DARE@IT; Department of Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UKNIHR Biomedical Research Centre for Ageing and Age-related Disease Award; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cambridgeshire and Peterborough NIHR CLAHRC; Nottingham University Hospitals NHS Trust; University of Sheffield; Sheffield Teaching Hospitals NHS Foundation Trust; Oxford Biomedical Research Centre; Walton Centre NHS Foundation Trust, Liverpool; bet365/Denise Coates Foundation; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work has been supported by the OCEAN project (EP/M006328/1) and MedIAN Network (EP/N026993/1) both funded by the Engineering and Physical Sciences Research Council (EPSRC) and the European Commission FP7 Project VPH-DARE@IT(FP7-ICT-2011-9-601055).The CFAS study is supported by the Department of Health and the Medical Research Council (grants MRC/G9901400 and MRC U.1052.00.0013); the UKNIHR Biomedical Research Centre for Ageing and Age-related Disease Award to the Newcastle upon Tyne Hospitals Foundation Trust; the Cambridge Brain Bank is supported by the NIHR Cambridge Biomedical Research Centre; The Cambridgeshire and Peterborough NIHR CLAHRC; Nottingham University Hospitals NHS Trust; University of Sheffield and the Sheffield Teaching Hospitals NHS Foundation Trust; The Thomas Willis Oxford Brain Collection, supported by the Oxford Biomedical Research Centre; The Walton Centre NHS Foundation Trust, Liverpool. The Nanozoomer XR scanner was funded by the bet365/Denise Coates Foundation.	Al-Mashhadi S, 2015, BRAIN PATHOL, V25, P565, DOI 10.1111/bpa.12216; Amici SA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01520; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Brayne C, 2006, INT J EPIDEMIOL, V35, P1140, DOI 10.1093/ije/dyl199; Bridges LR, 2014, J NEUROPATH EXP NEUR, V73, P1026, DOI 10.1097/NEN.0000000000000124; Brown WR, 2011, NEUROPATH APPL NEURO, V37, P56, DOI 10.1111/j.1365-2990.2010.01139.x; Brown WR, 2002, J NEUROL SCI, V203, P159, DOI 10.1016/S0022-510X(02)00283-6; Chen AQ, 2016, BRAIN, V139, P242, DOI 10.1093/brain/awv328; Coelho S, 2018, NEUROIMAGE, V179, P275, DOI 10.1016/j.neuroimage.2018.06.040; Fernando MS, 2006, STROKE, V37, P1391, DOI 10.1161/01.STR.0000221308.94473.14; Fernando MS, 2004, NEUROPATH APPL NEURO, V30, P385, DOI 10.1111/j.1365-2990.2004.00550.x; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Hainsworth AH, 2017, STROKE, V48, P2799, DOI 10.1161/STROKEAHA.117.018101; Hopperton K, 2018, MOL PSYCHIATR, V23, P177, DOI 10.1038/mp.2017.246; Huang YH, 2010, NEUROPATH APPL NEURO, V36, P237, DOI 10.1111/j.1365-2990.2009.01049.x; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Kabba JA, 2018, CELL MOL NEUROBIOL, V38, P53, DOI 10.1007/s10571-017-0504-2; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Minett T, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0601-z; MOODY DM, 1991, CLIN NEUR, V37, P372; Ohsawa K, 2000, J CELL SCI, V113, P3073; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Ryu JK, 2009, J CELL MOL MED, V13, P2911, DOI 10.1111/j.1582-4934.2008.00434.x; SCHELTENS P, 1993, J NEUROL SCI, V114, P7, DOI 10.1016/0022-510X(93)90041-V; Simpson JE, 2007, NEUROPATH APPL NEURO, V33, P670, DOI 10.1111/j.1365-2990.2007.00890.x; Simpson JE, 2007, NEUROPATH APPL NEURO, V33, P410, DOI 10.1111/j.1365-2990.2007.00828.x; Simpson JE, 2010, NEUROSCI LETT, V486, P246, DOI 10.1016/j.neulet.2010.09.063; Simpson JE, 2009, STROKE, V40, P369, DOI 10.1161/STROKEAHA.108.529214; Streit WJ, 2009, ACTA NEUROPATHOL, V118, P475, DOI 10.1007/s00401-009-0556-6; Walker DG, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0139-9; Wharton SB, 2015, BRAIN PATHOL, V25, P35, DOI 10.1111/bpa.12219; Young VG, 2008, NEUROLOGY, V71, P804, DOI 10.1212/01.wnl.0000319691.50117.54	33	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210888	10.1371/journal.pone.0210888	http://dx.doi.org/10.1371/journal.pone.0210888			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682074	Green Published, gold, Green Accepted			2022-12-26	WOS:000457037500072
J	Hong, H; Song, JM; Yeom, E				Hong, Hyeonji; Song, Jae Min; Yeom, Eunseop			Variations in pulsatile flow around stenosed microchannel depending on viscosity	PLOS ONE			English	Article							NON-NEWTONIAN MODELS; BLOOD ANALOG FLUID; SHEAR-STRESS; WHOLE-BLOOD; ARTERY; VISUALIZATION; ENLARGEMENT; DEPENDENCE; VOLUME; CELLS	In studying blood flow in the vessels, the characteristics of non-Newtonian fluid are important, considering the role of viscosity in rheology. Stenosis, which is an abnormal narrowing of the vessel, has an influence on flow behavior. Therefore, analysis of blood flow in stenosed vessels is essential. However, most of them exist as simulation outcomes. In this study, non-Newtonian fluid was observed in stenosed microchannels under the pulsatile flow condition. A polydimethylsiloxane channel with 60% stenosis was fabricated by combining an optic fiber and a petri dish, resembling a mold. Three types of samples were prepared by changing the concentrations of xanthan gum, which induces a shear thinning effect (phosphate buffered saline (PBS) solution as the Newtonian fluid and two non-Newtonian fluids mimicking normal blood and highly viscous blood analog). The viscosity of the samples was measured using a Y-shaped microfluidic viscometer. Thereafter, velocity profiles were analyzed under the pulsatile flow condition using the micro-particle image velocimetry (PIV) method. For the Newtonian fluid, the streamline was skewed more to the wall of the channel. The velocity profile of the non-Newtonian fluid was generally blunter than that of the Newtonian fluid. A highly oscillating wall shear stress (WSS) during the pulsatile phase may be attributed to such a bluntness of flow under the same wall shear rate condition with the Newtonian fluid. In addition, a highly viscous flow contributes to the variation in the WSS after passing through the stenosed structures. A similar tendency was observed in simulation results. Such a variation in the WSS was associated with plaque instability or rupture and damage of the tissue layer. These results, related to the influence on the damage to the endothelium or stenotic lesion, may help clinicians understand relevant mechanisms.	[Hong, Hyeonji; Yeom, Eunseop] Pusan Natl Univ, Sch Mech Engn, Busan, South Korea; [Song, Jae Min] Pusan Natl Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Busan, South Korea	Pusan National University; Pusan National University	Yeom, E (corresponding author), Pusan Natl Univ, Sch Mech Engn, Busan, South Korea.	esyeom@pusan.ac.kr	Yeom, Eunseop/AAR-8322-2020	Yeom, Eunseop/0000-0002-9717-030X	National Research Foundation (NRF) of Korea - Korea government (MSIP) [NRF-2016R1C1B2014255, 2017R1C1B5018423]	National Research Foundation (NRF) of Korea - Korea government (MSIP)	This work was supported by a National Research Foundation (NRF) of Korea grant funded by the Korea government (MSIP) (NRF-2016R1C1B2014255 and 2017R1C1B5018423). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amornsamankul S., 2006, INT J BIOL MED SCI, V1, P42; Anastasiou AD, 2012, MED ENG PHYS, V34, P211, DOI 10.1016/j.medengphy.2011.07.012; Ashrafizaadeh M, 2009, COMPUT MATH APPL, V58, P1045, DOI 10.1016/j.camwa.2009.02.021; Bishop JJ, 2002, AM J PHYSIOL-HEART C, V283, pH1985, DOI 10.1152/ajpheart.00888.2001; Bishop JJ, 2001, AM J PHYSIOL-HEART C, V281, pH951, DOI 10.1152/ajpheart.2001.281.2.H951; Bourdon CJ, 2006, J FLUID ENG-T ASME, V128, P883, DOI 10.1115/1.2201649; Brunette J, 2008, MED ENG PHYS, V30, P1193, DOI 10.1016/j.medengphy.2008.02.012; Cheng C, 2006, CIRCULATION, V113, P2744, DOI 10.1161/CIRCULATIONAHA.105.590018; CHIEN S, 1970, SCIENCE, V168, P977, DOI 10.1126/science.168.3934.977; Cowan AQ, 2012, CARDIOVASC DRUG THER, V26, P339, DOI 10.1007/s10557-012-6402-4; Deplano V, 2014, J BIOMECH, V47, P1262, DOI 10.1016/j.jbiomech.2014.02.026; Dolan JM, 2013, ANN BIOMED ENG, V41, P1411, DOI 10.1007/s10439-012-0695-0; Dolan JM, 2011, ANN BIOMED ENG, V39, P1620, DOI 10.1007/s10439-011-0267-8; FRY DL, 1968, CIRC RES, V22, P165, DOI 10.1161/01.RES.22.2.165; Gijsen FJH, 2008, AM J PHYSIOL-HEART C, V295, pH1608, DOI 10.1152/ajpheart.01081.2007; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; Ha H, 2016, KOREAN J RADIOL, V17, P445, DOI 10.3348/kjr.2016.17.4.445; Hong H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186300; Jahangiri M, 2018, INT J ADV DESIGN MAN, V11; Karri S, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000934; KUMAR N, 2013, INT J MICRONANOSCALE, V4, P33; Kwak BR, 2014, EUR HEART J, V35, P3013, DOI 10.1093/eurheartj/ehu353; Lima R, 2008, BIOMED MICRODEVICES, V10, P153, DOI 10.1007/s10544-007-9121-z; LOWE GDO, 1992, CIRCULATION, V85, P2329, DOI 10.1161/01.CIR.85.6.2329; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Mannino RG, 2015, SCI REP-UK, V5, DOI 10.1038/srep12401; Mejia J, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004408; Molla MM, 2012, MED ENG PHYS, V34, P1079, DOI 10.1016/j.medengphy.2011.11.013; Nandakumar N, 2015, EUR J MECH B-FLUID, V49, P29, DOI 10.1016/j.euromechflu.2014.07.005; Nejad AA, 2018, COMPUT METH PROG BIO, V154, P109, DOI 10.1016/j.cmpb.2017.11.016; Nguyen TT, 2004, J BIOMECH ENG-T ASME, V126, P529, DOI 10.1115/1.1785812; Olsen MG, 2003, J FLUID ENG-T ASME, V125, P895, DOI 10.1115/1.1598989; Poelma C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045247; Pratumwal Y., 2017, SONGKLA J SCI TECHNO, V39, P625, DOI 10.14456/sjst-psu.2017.77; Rabby M.G., 2014, J FLUIDS, V2014; Rabby MG, 2013, PROCEDIA ENGINEER, V56, P225, DOI 10.1016/j.proeng.2013.03.111; Samady H., 2011, CIRCULATION, pCIRCULATIONAHA; Schoenhagen P, 2000, CIRCULATION, V101, P598, DOI 10.1161/01.CIR.101.6.598; Siauw WL, 2000, MED ENG PHYS, V22, P265, DOI 10.1016/S1350-4533(00)00036-9; Steinman DA, 2000, J BIOMECH, V33, P623, DOI 10.1016/S0021-9290(99)00205-5; SUTERA SP, 1975, BIOPHYS J, V15, P1, DOI 10.1016/S0006-3495(75)85787-0; Tian FB, 2013, COMPUT BIOL MED, V43, P1098, DOI 10.1016/j.compbiomed.2013.05.023; Toraldo DM, 2013, LUNG, V191, P1, DOI 10.1007/s00408-012-9427-3; Tronc F, 2000, ARTERIOSCL THROM VAS, V20, pE120, DOI 10.1161/01.ATV.20.12.e120; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Usmani AY, 2016, EXP FLUIDS, V57, DOI 10.1007/s00348-016-2274-x; Vahidkhah K, 2016, SCI REP-UK, V6, DOI 10.1038/srep28194; van Wyk S, 2015, PHYS FLUIDS, V27, DOI 10.1063/1.4923311; Varnava AM, 2002, CIRCULATION, V105, P939, DOI 10.1161/hc0802.104327; Walker AM, 2014, ANN BIOMED ENG, V42, P97, DOI 10.1007/s10439-013-0893-4; Walker AM, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4007746; WELLS RE, 1961, SCIENCE, V133, P763, DOI 10.1126/science.133.3455.763; Yeom E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01985-w; Yeom E, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4883275	54	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210993	10.1371/journal.pone.0210993	http://dx.doi.org/10.1371/journal.pone.0210993			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677055	Green Published, Green Submitted, gold			2022-12-26	WOS:000456700400040
J	Lewis, KE; Rota, CT; Lituma, CM; Anderson, JT				Lewis, Katharine E.; Rota, Christopher T.; Lituma, Christopher M.; Anderson, James T.			Influence of the Agricultural Conservation Easement Program wetland practices on winter occupancy of Passerellidae sparrows and avian species richness	PLOS ONE			English	Article							ECOSYSTEM SERVICES; HABITAT RELATIONSHIPS; BIRDS; COMMUNITIES; SELECTION; SWAMP; AREA; ASSOCIATIONS; MITIGATION; PREDATION	Wetlands enrolled in the Agricultural Conservation Easement Program (ACEP) are established as a means of restoring wetland ecosystems and wildlife habitat on private, agricultural land. In West Virginia, USA, ACEP wetlands have never been evaluated to determine how they function as wildlife habitat in comparison to other available wetland habitat in the state. We measured the wintering occupancy of Passerellidae species and apparent avian species richness on ACEP wetlands and a set of reference wetlands located on public land in West Virginia to evaluate if ACEP wetlands are being used similarly by avian species to other available wetland habitat in the state. Apparent avian species richness and the occupancy probability of four Passerellidae species-song sparrows (Melospiza melodia), darkeyed juncos (Junco hyemalis), swamp sparrows (Melospiza georgiana), and white-throated sparrows (Zonotrichia albicollis)-did not differ between ACEP and reference sites. In addition to other vegetative and habitat associations for each species, dark-eyed junco occupancy was negatively correlated with wetland size while swamp sparrow occupancy and apparent avian species richness were positively associated with wetland size. These results indicate that ACEP wetlands are providing winter avian habitat as well as another source of wetland habitat in the state. Maintaining and expanding ACEP wetlands in West Virginia would continue to provide wetland systems in areas that are otherwise lacking these habitats.	[Lewis, Katharine E.; Rota, Christopher T.; Lituma, Christopher M.; Anderson, James T.] West Virginia Univ, Davis Coll Agr Nat Resources & Design, Morgantown, WV 26506 USA	West Virginia University	Rota, CT (corresponding author), West Virginia Univ, Davis Coll Agr Nat Resources & Design, Morgantown, WV 26506 USA.	christopher.rota@mail.wvu.edu		Lewis, Katharine/0000-0003-0442-6773; Rota, Christopher/0000-0001-9272-4687	WVU Davis College of Agriculture, Natural Resources, and Design [68-3D47-15-10]; USDA Natural Resources Conservation Service [68-3D47-15-10]; USDA National Institute of Food and Agriculture, McIntire Stennis projects [WVA00124, WVA00128, WVA00117]; West Virginia Agricultural and Forestry Experiment Station; National Science Foundation [OIA-1458952]	WVU Davis College of Agriculture, Natural Resources, and Design; USDA Natural Resources Conservation Service(United States Department of Agriculture (USDA)); USDA National Institute of Food and Agriculture, McIntire Stennis projects; West Virginia Agricultural and Forestry Experiment Station; National Science Foundation(National Science Foundation (NSF))	This project was funded through a cooperative agreement between the WVU Davis College of Agriculture, Natural Resources, and Design (https://www.davis.wvu.edu/), and the USDA Natural Resources Conservation Service (https://www.nrcs.usda.gov), grant number 68-3D47-15-10. This work also was supported by the USDA National Institute of Food and Agriculture, McIntire Stennis projects (https://nifa.usda.gov/) WVA00124 (C.T. Rota), WVA00128 (C.M. Lituma), and WVA00117 (J.T. Anderson); and the West Virginia Agricultural and Forestry Experiment Station. J.T. Anderson was supported by the National Science Foundation (https://www.nsf.gov/) under Cooperative Agreement no. OIA-1458952 during manuscript preparation. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	AMBUEL B, 1983, ECOLOGY, V64, P1057, DOI 10.2307/1937814; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2015, APPL HIERARCHICAL MO, DOI DOI 10.1016/C2013-0-19160-X; Balcombe CK, 2005, HYDROBIOLOGIA, V541, P175, DOI 10.1007/s10750-004-5706-1; Balcombe CK, 2005, ECOL ENG, V25, P85, DOI 10.1016/j.ecoleng.2005.03.003; Balcombe CK, 2005, WETLANDS, V25, P130, DOI 10.1672/0277-5212(2005)025[0130:ACOPCI]2.0.CO;2; Baldwin HQ, 2007, WILSON J ORNITHOL, V119, P189, DOI 10.1676/05-129.1; Beadell J, 2003, WILSON BULL, V115, P38, DOI 10.1676/02-041; Beck CW, 1997, CAN J ZOOL, V75, P1636, DOI 10.1139/z97-790; Blank PJ, 2011, WILSON J ORNITHOL, V123, P59, DOI 10.1676/09-202.1; BROWN M, 1986, J WILDLIFE MANAGE, V50, P392, DOI 10.2307/3801093; Brown SC, 1998, J WILDLIFE MANAGE, V62, P1480, DOI 10.2307/3802014; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carr JM, 2014, OECOLOGIA, V174, P713, DOI 10.1007/s00442-013-2804-7; Chandler RB, 2009, AUK, V126, P186, DOI 10.1525/auk.2009.08083; Clipp H.L., 2017, WINTER WATERBIRD COM, DOI [10.1155/2017/1730130, DOI 10.1155/2017/1730130]; Cowardin L.M., 1979, CLASSIFICATION WETLA; Dahl TE, 2011, STATUS TRENDS WETLAN; DAUBENMIRE R., 1959, NORTHWEST SCI, V33, P43; Dymond Jr, 2013, ECOSYSTEM SERVICES IN NEW ZEALAND: CONDITIONS AND TRENDS, P1; ESRI, 2016, ARCGIS DESKT VERS 10; Falls J.B., 2010, BIRDS N AM; Fennessy S, 2011, ECOL APPL, V21, pS49, DOI 10.1890/09-0269.1; Frayer W.E., 1983, STATUS TRENDS WETLAN; Fretwell J. D., 1996, NATL WATER SUMMARY W; GOTTFRIED BM, 1975, WILSON BULL, V87, P374; GREENBERG R, 1988, CONDOR, V90, P420, DOI 10.2307/1368570; Hansson LA, 2005, FRESHWATER BIOL, V50, P705, DOI 10.1111/j.1365-2427.2005.01352.x; Harms TM, 2015, WILSON J ORNITHOL, V127, P670, DOI 10.1676/15-001.1; Hooten MB, 2015, ECOL MONOGR, V85, P3, DOI 10.1890/14-0661.1; Kaminski MR, 2006, WILDLIFE SOC B, V34, P921, DOI 10.2193/0091-7648(2006)34[921:WRTHMO]2.0.CO;2; Kellner K., 2017, PACKAGE JAGSUI WRAPP; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Lewis K. R., 2018, THESIS; MAC ARTHUR ROBERT H., 1967; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION, DOI DOI 10.1016/C2012-0-01164-7; Marcus JF, 2000, WILSON BULL, V112, P517, DOI 10.1676/0043-5643(2000)112[0517:TEOFFB]2.0.CO;2; Mastrangelo ME, 2014, BIOL CONSERV, V179, P63, DOI 10.1016/j.biocon.2014.08.020; Miller AE, 2017, WILSON J ORNITHOL, V129, P85, DOI 10.1676/1559-4491-129.1.85; Mitsch WJ, 2013, AQUAT SCI, V75, P133, DOI 10.1007/s00027-012-0262-7; Moreno-Mateos D, 2009, BIODIVERS CONSERV, V18, P811, DOI 10.1007/s10531-008-9472-7; Morin R. S. G. M., 2017, RESOURCE UPDATE FS 1; MOWBRAY TB, 1997, BIRDS N AM; Mueller-Dombois D, 1974, AIMS METHODS VEGETAT, P48; Murkin HR, 1997, ECOL APPL, V7, P1144; Plummer M., 2003, P 3 INT WORKSH DISTR, V124, P1; PULLIAM HR, 1977, ECOLOGY, V58, P1393, DOI 10.2307/1935091; Ralph CJ, 1993, HDB FIELD METHODS MO; Riffell SK, 2001, WETLANDS, V21, P492, DOI 10.1672/0277-5212(2001)021[0492:AAHROB]2.0.CO;2; Rising JD, 1997, GUIDE IDENTIFICATION; Rota CT, 2016, METHODS ECOL EVOL, V7, P1164, DOI 10.1111/2041-210X.12587; Rousseau P, 2012, CAN J ZOOL, V90, P595, DOI 10.1139/Z2012-025; Schlossberg S, 2008, ECOL APPL, V18, P1325, DOI 10.1890/08-0020.1; Schlossberg S, 2011, LANDSCAPE URBAN PLAN, V103, P64, DOI 10.1016/j.landurbplan.2011.06.001; SCHNEIDER KJ, 1984, ECOLOGY, V65, P1820, DOI 10.2307/1937778; Smith LA, 2010, WETLANDS, V30, P553, DOI 10.1007/s13157-010-0048-4; TINER RW, 1994, RECENT WETLAND STATU; Weisberg PJ, 2014, ACTA OECOL, V59, P72, DOI 10.1016/j.actao.2014.06.002; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248	59	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210878	10.1371/journal.pone.0210878	http://dx.doi.org/10.1371/journal.pone.0210878			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677050	Green Submitted, gold, Green Published			2022-12-26	WOS:000456700400030
J	Merklinger-Gruchala, A; Jasienska, G; Kapiszewska, M				Merklinger-Gruchala, Anna; Jasienska, Grazyna; Kapiszewska, Maria			Paternal investment and low birth weight - The mediating role of parity	PLOS ONE			English	Article							FATHER INVOLVEMENT; INFANT-MORTALITY; PARTNER SUPPORT; SOCIAL SUPPORT; LIFE-HISTORY; PREGNANCY; STRESS; EVOLUTION; HEALTH; CONSEQUENCES	According to life-history theory, paternal investment affects the well-being of offspring. We hypothesized that environmental stress caused by a lack of paternal investment may diminish maternal resource allocation during pregnancy, especially for women who already have dependent children. Our study was conducted on a representative group of more than 80,500 singleton, live-born, full-term infants born in Krakow, Poland in the period 1995-2009. Birth data were obtained from the birth registry. We found that missing data about fathers (a proxy measure of low paternal investment) was associated with higher probability of multiparous mothers giving birth to low-birth-weight infants (1.48; 95% CI 1.05-2.08), but this was not the case with primiparous mothers (1.19; 95% CI 0.89-1.59). The statistically significant synergistic effect between parity and paternal investment was found (Synergy Factor = 2.12; 95% CI 1.47-3.05, p<0.001). These findings suggest that in situations of low paternal investment, multiparous mothers face trade-offs between investing in existing versus unborn children, therefore investment in the latter is lower. Such a strategy may benefit maternal fitness due to investment in older children, who have higher reproductive value.	[Merklinger-Gruchala, Anna; Kapiszewska, Maria] Andrzej Frycz Modrzewski Krakow Univ, Fac Med & Hlth Sci, Krakow, Poland; [Jasienska, Grazyna] Jagiellonian Univ, Med Coll, Fac Hlth Sci, Dept Environm Hlth, Krakow, Poland	Andrzej Frycz Modrzewski Krakow University; Jagiellonian University; Collegium Medicum Jagiellonian University	Merklinger-Gruchala, A (corresponding author), Andrzej Frycz Modrzewski Krakow Univ, Fac Med & Hlth Sci, Krakow, Poland.	amerklinger@afm.edu.pl	Merklinger-Gruchala, Anna/AAD-7255-2022; Kapiszewska, Maria/S-1860-2018	Merklinger-Gruchala, Anna/0000-0002-7822-6945; Jasienska, Grazyna/0000-0001-8716-6342; Kapiszewska, Maria/0000-0002-8864-6636	Ministry of Science and Higher Education [WZiNM/DS/6/2017]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This study was carried out within the Framework of a Project No. N N404 055 136, financed by the Ministry of Science and Higher Education (to Maria Kapiszewska), and Project No WZiNM/DS/6/2017 financed by the Ministry of Science and Higher Education (to Anna Merklinger-Gruchala). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LC, 2002, AM J HUM BIOL, V14, P551, DOI 10.1002/ajhb.10069; Alio AP, 2011, J COMMUN HEALTH, V36, P63, DOI 10.1007/s10900-010-9280-3; Aliyu MH, 2005, BIRTH-ISS PERINAT C, V32, P1, DOI [10.1111/j.0730-7659.2005.00339.x, DOI 10.1111/J.0730-7659.2005.00339.X]; Anderson KG, 2017, HUM NATURE-INT BIOS, V28, P168, DOI 10.1007/s12110-017-9284-0; Anderson KG, 2003, BIODEMOGRAPHY OF HUMAN REPRODUCTION AND FERTILITY, P57; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Bentley GR, 2009, STUDIES BIOSOCIAL SO, V3; Bracero L, 2009, J MATERN-FETAL NEO M, V22, P342, DOI 10.1080/14767050802663178; Bribiescas RG, 2010, EVOLUTIONARY ENDOCRI, P127; Bribiescas RG, 2012, CURR ANTHROPOL, V53, pS424, DOI 10.1086/667538; Buss D. M., 2015, EVOLUTIONARY PSYCHOL; Bussieres EL, 2015, DEV REV, V36, P179, DOI 10.1016/j.dr.2015.04.001; Campbell B., 1972, SEXUAL SELECTION DES, DOI DOI 10.1002/AJPA.1330400226; Chamie J., 2017, OUT OF WEDLOCK BIRTH; Cheng ER, 2016, J WOMENS HEALTH, V25, P672, DOI 10.1089/jwh.2015.5462; Coall DA, 2003, SOC SCI MED, V57, P1771, DOI 10.1016/S0277-9536(03)00022-4; Cohen K, 2016, MATERN CHILD HLTH J, V20, P2291, DOI 10.1007/s10995-016-2048-3; Cortina-Borja Mario, 2009, BMC Res Notes, V2, P105, DOI 10.1186/1756-0500-2-105; Coussons-Read ME, 2007, BRAIN BEHAV IMMUN, V21, P343, DOI 10.1016/j.bbi.2006.08.006; Dunkel Schetter C, 2010, HDB HLTH PSYCHOL; Dunkel-Schetter C, 1996, HDB SOCIAL SUPPORT F, P375, DOI 10.1007/s10995-016-2048-3; Elsenbruch S, 2007, HUM REPROD, V22, P869, DOI 10.1093/humrep/del432; Field T, 2006, INFANT BEHAV DEV, V29, P445, DOI 10.1016/j.infbeh.2006.03.003; Gaudino JA, 1999, SOC SCI MED, V48, P253, DOI 10.1016/S0277-9536(98)00342-6; Geary DC, 2000, PSYCHOL BULL, V126, P55, DOI 10.1037/0033-2909.126.1.55; Geary DC, 2021, MALE, FEMALE, 3 EDITION, P1, DOI 10.1037/0000181-000; Hinkle SN, 2014, PAEDIATR PERINAT EP, V28, P106, DOI 10.1111/ppe.12099; Hobel CJ, 2008, CLIN OBSTET GYNECOL, V51, P333, DOI 10.1097/GRF.0b013e31816f2709; Hornstra G, 2000, AM J CLIN NUTR, V71, p1262S, DOI 10.1093/ajcn/71.5.1262s; Hrdy S. B., 2007, FAM RELAT, P39, DOI DOI 10.1093/ACPROF:OSO/9780195320510.003.0003; Jasienska G., 2017, ARC LIFE EVOLUTION H, P159; Jasienska G., 2013, FRAGILE WISDOM EVOLU; Jasienska G, 2009, AM J HUM BIOL, V21, P524, DOI 10.1002/ajhb.20931; Kalantaridou SN, 2010, J REPROD IMMUNOL, V85, P33, DOI 10.1016/j.jri.2010.02.005; Kuzawa CW, 2012, CURR ANTHROPOL, V53, pS369, DOI 10.1086/667410; Lewandowski P, 2012, ADMITTING PATERNAL A, P7; Mann J., 1992, ADAPTED MIND EVOLUTI, P367; Martin LT, 2007, MATERN CHILD HLTH J, V11, P595, DOI 10.1007/s10995-007-0209-0; McDade TW, 2006, PSYCHOSOM MED, V68, P376, DOI 10.1097/01.psy.0000221371.43607.64; Midi H, 2010, J INTERDISCIP MATH, V13, P253, DOI 10.1080/09720502.2010.10700699; O'Donnell MH, 2017, THESIS; Padilla YC, 2001, CHILD YOUTH SERV REV, V23, P427, DOI 10.1016/S0190-7409(01)00136-0; Parker VJ, 2010, J REPROD IMMUNOL, V85, P86, DOI 10.1016/j.jri.2009.10.011; Pathak Priyali, 2004, Indian Journal of Pediatrics, V71, P1007; REDONDO T, 1989, BEHAV ECOL SOCIOBIOL, V25, P369, DOI 10.1007/BF00302995; Rini C, 2006, PERS RELATIONSHIP, V13, P207, DOI 10.1111/j.1475-6811.2006.00114.x; Schetter CD, 2011, ANNU REV PSYCHOL, V62, P531, DOI 10.1146/annurev.psych.031809.130727; Sear R., 2011, EVOLUTIONARY PSYCHOL, P215; Shah PS, 2011, MATERN CHILD HLTH J, V15, P1097, DOI 10.1007/s10995-010-0654-z; Shah PS, 2010, ACTA OBSTET GYN SCAN, V89, P862, DOI 10.3109/00016349.2010.486827; Shenk MK, 2011, FRONT COLLECT, P17, DOI 10.1007/978-3-642-13968-0_2; Stearns S.C., 1992, pi; Su Q, 2015, PEDIATR NEONATOL, V56, P376, DOI 10.1016/j.pedneo.2015.02.002; Szukalski P., 2017, B INFORM, V6; Tan Hongzhuan, 2004, BMC Pregnancy Childbirth, V4, P21, DOI 10.1186/1471-2393-4-21; Teitler JO, 2001, CHILD YOUTH SERV REV, V23, P403, DOI 10.1016/S0190-7409(01)00137-2; Trevathan W., 2017, HUMAN BIRTH EVOLUTIO, V3rd; TRIVERS RL, 1974, AM ZOOL, V14, P249; Wells JCK, 2003, J THEOR BIOL, V221, P143, DOI 10.1006/jtbi.2003.3183	59	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210715	10.1371/journal.pone.0210715	http://dx.doi.org/10.1371/journal.pone.0210715			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI8IY	30677049	Green Published, Green Submitted, gold			2022-12-26	WOS:000456700400025
J	Ballo, O; Tarazzit, I; Stratmann, J; Reinheimer, C; Hogardt, M; Wichelhaus, TA; Kempf, V; Serve, H; Finkelmeier, F; Brandts, C				Ballo, Olivier; Tarazzit, Ikram; Stratmann, Jan; Reinheimer, Claudia; Hogardt, Michael; Wichelhaus, Thomas A.; Kempf, Volkhard; Serve, Hubert; Finkelmeier, Fabian; Brandts, Christian			Colonization with multidrug resistant organisms determines the clinical course of patients with acute myeloid leukemia undergoing intensive induction chemotherapy	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; HIGH-RISK PATIENTS; HEMATOLOGICAL MALIGNANCIES; KLEBSIELLA-PNEUMONIAE; ENTEROBACTERIACEAE; IMPACT; RECOMMENDATIONS; NEUTROPENIA; THERAPY; SOCIETY	Introduction The global spread of multidrug-resistant organisms (MDRO) complicates treatment and isolation measures in hospitals and has shown to increase mortality. Patients with disease- or therapy-related immunodeficiency are especially at risk for fatal infections caused by MDRO. The impact of MDRO colonization on the clinical course of AML patients undergoing intensive induction chemotherapy a potentially curative but highly toxic treatment option- has not been systematically studied. Materials & methods 312 AML patients undergoing intensive induction chemotherapy between 2007 and 2015 were examined for MDRO colonization. Patients with evidence for MDRO before or during the hospital stay of induction chemotherapy were defined as colonized, patients who never had a positive swab for MDRO were defined as noncolonized. Results Of 312 AML patients 90 were colonized and 130 were noncolonized. Colonized patients suffered from significantly more days with fever, spent more days on the intensive care unit and had a higher median C-reactive protein value during the hospital stay. These findings did not result in a prolonged length of hospital stay or an increased mortality rate for colonized patients. However, in a subgroup analysis, patients colonized with carbapenem-resistant enterobacteriaceae (CRE) had a significantly reduced 60- and 90-day, as well as 1- and 2-year survival rates when compared to noncolonized patients. Conclusion Our analysis highlights the importance of intensive MDRO screening especially in patients with febrile neutropenia since persisting fever can be a sign of MDRO-colonization. CRE-colonized patients require special surveillance, since they seem to be at risk for death.	[Ballo, Olivier; Tarazzit, Ikram; Stratmann, Jan; Serve, Hubert; Brandts, Christian] Goethe Univ Hosp, Dept Med, Hematol Oncol, Frankfurt, Germany; [Ballo, Olivier; Serve, Hubert; Finkelmeier, Fabian; Brandts, Christian] Goethe Univ Hosp, Univ Canc Ctr Frankfurt UCT, Frankfurt, Germany; [Reinheimer, Claudia; Hogardt, Michael; Wichelhaus, Thomas A.; Kempf, Volkhard] Goethe Univ Hosp, Inst Med Microbiol & Infect Control, Frankfurt, Germany; [Reinheimer, Claudia; Hogardt, Michael; Wichelhaus, Thomas A.; Kempf, Volkhard; Serve, Hubert] Goethe Univ Hosp, Univ Ctr Infect Dis, Frankfurt, Germany; [Finkelmeier, Fabian] Goethe Univ Frankfurt, Dept Med Gastroenterol Hepatol & Endocrinol, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt	Ballo, O; Brandts, C (corresponding author), Goethe Univ Hosp, Dept Med, Hematol Oncol, Frankfurt, Germany.; Ballo, O; Brandts, C (corresponding author), Goethe Univ Hosp, Univ Canc Ctr Frankfurt UCT, Frankfurt, Germany.	olivier.ballo@kgu.de; brandts@em.uni-frankfurt.de						Ahn S, 2011, SUPPORT CARE CANCER, V19, P1151, DOI 10.1007/s00520-010-0928-4; Atallah E, 2007, BLOOD, V110, P3547, DOI 10.1182/blood-2007-06-095844; Chen CY, 2017, INT J ANTIMICROB AG, V49, P272, DOI 10.1016/j.ijantimicag.2016.11.009; Combariza JF, 2015, SUPPORT CARE CANCER, V23, P1009, DOI 10.1007/s00520-014-2454-2; Cornejo-Juarez P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035780; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Doyle D, 2012, J CLIN MICROBIOL, V50, P3877, DOI 10.1128/JCM.02117-12; Fernandez HF, 2009, NEW ENGL J MED, V361, P1249, DOI 10.1056/NEJMoa0904544; Ford CD, 2015, INFECT CONT HOSP EP, V36, P47, DOI 10.1017/ice.2014.3; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Gudiol C, 2013, CLIN MICROBIOL INFEC, V19, P474, DOI 10.1111/j.1469-0691.2012.03879.x; Gudiol C, 2011, J ANTIMICROB CHEMOTH, V66, P657, DOI 10.1093/jac/dkq494; HIDDEMANN W, 1987, BLOOD, V69, P744; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; Jaiswal SR, 2018, MEDITERR J HEMATOL I, V10, DOI 10.4084/MJHID.2018.025; Krug U, 2011, DTSCH ARZTEBL INT, V108, P863, DOI 10.3238/arztebl.2011.0863; Lehouritis P, 2015, SCI REP-UK, V5, DOI 10.1038/srep14554; Liss BJ, 2012, INFECTION, V40, P613, DOI 10.1007/s15010-012-0269-y; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Lye DC, 2012, CLIN MICROBIOL INFEC, V18, P502, DOI 10.1111/j.1469-0691.2011.03606.x; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mandelli F, 2009, J CLIN ONCOL, V27, P5397, DOI 10.1200/JCO.2008.20.6490; Marini BL, 2015, SUPPORT CARE CANCER, V23, P2287, DOI 10.1007/s00520-014-2582-8; Mellinghoff SC, 2018, ANN HEMATOL, V97, P197, DOI 10.1007/s00277-017-3196-2; Micozzi A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2297-9; Neumann S, 2013, ANN HEMATOL, V92, P433, DOI 10.1007/s00277-013-1698-0; Satlin MJ, 2014, CLIN INFECT DIS, V58, P1274, DOI 10.1093/cid/ciu052; Scheich S, 2017, BIOL BLOOD MARROW TR, V23, P1455, DOI 10.1016/j.bbmt.2017.05.016; Sostarich AM, 2008, INFECTION, V36, P31, DOI 10.1007/s15010-007-6316-4; Temkin E, 2014, ANN NY ACAD SCI, V1323, P22, DOI 10.1111/nyas.12537; Trecarichi EM, 2016, AM J HEMATOL, V91, P1076, DOI 10.1002/ajh.24489; Vehreschild MJGT, 2014, J ANTIMICROB CHEMOTH, V69, P3387, DOI 10.1093/jac/dku305; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; WIERNIK PH, 1989, SEMIN ONCOL, V16, P25	34	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210991	10.1371/journal.pone.0210991	http://dx.doi.org/10.1371/journal.pone.0210991			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673776	Green Published, gold, Green Submitted			2022-12-26	WOS:000456442800061
J	Brusa, P; Allais, G; Scarinzi, C; Baratta, F; Parente, M; Rolando, S; Gnavi, R; Spadea, T; Costa, G; Benedetto, C; Mana, M; Giaccone, M; Mandelli, A; Manzoni, GC; Bussone, G				Brusa, Paola; Allais, Gianni; Scarinzi, Cecilia; Baratta, Francesca; Parente, Marco; Rolando, Sara; Gnavi, Roberto; Spadea, Teresa; Costa, Giuseppe; Benedetto, Chiara; Mana, Massimo; Giaccone, Mario; Mandelli, Andrea; Manzoni, Gian Camillo; Bussone, Gennaro			Self-medication for migraine: A nationwide cross-sectional study in Italy	PLOS ONE			English	Article							HEADACHE; CARE; DISORDERS; EUROPE; COST	Headache disorders are considered the second leading cause of years lived with disability worldwide, and 90% of people have a headache episode at least once a year, thus representing a relevant public health priority. As the pharmacist is often the first and only point of reference for people complaining of headache, we carried out a survey in a nationwide sample of Italian pharmacies, in order to describe the distribution of migraine or non-migraine type headaches and medicines overuse among people entering pharmacies seeking for self-medication; and to evaluate the association, in particular of migraine, with socio-demographic and clinical characteristics, and with the pathway of care followed by the patients. A 14-item questionnaire, including socio-demographic and clinical factors, was administered by trained pharmacists to subjects who entered a pharmacy requesting self-medication for a headache attack. The ID Migraine TM Screener was used to classify headache sufferers in four classes. From June 2016 to January 2017, 4424 people have been interviewed. The prevalence of definite migraines was 40%, significantly higher among women and less educated people. About half of all headache sufferers and a third of migraineurs do not consider their condition as a disease and are not cared by any doctor. Among people seeking self medication in pharmacies for acute headache attacks, the rate of definite or probable migraine is high, and a large percentage of them is not correctly diagnosed and treated. The pharmacy can be a valuable observatory for the study of headaches, and the first important step to improve the quality of care delivered to these patients.	[Brusa, Paola; Baratta, Francesca; Parente, Marco] Univ Turin, Dept Sci & Technol Drugs, Turin, Italy; [Brusa, Paola; Giaccone, Mario] Order Pharmacists Turin, Turin, Italy; [Allais, Gianni; Rolando, Sara; Benedetto, Chiara] Univ Turin, Dept Surg Sci, Womens Headache Ctr, Turin, Italy; [Allais, Gianni; Manzoni, Gian Camillo; Bussone, Gennaro] Italian Headache Fdn, FI CEF Onlus, Milan, Italy; [Scarinzi, Cecilia; Gnavi, Roberto; Spadea, Teresa; Costa, Giuseppe] ASL TO3, Epidemiol Unit, Turin, Italy; [Mana, Massimo] ATF Informat, Cuneo, Italy; [Giaccone, Mario; Mandelli, Andrea] Federat Orders Italian Pharmacists, FOFI, Rome, Italy	University of Turin; University of Turin	Brusa, P (corresponding author), Univ Turin, Dept Sci & Technol Drugs, Turin, Italy.; Brusa, P (corresponding author), Order Pharmacists Turin, Turin, Italy.	paola.brusa@unito.it	costa, giuseppe/K-2526-2016; Baratta, Francesca/AAL-8754-2021; Spadea, Teresa/K-4991-2016; Allais, Gianni/AAE-6244-2019; Gnavi, Roberto/J-9263-2016	Baratta, Francesca/0000-0001-5483-8501; Spadea, Teresa/0000-0002-0771-0545; Allais, Gianni/0000-0002-1946-0109; Gnavi, Roberto/0000-0003-1919-2199; COSTA, Giuseppe/0000-0003-3187-4889; BRUSA, Paola/0000-0001-6266-4492	FOFI, Federation of the Orders of Italian Pharmacists, Rome, Italy; Federation of the Orders of Italian Pharmacists (FOFI)	FOFI, Federation of the Orders of Italian Pharmacists, Rome, Italy; Federation of the Orders of Italian Pharmacists (FOFI)	The authors declare that this study was funded by FOFI, Federation of the Orders of Italian Pharmacists, Rome, Italy. The source of the funding had no role in the design of the study or the analysis and interpretation of the data. The role of the Federation was solely to verify that the study had been conducted in accordance with the agreed methodology.; The authors would like to thank the Federation of the Orders of Italian Pharmacists (FOFI) for its contribution both to the extension of the project to the national level and financial support and the Italian Headache Foundation (FICEF Onlus) for its contribution in drawing up the project and the organisation of the online training course for pharmacists that participated in the study.	Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Brusa P, 2015, NEUROL SCI, V36, pS93, DOI 10.1007/s10072-015-2156-7; Brusa P, 2014, NEUROL SCI, V35, pA5, DOI 10.1007/s10072-014-1733-5; Brusa P, 2017, NEUROL SCI, V38, pS15, DOI 10.1007/s10072-017-2908-7; Cevoli S, 2009, CEPHALALGIA, V29, P1285, DOI 10.1111/j.1468-2982.2009.01874.x; D'Amico D, 2017, NEUROL SCI, V38, pS3, DOI 10.1007/s10072-017-2891-z; Dodick DW, 2018, HEADACHE, V58, P1358, DOI 10.1111/head.13426; Fischer M, 2016, HEADACHE, V56, P952, DOI 10.1111/head.12820; Giaccone M, 2014, NEUROL SCI, V35, pA1, DOI 10.1007/s10072-014-1732-6; Horvat N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052510; Katsarava Z, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0839-1; Linde M, 2012, EUR J NEUROL, V19, P703, DOI 10.1111/j.1468-1331.2011.03612.x; Lipton RB, 1998, HEADACHE, V38, P87, DOI 10.1046/j.1526-4610.1998.3802087.x; Lipton RB, 2003, NEUROLOGY, V61, P375, DOI 10.1212/01.WNL.0000078940.53438.83; Manzoni GC, 2011, J HEADACHE PAIN, V12, P585, DOI 10.1007/s10194-011-0393-6; Manzoni Gian Camillo, 2010, Handb Clin Neurol, V97, P3, DOI 10.1016/S0072-9752(10)97001-2; Martelletti P, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-017-0830-2; MATHEW NT, 1982, HEADACHE, V22, P66, DOI 10.1111/j.1526-4610.1982.hed2202066.x; Miller Sarah, 2014, Practitioner, V258, P19; Pugliatti M, 2008, NEUROL SCI, V29, P99, DOI 10.1007/s10072-008-0868-7; Rapoport AM, 2004, NEUROL SCI, V25, pS258, DOI 10.1007/s10072-004-0301-9; Saylor D, 2018, SEMIN NEUROL, V38, P182, DOI 10.1055/s-0038-1646946; UNESCO Institute for Statistics, 2012, INT STAND CLASS ED I; Vandenbussche N, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0875-x; Viana M, 2018, CEPHALALGIA, V38, P383, DOI 10.1177/0333102416683917; World Health Organization, 2011, LIFT BURD 2011 ATL H	26	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211191	10.1371/journal.pone.0211191	http://dx.doi.org/10.1371/journal.pone.0211191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673780	Green Published, gold			2022-12-26	WOS:000456442800080
J	Darwish, HYA; Dalirsefat, SB; Dong, XG; Hua, GY; Chen, JF; Zhang, YY; Li, JX; Xu, JS; Li, JY; Deng, XM; Wu, CX				Darwish, Hesham Y. A.; Dalirsefat, Seyed Benyamin; Dong, Xianggui; Hua, Guoying; Chen, Jianfei; Zhang, Yuanyuan; Li, Jianxiong; Xu, Jiansheng; Li, Junying; Deng, Xuemei; Wu, Changxin			Genome-wide association study and a post replication analysis revealed a promising genomic region and candidate genes for chicken eggshell blueness	PLOS ONE			English	Article							PRINCIPAL-COMPONENTS; PIGMENTS; STRATIFICATION; PROLIFERATION; BILIVERDIN; AJAP1; 1P36	The eggshell blueness is an interesting object for chicken genetic studies and blue-shelled chicken industry, especially after the discovery of the causative mutation of chicken blue eggshell. In the present study, genome wide association study (GWAS) was conducted in Chinese Dongxiang blue-shelled chicken underlying four traits of blue eggshell pigments: quantity of biliverdin (QB), quantity of protoporphyrin (QP), quantity of total pigment (QT), and color density trait (CD). A total of 139 individuals were randomly collected for GWAS. We detected two SNPs in genome-wise significance and 35 in suggestive significance, 24 out of the 37 SNP were located either within intron/exon or near 15 genes in a range of -1.17 Mb on GGA21. For further confirmation of the identified SNP loci by GWAS, the follow-up replication studies were performed in two populations. A total of 146 individuals of the second generation derived from the former GWAS population, as well as 280 individuals from an alternative independent population were employed for genotyping by MALDI-TOF MS in a genotype-phenotype association study. Eighteen SNPs evenly distributed on the GGA21 significant region were successfully genotyped in the two populations, of which 4 and 6 SNP loci were shown significantly associated with QB, QT and QP in the two repeat populations, respectively. Further, the SNPs were narrowed down to a region of similar to 653.819 Kb on GGA21 that harbors five candidate genes: AJAP1, TNFRSF9, C1ORF174, CAMTA1, and CEP104. Shell gland of chickens laying dark and light blue eggshell was chosen for detection of mRNA expression of the five candidate genes. The results showed differential expression levels of these genes in the two groups. The specific function of these genes has not yet been defined clearly in chickens and further in-depth studies are needed to explore the new functional role in chicken eggshell blueness.	[Darwish, Hesham Y. A.; Dalirsefat, Seyed Benyamin; Dong, Xianggui; Hua, Guoying; Chen, Jianfei; Zhang, Yuanyuan; Li, Junying; Deng, Xuemei; Wu, Changxin] China Agr Univ, Minist Agr, Natl Engn Lab Anim Breeding, Beijing, Peoples R China; [Darwish, Hesham Y. A.; Dalirsefat, Seyed Benyamin; Dong, Xianggui; Hua, Guoying; Chen, Jianfei; Zhang, Yuanyuan; Li, Junying; Deng, Xuemei; Wu, Changxin] China Agr Univ, Minist Agr, Key Lab Anim Genet Breeding & Reprod, Beijing, Peoples R China; [Darwish, Hesham Y. A.] Minist Agr & Land Reclamat, Agr Res Ctr, Res Inst Anim Prod, Giza, Egypt; [Dalirsefat, Seyed Benyamin] Univ Guilan, Fac Agr Sci, Dept Anim Sci, Rasht, Guilan, Iran; [Li, Jianxiong; Xu, Jiansheng] Jiangxi Donghua Livestock & Poultry Breeding Co L, Fuzhou, Jiangxi, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University; Ministry of Agriculture & Rural Affairs; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; Ministry of Agriculture & Land Reclamation - Egypt; University of Guilan	Deng, XM (corresponding author), China Agr Univ, Minist Agr, Natl Engn Lab Anim Breeding, Beijing, Peoples R China.; Deng, XM (corresponding author), China Agr Univ, Minist Agr, Key Lab Anim Genet Breeding & Reprod, Beijing, Peoples R China.	deng@cau.edu.cn		Zhang, Yuanyuan/0000-0001-7442-6846; Chen, Jianfei/0000-0001-6575-4493; Darwish, Hesham Y. A./0000-0002-4965-3630	National 863 Project of China [2013AA102501]; National Natural Science Foundation [31072024]; China Agriculture Research System [CARS-41]; Program for Changjiang Scholars and Innovative Research Team in University [IRT_15R62]	National 863 Project of China(National High Technology Research and Development Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported in part by grants from the National 863 Project of China (2013AA102501) to XMD, the National Natural Science Foundation (31072024) to XMD, the China Agriculture Research System (CARS-41) to CXW and the Program for Changjiang Scholars and Innovative Research Team in University (IRT_15R62). The funder National 863 Project of China provided support in the form of salaries for authors XGD, GYH, JFC, YYZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The authors JXL, JSX related to Jiangxi Donghua Livestock & Poultry Breeding Co. Ltd., Jiangxi, China did only play a role in blood and tissue sample collection, and had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Adkerson T, REV EGG COLOR CHICKE; Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116; Andersson L, 2009, GENETICA, V136, P341, DOI 10.1007/s10709-008-9312-4; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bolormaa S, 2011, J ANIM SCI, V89, P1684, DOI 10.2527/jas.2010-3079; Butcher GD, 1995, FACTORS CAUSING POOR; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Duggal P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-516; Duncan CG, 2010, ONCOTARGET, V1, P265, DOI 10.18632/oncotarget.137; Falconer D. S., 1996, Introduction to quantitative genetics.; Gross JC, 2009, MOL BIOL CELL, V20, P3598, DOI 10.1091/mbc.E08-12-1240; Henrich KO, 2011, CANCER RES, V71, P3142, DOI 10.1158/0008-5472.CAN-10-3014; HIMES JA, 1975, CORNELL VET, V65, P374; Hotte K, 2017, BIOL OPEN, V6, P723, DOI 10.1242/bio.022335; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; KENNEDY GY, 1973, COMP BIOCHEM PHYSIOL, V44, P11; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; LANG MR, 1987, WORLD POULTRY SCI J, V43, P238, DOI 10.1079/WPS19870016; Li QZ, 2008, GENET EPIDEMIOL, V32, P215, DOI 10.1002/gepi.20296; Lin NJ, 2012, MOL CANCER RES, V10, P208, DOI 10.1158/1541-7786.MCR-10-0109; Liu WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028600; Nicodemus KK, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S78; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Punnett RC, 1933, J GENET, V27, P465, DOI 10.1007/BF02981757; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schwarz H, 1996, BLOOD, V87, P2839, DOI 10.1182/blood.V87.7.2839.bloodjournal8772839; Scott TA, 2000, POULTRY SCI, V79, P1725, DOI 10.1093/ps/79.12.1725; Seamen E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000589; Sparks NHC, 2011, AVIAN BIOL RES, V4, P162, DOI 10.3184/175815511X13228269481875; Sun CJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1795-7; Tammana TVS, 2013, J CELL SCI, V126, P5018, DOI 10.1242/jcs.133439; Wang D, 2009, BMC P; Wang XT, 2007, POULTRY SCI, V86, P2236, DOI 10.1093/ps/86.10.2236; Wang XT, 2009, POULTRY SCI, V88, P1735, DOI 10.3382/ps.2008-00434; Wang ZP, 2011, J ANIM VET ADV, V10, P92; Wang ZP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003183; Wragg D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071393; Zeng L, 2014, INT J ONCOL, V45, P13, DOI 10.3892/ijo.2014.2425; Zhang XY, 2010, J IMMUNOL, V184, P787, DOI 10.4049/jimmunol.0901619; Zhao R, 2006, POULTRY SCI, V85, P546, DOI 10.1093/ps/85.3.546	41	3	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0209181	10.1371/journal.pone.0209181	http://dx.doi.org/10.1371/journal.pone.0209181			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673708	gold, Green Published, Green Submitted			2022-12-26	WOS:000456442800014
J	Magnusdottir, EE; Lim, R				Magnusdottir, Edda E.; Lim, Rangyn			Subarctic singers: Humpback whale (Megaptera novaeangliae) song structure and progression from an Icelandic feeding ground during winter	PLOS ONE			English	Article							NORTH PACIFIC; ACOUSTIC DETECTIONS; MIGRATION; HAWAIIAN; OCEAN; VOCALIZATIONS; EXCHANGE; DISTANCE; WESTERN; SEX	Humpback whale songs associated with breeding behaviors are increasingly reported outside of traditional low latitude breeding grounds. Songs from a subarctic feeding ground during the winter were quantitatively characterized to investigate the structure and temporal changes of the songs at such an atypical location. Recordings were collected from 26. January to 12. March, 2011, using bottom mounted recorders. Humpback songs were detected on 91% of the recording days with peak singing activities during 9.-26. February. The majority of the recordings included multiple chorusing singers. The songs were characterized by a) common static themes which transitioned consistently to predictable themes, b) shifting themes which occurred less predictably and c) rare themes. A set median sequence was found for four different periods (sets) of recordings (approximately 1 week each). The set medians were highly similar and formed a single cluster indicating that the sequences of themes sung in this area belonged to a single cluster of songs despite of the variation caused by the shifting themes. These subarctic winter songs could, thus, represent a characteristic song type for this area which is comparable to extensively studied songs from traditional low latitude breeding grounds. An increase in the number of themes per sequence was observed throughout the recording period including minor changes in the application of themes in the songs; indicating a gradual song progression. The results confirm that continual singing of sophisticated songs occur during the breeding season in the subarctic. In addition to being a well-established summer feeding ground the study area appears to be an important overwintering site for humpback whales delaying or canceling their migration where males engage in active sexual displays, i.e. singing. Importantly, such singing activity on a shared feeding ground likely aids the cultural transmission of songs in the North Atlantic.	[Magnusdottir, Edda E.; Lim, Rangyn] Univ Iceland, Res Ctr Husavik, Husavik, Iceland; [Magnusdottir, Edda E.; Lim, Rangyn] Univ Iceland, Dept Life & Environm Sci, Reykjavik, Iceland	University of Iceland; University of Iceland	Magnusdottir, EE (corresponding author), Univ Iceland, Res Ctr Husavik, Husavik, Iceland.; Magnusdottir, EE (corresponding author), Univ Iceland, Dept Life & Environm Sci, Reykjavik, Iceland.	eddaem@hi.is		Magnusdottir, Edda/0000-0001-8281-4232	Doctoral Grants of The University of Iceland Research Fund (in Icelandic); Conservation Fund of Palmi Jonasson	Doctoral Grants of The University of Iceland Research Fund (in Icelandic); Conservation Fund of Palmi Jonasson	This research was funded by the Doctoral Grants of The University of Iceland Research Fund (in Icelandic), 200913-Doktorsstyrkir Rannsoknasjoos Haskola Islands to EEM; http://sjodir.hi.is/sites/sjodir.hi.is/files/rsj_pdf_uthl2009.pdf. Further information about the grant can be found at the funder's website: http://sjodir.hi.is/research_funds_0. The second funder is The Conservation Fund of Palmi Jonasson, and a list of grant receivers can be found at the following webpage: http://www.natturuverndarsjodur.is/subpage2_2.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au WWL, 2006, J ACOUST SOC AM, V120, P1103, DOI 10.1121/1.2211547; Au WWL, 2000, MAR MAMMAL SCI, V16, P530, DOI 10.1111/j.1748-7692.2000.tb00949.x; BAKER CS, 1985, MAR MAMMAL SCI, V1, P304, DOI 10.1111/j.1748-7692.1985.tb00018.x; Barlow J, 1997, ECOLOGY, V78, P535; BROWN MR, 1995, P ROY SOC B-BIOL SCI, V259, P229, DOI 10.1098/rspb.1995.0034; Cerchio S, 2001, ANIM BEHAV, V62, P313, DOI 10.1006/anbe.2001.1747; Charif RA, 2001, MAR MAMMAL SCI, V17, P751, DOI 10.1111/j.1748-7692.2001.tb01297.x; CHITTLEBOROUGH R. G., 1958, AUSTRALIAN JOUR MARINE AND FRESHWATER RES, V9, P1; Cholewiak DM, 2013, MAR MAMMAL SCI, V29, pE312, DOI 10.1111/mms.12005; CLAPHAM PJ, 1987, CAN J ZOOL, V65, P2853, DOI 10.1139/z87-434; CLAPHAM PJ, 1990, MAR MAMMAL SCI, V6, P155, DOI 10.1111/j.1748-7692.1990.tb00238.x; CLAPHAM PJ, 1993, CAN J ZOOL, V71, P440, DOI 10.1139/z93-063; Clark CW, 2004, P ROY SOC B-BIOL SCI, V271, P1051, DOI 10.1098/rspb.2004.2699; Craig AS, 2003, BEHAVIOUR, V140, P981, DOI 10.1163/156853903322589605; Craig AS, 1997, CAN J ZOOL, V75, P1923, DOI 10.1139/z97-822; Darling JD, 2014, AQUAT BIOL, V21, P93, DOI 10.3354/ab00570; Darling JD, 2012, J ACOUST SOC AM, V132, P2955, DOI 10.1121/1.4757739; Darling JD, 2001, MAR MAMMAL SCI, V17, P570, DOI 10.1111/j.1748-7692.2001.tb01005.x; Dawbin W.H., 1966, WHALES DOLPHINS PORP, P145; de Heus L, 2014, THESIS; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; DOBSON CW, 1979, BEHAVIOUR, V68, P86, DOI 10.1163/156853979X00250; Eriksen N, 2005, BEHAVIOUR, V142, P305, DOI 10.1163/1568539053778283; Garland EC, 2015, CONSERV BIOL, V29, P1198, DOI 10.1111/cobi.12492; Garland EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079422; Garland EC, 2012, BEHAVIOUR, V149, P1413, DOI 10.1163/1568539X-00003032; Garland EC, 2013, J ACOUST SOC AM, V133, P560, DOI 10.1121/1.4770232; Garland EC, 2011, CURR BIOL, V21, P687, DOI 10.1016/j.cub.2011.03.019; Gunnlaugsson T., 1988, REPORT INT WHALING C, V38, P489; Helweg DA, 1998, BEHAVIOUR, V135, P1; Herman LM, 2013, BEHAV ECOL SOCIOBIOL, V67, P1653, DOI 10.1007/s00265-013-1576-8; Katahira K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024516; Kennedy AS, 2014, CAN J ZOOL, V92, P9, DOI 10.1139/cjz-2013-0161; KOHONEN T, 1985, PATTERN RECOGN LETT, V3, P309, DOI 10.1016/0167-8655(85)90061-3; Lagerquist BA, 2008, MAR MAMMAL SCI, V24, P815, DOI 10.1111/j.1748-7692.2008.00217.x; Lammers MO, 2008, J ACOUST SOC AM, V123, P1720, DOI 10.1121/1.2836780; LEMON RE, 1973, ANIM BEHAV, V21, P28, DOI 10.1016/S0003-3472(73)80037-5; LEMON RE, 1971, ANIM BEHAV, V19, P1, DOI 10.1016/S0003-3472(71)80129-X; Lim R. H., 2014, THESIS; Magnusdottir EE, 2015, J ACOUST SOC AM, V138, P3362, DOI 10.1121/1.4935517; Magnusdottir EE, 2014, POLAR BIOL, V37, P427, DOI 10.1007/s00300-014-1448-3; Marcoux M, 2007, BEHAV ECOL SOCIOBIOL, V61, P1093, DOI 10.1007/s00265-006-0342-6; Mate BR, 1998, CAN J ZOOL, V76, P863, DOI 10.1139/cjz-76-5-863; MATTILA DK, 1987, J MAMMAL, V68, P880, DOI 10.2307/1381574; MCSWEENEY DJ, 1989, MAR MAMMAL SCI, V5, P139, DOI 10.1111/j.1748-7692.1989.tb00328.x; Mellinger DK, 2011, J ACOUST SOC AM, V129, P4055, DOI 10.1121/1.3531926; Mellinger DK., 2002, ISHMAEL 1 0 USERS GU; Mercado E, 2005, ANIM COGN, V8, P93, DOI 10.1007/s10071-004-0238-7; Mercado E, 2010, J ACOUST SOC AM, V127, P2678, DOI 10.1121/1.3309453; MOBLEY JR, 1988, BEHAV ECOL SOCIOBIOL, V23, P211, DOI 10.1007/BF00302944; Murray A, 2012, MAR MAMMAL SCI, V28, pE41, DOI 10.1111/j.1748-7692.2011.00484.x; Nishiwaki M., 1959, Scientific Reports of the Whales Research Institute Tokyo, VNo. 14, P49; Nishiwaki M., 1962, Scientific Reports of the Whales Research Institute Tokyo, VNo. 16, P19; Nishiwaki M., 1960, Sci Sep Whales Res Inst, V15, P1; Noad MJ, 2000, NATURE, V408, P537, DOI 10.1038/35046199; Norris TF, 1999, J ACOUST SOC AM, V106, P506, DOI 10.1121/1.427071; PAYNE K, 1985, Z TIERPSYCHOL, V68, P89; Payne K., 1983, COMMUNICATION BEHAV, P9; Payne K, 2000, PROGR CHANGING SONGS, P135; Payne R., 1983, COMMUN BEHAV WHALES, V20, P333; PAYNE RS, 1971, SCIENCE, V173, P585, DOI 10.1126/science.173.3997.585; Petroni F, 2010, PHYSICA A, V389, P2280, DOI 10.1016/j.physa.2010.02.004; Reilly SB, 2008, MEGAPTERA NOVAEANGLI; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Sigurjonsson Johann, 1997, Journal of Northwest Atlantic Fishery Science, V22, P271; SILBER GK, 1986, CAN J ZOOL, V64, P2075, DOI 10.1139/z86-316; Simon M, 2010, J ACOUST SOC AM, V128, P3200, DOI 10.1121/1.3495946; Smith JN, 2008, ANIM BEHAV, V76, P467, DOI 10.1016/j.anbehav.2008.02.013; Smith TD, 1999, MAR MAMMAL SCI, V15, P1, DOI 10.1111/j.1748-7692.1999.tb00779.x; Smith Tim D., 2009, NAMMCO Scientific Publications, V7, P161; Stevick PT, 2006, J ZOOL, V270, P244, DOI 10.1111/j.1469-7998.2006.00128.x; Stevick PT, 2016, J MAR BIOL ASSOC UK, V96, P885, DOI 10.1017/S0025315416000321; Stevick PT, 2003, J ZOOL, V259, P231, DOI 10.1017/S0952836902003151; Stimpert AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051214; Stimpert AK, 2011, J ACOUST SOC AM, V129, P476, DOI 10.1121/1.3504708; Suzuki R, 2006, J ACOUST SOC AM, V119, P1849, DOI 10.1121/1.2161827; Tougaard J, 2006, BEHAVIOUR, V143, P239, DOI 10.1163/156853906775900685; TYACK P, 1981, BEHAV ECOL SOCIOBIOL, V8, P105, DOI 10.1007/BF00300822; Van Opzeeland I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073007; Vu ET, 2012, AQUAT BIOL, V14, P175, DOI 10.3354/ab00390; WINN HE, 1981, BEHAV ECOL SOCIOBIOL, V8, P41, DOI 10.1007/BF00302842; WINN HE, 1978, MAR BIOL, V47, P97, DOI 10.1007/BF00395631	82	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210057	10.1371/journal.pone.0210057	http://dx.doi.org/10.1371/journal.pone.0210057			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673737	Green Published, gold, Green Submitted			2022-12-26	WOS:000456442800028
J	Krzyzanowska, DM; Maciag, T; Ossowicki, A; Rajewska, M; Kaczynski, Z; Czerwicka, M; Rabalski, L; Czaplewska, P; Jafra, S				Krzyzanowska, Dorota M.; Maciag, Tomasz; Ossowicki, Adam; Rajewska, Magdalena; Kaczynski, Zbigniew; Czerwicka, Malgorzata; Rabalski, Lukasz; Czaplewska, Paulina; Jafra, Sylwia			Ochrobactrum quorumnocens sp. nov., a quorum quenching bacterium from the potato rhizosphere, and comparative genome analysis with related type strains	PLOS ONE			English	Article							UREASE GENE-CLUSTER; IDENTIFICATION; VIRULENCE; SUBSTITUTIONS; INACTIVATION; GENERATION; PATHOGEN; STANDARD; SIGNAL; ROOTS	Ochrobactrum spp. are ubiquitous bacteria attracting growing attention as important members of microbiomes of plants and nematodes and as a source of enzymes for biotechnology. Strain Ochrobactrum sp. A44(T) was isolated from the rhizosphere of a field-grown potato in Gelderland, the Netherlands. The strain can interfere with quorum sensing (QS) of Gram-negative bacteria through inactivation of N-acyl homoserine lactones (AHLs) and protect plant tissue against soft rot pathogens, the virulence of which is governed by QS. Phylo-genetic analysis based on 16S rRNA gene alone and concatenation of 16S rRNA gene and MLSA genes (groEL and gyrB) revealed that the closest relatives of A44(T) are O. grignonense OgA9a(T), O. thiophenivorans DSM 7216(T), O. pseudogrignonense CCUG 30717(T), O. pituitosum CCUG 50899(T), and O. rhizosphaerae PR17(T). Genomes of all six type strains were sequenced, significantly expanding the possibility of genome-based analyses in Ochrobactrum spp. Average nucleotide identity (ANIb) and genome-to-genome distance (GGDC) values for A44(T) and the related strains were below the single species thresholds (95% and 70%, respectively), with the highest scores obtained for O. pituitosum CCUG 50899(T) (87.31%; 35.6%), O. rhizosphaerae PR17(T) (86.80%; 34.3%), and O. grignonense OgA9a(T) (86.30%; 33.6%). Distinction of A44(T) from the related type strains was supported by chemotaxonomic and biochemical analyses. Comparative genomics revealed that the core genome for the newly sequenced strains comprises 2731 genes, constituting 50-66% of each individual genome. Through phenotype-to-genotype study, we found that the non-motile strain O. thiophenivorans DSM 7216(T) lacks a cluster of genes related to flagella formation. Moreover, we explored the genetic background of distinct urease activity among the strains. Here, we propose to establish a novel species Ochrobactrum quorumnocens, with A44(T) as the type strain (= LMG 30544(T) = PCM 2957(T)).	[Krzyzanowska, Dorota M.; Maciag, Tomasz; Ossowicki, Adam; Rajewska, Magdalena; Jafra, Sylwia] Univ Gdansk, Intercollegiate Fac Biotechnol, Lab Biol Plant Protect, Gdansk, Poland; [Krzyzanowska, Dorota M.; Maciag, Tomasz; Ossowicki, Adam; Rajewska, Magdalena; Rabalski, Lukasz; Czaplewska, Paulina; Jafra, Sylwia] Univ Gdansk, Med Univ Gdansk, Gdansk, Poland; [Kaczynski, Zbigniew; Czerwicka, Malgorzata] Univ Gdansk, Lab Struct Biochem, Fac Chem, Gdansk, Poland; [Rabalski, Lukasz] Univ Gdansk, Intercollegiate Fac Biotechnol, Lab Recombinant Vaccines, Gdansk, Poland; [Czaplewska, Paulina] Univ Gdansk, Intercollegiate Fac Biotechnol, Lab Mass Spectrometry, Gdansk, Poland; [Ossowicki, Adam] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; University of Gdansk; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Jafra, S (corresponding author), Univ Gdansk, Intercollegiate Fac Biotechnol, Lab Biol Plant Protect, Gdansk, Poland.; Jafra, S (corresponding author), Univ Gdansk, Med Univ Gdansk, Gdansk, Poland.	sylwia.jafra@biotech.ug.edu.pl	Ossowicki, Adam/B-6787-2018; Krzyzanowska, Dorota Magdalena/ABA-7067-2021; Rabalski, Lukasz/GON-8553-2022; KNAW, NIOO-KNAW/A-4320-2012	Ossowicki, Adam/0000-0003-1903-9688; Krzyzanowska, Dorota Magdalena/0000-0003-0177-377X; Rabalski, Lukasz/0000-0002-5292-9263; Maciag, Tomasz/0000-0002-4019-5944; Jafra, Sylwia/0000-0002-4194-6180; Kaczynski, Zbigniew/0000-0002-4590-4690; KNAW, NIOO-KNAW/0000-0002-3835-159X; Czaplewska, Paulina/0000-0002-6469-6014; Rajewska, Magdalena/0000-0001-7322-2374	National Science Centre, Poland (Narodowe Centrum Nauki, Polska) [2014/13/B/NZ9/02136]; personal scholarship START 2017 - Foundation for Polish Science (FNP) [START 40.2017]	National Science Centre, Poland (Narodowe Centrum Nauki, Polska); personal scholarship START 2017 - Foundation for Polish Science (FNP)	This study was funded by the National Science Centre, Poland (Narodowe Centrum Nauki, Polska) research grant 2014/13/B/NZ9/02136 to SJ. DK was supported by a personal scholarship START 2017 (START 40.2017) granted by the Foundation for Polish Science (FNP).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aujoulat F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083376; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Bohlin J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-249; Cegelski L, 2009, NAT REV MICROBIOL, V7, P836, DOI 10.1038/nrmicro2244; Chain PSG, 2011, J BACTERIOL, V193, P4274, DOI 10.1128/JB.05335-11; CHATTERJEE A, 1995, APPL ENVIRON MICROB, V61, P1959, DOI 10.1128/AEM.61.5.1959-1967.1995; Czajkowski R, 2011, ENV MICROBIOL REP, V3, P59, DOI 10.1111/j.1758-2229.2010.00188.x; De Reuse H, 2001, NITROGEN METABOLISM; deKoningWard TF, 1997, FEMS MICROBIOL LETT, V147, P221, DOI 10.1016/S0378-1097(96)00528-9; Dirksen P, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0258-1; Dziewit L, 2015, METHODS MOL BIOL, V1231, P15, DOI 10.1007/978-1-4939-1720-4_2; Fujii T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14276; FUQUA WC, 1994, J BACTERIOL, V176, P2796, DOI 10.1128/JB.176.10.2796-2806.1994; Galens K, 2011, STAND GENOMIC SCI, V4, P244, DOI 10.4056/sigs.1223234; Gohil KN, 2016, GENOM DATA, V8, P72, DOI 10.1016/j.gdata.2016.04.003; Grandclement C, 2016, FEMS MICROBIOL REV, V40, P86, DOI 10.1093/femsre/fuv038; Guimaraes LC, 2015, CURR GENOMICS, V16, P245, DOI 10.2174/1389202916666150423002311; Harrison PW, 2010, TRENDS MICROBIOL, V18, P141, DOI 10.1016/j.tim.2009.12.010; HOLMES B, 1988, INT J SYST BACTERIOL, V38, P406, DOI 10.1099/00207713-38-4-406; Huang SW, 2012, INT J MOL SCI, V13, P2563, DOI 10.3390/ijms13032563; Huber B, 2010, INT J SYST EVOL MICR, V60, P321, DOI 10.1099/ijs.0.011668-0; Jafra S, 2006, CAN J MICROBIOL, V52, P1006, DOI 10.1139/W06-062; Jafra S, 2004, J MICROBIOL METH, V57, P415, DOI 10.1016/j.mimet.2004.01.015; Kampfer P, 2008, INT J SYST EVOL MICR, V58, P1426, DOI 10.1099/ijs.0.65407-0; Kampfer P, 2007, INT J SYST EVOL MICR, V57, P2513, DOI 10.1099/ijs.0.65066-0; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kulkarni G, 2017, J INFECT PUBLIC HEAL, V10, P201, DOI 10.1016/j.jiph.2016.04.013; Kulkarni G, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-7; Kulkarni GJ, 2014, FEMS MICROBIOL LETT, V359, P12, DOI 10.1111/1574-6968.12549; Kumar SS, 2012, J HAZARD MATER, V199, P58, DOI 10.1016/j.jhazmat.2011.10.053; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lebuhn M, 2000, INT J SYST EVOL MICR, V50, P2207, DOI 10.1099/00207713-50-6-2207; Li L, 2016, ARCH MICROBIOL, V198, P171, DOI 10.1007/s00203-015-1170-8; McMillan DJ, 1998, GENE, V208, P243, DOI 10.1016/S0378-1119(97)00651-3; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; Niu B, 2017, P NATL ACAD SCI USA, V114, pE2450, DOI 10.1073/pnas.1616148114; Paulucci NS, 2015, MICROBIOL RES, V173, P1, DOI 10.1016/j.micres.2014.12.012; PIRHONEN M, 1993, EMBO J, V12, P2467, DOI 10.1002/j.1460-2075.1993.tb05901.x; Pohlner M, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.00541-17; Pozo C, 2002, J APPL MICROBIOL, V92, P1028, DOI 10.1046/j.1365-2672.2002.01613.x; Qiu XH, 2006, J APPL MICROBIOL, V101, P986, DOI 10.1111/j.1365-2672.2006.03016.x; Ramette A, 2011, SYST APPL MICROBIOL, V34, P180, DOI 10.1016/j.syapm.2010.10.005; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rossello-Mora R, 2017, ANTON LEEUW INT J G, V110, P455, DOI 10.1007/s10482-017-0841-7; Sambrook J, 2001, MOL CLONING LAB MANU; Sangari FJ, 2007, INFECT IMMUN, V75, P774, DOI 10.1128/IAI.01244-06; Scholz HC, 2008, SYST APPL MICROBIOL, V31, P1, DOI 10.1016/j.syapm.2007.10.004; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Sipahutar MK, 2017, J HAZARD MATER, V329, P38, DOI 10.1016/j.jhazmat.2017.01.020; Sonke T, 2005, APPL ENVIRON MICROB, V71, P7961, DOI 10.1128/AEM.71.12.7961-7973.2005; Sumayo M, 2013, PLANT PATHOLOGY J, V29, P174, DOI 10.5423/PPJ.SI.09.2012.0143; Swift Simon, 2008, P179, DOI 10.1007/978-3-540-74921-9_7; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tatusova T, 2016, NUCLEIC ACIDS RES, V44, P6614, DOI 10.1093/nar/gkw569; Teyssier C, 2005, J MED MICROBIOL, V54, P945, DOI 10.1099/jmm.0.46116-0; Toffanin A, 2002, ARCH MICROBIOL, V177, P290, DOI 10.1007/s00203-001-0392-0; Trujillo ME, 2005, APPL ENVIRON MICROB, V71, P1318, DOI 10.1128/AEM.71.3.1318-1327.2005; Velasco J, 1998, INT J SYST EVOL MICR, V48; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P185, DOI 10.1111/j.1574-6968.1998.tb13044.x; Wozniak-Karczewska M, 2018, NEW BIOTECHNOL, V43, P37, DOI 10.1016/j.nbt.2017.07.006; Zurdo-Pineiro JL, 2007, INT J SYST EVOL MICR, V57, P784, DOI 10.1099/ijs.0.64613-0	65	15	15	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210874	10.1371/journal.pone.0210874	http://dx.doi.org/10.1371/journal.pone.0210874			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668584	Green Published, Green Submitted, gold			2022-12-26	WOS:000456306400022
J	Yuan, ZY; Yan, JM; Wen, HY; Deng, XY; Li, XB; Su, ST				Yuan, Zhenya; Yan, Junmei; Wen, Hongyu; Deng, Xiaoyi; Li, Xianbin; Su, Siting			Feeding intolerance alters the gut microbiota of preterm infants	PLOS ONE			English	Article							NECROTIZING ENTEROCOLITIS; HEALTH; PROBIOTICS; HOST; CATALOG	Feeding intolerance (FI) is a common disease in preterm infants, often causing a delay in individual development. Gut microbiota play an important role in nutrient absorption and metabolism of preterm infants. To date, few studies have focused on the community composition of gut microbiota of preterm infants with feeding intolerance. In this study, we collected fecal samples from 41 preterm infants diagnosed with feeding intolerance and 29 preterm infants without feeding intolerance, at three specific times during the development and prevalence of feeding intolerance (after birth, when feeding intolerance was diagnosed, after feeding intolerance was gone), from different hospitals for 16S rRNA gene sequencing. The gut microbiota community composition of preterm infants diagnosed with feeding intolerance was significantly different from that of preterm infants without feeding intolerance. At the time when feeding intolerance was diagnosed, the relative abundance of Klebsiella in preterm infants with feeding intolerance increased significantly, and was significantly higher than that of the preterm infants without feeding intolerance. After feeding intolerance was cured, the relative abundance of Klebsiella significantly decreased in the infants diagnosed with feeding intolerance, while the relative abundance of Klebsiella in preterm infants without feeding intolerance was not significantly altered during the development and prevalence of feeding intolerance. Furthermore, we verified that Klebsiella was effective in the diagnosis of feeding intolerance (AUC = 1) in preterm infants, suggesting that Klebsiella is a potential diagnostic biomarker for feeding intolerance.	[Yuan, Zhenya; Wen, Hongyu; Li, Xianbin; Su, Siting] Jiangsu Normal Univ, Sch Life Sci, Xuzhou, Jiangsu, Peoples R China; [Yuan, Zhenya; Yan, Junmei; Deng, Xiaoyi] Xuzhou Matern & Child Hlth Care Hosp, Xuzhou, Jiangsu, Peoples R China	Jiangsu Normal University	Wen, HY (corresponding author), Jiangsu Normal Univ, Sch Life Sci, Xuzhou, Jiangsu, Peoples R China.	wenhy@jsnu.edu.cn		Yuan, Zhenya/0000-0003-2724-6003				Althani AA, 2016, J CELL PHYSIOL, V231, P1688, DOI 10.1002/jcp.25284; Amarachintha S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19868-z; Biedermann L, 2015, EUR J PEDIATR, V174, P151, DOI 10.1007/s00431-014-2476-2; Brooks DH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00328-7; Budden KF, 2017, NAT REV MICROBIOL, V15, P55, DOI 10.1038/nrmicro.2016.142; Chen CM, 2012, PEDIATR NEONATOL, V53, P2, DOI 10.1016/j.pedneo.2011.11.002; Cong Xiaomei, 2016, Yale Journal of Biology and Medicine, V89, P299; Dang S, 2015, J PERINATOL, V35, P447, DOI 10.1038/jp.2014.234; Dessi A, 2016, EXPERT REV MOL DIAGN, V16, P1053, DOI 10.1080/14737159.2016.1211933; Dobbler PT, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02243; Fanaro S, 2013, EARLY HUM DEV, V2, P13; Gensollen T, 2016, SCIENCE, V352, P539, DOI 10.1126/science.aad9378; Grishin A, 2016, J PEDIATR SURG, V51, P13, DOI 10.1016/j.jpedsurg.2015.10.006; Jacob JA, 2016, JAMA-J AM MED ASSOC, V315, P2264, DOI 10.1001/jama.2016.4341; Kuhre RE, 2018, MOL METAB, V11, P84, DOI 10.1016/j.molmet.2018.03.007; Lim ES, 2015, NAT MED, V21, P1228, DOI 10.1038/nm.3950; Litvak Y, 2017, CURR OPIN MICROBIOL, V39, P1, DOI 10.1016/j.mib.2017.07.003; Martin R, 2014, VIRULENCE, V5, P413, DOI 10.4161/viru.27864; Moore Tiffany A, 2011, Adv Neonatal Care, V11, P149, DOI 10.1097/ANC.0b013e31821ba28e; Nagpal R, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01997; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Neuman H, 2018, FEMS MICROBIOL REV, V42, P489, DOI 10.1093/femsre/fuy018; Oncel MY, 2015, J MATERN-FETAL NEO M, V28, P1790, DOI 10.3109/14767058.2014.968842; Pammi M, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0248-8; Patel RM, 2013, CLIN PERINATOL, V40, P11, DOI 10.1016/j.clp.2012.12.002; Putignani L, 2014, PEDIATR RES, V76, P2, DOI 10.1038/pr.2014.49; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rusconi B, 2017, J PEDIATR-US, V189, P40, DOI 10.1016/j.jpeds.2017.05.075; Sancak S, 2016, J MATERN-FETAL NEO M, V29, P1853, DOI 10.3109/14767058.2015.1066327; Sanchez B, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600240; Sanders ME, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0629-z; Simioni J, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0724-5; Tamburini S, 2016, NAT MED, V22, P713, DOI 10.1038/nm.4142; Trampert DC, 2018, BBA MOL CELL RES; von Mutius E, 2017, NAT MED, V23, P274, DOI 10.1038/nm.4299; Wang JF, 2018, GUT, V67, P1614, DOI 10.1136/gutjnl-2018-315988; Wen HY, 2018, J MICROBIOL BIOTECHN, V28, P652, DOI 10.4014/jmb.1711.11065	37	12	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210609	10.1371/journal.pone.0210609	http://dx.doi.org/10.1371/journal.pone.0210609			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668607	gold, Green Published, Green Submitted			2022-12-26	WOS:000456306400008
J	Ruffman, T; Then, R; Cheng, C; Imuta, K				Ruffman, Ted; Then, Rebecca; Cheng, Christie; Imuta, Kana			Lifespan differences in emotional contagion while watching emotion-eliciting videos	PLOS ONE			English	Article							EARLY PROSOCIAL BEHAVIOR; YOUNG-CHILDREN; SEE OTHERS; 1ST YEAR; DISTRESS; EMPATHY; AGE; SYMPATHY; INFANTS; MIND	Previous research has examined empathic concern by presenting toddlers with a sad stimulus and examining their emotional response, with the conclusion that toddlers display empathy. Yet, such research has failed to include basic control conditions involving some other aversive stimulus such as white noise. Nor has it compared toddlers to adults to examine potential development in empathy. In the present study, we showed toddlers and adults four video types: infant crying, infant laughing, infant babbling, and a neutral infant accompanied by white noise. We then coded happiness and sadness while viewing the videos, and created a difference score (happiness minus sadness), testing 52 toddlers and 61 adults. Whereas adults showed more sadness towards infant crying than any other stimulus, toddlers' response to crying and white noise was similar. Thus, the toddler response to crying was comparable to previous studies (slight sadness), but was no different to white noise and was significantly reduced relative to adults. As such, toddlers' response seemed to be better characterized as a reaction to an aversive stimulus rather than empathy.	[Ruffman, Ted; Then, Rebecca; Cheng, Christie] Univ OtagoDunedin, Dept Psychol, Dunedin, New Zealand; [Imuta, Kana] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia	University of Queensland	Ruffman, T (corresponding author), Univ OtagoDunedin, Dept Psychol, Dunedin, New Zealand.	tedr@psy.otago.ac.nz		Ruffman, Ted/0000-0001-8790-6451	Royal Marsden NHS Foundation Trust [15-UOO-185]	Royal Marsden NHS Foundation Trust(Royal Society of New ZealandMarsden Fund (NZ))	This work was supported by the Royal Marsden NHS Foundation Trust grant 15-UOO-185 to TR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AK, 2007, SOC COGN AFFECT NEUR, V2, P71, DOI 10.1093/scan/nsm022; Bailey PE, 2009, PSYCHOL AGING, V24, P224, DOI 10.1037/a0014112; Bischof-Kohler D, 2012, EMOT REV, V4, P40, DOI 10.1177/1754073911421377; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Brownell CA, 2013, INFANCY, V18, P91, DOI 10.1111/j.1532-7078.2012.00125.x; Brownell CA, 2009, INFANCY, V14, P117, DOI 10.1080/15250000802569868; Christov-Moore L, 2014, NEUROSCI BIOBEHAV R, V46, P604, DOI 10.1016/j.neubiorev.2014.09.001; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Davidov M, 2013, CHILD DEV PERSPECT, V7, P126, DOI 10.1111/cdep.12028; Dienes Z., 2017, MAKING MOST YOUR DAT; EISENBERG N, 1989, J PERS SOC PSYCHOL, V57, P55, DOI 10.1037/0022-3514.57.1.55; Gilbert HR, 1996, INT J PEDIATR OTORHI, V34, P237, DOI 10.1016/0165-5876(95)01273-7; Hauser DJ, 2016, BEHAV RES METHODS, V48, P400, DOI 10.3758/s13428-015-0578-z; Hepach R, 2016, CHILD DEV, V87, P1703, DOI 10.1111/cdev.12633; Hepach R, 2012, PSYCHOL SCI, V23, P967, DOI 10.1177/0956797612440571; Huhnel I, 2014, J EXP SOC PSYCHOL, V50, P136, DOI 10.1016/j.jesp.2013.09.011; Imuta K, 2016, DEV PSYCHOL, V52, P1192, DOI 10.1037/dev0000140; Kartner J, 2010, DEV PSYCHOL, V46, P905, DOI 10.1037/a0019718; Krevans J, 1996, CHILD DEV, V67, P3263, DOI 10.1111/j.1467-8624.1996.tb01913.x; Kumar S, 2008, J ACOUST SOC AM, V124, P3810, DOI 10.1121/1.3006380; MARTIN GB, 1982, DEV PSYCHOL, V18, P3, DOI 10.1037/0012-1649.18.1.3; Nichols SR, 2015, INFANCY, V20, P70, DOI 10.1111/infa.12066; Nichols Sara R, 2009, Cogn Brain Behav, V13, P449; Parsons CE, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01440; Preuschoff K, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00115; PROVINE RR, 1992, B PSYCHONOMIC SOC, V30, P1; Reuter C, 2011, J ACOUST SOC AM, V130; Richter D, 2011, PSYCHOL AGING, V26, P60, DOI 10.1037/a0021138; Roth-Hanania R, 2011, INFANT BEHAV DEV, V34, P447, DOI 10.1016/j.infbeh.2011.04.007; Rothganger H, 2003, EARLY HUM DEV, V75, P55, DOI 10.1016/j.earlhumdev.2003.09.003; Ruffman T, 2006, BRIT J DEV PSYCHOL, V24, P105, DOI 10.1348/026151005X82848; Ruffman T, 2002, CHILD DEV, V73, P734, DOI 10.1111/1467-8624.00435; Ruffman T, 2017, CHILD DEV PERSPECT, V11, P270, DOI 10.1111/cdep.12244; Ruffman T, 2014, DEV REV, V34, P265, DOI 10.1016/j.dr.2014.04.001; SAGI A, 1976, DEV PSYCHOL, V12, P175, DOI 10.1037/0012-1649.12.2.175; SHERMAN LW, 1975, CHILD DEV, V46, P53; SIMNER ML, 1971, DEV PSYCHOL, V5, P136, DOI 10.1037/h0031066; Staff RT, 2014, INTELLIGENCE, V47, P194, DOI 10.1016/j.intell.2014.09.013; Svetlova M, 2010, CHILD DEV, V81, P1814, DOI 10.1111/j.1467-8624.2010.01512.x; Trommsdorff G, 2007, INT J BEHAV DEV, V31, P284, DOI 10.1177/0165025407076441; Vaish A, 2009, DEV PSYCHOL, V45, P534, DOI 10.1037/a0014322; Volbrecht MM, 2007, J GENET PSYCHOL, V168, P105, DOI 10.3200/GNTP.168.2.105-130; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Waugh WE, 2017, INFANCY, V22, P665, DOI 10.1111/infa.12189; Young SK, 1999, DEV PSYCHOL, V35, P1189, DOI 10.1037/0012-1649.35.5.1189; ZAHNWAXLER C, 1992, DEV PSYCHOL, V28, P1038, DOI 10.1037/0012-1649.28.6.1038; ZAHNWAXLER C, 1992, DEV PSYCHOL, V28, P126, DOI 10.1037/0012-1649.28.1.126	47	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0209253	10.1371/journal.pone.0209253	http://dx.doi.org/10.1371/journal.pone.0209253			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8XI	30657754	gold, Green Published, Green Submitted			2022-12-26	WOS:000456017000005
J	Kechavarzi, BD; Wu, HM; Doman, TN				Kechavarzi, Bobak D.; Wu, Huanmei; Doman, Thompson N.			Bottom-up, integrated -omics analysis identifies broadly dosage-sensitive genes in breast cancer samples from TCGA	PLOS ONE			English	Article								The massive genomic data from The Cancer Genome Atlas (TCGA), including proteomics data from Clinical Proteomic Tumor Analysis Consortium (CPTAC), provides a unique opportunity to study cancer systematically. While most observations are made from a single type of genomics data, we apply big data analytics and systems biology approaches by simultaneously analyzing DNA amplification, mRNA and protein abundance. Using multiple genomic profiles, we have discovered widespread dosage compensation for the extensive aneuploidy observed in TCGA breast cancer samples. We do identify 11 genes that show strong correlation across all features (DNA/mRNA/protein) analogous to that of the well-known oncogene HER2 (ERBB2). These genes are generally less well-characterized regarding their role in cancer and we advocate their further study. We also discover that shRNA knockdown of these genes has an impact on cancer cell growth, suggesting a vulnerability that could be used for cancer therapy. Our study shows the advantages of systematic big data methodologies and also provides future research directions.	[Kechavarzi, Bobak D.; Wu, Huanmei; Doman, Thompson N.] Indiana Univ Purdue Univ, Sch Informat & Comp, Indianapolis, IN 46202 USA; [Kechavarzi, Bobak D.; Doman, Thompson N.] Eli Lilly, Indianapolis, IN 46241 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Eli Lilly	Kechavarzi, BD (corresponding author), Indiana Univ Purdue Univ, Sch Informat & Comp, Indianapolis, IN 46202 USA.; Kechavarzi, BD (corresponding author), Eli Lilly, Indianapolis, IN 46241 USA.	bkechava@indiana.edu		Wu, Huanmei/0000-0003-0346-6044	Eli Lilly	Eli Lilly(Eli Lilly)	The authors received no specific funding for this work. Eli Lilly provided support in the form of salaries for authors BDK and TND. The funder provided tuition reimbursement for BDK. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bloomfield M, 2016, MOL CYTOGENET, V9, DOI 10.1186/s13039-016-0297-x; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; Dumaual CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072977; Edwards NJ, 2016, PROTEIN REPORTS CPTA; Ellis MJ, 2013, CANCER DISCOV, V3, P1108, DOI 10.1158/2159-8290.CD-13-0219; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Garcia-Murillas I, 2014, ONCOGENE, V33, P2478, DOI 10.1038/onc.2013.202; Giam M, 2015, CELL DIV, V10, DOI 10.1186/s13008-015-0009-7; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Harris H, 2008, J CELL SCI, V121, P3, DOI 10.1242/jcs.025742; Laddha SV, 2014, MOL CANCER RES, V12, P485, DOI 10.1158/1541-7786.MCR-13-0614; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; National Cancer Institute National Human Genome Research Institute, 2010, CANC GEN ATL; OConnor C, 2008, NATURE ED, V1, P172; Parris TZ, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.8; Rasool N, 2010, CLIN CANCER RES, V16, P600, DOI 10.1158/1078-0432.CCR-09-1979; Reiter L, 2009, MOL CELL PROTEOMICS, V8, P2405, DOI 10.1074/mcp.M900317-MCP200; Santaguida S, 2015, NAT REV MOL CELL BIO, V16, P473, DOI 10.1038/nrm4025; Slattery ML, 2011, MUTAT RES-FUND MOL M, V706, P13, DOI 10.1016/j.mrfmmm.2010.10.005; Society AC, 2015, CANC FACTS FIGURES 2; Tabach Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014632; Tanaka S, 1997, CANCER RES, V57, P28; Technologies N, 2009, REF GEN NORM EXPR DA; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Torres EM, 2016, ELIFE, V5, DOI 10.7554/eLife.10996; Tuller T, 2007, PLOS COMPUT BIOL, V3, P2510, DOI 10.1371/journal.pcbi.0030248; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59	30	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210910	10.1371/journal.pone.0210910	http://dx.doi.org/10.1371/journal.pone.0210910			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653567	Green Published, gold, Green Submitted			2022-12-26	WOS:000456015500087
J	Wagner, AO; Friedrich, V; Barthels, C; Marconi, P; Blutke, A; Brombacher, F; Brocker, T				Wagner, Ana Ogrinc; Friedrich, Verena; Barthels, Christian; Marconi, Peggy; Blutke, Andreas; Brombacher, Frank; Brocker, Thomas			Strain specific maturation of Dendritic cells and production of IL-1 beta controls CD40-driven colitis	PLOS ONE			English	Article							REGULATORY T-CELLS; INFLAMMATORY-BOWEL-DISEASE; SOLUBLE CD40 LIGAND; TRANSCRIPTION-FACTOR; TGF-BETA; INTESTINAL INFLAMMATION; SIGNALING CONTROLS; CD103(+) DCS; TH1 CELLS; REG-CELLS	Intestinal integrity is maintained by balanced numbers of CD103(+) Dendritic cells (DCs), which generate peripherally induced regulatory T cells (iTregs). We have developed a mouse model where DC-specific constitutive CD40 signals caused a strong reduction of CD103(+) DCs in the lamina propria (LP) and intestinal lymph nodes (LN). As a consequence, also iTregs were strongly reduced and transgenic mice on the C57Bl/6-background (B6) developed fatal colitis. Here we describe that transgenic mice on a pure Balb/c-background (B/c) do not show any pathologies, while transgenic C57Bl/6 x Balb/c (F1) mice develop weak colon inflammation, without fatal colitis. This graded pathology correlated with the effects of CD40-signalling on DCs in each background, with striking loss of CD103(+) DCs in B6, but reduced in F1 and diminished in B/c background. We further show direct correlation of CD103(+) DC-numbers with numbers of iTregs, the frequencies of which behave correspondingly. Striking effects on B6-DCs reflected robust loss of surface MHCII, known to be crucial for iTreg induction. Furthermore, elevated levels of IL-23 together with IL-1, found only in B6 mice, support generation of intestinal IFN-gamma(+) IL-17(+) Th17 cells and IFN-gamma(+) Th1 cells, responsible for onset of disease. Together, this demonstrates a novel aspect of colitis-control, depending on genetic background. Moreover, strain-specific environmental sensing might alter the CD103(+) DC/iTreg-axis to tip intestinal homeostatic balance to pathology.	[Wagner, Ana Ogrinc; Friedrich, Verena; Barthels, Christian; Brocker, Thomas] Ludwig Maximilians Univ Munchen, Fac Med, Inst Immunol, Planegg Martinsried, Germany; [Marconi, Peggy] Univ Ferrara, Dept Chem & Pharmaceut Sci, Ferrara, Italy; [Blutke, Andreas] Helmholtz Zentrum Munchen, Res Unit Analyt Pathol, Neuherberg, Germany; [Brombacher, Frank] Univ Cape Town, Div Immunol, Cape Town, South Africa; [Brombacher, Frank] South African Med Res Council, Cape Town, South Africa; [Brombacher, Frank] Cape Town Component, Int Ctr Genet Engn & Biotechnol, Cape Town, South Africa	University of Munich; University of Ferrara; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Cape Town; South African Medical Research Council; International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town	Brocker, T (corresponding author), Ludwig Maximilians Univ Munchen, Fac Med, Inst Immunol, Planegg Martinsried, Germany.	brocker@lmu.de		Marconi, Peggy C. R./0000-0003-3488-0491; Brocker, Thomas/0000-0001-7060-5433	Deutsche Forschungsgemeinschaft [SFB1054 B03]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft SFB1054 B03 to T.B.	Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Ahlfors H, 2014, J IMMUNOL, V193, P4602, DOI 10.4049/jimmunol.1401244; Ai TL, 2014, IMMUNOL REV, V259, P60, DOI 10.1111/imr.12171; Awasthi A, 2003, J EXP MED, V197, P1037, DOI 10.1084/jem.20022033; Barthels C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14715; Boeglin E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025542; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cerovic V, 2013, MUCOSAL IMMUNOL, V6, P104, DOI 10.1038/mi.2012.53; Cerovic V, 2014, TRENDS IMMUNOL, V35, P270, DOI 10.1016/j.it.2014.04.003; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Danese S, 2004, GUT, V53, P1035, DOI 10.1136/gut.2003.026278; Danese S, 2003, GUT, V52, P1435, DOI 10.1136/gut.52.10.1435; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Esterhazy D, 2016, NAT IMMUNOL, V17, P545, DOI 10.1038/ni.3408; Fransen F, 2015, IMMUNITY, V43, P527, DOI 10.1016/j.immuni.2015.08.011; Gerosa F, 1996, J EXP MED, V183, P2559, DOI 10.1084/jem.183.6.2559; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gonsky R, 2014, INFLAMM BOWEL DIS, V20, P1794, DOI 10.1097/MIB.0000000000000172; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Harbour SN, 2015, P NATL ACAD SCI USA, V112, P7061, DOI 10.1073/pnas.1415675112; Hart AL, 2005, GASTROENTEROLOGY, V129, P50, DOI 10.1053/j.gastro.2005.05.013; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Homig-Holzel C, 2008, J EXP MED, V205, P1317, DOI 10.1084/jem.20080238; Hurdayal R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003699; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kasran A, 2005, ALIMENT PHARM THER, V22, P111, DOI 10.1111/j.1365-2036.2005.02526.x; Kishi Y, 2016, J EXP MED, V213, P2489, DOI 10.1084/jem.20151118; Krausgruber T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11627; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu T, 2002, INFECT IMMUN, V70, P6638, DOI 10.1128/IAI.70.12.6638-6645.2002; Liu ZJ, 1999, J IMMUNOL, V163, P4049; Liu ZJ, 2000, J IMMUNOL, V164, P6005, DOI 10.4049/jimmunol.164.11.6005; Loschko J, 2016, J EXP MED, V213, P517, DOI 10.1084/jem.20160062; Ludwiczek O, 2003, INT J COLORECTAL DIS, V18, P142, DOI 10.1007/s00384-002-0425-4; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Morrison PJ, 2013, MUCOSAL IMMUNOL, V6, P1143, DOI 10.1038/mi.2013.11; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Peters A, 2011, CURR OPIN IMMUNOL, V23, P702, DOI 10.1016/j.coi.2011.08.007; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Sellers RS, 2012, VET PATHOL, V49, P32, DOI 10.1177/0300985811429314; Shouval DS, 2016, GASTROENTEROLOGY, V151, P1100, DOI 10.1053/j.gastro.2016.08.055; Shouval DS, 2014, IMMUNITY, V40, P706, DOI 10.1016/j.immuni.2014.03.011; Stockinger B, 2017, NAT REV IMMUNOL, V17, P535, DOI 10.1038/nri.2017.50; Stuber E, 1996, J EXP MED, V183, P693, DOI 10.1084/jem.183.2.693; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Swee LK, 2009, BLOOD, V113, P6277, DOI 10.1182/blood-2008-06-161026; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Trinchieri G, 2007, J EXP MED, V204, P239, DOI 10.1084/jem.20070104; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; van Driel B, 2012, GASTROENTEROLOGY, V143, P1544, DOI 10.1053/j.gastro.2012.08.042; Watanabe H, 2004, SHOCK, V22, P460, DOI 10.1097/01.shk.0000142249.08135.e9; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012	67	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210998	10.1371/journal.pone.0210998	http://dx.doi.org/10.1371/journal.pone.0210998			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653608	gold, Green Published, Green Submitted			2022-12-26	WOS:000456015500095
